JP2002293764A - Aminoethanol derivative - Google Patents
Aminoethanol derivativeInfo
- Publication number
- JP2002293764A JP2002293764A JP2002017487A JP2002017487A JP2002293764A JP 2002293764 A JP2002293764 A JP 2002293764A JP 2002017487 A JP2002017487 A JP 2002017487A JP 2002017487 A JP2002017487 A JP 2002017487A JP 2002293764 A JP2002293764 A JP 2002293764A
- Authority
- JP
- Japan
- Prior art keywords
- group
- ethyl
- substituent
- compound
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、コレステリルエス
テル転送蛋白阻害を示す新規アミノエタノール誘導体な
どに関する。TECHNICAL FIELD The present invention relates to a novel aminoethanol derivative showing cholesteryl ester transfer protein inhibition and the like.
【0002】[0002]
【従来の技術】高コレステロール血症、特に血清中の低
密度リポ蛋白(LDL)−コレステロールが高いことが
動脈硬化性疾患(例、心筋梗塞、狭心症、脳梗塞など)
の危険因子であることは、数多くの疫学調査によって明
らかにされている。血清LDL−コレステロールを低下
させる薬剤としては、3−ヒドロキシ−3−メチルグル
タリルコエンザイムA(HMG−CoA)還元酵素を阻
害する薬剤が臨床において用いられており、冠動脈疾患
が発生する率の低下に対して一定の効果があることが大
規模臨床試験において明らかになっている(N.Eng
l.J.Med.,34,498-511(199
9))が、その効果は十分に満足できるものではない。
一方、血清中の高密度リポ蛋白(HDL)−コレステロ
ール濃度が冠動脈疾患の発生率と逆相関を示すことが疫
学的に知られており(N.Engl.J.Med.,3
21,1311-1316(1989),Am.Hea
rt J.,110,1100-1107(198
5))、血清HDL−コレステロールを上昇させる薬剤
が動脈硬化性疾患を予防、治療するための薬剤として注
目されている。コレステリルエステル転送蛋白(CET
P)はHDLからLDLおよび超低密度リポ蛋白(VL
DL)へのコレステリルエステルの転送を触媒する蛋白
質であり(J.Lipid Res.,34,1255-
1274(1993))、コレステロールの逆転送系、
すなわち末梢組織から肝臓へのコレステロールの転送に
大きく関与している。コレステロールの逆転送系として
は主に以下の3つの経路が知られている。 (1)末梢組織に蓄積した遊離コレステロールはHDL
により引き抜かれ、レシチン−コレステロールアシルト
ランスフェラーゼ(LCAT)の作用を受けてHDL上
でコレステリルエステルに変換される。HDL上のコレ
ステリルエステルはCETPによりLDLやVLDLに
トリグリセリドと交換で転送され、LDL受容体を介し
て肝臓にコレステロールが転送される。 (2)HDLはアポ蛋白E含有HDLとなった後にLD
L受容体を介して肝臓に取り込まれる。 (3)HDL上のコレステリルエステルがHDL受容体
を介して直接肝臓に取り込まれる。CETPはコレステ
ロール逆転送系に大きく関与していることから、その血
中での活性強度は血中HDL−コレステロール濃度制御
に関係があると考えられる。CETPと血中HDL−コ
レステロール濃度との関連に関しては例えば以下の知見
が得られている。ウサギおよびハムスターにおいてCE
TPモノクローナル抗体によりCETP活性を阻害すると血
清HDL−コレステロール濃度が上昇する(J.Cli
n.Invest.,84,129-137(198
9),Atherosclerosis,110,10
1-109(1994))。CETPを発現したトラン
スジェニックマウスおよびトランスジェニックラットに
おいてLDL−コレステロール濃度が上昇する(J.B
iol.Chem.,266,10796-10801
(1991),Nat.Med.,5,1383-13
89(1999))。また、疫学的調査から遺伝子変異
によりCETP活性が減少または欠損した人では血中H
DL−コレステロール濃度が上昇している(Natur
e,342,448-451(1989),Ather
osclerosis,58,175-186(198
5))。2. Description of the Related Art Hypercholesterolemia, in particular, high serum low density lipoprotein (LDL) -cholesterol is caused by arteriosclerotic diseases (eg, myocardial infarction, angina pectoris, cerebral infarction, etc.).
Have been identified in numerous epidemiological studies. As a drug that lowers serum LDL-cholesterol, a drug that inhibits 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase has been used in the clinic, and has been used to reduce the incidence of coronary artery disease. It has been shown in large-scale clinical trials that it has a certain effect (N. Eng
l. J. Med. , 34, 498-511 (199).
9)), but the effect is not sufficiently satisfactory.
On the other hand, it is epidemiologically known that the concentration of high-density lipoprotein (HDL) -cholesterol in serum shows an inverse correlation with the incidence of coronary artery disease (N. Engl. J. Med., 3).
21, 1311-1316 (1989), Am. Hea
rt J.R. , 110, 1100-1107 (198
5)), Drugs that increase serum HDL-cholesterol are receiving attention as drugs for preventing and treating arteriosclerotic diseases. Cholesteryl ester transfer protein (CET
P) from HDL to LDL and very low density lipoprotein (VL)
DL) is a protein that catalyzes the transfer of cholesteryl ester to (DL) (J. Lipid Res., 34, 1255-).
1274 (1993)), a reverse transfer system of cholesterol,
That is, it is greatly involved in the transfer of cholesterol from peripheral tissues to the liver. The following three pathways are mainly known as reverse cholesterol transfer systems. (1) Free cholesterol accumulated in peripheral tissues is HDL
And converted to cholesteryl ester on HDL under the action of lecithin-cholesterol acyltransferase (LCAT). Cholesteryl ester on HDL is transferred by CETP to LDL or VLDL in exchange for triglyceride, and cholesterol is transferred to the liver via LDL receptor. (2) After HDL becomes HDL containing apoprotein E, LD
It is taken up by the liver via the L receptor. (3) Cholesteryl ester on HDL is directly taken into liver via HDL receptor. Since CETP is greatly involved in the reverse cholesterol transfer system, its activity in blood is considered to be related to the control of blood HDL-cholesterol concentration. For example, the following findings have been obtained regarding the relationship between CETP and blood HDL-cholesterol levels. CE in rabbits and hamsters
Inhibition of CETP activity by TP monoclonal antibody increases serum HDL-cholesterol concentration (J. Cli).
n. Invest. , 84, 129-137 (198
9), Atherosclerosis, 110, 10
1-109 (1994)). LDL-cholesterol levels are elevated in CETP-expressing transgenic mice and transgenic rats (JB
iol. Chem. , 266, 10796-10801
(1991), Nat. Med. , 5,1383-13
89 (1999)). In addition, epidemiological studies show that those who have reduced or lost CETP activity due to gene mutation
DL-cholesterol levels are increasing (Natur
e, 342, 448-451 (1989), Ather
osclerosis, 58, 175-186 (198
5)).
【0003】以上の知見からCETP活性強度は動脈硬
化抑制的であるHDL−コレステロールと逆相関の関係
があると考えられ、CETP活性を阻害すれば冠動脈疾
患進展に対する危険度を下げることができると期待され
る。実際、CETP活性は動物種により差があり、CE
TP活性の高い動物(ウサギなど)においてはコレステ
ロール負荷による動脈硬化が惹起されるが、CETPを
有さない動物(ラットなど)では動脈硬化が惹起されに
くいことが知られている。また、ウサギにアンチセンス
RNAを投与することにより持続的にCETP活性を阻
害した場合に、血中HDL−コレステロール濃度が上昇
し、動脈硬化病変の進展が抑制された(J.Biol.
Chem.,273,5033-5036(199
8))。したがって、CETP活性を抑制する薬剤は、
HDLからLDL,VLDLへのコレステロール転送を
阻害し、動脈硬化抑制的であるHDL−コレステロール
を増加させると同時に動脈硬化促進的であるVLDL−
コレステロール,LDL−コレステロールを減少させる
ことにより、動脈硬化性疾患に対して抑制的に働くこと
が期待される。すなわちCETP活性を抑制する薬剤
は、急性冠動脈症候群、急性心筋梗塞、不安定狭心症、
PTCAあるいはステント留置後の動脈再狭窄、末梢動脈閉
塞症、高脂血症、脳梗塞、脳卒中等の疾患を予防または
治療する薬剤、あるいは動脈硬化巣の進展抑制剤になる
ことが期待される。CETP阻害作用を有する薬剤とし
ては、例えば国際特許WO99/41237号、lip
ids,29,811-818(1994)、国際特許
WO98/35937号,Atheroscleros
is,128,59-66(1997)、Bioor
g.Med.Chem.Lett.,6,919-92
2(1996)、米国特許第5,925,645号、米
国特許第5,932,587号、欧州特許825185
号、欧州特許818448号、Angew.Che
m.,Int.Ed.,38,3373-3375(1
999)、国際特許WO99/14174号、国際特許
WO00/18724号、国際特許WO00/1716
4号等に開示されている。[0003] From the above findings, it is considered that the intensity of CETP activity is inversely correlated with HDL-cholesterol, which is an arteriosclerosis-inhibiting agent, and it is expected that inhibiting CETP activity will reduce the risk of developing coronary artery disease. Is done. In fact, CETP activity varies between animal species,
It is known that cholesterol-loaded animals induce arteriosclerosis in animals having high TP activity (such as rabbits), whereas arteriosclerosis is unlikely to occur in animals without CETP (such as rats). In addition, when CETP activity was continuously inhibited by administering antisense RNA to rabbits, blood HDL-cholesterol levels increased, and the progression of arteriosclerotic lesions was suppressed (J. Biol.
Chem. , 273, 5033-5036 (199
8)). Therefore, drugs that suppress CETP activity
It inhibits the transfer of cholesterol from HDL to LDL and VLDL, increases HDL-cholesterol, which is an arteriosclerosis inhibitor, and at the same time, promotes VLDL-, which is an arteriosclerosis inhibitor.
By reducing cholesterol and LDL-cholesterol, it is expected to work in suppressing arteriosclerotic diseases. That is, drugs that suppress CETP activity include acute coronary syndrome, acute myocardial infarction, unstable angina,
It is expected to be a drug to prevent or treat diseases such as arterial restenosis, peripheral arterial occlusion, hyperlipidemia, cerebral infarction, and stroke after PTCA or stent placement, or as an inhibitor of the progression of atherosclerotic lesions. Drugs having CETP inhibitory activity include, for example, International Patent WO99 / 41237, lip
ids, 29, 811-818 (1994), International Patent WO98 / 35937, Atheroscleros.
is, 128, 59-66 (1997), Bioor
g. Med. Chem. Lett. , 6,919-92
2 (1996), US Pat. No. 5,925,645, US Pat. No. 5,932,587, European Patent 825185.
No., EP 818448, Angew. Che
m. , Int. Ed. , 38, 3373-3375 (1
999), International Patent WO99 / 14174, International Patent WO00 / 18724, International Patent WO00 / 1716
No. 4, etc.
【0004】一方、アミノエタノール誘導体としては、
例えば、特開平11−286478号に抗ウイルス剤の
原料となる化合物として、ベンジル-[2(S)-ヒドロ
キシ-2-チアゾール-2-イル-1(S)-(4-トリフル
オロメチル-ベンジル)-エチル]-カルバミン酸 ter
t-ブチルエステルが開示され、また、国際特許WO9
9/45928には自己免疫疾患を改善する作用を有す
る化合物の原料となる化合物が、特開平11−2464
37号には消化管粘膜保護作用を有する化合物の原料と
なる化合物が、国際特許WO98/18794にはキマ
ーゼ阻害作用を有する化合物の原料となる化合物が、L
ett.Pept.Sci.,2,229-232(1
995)にはHIV-1プロテアーゼ阻害作用およびD
PP-IV阻害作用を有する化合物の原料となる化合物
が、国際特許WO93/25574にはアンジオテンシ
ンIキマーゼ阻害作用を有する化合物の原料となる化合
物が、国際特許WO89/10752にはレトロウイル
スプロテアーゼ阻害作用を有する化合物の原料となる化
合物が、欧州特許第231919号にはレニン阻害作用
を有する化合物が、仏国特許第1578851号にはア
ドレナリン作動作用を有する化合物が、それぞれ開示さ
れているが、これらの化合物が動脈硬化性疾患予防・治
療作用を有することの開示はなく、またそれを示唆する
記述もない。On the other hand, aminoethanol derivatives include:
For example, in Japanese Patent Application Laid-Open No. 11-286478, benzyl- [2 (S) -hydroxy-2-thiazol-2-yl-1 (S)-(4-trifluoromethyl-benzyl) ) -Ethyl] -carbamic acid ter
t-butyl esters have been disclosed and have been described in International Patent
No. 9/45928 discloses a compound as a raw material of a compound having an action of improving an autoimmune disease, which is disclosed in JP-A-11-2464.
No. 37 discloses a compound which is a raw material of a compound having a protective effect on gastrointestinal mucosa, and WO 98/18794 discloses a compound which is a raw material of a compound having a chymase inhibitory effect.
ett. Pept. Sci. , 2,229-232 (1
995) has an inhibitory effect on HIV-1 protease and D
A compound serving as a raw material of a compound having a PP-IV inhibitory action is disclosed in International Patent WO93 / 25574, and a compound serving as a raw material of a compound having an angiotensin I chymase inhibitory action is described in International Patent WO89 / 10752. EP 231919 discloses a compound having a renin-inhibiting action, and French Patent No. 1578851 discloses a compound having an adrenergic action. Does not disclose that it has a preventive / therapeutic action for arteriosclerotic diseases, and there is no description suggesting this.
【0005】[0005]
【発明が解決しようとする課題】血漿HDL-コレステロー
ル(HDL-C)を増加させる薬剤としてはフィブラート系
薬剤、ニコチン酸が使用されているが、いずれもHDL-C
増加作用は間接的であり、また副作用が懸念されてい
る。HDL-コレステロールを直接増加させ、虚血性心およ
び脳疾患、末梢動脈閉塞症などの動脈硬化性疾患の予防
あるいは治療において、十分に満足できる効果を有する
新規な薬剤の開発が待たれているのが現状である。 発明の開示[0006] Fibrate drugs and nicotinic acid have been used as drugs for increasing plasma HDL-cholesterol (HDL-C), and all of them are HDL-C.
The increasing effect is indirect and side effects are of concern. The development of new drugs that directly increase HDL-cholesterol and have a sufficiently satisfactory effect in the prevention or treatment of atherosclerotic diseases such as ischemic heart and brain diseases and peripheral arterial occlusion is awaited. It is the current situation. Disclosure of the invention
【0006】[0006]
【課題を解決するための手段】本発明者らは、下記の特
異な置換基を有するアミノエタノール誘導体がコレステ
ロールエステルトランスファープロテイン(CETP)を阻
害することにより血漿HDL-Cを増加させ、優れた動脈硬
化性疾患予防・治療作用を発揮することを見い出して、
本研究を完成するに至った。Means for Solving the Problems The present inventors have found that an aminoethanol derivative having the following specific substituents increases plasma HDL-C by inhibiting cholesterol ester transfer protein (CETP), and has an excellent arterial potential. Finding the effect of preventing and treating sclerotic disease,
We have completed this study.
【0007】すなわち本発明は (1)式That is, the present invention provides the following equation (1)
【0008】[0008]
【化7】 Embedded image
【0009】〔式中、Ar1は置換基を有していてもよ
い芳香環基を、Ar2は置換基を有する芳香環基を、O
R’’は保護されていてもよい水酸基を、Rはアシル基
を、R’は水素原子または置換基を有していてもよい炭
化水素基を示す。〕で表される化合物またはその塩(た
だし、ベンジル-[2(S)-ヒドロキシ-2-チアゾール
-2-イル-1(S)-(4-トリフルオロメチル-ベンジ
ル)-エチル]-カルバミン酸 tert-ブチルエステ
ルは除く); (2)Ar1が置換基を有していてもよい5または6員
の芳香環基である前記(1)記載の化合物; (3)Ar1が置換基を有していてもよいフェニル基で
ある前記(1)記載の化合物; (4)Ar2が置換基を有する5または6員の芳香環基
である前記(1)記載の化合物; (5)Ar2が置換基を有するフェニル基である前記
(1)記載の化合物; (6)Rが式 R1NCO−(R1Nは置換基を有していて
もよい炭化水素基または置換基を有していてもよい複素
環基を示す)で表される基である前記(1)記載の化合
物; (7)R1Nが置換基を有していてもよい環状炭化水素基
または置換基を有していてもよい複素環基である前記
(6)記載の化合物; (8)R’’が水素原子またはアシル基である前記
(1)記載の化合物; (9)R’’が式 R1OCO−(R1Oは置換基を有して
いてもよい炭化水素基または置換基を有していてもよい
複素環基を示す)で表される基である前記(1)記載の
化合物; (10)R1Oが置換基を有していてもよいアルキル基で
ある前記(8)記載の化合物; (11)R’’が水素原子である前記(1)記載の化合
物; (12)R’が水素原子である前記(1)記載の化合
物; (13)Rが式 R1NCO−(R1Nは置換基を有してい
てもよい環状炭化水素基または置換基を有していてもよ
い複素環基を示す)で表される基であり、R’’が水素
原子であり、R’が水素原子である前記(1)記載の化
合物; (14)Ar1がハロゲン原子、ハロゲン化されていて
もよい低級アルキル基、ハロゲン化されていてもよい低
級アルコキシ基および置換基を有していてもよいアリー
ルオキシ基から選ばれる置換基を有していてもよい5ま
たは6員の芳香環基であり、Ar2がハロゲン原子、ハ
ロゲン化されていてもよい低級アルキル基およびハロゲ
ン化されていてもよい低級アルコキシ基から選ばれる置
換基を有する5または6員の芳香環基であり、Rがハロ
ゲン原子、ハロゲン化されていてもよいC1-6アルコキ
シおよびハロゲン化されていてもよいC1-6アルキルか
ら選ばれた置換基をそれぞれ有していてもよいC1-6ア
ルコキシ−カルボニル、C1-6アルキル−カルボニル、
C6-10アリール−カルボニル、ジヒドロナフタレンカル
ボニル、テトラヒドロナフタレンカルボニル、ベンゾシ
クロヘプテンカルボニルまたはベンゾシクロオクテンカ
ルボニルであり、R’’が水素原子であり、R’が水素
原子である前記(1)記載の化合物; (15)5または6員の芳香環基がフェニル基、ピリジ
ル基、チエニル基、フリル基またはチアゾリル基である
前記(14)記載の化合物; (16)5または6員の芳香環基がフェニル基、ピリジ
ル基またはチエニル基であり、Rがハロゲン原子、ハロ
ゲン化されていてもよいC1-6アルコキシおよびハロゲ
ン化されていてもよいC1-6アルキルから選ばれた置換
基をそれぞれ有していてもよくナフタレンカルボニル、
ジヒドロナフタレンカルボニル、テトラヒドロナフタレ
ンカルボニル、ベンゾシクロヘプテンカルボニルまたは
ベンゾシクロオクテンカルボニルである前記(14)記
載の化合物;[In the formula, Ar 1 represents an aromatic ring group which may have a substituent, Ar 2 represents an aromatic ring group having a substituent,
R ″ represents a hydroxyl group which may be protected, R represents an acyl group, and R ′ represents a hydrogen atom or a hydrocarbon group which may have a substituent. Or a salt thereof (provided that benzyl- [2 (S) -hydroxy-2-thiazole is
-2-yl-1 (S)-(4-trifluoromethyl-benzyl) -ethyl] -carbamic acid tert-butyl ester); (2) Ar 1 may have a substituent 5 or The compound according to the above (1), which is a 6-membered aromatic ring group; (3) the compound according to the above (1), wherein Ar 1 is a phenyl group which may have a substituent; (4) Ar 2 is substituted A compound according to the above (1), which is a 5- or 6-membered aromatic ring group having a group; (5) a compound according to the above (1), wherein Ar 2 is a phenyl group having a substituent; The compound according to the above (1), which is a group represented by 1N CO— (R 1N represents a hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent); (7) R 1N annular optionally substituted hydrocarbon group or optionally substituted heterocyclic group That the (6) The compound according; a 'has the formula R 1O CO- (R 1O substituent; (8) R''(9) R wherein is a hydrogen atom or an acyl group (1) compound described' A hydrocarbon group which may have or a heterocyclic group which may have a substituent). (10) R 1O has a substituent (11) The compound according to (1), wherein R ″ is a hydrogen atom; (12) the compound according to (1), wherein R ′ is a hydrogen atom (13) R is represented by the formula R 1N CO— (R 1N represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent) that a group, 'are hydrogen atoms, R' R 'wherein is a hydrogen atom (1) the compound according; (14) Ar 1 is a halogen atom, halogenoalkyl A 5- or 6-membered optionally substituted lower alkyl group, an optionally halogenated lower alkoxy group and an optionally substituted aryloxy group An aromatic ring group, wherein Ar 2 is a 5- or 6-membered aromatic ring group having a substituent selected from a halogen atom, an optionally halogenated lower alkyl group and an optionally halogenated lower alkoxy group; , R is a halogen atom, optionally halogenated and C 1-6 alkoxy and halogenated substituents selected from C 1-6 alkyl optionally optionally having respective C 1-6 alkoxy -Carbonyl, C 1-6 alkyl-carbonyl,
The above (1), wherein C 6-10 aryl-carbonyl, dihydronaphthalenecarbonyl, tetrahydronaphthalenecarbonyl, benzocycloheptenecarbonyl or benzocyclooctenecarbonyl, R ″ is a hydrogen atom and R ′ is a hydrogen atom. (15) The compound according to the above (14), wherein the 5- or 6-membered aromatic ring group is a phenyl group, a pyridyl group, a thienyl group, a furyl group or a thiazolyl group; (16) a 5- or 6-membered aromatic ring group Is a phenyl group, a pyridyl group or a thienyl group, and R is a substituent selected from a halogen atom, an optionally halogenated C 1-6 alkoxy and an optionally halogenated C 1-6 alkyl, Naphthalenecarbonyl, which may have
The compound according to the above (14), which is dihydronaphthalenecarbonyl, tetrahydronaphthalenecarbonyl, benzocycloheptenecarbonyl or benzocyclooctenecarbonyl;
【0010】(17)N-[(1RS,2SR)-2-
(4-フルオロフェニル)-2-ヒドロキシ-1-[4-(ト
リフルオロメチル)ベンジル]エチル]-6,7-ジヒド
ロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミ
ド、4-フルオロ-N-((1R,2S)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-((4-(トリフルオ
ロメチル)フェニル)メチル)エチル)-1-ナフタレン
カルボキサミド、N-[(1R,2S)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]エチル]-6,
7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カ
ルボキサミド、N-[(1RS,2SR)-2-(4-フル
オロフェニル)-2-ヒドロキシ-1-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]エチル]-
5,6-ジヒドロナフタレン-1-カルボキサミド、N-
[(1RS,2SR)-2-(4-フルオロフェニル)-2
-ヒドロキシ-1-[3-(1,1,2,2-テトラフルオ
ロエトキシ)ベンジル]エチル]-6,7,8,9-テト
ラヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボ
キサミド、4-フルオロ-N-[(1R,2S)-2-(4-
フルオロフェニル)-2-ヒドロキシ-1-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]エチ
ル]ナフタレン-1-カルボキサミド、N-[(1RS,
2SR)-2-(4-フルオロフェニル)-2-ヒドロキシ-
1-[3-(1,1,2,2-テトラフルオロエトキシ)
ベンジル]エチル]-5,6,7,8-テトラヒドロベン
ゾ[a]シクロオクテン-1-カルボキサミド、N-
[(1RS,2SR)-2-(4-フルオロフェニル)-2
-ヒドロキシ-1-(4-イソプロピルベンジル)エチル]
-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-
1-カルボキサミド、N-((1RS,2SR)-2-(3
-フルオロフェニル)-2-ヒドロキシ-1-((4-(トリ
フルオロメチル)フェニル)メチル)エチル)-6,7-
ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボ
キサミド、N-((1RS,2SR)-2-ヒドロキシ-2
-(4-フェノキシフェニル)-1-((4-(トリフルオ
ロメチル)フェニル)メチル)エチル)-6,7-ジヒド
ロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミ
ド、N-[(1RS,2SR)-2-(4-クロロフェニ
ル)-2-ヒドロキシ-1-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]エチル]-6,7-ジヒド
ロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミ
ド、N-((1RS,2SR)-2-ヒドロキシ-2-(4-
(フェニルオキシ)フェニル)-1-((3-((1,
1,2,2-テトラフルオロエチル)オキシ)フェニ
ル)メチル)エチル)-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド、N-((1
RS,2SR)-2-(4-((4-クロロ-3-エチルフェ
ニル)オキシ)フェニル)-2-ヒドロキシ-1-((3-
((1,1,2,2-テトラフルオロエチル)オキシ)
フェニル)メチル)エチル)-6,7-ジヒドロ-5H-ベ
ンゾ[a]シクロヘプテン-1-カルボキサミド、N-
((1RS,2SR)-2-(2-フルオロピリジン-4-
イル)-2-ヒドロキシ-1-((3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル)メチル)エチル)-
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボキサミド、N-((1RS,2RS)-2-(6-
フルオロピリジン-2-イル)-2-ヒドロキシ-1-((3
-(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)エチル)-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド、N−[(1
RS,2SR)−1−(4−tert−ブチルベンジ
ル)−2−(3−クロロフェニル)−2−ヒドロキシエ
チル]−5−クロロ−1−ナフトアミド、4−フルオロ
−N−{(1RS,2SR)−2−(4−フルオロフェ
ニル)−2−ヒドロキシ−1−[(2,2,3,3−テ
トラフルオロ−2,3−ジヒドロ−1,4−ベンゾジオ
キシン−6−イル)メチル]エチル}−1−ナフトアミ
ドまたはその塩である前記(1)記載の化合物; (18)式(17) N-[(1RS, 2SR) -2-
(4-Fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, 4-fluoro-N- ((1R, 2S) -2- (4-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -1-naphthalenecarboxamide, N-[(1R, 2S ) -2- (4-Fluorophenyl) -2-hydroxy-1- [3- (1,1,2,2
2-tetrafluoroethoxy) benzyl] ethyl] -6
7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,
2,2-tetrafluoroethoxy) benzyl] ethyl]-
5,6-dihydronaphthalene-1-carboxamide, N-
[(1RS, 2SR) -2- (4-fluorophenyl) -2
-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7,8,9-tetrahydro-5H-benzo [a] cycloheptene-1-carboxamide, 4- Fluoro-N-[(1R, 2S) -2- (4-
Fluorophenyl) -2-hydroxy-1- [3- (1,
1,2,2-tetrafluoroethoxy) benzyl] ethyl] naphthalene-1-carboxamide, N-[(1RS,
2SR) -2- (4-Fluorophenyl) -2-hydroxy-
1- [3- (1,1,2,2-tetrafluoroethoxy)
[Benzyl] ethyl] -5,6,7,8-tetrahydrobenzo [a] cyclooctene-1-carboxamide, N-
[(1RS, 2SR) -2- (4-fluorophenyl) -2
-Hydroxy-1- (4-isopropylbenzyl) ethyl]
-6,7-dihydro-5H-benzo [a] cycloheptene-
1-carboxamide, N-((1RS, 2SR) -2- (3
-Fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -6,7-
Dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-((1RS, 2SR) -2-hydroxy-2
-(4-phenoxyphenyl) -1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-[(1RS, 2SR) -2- (4-Chlorophenyl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] Cycloheptene-1-carboxamide, N-((1RS, 2SR) -2-hydroxy-2- (4-
(Phenyloxy) phenyl) -1-((3-((1,
1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-((1
RS, 2SR) -2- (4-((4-chloro-3-ethylphenyl) oxy) phenyl) -2-hydroxy-1-((3-
((1,1,2,2-tetrafluoroethyl) oxy)
Phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-
((1RS, 2SR) -2- (2-fluoropyridine-4-
Yl) -2-hydroxy-1-((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) ethyl)-
6,7-dihydro-5H-benzo [a] cycloheptene-1
-Carboxamide, N-((1RS, 2RS) -2- (6-
Fluoropyridin-2-yl) -2-hydroxy-1-((3
-(1,1,2,2-tetrafluoroethoxy) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-[(1
RS, 2SR) -1- (4-tert-butylbenzyl) -2- (3-chlorophenyl) -2-hydroxyethyl] -5-chloro-1-naphthamide, 4-fluoro-N-{(1RS, 2SR) -2- (4-Fluorophenyl) -2-hydroxy-1-[(2,2,3,3-tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-yl) methyl] ethyl} (18) the compound according to the above (1), which is -1-naphthamide or a salt thereof;
【0011】[0011]
【化8】 Embedded image
【0012】〔式中、Ar1は置換基を有していてもよ
い芳香環基を、Ar2は置換基を有する芳香環基を、O
R’’は保護されていてもよい水酸基を、Rはアシル基
を、R’は水素原子または置換基を有していてもよい炭
化水素基を示す。〕で表される化合物またはその塩のプ
ロドラッグ(ただし、ベンジル-[2(S)-ヒドロキシ
-2-チアゾール-2-イル-1(S)-(4-トリフルオロ
メチル-ベンジル)-エチル]-カルバミン酸 tert-
ブチルエステルは除く); (19)式[Wherein, Ar 1 represents an aromatic ring group which may have a substituent, Ar 2 represents an aromatic ring group having a substituent,
R ″ represents a hydroxyl group which may be protected, R represents an acyl group, and R ′ represents a hydrogen atom or a hydrocarbon group which may have a substituent. ] Or a prodrug thereof (provided that benzyl- [2 (S) -hydroxy
-2-thiazol-2-yl-1 (S)-(4-trifluoromethyl-benzyl) -ethyl] -carbamic acid tert-
(Excluding butyl ester);
【0013】[0013]
【化9】 Embedded image
【0014】〔式中、Ar1は置換基を有していてもよ
い芳香環基を、Ar2は置換基を有する芳香環基を、O
R’’は保護されていてもよい水酸基を、Rはアシル基
を、R’は水素原子または置換基を有していてもよい炭
化水素基を示す。〕で表される化合物またはその塩、ま
たはそのプロドラッグを含有してなる医薬組成物; (20)コレステリルエステル転送蛋白阻害剤である前
記(19)記載の組成物; (21)高密度リポ蛋白−コレステロール上昇剤である
前記(19)記載の組成物; (22)低密度リポ蛋白−コレステロール低下剤である
前記(19)記載の組成物; (23)超低密度リポ蛋白−コレステロール低下剤であ
る前記(19)記載の組成物; (24)トリグリセリド低下剤である前記(19)記載
の組成物; (25)急性冠動脈症候群の予防治療剤である前記(1
9)記載の組成物; (26)急性心筋梗塞の予防治療剤である前記(19)
記載の組成物; (27)不安定狭心症の予防治療剤である前記(19)
記載の組成物; (28)PTCAあるいはステント留置後の動脈再狭窄の予
防治療剤である前記(19)記載の組成物; (29)末梢動脈閉塞症の予防治療剤である前記(1
9)記載の組成物; (30)高脂血症の予防治療剤である前記(19)記載
の組成物; (31)脳梗塞の予防治療剤である前記(19)記載の
組成物; (32)脳卒中の予防治療剤である前記(19)記載の
組成物; (33)動脈硬化巣の進展抑制剤である前記(19)記
載の組成物; (34)式[Wherein, Ar 1 represents an aromatic ring group which may have a substituent, Ar 2 represents an aromatic ring group having a substituent,
R ″ represents a hydroxyl group which may be protected, R represents an acyl group, and R ′ represents a hydrogen atom or a hydrocarbon group which may have a substituent. (20) a composition according to (19), which is a cholesteryl ester transfer protein inhibitor; (21) a high-density lipoprotein. -The composition according to (19), which is a cholesterol-elevating agent; (22) the composition according to (19), which is a low-density lipoprotein-cholesterol-lowering agent; (24) The composition according to (19), which is a triglyceride-lowering agent; (25) The composition according to (1), which is a preventive or therapeutic agent for acute coronary syndrome.
(26) The composition according to (19), which is an agent for preventing or treating acute myocardial infarction.
(27) The composition according to (19), which is a preventive or therapeutic agent for unstable angina pectoris.
(28) The composition according to the above (19), which is a prophylactic / therapeutic agent for arterial restenosis after placement of PTCA or a stent;
(30) The composition according to (19), which is a prophylactic / therapeutic agent for hyperlipidemia; (31) the composition according to (19), which is a prophylactic / therapeutic agent for cerebral infarction; 32) The composition according to the above (19), which is an agent for preventing or treating stroke; (33) the composition according to the above (19), which is an agent for inhibiting the progression of arteriosclerotic lesions;
【0015】[0015]
【化10】 Embedded image
【0016】〔式中、Ar1は置換基を有していてもよ
い芳香環基を、Ar2'は置換基を有していてもよい芳香
環基を、OR’’は保護されていてもよい水酸基を、R
はアシル基を、R’は水素原子または置換基を有してい
てもよい炭化水素基を示す。〕で表される化合物または
その塩、またはそのプロドラッグを含有してなるコレス
テリルエステル転送蛋白阻害剤; (35)高脂血症の予防治療剤である前記(34)記載
の剤; (36)急性冠動脈症候群の予防治療剤である前記(3
4)記載の剤; (37)急性心筋梗塞の予防治療剤である前記(34)
記載の剤; (38)不安定狭心症の予防治療剤である前記(34)
記載の剤; (39)PTCAあるいはステント留置後の動脈再狭窄の予
防治療剤である前記(34)記載の剤; (40)末梢動脈閉塞症の予防治療剤である前記(3
4)記載の剤; (41)脳梗塞の予防治療剤である前記(34)記載の
剤; (42)脳卒中の予防治療剤である前記(34)記載の
剤; (43)動脈硬化巣の進展抑制剤である前記(34)記
載の剤; (44)前記(1)記載の化合物またはその塩の有効量
を哺乳動物に投与することを特徴とする哺乳動物におけ
るコレステリルエステル転送蛋白の阻害方法; (45)前記(1)記載の化合物またはその塩の有効量
を哺乳動物に投与することを特徴とする哺乳動物におけ
る高脂血症の予防または治療方法; (46)コレステリルエステル転送蛋白阻害のための医
薬の製造のための前記(1)記載の化合物またはその塩
の使用; (47)高脂血症の予防・治療のための医薬の製造のた
めの前記(1)記載の化合物またはその塩の使用; (48)前記(1)記載の化合物またはその塩の有効量
を哺乳動物に投与することを特徴とする哺乳動物におけ
る急性冠動脈症候群の予防または治療方法; (49)前記(1)記載の化合物またはその塩の有効量
を哺乳動物に投与することを特徴とする哺乳動物におけ
る急性心筋梗塞の予防または治療方法; (50)前記(1)記載の化合物またはその塩の有効量
を哺乳動物に投与することを特徴とする哺乳動物におけ
る不安定狭心症の予防または治療方法; (51)前記(1)記載の化合物またはその塩の有効量
を哺乳動物に投与することを特徴とする哺乳動物におけ
るPTCAあるいはステント留置後の冠動脈再狭窄の予防ま
たは治療方法; (52)前記(1)記載の化合物またはその塩の有効量
を哺乳動物に投与することを特徴とする哺乳動物におけ
る末梢動脈閉塞症の予防または治療方法; (53)前記(1)記載の化合物またはその塩の有効量
を哺乳動物に投与することを特徴とする哺乳動物におけ
る脳梗塞の予防または治療方法; (54)前記(1)記載の化合物またはその塩の有効量
を哺乳動物に投与することを特徴とする哺乳動物におけ
る脳卒中の予防または治療方法; (55)前記(1)記載の化合物またはその塩の有効量
を哺乳動物に投与することを特徴とする哺乳動物におけ
る動脈硬化巣の進展抑制方法; (56)急性冠動脈症候群の予防治療剤の製造のための
前記(1)記載の化合物またはその塩の使用; (57)急性心筋梗塞の予防治療剤の製造のための前記
(1)記載の化合物またはその塩の使用; (58)不安定狭心症の予防治療剤の製造のための前記
(1)記載の化合物またはその塩の使用; (59)末梢動脈閉塞症の予防治療剤の製造のための前
記(1)記載の化合物またはその塩の使用; (60)高脂血症の予防治療剤の製造のための前記
(1)記載の化合物またはその塩の使用; (61)脳梗塞の予防治療剤の製造のための前記(1)
記載の化合物またはその塩の使用; (62)脳卒中の予防治療剤の製造のための前記(1)
記載の化合物またはその塩の使用; (63)動脈硬化巣の進展抑制剤の製造のための前記
(1)記載の化合物またはその塩の使用; (64)前記(34)記載の式(I’)で表される化合
物またはその塩、またはそのプロドラッグの有効量を哺
乳動物に投与することを特徴とする哺乳動物におけるコ
レステリルエステル転送蛋白の阻害方法; (65)コレステリルエステル転送蛋白阻害のための医
薬の製造のため前記(34)記載の式(I’)で表され
る化合物またはその塩、またはそのプロドラッグの使
用; (66)式[In the formula, Ar 1 represents an optionally substituted aromatic ring group, Ar 2 ′ represents an optionally substituted aromatic ring group, and OR ″ represents a protected aromatic ring group. A good hydroxyl group is represented by R
Represents an acyl group, and R ′ represents a hydrogen atom or a hydrocarbon group which may have a substituent. (35) a cholesteryl ester transfer protein inhibitor comprising a compound represented by the formula: or a salt thereof, or a prodrug thereof; (35) the agent according to (34), which is a preventive or therapeutic agent for hyperlipidemia; (3) which is a prophylactic / therapeutic agent for acute coronary syndrome.
(37) The agent according to (34), which is an agent for preventing or treating acute myocardial infarction.
(38) The agent according to (34), which is a preventive or therapeutic agent for unstable angina pectoris.
(39) The agent according to (34), which is a prophylactic / therapeutic agent for PTCA or arterial restenosis after stent placement; (40) the agent (3), which is a prophylactic / therapeutic agent for peripheral arterial occlusion.
(41) the agent according to the above (34), which is a preventive / therapeutic agent for cerebral infarction; (42) the agent according to the above (34), which is a preventive / therapeutic agent for stroke; (43) an atherosclerotic lesion (44) a method of inhibiting a cholesteryl ester transfer protein in a mammal, which comprises administering to the mammal an effective amount of the compound or a salt thereof according to (1), which is an progress inhibitor; (45) a method for preventing or treating hyperlipidemia in a mammal, which comprises administering to the mammal an effective amount of the compound according to (1) or a salt thereof; (46) inhibiting cholesteryl ester transfer protein; (47) Use of the compound or a salt thereof according to (1) for the manufacture of a medicament for the prevention or treatment of hyperlipidemia. Use of salt; ( 8) a method for preventing or treating acute coronary syndrome in a mammal, which comprises administering to the mammal an effective amount of the compound according to (1) or a salt thereof; (49) the compound according to (1) or a salt thereof. A method for preventing or treating acute myocardial infarction in a mammal, which comprises administering an effective amount of a salt to the mammal; (50) administering an effective amount of the compound or a salt thereof according to the above (1) to the mammal. (51) a method for preventing or treating unstable angina in a mammal, comprising: (51) administering to the mammal an effective amount of the compound or a salt thereof according to the above (1); (52) a method for preventing or treating coronary restenosis after stent placement; (52) administering a compound or a salt thereof according to (1) to a mammal in an effective amount. (53) a method for preventing or treating cerebral infarction in a mammal, which comprises administering an effective amount of the compound or a salt thereof according to (1) to a mammal; 54) a method for preventing or treating stroke in a mammal, which comprises administering an effective amount of the compound or a salt thereof according to (1) to a mammal; (55) a method for preventing or treating stroke in a mammal; (56) a method for inhibiting the progression of atherosclerotic lesions in a mammal, which comprises administering an effective amount to a mammal; Use; (57) Use of the compound or the salt thereof according to (1) for the manufacture of a prophylactic / therapeutic agent for acute myocardial infarction; (58) Prior to the manufacture of a prophylactic / therapeutic agent for unstable angina pectoris. (59) Use of the compound or a salt thereof according to the above (1) for the manufacture of a prophylactic or therapeutic agent for peripheral arterial occlusion; (60) Prevention of hyperlipidemia (61) Use of the compound or a salt thereof according to (1) for the manufacture of a therapeutic agent;
(62) Use of the compound or a salt thereof according to the above (62) for the manufacture of an agent for preventing or treating stroke.
(63) Use of the compound or a salt thereof according to the above (1) for the manufacture of an agent for inhibiting progression of atherosclerotic lesions; (64) Formula (I ′) according to the above (34). A method for inhibiting a cholesteryl ester transfer protein in a mammal, which comprises administering to the mammal an effective amount of the compound represented by the formula (I) or a salt thereof, or a prodrug thereof; Use of the compound represented by the formula (I ′) described in the above (34) or a salt thereof, or a prodrug thereof for the manufacture of a medicament;
【0017】[0017]
【化11】 Embedded image
【0018】[式中の記号は、前記(1)記載と同意
義]で表される化合物またはその塩をアシル化反応に付
し、式A compound represented by the formula (1) is as defined in the above (1) or a salt thereof is subjected to an acylation reaction,
【0019】[0019]
【化12】 Embedded image
【0020】[式中の記号は、前記(1)記載と同意
義]で表される化合物またはその塩を得、所望により、
水酸基の保護反応に付すことを特徴とする前記(1)記
載またはその塩の製造法などに関する。Wherein the symbols in the formula are as defined in the above (1), or a salt thereof.
The present invention relates to the above-mentioned (1) or a method for producing a salt thereof, which is subjected to a hydroxyl group protection reaction.
【0021】本明細書中で用いられる用語「アシル基」
としては、例えばR1COOH、R1OCOOHなどのカ
ルボン酸、例えばR1SO3Hなどのスルホン酸、例えば
R1SO2Hなどのスルフィン酸、例えばR1OPO(O
R2)OHなどのリン酸、例えばR1N(R2)COOH
などのカルバミン酸(R1は置換基を有していてもよい
炭化水素基または置換基を有していてもよい複素環基を
示し、R2は水素原子または置換基を有していてもよい
炭化水素基を示す)などからOH基を除いて得られるア
シル基が用いられ、具体的にはR1CO、R1OCO、R
1SO2、R1SO、R1OPO(OR2)、R1N(R2)C
O(R1は置換基を有していてもよい炭化水素基または
置換基を有していてもよい複素環基を示し、R2は水素
原子または置換基を有していてもよい炭化水素基を示
す)などが用いられる。The term "acyl group" as used herein
As a carboxylic acid such as R 1 COOH and R 1 OCOOH; a sulfonic acid such as R 1 SO 3 H; and a sulfinic acid such as R 1 SO 2 H such as R 1 OPO (O
R 2 ) Phosphoric acid such as OH, for example R 1 N (R 2 ) COOH
Carbamic acid (R 1 represents a hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, and R 2 represents a hydrogen atom or a substituent which may have a substituent. An acyl group obtained by removing the OH group from, for example, a good hydrocarbon group) is used. Specifically, R 1 CO, R 1 OCO, R
1 SO 2 , R 1 SO, R 1 OPO (OR 2 ), R 1 N (R 2 ) C
O (R 1 represents a hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, and R 2 represents a hydrogen atom or a hydrocarbon which may have a substituent And the like) are used.
【0022】本明細書中で用いられる用語「置換されて
いてもよい炭化水素基」の「炭化水素基」とは、例えば
アルキル基、シクロアルキル基、アルケニル基、シクロ
アルケニル基、アルキニル基、アラルキル基、アリール
基などを示す。該「炭化水素基」が有していてもよい置
換基としては、後述する「アルキル基」及び「シクロア
ルキル基」が有していてもよい置換基と同様のものなど
が用いられる。該「アルキル基」としては、例えばメチ
ル、エチル、プロピル、イソプロピル、ブチル、イソブ
チル、sec−ブチル、tert−ブチル、ペンチル、ヘキシ
ル、ヘプチル、オクチル、ノニル、デシル、ウンデシ
ル、トリデシル、テトラデシル、ペンタデシルなどの
「直鎖状または分枝状のC1-15アルキル基」などが用い
られる。該「シクロアルキル基」としては、例えばシク
ロプロピル、シクロブチル、シクロペンチル、シクロヘ
キシル、シクロヘプチル、シクロオクチル、アダマンチ
ルなどの「C3-10シクロアルキル基」などが用いられ
る。As used herein, the term "hydrocarbon group" in the term "optionally substituted hydrocarbon group" means, for example, an alkyl group, a cycloalkyl group, an alkenyl group, a cycloalkenyl group, an alkynyl group, an aralkyl group. And an aryl group. As the substituent that the “hydrocarbon group” may have, the same substituents as the substituents that the “alkyl group” and the “cycloalkyl group” may have, which will be described later, are used. Examples of the "alkyl group" include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, tridecyl, tetradecyl, pentadecyl and the like. "A linear or branched C1-15 alkyl group" and the like are used. As the “cycloalkyl group”, for example, a “C 3-10 cycloalkyl group” such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, adamantyl and the like are used.
【0023】該「アルキル基」及び「シクロアルキル
基」が有していてもよい置換基としては、例えば(i)ニ
トロ基、(ii)ヒドロキシ基、オキソ基、(iii)シアノ
基、(iv)カルバモイル基、(v)モノ−またはジ−C1-4ア
ルキル−カルバモイル基(例えば、N−メチルカルバモ
イル、N−エチルカルバモイル、N,N−ジメチルカル
バモイル、N,N−ジエチルカルバモイルなど)、モノ
−またはジ−フェニル−カルバモイル基、モノ−または
ジ−ベンジル−カルバモイル基、カルボキシル−カルバ
モイル基、C1-4アルコキシ−カルボニル−カルバモイ
ル基、(vi)カルボキシル基、(vii)C1-4アルコキシ−カ
ルボニル基(例えば、メトキシカルボニル、エトキシカ
ルボニル、プロポキシカルボニル、イソプロポキシカル
ボニルなど)、(viii)スルホ基(−SO2OH)、(ix)
ハロゲン原子(例えば、フッ素、塩素、臭素、ヨウ素な
ど)、(x)ハロゲン化されていてもよいC1-4アルコキシ
基(例えば、メトキシ、エトキシ、プロポキシ、イソプ
ロポキシなど)、ヒドロキシ基で置換されていてもよい
C1-4アルコキシ基、カルボキシル基で置換されていて
もよいC1-4アルコキシ基、C1-4アルコキシ−カルボニ
ル基で置換されていてもよいC1-4アルコキシ基、C1-4
アルコキシ−C1-4アルコキシ基、(xi)フェノキシ基、
フェノキシ−C1-4アルキル基、フェノキシ−C1-4アル
コキシ基、 (xii)ハロゲン化されていてもよいフェニル
基、ハロゲン化されていてもよいフェニル−C1-4アル
キル基、ハロゲン化されていてもよいフェニル−C2-4
アルケニル基、ハロゲン化されていてもよいフェノキシ
基(例えば、o−,m−またはp−クロロフェノキシ、
o−,m−またはp−ブロモフェノキシなど)、ピリジ
ルオキシ基、C3-10シクロアルキル基、C3-10シクロア
ルキル−C1-4アルコキシ基、C3 -10シクロアルキル−
C1-4アルキル基、(xiii)ハロゲン化されていてもよい
C1- 4アルキル基、ハロゲン化されていてもよいC2-4ア
ルケニル基、ハロゲン化されていてもよいC1-4アルキ
ルチオ基(例えば、メチルチオ、エチルチオ、n−プロ
ピルチオ、イソプロピルチオ、n−ブチルチオなど)、
ヒドロキシ基で置換されていてもよいC1-4アルキル
基、ヒドロキシ基で置換されていてもよいC1-4アルキ
ルチオ基、(xiv)メルカプト基、チオキソ基、(xv)ハロ
ゲン原子、カルボキシル基およびC1-4アルコキシ−カ
ルボニル基から選ばれる置換基でそれぞれ置換されてい
てもよいベンジルオキシ基またはベンジルチオ基、(xv
i)ハロゲン化されていてもよいフェニルチオ基、ピリジ
ルチオ基、フェニルチオ−C1-4アルキル基、ピリジル
チオ−C1-4アルキル基、(xvii) ハロゲン化されていて
もよいC1-4アルキルスルフィニル基(例えば、メチル
スルフィニル、エチルスルフィニルなど)、フェニルス
ルフィニル基、フェニルスルフィニル−C1-4アルキル
基、(xviii) ハロゲン化されていてもよいC1-4アルキ
ルスルホニル基(例えば、メチルスルホニル、エチルス
ルホニルなど)、フェニルスルホニル基、フェニルスル
ホニル−C1-4アルキル基、(xix)アミノ基、アミノスル
ホニル基、(xx)C 1-3アシルアミノ基(例えば、アセチ
ルアミノ、プロピオニルアミノなど)、ベンジルオキシ
カルボニルアミノ、(xxi)モノ−またはジ−C1-4アルキ
ルアミノ基(例えば、メチルアミノ、エチルアミノ、ジ
メチルアミノ、ジエチルアミノなど)、(xxii)4ないし
6員環状アミノ基(例えば、1−アゼチジニル、1−ピ
ロリジニル、ピペリジノ、モルホリノ、チオモルホリ
ノ、1−ピペラジニルなど)、4ないし6員環状アミノ
−カルボニル基(例えば、1−アゼチジニルカルボニ
ル、1−ピロリジニルカルボニル、ピペリジノカルボニ
ル、モルホリノカルボニル、チオモルホリノカルボニ
ル、1−ピペラジニルカルボニルなど)、4ないし6員
環状アミノ−C1-4アルキル基、(xxiii)C1-6アシル基
(例えば、ホルミル、アセチルなどのハロゲン化されて
いてもよいC2-6アルカノイルなど)、(xxiv)ハロゲン
原子で置換されていてもよいベンゾイル基、(xxv)5な
いし10員複素環基(例えば、2−または3−チエニ
ル、2−または3−フリル、3−,4−または5−ピラ
ゾリル、2−,4−または5−チアゾリル、3−,4−
または5−イソチアゾリル、2−,4−または5−オキ
サゾリル、1,2,3−または1,2,4−トリアゾリ
ル、1H−または2H−テトラゾリル、2−,3−また
は4−ピリジル、2−,4−または5−ピリミジニル、
3−または4−ピリダジニル、キノリル、イソキノリル
インドリルなど)、(xxvi)5ないし10員複素環−カル
ボニル基(例えば、2−または3−チエニルカルボニ
ル、2−または3−フリルカルボニル、3−,4−また
は5−ピラゾリルカルボニル、2−,4−または5−チ
アゾリルカルボニル、3−,4−または5−イソチアゾ
リルカルボニル、2−,4−または5−オキサゾリルカ
ルボニル、1,2,3−または1,2,4−トリアゾリ
ルカルボニル、1H−または2H−テトラゾリルカルボ
ニル、2−,3−または4−ピリジルカルボニル、2
−,4−または5−ピリミジニルカルボニル、3−また
は4−ピリダジニルカルボニル、キノリルカルボニル、
イソキノリルカルボニル、インドリルカルボニルな
ど)、(xxvii) ハロゲン化されていてもよい直鎖状また
は分枝状のC2-5アルキレンオキシ基(例えば、エチレ
ンオキシ、プロピレンオキシ、イソブチレンオキシな
ど)および(xxviii) ハロゲン化されていてもよい直鎖
状または分枝状のC1-4アルキレンジオキシ基(例え
ば、メチレンジオキシ、エチレンジオキシ、プロピレン
ジオキシ、テトラフルオロエチレンジオキシなど)など
が用いられる。該「アルキル基」及び「シクロアルキル
基」は、置換可能な位置に、これらの置換基を1ないし
5個有していてもよい。The "alkyl group" and "cycloalkyl"
Examples of the substituent which the group may have include, for example, (i)
Toro group, (ii) hydroxy group, oxo group, (iii) cyano
Group, (iv) carbamoyl group, (v) mono- or di-C1-4A
Alkyl-carbamoyl group (for example, N-methylcarbamo
Yl, N-ethylcarbamoyl, N, N-dimethylcar
Bamoyl, N, N-diethylcarbamoyl, etc.), mono
-Or di-phenyl-carbamoyl group, mono- or
Di-benzyl-carbamoyl group, carboxyl-carba
Moyl group, C1-4Alkoxy-carbonyl-carbamoy
Group, (vi) carboxyl group, (vii) C1-4Alkoxy-ka
Rubonyl group (for example, methoxycarbonyl, ethoxyca
Rubonyl, propoxycarbonyl, isopropoxycal
Bonyl etc.), (viii) sulfo group (-SOTwoOH), (ix)
Halogen atoms (for example, fluorine, chlorine, bromine, iodine
And (x) optionally halogenated C1-4Alkoxy
Groups (eg, methoxy, ethoxy, propoxy, isop
Loxy, etc.), may be substituted with a hydroxy group
C1-4Substituted with an alkoxy group or a carboxyl group
Good C1-4Alkoxy group, C1-4Alkoxy-carboni
C which may be substituted with1-4Alkoxy group, C1-4
Alkoxy-C1-4Alkoxy group, (xi) phenoxy group,
Phenoxy-C1-4Alkyl group, phenoxy-C1-4Al
Coxy group, (xii) phenyl which may be halogenated
Group, optionally halogenated phenyl-C1-4Al
Alkyl group, phenyl-C which may be halogenated2-4
Alkenyl group, optionally halogenated phenoxy
Groups such as o-, m- or p-chlorophenoxy,
o-, m- or p-bromophenoxy), pyridi
Roxy group, C3-10Cycloalkyl group, C3-10Cycloa
Lequil-C1-4Alkoxy group, CThree -TenCycloalkyl-
C1-4Alkyl group, (xiii) optionally halogenated
C1- FourAlkyl group, optionally halogenated C2-4A
Lucenyl group, optionally halogenated C1-4Archi
Ruthio group (for example, methylthio, ethylthio, n-pro
Pyrthio, isopropylthio, n-butylthio, etc.),
C which may be substituted by a hydroxy group1-4Alkyl
Group optionally substituted by a hydroxy group or a hydroxy group1-4Archi
Luthio, (xiv) mercapto, thioxo, (xv) halo
Gen atom, carboxyl group and C1-4Alkoxy-ka
Each substituted with a substituent selected from a rubonyl group.
A benzyloxy group or a benzylthio group, (xv
i) an optionally halogenated phenylthio group, pyridi
Luthio group, phenylthio-C1-4Alkyl group, pyridyl
Thio-C1-4Alkyl group, (xvii) halogenated
Good C1-4Alkylsulfinyl group (for example, methyl
Sulfinyl, ethylsulfinyl, etc.), phenyls
Rufinyl group, phenylsulfinyl-C1-4Alkyl
Group, (xviii) optionally halogenated C1-4Archi
Rusulfonyl group (for example, methylsulfonyl, ethyls
Phenylsulfonyl group, phenylsulfonyl group
Honyl-C1-4Alkyl group, (xix) amino group, aminosul
Honyl group, (xx) C 1-3Acylamino group (for example, acetyl
Amino, propionylamino, etc.), benzyloxy
Carbonylamino, (xxi) mono- or di-C1-4Archi
Amino group (eg, methylamino, ethylamino, diamino
(Xxii) 4 to
6-membered cyclic amino group (for example, 1-azetidinyl, 1-pi
Loridinyl, piperidino, morpholino, thiomorpholin
, 1-piperazinyl, etc.) 4- to 6-membered cyclic amino
-Carbonyl group (for example, 1-azetidinylcarboni
, 1-pyrrolidinylcarbonyl, piperidinocarboni
, Morpholinocarbonyl, thiomorpholinocarboni
, 1-piperazinylcarbonyl, etc.), 4 to 6 members
Cyclic amino-C1-4Alkyl group, (xxiii) C1-6Acyl group
(For example, halogenated formyl, acetyl, etc.
May be C2-6Alkanoyl), (xxiv) halogen
A benzoyl group optionally substituted with an atom, such as (xxv) 5
10-membered heterocyclic group (for example, 2- or 3-thienyl
2-, 3- or 3-furyl, 3-, 4- or 5-pyr
Zolyl, 2-, 4- or 5-thiazolyl, 3-, 4-
Or 5-isothiazolyl, 2-, 4- or 5-oxo
Sazolyl, 1,2,3- or 1,2,4-triazolyl
1H- or 2H-tetrazolyl, 2-, 3- or
Is 4-pyridyl, 2-, 4- or 5-pyrimidinyl,
3- or 4-pyridazinyl, quinolyl, isoquinolyl
(Xxvi) 5- to 10-membered heterocyclic-cal
Bonyl group (for example, 2- or 3-thienylcarboni
2-, 3- or 3-furylcarbonyl, 3-, 4- or
Is 5-pyrazolylcarbonyl, 2-, 4- or 5-thio
Azolylcarbonyl, 3-, 4- or 5-isothiazo
Rylcarbonyl, 2-, 4- or 5-oxazolylca
Rubonyl, 1,2,3- or 1,2,4-triazoly
Carbonyl, 1H- or 2H-tetrazolylcarbo
Nil, 2-, 3- or 4-pyridylcarbonyl, 2
-, 4- or 5-pyrimidinylcarbonyl, 3- or
Is 4-pyridazinylcarbonyl, quinolylcarbonyl,
Isoquinolylcarbonyl, indolylcarbonyl
Etc.), (xxvii) linear or optionally halogenated
Is a branched C2-5Alkyleneoxy group (for example, ethylene
Oxy, propylene oxy, isobutylene oxy
And (xxviii) optionally halogenated straight chain
Or branched C1-4Alkylenedioxy group (eg,
For example, methylenedioxy, ethylenedioxy, propylene
Dioxy, tetrafluoroethylenedioxy, etc.)
Is used. The “alkyl group” and “cycloalkyl”
"Group" is a group in which 1 to 1
You may have five.
【0024】該「アルキル基」の好ましいものとして
は、例えばメチル、エチル、プロピル、イソプロピル、
ブチル、イソブチル、sec−ブチル、tert−ブチル、ペ
ンチル、ヘキシルなどの直鎖状または分枝状のC1-6ア
ルキル基が挙げられ、該「C1-6アルキル基」が有して
いてもよい置換基としては、例えばハロゲン原子、C
1-4アルコキシ基、ヒドロキシ基、C1-4アルコキシ−カ
ルボニル基、カルボキシル基、カルバモイル基、モノ−
またはジ−C1-4アルキルカルバモイル基、ピリジルチ
オ基などの1ないし3個が用いられる。該「アルケニル
基」としては、例えばビニル、アリル、イソプロペニ
ル、3−ブテニル、3−オクテニル、9−オクタデセニ
ルなどの「C2-18アルケニル基」などが用いられる。該
「シクロアルケニル基」としては、例えばシクロプロペ
ニル、シクロブテニル、シクロペンテニル、シクロヘキ
セニル、シクロヘプテニル、シクロオクテニルなどの
「C3-8シクロアルケニル基」などが用いられる。該
「アルケニル基」及び「シクロアルケニル基」が有して
いてもよい置換基としては、前記「アルキル基」が有し
ていてもよい置換基と同様のものが用いられる。該「ア
ルケニル基」の好ましいものとしては、例えばビニル、
アリル、2−ブテニル、3−ブテニルなどのC2-6アル
ケニル基などが挙げられる。該「C2-6アルケニル基」
が有していていてもよい置換基としては、例えば前記
「C1-6アルキル基」が有していてもよい置換基と同様
のものが用いられる。該「アルキニル基」としては、例
えば、エチニル、プロピニル、1−ブチニル、2−ブチ
ニル、1−ペンチニル、2−ペンチニル、3−ペンチニ
ルなどの「C 2-18アルキニル基」などが用いられる。該
「アルキニル基」が有していてもよい置換基としては、
前記「アルキル基」が有していてもよい置換基と同様の
ものが用いられる。該「アルキニル基」の好ましいもの
としては、例えばエチニル、プロピニル、1−ブチニ
ル、2−ブチニルなどのC2-6アルキニル基などが挙げ
られる。該「C2-6アルキニル基」が有していてもよい
置換基としては、例えば前記「C1-6アルキル基」が有
していてもよい置換基と同様のものが用いられる。Preferred examples of the "alkyl group"
Is, for example, methyl, ethyl, propyl, isopropyl,
Butyl, isobutyl, sec-butyl, tert-butyl,
Linear or branched C such as ethylene, hexyl, etc.1-6A
And the "C"1-6Alkyl group "has
Examples of the optional substituent include a halogen atom, C
1-4Alkoxy group, hydroxy group, C1-4Alkoxy-ka
Rubonyl group, carboxyl group, carbamoyl group, mono-
Or di-C1-4Alkylcarbamoyl group, pyridylti
One to three groups such as O groups are used. The alkenyl
Examples of the "group" include vinyl, allyl, and isopropenyl.
, 3-butenyl, 3-octenyl, 9-octadecenyl
"C2-18An "alkenyl group" and the like are used. The
As the “cycloalkenyl group”, for example, cycloprope
Nil, cyclobutenyl, cyclopentenyl, cyclohexyl
Cenyl, cycloheptenyl, cyclooctenyl, etc.
"C3-8And a "cycloalkenyl group". The
"Alkenyl group" and "cycloalkenyl group" have
The substituent that may be present has the aforementioned “alkyl group”.
The same substituents as those described above may be used. The "A
Preferred examples of the `` lucenyl group '' include, for example, vinyl,
C such as allyl, 2-butenyl and 3-butenyl2-6Al
And a kenyl group. The "C2-6Alkenyl group "
Examples of the substituent which may have
"C1-6Same as the substituent which the "alkyl group" may have
Is used. Examples of the “alkynyl group” include, for example,
For example, ethynyl, propynyl, 1-butynyl, 2-butyn
Nil, 1-pentynyl, 2-pentynyl, 3-pentini
"C 2-18An "alkynyl group" is used. The
Examples of the substituent which the “alkynyl group” may have include:
The same as the substituent which the "alkyl group" may have
Things are used. Preferred examples of the “alkynyl group”
For example, ethynyl, propynyl, 1-butini
And C such as 2-butynyl2-6Alkynyl groups and the like
Can be The "C2-6Alkynyl group "may have
Examples of the substituent include the aforementioned “C1-6Alkyl group "
The same substituents as those which may be used are used.
【0025】該「アラルキル基」としては、C7-16アラ
ルキル基などが用いられ、具体的には、例えばベンジ
ル、フェネチル、3−フェニルプロピル、4−フェニル
ブチルなどのフェニル−C1-6アルキル基および、例え
ば(1−ナフチル)メチル、2−(1−ナフチル)エチ
ル、2−(2−ナフチル)エチルなどのナフチル−C1-
6アルキル基などが挙げられる。該「アラルキル基」が
有していてもよい置換基としては、前記「アルキル基」
が有していてもよい置換基の他、例えばハロゲン原子
(例えば、フッ素、塩素、臭素、ヨウ素など)、C1-4
アルキル基(例えば、メチル、エチル、プロピル、イソ
プロピル、ブチルなど)、C2-6アルケニル基(例え
ば、ビニル、アリル、2−ブテニル、3−ブテニルな
ど)、C1-3アシル基(例えば、ホルミル、アセチルな
ど)、C1-4アルコキシ基(例えば、メトキシ、エトキ
シ、プロポキシ、イソプロポキシなど)、ニトロ基、シ
アノ基、ヒドロキシ基、C1-4アルコキシ−カルボニル
基(例えば、メトキシカルボニル、エトキシカルボニ
ル、プロポキシカルボニル、イソプロポキシカルボニル
など)、カルバモイル基、モノ−またはジ−C1-4アル
キル−カルバモイル基(例えば、N−メチルカルバモイ
ル、N−エチルカルバモイル、N,N−ジメチルカルバ
モイル、N,N−ジエチルカルバモイルなど)、モノ−
またはジ−C1-4アルケニル−カルバモイル基(例え
ば、N−ビニルカルバモイルなど)などが挙げられ、該
「アラルキル基」は置換可能な位置にこれらの置換基を
1ないし4個有していてもよい。該「アリール基」とし
ては、例えばフェニル、1−ナフチル、2−ナフチル、
フェナントリル、アントリル(anthryl)などの芳香族単
環式、2環式または3環式のC6-14アリール基、ビフェ
ニル基、トリル基などが用いられる。該「アリール基」
が有していてもよい置換基としては、前記「アラルキル
基」が有していてもよい置換基の他、オキソ基なども用
いられ、該「アリール基」は置換可能な位置にこれらの
置換基を1ないし4個、好ましくは1または2個有して
いてもよい。オキソ基を有するアリール基としては、例
えばベンゾキノニル、ナフトキノニル、アンスラキノニ
ルなどが挙げられる。「炭化水素基」が、シクロアルキ
ル基、アリール基またはアラルキル基である場合には、
例えば、C1-10アルキル基(例えば、メチル、エチル、
プロピル、イソプロピル、デシルなど)、C2-10アルケ
ニル基(例えば、ビニル、アリル、2−ブテニル、3−
ブテニルなど)、フェニル−C2-4アルケニル基(例え
ばフェニルエテニルなど)、モノ−またはジ−C1-6ア
ルケニル−カルバモイル基(例えば、N−ビニルカルバ
モイルなど)、C6-14アリール基(例えばフェニル、1
−ナフチル、2−ナフチル)、C7-20アラルキル基(例
えばベンジル、2−フェニルエチル、3−フェニルプロ
ピル、4−フェニルブチル、5−フェニルペンチル、6
−フェニルヘキシル、2−(1−ナフチル)エチル、2
−(2−ナフチル)エチルなど)、スチリル基、オキソ
基などで置換されていてもよい。「炭化水素基」の「置
換基」は置換可能な位置にlないし4個置換していても
よい。また、「炭化水素基」が、シクロアルキル基、シ
クロアルケニル基、アラルキル基、アリール基などの環
状基である場合、ハロゲン化されていてもよいC1-4ア
ルキレンジオキシ基、ハロゲン化されていてもよいC
2-5アルキレンオキシ基などの置換基を有していてもよ
く、あるいは、これらの環状基同士が縮合して、2環式
または3環式の縮合炭化水素基を形成していてもよく、
かかる縮合炭化水素基は、前述の「アルキル基」及び
「シクロアルキル基」が有していてもよい置換基と同様
な基を有していてもよい。As the "aralkyl group", a C 7-16 aralkyl group and the like are used, and specifically, for example, phenyl-C 1-6 alkyl such as benzyl, phenethyl, 3-phenylpropyl and 4-phenylbutyl Groups and naphthyl-C 1 -such as, for example, (1-naphthyl) methyl, 2- (1-naphthyl) ethyl, 2- (2-naphthyl) ethyl
6 alkyl groups and the like. Examples of the substituent which the “aralkyl group” may have include the aforementioned “alkyl group”.
May have, for example, a halogen atom (eg, fluorine, chlorine, bromine, iodine, etc.), C 1-4
Alkyl group (eg, methyl, ethyl, propyl, isopropyl, butyl, etc.), C 2-6 alkenyl group (eg, vinyl, allyl, 2-butenyl, 3-butenyl etc.), C 1-3 acyl group (eg, formyl , Acetyl, etc.), C 1-4 alkoxy group (eg, methoxy, ethoxy, propoxy, isopropoxy, etc.), nitro group, cyano group, hydroxy group, C 1-4 alkoxy-carbonyl group (eg, methoxycarbonyl, ethoxycarbonyl) , Propoxycarbonyl, isopropoxycarbonyl, etc.), carbamoyl group, mono- or di-C 1-4 alkyl-carbamoyl group (for example, N-methylcarbamoyl, N-ethylcarbamoyl, N, N-dimethylcarbamoyl, N, N- Monocarbamoyl), mono-
Or a di-C 1-4 alkenyl-carbamoyl group (eg, N-vinylcarbamoyl) and the like, and the “aralkyl group” may have 1 to 4 such substituents at substitutable positions. Good. Examples of the “aryl group” include phenyl, 1-naphthyl, 2-naphthyl,
An aromatic monocyclic, bicyclic or tricyclic C 6-14 aryl group such as phenanthryl and anthryl, a biphenyl group, a tolyl group and the like are used. The "aryl group"
As the substituent which may be possessed, in addition to the substituent which the aforementioned “aralkyl group” may have, an oxo group and the like are also used, and the “aryl group” is substituted at a substitutable position. It may have 1 to 4, preferably 1 or 2, groups. Examples of the aryl group having an oxo group include benzoquinonyl, naphthoquinonyl, anthraquinonyl and the like. When the `` hydrocarbon group '' is a cycloalkyl group, an aryl group or an aralkyl group,
For example, a C 1-10 alkyl group (eg, methyl, ethyl,
Propyl, isopropyl, decyl and the like), C 2-10 alkenyl group (for example, vinyl, allyl, 2-butenyl, 3-
Butenyl), a phenyl-C 2-4 alkenyl group (such as phenylethenyl), a mono- or di-C 1-6 alkenyl-carbamoyl group (such as N-vinylcarbamoyl), a C 6-14 aryl group ( For example, phenyl, 1
-Naphthyl, 2-naphthyl), a C7-20 aralkyl group (e.g., benzyl, 2-phenylethyl, 3-phenylpropyl, 4-phenylbutyl, 5-phenylpentyl, 6
-Phenylhexyl, 2- (1-naphthyl) ethyl, 2
-(2-naphthyl) ethyl), a styryl group, an oxo group and the like. The “substituent” of the “hydrocarbon group” may have 1 to 4 substituents at substitutable positions. Further, when the `` hydrocarbon group '' is a cyclic group such as a cycloalkyl group, a cycloalkenyl group, an aralkyl group, an aryl group, an optionally halogenated C 1-4 alkylenedioxy group, May be C
It may have a substituent such as a 2-5 alkyleneoxy group, or these cyclic groups may be condensed to form a bicyclic or tricyclic fused hydrocarbon group,
Such a condensed hydrocarbon group may have the same group as the substituent which the aforementioned “alkyl group” and “cycloalkyl group” may have.
【0026】本明細書中で用いられる用語「置換基を有
していてもよい複素環基」の「複素環基」としては、例
えば2−または3−チエニル、2−または3−フリル、
2−または3−ピロリル、2−、4−または5−オキサ
ゾリル、2−、4−または5−チアゾリル、3−、4−
または5−ピラゾリル、2−、4−または5−イミダゾ
リル、3−、4−または5−イソオキサゾリル、3−、
4−または5−イソチアゾリル、3−または5−(1,
2,4−オキサジアゾリル)、1,3,4−オキサジアゾ
リル、3−または5−(1,2,4−チアジアゾリル)、
1,3,4−チアジアゾリル、4−または5−(1,2,3
−チアジアゾリル)、1,2,5−チアジアゾリル、1,
2,3−トリアゾリル、1,2,4−トリアゾリル、1H
−または2H−テトラゾリル等の炭素原子以外に酸素原
子、硫黄原子、窒素原子等から選ばれたヘテロ原子を1
ないし4個含む5員環基、例えば2−、3−または4−
ピリジル、N−オキシド−2−、3−または4−ピリジ
ル、2−、4−または5−ピリミジニル、N−オキシド
−2−、4−または5−ピリミジニル、チオモルホリニ
ル、モルホリニル、オキソイミダゾリル、ジオキソトリ
アジニル、ピロリジニル、ピペリジニル、ピラニル、チ
オピラニル、1,4−オキサジニル、1,4−チアジニ
ル、1,3−チアジニル、ピペラジニル、トリアジニ
ル、オキソトリアジニル、3−または4−ピリダジニ
ル、ピラジニル、N−オキシド−3−または4−ピリダ
ジニル等の炭素原子以外に酸素原子、硫黄原子、窒素原
子等から選ばれたヘテロ原子を1ないし4個含む6員環
基、例えばベンゾフリル、ベンゾチアゾリル、ベンゾオ
キサゾリル、テトラゾロ〔1,5−b〕ピリダジニル、
トリアゾロ〔4,5−b〕ピリダジニル、ベンゾイミダ
ゾリル、キノリル、イソキノリル、シンノリニル、フタ
ラジニル、キナゾリニル、キノキサリニル、インドリジ
ニル、キノリジニル、1,8−ナフチリジニル、プリニ
ル、プテリジニル、ジベンゾフラニル、カルバゾリル、
アクリジニル、フェナントリジニル、クロマニル、ベン
ゾオキサジニル、フェナジニル、フェノチアジニル、フ
ェノキサジニル等の炭素原子以外に酸素原子、硫黄原
子、窒素原子等から選ばれたヘテロ原子を1ないし4個
含む2環性または3環性縮合環基等の炭素原子以外に例
えば酸素原子、硫黄原子、窒素原子などのヘテロ原子を
1ないし4個含む5ないし8員環またはその縮合環(ベ
ンゼン環との縮合も含む)等が用いられる。「置換基を
有していてもよい複素環基」の「置換基」としては、前
記「置換基を有していてもよい炭化水素基」の「置換
基」で述べたような基等、特に「炭化水素基」がシクロ
アルキル基、アリール基、アラルキル基である場合の置
換基等が用いられる。置換基は、複素環上の置換可能な
位置にlないし5個好ましくは1又は2個置換していて
もよい。As used herein, the term "heterocyclic group" of the term "heterocyclic group optionally having substituent (s)" includes, for example, 2- or 3-thienyl, 2- or 3-furyl,
2- or 3-pyrrolyl, 2-, 4- or 5-oxazolyl, 2-, 4- or 5-thiazolyl, 3-, 4-
Or 5-pyrazolyl, 2-, 4- or 5-imidazolyl, 3-, 4- or 5-isoxazolyl, 3-,
4- or 5-isothiazolyl, 3- or 5- (1,
2,4-oxadiazolyl), 1,3,4-oxadiazolyl, 3- or 5- (1,2,4-thiadiazolyl),
1,3,4-thiadiazolyl, 4- or 5- (1,2,3
-Thiadiazolyl), 1,2,5-thiadiazolyl, 1,
2,3-triazolyl, 1,2,4-triazolyl, 1H
-Or a hetero atom selected from an oxygen atom, a sulfur atom, a nitrogen atom and the like in addition to a carbon atom such as 2H-tetrazolyl.
A 5-membered ring group containing from 4 to 4, for example, 2-, 3- or 4-
Pyridyl, N-oxide-2-, 3- or 4-pyridyl, 2-, 4- or 5-pyrimidinyl, N-oxide-2-, 4- or 5-pyrimidinyl, thiomorpholinyl, morpholinyl, oxoimidazolyl, dioxotri Azinyl, pyrrolidinyl, piperidinyl, pyranyl, thiopyranyl, 1,4-oxazinyl, 1,4-thiazinyl, 1,3-thiazinyl, piperazinyl, triazinyl, oxotriazinyl, 3- or 4-pyridazinyl, pyrazinyl, N-oxide 6-membered ring group containing 1 to 4 heteroatoms selected from oxygen atom, sulfur atom, nitrogen atom and the like in addition to carbon atom such as -3- or 4-pyridazinyl, for example, benzofuryl, benzothiazolyl, benzoxazolyl, tetrazolo [1,5-b] pyridazinyl,
Triazolo [4,5-b] pyridazinyl, benzimidazolyl, quinolyl, isoquinolyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, indolizinyl, quinolizinyl, 1,8-naphthyridinyl, purinyl, pteridinyl, dibenzofuranyl, carbazolyl,
Bicyclic containing 1 to 4 heteroatoms selected from oxygen, sulfur, nitrogen, etc. in addition to carbon such as acridinyl, phenanthridinyl, chromanyl, benzoxazinyl, phenazinyl, phenothiazinyl, phenoxazinyl and the like Or a 5- to 8-membered ring containing 1 to 4 hetero atoms such as an oxygen atom, a sulfur atom and a nitrogen atom in addition to a carbon atom such as a tricyclic fused ring group or a condensed ring thereof (including condensed with a benzene ring) Are used. Examples of the `` substituent '' of the `` heterocyclic group which may have a substituent '' include the groups described in the `` substituent '' of the `` hydrocarbon group which may have a substituent '', In particular, a substituent when the "hydrocarbon group" is a cycloalkyl group, an aryl group, or an aralkyl group is used. Substituents may be substituted at 1 to 5, preferably 1 or 2, at substitutable positions on the heterocyclic ring.
【0027】本明細書中で用いられる用語「低級アルキ
ル基」は、例えばメチル、エチル、プロピル、イソプロ
ピル、ブチル、イソブチル、sec−ブチル、tert−ブチ
ル、ペンチル、ヘキシルなどの直鎖状もしくは分枝状の
炭素数1−6のアルキル基などを示す。As used herein, the term "lower alkyl" refers to a straight or branched chain such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, hexyl and the like. And an alkyl group having 1 to 6 carbon atoms.
【0028】前記式中、Ar1は置換基を有していても
よい芳香環基を、Ar2は置換基を有する芳香環基を示
す。Ar1としての「置換基を有していてもよい芳香環
基」における「芳香環基」が有していてもよい「置換
基」およびAr2としての「置換基を有する芳香環基」
における「芳香環基」が有する「置換基」としては、前
記「置換基を有していてもよい炭化水素基」の「置換
基」で述べたような基等が用いられる。置換基は、芳香
環基の置換可能な位置にlないし5個好ましくは1又は
2個置換していてもよい。Ar1としての「置換基を有
していてもよい芳香環基」における「芳香環基」が有し
ていてもよい「置換基」としては、ハロゲン原子、ハロ
ゲン化されていてもよい低級アルキル基、ハロゲン化さ
れていてもよい低級アルコキシ基、置換基を有していて
もよいアリールオキシ基(例、フェノキシ基など)など
が好ましく、Ar1としての「置換基を有していてもよ
い芳香環基」における「芳香環基」がフェニルであり、
該フェニルが1個の置換基を有する場合の置換位置とし
ては、メタ位またはパラ位が好ましい。Ar2としての
「置換基を有する芳香環基」における「芳香環基」が有
していてもよい「置換基」としては、ハロゲン原子、ハ
ロゲン化されていてもよい低級アルキル基、ハロゲン化
されていてもよい低級アルコキシ基などが好ましく、A
r2としての「置換基を有する芳香環基」における「芳
香環基」がフェニルであり、該フェニルが1個の置換基
を有する場合の置換位置としては、メタ位またはパラ位
が好ましい。Ar1としての「置換基を有していてもよ
い芳香環基」における「芳香環基」およびAr2として
の「置換基を有する芳香環基」における「芳香環基」と
しては、アリール基、ヘテロアリール基などが挙げられ
る。該「アリール基」としては、例えばフェニル、1−
ナフチル、2−ナフチル、フェナントリル、アントリル
(anthryl)などの芳香族単環式、2環式または3環式の
C6-14アリール基、ビフェニル基、トリル基などが用い
られるが、なかでも、フェニルが好ましく用いられる。
該「ヘテロアリール基」としては、例えば2−または3
−チエニル、2−または3−フリル、2−、4−または
5−オキサゾリル、2−、4−または5−チアゾリル、
3−、4−または5−ピラゾリル、2−、4−または5
−イミダゾリル、3−、4−または5−イソオキサゾリ
ル、3−、4−または5−イソチアゾリル、3−または
5−(1,2,4−オキサジアゾリル)、1,3,4−オキ
サジアゾリル、3−または5−(1,2,4−チアジアゾ
リル)、1,3,4−チアジアゾリル、4−または5−
(1,2,3−チアジアゾリル)、1,2,5−チアジアゾ
リル、1,2,3−トリアゾリル、1,2,4−トリアゾリ
ル、1H−または2H−テトラゾリル等の炭素原子以外
に酸素原子、硫黄原子、窒素原子等から選ばれたヘテロ
原子を1ないし4個含む5員の芳香環基、例えば2−、
3−または4−ピリジル、2−、4−または5−ピリミ
ジニル、ピリダジニル、ピラジニル等の炭素原子以外に
酸素原子、硫黄原子、窒素原子等から選ばれたヘテロ原
子を1ないし4個含む6員の芳香環基、またはこれらの
5または6員の芳香環基同士またはこれらの5または6
員の芳香環基がベンゼン環と結合して形成する縮合環基
(好ましくは、2環式の縮合環基)等が用いられる。A
r1としての「置換基を有していてもよい芳香環基」に
おける「芳香環基」およびAr2としての「置換基を有
する芳香環基」における「芳香環基」としては、それぞ
れ5または6員の芳香環基が好ましく用いられ、なかで
も、フェニル基、ピリジル基、チエニル基、フリル基、
チアゾリル基などが好ましく用いられる。前記式中、A
r2'は置換基を有していてもよい芳香環基を示す。Ar
2'としての「置換基を有していてもよい芳香環基」とし
ては、Ar2としての「置換基を有する芳香環基」にお
ける「芳香環基」およびAr2としての「置換基を有す
る芳香環基」などと同様なものが挙げられる。In the above formula, Ar 1 represents an aromatic ring group which may have a substituent, and Ar 2 represents an aromatic ring group having a substituent. "Aromatic ring group having a substituent" in the "aromatic ring group" which may have "substituents" and Ar 2 in the "aromatic ring group optionally having a substituent" as Ar 1
As the “substituent” of the “aromatic ring group” in the above, the groups described in “the substituent” of the “hydrocarbon group which may have a substituent” and the like are used. The substituent may be substituted at 1 to 5, preferably 1 or 2, at a substitutable position of the aromatic ring group. As the “substituent” that the “aromatic ring group” in the “aromatic ring group optionally having” as Ar 1 may have, a halogen atom, a lower alkyl optionally halogenated group, halogenated which may be a lower alkoxy group, an optionally substituted aryl group (e.g., phenoxy group and the like) is preferable, and may have a "substituent as Ar 1 `` Aromatic ring group '' in `` aromatic ring group '' is phenyl,
When the phenyl has one substituent, the substitution position is preferably the meta position or the para position. As the "substituent" that the "aromatic ring group" in the "aromatic ring group having a substituent" as Ar 2 may have, a halogen atom, a lower alkyl group which may be halogenated, And a lower alkoxy group which may be
The “aromatic ring group” in the “aromatic ring group having a substituent” as r 2 is phenyl, and when the phenyl has one substituent, the substitution position is preferably the meta position or the para position. As the `` aromatic ring group '' in the `` aromatic ring group which may have a substituent '' as Ar 1 and the `` aromatic ring group '' in the `` aromatic ring group having a substituent '' as Ar 2 , an aryl group, And a heteroaryl group. Examples of the “aryl group” include phenyl, 1-
Naphthyl, 2-naphthyl, phenanthryl, anthryl
An aromatic monocyclic, bicyclic or tricyclic C 6-14 aryl group such as (anthryl), a biphenyl group, a tolyl group and the like are used, and among them, phenyl is preferable.
As the “heteroaryl group”, for example, 2- or 3
-Thienyl, 2- or 3-furyl, 2-, 4- or 5-oxazolyl, 2-, 4- or 5-thiazolyl,
3-, 4- or 5-pyrazolyl, 2-, 4- or 5
-Imidazolyl, 3-, 4- or 5-isoxazolyl, 3-, 4- or 5-isothiazolyl, 3- or 5- (1,2,4-oxadiazolyl), 1,3,4-oxadiazolyl, 3- or 5 -(1,2,4-thiadiazolyl), 1,3,4-thiadiazolyl, 4- or 5-
(1,2,3-thiadiazolyl), 1,2,5-thiadiazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, 1H- or 2H-tetrazolyl, etc. Atom, a 5-membered aromatic ring group containing 1 to 4 heteroatoms selected from nitrogen atoms and the like, for example, 2-,
6-membered containing 1 to 4 heteroatoms selected from oxygen, sulfur, nitrogen and the like in addition to carbon atoms such as 3- or 4-pyridyl, 2-, 4- or 5-pyrimidinyl, pyridazinyl and pyrazinyl An aromatic ring group, or a 5- or 6-membered aromatic ring group thereof, or a 5- or 6-membered aromatic ring group thereof;
A condensed ring group formed by bonding a member aromatic ring group to a benzene ring (preferably a bicyclic condensed ring group) or the like is used. A
As the “aromatic ring group” in the “aromatic ring group optionally having substituent (s)” as r 1 and the “aromatic ring group” in the “aromatic ring group having a substituent” as Ar 2 , 5 or A 6-membered aromatic ring group is preferably used, and among them, a phenyl group, a pyridyl group, a thienyl group, a furyl group,
Thiazolyl groups and the like are preferably used. In the above formula, A
r 2 ′ represents an aromatic ring group which may have a substituent. Ar
As the "aromatic ring group optionally having a substituent" as 2 ', having a "substituent as" aromatic ring group "and Ar 2 in the" aromatic ring group having a substituent "as Ar 2 And the same as "aromatic ring group".
【0029】前記式中、Rはアシル基を示す。該「アシ
ル基」は前述の何れのものであってもよく、例えば、R
1NCOOH、R1NOCOOHなどのカルボン酸、例えば
R1NSO3Hなどのスルホン酸、例えばR1NSO2Hなど
のスルフィン酸、例えばR1NOPO(OR2N)OHなど
のリン酸、例えばR1NN(R2N)COOHなどのカルバ
ミン酸(R1Nは置換基を有していてもよい炭化水素基ま
たは置換基を有していてもよい複素環基を示し、R2Nは
水素原子または置換基を有していてもよい炭化水素基を
示す)などからOH基を除いて得られるアシル基が用い
られ、具体的にはR1NCO、R1NOCO、R1NSO2、
R1NSO、R1NOPO(OR2N)、R1NN(R2N)CO
(R1Nは置換基を有していてもよい炭化水素基または置
換基を有していてもよい複素環基を示し、R2Nは水素原
子または置換基を有していてもよい炭化水素基を示す)
などが用いられる。ここで、R1Nで示される「置換基を
有していてもよい炭化水素基」、R1Nで示される「置換
基を有していてもよい複素環基」およびR2Nで示される
「置換基を有していてもよい炭化水素基」としては、そ
れぞれ前記R1で示される「置換基を有していてもよい
炭化水素基」、前記R1で示される「置換基を有してい
てもよい複素環基」および前記R2で示される「置換基
を有していてもよい炭化水素基」と同様なものが用いら
れる。Rとしては、式 R1NCO−(R1Nは置換基を有
していてもよい炭化水素基または置換基を有していても
よい複素環基を示す)で表される基が好ましく用いられ
る。また、R1Nとしては、置換基を有していてもよい環
状炭化水素基(例、置換基を有していてもよいシクロア
ルキル基、置換基を有していてもよいシクロアルケニル
基、置換基を有していてもよいアリール基など)、置換
基を有していてもよい複素環基などの環状基が好まし
く、とりわけ、置換基を有していてもよいアリール基、
置換基を有していてもよいヘテロアリール基などの置換
基を有していてもよい芳香環基(Ar1としての「置換
基を有していてもよい芳香環基」と同様な基など)が好
ましく用いられる。なかでも、Rとしては、ハロゲン原
子、ハロゲン化されていてもよいC1-6アルコキシ、ハ
ロゲン化されていてもよいC1-6アルキルなどから選ば
れた置換基1〜3個をそれぞれ有していてもよいC1-6
アルコキシ−カルボニル、C1-6アルキル−カルボニ
ル、C6-10アリール−カルボニル(例、ベンゾイル、ナ
フトイルなど)、ジヒドロナフタレンカルボニル、テト
ラヒドロナフタレンカルボニル、ベンゾシクロヘプテン
カルボニル(好ましくはベンゾ[a]シクロヘプテン−
カルボニルなど)、ベンゾシクロオクテンカルボニルが
好ましい。前記式中、OR’’は保護されていてもよい
水酸基を示す。ここで、R’’は水素原子または水酸基
の保護基(好ましくは、R’’は水素原子またはアシル
基)を示し、水酸基の保護基としては、例えば、アシル
基、置換基を有していてもよいC1-6アルキル、置換基
を有していてもよいフェニル、置換基を有していてもよ
いC7-10アラルキル、置換基を有していてもよいピラニ
ル、置換基を有していてもよいフラニル、置換基を有し
ていてもよいシリルなどが挙げられる。R’’で示され
る「水酸基の保護基」としてのアシル基は前述の何れの
ものであってもよく、例えば、R1OCOOH、R1OOC
OOHなどのカルボン酸、例えばR1OSO3Hなどのス
ルホン酸、例えばR1OSO2Hなどのスルフィン酸、例
えばR1OOPO(OR2O)OHなどのリン酸、例えばR
1ON(R2O)COOHなどのカルバミン酸(R1Oは置換
基を有していてもよい炭化水素基または置換基を有して
いてもよい複素環基を示し、R2Oは水素原子または置換
基を有していてもよい炭化水素基を示す)などからOH
基を除いて得られるアシル基が用いられ、具体的にはR
1OCO、R1OOCO、R1OSO2、R1OSO、R1OOP
O(OR2O)、R1ON(R2O)CO(R1Oは置換基を有し
ていてもよい炭化水素基または置換基を有していてもよ
い複素環基を示し、R2Oは水素原子または置換基を有し
ていてもよい炭化水素基を示す)などが用いられる。こ
こで、R1Oで示される「置換基を有していてもよい炭化
水素基」、R1Oで示される「置換基を有していてもよい
複素環基」およびR2Oで示される「置換基を有していて
もよい炭化水素基」としては、それぞれ前記R1で示さ
れる「置換基を有していてもよい炭化水素基」、前記R
1で示される「置換基を有していてもよい複素環基」お
よび前記R2で示される「置換基を有していてもよい炭
化水素基」と同様なものが用いられる。R’’で示され
る「水酸基の保護基」としての「アシル基」としては、
式 R1 OCO−(R1Oは置換基を有していてもよい炭化
水素基または置換基を有していてもよい複素環基を示
す)で表される基が好ましく用いられる。また、R1Oと
しては、置換基を有していてもよい鎖状炭化水素基
(例、置換基を有していてもよいアルキル基、置換基を
有していてもよいアルケニル基、置換基を有していても
よいアルキニル基など)などが好ましく、なかでも、置
換基を有していてもよいアルキル基などが好ましく、と
りわけ、置換基を有するアルキル基(例えば、ハロゲン
原子、C1-4アルコキシ基、ヒドロキシ基、C1-4アルコ
キシ−カルボニル基、カルボキシル基、カルバモイル
基、モノ−またはジ−C1-4アルキルカルバモイル基、
アミノ基、モノ−またはジ−C1-4アルキルアミノ基、
ピリジルチオ基などから選ばれる置換基1ないし3個を
有するC1-6アルキル基など)などが好ましく用いられ
る。R’’で示される「水酸基の保護基」としての「置
換基を有していてもよいC 1-6アルキル基」における
「C1-6アルキル基」としては、例えば、メチル、エチ
ル、プロピル、イソプロピル、ブチル、tert−ブチルな
どが挙げられ、該「C1- 6アルキル基」は、ハロゲン原
子(例えば、フルオロ、クロロ、ブロモ、ヨードな
ど)、フェニル、C7-10アラルキル、ニトロ基などの置
換基を1ないし4個程度有していてもよい。R’’で示
される「水酸基の保護基」としての「置換基を有してい
てもよいフェニル基」における「フェニル基」が有して
いてもよい置換基としては、例えば、ハロゲン原子(例
えば、フルオロ、クロロ、ブロモ、ヨードなど)、C
1-6アルキル、フェニル、C7-10アラルキル、ニトロ基
などが用いられ、置換基の数は1ないし4個程度であ
る。R’’で示される「水酸基の保護基」としての「置
換基を有していてもよいC 7-10アラルキル」における
「C7-10アラルキル」としては、例えば、ベンジルなど
が挙げられ、該「C7-10アラルキル」が有していてもよ
い置換基としては、例えば、ハロゲン原子(例えば、フ
ルオロ、クロロ、ブロモ、ヨードなど)、C1- 6アルキ
ル、フェニル、C7-10アラルキル、ニトロ基などが用い
られ、置換基の数は1ないし4個程度である。R’’で
示される「水酸基の保護基」としての「置換基を有して
いてもよいピラニル基」における「ピラニル基」が有し
ていてもよい置換基としては、例えば、ハロゲン原子
(例えば、フルオロ、クロロ、ブロモ、ヨードなど)、
C1-6アルキル、フェニル、C7-10アラルキル、ニトロ
基などが用いられ、置換基の数は1ないし4個程度であ
る。R’’で示される「水酸基の保護基」としての「置
換基を有していてもよいフラニル基」における「フラニ
ル基」が有していてもよい置換基としては、例えば、ハ
ロゲン原子(例えば、フルオロ、クロロ、ブロモ、ヨー
ドなど)、C1-6アルキル、フェニル、C7-10アラルキ
ル、ニトロ基などが用いられ、置換基の数は1ないし4
個程度である。R’’で示される「水酸基の保護基」と
しての「置換基を有していてもよいシリル基」における
「シリル基」が有していてもよい置換基としては、例え
ば、C 1-6アルキル、フェニル、C7-10アラルキルなど
が用いられ、置換基の数は1ないし4個程度である。
R’’としては、水素原子などが好ましく用いられる。In the above formula, R represents an acyl group. The "Ashi
The group may be any of those described above, for example, R
1NCOOH, R1NCarboxylic acids such as OCOOH, for example
R1NSOThreeSulfonic acids such as H, for example R1NSOTwoH etc.
A sulfinic acid such as R1NOPO (OR2N) OH etc.
Phosphoric acid such as R1NN (R2N) Carba such as COOH
Minic acid (R1NIs a hydrocarbon group which may have a substituent.
Or a heterocyclic group which may have a substituent;2NIs
A hydrogen atom or a hydrocarbon group which may have a substituent
Acyl group obtained by removing the OH group from
And specifically, R1NCO, R1NOCO, R1NSOTwo,
R1NSO, R1NOPO (OR2N), R1NN (R2N) CO
(R1NIs a hydrocarbon group which may have a substituent or
A heterocyclic group which may have a substituent;2NIs hydrogen field
Represents a hydrocarbon group which may have a substituent or a substituent)
Are used. Where R1NRepresented by the "substituent
A hydrocarbon group which may be present ", R1NReplace with
A heterocyclic group which may have a group "and R2NIndicated by
As the “optionally substituted hydrocarbon group”,
Each of the above R1Represented by the `` may have a substituent
A hydrocarbon group ";1Having a substituent
A heterocyclic group which may beTwo"Substituent represented by
And the like may be used.
It is. As R, the formula R1NCO- (R1NHas a substituent
May have a hydrocarbon group or a substituent
Which represents a good heterocyclic group) is preferably used
You. Also, R1NRepresents a ring which may have a substituent
Hydrocarbon group (eg, cycloalkyl optionally having substituent (s))
Alkyl group, cycloalkenyl optionally having substituent (s)
Group, aryl group which may have a substituent, etc.),
A cyclic group such as an optionally substituted heterocyclic group is preferred.
And especially an aryl group which may have a substituent,
Substitution of an optionally substituted heteroaryl group, etc.
An aromatic ring group (Ar1Replace as
And the like aromatic groups which may have a group).
It is used well. Among them, R is a halogen atom
, Optionally halogenated C1-6Alkoxy, ha
C which may be formed into a log1-6Choose from alkyl, etc.
C which may have 1 to 3 substituents1-6
Alkoxy-carbonyl, C1-6Alkyl-carboni
Le, C6-10Aryl-carbonyl (eg, benzoyl, na
Etc.), dihydronaphthalenecarbonyl, tet
Lahydronaphthalene carbonyl, benzocycloheptene
Carbonyl (preferably benzo [a] cycloheptene-
Carbonyl), benzocyclooctenecarbonyl
preferable. In the above formula, OR ″ may be protected
Shows a hydroxyl group. Here, R ″ is a hydrogen atom or a hydroxyl group.
(Preferably, R ″ is a hydrogen atom or an acyl
And the protecting group for the hydroxyl group includes, for example, acyl
C which may have a group or a substituent1-6Alkyl, substituent
Optionally substituted phenyl, optionally substituted
C7-10Aralkyl, optionally substituted pirani
, A furanyl optionally having a substituent,
And optionally silyl. R ''
The acyl group as the “protecting group for hydroxyl group” may be any of the aforementioned groups.
May be, for example, R1OCOOH, R1OOC
Carboxylic acids such as OOH, for example R1OSOThreeH and others
Sulfonic acid, for example R1OSOTwoH and other sulfinic acids, eg
For example, R1OOPO (OR2O) Phosphoric acid such as OH, for example R
1ON (R2O) Carbamic acids such as COOH (R1OIs replaced
Having a hydrocarbon group or a substituent which may have a group
An optionally substituted heterocyclic group;2OIs a hydrogen atom or substitution
Represents a hydrocarbon group which may have a group)
An acyl group obtained by removing the group is used.
1OCO, R1OOCO, R1OSOTwo, R1OSO, R1OOP
O (OR2O), R1ON (R2O) CO (R1OHas a substituent
May have a hydrocarbon group or a substituent
A heterocyclic group;2OHas a hydrogen atom or a substituent
Or a hydrocarbon group which may be substituted). This
Where R1ORepresented by the "optionally substituted carbonized
Hydrogen group ", R1ORepresented by the `` may have a substituent
Heterocyclic group "and R2OHaving a substituent
Or a good hydrocarbon group ”.1Indicated by
The "optionally substituted hydrocarbon group" described above,
1Represented by an "optionally substituted heterocyclic group" and
And the RTwoRepresented by the "optionally substituted charcoal"
The same as the “hydrogen group” are used. R ''
Examples of the “acyl group” as the “hydroxyl protecting group” include:
Formula R1 OCO- (R1OIs a carbon atom which may have a substituent
Represents a hydrogen group or a heterocyclic group which may have a substituent.
Are preferably used. Also, R1OWhen
A chain hydrocarbon group which may have a substituent
(E.g., an alkyl group which may have a substituent,
Optionally having an alkenyl group, having a substituent
Such as a good alkynyl group) are preferred.
An alkyl group which may have a substituent is preferable, and
In other words, an alkyl group having a substituent (for example, halogen
Atom, C1-4Alkoxy group, hydroxy group, C1-4Arco
Xy-carbonyl group, carboxyl group, carbamoyl
Group, mono- or di-C1-4Alkylcarbamoyl group,
Amino group, mono- or di-C1-4Alkylamino group,
1 to 3 substituents selected from a pyridylthio group and the like
Having C1-6And the like are preferably used.
You. R "as a" protecting group for a hydroxyl group "
C optionally having a substituent 1-6Alkyl group "
"C1-6Examples of the "alkyl group" include, for example, methyl and ethyl.
Propyl, isopropyl, butyl, tert-butyl
And the "C1- 6An “alkyl group” is a halogen atom
Children (eg, fluoro, chloro, bromo, iodo
Etc.), phenyl, C7-10Aralkyl and nitro groups
It may have about 1 to 4 substituents. Indicated by R ''
Having a substituent as the "protecting group for hydroxyl group"
Phenyl group "may have" phenyl group "
Examples of the optional substituent include a halogen atom (eg,
For example, fluoro, chloro, bromo, iodo, etc.), C
1-6Alkyl, phenyl, C7-10Aralkyl, nitro group
And the like, and the number of substituents is about 1 to 4
You. R "as a" protecting group for a hydroxyl group "
C optionally having a substituent 7-10In aralkyl
"C7-10As "aralkyl", for example, benzyl
And the "C7-10Aralkyl "
Substituents include, for example, halogen atoms (eg,
Luoro, chloro, bromo, iodo, etc.), C1- 6Archi
Phenyl, C7-10Aralkyl and nitro groups are used
And the number of substituents is about 1 to 4. R ''
Having a substituent as the shown "protecting group for hydroxyl group"
"Pyranyl group" in "optionally pyranyl group"
Examples of the optionally substituted substituent include, for example, a halogen atom
(Eg, fluoro, chloro, bromo, iodo, etc.),
C1-6Alkyl, phenyl, C7-10Aralkyl, nitro
And the like, and the number of substituents is about 1 to 4
You. R "as a" protecting group for a hydroxyl group "
Furanyl group which may have a substituent
Substituents which the `` aryl group '' may have, for example,
Logen atom (eg, fluoro, chloro, bromo, iodo
C)1-6Alkyl, phenyl, C7-10Aralki
And nitro groups are used, and the number of substituents is 1 to 4
About one. A “protecting group for a hydroxyl group” represented by R ″;
In "optionally substituted silyl group"
Examples of the substituent which the “silyl group” may have include, for example,
If C 1-6Alkyl, phenyl, C7-10Aralkyl etc.
And the number of substituents is about 1 to 4.
As R ″, a hydrogen atom or the like is preferably used.
【0030】前記式中、R’は、水素原子または置換基
を有していてもよい炭化水素基を示す。R’としては、
水素原子、置換基を有していてもよい低級アルキル基
(好ましくは、ハロゲン原子、C1-4アルコキシ基、ヒ
ドロキシ基、C1-4アルコキシ−カルボニル基、カルボ
キシル基、カルバモイル基、モノ−またはジ−C1-4ア
ルキルカルバモイル基およびピリジルチオ基から選ばれ
た置換基1ないし3個を有していてもよいC1-6アルキ
ル基など)などが好ましく、水素原子、C1-6アルキル
基などがより好ましく、なかでも、水素原子が好ましく
用いられる。前記式(I)で表される化合物またはその
塩としては、Rが式 R1NCO−(R1Nは置換基を有し
ていてもよい環状炭化水素基または置換基を有していて
もよい複素環基を示す)で表される基であり、R’’が
水素原子であり、R’が水素原子である化合物またはそ
の塩;Ar1がハロゲン原子、ハロゲン化されていても
よい低級アルキル基、ハロゲン化されていてもよい低級
アルコキシ基および置換基を有していてもよいアリール
オキシ基から選ばれる置換基を有していてもよい5また
は6員の芳香環基(例えば、フェニル基、ピリジル基、
チエニル基、フリル基、チアゾリル基など;好ましく
は、フェニル基など)であり、Ar2がハロゲン原子、
ハロゲン化されていてもよい低級アルキル基およびハロ
ゲン化されていてもよい低級アルコキシ基から選ばれる
置換基を有する5または6員の芳香環基(例えば、フェ
ニル基、ピリジル基、チエニル基、フリル基、チアゾリ
ル基など;好ましくは、フェニル基など)であり、Rが
ハロゲン原子、ハロゲン化されていてもよいC1-6アル
コキシおよびハロゲン化されていてもよいC1-6アルキ
ルから選ばれた置換基をそれぞれ有していてもよいC
1-6アルコキシ−カルボニル、C1-6アルキル−カルボニ
ル、C6-10アリール−カルボニルまたはベンゾ[a]シ
クロヘプテン−カルボニルであり、R’’が水素原子で
あり、R’が水素原子である化合物またはその塩;など
が好ましく用いられる。また、式(I)または式
(I’)In the above formula, R 'represents a hydrogen atom or a hydrocarbon group which may have a substituent. As R ′,
A hydrogen atom, a lower alkyl group which may have a substituent (preferably, a halogen atom, a C 1-4 alkoxy group, a hydroxy group, a C 1-4 alkoxy-carbonyl group, a carboxyl group, a carbamoyl group, a mono- or A C 1-6 alkyl group which may have 1 to 3 substituent (s) selected from a di-C 1-4 alkylcarbamoyl group and a pyridylthio group, etc.), and a hydrogen atom, a C 1-6 alkyl group And the like are more preferable, and among them, a hydrogen atom is preferably used. As the compound represented by the formula (I) or a salt thereof, R is a compound represented by the formula R 1N CO— (R 1N may have a cyclic hydrocarbon group or a substituent which may have a substituent. A compound wherein R ″ is a hydrogen atom and R ′ is a hydrogen atom; or a salt thereof, wherein Ar 1 is a halogen atom, lower alkyl which may be halogenated. A 5- or 6-membered aromatic ring group which may have a substituent selected from a group, an optionally halogenated lower alkoxy group and an optionally substituted aryloxy group (for example, a phenyl group , A pyridyl group,
Thienyl group, furyl group, thiazolyl group and the like; preferably phenyl group and the like), and Ar 2 is a halogen atom,
5- or 6-membered aromatic ring group having a substituent selected from a lower alkyl group which may be halogenated and a lower alkoxy group which may be halogenated (for example, a phenyl group, a pyridyl group, a thienyl group, a furyl group) And a thiazolyl group; preferably a phenyl group), wherein R is a substituent selected from a halogen atom, an optionally halogenated C 1-6 alkoxy and an optionally halogenated C 1-6 alkyl. C optionally having a group
1-6 alkoxy-carbonyl, C 1-6 alkyl-carbonyl, C 6-10 aryl-carbonyl or benzo [a] cycloheptene-carbonyl, wherein R ″ is a hydrogen atom and R ′ is a hydrogen atom Or a salt thereof; and the like. Formula (I) or formula (I ′)
【0031】[0031]
【化13】 Embedded image
【0032】〔式中、各記号は前記と同意義〕で表され
る化合物は、少なくとも2個の不斉炭素を有するので、
これらの不斉炭素に基づく光学活性体は少なくとも4個
存在するが、その各々およびそれらの任意の混合物も
式(I)で表される化合物に包含される。また、式
(I)および式(I’)で表される化合物としては、式The compound represented by the formula: wherein each symbol is as defined above, has at least two asymmetric carbons.
There are at least four optically active isomers based on these asymmetric carbons, and each of them and any mixtures thereof also exist.
It is included in the compound represented by the formula (I). Compounds represented by the formula (I) and the formula (I ′) include a compound represented by the formula:
【0033】[0033]
【化14】 Embedded image
【0034】〔式中、各記号は前記と同意義〕で表され
る化合物が好ましく用いられる。A compound represented by the formula: wherein each symbol is as defined above, is preferably used.
【0035】本発明の式(I)または式(I’)で表さ
れる化合物の塩としては、医薬品として許容される塩な
いし生理学的に許容される酸付加塩が好ましい。このよ
うな塩としては、例えば無機酸(例えば、塩酸、リン
酸、臭化水素酸、硫酸など)あるいは有機酸(例えば、
酢酸、ギ酸、プロピオン酸、フマル酸、マレイン酸、コ
ハク酸、酒石酸、クエン酸、リンゴ酸、蓚酸、安息香
酸、メタンスルホン酸、ベンゼンスルホン酸など)など
が用いられる。さらに本発明の式(I)で表される化合
物がカルボン酸などの酸性基を有している場合、式
(I)で表される化合物は、例えば無機塩基(例えば、
ナトリウム、カリウム、カルシウム、マグネシウムなど
のアルカリ金属またはアルカリ土類金属、またはアンモ
ニアなど)あるいは有機塩基(例えば、トリエチルアミ
ンなどのトリ−C1-3アルキルアミンなど)と塩を形成
していてもよい。本発明の式(I)で表される化合物の
原料化合物も、上記と同様の塩が用いられるが、反応に
支障のない限り特に限定されない。本発明の式(I)で
表される化合物またはその塩〔以下、化合物(I)と称
することがある〕のプロドラッグは、生体内における生
理条件下で酵素や胃酸等による反応により化合物(I)
に変換する化合物、すなわち酵素的に酸化、還元、加水
分解等を起こして化合物(I)に変化する化合物、胃酸
等により加水分解などを起こして化合物(I)に変化す
る化合物をいう。化合物(I)のプロドラッグとして
は、化合物(I)のアミノ基がアシル化、アルキル化、
りん酸化された化合物(例えば、化合物(I)のアミノ
基がエイコサノイル化、アラニル化、ペンチルアミノカ
ルボニル化、(5−メチル−2−オキソ−1,3−ジオ
キソレン−4−イル)メトキシカルボニル化、テトラヒ
ドロフラニル化、ピロリジルメチル化、ピバロイルオキ
シメチル化、tert−ブチル化された化合物など)、
化合物(I)の水酸基がアシル化、アルキル化、りん酸
化、ほう酸化された化合物(例えば、化合物(I)の水
酸基がアセチル化、パルミトイル化、プロパノイル化、
ピバロイル化、サクシニル化、フマリル化、アラニル
化、ジメチルアミノメチルカルボニル化された化合物な
ど)、あるいは、化合物(I)のカルボキシル基がエス
テル化、アミド化された化合物(例えば、化合物(I)
のカルボキシル基がエチルエステル化、フェニルエステ
ル化、カルボキシメチルエステル化、ジメチルアミノメ
チルエステル化、ピバロイルオキシメチルエステル化、
エトキシカルボニルオキシエチルエステル化、フタリジ
ルエステル化、(5−メチル−2−オキソ−1,3−ジ
オキソレン−4−イル)メチルエステル化、シクロヘキ
シルオキシカルボニルエチルエステル化、メチルアミド
化された化合物など)等が挙げられる。これらの化合物
は自体公知の方法によって化合物(I)から製造するこ
とができる。また化合物(I)のプロドラッグは、広川
書店1990年刊「医薬品の開発」第7巻分子設計16
3頁から198頁に記載されているような、生理的条件
で化合物(I)に変化するものであってもよい。また、
式(I’)で表される化合物またはその塩〔以下、化合
物(I’)と称することがある〕のプロドラッグとして
は、化合物(I)のプロドラッグと同様なものが挙げら
れる。As the salt of the compound represented by the formula (I) or (I ') of the present invention, a pharmaceutically acceptable salt or a physiologically acceptable acid addition salt is preferable. Such salts include, for example, inorganic acids (eg, hydrochloric acid, phosphoric acid, hydrobromic acid, sulfuric acid, etc.) or organic acids (eg,
Acetic acid, formic acid, propionic acid, fumaric acid, maleic acid, succinic acid, tartaric acid, citric acid, malic acid, oxalic acid, benzoic acid, methanesulfonic acid, benzenesulfonic acid, and the like are used. Furthermore, when the compound represented by the formula (I) of the present invention has an acidic group such as a carboxylic acid, the compound represented by the formula (I) is, for example, an inorganic base (for example,
A salt may be formed with an alkali metal or alkaline earth metal such as sodium, potassium, calcium, and magnesium, or ammonia, or an organic base (eg, tri-C 1-3 alkylamine such as triethylamine). As the starting compound of the compound represented by the formula (I) of the present invention, the same salt as described above is used, but is not particularly limited as long as the reaction is not hindered. The prodrug of the compound represented by the formula (I) of the present invention or a salt thereof (hereinafter may be referred to as compound (I)) can be prepared by reacting the compound (I) with an enzyme or gastric acid under physiological conditions in a living body. )
A compound which is converted into a compound (I) by enzymatic oxidation, reduction, hydrolysis or the like, or a compound which is converted into a compound (I) by hydrolysis or the like by gastric acid or the like. As a prodrug of compound (I), the amino group of compound (I) is acylated, alkylated,
A phosphorylated compound (for example, the amino group of compound (I) is eicosanoylated, alanylated, pentylaminocarbonylated, (5-methyl-2-oxo-1,3-dioxolen-4-yl) methoxycarbonylated, Tetrahydrofuranylation, pyrrolidylmethylation, pivaloyloxymethylation, tert-butylated compound, etc.),
Compounds in which the hydroxyl group of compound (I) is acylated, alkylated, phosphorylated, and borated (for example, the hydroxyl group of compound (I) is acetylated, palmitoylated, propanoylated,
Pivaloylation, succinylation, fumarylation, alanylation, dimethylaminomethylcarbonylated compound, etc.) or a compound in which the carboxyl group of compound (I) is esterified or amidated (for example, compound (I)
The carboxyl group of ethyl esterification, phenyl esterification, carboxymethyl esterification, dimethylaminomethyl esterification, pivaloyloxymethyl esterification,
Ethoxycarbonyloxyethylesterification, phthalidylesterification, (5-methyl-2-oxo-1,3-dioxolen-4-yl) methylesterification, cyclohexyloxycarbonylethylesterification, methylamidated compound, etc.) Is mentioned. These compounds can be produced from compound (I) by a method known per se. The prodrug of compound (I) is described in “Development of Pharmaceuticals”, Hirokawa Shoten, 1990, Vol.
Compounds that change to compound (I) under physiological conditions as described on pages 3 to 198 may be used. Also,
Examples of the prodrug of the compound represented by the formula (I ′) or a salt thereof (hereinafter, sometimes referred to as compound (I ′)) include the same prodrugs as compound (I).
【0036】また、化合物(I)または化合物(I’)
は水和物であってもよい。化合物(I)または化合物
(I’)の光学的に活性な形態が必要とされる場合、例
えば、光学的に活性な出発物質を使用して、あるいは従
来の方法を使用する該化合物のラセミ形態の分割によっ
て得ることができる。Compound (I) or compound (I ')
May be a hydrate. If an optically active form of compound (I) or compound (I ') is required, for example, using an optically active starting material or a racemic form of said compound using conventional methods Can be obtained by dividing
【0037】本発明の化合物(I)の好ましい具体例を
以下に示す。N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[4-(トリフルオロ
メチル)ベンジル]エチル]-6,7-ジヒドロ-5H-ベ
ンゾ[a]シクロヘプテン-1-カルボキサミド、4-フ
ルオロ-N-((1R,2S)-2-(4-フルオロフェニ
ル)-2-ヒドロキシ-1-((4-(トリフルオロメチ
ル)フェニル)メチル)エチル)-1-ナフタレンカルボ
キサミド、N-[(1R,2S)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]-6,7-ジヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサ
ミド、N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]-5,6-ジヒ
ドロナフタレン-1-カルボキサミド、N-[(1RS,
2SR)-2-(4-フルオロフェニル)-2-ヒドロキシ-
1-[3-(1,1,2,2-テトラフルオロエトキシ)
ベンジル]エチル]-6,7,8,9-テトラヒドロ-5
H-ベンゾ[a]シクロヘプテン-1-カルボキサミド、
4-フルオロ-N-[(1R,2S)-2-(4-フルオロフ
ェニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テ
トラフルオロエトキシ)ベンジル]エチル]ナフタレン
-1-カルボキサミド、N-[(1RS,2SR)-2-
(4-フルオロフェニル)-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-5,6,7,8-テトラヒドロベンゾ
[a]シクロオクテン-1-カルボキサミド、N-[(1
RS,2SR)-2-(4-フルオロフェニル)-2-ヒド
ロキシ-1-(4-イソプロピルベンジル)エチル]-6,
7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カ
ルボキサミド、N-((1RS,2SR)-2-(3-フル
オロフェニル)-2-ヒドロキシ-1-((4-(トリフル
オロメチル)フェニル)メチル)エチル)-6,7-ジヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサ
ミド、N-((1RS,2SR)-2-ヒドロキシ-2-
(4-フェノキシフェニル)-1-((4-(トリフルオロ
メチル)フェニル)メチル)エチル)-6,7-ジヒドロ
-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミ
ド、N-[(1RS,2SR)-2-(4-クロロフェニ
ル)-2-ヒドロキシ-1-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]エチル]-6,7-ジヒド
ロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミ
ド、N-((1RS,2SR)-2-ヒドロキシ-2-(4-
(フェニルオキシ)フェニル)-1-((3-((1,
1,2,2-テトラフルオロエチル)オキシ)フェニ
ル)メチル)エチル)-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド、N-((1
RS,2SR)-2-(4-((4-クロロ-3-エチルフェ
ニル)オキシ)フェニル)-2-ヒドロキシ-1-((3-
((1,1,2,2-テトラフルオロエチル)オキシ)
フェニル)メチル)エチル)-6,7-ジヒドロ-5H-ベ
ンゾ[a]シクロヘプテン-1-カルボキサミド、N-
((1RS,2SR)-2-(2-フルオロピリジン-4-
イル)-2-ヒドロキシ-1-((3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル)メチル)エチル)-
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボキサミド、N-((1RS,2RS)-2-(6-
フルオロピリジン-2-イル)-2-ヒドロキシ-1-((3
-(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)エチル)-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド、N−[(1
RS,2SR)−1−(4−tert−ブチルベンジ
ル)−2−(3−クロロフェニル)−2−ヒドロキシエ
チル]−5−クロロ−1−ナフトアミド、4−フルオロ
−N−{(1RS,2SR)−2−(4−フルオロフェ
ニル)−2−ヒドロキシ−1−[(2,2,3,3−テ
トラフルオロ−2,3−ジヒドロ−1,4−ベンゾジオ
キシン−6−イル)メチル]エチル}−1−ナフトアミ
ドおよびこれらの塩など。Preferred specific examples of the compound (I) of the present invention are shown below. N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene -1-Carboxamide, 4-fluoro-N-((1R, 2S) -2- (4-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -1 -Naphthalenecarboxamide, N-[(1R, 2S) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6 , 7-Dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2 , 2-Tetrafluoroethoxy) benzyl] ethyl] -5,6-dihydrido Naphthalene-1-carboxamide, N - [(1RS,
2SR) -2- (4-Fluorophenyl) -2-hydroxy-
1- [3- (1,1,2,2-tetrafluoroethoxy)
[Benzyl] ethyl] -6,7,8,9-tetrahydro-5
H-benzo [a] cycloheptene-1-carboxamide,
4-fluoro-N-[(1R, 2S) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] naphthalene
-1-carboxamide, N-[(1RS, 2SR) -2-
(4-Fluorophenyl) -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -5,6,7,8-tetrahydrobenzo [a] cyclooctene-1-carboxamide, N-[(1
RS, 2SR) -2- (4-Fluorophenyl) -2-hydroxy-1- (4-isopropylbenzyl) ethyl] -6
7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-((1RS, 2SR) -2- (3-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl ) Methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-((1RS, 2SR) -2-hydroxy-2-
(4-phenoxyphenyl) -1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -6,7-dihydro
-5H-benzo [a] cycloheptene-1-carboxamide, N-[(1RS, 2SR) -2- (4-chlorophenyl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoro) Ethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-((1RS, 2SR) -2-hydroxy-2- (4-
(Phenyloxy) phenyl) -1-((3-((1,
1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-((1
RS, 2SR) -2- (4-((4-chloro-3-ethylphenyl) oxy) phenyl) -2-hydroxy-1-((3-
((1,1,2,2-tetrafluoroethyl) oxy)
Phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-
((1RS, 2SR) -2- (2-fluoropyridine-4-
Yl) -2-hydroxy-1-((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) ethyl)-
6,7-dihydro-5H-benzo [a] cycloheptene-1
-Carboxamide, N-((1RS, 2RS) -2- (6-
Fluoropyridin-2-yl) -2-hydroxy-1-((3
-(1,1,2,2-tetrafluoroethoxy) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-[(1
RS, 2SR) -1- (4-tert-butylbenzyl) -2- (3-chlorophenyl) -2-hydroxyethyl] -5-chloro-1-naphthamide, 4-fluoro-N-{(1RS, 2SR) -2- (4-Fluorophenyl) -2-hydroxy-1-[(2,2,3,3-tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-yl) methyl] ethyl} -1-naphthamide and salts thereof.
【0038】以下に本発明の化合物(I)の合成法を説
明するが、以下の各合成法の説明において塩を形成し得
る原料化合物は、塩の形で用いてもよく、このような塩
としては特に限定されないが、例えば前記化合物(I)
で述べたごとき塩が用いられる。本発明の化合物(I)
において、R’’が水素原子である化合物(Ia)は、
例えば、次の方法などによって合成することができる。 (i)The method for synthesizing the compound (I) of the present invention is described below. In the following description of each synthesis method, the starting compound capable of forming a salt may be used in the form of a salt. Is not particularly limited, for example, the compound (I)
Salts such as those described above are used. Compound (I) of the present invention
In the compound (Ia) wherein R ″ is a hydrogen atom,
For example, it can be synthesized by the following method. (I)
【0039】[0039]
【化15】 Embedded image
【0040】[式中の記号は、前記と同意義]本方法は
化合物(II)をアシル化して化合物(I)を得る方法で
ある。化合物(II)を化合物(I)に変換する反応は、
自体公知の反応であり、例えば第4版実験化学講座(丸
善)第22巻有機合成IV138-151頁,259-27
1頁、第24巻有機合成VI391-392頁,396-3
97頁などに記載あるいは引用されている条件に準じて
あるいは参考にして行うことができる。また、化合物
(I)において、R’’が水素原子である化合物(I
a)を水酸基の保護反応に付すことにより、R’’が水
酸基の保護基である化合物(Ib)への変換を行うこと
が可能であるが、例えば、R’’がアシル基である場合
には、本方法に準じて行うこともできる。水酸基への保
護基を導入する反応は、それ自体公知またはそれに準じ
る方法が用いられるが、例えば「PROTECTIVE
GROUPS IN ORGANIC SYNTHE
SIS」Second Edition(JOHN W
ILEY & SONS,INC.)10-142頁な
どに記載あるいは引用されている条件に準じてあるいは
参考にして行うことができる。[The symbols in the formula are as defined above.] This method is a method of acylating compound (II) to obtain compound (I). The reaction for converting the compound (II) into the compound (I) is as follows:
It is a reaction known per se, for example, the fourth edition of Experimental Chemistry Course (Maruzen), Vol. 22, Organic Synthesis IV, pp. 138-151, 259-27.
Page 1, Vol. 24, Organic Synthesis VI, 391-392, 396-3
It can be carried out according to or referring to the conditions described or cited on page 97 or the like. In the compound (I), the compound (I) wherein R ″ is a hydrogen atom
By subjecting a) to a hydroxyl-protecting reaction, it is possible to convert the compound (Ib) in which R ″ is a hydroxyl-protecting group. For example, when R ″ is an acyl group, Can be performed according to the present method. The reaction for introducing a protecting group to a hydroxyl group may be carried out by a method known per se or a method analogous thereto.
GROUPS IN ORGANIC SYNTHE
SIS "Second Edition (JOHN W
ILEY & SONS, INC. ) It can be performed according to or referring to the conditions described or cited on pages 10-142.
【0041】(ii)(Ii)
【0042】[0042]
【化16】 Embedded image
【0043】[式中の記号は、前記と同意義]化合物
(III)の還元反応では、化合物(III)に対して還元剤
を使用する方法、触媒存在下における接触水素添加、鉛
や白金を陰極とした電解還元などを用いることができ
る。還元剤としては、水素化ホウ素ナトリウム、シアノ
水素化ホウ素ナトリウム、水素化アルミニウムリチウ
ム、水素化ホウ素亜鉛などの金属水素錯化合物やジボラ
ンなどが挙げられ、還元剤は1当量ないし大過剰(好ま
しくは1−10当量)使用する。水素添加において用い
る触媒としてはパラジウム、白金、ニッケル、ロジウム
など金属あるいはこれらの酸化物、塩、錯体などが挙げ
られ、これらの触媒は炭素など種々の担持物に担持させ
て用いることもできる。また水素添加は常圧ないし加圧
下で行うことができる。この際用いる溶媒は、還元剤の
種類によって適宜選択することができ、例えばアルコー
ル類(例えば、メタノールやエタノールなど)、エーテ
ル類(例えば、テトラヒドロフラン、ジオキサン、ジエ
チルエーテルなど)、ハロゲン化炭化水素(例えば、塩
化メチレン、クロロホルムなど)、非プロトン性極性溶
媒(例えば、N,N-ジメチルホルムアミド、ジメチル
スルホキシドなど)などが挙げられる。また、還元剤を
用いる還元においては反応制御のために塩化亜鉛、塩化
マンガン、塩化アルミニウム、塩化マグネシウムなどの
金属ハロゲン化物を触媒量ないしは大過剰(好ましくは
0.1ないし2当量)加えて反応を行うこともできる。
反応時間は0.5ないし72時間、好ましくは1ないし
24時間である。反応温度は−100から100℃(好
ましくは−80ないし50℃)で行うことができる。[The symbols in the formula are as defined above] In the reduction reaction of compound (III), a method using a reducing agent for compound (III), catalytic hydrogenation in the presence of a catalyst, lead or platinum Electrolytic reduction or the like serving as a cathode can be used. Examples of the reducing agent include metal hydride complex compounds such as sodium borohydride, sodium cyanoborohydride, lithium aluminum hydride and zinc borohydride, and diborane. The reducing agent is used in an amount of 1 equivalent to a large excess (preferably -10 equivalents). Examples of the catalyst used in the hydrogenation include metals such as palladium, platinum, nickel, and rhodium, and oxides, salts, and complexes thereof. These catalysts can also be used by being supported on various supports such as carbon. The hydrogenation can be performed under normal pressure or under pressure. The solvent used at this time can be appropriately selected depending on the type of the reducing agent, and examples thereof include alcohols (eg, methanol and ethanol), ethers (eg, tetrahydrofuran, dioxane, diethyl ether, etc.), and halogenated hydrocarbons (eg, , Methylene chloride, chloroform, etc.), aprotic polar solvents (eg, N, N-dimethylformamide, dimethyl sulfoxide, etc.). In the reduction using a reducing agent, a metal halide such as zinc chloride, manganese chloride, aluminum chloride or magnesium chloride is added in a catalytic amount or a large excess (preferably 0.1 to 2 equivalents) to control the reaction. You can do it too.
The reaction time is 0.5 to 72 hours, preferably 1 to 24 hours. The reaction can be carried out at a temperature of -100 to 100C (preferably -80 to 50C).
【0044】化合物(II)は例えば以下に示す方法によ
って合成することができる。(i)R’が水素原子であ
る場合Compound (II) can be synthesized, for example, by the following method. (I) When R 'is a hydrogen atom
【0045】[0045]
【化17】 Embedded image
【0046】[式中、R3、R4およびR5はそれぞれ置
換基を有していてもよいC1-6アルキル、置換基を有し
ていてもよいC7-10アラルキル、置換基を有していても
よいC7- 16アラルキルを、Mはナトリウム、マグネシウ
ムなどの金属原子(2価の金属の場合、残りの1価はハ
ロゲン原子などで占有されていてもよい)を示し、M’
は水素原子またはナトリウム、マグネシウムなどの金属
原子(2価の金属の場合、残りの1価はハロゲン原子な
どで占有されていてもよい)を示し、その他の記号は前
記と同意義] 本方法は化合物(IV)にAr2CH2−Mを反応させ、生
成するイミンまたはイミニウムイオン(V)を還元した
後、シリルエーテルを酸により脱保護して化合物(I
I’)を得る方法である。該反応では化合物(IV)に対
して、Ar2CH2−Mを1当量ないし大過剰(好ましく
は1−10当量)使用する。引き続き行う還元反応は還
元剤を使用する方法、触媒存在下における接触水素添
加、鉛や白金を陰極とした電解還元などを用いることが
できる。還元剤としては、水素化ホウ素ナトリウム、シ
アノ水素化ホウ素ナトリウム、水素化アルミニウムリチ
ウム、水素化ホウ素亜鉛などの金属水素錯化合物やジボ
ランなどが挙げられ、還元剤は1当量ないし大過剰(好
ましくは1−10当量)使用する。水素添加において用
いる触媒としてはパラジウム、白金、ニッケル、ロジウ
ムなど金属あるいはこれらの酸化物、塩、錯体などが挙
げられ、これらの触媒は炭素など種々の担持物に担持さ
せて用いることもできる。また水素添加は常圧ないし加
圧下で行うことができる。この際用いる溶媒は、例えば
エーテル類(例えば、テトラヒドロフラン、ジオキサ
ン、ジエチルエーテルなど)、炭化水素(例えば、トル
エン、ヘキサンなど)、ハロゲン化炭化水素(例えば、
塩化メチレン、クロロホルムなど)などが挙げられる。
反応時間は0.5ないし72時間、好ましくは1ないし
24時間である。反応温度は−100から100℃(好
ましくは−80ないし50℃)で行うことができる。還
元反応の後、反応混合物に対し塩酸、硫酸、酢酸等の酸
の水溶液を加え、シリルエーテルを脱保護して、化合物
(II')を得ることができる。[In the formula, R 3 , R 4 and R 5 each represent a C 1-6 alkyl which may have a substituent, a C 7-10 aralkyl which may have a substituent, good C 7- 16 aralkyl optionally having, M is sodium, (if the divalent metal, the remaining monovalent may be occupied by a halogen atom) a metal atom such as magnesium indicates, M '
Represents a hydrogen atom or a metal atom such as sodium or magnesium (in the case of a divalent metal, the remaining monovalent may be occupied by a halogen atom or the like), and other symbols are as defined above. The compound (IV) is reacted with Ar 2 CH 2 -M to reduce the resulting imine or iminium ion (V), and the silyl ether is deprotected with an acid to give the compound (I
I '). In the reaction, Ar 2 CH 2 -M is used in an amount of 1 equivalent to a large excess (preferably 1 to 10 equivalents) relative to compound (IV). For the subsequent reduction reaction, a method using a reducing agent, catalytic hydrogenation in the presence of a catalyst, electrolytic reduction using lead or platinum as a cathode can be used. Examples of the reducing agent include metal hydride complex compounds such as sodium borohydride, sodium cyanoborohydride, lithium aluminum hydride and zinc borohydride, and diborane. The reducing agent is used in an amount of 1 equivalent to a large excess (preferably -10 equivalents). Examples of the catalyst used in the hydrogenation include metals such as palladium, platinum, nickel, and rhodium, and oxides, salts, and complexes thereof. These catalysts can also be used by being supported on various supports such as carbon. The hydrogenation can be performed under normal pressure or under pressure. The solvent used at this time is, for example, ethers (eg, tetrahydrofuran, dioxane, diethyl ether, etc.), hydrocarbons (eg, toluene, hexane, etc.), halogenated hydrocarbons (eg,
Methylene chloride, chloroform, etc.).
The reaction time is 0.5 to 72 hours, preferably 1 to 24 hours. The reaction can be carried out at a temperature of -100 to 100C (preferably -80 to 50C). After the reduction reaction, an aqueous solution of an acid such as hydrochloric acid, sulfuric acid, or acetic acid is added to the reaction mixture to deprotect the silyl ether, whereby the compound (II ′) can be obtained.
【0047】(ii)(Ii)
【0048】[0048]
【化18】 Embedded image
【0049】[式中、Dはtert-ブトキシカルボニ
ル、ベンジルオキシカルボニル、アセチル、トリフルオ
ロアセチル、ベンジル等のようなアミノ基の保護基を示
し、その他の記号は前記と同意義] 化合物(VI)のアミノ基の保護基を脱保護して化合物
(II)を得る方法である。アミノ基の保護基の除去反応
は、自体すべて公知の反応であり、それらの条件に準じ
て行うことができる。[Wherein D represents an amino-protecting group such as tert-butoxycarbonyl, benzyloxycarbonyl, acetyl, trifluoroacetyl, benzyl, etc., and other symbols are as defined above]. Compound (VI) In which the protecting group of the amino group is deprotected to obtain a compound (II). The reaction for removing the protecting group for the amino group is a reaction known per se, and can be performed under these conditions.
【0050】(iii)(Iii)
【化19】 Embedded image
【0051】[式中の記号は、前記と同意義] 化合物(VII)の化合物(II)への変換反応は、水酸化
ナトリウムや水素化カリウムなど金属水酸化物の水溶
液、塩酸や硫酸などの酸水溶液、ヨウ化トリメチルシリ
ルなど1当量ないし大過剰存在下で行われる。この際用
いる溶媒としては、例えば水、アルコール類(例えば、
メタノールやエタノールなど)、エーテル類(例えば、
テトラヒドロフラン、ジオキサン、ジエチルエーテルな
ど)、ハロゲン化炭化水素(例えば、塩化メチレン、ク
ロロホルム等)、ケトン類(例えば、アセトン、メチル
エチルケトンなど)、および非プロトン性極性溶媒(例
えば、N,N-ジメチルホルムアミド、ジメチルスルホ
キシドなど)などが挙げられる。反応時間は10分間な
いし24時間、反応温度は−20から200℃(好まし
くは0ないし100℃)で行うことができる。[The symbols in the formula are as defined above.] The conversion reaction of the compound (VII) into the compound (II) is performed by using an aqueous solution of a metal hydroxide such as sodium hydroxide or potassium hydride, or an aqueous solution of hydrochloric acid or sulfuric acid. The reaction is carried out in the presence of one equivalent to a large excess of an acid aqueous solution, trimethylsilyl iodide or the like. As the solvent used at this time, for example, water, alcohols (for example,
Methanol and ethanol), ethers (for example,
Tetrahydrofuran, dioxane, diethyl ether, etc.), halogenated hydrocarbons (eg, methylene chloride, chloroform, etc.), ketones (eg, acetone, methyl ethyl ketone, etc.), and aprotic polar solvents (eg, N, N-dimethylformamide, Dimethyl sulfoxide) and the like. The reaction can be performed for 10 minutes to 24 hours and at a reaction temperature of -20 to 200 ° C (preferably 0 to 100 ° C).
【0052】化合物(III)は例えば以下に示す方法に
よって合成することができる。Compound (III) can be synthesized, for example, by the following method.
【0053】[0053]
【化20】 Embedded image
【0054】[式中の記号は、前記と同意義] 化合物(VIII)の化合物(III)への変換反応は、例え
ば化合物(I)の合成における(i)に示す方法と同様
の条件下で行われる。[The symbols in the formula are as defined above.] The conversion reaction of the compound (VIII) into the compound (III) is carried out, for example, under the same conditions as in the method (i) in the synthesis of the compound (I). Done.
【0055】化合物(IV)は例えば以下に示す方法によ
って合成することができる。Compound (IV) can be synthesized, for example, by the following method.
【0056】[0056]
【化21】 Embedded image
【0057】[式中の記号は、前記と同意義] 化合物(IX)を化合物(IV)に変換する反応は、自体公
知の反応であり、例えばTetrahedron Le
tt.,26,4275-4278(1985)、J.
Org.Chem.,51,413-415(198
6)、Tetrahedron Lett.,28,5
513-5516(1987)、Chem.Let
t.,537-540(1991)、J.Chem.S
oc.Chem.Comm.1752-1753(19
91)、J.Org.Chem.,55,1479-1
483(1990)、J.Fluorine Che
m.,35,287-294(1987)、Tetra
hedron Lett.,33,2159-2162
(1992)、Tetrahedron Lett.,
34,4001-4004(1992)などに記載ある
いは引用されている条件に準じてあるいは参考にして行
うことができる。[The symbols in the formula are as defined above] The reaction for converting the compound (IX) to the compound (IV) is a reaction known per se, for example, Tetrahedron Le
tt. , 26, 4275-4278 (1985);
Org. Chem. , 51, 413-415 (198
6), Tetrahedron Lett. , 28,5
513-5516 (1987), Chem. Let
t. , 537-540 (1991); Chem. S
oc. Chem. Comm. 1752-1753 (19
91); Org. Chem. , 55,1479-1
483 (1990); Fluorine Che
m. , 35, 287-294 (1987), Tetra.
hedron Lett. , 33, 2159-2162
(1992), Tetrahedron Lett. ,
34, 4001-4004 (1992), etc., or according to or referring to the conditions described or cited.
【0058】化合物(VI)は例えば以下に示す方法によ
って合成することができる。 (i)Compound (VI) can be synthesized, for example, by the following method. (I)
【0059】[0059]
【化22】 Embedded image
【0060】[式中の記号は、前記と同意義] 化合物(X)の化合物(VI)への変換反応は、例えば化
合物(I)の合成における(ii)に示す方法と同様の
条件下で行われる。[The symbols in the formula are as defined above.] The conversion reaction of the compound (X) into the compound (VI) is performed, for example, under the same conditions as in the method (ii) in the synthesis of the compound (I). Done.
【0061】(ii)R’が水素原子である場合(Ii) When R 'is a hydrogen atom
【0062】[0062]
【化23】 Embedded image
【0063】[式中の記号は、前記と同意義] 化合物(XI)の化合物(VI')への変換反応は、例えば
化合物(II)の合成における(iii)に示す方法と同
様の条件下で行われる。[The symbols in the formula are as defined above.] The conversion reaction of the compound (XI) into the compound (VI ') is performed, for example, under the same conditions as in the method (iii) in the synthesis of the compound (II). Done in
【0064】化合物(VII)はR’が水素原子ではない
場合、例えば以下に示す方法によって合成することがで
きる。When R ′ is not a hydrogen atom, compound (VII) can be synthesized, for example, by the following method.
【0065】[0065]
【化24】 Embedded image
【0066】[式中の記号は、前記と同意義] この方法は化合物(VII’)をアルキル化剤と反応させ
て、化合物(VII)を得る方法である。該反応では化合
物(VII’)に対してアルキル化剤を1当量ないし大過
剰(好ましくは1−10当量)使用する。この際、例え
ば水酸化ナトリウム、水酸化カリウム、水素化ナトリウ
ム、炭酸カリウム、トリエチルアミン、ジイソプロピル
エチルアミン、ピリジン、4-N,N-ジメチルアミノピ
リジン(DMAP)、1,8-ジアザビシクロ〔5.4.
0〕-7-ウンデセン、1,4-ジアザビシクロ〔2.
2.2〕オクタン(DABCO)などの塩基性化合物を
1−10当量用いてもよい。用いるアルキル化剤として
は、ハロゲン化炭化水素、メタンスルホン酸アルキルや
p-トルエンスルホン酸アルキルなどのスルホン酸エス
テル類などが挙げられる。また該反応は、反応促進剤と
してヨウ化ナトリウムなどのヨウ化アルカリ金属を1当
量ないし大過剰(好ましくは1−10当量)加えてもよ
い。この際用いる溶媒としては、例えば水、アルコール
類(例えば、メタノールやエタノールなど)、エーテル
類(例えば、テトラヒドロフラン、ジオキサン、ジエチ
ルエーテルなど)、ハロゲン化炭化水素(例えば、塩化
メチレン、クロロホルム等)、ケトン類(例えば、アセ
トン、メチルエチルケトンなど)、および非プロトン性
極性溶媒(例えば、N,N-ジメチルホルムアミド、ジ
メチルスルホキシドなど)などが挙げられる。反応時間
は10分間ないし24時間、好ましくは0.5ないし6
時間である。反応温度は−20から200℃(好ましく
は0ないし150℃)で行うことができる。[The symbols in the formula are as defined above.] This method is a method of reacting compound (VII ') with an alkylating agent to obtain compound (VII). In the reaction, an alkylating agent is used in an amount of 1 equivalent to a large excess (preferably 1 to 10 equivalents) relative to compound (VII '). At this time, for example, sodium hydroxide, potassium hydroxide, sodium hydride, potassium carbonate, triethylamine, diisopropylethylamine, pyridine, 4-N, N-dimethylaminopyridine (DMAP), 1,8-diazabicyclo [5.4.
0] -7-undecene, 1,4-diazabicyclo [2.
2.2] A basic compound such as octane (DABCO) may be used in an amount of 1 to 10 equivalents. Examples of the alkylating agent to be used include halogenated hydrocarbons and sulfonates such as alkyl methanesulfonate and alkyl p-toluenesulfonate. In the reaction, 1 equivalent to a large excess (preferably 1 to 10 equivalents) of an alkali metal iodide such as sodium iodide may be added as a reaction accelerator. Examples of the solvent used at this time include water, alcohols (eg, methanol and ethanol), ethers (eg, tetrahydrofuran, dioxane, diethyl ether, etc.), halogenated hydrocarbons (eg, methylene chloride, chloroform, etc.), ketones (Eg, acetone, methyl ethyl ketone, etc.), and aprotic polar solvents (eg, N, N-dimethylformamide, dimethyl sulfoxide, etc.). The reaction time is 10 minutes to 24 hours, preferably 0.5 to 6 hours.
Time. The reaction can be carried out at a temperature of -20 to 200 ° C (preferably 0 to 150 ° C).
【0067】化合物(VII’)(化合物(VII)でR’が
水素原子の場合)は例えば以下に示す方法によって合成
することができる。Compound (VII ′) (when R ′ is a hydrogen atom in compound (VII)) can be synthesized, for example, by the following method.
【0068】[0068]
【化25】 Embedded image
【0069】[式中の記号は、前記と同意義] この方法は化合物(XII)のカルボキシル基をアシルア
ジドに変換し、これをいわゆるクルチウス(Curtius)
転移反応を用いてイソシアネートに誘導、生じたイソシ
アネートが分子内の水酸基と環化反応して化合物(VI
I')を得る方法である。該反応の中でアシルアジドは、
例えば以下に述べる3つの方法で合成することができ
る。[The symbols in the formula are as defined above] This method converts the carboxyl group of compound (XII) into an acyl azide, and converts this to a so-called Curtius.
The isocyanate is induced using a rearrangement reaction, and the resulting isocyanate undergoes a cyclization reaction with a hydroxyl group in the molecule to form a compound (VI
I '). In the reaction, the acyl azide is
For example, it can be synthesized by the following three methods.
【0070】A法:まず、化合物(XII)を1当量ない
し大過剰のハロゲン化剤(例えば塩化チオニル、塩化オ
キザリル、五塩化リンなど)で処理してハロゲン化アシ
ルに変換する。本反応ではピリジン、4-N,N-ジメチ
ルアミノピリジン、トリエチルアミンなどの塩基性化合
物を1−10当量用いてもよい。該反応は、反応促進剤
としてN,N-ジメチルホルムアミドを触媒量加えても
よい。この際用いる溶媒としては、例えばエーテル類
(例えば、テトラヒドロフラン、ジオキサン、ジエチル
エーテルなど)、ハロゲン化炭化水素(例えば、塩化メ
チレン、クロロホルム等)、ケトン類(例えば、アセト
ン、メチルエチルケトンなど)、エステル類(例えば酢
酸エチルなど)、および非プロトン性極性溶媒(例え
ば、N,N-ジメチルホルムアミド、ジメチルスルホキ
シドなど)などが挙げられる。反応温度は−100から
200℃(好ましくは−20ないし100℃)で行うこ
とができる。得られたハロゲン化アシルを、1当量ない
し大過剰のアジ化アルカリ金属塩(例えばアジ化ナトリ
ウムなど)と反応させてアシルアジドを生成する。本反
応ではピリジン、4-N,N-ジメチルアミノピリジン、
トリエチルアミンなどの塩基性化合物を1−10当量用
いてもよい。この際用いる溶媒としては、例えばエーテ
ル類(例えば、テトラヒドロフラン、ジオキサン、ジエ
チルエーテルなど)、ハロゲン化炭化水素(例えば、塩
化メチレン、クロロホルム等)、ケトン類(例えば、ア
セトン、メチルエチルケトンなど)、エステル類(例え
ば酢酸エチルなど)、および非プロトン性極性溶媒(例
えば、N,N-ジメチルホルムアミド、ジメチルスルホ
キシドなど)などが挙げられる。反応温度は−100か
ら200℃(好ましくは−20ないし100℃)で行う
ことができる。Method A: First, compound (XII) is treated with one equivalent to a large excess of a halogenating agent (eg, thionyl chloride, oxalyl chloride, phosphorus pentachloride, etc.) to convert to an acyl halide. In this reaction, 1 to 10 equivalents of a basic compound such as pyridine, 4-N, N-dimethylaminopyridine, or triethylamine may be used. In the reaction, a catalytic amount of N, N-dimethylformamide may be added as a reaction accelerator. Examples of the solvent used at this time include ethers (eg, tetrahydrofuran, dioxane, diethyl ether, etc.), halogenated hydrocarbons (eg, methylene chloride, chloroform, etc.), ketones (eg, acetone, methyl ethyl ketone, etc.), esters (eg, For example, ethyl acetate and the like, and aprotic polar solvents (for example, N, N-dimethylformamide, dimethyl sulfoxide and the like) and the like. The reaction can be carried out at a temperature of -100 to 200C (preferably -20 to 100C). The resulting acyl halide is reacted with one equivalent to a large excess of an alkali metal azide (eg, sodium azide) to form an acyl azide. In this reaction, pyridine, 4-N, N-dimethylaminopyridine,
A basic compound such as triethylamine may be used in 1 to 10 equivalents. Examples of the solvent used at this time include ethers (eg, tetrahydrofuran, dioxane, diethyl ether, etc.), halogenated hydrocarbons (eg, methylene chloride, chloroform, etc.), ketones (eg, acetone, methyl ethyl ketone, etc.), esters (eg, For example, ethyl acetate and the like, and aprotic polar solvents (for example, N, N-dimethylformamide, dimethyl sulfoxide and the like) and the like. The reaction can be carried out at a temperature of -100 to 200C (preferably -20 to 100C).
【0071】B法:化合物(XII)をA法で述べた方法
でハロゲン化アシルに変換した後、これを1当量ないし
大過剰のヒドラジンと処理してヒドラジドにする。本反
応ではピリジン、4-N,N-ジメチルアミノピリジン、
トリエチルアミンなどの塩基性化合物を1−10当量用
いてもよい。この際用いる溶媒としては、例えばエーテ
ル類(例えば、テトラヒドロフラン、ジオキサン、ジエ
チルエーテルなど)、ハロゲン化炭化水素(例えば、塩
化メチレン、クロロホルム等)、ケトン類(例えば、ア
セトン、メチルエチルケトンなど)、エステル類(例え
ば酢酸エチルなど)、および非プロトン性極性溶媒(例
えば、N,N-ジメチルホルムアミド、ジメチルスルホ
キシドなど)などが挙げられる。反応温度は−100か
ら200℃(好ましくは−20ないし100℃)で行う
ことができる。得られたヒドラジドを1当量ないし大過
剰の亜硝酸(酸存在下で例えば亜硝酸ナトリウムなどの
亜硝酸金属塩から発生させることもできる)と処理して
アシルアジドを生成する。この際用いる溶媒としては、
例えば水、アルコール類(例えば、メタノールやエタノ
ールなど)、エーテル類(例えば、テトラヒドロフラ
ン、ジオキサン、ジエチルエーテルなど)、ハロゲン化
炭化水素(例えば、塩化メチレン、クロロホルム等)、
ケトン類(例えば、アセトン、メチルエチルケトンな
ど)、エステル類(例えば酢酸エチルなど)、および非
プロトン性極性溶媒(例えば、N,N-ジメチルホルム
アミド、ジメチルスルホキシドなど)などが挙げられ
る。反応温度は−100から200℃(好ましくは−2
0ないし50℃)で行うことができる。Method B: After converting the compound (XII) into an acyl halide by the method described in Method A, the compound is treated with 1 equivalent or a large excess of hydrazine to give hydrazide. In this reaction, pyridine, 4-N, N-dimethylaminopyridine,
A basic compound such as triethylamine may be used in 1 to 10 equivalents. Examples of the solvent used at this time include ethers (eg, tetrahydrofuran, dioxane, diethyl ether, etc.), halogenated hydrocarbons (eg, methylene chloride, chloroform, etc.), ketones (eg, acetone, methyl ethyl ketone, etc.), esters (eg, For example, ethyl acetate and the like, and aprotic polar solvents (for example, N, N-dimethylformamide, dimethyl sulfoxide and the like) and the like. The reaction can be carried out at a temperature of -100 to 200C (preferably -20 to 100C). The resulting hydrazide is treated with one equivalent to a large excess of nitrous acid (which can also be generated from a metal nitrite such as sodium nitrite in the presence of an acid) to produce an acyl azide. As the solvent used at this time,
For example, water, alcohols (eg, methanol, ethanol, etc.), ethers (eg, tetrahydrofuran, dioxane, diethyl ether, etc.), halogenated hydrocarbons (eg, methylene chloride, chloroform, etc.),
Examples include ketones (eg, acetone, methyl ethyl ketone, etc.), esters (eg, ethyl acetate, etc.), and aprotic polar solvents (eg, N, N-dimethylformamide, dimethyl sulfoxide, etc.). The reaction temperature is from -100 to 200 ° C (preferably -2
(0 to 50 ° C).
【0072】C法:化合物(XII)に1当量ないし大過
剰のジフェニルホスホリルアジドを反応させてアシルア
ジドを生成する。この際、例えば水酸化ナトリウム、水
酸化カリウム、水素化ナトリウム、炭酸カリウム、トリ
エチルアミン、ジイソプロピルエチルアミン、ピリジ
ン、4-N,N-ジメチルアミノピリジン(DMAP)、1,
8-ジアザビシクロ〔5.4.0〕-7-ウンデセン、
1,4-ジアザビシクロ〔2.2.2〕オクタン(DA
BCO)などの塩基性化合物を1−10当量用いてもよ
い。この際用いる溶媒としては、例えば水、アルコール
類(例えば、メタノールやエタノールなど)、エーテル
類(例えば、テトラヒドロフラン、ジオキサン、ジエチ
ルエーテルなど)、ハロゲン化炭化水素(例えば、塩化
メチレン、クロロホルム等)、ケトン類(例えば、アセ
トン、メチルエチルケトンなど)、エステル類(例えば
酢酸エチルなど)、および非プロトン性極性溶媒(例え
ば、N,N-ジメチルホルムアミド、ジメチルスルホキ
シドなど)などが挙げられる。反応時間は10分間ない
し24時間、好ましくは0.5ないし6時間である。反
応温度は−20から200℃で行うことができる。Method C: Compound (XII) is reacted with 1 equivalent to a large excess of diphenylphosphoryl azide to produce an acyl azide. At this time, for example, sodium hydroxide, potassium hydroxide, sodium hydride, potassium carbonate, triethylamine, diisopropylethylamine, pyridine, 4-N, N-dimethylaminopyridine (DMAP),
8-diazabicyclo [5.4.0] -7-undecene,
1,4-diazabicyclo [2.2.2] octane (DA
A basic compound such as BCO) may be used in an amount of 1 to 10 equivalents. Examples of the solvent used at this time include water, alcohols (eg, methanol and ethanol), ethers (eg, tetrahydrofuran, dioxane, diethyl ether, etc.), halogenated hydrocarbons (eg, methylene chloride, chloroform, etc.), ketones (Eg, acetone, methyl ethyl ketone, etc.), esters (eg, ethyl acetate, etc.), and aprotic polar solvents (eg, N, N-dimethylformamide, dimethyl sulfoxide, etc.). The reaction time is 10 minutes to 24 hours, preferably 0.5 to 6 hours. The reaction temperature can be from -20 to 200C.
【0073】得られたアシルアジドをクルチウス転移反
応に供することにより、イソシアネートに誘導する。該
反応は得られたアシルアジドを30から200℃に加熱
することにより実施される。この際、例えばトリエチル
アミン、ジイソプロピルエチルアミン、ピリジン、4-
N,N-ジメチルアミノピリジン(DMAP)、1,8-ジア
ザビシクロ〔5.4.0〕-7-ウンデセン、1,4-ジ
アザビシクロ〔2.2.2〕オクタン(DABCO)な
どの塩基性化合物を1−10当量用いてもよい。この
際、例えば水、アルコール類(例えば、メタノールやエ
タノールなど)、エーテル類(例えば、テトラヒドロフ
ラン、ジオキサン、ジエチルエーテルなど)、ハロゲン
化炭化水素(例えば、塩化メチレン、クロロホルム
等)、ケトン類(例えば、アセトン、メチルエチルケト
ンなど)、エステル類(例えば酢酸エチルなど)、およ
び非プロトン性極性溶媒(例えば、N,N-ジメチルホ
ルムアミド、ジメチルスルホキシドなど)などの溶媒中
で行うこともできる。反応時間は10分間ないし24時
間、好ましくは0.5ないし6時間である。本反応条件
下で、クルチウス反応に引き続く分子内環化反応を同一
系内で進行させ、化合物(VII')へ誘導することもでき
る。クルチウス反応により得られたイソシアネートの化
合物(VII')への誘導は、イソシアネートを、30から
200℃に加熱することにより実施される。この際、例
えばトリエチルアミン、ジイソプロピルエチルアミン、
ピリジン、4-N,N-ジメチルアミノピリジン(DMA
P)、1,8-ジアザビシクロ〔5.4.0〕-7-ウンデ
セン、1,4-ジアザビシクロ〔2.2.2〕オクタン
(DABCO)などの塩基性化合物を1−10当量用い
てもよい。この際、例えば水、アルコール類(例えば、
メタノールやエタノールなど)、エーテル類(例えば、
テトラヒドロフラン、ジオキサン、ジエチルエーテルな
ど)、ハロゲン化炭化水素(例えば、塩化メチレン、ク
ロロホルム等)、ケトン類(例えば、アセトン、メチル
エチルケトンなど)、エステル類(例えば酢酸エチルな
ど)、および非プロトン性極性溶媒(例えば、N,N-
ジメチルホルムアミド、ジメチルスルホキシドなど)な
どの溶媒中で行うこともできる。反応時間は10分間な
いし24時間、好ましくは0.5ないし6時間である。
化合物(XII)から化合物(VII')までの一連の反応は
それぞれの中間体を単離することなく、同一系内で行う
こともできる。By subjecting the obtained acyl azide to a Curtius rearrangement reaction, an isocyanate is derived. The reaction is carried out by heating the obtained acyl azide to 30 to 200 ° C. At this time, for example, triethylamine, diisopropylethylamine, pyridine, 4-
Basic compounds such as N, N-dimethylaminopyridine (DMAP), 1,8-diazabicyclo [5.4.0] -7-undecene and 1,4-diazabicyclo [2.2.2] octane (DABCO) You may use 1-10 equivalent. At this time, for example, water, alcohols (eg, methanol or ethanol), ethers (eg, tetrahydrofuran, dioxane, diethyl ether, etc.), halogenated hydrocarbons (eg, methylene chloride, chloroform, etc.), ketones (eg, The reaction can also be performed in a solvent such as acetone, methyl ethyl ketone, etc., esters (eg, ethyl acetate, etc.), and aprotic polar solvents (eg, N, N-dimethylformamide, dimethyl sulfoxide, etc.). The reaction time is 10 minutes to 24 hours, preferably 0.5 to 6 hours. Under the reaction conditions, the intramolecular cyclization reaction following the Curtius reaction can be allowed to proceed in the same system to induce the compound (VII '). Derivation of the isocyanate obtained by the Curtius reaction into compound (VII ') is carried out by heating the isocyanate to 30 to 200 ° C. At this time, for example, triethylamine, diisopropylethylamine,
Pyridine, 4-N, N-dimethylaminopyridine (DMA
P), 1-10 equivalents of a basic compound such as 1,8-diazabicyclo [5.4.0] -7-undecene or 1,4-diazabicyclo [2.2.2] octane (DABCO) may be used. . At this time, for example, water, alcohols (for example,
Methanol and ethanol), ethers (for example,
Tetrahydrofuran, dioxane, diethyl ether, etc.), halogenated hydrocarbons (eg, methylene chloride, chloroform, etc.), ketones (eg, acetone, methyl ethyl ketone, etc.), esters (eg, ethyl acetate, etc.), and aprotic polar solvents (eg, ethyl acetate). For example, N, N-
(Dimethylformamide, dimethylsulfoxide, etc.). The reaction time is 10 minutes to 24 hours, preferably 0.5 to 6 hours.
A series of reactions from compound (XII) to compound (VII ') can be performed in the same system without isolating each intermediate.
【0074】化合物(VIII)は例えば以下に示す方法に
よって合成することができる。Compound (VIII) can be synthesized, for example, by the following method.
【0075】[0075]
【化26】 Embedded image
【0076】[式中の記号は、前記と同意義] 化合物(X)の化合物(VIII)への変換反応は、例えば
化合物(II)の合成における(ii)に示す方法と同様
の条件下で行われる。[The symbols in the formula are as defined above.] The conversion reaction of the compound (X) into the compound (VIII) is carried out, for example, under the same conditions as in the method (ii) in the synthesis of the compound (II). Done.
【0077】化合物(X)はR’が水素原子ではない場
合、例えば以下に示す方法によって合成することができ
る。When R ′ is not a hydrogen atom, compound (X) can be synthesized, for example, by the following method.
【0078】[0078]
【化27】 Embedded image
【0079】[式中の記号は、前記と同意義] 化合物(X')の化合物(X)への変換反応は、例えば化
合物(VII)の合成に示す方法と同様の条件下で行われ
る。[The symbols in the formula are as defined above.] The conversion reaction of compound (X ') into compound (X) is carried out, for example, under the same conditions as in the method shown in the synthesis of compound (VII).
【0080】化合物(X')(化合物(X)でR’が水素
原子の場合)は例えば以下に示す方法によって合成する
ことができる。Compound (X ′) (when R ′ is a hydrogen atom in compound (X)) can be synthesized, for example, by the following method.
【0081】[0081]
【化28】 Embedded image
【0082】[式中、Eはクロロ、ブロモ、ヨード等の
ハロゲン原子、メタンスルホニルオキシ、p-トルエン
スルホニルオキシ等のような脱離基を示し、その他の記
号は前記と同意義] 本反応は化合物(XIII)を塩基性化合物存在下でAr2
CH2-Eと反応させて化合物(X')を得る方法である。
該反応では化合物(XIII)に対して、1当量ないし大過
剰の塩基性化合物および1当量ないし大過剰のAr2C
H2-Eを使用する。この際用いる塩基性化合物として
は、例えば水酸化ナトリウム、水酸化カリウム、水素化
ナトリウム、炭酸カリウム、トリエチルアミン、ジイソ
プロピルエチルアミン、ピリジン、4-N,N-ジメチル
アミノピリジン(DMAP)、1,8-ジアザビシクロ
〔5.4.0〕-7-ウンデセン、1,4-ジアザビシク
ロ〔2.2.2〕オクタン(DABCO)などが挙げら
れる。この際用いる溶媒としては、例えば水、アルコー
ル類(例えば、メタノールやエタノールなど)、エーテ
ル類(例えば、テトラヒドロフラン、ジオキサン、ジエ
チルエーテルなど)、ハロゲン化炭化水素(例えば、塩
化メチレン、クロロホルム等)、ケトン類(例えば、ア
セトン、メチルエチルケトンなど)、エステル類(例え
ば酢酸エチルなど)、および非プロトン性極性溶媒(例
えば、N,N-ジメチルホルムアミド、ジメチルスルホ
キシドなど)などが挙げられる。反応時間は10分間な
いし24時間、好ましくは0.5ないし6時間である。
反応温度は−20から200℃(好ましくは0から80
℃)で行うことができる。[Wherein, E represents a halogen atom such as chloro, bromo, iodo or the like, or a leaving group such as methanesulfonyloxy, p-toluenesulfonyloxy, etc., and other symbols are as defined above]. Compound (XIII) is reacted with Ar 2 in the presence of a basic compound.
In this method, compound (X ′) is obtained by reacting with CH 2 -E.
In the reaction, 1 equivalent to a large excess of the basic compound and 1 equivalent to a large excess of Ar 2 C with respect to compound (XIII)
Use H 2 -E. Examples of the basic compound used at this time include sodium hydroxide, potassium hydroxide, sodium hydride, potassium carbonate, triethylamine, diisopropylethylamine, pyridine, 4-N, N-dimethylaminopyridine (DMAP), 1,8-diazabicyclo [5.4.0] -7-undecene, 1,4-diazabicyclo [2.2.2] octane (DABCO) and the like. Examples of the solvent used at this time include water, alcohols (eg, methanol and ethanol), ethers (eg, tetrahydrofuran, dioxane, diethyl ether, etc.), halogenated hydrocarbons (eg, methylene chloride, chloroform, etc.), ketones (Eg, acetone, methyl ethyl ketone, etc.), esters (eg, ethyl acetate, etc.), and aprotic polar solvents (eg, N, N-dimethylformamide, dimethyl sulfoxide, etc.). The reaction time is 10 minutes to 24 hours, preferably 0.5 to 6 hours.
The reaction temperature is -20 to 200 ° C (preferably 0 to 80 ° C).
C).
【0083】化合物(XI)は例えば以下に示す方法によ
って合成することができる。Compound (XI) can be synthesized, for example, by the following method.
【0084】[0084]
【化29】 Embedded image
【0085】[式中の記号は、前記と同意義] 本反応は化合物(VII')を塩基性化合物存在下でアミノ
基の保護基を導入するための試薬と反応させて化合物
(XI)を得る方法である。該反応では化合物(VII')に
対して、1当量ないし大過剰の塩基性化合物および1当
量ないし大過剰のアミノ基の保護基を導入するための試
薬を使用する。この際用いる塩基性化合物としては、例
えば水酸化ナトリウム、水酸化カリウム、水素化ナトリ
ウム、炭酸カリウム、トリエチルアミン、ジイソプロピ
ルエチルアミン、ピリジン、4-N,N-ジメチルアミノ
ピリジン(DMAP)、1,8-ジアザビシクロ〔5.4.
0〕-7-ウンデセン、1,4-ジアザビシクロ〔2.
2.2〕オクタン(DABCO)などが挙げられる。こ
の際用いるアミノ基の保護基を導入するための試薬とし
ては、例えば無水酢酸、無水トリフルオロ酢酸、酢酸ク
ロリド、クロロ炭酸ベンジル、二炭酸ジ-tert-ブチ
ルなどが挙げられる。この際用いる溶媒としては、例え
ば水、アルコール類(例えば、メタノールやエタノール
など)、エーテル類(例えば、テトラヒドロフラン、ジ
オキサン、ジエチルエーテルなど)、ハロゲン化炭化水
素(例えば、塩化メチレン、クロロホルム等)、ケトン
類(例えば、アセトン、メチルエチルケトンなど)、エ
ステル類(例えば酢酸エチルなど)、および非プロトン
性極性溶媒(例えば、N,N-ジメチルホルムアミド、
ジメチルスルホキシドなど)などが挙げられる。反応時
間は10分間ないし24時間、好ましくは0.5ないし
6時間である。反応温度は−20から200℃(好まし
くは0から80℃)で行うことができる。[The symbols in the formula are as defined above.] In this reaction, compound (XI) is reacted with a reagent for introducing an amino-protecting group in the presence of a basic compound to give compound (XI). How to get. In this reaction, 1 equivalent to a large excess of a basic compound and 1 equivalent to a large excess of a reagent for introducing an amino-group-protecting group to compound (VII ′) are used. Examples of the basic compound used at this time include sodium hydroxide, potassium hydroxide, sodium hydride, potassium carbonate, triethylamine, diisopropylethylamine, pyridine, 4-N, N-dimethylaminopyridine (DMAP), 1,8-diazabicyclo [5.4.
0] -7-undecene, 1,4-diazabicyclo [2.
2.2] octane (DABCO). As a reagent for introducing a protecting group for an amino group used at this time, for example, acetic anhydride, trifluoroacetic anhydride, acetate chloride, benzyl chlorocarbonate, di-tert-butyl dicarbonate and the like can be mentioned. Examples of the solvent used at this time include water, alcohols (eg, methanol and ethanol), ethers (eg, tetrahydrofuran, dioxane, diethyl ether, etc.), halogenated hydrocarbons (eg, methylene chloride, chloroform, etc.), ketones (Eg, acetone, methyl ethyl ketone, etc.), esters (eg, ethyl acetate, etc.), and aprotic polar solvents (eg, N, N-dimethylformamide,
Dimethyl sulfoxide) and the like. The reaction time is 10 minutes to 24 hours, preferably 0.5 to 6 hours. The reaction can be carried out at a temperature of -20 to 200C (preferably 0 to 80C).
【0086】化合物(XII)は例えば以下に示す方法に
よって合成することができる。Compound (XII) can be synthesized, for example, by the following method.
【0087】[0087]
【化30】 Embedded image
【0088】[式中、R'''は置換基を有していてもよ
いC1-6アルキル、置換基を有していてもよいC7-10ア
ラルキル、置換基を有していてもよいC7-16アラルキル
を示し、その他の記号は前記と同意義] 化合物(XIV)のエステル基を加水分解して化合物(XI
I)を得る方法である。エステル基の加水分解反応は、
自体すべて公知の反応であり、それらの条件に準じて行
うことができる。[Wherein, R ″ ′ represents C 1-6 alkyl which may have a substituent, C 7-10 aralkyl which may have a substituent, A good C 7-16 aralkyl, and the other symbols are as defined above.] The compound (XI) is obtained by hydrolyzing the ester group of the compound (XIV).
I) is the way to get. The hydrolysis reaction of the ester group is
All are per se known reactions, and can be carried out under these conditions.
【0089】化合物(XIII)は例えば以下に示す方法に
よって合成することができる。Compound (XIII) can be synthesized, for example, by the following method.
【0090】[0090]
【化31】 Embedded image
【0091】[式中の記号は、前記と同意義] 化合物(XV)のアミノ基に保護基を導入して化合物(XI
II)を得る方法である。アミノ基を保護基で保護する反
応は、自体すべて公知の反応であり、それらの条件に準
じて行うことができる。[The symbols in the formula are as defined above.] A compound (XI
II) is a method to obtain. The reactions for protecting the amino group with a protecting group are all known reactions per se, and can be performed according to those conditions.
【0092】化合物(XIV)は例えば以下に示す方法に
よって合成することができる。Compound (XIV) can be synthesized, for example, by the following method.
【0093】[0093]
【化32】 Embedded image
【0094】[式中の記号は、前記と同意義] 化合物(XVI)の化合物(XIV)への変換反応は、例えば
化合物(I)の合成における(ii)に示す方法と同様
の条件下で行われる。[The symbols in the formula are as defined above.] The conversion reaction of the compound (XVI) into the compound (XIV) is carried out, for example, under the same conditions as in the method (ii) in the synthesis of the compound (I). Done.
【0095】化合物(XV)は例えば以下に示す方法によ
って合成することができる。Compound (XV) can be synthesized, for example, by the following method.
【0096】[0096]
【化33】 Embedded image
【0097】[式中の記号は、前記と同意義] 化合物(XVII)の還元反応では触媒存在下における接触
水素添加などを用いることができる。水素添加において
用いる触媒としてはパラジウム、白金、ニッケル、ロジ
ウムなど金属あるいはこれらの酸化物、塩、錯体などが
挙げられ、これらの触媒は炭素など種々の担持物に担持
させて用いることもできる。また水素添加は常圧ないし
加圧下で行うことができる。この際用いる溶媒は、適宜
選択することができ、例えばアルコール類(例えば、メ
タノールやエタノールなど)、エーテル類(例えば、テ
トラヒドロフラン、ジオキサン、ジエチルエーテルな
ど)、ハロゲン化炭化水素(例えば、塩化メチレン、ク
ロロホルムなど)、エステル類(例えば酢酸エチルな
ど)、非プロトン性極性溶媒(例えば、N,N-ジメチ
ルホルムアミド、ジメチルスルホキシドなど)などが挙
げられる。反応時間は0.5ないし72時間、好ましく
は1ないし24時間である。反応温度は−100から1
00℃(好ましくは−70から50℃)で行うことがで
きる。[The symbols in the formula are as defined above] In the reduction reaction of compound (XVII), catalytic hydrogenation in the presence of a catalyst or the like can be used. Examples of the catalyst used in the hydrogenation include metals such as palladium, platinum, nickel, and rhodium, and oxides, salts, and complexes thereof. These catalysts can also be used by being supported on various supports such as carbon. The hydrogenation can be performed under normal pressure or under pressure. The solvent used at this time can be appropriately selected and includes, for example, alcohols (eg, methanol and ethanol), ethers (eg, tetrahydrofuran, dioxane, diethyl ether, etc.), halogenated hydrocarbons (eg, methylene chloride, chloroform) And the like, esters (eg, ethyl acetate, etc.), aprotic polar solvents (eg, N, N-dimethylformamide, dimethylsulfoxide, etc.). The reaction time is 0.5 to 72 hours, preferably 1 to 24 hours. Reaction temperature is -100 to 1
It can be carried out at 00 ° C (preferably -70 to 50 ° C).
【0098】化合物(XVI)は例えば以下に示す方法に
よって合成することができる。Compound (XVI) can be synthesized, for example, by the following method.
【0099】[0099]
【化34】 Embedded image
【0100】[式中の記号は、前記と同意義] 化合物(XVIII)の化合物(XVI)への変換反応は、例え
ば化合物(X')の合成に示す方法と同様の条件下で行わ
れる。なお、原料化合物である化合物(XVIII)は例え
ば、Heterocycles,23,2277-22
87(1985)、J.Org.Chem.,53,8
69-873(1988)、J.Org.Chem.,
53,873-875(1986)、Chem.Pha
rm.Bull.,38,103-109(1990)
などに記載あるいは引用されている条件に準じてまたは
参考にしてAr1COOHから、J.Am.Chem.
Soc.,109,7488-7494(1987)、
J.Org.Chem.,53,2968-2971
(1988)、Tetrahedron Lett.,
32,7731-7734(1991)などに記載ある
いは引用されている条件に準じてまたは参考にしてAr
1C(=O)Clから、J.Heterocyclic
Chem.,22,1033-1034(1985)、
J.Heterocyclic Chem.,25,1
737-1740(1988)、J.Med.Che
m.,34,798-806(1991)、Tetra
hedron,46,4473-4486(199
0)、J.Org.Chem.,64,1512-15
19(1999)などに記載あるいは引用されている条
件に準じてまたは参考にしてAr1C(=O)CH3か
ら、合成することができる。[The symbols in the formula are as defined above.] The conversion reaction of compound (XVIII) into compound (XVI) is carried out, for example, under the same conditions as in the method shown in the synthesis of compound (X '). In addition, the compound (XVIII) which is a raw material compound is described in, for example, Heterocycles, 23, 2277-22.
87 (1985); Org. Chem. , 53,8
69-873 (1988); Org. Chem. ,
53, 873-875 (1986); Chem. Pha
rm. Bull. , 38, 103-109 (1990).
From Ar 1 COOH according to the conditions described or cited in J. Am. Chem.
Soc. , 109, 7488-7494 (1987),
J. Org. Chem. , 53, 2968-2971
(1988), Tetrahedron Lett. ,
32, 7731-7734 (1991), etc., according to or referring to the conditions described in
From 1 C (= O) Cl, J.I. Heterocyclic
Chem. , 22, 1033-1034 (1985),
J. Heterocyclic Chem. , 25,1
737-1740 (1988); Med. Che
m. , 34, 798-806 (1991), Tetra.
hedron, 46, 4473-4486 (199)
0); Org. Chem. , 64, 1512-15
19 (1999) or the like, or can be synthesized from Ar 1 C (= O) CH 3 according to or referring to the conditions described or cited.
【0101】化合物(XVII)は例えば以下に示す方法に
よって合成することができる。Compound (XVII) can be synthesized, for example, by the following method.
【0102】[0102]
【化35】 Embedded image
【0103】[式中、Xはハロゲン原子を示し、その他
の記号は前記と同意義] 本反応は化合物(XIX)を1当量ないし大過剰のアジ化
アルカリ金属塩(例えばアジ化ナトリウムなど)と反応
させて化合物(XVII)を得る方法である。この際用いる
溶媒としては、例えば水、アルコール類(例えば、メタ
ノールやエタノールなど)、エーテル類(例えば、テト
ラヒドロフラン、ジオキサン、ジエチルエーテルな
ど)、ハロゲン化炭化水素(例えば、塩化メチレン、ク
ロロホルム等)、ケトン類(例えば、アセトン、メチル
エチルケトンなど)、エステル類(例えば酢酸エチルな
ど)、および非プロトン性極性溶媒(例えば、N,N-
ジメチルホルムアミド、ジメチルスルホキシドなど)な
どが挙げられる。反応時間は10分間ないし24時間で
ある。反応温度は−20から200℃(好ましくは0か
ら50℃)で行うことができる。[Wherein X represents a halogen atom and the other symbols have the same meanings as described above.] In this reaction, compound (XIX) is reacted with 1 equivalent to a large excess of an alkali metal azide (eg, sodium azide). This is a method of obtaining a compound (XVII) by reacting. Examples of the solvent used at this time include water, alcohols (eg, methanol and ethanol), ethers (eg, tetrahydrofuran, dioxane, diethyl ether, etc.), halogenated hydrocarbons (eg, methylene chloride, chloroform, etc.), ketones (Eg, acetone, methyl ethyl ketone, etc.), esters (eg, ethyl acetate, etc.), and aprotic polar solvents (eg, N, N-
Dimethylformamide, dimethylsulfoxide, etc.). The reaction time ranges from 10 minutes to 24 hours. The reaction can be carried out at a temperature of -20 to 200 ° C (preferably 0 to 50 ° C).
【0104】また、上記目的化合物および原料化合物を
合成する各反応において、使用される原料化合物は、置
換基としてアミノ基,カルボキシル基,ヒドロキシ基を
有する場合、これらの基にペプチド化学などで一般的に
用いられるような保護基が導入されたものであってもよ
く、反応後に必要に応じて保護基を除去することにより
目的とする化合物を得ることができる。アミノ基の保護
基としては、例えばそれぞれ置換基を有していてもよい
C1-6アルキルカルボニル(例えば、ホルミル、メチル
カルボニル、エチルカルボニルなど)、フェニルカルボ
ニル、C1-6アルキル−オキシカルボニル(例えば、メ
トキシカルボニル、エトキシカルボニルなど)、C6-10
アリール−オキシカルボニル(例えば、フェニルオキシ
カルボニルなど)、C7-10アラルキル−カルボニル(例
えば、ベンジルオキシカルボニルなど)、トリチル、フ
タロイルなどが用いられる。これらの置換基としては、
ハロゲン原子(例えば、フルオロ、クロロ、ブロモ、ヨ
ードなど)、C1-6アルキル−カルボニル(例えば、メ
チルカルボニル、エチルカルボニル、ブチルカルボニル
など)、ニトロ基などが用いられ、置換基の数は1ない
し3個程度である。カルボキシル基の保護基としては、
例えばそれぞれ置換基を有していてもよいC1-6アルキ
ル(例えば、メチル、エチル、プロピル、イソプロピ
ル、ブチル、tert−ブチルなど)、フェニル、トリチ
ル、シリルなどが用いられる。これらの置換基として
は、ハロゲン原子(例えば、フルオロ、クロロ、ブロ
モ、ヨードなど)、C1-6アルキルカルボニル(例え
ば、ホルミル、メチルカルボニル、エチルカルボニル、
ブチルカルボニルなど)、ニトロ基などが用いられ、置
換基の数は1ないし3個程度である。ヒドロキシ基の保
護基としては、例えばそれぞれ置換基を有していてもよ
いC 1-6アルキル(例えば、メチル、エチル、プロピ
ル、イソプロピル、ブチル、tert−ブチルなど)、フェ
ニル、C7-10アラルキル(例えば、ベンジルなど)、C
1 -6アルキルカルボニル(例えば、ホルミル、メチルカ
ルボニル、エチルカルボニルなど)、C6-10アリール−
オキシカルボニル(例えば、フェニルオキシカルボニル
など)、C7-10アラルキル−カルボニル(例えば、ベン
ジルオキシカルボニルなど)、ピラニル、フラニル、シ
リルなどが用いられる。これらの置換基としては、ハロ
ゲン原子(例えば、フルオロ、クロロ、ブロモ、ヨード
など)、C1- 6アルキル、フェニル、C7-10アラルキ
ル、ニトロ基などが用いられ、置換基の数は1ないし4
個程度である。また、保護基の除去方法としては、それ
自体公知またはそれに準じる方法が用いられるが、例え
ば酸、塩基、還元、紫外光、ヒドラジン、フェニルヒド
ラジン、N−メチルジチオカルバミン酸ナトリウム、テ
トラブチルアンモニウムフルオリド、酢酸パラジウムな
どで処理する方法が用いられる。Further, the target compound and the starting compound are
In each reaction to be synthesized, the starting compound used is
Amino, carboxyl, and hydroxy groups as substituents
If present, these groups are generally used in peptide chemistry, etc.
It may have introduced a protecting group such as used.
By removing protecting groups as necessary after the reaction.
The desired compound can be obtained. Amino group protection
As the group, for example, each may have a substituent
C1-6Alkylcarbonyl (eg, formyl, methyl
Carbonyl, ethylcarbonyl, etc.), phenylcarbo
Nil, C1-6Alkyl-oxycarbonyl (e.g.,
Ethoxycarbonyl, ethoxycarbonyl, etc.), C6-10
Aryl-oxycarbonyl (e.g., phenyloxy
Carbonyl, etc.), C7-10Aralkyl-carbonyl (eg
For example, benzyloxycarbonyl), trityl,
Taroyl or the like is used. As these substituents,
Halogen atom (eg, fluoro, chloro, bromo,
Mode), C1-6Alkyl-carbonyl (e.g.,
Tylcarbonyl, ethylcarbonyl, butylcarbonyl
), Nitro group, etc., and the number of substituents is not 1
There are about three. As a carboxyl protecting group,
For example, C which may have a substituent1-6Archi
(Eg, methyl, ethyl, propyl, isopropyl
Butyl, tert-butyl, etc.), phenyl, triti
And silyl are used. As these substituents
Is a halogen atom (eg, fluoro, chloro, bromine)
Mo, iodine, etc.), C1-6Alkylcarbonyl (eg,
For example, formyl, methylcarbonyl, ethylcarbonyl,
Butyl carbonyl), nitro group, etc.
The number of substituents is about 1 to 3. Preservation of hydroxy group
As the protective group, for example, each may have a substituent.
C 1-6Alkyl (eg, methyl, ethyl, propyl
Isopropyl, butyl, tert-butyl, etc.)
Nil, C7-10Aralkyl (eg, benzyl, etc.), C
1 -6Alkylcarbonyl (eg, formyl, methyl
Rubonyl, ethylcarbonyl, etc.), C6-10Aryl-
Oxycarbonyl (eg, phenyloxycarbonyl
Etc.), C7-10Aralkyl-carbonyl (e.g., ben
Diyloxycarbonyl), pyranyl, furanyl,
Rill and the like are used. These substituents include halo
Gen atoms (eg, fluoro, chloro, bromo, iodo)
Etc.), C1- 6Alkyl, phenyl, C7-10Aralki
And nitro groups are used, and the number of substituents is 1 to 4
About one. As a method for removing the protecting group,
A method known per se or a method similar thereto is used.
Acid, base, reduction, ultraviolet light, hydrazine, phenyl hydride
Azine, sodium N-methyldithiocarbamate,
Trabutylammonium fluoride, such as palladium acetate
A method of processing is used.
【0105】反応混合物からの化合物(I)およびその
原料の分別精製は、通常の分別精製手段(例、抽出、濃
縮、ろ過、再結晶、カラムクロマトグラフィー、薄層ク
ロマトグラフィー)に従って行われる。かくして得られ
る化合物(I)が遊離体で得られた場合には、自体公知
の方法あるいはそれに準じる方法(例えば、中和等)に
よって塩に変換することができ、逆に塩で得られた場合
には自体公知の方法あるいはそれに準じる方法により、
遊離体または他の塩に変換することができる。さらに、
化合物(I)が光学活性体である場合は、通常の光学分
割手段により、d体、l体に分離することができる。The fractional purification of the compound (I) and its raw material from the reaction mixture is carried out according to ordinary fractional purification means (eg, extraction, concentration, filtration, recrystallization, column chromatography, thin-layer chromatography). When the compound (I) thus obtained is obtained in a free form, it can be converted into a salt by a method known per se or a method analogous thereto (eg, neutralization and the like), and conversely, By a method known per se or a method analogous thereto,
It can be converted to a free form or other salts. further,
When the compound (I) is an optically active compound, it can be separated into d-form and l-form by ordinary optical resolution means.
【0106】本発明の化合物(I)および化合物
(I’)は低毒性で、医薬品として有用であり、コレス
テリルエステル転送蛋白阻害作用を有し、優れたHDL
-コレステロール上昇作用、LDL-コレステロール低下
作用、VLDL-コレステロール低下作用およびトリグ
リセリド低下作用を有する。それゆえ、本発明の剤は、
この薬理作用に基づく疾患の予防治療薬として有用であ
る。すなわち、哺乳動物(例、マウス、ラット、ハムス
ター、ウサギ、ネコ、イヌ、ウシ、ウマ、ヒツジ、サ
ル、ヒト等)の高脂血症、特に高LDL−コレステロー
ル血症、高リポ蛋白血症および高トリグリセリド血症、
低HDL−コレステロール血症、並びにそれから生じる
アテローム性動脈硬化血管病変およびそれらの続発症、
例えば、急性心筋梗塞、不安定狭心症等の急性冠動脈症
候群、末梢動脈閉塞症、経皮的冠動脈形成術(PTC
A)あるいはステント留置後の動脈再狭搾、心筋梗塞、
狭心症等の虚血性心疾患、動脈硬化症、間歇性跛行、脳
卒中(脳梗塞、脳塞栓、脳出血など)、ラクネ梗塞、脳
血管性痴呆、壊疽、糸球体硬化症、腎症、Tangie
r病等の治療および予防あるいは動脈硬化巣の進展抑制
などに特に適している。本発明の化合物(I)および化
合物(I’)は、LDL−コレステロール低下作用を有
するがHDL−コレステロール上昇作用を示さない薬剤
と比較すると、LDL−コレステロール低下作用のみで
は治療効果がない原発性低HDL血症などの予防・治療
に有用である。高脂血症治療薬の最終目的は心筋梗塞等
の致死的な疾患の発症を予防することであり、LDL低
下作用を有するが、HDL上昇作用を示さない薬剤でも
心筋梗塞などに対してある程度の発症予防効果が認めら
れるが、HDL−コレステロール上昇剤は心筋梗塞等の
発症をより強力に予防することが可能である。更に、L
DL低下作用を有するが、HDL上昇作用を示さない薬
剤では治療効果が認められない患者や疾患・症状(例え
ば、難治性の高脂血症など)にも有効であり、血清脂質
が正常レベルであるヒトにおいても、心筋梗塞等の致死
的な疾患の発症率を抑制し、治療効果を改善することが
可能である。The compounds (I) and (I ') of the present invention have low toxicity, are useful as pharmaceuticals, have a cholesteryl ester transfer protein inhibitory effect, and have excellent HDL
-Has cholesterol-elevating, LDL-cholesterol-lowering, VLDL-cholesterol-lowering and triglyceride-lowering effects. Therefore, the agent of the present invention
It is useful as a preventive or therapeutic drug for diseases based on this pharmacological action. That is, hyperlipidemia in mammals (eg, mice, rats, hamsters, rabbits, cats, dogs, cows, horses, sheep, monkeys, humans, etc.), particularly high LDL-cholesterolemia, hyperlipoproteinemia and Hypertriglyceridemia,
Low HDL-cholesterolemia and atherosclerotic vascular lesions resulting therefrom and their sequelae,
For example, acute myocardial infarction, acute coronary syndrome such as unstable angina, peripheral artery occlusion, percutaneous coronary angioplasty (PTC
A) or restenosis of the artery after stent placement, myocardial infarction,
Ischemic heart disease such as angina, arteriosclerosis, intermittent claudication, stroke (cerebral infarction, cerebral embolism, cerebral hemorrhage, etc.), lacne infarction, cerebrovascular dementia, gangrene, glomerulosclerosis, nephropathy, Tangie
It is particularly suitable for treatment and prevention of R disease and the like, or suppression of the progression of atherosclerotic lesions. The compounds (I) and (I ′) of the present invention have an LDL-cholesterol-lowering effect but do not show a HDL-cholesterol-elevating effect when compared with a drug having no LDL-cholesterol-lowering effect. It is useful for prevention and treatment of HDL blood and the like. The ultimate purpose of hyperlipidemia drugs is to prevent the onset of fatal diseases such as myocardial infarction. Although an effect of preventing onset is observed, an HDL-cholesterol-elevating agent can more strongly prevent the onset of myocardial infarction and the like. Furthermore, L
A drug that has a DL-lowering effect but does not show an HDL-elevating effect is also effective for patients or diseases / symptoms (eg, intractable hyperlipidemia) where no therapeutic effect is observed, and serum lipids are at normal levels. Even in a certain human, it is possible to suppress the incidence of fatal diseases such as myocardial infarction and improve the therapeutic effect.
【0107】化合物(I)および化合物(I’)は、原
末のままでもよいが、通常製剤用担体、例えば賦形剤
(例えば、炭酸カルシウム、カオリン、炭酸水素ナトリ
ウム、乳糖、澱粉類、結晶セルロース、タルク、グラニ
ュー糖、多孔性物質等)、結合剤(例えば、デキストリ
ン、ゴム類、アルコール化澱粉、ゼラチン、ヒドロキシ
プロピルセルロース、ヒドロキシプロピルメチルセルロ
ース、プルラン等)、崩壊剤(例えば、カルボキシメチ
ルセルロースカルシウム、クロスカルメロースナトリウ
ム、クロスポピドン、低置換度ヒドロキシプロピルセル
ロース、部分アルファー化澱粉等)、滑沢剤(例えば、
ステアリン酸マグネシウム、ステアリン酸カルシウム、
タルク、澱粉、安息香酸ナトリウム等)、着色剤(例え
ば、タール色素、カラメル、三二酸化鉄、酸化チタン、
リボフラビン類等)、矯味剤(例えば、甘味類、香料
等)、安定剤(例えば、亜硫酸ナトリウム等)及び保存
剤(例えば、パラベン類、ソルビン酸等)等の中から適
宜、適量用いて、常法に従って調製された形で投与され
る。前記製剤を含む本発明の予防治療剤は、化合物
(I)または化合物(I’)を疾病を治療及び予防する
のに有効な量を適宜含有する。化合物(I)および化合
物(I’)の本発明製剤中の含有量は、通常製剤全体の
0.1ないし100重量%である。また本発明で用いら
れる製剤は、活性成分として化合物(I)または化合物
(I’)以外の他の医薬成分を含有していてもよく、こ
れらの成分は本発明の目的が達成される限り特に限定さ
れず、適宜適当な配合割合で使用が可能である。剤形の
具体例としては、例えば錠剤(糖衣錠、フィルムコーテ
ィング錠を含む)、丸剤、カプセル剤、顆粒剤、細粒
剤、散剤、シロップ剤、乳剤、懸濁剤、注射剤、吸入
剤、軟膏剤等が用いられる。これらの製剤は常法(例え
ば日本薬局方記載の方法等)に従って調製される。The compound (I) and the compound (I ′) may be in the raw form, but are usually used as carriers for preparations such as excipients (eg, calcium carbonate, kaolin, sodium hydrogen carbonate, lactose, starches, crystals) Cellulose, talc, granulated sugar, porous substances, etc.), binders (eg, dextrin, gums, alcoholized starch, gelatin, hydroxypropylcellulose, hydroxypropylmethylcellulose, pullulan, etc.), disintegrants (eg, carboxymethylcellulose calcium, Croscarmellose sodium, crospovidone, low-substituted hydroxypropylcellulose, partially pregelatinized starch, etc.), lubricants (for example,
Magnesium stearate, calcium stearate,
Talc, starch, sodium benzoate, etc.), coloring agents (eg, tar dye, caramel, iron sesquioxide, titanium oxide,
Riboflavins, etc.), flavoring agents (eg, sweeteners, flavors, etc.), stabilizers (eg, sodium sulfite, etc.), and preservatives (eg, parabens, sorbic acid, etc.). It is administered in a form prepared according to the method. The prophylactic / therapeutic agent of the present invention containing the above-mentioned preparation suitably contains Compound (I) or Compound (I ′) in an amount effective for treating and preventing a disease. The content of compound (I) and compound (I ') in the preparation of the present invention is usually 0.1 to 100% by weight of the whole preparation. Further, the preparation used in the present invention may contain other pharmaceutical ingredients other than the compound (I) or the compound (I ′) as an active ingredient. It is not limited, and can be used at an appropriate mixing ratio. Specific examples of dosage forms include tablets (including sugar-coated tablets and film-coated tablets), pills, capsules, granules, fine granules, powders, syrups, emulsions, suspensions, injections, inhalants, Ointments and the like are used. These preparations are prepared according to a conventional method (for example, a method described in the Japanese Pharmacopoeia).
【0108】具体的には、錠剤の製造法は、化合物
(I)または化合物(I’)をそのまま、賦形剤、結合
剤、崩壊剤もしくはそのほかの適当な添加剤を加えて均
等に混和したものを、適当な方法で顆粒とした後、滑沢
剤等を加え、圧縮成型するか又は、化合物(I)または
化合物(I’)をそのまま、又は賦形剤、結合剤、崩壊
剤もしくはそのほかの適当な添加剤を加えて均等に混和
したものを、直接圧縮成型して製するか、又はあらかじ
め製した顆粒にそのまま、もしくは適当な添加剤を加え
て均等に混和した後、圧縮成型しても製造することもで
きる。また、本剤は、必要に応じて着色剤、矯味剤等を
加えることができる。さらに、本剤は、適当なコーティ
ング剤で剤皮を施すこともできる。注射剤の製造法は、
化合物(I)または化合物(I’)の一定量を、水性溶
剤の場合は注射用水、生理食塩水、リンゲル液等、非水
性溶剤の場合は通常植物油等に溶解、懸濁もしくは乳化
して一定量とするか、又は化合物(I)または化合物
(I’)の一定量をとり注射用の容器に密封して製する
ことができる。経口用製剤担体としては、例えばデンプ
ン、マンニトール、結晶セルロース、カルボキシメチル
セルロースナトリウム等の製剤分野において常用されて
いる物質が用いられる。注射用担体としては、例えば蒸
留水、生理食塩水、グルコース溶液、輸液剤等が用いら
れる。その他、製剤一般に用いられる添加剤を適宜添加
することもできる。また、本発明の製剤は、徐放性製剤
として用いることもできる。本発明の徐放性製剤は、例
えば水中乾燥法(o/w法、w/o/w法等)、相分離
法、噴霧乾燥法あるいはこれらに準ずる方法によって製
造されたマイクロカプセル(例えばマイクロスフェア・
マイクロカプセル、マイクロパーティクル等)をそのま
ま、あるいはこのマイクロカプセル又は球状、針状、ペ
レット状、フィルム状、クリーム状の医薬組成物を原料
物質として種々の剤型に製剤化し、投与することができ
る。該剤型としては、例えば非経口剤(例えば、筋肉
内、皮下、臓器等への注射又は埋め込み剤;鼻腔、直
腸、子宮等への経粘膜剤等)、経口剤(例えば、硬カプ
セル剤、軟カプセル剤、顆粒剤、散剤、懸濁剤等)等が
挙げられる。本発明の徐放性製剤が注射剤である場合
は、マイクロカプセルを分散剤(例えば、Tween
80,HCO−60等の界面活性剤;カルボキシメチル
セルロース、アルギン酸ナトリウム、ヒアルロン酸ナト
リウム等の多糖類;硫酸プロタミン、ポリエチレングリ
コール等)、保存剤(例えば、メチルパラベン、プロピ
ルパラベン等)、等張化剤(例えば、塩化ナトリウム、
マンニトール、ソルビトール、ブドウ糖等)、局所麻酔
剤(例えば、塩酸キシロカイン、クロロブタノール等)
等とともに水性懸濁剤とするか、植物油(例えば、ゴマ
油、コーン油等)あるいはこれにリン脂質(例えば、レ
シチン等)を混合したもの、又は中鎖脂肪酸トリグリセ
リド(例えば、ミグリオール812等)とともに分散し
て油性懸濁剤として徐放性注射剤とする。本発明の徐放
性製剤がマイクロカプセルである場合、その平均粒子径
は、約0.1ないし約300μmであり、好ましくは、
約1ないし約150μm、さらに好ましくは約2ないし
約100μmである。マイクロカプセルを無菌製剤にす
るには、製造全工程を無菌にする方法、ガンマ線で滅菌
する方法、防腐剤を添加する方法等が挙げられるが、特
に限定されない。Specifically, in the method for producing tablets, compound (I) or compound (I ′) was mixed as it was with an excipient, a binder, a disintegrant or other appropriate additives. The product is made into granules by an appropriate method, and then a lubricant or the like is added and compression-molded, or the compound (I) or the compound (I ′) is used as it is, or as an excipient, a binder, a disintegrant or other materials. What is added and uniformly mixed with the appropriate additive is directly compression-molded, or is directly mixed with granules prepared in advance, or after adding the appropriate additive and uniformly mixed, then compression-molded. Can also be manufactured. In addition, the present agent can contain a coloring agent, a flavoring agent, and the like as needed. Further, the agent can be coated with an appropriate coating agent. The production method for injections is
A certain amount of compound (I) or compound (I ') is dissolved, suspended or emulsified in water for injection, physiological saline, Ringer's solution or the like in the case of an aqueous solvent, and usually in vegetable oil or the like in the case of a non-aqueous solvent. Alternatively, a predetermined amount of the compound (I) or the compound (I ′) is taken and sealed in a container for injection. As the pharmaceutical carrier for oral use, substances commonly used in the field of pharmaceuticals such as starch, mannitol, crystalline cellulose and sodium carboxymethylcellulose are used. As the carrier for injection, for example, distilled water, physiological saline, glucose solution, infusion agent and the like are used. In addition, additives generally used in preparations can be appropriately added. Further, the preparation of the present invention can be used as a sustained release preparation. The sustained-release preparation of the present invention can be prepared, for example, by microcapsules (for example, microspheres) produced by an in-water drying method (o / w method, w / o / w method, etc.), a phase separation method, a spray drying method or a method analogous thereto.・
Microcapsules, microparticles, etc.) as they are, or these microcapsules or spherical, needle-like, pellet-like, film-like, or cream-like pharmaceutical compositions can be formulated into various dosage forms as a raw material and administered. Examples of the dosage form include parenteral preparations (for example, injections or implants for intramuscular, subcutaneous, organ, etc .; transmucosal preparations for nasal cavity, rectum, uterus, etc.), oral preparations (for example, hard capsules, Soft capsules, granules, powders, suspensions and the like). When the sustained-release preparation of the present invention is an injection, a microcapsule is used as a dispersant (for example, Tween
Surfactants such as 80, HCO-60; polysaccharides such as carboxymethylcellulose, sodium alginate and sodium hyaluronate; protamine sulfate, polyethylene glycol, etc.), preservatives (eg, methylparaben, propylparaben, etc.), isotonicity agents ( For example, sodium chloride,
Mannitol, sorbitol, glucose, etc.), local anesthetics (eg, xylocaine hydrochloride, chlorobutanol, etc.)
Or a vegetable oil (eg, sesame oil, corn oil, etc.) or a mixture thereof with a phospholipid (eg, lecithin) or a medium-chain fatty acid triglyceride (eg, Miglyol 812, etc.) To give a sustained-release injection as an oily suspension. When the sustained-release preparation of the present invention is a microcapsule, the average particle size is about 0.1 to about 300 μm, preferably,
It is about 1 to about 150 μm, more preferably about 2 to about 100 μm. Examples of methods for making the microcapsules into a sterile preparation include a method of sterilizing the whole production process, a method of sterilizing with gamma rays, and a method of adding a preservative, but are not particularly limited.
【0109】これらの疾患の治療において、化合物
(I)および化合物(I’)は単独で予防及び/又は治
療のために使用されてもよく、またその他の脂質低下
薬、コレステロール低下薬、心筋保護薬、冠動脈疾患治
療薬、糖尿病治療薬、甲状腺機能低下治療薬、ネフロー
ゼ症候群治療薬、骨粗鬆症治療薬または慢性腎不全治療
薬を含む他の医薬成分と共に使用されてもよく、この場
合、これらの化合物は経口製剤として投与されることが
好ましく、また必要により直腸製剤として坐薬の形態で
投与されてもよい。この場合組み合わせが可能な成分と
しては、例えば、(1)フィブラート類(例えば、クロ
フィブラート、ベザフィブラート、ジェムフィブロジ
ル、フェノフィブラート等)などのPPARα作動薬、
ニコチン酸、その誘導体及び類縁体(例えば、アシピモ
ックス、プロブコール等)、(2)胆汁酸結合樹脂(例
えば、コレスチラミン、コレスチポール等)、コレステ
ロール吸収を抑制する化合物(例えば、シトステロー
ル、ネオマイシン等)、(3)コレステロール生合成を
阻害する化合物(例えば、ロバスタチン、シンバスタチ
ン、プラバスタチン、セリバチタチン、アトロバスタチ
ン、フルバスタチン、イタバスタチン、ロスバスタチン
等のHMG−CoA還元酵素阻害薬)、スクアレンエポ
キシダーゼ阻害薬(例えば、NB−598及びその類縁
化合物等)、スクアレン合成酵素阻害薬(例えば、ベン
ゾオキサゼピン誘導体等)等が挙げられる。更に別の可
能な組み合わせ成分は、オキシドスクアレン−ラノステ
ロールサイクラーゼ(例えば、デカリン誘導体、アザデ
カリン誘導体、インダン誘導体等)、ミクロソームトリ
グリセリド転送蛋白阻害薬(implitapide
等)等である。また、糖尿病治療薬〔アクトス、ロジグ
リダソン、キネダック,ベンフィル,ヒューマリン,オ
イグルコン,グリミクロン,ダオニール,ノボリン,モ
ノタード,インシュリン類,グルコバイ,ジメリン,ラ
スチノン,バシルコン,デアメリンS,イスジリン
類〕;甲状腺機能低下症治療薬〔乾燥甲状腺(チレオイ
ド),レボチロキシンナトリウム(チラージンS),リ
オチロニジンナトリウム(サイロニン、チロミン); ネフローゼ症候群治療薬:プレドニゾロン(プレドニ
ン),コハク酸プレドニゾロンナトリウム(プレドニ
ン),コハク酸メチルプレドニゾロンナトリウム(ソル
・メドロール),ベタメタゾン(リンデロン)〕;抗凝
固療法剤〔ジピリダモール(ベルサンチン),塩酸ジラ
ゼプ(コメリアン)、チロピジン、クロビドグレル、X
a阻害剤〕;慢性腎不全治療薬〔利尿薬〔例、フロセミ
ド(ラシックス),ブメタニド(ルネトロン),アゾセ
ミド(ダイアート)〕,降圧薬(例、ACE阻害薬、
(マレイン酸エナラプリル(レニベース))及びCa 拮
抗薬(マニジピン)、α受容体遮断薬、AII拮抗薬
(カンデサルタン))などと組み合わせて、投与する
際、好ましくは経口投与で使用し得る。In the treatment of these diseases, Compound (I) and Compound (I ′) may be used alone for prophylaxis and / or treatment, and may also be used for other lipid-lowering drugs, cholesterol-lowering drugs, myocardial protection. Drugs, coronary artery disease drugs, diabetes drugs, hypothyroid drugs, nephrotic syndrome drugs, osteoporosis drugs or other pharmaceutical ingredients including chronic renal failure drugs, in which case these compounds may be used. Is preferably administered as an oral preparation, and if necessary, may be administered in the form of suppositories as a rectal preparation. In this case, the components that can be combined include, for example, (1) PPARα agonists such as fibrates (eg, clofibrate, bezafibrate, gemfibrozil, fenofibrate, etc.);
Nicotinic acid, its derivatives and analogs (eg, acipimox, probucol, etc.), (2) bile acid-binding resins (eg, cholestyramine, colestipol, etc.), compounds inhibiting cholesterol absorption (eg, sitosterol, neomycin, etc.), 3) Compounds that inhibit cholesterol biosynthesis (eg, HMG-CoA reductase inhibitors such as lovastatin, simvastatin, pravastatin, cerivastatin, atorvastatin, fluvastatin, itavastatin, rosuvastatin), squalene epoxidase inhibitors (eg, NB) -598 and analogs thereof), squalene synthase inhibitors (eg, benzoxazepine derivatives and the like) and the like. Still other possible combination components include oxidosqualene-lanosterol cyclase (eg, decalin derivatives, azadecalin derivatives, indane derivatives, etc.), microsomal triglyceride transfer protein inhibitors (implaptide)
Etc.). Also, a therapeutic agent for diabetes [Actos, rosiglidason, kinedac, benfil, humulin, oigurcon, glimicron, daoneil, novolin, monotard, insulins, glucoby, dimerin, rustinone, basilcon, deamelin S, isgilin]; hypothyroidism Therapeutic agent [dry thyroid (thyreoid), levothyroxine sodium (thyrazine S), liothyronidine sodium (thyronine, thyromin); Nephrotic syndrome therapeutic agent: prednisolone (prednin), prednisolone sodium succinate (prednin), methylprednisolone sodium succinate (Sol Medrol), Betamethasone (Rinderone)]; Anticoagulant [Dipyridamole (Versanthin), Dilazep hydrochloride (Comerian), Tylopidine, Clovide Grell, X
a inhibitor]; a drug for treating chronic renal failure [diuretic [eg, furosemide (Lasix), bumetanide (Lunetron), azosemide (Diart)]], antihypertensive (eg, ACE inhibitor,
When used in combination with (enalapril maleate (Lenibase)) and a Ca antagonist (manidipine), an α receptor blocker, an AII antagonist (candesartan), etc., it can be preferably used orally.
【0110】さらに化合物(I)および化合物(I’)
は、細胞の過剰増殖と関連する疾患の治療に適してい
る。細胞の過剰増殖と関連する疾患の主要な例は腫瘍で
ある。血清総コレステロール低下またはLDL−コレス
テロールまたはVLDL−コレステロール低下により腫
瘍増殖が抑えられることが報告されている(Lancet 33
9:1154-1156,1992)。したがって、化合物(I)および
化合物(I’)はLDL−コレステロールまたはVLD
L−コレステロール低下作用を有するので腫瘍の治療が
可能であり、単独で、または既知の治療法と組み合わせ
て腫瘍の治療に使用し得る。他の適用可能な疾患として
は、過剰増殖性皮膚疾患、例えば乾癬、基底細胞癌、扁
平上皮癌、角化症および角質化疾患が挙げられる。また
過剰増殖性血管疾患、例えば、PTCA(経皮的血管形
成術)あるいはバイパス手術の様な外科的手段により引
き起こされる血管狭窄および閉塞は、平滑筋細胞の増殖
に基づくものであり、本発明の化合物はLDL−コレス
テロールおよびVLDL−コレステロール低下作用から
考えて、これらの疾患の治療および予防にも適してい
る。その際それらは単独、または既知活性化合物、例え
ば静脈内投与されるヘパリンなどと組み合わせて、好ま
しくは経口投与で使用し得る。Further, compound (I) and compound (I ')
Is suitable for treating diseases associated with cell hyperproliferation. A major example of a disease associated with cell overgrowth is a tumor. It has been reported that lowering serum total cholesterol or lowering LDL-cholesterol or VLDL-cholesterol reduces tumor growth (Lancet 33).
9: 1154-1156, 1992). Therefore, compound (I) and compound (I ′) are prepared from LDL-cholesterol or VLD
It has an L-cholesterol lowering effect and is capable of treating tumors and can be used alone or in combination with known treatments to treat tumors. Other applicable diseases include hyperproliferative skin diseases such as psoriasis, basal cell carcinoma, squamous cell carcinoma, keratosis and keratinization disease. Hyperproliferative vascular disease, for example, vascular stenosis and occlusion caused by surgical means such as PTCA (percutaneous angioplasty) or bypass surgery is based on smooth muscle cell proliferation and The compounds are also suitable for treating and preventing these diseases in view of their LDL-cholesterol and VLDL-cholesterol lowering effects. They can be used here alone or in combination with known active compounds, such as, for example, intravenously administered heparin, preferably for oral administration.
【0111】本発明の化合物の更に可能な用途として、
胆石の予防および治療が挙げられる。胆汁液中のコレス
テロールがその最高溶解度を越えたときにコレステロー
ルの沈殿を生じ、胆石を形成する。フィブラート類の脂
質低下薬は胆汁への中性ステロイド分泌を増加させ、ま
た胆石形成の感受性を上昇させる。これとは対照的に、
ロバスタチンまたはプラバスタチンの様なコレステロー
ル生合成阻害薬は胆石形成を促進しないが、胆汁中コレ
ステロール濃度の低下を生じるため胆石形成指数を低下
し得る(Gut 31:348-350,1990)。さらに、ウルソデオ
キシ胆汁酸と組み合わせると、ロバスタチンは胆石溶解
に有効であることが報告されている(Gastroenterology
102, No.4, Pt.2, A319,1992)。それゆえ、作用様式
から考えて本発明の化合物は胆石の予防および治療に適
している。その際それらは単独で、または既知の治療薬
(例えばウルソデオキシ胆汁酸など)または既知の治療
法(例えば衝撃波砕石術など)と組み合わせて、好まし
くは経口投与で使用し得る。Further possible uses of the compounds of the present invention include:
Gallstone prevention and treatment. When cholesterol in bile exceeds its maximum solubility, cholesterol precipitates and forms gallstones. Fibrate lipid-lowering drugs increase the secretion of neutral steroids into the bile and increase the sensitivity of gallstone formation. In contrast,
Cholesterol biosynthesis inhibitors, such as lovastatin or pravastatin, do not promote gallstone formation, but can reduce the gallstone formation index because they cause a reduction in bile cholesterol levels (Gut 31: 348-350, 1990). Furthermore, lovastatin has been reported to be effective in dissolving gallstones in combination with ursodeoxy bile acids (Gastroenterology
102, No. 4, Pt. 2, A319, 1992). Thus, given the mode of action, the compounds of the invention are suitable for the prevention and treatment of gallstones. They may be used alone or in combination with known therapeutic agents (such as ursodeoxy bile acid) or known therapeutics (such as shockwave lithotripsy), preferably for oral administration.
【0112】本発明の化合物(I)および化合物
(I’)は血中HDL−コレステロール上昇作用を有す
る。血中HDL−コレステロール上昇により、コレステ
ロールが余剰となった細胞からのコレステロールが搬出
が促進される(Current Opinion inLipidology 4:3
92−400)ので、アテローム性動脈硬化の治療およ
び予防に適する。その生物学的性質を考えると、アテロ
ーム性動脈硬化血管病変およびそれらの純発症、例え
ば、冠動脈疾患(CHD)、脳虚血、間欠性跛行、壊疽
等の治療および予防に特に適している。本発明の別の用
途としてHDLの抗酸化作用に基づくものがある。血中
の脂質過酸化物はLDLよりもはるかにHDLに高濃度
になっており、またHDLには、例えばLDLの酸化な
ど生体で生じる脂質過酸化を防御する役割がある(Curr
ent Opinion in Lipidology 4:392−400,Curr
ent Opinion in Lipidology 5:354−364)。The compounds (I) and (I ') of the present invention have a blood HDL-cholesterol increasing effect. Increase in blood HDL-cholesterol promotes export of cholesterol from cells having excess cholesterol (Current Opinion in Lipidology 4: 3
92-400), so that it is suitable for treating and preventing atherosclerosis. Given their biological properties, they are particularly suitable for the treatment and prevention of atherosclerotic vascular lesions and their net onset, such as coronary artery disease (CHD), cerebral ischemia, intermittent claudication, gangrene, and the like. Another application of the present invention is based on the antioxidant action of HDL. Lipid peroxide in blood is much higher in HDL than in LDL, and HDL has a role in protecting against lipid peroxidation that occurs in the body, such as oxidation of LDL (Curr).
ent Opinion in Lipidology 4: 392-400, Curr
ent Opinion in Lipidology 5: 354-364).
【0113】本発明のさらに別の用途として高血圧症お
よびその続発症がある。高脂血症は動脈硬化症を増悪さ
せ、高血圧症を引き起こす。一方、HDLは、酸化LD
LによるEDRF(内皮由来弛緩因子)の生合成と遊離
阻害を防ぎ、また、マクロファージにおいては血管弛緩
因子のプロスタサイクリンを増加させることが知られて
いる(Current Opinion in Lipidology 5:354−3
64)。本発明物質の脂質低下作用および血中HDL-
コレステロール上昇作用から考えると、高血圧症および
その続発症、例えば、冠動脈疾患(CHD)、脳虚血な
どの治療および予防に適している。その際、式(I)ま
たは(I’)の化合物またはその塩は単独、あるいは以
下に例示する薬剤と組合わせて投与することができる。
この場合の可能な組合わせは、例えばアンジオテンシン
−II拮抗薬〔例、ロサルタンカリウム(ニュウロタ
ン)、カンデサルタンレキセチル(プロブレス)等〕、
ACE阻害薬〔例、マレイン酸エナラプリル(レニベー
ス)、リシノプリル(ゼストリル、ロンゲス)、塩酸デ
ラプリル(アデカット)、カプトプリル等〕、カルシウ
ム拮抗薬〔例、トシル酸アムロジピン(アムロジン、ノ
ルバスク)、塩酸マニジピン(カルスロット)等〕、降
圧利尿剤、α受容体遮断薬、β受容体遮断薬などが挙げ
られる。Still another use of the present invention is hypertension and its sequelae. Hyperlipidemia exacerbates arteriosclerosis and causes hypertension. On the other hand, HDL is an oxidized LD
L is known to prevent the inhibition of EDRF (endothelium-derived relaxing factor) biosynthesis and release, and to increase the vascular relaxing factor prostacyclin in macrophages (Current Opinion in Lipidology 5: 354-3).
64). Lipid-lowering effect of substance of the present invention and blood HDL-
Considering the cholesterol-elevating effect, it is suitable for treating and preventing hypertension and its sequelae, such as coronary artery disease (CHD) and cerebral ischemia. At that time, the compound of the formula (I) or (I ′) or a salt thereof can be administered alone or in combination with the agents exemplified below.
Possible combinations in this case include, for example, angiotensin-II antagonists [eg, losartan potassium (neurotan), candesartan rexetil (probres), etc.],
ACE inhibitors (eg, enalapril maleate (Lenibase), lisinopril (Zestril, Ronges), delapril hydrochloride (Adecat), captopril, etc.), calcium antagonists (eg, amlodipine tosylate (amlodin, norvasc), manidipine hydrochloride (calslot) ) Etc.], antihypertensive diuretics, α receptor blockers, β receptor blockers and the like.
【0114】本発明の化合物(I)および化合物
(I’)の可能な用途として胃液・膵液や胆汁など細胞
傷害性分泌液からの細胞保護作用に基づくものがある。
体液−組織間細胞は主に apoJを発現しており、また胃
液・膵液や胆汁など細胞傷害性分泌液に対する自然のバ
リアとなっており、HDLは apoJ(clusterin)のキ
ャリアである(Current Opinion in Lipidology 4:3
92−400)。本発明の化合物(I)および化合物
(I’)の血中HDL−コレステロール上昇作用から考
えて、本発明の化合物(I)および化合物(I’)は胃
潰瘍、膵炎および肝炎等の治療および予防に適してい
る。Possible uses of the compounds (I) and (I ′) of the present invention include those based on cytoprotective action from cytotoxic secretions such as gastric juice / pancreatic juice and bile.
Fluid-tissue cells mainly express apoJ and serve as a natural barrier to cytotoxic secretions such as gastric juice, pancreatic juice and bile, and HDL is a carrier of apoJ (clusterin) (Current Opinion in Lipidology 4: 3
92-400). Considering the blood HDL-cholesterol elevating effect of the compounds (I) and (I ') of the present invention, the compounds (I) and (I') of the present invention are useful for treating and preventing gastric ulcer, pancreatitis and hepatitis. Are suitable.
【0115】本発明の化合物(I)および化合物
(I’)のさらに可能な用途として細胞増殖活性に基づ
くものがある。HDLは、単独であるいは増殖因子と共
に血管内皮細胞(EC)や角膜内皮など細胞の増殖を促
進し、またHDLはヒトリンパ球の増殖を促進する(Cu
rrent Opinion in Lipidology 3:222−226)。
本発明の化合物(I)および化合物(I’)は血中HD
L−コレステロール上昇作用を有する。これらの細胞増
殖活性から考えて、アテローム性動脈硬化血管病変およ
びそれらの続発症、例えば冠動脈疾患、角膜損傷等の治
療および予防に適している。また、免疫能低下に基づく
疾患、例えば感染症や悪性腫瘍等の治療および予防にも
適している。Further possible uses of the compounds (I) and (I ') of the present invention include those based on cell proliferation activity. HDL alone or together with growth factors promotes proliferation of cells such as vascular endothelial cells (EC) and corneal endothelium, and HDL promotes proliferation of human lymphocytes (Cu
rrent Opinion in Lipidology 3: 222-226).
Compound (I) and compound (I ′) of the present invention have a high blood HD
It has an L-cholesterol increasing effect. Considering these cell proliferating activities, they are suitable for treating and preventing atherosclerotic vascular lesions and their sequelae, such as coronary artery disease and corneal injury. In addition, it is also suitable for treatment and prevention of diseases based on decreased immunocompetence, such as infectious diseases and malignant tumors.
【0116】本発明の化合物(I)および化合物
(I’)の追加すべき用途として、HDLはヒト胎盤移
植組織に特異的に作用し lactogen を分泌させる、ま
た、マクロファージからの apoE分泌を促進する(Curr
ent Opinion in Lipidology 3:222−226)。そ
の分泌促進活性を考えると、胎児発育不全等の治療およ
び予防にも適している。As an additional use of the compounds (I) and (I ') of the present invention, HDL specifically acts on human placenta transplant tissues to secrete lactogen and promotes apoE secretion from macrophages. (Curr
ent Opinion in Lipidology 3: 222-226). Considering its secretion promoting activity, it is also suitable for treatment and prevention of fetal growth failure and the like.
【0117】化合物(I)および化合物(I’)の更に
注目に値する適用例として、続発性高脂血症が挙げられ
る。これには、糖尿病、インスリン抵抗性(シンドロー
ムX)、甲状腺機能低下症、ネフローゼ症候群あるいは
慢性腎不全等が含まれ、これらの疾患によって高脂血症
が発症するが多くの場合、高脂血症がこれらの疾患を増
悪させ、いわゆる悪循環を形成しているといわれてい
る。脂質低下作用から考えて、化合物(I)および化合
物(I’)はこれらの疾患の治療及び進展予防にも適し
ており、その際、化合物(I)および化合物(I’)は
単独で、又は既知の活性化合物、つまり糖尿病治療薬と
の併用では、例えば、(1)利尿薬(例えば、フロセミ
ド、スピロノラクトン等)、(2)交感神経抑制薬(例
えば、アテノロール等)、(3)アンジオテンシンII拮
抗薬(例えば、ロサルタン、カンデサルタン等)、
(4)アンジオテンシンI変換酵素阻害薬(例えば、マ
レイン酸エナラプリル、塩酸デラプリル等)、(5)カ
ルシウム拮抗薬(例えば、ニフェジピン、塩酸マニジピ
ン等)等が挙げられ、また、甲状腺機能低下症の治療薬
との併用では、乾燥サイロイド、レボチロキシンナトリ
ウム、リオチロニンナトリウム等と、また腎疾患治療薬
との併用では、プレドニゾロン、コハク酸メチルプレド
ニゾロンナトリウム、フロセミド、ブメタニド、アゾセ
ミド等と組み合わせて、好ましくは経口投与で使用し得
る。A further noteworthy application of compound (I) and compound (I ') is secondary hyperlipidemia. These include diabetes, insulin resistance (syndrome X), hypothyroidism, nephrotic syndrome or chronic renal failure, etc. These diseases cause hyperlipidemia, but often hyperlipidemia. Is said to exacerbate these diseases and form a so-called vicious circle. In view of the lipid-lowering effect, compound (I) and compound (I ′) are also suitable for treating and preventing the progress of these diseases, wherein compound (I) and compound (I ′) are used alone or In combination with a known active compound, ie, a therapeutic agent for diabetes, for example, (1) a diuretic (eg, furosemide, spironolactone, etc.), (2) a sympathomimetic (eg, atenolol, etc.), (3) angiotensin II antagonist Drugs (eg, losartan, candesartan, etc.),
(4) Angiotensin I converting enzyme inhibitors (eg, enalapril maleate, delapril hydrochloride, etc.), (5) Calcium antagonists (eg, nifedipine, manidipine hydrochloride, etc.) and the like, and therapeutic agents for hypothyroidism In combination with dry thyroid, levothyroxine sodium, liothyronine sodium, etc., and in combination with renal disease drug, prednisolone, methylprednisolone sodium succinate, furosemide, bumetanide, azosemide, etc., preferably oral Can be used for administration.
【0118】化合物(I)および化合物(I’)はアル
ツハイマー病の予防、治療にも有用である。血中コレテ
ロールの上昇は、アルツハイマー病の危険因子であるこ
とが知られている。式(I)または(I’)で表わされ
る化合物またはその塩、またはそのプロドラッグなどの
CETP阻害薬は、その優れたHDL-コレステロール
上昇及び脂質低下作用により、アルツハイマー病の予
防、治療に用いることができ、その際、CETP阻害薬
は、単独あるいは以下に例示する薬剤と組み合わせて投
与することができる。この場合の可能な組み合わせは、
例えば、アセチルコリンエステラーゼ阻害薬(例えば、
アリセプト、エクセロンなど)、アミロイドβ産生・分
泌阻害薬(例えば、JT-52やLY-374973などのγあるいは
βセクレターゼ阻害剤、あるいはSIB-1848など)、アミ
ロイドβ凝集阻害薬(例えば、PTI-00703やBETABLOC(AN-
1792)など)などが挙げられる。化合物(I)および化合
物(I’)のさらに注目すべき適応症は、血中コレステ
ロールの上昇に伴う骨粗鬆症である。化合物(I)およ
び化合物(I’)の優れた脂質低下作用により、血中コ
レステロールの上昇に伴う骨粗鬆症の治療・予防に用い
ることができ、その際、化合物(I)および化合物
(I’)は単独あるいは以下に例示する薬剤と組合わせ
て投与することができる。この場合の可能な組合わせと
しては、例えば性ホルモンおよび関連薬剤〔例、エスト
ロゲン製剤、イプリフラボン(オステン)、ラロキシフ
ェン、オサテロン、チボロン等〕、カルシトニン類、ビ
タミンD製剤〔例、アルファカルシドール、カルシトリ
オール等〕、ビスホスホン酸類(例、エチドロネート、
クロドロネート等)などの骨吸収抑制剤、フッ素化合
物、PTHなどの骨形成促進剤などが挙げられる。Compound (I) and compound (I ') are also useful for preventing and treating Alzheimer's disease. Elevated blood cholesterol is known to be a risk factor for Alzheimer's disease. A CETP inhibitor such as a compound represented by the formula (I) or (I ′) or a salt thereof, or a prodrug thereof is used for prevention and treatment of Alzheimer's disease due to its excellent HDL-cholesterol increasing and lipid lowering effects. In this case, the CETP inhibitor can be administered alone or in combination with the agents exemplified below. Possible combinations in this case are:
For example, acetylcholinesterase inhibitors (e.g.,
Aricept, exelon, etc.), amyloid β production / secretion inhibitor (e.g., γ or β secretase inhibitor such as JT-52 or LY-374973, or SIB-1848, etc.), amyloid β aggregation inhibitor (e.g., PTI-00703 And BETABLOC (AN-
1792)). A further notable indication of compound (I) and compound (I ′) is osteoporosis associated with elevated blood cholesterol. Due to the excellent lipid-lowering effect of compound (I) and compound (I ′), it can be used for treatment and prevention of osteoporosis associated with an increase in blood cholesterol, in which case compound (I) and compound (I ′) It can be administered alone or in combination with the drugs exemplified below. Possible combinations in this case include, for example, sex hormones and related drugs (eg, estrogen preparations, ipriflavone (osten), raloxifene, osaterone, tibolone, etc.), calcitonins, vitamin D preparations (eg, alfacalcidol, calcitriol) Etc.), bisphosphonic acids (eg, etidronate,
Bone resorption inhibitors such as clodronate), fluorine compounds, and bone formation promoters such as PTH.
【0119】加えて、化合物(I)および化合物
(I’)は、高カイロミクロン血症に関連する疾患、例
えば、急性膵炎の治療に適している。膵炎発症の機序に
ついては、カイロミクロンによって膵毛細血管に微小塞
栓がおこる、あるいは高カイロミクロン血症のため膵リ
パーゼによってトリグリセリドが分解されて生成する遊
離脂肪酸が増加し局所を強く刺激するためにおこるとも
いわれている。したがって、本発明の化合物(I)およ
び化合物(I’)はトリグリセリド低下作用を有するの
で膵炎の治療が可能であり、単独で、または既知の治療
法と組み合わせて膵炎の治療に使用し得る。本疾患の治
療のために、本発明の化合物(I)および化合物
(I’)は経口投与または局所投与でき、またはそれら
は単独であるいは既知の活性化合物と組み合わせて使用
し得る。この場合の可能な組み合わせ成分は、例えば抗
酵素療用にアプロチニン(トラジロール),メシル酸ガ
ベキサート(エフオーワイFOY),メシル酸ナファモ
スタット(フサン),シチコリン(ニコリン),ウリナ
スタチン(ミラクリッド)等があげられる。又疼痛の除
去の目的で、抗コリン作動薬、非麻薬性鎮痛薬、麻薬も
使用される。In addition, compound (I) and compound (I ') are suitable for treating diseases associated with hyperchylomicronemia, for example, acute pancreatitis. Regarding the mechanism of pancreatitis onset, micro-emboli occur in pancreatic capillaries due to chylomicron, or triglyceride is degraded by pancreatic lipase due to hyperchylomicronemia, increasing the free fatty acids produced and strongly stimulating the local area It is said to happen. Therefore, the compounds (I) and (I ′) of the present invention have a triglyceride lowering effect, and thus can treat pancreatitis, and can be used alone or in combination with known therapeutic methods for treating pancreatitis. For the treatment of this disease, the compounds (I) and (I ′) of the present invention can be administered orally or topically, or they can be used alone or in combination with known active compounds. Possible combination components in this case include, for example, aprotinin (tradirol), gabexate mesilate (EFOY FOY), nafamostat mesilate (fusan), citicoline (nicoline), ulinastatin (miracride) for antienzyme therapy. . Anticholinergics, non-narcotic analgesics, and narcotics are also used for pain relief.
【0120】本発明の化合物(I)および化合物
(I’)の更に可能な用途は、血栓形成の抑制である。
血中トリグリセリド値と血液凝固に関与する第VII因子
とは正相関し、ω-3系脂肪酸の摂取によりトリグリセ
リドが低下すると共に、凝固は抑制されることから、高
トリグリセリド血症が血栓形成を促進する。また、正脂
血症者よりも高脂血症患者のVLDLが血管内皮細胞か
らのプラスミノーゲンアクチベータインヒビター分泌を
強く増加させたことから、トリグリセリドが線溶能を低
下させるとも考えられる。それゆえ、トリグリセリド低
下作用から考えて、化合物(I)および化合物(I’)
は血栓形成の予防および治療に適している。その際それ
らは単独で、または既知の下記治療薬と組み合わせて、
好ましくは経口投与で使用し得る。 血栓形成予防治療薬:血液凝固阻止薬〔例、ヘパリンナ
トリウム,ヘパリンカルシウム,ワルファリンカルシウ
ム(ワーファリン),Xa阻害薬〕,血栓溶解薬〔例、
tPA,ウロキナーゼ〕,抗血小板薬〔例、アスピリ
ン,スルフィンピラゾロ(アンツーラン),ジピリダモ
ール(ペルサンチン),チクロピジン(パナルジン),
シロスタゾール(プレタール),GPIIb/IIIa拮抗薬
(レオプロ)〕 冠血管拡張薬:ニフェジピン,ジルチアゼム,ニコラジ
ル,亜硝酸剤; 心筋保護薬:心臓ATP−K開口薬、エンドセリン拮抗
薬、ウロテンシン拮抗薬など。さらに、本発明の化合物
を上記各疾患に適用する際に、生物製剤(例:抗体、ワ
クチン製剤など)と併用することも可能であり、また、
遺伝子治療法などと組み合わせて、併用療法として適用
することも可能である。抗体およびワクチン製剤として
は、例えば、アンジオテンシンIIに対するワクチン製
剤、CETPに対するワクチン製剤、CETP抗体、TNFα抗体
や他のサイトカインに対する抗体、アミロイドβワクチ
ン製剤、1型糖尿病ワクチン(Peptor社のDIAPEP-277な
ど)などの他、サイトカイン、レニン・アンジオテンシ
ン系酵素およびその産物に対する抗体あるいはワクチン
製剤、血中脂質代謝に関与する酵素や蛋白に対する抗体
あるいはワクチン製剤、血中の凝固・線溶系に関与する
酵素や蛋白に関する抗体あるいはワクチン、糖代謝やイ
ンスリン抵抗性に関与する蛋白に対する抗体あるいはワ
クチン製剤などが挙げられる。また、遺伝子治療法とし
ては、例えば、サイトカイン、レニン・アンジオテンシ
ン系酵素およびその産物に関連する遺伝子を用いた治療
法、NFκBデコイなどのDNAデコイを用いる治療方法、ア
ンチセンスを用いる治療方法、血中脂質代謝に関与する
酵素や蛋白に関連する遺伝子(例えば、コレステロール
又はトリグリセリド又はHDL-コレステロール又は血中リ
ン脂質の代謝、排泄、吸収に関連する遺伝子など)を用
いた治療法、末梢血管閉塞症などを対象とした血管新生
療法に関与する酵素や蛋白(例えば、HGF,VEGF
などの増殖因子など)に関連する遺伝子を用いた治療
法、糖代謝やインスリン抵抗性に関与する蛋白に関連す
る遺伝子を用いた治療法、TNFなどのサイトカインに対
するアンチセンスなどが挙げられる。また、心臓再生、
腎再生、膵再生、血管再生など各種臓器再生法や骨髄細
胞(骨髄単核細胞、骨髄幹細胞など)の移植を利用した
血管新生療法と併用することも可能である。A further possible use of the compounds (I) and (I ') of the present invention is in the inhibition of thrombus formation.
Blood triglyceride levels are positively correlated with factor VII involved in blood coagulation. Ingestion of ω-3 fatty acids lowers triglycerides and suppresses coagulation, so hypertriglyceridemia promotes thrombus formation I do. In addition, since VLDL of hyperlipidemic patients increased plasminogen activator inhibitor secretion from vascular endothelial cells more strongly than normolipidemic patients, it is also considered that triglycerides decrease fibrinolytic ability. Therefore, in view of the triglyceride lowering action, compound (I) and compound (I ′)
Is suitable for the prevention and treatment of thrombus formation. In that case they can be used alone or in combination with the following known therapeutic agents,
Preferably it can be used for oral administration. Antithrombotic drug: Anticoagulant (eg, heparin sodium, heparin calcium, warfarin calcium (warfarin), Xa inhibitor), thrombolytic drug (eg,
tPA, urokinase], antiplatelet drugs [eg, aspirin, sulfinpyrazolo (anturane), dipyridamole (persantin), ticlopidine (panaldine),
Cilostazol (pletal), GPIIb / IIIa antagonist (Leopro)] Coronary vasodilators: nifedipine, diltiazem, nicorazil, nitrite; cardioprotective agents: cardiac ATP-K openers, endothelin antagonists, urotensin antagonists and the like. Furthermore, when the compound of the present invention is applied to each of the above diseases, it can be used in combination with a biological agent (eg, antibody, vaccine preparation, etc.),
It can be applied as a combination therapy in combination with a gene therapy or the like. Antibodies and vaccine preparations include, for example, a vaccine preparation against angiotensin II, a vaccine preparation against CETP, a CETP antibody, an antibody against TNFα antibody and other cytokines, an amyloid β vaccine preparation, a type 1 diabetes vaccine (such as DIAPEP-277 of Peptor) Antibodies or vaccines against cytokines, renin-angiotensin enzymes and their products, antibodies or vaccines against enzymes and proteins involved in blood lipid metabolism, enzymes and proteins involved in blood coagulation / fibrinolysis system Examples include an antibody or a vaccine, an antibody against a protein involved in glucose metabolism or insulin resistance, or a vaccine preparation. Examples of the gene therapy include, for example, a therapy using a gene related to a cytokine, a renin-angiotensin enzyme and its product, a therapy using a DNA decoy such as NFκB decoy, a therapy using an antisense, Therapy using genes related to enzymes and proteins involved in lipid metabolism (eg, genes related to metabolism, excretion and absorption of cholesterol or triglyceride or HDL-cholesterol or blood phospholipids), peripheral vascular obstruction, etc. Enzymes and proteins (eg, HGF, VEGF)
And the like, such as growth factors, etc.), therapies using genes related to proteins involved in glucose metabolism and insulin resistance, and antisense to cytokines such as TNF. Also, heart regeneration,
It can be used in combination with various organ regeneration methods such as kidney regeneration, pancreatic regeneration, and blood vessel regeneration, and angiogenesis therapy utilizing transplantation of bone marrow cells (bone marrow mononuclear cells, bone marrow stem cells, etc.).
【0121】本発明の製剤の投与量は、投与経路、症
状、患者の年令あるいは体重等によってもことなるが、
例えば、動脈硬化治療剤として、成人患者に経口的に投
与する場合、化合物(I)または化合物(I’)として
1日当たり0.2−50mg/day、好ましくは1.
5−30mg/dayを1−数回に分けて投与するのが
望ましい。投与経路は経口、非経口のいずれでもよい。
また、本発明の徐放性製剤の投与量は、投与経路、症
状、患者の年令あるいは体重等の他に、放出の持続時間
等によっても種々異なるが、活性成分である化合物
(I)または化合物(I’)の有効濃度が体内で保持さ
れる量であれば特に制限されず、その投与回数は、1日
ないし3日あるいは1週間ないし3カ月に1回等状況に
よって適宜選ぶことができる。The dose of the preparation of the present invention may vary depending on the administration route, symptoms, age of the patient, body weight and the like.
For example, when orally administered to an adult patient as a therapeutic agent for arteriosclerosis, the compound (I) or compound (I ′) is 0.2 to 50 mg / day, preferably 1.
It is preferable to administer 5 to 30 mg / day in 1 to several divided doses. The administration route may be oral or parenteral.
The dose of the sustained-release preparation of the present invention may vary depending on the route of administration, symptoms, age, weight, etc. of the patient, as well as the duration of release. There is no particular limitation as long as the effective concentration of compound (I ') is maintained in the body. .
【0122】[0122]
【発明の実施の形態】以下に、本発明の化合物(I)お
よび化合物(I’)の薬理効果を示す実験結果について
記載する。 試験例1 コレステリルエステル転送蛋白阻害活性の測
定 1) 超低比重リポ蛋白(VLDL)−低比重リポ蛋白
(LDL)の調製 新鮮ウサギ血清をKBrで1.063g/mlに比重調
整後、超遠心分離操作(SW41−Ti,40,000
rpm,18hrs,4℃,Beckmanmodel
L8−55)により浮上する画分(VLDL−LD
L,比重<1.063g/ml)を集め、0.15M
NaCl−10mM Tris−HCl,pH7.4
(TBS)に対して透析を行い、フィルターで無菌濾過
後、4℃で保存した。BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, experimental results showing the pharmacological effects of compound (I) and compound (I ') of the present invention will be described. Test Example 1 Measurement of cholesteryl ester transfer protein inhibitory activity 1) Preparation of very low density lipoprotein (VLDL) -low density lipoprotein (LDL) After adjusting the specific gravity of fresh rabbit serum to 1.063 g / ml with KBr, ultracentrifugation Operation (SW41-Ti, 40,000
rpm, 18 hrs, 4 ° C., Beckmanmodel
L8-55) (VLDL-LD)
L, specific gravity <1.063 g / ml)
NaCl-10 mM Tris-HCl, pH 7.4
(TBS) was dialyzed, sterile filtered with a filter, and stored at 4 ° C.
【0123】2) BODIPY−CEマイクロエマル
ジョン(BOBIPY−CE−ME)の調製 eggPC(ホスファチジルコリン)(5ng)、トリ
オレイン(2mg)にBODIPY−CE(0.6m
g)のクロロホルム溶液を加え溶解後、窒素ガス環流下
で脂質を風乾し、さらに高真空下で溶媒を除去した。こ
の脂質に、ヒトHDL(1.063<d<1.21)よ
りクロロホルム-メタノール(2:1,v/v)で脱脂
後、6M尿素含有TBSに溶解し、TBSに対して透析
して得たapo HDL溶液(7.5ml)を加え、ソ
ニック(BRANSON SONIFIRE CELL
DISRUPTOR 200、ダイアル6、5min
×4)を行いBOBIPY−CE−MEを調製した。遠
心分離(CENTRIPREP 10)後、フィルター
で無菌濾過し、4℃で保存した。2) Preparation of BODIPY-CE microemulsion (BOBIPY-CE-ME) EggPC (phosphatidylcholine) (5 ng) and triolein (2 mg) were added to BODIPY-CE (0.6 m).
After adding and dissolving the chloroform solution of g), the lipid was air-dried under nitrogen gas reflux and the solvent was removed under high vacuum. This lipid was defatted from human HDL (1.063 <d <1.21) with chloroform-methanol (2: 1, v / v), dissolved in 6M urea-containing TBS, and dialyzed against TBS. Apo HDL solution (7.5 ml) was added, and Sonic (Branson Sonifer Cell) was added.
DISRUPTOR 200, dial 6, 5 min
× 4) to prepare BOBIPY-CE-ME. After centrifugation (CENTRIPREP 10), the solution was sterile-filtered with a filter and stored at 4 ° C.
【0124】3) 標準測定系 被検化合物(20%DMSO溶液)5μl、TBS75
μl、acceptorリポ蛋白(VLDL−LD
L)20 μlおよび部分精製ヒトCETP25μlを
混合し、37℃で30分間保温後、BODIPY−CE
−ME25 μlを加え(全部で150 μl)、転送反
応を開始した。37℃、30分間反応後、Ex.490
nm/Em.530nmで蛍光強度を測定した。CET
P阻害活性(阻害率%)は以下に示す式で計算した。3) Standard measurement system Test compound (20% DMSO solution) 5 μl, TBS75
μl, acceptor lipoprotein (VLDL-LD
L) 20 μl and 25 μl of partially purified human CETP were mixed and incubated at 37 ° C. for 30 minutes, followed by BODIPY-CE
-Transfer reaction was started by adding 25 μl of ME (150 μl in total). After reaction at 37 ° C. for 30 minutes, Ex. 490
nm / Em. The fluorescence intensity was measured at 530 nm. CET
The P inhibitory activity (inhibition rate%) was calculated by the following formula.
【0125】[0125]
【数1】 (Equation 1)
【0126】4) 50%ヒト血漿含有測定系 被検化合物(20%DMSO溶液)5 μl、ヒト血漿
75 μl、acceptorリポ蛋白(VLDL−L
DL)20 μlおよび部分精製ヒトCETP25 μl
を混合し、37℃で30分間保温後、BODIPY-C
E-ME25 μlを加え(全部で150 μl)、転送
反応を開始した。37℃、60分間反応後、Ex.49
0nm/Em.530nmで蛍光強度を測定した。CE
TP阻害活性(阻害率%)は以下に示す式で計算した。4) Measurement system containing 50% human plasma 5 μl of test compound (20% DMSO solution), 75 μl of human plasma, acceptor lipoprotein (VLDL-L)
DL) 20 μl and partially purified human CETP 25 μl
, And kept at 37 ° C for 30 minutes, then BODIPY-C
Transfer reaction was started by adding 25 μl of E-ME (150 μl in total). After reaction at 37 ° C. for 60 minutes, Ex. 49
0 nm / Em. The fluorescence intensity was measured at 530 nm. CE
The TP inhibitory activity (inhibition rate%) was calculated by the following formula.
【0127】[0127]
【数2】 (Equation 2)
【0128】IC50値は被検化合物濃度の対数と阻害率
とをプロットすることにより50%阻害を示す濃度とし
て求めた。結果を表1に示す。The IC 50 value was determined as a concentration showing 50% inhibition by plotting the logarithm of the test compound concentration and the inhibition rate. Table 1 shows the results.
【0129】[0129]
【表1】 [Table 1]
【0130】上記結果から明らかなように、本化合物は
すぐれたコレステリルエステル転送蛋白阻害活性を有し
ている。As is apparent from the above results, the present compound has excellent cholesteryl ester transfer protein inhibitory activity.
【0131】[0131]
【実施例】本発明は、さらに下記の実施例および参考例
で詳しく説明されるが、これらの例は単なる実例であっ
て本発明を限定するものではなく、また本発明の範囲を
逸脱しない範囲で変化させてもよい。1H-NMRスペクトル
は、内部標準としてテトラメチルシランを用いてバリア
ンジェミニ200(200MHz)で測定し、全δ値をppmで示
した。混合溶媒において示した数値は、特に断らない限
り各溶媒の容積混合比である。%は特に断らない限り重
量%を意味する。また、シリカゲルクロマトグラフィー
における溶出溶媒は、特に断らない限り容量比を示す。
本明細書中における室温(常温)とは、約20℃から約3
0℃の温度を表す。The present invention will be further described in the following examples and reference examples, which are merely illustrative and do not limit the present invention, and do not depart from the scope of the present invention. May be changed. The 1 H-NMR spectrum was measured with a Varian Gemini 200 (200 MHz) using tetramethylsilane as an internal standard, and all δ values were shown in ppm. The numerical values shown for the mixed solvents are volume mixing ratios of the respective solvents unless otherwise specified. % Means% by weight unless otherwise specified. The elution solvent in silica gel chromatography indicates a volume ratio unless otherwise specified.
Room temperature (normal temperature) in this specification refers to about 20 ° C. to about 3 ° C.
Represents a temperature of 0 ° C.
【0132】なお、実施例、参考例中の各記号は次の意
味を表す。s:シングレット、d:ダブレット、t:ト
リプレット、q:クアルテット、br:幅広い、J:カップ
リング定数、dd:ダブルダブレット、m:マルチプレッ
ト、Hz:ヘルツ、CDCl3:重クロロホルム、DMSO-d6:重
ジメチルスルホキシド、CD3OD:重メタノール、%:重
量%。The symbols in the examples and reference examples have the following meanings. s: singlet, d: doublet, t: triplet, q: Kuarutetto, br: broad, J: coupling constant, dd: double doublet, m: multiplet, Hz: Hertz, CDCl 3: deuterated chloroform, DMSO-d 6 : Heavy dimethyl sulfoxide, CD 3 OD: heavy methanol,%:% by weight.
【0133】実施例1 N-[2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-1-ナフタレンカルボキサミド 1) N-[2-(4-フルオロフェニル)-2-オキソエ
チル]ホルムアミド α-ブロモ-4-フルオロアセトフェノン30.0g
(0.138モル)のN,N-ジメチルホルムアミド2
00ml溶液に氷冷下アジ化ナトリウム8.99g
(0.136モル)を加え氷冷下30分間撹拌した。反
応液を水で希釈した後、酢酸エチルで抽出し、抽出液を
水、飽和食塩水で順次洗浄した後、硫酸マグネシウムで
乾燥し減圧下濃縮した。残留物をメタノール300ml
に溶解し、10%Pd/C(50%含水)3.0gと濃
塩酸12.7ml(0.152モル)を加えた後、水素
気流下で21時間撹拌した。触媒をろ別した後、反応液
を減圧濃縮した。残留物にギ酸ナトリウム10.3g
(0.152モル)、無水酢酸140ml、ギ酸70m
lの混合溶液を加え室温で1時間撹拌した。反応液を減
圧濃縮した後、水で希釈し、酢酸エチルで抽出した。抽
出液を飽和食塩水で洗浄した後、硫酸マグネシウムで乾
燥し減圧下濃縮した。残留物を酢酸エチル−ヘキサンか
ら再結晶して、目的物20.21g(81%)を結晶と
して得た。1 H-NMR (CDCl3, 200MHz) δ 4.79 (2H, dd, J = 0.6 H
z, 4.4 Hz), 6.73 (1H, br s), 7.14-7.30 (2H, m), 7.
97-8.10 (2H, m), 8.35 (1H, s). 2) 2-(4-フルオロフェニル)-2-オキソ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チルホルムアミド 60%水素化ナトリウムの流動パラフィン懸濁物0.5
5g(0.0138モル)のN,N-ジメチルホルムア
ミド16ml溶液にN-[2-(4-フルオロフェニル)-
2-オキソエチル]ホルムアミド1.66g(9.17
ミリモル)を氷冷下で加え30分間撹拌した。反応液に
4-(トリフルオロメチル)ベンジルブロミド1.70
ml(0.011モル)を加え室温で2時間撹拌した。
反応液を酢酸エチルで抽出し、抽出液を水、飽和食塩水
で順次洗浄した後硫酸マグネシウムで乾燥し減圧下濃縮
した。残留物をシリカゲルカラムクロマトグラフィー
(酢酸エチル/ヘキサン=1/2-1/1)で精製し、
目的物1.65g(53%)を結晶として得た。 mp 78-81℃; 1H-NMR (CDCl3, 200MHz) δ 3.13 (1H, d
d, J = 5.4 Hz, 13.8 Hz), 3.38 (1H, dd, J = 6.6 Hz,
14.0 Hz), 5.87-5.96 (1H, m), 6.52 (1H, br d,J =
7.8 Hz), 7.07-7.25 (4H, m), 7.48 (2H, d, J = 8.0 H
z), 7.93-8.04 (2H, m), 8.25 (1H, s); IR (KBr) 329
5, 1680, 1661 cm-1; Anal. Calcd for C17H 13F4NO2:
C, 60.18; H, 3.86; N, 4.13. Found: C, 59.99; H, 3.
87; N, 4.05 3) 2-(4-フルオロフェニル)-2-オキソ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チルアミン・塩酸塩 2-(4-フルオロフェニル)-2-オキソ-1-[[4-
(トリフルオロメチル)フェニル]メチル]エチルホル
ムアミド13.87g(40.9ミリモル)のメタノー
ル100ml溶液に濃塩酸3.8ml(45.0ミリモ
ル)を加え、2時間加熱還流した。反応液を減圧下濃縮
して、残留物を酢酸エチルで洗浄して、目的物13.6
3g(96%)を結晶として得た。1 H-NMR (DMSO-d6, 200MHz) δ 3.17-3.29 (2H, m), 5.4
8 (1H, t, J = 6.6 Hz),7.27-7.44 (4H, m), 7.59 (2H,
d, J =8.0 Hz), 8.04-8.15 (2H, m), 8.38 (2H, br
s). 4) N-[2-(4-フルオロフェニル)-2-オキソ-1
-[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-1-ナフタレンカルボキサミド 1-ナフトエ酸0.49g(2.84ミリモル)のN,
N-ジメチルホルムアミド10ml溶液に1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩0.74g(3.87ミリモル)と1-ヒドロキシベ
ンゾトリアゾール水和物0.59g(3.87ミリモ
ル)を加え5分間撹拌した後、2-(4-フルオロフェニ
ル)-2-オキソ-1-[[4-(トリフルオロメチル)フ
ェニル]メチル]エチルアミン・塩酸塩0.9g(2.
58ミリモル)と1,8-ジアザビシクロ[5.4.
0]-7-ウンデセン0.42ml(2.84ミリモル)
を加え3時間撹拌した。反応液を酢酸エチルで抽出し、
抽出液を水、飽和食塩水で順次洗浄した後、硫酸マグネ
シウムで乾燥し、減圧下濃縮した。残留物をシリカゲル
カラムクロマトグラフィー(酢酸エチル/ヘキサン=1
/4)により精製して、目的物0.92g(77%)を
結晶として得た。 mp 163-164℃; 1H-NMR (CDCl3, 200MHz) δ 3.19 (1H,
dd, J = 6.2 Hz, 13.8 Hz), 3.55 (1H, dd, J = 6.2 H
z, 14.0 Hz), 6.16 (1H, dd, J = 6.2 Hz, 13.8 Hz),
6.88 (1H, d, J = 8.0 Hz), 7.15-7.30 (4H, m), 7.39-
7.59 (6H, m), 7.83-7.97 (2H, m), 8.04-8.16 (3H,
m); IR (KBr) 3289, 1686, 1640 cm-1; Anal.Calcd for
C27H19F4NO2・0.2H2O: C, 69.14; H, 4.17; N, 2.99. F
ound: C, 69.27; H, 4.07; N, 2.85. 5) N-[2-(4-フルオロフェニル)-2-ヒドロキ
シ-1-[[4-(トリフルオロメチル)フェニル]メチ
ル]エチル]-1-ナフタレンカルボキサミド N-[2-(4-フルオロフェニル)-2-オキソ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-1-ナフタレンカルボキサミド500mg(1.
08ミリモル)のメタノール5ml溶液に水素化ホウ素
ナトリウム20mg(0.538ミリモル)を加え氷冷
下30分間撹拌した。反応液を酢酸エチルで抽出し、抽
出液を1N塩酸水溶液、飽和食塩水で順次洗浄した後、
硫酸マグネシウムで乾燥し、減圧下濃縮した。残留物を
シリカゲルカラムクロマトグラフィー(酢酸エチル/ヘ
キサン=1/2)により精製して目的物480mg(9
6%、(1RS,2SR)体/(1RS,2RS)体=
1/3)を結晶として得た。 mp 159-181℃; 1H-NMR (CDCl3, 200MHz) δ 2.86 (1H×
1/4, dd, J = 11.0 Hz,14.6 Hz), 3.07 (1H×3/4, dd,
J = 4.8 Hz, 15.0 Hz), 3.19 (1H, d, J = 7.8Hz), 3.2
7 (1H×3/4, d, J = 4.6 Hz), 3.37 (1H×1/4, d, J =
3.6 Hz), 4.61(1H×3/4, ddd, J = 3.4 Hz, 7.6 Hz, 1
6.8 Hz), 4.73-4.86 (1H×1/4, m), 4.89 (1H×3/4, t,
J = 7.8 Hz), 5.08 (1H×1/4, t, J = 3.6 Hz), 5.98
(1H×1/4, d, J = 8.4 Hz), 6.20 (1H×/4, d, J = 9.2
Hz), 6.99-7.14 (2H, m), 7.16-7.55 (9H, m), 7.60
(2H, d, J = 8.4 Hz), 7.83 (2H, t , J = 8.8 Hz); IR
(KBr) 3384, 3304, 1645 cm-1; Anal. Calcd for C27H
21F4NO2: C, 69.37; H, 4.53; N, 3.00. Found: C, 69.
21; H, 4.58; N, 3.03.Example 1 N- [2- (4-fluorophenyl) -2-hydroxy-1-
[[4- (trifluoromethyl) phenyl] methyl] d
Tyl] -1-naphthalenecarboxamide 1) N- [2- (4-fluorophenyl) -2-oxoe
[Tyl] formamide α-bromo-4-fluoroacetophenone 30.0 g
(0.138 mol) of N, N-dimethylformamide 2
8.99 g of sodium azide in a 00 ml solution under ice-cooling
(0.136 mol) was added and the mixture was stirred under ice cooling for 30 minutes. Anti
After diluting the reaction solution with water, the mixture is extracted with ethyl acetate.
After washing with water and saturated saline solution in that order,
It was dried and concentrated under reduced pressure. 300 ml of methanol in the residue
And concentrated to 3.0 g of 10% Pd / C (containing 50% water).
After adding 12.7 ml (0.152 mol) of hydrochloric acid, hydrogen was added.
The mixture was stirred under a stream of air for 21 hours. After filtering off the catalyst, the reaction mixture
Was concentrated under reduced pressure. 10.3 g of sodium formate in the residue
(0.152 mol), 140 ml of acetic anhydride, 70 m of formic acid
l of the mixed solution was added, and the mixture was stirred at room temperature for 1 hour. Reduce reaction volume
After concentration under reduced pressure, the mixture was diluted with water and extracted with ethyl acetate. Lottery
The eluate was washed with saturated saline and dried over magnesium sulfate.
It was dried and concentrated under reduced pressure. Is the residue ethyl acetate-hexane
And recrystallized to give 20.21 g (81%) of the desired product as crystals.
I got it.1 H-NMR (CDClThree, 200MHz) δ 4.79 (2H, dd, J = 0.6 H
z, 4.4 Hz), 6.73 (1H, br s), 7.14-7.30 (2H, m), 7.
97-8.10 (2H, m), 8.35 (1H, s). 2) 2- (4-Fluorophenyl) -2-oxo-1-
[[4- (trifluoromethyl) phenyl] methyl] d
Tilformamide 60% sodium hydride liquid paraffin suspension 0.5
5 g (0.0138 mol) of N, N-dimethylforma
N- [2- (4-fluorophenyl)-
2-oxoethyl] formamide 1.66 g (9.17
(Mmol) was added under ice cooling and stirred for 30 minutes. To the reaction solution
4- (trifluoromethyl) benzyl bromide 1.70
ml (0.011 mol) was added and the mixture was stirred at room temperature for 2 hours.
The reaction solution was extracted with ethyl acetate, and the extract was washed with water and saturated saline.
And then dried over magnesium sulfate and concentrated under reduced pressure
did. Silica gel column chromatography of the residue
(Ethyl acetate / hexane = 1 / 2-1 / 1),
1.65 g (53%) of the desired product was obtained as crystals. mp 78-81 ° C;1H-NMR (CDClThree, 200MHz) δ 3.13 (1H, d
d, J = 5.4 Hz, 13.8 Hz), 3.38 (1H, dd, J = 6.6 Hz,
14.0 Hz), 5.87-5.96 (1H, m), 6.52 (1H, br d, J =
7.8 Hz), 7.07-7.25 (4H, m), 7.48 (2H, d, J = 8.0 H
z), 7.93-8.04 (2H, m), 8.25 (1H, s); IR (KBr) 329
5, 1680, 1661 cm-1; Anal. Calcd for C17H 13FFourNOTwo:
C, 60.18; H, 3.86; N, 4.13. Found: C, 59.99; H, 3.
87; N, 4.05 3) 2- (4-Fluorophenyl) -2-oxo-1-
[[4- (trifluoromethyl) phenyl] methyl] d
Tylamine hydrochloride 2- (4-fluorophenyl) -2-oxo-1-[[4-
(Trifluoromethyl) phenyl] methyl] ethylphor
13.87 g (40.9 mmol) of methanol
3.8 ml of concentrated hydrochloric acid (45.0 mM
And heated to reflux for 2 hours. Concentrate the reaction mixture under reduced pressure
The residue was washed with ethyl acetate to give the desired product (13.6).
3 g (96%) were obtained as crystals.1 H-NMR (DMSO-d6, 200MHz) δ 3.17-3.29 (2H, m), 5.4
8 (1H, t, J = 6.6 Hz), 7.27-7.44 (4H, m), 7.59 (2H,
d, J = 8.0 Hz), 8.04-8.15 (2H, m), 8.38 (2H, br
s). 4) N- [2- (4-Fluorophenyl) -2-oxo-1
-[[4- (Trifluoromethyl) phenyl] methyl] d
Tyl] -1-naphthalenecarboxamide 0.49 g (2.84 mmol) of 1-naphthoic acid in N,
1-Ethyl-3-
(3-dimethylaminopropyl) carbodiimide / hydrochloric acid
0.74 g (3.87 mmol) of salt and 1-hydroxy
0.59 g of nzotriazole hydrate (3.87 mmol
After stirring for 5 minutes, 2- (4-fluorophenyl) was added.
L) -2-oxo-1-[[4- (trifluoromethyl) phenyl
[Enyl] methyl] ethylamine hydrochloride 0.9 g (2.
58 mmol) and 1,8-diazabicyclo [5.4.
0] -7-undecene 0.42 ml (2.84 mmol)
Was added and stirred for 3 hours. The reaction was extracted with ethyl acetate,
The extract was washed successively with water and saturated saline, and then washed with magnesium sulfate.
It was dried over sodium and concentrated under reduced pressure. Silica gel residue
Column chromatography (ethyl acetate / hexane = 1
/ 4) to give 0.92 g (77%) of the desired product
Obtained as crystals. mp 163-164 ° C;1H-NMR (CDClThree, 200MHz) δ 3.19 (1H,
dd, J = 6.2 Hz, 13.8 Hz), 3.55 (1H, dd, J = 6.2 H
z, 14.0 Hz), 6.16 (1H, dd, J = 6.2 Hz, 13.8 Hz),
6.88 (1H, d, J = 8.0 Hz), 7.15-7.30 (4H, m), 7.39-
7.59 (6H, m), 7.83-7.97 (2H, m), 8.04-8.16 (3H,
m); IR (KBr) 3289, 1686, 1640 cm-1; Anal.Calcd for
C27H19FFourNOTwo・ 0.2HTwoO: C, 69.14; H, 4.17; N, 2.99. F
ound: C, 69.27; H, 4.07; N, 2.85.5) N- [2- (4-fluorophenyl) -2-hydroxy
C-1-[[4- (trifluoromethyl) phenyl] methyl
[Ethyl] -1-naphthalenecarboxamide N- [2- (4-fluorophenyl) -2-oxo-1-
[[4- (trifluoromethyl) phenyl] methyl] d
Tyl] -1-naphthalenecarboxamide 500 mg (1.
08 mmol) in 5 ml of methanol
20 mg (0.538 mmol) of sodium was added and ice-cooled
Stirred for under 30 minutes. The reaction solution was extracted with ethyl acetate and extracted.
The eluate was washed successively with a 1N aqueous hydrochloric acid solution and a saturated saline solution,
It was dried over magnesium sulfate and concentrated under reduced pressure. Residue
Silica gel column chromatography (ethyl acetate / f
Purified by hexane = 1/2) to give 480 mg of the desired product (9
6%, (1RS, 2RS) body / (1RS, 2RS) body =
1/3) was obtained as crystals. mp 159-181 ° C;1H-NMR (CDClThree, 200MHz) δ 2.86 (1H ×
1/4, dd, J = 11.0 Hz, 14.6 Hz), 3.07 (1H × 3/4, dd,
J = 4.8 Hz, 15.0 Hz), 3.19 (1H, d, J = 7.8Hz), 3.2
7 (1H × 3/4, d, J = 4.6 Hz), 3.37 (1H × 1/4, d, J =
3.6 Hz), 4.61 (1H × 3/4, ddd, J = 3.4 Hz, 7.6 Hz, 1
6.8 Hz), 4.73-4.86 (1H × 1/4, m), 4.89 (1H × 3/4, t,
J = 7.8 Hz), 5.08 (1H × 1/4, t, J = 3.6 Hz), 5.98
(1H × 1/4, d, J = 8.4 Hz), 6.20 (1H × / 4, d, J = 9.2
Hz), 6.99-7.14 (2H, m), 7.16-7.55 (9H, m), 7.60
(2H, d, J = 8.4 Hz), 7.83 (2H, t, J = 8.8 Hz); IR
(KBr) 3384, 3304, 1645 cm-1; Anal. Calcd for C27H
twenty oneFFourNOTwo: C, 69.37; H, 4.53; N, 3.00. Found: C, 69.
21; H, 4.58; N, 3.03.
【0134】実施例2 N-(2-(4-フルオロフェニル)-2-ヒドロキシ-1-
((4-(トリフルオロメチル)フェニル)メチル)エ
チル)-4-メチル-1-ナフタレンカルボキサミド 1) 1-(4-フルオロフェニル)-1-オキソ-3-(4
-(トリフルオロメチル)フェニル)-2-プロピルアミ
ン塩酸塩(600mg,1.73ミリモル)と4-メチ
ル-1-ナフタレンカルボン酸(354mg,1.90ミ
リモル)のN,N-ジメチルホルムアミド(10ml)
溶液に1-エチル-3-(3-ジメチルアミノプロピル)カ
ルボジイミド・塩酸塩(496mg,2.59ミリモ
ル)と1-ヒドロキシ-1H-ベンゾトリアゾール(39
6mg,2.59ミリモル)と1,8-ジアザビシクロ
[5.4.0]-7-ウンデセン(0.28ml,1.9
0ミリモル)を加えて終夜攪拌した。反応液に1規定塩
酸水溶液(10ml)と水(100ml)を加え、酢酸
エチル(50ml×2)で抽出した。抽出液を1規定水
酸化ナトリウム水溶液および飽和食塩水で洗浄し、無水
硫酸マグネシウムで乾燥後減圧留去した。残留物をシリ
カゲルカラムクロマトグラフィー(ヘキサン:酢酸エチ
ル=4:1)で精製し、酢酸エチル−ヘキサンから再結
晶させて、N-(2-(4-フルオロフェニル)-2-オキ
ソ-1-((4-(トリフルオロメチル)フェニル)メチ
ル)エチル)-4-メチル-1-ナフタレンカルボキサミド
(665mg,80%)を得た。 mp 149-150℃ IRν maxKBrcm-1: 1693, 1634, 1539, 1510. Anal. Calcd for C28H21F4NO2: C, 70.14; H, 4.41; N,
2.92 Found: C, 70.09; H, 4.42; N, 2.91.1 H-NMR (CDCl3)δ: 2.71 (3H, s), 3.19 (1H, dd, J =
14.0, 6.2 Hz), 3.55 (1H, d, J = 14.0, 6.2 Hz), 6.1
6 (1H, q, J = 7.0 Hz), 6.83 (1H, d, J = 7.4Hz), 7.
14-7.32 (5H, m), 7.36-7.64 (5H, m), 7.98-8.18 (4H,
m). 2) N-(2-(4-フルオロフェニル)-2-オキソ-1
-((4-(トリフルオロメチル)フェニル)メチル)エ
チル)-4-メチル-1-ナフタレンカルボキサミド(40
0mg,0.83ミリモル)のメタノール(30ml)
溶液に塩化マンガン(II)(210mg,1.67ミ
リモル)を加え、室温で30分攪拌した。反応液に氷冷
下、水素化ホウ素ナトリウム(63mg,1.67ミリ
モル)を加え、1時間攪拌した。反応液を1規定塩酸
(30ml)に注ぎ、酢酸エチル(50ml×2)で抽
出した。抽出液を水および飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=2:1)で精製し、得られた粗結晶をヘキサン:酢酸
エチル=10:1の混合溶媒で洗浄して、表題化合物
((1RS,2SR)体:(1RS,2RS)体=1:
2,329mg,82%)を得た。 IRν maxKBrcm-1: 1634, 1510, 1125. Anal. Calcd for C28H23F4NO2: C, 69.85; H, 4.81; N,
2.91 Found: C, 69.56; H, 4.75; N, 2.80.1 H-NMR (CDCl3)δ: 2.66 (3H, s), 2.70-3.10 (1H, m),
3.44 (2/3H, d, J = 4.8 Hz), 3.53 (1/3H, d, J = 3.
6 Hz), 4.50-4.68 (2/3H, m), 4.70-4.90 (1H, m), 5.0
4-5.10 (1/3H, m), 5.95 (1/3H, d, J = 8.8 Hz), 6.19
(2/3H, d, J = 8.8 Hz), 6.96-7.70 (13H, m), 7.96
(1H, d, J = 8.4 Hz).Example 2 N- (2- (4-fluorophenyl) -2-hydroxy-1-
((4- (trifluoromethyl) phenyl) methyl) ethyl) -4-methyl-1-naphthalenecarboxamide 1) 1- (4-fluorophenyl) -1-oxo-3- (4
N, N-dimethylformamide (10 ml) of-(trifluoromethyl) phenyl) -2-propylamine hydrochloride (600 mg, 1.73 mmol) and 4-methyl-1-naphthalenecarboxylic acid (354 mg, 1.90 mmol) )
1-Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (496 mg, 2.59 mmol) and 1-hydroxy-1H-benzotriazole (39
6 mg, 2.59 mmol) and 1,8-diazabicyclo [5.4.0] -7-undecene (0.28 ml, 1.9)
0 mmol) and stirred overnight. A 1N aqueous hydrochloric acid solution (10 ml) and water (100 ml) were added to the reaction solution, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed with a 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give N- (2- (4-fluorophenyl) -2-oxo-1- ( (4- (Trifluoromethyl) phenyl) methyl) ethyl) -4-methyl-1-naphthalenecarboxamide (665 mg, 80%) was obtained. mp 149-150 ° C IRν max KBr cm -1 : 1693, 1634, 1539, 1510. Anal.Calcd for C 28 H 21 F 4 NO 2 : C, 70.14; H, 4.41; N,
2.92 Found: C, 70.09; H, 4.42; N, 2.91. 1 H-NMR (CDCl 3 ) δ: 2.71 (3H, s), 3.19 (1H, dd, J =
14.0, 6.2 Hz), 3.55 (1H, d, J = 14.0, 6.2 Hz), 6.1
6 (1H, q, J = 7.0 Hz), 6.83 (1H, d, J = 7.4 Hz), 7.
14-7.32 (5H, m), 7.36-7.64 (5H, m), 7.98-8.18 (4H,
m). 2) N- (2- (4-fluorophenyl) -2-oxo-1
-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4-methyl-1-naphthalenecarboxamide (40
0 mg, 0.83 mmol) methanol (30 ml)
Manganese (II) chloride (210 mg, 1.67 mmol) was added to the solution, and the mixture was stirred at room temperature for 30 minutes. Sodium borohydride (63 mg, 1.67 mmol) was added to the reaction mixture under ice cooling, and the mixture was stirred for 1 hour. The reaction solution was poured into 1N hydrochloric acid (30 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1), and the obtained crude crystals were washed with a mixed solvent of hexane: ethyl acetate = 10: 1 to give the title compound ((1RS, 2SR) ) Body: (1RS, 2RS) body = 1:
2,329 mg, 82%). . IRν max KBr cm -1: 1634 , 1510, 1125. Anal Calcd for C 28 H 23 F 4 NO 2: C, 69.85; H, 4.81; N,
2.91 Found:. C, 69.56; H, 4.75; N, 2.80 1 H-NMR (CDCl 3) δ: 2.66 (3H, s), 2.70-3.10 (1H, m),
3.44 (2 / 3H, d, J = 4.8 Hz), 3.53 (1 / 3H, d, J = 3.
6 Hz), 4.50-4.68 (2 / 3H, m), 4.70-4.90 (1H, m), 5.0
4-5.10 (1 / 3H, m), 5.95 (1 / 3H, d, J = 8.8 Hz), 6.19
(2 / 3H, d, J = 8.8 Hz), 6.96-7.70 (13H, m), 7.96
(1H, d, J = 8.4 Hz).
【0135】実施例3 N-[2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-4-フェニルブチルアミドナフタレンカルボキサ
ミド 1) N-[2-(4-フルオロフェニル)-2-オキソ-1
-[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-4-フェニルブチルアミドナフタレンカルボキサ
ミド 実施例1の4)と同様にして、目的物1.01g(77
%)を結晶として得た。 mp 133-135℃; 1H-NMR (CDCl3, 200MHz) δ 1.87-2.02
(2H, m), 2.18-2.26 (2H, m), 2.62 (2H, t, J = 7.4 H
z), 3.08 (1H, dd, J = 5.2 Hz, 14.0 Hz), 3.33(1H, d
d, J = 6.6 Hz, 13.8 Hz), 5.78-5.88 (1H, m), 6.26
(1H, d, J = 7.6Hz), 7.05-7.33 (9H, m), 7.45 (2H,
d, J = 8.2 Hz), 7.92-8.03 (2H, m); IR(KBr) 3281, 1
645 cm-1; Anal. Calcd for C26H23F4NO2: C, 68.26;
H, 5.07; N, 3.06. Found: C, 68.07; H, 4.79; N, 3.1
0. 2) N-[2-(4-フルオロフェニル)-2-ヒドロキ
シ-1-[[4-(トリフルオロメチル)フェニル]メチ
ル]エチル]-4-フェニルブチルアミドナフタレンカル
ボキサミド 実施例1の5)と同様にして、目的物144mg(29
%、(1RS,2SR)体/(1RS,2RS)体=4
/1)を結晶として得た。 mp 145-151℃; 1H-NMR (CDCl3, 200MHz) δ 1.70-1.90
(2H, m), 2.00-2.14 (2H, m), 2.51 (2H, t, J = 7.4 H
z), 2.70-2.94 (2H, m), 3.44 (1H, d, J = 3.6Hz), 4.
30-4.56 (1H, m), 4.92-5.00 (1H, m), 5.38 (1H, d, J
= 7.0 Hz), 7.00-7.60 (13H, m); IR (KBr) 1645 c
m-1; Anal. Calcd for C26H25F4NO2: C, 67.96; H, 5.4
8; N, 3.05. Found: C, 67.85; H, 5.61; N, 3.04.Example 3 N- [2- (4-fluorophenyl) -2-hydroxy-1-
[[4- (trifluoromethyl) phenyl] methyl] ethyl] -4-phenylbutylamidonaphthalenecarboxamide 1) N- [2- (4-fluorophenyl) -2-oxo-1
-[[4- (Trifluoromethyl) phenyl] methyl] ethyl] -4-phenylbutylamidonaphthalenecarboxamide In the same manner as in 4 of Example 1, 1.01 g of the desired product (77
%) As crystals. mp 133-135 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 1.87-2.02
(2H, m), 2.18-2.26 (2H, m), 2.62 (2H, t, J = 7.4 H
z), 3.08 (1H, dd, J = 5.2 Hz, 14.0 Hz), 3.33 (1H, d
d, J = 6.6 Hz, 13.8 Hz), 5.78-5.88 (1H, m), 6.26
(1H, d, J = 7.6Hz), 7.05-7.33 (9H, m), 7.45 (2H,
d, J = 8.2 Hz), 7.92-8.03 (2H, m); IR (KBr) 3281, 1
645 cm -1 ; Anal.Calcd for C 26 H 23 F 4 NO 2 : C, 68.26;
H, 5.07; N, 3.06. Found: C, 68.07; H, 4.79; N, 3.1
0.2) N- [2- (4-Fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] -4-phenylbutylamidonaphthalenecarboxamide Example 1-5 In the same manner as in (1), 144 mg (29
%, (1RS, 2RS) / (1RS, 2RS) = 4
/ 1) were obtained as crystals. mp 145-151 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 1.70-1.90
(2H, m), 2.00-2.14 (2H, m), 2.51 (2H, t, J = 7.4 H
z), 2.70-2.94 (2H, m), 3.44 (1H, d, J = 3.6Hz), 4.
30-4.56 (1H, m), 4.92-5.00 (1H, m), 5.38 (1H, d, J
= 7.0 Hz), 7.00-7.60 (13H, m); IR (KBr) 1645 c
m -1 ; Anal.Calcd for C 26 H 25 F 4 NO 2 : C, 67.96; H, 5.4
8; N, 3.05. Found: C, 67.85; H, 5.61; N, 3.04.
【0136】実施例4 N-(2-(4-フルオロフェニル)-2-ヒドロキシ-1-
((4-(トリフルオロメチル)フェニル)メチル)エ
チル)-4-(2-チオフェニル)酪酸アミド 1) 1-(4-フルオロフェニル)-1-オキソ-3-(4
-(トリフルオロメチル)フェニル)-2-プロピルアミ
ン塩酸塩(600mg,1.73ミリモル)と4-(2-
チロフェニル)酪酸(323mg,1.90ミリモル)
のN,N-ジメチルホルムアミド(10ml)溶液に1-
エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩(496mg,2.59ミリモル)と1-
ヒドロキシ-1H-ベンゾトリアゾール(396mg,
2.59ミリモル)と1,8-ジアザビシクロ[5.
4.0]-7-ウンデセン(0.28ml,1.90ミリ
モル)を加えて終夜攪拌した。反応液に1規定塩酸水溶
液(10ml)と水(100ml)を加え、酢酸エチル
(50ml×2)で抽出した。抽出液を1規定水酸化ナ
トリウム水溶液および飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去し、酢酸エチル−ヘキサン
から再結晶させて、N-(2-(4-フルオロフェニル)-
2-オキソ-1-((4-(トリフルオロメチル)フェニ
ル)メチル)エチル)-4-(2-チオフェニル)酪酸ア
ミド(445mg,56%)を得た。 mp 123-124℃ IRν maxKBrcm-1: 3275, 1651, 1597, 1508, 1325, 123
2, 1159, 1124. Anal. Calcd for C24H21F4NO2S: C, 62.19; H, 4.57;
N, 3.02 Found: C, 62.02; H, 4.69; N, 3.28.1 H-NMR (CDCl3)δ: 1.94-2.10 (2H, m), 2.26 (2H, t,
J = 7.4 Hz), 2.84 (2H,t, J = 7.4 Hz), 3.08 (1H, d
d, J = 14.0, 5.2 Hz), 3.33 (1H, d, J = 14.0,5.2 H
z), 5.84 (1H, q, J = 6.4 Hz), 6.28 (1H, d, J = 7.4
Hz), 6.74-6.80(1H, m), 6.86-6.96 (1H, m), 7.04-7.
24 (5H, m), 7.46 (2H, d, J = 8.0 Hz),7.92-8.06 (2
H, m). 2) N-(2-(4-フルオロフェニル)-2-オキソ-1
-((4-(トリフルオロメチル)フェニル)メチル)エ
チル)-4-(2-チオフェニル)酪酸アミド(300m
g,0.65ミリモル)のメタノール(30ml)溶液
に塩化マンガン(II)(163mg,1.30ミリモ
ル)を加え、室温で30分攪拌した。反応液に氷冷下、
水素化ホウ素ナトリウム(49mg,1.30ミリモ
ル)を加え、1時間攪拌した。反応液を1規定塩酸(3
0ml)に注ぎ、酢酸エチル(50ml×2)で抽出し
た。抽出液を水および飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(ヘキサン:酢酸エチル=
2:1)で精製し、得られた粗結晶をヘキサン:酢酸エ
チル=10:1の混合溶媒で洗浄して、表題化合物
((1RS,2SR)体:(1RS,2RS)体=1:
1,204mg,68%)を得た。 IRν maxKBrcm-1: 1645, 1510, 1225, 1165, 1125. Anal. Calcd for C24H23F4NO2S: C, 61.92; H, 4.98;
N, 3.01 Found: C, 61.94; H, 4.98; N, 2.94.1 H-NMR (CDCl3)δ: 1.70-1.96 (2H, m), 2.00-2.16 (2
H, m), 2.60-3.00 (3H, m), 3.43 (1/2H, d, J = 5.2 H
z), 3.51 (1/2H, d, J = 3.6 Hz), 4.14-4.32 (1/2H,
m), 4.36-4.52 (1/2H, m), 4.68-4.80 (1/2H, m), 4.90
-4.98 (1/2H, m), 5.44 (1/2H, d, J = 8.4 Hz), 5.66
(1/2H, d, J = 8.4 Hz), 6.62-6.72 (1H, m), 6.88-7.6
0 (10H, m).Example 4 N- (2- (4-fluorophenyl) -2-hydroxy-1-
((4- (trifluoromethyl) phenyl) methyl) ethyl) -4- (2-thiophenyl) butyric acid amide 1) 1- (4-fluorophenyl) -1-oxo-3- (4
-(Trifluoromethyl) phenyl) -2-propylamine hydrochloride (600 mg, 1.73 mmol) and 4- (2-
Tyrophenyl) butyric acid (323 mg, 1.90 mmol)
To a solution of N, N-dimethylformamide (10 ml)
Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (496 mg, 2.59 mmol) and 1-
Hydroxy-1H-benzotriazole (396 mg,
2.59 mmol) and 1,8-diazabicyclo [5.
4.0] -7-undecene (0.28 ml, 1.90 mmol) was added and stirred overnight. A 1N aqueous hydrochloric acid solution (10 ml) and water (100 ml) were added to the reaction solution, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed with a 1N aqueous solution of sodium hydroxide and saturated saline, dried over anhydrous magnesium sulfate, distilled off under reduced pressure, recrystallized from ethyl acetate-hexane, and N- (2- (4-fluorophenyl)-
2-oxo-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4- (2-thiophenyl) butyric acid amide (445 mg, 56%) was obtained. mp 123-124 ° C IRν max KBr cm -1 : 3275, 1651, 1597, 1508, 1325, 123
2, 1159, 1124. Anal.Calcd for C 24 H 21 F 4 NO 2 S: C, 62.19; H, 4.57;
N, 3.02 Found:. C, 62.02; H, 4.69; N, 3.28 1 H-NMR (CDCl 3) δ: 1.94-2.10 (2H, m), 2.26 (2H, t,
J = 7.4 Hz), 2.84 (2H, t, J = 7.4 Hz), 3.08 (1H, d
d, J = 14.0, 5.2 Hz), 3.33 (1H, d, J = 14.0,5.2 H
z), 5.84 (1H, q, J = 6.4 Hz), 6.28 (1H, d, J = 7.4
Hz), 6.74-6.80 (1H, m), 6.86-6.96 (1H, m), 7.04-7.
24 (5H, m), 7.46 (2H, d, J = 8.0 Hz), 7.92-8.06 (2
H, m). 2) N- (2- (4-fluorophenyl) -2-oxo-1
-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4- (2-thiophenyl) butyric acid amide (300 m
g, 0.65 mmol) in methanol (30 ml) was added with manganese (II) chloride (163 mg, 1.30 mmol) and stirred at room temperature for 30 minutes. The reaction solution was cooled with ice,
Sodium borohydride (49 mg, 1.30 mmol) was added and stirred for 1 hour. The reaction solution was diluted with 1 N hydrochloric acid (3
0 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
2: 1), and the obtained crude crystals were washed with a mixed solvent of hexane: ethyl acetate = 10: 1 to give the title compound ((1RS, 2SR) form: (1RS, 2RS) form = 1: 1).
1,204 mg, 68%). IRν max KBr cm -1 : 1645, 1510, 1225, 1165, 1125. Anal.Calcd for C 24 H 23 F 4 NO 2 S: C, 61.92; H, 4.98;
N, 3.01 Found:. C, 61.94; H, 4.98; N, 2.94 1 H-NMR (CDCl 3) δ: 1.70-1.96 (2H, m), 2.00-2.16 (2
H, m), 2.60-3.00 (3H, m), 3.43 (1 / 2H, d, J = 5.2 H
z), 3.51 (1 / 2H, d, J = 3.6 Hz), 4.14-4.32 (1 / 2H,
m), 4.36-4.52 (1 / 2H, m), 4.68-4.80 (1 / 2H, m), 4.90
-4.98 (1 / 2H, m), 5.44 (1 / 2H, d, J = 8.4 Hz), 5.66
(1 / 2H, d, J = 8.4 Hz), 6.62-6.72 (1H, m), 6.88-7.6
0 (10H, m).
【0137】実施例5 N-[2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]シクロペンタンカルボキサミド 1) N-[2-(4-フルオロフェニル)-2-オキソ-1
-[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]シクロペンタンカルボキサミド 実施例1の4)と同様にして、目的物0.84g(71
%)を結晶として得た。 mp 158-159℃; 1H-NMR (CDCl3, 200MHz) δ 1.64-1.93
(8H, m), 2.47-2.64 (1H, m), 3.08 (1H, dd, J = 5.6
Hz, 13.6 Hz), 3.35 (1H, dd, J = 6.6 Hz, 13.8Hz),
5.78-5.88 (1H, m), 6.30 (1H, br d, J = 7.2 Hz), 7.
09 (2H, d, J = 8.0 Hz), 7.12-7.23 (2H, m), 7.47 (2
H, d, J = 8.0 Hz), 7.94-8.02 (2H, m);IR (KBr) 327
4, 1684, 1644 cm-1; Anal. Calcd for C22H21F4NO2:
C, 64.86; H, 5.20; N, 3.44. Found: C, 64.77; H, 5.
13; N, 3.36. 2) N-[2-(4-フルオロフェニル)-2-ヒドロキ
シ-1-[[4-(トリフルオロメチル)フェニル]メチ
ル]エチル]シクロペンタンカルボキサミド 実施例1の5)と同様にして、目的物433mg(86
%、(1RS,2SR)体/(1RS,2RS)体=3
/4)を結晶として得た。 mp 139-155℃; 1H-NMR (CDCl3, 200MHz) δ 1.40-1.80
(8H, m), 2.36 (1H, brs), 2.71-3.07 (2H, m), 3.73-
3.78 (1H, m), 4.12 (1H×4/7, ddd, J = 3.6 Hz, 8.0
Hz, 15.4 Hz), 4.33-4.47 (1H×3/7, m), 4.75 (1H×4/
7, t, J = 7.2 Hz), 4.95 (1H×3/7, t, J = 6.6 Hz),
5.40 (1H×3/7, br d, J = 8.4 Hz), 5.62(1H, br d, J
= 8.0 Hz), 6.94-7.14 (2H, m), 7.17-7.30 (2H, m),
7.32-7.42(2H, m), 7.47-7.60 (2H, m); IR (KBr) 331
2, 1651 cm-1; Anal. Calcd for C 22H23F4NO2: C, 64.5
4; H, 5.66; N, 3.42. Found: C, 64.58; H, 5.89; N,
3.67.Example 5 N- [2- (4-fluorophenyl) -2-hydroxy-1-
[[4- (trifluoromethyl) phenyl] methyl] d
Tyl] cyclopentanecarboxamide 1) N- [2- (4-fluorophenyl) -2-oxo-1
-[[4- (Trifluoromethyl) phenyl] methyl] d
[Tyl] cyclopentanecarboxamide 0.84 g of the desired product (71
%) As crystals. mp 158-159 ° C;1H-NMR (CDClThree, 200MHz) δ 1.64-1.93
(8H, m), 2.47-2.64 (1H, m), 3.08 (1H, dd, J = 5.6
Hz, 13.6 Hz), 3.35 (1H, dd, J = 6.6 Hz, 13.8Hz),
5.78-5.88 (1H, m), 6.30 (1H, br d, J = 7.2 Hz), 7.
09 (2H, d, J = 8.0 Hz), 7.12-7.23 (2H, m), 7.47 (2
H, d, J = 8.0 Hz), 7.94-8.02 (2H, m); IR (KBr) 327
4, 1684, 1644 cm-1; Anal. Calcd for Ctwenty twoHtwenty oneFFourNOTwo:
C, 64.86; H, 5.20; N, 3.44. Found: C, 64.77; H, 5.
13; N, 3.36. 2) N- [2- (4-fluorophenyl) -2-hydroxy
C-1-[[4- (trifluoromethyl) phenyl] methyl
[Ethyl] cyclopentanecarboxamide In the same manner as in Example 1, 5), 433 mg (86
%, (1RS, 2RS) / (1RS, 2RS) = 3
/ 4) was obtained as crystals. mp 139-155 ° C;1H-NMR (CDClThree, 200MHz) δ 1.40-1.80
(8H, m), 2.36 (1H, brs), 2.71-3.07 (2H, m), 3.73-
3.78 (1H, m), 4.12 (1H × 4/7, ddd, J = 3.6 Hz, 8.0
Hz, 15.4 Hz), 4.33-4.47 (1H × 3/7, m), 4.75 (1H × 4 /
7, t, J = 7.2 Hz), 4.95 (1H × 3/7, t, J = 6.6 Hz),
5.40 (1H × 3/7, br d, J = 8.4 Hz), 5.62 (1H, br d, J
= 8.0 Hz), 6.94-7.14 (2H, m), 7.17-7.30 (2H, m),
7.32-7.42 (2H, m), 7.47-7.60 (2H, m); IR (KBr) 331
2, 1651 cm-1; Anal. Calcd for C twenty twoHtwenty threeFFourNOTwo: C, 64.5
4; H, 5.66; N, 3.42. Found: C, 64.58; H, 5.89; N,
3.67.
【0138】実施例6 4-フルオロ-N-[2-(4-フルオロフェニル)-2-ヒ
ドロキシ-1-[[4-(トリフルオロメチル)フェニ
ル]メチル]エチル]ベンズアミド 1) 4-フルオロ-N-[2-(4-フルオロフェニル)-
2-オキソ-1-[[4-(トリフルオロメチル)フェニ
ル]メチル]エチル]ベンズアミド 実施例1の4)と同様にして、目的物1.16g(93
%)を結晶として得た。 mp 171-172℃; 1H-NMR (CDCl3, 200MHz) δ 3.22 (1H,
dd, J = 5.0 Hz, 13.8 Hz), 3.49 (1H, dd, J = 6.6 H
z, 14.0 Hz), 6.00 (1H, m), 6.97-7.28 (7H, m),7.46
(2H, d, J = 8.0 Hz), 7.74-7.85 (2H, m), 7.97-8.09
(2H, m); IR (KBr) 3316, 1698, 1638 cm-1; Anal. Cal
cd for C23H16F5NO2: C, 63.74; H, 3.72;N, 3.23. Fou
nd: C, 63.57; H, 3.87; N, 3.23. 2) 4-フルオロ-N-[2-(4-フルオロフェニル)-
2-ヒドロキシ-1-[[4-(トリフルオロメチル)フェ
ニル]メチル]エチル]ベンズアミド 実施例1の5)と同様にして、目的物423mg(94
%、(1RS,2SR)体/(1RS,2RS)体=3
/7)を結晶として得た。 mp 155-179℃; 1H-NMR (CDCl3, 200MHz) δ 2.90-2.97
(2H×1/3, m), 3.14 (2H×2/3, d, J = 7.6 Hz), 3.22
(1H×2/3, d, J = 4.2 Hz), 3.48 (1H×1/3, d,J = 3.8
Hz), 4.42 (1H×2/3, ddd, J = 3.4 Hz, 7.2 Hz, 15.8
Hz), 4.51-4.68(1H×1/3, m), 4.83 (1H×2/3, t, J =
3.9 Hz), 5.08 (1H×1/3, t, J = 3.1Hz), 6.09 (1H×
1/3, br d, J = 8.4 Hz), 6.34 (1H×2/3, br d, J =
8.4 Hz),6.93-7.13 (4H, m), 7.20-7.32 (2H, m), 7.37
-7.62 (6H, m); IR (KBr) 3301,1636 cm-1; Anal. Calc
d for C23H18F5NO2: C, 63.45; H, 4.17; N, 3.22. Fou
nd: C, 63.34; H, 4.36; N, 3.24.Example 6 4-Fluoro-N- [2- (4-fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] benzamide 1) 4-fluoro- N- [2- (4-fluorophenyl)-
2-oxo-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] benzamide 1.16 g of the desired product (93) in the same manner as 4) of Example 1.
%) As crystals. mp 171-172 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 3.22 (1H,
dd, J = 5.0 Hz, 13.8 Hz), 3.49 (1H, dd, J = 6.6 H
z, 14.0 Hz), 6.00 (1H, m), 6.97-7.28 (7H, m), 7.46
(2H, d, J = 8.0 Hz), 7.74-7.85 (2H, m), 7.97-8.09
(2H, m); IR (KBr) 3316, 1698, 1638 cm -1 ; Anal. Cal
cd for C 23 H 16 F 5 NO 2 : C, 63.74; H, 3.72; N, 3.23. Fou
nd: C, 63.57; H, 3.87; N, 3.23.2) 4-Fluoro-N- [2- (4-fluorophenyl)-
2-Hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] benzamide 423 mg of the desired product (94
%, (1RS, 2RS) / (1RS, 2RS) = 3
/ 7) as crystals. mp 155-179 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 2.90-2.97
(2H × 1/3, m), 3.14 (2H × 2/3, d, J = 7.6 Hz), 3.22
(1H × 2/3, d, J = 4.2 Hz), 3.48 (1H × 1/3, d, J = 3.8
Hz), 4.42 (1H × 2/3, ddd, J = 3.4 Hz, 7.2 Hz, 15.8
Hz), 4.51-4.68 (1H × 1/3, m), 4.83 (1H × 2/3, t, J =
3.9 Hz), 5.08 (1H × 1/3, t, J = 3.1Hz), 6.09 (1H ×
1/3, br d, J = 8.4 Hz), 6.34 (1H × 2/3, br d, J =
8.4 Hz), 6.93-7.13 (4H, m), 7.20-7.32 (2H, m), 7.37
-7.62 (6H, m); IR (KBr) 3301,1636 cm -1 ; Anal.Calc
d for C 23 H 18 F 5 NO 2 : C, 63.45; H, 4.17; N, 3.22. Fou
nd: C, 63.34; H, 4.36; N, 3.24.
【0139】実施例7 N-[2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-4-メトキシベンズアミド 1) N-[2-(4-フルオロフェニル)-2-オキソ-1
-[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-4-メトキシベンズアミド 実施例1の4)と同様にして、目的物1.11g(87
%)を結晶として得た。 mp 144℃; 1H-NMR (CDCl3, 200MHz) δ 3.21 (1H, dd,
J = 4.8 Hz, 14.0 Hz),3.48 (1H, dd, J = 6.6 Hz, 13.
6 Hz), 3.86 (3H, s), 6.01 (1H, ddd, J = 4.6Hz, 4.8
Hz, 6.6 Hz), 6.90-7.02 (3H, m), 7.08 (2H, d, J =
8.2 Hz), 7.12-7.25 (2H, m), 7.45 (2H, d, J = 8.0 H
z), 7.71-7.79 (2H, m), 7.97-8.08 (2H, m); IR (KBr)
3279,1694, 1651 cm-1; Anal. Calcd for C24H19F4N
O3: C, 64.72; H, 4.30; N, 3.14. Found: C, 64.53;
H, 4.27; N, 3.25. 2) N-[2-(4-フルオロフェニル)-2-ヒドロキ
シ-1-[[4-(トリフルオロメチル)フェニル]メチ
ル]エチル]-4-メトキシベンズアミド 実施例1の5)と同様にして、目的物0.48g(96
%、(1RS,2SR)体/(1RS,2RS)体=3
/2)を結晶として得た。 mp 174-176℃; 1H-NMR (CDCl3, 200MHz) δ 2.90-2.98
(2H×3/5, m), 3.12 (2H×2/5, d, J = 7.4 Hz), 3.76
(1H×2/5, d, J = 4.8 Hz), 3.82 (3H, s), 3.99(1H×3
/5, d, J = 3.6 Hz), 4.28-4.46 (1H×2/5, m), 4.49-
4.66 (1H×3/5, m), 4.81 (1H×2/5, t, J = 8.2 Hz),
5.06 (1H×3/5, t, J = 3.0 Hz), 6.08 (1H×3/5, d, J
= 8.2 Hz), 6.32 (1H×2/5, d, J = 8.6 Hz), 6.82-7.
13 (4H, m), 7.20-7.32 (2H, m), 7.34-7.59 (6H, m);
IR (KBr) 3341, 1609 cm-1; Anal.Calcd for C24H21F4N
O3: C, 64.43; H, 4.73; N, 3.13. Found: C, 64.49;
H, 4.74; N, 3.02.Example 7 N- [2- (4-fluorophenyl) -2-hydroxy-1-
[[4- (trifluoromethyl) phenyl] methyl] ethyl] -4-methoxybenzamide 1) N- [2- (4-fluorophenyl) -2-oxo-1
-[[4- (Trifluoromethyl) phenyl] methyl] ethyl] -4-methoxybenzamide 1.11 g of the desired product (87
%) As crystals. mp 144 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 3.21 (1H, dd,
J = 4.8 Hz, 14.0 Hz), 3.48 (1H, dd, J = 6.6 Hz, 13.
6 Hz), 3.86 (3H, s), 6.01 (1H, ddd, J = 4.6Hz, 4.8
Hz, 6.6 Hz), 6.90-7.02 (3H, m), 7.08 (2H, d, J =
8.2 Hz), 7.12-7.25 (2H, m), 7.45 (2H, d, J = 8.0 H
z), 7.71-7.79 (2H, m), 7.97-8.08 (2H, m); IR (KBr)
3279,1694, 1651 cm -1 ; Anal.Calcd for C 24 H 19 F 4 N
O 3 : C, 64.72; H, 4.30; N, 3.14. Found: C, 64.53;
H, 4.27; N, 3.25.2) N- [2- (4-Fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] -4-methoxybenzamide In the same manner as in 1-5), 0.48 g (96
%, (1RS, 2RS) / (1RS, 2RS) = 3
/ 2) were obtained as crystals. mp 174-176 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 2.90-2.98
(2H × 3/5, m), 3.12 (2H × 2/5, d, J = 7.4 Hz), 3.76
(1H × 2/5, d, J = 4.8 Hz), 3.82 (3H, s), 3.99 (1H × 3
/ 5, d, J = 3.6 Hz), 4.28-4.46 (1H × 2/5, m), 4.49-
4.66 (1H × 3/5, m), 4.81 (1H × 2/5, t, J = 8.2 Hz),
5.06 (1H × 3/5, t, J = 3.0 Hz), 6.08 (1H × 3/5, d, J
= 8.2 Hz), 6.32 (1H × 2/5, d, J = 8.6 Hz), 6.82-7.
13 (4H, m), 7.20-7.32 (2H, m), 7.34-7.59 (6H, m);
IR (KBr) 3341, 1609 cm -1 ; Anal.Calcd for C 24 H 21 F 4 N
O 3 : C, 64.43; H, 4.73; N, 3.13. Found: C, 64.49;
H, 4.74; N, 3.02.
【0140】実施例8 N-[2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]シクロヘキサンカルボキサミド 1) N-[2-(4-フルオロフェニル)-2-オキソ-1
-[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]シクロヘキサンカルボキサミド 実施例1の4)と同様にして、目的物0.90g(83
%)を結晶として得た。 mp 169-170℃; 1H-NMR (CDCl3, 200MHz) δ 1.51-1.52
(5H, m), 1.62-1.88 (5H, m), 2.04-2.20 (1H, m), 3.0
8 (1H, dd, J = 4.8 Hz, 14.0 Hz), 3.35 (1H, dd, J =
6.2 Hz, 13.8 Hz), 5.76-5.88 (1H, m), 6.30 (1H, d,
J = 7.6 Hz), 7.07 (2H, d, J = 8.2 Hz), 7.17 (2H,
t, J = 17.2 Hz), 7.47 (2H, d, J = 8.0Hz), 7.93-8.0
4 (2H, m); IR (KBr) 3274, 1686, 1640 cm-1; Anal. C
alcd forC23H23F4NO2: C, 65.55; H, 5.50; N, 3.32. F
ound: C, 65.52; H, 5.48; N, 3.44. 2) N-[2-(4-フルオロフェニル)-2-ヒドロキ
シ-1-[[4-(トリフルオロメチル)フェニル]メチ
ル]エチル]シクロヘキサンカルボキサミド 実施例1の5)と同様にして、目的物480mg(96
%、(1RS,2SR)体/(1RS,2RS)体=1
/1)を結晶として得た。 mp 161-178℃; 1H-NMR (CDCl3, 200MHz) δ 1.08-1.34
(5H, m), 1.48-1.80 (5H, m), 1.92 (1H, br s), 2.77
(0.5H, dd, J = 9.8 Hz, 14.6 Hz), 2.90 (0.5H,dd, J
= 5.4 Hz, 14.6 Hz), 3.06 (1H, d, J = 7.8 Hz), 3.76
(0.5H, d, J =2.0 Hz), 3.79 (0.5H, s), 4.11 (0.5H,
ddd, 3.8 Hz, 7.8 Hz, 15.8 Hz), 4.33-4.50 (0.5H,
m), 4.76 (0.5H, t, J = 9.0 Hz), 4.94 (0.5H, t, J =
7.0 Hz),5.38 (0.5H, d, J = 8.2 Hz), 5.61 (0.5H,
d, J = 8.4 Hz), 6.95-7.12 (2H,m), 7.18-7.29 (2H,
m), 7.32-7.41 (2H, m), 7.54 (2H, t, J = 18.0 Hz);
IR(KBr) 3384, 3304, 1645 cm-1; Anal. Calcd for C23
H25F4NO2: C, 65.24; H, 5.95; N, 3.31. Found: C, 6
4.99; H, 5.97; N, 3.25.Example 8 N- [2- (4-fluorophenyl) -2-hydroxy-1-
[[4- (Trifluoromethyl) phenyl] methyl] ethyl] cyclohexanecarboxamide 1) N- [2- (4-Fluorophenyl) -2-oxo-1
-[[4- (Trifluoromethyl) phenyl] methyl] ethyl] cyclohexanecarboxamide 0.90 g of the desired product (83
%) As crystals. mp 169-170 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 1.51-1.52
(5H, m), 1.62-1.88 (5H, m), 2.04-2.20 (1H, m), 3.0
8 (1H, dd, J = 4.8 Hz, 14.0 Hz), 3.35 (1H, dd, J =
6.2 Hz, 13.8 Hz), 5.76-5.88 (1H, m), 6.30 (1H, d,
J = 7.6 Hz), 7.07 (2H, d, J = 8.2 Hz), 7.17 (2H,
t, J = 17.2 Hz), 7.47 (2H, d, J = 8.0Hz), 7.93-8.0
4 (2H, m); IR (KBr) 3274, 1686, 1640 cm -1 ; Anal.C
alcd forC 23 H 23 F 4 NO 2 : C, 65.55; H, 5.50; N, 3.32. F
ound: C, 65.52; H, 5.48; N, 3.44.2) N- [2- (4-fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] cyclohexane Carboxamide In the same manner as in 5) of Example 1, 480 mg of the desired product (96 mg) was obtained.
%, (1RS, 2SR) / (1RS, 2RS) = 1
/ 1) were obtained as crystals. mp 161-178 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 1.08-1.34
(5H, m), 1.48-1.80 (5H, m), 1.92 (1H, br s), 2.77
(0.5H, dd, J = 9.8 Hz, 14.6 Hz), 2.90 (0.5H, dd, J
= 5.4 Hz, 14.6 Hz), 3.06 (1H, d, J = 7.8 Hz), 3.76
(0.5H, d, J = 2.0 Hz), 3.79 (0.5H, s), 4.11 (0.5H,
ddd, 3.8 Hz, 7.8 Hz, 15.8 Hz), 4.33-4.50 (0.5H,
m), 4.76 (0.5H, t, J = 9.0 Hz), 4.94 (0.5H, t, J =
7.0 Hz), 5.38 (0.5H, d, J = 8.2 Hz), 5.61 (0.5H,
d, J = 8.4 Hz), 6.95-7.12 (2H, m), 7.18-7.29 (2H,
m), 7.32-7.41 (2H, m), 7.54 (2H, t, J = 18.0 Hz);
IR (KBr) 3384, 3304, 1645 cm -1 ; Anal.Calcd for C 23
H 25 F 4 NO 2 : C, 65.24; H, 5.95; N, 3.31. Found: C, 6
4.99; H, 5.97; N, 3.25.
【0141】実施例9 4-クロロ-N-[2-(4-フルオロフェニル)-2-ヒド
ロキシ-1-[[4-(トリフルオロメチル)フェニル]
メチル]エチル]ベンズアミド 1) 4-クロロ-N-[2-(4-フルオロフェニル)-2
-オキソ-1-[[4-(トリフルオロメチル)フェニル]
メチル]エチル]ベンズアミド 実施例1の4)と同様にして、目的物1.20g(92
%)を結晶として得た。 mp 150-153℃; 1H-NMR (CDCl3, 200MHz) δ 3.22 (1H,
dd, J = 4.8 Hz, 14.0 Hz), 3.49 (1H, dd, J = 6.2 H
z, 14.0 Hz), 6.00 (1H, ddd, J = 4.8 Hz, 6.6 Hz, 6.
6 Hz), 7.02 (1H, br s), 7.07 (2H, d, J = 7.6 Hz),
7.20 (2H, t, J =8.6 Hz), 7.44 (2H, d, J = 8.4 Hz),
7.46 (2H, d, J = 8.0 Hz), 7.72 (2H, d, J = 8.8 H
z), 7.97-8.08 (2H, m); IR (KBr) 3281, 1686, 1644 c
m-1; Anal.Calcd for C23H16ClF4NO2: C, 61.41; H, 3.
59; N, 3.11. Found: C, 61.41; H,3.80; N, 3.09. 2) 4-クロロ-N-[2-(4-フルオロフェニル)-2
-ヒドロキシ-1-[[4-(トリフルオロメチル)フェニ
ル]メチル]エチル]ベンズアミド 実施例1の5)と同様にして、目的物467mg(93
%、(1RS,2SR)体/(1RS,2RS)体=1
/1)を結晶として得た。 mp 170-180℃; 1H-NMR (CDCl3, 200MHz) δ 2.92 (0.5
H, br s), 2.96 (0.5H, s), 3.04 (0.5H, d, J = 4.8 H
z), 3.15 (1H, d, J = 7.8 Hz), 3.32 (0.5H, d,J = 3.
8 Hz), 4.35-4.50 (0.5H, m), 4.53-4.68 (0.5H, m),
4.84 (0.5H, T, J= 3.7 Hz), 5.08 (0.5H, t, J = 3.8
Hz), 6.08 (0.5H, br d, J = 7.4 Hz), 6.34 (0.5H, br
d, J = 9.2 Hz), 6.94-7.14 (2H, m), 7.21-7.61 (10
H, m); IR (KBr) 3310, 1645 cm-1; Anal. Calcd for C
23H18ClF4NO2: C, 61.14; H, 4.02;N, 3.10. Found: C,
61.10; H, 4.22; N, 3.15.Example 9 4-Chloro-N- [2- (4-fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl]
Methyl] ethyl] benzamide 1) 4-Chloro-N- [2- (4-fluorophenyl) -2
-Oxo-1-[[4- (trifluoromethyl) phenyl]
Methyl] ethyl] benzamide 1.20 g (92%) of the target compound in the same manner as in 4) of Example 1.
%) As crystals. mp 150-153 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 3.22 (1H,
dd, J = 4.8 Hz, 14.0 Hz), 3.49 (1H, dd, J = 6.2 H
z, 14.0 Hz), 6.00 (1H, ddd, J = 4.8 Hz, 6.6 Hz, 6.
6 Hz), 7.02 (1H, br s), 7.07 (2H, d, J = 7.6 Hz),
7.20 (2H, t, J = 8.6 Hz), 7.44 (2H, d, J = 8.4 Hz),
7.46 (2H, d, J = 8.0 Hz), 7.72 (2H, d, J = 8.8 H
z), 7.97-8.08 (2H, m); IR (KBr) 3281, 1686, 1644 c
m -1; Anal.Calcd for C 23 H 16 ClF 4 NO 2: C, 61.41; H, 3.
59; N, 3.11. Found: C, 61.41; H, 3.80; N, 3.09.2) 4-Chloro-N- [2- (4-fluorophenyl) -2
-Hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] benzamide 467 mg of the desired product (93
%, (1RS, 2SR) / (1RS, 2RS) = 1
/ 1) were obtained as crystals. mp 170-180 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 2.92 (0.5
H, br s), 2.96 (0.5H, s), 3.04 (0.5H, d, J = 4.8 H
z), 3.15 (1H, d, J = 7.8 Hz), 3.32 (0.5H, d, J = 3.
8 Hz), 4.35-4.50 (0.5H, m), 4.53-4.68 (0.5H, m),
4.84 (0.5H, T, J = 3.7 Hz), 5.08 (0.5H, t, J = 3.8
Hz), 6.08 (0.5H, br d, J = 7.4 Hz), 6.34 (0.5H, br
d, J = 9.2 Hz), 6.94-7.14 (2H, m), 7.21-7.61 (10
H, m); IR (KBr) 3310, 1645 cm -1 ; Anal.Calcd for C
23 H 18 ClF 4 NO 2 : C, 61.14; H, 4.02; N, 3.10. Found: C,
61.10; H, 4.22; N, 3.15.
【0142】実施例10 N-[2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-2-フェニルベンズアミド 1) N-[2-(4-フルオロフェニル)-2-オキソ-1
-[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-2-フェニルベンズアミド 実施例1の4)と同様にして、目的物0.81g(57
%)を結晶として得た。 mp 148-149℃; 1H-NMR (CDCl3, 200MHz) δ 2.93 (1H,
dd, J = 5.2 Hz, 13.6 Hz), 3.06 (1H, dd, J = 6.6 H
z, 14.0 Hz), 5.80 (1H, ddd, J = 5.6 Hz, 6.6 Hz, 9.
2 Hz), 6.19 (1H, d, J = 7.6 Hz), 6.89 (2H, d, J =
8.4 Hz), 7.11 (2H, t, J = 8.4 Hz), 7.27-7.62 (1H,
m), 7.87 (2H, dd, J = 5.0 Hz, 8.6 Hz);IR (KBr) 328
1, 1684 cm-1; Anal. Calcd for C29H21F4NO2: C, 70.8
7; H, 4.31; N, 2.85. Found: C, 70.87; H, 4.30; N,
2.83. 2) N-[2-(4-フルオロフェニル)-2-ヒドロキ
シ-1-[[4-(トリフルオロメチル)フェニル]メチ
ル]エチル]-2-フェニルベンズアミド 実施例1の5)と同様にして、目的物0.48g(95
%、(1RS,2SR)体/(1RS,2RS)体=2
/3)を結晶として得た。 mp 133-134℃; 1H-NMR (CDCl3, 200MHz) δ 2.25-2.88
(3H, m), 4.22-4.52 (1H, m), 4.54 (1H×3/5, t, J =
4.4 Hz), 4.64 (1H×2/5, t, J = 3.8 Hz), 5.39(1H×2
/5, d, J = 8.8 Hz), 5.65 (1H×3/5, d, J = 8.2 Hz),
6.92-7.15 (4H,m), 7.20-7.56 (13H, m); IR (KBr) 33
35, 1645 cm-1; Anal. Calcd for C29H2 3F4NO2: C, 70.
58; H, 4.70; N, 2.84. Found: C, 70.46; H, 4.62; N,
2.93.Example 10 N- [2- (4-fluorophenyl) -2-hydroxy-1-
[[4- (Trifluoromethyl) phenyl] methyl] ethyl] -2-phenylbenzamide 1) N- [2- (4-Fluorophenyl) -2-oxo-1
-[[4- (Trifluoromethyl) phenyl] methyl] ethyl] -2-phenylbenzamide 0.81 g of the desired product (57
%) As crystals. mp 148-149 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.93 (1H,
dd, J = 5.2 Hz, 13.6 Hz), 3.06 (1H, dd, J = 6.6 H
z, 14.0 Hz), 5.80 (1H, ddd, J = 5.6 Hz, 6.6 Hz, 9.
2 Hz), 6.19 (1H, d, J = 7.6 Hz), 6.89 (2H, d, J =
8.4 Hz), 7.11 (2H, t, J = 8.4 Hz), 7.27-7.62 (1H,
m), 7.87 (2H, dd, J = 5.0 Hz, 8.6 Hz); IR (KBr) 328
1, 1684 cm -1 ; Anal.Calcd for C 29 H 21 F 4 NO 2 : C, 70.8
7; H, 4.31; N, 2.85. Found: C, 70.87; H, 4.30; N,
2.83. 2) N- [2- (4-Fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] -2-phenylbenzamide Same as 5) of Example 1 0.48 g (95
%, (1RS, 2SR) body / (1RS, 2RS) body = 2
/ 3) were obtained as crystals. mp 133-134 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 2.25-2.88
(3H, m), 4.22-4.52 (1H, m), 4.54 (1H × 3/5, t, J =
4.4 Hz), 4.64 (1H × 2/5, t, J = 3.8 Hz), 5.39 (1H × 2
/ 5, d, J = 8.8 Hz), 5.65 (1H × 3/5, d, J = 8.2 Hz),
6.92-7.15 (4H, m), 7.20-7.56 (13H, m); IR (KBr) 33
. 35, 1645 cm -1; Anal Calcd for C 29 H 2 3 F 4 NO 2: C, 70.
58; H, 4.70; N, 2.84. Found: C, 70.46; H, 4.62; N,
2.93.
【0143】実施例11 N-[2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-2-チオフェンカルボキサミド 1) N-[2-(4-フルオロフェニル)-2-オキソ-1
-[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-2-チオフェンカルボキサミド 実施例1の4)と同様にして、目的物0.94g(78
%)を結晶として得た。 mp 130-131℃; 1H-NMR (CDCl3, 200MHz) δ 3.21 (1H,
dd, J = 4.8 Hz, 13.8 Hz), 3.46 (1H, dd, J = 6.4 H
z, 13.6 Hz), 5.93-6.04 (1H, m), 6.91 (1H, d,J = 7.
0 Hz), 7.05-7.24 (5H, m), 7.45 (2H, d, J = 8.2 H
z), 7.50-7.54 (2H,m), 7.96-8.06 (2H, m); IR (KBr)
3308, 1694, 1682 cm-1; Anal. Calcd forC21H15F4NO
2S: C, 59.85; H, 3.59; N, 3.32. Found: C, 59.83;
H, 3.34; N, 3.24. 2) N-[2-(4-フルオロフェニル)-2-ヒドロキ
シ-1-[[4-(トリフルオロメチル)フェニル]メチ
ル]エチル]-2-チオフェンカルボキサミド 実施例1の5)と同様にして、目的物0.45g(89
%、(1RS,2SR)体/(1RS,2RS)体=2
/1)を結晶として得た。 mp 135-164℃; 1H-NMR (CDCl3, 200MHz) δ 2.92 (2H×
2/3, d, J = 7.8 Hz), 3.10-3.15 (1H, m), 3.40 (1H×
2/3, d, J = 3.8 Hz), 4.30-4.64 (1H, m), 4.82(1H×1
/3, t, J = 4.0 Hz), 5.08 (1H×2/3, t, J = 3.3 Hz),
6.00 (1H×2/3,br d, J = 8.4 Hz), 6.25 (1H×1/3, b
r d, J = 8.4 Hz), 6.94-7.14 (3H, m),7.21-7.61 (8H,
m); IR (KBr) 3301, 1636 cm-1; Anal. Calcd for C21
H17F4NO 2S: C, 59.57; H, 4.05; N, 3.31. Found: C, 5
9.59; H, 4.15; N, 3.24.Example 11 N- [2- (4-fluorophenyl) -2-hydroxy-1-
[[4- (trifluoromethyl) phenyl] methyl] d
Tyl] -2-thiophenecarboxamide 1) N- [2- (4-fluorophenyl) -2-oxo-1
-[[4- (Trifluoromethyl) phenyl] methyl] d
[Tyl] -2-thiophenecarboxamide In the same manner as in Example 1, 4), 0.94 g of the desired product (78
%) As crystals. mp 130-131 ° C;1H-NMR (CDClThree, 200MHz) δ 3.21 (1H,
dd, J = 4.8 Hz, 13.8 Hz), 3.46 (1H, dd, J = 6.4 H
z, 13.6 Hz), 5.93-6.04 (1H, m), 6.91 (1H, d, J = 7.
0 Hz), 7.05-7.24 (5H, m), 7.45 (2H, d, J = 8.2 H
z), 7.50-7.54 (2H, m), 7.96-8.06 (2H, m); IR (KBr)
3308, 1694, 1682 cm-1; Anal. Calcd forCtwenty oneH15FFourNO
TwoS: C, 59.85; H, 3.59; N, 3.32. Found: C, 59.83;
H, 3.34; N, 3.24.2) N- [2- (4-fluorophenyl) -2-hydroxy
C-1-[[4- (trifluoromethyl) phenyl] methyl
[Ethyl] -2-thiophenecarboxamide 0.45 g of the desired product (89
%, (1RS, 2SR) body / (1RS, 2RS) body = 2
/ 1) were obtained as crystals. mp 135-164 ° C;1H-NMR (CDClThree, 200MHz) δ 2.92 (2H ×
2/3, d, J = 7.8 Hz), 3.10-3.15 (1H, m), 3.40 (1H ×
2/3, d, J = 3.8 Hz), 4.30-4.64 (1H, m), 4.82 (1H × 1
/ 3, t, J = 4.0 Hz), 5.08 (1H × 2/3, t, J = 3.3 Hz),
6.00 (1H × 2/3, br d, J = 8.4 Hz), 6.25 (1H × 1/3, b
r d, J = 8.4 Hz), 6.94-7.14 (3H, m), 7.21-7.61 (8H,
m); IR (KBr) 3301, 1636 cm-1; Anal. Calcd for Ctwenty one
H17FFourNO TwoS: C, 59.57; H, 4.05; N, 3.31. Found: C, 5
9.59; H, 4.15; N, 3.24.
【0144】実施例12 N-[2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-4-(トリフルオロメチル)ベンズアミド 1) N-[2-(4-フルオロフェニル)-2-オキソ-1
-[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-4-(トリフルオロメチル)ベンズアミド 実施例1の4)と同様にして、目的物1.32g(95
%)を結晶として得た。 mp 172-174℃; 1H-NMR (CDCl3, 200MHz) δ 3.23 (1H,
dd, J = 4.8 Hz, 13.8 Hz), 3.51 (1H, dd, J = 6.2 H
z, 14.0 Hz), 6.01 (1H, ddd, J = 5.2 Hz, 6.4 Hz, 7.
0 Hz), 7.08 (2H, d, J = 8.0 Hz), 7.14 (1H, br s),
7.21 (2H, t, J =8.6 Hz), 7.47 (2H, d, J = 8.0 Hz),
7.73 (2H, d, J = 8.4 Hz), 7.88 (2H, d, J = 8.4 H
z), 7.98-8.10 (2H, m); IR (KBr) 3303, 1688, 1645 c
m-1; Anal.Calcd for C24H16F7NO2: C, 59.63; H, 3.3
4; N, 2.90. Found: C, 59.55; H, 3.58; N, 2.89. 2) N-[2-(4-フルオロフェニル)-2-ヒドロキ
シ-1-[[4-(トリフルオロメチル)フェニル]メチ
ル]エチル]-4-(トリフルオロメチル)ベンズアミド 実施例1の5)と同様にして、目的物444mg(88
%、(1RS,2SR)体/(1RS,2RS)体=1
/6)を結晶として得た。 mp 167-169℃; 1H-NMR (CDCl3, 200MHz) δ 2.87 (1H,
d, J = 4.4 Hz), 3.17 (2H, d, J = 7.6 Hz), 4.40-4.5
6 (1H, m), 4.86 (1H×6/7, t, J = 3.4 Hz), 5.10 (1H
×1/7, s), 6.43 (1H, d, J = 8.8 Hz), 6.95-7.14 (2
H, m), 7.22-7.32(2H, m), 7.43 (2H, d, J = 8.2 Hz),
7.59 (2H, d, J = 8.4 Hz), 7.67 (4H, s); IR (KBr)
3426, 3335, 1645 cm-1; Anal. Calcd for C24H18F7N
O2: C, 59.39; H, 3.74; N, 2.89. Found: C, 59.34;
H, 3.961; N, 2.89.Example 12 N- [2- (4-fluorophenyl) -2-hydroxy-1-
[[4- (Trifluoromethyl) phenyl] methyl] ethyl] -4- (trifluoromethyl) benzamide 1) N- [2- (4-Fluorophenyl) -2-oxo-1
-[[4- (Trifluoromethyl) phenyl] methyl] ethyl] -4- (trifluoromethyl) benzamide 1.32 g of the desired product (95
%) As crystals. mp 172-174 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 3.23 (1H,
dd, J = 4.8 Hz, 13.8 Hz), 3.51 (1H, dd, J = 6.2 H
z, 14.0 Hz), 6.01 (1H, ddd, J = 5.2 Hz, 6.4 Hz, 7.
0 Hz), 7.08 (2H, d, J = 8.0 Hz), 7.14 (1H, br s),
7.21 (2H, t, J = 8.6 Hz), 7.47 (2H, d, J = 8.0 Hz),
7.73 (2H, d, J = 8.4 Hz), 7.88 (2H, d, J = 8.4 H
z), 7.98-8.10 (2H, m); IR (KBr) 3303, 1688, 1645 c
m -1 ; Anal.Calcd for C 24 H 16 F 7 NO 2 : C, 59.63; H, 3.3
4; N, 2.90. Found: C, 59.55; H, 3.58; N, 2.89.2) N- [2- (4-fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl ] Methyl] ethyl] -4- (trifluoromethyl) benzamide In the same manner as in Example 1, 5), 444 mg (88
%, (1RS, 2SR) / (1RS, 2RS) = 1
/ 6) as crystals. mp 167-169 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 2.87 (1H,
d, J = 4.4 Hz), 3.17 (2H, d, J = 7.6 Hz), 4.40-4.5
6 (1H, m), 4.86 (1H × 6/7, t, J = 3.4 Hz), 5.10 (1H
× 1/7, s), 6.43 (1H, d, J = 8.8 Hz), 6.95-7.14 (2
H, m), 7.22-7.32 (2H, m), 7.43 (2H, d, J = 8.2 Hz),
7.59 (2H, d, J = 8.4 Hz), 7.67 (4H, s); IR (KBr)
3426, 3335, 1645 cm -1 ; Anal.Calcd for C 24 H 18 F 7 N
O 2 : C, 59.39; H, 3.74; N, 2.89. Found: C, 59.34;
H, 3.961; N, 2.89.
【0145】実施例13 4-ブチル-N-[2-(4-フルオロフェニル)-2-ヒド
ロキシ-1-[[4-(トリフルオロメチル)フェニル]
メチル]エチル]ベンズアミド 1) 4-ブチル-N-[2-(4-フルオロフェニル)-2
-オキソ-1-[[4-(トリフルオロメチル)フェニル]
メチル]エチル]ベンズアミド 実施例1の4)と同様にして、目的物1.16g(86
%)を結晶として得た。 mp 120-121℃; 1H-NMR (CDCl3, 200MHz) δ 0.93 (3H,
t, J = 7.1 Hz), 1.26-1.46 (2H, m), 1.53-1.70 (2H,
m), 2.67 (2H, t, J = 7.6 Hz), 3.21 (1H, dd,J = 4.6
Hz, 13.8 Hz), 3.49 (1H, dd, J = 6.4 Hz, 13.6 Hz),
6.02 (1H, ddd,J = 4.8 Hz, 6.4 Hz, 7.4 Hz), 7.00-
7.28 (7H, m), 7.45 (2H, d, J = 8.2 Hz), 7.69 (2H,
d, J = 8.2 Hz), 7.97-8.08 (2H, m); IR (KBr) 3281,
1688, 1636 cm-1; Anal. Calcd for C27H25F4NO2: C, 6
8.78; H, 5.34; N, 2.97. Found:C, 68.95; H, 5.43;
N, 2.96. 2) 4-ブチル-N-[2-(4-フルオロフェニル)-2
-ヒドロキシ-1-[[4-(トリフルオロメチル)フェニ
ル]メチル]エチル]ベンズアミド 実施例1の5)と同様にして、目的物946mg(95
%、(1RS,2SR)体/(1RS,2RS)体=4
/3)を結晶として得た。 mp 138-158℃; 1H-NMR (CDCl3, 200MHz) δ 0.92 (3H,
t, J = 7.1 Hz), 1.24-1.43 (2H, m), 1.50-1.67 (2H,
m), 2.63 (2H, t, J = 7.7 Hz), 2.90 (1H×4/7,d, J =
3.4 Hz), 2.94 (1H×4/7, s), 3.13 (2H×3/7, d, J =
4.4 Hz), 3.88(1H×4/7, d, J = 3.8 Hz), 4.37 (1H×
3/7, ddd, J = 2.8 Hz, 7.0 Hz, 15.4 Hz), 4.52-4.67
(1H×4/7, m), 4.82 (1H×3/7, t, J = 4.2 Hz), 5.06
(1H×4/7, t, J = 3.5 Hz), 6.14 (1H×4/7, d, J = 8.
2 Hz), 6.37 (1H×3/7, d, J = 8.6 Hz), 6.91-7.32 (6
H, m), 7.35-7.59 (6H, m); IR (KBr) 3274, 1615 c
m-1;Anal. Calcd for C27H27F4NO2: C, 68.49; H, 5.7
5; N, 2.96. Found: C, 68.35; H, 5.89; N, 3.04.Example 13 4-butyl-N- [2- (4-fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl]
Methyl] ethyl] benzamide 1) 4-butyl-N- [2- (4-fluorophenyl) -2
-Oxo-1-[[4- (trifluoromethyl) phenyl]
Methyl] ethyl] benzamide 1.16 g (86) of the target compound in the same manner as in 4) of Example 1.
%) As crystals. mp 120-121 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 0.93 (3H,
t, J = 7.1 Hz), 1.26-1.46 (2H, m), 1.53-1.70 (2H,
m), 2.67 (2H, t, J = 7.6 Hz), 3.21 (1H, dd, J = 4.6
Hz, 13.8 Hz), 3.49 (1H, dd, J = 6.4 Hz, 13.6 Hz),
6.02 (1H, ddd, J = 4.8 Hz, 6.4 Hz, 7.4 Hz), 7.00-
7.28 (7H, m), 7.45 (2H, d, J = 8.2 Hz), 7.69 (2H,
d, J = 8.2 Hz), 7.97-8.08 (2H, m); IR (KBr) 3281,
1688, 1636 cm -1 ; Anal.Calcd for C 27 H 25 F 4 NO 2 : C, 6
8.78; H, 5.34; N, 2.97. Found: C, 68.95; H, 5.43;
N, 2.96.2) 4-Butyl-N- [2- (4-fluorophenyl) -2
-Hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] benzamide 946 mg (95%) of the target compound in the same manner as in Example 1, 5).
%, (1RS, 2RS) / (1RS, 2RS) = 4
/ 3) were obtained as crystals. mp 138-158 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 0.92 (3H,
t, J = 7.1 Hz), 1.24-1.43 (2H, m), 1.50-1.67 (2H,
m), 2.63 (2H, t, J = 7.7 Hz), 2.90 (1H × 4/7, d, J =
3.4 Hz), 2.94 (1H × 4/7, s), 3.13 (2H × 3/7, d, J =
4.4 Hz), 3.88 (1H × 4/7, d, J = 3.8 Hz), 4.37 (1H ×
3/7, ddd, J = 2.8 Hz, 7.0 Hz, 15.4 Hz), 4.52-4.67
(1H × 4/7, m), 4.82 (1H × 3/7, t, J = 4.2 Hz), 5.06
(1H × 4/7, t, J = 3.5 Hz), 6.14 (1H × 4/7, d, J = 8.
2 Hz), 6.37 (1H × 3/7, d, J = 8.6 Hz), 6.91-7.32 (6
H, m), 7.35-7.59 (6H, m); IR (KBr) 3274, 1615 c
. m -1; Anal Calcd for C 27 H 27 F 4 NO 2: C, 68.49; H, 5.7
5; N, 2.96. Found: C, 68.35; H, 5.89; N, 3.04.
【0146】実施例14 N-[2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-2-ナフタレンカルボキサミド 1) N-[2-(4-フルオロフェニル)-2-オキソ-1
-[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-2-ナフタレンカルボキサミド 実施例1の4)と同様にして、目的物1.03g(77
%)を結晶として得た。mp 139-141℃; 1H-NMR (CDCl3,
200MHz) δ 3.26 (1H, dd, J = 4.8 Hz, 14.0Hz), 3.5
4 (1H, dd, J = 6.6 Hz, 13.4 Hz), 6.04-6.14 (1H,
m), 7.11 (2H, d, J = 8.2 Hz), 7.17-7.28 (3H, m),
7.46 (2H, d, J = 8.0 Hz), 7.51-7.64 (2H, m), 7.80-
7.97 (4H, m), 8.01-8.11 (2H, m), 8.29 (1H, s); IR
(KBr) 3293, 1694, 1645 cm-1; Anal. Calcd for C27H
19F4NO2: C, 69.67; H, 4.11; N, 3.01. Found: C, 69.
67; H, 4.11; N, 3.01. 2) N-[2-(4-フルオロフェニル)-2-ヒドロキ
シ-1-[[4-(トリフルオロメチル)フェニル]メチ
ル]エチル]-2-ナフタレンカルボキサミド 実施例1の5)と同様にして、目的物0.50g(10
0%、(1RS,2SR)体/(1RS,2RS)体=
1/1)を結晶として得た。 mp 148-150℃; 1H-NMR (CDCl3, 200MHz) δ 3.00 (1H,
d, J = 7.8 Hz), 3.20 (1H, d, J = 7.8 Hz), 3.38-3.5
3 (0.5H, m), 3.67-3.77 (0.5H, m), 4.39-4.55(0.5H,
m), 4.59-4.75 (0.5H, m), 4.85-4.93 (0.5H, m), 5.14
(0.5H, t, J =3.0 Hz), 6.28 (0.5H, br s), 6.53 (0.
5H, br s), 6.94-7.13 (2H, m), 7.26-7.36 (2H, m),
7.41-7.65 (7H, m), 7.82-7.89 (3H, m), 8.04 (1H, d,
J = 4.4Hz); IR (KBr) 3351, 1640 cm-1; Anal. Calcd
for C27H21F4NO2: C, 69.37; H,4.53; N, 3.00. Foun
d: C, 68.51; H, 5.02; N, 2.67.Example 14 N- [2- (4-fluorophenyl) -2-hydroxy-1-
[[4- (trifluoromethyl) phenyl] methyl] ethyl] -2-naphthalenecarboxamide 1) N- [2- (4-fluorophenyl) -2-oxo-1
-[[4- (Trifluoromethyl) phenyl] methyl] ethyl] -2-naphthalenecarboxamide In the same manner as in Example 1, 4), 1.03 g of the desired product (77
%) As crystals. mp 139-141 ° C; 1 H-NMR (CDCl 3 ,
200MHz) δ 3.26 (1H, dd, J = 4.8 Hz, 14.0Hz), 3.5
4 (1H, dd, J = 6.6 Hz, 13.4 Hz), 6.04-6.14 (1H,
m), 7.11 (2H, d, J = 8.2 Hz), 7.17-7.28 (3H, m),
7.46 (2H, d, J = 8.0 Hz), 7.51-7.64 (2H, m), 7.80-
7.97 (4H, m), 8.01-8.11 (2H, m), 8.29 (1H, s); IR
(KBr) 3293, 1694, 1645 cm -1 ; Anal.Calcd for C 27 H
19 F 4 NO 2 : C, 69.67; H, 4.11; N, 3.01. Found: C, 69.
67; H, 4.11; N, 3.01.2) N- [2- (4-fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] -2-naphthalenecarboxamide In the same manner as in 5) of Example 1, 0.50 g (10
0%, (1RS, 2RS) / (1RS, 2RS) =
1/1) as crystals. mp 148-150 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 3.00 (1H,
d, J = 7.8 Hz), 3.20 (1H, d, J = 7.8 Hz), 3.38-3.5
3 (0.5H, m), 3.67-3.77 (0.5H, m), 4.39-4.55 (0.5H,
m), 4.59-4.75 (0.5H, m), 4.85-4.93 (0.5H, m), 5.14
(0.5H, t, J = 3.0 Hz), 6.28 (0.5H, br s), 6.53 (0.
5H, br s), 6.94-7.13 (2H, m), 7.26-7.36 (2H, m),
7.41-7.65 (7H, m), 7.82-7.89 (3H, m), 8.04 (1H, d,
J = 4.4Hz); IR (KBr) 3351, 1640 cm -1 ; Anal.Calcd
for C 27 H 21 F 4 NO 2 : C, 69.37; H, 4.53; N, 3.00. Foun
d: C, 68.51; H, 5.02; N, 2.67.
【0147】実施例15 N-[2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]アダマンタン-1-カルボキサミド 1) N-[2-(4-フルオロフェニル)-2-オキソ-1
-[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]アダマンタン-1-カルボキサミド 実施例1の4)と同様にして、目的物0.89g(78
%)を結晶として得た。 mp 169-170℃; 1H-NMR (CDCl3, 200MHz) δ 1.71 (6H,
d, J = 2.6 Hz), 1.81 (6H, d, J = 3.0 Hz), 2.04 (3
H, br s), 3.08 (1H, dd, J = 5.2 Hz, 13.6 Hz),3.34
(1H, dd, J = 6.6 Hz, 14.0 Hz), 5.75-5.85 (1H, m),
6.49 (1H, br d,J = 7.6 Hz), 7.07 (1H, d, J = 7.8 H
z), 7.11-7.23 (2H, m), 7.47 (2H, d, J= 8.0 Hz), 7.
93-8.03 (2H, m); IR (KBr) 3347, 1682, 1632 cm-1; A
nal. Calcd for C27H27F4NO2: C, 68.49; H, 5.75; N,
2.96. Found: C, 68.41; H, 5.70; N, 2.93. 2) N-[2-(4-フルオロフェニル)-2-ヒドロキ
シ-1-[[4-(トリフルオロメチル)フェニル]メチ
ル]エチル]アダマンタン-1-カルボキサミド 実施例1の5)と同様にして、目的物488mg(97
%、(1RS,2SR)体/(1RS,2RS)体=3
/2)をアモルファスとして得た。1 H-NMR (CDCl3, 200MHz) δ 1.55-1.74 (12H, m), 1.97
(3H, br s), 2.63-3.06(2H, m), 4.01 (1H, br t, J =
3.4 Hz), 4.09 (1H×2/5, ddd, J = 4.0 Hz, 7.6 Hz,
15.6 Hz), 4.33-4.47 (1H×3/5, m), 4.75 (1H×2/5,
t, J = 8.8 Hz),4.91 (1H×3/5, t, J = 6.6 Hz), 5.48
(1H×3/5, d, J = 7.6 Hz), 5.76 (1H×2/5, d, J =
8.0 Hz), 6.94-7.13 (2H, m), 7.17-7.28 (2H, m), 7.3
0-7.40 (2H, m), 7.48-7.59 (2H, m); IR (KBr) 3441,
3353, 1634 cm-1; Anal. Calcd forC27H29F4NO2: C, 6
8.20; H, 6.15; N, 2.95. Found: C, 67.72; H, 6.31;
N, 2.86.Example 15 N- [2- (4-Fluorophenyl) -2-hydroxy-1-
[[4- (Trifluoromethyl) phenyl] methyl] ethyl] adamantane-1-carboxamide 1) N- [2- (4-Fluorophenyl) -2-oxo-1
-[[4- (Trifluoromethyl) phenyl] methyl] ethyl] adamantan-1-carboxamide 0.89 g of the desired product (78)
%) As crystals. mp 169-170 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 1.71 (6H,
d, J = 2.6 Hz), 1.81 (6H, d, J = 3.0 Hz), 2.04 (3
H, br s), 3.08 (1H, dd, J = 5.2 Hz, 13.6 Hz), 3.34
(1H, dd, J = 6.6 Hz, 14.0 Hz), 5.75-5.85 (1H, m),
6.49 (1H, br d, J = 7.6 Hz), 7.07 (1H, d, J = 7.8 H
z), 7.11-7.23 (2H, m), 7.47 (2H, d, J = 8.0 Hz), 7.
93-8.03 (2H, m); IR (KBr) 3347, 1682, 1632 cm -1 ; A
nal.Calcd for C 27 H 27 F 4 NO 2 : C, 68.49; H, 5.75; N,
2.96. Found: C, 68.41; H, 5.70; N, 2.93.2.2) N- [2- (4-fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl Adamantane-1-carboxamide In the same manner as in 5 of Example 1, 488 mg of the desired product (97 mg
%, (1RS, 2RS) / (1RS, 2RS) = 3
/ 2) was obtained as amorphous. 1 H-NMR (CDCl 3 , 200MHz) δ 1.55-1.74 (12H, m), 1.97
(3H, br s), 2.63-3.06 (2H, m), 4.01 (1H, br t, J =
3.4 Hz), 4.09 (1H × 2/5, ddd, J = 4.0 Hz, 7.6 Hz,
15.6 Hz), 4.33-4.47 (1H × 3/5, m), 4.75 (1H × 2/5,
t, J = 8.8 Hz), 4.91 (1H × 3/5, t, J = 6.6 Hz), 5.48
(1H × 3/5, d, J = 7.6 Hz), 5.76 (1H × 2/5, d, J =
8.0 Hz), 6.94-7.13 (2H, m), 7.17-7.28 (2H, m), 7.3
0-7.40 (2H, m), 7.48-7.59 (2H, m); IR (KBr) 3441,
. 3353, 1634 cm -1; Anal Calcd forC 27 H 29 F 4 NO 2: C, 6
8.20; H, 6.15; N, 2.95. Found: C, 67.72; H, 6.31;
N, 2.86.
【0148】実施例16 N-[2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-2,2-ジメチルプロピオンアミド 1) N-[2-(4-フルオロフェニル)-2-オキソ-1
-[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-2,2-ジメチルプロピオンアミド 実施例1の4)と同様にして、目的物0.89g(78
%)を結晶として得た。 mp 147-150℃; 1H-NMR (CDCl3, 200MHz) δ 1.17 (9H,
s), 3.08 (1H, dd, J =5.2 Hz, 13.6 Hz), 3.35 (1H, d
d, J = 6.2 Hz, 14.0 Hz), 5.74-5.84 (1H, m),6.52 (1
H, br d, J = 6.6 Hz), 7.08 (2H, d, J = 7.6 Hz), 7.
12-7.24 (2H, m), 7.47 (2H, d, J = 8.0 Hz), 7.94-8.
04 (2H, m); IR (KBr) 3391, 1682, 1634 cm-1; Anal.
Calcd for C21H21F4NO2: C, 63.79; H, 5.35; N, 3.54.
Found:C, 63.72; H, 5.21; N, 3.48. 2) N-[2-(4-フルオロフェニル)-2-ヒドロキ
シ-1-[[4-(トリフルオロメチル)フェニル]メチ
ル]エチル]-2,2-ジメチルプロピオンアミド 実施例1の5)と同様にして、目的物498mg(99
%、(1RS,2SR)体/(1RS,2RS)体=3
/2)を結晶として得た。 mp 97-99℃; 1H-NMR (CDCl3, 200MHz) δ 1.00 (9H,
s), 2.69-3.08 (2H, m), 3.83 (1H, br s), 4.13 (1H×
2/5, ddd, J = 3.6 Hz, 8.0 Hz, 15.8 Hz), 4.34-4.47
(1H×3/5, m), 4.76 (1H×2/5, t, J = 4.0 Hz), 4.92
(1H×3/5, t, J = 3.2 Hz), 5.54 (1H×3/5, t, J = 7.
0 Hz), 5.83 (1H×2/5, m), 6.95-7.12 (2H,m), 7.17-
7.25 (2H, m), 7.31-7.40 (2H, m), 7.47-7.59 (2H,
m); IR (KBr) 3333, 1645 cm-1; Anal. Calcd for C21H
23F4NO2: C, 63.47; H, 5.83; N, 3.52.Found: C, 63.3
3; H, 5.74; N, 3.50.Example 16 N- [2- (4-fluorophenyl) -2-hydroxy-1-
[[4- (trifluoromethyl) phenyl] methyl] ethyl] -2,2-dimethylpropionamide 1) N- [2- (4-fluorophenyl) -2-oxo-1
-[[4- (Trifluoromethyl) phenyl] methyl] ethyl] -2,2-dimethylpropionamide 0.89 g of the desired product (78)
%) As crystals. mp 147-150 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 1.17 (9H,
s), 3.08 (1H, dd, J = 5.2 Hz, 13.6 Hz), 3.35 (1H, d
d, J = 6.2 Hz, 14.0 Hz), 5.74-5.84 (1H, m), 6.52 (1
H, br d, J = 6.6 Hz), 7.08 (2H, d, J = 7.6 Hz), 7.
12-7.24 (2H, m), 7.47 (2H, d, J = 8.0 Hz), 7.94-8.
04 (2H, m); IR (KBr) 3391, 1682, 1634 cm -1 ; Anal.
Calcd for C 21 H 21 F 4 NO 2 : C, 63.79; H, 5.35; N, 3.54.
Found: C, 63.72; H, 5.21; N, 3.48. 2) N- [2- (4-fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl]- 2,2-Dimethylpropionamide In the same manner as in Example 1, 5), 498 mg (99%) of the desired product was obtained.
%, (1RS, 2RS) / (1RS, 2RS) = 3
/ 2) were obtained as crystals. mp 97-99 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.00 (9H,
s), 2.69-3.08 (2H, m), 3.83 (1H, br s), 4.13 (1H ×
2/5, ddd, J = 3.6 Hz, 8.0 Hz, 15.8 Hz), 4.34-4.47
(1H × 3/5, m), 4.76 (1H × 2/5, t, J = 4.0 Hz), 4.92
(1H × 3/5, t, J = 3.2 Hz), 5.54 (1H × 3/5, t, J = 7.
0 Hz), 5.83 (1H × 2/5, m), 6.95-7.12 (2H, m), 7.17-
7.25 (2H, m), 7.31-7.40 (2H, m), 7.47-7.59 (2H,
m); IR (KBr) 3333, 1645 cm -1 ; Anal.Calcd for C 21 H
23 F 4 NO 2 : C, 63.47; H, 5.83; N, 3.52.Found: C, 63.3
3; H, 5.74; N, 3.50.
【0149】実施例17 N-[2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-2,3,4-トリメチルベンズアミド 1) N-[2-(4-フルオロフェニル)-2-オキソ-1
-[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-2,3,4-トリメチルベンズアミド 実施例1の4)と同様にして、目的物0.48g(36
%)を結晶として得た。 mp 141-143℃; 1H-NMR (CDCl3, 200MHz) δ 2.08 (6H,
s), 2.25 (3H, s), 3.14(1H, dd, J = 7.2 Hz, 14.0 H
z), 3.36 (1H, dd, J = 6.2 Hz, 14.0 Hz), 6.07-6.18
(1H, m), 6.37 (1H, br d, J = 8.4 Hz), 6.80 (2H,
s), 7.18 (2H, t, J= 8.4 Hz), 7.24-7.31 (2H, m), 7.
50 (2H, d, J = 8.0 Hz), 8.01-8.11 (2H,m); IR (KBr)
3237, 1694, 1634 cm-1; Anal. Calcd for C26H23F4NO
2: C, 68.26; H, 5.07; N, 3.06. Found: C, 68.23; H,
5.25; N, 2.91. 2) N-[2-(4-フルオロフェニル)-2-ヒドロキ
シ-1-[[4-(トリフルオロメチル)フェニル]メチ
ル]エチル]-2,3,4-トリメチルベンズアミド 実施例1の5)と同様にして、目的物325mg(92
%、(1RS,2SR)体/(1RS,2RS)体=1
/10)をアモルファスとして得た。1 H-NMR (CDCl3, 200MHz) δ 1.86 (6H, s), 2.22 (3H,
s), 3.03 (1H, dd, J =7.3 Hz, 13.9 Hz), 3.12 (1H, d
d, J = 7.6 Hz, 13.4 Hz), 3.15-3.28 (1H, m),4.58 (1
H, ddd, J = 3.5 Hz, 7.8 Hz, 15.8 Hz), 4.70 (1H, br
s), 6.01 (1H,br d, J = 9.2 Hz), 6.73 (2H, s), 6.9
4-7.13 (2H, m), 7.22-7.31 (2H, m),7.45 (2H, d, J =
8.4 Hz), 7.58 (2H, d, J = 8.0 Hz); IR (KBr) 3268,
1620cm-1; Anal. Calcd for C26H25F4NO2: C, 67.96;
H, 5.48; N, 3.05. Found: C,67.80; H, 5.74; N, 3.0
4.Example 17 N- [2- (4-fluorophenyl) -2-hydroxy-1-
[[4- (Trifluoromethyl) phenyl] methyl] ethyl] -2,3,4-trimethylbenzamide 1) N- [2- (4-Fluorophenyl) -2-oxo-1
-[[4- (Trifluoromethyl) phenyl] methyl] ethyl] -2,3,4-trimethylbenzamide In the same manner as in Example 1, 4), 0.48 g of the desired product (36
%) As crystals. mp 141-143 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 2.08 (6H,
s), 2.25 (3H, s), 3.14 (1H, dd, J = 7.2 Hz, 14.0 H
z), 3.36 (1H, dd, J = 6.2 Hz, 14.0 Hz), 6.07-6.18
(1H, m), 6.37 (1H, br d, J = 8.4 Hz), 6.80 (2H,
s), 7.18 (2H, t, J = 8.4 Hz), 7.24-7.31 (2H, m), 7.
50 (2H, d, J = 8.0 Hz), 8.01-8.11 (2H, m); IR (KBr)
3237, 1694, 1634 cm -1 ; Anal.Calcd for C 26 H 23 F 4 NO
2 : C, 68.26; H, 5.07; N, 3.06. Found: C, 68.23; H,
5.25; N, 2.92.1.2) N- [2- (4-fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] -2,3,4-trimethylbenzamide 325 mg of the desired product (92%) was obtained in the same manner as in 5) of Example 1.
%, (1RS, 2SR) / (1RS, 2RS) = 1
/ 10) was obtained as amorphous. 1 H-NMR (CDCl 3 , 200MHz) δ 1.86 (6H, s), 2.22 (3H,
s), 3.03 (1H, dd, J = 7.3 Hz, 13.9 Hz), 3.12 (1H, d
d, J = 7.6 Hz, 13.4 Hz), 3.15-3.28 (1H, m), 4.58 (1
H, ddd, J = 3.5 Hz, 7.8 Hz, 15.8 Hz), 4.70 (1H, br
s), 6.01 (1H, br d, J = 9.2 Hz), 6.73 (2H, s), 6.9
4-7.13 (2H, m), 7.22-7.31 (2H, m), 7.45 (2H, d, J =
8.4 Hz), 7.58 (2H, d, J = 8.0 Hz); IR (KBr) 3268,
1620cm -1 ; Anal.Calcd for C 26 H 25 F 4 NO 2 : C, 67.96;
H, 5.48; N, 3.05. Found: C, 67.80; H, 5.74; N, 3.0
Four.
【0150】実施例18 2-フルオロ-N-[2-(4-フルオロフェニル)-2-ヒ
ドロキシ-1-[[4-(トリフルオロメチル)フェニ
ル]メチル]エチル]ベンズアミド 1) 2-フルオロ-N-[2-(4-フルオロフェニル)-
2-オキソ-1-[[4-(トリフルオロメチル)フェニ
ル]メチル]エチル]ベンズアミド 実施例1の4)と同様にして、目的物136mg(90
%)を結晶として得た。 mp 109-111℃; 1H-NMR (CDCl3, 200MHz) δ 3.22 (1H,
dd, J = 5.2 Hz, 13.6 Hz), 3.46 (1H, dd, J = 6.2 H
z, 13.4 Hz), 5.98-6.11 (1H, m), 7.09-7.33 (6H, m),
7.43-7.69 (4H, m), 7.97-8.11 (3H, m); IR (KBr) 34
39, 1686, 1655 cm -1; Anal. Calcd for C23H16F5NO2:
C, 63.74; H, 3.72; N, 3.23. Found: C, 63.56; H, 3.
66; N, 3.40. 2) 2-フルオロ-N-[2-(4-フルオロフェニル)-
2-ヒドロキシ-1-[[4-(トリフルオロメチル)フェ
ニル]メチル]エチル]ベンズアミド 実施例1の5)と同様にして、目的物367mg(68
%、(1RS,2SR)体/(1RS,2RS)体=1
/2)を結晶として得た。 mp 115-117℃; 1H-NMR (CDCl3, 200MHz) δ 3.00-3.22
(3H, m), 4.42-4.58 (1H, m), 4.82 (1H, m), 6.92-7.6
0 (12H, m); IR (KBr) 3447, 3333, 1644 cm-1;Anal. C
alcd for C23H18F5NO2: 63.45; H, 4.17; N, 3.22. Fou
nd: C, 63.45; H, 4.22; N, 3.15.Example 18 2-Fluoro-N- [2- (4-fluorophenyl) -2-h
Droxy-1-[[4- (trifluoromethyl) phenyi
[Methyl] ethyl] benzamide 1) 2-Fluoro-N- [2- (4-fluorophenyl)-
2-oxo-1-[[4- (trifluoromethyl) phenyl
[Methyl] ethyl] benzamide 136 mg (90%) of the target compound in the same manner as 4) of Example 1.
%) As crystals. mp 109-111 ° C;1H-NMR (CDClThree, 200MHz) δ 3.22 (1H,
dd, J = 5.2 Hz, 13.6 Hz), 3.46 (1H, dd, J = 6.2 H
z, 13.4 Hz), 5.98-6.11 (1H, m), 7.09-7.33 (6H, m),
7.43-7.69 (4H, m), 7.97-8.11 (3H, m); IR (KBr) 34
39, 1686, 1655 cm -1; Anal. Calcd for Ctwenty threeH16FFiveNOTwo:
C, 63.74; H, 3.72; N, 3.23. Found: C, 63.56; H, 3.
66; N, 3.40. 2) 2-Fluoro-N- [2- (4-fluorophenyl)-
2-hydroxy-1-[[4- (trifluoromethyl) fe
Nyl] methyl] ethyl] benzamide 367 mg (68%) of the target compound in the same manner as in 5) of Example 1.
%, (1RS, 2SR) / (1RS, 2RS) = 1
/ 2) were obtained as crystals. mp 115-117 ° C;1H-NMR (CDClThree, 200MHz) δ 3.00-3.22
(3H, m), 4.42-4.58 (1H, m), 4.82 (1H, m), 6.92-7.6
0 (12H, m); IR (KBr) 3447, 3333, 1644 cm-1; Anal. C
alcd for Ctwenty threeH18FFiveNOTwo: 63.45; H, 4.17; N, 3.22. Fou
nd: C, 63.45; H, 4.22; N, 3.15.
【0151】実施例19 4-tert-ブチル-N-[2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[[4-(トリフルオロメチル)フ
ェニル]メチル]エチル]ベンズアミド 1) 4-tert-ブチル-N-[2-(4-フルオロフェ
ニル)-2-オキソ-1-[[4-(トリフルオロメチル)
フェニル]メチル]エチル]ベンズアミド 実施例1の4)と同様にして、目的物1.06g(78
%)を結晶として得た。 mp 58℃; 1H-NMR (CDCl3, 200MHz) δ 1.34 (9H, s),
3.21 (1H, dd, J = 5.6 Hz, 14.0 Hz), 3.48 (1H, dd,
J = 6.6 Hz, 14.0 Hz), 6.03 (1H, ddd, J = 4.8Hz, 5.
6 Hz, 6.6 Hz), 7.04-7.26 (5H, m), 7.41-7.50 (4H,
m), 7.68-7.75 (2H, m), 7.97-8.08 (2H, m); IR (KBr)
3299, 1694 cm-1; Anal. Calcd for C27H2 5F4NO2・0.1H
2O:C,68.52;H,5.37;N, 2.96. Found: C, 68.33; H, 5.2
2; N, 2.92. 2) 4-tert-ブチル-N-[2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[[4-(トリフルオロメチ
ル)フェニル]メチル]エチル]ベンズアミド 実施例1の5)と同様にして、目的物0.50g(97
%、(1RS,2SR)体/(1RS,2RS)体=3
/2)をアモルファスとして得た。1 H-NMR (CDCl3, 200MHz) δ 1.31 (9H, s), 2.90-2.95
(2H×3/5, m), 3.14 (2H×2/5, d, J = 7.4 Hz), 3.64
(1H×2/5, d, J = 3.4 Hz), 3.83 (1H×3/5, d,J = 3.4
Hz), 4.37 (2H×2/5, ddd, J = 3.2 Hz, 7.2 Hz, 15.6
Hz), 4.53-4.68(1H×3/5, m), 4.83 (1H×2/5, t, J =
4.0 Hz), 5.06 (1H×3/5, t, J = 6.6Hz), 6.13 (1H×
3/5, d, J = 8.2 Hz), 6.37 (1H×2/5, d, J = 8.4 H
z), 6.92-7.13 (2H, m), 7.21-7.32 (2H, m), 7.36-7.5
9 (8H, m); IR (KBr) 3301, 1620cm-1; Anal. Calcd fo
r C27H27F4NO2・0.2H2O: C, 67.97; H, 5.79; N, 2.94.
Found: C, 67.97; H, 5.80; N, 2.89.Example 19 4-tert-butyl-N- [2- (4-fluorophenyl)
-2-Hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] benzamide 1) 4-tert-butyl-N- [2- (4-fluorophenyl) -2-oxo-1- [ [4- (trifluoromethyl)
Phenyl] methyl] ethyl] benzamide 1.06 g of the desired product (78) in the same manner as in 4) of Example 1.
%) As crystals. mp 58 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 1.34 (9H, s),
3.21 (1H, dd, J = 5.6 Hz, 14.0 Hz), 3.48 (1H, dd,
J = 6.6 Hz, 14.0 Hz), 6.03 (1H, ddd, J = 4.8Hz, 5.
6 Hz, 6.6 Hz), 7.04-7.26 (5H, m), 7.41-7.50 (4H,
m), 7.68-7.75 (2H, m), 7.97-8.08 (2H, m); IR (KBr)
3299, 1694 cm -1;. Anal Calcd for C 27 H 2 5 F 4 NO 2 · 0.1H
2O: C, 68.52; H, 5.37; N, 2.96.Found: C, 68.33; H, 5.2
2; N, 2.92.2.2) 4-tert-butyl-N- [2- (4-fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] benzamide In the same manner as in 1-5), 0.50 g (97
%, (1RS, 2RS) / (1RS, 2RS) = 3
/ 2) was obtained as amorphous. 1 H-NMR (CDCl 3 , 200MHz) δ 1.31 (9H, s), 2.90-2.95
(2H × 3/5, m), 3.14 (2H × 2/5, d, J = 7.4 Hz), 3.64
(1H × 2/5, d, J = 3.4 Hz), 3.83 (1H × 3/5, d, J = 3.4
Hz), 4.37 (2H × 2/5, ddd, J = 3.2 Hz, 7.2 Hz, 15.6
Hz), 4.53-4.68 (1H × 3/5, m), 4.83 (1H × 2/5, t, J =
4.0 Hz), 5.06 (1H × 3/5, t, J = 6.6Hz), 6.13 (1H ×
3/5, d, J = 8.2 Hz), 6.37 (1H × 2/5, d, J = 8.4 H
z), 6.92-7.13 (2H, m), 7.21-7.32 (2H, m), 7.36-7.5
9 (8H, m); IR (KBr) 3301, 1620cm -1 ; Anal.Calcd fo
r C 27 H 27 F 4 NO 2・ 0.2H 2 O: C, 67.97; H, 5.79; N, 2.94.
Found: C, 67.97; H, 5.80; N, 2.89.
【0152】実施例20 N-[2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-4-フェニルベンズアミド 1) N-[2-(4-フルオロフェニル)-2-オキソ-1
-[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-4-フェニルベンズアミド 実施例1の4)と同様にして、目的物1.24g(88
%)を結晶として得た。 mp 169℃; 1H-NMR (CDCl3, 200MHz) δ 3.24 (1H, dd,
J = 4.6 Hz, 14.0 Hz),3.52 (1H, dd, J = 6.4 Hz, 14.
0 Hz), 6.04 (1H, ddd, J = 4.6 Hz, 5.2 Hz, 6.4 Hz),
7.07-7.25 (5H, m), 7.38-7.52 (5H, m), 7.58-7.72
(4H, m), 7.86 (2H, d, J = 8.8 Hz), 7.99-8.10 (2H,
m); IR (KBr) 3291, 1688, 1645 cm-1; Anal. Calcd fo
r C29H21F4NO2: C, 70.87; H, 4.31; N, 2.85. Found:
C, 70.89;H, 4.23; N, 2.86. 2) N-[2-(4-フルオロフェニル)-2-ヒドロキ
シ-1-[[4-(トリフルオロメチル)フェニル]メチ
ル]エチル]-4-フェニルベンズアミド 実施例1の5)と同様にして、目的物0.49g(96
%、(1RS,2SR)体/(1RS,2RS)体=3
/2)を結晶として得た。 mp 178-185℃; 1H-NMR (CDCl3, 200MHz) δ 2.93-3.00
(2H×3/5, m), 3.17 (2H×2/5, d, J = 7.6 Hz), 3.36
(1H×2/5, d, J = 4.4 Hz), 3.63 (1H×3/5, d,J = 3.2
Hz), 4.35-4.52 (1H×2/5, m), 4.55-4.71 (1H×3/5,
m), 4.87 (1H×2/5, t, J = 3.9 Hz), 5.11 (1H×3/5,
t, J = 3.6 Hz), 6.17 (1H×3/5, d, J =8.6 Hz), 6.42
(1H×2/5, d, J = 8.0 Hz), 6.95-7.13 (2H, m), 7.24
-7.68 (15H, m); IR (KBr) 3304, 1634 cm-1; Anal. Ca
lcd for C29H23F4NO2: C, 70.58;H, 4.70; N, 2.84. Fo
und: C, 70.53; H, 4.72; N, 2.72.Example 20 N- [2- (4-fluorophenyl) -2-hydroxy-1-
[[4- (trifluoromethyl) phenyl] methyl] ethyl] -4-phenylbenzamide 1) N- [2- (4-fluorophenyl) -2-oxo-1
-[[4- (Trifluoromethyl) phenyl] methyl] ethyl] -4-phenylbenzamide 1.24 g of the desired product (88
%) As crystals. mp 169 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 3.24 (1H, dd,
J = 4.6 Hz, 14.0 Hz), 3.52 (1H, dd, J = 6.4 Hz, 14.
0 Hz), 6.04 (1H, ddd, J = 4.6 Hz, 5.2 Hz, 6.4 Hz),
7.07-7.25 (5H, m), 7.38-7.52 (5H, m), 7.58-7.72
(4H, m), 7.86 (2H, d, J = 8.8 Hz), 7.99-8.10 (2H,
m); IR (KBr) 3291, 1688, 1645 cm -1 ; Anal.Calcd fo
r C 29 H 21 F 4 NO 2 : C, 70.87; H, 4.31; N, 2.85. Found:
C, 70.89; H, 4.23; N, 2.86. 2) N- [2- (4-Fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] -4- Phenylbenzamide In the same manner as in Example 1, 5), 0.49 g (96
%, (1RS, 2RS) / (1RS, 2RS) = 3
/ 2) were obtained as crystals. mp 178-185 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 2.93-3.00
(2H × 3/5, m), 3.17 (2H × 2/5, d, J = 7.6 Hz), 3.36
(1H × 2/5, d, J = 4.4 Hz), 3.63 (1H × 3/5, d, J = 3.2
Hz), 4.35-4.52 (1H × 2/5, m), 4.55-4.71 (1H × 3/5,
m), 4.87 (1H × 2/5, t, J = 3.9 Hz), 5.11 (1H × 3/5,
t, J = 3.6 Hz), 6.17 (1H × 3/5, d, J = 8.6 Hz), 6.42
(1H × 2/5, d, J = 8.0 Hz), 6.95-7.13 (2H, m), 7.24
-7.68 (15H, m); IR (KBr) 3304, 1634 cm -1 ; Anal.Ca
lcd for C 29 H 23 F 4 NO 2 : C, 70.58; H, 4.70; N, 2.84. Fo
und: C, 70.53; H, 4.72; N, 2.72.
【0153】実施例21 N-[2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-3-ピリジンカルボキサミド 1) N-[2-(4-フルオロフェニル)-2-オキソ-1
-[[4-(トリフルオロメチル)フェニル]メチル]エ
チル]-3-ピリジンカルボキサミド 実施例1の4)と同様にして、目的物0.74g(62
%)を結晶として得た。 mp 137-138℃; 1H-NMR (CDCl3, 200MHz) δ 3.23 (1H,
dd, J = 5.0 Hz, 13.8 Hz), 3.49 (1H, dd, J = 6.6 H
z, 14.0 Hz), 5.98-6.07 (1H, m), 7.06-7.26 (5H, m),
7.37-7.43 (1H, m), 7.47 (2H, d, J = 8.4 Hz), 7.98
-8.11 (3H, m), 8.76 (1H, dd, J = 1.8 Hz, 4.8 Hz),
9.00 (1H, dd, J = 0.8 Hz, 2.2 Hz); IR (KBr) 3287,
1694, 1661 cm-1; Anal. Calcd for C22H16F4N2O2: C,
63.46; H, 3.87; N, 6.73. Found: C, 63.19; H, 4.03;
N, 6.68. 2) N-[2-(4-フルオロフェニル)-2-ヒドロキ
シ-1-[[4-(トリフルオロメチル)フェニル]メチ
ル]エチル]-3-ピリジンカルボキサミド 実施例1の5)と同様にして、目的物0.43g(86
%、(1RS,2SR)体/(1RS,2RS)体=5
/2)を結晶として得た。 mp 160-165℃; 1H-NMR (CDCl3, 200MHz) δ 2.95 (2H×
5/7, br s), 3.10 (1H×2/7, br s), 3.16 (2H×2/7,
d, J = 7.0 Hz), 3.35 (1H×5/7, br s), 4.43-4.75 (1
H, m), 4.86 (1H×2/7, br s), 5.10 (1H×5/7, br s),
6.25 (1H×5/7, br d, J = 8.6 Hz), 6.48 (1H×2/7,
br d, J = 8.8 Hz), 6.95-7.16 (2H, m), 7.21-7.62 (7
H, m), 7.87-7.95 (1H, m), 8.66-8.80 (2H, m); IR (K
Br) 3324, 3142, 1644 cm-1; Anal. Calcd for C22H18F
4N2O2: C, 63.16; H, 4.34; N, 6.70. Found: C, 62.9
7; H, 4.24; N, 6.51.Example 21 N- [2- (4-fluorophenyl) -2-hydroxy-1-
[[4- (Trifluoromethyl) phenyl] methyl] ethyl] -3-pyridinecarboxamide 1) N- [2- (4-Fluorophenyl) -2-oxo-1
-[[4- (Trifluoromethyl) phenyl] methyl] ethyl] -3-pyridinecarboxamide In the same manner as in Example 1, 4), 0.74 g of the desired product (62
%) As crystals. mp 137-138 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 3.23 (1H,
dd, J = 5.0 Hz, 13.8 Hz), 3.49 (1H, dd, J = 6.6 H
z, 14.0 Hz), 5.98-6.07 (1H, m), 7.06-7.26 (5H, m),
7.37-7.43 (1H, m), 7.47 (2H, d, J = 8.4 Hz), 7.98
-8.11 (3H, m), 8.76 (1H, dd, J = 1.8 Hz, 4.8 Hz),
9.00 (1H, dd, J = 0.8 Hz, 2.2 Hz); IR (KBr) 3287,
1694, 1661 cm -1 ; Anal.Calcd for C 22 H 16 F 4 N 2 O 2 : C,
63.46; H, 3.87; N, 6.73. Found: C, 63.19; H, 4.03;
N, 6.68.2) N- [2- (4-fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] -3-pyridinecarboxamide Example 1-5) 0.43 g (86
%, (1RS, 2RS) / (1RS, 2RS) = 5
/ 2) were obtained as crystals. mp 160-165 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.95 (2H ×
5/7, br s), 3.10 (1H × 2/7, br s), 3.16 (2H × 2/7,
d, J = 7.0 Hz), 3.35 (1H × 5/7, br s), 4.43-4.75 (1
H, m), 4.86 (1H × 2/7, br s), 5.10 (1H × 5/7, br s),
6.25 (1H × 5/7, br d, J = 8.6 Hz), 6.48 (1H × 2/7,
br d, J = 8.8 Hz), 6.95-7.16 (2H, m), 7.21-7.62 (7
H, m), 7.87-7.95 (1H, m), 8.66-8.80 (2H, m); IR (K
Br) 3324, 3142, 1644 cm -1 ; Anal.Calcd for C 22 H 18 F
4 N 2 O 2 : C, 63.16; H, 4.34; N, 6.70. Found: C, 62.9
7; H, 4.24; N, 6.51.
【0154】実施例22 N-(2-(4-フルオロフェニル)-2-ヒドロキシ-1-
((4-(トリフルオロメチル)フェニル)メチル)エ
チル)-4-オキソ-4H-ピラン-2-カルボキサミドおよ
び N-(2-(4-フルオロフェニル)-2-ヒドロキシ-1-
((4-(トリフルオロメチル)フェニル)メチル)エ
チル)-4-ヒドロキシテトラヒドロ-2H-ピラン-2-カ
ルボキサミド 1) 1-(4-フルオロフェニル)-1-オキソ-3-(4
-(トリフルオロメチル)フェニル)-2-プロピルアミ
ン塩酸塩(600mg,1.73ミリモル)と4-オキ
ソ-4H-ピラン-2-カルボン酸(266mg,1.90
ミリモル)のN,N-ジメチルホルムアミド(10m
l)溶液に1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(496mg,2.59ミ
リモル)と1-ヒドロキシ-1H-ベンゾトリアゾール
(396mg,2.59ミリモル)と1,8-ジアザビ
シクロ[5.4.0]-7-ウンデセン(0.28ml,
1.90ミリモル)を加えて終夜攪拌した。反応液に1
規定塩酸水溶液(10ml)と水(100ml)を加
え、酢酸エチル(50ml×2)で抽出した。抽出液を
1規定水酸化ナトリウム水溶液および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(酢酸エチ
ル)で精製し、酢酸エチル−ヘキサンから再結晶させ
て、N-(2-(4-フルオロフェニル)-2-オキソ-1-
((4-(トリフルオロメチル)フェニル)メチル)エ
チル)-4-オキソ-4H-ピラン-2-カルボキサミド(5
70mg,76%)を得た。 mp 115-116℃ IRν maxKBrcm-1: 1661, 1620, 1597, 1510, 1412. Anal. Calcd for C22H15F4NO4・0.1H2O: C, 60.72; H,
3.52; N, 3.22 Found: C, 60.60; H, 3.55; N, 3.24.1 H-NMR (CDCl3)δ: 3.23 (1H, dd, J = 14.0, 5.2 Hz),
3.43 (1H, dd, J = 14.0, 5.2 Hz), 5.93 (1H, q, J =
6.4 Hz), 6.44 (1H, dd, J = 5.8, 2.6 Hz), 7.07 (2
H, d, J = 8.0 Hz), 7.10-7.26 (2H, m), 7.48 (2H, d,
J = 8.0 Hz), 7.59 (1H, d, J = 7.4 Hz), 7.77 (1H,
d, J = 6.0 Hz), 7.92-8.06 (2H, m). 2) N-(2-(4-フルオロフェニル)-2-オキソ-1
-((4-(トリフルオロメチル)フェニル)メチル)エ
チル)-4-オキソ-4H-ピラン-2-カルボキサミド(4
00mg,0.92ミリモル)のメタノール(30m
l)溶液に塩化マンガン(II)(232mg,1.8
5ミリモル)を加え、室温で30分攪拌した。反応液に
氷冷下、水素化ホウ素ナトリウム(70mg,1.85
ミリモル)を加え、1時間攪拌した。反応液を1規定塩
酸(30ml)に注ぎ、酢酸エチル(50ml×2)で
抽出した。抽出液を水および飽和食塩水で洗浄し、無水
硫酸マグネシウムで乾燥後減圧留去した。残留物をシリ
カゲルカラムクロマトグラフィー(酢酸エチル)で精製
し、高極性のフラクションを集めて濃縮し、得られた粗
結晶をヘキサンで洗浄して、N-(2-(4-フルオロフ
ェニル)-2-ヒドロキシ-1-((4-(トリフルオロメ
チル)フェニル)メチル)エチル)-4-オキソ-4H-ピ
ラン-2-カルボキサミド((1RS,2SR)体:(1
RS,2RS)体=3:2,139mg,35%)を得
た。 IRν maxKBrcm-1: 1659, 1607, 1512, 1416. Anal. Calcd for C22H17F4NO4・0.1H2O: C, 60.44; H,
3.97; N, 3.20 Found: C, 61.24; H, 3.93; N, 3.03.1 H-NMR (CDCl3)δ: 2.60-2.82 (1H, m), 2.90-2.96 (1
H, m), 3.04-3.20 (1H, m), 4.40-4.70 (1H, m), 4.78-
4.84 (2/5H, m), 5.02-5.10 (3/5H, m), 6.36-6.42 (1
H, m), 6.70-7.80 (11H, m). また同時に低極性のフラクションを集めて濃縮し、N-
(2-(4-フルオロフェニル)-2-ヒドロキシ-1-
((4-(トリフルオロメチル)フェニル)メチル)エ
チル)-4-ヒドロキシテトラヒドロ-2H-ピラン-2-カ
ルボキサミド((1RS,2SR)体:(1RS,2R
S)体=7:3,139mg,35%)をアモルファス
として得た。 IRν maxKBrcm-1: 1645, 1510. Anal. Calcd for C22H23F4NO4: C, 59.86; H, 5.25; N,
3.17 Found: C, 60.02; H, 5.01; N, 3.04.1 H-NMR (CDCl3)δ: 1.70-2.00 (3H, m), 2.70-3.40 (3
H, m), 3.70-4.60 (4H, m), 4.68-4.78 (0.3H, m), 4.9
2-5.04 (0.7H, m), 6.00 (0.3H, d, J = 4.8 Hz),6.05
(0.7H, d, J = 4.6 Hz), 4.58-6.70 (0.7H, m), 6.76-
6.90 (0.3H, m), 6.95-7.60 (8H, m).Example 22 N- (2- (4-Fluorophenyl) -2-hydroxy-1-
((4- (trifluoromethyl) phenyl) methyl) ethyl) -4-oxo-4H-pyran-2-carboxamide and N- (2- (4-fluorophenyl) -2-hydroxy-1-
((4- (trifluoromethyl) phenyl) methyl) ethyl) -4-hydroxytetrahydro-2H-pyran-2-carboxamide 1) 1- (4-fluorophenyl) -1-oxo-3- (4
-(Trifluoromethyl) phenyl) -2-propylamine hydrochloride (600 mg, 1.73 mmol) and 4-oxo-4H-pyran-2-carboxylic acid (266 mg, 1.90)
Mmol) N, N-dimethylformamide (10 m
1) 1-Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (496 mg, 2.59 mmol), 1-hydroxy-1H-benzotriazole (396 mg, 2.59 mmol) and 1,8 -Diazabicyclo [5.4.0] -7-undecene (0.28 ml,
(1.90 mmol) and stirred overnight. 1 in the reaction solution
A normal hydrochloric acid aqueous solution (10 ml) and water (100 ml) were added, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed with a 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to give N- (2- (4-fluorophenyl) -2-oxo-1-oxo.
((4- (trifluoromethyl) phenyl) methyl) ethyl) -4-oxo-4H-pyran-2-carboxamide (5
70 mg, 76%). mp 115-116 ℃ IRν max KBr cm -1 : 1661, 1620, 1597, 1510, 1412. Anal.Calcd for C 22 H 15 F 4 NO 4・ 0.1H 2 O: C, 60.72; H,
3.52; N, 3.22 Found:. C, 60.60; H, 3.55; N, 3.24 1 H-NMR (CDCl 3) δ: 3.23 (1H, dd, J = 14.0, 5.2 Hz),
3.43 (1H, dd, J = 14.0, 5.2 Hz), 5.93 (1H, q, J =
6.4 Hz), 6.44 (1H, dd, J = 5.8, 2.6 Hz), 7.07 (2
H, d, J = 8.0 Hz), 7.10-7.26 (2H, m), 7.48 (2H, d,
J = 8.0 Hz), 7.59 (1H, d, J = 7.4 Hz), 7.77 (1H,
d, J = 6.0 Hz), 7.92-8.06 (2H, m). 2) N- (2- (4-fluorophenyl) -2-oxo-1
-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4-oxo-4H-pyran-2-carboxamide (4
00 mg, 0.92 mmol) of methanol (30 m
l) Manganese (II) chloride (232 mg, 1.8) was added to the solution.
5 mmol) and stirred at room temperature for 30 minutes. Sodium borohydride (70 mg, 1.85
Mmol) and stirred for 1 hour. The reaction solution was poured into 1N hydrochloric acid (30 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate), the highly polar fraction was collected and concentrated, and the obtained crude crystals were washed with hexane to give N- (2- (4-fluorophenyl) -2 -Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4-oxo-4H-pyran-2-carboxamide ((1RS, 2SR) form: (1
(RS, 2RS) form = 3: 2, 139 mg, 35%). IRν max KBr cm -1 : 1659, 1607, 1512, 1416. Anal.Calcd for C 22 H 17 F 4 NO 4・ 0.1H 2 O: C, 60.44; H,
3.97; N, 3.20 Found:. C, 61.24; H, 3.93; N, 3.03 1 H-NMR (CDCl 3) δ: 2.60-2.82 (1H, m), 2.90-2.96 (1
H, m), 3.04-3.20 (1H, m), 4.40-4.70 (1H, m), 4.78-
4.84 (2 / 5H, m), 5.02-5.10 (3 / 5H, m), 6.36-6.42 (1
H, m), 6.70-7.80 (11H, m). At the same time, low-polarity fractions were collected and concentrated, and N-
(2- (4-fluorophenyl) -2-hydroxy-1-
((4- (trifluoromethyl) phenyl) methyl) ethyl) -4-hydroxytetrahydro-2H-pyran-2-carboxamide ((1RS, 2SR) form: (1RS, 2R
S) form = 7: 3, 139 mg, 35%) was obtained as amorphous. IRν max KBr cm -1 : 1645, 1510.Anal.Calcd for C 22 H 23 F 4 NO 4 : C, 59.86; H, 5.25; N,
3.17 Found:. C, 60.02; H, 5.01; N, 3.04 1 H-NMR (CDCl 3) δ: 1.70-2.00 (3H, m), 2.70-3.40 (3
H, m), 3.70-4.60 (4H, m), 4.68-4.78 (0.3H, m), 4.9
2-5.04 (0.7H, m), 6.00 (0.3H, d, J = 4.8 Hz), 6.05
(0.7H, d, J = 4.6 Hz), 4.58-6.70 (0.7H, m), 6.76-
6.90 (0.3H, m), 6.95-7.60 (8H, m).
【0155】実施例23 4-フルオロ-N-[2-(4-フルオロフェニル)-2-ヒ
ドロキシ-1-[[4-(トリフルオロメチル)フェニ
ル]メチル]エチル]ベンゼンスルホンアミド 1) 4-フルオロ-N-[2-(4-フルオロフェニル)-
2-オキソ-1-[[4-(トリフルオロメチル)フェニ
ル]メチル]エチル]ベンゼンスルホンアミド 2-(4-フルオロフェニル)-2-オキソ-1-[[4-
(トリフルオロメチル)フェニル]メチル]エチルアミ
ン・塩酸塩1.0g(2.88ミリモル)のN,N-ジ
メチルホルムアミド10ml溶液に4-フルオロベンゼ
ンスルホニルクロリド0.84g(4.32ミリモル)
と1,8-ジアザビシクロ[5.4.0]-7-ウンデセ
ン1.3ml(8.64ミリモル)を加え4時間撹拌し
た。反応液を酢酸エチルで抽出し、抽出液を水、飽和食
塩水で順次洗浄した後硫酸マグネシウムで乾燥し、減圧
下濃縮した。残留物を酢酸エチル−ヘキサンから再結晶
して目的物1.02g(76%)を結晶として得た。 mp 209-210℃; 1H-NMR (CDCl3, 200MHz) δ 2.96 (1H,
dd, J =6.6 Hz, 14.0 Hz), 3.20 (1H, dd, J =5.6 Hz,
14.6 Hz), 5.05-5.18 (1H, m), 5.62 (1H, br d,J =6.4
Hz), 7.00 (2H, t, J =8.6 Hz), 7.04-7.20 (4H, m),
7.45 (2H, d, J=8.0 Hz), 7.65-7.72 (2H, m), 7.77-7.
84 (2H, m); IR (KBr) 3229, 1676, 1595 cm-1; Anal.
Calcd for C22H16F5NO3S: C, 56.29; H, 3.44; N, 2.9
8. Found:C, 56.15; H, 3.46; N, 3.26. 2) 4-フルオロ-N-[2-(4-フルオロフェニル)-
2-ヒドロキシ-1-[[4-(トリフルオロメチル)フェ
ニル]メチル]エチル]ベンゼンスルホンアミド 4-フルオロ-N-[2-(4-フルオロフェニル)-2-オ
キソ-1-[[4-(トリフルオロメチル)フェニル]メ
チル]エチル]ベンゼンスルホンアミド0.5g(1.
07ミリモル)のメタノール5ml溶液に氷冷下で水素
化ホウ素ナトリウム45mg(1.19ミリモル)を加
え1時間撹拌した。反応溶液に1N塩酸を加えた後室温
で10分間撹拌した。反応液を酢酸エチルで抽出し、抽
出液を水、飽和食塩水で順次洗浄した後硫酸マグネシウ
ムで乾燥し、減圧下濃縮した。残留物をシリカゲルカラ
ムクロマトグラフィー(酢酸エチル/ヘキサン=1/
2)により精製して目的物0.45g(89%、異性体
の1/3混合物)を結晶として得た。 mp 141-161℃; 1H-NMR (CDCl3, 200MHz) δ 2.30 (3/4
H, d, J =3.4 Hz), 2.52-2.79 (6/4H, m), 3.13 (3/4H,
dd, J =7.0 Hz, 14.0 Hz), 3.59 (1H, ddd, J =3.6 H
z, 7.4 Hz, 15.8 Hz), 4.75-4.83 (7/4H, m), 5.08-5.1
3 (1/4H, m), 6.83-7.00 (4H, m), 7.04-7.22 (4H, m),
7.29-7.49 (4H, m); IR (KBr) 3482, 3293cm-1 Example 23 4-Fluoro-N- [2- (4-fluorophenyl) -2-hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] benzenesulfonamide 1) 4- Fluoro-N- [2- (4-fluorophenyl)-
2-oxo-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] benzenesulfonamide 2- (4-fluorophenyl) -2-oxo-1-[[4-
0.84 g (4.32 mmol) of 4-fluorobenzenesulfonyl chloride in a solution of 1.0 g (2.88 mmol) of (trifluoromethyl) phenyl] methyl] ethylamine hydrochloride in 10 ml of N, N-dimethylformamide
And 1.3 ml (8.64 mmol) of 1,8-diazabicyclo [5.4.0] -7-undecene were added and stirred for 4 hours. The reaction solution was extracted with ethyl acetate, and the extract was washed with water and saturated brine in that order, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give 1.02 g (76%) of the desired product as crystals. mp 209-210 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 2.96 (1H,
dd, J = 6.6 Hz, 14.0 Hz), 3.20 (1H, dd, J = 5.6 Hz,
14.6 Hz), 5.05-5.18 (1H, m), 5.62 (1H, br d, J = 6.4
Hz), 7.00 (2H, t, J = 8.6 Hz), 7.04-7.20 (4H, m),
7.45 (2H, d, J = 8.0 Hz), 7.65-7.72 (2H, m), 7.77-7.
84 (2H, m); IR (KBr) 3229, 1676, 1595 cm -1 ; Anal.
Calcd for C 22 H 16 F 5 NO 3 S: C, 56.29; H, 3.44; N, 2.9
8. Found: C, 56.15; H, 3.46; N, 3.26. 2) 4-Fluoro-N- [2- (4-fluorophenyl)-
2-hydroxy-1-[[4- (trifluoromethyl) phenyl] methyl] ethyl] benzenesulfonamide 4-fluoro-N- [2- (4-fluorophenyl) -2-oxo-1-[[4- 0.5 g of (trifluoromethyl) phenyl] methyl] ethyl] benzenesulfonamide (1.
Sodium borohydride (45 mg, 1.19 mmol) was added to a methanol (5 ml) solution under ice-cooling, and the mixture was stirred for 1 hour. After adding 1N hydrochloric acid to the reaction solution, the mixture was stirred at room temperature for 10 minutes. The reaction solution was extracted with ethyl acetate, and the extract was washed with water and saturated brine in that order, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (ethyl acetate / hexane = 1 /
Purification by 2) gave 0.45 g of the desired product (89%, 1/3 mixture of isomers) as crystals. mp 141-161 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 2.30 (3/4
H, d, J = 3.4 Hz), 2.52-2.79 (6 / 4H, m), 3.13 (3 / 4H,
dd, J = 7.0 Hz, 14.0 Hz), 3.59 (1H, ddd, J = 3.6 H
z, 7.4 Hz, 15.8 Hz), 4.75-4.83 (7 / 4H, m), 5.08-5.1
3 (1 / 4H, m), 6.83-7.00 (4H, m), 7.04-7.22 (4H, m),
7.29-7.49 (4H, m); IR (KBr) 3482, 3293cm -1
【0156】実施例24 1,1-ジメチルエチル(1RS,2RS)-2-(4-フ
ルオロフェニル)-2-ヒドロキシ-1-((4-(トリフ
ルオロメチル)フェニル)メチル)エチルカルバメート 1) 4’-フルオロアセトフェノン(57.8g,
0.307モル)とエタノール(1ml)の炭酸ジエチ
ル(300ml)溶液に水素化ナトリウム(24.5
g,60%油性,0.63モル)を少しずつ加えた。徐
々に発熱するので、氷冷し、その後室温で2時間攪拌し
た。反応液に6規定塩酸を加えクエンチし、水(300
ml)を加え、酢酸エチルで抽出した。抽出液を水洗
後、無水硫酸マグネシウムで乾燥し、減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=50:1−5:1)で精製し、3-
(4-フルオロフェニル)-3-オキソプロピオン酸エチ
ル(71.2g,89%)を得た。 IRν maxKBrcm-1: 1744, 1696, 1431, 1325, 1202, 113
2, 1069, 1017, 853.1 H-NMR (CDCl3)δ: 1.28 (3H × 0.62, t, J = 7.8 H
z), 1.37 (3H × 0.38, t,J = 7.8 Hz), 4.04 (2H ×
0.62, s), 4.25 (2H × 0.62, q, J = 7.8 Hz), 4.31
(2H × 0.38, q, J = 7.8 Hz), 5.75 (1H × 0.38, s),
7.28 (1H × 0.62,s), 7.70 (2H × 0.38, d, J = 8.0
Hz), 7.78 (2H × 0.62, d, J = 8.0 Hz),7.90 (2H ×
0.38, d, J = 8.0 Hz), 8.08 (2H × 0.62, d, J = 8.
0 Hz). 2) 3-(4-フルオロフェニル)-3-オキソプロピオ
ン酸エチル(34.7g,115.5ミリモル)のアセ
トニトリル(300ml)溶液に4-トリフルオロメチ
ルベンジルブロミド(27.6g,115.5ミリモ
ル)および炭酸カリウム(31.9g,231ミリモ
ル)を加え、室温にて4時間攪拌した。反応液を水(1
L)で希釈し、酢酸エチル(500ml×2)で抽出し
た。抽出液を水および飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物にヘキサンを
加え、析出した結晶をヘキサンで洗浄して、3-(4-フ
ルオロフェニル)-3-オキソ-2-((4-(トリフルオ
ロメチル)フェニル)メチル)プロピオン酸エチル(3
1g,76%)を得た。 mp 56-57℃ IRν maxKBrcm-1: 1738, 1688, 1618, 1599, 1508. Anal. Calcd for C19H16F4O3: C, 61.96; H, 4.38 Found: C, 61.90; H, 4.43.1 H-NMR (CDCl3)δ: 1.16 (3H, t, J = 6.8 Hz), 3.38
(2H, d, J = 7.6 Hz), 4.14 (2H, q, J = 6.8 Hz), 4.5
8 (1H, t, J = 7.6 Hz), 7.04-7.20 (2H, m), 7.35 (2
H, d, J = 8.0 Hz), 7.52 (2H, d, J = 8.0 Hz), 7.92-
8.08 (2H, m). 3) 3-(4-フルオロフェニル)-3-オキソ-2-
((4-(トリフルオロメチル)フェニル)メチル)プ
ロピオン酸エチル(6g,16.3ミリモル)のメタノ
ール(100ml)溶液に氷冷下、水素化ホウ素ナトリ
ウム(640mg,16.9ミリモル)を加え、20分
攪拌した。反応液を1規定塩酸(50ml)に注ぎ、酢
酸エチル(100ml×2)で抽出した。抽出液を水お
よび飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=4:1)で精製し、
(2RS,3SR)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-((4-(トリフルオロメチル)フェニ
ル)メチル)プロピオン酸エチル(5.1g,84%)
を無色油状物として得た。 IRν maxKBrcm-1: 1728, 1607, 1510. Anal. Calcd for C19H18F4O3: C, 61.62; H, 4.90 Found: C, 61.52; H, 4.88.1 H-NMR (CDCl3)δ: 0.99 (3H, t, J = 7.4 Hz), 2.70-
3.10 (3H, m), 3.13 (1H,d, J = 6.2 Hz), 3.99 (2H,
q, J = 7.4 Hz), 4.76-4.86 (1H, m), 6.98-7.16(2H,
m), 7.20-7.40 (4H, m), 7.52 (2H, d, J = 8.0 Hz). 4) (2RS,3SR)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸エチル(4.85
g,13.1ミリモル)のメタノール(20ml)溶液
に1規定水酸化ナトリウム水溶液(13.1ml,1
3.1ミリモル)を加え、室温で6時間攪拌した。反応
液を減圧留去後、1規定塩酸(50ml)で希釈し、酢
酸エチル(100ml×2)で抽出した。抽出液を水お
よび飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去し、酢酸エチル−ヘキサンから再結晶させ
て、(2RS,3SR)-3-(4-フルオロフェニル)-
3-ヒドロキシ-2-((4-(トリフルオロメチル)フェ
ニル)メチル)プロピオン酸(3.8g,84%)を得
た。 mp 136-139℃; 1H-NMR (CDCl3, 200M Hz)δ2.75 (1H, d
d, J = 5.8 Hz, 13.4 Hz), 2.95 (1H, dd, J = 9.2 Hz,
13.2 Hz), 3.08 (2H, d, J = 8.0 Hz), 4.82 (1H, d,
J = 7.0 Hz), 7.08 (2H, t, J = 8.8 Hz), 7.22 (2H,
d, J = 8.0 Hz), 7.34 (2H, dd, J = 5.3 Hz, 8.8 Hz);
IR (KBr)3351, 3500-2400, 1713cm-1; Anal. Calcd fo
r C17H14F4O3: C, 59.65; H, 4.12.Found: C, 59.52;
H, 4.17. 5) (2RS,3SR)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸(3.75g,1
1.0ミリモル)のテトラヒドロフラン(70ml)溶
液にジフェニルホスホリルアジド(2.6ml,12.
1ミリモル)およびトリエチルアミン(2.30ml,
16.4ミリモル)を加えて3時間加熱還流した。反応
液を水(300ml)で希釈し、酢酸エチル(200m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=2:1−1:1)で精製し、酢酸エチル−ヘキサ
ンから再結晶させて、(4RS,5RS)-5-(4-フ
ルオロフェニル)-4-((4-(トリフルオロメチル)
フェニル)メチル)-1,3-オキサゾリジン-2-オン
(3.28g,88%)を得た。 mp 83-84℃ IRν maxKBrcm-1: 1755, 1609, 1514, 1420, 1387. Anal. Calcd for C17H13F4NO2: C, 60.18; H, 3.86; N,
4.13 Found: C, 60.08; H, 3.56; N, 4.10.1 H-NMR (CDCl3)δ: 2.90-3.16 (2H, m), 3.95 (1H, dd,
J = 12.8, 6.2 Hz), 5.19 (1H, d, J = 6.2 Hz), 5.73
(1H, brs), 7.00-7.12 (2H, m), 7.12-7.40 (4H, m),
7.60 (2H, d, J = 8.0 Hz). 6) (4RS,5RS)-5-(4-フルオロフェニ
ル)-4-((4-(トリフルオロメチル)フェニル)メ
チル)-1,3-オキサゾリジン-2-オン(3.19g,
9.41ミリモル)のアセトニトリル(30ml)溶液
に二炭酸ジ-t-ブチル(2.46g,11.29ミリモ
ル)および4-ジメチルアミノピリジン(114mg,
0.94ミリモル)を加えて室温で1時間攪拌した。反
応液を水(100ml)で希釈し、酢酸エチル(100
ml×2)で抽出した。抽出液を飽和食塩水で洗浄し、
無水硫酸マグネシウムで乾燥後減圧留去し、酢酸エチル
−ヘキサンから再結晶させて、(4RS,5RS)-5-
(4-フルオロフェニル)-2-オキソ-4-((4-(トリ
フルオロメチル)フェニル)メチル)-1,3-オキサゾ
リジン-3-カルボン酸1,1-ジメチルエチル(3.8
4g,93%)を得た。 mp 126-127℃ IRν maxKBrcm-1: 1817, 1724, 1514, 1325. Anal. Calcd for C22H21F4NO4: C, 60.14; H, 4.82; N,
3.19 Found: C, 60.05; H, 5.12; N, 3.11.1 H-NMR (CDCl3)δ: 1.58 (9H, s), 3.01 (1H, dd, J =
13.2, 9.8 Hz), 3.51 (1H, dd, J = 13.2, 3.6 Hz), 4.
26-4.38 (1H, m), 5.13 (1H, d, J = 2.6 Hz), 6.80-7.
04 (4H, m), 7.38 (2H, d, J = 8.0 Hz), 7.65 (2H, d,
J = 8.0 Hz). 7) (4RS,5RS)-5-(4-フルオロフェニ
ル)-2-オキソ-4-((4-(トリフルオロメチル)フ
ェニル)メチル)-1,3-オキサゾリジン-3-カルボン
酸1,1-ジメチルエチル(3.7g,8.42ミリモ
ル)のメタノール(20ml)溶液に水酸化ナトリウム
(0.40g,10.10ミリモル)のメタノール(2
0ml)溶液を氷冷下、徐々に加えた。反応液を1時間
攪拌後、1規定塩酸(15ml)および水(100m
l)で希釈し、酢酸エチル(100ml×2)で抽出し
た。抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去し、残留物をシリカゲルカラムクロ
マトグラフィー(ヘキサン:酢酸エチル=4:1)で精
製し、酢酸エチル−ヘキサンから再結晶させて、表題化
合物(2.24g,64%)を得た。 mp 95-96℃ IRν maxKBrcm-1: 1688, 1510. Anal. Calcd for C21H23F4NO3: C, 61.01; H, 5.61; N,
3.39 Found: C, 60.92; H, 5.55; N, 3.28.1 H-NMR (CDCl3)δ: 1.31 (9H, s), 2.80-3.10 (3H, m),
3.80-4.02 (1H, m), 4.62-4.80 (2H, m), 6.96-7.10
(2H, m), 7.22-7.40 (4H, m), 7.55 (2H, d, J =8.2 H
z).Example 24 1,1-Dimethylethyl (1RS, 2RS) -2- (4-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl carbamate 1) 4'-fluoroacetophenone (57.8 g,
Sodium hydride (24.5) in a solution of 0.307 mol) and ethanol (1 ml) in diethyl carbonate (300 ml).
g, 60% oily, 0.63 mol). Since heat was gradually generated, the mixture was cooled on ice and then stirred at room temperature for 2 hours. The reaction solution is quenched by adding 6N hydrochloric acid, and the solution is treated with water (300
ml) and extracted with ethyl acetate. The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 50: 1-5: 1),
Ethyl (4-fluorophenyl) -3-oxopropionate (71.2 g, 89%) was obtained. IRν max KBr cm -1 : 1744, 1696, 1431, 1325, 1202, 113
2, 1069, 1017, 853. 1 H-NMR (CDCl 3) δ: 1.28 (3H × 0.62, t, J = 7.8 H
z), 1.37 (3H × 0.38, t, J = 7.8 Hz), 4.04 (2H ×
0.62, s), 4.25 (2H × 0.62, q, J = 7.8 Hz), 4.31
(2H × 0.38, q, J = 7.8 Hz), 5.75 (1H × 0.38, s),
7.28 (1H × 0.62, s), 7.70 (2H × 0.38, d, J = 8.0
Hz), 7.78 (2H × 0.62, d, J = 8.0 Hz), 7.90 (2H ×
0.38, d, J = 8.0 Hz), 8.08 (2H × 0.62, d, J = 8.
0 Hz). 2) To a solution of ethyl 3- (4-fluorophenyl) -3-oxopropionate (34.7 g, 115.5 mmol) in acetonitrile (300 ml) was added 4-trifluoromethylbenzylbromide (27.6 g, 115.5 mmol) and potassium carbonate (31.9 g, 231 mmol) were added, and the mixture was stirred at room temperature for 4 hours. The reaction solution was washed with water (1
L) and extracted with ethyl acetate (500 ml x 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. Hexane was added to the residue, and the precipitated crystals were washed with hexane and washed with ethyl 3- (4-fluorophenyl) -3-oxo-2-((4- (trifluoromethyl) phenyl) methyl) propionate (3
1 g, 76%). mp 56-57 ℃ IRν max KBr cm -1 : 1738, 1688, 1618, 1599, 1508. Anal.Calcd for C 19 H 16 F 4 O 3 : C, 61.96; H, 4.38 Found: C, 61.90; H, 4.43. 1 H-NMR (CDCl 3 ) δ: 1.16 (3H, t, J = 6.8 Hz), 3.38
(2H, d, J = 7.6 Hz), 4.14 (2H, q, J = 6.8 Hz), 4.5
8 (1H, t, J = 7.6 Hz), 7.04-7.20 (2H, m), 7.35 (2
H, d, J = 8.0 Hz), 7.52 (2H, d, J = 8.0 Hz), 7.92-
8.08 (2H, m). 3) 3- (4-Fluorophenyl) -3-oxo-2-
To a solution of ethyl ((4- (trifluoromethyl) phenyl) methyl) propionate (6 g, 16.3 mmol) in methanol (100 ml) was added sodium borohydride (640 mg, 16.9 mmol) under ice-cooling. Stirred for 20 minutes. The reaction solution was poured into 1N hydrochloric acid (50 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1),
(2RS, 3SR) -3- (4-fluorophenyl) -3-
Ethyl hydroxy-2-((4- (trifluoromethyl) phenyl) methyl) propionate (5.1 g, 84%)
Was obtained as a colorless oil. . IRν max KBr cm -1: 1728 , 1607, 1510. Anal Calcd for C 19 H 18 F 4 O 3: C, 61.62; H, 4.90 Found:. C, 61.52; H, 4.88 1 H-NMR (CDCl 3 ) δ: 0.99 (3H, t, J = 7.4 Hz), 2.70-
3.10 (3H, m), 3.13 (1H, d, J = 6.2 Hz), 3.99 (2H,
q, J = 7.4 Hz), 4.76-4.86 (1H, m), 6.98-7.16 (2H,
m), 7.20-7.40 (4H, m), 7.52 (2H, d, J = 8.0 Hz). 4) (2RS, 3SR) -3- (4-fluorophenyl) -3-hydroxy-2-((4 Ethyl-(trifluoromethyl) phenyl) methyl) propionate (4.85)
g, 13.1 mmol) in methanol (20 ml) was added to a 1 N aqueous sodium hydroxide solution (13.1 ml, 1
3.1 mmol) and stirred at room temperature for 6 hours. After evaporating the reaction solution under reduced pressure, the reaction solution was diluted with 1N hydrochloric acid (50 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, evaporated under reduced pressure, and recrystallized from ethyl acetate-hexane to give (2RS, 3SR) -3- (4-fluorophenyl)-
3-Hydroxy-2-((4- (trifluoromethyl) phenyl) methyl) propionic acid (3.8 g, 84%) was obtained. mp 136-139 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ2.75 (1H, d
d, J = 5.8 Hz, 13.4 Hz), 2.95 (1H, dd, J = 9.2 Hz,
13.2 Hz), 3.08 (2H, d, J = 8.0 Hz), 4.82 (1H, d,
J = 7.0 Hz), 7.08 (2H, t, J = 8.8 Hz), 7.22 (2H,
d, J = 8.0 Hz), 7.34 (2H, dd, J = 5.3 Hz, 8.8 Hz);
IR (KBr) 3351, 3500-2400, 1713cm -1 ; Anal.Calcd fo
r C 17 H 14 F 4 O 3 : C, 59.65; H, 4.12.Found: C, 59.52;
H, 4.17.5) (2RS, 3SR) -3- (4-fluorophenyl) -3-hydroxy-2-((4- (trifluoromethyl) phenyl) methyl) propionic acid (3.75 g, 1
1.0 mmol) in tetrahydrofuran (70 ml) in diphenylphosphoryl azide (2.6 ml, 12.
1 mmol) and triethylamine (2.30 ml,
(16.4 mmol) and heated under reflux for 3 hours. The reaction solution was diluted with water (300 ml), and ethyl acetate (200 m
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1-1: 1) and recrystallized from ethyl acetate-hexane to give (4RS, 5RS) -5- (4-fluorophenyl)- 4-((4- (trifluoromethyl)
Phenyl) methyl) -1,3-oxazolidine-2-one (3.28 g, 88%) was obtained. mp 83-84 ℃ IRν max KBr cm -1 : 1755, 1609, 1514, 1420, 1387. Anal.Calcd for C 17 H 13 F 4 NO 2 : C, 60.18; H, 3.86; N,
4.13 Found:. C, 60.08; H, 3.56; N, 4.10 1 H-NMR (CDCl 3) δ: 2.90-3.16 (2H, m), 3.95 (1H, dd,
J = 12.8, 6.2 Hz), 5.19 (1H, d, J = 6.2 Hz), 5.73
(1H, brs), 7.00-7.12 (2H, m), 7.12-7.40 (4H, m),
7.60 (2H, d, J = 8.0 Hz). 6) (4RS, 5RS) -5- (4-fluorophenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine -2-one (3.19g,
Di-tert-butyl dicarbonate (2.46 g, 11.29 mmol) and 4-dimethylaminopyridine (114 mg, 9.41 mmol) in acetonitrile (30 ml) solution.
(0.94 mmol) and stirred at room temperature for 1 hour. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
ml × 2). Wash the extract with saturated saline,
After drying over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, recrystallized from ethyl acetate-hexane, and (4RS, 5RS) -5-
1,4-dimethylethyl (4-fluorophenyl) -2-oxo-4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-3-carboxylate (3.8
4 g, 93%). mp 126-127 ° C IRν max KBr cm -1 : 1817, 1724, 1514, 1325. Anal.Calcd for C 22 H 21 F 4 NO 4 : C, 60.14; H, 4.82; N,
3.19 Found: C, 60.05; H, 5.12; N, 3.11. 1 H-NMR (CDCl 3 ) δ: 1.58 (9H, s), 3.01 (1H, dd, J =
13.2, 9.8 Hz), 3.51 (1H, dd, J = 13.2, 3.6 Hz), 4.
26-4.38 (1H, m), 5.13 (1H, d, J = 2.6 Hz), 6.80-7.
04 (4H, m), 7.38 (2H, d, J = 8.0 Hz), 7.65 (2H, d,
J = 8.0 Hz). 7) (4RS, 5RS) -5- (4-fluorophenyl) -2-oxo-4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-3 To a solution of 1,1-dimethylethyl-carboxylate (3.7 g, 8.42 mmol) in methanol (20 ml) was added sodium hydroxide (0.40 g, 10.10 mmol) in methanol (2 g).
0 ml) solution was gradually added under ice-cooling. After stirring the reaction solution for 1 hour, 1N hydrochloric acid (15 ml) and water (100 m
1) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1), and recrystallized from ethyl acetate-hexane. The title compound (2.24 g, 64%) was obtained. mp 95-96 ℃ IRν max KBr cm -1 : 1688, 1510. Anal.Calcd for C 21 H 23 F 4 NO 3 : C, 61.01; H, 5.61; N,
3.39 Found:. C, 60.92; H, 5.55; N, 3.28 1 H-NMR (CDCl 3) δ: 1.31 (9H, s), 2.80-3.10 (3H, m),
3.80-4.02 (1H, m), 4.62-4.80 (2H, m), 6.96-7.10
(2H, m), 7.22-7.40 (4H, m), 7.55 (2H, d, J = 8.2 H
z).
【0157】実施例25 2-(エチルオキシ)-N-((1RS,2RS)-2-
(4-フルオロフェニル)-2-ヒドロキシ-1-((4-
(トリフルオロメチル)フェニル)メチル)エチル)-
1-ナフタレンカルボキサミド 1) 1-(4-フルオロフェニル)-1-オキソ-3-(4
-(トリフルオロメチル)フェニル)-2-プロピルアミ
ン塩酸塩(600mg,1.73ミリモル)と2-エチ
ルオキシ-1-ナフタレンカルボン酸(411mg,1.
90ミリモル)のN,N-ジメチルホルムアミド(10
ml)溶液に1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(496mg,2.59ミ
リモル)と1-ヒドロキシ-1H-ベンゾトリアゾール
(396mg,2.59ミリモル)と1,8-ジアザビ
シクロ[5.4.0]-7-ウンデセン(0.28ml,
1.90ミリモル)を加えて終夜攪拌した。反応液に1
規定塩酸水溶液(10ml)と水(100ml)を加
え、酢酸エチル(50ml×2)で抽出した。抽出液を
1規定水酸化ナトリウム水溶液および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去し、酢酸エ
チル−ヘキサンから再結晶させて、2-(エチルオキ
シ)-N-(2-(4-フルオロフェニル)-2-オキソ-1-
((4-(トリフルオロメチル)フェニル)メチル)エ
チル)-1-ナフタレンカルボキサミド(670mg,7
6%)を得た。 mp 188-189℃ IRν maxKBrcm-1: 1688, 1634, 1597, 1508, 1325. Anal. Calcd for C29H23F4NO3: C, 68.36; H, 4.55; N,
2.75 Found: C, 68.25; H, 4.58; N, 2.76.1 H-NMR (CDCl3)δ: 1, 24 (3H, t, J = 7.0 Hz), 3.20
(1H, dd, J = 14.0, 6.4Hz), 3.46 (1H, dd, J = 14.0,
6.4 Hz), 4.13 (2H, q, J = 7.0 Hz), 6.23 (1H, q, J
= 6.6 Hz), 6.96 (1H, d, J = 8.4 Hz), 7.10-7.56 (9
H, m), 7.60-7.80 (2H, m), 7.85 (1H, d, J = 9.0 H
z), 8.04-8.18 (2H, m). 2) 2-(エチルオキシ)-N-(2-(4-フルオロフ
ェニル)-2-オキソ-1-((4-(トリフルオロメチ
ル)フェニル)メチル)エチル)-1-ナフタレンカルボ
キサミド(400mg,0.79ミリモル)のメタノー
ル(30ml)溶液に塩化マンガン(II)(198m
g,1.57ミリモル)を加え、室温で30分攪拌し
た。反応液に氷冷下、水素化ホウ素ナトリウム(30m
g,0.79ミリモル)を加え、1時間攪拌した。反応
液を1規定塩酸(30ml)に注ぎ、酢酸エチル(50
ml×2)で抽出した。抽出液を水および飽和食塩水で
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去した。
残留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=2:1−1:1)で精製し、酢酸エチ
ル−ヘキサンから再結晶させて、表題化合物(227m
g,57%)を得た。 mp 186-187℃ IRν maxKBrcm-1: 1639, 1512, 1242, 1165. Anal. Calcd for C29H25F4NO3: C, 68.09; H, 4.93; N,
2.74 Found: C, 68.04; H, 4.79; N, 2.85.1 H-NMR (CDCl3)δ: 1.37 (3H, t, 6.8 Hz), 2.84-3.28
(2H, m), 3.34 (1H, d,J = 3.8 Hz), 4.08-4.26 (2H,
m), 4.60-4.84 (2H, m), 6.15 (1H, d, J = 8.6Hz), 6.
96-7.16 (3H, m), 7.20-7.50 (7H, m), 7.58 (2H, d, J
= 8.4 Hz), 7.76 (2H, dd, J = 18.2, 9.2 Hz).Example 25 2- (Ethyloxy) -N-((1RS, 2RS) -2-
(4-fluorophenyl) -2-hydroxy-1-((4-
(Trifluoromethyl) phenyl) methyl) ethyl)-
1-Naphthalenecarboxamide 1) 1- (4-Fluorophenyl) -1-oxo-3- (4
-(Trifluoromethyl) phenyl) -2-propylamine hydrochloride (600 mg, 1.73 mmol) and 2-ethyloxy-1-naphthalenecarboxylic acid (411 mg, 1.
90 mmol) of N, N-dimethylformamide (10
1) Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (496 mg, 2.59 mmol), 1-hydroxy-1H-benzotriazole (396 mg, 2.59 mmol) and 1,8 -Diazabicyclo [5.4.0] -7-undecene (0.28 ml,
(1.90 mmol) and stirred overnight. 1 in the reaction solution
A normal hydrochloric acid aqueous solution (10 ml) and water (100 ml) were added, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed with a 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, distilled off under reduced pressure, and recrystallized from ethyl acetate-hexane to give 2- (ethyloxy) -N- (2- ( 4-Fluorophenyl) -2-oxo-1-
((4- (trifluoromethyl) phenyl) methyl) ethyl) -1-naphthalenecarboxamide (670 mg, 7
6%). mp 188-189 ° C IRν max KBr cm -1 : 1688, 1634, 1597, 1508, 1325. Anal.Calcd for C 29 H 23 F 4 NO 3 : C, 68.36; H, 4.55; N,
2.75 Found:. C, 68.25; H, 4.58; N, 2.76 1 H-NMR (CDCl 3) δ: 1, 24 (3H, t, J = 7.0 Hz), 3.20
(1H, dd, J = 14.0, 6.4Hz), 3.46 (1H, dd, J = 14.0,
6.4 Hz), 4.13 (2H, q, J = 7.0 Hz), 6.23 (1H, q, J
= 6.6 Hz), 6.96 (1H, d, J = 8.4 Hz), 7.10-7.56 (9
H, m), 7.60-7.80 (2H, m), 7.85 (1H, d, J = 9.0 H
z), 8.04-8.18 (2H, m). 2) 2- (ethyloxy) -N- (2- (4-fluorophenyl) -2-oxo-1-((4- (trifluoromethyl) phenyl) methyl ) Ethyl) -1-naphthalenecarboxamide (400 mg, 0.79 mmol) in methanol (30 ml) solution.
g, 1.57 mmol) and stirred at room temperature for 30 minutes. Sodium borohydride (30 m
g, 0.79 mmol) and stirred for 1 hour. The reaction solution was poured into 1N hydrochloric acid (30 ml), and ethyl acetate (50 ml) was added.
ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1-1: 1) and recrystallized from ethyl acetate-hexane to give the title compound (227 m
g, 57%). mp 186-187 ° C IRν max KBr cm -1 : 1639, 1512, 1242, 1165. Anal.Calcd for C 29 H 25 F 4 NO 3 : C, 68.09; H, 4.93; N,
2.74 Found:. C, 68.04; H, 4.79; N, 2.85 1 H-NMR (CDCl 3) δ: 1.37 (3H, t, 6.8 Hz), 2.84-3.28
(2H, m), 3.34 (1H, d, J = 3.8 Hz), 4.08-4.26 (2H,
m), 4.60-4.84 (2H, m), 6.15 (1H, d, J = 8.6Hz), 6.
96-7.16 (3H, m), 7.20-7.50 (7H, m), 7.58 (2H, d, J
= 8.4 Hz), 7.76 (2H, dd, J = 18.2, 9.2 Hz).
【0158】実施例26 N-((1RS,2RS)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-1-ナフタレンカルボキサミ
ド 1) 1,1-ジメチルエチル(1RS,2RS)-2-
(4-フルオロフェニル)-2-ヒドロキシ-1-((4-
(トリフルオロメチル)フェニル)メチル)エチルカル
バメート(2.1g,5.08ミリモル)のエタノール
(25ml)溶液に20%塩化水素エタノール溶液(2
5ml)を加えて1時間加熱還流した。反応液を減圧留
去し、残留物をジエチルエーテルで洗浄して、(1R
S,2RS)-1-(4-フルオロフェニル)-1-ヒドロ
キシ-3-(4-(トリフルオロメチル)フェニル)-2-
プロピルアミン塩酸塩(1.7g,96%)を得た。 mp 166-167℃ IRν maxKBrcm-1: 1605, 1514, 1497. Anal. Calcd for C16H16ClF4NO: C, 54.11; H, 4.71;
N, 3.94 Found: C, 54.10; H, 4.62; N, 3.83.1 H-NMR (CD3OD)δ: 2.98 (2H, d, J = 7.4 Hz), 3.60-
3.78 (1H, m), 4.63 (1H,d, J = 6.2 Hz), 7.04-7.16
(2H, m), 7.36-7.50 (4H, m), 7.61 (2H, d, J =8.4 H
z). 2) (1RS,2RS)-1-(4-フルオロフェニ
ル)-1-ヒドロキシ-3-(4-(トリフルオロメチル)
フェニル)-2-プロピルアミン塩酸塩(150mg,
0.43ミリモル)の酢酸エチル(5ml)溶液に1-
ナフトイルクロリド(97mg,0.64ミリモル)お
よび飽和重曹水(5ml)を加えて室温で終夜攪拌し
た。反応液を水(50ml)で希釈し、酢酸エチル(5
0ml×2)で抽出した。抽出液を飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=4:1−1:1)で精製し、酢酸エチル−
ヘキサンから再結晶させて、表題化合物(145mg,
72%)を得た。 mp 134-135℃ IRν maxKBrcm-1: 1634, 1510. Anal. Calcd for C27H21F4NO2: C, 69.37; H, 4.53; N,
3.00 Found: C, 69.08; H, 4.80; N, 3.01.1 H-NMR (CDCl3)δ: 3.18-3.30 (3H, m), 4.54-4.72 (1
H, m), 4.92 (1H, brs),6.20 (1H, d, J = 8.8 Hz), 6.
96-7.14 (2H, m), 7.16-7.70 (11H, m), 7.78-7.90 (2
H, m).Example 26 N-((1RS, 2RS) -2- (4-fluorophenyl)
2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -1-naphthalenecarboxamide 1) 1,1-dimethylethyl (1RS, 2RS) -2-
(4-fluorophenyl) -2-hydroxy-1-((4-
(Trifluoromethyl) phenyl) methyl) ethyl carbamate (2.1 g, 5.08 mmol) in ethanol (25 ml) was added to a 20% hydrogen chloride ethanol solution (2
5 ml) and heated under reflux for 1 hour. The reaction solution was evaporated under reduced pressure, and the residue was washed with diethyl ether.
S, 2RS) -1- (4-Fluorophenyl) -1-hydroxy-3- (4- (trifluoromethyl) phenyl) -2-
Propylamine hydrochloride (1.7 g, 96%) was obtained. . mp 166-167 ℃ IRν max KBr cm -1: 1605, 1514, 1497. Anal Calcd for C 16 H 16 ClF 4 NO: C, 54.11; H, 4.71;
N, 3.94 Found:. C, 54.10; H, 4.62; N, 3.83 1 H-NMR (CD 3 OD) δ: 2.98 (2H, d, J = 7.4 Hz), 3.60-
3.78 (1H, m), 4.63 (1H, d, J = 6.2 Hz), 7.04-7.16
(2H, m), 7.36-7.50 (4H, m), 7.61 (2H, d, J = 8.4 H
z). 2) (1RS, 2RS) -1- (4-fluorophenyl) -1-hydroxy-3- (4- (trifluoromethyl)
Phenyl) -2-propylamine hydrochloride (150 mg,
0.43 mmol) in ethyl acetate (5 ml).
Naphthoyl chloride (97 mg, 0.64 mmol) and saturated aqueous sodium hydrogencarbonate (5 ml) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml), and ethyl acetate (5 ml) was added.
0 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Purification with ethyl acetate = 4: 1-1: 1)
Recrystallization from hexane gave the title compound (145 mg,
72%). mp 134-135 ℃ IRν max KBr cm -1 : 1634, 1510. Anal.Calcd for C 27 H 21 F 4 NO 2 : C, 69.37; H, 4.53; N,
3.00 Found: C, 69.08; H, 4.80; N, 3.01. 1 H-NMR (CDCl 3 ) δ: 3.18-3.30 (3H, m), 4.54-4.72 (1
H, m), 4.92 (1H, brs), 6.20 (1H, d, J = 8.8 Hz), 6.
96-7.14 (2H, m), 7.16-7.70 (11H, m), 7.78-7.90 (2
H, m).
【0159】実施例27 N-((1RS,2RS)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-4-(トリフルオロメチル)
ベンズアミド (1RS,2RS)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(150mg,0.43
ミリモル)の酢酸エチル(5ml)溶液に4-トリフル
オロベンゾイルクロリド(96mg,0.64ミリモ
ル)および飽和重曹水(5ml)を加えて室温で終夜攪
拌した。反応液を水(50ml)で希釈し、酢酸エチル
(50ml×2)で抽出した。抽出液を飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=4:1)で精製し、酢酸エチル−ヘキ
サンから再結晶させて、表題化合物(129mg,62
%)を得た。 mp 162-163℃ IRν maxKBrcm-1: 1653, 1508, 1329. Anal. Calcd for C24H18F7NO2: C, 59.39; H, 3.74; N,
2.89 Found: C, 59.20; H, 4.01; N, 2.91.1 H-NMR (CDCl3)δ: 3.18-3.30 (3H, m), 4.54-4.72 (1
H, m), 4.92 (1H, brs),6.20 (1H, d, J = 8.8 Hz), 6.
96-7.14 (2H, m), 7.16-7.70 (11H, m), 7.78-7.90 (2
H, m).Example 27 N-((1RS, 2RS) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4- (trifluoromethyl)
Benzamide (1RS, 2RS) -1- (4-fluorophenyl) -1-
Hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.43
(Mmol) in ethyl acetate (5 ml), 4-trifluorobenzoyl chloride (96 mg, 0.64 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the title compound (129 mg, 62 mg).
%). mp 162-163 ℃ IRν max KBr cm -1 : 1653, 1508, 1329. Anal.Calcd for C 24 H 18 F 7 NO 2 : C, 59.39; H, 3.74; N,
2.89 Found:. C, 59.20; H, 4.01; N, 2.91 1 H-NMR (CDCl 3) δ: 3.18-3.30 (3H, m), 4.54-4.72 (1
H, m), 4.92 (1H, brs), 6.20 (1H, d, J = 8.8 Hz), 6.
96-7.14 (2H, m), 7.16-7.70 (11H, m), 7.78-7.90 (2
H, m).
【0160】実施例28 1,1-ジメチルエチル(1RS,2SR)-2-(4-フ
ルオロフェニル)-2-ヒドロキシ-1-((4-(トリフ
ルオロメチル)フェニル)メチル)エチルカルバメート 1) 3-(4-フルオロフェニル)-3-オキソ-2-
((4-(トリフルオロメチル)フェニル)メチル)プ
ロピオン酸エチル(20.8g,56.5ミリモル)の
メタノール(500ml)溶液に塩化マンガン(II)
(14.2g,113ミリモル)を加え、室温で30分
攪拌した。反応液に氷冷下、水素化ホウ素ナトリウム
(4.28g,113ミリモル)を加え、20分攪拌し
た。反応液を1規定塩酸(300ml)に注ぎ、酢酸エ
チル(500ml×2)で抽出した。抽出液を水および
飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減
圧留去した。残留物をシリカゲルカラムクロマトグラフ
ィー(ヘキサン:酢酸エチル=4:1)で精製し、(2
RS,3RS)-3-(4-フルオロフェニル)-3-ヒド
ロキシ-2-((4-(トリフルオロメチル)フェニル)
メチル)プロピオン酸エチル(11.1g,53%)を
無色油状物として得た。 IRν maxKBrcm-1: 1726, 1618, 1607, 1510. Anal. Calcd for C19H18F4O3: C, 61.62; H, 4.90 Found: C, 61.62; H, 5.06.1 H-NMR (CDCl3)δ: 0.91 (3H, t, J = 7.0 Hz), 2.88-
3.10 (4H, m), 3.88 (2H,q, J = 7.0 Hz), 4.98-5.06
(1H, m), 6.96-7.12 (2H, m), 7.20 (2H, d, J =8.0 H
z), 7.30-7.44 (2H, m), 7.49 (2H, d, J = 8.0 Hz). 2) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸エチル(11.0
g,29.7ミリモル)のメタノール(90ml)溶液
に1規定水酸化ナトリウム水溶液(59.6ml,5
9.6ミリモル)を加え、室温で6時間攪拌した。反応
液を減圧留去後、1規定塩酸(100ml)で希釈し、
酢酸エチル(200ml×2)で抽出した。抽出液を水
および飽和食塩水で洗浄し、無水硫酸マグネシウムで乾
燥後減圧留去し、酢酸エチル−ヘキサンから再結晶させ
て、(2RS,3RS)-3-(4-フルオロフェニル)-
3-ヒドロキシ-2-((4-(トリフルオロメチル)フェ
ニル)メチル)プロピオン酸(8.6g,85%)を得
た。 mp 111-112℃ IRν maxKBrcm-1: 1713, 1607, 1512. Anal. Calcd for C17H14O3F4: C, 59.65; H, 4.12 Found: C, 59.65; H, 4.07.1 H-NMR (CDCl3)δ: 2.08 (1H, s), 2.94-3.20 (3H, m),
5.04-5.10 (1H, m), 6.98-7.12 (2H, m), 7.18 (2H,
d, J = 8.0 Hz), 7.30-7.42 (2H, m), 7.48 (2H,d, J =
8.0 Hz). 3) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸(4.30g,1
2.6ミリモル)のテトラヒドロフラン(80ml)溶
液にジフェニルホスホリルアジド(3.0ml,13.
8ミリモル)およびトリエチルアミン(2.63ml,
18.8ミリモル)を加えて4時間加熱還流した。反応
液を水(300ml)で希釈し、酢酸エチル(200m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=2:1−1:1)で精製し、酢酸エチル−ヘキサ
ンから再結晶させて、(4RS,5SR)-5-(4-フ
ルオロフェニル)-4-((4-(トリフルオロメチル)
フェニル)メチル)-1,3-オキサゾリジン-2-オン
(3.55g,83%)を得た。 mp 154-155℃ IRν maxKBrcm-1: 1755, 1611, 1514, 1235. Anal. Calcd for C17H13F4NO2: C, 60.18; H, 3.86; N,
4.13 Found: C, 60.20; H, 3.80; N, 4.21.1 H-NMR (CDCl3)δ: 2.20-2.44 (2H, m), 4.26 (1H, q,
J = 8.0 Hz), 5.25 (1H,brs), 5.79 (1H, d, J = 8.0 H
z), 7.06-7.20 (4H, m), 7.28-7.40 (2H, m), 7.54 (2
H, d, J = 8.0 Hz). 4) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((4-(トリフルオロメチル)フェニル)メ
チル)-1,3-オキサゾリジン-2-オン(3.50g,
10.32ミリモル)のアセトニトリル(30ml)溶
液に二炭酸ジ-t-ブチル(2.70g,12.39ミリ
モル)および4-ジメチルアミノピリジン(126m
g,1.03ミリモル)を加えて室温で1時間攪拌し
た。反応液を水(100ml)で希釈し、酢酸エチル
(100ml×2)で抽出した。抽出液を飽和食塩水で
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し、酢
酸エチル−ヘキサンから再結晶させて、(4RS,5S
R)-5-(4-フルオロフェニル)-2-オキソ-4-
((4-(トリフルオロメチル)フェニル)メチル)-
1,3-オキサゾリジン-3-カルボン酸1,1-ジメチル
エチル(4.09g,90%)を得た。 mp 155-156℃ IRν maxKBrcm-1: 1821, 1724, 1514, 1360. Anal. Calcd for C22H21F4NO4: C, 60.14; H, 4.82; N,
3.19 Found: C, 60.16; H, 4.84; N, 3.25.1 H-NMR (CDCl3)δ: 1.48 (9H, s), 2.61 (1H, dd, J =
14.2, 8.4 Hz), 2.91 (1H, dd, J = 14.2, 5.2 Hz), 4.
80 (1H, dd, J = 8.4, 7.0 Hz), 5.68 (1H, d, J= 7.0
Hz), 6.82 (2H, d, J = 8.0 Hz), 6.92-7.06 (2H, m),
7.10-7.24 (2H,m), 7.36 (2H, d, J = 8.0 Hz). 5) (4RS,5SR)-5-(4-フルオロフェニ
ル)-2-オキソ-4-((4-(トリフルオロメチル)フ
ェニル)メチル)-1,3-オキサゾリジン-3-カルボン
酸1,1-ジメチルエチル(4.0g,9.10ミリモ
ル)のメタノール(22ml)溶液に水酸化ナトリウム
(0.44g,10.92ミリモル)のメタノール(2
2ml)溶液を氷冷下、徐々に加えた。反応液を3時間
攪拌後、1規定塩酸(12ml)および水(100m
l)で希釈し、酢酸エチル(100ml×2)で抽出し
た。抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去し、残留物をシリカゲルカラムクロ
マトグラフィー(ヘキサン:酢酸エチル=4:1)で精
製し、酢酸エチル−ヘキサンから再結晶させて、表題化
合物(2.90g,77%)を得た。 mp 158-159℃ IRν maxKBrcm-1: 3358, 1682, 1532, 1514. Anal. Calcd for C21H23F4NO3: C, 61.01; H, 5.61; N,
3.39 Found: C, 60.95; H, 5.59; N, 3.20.1 H-NMR (CDCl3)δ: 1.32 (9H, s), 2.60-2.90 (2H, m),
3.11 (1H, brs), 4.00-4.20 (1H, m), 4.58 (1H, d, J
= 8.4 Hz), 4.92 (1H, s), 7.02-7.14 (2H, m),7.22
(2H, d, J = 8.0 Hz), 7.32-7.44 (2H, m), 7.51 (2H,
d, J = 8.0 Hz).Example 28 1,1-Dimethylethyl (1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl carbamate 1) 3- (4-fluorophenyl) -3-oxo-2-
Manganese (II) chloride was added to a methanol (500 ml) solution of ethyl ((4- (trifluoromethyl) phenyl) methyl) propionate (20.8 g, 56.5 mmol).
(14.2 g, 113 mmol) and stirred at room temperature for 30 minutes. Sodium borohydride (4.28 g, 113 mmol) was added to the reaction mixture under ice cooling, and the mixture was stirred for 20 minutes. The reaction solution was poured into 1N hydrochloric acid (300 ml) and extracted with ethyl acetate (500 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give (2
RS, 3RS) -3- (4-Fluorophenyl) -3-hydroxy-2-((4- (trifluoromethyl) phenyl)
Ethyl (methyl) propionate (11.1 g, 53%) was obtained as a colorless oil. . IRν max KBr cm -1: 1726 , 1618, 1607, 1510. Anal Calcd for C 19 H 18 F 4 O 3: C, 61.62; H, 4.90 Found:. C, 61.62; H, 5.06 1 H-NMR ( CDCl 3 ) δ: 0.91 (3H, t, J = 7.0 Hz), 2.88-
3.10 (4H, m), 3.88 (2H, q, J = 7.0 Hz), 4.98-5.06
(1H, m), 6.96-7.12 (2H, m), 7.20 (2H, d, J = 8.0 H
z), 7.30-7.44 (2H, m), 7.49 (2H, d, J = 8.0 Hz). 2) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((4 Ethyl (-(trifluoromethyl) phenyl) methyl) propionate (11.0
g, 29.7 mmol) in methanol (90 ml) was added to a 1 N aqueous sodium hydroxide solution (59.6 ml, 5 ml).
9.6 mmol) and stirred at room temperature for 6 hours. After distilling off the reaction solution under reduced pressure, the reaction solution was diluted with 1 N hydrochloric acid (100 ml).
Extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, evaporated under reduced pressure, and recrystallized from ethyl acetate-hexane to give (2RS, 3RS) -3- (4-fluorophenyl)-
3-Hydroxy-2-((4- (trifluoromethyl) phenyl) methyl) propionic acid (8.6 g, 85%) was obtained. . mp 111-112 ℃ IRν max KBr cm -1: 1713, 1607, 1512. Anal Calcd for C 17 H 14 O 3 F 4: C, 59.65; H, 4.12 Found:. C, 59.65; H, 4.07 1 H -NMR (CDCl 3 ) δ: 2.08 (1H, s), 2.94-3.20 (3H, m),
5.04-5.10 (1H, m), 6.98-7.12 (2H, m), 7.18 (2H,
d, J = 8.0 Hz), 7.30-7.42 (2H, m), 7.48 (2H, d, J =
8.0 Hz). 3) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((4- (trifluoromethyl) phenyl) methyl) propionic acid (4.30 g, 1
(2.6 mmol) in tetrahydrofuran (80 ml) in diphenylphosphoryl azide (3.0 ml, 13.
8 mmol) and triethylamine (2.63 ml,
(18.8 mmol) and heated under reflux for 4 hours. The reaction solution was diluted with water (300 ml), and ethyl acetate (200 m
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1-1: 1) and recrystallized from ethyl acetate-hexane to give (4RS, 5SR) -5- (4-fluorophenyl)- 4-((4- (trifluoromethyl)
Phenyl) methyl) -1,3-oxazolidin-2-one (3.55 g, 83%) was obtained. mp 154-155 ℃ IRν max KBr cm -1 : 1755, 1611, 1514, 1235. Anal.Calcd for C 17 H 13 F 4 NO 2 : C, 60.18; H, 3.86; N,
4.13 Found: C, 60.20; H, 3.80; N, 4.21. 1 H-NMR (CDCl 3 ) δ: 2.20-2.44 (2H, m), 4.26 (1H, q,
J = 8.0 Hz), 5.25 (1H, brs), 5.79 (1H, d, J = 8.0 H
z), 7.06-7.20 (4H, m), 7.28-7.40 (2H, m), 7.54 (2
H, d, J = 8.0 Hz). 4) (4RS, 5SR) -5- (4-fluorophenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2 -On (3.50g,
10.32 mmol) in acetonitrile (30 ml) was added to di-tert-butyl dicarbonate (2.70 g, 12.39 mmol) and 4-dimethylaminopyridine (126 mM).
g, 1.03 mmol) and stirred at room temperature for 1 hour. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, distilled off under reduced pressure, recrystallized from ethyl acetate-hexane, and purified with (4RS, 5S
R) -5- (4-Fluorophenyl) -2-oxo-4-
((4- (trifluoromethyl) phenyl) methyl)-
There was obtained 1,1-dimethylethyl 1,3-oxazolidine-3-carboxylate (4.09 g, 90%). mp 155-156 ° C IRν max KBr cm -1 : 1821, 1724, 1514, 1360. Anal.Calcd for C 22 H 21 F 4 NO 4 : C, 60.14; H, 4.82; N,
3.19 Found:. C, 60.16; H, 4.84; N, 3.25 1 H-NMR (CDCl 3) δ: 1.48 (9H, s), 2.61 (1H, dd, J =
14.2, 8.4 Hz), 2.91 (1H, dd, J = 14.2, 5.2 Hz), 4.
80 (1H, dd, J = 8.4, 7.0 Hz), 5.68 (1H, d, J = 7.0
Hz), 6.82 (2H, d, J = 8.0 Hz), 6.92-7.06 (2H, m),
7.10-7.24 (2H, m), 7.36 (2H, d, J = 8.0 Hz). 5) (4RS, 5SR) -5- (4-fluorophenyl) -2-oxo-4-((4- (tri Sodium hydroxide (0.44 g, 10%) was added to a methanol (22 ml) solution of 1,1-dimethylethyl (fluoromethyl) phenyl) methyl) -1,3-oxazolidine-3-carboxylate (4.0 g, 9.10 mmol). .92 mmol) of methanol (2
2 ml) solution was gradually added under ice-cooling. After stirring the reaction solution for 3 hours, 1N hydrochloric acid (12 ml) and water (100 m
1) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1), and recrystallized from ethyl acetate-hexane. Gave the title compound (2.90 g, 77%). mp 158-159 ° C IRν max KBr cm -1 : 3358, 1682, 1532, 1514. Anal.Calcd for C 21 H 23 F 4 NO 3 : C, 61.01; H, 5.61; N,
3.39 Found:. C, 60.95; H, 5.59; N, 3.20 1 H-NMR (CDCl 3) δ: 1.32 (9H, s), 2.60-2.90 (2H, m),
3.11 (1H, brs), 4.00-4.20 (1H, m), 4.58 (1H, d, J
= 8.4 Hz), 4.92 (1H, s), 7.02-7.14 (2H, m), 7.22
(2H, d, J = 8.0 Hz), 7.32-7.44 (2H, m), 7.51 (2H,
d, J = 8.0 Hz).
【0161】実施例29 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シ
クロヘプテン-1-カルボキサミド 1) 6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプ
テン-1-イルメタノールtert-ブチル(6,7-ジヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-1-イルメトキ
シ)ジメチルシラン(Tetrahedron,53,
15969-15982(1990)参照)1.079
g(3.740ミリモル)のテトラヒドロフラン30m
l溶液に、テトラブチルアンモニウムフルオリドの1.
0Mテトラヒドロフラン溶液3.74ml(3.74ミ
リモル)を加え、室温で15分撹拌した。反応液を濃縮
後、得られた粗生成物をシリカゲルカラムクロマトグラ
フィーにて精製し(ヘキサン/酢酸エチル=6/1−1
/1)、目的物を得た。無色液体 収量0.573g
収率88%1 H-NMR (CDCl3, 200MHz) δ 1.99-2.25 (4H, m), 2.71
(2H, t, J = 6.0 Hz), 4.73 (2H, s), 6.18 (1H, td, J
= 5.5 Hz, 11.6 Hz), 6.73 (1H, d, J = 11.6 Hz), 7.
11-7.25 (3H, m); IR (neat) 3330, 2930, 1449, 1067,
1020, 995, 772cm-1 2) 6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプ
テン-1-カルボン酸 6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-イルメタノール31.41g(180.3ミリモル)
のアセトン500ml溶液に、氷冷下、無水クロム酸3
6.1g(361ミリモル)と濃硫酸30mlを水12
0mlに溶解した溶液をゆっくりと滴下し、滴下終了
後、室温で1時間撹拌した。反応液を再び氷冷した後、
イソプロパノール60mlを加え、そのまま0.5時間
撹拌した。反応液のアセトンを減圧下留去した後、酢酸
エチルに希釈し、水で3回洗浄、無水硫酸マグネシウム
で乾燥、溶媒を減圧留去した。得られた残留物を冷ジイ
ソプロピルエーテルより結晶化して、目的物を得た。白
色結晶 収量19.78g 収率58% mp 146-147℃; 1H-NMR (CDCl3, 200MHz) δ 2.08-2.16
(4H, m), 2.70 (2H, t,J = 6.4 Hz), 6.24 (1H, td, J
= 6.4 Hz, 11.1 Hz), 7.14 (1H, d, J = 11.4 Hz), 7.2
3 (1H, t, J = 7.3 Hz), 7.39 (1H, d, J = 7.2 Hz),
7.92 (1H, dd, J= 1.5 Hz, 7.7 Hz); IR (KBr) 3065-25
30, 1686, 1451, 1414, 1300, 1277, 926, 779 cm-1; A
nal. Calcd for C12H12O2・0.1H2O: C, 75.85; H, 6.47.
Found: C, 75.88; H, 6.35. 3) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-[4-(トリフルオロメチル)フェニ
ル]プロパン-1-オール (4RS,5SR)-5-(4-フルオロフェニル)-4-
[4-(トリフルオロメチル)ベンジル]-1,3-オキ
サゾリジン-2-オン18.75g(55.26ミリモ
ル)と水酸化ナトリウム8.84g(221ミリモル)
をエタノール100ml−水10ml中で、5時間加熱
還流した。反応液を水で希釈し、酢酸エチルで2回抽出
した。集めた有機層を無水硫酸ナトリウムで乾燥、溶媒
を減圧留去した。残留物をシリカゲル(APSタイプ)
カラムクロマトグラフィーにて精製し(ヘキサン/酢酸
エチル=1/1−酢酸エチル)、ジエチルエーテル−ヘ
キサンより結晶化して、目的物を得た。白色結晶 収量
16.38g 収率95% mp 87-88℃; 1H-NMR (CDCl3, 200MHz) δ 1.60 (2H, br
s), 2.43 (1H, dd, J =10.2 Hz, 13.6 Hz), 2.87 (1H,
dd, J = 3.1 Hz, 13.7 Hz), 3.29 (1H, ddd J= 3.3 H
z, 5.2 Hz, 10.3 Hz), 4.66 (1H, d, J = 5.0 Hz), 7.0
8 (2H, t, J = 8.7 Hz), 7.27 (2H, d, J = 8.0 Hz),
7.38 (2H, dd, J = 5.4 Hz, 8.4 Hz), 7.55 (2H, d, J
= 7.6 Hz); IR (neat) 3360-2865, 1508, 1325, 1225,
1163, 1121, 1067, 826 cm-1; Anal. Calcd for C16H15
F4NO: C, 61.34; H, 4.83; N, 4.47. Found: C, 61.32;
H, 4.62; N, 4.48. 4) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[4-(トリフルオロメチ
ル)ベンジル]エチル]-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.157g(0.501ミリモ
ル)、6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプ
テン-1-カルボン酸94mg(0.50ミリモル)、1
-ヒドロキシベンゾトリアゾール水和物77mg(0.
50ミリモル)をアセトニトリル10ml中で撹拌しな
がら1-エチル-3-(3-ジメチルアミノプロピル)カル
ボジイミド・塩酸塩96mg(0.50ミリモル)を加
え、室温で一晩撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物を酢酸エチル−ヘキサンより結晶
化して、目的物を得た。白色結晶 収量0.134g
収率55% mp 197-198℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 1.
91-2.04 (2H, m), 2.17-2.27 (2H, m), 2.65 2.70 (2H,
m), 2.83-3.00 (2H, m), 4.62-4.76 (1H, m), 4.97 (1
H, t, J = 4.0 Hz), 5.04 (1H, d, J = 3.8 Hz), 5.84
(1H, td, J = 5.1Hz, 12.2 Hz), 6.11 (1H, d, J = 12.
0 Hz), 6.81 (1H, d, J = 8.8 Hz), 6.91(1H, dd, J =
1.9 Hz, 7.3 Hz), 7.01-7.14 (4H, m), 7.31 (2H, d, J
= 8.2 Hz), 7.47-7.54 (4H, m); IR (KBr) 3279, 294
0, 1640, 1534, 1514, 1325, 1229, 1163, 1121, 1069,
831 cm-1; Anal. Calcd for C28H25F4NO2: C, 69.56;
H,5.21; N, 2.90. Found: C, 69.41; H, 5.15; N, 2.9
1.Example 29 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1) 6,7-dihydro-5H-benzo [a Cyclohepten-1-ylmethanol tert-butyl (6,7-dihydro-5H-benzo [a] cyclohepten-1-ylmethoxy) dimethylsilane (Tetrahedron, 53,
15969-15982 (1990)) 1.079
g (3.740 mmol) of tetrahydrofuran 30 m
1 solution of tetrabutylammonium fluoride in 1.
3.74 ml (3.74 mmol) of a 0 M tetrahydrofuran solution was added, and the mixture was stirred at room temperature for 15 minutes. After concentrating the reaction solution, the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-1).
/ 1) to obtain the desired product. Colorless liquid Yield 0.573g
Yield 88% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.99-2.25 (4H, m), 2.71
(2H, t, J = 6.0 Hz), 4.73 (2H, s), 6.18 (1H, td, J
= 5.5 Hz, 11.6 Hz), 6.73 (1H, d, J = 11.6 Hz), 7.
11-7.25 (3H, m); IR (neat) 3330, 2930, 1449, 1067,
1020, 995, 772 cm -1 2) 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid 6,7-dihydro-5H-benzo [a] cycloheptene-1
31.41 g (180.3 mmol) of -ylmethanol
Chromic anhydride 3 in a 500 ml acetone solution under ice-cooling
6.1 g (361 mmol) and 30 ml of concentrated sulfuric acid were added to water 12
A solution dissolved in 0 ml was slowly added dropwise, and after completion of the addition, the mixture was stirred at room temperature for 1 hour. After ice-cooling the reaction solution again,
60 ml of isopropanol was added, and the mixture was stirred for 0.5 hour. The acetone in the reaction solution was distilled off under reduced pressure, diluted with ethyl acetate, washed three times with water, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from cold diisopropyl ether to obtain the desired product. White crystals Yield 19.78 g Yield 58% mp 146-147 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.08-2.16
(4H, m), 2.70 (2H, t, J = 6.4 Hz), 6.24 (1H, td, J
= 6.4 Hz, 11.1 Hz), 7.14 (1H, d, J = 11.4 Hz), 7.2
3 (1H, t, J = 7.3 Hz), 7.39 (1H, d, J = 7.2 Hz),
7.92 (1H, dd, J = 1.5 Hz, 7.7 Hz); IR (KBr) 3065-25
30, 1686, 1451, 1414, 1300, 1277, 926, 779 cm -1 ; A
nal.Calcd for C 12 H 12 O 2・ 0.1H 2 O: C, 75.85; H, 6.47.
Found: C, 75.88; H, 6.35. 3) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol (4RS , 5SR) -5- (4-Fluorophenyl) -4-
18.75 g (55.26 mmol) of [4- (trifluoromethyl) benzyl] -1,3-oxazolidin-2-one and 8.84 g (221 mmol) of sodium hydroxide
Was heated to reflux in 100 ml of ethanol and 10 ml of water for 5 hours. The reaction was diluted with water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. Residue is silica gel (APS type)
The product was purified by column chromatography (hexane / ethyl acetate = 1 / 1-ethyl acetate) and crystallized from diethyl ether-hexane to obtain the desired product. White crystals Yield 16.38 g Yield 95% mp 87-88 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.60 (2H, br
s), 2.43 (1H, dd, J = 10.2 Hz, 13.6 Hz), 2.87 (1H,
dd, J = 3.1 Hz, 13.7 Hz), 3.29 (1H, ddd J = 3.3 H
z, 5.2 Hz, 10.3 Hz), 4.66 (1H, d, J = 5.0 Hz), 7.0
8 (2H, t, J = 8.7 Hz), 7.27 (2H, d, J = 8.0 Hz),
7.38 (2H, dd, J = 5.4 Hz, 8.4 Hz), 7.55 (2H, d, J
= 7.6 Hz); IR (neat) 3360-2865, 1508, 1325, 1225,
1163, 1121, 1067, 826 cm -1 ; Anal.Calcd for C 16 H 15
F 4 NO: C, 61.34; H, 4.83; N, 4.47. Found: C, 61.32;
H, 4.62; N, 4.48. 4) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -6,7 -Dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.157 g (0.501 mmol), 94 mg (0.50 mmol) of 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid, 1
-Hydroxybenzotriazole hydrate 77 mg (0.
(50 mmol) was stirred in 10 ml of acetonitrile, and 96 mg (0.50 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added thereto, followed by stirring at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 0.134 g
Yield 55% mp 197-198 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 1.
91-2.04 (2H, m), 2.17-2.27 (2H, m), 2.65 2.70 (2H, m
m), 2.83-3.00 (2H, m), 4.62-4.76 (1H, m), 4.97 (1
H, t, J = 4.0 Hz), 5.04 (1H, d, J = 3.8 Hz), 5.84
(1H, td, J = 5.1Hz, 12.2 Hz), 6.11 (1H, d, J = 12.
0 Hz), 6.81 (1H, d, J = 8.8 Hz), 6.91 (1H, dd, J =
1.9 Hz, 7.3 Hz), 7.01-7.14 (4H, m), 7.31 (2H, d, J
= 8.2 Hz), 7.47-7.54 (4H, m); IR (KBr) 3279, 294
0, 1640, 1534, 1514, 1325, 1229, 1163, 1121, 1069,
831 cm -1 ; Anal.Calcd for C 28 H 25 F 4 NO 2 : C, 69.56;
H, 5.21; N, 2.90. Found: C, 69.41; H, 5.15; N, 2.9
1.
【0162】実施例30 4-フルオロ-N-((1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-((4-(トリフルオ
ロメチル)フェニル)メチル)エチル)-1-ナフタレン
カルボキサミド 1) 1,1-ジメチルエチル(1RS,2SR)-2-
(4-フルオロフェニル)-2-ヒドロキシ-1-((4-
(トリフルオロメチル)フェニル)メチル)エチルカル
バメート(2.58g,6.24ミリモル)のエタノー
ル(35ml)溶液に20%塩化水素エタノール溶液
(35ml)を加えて30分間加熱還流した。反応液を
減圧留去し、残留物をジエチルエーテルで洗浄して、
(1RS,2SR)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(2.05g,94%)
を得た。 mp 173-174℃ IRν maxKBrcm-1: 3314, 3009, 1611, 1512, 1331. Anal. Calcd for C16H16ClF4NO・0.5H2O: C, 53.57; H,
4.78; N, 3.90 Found: C, 53.81; H, 4.81; N, 3.74.1 H-NMR (DMSO-d6)δ: 2.79 (2H, d, J = 6.6 Hz), 3.64
-3.80 (1H, m), 5.03 (1H, s), 6.30 (1H, d, J = 4.0
Hz), 7.10-7.24 (2H, m), 7.33 (2H, d, J = 8.0Hz),
7.38-7.50 (2H, m), 7.59 (2H, d, J = 8.0 Hz), 8.07
(2H, brs). 2) 4-フルオロ-1-ナフタレンカルボン酸(163
mg,0.86ミリモル)のテトラヒドロフラン(5m
l)溶液に、オキサリルクロリド(0.15ml,1.
72ミリモル)およびN,N-ジメチルホルムアミド
(0.01ml)を加えて、室温で30分間攪拌し、反
応液を減圧留去した。残留物の酢酸エチル(5ml)溶
液に(1RS,2SR)-1-(4-フルオロフェニル)-
1-ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(200mg,0.57
ミリモル)および飽和重曹水(5ml)を加えて室温で
2時間攪拌した。反応液を水(50ml)で希釈し、酢
酸エチル(50ml×2)で抽出した。抽出液を飽和食
塩水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去
した。残留物をシリカゲルカラムクロマトグラフィー
(ヘキサン:酢酸エチル=2:1)で精製し、酢酸エチ
ル−ヘキサンから再結晶させて、表題化合物(214m
g,77%)を得た。 mp 210-211℃ IRν maxKBrcm-1: 3275, 1642, 1626, 1601. Anal. Calcd for C27H20F5NO2: C, 66.80; H, 4.15; N,
2.89 Found: C, 66.79; H, 4.19; N, 2.82.1 H-NMR (CDCl3)δ: 2.80-3.16 (2H, m), 3.18 (1H, d,
J = 3.6 Hz), 4.72-4.94(1H, m), 5.08-5.16 (1H, m),
5.92 (1H, d, J = 8.2 Hz), 7.00-7.70 (13H, m), 8.09
(1H, d, J = 8.0 Hz).Example 30 4-Fluoro-N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl)- 1-Naphthalenecarboxamide 1) 1,1-dimethylethyl (1RS, 2SR) -2-
(4-fluorophenyl) -2-hydroxy-1-((4-
A 20% ethanol solution of hydrogen chloride (35 ml) was added to a solution of (trifluoromethyl) phenyl) methyl) ethyl carbamate (2.58 g, 6.24 mmol) in ethanol (35 ml), and the mixture was heated under reflux for 30 minutes. The reaction solution was distilled off under reduced pressure, and the residue was washed with diethyl ether.
(1RS, 2SR) -1- (4-fluorophenyl) -1-
Hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (2.05 g, 94%)
I got mp 173-174 ° C IRν max KBr cm -1 : 3314, 3009, 1611, 1512, 1331. Anal.Calcd for C 16 H 16 ClF 4 NO ・ 0.5H 2 O: C, 53.57; H,
4.78; N, 3.90 Found:. C, 53.81; H, 4.81; N, 3.74 1 H-NMR (DMSO-d 6) δ: 2.79 (2H, d, J = 6.6 Hz), 3.64
-3.80 (1H, m), 5.03 (1H, s), 6.30 (1H, d, J = 4.0
Hz), 7.10-7.24 (2H, m), 7.33 (2H, d, J = 8.0Hz),
7.38-7.50 (2H, m), 7.59 (2H, d, J = 8.0 Hz), 8.07
(2H, brs). 2) 4-Fluoro-1-naphthalenecarboxylic acid (163
mg, 0.86 mmol) of tetrahydrofuran (5 m
l) Add oxalyl chloride (0.15 ml, 1.
72 mmol) and N, N-dimethylformamide (0.01 ml) were added, the mixture was stirred at room temperature for 30 minutes, and the reaction solution was distilled off under reduced pressure. (1RS, 2SR) -1- (4-fluorophenyl)-was added to a solution of the residue in ethyl acetate (5 ml).
1-hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (200 mg, 0.57
Mmol) and saturated aqueous sodium bicarbonate (5 ml), and the mixture was stirred at room temperature for 2 hours. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1) and recrystallized from ethyl acetate-hexane to give the title compound (214 m
g, 77%). . mp 210-211 ℃ IRν max KBr cm -1: 3275, 1642, 1626, 1601. Anal Calcd for C 27 H 20 F 5 NO 2: C, 66.80; H, 4.15; N,
2.89 Found:. C, 66.79; H, 4.19; N, 2.82 1 H-NMR (CDCl 3) δ: 2.80-3.16 (2H, m), 3.18 (1H, d,
J = 3.6 Hz), 4.72-4.94 (1H, m), 5.08-5.16 (1H, m),
5.92 (1H, d, J = 8.2 Hz), 7.00-7.70 (13H, m), 8.09
(1H, d, J = 8.0 Hz).
【0163】実施例31 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[4-(トリフルオロ
メチル)ベンジル]エチル]-5,6,7,8-テトラヒ
ドロナフタレン-1-カルボキサミド 1) 4-アミノ-5,6,7,8-テトラヒドロナフタ
レン-1-カルボン酸メチル 4-ニトロ-5,6,7,8-テトラヒドロナフタレン-1
-カルボン酸メチル(Chem.Abstr.,43,
202f(1949)、Chem.Abstr.,4
3,202b(1949)参照)1.816g(7.7
20ミリモル)のメタノール30ml溶液を10%パラ
ジウム/炭素(50%含水)0.5gを触媒として、原
料が消失するまで常温常圧下で水素添加した。触媒をろ
過して除いた後、濾液を短いシリカゲルカラムクロマト
グラフィーに通し、溶媒を減圧留去、目的物を得た。黄
色結晶 収量1.574g 収率99% 酢酸エチル−ヘキサンより再結晶して、淡黄色結晶を得
た。 mp 120-121℃; 1H-NMR (CDCl3, 200MHz) δ 1.68-1.90
(4H, m), 2.44 (2H, t,J = 6.2 Hz), 3.10 (2H, t, J =
6.0 Hz), 3.81 (3H, s), 3.92 (2H, br s), 6.50 (1H,
d, J = 8.4 Hz), 7.69 (1H, d, J = 8.4 Hz); IR (KB
r) 3486, 3374, 2948, 2930, 2868, 1688, 1626, 1590,
1481, 1449, 1431, 1310, 1267, 1253, 1196, 1142, 7
75 cm-1; Anal. Calcd for C12H15NO2: C, 70.22; H,
7.37; N, 6.82. Found: C, 70.25; H, 7.33; N, 6.67. 2) 4-フルオロ-5,6,7,8-テトラヒドロナフ
タレン-1-カルボン酸メチル 4-アミノ-5,6,7,8-テトラヒドロナフタレン-1
-カルボン酸メチル1.210g(5.895ミリモ
ル)、濃塩酸2mlを水20ml中で撹拌しながら、氷
冷下、亜硝酸ナトリウム0.49g(7.07ミリモ
ル)の水1ml溶液を滴下し、そのままの温度で10分
間撹拌した。反応液に氷冷下、60%ヘキサフルオロリ
ン酸水溶液1.48ml(10.0ミリモル)を激しく
撹拌しながら加え、そのまま0.5時間撹拌した。生じ
た沈殿をろ過し、水およびメタノール-ジエチルエーテ
ル(1:4)で洗浄後、乾燥して、ジアゾニウム塩を白
色粉末として得た。得られたジアゾニウム塩を流動パラ
フィン8ml中で、170℃にて0.5時間加熱した。
室温に冷却した後、炭酸水素ナトリウム水溶液を加え、
酢酸エチルで2回抽出した。集めた有機層を無水硫酸マ
グネシウムで乾燥、溶媒を減圧留去した。得られた粗生
成物をシリカゲルカラムクロマトグラフィーにて精製し
(ヘキサン/酢酸エチル=200/1−15/1)、目
的物を得た。白色結晶 収量0.487g 収率40% mp 44-45℃; 1H-NMR (CDCl3, 200MHz) δ 1.72-1.83 (4
H, m), 2.74 (2H, br s), 3.08 (2H, br s), 3.86 (3H,
s), 6.87 (1H, t, J = 8.6 Hz), 7.73 (1H, dd,J = 6.
0 Hz, 8.6 Hz); IR (KBr) 2944, 1721, 1582, 1472, 14
33, 1260, 1254,1190, 1157, 1130, 1038, 770 cm-1; A
nal. Calcd for C12H13FO2: C, 69.22;H, 6.29. Found:
C, 69.39; H, 6.43. 3) 4-フルオロ-5,6,7,8-テトラヒドロナフタ
レン-1-カルボン酸 4-フルオロ-5,6,7,8-テトラヒドロナフタレン-
1-カルボン酸メチル0.434g(2.084ミリモ
ル)のメタノール10ml−テトラヒドロフラン10m
l溶液に1N水酸化ナトリウム水溶液4.17ml
(4.17ミリモル)を加え、室温で一晩撹拌した。反
応液を濃縮、水で希釈し、1N塩酸で反応液を酸性にし
た後、酢酸エチルで2回抽出した。集めた有機層を無水
硫酸ナトリウムで乾燥、溶媒を減圧留去した。残留物を
ジエチルエーテル−ヘキサンより結晶化して、目的物を
得た。白色結晶 収量0.308g 収率76% mp 172-173℃; 1H-NMR (CDCl3, 200MHz) δ 1.74-1.82
(4H, m), 2.76 (2H, brs), 3.16 (2H, br s), 6.91 (1
H, t, J = 8.8 Hz), 7.91 (1H, dd, J = 6.1 Hz,8.5 H
z); IR (KBr) 3100-2600, 1686, 1588, 1429, 1304, 12
73, 1250, 1188 cm-1; Anal. Calcd for C11H11FO2: C,
68.03; H, 5.71. Found: C, 68.10; H, 6.00. 4) 4-フルオロ-N-[(1RS,2SR)-2-(4-
フルオロフェニル)-2-ヒドロキシ-1-[4-(トリフ
ルオロメチル)ベンジル]エチル]-5,6,7,8-テ
トラヒドロナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.164g(0.523ミリモ
ル)、4-フルオロ-5,6,7,8-テトラヒドロナフ
タレン-1-カルボン酸0.10g(0.52ミリモ
ル)、1-ヒドロキシベンゾトリアゾール水和物80m
g(0.52ミリモル)をアセトニトリル10ml中で
撹拌しながら1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩0.10g(0.52ミリ
モル)を加え、室温で一晩撹拌した。反応液を酢酸エチ
ルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無水硫
酸マグネシウムで乾燥、シリカゲルを通した後、溶媒を
減圧留去した。得られた残留物を酢酸エチル−ジイソプ
ロピルエーテル−ヘキサンより結晶化して、目的物を得
た。白色結晶 収量0.220g 収率86% mp 241-242℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 1.
53-1.75 (4H, m), 2.11-2.26 (1H, m), 2.30 2.48 (1H,
m), 2.61-2.67 (2H, m), 2.78-3.02 (2H, m), 4.59-4.
73 (1H, m), 4.95 (1H, t, J = 3.9 Hz), 5.10 (1H, d,
J = 3.6 Hz), 6.69-6.87 (3H, m), 7.06 (2H, t, J =
8.6 Hz), 7.30 (2H, d, J = 8.2 Hz), 7.47-7.54 (4H,
m); IR (KBr) 3272, 2942, 1642, 1514, 1327, 1229, 1
165, 1121,1069, 831 cm-1; Anal. Calcd for C27H24F5
NO2: C, 66.25; H, 4.94; N, 2.86. Found: C, 66.30;
H, 5.18; N, 2.66.Example 31 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -5,6 1,7,8-Tetrahydronaphthalene-1-carboxamide 1) Methyl 4-amino-5,6,7,8-tetrahydronaphthalene-1-carboxylate 4-Nitro-5,6,7,8-tetrahydronaphthalene-1
-Methyl carboxylate (Chem. Abstr., 43,
202f (1949), Chem. Abstr. , 4
3,816b (1949)) 1.816g (7.7
A solution of 20 mmol) in 30 ml of methanol was hydrogenated under normal temperature and pressure until the raw materials disappeared using 0.5 g of 10% palladium / carbon (containing 50% water) as a catalyst. After removing the catalyst by filtration, the filtrate was passed through a short silica gel column chromatography, and the solvent was distilled off under reduced pressure to obtain the desired product. Yellow crystals Yield 1.574 g Yield 99% Recrystallization from ethyl acetate-hexane gave pale yellow crystals. mp 120-121 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 1.68-1.90
(4H, m), 2.44 (2H, t, J = 6.2 Hz), 3.10 (2H, t, J =
6.0 Hz), 3.81 (3H, s), 3.92 (2H, br s), 6.50 (1H,
d, J = 8.4 Hz), 7.69 (1H, d, J = 8.4 Hz); IR (KB
r) 3486, 3374, 2948, 2930, 2868, 1688, 1626, 1590,
1481, 1449, 1431, 1310, 1267, 1253, 1196, 1142, 7
75 cm -1 ; Anal.Calcd for C 12 H 15 NO 2 : C, 70.22; H,
7.37; N, 6.82. Found: C, 70.25; H, 7.33; N, 6.67. 2) Methyl 4-fluoro-5,6,7,8-tetrahydronaphthalene-1-carboxylate 4-amino-5,6, 7,8-tetrahydronaphthalene-1
While stirring 1.210 g (5.895 mmol) of methyl carboxylate and 2 ml of concentrated hydrochloric acid in 20 ml of water, a solution of 0.49 g (7.07 mmol) of sodium nitrite in 1 ml of water was added dropwise under ice-cooling. The mixture was stirred at the same temperature for 10 minutes. Under ice-cooling, 1.48 ml (10.0 mmol) of a 60% aqueous solution of hexafluorophosphoric acid was added to the reaction solution with vigorous stirring, followed by stirring for 0.5 hour. The resulting precipitate was filtered, washed with water and methanol-diethyl ether (1: 4), and dried to obtain a diazonium salt as a white powder. The obtained diazonium salt was heated in 170 ml of liquid paraffin at 170 ° C. for 0.5 hour.
After cooling to room temperature, aqueous sodium hydrogen carbonate solution was added,
Extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 200 / 1-15 / 1) to obtain the desired product. White crystals Yield 0.487 g Yield 40% mp 44-45 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.72-1.83 (4
H, m), 2.74 (2H, br s), 3.08 (2H, br s), 3.86 (3H,
s), 6.87 (1H, t, J = 8.6 Hz), 7.73 (1H, dd, J = 6.
0 Hz, 8.6 Hz); IR (KBr) 2944, 1721, 1582, 1472, 14
33, 1260, 1254,1190, 1157, 1130, 1038, 770 cm -1 ; A
nal.Calcd for C 12 H 13 FO 2 : C, 69.22; H, 6.29. Found:
C, 69.39; H, 6.43. 3) 4-Fluoro-5,6,7,8-tetrahydronaphthalene-1-carboxylic acid 4-fluoro-5,6,7,8-tetrahydronaphthalene-
0.434 g (2.084 mmol) of methyl 1-carboxylate in 10 ml of methanol-10 m in tetrahydrofuran
4.17 ml of 1N aqueous sodium hydroxide solution
(4.17 mmol) and stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from diethyl ether-hexane to obtain the desired product. White crystals Yield 0.308 g Yield 76% mp 172-173 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.74-1.82
(4H, m), 2.76 (2H, brs), 3.16 (2H, br s), 6.91 (1
H, t, J = 8.8 Hz), 7.91 (1H, dd, J = 6.1 Hz, 8.5 H
z); IR (KBr) 3100-2600, 1686, 1588, 1429, 1304, 12
73, 1250, 1188 cm -1 ; Anal.Calcd for C 11 H 11 FO 2 : C,
68.03; H, 5.71. Found: C, 68.10; H, 6.00.4.) 4-Fluoro-N-[(1RS, 2SR) -2- (4-
Fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -5,6,7,8-tetrahydronaphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- ( 0.164 g (0.523 mmol) of 4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 4-fluoro-5,6,7,8-tetrahydronaphthalene-1- Carboxylic acid 0.10 g (0.52 mmol), 1-hydroxybenzotriazole hydrate 80 m
While stirring g (0.52 mmol) in 10 ml of acetonitrile, 0.10 g (0.52 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. . The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White crystal Yield 0.220 g Yield 86% mp 241-242 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 1.
53-1.75 (4H, m), 2.11-2.26 (1H, m), 2.30 2.48 (1H,
m), 2.61-2.67 (2H, m), 2.78-3.02 (2H, m), 4.59-4.
73 (1H, m), 4.95 (1H, t, J = 3.9 Hz), 5.10 (1H, d,
J = 3.6 Hz), 6.69-6.87 (3H, m), 7.06 (2H, t, J =
8.6 Hz), 7.30 (2H, d, J = 8.2 Hz), 7.47-7.54 (4H,
m); IR (KBr) 3272, 2942, 1642, 1514, 1327, 1229, 1
165, 1121,1069, 831 cm -1 ; Anal.Calcd for C 27 H 24 F 5
NO 2 : C, 66.25; H, 4.94; N, 2.86. Found: C, 66.30;
H, 5.18; N, 2.66.
【0164】実施例32 5-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[4-(トリフルオロ
メチル)ベンジル]エチル]ナフタレン-1-カルボキサ
ミド 1) 5-ニトロ-1-ナフトエ酸エチル 5-ニトロ-1-ナフトエ酸(Chem.Pharm.B
ull.,32,3968-80(1984)参照)
5.995g(27.60ミリモル)、濃硫酸2mlの
エタノール100ml溶液を1日間加熱還流した。反応
液を濃縮後、酢酸エチルで希釈、炭酸水素ナトリウム水
溶液および水で洗浄した。得られた酢酸エチル溶液を無
水硫酸マグネシウムで乾燥、溶媒を減圧留去して、目的
物を得た。黄色固体 収量6.212g 収率92% エタノールより再結晶して、淡黄色粉末を得た。 mp 92-93℃; 1H-NMR (CDCl3, 200MHz) δ 1.48 (3H, t,
J = 7.2 Hz), 4.50 (2H, q, J = 7.1 Hz), 7.67 (1H,
dd, J = 7.6 Hz, 8.8 Hz), 7.74 (1H, dd, J = 7.2 Hz,
8.8 Hz), 8.20 (1H, dd, J = 1.1 Hz, 7.7 Hz), 8.29
(1H, dd, J = 1.1Hz, 7.3 Hz), 8.66 (1H, td, J = 1.0
Hz, 8.8 Hz), 9.26 (1H, td, J = 1.0 Hz, 8.6 Hz); I
R (KBr) 1725, 1520, 1354, 1277, 1155, 793, 764 cm
-1; Anal.Calcd for C13H11NO4: C, 63.67; H, 4.52;
N, 5.71. Found: C, 63.45; H, 4.47; N, 5.69. 2) 5-アミノ-1-ナフトエ酸エチル 5-ニトロ-1-ナフトエ酸エチル3.304g(13.
47ミリモル)のエタノール10ml−テトラヒドロフ
ラン20ml溶液を10%パラジウム/炭素(50%含
水)0.5gを触媒として、原料が消失するまで常温常
圧下で水素添加した。触媒を濾過して除いた後、溶媒を
減圧留去した。得られた粗生成物をシリカゲルカラムク
ロマトグラフィーにて精製し(ヘキサン/酢酸エチル=
6/1−3/1)、目的物を得た。黄色液体 収量2.
797g 収率97%1 H-NMR (CDCl3, 200MHz) δ 1.45 (3H, t, J = 7.1 H
z), 4.16 (2H, br s), 4.47 (2H, q, J = 7.1 Hz), 6.8
5 (1H, dd, J = 0.8 Hz, 7.4 Hz), 7.41 (1H, dd,J =
7.5 Hz, 8.5 Hz), 7.47 (1H, dd, J = 7.2 Hz, 8.6 H
z), 8.05 (1H, td, J= 1.1 Hz, 8.5 Hz), 8.11 (1H, d
d, J = 1.2 Hz, 7.2 Hz), 8.28 (1H, td, J =0.9 Hz,
8.6 Hz); IR (neat) 3378, 2980, 1705, 1634, 1582, 1
464, 1260, 1213, 1107, 783 cm-1 3) 5-フルオロ-1-ナフトエ酸 5-アミノ-1-ナフトエ酸エチル1.380g(6.4
11ミリモル)、濃塩酸2mlを水15ml中で撹拌し
ながら、氷冷下、亜硝酸ナトリウム0.53g(7.6
9ミリモル)の水1.5ml溶液を滴下し、そのままの
温度で10分間撹拌した。反応液に氷冷下、60%ヘキ
サフルオロリン酸水溶液1.61ml(10.9ミリモ
ル)を激しく撹拌しながら加え、そのまま0.5時間撹
拌した。生じた沈殿をろ過し、水およびメタノール-ジ
エチルエーテル(1:4)で洗浄後、乾燥して、ジアゾ
ニウム塩を褐色粉末として得た。得られたジアゾニウム
塩を流動パラフィン8ml中で、170℃にて0.5時
間加熱した。室温に冷却した後、炭酸水素ナトリウム水
溶液を加え、酢酸エチルで2回抽出した。集めた有機層
を無水硫酸マグネシウムで乾燥、溶媒を減圧留去した。
得られた粗生成物をシリカゲルカラムクロマトグラフィ
ーにて精製し(ヘキサン/酢酸エチル=15/1)、5
-フルオロ-1-ナフトエ酸エチルと流動パラフィンの混
合物を無色液体として得た。得られた液体のエタノール
30ml−テトラヒドロフラン30ml溶液に1N水酸
化ナトリウム水溶液8ml(8ミリモル)を加え、室温
で一晩撹拌した。反応液を濃縮、水で希釈し、ジエチル
エーテルで洗浄した。得られた水溶液を1N塩酸で酸性
にし、生じた結晶をろ過し、水とヘキサンで洗浄して、
目的物を得た。白色結晶 収量0.409g 収率34
% mp 214-216℃; 1H-NMR (DMSO-d6, 200MHz) δ 7.44 (1
H, dd, J = 7.8 Hz, 10.4Hz), 7.60-7.75 (2H, m), 8.2
5 (1H, d, J = 7.0 Hz), 8.32 (1H, d, J = 8.8Hz), 8.
70 (1H, d, J = 8.4 Hz); IR (KBr) 3100-2500, 1678,
1599, 1302, 1246, 1117, 887, 781 cm-1; Anal. Calcd
for C11H7FO2: C, 69.47; H, 3.71. Found: C, 69.24;
H, 3.45. 4) 5-フルオロ-N-[(1RS,2SR)-2-(4-
フルオロフェニル)-2-ヒドロキシ-1-[4-(トリフ
ルオロメチル)ベンジル]エチル]ナフタレン-1-カル
ボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.163g(0.520ミリモ
ル)、5-フルオロ-1-ナフトエ酸0.10g(0.5
2ミリモル)、1-ヒドロキシベンゾトリアゾール水和
物80mg(0.52ミリモル)をアセトニトリル10
ml中で撹拌しながら1-エチル-3-(3-ジメチルアミ
ノプロピル)カルボジイミド・塩酸塩0.10g(0.
52ミリモル)を加え、室温で一晩撹拌した。反応液を
酢酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗
浄、無水硫酸マグネシウムで乾燥、シリカゲルを通した
後、溶媒を減圧留去した。得られた残留物を酢酸エチル
−ヘキサンより結晶化して、目的物を得た。白色結晶
収量0.216g 収率86% mp 222-224℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
93 (1H, dd, J = 10.8 Hz, 14.0 Hz), 3.19 (1H, dd, J
= 3.5 Hz, 14.5 Hz), 4.65-4.80 (1H, m), 4.91(1H,
t, J = 4.8 Hz), 5.44 (1H, d, J = 4.0 Hz), 7.02-7.2
9 (6H, m), 7.38-7.59 (7H, m), 7.90 (1H, d, J = 9.4
Hz), 8.08 (1H, d, J = 8.4 Hz); IR (KBr) 3283, 164
2, 1537, 1514, 1327, 1248, 1227, 1163, 1121, 1069,
831, 783cm-1; Anal. Calcd for C27H20F5NO2: C, 66.80; H, 4.15; N,
2.89. Found: C, 66.65; H, 4.21; N, 2.68.Example 32 5-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene-1- Carboxamide 1) Ethyl 5-nitro-1-naphthoic acid 5-Nitro-1-naphthoic acid (Chem. Pharm. B
ull. , 32, 3968-80 (1984)).
A solution of 5.995 g (27.60 mmol) and 2 ml of concentrated sulfuric acid in 100 ml of ethanol was heated to reflux for 1 day. After concentration, the reaction solution was diluted with ethyl acetate and washed with an aqueous sodium hydrogen carbonate solution and water. The obtained ethyl acetate solution was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain the desired product. Yellow solid Yield: 6.212 g Yield: 92% Recrystallization from ethanol gave a pale yellow powder. mp 92-93 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 1.48 (3H, t,
J = 7.2 Hz), 4.50 (2H, q, J = 7.1 Hz), 7.67 (1H,
dd, J = 7.6 Hz, 8.8 Hz), 7.74 (1H, dd, J = 7.2 Hz,
8.8 Hz), 8.20 (1H, dd, J = 1.1 Hz, 7.7 Hz), 8.29
(1H, dd, J = 1.1Hz, 7.3 Hz), 8.66 (1H, td, J = 1.0
Hz, 8.8 Hz), 9.26 (1H, td, J = 1.0 Hz, 8.6 Hz); I
R (KBr) 1725, 1520, 1354, 1277, 1155, 793, 764 cm
-1 ; Anal.Calcd for C 13 H 11 NO 4 : C, 63.67; H, 4.52;
N, 5.71. Found: C, 63.45; H, 4.47; N, 5.69. 2) Ethyl 5-amino-1-naphthoate 3.304 g of ethyl 5-nitro-1-naphthoate (13.
A solution (47 mmol) of ethanol (10 ml) -tetrahydrofuran (20 ml) was hydrogenated under normal temperature and pressure until the raw materials disappeared using 10% palladium / carbon (50% water-containing) 0.5 g as a catalyst. After removing the catalyst by filtration, the solvent was distilled off under reduced pressure. The obtained crude product is purified by silica gel column chromatography (hexane / ethyl acetate =
6 / 1-3 / 1) to obtain the desired product. Yellow liquid yield 2.
797 g 97% yield 1 H-NMR (CDCl 3 , 200 MHz) δ 1.45 (3H, t, J = 7.1 H
z), 4.16 (2H, br s), 4.47 (2H, q, J = 7.1 Hz), 6.8
5 (1H, dd, J = 0.8 Hz, 7.4 Hz), 7.41 (1H, dd, J =
7.5 Hz, 8.5 Hz), 7.47 (1H, dd, J = 7.2 Hz, 8.6 H
z), 8.05 (1H, td, J = 1.1 Hz, 8.5 Hz), 8.11 (1H, d
d, J = 1.2 Hz, 7.2 Hz), 8.28 (1H, td, J = 0.9 Hz,
8.6 Hz); IR (neat) 3378, 2980, 1705, 1634, 1582, 1
464, 1260, 1213, 1107, 783 cm -1 3) Ethyl 5-fluoro-1-naphthoate 1.380 g (6.4 g of ethyl 5-amino-1-naphthoate)
11 mmol) and 0.53 g (7.6 g) of sodium nitrite under ice-cooling while stirring 2 ml of concentrated hydrochloric acid in 15 ml of water.
(9 mmol) was added dropwise and stirred at the same temperature for 10 minutes. Under ice-cooling, 1.61 ml (10.9 mmol) of a 60% aqueous solution of hexafluorophosphoric acid was added to the reaction solution with vigorous stirring, followed by stirring for 0.5 hour. The resulting precipitate was filtered, washed with water and methanol-diethyl ether (1: 4), and dried to obtain a diazonium salt as a brown powder. The obtained diazonium salt was heated in 170 ml of liquid paraffin at 170 ° C. for 0.5 hour. After cooling to room temperature, an aqueous sodium hydrogen carbonate solution was added, and the mixture was extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure.
The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15/1).
A mixture of ethyl-fluoro-1-naphthoate and liquid paraffin was obtained as a colorless liquid. To a solution of the obtained liquid in 30 ml of ethanol-30 ml of tetrahydrofuran was added 8 ml (8 mmol) of a 1N aqueous sodium hydroxide solution, and the mixture was stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, and washed with diethyl ether. The resulting aqueous solution was acidified with 1N hydrochloric acid, the resulting crystals were filtered, washed with water and hexane,
The desired product was obtained. White crystals Yield 0.409 g Yield 34
% Mp 214-216 ° C; 1 H-NMR (DMSO-d 6 , 200 MHz) δ 7.44 (1
H, dd, J = 7.8 Hz, 10.4 Hz), 7.60-7.75 (2H, m), 8.2
5 (1H, d, J = 7.0 Hz), 8.32 (1H, d, J = 8.8Hz), 8.
70 (1H, d, J = 8.4 Hz); IR (KBr) 3100-2500, 1678,
1599, 1302, 1246, 1117, 887, 781 cm -1 ; Anal.Calcd
for C 11 H 7 FO 2 : C, 69.47; H, 3.71. Found: C, 69.24;
H, 3.45. 4) 5-Fluoro-N-[(1RS, 2SR) -2- (4-
Fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4 -(Trifluoromethyl) phenyl] propan-1-ol 0.163 g (0.520 mmol), 5-fluoro-1-naphthoic acid 0.10 g (0.5
80 mg (0.52 mmol) of 1-hydroxybenzotriazole hydrate in 10 ml of acetonitrile
While stirring in 0.1 ml, 0.10 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.
52 mmol) and stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals
Yield 0.216 g Yield 86% mp 222-224 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
93 (1H, dd, J = 10.8 Hz, 14.0 Hz), 3.19 (1H, dd, J
= 3.5 Hz, 14.5 Hz), 4.65-4.80 (1H, m), 4.91 (1H,
t, J = 4.8 Hz), 5.44 (1H, d, J = 4.0 Hz), 7.02-7.2
9 (6H, m), 7.38-7.59 (7H, m), 7.90 (1H, d, J = 9.4
Hz), 8.08 (1H, d, J = 8.4 Hz); IR (KBr) 3283, 164
2, 1537, 1514, 1327, 1248, 1227, 1163, 1121, 1069,
. 831, 783cm -1; Anal Calcd for C 27 H 20 F 5 NO 2: C, 66.80; H, 4.15; N,
2.89. Found: C, 66.65; H, 4.21; N, 2.68.
【0165】実施例33 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-5,6,7,8-テトラヒドロナフタレ
ン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.168g(0.536ミリモ
ル)、1,2,3,4-テトラヒドロナフタレン-1-カ
ルボン酸(Tetrahedron,53,15969
-15982(1990)参照)94mg(0.54ミ
リモル)、1-ヒドロキシベンゾトリアゾール水和物8
2mg(0.54ミリモル)をアセトニトリル10ml
中で撹拌しながら1-エチル-3-(3-ジメチルアミノプ
ロピル)カルボジイミド・塩酸塩0.10g(0.54
ミリモル)を加え、室温で一晩撹拌した。反応液を酢酸
エチルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無
水硫酸マグネシウムで乾燥、シリカゲルを通した後、溶
媒を減圧留去した。得られた残留物を酢酸エチル−ヘキ
サンより結晶化して、目的物を得た。白色結晶 収量
0.161g 収率64% mp 219-221℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 1.
50-1.73 (4H, m), 2.05-2.35 (2H, m), 2.70 (2H, t, J
= 6.4 Hz), 2.88 (1H, dd, J = 10.8 Hz, 14.4Hz), 3.
06 (1H, dd, J = 3.8 Hz, 14.0 Hz), 4.55-4.70 (1H,
m), 4.87 (1H, t,J = 4.4 Hz), 5.33 (1H, d, J = 3.6
Hz), 6.74 (1H, dd, J = 2.8 Hz, 5.6 Hz), 6.95-7.09
(4H, m), 7.28-7.37 (3H, m), 7.47-7.54 (4H, m); IR
(KBr) 3330, 1624, 1534, 1329, 1159, 1123, 1069, 83
1 cm-1; Anal. Calcd for C27H25F 4NO2: C, 68.78; H,
5.34; N, 2.97. Found: C, 68.62; H, 5.38; N, 2.90.Example 33 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) ben
[Zyl] ethyl] -5,6,7,8-tetrahydronaphthale
1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophene)
Nyl) -3- [4- (trifluoromethyl) phenyl] p
0.168 g of Lopan-1-ol (0.536 mm
Le), 1,2,3,4-tetrahydronaphthalene-1-ca
Rubonic acid (Tetrahedron, 53, 15969)
-15982 (1990)) 94mg (0.54m
Lmol) 1-hydroxybenzotriazole hydrate 8
2 mg (0.54 mmol) in 10 ml of acetonitrile
1-ethyl-3- (3-dimethylaminopropyl)
Ropyl) carbodiimide hydrochloride 0.10 g (0.54
Mmol) and stirred at room temperature overnight. Acetic acid
Dilute to ethyl, wash with aqueous sodium bicarbonate,
After drying over magnesium sulfate and passing through silica gel,
The medium was distilled off under reduced pressure. The residue obtained is ethyl acetate-hexane.
Crystallization from sun gave the desired product. White crystals Yield
0.161 g yield 64% mp 219-221 ° C;1H-NMR (CDClThree-DMSO-d6, 200MHz) δ 1.
50-1.73 (4H, m), 2.05-2.35 (2H, m), 2.70 (2H, t, J
= 6.4 Hz), 2.88 (1H, dd, J = 10.8 Hz, 14.4Hz), 3.
06 (1H, dd, J = 3.8 Hz, 14.0 Hz), 4.55-4.70 (1H,
m), 4.87 (1H, t, J = 4.4 Hz), 5.33 (1H, d, J = 3.6
Hz), 6.74 (1H, dd, J = 2.8 Hz, 5.6 Hz), 6.95-7.09
(4H, m), 7.28-7.37 (3H, m), 7.47-7.54 (4H, m); IR
(KBr) 3330, 1624, 1534, 1329, 1159, 1123, 1069, 83
1 cm-1; Anal. Calcd for C27Htwenty fiveF FourNOTwo: C, 68.78; H,
5.34; N, 2.97. Found: C, 68.62; H, 5.38; N, 2.90.
【0166】実施例34 4-クロロ-N-[(1RS,2SR)-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-[4-(トリフルオロメ
チル)ベンジル]エチル]ナフタレン-1-カルボキサミ
ド 1) 4-アミノ-1-ナフトエ酸・塩酸塩 4-アミノ-1-ナフタレンカルボニトリル9.948g
(59.14ミリモル)と水酸化カリウム25gを水1
50ml中で1日間加熱還流した。反応液を室温に冷却
した後、水150mlに希釈し、不溶物をろ別した。ろ
液を濃塩酸で酸性にし、生じた沈殿をろ過して集め、エ
タノールと水で洗浄して、目的物を得た。褐色粉末 収
量4.67g 収率35%1 H-NMR (DMSO-d6, 200MHz) δ 6.75 (1H, d, J = 8.4 H
z), 7.40-7.48 (1H, m),7.52-7.61 (1H, m), 8.06 (1H,
d, J = 8.6 Hz), 8.16 (1H, d, J = 7.6 Hz),9.10 (1
H, d, J = 7.8 Hz); IR (KBr) 2838, 1686, 1503, 126
0, 1204, 1094, 766 cm-1 2) 4-クロロ-1-ナフトエ酸メチル 4-アミノ-1-ナフトエ酸・塩酸塩2.330g(1
0.42ミリモル)を濃塩酸20ml中で撹拌しなが
ら、氷冷下、亜硝酸ナトリウム0.72g(10.4ミ
リモル)の水2ml溶液を滴下し、そのままの温度で
0.5時間撹拌した。反応液に氷冷下、塩化第一銅0.
57g(5.73ミリモル)の濃塩酸4ml溶液および
濃塩酸50mlを加え、100℃で4時間撹拌した。室
温に冷却した後、生じた沈殿をろ過して集め、水で洗浄
した。得られた沈殿を、10%塩化水素のメタノール溶
液40ml中で70℃にて一晩撹拌した。反応液の溶媒
を減圧留去し、得られた粗生成物をシリカゲルカラムク
ロマトグラフィーにて精製し(ヘキサン/酢酸エチル=
9/1)、目的物を得た。黄色液体 収量0.299g
収率13%1 H-NMR (CDCl3, 200MHz) δ 4.00 (3H, s), 7.58-7.73
(3H, m), 8.09 (1H, d,J = 7.8 Hz), 8.32-8.38 (1H,
m), 8.92-9.01 (1H, m); IR (neat) 1717, 1508,1275,
1246, 1194, 1140, 1024, 787, 766 cm-1 3) 4-クロロ-1-ナフトエ酸 4-クロロ-1-ナフトエ酸メチル0.299g(1.3
55ミリモル)のメタノール10ml−テトラヒドロフ
ラン5ml溶液に1N水酸化ナトリウム水溶液2.71
ml(2.71ミリモル)を加え、室温で一晩撹拌し
た。反応液を濃縮、水で希釈し、1N塩酸で反応液を酸
性にした後、酢酸エチルで2回抽出した。集めた有機層
を無水硫酸ナトリウムで乾燥、溶媒を減圧留去した。残
留物をジエチルエーテル−ヘキサンより結晶化して、目
的物を得た。淡褐色結晶 収量0.234g 収率84
% mp 215-217℃; 1H-NMR (DMSO-d6, 200MHz) δ 7.74-7.8
5 (3H, m), 8.12 (1H, d, J = 7.6 Hz), 8.27 8.35 (1
H, m), 8.91-9.00 (1H, m); IR (KBr) 3100-2500,1690,
1510, 1283, 1252, 785, 762 cm-1; Anal. Calcd for
C11H7ClO2・0.2H2O: C, 62.85; H, 3.55. Found: C, 62.
99; H, 3.31. 4) 4-クロロ-N-[(1RS,2SR)-2-(4-フ
ルオロフェニル)-2-ヒドロキシ-1-[4-(トリフル
オロメチル)ベンジル]エチル]ナフタレン-1-カルボ
キサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.155g(0.495ミリモ
ル)、4-クロロ-1-ナフトエ酸0.10g(0.49
ミリモル)、1-ヒドロキシベンゾトリアゾール水和物
76mg(0.49ミリモル)をアセトニトリル10m
l中で撹拌しながら1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド・塩酸塩95mg(0.49
ミリモル)を加え、室温で一晩撹拌した。反応液を酢酸
エチルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無
水硫酸マグネシウムで乾燥、シリカゲルを通した後、溶
媒を減圧留去した。得られた残留物を酢酸エチル−ヘキ
サンより結晶化して、目的物を得た。白色結晶 収量
0.173g 収率70% mp 222-223℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
92 (1H, dd, J = 10.5 Hz, 14.1 Hz), 3.07 (1H, dd, J
= 3.1 Hz, 14.1 Hz), 4.70-4.85 (1H, m), 5.00(1H,
t, J = 3.8 Hz), 5.23 (1H, d, J = 3.8 Hz), 7.07 (1
H, d, J = 8.8 Hz), 7.13 (2H, t, J = 8.6 Hz), 7.27-
7.62 (11H, m), 8.24 (1H, d, J = 8.4 Hz); IR (KBr)
3274, 1638, 1537, 1514, 1327, 1163, 1125, 1069, 83
3 cm-1; Anal. Calcd for C27H20ClF4NO2: C, 64.61;
H, 4.02; N, 2.79. Found: C, 64.26;H, 3.88; N, 2.5
9.Example 34 4-Chloro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene-1- Carboxamide 1) 9.948 g of 4-amino-1-naphthoic acid / hydrochloride 4-amino-1-naphthalenecarbonitrile
(59.14 mmol) and 25 g of potassium hydroxide in water 1
Heated to reflux in 50 ml for 1 day. After cooling the reaction solution to room temperature, it was diluted with 150 ml of water, and the insoluble matter was filtered off. The filtrate was acidified with concentrated hydrochloric acid, and the resulting precipitate was collected by filtration and washed with ethanol and water to obtain the desired product. Brown powder Yield 4.67 g Yield 35% 1 H-NMR (DMSO-d 6 , 200 MHz) δ 6.75 (1 H, d, J = 8.4 H)
z), 7.40-7.48 (1H, m), 7.52-7.61 (1H, m), 8.06 (1H,
d, J = 8.6 Hz), 8.16 (1H, d, J = 7.6 Hz), 9.10 (1
H, d, J = 7.8 Hz); IR (KBr) 2838, 1686, 1503, 126
0, 1204, 1094, 766 cm -1 2) Methyl 4-chloro-1-naphthoate 2.330 g (1
(0.42 mmol) in 20 ml of conc. The reaction solution was cooled with ice, and cuprous chloride was added to the reaction mixture.
A solution of 57 g (5.73 mmol) in 4 ml of concentrated hydrochloric acid and 50 ml of concentrated hydrochloric acid were added, and the mixture was stirred at 100 ° C. for 4 hours. After cooling to room temperature, the resulting precipitate was collected by filtration and washed with water. The resulting precipitate was stirred overnight at 70 ° C. in 40 ml of a 10% solution of hydrogen chloride in methanol. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate =
9/1), the desired product was obtained. 0.299 g of yellow liquid
Yield 13% 1 H-NMR (CDCl 3 , 200 MHz) δ 4.00 (3H, s), 7.58-7.73
(3H, m), 8.09 (1H, d, J = 7.8 Hz), 8.32-8.38 (1H,
m), 8.92-9.01 (1H, m); IR (neat) 1717, 1508,1275,
1246, 1194, 1140, 1024, 787, 766 cm -1 3) 4-chloro-1-naphthoic acid 0.299 g of methyl 4-chloro-1-naphthoate (1.3 g)
(55 mmol) in methanol (10 ml) -tetrahydrofuran (5 ml) was added to a 1N aqueous sodium hydroxide solution (2.71).
ml (2.71 mmol) was added and stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from diethyl ether-hexane to obtain the desired product. Light brown crystals Yield 0.234 g Yield 84
% Mp 215-217 ° C .; 1 H-NMR (DMSO-d 6 , 200 MHz) δ 7.74-7.8
5 (3H, m), 8.12 (1H, d, J = 7.6 Hz), 8.27 8.35 (1
H, m), 8.91-9.00 (1H, m); IR (KBr) 3100-2500,1690,
1510, 1283, 1252, 785, 762 cm -1 ; Anal.Calcd for
C 11 H 7 ClO 2・ 0.2H 2 O: C, 62.85; H, 3.55. Found: C, 62.
99; H, 3.31.4) 4-Chloro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene- 1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.155 g (0.495 mmol), 4 -Chloro-1-naphthoic acid 0.10 g (0.49
Mmol) 1-hydroxybenzotriazole hydrate (76 mg, 0.49 mmol) in acetonitrile 10 m
1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 95 mg (0.49
Mmol) and stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 0.173 g Yield 70% mp 222-223 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
92 (1H, dd, J = 10.5 Hz, 14.1 Hz), 3.07 (1H, dd, J
= 3.1 Hz, 14.1 Hz), 4.70-4.85 (1H, m), 5.00 (1H,
t, J = 3.8 Hz), 5.23 (1H, d, J = 3.8 Hz), 7.07 (1
H, d, J = 8.8 Hz), 7.13 (2H, t, J = 8.6 Hz), 7.27-
7.62 (11H, m), 8.24 (1H, d, J = 8.4 Hz); IR (KBr)
3274, 1638, 1537, 1514, 1327, 1163, 1125, 1069, 83
. 3 cm -1; Anal Calcd for C 27 H 20 ClF 4 NO 2: C, 64.61;
H, 4.02; N, 2.79.Found: C, 64.26; H, 3.88; N, 2.5
9.
【0167】実施例35 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]ナフタレン-1-カルボキサミド 1) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-[4-(トリフルオロメチル)ベンジ
ル]プロパン-1-オール・塩酸塩 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシエチル-1-[4-(トリフルオロメチ
ル)ベンジル]]カルバミン酸tert-ブチル2.5
8g(6.24ミリモル)のエタノール35ml溶液に
20%塩化水素エタノール溶液35mlを加えて30分
間加熱還流した。反応液を減圧下濃縮し、残留物をジエ
チルエーテルで洗浄して、目的物2.05g(94%)
を結晶として得た。 mp 173-174℃; 1H-NMR (DMSO-d6, 200MHz) δ 2.79 (2
H, d, J = 6.6 Hz), 3.64-3.80 (1H, m), 5.03 (1H,
s), 6.30 (1H, d, J = 4.0 Hz), 7.10-7.24 (2H, m),
7.33 (2H, d, J = 8.0 Hz), 7.38-7.50 (2H, m), 7.59
(2H, d, J = 8.0 Hz),8.07 (2H, br s); IR (KBr) 331
4, 3009 cm-1; Anal. Calcd for C16H16ClF4NO・0.5H2O:
C, 53.57; H, 4.78; N, 3.90. Found: C, 53.81; H,
4.81; N, 3.74. 2) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[4-(トリフルオロメチ
ル)ベンジル]エチル]ナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)ベンジル]プ
ロパン-1-オール・塩酸塩780mg(1.89ミリモ
ル)の酢酸エチル5ml溶液に1-ナフトイルクロリド
0.43ml(2.84ミリモル)と飽和重曹水5ml
を加えて30分間撹拌した。反応液を水で希釈し、酢酸
エチルで抽出した。抽出液を飽和食塩水で洗浄した後、
硫酸マグネシウムで乾燥し減圧下濃縮した。残留物をシ
リカゲルカラムクロマトグラフィー(酢酸エチル/ヘキ
サン=1/2)で精製した後、酢酸エチル−ヘキサンか
ら再結晶して、目的物354mg(40%)を結晶とし
て得た。 mp 214-216℃; 1H-NMR (CDCl3, 200MHz) δ 2.89 (1H,
dd, J = 11.0 Hz, 14.0Hz), 3.09 (1H, dd, J = 4.6 H
z, 13.6 Hz), 3.28 (1H, br s), 4.74-4.91 (1H,m), 5.
12 (1H, br s), 5.94 (1H, br d, J = 9.4 Hz), 7.05-
7.24 (2H, m), 7.30-7.66 (11H, m), 7.84 (2H, t, J =
9.3 Hz); IR (KBr) 3366, 3285, 1636 cm -1; Anal. Ca
lcd for C27H21F4NO2: C, 69.37; H, 4.53; N, 3.00. F
ound: C, 69.17; H, 4.56; N, 2.88.Example 35 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) ben
[Zyl] ethyl] naphthalene-1-carboxamide 1) (1RS, 2SR) -2-amino-1- (4-fluoro)
L-phenyl) -3- [4- (trifluoromethyl) benzyl
Ru] propan-1-ol hydrochloride N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxyethyl-1- [4- (trifluoromethyl
Tert-butyl carbamate 2.5)
8 g (6.24 mmol) in 35 ml ethanol solution
35 ml of a 20% ethanolic hydrogen chloride solution is added and 30 minutes
The mixture was refluxed while heating. The reaction solution was concentrated under reduced pressure, and the residue was
After washing with chill ether, 2.05 g of the desired product (94%)
Was obtained as crystals. mp 173-174 ° C;1H-NMR (DMSO-d6, 200MHz) δ 2.79 (2
H, d, J = 6.6 Hz), 3.64-3.80 (1H, m), 5.03 (1H,
s), 6.30 (1H, d, J = 4.0 Hz), 7.10-7.24 (2H, m),
7.33 (2H, d, J = 8.0 Hz), 7.38-7.50 (2H, m), 7.59
(2H, d, J = 8.0 Hz), 8.07 (2H, br s); IR (KBr) 331
4, 3009 cm-1; Anal. Calcd for C16H16ClFFourNO ・ 0.5HTwoO:
C, 53.57; H, 4.78; N, 3.90. Found: C, 53.81; H,
4.81; N, 3.74.2) N-[(1RS, 2SR) -2- (4-fluorophene)
Nil) -2-hydroxy-1- [4- (trifluoromethyl
L) benzyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophene)
Nyl) -3- [4- (trifluoromethyl) benzyl] p
Lopan-1-ol hydrochloride 780 mg (1.89 mmol
1) -Naphthoyl chloride in 5 ml of ethyl acetate
0.43 ml (2.84 mmol) and 5 ml of saturated aqueous sodium bicarbonate
Was added and stirred for 30 minutes. Dilute the reaction with water and add acetic acid
Extracted with ethyl. After washing the extract with saturated saline,
It was dried over magnesium sulfate and concentrated under reduced pressure. Remove the residue
Ricagel column chromatography (ethyl acetate / hex
After purifying with sun = 1/2), use ethyl acetate-hexane
To give 354 mg (40%) of the desired product as crystals
I got it. mp 214-216 ° C;1H-NMR (CDClThree, 200MHz) δ 2.89 (1H,
dd, J = 11.0 Hz, 14.0Hz), 3.09 (1H, dd, J = 4.6 H
z, 13.6 Hz), 3.28 (1H, br s), 4.74-4.91 (1H, m), 5.
12 (1H, br s), 5.94 (1H, br d, J = 9.4 Hz), 7.05-
7.24 (2H, m), 7.30-7.66 (11H, m), 7.84 (2H, t, J =
9.3 Hz); IR (KBr) 3366, 3285, 1636 cm -1; Anal. Ca
lcd for C27Htwenty oneFFourNOTwo: C, 69.37; H, 4.53; N, 3.00. F
ound: C, 69.17; H, 4.56; N, 2.88.
【0168】実施例36 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-4-メチル-1-ナフタレンカ
ルボキサミド (1R,2S)-2-アミノ-1-(4-フルオロフェニ
ル)-3-(4-(トリフルオロメチル)フェニル)-1-
プロパノール(450mg,1.44ミリモル)のアセ
トニトリル(30ml)溶液に4-メチル-1-ナフタレ
ンカルボン酸(268mg,1.44ミリモル)および
1-エチル-3-(3-ジメチルアミノプロピル)カルボジ
イミド・塩酸塩(413mg,2.15ミリモル)およ
び1-ヒドロキシ-1H-ベンゾトリアゾール(220m
g,1.44ミリモル)を加えて室温で終夜攪拌した。
反応液を水(100ml)で希釈し、酢酸エチル(10
0ml×2)で抽出した。抽出液を飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
アセトン=1:1)で精製し、酢酸エチル−ヘキサンか
ら再結晶させて、表題化合物(487mg,70%)を
得た。 mp 198-199℃ IRνmaxKBrcm-1: 1636, 1620, 1607. Anal. Calcd for C28H23F4NO2: C, 69.85; H, 4.81; N,
2.91 Found: C, 69.80; H, 4.92; N, 2.79.1 H-NMR (CDCl3)δ: 2.58 (3H, s), 2.66-3.06 (1H, m),
3.33 (1H, brs), 4.60-4.80 (1H, m), 4.98-5.06 (1H,
m), 5.80 (1H, d, J = 8.2 Hz), 6.92-7.54 (12H, m),
7.59 (1H, d, J = 8.6 Hz), 7.89 (1H, d, J = 8.2 H
z).Example 36 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4-methyl-1-naphthalenecarboxamide (1R, 2S) -2-amino-1- (4-fluorophenyl)- 3- (4- (trifluoromethyl) phenyl) -1-
In a solution of propanol (450 mg, 1.44 mmol) in acetonitrile (30 ml), 4-methyl-1-naphthalenecarboxylic acid (268 mg, 1.44 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide. Salt (413 mg, 2.15 mmol) and 1-hydroxy-1H-benzotriazole (220 m
g, 1.44 mmol) and stirred at room temperature overnight.
The reaction solution was diluted with water (100 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Purification with acetone = 1: 1) and recrystallization from ethyl acetate-hexane gave the title compound (487 mg, 70%). mp 198-199 ℃ IRνmax KBr cm -1 : 1636, 1620, 1607. Anal.Calcd for C 28 H 23 F 4 NO 2 : C, 69.85; H, 4.81; N,
2.91 Found:. C, 69.80; H, 4.92; N, 2.79 1 H-NMR (CDCl 3) δ: 2.58 (3H, s), 2.66-3.06 (1H, m),
3.33 (1H, brs), 4.60-4.80 (1H, m), 4.98-5.06 (1H,
m), 5.80 (1H, d, J = 8.2 Hz), 6.92-7.54 (12H, m),
7.59 (1H, d, J = 8.6 Hz), 7.89 (1H, d, J = 8.2 H
z).
【0169】実施例37 5-クロロ-N-[(1RS,2SR)-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-[4-(トリフルオロメ
チル)ベンジル]エチル]ナフタレン-1-カルボキサミ
ド 1) 5-クロロ-1-ナフトエ酸エチル 5-アミノ-1-ナフトエ酸エチル1.358g(6.3
09ミリモル)を濃塩酸10ml中で撹拌しながら、氷
冷下、亜硝酸ナトリウム0.52g(7.57ミリモ
ル)の水1ml溶液を滴下し、そのままの温度で0.5
時間撹拌した。反応液に氷冷下、塩化第一銅0.34g
(3.47ミリモル)の濃塩酸2ml溶液を加え、10
0℃で0.5時間撹拌した。室温に冷却した後、反応液
を水で希釈し、酢酸エチルで2回抽出した。集めた有機
層を無水硫酸ナトリウムで乾燥、溶媒を減圧留去した。
得られた粗生成物をシリカゲルカラムクロマトグラフィ
ーにて精製し(ヘキサン/酢酸エチル=15/1)、目
的物を得た。無色液体 収量0.713g 収率48%1 H-NMR (CDCl3, 200MHz) δ 1.47 (3H, t, J = 7.2 H
z), 4.48 (2H, q, J = 7.3Hz), 7.47-7.66 (3H, m), 8.
22 (1H, dd, J = 1.1 Hz, 7.3 Hz), 8.53 (1H, d,J =
8.6 Hz), 8.85 (1H, d, J = 8.4 Hz); IR (neat) 1717,
1262, 1196, 1142, 789 cm-1 2) 5-クロロ-1-ナフトエ酸 5-クロロ-1-ナフトエ酸エチル0.713g(3.0
38ミリモル)のメタノール20ml−テトラヒドロフ
ラン10ml溶液に1N水酸化ナトリウム水溶液4.5
6ml(4.56ミリモル)を加え、室温で一晩撹拌し
た。反応液を濃縮、水で希釈し、1N塩酸で反応液を酸
性にした。生じた沈殿をろ過して集め、水とヘキサンで
洗浄して、目的物を得た。白色結晶 収量0.547g
収率87% mp 248-250℃; 1H-NMR (DMSO-d6, 200MHz) δ 7.64 (1
H, t, J = 8.0 Hz), 7.74-7.83 (2H, m), 8.23 (1H, d,
J = 6.6 Hz), 8.46 (1H, d, J = 8.6 Hz), 8.84(1H,
d, J = 8.8 Hz); IR (KBr) 3100-2550, 1678, 1302, 78
3 cm-1; Anal. Calcd for C11H7ClO2: C, 63.94; H, 3.
41. Found: C, 63.96; H, 3.60. 3) 5-クロロ-N-[(1RS,2SR)-2-(4-フ
ルオロフェニル)-2-ヒドロキシ-1-[4-(トリフル
オロメチル)ベンジル]エチル]ナフタレン-1-カルボ
キサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.163g(0.520ミリモ
ル)、5-クロロ-1-ナフトエ酸0.11g(0.52
ミリモル)、1-ヒドロキシベンゾトリアゾール水和物
80mg(0.52ミリモル)をアセトニトリル10m
l中で撹拌しながら1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド・塩酸塩0.10g(0.5
2ミリモル)を加え、室温で一晩撹拌した。反応液を酢
酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗浄、
無水硫酸マグネシウムで乾燥、シリカゲルを通した後、
溶媒を減圧留去した。得られた残留物を酢酸エチル−ヘ
キサンより結晶化して、目的物を得た。白色結晶 収量
0.223g 収率85% mp 211-212℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
92 (1H, dd, J = 10.8 Hz, 14.0 Hz), 3.14 (1H, dd, J
= 2.7 Hz, 13.7 Hz), 4.68-4.83 (1H, m), 4.94(1H,
t, J = 4.5 Hz), 5.36 (1H, d, J = 3.6 Hz), 7.08 (2
H, t, J = 8.8 Hz), 7.17-7.58 (11H, m), 7.75 (1H,
d, J = 10.0 Hz), 8.27 (1H, d, J = 8.4 Hz); IR (KB
r) 3277, 1636, 1537, 1514, 1327, 1229, 1169, 1121,
1069, 1020,833, 785 cm-1; Anal. Calcd for C27H20C
lF4NO2: C, 64.61; H, 4.02; N, 2.79. Found: C, 64.4
7; H, 4.00; N, 2.58.Example 37 5-Chloro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene-1- Carboxamide 1) Ethyl 5-chloro-1-naphthoate 1.358 g of ethyl 5-amino-1-naphthoate (6.3 g)
(0.9 mmol) was added dropwise to a solution of 0.52 g (7.57 mmol) of sodium nitrite in 1 ml of water under ice-cooling while stirring in 10 ml of concentrated hydrochloric acid.
Stirred for hours. Cuprous chloride 0.34 g under ice-cooling
(3.47 mmol) in 2 ml of concentrated hydrochloric acid, and 10
Stirred at 0 ° C. for 0.5 hours. After cooling to room temperature, the reaction was diluted with water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure.
The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15/1) to obtain the desired product. Colorless liquid Yield 0.713 g Yield 48% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.47 (3H, t, J = 7.2 H)
z), 4.48 (2H, q, J = 7.3Hz), 7.47-7.66 (3H, m), 8.
22 (1H, dd, J = 1.1 Hz, 7.3 Hz), 8.53 (1H, d, J =
8.6 Hz), 8.85 (1H, d, J = 8.4 Hz); IR (neat) 1717,
1262, 1196, 1142, 789 cm -1 2) 5-chloro-1-naphthoic acid 0.713 g of ethyl 5-chloro-1-naphthoate (3.01 g)
38 mmol) in methanol (20 ml) -tetrahydrofuran (10 ml) and 1N aqueous sodium hydroxide solution (4.5).
6 ml (4.56 mmol) was added and stirred overnight at room temperature. The reaction solution was concentrated, diluted with water, and acidified with 1N hydrochloric acid. The resulting precipitate was collected by filtration and washed with water and hexane to obtain the desired product. 0.547 g of white crystals
Yield 87% mp 248-250 ° C; 1 H-NMR (DMSO-d 6 , 200 MHz) δ 7.64 (1
H, t, J = 8.0 Hz), 7.74-7.83 (2H, m), 8.23 (1H, d,
J = 6.6 Hz), 8.46 (1H, d, J = 8.6 Hz), 8.84 (1H,
d, J = 8.8 Hz); IR (KBr) 3100-2550, 1678, 1302, 78
3 cm -1 ; Anal.Calcd for C 11 H 7 ClO 2 : C, 63.94; H, 3.
41. Found: C, 63.96; H, 3.60.3) 5-Chloro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) Benzyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.163 g (0 .520 mmol) 0.11 g (0.52 mmol) of 5-chloro-1-naphthoic acid
80 mg (0.52 mmol) of 1-hydroxybenzotriazole hydrate in 10 m of acetonitrile
1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 0.10 g (0.5
2 mmol) and stirred at room temperature overnight. Dilute the reaction solution with ethyl acetate and wash with aqueous sodium hydrogen carbonate,
After drying over anhydrous magnesium sulfate and passing through silica gel,
The solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 0.223 g Yield 85% mp 211-212 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
92 (1H, dd, J = 10.8 Hz, 14.0 Hz), 3.14 (1H, dd, J
= 2.7 Hz, 13.7 Hz), 4.68-4.83 (1H, m), 4.94 (1H,
t, J = 4.5 Hz), 5.36 (1H, d, J = 3.6 Hz), 7.08 (2
H, t, J = 8.8 Hz), 7.17-7.58 (11H, m), 7.75 (1H,
d, J = 10.0 Hz), 8.27 (1H, d, J = 8.4 Hz); IR (KB
r) 3277, 1636, 1537, 1514, 1327, 1229, 1169, 1121,
1069, 1020,833, 785 cm -1 ; Anal.Calcd for C 27 H 20 C
lF 4 NO 2 : C, 64.61; H, 4.02; N, 2.79. Found: C, 64.4
7; H, 4.00; N, 2.58.
【0170】実施例38 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-4-ニトロ-5,6,7,8-テトラヒド
ロナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.139g(0.444ミリモ
ル)、4-ニトロ-5,6,7,8-テトラヒドロナフタ
レン-1-カルボン酸(Chem.Pharm.Bul
l.,32,3968-80(1984)参照)98m
g(0.44ミリモル)、1-ヒドロキシベンゾトリア
ゾール水和物68mg(0.44ミリモル)をアセトニ
トリル10ml中で撹拌しながら1-エチル-3-(3-ジ
メチルアミノプロピル)カルボジイミド・塩酸塩85m
g(0.44ミリモル)を加え、室温で一晩撹拌した。
反応液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶
液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲルを
通した後、溶媒を減圧留去した。得られた残留物を酢酸
エチル−ジイソプロピルエーテル−ヘキサンより結晶化
して、目的物を得た。白色結晶 収量0.146g 収
率64% mp 207-209℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 1.
51-1.75 (4H, m), 2.00-2.15 (1H, m), 2.28 2.43 (1H,
m), 2.80-3.07 (4H, m), 4.62-4.76 (1H, m), 4.93 (1
H, t, J = 4.2 Hz), 5.11 (1H, d, J = 3.6 Hz), 6.89
(1H, d, J = 8.0Hz), 7.08 (2H, t, J = 8.8 Hz), 7.18
(1H, d, J = 9.2 Hz), 7.32 (2H, d, J= 8.2 Hz), 7.4
8-7.54 (5H, m); IR (KBr) 3275, 2944, 1644, 1526, 1
331, 1159, 1127, 1069, 835 cm-1; Anal. Calcd for C
27H24F4N2O4: C, 62.79; H, 4.68; N, 5.42. Found: C,
62.53; H, 4.49; N, 5.30.Example 38 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -4-nitro-5,6,7,8-tetrahydronaphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- 0.139 g (0.444 mmol) of (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 4-nitro-5,6,7,8-tetrahydronaphthalene-1 -Carboxylic acid (Chem. Pharm. Bul)
l. , 32, 3968-80 (1984)) 98m
g (0.44 mmol) of 1-hydroxybenzotriazole hydrate (68 mg, 0.44 mmol) in 10 ml of acetonitrile while stirring 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 85 m
g (0.44 mmol) was added and stirred at room temperature overnight.
The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.146 g Yield 64% mp 207-209 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 1.
51-1.75 (4H, m), 2.00-2.15 (1H, m), 2.28 2.43 (1H,
m), 2.80-3.07 (4H, m), 4.62-4.76 (1H, m), 4.93 (1
H, t, J = 4.2 Hz), 5.11 (1H, d, J = 3.6 Hz), 6.89
(1H, d, J = 8.0Hz), 7.08 (2H, t, J = 8.8 Hz), 7.18
(1H, d, J = 9.2 Hz), 7.32 (2H, d, J = 8.2 Hz), 7.4
8-7.54 (5H, m); IR (KBr) 3275, 2944, 1644, 1526, 1
331, 1159, 1127, 1069, 835 cm -1 ; Anal.Calcd for C
27 H 24 F 4 N 2 O 4 : C, 62.79; H, 4.68; N, 5.42. Found: C,
62.53; H, 4.49; N, 5.30.
【0171】実施例39 6-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[4-(トリフルオロ
メチル)ベンジル]エチル]ナフタレン-1-カルボキサ
ミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.234g(0.747ミリモ
ル)、6-フルオロ-1-ナフトエ酸(欧州特許EP09
31547A1参照)0.14g(0.75ミリモ
ル)、1-ヒドロキシベンゾトリアゾール水和物0.1
1g(0.75ミリモル)をアセトニトリル10ml中
で撹拌しながら1-エチル-3-(3-ジメチルアミノプロ
ピル)カルボジイミド・塩酸塩0.14g(0.75ミ
リモル)を加え、室温で一晩撹拌した。反応液を酢酸エ
チルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無水
硫酸マグネシウムで乾燥、シリカゲルを通した後、溶媒
を減圧留去した。得られた残留物を酢酸エチル−ヘキサ
ンより結晶化して、目的物を得た。白色結晶 収量0.
302g 収率83% mp 223-224℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
85-3.08 (2H, m), 4.73-4.87 (1H, m), 5.04 (1H, s),
5.12 (1H, s), 7.05-7.16 (3H, m), 7.21-7.44 (6H,
m), 7.50-7.58 (5H, m), 7.79 (1H, d, J = 8.2 Hz); I
R (KBr) 3268, 1638, 1516, 1325, 1227, 1167, 1121,
1069, 864, 829 cm-1; Anal. Calcd for C27H20F5NO2・
0.1H2O: C, 66.56; H, 4.18; N, 2.87. Found: C, 66.3
8; H, 4.28; N, 3.11.Example 39 6-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene-1- Carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.234 g (0.747 mmol), 6-fluoro -1-Naphthoic acid (European Patent EP09
0.147 g (0.75 mmol), 1-hydroxybenzotriazole hydrate 0.1
While stirring 1 g (0.75 mmol) in 10 ml of acetonitrile, 0.14 g (0.75 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. . The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 0.
302g Yield 83% mp 223-224 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200MHz) δ 2.
85-3.08 (2H, m), 4.73-4.87 (1H, m), 5.04 (1H, s),
5.12 (1H, s), 7.05-7.16 (3H, m), 7.21-7.44 (6H,
m), 7.50-7.58 (5H, m), 7.79 (1H, d, J = 8.2 Hz); I
R (KBr) 3268, 1638, 1516, 1325, 1227, 1167, 1121,
1069, 864, 829 cm -1; . Anal Calcd for C 27 H 20 F 5 NO 2 ·
0.1H 2 O: C, 66.56; H, 4.18; N, 2.87. Found: C, 66.3
8; H, 4.28; N, 3.11.
【0172】実施例40 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-5-ニトロナフタレン-1-カルボキサミ
ド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.166g(0.530ミリモ
ル)、5-ニトロ-1-ナフトエ酸0.12g(0.53
ミリモル)、1-ヒドロキシベンゾトリアゾール水和物
81mg(0.53ミリモル)をアセトニトリル10m
l中で撹拌しながら1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド・塩酸塩0.10g(0.5
3ミリモル)を加え、室温で一晩撹拌した。反応液を酢
酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗浄、
無水硫酸マグネシウムで乾燥、シリカゲルを通した後、
溶媒を減圧留去した。得られた残留物を酢酸エチル−ヘ
キサンより結晶化して、目的物を得た。白色結晶 収量
0.258g 収率95% mp 211-214℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
85-3.13 (2H, m), 4.74-4.88 (1H, m), 5.00 (1H, t, J
= 4.3 Hz), 5.19 (1H, d, J = 3.6 Hz), 7.10 (2H, t,
J = 8.6 Hz), 7.34-7.42 (4H, m), 7.50-7.70 (7H,
m), 8.15 (1H, dd,J = 1.1 Hz, 7.7 Hz), 8.49 (1H, d,
J = 8.4 Hz); IR (KBr) 3287, 1680, 1526, 1329, 111
5 cm-1; Anal. Calcd for C27H20F4N2O4・DMF:C,61.54;
H,4.65;N, 7.18. Found: C, 61.24; H, 4.62; N, 7.17.Example 40 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -5-nitronaphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [ 4- (trifluoromethyl) phenyl] propan-1-ol 0.166 g (0.530 mmol), 5-nitro-1-naphthoic acid 0.12 g (0.53 g)
Mmol) 1-hydroxybenzotriazole hydrate 81 mg (0.53 mmol) in acetonitrile 10m
1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 0.10 g (0.5
3 mmol) and stirred overnight at room temperature. Dilute the reaction solution with ethyl acetate and wash with aqueous sodium hydrogen carbonate,
After drying over anhydrous magnesium sulfate and passing through silica gel,
The solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 0.258 g Yield 95% mp 211-214 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
85-3.13 (2H, m), 4.74-4.88 (1H, m), 5.00 (1H, t, J
= 4.3 Hz), 5.19 (1H, d, J = 3.6 Hz), 7.10 (2H, t,
J = 8.6 Hz), 7.34-7.42 (4H, m), 7.50-7.70 (7H,
m), 8.15 (1H, dd, J = 1.1 Hz, 7.7 Hz), 8.49 (1H, d,
J = 8.4 Hz); IR (KBr) 3287, 1680, 1526, 1329, 111
5 cm -1 ; Anal.Calcd for C 27 H 20 F 4 N 2 O 4・ DMF: C, 61.54;
H, 4.65; N, 7.18.Found: C, 61.24; H, 4.62; N, 7.17.
【0173】実施例41 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-1,2,3,4-テトラヒドロナフタレ
ン-1-カルボキサミド 1) 1,2,3,4-テトラヒドロナフタレン-1-カ
ルボン酸 3,4-ジヒドロナフタレン-1,1(2H)-ジカルボ
ン酸ジエチル(J.Org.Chem.,54,271
3-18(1989)参照)5.129g(18.56
ミリモル)、塩化ナトリウム2.17g(37.1ミリ
モル)、水1mlをジメチルスルホキシド10ml中で
180℃にて1.5日間加熱した。室温に冷却した後、
水を加え、酢酸エチルで2回抽出した。集めた有機層を
無水硫酸マグネシウムで乾燥、溶媒を減圧留去した。得
られた残留物をシリカゲルカラムクロマトグラフィーに
て精製し(ヘキサン/酢酸エチル=15/1)、1,
2,3,4-テトラヒドロナフタレン-1-カルボン酸エ
チルの粗生成物を黄色液体として得た。得られた液体の
メタノール20ml−テトラヒドロフラン10ml溶液
に1N水酸化ナトリウム水溶液30ml(30ミリモ
ル)を加え、室温で一晩撹拌した。反応液を濃縮、水で
希釈し、ジエチルエーテルで洗浄した。得られた水溶液
を1N塩酸で反応液を酸性にし、ジエチルエーテルで2
回抽出した。集めた有機層を無水硫酸マグネシウムで乾
燥、溶媒を減圧留去した。得られた残留物をジエチルエ
ーテル−ヘキサンより結晶化して、目的物を得た。白色
結晶 収量0.350g 収率11% mp 80-82℃; 1H-NMR (CDCl3, 200MHz) δ 1.67-2.27 (4
H, m), 2.67-2.93 (2H,m), 3.85 (1H, t, J = 5.5 Hz),
7.08-7.26 (4H, m); IR (KBr) 3065-2500, 1692, 129
8, 1225, 951, 752 cm-1; Anal. Calcd for C11H12O2:
C, 74.98; H, 6.86. Found: C, 74.58; H, 7.05. 2) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[4-(トリフルオロメチ
ル)ベンジル]エチル]-1,2,3,4-テトラヒドロ
ナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.295g(0.942ミリモ
ル)、1,2,3,4-テトラヒドロナフタレン-1-カ
ルボン酸0.17g(0.94ミリモル)、1-ヒドロ
キシベンゾトリアゾール水和物0.14g(0.94ミ
リモル)をアセトニトリル10ml中で撹拌しながら1
-エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩0.18g(0.94ミリモル)を加え、
室温で一晩撹拌した。反応液を酢酸エチルに希釈し、炭
酸水素ナトリウム水溶液で洗浄、無水硫酸マグネシウム
で乾燥、シリカゲルを通した後、溶媒を減圧留去した。
得られた残留物を酢酸エチル−ヘキサンより結晶化し
て、目的物を得た。白色結晶 収量0.359g 収率
81% mp 205-214℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 1.
35-1.95 (4H, m), 2.59-2.87 (4H, m), 3.45 (1H, t, J
= 6.1 Hz), 4.38-4.49 (1H, m), 4.73 (0.5H, t, J =
4.4 Hz), 4.82 (0.5H, t, J = 4.1 Hz), 5.28 (1H, d,
J = 4.0 Hz), 6.32 (0.5H, d, J = 8.8 Hz), 6.40 (0.5
H, d, J = 8.4 Hz), 6.56 (1H, d, J = 7.4 Hz), 6.91-
7.23 (7H, m), 7.34-7.50 (4H, m); IR (KBr) 3279, 16
47, 1514,1329, 1167, 1113, 1069 cm-1; Anal. Calcd
for C27H25F4NO2: C, 68.78; H, 5.34; N, 2.97. Foun
d: C, 68.62; H, 5.24; N, 2.90.Example 41 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -1,2,3,4-tetrahydronaphthalene-1-carboxamide 1) 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid Acid 3,4-dihydronaphthalene-1,1 (2H) -dicarboxylate (J. Org. Chem., 54, 271)
3-18 (1989)) 5.129 g (18.56
Mmol), 2.17 g (37.1 mmol) of sodium chloride and 1 ml of water were heated at 180 ° C. for 1.5 days in 10 ml of dimethyl sulfoxide. After cooling to room temperature,
Water was added, and the mixture was extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15/1).
A crude product of ethyl 2,3,4-tetrahydronaphthalene-1-carboxylate was obtained as a yellow liquid. To a solution of the obtained liquid in 20 ml of methanol / 10 ml of tetrahydrofuran was added 30 ml (30 mmol) of a 1N aqueous sodium hydroxide solution, and the mixture was stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, and washed with diethyl ether. The resulting aqueous solution is acidified with 1N hydrochloric acid, and the reaction solution is diluted with diethyl ether.
Extracted times. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diethyl ether-hexane to obtain the desired product. White crystals Yield 0.350 g Yield 11% mp 80-82 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.67-2.27 (4
H, m), 2.67-2.93 (2H, m), 3.85 (1H, t, J = 5.5 Hz),
7.08-7.26 (4H, m); IR (KBr) 3065-2500, 1692, 129
8, 1225, 951, 752 cm -1 ; Anal.Calcd for C 11 H 12 O 2 :
C, 74.98; H, 6.86. Found: C, 74.58; H, 7.05.2) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoro Methyl) benzyl] ethyl] -1,2,3,4-tetrahydronaphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) Phenyl] propan-1-ol 0.295 g (0.942 mmol), 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid 0.17 g (0.94 mmol), 1-hydroxybenzotriazole hydrate 0.14 g (0.94 mmol) of 1 in 10 ml of acetonitrile with stirring.
0.18 g (0.94 mmol) of -ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added,
Stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure.
The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 0.359 g Yield 81% mp 205-214 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 1.
35-1.95 (4H, m), 2.59-2.87 (4H, m), 3.45 (1H, t, J
= 6.1 Hz), 4.38-4.49 (1H, m), 4.73 (0.5H, t, J =
4.4 Hz), 4.82 (0.5H, t, J = 4.1 Hz), 5.28 (1H, d,
J = 4.0 Hz), 6.32 (0.5H, d, J = 8.8 Hz), 6.40 (0.5
H, d, J = 8.4 Hz), 6.56 (1H, d, J = 7.4 Hz), 6.91-
7.23 (7H, m), 7.34-7.50 (4H, m); IR (KBr) 3279, 16
47, 1514, 1329, 1167, 1113, 1069 cm -1 ; Anal.Calcd
for C 27 H 25 F 4 NO 2 : C, 68.78; H, 5.34; N, 2.97. Foun
d: C, 68.62; H, 5.24; N, 2.90.
【0174】実施例42 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-6,7,8,9-テトラヒドロ-5H-ベ
ンゾ[a]シクロヘプテン-1-カルボキサミド 1) 6,7,8,9-テトラヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボン酸 6,7,8,9-テトラヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-イルメタノール(Tetrahedro
n,53,15969-15982(1990)参照)
1.232g(6.990ミリモル)のアセトン50m
l溶液に、氷冷下、無水クロム酸2.10g(21.0
ミリモル)と濃硫酸2mlを水9mlに溶解した溶液を
ゆっくりと滴下し、滴下終了後、室温で2時間撹拌し
た。反応液を再び氷冷した後、イソプロパノール5ml
を加え、そのまま0.5時間撹拌した。反応液を酢酸エ
チルに希釈し、水で3回洗浄、無水硫酸マグネシウムで
乾燥、溶媒を減圧留去した。得られた残留物をエタノー
ル−水より結晶化して、目的物を得た。白色結晶 収量
0.916g 収率69% mp 111-112℃; 1H-NMR (CDCl3, 200MHz) δ 1.60-1.90
(6H, m), 2.88 (2H, t,J = 5.5 Hz), 3.17 (2H, t, J =
5.1 Hz), 7.14 (1H, t, J = 7.5 Hz), 7.28 (1H, d, J
= 7.8 Hz), 7.69 (1H, dd, J = 1.5 Hz, 7.7 Hz); IR
(KBr) 3200-2500, 1690, 1437, 1408, 1283, 1273, 91
6, 758 cm-1; Anal. Calcd for C12H14O2:C, 75.76; H,
7.42. Found: C, 75.71; H, 7.21. 2) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[4-(トリフルオロメチ
ル)ベンジル]エチル]-6,7,8,9-テトラヒドロ
-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.163g(0.520ミリモ
ル)、6,7,8,9-テトラヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボン酸99mg(0.5
2ミリモル)、1-ヒドロキシベンゾトリアゾール水和
物80mg(0.52ミリモル)をアセトニトリル10
ml中で撹拌しながら1-エチル-3-(3-ジメチルアミ
ノプロピル)カルボジイミド・塩酸塩0.10g(0.
52ミリモル)を加え、室温で一晩撹拌した。反応液を
酢酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗
浄、無水硫酸マグネシウムで乾燥、シリカゲルを通した
後、溶媒を減圧留去した。得られた残留物を酢酸エチル
−ヘキサンより結晶化して、目的物を得た。白色結晶
収量0.156g 収率62% mp 210-211℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 1.
35-1.48 (2H, m), 1.51-1.61 (2H, m), 1.68 1.81 (2H,
m), 2.39-2.47 (2H, m), 2.69-2.80 (2H, m), 2.85-3.
02 (2H, m), 4.63-4.77 (1H, m), 4.86 (1H, d, J = 3.
8 Hz), 4.98 (1H,t, J = 3.6 Hz), 6.67 (1H, d, J =
9.0 Hz), 6.76 (1H, dd, J = 1.4 Hz, 7.4Hz), 6.94 7.
11 (4H, m), 7.30 (2H, d, J = 8.0 Hz), 7.46-7.53 (4
H, m); IR(KBr) 3335, 2922, 1622, 1532, 1508, 2327,
1171, 1127, 831 cm-1; Anal. Calcd for C28H27F4N
O2: C, 69.27; H, 5.61; N, 2.88. Found: C, 69.20;
H, 5.62; N, 2.86.Example 42 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -6,7,8,9-tetrahydro-5H-benzo [a] cycloheptene-1-carboxamide 1) 6,7,8,9 6,7,8,9-Tetrahydro-5H-benzo [a] cyclohepten-1-ylmethanol (tetrahydro-5H-benzo [a] cycloheptene-1-carboxylic acid)
n, 53, 15969-15982 (1990))
1.232 g (6.990 mmol) of acetone 50m
Chromic anhydride 2.10 g (21.0 g)
(Mmol) and 2 ml of concentrated sulfuric acid in 9 ml of water were slowly added dropwise, and after completion of the addition, the mixture was stirred at room temperature for 2 hours. After the reaction solution was cooled again with ice, isopropanol 5 ml
Was added and the mixture was stirred as it was for 0.5 hour. The reaction solution was diluted with ethyl acetate, washed with water three times, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethanol-water to obtain the desired product. White crystals Yield 0.916 g Yield 69% mp 111-112 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.60-1.90
(6H, m), 2.88 (2H, t, J = 5.5 Hz), 3.17 (2H, t, J =
5.1 Hz), 7.14 (1H, t, J = 7.5 Hz), 7.28 (1H, d, J
= 7.8 Hz), 7.69 (1H, dd, J = 1.5 Hz, 7.7 Hz); IR
(KBr) 3200-2500, 1690, 1437, 1408, 1283, 1273, 91
6, 758 cm -1 ; Anal.Calcd for C 12 H 14 O 2 : C, 75.76; H,
7.42. Found: C, 75.71; H, 7.21.2) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -6,7,8,9-tetrahydro
-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 163 g (0.520 mmol), 99 mg of 6,7,8,9-tetrahydro-5H-benzo [a] cycloheptene-1-carboxylic acid (0.5 mg)
80 mg (0.52 mmol) of 1-hydroxybenzotriazole hydrate in 10 ml of acetonitrile
While stirring in 0.1 ml, 0.10 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.
52 mmol) and stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals
Yield 0.156 g Yield 62% mp 210-211 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 1.
35-1.48 (2H, m), 1.51-1.61 (2H, m), 1.68 1.81 (2H, m
m), 2.39-2.47 (2H, m), 2.69-2.80 (2H, m), 2.85-3.
02 (2H, m), 4.63-4.77 (1H, m), 4.86 (1H, d, J = 3.
8 Hz), 4.98 (1H, t, J = 3.6 Hz), 6.67 (1H, d, J =
9.0 Hz), 6.76 (1H, dd, J = 1.4 Hz, 7.4Hz), 6.94 7.
11 (4H, m), 7.30 (2H, d, J = 8.0 Hz), 7.46-7.53 (4
H, m); IR (KBr) 3335, 2922, 1622, 1532, 1508, 2327,
1171, 1127, 831 cm -1 ; Anal.Calcd for C 28 H 27 F 4 N
O 2 : C, 69.27; H, 5.61; N, 2.88. Found: C, 69.20;
H, 5.62; N, 2.86.
【0175】実施例43 4-ブロモ-N-[(1RS,2SR)-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-[4-(トリフルオロメ
チル)ベンジル]エチル]ナフタレン-1-カルボキサミ
ド 1) 酢酸(4-ブロモ-1-ナフチル)メチル 1-ブロモ-4-メチルナフタレン14.98g(67.
75ミリモル)、N-ブロモスクシンイミド12.1g
(67.8ミリモル)、2,2’-アゾビス(イソブチ
ロニトリル)50mgの四塩化炭素50ml溶液を0.
5時間加熱還流した。反応液を室温に冷却した後、白色
沈殿を濾過して除き、沈殿をジエチルエーテルで洗浄し
た。集めた濾液の溶媒を減圧留去して、1-ブロモ-4-
(ブロモメチル)ナフタレンの粗生成物を淡黄色液体と
して得た。得られた液体をN,N-ジメチルホルムアミ
ド30mlに溶かし、酢酸ナトリウム11.1g(13
6ミリモル)を加え、60℃で6時間撹拌した。室温に
冷却した後、反応液を水で希釈し、酢酸エチルで2回抽
出した。集めた有機層を無水硫酸ナトリウムで乾燥、溶
媒を減圧留去した。得られた粗生成物をシリカゲルカラ
ムクロマトグラフィーにて精製し(ヘキサン/酢酸エチ
ル=20/1−6/1)、目的物を得た。黄色液体 収
量14.97g 収率79%1 H-NMR (CDCl3, 200MHz) δ 2.11 (3H, s), 5.53 (2H,
s), 7.40 (1H, d, J = 7.8 Hz), 7.58-7.69 (2H, m),
7.77 (1H, d, J = 7.4 Hz), 7.97-8.05 (1H, m),8.28-
8.36 (1H, m); IR (neat) 1740, 1381, 1366, 1225, 10
24, 824, 758 cm-1 2) (4-ブロモ-1-ナフチル)メタノール 酢酸(4-ブロモ-1-ナフチル)メチル14.97g
(53.63ミリモル)、水酸化ナトリウム3.22g
(80.4ミリモル)をメタノール50ml−水30m
l−テトラヒドロフラン30ml中で、室温にて30分
間撹拌した。反応液を濃縮、水で希釈し、酢酸エチルで
2回抽出した。集めた有機層を無水硫酸ナトリウムで乾
燥、溶媒を減圧留去した。得られた粗生成物をシリカゲ
ルカラムクロマトグラフィーにて精製(ヘキサン/酢酸
エチル=3/1−2/1)、酢酸エチル−ヘキサンより
結晶化して、目的物を得た。白色結晶 収量11.77
g 収率93% mp 92-93℃; 1H-NMR (CDCl3, 200MHz) δ 1.80 (1H, t,
J = 5.9 Hz), 5.13 (2H, d, J = 5.8 Hz), 7.38 (1H,
d, J = 7.6 Hz), 7.56-7.68 (2H, m), 7.76 (1H,d, J =
7.6 Hz), 8.07-8.15 (1H, m), 8.27-8.35 (1H, m); IR
(KBr) 3214, 1375, 1258, 1073, 997, 822, 748 cm-1;
Anal. Calcd for C11H9BrO: C, 55.72; H, 3.83. Foun
d: C, 55.86; H, 3.70. 3) 4-ブロモ-1-ナフトエ酸 (4-ブロモ-1-ナフチル)メタノール1.329g
(6.027ミリモル)のアセトン50ml溶液に、氷
冷下、無水クロム酸1.81g(18.1ミリモル)と
濃硫酸2mlを水9mlに溶解した溶液をゆっくりと滴
下し、滴下終了後、室温で2時間撹拌した。反応液のア
セトンを減圧下留去した後、酢酸エチルに希釈し、水で
3回洗浄、無水硫酸マグネシウムで乾燥、溶媒を減圧留
去した。得られた残留物をエタノール-水より結晶化し
て、目的物を得た。淡褐色結晶 収量1.272g 収
率84% mp 223-224℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 7.
60-7.69 (2H, m), 7.83(1H, d, J = 7.8 Hz), 8.06 (1
H, d, J = 8.2 Hz), 8.28-8.36 (1H, m), 8.99-9.08 (1
H, m); IR (KBr) 3100-2500, 1694, 1566, 1508, 1279,
1252, 1190, 903, 785, 762 cm-1; Anal. Calcd for C
11H7BrO2: C, 52.62; H, 2.81. Found: C,52.42; H, 2.
87.4) 4-ブロモ-N-[(1RS,2SR)-2-(4
-フルオロフェニル)-2-ヒドロキシ-1-[4-(トリフ
ルオロメチル)ベンジル]エチル]ナフタレン-1-カル
ボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.209g(0.667ミリモ
ル)、4-ブロモ-1-ナフトエ酸0.17g(0.67
ミリモル)、1-ヒドロキシベンゾトリアゾール水和物
0.10g(0.67ミリモル)をアセトニトリル10
ml中で撹拌しながら1-エチル-3-(3-ジメチルアミ
ノプロピル)カルボジイミド・塩酸塩0.13g(0.
67ミリモル)を加え、室温で一晩撹拌した。反応液を
酢酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗
浄、無水硫酸マグネシウムで乾燥、シリカゲルを通した
後、溶媒を減圧留去した。得られた残留物を酢酸エチル
−ヘキサンより結晶化して、目的物を得た。白色結晶
収量0.309g 収率85% mp 229-231℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
84-3.11 (2H, m), 4.71-4.85 (1H, m), 5.00 (1H, t, J
= 4.0 Hz), 5.24 (1H, d, J = 3.8 Hz), 7.04-7.13 (3
H, m), 7.33-7.60 (10H, m), 7.69 (1H, d, J = 7.4 H
z), 8.20 (1H, d,J = 8.8 Hz); IR (KBr) 3262, 1638,
1537, 1514, 1329, 1163, 1125, 1069, 833, 754 cm-1;
Anal. Calcd for C27H20BrF4NO2: C, 59.36; H, 3.69;
N, 2.56.Found: C, 59.31; H, 3.84; N, 2.72.Example 43 4-Bromo-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene-1- Carboxamide 1) 14.98 g of (4-bromo-1-naphthyl) methyl acetate 1-bromo-4-methylnaphthalene (67.
75 mmol), 12.1 g of N-bromosuccinimide
(67.8 mmol) and 50 mg of 2,2'-azobis (isobutyronitrile) in 50 ml of carbon tetrachloride.
The mixture was refluxed for 5 hours. After cooling the reaction solution to room temperature, a white precipitate was removed by filtration, and the precipitate was washed with diethyl ether. The solvent of the collected filtrate was distilled off under reduced pressure to give 1-bromo-4-
A crude product of (bromomethyl) naphthalene was obtained as a pale yellow liquid. The obtained liquid was dissolved in 30 ml of N, N-dimethylformamide, and 11.1 g of sodium acetate (13.
6 mmol) and stirred at 60 ° C. for 6 hours. After cooling to room temperature, the reaction was diluted with water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 20 / 1-6 / 1) to obtain the desired product. Yellow liquid Yield 14.97 g Yield 79% 1 H-NMR (CDCl 3 , 200 MHz) δ 2.11 (3H, s), 5.53 (2H,
s), 7.40 (1H, d, J = 7.8 Hz), 7.58-7.69 (2H, m),
7.77 (1H, d, J = 7.4 Hz), 7.97-8.05 (1H, m), 8.28-
8.36 (1H, m); IR (neat) 1740, 1381, 1366, 1225, 10
24, 824, 758 cm -1 2) (4-bromo-1-naphthyl) methanol 14.97 g of (4-bromo-1-naphthyl) methyl acetate
(53.63 mmol), 3.22 g of sodium hydroxide
(80.4 mmol) in 50 ml of methanol-30 m of water
The mixture was stirred in 30 ml of 1-tetrahydrofuran at room temperature for 30 minutes. The reaction solution was concentrated, diluted with water, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-2 / 1), and crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 11.77
g Yield 93% mp 92-93 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.80 (1H, t,
J = 5.9 Hz), 5.13 (2H, d, J = 5.8 Hz), 7.38 (1H,
d, J = 7.6 Hz), 7.56-7.68 (2H, m), 7.76 (1H, d, J =
7.6 Hz), 8.07-8.15 (1H, m), 8.27-8.35 (1H, m); IR
(KBr) 3214, 1375, 1258, 1073, 997, 822, 748 cm -1 ;
. Anal Calcd for C 11 H 9 BrO:. C, 55.72; H, 3.83 Foun
d: C, 55.86; H, 3.70.3) 4-Bromo-1-naphthoic acid 1.329 g of (4-bromo-1-naphthyl) methanol
A solution of 1.81 g (18.1 mmol) of chromic anhydride and 2 ml of concentrated sulfuric acid in 9 ml of water was slowly added dropwise to a 50 ml solution of acetone (6.027 mmol) under ice-cooling. For 2 hours. The acetone in the reaction solution was distilled off under reduced pressure, diluted with ethyl acetate, washed three times with water, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethanol-water to give the desired product. Light brown crystal Yield 1.272 g Yield 84% mp 223-224 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 7.
60-7.69 (2H, m), 7.83 (1H, d, J = 7.8 Hz), 8.06 (1
H, d, J = 8.2 Hz), 8.28-8.36 (1H, m), 8.99-9.08 (1
H, m); IR (KBr) 3100-2500, 1694, 1566, 1508, 1279,
1252, 1190, 903, 785, 762 cm -1 ; Anal.Calcd for C
11 H 7 BrO 2 : C, 52.62; H, 2.81.Found: C, 52.42; H, 2.
87.4) 4-Bromo-N-[(1RS, 2SR) -2- (4
-Fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [ 0.209 g (0.667 mmol) of 4- (trifluoromethyl) phenyl] propan-1-ol 0.17 g (0.67 g) of 4-bromo-1-naphthoic acid
Mmol) 1-hydroxybenzotriazole hydrate 0.10 g (0.67 mmol) in acetonitrile 10
0.13 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.1 ml) while stirring in 0.1 ml.
67 mmol) and stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals
Yield 0.309 g Yield 85% mp 229-231 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
84-3.11 (2H, m), 4.71-4.85 (1H, m), 5.00 (1H, t, J
= 4.0 Hz), 5.24 (1H, d, J = 3.8 Hz), 7.04-7.13 (3
H, m), 7.33-7.60 (10H, m), 7.69 (1H, d, J = 7.4 H
z), 8.20 (1H, d, J = 8.8 Hz); IR (KBr) 3262, 1638,
1537, 1514, 1329, 1163, 1125, 1069, 833, 754 cm -1 ;
. Anal Calcd for C 27 H 20 BrF 4 NO 2: C, 59.36; H, 3.69;
N, 2.56.Found: C, 59.31; H, 3.84; N, 2.72.
【0176】実施例44 2-シクロペンチル-N-[(1RS,2SR)-2-(4-
フルオロフェニル)-2-ヒドロキシ-1-[4-(トリフ
ルオロメチル)ベンジル]エチル]アセトアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.156g(0.498ミリモ
ル)、シクロペンチル酢酸64mg(0.50ミリモ
ル)、1-ヒドロキシベンゾトリアゾール水和物76m
g(0.50ミリモル)をアセトニトリル10ml中で
撹拌しながら1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩95mg(0.50ミリモ
ル)を加え、室温で一晩撹拌した。反応液を酢酸エチル
に希釈し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸
マグネシウムで乾燥、シリカゲルを通した後、溶媒を減
圧留去した。得られた残留物をヘキサンより結晶化し
て、目的物を得た。白色結晶 収量0.185g 収率
88% mp 195-196℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 0.
75-1.05 (2H, m), 1.25-1.65 (6H, m), 1.92 2.12 (3H,
m), 2.77-2.81 (2H, m), 4.39-4.52 (1H, m), 4.65 (1
H, d, J = 3.4 Hz), 4.93 (1H, t, J = 3.3 Hz), 6.10
(1H, br d, J = 8.4 Hz), 7.06 (2H, t, J = 8.8 Hz),
7.21 (2H, d, J = 8.0 Hz), 7.39-7.49 (4H, m); IR (K
Br) 3301, 2949, 1645, 1539, 1514, 1327, 1163, 112
5, 1069, 829 cm-1; Anal. Calcd for C23H25F4NO2: C,
65.24; H, 5.95; N, 3.31. Found:C, 65.08; H, 5.90;
N, 3.41.Example 44 2-Cyclopentyl-N-[(1RS, 2SR) -2- (4-
Fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] acetamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoro Methyl) phenyl] propan-1-ol 0.156 g (0.498 mmol), cyclopentyl acetic acid 64 mg (0.50 mmol), 1-hydroxybenzotriazole hydrate 76 m
While stirring g (0.50 mmol) in 10 ml of acetonitrile, 95 mg (0.50 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from hexane to obtain the desired product. White crystals Yield 0.185 g Yield 88% mp 195-196 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 0.
75-1.05 (2H, m), 1.25-1.65 (6H, m), 1.92 2.12 (3H,
m), 2.77-2.81 (2H, m), 4.39-4.52 (1H, m), 4.65 (1
H, d, J = 3.4 Hz), 4.93 (1H, t, J = 3.3 Hz), 6.10
(1H, br d, J = 8.4 Hz), 7.06 (2H, t, J = 8.8 Hz),
7.21 (2H, d, J = 8.0 Hz), 7.39-7.49 (4H, m); IR (K
Br) 3301, 2949, 1645, 1539, 1514, 1327, 1163, 112
5, 1069, 829 cm -1 ; Anal.Calcd for C 23 H 25 F 4 NO 2 : C,
65.24; H, 5.95; N, 3.31. Found: C, 65.08; H, 5.90;
N, 3.41.
【0177】実施例45 3-シクロペンチル-N-[(1RS,2SR)-2-(4-
フルオロフェニル)-2-ヒドロキシ-1-[4-(トリフ
ルオロメチル)ベンジル]エチル]プロピオンアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.157g(0.501ミリモ
ル)、3-シクロペンチルプロピオン酸71mg(0.
50ミリモル)、1-ヒドロキシベンゾトリアゾール水
和物77mg(0.50ミリモル)をアセトニトリル1
0ml中で撹拌しながら1-エチル-3-(3-ジメチルア
ミノプロピル)カルボジイミド・塩酸塩96mg(0.
50ミリモル)を加え、室温で一晩撹拌した。反応液を
酢酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗
浄、無水硫酸マグネシウムで乾燥、シリカゲルを通した
後、溶媒を減圧留去した。得られた残留物をヘキサンよ
り結晶化して、目的物を得た。白色結晶 収量0.18
0g 収率82% mp 169-170℃; 1H-NMR (CDCl3, 200MHz) δ 0.98 (2H,
br s), 1.35-1.70 (9H,m), 2.07 (2H, dt, J = 2.6 Hz,
7.4 Hz), 2.76 (1H, dd, J = 10.4 Hz, 14.4 Hz), 2.9
0 (1H, dd, J = 4.4 Hz, 14.6 Hz), 3.61 (1H, d, J =
3.6 Hz), 4.36-4.50 (1H, m), 4.97 (1H, t, J = 3.5 H
z), 5.39 (1H, br d, J = 7.8 Hz), 7.08(2H, t, J =
8.8 Hz), 7.21 (2H, d, J = 7.8 Hz), 7.39 (2H, dd, J
= 5.6 Hz, 8.4 Hz), 7.51 (2H, d, J = 8.0 Hz); IR
(KBr) 3303, 2951, 1645, 1537, 1514, 1327, 1163, 11
23, 1069, 829 cm-1; Anal. Calcd for C24H27F4NO2:
C, 65.89; H, 6.22; N, 3.20. Found: C, 65.61; H, 6.
16; N, 3.32.Example 45 3-Cyclopentyl-N-[(1RS, 2SR) -2- (4-
(Fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] propionamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (tri Fluoromethyl) phenyl] propan-1-ol 0.157 g (0.501 mmol) 3-cyclopentylpropionic acid 71 mg (0.
50 mmol) 1-hydroxybenzotriazole hydrate 77 mg (0.50 mmol) was added to acetonitrile 1
While stirring in 0 ml, 96 mg of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.
(50 mmol) and stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from hexane to obtain the desired product. White crystals Yield 0.18
0g Yield 82% mp 169-170 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 0.98 (2H,
br s), 1.35-1.70 (9H, m), 2.07 (2H, dt, J = 2.6 Hz,
7.4 Hz), 2.76 (1H, dd, J = 10.4 Hz, 14.4 Hz), 2.9
0 (1H, dd, J = 4.4 Hz, 14.6 Hz), 3.61 (1H, d, J =
3.6 Hz), 4.36-4.50 (1H, m), 4.97 (1H, t, J = 3.5 H
z), 5.39 (1H, br d, J = 7.8 Hz), 7.08 (2H, t, J =
8.8 Hz), 7.21 (2H, d, J = 7.8 Hz), 7.39 (2H, dd, J
= 5.6 Hz, 8.4 Hz), 7.51 (2H, d, J = 8.0 Hz); IR
(KBr) 3303, 2951, 1645, 1537, 1514, 1327, 1163, 11
23, 1069, 829 cm -1 ; Anal.Calcd for C 24 H 27 F 4 NO 2 :
C, 65.89; H, 6.22; N, 3.20. Found: C, 65.61; H, 6.
16; N, 3.32.
【0178】実施例46 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-1-ベンゾチオフェン-3-カルボキサミ
ド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.173g(0.552ミリモ
ル)、1-ベンゾチオフェン-3-カルボン酸(Synt
h.Commun.,15,711-713(198
4)参照)0.10g(0.55ミリモル)、1-ヒド
ロキシベンゾトリアゾール水和物85mg(0.55ミ
リモル)をアセトニトリル10ml中で撹拌しながら1
-エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩0.11g(0.55ミリモル)を加え、
室温で一晩撹拌した。反応液を酢酸エチルに希釈し、炭
酸水素ナトリウム水溶液で洗浄、無水硫酸マグネシウム
で乾燥、シリカゲルを通した後、溶媒を減圧留去した。
得られた残留物をジエチルエーテル−ヘキサンより結晶
化して、目的物を得た。白色結晶 収量0.204g
収率78% mp 188-189℃; 1H-NMR (CDCl3, 200MHz) δ 2.88-3.08
(2H, m), 3.64 (1H, d,J = 3.6 Hz), 4.59-4.72 (1H,
m), 5.13 (1H, t, J = 3.2 Hz), 6.04 (1H, d, J= 8.8
Hz), 7.09 (2H, t, J = 8.8 Hz), 7.31-7.60 (9H, m),
7.82-7.92 (2H,m); IR (KBr) 3333, 1622, 1537, 1510,
1331, 1159, 1123, 1069, 833, 766 cm -1; Anal. Calc
d for C25H19F4NO2S: C, 63.42; H, 4.04; N, 2.96. Fo
und: C,63.50; H, 4.10; N, 2.90.Example 46 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) ben
[Zyl] ethyl] -1-benzothiophene-3-carboxami
Do (1RS, 2SR) -2-amino-1- (4-fluorophene)
Nyl) -3- [4- (trifluoromethyl) phenyl] p
0.173 g of Lopan-1-ol (0.552 mmol
), 1-benzothiophene-3-carboxylic acid (Synt
h. Commun. , 15, 711-713 (198
4)) 0.10 g (0.55 mmol), 1-hydrido
Roxybenzotriazole hydrate 85mg (0.55m
Lmol) in 10 ml of acetonitrile while stirring.
-Ethyl-3- (3-dimethylaminopropyl) carbodii
0.11 g (0.55 mmol) of mido hydrochloride was added,
Stirred overnight at room temperature. Dilute the reaction solution with ethyl acetate and add
Washed with sodium hydrogen oxyacid solution, anhydrous magnesium sulfate
After drying over and passing through silica gel, the solvent was distilled off under reduced pressure.
The obtained residue was crystallized from diethyl ether-hexane.
To give the desired product. 0.204 g of white crystals
Yield 78% mp 188-189 ° C;1H-NMR (CDClThree, 200MHz) δ 2.88-3.08
(2H, m), 3.64 (1H, d, J = 3.6 Hz), 4.59-4.72 (1H,
m), 5.13 (1H, t, J = 3.2 Hz), 6.04 (1H, d, J = 8.8
Hz), 7.09 (2H, t, J = 8.8 Hz), 7.31-7.60 (9H, m),
7.82-7.92 (2H, m); IR (KBr) 3333, 1622, 1537, 1510,
1331, 1159, 1123, 1069, 833, 766 cm -1; Anal. Calc
d for Ctwenty fiveH19FFourNOTwoS: C, 63.42; H, 4.04; N, 2.96. Fo
und: C, 63.50; H, 4.10; N, 2.90.
【0179】実施例47 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-4-フェニル酪酸アミド 4-フェニル酪酸(141mg,0.86ミリモル)の
テトラヒドロフラン(5ml)溶液に、オキサリルクロ
リド(0.15ml,1.72ミリモル)およびN,N
-ジメチルホルムアミド(0.01ml)を加えて、室
温で30分間攪拌し、反応液を減圧留去した。残留物の
酢酸エチル(5ml)溶液に(1RS,2SR)-1-
(4-フルオロフェニル)-1-ヒドロキシ-3-(4-(ト
リフルオロメチル)フェニル)-2-プロピルアミン塩酸
塩(200mg,0.57ミリモル)および飽和重曹水
(5ml)を加えて室温で終夜攪拌した。反応液を水
(50ml)で希釈し、酢酸エチル(50ml×2)で
抽出した。抽出液を飽和食塩水で洗浄し、無水硫酸マグ
ネシウムで乾燥後減圧留去した。残留物をシリカゲルカ
ラムクロマトグラフィー(ヘキサン:酢酸エチル=4:
1−1:1)で精製し、酢酸エチル−ヘキサンから再結
晶させて、表題化合物(179mg,68%)を得た。 mp 150-151℃ IRν maxKBrcm-1: 1645, 1508. Anal. Calcd for C26H25F4NO2: C, 67.96; H, 5.48; N,
3.05 Found: C, 67.91; H, 5.35; N, 2.98.1 H-NMR (CDCl3)δ: 1.70-1.90 (2H, m), 2.00-2.14 (2
H, m), 2.51 (2H, t, J =7.4 Hz), 2.70-2.94 (2H, m),
3.44 (1H, d, J = 3.6 Hz), 4.30-4.56 (1H, m), 4.92
-5.00 (1H, m), 5.38 (1H, d, J = 7.0 Hz), 7.00-7.60
(13H, m).Example 47 N-((1RS, 2SR) -2- (4-fluorophenyl)
Oxalyl chloride was added to a solution of 4-phenylbutyric acid (141 mg, 0.86 mmol) in tetrahydrofuran (5 ml). (0.15 ml, 1.72 mmol) and N, N
-Dimethylformamide (0.01 ml) was added, the mixture was stirred at room temperature for 30 minutes, and the reaction solution was distilled off under reduced pressure. (1RS, 2SR) -1- was added to a solution of the residue in ethyl acetate (5 ml).
(4-Fluorophenyl) -1-hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (200 mg, 0.57 mmol) and saturated aqueous sodium hydrogencarbonate (5 ml) were added, and the mixture was added at room temperature. Stirred overnight. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 4:
1-1: 1) and recrystallized from ethyl acetate-hexane to give the title compound (179 mg, 68%). mp 150-151 ° C IRν max KBr cm -1 : 1645, 1508. Anal.Calcd for C 26 H 25 F 4 NO 2 : C, 67.96; H, 5.48; N,
3.05 Found:. C, 67.91; H, 5.35; N, 2.98 1 H-NMR (CDCl 3) δ: 1.70-1.90 (2H, m), 2.00-2.14 (2
H, m), 2.51 (2H, t, J = 7.4 Hz), 2.70-2.94 (2H, m),
3.44 (1H, d, J = 3.6 Hz), 4.30-4.56 (1H, m), 4.92
-5.00 (1H, m), 5.38 (1H, d, J = 7.0 Hz), 7.00-7.60
(13H, m).
【0180】実施例48 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-3-フェニルプロパンアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)の酢
酸エチル(20ml)溶液に3-フェニルプロピオニル
クロリド(320ml,2.15ミリモル)および飽和
重曹水(20ml)を加えて室温で終夜攪拌した。反応
液を水(100ml)で希釈し、酢酸エチル(100m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物を酢
酸エチル−ヘキサンから再結晶させて表題化合物(56
0mg,88%)を得た。 mp 144-145℃ IRνmaxKBrcm-1: 1636, 1541. Anal. Calcd for C25H23F4NO2: C, 67.41; H, 5.20; N,
3.14 Found: C, 67.30; H, 5.21; N, 3.38.1 H-NMR (CDCl3)δ: 2.30-2.44 (2H, m), 2.58-2.94 (4
H, m), 3.29 (1H, d, J =4.0 Hz), 4.30-4.48 (1H, m),
4.76-7.86 (1H, m), 5.33 (1H, d, J = 8.4 Hz), 6.98
-7.38 (11H, m), 7.46 (2H, d, J = 8.0 Hz).Example 48 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -3-phenylpropanamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- ( 4- (trifluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.44 mmol) in ethyl acetate (20 ml) were added 3-phenylpropionyl chloride (320 ml, 2.15 mmol) and saturated aqueous sodium hydrogen carbonate (20 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (56
0 mg, 88%). mp 144-145 ℃ IRνmax KBr cm -1 : 1636, 1541. Anal.Calcd for C 25 H 23 F 4 NO 2 : C, 67.41; H, 5.20; N,
3.14 Found:. C, 67.30; H, 5.21; N, 3.38 1 H-NMR (CDCl 3) δ: 2.30-2.44 (2H, m), 2.58-2.94 (4
H, m), 3.29 (1H, d, J = 4.0 Hz), 4.30-4.48 (1H, m),
4.76-7.86 (1H, m), 5.33 (1H, d, J = 8.4 Hz), 6.98
-7.38 (11H, m), 7.46 (2H, d, J = 8.0 Hz).
【0181】実施例49 4,4,4-トリフルオロ-N-[(1RS,2SR)-2
-(4-フルオロフェニル)-2-ヒドロキシ-1-[4-
(トリフルオロメチル)ベンジル]エチル]-2-メチル
-2-ブテンアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.154g(0.492ミリモ
ル)、4,4,4-トリフルオロ-2-メチル-2-ブテン
酸76mg(0.49ミリモル)、1-ヒドロキシベン
ゾトリアゾール水和物75mg(0.49ミリモル)を
アセトニトリル10ml中で撹拌しながら1-エチル-3
-(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩94mg(0.49ミリモル)を加え、室温で一晩撹
拌した。反応液を酢酸エチルに希釈し、炭酸水素ナトリ
ウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、シリ
カゲルを通した後、溶媒を減圧留去した。得られた残留
物をジイソプロピルエーテル−ヘキサンより結晶化し
て、目的物を得た。白色結晶 収量0.178g 収率
81% mp 182-183℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
04 (3H, s), 2.80-2.84(2H, m), 4.41-4.54 (1H, m),
4.84 (1H, d, J = 3.2 Hz), 4.94 (1H, t, J = 3.3 H
z), 6.24-6.26 (1H, m), 7.06 (2H, t, J = 8.6 Hz),
7.20 (2H, d, J = 7.8 Hz), 7.33 (1H, d, J = 8.6 H
z), 7.42-7.49 (4H, m); IR (KBr) 3297, 1647,1541, 1
514, 1329, 1167, 1119, 1069, 831 cm-1; Anal. Calcd
for C21H18F7NO2: C, 56.13; H, 4.04; N, 3.12. Foun
d: C, 56.02; H, 4.04; N, 2.82.Example 49 4,4,4-Trifluoro-N-[(1RS, 2SR) -2
-(4-Fluorophenyl) -2-hydroxy-1- [4-
(Trifluoromethyl) benzyl] ethyl] -2-methyl
2-butenamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.154 g (0.492 mmol), 76 mg (0.49 mmol) of 4,4,4-trifluoro-2-methyl-2-butenoic acid and 75 mg (0.49 mmol) of 1-hydroxybenzotriazole hydrate were stirred in 10 ml of acetonitrile for 1-. Ethyl-3
94 mg (0.49 mmol) of-(3-dimethylaminopropyl) carbodiimide hydrochloride was added and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.178 g Yield 81% mp 182-183 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
04 (3H, s), 2.80-2.84 (2H, m), 4.41-4.54 (1H, m),
4.84 (1H, d, J = 3.2 Hz), 4.94 (1H, t, J = 3.3 H)
z), 6.24-6.26 (1H, m), 7.06 (2H, t, J = 8.6 Hz),
7.20 (2H, d, J = 7.8 Hz), 7.33 (1H, d, J = 8.6 H
z), 7.42-7.49 (4H, m); IR (KBr) 3297, 1647,1541, 1
514, 1329, 1167, 1119, 1069, 831 cm -1 ; Anal.Calcd
for C 21 H 18 F 7 NO 2 : C, 56.13; H, 4.04; N, 3.12. Foun
d: C, 56.02; H, 4.04; N, 2.82.
【0182】実施例50 2,3-ジクロロ-N-((1RS,2SR)-2-(4-フ
ルオロフェニル)-2-ヒドロキシ-1-((4-(トリフ
ルオロメチル)フェニル)メチル)エチル)ベンズアミ
ド (1RS,2RS)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(150mg,0.43
ミリモル)の酢酸エチル(5ml)溶液に2,3-ジク
ロロベンゾイルクロリド(135mg,0.64ミリモ
ル)および飽和重曹水(5ml)を加えて室温で終夜攪
拌した。反応液を水(50ml)で希釈し、酢酸エチル
(50ml×2)で抽出した。抽出液を飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=2:1)で精製し、酢酸エチル−ヘキ
サンから再結晶させて、表題化合物(161mg,77
%)を得た。 mp 187-188℃ IRνmaxKBrcm-1: 1647, 1537, 1514. Anal. Calcd for C23H17Cl2F4NO2: C, 56.81; H, 3.52;
N, 2.88 Found: C, 56.82; H, 3.38; N, 2.85.1 H-NMR (CDCl3)δ: 2.80-3.10 (3H, m), 4.60-4.80 (1
H, m), 5.08 (1H, d, J =3.8 Hz), 6.06 (1H, d, J =
8.8 Hz), 6.96-7.38 (6H, m), 7.40-7.62 (5H, m).Example 50 2,3-Dichloro-N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl ) Benzamide (1RS, 2RS) -1- (4-fluorophenyl) -1-
Hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.43
2,3-Dichlorobenzoyl chloride (135 mg, 0.64 mmol) and saturated aqueous sodium hydrogencarbonate (5 ml) were added to a solution of the resulting mixture in an aqueous solution of ethyl acetate (5 ml) and the mixture was stirred overnight at room temperature. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1) and recrystallized from ethyl acetate-hexane to give the title compound (161 mg, 77).
%). mp 187-188 ° C IRνmax KBr cm -1 : 1647, 1537, 1514. Anal.Calcd for C 23 H 17 Cl 2 F 4 NO 2 : C, 56.81; H, 3.52;
N, 2.88 Found:. C, 56.82; H, 3.38; N, 2.85 1 H-NMR (CDCl 3) δ: 2.80-3.10 (3H, m), 4.60-4.80 (1
H, m), 5.08 (1H, d, J = 3.8 Hz), 6.06 (1H, d, J =
(8.8 Hz), 6.96-7.38 (6H, m), 7.40-7.62 (5H, m).
【0183】実施例51 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-6-ニトロナフタレン-1-カルボキサミ
ド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.178g(0.568ミリモ
ル)、6-ニトロ-1-ナフトエ酸(J.Org.Che
m.,54,3596-602(1989)参照)0.
12g(0.57ミリモル)、1-ヒドロキシベンゾト
リアゾール水和物87mg(0.57ミリモル)をアセ
トニトリル10ml中で撹拌しながら1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩0.11g(0.57ミリモル)を加え、室温で一晩
撹拌した。反応液を酢酸エチルに希釈し、炭酸水素ナト
リウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、シ
リカゲルを通した後、溶媒を減圧留去した。得られた残
留物を酢酸エチル−ヘキサンより結晶化して、目的物を
得た。白色結晶 収量0.256g 収率88% mp 206-207℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
93 (1H, dd, J = 11.0 Hz, 13.8 Hz), 3.20 (1H, dd, J
= 3.1 Hz, 14.1 Hz), 4.67-4.82 (1H, m), 4.93(1H,
t, J = 4.7 Hz), 5.44 (1H, d, J = 4.0 Hz), 7.09 (2
H, t, J = 8.6 Hz), 7.38-7.42 (3H, m), 7.51-7.61 (6
H, m), 7.95-8.09 (3H, m), 8.76 (1H, d,J = 2.2 Hz);
IR (KBr) 3297, 1638, 1535, 1346, 1327, 1113, 1069
cm-1; Anal. Calcd for C27H20F4N2O4: C, 63.28; H,
3.93; N, 5.47. Found: C, 63.11;H, 3.80; N, 5.34.Example 51 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -6-nitronaphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [ 4- (trifluoromethyl) phenyl] propan-1-ol 0.178 g (0.568 mmol), 6-nitro-1-naphthoic acid (J. Org. Che)
m. , 54, 3596-602 (1989)).
12 g (0.57 mmol) of 1-hydroxybenzotriazole hydrate (87 mg, 0.57 mmol) were stirred in 10 ml of acetonitrile with 1-ethyl-3-ethyl.
0.11 g (0.57 mmol) of (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 0.256 g Yield 88% mp 206-207 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
93 (1H, dd, J = 11.0 Hz, 13.8 Hz), 3.20 (1H, dd, J
= 3.1 Hz, 14.1 Hz), 4.67-4.82 (1H, m), 4.93 (1H,
t, J = 4.7 Hz), 5.44 (1H, d, J = 4.0 Hz), 7.09 (2
H, t, J = 8.6 Hz), 7.38-7.42 (3H, m), 7.51-7.61 (6
H, m), 7.95-8.09 (3H, m), 8.76 (1H, d, J = 2.2 Hz);
IR (KBr) 3297, 1638, 1535, 1346, 1327, 1113, 1069
cm -1 ; Anal.Calcd for C 27 H 20 F 4 N 2 O 4 : C, 63.28; H,
3.93; N, 5.47. Found: C, 63.11; H, 3.80; N, 5.34.
【0184】実施例52 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)シクロヘキサンカルボキサミ
ド (1RS,2SR)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(200mg,0.57
ミリモル)の酢酸エチル(5ml)溶液にシクロヘキサ
ンカルボニルクロリド(126mg,0.86ミリモ
ル)および飽和重曹水(5ml)を加えて室温で1時間
攪拌した。反応液を水(50ml)で希釈し、酢酸エチ
ル(50ml×2)で抽出した。抽出液を飽和食塩水で
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し、酢
酸エチル−ヘキサンから再結晶させて、表題化合物(1
66mg,69%)を得た。 mp 203-204℃ IRν maxKBrcm-1: 3275, 1645, 1512. Anal. Calcd for C23H25F4NO2: C, 65.24; H, 5.95; N,
3.31 Found: C, 65.14; H, 5.83; N, 3.50.1 H-NMR (CDCl3)δ: 1.00-1.40 (6H, m), 1.50-1.80 (4
H, m), 1.80-2.10 (1H, m), 2.72-3.00 (2H, m), 3.73
(1H, d, J = 3.6 Hz), 4.32-4.52 (1H, m), 4.94-5.00
(1H, m), 5.36 (1H, d, J = 8.0 Hz), 7.02-7.16 (2H,
m), 7.21 (2H, d,J = 8.4 Hz), 7.30-7.44 (2H, m), 7.
51 (2H, d, J = 8.4 Hz).Example 52 N-((1RS, 2SR) -2- (4-fluorophenyl)
2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) cyclohexanecarboxamide (1RS, 2SR) -1- (4-fluorophenyl) -1-
Hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (200 mg, 0.57
Cyclohexanecarbonyl chloride (126 mg, 0.86 mmol) and saturated aqueous sodium bicarbonate (5 ml) were added to a solution of the resulting mixture in an aqueous solution of ethyl acetate (5 mmol) and the mixture was stirred at room temperature for 1 hour. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with brine, dried over anhydrous magnesium sulfate, evaporated under reduced pressure, and recrystallized from ethyl acetate-hexane to give the title compound (1
(66 mg, 69%). mp 203-204 ℃ IRν max KBr cm -1 : 3275, 1645, 1512. Anal.Calcd for C 23 H 25 F 4 NO 2 : C, 65.24; H, 5.95; N,
3.31 Found:. C, 65.14; H, 5.83; N, 3.50 1 H-NMR (CDCl 3) δ: 1.00-1.40 (6H, m), 1.50-1.80 (4
H, m), 1.80-2.10 (1H, m), 2.72-3.00 (2H, m), 3.73
(1H, d, J = 3.6 Hz), 4.32-4.52 (1H, m), 4.94-5.00
(1H, m), 5.36 (1H, d, J = 8.0 Hz), 7.02-7.16 (2H,
m), 7.21 (2H, d, J = 8.4 Hz), 7.30-7.44 (2H, m), 7.
51 (2H, d, J = 8.4 Hz).
【0185】実施例53 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-3-オキソ-2,3-ジヒドロ
-1H-インデン-1-カルボキサミド (1RS,2RS)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン(150mg,0.42ミリモ
ル)のアセトニトリル(10ml)溶液に3-オキソ-
2,3-ジヒドロ-1H-インデン-1-カルボン酸(73
mg,0.42ミリモル)および1-エチル-3-(3-ジ
メチルアミノプロピル)カルボジイミド・塩酸塩(11
9mg,0.62ミリモル)および1-ヒドロキシ-1H
-ベンゾトリアゾール(63.6mg,0.42ミリモ
ル)を加えて室温で終夜攪拌した。反応液を水(50m
l)で希釈し、酢酸エチル(50ml×2)で抽出し
た。抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去した。残留物をシリカゲルカラムク
ロマトグラフィー(ヘキサン:酢酸エチル=1:1)で
精製し、酢酸エチル−ヘキサンから再結晶させて、表題
化合物の高極性異性体(61mg,31%)を得た。 mp 242-243℃ IRνmaxKBrcm-1: 1703, 1649, 1539, 1510. Anal. Calcd for C26H21F4NO3・0.1H2O: C, 65.99; H,
4.52; N, 2.96 Found: C, 65.70; H, 4.41; N, 2.83.1 H-NMR (CDCl3)δ: 2.20-2.60 (2H, m), 2.70-3.00 (3
H, m), 3.86-3.98 (1H, m), 4.40-4.62 (1H, m), 4.92-
5.02 (1H, m), 6.46-6.60 (1H, m), 6.60-7.00 (1H,
m), 7.00-7.20 (2H, m), 7.20-7.60 (8H, m), 7.70 (1
H, d, J = 6.2 Hz). また同時に、表題化合物の低極性異性体(74mg,3
8%)を得た。 mp 237-238℃ IRνmaxKBrcm-1: 1715, 1651, 1549, 1513. Anal. Calcd for C26H21F4NO3: C, 66.24; H, 4.49; N,
2.97 Found: C, 66.19; H, 4.36; N, 2.90.1 H-NMR (CDCl3)δ: 2.64-2.92 (4H, m), 3.92-4.00 (1
H, m), 4.36-4.52 (1H, m), 4.83 (1H, d, J = 4.6 H
z), 6.81 (1H, d, J = 7.8 Hz), 7.00-7.22 (5H, m),
7.38-7.58 (5H, m), 7.54 (1H, d, J = 7.0 Hz).Example 53 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -3-oxo-2,3-dihydro
-1H-indene-1-carboxamide (1RS, 2RS) -1- (4-fluorophenyl) -1-
A solution of hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine (150 mg, 0.42 mmol) in acetonitrile (10 ml) was treated with 3-oxo-
2,3-dihydro-1H-indene-1-carboxylic acid (73
mg, 0.42 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (11
9 mg, 0.62 mmol) and 1-hydroxy-1H
-Benzotriazole (63.6 mg, 0.42 mmol) was added and the mixture was stirred at room temperature overnight. The reaction solution was washed with water (50 m
1) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1) and recrystallized from ethyl acetate-hexane to obtain a highly polar isomer of the title compound (61 mg, 31%). mp 242-243 ℃ IRνmax KBr cm -1 : 1703, 1649, 1539, 1510. Anal.Calcd for C 26 H 21 F 4 NO 3・ 0.1H 2 O: C, 65.99; H,
4.52; N, 2.96 Found: C, 65.70; H, 4.41; N, 2.83. 1 H-NMR (CDCl 3 ) δ: 2.20-2.60 (2H, m), 2.70-3.00 (3
H, m), 3.86-3.98 (1H, m), 4.40-4.62 (1H, m), 4.92-
5.02 (1H, m), 6.46-6.60 (1H, m), 6.60-7.00 (1H,
m), 7.00-7.20 (2H, m), 7.20-7.60 (8H, m), 7.70 (1
H, d, J = 6.2 Hz). At the same time, the less polar isomer of the title compound (74 mg, 3
8%). mp 237-238 ℃ IRνmax KBr cm -1 : 1715, 1651, 1549, 1513. Anal.Calcd for C 26 H 21 F 4 NO 3 : C, 66.24; H, 4.49; N,
2.97 Found:. C, 66.19; H, 4.36; N, 2.90 1 H-NMR (CDCl 3) δ: 2.64-2.92 (4H, m), 3.92-4.00 (1
H, m), 4.36-4.52 (1H, m), 4.83 (1H, d, J = 4.6 H
z), 6.81 (1H, d, J = 7.8 Hz), 7.00-7.22 (5H, m),
7.38-7.58 (5H, m), 7.54 (1H, d, J = 7.0 Hz).
【0186】実施例54 4-シアノ-N-[(1RS,2SR)-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-[4-(トリフルオロメ
チル)ベンジル]エチル]ナフタレン-1-カルボキサミ
ド 1) 4-(メトキシカルボニル)-1-ナフトエ酸 ナフタレン-1,4-ジカルボン酸25.90g(11
9.8ミリモル)をテトラヒドロフラン80ml−N,
N-ジメチルホルムアミド50ml中で撹拌しながら、
1,8-ジアザビシクロ〔5.4.0〕-7-ウンデセン
18.2g(120ミリモル)を室温で加え、そのまま
0.5時間撹拌した。反応液にヨードメタン51.0g
(359ミリモル)を室温で加え、そのまま一晩撹拌し
た。反応液を炭酸水素ナトリウム水溶液に希釈し、酢酸
エチルで洗浄した。得られた水溶液を濃塩酸で酸性と
し、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸マグネシウムで乾燥、溶媒を減圧留去した。得られた
残留物をシリカゲルカラムクロマトグラフィーにて精製
し(ヘキサン/酢酸エチル=1/1)、酢酸エチル−ヘ
キサンより結晶化して、目的物を得た。淡褐色結晶 収
量6.309g 収率23% mp 148-150℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 4.
02 (3H, s), 7.59-7.68(2H, m), 8.09 (1H, d, J = 7.4
Hz), 8.14 (1H, d, J = 7.4 Hz), 8.75-8.84 (1H, m),
8.88-8.96 (1H, m); IR (KBr) 3100- 2635, 1723, 170
1, 1291, 1281,1256. 1206, 1152, 775 cm-1; Anal. Ca
lcd for C13H10O4: C, 67.82; H, 4.38.Found: C, 67.8
2; H, 4.28. 2) 4-(アミノカルボニル)-1-ナフトエ酸メチル 4-(メトキシカルボニル)-1-ナフトエ酸2.553
g(11.09ミリモル)とN,N-ジメチルホルムア
ミド2滴のテトラヒドロフラン40ml溶液に、塩化オ
キザリル1.93ml(22.2ミリモル)を室温で滴
下し、0.5時間撹拌した。反応液の溶媒を減圧留去
し、酸クロリドの粗生成物を液体として得た。15%ア
ンモニア水1.52g(22.2ミリモル)と炭酸水素
ナトリウム1.86g(22.2ミリモル)をテトラヒ
ドロフラン40ml中で氷冷下撹拌しながら、上で得た
液体をテトラヒドロフラン40mlに溶解したものを滴
下し、氷冷下0.5時間、さらに室温で0.5時間撹拌
した。反応液を炭酸水素ナトリウム水溶液に注ぎ、酢酸
エチルで2回抽出した。集めた有機層を無水硫酸マグネ
シウムで乾燥、溶媒を減圧留去した。得られた残留物
を、酢酸エチル−ジエチルエーテル−ヘキサンより結晶
化して、目的物を得た。淡褐色結晶 収量2.418g
収率95% mp 182-184℃; 1H-NMR (CDCl3, 200MHz) δ 4.02 (3H,
s), 6.64 (1H, br s), 7.21 (1H, br s), 7.56-7.71 (3
H, m), 8.13 (1H, d, J = 7.8 Hz), 8.34-8.43 (1H,
m), 8.83-8.91 (1H, m); IR (KBr) 3374, 3193, 1719,
1647, 1578, 1279,1250, 1198, 1127, 783 cm-1; Anal.
Calcd for C13H11NO3: C, 68.11; H, 4.84; N, 6.11.
Found: C, 67.77; H, 5.20; N, 5.79. 3) 4-シアノ-1-ナフトエ酸メチル 4-(アミノカルボニル)-1-ナフトエ酸メチル1.7
56g(7.660ミリモル)と塩化チオニル0.68
ml(15.3ミリモル)をトルエン30ml中で80
℃にて30分間撹拌した。反応液を炭酸水素ナトリウム
水溶液に注ぎ、酢酸エチルで2回抽出した。集めた有機
層を無水硫酸マグネシウムで乾燥、溶媒を減圧留去し
た。得られた残留物をシリカゲルカラムクロマトグラフ
ィーにて精製し(ヘキサン/酢酸エチル=6/1)、酢
酸エチル−ヘキサンより結晶化して、目的物を得た。白
色結晶 収量1.021g 収率63% mp 109-110℃; 1H-NMR (CDCl3, 200MHz) δ 4.05 (3H,
s), 7.69-7.80 (2H, M),7.94 (1H, d, J = 7.6 Hz), 8.
15 (1H, d, J = 7.6 Hz), 8.28-8.36 (1H, m),8.86-8.9
4 (1H, m); IR (KBr) 2332, 1717, 1298, 1256, 766 cm
-1; Anal. Calcd for C13H9NO2: C, 73.92; H, 4.29;
N, 6.63. Found: C, 73.93; H, 4.29; N,6.65. 4) 4-シアノ-1-ナフトエ酸 4-シアノナフトエ酸メチル0.862g(4.081
ミリモル)のメタノール20ml−テトラヒドロフラン
20ml溶液に1N水酸化ナトリウム水溶液8.16m
l(8.16ミリモル)を加え、室温で一晩撹拌した。
反応液を濃縮、水で希釈し、1N塩酸で反応液を酸性に
した後、酢酸エチルで2回抽出した。集めた有機層を無
水硫酸ナトリウムで乾燥、溶媒を減圧留去した。残留物
を酢酸エチル−ヘキサンより結晶化して、目的物を得
た。白色結晶 収量0.730g 収率91%mp 2
37−238℃; 1H-NMR (DMSO-d6, 200MHz) δ 7.77-
7.91 (2H, m), 8.14-8.27 (3H, m), 8.83-8.92 (1H,
m); IR (KBr) 3100-2550, 2226, 1698, 1516, 1285, 12
64, 1204, 795, 770 cm-1; Anal. Calcd for C12H7NO2:
C, 73.09; H, 3.58; N, 7.10. Found: C, 72.96; H,
3.42; N, 7.07. 5) 4-シアノ-N-[(1RS,2SR)-2-(4-フ
ルオロフェニル)-2-ヒドロキシ-1-[4-(トリフル
オロメチル)ベンジル]エチル]ナフタレン-1-カルボ
キサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.155g(0.495ミリモ
ル)、4-シアノ-1-ナフトエ酸0.10g(0.49
ミリモル)、1-ヒドロキシベンゾトリアゾール水和物
76mg(0.49ミリモル)をアセトニトリル10m
l中で撹拌しながら1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド・塩酸塩94mg(0.49
ミリモル)を加え、室温で一晩撹拌した。反応液を酢酸
エチルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無
水硫酸マグネシウムで乾燥、シリカゲルを通した後、溶
媒を減圧留去した。得られた残留物を酢酸エチル−ヘキ
サンより結晶化して、目的物を得た。白色結晶 収量
0.204g 収率84% mp 199-201℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
84-2.98 (1H, m), 3.18-3.28 (1H, m), 4.65 4.80 (1H,
m), 4.85 (1H, t, J = 5.3 Hz), 5.53 (1H, d,J = 4.0
Hz), 7.09 (2H, t, J = 8.8 Hz), 7.17-7.26 (2H, m),
7.37-7.44 (3H,m), 7.52-7.58 (4H, m), 7.64-7.72 (1
H, m), 7.86 (1H, d, J = 7.4 Hz), 8.13-8.22 (2H,
m); IR (KBr) 3283, 2228, 1642, 1539, 1512, 1327, 1
163, 1125,1111, 1069, 839 cm-1; Anal. Calcd for C
28H20F4N2O2・0.1H2O: C, 68.04; H,4.12; N, 5.67. Fou
nd: C, 67.86; H, 4.19; N, 5.55.Example 54 4-cyano-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene-1- Carboxamide 1) 4- (methoxycarbonyl) -1-naphthoic acid 25.90 g of naphthalene-1,4-dicarboxylic acid (11
9.8 mmol) in 80 ml of tetrahydrofuran-N,
While stirring in 50 ml of N-dimethylformamide,
18.2 g (120 mmol) of 1,8-diazabicyclo [5.4.0] -7-undecene was added at room temperature, and the mixture was stirred for 0.5 hour. 51.0 g of iodomethane was added to the reaction solution.
(359 mmol) was added at room temperature, and the mixture was stirred overnight. The reaction solution was diluted with an aqueous sodium hydrogen carbonate solution and washed with ethyl acetate. The resulting aqueous solution was acidified with concentrated hydrochloric acid and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 1/1), and crystallized from ethyl acetate-hexane to obtain the desired product. Light brown crystal Yield 6.309 g Yield 23% mp 148-150 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 4.
02 (3H, s), 7.59-7.68 (2H, m), 8.09 (1H, d, J = 7.4
Hz), 8.14 (1H, d, J = 7.4 Hz), 8.75-8.84 (1H, m),
8.88-8.96 (1H, m); IR (KBr) 3100-2635, 1723, 170
1, 1291, 1281,1256.1206, 1152, 775 cm -1 ; Anal.Ca
lcd for C 13 H 10 O 4 : C, 67.82; H, 4.38.Found: C, 67.8
2; H, 4.28.2) methyl 4- (aminocarbonyl) -1-naphthoate 2.553 4- (methoxycarbonyl) -1-naphthoic acid
To a solution of g (11.09 mmol) and 2 drops of N, N-dimethylformamide in 40 ml of tetrahydrofuran, 1.93 ml (22.2 mmol) of oxalyl chloride was added dropwise at room temperature, and the mixture was stirred for 0.5 hour. The solvent of the reaction solution was distilled off under reduced pressure to obtain a crude acid chloride product as a liquid. 1.52 g (22.2 mmol) of 15% aqueous ammonia and 1.86 g (22.2 mmol) of sodium hydrogen carbonate dissolved in 40 ml of tetrahydrofuran while stirring under ice-cooling in 40 ml of tetrahydrofuran Was added dropwise, and the mixture was stirred under ice cooling for 0.5 hour and further at room temperature for 0.5 hour. The reaction solution was poured into an aqueous solution of sodium hydrogen carbonate, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diethyl ether-hexane to obtain the desired product. Light brown crystal Yield 2.418 g
Yield 95% mp 182-184 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 4.02 (3H,
s), 6.64 (1H, br s), 7.21 (1H, br s), 7.56-7.71 (3
H, m), 8.13 (1H, d, J = 7.8 Hz), 8.34-8.43 (1H,
m), 8.83-8.91 (1H, m); IR (KBr) 3374, 3193, 1719,
1647, 1578, 1279,1250, 1198, 1127, 783 cm -1 ; Anal.
Calcd for C 13 H 11 NO 3 : C, 68.11; H, 4.84; N, 6.11.
Found: C, 67.77; H, 5.20; N, 5.79. 3) Methyl 4-cyano-1-naphthoate 1.7 (methyl) 4- (aminocarbonyl) -1-naphthoate
56 g (7.660 mmol) and 0.68 thionyl chloride
ml (15.3 mmol) in 30 ml toluene
Stirred at C for 30 minutes. The reaction solution was poured into an aqueous solution of sodium hydrogen carbonate, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 6/1), and crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 1.021 g Yield 63% mp 109-110 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 4.05 (3H,
s), 7.69-7.80 (2H, M), 7.94 (1H, d, J = 7.6 Hz), 8.
15 (1H, d, J = 7.6 Hz), 8.28-8.36 (1H, m), 8.86-8.9
4 (1H, m); IR (KBr) 2332, 1717, 1298, 1256, 766 cm
-1 ; Anal.Calcd for C 13 H 9 NO 2 : C, 73.92; H, 4.29;
N, 6.63. Found: C, 73.93; H, 4.29; N, 6.6.4. 4) 4-cyano-1-naphthoic acid 0.862 g of methyl 4-cyanonaphthoate (4.081)
Mmol) in methanol (20 ml) -tetrahydrofuran (20 ml) solution.
1 (8.16 mmol) was added and stirred at room temperature overnight.
The reaction solution was concentrated, diluted with water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 0.730 g Yield 91% mp 2
37-238 ° C; 1 H-NMR (DMSO-d 6 , 200 MHz) δ 7.77-
7.91 (2H, m), 8.14-8.27 (3H, m), 8.83-8.92 (1H,
m); IR (KBr) 3100-2550, 2226, 1698, 1516, 1285, 12
64, 1204, 795, 770 cm -1 ; Anal.Calcd for C 12 H 7 NO 2 :
C, 73.09; H, 3.58; N, 7.10. Found: C, 72.96; H,
3.42; N, 7.07.5) 4-cyano-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene- 1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.155 g (0.495 mmol), 4 0.10 g (0.49-cyano-1-naphthoic acid)
Mmol) 1-hydroxybenzotriazole hydrate (76 mg, 0.49 mmol) in acetonitrile 10 m
1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 94 mg (0.49
Mmol) and stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 0.204 g Yield 84% mp 199-201 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
84-2.98 (1H, m), 3.18-3.28 (1H, m), 4.65 4.80 (1H, m
m), 4.85 (1H, t, J = 5.3 Hz), 5.53 (1H, d, J = 4.0
Hz), 7.09 (2H, t, J = 8.8 Hz), 7.17-7.26 (2H, m),
7.37-7.44 (3H, m), 7.52-7.58 (4H, m), 7.64-7.72 (1
H, m), 7.86 (1H, d, J = 7.4 Hz), 8.13-8.22 (2H,
m); IR (KBr) 3283, 2228, 1642, 1539, 1512, 1327, 1
163, 1125,1111, 1069, 839 cm -1 ; Anal.Calcd for C
28 H 20 F 4 N 2 O 2・ 0.1H 2 O: C, 68.04; H, 4.12; N, 5.67. Fou
nd: C, 67.86; H, 4.19; N, 5.55.
【0187】実施例55 4-フルオロ-N-((1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-((4-(トリフルオ
ロメチル)フェニル)メチル)エチル)ベンズアミド (1RS,2SR)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(200mg,0.57
ミリモル)の酢酸エチル(5ml)溶液に4-フルオロ
ベンゾイルクロリド(136mg,0.86ミリモル)
および飽和重曹水(5ml)を加えて室温で1時間攪拌
した。反応液を水(50ml)で希釈し、酢酸エチル
(50ml×2)で抽出した。抽出液を飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去し、酢酸
エチル−ヘキサンから再結晶させて、表題化合物(18
2mg,73%)を得た。 mp 202-203℃ IRν maxKBrcm-1: 3297, 1640, 1607, 1508. Anal. Calcd for C23H18F5NO2: C, 63.45; H, 4.17; N,
3.22 Found: C, 63.30; H, 4.26; N, 3.28.1 H-NMR (CDCl3)δ: 2.80-3.06 (2H, m), 3.43 (1H, d,
J = 3.8 Hz), 4.50-4.70(1H, m), 5.04-5.14 (1H, m),
6.07 (1H, d, J = 9.0 Hz), 7.00-7.20 (4H, m), 7.20-
7.36 (2H, m), 7.40-7.64 (6H, m).Example 55 4-Fluoro-N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) benzamide (1RS, 2SR) -1- (4-fluorophenyl) -1-
Hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (200 mg, 0.57
Mmol) in ethyl acetate (5 ml) in 4-fluorobenzoyl chloride (136 mg, 0.86 mmol)
And saturated aqueous sodium hydrogen carbonate (5 ml), and the mixture was stirred at room temperature for 1 hour. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with brine, dried over anhydrous magnesium sulfate, evaporated under reduced pressure, and recrystallized from ethyl acetate-hexane to give the title compound (18
2 mg, 73%). mp 202-203 ℃ IRν max KBr cm -1 : 3297, 1640, 1607, 1508. Anal.Calcd for C 23 H 18 F 5 NO 2 : C, 63.45; H, 4.17; N,
3.22 Found:. C, 63.30; H, 4.26; N, 3.28 1 H-NMR (CDCl 3) δ: 2.80-3.06 (2H, m), 3.43 (1H, d,
J = 3.8 Hz), 4.50-4.70 (1H, m), 5.04-5.14 (1H, m),
6.07 (1H, d, J = 9.0 Hz), 7.00-7.20 (4H, m), 7.20-
7.36 (2H, m), 7.40-7.64 (6H, m).
【0188】実施例56 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-6-(メチルオキシ)-1-ナ
フタレンカルボキサミド 6-メトキシ-1-ナフタレンカルボン酸(129mg,
0.64ミリモル)のテトラヒドロフラン(5ml)溶
液に、オキサリルクロリド(0.11ml,1.28ミ
リモル)およびN,N-ジメチルホルムアミド(0.0
1ml)を加えて、室温で30分間攪拌し、反応液を減
圧留去した。残留物の酢酸エチル(5ml)溶液に(1
RS,2SR)-1-(4-フルオロフェニル)-1-ヒド
ロキシ-3-(4-(トリフルオロメチル)フェニル)-2
-プロピルアミン塩酸塩(150mg,0.43ミリモ
ル)および飽和重曹水(5ml)を加えて室温で終夜攪
拌した。反応液を水(50ml)で希釈し、酢酸エチル
(50ml×2)で抽出した。抽出液を飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=2:1)で精製し、酢酸エチル−ヘキ
サンから再結晶させて、表題化合物(148mg,69
%)を得た。 mp 193-194℃ IRν maxKBrcm-1: 1636, 1512. Anal. Calcd for C28H23F4NO3・0.1H2O: C, 67.36; H,
4.68; N, 2.81 Found: C, 67.24; H, 4.71; N, 2.81.1 H-NMR (CDCl3)δ: 2.80-3.16 (2H, m), 3.37 (1H, br
s), 3.91 (3H, s), 4.70-4.90 (1H, m), 5.09 (1H, br
s), 5.95 (1H, d, J = 8.4 Hz), 6.98-7.18 (5H, m),
7.20-7.40 (3H, m), 7.40-7.60 (5H, m), 7.75 (1H, d,
J = 8.0 Hz).Example 56 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -6- (methyloxy) -1-naphthalenecarboxamide 6-methoxy-1-naphthalenecarboxylic acid (129 mg,
Oxalyl chloride (0.11 ml, 1.28 mmol) and N, N-dimethylformamide (0.04 mmol) in tetrahydrofuran (5 ml) solution.
1 ml), and the mixture was stirred at room temperature for 30 minutes, and the reaction solution was evaporated under reduced pressure. (1 ml) was added to a solution of the residue in ethyl acetate (5 ml).
RS, 2SR) -1- (4-Fluorophenyl) -1-hydroxy-3- (4- (trifluoromethyl) phenyl) -2
-Propylamine hydrochloride (150 mg, 0.43 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1) and recrystallized from ethyl acetate-hexane to give the title compound (148 mg, 69).
%). mp 193-194 ℃ IRν max KBr cm -1 : 1636, 1512. Anal.Calcd for C 28 H 23 F 4 NO 3・ 0.1H 2 O: C, 67.36; H,
4.68; N, 2.81 Found:. C, 67.24; H, 4.71; N, 2.81 1 H-NMR (CDCl 3) δ: 2.80-3.16 (2H, m), 3.37 (1H, br
s), 3.91 (3H, s), 4.70-4.90 (1H, m), 5.09 (1H, br
s), 5.95 (1H, d, J = 8.4 Hz), 6.98-7.18 (5H, m),
7.20-7.40 (3H, m), 7.40-7.60 (5H, m), 7.75 (1H, d,
J = 8.0 Hz).
【0189】実施例57 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-4-キノリンカルボキサミド 4-キノリンカルボン酸(111mg,0.64ミリモ
ル)のテトラヒドロフラン(5ml)溶液に、オキサリ
ルクロリド(0.11ml,1.72ミリモル)および
N,N-ジメチルホルムアミド(0.01ml)を加え
て、室温で30分間攪拌し、反応液を減圧留去した。残
留物の酢酸エチル(5ml)溶液に(1RS,2SR)
-1-(4-フルオロフェニル)-1-ヒドロキシ-3-(4-
(トリフルオロメチル)フェニル)-2-プロピルアミン
塩酸塩(150mg,0.43ミリモル)および飽和重
曹水(5ml)を加えて室温で終夜攪拌した。反応液を
水(50ml)で希釈し、酢酸エチル(50ml×2)
で抽出した。抽出液を飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(酢酸エチル)で精製し、酢
酸エチル−ヘキサンから再結晶させて、表題化合物(6
3mg,32%)を得た。 mp 227-228℃ IRν maxKBrcm-1: 1644, 1508, 1331. Anal. Calcd for C26H20F4N2O2・0.5H2O: C, 65.41; H,
4.43; N, 5.87 Found: C, 65.31; H, 4.68; N, 5.61.1 H-NMR (CDCl3)δ: 2.76-2.98 (1H, m), 3.00-3.16 (1
H, m), 4.72-4.92 (1H, m), 5.05 (1H, d, J = 4.0 H
z), 6.60-6.80 (1H, m), 7.02-7.20 (3H, m), 7.22-7.6
0 (8H, m), 7.62-7.78 (1H, m), 8.05 (1H, d, J = 8.4
Hz), 8.82 (1H, brs).Example 57 N-((1RS, 2SR) -2- (4-fluorophenyl)
2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4-quinolinecarboxamide Oxalyl chloride was added to a solution of 4-quinolinecarboxylic acid (111 mg, 0.64 mmol) in tetrahydrofuran (5 ml). (0.11 ml, 1.72 mmol) and N, N-dimethylformamide (0.01 ml) were added, the mixture was stirred at room temperature for 30 minutes, and the reaction solution was distilled off under reduced pressure. To a solution of the residue in ethyl acetate (5 ml) (1RS, 2SR)
-1- (4-Fluorophenyl) -1-hydroxy-3- (4-
(Trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.43 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and ethyl acetate (50 ml × 2)
Extracted. The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to give the title compound (6
3 mg, 32%). mp 227-228 ° C IRν max KBr cm -1 : 1644, 1508, 1331. Anal.Calcd for C 26 H 20 F 4 N 2 O 2・ 0.5H 2 O: C, 65.41; H,
4.43; N, 5.87 Found:. C, 65.31; H, 4.68; N, 5.61 1 H-NMR (CDCl 3) δ: 2.76-2.98 (1H, m), 3.00-3.16 (1
H, m), 4.72-4.92 (1H, m), 5.05 (1H, d, J = 4.0 H
z), 6.60-6.80 (1H, m), 7.02-7.20 (3H, m), 7.22-7.6
0 (8H, m), 7.62-7.78 (1H, m), 8.05 (1H, d, J = 8.4
Hz), 8.82 (1H, brs).
【0190】実施例58 3-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[4-(トリフルオロ
メチル)ベンジル]エチル]ナフタレン-1-カルボキサ
ミド 1) 3-ニトロ-1-ナフトエ酸エチル 3-ニトロ-1-ナフトエ酸(J.Org.Chem.,
54,3596-602(1989)参照)3.020
g(13.91ミリモル)、濃硫酸1mlのエタノール
50ml溶液を1日間加熱還流した。反応液を濃縮後、
酢酸エチルで希釈、炭酸水素ナトリウム水溶液および水
で洗浄した。得られた酢酸エチル溶液を無水硫酸マグネ
シウムで乾燥、溶媒を減圧留去した。得られた残留物を
ジエチルエーテル−ヘキサンより結晶化して、目的物を
得た。黄色結晶 収量3.137g 収率92% mp 78-79℃; 1H-NMR (CDCl3, 200MHz) δ 1.50 (3H, t,
J = 7.1 Hz), 4.53 (2H, q, J = 7.1 Hz), 7.71 (1H,
ddd, J = 1.0 Hz, 6.8 Hz, 8.2 Hz), 7.83 (1H,ddd, J
= 1.3 Hz, 6.7 Hz, 8.8 Hz), 8.10 (1H, d, J = 8.8 H
z), 8.92 (1H, d,J = 2.6 Hz), 8.96 (1H, d, J = 2.6
Hz), 9.03 (1H, d, J = 8.8 Hz); IR (KBr) 1717, 160
3, 1526, 1453, 1339, 1281, 1240, 1190, 1155, 1140
1024, 795,766 cm-1; Anal. Calcd for C13H11NO4: C,
63.67; H, 4.52; N, 5.71. Found:C, 63.64; H, 4.44;
N, 5.64. 2) 3-アミノ-1-ナフトエ酸エチル 3-ニトロ-1-ナフトエ酸エチル5.371g(21.
90ミリモル)のエタノール30ml溶液を10%パラ
ジウム/炭素(50%含水)0.5gを触媒として、原
料が消失するまで常温常圧下で水素添加した。触媒を濾
過して除いた後、溶媒を減圧留去した。得られた粗生成
物をシリカゲルカラムクロマトグラフィーにて精製し
(ヘキサン/酢酸エチル=6/1−3/1)、目的物を
得た。橙色液体 収量4.681g 収率99%1 H-NMR (CDCl3, 200MHz) δ 1.45 (3H, t, J = 7.1 H
z), 3.89 (2H, br s), 4.46 (2H, q, J = 7.1 Hz), 7.1
5 (1H, d, J = 2.2 Hz), 7.30-7.45 (2H, m), 7.60-7.6
6 (2H, m), 8.70 (1H, dd, J = 1.6 Hz, 8.2 Hz); IR
(neat) 3465, 3374,2980, 1705, 1626, 1236, 1202 cm
-1 3) 3-フルオロ-1-ナフトエ酸 3-アミノ-1-ナフトエ酸エチル2.318g(10.
77ミリモル)、濃塩酸4mlを水30ml中で撹拌し
ながら、氷冷下、亜硝酸ナトリウム0.89g(12.
9ミリモル)の水2ml溶液を滴下し、そのままの温度
で10分間撹拌した。反応液に氷冷下、60%ヘキサフ
ルオロリン酸水溶液2.70ml(18.3ミリモル)
を激しく撹拌しながら加え、そのまま0.5時間撹拌し
た。生じた沈殿をろ過し、水およびメタノール-ジエチ
ルエーテル(1:4)で洗浄後、乾燥して、ジアゾニウ
ム塩を褐色粉末として得た。得られたジアゾニウム塩を
流動パラフィン8ml中で、170℃にて0.5時間加
熱した。室温に冷却した後、炭酸水素ナトリウム水溶液
を加え、酢酸エチルで2回抽出した。集めた有機層を無
水硫酸マグネシウムで乾燥、溶媒を減圧留去した。得ら
れた粗生成物をシリカゲルカラムクロマトグラフィーに
て精製し(ヘキサン/酢酸エチル=15/1)、3-フ
ルオロ-1-ナフトエ酸エチルと流動パラフィンの混合物
を淡黄色液体として得た。得られた液体のエタノール3
0ml−テトラヒドロフラン40ml溶液に1N水酸化
ナトリウム水溶液10ml(10ミリモル)を加え、室
温で一晩撹拌した。反応液を濃縮、水で希釈、希塩酸で
酸性にし、酢酸エチルで2回抽出した。集めた有機層を
無水硫酸ナトリウムで乾燥、溶媒を減圧留去した。残留
物を酢酸エチル−ヘキサンより結晶化して、目的物を得
た。淡黄色結晶 収量0.629g 収率31% mp 185-187℃; 1H-NMR (DMSO-d6, 200MHz) δ 7.58-7.6
6 (2H, m), 7.94-8.03 (3H, m), 8.82-8.88 (1H, m); I
R (KBr) 3150-2550, 1696, 1682, 1296, 1252, 1221, 7
50 cm-1; Anal. Calcd for C11H7FO2: C, 69.47; H, 3.
71. Found: C, 69.57; H, 3.80. 4) 3-フルオロ-N-[(1RS,2SR)-2-(4-
フルオロフェニル)-2-ヒドロキシ-1-[4-(トリフ
ルオロメチル)ベンジル]エチル]ナフタレン-1-カル
ボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.158g(0.504ミリモ
ル)、3-フルオロ-1-ナフトエ酸0.10g(0.5
0ミリモル)、1-ヒドロキシベンゾトリアゾール水和
物77mg(0.50ミリモル)をアセトニトリル10
ml中で撹拌しながら1-エチル-3-(3-ジメチルアミ
ノプロピル)カルボジイミド・塩酸塩0.10g(0.
50ミリモル)を加え、室温で一晩撹拌した。反応液を
酢酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗
浄、無水硫酸マグネシウムで乾燥、シリカゲルを通した
後、溶媒を減圧留去した。得られた残留物を酢酸エチル
−ヘキサンより結晶化して、目的物を得た。白色結晶
収量0.199g 収率81% mp 223-225℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
92 (1H, dd, J = 11.3 Hz, 14.3 Hz), 3.17 (1H, dd, J
= 3.3 Hz, 13.9 Hz), 4.64-4.80 (1H, m), 4.91(1H,
t, J = 4.4 Hz), 5.45 (1H, d, J = 4.0 Hz), 6.98 (1
H, dd, J = 2.4 Hz, 8.8 Hz), 7.08 (2H, t, J = 8.8 H
z), 7.21-7.60 (10H, m), 7.74 (1H, d, J= 8.6 Hz),
7.99 (1H, d, J = 10.0 Hz); IR (KBr) 3277, 1642, 16
24, 1537, 1514, 1325, 1231, 1165, 1127, 1069, 831
cm-1; Anal. Calcd for C27H20F5NO2: C, 66.80; H, 4.
15; N, 2.89. Found: C, 66.66; H, 4.21; N, 2.70.Example 58 3-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene-1- Carboxamide 1) Ethyl 3-nitro-1-naphthoate 3-Nitro-1-naphthoic acid (J. Org. Chem.,
54, 3596-602 (1989)) 3.020
g (13.91 mmol) and a solution of concentrated sulfuric acid (1 ml) in ethanol (50 ml) were heated under reflux for 1 day. After concentrating the reaction solution,
Dilute with ethyl acetate and wash with aqueous sodium bicarbonate and water. The obtained ethyl acetate solution was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diethyl ether-hexane to obtain the desired product. Yellow crystal Yield 3.137 g Yield 92% mp 78-79 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.50 (3H, t,
J = 7.1 Hz), 4.53 (2H, q, J = 7.1 Hz), 7.71 (1H,
ddd, J = 1.0 Hz, 6.8 Hz, 8.2 Hz), 7.83 (1H, ddd, J
= 1.3 Hz, 6.7 Hz, 8.8 Hz), 8.10 (1H, d, J = 8.8 H
z), 8.92 (1H, d, J = 2.6 Hz), 8.96 (1H, d, J = 2.6
Hz), 9.03 (1H, d, J = 8.8 Hz); IR (KBr) 1717, 160
3, 1526, 1453, 1339, 1281, 1240, 1190, 1155, 1140
1024, 795,766 cm -1 ; Anal.Calcd for C 13 H 11 NO 4 : C,
63.67; H, 4.52; N, 5.71. Found: C, 63.64; H, 4.44;
N, 5.64.2) Ethyl 3-amino-1-naphthoate 5.371 g of ethyl 3-nitro-1-naphthoate (21.
A solution of 90 mmol) in 30 ml of ethanol was hydrogenated under normal temperature and pressure until the raw materials disappeared using 0.5 g of 10% palladium / carbon (containing 50% water) as a catalyst. After removing the catalyst by filtration, the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-3 / 1) to obtain the desired product. Orange liquid Yield 4.681 g Yield 99% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.45 (3H, t, J = 7.1 H)
z), 3.89 (2H, br s), 4.46 (2H, q, J = 7.1 Hz), 7.1
5 (1H, d, J = 2.2 Hz), 7.30-7.45 (2H, m), 7.60-7.6
6 (2H, m), 8.70 (1H, dd, J = 1.6 Hz, 8.2 Hz); IR
(neat) 3465, 3374,2980, 1705, 1626, 1236, 1202 cm
-1 3) 3-Fluoro-1-naphthoic acid 3-amino-1-ethyl-naphthoic acid 2.318g (10.
77 mmol) and 0.89 g of sodium nitrite (12.
(9 mmol) was added dropwise and stirred at the same temperature for 10 minutes. 2.70 ml (18.3 mmol) of a 60% aqueous solution of hexafluorophosphoric acid was added to the reaction solution under ice cooling.
Was added with vigorous stirring, and the mixture was stirred for 0.5 hour as it was. The resulting precipitate was filtered, washed with water and methanol-diethyl ether (1: 4), and dried to obtain a diazonium salt as a brown powder. The obtained diazonium salt was heated in 170 ml of liquid paraffin at 170 ° C. for 0.5 hour. After cooling to room temperature, an aqueous sodium hydrogen carbonate solution was added, and the mixture was extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15/1) to obtain a mixture of ethyl 3-fluoro-1-naphthoate and liquid paraffin as a pale yellow liquid. The obtained liquid ethanol 3
10 ml (10 mmol) of a 1N aqueous sodium hydroxide solution was added to a 0 ml-tetrahydrofuran 40 ml solution, and the mixture was stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, acidified with diluted hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from ethyl acetate-hexane to obtain the desired product. Pale yellow crystal yield 0.629 g yield 31% mp 185-187 ° C; 1 H-NMR (DMSO-d 6 , 200 MHz) δ 7.58-7.6
6 (2H, m), 7.94-8.03 (3H, m), 8.82-8.88 (1H, m); I
R (KBr) 3150-2550, 1696, 1682, 1296, 1252, 1221, 7
. 50 cm -1; Anal Calcd for C 11 H 7 FO 2: C, 69.47; H, 3.
71. Found: C, 69.57; H, 3.80.4) 3-Fluoro-N-[(1RS, 2SR) -2- (4-
(Fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4 -(Trifluoromethyl) phenyl] propan-1-ol 0.158 g (0.504 mmol), 3-fluoro-1-naphthoic acid 0.10 g (0.5
0 mmol) 1-hydroxybenzotriazole hydrate 77 mg (0.50 mmol) in acetonitrile 10
While stirring in 0.1 ml, 0.10 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.
(50 mmol) and stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals
Yield 0.199 g Yield 81% mp 223-225 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
92 (1H, dd, J = 11.3 Hz, 14.3 Hz), 3.17 (1H, dd, J
= 3.3 Hz, 13.9 Hz), 4.64-4.80 (1H, m), 4.91 (1H,
t, J = 4.4 Hz), 5.45 (1H, d, J = 4.0 Hz), 6.98 (1
H, dd, J = 2.4 Hz, 8.8 Hz), 7.08 (2H, t, J = 8.8 H
z), 7.21-7.60 (10H, m), 7.74 (1H, d, J = 8.6 Hz),
7.99 (1H, d, J = 10.0 Hz); IR (KBr) 3277, 1642, 16
24, 1537, 1514, 1325, 1231, 1165, 1127, 1069, 831
. cm -1; Anal Calcd for C 27 H 20 F 5 NO 2: C, 66.80; H, 4.
15; N, 2.89. Found: C, 66.66; H, 4.21; N, 2.70.
【0191】実施例59 4,4,4-トリフルオロ-N-[(1RS,2SR)-2
-(4-フルオロフェニル)-2-ヒドロキシ-1-[4-
(トリフルオロメチル)ベンジル]エチル]ブチルアミ
ド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.170g(0.543ミリモ
ル)、4,4,4-トリフルオロブタン酸77mg
(0.54ミリモル)、1-ヒドロキシベンゾトリアゾ
ール水和物83mg(0.54ミリモル)をアセトニト
リル10ml中で撹拌しながら1-エチル-3-(3-ジメ
チルアミノプロピル)カルボジイミド・塩酸塩0.10
g(0.54ミリモル)を加え、室温で一晩撹拌した。
反応液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶
液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲルを
通した後、溶媒を減圧留去した。得られた残留物をジイ
ソプロピルエーテル−ヘキサンより結晶化して、目的物
を得た。白色結晶 収量0.210g 収率88% mp 178-179℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
15-2.45 (4H, m), 2.74-2.81 (2H, m), 4.33 4.46 (1H,
m), 4.88 (1H, d, J = 3.2 Hz), 4.92 (1H, t,J = 3.3
Hz), 7.05 (2H, t, J = 8.8 Hz), 7.07 (1H, d, J =
8.8 Hz), 7.20 (2H, d, J = 8.0 Hz), 7.38-7.47 (4H,
m); IR (KBr) 3299, 1655, 1557, 1514, 1329, 1229, 1
107, 1069, 829 cm-1; Anal. Calcd for C20H18F7NO2:
C, 54.93;H, 4.15; N, 3.20. Found: C, 54.96; H, 4.2
2; N, 2.95.Example 59 4,4,4-Trifluoro-N-[(1RS, 2SR) -2
-(4-Fluorophenyl) -2-hydroxy-1- [4-
0.170 g of (trifluoromethyl) benzyl] ethyl] butyramide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol ( 0.543 mmol), 77 mg of 4,4,4-trifluorobutanoic acid
(0.54 mmol) 83 mg (0.54 mmol) of 1-hydroxybenzotriazole hydrate in 10 ml of acetonitrile while stirring 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 0.10.
g (0.54 mmol) was added and stirred at room temperature overnight.
The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.210 g Yield 88% mp 178-179 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
15-2.45 (4H, m), 2.74-2.81 (2H, m), 4.33 4.46 (1H,
m), 4.88 (1H, d, J = 3.2 Hz), 4.92 (1H, t, J = 3.3
Hz), 7.05 (2H, t, J = 8.8 Hz), 7.07 (1H, d, J =
8.8 Hz), 7.20 (2H, d, J = 8.0 Hz), 7.38-7.47 (4H,
m); IR (KBr) 3299, 1655, 1557, 1514, 1329, 1229, 1
107, 1069, 829 cm -1 ; Anal.Calcd for C 20 H 18 F 7 NO 2 :
C, 54.93; H, 4.15; N, 3.20. Found: C, 54.96; H, 4.2
2; N, 2.95.
【0192】実施例60 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-4-(メチルオキシ)ベンズ
アミド (1RS,2SR)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(200mg,0.57
ミリモル)の酢酸エチル(5ml)溶液に4-アニソイ
ルクロリド(146mg,0.86ミリモル)および飽
和重曹水(5ml)を加えて室温で終夜攪拌した。反応
液を水(50ml)で希釈し、酢酸エチル(50ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=4:1)で精製し、酢酸エチル−ヘキサンから再結晶
させて、表題化合物(185mg,72%)を得た。 mp 192-193℃ IRν maxKBrcm-1: 1624, 1609, 1539, 1507, 1329. Anal. Calcd for C24H21F4NO3: C, 64.43; H, 4.73; N,
3.13 Found: C, 64.44; H, 4.66; N, 3.09.1 H-NMR (CDCl3)δ: 2.86-3.00 (2H, m), 3.84 (3H, s),
3.80-3.88 (1H, m), 4.50-4.66 (1H, m), 5.06-5.14
(1H, m), 6.00 (1H, d, J = 8.0 Hz), 6.88 (2H,d, J =
8.8 Hz), 7.02-7.14 (2H, m), 7.20-7.30 (2H, m), 7.
36-7.60 (6H, m).Example 60 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4- (methyloxy) benzamide (1RS, 2SR) -1- (4-fluorophenyl) -1-
Hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (200 mg, 0.57
4-anisoyl chloride (146 mg, 0.86 mmol) and saturated aqueous sodium bicarbonate (5 ml) were added to a solution of the resulting solution in an aqueous solution of ethyl acetate (5 mmol) and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml), and ethyl acetate (50 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the title compound (185 mg, 72%). mp 192-193 ° C IRν max KBr cm -1 : 1624, 1609, 1539, 1507, 1329. Anal.Calcd for C 24 H 21 F 4 NO 3 : C, 64.43; H, 4.73; N,
3.13 Found:. C, 64.44; H, 4.66; N, 3.09 1 H-NMR (CDCl 3) δ: 2.86-3.00 (2H, m), 3.84 (3H, s),
3.80-3.88 (1H, m), 4.50-4.66 (1H, m), 5.06-5.14
(1H, m), 6.00 (1H, d, J = 8.0 Hz), 6.88 (2H, d, J =
8.8 Hz), 7.02-7.14 (2H, m), 7.20-7.30 (2H, m), 7.
36-7.60 (6H, m).
【0193】実施例61 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-9-オキソ-9H-フルオレン
-4-カルボキサミド 9-オキソ-9H-フルオレン-4-カルボン酸(144m
g,0.64ミリモル)のテトラヒドロフラン(5m
l)溶液に、オキサリルクロリド(0.11ml,1.
72ミリモル)およびN,N-ジメチルホルムアミド
(0.01ml)を加えて、室温で30分間攪拌し、反
応液を減圧留去した。残留物の酢酸エチル(5ml)溶
液に(1RS,2SR)-1-(4-フルオロフェニル)-
1-ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(150mg,0.43
ミリモル)および飽和重曹水(5ml)を加えて室温で
終夜攪拌した。反応液を水(50ml)で希釈し、酢酸
エチル(50ml×2)で抽出した。抽出液を飽和食塩
水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=4:1−1:1)で精製し、酢酸
エチル−ヘキサンから再結晶させて、表題化合物(15
4mg,69%)を得た。 mp 231-232℃ IRνmaxKBrcm-1: 1725, 1638, 1607. Anal. Calcd for C30H21F4NO3: C, 69.36; H, 4.07; N,
2.70 Found: C, 69.13; H, 4.22; N, 2.53.1 H-NMR (CD3OD)δ: 2.78-2.96 (1H, m), 3.49 (1H, d,
J = 13.2 Hz), 4.70-4.80 (2H, m), 6.72 (1H, d, J =
7.4 Hz), 6.89 (1H, d, J = 7.8 Hz), 7.04-7.32(5H,
m), 7.46-7.66 (8H, m).Example 61 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -9-oxo-9H-fluorene
-4-Carboxamide 9-oxo-9H-fluorene-4-carboxylic acid (144 m
g, 0.64 mmol) of tetrahydrofuran (5 m
l) Add oxalyl chloride (0.11 ml, 1.
72 mmol) and N, N-dimethylformamide (0.01 ml) were added, the mixture was stirred at room temperature for 30 minutes, and the reaction solution was distilled off under reduced pressure. (1RS, 2SR) -1- (4-fluorophenyl)-was added to a solution of the residue in ethyl acetate (5 ml).
1-hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.43
Mmol) and saturated aqueous sodium hydrogen carbonate (5 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-1: 1) and recrystallized from ethyl acetate-hexane to give the title compound (15
4 mg, 69%). mp 231-232 ℃ IRνmax KBr cm -1 : 1725, 1638, 1607. Anal.Calcd for C 30 H 21 F 4 NO 3 : C, 69.36; H, 4.07; N,
2.70 Found: C, 69.13; H, 4.22; N, 2.53. 1 H-NMR (CD 3 OD) δ: 2.78-2.96 (1H, m), 3.49 (1H, d,
J = 13.2 Hz), 4.70-4.80 (2H, m), 6.72 (1H, d, J =
7.4 Hz), 6.89 (1H, d, J = 7.8 Hz), 7.04-7.32 (5H,
m), 7.46-7.66 (8H, m).
【0194】実施例62 3,3-ジメチル-N-[(1RS,2SR)-2-(4-フ
ルオロフェニル)-2-ヒドロキシ-1-[4-(トリフル
オロメチル)ベンジル]エチル]ブチルアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.168g(0.536ミリモ
ル)、3,3-ジメチルブタン酸62mg(0.54ミ
リモル)、1-ヒドロキシベンゾトリアゾール水和物8
2mg(0.54ミリモル)をアセトニトリル10ml
中で撹拌しながら1-エチル-3-(3-ジメチルアミノプ
ロピル)カルボジイミド・塩酸塩0.10g(0.54
ミリモル)を加え、室温で一晩撹拌した。反応液を酢酸
エチルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無
水硫酸マグネシウムで乾燥、シリカゲルを通した後、溶
媒を減圧留去した。得られた残留物をヘキサンより結晶
化して、目的物を得た。白色結晶 収量0.155g
収率70% mp 140-141℃; 1H-NMR (CDCl3, 200MHz) δ 0.81 (9H,
s), 1.87 (1H, d, J = 12.8 Hz), 1.99 (1H, d, J = 1
3.0 Hz), 2.71 (1H, dd, J = 10.8 Hz, 14.8 Hz),2.91
(1H, dd, J = 4.4 Hz, 15.0 Hz), 3.47 (1H, d, J = 3.
6 Hz), 4.32-4.56(1H, m), 4.97 (1H, t, J = 3.1 Hz),
5.31 (1H, br d, J = 8.4 Hz), 7.07 (2H, t, J = 8.6
Hz), 7.22 (2H, d, J = 8.4 Hz), 7.40 (2H, dd, J =
5.4 Hz, 8.4 Hz), 7.50 (2H, d, J = 8.0 Hz); IR (KB
r) 3337, 2963, 1626, 1534, 1510,1333, 1231, 1159,
1127, 1071, 826 cm-1; Anal. Calcd for C22H25F4NO2:
C,64.22; H, 6.12; N, 3.40. Found: C, 64.03; H, 6.
20; N, 3.16.Example 62 3,3-Dimethyl-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] butylamide ( 0.168 g (0.536 mmol) of 1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol, 3,3-dimethyl Butanoic acid 62 mg (0.54 mmol), 1-hydroxybenzotriazole hydrate 8
2 mg (0.54 mmol) in 10 ml of acetonitrile
0.10 g (0.54 g) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride while stirring in water.
Mmol) and stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from hexane to obtain the desired product. White crystals Yield 0.155 g
Yield 70% mp 140-141 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 0.81 (9H,
s), 1.87 (1H, d, J = 12.8 Hz), 1.99 (1H, d, J = 1
3.01), 2.71 (1H, dd, J = 10.8 Hz, 14.8 Hz), 2.91
(1H, dd, J = 4.4 Hz, 15.0 Hz), 3.47 (1H, d, J = 3.
6 Hz), 4.32-4.56 (1H, m), 4.97 (1H, t, J = 3.1 Hz),
5.31 (1H, br d, J = 8.4 Hz), 7.07 (2H, t, J = 8.6
Hz), 7.22 (2H, d, J = 8.4 Hz), 7.40 (2H, dd, J =
5.4 Hz, 8.4 Hz), 7.50 (2H, d, J = 8.0 Hz); IR (KB
r) 3337, 2963, 1626, 1534, 1510,1333, 1231, 1159,
1127, 1071, 826 cm -1 ; Anal.Calcd for C 22 H 25 F 4 NO 2 :
C, 64.22; H, 6.12; N, 3.40. Found: C, 64.03; H, 6.
20; N, 3.16.
【0195】実施例63 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-2-ナフタレンカルボキサミ
ド (1RS,2SR)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(200mg,0.57
ミリモル)の酢酸エチル(5ml)溶液に2-ナフトイ
ルクロリド(164mg,0.86ミリモル)および飽
和重曹水(5ml)を加えて室温で終夜攪拌した。反応
液を水(50ml)で希釈し、酢酸エチル(50ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=4:1)で精製し、酢酸エチル−ヘキサンから再結晶
させて、表題化合物(175mg,65%)を得た。 mp 174-175℃ IRν maxKBrcm-1: 1640, 1537, 1514. Anal. Calcd for C27H21F4NO2: C, 69.37; H, 4.53; N,
3.00 Found: C, 69.23; H, 4.49; N, 2.92.1 H-NMR (CDCl3)δ: 2.96-3.04 (2H, m), 3.70 (1H, d,
J = 3.6 Hz), 4.58-4.76(1H, m), 5.12-5.20 (1H, m),
6.26 (1H, d, J = 8.0 Hz), 7.02-7.16 (2H, m), 7.31
(1H, s), 7.40-7.64 (7H, m), 7.80-7.90 (3H, m), 8.0
4 (1H, s).Example 63 N-((1RS, 2SR) -2- (4-fluorophenyl)
2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -2-naphthalenecarboxamide (1RS, 2SR) -1- (4-fluorophenyl) -1-
Hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (200 mg, 0.57
2-naphthoyl chloride (164 mg, 0.86 mmol) and saturated aqueous sodium bicarbonate (5 ml) were added to a solution of the resulting compound in an aqueous solution of ethyl acetate (5 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (50 ml), and ethyl acetate (50 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the title compound (175 mg, 65%). mp 174-175 ° C IRν max KBr cm -1 : 1640, 1537, 1514. Anal.Calcd for C 27 H 21 F 4 NO 2 : C, 69.37; H, 4.53; N,
3.00 Found:. C, 69.23; H, 4.49; N, 2.92 1 H-NMR (CDCl 3) δ: 2.96-3.04 (2H, m), 3.70 (1H, d,
J = 3.6 Hz), 4.58-4.76 (1H, m), 5.12-5.20 (1H, m),
6.26 (1H, d, J = 8.0 Hz), 7.02-7.16 (2H, m), 7.31
(1H, s), 7.40-7.64 (7H, m), 7.80-7.90 (3H, m), 8.0
4 (1H, s).
【0196】実施例64 4-(ジフルオロメチル)-N-((1S,2R)-2-
(4-フルオロフェニル)-2-ヒドロキシ-1-((4-
(トリフルオロメチル)フェニル)メチル)エチル)-
1-ナフタレンカルボキサミド 1) 4-メチル-1-ナフタレンカルボン酸(4.14
g,22.2ミリモル)のメタノール(50ml)溶液
に塩化チオニル(3ml)を加え、60℃にて終夜攪拌
した。反応液を濃縮後、水(100ml)を加えて酢酸
エチル(100ml×2)で抽出した。抽出液を飽和重
曹水、飽和食塩水で順次洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去し4-メチル-1-ナフタレンカルボン
酸メチル(4.32g,97%)を無色油状物として得
た。 IRνmaxKBrcm-1: 1715, 1591.1 H-NMR (CDCl3)δ: 2.75 (3H, s), 3.99 (3H, s), 7.35
(1H, d, J = 7.6 Hz),7.50-7.68 (2H, m), 8.00-8.14
(2H, m), 8.92-9.02 (1H, m). 2) 4-メチル-1-ナフタレンカルボン酸メチル
(4.23g,21.1ミリモル)のクロロホルム(7
0ml)溶液にN-ブロモスクシンイミド(4.1g,
23.2ミリモル)および2,2'-アゾビス(イソブチ
ロニトリル)(175mg,1.05ミリモル)を加え
30分加熱還流した。反応液を濃縮後、水(100m
l)を加えて酢酸エチル(100ml×2)で抽出し
た。抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去した。残留物をN,N-ジメチルホ
ルムアミド(50ml)に溶解させ、酢酸ナトリウム
(3.46g,42.2ミリモル)を加え、室温で1時
間攪拌後、60℃で終夜攪拌した。反応液を濃縮後、水
(100ml)を加えて酢酸エチル(100ml×2)
で抽出した。抽出液を飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(ヘキサン:酢酸エチル=2
0:1)で精製し4-((アセチルオキシ)メチル)-1
-ナフタレンカルボン酸メチル(4.1g,74%)を
得た。 IRνmaxKBrcm-1: 1744, 1717, 1595, 1518. Anal. Calcd for C15H14O4: C, 69.76; H, 5.46 Found: C, 69.63; H, 5.54.1 H-NMR (CDCl3)δ: 2.14 (3H, s), 4.00 (3H, s), 5.59
(2H, s), 7.52-7.70 (3H, m), 7.98-8.08 (1H, m), 8.
12 (1H, d, J = 7.2 Hz), 8.90-9.00 (1H, m). 3) 4-((アセチルオキシ)メチル)-1-ナフタレ
ンカルボン酸メチル(3.91g,15.1ミリモル)
のメタノール(20ml)溶液に1規定水酸化ナトリウ
ム水溶液(15.1ml,15.1ミリモル)を加え、
室温で5分攪拌した。反応液に1規定塩酸(20ml)
を加え、酢酸エチル(50ml×2)で抽出した。抽出
液を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=1:1)で精製し4
-(ヒドロキシメチル)-1-ナフタレンカルボン酸メチ
ル(2.78g,85%)を得た。 IRνmaxKBrcm-1: 1715. Anal. Calcd for C13H12O3: C, 72.21; H, 5.59 Found: C, 71.92; H, 5.49.1 H-NMR (CDCl3)δ: 3.99 (3H, s), 5.16 (2H, s), 7.50
-7.68 (3H, m), 8.00-8.16 (2H, m), 8.88-8.96 (1H,
m). 4) 4-(ヒドロキシメチル)-1-ナフタレンカルボ
ン酸メチル(2.0g,9.25ミリモル)のクロロホ
ルム(40ml)溶液に二酸化マンガン(4.0g)を
加え、室温で2時間攪拌した。反応液から二酸化マンガ
ンをセライトを用いてろ過し、ろ液を減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=2:1)で精製し、酢酸エチル−ヘキ
サンから再結晶させて4-ホルミル-1-ナフタレンカル
ボン酸メチル(1.41g,85%)を得た。 mp 95-96℃ IRνmaxKBrcm-1: 1723, 1696. Anal. Calcd for C13H10O3: C, 72.89; H, 4.71 Found: C, 72.81; H, 4.87.1 H-NMR (CDCl3)δ: 4.04 (3H, s), 7.60-7.78 (2H, m),
7.98 (1H, d, J = 7.2Hz), 8.17 (1H, d, J = 7.2 H
z), 8.76-8.82 (1H, m), 9.20-9.28 (1H, m), 10.47 (1
H, s). 5) 4-ホルミル-1-ナフタレンカルボン酸メチル
(800mg,3.73ミリモル)のトルエン(15m
l)溶液にジエチルアミノ硫黄トリフルオリド(750
ml,5.1ミリモル)を加え室温で終夜攪拌した。反
応液に飽和重曹水(10ml)を加え、酢酸エチル(5
0ml×2)で抽出した。抽出液を飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=10:1)で精製し4-(ジフルオロメチ
ル)-1-ナフタレンカルボン酸メチル(522mg,5
9%)を得た。 IRνmaxKBrcm-1: 1723. Anal. Calcd for C13H10F2O2: C, 66.10; H, 4.27 Found: C, 66.07; H, 4.35.1 H-NMR (CDCl3)δ: 4.03 (3H, s), 7.19 (1H, t, J = 5
5.0 Hz), 7.60-7.70 (2H, m), 7.75 (1H, d, J = 7.8 H
z), 8.10-8.22 (2H, m), 8.86-8.96 (1H, m). 6) 4-(ジフルオロメチル)-1-ナフタレンカルボ
ン酸メチル(450mg,1.91ミリモル)のメタノ
ール(5ml)溶液に2規定水酸化ナトリウム水溶液
(1.9ml,3.8ミリモル)を加え、室温で終夜攪
拌した。反応液に1規定塩酸(5ml)を加え、酢酸エ
チル(20ml×2)で抽出した。抽出液を飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて4
-(ジフルオロメチル)-1-ナフタレンカルボン酸(3
44mg,81%)を得た。 mp 179-180℃ IRνmaxKBrcm-1: 1701. Anal. Calcd for C12H8F2O2: C, 64.87; H, 3.63 Found: C, 64.76; H, 3.55.1 H-NMR (CDCl3)δ: 7.22 (1H, t, J = 54.8 Hz), 7.62-
7.70 (2H, m), 7.81 (1H, d, J = 7.6 Hz), 8.21 (1H,
d, J = 6.6 Hz), 8.39 (1H, d, J = 7.6 Hz), 9.02-9.1
8 (1H, m). 7) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(300mg,0.96ミリモ
ル)のアセトニトリル(30ml)溶液に4-(ジフル
オロメチル)-1-ナフタレンカルボン酸(213mg,
0.96ミリモル)および1-エチル-3-(3-ジメチル
アミノプロピル)カルボジイミド・塩酸塩(275m
g,1.44ミリモル)および1-ヒドロキシ-1H-ベ
ンゾトリアゾール(147mg,0.96ミリモル)を
加えて室温で終夜攪拌した。反応液を水(100ml)
で希釈し、酢酸エチル(100ml×2)で抽出した。
抽出液を1規定塩酸、1規定水酸化ナトリウム水溶液、
飽和食塩水で順次洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=4:1)で精製し酢
酸エチル−ヘキサンから再結晶させて、表題化合物(4
10mg,83%)を得た。 mp 212-213℃ IRνmaxKBrcm-1: 1640, 1618, 1513. Anal. Calcd for C28H21F6NO2: C, 64.99; H, 4.09; N,
2.71 Found: C, 64.77; H, 4.36; N, 2.45.1 H-NMR (CDCl3)δ: 2.85 (1H, dd, J = 14.6, 11.0 H
z), 3.00-3.16 (2H, m), 4.76-4.92 (1H, m), 5.04-5.1
2 (1H, m), 6.00 (1H, d, J = 9.2 Hz), 6.82-7.66(14
H, m), 8.10 (1H, d, J = 8.4 Hz).Example 64 4- (Difluoromethyl) -N-((1S, 2R) -2-
(4-fluorophenyl) -2-hydroxy-1-((4-
(Trifluoromethyl) phenyl) methyl) ethyl)-
1-Naphthalenecarboxamide 1) 4-methyl-1-naphthalenecarboxylic acid (4.14
g, 22.2 mmol) in methanol (50 ml) was added with thionyl chloride (3 ml) and stirred at 60 ° C. overnight. After concentrating the reaction solution, water (100 ml) was added, and the mixture was extracted with ethyl acetate (100 ml × 2). The extract was washed successively with saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure to give methyl 4-methyl-1-naphthalenecarboxylate (4.32 g, 97%) as a colorless oil. . IRνmax KBr cm -1: 1715, 1591. 1 H-NMR (CDCl 3) δ: 2.75 (3H, s), 3.99 (3H, s), 7.35
(1H, d, J = 7.6 Hz), 7.50-7.68 (2H, m), 8.00-8.14
(2H, m), 8.92-9.02 (1H, m). 2) Methyl 4-methyl-1-naphthalenecarboxylate (4.23 g, 21.1 mmol) in chloroform (7
0 ml) to a solution of N-bromosuccinimide (4.1 g,
23.2 mmol) and 2,2'-azobis (isobutyronitrile) (175 mg, 1.05 mmol) were added, and the mixture was heated under reflux for 30 minutes. After concentrating the reaction solution, water (100 m
1) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was dissolved in N, N-dimethylformamide (50 ml), sodium acetate (3.46 g, 42.2 mmol) was added, and the mixture was stirred at room temperature for 1 hour and then at 60 ° C. overnight. After concentrating the reaction solution, water (100 ml) was added and ethyl acetate (100 ml × 2).
Extracted. The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 2
0: 1) to give 4-((acetyloxy) methyl) -1
-Methyl naphthalenecarboxylate (4.1 g, 74%) was obtained. . IRνmax KBr cm -1: 1744, 1717, 1595, 1518. Anal Calcd for C 15 H 14 O 4: C, 69.76; H, 5.46 Found:. C, 69.63; H, 5.54 1 H-NMR (CDCl 3) δ: 2.14 (3H, s), 4.00 (3H, s), 5.59
(2H, s), 7.52-7.70 (3H, m), 7.98-8.08 (1H, m), 8.
12 (1H, d, J = 7.2 Hz), 8.90-9.00 (1H, m). 3) Methyl 4-((acetyloxy) methyl) -1-naphthalenecarboxylate (3.91 g, 15.1 mmol)
1N aqueous sodium hydroxide solution (15.1 ml, 15.1 mmol) was added to a methanol (20 ml) solution of
Stirred at room temperature for 5 minutes. 1N hydrochloric acid (20 ml) was added to the reaction solution.
And extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1) to give 4
There was obtained methyl-(hydroxymethyl) -1-naphthalenecarboxylate (2.78 g, 85%). . IRνmax KBr cm -1: 1715. Anal Calcd for C 13 H 12 O 3: C, 72.21; H, 5.59 Found:. C, 71.92; H, 5.49 1 H-NMR (CDCl 3) δ: 3.99 (3H, s), 5.16 (2H, s), 7.50
-7.68 (3H, m), 8.00-8.16 (2H, m), 8.88-8.96 (1H,
m). 4) To a solution of methyl 4- (hydroxymethyl) -1-naphthalenecarboxylate (2.0 g, 9.25 mmol) in chloroform (40 ml) was added manganese dioxide (4.0 g), and the mixture was stirred at room temperature for 2 hours. did. Manganese dioxide was filtered from the reaction solution using celite, and the filtrate was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1) and recrystallized from ethyl acetate-hexane to obtain methyl 4-formyl-1-naphthalenecarboxylate (1.41 g, 85%). Was. . mp 95-96 ℃ IRνmax KBr cm -1 : 1723, 1696. Anal Calcd for C 13 H 10 O 3: C, 72.89; H, 4.71 Found:. C, 72.81; H, 4.87 1 H-NMR (CDCl 3 ) δ: 4.04 (3H, s), 7.60-7.78 (2H, m),
7.98 (1H, d, J = 7.2Hz), 8.17 (1H, d, J = 7.2H
z), 8.76-8.82 (1H, m), 9.20-9.28 (1H, m), 10.47 (1
H, s). 5) Methyl 4-formyl-1-naphthalenecarboxylate (800 mg, 3.73 mmol) in toluene (15 m
1) Add diethylaminosulfur trifluoride (750
ml, 5.1 mmol) and stirred at room temperature overnight. To the reaction solution was added a saturated aqueous sodium bicarbonate solution (10 ml), and ethyl acetate (5 mL) was added.
0 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Purified with ethyl acetate = 10: 1) and methyl 4- (difluoromethyl) -1-naphthalenecarboxylate (522 mg, 5
9%). . IRνmax KBr cm -1: 1723. Anal Calcd for C 13 H 10 F 2 O 2: C, 66.10; H, 4.27 Found:. C, 66.07; H, 4.35 1 H-NMR (CDCl 3) δ: 4.03 ( 3H, s), 7.19 (1H, t, J = 5
5.0 Hz), 7.60-7.70 (2H, m), 7.75 (1H, d, J = 7.8 H
z), 8.10-8.22 (2H, m), 8.86-8.96 (1H, m). 6) A solution of methyl 4- (difluoromethyl) -1-naphthalenecarboxylate (450 mg, 1.91 mmol) in methanol (5 ml) To the mixture was added a 2N aqueous sodium hydroxide solution (1.9 ml, 3.8 mmol), and the mixture was stirred at room temperature overnight. 1N hydrochloric acid (5 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (20 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give 4
-(Difluoromethyl) -1-naphthalenecarboxylic acid (3
44 mg, 81%). . mp 179-180 ℃ IRνmax KBr cm -1 : 1701. Anal Calcd for C 12 H 8 F 2 O 2: C, 64.87; H, 3.63 Found:. C, 64.76; H, 3.55 1 H-NMR (CDCl 3 ) δ: 7.22 (1H, t, J = 54.8 Hz), 7.62-
7.70 (2H, m), 7.81 (1H, d, J = 7.6 Hz), 8.21 (1H,
d, J = 6.6 Hz), 8.39 (1H, d, J = 7.6 Hz), 9.02-9.1
8 (1H, m). 7) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4- (trifluoromethyl) phenyl) -1-propanol (300 mg, 0.96 Mmol) in acetonitrile (30 ml) was added to 4- (difluoromethyl) -1-naphthalenecarboxylic acid (213 mg,
0.96 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (275 m
g, 1.44 mmol) and 1-hydroxy-1H-benzotriazole (147 mg, 0.96 mmol) were added and stirred at room temperature overnight. The reaction solution was water (100 ml)
And extracted with ethyl acetate (100 ml × 2).
1N hydrochloric acid, 1N aqueous sodium hydroxide solution,
The extract was washed successively with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the title compound (4
(10 mg, 83%). mp 212-213 ° C IRνmax KBr cm -1 : 1640, 1618, 1513. Anal.Calcd for C 28 H 21 F 6 NO 2 : C, 64.99; H, 4.09; N,
2.71 Found:. C, 64.77; H, 4.36; N, 2.45 1 H-NMR (CDCl 3) δ: 2.85 (1H, dd, J = 14.6, 11.0 H
z), 3.00-3.16 (2H, m), 4.76-4.92 (1H, m), 5.04-5.1
2 (1H, m), 6.00 (1H, d, J = 9.2 Hz), 6.82-7.66 (14
H, m), 8.10 (1H, d, J = 8.4 Hz).
【0197】実施例65 N-((1S,2R)-2-(4-フルオロフェニル)-2-
ヒドロキシ-1-((4-(トリフルオロメチル)フェニ
ル)メチル)エチル)-4-((メチルオキシ)メチル)
-1-ナフタレンカルボキサミド 1) 4-(ヒドロキシメチル)-1-ナフタレンカルボ
ン酸メチル(1.0g,4.62ミリモル)のN,N-
ジメチルホルムアミド(10ml)溶液にヨウ化メチル
(1ml)を加え、更に水素化ナトリウム(222m
g,5.55ミリモル,60%油性)を0℃にて加え、
室温で10分攪拌した。反応液に水(30ml)を加
え、酢酸エチル(50ml×2)で抽出した。抽出液を
飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減
圧留去した。残留物をシリカゲルカラムクロマトグラフ
ィー(ヘキサン:酢酸エチル=20:1−10:1)で
精製し4-((メチルオキシ)メチル)-1-ナフタレン
カルボン酸メチル(898mg,84%)を得た。 IRνmaxKBrcm-1: 1717. Anal. Calcd for C14H14O3・0.1H2O: C, 72.46; H, 6.1
6 Found: C, 72.66; H, 6.09.1 H-NMR (CDCl3)δ: 3.48 (3H, s), 4.00 (3H, s), 4.94
(2H, s), 7.50-7.68 (3H, m), 8.04-8.18 (2H, m), 8.
90-8.98 (1H, m). 2) 4-((メチルオキシ)メチル)-1-ナフタレン
カルボン酸メチル(780mg,3.38ミリモル)の
メタノール(10ml)溶液に1規定水酸化ナトリウム
水溶液(6.76ml,6.76ミリモル)を加え、室
温で終夜攪拌した。反応液に1規定塩酸(10ml)を
加え、酢酸エチル(50ml×2)で抽出した。抽出液
を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後
減圧留去した。残留物を酢酸エチル−ヘキサンから再結
晶させて4-((メチルオキシ)メチル)-1-ナフタレ
ンカルボン酸(615mg,84%)を得た。 mp 133-134℃ IRνmaxKBrcm-1: 1694. Anal. Calcd for C13H12O3: C, 72.21; H, 5.59 Found: C, 72.10; H, 5.64.1 H-NMR (CDCl3)δ: 3.52 (3H, s), 4.99 (2H, s), 7.56
-7.70 (3H, m), 8.10-8.18 (1H, m), 8.37 (1H, d, J =
7.2 Hz), 9.10-9.16 (1H, m). 3) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(300mg,0.96ミリモ
ル)のアセトニトリル(30ml)溶液に4-((メチ
ルオキシ)メチル)-1-ナフタレンカルボン酸(207
mg,0.96ミリモル)および1-エチル-3-(3-ジ
メチルアミノプロピル)カルボジイミド・塩酸塩(27
5mg,1.44ミリモル)および1-ヒドロキシ-1H
-ベンゾトリアゾール(147mg,0.96ミリモ
ル)を加えて室温で終夜攪拌した。反応液を水(100
ml)で希釈し、酢酸エチル(100ml×2)で抽出
した。抽出液を1規定塩酸、1規定水酸化ナトリウム水
溶液、飽和食塩水で順次洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物をシリカゲルカラムクロ
マトグラフィー(ヘキサン:酢酸エチル=4:1−2:
1)で精製し酢酸エチル−ヘキサンから再結晶させて、
表題化合物(340mg,69%)を得た。 mp 170-171℃ IRνmaxKBrcm-1: 1638, 1618, 1607, 1510. Anal. Calcd for C29H25F4NO3: C, 68.09; H, 4.93; N,
2.74 Found: C, 67.89; H, 5.05; N, 2.45.1 H-NMR (CDCl3)δ: 2.82 (1H, dd, J = 14.6, 11.0 H
z), 3.03 (1H, dd, J = 14.6, 4.4 Hz), 3.46 (3H, s),
4.68-4.88 (1H, m), 4.85 (2H, s), 4.92-5.00 (1H,
m), 6.05 (1H, d, J = 8.8 Hz), 7.00-7.16 (3H, m),
7.22-7.62 (10H, m),8.01 (1H, d, J = 8.4 Hz).Example 65 N-((1S, 2R) -2- (4-fluorophenyl) -2-
Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4-((methyloxy) methyl)
1-Naphthalenecarboxamide 1) N, N- of methyl 4- (hydroxymethyl) -1-naphthalenecarboxylate (1.0 g, 4.62 mmol)
Methyl iodide (1 ml) was added to a dimethylformamide (10 ml) solution, and sodium hydride (222 ml) was further added.
g, 5.55 mmol, 60% oil) at 0 ° C.
Stirred at room temperature for 10 minutes. Water (30 ml) was added to the reaction solution, and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 20: 1-10: 1) to obtain methyl 4-((methyloxy) methyl) -1-naphthalenecarboxylate (898 mg, 84%). IRνmax KBr cm -1 : 1717.Anal.Calcd for C 14 H 14 O 3・ 0.1H 2 O: C, 72.46; H, 6.1
6 Found: C, 72.66; H, 6.09. 1 H-NMR (CDCl 3 ) δ: 3.48 (3H, s), 4.00 (3H, s), 4.94
(2H, s), 7.50-7.68 (3H, m), 8.04-8.18 (2H, m), 8.
90-8.98 (1H, m). 2) To a solution of methyl 4-((methyloxy) methyl) -1-naphthalenecarboxylate (780 mg, 3.38 mmol) in methanol (10 ml) was added a 1 N aqueous solution of sodium hydroxide (6 ml). (.76 ml, 6.76 mmol) and stirred at room temperature overnight. 1N hydrochloric acid (10 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give 4-((methyloxy) methyl) -1-naphthalenecarboxylic acid (615 mg, 84%). . mp 133-134 ℃ IRνmax KBr cm -1 : 1694. Anal Calcd for C 13 H 12 O 3: C, 72.21; H, 5.59 Found:. C, 72.10; H, 5.64 1 H-NMR (CDCl 3) δ : 3.52 (3H, s), 4.99 (2H, s), 7.56
-7.70 (3H, m), 8.10-8.18 (1H, m), 8.37 (1H, d, J =
7.2 Hz), 9.10-9.16 (1H, m). 3) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4- (trifluoromethyl) phenyl) -1-propanol (300 mg, 0.96 mmol) in acetonitrile (30 ml) was added to 4-((methyloxy) methyl) -1-naphthalenecarboxylic acid (207
mg, 0.96 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (27
5 mg, 1.44 mmol) and 1-hydroxy-1H
-Benzotriazole (147 mg, 0.96 mmol) was added and the mixture was stirred at room temperature overnight. The reaction solution was washed with water (100
ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 4: 1-2:
Purified in 1) and recrystallized from ethyl acetate-hexane,
The title compound (340 mg, 69%) was obtained. mp 170-171 ° C IRνmax KBr cm -1 : 1638, 1618, 1607, 1510. Anal.Calcd for C 29 H 25 F 4 NO 3 : C, 68.09; H, 4.93; N,
2.74 Found:. C, 67.89; H, 5.05; N, 2.45 1 H-NMR (CDCl 3) δ: 2.82 (1H, dd, J = 14.6, 11.0 H
z), 3.03 (1H, dd, J = 14.6, 4.4 Hz), 3.46 (3H, s),
4.68-4.88 (1H, m), 4.85 (2H, s), 4.92-5.00 (1H,
m), 6.05 (1H, d, J = 8.8 Hz), 7.00-7.16 (3H, m),
7.22-7.62 (10H, m), 8.01 (1H, d, J = 8.4 Hz).
【0198】実施例66 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-1-アントラセンカルボキサ
ミド 1-アントラセンカルボン酸(143mg,0.64ミ
リモル)のテトラヒドロフラン(5ml)溶液に、オキ
サリルクロリド(0.11ml,1.72ミリモル)お
よびN,N-ジメチルホルムアミド(0.01ml)を
加えて、室温で30分間攪拌し、反応液を減圧留去し
た。残留物の酢酸エチル(5ml)溶液に(1RS,2
SR)-1-(4-フルオロフェニル)-1-ヒドロキシ-3
-(4-(トリフルオロメチル)フェニル)-2-プロピル
アミン塩酸塩(150mg,0.43ミリモル)および
飽和重曹水(5ml)を加えて室温で終夜攪拌した。反
応液を水(50ml)で希釈し、酢酸エチル(50ml
×2)で抽出した。抽出液を飽和食塩水で洗浄し、無水
硫酸マグネシウムで乾燥後減圧留去した。残留物をシリ
カゲルカラムクロマトグラフィー(ヘキサン:酢酸エチ
ル=2:1)で精製し、酢酸エチル−ヘキサンから再結
晶させて、表題化合物(147mg,66%)を得た。 mp 227-228℃ IRν maxKBrcm-1: 1638, 1615, 1514, 1323. Anal. Calcd for C31H23F4NO2: C, 71.70; H, 4.50; N,
2.70 Found: C, 71.57; H, 4.41; N, 2.68.1 H-NMR (CDCl3)δ: 2.90 (1H, dd, J = 13.2, 9.8 Hz),
3.54 (1H, d, J = 13.2Hz), 4.70-4.90 (2H, m), 6.94
(1H, d, J = 7.0 Hz), 7.06-7.20 (2H, m), 7.28-7.40
(1H, m), 7.40-7.78 (9H, m), 7.81 (1H, s), 7.92-8.
06 (2H, m), 8.41 (1H, s).Example 66 N-((1RS, 2SR) -2- (4-fluorophenyl)
Oxalyl chloride was added to a solution of 1-anthracenecarboxylic acid (143 mg, 0.64 mmol) in tetrahydrofuran (5 ml). (0.11 ml, 1.72 mmol) and N, N-dimethylformamide (0.01 ml) were added, the mixture was stirred at room temperature for 30 minutes, and the reaction solution was distilled off under reduced pressure. To a solution of the residue in ethyl acetate (5 ml) was added (1RS, 2
SR) -1- (4-Fluorophenyl) -1-hydroxy-3
-(4- (Trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.43 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml), and ethyl acetate (50 ml) was added.
× 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1) and recrystallized from ethyl acetate-hexane to give the title compound (147 mg, 66%). mp 227-228 ℃ IRν max KBr cm -1 : 1638, 1615, 1514, 1323. Anal.Calcd for C 31 H 23 F 4 NO 2 : C, 71.70; H, 4.50; N,
2.70 Found:. C, 71.57; H, 4.41; N, 2.68 1 H-NMR (CDCl 3) δ: 2.90 (1H, dd, J = 13.2, 9.8 Hz),
3.54 (1H, d, J = 13.2Hz), 4.70-4.90 (2H, m), 6.94
(1H, d, J = 7.0 Hz), 7.06-7.20 (2H, m), 7.28-7.40
(1H, m), 7.40-7.78 (9H, m), 7.81 (1H, s), 7.92-8.
06 (2H, m), 8.41 (1H, s).
【0199】実施例67 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-2-メチルナフタレン-1-カルボキサミ
ド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.224g(0.715ミリモ
ル)、2-メチル-1-ナフトエ酸0.13g(0.71
ミリモル)、1-ヒドロキシベンゾトリアゾール水和物
0.11g(0.71ミリモル)をアセトニトリル10
ml中で撹拌しながら1-エチル-3-(3-ジメチルアミ
ノプロピル)カルボジイミド・塩酸塩0.14g(0.
71ミリモル)を加え、70℃で5時間撹拌した。反応
液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶液で
洗浄、無水硫酸マグネシウムで乾燥、溶媒を減圧留去し
た。得られた粗生成物をシリカゲルカラムクロマトグラ
フィーにて精製し(ヘキサン/酢酸エチル=3/1−1
/1)、ジエチルエーテル−ヘキサンより結晶化して、
目的物を得た。白色結晶 収量0.233g 収率68
% mp 96-98℃; 1H-NMR (CDCl3, 200MHz) δ 2.11 (3H,
s), 2.69 (1H, dd, J = 11.1 Hz, 14.5 Hz), 2.99 3.08
(2H, m), 4.96-5.14 (2H, m), 5.88 (1H, d, J =9.6 H
z), 7.02-7.41 (8H, m), 7.46-7.57 (4H, m), 7.68 7.7
5 (2H, m); IR (KBr) 3241, 3058, 1632, 1510, 1327,
1225, 1163, 1123, 1069, 814 cm-1; Anal.Calcd for C
28H23F4NO2: C, 69.85; H, 4.81; N, 2.91. Found: C,
69.64; H,4.72; N, 2.82.Example 67 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -2-methylnaphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [ 4- (trifluoromethyl) phenyl] propan-1-ol 0.224 g (0.715 mmol), 2-methyl-1-naphthoic acid 0.13 g (0.71 mmol)
Mmol) 1-hydroxybenzotriazole hydrate (0.11 g, 0.71 mmol) in acetonitrile 10
While stirring in 0.1 ml, 0.14 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.
(71 mmol) and stirred at 70 ° C. for 5 hours. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product is purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1).
/ 1), crystallized from diethyl ether-hexane,
The desired product was obtained. White crystals Yield 0.233 g Yield 68
% Mp 96-98 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.11 (3H,
s), 2.69 (1H, dd, J = 11.1 Hz, 14.5 Hz), 2.99 3.08
(2H, m), 4.96-5.14 (2H, m), 5.88 (1H, d, J = 9.6 H
z), 7.02-7.41 (8H, m), 7.46-7.57 (4H, m), 7.68 7.7
5 (2H, m); IR (KBr) 3241, 3058, 1632, 1510, 1327,
1225, 1163, 1123, 1069, 814 cm -1 ; Anal.Calcd for C
28 H 23 F 4 NO 2 : C, 69.85; H, 4.81; N, 2.91. Found: C,
69.64; H, 4.72; N, 2.82.
【0200】実施例68 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]ベンズアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.166g(0.530ミリモ
ル)、安息香酸65mg(0.53ミリモル)、1-ヒ
ドロキシベンゾトリアゾール水和物81mg(0.53
ミリモル)をアセトニトリル10ml中で撹拌しながら
1-エチル-3-(3-ジメチルアミノプロピル)カルボジ
イミド・塩酸塩0.10g(0.53ミリモル)を加
え、室温で一晩撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物を酢酸エチル−ヘキサンより結晶
化して、目的物を得た。白色結晶 収量0.178g
収率81% mp 193-194℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
86 (1H, dd, J = 4.2 Hz, 14.6 Hz), 2.99 (1H, dd, J
= 10.5 Hz, 14.1 Hz), 4.56-4.69 (1H, m), 5.06(1H,
t, J = 2.9 Hz), 5.12 (1H, d, J = 3.2 Hz), 7.06 (2
H, t, J = 8.7 Hz), 7.17-7.26 (3H, m), 7.35-7.53 (7
H, m), 7.67 (2H, d, J = 8.0 Hz); IR (KBr) 3303, 16
38, 1534, 1325, 1227, 1167, 1125, 1069, 829, 698 c
m-1; Anal.Calcd for C23H19F4NO2: C, 66.18; H, 4.5
9; N, 3.36. Found: C, 66.05; H, 4.51; N, 3.44.Example 68 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] benzamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl ] Propan-1-ol 0.166 g (0.530 mmol), benzoic acid 65 mg (0.53 mmol), 1-hydroxybenzotriazole hydrate 81 mg (0.53 mmol)
(0.1 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride while stirring in 10 ml of acetonitrile, and stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 0.178 g
Yield 81% mp 193-194 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
86 (1H, dd, J = 4.2 Hz, 14.6 Hz), 2.99 (1H, dd, J
= 10.5 Hz, 14.1 Hz), 4.56-4.69 (1H, m), 5.06 (1H,
t, J = 2.9 Hz), 5.12 (1H, d, J = 3.2 Hz), 7.06 (2
H, t, J = 8.7 Hz), 7.17-7.26 (3H, m), 7.35-7.53 (7
H, m), 7.67 (2H, d, J = 8.0 Hz); IR (KBr) 3303, 16
38, 1534, 1325, 1227, 1167, 1125, 1069, 829, 698 c
m -1 ; Anal.Calcd for C 23 H 19 F 4 NO 2 : C, 66.18; H, 4.5
9; N, 3.36. Found: C, 66.05; H, 4.51; N, 3.44.
【0201】実施例69 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-2-フェニルアセトアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)の酢
酸エチル(20ml)溶液にフェニルアセチルクロリド
(285ml,2.15ミリモル)および飽和重曹水
(20ml)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて表題化合物(578m
g,93%)を得た。 mp 173-174℃ IRνmaxKBrcm-1: 1651, 1539, 1514. Anal. Calcd for C24H21F4NO2: C, 66.82; H, 4.91; N,
3.25 Found: C, 66.63; H, 4.78; N, 3.19.1 H-NMR (CDCl3)δ: 2.62 (1H, dd, J = 14.2, 10.6 H
z), 2.81 (1H, dd, J = 14.2, 4.4 Hz), 3.44 (2H, s),
3.50 (1H, d, J = 3.6 Hz), 4.28-4.42 (1H, m),4.84-
4.92 (1H, m), 5.25 (1H, d, J = 8.2 Hz), 6.90-7.10
(6H, m), 7.24-7.36 (5H, m), 7.45 (2H, d, J = 7.6 H
z).Example 69 N-((1RS, 2SR) -2- (4-fluorophenyl)
2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -2-phenylacetamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4 -(Trifluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.44 mmol) in ethyl acetate (20 ml) were added phenylacetyl chloride (285 ml, 2.15 mmol) and saturated aqueous sodium hydrogen carbonate (20 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (578m
g, 93%). mp 173-174 ℃ IRνmax KBr cm -1 : 1651, 1539, 1514. Anal.Calcd for C 24 H 21 F 4 NO 2 : C, 66.82; H, 4.91; N,
3.25 Found:. C, 66.63; H, 4.78; N, 3.19 1 H-NMR (CDCl 3) δ: 2.62 (1H, dd, J = 14.2, 10.6 H
z), 2.81 (1H, dd, J = 14.2, 4.4 Hz), 3.44 (2H, s),
3.50 (1H, d, J = 3.6 Hz), 4.28-4.42 (1H, m), 4.84
4.92 (1H, m), 5.25 (1H, d, J = 8.2 Hz), 6.90-7.10
(6H, m), 7.24-7.36 (5H, m), 7.45 (2H, d, J = 7.6 H
z).
【0202】実施例70 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-2,2,2-トリフルオロアセトアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.155g(0.495ミリモル)
と炭酸水素ナトリウム83mg(0.99ミリモル)を
テトラヒドロフラン10ml中で撹拌しながら無水トリ
フルオロ酢酸0.08ml(0.59ミリモル)を加
え、室温で一晩撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物を酢酸エチル−ヘキサンより結晶
化して、目的物を得た。白色結晶 収量0.154g
収率76% mp 162-163℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
81-2.97 (2H, m), 4.31-4.48 (1H, m), 4.85 5.00 (2H,
m), 7.01-7.11 (2H, m), 7.17 (2H, d, J = 8.0Hz),
7.39-7.47 (4H, m), 7.79-7.92 (1H, m); IR (KBr) 330
1, 1701, 1564, 1514, 1327, 1233, 1182, 1128, 1069,
833 cm-1; Anal. Calcd for C18H14F7NO2: C, 52.82;
H, 3.45; N, 3.42. Found: C, 52.98; H, 3.43; N, 3.2
5.Example 70 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -2,2,2-trifluoroacetamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.155 g (0.495 mmol)
And 83 mg (0.99 mmol) of sodium hydrogen carbonate in 10 ml of tetrahydrofuran were added with 0.08 ml (0.59 mmol) of trifluoroacetic anhydride, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. 0.154 g of white crystals
Yield 76% mp 162-163 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200MHz) δ 2.
81-2.97 (2H, m), 4.31-4.48 (1H, m), 4.85 5.00 (2H, m
m), 7.01-7.11 (2H, m), 7.17 (2H, d, J = 8.0Hz),
7.39-7.47 (4H, m), 7.79-7.92 (1H, m); IR (KBr) 330
1, 1701, 1564, 1514, 1327, 1233, 1182, 1128, 1069,
833 cm -1 ; Anal.Calcd for C 18 H 14 F 7 NO 2 : C, 52.82;
H, 3.45; N, 3.42. Found: C, 52.98; H, 3.43; N, 3.2
Five.
【0203】実施例71 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-2,2,3,3-テトラフルオロプロピ
オンアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.153g(0.488ミリモ
ル)、2,2,3,3-テトラフルオロプロピオン酸7
1mg(0.49ミリモル)、1-ヒドロキシベンゾト
リアゾール水和物75mg(0.49ミリモル)をアセ
トニトリル10ml中で撹拌しながら1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩94mg(0.49ミリモル)を加え、室温で一晩撹
拌した。反応液を酢酸エチルに希釈し、炭酸水素ナトリ
ウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、溶媒
を減圧留去した。得られた粗生成物をシリカゲルカラム
クロマトグラフィーにて精製し(ヘキサン/酢酸エチル
=1/1)、ヘキサンより結晶化して、目的物を得た。
白色結晶 収量90mg 収率42% mp 164-166℃; 1H-NMR (CDCl3, 200MHz) δ 2.66 (1H,
br s), 2.79-2.96 (2H,m), 4.41-4.55 (1H, m), 4.97
(1H, d, J = 4.0 Hz), 5.94 (1H, tt, J = 5.5 Hz, 52.
9 Hz), 6.55 (1H, br d, J = 9.2 Hz), 7.10 (2H, t, J
= 8.6 Hz), 7.18(2H, d, J = 8.0 Hz), 7.40 (2H, dd,
J = 5.8 Hz, 8.6 Hz), 7.50 (2H, d, J= 8.0 Hz); IR
(KBr) 3304, 1686, 1329, 1231, 1175, 1113, 1069, 82
9 cm-1 Example 71 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -2,2,3,3-tetrafluoropropionamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) 0.153 g (0.488 mmol) of -3- [4- (trifluoromethyl) phenyl] propan-1-ol, 2,2,3,3-tetrafluoropropionic acid 7
1 mg (0.49 mmol) of 1-hydroxybenzotriazole hydrate (75 mg, 0.49 mmol) is stirred in 10 ml of acetonitrile with 1-ethyl-3-ethyl.
94 mg (0.49 mmol) of (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 1/1), and crystallized from hexane to obtain the desired product.
White crystals Yield 90 mg Yield 42% mp 164-166 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.66 (1H,
br s), 2.79-2.96 (2H, m), 4.41-4.55 (1H, m), 4.97
(1H, d, J = 4.0 Hz), 5.94 (1H, tt, J = 5.5 Hz, 52.
9 Hz), 6.55 (1H, br d, J = 9.2 Hz), 7.10 (2H, t, J
= 8.6 Hz), 7.18 (2H, d, J = 8.0 Hz), 7.40 (2H, dd,
J = 5.8 Hz, 8.6 Hz), 7.50 (2H, d, J = 8.0 Hz); IR
(KBr) 3304, 1686, 1329, 1231, 1175, 1113, 1069, 82
9 cm -1
【0204】実施例72 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-1,3-ベンゾジオキソール
-5-カルボキサミド (1RS,2RS)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(150mg,0.43
ミリモル)の酢酸エチル(5ml)溶液にピバロイルク
ロリド(119mg,0.64ミリモル)および飽和重
曹水(5ml)を加えて室温で終夜攪拌した。反応液を
水(50ml)で希釈し、酢酸エチル(50ml×2)
で抽出した。抽出液を飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物を酢酸エチル
−ヘキサンから再結晶させて、表題化合物(160m
g,81%)を得た。 mp 180-181℃ IRνmaxKBrcm-1: 1640, 1605, 1507, 1485. Anal. Calcd for C24H19F4NO4: C, 62.47; H, 4.15; N,
3.04 Found: C, 62.43; H, 4.06; N, 3.06.1 H-NMR (CDCl3)δ: 2.80-3.06 (2H, m), 3.70 (1H, d,
J = 3.6 Hz), 4.50-4.66(1H, m), 5.02-5.10 (1H, m),
5.90-6.10 (1H, m), 6.02 (2H, s), 6.77 (1H,d, J =
8.8 Hz), 7.00-7.16 (4H, m), 7.20-7.30 (2H, m), 7.3
6-7.58 (4H, m).Example 72 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -1,3-benzodioxole
-5-carboxamide (1RS, 2RS) -1- (4-fluorophenyl) -1-
Hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.43
Pivaloyl chloride (119 mg, 0.64 mmol) and saturated aqueous sodium bicarbonate (5 ml) were added to a solution of the resulting compound in an aqueous solution of ethyl acetate (5 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and ethyl acetate (50 ml × 2)
Extracted. The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (160 m
g, 81%). mp 180-181 ° C IRνmax KBr cm -1 : 1640, 1605, 1507, 1485. Anal.Calcd for C 24 H 19 F 4 NO 4 : C, 62.47; H, 4.15; N,
3.04 Found:. C, 62.43; H, 4.06; N, 3.06 1 H-NMR (CDCl 3) δ: 2.80-3.06 (2H, m), 3.70 (1H, d,
J = 3.6 Hz), 4.50-4.66 (1H, m), 5.02-5.10 (1H, m),
5.90-6.10 (1H, m), 6.02 (2H, s), 6.77 (1H, d, J =
8.8 Hz), 7.00-7.16 (4H, m), 7.20-7.30 (2H, m), 7.3
6-7.58 (4H, m).
【0205】実施例73 4-(4-フルオロフェニル)-N-[(1RS,2SR)
-2-(4-フルオロフェニル)-2-ヒドロキシ-1-[4-
(トリフルオロメチル)ベンジル]エチル]-5-メチル
-2-(1-メチルエチル)フラン-3-カルボキサミド 1) 1-フルオロ-4-(2-ニトロ-1-プロペニル)ベ
ンゼン 4-フルオロベンズアルデヒド17.02g(137.
1ミリモル)、酢酸11.5g(192ミリモル)、メ
チルアミン・塩酸塩3.70g(54.9ミリモル)、
酢酸ナトリウム4.50g(54.9ミリモル)、ニト
ロエタン41.2g(549ミリモル)の混合物を10
0℃で1.5時間撹拌した。反応液を水に注ぎ、酢酸エ
チルで3回抽出した。集めた有機層を無水硫酸ナトリウ
ムで乾燥、溶媒を減圧留去した。残留物をジエチルエー
テル−ヘキサンより結晶化して、目的物を得た。黄色結
晶 収量18.40g 収率74% mp 59-61℃; 1H-NMR (CDCl3, 200MHz) δ 2.45 (3H,
s), 7.16 (2H, d, J = 8.6Hz), 7.44 (2H, dd, J = 5.4
Hz, 8.8 Hz), 8.06 (1H, s); IR (KBr) 1514, 1318, 1
225, 982, 847 cm-1; Anal. Calcd for C9H8FNO2: C, 5
9.67; H, 4.45; N,7.73. Found: C, 59.51; H, 4.39;
N, 7.80. 2) 4-(4-フルオロフェニル)-5-メチル-2-(1
-メチルエチル)フラン-3-カルボン酸エチル イソブチリル酢酸エチル20.06g(126.8ミリ
モル)と1-フルオロ-4-(2-ニトロ-1-プロペニル)
ベンゼン23.0g(127ミリモル)のエタノール1
00ml溶液にピペリジン12.5ml(127ミリモ
ル)を室温で加え、室温で一晩、80℃で1時間撹拌し
た。反応液の溶媒を減圧留去し、残留物に水50mlと
濃塩酸30mlを加え、室温で1時間撹拌した。反応液
を酢酸エチルで2回抽出し、集めた有機層を無水硫酸ナ
トリウムで乾燥、溶媒を減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィーにて精製して(ヘキサン
/酢酸エチル=20/1)、目的物を得た。淡黄色固体
収量5.958g 収率16% 冷メタノールより再結晶して、白色結晶を得た。 mp 27-28℃; 1H-NMR (CDCl3, 200MHz) δ 1.09 (3H, t,
J = 7.2 Hz), 1.30 (6H, d, J = 7.4 Hz), 2.18 (3H,
s), 3.65-3.79 (1H, m), 4.11 (2H, q, J = 7.2Hz), 7.
04 (2H, t, J = 8.8 Hz), 7.21 (2H, dd, J = 5.6 Hz,
8.8 Hz); IR (neat) 2974, 1707, 1578, 1510, 1221, 1
149, 1059 cm-1; Anal. Calcd for C17H1 9FO3: C, 70.3
3; H, 6.60. Found: C, 70.36; H, 6.53. 3) 4-(4-フルオロフェニル)-5-メチル-2-(1
-メチルエチル)フラン-3-カルボン酸 4-(4-フルオロフェニル)-5-メチル-2-(1-メチ
ルエチル)フラン-3-カルボン酸エチル1.500g
(5.167ミリモル)と水酸化ナトリウム1.65g
(41.3ミリモル)をメタノール15ml−水5ml
中で、70℃にて8時間撹拌した。反応液を水で希釈
し、希塩酸で反応液を酸性にした後、酢酸エチルで2回
抽出した。集めた有機層を無水硫酸ナトリウムで乾燥、
溶媒を減圧留去した。残留物をヘキサンより結晶化し
て、目的物を得た。白色結晶 収量0.958g 収率
71% mp 176-177℃; 1H-NMR (CDCl3, 200MHz) δ 1.28 (6H,
d, J = 7.0 Hz), 2.17 (3H, s), 3.71-3.84 (1H, m),
7.05 (2H, t, J = 8.8 Hz), 7.22 (2H, dd, J = 5.4 H
z, 8.8 Hz); IR (KBr) 3050-2500, 1680, 1512, 1225,
1074, 845 cm-1; Anal. Calcd for C15H15FO3: C, 68.6
9; H, 5.76. Found: C, 68.57; H, 5.84. 4) 4-(4-フルオロフェニル)-N-[(1RS,2
SR)-2-(4-フルオロフェニル)-2-ヒドロキシ-1
-[4-(トリフルオロメチル)ベンジル]エチル]-5-
メチル-2-(1-メチルエチル)フラン-3-カルボキサ
ミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.211g(0.673ミリモ
ル)、4-(4-フルオロフェニル)-5-メチル-2-(1
-メチルエチル)フラン-3-カルボン酸0.18g
(0.67ミリモル)、1-ヒドロキシベンゾトリアゾ
ール水和物0.10g(0.67ミリモル)をアセトニ
トリル10ml中で撹拌しながら1-エチル-3-(3-ジ
メチルアミノプロピル)カルボジイミド・塩酸塩0.1
3g(0.67ミリモル)を加え、室温で一晩撹拌し
た。反応液を酢酸エチルに希釈し、炭酸水素ナトリウム
水溶液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲ
ルを通した後、溶媒を減圧留去した。得られた残留物を
酢酸エチル−ヘキサンより結晶化して、目的物を得た。
白色粉末 収量0.288g 収率77% mp 134-136℃; 1H-NMR (CDCl3, 200MHz) δ 1.19 (3H,
d, J = 7.0 Hz), 1.25 (3H, d, J = 7.0 Hz), 2.09 (3
H, s), 2.38 (1H, dd, J = 10.5 Hz, 14.9 Hz), 2.71
(1H, dd, J = 4.3 Hz, 14.3 Hz), 3.51-3.65 (1H, m),
3.76 (1H, d, J = 4.4 Hz), 4.40-4.53 (1H, m), 4.80
(1H, t, J = 3.3 Hz), 5.19 (1H, d, J = 8.0 Hz), 6.9
0-7.13 (7H, m), 7.23-7.30 (3H, m), 7.45 (2H, d, J
= 8.0 Hz); IR (KBr) 3347, 2973, 2634, 1620, 1605,
1512, 1329, 1223, 1163, 1125, 1069, 839 cm-1; Ana
l. Calcd for C31H28F5NO3: C, 66.78; H, 5.06; N, 2.
51. Found: C, 66.43; H, 5.20; N, 2.41.Example 73 4- (4-Fluorophenyl) -N-[(1RS, 2SR)
-2- (4-Fluorophenyl) -2-hydroxy-1- [4-
(Trifluoromethyl) benzyl] ethyl] -5-methyl
2- (1-methylethyl) furan-3-carboxamide 1) 1-fluoro-4- (2-nitro-1-propenyl) benzene 17.02 g of 4-fluorobenzaldehyde (137.
1 mmol), 11.5 g (192 mmol) of acetic acid, 3.70 g (54.9 mmol) of methylamine hydrochloride,
A mixture of 4.50 g (54.9 mmol) of sodium acetate and 41.2 g (549 mmol) of nitroethane was added to 10
Stirred at 0 ° C. for 1.5 hours. The reaction solution was poured into water and extracted three times with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from diethyl ether-hexane to obtain the desired product. Yellow crystal Yield 18.40 g Yield 74% mp 59-61 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.45 (3H,
s), 7.16 (2H, d, J = 8.6Hz), 7.44 (2H, dd, J = 5.4
Hz, 8.8 Hz), 8.06 (1H, s); IR (KBr) 1514, 1318, 1
. 225, 982, 847 cm -1 ; Anal Calcd for C 9 H 8 FNO 2: C, 5
9.67; H, 4.45; N, 7.73. Found: C, 59.51; H, 4.39;
N, 7.80. 2) 4- (4-Fluorophenyl) -5-methyl-2- (1
Ethyl 2-methylethyl) furan-3-carboxylate 20.06 g (126.8 mmol) of ethyl isobutyryl acetate and 1-fluoro-4- (2-nitro-1-propenyl)
23.0 g (127 mmol) of benzene in ethanol 1
12.5 ml (127 mmol) of piperidine was added to the 00 ml solution at room temperature, and the mixture was stirred at room temperature overnight and at 80 ° C. for 1 hour. The solvent of the reaction solution was distilled off under reduced pressure, and 50 ml of water and 30 ml of concentrated hydrochloric acid were added to the residue, followed by stirring at room temperature for 1 hour. The reaction solution was extracted twice with ethyl acetate, the collected organic layers were dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 20/1) to obtain the desired product. Pale yellow solid Yield 5.958 g Yield 16% Recrystallization from cold methanol gave white crystals. mp 27-28 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 1.09 (3H, t,
J = 7.2 Hz), 1.30 (6H, d, J = 7.4 Hz), 2.18 (3H,
s), 3.65-3.79 (1H, m), 4.11 (2H, q, J = 7.2Hz), 7.
04 (2H, t, J = 8.8 Hz), 7.21 (2H, dd, J = 5.6 Hz,
8.8 Hz); IR (neat) 2974, 1707, 1578, 1510, 1221, 1
. 149, 1059 cm -1; Anal Calcd for C 17 H 1 9 FO 3: C, 70.3
3; H, 6.60. Found: C, 70.36; H, 6.53. 3) 4- (4-Fluorophenyl) -5-methyl-2- (1
1.500 g of ethyl 4- (4-fluorophenyl) -5-methyl-2- (1-methylethyl) furan-3-carboxylate
(5.167 mmol) and 1.65 g of sodium hydroxide
(41.3 mmol) in methanol 15 ml-water 5 ml
And stirred at 70 ° C. for 8 hours. The reaction solution was diluted with water, acidified with dilute hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer is dried over anhydrous sodium sulfate,
The solvent was distilled off under reduced pressure. The residue was crystallized from hexane to obtain the desired product. White crystals Yield 0.958 g Yield 71% mp 176-177 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.28 (6H,
d, J = 7.0 Hz), 2.17 (3H, s), 3.71-3.84 (1H, m),
7.05 (2H, t, J = 8.8 Hz), 7.22 (2H, dd, J = 5.4 H
z, 8.8 Hz); IR (KBr) 3050-2500, 1680, 1512, 1225,
. 1074, 845 cm -1; Anal Calcd for C 15 H 15 FO 3: C, 68.6
9; H, 5.76. Found: C, 68.57; H, 5.84. 4) 4- (4-Fluorophenyl) -N-[(1RS, 2
SR) -2- (4-Fluorophenyl) -2-hydroxy-1
-[4- (Trifluoromethyl) benzyl] ethyl] -5-
Methyl-2- (1-methylethyl) furan-3-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propane-1- All 0.211 g (0.673 mmol), 4- (4-fluorophenyl) -5-methyl-2- (1
-Methylethyl) furan-3-carboxylic acid 0.18g
(0.67 mmol) 1-hydroxybenzotriazole hydrate 0.10 g (0.67 mmol) in 10 ml of acetonitrile while stirring 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 0 .1
3 g (0.67 mmol) was added and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product.
White powder Yield 0.288 g Yield 77% mp 134-136 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.19 (3H,
d, J = 7.0 Hz), 1.25 (3H, d, J = 7.0 Hz), 2.09 (3
H, s), 2.38 (1H, dd, J = 10.5 Hz, 14.9 Hz), 2.71
(1H, dd, J = 4.3 Hz, 14.3 Hz), 3.51-3.65 (1H, m),
3.76 (1H, d, J = 4.4 Hz), 4.40-4.53 (1H, m), 4.80
(1H, t, J = 3.3 Hz), 5.19 (1H, d, J = 8.0 Hz), 6.9
0-7.13 (7H, m), 7.23-7.30 (3H, m), 7.45 (2H, d, J
= 8.0 Hz); IR (KBr) 3347, 2973, 2634, 1620, 1605,
1512, 1329, 1223, 1163, 1125, 1069, 839 cm -1 ; Ana
l. Calcd for C 31 H 28 F 5 NO 3 : C, 66.78; H, 5.06; N, 2.
51. Found: C, 66.43; H, 5.20; N, 2.41.
【0206】実施例74 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)[1,1'-ビフェニル]-3-
カルボキサミド 3-ビフェニルカルボン酸(127mg,0.64ミリ
モル)のテトラヒドロフラン(5ml)溶液に、オキサ
リルクロリド(0.11ml,1.72ミリモル)およ
びN,N-ジメチルホルムアミド(0.01ml)を加
えて、室温で30分間攪拌し、反応液を減圧留去した。
残留物の酢酸エチル(5ml)溶液に(1RS,2S
R)-1-(4-フルオロフェニル)-1-ヒドロキシ-3-
(4-(トリフルオロメチル)フェニル)-2-プロピル
アミン塩酸塩(150mg,0.43ミリモル)および
飽和重曹水(5ml)を加えて室温で終夜攪拌した。反
応液を水(50ml)で希釈し、酢酸エチル(50ml
×2)で抽出した。抽出液を飽和食塩水で洗浄し、無水
硫酸マグネシウムで乾燥後減圧留去した。残留物をシリ
カゲルカラムクロマトグラフィー(ヘキサン:酢酸エチ
ル=4:1)で精製し、酢酸エチル−ヘキサンから再結
晶させて、表題化合物(147mg,69%)を得た。 mp 165-166℃ IRνmaxKBrcm-1: 1641, 1539, 1510.Anal. Calcd for C
29H23F4NO2: C, 70.58; H, 4.70; N, 2.84 Found: C, 70.32; H, 4.80; N, 2.67.1 H-NMR (CDCl3)δ: 2.90-3.02 (1H, m), 2.99 (1H, s),
3.64 (1H, d, J = 3.6Hz), 4.50-4.70 (1H, m), 5.08-
5.18 (1H, m), 6.14 (1H, d, J = 6.4 Hz), 7.02-7.18
(2H, m), 7.24-7.34 (2H, m), 7.38-7.58 (11H, m), 7.
70-7.76 (2H, m).Example 74 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) [1,1'-biphenyl] -3-
Oxalyl chloride (0.11 ml, 1.72 mmol) and N, N-dimethylformamide (0.01 ml) were added to a solution of carboxamide 3-biphenylcarboxylic acid (127 mg, 0.64 mmol) in tetrahydrofuran (5 ml). After stirring at room temperature for 30 minutes, the reaction solution was distilled off under reduced pressure.
To a solution of the residue in ethyl acetate (5 ml) was added (1RS, 2S
R) -1- (4-Fluorophenyl) -1-hydroxy-3-
(4- (Trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.43 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml), and ethyl acetate (50 ml) was added.
× 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the title compound (147 mg, 69%). mp 165-166 ℃ IRνmax KBr cm -1 : 1641, 1539, 1510.Anal.Calcd for C
29 H 23 F 4 NO 2: C, 70.58; H, 4.70; N, 2.84 Found:. C, 70.32; H, 4.80; N, 2.67 1 H-NMR (CDCl 3) δ: 2.90-3.02 (1H, m ), 2.99 (1H, s),
3.64 (1H, d, J = 3.6Hz), 4.50-4.70 (1H, m), 5.08-
5.18 (1H, m), 6.14 (1H, d, J = 6.4 Hz), 7.02-7.18
(2H, m), 7.24-7.34 (2H, m), 7.38-7.58 (11H, m), 7.
70-7.76 (2H, m).
【0207】実施例75 4-(ジメチルアミノ)-N-((1RS,2SR)-2-
(4-フルオロフェニル)-2-ヒドロキシ-1-((4-
(トリフルオロメチル)フェニル)メチル)エチル)-
1-ナフタレンカルボキサミド (1RS,2RS)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン(150mg,0.42ミリモ
ル)のアセトニトリル(10ml)溶液に4-ジメチル
アミノナフタレンカルボン酸(89mg,0.42ミリ
モル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(119mg,0.62ミ
リモル)および1-ヒドロキシ-1H-ベンゾトリアゾー
ル(63.6mg,0.42ミリモル)を加えて室温で
終夜攪拌した。反応液を水(50ml)で希釈し、酢酸
エチル(50ml×2)で抽出した。抽出液を飽和食塩
水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=1:1)で精製し、酢酸エチル−
ヘキサンから再結晶させて、表題化合物(149mg,
70%)を得た。 mp 169-170℃ IRνmaxKBrcm-1: 1634, 1578, 1510.Anal. Calcd for C
29H26F4N2O2: C, 68.23; H, 5.13; N, 5.49 Found: C, 68.09; H, 5.11; N, 5.32.1 H-NMR (CDCl3)δ: 2.88 (6H, s), 2.76-3.14 (2H, m),
3.71 (1H, d, J = 4.0Hz), 4.66-4.84 (2H, m), 5.04-
5.12 (1H, m), 5.90 (1H, d, J = 8.4 Hz), 6.86 (1H,
d, J = 7.6 Hz), 7.02-7.18 (3H, m), 7.30-7.60 (8H,
m), 7.75 (1H, d, J = 8.4 Hz), 8.17 (1H, d, J = 8.4
Hz).Example 75 4- (Dimethylamino) -N-((1RS, 2SR) -2-
(4-fluorophenyl) -2-hydroxy-1-((4-
(Trifluoromethyl) phenyl) methyl) ethyl)-
1-Naphthalenecarboxamide (1RS, 2RS) -1- (4-fluorophenyl) -1-
4-dimethylaminonaphthalenecarboxylic acid (89 mg, 0.42 mmol) and a solution of hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine (150 mg, 0.42 mmol) in acetonitrile (10 ml) and 1-Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (119 mg, 0.62 mmol) and 1-hydroxy-1H-benzotriazole (63.6 mg, 0.42 mmol) were added, and the mixture was added at room temperature overnight. Stirred. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1).
Recrystallization from hexane gave the title compound (149 mg,
70%). mp 169-170 ℃ IRνmax KBr cm -1 : 1634, 1578, 1510.Anal. Calcd for C
29 H 26 F 4 N 2 O 2: C, 68.23; H, 5.13; N, 5.49 Found:. C, 68.09; H, 5.11; N, 5.32 1 H-NMR (CDCl 3) δ: 2.88 (6H, s ), 2.76-3.14 (2H, m),
3.71 (1H, d, J = 4.0Hz), 4.66-4.84 (2H, m), 5.04-
5.12 (1H, m), 5.90 (1H, d, J = 8.4 Hz), 6.86 (1H,
d, J = 7.6 Hz), 7.02-7.18 (3H, m), 7.30-7.60 (8H,
m), 7.75 (1H, d, J = 8.4 Hz), 8.17 (1H, d, J = 8.4
Hz).
【0208】実施例76 3-クロロ-N-[(1RS,2SR)-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-[4-(トリフルオロメ
チル)ベンジル]エチル]ナフタレン-1-カルボキサミ
ド 1) 3-クロロ-1-ナフトエ酸エチル 3-アミノ-1-ナフトエ酸エチル2.317g(10.
76ミリモル)を濃塩酸30ml中で撹拌しながら、氷
冷下、亜硝酸ナトリウム0.89g(12.9ミリモ
ル)の水2ml溶液を滴下し、そのままの温度で0.5
時間撹拌した。反応液に氷冷下、塩化第一銅0.53g
(5.38ミリモル)の濃塩酸4ml溶液を氷冷下加
え、100℃で0.5時間撹拌した。室温に冷却した
後、反応液を水で希釈し、酢酸エチルで2回抽出した。
集めた有機層を無水硫酸ナトリウムで乾燥、溶媒を減圧
留去した。得られた粗生成物をシリカゲルカラムクロマ
トグラフィーにて精製し(ヘキサン/酢酸エチル=15
/1)、目的物を得た。無色液体 収量1.058g
収率42%1 H-NMR (CDCl3, 200MHz) δ 1.47 (3H, t, J = 7.0 H
z), 4.48 (2H, q, J = 7.1Hz), 7.51-7.65 (2H, m), 7.
80 (1H, dd, J = 2.2 Hz, 7.2 Hz), 7.99 (1H, d,J =
2.2 Hz), 8.12 (1H, d, J = 2.2 Hz), 8.87 (1H, dd, J
= 2.2 Hz, 7.4 Hz); IR (KBr) 1717, 1279, 1240, 118
8, 1142 cm-1 2) 3-クロロ-1-ナフトエ酸 3-クロロ-1-ナフトエ酸エチル1.056g(4.5
00ミリモル)のメタノール10ml−テトラヒドロフ
ラン10ml溶液に1N水酸化ナトリウム水溶液9.0
0ml(9.00ミリモル)を加え、室温で一晩撹拌し
た。反応液を濃縮、水で希釈し、1N塩酸で反応液を酸
性にした後、酢酸エチルで2回抽出した。集めた有機層
を無水硫酸ナトリウムで乾燥、溶媒を減圧留去した。残
留物を酢酸エチル−ヘキサンより結晶化して、目的物を
得た。白色結晶 収量0.769g 収率83% mp 217-218℃; 1H-NMR (DMSO-d6, 200MHz) δ 7.59-7.7
2 (2H, m), 7.97-8.07 (2H, m), 8.30 (1H, d, J = 2.2
Hz), 8.81-8.86 (1H, m); IR (KBr) 3100-2600,1699,
1285, 1254, 1196, 883, 793, 745 cm-1; Anal. Calcd
for C11H7ClO2:C, 63.94; H, 3.41. Found: C, 64.00;
H, 3.44. 3) 3-クロロ-N-[(1RS,2SR)-2-(4-フ
ルオロフェニル)-2-ヒドロキシ-1-[4-(トリフル
オロメチル)ベンジル]エチル]ナフタレン-1-カルボ
キサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.153g(0.488ミリモ
ル)、3-クロロ-1-ナフトエ酸0.10g(0.49
ミリモル)、1-ヒドロキシベンゾトリアゾール水和物
75mg(0.49ミリモル)をアセトニトリル10m
l中で撹拌しながら1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド・塩酸塩94mg(0.49
ミリモル)を加え、室温で一晩撹拌した。反応液を酢酸
エチルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無
水硫酸マグネシウムで乾燥、シリカゲルを通した後、溶
媒を減圧留去した。得られた残留物を酢酸エチル−ヘキ
サンより結晶化して、目的物を得た。白色結晶 収量
0.210g 収率86% mp 220-221℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
91 (1H, dd, J = 10.7 Hz, 13.5 Hz), 3.19 (1H, dd, J
= 2.2 Hz, 13.2 Hz), 4.62-4.77 (1H, m), 4.89(1H,
t, J = 5.0 Hz), 5.50 (1H, d, J = 4.4 Hz), 7.04-7.1
3 (3H, m), 7.22-7.34 (2H, m), 7.38-7.59 (7H, m),
7.73 (1H, d, J = 8.0 Hz), 7.82 (1H, d,J = 2.0 Hz),
8.10 (1H, d, J = 10.0 Hz); IR (KBr) 3285, 1642, 1
541, 1514,1325, 1163, 1119, 1069, 837 cm-1; Anal.
Calcd for C27H20ClF4NO2: C, 64.61; H, 4.02; N, 2.7
9. Found: C, 64.82; H, 4.17; N, 2.74.Example 76 3-Chloro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene-1- Carboxamide 1) Ethyl 3-chloro-1-naphthoate 2.317 g of ethyl 3-amino-1-naphthoate (10.
(76 mmol) in concentrated hydrochloric acid (30 ml), a solution of sodium nitrite (0.89 g, 12.9 mmol) in water (2 ml) was added dropwise under ice-cooling.
Stirred for hours. 0.53 g of cuprous chloride under ice-cooling
(5.38 mmol) in 4 ml of concentrated hydrochloric acid was added under ice cooling, and the mixture was stirred at 100 ° C. for 0.5 hour. After cooling to room temperature, the reaction was diluted with water and extracted twice with ethyl acetate.
The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15).
/ 1) to obtain the desired product. Colorless liquid yield 1.058g
Yield 42% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.47 (3H, t, J = 7.0 H
z), 4.48 (2H, q, J = 7.1Hz), 7.51-7.65 (2H, m), 7.
80 (1H, dd, J = 2.2 Hz, 7.2 Hz), 7.99 (1H, d, J =
2.2 Hz), 8.12 (1H, d, J = 2.2 Hz), 8.87 (1H, dd, J
= 2.2 Hz, 7.4 Hz); IR (KBr) 1717, 1279, 1240, 118
8, 1142 cm -1 2) 3-chloro-1-naphthoic acid 1.056 g of ethyl 3-chloro-1-naphthoate (4.5)
00 mmol) in 10 ml of methanol-10 ml of tetrahydrofuran.
0 ml (9.00 mmol) was added and stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 0.769 g Yield 83% mp 217-218 ° C; 1 H-NMR (DMSO-d 6 , 200 MHz) δ 7.59-7.7
2 (2H, m), 7.97-8.07 (2H, m), 8.30 (1H, d, J = 2.2
Hz), 8.81-8.86 (1H, m); IR (KBr) 3100-2600,1699,
1285, 1254, 1196, 883, 793, 745 cm -1 ; Anal.Calcd
for C 11 H 7 ClO 2 : C, 63.94; H, 3.41. Found: C, 64.00;
H, 3.44.3) 3-Chloro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene-1- Carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.153 g (0.488 mmol), 3-chloro 0.1-g of 1-naphthoic acid (0.49
Mmol) 1-hydroxybenzotriazole hydrate (75 mg, 0.49 mmol) in acetonitrile 10m
1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 94 mg (0.49
Mmol) and stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 0.210 g Yield 86% mp 220-221 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
91 (1H, dd, J = 10.7 Hz, 13.5 Hz), 3.19 (1H, dd, J
= 2.2 Hz, 13.2 Hz), 4.62-4.77 (1H, m), 4.89 (1H,
t, J = 5.0 Hz), 5.50 (1H, d, J = 4.4 Hz), 7.04-7.1
3 (3H, m), 7.22-7.34 (2H, m), 7.38-7.59 (7H, m),
7.73 (1H, d, J = 8.0 Hz), 7.82 (1H, d, J = 2.0 Hz),
8.10 (1H, d, J = 10.0 Hz); IR (KBr) 3285, 1642, 1
541, 1514, 1325, 1163, 1119, 1069, 837 cm -1 ; Anal.
Calcd for C 27 H 20 ClF 4 NO 2: C, 64.61; H, 4.02; N, 2.7
9. Found: C, 64.82; H, 4.17; N, 2.74.
【0209】実施例77 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-2,3-ジヒドロ-1-ベンゾ
フラン-7-カルボキサミド 2,3-ジヒドロ-1-ベンゾフラン7-カルボン酸(10
6mg,0.64ミリモル)のテトラヒドロフラン(5
ml)溶液に、オキサリルクロリド(0.11ml,
1.72ミリモル)およびN,N-ジメチルホルムアミ
ド(0.01ml)を加えて、室温で30分間攪拌し、
反応液を減圧留去した。残留物の酢酸エチル(5ml)
溶液に(1RS,2SR)-1-(4-フルオロフェニ
ル)-1-ヒドロキシ-3-(4-(トリフルオロメチル)
フェニル)-2-プロピルアミン塩酸塩(150mg,
0.43ミリモル)および飽和重曹水(5ml)を加え
て室温で終夜攪拌した。反応液を水(50ml)で希釈
し、酢酸エチル(50ml×2)で抽出した。抽出液を
飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減
圧留去した。残留物を酢酸エチル−ヘキサンから再結晶
させて、表題化合物(160mg,81%)を得た。 mp 121-122℃ IRνmaxKBrcm-1: 1780, 1644, 1537.Anal. Calcd for C
25H21F4NO3: C, 65.36; H, 4.61; N, 3.05 Found: C, 65.41; H, 4.38; N, 2.76.1 H-NMR (CDCl3)δ: 2.76-3.00 (2H, m), 3.18-3.30 (2
H, m), 4.12 (1H, d, J =3.6 Hz), 4.48-4.76 (4H, m),
5.08 (1H, s), 6.90-7.16 (2H, m), 7.20-7.52(6H,
m), 7.60 (1H, d, J = 7.6 Hz), 7.85 (1H, d, J = 7.6
Hz).Example 77 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -2,3-dihydro-1-benzofuran-7-carboxamide 2,3-dihydro-1-benzofuran 7-carboxylic acid ( 10
6 mg, 0.64 mmol) in tetrahydrofuran (5
oxalyl chloride (0.11 ml,
1.72 mmol) and N, N-dimethylformamide (0.01 ml) were added and stirred at room temperature for 30 minutes.
The reaction solution was distilled off under reduced pressure. Ethyl acetate of residue (5 ml)
Add (1RS, 2SR) -1- (4-fluorophenyl) -1-hydroxy-3- (4- (trifluoromethyl)
Phenyl) -2-propylamine hydrochloride (150 mg,
0.43 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (160 mg, 81%). mp 121-122 ℃ IRνmax KBr cm -1 : 1780, 1644, 1537.Anal.Calcd for C
25 H 21 F 4 NO 3: C, 65.36; H, 4.61; N, 3.05 Found:. C, 65.41; H, 4.38; N, 2.76 1 H-NMR (CDCl 3) δ: 2.76-3.00 (2H, m ), 3.18-3.30 (2
H, m), 4.12 (1H, d, J = 3.6 Hz), 4.48-4.76 (4H, m),
5.08 (1H, s), 6.90-7.16 (2H, m), 7.20-7.52 (6H,
m), 7.60 (1H, d, J = 7.6 Hz), 7.85 (1H, d, J = 7.6 Hz)
Hz).
【0210】実施例78 2-ブロモ-N-((1RS,2SR)-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-((4-(トリフルオロ
メチル)フェニル)メチル)エチル)アセトアミド (1RS,2RS)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン(2.0g,5.54ミリモ
ル)の酢酸エチル(50ml)溶液にブロモアセチルブ
ロミド(723ml,8.30ミリモル)および飽和重
曹水(50ml)を加えて室温で3時間攪拌した。反応
液を水(100ml)で希釈し、酢酸エチル(200m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=2:1−1:1)で精製し、酢酸エチル−ヘキサ
ンから再結晶させて、表題化合物(2.0g,83%)
を得た。 mp 151-152℃ IRνmaxKBrcm-1: 1659, 1647, 1547.Anal. Calcd for C
18H16BrF4NO2: C, 49.79; H, 3.71; N, 3.23 Found: C, 49.80; H, 3.41; N, 3.03.1 H-NMR (CDCl3)δ: 2.72-2.96 (3H, m), 3.74 (2H, dd,
J = 18.4, 13.6 Hz), 4.38-4.52 (1H, m), 4.92-5.00
(1H, m), 6.53 (1H, d, J = 8.4 Hz), 7.02-7.18(2H,
m), 7.22 (2H, d, J = 8.0 Hz), 7.32-7.50 (2H, m),
7.51 (2H, d, J =8.0 Hz).Example 78 2-Bromo-N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) acetamide (1RS, 2RS) -1- (4-fluorophenyl) -1-
To a solution of hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine (2.0 g, 5.54 mmol) in ethyl acetate (50 ml) was added bromoacetyl bromide (723 ml, 8.30 mmol) and saturated. Aqueous sodium bicarbonate (50 ml) was added, and the mixture was stirred at room temperature for 3 hours. The reaction solution was diluted with water (100 ml), and ethyl acetate (200 ml) was added.
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1-1: 1) and recrystallized from ethyl acetate-hexane to give the title compound (2.0 g, 83%).
I got mp 151-152 ℃ IRνmax KBr cm -1 : 1659, 1647, 1547.Anal. Calcd for C
18 H 16 BrF 4 NO 2: C, 49.79; H, 3.71; N, 3.23 Found:. C, 49.80; H, 3.41; N, 3.03 1 H-NMR (CDCl 3) δ: 2.72-2.96 (3H, m ), 3.74 (2H, dd,
J = 18.4, 13.6 Hz), 4.38-4.52 (1H, m), 4.92-5.00
(1H, m), 6.53 (1H, d, J = 8.4 Hz), 7.02-7.18 (2H,
m), 7.22 (2H, d, J = 8.0 Hz), 7.32-7.50 (2H, m),
7.51 (2H, d, J = 8.0 Hz).
【0211】実施例79 4-ブチル-N-((1RS,2SR)-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-((4-(トリフルオロ
メチル)フェニル)メチル)エチル)ベンズアミド 4-n-ブチル安息香酸(153mg,0.86ミリモ
ル)のテトラヒドロフラン(5ml)溶液に、オキサリ
ルクロリド(0.15ml,1.72ミリモル)および
N,N-ジメチルホルムアミド(0.01ml)を加え
て、室温で30分間攪拌し、反応液を減圧留去した。残
留物の酢酸エチル(5ml)溶液に(1RS,2SR)
-1-(4-フルオロフェニル)-1-ヒドロキシ-3-(4-
(トリフルオロメチル)フェニル)-2-プロピルアミン
塩酸塩(200mg,0.57ミリモル)および飽和重
曹水(5ml)を加えて室温で終夜攪拌した。反応液を
水(50ml)で希釈し、酢酸エチル(50ml×2)
で抽出した。抽出液を飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(ヘキサン:酢酸エチル=
4:1−1:1)で精製し、酢酸エチル−ヘキサンから
再結晶させて、表題化合物(172mg,64%)を得
た。 mp 171-172℃ IRν maxKBrcm-1: 1638, 1609, 1537, 1512.Anal. Calc
d for C27H27F4NO2: C, 68.49; H, 5.75; N, 2.96 Found: C, 68.46; H, 5.89; N, 2.94.1 H-NMR (CDCl3)δ: 0.92 (3H, t, J = 7.2 Hz), 1.22-
1.44 (2H, m), 1.48-1.70(2H, m), 2.63 (2H, t, J =
8.0 Hz), 2.80-3.06 (2H, m), 3.84 (1H, d, J =3.0 H
z), 4.50-4.70 (1H, m), 5.08 (1H, s), 6.12 (1H, d,
J = 8.2 Hz), 7.00-7.36 (6H, m), 7.38-7.58 (6H, m).Example 79 4-butyl-N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) benzamide Oxalyl chloride (0.15 ml, 1.72 mmol) and N, N-dimethylformamide (0.01 ml) were added to a solution of 4-n-butylbenzoic acid (153 mg, 0.86 mmol) in tetrahydrofuran (5 ml). After stirring at room temperature for 30 minutes, the reaction solution was distilled off under reduced pressure. To a solution of the residue in ethyl acetate (5 ml) (1RS, 2SR)
-1- (4-Fluorophenyl) -1-hydroxy-3- (4-
(Trifluoromethyl) phenyl) -2-propylamine hydrochloride (200 mg, 0.57 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and ethyl acetate (50 ml × 2)
Extracted. The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
4: 1-1: 1) and recrystallized from ethyl acetate-hexane to give the title compound (172 mg, 64%). mp 171-172 ° C IRν max KBr cm -1 : 1638, 1609, 1537, 1512.Anal. Calc
d for C 27 H 27 F 4 NO 2: C, 68.49; H, 5.75; N, 2.96 Found:. C, 68.46; H, 5.89; N, 2.94 1 H-NMR (CDCl 3) δ: 0.92 (3H, t, J = 7.2 Hz), 1.22-
1.44 (2H, m), 1.48-1.70 (2H, m), 2.63 (2H, t, J =
8.0 Hz), 2.80-3.06 (2H, m), 3.84 (1H, d, J = 3.0 H
z), 4.50-4.70 (1H, m), 5.08 (1H, s), 6.12 (1H, d,
J = 8.2 Hz), 7.00-7.36 (6H, m), 7.38-7.58 (6H, m).
【0212】実施例80 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-8-キノリンカルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)のア
セトニトリル(30ml)溶液に8-キノリンカルボン
酸(249mg,1.44ミリモル)および1-エチル-
3-(3-ジメチルアミノプロピル)カルボジイミド・塩
酸塩(413mg,2.15ミリモル)および1-ヒド
ロキシ-1H-ベンゾトリアゾール(220mg,1.4
4ミリモル)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=1:1)で精製し、酢酸エチル−ヘキサンから再結晶
させて、表題化合物(162mg,24%)を得た。 mp 83-84℃ IRνmaxKBrcm-1: 1644, 1574, 1549.Anal. Calcd for C
26H20F4N2O2・1.0H2O: C, 64.19; H, 4.56; N, 5.76 Found: C, 64.07; H, 4.39; N, 5.61.1 H-NMR (CDCl3)δ: 2.99 (2H, d, J = 7.4 Hz), 4.52
(1H, d, J = 3.6 Hz), 4.70-4.90 (1H, m), 5.12-5.20
(1H, m), 6.96-7.08 (2H, m), 7.31 (2H, d, J =8.0 H
z), 7.36-7.54 (5H, m), 7.67 (1H, t, J = 7.6 Hz),
7.98 (1H, dd, J =8.0, 1.8 Hz), 8.28 (1H, dd, J =
8.0, 1.8 Hz), 8.71 (1H, dd, J = 4.0, 1.8Hz), 8.79
(1H, dd, J = 7.4, 1.8 Hz), 11.49 (1H, d, J = 7.6 H
z).Example 80 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl
Enyl) methyl) ethyl) -8-quinolinecarboxamide (1RS, 2SR) -2-amino-1- (4-fluorophene)
Nyl) -3- (4- (trifluoromethyl) phenyl) -1
Of propanol (450 mg, 1.44 mmol)
8-quinolinecarboxyl in acetonitrile (30 ml) solution
Acid (249 mg, 1.44 mmol) and 1-ethyl-
3- (3-dimethylaminopropyl) carbodiimide salt
Acid salt (413 mg, 2.15 mmol) and 1-hydrido
Roxy-1H-benzotriazole (220 mg, 1.4
4 mmol) and stirred overnight at room temperature. Water
(100 ml) and diluted with ethyl acetate (100 ml ×
Extracted in 2). The extract is washed with a saturated saline solution,
After drying with magnesium acid, it was distilled off under reduced pressure. Silica residue
Gel column chromatography (hexane: ethyl acetate
= 1: 1) and recrystallized from ethyl acetate-hexane
This afforded the title compound (162 mg, 24%). mp 83-84 ℃ IRνmax KBr cm -1 : 1644, 1574, 1549.Anal.Calcd for C
26 H 20 F Four N Two O Two ・ 1.0H Two O: C, 64.19; H, 4.56; N, 5.76 Found: C, 64.07; H, 4.39; N, 5.61. 1 H-NMR (CDCl Three ) δ: 2.99 (2H, d, J = 7.4 Hz), 4.52
(1H, d, J = 3.6 Hz), 4.70-4.90 (1H, m), 5.12-5.20
(1H, m), 6.96-7.08 (2H, m), 7.31 (2H, d, J = 8.0 H
z), 7.36-7.54 (5H, m), 7.67 (1H, t, J = 7.6 Hz),
7.98 (1H, dd, J = 8.0, 1.8 Hz), 8.28 (1H, dd, J =
8.0, 1.8 Hz), 8.71 (1H, dd, J = 4.0, 1.8Hz), 8.79
(1H, dd, J = 7.4, 1.8 Hz), 11.49 (1H, d, J = 7.6 H
z).
【0213】実施例81 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-4-(トリフルオロメチル)
ベンズアミド (1RS,2SR)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(200mg,0.57
ミリモル)の酢酸エチル(5ml)溶液に4-(トリフ
ルオロメチル)ベンゾイルクロリド(179mg,0.
86ミリモル)および飽和重曹水(5ml)を加えて室
温で1時間攪拌した。反応液を水(50ml)で希釈
し、酢酸エチル(50ml×2)で抽出した。抽出液を
飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減
圧留去した。残留物をシリカゲルカラムクロマトグラフ
ィー(ヘキサン:酢酸エチル=2:1)で精製し、酢酸
エチル−ヘキサンから再結晶させて、表題化合物(17
1mg,62%)を得た。 mp 228-229℃ IRν maxKBrcm-1: 3285, 1641, 1329.Anal. Calcd for
C24H18F7NO2: C, 59.39; H, 3.74; N, 2.89 Found: C, 59.30; H, 3.74; N, 3.04.1 H-NMR (CDCl3)δ: 2.90-3.08 (3H, m), 4.56-4.70 (1
H, m), 5.04-5.14 (1H, m), 6.06-6.20 (1H, m), 7.00-
7.20 (2H, m), 7.20-7.34 (2H, m), 7.36-7.56 (4H,
m), 7.60-7.70 (4H, m).Example 81 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4- (trifluoromethyl)
Benzamide (1RS, 2SR) -1- (4-fluorophenyl) -1-
Hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (200 mg, 0.57
4- (trifluoromethyl) benzoyl chloride (179 mg, 0.
86 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml) were added, and the mixture was stirred at room temperature for 1 hour. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1) and recrystallized from ethyl acetate-hexane to give the title compound (17).
(1 mg, 62%). mp 228-229 ℃ IRν max KBr cm -1 : 3285, 1641, 1329.Anal. Calcd for
C 24 H 18 F 7 NO 2 : C, 59.39; H, 3.74; N, 2.89 Found:. C, 59.30; H, 3.74; N, 3.04 1 H-NMR (CDCl 3) δ: 2.90-3.08 (3H, m), 4.56-4.70 (1
H, m), 5.04-5.14 (1H, m), 6.06-6.20 (1H, m), 7.00-
7.20 (2H, m), 7.20-7.34 (2H, m), 7.36-7.56 (4H,
m), 7.60-7.70 (4H, m).
【0214】実施例82 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-2-(1-ナフタレニル)ア
セトアミド 1-ナフタレン酢酸(160mg,0.86ミリモル)
のテトラヒドロフラン(5ml)溶液に、オキサリルク
ロリド(0.15ml,1.72ミリモル)およびN,
N-ジメチルホルムアミド(0.01ml)を加えて、
室温で30分間攪拌し、反応液を減圧留去した。残留物
の酢酸エチル(5ml)溶液に(1RS,2SR)-1-
(4-フルオロフェニル)-1-ヒドロキシ-3-(4-(ト
リフルオロメチル)フェニル)-2-プロピルアミン塩酸
塩(200mg,0.57ミリモル)および飽和重曹水
(5ml)を加えて室温で2時間攪拌した。反応液を水
(50ml)で希釈し、酢酸エチル(50ml×2)で
抽出した。抽出液を飽和食塩水で洗浄し、無水硫酸マグ
ネシウムで乾燥後減圧留去した。残留物をシリカゲルカ
ラムクロマトグラフィー(ヘキサン:酢酸エチル=2:
1−1:1)で精製し、酢酸エチル−ヘキサンから再結
晶させて、表題化合物(175mg,64%)を得た。 mp 186-187℃ IRν maxKBrcm-1: 3285, 1657, 1539, 1512, 1120.Ana
l. Calcd for C28H23F4NO2: C, 69.85; H, 4.81; N, 2.
91 Found: C, 69.62; H, 4.68; N, 2.85.1 H-NMR (CDCl3)δ: 2.40 (1H, dd, J = 14.2, 10.4 H
z), 2.70 (1H, dd, J = 14.2, 4.0 Hz), 3.28 (2H, d,
J = 3.6 Hz), 3.90 (2H, d, J = 2.2 Hz), 4.24-4.40
(1H, m), 4.70-4.84 (1H, m), 5.15 (1H, d, J = 7.8 H
z), 6.78 (2H, d, J= 8.0 Hz), 6.88-7.00 (2H, m), 7.
04-7.20 (3H, m), 7.20-7.34 (2H, m), 7.36-7.60 (3H,
m), 7.70-7.94 (3H, m).Example 82 N-((1RS, 2SR) -2- (4-fluorophenyl)
2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -2- (1-naphthalenyl) acetamide 1-naphthaleneacetic acid (160 mg, 0.86 mmol)
In a solution of oxalyl chloride (0.15 ml, 1.72 mmol) and N,
Add N-dimethylformamide (0.01 ml)
After stirring at room temperature for 30 minutes, the reaction solution was distilled off under reduced pressure. (1RS, 2SR) -1- was added to a solution of the residue in ethyl acetate (5 ml).
(4-Fluorophenyl) -1-hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (200 mg, 0.57 mmol) and saturated aqueous sodium hydrogencarbonate (5 ml) were added, and the mixture was added at room temperature. Stir for 2 hours. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 2:
1-1: 1) and recrystallized from ethyl acetate-hexane to give the title compound (175 mg, 64%). mp 186-187 ℃ IRν max KBr cm -1 : 3285, 1657, 1539, 1512, 1120.Ana
l. Calcd for C 28 H 23 F 4 NO 2 : C, 69.85; H, 4.81; N, 2.
91 Found:. C, 69.62; H, 4.68; N, 2.85 1 H-NMR (CDCl 3) δ: 2.40 (1H, dd, J = 14.2, 10.4 H
z), 2.70 (1H, dd, J = 14.2, 4.0 Hz), 3.28 (2H, d,
J = 3.6 Hz), 3.90 (2H, d, J = 2.2 Hz), 4.24-4.40
(1H, m), 4.70-4.84 (1H, m), 5.15 (1H, d, J = 7.8 H
z), 6.78 (2H, d, J = 8.0 Hz), 6.88-7.00 (2H, m), 7.
04-7.20 (3H, m), 7.20-7.34 (2H, m), 7.36-7.60 (3H, m
m), 7.70-7.94 (3H, m).
【0215】実施例83 2-(エチルオキシ)-N-((1RS,2SR)-2-
(4-フルオロフェニル)-2-ヒドロキシ-1-((4-
(トリフルオロメチル)フェニル)メチル)エチル)-
1-ナフタレンカルボキサミド 2-(エチルオキシ)-N-(2-(4-フルオロフェニ
ル)-2-オキソ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-1-ナフタレンカルボキサミ
ド(400mg,0.79ミリモル)のメタノール(3
0ml)溶液に塩化マンガン(II)(198mg,
1.57ミリモル)を加え、室温で30分攪拌した。反
応液に氷冷下、水素化ホウ素ナトリウム(30mg,
0.79ミリモル)を加え、1時間攪拌した。反応液を
1規定塩酸(30ml)に注ぎ、酢酸エチル(50ml
×2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=2:1−1:1)で精製し、酢酸エチル−
ヘキサンから再結晶して、2-(エチルオキシ)-N-
((1RS,2SR)-2-(4-フルオロフェニル)-2
-ヒドロキシ-1-((4-(トリフルオロメチル)フェニ
ル)メチル)エチル)-1-ナフタレンカルボキサミドを
得た。再結晶後の母液を減圧留去し、得られた粗結晶を
ヘキサン:酢酸エチル=10:1の混合溶媒で洗浄し
て、表題化合物(37.2mg,9%)を得た。 mp 157-158℃ IRν maxKBrcm-1: 1622, 1510, 1300, 1236.Anal. Calc
d for C29H25F4NO3: C, 68.09; H, 4.93; N, 2.74 Found: C, 67.96; H, 4.86; N, 2.82.1 H-NMR (CDCl3)δ: 1.38 (3H, t, 7.0 Hz), 2.62-3.10
(2H, m), 3.28 (1H, d,J = 4.0 Hz), 4.06-4.30 (2H,
m), 4.88-5.04 (1H, m), 5.10-5.22 (1H, m), 6.03 (1
H, d, J = 9.6 Hz), 7.00-7.20 (3H, m), 7.20-7.60 (9
H, m), 7.77 (2H,dd, J = 20.0, 8.2 Hz).Example 83 2- (Ethyloxy) -N-((1RS, 2SR) -2-
(4-fluorophenyl) -2-hydroxy-1-((4-
(Trifluoromethyl) phenyl) methyl) ethyl)-
1-Naphthalenecarboxamide 2- (ethyloxy) -N- (2- (4-fluorophenyl) -2-oxo-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -1-naphthalenecarboxamide (400 mg , 0.79 mmol) of methanol (3
Manganese (II) chloride (198 mg,
(1.57 mmol) and stirred at room temperature for 30 minutes. Sodium borohydride (30 mg,
(0.79 mmol) and stirred for 1 hour. The reaction solution was poured into 1N hydrochloric acid (30 ml), and ethyl acetate (50 ml) was added.
× 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Ethyl acetate = 2: 1-1: 1) to give ethyl acetate-
Recrystallized from hexane to give 2- (ethyloxy) -N-
((1RS, 2SR) -2- (4-fluorophenyl) -2
-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -1-naphthalenecarboxamide was obtained. The mother liquor after recrystallization was distilled off under reduced pressure, and the obtained crude crystals were washed with a mixed solvent of hexane: ethyl acetate = 10: 1 to obtain the title compound (37.2 mg, 9%). mp 157-158 ℃ IRν max KBr cm -1 : 1622, 1510, 1300, 1236.Anal. Calc
d for C 29 H 25 F 4 NO 3 : C, 68.09; H, 4.93; N, 2.74 Found: C, 67.96; H, 4.86; N, 2.82. 1 H-NMR (CDCl 3 ) δ: 1.38 (3H, t, 7.0 Hz), 2.62-3.10
(2H, m), 3.28 (1H, d, J = 4.0 Hz), 4.06-4.30 (2H,
m), 4.88-5.04 (1H, m), 5.10-5.22 (1H, m), 6.03 (1
H, d, J = 9.6 Hz), 7.00-7.20 (3H, m), 7.20-7.60 (9
H, m), 7.77 (2H, dd, J = 20.0, 8.2 Hz).
【0216】実施例84 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-9-アントラセンカルボキサ
ミド 9-アントラセンカルボン酸(143mg,0.64ミ
リモル)のテトラヒドロフラン(5ml)溶液に、オキ
サリルクロリド(0.11ml,1.72ミリモル)お
よびN,N-ジメチルホルムアミド(0.01ml)を
加えて、室温で30分間攪拌し、反応液を減圧留去し
た。残留物の酢酸エチル(5ml)溶液に(1RS,2
SR)-1-(4-フルオロフェニル)-1-ヒドロキシ-3
-(4-(トリフルオロメチル)フェニル)-2-プロピル
アミン塩酸塩(150mg,0.43ミリモル)および
飽和重曹水(5ml)を加えて室温で終夜攪拌した。反
応液を水(50ml)で希釈し、酢酸エチル(50ml
×2)で抽出した。抽出液を飽和食塩水で洗浄し、無水
硫酸マグネシウムで乾燥後減圧留去した。残留物をシリ
カゲルカラムクロマトグラフィー(ヘキサン:酢酸エチ
ル=2:1)で精製し、酢酸エチル−ヘキサンから再結
晶させて、表題化合物(136mg,61%)を得た。 mp 251-252℃ IRν maxKBrcm-1: 1655, 1514, 1335, 1161, 1111. Anal. Calcd for C31H23F4NO2: C, 71.95; H, 4.48; N,
2.71 Found: C, 71.81; H, 4.55; N, 2.74.1 H-NMR (CDCl3)δ: 2.82 (1H, dd, J = 14.2, 11.8 H
z), 3.59 (1H, d, J = 14.0 Hz), 4.74 (1H, d, J = 8.
0 Hz), 5.16-5.32 (1H, m), 6.57 (1H, d, J = 8.8Hz),
6.76 (1H, d, J = 8.8 Hz), 6.96-7.10 (1H, m), 7.10
-7.30 (3H, m), 7.30-7.46 (2H, m), 7.54-7.76 (6H,
m), 7.84-8.00 (2H, m), 8.42 (1H, s).Example 84 N-((1RS, 2SR) -2- (4-fluorophenyl)
Oxalyl chloride was added to a solution of 9-anthracenecarboxylic acid (143 mg, 0.64 mmol) in tetrahydrofuran (5 ml). (0.11 ml, 1.72 mmol) and N, N-dimethylformamide (0.01 ml) were added, the mixture was stirred at room temperature for 30 minutes, and the reaction solution was distilled off under reduced pressure. To a solution of the residue in ethyl acetate (5 ml) was added (1RS, 2
SR) -1- (4-Fluorophenyl) -1-hydroxy-3
-(4- (Trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.43 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml), and ethyl acetate (50 ml) was added.
× 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1) and recrystallized from ethyl acetate-hexane to give the title compound (136 mg, 61%). mp 251-252 ° C IRν max KBr cm -1 : 1655, 1514, 1335, 1161, 1111. Anal.Calcd for C 31 H 23 F 4 NO 2 : C, 71.95; H, 4.48; N,
2.71 Found:. C, 71.81; H, 4.55; N, 2.74 1 H-NMR (CDCl 3) δ: 2.82 (1H, dd, J = 14.2, 11.8 H
z), 3.59 (1H, d, J = 14.0 Hz), 4.74 (1H, d, J = 8.
0 Hz), 5.16-5.32 (1H, m), 6.57 (1H, d, J = 8.8Hz),
6.76 (1H, d, J = 8.8 Hz), 6.96-7.10 (1H, m), 7.10
-7.30 (3H, m), 7.30-7.46 (2H, m), 7.54-7.76 (6H,
m), 7.84-8.00 (2H, m), 8.42 (1H, s).
【0217】実施例85 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-9-オキソ-9H-フルオレン
-1-カルボキサミド 9-オキソ-9H-フルオレン-1-カルボン酸(144m
g,0.64ミリモル)のテトラヒドロフラン(5m
l)溶液に、オキサリルクロリド(0.11ml,1.
72ミリモル)およびN,N-ジメチルホルムアミド
(0.01ml)を加えて、室温で30分間攪拌し、反
応液を減圧留去した。残留物の酢酸エチル(5ml)溶
液に(1RS,2SR)-1-(4-フルオロフェニル)-
1-ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(150mg,0.43
ミリモル)および飽和重曹水(5ml)を加えて室温で
終夜攪拌した。反応液を水(50ml)で希釈し、酢酸
エチル(50ml×2)で抽出した。抽出液を飽和食塩
水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて、
表題化合物(137mg,61%)を得た。 mp 185-186℃ IRνmaxKBrcm-1: 1698, 1607, 1574. Anal. Calcd for C30H21F4NO3・0.1H2O: C, 69.12; H,
4.10; N, 2.69 Found: C, 68.98; H, 3.91; N, 2.63.1 H-NMR (CDCl3)δ: 2.90-3.12 (2H, m), 3.85 (1H, s),
4.64-4.80 (1H, m), 5.20 (1H, s), 7.00-7.16 (2H,
m), 7.20-7.70 (12H, m), 8.12 (1H, dd, J = 7.2, 2.0
Hz), 10.16 (1H, d, J = 7.6 Hz).Example 85 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -9-oxo-9H-fluorene
-1-Carboxamide 9-oxo-9H-fluorene-1-carboxylic acid (144 m
g, 0.64 mmol) of tetrahydrofuran (5 m
l) Add oxalyl chloride (0.11 ml, 1.
72 mmol) and N, N-dimethylformamide (0.01 ml) were added, the mixture was stirred at room temperature for 30 minutes, and the reaction solution was distilled off under reduced pressure. (1RS, 2SR) -1- (4-fluorophenyl)-was added to a solution of the residue in ethyl acetate (5 ml).
1-hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.43
Mmol) and saturated aqueous sodium hydrogen carbonate (5 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane,
The title compound (137 mg, 61%) was obtained. mp 185-186 ° C IRνmax KBr cm -1 : 1698, 1607, 1574. Anal.Calcd for C 30 H 21 F 4 NO 3・ 0.1H 2 O: C, 69.12; H,
4.10; N, 2.69 Found:. C, 68.98; H, 3.91; N, 2.63 1 H-NMR (CDCl 3) δ: 2.90-3.12 (2H, m), 3.85 (1H, s),
4.64-4.80 (1H, m), 5.20 (1H, s), 7.00-7.16 (2H,
m), 7.20-7.70 (12H, m), 8.12 (1H, dd, J = 7.2, 2.0
Hz), 10.16 (1H, d, J = 7.6 Hz).
【0218】実施例86 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-3,5-ビス(トリフルオロ
メチル)ベンズアミド (1RS,2SR)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(150mg,0.43
ミリモル)の酢酸エチル(5ml)溶液に3,5-ビス
(トリフルオロメチル)ベンゾイルクロリド(117m
l,0.64ミリモル)および飽和重曹水(5ml)を
加えて室温で終夜攪拌した。反応液を水(50ml)で
希釈し、酢酸エチル(50ml×2)で抽出した。抽出
液を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物をジイソプロピルエーテル−ヘ
キサンから再結晶させて、表題化合物(73mg,31
%)を得た。 mp 150-151℃ IRνmaxKBrcm-1: 1651, 1620, 1543, 1512. Anal. Calcd for C25H17F10NO2: C, 54.26; H, 3.10;
N, 2.53 Found: C, 54.12; H, 2.95; N, 2.38.1 H-NMR (CDCl3)δ: 2.80-3.04 (3H, m), 4.60-4.78 (1
H, m), 5.13 (1H, s), 6.24 (1H, d, J = 8.4 Hz), 7.0
2-7.20 (2H, m), 7.20-7.32 (2H, m), 7.40-7.56(4H,
m), 7.90-8.02 (3H, m).Example 86 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -3,5-bis (trifluoromethyl) benzamide (1RS, 2SR) -1- (4-fluorophenyl) -1 -
Hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.43
Mmol) in ethyl acetate (5 ml) was added to 3,5-bis (trifluoromethyl) benzoyl chloride (117 m
1,0.64 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to give the title compound (73 mg, 31
%). mp 150-151 ° C IRνmax KBr cm -1 : 1651, 1620, 1543, 1512. Anal.Calcd for C 25 H 17 F 10 NO 2 : C, 54.26; H, 3.10;
N, 2.53 Found:. C, 54.12; H, 2.95; N, 2.38 1 H-NMR (CDCl 3) δ: 2.80-3.04 (3H, m), 4.60-4.78 (1
H, m), 5.13 (1H, s), 6.24 (1H, d, J = 8.4 Hz), 7.0
2-7.20 (2H, m), 7.20-7.32 (2H, m), 7.40-7.56 (4H, m
m), 7.90-8.02 (3H, m).
【0219】実施例87 8-ブロモ-N-((1RS,2SR)-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-((4-(トリフルオロ
メチル)フェニル)メチル)エチル)-1-ナフタレンカ
ルボキサミド 8-ブロモ-1-ナフタレンカルボン酸(161mg,
0.64ミリモル)のテトラヒドロフラン(5ml)溶
液に、オキサリルクロリド(0.11ml,1.72ミ
リモル)およびN,N-ジメチルホルムアミド(0.0
1ml)を加えて、室温で30分間攪拌し、反応液を減
圧留去した。残留物の酢酸エチル(5ml)溶液に(1
RS,2SR)-1-(4-フルオロフェニル)-1-ヒド
ロキシ-3-(4-(トリフルオロメチル)フェニル)-2
-プロピルアミン塩酸塩(150mg,0.43ミリモ
ル)および飽和重曹水(5ml)を加えて室温で終夜攪
拌した。反応液を水(50ml)で希釈し、酢酸エチル
(50ml×2)で抽出した。抽出液を飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=2:1−1:1)で精製し、酢酸エチ
ル−ヘキサンから再結晶させて、表題化合物(67m
g,29%)を得た。 mp 191-192℃ IRνmaxKBrcm-1: 1653, 1634, 1510. Anal. Calcd for C27H20BrF4NO2・0.2H2O: C, 58.97;
H, 3.74; N, 2.55 Found: C, 58.73; H, 3.44; N, 2.49.1 H-NMR (CDCl3)δ: 2.80-3.02 (2H, m), 4.78 (1H, br
s), 5.02-5.20 (1H, m),5.60-5.80 (1H, m), 7.04-7.20
(2H, m), 7.22-7.44 (5H, m), 7.44-7.70 (4H,m), 7.7
4-7.96 (3H, m).Example 87 8-Bromo-N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl)- 1-naphthalenecarboxamide 8-bromo-1-naphthalenecarboxylic acid (161 mg,
Oxalyl chloride (0.11 ml, 1.72 mmol) and N, N-dimethylformamide (0.04 mmol) in tetrahydrofuran (5 ml) solution.
1 ml), and the mixture was stirred at room temperature for 30 minutes, and the reaction solution was evaporated under reduced pressure. (1 ml) was added to a solution of the residue in ethyl acetate (5 ml).
RS, 2SR) -1- (4-Fluorophenyl) -1-hydroxy-3- (4- (trifluoromethyl) phenyl) -2
-Propylamine hydrochloride (150 mg, 0.43 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1-1: 1) and recrystallized from ethyl acetate-hexane to give the title compound (67 m
g, 29%). mp 191-192 ° C IRνmax KBr cm -1 : 1653, 1634, 1510. Anal.Calcd for C 27 H 20 BrF 4 NO 2・ 0.2H 2 O: C, 58.97;
H, 3.74; N, 2.55 Found :. C, 58.73; H, 3.44; N, 2.49 1 H-NMR (CDCl 3) δ: 2.80-3.02 (2H, m), 4.78 (1H, br
s), 5.02-5.20 (1H, m), 5.60-5.80 (1H, m), 7.04-7.20
(2H, m), 7.22-7.44 (5H, m), 7.44-7.70 (4H, m), 7.7
4-7.96 (3H, m).
【0220】実施例88 4-(4-フルオロベンゾイル)-N-[(1RS,2S
R)-2-(4-フルオロフェニル)-2-ヒドロキシ-1-
[4-(トリフルオロメチル)ベンジル]エチル]ベン
ゼンカルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.224g(0.715ミリモ
ル)、4-(4-フルオロベンゾイル)安息香酸0.17
g(0.71ミリモル)、1-ヒドロキシベンゾトリア
ゾール水和物0.11g(0.71ミリモル)をアセト
ニトリル10ml中で撹拌しながら1-エチル-3-(3-
ジメチルアミノプロピル)カルボジイミド・塩酸塩0.
14g(0.71ミリモル)を加え、室温で一晩撹拌し
た。反応液を酢酸エチルに希釈し、炭酸水素ナトリウム
水溶液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲ
ルを通した後、溶媒を減圧留去した。得られた残留物を
酢酸エチル−ヘキサンより結晶化して、目的物を得た。
白色結晶 収量0.321g 収率83% mp 156-157℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
83-3.06 (2H, m), 4.60-4.71 (1H, m), 4.91 (1H, d, J
= 3.2 Hz), 5.08 (1H, t, J = 3.1 Hz), 7.08 (2H, t,
J = 8.6 Hz), 7.14-7.31 (5H, m), 7.45 (2H, d, J =
7.4 Hz), 7.50 (2H, dd, J = 5.6 Hz, 8.8 Hz), 7.77
(4H, s), 7.83 (2H, dd, J = 5.4 Hz, 9.0Hz); IR (KB
r) 3536, 3303, 1644, 1601, 1541, 1507, 1329, 1281,
1225, 1161, 1111, 1069, 864, 849 cm-1; Anal. Calc
d for C30H22F5NO3・0.2H2O: C, 66.35; H, 4.16; N, 2.
58. Found: C, 66.14; H, 4.06; N, 2.57.Example 88 4- (4-Fluorobenzoyl) -N-[(1RS, 2S
R) -2- (4-Fluorophenyl) -2-hydroxy-1-
[4- (trifluoromethyl) benzyl] ethyl] benzenecarboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.224 g (0.715 mmol) 4- (4-fluorobenzoyl) benzoic acid 0.17
g (0.71 mmol) and 0.11 g (0.71 mmol) of 1-hydroxybenzotriazole hydrate in 10 ml of acetonitrile while stirring with 1-ethyl-3- (3- (3-ethyl-3-benzotriazole).
Dimethylaminopropyl) carbodiimide hydrochloride
14 g (0.71 mmol) was added and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product.
White crystals Yield 0.321 g Yield 83% mp 156-157 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
83-3.06 (2H, m), 4.60-4.71 (1H, m), 4.91 (1H, d, J
= 3.2 Hz), 5.08 (1H, t, J = 3.1 Hz), 7.08 (2H, t,
J = 8.6 Hz), 7.14-7.31 (5H, m), 7.45 (2H, d, J =
7.4 Hz), 7.50 (2H, dd, J = 5.6 Hz, 8.8 Hz), 7.77
(4H, s), 7.83 (2H, dd, J = 5.4 Hz, 9.0Hz); IR (KB
r) 3536, 3303, 1644, 1601, 1541, 1507, 1329, 1281,
1225, 1161, 1111, 1069, 864, 849 cm -1 ; Anal.Calc
d for C 30 H 22 F 5 NO 3・ 0.2H 2 O: C, 66.35; H, 4.16; N, 2.
58.Found: C, 66.14; H, 4.06; N, 2.57.
【0221】実施例89 4-[(Z)-2-(4-クロロフェニル)エテニル]-N-
[(1RS,2SR)-2-(4-フルオロフェニル)-2
-ヒドロキシ-1-[4-(トリフルオロメチル)ベンジ
ル]エチル]ベンゼンカルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.245g(0.782ミリモ
ル)、(Z)-4-[2-(4-クロロフェニル)エテニ
ル]安息香酸0.20g(0.78ミリモル)、1-ヒ
ドロキシベンゾトリアゾール水和物0.12g(0.7
8ミリモル)をアセトニトリル10ml中で撹拌しなが
ら1-エチル-3-(3-ジメチルアミノプロピル)カルボ
ジイミド・塩酸塩0.15g(0.78ミリモル)を加
え、室温で一晩撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物を酢酸エチル−ヘキサンより結晶
化して、目的物を得た。白色結晶 収量0.378g
収率87% mp 193-194℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
77-3.03 (2H, m), 4.56-4.69 (1H, m), 4.82 (1H, d, J
= 3.4 Hz), 5.05 (1H, t, J = 2.8 Hz), 6.61 (2H,
s), 6.95 (1H, d, J = 9.0 Hz), 7.06 (2H, t, J = 8.6
Hz), 7.14-7.30 (8H, m), 7.42-7.56 (6H, m); IR (KB
r) 3260, 1642, 1512, 1325, 1165, 1115, 1067, 872,
826 cm-1; Anal. Calcd for C31H24ClF4NO2: C, 67.21;
H, 4.37; N,2.53. Found: C, 67.00; H, 4.42; N, 2.4
8.Example 89 4-[(Z) -2- (4-chlorophenyl) ethenyl] -N-
[(1RS, 2SR) -2- (4-fluorophenyl) -2
-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] benzenecarboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] 0.245 g (0.782 mmol) of propan-1-ol, 0.20 g (0.78 mmol) of (Z) -4- [2- (4-chlorophenyl) ethenyl] benzoic acid, 1-hydroxybenzotriazole hydrate 0.12 g (0.7
(8 mmol) was stirred in 10 ml of acetonitrile, and 0.15 g (0.78 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added thereto, followed by stirring at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. 0.378 g of white crystals
Yield 87% mp 193-194 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200MHz) δ 2.
77-3.03 (2H, m), 4.56-4.69 (1H, m), 4.82 (1H, d, J
= 3.4 Hz), 5.05 (1H, t, J = 2.8 Hz), 6.61 (2H,
s), 6.95 (1H, d, J = 9.0 Hz), 7.06 (2H, t, J = 8.6
Hz), 7.14-7.30 (8H, m), 7.42-7.56 (6H, m); IR (KB
r) 3260, 1642, 1512, 1325, 1165, 1115, 1067, 872,
. 826 cm -1; Anal Calcd for C 31 H 24 ClF 4 NO 2: C, 67.21;
H, 4.37; N, 2.53. Found: C, 67.00; H, 4.42; N, 2.4
8.
【0222】実施例90 4-(4-クロロフェノキシ)-N-[(1RS,2SR)
-2-(4-フルオロフェニル)-2-ヒドロキシ-1-[4-
(トリフルオロメチル)ベンジル]エチル]ベンゼンカ
ルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.235g(0.750ミリモ
ル)、4-(4-クロロフェノキシ)安息香酸0.19g
(0.75ミリモル)、1-ヒドロキシベンゾトリアゾ
ール水和物0.11g(0.75ミリモル)をアセトニ
トリル10ml中で撹拌しながら1-エチル-3-(3-ジ
メチルアミノプロピル)カルボジイミド・塩酸塩0.1
4g(0.75ミリモル)を加え、室温で一晩撹拌し
た。反応液を酢酸エチルに希釈し、炭酸水素ナトリウム
水溶液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲ
ルを通した後、溶媒を減圧留去した。得られた残留物を
酢酸エチル−ヘキサンより結晶化して、目的物を得た。
白色結晶 収量0.353g 収率87% mp 188-189℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
77-3.03 (2H, m), 4.56-4.69 (1H, m), 4.75 (1H, d, J
= 3.2 Hz), 5.06 (1H, t, J = 3.1 Hz), 6.85 (1H, d,
J = 8.4 Hz), 6.95 (2H, d, J = 8.8 Hz), 6.97 (2H,
d, J = 9.2 Hz),7.07 (2H, t, J = 8.8 Hz), 7.23 (2H,
d, J = 8.0 Hz), 7.33 (2H, d, J = 9.2Hz), 7.43-7.5
1 (4H, m), 7.64 (2H, d, J = 9.2 Hz); IR (KBr) 329
1, 1636,1512, 1487, 1329, 1256, 1121, 1069, 837, 8
28 cm-1; Anal. Calcd for C29H2 2ClF4NO3: C, 64.04;
H, 4.08; N, 2.58. Found: C, 63.86; H, 4.06; N, 2.5
5.Example 90 4- (4-chlorophenoxy) -N-[(1RS, 2SR)
-2- (4-Fluorophenyl) -2-hydroxy-1- [4-
(Trifluoromethyl) benzyl] ethyl] benzenecarboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.235 g (0.750 mmol) 0.19 g of 4- (4-chlorophenoxy) benzoic acid
0.17 g (0.75 mmol) of 1-hydroxybenzotriazole hydrate in 10 ml of acetonitrile was stirred with 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 0 (0.75 mmol). .1
4 g (0.75 mmol) was added and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product.
White crystals Yield 0.353 g Yield 87% mp 188-189 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
77-3.03 (2H, m), 4.56-4.69 (1H, m), 4.75 (1H, d, J
= 3.2 Hz), 5.06 (1H, t, J = 3.1 Hz), 6.85 (1H, d,
J = 8.4 Hz), 6.95 (2H, d, J = 8.8 Hz), 6.97 (2H,
d, J = 9.2 Hz), 7.07 (2H, t, J = 8.8 Hz), 7.23 (2H,
d, J = 8.0 Hz), 7.33 (2H, d, J = 9.2Hz), 7.43-7.5
1 (4H, m), 7.64 (2H, d, J = 9.2 Hz); IR (KBr) 329
1, 1636,1512, 1487, 1329, 1256, 1121, 1069, 837, 8
28 cm -1 ; Anal.Calcd for C 29 H 2 2 ClF 4 NO 3 : C, 64.04;
H, 4.08; N, 2.58. Found: C, 63.86; H, 4.06; N, 2.5
Five.
【0223】実施例91 4-(4-フルオロフェニル)-N-[(1RS,2SR)
-2-(4-フルオロフェニル)-2-ヒドロキシ-1-[4-
(トリフルオロメチル)ベンジル]エチル]-5-[(メ
トキシ)メチル]-2-フェニルフラン-3-カルボキサミ
ド 1) 4-(4-フルオロフェニル)-5-メチル-2-フェ
ニルフラン-3-カルボン酸エチル ベンゾイル酢酸エチル12.43g(64.67ミリモ
ル)と1-フルオロ-4-(2-ニトロ-1-プロペニル)ベ
ンゼン11.7g(64.7ミリモル)のエタノール6
0ml溶液にピペリジン6.40ml(64.7ミリモ
ル)を室温で加え、室温で一晩撹拌した。反応液に水5
0mlと濃塩酸15mlを加え、室温で1時間撹拌し
た。反応液を酢酸エチルで2回抽出し、集めた有機層を
無水硫酸ナトリウムで乾燥、溶媒を減圧留去した。残留
物をシリカゲルカラムクロマトグラフィーにて精製して
(ヘキサン/酢酸エチル=20/1)、目的物を得た。
淡黄色固体 収量7.860g 収率38% メタノールより再結晶して、白色粉末を得た。 mp 78-79℃; 1H-NMR (CDCl3, 200MHz) δ 1.02 (3H, t,
J = 7.1 Hz), 2.30 (3H, s), 4.10 (2H, q, J = 7.1 H
z), 7.09 (2H, t, J = 8.6 Hz), 7.19-7.48 (5H,m), 7.
82 (2H, dd, J = 1.9 Hz, 7.7 Hz); IR (KBr) 1716, 15
10, 1323, 1223,1105 cm-1; Anal. Calcd for C20H17FO
3: C, 74.06; H, 5.28. Found: C, 73.82; H, 5.35. 2) 5-[(アセトキシ)メチル]-4-(4-フルオロ
フェニル)-2-フェニルフラン-3-カルボン酸エチル 4-(4-フルオロフェニル)-5-メチル-2-フェニルフ
ラン-3-カルボン酸エチル19.06g(58.76ミ
リモル)、N-ブロモスクシンイミド10.5g(5
8.8ミリモル)、2,2’-アゾビス(イソブチロニ
トリル)50mgの四塩化炭素50ml溶液を0.5時
間加熱還流した。反応液を室温に冷却した後、白色沈殿
を濾過して除き、沈殿をジエチルエーテルで洗浄した。
集めた濾液の溶媒を減圧留去して、5-(ブロモメチ
ル)-4-(4-フルオロフェニル)-2-フェニルフラン-
3-カルボン酸エチルの粗生成物を黄色液体として得
た。得られた液体をN,N-ジメチルホルムアミド40
mlに溶かし、酢酸ナトリウム9.64g(118ミリ
モル)を加え、室温で一晩撹拌した。反応液を水で希釈
し、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸ナトリウムで乾燥、溶媒を減圧留去した。得られた粗
生成物をシリカゲルカラムクロマトグラフィーにて精製
し(ヘキサン/酢酸エチル=6/1)、目的物を得た。
淡黄色固体 収量17.24g 収率77% ジイソプロピルエーテルより再結晶して、淡褐色粉末を
得た。 mp 114-116℃; 1H-NMR (CDCl3, 200MHz) δ 1.02 (3H,
t, J = 7.1 Hz), 2.10 (3H, s), 4.11 (2H, q, J = 7.1
Hz), 5.01 (2H, s), 7.11 (2H, t, J = 8.6 Hz), 7.33
(2H, dd, J = 5.6 Hz, 8.8 Hz), 7.42-7.51 (3H, m),
7.81-7.87 (2H, m); IR (KBr) 1740, 1717, 1508, 124
2, 1223, 1130, 1024, 849, 700 cm-1; Anal. Calcd fo
r C22H19FO5: C, 69.10; H, 5.01. Found: C, 69.08;
H, 5.07. 3) 4-(4-フルオロフェニル)-5-[(メトキシ)
メチル]-2-フェニルフラン-3-カルボン酸エチル 5-[(アセトキシ)メチル]-4-(4-フルオロフェニ
ル)-2-フェニルフラン-3-カルボン酸エチル4.02
0g(10.51ミリモル)と10%塩化水素のメタノ
ール溶液50mlの混合物を、室温で2.5日間撹拌し
た。反応液の溶媒を減圧留去して、得られた粗生成物を
シリカゲルカラムクロマトグラフィーにて精製し(ヘキ
サン/酢酸エチル=9/1)、目的物を得た。黄色液体
収量2.130g 収率57%1 H-NMR (CDCl3, 200MHz) δ 1.02 (3H, t, J = 7.1 H
z), 3.37 (3H, s), 4.12 (2H, q, J = 7.2 Hz), 4.33
(2H, s), 7.10 (2H, t, J = 8.8 Hz), 7.36 (2H, dd, J
= 5.4 Hz, 8.8 Hz), 7.40-7.49 (3H, m), 7.81-7.89
(2H, m); IR (neat) 1717, 1508, 1223, 1109, 1096 cm
-1 4) 4-(4-フルオロフェニル)-5-[(メトキシ)
メチル]-2-フェニルフラン-3-カルボン酸 4-(4-フルオロフェニル)-5-[(メトキシ)メチ
ル]-2-フェニルフラン-3-カルボン酸エチル1.53
5g(4.332ミリモル)と2N水酸化ナトリウム水
溶液4.33ml(8.66ミリモル)をメタノール2
0ml中で、70℃にて8時間撹拌した。反応液を水で
希釈し、希塩酸で反応液を酸性にした後、酢酸エチルで
2回抽出した。集めた有機層を無水硫酸ナトリウムで乾
燥、溶媒を減圧留去した。残留物をシリカゲルカラムク
ロマトグラフィーにて精製し(ヘキサン/酢酸エチル=
3/1−酢酸エチル)、ヘキサンより結晶化して、目的
物を得た。淡褐色結晶 収量1.006g 収率71% mp 175-176℃; 1H-NMR (CDCl3, 200MHz) δ 3.36 (3H,
s), 4.31 (2H, s), 7.08(2H, t, J = 8.8 Hz), 7.35 (2
H, dd, J = 5.6 Hz, 8.8 Hz), 7.41-7.44 (3H,m), 7.78
-7.85 (2H, m); IR (KBr) 3055-2555, 1686, 1508, 122
5, 1100, 851 cm-1; Anal. Calcd for C19H15FO4: C, 6
9.93; H, 4.63. Found: C, 69.76; H, 4.71. 5) 4-(4-フルオロフェニル)-N-[(1RS,2
SR)-2-(4-フルオロフェニル)-2-ヒドロキシ-1
-[4-(トリフルオロメチル)ベンジル]エチル]-5-
[(メトキシ)メチル]-2-フェニルフラン-3-カルボ
キサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.228g(0.728ミリモ
ル)、4-(4-フルオロフェニル)-5-[(メトキシ)
メチル]-2-フェニルフラン-3-カルボン酸0.24g
(0.73ミリモル)、1-ヒドロキシベンゾトリアゾ
ール水和物0.11g(0.73ミリモル)をアセトニ
トリル10ml中で撹拌しながら1-エチル-3-(3-ジ
メチルアミノプロピル)カルボジイミド・塩酸塩0.1
4g(0.73ミリモル)を加え、室温で一晩撹拌し
た。反応液を酢酸エチルに希釈し、炭酸水素ナトリウム
水溶液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲ
ルを通した後、溶媒を減圧留去した。得られた残留物を
酢酸エチル−ヘキサンより結晶化して、目的物を得た。
白色結晶 収量0.341g 収率75% mp 204-206℃; 1H-NMR (CDCl3, 200MHz) δ 2.48 (1H,
d, J = 4.0 Hz), 2.51-2.70 (2H, m), 3.43 (3H, s),
4.32 (2H, s), 4.51-4.64 (1H, m), 4.75 (1H, t,J =
3.7 Hz), 5.61 (1H, d, J = 8.4 Hz), 6.90-7.00 (4H,
m), 7.09 (2H, t,J = 8.6 Hz), 7.19 (2H, dd, J = 5.2
Hz, 8.6 Hz), 7.30-7.42 (7H, m), 7.56-7.61 (2H,
m); IR (KBr) 3301, 1636, 1512, 1329, 1223, 1163, 1
123, 1094, 1069, 839 cm-1; Anal. Calcd for C35H28F
5NO4: C, 67.63; H, 4.54; N, 2.25.Found: C, 67.46;
H, 4.71; N, 2.25.Example 91 4- (4-fluorophenyl) -N-[(1RS, 2SR)
-2- (4-Fluorophenyl) -2-hydroxy-1- [4-
(Trifluoromethyl) benzyl] ethyl] -5-[(methoxy) methyl] -2-phenylfuran-3-carboxamide 1) 4- (4-fluorophenyl) -5-methyl-2-phenylfuran-3-carboxylic Ethyl benzoylate 12.43 g (64.67 mmol) of ethyl acetate and 11.7 g (64.7 mmol) of 1-fluoro-4- (2-nitro-1-propenyl) benzene in ethanol 6
6.40 ml (64.7 mmol) of piperidine was added to the 0 ml solution at room temperature, and the mixture was stirred at room temperature overnight. Water 5
0 ml and 15 ml of concentrated hydrochloric acid were added, and the mixture was stirred at room temperature for 1 hour. The reaction solution was extracted twice with ethyl acetate, the collected organic layers were dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 20/1) to obtain the desired product.
A pale yellow solid, 7.860 g, 38% yield, was recrystallized from methanol to give a white powder. mp 78-79 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 1.02 (3H, t,
J = 7.1 Hz), 2.30 (3H, s), 4.10 (2H, q, J = 7.1 H
z), 7.09 (2H, t, J = 8.6 Hz), 7.19-7.48 (5H, m), 7.
82 (2H, dd, J = 1.9 Hz, 7.7 Hz); IR (KBr) 1716, 15
10, 1323, 1223,1105 cm -1 ; Anal.Calcd for C 20 H 17 FO
3 : C, 74.06; H, 5.28. Found: C, 73.82; H, 5.35.2) 5-[(acetoxy) methyl] -4- (4-fluorophenyl) -2-phenylfuran-3-carboxylate 19.06 g (58.76 mmol) of ethyl 4- (4-fluorophenyl) -5-methyl-2-phenylfuran-3-carboxylate, 10.5 g of N-bromosuccinimide (5.
8.8 mmol) and a solution of 50 mg of 2,2′-azobis (isobutyronitrile) in 50 ml of carbon tetrachloride were heated under reflux for 0.5 hour. After cooling the reaction solution to room temperature, a white precipitate was removed by filtration, and the precipitate was washed with diethyl ether.
The solvent of the collected filtrate was distilled off under reduced pressure to give 5- (bromomethyl) -4- (4-fluorophenyl) -2-phenylfuran-
The crude product of ethyl 3-carboxylate was obtained as a yellow liquid. The obtained liquid is washed with N, N-dimethylformamide 40
Then, 9.64 g (118 mmol) of sodium acetate was added, and the mixture was stirred at room temperature overnight. The reaction was diluted with water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6/1) to obtain the desired product.
Light yellow solid Yield 17.24 g Yield 77% Recrystallization from diisopropyl ether gave a light brown powder. mp 114-116 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.02 (3H,
t, J = 7.1 Hz), 2.10 (3H, s), 4.11 (2H, q, J = 7.1
Hz), 5.01 (2H, s), 7.11 (2H, t, J = 8.6 Hz), 7.33
(2H, dd, J = 5.6 Hz, 8.8 Hz), 7.42-7.51 (3H, m),
7.81-7.87 (2H, m); IR (KBr) 1740, 1717, 1508, 124
2, 1223, 1130, 1024, 849, 700 cm -1 ; Anal.Calcd fo
r C 22 H 19 FO 5 : C, 69.10; H, 5.01. Found: C, 69.08;
H, 5.07.3) 4- (4-Fluorophenyl) -5-[(methoxy)
Ethyl methyl] -2-phenylfuran-3-carboxylate Ethyl 5-[(acetoxy) methyl] -4- (4-fluorophenyl) -2-phenylfuran-3-carboxylate 4.02
A mixture of 0 g (10.51 mmol) and 50 ml of a 10% solution of hydrogen chloride in methanol was stirred at room temperature for 2.5 days. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 9/1) to obtain the desired product. Yellow liquid Yield 2.130 g Yield 57% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.02 (3H, t, J = 7.1 H)
z), 3.37 (3H, s), 4.12 (2H, q, J = 7.2 Hz), 4.33
(2H, s), 7.10 (2H, t, J = 8.8 Hz), 7.36 (2H, dd, J
= 5.4 Hz, 8.8 Hz), 7.40-7.49 (3H, m), 7.81-7.89
(2H, m); IR (neat) 1717, 1508, 1223, 1109, 1096 cm
-14 ) 4- (4-Fluorophenyl) -5-[(methoxy)
Methyl] -2-phenylfuran-3-carboxylic acid ethyl 4- (4-fluorophenyl) -5-[(methoxy) methyl] -2-phenylfuran-3-carboxylate 1.53
5 g (4.332 mmol) and 4.33 ml (8.66 mmol) of a 2N aqueous sodium hydroxide solution in methanol 2
The mixture was stirred in 0 ml at 70 ° C. for 8 hours. The reaction solution was diluted with water, acidified with dilute hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate =
Crystallized from 3 / 1-ethyl acetate) and hexane to give the desired product. Light brown crystal Yield 1.006 g Yield 71% mp 175-176 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 3.36 (3H,
s), 4.31 (2H, s), 7.08 (2H, t, J = 8.8 Hz), 7.35 (2
H, dd, J = 5.6 Hz, 8.8 Hz), 7.41-7.44 (3H, m), 7.78
-7.85 (2H, m); IR (KBr) 3055-2555, 1686, 1508, 122
. 5, 1100, 851 cm -1 ; Anal Calcd for C 19 H 15 FO 4: C, 6
9.93; H, 4.63. Found: C, 69.76; H, 4.71.5) 4- (4-Fluorophenyl) -N-[(1RS, 2
SR) -2- (4-Fluorophenyl) -2-hydroxy-1
-[4- (Trifluoromethyl) benzyl] ethyl] -5-
[(Methoxy) methyl] -2-phenylfuran-3-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propane-1- All 0.228 g (0.728 mmol), 4- (4-fluorophenyl) -5-[(methoxy)
Methyl] -2-phenylfuran-3-carboxylic acid 0.24 g
0.17 g (0.73 mmol) of 1-hydroxybenzotriazole hydrate in 10 ml of acetonitrile was stirred with 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 0 (0.73 mmol). .1
4 g (0.73 mmol) was added and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product.
White crystals Yield 0.341 g Yield 75% mp 204-206 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.48 (1H,
d, J = 4.0 Hz), 2.51-2.70 (2H, m), 3.43 (3H, s),
4.32 (2H, s), 4.51-4.64 (1H, m), 4.75 (1H, t, J =
3.7 Hz), 5.61 (1H, d, J = 8.4 Hz), 6.90-7.00 (4H,
m), 7.09 (2H, t, J = 8.6 Hz), 7.19 (2H, dd, J = 5.2
Hz, 8.6 Hz), 7.30-7.42 (7H, m), 7.56-7.61 (2H,
m); IR (KBr) 3301, 1636, 1512, 1329, 1223, 1163, 1
123, 1094, 1069, 839 cm -1 ; Anal.Calcd for C 35 H 28 F
5 NO 4 : C, 67.63; H, 4.54; N, 2.25.Found: C, 67.46;
H, 4.71; N, 2.25.
【0224】実施例92 4-[2-(4-クロロフェニル)エチル]-N-[(1R
S,2SR)-2-(4-フルオロフェニル)-2-ヒドロ
キシ-1-[4-(トリフルオロメチル)ベンジル]エチ
ル]ベンゼンカルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.219g(0.699ミリモ
ル)、4-[2-(4-クロロフェニル)エチル]安息香
酸0.18g(0.70ミリモル)、1-ヒドロキシベ
ンゾトリアゾール水和物0.11g(0.70ミリモ
ル)をアセトニトリル10ml中で撹拌しながら1-エ
チル-3-(3-ジメチルアミノプロピル)カルボジイミ
ド・塩酸塩0.13g(0.70ミリモル)を加え、室
温で一晩撹拌した。反応液を酢酸エチルに希釈し、炭酸
水素ナトリウム水溶液で洗浄、無水硫酸マグネシウムで
乾燥、シリカゲルを通した後、溶媒を減圧留去した。得
られた残留物を酢酸エチル−ヘキサンより結晶化して、
目的物を得た。白色結晶 収量0.345g 収率89
% mp 211-212℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
56-3.06 (6H, m), 4.53-4.66 (1H, m), 5.03 (1H, t, J
= 3.1 Hz), 5.32 (1H, d, J = 3.6 Hz), 7.01-7.27 (9
H, m), 7.36-7.54 (6H, m), 7.60 (2H, d, J = 8.2 H
z); IR (KBr) 3287,1638, 1541, 1512, 1325, 1229, 11
63, 1115, 1067, 837 cm-1; Anal. Calcd for C31H26Cl
F4NO2: C, 66.97; H, 4.71; N, 2.52. Found: C, 66.6
5; H, 4.62;N, 2.51.Example 92 4- [2- (4-Chlorophenyl) ethyl] -N-[(1R
S, 2SR) -2- (4-Fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] benzenecarboxamide (1RS, 2SR) -2-amino-1- (4-fluoro 0.219 g (0.699 mmol) of phenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.18 g of 4- [2- (4-chlorophenyl) ethyl] benzoic acid (0. 0.11 g (0.70 mmol) of 1-hydroxybenzotriazole hydrate in 10 ml of acetonitrile while stirring 0.11 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (70 mmol). (0.70 mmol) and stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane,
The desired product was obtained. White crystals Yield 0.345 g Yield 89
% Mp 211-212 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
56-3.06 (6H, m), 4.53-4.66 (1H, m), 5.03 (1H, t, J
= 3.1 Hz), 5.32 (1H, d, J = 3.6 Hz), 7.01-7.27 (9
H, m), 7.36-7.54 (6H, m), 7.60 (2H, d, J = 8.2 H
z); IR (KBr) 3287,1638, 1541, 1512, 1325, 1229, 11
63, 1115, 1067, 837 cm -1 ; Anal.Calcd for C 31 H 26 Cl
F 4 NO 2 : C, 66.97; H, 4.71; N, 2.52. Found: C, 66.6
5; H, 4.62; N, 2.51.
【0225】実施例93 4-[cis-3-(4-クロロフェニル)オキシラン-2-
イル]-N-[(1RS,2SR)-2-(4-フルオロフ
ェニル)-2-ヒドロキシ-1-[4-(トリフルオロメチ
ル)ベンジル]エチル]ベンゼンカルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.264g(0.843ミリモ
ル)、cis-4-[3-(4-クロロフェニル)オキシラ
ン-2-イル]安息香酸0.23g(0.84ミリモ
ル)、1-ヒドロキシベンゾトリアゾール水和物0.1
3g(0.84ミリモル)をアセトニトリル10ml中
で撹拌しながら1-エチル-3-(3-ジメチルアミノプロ
ピル)カルボジイミド・塩酸塩0.16g(0.84ミ
リモル)を加え、室温で一晩撹拌した。反応液を酢酸エ
チルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無水
硫酸マグネシウムで乾燥、シリカゲルを通した後、溶媒
を減圧留去した。得られた残留物を酢酸エチル−ヘキサ
ンより結晶化して、目的物を得た。白色粉末 収量0.
288g 収率60% mp 162-166℃; 1H-NMR (CDCl3, 200MHz) δ 2.91 (2H,
d, J = 7.4 Hz), 3.49 (1H, dd, J = 3.5 Hz, 10.5 H
z), 4.36 (2H, s), 4.46-4.63 (1H, m), 5.05 (1H,t, J
= 3.1 Hz), 6.03-6.08 (1H, m), 7.02-7.23 (10H, m),
7.36-7.43 (4H, m), 7.47 (2H, d, J = 8.0 Hz); IR
(KBr) 3289, 1642, 1541, 1510, 1325, 1229, 1163, 11
11, 1067, 1019, 828 cm-1; Anal. Calcd for C31H24Cl
F4NO3: C, 65.32; H, 4.24; N, 2.46. Found: C, 65.2
1; H, 4.01; N, 2.44.Example 93 4- [cis-3- (4-chlorophenyl) oxirane-2-
Yl] -N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] benzenecarboxamide (1RS, 2SR) -2-amino 0.264 g (0.843 mmol) of -1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol, cis-4- [3- (4-chlorophenyl) oxirane 2--2-yl] benzoic acid 0.23 g (0.84 mmol), 1-hydroxybenzotriazole hydrate 0.1
While stirring 3 g (0.84 mmol) in 10 ml of acetonitrile, 0.16 g (0.84 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. . The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White powder Yield 0.
288 g yield 60% mp 162-166 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.91 (2H,
d, J = 7.4 Hz), 3.49 (1H, dd, J = 3.5 Hz, 10.5 H
z), 4.36 (2H, s), 4.46-4.63 (1H, m), 5.05 (1H, t, J
= 3.1 Hz), 6.03-6.08 (1H, m), 7.02-7.23 (10H, m),
7.36-7.43 (4H, m), 7.47 (2H, d, J = 8.0 Hz); IR
(KBr) 3289, 1642, 1541, 1510, 1325, 1229, 1163, 11
11, 1067, 1019, 828 cm -1 ; Anal.Calcd for C 31 H 24 Cl
F 4 NO 3 : C, 65.32; H, 4.24; N, 2.46. Found: C, 65.2
1; H, 4.01; N, 2.44.
【0226】実施例94 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-4-(2-フェニル-1,3-ジチオラン-
2-イル)ベンゼンカルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.218g(0.696ミリモ
ル)、4-(2-フェニル-1,3-ジチオラン-2-イル)
安息香酸0.21g(0.70ミリモル)、1-ヒドロ
キシベンゾトリアゾール水和物0.11g(0.70ミ
リモル)をアセトニトリル10ml中で撹拌しながら1
-エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩0.13g(0.70ミリモル)を加え、
室温で一晩撹拌した。反応液を酢酸エチルに希釈し、炭
酸水素ナトリウム水溶液で洗浄、無水硫酸マグネシウム
で乾燥、シリカゲルを通した後、溶媒を減圧留去した。
得られた残留物を酢酸エチル−ヘキサンより結晶化し
て、目的物を得た。白色アモルファス粉末 収量0.3
63g 収率87%1 H-NMR (CDCl3, 200MHz) δ 2.82-2.99 (2H, m), 3.32-
3.51 (4H, m), 3.56 (1H, d, J = 3.6 Hz), 4.54-4.68
(1H, m), 5.06 (1H, t, J = 3.1 Hz), 6.12 (1H,d, J =
8.4 Hz), 7.08 (2H, t, J = 8.6 Hz), 7.22-7.35 (6H,
m), 7.38-7.57(7H, m), 7.64 (2H, d, J = 8.4 Hz); I
R (KBr) 3241, 1640, 1624, 1541, 1510, 1325, 1223,
1161, 1119, 1067, 829 cm-1; Anal. Calcd for C32H27
F4NO2S2:C, 64.31; H, 4.55; N, 2.34. Found: C, 64.2
0; H, 4.44; N, 2.60.Example 94 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -4- (2-phenyl-1,3-dithiolane-
2-yl) benzenecarboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.218 g (0.696 mmol) ), 4- (2-phenyl-1,3-dithiolan-2-yl)
0.21 g (0.70 mmol) of benzoic acid and 0.11 g (0.70 mmol) of 1-hydroxybenzotriazole hydrate were added to 10 ml of acetonitrile while stirring.
0.13 g (0.70 mmol) of -ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added,
Stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure.
The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White amorphous powder Yield 0.3
63 g Yield 87% 1 H-NMR (CDCl 3 , 200 MHz) δ 2.82-2.99 (2H, m), 3.32-
3.51 (4H, m), 3.56 (1H, d, J = 3.6 Hz), 4.54-4.68
(1H, m), 5.06 (1H, t, J = 3.1 Hz), 6.12 (1H, d, J =
8.4 Hz), 7.08 (2H, t, J = 8.6 Hz), 7.22-7.35 (6H,
m), 7.38-7.57 (7H, m), 7.64 (2H, d, J = 8.4 Hz); I
R (KBr) 3241, 1640, 1624, 1541, 1510, 1325, 1223,
1161, 1119, 1067, 829 cm -1 ; Anal.Calcd for C 32 H 27
F 4 NO 2 S 2 : C, 64.31; H, 4.55; N, 2.34. Found: C, 64.2
0; H, 4.44; N, 2.60.
【0227】実施例95 5-(4-フルオロフェニル)-N-[(1RS,2SR)
-2-(4-フルオロフェニル)-2-ヒドロキシ-1-[4-
(トリフルオロメチル)ベンジル]エチル]-2-メチル
フラン-3-カルボキサミド 1) 5-(4-フルオロフェニル)-2-メチル-3-フラ
ンカルボン酸メチル 1,8-ジアザビシクロ[5.4.0]-7-ウンデセン
44.2g(290ミリモル)のトルエン250ml溶
液に室温でアセト酢酸メチル33.7g(290ミリモ
ル)を加え、引き続き2-クロロ-4’-フルオロアセト
フェノン50.08g(290.2ミリモル)を加え、
室温で1時間撹拌した。得られたトルエン溶液を水で3
回洗浄し後、p-トルエンスルホン酸一水和物5gを加
え、ディーン-スタークトラップを取り付けた反応容器
中で脱水条件で1時間加熱還流した。反応液を室温まで
冷却し、水で洗浄、無水硫酸マグネシウムで乾燥後、溶
媒を減圧留去した。得られた粗生成物をシリカゲルカラ
ムクロマトグラフィーにて精製し(ヘキサン/酢酸エチ
ル=20/1−9/1)、冷メタノールより結晶化し
て、目的物を得た。黄色結晶 収量31.26g 収率
46% mp 96-97℃; 1H-NMR (CDCl3, 200MHz) δ 2.64 (3H,
s), 3.85 (3H, s), 6.81 (1H, s), 7.08 (2H, t, J =
8.8 Hz), 7.60 (2H, dd, J = 5.4 Hz, 9.0 Hz); IR(KB
r) 1705, 1501, 1449, 1233, 1105, 1044, 843, 829, 7
79 cm-1; Anal. Calcd for C13H11FO3: C, 66.66; H,
4.73. Found: C, 66.63; H, 4.56. 2) 5-(4-フルオロフェニル)-2-メチル-3-フラ
ンカルボン酸 5-(4-フルオロフェニル)-2-メチル-3-フランカル
ボン酸メチル15.36g(65.58ミリモル)と水
酸化ナトリウム5.25g(131ミリモル)をメタノ
ール100ml−水50ml中で、室温にて一晩撹拌し
た。反応液を濃縮、水で希釈し、濃塩酸で反応液を酸性
にした後、酢酸エチルで3回抽出した。集めた有機層を
無水硫酸ナトリウムで乾燥、溶媒を減圧留去した。残留
物を酢酸エチル−ヘキサンより結晶化して、目的物を得
た。淡黄色結晶 収量13.42g 収率93% mp 217-218℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
65 (3H, s), 6.83 (1H,s), 7.07 (2H, t, J = 8.6 Hz),
7.60 (2H, dd, J = 5.0 Hz, 8.8 Hz); IR (KBr) 3100-
2500, 1694, 1505, 1474, 1233, 774 cm-1; Anal. Calc
d for C12H9FO3:C, 65.46; H, 4.12. Found: C, 65.50;
H, 4.15. 3) 5-(4-フルオロフェニル)-N-[(1RS,2
SR)-2-(4-フルオロフェニル)-2-ヒドロキシ-1
-[4-(トリフルオロメチル)ベンジル]エチル]-2-
メチルフラン-3-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.219g(0.699ミリモ
ル)、5-(4-フルオロフェニル)-2-メチル-3-フラ
ンカルボン酸0.15g(0.70ミリモル)、1-ヒ
ドロキシベンゾトリアゾール水和物0.11g(0.7
0ミリモル)をアセトニトリル10ml中で撹拌しなが
ら1-エチル-3-(3-ジメチルアミノプロピル)カルボ
ジイミド・塩酸塩0.13g(0.70ミリモル)を加
え、室温で一晩撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物を酢酸エチル−ヘキサンより結晶
化して、目的物を得た。白色粉末 収量0.273g
収率76% mp 179-181℃; 1H-NMR (CDCl3, 200MHz) δ 2.52 (3H,
s), 2.76-2.99 (2H, m),3.73 (1H, d, J = 3.6 Hz), 4.
51-4.66 (1H, m), 5.08 (1H, t, J = 3.3 Hz),5.74 (1
H, d, J = 8.2 Hz), 6.35 (1H, s), 7.03-7.15 (4H,
m), 7.24 (2H, d,J = 8.0 Hz), 7.43 (2H, dd, J = 5.4
Hz, 8.8 Hz), 7.49-7.58 (4H, m); IR (KBr) 3266, 16
40, 1510, 1501, 1327, 1233, 1165, 1123, 1069, 837
cm-1 Example 95 5- (4-fluorophenyl) -N-[(1RS, 2SR)
-2- (4-Fluorophenyl) -2-hydroxy-1- [4-
(Trifluoromethyl) benzyl] ethyl] -2-methylfuran-3-carboxamide 1) methyl 5- (4-fluorophenyl) -2-methyl-3-furancarboxylate 1,8-diazabicyclo [5.4.0] ] To a solution of 44.2 g (290 mmol) of 7-undecene in 250 ml of toluene was added 33.7 g (290 mmol) of methyl acetoacetate at room temperature, followed by 50.08 g (290.2 mmol) of 2-chloro-4'-fluoroacetophenone. )
Stirred at room temperature for 1 hour. The obtained toluene solution is washed with water
After washing twice, 5 g of p-toluenesulfonic acid monohydrate was added, and the mixture was heated under reflux for 1 hour under dehydration conditions in a reaction vessel equipped with a Dean-Stark trap. The reaction solution was cooled to room temperature, washed with water, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 20 / 1-9 / 1), and crystallized from cold methanol to obtain the desired product. Yellow crystal Yield 31.26 g Yield 46% mp 96-97 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.64 (3H,
s), 3.85 (3H, s), 6.81 (1H, s), 7.08 (2H, t, J =
8.8 Hz), 7.60 (2H, dd, J = 5.4 Hz, 9.0 Hz); IR (KB
r) 1705, 1501, 1449, 1233, 1105, 1044, 843, 829, 7
79 cm -1 ; Anal.Calcd for C 13 H 11 FO 3 : C, 66.66; H,
4.73. Found: C, 66.63; H, 4.56.2) 5- (4-fluorophenyl) -2-methyl-3-furancarboxylic acid 5- (4-fluorophenyl) -2-methyl-3-furancarboxylic acid 15.36 g (65.58 mmol) of methyl and 5.25 g (131 mmol) of sodium hydroxide were stirred in 100 ml of methanol-50 ml of water at room temperature overnight. The reaction mixture was concentrated, diluted with water, acidified with concentrated hydrochloric acid, and extracted three times with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from ethyl acetate-hexane to obtain the desired product. Pale yellow crystal yield 13.42 g yield 93% mp 217-218 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
65 (3H, s), 6.83 (1H, s), 7.07 (2H, t, J = 8.6 Hz),
7.60 (2H, dd, J = 5.0 Hz, 8.8 Hz); IR (KBr) 3100-
2500, 1694, 1505, 1474, 1233, 774 cm -1 ; Anal.Calc
d for C 12 H 9 FO 3 : C, 65.46; H, 4.12. Found: C, 65.50;
H, 4.15.3) 5- (4-fluorophenyl) -N-[(1RS, 2
SR) -2- (4-Fluorophenyl) -2-hydroxy-1
-[4- (Trifluoromethyl) benzyl] ethyl] -2-
Methylfuran-3-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.219 g (0.699 mmol ), 5- (4-fluorophenyl) -2-methyl-3-furancarboxylic acid 0.15 g (0.70 mmol), 1-hydroxybenzotriazole hydrate 0.11 g (0.7
(0 mmol) was stirred in 10 ml of acetonitrile, and 0.13 g (0.70 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added thereto, followed by stirring at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. 0.273 g of white powder
Yield 76% mp 179-181 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.52 (3H,
s), 2.76-2.99 (2H, m), 3.73 (1H, d, J = 3.6 Hz), 4.
51-4.66 (1H, m), 5.08 (1H, t, J = 3.3 Hz), 5.74 (1
H, d, J = 8.2 Hz), 6.35 (1H, s), 7.03-7.15 (4H,
m), 7.24 (2H, d, J = 8.0 Hz), 7.43 (2H, dd, J = 5.4
Hz, 8.8 Hz), 7.49-7.58 (4H, m); IR (KBr) 3266, 16
40, 1510, 1501, 1327, 1233, 1165, 1123, 1069, 837
cm -1
【0228】実施例96 4-[(Z)-2-(2-クロロフェニル)エテニル]-N-
[(1RS,2SR)-2-(4-フルオロフェニル)-2
-ヒドロキシ-1-[4-(トリフルオロメチル)ベンジ
ル]エチル]ベンゼンカルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.208g(0.664ミリモ
ル)、(Z)-4-[2-(2-クロロフェニル)エテニ
ル]安息香酸0.17g(0.66ミリモル)、1-ヒ
ドロキシベンゾトリアゾール水和物0.10g(0.6
6ミリモル)をアセトニトリル10ml中で撹拌しなが
ら1-エチル-3-(3-ジメチルアミノプロピル)カルボ
ジイミド・塩酸塩0.13g(0.66ミリモル)を加
え、室温で一晩撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物を酢酸エチル−ヘキサンより結晶
化して、目的物を得た。白色粉末 収量0.312g
収率85% mp 153-154℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
81-2.97 (2H, m), 3.60(1H, d, J = 3.4 Hz), 4.51-4.6
4 (1H, m), 5.06 (1H, s), 6.09 (1H, d, J = 8.4 Hz),
6.68 (1H, d, J = 12.2 Hz), 6.78 (1H, d, J = 12.4
Hz), 6.99-7.26(9H, m), 7.36-7.50 (7H, m); IR (KBr)
3291, 1638, 1539, 1514, 1325, 1231,1165, 1119, 10
69 cm-1; Anal. Calcd for C31H24ClF4NO2: C, 67.21;
H, 4.37; N, 2.53. Found: C, 66.90; H, 4.01; N, 2.3
9.Example 96 4-[(Z) -2- (2-chlorophenyl) ethenyl] -N-
[(1RS, 2SR) -2- (4-fluorophenyl) -2
-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] benzenecarboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] 0.208 g (0.664 mmol) of propan-1-ol, 0.17 g (0.66 mmol) of (Z) -4- [2- (2-chlorophenyl) ethenyl] benzoic acid, 1-hydroxybenzotriazole hydrate 0.10g (0.6
(6 mmol) was stirred in 10 ml of acetonitrile, and 0.13 g (0.66 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added thereto, followed by stirring at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. 0.312 g of white powder
Yield 85% mp 153-154 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200MHz) δ 2.
81-2.97 (2H, m), 3.60 (1H, d, J = 3.4 Hz), 4.51-4.6
4 (1H, m), 5.06 (1H, s), 6.09 (1H, d, J = 8.4 Hz),
6.68 (1H, d, J = 12.2 Hz), 6.78 (1H, d, J = 12.4
Hz), 6.99-7.26 (9H, m), 7.36-7.50 (7H, m); IR (KBr)
3291, 1638, 1539, 1514, 1325, 1231,1165, 1119, 10
69 cm -1 ; Anal.Calcd for C 31 H 24 ClF 4 NO 2 : C, 67.21;
H, 4.37; N, 2.53. Found: C, 66.90; H, 4.01; N, 2.3
9.
【0229】実施例97 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-2-[(フェニルチオ)メチル]ナフタ
レン-1-カルボキサミド 1) 2-メチル-1-ナフトエ酸メチル 2-メチル-1-ナフトエ酸7.579g(40.70ミ
リモル)とN,N-ジメチルホルムアミド3滴のテトラ
ヒドロフラン40ml溶液に、塩化オキザリル7.10
ml(81.4ミリモル)を室温で滴下し、0.5時間
撹拌した。反応液の溶媒を減圧留去し、酸クロリドの粗
生成物を液体として得た。メタノール2.47ml(6
1.1ミリモル)、4-N,N-ジメチルアミノピリジン
0.50g(4.07ミリモル)、トリエチルアミン
8.51ml(61.1ミリモル)のアセトニトリル5
0ml溶液に、氷冷下、上で得た液体をアセトニトリル
20mlに溶解したものを滴下し、室温で一晩撹拌し
た。反応液を水に注ぎ、酢酸エチルで2回抽出した。集
めた有機層を無水硫酸マグネシウムで乾燥、溶媒を減圧
留去した。得られた残留物を、シリカゲルカラムクロマ
トグラフィーにて精製して(ヘキサン/酢酸エチル=6
/1)、目的物を得た。淡黄色液体 収量7.866g
収率97%1 H-NMR (CDCl3, 200MHz) δ 2.51 (3H, s), 4.04 (3H,
s), 7.32 (1H, d, J = 8.4 Hz), 7.41-7.55 (2H, m),
7.77-7.83 (3H, m); IR (neat) 1728, 1435, 1281, 124
4, 1219, 1138, 1051, 814 cm-1 2) 2-[(フェニルチオ)メチル]-1-ナフトエ酸
メチル 2-メチル-1-ナフトエ酸メチル1.277g(6.3
77ミリモル)、N-ブロモスクシンイミド1.14g
(6.38ミリモル)、2,2’-アゾビス(イソブチ
ロニトリル)10mgの四塩化炭素10ml溶液を0.
5時間加熱還流した。反応液を室温に冷却した後、白色
沈殿を濾過して除き、沈殿をジエチルエーテルで洗浄し
た。集めた濾液の溶媒を減圧留去して、2-ブロモメチ
ル-1-ナフトエ酸メチルの粗生成物を淡黄色液体として
得た。得られた液体をチオフェノール0.84g(7.
65ミリモル)、1,8-ジアザビシクロ[5.4.
0]-7-ウンデセン1.14ml(7.65ミリモル)
とともにアセトニトリル20ml中で室温にて一晩撹拌
した。反応液の溶媒を減圧留去し、得られた粗生成物を
シリカゲルカラムクロマトグラフィーにて精製し(ヘキ
サン/酢酸エチル=20/1−9/1)、目的物を得
た。黄色液体 収量1.606g 収率82%1 H-NMR (CDCl3, 200MHz) δ 3.99 (3H, s), 4.32 (2H,
s), 7.14-7.35 (5H, m),7.40-7.56 (3H, m), 7.79-7.88
(3H, m); IR (neat) 1723, 1437, 1287, 1252,1233, 1
209, 1140, 1036, 747 cm-1 3) 2-[(フェニルチオ)メチル]-1-ナフトエ酸 2-[(フェニルチオ)メチル]-1-ナフトエ酸メチル
1.477g(4.789ミリモル)と水酸化ナトリウ
ム2.50g(62.5ミリモル)をメタノール30m
l−テトラヒドロフラン20ml中で、6時間加熱還流
した。反応液を濃縮した後、水で希釈し、濃塩酸で反応
液を酸性にした後、酢酸エチルで2回抽出した。集めた
有機層を無水硫酸ナトリウムで乾燥、溶媒を減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィーにて
精製し(ヘキサン/酢酸エチル=3/1−1/1)、ジ
エチルエーテル−ヘキサンより結晶化して、目的物を得
た。淡黄色結晶 収量0.880g 収率62% mp 100-101℃; 1H-NMR (CDCl3, 200MHz) δ 4.47 (2H,
s), 7.16-7.58 (8H, m),7.81-7.87 (2H, m), 8.13-8.18
(1H, m); IR (KBr) 3100-2600, 1680, 1283, 1262, 75
6, 733 cm-1; Anal. Calcd for C18H14O2S: C, 73.44;
H, 4.79. Found:C, 73.17; H, 4.81. 4) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[4-(トリフルオロメチ
ル)ベンジル]エチル]-2-[(フェニルチオ)メチ
ル]ナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.260g(0.830ミリモ
ル)、2-[(フェニルチオ)メチル]-1-ナフトエ酸
0.24g(0.83ミリモル)、1-ヒドロキシベン
ゾトリアゾール水和物0.13g(0.83ミリモル)
をアセトニトリル10ml中で撹拌しながら1-エチル-
3-(3-ジメチルアミノプロピル)カルボジイミド・塩
酸塩0.16g(0.83ミリモル)を加え、80℃で
一晩撹拌した。反応液を酢酸エチルに希釈し、炭酸水素
ナトリウム水溶液で洗浄、無水硫酸マグネシウムで乾
燥、溶媒を減圧留去した。得られた粗生成物をシリカゲ
ルカラムクロマトグラフィーにて精製し(ヘキサン/酢
酸エチル=3/1−1/1)、酢酸エチル−ヘキサンよ
り結晶化して、目的物を得た。白色粉末 収量0.33
7g 収率69% mp 102-104℃; 1H-NMR (CDCl3, 200MHz) δ 2.65-2.91
(2H, m), 3.05 (1H, d,J = 4.0 Hz), 3.97-4.17 (1H,
m), 4.35 (1H, br s), 4.92-5.04 (1H, m), 5.14(1H,
s), 6.21 (1H, d, J = 8.6 Hz), 6.70 (1H, br s), 7.0
3-7.55 (16H, m),7.73 (2H, d, J = 8.6 Hz); IR (KBr)
3212, 3056, 1628, 1512, 1329, 1227,1165, 1117, 10
69, 762 cm-1; Anal. Calcd for C34H27F4NO2S: C, 69.
26; H, 4.62; N, 2.38. Found: C, 69.45; H, 4.93; N,
2.22.Example 97 N-[(1RS, 2SR) -2- (4-fluorophenyl)
2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -2-[(phenylthio) methyl] naphthalene-1-carboxamide 1) Methyl 2-methyl-1-naphthoate 2-methyl-1- Oxalyl chloride 7.10 was added to a solution of 7.579 g (40.70 mmol) of naphthoic acid and 3 drops of N, N-dimethylformamide in 40 ml of tetrahydrofuran.
ml (81.4 mmol) was added dropwise at room temperature and stirred for 0.5 hour. The solvent of the reaction solution was distilled off under reduced pressure to obtain a crude acid chloride product as a liquid. 2.47 ml of methanol (6
1.1 mmol), 0.50 g (4.07 mmol) of 4-N, N-dimethylaminopyridine, 8.51 ml (61.1 mmol) of triethylamine in acetonitrile 5
A solution obtained by dissolving the liquid obtained above in 20 ml of acetonitrile was added dropwise to the 0 ml solution under ice cooling, and the mixture was stirred overnight at room temperature. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 6).
/ 1) to obtain the desired product. 7.866 g of pale yellow liquid yield
Yield 97% 1 H-NMR (CDCl 3 , 200 MHz) δ 2.51 (3H, s), 4.04 (3H,
s), 7.32 (1H, d, J = 8.4 Hz), 7.41-7.55 (2H, m),
7.77-7.83 (3H, m); IR (neat) 1728, 1435, 1281, 124
4, 1219, 1138, 1051, 814 cm -1 2) Methyl 2-[(phenylthio) methyl] -1-naphthoate 1.277 g of methyl 2-methyl-1-naphthoate (6.3 g)
77 mmol), 1.14 g of N-bromosuccinimide
(6.38 mmol), 10 mg of a solution of 2,2′-azobis (isobutyronitrile) in 10 ml of carbon tetrachloride.
The mixture was refluxed for 5 hours. After cooling the reaction solution to room temperature, a white precipitate was removed by filtration, and the precipitate was washed with diethyl ether. The solvent of the collected filtrate was distilled off under reduced pressure to obtain a crude product of methyl 2-bromomethyl-1-naphthoate as a pale yellow liquid. 0.84 g of thiophenol (7.
65 mmol), 1,8-diazabicyclo [5.4.
0] -7-undecene 1.14 ml (7.65 mmol)
And stirred in 20 ml of acetonitrile at room temperature overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 20 / 1-9 / 1) to obtain the desired product. Yellow liquid Yield 1.606 g Yield 82% 1 H-NMR (CDCl 3 , 200 MHz) δ 3.99 (3H, s), 4.32 (2H,
s), 7.14-7.35 (5H, m), 7.40-7.56 (3H, m), 7.79-7.88
(3H, m); IR (neat) 1723, 1437, 1287, 1252,1233, 1
209, 1140, 1036, 747 cm -1 3) 2 - [( phenylthio) methyl] -1-naphthoic acid 2 - [(phenylthio) methyl] -1-methyl-naphthoic acid 1.477g (4.789 mmol) and water 2.50 g (62.5 mmol) of sodium oxide was added to 30 m of methanol.
The mixture was heated under reflux in 20 ml of 1-tetrahydrofuran for 6 hours. The reaction solution was concentrated, diluted with water, acidified with concentrated hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from diethyl ether-hexane to obtain the desired product. Pale yellow crystal yield 0.880 g yield 62% mp 100-101 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 4.47 (2H,
s), 7.16-7.58 (8H, m), 7.81-7.87 (2H, m), 8.13-8.18
(1H, m); IR (KBr) 3100-2600, 1680, 1283, 1262, 75
6, 733 cm -1 ; Anal.Calcd for C 18 H 14 O 2 S: C, 73.44;
H, 4.79. Found: C, 73.17; H, 4.81. 4) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] Ethyl] -2-[(phenylthio) methyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propane-1 0.20 g (0.830 mmol) of 2-ol (0.24 g (0.83 mmol) of 2-[(phenylthio) methyl] -1-naphthoic acid) 0.13 g (0.83 mmol) of 1-hydroxybenzotriazole hydrate Mmol)
Was stirred in 10 ml of acetonitrile while stirring in 1-ethyl-
0.16 g (0.83 mmol) of 3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at 80 ° C. overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from ethyl acetate-hexane to obtain the desired product. White powder Yield 0.33
7g Yield 69% mp 102-104 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 2.65-2.91
(2H, m), 3.05 (1H, d, J = 4.0 Hz), 3.97-4.17 (1H,
m), 4.35 (1H, br s), 4.92-5.04 (1H, m), 5.14 (1H,
s), 6.21 (1H, d, J = 8.6 Hz), 6.70 (1H, br s), 7.0
3-7.55 (16H, m), 7.73 (2H, d, J = 8.6 Hz); IR (KBr)
3212, 3056, 1628, 1512, 1329, 1227,1165, 1117, 10
. 69, 762 cm -1; Anal Calcd for C 34 H 27 F 4 NO 2 S: C, 69.
26; H, 4.62; N, 2.38. Found: C, 69.45; H, 4.93; N,
2.22.
【0230】実施例98 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-1-メチル-1H-インドール-3-カルボ
キサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.172g(0.549ミリモ
ル)、1-メチルインドール-3-カルボン酸0.10g
(0.55ミリモル)、1-ヒドロキシベンゾトリアゾ
ール水和物84mg(0.55ミリモル)をアセトニト
リル10ml中で撹拌しながら1-エチル-3-(3-ジメ
チルアミノプロピル)カルボジイミド・塩酸塩0.11
g(0.55ミリモル)を加え、室温で一晩撹拌した。
反応液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶
液で洗浄、無水硫酸マグネシウムで乾燥後、溶媒を減圧
留去した。得られた残留物をシリカゲルカラムクロマト
グラフィーにて精製し(ヘキサン/酢酸エチル=2/1
−1/1)、ジエチルエーテル−ヘキサンより結晶化し
て、目的物を得た。白色結晶 収量0.183g 収率
71% mp 129-131℃; 1H-NMR (CDCl3, 200MHz) δ 2.91 (1H,
dd, J = 9.5 Hz, 13.9 Hz), 3.01 (1H, dd, J = 5.2 H
z, 14.8 Hz), 3.76 (3H, s), 4.58-4.71 (1H, m),4.73
(1H, br s), 5.10 (1H, br s), 5.89 (1H, d, J = 7.8
Hz), 7.05 (2H, t, J = 8.8 Hz), 7.11-7.19 (1H, m),
7.23-7.30 (4H, m), 7.36-7.51 (6H, m);IR (KBr) 332
8, 1624, 1545, 1508, 1325, 1229, 1163, 1128, 1067,
747 cm-1;Anal. Calcd for C26H22F4N2O2: C, 66.38;
H, 4.71; N, 5.95. Found: C, 66.27; H, 4.71; N, 5.8
2.Example 98 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -1-methyl-1H-indole-3-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl)- 0.172 g (0.549 mmol) of 3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.10 g of 1-methylindole-3-carboxylic acid
(0.55 mmol) 1-Hydroxybenzotriazole hydrate 84 mg (0.55 mmol) in 10 ml of acetonitrile while stirring 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 0.11.
g (0.55 mmol) was added and stirred at room temperature overnight.
The reaction solution was diluted with ethyl acetate, washed with an aqueous solution of sodium hydrogen carbonate, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 2/1).
-1/1) and crystallized from diethyl ether-hexane to obtain the desired product. White crystals Yield 0.183 g Yield 71% mp 129-131 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.91 (1H,
dd, J = 9.5 Hz, 13.9 Hz), 3.01 (1H, dd, J = 5.2 H
z, 14.8 Hz), 3.76 (3H, s), 4.58-4.71 (1H, m), 4.73
(1H, br s), 5.10 (1H, br s), 5.89 (1H, d, J = 7.8
Hz), 7.05 (2H, t, J = 8.8 Hz), 7.11-7.19 (1H, m),
7.23-7.30 (4H, m), 7.36-7.51 (6H, m); IR (KBr) 332
8, 1624, 1545, 1508, 1325, 1229, 1163, 1128, 1067,
747 cm -1 ; Anal.Calcd for C 26 H 22 F 4 N 2 O 2 : C, 66.38;
H, 4.71; N, 5.95. Found: C, 66.27; H, 4.71; N, 5.8
2.
【0231】実施例99 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-5-フェニルペンタンアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)のア
セトニトリル(30ml)溶液に5-フェニルペンタン
酸(257mg,1.44ミリモル)および1-エチル-
3-(3-ジメチルアミノプロピル)カルボジイミド・塩
酸塩(413mg,2.15ミリモル)および1-ヒド
ロキシ-1H-ベンゾトリアゾール(220mg,1.4
4ミリモル)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=1:1)で精製し、酢酸エチル−ヘキサンから再結晶
させて、表題化合物(471mg,69%)を得た。 mp 152-153℃ IRνmaxKBrcm-1: 1647, 1549, 1512. Anal. Calcd for C27H27F4NO2: C, 68.49; H, 5.75; N,
2.96 Found: C, 68.39; H, 5.52; N, 2.78.1 H-NMR (CDCl3)δ: 1.40-1.56 (4H, m), 2.00-2.16 (2
H, m), 2.48-2.64 (2H, m), 2.64-2.94 (2H, m), 3.52
(1H, d, J = 3.8 Hz), 4.32-4.50 (1H, m), 4.90-5.00
(1H, m), 5.36 (1H, d, J = 8.4 Hz), 7.00-7.56 (13H,
m).Example 99 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -5-phenylpentanamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- ( 4- (trifluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.44 mmol) in acetonitrile (30 ml) was added 5-phenylpentanoic acid (257 mg, 1.44 mmol) and 1-ethyl-.
3- (3-dimethylaminopropyl) carbodiimide hydrochloride (413 mg, 2.15 mmol) and 1-hydroxy-1H-benzotriazole (220 mg, 1.4)
4 mmol) and stirred overnight at room temperature. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1), and recrystallized from ethyl acetate-hexane to give the title compound (471 mg, 69%). mp 152-153 ℃ IRνmax KBr cm -1 : 1647, 1549, 1512. Anal.Calcd for C 27 H 27 F 4 NO 2 : C, 68.49; H, 5.75; N,
2.96 Found:. C, 68.39; H, 5.52; N, 2.78 1 H-NMR (CDCl 3) δ: 1.40-1.56 (4H, m), 2.00-2.16 (2
H, m), 2.48-2.64 (2H, m), 2.64-2.94 (2H, m), 3.52
(1H, d, J = 3.8 Hz), 4.32-4.50 (1H, m), 4.90-5.00
(1H, m), 5.36 (1H, d, J = 8.4 Hz), 7.00-7.56 (13H,
m).
【0232】実施例100 1,1-ジメチルエチル(1S)-2-(((1RS,2
SR)-2-(4-フルオロフェニル)-2-ヒドロキシ-1
-((4-(トリフルオロメチル)フェニル)メチル)エ
チル)アミノ)-2-オキソ-1-(フェニルメチル)エチ
ルカルバメート (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)のア
セトニトリル(30ml)溶液にN-t-ブチルオキシカ
ルボニル-L-フェニルアラニン(382mg,1.44
ミリモル)および1-エチル-3-(3-ジメチルアミノプ
ロピル)カルボジイミド・塩酸塩(413mg,2.1
5ミリモル)および1-ヒドロキシ-1H-ベンゾトリア
ゾール(220mg,1.44ミリモル)を加えて室温
で終夜攪拌した。反応液を水(100ml)で希釈し、
酢酸エチル(100ml×2)で抽出した。抽出液を飽
和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減圧
留去した。残留物をシリカゲルカラムクロマトグラフィ
ー(酢酸エチル)で精製し、酢酸エチル−ヘキサンから
再結晶させて、表題化合物(315mg,39%)を得
た。 mp 230-231℃ IRνmaxKBrcm-1: 1678, 1659, 1524.1 H-NMR (CDCl3)δ: 1.36 (9H, s), 2.60-2.90 (4H, m),
3.78-3.90 (4H, m), 4.10-4.40 (2H, m), 4.60-4.68
(1H, m), 5.50 (1H, d, J = 8.8 Hz), 6.96-7.50(13H,
m).Example 100 1,1-Dimethylethyl (1S) -2-(((1RS, 2
SR) -2- (4-Fluorophenyl) -2-hydroxy-1
-((4- (trifluoromethyl) phenyl) methyl) ethyl) amino) -2-oxo-1- (phenylmethyl) ethyl carbamate (1RS, 2SR) -2-amino-1- (4-fluorophenyl)- 3- (4- (trifluoromethyl) phenyl) -1
N-tert-butyloxycarbonyl-L-phenylalanine (382 mg, 1.44) was added to a solution of -propanol (450 mg, 1.44 mmol) in acetonitrile (30 ml).
Mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (413 mg, 2.1
5 mmol) and 1-hydroxy-1H-benzotriazole (220 mg, 1.44 mmol) were added and stirred at room temperature overnight. Dilute the reaction with water (100 ml)
Extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to give the title compound (315 mg, 39%). mp 230-231 ℃ IRνmax KBr cm -1: 1678, 1659, 1524. 1 H-NMR (CDCl 3) δ: 1.36 (9H, s), 2.60-2.90 (4H, m),
3.78-3.90 (4H, m), 4.10-4.40 (2H, m), 4.60-4.68
(1H, m), 5.50 (1H, d, J = 8.8 Hz), 6.96-7.50 (13H,
m).
【0233】実施例101 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-4-メトキシナフタレン-1-カルボキサ
ミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.174g(0.555ミリモ
ル)、4-メトキシ-1-ナフトエ酸0.11g(0.5
6ミリモル)、1-ヒドロキシベンゾトリアゾール水和
物85mg(0.56ミリモル)をアセトニトリル10
ml中で撹拌しながら1-エチル-3-(3-ジメチルアミ
ノプロピル)カルボジイミド・塩酸塩0.11g(0.
56ミリモル)を加え、室温で一晩撹拌した。反応液を
酢酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗
浄、無水硫酸マグネシウムで乾燥、シリカゲルを通した
後、溶媒を減圧留去した。得られた残留物を酢酸エチル
−ヘキサンより結晶化して、目的物を得た。白色結晶
収量0.209g 収率76% mp 227-228℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
88-3.20 (2H, m), 4.00(3H, s), 4.60-4.75 (1H, m),
4.93 (1H, t, J = 4.2 Hz), 5.49 (1H, d, J = 3.6 H
z), 6.72 (1H, d, J = 8.0 Hz), 7.03-7.19 (3H, m),
7.29-7.71 (10H, m),8.19 (1H, d, J = 7.8 Hz); IR (K
Br) 3281, 1636, 1588, 1530, 1512, 1327,1265, 1167,
1125, 1069, 839 cm-1; Anal. Calcd for C28H23F4N
O3: C, 67.60;H, 4.66; N, 2.82. Found: C, 67.58; H,
4.83; N, 2.73.Example 101 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -4-methoxynaphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [ 4- (trifluoromethyl) phenyl] propan-1-ol 0.174 g (0.555 mmol), 4-methoxy-1-naphthoic acid 0.11 g (0.5
6 mmol) of 1-hydroxybenzotriazole hydrate (85 mg, 0.56 mmol) in acetonitrile 10
While stirring in 0.1 ml, 0.11 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.
56 mmol) and stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals
Yield 0.209 g Yield 76% mp 227-228 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
88-3.20 (2H, m), 4.00 (3H, s), 4.60-4.75 (1H, m),
4.93 (1H, t, J = 4.2 Hz), 5.49 (1H, d, J = 3.6 H
z), 6.72 (1H, d, J = 8.0 Hz), 7.03-7.19 (3H, m),
7.29-7.71 (10H, m), 8.19 (1H, d, J = 7.8 Hz); IR (K
Br) 3281, 1636, 1588, 1530, 1512, 1327,1265, 1167,
1125, 1069, 839 cm -1 ; Anal.Calcd for C 28 H 23 F 4 N
O 3 : C, 67.60; H, 4.66; N, 2.82. Found: C, 67.58; H,
4.83; N, 2.73.
【0234】実施例102 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-3-ニトロナフタレン-1-カルボキサミ
ド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.174g(0.555ミリモ
ル)、3-ニトロ-1-ナフトエ酸0.12g(0.56
ミリモル)、1-ヒドロキシベンゾトリアゾール水和物
85mg(0.56ミリモル)をアセトニトリル10m
l中で撹拌しながら1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド・塩酸塩0.11g(0.5
6ミリモル)を加え、室温で一晩撹拌した。反応液を酢
酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗浄、
無水硫酸マグネシウムで乾燥、シリカゲルを通した後、
溶媒を減圧留去した。得られた残留物を酢酸エチル−ヘ
キサンより結晶化して、目的物を得た。淡黄色結晶 収
量0.239g 収率84% mp 231-232℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
92 (1H, dd, J = 11.4 Hz, 14.0 Hz), 3.20 (1H, dd, J
= 3.6 Hz, 13.0 Hz), 4.65-4.79 (1H, m), 4.94(1H,
t, J = 4.5 Hz), 5.53 (1H, d, J = 4.4 Hz), 7.10 (2
H, t, J = 8.6 Hz), 7.36-7.66 (9H, m), 7.95 (1H, d,
J = 2.6 Hz), 8.03 (1H, d, J = 8.0 Hz),8.18 (1H,
d, J = 9.2 Hz), 8.78 (1H, d, J = 2.2 Hz); IR (KBr)
3283, 1642, 1537, 1327, 1123, 1169, 835 cm-1; Ana
l. Calcd for C27H20F4N2O4: C, 63.28; H, 3.93; N,
5.47. Found: C, 63.23; H, 3.65; N, 5.73.Example 102 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -3-nitronaphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [ 4- (trifluoromethyl) phenyl] propan-1-ol 0.174 g (0.555 mmol), 3-nitro-1-naphthoic acid 0.12 g (0.56 g)
Mmol) 1-hydroxybenzotriazole hydrate (85 mg, 0.56 mmol) in acetonitrile 10m
1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 0.11 g (0.5
6 mmol) and stirred at room temperature overnight. Dilute the reaction solution with ethyl acetate and wash with aqueous sodium hydrogen carbonate,
After drying over anhydrous magnesium sulfate and passing through silica gel,
The solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. Light yellow crystal Yield 0.239 g Yield 84% mp 231-232 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
92 (1H, dd, J = 11.4 Hz, 14.0 Hz), 3.20 (1H, dd, J
= 3.6 Hz, 13.0 Hz), 4.65-4.79 (1H, m), 4.94 (1H,
t, J = 4.5 Hz), 5.53 (1H, d, J = 4.4 Hz), 7.10 (2
H, t, J = 8.6 Hz), 7.36-7.66 (9H, m), 7.95 (1H, d,
J = 2.6 Hz), 8.03 (1H, d, J = 8.0 Hz), 8.18 (1H,
d, J = 9.2 Hz), 8.78 (1H, d, J = 2.2 Hz); IR (KBr)
3283, 1642, 1537, 1327, 1123, 1169, 835 cm -1 ; Ana
. l Calcd for C 27 H 20 F 4 N 2 O 4: C, 63.28; H, 3.93; N,
5.47. Found: C, 63.23; H, 3.65; N, 5.73.
【0235】実施例103 4-[[[(1RS,2SR)-2-(4-フルオロフェニ
ル)-2-ヒドロキシ-1-[4-(トリフルオロメチル)
ベンジル]エチル]アミノ]カルボニル]-1-ナフトエ
酸メチル (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.287g(0.916ミリモ
ル)、4-(メトキシカルボニル)-1-ナフトエ酸0.
21g(0.92ミリモル)、1-ヒドロキシベンゾト
リアゾール水和物0.14g(0.92ミリモル)をア
セトニトリル10ml中で撹拌しながら1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩0.18g(0.92ミリモル)を加え、室温で一晩
撹拌した。反応液を酢酸エチルに希釈し、炭酸水素ナト
リウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、シ
リカゲルを通した後、溶媒を減圧留去した。得られた残
留物を酢酸エチル−ヘキサンより結晶化して、目的物を
得た。白色アモルファス粉末 収量0.449g 収率
93%1 H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.92 (1H, dd, J
= 11.0 Hz, 14.0 Hz), 3.17 (1H, dd, J = 3.2 Hz, 14.
0 Hz), 3.99 (3H, s), 4.72-4.85 (1H, m), 4.93(1H,
d, J = 5.4 Hz), 5.35 (1H, br s), 7.09 (2H, t, J =
8.6 Hz), 7.13 (1H, d, J = 7.4 Hz), 7.26-7.42 (4H,
m), 7.52-7.60 (5H, m), 7.86 (1H, d, J= 9.2 Hz), 8.
03 (1H, d, J = 7.2 Hz), 8.77 (1H, d, J = 8.8 Hz);
IR (KBr)3283, 1721, 1640, 1512, 1327, 1254, 1163,
1123, 1069, 839 cm-1; Anal. Calcd for C29H23F4NO4:
C, 66.28; H, 4.41; N, 2.67. Found: C, 66.06; H,
4.49; N, 2.58.Example 103 4-[[[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl)
Methyl [benzyl] ethyl] amino] carbonyl] -1-naphthoate (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.287 g (0.916 mmol) 4- (methoxycarbonyl) -1-naphthoic acid
21 g (0.92 mmol) of 1-hydroxybenzotriazole hydrate 0.14 g (0.92 mmol) are stirred in 10 ml of acetonitrile in 1-ethyl-3-ethyl.
0.18 g (0.92 mmol) of (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White amorphous powder Yield 0.449 g Yield 93% 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.92 (1H, dd, J
= 11.0 Hz, 14.0 Hz), 3.17 (1H, dd, J = 3.2 Hz, 14.
0 Hz), 3.99 (3H, s), 4.72-4.85 (1H, m), 4.93 (1H,
d, J = 5.4 Hz), 5.35 (1H, br s), 7.09 (2H, t, J =
8.6 Hz), 7.13 (1H, d, J = 7.4 Hz), 7.26-7.42 (4H,
m), 7.52-7.60 (5H, m), 7.86 (1H, d, J = 9.2 Hz), 8.
03 (1H, d, J = 7.2 Hz), 8.77 (1H, d, J = 8.8 Hz);
IR (KBr) 3283, 1721, 1640, 1512, 1327, 1254, 1163,
1123, 1069, 839 cm -1 ; Anal.Calcd for C 29 H 23 F 4 NO 4 :
C, 66.28; H, 4.41; N, 2.67. Found: C, 66.06; H,
4.49; N, 2.58.
【0236】実施例104 N1-[(1RS,2SR)-2-(4-フルオロフェニ
ル)-2-ヒドロキシ-1-[4-(トリフルオロメチル)
ベンジル]エチル]ナフタレン-1,4-ジカルボキサミ
ド 1) 4-(アミノカルボニル)-1-ナフトエ酸 4-(アミノカルボニル)-1-ナフトエ酸メチル0.4
99g(2.177ミリモル)のメタノール20ml−
テトラヒドロフラン20ml溶液に1N水酸化ナトリウ
ム水溶液6.53ml(6.53ミリモル)を加え、室
温で一晩撹拌した。反応液を濃縮、水で希釈し、希塩酸
で反応液を酸性にした。生じた沈殿をろ過して集め水と
ヘキサンで洗浄して、目的物を得た。白色粉末 収量
0.340g 収率73% mp 294-295℃; 1H-NMR (DMSO-d6, 200MHz) δ 7.58-7.7
1 (3H, m), 7.76 (1H, br s), 8.10-8.13 (2H, m), 8.2
5-8.30 (1H, m), 8.84-8.89 (1H, m); IR (KBr)3191, 3
300-2500, 1694, 1466, 1410, 1368, 1325, 1294, 126
4, 770 cm-1; Anal. Calcd for C12H9NO3: C, 66.97;
H, 4.22; N, 6.51. Found: C, 66.85; H, 4.11; N, 6.6
8. 2) N1-[(1RS,2SR)-2-(4-フルオロフ
ェニル)-2-ヒドロキシ-1-[4-(トリフルオロメチ
ル)ベンジル]エチル]ナフタレン-1,4-ジカルボキ
サミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.154g(0.492ミリモ
ル)、4-(アミノカルボニル)-1-ナフトエ酸0.1
1g(0.49ミリモル)、1-ヒドロキシベンゾトリ
アゾール水和物75mg(0.49ミリモル)をアセト
ニトリル10ml中で撹拌しながら1-エチル-3-(3-
ジメチルアミノプロピル)カルボジイミド・塩酸塩94
mg(0.49ミリモル)を加え、室温で一晩撹拌し
た。反応液を水で希釈し、生じた沈殿をろ過して集め、
水とジエチルエーテルで洗浄して、目的物を得た。白色
粉末 収量0.221g 収率88% mp 255-256℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
86-2.97 (1H, m), 3.15-3.24 (1H, m), 4.67-4.81 (1H,
m), 4.89 (1H, t, J = 5.0 Hz), 5.46 (1H, d,J = 4.0
Hz), 6.89 (1H, br s), 7.08 (2H, t, J = 8.8 Hz),
7.11 (1H, d, J =7.0 Hz), 7.29-7.58 (11H, m), 7.94
(1H, d, J = 9.2 Hz), 8.32 (1H, d, J =8.4 Hz); IR
(KBr) 3283, 1638, 1510, 1329, 1161, 1123, 1069, 83
7 cm-1; Anal. Calcd for C28H22F4N2O3・0.5H2O: C, 6
4.74; H, 4.46; N, 5.39. Found: C, 64.60; H, 4.72;
N, 5.42.Example 104 N1-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl)
Benzyl] ethyl] naphthalene-1,4-dicarboxamide 1) 4- (aminocarbonyl) -1-naphthoic acid 4- (aminocarbonyl) -1-methyl naphthoate 0.4
99 g (2.177 mmol) of methanol 20 ml
6.53 ml (6.53 mmol) of a 1N aqueous sodium hydroxide solution was added to a 20 ml solution of tetrahydrofuran, and the mixture was stirred overnight at room temperature. The reaction solution was concentrated, diluted with water, and acidified with diluted hydrochloric acid. The resulting precipitate was collected by filtration and washed with water and hexane to obtain the desired product. White powder Yield 0.340 g Yield 73% mp 294-295 ° C; 1 H-NMR (DMSO-d 6 , 200 MHz) δ 7.58-7.7
1 (3H, m), 7.76 (1H, br s), 8.10-8.13 (2H, m), 8.2
5-8.30 (1H, m), 8.84-8.89 (1H, m); IR (KBr) 3191, 3
300-2500, 1694, 1466, 1410, 1368, 1325, 1294, 126
4, 770 cm -1 ; Anal.Calcd for C 12 H 9 NO 3 : C, 66.97;
H, 4.22; N, 6.51. Found: C, 66.85; H, 4.11; N, 6.6
8.2) N1-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene-1,4-dicarboxamide (1RS , 2SR) -2-Amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.154 g (0.492 mmol), 4- (aminocarbonyl) -1-Naphthoic acid 0.1
1 g (0.49 mmol) of 1-hydroxybenzotriazole hydrate (75 mg, 0.49 mmol) is stirred in 10 ml of acetonitrile with stirring in 1-ethyl-3- (3- (3-methyl-3-benzotriazole).
Dimethylaminopropyl) carbodiimide hydrochloride 94
mg (0.49 mmol) was added and stirred at room temperature overnight. The reaction solution was diluted with water, and the resulting precipitate was collected by filtration.
The desired product was obtained by washing with water and diethyl ether. White powder Yield 0.221 g Yield 88% mp 255-256 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
86-2.97 (1H, m), 3.15-3.24 (1H, m), 4.67-4.81 (1H,
m), 4.89 (1H, t, J = 5.0 Hz), 5.46 (1H, d, J = 4.0
Hz), 6.89 (1H, br s), 7.08 (2H, t, J = 8.8 Hz),
7.11 (1H, d, J = 7.0 Hz), 7.29-7.58 (11H, m), 7.94
(1H, d, J = 9.2 Hz), 8.32 (1H, d, J = 8.4 Hz); IR
(KBr) 3283, 1638, 1510, 1329, 1161, 1123, 1069, 83
7 cm -1 ; Anal.Calcd for C 28 H 22 F 4 N 2 O 3・ 0.5H 2 O: C, 6
4.74; H, 4.46; N, 5.39. Found: C, 64.60; H, 4.72;
N, 5.42.
【0237】実施例105 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-4-(ヒドロキシメチル)-
1-ナフタレンカルボキサミド 1) 4-(ヒドロキシメチル)-1-ナフタレンカルボ
ン酸メチル(700mg,3.24ミリモル)のメタノ
ール(10ml)溶液に1規定水酸化ナトリウム水溶液
(3.24ml,3.24ミリモル)を加え、室温で終
夜攪拌した。反応液に1規定塩酸(5ml)を加え、酢
酸エチル(50ml×2)で抽出した。抽出液を飽和食
塩水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去
した。残留物を酢酸エチル−ヘキサンから再結晶させて
4-(ヒドロキシメチル)-1-ナフタレンカルボン酸
(570mg,87%)を得た。 mp 183-184℃ IRνmaxKBrcm-1: 1694, 1593, 1518.1 H-NMR (CDCl3)δ: 5.02 (2H, s), 7.54-7.70 (3H, m),
8.04-8.18 (2H, m), 8.86-8.98 (1H, m). 2) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(300mg,0.96ミリモ
ル)のアセトニトリル(30ml)溶液に4-(ヒドロ
キシメチル)-1-ナフタレンカルボン酸(194mg,
0.96ミリモル)および1-エチル-3-(3-ジメチル
アミノプロピル)カルボジイミド・塩酸塩(275m
g,1.44ミリモル)および1-ヒドロキシ-1H-ベ
ンゾトリアゾール(147mg,0.96ミリモル)を
加えて室温で終夜攪拌した。反応液を水(100ml)
で希釈し、酢酸エチル(100ml×2)で抽出した。
抽出液を1規定塩酸、1規定水酸化ナトリウム水溶液、
飽和食塩水で順次洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=2:1)で精製し酢
酸エチル−ヘキサンから再結晶させて、表題化合物(3
65mg,77%)を得た。 mp 202-203℃ IRνmaxKBrcm-1: 1638, 1618, 1605, 1537. Anal. Calcd for C28H23F4NO3: C, 67.60; H, 4.66; N,
2.82 Found: C, 67.41; H, 4.64; N, 2.53.1 H-NMR (CDCl3)δ: 1.88 (1H, br s), 2.87 (1H, dd, J
= 14.4, 10.6 Hz), 3.09 (1H, dd, J = 14.4, 4.4 H
z), 4.72-4.90 (1H, m), 5.02-5.16 (3H, m), 5.94(1H,
d, J = 8.0 Hz), 7.04-7.66 (13H, m), 8.02 (1H, d,
J = 8.4 Hz).Example 105 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4- (hydroxymethyl)-
1-Naphthalenecarboxamide 1) To a solution of methyl 4- (hydroxymethyl) -1-naphthalenecarboxylate (700 mg, 3.24 mmol) in methanol (10 ml), 1 N aqueous sodium hydroxide solution (3.24 ml, 3.24 mmol) Was added and stirred at room temperature overnight. 1N hydrochloric acid (5 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give 4- (hydroxymethyl) -1-naphthalenecarboxylic acid (570 mg, 87%). mp 183-184 ℃ IRνmax KBr cm -1: 1694, 1593, 1518. 1 H-NMR (CDCl 3) δ: 5.02 (2H, s), 7.54-7.70 (3H, m),
8.04-8.18 (2H, m), 8.86-8.98 (1H, m). 2) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4- (trifluoromethyl) phenyl ) -1-Propanol (300 mg, 0.96 mmol) in acetonitrile (30 ml) was added to a solution of 4- (hydroxymethyl) -1-naphthalenecarboxylic acid (194 mg,
0.96 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (275 m
g, 1.44 mmol) and 1-hydroxy-1H-benzotriazole (147 mg, 0.96 mmol) were added and stirred at room temperature overnight. The reaction solution was water (100 ml)
And extracted with ethyl acetate (100 ml × 2).
1N hydrochloric acid, 1N aqueous sodium hydroxide solution,
The extract was washed successively with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1) and recrystallized from ethyl acetate-hexane to give the title compound (3
(65 mg, 77%). . mp 202-203 ℃ IRνmax KBr cm -1 : 1638, 1618, 1605, 1537. Anal Calcd for C 28 H 23 F 4 NO 3: C, 67.60; H, 4.66; N,
2.82 Found: C, 67.41; H, 4.64; N, 2.53. 1 H-NMR (CDCl 3 ) δ: 1.88 (1H, br s), 2.87 (1H, dd, J
= 14.4, 10.6 Hz), 3.09 (1H, dd, J = 14.4, 4.4 H
z), 4.72-4.90 (1H, m), 5.02-5.16 (3H, m), 5.94 (1H,
d, J = 8.0 Hz), 7.04-7.66 (13H, m), 8.02 (1H, d,
J = 8.4 Hz).
【0238】実施例106 4-[[[(1RS,2SR)-2-(4-フルオロフェニ
ル)-2-ヒドロキシ-1-[4-(トリフルオロメチル)
ベンジル]エチル]アミノ]カルボニル]-1-ナフトエ
酸 4-[[[(1RS,2SR)-2-(4-フルオロフェニ
ル)-2-ヒドロキシ-1-[4-(トリフルオロメチル)
ベンジル]エチル]アミノ]カルボニル]-1-ナフトエ
酸メチル0.216g(0.411ミリモル)のメタノ
ール5ml−テトラヒドロフラン5ml溶液に1N水酸
化ナトリウム水溶液1.64ml(1.64ミリモル)
を加え、室温で5時間撹拌した。反応液を濃縮、水で希
釈し、希塩酸で反応液を酸性にした。生じた沈殿をろ過
して集め水とヘキサンで洗浄して、目的物を得た。白色
粉末 収量0.148g 収率70% mp 209-212℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
92 (1H, dd, J = 11.2 Hz, 14.0 Hz), 3.14 (1H, dd, J
= 3.1 Hz,13.7 Hz), 4.71-4.86 (1H, m), 4.95(1H, d,
J = 3.6 Hz), 5.31 (1H, br s), 7.09 (2H, t, J = 8.
8 Hz), 7.16 (1H, d, J = 7.4 Hz), 7.31-7.41 (4H,
m), 7.50-7.59 (5H, m), 7.79 (1H, d, J =9.8 Hz), 8.
08 (1H, d, J = 7.4 Hz), 8.91 (1H, δ , J = 8.8 H
z); IR (KBr)3281, 1690, 1640, 1532, 1512, 1329, 12
33, 1165, 1125, 1069, 837 cm-1; Anal. Calcd for C
28H21F4NO4・1.0H2O: C, 63.52; H, 4.38; N, 2.65. Fou
nd: C,63.45; H, 4.53; N, 2.49.Example 106 4-[[[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl)
Benzyl] ethyl] amino] carbonyl] -1-naphthoic acid 4-[[[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl)
1.64 ml (1.64 mmol) of a 1N aqueous sodium hydroxide solution in a solution of 0.216 g (0.411 mmol) of methyl benzyl [ethyl] amino] carbonyl] -1-naphthoate in 5 ml of methanol and 5 ml of tetrahydrofuran.
Was added and stirred at room temperature for 5 hours. The reaction solution was concentrated, diluted with water, and acidified with diluted hydrochloric acid. The resulting precipitate was collected by filtration and washed with water and hexane to obtain the desired product. White powder Yield 0.148 g Yield 70% mp 209-212 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
92 (1H, dd, J = 11.2 Hz, 14.0 Hz), 3.14 (1H, dd, J
= 3.1 Hz, 13.7 Hz), 4.71-4.86 (1H, m), 4.95 (1H, d,
J = 3.6 Hz), 5.31 (1H, br s), 7.09 (2H, t, J = 8.
8 Hz), 7.16 (1H, d, J = 7.4 Hz), 7.31-7.41 (4H,
m), 7.50-7.59 (5H, m), 7.79 (1H, d, J = 9.8 Hz), 8.
08 (1H, d, J = 7.4 Hz), 8.91 (1H, δ, J = 8.8 H
z); IR (KBr) 3281, 1690, 1640, 1532, 1512, 1329, 12
33, 1165, 1125, 1069, 837 cm -1 ; Anal.Calcd for C
28 H 21 F 4 NO 4・ 1.0H 2 O: C, 63.52; H, 4.38; N, 2.65. Fou
nd: C, 63.45; H, 4.53; N, 2.49.
【0239】実施例107 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-3-フェノキシベンズアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(400mg,1.28ミリモル)のア
セトニトリル(20ml)溶液に3-フェノキシ安息香
酸(274mg,1.28ミリモル)および1-エチル-
3-(3-ジメチルアミノプロピル)カルボジイミド・塩
酸塩(368mg,1.92ミリモル)および1-ヒド
ロキシ-1H-ベンゾトリアゾール(196mg,1.2
8ミリモル)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を1規定塩酸、1規定水酸化ナ
トリウム水溶液、飽和食塩水で順次洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物を酢酸エチル
−ヘキサンから再結晶させて、表題化合物(400m
g,61%)を得た。 mp 144-145℃ IRνmaxKBrcm-1: 1644, 1580, 1510, 1491, 1481. Anal. Calcd for C29H23F4NO3・0.1H2O: C, 68.13; H,
4.57; N, 2.74 Found: C, 67.85; H, 4.51; N, 2.53.1 H-NMR (CDCl3)δ: 2.80-3.00 (2H, m), 3.30-3.70 (1
H, m), 4.50-4.64 (1H, m), 5.05 (1H, d, J = 3.2 H
z), 6.11 (1H, d, J = 8.6 Hz), 6.96-7.52 (17H, m).Example 107 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -3-phenoxybenzamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4 -(Trifluoromethyl) phenyl) -1
To a solution of -propanol (400 mg, 1.28 mmol) in acetonitrile (20 ml) was added 3-phenoxybenzoic acid (274 mg, 1.28 mmol) and 1-ethyl-
3- (3-dimethylaminopropyl) carbodiimide hydrochloride (368 mg, 1.92 mmol) and 1-hydroxy-1H-benzotriazole (196 mg, 1.2
(8 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (400 m
g, 61%). . mp 144-145 ℃ IRνmax KBr cm -1 : 1644, 1580, 1510, 1491, 1481. Anal Calcd for C 29 H 23 F 4 NO 3 · 0.1H 2 O: C, 68.13; H,
4.57; N, 2.74 Found:. C, 67.85; H, 4.51; N, 2.53 1 H-NMR (CDCl 3) δ: 2.80-3.00 (2H, m), 3.30-3.70 (1
H, m), 4.50-4.64 (1H, m), 5.05 (1H, d, J = 3.2 H
z), 6.11 (1H, d, J = 8.6 Hz), 6.96-7.52 (17H, m).
【0240】実施例108 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-4-フェノキシベンズアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(400mg,1.28ミリモル)のア
セトニトリル(20ml)溶液に4-フェノキシ安息香
酸(274mg,1.28ミリモル)および1-エチル-
3-(3-ジメチルアミノプロピル)カルボジイミド・塩
酸塩(368mg,1.92ミリモル)および1-ヒド
ロキシ-1H-ベンゾトリアゾール(196mg,1.2
8ミリモル)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を1規定塩酸、1規定水酸化ナ
トリウム水溶液、飽和食塩水で順次洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物を酢酸エチル
−ヘキサンから再結晶させて、表題化合物(451m
g,69%)を得た。 mp 186-187℃ IRνmaxKBrcm-1: 1622, 1609, 1590, 1532, 1510, 150
1, 1489.1 H-NMR (CDCl3)δ: 2.80-3.02 (2H, m), 3.80-4.00 (1
H, m), 4.50-4.70 (1H, m), 5.06 (1H, d, J = 3.2 H
z), 6.17 (1H, d, J = 8.4 Hz), 6.90-7.60 (17H, m).Example 108 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4-phenoxybenzamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4 -(Trifluoromethyl) phenyl) -1
To a solution of -propanol (400 mg, 1.28 mmol) in acetonitrile (20 ml) was added 4-phenoxybenzoic acid (274 mg, 1.28 mmol) and 1-ethyl-
3- (3-dimethylaminopropyl) carbodiimide hydrochloride (368 mg, 1.92 mmol) and 1-hydroxy-1H-benzotriazole (196 mg, 1.2
(8 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (451 m
g, 69%). mp 186-187 ℃ IRνmax KBr cm -1 : 1622, 1609, 1590, 1532, 1510, 150
1, 1489. 1 H-NMR (CDCl 3 ) δ: 2.80-3.02 (2H, m), 3.80-4.00 (1
H, m), 4.50-4.70 (1H, m), 5.06 (1H, d, J = 3.2 H
z), 6.17 (1H, d, J = 8.4 Hz), 6.90-7.60 (17H, m).
【0241】実施例109 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-3,3,3-トリフルオロプロピオンア
ミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.166g(0.530ミリモ
ル)、3,3,3-トリフルオロプロピオン酸68mg
(0.53ミリモル)、1-ヒドロキシベンゾトリアゾ
ール水和物81mg(0.53ミリモル)をアセトニト
リル10ml中で撹拌しながら1-エチル-3-(3-ジメ
チルアミノプロピル)カルボジイミド・塩酸塩0.10
g(0.53ミリモル)を加え、室温で一晩撹拌した。
反応液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶
液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲルを
通した後、溶媒を減圧留去した。得られた残留物をヘキ
サンより結晶化して、目的物を得た。白色結晶 収量
0.185g 収率83% mp 179-180℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
79-2.83 (2H, m), 2.90(1H, d, J = 10.6 Hz), 3.01 (1
H, d, J = 10.6 Hz), 4.35-4.49 (1H, m), 4.64(1H, d,
J = 3.2 Hz), 4.93 (1H, t, J = 3.4 Hz), 7.06 (2H,
t, J = 8.6 Hz), 7.17-7.21 (3H, m), 7.40-7.47 (4H,
m); IR (KBr) 3308, 1663, 1514, 1327,1238, 1175, 11
13, 1069, 831 cm-1; Anal. Calcd for C19H16F7NO2:
C, 53.91; H, 3.81; N, 3.31. Found: C, 53.84; H, 3.
61; N, 3.13.Example 109 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -3,3,3-trifluoropropionamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3 -[4- (trifluoromethyl) phenyl] propan-1-ol 0.166 g (0.530 mmol), 3,3,3-trifluoropropionic acid 68 mg
(0.53 mmol) 1-Hydroxybenzotriazole hydrate 81 mg (0.53 mmol) in 10 ml of acetonitrile while stirring 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 0.10.
g (0.53 mmol) was added and stirred at room temperature overnight.
The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from hexane to obtain the desired product. White crystals Yield 0.185 g Yield 83% mp 179-180 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
79-2.83 (2H, m), 2.90 (1H, d, J = 10.6 Hz), 3.01 (1
H, d, J = 10.6 Hz), 4.35-4.49 (1H, m), 4.64 (1H, d,
J = 3.2 Hz), 4.93 (1H, t, J = 3.4 Hz), 7.06 (2H,
t, J = 8.6 Hz), 7.17-7.21 (3H, m), 7.40-7.47 (4H,
m); IR (KBr) 3308, 1663, 1514, 1327,1238, 1175, 11
13, 1069, 831 cm -1 ; Anal.Calcd for C 19 H 16 F 7 NO 2 :
C, 53.91; H, 3.81; N, 3.31. Found: C, 53.84; H, 3.
61; N, 3.13.
【0242】実施例110 2-シクロペンチル-N-[(1RS,2SR)-2-(4-
フルオロフェニル)-2-ヒドロキシ-1-[4-(トリフ
ルオロメチル)ベンジル]エチル]-2-フェニルアセト
アミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.156g(0.498ミリモ
ル)、2-シクロペンチル-2-フェニル酢酸0.10g
(0.50ミリモル)、1-ヒドロキシベンゾトリアゾ
ール水和物76mg(0.50ミリモル)をアセトニト
リル10ml中で撹拌しながら1-エチル-3-(3-ジメ
チルアミノプロピル)カルボジイミド・塩酸塩95mg
(0.50ミリモル)を加え、室温で一晩撹拌した。反
応液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶液
で洗浄、無水硫酸マグネシウムで乾燥、シリカゲルを通
した後、溶媒を減圧留去した。得られた残留物をジイソ
プロピルエーテル−ヘキサンより結晶化して、目的物を
得た。白色結晶 収量0.208g 収率84% mp 201-202℃; 1H-NMR (CDCl3, 200MHz) δ 0.73-1.08
(2H, m), 1.30-1.70 (6H, m), 2.38-2.93 (4H, m), 3.4
3 (0.5H, d, J = 3.6 Hz), 3.53 (0.5H, d, J =3.6 H
z), 4.34-4.48 (1H, m), 4.80-4.85 (1H, m), 5.23 (0.
5H, br d, J = 8.4Hz), 5.34 (0.5H, br d, J = 6.6 H
z), 6.88-7.31 (12H, m), 7.43 (1H, d, J= 8.0 Hz); I
R (KBr) 3316, 2957, 1645, 1530, 1514, 1327, 1233,
1167, 1123, 1069, 831 cm-1; Anal. Calcd for C29H29
F4NO2: C, 69.73; H, 5.85; N, 2.80. Found: C, 69.7
1; H, 5.95; N, 2.63.Example 110 2-Cyclopentyl-N-[(1RS, 2SR) -2- (4-
Fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -2-phenylacetamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4 -(Trifluoromethyl) phenyl] propan-1-ol 0.156 g (0.498 mmol), 2-cyclopentyl-2-phenylacetic acid 0.10 g
(0.50 mmol) 1-hydroxybenzotriazole hydrate (76 mg, 0.50 mmol) was stirred in 10 ml of acetonitrile while stirring 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide.hydrochloride 95 mg.
(0.50 mmol) and stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.208 g Yield 84% mp 201-202 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 0.73-1.08
(2H, m), 1.30-1.70 (6H, m), 2.38-2.93 (4H, m), 3.4
3 (0.5H, d, J = 3.6 Hz), 3.53 (0.5H, d, J = 3.6 H
z), 4.34-4.48 (1H, m), 4.80-4.85 (1H, m), 5.23 (0.
5H, br d, J = 8.4Hz), 5.34 (0.5H, br d, J = 6.6H)
z), 6.88-7.31 (12H, m), 7.43 (1H, d, J = 8.0 Hz); I
R (KBr) 3316, 2957, 1645, 1530, 1514, 1327, 1233,
1167, 1123, 1069, 831 cm -1 ; Anal.Calcd for C 29 H 29
F 4 NO 2 : C, 69.73; H, 5.85; N, 2.80. Found: C, 69.7
1; H, 5.95; N, 2.63.
【0243】実施例111 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-3-ニトロ-5,6,7,8-テトラヒド
ロナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.150g(0.479ミリモ
ル)、3-ニトロ-5,6,7,8-テトラヒドロナフタ
レン-1-カルボン酸(Chem.Pharm.Bul
l.,32,3968-80(1984)参照)0.1
1g(0.48ミリモル)、1-ヒドロキシベンゾトリ
アゾール水和物73mg(0.48ミリモル)をアセト
ニトリル10ml中で撹拌しながら1-エチル-3-(3-
ジメチルアミノプロピル)カルボジイミド・塩酸塩92
mg(0.48ミリモル)を加え、室温で一晩撹拌し
た。反応液を酢酸エチルに希釈し、炭酸水素ナトリウム
水溶液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲ
ルを通した後、溶媒を減圧留去した。得られた残留物を
酢酸エチル−ジイソプロピルエーテル−ヘキサンより結
晶化して、目的物を得た。白色結晶 収量0.180g
収率73% mp 216-217℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 1.
49-1.78 (4H, m), 1.97-2.13 (1H, m), 2.36-2.52 (1H,
m), 2.77-2.93 (3H, m), 3.02 (1H, dd, J = 4.3 Hz,
14.5 Hz), 4.58-4.73 (1H, m), 4.96 (1H, t, J = 4.2
Hz), 5.28 (1H, d, J = 3.6 Hz), 7.08 (2H, t, J = 8.
8 Hz), 7.30-7.56 (6H, m), 7.72 (1H, d,J = 2.2 Hz),
7.89 (1H, d, J = 2.2 Hz); IR (KBr) 3260, 1642, 15
34, 1514,1346, 1327, 1231, 1165, 1123, 1067, 837 c
m-1; Anal. Calcd for C27H24F4N 2O4: C, 62.79; H, 4.
68; N, 5.42. Found: C, 62.68; H, 4.45; N, 5.33.Example 111 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) ben
[Zyl] ethyl] -3-nitro-5,6,7,8-tetrahydride
Lonaphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophene)
Nyl) -3- [4- (trifluoromethyl) phenyl] p
Lopan-1-ol 0.150g (0.479mm
Le) 3-nitro-5,6,7,8-tetrahydronaphtha
Ren-1-carboxylic acid (Chem. Pharm. Bul)
l. , 32, 3968-80 (1984)) 0.1
1 g (0.48 mmol), 1-hydroxybenzotri
73 mg (0.48 mmol) of azole hydrate was
While stirring in 10 ml of nitrile, 1-ethyl-3- (3-
Dimethylaminopropyl) carbodiimide hydrochloride 92
mg (0.48 mmol) and stirred at room temperature overnight.
Was. Dilute the reaction solution with ethyl acetate and add sodium bicarbonate
Wash with aqueous solution, dry with anhydrous magnesium sulfate, silica gel
Then, the solvent was distilled off under reduced pressure. The resulting residue
Concluded from ethyl acetate-diisopropyl ether-hexane
Crystallization gave the desired product. 0.180 g of white crystals
Yield 73% mp 216-217 ° C;1H-NMR (CDClThree-DMSO-d6, 200MHz) δ 1.
49-1.78 (4H, m), 1.97-2.13 (1H, m), 2.36-2.52 (1H,
m), 2.77-2.93 (3H, m), 3.02 (1H, dd, J = 4.3 Hz,
14.5 Hz), 4.58-4.73 (1H, m), 4.96 (1H, t, J = 4.2
Hz), 5.28 (1H, d, J = 3.6 Hz), 7.08 (2H, t, J = 8.
8 Hz), 7.30-7.56 (6H, m), 7.72 (1H, d, J = 2.2 Hz),
7.89 (1H, d, J = 2.2 Hz); IR (KBr) 3260, 1642, 15
34, 1514, 1346, 1327, 1231, 1165, 1123, 1067, 837 c
m-1; Anal. Calcd for C27Htwenty fourFFourN TwoOFour: C, 62.79; H, 4.
68; N, 5.42. Found: C, 62.68; H, 4.45; N, 5.33.
【0244】実施例112 2-ベンジル-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[4-(トリフルオロ
メチル)ベンジル]エチル]-3,3-ジメチルブチルア
ミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.264g(0.843ミリモ
ル)、2-ベンジル-3,3-ジメチルブタン酸0.17
g(0.84ミリモル)、4-N,N-ジメチルアミノピ
リジン0.10g(0.84ミリモル)、1-ヒドロキ
シベンゾトリアゾール水和物0.13g(0.84ミリ
モル)をアセトニトリル10ml中で撹拌しながら1-
エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩0.16g(0.84ミリモル)を加え、
60℃で3日間撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物をジイソプロピルエーテル−ヘキ
サンより結晶化して、目的物を得た。白色結晶 収量
0.206g 収率49% mp 175-176℃; 1H-NMR (CDCl3, 200MHz) δ 0.76 (3.5
H, s), 0.90 (5.5 H, s),1.80-1.93 (1H, m), 2.15-3.0
2 (5H, m), 4.25-4.40 (1H, m), 4.48-4.53 (1H,m), 4.
92-5.04 (1H, m), 6.76-7.45 (13H, m); IR (KBr) 355
1, 2967, 1651, 1507, 1333, 1154, 1127, 1123, 1069,
835 cm-1; Anal. Calcd for C29H31F4NO2: C, 69.45;
H, 6.23; N, 2.79. Found: C, 69.09; H, 6.28; N, 2.8
0.Example 112 2-Benzyl-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -3,3 -Dimethylbutyramide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.264 g (0.843 mmol), 2-benzyl-3,3-dimethylbutanoic acid 0.17
g (0.84 mmol), 0.10 g (0.84 mmol) of 4-N, N-dimethylaminopyridine and 0.13 g (0.84 mmol) of 1-hydroxybenzotriazole hydrate were stirred in 10 ml of acetonitrile. 1-
0.16 g (0.84 mmol) of ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added,
Stirred at 60 ° C. for 3 days. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.206 g Yield 49% mp 175-176 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 0.76 (3.5
H, s), 0.90 (5.5 H, s), 1.80-1.93 (1H, m), 2.15-3.0
2 (5H, m), 4.25-4.40 (1H, m), 4.48-4.53 (1H, m), 4.
92-5.04 (1H, m), 6.76-7.45 (13H, m); IR (KBr) 355
1, 2967, 1651, 1507, 1333, 1154, 1127, 1123, 1069,
. 835 cm -1; Anal Calcd for C 29 H 31 F 4 NO 2: C, 69.45;
H, 6.23; N, 2.79.Found: C, 69.09; H, 6.28; N, 2.8
0.
【0245】実施例113 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]-3,4-ジヒドロ-2H-1,5-ベンゾ
ジオキセピン-6-カルボキサミド 1) 2,3-ジヒドロキシ安息香酸メチル 2,3-ジヒドロキシ安息香酸5.029g(32.6
3ミリモル)を10%塩化水素のメタノール溶液80m
l中で3日間加熱還流した。反応液の溶媒を減圧留去
し、水で希釈後、酢酸エチルで抽出した。得られた酢酸
エチル溶液を無水硫酸マグネシウムで乾燥、シリカゲル
を通した後、溶媒を減圧留去した。得られた残留物を冷
ジイソプロピルエーテル−ヘキサンより結晶化して、目
的物を得た。褐色結晶 収量4.439g 収率81% mp 77-78℃; 1H-NMR (CDCl3, 200MHz) δ 3.96 (3H,
s), 5.65 (1H, s), 6.80 (1H, t, J = 8.1 Hz), 7.11
(1H, dd, J = 1.5 Hz, 7.7 Hz), 7.37 (1H, dd, J =1.1
Hz, 8.1 Hz), 10.89 (1H, s); IR (KBr) 3465, 3100 2
850, 1674, 1468, 1437, 1321, 1269, 1194, 1152, 107
6, 1009, 837, 758 cm-1; Anal. Calcd forC8H8O4: C,
57.14; H, 4.80. Found: C, 56.93; H, 4.94. 2) 3,4-ジヒドロ-2H-1,5-ベンゾジオキセピ
ン-6-カルボン酸メチル2,3-ジヒドロキシ安息香酸
メチル1.870g(11.12ミリモル)、1,3-
ジブロモプロパン2.25g(11.1ミリモル)、炭
酸カリウム6.15g(44.5ミリモル)をN,N-
ジメチルホルムアミド20ml中で60℃にて一晩撹拌
した。反応液を水に注ぎ、酢酸エチルで2回抽出した。
集めた有機層を無水硫酸ナトリウムで乾燥、溶媒を減圧
留去した。残留物をシリカゲルカラムクロマトグラフィ
ーにて精製して(ヘキサン/酢酸エチル=6/1−3/
1)、目的物を得た。無色液体 収量1.711g 収
率74%1 H-NMR (CDCl3, 200MHz) δ 2.18-2.29 (2H, m), 3.89
(3H, s), 4.25 (2H, t,J = 5.7 Hz), 4.30 (2H, t, J =
5.7 Hz), 6.95 (1H, t, J = 7.9 Hz), 7.12 (1H, dd,
J = 1.8 Hz, 8.0 Hz), 7.36 (1H, dd, J = 1.8 Hz, 7.8
Hz); IR (neat)2953, 1732, 1478, 1454, 1296, 1262,
1225, 1138, 1080, 1044 cm-1 3) 3,4-ジヒドロ-2H-1,5-ベンゾジオキセピ
ン-6-カルボン酸 3,4-ジヒドロ-2H-1,5-ベンゾジオキセピン-6-
カルボン酸メチル1.615g(7.757ミリモル)
のメタノール20ml−テトラヒドロフラン10ml溶
液に1N水酸化ナトリウム水溶液15.5ml(15.
5ミリモル)を加え、室温で一晩撹拌した。反応液を濃
縮、水で希釈し、希塩酸で反応液を酸性にした後、酢酸
エチルで2回抽出した。集めた有機層を無水硫酸ナトリ
ウムで乾燥、溶媒を減圧留去した。残留物をヘキサンよ
り結晶化して、目的物を得た。白色結晶 収量1.37
6g 収率91% mp 68-70℃; 1H-NMR (CDCl3, 200MHz) δ 2.29-2.40 (2
H, m), 4.30 (2H, t, J= 5.8 Hz), 4.52 (2H, t, J =
5.6 Hz), 7.09 (1H, t, J = 7.9 Hz), 7.24 (1H,dd, J
= 2.0 Hz, 8.2 Hz), 7.85 (1H, dd, J = 1.8 Hz, 7.6 H
z); IR (KBr) 3171, 1725, 1478, 1348, 1264, 1022, 7
52 cm-1; Anal. Calcd for C10H10O4: C,61.85; H, 5.1
9. Found: C, 61.77; H, 5.49. 4) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[4-(トリフルオロメチ
ル)ベンジル]エチル]-3,4-ジヒドロ-2H-1,5
-ベンゾジオキセピン-6-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.262g(0.836ミリモ
ル)、3,4-ジヒドロ-2H-1,5-ベンゾジオキセピ
ン-6-カルボン酸0.16g(0.84ミリモル)、1
-ヒドロキシベンゾトリアゾール水和物0.13g
(0.84ミリモル)をアセトニトリル10ml中で撹
拌しながら1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩0.16g(0.84ミリ
モル)を加え、室温で一晩撹拌した。反応液を酢酸エチ
ルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無水硫
酸マグネシウムで乾燥、シリカゲルを通した後、溶媒を
減圧留去した。得られた残留物をジイソプロピルエーテ
ル−ヘキサンより結晶化して、目的物を得た。白色結晶
収量0.361g 収率88% mp 155-156℃; 1H-NMR (CDCl3, 200MHz) δ 2.05-2.16
(2H, m), 2.93-2.97 (2H, m), 3.69-3.86 (2H, m), 4.0
9-4.20 (3H, m), 4.55-4.67 (1H, m), 5.10 (1H,t, J =
3.3 Hz), 6.98-7.15 (4H, m), 7.26 (2H, d, J = 7.8
Hz), 7.38-7.52(4H, m), 7.76 (1H, dd, J = 1.8 Hz,
7.8 Hz), 7.92 (1H, br d, J = 7.8 Hz);IR (KBr) 327
9, 1636, 1541, 1512, 1325, 1264, 1231, 1169, 1121,
1069, 1044, 837 cm-1; Anal. Calcd for C26H23F4N
O4: C, 63.80; H, 4.74; N, 2.86. Found: C, 63.63;
H, 4.72; N, 2.80.Example 113 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -3,4-dihydro-2H-1,5-benzodioxepin-6-carboxamide 1) Methyl 2,3-dihydroxybenzoate 5.029 g (32.6) of 2,3-dihydroxybenzoic acid
3 mmol) in 80% methanol solution of 10% hydrogen chloride
Heated to reflux in 1 L for 3 days. The solvent of the reaction solution was distilled off under reduced pressure, diluted with water, and extracted with ethyl acetate. The obtained ethyl acetate solution was dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from cold diisopropyl ether-hexane to obtain the desired product. Brown crystals Yield 4.439 g Yield 81% mp 77-78 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 3.96 (3H,
s), 5.65 (1H, s), 6.80 (1H, t, J = 8.1 Hz), 7.11
(1H, dd, J = 1.5 Hz, 7.7 Hz), 7.37 (1H, dd, J = 1.1
Hz, 8.1 Hz), 10.89 (1H, s); IR (KBr) 3465, 3100 2
850, 1674, 1468, 1437, 1321, 1269, 1194, 1152, 107
6, 1009, 837, 758 cm -1 ; Anal.Calcd forC 8 H 8 O 4 : C,
57.14; H, 4.80. Found: C, 56.93; H, 4.94. 2) Methyl 3,4-dihydro-2H-1,5-benzodioxepine-6-carboxylate Methyl 2,3-dihydroxybenzoate 870 g (11.12 mmol), 1,3-
2.25 g (11.1 mmol) of dibromopropane and 6.15 g (44.5 mmol) of potassium carbonate were added to N, N-
Stirred in 60 ml of dimethylformamide overnight. The reaction solution was poured into water and extracted twice with ethyl acetate.
The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-3 /
1) The desired product was obtained. Colorless liquid Yield 1.711 g Yield 74% 1 H-NMR (CDCl 3 , 200 MHz) δ 2.18-2.29 (2H, m), 3.89
(3H, s), 4.25 (2H, t, J = 5.7 Hz), 4.30 (2H, t, J =
5.7 Hz), 6.95 (1H, t, J = 7.9 Hz), 7.12 (1H, dd,
J = 1.8 Hz, 8.0 Hz), 7.36 (1H, dd, J = 1.8 Hz, 7.8
Hz); IR (neat) 2953, 1732, 1478, 1454, 1296, 1262,
1225, 1138, 1080, 1044 cm -1 3) 3,4-dihydro-2H-1,5-benzodioxepin-6-carboxylic acid 3,4-dihydro-2H-1,5-benzodioxepin- 6-
1.615 g (7.757 mmol) of methyl carboxylate
15.5 ml of a 1N aqueous sodium hydroxide solution (15.
5 mmol) and stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, acidified with dilute hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from hexane to obtain the desired product. White crystals Yield 1.37
6g Yield 91% mp 68-70 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 2.29-2.40 (2
H, m), 4.30 (2H, t, J = 5.8 Hz), 4.52 (2H, t, J =
5.6 Hz), 7.09 (1H, t, J = 7.9 Hz), 7.24 (1H, dd, J
= 2.0 Hz, 8.2 Hz), 7.85 (1H, dd, J = 1.8 Hz, 7.6 H
z); IR (KBr) 3171, 1725, 1478, 1348, 1264, 1022, 7
52 cm -1 ; Anal.Calcd for C 10 H 10 O 4 : C, 61.85; H, 5.1
9. Found: C, 61.77; H, 5.49.4) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -3,4-dihydro-2H-1,5
-Benzodioxepin-6-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol 0.262 g (0 0.836 mmol), 0.16 g (0.84 mmol) of 3,4-dihydro-2H-1,5-benzodioxepin-6-carboxylic acid, 1
-Hydroxybenzotriazole hydrate 0.13g
(0.84 mmol) was stirred in 10 ml of acetonitrile, and 0.16 g (0.84 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added thereto, followed by stirring at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.361 g Yield 88% mp 155-156 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.05-2.16
(2H, m), 2.93-2.97 (2H, m), 3.69-3.86 (2H, m), 4.0
9-4.20 (3H, m), 4.55-4.67 (1H, m), 5.10 (1H, t, J =
3.3 Hz), 6.98-7.15 (4H, m), 7.26 (2H, d, J = 7.8
Hz), 7.38-7.52 (4H, m), 7.76 (1H, dd, J = 1.8 Hz,
7.8 Hz), 7.92 (1H, br d, J = 7.8 Hz); IR (KBr) 327
9, 1636, 1541, 1512, 1325, 1264, 1231, 1169, 1121,
1069, 1044, 837 cm -1 ; Anal.Calcd for C 26 H 23 F 4 N
O 4 : C, 63.80; H, 4.74; N, 2.86. Found: C, 63.63;
H, 4.72; N, 2.80.
【0246】実施例114 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]カルバミン酸ベンジル (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.159g(0.508ミリモル)
と炭酸水素ナトリウム85mg(1.02ミリモル)を
テトラヒドロフラン10ml中で撹拌しながらクロロ炭
酸ベンジル0.09ml(0.61ミリモル)を加え、
室温で一晩撹拌した。反応液を酢酸エチルに希釈し、炭
酸水素ナトリウム水溶液で洗浄、無水硫酸マグネシウム
で乾燥、シリカゲルを通した後、溶媒を減圧留去した。
得られた残留物をジイソプロピルエーテル−ヘキサンよ
り結晶化して、目的物を得た。白色結晶 収量0.19
0g 収率84% mp 151-152℃; 1H-NMR (CDCl3, 200MHz) δ 2.68-2.91
(3H, m), 4.08-4.22 (1H, m), 4.81 (1H, br d, J = 8.
8 Hz), 4.94 (1H, br s), 5.00 (2H, s), 7.06 (2H, t,
J = 8.6 Hz), 7.17-7.40 (9H, m), 7.48 (2H, d, J =
7.8 Hz); IR (KBr) 3337, 1694, 1539, 1327, 1163, 11
21, 1069, 829 cm-1; Anal. Calcd for C2 4H21F4NO3:
C, 64.43; H, 4.73; N, 3.13. Found: C, 64.46; H, 4.
77; N, 2.94.Example 114 N-[(1RS, 2SR) -2- (4-fluorophenyl)
Benzyl-2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] carbamate (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl ) Phenyl] propan-1-ol 0.159 g (0.508 mmol)
And 85 mg (1.02 mmol) of sodium hydrogen carbonate in 10 ml of tetrahydrofuran while adding 0.09 ml (0.61 mmol) of benzyl chlorocarbonate,
Stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure.
The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.19
0 g Yield 84% mp 151-152 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.68-2.91
(3H, m), 4.08-4.22 (1H, m), 4.81 (1H, br d, J = 8.
8 Hz), 4.94 (1H, br s), 5.00 (2H, s), 7.06 (2H, t,
J = 8.6 Hz), 7.17-7.40 (9H, m), 7.48 (2H, d, J =
7.8 Hz); IR (KBr) 3337, 1694, 1539, 1327, 1163, 11
21, 1069, 829 cm -1 ; Anal.Calcd for C 2 4 H 21 F 4 NO 3 :
C, 64.43; H, 4.73; N, 3.13. Found: C, 64.46; H, 4.
77; N, 2.94.
【0247】実施例115 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]カルバミン酸エチル (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.401g(1.280ミリモル)
と炭酸水素ナトリウム0.22g(2.56ミリモル)
をテトラヒドロフラン10ml−水2ml中で撹拌しな
がらクロロ炭酸エチル0.15ml(1.54ミリモ
ル)を加え、室温で一晩撹拌した。反応液を酢酸エチル
に希釈し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸
マグネシウムで乾燥、シリカゲルを通した後、溶媒を減
圧留去した。得られた残留物を酢酸エチル−ヘキサンよ
り結晶化して、目的物を得た。白色結晶 収量0.41
3g 収率84% mp 143-144℃; 1H-NMR (CDCl3, 200MHz) δ 1.15 (3H,
t, J = 7.0 Hz), 2.67-2.95 (3H, m), 3.93-4.20 (3H,
m), 4.71 (1H, d, J = 8.6 Hz), 4.95 (1H, s),7.08 (2
H, t, J = 8.6 Hz), 7.21 (2H, d, J = 8.0 Hz), 7.39
(2H, dd, J = 5.5 Hz, 8.5 Hz), 7.51 (2H, d, J = 8.0
Hz); IR (KBr) 3318, 1690, 1547, 1329, 1163, 1117,
1069, 829 cm-1; Anal. Calcd for C19H19F4NO3: C, 5
9.22; H,4.97; N, 3.63. Found: C, 59.28; H, 5.10;
N, 3.63.Example 115 N-[(1RS, 2SR) -2- (4-fluorophenyl)
Ethyl-2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] carbamate (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl ) Phenyl] propan-1-ol 0.401 g (1.280 mmol)
And sodium hydrogencarbonate 0.22 g (2.56 mmol)
Was stirred in 10 ml of tetrahydrofuran-2 ml of water, 0.15 ml (1.54 mmol) of ethyl chlorocarbonate was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. 0.41 white crystals
3g Yield 84% mp 143-144 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.15 (3H,
t, J = 7.0 Hz), 2.67-2.95 (3H, m), 3.93-4.20 (3H,
m), 4.71 (1H, d, J = 8.6 Hz), 4.95 (1H, s), 7.08 (2
H, t, J = 8.6 Hz), 7.21 (2H, d, J = 8.0 Hz), 7.39
(2H, dd, J = 5.5 Hz, 8.5 Hz), 7.51 (2H, d, J = 8.0
Hz); IR (KBr) 3318, 1690, 1547, 1329, 1163, 1117,
1069, 829 cm -1 ; Anal.Calcd for C 19 H 19 F 4 NO 3 : C, 5
9.22; H, 4.97; N, 3.63. Found: C, 59.28; H, 5.10;
N, 3.63.
【0248】実施例116 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]カルバミン酸ネオペンチル (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロパン-1-オール0.171g(0.546ミリモル)
と炭酸水素ナトリウム92mg(1.09ミリモル)を
テトラヒドロフラン10ml中で撹拌しながらクロロ炭
酸ネオペンチル0.10ml(0.65ミリモル)を加
え、室温で一晩撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物をヘキサンより結晶化して、目的
物を得た。白色結晶 収量0.168g 収率72% mp 112-113℃; 1H-NMR (CDCl3, 200MHz) δ 0.82 (9H,
s), 2.66-2.92 (3H, m),3.67 (2H, br s), 4.14 (1H, b
r s), 4.72 (1H, br d, J = 8.2 Hz), 4.95 (1H, br
s), 7.08 (2H, t, J = 8.6 Hz), 7.22 (2H, d, J = 8.0
Hz), 7.39 (2H, dd, J = 5.2 Hz, 8.4 Hz), 7.50 (2H,
d, J = 8.0 Hz); IR (KBr) 3326, 2967, 1690, 1545,
1327, 1127, 1069, 833 cm-1; Anal. Calcd for C22H25
F4NO3: C, 61.82; H, 5.90; N, 3.28. Found: C, 61.4
7; H, 5.85; N, 3.04.Example 116 N-[(1RS, 2SR) -2- (4-fluorophenyl)
Neopentyl 2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] carbamate (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethyl ) Phenyl] propan-1-ol 0.171 g (0.546 mmol)
Then, 0.10 ml (0.65 mmol) of neopentyl chlorocarbonate was added while stirring in 10 ml of tetrahydrofuran and 92 mg (1.09 mmol) of sodium hydrogencarbonate, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from hexane to obtain the desired product. White crystals Yield 0.168 g Yield 72% mp 112-113 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 0.82 (9H,
s), 2.66-2.92 (3H, m), 3.67 (2H, br s), 4.14 (1H, b
rs), 4.72 (1H, br d, J = 8.2 Hz), 4.95 (1H, br
s), 7.08 (2H, t, J = 8.6 Hz), 7.22 (2H, d, J = 8.0
Hz), 7.39 (2H, dd, J = 5.2 Hz, 8.4 Hz), 7.50 (2H,
d, J = 8.0 Hz); IR (KBr) 3326, 2967, 1690, 1545,
1327, 1127, 1069, 833 cm -1 ; Anal.Calcd for C 22 H 25
F 4 NO 3 : C, 61.82; H, 5.90; N, 3.28. Found: C, 61.4
7; H, 5.85; N, 3.04.
【0249】実施例117 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-1-ナフタレンスルホンアミ
ド (1RS,2SR)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(150mg,0.43
ミリモル)の酢酸エチル(5ml)溶液に1-ナフタレ
ンスルホニルクロリド(107mg,0.47ミリモ
ル)および飽和重曹水(5ml)を加えて室温で終夜攪
拌した。反応液を水(50ml)で希釈し、酢酸エチル
(50ml×2)で抽出した。抽出液を飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=4:1)で精製し、酢酸エチル−ヘキ
サンから再結晶させて、表題化合物(109mg,50
%)を得た。 mp 176-177℃ IRν maxKBrcm-1: 1508, 1325, 1223, 1161, 1129. Anal. Calcd for C26H21F4NO3S: C, 62.02; H, 4.20;
N, 2.78 Found: C, 61.73; H, 4.20; N, 2.74.1 H-NMR (CDCl3)δ: 2.40-2.62 (2H, m), 2.95 (1H, br
s), 3.56-3.70 (1H, m),5.15 (2H, s), 6.60 (2H, d, J
= 8.0 Hz), 6.79 (2H, d, J = 8.0 Hz), 6.90-7.04 (2
H, m), 7.20-7.40 (3H, m), 7.40-7.56 (2H, m), 7.70-
7.84 (1H, m), 7.91 (1H, d, J = 8.0 Hz), 8.05 (1H,
d, J = 8.0 Hz), 8.20-8.30 (1H, m).Example 117 N-((1RS, 2SR) -2- (4-fluorophenyl)
2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -1-naphthalenesulfonamide (1RS, 2SR) -1- (4-fluorophenyl) -1-
Hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.43
1 mmol) and 1-naphthalenesulfonyl chloride (107 mg, 0.47 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml) were added to the solution, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the title compound (109 mg, 50 mg).
%). mp 176-177 ℃ IRν max KBr cm -1 : 1508, 1325, 1223, 1161, 1129. Anal.Calcd for C 26 H 21 F 4 NO 3 S: C, 62.02; H, 4.20;
N, 2.78 Found:. C, 61.73; H, 4.20; N, 2.74 1 H-NMR (CDCl 3) δ: 2.40-2.62 (2H, m), 2.95 (1H, br
s), 3.56-3.70 (1H, m), 5.15 (2H, s), 6.60 (2H, d, J
= 8.0 Hz), 6.79 (2H, d, J = 8.0 Hz), 6.90-7.04 (2
H, m), 7.20-7.40 (3H, m), 7.40-7.56 (2H, m), 7.70-
7.84 (1H, m), 7.91 (1H, d, J = 8.0 Hz), 8.05 (1H,
d, J = 8.0 Hz), 8.20-8.30 (1H, m).
【0250】実施例118 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-N'-(1-ナフタレニル)ウ
レア (1RS,2SR)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(150mg,0.43
ミリモル)のアセトニトリル(10ml)溶液にトリエ
チルアミン(0.089ml,0.64ミリモル)およ
び1-ナフチルイソシアネート(0.062ml,0.
43ミリモル)を加え、室温で終夜攪拌した。反応液を
水(50ml)で希釈し、酢酸エチル(50ml×2)
で抽出した。抽出液を1N塩酸、1N水酸化ナトリウム
水溶液、飽和食塩水で順次洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去した。残留物を酢酸エチル−ヘキサ
ンから再結晶させて、表題化合物(135mg,65
%)を得た。 mp 222-223℃ IRν maxKBrcm-1: 1661, 1638, 1557, 1510. Anal. Calcd for C27H22F4N2O2: C, 67.21; H, 4.60;
N, 5.81 Found: C, 67.02; H, 4.47; N, 5.78.1 H-NMR (CDCl3)δ: 2.47 (1H, dd, J = 14.4, 10.0 H
z), 2.78 (1H, dd, J = 14.4, 3.6 Hz), 4.20-4.40 (3
H, m), 4.91 (1H, br s), 6.36 (1H, s), 6.92-7.10(5
H, m), 7.22-7.40 (5H, m), 7.40-7.58 (2H, m), 7.74-
7.94 (3H, m).Example 118 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -N '-(1-naphthalenyl) urea (1RS, 2SR) -1- (4-fluorophenyl) -1-
Hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.43
Mmol) in acetonitrile (10 ml) in triethylamine (0.089 ml, 0.64 mmol) and 1-naphthyl isocyanate (0.062 ml, 0.
43 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and ethyl acetate (50 ml × 2)
Extracted. The extract was washed successively with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (135 mg, 65 mg).
%). mp 222-223 ° C IRν max KBr cm -1 : 1661, 1638, 1557, 1510. Anal.Calcd for C 27 H 22 F 4 N 2 O 2 : C, 67.21; H, 4.60;
N, 5.81 Found:. C, 67.02; H, 4.47; N, 5.78 1 H-NMR (CDCl 3) δ: 2.47 (1H, dd, J = 14.4, 10.0 H
z), 2.78 (1H, dd, J = 14.4, 3.6 Hz), 4.20-4.40 (3
H, m), 4.91 (1H, br s), 6.36 (1H, s), 6.92-7.10 (5
H, m), 7.22-7.40 (5H, m), 7.40-7.58 (2H, m), 7.74-
7.94 (3H, m).
【0251】実施例119 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-N'-(4-(トリフルオロメ
チル)フェニル)ウレア (1RS,2SR)-1-(4-フルオロフェニル)-1-
ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(150mg,0.43
ミリモル)のアセトニトリル(10ml)溶液にトリエ
チルアミン(0.089ml,0.64ミリモル)およ
び4-トリフルオロメチルフェニルイソシアネート
(0.061ml,0.43ミリモル)を加え、室温で
終夜攪拌した。反応液を水(50ml)で希釈し、酢酸
エチル(50ml×2)で抽出した。抽出液を1N塩
酸、1N水酸化ナトリウム水溶液、飽和食塩水で順次洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去した。残
留物を酢酸エチル−ヘキサンから再結晶させて、表題化
合物(139mg,65%)を得た。 mp 160-161℃ IRν maxKBrcm-1: 1659, 1605, 1557, 1508. Anal. Calcd for C24H19F7N2O2: C, 57.60; H, 3.83;
N, 5.60 Found: C, 57.61; H, 3.59; N, 5.65.1 H-NMR (CDCl3)δ: 2.60-2.92 (2H, m), 3.50 (1H, br
s), 4.22-4.50 (1H, m),4.80 (1H, d, J = 8.0 Hz), 5.
01 (1H, s), 6.75 (1H, s), 7.00-7.18 (2H, m), 7.18-
7.60 (10H, m).Example 119 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -N '-(4- (trifluoromethyl) phenyl) urea (1RS, 2SR) -1- (4-fluorophenyl) ) -1-
Hydroxy-3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.43
To a solution of (mmol) in acetonitrile (10 ml) were added triethylamine (0.089 ml, 0.64 mmol) and 4-trifluoromethylphenylisocyanate (0.061 ml, 0.43 mmol), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed successively with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (139 mg, 65%). mp 160-161 ℃ IRν max KBr cm -1 : 1659, 1605, 1557, 1508. Anal.Calcd for C 24 H 19 F 7 N 2 O 2 : C, 57.60; H, 3.83;
N, 5.60 Found:. C, 57.61; H, 3.59; N, 5.65 1 H-NMR (CDCl 3) δ: 2.60-2.92 (2H, m), 3.50 (1H, br
s), 4.22-4.50 (1H, m), 4.80 (1H, d, J = 8.0 Hz), 5.
01 (1H, s), 6.75 (1H, s), 7.00-7.18 (2H, m), 7.18-
7.60 (10H, m).
【0252】実施例120 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-N-(1-ナフタレニルメチ
ル)アセトアミド 1) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((4-(トリフルオロメチル)フェニル)メ
チル)-1,3-オキサゾリジン-2-オン(1g,2.9
5ミリモル)のN,N-ジメチルホルムアミド(10m
l)溶液に60%水素化ナトリウム(142mg,3.
54ミリモル)を加え、室温で15分間攪拌した。反応
液に1-ナフチルメチルクロリド(480ml,3.25
ミリモル)を加え、1時間攪拌した。反応液を水(10
0ml)で希釈し、酢酸エチル(100ml×2)で抽
出した。抽出液を水、飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(ヘキサン:酢酸エチル=
4:1)で精製し、ジイソプロピルエーテル−ヘキサン
から再結晶させて、(4RS,5SR)-5-(4-フル
オロフェニル)-3-(1-ナフタレニルメチル)-4-
((4-(トリフルオロメチル)フェニル)メチル)-
1,3-オキサゾリジン-2-オン(1.23g,87
%)を得た。 mp 136-137℃ IRνmaxKBrcm-1: 1748, 1609. Anal. Calcd for C28H21F4NO2: C, 70.14; H, 4.41; N,
2.92 Found: C, 70.15; H, 4.23; N, 2.78.1 H-NMR (CDCl3)δ: 2.34 (1H, dd, J = 14.4, 8.0 Hz),
2.81 (1H, dd, J = 14.4, 5.2 Hz), 3.70-3.84 (1H,
m), 4.24 (1H, d, J = 15.2 Hz), 5.28 (1H, d, J= 7.6
Hz), 5.40 (1H, d, J = 15.2 Hz), 6.48 (2H, d, J =
8.2 Hz), 6.76-7.10 (5H, m), 7.14-7.56 (5H, m), 7.7
0-8.00 (3H, m). 2) (4RS,5SR)-5-(4-フルオロフェニ
ル)-3-(1-ナフタレニルメチル)-4-((4-(トリ
フルオロメチル)フェニル)メチル)-1,3-オキサゾ
リジン-2-オン(100mg,0.21ミリモル)のエ
タノール(2ml)溶液に8規定水酸化ナトリウム水溶
液(130ml)を加え、4時間加熱還流した。反応液
を水(50ml)で希釈し、酢酸エチル(50ml×
2)で抽出した。抽出液を水、飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=2:1)で精製し、ジイソプロピルエーテル−ヘ
キサンから再結晶させて、(1RS,2SR)-1-(4
-フルオロフェニル)-2-((1-ナフタレニルメチル)
アミノ)-3-(4-(トリフルオロメチル)フェニル)-
1-プロパノール(29.6mg,31%)を得た。 mp 94-95℃ IRνmaxKBrcm-1: 1605, 1510, 1325. Anal. Calcd for C27H23F4NO: C, 71.51; H, 5.11; N,
3.09 Found: C, 71.40; H, 5.07; N, 2.98.1 H-NMR (CDCl3)δ: 2.45 (2H, d, J = 7.4 Hz), 3.02-
3.14 (1H, m), 3.71 (1H,br s), 4.03 (1H, d, J = 13.
2 Hz), 4.33 (1H, d, J = 13.2 Hz), 5.06 (1H,d, J =
3.6 Hz), 6.92 (2H, d, J = 7.6 Hz), 7.00-7.16 (2H,
m), 7.20-7.58 (9H, m), 7.70-7.88 (2H, m). 3) (1RS,2SR)-1-(4-フルオロフェニ
ル)-2-((1-ナフタレニルメチル)アミノ)-3-
(4-(トリフルオロメチル)フェニル)-1-プロパノ
ール(100mg,0.22ミリモル)の酢酸エチル
(5ml)溶液にアセチルクロリド(225ml,3.
3ミリモル)および飽和重曹水(5ml)を加えて室温
で終夜攪拌した。反応液を水(50ml)で希釈し、酢
酸エチル(50ml×2)で抽出した。抽出液を飽和食
塩水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去
した。残留物をシリカゲルカラムクロマトグラフィー
(ヘキサン:酢酸エチル=1:1)で精製し表題化合物
(45mg,41%)を得た。 IRνmaxKBrcm-1: 1622, 1508, 1456.1 H-NMR (CDCl3)δ: 2.32 (3H, s), 2.73 (1H, d, J = 1
1.0 Hz), 3.32-3.76 (3H, m), 4.76 (1H, s), 4.82 (1
H, d, J = 15.6 Hz), 6.50-6.64 (2H, m), 6.70-6.84
(2H, m), 7.00-7.18 (3H, m), 7.40-7.60 (6H, m), 7.8
2-8.00 (2H, m).Example 120 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -N- (1-naphthalenylmethyl) acetamide 1) (4RS, 5SR) -5- (4-fluorophenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-2-one (1 g, 2.9
5 mmol) of N, N-dimethylformamide (10 m
l) 60% sodium hydride (142 mg, 3.
(54 mmol) and stirred at room temperature for 15 minutes. 1-Naphthylmethyl chloride (480 ml, 3.25) was added to the reaction mixture.
Mmol) and stirred for 1 hour. The reaction solution was diluted with water (10
0 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
4: 1) and recrystallized from diisopropyl ether-hexane to give (4RS, 5SR) -5- (4-fluorophenyl) -3- (1-naphthalenylmethyl) -4-.
((4- (trifluoromethyl) phenyl) methyl)-
1,3-oxazolidine-2-one (1.23 g, 87
%). mp 136-137 ℃ IRνmax KBr cm -1 : 1748, 1609. Anal.Calcd for C 28 H 21 F 4 NO 2 : C, 70.14; H, 4.41; N,
2.92 Found:. C, 70.15; H, 4.23; N, 2.78 1 H-NMR (CDCl 3) δ: 2.34 (1H, dd, J = 14.4, 8.0 Hz),
2.81 (1H, dd, J = 14.4, 5.2 Hz), 3.70-3.84 (1H,
m), 4.24 (1H, d, J = 15.2 Hz), 5.28 (1H, d, J = 7.6
Hz), 5.40 (1H, d, J = 15.2 Hz), 6.48 (2H, d, J =
8.2 Hz), 6.76-7.10 (5H, m), 7.14-7.56 (5H, m), 7.7
0-8.00 (3H, m). 2) (4RS, 5SR) -5- (4-fluorophenyl) -3- (1-naphthalenylmethyl) -4-((4- (trifluoromethyl) phenyl) To a solution of (methyl) -1,3-oxazolidin-2-one (100 mg, 0.21 mmol) in ethanol (2 ml) was added an 8N aqueous sodium hydroxide solution (130 ml), and the mixture was heated under reflux for 4 hours. The reaction solution was diluted with water (50 ml), and ethyl acetate (50 ml ×
Extracted in 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1) and recrystallized from diisopropyl ether-hexane to give (1RS, 2SR) -1- (4
-Fluorophenyl) -2-((1-naphthalenylmethyl)
Amino) -3- (4- (trifluoromethyl) phenyl)-
1-propanol (29.6 mg, 31%) was obtained. mp 94-95 ℃ IRνmax KBr cm -1 : 1605, 1510, 1325. Anal.Calcd for C 27 H 23 F 4 NO: C, 71.51; H, 5.11; N,
3.09 Found:. C, 71.40; H, 5.07; N, 2.98 1 H-NMR (CDCl 3) δ: 2.45 (2H, d, J = 7.4 Hz), 3.02-
3.14 (1H, m), 3.71 (1H, br s), 4.03 (1H, d, J = 13.
2 Hz), 4.33 (1H, d, J = 13.2 Hz), 5.06 (1H, d, J =
3.6 Hz), 6.92 (2H, d, J = 7.6 Hz), 7.00-7.16 (2H,
m), 7.20-7.58 (9H, m), 7.70-7.88 (2H, m). 3) (1RS, 2SR) -1- (4-fluorophenyl) -2-((1-naphthalenylmethyl) amino ) -3-
To a solution of (4- (trifluoromethyl) phenyl) -1-propanol (100 mg, 0.22 mmol) in ethyl acetate (5 ml) was added acetyl chloride (225 ml, 3.25 ml).
3 mmol) and saturated aqueous sodium hydrogencarbonate (5 ml) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1) to give the title compound (45 mg, 41%). IRνmax KBr cm -1: 1622, 1508 , 1456. 1 H-NMR (CDCl 3) δ: 2.32 (3H, s), 2.73 (1H, d, J = 1
1.0 Hz), 3.32-3.76 (3H, m), 4.76 (1H, s), 4.82 (1
H, d, J = 15.6 Hz), 6.50-6.64 (2H, m), 6.70-6.84
(2H, m), 7.00-7.18 (3H, m), 7.40-7.60 (6H, m), 7.8
2-8.00 (2H, m).
【0253】実施例121 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-N-メチル-1-ナフタレンカ
ルボキサミド 1) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((4-(トリフルオロメチル)フェニル)メ
チル)-1,3-オキサゾリジン-2-オン(5g,14.
7ミリモル)のN,N-ジメチルホルムアミド(30m
l)溶液に60%水素化ナトリウム(710mg,1
7.7ミリモル)を加え、室温で15分間攪拌した。反
応液にヨウ化メチル(5ml,80ミリモル)を加え、
1時間攪拌した。反応液を水(300ml)で希釈し、
酢酸エチル(200ml×2)で抽出した。抽出液を
水、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物をジイソプロピルエーテル−ヘ
キサンから再結晶させて、(4RS,5SR)-5-(4
-フルオロフェニル)-3-メチル-4-((4-(トリフル
オロメチル)フェニル)メチル)-1,3-オキサゾリジ
ン-2-オン(4.76g,91%)を得た。 mp 77-78℃ IRνmaxKBrcm-1: 1759, 1609, 1514. Anal. Calcd for C18H15F4NO2: C, 61.19; H, 4.28; N,
3.96 Found: C, 61.25; H, 4.21; N, 3.96.1 H-NMR (CDCl3)δ: 2.45 (1H, dd, J = 14.2, 7.2 Hz),
2.77 (1H, dd, 14.2, 7.2 Hz), 4.30 (1H, q, J = 6.6
Hz), 5.59 (1H, d, J = 8.0 Hz), 6.92 (2H, d,J = 8.
0 Hz), 6.94-7.08 (2H, m), 7.10-7.20 (2H, m), 7.44
(2H, d, J = 8.0Hz). 2) (4RS,5SR)-5-(4-フルオロフェニ
ル)-3-メチル-4-((4-(トリフルオロメチル)フ
ェニル)メチル)-1,3-オキサゾリジン-2-オン
(4.56g,12.9ミリモル)のエタノール(20
ml)溶液に8規定水酸化ナトリウム水溶液(8.07
ml)を加え、3時間加熱還流した。反応液を水(20
0ml)で希釈し、酢酸エチル(200ml×2)で抽
出した。抽出液を水、飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をジイソプロ
ピルエーテル−ヘキサンから再結晶させて、(1RS,
2SR)-1-(4-フルオロフェニル)-2-(メチルア
ミノ)-3-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(3.34mg,79%)を得た。 mp 79-80℃ IRνmaxKBrcm-1: 1618, 1605, 1510. Anal. Calcd for C17H17F4NO: C, 62.38; H, 5.23; N,
4.28 Found: C, 62.38; H, 5.11; N, 4.27.1 H-NMR (CDCl3)δ: 2.41 (3H, s), 2.44-2.60 (2H, m),
2.84-2.96 (1H, m), 4.94 (1H, d, J = 3.2 Hz), 7.00
-7.12 (2H, m), 7.18 (2H, d, J = 8.0 Hz), 7.32-7.50
(2H, m), 7.52 (2H, d, J = 8.0 Hz). 3) (1RS,2SR)-1-(4-フルオロフェニ
ル)-2-(メチルアミノ)-3-(4-(トリフルオロメ
チル)フェニル)-1-プロパノール(150mg,0.
46ミリモル)の酢酸エチル(5ml)溶液に1-ナフ
トイルクロリド(76ml,0.50ミリモル)および
飽和重曹水(5ml)を加えて室温で6時間攪拌した。
反応液を水(50ml)で希釈し、酢酸エチル(50m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=4:1−1:1)で精製し酢酸エチル−ヘキサン
から再結晶させて、表題化合物(166mg,75%)
を得た。 mp 196-197℃ IRνmaxKBrcm-1: 1605, 1510, 1325. Anal. Calcd for C28H23F4NO2: C, 69.85; H, 4.81; N,
2.91 Found: C, 69.76; H, 4.89; N, 2.80.1 H-NMR (CDCl3)δ: 2.48 (3H, d, J = 4.4 Hz), 3.02-
3.30 (1H, m), 3.60-3.78(1H, m), 6.08 (1H, d, J =
8.6 Hz), 6.24-6.36 (1H, m), 7.00-7.50 (6H, m), 7.5
8-7.80 (9H, m).Example 121 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -N-methyl-1-naphthalenecarboxamide 1) (4RS, 5SR) -5- (4-fluorophenyl) -4- ((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2-one (5 g, 14.
7 mmol) of N, N-dimethylformamide (30 m
l) Add 60% sodium hydride (710 mg, 1
(7.7 mmol) and stirred at room temperature for 15 minutes. Methyl iodide (5 ml, 80 mmol) was added to the reaction solution,
Stir for 1 hour. Dilute the reaction with water (300 ml)
Extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to give (4RS, 5SR) -5- (4
-Fluorophenyl) -3-methyl-4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2-one (4.76 g, 91%) was obtained. mp 77-78 ℃ IRνmax KBr cm -1 : 1759, 1609, 1514. Anal.Calcd for C 18 H 15 F 4 NO 2 : C, 61.19; H, 4.28; N,
3.96 Found:. C, 61.25; H, 4.21; N, 3.96 1 H-NMR (CDCl 3) δ: 2.45 (1H, dd, J = 14.2, 7.2 Hz),
2.77 (1H, dd, 14.2, 7.2 Hz), 4.30 (1H, q, J = 6.6
Hz), 5.59 (1H, d, J = 8.0 Hz), 6.92 (2H, d, J = 8.
0 Hz), 6.94-7.08 (2H, m), 7.10-7.20 (2H, m), 7.44
(2H, d, J = 8.0 Hz). 2) (4RS, 5SR) -5- (4-fluorophenyl) -3-methyl-4-((4- (trifluoromethyl) phenyl) methyl) -1, 3-Oxazolidin-2-one (4.56 g, 12.9 mmol) in ethanol (20
8N aqueous sodium hydroxide solution (8.07
ml) and heated to reflux for 3 hours. The reaction solution was washed with water (20
0 ml) and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to give (1RS,
2SR) -1- (4-Fluorophenyl) -2- (methylamino) -3- (4- (trifluoromethyl) phenyl) -1
-Propanol (3.34 mg, 79%) was obtained. mp 79-80 ℃ IRνmax KBr cm -1 : 1618, 1605, 1510. Anal.Calcd for C 17 H 17 F 4 NO: C, 62.38; H, 5.23; N,
4.28 Found:. C, 62.38; H, 5.11; N, 4.27 1 H-NMR (CDCl 3) δ: 2.41 (3H, s), 2.44-2.60 (2H, m),
2.84-2.96 (1H, m), 4.94 (1H, d, J = 3.2 Hz), 7.00
-7.12 (2H, m), 7.18 (2H, d, J = 8.0 Hz), 7.32-7.50
(2H, m), 7.52 (2H, d, J = 8.0 Hz). 3) (1RS, 2SR) -1- (4-fluorophenyl) -2- (methylamino) -3- (4- (trifluoro Methyl) phenyl) -1-propanol (150 mg, 0.1 mg).
1-Naphthoyl chloride (76 ml, 0.50 mmol) and a saturated aqueous sodium hydrogen carbonate solution (5 ml) were added to a solution of ethyl acetate (5 ml) in a mixture of 46 mmol) and stirred at room temperature for 6 hours.
The reaction solution was diluted with water (50 ml), and ethyl acetate (50 m
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-1: 1) and recrystallized from ethyl acetate-hexane to give the title compound (166 mg, 75%).
I got mp 196-197 ° C IRνmax KBr cm -1 : 1605, 1510, 1325. Anal.Calcd for C 28 H 23 F 4 NO 2 : C, 69.85; H, 4.81; N,
2.91 Found:. C, 69.76; H, 4.89; N, 2.80 1 H-NMR (CDCl 3) δ: 2.48 (3H, d, J = 4.4 Hz), 3.02-
3.30 (1H, m), 3.60-3.78 (1H, m), 6.08 (1H, d, J =
8.6 Hz), 6.24-6.36 (1H, m), 7.00-7.50 (6H, m), 7.5
8-7.80 (9H, m).
【0254】実施例122 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド 1) 3-(4-フルオロフェニル)-3-オキソ-2-[3
-(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]プロピオン酸エチル 3-(1,1,2,2-テトラフルオロエトキシ)トルエ
ン6.70g(32.2ミリモル)、N-ブロモスクシ
ンイミド5.73g(32.2ミリモル)、2,2’-
アゾビス(イソブチロニトリル)10mgの四塩化炭素
30ml溶液を0.5時間加熱還流した。反応液を室温
に冷却した後、白色沈殿を濾過して除き、沈殿をジエチ
ルエーテルで洗浄した。集めた濾液の溶媒を減圧留去し
て、3-(1,1,2,2-テトラフルオロエトキシ)ベ
ンジルブロミドの粗生成物を淡黄色液体として得た。
(4-フルオロベンゾイル)酢酸エチル6.153g
(29.27ミリモル)の1,2-ジメトキシエタン5
0ml溶液に氷冷下60%水素化ナトリウムの流動パラ
フィン懸濁物1.17g(29.3ミリモル)を加え、
そのまま0.5時間撹拌した。これに上で得た3-
(1,1,2,2-テトラフルオロエトキシ)ベンジル
ブロミドの1,2-ジメトキシエタン10ml溶液を室
温で加え、室温で8時間撹拌した。反応液を水に注ぎ、
酢酸エチルで2回抽出した。集めた有機層を無水硫酸マ
グネシウムで乾燥、溶媒を減圧留去した。得られた残留
物をシリカゲルカラムクロマトグラフィーにて精製し
(ヘキサン/酢酸エチル=15/1−9/1)、ヘキサ
ンより結晶化して、目的物を得た。白色結晶 収量7.
539g 収率62% mp 53-54℃; 1H-NMR (CDCl3, 200MHz) δ 1.12 (3H, t,
J = 7.1 Hz), 3.34 (2H, d, J = 7.6 Hz), 4.10 (2H,
q, J = 7.1 Hz), 4.56 (1H, t, J = 7.3 Hz), 5.89 (1
H, tt, J = 2.8 Hz, 53.1 Hz), 7.04-7.16 (5H, m), 7.
27 (1H, t, J = 7.7 Hz), 7.99 (2H, dd, J = 5.5 Hz,
8.7 Hz); IR (KBr) 1728, 1682, 1597, 1325, 1275, 12
36, 1205, 1157, 1134, 1100, 847 cm-1; Anal. Calcd
for C20H17F 5O4: C, 57.70; H, 4.12. Found: C, 57.7
1; H, 4.15. 2) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]プロピオン酸エチル塩化
亜鉛4.70g(34.5ミリモル)をジエチルエーテ
ル80ml中で撹拌しながら水素化ホウ素ナトリウム
2.61g(68.9ミリモル)を室温で加え、そのま
ま2時間撹拌した。混合物の不溶物をろ過で除き(ジエ
チルエーテルで洗浄)、水素化ホウ素亜鉛のジエチルエ
ーテル溶液を得た。得られた溶液に、3-(4-フルオロ
フェニル)-3-オキソ-2-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]プロピオン酸エチル
7.176g(17.24ミリモル)のジエチルエーテ
ル30ml溶液を室温で加え、そのまま2時間撹拌し
た。反応液に希塩酸を少しずつ加えて過剰の水素化ホウ
素亜鉛を分解した後、酢酸エチルで2回抽出した。集め
た有機層を無水硫酸マグネシウムで乾燥、溶媒を減圧留
去した。得られた粗生成物をシリカゲルカラムクロマト
グラフィーにて精製し(ヘキサン/酢酸エチル=6/1
−3/1)、目的物を得た。無色液体 収量7.295
g 収率100%1 H-NMR (CDCl3, 200MHz) δ 0.93 (3H, t, J = 7.1 H
z), 2.90-3.04 (4H, m), 3.89 (2H, q, J = 7.1 Hz),
5.02 (1H, t, J = 3.6 Hz), 5.88 (1H, tt, J = 2.9Hz,
53.2 Hz), 6.95-7.10 (5H, m), 7.24 (1H, t, J = 7.8
Hz), 7.37 (2H, dd, J = 5.5 Hz, 8.7 Hz); IR (neat)
3463, 1725, 1510, 1302, 1279, 1227, 1198, 1159, 1
123, 839 cm-1 3) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]プロピオン酸(2RS,
3RS)-3-(4-フルオロフェニル)-3-ヒドロキシ-
2-[3-(1,1,2,2-テトラフルオロエトキシ)
ベンジル]プロピオン酸エチル7.252g(17.3
3ミリモル)のメタノール30ml−テトラヒドロフラ
ン30ml溶液に1N水酸化ナトリウム水溶液34.7
ml(34.7ミリモル)を加え、室温で一晩撹拌し
た。反応液を濃縮、水で希釈し、1N塩酸で反応液を酸
性にした後、酢酸エチルで2回抽出した。集めた有機層
を無水硫酸ナトリウムで乾燥、溶媒を減圧留去した。残
留物をヘキサンより結晶化して、目的物を得た。白色結
晶 収量5.795g 収率86% mp 116-117℃; 1H-NMR (CDCl3, 200MHz) δ 2.92-3.08
(3H, m), 5.06 (1H, s),5.88 (1H, tt, J = 2.9 Hz, 5
3.2 Hz), 6.94-7.09 (5H, m), 7.23 (1H, t, J =7.9 H
z), 7.36 (2H, dd, J = 5.4 Hz, 8.6 Hz); IR (KBr) 33
70-2850, 1713, 1229, 1206, 1186, 1115, 841 cm-1; A
nal. Calcd for C18H15F5O4: C, 55.39; H, 3.87. Foun
d: C, 55.51; H, 3.68. 4) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-[3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]-1,3-オキサゾリジン-2-オン (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[3-(1,1,2,2-テトラフルオロ
エトキシ)ベンジル]プロピオン酸4.544g(1
1.64ミリモル)のテトラヒドロフラン40ml溶液
にトリエチルアミン2.43ml(17.5ミリモ
ル)、ジフェニルホスホリルアジド3.52g(12.
8ミリモル)を加え、一晩加熱還流した。反応液の溶媒
を減圧留去し、得られた粗生成物をシリカゲルカラムク
ロマトグラフィーにて精製し(ヘキサン/酢酸エチル=
3/1−1/1)、ジエチルエーテル−ヘキサンより結
晶化して、目的物を得た。白色結晶 収量4.241g
収率94% mp 135-136℃; 1H-NMR (CDCl3, 200MHz) δ 2.20-2.36
(2H, m), 4.26 (1H, dt,J = 5.5 Hz, 8.6 Hz), 4.97 (1
H, br s), 5.80 (1H, d, J = 8.2 Hz), 5.90 (1H, tt,
J = 2.8 Hz, 53.0 Hz), 6.88 (1H, s), 6.95 (1H, d, J
= 7.6 Hz), 7.07-7.17 (3H, m), 7.31-7.39 (3H, m);
IR (KBr) 3241, 1740, 1514, 1236, 1223, 1196, 1144,
1127, 851 cm-1; Anal. Calcd for C18H14F5NO3: C, 5
5.82; H,3.64; N, 3.62. Found: C, 55.96; H, 3.77;
N, 3.38. 5) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-[3-(1,1,2,2-テトラフルオ
ロエトキシ)フェニル]プロパン-1-オール (4RS,5SR)-5-(4-フルオロフェニル)-4-
[3-(1,1,2,2-テトラフルオロエトキシ)ベン
ジル]-1,3-オキサゾリジン-2-オン4.069g
(10.51ミリモル)と水酸化ナトリウム1.68g
(42.0ミリモル)をエタノール30ml−水2ml
中で、6時間加熱還流した。反応液を水で希釈し、酢酸
エチルで2回抽出した。集めた有機層を無水硫酸ナトリ
ウムで乾燥、溶媒を減圧留去した。残留物をジイソプロ
ピルエーテル−ヘキサンより結晶化して、目的物を得
た。白色結晶 収量2.961g 収率78% mp 87-88℃; 1H-NMR (CDCl3, 200MHz) δ 2.38 (1H, d
d, J = 10.4 Hz, 13.8 Hz), 2.81 (1H, dd, J = 3.0 H
z, 14.0 Hz), 3.27 (1H, ddd, J = 3.4 Hz, 4.9 Hz, 1
0.4 Hz), 4.65 (1H, d, J = 5.2 Hz), 5.89 (1H, tt, J
= 2.8 Hz, 53.1 Hz), 7.00-7.13 (5H, m), 7.30-7.40
(3H, m); IR (KBr) 3368, 3250-2720, 1508,1211, 119
9, 1127, 1101, 1044 cm-1; Anal. Calcd for C17H16F5
NO2: C, 56.51; H, 4.46; N, 3.88. Found: C, 56.43;
H, 4.50; N, 3.58. 6) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]-6,7-ジヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサ
ミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.173g
(0.479ミリモル)、6,7-ジヒドロ-5H-ベン
ゾ[a]シクロヘプテン-1-カルボン酸90mg(0.
48ミリモル)、1-ヒドロキシベンゾトリアゾール水
和物73mg(0.48ミリモル)をアセトニトリル1
0ml中で撹拌しながら1-エチル-3-(3-ジメチルア
ミノプロピル)カルボジイミド・塩酸塩92mg(0.
48ミリモル)を加え、室温で一晩撹拌した。反応液を
酢酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗
浄、無水硫酸マグネシウムで乾燥、シリカゲルを通した
後、溶媒を減圧留去した。得られた残留物をジイソプロ
ピルエーテル−ヘキサンより結晶化して、目的物を得
た。白色結晶 収量0.216g 収率85% mp 176-177℃; 1H-NMR (CDCl3, 200MHz) δ 1.93-2.05
(2H, m), 2.15-2.24 (2H, m), 2.67 (2H, t, J = 5.8 H
z), 2.78 (1H, dd, J = 10.8 Hz, 14.4 Hz), 3.00 (1H,
dd, J = 4.2 Hz, 14.4 Hz), 3.61 (1H, d, J = 3.6 H
z), 4.60-4.73 (1H, m), 5.03 (1H, t, J = 3.8 Hz),
5.73 (1H, d, J = 8.2 Hz), 5.88 (1H, tt,J = 2.5 Hz,
53.1 Hz), 5.92 (1H, td, J = 5.4 Hz, 12.2 Hz), 6.2
0 (1H, d, J= 11.8 Hz), 6.94-7.17 (8H, m), 7.30 (1
H, t, J = 7.8 Hz), 7.43 (2H, dd,J = 5.6 Hz, 8.4 H
z); IR (KBr) 3270, 1640, 1510, 1227, 1198, 1127 cm
-1; Anal. Calcd for C29H26F5NO3: C, 65.53; H, 4.9
3; N, 2.64. Found: C, 65.39;H, 4.84; N, 2.63.Example 122 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafur
Oroethoxy) benzyl] ethyl] -6,7-dihydro-
5H-benzo [a] cycloheptene-1-carboxamide 1) 3- (4-fluorophenyl) -3-oxo-2- [3
-(1,1,2,2-tetrafluoroethoxy) benzyl
Ethyl propionate 3- (1,1,2,2-tetrafluoroethoxy) tolue
6.70 g (32.2 mmol), N-bromosuccinate
5.73 g (32.2 mmol) of imido, 2,2'-
Azobis (isobutyronitrile) 10mg carbon tetrachloride
The 30 ml solution was heated to reflux for 0.5 hours. Reaction solution at room temperature
After cooling to room temperature, the white precipitate was removed by filtration, and the precipitate was
Washed with ether. The solvent of the collected filtrate was distilled off under reduced pressure.
3- (1,1,2,2-tetrafluoroethoxy)
The crude product of benzyl bromide was obtained as a pale yellow liquid.
6.153 g of ethyl (4-fluorobenzoyl) acetate
(29.27 mmol) 1,2-dimethoxyethane 5
0 ml solution of 60% sodium hydride in ice
1.17 g (29.3 mmol) of the fin suspension are added,
The mixture was stirred for 0.5 hours as it was. This was obtained above 3-
(1,1,2,2-tetrafluoroethoxy) benzyl
A 10 ml solution of bromide in 1,2-dimethoxyethane
The mixture was added at room temperature and stirred at room temperature for 8 hours. Pour the reaction into water,
Extracted twice with ethyl acetate. The collected organic layer is dried over anhydrous sulfuric acid.
The extract was dried over magnesium and the solvent was distilled off under reduced pressure. The residue obtained
The product was purified by silica gel column chromatography.
(Hexane / ethyl acetate = 15 / 1-9 / 1), hexa
The product was crystallized from the compound to give the desired product. White crystals Yield 7.
539 g yield 62% mp 53-54 ° C;1H-NMR (CDClThree, 200MHz) δ 1.12 (3H, t,
J = 7.1 Hz), 3.34 (2H, d, J = 7.6 Hz), 4.10 (2H,
q, J = 7.1 Hz), 4.56 (1H, t, J = 7.3 Hz), 5.89 (1
H, tt, J = 2.8 Hz, 53.1 Hz), 7.04-7.16 (5H, m), 7.
27 (1H, t, J = 7.7 Hz), 7.99 (2H, dd, J = 5.5 Hz,
8.7 Hz); IR (KBr) 1728, 1682, 1597, 1325, 1275, 12
36, 1205, 1157, 1134, 1100, 847 cm-1; Anal. Calcd
for C20H17F FiveOFour: C, 57.70; H, 4.12. Found: C, 57.7
1; H, 4.15.2) (2RS, 3RS) -3- (4-fluorophenyl)
) -3-Hydroxy-2- [3- (1,1,2,2-tetra
Fluoroethoxy) benzyl] ethyl propionate chloride
4.70 g (34.5 mmol) of zinc was added to diethyl ether
Sodium borohydride with stirring in 80 ml
2.61 g (68.9 mmol) are added at room temperature and
The mixture was further stirred for 2 hours. The mixture is filtered to remove insolubles (die
Butyl ether)
A solution was obtained. To the resulting solution, add 3- (4-fluoro
Phenyl) -3-oxo-2- [3- (1,1,2,2-tet
Lafluoroethoxy) benzyl] ethyl propionate
7.176 g (17.24 mmol) of diethyl ether
30 ml solution at room temperature and stir for 2 hours
Was. Dilute hydrochloric acid is added little by little to the reaction mixture, and excess borohydride is added.
After decomposing the zinc oxide, it was extracted twice with ethyl acetate. gather
The dried organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure.
I left. The obtained crude product is subjected to silica gel column chromatography.
Purified by chromatography (hexane / ethyl acetate = 6/1)
-3/1) to obtain the desired product. Colorless liquid yield 7.295
g 100% yield1 H-NMR (CDClThree, 200MHz) δ 0.93 (3H, t, J = 7.1 H
z), 2.90-3.04 (4H, m), 3.89 (2H, q, J = 7.1 Hz),
5.02 (1H, t, J = 3.6 Hz), 5.88 (1H, tt, J = 2.9 Hz,
53.2 Hz), 6.95-7.10 (5H, m), 7.24 (1H, t, J = 7.8
Hz), 7.37 (2H, dd, J = 5.5 Hz, 8.7 Hz); IR (neat)
3463, 1725, 1510, 1302, 1279, 1227, 1198, 1159, 1
123, 839 cm-1 3) (2RS, 3RS) -3- (4-fluorophenyl)
) -3-Hydroxy-2- [3- (1,1,2,2-tetra
Fluoroethoxy) benzyl] propionic acid (2RS,
3RS) -3- (4-Fluorophenyl) -3-hydroxy-
2- [3- (1,1,2,2-tetrafluoroethoxy)
7.252 g of ethyl [benzyl] propionate (17.3 g)
3 mmol) of methanol 30 ml-tetrahydrofura
34.7% 1N aqueous sodium hydroxide solution in 30 ml solution
ml (34.7 mmol) and stirred at room temperature overnight.
Was. The reaction mixture was concentrated, diluted with water, and acidified with 1N hydrochloric acid.
After quenching, it was extracted twice with ethyl acetate. Organic layer collected
Was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. Remaining
The distillate was crystallized from hexane to obtain the desired product. White
Crystal yield 5.795 g yield 86% mp 116-117 ° C;1H-NMR (CDClThree, 200MHz) δ 2.92-3.08
(3H, m), 5.06 (1H, s), 5.88 (1H, tt, J = 2.9 Hz, 5
3.2 Hz), 6.94-7.09 (5H, m), 7.23 (1H, t, J = 7.9 H
z), 7.36 (2H, dd, J = 5.4 Hz, 8.6 Hz); IR (KBr) 33
70-2850, 1713, 1229, 1206, 1186, 1115, 841 cm-1; A
nal.Calcd for C18H15FFiveOFour: C, 55.39; H, 3.87. Foun
d: C, 55.51; H, 3.68. 4) (4RS, 5SR) -5- (4-fluorophenyl)
) -4- [3- (1,1,2,2-tetrafluoroethoxy)
B) Benzyl] -1,3-oxazolidin-2-one (2RS, 3RS) -3- (4-fluorophenyl) -3-
Hydroxy-2- [3- (1,1,2,2-tetrafluoro
[Ethoxy] benzyl] propionic acid 4.544 g (1
1.64 mmol) in 40 ml of tetrahydrofuran
2.43 ml of triethylamine (17.5 mmol
3.52 g of diphenylphosphoryl azide (12.
(8 mmol) and heated to reflux overnight. Reaction solvent
Was distilled off under reduced pressure, and the resulting crude product was
Purify by chromatography (hexane / ethyl acetate =
3 / 1-1-1), formed from diethyl ether-hexane
Crystallization gave the desired product. 4.241 g of white crystals
Yield 94% mp 135-136 ° C;1H-NMR (CDClThree, 200MHz) δ 2.20-2.36
(2H, m), 4.26 (1H, dt, J = 5.5 Hz, 8.6 Hz), 4.97 (1
H, br s), 5.80 (1H, d, J = 8.2 Hz), 5.90 (1H, tt,
J = 2.8 Hz, 53.0 Hz), 6.88 (1H, s), 6.95 (1H, d, J
= 7.6 Hz), 7.07-7.17 (3H, m), 7.31-7.39 (3H, m);
IR (KBr) 3241, 1740, 1514, 1236, 1223, 1196, 1144,
1127, 851 cm-1; Anal. Calcd for C18H14FFiveNOThree: C, 5
5.82; H, 3.64; N, 3.62. Found: C, 55.96; H, 3.77;
N, 3.38.5) (1RS, 2SR) -2-amino-1- (4-fluoro
L-phenyl) -3- [3- (1,1,2,2-tetrafluoro
Roethoxy) phenyl] propan-1-ol (4RS, 5SR) -5- (4-fluorophenyl) -4-
[3- (1,1,2,2-tetrafluoroethoxy) benne
Jill] -1,3-oxazolidine-2-one 4.069 g
(10.51 mmol) and 1.68 g of sodium hydroxide
(42.0 mmol) in 30 ml of ethanol-2 ml of water
And heated to reflux for 6 hours. Dilute the reaction with water and add acetic acid
Extracted twice with ethyl. The collected organic layer is dried over anhydrous sodium sulfate.
And dried under reduced pressure. Diisopro residue
Crystallized from pill ether-hexane to obtain the desired product
Was. White crystal yield 2.961 g yield 78% mp 87-88 ° C;1H-NMR (CDClThree, 200MHz) δ 2.38 (1H, d
d, J = 10.4 Hz, 13.8 Hz), 2.81 (1H, dd, J = 3.0 H
z, 14.0 Hz), 3.27 (1H, ddd, J = 3.4 Hz, 4.9 Hz, 1
0.4 Hz), 4.65 (1H, d, J = 5.2 Hz), 5.89 (1H, tt, J
= 2.8 Hz, 53.1 Hz), 7.00-7.13 (5H, m), 7.30-7.40
(3H, m); IR (KBr) 3368, 3250-2720, 1508,1211, 119
9, 1127, 1101, 1044 cm-1; Anal. Calcd for C17H16FFive
NOTwo: C, 56.51; H, 4.46; N, 3.88. Found: C, 56.43;
H, 4.50; N, 3.58.6) N-[(1RS, 2SR) -2- (4-fluorophene)
Nil) -2-hydroxy-1- [3- (1,1,2,2-tetra
Lafluoroethoxy) benzyl] ethyl] -6,7-dihi
Dro-5H-benzo [a] cycloheptene-1-carboxa
Mid (1RS, 2SR) -2-amino-1- (4-fluorophene)
Nyl) -3- [3- (1,1,2,2-tetrafluoroeth
[Xy) phenyl] propan-1-ol 0.173 g
(0.479 mmol), 6,7-dihydro-5H-ben
90 mg of zo [a] cycloheptene-1-carboxylic acid (0.
48 mmol) 1-hydroxybenzotriazole water
73 mg (0.48 mmol) of acetonitrile 1
While stirring in 0 ml, 1-ethyl-3- (3-dimethyla
Minopropyl) carbodiimide hydrochloride 92 mg (0.
48 mmol) and stirred at room temperature overnight. Reaction solution
Dilute in ethyl acetate and wash with aqueous sodium bicarbonate
Purified, dried over anhydrous magnesium sulfate, passed through silica gel
Thereafter, the solvent was distilled off under reduced pressure. The resulting residue is
Crystallized from pill ether-hexane to obtain the desired product
Was. White crystals Yield 0.216 g Yield 85% mp 176-177 ° C;1H-NMR (CDClThree, 200MHz) δ 1.93-2.05
(2H, m), 2.15-2.24 (2H, m), 2.67 (2H, t, J = 5.8 H
z), 2.78 (1H, dd, J = 10.8 Hz, 14.4 Hz), 3.00 (1H,
dd, J = 4.2 Hz, 14.4 Hz), 3.61 (1H, d, J = 3.6 H
z), 4.60-4.73 (1H, m), 5.03 (1H, t, J = 3.8 Hz),
5.73 (1H, d, J = 8.2 Hz), 5.88 (1H, tt, J = 2.5 Hz,
53.1 Hz), 5.92 (1H, td, J = 5.4 Hz, 12.2 Hz), 6.2
0 (1H, d, J = 11.8 Hz), 6.94-7.17 (8H, m), 7.30 (1
H, t, J = 7.8 Hz), 7.43 (2H, dd, J = 5.6 Hz, 8.4 H
z); IR (KBr) 3270, 1640, 1510, 1227, 1198, 1127 cm
-1; Anal. Calcd for C29H26FFiveNOThree: C, 65.53; H, 4.9
3; N, 2.64. Found: C, 65.39; H, 4.84; N, 2.63.
【0255】実施例123 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-5,6-ジヒドロナ
フタレン-1-カルボキサミド 1) 5,6-ジヒドロナフタレン-1-カルボン酸メチ
ル 8-ヒドロキシ-5,6,7,8-テトラヒドロナフタレ
ン-1-カルボン酸メチル(Tetrahedron,5
3,15969-15982(1990)参照)5.0
29g(32.63ミリモル)を10%塩化水素のメタ
ノール溶液80ml中で一晩加熱還流した。反応液の溶
媒を減圧留去し、得られた残留物をシリカゲルカラムク
ロマトグラフィーにて精製して(ヘキサン/酢酸エチル
=6/1)、目的物を得た。無色液体 収量0.239
g 収率17%1 H-NMR (CDCl3, 200MHz) δ 2.23-2.34 (2H, m), 2.81
(2H, t, J = 8.2 Hz), 3.89 (3H, s), 6.22 (1H, td, J
= 4.8 Hz, 9.7 Hz), 7.14 (1H, t, J = 7.5 Hz), 7.25
(1H, d, J = 7.4 Hz), 7.33 (1H, td, J = 1.6 Hz, 1
0.2 Hz), 7.69 (1H, dd, J = 1.5 Hz, 7.7 Hz); IR (ne
at) 1721, 1264, 1142, 781 cm-1 2) 5,6-ジヒドロナフタレン-1-カルボン酸 5,6-ジヒドロナフタレン-1-カルボン酸メチル0.
276g(1.466ミリモル)のメタノール30ml
溶液に1N水酸化ナトリウム水溶液8.80ml(8.
80ミリモル)を加え、70℃で8時間撹拌した。反応
液を水で希釈し、希塩酸で反応液を酸性にした後、酢酸
エチルで2回抽出した。集めた有機層を無水硫酸ナトリ
ウムで乾燥、溶媒を減圧留去した。残留物をヘキサンよ
り結晶化して、目的物を得た。白色結晶 収量0.15
8g 収率62% mp 119-120℃; 1H-NMR (CDCl3, 200MHz) δ 2.25-2.36
(2H, m), 2.83 (2H, t,J = 8.2 Hz), 6.27 (1H, td, J
= 4.8 Hz, 9.7 Hz), 7.19 (1H, t, J = 7.6 Hz), 7.32
(1H, d, J = 7.4 Hz), 7.49 (1H, td, J = 1.6 Hz, 10.
0 Hz), 7.87 (1H, dd, J = 1.3 Hz, 7.9 Hz), 11.60 (1
H, br s); 3) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]-5,6-ジヒ
ドロナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.203g
(0.562ミリモル)、5,6-ジヒドロナフタレン-
1-カルボン酸98mg(0.56ミリモル)、1-ヒド
ロキシベンゾトリアゾール水和物86mg(0.56ミ
リモル)をアセトニトリル10ml中で撹拌しながら1
-エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩0.11g(0.56ミリモル)を加え、
室温で一晩撹拌した。反応液を酢酸エチルに希釈し、炭
酸水素ナトリウム水溶液で洗浄、無水硫酸マグネシウム
で乾燥、シリカゲルを通した後、溶媒を減圧留去した。
得られた残留物をジイソプロピルエーテル−ヘキサンよ
り結晶化して、目的物を得た。白色結晶 収量0.24
2g 収率83% mp 165-166℃; 1H-NMR (CDCl3, 200MHz) δ 2.18-2.28
(2H, m), 2.70-2.85 (3H, m), 3.01 (1H, dd, J = 4.5
Hz, 14.3 Hz), 3.57 (1H, d, J = 3.6 Hz), 4.59-4.73
(1H, m), 5.04 (1H, t, J = 3.8 Hz), 5.67 (1H, d, J
= 8.2 Hz), 5.89(1H, tt, J = 2.8 Hz, 53.1 Hz), 6.00
(1H, td, J = 9.3 Hz, 9.4 Hz), 6.34 (1H, d, J = 1
0.0 Hz), 6.85 (1H, d, J = 6.6 Hz), 6.99-7.14 (7H,
m), 7.31 (1H, t, J = 7.6 Hz), 7.43 (2H, dd, J = 5.
4 Hz, 8.8 Hz); IR (KBr) 3266, 1640, 1514, 1209, 11
23 cm-1; Anal. Calcd for C28H24F5NO3: C, 64.99; H,
4.67; N, 2.71. Found: C, 65.05; H, 4.66; N, 2.75.Example 123 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -5,6-dihydronaphthalene-1-carboxamide 1) 5,6-dihydronaphthalene-1-carboxylic acid Methyl acid methyl 8-hydroxy-5,6,7,8-tetrahydronaphthalene-1-carboxylate (Tetrahedron, 5
3, 15969-15982 (1990)) 5.0
29 g (32.63 mmol) was heated to reflux overnight in 80 ml of a 10% methanol solution of hydrogen chloride. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 6/1) to obtain the desired product. Colorless liquid Yield 0.239
g Yield 17% 1 H-NMR (CDCl 3 , 200 MHz) δ 2.23-2.34 (2H, m), 2.81
(2H, t, J = 8.2 Hz), 3.89 (3H, s), 6.22 (1H, td, J
= 4.8 Hz, 9.7 Hz), 7.14 (1H, t, J = 7.5 Hz), 7.25
(1H, d, J = 7.4 Hz), 7.33 (1H, td, J = 1.6 Hz, 1
0.2 Hz), 7.69 (1H, dd, J = 1.5 Hz, 7.7 Hz); IR (ne
at) 1721, 1264, 1142, 781 cm -1 2) 5,6-dihydronaphthalene-1-carboxylic acid methyl 5,6-dihydronaphthalene-1-carboxylate
30 ml of 276 g (1.466 mmol) of methanol
8.80 ml of 1N aqueous sodium hydroxide solution (8.8.
(80 mmol) and stirred at 70 ° C. for 8 hours. The reaction solution was diluted with water, acidified with dilute hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from hexane to obtain the desired product. White crystals Yield 0.15
8g Yield 62% mp 119-120 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 2.25-2.36
(2H, m), 2.83 (2H, t, J = 8.2 Hz), 6.27 (1H, td, J
= 4.8 Hz, 9.7 Hz), 7.19 (1H, t, J = 7.6 Hz), 7.32
(1H, d, J = 7.4 Hz), 7.49 (1H, td, J = 1.6 Hz, 10.
0 Hz), 7.87 (1H, dd, J = 1.3 Hz, 7.9 Hz), 11.60 (1
H, brs); 3) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] Ethyl] -5,6-dihydronaphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) [Phenyl] propan-1-ol 0.203 g
(0.562 mmol), 5,6-dihydronaphthalene-
98 mg (0.56 mmol) of 1-carboxylic acid, 86 mg (0.56 mmol) of 1-hydroxybenzotriazole hydrate were added to 10 ml of acetonitrile while stirring.
0.11 g (0.56 mmol) of -ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added,
Stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure.
The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.24
2g yield 83% mp 165-166 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 2.18-2.28
(2H, m), 2.70-2.85 (3H, m), 3.01 (1H, dd, J = 4.5
Hz, 14.3 Hz), 3.57 (1H, d, J = 3.6 Hz), 4.59-4.73
(1H, m), 5.04 (1H, t, J = 3.8 Hz), 5.67 (1H, d, J
= 8.2 Hz), 5.89 (1H, tt, J = 2.8 Hz, 53.1 Hz), 6.00
(1H, td, J = 9.3 Hz, 9.4 Hz), 6.34 (1H, d, J = 1
0.0 Hz), 6.85 (1H, d, J = 6.6 Hz), 6.99-7.14 (7H,
m), 7.31 (1H, t, J = 7.6 Hz), 7.43 (2H, dd, J = 5.
4 Hz, 8.8 Hz); IR (KBr) 3266, 1640, 1514, 1209, 11
23 cm -1 ; Anal.Calcd for C 28 H 24 F 5 NO 3 : C, 64.99; H,
4.67; N, 2.71. Found: C, 65.05; H, 4.66; N, 2.75.
【0256】実施例124 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7,8,9-テ
トラヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カル
ボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.259g
(0.717ミリモル)、6,7,8,9-テトラヒド
ロ-5H-ベンゾ[a]シクロヘプテン-1-カルボン酸
0.14g(0.72ミリモル)、1-ヒドロキシベン
ゾトリアゾール水和物0.11g(0.72ミリモル)
をアセトニトリル10ml中で撹拌しながら1-エチル-
3-(3-ジメチルアミノプロピル)カルボジイミド・塩
酸塩0.14g(0.72ミリモル)を加え、室温で一
晩撹拌した。反応液を酢酸エチルに希釈し、炭酸水素ナ
トリウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、
シリカゲルを通した後、溶媒を減圧留去した。得られた
残留物をジイソプロピルエーテル−ヘキサンより結晶化
して、目的物を得た。白色結晶 収量0.339g 収
率89% mp 194-195℃; 1H-NMR (CDCl3, 200MHz) δ 1.41-1.63
(4H, m), 1.71-1.80 (2H, m), 2.57-2.63 (2H, m), 2.7
2 (1H, dd, J = 10.9 Hz, 14.5 Hz), 2.73-2.79(2H,
m), 3.03 (1H, dd, J = 3.8 Hz, 14.4 Hz), 3.52 (1H,
d, J = 3.8 Hz), 4.63-4.76 (1H, m), 5.02 (1H, t, J
= 3.8 Hz), 5.60 (1H, d, J = 8.8 Hz), 5.89 (1H, tt,
J = 2.8 Hz, 53.1 Hz), 6.68 (1H, dd, J = 1.5 Hz,
7.4 Hz), 6.93-7.14 (6H, m), 7.26-7.35 (2H, m), 7.4
3 (2H, dd, J = 5.4 Hz, 8.6 Hz); IR(KBr) 3270, 292
6, 1638, 1530, 1514, 1227, 1211, 1125 cm-1; Anal.
Calcdfor C29H28F5NO3: C, 65.28; H, 5.29; N, 2.63.
Found: C, 65.23; H, 5.58; N, 2.64.Example 124 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7,8,9-tetrahydro-5H-benzo [a] cycloheptene-1-carboxamide ( 0.259 g of 1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol
(0.717 mmol), 6,7,8,9-tetrahydro-5H-benzo [a] cycloheptene-1-carboxylic acid 0.14 g (0.72 mmol), 1-hydroxybenzotriazole hydrate 0.11 g (0.72 mmol)
Was stirred in 10 ml of acetonitrile while stirring in 1-ethyl-
0.14 g (0.72 mmol) of 3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous solution of sodium hydrogen carbonate, and dried over anhydrous magnesium sulfate.
After passing through silica gel, the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.339 g Yield 89% mp 194-195 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.41-1.63
(4H, m), 1.71-1.80 (2H, m), 2.57-2.63 (2H, m), 2.7
2 (1H, dd, J = 10.9 Hz, 14.5 Hz), 2.73-2.79 (2H,
m), 3.03 (1H, dd, J = 3.8 Hz, 14.4 Hz), 3.52 (1H,
d, J = 3.8 Hz), 4.63-4.76 (1H, m), 5.02 (1H, t, J
= 3.8 Hz), 5.60 (1H, d, J = 8.8 Hz), 5.89 (1H, tt,
J = 2.8 Hz, 53.1 Hz), 6.68 (1H, dd, J = 1.5 Hz,
7.4 Hz), 6.93-7.14 (6H, m), 7.26-7.35 (2H, m), 7.4
3 (2H, dd, J = 5.4 Hz, 8.6 Hz); IR (KBr) 3270, 292
6, 1638, 1530, 1514, 1227, 1211, 1125 cm -1 ; Anal.
Calcdfor C 29 H 28 F 5 NO 3 : C, 65.28; H, 5.29; N, 2.63.
Found: C, 65.23; H, 5.58; N, 2.64.
【0257】実施例125 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]エチル]ナフ
タレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.165g
(0.457ミリモル)、4-フルオロ-1-ナフトエ酸
87mg(0.46ミリモル)、1-ヒドロキシベンゾ
トリアゾール水和物70mg(0.46ミリモル)をア
セトニトリル10ml中で撹拌しながら1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩87mg(0.46ミリモル)を加え、室温で一晩撹
拌した。反応液を酢酸エチルに希釈し、炭酸水素ナトリ
ウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、シリ
カゲルを通した後、溶媒を減圧留去した。得られた残留
物をジイソプロピルエーテル−ヘキサンより結晶化し
て、目的物を得た。白色結晶 収量0.198g 収率
81% mp 186-187℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
89 (1H, dd, J = 10.1 Hz, 14.1 Hz), 3.00 (1H, dd, J
= 4.8 Hz, 14.4 Hz), 4.69-4.84 (1H, m), 5.00-5.06
(2H, m), 5.93 (1H, tt, J = 2.9 Hz, 53.1 Hz), 6.98-
7.57 (13H, m), 7.75 (1H, d, J = 8.0 Hz), 8.06 (1H,
d, J = 7.4 Hz); IR (KBr) 3272, 1640,1624, 1601, 1
535, 1512, 1229, 1198, 1127, 835, 760 cm-1; Anal.
Calcd forC28H21F6NO3: C, 63.04; H, 3.97; N, 2.63.
Found: C, 63.05; H, 4.17; N, 2.49.Example 125 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2,2
2-tetrafluoroethoxy) benzyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (1,1,2,2-tetrafluoro Ethoxy) phenyl] propan-1-ol 0.165 g
(0.457 mmol) 4-fluoro-1-naphthoic acid 87 mg (0.46 mmol), 1-hydroxybenzotriazole hydrate 70 mg (0.46 mmol) were stirred in 10 ml of acetonitrile with 1-ethyl- 3-
87 mg (0.46 mmol) of (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.198 g Yield 81% mp 186-187 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
89 (1H, dd, J = 10.1 Hz, 14.1 Hz), 3.00 (1H, dd, J
= 4.8 Hz, 14.4 Hz), 4.69-4.84 (1H, m), 5.00-5.06
(2H, m), 5.93 (1H, tt, J = 2.9 Hz, 53.1 Hz), 6.98-
7.57 (13H, m), 7.75 (1H, d, J = 8.0 Hz), 8.06 (1H,
d, J = 7.4 Hz); IR (KBr) 3272, 1640,1624, 1601, 1
535, 1512, 1229, 1198, 1127, 835, 760 cm -1 ; Anal.
Calcd forC 28 H 21 F 6 NO 3 : C, 63.04; H, 3.97; N, 2.63.
Found: C, 63.05; H, 4.17; N, 2.49.
【0258】実施例126 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-5,6,7,8-テ
トラヒドロベンゾ[a]シクロオクテン-1-カルボキサ
ミド 1) 7,8,9,10-テトラヒドロベンゾ[a]シ
クロオクテン-5(6H)-オン 6-フェニルヘキサン酸26.16g(136.1ミリ
モル)、N,N-ジメチルホルムアミド0.1mlのテ
トラヒドロフラン130ml溶液に室温で塩化オキザリ
ル17.8ml(204ミリモル)を滴下した後、その
まま0.5時間撹拌した。反応混合物の溶媒を減圧留去
し、酸塩化物を黄色液体として得た。塩化アルミニウム
36.3g(272ミリモル)の塩化メチレン250m
l懸濁液を撹拌しながら、これに上で得た酸塩化物の塩
化メチレン1.2l溶液を3日間かけて滴下した。反応
液を氷冷しながら、水を加えて反応をクエンチした。混
合物の塩化メチレン層を分離し、水層をジエチルエーテ
ルで抽出した。集めた有機層を無水硫酸マグネシウムで
乾燥、溶媒を減圧留去した。得られた残留物をシリカゲ
ルカラムクロマトグラフィーにて精製して(ヘキサン/
酢酸エチル=15/1−6/1)、目的物を得た。淡黄
色液体 収量16.91g 収率71%1 H-NMR (CDCl3, 200MHz) δ 1.47-1.59 (2H, m), 1.75-
1.91 (4H, m), 2.93 (2H, t, J = 6.8 Hz), 3.05 (2H,
t, J = 6.6 Hz), 7.16-7.44 (3H, m), 7.65 (1H,dd, J
= 1.5 Hz, 7.7 Hz); IR (neat) 2930, 1667, 1445, 126
0, 752 cm-1 2) 5,6,7,8,9,10-ヘキサヒドロベンゾ
[a]シクロオクテン-5-オール 7,8,9,10-テトラヒドロベンゾ[a]シクロオ
クテン-5(6H)-オン16.91g(97.05ミリ
モル)のメタノール100ml溶液に、氷冷下、水素化
ほう素ナトリウム3.67g(97.1ミリモル)を少
しずつ加えた後、室温で1時間撹拌した。反応液を水で
希釈し、室温で0.5時間撹拌した。生じた沈殿を集め
水で洗浄して、目的物を得た。白色結晶 収量16.5
7g 収率97% mp 79-80℃; 1H-NMR (CDCl3, 200MHz) δ 0.87-1.06 (1
H, m), 1.30-1.66 (5H,m), 1.85 (1H, d, J = 2.8 Hz),
1.88-2.00 (1H, m), 2.05-2.22 (1H, m), 2.69-2.86
(2H, m), 5.12-5.21 (1H, m), 7.08-7.30 (3H, m), 7.5
4 (1H, dd, J = 1.4Hz, 7.4 Hz); IR (KBr) 3293, 291
7, 1451, 1028, 760 cm-1; Anal. Calcd for C12H16O・
0.1H2O: C, 80.95; H, 9.17. Found: C, 80.93; H, 9.1
4. 3) 4-(ヒドロキシメチル)-5,6,7,8,9,
10-ヘキサヒドロベンゾ[a]シクロオクテン-5-オ
ール 5,6,7,8,9,10-ヘキサヒドロベンゾ[a]
シクロオクテン-5-オール16.34g(92.70ミ
リモル)とN,N,N’,N’-テトラメチルエチレン
ジアミン30.8g(204ミリモル)のヘキサン20
0ml溶液に、氷冷下で1.6Mn-ブチルリチウムの
ヘキサン溶液127ml(204ミリモル)を滴下した
後、35℃で一晩撹拌した。反応混合物を−78℃に冷
却した後、砕いたドライアイス40gを加え、撹拌しな
がら室温まで昇温した。反応液を水で希釈し、濃塩酸で
酸性にした後、酢酸エチルで3回抽出した。集めた有機
層を無水硫酸マグネシウムで乾燥、溶媒を減圧留去し
た。得られた粗生成物をシリカゲルカラムクロマトグラ
フィー(ヘキサン/酢酸エチル=6/1)に通し、6,
7,8,9,10,10a-ヘキサヒドロ-2H-シクロ
オクタ[cd][2]ベンゾフラン-2-オンの粗生成物
(15.85g)を黄色液体として得た。水素化リチウ
ムアルミニウム2.97g(78.4ミリモル)のテト
ラヒドロフラン150ml懸濁液に、氷冷下、上で得た
液体のテトラヒドロフラン100ml溶液を滴下し、室
温で1時間撹拌した。反応液を氷冷した後、水3ml、
15%水酸化ナトリウム水溶液3ml、水8mlを順次
滴下して、過剰の水素化リチウムアルミニウムを分解
し、そのまま室温で2時間撹拌した。生じた沈殿をろ過
して除き、沈殿を酢酸エチルで洗浄した。集めた濾液の
溶媒を減圧留去した。得られた粗生成物をシリカゲルカ
ラムクロマトグラフィーにて精製し(ヘキサン/酢酸エ
チル=6/1−酢酸エチル)、ジイソプロピルエーテル
より結晶化して目的物を得た。白色結晶 収量11.7
4g 収率61% mp 137-138℃; 1H-NMR (CDCl3, 200MHz) δ 0.66-0.85
(1H, m), 1.24-1.44 (2H, m), 1.55-1.79 (2H, m), 1.9
3-2.11 (3H, m), 2.76-2.84 (2H, m), 2.94 (1H,s), 3.
46 (1H, br s), 4.46 (1H, dd, J = 8.4 Hz, 11.2 Hz),
5.02 (1H, dd,J = 2.9 Hz, 11.7 Hz), 5.44 (1H, t, J
= 8.1 Hz), 7.06-7.23 (3H, m); IR (KBr) 3220, 292
2, 1449, 1053, 1009, 754 cm-1; Anal. Calcd for C13
H18O2: C,75.69; H, 8.80. Found: C, 75.72; H, 8.99. 4) 4-[[[tert-ブチル(ジメチル)シリル]
オキシ]メチル]-5,6,7,8,9,10-ヘキサヒ
ドロベンゾ[a]シクロオクテン-5-オール 4-(ヒドロキシメチル)-5,6,7,8,9,10-
ヘキサヒドロベンゾ[a]シクロオクテン-5-オール1
1.51g(55.80ミリモル)、4-N,N-ジメチ
ルアミノピリジン0.5g、トリエチルアミン9.33
ml(67.0ミリモル)のテトラヒドロフラン70m
l溶液に、室温でtert-ブチルジメチルクロロシラ
ン9.25g(61.4ミリモル)を加え、そのまま一
晩撹拌した。反応液を水に注ぎ、酢酸エチルで2回抽出
した。集めた有機層を無水硫酸マグネシウムで乾燥、溶
媒を減圧留去した。得られた粗生成物をシリカゲルカラ
ムクロマトグラフィーにて精製し(ヘキサン/酢酸エチ
ル=15/1−9/1)、目的物を得た。無色液体 収
量17.90g 収率100%1 H-NMR (CDCl3, 200MHz) δ 0.08 (3H, s), 0.14 (3H,
s), 0.91 (9H, s), 1.23-1.57 (2H, m), 1.60-1.77 (2
H, m), 1.91-2.06 (2H, m), 2.86 (2H, t, J = 4.8 H
z), 3.93 (1H, br d, J = 4.8 Hz), 4.79 (1H, d, J =
12.4 Hz), 5.04 (1H,d, J = 12.0 Hz), 5.30-5.40 (1H,
m), 7.07 (1H, dd, J = 2.0 Hz, 7.2 Hz),7.16 (1H,
t, J = 7.3 Hz), 7.23 (1H, dd, J = 2.0 Hz, 7.4 Hz);
IR (neat) 3412, 2928, 2855, 1472, 1462, 1254, 107
3, 835, 779 cm-1 5) tert-ブチル(5,6,7,8-テトラヒドロ
ベンゾ[a]シクロオクテン-1-イルメトキシ)ジメチ
ルシラン 4-[[[tert-ブチル(ジメチル)シリル]オキ
シ]メチル]-5,6,7,8,9,10-ヘキサヒドロ
ベンゾ[a]シクロオクテン-5-オール17.90g
(55.84ミリモル)、トリエチルアミン15.6m
l(112ミリモル)、4-N,N-ジメチルアミノピリ
ジン0.68g(5.58ミリモル)のアセトニトリル
100ml溶液に氷冷下、メタンスルホニルクロリド
9.59g(83.8ミリモル)のアセトニトリル10
ml溶液を氷冷下滴下した。これに塩化リチウム3.5
5g(83.8ミリモル)を加え、室温で6時間撹拌し
た。反応液を水に注ぎ、酢酸エチルで2回抽出した。集
めた有機層を無水硫酸マグネシウムで乾燥、溶媒を減圧
留去した。得られた残留物をN,N-ジメチルホルムア
ミド80mlにとかし1,8-ジアザビシクロ[5.
4.0]-7-ウンデセン16.7ml(112ミリモ
ル)を加え、80℃で一晩撹拌した。反応液を水に注
ぎ、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸マグネシウムで乾燥、溶媒を減圧留去した。得られた
粗生成物をシリカゲルカラムクロマトグラフィーにて精
製し(ヘキサン/酢酸エチル=15/1)、目的物を得
た。無色液体 収量10.94g 収率65%1 H-NMR (CDCl3, 200MHz) δ 0.10 (6H, s), 0.95 (9H,
s), 1.37-1.49 (2H, m),1.67 (2H, br s), 1.99-2.07
(2H, m), 2.74 (2H, t, J = 5.9 Hz), 4.67 (2H,s), 5.
95 (1H, td, J = 6.7 Hz, 11.5 Hz), 6.32 (1H, d, J =
11.2 Hz), 7.10(1H, dd, J = 1.3 Hz, 7.5 Hz), 7.22
(1H, t, J = 7.8 Hz), 7.35 (1H, d, J= 7.6 Hz); IR
(neat) 2928, 2855, 1472, 1464, 1254, 1111, 1078, 8
37, 777cm-1 6) 5,6,7,8-テトラヒドロベンゾ[a]シク
ロオクテン-1-イルメタノール tert-ブチル(5,6,7,8-テトラヒドロベンゾ
[a]シクロオクテン-1-イルメトキシ)ジメチルシラ
ン10.94g(36.16ミリモル)のテトラヒドロ
フラン100ml溶液に室温で1.0Mテトラブチルア
ンモニウムフルオリドのテトラヒドロフラン溶液43.
4ml(43.4ミリモル)を加え、室温で15分間撹
拌した。反応液を水に注ぎ、酢酸エチルで2回抽出し
た。集めた有機層を無水硫酸マグネシウムで乾燥、溶媒
を減圧留去した。得られた粗生成物をシリカゲルカラム
クロマトグラフィーにて精製し(ヘキサン/酢酸エチル
=6/1−3/1)、目的物を得た。無色液体 収量
5.499g 収率81%1 H-NMR (CDCl3, 200MHz) δ 1.40-1.52 (2H, m), 1.60-
1.74 (3H, m), 2.00-2.11 (2H, m), 2.76 (2H, t, J =
5.8 Hz), 4.68 (2H, d, J = 5.6 Hz), 6.03 (1H,td, J
= 6.7 Hz, 11.7 Hz), 6.50 (1H, d, J = 11.6 Hz), 7.1
4-7.28 (3H, m);IR (neat) 3324, 2926, 2853, 1449, 1
065, 1007, 766 cm-1 7) 5,6,7,8-テトラヒドロベンゾ[a]シク
ロオクテン-1-カルボン酸 5,6,7,8-テトラヒドロベンゾ[a]シクロオク
テン-1-イルメタノール5.419g(28.78ミリ
モル)のアセトン100ml溶液に、氷冷下、無水クロ
ム酸7.20g(72.0ミリモル)と濃硫酸6mlを
水20mlに溶解した溶液をゆっくりと滴下し、滴下終
了後、室温で0.5時間撹拌した。反応液を再び氷冷し
た後、イソプロパノール20mlを加え、そのまま0.
5時間撹拌した。反応液のアセトンを減圧下留去した
後、酢酸エチルに希釈し、水で3回洗浄、無水硫酸マグ
ネシウムで乾燥、溶媒を減圧留去した。得られた残留物
を酢酸エチル−ヘキサンより結晶化して、目的物を得
た。白色結晶 収量2.413g 収率42% mp 164-165℃; 1H-NMR (CDCl3, 200MHz) δ 1.46 (2H,
br s), 1.72 (2H, br s), 2.03 (2H, br s), 2.81 (2H,
t, J = 5.8 Hz), 5.98 (1H, td, J = 7.2 Hz, 11.6 H
z), 6.85 (1H, d, J = 11.8 Hz), 7.29 (1H, t, J = 7.
8 Hz), 7.45 (1H,dd, J = 1.4 Hz, 7.8 Hz), 7.94 (1H,
dd, J = 1.4 Hz, 7.8 Hz); IR (KBr) 3080-2520, 169
0, 1451, 1408, 1275, 924, 770 cm-1; Anal. Calcd fo
r C13H14O2:C, 77.20; H, 6.98. Found: C, 77.38; H,
7.06. 8) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]-5,6,
7,8-テトラヒドロベンゾ[a]シクロオクテン-1-
カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.274g
(0.758ミリモル)、5,6,7,8-テトラヒド
ロベンゾ[a]シクロオクテン-1-カルボン酸0.15
g(0.76ミリモル)、1-ヒドロキシベンゾトリア
ゾール水和物0.12g(0.76ミリモル)をアセト
ニトリル10ml中で撹拌しながら1-エチル-3-(3-
ジメチルアミノプロピル)カルボジイミド・塩酸塩0.
15g(0.76ミリモル)を加え、室温で一晩撹拌し
た。反応液を酢酸エチルに希釈し、炭酸水素ナトリウム
水溶液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲ
ルを通した後、溶媒を減圧留去した。得られた残留物を
ジイソプロピルエーテル−ヘキサンより結晶化して、目
的物を得た。白色粉末 収量0.365g 収率86% mp 189-190℃; 1H-NMR (CDCl3, 200MHz) δ 1.34-1.49
(2H, m), 1.53-1.73 (2H, m), 1.95-2.06 (2H, m), 2.7
0 (2H, t, J = 5.9 Hz), 2.77 (1H, dd, J = 10.4 Hz,
14.4 Hz), 2.97 (1H, dd, J = 4.2 Hz, 14.4 Hz), 3.91
(1H, br s), 4.58-4.71 (1H, m), 5.04 (1H, t, J =
3.7 Hz), 5.80 (1H, td, J = 6.8 Hz, 11.8Hz), 5.88
(1H, tt, J = 2.9 Hz, 53.0 Hz), 6.01 (1H, d, J = 7.
8 Hz), 6.10(1H, d, J = 11.8 Hz), 7.00-7.13 (5H,
m), 7.17-7.32 (4H, m), 7.41 (2H, dd, J = 5.5 Hz,
8.5 Hz); IR (KBr) 3272, 2928, 1640, 1535, 1514, 12
25, 1198, 1128, 777 cm-1; Anal. Calcd for C30H28F5
NO3: C, 66.05; H, 5.17; N, 2.57. Found: C, 65.96;
H, 5.13; N, 2.55.Example 126 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -5,6,7,8-tetrahydrobenzo [a] cyclooctene-1-carboxamide 1) 7 , 8,9,10-Tetrahydrobenzo [a] cycloocten-5 (6H) -one A solution of 26.16 g (136.1 mmol) of 6-phenylhexanoic acid and 0.1 ml of N, N-dimethylformamide in 130 ml of tetrahydrofuran After 17.8 ml (204 mmol) of oxalyl chloride was added dropwise at room temperature, the mixture was stirred for 0.5 hour. The solvent of the reaction mixture was distilled off under reduced pressure to obtain an acid chloride as a yellow liquid. 250 m of methylene chloride of 36.3 g (272 mmol) of aluminum chloride
While stirring the suspension, a solution of the acid chloride obtained above in 1.2 l of methylene chloride was added dropwise thereto over 3 days. The reaction was quenched by adding water while cooling the reaction mixture with ice. The methylene chloride layer of the mixture was separated, and the aqueous layer was extracted with diethyl ether. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The resulting residue was purified by silica gel column chromatography (hexane / hexane).
Ethyl acetate = 15 / 1-6 / 1) to give the desired product. Light yellow liquid Yield 16.91 g Yield 71% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.47-1.59 (2H, m), 1.75-
1.91 (4H, m), 2.93 (2H, t, J = 6.8 Hz), 3.05 (2H,
t, J = 6.6 Hz), 7.16-7.44 (3H, m), 7.65 (1H, dd, J
= 1.5 Hz, 7.7 Hz); IR (neat) 2930, 1667, 1445, 126
0,752 cm -1 2) 5,6,7,8,9,10-hexahydrobenzo [a] cycloocten-5-ol 7,8,9,10-tetrahydrobenzo [a] cyclooctene-5 ( To a solution of 16.Hg-one (16.91 g, 97.05 mmol) in methanol (100 ml) was added sodium borohydride (3.67 g, 97.1 mmol) little by little under ice-cooling, followed by stirring at room temperature for 1 hour. . The reaction was diluted with water and stirred at room temperature for 0.5 hours. The resulting precipitate was collected and washed with water to obtain the desired product. White crystals Yield 16.5
7g Yield 97% mp 79-80 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 0.87-1.06 (1
H, m), 1.30-1.66 (5H, m), 1.85 (1H, d, J = 2.8 Hz),
1.88-2.00 (1H, m), 2.05-2.22 (1H, m), 2.69-2.86
(2H, m), 5.12-5.21 (1H, m), 7.08-7.30 (3H, m), 7.5
4 (1H, dd, J = 1.4Hz, 7.4Hz); IR (KBr) 3293, 291
7, 1451, 1028, 760 cm -1 ; Anal.Calcd for C 12 H 16 O ・
0.1H 2 O: C, 80.95; H, 9.17. Found: C, 80.93; H, 9.1
4.3) 4- (Hydroxymethyl) -5,6,7,8,9,
10-hexahydrobenzo [a] cycloocten-5-ol 5,6,7,8,9,10-hexahydrobenzo [a]
16.34 g (92.70 mmol) of cycloocten-5-ol and 30.8 g (204 mmol) of N, N, N ', N'-tetramethylethylenediamine in hexane 20
127 ml (204 mmol) of a 1.6 Mn-butyllithium hexane solution was added dropwise to the 0 ml solution under ice-cooling, followed by stirring at 35 ° C. overnight. After cooling the reaction mixture to −78 ° C., 40 g of crushed dry ice was added, and the temperature was raised to room temperature with stirring. The reaction solution was diluted with water, acidified with concentrated hydrochloric acid, and extracted three times with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was passed through silica gel column chromatography (hexane / ethyl acetate = 6/1) to give 6,
A crude product of 7,8,9,10,10a-hexahydro-2H-cycloocta [cd] [2] benzofuran-2-one (15.85 g) was obtained as a yellow liquid. To a suspension of 2.97 g (78.4 mmol) of lithium aluminum hydride in 150 ml of tetrahydrofuran was added dropwise a solution of the above obtained liquid in 100 ml of tetrahydrofuran under ice-cooling, followed by stirring at room temperature for 1 hour. After cooling the reaction solution with ice, 3 ml of water was added.
An excess of lithium aluminum hydride was decomposed by sequentially adding 3 ml of 15% aqueous sodium hydroxide solution and 8 ml of water, and the mixture was stirred at room temperature for 2 hours. The resulting precipitate was removed by filtration, and the precipitate was washed with ethyl acetate. The solvent of the collected filtrate was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-ethyl acetate), and crystallized from diisopropyl ether to obtain the desired product. White crystals Yield 11.7
4g Yield 61% mp 137-138 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 0.66-0.85
(1H, m), 1.24-1.44 (2H, m), 1.55-1.79 (2H, m), 1.9
3-2.11 (3H, m), 2.76-2.84 (2H, m), 2.94 (1H, s), 3.
46 (1H, br s), 4.46 (1H, dd, J = 8.4 Hz, 11.2 Hz),
5.02 (1H, dd, J = 2.9 Hz, 11.7 Hz), 5.44 (1H, t, J
= 8.1 Hz), 7.06-7.23 (3H, m); IR (KBr) 3220, 292
2, 1449, 1053, 1009, 754 cm -1 ; Anal.Calcd for C 13
. H 18 O 2: C, 75.69; H, 8.80 Found:. C, 75.72; H, 8.99 4) 4 - [[[tert- butyl (dimethyl) silyl]
[Oxy] methyl] -5,6,7,8,9,10-hexahydrobenzo [a] cycloocten-5-ol 4- (hydroxymethyl) -5,6,7,8,9,10-
Hexahydrobenzo [a] cycloocten-5-ol 1
1.51 g (55.80 mmol), 4-N, N-dimethylaminopyridine 0.5 g, triethylamine 9.33
ml (67.0 mmol) of tetrahydrofuran 70 m
To the solution was added 9.25 g (61.4 mmol) of tert-butyldimethylchlorosilane at room temperature, and the mixture was stirred overnight. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-9 / 1) to obtain the desired product. Colorless liquid Yield 17.90 g Yield 100% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.08 (3H, s), 0.14 (3H,
s), 0.91 (9H, s), 1.23-1.57 (2H, m), 1.60-1.77 (2
H, m), 1.91-2.06 (2H, m), 2.86 (2H, t, J = 4.8 H
z), 3.93 (1H, br d, J = 4.8 Hz), 4.79 (1H, d, J =
12.4 Hz), 5.04 (1H, d, J = 12.0 Hz), 5.30-5.40 (1H,
m), 7.07 (1H, dd, J = 2.0 Hz, 7.2 Hz), 7.16 (1H,
t, J = 7.3 Hz), 7.23 (1H, dd, J = 2.0 Hz, 7.4 Hz);
IR (neat) 3412, 2928, 2855, 1472, 1462, 1254, 107
3, 835, 779 cm -15 5) tert-butyl (5,6,7,8-tetrahydrobenzo [a] cycloocten-1-ylmethoxy) dimethylsilane 4-[[[tert-butyl (dimethyl) silyl] oxy ] Methyl] -5,6,7,8,9,10-hexahydrobenzo [a] cycloocten-5-ol 17.90 g
(55.84 mmol), 15.6 m of triethylamine
1 (112 mmol) of a methanesulfonyl chloride 9.59 g (83.8 mmol) of acetonitrile 10 in a solution of 0.68 g (5.58 mmol) of 4-N, N-dimethylaminopyridine in 100 ml of acetonitrile under ice-cooling.
The ml solution was added dropwise under ice cooling. To this, lithium chloride 3.5
5 g (83.8 mmol) was added, and the mixture was stirred at room temperature for 6 hours. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was dissolved in N, N-dimethylformamide (80 ml) to give 1,8-diazabicyclo [5.
4.0] -7-undecene (16.7 ml, 112 mmol) was added, and the mixture was stirred at 80 ° C overnight. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15/1) to obtain the desired product. Colorless liquid Yield 10.94 g Yield 65% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.10 (6H, s), 0.95 (9H,
s), 1.37-1.49 (2H, m), 1.67 (2H, br s), 1.99-2.07
(2H, m), 2.74 (2H, t, J = 5.9 Hz), 4.67 (2H, s), 5.
95 (1H, td, J = 6.7 Hz, 11.5 Hz), 6.32 (1H, d, J =
11.2 Hz), 7.10 (1H, dd, J = 1.3 Hz, 7.5 Hz), 7.22
(1H, t, J = 7.8 Hz), 7.35 (1H, d, J = 7.6 Hz); IR
(neat) 2928, 2855, 1472, 1464, 1254, 1111, 1078, 8
37,777cm - 16) 5,6,7,8-tetrahydrobenzo [a] cycloocten-1-ylmethanol tert-butyl (5,6,7,8-tetrahydrobenzo [a] cycloocten-1-ylmethoxy ) A solution of 1.0 M tetrabutylammonium fluoride in tetrahydrofuran in a solution of 10.94 g (36.16 mmol) of dimethylsilane in 100 ml of tetrahydrofuran 43.
4 ml (43.4 mmol) was added and stirred at room temperature for 15 minutes. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-3 / 1) to obtain the desired product. Colorless liquid Yield 5.499 g Yield 81% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.40-1.52 (2H, m), 1.60-
1.74 (3H, m), 2.00-2.11 (2H, m), 2.76 (2H, t, J =
5.8 Hz), 4.68 (2H, d, J = 5.6 Hz), 6.03 (1H, td, J
= 6.7 Hz, 11.7 Hz), 6.50 (1H, d, J = 11.6 Hz), 7.1
4-7.28 (3H, m); IR (neat) 3324, 2926, 2853, 1449, 1
065, 1007, 766 cm -1 7 ) 5,6,7,8- tetrahydrobenzo [a] cyclooctene-1-carboxylic acid 5,6,7,8-tetrahydrobenzo [a] cyclooctene-1-ylmethanol A solution obtained by dissolving 7.20 g (72.0 mmol) of chromic anhydride and 6 ml of concentrated sulfuric acid in 20 ml of water was slowly added dropwise to a solution of 5.419 g (28.78 mmol) in 100 ml of acetone under ice-cooling. Thereafter, the mixture was stirred at room temperature for 0.5 hour. After the reaction solution was ice-cooled again, 20 ml of isopropanol was added, and the mixture was added to 0.1 ml.
Stir for 5 hours. The acetone in the reaction solution was distilled off under reduced pressure, diluted with ethyl acetate, washed three times with water, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 2.413 g Yield 42% mp 164-165 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.46 (2H,
br s), 1.72 (2H, br s), 2.03 (2H, br s), 2.81 (2H,
t, J = 5.8 Hz), 5.98 (1H, td, J = 7.2 Hz, 11.6 H
z), 6.85 (1H, d, J = 11.8 Hz), 7.29 (1H, t, J = 7.
8 Hz), 7.45 (1H, dd, J = 1.4 Hz, 7.8 Hz), 7.94 (1H,
dd, J = 1.4 Hz, 7.8 Hz); IR (KBr) 3080-2520, 169
0, 1451, 1408, 1275, 924, 770 cm -1 ; Anal.Calcd fo
r C 13 H 14 O 2 : C, 77.20; H, 6.98.Found: C, 77.38; H,
7.06.8) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -5 , 6,
7,8-tetrahydrobenzo [a] cyclooctene-1-
Carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol 0.274 g
(0.758 mmol), 5,6,7,8-tetrahydrobenzo [a] cyclooctene-1-carboxylic acid 0.15
g (0.76 mmol) of 0.12 g (0.76 mmol) of 1-hydroxybenzotriazole hydrate in 10 ml of acetonitrile while stirring in 1-ethyl-3- (3- (3-ethyl-3-hydroxybenzotriazole).
Dimethylaminopropyl) carbodiimide hydrochloride
15 g (0.76 mmol) was added and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White powder Yield 0.365 g Yield 86% mp 189-190 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.34-1.49
(2H, m), 1.53-1.73 (2H, m), 1.95-2.06 (2H, m), 2.7
0 (2H, t, J = 5.9 Hz), 2.77 (1H, dd, J = 10.4 Hz,
14.4 Hz), 2.97 (1H, dd, J = 4.2 Hz, 14.4 Hz), 3.91
(1H, br s), 4.58-4.71 (1H, m), 5.04 (1H, t, J =
3.7 Hz), 5.80 (1H, td, J = 6.8 Hz, 11.8Hz), 5.88
(1H, tt, J = 2.9 Hz, 53.0 Hz), 6.01 (1H, d, J = 7.
8 Hz), 6.10 (1H, d, J = 11.8 Hz), 7.00-7.13 (5H,
m), 7.17-7.32 (4H, m), 7.41 (2H, dd, J = 5.5 Hz,
8.5 Hz); IR (KBr) 3272, 2928, 1640, 1535, 1514, 12
25, 1198, 1128, 777 cm -1 ; Anal.Calcd for C 30 H 28 F 5
NO 3 : C, 66.05; H, 5.17; N, 2.57. Found: C, 65.96;
H, 5.13; N, 2.55.
【0259】実施例127 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-8-メチル-6,7-
ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボ
キサミド 1) 6-メチル-5-オキソ-6,7,8,9-テトラヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-6-カルボン酸
メチル 6,7,8,9-テトラヒドロ-5H-ベンゾ[a]シク
ロヘプテン-5-オン24.99g(156.0ミリモ
ル)と炭酸ジメチル42.2g(468ミリモル)のテ
トラヒドロフラン150ml溶液に室温で60%水素化
ナトリウムの流動パラフィン懸濁物12.5g(312
ミリモル)を加えた後、1時間加熱還流した。反応液を
水に注ぎ、1N塩酸で酸性にした後、酢酸エチルで2回
抽出した。集めた有機層を無水硫酸マグネシウムで乾
燥、溶媒を減圧留去した。得られた残留物をシリカゲル
カラムクロマトグラフィーにて精製して(ヘキサン/酢
酸エチル=15/1)、5-オキソ-6,7,8,9-テ
トラヒドロ-5H-ベンゾ[a]シクロヘプテン-6-カル
ボン酸メチルを黄色液体として得た。上で得た液体のテ
トラヒドロフラン250ml溶液に氷冷下60%水素化
ナトリウムの流動パラフィン懸濁物6.86g(172
ミリモル)を加え、そのまま0.5時間撹拌した。混合
物にヨウ化メチル33.2g(234ミリモル)を0℃
で加え、室温で1時間撹拌した。反応液を水に注ぎ、酢
酸エチルで2回抽出した。集めた有機層を無水硫酸マグ
ネシウムで乾燥、溶媒を減圧留去した。得られた残留物
をシリカゲルカラムクロマトグラフィーにて精製して
(ヘキサン/酢酸エチル=20/1−6/1)、目的物
を得た。淡黄色液体 収量35.13g 収率97%1 H-NMR (CDCl3, 200MHz) δ 1.49 (3H, s), 1.69-2.08
(3H, m), 2.25-2.38 (1H, m), 2.70-3.00 (2H, m), 3.6
2 (3H, s), 7.13 (1H, d, J = 7.4 Hz), 7.23-7.46 (3
H, m); IR (neat) 2949, 1740, 1686, 1451, 1262, 123
6, 1215, 963 cm-1 2) 6-メチル-6,7,8,9-テトラヒドロ-5H-
ベンゾ[a]シクロヘプテン-5-オン 6-メチル-5-オキソ-6,7,8,9-テトラヒドロ-5
H-ベンゾ[a]シクロヘプテン-6-カルボン酸メチル
35.13g(151.2ミリモル)と濃塩酸50ml
の酢酸100ml溶液を110℃で一晩撹拌した。反応
液を濃縮した後水に希釈し、酢酸エチルで2回抽出し
た。集めた有機層を無水硫酸マグネシウムで乾燥、溶媒
を減圧留去した。得られた残留物をシリカゲルカラムク
ロマトグラフィーにて精製して(ヘキサン/酢酸エチル
=6/1)、目的物を得た。黄色液体 収量25.36
g 収率96%1 H-NMR (CDCl3, 200MHz) δ 1.22 (3H, d, J = 6.6 H
z), 1.51-2.15 (4H, m), 2.85-3.10 (3H, m), 7.19-7.4
2 (3H, m), 7.67 (1H, dd, J = 1.7 Hz, 7.5 Hz);IR (n
eat) 2932, 1686, 1597, 1448, 1223, 737 cm-1 3) 6-メチル-6,7,8,9-テトラヒドロ-5H-
ベンゾ[a]シクロヘプテン-5-オール 6-メチル-6,7,8,9-テトラヒドロ-5H-ベンゾ
[a]シクロヘプテン-5-オン24.93g(143.
1ミリモル)のメタノール150ml溶液に、氷冷下、
水素化ほう素ナトリウム5.41g(143ミリモル)
を少しずつ加えた後、室温で1時間撹拌した。反応液の
溶媒を減圧留去し、水を加え、酢酸エチルで2回抽出し
た。集めた有機層を無水硫酸マグネシウムで乾燥、溶媒
を減圧留去した。得られた残留物をシリカゲルカラムク
ロマトグラフィーにて精製して(ヘキサン/酢酸エチル
=2/1)、目的物を得た。無色液体 収量25.60
g 収率100%1 H-NMR (CDCl3, 200MHz) δ 0.85 (1.5H, d, J = 7.0 H
z), 0.90 (1.5H, d, J =6.8 Hz), 1.52-2.18 (6H, m),
2.59-2.73 (1H, m), 2.92-3.10 (1H, m), 4.61(0.5H, d
d, J = 2.2 Hz, 6.8 Hz), 4.89 (0.5H, s), 7.05-7.23
(3H, m), 7.28-7.35 (1H, m); IR (neat) 3382, 2924,
1454, 1034, 747 cm-1 4) 4-[[[tert-ブチル(ジメチル)シリル]
オキシ]メチル]-6-メチル-6,7,8,9-テトラヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-5-オール 6-メチル-6,7,8,9-テトラヒドロ-5H-ベンゾ
[a]シクロヘプテン-5-オール25.17g(14
2.8ミリモル)とN,N,N’,N’-テトラメチル
エチレンジアミン47.4g(314ミリモル)のヘキ
サン250ml溶液に、氷冷下で1.6Mn-ブチルリ
チウムのヘキサン溶液196ml(314ミリモル)を
滴下した後、35℃で一晩撹拌した。反応混合物を−7
8℃に冷却した後、砕いたドライアイス30gを加え、
撹拌しながら室温まで昇温した。反応液を水で希釈し、
濃塩酸で酸性にした後、酢酸エチルで3回抽出した。集
めた有機層を無水硫酸マグネシウムで乾燥、溶媒を減圧
留去した。得られた粗生成物をシリカゲルカラムクロマ
トグラフィー(ヘキサン/酢酸エチル=6/1)に通
し、9-メチル-7,8,9,9a-テトラヒドロシクロ
ペンタ[cd][2]ベンゾフラン-2(6H)-オンの
粗生成物(9.06g)を黄色液体として得た。水素化
リチウムアルミニウム1.70g(44.8ミリモル)
のテトラヒドロフラン100ml懸濁液に、氷冷下、上
で得た液体のテトラヒドロフラン80ml溶液を滴下
し、室温で1時間撹拌した。反応液を氷冷した後、水
1.5ml、15%水酸化ナトリウム水溶液1.5m
l、水4mlを順次滴下して、過剰の水素化リチウムア
ルミニウムを分解し、そのまま室温で2時間撹拌した。
生じた沈殿をろ過して除き、沈殿を酢酸エチルで洗浄し
た。集めた濾液の溶媒を減圧留去した。得られた残留物
をシリカゲルカラムクロマトグラフィー(ヘキサン/酢
酸エチル=6/1−1/2)に通し、4-(ヒドロキシ
メチル)-6-メチル-6,7,8,9-テトラヒドロ-5
H-ベンゾ[a]シクロヘプテン-5-オールの粗生成物
(8.762g)を無色液体として得た。上で得た液
体、4-N,N-ジメチルアミノピリジン0.2g、トリ
エチルアミン7.49ml(53.7ミリモル)のテト
ラヒドロフラン100ml溶液に、室温でtert-ブ
チルジメチルクロロシラン7.42g(49.2ミリモ
ル)を加え、そのまま一晩撹拌した。反応液を水に注
ぎ、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸マグネシウムで乾燥、溶媒を減圧留去した。得られた
粗生成物をシリカゲルカラムクロマトグラフィーにて精
製し(ヘキサン/酢酸エチル=15/1−6/1)、目
的物を得た。無色液体 収量14.43g 収率32%1 H-NMR (CDCl3, 200MHz) δ 0.08-0.13 (6H, m), 0.91-
1.16 (12H, m), 1.39-2.11 (5H, m), 2.54-2.70 (2H,
m), 3.18-3.33 (1H, m), 4.57-5.11 (3H, m), 7.04-7.1
4 (3H, m); IR (neat) 3416, 2955, 2928, 2857, 1472,
1462, 1256, 1070, 837, 775 cm-1 5) tert-ブチル(8-メチル-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-イルメトキシ)
ジメチルシラン 4-[[[tert-ブチル(ジメチル)シリル]オキ
シ]メチル]-6-メチル-6,7,8,9-テトラヒドロ
-5H-ベンゾ[a]シクロヘプテン-5-オール14.4
3g(45.02ミリモル)、トリエチルアミン7.5
3ml(54.0ミリモル)、4-N,N-ジメチルアミ
ノピリジン0.55g(4.50ミリモル)のアセトニ
トリル50ml溶液に氷冷下、メタンスルホニルクロリ
ド5.67g(49.5ミリモル)のアセトニトリル1
0ml溶液を氷冷下滴下した。これに塩化リチウム2.
86g(67.5ミリモル)を加え、室温で6時間撹拌
した。反応液を水に注ぎ、酢酸エチルで2回抽出した。
集めた有機層を無水硫酸マグネシウムで乾燥、溶媒を減
圧留去した。得られた残留物をN,N-ジメチルホルム
アミド50mlに溶かし、1,8-ジアザビシクロ
[5.4.0]-7-ウンデセン13.5ml(90.0
ミリモル)を加え、80℃で一晩撹拌した。反応液を水
に注ぎ、酢酸エチルで2回抽出した。集めた有機層を無
水硫酸マグネシウムで乾燥、溶媒を減圧留去した。得ら
れた粗生成物をシリカゲルカラムクロマトグラフィーに
て精製し(ヘキサン/酢酸エチル=50/1)、目的物
を得た。無色液体 収量5.608g 収率41%1 H-NMR (CDCl3, 200MHz) δ 0.10 (6H, s), 0.94 (9H,
s), 1.92-2.17 (4H, m),2.00 (3H, s), 2.60 (2H, t, J
= 6.4 Hz), 4.70 (2H, s), 6.32 (1H, s), 7.04-7.15
(2H, m), 7.32 (1H, d, J = 7.8 Hz); IR (neat) 2928,
2857, 1254, 1109, 1078, 835, 775 cm-1 6) 8-メチル-6,7-ジヒドロ-5H-ベンゾ[a]
シクロヘプテン-1-イルメタノール tert-ブチル(8-メチル-6,7-ジヒドロ-5H-ベ
ンゾ[a]シクロヘプテン-1-イルメトキシ)ジメチル
シラン5.594g(18.49ミリモル)のテトラヒ
ドロフラン50ml溶液に室温で1.0Mテトラブチル
アンモニウムフルオリドのテトラヒドロフラン溶液2
2.2ml(22.2ミリモル)を加え、室温で15分
間撹拌した。反応液を水に注ぎ、酢酸エチルで2回抽出
した。集めた有機層を無水硫酸マグネシウムで乾燥、溶
媒を減圧留去した。得られた粗生成物をシリカゲルカラ
ムクロマトグラフィーにて精製し(ヘキサン/酢酸エチ
ル=6/1)、目的物を得た。無色液体 収量3.00
0g 収率86%1 H-NMR (CDCl3, 200MHz) δ 1.59 (1H, t, J = 6.0 H
z), 1.99-2.19 (4H, m), 2.01 (3H, d, J = 1.6 Hz),
2.62 (2H, t, J = 6.4 Hz), 4.69 (2H, d, J = 5.8Hz),
6.47 (1H, d, J = 1.6 Hz), 7.11-7.24 (3H, m); IR
(neat) 3333, 2928,1454, 1019, 791 cm-1 7) 8-メチル-6,7-ジヒドロ-5H-ベンゾ[a]
シクロヘプテン-1-カルボン酸 8-メチル-6,7-ジヒドロ-5H-ベンゾ[a]シクロ
ヘプテン-1-イルメタノール2.939g(15.61
ミリモル)のアセトン50ml溶液に、氷冷下、無水ク
ロム酸3.90g(39.0ミリモル)と濃硫酸3ml
を水10mlに溶解した溶液をゆっくりと滴下し、滴下
終了後、室温で0.5時間撹拌した。反応液を再び氷冷
した後、イソプロパノール10mlを加え、そのまま
0.5時間撹拌した。反応液のアセトンを減圧下留去し
た後、酢酸エチルに希釈し、水で3回洗浄、無水硫酸マ
グネシウムで乾燥、溶媒を減圧留去した。得られた残留
物を酢酸エチル−ヘキサンより結晶化して、目的物を得
た。白色結晶 収量1.086g 収率34% mp 139-140℃; 1H-NMR (CDCl3, 200MHz) δ 1.96-2.21
(4H, m), 2.05 (3H, d,J = 1.4 Hz), 2.63 (2H, t, J =
6.6 Hz), 6.90 (1H, d, J = 1.2 Hz), 7.191 (1H, t,
J = 7.7 Hz), 7.38 (1H, d, J = 7.8 Hz), 7.90 (1H, d
d, J = 1.3 Hz,7.9 Hz); IR (KBr) 3055-2530, 1682, 1
449, 1310, 1298, 1277, 1262 cm-1; Anal. Calcd for
C13H14O2: C, 77.20; H, 6.98. Found: C, 77.25; H,
7.00. 8) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]-8-メチル-
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.272g
(0.753ミリモル)、8-メチル-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボン酸0.
15g(0.75ミリモル)、1-ヒドロキシベンゾト
リアゾール水和物0.12g(0.75ミリモル)をア
セトニトリル10ml中で撹拌しながら1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩0.14g(0.75ミリモル)を加え、室温で一晩
撹拌した。反応液を酢酸エチルに希釈し、炭酸水素ナト
リウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、シ
リカゲルを通した後、溶媒を減圧留去した。得られた残
留物をジイソプロピルエーテル−ヘキサンより結晶化し
て、目的物を得た。白色結晶 収量0.365g 収率
89% mp 149-150℃; 1H-NMR (CDCl3, 200MHz) δ 1.86 (3H,
s), 1.96-2.14 (4H, m),2.58 (2H, t, J = 6.1 Hz), 2.
78 (1H, dd, J = 10.1 Hz, 14.5 Hz), 2.97 (1H, dd, J
= 4.6 Hz, 14.4 Hz), 3.93 (1H, br s), 4.57-4.70 (1
H, m), 5.03 (1H, s), 5.87 (1H, tt, J = 3.0 Hz, 52.
9 Hz), 5.89 (1H, s), 6.14 (1H, s), 6.99-7.33 (9H,
m), 7.42 (2H, dd, J = 5.4 Hz, 8.4 Hz); IR (KBr) 32
66, 2938,1638, 1512, 1198, 1128 cm-1; Anal. Calcd
for C30H28F5NO3: C, 66.05; H,5.17; N, 2.57. Found:
C, 66.02; H, 5.28; N, 2.57.Example 127 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -8-methyl-6,7-
Dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1) Methyl 6-methyl-5-oxo-6,7,8,9-tetrahydro-5H-benzo [a] cycloheptene-6-carboxylate 6,7, Flow of 60% sodium hydride in a solution of 24.99 g (156.0 mmol) of 8,9-tetrahydro-5H-benzo [a] cyclohepten-5-one and 42.2 g (468 mmol) of dimethyl carbonate in 150 ml of tetrahydrofuran at room temperature. 12.5 g of paraffin suspension (312
(Mmol) was added and the mixture was heated under reflux for 1 hour. The reaction solution was poured into water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15/1) to give 5-oxo-6,7,8,9-tetrahydro-5H-benzo [a] cycloheptene-6-. Methyl carboxylate was obtained as a yellow liquid. 6.86 g (172) of a liquid paraffin suspension of 60% sodium hydride was added to a 250 ml solution of the liquid tetrahydrofuran obtained above under ice-cooling.
Mmol) and the mixture was stirred as it was for 0.5 hour. To the mixture was added 33.2 g (234 mmol) of methyl iodide at 0 ° C.
And stirred at room temperature for 1 hour. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 20 / 1-6 / 1) to obtain the desired product. Light yellow liquid Yield 35.13 g Yield 97% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.49 (3H, s), 1.69-2.08
(3H, m), 2.25-2.38 (1H, m), 2.70-3.00 (2H, m), 3.6
2 (3H, s), 7.13 (1H, d, J = 7.4 Hz), 7.23-7.46 (3
H, m); IR (neat) 2949, 1740, 1686, 1451, 1262, 123
6, 1215, 963 cm -1 2) 6-methyl-6,7,8,9-tetrahydro-5H-
Benzo [a] cyclohepten-5-one 6-methyl-5-oxo-6,7,8,9-tetrahydro-5
35.13 g (151.2 mmol) of methyl H-benzo [a] cycloheptene-6-carboxylate and 50 ml of concentrated hydrochloric acid
Of acetic acid was stirred at 110 ° C. overnight. The reaction solution was concentrated, diluted with water, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 6/1) to obtain the desired product. Yellow liquid Yield 25.36
g 96% yield 1 H-NMR (CDCl 3 , 200 MHz) δ 1.22 (3H, d, J = 6.6 H
z), 1.51-2.15 (4H, m), 2.85-3.10 (3H, m), 7.19-7.4
2 (3H, m), 7.67 (1H, dd, J = 1.7 Hz, 7.5 Hz); IR (n
eat) 2932, 1686, 1597, 1448, 1223, 737 cm -1 3) 6-methyl-6,7,8,9-tetrahydro-5H-
Benzo [a] cyclohepten-5-ol 24.93 g of 6-methyl-6,7,8,9-tetrahydro-5H-benzo [a] cyclohepten-5-one (143.g)
1 mmol) in 150 ml of methanol under ice-cooling.
Sodium borohydride (5.41 g, 143 mmol)
Was added little by little, and the mixture was stirred at room temperature for 1 hour. The solvent of the reaction solution was distilled off under reduced pressure, water was added, and the mixture was extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 2/1) to obtain the desired product. Colorless liquid Yield 25.60
g Yield 100% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.85 (1.5 H, d, J = 7.0 H
z), 0.90 (1.5H, d, J = 6.8 Hz), 1.52-2.18 (6H, m),
2.59-2.73 (1H, m), 2.92-3.10 (1H, m), 4.61 (0.5H, d
d, J = 2.2 Hz, 6.8 Hz), 4.89 (0.5H, s), 7.05-7.23
(3H, m), 7.28-7.35 (1H, m); IR (neat) 3382, 2924,
1454, 1034, 747 cm -1 4) 4-[[[tert-butyl (dimethyl) silyl]
Oxy] methyl] -6-methyl-6,7,8,9-tetrahydro-5H-benzo [a] cyclohepten-5-ol 6-methyl-6,7,8,9-tetrahydro-5H-benzo [a] 25.17 g of cyclohepten-5-ol (14
2.8 ml) and 47.4 g (314 mmol) of N, N, N ', N'-tetramethylethylenediamine in 250 ml of hexane under ice cooling, 196 ml (314 mmol) of a 1.6 Mn-butyllithium hexane solution. After dropwise addition, the mixture was stirred at 35 ° C. overnight. The reaction mixture was
After cooling to 8 ° C, 30 g of crushed dry ice was added,
The temperature was raised to room temperature with stirring. Dilute the reaction with water,
After acidifying with concentrated hydrochloric acid, the mixture was extracted three times with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was subjected to silica gel column chromatography (hexane / ethyl acetate = 6/1) to give 9-methyl-7,8,9,9a-tetrahydrocyclopenta [cd] [2] benzofuran-2 (6H ) -One crude product (9.06 g) was obtained as a yellow liquid. 1.70 g (44.8 mmol) of lithium aluminum hydride
Was added dropwise to a suspension of 100 ml of tetrahydrofuran in ice-cooled solution under ice-cooling, and the mixture was stirred at room temperature for 1 hour. After the reaction solution was ice-cooled, 1.5 ml of water and 1.5 m of a 15% aqueous sodium hydroxide solution were used.
l and 4 ml of water were sequentially added dropwise to decompose excess lithium aluminum hydride, and the mixture was stirred at room temperature for 2 hours.
The resulting precipitate was removed by filtration, and the precipitate was washed with ethyl acetate. The solvent of the collected filtrate was distilled off under reduced pressure. The obtained residue is subjected to silica gel column chromatography (hexane / ethyl acetate = 6 / 1-1 / 2) to give 4- (hydroxymethyl) -6-methyl-6,7,8,9-tetrahydro-5.
A crude product of H-benzo [a] cyclohepten-5-ol (8.762 g) was obtained as a colorless liquid. To a solution of the liquid obtained above, 0.2 g of 4-N, N-dimethylaminopyridine and 7.49 ml (53.7 mmol) of triethylamine in 100 ml of tetrahydrofuran, 7.42 g (49.2 mmol) of tert-butyldimethylchlorosilane at room temperature. ) Was added and the mixture was stirred overnight. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-6 / 1) to obtain the desired product. Colorless liquid Yield 14.43 g Yield 32% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.08-0.13 (6H, m), 0.91-
1.16 (12H, m), 1.39-2.11 (5H, m), 2.54-2.70 (2H,
m), 3.18-3.33 (1H, m), 4.57-5.11 (3H, m), 7.04-7.1
4 (3H, m); IR (neat) 3416, 2955, 2928, 2857, 1472,
1462, 1256, 1070, 837, 775 cm -1 5) tert- butyl (8-methyl-6,7-dihydro -
5H-benzo [a] cyclohepten-1-ylmethoxy)
Dimethylsilane 4-[[[tert-butyl (dimethyl) silyl] oxy] methyl] -6-methyl-6,7,8,9-tetrahydro
-5H-benzo [a] cyclohepten-5-ol 14.4
3 g (45.02 mmol), triethylamine 7.5
To a solution of 3 ml (54.0 mmol) of 4-N, N-dimethylaminopyridine 0.55 g (4.50 mmol) of acetonitrile in 50 ml of acetonitrile was cooled under ice-cooling 5.67 g (49.5 mmol) of methanesulfonyl chloride in acetonitrile 1
A 0 ml solution was added dropwise under ice cooling. This is followed by lithium chloride 2.
86 g (67.5 mmol) was added and the mixture was stirred at room temperature for 6 hours. The reaction solution was poured into water and extracted twice with ethyl acetate.
The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was dissolved in 50 ml of N, N-dimethylformamide and 13.5 ml of 1,8-diazabicyclo [5.4.0] -7-undecene (90.0 ml)
Mmol) and stirred at 80 ° C. overnight. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 50/1) to obtain the desired product. Colorless liquid Yield 5.608 g Yield 41% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.10 (6H, s), 0.94 (9H,
s), 1.92-2.17 (4H, m), 2.00 (3H, s), 2.60 (2H, t, J
= 6.4 Hz), 4.70 (2H, s), 6.32 (1H, s), 7.04-7.15
(2H, m), 7.32 (1H, d, J = 7.8 Hz); IR (neat) 2928,
2857, 1254, 1109, 1078, 835, 775 cm -1 6) 8-Methyl-6,7-dihydro-5H-benzo [a]
Cyclohepten-1-ylmethanol tert-butyl (8-methyl-6,7-dihydro-5H-benzo [a] cyclohepten-1-ylmethoxy) dimethylsilane 5.594 g (18.49 mmol) of tetrahydrofuran in 50 ml of tetrahydrofuran at room temperature. 1.0 M tetrabutylammonium fluoride in tetrahydrofuran solution 2
2.2 ml (22.2 mmol) were added and stirred at room temperature for 15 minutes. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6/1) to obtain the desired product. Colorless liquid Yield 3.00
0 g Yield 86% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.59 (1 H, t, J = 6.0 H
z), 1.99-2.19 (4H, m), 2.01 (3H, d, J = 1.6 Hz),
2.62 (2H, t, J = 6.4 Hz), 4.69 (2H, d, J = 5.8 Hz),
6.47 (1H, d, J = 1.6 Hz), 7.11-7.24 (3H, m); IR
(neat) 3333, 2928,1454, 1019 , 791 cm -1 7) 8- methyl-6,7-dihydro -5H- benzo [a]
Cyclohepten-1-carboxylic acid 8-methyl-6,7-dihydro-5H-benzo [a] cyclohepten-1-ylmethanol 2.939 g (15.61
3.90 g (39.0 mmol) of chromic anhydride and 3 ml of concentrated sulfuric acid in a 50 ml acetone solution of
Was dissolved in 10 ml of water, and the solution was slowly added dropwise. After completion of the addition, the mixture was stirred at room temperature for 0.5 hour. After the reaction solution was again ice-cooled, 10 ml of isopropanol was added, and the mixture was stirred for 0.5 hour. The acetone in the reaction solution was distilled off under reduced pressure, diluted with ethyl acetate, washed three times with water, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 1.086 g Yield 34% mp 139-140 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.96-2.21
(4H, m), 2.05 (3H, d, J = 1.4 Hz), 2.63 (2H, t, J =
6.6 Hz), 6.90 (1H, d, J = 1.2 Hz), 7.191 (1H, t,
J = 7.7 Hz), 7.38 (1H, d, J = 7.8 Hz), 7.90 (1H, d
d, J = 1.3 Hz, 7.9 Hz); IR (KBr) 3055-2530, 1682, 1
449, 1310, 1298, 1277, 1262 cm -1 ; Anal.Calcd for
C 13 H 14 O 2 : C, 77.20; H, 6.98. Found: C, 77.25; H,
7.00.8) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -8 -Methyl-
6,7-dihydro-5H-benzo [a] cycloheptene-1
-Carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol 0.272 g
(0.753 mmol), 8-methyl-6,7-dihydro-
5H-benzo [a] cycloheptene-1-carboxylic acid
15 g (0.75 mmol) of 1-hydroxybenzotriazole hydrate 0.12 g (0.75 mmol) in 10 ml of acetonitrile with stirring in 1-ethyl-3-ethyl.
0.14 g (0.75 mmol) of (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.365 g Yield 89% mp 149-150 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.86 (3H,
s), 1.96-2.14 (4H, m), 2.58 (2H, t, J = 6.1 Hz), 2.
78 (1H, dd, J = 10.1 Hz, 14.5 Hz), 2.97 (1H, dd, J
= 4.6 Hz, 14.4 Hz), 3.93 (1H, br s), 4.57-4.70 (1
H, m), 5.03 (1H, s), 5.87 (1H, tt, J = 3.0 Hz, 52.
9 Hz), 5.89 (1H, s), 6.14 (1H, s), 6.99-7.33 (9H,
m), 7.42 (2H, dd, J = 5.4 Hz, 8.4 Hz); IR (KBr) 32
66, 2938,1638, 1512, 1198, 1128 cm -1 ; Anal.Calcd
for C 30 H 28 F 5 NO 3 : C, 66.05; H, 5.17; N, 2.57. Found:
C, 66.02; H, 5.28; N, 2.57.
【0260】実施例128 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-3,4-ジヒドロ-
2H-1,5-ベンゾジオキセピン-6-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.221g
(0.612ミリモル)、3,4-ジヒドロ-2H-1,
5-ベンゾジオキセピン-6-カルボン酸0.12g
(0.61ミリモル)、1-ヒドロキシベンゾトリアゾ
ール水和物94mg(0.61ミリモル)をアセトニト
リル10ml中で撹拌しながら1-エチル-3-(3-ジメ
チルアミノプロピル)カルボジイミド・塩酸塩0.12
g(0.61ミリモル)を加え、室温で一晩撹拌した。
反応液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶
液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲルを
通した後、溶媒を減圧留去した。得られた残留物をジイ
ソプロピルエーテル−ヘキサンより結晶化して、目的物
を得た。白色結晶 収量0.261g 収率79% mp 147-148℃; 1H-NMR (CDCl3, 200MHz) δ 2.04-2.17
(2H, m), 2.82 (1H, dd,J = 9.9 Hz, 14.7 Hz), 2.95
(1H, dd, J = 5.0 Hz, 15.0 Hz), 3.84 (2H, t,J = 5.7
Hz), 4.05-4.22 (2H, m), 4.27 (1H, d, J = 4.2 Hz),
4.58-4.70 (1H,m), 5.09 (1H, t, J = 3.1 Hz), 5.86
(1H, tt, J = 2.8 Hz, 53.0 Hz), 6.97-7.13 (7H, m),
7.26 (1H, t, J = 7.9 Hz), 7.42 (2H, dd, J = 5.2 H
z, 8.6 Hz), 7.77 (1H, dd, J = 2.1 Hz, 7.5 Hz), 7.9
4 (1H, br d, J = 7.0 Hz); IR (KBr) 3283, 1636, 154
7, 1512, 1304, 1264, 1229, 1204, 1125, 1044 cm-1;
Anal. Calcd for C27H24F5NO5: C, 60.34; H, 4.50; N,
2.61. Found: C, 60.43; H, 4.46; N, 2.82.Example 128 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -3,4-dihydro-
2H-1,5-benzodioxepin-6-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) ) Phenyl] propan-1-ol 0.221 g
(0.612 mmol), 3,4-dihydro-2H-1,
0.12 g of 5-benzodioxepin-6-carboxylic acid
(0.61 mmol) 1-Hydroxybenzotriazole hydrate 94 mg (0.61 mmol) in 10 ml of acetonitrile while stirring 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 0.12
g (0.61 mmol) was added and stirred at room temperature overnight.
The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.261 g Yield 79% mp 147-148 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.04-2.17
(2H, m), 2.82 (1H, dd, J = 9.9 Hz, 14.7 Hz), 2.95
(1H, dd, J = 5.0 Hz, 15.0 Hz), 3.84 (2H, t, J = 5.7
Hz), 4.05-4.22 (2H, m), 4.27 (1H, d, J = 4.2 Hz),
4.58-4.70 (1H, m), 5.09 (1H, t, J = 3.1 Hz), 5.86
(1H, tt, J = 2.8 Hz, 53.0 Hz), 6.97-7.13 (7H, m),
7.26 (1H, t, J = 7.9 Hz), 7.42 (2H, dd, J = 5.2 H
z, 8.6 Hz), 7.77 (1H, dd, J = 2.1 Hz, 7.5 Hz), 7.9
4 (1H, br d, J = 7.0 Hz); IR (KBr) 3283, 1636, 154
7, 1512, 1304, 1264, 1229, 1204, 1125, 1044 cm -1 ;
Anal.Calcd for C 27 H 24 F 5 NO 5 : C, 60.34; H, 4.50; N,
2.61. Found: C, 60.43; H, 4.46; N, 2.82.
【0261】実施例129 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]カルバミン酸エチル (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール1.604g
(4.439ミリモル)と炭酸水素ナトリウム0.75
g(8.88ミリモル)をテトラヒドロフラン30ml
中で撹拌しながらクロロ炭酸エチル0.47ml(4.
88ミリモル)を加え、室温で一晩撹拌した。反応液を
酢酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗
浄、無水硫酸マグネシウムで乾燥、シリカゲルを通した
後、溶媒を減圧留去した。得られた残留物をジイソプロ
ピルエーテル−ヘキサンより結晶化して、目的物を得
た。白色結晶 収量1.696g 収率88% mp 113-114℃; 1H-NMR (CDCl3, 200MHz) δ 1.16 (3H,
t, J = 6.9 Hz), 2.68 (1H, dd, J = 9.8 Hz, 14.6 H
z), 2.80 (1H, dd, J = 5.2 Hz, 14.6 Hz), 3.01 (1H,
br s), 3.95-4.17 (3H, m), 4.71 (1H, d, J = 8.8 H
z), 4.93 (1H, s), 5.89 (1H, tt, J = 2.9 Hz, 53.1 H
z), 6.95-7.14 (5H, m), 7.27 (1H, t, J = 7.9 Hz),
7.38 (2H, dd, J = 5.3 Hz, 8.7 Hz); IR (KBr) 3333,
1686, 1541, 1231, 1206, 1132 cm-1; Anal. Calcd for
C20H20F5NO4: C, 55.43; H, 4.65; N, 3.23. Found:
C, 55.65; H, 4.41; N, 3.15.Example 129 N-[(1RS, 2SR) -2- (4-fluorophenyl)
Ethyl-2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] carbamate (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3 -[3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol 1.604 g
(4.439 mmol) and 0.75 sodium hydrogen carbonate
g (8.88 mmol) in 30 ml of tetrahydrofuran
0.47 ml of ethyl chlorocarbonate (4.
(88 mmol) and stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystal Yield 1.696 g Yield 88% mp 113-114 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.16 (3H,
t, J = 6.9 Hz), 2.68 (1H, dd, J = 9.8 Hz, 14.6 H
z), 2.80 (1H, dd, J = 5.2 Hz, 14.6 Hz), 3.01 (1H,
br s), 3.95-4.17 (3H, m), 4.71 (1H, d, J = 8.8 H
z), 4.93 (1H, s), 5.89 (1H, tt, J = 2.9 Hz, 53.1 H
z), 6.95-7.14 (5H, m), 7.27 (1H, t, J = 7.9 Hz),
7.38 (2H, dd, J = 5.3 Hz, 8.7 Hz); IR (KBr) 3333,
1686, 1541, 1231, 1206, 1132 cm -1 ; Anal.Calcd for
C 20 H 20 F 5 NO 4 : C, 55.43; H, 4.65; N, 3.23. Found:
C, 55.65; H, 4.41; N, 3.15.
【0262】実施例130 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]カルバミン酸ter
t-ブチル (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール2.085g
(5.771ミリモル)と二炭酸ジ-tert-ブチル
1.51g(6.92ミリモル)をテトラヒドロフラン
50ml中で、室温にて1時間撹拌した。反応液溶媒を
減圧留去し、得られた残留物をヘキサンより結晶化し
て、目的物を得た。白色結晶 収量2.555g 収率
96% mp 145-146℃; 1H-NMR (CDCl3, 200MHz) δ 1.35 (9H,
s), 2.63-2.85 (2H, m),3.25 (1H, br s), 4.00-4.12
(1H, m), 4.56 (1H, br d, J = 8.8 Hz), 4.92 (1H, br
s), 5.89 (1H, tt, J = 2.8 Hz, 53.1 Hz), 6.97-7.11
(5H, m), 7.27 (1H, t, J = 7.8 Hz), 7.38 (2H, dd,
J = 5.4 Hz, 8.4 Hz); IR (KBr) 3357, 1682, 1532, 12
11, 1123 cm-1; Anal. Calcd for C22H24F5NO4: C, 57.
27; H, 5.24; N, 3.04. Found: C, 57.29; H, 5.20; N,
2.96.Example 130 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] carbamic acid ter
t-butyl (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol 2.085 g
(5.771 mmol) and 1.51 g (6.92 mmol) of di-tert-butyl dicarbonate were stirred in 50 ml of tetrahydrofuran at room temperature for 1 hour. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was crystallized from hexane to obtain the desired product. White crystals Yield 2.555 g Yield 96% mp 145-146 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.35 (9H,
s), 2.63-2.85 (2H, m), 3.25 (1H, br s), 4.00-4.12
(1H, m), 4.56 (1H, br d, J = 8.8 Hz), 4.92 (1H, br
s), 5.89 (1H, tt, J = 2.8 Hz, 53.1 Hz), 6.97-7.11
(5H, m), 7.27 (1H, t, J = 7.8 Hz), 7.38 (2H, dd,
J = 5.4 Hz, 8.4 Hz); IR (KBr) 3357, 1682, 1532, 12
11, 1123 cm -1 ; Anal.Calcd for C 22 H 24 F 5 NO 4 : C, 57.
27; H, 5.24; N, 3.04. Found: C, 57.29; H, 5.20; N,
2.96.
【0263】実施例131 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[4-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]エチル]ナフ
タレン-1-カルボキサミド 1) 3-(4-フルオロフェニル)-3-オキソ-2-[4
-(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]プロピオン酸エチル 4-(1,1,2,2-テトラフルオロエトキシ)トルエ
ン6.73g(32.3ミリモル)、N-ブロモスクシ
ンイミド5.75g(32.3ミリモル)、2,2’-
アゾビス(イソブチロニトリル)0.2gの四塩化炭素
30ml溶液を0.5時間加熱還流した。反応液を室温
に冷却した後、白色沈殿を濾過して除き、沈殿をジエチ
ルエーテルで洗浄した。集めた濾液の溶媒を減圧留去し
て、4-(1,1,2,2-テトラフルオロエトキシ)ベ
ンジルブロミドの粗生成物を淡黄色液体として得た。
(4-フルオロベンゾイル)酢酸エチル6.177g
(29.39ミリモル)の1,2-ジメトキシエタン5
0ml溶液に氷冷下60%水素化ナトリウムの流動パラ
フィン懸濁物1.18g(29.4ミリモル)を加え、
そのまま0.5時間撹拌した。これに上で得た4-
(1,1,2,2-テトラフルオロエトキシ)ベンジル
ブロミドの1,2-ジメトキシエタン10ml溶液を室
温で加え、室温で8時間撹拌した。反応液を水に注ぎ、
酢酸エチルで2回抽出した。集めた有機層を無水硫酸マ
グネシウムで乾燥、溶媒を減圧留去した。得られた残留
物をシリカゲルカラムクロマトグラフィーにて精製し
(ヘキサン/酢酸エチル=15/1−9/1)、ヘキサ
ンより結晶化して、目的物を得た。白色結晶 収量8.
228g 収率67% mp 67-68℃; 1H-NMR (CDCl3, 200MHz) δ 1.11 (3H, t,
J = 7.1 Hz), 3.32 (2H, d, J = 7.4 Hz), 4.10 (2H,
q, J = 7.1 Hz), 4.55 (1H, t, J = 7.3 Hz), 5.88 (1
H, tt, J = 2.9 Hz, 53.1 Hz), 7.08-7.26 (6H, m), 7.
98 (2H, dd, J = 5.3 Hz, 8.9 Hz); IR (KBr) 1725, 16
76, 1599, 1512, 1304, 1281, 1242, 1215,1202, 1186,
1155, 1115, 1098, 843 cm-1; Anal. Calcd for C20H
17F5O4: C,57.70; H, 4.12. Found: C, 57.70; H, 4.2
2. 2) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[4-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]プロピオン酸エチル 塩化亜鉛5.15g(37.8ミリモル)をジエチルエ
ーテル80ml中で撹拌しながら水素化ホウ素ナトリウ
ム2.86g(75.6ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、3-(4-フルオ
ロフェニル)-3-オキソ-2-[4-(1,1,2,2-テ
トラフルオロエトキシ)ベンジル]プロピオン酸エチル
7.865g(18.89ミリモル)のジエチルエーテ
ル30ml溶液を室温で加え、そのまま2時間撹拌し
た。反応液に希塩酸を少しずつ加えて過剰の水素化ホウ
素亜鉛を分解した後、酢酸エチルで2回抽出した。集め
た有機層を無水硫酸マグネシウムで乾燥、溶媒を減圧留
去した。得られた粗生成物をシリカゲルカラムクロマト
グラフィーにて精製し(ヘキサン/酢酸エチル=6/1
−3/1)、目的物を得た。無色液体 収量7.687
g 収率97%1 H-NMR (CDCl3, 200MHz) δ 0.91 (3H, t, J = 7.2 H
z), 2.88-3.03 (4H, m), 3.88 (2H, dq, J = 1.7 Hz,
7.1 Hz), 5.02 (1H, t, J = 3.3 Hz), 5.88 (1H, tt, J
= 2.9 Hz, 53.1 Hz), 7.05 (2H, t, J = 8.8 Hz), 7.0
8 (4H, s), 7.37 (2H, dd, J = 5.6 Hz, 8.8 Hz); IR
(neat) 3468, 1725, 1508, 1306, 1277, 1190,1159, 11
23, 837 cm-1 3) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[4-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]プロピオン酸 (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[4-(1,1,2,2-テトラフルオロ
エトキシ)ベンジル]プロピオン酸エチル7.556g
(18.06ミリモル)のメタノール30ml−テトラ
ヒドロフラン30ml溶液に1N水酸化ナトリウム水溶
液36.1ml(36.1ミリモル)を加え、室温で一
晩撹拌した。反応液を濃縮、水で希釈し、1N塩酸で反
応液を酸性にした後、酢酸エチルで2回抽出した。集め
た有機層を無水硫酸ナトリウムで乾燥、溶媒を減圧留去
した。残留物をヘキサンより結晶化して、目的物を得
た。白色結晶 収量6.260g 収率89% mp 128-129℃; 1H-NMR (CDCl3, 200MHz) δ 2.91-3.07
(3H, m), 5.05 (1H, s),5.88 (1H, tt, J = 2.8 Hz, 5
3.1 Hz), 7.04 (2H, t, J = 8.6 Hz), 7.07 (4H,s), 7.
35 (2H, dd, J = 5.3 Hz, 8.5 Hz); IR (KBr) 3630, 32
00-2480, 1698,1512, 1283, 1233, 1190, 1128, 1100,
839 cm-1; Anal. Calcd for C18H15F5O4: C, 55.39; H,
3.87. Found: C, 55.42; H, 3.71. 4) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-[4-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]-1,3-オキサゾリジン-2-オン (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[4-(1,1,2,2-テトラフルオロ
エトキシ)ベンジル]プロピオン酸5.072g(1
2.99ミリモル)のテトラヒドロフラン40ml溶液
にトリエチルアミン2.72ml(19.5ミリモ
ル)、ジフェニルホスホリルアジド3.93g(14.
3ミリモル)を加え、一晩加熱還流した。反応液の溶媒
を減圧留去し、得られた粗生成物をシリカゲルカラムク
ロマトグラフィーにて精製し(ヘキサン/酢酸エチル=
3/1−1/1)、ジエチルエーテル−ヘキサンより結
晶化して、目的物を得た。白色結晶 収量4.673g
収率93% mp 154-155℃; 1H-NMR (CDCl3, 200MHz) δ 2.18-2.35
(2H, m), 4.24 (1H, dt,J = 5.4 Hz, 8.7 Hz), 5.05 (1
H, br s), 5.80 (1H, d, J = 8.0 Hz), 5.90 (1H, tt,
J = 2.8 Hz, 53.1 Hz), 7.05 (2H, t, J = 8.4 Hz), 7.
14 (2H, d, J =8.8 Hz), 7.15 (2H, d, J = 8.6 Hz),
7.36 (2H, dd, J = 5.2 Hz, 8.6 Hz); IR(KBr) 3258, 1
736, 1510, 1231, 1213, 1192, 1128, 1105 cm-1; Ana
l. Calcdfor C18H14F5NO3: C, 55.82; H, 3.64; N, 3.6
2. Found: C, 55.89; H, 3.63; N, 3.44. 5) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-[4-(1,1,2,2-テトラフルオ
ロエトキシ)フェニル]プロパン-1-オール (4RS,5SR)-5-(4-フルオロフェニル)-4-
[4-(1,1,2,2-テトラフルオロエトキシ)ベン
ジル]-1,3-オキサゾリジン-2-オン4.485g
(11.58ミリモル)と水酸化ナトリウム1.85g
(46.3ミリモル)をエタノール30ml−水2ml
中で、6時間加熱還流した。反応液を水で希釈し、酢酸
エチルで2回抽出した。集めた有機層を無水硫酸ナトリ
ウムで乾燥、溶媒を減圧留去した。残留物をシリカゲル
(APSタイプ)カラムクロマトグラフィーにて精製し
(ヘキサン/酢酸エチル=3/1−酢酸エチル)、ジイ
ソプロピルエーテル−ヘキサンより結晶化して、目的物
を得た。白色結晶 収量3.447g 収率82% mp 78-79℃; 1H-NMR (CDCl3, 200MHz) δ 2.36 (1H, d
d, J = 10.5 Hz, 13.7 Hz), 2.80 (1H, dd, J = 3.0 H
z, 13.8 Hz), 3.26 (1H, ddd, J = 3.5 Hz, 4.9 Hz, 1
0.2 Hz), 4.65 (1H, d, J = 4.8 Hz), 5.90 (1H, tt, J
= 3.0 Hz, 53.1 Hz), 7.08 (2H, t, J = 8.6 Hz), 7.1
4 (4H, s), 7.37 (2H, dd, J = 5.6 Hz, 8.4Hz); IR (K
Br) 3360, 2740, 1508, 1275, 1231, 1215, 1192, 111
9, 1096, 1040, 856 cm-1; Anal. Calcd for C17H16F5N
O2: C, 56.51; H, 4.46; N, 3.88. Found: C, 56.52;
H, 4.41; N, 3.66. 6) 4-フルオロ-N-[(1RS,2SR)-2-(4-
フルオロフェニル)-2-ヒドロキシ-1-[4-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]エチ
ル]ナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.163g
(0.451ミリモル)、4-フルオロ-1-ナフトエ酸
86mg(0.45ミリモル)、1-ヒドロキシベンゾ
トリアゾール水和物69mg(0.45ミリモル)をア
セトニトリル10ml中で撹拌しながら1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩86mg(0.45ミリモル)を加え、室温で一晩撹
拌した。反応液を酢酸エチルに希釈し、炭酸水素ナトリ
ウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、シリ
カゲルを通した後、溶媒を減圧留去した。得られた残留
物をジイソプロピルエーテル−ヘキサンより結晶化し
て、目的物を得た。白色結晶 収量0.212g 収率
88% mp 192-193℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
87 (1H, dd, J = 10.4 Hz, 14.4 Hz), 2.97 (1H, dd, J
= 4.8 Hz, 13.8 Hz), 4.68-4.82 (1H, m), 5.01-5.08
(2H, m), 5.94 (1H, tt, J = 2.9 Hz, 53.1 Hz), 6.99-
7.12 (6H, m), 7.19-7.26 (3H, m), 7.41-7.58 (4H,
m), 7.73 (1H, d, J = 8.2 Hz), 8.07 (1H,d, J = 7.8
Hz); IR (KBr) 3285, 1644, 1628, 1601, 1535, 1508,
1314, 1264,1233, 1200, 1127, 1113, 1094, 837 cm-1;
Anal. Calcd for C28H21F6NO3: C,63.04; H, 3.97; N,
2.63. Found: C, 62.98; H, 3.86; N, 2.60.Example 131 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (1,1,2,2
2-tetrafluoroethoxy) benzyl] ethyl] naphthalene-1-carboxamide 1) 3- (4-fluorophenyl) -3-oxo-2- [4
-(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl propionate 6.73 g (32.3 mmol) of 4- (1,1,2,2-tetrafluoroethoxy) toluene, N-bromosuccinimide 5 .75 g (32.3 mmol), 2,2'-
A solution of 0.2 g of azobis (isobutyronitrile) in 30 ml of carbon tetrachloride was heated under reflux for 0.5 hour. After cooling the reaction solution to room temperature, a white precipitate was removed by filtration, and the precipitate was washed with diethyl ether. The solvent of the collected filtrate was distilled off under reduced pressure to obtain a crude product of 4- (1,1,2,2-tetrafluoroethoxy) benzyl bromide as a pale yellow liquid.
6.177 g of ethyl (4-fluorobenzoyl) acetate
(29.39 mmol) of 1,2-dimethoxyethane 5
To a 0 ml solution was added 1.18 g (29.4 mmol) of a 60% sodium hydride liquid paraffin suspension under ice-cooling.
The mixture was stirred for 0.5 hours as it was. 4-
A solution of (1,1,2,2-tetrafluoroethoxy) benzyl bromide in 10 ml of 1,2-dimethoxyethane was added at room temperature, and the mixture was stirred at room temperature for 8 hours. Pour the reaction into water,
Extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-9 / 1), and crystallized from hexane to obtain the desired product. White crystals Yield 8.
228 g Yield 67% mp 67-68 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.11 (3H, t,
J = 7.1 Hz), 3.32 (2H, d, J = 7.4 Hz), 4.10 (2H,
q, J = 7.1 Hz), 4.55 (1H, t, J = 7.3 Hz), 5.88 (1
H, tt, J = 2.9 Hz, 53.1 Hz), 7.08-7.26 (6H, m), 7.
98 (2H, dd, J = 5.3 Hz, 8.9 Hz); IR (KBr) 1725, 16
76, 1599, 1512, 1304, 1281, 1242, 1215,1202, 1186,
1155, 1115, 1098, 843 cm -1 ; Anal.Calcd for C 20 H
17 F 5 O 4 : C, 57.70; H, 4.12. Found: C, 57.70; H, 4.2
2.2) Ethyl (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- [4- (1,1,2,2-tetrafluoroethoxy) benzyl] propionate Zinc chloride While stirring 15 g (37.8 mmol) in 80 ml of diethyl ether, 2.86 g (75.6 mmol) of sodium borohydride was added at room temperature, followed by stirring for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. 7.865 g (18.89 mmol) of ethyl 3- (4-fluorophenyl) -3-oxo-2- [4- (1,1,2,2-tetrafluoroethoxy) benzyl] propionate was added to the obtained solution. ) Was added at room temperature, and the mixture was stirred for 2 hours. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6/1).
-3/1) to obtain the desired product. Colorless liquid Yield 7.687
g Yield 97% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.91 (3H, t, J = 7.2 H
z), 2.88-3.03 (4H, m), 3.88 (2H, dq, J = 1.7 Hz,
7.1 Hz), 5.02 (1H, t, J = 3.3 Hz), 5.88 (1H, tt, J
= 2.9 Hz, 53.1 Hz), 7.05 (2H, t, J = 8.8 Hz), 7.0
8 (4H, s), 7.37 (2H, dd, J = 5.6 Hz, 8.8 Hz); IR
(neat) 3468, 1725, 1508, 1306, 1277, 1190,1159, 11
23, 837 cm -1 3) ( 2RS, 3RS) -3- (4- fluorophenyl) -3-hydroxy-2- [4- (1,1,2,2-tetrafluoroethoxy) benzyl] propionic acid ( 2RS, 3RS) -3- (4-Fluorophenyl) -3-
7.556 g of ethyl hydroxy-2- [4- (1,1,2,2-tetrafluoroethoxy) benzyl] propionate
To a solution of (18.06 mmol) in 30 ml of methanol-30 ml of tetrahydrofuran was added 36.1 ml (36.1 mmol) of a 1N aqueous sodium hydroxide solution, and the mixture was stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from hexane to obtain the desired product. White crystal Yield 6.260 g Yield 89% mp 128-129 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.91-3.07
(3H, m), 5.05 (1H, s), 5.88 (1H, tt, J = 2.8 Hz, 5
3.1 Hz), 7.04 (2H, t, J = 8.6 Hz), 7.07 (4H, s), 7.
35 (2H, dd, J = 5.3 Hz, 8.5 Hz); IR (KBr) 3630, 32
00-2480, 1698,1512, 1283, 1233, 1190, 1128, 1100,
. 839 cm -1; Anal Calcd for C 18 H 15 F 5 O 4: C, 55.39; H,
3.87. Found: C, 55.42; H, 3.71.4) (4RS, 5SR) -5- (4-fluorophenyl) -4- [4- (1,1,2,2-tetrafluoroethoxy) benzyl]- 1,3-oxazolidine-2-one (2RS, 3RS) -3- (4-fluorophenyl) -3-
Hydroxy-2- [4- (1,1,2,2-tetrafluoroethoxy) benzyl] propionic acid 5.072 g (1
2.72 ml (19.5 mmol) of triethylamine and 3.93 g of diphenylphosphoryl azide (14.99 mmol) in 40 ml of tetrahydrofuran solution of 2.99 mmol).
3 mmol) and heated to reflux overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate =
3 / 1-1 / 1) and crystallized from diethyl ether-hexane to obtain the desired product. 4.673 g of white crystals
Yield 93% mp 154-155 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.18-2.35
(2H, m), 4.24 (1H, dt, J = 5.4 Hz, 8.7 Hz), 5.05 (1
H, br s), 5.80 (1H, d, J = 8.0 Hz), 5.90 (1H, tt,
J = 2.8 Hz, 53.1 Hz), 7.05 (2H, t, J = 8.4 Hz), 7.
14 (2H, d, J = 8.8 Hz), 7.15 (2H, d, J = 8.6 Hz),
7.36 (2H, dd, J = 5.2 Hz, 8.6 Hz); IR (KBr) 3258, 1
736, 1510, 1231, 1213, 1192, 1128, 1105 cm -1 ; Ana
l. Calcdfor C 18 H 14 F 5 NO 3 : C, 55.82; H, 3.64; N, 3.6
2. Found: C, 55.89; H, 3.63; N, 3.44.5) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (1,1,2,2 -Tetrafluoroethoxy) phenyl] propan-1-ol (4RS, 5SR) -5- (4-fluorophenyl) -4-
[4- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,485-oxazolidin-2-one 4.485 g
(11.58 mmol) and 1.85 g of sodium hydroxide
(46.3 mmol) in ethanol 30 ml-water 2 ml
And heated to reflux for 6 hours. The reaction was diluted with water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel (APS type) column chromatography (hexane / ethyl acetate = 3 / 1-ethyl acetate), and crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 3.447 g Yield 82% mp 78-79 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.36 (1H, d
d, J = 10.5 Hz, 13.7 Hz), 2.80 (1H, dd, J = 3.0 H
z, 13.8 Hz), 3.26 (1H, ddd, J = 3.5 Hz, 4.9 Hz, 1
0.2 Hz), 4.65 (1H, d, J = 4.8 Hz), 5.90 (1H, tt, J
= 3.0 Hz, 53.1 Hz), 7.08 (2H, t, J = 8.6 Hz), 7.1
4 (4H, s), 7.37 (2H, dd, J = 5.6 Hz, 8.4 Hz); IR (K
Br) 3360, 2740, 1508, 1275, 1231, 1215, 1192, 111
9, 1096, 1040, 856 cm -1 ; Anal.Calcd for C 17 H 16 F 5 N
O 2 : C, 56.51; H, 4.46; N, 3.88. Found: C, 56.52;
H, 4.41; N, 3.66. 6) 4-Fluoro-N-[(1RS, 2SR) -2- (4-
Fluorophenyl) -2-hydroxy-1- [4- (1,
1,2,2-tetrafluoroethoxy) benzyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (1,1,2,2 2-tetrafluoroethoxy) phenyl] propan-1-ol 0.163 g
(0.451 mmol) 4-fluoro-1-naphthoic acid 86 mg (0.45 mmol), 1-hydroxybenzotriazole hydrate 69 mg (0.45 mmol) in 10 ml of acetonitrile with stirring in 1-ethyl- 3-
86 mg (0.45 mmol) of (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystal Yield 0.212 g Yield 88% mp 192-193 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
87 (1H, dd, J = 10.4 Hz, 14.4 Hz), 2.97 (1H, dd, J
= 4.8 Hz, 13.8 Hz), 4.68-4.82 (1H, m), 5.01-5.08
(2H, m), 5.94 (1H, tt, J = 2.9 Hz, 53.1 Hz), 6.99-
7.12 (6H, m), 7.19-7.26 (3H, m), 7.41-7.58 (4H, m
m), 7.73 (1H, d, J = 8.2 Hz), 8.07 (1H, d, J = 7.8
Hz); IR (KBr) 3285, 1644, 1628, 1601, 1535, 1508,
1314, 1264,1233, 1200, 1127, 1113, 1094, 837 cm -1 ;
Anal.Calcd for C 28 H 21 F 6 NO 3 : C, 63.04; H, 3.97; N,
2.63. Found: C, 62.98; H, 3.86; N, 2.60.
【0264】実施例132 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[3-(トリフルオロ
メトキシ)ベンジル]エチル]ナフタレン-1-カルボキ
サミド 1) 3-(4-フルオロフェニル)-3-オキソ-2-[3
-(トリフルオロメトキシ)ベンジル]プロピオン酸エ
チル (4-フルオロベンゾイル)酢酸エチル4.530g
(21.55ミリモル)の1,2-ジメトキシエタン5
0ml溶液に氷冷下60%水素化ナトリウムの流動パラ
フィン懸濁物0.86g(21.6ミリモル)を加え、
そのまま0.5時間撹拌した。3-(トリフルオロメト
キシ)ベンジルブロミド5.50g(21.6ミリモ
ル)の1,2-ジメトキシエタン10ml溶液を室温で
加え、室温で8時間撹拌した。反応液を水に注ぎ、酢酸
エチルで2回抽出した。集めた有機層を無水硫酸マグネ
シウムで乾燥、溶媒を減圧留去した。得られた残留物を
シリカゲルカラムクロマトグラフィーにて精製し(ヘキ
サン/酢酸エチル=15/1−9/1)、ヘキサンより
結晶化して、目的物を得た。白色結晶 収量6.824
g 収率82% mp 56-57℃; 1H-NMR (CDCl3, 200MHz) δ 1.12 (3H, t,
J = 7.1 Hz), 3.34 (2H, d, J = 7.6 Hz), 4.10 (2H,
q, J = 7.1 Hz), 4.55 (1H, t, J = 7.6 Hz), 7.03-7.1
6 (5H, m), 7.28 (1H, dt, J = 0.7 Hz, 7.7 Hz), 7.98
(2H, dd, J = 5.3 Hz, 8.9 Hz); IR (KBr) 1717, 168
6, 1599, 1271, 1258, 1236, 1217, 1177,1152 cm-1; A
nal. Calcd for C19H16F4O4: C, 59.38; H, 4.20. Foun
d: C, 59.33; H, 4.38. 2) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[3-(トリフルオロメトキ
シ)ベンジル]プロピオン酸エチル 塩化亜鉛4.65g(34.1ミリモル)をジエチルエ
ーテル50ml中で撹拌しながら水素化ホウ素ナトリウ
ム2.58g(68.3ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、3-(4-フルオ
ロフェニル)-3-オキソ-2-[3-(トリフルオロメト
キシ)ベンジル]プロピオン酸エチル6.559g(1
7.07ミリモル)のジエチルエーテル30ml溶液を
室温で加え、そのまま2時間撹拌した。反応液に希塩酸
を少しずつ加えて過剰の水素化ホウ素亜鉛を分解した
後、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸マグネシウムで乾燥、溶媒を減圧留去した。得られた
粗生成物をシリカゲルカラムクロマトグラフィーにて精
製し(ヘキサン/酢酸エチル=6/1−3/1)、目的
物を得た。無色液体 収量6.574g 収率100%1 H-NMR (CDCl3, 200MHz) δ 0.93 (3H, t, J = 7.1 H
z), 2.89 (1H, d, J = 2.8Hz), 2.91-3.07 (3H, m), 3.
88 (2H, q, J = 7.2 Hz), 5.02 (1H, t, J = 3.6Hz),
6.95-7.11 (5H, m), 7.25 (1H, t, J = 7.9 Hz), 7.37
(2H, dd, J = 5.2Hz, 8.4 Hz); IR (neat) 3445, 1728,
1715, 1512, 1260, 1219, 1161, 839 cm- 1 3) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[3-(トリフルオロメトキ
シ)ベンジル]プロピオン酸 (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[3-(トリフルオロメトキシ)ベンジ
ル]プロピオン酸エチル6.391g(16.54ミリ
モル)のメタノール30ml−テトラヒドロフラン20
ml溶液に1N水酸化ナトリウム水溶液33.1ml
(33.1ミリモル)を加え、室温で一晩撹拌した。反
応液を濃縮、水で希釈し、1N塩酸で反応液を酸性にし
た後、酢酸エチルで2回抽出した。集めた有機層を無水
硫酸ナトリウムで乾燥、溶媒を減圧留去した。残留物を
ヘキサンより結晶化して、目的物を得た。白色結晶 収
量5.055g 収率85% mp 108-110℃; 1H-NMR (CDCl3, 200MHz) δ 2.90-3.10
(3H, m), 5.06 (1H, s),6.95-7.11 (5H, m), 7.25 (1H,
t, J = 7.9 Hz), 7.36 (2H, dd, J = 5.6 Hz,8.8 Hz);
IR (KBr) 3343, 3020-2550, 1694, 1516, 1283, 1258,
1238, 1225, 1165, 837 cm-1; Anal. Calcd for C17H
14F4O4: C, 56.99; H, 3.94. Found: C,56.98; H, 3.8
5. 4) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-[3-(トリフルオロメトキシ)ベンジル]-
1,3-オキサゾリジン-2-オン (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[3-(トリフルオロメトキシ)ベンジ
ル]プロピオン酸4.649g(12.98ミリモル)
のテトラヒドロフラン50ml溶液にトリエチルアミン
2.71ml(19.5ミリモル)、ジフェニルホスホ
リルアジド3.93g(14.3ミリモル)を加え、一
晩加熱還流した。反応液の溶媒を減圧留去し、得られた
粗生成物をシリカゲルカラムクロマトグラフィーにて精
製し(ヘキサン/酢酸エチル=3/1−1/1)、ジエ
チルエーテル−ヘキサンより結晶化して、目的物を得
た。白色結晶 収量4.330g 収率94% mp 145-146℃; 1H-NMR (CDCl3, 200MHz) δ 2.21-2.37
(2H, m), 4.26 (1H, dt,J = 6.1 Hz, 8.3 Hz), 5.11 (1
H, br s), 5.80 (1H, d, J = 8.0 Hz), 6.87 (1H, s),
6.96 (1H, d, J = 7.2 Hz), 7.09-7.19 (3H, m), 7.28
7.39 (3H, m); IR (KBr) 3248, 1736, 1516, 1256, 122
7, 1163 cm-1; Anal. Calcd for C17H13F 4NO3: C, 57.4
7; H, 3.69; N, 3.94. Found: C, 57.54; H, 3.73; N,
4.01 5) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-[3-(トリフルオロメトキシ)フェ
ニル]プロパン-1-オール (4RS,5SR)-5-(4-フルオロフェニル)-4-
[3-(トリフルオロメトキシ)ベンジル]-1,3-オ
キサゾリジン-2-オン4.071g(11.46ミリモ
ル)と水酸化ナトリウム1.83g(45.8ミリモ
ル)をエタノール30ml−水2ml中で、6時間加熱
還流した。反応液を水で希釈し、酢酸エチルで2回抽出
した。集めた有機層を無水硫酸ナトリウムで乾燥、溶媒
を減圧留去した。残留物をシリカゲル(APSタイプ)
カラムクロマトグラフィーにて精製し(ヘキサン/酢酸
エチル=3/1−酢酸エチル)、目的物を得た。淡黄色
液体 収量3.722g 収率99%1 H-NMR (CDCl3, 200MHz) δ 2.38 (1H, dd, J = 10.3 H
z, 13.9 Hz), 2.82 (1H,dd, J = 3.3 Hz, 13.9 Hz), 3.
27 (1H, ddd, 3.4 Hz, 4.8 Hz, 10.3 Hz), 4.65(1H, d,
J = 5.0 Hz), 7.01-7.13 (5H, m), 7.27-7.42 (3H,
m); IR (neat) 2260-2860, 1508, 1260, 1217, 1159 cm
-1 6) 4-フルオロ-N-[(1RS,2SR)-2-(4-
フルオロフェニル)-2-ヒドロキシ-1-[3-(トリフ
ルオロメトキシ)ベンジル]エチル]ナフタレン-1-カ
ルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(トリフルオロメトキシ)フェニル]
プロパン-1-オール0.247g(0.750ミリモ
ル)、4-フルオロ-1-ナフトエ酸0.14g(0.7
5ミリモル)、1-ヒドロキシベンゾトリアゾール水和
物0.11g(0.75ミリモル)をアセトニトリル1
0ml中で撹拌しながら1-エチル-3-(3-ジメチルア
ミノプロピル)カルボジイミド・塩酸塩0.14g
(0.75ミリモル)を加え、室温で一晩撹拌した。反
応液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶液
で洗浄、無水硫酸マグネシウムで乾燥、シリカゲルを通
した後、溶媒を減圧留去した。得られた残留物をジイソ
プロピルエーテル−ヘキサンより結晶化して、目的物を
得た。白色結晶 収量0.262g 収率70% mp 189-190℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
90 (1H, dd, J = 10.7 Hz, 14.3 Hz), 3.04 (1H, dd, J
= 4.3 Hz, 14.1 Hz), 4.67-4.81 (1H, m), 5.00(1H,
t, J = 4.0 Hz), 5.21 (1H, d, J = 3.6 Hz), 6.99-7.3
4 (8H, m), 7.39-7.57 (5H, m), 7.69 (1H, d, J = 8.0
Hz), 8.06 (1H, d, J = 7.2 Hz); IR (KBr) 3268, 164
2, 1624, 1601, 1537, 1512, 1269, 1227, 1173, 835,
760 cm-1;Anal. Calcd for C27H20F5NO3: C, 64.67; H,
4.02; N, 2.79. Found: C, 64.58; H, 4.05; N, 2.59.Example 132 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluoro
L-phenyl) -2-hydroxy-1- [3- (trifluoro
Methoxy) benzyl] ethyl] naphthalene-1-carboxy
Samide 1) 3- (4-Fluorophenyl) -3-oxo-2- [3
-(Trifluoromethoxy) benzyl] propionic acid
4.530 g of ethyl butyl (4-fluorobenzoyl) acetate
(21.55 mmol) of 1,2-dimethoxyethane 5
0 ml solution of 60% sodium hydride in ice
0.86 g (21.6 mmol) of the fin suspension were added,
The mixture was stirred for 0.5 hours as it was. 3- (trifluoromethoate
5.50 g of (xy) benzyl bromide (21.6 mmol
A) in 10 ml of 1,2-dimethoxyethane at room temperature
The mixture was stirred at room temperature for 8 hours. Pour the reaction solution into water and add acetic acid
Extracted twice with ethyl. The collected organic layer is dried over anhydrous magnesium sulfate.
After drying with sodium, the solvent was distilled off under reduced pressure. The resulting residue
Purify by silica gel column chromatography.
Sun / ethyl acetate = 15 / 1-9 / 1), from hexane
Crystallization gave the desired product. White crystal yield 6.824
g yield 82% mp 56-57 ° C;1H-NMR (CDClThree, 200MHz) δ 1.12 (3H, t,
J = 7.1 Hz), 3.34 (2H, d, J = 7.6 Hz), 4.10 (2H,
q, J = 7.1 Hz), 4.55 (1H, t, J = 7.6 Hz), 7.03-7.1
6 (5H, m), 7.28 (1H, dt, J = 0.7 Hz, 7.7 Hz), 7.98
(2H, dd, J = 5.3 Hz, 8.9 Hz); IR (KBr) 1717, 168
6, 1599, 1271, 1258, 1236, 1217, 1177,1152 cm-1; A
nal.Calcd for C19H16FFourOFour: C, 59.38; H, 4.20. Foun
d: C, 59.33; H, 4.38.2) (2RS, 3RS) -3- (4-fluorophenyl)
) -3-hydroxy-2- [3- (trifluoromethoxy)
E) Benzyl] ethyl propionate 4.65 g (34.1 mmol) of zinc chloride was added to diethyl ether.
Sodium borohydride while stirring in 50 ml
2.58 g (68.3 mmol) were added at room temperature and the
The mixture was stirred for 2 hours. The insolubles of the mixture are removed by filtration.
Washed with ethyl ether), zinc borohydride in diethyl
An ether solution was obtained. Add 3- (4-fluoro) to the resulting solution.
L-phenyl) -3-oxo-2- [3- (trifluoromethoate
6.559 g of ethyl [xy) benzyl] propionate (1
7.07 mmol) in 30 ml of diethyl ether.
The mixture was added at room temperature and stirred for 2 hours. Dilute hydrochloric acid in the reaction solution
Was added little by little to decompose excess zinc borohydride
Thereafter, the mixture was extracted twice with ethyl acetate. The collected organic layer is anhydrous sulfur
After drying with magnesium acid, the solvent was distilled off under reduced pressure. Got
The crude product is purified by silica gel column chromatography.
(Hexane / ethyl acetate = 6 / 1-3 / 1)
I got something. Colorless liquid Yield 6.574 g Yield 100%1 H-NMR (CDClThree, 200MHz) δ 0.93 (3H, t, J = 7.1 H
z), 2.89 (1H, d, J = 2.8Hz), 2.91-3.07 (3H, m), 3.
88 (2H, q, J = 7.2 Hz), 5.02 (1H, t, J = 3.6Hz),
6.95-7.11 (5H, m), 7.25 (1H, t, J = 7.9 Hz), 7.37
(2H, dd, J = 5.2Hz, 8.4 Hz); IR (neat) 3445, 1728,
1715, 1512, 1260, 1219, 1161, 839 cm- 1 3) (2RS, 3RS) -3- (4-fluorophenyl)
) -3-hydroxy-2- [3- (trifluoromethoxy)
B) Benzyl] propionic acid (2RS, 3RS) -3- (4-fluorophenyl) -3-
Hydroxy-2- [3- (trifluoromethoxy) benzyl
E) ethyl propionate 6.391 g (16.54 mm
Mol) methanol 30 ml-tetrahydrofuran 20
33.1 ml of 1N aqueous sodium hydroxide solution
(33.1 mmol) and stirred at room temperature overnight. Anti
Concentrate the reaction solution, dilute with water, and acidify the reaction solution with 1N hydrochloric acid.
After that, the mixture was extracted twice with ethyl acetate. Dry the collected organic layer
After drying over sodium sulfate, the solvent was distilled off under reduced pressure. Residue
Crystallization from hexane gave the desired product. White crystals
5.055 g yield 85% mp 108-110 ° C;1H-NMR (CDClThree, 200MHz) δ 2.90-3.10
(3H, m), 5.06 (1H, s), 6.95-7.11 (5H, m), 7.25 (1H,
t, J = 7.9 Hz), 7.36 (2H, dd, J = 5.6 Hz, 8.8 Hz);
IR (KBr) 3343, 3020-2550, 1694, 1516, 1283, 1258,
1238, 1225, 1165, 837 cm-1; Anal. Calcd for C17H
14FFourOFour: C, 56.99; H, 3.94. Found: C, 56.98; H, 3.8
5.4) (4RS, 5SR) -5- (4-fluorophenyl)
) -4- [3- (Trifluoromethoxy) benzyl]-
1,3-oxazolidine-2-one (2RS, 3RS) -3- (4-fluorophenyl) -3-
Hydroxy-2- [3- (trifluoromethoxy) benzyl
Ru] propionic acid 4.649 g (12.98 mmol)
Triethylamine in a 50 ml solution of
2.71 ml (19.5 mmol), diphenylphospho
3.93 g (14.3 mmol) of rilazide were added,
Heated to reflux overnight. The solvent of the reaction solution was distilled off under reduced pressure to obtain
The crude product is purified by silica gel column chromatography.
(Hexane / ethyl acetate = 3 / 1-1 / 1)
Crystallized from tyl ether-hexane to obtain the desired product
Was. White crystals Yield 4.330 g Yield 94% mp 145-146 ° C;1H-NMR (CDClThree, 200MHz) δ 2.21-2.37
(2H, m), 4.26 (1H, dt, J = 6.1 Hz, 8.3 Hz), 5.11 (1
H, br s), 5.80 (1H, d, J = 8.0 Hz), 6.87 (1H, s),
6.96 (1H, d, J = 7.2 Hz), 7.09-7.19 (3H, m), 7.28
7.39 (3H, m); IR (KBr) 3248, 1736, 1516, 1256, 122
7, 1163 cm-1; Anal. Calcd for C17H13F FourNOThree: C, 57.4
7; H, 3.69; N, 3.94. Found: C, 57.54; H, 3.73; N,
4.01 5) (1RS, 2SR) -2-amino-1- (4-fluoro)
L-phenyl) -3- [3- (trifluoromethoxy) fe
Nyl] propan-1-ol (4RS, 5SR) -5- (4-fluorophenyl) -4-
[3- (trifluoromethoxy) benzyl] -1,3-o
4.071 g of oxazolidine-2-one (11.46 mmol
1.83 g (45.8 mmol)
Is heated in 30 ml of ethanol and 2 ml of water for 6 hours.
Refluxed. Dilute the reaction solution with water and extract twice with ethyl acetate
did. Dry the collected organic layer over anhydrous sodium sulfate,
Was distilled off under reduced pressure. Residue is silica gel (APS type)
Purified by column chromatography (hexane / acetic acid
Ethyl = 3 / 1-ethyl acetate) to obtain the desired product. Pale yellow
Liquid Yield 3.722 g Yield 99%1 H-NMR (CDClThree, 200MHz) δ 2.38 (1H, dd, J = 10.3 H
z, 13.9 Hz), 2.82 (1H, dd, J = 3.3 Hz, 13.9 Hz), 3.
27 (1H, ddd, 3.4 Hz, 4.8 Hz, 10.3 Hz), 4.65 (1H, d,
J = 5.0 Hz), 7.01-7.13 (5H, m), 7.27-7.42 (3H,
m); IR (neat) 2260-2860, 1508, 1260, 1217, 1159 cm
-1 6) 4-Fluoro-N-[(1RS, 2SR) -2- (4-
Fluorophenyl) -2-hydroxy-1- [3- (trif
Fluoromethoxy) benzyl] ethyl] naphthalene-1-ca
Luboxamide (1RS, 2SR) -2-amino-1- (4-fluorophene)
Nyl) -3- [3- (trifluoromethoxy) phenyl]
0.247 g of propan-1-ol (0.750 mmol
), 0.14 g of 4-fluoro-1-naphthoic acid (0.7
5 mmol) 1-hydroxybenzotriazole hydrate
0.11 g (0.75 mmol) of acetonitrile 1
While stirring in 0 ml, 1-ethyl-3- (3-dimethyla
Minopropyl) carbodiimide hydrochloride 0.14 g
(0.75 mmol) and stirred at room temperature overnight. Anti
Dilute the reaction solution in ethyl acetate and add aqueous sodium hydrogen carbonate
, Dried over anhydrous magnesium sulfate and passed through silica gel.
After that, the solvent was distilled off under reduced pressure. The resulting residue is
Crystallized from propyl ether-hexane to give the desired product
Obtained. White crystals Yield 0.262 g Yield 70% mp 189-190 ° C;1H-NMR (CDClThree-DMSO-d6, 200MHz) δ 2.
90 (1H, dd, J = 10.7 Hz, 14.3 Hz), 3.04 (1H, dd, J
= 4.3 Hz, 14.1 Hz), 4.67-4.81 (1H, m), 5.00 (1H,
t, J = 4.0 Hz), 5.21 (1H, d, J = 3.6 Hz), 6.99-7.3
4 (8H, m), 7.39-7.57 (5H, m), 7.69 (1H, d, J = 8.0
Hz), 8.06 (1H, d, J = 7.2 Hz); IR (KBr) 3268, 164
2, 1624, 1601, 1537, 1512, 1269, 1227, 1173, 835,
760 cm-1; Anal. Calcd for C27H20FFiveNOThree: C, 64.67; H,
4.02; N, 2.79. Found: C, 64.58; H, 4.05; N, 2.59.
【0265】実施例133 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(トリフルオロメトキシ)ベ
ンジル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]
シクロヘプテン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(トリフルオロメトキシ)フェニル]
プロパン-1-オール0.239g(0.726ミリモ
ル)、6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプ
テン-1-カルボン酸0.14g(0.73ミリモル)、
1-ヒドロキシベンゾトリアゾール水和物0.11g
(0.73ミリモル)をアセトニトリル10ml中で撹
拌しながら1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩0.14g(0.73ミリ
モル)を加え、室温で一晩撹拌した。反応液を酢酸エチ
ルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無水硫
酸マグネシウムで乾燥、シリカゲルを通した後、溶媒を
減圧留去した。得られた残留物をジイソプロピルエーテ
ル−ヘキサンより結晶化して、目的物を得た。白色結晶
収量0.274g 収率76% mp 177-178℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 1.
91-2.04 (2H, m), 2.18-2.27 (2H, m), 2.68 (2H, t, J
= 5.9 Hz), 2.78-2.96 (2H, m), 4.60-4.74 (1H, m),
4.93 (1H, d, J = 3.6 Hz), 4.98 (1H, t, J = 3.7 H
z), 5.88 (1H, td,J = 5.3 Hz, 11.9 Hz), 6.18 (1H,
d, J = 12.2 Hz), 6.73 (1H, d, J = 9.2 Hz), 6.92 (1
H, dd, J = 1.9 Hz, 7.3 Hz), 7.01-7.16 (7H, m), 7.2
6 (1H, d, J= 8.8 Hz), 7.49 (2H, dd, J = 5.5 Hz, 8.
5 Hz); IR (KBr) 3268, 1640, 1539,1512, 1269, 1221,
1153 cm-1; Anal. Calcd for C28H25F4NO3: C, 67.33;
H,5.04; N, 2.80. Found: C, 67.22; H, 4.98; N, 2.7
8.Example 133 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (trifluoromethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a]
Cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (trifluoromethoxy) phenyl]
0.239 g (0.726 mmol) of propan-1-ol, 0.14 g (0.73 mmol) of 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid,
0.11 g of 1-hydroxybenzotriazole hydrate
While stirring (0.73 mmol) in 10 ml of acetonitrile, 0.14 g (0.73 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystal Yield 0.274 g Yield 76% mp 177-178 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 1.
91-2.04 (2H, m), 2.18-2.27 (2H, m), 2.68 (2H, t, J
= 5.9 Hz), 2.78-2.96 (2H, m), 4.60-4.74 (1H, m),
4.93 (1H, d, J = 3.6 Hz), 4.98 (1H, t, J = 3.7 H
z), 5.88 (1H, td, J = 5.3 Hz, 11.9 Hz), 6.18 (1H,
d, J = 12.2 Hz), 6.73 (1H, d, J = 9.2 Hz), 6.92 (1
H, dd, J = 1.9 Hz, 7.3 Hz), 7.01-7.16 (7H, m), 7.2
6 (1H, d, J = 8.8 Hz), 7.49 (2H, dd, J = 5.5 Hz, 8.
5 Hz); IR (KBr) 3268, 1640, 1539,1512, 1269, 1221,
1153 cm -1 ; Anal.Calcd for C 28 H 25 F 4 NO 3 : C, 67.33;
H, 5.04; N, 2.80.Found: C, 67.22; H, 4.98; N, 2.7
8.
【0266】実施例134 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[4-(トリフルオロ
メトキシ)ベンジル]エチル]ナフタレン-1-カルボキ
サミド 1) 3-(4-フルオロフェニル)-3-オキソ-2-[4
-(トリフルオロメトキシ)ベンジル]プロピオン酸エ
チル (4-フルオロベンゾイル)酢酸エチル4.140g
(19.70ミリモル)の1,2-ジメトキシエタン5
0ml溶液に氷冷下60%水素化ナトリウムの流動パラ
フィン懸濁物0.79g(19.7ミリモル)を加え、
そのまま0.5時間撹拌した。4-(トリフルオロメト
キシ)ベンジルブロミド5.02g(19.7ミリモ
ル)の1,2-ジメトキシエタン10ml溶液を室温で
加え、室温で8時間撹拌した。反応液を水に注ぎ、酢酸
エチルで2回抽出した。集めた有機層を無水硫酸マグネ
シウムで乾燥、溶媒を減圧留去した。得られた残留物を
シリカゲルカラムクロマトグラフィーにて精製し(ヘキ
サン/酢酸エチル=15/1−9/1)、ヘキサンより
結晶化して、目的物を得た。白色結晶 収量5.869
g 収率78% mp 53.5-54.5℃; 1H-NMR (CDCl3, 200MHz) δ 1.11 (3
H, t, J = 7.1 Hz), 3.32(2H, d, J = 7.4 Hz), 4.10
(2H, q, J = 7.1 Hz), 4.54 (1H, t, J = 7.3 Hz), 7.1
0 (2H, d, J = 8.4 Hz), 7.12 (2H, t, J = 8.6 Hz),
7.25 (2H, d, J = 8.8 Hz), 7.98 (2H, dd, J = 5.2 H
z, 9.0 Hz); IR (KBr) 1732, 1682, 1597, 1507, 1325,
1273, 1236, 1152, 1101, 851 cm-1; Anal. Calcd for
C19H16F4O4:C, 59.38; H, 4.20. Found: C, 59.38; H,
4.27. 2) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[4-(トリフルオロメトキ
シ)ベンジル]プロピオン酸エチル 塩化亜鉛3.98g(29.2ミリモル)をジエチルエ
ーテル50ml中で撹拌しながら水素化ホウ素ナトリウ
ム2.21g(58.4ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、3-(4-フルオ
ロフェニル)-3-オキソ-2-[4-(トリフルオロメト
キシ)ベンジル]プロピオン酸エチル5.610g(1
4.60ミリモル)のジエチルエーテル30ml溶液を
室温で加え、そのまま2時間撹拌した。反応液に希塩酸
を少しずつ加えて過剰の水素化ホウ素亜鉛を分解した
後、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸マグネシウムで乾燥、溶媒を減圧留去した。得られた
粗生成物をシリカゲルカラムクロマトグラフィーにて精
製し(ヘキサン/酢酸エチル=6/1−3/1)、目的
物を得た。無色液体 収量5.601g 収率99%1 H-NMR (CDCl3, 200MHz) δ 0.91 (3H, t, J = 7.2 H
z), 2.89 (1H, d, J = 2.6Hz), 2.93-3.03 (3H, m), 3.
88 (2H, dq, J = 1.5 Hz, 7.2 Hz), 5.02 (1H, t,J =
3.6 Hz), 7.05 (2H, t, J = 8.8 Hz), 7.09 (4H, s),
7.37 (2H, dd, J =5.6 Hz, 8.4 Hz); IR (neat) 3445,
1728, 1715, 1510, 1264, 1225, 1161, 839cm-1 3) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[4-(トリフルオロメトキ
シ)ベンジル]プロピオン酸 (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[4-(トリフルオロメトキシ)ベンジ
ル]プロピオン酸エチル5.440g(14.08ミリ
モル)のメタノール30ml−テトラヒドロフラン20
ml溶液に1N水酸化ナトリウム水溶液28.2ml
(28.2ミリモル)を加え、室温で一晩撹拌した。反
応液を濃縮、水で希釈し、1N塩酸で反応液を酸性にし
た後、酢酸エチルで2回抽出した。集めた有機層を無水
硫酸ナトリウムで乾燥、溶媒を減圧留去した。残留物を
ヘキサンより結晶化して、目的物を得た。白色結晶 収
量4.071g 収率80% mp 111-112℃; 1H-NMR (CDCl3, 200MHz) δ 2.90-3.10
(3H, m), 5.05-5.08 (1H, m), 7.05 (2H, t, J = 8.4 H
z), 7.08 (4H, s), 7.36 (2H, dd, J = 5.6 Hz,8.8 H
z); IR (KBr) 3343, 3100-2550, 1692, 1514, 1285, 12
08, 1163, 839 cm- 1; Anal. Calcd for C17H14F4O4: C,
56.99; H, 3.94. Found: C, 56.97; H, 4.05. 4) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-[4-(トリフルオロメトキシ)ベンジル]-
1,3-オキサゾリジン-2-オン (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[4-(トリフルオロメトキシ)ベンジ
ル]プロピオン酸3.637g(10.15ミリモル)
のテトラヒドロフラン50ml溶液にトリエチルアミン
2.12ml(15.2ミリモル)、ジフェニルホスホ
リルアジド3.07g(11.2ミリモル)を加え、一
晩加熱還流した。反応液の溶媒を減圧留去し、得られた
粗生成物をシリカゲルカラムクロマトグラフィーにて精
製し(ヘキサン/酢酸エチル=3/1−1/1)、ジエ
チルエーテル−ヘキサンより結晶化して、目的物を得
た。白色結晶 収量3.340g 収率93% mp 163-164℃; 1H-NMR (CDCl3, 200MHz) δ 2.19-2.35
(2H, m), 4.17-4.29 (1H, m), 4.96 (1H, br s), 5.80
(1H, d, J = 8.2 Hz), 7.02-7.17 (6H, m), 7.36(2H, d
d, J = 5.2 Hz, 9.0 Hz); IR (KBr) 3243, 1736, 1510,
1275, 1236, 1150 cm-1; Anal. Calcd for C17H13F4NO
3: C, 57.47; H, 3.69; N, 3.94. Found:C, 57.48; H,
3.58; N, 4.04. 5) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-[4-(トリフルオロメトキシ)フェ
ニル]プロパン-1-オール (4RS,5SR)-5-(4-フルオロフェニル)-4-
[4-(トリフルオロメトキシ)ベンジル]-1,3-オ
キサゾリジン-2-オン3.057g(8.604ミリモ
ル)と水酸化ナトリウム1.38g(34.4ミリモ
ル)をエタノール30ml−水1.5ml中で、6時間
加熱還流した。反応液を水で希釈し、酢酸エチルで2回
抽出した。集めた有機層を無水硫酸ナトリウムで乾燥、
溶媒を減圧留去した。残留物をシリカゲル(APSタイ
プ)カラムクロマトグラフィーにて精製し(ヘキサン/
酢酸エチル=3/1−酢酸エチル)、ジイソプロピルエ
ーテル−ヘキサンより結晶化して、目的物を得た。白色
結晶 収量2.406g 収率85% mp 84-85℃; 1H-NMR (CDCl3, 200MHz) δ 2.36 (1H, d
d, J = 10.3 Hz, 13.9 Hz), 2.81 (1H, dd, J = 3.3 H
z, 13.5 Hz), 3.26 (1H, ddd, J = 3.3 Hz, 4.8 Hz, 1
0.3 Hz), 4.65 (1H, d, J = 4.8 Hz), 7.07 (2H, t, J
= 8.8 Hz), 7.15 (4H, s), 7.37 (2H, dd, J = 5.2 Hz,
8.4 Hz); IR (KBr) 3350-2750, 1508, 1277,1217, 119
4, 1165, 1047 cm-1; Anal. Calcd for C16H15F4NO2:
C, 58.36; H,4.59; N, 4.25. Found: C, 58.43; H, 4.5
4; N, 4.31. 6) 4-フルオロ-N-[(1RS,2SR)-2-(4-
フルオロフェニル)-2-ヒドロキシ-1-[4-(トリフ
ルオロメトキシ)ベンジル]エチル]ナフタレン-1-カ
ルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメトキシ)フェニル]
プロパン-1-オール0.212g(0.644ミリモ
ル)、4-フルオロ-1-ナフトエ酸0.12g(0.6
4ミリモル)、1-ヒドロキシベンゾトリアゾール水和
物0.10g(0.64ミリモル)をアセトニトリル1
0ml中で撹拌しながら1-エチル-3-(3-ジメチルア
ミノプロピル)カルボジイミド・塩酸塩0.12g
(0.64ミリモル)を加え、室温で一晩撹拌した。反
応液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶液
で洗浄、無水硫酸マグネシウムで乾燥、シリカゲルを通
した後、溶媒を減圧留去した。得られた残留物を酢酸エ
チル−ジイソプロピルエーテル−ヘキサンより結晶化し
て、目的物を得た。白色結晶 収量0.276g 収率
86% mp 230-231℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
87 (1H, dd, J = 10.8 Hz, 14.6 Hz), 3.00 (1H, dd, J
= 4.2 Hz, 14.2 Hz), 4.67-4.81 (1H, m), 5.02(1H,
t, J = 4.1 Hz), 5.19 (1H, d, J = 3.8 Hz), 6.99-7.5
7 (13H, m), 7.67(1H, d, J = 8.4 Hz), 8.06 (1H, d,
J = 8.0 Hz); IR (KBr) 3281, 1644, 1537, 1512, 126
9, 1227, 1217, 1175, 835 cm-1; Anal. Calcd for C27
H20F5NO3:C, 64.67; H, 4.02; N, 2.79. Found: C, 64.
57; H, 4.02; N, 2.61.Example 134 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethoxy) benzyl] ethyl] naphthalene-1- Carboxamide 1) 3- (4-Fluorophenyl) -3-oxo-2- [4
Ethyl-(trifluoromethoxy) benzyl] propionate 4.140 g of ethyl (4-fluorobenzoyl) acetate
(19.70 mmol) 1,2-dimethoxyethane 5
To a 0 ml solution was added 0.79 g (19.7 mmol) of a 60% sodium hydride liquid paraffin suspension under ice-cooling.
The mixture was stirred for 0.5 hours as it was. A solution of 5.02 g (19.7 mmol) of 4- (trifluoromethoxy) benzyl bromide in 10 ml of 1,2-dimethoxyethane was added at room temperature, and the mixture was stirred at room temperature for 8 hours. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-9 / 1), and crystallized from hexane to obtain the desired product. White crystal yield 5.869
g Yield 78% mp 53.5-54.5 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.11 (3
H, t, J = 7.1 Hz), 3.32 (2H, d, J = 7.4 Hz), 4.10
(2H, q, J = 7.1 Hz), 4.54 (1H, t, J = 7.3 Hz), 7.1
0 (2H, d, J = 8.4 Hz), 7.12 (2H, t, J = 8.6 Hz),
7.25 (2H, d, J = 8.8 Hz), 7.98 (2H, dd, J = 5.2 H
z, 9.0 Hz); IR (KBr) 1732, 1682, 1597, 1507, 1325,
1273, 1236, 1152, 1101, 851 cm -1 ; Anal.Calcd for
C 19 H 16 F 4 O 4 : C, 59.38; H, 4.20. Found: C, 59.38; H,
4.27.2) Ethyl (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- [4- (trifluoromethoxy) benzyl] propionate 3.98 g (29.2 mmol) of zinc chloride While stirring in 50 ml of diethyl ether, 2.21 g (58.4 mmol) of sodium borohydride was added at room temperature, and the mixture was stirred for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. 5.610 g of ethyl 3- (4-fluorophenyl) -3-oxo-2- [4- (trifluoromethoxy) benzyl] propionate was added to the resulting solution.
(4.60 mmol) in 30 ml of diethyl ether was added at room temperature, and the mixture was stirred for 2 hours. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-3 / 1) to obtain the desired product. Colorless liquid Yield 5.601 g Yield 99% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.91 (3H, t, J = 7.2 H)
z), 2.89 (1H, d, J = 2.6Hz), 2.93-3.03 (3H, m), 3.
88 (2H, dq, J = 1.5 Hz, 7.2 Hz), 5.02 (1H, t, J =
3.6 Hz), 7.05 (2H, t, J = 8.8 Hz), 7.09 (4H, s),
7.37 (2H, dd, J = 5.6 Hz, 8.4 Hz); IR (neat) 3445,
1728, 1715, 1510, 1264, 1225, 1161, 839cm -1 3) (2RS, 3RS) -3- (4- fluorophenyl) -3-hydroxy-2- [4- (trifluoromethoxy) benzyl] propionic acid (2RS, 3RS) -3- (4-fluorophenyl) -3-
5.440 g (14.08 mmol) of ethyl hydroxy-2- [4- (trifluoromethoxy) benzyl] propionate in 30 ml of methanol-tetrahydrofuran 20
28.2 ml of 1N aqueous sodium hydroxide solution
(28.2 mmol) and stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from hexane to obtain the desired product. White crystals Yield 4.071 g Yield 80% mp 111-112 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.90-3.10
(3H, m), 5.05-5.08 (1H, m), 7.05 (2H, t, J = 8.4 H
z), 7.08 (4H, s), 7.36 (2H, dd, J = 5.6 Hz, 8.8 H
z); IR (KBr) 3343, 3100-2550, 1692, 1514, 1285, 12
08, 1163, 839 cm - 1 ; Anal.Calcd for C 17 H 14 F 4 O 4 : C,
56.99; H, 3.94. Found: C, 56.97; H, 4.05.4. (4RS, 5SR) -5- (4-fluorophenyl) -4- [4- (trifluoromethoxy) benzyl]-
1,3-oxazolidine-2-one (2RS, 3RS) -3- (4-fluorophenyl) -3-
3.637 g (10.15 mmol) of hydroxy-2- [4- (trifluoromethoxy) benzyl] propionic acid
To a solution of the above in 50 ml of tetrahydrofuran were added 2.12 ml (15.2 mmol) of triethylamine and 3.07 g (11.2 mmol) of diphenylphosphoryl azide, and the mixture was heated under reflux overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from diethyl ether / hexane. I got something. White crystal Yield 3.340 g Yield 93% mp 163-164 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.19-2.35
(2H, m), 4.17-4.29 (1H, m), 4.96 (1H, br s), 5.80
(1H, d, J = 8.2 Hz), 7.02-7.17 (6H, m), 7.36 (2H, d
d, J = 5.2 Hz, 9.0 Hz); IR (KBr) 3243, 1736, 1510,
1275, 1236, 1150 cm -1 ; Anal.Calcd for C 17 H 13 F 4 NO
3 : C, 57.47; H, 3.69; N, 3.94. Found: C, 57.48; H,
3.58; N, 4.04.5) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4- (trifluoromethoxy) phenyl] propan-1-ol (4RS, 5SR)- 5- (4-fluorophenyl) -4-
[4- (trifluoromethoxy) benzyl] -1,3-oxazolidin-2-one 3.057 g (8.604 mmol) and 1.38 g (34.4 mmol) of sodium hydroxide were added to 30 ml of ethanol and 1.5 ml of water. And heated to reflux for 6 hours. The reaction was diluted with water and extracted twice with ethyl acetate. The collected organic layer is dried over anhydrous sodium sulfate,
The solvent was distilled off under reduced pressure. The residue was purified by silica gel (APS type) column chromatography (hexane /
Crystallization from ethyl acetate = 3 / 1-ethyl acetate) and diisopropyl ether-hexane gave the desired product. White crystal Yield 2.406 g Yield 85% mp 84-85 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.36 (1H, d
d, J = 10.3 Hz, 13.9 Hz), 2.81 (1H, dd, J = 3.3 H
z, 13.5 Hz), 3.26 (1H, ddd, J = 3.3 Hz, 4.8 Hz, 1
0.3 Hz), 4.65 (1H, d, J = 4.8 Hz), 7.07 (2H, t, J
= 8.8 Hz), 7.15 (4H, s), 7.37 (2H, dd, J = 5.2 Hz,
8.4 Hz); IR (KBr) 3350-2750, 1508, 1277,1217, 119
. 4, 1165, 1047 cm -1 ; Anal Calcd for C 16 H 15 F 4 NO 2:
C, 58.36; H, 4.59; N, 4.25. Found: C, 58.43; H, 4.5
4; N, 4.31.6.) 4-Fluoro-N-[(1RS, 2SR) -2- (4-
(Fluorophenyl) -2-hydroxy-1- [4- (trifluoromethoxy) benzyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [4 -(Trifluoromethoxy) phenyl]
0.212 g (0.644 mmol) of propan-1-ol 0.12 g (0.64 g of 4-fluoro-1-naphthoic acid)
4 mmol) and 0.10 g (0.64 mmol) of 1-hydroxybenzotriazole hydrate in acetonitrile 1
0.12 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride while stirring in 0 ml
(0.64 mmol) and stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White crystal Yield 0.276 g Yield 86% mp 230-231 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
87 (1H, dd, J = 10.8 Hz, 14.6 Hz), 3.00 (1H, dd, J
= 4.2 Hz, 14.2 Hz), 4.67-4.81 (1H, m), 5.02 (1H,
t, J = 4.1 Hz), 5.19 (1H, d, J = 3.8 Hz), 6.99-7.5
7 (13H, m), 7.67 (1H, d, J = 8.4 Hz), 8.06 (1H, d,
J = 8.0 Hz); IR (KBr) 3281, 1644, 1537, 1512, 126
9, 1227, 1217, 1175, 835 cm -1 ; Anal.Calcd for C 27
H 20 F 5 NO 3 : C, 64.67; H, 4.02; N, 2.79. Found: C, 64.
57; H, 4.02; N, 2.61.
【0267】実施例135 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメトキシ)ベ
ンジル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]
シクロヘプテン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメトキシ)フェニル]
プロパン-1-オール0.238g(0.723ミリモ
ル)、6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプ
テン-1-カルボン酸0.14g(0.72ミリモル)、
1-ヒドロキシベンゾトリアゾール水和物0.11g
(0.72ミリモル)をアセトニトリル10ml中で撹
拌しながら1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩0.14g(0.72ミリ
モル)を加え、室温で一晩撹拌した。反応液を酢酸エチ
ルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無水硫
酸マグネシウムで乾燥、シリカゲルを通した後、溶媒を
減圧留去した。得られた残留物をジイソプロピルエーテ
ル−ヘキサンより結晶化して、目的物を得た。白色結晶
収量0.279g 収率77% mp 202-203℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 1.
91-2.04 (2H, m), 2.18-2.27 (2H, m), 2.68 (2H, t, J
= 5.9 Hz), 2.78-2.92 (2H, m), 4.62-4.72 (1H, m),
4.96-5.02 (2H, m), 5.88 (1H, td, J = 5.3 Hz, 11.7
Hz), 6.17 (1H, d, J = 12.2 Hz), 6.74 (1H, d, J = 1
0.0 Hz), 6.90 (1H, dd, J = 2.0 Hz, 7.6Hz), 7.01-7.
15 (6H, m), 7.22 (2H, d, J = 8.8 Hz), 7.50 (2H, d
d, J = 5.6Hz, 8.6 Hz); IR (KBr) 3272, 1640, 1539,
1512, 1269, 1229, 1202, 1159 cm -1; Anal. Calcd for
C28H25F4NO3: C, 67.33; H, 5.04; N, 2.80. Found:
C, 67.16; H, 4.94; N, 2.75.Example 135 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [4- (trifluoromethoxy) be
[Ndyl] ethyl] -6,7-dihydro-5H-benzo [a]
Cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophene)
Nyl) -3- [4- (trifluoromethoxy) phenyl]
0.238 g of propan-1-ol (0.723 mmol
Le), 6,7-dihydro-5H-benzo [a] cyclohep
0.14 g (0.72 mmol) of ten-1-carboxylic acid,
0.11 g of 1-hydroxybenzotriazole hydrate
(0.72 mmol) in 10 ml of acetonitrile.
While stirring, 1-ethyl-3- (3-dimethylaminopropyl
B) 0.14 g (0.72 mm) carbodiimide hydrochloride
Mol) was added and stirred overnight at room temperature. Ethyl acetate
Diluted with water, washed with aqueous sodium hydrogen carbonate solution,
After drying with magnesium acid and passing through silica gel, the solvent was removed.
It was distilled off under reduced pressure. The resulting residue is
Crystallization from l-hexane gave the desired product. White crystals
0.279 g yield 77% mp 202-203 ° C;1H-NMR (CDClThree-DMSO-d6, 200MHz) δ 1.
91-2.04 (2H, m), 2.18-2.27 (2H, m), 2.68 (2H, t, J
= 5.9 Hz), 2.78-2.92 (2H, m), 4.62-4.72 (1H, m),
4.96-5.02 (2H, m), 5.88 (1H, td, J = 5.3 Hz, 11.7
Hz), 6.17 (1H, d, J = 12.2 Hz), 6.74 (1H, d, J = 1
0.0 Hz), 6.90 (1H, dd, J = 2.0 Hz, 7.6Hz), 7.01-7.
15 (6H, m), 7.22 (2H, d, J = 8.8 Hz), 7.50 (2H, d
d, J = 5.6Hz, 8.6 Hz); IR (KBr) 3272, 1640, 1539,
1512, 1269, 1229, 1202, 1159 cm -1; Anal. Calcd for
C28Htwenty fiveFFourNOThree: C, 67.33; H, 5.04; N, 2.80. Found:
C, 67.16; H, 4.94; N, 2.75.
【0268】実施例136 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((3-(トリフルオロメチル)フ
ェニル)メチル)エチル)-1-ナフタレンカルボキサミ
ド 1) 3-(4-フルオロフェニル)-3-オキソプロピオ
ン酸エチル(10g,47.6ミリモル)と3-トリフ
ルオロメチルベンジルクロリド(8.33g,42.8
ミリモル)、炭酸カリウム(13.2g,95.1ミリ
モル)、アセトニトリル(200ml)の混合液を60
℃で24時間撹拌した。反応液を減圧濃縮し、水(20
0ml)を加えて酢酸エチル(200,100ml)で
抽出した。抽出液を水洗後、無水硫酸マグネシウムで乾
燥し、減圧留去した。残留物をシリカゲルカラムクロマ
トグラフィー(ヘキサン:トルエン=1:1−1:2-
トルエン)で精製し、3-(4-フルオロフェニル)-3-
オキソ-2-(3-トリフルオロメチルベンジル)プロピ
オン酸エチル(10.2g,65%)を油状物として得
た。 IRνmaxNeatcm-1: 1736, 1690, 1599, 1331, 1161, 112
7, 1074.1 H-NMR (CDCl3)δ: 1.12 (3H, t, J = 7.1 Hz), 3.38
(2H, d, J = 7.4 Hz), 4.10 (2H, q, J = 7.1 Hz), 4.5
7 (1H, t, J = 7.4 Hz), 7.13 (2H, t, J = 8.8 Hz),
7.35-7.60 (4H, m), 7.95-8.10 (2H, m). 2) 無水塩化亜鉛(7.4g,54.3ミリモル)の
ジエチルエーテル(50ml)溶液に、水素化ほう素ナ
トリウム(4.11g,0.11モル)を加えて室温で
2時間撹拌した。不溶物を濾去し、濾液に3-(4-フル
オロフェニル)-3-オキソ-2-(3-トリフルオロメチ
ルベンジル)プロピオン酸エチル(10g,27.1ミ
リモル)のジエチルエーテル(20ml)溶液を加えて
室温で1時間撹拌した。反応液に1規定塩酸を加えて反
応を停止し、酢酸エチル(100ml)を加えて抽出し
た。抽出液を水と飽和重曹水で洗浄後、無水硫酸マグネ
シウムで乾燥し、減圧留去した。残留物をシリカゲルカ
ラムクロマトグラフィー(ヘキサン:酢酸エチル=2
0:1−5:1)で精製して、(2RS,3RS)-3-
(4-フルオロフェニル)-3-ヒドロキシ-2-(3-トリ
フルオロメチルベンジル)プロピオン酸エチル(7.9
g,79%)を無色油状物として得た。 IRνmaxNeatcm-1: 1717, 1510, 1329, 1161, 1127, 107
4, 839.1 H-NMR (CDCl3)δ: 0.92 (3H, t, J = 7.2 Hz), 2.93
(1H, d, J = 2.6 Hz), 2.90-3.12 (3H, m), 3.88 (2H,
q, J = 7.2 Hz), 5.00-5.10 (1H, m), 7.05 (2H,t, J =
8.7 Hz), 7.20-7.55 (6H, m). 3) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-(3-トリフルオロメチルベン
ジル)プロピオン酸エチル(7.9g,21.3ミリモ
ル)のメタノール(50ml)溶液に、1規定水酸化ナ
トリウム水溶液(42.7ml,42.7ミリモル)を
加えて室温で3時間撹拌した。反応液を1規定塩酸(1
00ml)で酸性とした後、酢酸エチル(200ml×
2)で抽出した。抽出液を水洗後、無水硫酸マグネシウ
ムで乾燥し、減圧留去し、残留物をヘキサンとジエチル
エーテルの混合液から結晶化させて、(2RS,3R
S)-3-(4-フルオロフェニル)-3-ヒドロキシ-2-
(3-トリフルオロメチルベンジル)プロピオン酸
(6.20g,85%)を得た。 mp 116-118℃ IRνmaxKBrcm-1: 3424, 1717, 1678, 1514, 1325, 123
8, 1128, 1074, 839. 元素分析値C17H14F4O3として、 計算値: C, 59.65; H, 4.12 実測値: C, 59.55; H, 4.10.1 H-NMR (DMSO-d6)δ: 2.80-2.95 (1H, m), 2.99 (1H,
d, J = 10.4 Hz), 3.15 (1H, d, J = 10.4 Hz), 4.74
(1H, d, J = 6.2 Hz), 5.65-5.90 (1H, br), 7.12(2H,
t, J = 8.8 Hz), 7.32-7.60 (6H, m). 4) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-(3-トリフルオロメチルベン
ジル)プロピオン酸(5.85g,17.1ミリモル)
のテトラヒドロフラン(100ml)溶液に、ジフェニ
ルホスホリルアジド(4.78ml,22.2ミリモ
ル)とトリエチルアミン(3.33ml,23.9ミリ
モル)を加えた。反応液を4時間加熱還流し、冷後、水
(200ml)を加えて酢酸エチル(200ml)で抽
出した。抽出液を1規定塩酸と飽和重曹水で洗浄後、無
水硫酸マグネシウムで乾燥し、減圧留去した。残留物を
シリカゲルカラムクロマトグラフィー(クロロホルム:
酢酸エチル=10:1−5:1)で精製して、(4R
S,5SR)-5-(4-フルオロフェニル)-4-((3-
(トリフルオロメチル)フェニル)メチル)-1,3-オ
キサゾリジン-2-オン(5.30g,91%)を結晶と
して得た。 mp 177-178℃ 元素分析値C17H13F4NO2として、 計算値: C, 60.18; H, 3.86; N, 4.13 実測値: C, 60.20; H, 3.83; N, 4.09.1 H-NMR (CDCl3)δ: 2.30-2.45 (2H, m), 4.20-4.40 (1
H, m), 5.11 (1H, brs),5.80 (1H, d, J = 8.0 Hz), 7.
13 (2H, t, J = 8.6 Hz), 7.15-7.60 (6H, m). 5) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((3-(トリフルオロメチル)フェニル)メ
チル)-1,3-オキサゾリジン-2-オン(4.0g,1
1.8ミリモル)のエタノール(80ml)溶液に8規
定水酸化ナトリウム水溶液(7.4ml,59ミリモ
ル)を加え、4時間加熱還流した。反応液を濃縮後、水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて、(1RS,2SR)
-2-アミノ-1-(4-フルオロフェニル)-3-(3-(ト
リフルオロメチル)フェニル)-1-プロパノール(2.
97g,80%)を得た。 mp 76-77℃ IRνmaxKBrcm-1: 1605. Anal. Calcd for C16H15F4NO: C, 61.34; H, 4.83; N,
4.47 Found: C, 61.19; H, 4.82; N, 4.36.1 H-NMR (CDCl3)δ: 2.42 (1H, dd, J = 13.8, 10.2 H
z), 2.89 (1H, dd, J = 13.8, 3.2 Hz), 3.20-3.38 (1
H, m), 4.66 (1H, d, J = 4.6 Hz), 7.00-7.16 (2H,m),
7.22-7.52 (6H, m). 6) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(3-(トリフルオロメチル)フェニ
ル)-1-プロパノール(450mg,1.44ミリモ
ル)の酢酸エチル(15ml)溶液に1-ナフトイルク
ロリド(282ml,1.87ミリモル)および飽和重
曹水(15ml)を加えて室温で2時間攪拌した。反応
液を水(100ml)で希釈し、酢酸エチル(100m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物を酢
酸エチル−ヘキサンから再結晶させて表題化合物(58
2mg,87%)を得た。 mp 158-159℃ IRνmaxKBrcm-1: 1638, 1622, 1534. Anal. Calcd for C27H21F4NO2: C, 69.37; H, 4.53; N,
3.00 Found: C, 69.47; H, 4.23; N, 2.97.1 H-NMR (CDCl3)δ: 2.79 (1H, dd, J = 14.4, 11.0 H
z), 2.97 (1H, dd, J = 14.4, 4.0 Hz), 3.93 (1H, s),
4.70-4.90 (1H, m), 5.18 (1H, s), 5.98 (1H, d,J =
8.2 Hz), 6.92-7.08 (2H, m), 7.10-7.30 (3H, m), 7.3
2-7.80 (8H, m), 7.80-7.96 (2H, m).Example 136 N-((1RS, 2SR) -2- (4-fluorophenyl)
2-Hydroxy-1-((3- (trifluoromethyl) phenyl) methyl) ethyl) -1-naphthalenecarboxamide 1) Ethyl 3- (4-fluorophenyl) -3-oxopropionate (10 g, 47.6) Mmol) and 3-trifluoromethylbenzyl chloride (8.33 g, 42.8)
Mmol), potassium carbonate (13.2 g, 95.1 mmol), and acetonitrile (200 ml) in 60 ml.
Stirred at C for 24 hours. The reaction solution was concentrated under reduced pressure, and water (20
0 ml) and extracted with ethyl acetate (200, 100 ml). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: toluene = 1: 11-1: 2-
3- (4-fluorophenyl) -3-
Ethyl oxo-2- (3-trifluoromethylbenzyl) propionate (10.2 g, 65%) was obtained as an oil. IRνmax Neat cm -1 : 1736, 1690, 1599, 1331, 1161, 112
7, 1074. 1 H-NMR ( CDCl 3) δ: 1.12 (3H, t, J = 7.1 Hz), 3.38
(2H, d, J = 7.4 Hz), 4.10 (2H, q, J = 7.1 Hz), 4.5
7 (1H, t, J = 7.4 Hz), 7.13 (2H, t, J = 8.8 Hz),
7.35-7.60 (4H, m), 7.95-8.10 (2H, m). 2) To a solution of anhydrous zinc chloride (7.4 g, 54.3 mmol) in diethyl ether (50 ml) was added sodium borohydride (4. 11g, 0.11 mol) and stirred at room temperature for 2 hours. The insoluble material was removed by filtration, and the filtrate was treated with a solution of ethyl 3- (4-fluorophenyl) -3-oxo-2- (3-trifluoromethylbenzyl) propionate (10 g, 27.1 mmol) in diethyl ether (20 ml). Was added and stirred at room temperature for 1 hour. The reaction was quenched by adding 1N hydrochloric acid to the reaction solution, and extracted with ethyl acetate (100 ml). The extract was washed with water and saturated aqueous sodium hydrogen carbonate, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 2
0: 1-5: 1) to give (2RS, 3RS) -3-
Ethyl (4-fluorophenyl) -3-hydroxy-2- (3-trifluoromethylbenzyl) propionate (7.9
g, 79%) as a colorless oil. IRνmax Neat cm -1 : 1717, 1510, 1329, 1161, 1127, 107
4, 839. 1 H-NMR ( CDCl 3) δ: 0.92 (3H, t, J = 7.2 Hz), 2.93
(1H, d, J = 2.6 Hz), 2.90-3.12 (3H, m), 3.88 (2H,
q, J = 7.2 Hz), 5.00-5.10 (1H, m), 7.05 (2H, t, J =
8.7 Hz), 7.20-7.55 (6H, m). 3) Ethyl (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- (3-trifluoromethylbenzyl) propionate (7. To a solution of 9 g (21.3 mmol) in methanol (50 ml) was added a 1N aqueous sodium hydroxide solution (42.7 ml, 42.7 mmol) and the mixture was stirred at room temperature for 3 hours. The reaction solution was diluted with 1N hydrochloric acid (1
00 ml), and then ethyl acetate (200 ml ×
Extracted in 2). The extract was washed with water, dried over anhydrous magnesium sulfate, evaporated under reduced pressure, and the residue was crystallized from a mixture of hexane and diethyl ether to give (2RS, 3R
S) -3- (4-Fluorophenyl) -3-hydroxy-2-
(3-Trifluoromethylbenzyl) propionic acid (6.20 g, 85%) was obtained. mp 116-118 ℃ IRνmax KBr cm -1 : 3424, 1717, 1678, 1514, 1325, 123
8, 1128, 1074, as 839. Elemental analysis C 17 H 14 F 4 O 3 , Calcd: C, 59.65; H, 4.12 Found:. C, 59.55; H, 4.10 1 H-NMR (DMSO-d 6 ) δ: 2.80-2.95 (1H, m), 2.99 (1H,
d, J = 10.4 Hz), 3.15 (1H, d, J = 10.4 Hz), 4.74
(1H, d, J = 6.2 Hz), 5.65-5.90 (1H, br), 7.12 (2H,
t, J = 8.8 Hz), 7.32-7.60 (6H, m). 4) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- (3-trifluoromethylbenzyl) propionic acid (5.85 g, 17.1 mmol)
To a solution of the above in tetrahydrofuran (100 ml) was added diphenylphosphoryl azide (4.78 ml, 22.2 mmol) and triethylamine (3.33 ml, 23.9 mmol). The reaction solution was heated under reflux for 4 hours, cooled, added with water (200 ml), and extracted with ethyl acetate (200 ml). The extract was washed with 1N hydrochloric acid and saturated aqueous sodium hydrogen carbonate, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (chloroform:
Purification with ethyl acetate = 10: 1-5: 1) gave (4R
S, 5SR) -5- (4-fluorophenyl) -4-((3-
(Trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2-one (5.30 g, 91%) was obtained as crystals. As mp 177-178 ° C. Elemental analysis C 17 H 13 F 4 NO 2 , calc: C, 60.18; H, 3.86 ; N, 4.13 Found:. C, 60.20; H, 3.83; N, 4.09 1 H- NMR (CDCl 3 ) δ: 2.30-2.45 (2H, m), 4.20-4.40 (1
H, m), 5.11 (1H, brs), 5.80 (1H, d, J = 8.0 Hz), 7.
13 (2H, t, J = 8.6 Hz), 7.15-7.60 (6H, m). 5) (4RS, 5SR) -5- (4-fluorophenyl) -4-((3- (trifluoromethyl) phenyl ) Methyl) -1,3-oxazolidin-2-one (4.0 g, 1
To a solution of (1.8 mmol) in ethanol (80 ml) was added an 8 N aqueous sodium hydroxide solution (7.4 ml, 59 mmol), and the mixture was heated under reflux for 4 hours. After concentrating the reaction solution, the reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR)
2-Amino-1- (4-fluorophenyl) -3- (3- (trifluoromethyl) phenyl) -1-propanol (2.
97 g, 80%). . mp 76-77 ℃ IRνmax KBr cm -1 : 1605. Anal Calcd for C 16 H 15 F 4 NO: C, 61.34; H, 4.83; N,
4.47 Found:. C, 61.19; H, 4.82; N, 4.36 1 H-NMR (CDCl 3) δ: 2.42 (1H, dd, J = 13.8, 10.2 H
z), 2.89 (1H, dd, J = 13.8, 3.2 Hz), 3.20-3.38 (1
H, m), 4.66 (1H, d, J = 4.6 Hz), 7.00-7.16 (2H, m),
7.22-7.52 (6H, m). 6) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (3- (trifluoromethyl) phenyl) -1-propanol (450 mg, 1 (.44 mmol) in ethyl acetate (15 ml), 1-naphthoyl chloride (282 ml, 1.87 mmol) and saturated aqueous sodium hydrogen carbonate (15 ml) were added, and the mixture was stirred at room temperature for 2 hours. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (58
2 mg, 87%). mp 158-159 ℃ IRνmax KBr cm -1 : 1638, 1622, 1534. Anal.Calcd for C 27 H 21 F 4 NO 2 : C, 69.37; H, 4.53; N,
3.00 Found:. C, 69.47; H, 4.23; N, 2.97 1 H-NMR (CDCl 3) δ: 2.79 (1H, dd, J = 14.4, 11.0 H
z), 2.97 (1H, dd, J = 14.4, 4.0 Hz), 3.93 (1H, s),
4.70-4.90 (1H, m), 5.18 (1H, s), 5.98 (1H, d, J =
8.2 Hz), 6.92-7.08 (2H, m), 7.10-7.30 (3H, m), 7.3
2-7.80 (8H, m), 7.80-7.96 (2H, m).
【0269】実施例137 4-フルオロ-N-((1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-((3-(トリフルオ
ロメチル)フェニル)メチル)エチル)-1-ナフタレン
カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(3-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)のア
セトニトリル(30ml)溶液に4-フルオロナフタレ
ンカルボン酸(274mg,1.44ミリモル)および
1-エチル-3-(3-ジメチルアミノプロピル)カルボジ
イミド・塩酸塩(358mg,1.87ミリモル)およ
び1-ヒドロキシ-1H-ベンゾトリアゾール(220m
g,1.44ミリモル)を加えて室温で終夜攪拌した。
反応液を水(100ml)で希釈し、酢酸エチル(10
0ml×2)で抽出した。抽出液を飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(酢酸エチ
ル)で精製し、酢酸エチル−ヘキサンから再結晶させ
て、表題化合物(490mg,70%)を得た。 mp 193-194℃ IRνmaxKBrcm-1: 1642, 1626, 1601, 1514, 1329. Anal. Calcd for C27H20F5NO2: C, 66.80; H, 4.15; N,
2.89 Found: C, 66.70; H, 4.11; N, 2.75.1 H-NMR (CDCl3)δ: 2.89 (1H, dd, J = 14.2, 10.6 H
z), 3.09 (1H, dd, J = 14.2, 4.0 Hz), 3.34 (1H, s),
4.70-4.84 (1H, m), 5.06-5.14 (1H, m), 5.98 (1H,
d, J = 8.8 Hz), 6.92-7.20 (4H, m), 7.40-7.60 (8H,
m), 7.75 (1H, d, J= 8.0 Hz), 8.08 (1H, d, J = 8.0
Hz).Example 137 4-Fluoro-N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-((3- (trifluoromethyl) phenyl) methyl) ethyl)- 1-naphthalenecarboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (3- (trifluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.44 mmol) in acetonitrile (30 ml) was added 4-fluoronaphthalenecarboxylic acid (274 mg, 1.44 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride ( 358 mg, 1.87 mmol) and 1-hydroxy-1H-benzotriazole (220 m
g, 1.44 mmol) and stirred at room temperature overnight.
The reaction solution was diluted with water (100 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to give the title compound (490 mg, 70%). mp 193-194 ° C IRνmax KBr cm -1 : 1642, 1626, 1601, 1514, 1329. Anal.Calcd for C 27 H 20 F 5 NO 2 : C, 66.80; H, 4.15; N,
2.89 Found:. C, 66.70; H, 4.11; N, 2.75 1 H-NMR (CDCl 3) δ: 2.89 (1H, dd, J = 14.2, 10.6 H
z), 3.09 (1H, dd, J = 14.2, 4.0 Hz), 3.34 (1H, s),
4.70-4.84 (1H, m), 5.06-5.14 (1H, m), 5.98 (1H,
d, J = 8.8 Hz), 6.92-7.20 (4H, m), 7.40-7.60 (8H,
m), 7.75 (1H, d, J = 8.0 Hz), 8.08 (1H, d, J = 8.0
Hz).
【0270】実施例138 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((3-(トリフルオロメチル)フ
ェニル)メチル)エチル)シクロヘキサンカルボキサミ
ド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(3-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)の酢
酸エチル(15ml)溶液にシクロヘキサンカルボニル
クロリド(288ml,2.15ミリモル)および飽和
重曹水(15ml)を加えて室温で3時間攪拌した。反
応液を水(100ml)で希釈し、酢酸エチル(100
ml×2)で抽出した。抽出液を飽和食塩水で洗浄し、
無水硫酸マグネシウムで乾燥後減圧留去した。残留物を
酢酸エチル−ヘキサンから再結晶させて表題化合物(5
32mg,87%)を得た。 mp 190-191℃ IRνmaxKBrcm-1: 1645, 1541, 1516, 1331. Anal. Calcd for C23H25F4NO2: C, 65.24; H, 5.95; N,
3.31 Found: C, 65.27; H, 5.92; N, 3.21.1 H-NMR (CDCl3)δ: 1.00-1.38 (5H, m), 1.50-1.80 (5
H, m), 1.84-2.06 (1H, m), 2.78 (1H, dd, J = 14.4,
10.2 Hz), 2.93 (1H, dd, J = 14.4, 4.4 Hz), 3.83 (1
H, d, J = 3.2 Hz), 4.30-4.50 (1H, m), 4.97 (1H, br
s), 5.42 (1H, d,J = 8.4 Hz), 7.02-7.18 (2H, m), 7.
24-7.54 (6H, m).Example 138 N-((1RS, 2SR) -2- (4-fluorophenyl)
2-Hydroxy-1-((3- (trifluoromethyl) phenyl) methyl) ethyl) cyclohexanecarboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (3- (tri Fluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.44 mmol) in ethyl acetate (15 ml) were added cyclohexanecarbonyl chloride (288 ml, 2.15 mmol) and saturated aqueous sodium hydrogen carbonate (15 ml), and the mixture was stirred at room temperature for 3 hours. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
ml × 2). Wash the extract with saturated saline,
After drying over anhydrous magnesium sulfate, the solution was distilled off under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (5
32 mg, 87%). mp 190-191 ° C IRνmax KBr cm -1 : 1645, 1541, 1516, 1331. Anal.Calcd for C 23 H 25 F 4 NO 2 : C, 65.24; H, 5.95; N,
3.31 Found: C, 65.27; H, 5.92; N, 3.21. 1 H-NMR (CDCl 3 ) δ: 1.00-1.38 (5H, m), 1.50-1.80 (5
H, m), 1.84-2.06 (1H, m), 2.78 (1H, dd, J = 14.4,
10.2 Hz), 2.93 (1H, dd, J = 14.4, 4.4 Hz), 3.83 (1
H, d, J = 3.2 Hz), 4.30-4.50 (1H, m), 4.97 (1H, br
s), 5.42 (1H, d, J = 8.4 Hz), 7.02-7.18 (2H, m), 7.
24-7.54 (6H, m).
【0271】実施例139 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((3-(トリフルオロメチル)フ
ェニル)メチル)エチル)-4-フェニル酪酸アミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(3-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)のア
セトニトリル(30ml)溶液に4-フェニル-n-酪酸
(236mg,1.44ミリモル)および1-エチル-3
-(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩(358mg,1.87ミリモル)および1-ヒドロ
キシ-1H-ベンゾトリアゾール(220mg,1.44
ミリモル)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(酢酸エチル)で精製
し、酢酸エチル−ヘキサンから再結晶させて、表題化合
物(432mg,65%)を得た。 mp 110-111℃ IRνmaxKBrcm-1: 1644, 1605, 1510. Anal. Calcd for C26H25F4NO2: C, 67.96; H, 5.48; N,
3.05 Found: C, 67.99; H, 5.63; N, 2.96.1 H-NMR (CDCl3)δ: 1.66-1.90 (2H, m), 1.96-2.16 (2
H, m), 2.40-2.56 (2H, m), 2.68-2.96 (2H, m), 3.56
(1H, d, J = 3.8 Hz), 4.32-4.50 (1H, m), 4.90-5.00
(1H, m), 5.46 (1H, d, J = 8.4 Hz), 7.00-7.50 (13H,
m).Example 139 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((3- (trifluoromethyl) phenyl) methyl) ethyl) -4-phenylbutyric acid amide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- ( 3- (trifluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.44 mmol) in acetonitrile (30 ml) was added 4-phenyl-n-butyric acid (236 mg, 1.44 mmol) and 1-ethyl-3.
-(3-Dimethylaminopropyl) carbodiimide hydrochloride (358 mg, 1.87 mmol) and 1-hydroxy-1H-benzotriazole (220 mg, 1.44)
Mmol) and stirred overnight at room temperature. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to give the title compound (432 mg, 65%). mp 110-111 ℃ IRνmax KBr cm -1 : 1644, 1605, 1510. Anal.Calcd for C 26 H 25 F 4 NO 2 : C, 67.96; H, 5.48; N,
3.05 Found:. C, 67.99; H, 5.63; N, 2.96 1 H-NMR (CDCl 3) δ: 1.66-1.90 (2H, m), 1.96-2.16 (2
H, m), 2.40-2.56 (2H, m), 2.68-2.96 (2H, m), 3.56
(1H, d, J = 3.8 Hz), 4.32-4.50 (1H, m), 4.90-5.00
(1H, m), 5.46 (1H, d, J = 8.4 Hz), 7.00-7.50 (13H,
m).
【0272】実施例140 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((2-(トリフルオロメチル)フ
ェニル)メチル)エチル)-1-ナフタレンカルボキサミ
ド 1) 3-(4-フルオロフェニル)-3-オキソプロピオ
ン酸エチル(18g,85.7ミリモル)と2-トリフ
ルオロメチルベンジルクロリド(15.0g,77.1
ミリモル)、炭酸カリウム(23.7g,0.17モ
ル)、アセトニトリル(200ml)の混合液を60℃
で10時間撹拌した。反応液を減圧濃縮し、水(200
ml)を加えて酢酸エチル(200ml×2)で抽出し
た。抽出液を水洗後、無水硫酸マグネシウムで乾燥し、
減圧留去した。残留物をシリカゲルカラムクロマトグラ
フィー(ヘキサン:トルエン=1:1)で精製し、3-
(4-フルオロフェニル)-3-オキソ-2-(2-トリフル
オロメチル)ベンジルプロピオン酸エチル(22.3
g,71%)を油状物として得た。 IRνmaxNeatcm-1: 1738, 1690, 1599, 1316, 1159, 112
1, 1040, 851.1 H-NMR (CDCl3)δ: 1.11 (3H, t, J = 7.2 Hz), 3.53
(2H, d, J = 7.4 Hz), 4.10 (2H, q, J = 7.2 Hz), 4.6
3 (1H, t, J = 7.2 Hz), 7.10 (2H, t, J = 8.6 Hz),
7.20-7.45 (3H, m), 7.64 (1H, d, J = 7.2 Hz), 7.90-
8.03 (2H, m). 2) 無水塩化亜鉛(15.4g,0.113モル)の
ジエチルエーテル(200ml)溶液に、水素化ほう素
ナトリウム(9.5g,0.226モル)を加えて室温
で2時間撹拌した。不溶物を濾去し、濾液に3-(4-フ
ルオロフェニル)-3-オキソ-2-(2-トリフルオロメ
チル)ベンジルプロピオン酸エチル(20.8g,5
6.5ミリモル)のジエチルエーテル(50ml)溶液
を加えて室温で1時間撹拌した。氷冷下、反応液に1規
定塩酸を加えて反応を停止し、水(200ml)と酢酸
エチル(300ml)を加えて抽出した。抽出液を水と
飽和重曹水で洗浄後、無水硫酸マグネシウムで乾燥し、
減圧留去した。残留物をシリカゲルカラムクロマトグラ
フィー(ヘキサン:酢酸エチル=20:1−10:1)
で精製して、(2RS,3RS)-3-(4-フルオロフ
ェニル)-3-ヒドロキシ-2-(2-トリフルオロメチ
ル)ベンジルプロピオン酸エチル(16.9g,82
%)を無色油状物として得た。 IRνmaxNeatcm-1: 1715, 1607, 1510, 1316, 1225, 115
9, 1121, 1040, 839.1 H-NMR (CDCl3)δ: 0.91 (3H, t, J = 7.1 Hz), 2.98-
3.30 (4H, m), 3.88 (2H,q, J = 7.1 Hz), 5.00-5.10
(1H, m), 7.59 (1H, d, J = 7.4 Hz). 3) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-(2-トリフルオロメチル)ベ
ンジルプロピオン酸エチル(16.7g,45ミリモ
ル)のメタノール(100ml)溶液に、2規定水酸化
ナトリウム水溶液(45ml,90.2ミリモル)を加
えて室温で4時間撹拌した。反応液を1規定塩酸(15
0ml)で酸性とした後、酢酸エチル(150ml×
2)で抽出した。抽出液を水洗後、無水硫酸マグネシウ
ムで乾燥し、減圧留去し、残留物をヘキサンから結晶化
させて、(2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-(2-トリフルオロメチル)ベ
ンジルプロピオン酸(12.6g,82%)を得た。 mp 158-159℃ IRνmaxKBrcm-1: 1694, 1514, 1319, 1227, 1115, 104
2, 839. 元素分析値C17H14F4O3として、 計算値: C, 59.65; H, 4.12 実測値: C, 59.56; H, 4.07.1 H-NMR (DMSO-d6)δ: 2.70-2.95 (1H, m), 2.98-3.17
(1H, m), 4.70-4.82 (1H,m), 5.70-5.85 (1H, m), 7.13
(2H, t, J = 9.0 Hz), 7.32-7.50 (4H, m), 7.50-7.70
(2H, m). 4) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-(2-トリフルオロメチル)ベ
ンジルプロピオン酸(12.3g,35.9ミリモル)
のテトラヒドロフラン(100ml)溶液に、ジフェニ
ルホスホリルアジド(10.0ml,46.7ミリモ
ル)とトリエチルアミン(7.0ml,50.3ミリモ
ル)を加え、30分間撹拌した。さらに4時間加熱還流
した後、放冷し、水(200ml)を加えて酢酸エチル
(200ml)で抽出した。抽出液を1規定塩酸と飽和
重曹水で洗浄後、無水硫酸マグネシウムで乾燥し、減圧
留去した。残留物をシリカゲルカラムクロマトグラフィ
ー(クロロホルム:酢酸エチル=10:1−5:1)で
精製して、(4RS,5SR)-5-(4-フルオロフェ
ニル)-4-((2-(トリフルオロメチル)フェニル)
メチル)-1,3-オキサゾリジン-2-オン(11.8
g,97%)を結晶として得た。 mp 138-140℃ IRνmaxKBrcm-1: 1761, 1609, 1514, 1316, 1235, 115
4, 1115, 1063, 964, 833. 元素分析値C17H13F4NO2として、 計算値: C, 60.18; H, 3.86; N, 4.13 実測値: C, 60.18; H, 4.05; N, 4.06.1 H-NMR (CDCl3)δ: 2.20-2.40 (1H, m), 2.50-2.65 (1
H, m), 4.18-4.35 (1H, m), 5.09 (1H, brs), 5.84 (1
H, d, J = 7.6 Hz), 7.10-7.60 (7H, m), 7.66 (1H, d,
J = 8.4 Hz). 5) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((2-(トリフルオロメチル)フェニル)メ
チル)-1,3-オキサゾリジン-2-オン(10.95
g,32.3ミリモル)のエタノール(200ml)溶
液に8規定水酸化ナトリウム水溶液(20ml,160
ミリモル)を加え、4時間加熱還流した。反応液を濃縮
後、水(200ml)で希釈し、酢酸エチル(200m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物を酢
酸エチル−ヘキサンから再結晶させて、(1RS,2S
R)-2-アミノ-1-(4-フルオロフェニル)-3-(2-
(トリフルオロメチル)フェニル)-1-プロパノール
(7.56g,75%)を得た。 mp 57-58℃ Anal. Calcd for C16H15F4NO: C, 61.34; H, 4.83; N,
4.47 Found: C, 61.52; H, 4.78; N, 4.39. IRνmaxKBrcm-1: 1607, 1508, 1316.1 H-NMR (CDCl3)δ: 2.34-2.52 (1H, m), 2.90-3.10 (1
H, m), 3.30-3.42 (1H, m), 4.74 (1H, d, J = 4.4 H
z), 7.02-7.16 (2H, m), 7.20-7.52 (5H, m), 7.63(1H,
d, J = 7.6 Hz). 6) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(2-(トリフルオロメチル)フェニ
ル)-1-プロパノール(450mg,1.44ミリモ
ル)の酢酸エチル(15ml)溶液に1-ナフトイルク
ロリド(282ml,1.87ミリモル)および飽和重
曹水(15ml)を加えて室温で終夜攪拌した。反応液
を水(100ml)で希釈し、酢酸エチル(100ml
×2)で抽出した。抽出液を飽和食塩水で洗浄し、無水
硫酸マグネシウムで乾燥後減圧留去した。残留物を酢酸
エチル−ヘキサンから再結晶させて表題化合物(536
mg,80%)を得た。 mp 193-194℃ IRνmaxKBrcm-1: 1636, 1622, 1607, 1539. Anal. Calcd for C27H21F4NO2: C, 69.37; H, 4.53; N,
3.00 Found: C, 69.13; H, 4.37; N, 3.09.1 H-NMR (CDCl3)δ: 2.90-3.20 (2H, m), 3.33 (1H, d,
J = 3.0 Hz), 4.80-5.00(1H, m), 5.12-5.20 (1H, m),
6.07 (1H, d, J = 8.8 Hz), 7.00-7.20 (3H, m), 7.24-
7.58 (8H, m), 7.60-7.78 (2H, m), 7.80-7.92 (2H,
m).Example 140 N-((1RS, 2SR) -2- (4-fluorophenyl)
2-Hydroxy-1-((2- (trifluoromethyl) phenyl) methyl) ethyl) -1-naphthalenecarboxamide 1) Ethyl 3- (4-fluorophenyl) -3-oxopropionate (18 g, 85.7) Mmol) and 2-trifluoromethylbenzyl chloride (15.0 g, 77.1).
Mmol), potassium carbonate (23.7 g, 0.17 mol) and acetonitrile (200 ml) at 60 ° C.
For 10 hours. The reaction solution was concentrated under reduced pressure, and water (200
ml) and extracted with ethyl acetate (200 ml × 2). After washing the extract with water, drying over anhydrous magnesium sulfate,
The solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane: toluene = 1: 1) to give 3-
Ethyl (4-fluorophenyl) -3-oxo-2- (2-trifluoromethyl) benzylpropionate (22.3
g, 71%) as an oil. IRνmax Neat cm -1 : 1738, 1690, 1599, 1316, 1159, 112
1, 1040, 851. 1 H- NMR (CDCl 3) δ: 1.11 (3H, t, J = 7.2 Hz), 3.53
(2H, d, J = 7.4 Hz), 4.10 (2H, q, J = 7.2 Hz), 4.6
3 (1H, t, J = 7.2 Hz), 7.10 (2H, t, J = 8.6 Hz),
7.20-7.45 (3H, m), 7.64 (1H, d, J = 7.2 Hz), 7.90-
8.03 (2H, m). 2) To a solution of anhydrous zinc chloride (15.4 g, 0.113 mol) in diethyl ether (200 ml) was added sodium borohydride (9.5 g, 0.226 mol) and room temperature was added. For 2 hours. The insoluble material was removed by filtration, and the filtrate was mixed with ethyl 3- (4-fluorophenyl) -3-oxo-2- (2-trifluoromethyl) benzylpropionate (20.8 g, 5
(6.5 mmol) in diethyl ether (50 ml) and stirred at room temperature for 1 hour. Under ice-cooling, 1N hydrochloric acid was added to the reaction solution to stop the reaction, and water (200 ml) and ethyl acetate (300 ml) were added for extraction. After the extract was washed with water and saturated aqueous sodium hydrogen carbonate, dried over anhydrous magnesium sulfate,
The solvent was distilled off under reduced pressure. The residue is subjected to silica gel column chromatography (hexane: ethyl acetate = 20: 1-10: 1).
And purified with ethyl (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- (2-trifluoromethyl) benzylpropionate (16.9 g, 82
%) As a colorless oil. IRνmax Neat cm -1 : 1715, 1607, 1510, 1316, 1225, 115
9, 1121, 1040, 839. 1 H-NMR (CDCl 3) δ: 0.91 (3H, t, J = 7.1 Hz), 2.98-
3.30 (4H, m), 3.88 (2H, q, J = 7.1 Hz), 5.00-5.10
(1H, m), 7.59 (1H, d, J = 7.4 Hz). 3) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- (2-trifluoromethyl) benzylpropion To a solution of ethyl acetate (16.7 g, 45 mmol) in methanol (100 ml) was added a 2N aqueous sodium hydroxide solution (45 ml, 90.2 mmol), and the mixture was stirred at room temperature for 4 hours. The reaction solution was diluted with 1 N hydrochloric acid (15
0 ml) and ethyl acetate (150 ml ×
Extracted in 2). The extract was washed with water, dried over anhydrous magnesium sulfate, evaporated under reduced pressure, and the residue was crystallized from hexane to give (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- ( There was obtained 2-trifluoromethyl) benzylpropionic acid (12.6 g, 82%). mp 158-159 ℃ IRνmax KBr cm -1 : 1694, 1514, 1319, 1227, 1115, 104
2, as 839. Elemental analysis C 17 H 14 F 4 O 3 , Calcd: C, 59.65; H, 4.12 Found:. C, 59.56; H, 4.07 1 H-NMR (DMSO-d 6) δ: 2.70-2.95 (1H, m), 2.98-3.17
(1H, m), 4.70-4.82 (1H, m), 5.70-5.85 (1H, m), 7.13
(2H, t, J = 9.0 Hz), 7.32-7.50 (4H, m), 7.50-7.70
(2H, m). 4) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- (2-trifluoromethyl) benzylpropionic acid (12.3 g, 35.9 mmol)
To a tetrahydrofuran (100 ml) solution of was added diphenylphosphoryl azide (10.0 ml, 46.7 mmol) and triethylamine (7.0 ml, 50.3 mmol), and the mixture was stirred for 30 minutes. After heating under reflux for further 4 hours, the mixture was allowed to cool, water (200 ml) was added, and the mixture was extracted with ethyl acetate (200 ml). The extract was washed with 1N hydrochloric acid and saturated aqueous sodium hydrogen carbonate, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (chloroform: ethyl acetate = 10: 1-5: 1) to give (4RS, 5SR) -5- (4-fluorophenyl) -4-((2- (trifluoro Methyl) phenyl)
Methyl) -1,3-oxazolidin-2-one (11.8
g, 97%) as crystals. mp 138-140 ° C IRνmax KBr cm -1 : 1761, 1609, 1514, 1316, 1235, 115
4, 1115, 1063, 964, 833.Calculated for C 17 H 13 F 4 NO 2 Calculated: C, 60.18; H, 3.86; N, 4.13 Found: C, 60.18; H, 4.05; N, 4.06. 1 H-NMR (CDCl 3 ) δ: 2.20-2.40 (1H, m), 2.50-2.65 (1
H, m), 4.18-4.35 (1H, m), 5.09 (1H, brs), 5.84 (1
H, d, J = 7.6 Hz), 7.10-7.60 (7H, m), 7.66 (1H, d,
J = 8.4 Hz). 5) (4RS, 5SR) -5- (4-fluorophenyl) -4-((2- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2-one (10 .95
g, 32.3 mmol) in an ethanol (200 ml) solution and an 8 N aqueous sodium hydroxide solution (20 ml, 160 ml).
(Mmol) was heated and refluxed for 4 hours. After concentrating the reaction solution, the reaction solution was diluted with water (200 ml), and ethyl acetate (200 m
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2S
R) -2-Amino-1- (4-fluorophenyl) -3- (2-
(Trifluoromethyl) phenyl) -1-propanol (7.56 g, 75%) was obtained. . mp 57-58 ℃ Anal Calcd for C 16 H 15 F 4 NO: C, 61.34; H, 4.83; N,
4.47 Found:. C, 61.52; H, 4.78; N, 4.39 IRνmax KBr cm -1: 1607, 1508, 1316. 1 H-NMR (CDCl 3) δ: 2.34-2.52 (1H, m), 2.90-3.10 ( 1
H, m), 3.30-3.42 (1H, m), 4.74 (1H, d, J = 4.4 H
z), 7.02-7.16 (2H, m), 7.20-7.52 (5H, m), 7.63 (1H,
d, J = 7.6 Hz). 6) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (2- (trifluoromethyl) phenyl) -1-propanol (450 mg, 1. 44 mmol) in ethyl acetate (15 ml) was added with 1-naphthoyl chloride (282 ml, 1.87 mmol) and saturated aqueous sodium hydrogen carbonate (15 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
× 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (536).
mg, 80%). mp 193-194 ° C IRνmax KBr cm -1 : 1636, 1622, 1607, 1539. Anal.Calcd for C 27 H 21 F 4 NO 2 : C, 69.37; H, 4.53; N,
3.00 Found:. C, 69.13; H, 4.37; N, 3.09 1 H-NMR (CDCl 3) δ: 2.90-3.20 (2H, m), 3.33 (1H, d,
J = 3.0 Hz), 4.80-5.00 (1H, m), 5.12-5.20 (1H, m),
6.07 (1H, d, J = 8.8 Hz), 7.00-7.20 (3H, m), 7.24-
7.58 (8H, m), 7.60-7.78 (2H, m), 7.80-7.92 (2H, m
m).
【0273】実施例141 4-フルオロ-N-((1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-((2-(トリフルオ
ロメチル)フェニル)メチル)エチル)-1-ナフタレン
カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(2-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)のア
セトニトリル(30ml)溶液に4-フルオロナフタレ
ンカルボン酸(274mg,1.44ミリモル)および
1-エチル-3-(3-ジメチルアミノプロピル)カルボジ
イミド・塩酸塩(358mg,1.87ミリモル)およ
び1-ヒドロキシ-1H-ベンゾトリアゾール(220m
g,1.44ミリモル)を加えて室温で終夜攪拌した。
反応液を水(100ml)で希釈し、酢酸エチル(10
0ml×2)で抽出した。抽出液を飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=1:1)で精製し、酢酸エチル−ヘキサン
から再結晶させて、表題化合物(548mg,79%)
を得た。 mp 200-201℃ IRνmaxKBrcm-1: 1640, 1626, 1601, 1537. Anal. Calcd for C27H20F5NO2: C, 66.80; H, 4.15; N,
2.89 Found: C, 66.67; H, 4.12; N, 2.80.1 H-NMR (CDCl3)δ: 2.98-3.22 (3H, m), 4.80-4.98 (1
H, m), 5.14-5.20 (1H, m), 6.04 (1H, d, J = 8.4 H
z), 6.96-7.20 (4H, m), 7.26-7.60 (7H, m), 7.65(1H,
d, J = 7.8 Hz), 7.75 (1H, d, J = 8.4 Hz), 8.08 (1
H, d, J = 8.2 Hz).Example 141 4-Fluoro-N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-((2- (trifluoromethyl) phenyl) methyl) ethyl)- 1-naphthalenecarboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (2- (trifluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.44 mmol) in acetonitrile (30 ml) was added 4-fluoronaphthalenecarboxylic acid (274 mg, 1.44 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride ( 358 mg, 1.87 mmol) and 1-hydroxy-1H-benzotriazole (220 m
g, 1.44 mmol) and stirred at room temperature overnight.
The reaction solution was diluted with water (100 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
The residue was purified with ethyl acetate = 1: 1) and recrystallized from ethyl acetate-hexane to give the title compound (548 mg, 79%).
I got . mp 200-201 ℃ IRνmax KBr cm -1 : 1640, 1626, 1601, 1537. Anal Calcd for C 27 H 20 F 5 NO 2: C, 66.80; H, 4.15; N,
2.89 Found:. C, 66.67; H, 4.12; N, 2.80 1 H-NMR (CDCl 3) δ: 2.98-3.22 (3H, m), 4.80-4.98 (1
H, m), 5.14-5.20 (1H, m), 6.04 (1H, d, J = 8.4 H
z), 6.96-7.20 (4H, m), 7.26-7.60 (7H, m), 7.65 (1H,
d, J = 7.8 Hz), 7.75 (1H, d, J = 8.4 Hz), 8.08 (1
(H, d, J = 8.2 Hz).
【0274】実施例142 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((2-(トリフルオロメチル)フ
ェニル)メチル)エチル)シクロヘキサンカルボキサミ
ド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(2-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)の酢
酸エチル(15ml)溶液にシクロヘキサンカルボニル
クロリド(288ml,2.15ミリモル)および飽和
重曹水(15ml)を加えて室温で3時間攪拌した。反
応液を水(100ml)で希釈し、酢酸エチル(100
ml×2)で抽出した。抽出液を飽和食塩水で洗浄し、
無水硫酸マグネシウムで乾燥後減圧留去した。残留物を
酢酸エチル−ヘキサンから再結晶させて表題化合物(4
34mg,87%)を得た。 mp 216-217℃ IRνmaxKBrcm-1: 1645, 1607, 1539. Anal. Calcd for C23H25F4NO2: C, 65.24; H, 5.95; N,
3.31 Found: C, 64.96; H, 5.92; N, 3.19.1 H-NMR (CDCl3)δ: 1.00-1.30 (5H, m), 1.40-1.80 (5
H, m), 1.80-2.02 (1H, m), 2.80-3.02 (2H, m), 3.70
(1H, d, J = 3.6 Hz), 4.40-4.60 (1H, m), 4.98-5.06
(1H, m), 5.51 (1H, d, J = 8.2 Hz), 7.00-7.16 (2H,
m), 7.20-7.52 (5H, m), 7.59 (1H, d, J = 7.6 Hz).Example 142 N-((1RS, 2SR) -2- (4-fluorophenyl)
2-Hydroxy-1-((2- (trifluoromethyl) phenyl) methyl) ethyl) cyclohexanecarboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (2- (tri Fluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.44 mmol) in ethyl acetate (15 ml) were added cyclohexanecarbonyl chloride (288 ml, 2.15 mmol) and saturated aqueous sodium hydrogen carbonate (15 ml), and the mixture was stirred at room temperature for 3 hours. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
ml × 2). Wash the extract with saturated saline,
After drying over anhydrous magnesium sulfate, the solution was distilled off under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (4
34 mg, 87%). mp 216-217 ° C IRνmax KBr cm -1 : 1645, 1607, 1539. Anal.Calcd for C 23 H 25 F 4 NO 2 : C, 65.24; H, 5.95; N,
3.31 Found:. C, 64.96; H, 5.92; N, 3.19 1 H-NMR (CDCl 3) δ: 1.00-1.30 (5H, m), 1.40-1.80 (5
H, m), 1.80-2.02 (1H, m), 2.80-3.02 (2H, m), 3.70
(1H, d, J = 3.6 Hz), 4.40-4.60 (1H, m), 4.98-5.06
(1H, m), 5.51 (1H, d, J = 8.2 Hz), 7.00-7.16 (2H,
m), 7.20-7.52 (5H, m), 7.59 (1H, d, J = 7.6 Hz).
【0275】実施例143 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((2-(トリフルオロメチル)フ
ェニル)メチル)エチル)-4-フェニル酪酸アミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(2-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)のア
セトニトリル(30ml)溶液に4-フェニル-n-酪酸
(236mg,1.44ミリモル)および1-エチル-3
-(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩(358mg,1.87ミリモル)および1-ヒドロ
キシ-1H-ベンゾトリアゾール(220mg,1.44
ミリモル)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:アセトン=
1:1)で精製し、酢酸エチル−ヘキサンから再結晶さ
せて、表題化合物(501mg,76%)を得た。 mp 161-162℃ IRνmaxKBrcm-1: 1645, 1537, 1514. Anal. Calcd for C26H25F4NO2: C, 67.96; H, 5.48; N,
3.05 Found: C, 67.96; H, 5.41; N, 2.94.1 H-NMR (CDCl3)δ: 1.64-1.84 (2H, m), 1.86-2.12 (2
H, m), 2.38-2.44 (2H, m), 2.91 (2H, d, J = 7.2 H
z), 3.29 (1H, d, J = 3.6 Hz), 4.40-4.60 (1H, m),
4.98-5.06 (1H, m), 5.51 (1H, d, J = 7.6 Hz), 7.00-
7.34 (9H, m), 7.36-7.48 (3H, m), 7.57 (1H, d, J =
7.6 Hz).Example 143 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((2- (trifluoromethyl) phenyl) methyl) ethyl) -4-phenylbutyric acid amide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- ( 2- (trifluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.44 mmol) in acetonitrile (30 ml) was added 4-phenyl-n-butyric acid (236 mg, 1.44 mmol) and 1-ethyl-3.
-(3-Dimethylaminopropyl) carbodiimide hydrochloride (358 mg, 1.87 mmol) and 1-hydroxy-1H-benzotriazole (220 mg, 1.44)
Mmol) and stirred overnight at room temperature. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: acetone =
1: 1) and recrystallized from ethyl acetate-hexane to give the title compound (501 mg, 76%). mp 161-162 ° C IRνmax KBr cm -1 : 1645, 1537, 1514. Anal.Calcd for C 26 H 25 F 4 NO 2 : C, 67.96; H, 5.48; N,
3.05 Found:. C, 67.96; H, 5.41; N, 2.94 1 H-NMR (CDCl 3) δ: 1.64-1.84 (2H, m), 1.86-2.12 (2
H, m), 2.38-2.44 (2H, m), 2.91 (2H, d, J = 7.2 H
z), 3.29 (1H, d, J = 3.6 Hz), 4.40-4.60 (1H, m),
4.98-5.06 (1H, m), 5.51 (1H, d, J = 7.6 Hz), 7.00-
7.34 (9H, m), 7.36-7.48 (3H, m), 7.57 (1H, d, J =
7.6 Hz).
【0276】実施例144 N-((1RS,2SR)-2-(4-フルオロフェニル)
-1-((4-フルオロフェニル)メチル)-2-ヒドロキ
シエチル)-1-ナフタレンカルボキサミド 1) 3-(4-フルオロフェニル)-3-オキソプロピオ
ン酸エチル(20g,95.1ミリモル)と4-フルオ
ロベンジルブロミド(18.0g,85.6ミリモ
ル)、炭酸カリウム(26.3g,0.19モル)、ア
セトニトリル(300ml)の混合液を60℃で2時間
撹拌した。反応液を減圧濃縮し、水(200ml)を加
えて酢酸エチル(200,100ml)で抽出した。抽
出液を水洗後、無水硫酸マグネシウムで乾燥し、減圧留
去した。残留物をシリカゲルカラムクロマトグラフィー
(ヘキサン:トルエン=1:1−1:5)で精製し、2
-(4-フルオロベンジル)-3-(4-フルオロフェニ
ル)-3-オキソプロピオン酸エチル(19.0g,63
%)を油状物として得た。 IRνmaxNeatcm-1: 1732, 1688, 1599, 1510, 1159, 85
1.1 H-NMR (CDCl3)δ: 1.12 (3H, t, J = 7.1 Hz), 3.29
(2H, d, J = 7.4 Hz), 4.01 (2H, q, J = 7.1 Hz), 4.5
3 (1H, t, J = 7.4 Hz), 6.88-7.30 (6H, m), 7.90-8.0
8 (2H, m). 2) 無水塩化亜鉛(15.4g,0.113モル)の
ジエチルエーテル(200ml)溶液に、水素化ほう素
ナトリウム(9.5g,0.226モル)を加えて室温
で2時間撹拌した。不溶物を濾去し、濾液に2-(4-フ
ルオロベンジル)-3-(4-フルオロフェニル)3-オキ
ソプロピオン酸エチル(18g,56.5ミリモル)の
ジエチルエーテル(50ml)溶液を加えて室温で1時
間撹拌した。氷冷下、反応液に1規定塩酸を加えて反応
を停止し、水(200ml)と酢酸エチル(200m
l)を加えて抽出した。抽出液を水と飽和重曹水で洗浄
後、無水硫酸マグネシウムで乾燥し、減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=10:1−3:1)で精製して、(2
RS,3RS)-2-(4-フルオロベンジル)-3-(4-
フルオロフェニル)-3-ヒドロキシプロピオン酸エチル
(16.8g,93%)を無色油状物として得た。 IRνmaxNeatcm-1: 1726, 1713, 1605, 1510, 1225, 115
9, 1030, 835.1 H-NMR (CDCl3)δ: 0.94 (3H, t, J = 7.0 Hz), 2.80-
3.02 (4H, m), 3.88 (2H,q, J = 7.0 Hz), 4.99 (1H,
d, J = 4.8 Hz), 6.85-7.15 (6H, m), 7.30-7.50(2H,
m). 3) (2RS,3RS)-2-(4-フルオロベンジ
ル)-3-(4-フルオロフェニル)-3-ヒドロキシプロ
ピオン酸エチル(16.5g,51.5ミリモル)のメ
タノール(50ml)溶液に、2規定水酸化ナトリウム
水溶液(51.5ml,0.103モル)を加えて室温
で3時間撹拌した。反応液を1規定塩酸(130ml)
で酸性とした後、酢酸エチル(200,100ml)で
抽出した。抽出液を水洗後、無水硫酸マグネシウムで乾
燥し、減圧留去し、残留物をヘキサンから結晶化させ
て、(2RS,3RS)-3-(4-フルオロフェニル)-
2-(4-フルオロベンジル)-3-ヒドロキシプロピオン
酸(14.2g,94%)を得た。 mp 169-170℃ IRνmaxKBrcm-1: 1692, 1607, 1510, 1231, 1015, 839,
826. 元素分析値C16H14F2O3として、 計算値: C, 66.75; H, 4.83 実測値: C, 66.76; H, 4.64.1 H-NMR (DMSO-d6)δ: 2.70-2.95 (2H, m), 3.05 (1H,
d, J = 11.0 Hz), 4.60-4.80 (1H, m), 5.65-5.80 (1H,
m), 6.97-7.22 (6H, m), 7.30-7.45 (2H, m), 11.80-1
2.00 (1H, br, OH). 4) (2RS,3RS)-3-(4-フルオロフェニ
ル)-2-(4-フルオロベンジル)-3-ヒドロキシプロ
ピオン酸(13.8g,47.2ミリモル)のテトラヒ
ドロフラン(150ml)溶液に、ジフェニルホスホリ
ルアジド(13.2ml,61.4ミリモル)とトリエ
チルアミン(9.2ml,66.1ミリモル)を加え、
30分間撹拌した。さらに4時間加熱還流した後、放冷
し、水(200ml)を加えて酢酸エチル(200m
l)で抽出した。抽出液を1規塩酸と飽和重曹水で洗浄
後、無水硫酸マグネシウムで乾燥し、少量のシリカゲル
に通した後、減圧留去した。残留物をヘキサン-酢酸エ
チルから結晶化させて、(4RS,5SR)-5-(4-
フルオロフェニル)-4-((4-フルオロフェニル)メ
チル)-1,3-オキサゾリジン-2-オン(12.8g,
94%)を結晶として得た。 mp 197-198℃ IRνmaxKBrcm-1: 1738, 1611, 1510, 1231, 1069, 101
3, 980, 853. 元素分析値C16H13F2NO2として、 計算値: C, 66.43; H, 4.53; N, 4.84 実測値: C, 66.39; H, 4.40; N, 4.79.1 H-NMR (CDCl3)δ: 2.10-2.35 (2H, m), 4.10-4.30 (1
H, m), 4.91 (1H, s), 5.79 (1H, d, J = 7.6 Hz), 6.9
8 (4H, d, J = 7.4 Hz), 7.13 (2H, t, J = 8.4 Hz),
7.30-7.43 (2H, m). 5) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((4-フルオロフェニル)メチル)-1,3-
オキサゾリジン-2-オン(11.87g,41.0ミリ
モル)のエタノール(200ml)溶液に8規定水酸化
ナトリウム水溶液(25.6ml,205ミリモル)を
加え、4時間加熱還流した。反応液を濃縮後、水(20
0ml)で希釈し、酢酸エチル(200ml×2)で抽
出した。抽出液を飽和食塩水で洗浄し、無水硫酸マグネ
シウムで乾燥後減圧留去した。残留物を酢酸エチル−ヘ
キサンから再結晶させて、(1RS,2SR)-2-アミ
ノ-1,3-ビス(4-フルオロフェニル)-1-プロパノ
ール(9.33g,86%)を得た。 mp 66-67℃ IRνmaxKBrcm-1: 1603, 1510, 1225. Anal. Calcd for C15H15F2NO: C, 68.43; H, 5.74; N,
5.32 Found: C, 68.30; H, 5.68; N, 5.17.1 H-NMR (CDCl3)δ: 2.32 (1H, dd, J = 13.4, 10.2 H
z), 2.77 (1H, dd, J = 13.4, 3.0 Hz), 3.16-3.30 (1
H, m), 4.64 (1H, d, J = 5.2 Hz), 6.90-7.18 (6H,m),
7.30-7.42 (2H, m). 6) (1RS,2SR)-2-アミノ-1,3-ビス(4
-フルオロフェニル)-1-プロパノール(450mg,
1.71ミリモル)の酢酸エチル(15ml)溶液に1
-ナフトイルクロリド(386ml,2.56ミリモル)
および飽和重曹水(15ml)を加えて室温で終夜攪拌
した。反応液を水(100ml)で希釈し、酢酸エチル
(100ml×2)で抽出した。抽出液を飽和食塩水で
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去した。
残留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:アセトン=1:1)で精製し、酢酸エチル−ヘキサ
ンから再結晶させて表題化合物(515mg,72%)
を得た。 mp 199-200℃ IRνmaxKBrcm-1: 1640, 1605, 1539, 1510. Anal. Calcd for C26H21F2NO2: C, 74.81; H, 5.07; N,
3.36 Found: C, 74.56; H, 5.04; N, 3.27.1 H-NMR (CDCl3)δ: 2.75 (1H, dd, J = 14.2, 10.6 H
z), 3.01 (1H, dd, J = 14.2, 4.0 Hz), 3.63 (1H, d,
J = 4.0 Hz), 4.68-4.84 (1H, m), 5.04-5.10 (1H,m),
5.89 (1H, d, J = 8.4 Hz), 6.92-7.30 (7H, m), 7.32-
7.52 (5H, m), 7.69 (1H, d, J = 8.2 Hz), 7.78-7.92
(2H, m).Example 144 N-((1RS, 2SR) -2- (4-fluorophenyl)
1-((4-Fluorophenyl) methyl) -2-hydroxyethyl) -1-naphthalenecarboxamide 1) Ethyl 3- (4-fluorophenyl) -3-oxopropionate (20 g, 95.1 mmol) and 4 A mixture of -fluorobenzyl bromide (18.0 g, 85.6 mmol), potassium carbonate (26.3 g, 0.19 mol), and acetonitrile (300 ml) was stirred at 60 ° C for 2 hours. The reaction solution was concentrated under reduced pressure, water (200 ml) was added, and the mixture was extracted with ethyl acetate (200, 100 ml). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: toluene = 1: 1-1: 5) to give 2
Ethyl-(4-fluorobenzyl) -3- (4-fluorophenyl) -3-oxopropionate (19.0 g, 63
%) As an oil. IRνmax Neat cm -1 : 1732, 1688, 1599, 1510, 1159, 85
1. 1 H-NMR (CDCl 3 ) δ: 1.12 (3H, t, J = 7.1 Hz), 3.29
(2H, d, J = 7.4 Hz), 4.01 (2H, q, J = 7.1 Hz), 4.5
3 (1H, t, J = 7.4 Hz), 6.88-7.30 (6H, m), 7.90-8.0
8 (2H, m). 2) To a solution of anhydrous zinc chloride (15.4 g, 0.113 mol) in diethyl ether (200 ml) was added sodium borohydride (9.5 g, 0.226 mol), and the mixture was stirred at room temperature. For 2 hours. The insoluble material was removed by filtration, and to the filtrate was added a solution of ethyl 2- (4-fluorobenzyl) -3- (4-fluorophenyl) -3-oxopropionate (18 g, 56.5 mmol) in diethyl ether (50 ml). Stirred at room temperature for 1 hour. Under ice-cooling, 1N hydrochloric acid was added to the reaction solution to stop the reaction. Water (200 ml) and ethyl acetate (200 ml) were added.
l) was added and extracted. The extract was washed with water and saturated aqueous sodium hydrogen carbonate, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1-3: 1) to give (2
RS, 3RS) -2- (4-fluorobenzyl) -3- (4-
Ethyl (fluorophenyl) -3-hydroxypropionate (16.8 g, 93%) was obtained as a colorless oil. IRνmax Neat cm -1 : 1726, 1713, 1605, 1510, 1225, 115
9, 1030, 835. 1 H- NMR (CDCl 3) δ: 0.94 (3H, t, J = 7.0 Hz), 2.80-
3.02 (4H, m), 3.88 (2H, q, J = 7.0 Hz), 4.99 (1H,
d, J = 4.8 Hz), 6.85-7.15 (6H, m), 7.30-7.50 (2H,
m). 3) Ethyl (2RS, 3RS) -2- (4-fluorobenzyl) -3- (4-fluorophenyl) -3-hydroxypropionate (16.5 g, 51.5 mmol) in methanol (50 ml). A 2N aqueous sodium hydroxide solution (51.5 ml, 0.103 mol) was added to the solution, and the mixture was stirred at room temperature for 3 hours. The reaction solution was 1N hydrochloric acid (130 ml)
After acidification with, the mixture was extracted with ethyl acetate (200, 100 ml). The extract was washed with water, dried over anhydrous magnesium sulfate, evaporated under reduced pressure, and the residue was crystallized from hexane to give (2RS, 3RS) -3- (4-fluorophenyl)-
2- (4-Fluorobenzyl) -3-hydroxypropionic acid (14.2 g, 94%) was obtained. mp 169-170 ° C IRνmax KBr cm -1 : 1692, 1607, 1510, 1231, 1015, 839,
826. As Elemental analysis C 16 H 14 F 2 O 3 , Calcd: C, 66.75; H, 4.83 Found:. C, 66.76; H, 4.64 1 H-NMR (DMSO-d 6) δ: 2.70- 2.95 (2H, m), 3.05 (1H,
d, J = 11.0 Hz), 4.60-4.80 (1H, m), 5.65-5.80 (1H,
m), 6.97-7.22 (6H, m), 7.30-7.45 (2H, m), 11.80-1
2.00 (1H, br, OH). 4) (2RS, 3RS) -3- (4-fluorophenyl) -2- (4-fluorobenzyl) -3-hydroxypropionic acid (13.8 g, 47.2 mmol) To a tetrahydrofuran (150 ml) solution of diphenylphosphoryl azide (13.2 ml, 61.4 mmol) and triethylamine (9.2 ml, 66.1 mmol),
Stir for 30 minutes. After heating and refluxing for further 4 hours, the mixture was allowed to cool, water (200 ml) was added, and ethyl acetate (200 m
Extracted in l). The extract was washed with 1N hydrochloric acid and saturated aqueous sodium hydrogen carbonate, dried over anhydrous magnesium sulfate, passed through a small amount of silica gel, and evaporated under reduced pressure. The residue was crystallized from hexane-ethyl acetate to give (4RS, 5SR) -5- (4-
Fluorophenyl) -4-((4-fluorophenyl) methyl) -1,3-oxazolidin-2-one (12.8 g,
94%) as crystals. mp 197-198 ° C IRνmax KBr cm -1 : 1738, 1611, 1510, 1231, 1069, 101
3, 980, 853. Elemental analysis: C 16 H 13 F 2 NO 2 Calculated: C, 66.43; H, 4.53; N, 4.84 Found: C, 66.39; H, 4.40; N, 4.79. 1 H -NMR (CDCl 3 ) δ: 2.10-2.35 (2H, m), 4.10-4.30 (1
H, m), 4.91 (1H, s), 5.79 (1H, d, J = 7.6 Hz), 6.9
8 (4H, d, J = 7.4 Hz), 7.13 (2H, t, J = 8.4 Hz),
7.30-7.43 (2H, m). 5) (4RS, 5SR) -5- (4-fluorophenyl) -4-((4-fluorophenyl) methyl) -1,3-
To a solution of oxazolidin-2-one (11.87 g, 41.0 mmol) in ethanol (200 ml) was added an 8 N aqueous sodium hydroxide solution (25.6 ml, 205 mmol), and the mixture was heated under reflux for 4 hours. After concentrating the reaction solution, water (20
0 ml) and extracted with ethyl acetate (200 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR) -2-amino-1,3-bis (4-fluorophenyl) -1-propanol (9.33 g, 86%). mp 66-67 ℃ IRνmax KBr cm -1 : 1603, 1510, 1225. Anal.Calcd for C 15 H 15 F 2 NO: C, 68.43; H, 5.74; N,
5.32 Found:. C, 68.30; H, 5.68; N, 5.17 1 H-NMR (CDCl 3) δ: 2.32 (1H, dd, J = 13.4, 10.2 H
z), 2.77 (1H, dd, J = 13.4, 3.0 Hz), 3.16-3.30 (1
H, m), 4.64 (1H, d, J = 5.2 Hz), 6.90-7.18 (6H, m),
7.30-7.42 (2H, m). 6) (1RS, 2SR) -2-amino-1,3-bis (4
-Fluorophenyl) -1-propanol (450 mg,
1.71 mmol) in ethyl acetate (15 ml).
-Naphthoyl chloride (386 ml, 2.56 mmol)
And a saturated aqueous sodium hydrogen carbonate solution (15 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was purified by silica gel column chromatography (hexane: acetone = 1: 1) and recrystallized from ethyl acetate-hexane to give the title compound (515 mg, 72%).
I got mp 199-200 ℃ IRνmax KBr cm -1 : 1640, 1605, 1539, 1510. Anal.Calcd for C 26 H 21 F 2 NO 2 : C, 74.81; H, 5.07; N,
3.36 Found:. C, 74.56; H, 5.04; N, 3.27 1 H-NMR (CDCl 3) δ: 2.75 (1H, dd, J = 14.2, 10.6 H
z), 3.01 (1H, dd, J = 14.2, 4.0 Hz), 3.63 (1H, d,
J = 4.0 Hz), 4.68-4.84 (1H, m), 5.04-5.10 (1H, m),
5.89 (1H, d, J = 8.4 Hz), 6.92-7.30 (7H, m), 7.32-
7.52 (5H, m), 7.69 (1H, d, J = 8.2 Hz), 7.78-7.92
(2H, m).
【0277】実施例145 4-フルオロ-N-((1RS,2SR)-2-(4-フルオ
ロフェニル)-1-((4-フルオロフェニル)メチル)-
2-ヒドロキシエチル)-1-ナフタレンカルボキサミド (1RS,2SR)-2-アミノ-1,3-ビス(4-フル
オロフェニル)-1-プロパノール(450mg,1.7
1ミリモル)のアセトニトリル(30ml)溶液に4-
フルオロナフタレンカルボン酸(325mg,1.71
ミリモル)および1-エチル-3-(3-ジメチルアミノプ
ロピル)カルボジイミド・塩酸塩(491mg,2.5
6ミリモル)および1-ヒドロキシ-1H-ベンゾトリア
ゾール(261mg,1.71ミリモル)を加えて室温
で終夜攪拌した。反応液を水(100ml)で希釈し、
酢酸エチル(100ml×2)で抽出した。抽出液を飽
和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減圧
留去した。残留物をシリカゲルカラムクロマトグラフィ
ー(酢酸エチル)で精製し、酢酸エチル−ヘキサンから
再結晶させて、表題化合物(571mg,77%)を得
た。 mp 233-234℃ IRνmaxKBrcm-1: 1644, 1626, 1601, 1508. Anal. Calcd for C26H20F3NO2: C, 71.72; H, 4.63; N,
3.22 Found: C, 71.58; H, 4.56; N, 3.12.1 H-NMR (CDCl3)δ: 2.77 (1H, dd, J = 14.4, 11.0 H
z), 3.03 (1H, dd, J = 14.4, 4.4 Hz), 3.42-3.50 (1
H, m), 4.64-4.84 (1H, m), 5.04-5.12 (1H, m), 5.84
(1H, d, J = 8.4 Hz), 6.92-7.32 (8H, m), 7.40-7.60
(4H, m), 7.74 (1H,d, J = 8.0 Hz), 8.09 (1H, d, J =
8.4 Hz).Example 145 4-Fluoro-N-((1RS, 2SR) -2- (4-fluorophenyl) -1-((4-fluorophenyl) methyl)-
2-Hydroxyethyl) -1-naphthalenecarboxamide (1RS, 2SR) -2-amino-1,3-bis (4-fluorophenyl) -1-propanol (450 mg, 1.7
1 mmol) in acetonitrile (30 ml) solution.
Fluoronaphthalenecarboxylic acid (325 mg, 1.71)
Mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (491 mg, 2.5
6 mmol) and 1-hydroxy-1H-benzotriazole (261 mg, 1.71 mmol) were added and stirred at room temperature overnight. Dilute the reaction with water (100 ml)
Extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to give the title compound (571 mg, 77%). . mp 233-234 ℃ IRνmax KBr cm -1 : 1644, 1626, 1601, 1508. Anal Calcd for C 26 H 20 F 3 NO 2: C, 71.72; H, 4.63; N,
3.22 Found:. C, 71.58; H, 4.56; N, 3.12 1 H-NMR (CDCl 3) δ: 2.77 (1H, dd, J = 14.4, 11.0 H
z), 3.03 (1H, dd, J = 14.4, 4.4 Hz), 3.42-3.50 (1
H, m), 4.64-4.84 (1H, m), 5.04-5.12 (1H, m), 5.84
(1H, d, J = 8.4 Hz), 6.92-7.32 (8H, m), 7.40-7.60
(4H, m), 7.74 (1H, d, J = 8.0 Hz), 8.09 (1H, d, J =
8.4 Hz).
【0278】実施例146 N-((1RS,2SR)-2-(4-フルオロフェニル)
-1-((4-フルオロフェニル)メチル)-2-ヒドロキ
シエチル)シクロヘキサンカルボキサミド (1RS,2RS)-2-アミノ-1,3-ビス(4-フル
オロフェニル)-1-プロパノール(450mg,1.7
1ミリモル)の酢酸エチル(15ml)溶液にシクロヘ
キサンカルボニルクロリド(342ml,2.56ミリ
モル)および飽和重曹水(15ml)を加えて室温で3
時間攪拌した。反応液を水(100ml)で希釈し、酢
酸エチル(100ml×2)で抽出した。抽出液を飽和
食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留
去した。残留物を酢酸エチル−ヘキサンから再結晶させ
て表題化合物(553mg,87%)を得た。 mp 203-204℃ IRνmaxKBrcm-1: 1645, 1537, 1512. Anal. Calcd for C22H25F2NO2: C, 70.76; H, 6.75; N,
3.75 Found: C, 70.79; H, 6.80; N, 3.63.1 H-NMR (CDCl3)δ: 1.02-1.38 (5H, m), 1.50-1.80 (5
H, m), 1.82-2.04 (1H, m), 2.63 (1H, dd, J = 14.4,
10.4 Hz), 2.84 (1H, dd, J = 14.4, 4.4 Hz), 4.06 (1
H, d, J = 4.0 Hz), 4.30-4.46 (1H, m), 4.90-4.96 (1
H, m), 5.29 (1H,d, J = 8.4 Hz), 6.90-7.14 (6H, m),
7.30-7.42 (2H, m).Example 146 N-((1RS, 2SR) -2- (4-fluorophenyl)
-1-((4-Fluorophenyl) methyl) -2-hydroxyethyl) cyclohexanecarboxamide (1RS, 2RS) -2-amino-1,3-bis (4-fluorophenyl) -1-propanol (450 mg, 1. 7
Cyclohexanecarbonyl chloride (342 ml, 2.56 mmol) and saturated aqueous sodium bicarbonate (15 ml) were added to a solution of ethyl acetate (15 mmol) in ethyl acetate (15 ml).
Stirred for hours. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (553 mg, 87%). mp 203-204 ℃ IRνmax KBr cm -1 : 1645, 1537, 1512. Anal.Calcd for C 22 H 25 F 2 NO 2 : C, 70.76; H, 6.75; N,
3.75 Found:. C, 70.79; H, 6.80; N, 3.63 1 H-NMR (CDCl 3) δ: 1.02-1.38 (5H, m), 1.50-1.80 (5
H, m), 1.82-2.04 (1H, m), 2.63 (1H, dd, J = 14.4,
10.4 Hz), 2.84 (1H, dd, J = 14.4, 4.4 Hz), 4.06 (1
H, d, J = 4.0 Hz), 4.30-4.46 (1H, m), 4.90-4.96 (1
H, m), 5.29 (1H, d, J = 8.4 Hz), 6.90-7.14 (6H, m),
7.30-7.42 (2H, m).
【0279】実施例147 N-((1RS,2SR)-2-(4-フルオロフェニル)
-1-((4-フルオロフェニル)メチル)-2-ヒドロキ
シエチル)-4-フェニル酪酸アミド (1RS,2SR)-2-アミノ-1,3-ビス(4-フル
オロフェニル)-1-プロパノール(450mg,1.7
1ミリモル)のアセトニトリル(30ml)溶液に4-
フェニル-n-酪酸(280mg,1.71ミリモル)お
よび1-エチル-3-(3-ジメチルアミノプロピル)カル
ボジイミド・塩酸塩(491mg,2.56ミリモル)
および1-ヒドロキシ-1H-ベンゾトリアゾール(26
1mg,1.71ミリモル)を加えて室温で終夜攪拌し
た。反応液を水(100ml)で希釈し、酢酸エチル
(100ml×2)で抽出した。抽出液を飽和食塩水で
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去した。
残留物をシリカゲルカラムクロマトグラフィー(酢酸エ
チル)で精製し、酢酸エチル−ヘキサンから再結晶させ
て、表題化合物(523mg,75%)を得た。 mp 147-148℃ IRνmaxKBrcm-1: 1645, 1609, 1549. Anal. Calcd for C25H25F2NO2: C, 73.33; H, 6.15; N,
3.42 Found: C, 73.34; H, 6.09; N, 3.35.1 H-NMR (CDCl3)δ: 1.70-1.90 (2H, m), 2.00-2.12 (2
H, m), 2.44-2.58 (2H, m), 2.62 (1H, dd, J = 14.4,
10.4 Hz), 2.80 (1H, dd, J = 14.4, 4.4 Hz), 3.74 (1
H, s), 4.32-4.48 (1H, m), 4.90-4.98 (1H, m), 5.32
(1H, d, J = 7.6 Hz), 6.84-7.16 (8H, m), 7.20-7.42
(5H, m).Example 147 N-((1RS, 2SR) -2- (4-fluorophenyl)
-1-((4-Fluorophenyl) methyl) -2-hydroxyethyl) -4-phenylbutyric acid amide (1RS, 2SR) -2-amino-1,3-bis (4-fluorophenyl) -1-propanol ( 450 mg, 1.7
1 mmol) in acetonitrile (30 ml) solution.
Phenyl-n-butyric acid (280 mg, 1.71 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (491 mg, 2.56 mmol)
And 1-hydroxy-1H-benzotriazole (26
(1 mg, 1.71 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to give the title compound (523 mg, 75%). mp 147-148 ℃ IRνmax KBr cm -1 : 1645, 1609, 1549. Anal.Calcd for C 25 H 25 F 2 NO 2 : C, 73.33; H, 6.15; N,
3.42 Found:. C, 73.34; H, 6.09; N, 3.35 1 H-NMR (CDCl 3) δ: 1.70-1.90 (2H, m), 2.00-2.12 (2
H, m), 2.44-2.58 (2H, m), 2.62 (1H, dd, J = 14.4,
10.4 Hz), 2.80 (1H, dd, J = 14.4, 4.4 Hz), 3.74 (1
H, s), 4.32-4.48 (1H, m), 4.90-4.98 (1H, m), 5.32
(1H, d, J = 7.6 Hz), 6.84-7.16 (8H, m), 7.20-7.42
(5H, m).
【0280】実施例148 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(メチルオキシ)フェニ
ル)メチル)エチル)-1-ナフタレンカルボキサミド 1) 3-(4-フルオロフェニル)-3-オキソプロピオ
ン酸エチル(20g,95.1ミリモル)と4-メトキ
シベンジルクロリド(11.6ml,85.6ミリモ
ル)、炭酸カリウム(26.3g,0.19モル)、ア
セトニトリル(300ml)の混合液を60℃で6時間
撹拌した。反応液を減圧濃縮し、水(300ml)を加
えて酢酸エチル(300ml×2)で抽出した。抽出液
を水洗後、無水硫酸マグネシウムで乾燥し、減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=10:1−5:1)で精製し、3
-(4-フルオロフェニル)-3-オキソ-2-(4-メトキ
シベンジル)プロピオン酸エチル(26.6g,85
%)を油状物として得た。 IRνmaxNeatcm-1: 1734, 1686, 1597, 1514, 1250, 117
9, 1159, 1034, 849, 824.1 H-NMR (CDCl3)δ: 1.13 (3H, t, J = 7.2 Hz), 3.26
(2H, d, J = 7.6 Hz), 3.76 (3H, s), 4.10 (2H, q, J
= 7.2 Hz), 4.53 (2H, t, J = 7.2 Hz), 6.79 (2H, d,
J = 8.2 Hz), 6.95-7.20 (3H, m), 7.90-8.10 (2H, m). 2) 塩化亜鉛(21.2g,0.156モル)のジエ
チルエーテル(200ml)溶液に、水素化ほう素ナト
リウム(13.1g,0.31モル)を加えて室温で2
時間撹拌した。不溶物を濾去し、濾液に3-(4-フルオ
ロフェニル)-3-オキソ-2-(4-メトキシベンジル)
プロピオン酸エチル(25.7g,77.8ミリモル)
のジエチルエーテル(50ml)溶液を加えて室温で1
時間撹拌した。氷冷下、反応液に1規定塩酸を加えて反
応を停止し、水(200ml)と酢酸エチル(200m
l)を加えて抽出した。抽出液を水と飽和重曹水で洗浄
後、無水硫酸マグネシウムで乾燥し、減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=10:1−3:1)で精製して、(2
RS,3RS)-3-(4-フルオロフェニル)-3-ヒド
ロキシ-2-(4-メトキシベンジル)プロピオン酸エチ
ル(23.3g,90%)を無色油状物として得た。 IRνmaxNeatcm-1: 1726, 1607, 1512, 1248, 1223, 117
9, 1034, 839.1 H-NMR (CDCl3)δ: 0.95 (3H, t, J = 7.2 Hz), 2.85-
3.00 (3H, m), 3.76 (3H,s, OMe), 3.89 (2H, q, J =
7.2 Hz), 4.95-5.07 (1H, m), 6.70-6.88 (2H, m), 6.9
3-7.12 (4H, m), 7.30-7.47 (2H, m). 3) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-(4-メトキシベンジル)プロ
ピオン酸エチル(22.8g,68.6ミリモル)のメ
タノール(100ml)溶液に、2規定水素化ナトリウ
ム水溶液(69ml,0.137モル)を加えて室温で
4時間撹拌した。反応液を6規定塩酸で酸性とした後、
水(300ml)を加え、酢酸エチル(200ml×
2)で抽出した。抽出液を水洗後、無水硫酸マグネシウ
ムで乾燥し、減圧留去し、残留物をヘキサンとジエチル
エーテルの混合液から結晶化させて、(2RS,3R
S)-3-(4-フルオロフェニル)-3-ヒドロキシ-2-
(4-メトキシベンジル)プロピオン酸(14.8g,
71%)を得た。 mp 96-98℃ IRνmaxKBrcm-1: 1690, 1611, 1514, 1254, 1235, 103
6, 837. 元素分析値C17H17FO4として、 計算値: C, 67.10; H, 5.63 実測値: C, 67.11; H, 5.65.1 H-NMR (DMSO-d6)δ: 2.70-2.90 (2H, m), 2.95-3.10
(1H, m), 3.70 (3H, s),4.60-4.75 (1H, m), 5.60-5.75
(1H, m), 6.79 (2H, d, J = 8.8 Hz), 7.00-7.20 (4H,
m), 7.30-7.45 (2H, m), 11.80-11.95 (1H, br, OH). 4) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-(4-メトキシベンジル)プロ
ピオン酸(13.7g,45.0ミリモル)のテトラヒ
ドロフラン(150ml)溶液に、ジフェニルホスホリ
ルアジド(12.6ml,58.5ミリモル)とトリエ
チルアミン(8.78ml,63.0ミリモル)を加
え、30分間撹拌した。さらに4時間加熱還流した後、
放冷し、水(200ml)を加えて酢酸エチル(200
ml)で抽出した。抽出液を1規定塩酸と飽和重曹水で
洗浄後、無水硫酸マグネシウムで乾燥し、減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ク
ロロホルム:酢酸エチル=4:1−2:1)で精製し
て、(4RS,5SR)-5-(4-フルオロフェニル)-
4-((4-(メチルオキシ)フェニル)メチル)-1,
3-オキサゾリジン-2-オン(13.0g,96%)を
結晶として得た。 mp 125-126℃ IRνmaxKBrcm-1: 1738, 1613, 1514, 1248, 1107, 103
6, 845, 824. 元素分析値C17H16FNO3・1/4H2Oとして、 計算値: C, 66.77; H, 5.44; N, 4.58 実測値: C, 66.57; H, 5.31; N, 4.49.1 H-NMR (CDCl3)δ: 2.10-2.30 (3H, m), 3.78 (3H, s),
4.10-4.30 (1H, m), 4.94 (1H, brs), 5.78 (1H, d, J
= 7.6 Hz), 6.78-6.90 (2H, m), 6.90-7.00 (2H, m),
7.07-7.20 (2H, m), 7.30-7.45 (2H, m). 5) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((4-(メチルオキシ)フェニル)メチル)-
1,3-オキサゾリジン-2-オン(12.8g,42.
5ミリモル)のエタノール(200ml)溶液に8規定
水酸化ナトリウム水溶液(26.6ml,210ミリモ
ル)を加え、4時間加熱還流した。反応液を濃縮後、水
(200ml)で希釈し、酢酸エチル(200ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて、(1RS,2SR)
-2-アミノ-1-(4-フルオロフェニル)-3-(4-(メ
チルオキシ)フェニル)-1-プロパノール(10.08
g,86%)を得た。 mp 78-79℃ IRνmaxKBrcm-1: 1611, 1603, 1584, 1512. Anal. Calcd for C16H18FNO2: C, 69.80; H, 6.59; N,
5.09 Found: C, 69.69; H, 6.65; N, 5.00.1 H-NMR (CDCl3)δ: 2.27 (1H, dd, J = 13.8, 10.4 H
z), 2.72 (1H, dd, J = 13.8, 3.2 Hz), 3.16-3.28 (1
H, m), 3.78 (3H, s), 4.65 (1H, d, J = 4.6 Hz),6.78
-6.86 (2H, m), 7.00-7.12 (4H, m), 7.32-7.72 (2H,
m). 6) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(4-(メチルオキシ)フェニル)-1
-プロパノール(450mg,1.64ミリモル)の酢
酸エチル(15ml)溶液に1-ナフトイルクロリド
(369ml,2.45ミリモル)および飽和重曹水
(15ml)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて表題化合物(622m
g,89%)を得た。 mp 198-199℃ IRνmaxKBrcm-1: 1640, 1611, 1541, 1510. Anal. Calcd for C27H24FNO3: C, 75.51; H, 5.63; N,
3.26 Found: C, 75.25; H, 5.88; N, 3.18.1 H-NMR (CDCl3)δ: 2.69 (1H, dd, J = 14.2, 10.6 H
z), 3.01 (1H, dd, J = 14.2, 4.0 Hz), 3.80 (3H, s),
3.93 (1H, d, J = 4.0 Hz), 4.70-4.88 (1H, m),5.02-
5.10 (1H, m), 5.82 (1H, d, J = 8.2 Hz), 6.86 (2H,
d, J = 8.6 Hz), 7.00-7.20 (4H, m), 7.20-7.52 (6H,
m), 7.73 (1H, d, J = 8.0 Hz), 7.80-7.92(2H, m).Example 148 N-((1RS, 2SR) -2- (4-fluorophenyl)
2-Hydroxy-1-((4- (methyloxy) phenyl) methyl) ethyl) -1-naphthalenecarboxamide 1) Ethyl 3- (4-fluorophenyl) -3-oxopropionate (20 g, 95.1 mmol) ), 4-methoxybenzyl chloride (11.6 ml, 85.6 mmol), potassium carbonate (26.3 g, 0.19 mol), and acetonitrile (300 ml) were stirred at 60 ° C for 6 hours. The reaction solution was concentrated under reduced pressure, water (300 ml) was added, and the mixture was extracted with ethyl acetate (300 ml × 2). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1-5: 1) to give 3
Ethyl-(4-fluorophenyl) -3-oxo-2- (4-methoxybenzyl) propionate (26.6 g, 85
%) As an oil. IRνmax Neat cm -1 : 1734, 1686, 1597, 1514, 1250, 117
9, 1159, 1034, 849, 824. 1 H-NMR (CDCl 3) δ: 1.13 (3H, t, J = 7.2 Hz), 3.26
(2H, d, J = 7.6 Hz), 3.76 (3H, s), 4.10 (2H, q, J
= 7.2 Hz), 4.53 (2H, t, J = 7.2 Hz), 6.79 (2H, d,
J = 8.2 Hz), 6.95-7.20 (3H, m), 7.90-8.10 (2H, m). 2) To a solution of zinc chloride (21.2 g, 0.156 mol) in diethyl ether (200 ml), Sodium chloride (13.1 g, 0.31 mol)
Stirred for hours. The insoluble material was removed by filtration, and the filtrate was treated with 3- (4-fluorophenyl) -3-oxo-2- (4-methoxybenzyl).
Ethyl propionate (25.7 g, 77.8 mmol)
Of diethyl ether (50 ml) was added to the solution at room temperature.
Stirred for hours. Under ice-cooling, 1N hydrochloric acid was added to the reaction solution to stop the reaction. Water (200 ml) and ethyl acetate (200 ml) were added.
l) was added and extracted. The extract was washed with water and saturated aqueous sodium hydrogen carbonate, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1-3: 1) to give (2
Ethyl RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- (4-methoxybenzyl) propionate (23.3 g, 90%) was obtained as a colorless oil. IRνmax Neat cm -1 : 1726, 1607, 1512, 1248, 1223, 117
9, 1034, 839. 1 H- NMR (CDCl 3) δ: 0.95 (3H, t, J = 7.2 Hz), 2.85-
3.00 (3H, m), 3.76 (3H, s, OMe), 3.89 (2H, q, J =
7.2 Hz), 4.95-5.07 (1H, m), 6.70-6.88 (2H, m), 6.9
3-7.12 (4H, m), 7.30-7.47 (2H, m). 3) Ethyl (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- (4-methoxybenzyl) propionate To a solution of (22.8 g, 68.6 mmol) in methanol (100 ml) was added a 2N aqueous solution of sodium hydride (69 ml, 0.137 mol) and the mixture was stirred at room temperature for 4 hours. After acidifying the reaction solution with 6N hydrochloric acid,
Water (300 ml) was added, and ethyl acetate (200 ml ×
Extracted in 2). The extract was washed with water, dried over anhydrous magnesium sulfate, evaporated under reduced pressure, and the residue was crystallized from a mixture of hexane and diethyl ether to give (2RS, 3R
S) -3- (4-Fluorophenyl) -3-hydroxy-2-
(4-methoxybenzyl) propionic acid (14.8 g,
71%). mp 96-98 ℃ IRνmax KBr cm -1 : 1690, 1611, 1514, 1254, 1235, 103
6, as 837. Elemental analysis C 17 H 17 FO 4, Calculated: C, 67.10; H, 5.63 Found:. C, 67.11; H, 5.65 1 H-NMR (DMSO-d 6) δ: 2.70- 2.90 (2H, m), 2.95-3.10
(1H, m), 3.70 (3H, s), 4.60-4.75 (1H, m), 5.60-5.75
(1H, m), 6.79 (2H, d, J = 8.8 Hz), 7.00-7.20 (4H,
m), 7.30-7.45 (2H, m), 11.80-11.95 (1H, br, OH). 4) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- (4-methoxy To a solution of benzyl) propionic acid (13.7 g, 45.0 mmol) in tetrahydrofuran (150 ml), diphenylphosphoryl azide (12.6 ml, 58.5 mmol) and triethylamine (8.78 ml, 63.0 mmol) were added. Stir for 30 minutes. After heating and refluxing for another 4 hours,
After cooling, water (200 ml) was added and ethyl acetate (200 ml) was added.
ml). The extract was washed with 1N hydrochloric acid and saturated aqueous sodium hydrogen carbonate, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (chloroform: ethyl acetate = 4: 1-2: 1) to give (4RS, 5SR) -5- (4-fluorophenyl)-
4-((4- (methyloxy) phenyl) methyl) -1,
3-Oxazolidin-2-one (13.0 g, 96%) was obtained as crystals. mp 125-126 ℃ IRνmax KBr cm -1 : 1738, 1613, 1514, 1248, 1107, 103
6, 845, 824. As Elemental analysis C 17 H 16 FNO 3 · 1 / 4H 2 O, Calculated: C, 66.77; H, 5.44 ; N, 4.58 Found: C, 66.57; H, 5.31 ; N, 4.49. 1 H-NMR (CDCl 3 ) δ: 2.10-2.30 (3H, m), 3.78 (3H, s),
4.10-4.30 (1H, m), 4.94 (1H, brs), 5.78 (1H, d, J
= 7.6 Hz), 6.78-6.90 (2H, m), 6.90-7.00 (2H, m),
7.07-7.20 (2H, m), 7.30-7.45 (2H, m). 5) (4RS, 5SR) -5- (4-fluorophenyl) -4-((4- (methyloxy) phenyl) methyl)-
1,3-Oxazolidin-2-one (12.8 g, 42.
To a solution of 5 mmol) in ethanol (200 ml) was added an 8 N aqueous sodium hydroxide solution (26.6 ml, 210 mmol), and the mixture was heated under reflux for 4 hours. After concentrating the reaction solution, the reaction solution was diluted with water (200 ml), and ethyl acetate (200 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR)
2-amino-1- (4-fluorophenyl) -3- (4- (methyloxy) phenyl) -1-propanol (10.08
g, 86%). mp 78-79 ℃ IRνmax KBr cm -1 : 1611, 1603, 1584, 1512. Anal.Calcd for C 16 H 18 FNO 2 : C, 69.80; H, 6.59; N,
5.09 Found:. C, 69.69; H, 6.65; N, 5.00 1 H-NMR (CDCl 3) δ: 2.27 (1H, dd, J = 13.8, 10.4 H
z), 2.72 (1H, dd, J = 13.8, 3.2 Hz), 3.16-3.28 (1
H, m), 3.78 (3H, s), 4.65 (1H, d, J = 4.6 Hz), 6.78
-6.86 (2H, m), 7.00-7.12 (4H, m), 7.32-7.72 (2H, m
m). 6) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4- (methyloxy) phenyl) -1
To a solution of -propanol (450 mg, 1.64 mmol) in ethyl acetate (15 ml) was added 1-naphthoyl chloride (369 ml, 2.45 mmol) and saturated aqueous sodium hydrogen carbonate (15 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (622 m
g, 89%). . mp 198-199 ℃ IRνmax KBr cm -1 : 1640, 1611, 1541, 1510. Anal Calcd for C 27 H 24 FNO 3: C, 75.51; H, 5.63; N,
3.26 Found:. C, 75.25; H, 5.88; N, 3.18 1 H-NMR (CDCl 3) δ: 2.69 (1H, dd, J = 14.2, 10.6 H
z), 3.01 (1H, dd, J = 14.2, 4.0 Hz), 3.80 (3H, s),
3.93 (1H, d, J = 4.0 Hz), 4.70-4.88 (1H, m), 5.02-
5.10 (1H, m), 5.82 (1H, d, J = 8.2 Hz), 6.86 (2H,
d, J = 8.6 Hz), 7.00-7.20 (4H, m), 7.20-7.52 (6H,
m), 7.73 (1H, d, J = 8.0 Hz), 7.80-7.92 (2H, m).
【0281】実施例149 4-フルオロ-N-((1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-((4-(メチルオキ
シ)フェニル)メチル)エチル)-1-ナフタレンカルボ
キサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(4-(メチルオキシ)フェニル)-1-プロ
パノール(450mg,1.64ミリモル)のアセトニ
トリル(30ml)溶液に4-フルオロナフタレンカル
ボン酸(311mg,1.64ミリモル)および1-エ
チル-3-(3-ジメチルアミノプロピル)カルボジイミ
ド・塩酸塩(470mg,2.43ミリモル)および1
-ヒドロキシ-1H-ベンゾトリアゾール(250mg,
1.64ミリモル)を加えて室温で終夜攪拌した。反応
液を水(100ml)で希釈し、酢酸エチル(100m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=1:1)で精製し、酢酸エチル−ヘキサンから再
結晶させて、表題化合物(558mg,76%)を得
た。 mp 210-211℃ IRνmaxKBrcm-1: 1640, 1624, 1599, 1539, 1512. Anal. Calcd for C27H23F2NO3: C, 72.47; H, 5.18; N,
3.13 Found: C, 72.39; H, 5.08; N, 3.01.1 H-NMR (CDCl3)δ: 2.70 (1H, dd, J = 14.4, 10.8 H
z), 3.00 (1H, dd, J = 14.4, 4.0 Hz), 3.80 (3H, s),
3.84 (1H, d, J = 3.6 Hz), 4.66-4.84 (1H, m),5.02-
5.10 (1H, m), 5.81 (1H, d, J = 7.6 Hz), 6.85 (2H,
d, J = 8.8 Hz), 6.92-7.22 (6H, m), 7.40-7.60 (4H,
m), 7.76 (1H, d, J = 8.4 Hz), 8.08 (1H,d, J = 8.0
Hz).Example 149 4-Fluoro-N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-((4- (methyloxy) phenyl) methyl) ethyl) -1 -Naphthalenecarboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4- (methyloxy) phenyl) -1-propanol (450 mg, 1.64 mmol) in acetonitrile (30 ml) 4-Fluoronaphthalenecarboxylic acid (311 mg, 1.64 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (470 mg, 2.43 mmol) and 1
-Hydroxy-1H-benzotriazole (250 mg,
(1.64 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1) and recrystallized from ethyl acetate-hexane to give the title compound (558 mg, 76%). . mp 210-211 ℃ IRνmax KBr cm -1 : 1640, 1624, 1599, 1539, 1512. Anal Calcd for C 27 H 23 F 2 NO 3: C, 72.47; H, 5.18; N,
3.13 Found: C, 72.39; H, 5.08; N, 3.01. 1 H-NMR (CDCl 3 ) δ: 2.70 (1H, dd, J = 14.4, 10.8 H
z), 3.00 (1H, dd, J = 14.4, 4.0 Hz), 3.80 (3H, s),
3.84 (1H, d, J = 3.6 Hz), 4.66-4.84 (1H, m), 5.02-
5.10 (1H, m), 5.81 (1H, d, J = 7.6 Hz), 6.85 (2H,
d, J = 8.8 Hz), 6.92-7.22 (6H, m), 7.40-7.60 (4H,
m), 7.76 (1H, d, J = 8.4 Hz), 8.08 (1H, d, J = 8.0
Hz).
【0282】実施例150 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(メチルオキシ)フェニ
ル)メチル)エチル)シクロヘキサンカルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(4-(メチルオキシ)フェニル)-1-プロ
パノール(450mg,1.64ミリモル)の酢酸エチ
ル(15ml)溶液にシクロヘキサンカルボニルクロリ
ド(328ml,2.45ミリモル)および飽和重曹水
(15ml)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて表題化合物(529m
g,84%)を得た。 mp 193-194℃ IRνmaxKBrcm-1: 1647, 1539, 1512. Anal. Calcd for C23H28FNO3: C, 71.66; H, 7.32; N,
3.63 Found: C, 71.57; H, 7.40; N, 3.55.1 H-NMR (CDCl3)δ: 1.02-1.40 (5H, m), 1.54-1.80 (5
H, m), 1.88-2.08 (1H, m), 2.56 (1H, dd, J = 14.4,
10.2 Hz), 2.82 (1H, dd, J = 14.4, 5.2 Hz), 3.78 (3
H, s), 4.30-4.50 (1H, m), 4.45 (1H, d, J = 4.4 H
z), 4.88-4.92 (1H,m), 5.24 (1H, d, J = 7.0 Hz), 6.
81 (2H, d, J = 8.8 Hz), 6.98-7.10 (4H, m), 7.28-7.
40 (2H, m).Example 150 N-((1RS, 2SR) -2- (4-fluorophenyl)
2-Hydroxy-1-((4- (methyloxy) phenyl) methyl) ethyl) cyclohexanecarboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4- (methyloxy ) To a solution of phenyl) -1-propanol (450 mg, 1.64 mmol) in ethyl acetate (15 ml) were added cyclohexanecarbonyl chloride (328 ml, 2.45 mmol) and saturated aqueous sodium hydrogen carbonate (15 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (529 m
g, 84%). . mp 193-194 ℃ IRνmax KBr cm -1 : 1647, 1539, 1512. Anal Calcd for C 23 H 28 FNO 3: C, 71.66; H, 7.32; N,
3.63 Found:. C, 71.57; H, 7.40; N, 3.55 1 H-NMR (CDCl 3) δ: 1.02-1.40 (5H, m), 1.54-1.80 (5
H, m), 1.88-2.08 (1H, m), 2.56 (1H, dd, J = 14.4,
10.2 Hz), 2.82 (1H, dd, J = 14.4, 5.2 Hz), 3.78 (3
H, s), 4.30-4.50 (1H, m), 4.45 (1H, d, J = 4.4 H
z), 4.88-4.92 (1H, m), 5.24 (1H, d, J = 7.0 Hz), 6.
81 (2H, d, J = 8.8 Hz), 6.98-7.10 (4H, m), 7.28-7.
40 (2H, m).
【0283】実施例151 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(メチルオキシ)フェニ
ル)メチル)エチル)-4-フェニル酪酸アミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(4-(メチルオキシ)フェニル)-1-プロ
パノール(450mg,1.64ミリモル)のアセトニ
トリル(30ml)溶液に4-フェニル-n-酪酸(26
8mg,1.64ミリモル)および1-エチル-3-(3-
ジメチルアミノプロピル)カルボジイミド・塩酸塩(4
70mg,2.45ミリモル)および1-ヒドロキシ-1
H-ベンゾトリアゾール(250mg,1.64ミリモ
ル)を加えて室温で終夜攪拌した。反応液を水(100
ml)で希釈し、酢酸エチル(100ml×2)で抽出
した。抽出液を飽和食塩水で洗浄し、無水硫酸マグネシ
ウムで乾燥後減圧留去した。残留物をシリカゲルカラム
クロマトグラフィー(ヘキサン:アセトン=1:1)で
精製し、酢酸エチル−ヘキサンから再結晶させて、表題
化合物(575mg,83%)を得た。 mp 130-131℃ IRνmaxKBrcm-1: 1645, 1607, 1512. Anal. Calcd for C26H28FNO3: C, 74.09; H, 6.70; N,
3.32 Found: C, 74.05; H, 6.82; N, 3.24.1 H-NMR (CDCl3)δ: 1.70-1.90 (2H, m), 2.00-2.12 (2
H, m), 2.40-2.62 (3H, m), 2.80 (1H, dd, J = 14.2,
4.4 Hz), 3.72 (3H, s), 4.05 (1H, d, J = 4.4 Hz),
4.32-4.48 (1H, m), 4.88-4.98 (1H, m), 5.27 (1H, d,
J = 7.2 Hz), 6.79(2H, d, J = 8.6 Hz), 6.96-7.14
(6H, m), 7.16-7.40 (5H, m).Example 151 N-((1RS, 2SR) -2- (4-fluorophenyl)
2-Hydroxy-1-((4- (methyloxy) phenyl) methyl) ethyl) -4-phenylbutyric acid amide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4 To a solution of-(methyloxy) phenyl) -1-propanol (450 mg, 1.64 mmol) in acetonitrile (30 ml) was added 4-phenyl-n-butyric acid (26
8 mg, 1.64 mmol) and 1-ethyl-3- (3-
Dimethylaminopropyl) carbodiimide hydrochloride (4
70 mg, 2.45 mmol) and 1-hydroxy-1
H-benzotriazole (250 mg, 1.64 mmol) was added and the mixture was stirred at room temperature overnight. The reaction solution was washed with water (100
ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: acetone = 1: 1), and recrystallized from ethyl acetate-hexane to give the title compound (575 mg, 83%). . mp 130-131 ℃ IRνmax KBr cm -1 : 1645, 1607, 1512. Anal Calcd for C 26 H 28 FNO 3: C, 74.09; H, 6.70; N,
3.32 Found:. C, 74.05; H, 6.82; N, 3.24 1 H-NMR (CDCl 3) δ: 1.70-1.90 (2H, m), 2.00-2.12 (2
H, m), 2.40-2.62 (3H, m), 2.80 (1H, dd, J = 14.2,
4.4 Hz), 3.72 (3H, s), 4.05 (1H, d, J = 4.4 Hz),
4.32-4.48 (1H, m), 4.88-4.98 (1H, m), 5.27 (1H, d,
J = 7.2 Hz), 6.79 (2H, d, J = 8.6 Hz), 6.96-7.14
(6H, m), 7.16-7.40 (5H, m).
【0284】実施例152 N-[(1RS,2SR)-1-(4-シアノベンジル)-
2-(4-フルオロフェニル)-2-ヒドロキシエチル]カ
ルバミン酸tert-ブチル 1) 2-(4-シアノベンジル)-3-(4-フルオロフ
ェニル)-3-オキソプロピオン酸エチル (4-フルオロベンゾイル)酢酸エチル15.30g
(72.79ミリモル)の1,2-ジメトキシエタン1
00ml溶液に氷冷下60%水素化ナトリウムの流動パ
ラフィン懸濁物2.91g(72.8ミリモル)を加
え、そのまま0.5時間撹拌した。4-シアノベンジル
ブロミド14.3g(72.8ミリモル)の1,2-ジ
メトキシエタン50ml溶液を室温で加え、室温で4時
間撹拌した。反応液を水に注ぎ、酢酸エチルで2回抽出
した。集めた有機層を無水硫酸マグネシウムで乾燥、溶
媒を減圧留去した。得られた残留物をシリカゲルカラム
クロマトグラフィーにて精製し(ヘキサン/トルエン=
1/1−1/1.5)、ジエチルエーテル−ヘキサンよ
り結晶化して、目的物を得た。白色結晶 収量20.6
0g 収率87% mp 85-86℃; 1H-NMR (CDCl3, 200MHz) δ 1.12 (3H, t,
J = 7.2 Hz), 3.38 (2H, d, J = 7.2 Hz), 4.10 (2H,
q, J = 7.1 Hz), 4.56 (1H, t, J = 7.5 Hz), 7.14 (2
H, t, J = 8.6 Hz), 7.35 (2H, d, J = 8.0 Hz), 7.56
(2H, d, J = 8.0 Hz), 8.00 (2H, dd, J = 5.4 Hz, 9.0
Hz); IR (KBr) 2230, 1730, 1692, 1599,1508, 1306,
1285, 1236, 1202, 1161, 851 cm-1; Anal. Calcd for
C19H16FNO3: C, 70.14; H, 4.96; N, 4.31. Found: C,
70.20; H, 4.84; N, 4.29. 2) (2RS,3RS)-2-(4-シアノベンジル)-
3-(4-フルオロフェニル)-3-ヒドロキシプロピオン
酸エチル 塩化亜鉛8.52g(62.5ミリモル)をジエチルエ
ーテル100ml中で撹拌しながら水素化ホウ素ナトリ
ウム4.73g(125ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、2-(4-シアノ
ベンジル)-3-(4-フルオロフェニル)-3-オキソプ
ロピオン酸エチル10.17g(31.26ミリモル)
のジエチルエーテル50ml溶液を室温で加え、そのま
ま2時間撹拌した。反応液に希塩酸を少しずつ加えて過
剰の水素化ホウ素亜鉛を分解した後、酢酸エチルで2回
抽出した。集めた有機層を無水硫酸マグネシウムで乾
燥、溶媒を減圧留去した。得られた粗生成物をシリカゲ
ルカラムクロマトグラフィーにて精製し(ヘキサン/酢
酸エチル=3/1−2/1)、目的物を得た。無色液体
収量4.297g 収率42%1 H-NMR (CDCl3, 200MHz) δ 0.93 (3H, t, J = 7.1 H
z), 2.82 (1H, d, J = 2.8Hz), 2.89-3.08 (3H, m), 3.
88 (2H, q, J = 7.2 Hz), 5.03 (1H, dd, J = 2.5Hz,
5.1 Hz), 7.05 (2H, t, J = 8.8 Hz), 7.20 (2H, d, J
= 8.4 Hz), 7.37 (2H, dd, J = 5.2 Hz, 8.4 Hz), 7.53
(2H, d, J = 8.4 Hz); IR (neat) 3484, 2230. 1725,
1607, 1508, 1223, 1179, 1159, 1032, 839 cm-1 3) (2RS,3RS)-2-(4-シアノベンジル)-
3-(4-フルオロフェニル)-3-ヒドロキシプロピオン
酸 (2RS,3RS)-2-(4-シアノベンジル)-3-
(4-フルオロフェニル)-3-ヒドロキシプロピオン酸
エチル4.145g(12.66ミリモル)のメタノー
ル30ml−テトラヒドロフラン20ml溶液に1N水
酸化ナトリウム水溶液25.3ml(25.3ミリモ
ル)を加え、室温で一晩撹拌した。反応液を濃縮、水で
希釈し、1N塩酸で反応液を酸性にした後、酢酸エチル
で2回抽出した。集めた有機層を無水硫酸ナトリウムで
乾燥、溶媒を減圧留去した。残留物をジエチルエーテル
−ヘキサンより結晶化して、目的物を得た。白色結晶
収量3.559g 収率94% mp 165-168℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
89-3.15 (3H, m), 5.03(1H, d, J = 5.0 Hz), 7.03 (2
H, t, J = 8.6 Hz), 7.24 (2H, d, J = 8.2 Hz),7.40
(2H, dd, J = 5.5 Hz, 8.5 Hz), 7.51 (2H, d, J = 8.4
Hz); IR (KBr) 3476, 3152, 2232, 1719, 1678, 1605,
1508, 1406, 1225, 1175, 1157, 845 cm- 1; Anal. Cal
cd for C17H14FNO3: C, 68.22; H, 4.71; N, 4.68. Fou
nd: C, 67.98; H, 4.83; N, 4.47. 4) (4RS,5SR)-4-(4-シアノベンジル)-
5-(4-フルオロフェニル)-1,3-オキサゾリジン-
2-オン (2RS,3RS)-2-(4-シアノベンジル)-3-
(4-フルオロフェニル)-3-ヒドロキシプロピオン酸
3.385g(11.31ミリモル)のテトラヒドロフ
ラン50ml溶液にトリエチルアミン2.36ml(1
7.0ミリモル)、ジフェニルホスホリルアジド3.4
2g(12.4ミリモル)を加え、一晩加熱還流した。
反応液の溶媒を減圧留去し、得られた粗生成物をシリカ
ゲルカラムクロマトグラフィーにて精製し(ヘキサン/
酢酸エチル=3/1−1/2)、ジエチルエーテル−ヘ
キサンより結晶化して、目的物を得た。白色結晶 収量
2.741g 収率82% mp 170-173℃; 1H-NMR (CDCl3, 200MHz) δ 2.36 (2H,
d, J = 6.6 Hz), 4.27 (1H, dt, J = 7.5 Hz, 7.5 Hz),
5.17 (1H, br s), 5,81 (1H, d, J = 7.8 Hz),7.13 (2
H, t, J = 8.6 Hz), 7.13 (2H, d, J = 8.0 Hz), 7.35
(2H, dd, J = 5.2 Hz, 8.4 Hz), 7.59 (2H, d, J = 8.0
Hz); IR (KBr) 3324, 2240, 1748, 1514, 1225
cm−1; Anal. Calcd for C
17H13FN2O2: C, 68.91; H,
4.42; N, 9.45. Found: C,
68.98; H, 4.43; N, 9.33. 5) (4RS,5SR)-4-(4-シアノベンジル)-
5-(4-フルオロフェニル)-2-オキソ-1,3-オキサ
ゾリジン-3-カルボン酸tert-ブチル (4RS,5SR)-4-(4-シアノベンジル)-5-
(4-フルオロフェニル)-1,3-オキサゾリジン-2-
オン2.622g(8.849ミリモル)、二炭酸ジ-
tert-ブチル2.32g(10.6ミリモル)、4-
N,N-ジメチルアミノピリジン0.11g(0.88
ミリモル)のアセトニトリル30ml溶液を室温で一晩
撹拌した。反応液を酢酸エチルに希釈し、水で洗浄、無
水硫酸マグネシウムで乾燥、シリカゲルを通した後、溶
媒を減圧留去した。得られた残留物を酢酸エチル−ヘキ
サンより結晶化して、目的物を得た。白色結晶 収量
3.243g 収率92% mp 161-163℃; 1H-NMR (CDCl3, 200MHz) δ 1.51 (9H,
s), 2.63 (1H, dd, J =8.6 Hz, 14.2 Hz), 2.93 (1H, d
d, J = 4.7 Hz, 14.3 Hz), 4.74-4.85 (1H, m),5.68 (1
H, d, J = 6.6 Hz), 6.80 (2H, d, J = 8.0 Hz), 7.00
(2H, t, J = 8.6 Hz), 7.16 (2H, dd, J = 5.4 Hz, 8.6
Hz), 7.39 (2H, d, J = 8.0 Hz); IR (KBr) 2982, 222
8, 1815, 1721, 1514, 1368, 1152, 1069 cm-1; Anal.
Calcd for C22H21FN2O4: C, 66.66; H, 5.34; N, 7.07.
Found: C, 66.76; H, 5.37; N,7.09. 6) N-[(1RS,2SR)-1-(4-シアノベンジ
ル)-2-(4-フルオロフェニル)-2-ヒドロキシエチ
ル]カルバミン酸tert-ブチル (4RS,5SR)-4-(4-シアノベンジル)-5-
(4-フルオロフェニル)-2-オキソ-1,3-オキサゾ
リジン-3-カルボン酸tert-ブチル3.014g
(7.603ミリモル)のメタノール20ml−テトラ
ヒドロフラン10ml溶液に水酸化ナトリウム0.33
g(8.36ミリモル)のメタノール20ml溶液を氷
冷下加え、室温で3時間撹拌した。反応液を酢酸エチル
に希釈し、希塩酸で洗浄、無水硫酸マグネシウムで乾
燥、シリカゲルを通した後、溶媒を減圧留去した。得ら
れた残留物を酢酸エチル−ヘキサンより結晶化して、目
的物を得た。白色結晶 収量2.366g 収率84% mp 203-204℃; 1H-NMR (CDCl3, 200MHz) δ 1.33 (9H,
s), 2.67-2.98 (3H, m),4.06 (1H, br s), 4.63 (1H, b
r d, J = 8.4 Hz), 4.93 (1H, br s), 7.07 (2H, t, J
= 8.6 Hz), 7.21 (2H, d, J = 8.2 Hz), 7.38 (2H, dd,
J = 5.4 Hz, 8.6 Hz), 7.54 (2H, d, J = 8.4 Hz); IR
(KBr) 3466, 3366, 2236, 1684, 1508,1530, 1221, 11
71 cm-1; Anal. Calcd for C21H23FN2O3: C, 68.09; H,
6.26; N, 7.56. Found: C, 68.20; H, 6.18; N, 7.60.Example 152 N-[(1RS, 2SR) -1- (4-cyanobenzyl)-
Tert-butyl 2- (4-fluorophenyl) -2-hydroxyethyl] carbamate 1) ethyl 2- (4-cyanobenzyl) -3- (4-fluorophenyl) -3-oxopropionate (4-fluorobenzoyl 15.30 g of ethyl acetate
(72.79 mmol) of 1,2-dimethoxyethane 1
2.91 g (72.8 mmol) of a 60% sodium hydride liquid paraffin suspension was added to the 00 ml solution under ice cooling, and the mixture was stirred for 0.5 hour. A solution of 14.3 g (72.8 mmol) of 4-cyanobenzyl bromide in 50 ml of 1,2-dimethoxyethane was added at room temperature, and the mixture was stirred at room temperature for 4 hours. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue is purified by silica gel column chromatography (hexane / toluene =
1 / 1-1 / 1.5) and crystallized from diethyl ether-hexane to obtain the desired product. White crystals Yield 20.6
0g Yield 87% mp 85-86 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 1.12 (3H, t,
J = 7.2 Hz), 3.38 (2H, d, J = 7.2 Hz), 4.10 (2H,
q, J = 7.1 Hz), 4.56 (1H, t, J = 7.5 Hz), 7.14 (2
H, t, J = 8.6 Hz), 7.35 (2H, d, J = 8.0 Hz), 7.56
(2H, d, J = 8.0 Hz), 8.00 (2H, dd, J = 5.4 Hz, 9.0
Hz); IR (KBr) 2230, 1730, 1692, 1599, 1508, 1306,
1285, 1236, 1202, 1161, 851 cm -1 ; Anal.Calcd for
C 19 H 16 FNO 3 : C, 70.14; H, 4.96; N, 4.31. Found: C,
70.20; H, 4.84; N, 4.29.2) (2RS, 3RS) -2- (4-cyanobenzyl)-
Ethyl 3- (4-fluorophenyl) -3-hydroxypropionate While stirring 8.52 g (62.5 mmol) of zinc chloride in 100 ml of diethyl ether, 4.73 g (125 mmol) of sodium borohydride was added at room temperature. The mixture was stirred for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. 10.17 g (31.26 mmol) of ethyl 2- (4-cyanobenzyl) -3- (4-fluorophenyl) -3-oxopropionate was added to the resulting solution.
Was added at room temperature, followed by stirring for 2 hours. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-2 / 1) to obtain the desired product. Colorless liquid Yield 4.297 g Yield 42% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.93 (3H, t, J = 7.1 H)
z), 2.82 (1H, d, J = 2.8Hz), 2.89-3.08 (3H, m), 3.
88 (2H, q, J = 7.2 Hz), 5.03 (1H, dd, J = 2.5 Hz,
5.1 Hz), 7.05 (2H, t, J = 8.8 Hz), 7.20 (2H, d, J
= 8.4 Hz), 7.37 (2H, dd, J = 5.2 Hz, 8.4 Hz), 7.53
(2H, d, J = 8.4 Hz); IR (neat) 3484, 2230. 1725,
1607, 1508, 1223, 1179, 1159, 1032, 839 cm -1 3) (2RS, 3RS) -2- (4- cyanobenzyl) -
3- (4-Fluorophenyl) -3-hydroxypropionic acid (2RS, 3RS) -2- (4-cyanobenzyl) -3-
To a solution of 4.145 g (12.66 mmol) of ethyl (4-fluorophenyl) -3-hydroxypropionate in 30 ml of methanol and 20 ml of tetrahydrofuran was added 25.3 ml (25.3 mmol) of a 1N aqueous sodium hydroxide solution, and the mixture was added at room temperature. Stirred overnight. The reaction solution was concentrated, diluted with water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from diethyl ether-hexane to obtain the desired product. White crystals
Yield 3.559 g Yield 94% mp 165-168 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
89-3.15 (3H, m), 5.03 (1H, d, J = 5.0 Hz), 7.03 (2
H, t, J = 8.6 Hz), 7.24 (2H, d, J = 8.2 Hz), 7.40
(2H, dd, J = 5.5 Hz, 8.5 Hz), 7.51 (2H, d, J = 8.4
Hz); IR (KBr) 3476, 3152, 2232, 1719, 1678, 1605,
1508, 1406, 1225, 1175, 1157, 845 cm - 1 ; Anal. Cal
cd for C 17 H 14 FNO 3 :. C, 68.22; H, 4.71; N, 4.68 Fou
nd: C, 67.98; H, 4.83; N, 4.47.4) (4RS, 5SR) -4- (4-cyanobenzyl)-
5- (4-fluorophenyl) -1,3-oxazolidine-
2-one (2RS, 3RS) -2- (4-cyanobenzyl) -3-
To a solution of 3.385 g (11.31 mmol) of (4-fluorophenyl) -3-hydroxypropionic acid in 50 ml of tetrahydrofuran, 2.36 ml of triethylamine (1
7.0 mmol), diphenylphosphoryl azide 3.4
2 g (12.4 mmol) was added, and the mixture was heated under reflux overnight.
The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / hexane).
Ethyl acetate = 3 / 1-1 / 2) and crystallization from diethyl ether-hexane to give the desired product. White crystals Yield 2.741 g Yield 82% mp 170-173 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.36 (2H,
d, J = 6.6 Hz), 4.27 (1H, dt, J = 7.5 Hz, 7.5 Hz),
5.17 (1H, br s), 5,81 (1H, d, J = 7.8 Hz), 7.13 (2
H, t, J = 8.6 Hz), 7.13 (2H, d, J = 8.0 Hz), 7.35
(2H, dd, J = 5.2 Hz, 8.4 Hz), 7.59 (2H, d, J = 8.0
Hz); IR (KBr) 3324, 2240, 1748, 1514, 1225
cm -1 ; Anal. Calcd for C
17 H 13 FN 2 O 2: C, 68.91; H,
4.42; N, 9.45. Found: C,
68.98; H, 4.43; N, 9.33. 5) (4RS, 5SR) -4- (4-cyanobenzyl)-
Tert-Butyl 5- (4-fluorophenyl) -2-oxo-1,3-oxazolidine-3-carboxylate (4RS, 5SR) -4- (4-cyanobenzyl) -5-
(4-Fluorophenyl) -1,3-oxazolidine-2-
2.622 g (8.849 mmol) of di-dicarbonate
2.32 g (10.6 mmol) of tert-butyl, 4-
0.11 g of N, N-dimethylaminopyridine (0.88
(Mmol) in 30 ml of acetonitrile was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with water, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystal Yield 3.243 g Yield 92% mp 161-163 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.51 (9H,
s), 2.63 (1H, dd, J = 8.6 Hz, 14.2 Hz), 2.93 (1H, d
d, J = 4.7 Hz, 14.3 Hz), 4.74-4.85 (1H, m), 5.68 (1
H, d, J = 6.6 Hz), 6.80 (2H, d, J = 8.0 Hz), 7.00
(2H, t, J = 8.6 Hz), 7.16 (2H, dd, J = 5.4 Hz, 8.6
Hz), 7.39 (2H, d, J = 8.0 Hz); IR (KBr) 2982, 222
8, 1815, 1721, 1514, 1368, 1152, 1069 cm -1 ; Anal.
Calcd for C 22 H 21 FN 2 O 4 : C, 66.66; H, 5.34; N, 7.07.
Found: C, 66.76; H, 5.37; N, 7.09.6) N-[(1RS, 2SR) -1- (4-cyanobenzyl) -2- (4-fluorophenyl) -2-hydroxyethyl] carbamic acid tert-butyl (4RS, 5SR) -4- (4-cyanobenzyl) -5-
Tert-Butyl (4-fluorophenyl) -2-oxo-1,3-oxazolidine-3-carboxylate 3.014 g
(7.603 mmol) in methanol (20 ml) -tetrahydrofuran (10 ml) was treated with sodium hydroxide 0.33.
g (8.36 mmol) in 20 ml of methanol was added under ice-cooling, and the mixture was stirred at room temperature for 3 hours. The reaction solution was diluted with ethyl acetate, washed with dilute hydrochloric acid, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystal Yield 2.366 g Yield 84% mp 203-204 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.33 (9H,
s), 2.67-2.98 (3H, m), 4.06 (1H, br s), 4.63 (1H, b
rd, J = 8.4 Hz), 4.93 (1H, br s), 7.07 (2H, t, J
= 8.6 Hz), 7.21 (2H, d, J = 8.2 Hz), 7.38 (2H, dd,
J = 5.4 Hz, 8.6 Hz), 7.54 (2H, d, J = 8.4 Hz); IR
(KBr) 3466, 3366, 2236, 1684, 1508,1530, 1221, 11
. 71 cm -1; Anal Calcd for C 21 H 23 FN 2 O 3: C, 68.09; H,
6.26; N, 7.56. Found: C, 68.20; H, 6.18; N, 7.60.
【0285】実施例153 N-[(1RS,2SR)-1-(4-シアノベンジル)-
2-(4-フルオロフェニル)-2-ヒドロキシエチル]-
4-フルオロナフタレン-1-カルボキサミド 1) (1RS,2SR)-2-アミノ-3-(4-シアノ
フェニル)-1-(4-フルオロフェニル)プロパン-1-
オール N-[(1RS,2SR)-1-(4-シアノベンジル)-
2-(4-フルオロフェニル)-2-ヒドロキシエチル]カ
ルバミン酸tert-ブチル2.199g(5.937
ミリモル)、濃塩酸4mlのメタノール30ml−テト
ラヒドロフラン20ml溶液を60℃で30分間撹拌し
た。反応液を水で希釈し、炭酸カリウムでアルカリ性と
し、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸ナトリウムで乾燥、溶媒を減圧留去した。残留物をジ
エチルエーテル−ヘキサンより沈殿化して、目的物を得
た。白色アモルファス粉末 収量1.557g 収率9
7%1 H-NMR (CDCl3, 200MHz) δ 2.44 (1H, dd, J = 10.3 H
z, 13.5 Hz), 2.88 (1H,dd, J = 2.9 Hz, 13.9 Hz), 3.
28 (1H, ddd, J = 3.2 Hz, 5.1 Hz, 10.2 Hz),4.64 (1
H, d, J = 5.2 Hz), 7.08 (2H, t, J = 8.8 Hz), 7.27
(2H, d, J = 8.6Hz), 7.37 (2H, dd, J = 5.6 Hz, 8.8
Hz), 7.58 (2H, d, J = 8.0 Hz); IR (KBr) 3350-2750,
2224, 1605, 1507, 1221, 1044, 828 cm-1; Anal. Cal
cd for C 16H15FN2O・0.2H2O: C, 70.16; H, 5.67; N, 1
0.23. Found: C, 70.55; H, 5.84;N, 9.95. 2) N-[(1RS,2SR)-1-(4-シアノベンジ
ル)-2-(4-フルオロフェニル)-2-ヒドロキシエチ
ル]-4-フルオロナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-3-(4-シアノフェニ
ル)-1-(4-フルオロフェニル)プロパン-1-オール
0.168g(0.622ミリモル)、4-フルオロ-1
-ナフトエ酸0.12g(0.62ミリモル)、1-ヒド
ロキシベンゾトリアゾール水和物0.10g(0.62
ミリモル)をアセトニトリル10ml中で撹拌しながら
1-エチル-3-(3-ジメチルアミノプロピル)カルボジ
イミド・塩酸塩0.12g(0.62ミリモル)を加
え、室温で一晩撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物を酢酸エチル−ヘキサンより結晶
化して、目的物を得た。白色結晶 収量0.217g
収率79% mp 248-249℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
93 (1H, dd, J = 11.0 Hz, 14.4 Hz), 3.14 (1H, dd, J
= 3.4 Hz, 13.6 Hz), 4.64-4.79 (1H, m), 4.94(1H,
t, J = 4.6 Hz), 5.42 (1H, d, J = 4.2 Hz), 7.02-7.1
2 (3H, m), 7.20(1H, dd, J = 5.5 Hz, 7.7 Hz), 7.37-
7.58 (9H, m), 7.78 (1H, d, J = 9.4 H), 8.05 (1H,
d, J = 7.6 Hz); IR (KBr) 3476, 3291, 2232, 1642, 1
626, 1603,1537, 1508, 1225, 847 cm-1; Anal. Calcd
for C27H20F2N2O2: C, 73.29; H,4.56; N, 6.33. Foun
d: C, 73.08; H, 4.43; N, 6.10.Example 153 N-[(1RS, 2SR) -1- (4-cyanobenzyl)-
2- (4-fluorophenyl) -2-hydroxyethyl]-
4-Fluoronaphthalene-1-carboxamide 1) (1RS, 2SR) -2-amino-3- (4-cyano
Phenyl) -1- (4-fluorophenyl) propane-1-
All N-[(1RS, 2SR) -1- (4-cyanobenzyl)-
2- (4-fluorophenyl) -2-hydroxyethyl] ca
2.199 g of tert-butyl rubamate (5.937)
Mmol), 4 ml of concentrated hydrochloric acid, 30 ml of methanol
A 20 ml solution of lahydrofuran is stirred at 60 ° C. for 30 minutes.
Was. Dilute the reaction solution with water and make it alkaline with potassium carbonate.
And extracted twice with ethyl acetate. The collected organic layer is anhydrous sulfur
The extract was dried over sodium acid and the solvent was distilled off under reduced pressure. Remove the residue
Precipitation from ethyl ether-hexane gave the desired product.
Was. White amorphous powder Yield 1.557 g Yield 9
7%1 H-NMR (CDClThree, 200MHz) δ 2.44 (1H, dd, J = 10.3 H
z, 13.5 Hz), 2.88 (1H, dd, J = 2.9 Hz, 13.9 Hz), 3.
28 (1H, ddd, J = 3.2 Hz, 5.1 Hz, 10.2 Hz), 4.64 (1
H, d, J = 5.2 Hz), 7.08 (2H, t, J = 8.8 Hz), 7.27
(2H, d, J = 8.6Hz), 7.37 (2H, dd, J = 5.6Hz, 8.8
Hz), 7.58 (2H, d, J = 8.0 Hz); IR (KBr) 3350-2750,
2224, 1605, 1507, 1221, 1044, 828 cm-1; Anal. Cal
cd for C 16H15FNTwoO ・ 0.2HTwoO: C, 70.16; H, 5.67; N, 1
0.23. Found: C, 70.55; H, 5.84; N, 9.95. 2) N-[(1RS, 2SR) -1- (4-cyanobenzy)
) -2- (4-Fluorophenyl) -2-hydroxyethyl
Ru] -4-Fluoronaphthalene-1-carboxamide (1RS, 2SR) -2-amino-3- (4-cyanophenyi)
) -1- (4-Fluorophenyl) propan-1-ol
0.168 g (0.622 mmol), 4-fluoro-1
-Naphthoic acid 0.12 g (0.62 mmol), 1-hydrido
Roxybenzotriazole hydrate 0.10 g (0.62
Mmol) in 10 ml of acetonitrile with stirring
1-ethyl-3- (3-dimethylaminopropyl) carbodi
0.12 g (0.62 mmol) of imide / hydrochloride was added.
And stirred overnight at room temperature. Dilute the reaction solution in ethyl acetate
And washed with aqueous sodium bicarbonate solution, anhydrous magnesium sulfate
After drying with silica and passing through silica gel, the solvent is distilled off under reduced pressure
did. The obtained residue was crystallized from ethyl acetate-hexane.
To give the desired product. 0.217 g of white crystals
Yield 79% mp 248-249 ° C;1H-NMR (CDClThree-DMSO-d6, 200MHz) δ 2.
93 (1H, dd, J = 11.0 Hz, 14.4 Hz), 3.14 (1H, dd, J
= 3.4 Hz, 13.6 Hz), 4.64-4.79 (1H, m), 4.94 (1H,
t, J = 4.6 Hz), 5.42 (1H, d, J = 4.2 Hz), 7.02-7.1
2 (3H, m), 7.20 (1H, dd, J = 5.5 Hz, 7.7 Hz), 7.37-
7.58 (9H, m), 7.78 (1H, d, J = 9.4 H), 8.05 (1H,
d, J = 7.6 Hz); IR (KBr) 3476, 3291, 2232, 1642, 1
626, 1603, 1537, 1508, 1225, 847 cm-1; Anal. Calcd
for C27H20FTwoNTwoOTwo: C, 73.29; H, 4.56; N, 6.33. Foun
d: C, 73.08; H, 4.43; N, 6.10.
【0286】実施例154 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-(4-イソプロピルベ
ンジル)エチル]ナフタレン-1-カルボキサミド1)
3-(4-フルオロフェニル)-2-(4-イソプロピルベ
ンジル)-3-オキソプロピオン酸エチル (4-フルオロベンゾイル)酢酸エチル23.21g
(110.4ミリモル)の1,2-ジメトキシエタン1
50ml溶液に氷冷下60%水素化ナトリウムの流動パ
ラフィン懸濁物4.42g(110ミリモル)を加え、
そのまま0.5時間撹拌した。4-イソプロピルベンジ
ルクロリド18.6g(110ミリモル)の1,2-ジ
メトキシエタン50ml溶液を室温で加え、70℃で一
晩撹拌した。反応液を水に注ぎ、酢酸エチルで2回抽出
した。集めた有機層を無水硫酸マグネシウムで乾燥、溶
媒を減圧留去した。得られた残留物をシリカゲルカラム
クロマトグラフィーにて精製して(ヘキサン/酢酸エチ
ル=15/1−9/1)、目的物を得た。黄色液体 収
量21.01g 収率56%1 H-NMR (CDCl3, 200MHz) δ 1.12 (3H, t, J = 7.1 H
z), 1.20 (6H, d, J = 7.0Hz), 2.78-2.91 (1H, m), 3.
28 (2H, d, J = 7.2 Hz), 4.10 (2H, q, J = 7.1Hz),
4.55 (1H, t, J = 7.3 Hz), 7.06-7.26 (6H, m), 7.98
(2H, dd, J = 5.7Hz, 8.7 Hz); IR (neat) 2961, 1738,
1688, 1599, 1508, 1271, 1235, 1159, 849 cm-1 2) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-(4-イソプロピルベンジル)
プロピオン酸エチル 塩化亜鉛8.41g(61.7ミリモル)をジエチルエ
ーテル100ml中で撹拌しながら水素化ホウ素ナトリ
ウム4.67g(123ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、3-(4-フルオ
ロフェニル)-2-(4-イソプロピルベンジル)-3-オ
キソプロピオン酸エチル10.57g(30.87ミリ
モル)のジエチルエーテル50ml溶液を室温で加え、
そのまま2時間撹拌した。反応液に希塩酸を少しずつ加
えて過剰の水素化ホウ素亜鉛を分解した後、酢酸エチル
で2回抽出した。集めた有機層を無水硫酸マグネシウム
で乾燥、溶媒を減圧留去した。得られた粗生成物をシリ
カゲルカラムクロマトグラフィーにて精製し(ヘキサン
/酢酸エチル=6/1−3/1)、目的物を得た。無色
液体 収量8.433g 収率79%1 H-NMR (CDCl3, 200MHz) δ 0.91 (3H, t, J = 7.1 H
z), 1.20 (6H, d, J = 7.0Hz), 2.71-3.09 (4H, m), 3.
80-4.96 (2H, m), 5.00 (1H, s), 6.94-7.11 (6H,m),
7.37 (2H, dd, J = 5.6 Hz, 8.6 Hz); IR (neat) 3445,
2961, 1726, 1713, 1510, 1225, 1157, 1032, 837 cm
-1 3) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-(4-イソプロピルベンジル)
プロピオン酸 (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-(4-イソプロピルベンジル)プロピオ
ン酸エチル8.267g(24.00ミリモル)のメタ
ノール40ml−テトラヒドロフラン50ml溶液に1
N水酸化ナトリウム水溶液48.0ml(48.0ミリ
モル)を加え、室温で一晩撹拌した。反応液を濃縮、水
で希釈し、1N塩酸で反応液を酸性にした後、酢酸エチ
ルで2回抽出した。集めた有機層を無水硫酸ナトリウム
で乾燥、溶媒を減圧留去した。残留物をジエチルエーテ
ル−ヘキサンより結晶化して、目的物を得た。白色結晶
収量6.275g 収率83% mp 147-148℃; 1H-NMR (CDCl3, 200MHz) δ 1.21 (6H,
d, J = 7.0 Hz), 2.78-3.09 (4H, m), 5.04 (1H, d, J
= 4.4 Hz), 6.98-7.12 (6H, m), 7.36 (2H, dd,J = 5.2
Hz, 8.6 Hz); IR (KBr) 3330, 3050-2600, 1690, 151
8, 1240, 1221, 1196, 849, 839 cm-1; Anal. Calcd fo
r C19H21FO3: C, 72.13; H, 6.69. Found:C, 72.03; H,
6.55. 4) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-(4-イソプロピルベンジル)-1,3-オキサ
ゾリジン-2-オン (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-(4-イソプロピルベンジル)プロピオ
ン酸6.128g(19.37ミリモル)のテトラヒド
ロフラン80ml溶液にトリエチルアミン4.05ml
(29.1ミリモル)、ジフェニルホスホリルアジド
5.86g(21.3ミリモル)を加え、一晩加熱還流
した。反応液の溶媒を減圧留去し、得られた粗生成物を
シリカゲルカラムクロマトグラフィーにて精製し(ヘキ
サン/酢酸エチル=3/1−1/1)、トルエン−ヘキ
サンより結晶化して、目的物を得た。白色結晶 収量
5.680g 収率94% mp 185-186℃; 1H-NMR (CDCl3, 200MHz) δ 1.22 (6H,
d, J = 7.0 Hz), 2.10-2.30 (2H, m), 2.80-2.94 (1H,
m), 4.20 (1H, ddd, J = 4.2 Hz, 7.8 Hz, 10.4Hz), 4.
90 (1H, br s), 5.79 (1H, d, J = 7.6 Hz), 6.95 (2H,
d, J = 8.0 Hz), 7.09-7.18 (4H, m), 7.37 (2H, dd,
J = 5.2 Hz, 8.8 Hz); IR (KBr) 3262, 2961, 1738, 15
14, 1231, 1009, 855 cm-1; Anal. Calcd for C19H20FN
O2: C, 72.82; H, 6.43; N, 4.47. Found: C, 72.68;
H, 6.30; N, 4.65. 5) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(4-イソプロピルフェニル)プロパ
ン-1-オール (4RS,5SR)-5-(4-フルオロフェニル)-4-
(4-イソプロピルベンジル)-1,3-オキサゾリジン-
2-オン5.503g(17.56ミリモル)と水酸化
ナトリウム2.81g(70.2ミリモル)をエタノー
ル40ml−水3ml中で、7時間加熱還流した。反応
液を水で希釈し、室温で10分間撹拌した。生じた沈殿
をろ過して集め、水で洗浄して、目的物を得た。白色結
晶 収量4.097g 収率81% mp 74-75℃; 1H-NMR (CDCl3, 200MHz) δ 1.23 (6H, d,
J = 6.8 Hz), 2.29 (1H, dd, J = 10.4 Hz, 13.8 Hz),
2.75 (1H, dd, J = 2.8 Hz, 13.2 Hz), 2.80-2.94 (1
H, m), 3.26 (1H, ddd, J = 3.5 Hz, 4.8 Hz, 10.5 H
z), 4.66 (1H, d, J= 5.2 Hz), 7.03-7.17 (6H, m), 7.
37 (2H, dd, J = 5.6 Hz, 8.4 Hz); IR (KBr) 3627, 33
49, 3281, 3150-2700, 1507, 1219, 1042, 855, 924 cm
-1; Anal. Calcd for C18H22FNO・0.2H2O: C, 74.30; H,
7.76; N, 4.81. Found: C, 74.38; H, 7.80; N, 4.65. 6) 4-フルオロ-N-[(1RS,2SR)-2-(4-
フルオロフェニル)-2-ヒドロキシ-1-(4-イソプロ
ピルベンジル)エチル]ナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(4-イソプロピルフェニル)プロパン-1-
オール0.164g(0.571ミリモル)、4-フル
オロ-1-ナフトエ酸0.11g(0.57ミリモル)、
1-ヒドロキシベンゾトリアゾール水和物87mg
(0.57ミリモル)をアセトニトリル10ml中で撹
拌しながら1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩0.11g(0.57ミリ
モル)を加え、室温で一晩撹拌した。反応液を酢酸エチ
ルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無水硫
酸マグネシウムで乾燥、シリカゲルを通した後、溶媒を
減圧留去した。得られた残留物を酢酸エチル−ヘキサン
より結晶化して、目的物を得た。白色結晶 収量0.2
11g 収率80% mp 189-192℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 1.
23 (6H, d, J = 6.8 Hz), 2.77-3.06 (3H, m), 4.62-4.
76 (1H, m), 4.95 (1H, t, J = 4.2 Hz), 5.33 (1H, d,
J = 4.0 Hz), 6.99-7.24 (8H, m), 7.37-7.65 (6H,
m), 8.04 (1H, d, J= 8.6 Hz); IR (KBr) 3299, 2959,
1642, 1626, 1539, 1512, 1227, 835 cm-1;Anal. Calcd
for C29H27F2NO2: C, 75.80; H, 5.92; N, 3.05. Foun
d: C, 75.67; H, 5.77; N, 2.87.Example 154 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- (4-isopropylbenzyl) ethyl] naphthalene-1-carboxamide 1)
Ethyl 3- (4-fluorophenyl) -2- (4-isopropylbenzyl) -3-oxopropionate 23.21 g of ethyl (4-fluorobenzoyl) acetate
(110.4 mmol) of 1,2-dimethoxyethane 1
To a 50 ml solution was added 4.42 g (110 mmol) of a 60% sodium hydride liquid paraffin suspension under ice cooling.
The mixture was stirred for 0.5 hours as it was. A solution of 18.6 g (110 mmol) of 4-isopropylbenzyl chloride in 50 ml of 1,2-dimethoxyethane was added at room temperature, and the mixture was stirred at 70 ° C. overnight. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-9 / 1) to obtain the desired product. Yellow liquid Yield 21.01 g Yield 56% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.12 (3H, t, J = 7.1 H)
z), 1.20 (6H, d, J = 7.0Hz), 2.78-2.91 (1H, m), 3.
28 (2H, d, J = 7.2 Hz), 4.10 (2H, q, J = 7.1 Hz),
4.55 (1H, t, J = 7.3 Hz), 7.06-7.26 (6H, m), 7.98
(2H, dd, J = 5.7Hz, 8.7 Hz); IR (neat) 2961, 1738,
1688, 1599, 1508, 1271, 1235, 1159, 849 cm -1 2) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- (4-isopropylbenzyl)
Ethyl propionate While stirring 8.41 g (61.7 mmol) of zinc chloride in 100 ml of diethyl ether, 4.67 g (123 mmol) of sodium borohydride was added at room temperature, and the mixture was stirred for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. To the resulting solution was added a solution of 10.57 g (30.87 mmol) of ethyl 3- (4-fluorophenyl) -2- (4-isopropylbenzyl) -3-oxopropionate in 50 ml of diethyl ether at room temperature.
The mixture was stirred for 2 hours. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-3 / 1) to obtain the desired product. Colorless liquid Yield 8.433 g Yield 79% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.91 (3H, t, J = 7.1 H)
z), 1.20 (6H, d, J = 7.0Hz), 2.71-3.09 (4H, m), 3.
80-4.96 (2H, m), 5.00 (1H, s), 6.94-7.11 (6H, m),
7.37 (2H, dd, J = 5.6 Hz, 8.6 Hz); IR (neat) 3445,
2961, 1726, 1713, 1510, 1225, 1157, 1032, 837 cm
-1 3) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- (4-isopropyl-benzyl)
Propionic acid (2RS, 3RS) -3- (4-fluorophenyl) -3-
A solution of 8.267 g (24.00 mmol) of ethyl hydroxy-2- (4-isopropylbenzyl) propionate in 40 ml of methanol-50 ml of tetrahydrofuran was added to a solution.
48.0 ml (48.0 mmol) of an N sodium hydroxide aqueous solution was added, and the mixture was stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from diethyl ether-hexane to obtain the desired product. White crystal Yield 6.275 g Yield 83% mp 147-148 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.21 (6H,
d, J = 7.0 Hz), 2.78-3.09 (4H, m), 5.04 (1H, d, J
= 4.4 Hz), 6.98-7.12 (6H, m), 7.36 (2H, dd, J = 5.2
Hz, 8.6 Hz); IR (KBr) 3330, 3050-2600, 1690, 151
8, 1240, 1221, 1196, 849, 839 cm -1 ; Anal.Calcd fo
r C 19 H 21 FO 3 : C, 72.13; H, 6.69.Found: C, 72.03; H,
6.55.4. 4) (4RS, 5SR) -5- (4-fluorophenyl) -4- (4-isopropylbenzyl) -1,3-oxazolidine-2-one (2RS, 3RS) -3- (4-fluorophenyl) ) -3-
To a solution of 6.128 g (19.37 mmol) of hydroxy-2- (4-isopropylbenzyl) propionic acid in 80 ml of tetrahydrofuran, 4.05 ml of triethylamine was added.
(29.1 mmol) and 5.86 g (21.3 mmol) of diphenylphosphoryl azide, and the mixture was refluxed overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1) and crystallized from toluene-hexane to give the desired product I got White crystal Yield 5.680 g Yield 94% mp 185-186 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.22 (6H,
d, J = 7.0 Hz), 2.10-2.30 (2H, m), 2.80-2.94 (1H,
m), 4.20 (1H, ddd, J = 4.2 Hz, 7.8 Hz, 10.4 Hz), 4.
90 (1H, br s), 5.79 (1H, d, J = 7.6 Hz), 6.95 (2H,
d, J = 8.0 Hz), 7.09-7.18 (4H, m), 7.37 (2H, dd,
J = 5.2 Hz, 8.8 Hz); IR (KBr) 3262, 2961, 1738, 15
14, 1231, 1009, 855 cm -1 ; Anal.Calcd for C 19 H 20 FN
O 2 : C, 72.82; H, 6.43; N, 4.47. Found: C, 72.68;
H, 6.30; N, 4.65.5) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4-isopropylphenyl) propan-1-ol (4RS, 5SR) -5- (4-fluorophenyl) -4-
(4-isopropylbenzyl) -1,3-oxazolidine-
5.503 g (17.56 mmol) of 2-one and 2.81 g (70.2 mmol) of sodium hydroxide were heated to reflux in 40 ml of ethanol-3 ml of water for 7 hours. The reaction was diluted with water and stirred at room temperature for 10 minutes. The resulting precipitate was collected by filtration and washed with water to obtain the desired product. White crystals Yield 4.097 g Yield 81% mp 74-75 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.23 (6H, d,
J = 6.8 Hz), 2.29 (1H, dd, J = 10.4 Hz, 13.8 Hz),
2.75 (1H, dd, J = 2.8 Hz, 13.2 Hz), 2.80-2.94 (1
H, m), 3.26 (1H, ddd, J = 3.5 Hz, 4.8 Hz, 10.5 H
z), 4.66 (1H, d, J = 5.2 Hz), 7.03-7.17 (6H, m), 7.
37 (2H, dd, J = 5.6 Hz, 8.4 Hz); IR (KBr) 3627, 33
49, 3281, 3150-2700, 1507, 1219, 1042, 855, 924 cm
-1 ; Anal.Calcd for C 18 H 22 FNO ・ 0.2H 2 O: C, 74.30; H,
7.76; N, 4.81. Found: C, 74.38; H, 7.80; N, 4.65.6) 4-Fluoro-N-[(1RS, 2SR) -2- (4-
Fluorophenyl) -2-hydroxy-1- (4-isopropylbenzyl) ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4-isopropylphenyl) Propane-1-
0.164 g (0.571 mmol) of all, 0.11 g (0.57 mmol) of 4-fluoro-1-naphthoic acid,
87 mg of 1-hydroxybenzotriazole hydrate
(0.57 mmol) was stirred in 10 ml of acetonitrile, and 0.11 g (0.57 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added thereto, followed by stirring at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 0.2
11g Yield 80% mp 189-192 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200MHz) δ 1.
23 (6H, d, J = 6.8 Hz), 2.77-3.06 (3H, m), 4.62-4.
76 (1H, m), 4.95 (1H, t, J = 4.2 Hz), 5.33 (1H, d,
J = 4.0 Hz), 6.99-7.24 (8H, m), 7.37-7.65 (6H,
m), 8.04 (1H, d, J = 8.6 Hz); IR (KBr) 3299, 2959,
1642, 1626, 1539, 1512, 1227, 835 cm -1 ; Anal.Calcd
for C 29 H 27 F 2 NO 2 : C, 75.80; H, 5.92; N, 3.05. Foun
d: C, 75.67; H, 5.77; N, 2.87.
【0287】実施例155 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-(4-イソプロピルベンジル)エチ
ル]-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテ
ン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(4-イソプロピルフェニル)プロパン-1-
オール0.219g(0.762ミリモル)、6,7-
ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボ
ン酸0.14g(0.76ミリモル)、1-ヒドロキシ
ベンゾトリアゾール水和物0.12g(0.76ミリモ
ル)をアセトニトリル10ml中で撹拌しながら1-エ
チル-3-(3-ジメチルアミノプロピル)カルボジイミ
ド・塩酸塩0.15g(0.76ミリモル)を加え、室
温で一晩撹拌した。反応液を酢酸エチルに希釈し、炭酸
水素ナトリウム水溶液で洗浄、無水硫酸マグネシウムで
乾燥、シリカゲルを通した後、溶媒を減圧留去した。得
られた残留物をジイソプロピルエーテル−ヘキサンより
結晶化して、目的物を得た。白色粉末 収量0.294
g 収率84% mp 168-169℃; 1H-NMR (CDCl3, 200MHz) δ 1.23 (6H,
d, J = 7.0 Hz), 1.95-2.06 (2H, m), 2.14-2.23 (2H,
m), 2.61-2.76 (3H, m), 2.86 (1H, dd, J = 6.6Hz, 1
4.0 Hz), 2.97 (1H, dd, J = 4.4 Hz, 13.6 Hz), 4.14
(1H, d, J = 4.4Hz), 4.61-4.74 (1H, m), 5.02 (1H,
t, J = 3.1 Hz), 5.63 (1H, d, J = 7.8 Hz), 5.93 (1
H, td, J = 5.7 Hz, 11.3 Hz), 6.24 (1H, d, J = 11.8
Hz), 6.89(1H, d, J = 7.4 Hz), 7.00-7.18 (8H, m),
7.42 (2H, dd, J = 5.4 Hz, 8.6 Hz); IR (KBr) 3291,
1638, 1534, 1512, 1225, 1038, 826 cm-1; Anal. Calc
d for C30H32FNO2: C, 78.75; H, 7.05; N, 3.06. Foun
d: C, 78.66; H, 6.98; N, 3.06.Example 155 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- (4-isopropylbenzyl) ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl ) -3- (4-Isopropylphenyl) propane-1-
0.219 g (0.762 mmol) of all, 6,7-
0.14 g (0.76 mmol) of dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid and 0.12 g (0.76 mmol) of 1-hydroxybenzotriazole hydrate were added to 10 ml of acetonitrile while stirring. 0.15 g (0.76 mmol) of -ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White powder Yield 0.294
g Yield 84% mp 168-169 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.23 (6H,
d, J = 7.0 Hz), 1.95-2.06 (2H, m), 2.14-2.23 (2H,
m), 2.61-2.76 (3H, m), 2.86 (1H, dd, J = 6.6Hz, 1
4.0 Hz), 2.97 (1H, dd, J = 4.4 Hz, 13.6 Hz), 4.14
(1H, d, J = 4.4Hz), 4.61-4.74 (1H, m), 5.02 (1H,
t, J = 3.1 Hz), 5.63 (1H, d, J = 7.8 Hz), 5.93 (1
H, td, J = 5.7 Hz, 11.3 Hz), 6.24 (1H, d, J = 11.8
Hz), 6.89 (1H, d, J = 7.4 Hz), 7.00-7.18 (8H, m),
7.42 (2H, dd, J = 5.4 Hz, 8.6 Hz); IR (KBr) 3291,
1638, 1534, 1512, 1225, 1038, 826 cm -1 ; Anal.Calc
d for C 30 H 32 FNO 2 :. C, 78.75; H, 7.05; N, 3.06 Foun
d: C, 78.66; H, 6.98; N, 3.06.
【0288】実施例156 N-((1RS,2SR)-2-(4-フルオロフェニル)
-1-((3-フルオロ-4-(トリフルオロメチル)フェ
ニル)メチル)-2-ヒドロキシエチル)-4-フルオロ-
1-ナフタレンカルボキサミド 1) 3-フルオロ-4-(トリフルオロメチル)安息香
酸(10.5g,50.7ミリモル)のテトラヒドロフ
ラン(30ml)溶液にボラン1Mテトラヒドロフラン
溶液(63ml,63ミリモル)を加えて室温で8時間
攪拌した。反応液に1規定塩酸(100ml)を加え、
酢酸エチル(300ml×2)で抽出した。抽出液を飽
和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減圧
留去した。残留物をシリカゲルカラムクロマトグラフィ
ー(酢酸エチル)で精製し、3-フルオロ-4-(トリフ
ルオロメチル)ベンジルアルコール(10.3g,90
%純度,94%)を得た。1 H-NMR (CDCl3)δ: 1.91 (1H, t, J = 5.4 Hz), 4.78
(2H, d, J = 5.4 Hz), 7.16-7.30 (2H, m), 7.59 (1H,
t, J = 7.6 Hz). 2) 3-フルオロ-4-(トリフルオロメチル)ベンジ
ルアルコール(10g,52ミリモル)のクロロホルム
(20ml)溶液に塩化チオニル(18.5ml,25
7ミリモル)を加え、4時間加熱還流した。反応液を濃
縮後、残留物をシリカゲルカラムクロマトグラフィー
(ヘキサン:酢酸エチル=4:1)で精製し、3-フル
オロ-4-(トリフルオロメチル)ベンジルクロリド
(9.52g,87%)を得た。 IRνmaxKBrcm-1: 1634, 1589, 1512, 1435.1 H-NMR (CDCl3)δ: 4.58 (2H, s), 7.20-7.32 (2H, m),
7.60 (1H, t, J = 7.6Hz). 3) 3-(4-フルオロフェニル)-3-オキソプロピオ
ン酸エチル(8.9g,42.3ミリモル)の1,2-
ジメトキシエタン(50ml)溶液に水素化ナトリウム
(60%油性,1.69g,42.3ミリモル)を氷冷
下加え、室温で30分攪拌した。反応液の中に3-フル
オロ-4-(トリフルオロメチル)ベンジルブロミド
(9.0g,42.3ミリモル)の1,2-ジメトキシ
エタン(50ml)溶液を滴下し、反応液を室温で3時
間攪拌した。反応液を水(200ml)の中に注ぎ、酢
酸エチル(200ml×2)で抽出した。抽出液を水お
よび飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(トルエン:ヘキサン=1:1−トルエン)で
精製し、ジイソプロピルエーテル−ヘキサンから再結晶
させて3-(4-フルオロフェニル)-2-((3-フルオ
ロ-4-(トリフルオロメチル)フェニル)メチル)-3-
オキソプロピオン酸エチル(10.8g,66%)を得
た。 mp 56-57℃ IRνmaxKBrcm-1: 1738, 1688, 1630, 1599, 1508. Anal. Calcd for C19H15O3F5: C, 59.07; H, 3.91 Found: C, 59.10; H, 3.68.1 H-NMR (CDCl3)δ: 1.13 (3H, t, J = 7.2 Hz), 3.37
(2H, d, J = 7.2 Hz), 4.12 (2H, q, J = 7.2 Hz), 4.5
7 (1H, t, J = 7.2 Hz), 7.02-7.20 (4H, m), 7.50 (1
H, t, J = 8.0 Hz), 7.96-8.10 (2H, m). 4) 塩化亜鉛(7.06g,51.8ミリモル)のジ
エチルエーテル(100ml)溶液に水素化ホウ素ナト
リウム(3.92g,103.5ミリモル)を加えて室
温で30分攪拌した。不溶物をろ去し、ろ液に3-(4-
フルオロフェニル)-2-((3-フルオロ-4-(トリフ
ルオロメチル)フェニル)メチル)-3-オキソプロピオ
ン酸エチル(10g,25.9ミリモル)のジエチルエ
ーテル(50ml)溶液を加えて室温で30分攪拌し
た。氷冷下、反応液に1規定塩酸を加えてクエンチし、
更に水(200ml)を加え、酢酸エチル(300ml
×2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(酢酸エチ
ル)で精製し、(2RS,3RS)-3-(4-フルオロ
フェニル)-2-((3-フルオロ-4-(トリフルオロメ
チル)フェニル)メチル)-3-ヒドロキシプロピオン酸
エチル(10.0g,99%)を無色油状物として得
た。 IRνmaxKBrcm-1: 1715, 1632, 1607, 1584. Anal. Calcd for C19H17O3F5: C, 58.77; H, 4.41 Found: C, 58.54; H, 4.51.1 H-NMR (CDCl3)δ: 0.95 (3H, t, J = 7.2 Hz), 2.86-
3.10 (4H, m), 3.91 (2H,q, J = 7.2 Hz), 4.98-5.06
(1H, m), 6.90-7.10 (4H, m), 7.30-7.50 (3H, m). 5) (2RS,3RS)-3-(4-フルオロフェニ
ル)-2-((3-フルオロ-4-(トリフルオロメチル)
フェニル)メチル)-3-ヒドロキシプロピオン酸エチル
(9.9g,25.5ミリモル)のメタノール(40m
l)溶液に、2規定水酸化ナトリウム水溶液(25.5
ml,51.0ミリモル)を加えて室温で終夜攪拌し
た。反応液を1規定塩酸で酸性とした後、酢酸エチル
(200ml×2)で抽出した。抽出液を水および飽和
食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留
去した。残留物を酢酸エチル−ヘキサンから再結晶させ
て(2RS,3RS)-3-(4-フルオロフェニル)-2
-((3-フルオロ-4-(トリフルオロメチル)フェニ
ル)メチル)-3-ヒドロキシプロピオン酸(8.3g,
90%)を得た。 mp 74-75℃ IRνmaxKBrcm-1: 1713, 1632, 1607, 1586, 1512, 143
5.1 H-NMR (CDCl3)δ: 2.80-3.16 (3H, m), 5.09 (1H, d,
J = 4.2 Hz), 6.88-7.12(4H, m), 7.30-7.52 (3H, m). 6) (2RS,3RS)-3-(4-フルオロフェニ
ル)-2-((3-フルオロ-4-(トリフルオロメチル)
フェニル)メチル)-3-ヒドロキシプロピオン酸(7.
0g,19.4ミリモル)のテトラヒドロフラン(18
0ml)溶液に、ジフェニルホスホリルアジド(4.6
ml,21.4ミリモル)とトリエチルアミン(4.1
ml,29.2ミリモル)を加え、6時間加熱還流し
た。反応液を放冷後、水(200ml)を加えて酢酸エ
チル(200ml×2)で抽出した。抽出液を1規定塩
酸、飽和重曹水、飽和食塩水で順次洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(酢酸エチル)で精製し、残
留物を酢酸エチル−ヘキサンから再結晶させて(4R
S,5SR)-5-(4-フルオロフェニル)-4-((3-
フルオロ-4-(トリフルオロメチル)フェニル)メチ
ル)-1,3-オキサゾリジン-2-オン(5.26g,7
6%)を得た。 mp 122-123℃ IRνmaxKBrcm-1: 1759, 1632, 1611, 1586, 1514, 143
5. Anal. Calcd for C17H12O2F5N: C, 57.15; H, 3.39; N,
3.92 Found: C, 57.18; H, 3.39; N, 3.75.1 H-NMR (CDCl3)δ: 2.35 (2H, d, J = 7.4 Hz), 4.22-
4.36 (1H, m), 5.44 (1H,s), 5.80 (1H, d, J = 7.8 H
z), 6.80-6.96 (2H, m), 7.04-7.20 (2H, m), 7.22-7.4
2 (2H, m), 7.46-8.00 (1H, m). 7) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((3-フルオロ-4-(トリフルオロメチル)
フェニル)メチル)-1,3-オキサゾリジン-2-オン
(4.0g,11.2ミリモル)のエタノール(70m
l)溶液に8規定水酸化ナトリウム水溶液(7.0m
l,56ミリモル)を加え、6時間加熱還流した。反応
液を濃縮後、水(300ml)で希釈し、酢酸エチル
(300ml×2)で抽出した。抽出液を飽和食塩水で
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去した。
残留物を酢酸エチル−ヘキサンから再結晶させて、(1
RS,2SR)-2-アミノ-1-(4-フルオロフェニ
ル)-3-(3-フルオロ-4-(トリフルオロメチル)フ
ェニル)-1-プロパノール(3.21g,87%)を得
た。 mp 86-87℃ IRνmaxKBrcm-1: 1630, 1590, 1508, 1433, 1331. Anal. Calcd for C16H14F5NO: C, 58.01; H, 4.26; N,
4.23 Found: C, 58.02; H, 4.29; N, 4.00.1 H-NMR (CDCl3)δ: 2.44 (1H, dd, J = 13.6, 10.2 H
z), 2.87 (1H, dd, J = 13.6, 2.6 Hz), 3.22-3.36 (1
H, m), 4.64 (1H, d, J = 5.2 Hz), 6.96-7.16 (4H,m),
7.30-7.42 (2H, m), 7.44-7.58 (1H, m). 8) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(3-フルオロ-4-(トリフルオロメ
チル)フェニル)-1-プロパノール(400mg,1.
21ミリモル)のアセトニトリル(30ml)溶液に4
-フルオロナフタレンカルボン酸(230mg,1.2
1ミリモル)および1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド・塩酸塩(347mg,1.
81ミリモル)および1-ヒドロキシ-1H-ベンゾトリ
アゾール(185mg,1.21ミリモル)を加えて室
温で終夜攪拌した。反応液を水(100ml)で希釈
し、酢酸エチル(100ml×2)で抽出した。抽出液
を1規定塩酸、1規定水酸化ナトリウム水溶液、飽和食
塩水で順次洗浄し、無水硫酸マグネシウムで乾燥後減圧
留去した。残留物を酢酸エチル−ヘキサンから再結晶さ
せて、表題化合物(525mg,86%)を得た。 mp 212-213℃ IRνmaxKBrcm-1: 1640, 1626, 1599, 1514, 1435, 132
5. Anal. Calcd for C27H19F6NO2・0.1H2O: C, 64.19; H,
3.83; N, 2.77 Found: C, 63.97; H, 3.83; N, 2.52.1 H-NMR (CDCl3)δ: 2.82-3.16 (3H, m), 4.70-4.90 (1
H, m), 5.12 (1H, d, J =3.6 Hz), 6.05 (1H, d, J =
8.8 Hz), 7.00-7.30 (6H, m), 7.40-7.62 (5H, m), 7.7
2 (1H, d, J = 8.0 Hz), 8.11 (1H, d, J = 7.8 Hz).Example 156 N-((1RS, 2SR) -2- (4-fluorophenyl)
-1-((3-Fluoro-4- (trifluoromethyl) phenyl) methyl) -2-hydroxyethyl) -4-fluoro-
1-Naphthalenecarboxamide 1) To a solution of 3-fluoro-4- (trifluoromethyl) benzoic acid (10.5 g, 50.7 mmol) in tetrahydrofuran (30 ml) was added a 1M borane solution in tetrahydrofuran (63 ml, 63 mmol) and room temperature. For 8 hours. 1N hydrochloric acid (100 ml) was added to the reaction solution,
Extracted with ethyl acetate (300 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate), and 3-fluoro-4- (trifluoromethyl) benzyl alcohol (10.3 g, 90
% Purity, 94%). 1 H-NMR (CDCl 3 ) δ: 1.91 (1H, t, J = 5.4 Hz), 4.78
(2H, d, J = 5.4 Hz), 7.16-7.30 (2H, m), 7.59 (1H,
t, J = 7.6 Hz). 2) Thionyl chloride (18.5 ml, 25 ml) was added to a solution of 3-fluoro-4- (trifluoromethyl) benzyl alcohol (10 g, 52 mmol) in chloroform (20 ml).
(7 mmol) and heated to reflux for 4 hours. After concentrating the reaction solution, the residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to obtain 3-fluoro-4- (trifluoromethyl) benzyl chloride (9.52 g, 87%). Was. IRνmax KBr cm -1: 1634, 1589 , 1512, 1435. 1 H-NMR (CDCl 3) δ: 4.58 (2H, s), 7.20-7.32 (2H, m),
7.60 (1H, t, J = 7.6 Hz). 3) 1,2-Ethyl 3- (4-fluorophenyl) -3-oxopropionate (8.9 g, 42.3 mmol)
Sodium hydride (60% oily, 1.69 g, 42.3 mmol) was added to a dimethoxyethane (50 ml) solution under ice-cooling, and the mixture was stirred at room temperature for 30 minutes. A solution of 3-fluoro-4- (trifluoromethyl) benzyl bromide (9.0 g, 42.3 mmol) in 1,2-dimethoxyethane (50 ml) was added dropwise to the reaction solution, and the reaction solution was allowed to stand at room temperature for 3 hours. Stirred. The reaction solution was poured into water (200 ml) and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene: hexane = 1: 1-toluene) and recrystallized from diisopropyl ether-hexane to give 3- (4-fluorophenyl) -2-((3-fluoro-4- (Trifluoromethyl) phenyl) methyl) -3-
Ethyl oxopropionate (10.8 g, 66%) was obtained. mp 56-57 ℃ IRνmax KBr cm -1 : 1738, 1688, 1630, 1599, 1508. Anal.Calcd for C 19 H 15 O 3 F 5 : C, 59.07; H, 3.91 Found: C, 59.10; H, 3.68 . 1 H-NMR (CDCl 3 ) δ: 1.13 (3H, t, J = 7.2 Hz), 3.37
(2H, d, J = 7.2 Hz), 4.12 (2H, q, J = 7.2 Hz), 4.5
7 (1H, t, J = 7.2 Hz), 7.02-7.20 (4H, m), 7.50 (1
H, t, J = 8.0 Hz), 7.96-8.10 (2H, m). 4) To a solution of zinc chloride (7.06 g, 51.8 mmol) in diethyl ether (100 ml) was added sodium borohydride (3.92 g, (103.5 mmol) and stirred at room temperature for 30 minutes. The insoluble material was removed by filtration, and the filtrate was added with 3- (4-
A solution of ethyl fluorophenyl) -2-((3-fluoro-4- (trifluoromethyl) phenyl) methyl) -3-oxopropionate (10 g, 25.9 mmol) in diethyl ether (50 ml) was added, and the mixture was added at room temperature. Stir for 30 minutes. Under ice cooling, the reaction solution is quenched by adding 1N hydrochloric acid,
Further, water (200 ml) was added, and ethyl acetate (300 ml) was added.
× 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) to give (2RS, 3RS) -3- (4-fluorophenyl) -2-((3-fluoro-4- (trifluoromethyl) phenyl) methyl)- Ethyl 3-hydroxypropionate (10.0 g, 99%) was obtained as a colorless oil. . IRνmax KBr cm -1: 1715, 1632, 1607, 1584. Anal Calcd for C 19 H 17 O 3 F 5: C, 58.77; H, 4.41 Found:. C, 58.54; H, 4.51 1 H-NMR (CDCl 3 ) δ: 0.95 (3H, t, J = 7.2 Hz), 2.86-
3.10 (4H, m), 3.91 (2H, q, J = 7.2 Hz), 4.98-5.06
(1H, m), 6.90-7.10 (4H, m), 7.30-7.50 (3H, m). 5) (2RS, 3RS) -3- (4-fluorophenyl) -2-((3-fluoro-4 -(Trifluoromethyl)
Ethyl (phenyl) methyl) -3-hydroxypropionate (9.9 g, 25.5 mmol) in methanol (40 m
l) Add 2N aqueous sodium hydroxide solution (25.5
ml, 51.0 mmol) and stirred overnight at room temperature. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (2RS, 3RS) -3- (4-fluorophenyl) -2.
-((3-Fluoro-4- (trifluoromethyl) phenyl) methyl) -3-hydroxypropionic acid (8.3 g,
90%). mp 74-75 ℃ IRνmax KBr cm -1 : 1713, 1632, 1607, 1586, 1512, 143
5. 1 H-NMR (CDCl 3 ) δ: 2.80-3.16 (3H, m), 5.09 (1H, d,
J = 4.2 Hz), 6.88-7.12 (4H, m), 7.30-7.52 (3H, m). 6) (2RS, 3RS) -3- (4-fluorophenyl) -2-((3-fluoro-4 -(Trifluoromethyl)
(Phenyl) methyl) -3-hydroxypropionic acid (7.
0 g, 19.4 mmol) of tetrahydrofuran (18
0 ml) solution in diphenylphosphoryl azide (4.6).
ml, 21.4 mmol) and triethylamine (4.1
ml, 29.2 mmol) and heated to reflux for 6 hours. After allowing the reaction solution to cool, water (200 ml) was added, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate), and the residue was recrystallized from ethyl acetate-hexane (4R
S, 5SR) -5- (4-fluorophenyl) -4-((3-
Fluoro-4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2-one (5.26 g, 7
6%). mp 122-123 ℃ IRνmax KBr cm -1 : 1759, 1632, 1611, 1586, 1514, 143
. 5. Anal Calcd for C 17 H 12 O 2 F 5 N: C, 57.15; H, 3.39; N,
3.92 Found:. C, 57.18; H, 3.39; N, 3.75 1 H-NMR (CDCl 3) δ: 2.35 (2H, d, J = 7.4 Hz), 4.22-
4.36 (1H, m), 5.44 (1H, s), 5.80 (1H, d, J = 7.8 H
z), 6.80-6.96 (2H, m), 7.04-7.20 (2H, m), 7.22-7.4
2 (2H, m), 7.46-8.00 (1H, m). 7) (4RS, 5SR) -5- (4-fluorophenyl) -4-((3-fluoro-4- (trifluoromethyl)
Phenyl) methyl) -1,3-oxazolidin-2-one (4.0 g, 11.2 mmol) in ethanol (70 m
l) 8N aqueous sodium hydroxide solution (7.0 m
(1, 56 mmol) and heated to reflux for 6 hours. After concentration, the reaction solution was diluted with water (300 ml) and extracted with ethyl acetate (300 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was recrystallized from ethyl acetate-hexane to give (1
RS, 2SR) -2-Amino-1- (4-fluorophenyl) -3- (3-fluoro-4- (trifluoromethyl) phenyl) -1-propanol (3.21 g, 87%) was obtained. mp 86-87 ℃ IRνmax KBr cm -1 : 1630, 1590, 1508, 1433, 1331. Anal.Calcd for C 16 H 14 F 5 NO: C, 58.01; H, 4.26; N,
4.23 Found:. C, 58.02; H, 4.29; N, 4.00 1 H-NMR (CDCl 3) δ: 2.44 (1H, dd, J = 13.6, 10.2 H
z), 2.87 (1H, dd, J = 13.6, 2.6 Hz), 3.22-3.36 (1
H, m), 4.64 (1H, d, J = 5.2 Hz), 6.96-7.16 (4H, m),
7.30-7.42 (2H, m), 7.44-7.58 (1H, m). 8) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (3-fluoro-4- (tri (Fluoromethyl) phenyl) -1-propanol (400 mg, 1.
21 mmol) in acetonitrile (30 ml) solution.
-Fluoronaphthalenecarboxylic acid (230 mg, 1.2
1 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (347 mg, 1.
81 mmol) and 1-hydroxy-1H-benzotriazole (185 mg, 1.21 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (525 mg, 86%). mp 212-213 ° C IRνmax KBr cm -1 : 1640, 1626, 1599, 1514, 1435, 132
5. Anal.Calcd for C 27 H 19 F 6 NO 2・ 0.1H 2 O: C, 64.19; H,
3.83; N, 2.77 Found:. C, 63.97; H, 3.83; N, 2.52 1 H-NMR (CDCl 3) δ: 2.82-3.16 (3H, m), 4.70-4.90 (1
H, m), 5.12 (1H, d, J = 3.6 Hz), 6.05 (1H, d, J =
8.8 Hz), 7.00-7.30 (6H, m), 7.40-7.62 (5H, m), 7.7
2 (1H, d, J = 8.0 Hz), 8.11 (1H, d, J = 7.8 Hz).
【0289】実施例157 N-((1RS,2SR)-2-(4-フルオロフェニル)
-1-((3-フルオロ-4-(トリフルオロメチル)フェ
ニル)メチル)-2-ヒドロキシエチル)-3-フェニルプ
ロパンアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(3-フルオロ-4-(トリフルオロメチル)
フェニル)-1-プロパノール(400mg,1.21ミ
リモル)の酢酸エチル(20ml)溶液に3-フェニル
プロピオニルクロリド(269ml,1.81ミリモ
ル)および飽和重曹水(20ml)を加えて室温で終夜
攪拌した。反応液を水(100ml)で希釈し、酢酸エ
チル(100ml×2)で抽出した。抽出液を飽和食塩
水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて表
題化合物(486mg,87%)を得た。 mp 126-127℃ IRνmaxKBrcm-1: 1632, 1510, 1435, 1325. Anal. Calcd for C25H22F5NO2: C, 64.79; H, 4.78; N,
3.02 Found: C, 64.61; H, 4.77; N, 2.80.1 H-NMR (CDCl3)δ: 2.32-2.44 (2H, m), 2.58-2.80 (2
H, m), 2.88 (2H, t, J =7.4 Hz), 3.00 (1H, d, J =
4.2 Hz), 4.26-4.42 (1H, m), 4.76-4.84 (1H, m), 5.3
8 (1H, d, J = 8.4 Hz), 6.78-6.90 (2H, m), 7.00-7.5
0 (10H, m).Example 157 N-((1RS, 2SR) -2- (4-fluorophenyl)
-1-((3-Fluoro-4- (trifluoromethyl) phenyl) methyl) -2-hydroxyethyl) -3-phenylpropanamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (3-Fluoro-4- (trifluoromethyl)
To a solution of (phenyl) -1-propanol (400 mg, 1.21 mmol) in ethyl acetate (20 ml) were added 3-phenylpropionyl chloride (269 ml, 1.81 mmol) and saturated aqueous sodium hydrogen carbonate (20 ml), and the mixture was stirred at room temperature overnight. . The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (486 mg, 87%). mp 126-127 ℃ IRνmax KBr cm -1 : 1632, 1510, 1435, 1325. Anal.Calcd for C 25 H 22 F 5 NO 2 : C, 64.79; H, 4.78; N,
3.02 Found:. C, 64.61; H, 4.77; N, 2.80 1 H-NMR (CDCl 3) δ: 2.32-2.44 (2H, m), 2.58-2.80 (2
H, m), 2.88 (2H, t, J = 7.4 Hz), 3.00 (1H, d, J =
4.2 Hz), 4.26-4.42 (1H, m), 4.76-4.84 (1H, m), 5.3
8 (1H, d, J = 8.4 Hz), 6.78-6.90 (2H, m), 7.00-7.5
0 (10H, m).
【0290】実施例158 4-フルオロ-N-((1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-((4-(フェニルオ
キシ)フェニル)メチル)エチル)-1-ナフタレンカル
ボキサミド 1) 4-(フェニルオキシ)安息香酸(10.4g,
48.7ミリモル)のテトラヒドロフラン(30ml)
溶液にボラン1Mテトラヒドロフラン溶液(63ml,
63ミリモル)を室温で加え、終夜攪拌した。反応液に
1N塩酸を加えクエンチし、酢酸エチル(100ml×
2)で抽出した。抽出液を水、飽和食塩水で順次洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(酢酸エチ
ル)で精製し、ヘキサンより再結晶させて、(4-(フ
ェニルオキシ)フェニル)メタノール(8.51g,8
7%)を得た。 mp 48-49℃ IRνmaxKBrcm-1: 1590, 1507, 1489, 1240. Anal. Calcd for C13H12O2: C, 77.98; H, 6.04 Found: C, 77.94; H, 5.74.1 H-NMR (CDCl3)δ: 1.67 (1H, brs), 4.67 (2H, d, J =
4.0 Hz), 6.96-7.18 (5H, m), 7.22-7.40 (4H, m). 2) (4-(フェニルオキシ)フェニル)メタノール
(8g,40.0ミリモル)のクロロホルム(20m
l)溶液に塩化チオニル(36ml,500ミリモル)
を加え、終夜加熱還流した。反応液を濃縮後、残留物を
シリカゲルカラムクロマトグラフィー(酢酸エチル)で
精製し、1-(クロロメチル)-4-(フェニルオキシ)
ベンゼン(8.1g,93%)を得た。 IRνmaxKBrcm-1: 1590, 1507, 1489, 1240.1 H-NMR (CDCl3)δ: 3.93 (1H, brs), 4.57 (2H, s), 6.
80-7.40 (9H, m). 3) 3-(4-フルオロフェニル)-3-オキソプロピオ
ン酸エチル(6.49g,30.9ミリモル)の1,2
-ジメトキシエタン(50ml)溶液に水素化ナトリウ
ム(60%油性,1.23g,30.9ミリモル)を氷
冷下加え、室温で30分攪拌した。反応液の中に1-
(クロロメチル)-4-(フェニルオキシ)ベンゼン
(8.1g,37.0ミリモル)の1,2-ジメトキシ
エタン(50ml)溶液を滴下し、反応液を終夜加熱還
流した。反応液を水(200ml)の中に注ぎ、酢酸エ
チル(200ml×2)で抽出した。抽出液を水および
飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減
圧留去した。残留物をシリカゲルカラムクロマトグラフ
ィー(トルエン:ヘキサン=1:1−トルエン)で精製
し、3-(4-フルオロフェニル)-3-オキソ-2-((4
-(フェニルオキシ)フェニル)メチル)プロピオン酸
エチル(7.76g,crude,64%)を得た。1 H-NMR (CDCl3)δ: 1.14 (3H, t, J = 7.4 Hz), 3.30
(2H, d, J = 7.6 Hz), 4.12 (2H, q, J = 7.4 Hz), 4.5
6 (1H, t, J = 7.6 Hz), 6.80-7.40 (11H, m), 7.90-8.
08 (2H, m). 4) 塩化亜鉛(5.39g,39.6ミリモル)のジ
エチルエーテル(100ml)溶液に水素化ホウ素ナト
リウム(3.00g,79.1ミリモル)を加えて室温
で30分攪拌した。不溶物をろ去し、ろ液に3-(4-フ
ルオロフェニル)-3-オキソ-2-((4-(フェニルオ
キシ)フェニル)メチル)プロピオン酸エチル(7.7
6g,19.8ミリモル)のジエチルエーテル(50m
l)溶液を加えて室温で30分攪拌した。氷冷下、反応
液に1規定塩酸を加えてクエンチし、更に水(200m
l)を加え、酢酸エチル(300ml×2)で抽出し
た。抽出液を水および飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(ヘキサン:酢酸エチル=
4:1−1:1)で精製し、(2RS,3RS)-3-
(4-フルオロフェニル)-3-ヒドロキシ-2-((4-
(フェニルオキシ)フェニル)メチル)プロピオン酸エ
チル(6.66g,85%)を無色油状物として得た。 IRνmaxKBrcm-1: 1726, 1590, 1507, 1489.1 H-NMR (CDCl3)δ: 0.97 (3H, t, J = 7.0 Hz), 2.90-
3.00 (4H, m), 3.91 (2H,q, J = 7.0 Hz), 5.00 (1H, b
rs), 6.82-7.20 (9H, m), 7.24-7.42 (4H, m). 5) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((4-(フェニルオキシ)フ
ェニル)メチル)プロピオン酸エチル(6.6g,1
6.7ミリモル)のメタノール(30ml)溶液に、2
規定水酸化ナトリウム水溶液(16.7ml,33.4
ミリモル)を加えて室温で終夜攪拌した。反応液を1規
定塩酸で酸性とした後、酢酸エチル(200ml×2)
で抽出した。抽出液を水および飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=1:1)で精製し(2RS,3RS)-3-(4-
フルオロフェニル)-3-ヒドロキシ-2-((4-(フェ
ニルオキシ)フェニル)メチル)プロピオン酸(5.8
g,95%)を得た。 IRνmaxKBrcm-1: 1713, 1590. Anal. Calcd for C22H19FO4: C, 72.12; H, 5.23 Found: C, 72.20; H, 5.23.1 H-NMR (CDCl3)δ: 2.90-3.08 (3H, m), 3.92 (1H, s),
5.05 (1H, d, J = 4.4Hz), 6.80-7.20 (9H, m), 7.30-
7.44 (4H, m). 6) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((4-(フェニルオキシ)フ
ェニル)メチル)プロピオン酸(5.5g,15.0ミ
リモル)のテトラヒドロフラン(150ml)溶液に、
ジフェニルホスホリルアジド(3.56ml,16.5
ミリモル)とトリエチルアミン(3.15ml,22.
5ミリモル)を加え、4時間加熱還流した。反応液を放
冷後、水(200ml)を加えて酢酸エチル(200m
l×2)で抽出した。抽出液を1規定塩酸、飽和重曹
水、飽和食塩水で順次洗浄し、無水硫酸マグネシウムで
乾燥後減圧留去した。残留物をシリカゲルカラムクロマ
トグラフィー(ヘキサン:酢酸エチル=4:1−1:
1)で精製し、酢酸エチル−ヘキサンより再結晶させ
て、(4RS,5SR)-5-(4-フルオロフェニル)-
4-((4-(フェニルオキシ)フェニル)メチル)-
1,3-オキサゾリジン-2-オン(3.74g,69
%)を得た。 mp 144-145℃ IRνmaxKBrcm-1: 1755, 1590, 1505.1 H-NMR (CDCl3)δ: 2.16-2.30 (2H, m), 4.16-4.30 (1
H, m), 5.14 (1H, s), 5.79 (1H, d, J = 8.0 Hz), 6.8
0-7.42 (13H, m). 7) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((4-(フェニルオキシ)フェニル)メチ
ル)-1,3-オキサゾリジン-2-オン(2.5g,6.
88ミリモル)のエタノール(20ml)溶液に8規定
水酸化ナトリウム水溶液(4.30ml,34.4ミリ
モル)を加え、6時間加熱還流した。反応液を濃縮後、
水(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去し、(1RS,2S
R)-2-アミノ-1-(4-フルオロフェニル)-3-(4-
(フェニルオキシ)フェニル)-1-プロパノール(2.
2g,95%)を得た。 IRνmaxKBrcm-1: 1590, 1507, 1489, 1238.1 H-NMR (CDCl3)δ: 2.00-2.40 (2H, m), 3.93 (1H, s),
5.11 (1H, d, J = 7.4Hz), 6.80-7.40 (13H, m). 8) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(4-(フェニルオキシ)フェニル)-
1-プロパノール(353mg,1.05ミリモル)の
アセトニトリル(20ml)溶液に4-フルオロナフタ
レンカルボン酸(200mg,1.05ミリモル)およ
び1-エチル-3-(3-ジメチルアミノプロピル)カルボ
ジイミド・塩酸塩(302mg,1.58ミリモル)お
よび1-ヒドロキシ-1H-ベンゾトリアゾール(161
mg,1.05ミリモル)を加えて室温で終夜攪拌し
た。反応液を水(100ml)で希釈し、酢酸エチル
(100ml×2)で抽出した。抽出液を1規定塩酸、
1規定水酸化ナトリウム水溶液、飽和食塩水で順次洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=4:1−1:1)で精製し、酢酸エチル−
ヘキサンから再結晶させて、表題化合物(166mg,
31%)を得た。 mp 104-105℃ IRνmaxKBrcm-1: 1644, 1626, 1601, 1590, 1507, 148
9.1 H-NMR (CDCl3)δ: 2.75 (1H, dd, J = 14.4, 11.0 H
z), 3.06 (1H, dd, J = 14.4, 4.0 Hz), 3.64-3.70 (1
H, m), 4.70-4.88 (1H, m), 5.04-5.12 (1H, m), 5.90
(1H, d, J = 8.4 Hz), 6.90-7.60 (17H, m), 7.78-7.86
(1H, m), 8.09 (1H,d, J = 7.8 Hz).Example 158 4-Fluoro-N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-((4- (phenyloxy) phenyl) methyl) ethyl) -1 -Naphthalenecarboxamide 1) 4- (phenyloxy) benzoic acid (10.4 g,
48.7 mmol) in tetrahydrofuran (30 ml)
A borane 1M tetrahydrofuran solution (63 ml,
63 mmol) at room temperature and stirred overnight. The reaction solution is quenched by adding 1N hydrochloric acid, and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed successively with water and saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from hexane to give (4- (phenyloxy) phenyl) methanol (8.51 g, 8
7%). . mp 48-49 ℃ IRνmax KBr cm -1 : 1590, 1507, 1489, 1240. Anal Calcd for C 13 H 12 O 2: C, 77.98; H, 6.04 Found:. C, 77.94; H, 5.74 1 H- NMR (CDCl 3 ) δ: 1.67 (1H, brs), 4.67 (2H, d, J =
4.0 Hz), 6.96-7.18 (5H, m), 7.22-7.40 (4H, m). 2) (4- (phenyloxy) phenyl) methanol (8 g, 40.0 mmol) in chloroform (20 m
1) Thionyl chloride (36 ml, 500 mmol) was added to the solution.
Was added and heated to reflux overnight. After concentrating the reaction solution, the residue was purified by silica gel column chromatography (ethyl acetate), and 1- (chloromethyl) -4- (phenyloxy)
Benzene (8.1 g, 93%) was obtained. IRνmax KBr cm -1: 1590, 1507 , 1489, 1240. 1 H-NMR (CDCl 3) δ: 3.93 (1H, brs), 4.57 (2H, s), 6.
80-7.40 (9H, m). 3) 1,3-Ethyl 3- (4-fluorophenyl) -3-oxopropionate (6.49 g, 30.9 mmol)
To a solution of -dimethoxyethane (50 ml) was added sodium hydride (60% oily, 1.23 g, 30.9 mmol) under ice-cooling, and the mixture was stirred at room temperature for 30 minutes. 1- in the reaction solution
A solution of (chloromethyl) -4- (phenyloxy) benzene (8.1 g, 37.0 mmol) in 1,2-dimethoxyethane (50 ml) was added dropwise, and the reaction solution was heated to reflux overnight. The reaction solution was poured into water (200 ml) and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene: hexane = 1: 1-toluene) to give 3- (4-fluorophenyl) -3-oxo-2-((4
Ethyl (-(phenyloxy) phenyl) methyl) propionate (7.76 g, crude, 64%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.14 (3H, t, J = 7.4 Hz), 3.30
(2H, d, J = 7.6 Hz), 4.12 (2H, q, J = 7.4 Hz), 4.5
6 (1H, t, J = 7.6 Hz), 6.80-7.40 (11H, m), 7.90-8.
08 (2H, m). 4) Sodium borohydride (3.00 g, 79.1 mmol) was added to a solution of zinc chloride (5.39 g, 39.6 mmol) in diethyl ether (100 ml), and the mixture was added at room temperature for 30 minutes. Stirred. The insoluble material was removed by filtration, and the filtrate was added with ethyl 3- (4-fluorophenyl) -3-oxo-2-((4- (phenyloxy) phenyl) methyl) propionate (7.7).
6 g, 19.8 mmol) of diethyl ether (50 m
l) The solution was added and stirred at room temperature for 30 minutes. Under ice-cooling, the reaction solution was quenched by adding 1N hydrochloric acid, and further added with water (200 m 2).
1) and extracted with ethyl acetate (300 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
4: 1-1: 1), and purified by (2RS, 3RS) -3-
(4-fluorophenyl) -3-hydroxy-2-((4-
Ethyl (phenyloxy) phenyl) methyl) propionate (6.66 g, 85%) was obtained as a colorless oil. IRνmax KBr cm -1 : 1726, 1590, 1507, 1489. 1 H-NMR (CDCl 3 ) δ: 0.97 (3H, t, J = 7.0 Hz), 2.90-
3.00 (4H, m), 3.91 (2H, q, J = 7.0 Hz), 5.00 (1H, b
rs), 6.82-7.20 (9H, m), 7.24-7.42 (4H, m). 5) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((4- (phenyl Ethyl oxy) phenyl) methyl) propionate (6.6 g, 1
6.7 mmol) in methanol (30 ml).
Normal sodium hydroxide aqueous solution (16.7 ml, 33.4
Mmol) and stirred overnight at room temperature. The reaction solution was acidified with 1N hydrochloric acid, and then ethyl acetate (200 ml × 2).
Extracted. The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1) to give (2RS, 3RS) -3- (4-)
Fluorophenyl) -3-hydroxy-2-((4- (phenyloxy) phenyl) methyl) propionic acid (5.8
g, 95%). . IRνmax KBr cm -1: 1713, 1590. Anal Calcd for C 22 H 19 FO 4: C, 72.12; H, 5.23 Found:. C, 72.20; H, 5.23 1 H-NMR (CDCl 3) δ: 2.90- 3.08 (3H, m), 3.92 (1H, s),
5.05 (1H, d, J = 4.4Hz), 6.80-7.20 (9H, m), 7.30-
7.44 (4H, m). 6) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((4- (phenyloxy) phenyl) methyl) propionic acid (5.5 g, 15 2.0 mmol) in tetrahydrofuran (150 ml),
Diphenyl phosphoryl azide (3.56 ml, 16.5
Mmol) and triethylamine (3.15 ml, 22.
(5 mmol) and heated to reflux for 4 hours. After allowing the reaction solution to cool, water (200 ml) was added, and ethyl acetate (200 ml) was added.
1 × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 4: 1-1:
Purified in 1) and recrystallized from ethyl acetate-hexane to give (4RS, 5SR) -5- (4-fluorophenyl)-
4-((4- (phenyloxy) phenyl) methyl)-
1,3-Oxazolidin-2-one (3.74 g, 69
%). mp 144-145 ℃ IRνmax KBr cm -1: 1755, 1590, 1505. 1 H-NMR (CDCl 3) δ: 2.16-2.30 (2H, m), 4.16-4.30 (1
H, m), 5.14 (1H, s), 5.79 (1H, d, J = 8.0 Hz), 6.8
0-7.42 (13H, m). 7) (4RS, 5SR) -5- (4-fluorophenyl) -4-((4- (phenyloxy) phenyl) methyl) -1,3-oxazolidin-2-one (2.5 g, 6.
To a solution of 88 mmol) in ethanol (20 ml) was added an 8 N aqueous sodium hydroxide solution (4.30 ml, 34.4 mmol), and the mixture was heated under reflux for 6 hours. After concentrating the reaction solution,
Dilute with water (100ml) and add ethyl acetate (100ml x
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure to give (1RS, 2S
R) -2-Amino-1- (4-fluorophenyl) -3- (4-
(Phenyloxy) phenyl) -1-propanol (2.
2 g, 95%). IRνmax KBr cm -1: 1590, 1507 , 1489, 1238. 1 H-NMR (CDCl 3) δ: 2.00-2.40 (2H, m), 3.93 (1H, s),
5.11 (1H, d, J = 7.4 Hz), 6.80-7.40 (13H, m). 8) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4- (phenyloxy ) Phenyl)-
In a solution of 1-propanol (353 mg, 1.05 mmol) in acetonitrile (20 ml), 4-fluoronaphthalenecarboxylic acid (200 mg, 1.05 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (302 mg, 1.58 mmol) and 1-hydroxy-1H-benzotriazole (161
mg, 1.05 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). Extract solution is 1N hydrochloric acid,
The extract was washed successively with a 1N aqueous sodium hydroxide solution and a saturated saline solution, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Purification with ethyl acetate = 4: 1-1: 1)
Recrystallization from hexane gave the title compound (166 mg,
31%). mp 104-105 ℃ IRνmax KBr cm -1 : 1644, 1626, 1601, 1590, 1507, 148
9. 1 H-NMR (CDCl 3 ) δ: 2.75 (1H, dd, J = 14.4, 11.0 H
z), 3.06 (1H, dd, J = 14.4, 4.0 Hz), 3.64-3.70 (1
H, m), 4.70-4.88 (1H, m), 5.04-5.12 (1H, m), 5.90
(1H, d, J = 8.4 Hz), 6.90-7.60 (17H, m), 7.78-7.86
(1H, m), 8.09 (1H, d, J = 7.8 Hz).
【0291】実施例159 N-(1RS,2SR)-(2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-(フェニルオキシ)フェニ
ル)メチル)エチル)-3-フェニルプロパンアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(4-(フェニルオキシ)フェニル)-1-プ
ロパノール(550mg,1.63ミリモル)の酢酸エ
チル(20ml)溶液に3-フェニルプロピオニルクロ
リド(360ml,2.45ミリモル)および飽和重曹
水(20ml)を加えて室温で終夜攪拌した。反応液を
水(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=4:1−1:1)で精製し、酢酸エチル−ヘキサンか
ら再結晶させて表題化合物(152mg,20%)を得
た。 mp 108-110℃ IRνmaxKBrcm-1: 1644, 1605, 1507, 1489.1 H-NMR (CDCl3)δ: 2.24-2.40 (2H, m), 2.40-3.00 (5
H, m), 4.30-4.44 (1H, m), 4.76-4.84 (1H, m), 5.69
(1H, d, J = 8.0 Hz), 6.80-7.36 (18H, m).Example 159 N- (1RS, 2SR)-(2- (4-fluorophenyl)
-2-Hydroxy-1-((4- (phenyloxy) phenyl) methyl) ethyl) -3-phenylpropanamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4 To a solution of-(phenyloxy) phenyl) -1-propanol (550 mg, 1.63 mmol) in ethyl acetate (20 ml) was added 3-phenylpropionyl chloride (360 ml, 2.45 mmol) and saturated aqueous sodium bicarbonate (20 ml). Stirred overnight at room temperature. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-1: 1), and recrystallized from ethyl acetate-hexane to obtain the title compound (152 mg, 20%). mp 108-110 ° C IRνmax KBr cm -1 : 1644, 1605, 1507, 1489. 1 H-NMR (CDCl 3 ) δ: 2.24-2.40 (2H, m), 2.40-3.00 (5
H, m), 4.30-4.44 (1H, m), 4.76-4.84 (1H, m), 5.69
(1H, d, J = 8.0 Hz), 6.80-7.36 (18H, m).
【0292】実施例160 4-フルオロ-N-((1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-((3-(フェニルオ
キシ)フェニル)メチル)エチル)-1-ナフタレンカル
ボキサミド 1) (3-(フェニルオキシ)フェニル)メタノール
(10g,49.4ミリモル)のクロロホルム(20m
l)溶液に塩化チオニル(36ml,500ミリモル)
を加え、終夜加熱還流した。反応液を濃縮後、残留物を
シリカゲルカラムクロマトグラフィー(酢酸エチル)で
精製し、1-(クロロメチル)-3-(フェニルオキシ)
ベンゼン(10.7g,98%)を得た。 IRνmaxKBrcm-1: 1584, 1487, 1445.1 H-NMR (CDCl3)δ: 4.53 (2H, s), 6.80-7.40 (9H, m). 2) 3-(4-フルオロフェニル)-3-オキソプロピオ
ン酸エチル(7.2g,34.3ミリモル)の1,2-
ジメトキシエタン(50ml)溶液に水素化ナトリウム
(60%油性,1.37g,34.3ミリモル)を氷冷
下加え、室温で30分攪拌した。反応液の中に1-(ク
ロロメチル)-3-(フェニルオキシ)ベンゼン(9.0
g,41.6ミリモル)の1,2-ジメトキシエタン
(50ml)溶液を滴下し、反応液を終夜加熱還流し
た。反応液を水(200ml)の中に注ぎ、酢酸エチル
(200ml×2)で抽出した。抽出液を水および飽和
食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留
去した。残留物をシリカゲルカラムクロマトグラフィー
(トルエン:ヘキサン=1:1−トルエン)で精製し、
3-(4-フルオロフェニル)-3-オキソ-2-((3-
(フェニルオキシ)フェニル)メチル)プロピオン酸エ
チル(10.2g,crude,76%)を得た。1 H-NMR (CDCl3)δ: 1.12 (3H, t, J = 7.0 Hz), 3.29
(2H, d, J = 7.2 Hz), 4.09 (2H, q, J = 7.0 Hz), 4.5
5 (1H, t, J = 7.2 Hz), 6.70-7.40 (11H, m), 7.90-8.
04 (2H, m). 3) 塩化亜鉛(7.08g,51.9ミリモル)のジ
エチルエーテル(100ml)溶液に水素化ホウ素ナト
リウム(3.93g,103.9ミリモル)を加えて室
温で30分攪拌した。不溶物をろ去し、ろ液に3-(4-
フルオロフェニル)-3-オキソ-2-((3-(フェニル
オキシ)フェニル)メチル)プロピオン酸エチル(1
0.2g,26.0ミリモル)のジエチルエーテル(5
0ml)溶液を加えて室温で30分攪拌した。氷冷下、
反応液に1規定塩酸を加えてクエンチし、更に水(20
0ml)を加え、酢酸エチル(300ml×2)で抽出
した。抽出液を水および飽和食塩水で洗浄し、無水硫酸
マグネシウムで乾燥後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(酢酸エチル)で精製し、
(2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-((3-(フェニルオキシ)フェニル)
メチル)プロピオン酸エチル(5.26g,51%)を
無色油状物として得た。 IRνmaxKBrcm-1: 1728, 1715, 1582, 1487.1 H-NMR (CDCl3)δ: 0.96 (3H, t, J = 7.2 Hz), 2.82-
3.04 (4H, m), 3.89 (2H,q, J = 7.2 Hz), 5.00 (1H, b
rs), 6.78-7.40 (13H, m). 4) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((3-(フェニルオキシ)フ
ェニル)メチル)プロピオン酸エチル(5.26g,1
3.3ミリモル)のメタノール(40ml)溶液に、2
規定水酸化ナトリウム水溶液(13.4ml,26.8
ミリモル)を加えて室温で終夜攪拌した。反応液を1規
定塩酸で酸性とした後、酢酸エチル(200ml×2)
で抽出した。抽出液を水および飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=1:1)で精製し(2RS,3RS)-3-(4-
フルオロフェニル)-3-ヒドロキシ-2-((3-(フェ
ニルオキシ)フェニル)メチル)プロピオン酸(2.3
1g,47%)を得た。 IRνmaxKBrcm-1: 1713, 1584, 1510, 1487.1 H-NMR (CDCl3)δ: 2.84-3.06 (4H, m), 5.04 (1H, d,
J = 4.4 Hz), 6.76-7.40(13H, m). 5) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((3-(フェニルオキシ)フ
ェニル)メチル)プロピオン酸(2.2g,6.00ミ
リモル)のテトラヒドロフラン(60ml)溶液に、ジ
フェニルホスホリルアジド(1.42ml,6.60ミ
リモル)とトリエチルアミン(1.26ml,9.00
ミリモル)を加え、4時間加熱還流した。反応液を放冷
後、水(200ml)を加えて酢酸エチル(200ml
×2)で抽出した。抽出液を1規定塩酸、飽和重曹水、
飽和食塩水で順次洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=4:1−1:1)で
精製し、(4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((3-(フェニルオキシ)フェニル)メチ
ル)-1,3-オキサゾリジン-2-オン(1.69g,7
7%)を得た。 IRνmaxKBrcm-1: 1759, 1608, 1584.1 H-NMR (CDCl3)δ: 2.10-2.32 (2H, m), 4.16-4.30 (1
H, m), 5.13 (1H, s), 5.77 (1H, d, J = 7.8 Hz), 6.6
0-7.40 (13H, m). 6) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((3-(フェニルオキシ)フェニル)メチ
ル)-1,3-オキサゾリジン-2-オン(877mg,
2.41ミリモル)のエタノール(10ml)溶液に8
規定水酸化ナトリウム水溶液(1.51ml,12.1
ミリモル)を加え、6時間加熱還流した。反応液を濃縮
後、水(100ml)で希釈し、酢酸エチル(100m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去し、(1RS,2
SR)-2-アミノ-1-(4-フルオロフェニル)-3-
(3-(フェニルオキシ)フェニル)-1-プロパノール
(831mg,100%)を得た。 IRνmaxKBrcm-1: 1582, 1507, 1487, 1445.1 H-NMR (CDCl3)δ: 2.31 (1H, dd, J = 13.6, 10.2 H
z), 2.75 (1H, dd, J = 13.6, 3.0 Hz), 3.18-3.36 (1
H, m), 4.65 (1H, d, J = 4.6 Hz), 6.78-7.40 (13H,
m). 7) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(3-(フェニルオキシ)フェニル)-
1-プロパノール(300mg,0.89ミリモル)の
アセトニトリル(20ml)溶液に4-フルオロナフタ
レンカルボン酸(169mg,0.89ミリモル)およ
び1-エチル-3-(3-ジメチルアミノプロピル)カルボ
ジイミド・塩酸塩(256mg,1.33ミリモル)お
よび1-ヒドロキシ-1H-ベンゾトリアゾール(136
mg,0.89ミリモル)を加えて室温で終夜攪拌し
た。反応液を水(100ml)で希釈し、酢酸エチル
(100ml×2)で抽出した。抽出液を1規定塩酸、
1規定水酸化ナトリウム水溶液、飽和食塩水で順次洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=4:1−1:1)で精製し、酢酸エチル−
ヘキサンから再結晶させて、表題化合物(148mg,
33%)を得た。 mp 120-121℃ IRνmaxKBrcm-1: 1642, 1626, 1601, 1584. Anal. Calcd for C32H25F2NO3: C, 75.43; H, 4.95; N,
2.75 Found: C, 75.33; H, 5.05; N, 2.54.1 H-NMR (CDCl3)δ: 2.73 (1H, dd, J = 14.4, 10.6 H
z), 3.02 (1H, dd, J = 14.4, 4.0 Hz), 3.60-3.64 (1
H, m), 4.66-4.82 (1H, m), 5.04-5.12 (1H, m), 5.87
(1H, d, J = 8.4 Hz), 6.80-7.36 (13H, m), 7.38-7.62
(4H, m), 7.81 (1H,d, J = 8.0 Hz), 8.09 (1H, d, J
= 7.8 Hz).Example 160 4-Fluoro-N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-((3- (phenyloxy) phenyl) methyl) ethyl) -1 -Naphthalenecarboxamide 1) (3- (phenyloxy) phenyl) methanol (10 g, 49.4 mmol) in chloroform (20 m
1) Thionyl chloride (36 ml, 500 mmol) was added to the solution.
Was added and heated to reflux overnight. After concentrating the reaction solution, the residue was purified by silica gel column chromatography (ethyl acetate), and 1- (chloromethyl) -3- (phenyloxy)
Benzene (10.7 g, 98%) was obtained. IRνmax KBr cm -1: 1584, 1487 , 1445. 1 H-NMR (CDCl 3) δ:. 4.53 (2H, s), 6.80-7.40 (9H, m) 2) 3- (4- fluorophenyl) -3 1,2-Ethyl-oxopropionate (7.2 g, 34.3 mmol)
Sodium hydride (60% oily, 1.37 g, 34.3 mmol) was added to a dimethoxyethane (50 ml) solution under ice-cooling, and the mixture was stirred at room temperature for 30 minutes. 1- (chloromethyl) -3- (phenyloxy) benzene (9.0
g, 41.6 mmol) in 1,2-dimethoxyethane (50 ml) was added dropwise and the reaction was heated to reflux overnight. The reaction solution was poured into water (200 ml) and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene: hexane = 1: 1-toluene),
3- (4-fluorophenyl) -3-oxo-2-((3-
Ethyl (phenyloxy) phenyl) methyl) propionate (10.2 g, crude, 76%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.12 (3H, t, J = 7.0 Hz), 3.29
(2H, d, J = 7.2 Hz), 4.09 (2H, q, J = 7.0 Hz), 4.5
5 (1H, t, J = 7.2 Hz), 6.70-7.40 (11H, m), 7.90-8.
04 (2H, m). 3) To a solution of zinc chloride (7.08 g, 51.9 mmol) in diethyl ether (100 ml) was added sodium borohydride (3.93 g, 103.9 mmol) and the mixture was added at room temperature for 30 minutes. Stirred. The insoluble material was removed by filtration, and the filtrate was added with 3- (4-
Ethyl fluorophenyl) -3-oxo-2-((3- (phenyloxy) phenyl) methyl) propionate (1
0.2 g, 26.0 mmol) of diethyl ether (5
0 ml) solution and stirred at room temperature for 30 minutes. below freezing,
The reaction solution is quenched by adding 1N hydrochloric acid, and further added with water (20 mL).
0 ml) and extracted with ethyl acetate (300 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate),
(2RS, 3RS) -3- (4-fluorophenyl) -3-
Hydroxy-2-((3- (phenyloxy) phenyl)
Ethyl (methyl) propionate (5.26 g, 51%) was obtained as a colorless oil. IRνmax KBr cm -1: 1728, 1715 , 1582, 1487. 1 H-NMR (CDCl 3) δ: 0.96 (3H, t, J = 7.2 Hz), 2.82-
3.04 (4H, m), 3.89 (2H, q, J = 7.2 Hz), 5.00 (1H, b
rs), 6.78-7.40 (13H, m). 4) Ethyl (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((3- (phenyloxy) phenyl) methyl) propionate (5.26 g, 1
3.3 mmol) in methanol (40 ml).
Normal sodium hydroxide aqueous solution (13.4 ml, 26.8)
Mmol) and stirred overnight at room temperature. The reaction solution was acidified with 1N hydrochloric acid, and then ethyl acetate (200 ml × 2).
Extracted. The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1) to give (2RS, 3RS) -3- (4-)
Fluorophenyl) -3-hydroxy-2-((3- (phenyloxy) phenyl) methyl) propionic acid (2.3
1 g, 47%). IRνmax KBr cm -1: 1713, 1584 , 1510, 1487. 1 H-NMR (CDCl 3) δ: 2.84-3.06 (4H, m), 5.04 (1H, d,
J = 4.4 Hz), 6.76-7.40 (13H, m). 5) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((3- (phenyloxy) phenyl) methyl) In a solution of propionic acid (2.2 g, 6.00 mmol) in tetrahydrofuran (60 ml), diphenylphosphoryl azide (1.42 ml, 6.60 mmol) and triethylamine (1.26 ml, 9.00 mmol).
(Mmol) was heated and refluxed for 4 hours. After allowing the reaction solution to cool, water (200 ml) was added, and ethyl acetate (200 ml) was added.
× 2). The extract was diluted with 1N hydrochloric acid, saturated aqueous sodium bicarbonate,
The extract was washed successively with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-1: 1) to give (4RS, 5SR) -5- (4-fluorophenyl) -4-((3- (phenyloxy) Phenyl) methyl) -1,3-oxazolidin-2-one (1.69 g, 7
7%). IRνmax KBr cm -1 : 1759, 1608, 1584. 1 H-NMR (CDCl 3 ) δ: 2.10-2.32 (2H, m), 4.16-4.30 (1
H, m), 5.13 (1H, s), 5.77 (1H, d, J = 7.8 Hz), 6.6
0-7.40 (13H, m). 6) (4RS, 5SR) -5- (4-fluorophenyl) -4-((3- (phenyloxy) phenyl) methyl) -1,3-oxazolidin-2-one (877 mg,
8 in a solution of 2.41 mmol) in ethanol (10 ml).
Normal aqueous sodium hydroxide solution (1.51 ml, 12.1
(Mmol) was heated and refluxed for 6 hours. After the reaction solution was concentrated, it was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure to give (1RS, 2
SR) -2-Amino-1- (4-fluorophenyl) -3-
(3- (Phenyloxy) phenyl) -1-propanol (831 mg, 100%) was obtained. IRνmax KBr cm -1: 1582, 1507 , 1487, 1445. 1 H-NMR (CDCl 3) δ: 2.31 (1H, dd, J = 13.6, 10.2 H
z), 2.75 (1H, dd, J = 13.6, 3.0 Hz), 3.18-3.36 (1
H, m), 4.65 (1H, d, J = 4.6 Hz), 6.78-7.40 (13H,
m). 7) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (3- (phenyloxy) phenyl)-
In a solution of 1-propanol (300 mg, 0.89 mmol) in acetonitrile (20 ml), 4-fluoronaphthalenecarboxylic acid (169 mg, 0.89 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (256 mg, 1.33 mmol) and 1-hydroxy-1H-benzotriazole (136
mg, 0.89 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). Extract solution is 1N hydrochloric acid,
The extract was washed successively with a 1N aqueous sodium hydroxide solution and a saturated saline solution, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Purification with ethyl acetate = 4: 1-1: 1)
Recrystallization from hexane gave the title compound (148 mg,
33%). mp 120-121 ℃ IRνmax KBr cm -1 : 1642, 1626, 1601, 1584. Anal.Calcd for C 32 H 25 F 2 NO 3 : C, 75.43; H, 4.95; N,
2.75 Found:. C, 75.33; H, 5.05; N, 2.54 1 H-NMR (CDCl 3) δ: 2.73 (1H, dd, J = 14.4, 10.6 H
z), 3.02 (1H, dd, J = 14.4, 4.0 Hz), 3.60-3.64 (1
H, m), 4.66-4.82 (1H, m), 5.04-5.12 (1H, m), 5.87
(1H, d, J = 8.4 Hz), 6.80-7.36 (13H, m), 7.38-7.62
(4H, m), 7.81 (1H, d, J = 8.0 Hz), 8.09 (1H, d, J
= 7.8 Hz).
【0293】実施例161 N-(1RS,2SR)-(2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((3-(フェニルオキシ)フェニ
ル)メチル)エチル)-3-フェニルプロパンアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(3-(フェニルオキシ)フェニル)-1-プ
ロパノール(550mg,1.63ミリモル)の酢酸エ
チル(20ml)溶液に3-フェニルプロピオニルクロ
リド(360ml,2.45ミリモル)および飽和重曹
水(20ml)を加えて室温で終夜攪拌した。反応液を
水(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=4:1−1:1)で精製し、酢酸エチル−ヘキサンか
ら再結晶させて表題化合物(422mg,55%)を得
た。 mp 91-93℃ IRνmaxKBrcm-1: 1645, 1584, 1510, 1487, 1447.1 H-NMR (CDCl3)δ: 2.22-2.90 (6H, m), 4.22-4.42 (1
H, m), 4.81 (1H, s), 5.30 (1H, d, J = 8.2 Hz), 6.6
2-7.40 (18H, m).Example 161 N- (1RS, 2SR)-(2- (4-fluorophenyl)
-2-Hydroxy-1-((3- (phenyloxy) phenyl) methyl) ethyl) -3-phenylpropanamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (3 To a solution of-(phenyloxy) phenyl) -1-propanol (550 mg, 1.63 mmol) in ethyl acetate (20 ml) was added 3-phenylpropionyl chloride (360 ml, 2.45 mmol) and saturated aqueous sodium bicarbonate (20 ml). Stirred overnight at room temperature. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-1: 1), and recrystallized from ethyl acetate-hexane to obtain the title compound (422 mg, 55%). mp 91-93 ℃ IRνmax KBr cm -1: 1645, 1584, 1510, 1487, 1447. 1 H-NMR (CDCl 3) δ: 2.22-2.90 (6H, m), 4.22-4.42 (1
H, m), 4.81 (1H, s), 5.30 (1H, d, J = 8.2 Hz), 6.6
2-7.40 (18H, m).
【0294】実施例162 1,1-ジメチルエチル(1RS,2SR)-2-(4-フ
ルオロフェニル)-2-ヒドロキシ-1-((5-(トリフ
ルオロメチル)-2-フラニル)メチル)エチルカルバメ
ート 1) トリフルオロアセト酢酸エチル(75g,407
ミリモル)の1,2-ジメトキシエタン(200ml)
溶液に水素化ナトリウム(60%油性,16.3g,4
07ミリモル)を氷冷下加え、室温で30分攪拌した。
反応液の中にクロロアセトン(43.3g,469ミリ
モル)の1,2-ジメトキシエタン(50ml)溶液を
滴下し、さらにヨウ化カリウム(800mg,4.8ミ
リモル)を加え、反応液を終夜加熱還流した。反応液を
水(500ml)の中に注ぎ、ジエチルエーテル(50
0ml×2)で抽出した。抽出液を水および飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を減圧下蒸留し、4-オキソ-2-(2,2,
2-トリフルオロアセチル)吉草酸エチル(40.5
g,41%)を得た。 IRνmaxKBrcm-1: 1742, 1723.1 H-NMR (CDCl3)δ: 1.28 (3H, t, J = 7.0 Hz), 2.22
(3H, s), 3.26 (2H, d, J= 7.0 Hz), 4.10-4.50 (3H,
m). bp 110-125℃/0.1mmHg 2) 4-オキソ-2-(2,2,2-トリフルオロアセチ
ル)吉草酸エチル(40g,167ミリモル)のトルエ
ン(250ml)溶液にp-トルエンスルホン酸(3
g,16ミリモル)を加え、ディーンスターク装置で水
を除きながら終夜加熱還流した。反応液を濃縮し、残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=10:1)で精製し5-メチル-2-(トリ
フルオロメチル)-3-フランカルボン酸エチル(25.
8g,70%)を得た。 IRνmaxKBrcm-1: 1732, 1574.1 H-NMR (CDCl3)δ: 1.35 (3H, t, J = 7.4 Hz), 2.35
(3H, s), 4.32 (2H, q, J= 7.4 Hz), 4.62 (1H, s). 3) 5-メチル-2-(トリフルオロメチル)-3-フラ
ンカルボン酸エチル(25g,113ミリモル)のエタ
ノール(200ml)溶液に2規定水酸化ナトリウム水
溶液(61.9ml,123.8ミリモル)を加え、4
5分間加熱還流した。反応液を濃縮後、水(150m
l)で希釈し、さらに6規定塩酸をpHが約5になるま
で徐々に加えた。析出した結晶をろ取し、水で洗浄して
5-メチル-2-(トリフルオロメチル)-3-フランカル
ボン酸(20.5g,94%)を得た。 IRνmaxKBrcm-1: 1711, 1574. mp 118-119℃1 H-NMR (CDCl3)δ: 2.38 (3H, s), 6.52 (1H, s). 4) 5-メチル-2-(トリフルオロメチル)-3-フラ
ンカルボン酸(20g,103ミリモル)のキノリン
(36ml)溶液に硫酸銅(I)(1g,6.3ミリモ
ル)を加え、窒素をバブリングしながら230℃のオイ
ルバスに気体が発生しなくなるまで浸けた。発生した気
体を集め、さらに再蒸留して2-メチル-5-(トリフル
オロメチル)フラン(8.34g,54%)を得た。1 H-NMR (CDCl3)δ: 2.34 (3H, s), 6.05 (1H, d, J =
3.4 Hz), 6.60 (1H, d, J= 2.2 Hz). bp 80-85℃/760mmHg (Lit.81-82℃, J. Hetrocyclic Ch
em., 5, 95 (1968)) 5) 2-メチル-5-(トリフルオロメチル)フラン
(4g,26.6ミリモル)のクロロホルム(60m
l)溶液にN-ブロモスクシンイミド(5.2g,2
9.3ミリモル)および2,2'-アゾビス(イソブチロ
ニトリル)(220mg,1.33ミリモル)を加え
た。反応液を15分間加熱還流し、反応液を冷却後、水
(200ml)の中に注ぎ、クロロホルムで抽出した。
抽出液を水および飽和食塩水で洗浄し、無水硫酸マグネ
シウムで乾燥後減圧留去し、2-(ブロモメチル)-5-
(トリフルオロメチル)フラン(4.79g,78%)
を得た。 IRνmaxKBrcm-1: 1738, 1688, 1599, 1559.1 H-NMR (CDCl3)δ: 4.46 (2H, s), 6.45 (1H, d, J =
3.8 Hz), 6.75 (1H, d, J= 3.8 Hz). 6) 3-(4-フルオロフェニル)-3-オキソプロピオ
ン酸エチル(5.0g,24ミリモル)の1,2-ジメ
トキシエタン(40ml)溶液に水素化ナトリウム(6
0%油性,576mg,24ミリモル)を氷冷下加え、
室温で1時間攪拌した。反応液の中に2-(ブロモメチ
ル)-5-(トリフルオロメチル)フラン(6g,26ミ
リモル)の1,2-ジメトキシエタン(50ml)溶液
を滴下し、反応液を室温で終夜攪拌した。反応液を水
(200ml)の中に注ぎ、飽和重曹水を加え、酢酸エ
チル(200ml×2)で抽出した。抽出液を水および
飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減
圧留去した。残留物をシリカゲルカラムクロマトグラフ
ィー(ヘキサン:酢酸エチル=4:1)で精製し3-
(4-フルオロフェニル)-3-オキソ-2-((5-(トリ
フルオロメチル)-2-フラニル)メチル)プロピオン酸
エチル(4.5g,52%)を得た。 IRνmaxKBrcm-1: 1738, 1688, 1599, 1559.1 H-NMR (CDCl3)δ: 1.16 (3H, t, J = 7.2 Hz), 3.14-
3.50 (2H, m), 4.14 (2H,q, J = 7.2 Hz), 4.73 (1H,
t, J = 7.4 Hz), 6.15 (1H, d, J = 4.0 Hz), 6.60-6.6
6 (1H, m), 7.08-7.30 (3H, m), 7.98-8.10 (2H, m). 7) 塩化亜鉛(3.35g,24.6ミリモル)のジ
エチルエーテル(70ml)溶液に水素化ホウ素ナトリ
ウム(1.86g,49.1ミリモル)を加えて室温で
30分攪拌した。不溶物をろ去し、ろ液に3-(4-フル
オロフェニル)-3-オキソ-2-((5-(トリフルオロ
メチル)-2-フラニル)メチル)プロピオン酸エチル
(4.40g,12.3ミリモル)のジエチルエーテル
(30ml)溶液を加えて室温で2時間攪拌した。氷冷
下、反応液に1規定塩酸を加えてクエンチし、更に水
(100ml)を加え、酢酸エチル(100ml×2)
で抽出した。抽出液を水および飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=4:1)で精製し、(2RS,3RS)-3-(4
-フルオロフェニル)-3-ヒドロキシ-2-((5-(トリ
フルオロメチル)-2-フラニル)メチル)プロピオン酸
エチル(3.46g,78%)を得た。 IRνmaxKBrcm-1: 1717, 1607, 1561.1 H-NMR (CDCl3)δ: 1.06 (3H, t, J = 7.0 Hz), 2.90-
3.22 (4H, m), 4.00 (2H,q, J = 7.0 Hz), 5.00-5.08
(1H, m), 6.05 (1H, d, J = 3.4 Hz), 6.58-6.64(1H,
m), 6.98-7.10 (2H, m), 7.30-7.42 (2H, m). 8) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((5-(トリフルオロメチ
ル)-2-フラニル)メチル)プロピオン酸エチル(3.
3g,9.16ミリモル)のメタノール(9.2ml)
溶液に、2規定水酸化ナトリウム水溶液(9.2ml,
18.4ミリモル)を加えて室温で終夜攪拌した。反応
液を1規定塩酸で酸性とし、酢酸エチル(100ml×
2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をジイソプロピルエーテル−ヘキサンから再結晶させ
て(2RS,3RS)-3-(4-フルオロフェニル)-3
-ヒドロキシ-2-((5-(トリフルオロメチル)-2-フ
ラニル)メチル)プロピオン酸(2.43g,80%)
を得た。 IRνmaxKBrcm-1: 1715, 1563, 1513. mp 86-87℃1 H-NMR (CDCl3)δ: 2.92-3.22 (3H, m), 5.13 (1H, d,
J = 4.0 Hz), 6.06 (1H,d, J = 3.2 Hz), 6.60-6.68 (1
H, m), 7.00-7.16 (2H, m), 7.30-7.44 (2H, m). 9) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((5-(トリフルオロメチ
ル)-2-フラニル)メチル)プロピオン酸(2.33
g,7.01ミリモル)のテトラヒドロフラン(60m
l)溶液に、ジフェニルホスホリルアジド(1.66m
l,7.71ミリモル)とトリエチルアミン(1.47
ml,10.5ミリモル)を加え、4時間加熱還流し
た。反応液を放冷後、水(50ml)を加えて酢酸エチ
ル(100ml×2)で抽出した。抽出液を水、飽和食
塩水で順次洗浄し、無水硫酸マグネシウムで乾燥後減圧
留去した。残留物をシリカゲルカラムクロマトグラフィ
ー(酢酸エチル)で精製し、酢酸エチル−ヘキサンから
再結晶させて(4RS,5SR)-5-(4-フルオロフ
ェニル)-4-((5-(トリフルオロメチル)-2-フラ
ニル)メチル)-1,3-オキサゾリジン-2-オン(1.
78mg,77%)を得た。 IRνmaxKBrcm-1: 1759, 1611, 1559, 1514. mp 177-179℃1 H-NMR (CDCl3)δ: 2.30-2.58 (2H, m), 4.32-4.50 (1
H, m), 5.67 (1H, brs),5.80 (1H, d, J = 8.0 Hz), 6.
00 (1H, d, J = 3.6 Hz), 6.65 (1H, d, J = 2.2Hz),
7.02-7.20 (2H, m), 7.24-7.40 (2H, m). 10) (4RS,5SR)-5-(4フルオロフェニ
ル)-4-((5-(トリフルオロメチル)-2-フラニ
ル)メチル)-1,3-オキサゾリジン-2-オン(1.6
0g,4.86ミリモル)のアセトニトリル(15m
l)溶液に二炭酸ジ-t-ブチル(1.27g,5.83
ミリモル)およびジメチルアミノピリジン(60mg,
0.49ミリモル)を加え、室温で30分攪拌した。反
応液を濃縮後、水(30ml)で希釈し、酢酸エチル
(30ml×2)で抽出した。抽出液を飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=1:1)で精製し酢酸エチル−ヘキサ
ンから再結晶させて(4RS,5SR)-5-(4-フル
オロフェニル)-2-オキソ-4-((5-(トリフルオロ
メチル)-2-フラニル)メチル)-1,3-オキサゾリジ
ン-3-カルボン酸1,1-ジメチルエチル(1.99
g,95%)を得た。 IRνmaxKBrcm-1: 1823, 1728, 1615, 1559. mp 134-135℃1 H-NMR (CDCl3)δ: 1.55 (9H, s), 2.70-2.98 (2H, m),
4.86-4.98 (1H, m), 5.52 (1H, d, J = 3.2 Hz), 5.70
(1H, d, J = 7.0 Hz), 6.46-6.52 (1H, m), 6.94-7.06
(2H, m), 7.12-7.22 (2H, m). 11) (4RS,5SR)-5-(4-フルオロフェニ
ル)-2-オキソ-4-((5-(トリフルオロメチル)-2
-フラニル)メチル)-1,3-オキサゾリジン-3-カル
ボン酸1,1-ジメチルエチル(1.91g,4.45
ミリモル)のメタノール(10.7ml)に0.5Nの
水酸化ナトリウムメタノール溶液(10.7ml,5.
35ミリモル)を氷冷下加え、室温で10分攪拌した。
反応液に水(50ml)を加え、酢酸エチル(50ml
×2)で抽出した。抽出液を飽和食塩水で洗浄し、無水
硫酸マグネシウムで乾燥後減圧留去した。残留物を酢酸
エチル−ヘキサンから再結晶させて表題化合物(1.7
9g,100%)を得た。 IRνmaxKBrcm-1: 1692, 1561, 1510. mp 111-112℃1 H-NMR (CDCl3)δ: 1.39 (9H, s), 2.78-2.90 (2H, m),
3.12 (1H, brs), 4.02-4.20 (1H, m), 4.76 (1H, d, J
= 8.4 Hz), 4.92 (1H, brs), 6.12 (1H, d, J =3.0 H
z), 6.62-6.68 (1H, m), 7.00-7.12 (2H, m), 7.28-7.4
2 (2H, m).Example 162 1,1-Dimethylethyl (1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-((5- (trifluoromethyl) -2-furanyl) methyl) ethyl Carbamate 1) Ethyl trifluoroacetoacetate (75 g, 407)
Mmol) of 1,2-dimethoxyethane (200 ml)
Add sodium hydride (60% oily, 16.3 g, 4
(07 mmol) under ice-cooling and stirred at room temperature for 30 minutes.
A solution of chloroacetone (43.3 g, 469 mmol) in 1,2-dimethoxyethane (50 ml) was added dropwise to the reaction solution, potassium iodide (800 mg, 4.8 mmol) was added, and the reaction solution was heated overnight. Refluxed. The reaction solution was poured into water (500 ml), and diethyl ether (50 ml) was added.
0 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was distilled under reduced pressure to give 4-oxo-2- (2,2,2
2-trifluoroacetyl) ethyl valerate (40.5
g, 41%). IRνmax KBr cm -1: 1742, 1723. 1 H-NMR (CDCl 3) δ: 1.28 (3H, t, J = 7.0 Hz), 2.22
(3H, s), 3.26 (2H, d, J = 7.0 Hz), 4.10-4.50 (3H,
m). bp 110-125 ° C / 0.1 mmHg 2) p-Toluenesulfone was added to a toluene (250 ml) solution of ethyl 4-oxo-2- (2,2,2-trifluoroacetyl) valerate (40 g, 167 mmol). Acid (3
g, 16 mmol) and heated to reflux overnight while removing water with a Dean-Stark apparatus. The reaction mixture was concentrated, and the residue was subjected to silica gel column chromatography (hexane:
Purified with ethyl acetate = 10: 1) and ethyl 5-methyl-2- (trifluoromethyl) -3-furancarboxylate (25.
8g, 70%). IRνmax KBr cm -1: 1732, 1574. 1 H-NMR (CDCl 3) δ: 1.35 (3H, t, J = 7.4 Hz), 2.35
(3H, s), 4.32 (2H, q, J = 7.4 Hz), 4.62 (1H, s). 3) Ethyl 5-methyl-2- (trifluoromethyl) -3-furancarboxylate (25 g, 113 mmol) 2) aqueous sodium hydroxide solution (61.9 ml, 123.8 mmol) was added to an ethanol (200 ml) solution of
The mixture was refluxed for 5 minutes. After concentrating the reaction solution, water (150 m
The mixture was diluted in 1), and 6N hydrochloric acid was gradually added until the pH reached about 5. The precipitated crystals were collected by filtration and washed with water to give 5-methyl-2- (trifluoromethyl) -3-furancarboxylic acid (20.5 g, 94%). IRνmax KBr cm -1 : 1711, 1574. mp 118-119 ° C 1 H-NMR (CDCl 3 ) δ: 2.38 (3H, s), 6.52 (1H, s). 4) 5-Methyl-2- (trifluoro To a quinoline (36 ml) solution of (methyl) -3-furancarboxylic acid (20 g, 103 mmol) was added copper (I) sulfate (1 g, 6.3 mmol), and gas was introduced into an oil bath at 230 ° C. while bubbling nitrogen through. Soaked until no more occurs. The evolved gas was collected and redistilled to obtain 2-methyl-5- (trifluoromethyl) furan (8.34 g, 54%). 1 H-NMR (CDCl 3 ) δ: 2.34 (3H, s), 6.05 (1H, d, J =
3.4 Hz), 6.60 (1H, d, J = 2.2 Hz) .bp 80-85 ℃ / 760mmHg (Lit.81-82 ℃, J. Hetrocyclic Ch)
em., 5, 95 (1968)) 5) 2-Methyl-5- (trifluoromethyl) furan (4 g, 26.6 mmol) in chloroform (60 m
l) Add N-bromosuccinimide (5.2 g, 2
9.3 mmol) and 2,2′-azobis (isobutyronitrile) (220 mg, 1.33 mmol). The reaction solution was heated under reflux for 15 minutes, cooled, poured into water (200 ml), and extracted with chloroform.
The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure to give 2- (bromomethyl) -5-.
(Trifluoromethyl) furan (4.79 g, 78%)
I got IRνmax KBr cm -1: 1738, 1688 , 1599, 1559. 1 H-NMR (CDCl 3) δ: 4.46 (2H, s), 6.45 (1H, d, J =
3.8 Hz), 6.75 (1H, d, J = 3.8 Hz). 6) Ethyl 3- (4-fluorophenyl) -3-oxopropionate (5.0 g, 24 mmol) in 1,2-dimethoxyethane (40 ml) ) Solution in sodium hydride (6
0% oily, 576 mg, 24 mmol) under ice-cooling,
Stirred at room temperature for 1 hour. A solution of 2- (bromomethyl) -5- (trifluoromethyl) furan (6 g, 26 mmol) in 1,2-dimethoxyethane (50 ml) was added dropwise to the reaction solution, and the reaction solution was stirred at room temperature overnight. The reaction solution was poured into water (200 ml), saturated aqueous sodium hydrogen carbonate was added, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give 3-
Ethyl (4-fluorophenyl) -3-oxo-2-((5- (trifluoromethyl) -2-furanyl) methyl) propionate (4.5 g, 52%) was obtained. IRνmax KBr cm -1: 1738, 1688 , 1599, 1559. 1 H-NMR (CDCl 3) δ: 1.16 (3H, t, J = 7.2 Hz), 3.14-
3.50 (2H, m), 4.14 (2H, q, J = 7.2 Hz), 4.73 (1H,
t, J = 7.4 Hz), 6.15 (1H, d, J = 4.0 Hz), 6.60-6.6
6 (1H, m), 7.08-7.30 (3H, m), 7.98-8.10 (2H, m). 7) Boron hydride was added to a solution of zinc chloride (3.35 g, 24.6 mmol) in diethyl ether (70 ml). Sodium (1.86 g, 49.1 mmol) was added and the mixture was stirred at room temperature for 30 minutes. The insoluble material was removed by filtration, and the filtrate was subjected to ethyl 3- (4-fluorophenyl) -3-oxo-2-((5- (trifluoromethyl) -2-furanyl) methyl) propionate (4.40 g, 12 (0.3 mmol) in diethyl ether (30 ml) and stirred at room temperature for 2 hours. Under ice-cooling, the reaction solution is quenched by adding 1N hydrochloric acid, and water (100 ml) is further added, and ethyl acetate (100 ml × 2) is added.
Extracted. The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give (2RS, 3RS) -3- (4
Ethyl-fluorophenyl) -3-hydroxy-2-((5- (trifluoromethyl) -2-furanyl) methyl) propionate (3.46 g, 78%) was obtained. IRνmax KBr cm -1: 1717, 1607 , 1561. 1 H-NMR (CDCl 3) δ: 1.06 (3H, t, J = 7.0 Hz), 2.90-
3.22 (4H, m), 4.00 (2H, q, J = 7.0 Hz), 5.00-5.08
(1H, m), 6.05 (1H, d, J = 3.4 Hz), 6.58-6.64 (1H,
m), 6.98-7.10 (2H, m), 7.30-7.42 (2H, m). 8) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((5- (tri Fluoromethyl) -2-furanyl) methyl) ethyl propionate (3.
3 g, 9.16 mmol) methanol (9.2 ml)
A 2N aqueous sodium hydroxide solution (9.2 ml,
18.4 mmol) and stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid, and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to give (2RS, 3RS) -3- (4-fluorophenyl) -3.
-Hydroxy-2-((5- (trifluoromethyl) -2-furanyl) methyl) propionic acid (2.43 g, 80%)
I got IRνmax KBr cm -1 : 1715, 1563, 1513.mp 86-87 ° C 1 H-NMR (CDCl 3 ) δ: 2.92-3.22 (3H, m), 5.13 (1H, d,
J = 4.0 Hz), 6.06 (1H, d, J = 3.2 Hz), 6.60-6.68 (1
H, m), 7.00-7.16 (2H, m), 7.30-7.44 (2H, m). 9) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((5- (Trifluoromethyl) -2-furanyl) methyl) propionic acid (2.33)
g, 7.01 mmol) of tetrahydrofuran (60 m
l) Diphenylphosphoryl azide (1.66 m
1, 7.71 mmol) and triethylamine (1.47)
ml, 10.5 mmol) and heated under reflux for 4 hours. After allowing the reaction solution to cool, water (50 ml) was added, and the mixture was extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to give (4RS, 5SR) -5- (4-fluorophenyl) -4-((5- (trifluoromethyl) -2-furanyl) methyl) -1,3-oxazolidin-2-one (1.
78 mg, 77%). IRνmax KBr cm -1 : 1759, 1611, 1559, 1514.mp 177-179 ° C 1 H-NMR (CDCl 3 ) δ: 2.30-2.58 (2H, m), 4.32-4.50 (1
H, m), 5.67 (1H, brs), 5.80 (1H, d, J = 8.0 Hz), 6.
00 (1H, d, J = 3.6 Hz), 6.65 (1H, d, J = 2.2 Hz),
7.02-7.20 (2H, m), 7.24-7.40 (2H, m). 10) (4RS, 5SR) -5- (4fluorophenyl) -4-((5- (trifluoromethyl) -2-furanyl) Methyl) -1,3-oxazolidin-2-one (1.6
0 g, 4.86 mmol) of acetonitrile (15 m
l) Di-t-butyl dicarbonate (1.27 g, 5.83) was added to the solution.
Mmol) and dimethylaminopyridine (60 mg,
0.49 mmol) and stirred at room temperature for 30 minutes. After concentration, the reaction solution was diluted with water (30 ml) and extracted with ethyl acetate (30 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1) and recrystallized from ethyl acetate-hexane to give (4RS, 5SR) -5- (4-fluorophenyl) -2-oxo-4--4-. 1,1-dimethylethyl ((5- (trifluoromethyl) -2-furanyl) methyl) -1,3-oxazolidine-3-carboxylate (1.99
g, 95%). IRνmax KBr cm -1 : 1823, 1728, 1615, 1559.mp 134-135 ℃ 1 H-NMR (CDCl 3 ) δ: 1.55 (9H, s), 2.70-2.98 (2H, m),
4.86-4.98 (1H, m), 5.52 (1H, d, J = 3.2 Hz), 5.70
(1H, d, J = 7.0 Hz), 6.46-6.52 (1H, m), 6.94-7.06
(2H, m), 7.12-7.22 (2H, m). 11) (4RS, 5SR) -5- (4-fluorophenyl) -2-oxo-4-((5- (trifluoromethyl) -2
-Furanyl) methyl) -1,1-dimethylethyl-1,3-oxazolidine-3-carboxylate (1.91 g, 4.45)
Mmol) in methanol (10.7 ml) in 0.5N methanolic sodium hydroxide solution (10.7 ml, 5.0 mL).
(35 mmol) under ice-cooling and stirred at room temperature for 10 minutes.
Water (50 ml) was added to the reaction solution, and ethyl acetate (50 ml) was added.
× 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (1.7
9 g, 100%). IRνmax KBr cm -1 : 1692, 1561, 1510.mp 111-112 ℃ 1 H-NMR (CDCl 3 ) δ: 1.39 (9H, s), 2.78-2.90 (2H, m),
3.12 (1H, brs), 4.02-4.20 (1H, m), 4.76 (1H, d, J
= 8.4 Hz), 4.92 (1H, brs), 6.12 (1H, d, J = 3.0 H
z), 6.62-6.68 (1H, m), 7.00-7.12 (2H, m), 7.28-7.4
2 (2H, m).
【0295】実施例163 4-フルオロ-N-((1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-((5-(トリフルオ
ロメチル)-2-フラニル)メチル)エチル)-1-ナフタ
レンカルボキサミド 1) 1,1-ジメチルエチル(1RS,2SR)-2-
(4-フルオロフェニル)-2-ヒドロキシ-1-((5-
(トリフルオロメチル)-2-フラニル)メチル)エチル
カルバメート(1.70g,4.21ミリモル)にトリ
フルオロ酢酸(15ml)を0℃で加え、10分攪拌し
た。反応液を濃縮後、水(20ml)で希釈し、酢酸エ
チル(20ml×2)で抽出した。抽出液を飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をジイソプロピルエーテル−ヘキサンから再
結晶させて(1RS,2SR)-2-アミノ-1-(4-フ
ルオロフェニル)-3-(5-(トリフルオロメチル)-2
-フラニル)-1-プロパノール(1.30g,100
%)を得た。 IRνmaxKBrcm-1: 1605, 1558, 1510.1 H-NMR (CDCl3)δ: 2.07 (2H, brs), 2.56 (1H, dd, J
= 15.0, 9.8 Hz), 2.78(1H, dd, J = 15.0, 3.6 Hz),
3.32-3.46 (1H, m), 4.66 (1H, d, J = 4.8 Hz),6.12
(1H, d, J = 3.4 Hz), 6.62-6.70 (1H, m), 7.00-7.12
(2H, m), 7.30-7.42 (2H, m). 2) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(5-(トリフルオロメチル)-2-フ
ラニル)-1-プロパノール(300mg,0.99ミリ
モル)のアセトニトリル(20ml)溶液に4-フルオ
ロナフタレンカルボン酸(188mg,0.99ミリモ
ル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(283mg,1.48ミ
リモル)および1-ヒドロキシ-1H-ベンゾトリアゾー
ル(151mg,0.99ミリモル)を加えて室温で終
夜攪拌した。反応液を水(100ml)で希釈し、酢酸
エチル(100ml×2)で抽出した。抽出液を水、飽
和食塩水で順次洗浄し、無水硫酸マグネシウムで乾燥後
減圧留去した。残留物をシリカゲルカラムクロマトグラ
フィー(ヘキサン:酢酸エチル=4:1)で精製し、酢
酸エチル−ヘキサンから再結晶させて、表題化合物(1
91mg,41%)を得た。 IRνmaxKBrcm-1: 1643, 1601, 1512. mp 153-154℃1 H-NMR (CDCl3)δ: 3.54 (2H, d, J = 7.4 Hz), 3.23
(1H, d, J = 3.4 Hz), 4.68-4.86 (1H, m), 5.06-5.12
(1H, m), 6.12-6.28 (2H, m), 6.72 (1H, d, J =2.2 H
z), 7.00-7.16 (3H, m), 7.32-7.62 (5H, m), 8.00-8.2
0 (2H, m).Example 163 4-Fluoro-N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-((5- (trifluoromethyl) -2-furanyl) methyl) Ethyl) -1-naphthalenecarboxamide 1) 1,1-dimethylethyl (1RS, 2SR) -2-
(4-fluorophenyl) -2-hydroxy-1-((5-
To (trifluoromethyl) -2-furanyl) methyl) ethyl carbamate (1.70 g, 4.21 mmol) was added trifluoroacetic acid (15 ml) at 0 ° C., and the mixture was stirred for 10 minutes. After concentration, the reaction solution was diluted with water (20 ml) and extracted with ethyl acetate (20 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to give (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (5- (trifluoromethyl) -2
-Furanyl) -1-propanol (1.30 g, 100
%). IRνmax KBr cm -1: 1605, 1558 , 1510. 1 H-NMR (CDCl 3) δ: 2.07 (2H, brs), 2.56 (1H, dd, J
= 15.0, 9.8 Hz), 2.78 (1H, dd, J = 15.0, 3.6 Hz),
3.32-3.46 (1H, m), 4.66 (1H, d, J = 4.8 Hz), 6.12
(1H, d, J = 3.4 Hz), 6.62-6.70 (1H, m), 7.00-7.12
(2H, m), 7.30-7.42 (2H, m). 2) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (5- (trifluoromethyl) -2-furanyl ) To a solution of 1-propanol (300 mg, 0.99 mmol) in acetonitrile (20 ml) was added 4-fluoronaphthalenecarboxylic acid (188 mg, 0.99 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide. Hydrochloride (283 mg, 1.48 mmol) and 1-hydroxy-1H-benzotriazole (151 mg, 0.99 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the title compound (1
91 mg, 41%). IRνmax KBr cm -1 : 1643, 1601, 1512.mp 153-154 ℃ 1 H-NMR (CDCl 3 ) δ: 3.54 (2H, d, J = 7.4 Hz), 3.23
(1H, d, J = 3.4 Hz), 4.68-4.86 (1H, m), 5.06-5.12
(1H, m), 6.12-6.28 (2H, m), 6.72 (1H, d, J = 2.2 H
z), 7.00-7.16 (3H, m), 7.32-7.62 (5H, m), 8.00-8.2
0 (2H, m).
【0296】実施例164 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((5-(トリフルオロメチル)-2
-フラニル)メチル)エチル)-3-フェニルプロパンア
ミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(5-(トリフルオロメチル)-2-フラニ
ル)-1-プロパノール(300mg,099ミリモル)
の酢酸エチル(10ml)溶液に3-フェニルプロピオ
ニルクロリド(220ml,1.48ミリモル)および
飽和重曹水(10ml)を加えて室温で終夜攪拌した。
反応液を水(100ml)で希釈し、酢酸エチル(10
0ml×2)で抽出した。抽出液を飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物を酢酸エチル−ヘキサンから再結晶させて表題化合物
(321mg,75%)を得た。 IRνmaxKBrcm-1: 1645, 1559, 1510. mp 91-92℃1 H-NMR (CDCl3)δ: 2.32-2.60 (2H, m), 2.73 (2H, d,
J = 7.6 Hz), 2.80-3.00(2H, m), 3.10 (1H, s), 4.30-
4.48 (1H, m), 4.76-4.84 (1H, m), 5.58 (1H,d, J =
7.6 Hz), 6.00 (1H, d, J = 3.4 Hz), 6.58-6.64 (1H,
m), 6.92-7.10 (2H, m), 7.10-7.36 (7H, m).Example 164 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((5- (trifluoromethyl) -2
-Furanyl) methyl) ethyl) -3-phenylpropanamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (5- (trifluoromethyl) -2-furanyl) -1- Propanol (300 mg, 099 mmol)
3-Ethylpropionyl chloride (220 ml, 1.48 mmol) and saturated aqueous sodium hydrogen carbonate (10 ml) were added to a solution of the above in ethyl acetate (10 ml), and the mixture was stirred overnight at room temperature.
The reaction solution was diluted with water (100 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (321 mg, 75%). IRνmax KBr cm -1 : 1645, 1559, 1510.mp 91-92 ° C 1 H-NMR (CDCl 3 ) δ: 2.32-2.60 (2H, m), 2.73 (2H, d,
J = 7.6 Hz), 2.80-3.00 (2H, m), 3.10 (1H, s), 4.30-
4.48 (1H, m), 4.76-4.84 (1H, m), 5.58 (1H, d, J =
7.6 Hz), 6.00 (1H, d, J = 3.4 Hz), 6.58-6.64 (1H,
m), 6.92-7.10 (2H, m), 7.10-7.36 (7H, m).
【0297】実施例165 N-[(1RS,2SR)-1-[4-(ジフルオロメチ
ル)ベンジル]-2-(4-フルオロフェニル)-2-ヒド
ロキシエチル]-4-フルオロナフタレン-1-カルボキサ
ミド 1) 4-(ジフルオロメチル)安息香酸メチル (ジエチルアミノ)サルファートリフルオリド12.8
g(79.4ミリモル)のトルエン30ml溶液に−7
8℃で4-ホルミル安息香酸メチル10.86g(6
6.15ミリモル)のトルエン50ml溶液を加え、室
温で3時間撹拌した。反応液に炭酸水素ナトリウム水溶
液を加え、撹拌した後、トルエン層を分離した。水層は
酢酸エチルで抽出し、集めた有機層を無水硫酸マグネシ
ウムで乾燥、溶媒を減圧留去した。得られた残留物をシ
リカゲルカラムクロマトグラフィーにて精製して(ヘキ
サン/酢酸エチル=20/1−15/1)、目的物を得
た。淡黄色固体 収量9.671g 収率79% mp 37-38℃; 1H-NMR (CDCl3, 200MHz) δ 3.95 (3H,
s), 6.69 (1H, t, J = 56.2 Hz), 7.59 (2H, d, J = 8.
2 Hz), 8.13 (2H, d, J = 8.4 Hz); IR (neat) 1728, 1
437, 1283, 1219, 1113, 1074, 1034, 1020 cm-1; Ana
l. Calcd for C9H8F2O2: C, 58.07; H, 4.33. Found:
C, 58.31; H, 4.24. 2) 4-(ジフルオロメチル)ベンジルアルコール 水素化リチウムアルミニウム2.86g(75.3ミリ
モル)のテトラヒドロフラン50ml懸濁液に、氷冷
下、4-(ジフルオロメチル)安息香酸メチル9.34
1g(50.18ミリモル)のテトラヒドロフラン50
ml溶液を滴下し、室温で1時間撹拌した。反応液を氷
冷した後、水3ml、15%水酸化ナトリウム水溶液3
ml、水8mlを順次滴下して、過剰の水素化リチウム
アルミニウムを分解し、そのまま室温で2時間撹拌し
た。生じた沈殿をろ過して除き、沈殿を酢酸エチルで洗
浄した。集めた濾液の溶媒を減圧留去した。得られた残
留物をシリカゲルカラムクロマトグラフィーにて精製し
て(ヘキサン/酢酸エチル=3/1−1/1)、目的物
を得た。無色液体 収量7.948g 収率100%1 H-NMR (CDCl3, 200MHz) δ 1.78 (1H, t, J = 6.0 H
z), 4.76 (2H, d, J = 5.4Hz), 6.65 (1H, t, J = 56.4
Hz), 7.45 (2H, d, J = 8.6 Hz), 7.52 (2H, d,J = 8.
6 Hz); IR (neat) 3330, 1379, 1221, 1074, 1019 cm-1 3) 2-[4-(ジフルオロメチル)ベンジル]-3-
(4-フルオロフェニル)-3-オキソプロピオン酸エチ
ル 4-(ジフルオロメチル)ベンジルアルコール2.65
g(16.7ミリモル)、トリエチルアミン3.50m
l(25.1ミリモル)の酢酸エチル40ml溶液に氷
冷下塩化メタンスルホニル2.11g(18.4ミリモ
ル)の酢酸エチル10ml溶液を滴下し、そのまま10
分間撹拌した。生じた沈殿を濾過して除き、沈殿をジエ
チルエーテルで洗浄した。集めた濾液の溶媒を減圧留去
して、メタンスルホン酸エステルの粗生成物を黄色液体
として得た。(4-フルオロベンゾイル)酢酸エチル
3.516g(16.73ミリモル)の1,2-ジメト
キシエタン30ml溶液に氷冷下60%水素化ナトリウ
ムの流動パラフィン懸濁物0.67g(16.7ミリモ
ル)を加え、そのまま0.5時間撹拌した。これに上で
得たメタンスルホン酸エステルの1,2-ジメトキシエ
タン10ml溶液を室温で加え、室温で8時間撹拌し
た。反応液を水に注ぎ、酢酸エチルで2回抽出した。集
めた有機層を無水硫酸マグネシウムで乾燥、溶媒を減圧
留去した。得られた残留物をシリカゲルカラムクロマト
グラフィーにて精製し(ヘキサン/酢酸エチル=15/
1−9/1)、ヘキサンより結晶化して、目的物を得
た。白色結晶 収量3.044g 収率52% mp 54-55℃; 1H-NMR (CDCl3, 200MHz) δ 1.11 (3H, t,
J = 7.2 Hz), 3.36 (2H, d, J = 7.4 Hz), 4.10 (2H,
q, J = 7.2 Hz), 4.57 (1H, t, J = 7.5 Hz), 6.59 (1
H, t, J = 56.4 Hz), 7.12 (2H, t, J = 8.6 Hz), 7.31
(2H, d, J = 8.4Hz), 7.41 (2H, d, J = 7.8 Hz), 8.0
0 (2H, dd, J = 5.4 Hz, 8.8 Hz); IR (KBr) 1721, 168
4, 1597, 1327, 1281, 1231, 1177, 1155, 1024, 847 c
m-1; Anal.Calcd for C19H17F3O3: C, 65.14; H, 4.89.
Found: C, 65.21; H, 4.82. 4) (2RS,3RS)-2-[4-(ジフルオロメチ
ル)ベンジル]-3-(4-フルオロフェニル)-3-ヒド
ロキシプロピオン酸エチル 塩化亜鉛2.17g(16.0ミリモル)をジエチルエ
ーテル50ml中で撹拌しながら水素化ホウ素ナトリウ
ム1.21g(31.9ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、2-[4-(ジフ
ルオロメチル)ベンジル]-3-(4-フルオロフェニ
ル)-3-オキソプロピオン酸エチル2.794g(7.
975ミリモル)のジエチルエーテル30ml溶液を室
温で加え、そのまま2時間撹拌した。反応液に希塩酸を
少しずつ加えて過剰の水素化ホウ素亜鉛を分解した後、
酢酸エチルで2回抽出した。集めた有機層を無水硫酸マ
グネシウムで乾燥、溶媒を減圧留去した。得られた粗生
成物をシリカゲルカラムクロマトグラフィーにて精製し
(ヘキサン/酢酸エチル=6/1−3/1)、目的物を
得た。無色液体 収量2.800g 収率100%1 H-NMR (CDCl3, 200MHz) δ 0.92 (3H, t, J = 7.1 H
z), 2.90 (1H, d, J = 2.8Hz), 2.93-3.06 (3H, m), 3.
88 (2H, q, J = 7.2 Hz), 5.02 (1H, dd, J = 2.6Hz,
4.6 Hz), 6.59 (1H, t, J = 56.6 Hz), 7.05 (2H, t, J
= 8.6 Hz), 7.17(2H, d, J = 8.0 Hz), 7.34-7.41 (4
H, m); IR (neat) 3445, 1725, 1715, 1510, 1377, 122
3, 1026, 839 cm-1 5) (2RS,3RS)-2-[4-(ジフルオロメチ
ル)ベンジル]-3-(4-フルオロフェニル)-3-ヒド
ロキシプロピオン酸 (2RS,3RS)-2-[4-(ジフルオロメチル)ベ
ンジル]-3-(4-フルオロフェニル)-3-ヒドロキシ
プロピオン酸エチル2.739g(7.774ミリモ
ル)のメタノール20ml−テトラヒドロフラン20m
l溶液に1N水酸化ナトリウム水溶液15.5ml(1
5.5ミリモル)を加え、室温で一晩撹拌した。反応液
を濃縮、水で希釈し、1N塩酸で反応液を酸性にした
後、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸ナトリウムで乾燥、溶媒を減圧留去した。残留物をヘ
キサンより結晶化して、目的物を得た。白色結晶 収量
2.232g 収率89% mp 132-133℃; 1H-NMR (CDCl3, 200MHz) δ 2.95-3.10
(3H, m), 5.06 (1H, s),6.60 (1H, t, J = 56.6 Hz),
7.05 (2H, t, J = 8.8 Hz), 7.16 (2H, d, J = 8.0 H
z), 7.33-7.40 (4H, m); IR (KBr) 3349, 3020-2550, 1
694, 1514, 1238, 1022, 841 cm-1; Anal. Calcd for C
17H15F3O3: C, 62.96; H, 4.66. Found: C,63.04; H,
4.85. 6) (4RS,5SR)-4-[4-(ジフルオロメチ
ル)ベンジル]-5-(4-フルオロフェニル)-1,3-
オキサゾリジン-2-オン (2RS,3RS)-2-[4-(ジフルオロメチル)ベ
ンジル]-3-(4-フルオロフェニル)-3-ヒドロキシ
プロピオン酸2.060g(6.352ミリモル)のテ
トラヒドロフラン40ml溶液にトリエチルアミン1.
33ml(9.53ミリモル)、ジフェニルホスホリル
アジド1.92g(6.99ミリモル)を加え、一晩加
熱還流した。反応液の溶媒を減圧留去し、得られた粗生
成物をシリカゲルカラムクロマトグラフィーにて精製し
(ヘキサン/酢酸エチル=3/1−1/1)、ジエチル
エーテル−ヘキサンより結晶化して、目的物を得た。白
色結晶 収量1.888g 収率93% mp 161-162℃; 1H-NMR (CDCl3, 200MHz) δ 2.22-2.38
(2H, m), 4.25 (1H, dt,J = 4.8 Hz, 8.7 Hz), 5.02 (1
H, br s), 5.80 (1H, d, J = 8.0 Hz), 6.61 (1H, t, J
= 56.4 Hz), 7.09-7.19 (4H, m), 7.34 (2H, dd, J =
5.2 Hz, 8.6 Hz), 7.44 (2H, d, J = 8.0 Hz); IR (KB
r) 3250, 1734, 1516, 1383, 1229, 1076,1032, 849 cm
-1; Anal. Calcd for C17H14F3NO2: C, 63.55; H, 4.3
9; N, 4.36. Found: C, 63.63; H, 4.42; N, 4.16. 7) (1RS,2SR)-2-アミノ-3-[4-(ジフ
ルオロメチル)フェニル]-1-(4-フルオロフェニ
ル)プロパン-1-オール (4RS,5SR)-4-[4-(ジフルオロメチル)ベ
ンジル]-5-(4-フルオロフェニル)-1,3-オキサ
ゾリジン-2-オン1.705g(5.307ミリモル)
と水酸化ナトリウム0.85g(21.2ミリモル)を
エタノール20ml−水1ml中で、6時間加熱還流し
た。反応液を水で希釈し、酢酸エチルで2回抽出した。
集めた有機層を無水硫酸ナトリウムで乾燥、溶媒を減圧
留去した。残留物をジイソプロピルエーテル−ヘキサン
より結晶化して、目的物を得た。白色結晶 収量1.2
68g 収率81% mp 89-90℃; 1H-NMR (CDCl3, 200MHz) δ 2.40 (1H, d
d, J = 10.3 Hz, 13.1 Hz), 2.84 (1H, d, J = 14.0 H
z), 3.24-3.34 (1H, m), 4.67 (1H, d, J = 4.8 Hz),
6.621 (1H, t, J = 56.6 Hz), 7.08 (2H, t, J = 8.8 H
z), 7.24 (2H, d, J= 8.0 Hz), 7.38 (2H, dd, J = 5.6
Hz, 8.6 Hz), 7.44 (2H, d, J = 8.0 Hz);IR (KBr) 33
50 2870, 1593, 1508, 1381, 1215, 1047, 1001, 829 c
m-1; Anal.Calcd for C16H16F3NO: C, 65.08; H, 5.46;
N, 4.74. Found: C, 65.10; H, 5.72; N, 4.47. 8) N-[(1RS,2SR)-1-[4-(ジフルオロ
メチル)ベンジル]-2-(4-フルオロフェニル)-2-
ヒドロキシエチル]-4-フルオロナフタレン-1-カルボ
キサミド (1RS,2SR)-2-アミノ-3-[4-(ジフルオロ
メチル)フェニル]-1-(4-フルオロフェニル)プロ
パン-1-オール0.167g(0.566ミリモル)、
4-フルオロ-1-ナフトエ酸0.11g(0.57ミリ
モル)、1-ヒドロキシベンゾトリアゾール水和物87
mg(0.57ミリモル)をアセトニトリル10ml中
で撹拌しながら1-エチル-3-(3-ジメチルアミノプロ
ピル)カルボジイミド・塩酸塩0.11g(0.57ミ
リモル)を加え、室温で一晩撹拌した。反応液を酢酸エ
チルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無水
硫酸マグネシウムで乾燥、シリカゲルを通した後、溶媒
を減圧留去した。得られた残留物を酢酸エチル−ジイソ
プロピルエーテル−ヘキサンより結晶化して、目的物を
得た。白色結晶 収量0.222g 収率84% mp 212-213℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
84-3.05 (2H, m), 4.71-4.85 (1H, m), 4.97-5.16 (2H,
m), 6.63 (1H, t, J = 56.4 Hz), 6.98-7.63 (14H,
m), 8.06 (1H, d, J = 8.4 Hz); IR (KBr) 3274, 1642,
1626, 1537, 1512,1229, 1030, 837 cm-1; Anal. Calc
d for C27H21F4NO2: C, 69.37; H, 4.53; N, 3.00. Fou
nd: C, 69.11; H, 4.72; N, 2.74.Example 165 N-[(1RS, 2SR) -1- [4- (difluoromethyl) benzyl] -2- (4-fluorophenyl) -2-hydroxyethyl] -4-fluoronaphthalene-1-carboxamide 1) Methyl 4- (difluoromethyl) benzoate (Diethylamino) sulfur trifluoride 12.8
g (79.4 mmol) in a 30 ml toluene solution.
At 8.degree. C., 10.86 g of methyl 4-formylbenzoate (6.
(6.15 mmol) in 50 ml of toluene and stirred at room temperature for 3 hours. An aqueous solution of sodium hydrogen carbonate was added to the reaction solution, and after stirring, the toluene layer was separated. The aqueous layer was extracted with ethyl acetate, the collected organic layers were dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 20 / 1-15 / 1) to obtain the desired product. Light yellow solid Yield 9.671 g Yield 79% mp 37-38 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 3.95 (3H,
s), 6.69 (1H, t, J = 56.2 Hz), 7.59 (2H, d, J = 8.
2 Hz), 8.13 (2H, d, J = 8.4 Hz); IR (neat) 1728, 1
437, 1283, 1219, 1113, 1074, 1034, 1020 cm -1 ; Ana
l. Calcd for C 9 H 8 F 2 O 2 : C, 58.07; H, 4.33. Found:
H, 4.24.2) 4- (Difluoromethyl) benzyl alcohol To a suspension of 2.86 g (75.3 mmol) of lithium aluminum hydride in 50 ml of tetrahydrofuran was added 4- (difluoromethyl) benzoate under ice-cooling. 9.34 methyl ester
1 g (50.18 mmol) of tetrahydrofuran 50
The solution was added dropwise and stirred at room temperature for 1 hour. After cooling the reaction solution with ice, 3 ml of water and 3% aqueous solution of 15% sodium hydroxide were added.
Then, 8 ml of water and 8 ml of water were sequentially added dropwise to decompose excess lithium aluminum hydride, and the mixture was stirred at room temperature for 2 hours. The resulting precipitate was removed by filtration, and the precipitate was washed with ethyl acetate. The solvent of the collected filtrate was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1) to obtain the desired product. Colorless liquid Yield 7.948 g Yield 100% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.78 (1 H, t, J = 6.0 H)
z), 4.76 (2H, d, J = 5.4Hz), 6.65 (1H, t, J = 56.4
Hz), 7.45 (2H, d, J = 8.6 Hz), 7.52 (2H, d, J = 8.
6 Hz); IR (neat) 3330, 1379, 1221, 1074, 1019 cm -1 3) 2- [4- (difluoromethyl) benzyl] -3-
Ethyl (4-fluorophenyl) -3-oxopropionate 4- (difluoromethyl) benzyl alcohol 2.65
g (16.7 mmol), triethylamine 3.50 m
1 (25.1 mmol) in 40 ml of ethyl acetate was added dropwise with a solution of 2.11 g (18.4 mmol) of methanesulfonyl chloride in 10 ml of ethyl acetate under ice-cooling.
Stirred for minutes. The resulting precipitate was removed by filtration, and the precipitate was washed with diethyl ether. The solvent of the collected filtrate was distilled off under reduced pressure to obtain a crude product of methanesulfonic acid ester as a yellow liquid. 0.67 g (16.7 mmol) of a liquid paraffin suspension of 60% sodium hydride in a solution of 3.516 g (16.73 mmol) of ethyl (4-fluorobenzoyl) acetate in 30 ml of 1,2-dimethoxyethane under ice cooling. Was added and the mixture was stirred as it was for 0.5 hour. To this was added a solution of methanesulfonic acid ester obtained above in 10 ml of 1,2-dimethoxyethane at room temperature, and the mixture was stirred at room temperature for 8 hours. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15 /
1-9 / 1) and crystallized from hexane to obtain the desired product. White crystals Yield 3.044 g Yield 52% mp 54-55 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.11 (3H, t,
J = 7.2 Hz), 3.36 (2H, d, J = 7.4 Hz), 4.10 (2H,
q, J = 7.2 Hz), 4.57 (1H, t, J = 7.5 Hz), 6.59 (1
H, t, J = 56.4 Hz), 7.12 (2H, t, J = 8.6 Hz), 7.31
(2H, d, J = 8.4Hz), 7.41 (2H, d, J = 7.8Hz), 8.0
0 (2H, dd, J = 5.4 Hz, 8.8 Hz); IR (KBr) 1721, 168
4, 1597, 1327, 1281, 1231, 1177, 1155, 1024, 847 c
m -1 ; Anal.Calcd for C 19 H 17 F 3 O 3 : C, 65.14; H, 4.89.
Found: C, 65.21; H, 4.82.4 Ethyl (2RS, 3RS) -2- [4- (difluoromethyl) benzyl] -3- (4-fluorophenyl) -3-hydroxypropionate Zinc chloride 2.17 g While stirring (16.0 mmol) in 50 ml of diethyl ether, 1.21 g (31.9 mmol) of sodium borohydride was added at room temperature, followed by stirring for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. To the resulting solution, 2.794 g of ethyl 2- [4- (difluoromethyl) benzyl] -3- (4-fluorophenyl) -3-oxopropionate (7.
(975 mmol) in 30 ml of diethyl ether was added at room temperature and stirred for 2 hours. After decomposing excess zinc borohydride by adding dilute hydrochloric acid little by little to the reaction solution,
Extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-3 / 1) to obtain the desired product. Colorless liquid Yield 2.800 g Yield 100% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.92 (3H, t, J = 7.1 H)
z), 2.90 (1H, d, J = 2.8Hz), 2.93-3.06 (3H, m), 3.
88 (2H, q, J = 7.2 Hz), 5.02 (1H, dd, J = 2.6 Hz,
4.6 Hz), 6.59 (1H, t, J = 56.6 Hz), 7.05 (2H, t, J
= 8.6 Hz), 7.17 (2H, d, J = 8.0 Hz), 7.34-7.41 (4
H, m); IR (neat) 3445, 1725, 1715, 1510, 1377, 122
3, 1026, 839 cm -1 5 ) (2RS, 3RS) -2- [4- ( difluoromethyl) benzyl] -3- (4-fluorophenyl) -3-hydroxypropionic acid (2RS, 3RS)-2- Ethyl [4- (difluoromethyl) benzyl] -3- (4-fluorophenyl) -3-hydroxypropionate 2.739 g (7.774 mmol) of methanol 20 ml-tetrahydrofuran 20 m
15.5 ml of 1N aqueous sodium hydroxide solution (1
5.5 mmol) and stirred overnight at room temperature. The reaction solution was concentrated, diluted with water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from hexane to obtain the desired product. White crystal Yield 2.232 g Yield 89% mp 132-133 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.95-3.10
(3H, m), 5.06 (1H, s), 6.60 (1H, t, J = 56.6 Hz),
7.05 (2H, t, J = 8.8 Hz), 7.16 (2H, d, J = 8.0 H
z), 7.33-7.40 (4H, m); IR (KBr) 3349, 3020-2550, 1
694, 1514, 1238, 1022, 841 cm -1 ; Anal.Calcd for C
17 H 15 F 3 O 3 : C, 62.96; H, 4.66. Found: C, 63.04; H,
4.85. 6) (4RS, 5SR) -4- [4- (difluoromethyl) benzyl] -5- (4-fluorophenyl) -1,3-
Oxazolidin-2-one (2RS, 3RS) -2- [4- (difluoromethyl) benzyl] -3- (4-fluorophenyl) -3-hydroxypropionic acid 2.060 g (6.352 mmol) solution in 40 ml of tetrahydrofuran And triethylamine.
33 ml (9.53 mmol) and 1.92 g (6.99 mmol) of diphenylphosphoryl azide were added, and the mixture was heated under reflux overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from diethyl ether / hexane. I got something. White crystal Yield 1.888 g Yield 93% mp 161-162 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.22-2.38
(2H, m), 4.25 (1H, dt, J = 4.8 Hz, 8.7 Hz), 5.02 (1
H, br s), 5.80 (1H, d, J = 8.0 Hz), 6.61 (1H, t, J
= 56.4 Hz), 7.09-7.19 (4H, m), 7.34 (2H, dd, J =
5.2 Hz, 8.6 Hz), 7.44 (2H, d, J = 8.0 Hz); IR (KB
r) 3250, 1734, 1516, 1383, 1229, 1076,1032, 849 cm
-1 ; Anal.Calcd for C 17 H 14 F 3 NO 2 : C, 63.55; H, 4.3
9; N, 4.36. Found: C, 63.63; H, 4.42; N, 4.16.7) (1RS, 2SR) -2-amino-3- [4- (difluoromethyl) phenyl] -1- (4-fluoro Phenyl) propan-1-ol (4RS, 5SR) -4- [4- (difluoromethyl) benzyl] -5- (4-fluorophenyl) -1,3-oxazolidin-2-one 1.705 g (5.307 Mmol)
And 0.85 g (21.2 mmol) of sodium hydroxide were heated under reflux in 20 ml of ethanol and 1 ml of water for 6 hours. The reaction was diluted with water and extracted twice with ethyl acetate.
The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 1.2
68g Yield 81% mp 89-90 ° C; 1 H-NMR (CDCl 3 , 200MHz) δ 2.40 (1H, d
d, J = 10.3 Hz, 13.1 Hz), 2.84 (1H, d, J = 14.0 H
z), 3.24-3.34 (1H, m), 4.67 (1H, d, J = 4.8 Hz),
6.621 (1H, t, J = 56.6 Hz), 7.08 (2H, t, J = 8.8 H
z), 7.24 (2H, d, J = 8.0 Hz), 7.38 (2H, dd, J = 5.6
Hz, 8.6 Hz), 7.44 (2H, d, J = 8.0 Hz); IR (KBr) 33
50 2870, 1593, 1508, 1381, 1215, 1047, 1001, 829 c
m -1 ; Anal.Calcd for C 16 H 16 F 3 NO: C, 65.08; H, 5.46;
N, 4.74. Found: C, 65.10; H, 5.72; N, 4.47.8) N-[(1RS, 2SR) -1- [4- (difluoromethyl) benzyl] -2- (4-fluorophenyl)- 2-
0.167 g of hydroxyethyl] -4-fluoronaphthalene-1-carboxamide (1RS, 2SR) -2-amino-3- [4- (difluoromethyl) phenyl] -1- (4-fluorophenyl) propan-1-ol (0.566 mmol),
0.11 g (0.57 mmol) of 4-fluoro-1-naphthoic acid, 1-hydroxybenzotriazole hydrate 87
While stirring mg (0.57 mmol) in 10 ml of acetonitrile, 0.11 g (0.57 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. . The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.222 g Yield 84% mp 212-213 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
84-3.05 (2H, m), 4.71-4.85 (1H, m), 4.97-5.16 (2H, m
m), 6.63 (1H, t, J = 56.4 Hz), 6.98-7.63 (14H,
m), 8.06 (1H, d, J = 8.4 Hz); IR (KBr) 3274, 1642,
1626, 1537, 1512,1229, 1030, 837 cm -1 ; Anal.Calc
d for C 27 H 21 F 4 NO 2 : C, 69.37; H, 4.53; N, 3.00. Fou
nd: C, 69.11; H, 4.72; N, 2.74.
【0298】実施例166 N-[(1RS,2SR)-1-[4-(1,1-ジフルオ
ロエチル)ベンジル]-2-(4-フルオロフェニル)-2
-ヒドロキシエチル]-4-フルオロナフタレン-1-カル
ボキサミド 1) 4-(1,1-ジフルオロエチル)安息香酸メチル (ジエチルアミノ)サルファートリフルオリド10.6
g(66.1ミリモル)のトルエン30ml溶液に−7
8℃で4-アセチル安息香酸メチル10.58g(5
5.04ミリモル)のトルエン50ml溶液を加え、室
温で1週間、50℃で1日間撹拌した。反応液にさらに
(ジエチルアミノ)サルファートリフルオリド5.32
g(33.0ミリモル)を追加し、60℃で3日間撹拌
した。反応液に炭酸水素ナトリウム水溶液を加え、撹拌
した後、トルエン層を分離した。水層は酢酸エチルで抽
出し、集めた有機層を無水硫酸マグネシウムで乾燥、溶
媒を減圧留去した。得られた残留物をシリカゲルカラム
クロマトグラフィーにて精製して(ヘキサン/酢酸エチ
ル=9/1)、目的物を得た。黄色液体 収量3.95
8g 収率34%1 H-NMR (CDCl3, 200MHz) δ 1.41 (3H, t, J = 7.1 H
z), 1.93 (3H, t, J = 18.1 Hz), 4.40 (2H, q, J = 7.
2 Hz), 7.57 (2H, d, J = 8.0 Hz), 8.10 (2H, d,J =
8.0 Hz); IR (neat) 1721, 1277, 1101 cm-1 2) 4-(1,1-ジフルオロエチル)ベンジルアルコ
ール 水素化リチウムアルミニウム1.03g(27.3ミリ
モル)のテトラヒドロフラン30ml懸濁液に、氷冷
下、4-(1,1-ジフルオロエチル)安息香酸メチル
3.894g(18.18ミリモル)のテトラヒドロフ
ラン50ml溶液を滴下し、室温で1時間撹拌した。反
応液を氷冷した後、水1ml、15%水酸化ナトリウム
水溶液1ml、水2.5mlを順次滴下して、過剰の水
素化リチウムアルミニウムを分解し、そのまま室温で2
時間撹拌した。生じた沈殿をろ過して除き、沈殿を酢酸
エチルで洗浄した。集めた濾液の溶媒を減圧留去した。
得られた残留物をシリカゲルカラムクロマトグラフィー
にて精製して(ヘキサン/酢酸エチル=3/1−1/
1)、目的物を得た。無色液体 収量2.700g 収
率86%1 H-NMR (CDCl3, 200MHz) δ 1.72 (1H, t, J = 5.8 H
z), 1.92 (3H, t, J = 18.1 Hz), 4.74 (2H, d, J = 6.
0 Hz), 7.42 (2H, d, J = 8.4 Hz), 7.51 (2H, d,J =
8.4 Hz); IR (neat) 3330, 1296, 1175, 918 cm-1 3) 2-[4-(1,1-ジフルオロエチル)ベンジ
ル]-3-(4-フルオロフェニル)-3-オキソプロピオ
ン酸エチル 4-(1,1-ジフルオロエチル)ベンジルアルコール
2.65g(15.4ミリモル)、トリエチルアミン
3.22ml(23.1ミリモル)の酢酸エチル40m
l溶液に氷冷下塩化メタンスルホニル1.94g(1
6.9ミリモル)の酢酸エチル10ml溶液を滴下し、
そのまま10分間撹拌した。生じた沈殿を濾過して除
き、沈殿をジエチルエーテルで洗浄した。集めた濾液の
溶媒を減圧留去して、メタンスルホン酸エステルの粗生
成物を黄色液体として得た。(4-フルオロベンゾイ
ル)酢酸エチル3.235g(15.39ミリモル)の
1,2-ジメトキシエタン30ml溶液に氷冷下60%
水素化ナトリウムの流動パラフィン懸濁物0.62g
(15.4ミリモル)を加え、そのまま0.5時間撹拌
した。これに上で得たメタンスルホン酸エステルの1,
2-ジメトキシエタン10ml溶液を室温で加え、室温
で8時間撹拌した。反応液を水に注ぎ、酢酸エチルで2
回抽出した。集めた有機層を無水硫酸マグネシウムで乾
燥、溶媒を減圧留去した。得られた残留物をシリカゲル
カラムクロマトグラフィーにて精製し(ヘキサン/酢酸
エチル=15/1−9/1)、ヘキサンより結晶化し
て、目的物を得た。白色結晶 収量2.790g 収率
50% mp 56-57℃; 1H-NMR (CDCl3, 200MHz) δ 1.12 (3H, t,
J = 7.2 Hz), 1.88 (3H, t, J = 18.2 Hz), 3.35 (2H,
d, J = 7.2 Hz), 4.11 (2H, q, J = 7.2 Hz), 4.57 (1
H, t, J = 7.4 Hz), 7.13 (2H, t, J = 8.6 Hz), 7.28
(2H, d, J = 8.0Hz), 7.40 (2H, d, J = 8.0 Hz), 8.00
(2H, dd, J = 5.4 Hz, 8.8 Hz); IR (KBr) 1719, 167
8, 1599, 1300, 1231, 1154, 924, 847 cm-1; Anal. Ca
lcd for C2 0H19F3O3: C, 65.93; H, 5.26. Found: C, 6
6.03; H, 5.28. 4) (2RS,3RS)-2-[4-(1,1-ジフルオ
ロエチル)ベンジル]-3-(4-フルオロフェニル)-3
-ヒドロキシプロピオン酸エチル 塩化亜鉛1.91g(14.0ミリモル)をジエチルエ
ーテル50ml中で撹拌しながら水素化ホウ素ナトリウ
ム1.06g(28.1ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、2-[4-(1,
1-ジフルオロエチル)ベンジル]-3-(4-フルオロフ
ェニル)-3-オキソプロピオン酸エチル2.556g
(7.015ミリモル)のジエチルエーテル30ml溶
液を室温で加え、そのまま2時間撹拌した。反応液に希
塩酸を少しずつ加えて過剰の水素化ホウ素亜鉛を分解し
た後、酢酸エチルで2回抽出した。集めた有機層を無水
硫酸マグネシウムで乾燥、溶媒を減圧留去した。得られ
た粗生成物をシリカゲルカラムクロマトグラフィーにて
精製し(ヘキサン/酢酸エチル=6/1−3/1)、目
的物を得た。無色液体 収量2.615g 収率100
%1 H-NMR (CDCl3, 200MHz) δ 0.92 (3H, t, J = 7.1 H
z), 1.88 (3H, t, J = 18.2 Hz), 2.91 (1H, d, J = 2.
6 Hz), 2.94-3.12 (3H, m), 3.88 (2H, q, J = 7.2Hz),
5.02 (1H, t, J = 3.6 Hz), 7.05 (2H, t, J = 8.6 H
z), 7.14 (2H, d, J= 8.2 Hz), 7.35-7.41 (4H, m); IR
(neat) 3461, 1717, 1510, 1298, 1225, 1177, 1159,
837 cm-1 5) (2RS,3RS)-2-[4-(1,1-ジフルオ
ロエチル)ベンジル]-3-(4-フルオロフェニル)-3
-ヒドロキシプロピオン酸 (2RS,3RS)-2-[4-(1,1-ジフルオロエチ
ル)ベンジル]-3-(4-フルオロフェニル)-3-ヒド
ロキシプロピオン酸エチル2.489g(6.793ミ
リモル)のメタノール20ml−テトラヒドロフラン2
0ml溶液に1N水酸化ナトリウム水溶液13.6ml
(13.6ミリモル)を加え、室温で一晩撹拌した。反
応液を濃縮、水で希釈し、1N塩酸で反応液を酸性にし
た後、酢酸エチルで2回抽出した。集めた有機層を無水
硫酸ナトリウムで乾燥、溶媒を減圧留去した。残留物を
ヘキサンより結晶化して、目的物を得た。白色結晶 収
量1.986g 収率86% mp 127-128℃; 1H-NMR (CDCl3, 200MHz) δ 1.89 (3H,
t, J = 18.1 Hz), 2.89-3.10 (3H, m), 5.06 (1H, d, J
= 3.2 Hz), 7.05 (2H, t, J = 8.7 Hz), 7.13 (2H, d,
J = 8.4 Hz), 7.33-7.39 (4H, m); IR (KBr) 3330, 30
10-2550, 1688, 1518, 1300, 1240, 1225, 1198, 839 c
m-1; Anal. Calcd for C18H17F3O3: C, 63.90; H, 5.0
6. Found: C, 64.09; H, 5.03. 6) (4RS,5SR)-4-[4-(1,1-ジフルオ
ロエチル)ベンジル]-5-(4-フルオロフェニル)-
1,3-オキサゾリジン-2-オン (2RS,3RS)-2-[4-(1,1-ジフルオロエチ
ル)ベンジル]-3-(4-フルオロフェニル)-3-ヒド
ロキシプロピオン酸1.836g(5.427ミリモ
ル)のテトラヒドロフラン40ml溶液にトリエチルア
ミン1.13ml(8.14ミリモル)、ジフェニルホ
スホリルアジド1.64g(5.97ミリモル)を加
え、一晩加熱還流した。反応液の溶媒を減圧留去し、得
られた粗生成物をシリカゲルカラムクロマトグラフィー
にて精製し(ヘキサン/酢酸エチル=3/1−1/
1)、ジエチルエーテル−ヘキサンより結晶化して、目
的物を得た。白色結晶 収量1.704g 収率94% mp 205-206℃; 1H-NMR (CDCl3, 200MHz) δ 1.90 (3H,
t, J = 18.2 Hz), 2.19-2.40 (2H, m), 4.23 (1H, dt,
J = 5.3 Hz, 8.7 Hz), 4.92 (1H, br s), 5.80 (1H, d,
J = 8.0 Hz), 7.09 (2H, d, J = 7.6 Hz), 7.14 (2H,
t, J = 8.8 Hz),7.37 (2H, dd, J = 5.0 Hz, 8.4 Hz),
7.43 (2H, d, J = 8.8 Hz); IR (KBr) 3245, 1732, 138
5, 1300, 1231, 1107, 1011, 924 cm-1; Anal. Calcd f
or C18H16F3NO2: C, 64.47; H, 4.81; N, 4.18. Found:
C, 64.47; H, 4.82; N, 4.02. 7) (1RS,2SR)-2-アミノ-3-[4-(1,
1-ジフルオロエチル)フェニル]-1-(4-フルオロフ
ェニル)プロパン-1-オール (4RS,5SR)-4-[4-(1,1-ジフルオロエチ
ル)ベンジル]-5-(4-フルオロフェニル)-1,3-
オキサゾリジン-2-オン1.557g(4.643ミリ
モル)と水酸化ナトリウム0.74g(18.6ミリモ
ル)をエタノール20ml−水1ml中で、6時間加熱
還流した。反応液を水で希釈し、酢酸エチルで2回抽出
した。集めた有機層を無水硫酸ナトリウムで乾燥、溶媒
を減圧留去した。残留物をシリカゲル(APSタイプ)
カラムクロマトグラフィーにて精製し(ヘキサン/酢酸
エチル=3/1−酢酸エチル)、目的物を得た。黄色液
体 収量0.916g 収率64%1 H-NMR (CDCl3, 200MHz) δ 1.91 (3H, t, J = 18.3 H
z), 2.38 (1H, dd, J = 10.4 Hz, 13.6 Hz), 2.83 (1H,
dd, J = 3.0 Hz, 13.8 Hz), 3.29 (1H, ddd, J =3.3 H
z, 4.8 Hz, 10.3 Hz), 4.67 (1H, d, J = 5.2 Hz), 7.0
8 (2H, t, J = 8.8 Hz), 7.20 (2H, d, J = 7.6 Hz),
7.38 (2H, dd, J = 5.6 Hz, 8.4 Hz), 7.44(2H, d, J =
7.6 Hz); IR (neat) 3360-2860, 1605, 1508, 2385, 1
298, 1223,1175, 918, 826 cm-1 8) N-[(1RS,2SR)-1-[4-(1,1-ジ
フルオロエチル)ベンジル]-2-(4-フルオロフェニ
ル)-2-ヒドロキシエチル]-4-フルオロナフタレン-
1-カルボキサミド (1RS,2SR)-2-アミノ-3-[4-(1,1-ジフ
ルオロエチル)フェニル]-1-(4-フルオロフェニ
ル)プロパン-1-オール0.173g(0.559ミリ
モル)、4-フルオロ-1-ナフトエ酸0.11g(0.
56ミリモル)、1-ヒドロキシベンゾトリアゾール水
和物86mg(0.56ミリモル)をアセトニトリル1
0ml中で撹拌しながら1-エチル-3-(3-ジメチルア
ミノプロピル)カルボジイミド・塩酸塩0.11g
(0.56ミリモル)を加え、室温で一晩撹拌した。反
応液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶液
で洗浄、無水硫酸マグネシウムで乾燥、シリカゲルを通
した後、溶媒を減圧留去した。得られた残留物を酢酸エ
チル−ジイソプロピルエーテルより結晶化して、目的物
を得た。白色結晶 収量0.245g 収率91% mp 220-221℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 1.
90 (3H, t, J = 18.1 Hz), 2.84-3.06 (2H, m), 4.69-
4.84 (1H, m), 5.03 (1H, t, J = 3.5 Hz), 5.16(1H,
d, J = 3.8 Hz), 6.99-7.12 (3H, m), 7.18-7.30 (4H,
m), 7.39-7.65 (7H, m), 8.06 (1H, d, J = 8.4 Hz); I
R (KBr) 3281, 1642, 1626, 1539, 1512, 1298, 1231,
1163, 843, 835, 758 cm-1; Anal. Calcd for C28H23F4
NO2: C, 69.85; H, 4.81; N, 2.91. Found: C, 69.70;
H, 4.98; N, 2.84.Example 166 N-[(1RS, 2SR) -1- [4- (1,1-difluoroethyl) benzyl] -2- (4-fluorophenyl) -2
-Hydroxyethyl] -4-fluoronaphthalene-1-carboxamide 1) Methyl 4- (1,1-difluoroethyl) benzoate (diethylamino) sulfur trifluoride 10.6
g (66.1 mmol) in 30 ml toluene solution
At 8.degree. C., 10.58 g of methyl 4-acetylbenzoate (5.
(5.04 mmol) in 50 ml of toluene was added, and the mixture was stirred at room temperature for 1 week and at 50 ° C. for 1 day. The reaction mixture was further added with (diethylamino) sulfur trifluoride 5.32.
g (33.0 mmol) was added, and the mixture was stirred at 60 ° C. for 3 days. An aqueous solution of sodium hydrogen carbonate was added to the reaction solution, and after stirring, the toluene layer was separated. The aqueous layer was extracted with ethyl acetate, the collected organic layers were dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 9/1) to obtain the desired product. Yellow liquid yield 3.95
8 g Yield 34% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.41 (3H, t, J = 7.1 H
z), 1.93 (3H, t, J = 18.1 Hz), 4.40 (2H, q, J = 7.
2 Hz), 7.57 (2H, d, J = 8.0 Hz), 8.10 (2H, d, J =
8.0 Hz); IR (neat) 1721, 1277, 1101 cm -1 2) 4- (1,1-difluoroethyl) benzyl alcohol To a suspension of 1.03 g (27.3 mmol) of lithium aluminum hydride in 30 ml of tetrahydrofuran. Under ice cooling, a solution of 3.894 g (18.18 mmol) of methyl 4- (1,1-difluoroethyl) benzoate in 50 ml of tetrahydrofuran was added dropwise, and the mixture was stirred at room temperature for 1 hour. After cooling the reaction solution with ice, 1 ml of water, 1 ml of a 15% aqueous sodium hydroxide solution and 2.5 ml of water are successively added dropwise to decompose excess lithium aluminum hydride and leave it at room temperature for 2 hours.
Stirred for hours. The resulting precipitate was removed by filtration, and the precipitate was washed with ethyl acetate. The solvent of the collected filtrate was distilled off under reduced pressure.
The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 /
1) The desired product was obtained. Colorless liquid Yield 2.700 g Yield 86% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.72 (1 H, t, J = 5.8 H)
z), 1.92 (3H, t, J = 18.1 Hz), 4.74 (2H, d, J = 6.
0 Hz), 7.42 (2H, d, J = 8.4 Hz), 7.51 (2H, d, J =
8.4 Hz); IR (neat) 3330, 1296, 1175, 918 cm -1 3) 2- [4- (1,1-difluoroethyl) benzyl] -3- (4-fluorophenyl) -3-oxopropionic acid Ethyl 4- (1,1-difluoroethyl) benzyl alcohol 2.65 g (15.4 mmol), triethylamine 3.22 ml (23.1 mmol) ethyl acetate 40 m
1.94 g of methanesulfonyl chloride (1
6.9 mmol) in 10 ml of ethyl acetate was added dropwise,
The mixture was stirred for 10 minutes. The resulting precipitate was removed by filtration, and the precipitate was washed with diethyl ether. The solvent of the collected filtrate was distilled off under reduced pressure to obtain a crude product of methanesulfonic acid ester as a yellow liquid. To a solution of 3.235 g (15.39 mmol) of ethyl (4-fluorobenzoyl) acetate in 30 ml of 1,2-dimethoxyethane was added 60% under ice-cooling.
0.62 g of liquid paraffin suspension of sodium hydride
(15.4 mmol) and the mixture was stirred for 0.5 hour. The methanesulfonic acid ester 1,
A 10 ml solution of 2-dimethoxyethane was added at room temperature, and the mixture was stirred at room temperature for 8 hours. The reaction solution was poured into water, and extracted with ethyl acetate.
Extracted times. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-9 / 1), and crystallized from hexane to obtain the desired product. White crystals Yield 2.790 g Yield 50% mp 56-57 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.12 (3H, t,
J = 7.2 Hz), 1.88 (3H, t, J = 18.2 Hz), 3.35 (2H,
d, J = 7.2 Hz), 4.11 (2H, q, J = 7.2 Hz), 4.57 (1
H, t, J = 7.4 Hz), 7.13 (2H, t, J = 8.6 Hz), 7.28
(2H, d, J = 8.0Hz), 7.40 (2H, d, J = 8.0Hz), 8.00
(2H, dd, J = 5.4 Hz, 8.8 Hz); IR (KBr) 1719, 167
8, 1599, 1300, 1231, 1154, 924, 847 cm -1 ; Anal.Ca
lcd for C 2 0 H 19 F 3 O 3 : C, 65.93; H, 5.26. Found: C, 6
6.03; H, 5.28.4) (2RS, 3RS) -2- [4- (1,1-difluoroethyl) benzyl] -3- (4-fluorophenyl) -3
Ethyl-hydroxypropionate While stirring 1.91 g (14.0 mmol) of zinc chloride in 50 ml of diethyl ether, 1.06 g (28.1 mmol) of sodium borohydride was added at room temperature, and the mixture was stirred as it was for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. In the obtained solution, 2- [4- (1,
2.556 g of ethyl 1-difluoroethyl) benzyl] -3- (4-fluorophenyl) -3-oxopropionate
(7.015 mmol) in 30 ml of diethyl ether was added at room temperature, and the mixture was stirred for 2 hours. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-3 / 1) to obtain the desired product. Colorless liquid Yield 2.615 g Yield 100
% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.92 (3H, t, J = 7.1 H
z), 1.88 (3H, t, J = 18.2 Hz), 2.91 (1H, d, J = 2.
6 Hz), 2.94-3.12 (3H, m), 3.88 (2H, q, J = 7.2Hz),
5.02 (1H, t, J = 3.6 Hz), 7.05 (2H, t, J = 8.6 H
z), 7.14 (2H, d, J = 8.2 Hz), 7.35-7.41 (4H, m); IR
(neat) 3461, 1717, 1510, 1298, 1225, 1177, 1159,
837 cm -1 5) (2RS, 3RS) -2- [4- (1,1- difluoroethyl) benzyl] -3- (4-fluorophenyl) -3
Ethyl 2-hydroxypropionate (2RS, 3RS) -2- [4- (1,1-difluoroethyl) benzyl] -3- (4-fluorophenyl) -3-hydroxypropionate 2.489 g (6.793 mmol) 20 ml of methanol-tetrahydrofuran 2
13.6 ml of 1N aqueous sodium hydroxide solution in 0 ml solution
(13.6 mmol) and stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from hexane to obtain the desired product. White crystal Yield 1.986 g Yield 86% mp 127-128 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.89 (3H,
t, J = 18.1 Hz), 2.89-3.10 (3H, m), 5.06 (1H, d, J
= 3.2 Hz), 7.05 (2H, t, J = 8.7 Hz), 7.13 (2H, d,
J = 8.4 Hz), 7.33-7.39 (4H, m); IR (KBr) 3330, 30
10-2550, 1688, 1518, 1300, 1240, 1225, 1198, 839 c
m -1 ; Anal.Calcd for C 18 H 17 F 3 O 3 : C, 63.90; H, 5.0
6. Found: C, 64.09; H, 5.03.6) (4RS, 5SR) -4- [4- (1,1-difluoroethyl) benzyl] -5- (4-fluorophenyl)-
1,36-oxazolidin-2-one (2RS, 3RS) -2- [4- (1,1-difluoroethyl) benzyl] -3- (4-fluorophenyl) -3-hydroxypropionic acid 1.836 g (5 1.427 ml) of triethylamine and 1.64 g (5.97 mmol) of diphenylphosphoryl azide were added to a 40 ml solution of tetrahydrofuran, and the mixture was heated under reflux overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the resulting crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1).
1) Crystallization from diethyl ether-hexane gave the desired product. White crystals Yield 1.704 g Yield 94% mp 205-206 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.90 (3H,
t, J = 18.2 Hz), 2.19-2.40 (2H, m), 4.23 (1H, dt,
J = 5.3 Hz, 8.7 Hz), 4.92 (1H, br s), 5.80 (1H, d,
J = 8.0 Hz), 7.09 (2H, d, J = 7.6 Hz), 7.14 (2H,
t, J = 8.8 Hz), 7.37 (2H, dd, J = 5.0 Hz, 8.4 Hz),
7.43 (2H, d, J = 8.8 Hz); IR (KBr) 3245, 1732, 138
5, 1300, 1231, 1107, 1011, 924 cm -1 ; Anal.Calcd f
or C 18 H 16 F 3 NO 2 : C, 64.47; H, 4.81; N, 4.18. Found:
C, 64.47; H, 4.82; N, 4.02.7) (1RS, 2SR) -2-amino-3- [4- (1,
1-difluoroethyl) phenyl] -1- (4-fluorophenyl) propan-1-ol (4RS, 5SR) -4- [4- (1,1-difluoroethyl) benzyl] -5- (4-fluorophenyl ) -1, 3-
1.557 g (4.643 mmol) of oxazolidine-2-one and 0.74 g (18.6 mmol) of sodium hydroxide were heated to reflux in 20 ml of ethanol-1 ml of water for 6 hours. The reaction was diluted with water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. Residue is silica gel (APS type)
Purification by column chromatography (hexane / ethyl acetate = 3 / 1-ethyl acetate) gave the desired product. Yellow liquid Yield 0.916 g Yield 64% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.91 (3H, t, J = 18.3 H)
z), 2.38 (1H, dd, J = 10.4 Hz, 13.6 Hz), 2.83 (1H,
dd, J = 3.0 Hz, 13.8 Hz), 3.29 (1H, ddd, J = 3.3 H
z, 4.8 Hz, 10.3 Hz), 4.67 (1H, d, J = 5.2 Hz), 7.0
8 (2H, t, J = 8.8 Hz), 7.20 (2H, d, J = 7.6 Hz),
7.38 (2H, dd, J = 5.6 Hz, 8.4 Hz), 7.44 (2H, d, J =
7.6 Hz); IR (neat) 3360-2860, 1605, 1508, 2385, 1
298, 1223,1175, 918, 826 cm - 18 18) N-[(1RS, 2SR) -1- [4- (1,1-difluoroethyl) benzyl] -2- (4-fluorophenyl) -2- Hydroxyethyl] -4-fluoronaphthalene-
1-carboxamide (1RS, 2SR) -2-amino-3- [4- (1,1-difluoroethyl) phenyl] -1- (4-fluorophenyl) propan-1-ol 0.173 g (0.559 mmol) ) 4-Fluoro-1-naphthoic acid 0.11 g (0.
86 mg (0.56 mmol) of 1-hydroxybenzotriazole hydrate was dissolved in acetonitrile 1
0.11 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride while stirring in 0 ml
(0.56 mmol) and stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether to obtain the desired product. White crystals Yield 0.245 g Yield 91% mp 220-221 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 1.
90 (3H, t, J = 18.1 Hz), 2.84-3.06 (2H, m), 4.69-
4.84 (1H, m), 5.03 (1H, t, J = 3.5 Hz), 5.16 (1H,
d, J = 3.8 Hz), 6.99-7.12 (3H, m), 7.18-7.30 (4H,
m), 7.39-7.65 (7H, m), 8.06 (1H, d, J = 8.4 Hz); I
R (KBr) 3281, 1642, 1626, 1539, 1512, 1298, 1231,
1163, 843, 835, 758 cm -1;. Anal Calcd for C 28 H 23 F 4
NO 2 : C, 69.85; H, 4.81; N, 2.91. Found: C, 69.70;
H, 4.98; N, 2.84.
【0299】実施例167 N-[(1RS,2SR)-1-[(2,2-ジフルオロ-
1,3-ベンゾジオキソール-5-イル)メチル]-2-
(4-フルオロフェニル)-2-ヒドロキシエチル]-4-
フルオロナフタレン-1-カルボキサミド 1) (2,2-ジフルオロ-1,3-ベンゾジオキソー
ル-5-イル)メタノール水素化リチウムアルミニウム
1.86g(48.9ミリモル)のテトラヒドロフラン
30ml懸濁液に、氷冷下、2,2-ジフルオロ-1,3
-ベンゾジオキソール-5-カルボン酸4.942g(2
4.45ミリモル)のテトラヒドロフラン30ml溶液
を滴下し、室温で1時間撹拌した。反応液を氷冷した
後、水2ml、15%水酸化ナトリウム水溶液2ml、
水5mlを順次滴下して、過剰の水素化リチウムアルミ
ニウムを分解し、そのまま室温で2時間撹拌した。生じ
た沈殿をろ過して除き、沈殿を酢酸エチルで洗浄した。
集めた濾液の溶媒を減圧留去した。得られた残留物をシ
リカゲルカラムクロマトグラフィーにて精製して(ヘキ
サン/酢酸エチル=6/1−1/1)、目的物を得た。
無色液体 収量3.658g 収率80%1 H-NMR (CDCl3, 200MHz) δ 1.73 (1H, t, J = 6.0 H
z), 4.68 (2H, d, J = 5.8Hz), 7.02 (1H, d, J = 8.4
Hz), 7.08 (1H, d, J = 8.0 Hz), 7.23 (1H, s);IR (ne
at) 3318, 1501, 1449, 1238, 1148, 1036 cm-1 2) 2-[(2,2-ジフルオロ-1,3-ベンゾジオキ
ソール-5-イル)メチル]-3-(4-フルオロフェニ
ル)-3-オキソプロピオン酸エチル (2,2-ジフルオロ-1,3-ベンゾジオキソール-5-
イル)メタノール3.60g(19.1ミリモル)、ト
リエチルアミン4.00ml(28.7ミリモル)の酢
酸エチル40ml溶液に氷冷下塩化メタンスルホニル
2.41g(21.1ミリモル)の酢酸エチル10ml
溶液を滴下し、そのまま10分間撹拌した。生じた沈殿
を濾過して除き、沈殿をジエチルエーテルで洗浄した。
集めた濾液の溶媒を減圧留去して、メタンスルホン酸エ
ステルの粗生成物を黄色液体として得た。(4-フルオ
ロベンゾイル)酢酸エチル4.024g(19.14ミ
リモル)の1,2-ジメトキシエタン30ml溶液に氷
冷下60%水素化ナトリウムの流動パラフィン懸濁物
0.77g(19.1ミリモル)を加え、そのまま0.
5時間撹拌した。これに上で得たメタンスルホン酸エス
テルの1,2-ジメトキシエタン10ml溶液を室温で
加え、室温で8時間撹拌した。反応液を水に注ぎ、酢酸
エチルで2回抽出した。集めた有機層を無水硫酸マグネ
シウムで乾燥、溶媒を減圧留去した。得られた残留物を
シリカゲルカラムクロマトグラフィーにて精製し(ヘキ
サン/酢酸エチル=15/1−9/1)、ヘキサンより
結晶化して、目的物を得た。白色結晶 収量5.047
g 収率69% mp 66-67℃; 1H-NMR (CDCl3, 200MHz) δ 1.13 (3H, t,
J = 7.2 Hz), 3.31 (2H, d, J = 7.4 Hz), 4.11 (2H,
q, J = 7.2 Hz), 4.51 (1H, t, J = 7.3 Hz), 6.93-6.9
7 (3H, m), 7.14 (2H, t, J = 8.6 Hz), 8.00 (2H, dd,
J = 5.4 Hz, 9.0Hz); IR (KBr) 1725, 1682, 1597, 15
01, 1258, 1233, 1150 cm-1; Anal. Calcd for C19H15F
3O5: C, 60.00; H, 3.98. Found: C, 60.03; H, 4.02. 3) (2RS,3RS)-2-[(2,2-ジフルオロ-
1,3-ベンゾジオキソール-5-イル)メチル]-3-
(4-フルオロフェニル)-3-ヒドロキシプロピオン酸
エチル 塩化亜鉛3.50g(25.7ミリモル)をジエチルエ
ーテル50ml中で撹拌しながら水素化ホウ素ナトリウ
ム1.94g(51.4ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、2-[(2,2-
ジフルオロ-1,3-ベンゾジオキソール-5-イル)メチ
ル]-3-(4-フルオロフェニル)-3-オキソプロピオ
ン酸エチル4.888g(12.85ミリモル)のジエ
チルエーテル30ml溶液を室温で加え、そのまま2時
間撹拌した。反応液に希塩酸を少しずつ加えて過剰の水
素化ホウ素亜鉛を分解した後、酢酸エチルで2回抽出し
た。集めた有機層を無水硫酸マグネシウムで乾燥、溶媒
を減圧留去した。得られた粗生成物をシリカゲルカラム
クロマトグラフィーにて精製し(ヘキサン/酢酸エチル
=6/1−3/1)、目的物を得た。無色液体 収量
4.849g 収率99%1 H-NMR (CDCl3, 200MHz) δ 0.96 (3H, t, J = 7.1 H
z), 2.82 (1H, d, J = 2.6Hz), 2.85-3.02 (3H, m), 3.
91 (2H, q, J = 7.1 Hz), 4.99 (1H, dd, J = 2.5Hz,
5.1 Hz), 6.75-6.81 (2H, m), 6.91 (1H, d, J = 8.0 H
z), 7.05 (2H, t,J = 8.6 Hz), 7.36 (2H, dd, J = 5.3
Hz, 8.7 Hz); IR (neat) 3468, 1725, 1499, 1449, 12
40, 1155, 1036, 839 cm-1 4) (2RS,3RS)-2-[(2,2-ジフルオロ-
1,3-ベンゾジオキソール-5-イル)メチル]-3-
(4-フルオロフェニル)-3-ヒドロキシプロピオン酸 (2RS,3RS)-2-[(2,2-ジフルオロ-1,3
-ベンゾジオキソール-5-イル)メチル]-3-(4-フル
オロフェニル)-3-ヒドロキシプロピオン酸エチル4.
725g(12.36ミリモル)のメタノール30ml
−テトラヒドロフラン30ml溶液に1N水酸化ナトリ
ウム水溶液24.7ml(24.7ミリモル)を加え、
室温で一晩撹拌した。反応液を濃縮、水で希釈し、1N
塩酸で反応液を酸性にした後、酢酸エチルで2回抽出し
た。集めた有機層を無水硫酸ナトリウムで乾燥、溶媒を
減圧留去した。残留物をヘキサンより結晶化して、目的
物を得た。白色結晶 収量3.743g 収率86% mp 115-117℃; 1H-NMR (CDCl3, 200MHz) δ 2.97 (3H,
s), 5.03-5.06 (1H, m),6.76 (1H, dd, J = 1.6 Hz, 8.
2 Hz), 6.80 (1H, s), 6.90 (1H, d, J = 8.2 Hz), 7.0
5 (2H, t, J = 8.6 Hz), 7.36 (2H, dd, J = 5.4 Hz,
8.6 Hz); IR (KBr) 3333, 3100-2550, 1694, 1518, 149
9, 1447, 1273, 1260, 1244, 1163, 1148,841 cm-1; An
al. Calcd for C17H13F3O5: C, 57.63; H, 3.70. Foun
d: C, 57.64; H, 3.51. 5) (4RS,5SR)-4-[(2,2-ジフルオロ-
1,3-ベンゾジオキソール-5-イル)メチル]-5-
(4-フルオロフェニル)-1,3-オキサゾリジン-2-
オン (2RS,3RS)-2-[(2,2-ジフルオロ-1,3
-ベンゾジオキソール-5-イル)メチル]-3-(4-フル
オロフェニル)-3-ヒドロキシプロピオン酸3.387
g(9.560ミリモル)のテトラヒドロフラン50m
l溶液にトリエチルアミン2.00ml(14.3ミリ
モル)、ジフェニルホスホリルアジド2.89g(1
0.5ミリモル)を加え、一晩加熱還流した。反応液の
溶媒を減圧留去し、得られた粗生成物をシリカゲルカラ
ムクロマトグラフィーにて精製し(ヘキサン/酢酸エチ
ル=3/1−1/1)、ジエチルエーテル−ヘキサンよ
り結晶化して、目的物を得た。白色結晶 収量3.14
4g 収率94% mp 177-178℃; 1H-NMR (CDCl3, 200MHz) δ 2.16-2.35
(2H, m), 4.13-4.25 (1H, m), 5.10 (1H, br s), 5.79
(1H, d, J = 7.6 Hz), 6.72 (1H, d, J = 8.4 Hz), 6.7
4 (1H, s), 6.98 (1H, d, J = 8.6 Hz), 7.14 (2H, t,
J = 8.6 Hz), 7.36 (2H, dd, J = 5.0 Hz, 8.8 Hz); IR
(KBr) 3241, 3139, 1736, 1501, 1258, 1238, 1152 cm
-1; Anal. Calcd for C17H12F3NO4: C, 58.13; H, 3.4
4; N, 3.99.Found: C, 58.16; H, 3.42; N, 3.85. 6) (1RS,2SR)-2-アミノ-3-(2,2-ジ
フルオロ-1,3-ベンゾジオキソール-5-イル)-1-
(4-フルオロフェニル)プロパン-1-オール (4RS,5SR)-4-[(2,2-ジフルオロ-1,3
-ベンゾジオキソール-5-イル)メチル]-5-(4-フル
オロフェニル)-1,3-オキサゾリジン-2-オン2.9
62g(8.432ミリモル)と水酸化ナトリウム1.
35g(33.7ミリモル)をエタノール30ml−水
1.5ml中で、6時間加熱還流した。反応液を水で希
釈し、酢酸エチルで2回抽出した。集めた有機層を無水
硫酸ナトリウムで乾燥、溶媒を減圧留去した。残留物を
シリカゲル(APSタイプ)カラムクロマトグラフィー
にて精製し(ヘキサン/酢酸エチル=3/1−酢酸エチ
ル)、ジイソプロピルエーテル−ヘキサンより結晶化し
て、目的物を得た。白色結晶 収量2.225g 収率
81% mp 77-78℃; 1H-NMR (CDCl3, 200MHz) δ 2.36 (1H, d
d, J = 10.1 Hz, 13.7 Hz), 2.81 (1H, dd, J = 3.1 H
z, 13.7 Hz), 3.22 (1H, ddd, J = 3.2 Hz, 5.2 Hz, 1
0.0 Hz), 4.63 (1H, d, J = 5.2 Hz), 6.82-6.87 (2H,
m), 6.97 (1H, d, J= 8.0 Hz), 7.08 (2H, t, J = 8.8
Hz), 7.37 (2H, dd, J = 5.4 Hz, 8.6 Hz);IR (KBr) 33
40-2865, 1501, 1447, 1262, 1242, 1213, 1157, 1063,
779 cm-1;Anal. Calcd for C16H14F3NO3: C, 59.08;
H, 4.34; N, 4.31. Found: C, 59.08; H, 4.39; N, 4.1
0. 7) N-[(1RS,2SR)-1-[(2,2-ジフル
オロ-1,3-ベンゾジオキソール-5-イル)メチル]-
2-(4-フルオロフェニル)-2-ヒドロキシエチル]-
4-フルオロナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-3-(2,2-ジフルオ
ロ-1,3-ベンゾジオキソール-5-イル)-1-(4-フ
ルオロフェニル)プロパン-1-オール0.167g
(0.513ミリモル)、4-フルオロ-1-ナフトエ酸
0.10g(0.51ミリモル)、1-ヒドロキシベン
ゾトリアゾール水和物79mg(0.51ミリモル)を
アセトニトリル10ml中で撹拌しながら1-エチル-3
-(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩0.10g(0.51ミリモル)を加え、室温で一晩
撹拌した。反応液を酢酸エチルに希釈し、炭酸水素ナト
リウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、シ
リカゲルを通した後、溶媒を減圧留去した。得られた残
留物をジイソプロピルエーテル−ヘキサンより結晶化し
て、目的物を得た。白色結晶 収量0.230g 収率
90% mp 219-220℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
85 (1H, dd, J = 10.0Hz, 14.4 Hz), 2.97 (1H, dd, J
= 4.2 Hz, 13.8 Hz), 4.64-4.78 (1H, m), 5.01(1H, t,
J = 3.8 Hz), 5.10 (1H, d, J = 3.6 Hz), 6.93-7.13
(6H, m), 7.25-7.58 (6H, m), 7.69 (1H, d, J = 8.0 H
z), 8.07 (1H, d, J = 8.0 Hz); IR (KBr) 3266, 1644,
1626, 1541, 1514, 1497, 1244, 1146 cm-1; Anal. Ca
lcd for C 27H19F4NO4: C, 65.19; H, 3.85; N, 2.82. F
ound: C, 65.22; H, 3.87; N, 2.57.Example 167 N-[(1RS, 2SR) -1-[(2,2-difluoro-
1,3-benzodioxol-5-yl) methyl] -2-
(4-Fluorophenyl) -2-hydroxyethyl] -4-
Fluoronaphthalene-1-carboxamide 1) (2,2-difluoro-1,3-benzodioxo)
Ru-5-yl) methanol lithium aluminum hydride
1.86 g (48.9 mmol) of tetrahydrofuran
To a 30 ml suspension was added 2,2-difluoro-1,3 under ice-cooling.
-Benzodioxole-5-carboxylic acid 4.942 g (2
Solution of 4.45 mmol) in 30 ml of tetrahydrofuran
Was added dropwise and stirred at room temperature for 1 hour. The reaction was cooled on ice
Then, 2 ml of water, 2 ml of 15% aqueous sodium hydroxide solution,
5 ml of water is added dropwise to the excess lithium aluminum hydride
The nitrogen was decomposed and the mixture was stirred at room temperature for 2 hours. Arising
The precipitated precipitate was removed by filtration, and the precipitate was washed with ethyl acetate.
The solvent of the collected filtrate was distilled off under reduced pressure. The resulting residue is
Purify by Ricagel column chromatography
Sun / ethyl acetate = 6 / 1-1 / 1) to obtain the desired product.
Colorless liquid yield 3.658 g yield 80%1 H-NMR (CDClThree, 200MHz) δ 1.73 (1H, t, J = 6.0 H
z), 4.68 (2H, d, J = 5.8Hz), 7.02 (1H, d, J = 8.4
Hz), 7.08 (1H, d, J = 8.0 Hz), 7.23 (1H, s); IR (ne
at) 3318, 1501, 1449, 1238, 1148, 1036 cm-1 2) 2-[(2,2-difluoro-1,3-benzodioxy)
Sole-5-yl) methyl] -3- (4-fluorophenyl)
E) -Ethyl 3-oxopropionate (2,2-difluoro-1,3-benzodioxole-5-
Il) 3.60 g (19.1 mmol) of methanol,
4.00 ml (28.7 mmol) of vinegar
Methanesulfonyl chloride in a 40 ml solution of ethyl acid under ice-cooling
2.41 g (21.1 mmol) of ethyl acetate 10 ml
The solution was added dropwise and stirred for 10 minutes. The resulting precipitate
Was removed by filtration, and the precipitate was washed with diethyl ether.
The solvent of the collected filtrate was distilled off under reduced pressure to give methanesulfonic acid
The crude product of steal was obtained as a yellow liquid. (4-Fluoro
4.024 g (19.14 mi) of ethyl (benzobenzoyl) acetate
Ice) in a 30 ml solution of 1,2-dimethoxyethane
Liquid paraffin suspension of 60% sodium hydride under cooling
0.77 g (19.1 mmol) was added.
Stir for 5 hours. Methanesulfonic acid S obtained above
10 ml solution of ter in 1,2-dimethoxyethane at room temperature
The mixture was stirred at room temperature for 8 hours. Pour the reaction solution into water and add acetic acid
Extracted twice with ethyl. The collected organic layer is dried over anhydrous magnesium sulfate.
After drying with sodium, the solvent was distilled off under reduced pressure. The resulting residue
Purify by silica gel column chromatography.
Sun / ethyl acetate = 15 / 1-9 / 1), from hexane
Crystallization gave the desired product. White crystals Yield 5.047
g yield 69% mp 66-67 ° C;1H-NMR (CDClThree, 200MHz) δ 1.13 (3H, t,
J = 7.2 Hz), 3.31 (2H, d, J = 7.4 Hz), 4.11 (2H,
q, J = 7.2 Hz), 4.51 (1H, t, J = 7.3 Hz), 6.93-6.9
7 (3H, m), 7.14 (2H, t, J = 8.6 Hz), 8.00 (2H, dd,
J = 5.4 Hz, 9.0Hz); IR (KBr) 1725, 1682, 1597, 15
01, 1258, 1233, 1150 cm-1; Anal. Calcd for C19H15F
ThreeOFive: C, 60.00; H, 3.98. Found: C, 60.03; H, 4.02. 3) (2RS, 3RS) -2-[(2,2-difluoro-
1,3-benzodioxol-5-yl) methyl] -3-
(4-fluorophenyl) -3-hydroxypropionic acid
Ethyl 3.55 g (25.7 mmol) of zinc chloride was added to diethyl ether.
Sodium borohydride while stirring in 50 ml
1.94 g (51.4 mmol) were added at room temperature and the
The mixture was stirred for 2 hours. The insolubles of the mixture are removed by filtration.
Washed with ethyl ether), zinc borohydride in diethyl
An ether solution was obtained. 2-[(2,2-
Difluoro-1,3-benzodioxol-5-yl) methyl
Ru] -3- (4-Fluorophenyl) -3-oxopropio
4.888 g (12.85 mmol) of ethyl acetate
Add 30 ml of chilled ether solution at room temperature
While stirring. Dilute hydrochloric acid is added to the reaction solution little by little and excess water is added.
After decomposing the zinc borohydride, extract twice with ethyl acetate
Was. Dry the collected organic layer over anhydrous magnesium sulfate,
Was distilled off under reduced pressure. The resulting crude product is passed through a silica gel column.
Purify by chromatography (hexane / ethyl acetate
= 6 / 1-3 / 1) to obtain the desired product. Colorless liquid yield
4.849 g, 99% yield1 H-NMR (CDClThree, 200MHz) δ 0.96 (3H, t, J = 7.1 H
z), 2.82 (1H, d, J = 2.6Hz), 2.85-3.02 (3H, m), 3.
91 (2H, q, J = 7.1 Hz), 4.99 (1H, dd, J = 2.5 Hz,
5.1 Hz), 6.75-6.81 (2H, m), 6.91 (1H, d, J = 8.0 H
z), 7.05 (2H, t, J = 8.6 Hz), 7.36 (2H, dd, J = 5.3
Hz, 8.7 Hz); IR (neat) 3468, 1725, 1499, 1449, 12
40, 1155, 1036, 839 cm-1 4) (2RS, 3RS) -2-[(2,2-difluoro-
1,3-benzodioxol-5-yl) methyl] -3-
(4-fluorophenyl) -3-hydroxypropionic acid (2RS, 3RS) -2-[(2,2-difluoro-1,3
-Benzodioxol-5-yl) methyl] -3- (4-fur
3. ethyl (olophenyl) -3-hydroxypropionate
30 ml of 725 g (12.36 mmol) of methanol
-1N sodium hydroxide in 30 ml of tetrahydrofuran solution
24.7 ml (24.7 mmol) of an aqueous solution of
Stirred overnight at room temperature. Concentrate the reaction solution, dilute with water, and add 1N
After acidifying the reaction solution with hydrochloric acid, the mixture was extracted twice with ethyl acetate.
Was. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was removed.
It was distilled off under reduced pressure. The residue was crystallized from hexane,
I got something. White crystals Yield 3.743 g Yield 86% mp 115-117 ° C;1H-NMR (CDClThree, 200MHz) δ 2.97 (3H,
s), 5.03-5.06 (1H, m), 6.76 (1H, dd, J = 1.6 Hz, 8.
2 Hz), 6.80 (1H, s), 6.90 (1H, d, J = 8.2 Hz), 7.0
5 (2H, t, J = 8.6 Hz), 7.36 (2H, dd, J = 5.4 Hz,
8.6 Hz); IR (KBr) 3333, 3100-2550, 1694, 1518, 149
9, 1447, 1273, 1260, 1244, 1163, 1148,841 cm-1; An
al. Calcd for C17H13FThreeOFive: C, 57.63; H, 3.70. Foun
d: C, 57.64; H, 3.51.5) (4RS, 5SR) -4-[(2,2-difluoro-
1,3-benzodioxol-5-yl) methyl] -5-
(4-Fluorophenyl) -1,3-oxazolidine-2-
ON (2RS, 3RS) -2-[(2,2-difluoro-1,3
-Benzodioxol-5-yl) methyl] -3- (4-fur
Orophenyl) -3-hydroxypropionic acid 3.387
g (9.560 mmol) of tetrahydrofuran 50 m
1.00 ml of triethylamine (14.3 mm
Mol), 2.89 g of diphenylphosphoryl azide (1
(0.5 mmol) and heated to reflux overnight. Reaction solution
The solvent was distilled off under reduced pressure.
Purification by column chromatography (hexane / ethyl acetate
= 3/1-1/1), from diethyl ether-hexane
Recrystallization gave the desired product. White crystals Yield 3.14
4g yield 94% mp 177-178 ° C;1H-NMR (CDClThree, 200MHz) δ 2.16-2.35
(2H, m), 4.13-4.25 (1H, m), 5.10 (1H, br s), 5.79
(1H, d, J = 7.6 Hz), 6.72 (1H, d, J = 8.4 Hz), 6.7
4 (1H, s), 6.98 (1H, d, J = 8.6 Hz), 7.14 (2H, t,
J = 8.6 Hz), 7.36 (2H, dd, J = 5.0 Hz, 8.8 Hz); IR
(KBr) 3241, 3139, 1736, 1501, 1258, 1238, 1152 cm
-1; Anal. Calcd for C17H12FThreeNOFour: C, 58.13; H, 3.4
4; N, 3.99.Found: C, 58.16; H, 3.42; N, 3.85. 6) (1RS, 2SR) -2-amino-3- (2,2-di)
Fluoro-1,3-benzodioxol-5-yl) -1-
(4-fluorophenyl) propan-1-ol (4RS, 5SR) -4-[(2,2-difluoro-1,3
-Benzodioxol-5-yl) methyl] -5- (4-fur
(Orophenyl) -1,3-oxazolidin-2-one 2.9
62 g (8.432 mmol) and sodium hydroxide 1.
35 g (33.7 mmol) of ethanol 30 ml-water
The mixture was refluxed for 6 hours in 1.5 ml. Dilute the reaction solution with water
And extracted twice with ethyl acetate. Dry the collected organic layer
After drying over sodium sulfate, the solvent was distilled off under reduced pressure. Residue
Silica gel (APS type) column chromatography
(Hexane / ethyl acetate = 3 / 1-ethyl acetate)
), Crystallized from diisopropyl ether-hexane
Then, the desired product was obtained. White crystals Yield 2.225 g Yield
81% mp 77-78 ° C;1H-NMR (CDClThree, 200MHz) δ 2.36 (1H, d
d, J = 10.1 Hz, 13.7 Hz), 2.81 (1H, dd, J = 3.1 H
z, 13.7 Hz), 3.22 (1H, ddd, J = 3.2 Hz, 5.2 Hz, 1
0.0 Hz), 4.63 (1H, d, J = 5.2 Hz), 6.82-6.87 (2H,
m), 6.97 (1H, d, J = 8.0 Hz), 7.08 (2H, t, J = 8.8
Hz), 7.37 (2H, dd, J = 5.4 Hz, 8.6 Hz); IR (KBr) 33
40-2865, 1501, 1447, 1262, 1242, 1213, 1157, 1063,
779 cm-1; Anal. Calcd for C16H14FThreeNOThree: C, 59.08;
H, 4.34; N, 4.31. Found: C, 59.08; H, 4.39; N, 4.1
0.7) N-[(1RS, 2SR) -1-[(2,2-diflu
Oro-1,3-benzodioxol-5-yl) methyl]-
2- (4-fluorophenyl) -2-hydroxyethyl]-
4-Fluoronaphthalene-1-carboxamide (1RS, 2SR) -2-amino-3- (2,2-difluoro
B-1,3-benzodioxol-5-yl) -1- (4-f
Fluorophenyl) propan-1-ol 0.167 g
(0.513 mmol) 4-fluoro-1-naphthoic acid
0.10 g (0.51 mmol), 1-hydroxyben
79 mg (0.51 mmol) of zotriazole hydrate
1-ethyl-3 with stirring in 10 ml of acetonitrile
-(3-Dimethylaminopropyl) carbodiimide / hydrochloric acid
Add 0.10 g (0.51 mmol) of salt and overnight at room temperature
Stirred. Dilute the reaction mixture with ethyl acetate and add sodium hydrogen carbonate
Wash with aqueous solution of lithium, dry over anhydrous magnesium sulfate,
After passing through Licagel, the solvent was distilled off under reduced pressure. Obtained residue
The distillate was crystallized from diisopropyl ether-hexane.
Then, the desired product was obtained. White crystals Yield 0.230 g Yield
90% mp 219-220 ° C;1H-NMR (CDClThree-DMSO-d6, 200MHz) δ 2.
85 (1H, dd, J = 10.0Hz, 14.4 Hz), 2.97 (1H, dd, J
= 4.2 Hz, 13.8 Hz), 4.64-4.78 (1H, m), 5.01 (1H, t,
J = 3.8 Hz), 5.10 (1H, d, J = 3.6 Hz), 6.93-7.13
(6H, m), 7.25-7.58 (6H, m), 7.69 (1H, d, J = 8.0 H
z), 8.07 (1H, d, J = 8.0 Hz); IR (KBr) 3266, 1644,
1626, 1541, 1514, 1497, 1244, 1146 cm-1; Anal. Ca
lcd for C 27H19FFourNOFour: C, 65.19; H, 3.85; N, 2.82. F
ound: C, 65.22; H, 3.87; N, 2.57.
【0300】実施例168 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[[2-(トリフルオロメチル)-
1,3-チアゾール-5-イル]メチル]エチル]カルバ
ミン酸tert-ブチル 1) 2-(トリフルオロメチル)-1,3-チアゾール-
5-カルボン酸エチル 2,2,2-トリフルオロアセトアミド12.27g
(純度85%、80.8ミリモル)、クロロホルミル酢
酸エチル・カリウム塩15.2g(80.8ミリモ
ル)、酢酸4.85g(80.8ミリモル)をエタノー
ル100ml中で、一晩加熱還流した。反応液の溶媒を
減圧留去した後、炭酸水素ナトリウム水溶液で希釈し、
酢酸エチルで2回抽出した。集めた有機層を無水硫酸ナ
トリウムで乾燥、溶媒を減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィーにて精製して(ヘキサン
/酢酸エチル=9/1)、目的物を得た。黄色液体 収
量12.72g 収率70%1 H-NMR (CDCl3, 200MHz) δ 1.41 (3H, t, J = 7.1 H
z), 4.43 (2H, q, J = 7.1Hz), 8.49 (1H, s); IR (nea
t) 1728, 1522, 1304, 1285, 1246, 1196, 1152,1094,
1038 cm-1 2) [2-(トリフルオロメチル)-1,3-チアゾー
ル-5-イル]メタノール水素化リチウムアルミニウム
2.17g(57.1ミリモル)のテトラヒドロフラン
80ml懸濁液に、氷冷下、2-(トリフルオロメチ
ル)-1,3-チアゾール-5-カルボン酸エチル8.57
9g(38.10ミリモル)のテトラヒドロフラン40
ml溶液を滴下し、0℃で1時間撹拌した。反応液を氷
冷して、水2ml、15%水酸化ナトリウム水溶液2m
l、水5mlを順次滴下して、過剰の水素化リチウムア
ルミニウムを分解し、そのまま室温で2時間撹拌した。
生じた沈殿をろ過して除き、沈殿を酢酸エチルで洗浄し
た。集めた濾液の溶媒を減圧留去した。得られた残留物
をシリカゲルカラムクロマトグラフィーにて精製して
(ヘキサン/酢酸エチル=6/1−1/1)、目的物を
得た。褐色液体 収量5.499g 収率79%1 H-NMR (CDCl3, 200MHz) δ 2.24 (1H, t, J = 5.7 H
z), 4.97 (2H, d, J = 5.6Hz), 7.82 (1H, s); IR (nea
t) 3308, 1532, 1456, 1333, 1312, 1196, 1144,1036 c
m-1 3) 3-(4-フルオロフェニル)-3-オキソ-2-
[[2-(トリフルオロメチル)-1,3-チアゾール-5
-イル]メチル]プロピオン酸エチル [2-(トリフルオロメチル)-1,3-チアゾール-5-
イル]メタノール2.61g(14.3ミリモル)、ト
リエチルアミン2.39ml(17.1ミリモル)の酢
酸エチル40ml溶液に氷冷下塩化メタンスルホニル
1.80g(15.7ミリモル)の酢酸エチル10ml
溶液を滴下し、そのまま10分間撹拌した。生じた沈殿
を濾過して除き、沈殿をジエチルエーテルで洗浄した。
集めた濾液の溶媒を減圧留去して、メタンスルホン酸エ
ステルの粗生成物を黄色液体として得た。(4-フルオ
ロベンゾイル)酢酸エチル2.998g(14.26ミ
リモル)の1,2-ジメトキシエタン30ml溶液に氷
冷下60%水素化ナトリウムの流動パラフィン懸濁物
0.57g(14.3ミリモル)を加え、そのまま0.
5時間撹拌した。これに上で得たメタンスルホン酸エス
テルの1,2-ジメトキシエタン10ml溶液を室温で
加え、室温で一晩撹拌した。反応液を水に注ぎ、酢酸エ
チルで2回抽出した。集めた有機層を無水硫酸マグネシ
ウムで乾燥、溶媒を減圧留去した。得られた残留物をシ
リカゲルカラムクロマトグラフィーにて精製して(ヘキ
サン/酢酸エチル=9/1−6/1)、目的物を得た。
白色結晶 収量4.275g 収率80%1 H-NMR (CDCl3, 200MHz) δ 1.15 (3H, t, J = 7.1 H
z), 3.61 (2H, d, J = 7.0Hz), 4.15 (2H, q, J = 7.1
Hz), 4.57 (1H, t, J = 7.1 Hz), 7.17 (2H, t, J= 8.6
Hz), 7.70 (1H, s), 8.04 (2H, dd, J = 5.3 Hz, 8.9
Hz); IR (neat) 1740, 1732, 1682, 1599, 1508, 1456,
1329, 1300, 1238, 1194, 1157, 1034, 849 cm-1 4) (1RS,2RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[[2-(トリフルオロメチ
ル)-1,3-チアゾール-5-イル]メチル]プロピオン
酸エチル 塩化亜鉛2.80g(20.5ミリモル)をジエチルエ
ーテル50ml中で撹拌しながら水素化ホウ素ナトリウ
ム1.55g(41.1ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、3-(4-フルオ
ロフェニル)-3-オキソ-2-[[2-(トリフルオロメ
チル)-1,3-チアゾール-5-イル]メチル]プロピオ
ン酸エチル3.856g(10.27ミリモル)のジエ
チルエーテル30ml溶液を室温で加え、そのまま2時
間撹拌した。反応液に希塩酸を少しずつ加えて過剰の水
素化ホウ素亜鉛を分解した後、酢酸エチルで2回抽出し
た。集めた有機層を無水硫酸マグネシウムで乾燥、溶媒
を減圧留去した。得られた粗生成物をシリカゲルカラム
クロマトグラフィーにて精製し(ヘキサン/酢酸エチル
=6/1−3/1)、目的物を得た。無色液体 収量
1.989g 収率51%1 H-NMR (CDCl3, 200MHz) δ 1.27 (3H, t, J = 7.1 H
z), 2.64 (1H, d, J = 3.0Hz), 2.98 (1H, ddd, J = 4.
0 Hz, 6.2 Hz, 10.2 Hz), 3.23 (1H, dd, J = 4.2Hz, 1
5.2 Hz), 3.39 (1H, dd, J = 10.2 Hz, 15.2 Hz), 3.99
(2H, q, J = 7.1Hz), 5.03 (1H, dd, J = 2.9 Hz, 6.3
Hz), 7.06 (2H, t, J = 8.6 Hz), 7.36(2H, dd, J =
5.3 Hz, 8.7 Hz), 7.59 (1H, s); IR (neat) 3409, 172
6, 1510,1454, 1329, 1300, 1225, 1192, 1150, 1034,
839 cm-1 5) (1RS,2RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[[2-(トリフルオロメチ
ル)-1,3-チアゾール-5-イル]メチル]プロピオン
酸 (1RS,2RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[[2-(トリフルオロメチル)-1,3
-チアゾール-5-イル]メチル]プロピオン酸エチル
1.883g(4.990ミリモル)のメタノール20
ml溶液に1N水酸化ナトリウム水溶液9.98ml
(9.98ミリモル)を加え、室温で一晩撹拌した。反
応液を濃縮、水で希釈し、1N塩酸で反応液を酸性にし
た後、酢酸エチルで2回抽出した。集めた有機層を無水
硫酸ナトリウムで乾燥、溶媒を減圧留去した。得られた
粗生成物をシリカゲルカラムクロマトグラフィーにて精
製し(ヘキサン/酢酸エチル=3/1−1/1)、目的
物を得た。淡黄色液体 収量1.420g 収率82%1 H-NMR (CDCl3, 200MHz) δ 3.04 (1H, ddd, J = 4.0 H
z, 5.8 Hz, 9.7 Hz), 3.18 (1H, dd, J = 3.6 Hz, 15.0
Hz), 3.40 (1H, dd, J = 10.0 Hz, 15.4 Hz), 5.13 (1
H, d, J = 5.4 Hz), 7.08 (2H, t, J = 8.8 Hz), 7.38
(2H, dd, J = 5.4Hz, 8.6 Hz), 7.59 (1H, s); IR (nea
t) 3500-2900, 1715, 1510, 1456, 1331,1300, 1227, 1
196, 1152, 1040, 841 cm-1 6) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-[[2-(トリフルオロメチル)-1,3-チア
ゾール-5-イル]メチル]-1,3-オキサゾリジン-2-
オン (1RS,2RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[[2-(トリフルオロメチル)-1,3
-チアゾール-5-イル]メチル]プロピオン酸1.31
0g(1.310ミリモル)のテトラヒドロフラン50
ml溶液にトリエチルアミン0.78ml(5.63ミ
リモル)、ジフェニルホスホリルアジド1.14g
(4.13ミリモル)を加え、一晩加熱還流した。反応
液の溶媒を減圧留去し、得られた粗生成物をシリカゲル
カラムクロマトグラフィーにて精製して(ヘキサン/酢
酸エチル=3/1−1/1)、目的物を得た。1 H-NMR (CDCl3, 200MHz) δ 2.58 (1H, dd, J = 5.2 H
z, 15.0 Hz), 2.69 (1H,dd, J = 8.8 Hz, 15.0 Hz), 4.
23-4.35 (1H, m), 5.67 (1H, br s), 5.83 (1H,d, J =
7.6 Hz), 7.13 (2H, t, J = 8.6 Hz), 7.32 (2H, dd, J
= 5.2 Hz, 8.8Hz), 7.49 (1H, s); IR (neat) 3272, 1
780-1730, 1514, 1456, 1331, 1300, 1233, 1194, 114
8, 1032 cm-1 7) (4RS,5SR)-5-(4-フルオロフェニ
ル)-2-オキソ-4-[[2-(トリフルオロメチル)-
1,3-チアゾール-5-イル]メチル]-1,3-オキサ
ゾリジン-3-カルボン酸tert-ブチル (4RS,5SR)-5-(4-フルオロフェニル)-4-
[[2-(トリフルオロメチル)-1,3-チアゾール-5
-イル]メチル]-1,3-オキサゾリジン-2-オン1.
062g(3.067ミリモル)、二炭酸ジ-tert-
ブチル0.80g(3.68ミリモル)、4-N,N-ジ
メチルアミノピリジン37mg(0.31ミリモル)の
アセトニトリル10ml溶液を室温で一晩撹拌した。反
応液を酢酸エチルに希釈し、水で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物を酢酸エチル−ヘキサンより結晶
化して、目的物を得た。白色結晶 収量1.186g
収率87% mp 192-193℃; 1H-NMR (CDCl3, 200MHz) δ 1.55 (9H,
s), 2.99 (1H, dd, J =7.4 Hz, 15.0 Hz), 3.09 (1H, d
d, J = 5.2 Hz, 15.4 Hz), 4.75 (1H, dt, J =4.9 Hz,
14.9 Hz), 5.73 (1H, d, J = 7.0 Hz), 7.04 (1H, s),
7.06 (2H, t, J= 8.6 Hz), 7.22 (2H, dd, J = 5.2 Hz,
8.4 Hz); IR (KBr) 1792, 1370, 1304, 1192, 1163, 1
034 cm-1; Anal. Calcd for C19H18F4N2O4S: C, 51.12;
H, 4.06; N, 6.28. Found: C, 50.94; H, 4.10; N, 6.
48. 8) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[[2-(トリフルオロメチ
ル)-1,3-チアゾール-5-イル]メチル]エチル]カ
ルバミン酸tert-ブチル (4RS,5SR)-5-(4-フルオロフェニル)-2-
オキソ-4-[[2-(トリフルオロメチル)-1,3-チ
アゾール-5-イル]メチル]-1,3-オキサゾリジン-
3-カルボン酸tert-ブチル1.079g(2.41
7ミリモル)のメタノール10ml−テトラヒドロフラ
ン10ml溶液に水酸化ナトリウム0.11g(2.6
6ミリモル)のメタノール5ml溶液を氷冷下加え、室
温で3時間撹拌した。反応液を酢酸エチルに希釈し、水
で洗浄、無水硫酸マグネシウムで乾燥、シリカゲルを通
した後、溶媒を減圧留去した。得られた残留物をジイソ
プロピルエーテル−ヘキサンより結晶化して、目的物を
得た。白色結晶 収量0.842g 収率83% mp 137-138℃; 1H-NMR (CDCl3, 200MHz) δ 1.38 (9H,
s), 2.61 (1H, br s), 3.07 (2H, d, J = 7.0 Hz), 3.9
4-4.05 (1H, m), 4.76 (1H, br d, J = 8.4 Hz),4.91
(1H, br s), 7.08 (2H, t, J = 8.6 Hz), 7.38 (2H, d
d, J = 5.4 Hz, 8.6 Hz), 7.61 (1H, s); IR (KBr) 333
7, 1682, 1532, 1138, 1038 cm-1; Anal. Calcd for C
18H20F4N2O3S: C, 51.42; H, 4.79; N, 6.66. Found:
C, 51.50; H,4.70; N, 6.90.Example 168 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-[[2- (trifluoromethyl)-
Tert-Butyl 1,3-thiazol-5-yl] methyl] ethyl] carbamate 1) 2- (trifluoromethyl) -1,3-thiazole-
Ethyl 5-carboxylate 12.27 g 2,2,2-trifluoroacetamide
(Purity 85%, 80.8 mmol), 15.2 g (80.8 mmol) of ethyl chloroformate acetate potassium salt, and 4.85 g (80.8 mmol) of acetic acid were heated under reflux overnight in 100 ml of ethanol. After evaporating the solvent of the reaction solution under reduced pressure, the reaction solution was diluted with an aqueous solution of sodium hydrogen carbonate,
Extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 9/1) to obtain the desired product. Yellow liquid Yield 12.72 g Yield 70% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.41 (3H, t, J = 7.1 H)
z), 4.43 (2H, q, J = 7.1Hz), 8.49 (1H, s); IR (nea
t) 1728, 1522, 1304, 1285, 1246, 1196, 1152,1094,
1038 cm -1 2) [2- (trifluoromethyl) -1,3-thiazol-5-yl] methanol A suspension of 2.17 g (57.1 mmol) of lithium aluminum hydride in 80 ml of tetrahydrofuran was cooled with ice. 8.57 ethyl ethyl 2- (trifluoromethyl) -1,3-thiazole-5-carboxylate
9 g (38.10 mmol) of tetrahydrofuran 40
The solution was added dropwise and stirred at 0 ° C. for 1 hour. The reaction solution was cooled on ice, and 2 ml of water and 2 m of a 15% aqueous sodium hydroxide solution were used.
1 and 5 ml of water were sequentially added dropwise to decompose excess lithium aluminum hydride, and the mixture was stirred at room temperature for 2 hours.
The resulting precipitate was removed by filtration, and the precipitate was washed with ethyl acetate. The solvent of the collected filtrate was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-1 / 1) to obtain the desired product. Brown liquid Yield 5.499 g Yield 79% 1 H-NMR (CDCl 3 , 200 MHz) δ 2.24 (1 H, t, J = 5.7 H)
z), 4.97 (2H, d, J = 5.6Hz), 7.82 (1H, s); IR (nea
t) 3308, 1532, 1456, 1333, 1312, 1196, 1144,1036 c
m -1 3) 3- (4-fluorophenyl) -3-oxo-2-
[[2- (trifluoromethyl) -1,3-thiazole-5
Ethyl [-yl] methyl] propionate [2- (trifluoromethyl) -1,3-thiazole-5-
[Il] A solution of 2.61 g (14.3 mmol) of methanol and 2.39 ml (17.1 mmol) of triethylamine in 40 ml of ethyl acetate under ice-cooling 1.80 g (15.7 mmol) of methanesulfonyl chloride in 10 ml of ethyl acetate
The solution was added dropwise and stirred for 10 minutes. The resulting precipitate was removed by filtration, and the precipitate was washed with diethyl ether.
The solvent of the collected filtrate was distilled off under reduced pressure to obtain a crude product of methanesulfonic acid ester as a yellow liquid. 0.57 g (14.3 mmol) of a 60% sodium hydride liquid paraffin suspension in a solution of 2.998 g (14.26 mmol) of ethyl (4-fluorobenzoyl) acetate in 30 ml of 1,2-dimethoxyethane under ice cooling. And add 0.
Stir for 5 hours. To this was added a solution of methanesulfonic acid ester obtained above in 1,2-dimethoxyethane (10 ml) at room temperature, and the mixture was stirred at room temperature overnight. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 9 / 1-6 / 1) to obtain the desired product.
White crystal Yield 4.275 g Yield 80% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.15 (3H, t, J = 7.1 H)
z), 3.61 (2H, d, J = 7.0Hz), 4.15 (2H, q, J = 7.1
Hz), 4.57 (1H, t, J = 7.1 Hz), 7.17 (2H, t, J = 8.6
Hz), 7.70 (1H, s), 8.04 (2H, dd, J = 5.3 Hz, 8.9
Hz); IR (neat) 1740, 1732, 1682, 1599, 1508, 1456,
1329, 1300, 1238, 1194, 1157, 1034, 849 cm -1 4) (1RS, 2RS) -3- (4- fluorophenyl) -3-hydroxy-2 - [[2- (trifluoromethyl) -1 Ethyl 3,3-thiazol-5-yl] methyl] propionate While stirring 2.80 g (20.5 mmol) of zinc chloride in 50 ml of diethyl ether, 1.55 g (41.1 mmol) of sodium borohydride was added at room temperature. The mixture was further stirred for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. 3.856 g of ethyl 3- (4-fluorophenyl) -3-oxo-2-[[2- (trifluoromethyl) -1,3-thiazol-5-yl] methyl] propionate was added to the resulting solution. (10.27 mmol) in 30 ml of diethyl ether was added at room temperature, and the mixture was stirred for 2 hours. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-3 / 1) to obtain the desired product. Colorless liquid Yield 1.989 g Yield 51% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.27 (3H, t, J = 7.1 H)
z), 2.64 (1H, d, J = 3.0Hz), 2.98 (1H, ddd, J = 4.
0 Hz, 6.2 Hz, 10.2 Hz), 3.23 (1H, dd, J = 4.2Hz, 1
5.2 Hz), 3.39 (1H, dd, J = 10.2 Hz, 15.2 Hz), 3.99
(2H, q, J = 7.1Hz), 5.03 (1H, dd, J = 2.9 Hz, 6.3
Hz), 7.06 (2H, t, J = 8.6 Hz), 7.36 (2H, dd, J =
5.3 Hz, 8.7 Hz), 7.59 (1H, s); IR (neat) 3409, 172
6, 1510, 1454, 1329, 1300, 1225, 1192, 1150, 1034,
839 cm -1 5) (1RS, 2RS) -3- (4- fluorophenyl) -3-hydroxy-2 - [[2- (trifluoromethyl) -1,3-thiazol-5-yl] methyl] propionic Acid (1RS, 2RS) -3- (4-fluorophenyl) -3-
Hydroxy-2-[[2- (trifluoromethyl) -1,3
1.883 g (4.990 mmol) of ethyl-thiazol-5-yl] methyl] propionate in methanol 20
9.98 ml of 1N aqueous sodium hydroxide solution
(9.98 mmol) and stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1) to obtain the desired product. Light yellow liquid Yield 1.420 g Yield 82% 1 H-NMR (CDCl 3 , 200 MHz) δ 3.04 (1H, ddd, J = 4.0 H)
z, 5.8 Hz, 9.7 Hz), 3.18 (1H, dd, J = 3.6 Hz, 15.0
Hz), 3.40 (1H, dd, J = 10.0 Hz, 15.4 Hz), 5.13 (1
H, d, J = 5.4 Hz), 7.08 (2H, t, J = 8.8 Hz), 7.38
(2H, dd, J = 5.4Hz, 8.6 Hz), 7.59 (1H, s); IR (nea
t) 3500-2900, 1715, 1510, 1456, 1331,1300, 1227, 1
196, 1152, 1040, 841 cm -1 6) (4RS, 5SR) -5- (4- fluorophenyl) -4 - [[2- (trifluoromethyl) -1,3-thiazol-5-yl] methyl ] -1,3-Oxazolidine-2-
ON (1RS, 2RS) -3- (4-fluorophenyl) -3-
Hydroxy-2-[[2- (trifluoromethyl) -1,3
-Thiazol-5-yl] methyl] propionic acid 1.31
0 g (1.310 mmol) of tetrahydrofuran 50
0.78 ml (5.63 mmol) of triethylamine and 1.14 g of diphenylphosphoryl azide
(4.13 mmol) and heated to reflux overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1) to obtain the desired product. 1 H-NMR (CDCl 3 , 200MHz) δ 2.58 (1H, dd, J = 5.2 H
z, 15.0 Hz), 2.69 (1H, dd, J = 8.8 Hz, 15.0 Hz), 4.
23-4.35 (1H, m), 5.67 (1H, br s), 5.83 (1H, d, J =
7.6 Hz), 7.13 (2H, t, J = 8.6 Hz), 7.32 (2H, dd, J
= 5.2 Hz, 8.8Hz), 7.49 (1H, s); IR (neat) 3272, 1
780-1730, 1514, 1456, 1331, 1300, 1233, 1194, 114
8, 1032 cm -1 7) ( 4RS, 5SR) -5- (4- fluorophenyl) -2-oxo-4 - [[2- (trifluoromethyl) -
1,3-thiazol-5-yl] methyl] -1,3-oxazolidin-3-carboxylate tert-butyl (4RS, 5SR) -5- (4-fluorophenyl) -4-
[[2- (trifluoromethyl) -1,3-thiazole-5
-Yl] methyl] -1,3-oxazolidin-2-one
062 g (3.067 mmol), di-tert-dicarbonate
A solution of 0.80 g (3.68 mmol) of butyl and 37 mg (0.31 mmol) of 4-N, N-dimethylaminopyridine in 10 ml of acetonitrile was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with water, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. 1.186 g of white crystals
Yield 87% mp 192-193 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.55 (9H,
s), 2.99 (1H, dd, J = 7.4 Hz, 15.0 Hz), 3.09 (1H, d
d, J = 5.2 Hz, 15.4 Hz), 4.75 (1H, dt, J = 4.9 Hz,
14.9 Hz), 5.73 (1H, d, J = 7.0 Hz), 7.04 (1H, s),
7.06 (2H, t, J = 8.6 Hz), 7.22 (2H, dd, J = 5.2 Hz,
8.4 Hz); IR (KBr) 1792, 1370, 1304, 1192, 1163, 1
034 cm -1 ; Anal.Calcd for C 19 H 18 F 4 N 2 O 4 S: C, 51.12;
H, 4.06; N, 6.28. Found: C, 50.94; H, 4.10; N, 6.
48.8) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-[[2- (trifluoromethyl) -1,3-thiazol-5-yl] methyl] methyl Ethyl tert-butyl carbamate (4RS, 5SR) -5- (4-fluorophenyl) -2-
Oxo-4-[[2- (trifluoromethyl) -1,3-thiazol-5-yl] methyl] -1,3-oxazolidine-
1.079 g of tert-butyl 3-carboxylate (2.41
0.1 mmol (2.6 mmol) of sodium hydroxide in a solution of 7 mmol) of methanol (10 ml) -tetrahydrofuran (10 ml).
A solution of 6 mmol) in 5 ml of methanol was added under ice-cooling, and the mixture was stirred at room temperature for 3 hours. The reaction solution was diluted with ethyl acetate, washed with water, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.842 g Yield 83% mp 137-138 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.38 (9H,
s), 2.61 (1H, br s), 3.07 (2H, d, J = 7.0 Hz), 3.9
4-4.05 (1H, m), 4.76 (1H, br d, J = 8.4 Hz), 4.91
(1H, br s), 7.08 (2H, t, J = 8.6 Hz), 7.38 (2H, d
d, J = 5.4 Hz, 8.6 Hz), 7.61 (1H, s); IR (KBr) 333
7, 1682, 1532, 1138, 1038 cm -1 ; Anal.Calcd for C
18 H 20 F 4 N 2 O 3 S: C, 51.42; H, 4.79; N, 6.66. Found:
C, 51.50; H, 4.70; N, 6.90.
【0301】実施例169 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[[2-(トリフルオ
ロメチル)-1,3-チアゾール-5-イル]メチル]エチ
ル]ナフタレン-1-カルボキサミド 1) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-[2-(トリフルオロメチル)-1,3
-チアゾール-5-イル]プロパン-1-オール N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[[2-(トリフルオロメチル)-
1,3-チアゾール-5-イル]メチル]エチル]カルバ
ミン酸tert-ブチル0.711g(1.691ミリ
モル)、濃塩酸0.5mlのメタノール5ml溶液を1
0分間加熱還流した。反応液を水で希釈し、炭酸カリウ
ムでアルカリ性とし、酢酸エチルで2回抽出した。集め
た有機層を無水硫酸ナトリウムで乾燥、溶媒を減圧留去
した。残留物をシリカゲル(APSタイプ)カラムクロ
マトグラフィーにて精製して(酢酸エチル)、目的物を
得た。無色液体 収量0.534g 収率99%1 H-NMR (CDCl3, 200MHz) δ 2.82 (1H, dd, J = 9.4 H
z, 14.8 Hz), 3.08-3.26(2H, m), 4.56 (1H, d, J = 5.
8 Hz), 7.09 (2H,, t, J = 8.6 Hz), 7.36 (2H,dd, J =
5.6 Hz, 8.8 Hz), 7.68 (1H, s); IR (neat) 3364, 15
07, 1456, 1331,1300, 1225, 1192, 1144, 1032, 837 c
m-1 2) 4-フルオロ-N-[(1RS,2SR)-2-(4-
フルオロフェニル)-2-ヒドロキシ-1-[[2-(トリ
フルオロメチル)-1,3-チアゾール-5-イル]メチ
ル]エチル]ナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[2-(トリフルオロメチル)-1,3-チア
ゾール-5-イル]プロパン-1-オール0.226g
(0.702ミリモル)、4-フルオロ-1-ナフトエ酸
0.13g(0.71ミリモル)、1-ヒドロキシベン
ゾトリアゾール水和物0.11g(0.71ミリモル)
をアセトニトリル10ml中で撹拌しながら1-エチル-
3-(3-ジメチルアミノプロピル)カルボジイミド・塩
酸塩0.14g(0.71ミリモル)を加え、室温で一
晩撹拌した。反応液を酢酸エチルに希釈し、炭酸水素ナ
トリウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、
シリカゲルを通した後、溶媒を減圧留去した。得られた
残留物をジイソプロピルエーテル−ヘキサンより結晶化
して、目的物を得た。白色結晶 収量0.301g 収
率87% mp 197-198℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 3.
28 (2H, d, J = 7.0 Hz), 4.62-4.76 (1H, m), 4.97 (1
H, t, J = 3.9 Hz), 5.18 (1H, d, J = 3.2 Hz),7.08
(2H, t, J = 8.8 Hz), 7.11 (1H, d, J = 9.2 Hz), 7.3
8 (1H, dd, J = 5.4 Hz, 7.8 Hz), 7.47-7.65 (5H, m),
7.68 (1H, s), 7.80-7.86 (1H, m), 8.08-8.12 (1H,
m); IR (KBr) 3264, 1642, 1626, 1601, 1535, 1512, 1
454, 1331,1300, 1227, 1192, 1140, 1040, 760 cm-1;
Anal. Calcd for C24H17F5N2O2S: C, 58.53; H, 3.48;
N, 5.69. Found: C, 58.30; H, 3.68; N, 5.76.Example 169 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-[[2- (trifluoromethyl) -1,3-thiazole- 5-yl] methyl] ethyl] naphthalene-1-carboxamide 1) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [2- (trifluoromethyl) -1,3
-Thiazol-5-yl] propan-1-ol N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-[[2- (trifluoromethyl)-
0.711 g (1.691 mmol) of tert-butyl 1,3-thiazol-5-yl] methyl] ethyl] carbamate and 0.5 ml of concentrated hydrochloric acid in 5 ml of methanol were added.
Heated to reflux for 0 minutes. The reaction was diluted with water, made alkaline with potassium carbonate and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel (APS type) column chromatography (ethyl acetate) to obtain the desired product. Colorless liquid Yield 0.534 g Yield 99% 1 H-NMR (CDCl 3 , 200 MHz) δ 2.82 (1H, dd, J = 9.4 H)
z, 14.8 Hz), 3.08-3.26 (2H, m), 4.56 (1H, d, J = 5.
8 Hz), 7.09 (2H ,, t, J = 8.6 Hz), 7.36 (2H, dd, J =
5.6 Hz, 8.8 Hz), 7.68 (1H, s); IR (neat) 3364, 15
07, 1456, 1331,1300, 1225, 1192, 1144, 1032, 837 c
m -1 2) 4-Fluoro-N-[(1RS, 2SR) -2- (4-
Fluorophenyl) -2-hydroxy-1-[[2- (trifluoromethyl) -1,3-thiazol-5-yl] methyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1 0.226 g of-(4-fluorophenyl) -3- [2- (trifluoromethyl) -1,3-thiazol-5-yl] propan-1-ol
(0.702 mmol) 0.13 g (0.71 mmol) of 4-fluoro-1-naphthoic acid 0.11 g (0.71 mmol) of 1-hydroxybenzotriazole hydrate
Was stirred in 10 ml of acetonitrile while stirring in 1-ethyl-
0.14 g (0.71 mmol) of 3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous solution of sodium hydrogen carbonate, and dried over anhydrous magnesium sulfate.
After passing through silica gel, the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.301 g Yield 87% mp 197-198 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 3.
28 (2H, d, J = 7.0 Hz), 4.62-4.76 (1H, m), 4.97 (1
H, t, J = 3.9 Hz), 5.18 (1H, d, J = 3.2 Hz), 7.08
(2H, t, J = 8.8 Hz), 7.11 (1H, d, J = 9.2 Hz), 7.3
8 (1H, dd, J = 5.4 Hz, 7.8 Hz), 7.47-7.65 (5H, m),
7.68 (1H, s), 7.80-7.86 (1H, m), 8.08-8.12 (1H,
m); IR (KBr) 3264, 1642, 1626, 1601, 1535, 1512, 1
454, 1331, 1300, 1227, 1192, 1140, 1040, 760 cm -1 ;
Anal.Calcd for C 24 H 17 F 5 N 2 O 2 S: C, 58.53; H, 3.48;
N, 5.69. Found: C, 58.30; H, 3.68; N, 5.76.
【0302】実施例170 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((3-(2,2,2-トリフルオロ
エトキシ)フェニル)メチル)エチル)-4-フルオロ-
1-ナフタレンカルボキサミド 1) 3-ヒドロキシトルエン(5.0g,46.2ミ
リモル)のN,N-ジメチルホルムアミド(50ml)
溶液に2,2,2-トリフルオロ-1-ヨードエタン(1
0.7g,50.9ミリモル)および炭酸カリウム(1
2.8g,92.5ミリモル)を加え、80℃で終夜攪
拌した。反応液を水(200ml)で希釈し、ジエチル
エーテル(300ml×2)で抽出した。抽出液を水、
飽和食塩水で順次洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=10:1)で精製
し、3-(2,2,2-トリフルオロエトキシ)トルエン
(7.60g,86%)を無色油状物として得た。 IRνmaxKBrcm-1: 1752, 1680, 1615, 1588, 1487.1 H-NMR (CDCl3)δ: 2.34 (3H, s), 4.33 (2H, q, J =
8.0 Hz), 6.70-6.90 (3H,m), 7.20 (1H, t, J = 7.6 H
z). 2) 3-(2,2,2-トリフルオロエトキシ)トルエ
ン(7.34g,38.6ミリモル)の四塩化炭素(1
00ml)溶液にN-ブロモスクシンイミド(7.56
g,42.5ミリモル)および2,2'-アゾビス(イソ
ブチロニトリル)(633mg,3.86ミリモル)を
加え、終夜加熱還流した。不溶物をセライトを用いてろ
過し、ろ液を濃縮し、ブロモ体を調製した。3-オキソ-
3-(4-フルオロフェニル)プロピオン酸エチル(7.
3g,34.7ミリモル)の1,2-ジメトキシエタン
(70ml)溶液に水素化ナトリウム(60%油性,
1.39g,34.7ミリモル)を氷冷下加え、室温で
30分攪拌した。反応液の中に先に合成したブロモ体の
1,2-ジメトキシエタン(20ml)溶液を滴下し、
反応液を室温で1時間攪拌した。反応液を水(200m
l)の中に注ぎ、酢酸エチル(200ml×2)で抽出
した。抽出液を水および飽和食塩水で洗浄し、無水硫酸
マグネシウムで乾燥後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
4:1)で精製し、ジイソプロピルエーテル−ヘキサン
から再結晶させて、3-(4-フルオロフェニル)-3-オ
キソ-2-((3-(2,2,2-トリフルオロエトキシ)
フェニル)メチル)プロピオン酸エチル(4.23g,
31%)を得た。 mp 48-49℃ IRνmaxKBrcm-1: 1738, 1688, 1599, 1508, 1493, 145
3. Anal. Calcd for C20H18F4O4: C, 60.30; H, 4.55 Found: C, 60.11; H, 4.36.1H-NMR (CDCl3)δ: 1.23 (3
H, t, J = 7.0 Hz), 3.30 (2H, d, J = 7.2 Hz), 4.11
(2H, q, J = 7.0 Hz), 4.30 (2H, q, J = 8.0 Hz), 4.5
6 (1H, t, J = 7.2 Hz), 6.70-6.96 (3H, m), 7.06-7.3
0 (3H, m), 7.92-8.10 (2H, m). 3) 塩化亜鉛(2.81g,20.6ミリモル)のジ
エチルエーテル(100ml)溶液に水素化ホウ素ナト
リウム(1.56g,41.2ミリモル)を加えて室温
で30分攪拌した。不溶物をろ去し、ろ液に3-(4-フ
ルオロフェニル)-3-オキソ-2-((3-(2,2,2-
トリフルオロエトキシ)フェニル)メチル)プロピオン
酸エチル(4.10g,10.3ミリモル)のジエチル
エーテル(50ml)溶液を加えて室温で30分攪拌し
た。氷冷下、反応液に1規定塩酸を加えてクエンチし、
更に水(200ml)を加え、酢酸エチル(300ml
×2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=4:1)で精製し、(2RS,3RS)-
3-(4-フルオロフェニル)-3-ヒドロキシ-2-((3
-(2,2,2-トリフルオロエトキシ)フェニル)メチ
ル)プロピオン酸エチル(3.51g,85%)を無色
油状物として得た。 IRνmaxKBrcm-1: 1715, 1605, 1590, 1510. Anal. Calcd for C20H20F4O4・0.1H2O: C, 59.73; H,
5.06 Found: C, 59.55; H, 5.06.1 H-NMR (CDCl3)δ: 0.94 (3H, t, J = 7.0 Hz), 2.88-
3.00 (3H, m), 3.90 (2H,q, J = 7.0 Hz), 4.30 (2H,
q, J = 8.0 Hz), 5.01 (1H, brs), 6.60-6.82 (3H, m),
7.00-7.30 (3H, m), 7.32-7.44 (2H, m). 4) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((3-(2,2,2-トリフル
オロエトキシ)フェニル)メチル)プロピオン酸エチル
(3.4g,8.49ミリモル)のメタノール(15m
l)溶液に、2規定水酸化ナトリウム水溶液(8.5m
l,17.0ミリモル)を加えて室温で終夜攪拌した。
反応液を1規定塩酸で酸性とした後、酢酸エチル(10
0ml×2)で抽出した。抽出液を水および飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンより再結晶させて、
(2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-((3-(2,2,2-トリフルオロエト
キシ)フェニル)メチル)プロピオン酸(2.78g,
88%)を得た。 mp 142-143℃ IRνmaxKBrcm-1: 1715, 1607, 1588. Anal. Calcd for C18H16F4O4: C, 58.07; H, 4.33 Found: C, 58.00; H, 4.27.1 H-NMR (CDCl3)δ: 2.82-3.10 (3H, m), 4.29 (2H, q,
J = 8.0 Hz), 5.06 (1H,d, J = 4.4 Hz), 6.69 (1H,
s), 6.70-7.02 (2H, m), 7.00-7.24 (3H, m), 7.30-7.4
4 (2H, m). 5) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((3-(2,2,2-トリフル
オロエトキシ)フェニル)メチル)プロピオン酸(2.
68g,7.20ミリモル)のテトラヒドロフラン(6
0ml)溶液に、ジフェニルホスホリルアジド(1.7
1ml,7.92ミリモル)とトリエチルアミン(1.
51ml,10.8ミリモル)を加え、3時間加熱還流
した。反応液を放冷後、水(200ml)を加えて酢酸
エチル(200ml×2)で抽出した。抽出液を1規定
塩酸、飽和重曹水、飽和食塩水で順次洗浄し、無水硫酸
マグネシウムで乾燥後減圧留去した。残留物を酢酸エチ
ル−ヘキサンより再結晶させて、(4RS,5SR)-
5-(4-フルオロフェニル)-4-((3-(2,2,2-
トリフルオロエトキシ)フェニル)メチル)-1,3-オ
キサゾリジン-2-オン(2.31g,87%)を得た。 mp 148-149℃ IRνmaxKBrcm-1: 1759, 1609, 1590, 1514. Anal. Calcd for C18H15F4NO3: C, 58.54; H, 4.09; N,
3.79 Found: C, 58.54; H, 4.01; N, 3.88.1 H-NMR (CDCl3)δ: 2.12-2.38 (2H, m), 4.16-4.28 (1
H, m), 4.32 (2H, q, J =8.0 Hz), 5.17 (1H, brs), 5.
79 (1H, d, J = 8.0 Hz), 6.62 (1H, d, J = 1.8Hz),
6.72 (1H, d, J = 7.6 Hz), 6.77-6.84 (1H, m), 7.04-
7.42 (5H, m). 6) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((3-(2,2,2-トリフルオロエトキシ)
フェニル)メチル)-1,3-オキサゾリジン-2-オン
(1.2g,3.25ミリモル)のエタノール(10m
l)溶液に8規定水酸化ナトリウム水溶液(2.0m
l,16ミリモル)を加え、2時間加熱還流した。反応
液を濃縮後、水(100ml)で希釈し、酢酸エチル
(100ml×2)で抽出した。抽出液を飽和食塩水で
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し、残
留物を酢酸エチル−ヘキサンから再結晶させて(1R
S,2SR)-2-アミノ-1-(4-フルオロフェニル)-
3-(3-(2,2,2-トリフルオロエトキシ)フェニ
ル)-1-プロパノール(913mg,82%)を得た。 mp 94-95℃ IRνmaxKBrcm-1: 1605, 1588, 1508, 1489, 1454 Anal. Calcd for C17H17F4NO2: C, 59.47; H, 4.99; N,
4.08 Found: C, 59.34; H, 4.87; N, 4.19.1 H-NMR (CDCl3)δ: 2.33 (1H, dd, J = 14.0, 10.6 H
z), 2.78 (1H, dd, J = 14.0, 3.0 Hz), 3.20-3.34 (1
H, m), 4.33 (2H, q, J = 8.0 Hz), 4.66 (1H, d, J=
4.6 Hz), 6.70-6.90 (3H, m), 7.00-7.16 (2H, m), 7.2
0-7.30 (1H, m), 7.30-7.44 (2H, m). 7) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(3-(2,2,2-トリフルオロエト
キシ)フェニル)-1-プロパノール(181mg,0.
53ミリモル)のアセトニトリル(20ml)溶液に4
-フルオロナフタレンカルボン酸(100mg,0.5
3ミリモル)および1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド・塩酸塩(151mg,0.
79ミリモル)および1-ヒドロキシ-1H-ベンゾトリ
アゾール(81mg,0.53ミリモル)を加えて室温
で終夜攪拌した。反応液を水(100ml)で希釈し、
酢酸エチル(100ml×2)で抽出した。抽出液を1
規定塩酸、1規定水酸化ナトリウム水溶液、飽和食塩水
で順次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去
した。残留物を酢酸エチル−ヘキサンから再結晶させ
て、表題化合物(206mg,76%)を得た。 mp 192-193℃ IRνmaxKBrcm-1: 1642, 1626, 1601, 1512. Anal. Calcd for C28H22F5NO3・0.1H2O: C, 65.02; H,
4.32; N, 2.71 Found: C, 64.89; H, 4.43; N, 2.93.1 H-NMR (CDCl3)δ: 2.78 (1H, dd, J = 14.6, 11.0 H
z), 3.04 (1H, dd, J = 14.6, 4.0 Hz), 4.28 (2H, q,
J = 8.0 Hz), 4.70-4.88 (1H, m), 5.09 (1H, d, J= 3.
8 Hz), 5.90 (1H, d, J = 8.8 Hz), 6.76-7.36 (8H,
m), 7.40-7.60 (4H,m), 7.77 (1H, d, J = 7.6 Hz), 8.
09 (1H, d, J = 7.6 Hz).Example 170 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((3- (2,2,2-trifluoroethoxy) phenyl) methyl) ethyl) -4-fluoro-
1-Naphthalenecarboxamide 1) 3-Hydroxytoluene (5.0 g, 46.2 mmol) in N, N-dimethylformamide (50 ml)
Add 2,2,2-trifluoro-1-iodoethane (1
0.7 g, 50.9 mmol) and potassium carbonate (1
(2.8 g, 92.5 mmol) and stirred at 80 ° C. overnight. The reaction solution was diluted with water (200 ml) and extracted with diethyl ether (300 ml × 2). Extract water with water,
The extract was washed successively with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1) to give 3- (2,2,2-trifluoroethoxy) toluene (7.60 g, 86%) as a colorless oil. . IRνmax KBr cm -1 : 1752, 1680, 1615, 1588, 1487. 1 H-NMR (CDCl 3 ) δ: 2.34 (3H, s), 4.33 (2H, q, J =
8.0 Hz), 6.70-6.90 (3H, m), 7.20 (1H, t, J = 7.6 H
z). 2) 3- (2,2,2-trifluoroethoxy) toluene (7.34 g, 38.6 mmol) in carbon tetrachloride (1
00 ml) solution with N-bromosuccinimide (7.56).
g, 42.5 mmol) and 2,2′-azobis (isobutyronitrile) (633 mg, 3.86 mmol), and the mixture was heated under reflux overnight. The insolubles were filtered using celite, and the filtrate was concentrated to prepare a bromo compound. 3-oxo-
Ethyl 3- (4-fluorophenyl) propionate (7.
3g, 34.7 mmol) in 1,2-dimethoxyethane (70 ml) was added to a solution of sodium hydride (60% oily,
(1.39 g, 34.7 mmol) under ice-cooling, and the mixture was stirred at room temperature for 30 minutes. A solution of the previously synthesized bromo compound in 1,2-dimethoxyethane (20 ml) was dropped into the reaction solution,
The reaction was stirred at room temperature for 1 hour. The reaction solution was washed with water (200 m
1) and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
4: 1) and recrystallized from diisopropyl ether-hexane to give 3- (4-fluorophenyl) -3-oxo-2-((3- (2,2,2-trifluoroethoxy)
Phenyl) methyl) ethyl propionate (4.23 g,
31%). mp 48-49 ° C IRνmax KBr cm -1 : 1738, 1688, 1599, 1508, 1493, 145
. 3. Anal Calcd for C 20 H 18 F 4 O 4: C, 60.30; H, 4.55 Found:. C, 60.11; H, 4.36 1 H-NMR (CDCl 3) δ: 1.23 (3
H, t, J = 7.0 Hz), 3.30 (2H, d, J = 7.2 Hz), 4.11
(2H, q, J = 7.0 Hz), 4.30 (2H, q, J = 8.0 Hz), 4.5
6 (1H, t, J = 7.2 Hz), 6.70-6.96 (3H, m), 7.06-7.3
0 (3H, m), 7.92-8.10 (2H, m). 3) To a solution of zinc chloride (2.81 g, 20.6 mmol) in diethyl ether (100 ml) was added sodium borohydride (1.56 g, 41.2). Mmol) and stirred at room temperature for 30 minutes. The insoluble material was removed by filtration, and the filtrate was treated with 3- (4-fluorophenyl) -3-oxo-2-((3- (2,2,2-
A solution of ethyl trifluoroethoxy) phenyl) methyl) propionate (4.10 g, 10.3 mmol) in diethyl ether (50 ml) was added, and the mixture was stirred at room temperature for 30 minutes. Under ice cooling, the reaction solution is quenched by adding 1N hydrochloric acid,
Further, water (200 ml) was added, and ethyl acetate (300 ml) was added.
× 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Purified with ethyl acetate = 4: 1) to give (2RS, 3RS)-
3- (4-fluorophenyl) -3-hydroxy-2-((3
Ethyl-(2,2,2-trifluoroethoxy) phenyl) methyl) propionate (3.51 g, 85%) was obtained as a colorless oil. IRνmax KBr cm -1 : 1715, 1605, 1590, 1510. Anal.Calcd for C 20 H 20 F 4 O 4・ 0.1H 2 O: C, 59.73; H,
5.06 Found:. C, 59.55; H, 5.06 1 H-NMR (CDCl 3) δ: 0.94 (3H, t, J = 7.0 Hz), 2.88-
3.00 (3H, m), 3.90 (2H, q, J = 7.0 Hz), 4.30 (2H,
q, J = 8.0 Hz), 5.01 (1H, brs), 6.60-6.82 (3H, m),
7.00-7.30 (3H, m), 7.32-7.44 (2H, m). 4) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((3- (2,2, Ethyl 2-trifluoroethoxy) phenyl) methyl) propionate (3.4 g, 8.49 mmol) in methanol (15 m
1) Add 2N aqueous sodium hydroxide solution (8.5 m
1,17.0 mmol) and stirred at room temperature overnight.
The reaction solution was acidified with 1N hydrochloric acid and then ethyl acetate (10%).
0 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane,
(2RS, 3RS) -3- (4-fluorophenyl) -3-
Hydroxy-2-((3- (2,2,2-trifluoroethoxy) phenyl) methyl) propionic acid (2.78 g,
88%). . mp 142-143 ℃ IRνmax KBr cm -1 : 1715, 1607, 1588. Anal Calcd for C 18 H 16 F 4 O 4: C, 58.07; H, 4.33 Found:. C, 58.00; H, 4.27 1 H- NMR (CDCl 3 ) δ: 2.82-3.10 (3H, m), 4.29 (2H, q,
J = 8.0 Hz), 5.06 (1H, d, J = 4.4 Hz), 6.69 (1H,
s), 6.70-7.02 (2H, m), 7.00-7.24 (3H, m), 7.30-7.4
4 (2H, m). 5) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((3- (2,2,2-trifluoroethoxy) phenyl) methyl) propion Acid (2.
68 g, 7.20 mmol) of tetrahydrofuran (6
0 ml) solution in diphenylphosphoryl azide (1.7).
1 ml, 7.92 mmol) and triethylamine (1.
(51 ml, 10.8 mmol) and heated to reflux for 3 hours. After allowing the reaction solution to cool, water (200 ml) was added, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (4RS, 5SR)-
5- (4-fluorophenyl) -4-((3- (2,2,2-
Trifluoroethoxy) phenyl) methyl) -1,3-oxazolidin-2-one (2.31 g, 87%) was obtained. mp 148-149 ° C IRνmax KBr cm -1 : 1759, 1609, 1590, 1514. Anal.Calcd for C 18 H 15 F 4 NO 3 : C, 58.54; H, 4.09; N,
3.79 Found:. C, 58.54; H, 4.01; N, 3.88 1 H-NMR (CDCl 3) δ: 2.12-2.38 (2H, m), 4.16-4.28 (1
H, m), 4.32 (2H, q, J = 8.0 Hz), 5.17 (1H, brs), 5.
79 (1H, d, J = 8.0Hz), 6.62 (1H, d, J = 1.8Hz),
6.72 (1H, d, J = 7.6 Hz), 6.77-6.84 (1H, m), 7.04-
7.42 (5H, m). 6) (4RS, 5SR) -5- (4-fluorophenyl) -4-((3- (2,2,2-trifluoroethoxy)
Phenyl) methyl) -1,3-oxazolidin-2-one (1.2 g, 3.25 mmol) in ethanol (10 m
l) 8N aqueous sodium hydroxide solution (2.0m
1, 16 mmol) and heated to reflux for 2 hours. After concentration, the reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane (1R
S, 2SR) -2-Amino-1- (4-fluorophenyl)-
3- (3- (2,2,2-trifluoroethoxy) phenyl) -1-propanol (913 mg, 82%) was obtained. mp 94-95 ° C IRνmax KBr cm -1 : 1605, 1588, 1508, 1489, 1454 Anal.Calcd for C 17 H 17 F 4 NO 2 : C, 59.47; H, 4.99; N,
4.08 Found:. C, 59.34; H, 4.87; N, 4.19 1 H-NMR (CDCl 3) δ: 2.33 (1H, dd, J = 14.0, 10.6 H
z), 2.78 (1H, dd, J = 14.0, 3.0 Hz), 3.20-3.34 (1
H, m), 4.33 (2H, q, J = 8.0 Hz), 4.66 (1H, d, J =
4.6 Hz), 6.70-6.90 (3H, m), 7.00-7.16 (2H, m), 7.2
0-7.30 (1H, m), 7.30-7.44 (2H, m). 7) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (3- (2,2,2 -Trifluoroethoxy) phenyl) -1-propanol (181 mg, 0.1 mg).
53 mmol) in acetonitrile (20 ml) solution.
-Fluoronaphthalenecarboxylic acid (100 mg, 0.5
3 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (151 mg, 0.1 mg).
79 mmol) and 1-hydroxy-1H-benzotriazole (81 mg, 0.53 mmol) were added, and the mixture was stirred at room temperature overnight. Dilute the reaction with water (100 ml)
Extracted with ethyl acetate (100 ml × 2). Extract 1
The mixture was washed successively with normal hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (206 mg, 76%). mp 192-193 ℃ IRνmax KBr cm -1 : 1642, 1626, 1601, 1512. Anal.Calcd for C 28 H 22 F 5 NO 3・ 0.1H 2 O: C, 65.02;
4.32; N, 2.71 Found: C, 64.89; H, 4.43; N, 2.93. 1 H-NMR (CDCl 3 ) δ: 2.78 (1H, dd, J = 14.6, 11.0 H
z), 3.04 (1H, dd, J = 14.6, 4.0 Hz), 4.28 (2H, q,
J = 8.0 Hz), 4.70-4.88 (1H, m), 5.09 (1H, d, J = 3.
8 Hz), 5.90 (1H, d, J = 8.8 Hz), 6.76-7.36 (8H,
m), 7.40-7.60 (4H, m), 7.77 (1H, d, J = 7.6 Hz), 8.
09 (1H, d, J = 7.6 Hz).
【0303】実施例171 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((3-(2,2,2-トリフルオロ
エトキシ)フェニル)メチル)エチル)-6,7-ジヒド
ロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミ
ド (1RS,2SR)-2-アミノ-1-(2-フルオロフェ
ニル)-3-(3-(2,2,2-トリフルオロエトキシ)
フェニル)-1-プロパノール(183mg,0.53ミ
リモル)のアセトニトリル(20ml)溶液に6,7-
ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボ
ン酸(100mg,0.53ミリモル)および1-エチ
ル-3-(3-ジメチルアミノプロピル)カルボジイミド
・塩酸塩(153mg,0.80ミリモル)および1-
ヒドロキシ-1H-ベンゾトリアゾール(81mg,0.
53ミリモル)を加えて室温で終夜攪拌した。反応液を
水(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を1規定塩酸、1規定水酸化ナ
トリウム水溶液、飽和食塩水で順次洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物を酢酸エチル
−ヘキサンから再結晶させて、表題化合物(225m
g,82%)を得た。 mp 172-173℃ IRνmaxKBrcm-1: 1636, 1605, 1588, 1510.1 H-NMR (CDCl3)δ: 1.90-2.08 (2H, m), 2.10-2.36 (2
H, m), 2.60-2.80 (3H, m), 2.97 (1H, dd, J = 14.2,
4.0 Hz), 3.78 (1H, s), 4.30 (2H, q, J = 8.2 Hz),
4.60-4.76 (1H, m), 5.01 (1H, d, J = 3.2 Hz), 5.75
(1H, d, J = 8.4 Hz), 5.82-6.00 (1H, m), 6.17 (1H,
d, J = 11.8 Hz), 6.77 (1H, s), 6.80-6.92(1H, m),
6.94-7.30 (7H, m), 7.38-7.50 (2H, m).Example 171 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((3- (2,2,2-trifluoroethoxy) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR ) -2-Amino-1- (2-fluorophenyl) -3- (3- (2,2,2-trifluoroethoxy)
To a solution of phenyl) -1-propanol (183 mg, 0.53 mmol) in acetonitrile (20 ml) was added 6,7-
Dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (100 mg, 0.53 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (153 mg, 0.80 mmol) and 1 -
Hydroxy-1H-benzotriazole (81 mg, 0.1 mg).
(53 mmol) and stirred overnight at room temperature. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (225m
g, 82%). mp 172-173 ℃ IRνmax KBr cm -1: 1636, 1605, 1588, 1510. 1 H-NMR (CDCl 3) δ: 1.90-2.08 (2H, m), 2.10-2.36 (2
H, m), 2.60-2.80 (3H, m), 2.97 (1H, dd, J = 14.2,
4.0 Hz), 3.78 (1H, s), 4.30 (2H, q, J = 8.2 Hz),
4.60-4.76 (1H, m), 5.01 (1H, d, J = 3.2 Hz), 5.75
(1H, d, J = 8.4 Hz), 5.82-6.00 (1H, m), 6.17 (1H,
d, J = 11.8 Hz), 6.77 (1H, s), 6.80-6.92 (1H, m),
6.94-7.30 (7H, m), 7.38-7.50 (2H, m).
【0304】実施例172 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((3-(2,2,3,3-テトラフ
ルオロプロピルオキシ)フェニル)メチル)エチル)-
4-フルオロ-1-ナフタレンカルボキサミド 1) 3-ヒドロキシトルエン(5.0g,46.2ミ
リモル)のN,N-ジメチルホルムアミド(50ml)
溶液に2,2,3,3-テトラフルオロ-1-ヨードプロ
パン(12.3g,50.9ミリモル)および炭酸カリ
ウム(12.8g,92.5ミリモル)を加え、80℃
で終夜攪拌した。反応液を水(200ml)で希釈し、
ジエチルエーテル(300ml×2)で抽出した。抽出
液を水、飽和食塩水で順次洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去した。残留物をシリカゲルカラムク
ロマトグラフィー(ヘキサン:酢酸エチル=10:1)
で精製し、3-(2,2,3,3-テトラフルオロプロピ
ルオキシ)トルエン(10.0g,97%)を無色油状
物として得た。 IRνmaxKBrcm-1: 1607, 1588, 1491, 1458. Anal. Calcd for C10H10F4O・0.2H2O: C, 53.20; H, 4.
64 Found: C, 53.01; H, 4.40.1 H-NMR (CDCl3)δ: 2.34 (3H, s), 4.32 (2H, tt, J =
12.0, 1.6 Hz), 6.07 (1H, tt, J = 53.2, 5.0 Hz), 6.
70-6.90 (3H, m), 7.16-7.24 (1H, m). 2) 3-(2,2,3,3-テトラフルオロプロピルオ
キシ)トルエン(7.0g,31.5ミリモル)の四塩
化炭素(100ml)溶液にN-ブロモスクシンイミド
(6.17g,34.7ミリモル)および2,2'-アゾ
ビス(イソブチロニトリル)(517mg,3.15ミ
リモル)を加え、終夜加熱還流した。不溶物をセライト
を用いてろ過し、ろ液を濃縮し、ブロモ体を調製した。
3-(4-フルオロフェニル)-3-オキソプロピオン酸エ
チル(5.96g,28.4ミリモル)の1,2-ジメ
トキシエタン(60ml)溶液に水素化ナトリウム(6
0%油性,1.13g,28.4ミリモル)を氷冷下加
え、室温で30分攪拌した。反応液の中に先に合成した
ブロモ体の1,2-ジメトキシエタン(20ml)溶液
を滴下し、反応液を室温で1時間攪拌した。反応液を水
(200ml)の中に注ぎ、酢酸エチル(200ml×
2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=4:1)で精製し、ジイソプロピルエーテ
ル−ヘキサンから再結晶させて、3-(4-フルオロフェ
ニル)-3-オキソ-2-((3-(2,2,3,3-テトラ
フルオロプロピルオキシ)フェニル)メチル)プロピオ
ン酸エチル(5.63g,46%)を得た。 mp 55-56℃ IRνmaxKBrcm-1: 1738, 1688, 1599, 1508, 1489, 144
9. Anal. Calcd for C21H19F5O4: C, 58.61; H, 4.45 Found: C, 58.50; H, 4.41.1 H-NMR (CDCl3)δ: 1.13 (3H, t, J = 7.2 Hz), 3.30
(2H, d, J = 7.2 Hz), 4.11 (2H, q, J = 7.2 Hz), 4.2
0-4.38 (2H, m), 4.56 (1H, t, J = 7.2 Hz), 6.05 (1
H, tt, J = 53.0, 5.0 Hz), 6.70-6.88 (2H, m), 6.91
(1H, d, J = 7.2 Hz), 7.06-7.30 (3H, m), 7.92-8.08
(2H, m). 3) 塩化亜鉛(3.50g,25.6ミリモル)のジ
エチルエーテル(100ml)溶液に水素化ホウ素ナト
リウム(1.93g,51.1ミリモル)を加えて室温
で30分攪拌した。不溶物をろ去し、ろ液に3-(4-フ
ルオロフェニル)-3-オキソ-2-((3-(2,2,
3,3-テトラフルオロプロピルオキシ)フェニル)メ
チル)プロピオン酸エチル(5.50g,12.8ミリ
モル)のジエチルエーテル(50ml)溶液を加えて室
温で30分攪拌した。氷冷下、反応液に1規定塩酸を加
えてクエンチし、更に水(200ml)を加え、酢酸エ
チル(300ml×2)で抽出した。抽出液を水および
飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減
圧留去した。残留物をシリカゲルカラムクロマトグラフ
ィー(ヘキサン:酢酸エチル=4:1)で精製し、(2
RS,3RS)-3-(4-フルオロフェニル)-3-ヒド
ロキシ-2-((3-(2,2,3,3-テトラフルオロプ
ロピルオキシ)フェニル)メチル)プロピオン酸エチル
(4.99g,90%)を無色油状物として得た。 IRνmaxKBrcm-1: 1725, 1605, 1588, 1511. Anal. Calcd for C21H21F5O4: C, 58.33; H, 4.90 Found: C, 58.20; H, 4.92.1 H-NMR (CDCl3)δ: 0.94 (3H, t, J = 7.0 Hz), 2.89
(1H, d, J = 2.8 Hz), 2.92-3.02 (3H, m), 3.90 (2H,
q, J = 7.0 Hz), 4.29 (2H, t, J = 12.0 Hz), 5.02 (1
H, s), 6.05 (1H, tt, J = 53.0, 5.0 Hz), 6.62-6.82
(3H, m), 7.00-7.24 (3H, m), 7.32-7.44 (2H, m). 4) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((3-(2,2,3,3-テト
ラフルオロプロピルオキシ)フェニル)メチル)プロピ
オン酸エチル(4.75g,11.0ミリモル)のメタ
ノール(40ml)溶液に、2規定水酸化ナトリウム水
溶液(11ml,22.0ミリモル)を加えて室温で終
夜攪拌した。反応液を1規定塩酸で酸性とした後、酢酸
エチル(100ml×2)で抽出した。抽出液を水およ
び飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後
減圧留去した。残留物をジイソプロピルエーテル−ヘキ
サンより再結晶させて、(2RS,3RS)-3-(4-
フルオロフェニル)-3-ヒドロキシ-2-((3-(2,
2,3,3-テトラフルオロプロピルオキシ)フェニ
ル)メチル)プロピオン酸(3.91g,88%)を得
た。 mp 114-115℃ IRνmaxKBrcm-1: 1715, 1607, 1512. Anal. Calcd for C19H17F5O4: C, 56.44; H, 4.24 Found: C, 56.52; H, 4.35.1 H-NMR (CDCl3)δ: 2.84-3.08 (3H, m), 4.19-4.37 (2
H, m), 5.06 (1H, d, J =4.4 Hz), 6.04 (1H, tt, J =
53.0, 5.0 Hz), 6.60-6.68 (1H, m), 6.68-6.80(2H,
m), 7.00-7.30 (3H, m), 7.30-7.42 (2H, m). 5) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((3-(2,2,3,3-テト
ラフルオロプロピルオキシ)フェニル)メチル)プロピ
オン酸(2.0g,4.95ミリモル)のテトラヒドロ
フラン(40ml)溶液に、ジフェニルホスホリルアジ
ド(1.17ml,5.44ミリモル)とトリエチルア
ミン(1.04ml,7.43ミリモル)を加え、3時
間加熱還流した。反応液を放冷後、水(200ml)を
加えて酢酸エチル(200ml×2)で抽出した。抽出
液を1規定塩酸、飽和重曹水、飽和食塩水で順次洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物を酢酸エチル−ヘキサンより再結晶させて、(4R
S,5SR)-5-(4-フルオロフェニル)-4-((3-
(2,2,3,3-テトラフルオロプロピルオキシ)フ
ェニル)メチル)-1,3-オキサゾリジン-2-オン
(1.68g,85%)を得た。 mp 113-114℃ IRνmaxKBrcm-1: 1759, 1608, 1588, 1514. Anal. Calcd for C19H16F5NO3: C, 56.89; H, 4.02; N,
3.49 Found: C, 56.99; H, 4.15; N, 3.53.1 H-NMR (CDCl3)δ: 2.10-2.40 (2H, m), 4.18-4.40 (3
H, m), 5.22 (1H, brs),5.79 (1H, d, J = 8.4 Hz), 6.
05 (1H, tt, J = 53.2, 5.0 Hz), 6.59 (1H, s),6.66-
6.82 (2H, m), 7.04-7.40 (5H, m). 6) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((3-(2,2,3,3-テトラフルオロプロ
ピルオキシ)フェニル)メチル)-1,3-オキサゾリジ
ン-2-オン(1.0g,2.49ミリモル)のエタノー
ル(10ml)溶液に8規定水酸化ナトリウム水溶液
(1.56ml,12.5ミリモル)を加え、3時間加
熱還流した。反応液を濃縮後、水(100ml)で希釈
し、酢酸エチル(100ml×2)で抽出した。抽出液
を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後
減圧留去し、残留物を酢酸エチル−ヘキサンから再結晶
させて(1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(3-(2,2,3,3-テトラフルオ
ロプロピルオキシ)フェニル)-1-プロパノール(82
5mg,88%)を得た。 mp 77-78℃ IRνmaxKBrcm-1: 1605, 1586, 1508, 1489. Anal. Calcd for C18H18F5NO2: C, 57.60; H, 4.83; N,
3.73 Found: C, 57.62; H, 4.70; N, 3.76.1 H-NMR (CDCl3)δ: 2.33 (1H, dd, J = 14.0, 10.4 H
z), 2.79 (1H, dd, J = 14.0, 3.0 Hz), 3.22-3.34 (1
H, m), 4.32 (2H, t, J = 12.0 Hz), 4.66 (1H, d,J =
4.8 Hz), 6.06 (1H, tt, J = 53.0, 5.0 Hz), 6.70-6.9
0 (3H, m), 7.00-7.14 (2H, m), 7.20-7.30 (1H, m),
7.30-7.44 (2H, m). 7) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(3-(2,2,3,3-テトラフルオ
ロプロピルオキシ)フェニル)-1-プロパノール(19
7mg,0.53ミリモル)のアセトニトリル(20m
l)溶液に4-フルオロナフタレンカルボン酸(100
mg,0.53ミリモル)および1-エチル-3-(3-ジ
メチルアミノプロピル)カルボジイミド・塩酸塩(15
1mg,0.79ミリモル)および1-ヒドロキシ-1H
-ベンゾトリアゾール(81mg,0.53ミリモル)
を加えて室温で終夜攪拌した。反応液を水(100m
l)で希釈し、酢酸エチル(100ml×2)で抽出し
た。抽出液を1規定塩酸、1規定水酸化ナトリウム水溶
液、飽和食塩水で順次洗浄し、無水硫酸マグネシウムで
乾燥後減圧留去した。残留物を酢酸エチル−ヘキサンか
ら再結晶させて、表題化合物(240mg,84%)を
得た。 mp 160-161℃ IRνmaxKBrcm-1: 1641, 1626, 1601, 1535, 1512. Anal. Calcd for C29H23F6NO3・0.2H2O: C, 63.21; H,
4.28; N, 2.54 Found: C, 62.99; H, 4.39; N, 2.84.1 H-NMR (CDCl3)δ: 2.79 (1H, dd, J = 14.4, 10.6 H
z), 3.04 (1H, dd, J = 14.4, 4.0 Hz), 4.28 (2H, t,
J = 12.0 Hz), 4.70-4.84 (1H, m), 5.10 (1H, d,J =
4.0 Hz), 5.90 (1H, d, J = 8.4 Hz), 6.01 (1H, tt, J
= 53.0, 5.0 Hz),6.74-7.30 (8H, m), 7.40-7.60 (4H,
m), 7.77 (1H, d, J = 8.2 Hz), 8.09 (1H, d, J = 7.
6 Hz).Example 172 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((3- (2,2,3,3-tetrafluoropropyloxy) phenyl) methyl) ethyl)-
4-Fluoro-1-naphthalenecarboxamide 1) 3-Hydroxytoluene (5.0 g, 46.2 mmol) in N, N-dimethylformamide (50 ml)
To the solution were added 2,2,3,3-tetrafluoro-1-iodopropane (12.3 g, 50.9 mmol) and potassium carbonate (12.8 g, 92.5 mmol),
And stirred overnight. Dilute the reaction with water (200 ml)
Extracted with diethyl ether (300 ml × 2). The extract was washed successively with water and saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue is subjected to silica gel column chromatography (hexane: ethyl acetate = 10: 1).
To give 3- (2,2,3,3-tetrafluoropropyloxy) toluene (10.0 g, 97%) as a colorless oil. IRνmax KBr cm -1 : 1607, 1588, 1491, 1458.Anal.Calcd for C 10 H 10 F 4 O ・ 0.2H 2 O: C, 53.20; H, 4.
64 Found:. C, 53.01; H, 4.40 1 H-NMR (CDCl 3) δ: 2.34 (3H, s), 4.32 (2H, tt, J =
12.0, 1.6 Hz), 6.07 (1H, tt, J = 53.2, 5.0 Hz), 6.
70-6.90 (3H, m), 7.16-7.24 (1H, m). 2) Tetrachloride of 3- (2,2,3,3-tetrafluoropropyloxy) toluene (7.0 g, 31.5 mmol) N-bromosuccinimide (6.17 g, 34.7 mmol) and 2,2'-azobis (isobutyronitrile) (517 mg, 3.15 mmol) were added to a carbon (100 ml) solution, and the mixture was heated under reflux overnight. The insolubles were filtered using celite, and the filtrate was concentrated to prepare a bromo compound.
To a solution of ethyl 3- (4-fluorophenyl) -3-oxopropionate (5.96 g, 28.4 mmol) in 1,2-dimethoxyethane (60 ml) was added sodium hydride (6 ml).
(0% oily, 1.13 g, 28.4 mmol) under ice-cooling and stirred at room temperature for 30 minutes. A solution of the previously synthesized bromo compound in 1,2-dimethoxyethane (20 ml) was dropped into the reaction solution, and the reaction solution was stirred at room temperature for 1 hour. The reaction solution was poured into water (200 ml), and ethyl acetate (200 ml ×
Extracted in 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
The product was purified with ethyl acetate = 4: 1, recrystallized from diisopropyl ether-hexane, and treated with 3- (4-fluorophenyl) -3-oxo-2-((3- (2,2,3,3-tetra Ethyl fluoropropyloxy) phenyl) methyl) propionate (5.63 g, 46%) was obtained. mp 55-56 ° C IRνmax KBr cm -1 : 1738, 1688, 1599, 1508, 1489, 144
9. Anal.Calcd for C 21 H 19 F 5 O 4 : C, 58.61; H, 4.45 Found: C, 58.50; H, 4.41. 1 H-NMR (CDCl 3 ) δ: 1.13 (3H, t, J = 7.2 Hz), 3.30
(2H, d, J = 7.2 Hz), 4.11 (2H, q, J = 7.2 Hz), 4.2
0-4.38 (2H, m), 4.56 (1H, t, J = 7.2 Hz), 6.05 (1
H, tt, J = 53.0, 5.0 Hz), 6.70-6.88 (2H, m), 6.91
(1H, d, J = 7.2 Hz), 7.06-7.30 (3H, m), 7.92-8.08
(2H, m). 3) To a solution of zinc chloride (3.50 g, 25.6 mmol) in diethyl ether (100 ml) was added sodium borohydride (1.93 g, 51.1 mmol), and the mixture was stirred at room temperature for 30 minutes. did. The insoluble material was removed by filtration, and the filtrate was treated with 3- (4-fluorophenyl) -3-oxo-2-((3- (2,2,2
A solution of ethyl 3,3-tetrafluoropropyloxy) phenyl) methyl) propionate (5.50 g, 12.8 mmol) in diethyl ether (50 ml) was added, and the mixture was stirred at room temperature for 30 minutes. Under ice-cooling, the reaction solution was quenched by adding 1N hydrochloric acid, further added with water (200 ml), and extracted with ethyl acetate (300 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give (2
Ethyl RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((3- (2,2,3,3-tetrafluoropropyloxy) phenyl) methyl) propionate (4.99 g, 90%) as a colorless oil. . IRνmax KBr cm -1: 1725, 1605, 1588, 1511. Anal Calcd for C 21 H 21 F 5 O 4: C, 58.33; H, 4.90 Found:. C, 58.20; H, 4.92 1 H-NMR (CDCl 3 ) δ: 0.94 (3H, t, J = 7.0 Hz), 2.89
(1H, d, J = 2.8 Hz), 2.92-3.02 (3H, m), 3.90 (2H,
q, J = 7.0 Hz), 4.29 (2H, t, J = 12.0 Hz), 5.02 (1
H, s), 6.05 (1H, tt, J = 53.0, 5.0 Hz), 6.62-6.82
(3H, m), 7.00-7.24 (3H, m), 7.32-7.44 (2H, m). 4) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((3 To a solution of ethyl-(2,2,3,3-tetrafluoropropyloxy) phenyl) methyl) propionate (4.75 g, 11.0 mmol) in methanol (40 ml) was added 2N aqueous sodium hydroxide solution (11 ml, 22 (1.0 mmol) and stirred overnight at room temperature. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (100 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to give (2RS, 3RS) -3- (4-
Fluorophenyl) -3-hydroxy-2-((3- (2,
2,3,3-Tetrafluoropropyloxy) phenyl) methyl) propionic acid (3.91 g, 88%) was obtained. . mp 114-115 ℃ IRνmax KBr cm -1 : 1715, 1607, 1512. Anal Calcd for C 19 H 17 F 5 O 4: C, 56.44; H, 4.24 Found:. C, 56.52; H, 4.35 1 H- NMR (CDCl 3 ) δ: 2.84-3.08 (3H, m), 4.19-4.37 (2
H, m), 5.06 (1H, d, J = 4.4 Hz), 6.04 (1H, tt, J =
53.0, 5.0 Hz), 6.60-6.68 (1H, m), 6.68-6.80 (2H,
m), 7.00-7.30 (3H, m), 7.30-7.42 (2H, m). 5) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((3- (2 To a solution of (2,3,3-tetrafluoropropyloxy) phenyl) methyl) propionic acid (2.0 g, 4.95 mmol) in tetrahydrofuran (40 ml) was added diphenylphosphoryl azide (1.17 ml, 5.44 mmol). Triethylamine (1.04 ml, 7.43 mmol) was added, and the mixture was heated under reflux for 3 hours. After allowing the reaction solution to cool, water (200 ml) was added, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (4R
S, 5SR) -5- (4-fluorophenyl) -4-((3-
(2,2,3,3-tetrafluoropropyloxy) phenyl) methyl) -1,3-oxazolidin-2-one (1.68 g, 85%) was obtained. mp 113-114 ° C IRνmax KBr cm -1 : 1759, 1608, 1588, 1514. Anal.Calcd for C 19 H 16 F 5 NO 3 : C, 56.89; H, 4.02; N,
3.49 Found:. C, 56.99; H, 4.15; N, 3.53 1 H-NMR (CDCl 3) δ: 2.10-2.40 (2H, m), 4.18-4.40 (3
H, m), 5.22 (1H, brs), 5.79 (1H, d, J = 8.4 Hz), 6.
05 (1H, tt, J = 53.2, 5.0 Hz), 6.59 (1H, s), 6.66
6.82 (2H, m), 7.04-7.40 (5H, m). 6) (4RS, 5SR) -5- (4-fluorophenyl) -4-((3- (2,2,3,3-tetrafluoro To a solution of propyloxy) phenyl) methyl) -1,3-oxazolidine-2-one (1.0 g, 2.49 mmol) in ethanol (10 ml) was added an 8 N aqueous sodium hydroxide solution (1.56 ml, 12.5 mmol). Was added and heated under reflux for 3 hours. After concentration, the reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR) -2-amino-1- (4-fluorophenyl). ) -3- (3- (2,2,3,3-tetrafluoropropyloxy) phenyl) -1-propanol (82
5 mg, 88%). mp 77-78 ° C IRνmax KBr cm -1 : 1605, 1586, 1508, 1489. Anal.Calcd for C 18 H 18 F 5 NO 2 : C, 57.60; H, 4.83; N,
3.73 Found:. C, 57.62; H, 4.70; N, 3.76 1 H-NMR (CDCl 3) δ: 2.33 (1H, dd, J = 14.0, 10.4 H
z), 2.79 (1H, dd, J = 14.0, 3.0 Hz), 3.22-3.34 (1
H, m), 4.32 (2H, t, J = 12.0 Hz), 4.66 (1H, d, J =
4.8 Hz), 6.06 (1H, tt, J = 53.0, 5.0 Hz), 6.70-6.9
0 (3H, m), 7.00-7.14 (2H, m), 7.20-7.30 (1H, m),
7.30-7.44 (2H, m). 7) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (3- (2,2,3,3-tetrafluoropropyloxy) phenyl ) -1-Propanol (19
7 mg, 0.53 mmol) of acetonitrile (20 m
l) Add 4-fluoronaphthalenecarboxylic acid (100
mg, 0.53 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (15 mg).
1 mg, 0.79 mmol) and 1-hydroxy-1H
-Benzotriazole (81 mg, 0.53 mmol)
Was added and stirred at room temperature overnight. The reaction solution was washed with water (100 m
1) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (240 mg, 84%). mp 160-161 ℃ IRνmax KBr cm -1 : 1641, 1626, 1601, 1535, 1512. Anal.Calcd for C 29 H 23 F 6 NO 3・ 0.2H 2 O: C, 63.21; H,
4.28; N, 2.54 Found:. C, 62.99; H, 4.39; N, 2.84 1 H-NMR (CDCl 3) δ: 2.79 (1H, dd, J = 14.4, 10.6 H
z), 3.04 (1H, dd, J = 14.4, 4.0 Hz), 4.28 (2H, t,
J = 12.0 Hz), 4.70-4.84 (1H, m), 5.10 (1H, d, J =
4.0 Hz), 5.90 (1H, d, J = 8.4 Hz), 6.01 (1H, tt, J
= 53.0, 5.0 Hz), 6.74-7.30 (8H, m), 7.40-7.60 (4H,
m), 7.77 (1H, d, J = 8.2 Hz), 8.09 (1H, d, J = 7.
6 Hz).
【0305】実施例173 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((3-(2,2,3,3-テトラフ
ルオロプロピルオキシ)フェニル)メチル)エチル)-
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボキサミド (1RS,2SR)-2-アミノ-1-(2-フルオロフェ
ニル)-3-(3-(2,2,3,3-テトラフルオロプロ
ピルオキシ)フェニル)-1-プロパノール(200m
g,0.53ミリモル)のアセトニトリル(20ml)
溶液に6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプ
テン-1-カルボン酸(100mg,0.53ミリモル)
および1-エチル-3-(3-ジメチルアミノプロピル)カ
ルボジイミド・塩酸塩(153mg,0.80ミリモ
ル)および1-ヒドロキシ-1H-ベンゾトリアゾール
(81mg,0.53ミリモル)を加えて室温で終夜攪
拌した。反応液を水(100ml)で希釈し、酢酸エチ
ル(100ml×2)で抽出した。抽出液を1規定塩
酸、1規定水酸化ナトリウム水溶液、飽和食塩水で順次
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去した。
残留物を酢酸エチル−ヘキサンから再結晶させて、表題
化合物(224mg,77%)を得た。 mp 169-170℃ IRνmaxKBrcm-1: 1640, 1605, 1587, 1510.1 H-NMR (CDCl3)δ: 1.90-2.08 (2H, m), 2.10-2.28 (2
H, m), 2.60-2.80 (3H, m), 2.97 (1H, dd, J = 14.6,
4.0 Hz), 3.77 (1H, brs), 4.30 (2H, t, J = 12.0 H
z), 4.58-4.76 (1H, m), 5.02 (1H, d, J = 3.6 Hz),
5.70-5.82 (1H, m), 5.84-5.98 (1H, m), 6.04 (1H, t
t, J = 53.0, 5.0 Hz), 6.17 (1H, d, J = 12.0Hz), 6.
75 (1H, s), 6.78-6.90 (2H, m), 6.90-7.30 (6H, m),
7.38-7.50 (2H,m).Example 173 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((3- (2,2,3,3-tetrafluoropropyloxy) phenyl) methyl) ethyl)-
6,7-dihydro-5H-benzo [a] cycloheptene-1
-Carboxamide (1RS, 2SR) -2-amino-1- (2-fluorophenyl) -3- (3- (2,2,3,3-tetrafluoropropyloxy) phenyl) -1-propanol (200 m
g, 0.53 mmol) of acetonitrile (20 ml)
6,7-Dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (100 mg, 0.53 mmol) was added to the solution.
And 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (153 mg, 0.80 mmol) and 1-hydroxy-1H-benzotriazole (81 mg, 0.53 mmol) were added, and the mixture was stirred at room temperature overnight. did. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was recrystallized from ethyl acetate-hexane to give the title compound (224 mg, 77%). mp 169-170 ℃ IRνmax KBr cm -1: 1640, 1605, 1587, 1510. 1 H-NMR (CDCl 3) δ: 1.90-2.08 (2H, m), 2.10-2.28 (2
H, m), 2.60-2.80 (3H, m), 2.97 (1H, dd, J = 14.6,
4.0 Hz), 3.77 (1H, brs), 4.30 (2H, t, J = 12.0 H
z), 4.58-4.76 (1H, m), 5.02 (1H, d, J = 3.6 Hz),
5.70-5.82 (1H, m), 5.84-5.98 (1H, m), 6.04 (1H, t
t, J = 53.0, 5.0 Hz), 6.17 (1H, d, J = 12.0Hz), 6.
75 (1H, s), 6.78-6.90 (2H, m), 6.90-7.30 (6H, m),
7.38-7.50 (2H, m).
【0306】実施例174 4-フルオロ-N-((1RS,2SR)-2-ヒドロキシ-
2-フェニル-1-((4-(トリフルオロメチル)フェニ
ル)メチル)エチル)-1-ナフタレンカルボキサミド 1) 3-オキソ-3-フェニルプロピオン酸エチル(2
8.6g,145ミリモル)の1,2-ジメトキシエタ
ン(150ml)溶液に水素化ナトリウム(60%油
性,5.65g,141ミリモル)を氷冷下加え、室温
で1時間攪拌した。反応液の中に4-トリフルオロメチ
ルベンジルブロミド(33.8g,141ミリモル)の
1,2-ジメトキシエタン(50ml)溶液を滴下し、
反応液を室温で2時間攪拌した。反応液を水(500m
l)の中に注ぎ、酢酸エチル(500ml×2)で抽出
した。抽出液を水および飽和食塩水で洗浄し、無水硫酸
マグネシウムで乾燥後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(トルエン)で精製し、3
-オキソ-3-フェニル-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸エチル(45.4
g,75%)を黄色油状物として得た。 IRνmaxKBrcm-1: 1738, 1688.1 H-NMR (CDCl3)δ: 1.11 (3H, t, J = 7.2 Hz), 3.39
(2H, d, J = 7.8 Hz), 4.10 (2H, q, J = 7.2 Hz), 4.6
3 (1H, t, J = 8.4 Hz), 7.10-7.64 (7H, m), 7.96 (2
H, d, J = 8.4 Hz). 2) 塩化亜鉛(14.7g,108ミリモル)のジエ
チルエーテル(250ml)溶液に水素化ホウ素ナトリ
ウム(8.2g,216ミリモル)を加えて室温で2時
間攪拌した。不溶物をろ去し、ろ液に3-オキソ-3-フ
ェニル-2-((4-(トリフルオロメチル)フェニル)
メチル)プロピオン酸(22g,54ミリモル)のジエ
チルエーテル(50ml)溶液を加えて室温で30分攪
拌した。氷冷下、反応液に1規定塩酸を加えてクエンチ
し、更に水(200ml)を加え、酢酸エチル(300
ml×2)で抽出した。抽出液を水および飽和食塩水で
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去した。
残留物をシリカゲルカラムクロマトグラフィー(トルエ
ン)で精製し、(2RS,3RS)-3-ヒドロキシ-3-
フェニル-2-((4-(トリフルオロメチル)フェニ
ル)メチル)プロピオン酸エチル(15.6g,83
%)を無色油状物として得た。 IRνmaxKBrcm-1: 1717. Anal. Calcd for C19H19F3O3: C, 64.77; H, 5.44 Found: C, 64.65; H, 5.67.1 H-NMR (CDCl3)δ: 0.91 (3H, t, J = 7.2 Hz), 2.96-
3.10 (3H, m), 3.88 (2H,q, J = 7.2 Hz), 5.00-5.08
(1H, m), 7.12-7.56 (9H, m). 3) (2RS,3RS)-3-ヒドロキシ-3-フェニル
-2-((4-(トリフルオロメチル)フェニル)メチ
ル)プロピオン酸エチル(10.0g,28.4ミリモ
ル)のメタノール(40ml)溶液に、2規定水酸化ナ
トリウム水溶液(28.4ml,56.8ミリモル)を
加えて室温で終夜攪拌した。反応液を1規定塩酸で酸性
とした後、酢酸エチル(200ml×2)で抽出した。
抽出液を水および飽和食塩水で洗浄し、無水硫酸マグネ
シウムで乾燥後減圧留去した。残留物を酢酸エチル−ヘ
キサンから再結晶させて(2RS,3RS)-3-ヒドロ
キシ-3-フェニル-2-((4-(トリフルオロメチル)
フェニル)メチル)プロピオン酸(7.87g,86
%)を得た。 mp 138-139℃ IRνmaxKBrcm-1: 1694. Anal. Calcd for C17H15F3O3: C, 62.96; H, 4.66 Found: C, 62.90; H, 4.89.1 H-NMR (CDCl3)δ: 2.90-3.12 (3H, m), 5.11 (1H, d,
J = 3.0 Hz), 7.17 (2H,d, J = 8.0 Hz), 7.30-7.42 (5
H, m), 7.46 (2H, d, J = 8.0 Hz). 4) (2RS,3RS)-3-ヒドロキシ-3-フェニル
-2-((4-(トリフルオロメチル)フェニル)メチ
ル)プロピオン酸(7g,21.6ミリモル)のテトラ
ヒドロフラン(200ml)溶液に、ジフェニルホスホ
リルアジド(5.12ml,23.7ミリモル)とトリ
エチルアミン(4.5ml,32.4ミリモル)を加
え、4時間加熱還流した。反応液を放冷後、水(200
ml)を加えて酢酸エチル(200ml×2)で抽出し
た。抽出液を1規定塩酸、飽和重曹水、飽和食塩水で順
次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて
(4RS,5SR)-5-フェニル-4-((4-(トリフ
ルオロメチル)フェニル)メチル)-1,3-オキサゾリ
ジン-2-オン(6.5g,93%)を得た。 mp 158-159℃ IRνmaxKBrcm-1: 1732. Anal. Calcd for C17H14F3NO2: C, 63.55; H, 4.39; N,
4.36 Found: C, 63.38; H, 4.60; N, 4.21.1 H-NMR (CDCl3)δ: 2.22-2.42 (1H, m), 2.37 (1H, s),
4.20-4.34 (1H, m), 5.05 (1H, s), 5.83 (1H, d, J =
8.0 Hz), 7.14 (2H, d, J = 8.0 Hz), 7.30-7.50 (5H,
m), 7.54 (2H, d, J = 8.0 Hz). 5) (4RS,5SR)-5-フェニル-4-((4-
(トリフルオロメチル)フェニル)メチル)-1,3-オ
キサゾリジン-2-オン(6.0g,18.7ミリモル)
のエタノール(100ml)溶液に8規定水酸化ナトリ
ウム水溶液(11.7ml,93ミリモル)を加え、4
時間加熱還流した。反応液を濃縮後、水(300ml)
で希釈し、酢酸エチル(300ml×2)で抽出した。
抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウムで
乾燥後減圧留去した。残留物をジイソプロピルエーテル
−ヘキサンから再結晶させて、(1RS,2SR)-2-
アミノ-1-フェニル-3-(4-(トリフルオロメチル)
フェニル)-1-プロパノール(4.8g,87%)を得
た。 mp 64-65℃ IRνmaxKBrcm-1: 1584, 1331. Anal. Calcd for C16H16F3NO: C, 65.08; H, 5.46; N,
4.74 Found: C, 65.05; H, 5.65; N, 4.62.1 H-NMR (CDCl3)δ: 2.45 (1H, dd, J = 13.8, 10.2 H
z), 2.91 (1H, dd, J = 13.8, 2.8 Hz), 3.22-3.36 (1
H, m), 4.65 (1H, d, J = 5.0 Hz), 7.20-7.42 (7H,m),
7.53 (2H, d, J = 8.0 Hz). 6) (1RS,2SR)-2-アミノ-1-フェニル-3-
(4-(トリフルオロメチル)フェニル)-1-プロパノ
ール(500mg,1.69ミリモル)のアセトニトリ
ル(30ml)溶液に4-フルオロナフタレンカルボン
酸(322mg,1.69ミリモル)および1-エチル-
3-(3-ジメチルアミノプロピル)カルボジイミド・塩
酸塩(487mg,2.54ミリモル)および1-ヒド
ロキシ-1H-ベンゾトリアゾール(259mg,1.6
9ミリモル)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を1規定塩酸、1規定水酸化ナ
トリウム水溶液、飽和食塩水で順次洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(酢酸エチル)で精製し酢酸
エチル−ヘキサンから再結晶させて、表題化合物(65
0mg,84%)を得た。 mp 217-218℃ IRνmaxKBrcm-1: 1644, 1626, 1601, 1537. Anal. Calcd for C27H21F4NO2: C, 69.37; H, 4.53; N,
3.00 Found: C, 69.15; H, 4.59; N, 2.80.1 H-NMR (CDCl3)δ: 2.89 (1H, dd, J = 14.2, 10.6 H
z), 3.02-3.20 (2H, m), 4.78-4.96 (1H, m), 5.13 (1
H, d, J = 3.8 Hz), 4.97 (1H, d, J = 9.2 Hz), 6.94-
7.08 (1H, m), 7.10-7.70 (13H, m), 8.08 (1H, d, J =
7.6 Hz).Example 174 4-Fluoro-N-((1RS, 2SR) -2-hydroxy-
2-Phenyl-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -1-naphthalenecarboxamide 1) Ethyl 3-oxo-3-phenylpropionate (2
Sodium hydride (60% oily, 5.65 g, 141 mmol) was added to a solution of 8.6 g (145 mmol) in 1,2-dimethoxyethane (150 ml) under ice-cooling, and the mixture was stirred at room temperature for 1 hour. A solution of 4-trifluoromethylbenzyl bromide (33.8 g, 141 mmol) in 1,2-dimethoxyethane (50 ml) was added dropwise to the reaction solution,
The reaction was stirred at room temperature for 2 hours. The reaction solution was washed with water (500 m
1) and extracted with ethyl acetate (500 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene),
Ethyl-oxo-3-phenyl-2-((4- (trifluoromethyl) phenyl) methyl) propionate (45.4
g, 75%) as a yellow oil. IRνmax KBr cm -1: 1738, 1688. 1 H-NMR (CDCl 3) δ: 1.11 (3H, t, J = 7.2 Hz), 3.39
(2H, d, J = 7.8 Hz), 4.10 (2H, q, J = 7.2 Hz), 4.6
3 (1H, t, J = 8.4 Hz), 7.10-7.64 (7H, m), 7.96 (2
H, d, J = 8.4 Hz). 2) To a solution of zinc chloride (14.7 g, 108 mmol) in diethyl ether (250 ml) was added sodium borohydride (8.2 g, 216 mmol), and the mixture was stirred at room temperature for 2 hours. did. The insoluble material is removed by filtration, and the filtrate is treated with 3-oxo-3-phenyl-2-((4- (trifluoromethyl) phenyl).
A solution of methyl) propionic acid (22 g, 54 mmol) in diethyl ether (50 ml) was added, and the mixture was stirred at room temperature for 30 minutes. Under ice-cooling, the reaction solution was quenched by adding 1N hydrochloric acid, and water (200 ml) was further added thereto.
ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was purified by silica gel column chromatography (toluene) to give (2RS, 3RS) -3-hydroxy-3-hydroxy.
Ethyl phenyl-2-((4- (trifluoromethyl) phenyl) methyl) propionate (15.6 g, 83
%) As a colorless oil. . IRνmax KBr cm -1: 1717. Anal Calcd for C 19 H 19 F 3 O 3: C, 64.77; H, 5.44 Found:. C, 64.65; H, 5.67 1 H-NMR (CDCl 3) δ: 0.91 ( 3H, t, J = 7.2 Hz), 2.96-
3.10 (3H, m), 3.88 (2H, q, J = 7.2 Hz), 5.00-5.08
(1H, m), 7.12-7.56 (9H, m). 3) (2RS, 3RS) -3-hydroxy-3-phenyl
To a solution of ethyl 2--2-((4- (trifluoromethyl) phenyl) methyl) propionate (10.0 g, 28.4 mmol) in methanol (40 ml), a 2N aqueous solution of sodium hydroxide (28.4 ml, 56.4 ml) was added. (8 mmol) and stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (200 ml × 2).
The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (2RS, 3RS) -3-hydroxy-3-phenyl-2-((4- (trifluoromethyl)
Phenyl) methyl) propionic acid (7.87 g, 86
%). . mp 138-139 ℃ IRνmax KBr cm -1 : 1694. Anal Calcd for C 17 H 15 F 3 O 3: C, 62.96; H, 4.66 Found:. C, 62.90; H, 4.89 1 H-NMR (CDCl 3 ) δ: 2.90-3.12 (3H, m), 5.11 (1H, d,
J = 3.0 Hz), 7.17 (2H, d, J = 8.0 Hz), 7.30-7.42 (5
H, m), 7.46 (2H, d, J = 8.0 Hz). 4) (2RS, 3RS) -3-hydroxy-3-phenyl
In a solution of 2-((4- (trifluoromethyl) phenyl) methyl) propionic acid (7 g, 21.6 mmol) in tetrahydrofuran (200 ml), diphenylphosphoryl azide (5.12 ml, 23.7 mmol) and triethylamine ( (4.5 ml, 32.4 mmol) and the mixture was refluxed for 4 hours. After allowing the reaction solution to cool, water (200
ml) and extracted with ethyl acetate (200 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (4RS, 5SR) -5-phenyl-4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2-one (6. (5 g, 93%). mp 158-159 ° C IRνmax KBr cm -1 : 1732.Analyzed Calcd for C 17 H 14 F 3 NO 2 : C, 63.55; H, 4.39; N,
4.36 Found: C, 63.38; H, 4.60; N, 4.21. 1 H-NMR (CDCl 3 ) δ: 2.22-2.42 (1H, m), 2.37 (1H, s),
4.20-4.34 (1H, m), 5.05 (1H, s), 5.83 (1H, d, J =
8.0 Hz), 7.14 (2H, d, J = 8.0 Hz), 7.30-7.50 (5H,
m), 7.54 (2H, d, J = 8.0 Hz). 5) (4RS, 5SR) -5-phenyl-4-((4-
(Trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2-one (6.0 g, 18.7 mmol)
8N sodium hydroxide aqueous solution (11.7 ml, 93 mmol) was added to an ethanol (100 ml) solution of
Heated to reflux for an hour. After concentrating the reaction solution, water (300 ml)
And extracted with ethyl acetate (300 ml × 2).
The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to give (1RS, 2SR) -2-
Amino-1-phenyl-3- (4- (trifluoromethyl)
Phenyl) -1-propanol (4.8 g, 87%) was obtained. mp 64-65 ℃ IRνmax KBr cm -1 : 1584, 1331. Anal.Calcd for C 16 H 16 F 3 NO: C, 65.08; H, 5.46; N,
4.74 Found:. C, 65.05; H, 5.65; N, 4.62 1 H-NMR (CDCl 3) δ: 2.45 (1H, dd, J = 13.8, 10.2 H
z), 2.91 (1H, dd, J = 13.8, 2.8 Hz), 3.22-3.36 (1
H, m), 4.65 (1H, d, J = 5.0 Hz), 7.20-7.42 (7H, m),
7.53 (2H, d, J = 8.0 Hz). 6) (1RS, 2SR) -2-amino-1-phenyl-3-
A solution of (4- (trifluoromethyl) phenyl) -1-propanol (500 mg, 1.69 mmol) in acetonitrile (30 ml) was treated with 4-fluoronaphthalenecarboxylic acid (322 mg, 1.69 mmol) and 1-ethyl-
3- (3-dimethylaminopropyl) carbodiimide hydrochloride (487 mg, 2.54 mmol) and 1-hydroxy-1H-benzotriazole (259 mg, 1.6)
9 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to give the title compound (65
0 mg, 84%). mp 217-218 ℃ IRνmax KBr cm -1 : 1644, 1626, 1601, 1537. Anal.Calcd for C 27 H 21 F 4 NO 2 : C, 69.37; H, 4.53; N,
3.00 Found:. C, 69.15; H, 4.59; N, 2.80 1 H-NMR (CDCl 3) δ: 2.89 (1H, dd, J = 14.2, 10.6 H
z), 3.02-3.20 (2H, m), 4.78-4.96 (1H, m), 5.13 (1
H, d, J = 3.8 Hz), 4.97 (1H, d, J = 9.2 Hz), 6.94-
7.08 (1H, m), 7.10-7.70 (13H, m), 8.08 (1H, d, J =
7.6 Hz).
【0307】実施例175 N-((1RS,2SR)-2-ヒドロキシ-2-フェニル-
1-((4-(トリフルオロメチル)フェニル)メチル)
エチル)-3-フェニルプロパンアミド (1RS,2SR)-2-アミノ-1-フェニル-3-(4-
(トリフルオロメチル)フェニル)-1-プロパノール
(500mg,1.69ミリモル)の酢酸エチル(15
ml)溶液に3-フェニルプロピオニルクロリド(37
7ml,2.54ミリモル)および飽和重曹水(15m
l)を加えて室温で終夜攪拌した。反応液を水(100
ml)で希釈し、酢酸エチル(100ml×2)で抽出
した。抽出液を飽和食塩水で洗浄し、無水硫酸マグネシ
ウムで乾燥後減圧留去した。残留物を酢酸エチル−ヘキ
サンから再結晶させて表題化合物(628mg,87
%)を得た。 mp 147-148℃ IRνmaxKBrcm-1: 1632, 1547, 1537. Anal. Calcd for C25H24F3NO2: C, 70.24; H, 5.66; N,
3.28 Found: C, 70.28; H, 5.85; N, 3.13.1 H-NMR (CDCl3)δ: 2.38 (2H, t, J = 7.4 Hz), 2.60-
2.80 (2H, m), 2.86 (2H,t, J = 7.4 Hz), 3.08 (1H,
d, J = 4.0 Hz), 4.38-4.50 (1H, m), 4.80-4.88(1H,
m), 5.34 (1H, d, J = 8.8 Hz), 7.04-7.40 (12H, m),
7.46 (2H, d, J =8.0 Hz).Example 175 N-((1RS, 2SR) -2-hydroxy-2-phenyl-
1-((4- (trifluoromethyl) phenyl) methyl)
Ethyl) -3-phenylpropanamide (1RS, 2SR) -2-amino-1-phenyl-3- (4-
(Trifluoromethyl) phenyl) -1-propanol (500 mg, 1.69 mmol) in ethyl acetate (15 mg).
3-phenylpropionyl chloride (37 ml)
7ml, 2.54mmol) and saturated aqueous sodium bicarbonate (15m
l) was added and the mixture was stirred at room temperature overnight. The reaction solution was washed with water (100
ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (628 mg, 87
%). mp 147-148 ° C IRνmax KBr cm -1 : 1632, 1547, 1537. Anal.Calcd for C 25 H 24 F 3 NO 2 : C, 70.24; H, 5.66; N,
3.28 Found:. C, 70.28; H, 5.85; N, 3.13 1 H-NMR (CDCl 3) δ: 2.38 (2H, t, J = 7.4 Hz), 2.60-
2.80 (2H, m), 2.86 (2H, t, J = 7.4 Hz), 3.08 (1H,
d, J = 4.0 Hz), 4.38-4.50 (1H, m), 4.80-4.88 (1H,
m), 5.34 (1H, d, J = 8.8 Hz), 7.04-7.40 (12H, m),
7.46 (2H, d, J = 8.0 Hz).
【0308】実施例176 4-フルオロ-N-((1RS,2SR)-2-(3-フルオ
ロフェニル)-2-ヒドロキシ-1-((4-(トリフルオ
ロメチル)フェニル)メチル)エチル)-1-ナフタレン
カルボキサミド 1) 3-フルオロ安息香酸(25.5g,182ミリ
モル)のテトラヒドロフラン(300ml)溶液に1,
1'-カルボニルビス-1H-イミダゾール(32.4g,
200ミリモル)を加え、室温で30分攪拌した。反応
液にマロン酸モノエチルマグネシウム塩(27.1g,
94.7ミリモル)を加え、30分加熱還流した。反応
液に酢酸エチル(50ml)および水(50ml)を加
え、更に水層のpHが酸性になるまで濃塩酸を加えた。
反応液を酢酸エチル(200ml×2)で抽出し、抽出
液を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=4:1)で精製し、
3-(3-フルオロフェニル)-3-オキソプロピオン酸エ
チル(34.6g,91%)を無色油状物として得た。 IRνmaxKBrcm-1: 1738, 1694, 1651, 1589. Anal. Calcd for C11H11FO3: C, 62.85; H, 5.27 Found: C, 62.76; H, 5.24.1 H-NMR (CDCl3)δ: 1.26 (9/4H, t, J = 7.0 Hz), 1.34
(3/4H, t, J = 7.0 Hz), 3.97 (6/4H, s), 4.18-4.32
(2H, m), 5.66 (1/4H, s), 7.10-7.76 (4H, m).2)
3-(3-フルオロフェニル)-3-オキソプロピオン酸エ
チル(20g,95ミリモル)の1,2-ジメトキシエ
タン(100ml)溶液に水素化ナトリウム(60%油
性,3.80g,95ミリモル)を氷冷下加え、室温で
30分攪拌した。反応液の中に4-トリフルオロメチル
ベンジルブロミド(22.7g,95ミリモル)の1,
2-ジメトキシエタン(50ml)溶液を滴下し、反応
液を室温で4時間攪拌した。反応液を水(300ml)
の中に注ぎ、酢酸エチル(500ml×2)で抽出し
た。抽出液を水および飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(トルエン:ヘキサン=1:
1−トルエン)で精製し、酢酸エチル−ヘキサンから再
結晶させて3-(3-フルオロフェニル)-3-オキソ-2-
((4-(トリフルオロメチル)フェニル)メチル)プ
ロピオン酸エチル(28.8g,82%)を得た。 mp 50-51℃ IRνmaxKBrcm-1: 1738, 1694, 1618, 1590. Anal. Calcd for C19H16F4O3: C, 61.96; H, 4.38 Found: C, 61.96; H, 4.33.1 H-NMR (CDCl3)δ: 1.12 (3H, t, J = 7.0 Hz), 3.39
(2H, d, J = 7.4 Hz), 4.12 (2H, q, J = 7.0 Hz), 4.5
7 (1H, t, J = 7.4 Hz), 7.22-7.80 (8H, m). 3) 塩化亜鉛(14.8g,108.6ミリモル)の
ジエチルエーテル(150ml)溶液に水素化ホウ素ナ
トリウム(8.22g,217ミリモル)を加えて室温
で30分攪拌した。不溶物をろ去し、ろ液に3-(3-フ
ルオロフェニル)-3-オキソ-2-((4-(トリフルオ
ロメチル)フェニル)メチル)プロピオン酸エチル(2
0g,54.3ミリモル)のジエチルエーテル(50m
l)溶液を加えて室温で30分攪拌した。氷冷下、反応
液に1規定塩酸を加えてクエンチし、更に水(200m
l)を加え、酢酸エチル(300ml×2)で抽出し
た。抽出液を水および飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(ヘキサン:酢酸エチル=
2:1−1:1)で精製し、(2RS,3RS)-3-
(3-フルオロフェニル)-3-ヒドロキシ-2-((4-
(トリフルオロメチル)フェニル)メチル)プロピオン
酸エチル(19.4g,96%)を無色油状物として得
た。 IRνmaxKBrcm-1: 1726, 1713, 1617, 1593. Anal. Calcd for C19H18F4O3: C, 61.62; H, 4.90 Found: C, 61.46; H, 4.83.1 H-NMR (CDCl3)δ: 0.94 (3H, t, J = 7.0 Hz), 2.90-
3.16 (4H, m), 3.91 (2H,q, J = 7.0 Hz), 5.00-5.10
(1H, m), 6.92-7.40 (6H, m), 7.48 (2H, d, J =8.0 H
z). 4) (2RS,3RS)-3-(3-フルオロフェニ
ル)-3-ヒドロキシ-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸エチル(19g,
51.3ミリモル)のメタノール(100ml)溶液
に、2規定水酸化ナトリウム水溶液(51ml,102
ミリモル)を加えて室温で終夜攪拌した。反応液を1規
定塩酸で酸性とした後、酢酸エチル(200ml×2)
で抽出した。抽出液を水および飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物を酢
酸エチル−ヘキサンから再結晶させて(2RS,3R
S)-3-(3-フルオロフェニル)-3-ヒドロキシ-2-
((4-(トリフルオロメチル)フェニル)メチル)プ
ロピオン酸(15.6g,89%)を得た。 mp 128-129℃ IRνmaxKBrcm-1: 1713, 1618, 1593. Anal. Calcd for C17H14F4O3: C, 59.65; H, 4.12 Found: C, 59.53; H, 3.85.1 H-NMR (CDCl3)δ: 2.87-3.17 (3H, m), 5.13 (1H, s),
6.90-7.42 (6H, m), 7.47 (2H, d, J = 8.0 Hz). 5) (2RS,3RS)-3-(3-フルオロフェニ
ル)-3-ヒドロキシ-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸(10.0g,2
9.2ミリモル)のテトラヒドロフラン(250ml)
溶液に、ジフェニルホスホリルアジド(6.9ml,3
2.1ミリモル)とトリエチルアミン(6.1ml,4
3.8ミリモル)を加え、4時間加熱還流した。反応液
を放冷後、水(200ml)を加えて酢酸エチル(20
0ml×2)で抽出した。抽出液を1規定塩酸、飽和重
曹水、飽和食塩水で順次洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物を酢酸エチル−ヘキサン
から再結晶させて(4RS,5SR)-5-(3-フルオ
ロフェニル)-4-((4-(トリフルオロメチル)フェ
ニル)メチル)-1,3-オキサゾリジン-2-オン(8.
88g,90%)を得た。 mp 143-144℃ IRνmaxKBrcm-1: 1761, 1618, 1593. Anal. Calcd for C17H13F4NO2: C, 60.18; H, 3.86; N,
4.13 Found: C, 60.06; H, 3.85; N, 4.06.1 H-NMR (CDCl3)δ: 2.24-2.48 (2H, m), 4.20-4.36 (1
H, m), 5.03 (1H, s), 5.81 (1H, d, J = 7.6 Hz), 7.0
2-7.22 (5H, m), 7.36-7.50 (1H, m), 7.56 (2H,d, J =
8.0 Hz). 6) (4RS,5SR)-5-(3-フルオロフェニ
ル)-4-((4-(トリフルオロメチル)フェニル)メ
チル)-1,3-オキサゾリジン-2-オン(7.0g,2
0.6ミリモル)のエタノール(100ml)溶液に8
規定水酸化ナトリウム水溶液(12.9ml,103ミ
リモル)を加え、4時間加熱還流した。反応液を濃縮
後、水(300ml)で希釈し、酢酸エチル(300m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物を酢
酸エチル−ヘキサンから再結晶させて、(1RS,2S
R)-2-アミノ-1-(3-フルオロフェニル)-3-(4-
(トリフルオロメチル)フェニル)-1-プロパノール
(5.43g,84%)を得た。 mp 81-82℃ IRνmaxKBrcm-1: 1616, 1590. Anal. Calcd for C16H15F4NO: C, 61.34; H, 4.83; N,
4.47 Found: C, 61.31; H, 4.81; N, 4.37.1 H-NMR (CDCl3)δ: 0.80-1.70 (2H, br), 2.43 (1H, d
d, J = 13.6, 9.8 Hz), 2.83 (1H, dd, J = 13.6, 2.8
Hz), 3.26-3.40 (1H, m), 4.69 (1H, d, J = 4.8Hz),
6.94-7.08 (1H, m), 7.16 (2H, d, J = 8.0 Hz), 7.20-
7.42 (3H, m), 7.55 (2H, d, J = 8.0 Hz). 7) (1RS,2SR)-2-アミノ-1-(3-フルオ
ロフェニル)-3-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(450mg,1.44ミリモ
ル)のアセトニトリル(20ml)溶液に4-フルオロ
ナフタレンカルボン酸(274mg,1.44ミリモ
ル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(412mg,2.15ミ
リモル)および1-ヒドロキシ-1H-ベンゾトリアゾー
ル(221mg,1.44ミリモル)を加えて室温で終
夜攪拌した。反応液を水(100ml)で希釈し、酢酸
エチル(100ml×2)で抽出した。抽出液を1規定
塩酸、1規定水酸化ナトリウム水溶液、飽和食塩水で順
次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて、
表題化合物(573mg,82%)を得た。 mp 200-201℃ IRνmaxKBrcm-1: 1644, 1626. Anal. Calcd for C27H20F5NO2・0.1H2O: C, 66.56; H,
4.18; N, 2.87 Found: C, 66.39; H, 3.99; N, 2.97.1 H-NMR (CDCl3)δ: 2.80-3.12 (2H, m), 3.20-3.50 (1
H, br), 4.72-4.90 (1H,m), 5.15 (1H, d, J = 3.2 H
z), 6.02 (1H, d, J = 8.0 Hz), 6.92-7.62 (12H,m),
7.67 (1H, d, J = 8.0 Hz), 8.08 (1H, d, J = 8.4 H
z).Example 176 4-Fluoro-N-((1RS, 2SR) -2- (3-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl)- 1-Naphthalenecarboxamide 1) To a solution of 3-fluorobenzoic acid (25.5 g, 182 mmol) in tetrahydrofuran (300 ml),
1′-carbonylbis-1H-imidazole (32.4 g,
(200 mmol) and stirred at room temperature for 30 minutes. Monoethyl magnesium malonate (27.1 g,
94.7 mmol) and heated under reflux for 30 minutes. Ethyl acetate (50 ml) and water (50 ml) were added to the reaction solution, and concentrated hydrochloric acid was further added until the pH of the aqueous layer became acidic.
The reaction solution was extracted with ethyl acetate (200 ml × 2), the extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1),
Ethyl 3- (3-fluorophenyl) -3-oxopropionate (34.6 g, 91%) was obtained as a colorless oil. . IRνmax KBr cm -1: 1738, 1694, 1651, 1589. Anal Calcd for C 11 H 11 FO 3: C, 62.85; H, 5.27 Found:. C, 62.76; H, 5.24 1 H-NMR (CDCl 3) δ: 1.26 (9 / 4H, t, J = 7.0 Hz), 1.34
(3 / 4H, t, J = 7.0 Hz), 3.97 (6 / 4H, s), 4.18-4.32
(2H, m), 5.66 (1 / 4H, s), 7.10-7.76 (4H, m) .2)
Sodium hydride (60% oily, 3.80 g, 95 mmol) was added to a solution of ethyl 3- (3-fluorophenyl) -3-oxopropionate (20 g, 95 mmol) in 1,2-dimethoxyethane (100 ml) using ice. The mixture was added under cooling and stirred at room temperature for 30 minutes. 4-trifluoromethylbenzyl bromide (22.7 g, 95 mmol) in 1,
A solution of 2-dimethoxyethane (50 ml) was added dropwise and the reaction was stirred at room temperature for 4 hours. The reaction solution was water (300 ml)
And extracted with ethyl acetate (500 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (toluene: hexane = 1: 1).
1-toluene) and recrystallized from ethyl acetate-hexane to give 3- (3-fluorophenyl) -3-oxo-2-.
Ethyl ((4- (trifluoromethyl) phenyl) methyl) propionate (28.8 g, 82%) was obtained. mp 50-51 ° C IRνmax KBr cm -1 : 1738, 1694, 1618, 1590.Anal.Calcd for C 19 H 16 F 4 O 3 : C, 61.96; H, 4.38 Found: C, 61.96; H, 4.33. 1 H-NMR (CDCl 3 ) δ: 1.12 (3H, t, J = 7.0 Hz), 3.39
(2H, d, J = 7.4 Hz), 4.12 (2H, q, J = 7.0 Hz), 4.5
7 (1H, t, J = 7.4 Hz), 7.22-7.80 (8H, m). 3) To a solution of zinc chloride (14.8 g, 108.6 mmol) in diethyl ether (150 ml) was added sodium borohydride (8. (22 g, 217 mmol) and stirred at room temperature for 30 minutes. The insolubles were removed by filtration, and the filtrate was treated with ethyl 3- (3-fluorophenyl) -3-oxo-2-((4- (trifluoromethyl) phenyl) methyl) propionate (2
0 g, 54.3 mmol) of diethyl ether (50 m
l) The solution was added and stirred at room temperature for 30 minutes. Under ice-cooling, the reaction solution was quenched by adding 1N hydrochloric acid, and further added with water (200 m 2).
1) and extracted with ethyl acetate (300 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
2: 1-1: 1) to give (2RS, 3RS) -3-
(3-fluorophenyl) -3-hydroxy-2-((4-
Ethyl (trifluoromethyl) phenyl) methyl) propionate (19.4 g, 96%) was obtained as a colorless oil. . IRνmax KBr cm -1: 1726, 1713, 1617, 1593. Anal Calcd for C 19 H 18 F 4 O 3: C, 61.62; H, 4.90 Found:. C, 61.46; H, 4.83 1 H-NMR (CDCl 3 ) δ: 0.94 (3H, t, J = 7.0 Hz), 2.90-
3.16 (4H, m), 3.91 (2H, q, J = 7.0 Hz), 5.00-5.10
(1H, m), 6.92-7.40 (6H, m), 7.48 (2H, d, J = 8.0 H
z). 4) Ethyl (2RS, 3RS) -3- (3-fluorophenyl) -3-hydroxy-2-((4- (trifluoromethyl) phenyl) methyl) propionate (19 g,
51.3 mmol) in methanol (100 ml) was added to a 2N aqueous sodium hydroxide solution (51 ml, 102 ml).
Mmol) and stirred overnight at room temperature. The reaction solution was acidified with 1N hydrochloric acid, and then ethyl acetate (200 ml × 2).
Extracted. The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane (2RS, 3R
S) -3- (3-Fluorophenyl) -3-hydroxy-2-
((4- (Trifluoromethyl) phenyl) methyl) propionic acid (15.6 g, 89%) was obtained. mp 128-129 ° C IRνmax KBr cm -1 : 1713, 1618, 1593.Anal.Calcd for C 17 H 14 F 4 O 3 : C, 59.65; H, 4.12 Found: C, 59.53; H, 3.85. 1 H- NMR (CDCl 3 ) δ: 2.87-3.17 (3H, m), 5.13 (1H, s),
6.90-7.42 (6H, m), 7.47 (2H, d, J = 8.0 Hz). 5) (2RS, 3RS) -3- (3-fluorophenyl) -3-hydroxy-2-((4- (tri (Fluoromethyl) phenyl) methyl) propionic acid (10.0 g, 2
9.2 mmol) in tetrahydrofuran (250 ml)
To the solution was added diphenyl phosphoryl azide (6.9 ml, 3
2.1 mmol) and triethylamine (6.1 ml, 4
(3.8 mmol) and heated to reflux for 4 hours. After allowing the reaction solution to cool, water (200 ml) was added, and ethyl acetate (20 ml) was added.
0 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (4RS, 5SR) -5- (3-fluorophenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-2. -ON (8.
(88 g, 90%). . mp 143-144 ℃ IRνmax KBr cm -1 : 1761, 1618, 1593. Anal Calcd for C 17 H 13 F 4 NO 2: C, 60.18; H, 3.86; N,
4.13 Found:. C, 60.06; H, 3.85; N, 4.06 1 H-NMR (CDCl 3) δ: 2.24-2.48 (2H, m), 4.20-4.36 (1
H, m), 5.03 (1H, s), 5.81 (1H, d, J = 7.6 Hz), 7.0
2-7.22 (5H, m), 7.36-7.50 (1H, m), 7.56 (2H, d, J =
8.0 Hz). 6) (4RS, 5SR) -5- (3-fluorophenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2-one (7.0 g) , 2
0.6 mmol) in ethanol (100 ml).
A normal aqueous sodium hydroxide solution (12.9 ml, 103 mmol) was added, and the mixture was heated under reflux for 4 hours. After concentrating the reaction solution, the reaction solution was diluted with water (300 ml), and ethyl acetate (300 m
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2S
R) -2-Amino-1- (3-fluorophenyl) -3- (4-
(Trifluoromethyl) phenyl) -1-propanol (5.43 g, 84%) was obtained. . mp 81-82 ℃ IRνmax KBr cm -1 : 1616, 1590. Anal Calcd for C 16 H 15 F 4 NO: C, 61.34; H, 4.83; N,
4.47 Found:. C, 61.31; H, 4.81; N, 4.37 1 H-NMR (CDCl 3) δ: 0.80-1.70 (2H, br), 2.43 (1H, d
d, J = 13.6, 9.8 Hz), 2.83 (1H, dd, J = 13.6, 2.8
Hz), 3.26-3.40 (1H, m), 4.69 (1H, d, J = 4.8Hz),
6.94-7.08 (1H, m), 7.16 (2H, d, J = 8.0 Hz), 7.20-
7.42 (3H, m), 7.55 (2H, d, J = 8.0 Hz). 7) (1RS, 2SR) -2-amino-1- (3-fluorophenyl) -3- (4- (trifluoromethyl) To a solution of (phenyl) -1-propanol (450 mg, 1.44 mmol) in acetonitrile (20 ml) was added 4-fluoronaphthalenecarboxylic acid (274 mg, 1.44 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide. -Hydrochloride (412 mg, 2.15 mmol) and 1-hydroxy-1H-benzotriazole (221 mg, 1.44 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane,
The title compound (573 mg, 82%) was obtained. mp 200-201 ℃ IRνmax KBr cm -1 : 1644, 1626. Anal.Calcd for C 27 H 20 F 5 NO 2・ 0.1H 2 O: C, 66.56; H,
4.18; N, 2.87 Found:. C, 66.39; H, 3.99; N, 2.97 1 H-NMR (CDCl 3) δ: 2.80-3.12 (2H, m), 3.20-3.50 (1
H, br), 4.72-4.90 (1H, m), 5.15 (1H, d, J = 3.2 H
z), 6.02 (1H, d, J = 8.0 Hz), 6.92-7.62 (12H, m),
7.67 (1H, d, J = 8.0 Hz), 8.08 (1H, d, J = 8.4 H
z).
【0309】実施例177 N-((1RS,2SR)-2-(3-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-6,7-ジヒドロ-5H-ベン
ゾ[a]シクロヘプテン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(3-フルオロフェ
ニル)-3-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(167mg,0.53ミリモル)のア
セトニトリル(20ml)溶液に6,7-ジヒドロ-5H
-ベンゾ[a]シクロヘプテン-1-カルボン酸(100
mg,0.53ミリモル)および1-エチル-3-(3-ジ
メチルアミノプロピル)カルボジイミド・塩酸塩(15
3mg,0.80ミリモル)および1-ヒドロキシ-1H
-ベンゾトリアゾール(81mg,0.53ミリモル)
を加えて室温で終夜攪拌した。反応液を水(100m
l)で希釈し、酢酸エチル(100ml×2)で抽出し
た。抽出液を1規定塩酸、1規定水酸化ナトリウム水溶
液、飽和食塩水で順次洗浄し、無水硫酸マグネシウムで
乾燥後減圧留去した。残留物を酢酸エチル−ヘキサンか
ら再結晶させて、表題化合物(209mg,81%)を
得た。 mp 151-152℃ IRνmaxKBrcm-1: 1638, 1618, 1590, 1518, 1327. Anal. Calcd for C28H25F4NO2・0.2H2O: C, 69.04; H,
5.25; N, 2.88 Found: C, 68.98; H, 5.16; N, 2.94.1 H-NMR (CDCl3)δ: 1.90-2.10 (2H, m), 2.12-2.28 (2
H, m), 2.60-2.70 (2H, m), 2.84 (1H, dd, J = 14.4,
10.6 Hz), 3.00 (1H, dd, J = 15.0, 4.0 Hz), 3.61 (1
H, brs), 4.60-4.80 (1H, m), 5.09 (1H, brs), 5.82
(1H, d, J = 8.2 Hz), 5.84-5.98 (1H, m), 6.16 (1H,
d, J = 11.6 Hz), 6.92-7.42 (9H, m), 7.53(2H, d, J
= 8.0 Hz).Example 177 N-((1RS, 2SR) -2- (3-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino- 1- (3-fluorophenyl) -3- (4- (trifluoromethyl) phenyl) -1
6,7-dihydro-5H was added to a solution of -propanol (167 mg, 0.53 mmol) in acetonitrile (20 ml).
-Benzo [a] cycloheptene-1-carboxylic acid (100
mg, 0.53 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (15 mg).
3 mg, 0.80 mmol) and 1-hydroxy-1H
-Benzotriazole (81 mg, 0.53 mmol)
Was added and stirred at room temperature overnight. The reaction solution was washed with water (100 m
1) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (209 mg, 81%). mp 151-152 ° C IRνmax KBr cm -1 : 1638, 1618, 1590, 1518, 1327. Anal.Calcd for C 28 H 25 F 4 NO 2・ 0.2H 2 O: C, 69.04; H,
5.25; N, 2.88 Found:. C, 68.98; H, 5.16; N, 2.94 1 H-NMR (CDCl 3) δ: 1.90-2.10 (2H, m), 2.12-2.28 (2
H, m), 2.60-2.70 (2H, m), 2.84 (1H, dd, J = 14.4,
10.6 Hz), 3.00 (1H, dd, J = 15.0, 4.0 Hz), 3.61 (1
H, brs), 4.60-4.80 (1H, m), 5.09 (1H, brs), 5.82
(1H, d, J = 8.2 Hz), 5.84-5.98 (1H, m), 6.16 (1H,
d, J = 11.6 Hz), 6.92-7.42 (9H, m), 7.53 (2H, d, J
= 8.0 Hz).
【0310】実施例178 N-((1RS,2SR)-2-(3-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-3-フェニルプロパンアミド (1RS,2SR)-2-アミノ-1-(3-フルオロフェ
ニル)-3-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)の酢
酸エチル(20ml)溶液に3-フェニルプロピオニル
クロリド(320ml,2.15ミリモル)および飽和
重曹水(20ml)を加えて室温で終夜攪拌した。反応
液を水(100ml)で希釈し、酢酸エチル(100m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物を酢
酸エチル−ヘキサンから再結晶させて表題化合物(52
8mg,83%)を得た。 mp 151-152℃ IRνmaxKBrcm-1: 1651, 1620, 1590. Anal. Calcd for C25H23F4NO2: C, 67.41; H, 5.20; N,
3.14 Found: C, 67.38; H, 5.05; N, 3.10.1 H-NMR (CDCl3)δ: 2.36-2.44 (2H, m), 2.60-2.76 (2
H, m), 2.80-2.94 (2H, m), 3.20-3.28 (1H, m), 4.30-
4.48 (1H, m), 4.80-4.90 (1H, m), 5.35 (1H, d,J =
7.8 Hz), 6.92-7.40 (11H, m), 7.46 (2H, d, J = 8.0
Hz).Example 178 N-((1RS, 2SR) -2- (3-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -3-phenylpropanamide (1RS, 2SR) -2-amino-1- (3-fluorophenyl) -3- ( 4- (trifluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.44 mmol) in ethyl acetate (20 ml) were added 3-phenylpropionyl chloride (320 ml, 2.15 mmol) and saturated aqueous sodium hydrogen carbonate (20 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (52
8 mg, 83%). mp 151-152 ℃ IRνmax KBr cm -1 : 1651, 1620, 1590. Anal.Calcd for C 25 H 23 F 4 NO 2 : C, 67.41; H, 5.20; N,
3.14 Found:. C, 67.38; H, 5.05; N, 3.10 1 H-NMR (CDCl 3) δ: 2.36-2.44 (2H, m), 2.60-2.76 (2
H, m), 2.80-2.94 (2H, m), 3.20-3.28 (1H, m), 4.30-
4.48 (1H, m), 4.80-4.90 (1H, m), 5.35 (1H, d, J =
7.8 Hz), 6.92-7.40 (11H, m), 7.46 (2H, d, J = 8.0
Hz).
【0311】実施例179 4-フルオロ-N-((1RS,2SR)-2-(2-フルオ
ロフェニル)-2-ヒドロキシ-1-((4-(トリフルオ
ロメチル)フェニル)メチル)エチル)-1-ナフタレン
カルボキサミド 1) 2-フルオロ安息香酸(25.3g,181ミリ
モル)のテトラヒドロフラン(300ml)溶液に1,
1'-カルボニルビス-1H-イミダゾール(32.2g,
198ミリモル)を加え、室温で30分攪拌した。反応
液にマロン酸モノエチルマグネシウム塩(27.1g,
94.7ミリモル)を加え、30分加熱還流した。反応
液に酢酸エチル(50ml)および水(50ml)を加
え、更に水層のpHが酸性になるまで濃塩酸を加えた。
反応液を酢酸エチル(200ml×2)で抽出し、抽出
液を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=4:1)で精製し、
3-(2-フルオロフェニル)-3-オキソプロピオン酸エ
チル(31.9g,84%)を無色油状物として得た。 IRνmaxKBrcm-1: 1748, 1694, 1651, 1611. Anal. Calcd for C11H11FO3: C, 62.85; H, 5.27 Found: C, 62.74; H, 5.24.1 H-NMR (CDCl3)δ: 1.26 (3H, t, J = 7.2 Hz), 3.99
(8/5H, d, J = 3.6 Hz),4.18-4.30 (2H, m), 5.85 (1/5
H, s), 7.06-7.32 (4H, m), 7.32-7.52 (2/5H, m), 7.5
2-7.64 (8/5H, m), 7.82-8.02 (2H, m). 2) 3-(2-フルオロフェニル)-3-オキソプロピオ
ン酸エチル(20g,95ミリモル)の1,2-ジメト
キシエタン(100ml)溶液に水素化ナトリウム(6
0%油性,3.80g,95ミリモル)を氷冷下加え、
室温で30分攪拌した。反応液の中に4-トリフルオロ
メチルベンジルブロミド(22.7g,95ミリモル)
の1,2-ジメトキシエタン(50ml)溶液を滴下
し、反応液を室温で4時間攪拌した。反応液を水(30
0ml)の中に注ぎ、酢酸エチル(500ml×2)で
抽出した。抽出液を水および飽和食塩水で洗浄し、無水
硫酸マグネシウムで乾燥後減圧留去した。残留物をシリ
カゲルカラムクロマトグラフィー(トルエン:ヘキサン
=1:1−トルエン)で精製し、3-(2-フルオロフェ
ニル)-3-オキソ-2-((4-(トリフルオロメチル)
フェニル)メチル)プロピオン酸エチル(25.7g,
73%)を無色油状物として得た。 IRνmaxKBrcm-1: 1744, 1690. Anal. Calcd for C19H16F4O3: C, 61.96; H, 4.38 Found: C, 62.04; H, 4.31.1 H-NMR (CDCl3)δ: 1.12 (3H, t, J = 7.0 Hz), 3.24-
3.50 (2H, m), 4.12 (2H,q, J = 7.0 Hz), 4.58 (1H,
t, J = 7.2 Hz), 7.04-7.60 (7H, m), 7.78-7.90(1H,
m). 3) 塩化亜鉛(14.8g,108.6ミリモル)の
ジエチルエーテル(150ml)溶液に水素化ホウ素ナ
トリウム(8.22g,217ミリモル)を加えて室温
で30分攪拌した。不溶物をろ去し、ろ液に3-(2-フ
ルオロフェニル)-3-オキソ-2-((4-(トリフルオ
ロメチル)フェニル)メチル)プロピオン酸エチル(2
0g,54.3ミリモル)のジエチルエーテル(50m
l)溶液を加えて室温で30分攪拌した。氷冷下、反応
液に1規定塩酸を加えてクエンチし、更に水(200m
l)を加え、酢酸エチル(300ml×2)で抽出し
た。抽出液を水および飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(ヘキサン:酢酸エチル=
9:1−4:1)で精製し、(2RS,3RS)-3-
(2-フルオロフェニル)-3-ヒドロキシ-2-((4-
(トリフルオロメチル)フェニル)メチル)プロピオン
酸エチル(16.2g,81%)を無色油状物として得
た。 IRνmaxKBrcm-1: 1717, 1618, 1586. Anal. Calcd for C19H18F4O3: C, 61.62; H, 4.90 Found: C, 61.51; H, 4.74.1 H-NMR (CDCl3)δ: 0.96 (3H, t, J = 7.4 Hz), 2.84-
3.20 (3H, m), 3.22 (1H,d, J = 3.8 Hz), 3.94 (2H,
q, J = 7.4 Hz), 5.30-5.40 (1H, m), 6.98-7.38(5H,
m), 7.40-7.62 (3H, m). 4) (2RS,3RS)-3-(2-フルオロフェニ
ル)-3-ヒドロキシ-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸エチル(15.7
g,42.5ミリモル)のメタノール(100ml)溶
液に、2規定水酸化ナトリウム水溶液(43ml,86
ミリモル)を加えて室温で終夜攪拌した。反応液を1規
定塩酸で酸性とした後、酢酸エチル(200ml×2)
で抽出した。抽出液を水および飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物を酢
酸エチル−ヘキサンから再結晶させて(2RS,3R
S)-3-(2-フルオロフェニル)-3-ヒドロキシ-2-
((4-(トリフルオロメチル)フェニル)メチル)プ
ロピオン酸(11.7g,80%)を得た。 mp 122-123℃ IRνmaxKBrcm-1: 1713, 1491. Anal. Calcd for C17H14F4O3: C, 59.65; H, 4.12 Found: C, 59.60; H, 4.03.1 H-NMR (CDCl3)δ: 2.82-3.12 (2H, m), 3.12-3.30 (1
H, m), 5.44 (1H, d, J =4.0 Hz), 6.96-7.40 (5H, m),
7.40-7.60 (3H, m). 5) (2RS,3RS)-3-(2-フルオロフェニ
ル)-3-ヒドロキシ-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸(10.0g,2
9.2ミリモル)のテトラヒドロフラン(250ml)
溶液に、ジフェニルホスホリルアジド(6.9ml,3
2.1ミリモル)とトリエチルアミン(6.1ml,4
3.8ミリモル)を加え、4時間加熱還流した。反応液
を放冷後、水(200ml)を加えて酢酸エチル(20
0ml×2)で抽出した。抽出液を1規定塩酸、飽和重
曹水、飽和食塩水で順次洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物を酢酸エチル−ヘキサン
から再結晶させて(4RS,5SR)-5-(2-フルオ
ロフェニル)-4-((4-(トリフルオロメチル)フェ
ニル)メチル)-1,3-オキサゾリジン-2-オン(8.
73g,88%)を得た。 mp 146-147℃ IRνmaxKBrcm-1: 1767. Anal. Calcd for C17H13F4NO2: C, 60.18; H, 3.86; N,
4.13 Found: C, 59.99; H, 3.92; N, 3.90.1 H-NMR (CDCl3)δ: 2.20-2.60 (2H, m), 4.26-4.46 (1
H, m), 5.06 (1H, s), 6.05 (1H, d, J = 7.8 Hz), 7.0
0-7.70 (8H, m). 6) (4RS,5SR)-5-(2-フルオロフェニ
ル)-4-((4-(トリフルオロメチル)フェニル)メ
チル)-1,3-オキサゾリジン-2-オン(7.0g,2
0.6ミリモル)のエタノール(100ml)溶液に8
規定水酸化ナトリウム水溶液(12.9ml,103ミ
リモル)を加え、6時間加熱還流した。反応液を濃縮
後、水(300ml)で希釈し、酢酸エチル(300m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(酢酸エチル)で精
製し、(1RS,2SR)-2-アミノ-1-(2-フルオ
ロフェニル)-3-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(6.2g,96%)を無色油状
物として得た。 IRνmaxKBrcm-1: 1618, 1584, 1487. Anal. Calcd for C16H15F4NO・0.1H2O: C, 60.99; H,
4.86; N, 4.45 Found: C, 60.90; H, 4.81; N, 4.20.1 H-NMR (CDCl3)δ: 1.0-1.8 (2H, br), 2.41 (1H, dd,
J = 13.6, 11.0 Hz), 2.86 (1H, dd, J = 14.0, 2.2 H
z), 3.36-3.48 (1H, m), 5.06 (1H, d, J = 4.4 Hz),
7.00-7.38 (5H, m), 7.48-7.62 (3H, m). 7) (1RS,2SR)-2-アミノ-1-(2-フルオ
ロフェニル)-3-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(450mg,1.44ミリモ
ル)のアセトニトリル(20ml)溶液に4-フルオロ
ナフタレンカルボン酸(274mg,1.44ミリモ
ル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(412mg,2.15ミ
リモル)および1-ヒドロキシ-1H-ベンゾトリアゾー
ル(221mg,1.44ミリモル)を加えて室温で終
夜攪拌した。反応液を水(100ml)で希釈し、酢酸
エチル(100ml×2)で抽出した。抽出液を1規定
塩酸、1規定水酸化ナトリウム水溶液、飽和食塩水で順
次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=4:1)で精製し酢酸エチル−ヘ
キサンから再結晶させて、表題化合物(465mg,6
7%)を得た。 mp 190-191℃ IRνmaxKBrcm-1: 1645, 1628, 1601, 1537. Anal. Calcd for C27H20F5NO2: C, 66.80; H, 4.15; N,
2.89 Found: C, 66.58; H, 4.12; N, 2.79.1 H-NMR (CDCl3)δ: 2.94 (1H, dd, J = 14.2, 11.0 H
z), 3.23 (1H, dd, J = 14.2, 4.0 Hz), 3.72 (1H, d,
J = 4.2 Hz), 4.74-4.94 (1H, m), 5.36-5.46 (1H,m),
5.96 (1H, d, J = 8.4 Hz), 6.96-7.74 (13H, m), 8.08
(1H, d, J = 8.4Hz).Example 179 4-Fluoro-N-((1RS, 2SR) -2- (2-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl)- 1-Naphthalenecarboxamide 1) To a solution of 2-fluorobenzoic acid (25.3 g, 181 mmol) in tetrahydrofuran (300 ml),
1′-carbonylbis-1H-imidazole (32.2 g,
198 mmol) and stirred at room temperature for 30 minutes. Monoethyl magnesium malonate (27.1 g,
94.7 mmol) and heated under reflux for 30 minutes. Ethyl acetate (50 ml) and water (50 ml) were added to the reaction solution, and concentrated hydrochloric acid was further added until the pH of the aqueous layer became acidic.
The reaction solution was extracted with ethyl acetate (200 ml × 2), the extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1),
Ethyl 3- (2-fluorophenyl) -3-oxopropionate (31.9 g, 84%) was obtained as a colorless oil. . IRνmax KBr cm -1: 1748, 1694, 1651, 1611. Anal Calcd for C 11 H 11 FO 3: C, 62.85; H, 5.27 Found:. C, 62.74; H, 5.24 1 H-NMR (CDCl 3) δ: 1.26 (3H, t, J = 7.2 Hz), 3.99
(8 / 5H, d, J = 3.6 Hz), 4.18-4.30 (2H, m), 5.85 (1/5
H, s), 7.06-7.32 (4H, m), 7.32-7.52 (2 / 5H, m), 7.5
2-7.64 (8 / 5H, m), 7.82-8.02 (2H, m). 2) 1,3-Dimethoxyethane of ethyl 3- (2-fluorophenyl) -3-oxopropionate (20 g, 95 mmol) (100 ml) solution in sodium hydride (6
0% oily, 3.80 g, 95 mmol) under ice-cooling,
Stirred at room temperature for 30 minutes. 4-trifluoromethylbenzyl bromide (22.7 g, 95 mmol) in the reaction solution
Was added dropwise, and the reaction solution was stirred at room temperature for 4 hours. The reaction solution was washed with water (30
0 ml) and extracted with ethyl acetate (500 ml x 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene: hexane = 1: 1-toluene) to give 3- (2-fluorophenyl) -3-oxo-2-((4- (trifluoromethyl)
Phenyl) methyl) ethyl propionate (25.7 g,
73%) as a colorless oil. IRνmax KBr cm -1 : 1744, 1690.Anal.Calcd for C 19 H 16 F 4 O 3 : C, 61.96; H, 4.38 Found: C, 62.04; H, 4.31. 1 H-NMR (CDCl 3 ) δ: 1.12 (3H, t, J = 7.0 Hz), 3.24-
3.50 (2H, m), 4.12 (2H, q, J = 7.0 Hz), 4.58 (1H,
t, J = 7.2 Hz), 7.04-7.60 (7H, m), 7.78-7.90 (1H,
m). 3) To a solution of zinc chloride (14.8 g, 108.6 mmol) in diethyl ether (150 ml) was added sodium borohydride (8.22 g, 217 mmol), and the mixture was stirred at room temperature for 30 minutes. The insoluble material was removed by filtration, and the filtrate was treated with ethyl 3- (2-fluorophenyl) -3-oxo-2-((4- (trifluoromethyl) phenyl) methyl) propionate (2
0 g, 54.3 mmol) of diethyl ether (50 m
l) The solution was added and stirred at room temperature for 30 minutes. Under ice-cooling, the reaction solution was quenched by adding 1N hydrochloric acid, and further added with water (200 m 2).
1) and extracted with ethyl acetate (300 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
9: 1-4: 1) to give (2RS, 3RS) -3-
(2-fluorophenyl) -3-hydroxy-2-((4-
Ethyl (trifluoromethyl) phenyl) methyl) propionate (16.2 g, 81%) was obtained as a colorless oil. . IRνmax KBr cm -1: 1717, 1618, 1586. Anal Calcd for C 19 H 18 F 4 O 3: C, 61.62; H, 4.90 Found:. C, 61.51; H, 4.74 1 H-NMR (CDCl 3) δ: 0.96 (3H, t, J = 7.4 Hz), 2.84-
3.20 (3H, m), 3.22 (1H, d, J = 3.8 Hz), 3.94 (2H,
q, J = 7.4 Hz), 5.30-5.40 (1H, m), 6.98-7.38 (5H,
m), 7.40-7.62 (3H, m). 4) (2RS, 3RS) -3- (2-fluorophenyl) -3-hydroxy-2-((4- (trifluoromethyl) phenyl) methyl) propionic acid Ethyl (15.7
g, 42.5 mmol) in methanol (100 ml) was added to a 2N aqueous sodium hydroxide solution (43 ml, 86 ml).
Mmol) and stirred overnight at room temperature. The reaction solution was acidified with 1N hydrochloric acid, and then ethyl acetate (200 ml × 2).
Extracted. The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane (2RS, 3R
S) -3- (2-Fluorophenyl) -3-hydroxy-2-
((4- (Trifluoromethyl) phenyl) methyl) propionic acid (11.7 g, 80%) was obtained. . mp 122-123 ℃ IRνmax KBr cm -1 : 1713, 1491. Anal Calcd for C 17 H 14 F 4 O 3: C, 59.65; H, 4.12 Found:. C, 59.60; H, 4.03 1 H-NMR ( CDCl 3 ) δ: 2.82-3.12 (2H, m), 3.12-3.30 (1
H, m), 5.44 (1H, d, J = 4.0 Hz), 6.96-7.40 (5H, m),
7.40-7.60 (3H, m). 5) (2RS, 3RS) -3- (2-fluorophenyl) -3-hydroxy-2-((4- (trifluoromethyl) phenyl) methyl) propionic acid (10. 0g, 2
9.2 mmol) in tetrahydrofuran (250 ml)
To the solution was added diphenyl phosphoryl azide (6.9 ml, 3
2.1 mmol) and triethylamine (6.1 ml, 4
(3.8 mmol) and heated to reflux for 4 hours. After allowing the reaction solution to cool, water (200 ml) was added, and ethyl acetate (20 ml) was added.
0 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (4RS, 5SR) -5- (2-fluorophenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-2. -ON (8.
73 g, 88%). . mp 146-147 ℃ IRνmax KBr cm -1 : 1767. Anal Calcd for C 17 H 13 F 4 NO 2: C, 60.18; H, 3.86; N,
4.13 Found:. C, 59.99; H, 3.92; N, 3.90 1 H-NMR (CDCl 3) δ: 2.20-2.60 (2H, m), 4.26-4.46 (1
H, m), 5.06 (1H, s), 6.05 (1H, d, J = 7.8 Hz), 7.0
0-7.70 (8H, m). 6) (4RS, 5SR) -5- (2-fluorophenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-2- ON (7.0 g, 2
0.6 mmol) in ethanol (100 ml).
A normal aqueous sodium hydroxide solution (12.9 ml, 103 mmol) was added, and the mixture was heated under reflux for 6 hours. After concentrating the reaction solution, the reaction solution was diluted with water (300 ml), and ethyl acetate (300 m
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) to give (1RS, 2SR) -2-amino-1- (2-fluorophenyl) -3- (4- (trifluoromethyl) phenyl) -1-propanol (6.2 g, 96%) as a colorless oil. IRνmax KBr cm -1 : 1618, 1584, 1487. Anal.Calcd for C 16 H 15 F 4 NO ・ 0.1H 2 O: C, 60.99; H,
4.86; N, 4.45 Found:. C, 60.90; H, 4.81; N, 4.20 1 H-NMR (CDCl 3) δ: 1.0-1.8 (2H, br), 2.41 (1H, dd,
J = 13.6, 11.0 Hz), 2.86 (1H, dd, J = 14.0, 2.2 H
z), 3.36-3.48 (1H, m), 5.06 (1H, d, J = 4.4 Hz),
7.00-7.38 (5H, m), 7.48-7.62 (3H, m). 7) (1RS, 2SR) -2-amino-1- (2-fluorophenyl) -3- (4- (trifluoromethyl) phenyl ) To a solution of 1-propanol (450 mg, 1.44 mmol) in acetonitrile (20 ml) was added 4-fluoronaphthalenecarboxylic acid (274 mg, 1.44 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide. Hydrochloride (412 mg, 2.15 mmol) and 1-hydroxy-1H-benzotriazole (221 mg, 1.44 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the title compound (465 mg, 6
7%). . mp 190-191 ℃ IRνmax KBr cm -1 : 1645, 1628, 1601, 1537. Anal Calcd for C 27 H 20 F 5 NO 2: C, 66.80; H, 4.15; N,
2.89 Found:. C, 66.58; H, 4.12; N, 2.79 1 H-NMR (CDCl 3) δ: 2.94 (1H, dd, J = 14.2, 11.0 H
z), 3.23 (1H, dd, J = 14.2, 4.0 Hz), 3.72 (1H, d,
J = 4.2 Hz), 4.74-4.94 (1H, m), 5.36-5.46 (1H, m),
5.96 (1H, d, J = 8.4 Hz), 6.96-7.74 (13H, m), 8.08
(1H, d, J = 8.4Hz).
【0312】実施例180 N-((1RS,2SR)-2-(2-フルオロフェニル)
-2-ヒドロキシ-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-3-フェニルプロパンアミド (1RS,2SR)-2-アミノ-1-(2-フルオロフェ
ニル)-3-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)の酢
酸エチル(20ml)溶液に3-フェニルプロピオニル
クロリド(320ml,2.15ミリモル)および飽和
重曹水(20ml)を加えて室温で終夜攪拌した。反応
液を水(100ml)で希釈し、酢酸エチル(100m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物を酢
酸エチル−ヘキサンから再結晶させて表題化合物(49
7mg,78%)を得た。 mp 124-125℃ IRνmaxKBrcm-1: 1651, 1620, 1520. Anal. Calcd for C25H23F4NO2: C, 67.41; H, 5.20; N,
3.14 Found: C, 67.30; H, 5.19; N, 2.89.1 H-NMR (CDCl3)δ: 2.30-2.42 (2H, m), 2.66-2.98 (4
H, m), 3.92-4.04 (1H, m), 4.28-4.46 (1H, m), 5.12-
5.22 (1H, m), 5.39 (1H, d, J = 8.8 Hz), 6.98-7.40
(10H, m), 7.40-7.56 (3H, m).Example 180 N-((1RS, 2SR) -2- (2-fluorophenyl)
-2-Hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -3-phenylpropanamide (1RS, 2SR) -2-amino-1- (2-fluorophenyl) -3- ( 4- (trifluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.44 mmol) in ethyl acetate (20 ml) were added 3-phenylpropionyl chloride (320 ml, 2.15 mmol) and saturated aqueous sodium hydrogen carbonate (20 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (49
7 mg, 78%). mp 124-125 ℃ IRνmax KBr cm -1 : 1651, 1620, 1520. Anal.Calcd for C 25 H 23 F 4 NO 2 : C, 67.41; H, 5.20; N,
3.14 Found:. C, 67.30; H, 5.19; N, 2.89 1 H-NMR (CDCl 3) δ: 2.30-2.42 (2H, m), 2.66-2.98 (4
H, m), 3.92-4.04 (1H, m), 4.28-4.46 (1H, m), 5.12-
5.22 (1H, m), 5.39 (1H, d, J = 8.8 Hz), 6.98-7.40
(10H, m), 7.40-7.56 (3H, m).
【0313】実施例181 N-((1RS,2SR)-2-(2,4-ジフルオロフェ
ニル)-2-ヒドロキシ-1-((4-(トリフルオロメチ
ル)フェニル)メチル)エチル)-4-フルオロ-1-ナフ
タレンカルボキサミド 1) 2,4-ジフルオロ安息香酸(10g,63.3
ミリモル)のテトラヒドロフラン(150ml)溶液に
1,1'-カルボニルビス-1H-イミダゾール(11.3
g,69.6ミリモル)を加え、室温で30分攪拌し
た。反応液にマロン酸モノエチルマグネシウム塩(10
g,34.8ミリモル)を加え、室温で2時間攪拌し
た。反応液に酢酸エチル(50ml)および水(50m
l)を加え、更に水層のpHが酸性になるまで濃塩酸を
加えた。反応液を酢酸エチル(200ml×2)で抽出
し、抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去した。残留物をシリカゲルカラムク
ロマトグラフィー(ヘキサン:酢酸エチル=4:1)で
精製し、3-(2,4-ジフルオロフェニル)-3-オキソ
プロピオン酸エチル(9.85g,74%)を褐色油状
物として得た。 IRνmaxKBrcm-1: 1746, 1690, 1615, 1507. Anal. Calcd for C11H10O3F2・0.1H2O: C, 57.45; H,
4.47 Found: C, 57.56; H, 4.48.1 H-NMR (CDCl3)δ: 1.26 (3H×5/6, t, J = 7.4 Hz),
1.34 (3H×1/6, t, J = 7.4 Hz), 3.96 (2H×5/6, d, J
= 4.0 Hz), 4.18-4.32 (2H, m), 5.80 (1H×1/6,s),
6.80-7.06 (2H, m), 7.80-8.06 (1H, m). 2) 3-(2,4-ジフルオロフェニル)-3-オキソプ
ロピオン酸エチル(9g,39.4ミリモル)の1,2
-ジメトキシエタン(50ml)溶液に水素化ナトリウ
ム(60%油性,1.58g,39.4ミリモル)を氷
冷下加え、室温で30分攪拌した。反応液の中に4-ト
リフルオロメチルベンジルブロミド(9.43g,3
9.4ミリモル)の1,2-ジメトキシエタン(50m
l)溶液を滴下し、反応液を室温で3時間攪拌した。反
応液を水(200ml)の中に注ぎ、酢酸エチル(20
0ml×2)で抽出した。抽出液を水および飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ト
ルエン:ヘキサン=1:1−トルエン)で精製し、ジイ
ソプロピルエーテル−ヘキサンから再結晶させて3-
(2,4-ジフルオロフェニル)-3-オキソ-2-((4-
(トリフルオロメチル)フェニル)メチル)プロピオン
酸エチル(11.6g,77%)を得た。 mp 34-35℃ IRνmaxKBrcm-1: 1742, 1690, 1613, 1593, 1499, 142
9. Anal. Calcd for C19H15O3F5: C, 59.07; H, 3.91 Found: C, 58.86; H, 3.67.1 H-NMR (CDCl3)δ: 1.13 (3H, t, J = 7.4 Hz), 3.22-
3.50 (2H, m), 4.13 (2H,q, J = 7.4 Hz), 4.53 (1H,
t, J = 7.2 Hz), 6.80-7.02 (2H, m), 7.38 (2H,d, J =
8.0 Hz), 7.52 (2H, d, J = 8.0 Hz), 7.82-8.00 (1H,
m). 3) 塩化亜鉛(7.06g,51.8ミリモル)のジ
エチルエーテル(100ml)溶液に水素化ホウ素ナト
リウム(3.92g,103.5ミリモル)を加えて室
温で30分攪拌した。不溶物をろ去し、ろ液に3-
(2,4-ジフルオロフェニル)-3-オキソ-2-((4-
(トリフルオロメチル)フェニル)メチル)プロピオン
酸エチル(10g,25.9ミリモル)のジエチルエー
テル(50ml)溶液を加えて室温で30分攪拌した。
氷冷下、反応液に1規定塩酸を加えてクエンチし、更に
水(200ml)を加え、酢酸エチル(300ml×
2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=4:1)で精製し、(2RS,3RS)-
3-(2,4-ジフルオロフェニル)-3-ヒドロキシ-2-
((4-(トリフルオロメチル)フェニル)メチル)プ
ロピオン酸エチル(8.23g,82%)を無色油状物
として得た。 IRνmaxKBrcm-1: 1713, 1618, 1505, 1420. Anal. Calcd for C19H17O3F5・0.2H2O: C, 58.23; H,
4.47 Found: C, 58.04; H, 4.60.1 H-NMR (CDCl3)δ: 0.97 (3H, t, J = 7.0 Hz), 2.80-
3.18 (3H, m), 3.25 (1H,d, J = 3.6 Hz), 3.95 (2H,
q, J = 7.0 Hz), 5.28-5.38 (1H, m), 6.72-7.00(2H,
m), 7.18 (2H, d, J = 8.0 Hz), 7.48 (2H, d, J = 8.0
Hz), 7.40-7.60 (1H, m). 4) (2RS,3RS)-3-(2,4-ジフルオロフ
ェニル)-3-ヒドロキシ-2-((4-(トリフルオロメ
チル)フェニル)メチル)プロピオン酸エチル(8.1
g,20.8ミリモル)のメタノール(40ml)溶液
に、2規定水酸化ナトリウム水溶液(20.8ml,4
1.6ミリモル)を加えて室温で終夜攪拌した。反応液
を1規定塩酸で酸性とした後、酢酸エチル(200ml
×2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物を酢酸エチル−ヘキサンから再結晶させて(2RS,
3RS)-3-(2,4-ジフルオロフェニル)-3-ヒド
ロキシ-2-((4-(トリフルオロメチル)フェニル)
メチル)プロピオン酸(6.0g,80%)を得た。 mp 120-121℃ IRνmaxKBrcm-1: 1713, 1620, 1505, 1418. Anal. Calcd for C17H13O3F5: C, 56.57; H, 3.64 Found: C, 56.68; H, 3.59.1 H-NMR (CDCl3)δ: 2.84-3.24 (3H, m), 5.38 (1H, d,
J = 4.0 Hz), 6.70-6.98(2H, m), 7.16 (2H, d, J = 8.
0 Hz), 7.46 (2H, d, J = 8.0 Hz), 7.50-7.58(1H, m). 5) (2RS,3RS)-3-(2,4-ジフルオロフ
ェニル)-3-ヒドロキシ-2-((4-(トリフルオロメ
チル)フェニル)メチル)プロピオン酸(5.0g,1
3.9ミリモル)のテトラヒドロフラン(150ml)
溶液に、ジフェニルホスホリルアジド(3.3ml,1
5.3ミリモル)とトリエチルアミン(2.9ml,2
0.8ミリモル)を加え、6時間加熱還流した。反応液
を放冷後、水(200ml)を加えて酢酸エチル(20
0ml×2)で抽出した。抽出液を1規定塩酸、飽和重
曹水、飽和食塩水で順次洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物をシリカゲルカラムクロ
マトグラフィー(酢酸エチル)で精製し、残留物を酢酸
エチル−ヘキサンから再結晶させて(4RS,5SR)
-5-(2,4-ジフルオロフェニル)-4-((4-(トリ
フルオロメチル)フェニル)メチル)-1,3-オキサゾ
リジン-2-オン(3.86g,78%)を得た。 mp 147-148℃ IRνmaxKBrcm-1: 1767, 1622, 1607, 1507. Anal. Calcd for C17H12O2F5N: C, 57.15; H, 3.39; N,
3.92 Found: C, 57.12; H, 3.12; N, 3.63.1 H-NMR (CDCl3)δ: 2.24-2.56 (2H, m), 4.28-4.44 (1
H, m), 5.12 (1H, s), 5.99 (1H, d, J = 7.6 Hz), 6.7
8-6.92 (1H, m), 6.92-7.08 (1H, m), 7.17 (2H,d, J =
7.6 Hz), 7.50-7.64 (3H, m). 6) (4RS,5SR)-5-(2,4-ジフルオロフ
ェニル)-4-((4-(トリフルオロメチル)フェニ
ル)メチル)-1,3-オキサゾリジン-2-オン(3.5
g,9.8ミリモル)のエタノール(60ml)溶液に
8規定水酸化ナトリウム水溶液(6.1ml,49ミリ
モル)を加え、6時間加熱還流した。反応液を濃縮後、
水(300ml)で希釈し、酢酸エチル(300ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて、(1RS,2SR)
-2-アミノ-1-(2,4-ジフルオロフェニル)-3-
(4-(トリフルオロメチル)フェニル)-1-プロパノ
ール(2.27g,70%)を得た。 mp 99-100℃ IRνmaxKBrcm-1: 1618, 1501, 1427, 1420. Anal. Calcd for C16H14OF5N: C, 58.01; H, 4.26; N,
4.23 Found: C, 58.09; H, 4.14; N, 4.07.1 H-NMR (CDCl3)δ: 2.39 (1H, dd, J = 14.0, 10.6 H
z), 2.83 (1H, dd, J = 14.0, 3.0 Hz), 3.36-3.48 (1
H, m), 5.01 (1H, d, J = 4.4 Hz), 6.78-7.00 (2H,m),
7.24 (2H, d, J = 8.0 Hz), 7.54 (2H, d, J = 8.0 H
z), 7.50-7.62 (1H,m). 7) (1RS,2SR)-2-アミノ-1-(2,4-ジ
フルオロフェニル)-3-(4-(トリフルオロメチル)
フェニル)-1-プロパノール(400mg,1.21ミ
リモル)のアセトニトリル(30ml)溶液に4-フル
オロナフタレンカルボン酸(230mg,1.21ミリ
モル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(347mg,1.81ミ
リモル)および1-ヒドロキシ-1H-ベンゾトリアゾー
ル(185mg,1.21ミリモル)を加えて室温で終
夜攪拌した。反応液を水(100ml)で希釈し、酢酸
エチル(100ml×2)で抽出した。抽出液を1規定
塩酸、1規定水酸化ナトリウム水溶液、飽和食塩水で順
次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて、
表題化合物(538mg,89%)を得た。 mp 194-195℃ IRνmaxKBrcm-1: 1645, 1622, 1601, 1537, 1507. Anal. Calcd for C27H19O2F6N: C, 64.42; H, 3.80; N,
2.78 Found: C, 64.14; H, 3.59; N, 2.63.1 H-NMR (CDCl3)δ: 2.92 (1H, dd, J = 14.6, 11.2 H
z), 3.19 (1H, dd, J = 14.6, 3.8 Hz), 3.88 (1H, br
s), 4.70-4.88 (1H, m), 5.33 (1H, d, J = 4.0 Hz),
5.96 (1H, d, J = 8.8 Hz), 6.78-7.18 (4H, m), 7.22-
7.70 (8H, m), 8.08 (1H, d, J = 8.4 Hz).Example 181 N-((1RS, 2SR) -2- (2,4-difluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4- Fluoro-1-naphthalenecarboxamide 1) 2,4-difluorobenzoic acid (10 g, 63.3)
1,1′-carbonylbis-1H-imidazole (11.3 mmol) in a solution of tetrahydrofuran (150 ml).
g, 69.6 mmol) and stirred at room temperature for 30 minutes. The reaction solution was mixed with monoethyl magnesium malonate (10
g, 34.8 mmol) and stirred at room temperature for 2 hours. Ethyl acetate (50 ml) and water (50 m
l) was added, and concentrated hydrochloric acid was further added until the pH of the aqueous layer became acidic. The reaction solution was extracted with ethyl acetate (200 ml × 2), the extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1), and ethyl 3- (2,4-difluorophenyl) -3-oxopropionate (9.85 g, 74%) was obtained as a brown oil. As obtained. IRνmax KBr cm -1 : 1746, 1690, 1615, 1507. Anal.Calcd for C 11 H 10 O 3 F 2・ 0.1H 2 O: C, 57.45; H,
4.47 Found:. C, 57.56; H, 4.48 1 H-NMR (CDCl 3) δ: 1.26 (3H × 5/6, t, J = 7.4 Hz),
1.34 (3H × 1/6, t, J = 7.4 Hz), 3.96 (2H × 5/6, d, J
= 4.0 Hz), 4.18-4.32 (2H, m), 5.80 (1H × 1/6, s),
6.80-7.06 (2H, m), 7.80-8.06 (1H, m). 2) 1,3-Ethyl 3- (2,4-difluorophenyl) -3-oxopropionate (9 g, 39.4 mmol)
Sodium hydride (60% oily, 1.58 g, 39.4 mmol) was added to a solution of -dimethoxyethane (50 ml) under ice cooling, and the mixture was stirred at room temperature for 30 minutes. 4-trifluoromethylbenzyl bromide (9.43 g, 3
9.4 mmol) of 1,2-dimethoxyethane (50 m
l) The solution was added dropwise and the reaction was stirred at room temperature for 3 hours. The reaction solution was poured into water (200 ml), and ethyl acetate (20 ml) was added.
0 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene: hexane = 1: 1-toluene) and recrystallized from diisopropyl ether-hexane to give 3-
(2,4-difluorophenyl) -3-oxo-2-((4-
Ethyl (trifluoromethyl) phenyl) methyl) propionate (11.6 g, 77%) was obtained. mp 34-35 ℃ IRνmax KBr cm -1 : 1742, 1690, 1613, 1593, 1499, 142
. 9. Anal Calcd for C 19 H 15 O 3 F 5: C, 59.07; H, 3.91 Found:. C, 58.86; H, 3.67 1 H-NMR (CDCl 3) δ: 1.13 (3H, t, J = 7.4 Hz), 3.22-
3.50 (2H, m), 4.13 (2H, q, J = 7.4 Hz), 4.53 (1H,
t, J = 7.2 Hz), 6.80-7.02 (2H, m), 7.38 (2H, d, J =
8.0 Hz), 7.52 (2H, d, J = 8.0 Hz), 7.82-8.00 (1H,
m). 3) To a solution of zinc chloride (7.06 g, 51.8 mmol) in diethyl ether (100 ml) was added sodium borohydride (3.92 g, 103.5 mmol), and the mixture was stirred at room temperature for 30 minutes. Remove the insoluble material by filtration, and add 3-
(2,4-difluorophenyl) -3-oxo-2-((4-
A solution of ethyl (trifluoromethyl) phenyl) methyl) propionate (10 g, 25.9 mmol) in diethyl ether (50 ml) was added, and the mixture was stirred at room temperature for 30 minutes.
Under ice-cooling, the reaction solution was quenched by adding 1N hydrochloric acid, and water (200 ml) was further added, and ethyl acetate (300 ml ×
Extracted in 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Purified with ethyl acetate = 4: 1) to give (2RS, 3RS)-
3- (2,4-difluorophenyl) -3-hydroxy-2-
Ethyl ((4- (trifluoromethyl) phenyl) methyl) propionate (8.23 g, 82%) was obtained as a colorless oil. IRνmax KBr cm -1 : 1713, 1618, 1505, 1420. Anal.Calcd for C 19 H 17 O 3 F 5・ 0.2H 2 O: C, 58.23; H,
4.47 Found:. C, 58.04; H, 4.60 1 H-NMR (CDCl 3) δ: 0.97 (3H, t, J = 7.0 Hz), 2.80-
3.18 (3H, m), 3.25 (1H, d, J = 3.6 Hz), 3.95 (2H,
q, J = 7.0 Hz), 5.28-5.38 (1H, m), 6.72-7.00 (2H,
m), 7.18 (2H, d, J = 8.0 Hz), 7.48 (2H, d, J = 8.0
Hz), 7.40-7.60 (1H, m). 4) (2RS, 3RS) -3- (2,4-difluorophenyl) -3-hydroxy-2-((4- (trifluoromethyl) phenyl) methyl) Ethyl propionate (8.1
g, 20.8 mmol) in a methanol (40 ml) solution.
(1.6 mmol) and stirred at room temperature overnight. After the reaction solution was acidified with 1N hydrochloric acid, ethyl acetate (200 ml) was added.
× 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane (2RS,
3RS) -3- (2,4-difluorophenyl) -3-hydroxy-2-((4- (trifluoromethyl) phenyl)
Methyl) propionic acid (6.0 g, 80%) was obtained. . mp 120-121 ℃ IRνmax KBr cm -1 : 1713, 1620, 1505, 1418. Anal Calcd for C 17 H 13 O 3 F 5: C, 56.57; H, 3.64 Found:. C, 56.68; H, 3.59 1 H-NMR (CDCl 3) δ : 2.84-3.24 (3H, m), 5.38 (1H, d,
J = 4.0 Hz), 6.70-6.98 (2H, m), 7.16 (2H, d, J = 8.
0 Hz), 7.46 (2H, d, J = 8.0 Hz), 7.50-7.58 (1H, m). 5) (2RS, 3RS) -3- (2,4-difluorophenyl) -3-hydroxy-2- ((4- (trifluoromethyl) phenyl) methyl) propionic acid (5.0 g, 1
3.9 mmol) in tetrahydrofuran (150 ml)
To the solution was added diphenylphosphoryl azide (3.3 ml, 1
5.3 mmol) and triethylamine (2.9 ml, 2
(0.8 mmol) and heated to reflux for 6 hours. After allowing the reaction solution to cool, water (200 ml) was added, and ethyl acetate (20 ml) was added.
0 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate), and the residue was recrystallized from ethyl acetate-hexane (4RS, 5SR).
-5- (2,4-Difluorophenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2-one (3.86 g, 78%) was obtained. . mp 147-148 ℃ IRνmax KBr cm -1 : 1767, 1622, 1607, 1507. Anal Calcd for C 17 H 12 O 2 F 5 N: C, 57.15; H, 3.39; N,
3.92 Found:. C, 57.12; H, 3.12; N, 3.63 1 H-NMR (CDCl 3) δ: 2.24-2.56 (2H, m), 4.28-4.44 (1
H, m), 5.12 (1H, s), 5.99 (1H, d, J = 7.6 Hz), 6.7
8-6.92 (1H, m), 6.92-7.08 (1H, m), 7.17 (2H, d, J =
7.6 Hz), 7.50-7.64 (3H, m). 6) (4RS, 5SR) -5- (2,4-difluorophenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1, 3-oxazolidine-2-one (3.5
g, 9.8 mmol) in ethanol (60 ml) was added with 8N aqueous sodium hydroxide solution (6.1 ml, 49 mmol), and the mixture was refluxed for 6 hours. After concentrating the reaction solution,
Dilute with water (300ml) and add ethyl acetate (300ml x
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR)
-2-Amino-1- (2,4-difluorophenyl) -3-
(4- (Trifluoromethyl) phenyl) -1-propanol (2.27 g, 70%) was obtained. . mp 99-100 ℃ IRνmax KBr cm -1 : 1618, 1501, 1427, 1420. Anal Calcd for C 16 H 14 OF 5 N: C, 58.01; H, 4.26; N,
4.23 Found:. C, 58.09; H, 4.14; N, 4.07 1 H-NMR (CDCl 3) δ: 2.39 (1H, dd, J = 14.0, 10.6 H
z), 2.83 (1H, dd, J = 14.0, 3.0 Hz), 3.36-3.48 (1
H, m), 5.01 (1H, d, J = 4.4 Hz), 6.78-7.00 (2H, m),
7.24 (2H, d, J = 8.0 Hz), 7.54 (2H, d, J = 8.0 H
z), 7.50-7.62 (1H, m). 7) (1RS, 2SR) -2-amino-1- (2,4-difluorophenyl) -3- (4- (trifluoromethyl)
To a solution of (phenyl) -1-propanol (400 mg, 1.21 mmol) in acetonitrile (30 ml) was added 4-fluoronaphthalenecarboxylic acid (230 mg, 1.21 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide. -Hydrochloride (347 mg, 1.81 mmol) and 1-hydroxy-1H-benzotriazole (185 mg, 1.21 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane,
The title compound (538 mg, 89%) was obtained. mp 194-195 ° C IRνmax KBr cm -1 : 1645, 1622, 1601, 1537, 1507. Anal.Calcd for C 27 H 19 O 2 F 6 N: C, 64.42; H, 3.80; N,
2.78 Found:. C, 64.14; H, 3.59; N, 2.63 1 H-NMR (CDCl 3) δ: 2.92 (1H, dd, J = 14.6, 11.2 H
z), 3.19 (1H, dd, J = 14.6, 3.8 Hz), 3.88 (1H, br
s), 4.70-4.88 (1H, m), 5.33 (1H, d, J = 4.0 Hz),
5.96 (1H, d, J = 8.8 Hz), 6.78-7.18 (4H, m), 7.22-
7.70 (8H, m), 8.08 (1H, d, J = 8.4 Hz).
【0314】実施例182 N-((1RS,2SR)-2-(2,4-ジフルオロフェ
ニル)-2-ヒドロキシ-1-((4-(トリフルオロメチ
ル)フェニル)メチル)エチル)-3-フェニルプロパン
アミド (1RS,2SR)-2-アミノ-1-(2,4-ジフルオ
ロフェニル)-3-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(400mg,1.21ミリモ
ル)の酢酸エチル(20ml)溶液に3-フェニルプロ
ピオニルクロリド(269ml,1.81ミリモル)お
よび飽和重曹水(20ml)を加えて室温で終夜攪拌し
た。反応液を水(100ml)で希釈し、酢酸エチル
(100ml×2)で抽出した。抽出液を飽和食塩水で
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去した。
残留物を酢酸エチル−ヘキサンから再結晶させて表題化
合物(498mg,89%)を得た。 mp 126-127℃ IRνmaxKBrcm-1: 1645, 1620, 1503, 1427. Anal. Calcd for C25H22O2F5N: C, 64.79; H, 4.78; N,
3.02 Found: C, 64.82; H, 4.57; N, 2.86.1 H-NMR (CDCl3)δ: 2.30-2.46 (2H, m), 2.64-2.92 (4
H, m), 4.11 (1H, d, J =4.0 Hz), 4.22-4.38 (1H, m),
5.04-5.14 (1H, m), 5.39 (1H, d, J = 8.0 Hz), 6.70
-6.92 (2H, m), 7.02-7.52 (10H, m).Example 182 N-((1RS, 2SR) -2- (2,4-difluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -3- Phenylpropanamide Acetic acid of (1RS, 2SR) -2-amino-1- (2,4-difluorophenyl) -3- (4- (trifluoromethyl) phenyl) -1-propanol (400 mg, 1.21 mmol) To the ethyl (20 ml) solution were added 3-phenylpropionyl chloride (269 ml, 1.81 mmol) and saturated aqueous sodium hydrogen carbonate (20 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was recrystallized from ethyl acetate-hexane to give the title compound (498 mg, 89%). mp 126-127 ℃ IRνmax KBr cm -1 : 1645, 1620, 1503, 1427. Anal.Calcd for C 25 H 22 O 2 F 5 N: C, 64.79; H, 4.78; N,
3.02 Found:. C, 64.82; H, 4.57; N, 2.86 1 H-NMR (CDCl 3) δ: 2.30-2.46 (2H, m), 2.64-2.92 (4
H, m), 4.11 (1H, d, J = 4.0 Hz), 4.22-4.38 (1H, m),
5.04-5.14 (1H, m), 5.39 (1H, d, J = 8.0 Hz), 6.70
-6.92 (2H, m), 7.02-7.52 (10H, m).
【0315】実施例183 N-((1RS,2SR)-2-(3,4-ジフルオロフェ
ニル)-2-ヒドロキシ-1-((4-(トリフルオロメチ
ル)フェニル)メチル)エチル)-4-フルオロ-1-ナフ
タレンカルボキサミド 1) 3,4-ジフルオロ安息香酸(10g,63.3
ミリモル)のテトラヒドロフラン(300ml)溶液に
1,1'-カルボニルビス-1H-イミダゾール(11.3
g,69.6ミリモル)を加え、室温で30分攪拌し
た。反応液にマロン酸モノエチルマグネシウム塩(10
g,34.8ミリモル)を加え、室温で2時間攪拌し
た。反応液に酢酸エチル(50ml)および水(50m
l)を加え、更に水層のpHが酸性になるまで濃塩酸を
加えた。反応液を酢酸エチル(200ml×2)で抽出
し、抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去した。残留物をシリカゲルカラムク
ロマトグラフィー(ヘキサン:酢酸エチル=4:1)で
精製し、3-(3,4-ジフルオロフェニル)-3-オキソ
プロピオン酸エチル(10.3g,77%)を褐色油状
物として得た。 IRνmaxKBrcm-1: 1742, 1694, 1613, 1520, 1433. Anal. Calcd for C11H10O3F2: C, 57.90; H, 4.42 Found: C, 57.78; H, 4.56.1 H-NMR (CDCl3)δ: 1.26 (3H×4/5, t, J = 7.4 Hz),
1.33 (3H×1/5, t, J = 7.4 Hz), 3.94 (2H×4/5, s),
4.10-4.32 (2H, m), 5.60 (1H×1/5, s), 7.12-7.34 (1
H, m), 7.48-7.86 (2H, m). 2) 3-(3,4-ジフルオロフェニル)-3-オキソプ
ロピオン酸エチル(9g,39.4ミリモル)の1,2
-ジメトキシエタン(50ml)溶液に水素化ナトリウ
ム(60%油性,1.58g,39.4ミリモル)を氷
冷下加え、室温で30分攪拌した。反応液の中に4-ト
リフルオロメチルベンジルブロミド(9.43g,3
9.4ミリモル)の1,2-ジメトキシエタン(50m
l)溶液を滴下し、反応液を室温で3時間攪拌した。反
応液を水(200ml)の中に注ぎ、酢酸エチル(20
0ml×2)で抽出した。抽出液を水および飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ト
ルエン:ヘキサン=1:1)で精製し、ジイソプロピル
エーテル−ヘキサンから再結晶させて3-(3,4-ジフ
ルオロフェニル)-3-オキソ-2-((4-(トリフルオ
ロメチル)フェニル)メチル)プロピオン酸エチル(1
0.9g,71%)を得た。 mp 48-49℃ IRνmaxKBrcm-1: 1738, 1694, 1615, 1518, 1429. Anal. Calcd for C19H15O3F5: C, 59.07; H, 3.91 Found: C, 59.06; H, 3.87.1 H-NMR (CDCl3)δ: 1.30 (3H, t, J = 7.2 Hz), 3.38
(2H, d, J = 7.2 Hz), 4.11 (2H, q, J = 7.2 Hz), 4.5
3 (1H, t, J = 7.2 Hz), 7.16-7.30 (1H, m), 7.34 (2
H, d, J = 8.0 Hz), 7.53 (2H, d, J = 8.0 Hz), 7.70-
7.90 (2H, m). 3) 塩化亜鉛(7.06g,51.8ミリモル)のジ
エチルエーテル(100ml)溶液に水素化ホウ素ナト
リウム(3.92g,103.5ミリモル)を加えて室
温で30分攪拌した。不溶物をろ去し、ろ液に3-
(3,4-ジフルオロフェニル)-3-オキソ-2-((4-
(トリフルオロメチル)フェニル)メチル)プロピオン
酸エチル(10g,25.9ミリモル)のジエチルエー
テル(50ml)溶液を加えて室温で30分攪拌した。
氷冷下、反応液に1規定塩酸を加えてクエンチし、更に
水(200ml)を加え、酢酸エチル(300ml×
2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=4:1)で精製し、(2RS,3RS)-
3-(3,4-ジフルオロフェニル)-3-ヒドロキシ-2-
((4-(トリフルオロメチル)フェニル)メチル)プ
ロピオン酸エチル(9.84g,98%)を無色油状物
として得た。 IRνmaxKBrcm-1: 1715, 1620, 1520, 1435. Anal. Calcd for C19H17O3F5・0.2H2O: C, 58.23; H,
4.47 Found: C, 58.07; H, 4.41.1 H-NMR (CDCl3)δ: 0.95 (3H, t, J = 7.2 Hz), 2.86-
3.12 (4H, m), 3.91 (2H,q, J = 7.2 Hz), 5.00-5.05
(1H, m), 7.04-7.34 (5H, m), 7.49 (2H, d, J =8.0 H
z). 4) (2RS,3RS)-3-(3,4-ジフルオロフ
ェニル)-3-ヒドロキシ-2-((4-(トリフルオロメ
チル)フェニル)メチル)プロピオン酸エチル(9.7
g,25.0ミリモル)のメタノール(40ml)溶液
に、2規定水酸化ナトリウム水溶液(25ml,50.
0ミリモル)を加えて室温で終夜攪拌した。反応液を1
規定塩酸で酸性とした後、酢酸エチル(200ml×
2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物を酢酸エチル−ヘキサンから再結晶させて(2RS,
3RS)-3-(3,4-ジフルオロフェニル)-3-ヒド
ロキシ-2-((4-(トリフルオロメチル)フェニル)
メチル)プロピオン酸(6.7g,74%)を得た。 mp 76-77℃ IRνmaxKBrcm-1: 1713, 1620, 1520, 1435.1 H-NMR (CDCl3)δ: 2.90-3.18 (3H, m), 5.07 (1H, s),
7.04-7.34 (5H, m), 7.49 (2H, d, J = 8.0 Hz). 5) (2RS,3RS)-3-(3,4-ジフルオロフ
ェニル)-3-ヒドロキシ-2-((4-(トリフルオロメ
チル)フェニル)メチル)プロピオン酸(5.0g,1
3.9ミリモル)のテトラヒドロフラン(150ml)
溶液に、ジフェニルホスホリルアジド(3.3ml,1
5.3ミリモル)とトリエチルアミン(2.9ml,2
0.8ミリモル)を加え、6時間加熱還流した。反応液
を放冷後、水(200ml)を加えて酢酸エチル(20
0ml×2)で抽出した。抽出液を1規定塩酸、飽和重
曹水、飽和食塩水で順次洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物をシリカゲルカラムクロ
マトグラフィー(酢酸エチル)で精製し、残留物を酢酸
エチル−ヘキサンから再結晶させて(4RS,5SR)
-5-(3,4-ジフルオロフェニル)-4-((4-(トリ
フルオロメチル)フェニル)メチル)-1,3-オキサゾ
リジン-2-オン(3.81g,77%)を得た。 mp 157-158℃ IRνmaxKBrcm-1: 1761, 1617, 1524. Anal. Calcd for C17H12O2F5N: C, 57.15; H, 3.39; N,
3.92 Found: C, 57.12; H, 3.26; N, 3.76.1 H-NMR (CDCl3)δ: 2.24-2.44 (2H, m), 4.20-4.38 (1
H, m), 5.31 (1H, s), 5.76 (1H, d, J = 7.6 Hz), 7.0
4-7.30 (5H, m), 7.55 (2H, d, J = 8.0 Hz). 6) (4RS,5SR)-5-(3,4-ジフルオロフ
ェニル)-4-((4-(トリフルオロメチル)フェニ
ル)メチル)-1,3-オキサゾリジン-2-オン(3.5
g,9.8ミリモル)のエタノール(60ml)溶液に
8規定水酸化ナトリウム水溶液(6.1ml,49ミリ
モル)を加え、6時間加熱還流した。反応液を濃縮後、
水(300ml)で希釈し、酢酸エチル(300ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて、(1RS,2SR)
-2-アミノ-1-(3,4-ジフルオロフェニル)-3-
(4-(トリフルオロメチル)フェニル)-1-プロパノ
ール(2.43g,75%)を得た。 mp 99-100℃ IRνmaxKBrcm-1: 1618, 1576, 1518, 1429. Anal. Calcd for C16H14OF5N: C, 58.01; H, 4.26; N,
4.23 Found: C, 58.01; H, 3.97; N, 4.05.1 H-NMR (CDCl3)δ: 2.41 (1H, dd, J = 14.0, 10.4 H
z), 2.79 (1H, dd, J = 14.0, 3.0 Hz), 3.22-3.36 (1
H, m), 4.66 (1H, d, J = 4.8 Hz), 7.04-7.32 (5H,m),
7.55 (2H, d, J = 8.2 Hz). 7) (1RS,2SR)-2-アミノ-1-(3,4-ジ
フルオロフェニル)-3-(4-(トリフルオロメチル)
フェニル)-1-プロパノール(400mg,1.21ミ
リモル)のアセトニトリル(30ml)溶液に4-フル
オロナフタレンカルボン酸(230mg,1.21ミリ
モル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(347mg,1.81ミ
リモル)および1-ヒドロキシ-1H-ベンゾトリアゾー
ル(185mg,1.21ミリモル)を加えて室温で終
夜攪拌した。反応液を水(100ml)で希釈し、酢酸
エチル(100ml×2)で抽出した。抽出液を1規定
塩酸、1規定水酸化ナトリウム水溶液、飽和食塩水で順
次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて、
表題化合物(522mg,86%)を得た。 mp 197-198℃ IRνmaxKBrcm-1: 1642, 1626, 1601, 1522, 1424. Anal. Calcd for C27H19O2F6N: C, 64.42; H, 3.80; N,
2.78 Found: C, 64.20; H, 3.68; N, 2.69.1 H-NMR (CDCl3)δ: 2.80-3.10 (2H, m), 4.64-4.84 (1
H, m), 5.06-5.18 (1H, m), 6.01 (1H, d, J = 8.8 H
z), 6.94-7.72 (12H, m), 8.09 (1H, d, J = 8.8 Hz).Example 183 N-((1RS, 2SR) -2- (3,4-difluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4- Fluoro-1-naphthalenecarboxamide 1) 3,4-difluorobenzoic acid (10 g, 63.3)
1,1′-carbonylbis-1H-imidazole (11.3 mmol) in a solution of (1 mmol) in tetrahydrofuran (300 ml).
g, 69.6 mmol) and stirred at room temperature for 30 minutes. The reaction solution was mixed with monoethyl magnesium malonate (10
g, 34.8 mmol) and stirred at room temperature for 2 hours. Ethyl acetate (50 ml) and water (50 m
l) was added, and concentrated hydrochloric acid was further added until the pH of the aqueous layer became acidic. The reaction solution was extracted with ethyl acetate (200 ml × 2), the extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1), and ethyl 3- (3,4-difluorophenyl) -3-oxopropionate (10.3 g, 77%) was added as a brown oil. As obtained. . IRνmax KBr cm -1: 1742, 1694, 1613, 1520, 1433. Anal Calcd for C 11 H 10 O 3 F 2: C, 57.90; H, 4.42 Found:. C, 57.78; H, 4.56 1 H-NMR (CDCl 3 ) δ: 1.26 (3H × 4/5, t, J = 7.4 Hz),
1.33 (3H × 1/5, t, J = 7.4 Hz), 3.94 (2H × 4/5, s),
4.10-4.32 (2H, m), 5.60 (1H × 1/5, s), 7.12-7.34 (1
H, m), 7.48-7.86 (2H, m). 2) 1,2 of ethyl 3- (3,4-difluorophenyl) -3-oxopropionate (9 g, 39.4 mmol).
Sodium hydride (60% oily, 1.58 g, 39.4 mmol) was added to a solution of -dimethoxyethane (50 ml) under ice cooling, and the mixture was stirred at room temperature for 30 minutes. 4-trifluoromethylbenzyl bromide (9.43 g, 3
9.4 mmol) of 1,2-dimethoxyethane (50 m
l) The solution was added dropwise and the reaction was stirred at room temperature for 3 hours. The reaction solution was poured into water (200 ml), and ethyl acetate (20 ml) was added.
0 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene: hexane = 1: 1) and recrystallized from diisopropyl ether-hexane to give 3- (3,4-difluorophenyl) -3-oxo-2-((4- Ethyl (trifluoromethyl) phenyl) methyl) propionate (1
0.9 g, 71%). mp 48-49 ° C IRνmax KBr cm -1 : 1738, 1694, 1615, 1518, 1429. Anal.Calcd for C 19 H 15 O 3 F 5 : C, 59.07; H, 3.91 Found: C, 59.06; H, 3.87 . 1 H-NMR (CDCl 3 ) δ: 1.30 (3H, t, J = 7.2 Hz), 3.38
(2H, d, J = 7.2 Hz), 4.11 (2H, q, J = 7.2 Hz), 4.5
3 (1H, t, J = 7.2 Hz), 7.16-7.30 (1H, m), 7.34 (2
H, d, J = 8.0 Hz), 7.53 (2H, d, J = 8.0 Hz), 7.70-
7.90 (2H, m). 3) To a solution of zinc chloride (7.06 g, 51.8 mmol) in diethyl ether (100 ml) was added sodium borohydride (3.92 g, 103.5 mmol), and the mixture was stirred at room temperature for 30 minutes. Stirred. Remove the insoluble material by filtration, and add 3-
(3,4-difluorophenyl) -3-oxo-2-((4-
A solution of ethyl (trifluoromethyl) phenyl) methyl) propionate (10 g, 25.9 mmol) in diethyl ether (50 ml) was added, and the mixture was stirred at room temperature for 30 minutes.
Under ice-cooling, the reaction solution was quenched by adding 1N hydrochloric acid, and water (200 ml) was further added, and ethyl acetate (300 ml ×
Extracted in 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Purified with ethyl acetate = 4: 1) to give (2RS, 3RS)-
3- (3,4-difluorophenyl) -3-hydroxy-2-
Ethyl ((4- (trifluoromethyl) phenyl) methyl) propionate (9.84 g, 98%) was obtained as a colorless oil. . IRνmax KBr cm -1: 1715, 1620, 1520, 1435. Anal Calcd for C 19 H 17 O 3 F 5 · 0.2H 2 O: C, 58.23; H,
4.47 Found:. C, 58.07; H, 4.41 1 H-NMR (CDCl 3) δ: 0.95 (3H, t, J = 7.2 Hz), 2.86-
3.12 (4H, m), 3.91 (2H, q, J = 7.2 Hz), 5.00-5.05
(1H, m), 7.04-7.34 (5H, m), 7.49 (2H, d, J = 8.0 H
z). 4) Ethyl (2RS, 3RS) -3- (3,4-difluorophenyl) -3-hydroxy-2-((4- (trifluoromethyl) phenyl) methyl) propionate (9.7
g, 25.0 mmol) in a solution of methanol (40 ml) in 2N aqueous sodium hydroxide (25 ml, 50.50 g).
0 mmol) and stirred at room temperature overnight. Reaction solution 1
After acidification with normal hydrochloric acid, ethyl acetate (200 ml ×
Extracted in 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane (2RS,
3RS) -3- (3,4-Difluorophenyl) -3-hydroxy-2-((4- (trifluoromethyl) phenyl)
Methyl) propionic acid (6.7 g, 74%) was obtained. mp 76-77 ℃ IRνmax KBr cm -1: 1713, 1620, 1520, 1435. 1 H-NMR (CDCl 3) δ: 2.90-3.18 (3H, m), 5.07 (1H, s),
7.04-7.34 (5H, m), 7.49 (2H, d, J = 8.0 Hz). 5) (2RS, 3RS) -3- (3,4-difluorophenyl) -3-hydroxy-2-((4- (Trifluoromethyl) phenyl) methyl) propionic acid (5.0 g, 1
3.9 mmol) in tetrahydrofuran (150 ml)
To the solution was added diphenylphosphoryl azide (3.3 ml, 1
5.3 mmol) and triethylamine (2.9 ml, 2
(0.8 mmol) and heated to reflux for 6 hours. After allowing the reaction solution to cool, water (200 ml) was added, and ethyl acetate (20 ml) was added.
0 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate), and the residue was recrystallized from ethyl acetate-hexane (4RS, 5SR).
This gave -5- (3,4-difluorophenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2-one (3.81 g, 77%). . mp 157-158 ℃ IRνmax KBr cm -1 : 1761, 1617, 1524. Anal Calcd for C 17 H 12 O 2 F 5 N: C, 57.15; H, 3.39; N,
3.92 Found:. C, 57.12; H, 3.26; N, 3.76 1 H-NMR (CDCl 3) δ: 2.24-2.44 (2H, m), 4.20-4.38 (1
H, m), 5.31 (1H, s), 5.76 (1H, d, J = 7.6 Hz), 7.0
4-7.30 (5H, m), 7.55 (2H, d, J = 8.0 Hz). 6) (4RS, 5SR) -5- (3,4-difluorophenyl) -4-((4- (trifluoromethyl ) Phenyl) methyl) -1,3-oxazolidin-2-one (3.5
g, 9.8 mmol) in ethanol (60 ml) was added with 8N aqueous sodium hydroxide solution (6.1 ml, 49 mmol), and the mixture was refluxed for 6 hours. After concentrating the reaction solution,
Dilute with water (300ml) and add ethyl acetate (300ml x
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR)
-2-Amino-1- (3,4-difluorophenyl) -3-
(4- (Trifluoromethyl) phenyl) -1-propanol (2.43 g, 75%) was obtained. . mp 99-100 ℃ IRνmax KBr cm -1 : 1618, 1576, 1518, 1429. Anal Calcd for C 16 H 14 OF 5 N: C, 58.01; H, 4.26; N,
4.23 Found:. C, 58.01; H, 3.97; N, 4.05 1 H-NMR (CDCl 3) δ: 2.41 (1H, dd, J = 14.0, 10.4 H
z), 2.79 (1H, dd, J = 14.0, 3.0 Hz), 3.22-3.36 (1
H, m), 4.66 (1H, d, J = 4.8 Hz), 7.04-7.32 (5H, m),
7.55 (2H, d, J = 8.2 Hz). 7) (1RS, 2SR) -2-amino-1- (3,4-difluorophenyl) -3- (4- (trifluoromethyl)
To a solution of (phenyl) -1-propanol (400 mg, 1.21 mmol) in acetonitrile (30 ml) was added 4-fluoronaphthalenecarboxylic acid (230 mg, 1.21 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide. -Hydrochloride (347 mg, 1.81 mmol) and 1-hydroxy-1H-benzotriazole (185 mg, 1.21 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane,
The title compound (522 mg, 86%) was obtained. mp 197-198 ° C IRνmax KBr cm -1 : 1642, 1626, 1601, 1522, 1424. Anal.Calcd for C 27 H 19 O 2 F 6 N: C, 64.42; H, 3.80; N,
2.78 Found:. C, 64.20; H, 3.68; N, 2.69 1 H-NMR (CDCl 3) δ: 2.80-3.10 (2H, m), 4.64-4.84 (1
H, m), 5.06-5.18 (1H, m), 6.01 (1H, d, J = 8.8 H
z), 6.94-7.72 (12H, m), 8.09 (1H, d, J = 8.8 Hz).
【0316】実施例184 N-((1RS,2SR)-2-(3,4-ジフルオロフェ
ニル)-2-ヒドロキシ-1-((4-(トリフルオロメチ
ル)フェニル)メチル)エチル)-3-フェニルプロパン
アミド (1RS,2SR)-2-アミノ-1-(3,4-ジフルオ
ロフェニル)-3-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(400mg,1.21ミリモ
ル)の酢酸エチル(20ml)溶液に3-フェニルプロ
ピオニルクロリド(269ml,1.81ミリモル)お
よび飽和重曹水(20ml)を加えて室温で終夜攪拌し
た。反応液を水(100ml)で希釈し、酢酸エチル
(100ml×2)で抽出した。抽出液を飽和食塩水で
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去した。
残留物を酢酸エチル−ヘキサンから再結晶させて表題化
合物(471mg,84%)を得た。 mp 114-115℃ IRνmaxKBrcm-1: 1647, 1620, 1518, 1433. Anal. Calcd for C25H22O2F5N: C, 64.79; H, 4.78; N,
3.02 Found: C, 64.88; H, 4.59; N, 2.90.1 H-NMR (CDCl3)δ: 2.26-2.50 (2H, m), 2.58-2.80 (2
H, m), 2.82-2.96 (2H, m), 3.36 (1H, brs), 4.22-4.4
0 (1H, m), 4.81 (1H, d, J = 2.6 Hz), 5.34 (1H, d,
J = 7.2 Hz), 6.98-7.38 (10H, m), 7.47 (2H, d, J =
8.0 Hz).Example 184 N-((1RS, 2SR) -2- (3,4-difluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -3- Phenylpropanamide Acetic acid of (1RS, 2SR) -2-amino-1- (3,4-difluorophenyl) -3- (4- (trifluoromethyl) phenyl) -1-propanol (400 mg, 1.21 mmol) To the ethyl (20 ml) solution were added 3-phenylpropionyl chloride (269 ml, 1.81 mmol) and saturated aqueous sodium hydrogen carbonate (20 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was recrystallized from ethyl acetate-hexane to give the title compound (471 mg, 84%). mp 114-115 ℃ IRνmax KBr cm -1 : 1647, 1620, 1518, 1433. Anal.Calcd for C 25 H 22 O 2 F 5 N: C, 64.79; H, 4.78; N,
3.02 Found:. C, 64.88; H, 4.59; N, 2.90 1 H-NMR (CDCl 3) δ: 2.26-2.50 (2H, m), 2.58-2.80 (2
H, m), 2.82-2.96 (2H, m), 3.36 (1H, brs), 4.22-4.4
0 (1H, m), 4.81 (1H, d, J = 2.6 Hz), 5.34 (1H, d,
J = 7.2 Hz), 6.98-7.38 (10H, m), 7.47 (2H, d, J =
8.0 Hz).
【0317】実施例185 N-((1RS,2SR)-2-ヒドロキシ-2-(1-ナフ
タレニル)-1-((4-(トリフルオロメチル)フェニ
ル)メチル)エチル)-1-ナフタレンカルボキサミド 1) 1’-アセトナフトン(28.29g,0.16
62ミリモル)とエタノール(0.5ml)の炭酸ジエ
チル(200ml)溶液に水素化ナトリウム(13.3
g,60%油性,0.332モル)を少しずつ加え、8
0℃で1.5時間攪拌した。反応液を水に注ぎ、希塩酸
で酸性にし、酢酸エチルで2回抽出した。抽出液を水洗
後、無水硫酸マグネシウムで乾燥し、減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=20:1−6:1)で精製し、(1-
ナフトイル)酢酸エチル(38.14g,95%)を黄
色液体として得た。1 H-NMR (CDCl3, 200M Hz) δ 1.21 (2.4H, t, J = 7.2
Hz), 1.36 (0.6H, t, J= 7.1 Hz), 4.11 (1.6H, s), 4.
20 (1.6H, q, J = 7.2 Hz), 4.31 (0.4H, q, J= 7.1 H
z), 5.50 (0.2H, s), 7.44-7.67 (4H, m), 7.86-7.95
(2H, m), 8.03 (1H, d, J = 8.0 Hz), 8.75 (1H, d, J
= 8.4 Hz); IR (neat) 1740, 1682, 1315,1211, 802, 7
75 cm-1 2) (1-ナフトイル)酢酸エチル(10.2g,3
9.9ミリモル)のアセトニトリル(100ml)溶液
に4-(トリフルオロメチル)ベンジルブロミド(9.
54g,39.9ミリモル)を加え、室温で終夜攪拌し
た。反応液を濃縮後、水(500ml)で希釈し、酢酸
エチル(300ml×2)で抽出した。抽出液を飽和食
塩水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去
した。残留物をシリカゲルカラムクロマトグラフィー
(ヘキサン:トルエン=1:1)で精製した。得られた
モノアルキル体の粗生成物(7.46g,18.63ミ
リモル)のエーテル(100ml)溶液に、塩化亜鉛
(5.07g,37.3ミリモル)および水素化ホウ素
ナトリウム(2.82g,74.5ミリモル)より調製
したZn(NH4)2のエーテル(100ml)溶液を加
え、室温で30分攪拌した。反応液を1規定塩酸水溶液
(100ml)に注ぎ、酢酸エチル(300ml×2)
で抽出した。抽出液を飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(トルエン)で精製した。得
られた還元体の粗生成物(3.74g,9.29ミリモ
ル)のメタノール(40ml)溶液に、1規定水酸化ナ
トリウム水溶液(20ml,20ミリモル)を加え、室
温で4時間攪拌した。反応液を1規定塩酸水溶液(40
ml)に注ぎ、酢酸エチル(100ml×2)で抽出し
た。抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去した。残留物をジイソプロピルエー
テル−ヘキサンから再結晶させて、(2RS,3RS)
-3-ヒドロキシ-3-(1-ナフタレニル)-2-((4-
(トリフルオロメチル)フェニル)メチル)プロピオン
酸(2.48g,16%)を得た。 mp 151-152℃ IRνmaxKBrcm-1: 1713. Anal. Calcd for C21H17F3O3・0.1H2O: C, 67.05; H,
4.61 Found: C, 67.02; H, 4.45.1 H-NMR (CDCl3)δ: 2.87 (1H, d, J = 14.0 Hz), 3.10-
3.40 (2H, m), 6.04 (1H, d, J = 2.8 Hz), 6.98 (2H,
d, J = 8.0 Hz), 7.34 (2H, d, J = 8.0 Hz), 7.42-7.6
2 (3H, m), 7.72-7.98 (3H, m), 8.03 (1H, d, J = 9.2
Hz). 3) (2RS,3RS)-3-ヒドロキシ-3-(1-ナ
フタレニル)-2-((4-(トリフルオロメチル)フェ
ニル)メチル)プロピオン酸(2.64g,7.05ミ
リモル)のテトラヒドロフラン(50ml)溶液にジフ
ェニルホスホリルアジド(1.67ml,7.76ミリ
モル)およびトリエチルアミン(1.5ml,10.6
ミリモル)を加えて1時間加熱還流した。反応液を水
(300ml)で希釈し、酢酸エチル(200ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて、(4RS,5SR)
-5-(1-ナフタレニル)-4-((4-(トリフルオロメ
チル)フェニル)メチル)-1,3-オキサゾリジン-2-
オン(2.19g,84%)を得た。 mp 202-203℃ IRνmaxKBrcm-1: 1761. Anal. Calcd for C21H16F3NO2: C, 67.92; H, 4.34; N,
3.77 Found: C, 67.90; H, 4.15; N, 3.63.1 H-NMR (CDCl3)δ: 2.15 (1H, dd, J = 13.6, 4.4 Hz),
2.37 (1H, dd, J = 13.6, 10.2 Hz), 4.46-4.64 (1H,
m), 5.38 (1H, brs), 6.53 (1H, d, J = 7.6 Hz), 6.97
(2H, d, J = 8.0 Hz), 7.39 (2H, d, J = 8.0 Hz), 7.
46-7.80 (4H, m),7.80-8.00 (3H, m). 4) (4RS,5SR)-5-(1-ナフタレニル)-4
-((4-(トリフルオロメチル)フェニル)メチル)-
1,3-オキサゾリジン-2-オン(2.10g,5.6
6ミリモル)のエタノール(30ml)溶液に8規定水
酸化ナトリウム水溶液(3.53ml,28.3ミリモ
ル)を加え、1時間加熱還流した。反応液を濃縮後、水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物の酢酸エ
チル(100ml)溶液にHCl・酢酸エチル溶液を加
え、溶媒を濃縮し、得られた粗結晶をエーテルで洗浄
し、(1RS,2SR)-1-ヒドロキシ-1-(1-ナフ
タレニル)-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(1.56g,72%)
を得た。 mp 229-230℃ IRνmaxKBrcm-1: 1761. Anal. Calcd for C20H19ClF3NO・0.1H2O: C, 62.62; H,
5.04; N, 3.65 Found: C, 62.44; H, 5.07; N, 3.88.1 H-NMR (CD3OD)δ: 2.80-3.04 (2H, m), 3.96-4.10 (1
H, m), 5.93 (1H, d, J =2.6 Hz), 7.02 (2H, d, J =
8.0 Hz), 7.37 (2H, d, J = 8.0 Hz), 7.46-7.62(3H,
m), 7.78-7.96 (3H, m), 8.07 (1H, d, J = 8.0 Hz). 5) (1RS,2SR)-1-ヒドロキシ-1-(1-ナ
フタレニル)-3-(4-(トリフルオロメチル)フェニ
ル)-2-プロピルアミン塩酸塩(150mg,0.39
ミリモル)の酢酸エチル(5ml)溶液に1-ナフトイ
ルクロリド(89ml,0.59ミリモル)および飽和
重曹水(5ml)を加えて室温で終夜攪拌した。反応液
を水(50ml)で希釈し、酢酸エチル(50ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて、表題化合物(172
mg,88%)を得た。 mp 217-218℃ IRνmaxKBrcm-1: 1615, 1591, 1537, 1526. Anal. Calcd for C31H24F3NO2: C, 74.54; H, 4.84; N,
2.80 Found: C, 74.33; H, 4.96; N, 2.76.1 H-NMR (CDCl3)δ: 2.80-3.14 (3H, m), 4.94-5.12 (1
H, m), 6.04 (1H, brs),6.32 (1H, d, J = 8.8 Hz), 7.
17 (2H, d, J = 8.2 Hz), 7.20-8.00 (15H, m),8.45 (1
H, d, J = 8.4 Hz).Example 185 N-((1RS, 2SR) -2-hydroxy-2- (1-naphthalenyl) -1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -1-naphthalenecarboxamide 1 ) 1'-acetonaphthone (28.29 g, 0.16
Sodium hydride (13.3) in a solution of ethanol (0.5 ml) and diethyl carbonate (200 ml) in ethanol (0.5 ml).
g, 60% oily, 0.332 mol) was added little by little, and 8
Stirred at 0 ° C. for 1.5 hours. The reaction was poured into water, acidified with dilute hydrochloric acid and extracted twice with ethyl acetate. The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 20: 1-6: 1) to give (1-
Naphthoyl) ethyl acetate (38.14 g, 95%) was obtained as a yellow liquid. 1 H-NMR (CDCl 3 , 200 MHz) δ 1.21 (2.4H, t, J = 7.2
Hz), 1.36 (0.6H, t, J = 7.1 Hz), 4.11 (1.6H, s), 4.
20 (1.6H, q, J = 7.2 Hz), 4.31 (0.4H, q, J = 7.1 H
z), 5.50 (0.2H, s), 7.44-7.67 (4H, m), 7.86-7.95
(2H, m), 8.03 (1H, d, J = 8.0 Hz), 8.75 (1H, d, J
= 8.4 Hz); IR (neat) 1740, 1682, 1315,1211, 802, 7
75 cm -1 2) Ethyl (1-naphthoyl) acetate (10.2 g, 3
9.9 mmol) in acetonitrile (100 ml) was added to 4- (trifluoromethyl) benzylbromide (9.9).
(54 g, 39.9 mmol) and stirred at room temperature overnight. After concentration, the reaction solution was diluted with water (500 ml) and extracted with ethyl acetate (300 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: toluene = 1: 1). To a solution of the obtained crude product of the monoalkyl compound (7.46 g, 18.63 mmol) in ether (100 ml), zinc chloride (5.07 g, 37.3 mmol) and sodium borohydride (2.82 g, 74.5 mmol) of Zn (NH 4 ) 2 in ether (100 ml) and stirred at room temperature for 30 minutes. The reaction solution was poured into a 1N aqueous hydrochloric acid solution (100 ml), and ethyl acetate (300 ml × 2) was added.
Extracted. The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene). To a solution of the obtained crude product of the reduced form (3.74 g, 9.29 mmol) in methanol (40 ml) was added a 1 N aqueous sodium hydroxide solution (20 ml, 20 mmol), and the mixture was stirred at room temperature for 4 hours. The reaction solution was diluted with a 1N aqueous hydrochloric acid solution (40
ml) and extracted with ethyl acetate (100 ml x 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to give (2RS, 3RS)
-3-Hydroxy-3- (1-naphthalenyl) -2-((4-
(Trifluoromethyl) phenyl) methyl) propionic acid (2.48 g, 16%) was obtained. mp 151-152 ℃ IRνmax KBr cm -1 : 1713. Anal.Calcd for C 21 H 17 F 3 O 3・ 0.1H 2 O: C, 67.05; H,
4.61 Found:. C, 67.02; H, 4.45 1 H-NMR (CDCl 3) δ: 2.87 (1H, d, J = 14.0 Hz), 3.10-
3.40 (2H, m), 6.04 (1H, d, J = 2.8 Hz), 6.98 (2H,
d, J = 8.0 Hz), 7.34 (2H, d, J = 8.0 Hz), 7.42-7.6
2 (3H, m), 7.72-7.98 (3H, m), 8.03 (1H, d, J = 9.2
Hz). 3) (2RS, 3RS) -3-hydroxy-3- (1-naphthalenyl) -2-((4- (trifluoromethyl) phenyl) methyl) propionic acid (2.64 g, 7.05 mmol) Was added to a solution of diphenylphosphoryl azide (1.67 ml, 7.76 mmol) and triethylamine (1.5 ml, 10.6) in tetrahydrofuran (50 ml).
(Mmol) was added and the mixture was heated under reflux for 1 hour. The reaction solution was diluted with water (300 ml), and ethyl acetate (200 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (4RS, 5SR)
-5- (1-Naphthalenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-2-
ON (2.19 g, 84%) was obtained. mp 202-203 ℃ IRνmax KBr cm -1 : 1761. Anal.Calcd for C 21 H 16 F 3 NO 2 : C, 67.92; H, 4.34; N,
3.77 Found:. C, 67.90; H, 4.15; N, 3.63 1 H-NMR (CDCl 3) δ: 2.15 (1H, dd, J = 13.6, 4.4 Hz),
2.37 (1H, dd, J = 13.6, 10.2 Hz), 4.46-4.64 (1H,
m), 5.38 (1H, brs), 6.53 (1H, d, J = 7.6 Hz), 6.97
(2H, d, J = 8.0 Hz), 7.39 (2H, d, J = 8.0 Hz), 7.39
46-7.80 (4H, m), 7.80-8.00 (3H, m). 4) (4RS, 5SR) -5- (1-naphthalenyl) -4
-((4- (trifluoromethyl) phenyl) methyl)-
1,3-Oxazolidin-2-one (2.10 g, 5.6
To a solution of 6 mmol) in ethanol (30 ml) was added an 8 N aqueous sodium hydroxide solution (3.53 ml, 28.3 mmol), and the mixture was heated under reflux for 1 hour. After concentrating the reaction solution, the reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. HCl / ethyl acetate solution was added to a solution of the residue in ethyl acetate (100 ml), the solvent was concentrated, and the obtained crude crystals were washed with ether, and (1RS, 2SR) -1-hydroxy-1- (1-naphthalenyl). ) -3- (4- (Trifluoromethyl) phenyl) -2-propylamine hydrochloride (1.56 g, 72%)
I got mp 229-230 ° C IRνmax KBr cm -1 : 1761. Anal.Calcd for C 20 H 19 ClF 3 NO ・ 0.1H 2 O: C, 62.62; H,
5.04; N, 3.65 Found:. C, 62.44; H, 5.07; N, 3.88 1 H-NMR (CD 3 OD) δ: 2.80-3.04 (2H, m), 3.96-4.10 (1
H, m), 5.93 (1H, d, J = 2.6 Hz), 7.02 (2H, d, J =
8.0 Hz), 7.37 (2H, d, J = 8.0 Hz), 7.46-7.62 (3H,
m), 7.78-7.96 (3H, m), 8.07 (1H, d, J = 8.0 Hz). 5) (1RS, 2SR) -1-hydroxy-1- (1-naphthalenyl) -3- (4- ( (Trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.39
(1 mmol)) in ethyl acetate (5 ml), 1-naphthoyl chloride (89 ml, 0.59 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml), and ethyl acetate (50 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (172
mg, 88%). mp 217-218 ° C IRνmax KBr cm -1 : 1615, 1591, 1537, 1526. Anal.Calcd for C 31 H 24 F 3 NO 2 : C, 74.54; H, 4.84; N,
2.80 Found:. C, 74.33; H, 4.96; N, 2.76 1 H-NMR (CDCl 3) δ: 2.80-3.14 (3H, m), 4.94-5.12 (1
H, m), 6.04 (1H, brs), 6.32 (1H, d, J = 8.8 Hz), 7.
17 (2H, d, J = 8.2 Hz), 7.20-8.00 (15H, m), 8.45 (1
(H, d, J = 8.4 Hz).
【0318】実施例186 4-フルオロ-N-((1RS,2SR)-2-ヒドロキシ-
2-(1-ナフタレニル)-1-((4-(トリフルオロメ
チル)フェニル)メチル)エチル)-1-ナフタレンカル
ボキサミド 4-フルオロナフタレン-1-カルボン酸(112mg,
0.59ミリモル)のテトラヒドロフラン(5ml)溶
液に、オキサリルクロリド(0.10ml,1.18ミ
リモル)およびN,N-ジメチルホルムアミド(0.0
1ml)を加えて、室温で30分間攪拌し、反応液を減
圧留去した。残留物の酢酸エチル(5ml)溶液に(1
RS,2SR)-1-ヒドロキシ-1-(1-ナフタレニ
ル)-3-(4-(トリフルオロメチル)フェニル)-2-
プロピルアミン塩酸塩(150mg,0.39ミリモ
ル)および飽和重曹水(5ml)を加えて室温で終夜攪
拌した。反応液を水(50ml)で希釈し、酢酸エチル
(50ml×2)で抽出した。抽出液を飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=4:1)で精製し、酢酸エチル−ヘキ
サンから再結晶させて、表題化合物(147mg,72
%)を得た。 mp 195-196℃ IRνmaxKBrcm-1: 1644, 1620, 1514. Anal. Calcd for C31H23F4NO2: C, 71.95; H, 4.48; N,
2.71 Found: C, 71.67; H, 4.63; N, 2.56.1 H-NMR (CDCl3)δ: 2.78 (1H, d, J = 3.0 Hz), 2.80-
3.16 (2H, m), 4.96-5.14(1H, m), 6.05 (1H, s), 6.27
(1H, d, J = 8.8 Hz), 6.98-7.10 (1H, m), 7.14-7.30
(3H, m), 7.40-8.00 (11H, m), 8.09 (1H, d, J = 8.4
Hz), 8.44 (1H,d, J = 8.4 Hz).Example 186 4-Fluoro-N-((1RS, 2SR) -2-hydroxy-
2- (1-naphthalenyl) -1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -1-naphthalenecarboxamide 4-fluoronaphthalene-1-carboxylic acid (112 mg,
Oxalyl chloride (0.10 ml, 1.18 mmol) and N, N-dimethylformamide (0.09 mmol) in a solution of 0.59 mmol) in tetrahydrofuran (5 ml).
1 ml), and the mixture was stirred at room temperature for 30 minutes, and the reaction solution was evaporated under reduced pressure. (1 ml) was added to a solution of the residue in ethyl acetate (5 ml).
RS, 2SR) -1-Hydroxy-1- (1-naphthalenyl) -3- (4- (trifluoromethyl) phenyl) -2-
Propylamine hydrochloride (150 mg, 0.39 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the title compound (147 mg, 72).
%). . mp 195-196 ℃ IRνmax KBr cm -1 : 1644, 1620, 1514. Anal Calcd for C 31 H 23 F 4 NO 2: C, 71.95; H, 4.48; N,
2.71 Found:. C, 71.67; H, 4.63; N, 2.56 1 H-NMR (CDCl 3) δ: 2.78 (1H, d, J = 3.0 Hz), 2.80-
3.16 (2H, m), 4.96-5.14 (1H, m), 6.05 (1H, s), 6.27
(1H, d, J = 8.8 Hz), 6.98-7.10 (1H, m), 7.14-7.30
(3H, m), 7.40-8.00 (11H, m), 8.09 (1H, d, J = 8.4
Hz), 8.44 (1H, d, J = 8.4 Hz).
【0319】実施例187 N-((1RS,2SR)-2-ヒドロキシ-2-(1-ナフ
タレニル)-1-((4-(トリフルオロメチル)フェニ
ル)メチル)エチル)-2-ナフタレンカルボキサミド (1RS,2SR)-1-ヒドロキシ-1-(1-ナフタレ
ニル)-3-(4-(トリフルオロメチル)フェニル)-2
-プロピルアミン塩酸塩(150mg,0.39ミリモ
ル)の酢酸エチル(5ml)溶液に2-ナフトイルクロ
リド(112mg,0.59ミリモル)および飽和重曹
水(5ml)を加えて室温で終夜攪拌した。反応液を水
(50ml)で希釈し、酢酸エチル(50ml×2)で
抽出した。抽出液を飽和食塩水で洗浄し、無水硫酸マグ
ネシウムで乾燥後減圧留去した。残留物を酢酸エチル−
ヘキサンから再結晶させて、表題化合物(160mg,
82%)を得た。 mp 251-252℃ IRνmaxKBrcm-1: 1644, 1620. Anal. Calcd for C31H24F3NO2: C, 74.54; H, 4.84; N,
2.80 Found: C, 74.25; H, 4.56; N, 2.75.1 H-NMR (CDCl3)δ: 2.82-3.30 (3H, m), 4.80-5.00 (1
H, m), 6.08 (1H, s), 6.59 (1H, d, J = 7.4 Hz), 7.1
5 (2H, d, J = 8.2 Hz), 7.40 (2H, d, J = 8.2 Hz),
7.50-7.80 (6H, m), 7.80-7.98 (6H, m), 8.12 (1H,
s), 8.45 (1H, d, J =8.4 Hz).Example 187 N-((1RS, 2SR) -2-hydroxy-2- (1-naphthalenyl) -1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -2-naphthalenecarboxamide ( 1RS, 2SR) -1-hydroxy-1- (1-naphthalenyl) -3- (4- (trifluoromethyl) phenyl) -2
To a solution of -propylamine hydrochloride (150 mg, 0.39 mmol) in ethyl acetate (5 ml) was added 2-naphthoyl chloride (112 mg, 0.59 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was ethyl acetate-
Recrystallization from hexane gave the title compound (160 mg,
82%). mp 251-252 ° C IRνmax KBr cm -1 : 1644, 1620. Anal.Calcd for C 31 H 24 F 3 NO 2 : C, 74.54; H, 4.84; N,
2.80 Found:. C, 74.25; H, 4.56; N, 2.75 1 H-NMR (CDCl 3) δ: 2.82-3.30 (3H, m), 4.80-5.00 (1
H, m), 6.08 (1H, s), 6.59 (1H, d, J = 7.4 Hz), 7.1
5 (2H, d, J = 8.2 Hz), 7.40 (2H, d, J = 8.2 Hz),
7.50-7.80 (6H, m), 7.80-7.98 (6H, m), 8.12 (1H,
s), 8.45 (1H, d, J = 8.4 Hz).
【0320】実施例188 4-フルオロ-N-((1RS,2SR)-2-ヒドロキシ-
2-(1-ナフタレニル)-1-((4-(トリフルオロメ
チル)フェニル)メチル)エチル)ベンズアミド (1RS,2SR)-1-ヒドロキシ-1-(1-ナフタレ
ニル)-3-(4-(トリフルオロメチル)フェニル)-2
-プロピルアミン塩酸塩(150mg,0.39ミリモ
ル)の酢酸エチル(5ml)溶液に4-フルオロベンゾ
イルクロリド(70ml,0.59ミリモル)および飽
和重曹水(5ml)を加えて室温で終夜攪拌した。反応
液を水(50ml)で希釈し、酢酸エチル(50ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて、表題化合物(152
mg,83%)を得た。 mp 194-195℃ IRνmaxKBrcm-1: 1638, 1605, 1539, 1501. Anal. Calcd for C27H21F4NO2: C, 69.37; H, 4.53; N,
3.00 Found: C, 69.32; H, 4.54; N, 2.94.1 H-NMR (CDCl3)δ: 2.80-3.18 (3H, m), 4.76-4.92 (1
H, m), 5.98 (1H, brs),6.40 (1H, d, J = 8.4 Hz), 7.
00-7.14 (4H, m), 7.38 (2H, d, J = 8.4 Hz), 7.46-7.
70 (5H, m), 7.80-7.96 (3H, m), 8.38 (1H, d, J = 8.
4 Hz).Example 188 4-Fluoro-N-((1RS, 2SR) -2-hydroxy-
2- (1-naphthalenyl) -1-((4- (trifluoromethyl) phenyl) methyl) ethyl) benzamide (1RS, 2SR) -1-hydroxy-1- (1-naphthalenyl) -3- (4- ( Trifluoromethyl) phenyl) -2
To a solution of -propylamine hydrochloride (150 mg, 0.39 mmol) in ethyl acetate (5 ml) was added 4-fluorobenzoyl chloride (70 ml, 0.59 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml), and ethyl acetate (50 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (152
mg, 83%). . mp 194-195 ℃ IRνmax KBr cm -1 : 1638, 1605, 1539, 1501. Anal Calcd for C 27 H 21 F 4 NO 2: C, 69.37; H, 4.53; N,
3.00 Found:. C, 69.32; H, 4.54; N, 2.94 1 H-NMR (CDCl 3) δ: 2.80-3.18 (3H, m), 4.76-4.92 (1
H, m), 5.98 (1H, brs), 6.40 (1H, d, J = 8.4 Hz), 7.
00-7.14 (4H, m), 7.38 (2H, d, J = 8.4 Hz), 7.46-7.
70 (5H, m), 7.80-7.96 (3H, m), 8.38 (1H, d, J = 8.
4 Hz).
【0321】実施例189 N-((1RS,2SR)-2-ヒドロキシ-2-(1-ナフ
タレニル)-1-((4-(トリフルオロメチル)フェニ
ル)メチル)エチル)-4-(トリフルオロメチル)ベン
ズアミド (1RS,2SR)-1-ヒドロキシ-1-(1-ナフタレ
ニル)-3-(4-(トリフルオロメチル)フェニル)-2
-プロピルアミン塩酸塩(150mg,0.39ミリモ
ル)の酢酸エチル(5ml)溶液に4-トリフルオロメ
チルベンゾイルクロリド(87.5ml,0.59ミリ
モル)および飽和重曹水(5ml)を加えて室温で終夜
攪拌した。反応液を水(50ml)で希釈し、酢酸エチ
ル(50ml×2)で抽出した。抽出液を飽和食塩水で
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去した。
残留物を酢酸エチル−ヘキサンから再結晶させて、表題
化合物(178mg,88%)を得た。 mp 232-233℃ IRνmaxKBrcm-1: 1644, 1534. Anal. Calcd for C28H21F6NO2: C, 64.99; H, 4.09; N,
2.71 Found: C, 64.77; H, 3.93; N, 2.55.1 H-NMR (CDCl3)δ: 2.68-2.74 (1H, m), 2.80-3.20 (2
H, m), 4.82-5.00 (1H, m), 6.00 (1H, s), 6.39 (1H,
d, J = 8.4 Hz), 7.12 (2H, d, J = 8.4 Hz), 7.40 (2
H, d, J = 8.4 Hz), 7.50-7.78 (7H, m), 7.82-7.98 (3
H, m), 8.39 (1H, d, J = 8.0 Hz).Example 189 N-((1RS, 2SR) -2-hydroxy-2- (1-naphthalenyl) -1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4- (trifluoro Methyl) benzamide (1RS, 2SR) -1-hydroxy-1- (1-naphthalenyl) -3- (4- (trifluoromethyl) phenyl) -2
To a solution of -propylamine hydrochloride (150 mg, 0.39 mmol) in ethyl acetate (5 ml) was added 4-trifluoromethylbenzoyl chloride (87.5 ml, 0.59 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml), and the mixture was added at room temperature. Stirred overnight. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was recrystallized from ethyl acetate-hexane to give the title compound (178 mg, 88%). mp 232-233 ℃ IRνmax KBr cm -1 : 1644, 1534. Anal.Calcd for C 28 H 21 F 6 NO 2 : C, 64.99; H, 4.09; N,
2.71 Found:. C, 64.77; H, 3.93; N, 2.55 1 H-NMR (CDCl 3) δ: 2.68-2.74 (1H, m), 2.80-3.20 (2
H, m), 4.82-5.00 (1H, m), 6.00 (1H, s), 6.39 (1H,
d, J = 8.4 Hz), 7.12 (2H, d, J = 8.4 Hz), 7.40 (2
H, d, J = 8.4 Hz), 7.50-7.78 (7H, m), 7.82-7.98 (3
H, m), 8.39 (1H, d, J = 8.0 Hz).
【0322】実施例190 N-((1RS,2SR)-2-ヒドロキシ-2-(1-ナフ
タレニル)-1-((4-(トリフルオロメチル)フェニ
ル)メチル)エチル)シクロヘキサンカルボキサミド (1RS,2SR)-1-ヒドロキシ-1-(1-ナフタレ
ニル)-3-(4-(トリフルオロメチル)フェニル)-2
-プロピルアミン塩酸塩(150mg,0.39ミリモ
ル)の酢酸エチル(5ml)溶液にシクロヘキサンカル
ボニルクロリド(87.8ml,0.59ミリモル)お
よび飽和重曹水(5ml)を加えて室温で終夜攪拌し
た。反応液を水(50ml)で希釈し、酢酸エチル(5
0ml×2)で抽出した。抽出液を飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=4:1)で精製し、酢酸エチル−ヘキサン
から再結晶させて表題化合物(141mg,79%)を
得た。 mp 156-157℃ IRνmaxKBrcm-1: 1645, 1508. Anal. Calcd for C27H28F3NO2: C, 71.19; H, 6.20; N,
3.07 Found: C, 71.14; H, 6.43; N, 3.06.1 H-NMR (CDCl3)δ: 1.00-1.44 (5H, m), 1.50-1.80 (5
H, m), 1.86-2.10 (1H, m), 2.70-3.10 (2H, m), 3.15
(1H, d, J = 3.0 Hz), 4.52-4.70 (1H, m), 5.74(1H,
d, J = 8.0 Hz), 5.84 (1H, s), 7.05 (2H, d, J = 8.2
Hz), 7.39 (2H, d, J = 8.2 Hz), 7.44-7.70 (3H, m),
7.78-7.98 (3H, m), 8.29 (1H, d, J = 8.4 Hz).Example 190 N-((1RS, 2SR) -2-hydroxy-2- (1-naphthalenyl) -1-((4- (trifluoromethyl) phenyl) methyl) ethyl) cyclohexanecarboxamide (1RS, 2SR ) -1-Hydroxy-1- (1-naphthalenyl) -3- (4- (trifluoromethyl) phenyl) -2
To a solution of -propylamine hydrochloride (150 mg, 0.39 mmol) in ethyl acetate (5 ml) were added cyclohexanecarbonyl chloride (87.8 ml, 0.59 mmol) and saturated aqueous sodium hydrogen carbonate (5 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (50 ml), and ethyl acetate (5 ml) was added.
0 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
The residue was purified with ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the title compound (141 mg, 79%). . mp 156-157 ℃ IRνmax KBr cm -1 : 1645, 1508. Anal Calcd for C 27 H 28 F 3 NO 2: C, 71.19; H, 6.20; N,
3.07 Found:. C, 71.14; H, 6.43; N, 3.06 1 H-NMR (CDCl 3) δ: 1.00-1.44 (5H, m), 1.50-1.80 (5
H, m), 1.86-2.10 (1H, m), 2.70-3.10 (2H, m), 3.15
(1H, d, J = 3.0 Hz), 4.52-4.70 (1H, m), 5.74 (1H,
d, J = 8.0 Hz), 5.84 (1H, s), 7.05 (2H, d, J = 8.2
Hz), 7.39 (2H, d, J = 8.2 Hz), 7.44-7.70 (3H, m),
7.78-7.98 (3H, m), 8.29 (1H, d, J = 8.4 Hz).
【0323】実施例191 N-((1RS,2SR)-2-ヒドロキシ-2-(1-ナフ
タレニル)-1-((4-(トリフルオロメチル)フェニ
ル)メチル)エチル)-4-(2-チエニル)酪酸アミド 4-(2-チエニル)酪酸(86ml,0.59ミリモ
ル)のテトラヒドロフラン(5ml)溶液に、オキサリ
ルクロリド(0.10ml,1.18ミリモル)および
N,N-ジメチルホルムアミド(0.01ml)を加え
て、室温で30分間攪拌し、反応液を減圧留去した。残
留物の酢酸エチル(5ml)溶液に(1RS,2SR)
-1-ヒドロキシ-1-(1-ナフタレニル)-3-(4-(ト
リフルオロメチル)フェニル)-2-プロピルアミン塩酸
塩(150mg,0.39ミリモル)および飽和重曹水
(5ml)を加えて室温で終夜攪拌した。反応液を水
(50ml)で希釈し、酢酸エチル(50ml×2)で
抽出した。抽出液を飽和食塩水で洗浄し、無水硫酸マグ
ネシウムで乾燥後減圧留去した。残留物を酢酸エチル−
ヘキサンから再結晶させて、表題化合物(110mg,
56%)を得た。 mp 139-140℃ IRνmaxKBrcm-1: 1651, 1644, 1514. Anal. Calcd for C28H26F3NO2S・0.1H2O: C, 67.34; H,
5.29; N, 2.80 Found: C, 67.18; H, 5.44; N, 2.69.1 H-NMR (CDCl3)δ: 1.80-2.00 (2H, m), 2.02-2.30 (2
H, m), 2.60-3.04 (5H, m), 4.58-4.76 (1H, m), 5.75
(1H, d, J = 8.4 Hz), 5.85 (1H, s), 6.64-6.70(1H,
m), 6.86-6.96 (1H, m), 7.00-7.18 (3H, m), 7.36-7.7
0 (5H, m), 7.76-7.96 (3H, m), 8.30 (1H, d, J = 8.4
Hz).Example 191 N-((1RS, 2SR) -2-hydroxy-2- (1-naphthalenyl) -1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4- (2- Thienyl) butyric acid amide In a solution of 4- (2-thienyl) butyric acid (86 ml, 0.59 mmol) in tetrahydrofuran (5 ml), oxalyl chloride (0.10 ml, 1.18 mmol) and N, N-dimethylformamide (0. 01 ml), and the mixture was stirred at room temperature for 30 minutes, and the reaction solution was distilled off under reduced pressure. To a solution of the residue in ethyl acetate (5 ml) (1RS, 2SR)
-1-Hydroxy-1- (1-naphthalenyl) -3- (4- (trifluoromethyl) phenyl) -2-propylamine hydrochloride (150 mg, 0.39 mmol) and saturated aqueous sodium bicarbonate (5 ml) were added. Stirred overnight at room temperature. The reaction solution was diluted with water (50 ml) and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was ethyl acetate-
Recrystallization from hexane gave the title compound (110 mg,
56%). mp 139-140 ℃ IRνmax KBr cm -1 : 1651, 1644, 1514. Anal.Calcd for C 28 H 26 F 3 NO 2 S ・ 0.1H 2 O: C, 67.34; H,
5.29; N, 2.80 Found:. C, 67.18; H, 5.44; N, 2.69 1 H-NMR (CDCl 3) δ: 1.80-2.00 (2H, m), 2.02-2.30 (2
H, m), 2.60-3.04 (5H, m), 4.58-4.76 (1H, m), 5.75
(1H, d, J = 8.4 Hz), 5.85 (1H, s), 6.64-6.70 (1H,
m), 6.86-6.96 (1H, m), 7.00-7.18 (3H, m), 7.36-7.7
0 (5H, m), 7.76-7.96 (3H, m), 8.30 (1H, d, J = 8.4
Hz).
【0324】実施例192 4-フルオロ-N-((1RS,2SR)-2-ヒドロキシ-
2-(4-メトキシフェニル)-1-((4-(トリフルオ
ロメチル)フェニル)メチル)エチル)-1-ナフタレン
カルボキサミド 1) 4-メトキシ安息香酸(26.2g,172ミリ
モル)のテトラヒドロフラン(150ml)溶液に1,
1'-カルボニルビス-1H-イミダゾール(30.7g,
189ミリモル)を加え、室温で5時間攪拌した。反応
液にマロン酸モノエチルマグネシウム塩(27.1g,
94.7ミリモル)を加え、60℃で2時間攪拌した。
反応液に酢酸エチル(50ml)および水(50ml)
を加え、更に水層のpHが酸性になるまで濃塩酸を加え
た。反応液を酢酸エチル(200ml×2)で抽出し、
抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウムで
乾燥後減圧留去した。残留物をシリカゲルカラムクロマ
トグラフィー(ヘキサン:酢酸エチル=4:1)で精製
し、3-(4-メトキシフェニル)-3-オキソプロピオン
酸エチル(37.6g,94%w/w,92%)を無色
油状物として得た。 IRνmaxKBrcm-1: 1738, 1682, 1601, 1576. Anal. Calcd for C12H14O4: C, 64.85; H, 6.35 Found: C, 64.93; H, 6.26.1 H-NMR (CDCl3)δ: 1.26 (3H, t, J = 7.0 Hz), 3.85
(3/10H, s), 3.88 (27/10H, s), 3.94 (18/10H, s), 4.
21 (2H, q, J = 7.0 Hz), 5.58 (1/10H, s), 6.90-7.00
(2H, m), 7.70-7.78 (2/10H, m), 7.88-7.98 (18/10H,
m). 2) 3-(4-メトキシフェニル)-3-オキソプロピオ
ン酸エチル(20g,84.6ミリモル)のアセトニト
リル(200ml)溶液に4-トリフルオロメチルベン
ジルブロミド(20.2g,84.6ミリモル)および
炭酸カリウム(23.4g,169ミリモル)を加え、
60℃にて2時間攪拌した。反応液を減圧留去後、水
(500ml)で希釈し、酢酸エチル(500ml×
2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(トルエン:
ヘキサン=1:1−トルエン)で精製し3-(4-メトキ
シフェニル)-3-オキソ-2-((4-(トリフルオロメ
チル)フェニル)メチル)プロピオン酸エチル(19.
2g,56%)を無色油状物として得た。 IRνmaxKBrcm-1: 1732, 1682, 1601, 1576. Anal. Calcd for C20H19F3O4: C, 63.15; H, 5.03 Found: C, 63.14; H, 4.83.1 H-NMR (CDCl3)δ: 1.12 (3H, t, J = 7.4 Hz), 3.37
(2H, d, J = 7.2 Hz), 3.85 (3H, s), 4.10 (2H, q, J
= 7.4 Hz), 4.58 (1H, t, J = 7.2 Hz), 6.92 (2H, d,
J = 8.8 Hz), 7.35 (2H, d, J = 8.0 Hz), 7.51 (2H,
d, J = 8.0 Hz), 7.95 (2H, d, J = 8.8 Hz). 3) 塩化亜鉛(12.3g,90.4ミリモル)のジ
エチルエーテル(150ml)溶液に水素化ホウ素ナト
リウム(6.85g,181ミリモル)を加えて室温で
30分攪拌した。不溶物をろ去し、ろ液に3-(4-メト
キシフェニル)-3-オキソ-2-((4-(トリフルオロ
メチル)フェニル)メチル)プロピオン酸エチル(1
7.2g,45.2ミリモル)のジエチルエーテル(5
0ml)溶液を加えて室温で30分攪拌した。氷冷下、
反応液に1規定塩酸を加えてクエンチし、更に水(20
0ml)を加え、酢酸エチル(300ml×2)で抽出
した。抽出液を水および飽和食塩水で洗浄し、無水硫酸
マグネシウムで乾燥後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
4:1−2:1)で精製し、(2RS,3RS)-3-ヒ
ドロキシ-3-(4-メトキシフェニル)-2-((4-(ト
リフルオロメチル)フェニル)メチル)プロピオン酸エ
チル(15.1g,87%)を無色油状物として得た。 IRνmaxKBrcm-1: 1728, 1615, 1586, 1514. Anal. Calcd for C20H21F3O4: C, 62.82; H, 5.54 Found: C, 62.71; H, 5.42.1 H-NMR (CDCl3)δ: 0.91 (3H, t, J = 7.0 Hz), 2.72
(1H, d, J = 2.6 Hz), 2.90-3.10 (3H, m), 3.81 (3H,
s), 3.87 (2H, q, J = 7.0 Hz), 4.96-5.04 (1H,m), 6.
89 (2H, d, J = 8.8 Hz), 7.22 (2H, d, J = 8.0 Hz),
7.31 (2H, d, J =8.8 Hz), 7.48 (2H, d, J = 8.0 Hz). 4) (2RS,3RS)-3-ヒドロキシ-3-(4-メ
トキシフェニル)-2-((4-(トリフルオロメチル)
フェニル)メチル)プロピオン酸エチル(14.7g,
38.4ミリモル)のメタノール(60ml)溶液に、
2規定水酸化ナトリウム水溶液(38.5ml,77ミ
リモル)を加えて室温で終夜攪拌した。反応液を1規定
塩酸で酸性とした後、酢酸エチル(200ml×2)で
抽出した。抽出液を水および飽和食塩水で洗浄し、無水
硫酸マグネシウムで乾燥後減圧留去した。残留物を酢酸
エチル−ヘキサンから再結晶させて(2RS,3RS)
-3-ヒドロキシ-3-(4-メトキシフェニル)-2-
((4-(トリフルオロメチル)フェニル)メチル)プ
ロピオン酸(11.7g,86%)を得た。 mp 113-114℃ IRνmaxKBrcm-1: 1715, 1614, 1514. Anal. Calcd for C18H17F3O4: C, 61.02; H, 4.84 Found: C, 61.03; H, 4.85.1 H-NMR (CDCl3)δ: 3.03 (3H, s), 3.80 (3H, s), 4.98
-5.06 (1H, m), 6.89 (2H, d, J = 8.8 Hz), 7.19 (2H,
d, J = 8.0 Hz), 7.29 (2H, d, J = 8.8 Hz), 7.47 (2
H, d, J = 8.0 Hz). 5) (2RS,3RS)-3-ヒドロキシ-3-(4-メ
トキシフェニル)-2-((4-(トリフルオロメチル)
フェニル)メチル)プロピオン酸(10.0g,28.
2ミリモル)のテトラヒドロフラン(250ml)溶液
に、ジフェニルホスホリルアジド(6.7ml,31.
1ミリモル)とトリエチルアミン(5.9ml,42.
3ミリモル)を加え、4時間加熱還流した。反応液を放
冷後、水(200ml)を加えて酢酸エチル(200m
l×2)で抽出した。抽出液を1規定塩酸、飽和重曹
水、飽和食塩水で順次洗浄し、無水硫酸マグネシウムで
乾燥後減圧留去した。残留物を酢酸エチル−ヘキサンか
ら再結晶させて(4RS,5SR)-5-(4-メトキシ
フェニル)-4-((4-(トリフルオロメチル)フェニ
ル)メチル)-1,3-オキサゾリジン-2-オン(9.8
9g,99%)を得た。 mp 164-165℃ IRνmaxKBrcm-1: 1755, 1615, 1516. Anal. Calcd for C18H16F3NO3: C, 61.54; H, 4.59; N,
3.99 Found: C, 61.25; H, 4.50; N, 3.82.1 H-NMR (CDCl3)δ: 2.37 (2H, d, J = 7.4 Hz), 3.83
(3H, s), 4.23 (1H, q, J= 7.8 Hz), 5.32 (1H, brs),
5.75 (1H, d, J = 7.8 Hz), 6.88-7.00 (2H, m),7.11
(2H, d, J = 8.0 Hz), 7.20-7.32 (2H, m), 7.52 (2H,
d, J = 8.0 Hz). 6) (4RS,5SR)-5-(4-メトキシフェニ
ル)-4-((4-(トリフルオロメチル)フェニル)メ
チル)-1,3-オキサゾリジン-2-オン(7.0g,1
9.9ミリモル)のエタノール(100ml)溶液に8
規定水酸化ナトリウム水溶液(12.45ml,99.
6ミリモル)を加え、4時間加熱還流した。反応液を濃
縮後、水(300ml)で希釈し、酢酸エチル(300
ml×2)で抽出した。抽出液を飽和食塩水で洗浄し、
無水硫酸マグネシウムで乾燥後減圧留去した。残留物を
酢酸エチル−ヘキサンから再結晶させて、(1RS,2
SR)-2-アミノ-1-(4-メトキシフェニル)-3-
(4-(トリフルオロメチル)フェニル)-1-プロパノ
ール(5.87g,91%)を得た。 mp 116-117℃ IRνmaxKBrcm-1: 1614, 1584, 1514. Anal. Calcd for C17H18F3NO2: C, 62.76; H, 5.58; N,
4.31 Found: C, 62.74; H, 5.58; N, 4.23.1 H-NMR (CDCl3)δ: 1.40-1.80 (2H, br), 2.45 (1H, d
d, J = 13.6, 10.0 Hz),2.95 (1H, dd, J = 13.6, 3.2
Hz), 3.18-3.34 (1H, m), 3.82 (3H, s), 4.58 (1H, d,
J = 5.0 Hz), 6.92 (2H, d, J = 8.8 Hz), 7.22-7.38
(4H, m), 7.54 (2H, d, J = 8.4 Hz). 7) (1RS,2SR)-2-アミノ-1-(4-メトキ
シフェニル)-3-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(450mg,1.38ミリモ
ル)のアセトニトリル(20ml)溶液に4-フルオロ
ナフタレンカルボン酸(263mg,1.38ミリモ
ル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(397mg,2.08ミ
リモル)および1-ヒドロキシ-1H-ベンゾトリアゾー
ル(212mg,1.38ミリモル)を加えて室温で終
夜攪拌した。反応液を水(100ml)で希釈し、酢酸
エチル(100ml×2)で抽出した。抽出液を1規定
塩酸、1規定水酸化ナトリウム水溶液、飽和食塩水で順
次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて、
表題化合物(558mg,81%)を得た。 mp 184-185℃ IRνmaxKBrcm-1: 1643, 1626, 1601. Anal. Calcd for C28H23F4NO3: C, 67.60; H, 4.66; N,
2.82 Found: C, 67.37; H, 4.49; N, 2.87.1 H-NMR (CDCl3)δ: 2.83 (1H, dd, J = 14.4, 10.6 H
z), 3.07 (1H, dd, J = 14.4, 4.0 Hz), 3.81 (3H, s),
4.70-4.90 (1H, m), 4.99 (1H, d, J = 3.6 Hz),6.05
(1H, d, J = 8.8 Hz), 6.88-7.00 (3H, m), 7.04-7.16
(1H, m), 7.24-7.44 (5H, m), 7.44-7.60 (4H, m), 8.0
5 (1H, d, J = 8.0 Hz).Example 192 4-Fluoro-N-((1RS, 2SR) -2-hydroxy-
2- (4-Methoxyphenyl) -1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -1-naphthalenecarboxamide 1) 4-methoxybenzoic acid (26.2 g, 172 mmol) in tetrahydrofuran (150 ml) ) 1
1′-carbonylbis-1H-imidazole (30.7 g,
189 mmol) and stirred at room temperature for 5 hours. Monoethyl magnesium malonate (27.1 g,
94.7 mmol) and stirred at 60 ° C. for 2 hours.
Ethyl acetate (50 ml) and water (50 ml) were added to the reaction solution.
And concentrated hydrochloric acid was further added until the pH of the aqueous layer became acidic. The reaction solution was extracted with ethyl acetate (200 ml × 2),
The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1), and ethyl 3- (4-methoxyphenyl) -3-oxopropionate (37.6 g, 94% w / w, 92%). Was obtained as a colorless oil. . IRνmax KBr cm -1: 1738, 1682, 1601, 1576. Anal Calcd for C 12 H 14 O 4: C, 64.85; H, 6.35 Found:. C, 64.93; H, 6.26 1 H-NMR (CDCl 3) δ: 1.26 (3H, t, J = 7.0 Hz), 3.85
(3 / 10H, s), 3.88 (27 / 10H, s), 3.94 (18 / 10H, s), 4.
21 (2H, q, J = 7.0 Hz), 5.58 (1 / 10H, s), 6.90-7.00
(2H, m), 7.70-7.78 (2 / 10H, m), 7.88-7.98 (18 / 10H,
m). 2) 4-Trifluoromethylbenzyl bromide (20.2 g, 84.6) in a solution of ethyl 3- (4-methoxyphenyl) -3-oxopropionate (20 g, 84.6 mmol) in acetonitrile (200 ml). Mmol) and potassium carbonate (23.4 g, 169 mmol)
The mixture was stirred at 60 ° C. for 2 hours. After evaporating the reaction solution under reduced pressure, the reaction solution was diluted with water (500 ml), and ethyl acetate (500 ml ×
Extracted in 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (toluene:
Purification with hexane = 1: 1-toluene) and ethyl 3- (4-methoxyphenyl) -3-oxo-2-((4- (trifluoromethyl) phenyl) methyl) propionate (19.
2g, 56%) as a colorless oil. . IRνmax KBr cm -1: 1732, 1682, 1601, 1576. Anal Calcd for C 20 H 19 F 3 O 4: C, 63.15; H, 5.03 Found:. C, 63.14; H, 4.83 1 H-NMR (CDCl 3 ) δ: 1.12 (3H, t, J = 7.4 Hz), 3.37
(2H, d, J = 7.2 Hz), 3.85 (3H, s), 4.10 (2H, q, J
= 7.4 Hz), 4.58 (1H, t, J = 7.2 Hz), 6.92 (2H, d,
J = 8.8 Hz), 7.35 (2H, d, J = 8.0 Hz), 7.51 (2H,
d, J = 8.0 Hz), 7.95 (2H, d, J = 8.8 Hz). 3) Sodium borohydride (6.85 g) was added to a solution of zinc chloride (12.3 g, 90.4 mmol) in diethyl ether (150 ml). , 181 mmol) and stirred at room temperature for 30 minutes. The insoluble material was removed by filtration, and the filtrate was treated with ethyl 3- (4-methoxyphenyl) -3-oxo-2-((4- (trifluoromethyl) phenyl) methyl) propionate (1
7.2 g, 45.2 mmol) of diethyl ether (5
0 ml) solution and stirred at room temperature for 30 minutes. below freezing,
The reaction solution is quenched by adding 1N hydrochloric acid, and further added with water (20 mL).
0 ml) and extracted with ethyl acetate (300 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
4: 1-2: 1) and purified with ethyl (2RS, 3RS) -3-hydroxy-3- (4-methoxyphenyl) -2-((4- (trifluoromethyl) phenyl) methyl) propionate ( 15.1 g, 87%) as a colorless oil. IRνmax KBr cm -1 : 1728, 1615, 1586, 1514.Anal.Calcd for C 20 H 21 F 3 O 4 : C, 62.82; H, 5.54 Found: C, 62.71; H, 5.42. 1 H-NMR (CDCl 3 ) δ: 0.91 (3H, t, J = 7.0 Hz), 2.72
(1H, d, J = 2.6 Hz), 2.90-3.10 (3H, m), 3.81 (3H,
s), 3.87 (2H, q, J = 7.0 Hz), 4.96-5.04 (1H, m), 6.
89 (2H, d, J = 8.8 Hz), 7.22 (2H, d, J = 8.0 Hz),
7.31 (2H, d, J = 8.8 Hz), 7.48 (2H, d, J = 8.0 Hz). 4) (2RS, 3RS) -3-hydroxy-3- (4-methoxyphenyl) -2-((4 -(Trifluoromethyl)
Phenyl) methyl) ethyl propionate (14.7 g,
38.4 mmol) in methanol (60 ml)
A 2N aqueous sodium hydroxide solution (38.5 ml, 77 mmol) was added, and the mixture was stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane (2RS, 3RS)
-3-Hydroxy-3- (4-methoxyphenyl) -2-
((4- (Trifluoromethyl) phenyl) methyl) propionic acid (11.7 g, 86%) was obtained. mp 113-114 ° C IRνmax KBr cm -1 : 1715, 1614, 1514.Anal.Calcd for C 18 H 17 F 3 O 4 : C, 61.02; H, 4.84 Found: C, 61.03; H, 4.85. 1 H- NMR (CDCl 3 ) δ: 3.03 (3H, s), 3.80 (3H, s), 4.98
-5.06 (1H, m), 6.89 (2H, d, J = 8.8 Hz), 7.19 (2H,
d, J = 8.0 Hz), 7.29 (2H, d, J = 8.8 Hz), 7.47 (2
H, d, J = 8.0 Hz). 5) (2RS, 3RS) -3-hydroxy-3- (4-methoxyphenyl) -2-((4- (trifluoromethyl)
Phenyl) methyl) propionic acid (10.0 g, 28.
Diphenylphosphoryl azide (6.7 ml, 31.2 mmol) in a solution of tetrahydrofuran (250 ml).
1 mmol) and triethylamine (5.9 ml, 42.
(3 mmol) and heated to reflux for 4 hours. After allowing the reaction solution to cool, water (200 ml) was added, and ethyl acetate (200 ml) was added.
1 × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (4RS, 5SR) -5- (4-methoxyphenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-2. -ON (9.8
9g, 99%). mp 164-165 ℃ IRνmax KBr cm -1 : 1755, 1615, 1516. Anal.Calcd for C 18 H 16 F 3 NO 3 : C, 61.54; H, 4.59; N,
3.99 Found: C, 61.25; H, 4.50; N, 3.82. 1 H-NMR (CDCl 3 ) δ: 2.37 (2H, d, J = 7.4 Hz), 3.83
(3H, s), 4.23 (1H, q, J = 7.8 Hz), 5.32 (1H, brs),
5.75 (1H, d, J = 7.8 Hz), 6.88-7.00 (2H, m), 7.11
(2H, d, J = 8.0 Hz), 7.20-7.32 (2H, m), 7.52 (2H,
d, J = 8.0 Hz). 6) (4RS, 5SR) -5- (4-methoxyphenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2-one (7.0 g, 1
9.9 mmol) in ethanol (100 ml).
Normal aqueous sodium hydroxide solution (12.45 ml, 99.
6 mmol) and heated under reflux for 4 hours. After concentrating the reaction solution, the reaction solution was diluted with water (300 ml) and ethyl acetate (300 ml).
ml × 2). Wash the extract with saturated saline,
After drying over anhydrous magnesium sulfate, the solution was distilled off under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2
SR) -2-Amino-1- (4-methoxyphenyl) -3-
(4- (trifluoromethyl) phenyl) -1-propanol (5.87 g, 91%) was obtained. mp 116-117 ℃ IRνmax KBr cm -1 : 1614, 1584, 1514. Anal.Calcd for C 17 H 18 F 3 NO 2 : C, 62.76; H, 5.58; N,
4.31 Found:. C, 62.74; H, 5.58; N, 4.23 1 H-NMR (CDCl 3) δ: 1.40-1.80 (2H, br), 2.45 (1H, d
d, J = 13.6, 10.0 Hz), 2.95 (1H, dd, J = 13.6, 3.2
Hz), 3.18-3.34 (1H, m), 3.82 (3H, s), 4.58 (1H, d,
J = 5.0 Hz), 6.92 (2H, d, J = 8.8 Hz), 7.22-7.38
(4H, m), 7.54 (2H, d, J = 8.4 Hz). 7) (1RS, 2SR) -2-amino-1- (4-methoxyphenyl) -3- (4- (trifluoromethyl) phenyl ) To a solution of 1-propanol (450 mg, 1.38 mmol) in acetonitrile (20 ml) was added 4-fluoronaphthalenecarboxylic acid (263 mg, 1.38 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide. Hydrochloride (397 mg, 2.08 mmol) and 1-hydroxy-1H-benzotriazole (212 mg, 1.38 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane,
The title compound (558 mg, 81%) was obtained. mp 184-185 ℃ IRνmax KBr cm -1 : 1643, 1626, 1601.Anal.Calcd for C 28 H 23 F 4 NO 3 : C, 67.60; H, 4.66; N,
2.82 Found:. C, 67.37; H, 4.49; N, 2.87 1 H-NMR (CDCl 3) δ: 2.83 (1H, dd, J = 14.4, 10.6 H
z), 3.07 (1H, dd, J = 14.4, 4.0 Hz), 3.81 (3H, s),
4.70-4.90 (1H, m), 4.99 (1H, d, J = 3.6 Hz), 6.05
(1H, d, J = 8.8 Hz), 6.88-7.00 (3H, m), 7.04-7.16
(1H, m), 7.24-7.44 (5H, m), 7.44-7.60 (4H, m), 8.0
5 (1H, d, J = 8.0 Hz).
【0325】実施例193 N-((1RS,2SR)-2-ヒドロキシ-2-(4-メト
キシフェニル)-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-3-フェニルプロパンアミド (1RS,2SR)-2-アミノ-1-(4-メトキシフェ
ニル)-3-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.38ミリモル)の酢
酸エチル(20ml)溶液に3-フェニルプロピオニル
クロリド(308ml,2.07ミリモル)および飽和
重曹水(20ml)を加えて室温で終夜攪拌した。反応
液を水(100ml)で希釈し、酢酸エチル(100m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物を酢
酸エチル−ヘキサンから再結晶させて表題化合物(57
4mg,91%)を得た。 mp 116-117℃ IRνmaxKBrcm-1: 1645, 1615. Anal. Calcd for C26H26F3NO3: C, 68.26; H, 5.73; N,
3.06 Found: C, 68.10; H, 5.99; N, 2.99.1 H-NMR (CDCl3)δ: 2.37 (2H, t, J = 7.2 Hz), 2.60-
2.90 (4H, m), 3.04-3.20(1H, m), 3.81 (3H, s), 4.32
-4.50 (1H, m), 4.72-4.84 (1H, m), 5.35 (1H,d, J =
8.4 Hz), 6.88 (2H, d, J = 8.8 Hz), 7.08-7.40 (9H,
m), 7.46 (2H, d, J = 8.0 Hz).Example 193 N-((1RS, 2SR) -2-hydroxy-2- (4-methoxyphenyl) -1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -3-phenylpropane Amido (1RS, 2SR) -2-amino-1- (4-methoxyphenyl) -3- (4- (trifluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.38 mmol) in ethyl acetate (20 ml) were added 3-phenylpropionyl chloride (308 ml, 2.07 mmol) and saturated aqueous sodium hydrogen carbonate (20 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (57
4 mg, 91%). mp 116-117 ° C IRνmax KBr cm -1 : 1645, 1615. Anal.Calcd for C 26 H 26 F 3 NO 3 : C, 68.26; H, 5.73; N,
3.06 Found:. C, 68.10; H, 5.99; N, 2.99 1 H-NMR (CDCl 3) δ: 2.37 (2H, t, J = 7.2 Hz), 2.60-
2.90 (4H, m), 3.04-3.20 (1H, m), 3.81 (3H, s), 4.32
-4.50 (1H, m), 4.72-4.84 (1H, m), 5.35 (1H, d, J =
8.4 Hz), 6.88 (2H, d, J = 8.8 Hz), 7.08-7.40 (9H,
m), 7.46 (2H, d, J = 8.0 Hz).
【0326】実施例194 N-[(1RS,2SR)-2-(4-クロロフェニル)-
2-ヒドロキシ-1-[4-(トリフルオロメチル)ベンジ
ル]エチル]-4-フルオロナフタレン-1-カルボキサミ
ド 1) (4-クロロベンゾイル)酢酸エチル 4-クロロ安息香酸15.77g(100.7ミリモ
ル)のテトラヒドロフラン100ml溶液に1,1’-
カルボニルジイミダゾール18.0g(111ミリモ
ル)を室温で加え、そのまま6時間撹拌した。この混合
物にマロン酸モノエチルエステルモノマグネシウム塩1
5.9g(55.4ミリモル)を室温で加え、60℃で
3時間撹拌した。反応液を酢酸エチルと水で希釈し、濃
塩酸で反応液を酸性にした後、酢酸エチル層を分離し、
水層を酢酸エチルで抽出した。集めた有機層を無水硫酸
ナトリウムで乾燥、溶媒を減圧留去した。得られた粗生
成物をシリカゲルカラムクロマトグラフィーにて精製し
て(ヘキサン/酢酸エチル=6/1)、目的物を得た。
赤色液体 収量19.64g 収率86%1 H-NMR (CDCl3, 200MHz) δ 1.26 (2.4H, t, J = 7.4 H
z), 1.34 (0.6H, t, J =7.0 Hz), 3.97 (1.6H, s), 4.2
2 (1.6H, q, J = 7.1 Hz), 4.27 (0.4H, q, J =7.1 H
z), 5.64 (0.2H, s), 7.40 (0.4H, d, J = 8.8 Hz), 7.
46 (1.6H, d, J =8.6 Hz), 7.72 (0.4H, d, J = 8.6 H
z), 7.90 (1.6H, d, J = 8.0 Hz); IR (neat) 1742, 16
90, 1622, 1590, 1325, 1265, 1200, 1092, 1013 cm-1 2) 3-(4-クロロフェニル)-3-オキソ-2-[4-
(トリフルオロメチル)ベンジル]プロピオン酸エチル (4-クロロベンゾイル)酢酸エチル14.28g(6
3.00ミリモル)の1,2-ジメトキシエタン100
ml溶液に氷冷下60%水素化ナトリウムの流動パラフ
ィン懸濁物2.52g(63.0ミリモル)を加え、そ
のまま0.5時間撹拌した。4-(トリフルオロメチ
ル)ベンジルブロミド15.1g(63.0ミリモル)
の1,2-ジメトキシエタン20ml溶液を室温で加
え、室温で6時間撹拌した。反応液を水に注ぎ、酢酸エ
チルで2回抽出した。集めた有機層を無水硫酸マグネシ
ウムで乾燥、溶媒を減圧留去した。得られた残留物をシ
リカゲルカラムクロマトグラフィーにて精製し(ヘキサ
ン/酢酸エチル=15/1−9/1)、ヘキサンより結
晶化して、目的物を得た。白色結晶 収量18.87g
収率78% mp 69-70℃; 1H-NMR (CDCl3, 200MHz) δ 1.12 (3H, t,
J = 7.1 Hz), 3.38 (2H, d, J = 7.4 Hz), 4.10 (2H,
q, J = 7.3 Hz), 4.56 (1H, t, J = 7.5 Hz), 7.34 (2
H, d, J = 8.0 Hz), 7.43 (2H, d, J = 8.8 Hz), 7.52
(2H, d, J = 8.0 Hz), 7.90 (2H, d, J = 8.4 Hz); IR
(KBr) 1717, 1690, 1590, 1329, 1283, 1229, 1179, 11
57, 1111, 1092, 1071, 845, 828 cm-1; Anal. Calcd f
or C19H16ClF3O3: C, 59.31; H, 4.19. Found: C, 59.2
9; H, 4.05. 3) (2RS,3RS)-3-(4-クロロフェニル)-
3-ヒドロキシ-2-[4-(トリフルオロメチル)ベンジ
ル]プロピオン酸エチル 塩化亜鉛7.18g(52.7ミリモル)をジエチルエ
ーテル100ml中で撹拌しながら水素化ホウ素ナトリ
ウム3.98g(105ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、3-(4-クロロ
フェニル)-3-オキソ-2-[4-(トリフルオロメチ
ル)ベンジル]プロピオン酸エチル10.13g(2
6.33ミリモル)のジエチルエーテル50ml溶液を
室温で加え、そのまま2時間撹拌した。反応液に希塩酸
を少しずつ加えて過剰の水素化ホウ素亜鉛を分解した
後、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸マグネシウムで乾燥、溶媒を減圧留去した。得られた
粗生成物をシリカゲルカラムクロマトグラフィーにて精
製し(ヘキサン/酢酸エチル=9/1−3/1)、目的
物を得た。無色液体 収量9.971g 収率98%1 H-NMR (CDCl3, 200MHz) δ 0.93 (3H, t, J = 7.1 H
z), 2.90-3.14 (4H, m), 3.90 (2H, q, J = 7.1 Hz),
5.04 (1H, dd, J = 3.0 Hz, 4.8 Hz), 7.19 (2H, d,J =
8.2 Hz), 7.34 (4H, s), 7.48 (2H, d, J = 8.2 Hz);
IR (neat) 3466, 1715, 1325, 1163, 1125, 1109, 106
9, 1019, 829 cm-1 4) (2RS,3RS)-3-(4-クロロフェニル)-
3-ヒドロキシ-2-[4-(トリフルオロメチル)ベンジ
ル]プロピオン酸 (2RS,3RS)-3-(4-クロロフェニル)-3-ヒ
ドロキシ-2-[4-(トリフルオロメチル)ベンジル]
プロピオン酸エチル9.756g(25.22ミリモ
ル)のメタノール40ml−テトラヒドロフラン40m
l溶液に1N水酸化ナトリウム水溶液50.4ml(5
0.4ミリモル)を加え、室温で一晩撹拌した。反応液
を濃縮、水で希釈し、1N塩酸で反応液を酸性にした
後、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸ナトリウムで乾燥、溶媒を減圧留去した。残留物をジ
エチルエーテル−ヘキサンより結晶化して、目的物を得
た。白色結晶 収量7.152g 収率79% mp 100-101℃; 1H-NMR (CDCl3, 200MHz) δ 2.94-3.13
(3H, m), 5.09 (1H, t,J = 2.2 Hz), 7.18 (2H, d, J =
7.6 Hz), 7.34 (4H, s), 7.48 (2H, d, J = 8.0 Hz);
IR (KBr) 3400-2550, 1696, 1323, 1167, 1130, 1119,
1107, 828 cm-1;Anal. Calcd for C17H14ClF3O3: C, 5
6.92; H, 3.93. Found: C, 56.98; H, 3.73. 5) (4RS,5SR)-5-(4-クロロフェニル)-
4-[4-(トリフルオロメチル)ベンジル]-1,3-オ
キサゾリジン-2-オン (2RS,3RS)-3-(4-クロロフェニル)-3-ヒ
ドロキシ-2-[4-(トリフルオロメチル)ベンジル]
プロピオン酸6.931g(19.32ミリモル)のテ
トラヒドロフラン80ml溶液にトリエチルアミン4.
04ml(29.0ミリモル)、ジフェニルホスホリル
アジド5.85g(21.3ミリモル)を加え、一晩加
熱還流した。反応液の溶媒を減圧留去し、得られた粗生
成物をシリカゲルカラムクロマトグラフィーにて精製し
(ヘキサン/酢酸エチル=3/1−1/1)、酢酸エチ
ル−ヘキサンより結晶化して、目的物を得た。白色結晶
収量6.120g 収率89% mp 159-160℃; 1H-NMR (CDCl3, 200MHz) δ 2.24-2.40
(2H, m), 4.20-4.32 (1H, m), 5.02 (1H, br s), 5.80
(1H, d, J = 8.2 Hz), 7.15 (2H, d, J = 8.0 Hz), 7.3
2 (2H, d, J = 8.4 Hz), 7.42 (2H, d, J = 8.4 Hz),
7.55 (2H, d, J =8.0 Hz); IR (KBr) 3248, 1736, 132
7, 1167, 1138, 1109, 1096, 1067 cm-1; Anal. Calcd
for C17H13ClF3NO2: C, 57.40; H, 3.68; N, 3.94. Fou
nd: C, 57.41; H, 3.58; N, 3.85. 6) (1RS,2SR)-2-アミノ-1-(4-クロロ
フェニル)-3-[4-(トリフルオロメチル)フェニ
ル]プロパン-1-オール (4RS,5SR)-5-(4-クロロフェニル)-4-
[4-(トリフルオロメチル)ベンジル]-1,3-オキ
サゾリジン-2-オン5.902g(16.59ミリモ
ル)と水酸化ナトリウム2.65g(66.4ミリモ
ル)をエタノール40ml−水2.5ml中で、7時間
加熱還流した。反応液を水で希釈し、そのまま10分間
撹拌した。生じた沈殿をろ過して集め、水で洗浄して、
目的物を得た。白色結晶 収量4.902g 収率90
% mp 103-105℃; 1H-NMR (CDCl3, 200MHz) δ 2.41 (1H,
dd, J = 10.3 Hz, 13.5Hz), 2.83 (1H, dd, J = 3.1 H
z, 13.7 Hz), 3.29 (1H, ddd, J = 3.3 Hz, 4.9Hz, 10.
5 Hz), 4.66 (1H, d, J = 4.8 Hz), 7.25 (2H, d, J =
8.0 Hz), 7.31-7.40 (4H, m), 7.54 (2H, d, J = 8.0 H
z); IR (KBr) 3150-2760, 1329, 1165, 1130, 1115, 10
69, 1042, 851 cm-1; Anal. Calcd for C16H15ClF3NO:
C, 58.28;H, 4.59; N, 4.25. Found: C, 58.03; H, 4.7
2; N, 4.16. 7) N-[(1RS,2SR)-2-(4-クロロフェニ
ル)-2-ヒドロキシ-1-[4-(トリフルオロメチル)
ベンジル]エチル]-4-フルオロナフタレン-1-カルボ
キサミド (1RS,2SR)-2-アミノ-1-(4-クロロフェニ
ル)-3-[4-(トリフルオロメチル)フェニル]プロ
パン-1-オール0.173g(0.525ミリモル)、
4-フルオロ-1-ナフトエ酸0.10g(0.52ミリ
モル)、1-ヒドロキシベンゾトリアゾール水和物80
mg(0.52ミリモル)をアセトニトリル10ml中
で撹拌しながら1-エチル-3-(3-ジメチルアミノプロ
ピル)カルボジイミド・塩酸塩0.10g(0.52ミ
リモル)を加え、室温で一晩撹拌した。反応液を酢酸エ
チルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無水
硫酸マグネシウムで乾燥、シリカゲルを通した後、溶媒
を減圧留去した。得られた残留物を酢酸エチル−ヘキサ
ンより結晶化して、目的物を得た。白色結晶 収量0.
216g 収率82% mp 203-204℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
93 (1H, dd, J = 10.6 Hz, 14.4 Hz), 3.11 (1H, dd, J
= 3.1 Hz, 13.3 Hz), 4.66-4.81 (1H, m), 4.95(1H,
t, J = 4.6 Hz), 5.43 (1H, d, J = 4.0 Hz), 7.05 (1
H, dd, J = 7.7 Hz, 9.9 Hz), 7.20 (1H, dd, J = 5.5
Hz, 8.1 Hz), 7.33-7.57 (11H, m), 7.71 (1H, d, J =
9.6 Hz), 8.05 (1H, d, J = 8.4 Hz); IR (KBr) 3343,
1638, 1620,1601, 1534, 1327, 1159, 1125, 1069, 833
cm-1; Anal. Calcd for C27H20ClF 4NO2: C, 64.61; H,
4.02; N, 2.79. Found: C, 64.42; H, 3.98; N, 2.61.Example 194 N-[(1RS, 2SR) -2- (4-chlorophenyl)-
2-hydroxy-1- [4- (trifluoromethyl) benzyl
[Ethyl] -4-fluoronaphthalene-1-carboxami
1) Ethyl (4-chlorobenzoyl) acetate 15.77 g (100.7 mmol) of 4-chlorobenzoic acid
1,1′-) in 100 ml of tetrahydrofuran
18.0 g of carbonyldiimidazole (111 mmol
) Was added at room temperature, and the mixture was stirred as it was for 6 hours. This mixture
To the product, malonic acid monoethyl ester monomagnesium salt 1
At room temperature, add 5.9 g (55.4 mmol) at 60 ° C.
Stir for 3 hours. Dilute the reaction with ethyl acetate and water and concentrate.
After acidifying the reaction solution with hydrochloric acid, the ethyl acetate layer was separated,
The aqueous layer was extracted with ethyl acetate. The collected organic layer is sulfuric anhydride
After drying with sodium, the solvent was distilled off under reduced pressure. Obtained crude
The product is purified by silica gel column chromatography.
(Hexane / ethyl acetate = 6/1) to obtain the desired product.
Red liquid Yield 19.64 g Yield 86%1 H-NMR (CDClThree, 200MHz) δ 1.26 (2.4H, t, J = 7.4H
z), 1.34 (0.6H, t, J = 7.0 Hz), 3.97 (1.6H, s), 4.2
2 (1.6H, q, J = 7.1 Hz), 4.27 (0.4H, q, J = 7.1 H
z), 5.64 (0.2H, s), 7.40 (0.4H, d, J = 8.8 Hz), 7.
46 (1.6H, d, J = 8.6 Hz), 7.72 (0.4H, d, J = 8.6 H
z), 7.90 (1.6H, d, J = 8.0 Hz); IR (neat) 1742, 16
90, 1622, 1590, 1325, 1265, 1200, 1092, 1013 cm-1 2) 3- (4-chlorophenyl) -3-oxo-2- [4-
Ethyl (trifluoromethyl) benzyl] propionate 14.28 g of ethyl (4-chlorobenzoyl) acetate (6
3.00 mmol) of 1,2-dimethoxyethane 100
liquid paraffin of 60% sodium hydride under ice-cooling
2.52 g (63.0 mmol) of the
The mixture was stirred for 0.5 hours as it was. 4- (trifluoromethy
G) Benzyl bromide 15.1 g (63.0 mmol)
Of 1,2-dimethoxyethane at room temperature.
And stirred at room temperature for 6 hours. Pour the reaction mixture into water and add
Extracted twice with chill. The collected organic layer is dried over anhydrous magnesium sulfate.
And dried under reduced pressure. The resulting residue is
Purified by Ricagel column chromatography (hexa
Ethyl acetate / ethyl acetate = 15 / 1-9 / 1)
Crystallization gave the desired product. 18.87 g of white crystals
Yield 78% mp 69-70 ° C;1H-NMR (CDClThree, 200MHz) δ 1.12 (3H, t,
J = 7.1 Hz), 3.38 (2H, d, J = 7.4 Hz), 4.10 (2H,
q, J = 7.3 Hz), 4.56 (1H, t, J = 7.5 Hz), 7.34 (2
H, d, J = 8.0 Hz), 7.43 (2H, d, J = 8.8 Hz), 7.52
(2H, d, J = 8.0 Hz), 7.90 (2H, d, J = 8.4 Hz); IR
(KBr) 1717, 1690, 1590, 1329, 1283, 1229, 1179, 11
57, 1111, 1092, 1071, 845, 828 cm-1; Anal. Calcd f
or C19H16ClFThreeOThree: C, 59.31; H, 4.19. Found: C, 59.2
9; H, 4.05.3. (2RS, 3RS) -3- (4-chlorophenyl)-
3-hydroxy-2- [4- (trifluoromethyl) benzyl
Ethyl] propionate 7.18 g (52.7 mmol) of zinc chloride in diethyl ether
Sodium borohydride while stirring in 100 ml
3.98 g (105 mmol) were added at room temperature.
The mixture was stirred for 2 hours. The insolubles of the mixture are removed by filtration.
Washed with ethyl ether), zinc borohydride in diethyl
An ether solution was obtained. To the resulting solution, add 3- (4-chloro
Phenyl) -3-oxo-2- [4- (trifluoromethyl
L) benzyl] ethyl propionate 10.13 g (2
(6.33 mmol) in 50 ml of diethyl ether.
The mixture was added at room temperature and stirred for 2 hours. Dilute hydrochloric acid in the reaction solution
Was added little by little to decompose excess zinc borohydride
Thereafter, the mixture was extracted twice with ethyl acetate. The collected organic layer is anhydrous sulfur
After drying with magnesium acid, the solvent was distilled off under reduced pressure. Got
The crude product is purified by silica gel column chromatography.
(Hexane / ethyl acetate = 9 / 1-3 / 1)
I got something. Colorless liquid Yield 9.971 g 98% yield1 H-NMR (CDClThree, 200MHz) δ 0.93 (3H, t, J = 7.1 H
z), 2.90-3.14 (4H, m), 3.90 (2H, q, J = 7.1 Hz),
5.04 (1H, dd, J = 3.0 Hz, 4.8 Hz), 7.19 (2H, d, J =
8.2 Hz), 7.34 (4H, s), 7.48 (2H, d, J = 8.2 Hz);
IR (neat) 3466, 1715, 1325, 1163, 1125, 1109, 106
9, 1019, 829 cm-1 4) (2RS, 3RS) -3- (4-chlorophenyl)-
3-hydroxy-2- [4- (trifluoromethyl) benzyl
] Propionic acid (2RS, 3RS) -3- (4-chlorophenyl) -3-h
Droxy-2- [4- (trifluoromethyl) benzyl]
9.756 g of ethyl propionate (25.22 mmol
M) -methanol 40 ml-tetrahydrofuran 40 m
1N aqueous sodium hydroxide solution 50.4 ml (5
0.4 mmol) and stirred at room temperature overnight. Reaction liquid
Was concentrated, diluted with water, and the reaction solution was acidified with 1N hydrochloric acid.
Thereafter, the mixture was extracted twice with ethyl acetate. The collected organic layer is anhydrous sulfur
The extract was dried over sodium acid and the solvent was distilled off under reduced pressure. Remove the residue
Crystallized from ethyl ether-hexane to obtain the desired product
Was. White crystals Yield 7.152 g Yield 79% mp 100-101 ° C;1H-NMR (CDClThree, 200MHz) δ 2.94-3.13
(3H, m), 5.09 (1H, t, J = 2.2 Hz), 7.18 (2H, d, J =
7.6 Hz), 7.34 (4H, s), 7.48 (2H, d, J = 8.0 Hz);
IR (KBr) 3400-2550, 1696, 1323, 1167, 1130, 1119,
1107, 828 cm-1; Anal. Calcd for C17H14ClFThreeOThree: C, 5
6.92; H, 3.93. Found: C, 56.98; H, 3.73.5) (4RS, 5SR) -5- (4-chlorophenyl)-
4- [4- (trifluoromethyl) benzyl] -1,3-o
Oxazolidine-2-one (2RS, 3RS) -3- (4-chlorophenyl) -3-h
Droxy-2- [4- (trifluoromethyl) benzyl]
6.931 g (19.32 mmol) of propionic acid
3. Triethylamine in 80 ml solution of trahydrofuran.
04 ml (29.0 mmol), diphenylphosphoryl
Add 5.85 g (21.3 mmol) of azide and add overnight.
Heated to reflux. The solvent of the reaction solution was distilled off under reduced pressure to obtain a crude product.
The product is purified by silica gel column chromatography.
(Hexane / ethyl acetate = 3 / 1-1 / 1), ethyl acetate
Crystallization from l-hexane gave the desired product. White crystals
6.120 g yield 89% mp 159-160 ° C;1H-NMR (CDClThree, 200MHz) δ 2.24-2.40
(2H, m), 4.20-4.32 (1H, m), 5.02 (1H, br s), 5.80
(1H, d, J = 8.2 Hz), 7.15 (2H, d, J = 8.0 Hz), 7.3
2 (2H, d, J = 8.4 Hz), 7.42 (2H, d, J = 8.4 Hz),
7.55 (2H, d, J = 8.0 Hz); IR (KBr) 3248, 1736, 132
7, 1167, 1138, 1109, 1096, 1067 cm-1; Anal. Calcd
for C17H13ClFThreeNOTwo: C, 57.40; H, 3.68; N, 3.94. Fou
nd: C, 57.41; H, 3.58; N, 3.85. 6) (1RS, 2SR) -2-amino-1- (4-chloro)
Phenyl) -3- [4- (trifluoromethyl) phenyl
Ru] propan-1-ol (4RS, 5SR) -5- (4-chlorophenyl) -4-
[4- (trifluoromethyl) benzyl] -1,3-oxo
5.902 g of sazolidine-2-one (16.59 mmol
) And 2.65 g of sodium hydroxide (66.4 mmol
7) in 40 ml of ethanol-2.5 ml of water for 7 hours
Heated to reflux. Dilute the reaction with water and leave for 10 minutes
Stirred. The resulting precipitate is collected by filtration, washed with water,
The desired product was obtained. White crystals Yield 4.902 g Yield 90
% Mp 103-105 ° C;1H-NMR (CDClThree, 200MHz) δ 2.41 (1H,
dd, J = 10.3 Hz, 13.5Hz), 2.83 (1H, dd, J = 3.1 H
z, 13.7 Hz), 3.29 (1H, ddd, J = 3.3 Hz, 4.9Hz, 10.
5 Hz), 4.66 (1H, d, J = 4.8 Hz), 7.25 (2H, d, J =
8.0 Hz), 7.31-7.40 (4H, m), 7.54 (2H, d, J = 8.0 H
z); IR (KBr) 3150-2760, 1329, 1165, 1130, 1115, 10
69, 1042, 851 cm-1; Anal. Calcd for C16H15ClFThreeNO:
C, 58.28; H, 4.59; N, 4.25. Found: C, 58.03; H, 4.7
2; N, 4.16.7) N-[(1RS, 2SR) -2- (4-chlorophenyl)
) -2-Hydroxy-1- [4- (trifluoromethyl)
[Benzyl] ethyl] -4-fluoronaphthalene-1-carbo
Oxamide (1RS, 2SR) -2-amino-1- (4-chlorophenyi)
) -3- [4- (Trifluoromethyl) phenyl] pro
0.173 g (0.525 mmol) of pan-1-ol,
0.10 g of 4-fluoro-1-naphthoic acid (0.52 mm
Mol) 1-hydroxybenzotriazole hydrate 80
mg (0.52 mmol) in 10 ml of acetonitrile
1-ethyl-3- (3-dimethylaminopro
Pill) 0.10 g (0.52 mi) carbodiimide hydrochloride
Lmol) and stirred overnight at room temperature. The reaction solution was
Dilute to chill, wash with aqueous sodium bicarbonate, anhydrous
After drying over magnesium sulfate and passing through silica gel, the solvent
Was distilled off under reduced pressure. The obtained residue is ethyl acetate-hexa.
The product was crystallized from the compound to give the desired product. White crystals Yield 0.
216 g yield 82% mp 203-204 ° C;1H-NMR (CDClThree-DMSO-d6, 200MHz) δ 2.
93 (1H, dd, J = 10.6 Hz, 14.4 Hz), 3.11 (1H, dd, J
= 3.1 Hz, 13.3 Hz), 4.66-4.81 (1H, m), 4.95 (1H,
t, J = 4.6 Hz), 5.43 (1H, d, J = 4.0 Hz), 7.05 (1
H, dd, J = 7.7 Hz, 9.9 Hz), 7.20 (1H, dd, J = 5.5
Hz, 8.1 Hz), 7.33-7.57 (11H, m), 7.71 (1H, d, J =
9.6 Hz), 8.05 (1H, d, J = 8.4 Hz); IR (KBr) 3343,
1638, 1620,1601, 1534, 1327, 1159, 1125, 1069, 833
cm-1; Anal. Calcd for C27H20ClF FourNOTwo: C, 64.61; H,
4.02; N, 2.79. Found: C, 64.42; H, 3.98; N, 2.61.
【0327】実施例195 4-フルオロ-N-((1RS,2SR)-2-(3-フラニ
ル)-2-ヒドロキシ-1-((4-(トリフルオロメチ
ル)フェニル)メチル)エチル)-1-ナフタレンカルボ
キサミド 1) 3-フランカルボン酸(25.5g,227ミリ
モル)のテトラヒドロフラン(200ml)溶液に1,
1'-カルボニルビス-1H-イミダゾール(40.5g,
250ミリモル)を加え、60℃で2時間攪拌した。反
応液にマロン酸モノエチルマグネシウム塩(35.8
g,125ミリモル)を加え、30分加熱還流した。反
応液に酢酸エチル(50ml)および水(50ml)を
加え、更に水層のpHが酸性になるまで濃塩酸を加え
た。反応液を酢酸エチル(200ml×2)で抽出し、
抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウムで
乾燥後減圧留去した。残留物をシリカゲルカラムクロマ
トグラフィー(ヘキサン:酢酸エチル=4:1)で精製
し、3-(3-フラニル)-3-オキソプロピオン酸エチル
(42g,100%)を無色油状物として得た。 IRνmaxKBrcm-1: 1738, 1682. Anal. Calcd for C9H10O4・0.1H2O: C, 58.76; H, 5.59 Found: C, 58.90; H, 5.56.1 H-NMR (CDCl3)δ: 1.27 (3H, t, J = 7.0 Hz), 3.78
(18/10H, s), 4.21 (2H,q, J = 7.0 Hz), 5.37 (1/10H,
s), 6.57 (1/10H, s), 6.79 (9/10H, s), 7.40-7.50
(1H, m), 7.90 (1/10H, s), 8.11 (9/10H, s). 2) 3-(3-フラニル)-3-オキソプロピオン酸エチ
ル(20g,110ミリモル)の1,2-ジメトキシエ
タン(100ml)溶液に水素化ナトリウム(60%油
性,4.4g,110ミリモル)を氷冷下加え、室温で
30分攪拌した。反応液の中に4-トリフルオロメチル
ベンジルブロミド(26.2g,110ミリモル)の
1,2-ジメトキシエタン(50ml)溶液を滴下し、
反応液を室温で3時間攪拌した。反応液を水(300m
l)の中に注ぎ、酢酸エチル(500ml×2)で抽出
した。抽出液を水および飽和食塩水で洗浄し、無水硫酸
マグネシウムで乾燥後減圧留去した。残留物をジイソプ
ロピルエーテル−ヘキサンより再結晶させて、3-(3-
フラニル)-3-オキソ-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸エチル(28.8
g,77%)を得た。 mp 55-56℃ IRνmaxKBrcm-1: 1738, 1682. Anal. Calcd for C17H15F3O4: C, 60.00; H, 4.44 Found: C, 59.89; H, 4.38.1 H-NMR (CDCl3)δ: 1.16 (3H, t, J = 7.0 Hz), 3.35
(2H, d, J = 7.6 Hz), 4.06-4.24 (3H, m), 6.76-6.80
(1H, m), 7.34 (2H, d, J = 8.0 Hz), 7.40-7.48(1H,
m), 7.53 (2H, d, J = 8.0 Hz), 8.09 (1H, s). 3) 塩化亜鉛(16.0g,117ミリモル)のジエ
チルエーテル(250ml)溶液に水素化ホウ素ナトリ
ウム(8.9g,235ミリモル)を加えて室温で2時
間攪拌した。不溶物をろ去し、ろ液に3-(3-フラニ
ル)-3-オキソ-2-((4-(トリフルオロメチル)フ
ェニル)メチル)プロピオン酸エチル(20g,58.
8ミリモル)のジエチルエーテル(50ml)溶液を加
えて室温で30分攪拌した。氷冷下、反応液に1規定塩
酸を加えてクエンチし、更に水(200ml)を加え、
酢酸エチル(300ml×2)で抽出した。抽出液を水
および飽和食塩水で洗浄し、無水硫酸マグネシウムで乾
燥後減圧留去し、(2RS,3RS)-3-(3-フラニ
ル)-3-ヒドロキシ-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸エチル(19.7
g,98%)を無色油状物として得た。 IRνmaxKBrcm-1: 1728. Anal. Calcd for C17H17F3O4: C, 59.65; H, 5.01 Found: C, 59.35; H, 5.19.1 H-NMR (CDCl3)δ: 1.00 (3H, t, J = 7.2 Hz), 2.80
(1H, d, J = 3.8 Hz), 2.86-3.14 (3H, m), 3.96 (2H,
q, J = 7.2 Hz), 5.01 (1H, t, J = 4.0 Hz), 6.40 (1
H, s), 7.25 (2H, d, J = 8.0 Hz), 7.38-7.60 (4H,
m). 4) (2RS,3RS)-3-(3-フラニル)-3-ヒ
ドロキシ-2-((4-(トリフルオロメチル)フェニ
ル)メチル)プロピオン酸エチル(19.0g,55.
5ミリモル)のメタノール(100ml)溶液に、2規
定水酸化ナトリウム水溶液(55.5ml,111ミリ
モル)を加えて室温で終夜攪拌した。反応液を1規定塩
酸で酸性とした後、酢酸エチル(200ml×2)で抽
出した。抽出液を水および飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物をジイソ
プロピルエーテル−ヘキサンから再結晶させて(2R
S,3RS)-3-(3-フラニル)-3-ヒドロキシ-2-
((4-(トリフルオロメチル)フェニル)メチル)プ
ロピオン酸(15.1g,86%)を得た。 mp 104-105℃ IRνmaxKBrcm-1: 1713. Anal. Calcd for C15H13F3O4: C, 57.33; H, 4.17 Found: C, 57.42; H, 4.15.1 H-NMR (CDCl3)δ: 2.90-3.20 (3H, m), 5.02 (1H, d,
J = 4.0 Hz), 6.39 (1H,s), 7.26 (2H, d, J = 8.2 H
z), 7.40-7.50 (2H, m), 7.52 (2H, d, J = 8.2 Hz). 5) (2RS,3RS)-3-(3-フラニル)-3-ヒ
ドロキシ-2-((4-(トリフルオロメチル)フェニ
ル)メチル)プロピオン酸(10.0g,31.8ミリ
モル)のテトラヒドロフラン(250ml)溶液に、ジ
フェニルホスホリルアジド(7.5ml,35.0ミリ
モル)とトリエチルアミン(6.7ml,47.7ミリ
モル)を加え、4時間加熱還流した。反応液を放冷後、
水(200ml)を加えて酢酸エチル(200ml×
2)で抽出した。抽出液を1規定塩酸、飽和重曹水、飽
和食塩水で順次洗浄し、無水硫酸マグネシウムで乾燥後
減圧留去した。残留物をジイソプロピルエーテル−ヘキ
サンから再結晶させて(4RS,5SR)-5-(3-フ
ラニル)-4-((4-(トリフルオロメチル)フェニ
ル)メチル)-1,3-オキサゾリジン-2-オン(8.2
5g,83%)を得た。 mp 111-112℃ IRνmaxKBrcm-1: 1759. Anal. Calcd for C15H12F3NO3: C, 57.88; H, 3.89; N,
4.50 Found: C, 57.94; H, 3.97; N, 4.38.1 H-NMR (CDCl3)δ: 2.48-2.72 (2H, m), 4.12-4.28 (1
H, m), 5.09 (1H, brs),5.75 (1H, d, J = 7.8 Hz), 6.
47 (1H, s), 7.22 (2H, d, J = 8.0 Hz), 7.48-7.62 (4
H, m). 6) (4RS,5SR)-5-(3-フラニル)-4-
((4-(トリフルオロメチル)フェニル)メチル)-
1,3-オキサゾリジン-2-オン(7.0g,22.5
ミリモル)のエタノール(100ml)溶液に8規定水
酸化ナトリウム水溶液(14.0ml,112.5ミリ
モル)を加え、3時間加熱還流した。反応液を濃縮後、
水(300ml)で希釈し、酢酸エチル(300ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて、(1RS,2SR)
-2-アミノ-1-(3-フラニル)-3-(4-(トリフルオ
ロメチル)フェニル)-1-プロパノール(5.54g,
86%)を得た。 mp 91-92℃ IRνmaxKBrcm-1: 1572, 1500, 1331. Anal. Calcd for C14H14F3NO2: C, 58.95; H, 4.95; N,
4.91 Found: C, 58.91; H, 5.08; N, 4.78.1 H-NMR (CDCl3)δ: 2.49 (1H, dd, J = 13.6, 9.8 Hz),
2.96 (1H, dd, J = 14.0, 3.6 Hz), 3.20-3.32 (1H,
m), 4.62 (1H, d, J = 5.2 Hz), 6.44 (1H, s), 7.30
(2H, d, J = 8.0 Hz), 7.40-7.50 (2H, m), 7.56 (2H,
d, J = 8.0 Hz). 7) (1RS,2SR)-2-アミノ-1-(3-フラニ
ル)-3-(4-(トリフルオロメチル)フェニル)-1-
プロパノール(500mg,1.75ミリモル)のアセ
トニトリル(30ml)溶液に4-フルオロナフタレン
カルボン酸(333mg,1.75ミリモル)および1
-エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩(504mg,2.63ミリモル)および
1-ヒドロキシ-1H-ベンゾトリアゾール(268m
g,1.75ミリモル)を加えて室温で終夜攪拌した。
反応液を水(100ml)で希釈し、酢酸エチル(10
0ml×2)で抽出した。抽出液を1規定塩酸、1規定
水酸化ナトリウム水溶液、飽和食塩水で順次洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=4:1)で精製し酢酸エチル−ヘキサンから再結
晶させて、表題化合物(573mg,71%)を得た。 mp 206-207℃ IRνmaxKBrcm-1: 1644, 1626, 1601, 1537, 1329. Anal. Calcd for C25H19F4NO3: C, 65.64; H, 4.19; N,
3.06 Found: C, 65.49; H, 4.37; N, 2.91.1 H-NMR (CDCl3)δ: 2.89 (1H, dd, J = 14.2, 10.2 H
z), 3.15 (1H, dd, J = 14.2, 4.2 Hz), 3.24 (1H, br
s), 4.70-4.88 (1H, m), 5.03 (1H, d, J = 3.2 Hz),
6.02 (1H, d, J = 8.6 Hz), 6.51 (1H, s), 6.92-7.08
(1H, m), 7.12-7.24 (1H, m), 7.30-7.62 (8H, m), 7.7
0 (1H, d, J = 8.4 Hz), 8.08 (1H, d, J = 8.2 Hz).Example 195 4-Fluoro-N-((1RS, 2SR) -2- (3-furanyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -1 -Naphthalenecarboxamide 1) To a solution of 3-furancarboxylic acid (25.5 g, 227 mmol) in tetrahydrofuran (200 ml),
1′-carbonylbis-1H-imidazole (40.5 g,
(250 mmol) and stirred at 60 ° C. for 2 hours. Monoethyl magnesium malonate (35.8) was added to the reaction solution.
g, 125 mmol) and heated to reflux for 30 minutes. Ethyl acetate (50 ml) and water (50 ml) were added to the reaction solution, and concentrated hydrochloric acid was further added until the pH of the aqueous layer became acidic. The reaction solution was extracted with ethyl acetate (200 ml × 2),
The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give ethyl 3- (3-furanyl) -3-oxopropionate (42 g, 100%) as a colorless oil. . IRνmax KBr cm -1: 1738, 1682. Anal Calcd for C 9 H 10 O 4 · 0.1H 2 O: C, 58.76; H, 5.59 Found:. C, 58.90; H, 5.56 1 H-NMR (CDCl 3 ) δ: 1.27 (3H, t, J = 7.0 Hz), 3.78
(18 / 10H, s), 4.21 (2H, q, J = 7.0 Hz), 5.37 (1 / 10H,
s), 6.57 (1 / 10H, s), 6.79 (9 / 10H, s), 7.40-7.50
(1H, m), 7.90 (1 / 10H, s), 8.11 (9 / 10H, s). 2) Ethyl 3- (3-furanyl) -3-oxopropionate (20 g, 110 mmol) Sodium hydride (60% oily, 4.4 g, 110 mmol) was added to a solution of -dimethoxyethane (100 ml) under ice-cooling, and the mixture was stirred at room temperature for 30 minutes. A solution of 4-trifluoromethylbenzyl bromide (26.2 g, 110 mmol) in 1,2-dimethoxyethane (50 ml) was added dropwise to the reaction solution.
The reaction was stirred at room temperature for 3 hours. The reaction solution was washed with water (300 m
1) and extracted with ethyl acetate (500 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to give 3- (3-
Ethyl furanyl) -3-oxo-2-((4- (trifluoromethyl) phenyl) methyl) propionate (28.8
g, 77%). . mp 55-56 ℃ IRνmax KBr cm -1 : 1738, 1682. Anal Calcd for C 17 H 15 F 3 O 4: C, 60.00; H, 4.44 Found:. C, 59.89; H, 4.38 1 H-NMR ( CDCl 3 ) δ: 1.16 (3H, t, J = 7.0 Hz), 3.35
(2H, d, J = 7.6 Hz), 4.06-4.24 (3H, m), 6.76-6.80
(1H, m), 7.34 (2H, d, J = 8.0 Hz), 7.40-7.48 (1H,
m), 7.53 (2H, d, J = 8.0 Hz), 8.09 (1H, s). 3) To a solution of zinc chloride (16.0 g, 117 mmol) in diethyl ether (250 ml) was added sodium borohydride (8.9 g). , 235 mmol) and stirred at room temperature for 2 hours. The insoluble material was removed by filtration, and the filtrate was treated with ethyl 3- (3-furanyl) -3-oxo-2-((4- (trifluoromethyl) phenyl) methyl) propionate (20 g, 58.
(8 mmol) in diethyl ether (50 ml) and stirred at room temperature for 30 minutes. The reaction solution was quenched by adding 1N hydrochloric acid under ice-cooling, and water (200 ml) was further added.
Extracted with ethyl acetate (300 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure to give (2RS, 3RS) -3- (3-furanyl) -3-hydroxy-2-((4- (trifluoro Methyl) phenyl) methyl) ethyl propionate (19.7
g, 98%) as a colorless oil. . IRνmax KBr cm -1: 1728. Anal Calcd for C 17 H 17 F 3 O 4: C, 59.65; H, 5.01 Found:. C, 59.35; H, 5.19 1 H-NMR (CDCl 3) δ: 1.00 ( 3H, t, J = 7.2 Hz), 2.80
(1H, d, J = 3.8 Hz), 2.86-3.14 (3H, m), 3.96 (2H,
q, J = 7.2 Hz), 5.01 (1H, t, J = 4.0 Hz), 6.40 (1
H, s), 7.25 (2H, d, J = 8.0 Hz), 7.38-7.60 (4H,
m). 4) Ethyl (2RS, 3RS) -3- (3-furanyl) -3-hydroxy-2-((4- (trifluoromethyl) phenyl) methyl) propionate (19.0 g, 55.5 g).
To a solution of 5 mmol) in methanol (100 ml) was added a 2 N aqueous solution of sodium hydroxide (55.5 ml, 111 mmol) and the mixture was stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane (2R
S, 3RS) -3- (3-Furanyl) -3-hydroxy-2-
((4- (trifluoromethyl) phenyl) methyl) propionic acid (15.1 g, 86%) was obtained. . mp 104-105 ℃ IRνmax KBr cm -1 : 1713. Anal Calcd for C 15 H 13 F 3 O 4: C, 57.33; H, 4.17 Found:. C, 57.42; H, 4.15 1 H-NMR (CDCl 3 ) δ: 2.90-3.20 (3H, m), 5.02 (1H, d,
J = 4.0 Hz), 6.39 (1H, s), 7.26 (2H, d, J = 8.2 H
z), 7.40-7.50 (2H, m), 7.52 (2H, d, J = 8.2 Hz). 5) (2RS, 3RS) -3- (3-furanyl) -3-hydroxy-2-((4- In a solution of (trifluoromethyl) phenyl) methyl) propionic acid (10.0 g, 31.8 mmol) in tetrahydrofuran (250 ml), diphenylphosphoryl azide (7.5 ml, 35.0 mmol) and triethylamine (6.7 ml, 47). (0.7 mmol) and heated under reflux for 4 hours. After allowing the reaction solution to cool,
Add water (200 ml) and add ethyl acetate (200 ml ×
Extracted in 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to give (4RS, 5SR) -5- (3-furanyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-2-. ON (8.2
(5 g, 83%). . mp 111-112 ℃ IRνmax KBr cm -1 : 1759. Anal Calcd for C 15 H 12 F 3 NO 3: C, 57.88; H, 3.89; N,
4.50 Found:. C, 57.94; H, 3.97; N, 4.38 1 H-NMR (CDCl 3) δ: 2.48-2.72 (2H, m), 4.12-4.28 (1
H, m), 5.09 (1H, brs), 5.75 (1H, d, J = 7.8 Hz), 6.
47 (1H, s), 7.22 (2H, d, J = 8.0 Hz), 7.48-7.62 (4
H, m). 6) (4RS, 5SR) -5- (3-furanyl) -4-
((4- (trifluoromethyl) phenyl) methyl)-
1,3-oxazolidine-2-one (7.0 g, 22.5
8 mmol sodium hydroxide aqueous solution (14.0 ml, 112.5 mmol) was added to an ethanol (100 ml) solution of the resultant solution, and the mixture was refluxed for 3 hours. After concentrating the reaction solution,
Dilute with water (300ml) and add ethyl acetate (300ml x
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR)
-2-amino-1- (3-furanyl) -3- (4- (trifluoromethyl) phenyl) -1-propanol (5.54 g,
86%). mp 91-92 ° C IRνmax KBr cm -1 : 1572, 1500, 1331. Anal.Calcd for C 14 H 14 F 3 NO 2 : C, 58.95; H, 4.95; N,
4.91 Found:. C, 58.91; H, 5.08; N, 4.78 1 H-NMR (CDCl 3) δ: 2.49 (1H, dd, J = 13.6, 9.8 Hz),
2.96 (1H, dd, J = 14.0, 3.6 Hz), 3.20-3.32 (1H,
m), 4.62 (1H, d, J = 5.2 Hz), 6.44 (1H, s), 7.30
(2H, d, J = 8.0 Hz), 7.40-7.50 (2H, m), 7.56 (2H,
d, J = 8.0 Hz). 7) (1RS, 2SR) -2-amino-1- (3-furanyl) -3- (4- (trifluoromethyl) phenyl) -1-
To a solution of propanol (500 mg, 1.75 mmol) in acetonitrile (30 ml) was added 4-fluoronaphthalenecarboxylic acid (333 mg, 1.75 mmol) and 1
-Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (504 mg, 2.63 mmol) and 1-hydroxy-1H-benzotriazole (268 m
g, 1.75 mmol) and stirred at room temperature overnight.
The reaction solution was diluted with water (100 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to obtain the title compound (573 mg, 71%). mp 206-207 ℃ IRνmax KBr cm -1 : 1644, 1626, 1601, 1537, 1329. Anal.Calcd for C 25 H 19 F 4 NO 3 : C, 65.64; H, 4.19; N,
3.06 Found:. C, 65.49; H, 4.37; N, 2.91 1 H-NMR (CDCl 3) δ: 2.89 (1H, dd, J = 14.2, 10.2 H
z), 3.15 (1H, dd, J = 14.2, 4.2 Hz), 3.24 (1H, br
s), 4.70-4.88 (1H, m), 5.03 (1H, d, J = 3.2 Hz),
6.02 (1H, d, J = 8.6 Hz), 6.51 (1H, s), 6.92-7.08
(1H, m), 7.12-7.24 (1H, m), 7.30-7.62 (8H, m), 7.7
0 (1H, d, J = 8.4 Hz), 8.08 (1H, d, J = 8.2 Hz).
【0328】実施例196 N-((1RS,2SR)-2-(3-フラニル)-2-ヒド
ロキシ-1-((4-(トリフルオロメチル)フェニル)
メチル)エチル)-3-フェニルプロパンアミド (1RS,2SR)-2-アミノ-1-(3-フラニル)-3
-(4-(トリフルオロメチル)フェニル)-1-プロパノ
ール(500mg,1.75ミリモル)の酢酸エチル
(20ml)溶液に3-フェニルプロピオニルクロリド
(390ml,2.63ミリモル)および飽和重曹水
(20ml)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて表題化合物(650m
g,89%)を得た。 mp 134-135℃ IRνmaxKBrcm-1: 1645, 1520. Anal. Calcd for C23H22F3NO3: C, 66.18; H, 5.31; N,
3.36 Found: C, 66.18; H, 5.40; N, 3.22.1 H-NMR (CDCl3)δ: 2.39 (2H, t, J = 7.0 Hz), 2.64-
2.92 (4H, m), 3.08-3.36(1H, m), 4.26-4.44 (1H, m),
4.75 (1H, s), 5.30-5.50 (1H, m), 6.31 (1H,s), 7.0
6-7.34 (7H, m), 7.38 (2H, d, J = 6.8 Hz), 7.49 (2
H, d, J = 8.2 Hz).Example 196 N-((1RS, 2SR) -2- (3-furanyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl)
Methyl) ethyl) -3-phenylpropanamide (1RS, 2SR) -2-amino-1- (3-furanyl) -3
To a solution of-(4- (trifluoromethyl) phenyl) -1-propanol (500 mg, 1.75 mmol) in ethyl acetate (20 ml) was added 3-phenylpropionyl chloride (390 ml, 2.63 mmol) and saturated aqueous sodium hydrogen carbonate (20 ml). ) Was added and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (650 m
g, 89%). mp 134-135 ℃ IRνmax KBr cm -1 : 1645, 1520. Anal.Calcd for C 23 H 22 F 3 NO 3 : C, 66.18; H, 5.31; N,
3.36 Found:. C, 66.18; H, 5.40; N, 3.22 1 H-NMR (CDCl 3) δ: 2.39 (2H, t, J = 7.0 Hz), 2.64-
2.92 (4H, m), 3.08-3.36 (1H, m), 4.26-4.44 (1H, m),
4.75 (1H, s), 5.30-5.50 (1H, m), 6.31 (1H, s), 7.0
6-7.34 (7H, m), 7.38 (2H, d, J = 6.8 Hz), 7.49 (2
(H, d, J = 8.2 Hz).
【0329】実施例197 N-[(1RS,2RS)-2-(5-クロロ-2-チエニ
ル)-2-ヒドロキシ-1-[4-(トリフルオロメチル)
ベンジル]エチル]-4-フルオロナフタレン-1-カルボ
キサミド 1) 3-(5-クロロ-2-チエニル)-3-オキソプロピ
オン酸エチル 5-クロロチオフェン-2-カルボン酸10.12g(6
2.24ミリモル)のテトラヒドロフラン80ml溶液
に1,1’-カルボニルジイミダゾール11.1g(6
8.5ミリモル)を室温で加え、そのまま6時間撹拌し
た。この混合物にマロン酸モノエチルエステルモノマグ
ネシウム塩9.81g(34.2ミリモル)を室温で加
え、60℃で3時間撹拌した。反応液を酢酸エチルと水
で希釈し、濃塩酸で反応液を酸性にした後、酢酸エチル
層を分離し、水層を酢酸エチルで抽出した。集めた有機
層を無水硫酸ナトリウムで乾燥、溶媒を減圧留去した。
得られた粗生成物をシリカゲルカラムクロマトグラフィ
ーにて精製して(ヘキサン/酢酸エチル=6/1)、目
的物を得た。暗赤色液体 収量13.89g 収率96
%1 H-NMR (CDCl3, 200MHz) δ 1.27 (3H, t, J = 7.2 H
z), 3.85 (2H, s), 4.21 (2H, q, J = 7.1 Hz), 6.99
(1H, d, J = 4.0 Hz), 7.53 (1H, d, J = 4.0 Hz);IR
(neat) 1738, 1667, 1418, 1329, 1215, 1017 cm-1 2) 3-(5-クロロ-2-チエニル)-3-オキソ-2-
[4-(トリフルオロメチル)ベンジル]プロピオン酸
エチル 3-(5-クロロ-2-チエニル)-3-オキソプロピオン酸
エチル13.57g(58.32ミリモル)の1,2-
ジメトキシエタン100ml溶液に氷冷下60%水素化
ナトリウムの流動パラフィン懸濁物2.33g(58.
3ミリモル)を加え、そのまま0.5時間撹拌した。4
-(トリフルオロメチル)ベンジルブロミド13.9g
(58.3ミリモル)の1,2-ジメトキシエタン20
ml溶液を室温で加え、室温で6時間撹拌した。反応液
を水に注ぎ、酢酸エチルで2回抽出した。集めた有機層
を無水硫酸マグネシウムで乾燥、溶媒を減圧留去した。
得られた残留物をシリカゲルカラムクロマトグラフィー
にて精製し(ヘキサン/酢酸エチル=15/1−9/
1)、ヘキサンより結晶化して、目的物を得た。白色結
晶 収量18.30g 収率80% mp 87-88℃; 1H-NMR (CDCl3, 200MHz) δ 1.16 (3H, t,
J = 7.2 Hz), 3.36 (2H, d, J = 7.8 Hz), 4.14 (2H,
q, J = 7.2 Hz), 4.35 (1H, t, J = 7.5 Hz), 6.94 (1
H, d, J = 4.0 Hz), 7.33 (2H, d, J = 8.0 Hz), 7.53
(2H, d, J = 8.4 Hz), 7.55 (1H, d, J = 4.0 Hz); IR
(KBr) 1721, 1659, 1418, 1329, 1285, 1236, 1155, 11
19, 1071 cm-1; Anal. Calcd for C17H14ClF3O3S: C, 5
2.25; H, 3.61. Found: C, 52.22; H, 3.42. 3) (2RS,3RS)-3-(5-クロロ-2-チエニ
ル)-3-ヒドロキシ-2-[4-(トリフルオロメチル)
ベンジル]プロピオン酸エチル 塩化亜鉛6.47g(47.5ミリモル)をジエチルエ
ーテル100ml中で撹拌しながら水素化ホウ素ナトリ
ウム3.59g(94.9ミリモル)を室温で加え、そ
のまま2時間撹拌した。混合物の不溶物をろ過で除き
(ジエチルエーテルで洗浄)、水素化ホウ素亜鉛のジエ
チルエーテル溶液を得た。得られた溶液に、3-(5-ク
ロロ-2-チエニル)-3-オキソ-2-[4-(トリフルオ
ロメチル)ベンジル]プロピオン酸エチル9.272g
(23.73ミリモル)のジエチルエーテル50ml溶
液を室温で加え、そのまま2時間撹拌した。反応液に希
塩酸を少しずつ加えて過剰の水素化ホウ素亜鉛を分解し
た後、酢酸エチルで2回抽出した。集めた有機層を無水
硫酸マグネシウムで乾燥、溶媒を減圧留去した。得られ
た粗生成物をシリカゲルカラムクロマトグラフィーにて
精製し(ヘキサン/酢酸エチル=9/1−3/1)、目
的物を得た。無色液体 収量9.093g 収率98%1 H-NMR (CDCl3, 200MHz) δ 0.99 (3H, t, J = 7.1 H
z), 2.96-3.16 (4H, m), 3.96 (2H, q, J = 7.1 Hz),
5.15 (1H, t, J = 4.2 Hz), 6.76 (1H, d, J = 3.8Hz),
6.79 (1H, d, J = 3.6 Hz), 7.26 (2H, d, J = 8.2 H
z), 7.52 (2H, d, J= 8.0 Hz); IR (neat) 3459, 1715,
1325, 1163, 1125, 1109, 1069, 1020 cm-1 4) (2RS,3RS)-3-(5-クロロ-2-チエニ
ル)-3-ヒドロキシ-2-[4-(トリフルオロメチル)
ベンジル]プロピオン酸 (2RS,3RS)-3-(5-クロロ-2-チエニル)-3
-ヒドロキシ-2-[4-(トリフルオロメチル)ベンジ
ル]プロピオン酸エチル8.878g(22.60ミリ
モル)のメタノール30ml−テトラヒドロフラン30
ml溶液に1N水酸化ナトリウム水溶液45.2ml
(45.2ミリモル)を加え、室温で一晩撹拌した。反
応液を濃縮、水で希釈し、1N塩酸で反応液を酸性にし
た後、酢酸エチルで2回抽出した。集めた有機層を無水
硫酸ナトリウムで乾燥、溶媒を減圧留去した。残留物を
ジエチルエーテル−ヘキサンより結晶化して、目的物を
得た。白色結晶 収量7.092g 収率86% mp 150-151℃; 1H-NMR (CDCl3, 200MHz) δ 3.06-3.15
(3H, m), 5.17 (1H, d,J = 4.8 Hz), 6.79 (2H, s), 7.
27 (2H, d, J = 8.0 Hz), 7.53 (2H, d, J = 8.4 Hz);
IR (KBr) 3382, 3050-2650, 1698, 1333, 1159, 1130,
1111, 1071, 802cm-1; Anal. Calcd for C15H12ClF3O
3S: C, 49.39; H, 3.32. Found: C, 49.40; H, 3.29. 5) (4RS,5RS)-5-(5-クロロ-2-チエニ
ル)-4-[4-(トリフルオロメチル)ベンジル]-1,
3-オキサゾリジン-2-オン (2RS,3RS)-3-(5-クロロ-2-チエニル)-3
-ヒドロキシ-2-[4-(トリフルオロメチル)ベンジ
ル]プロピオン酸6.918g(18.97ミリモル)
のテトラヒドロフラン80ml溶液にトリエチルアミン
3.97ml(28.4ミリモル)、ジフェニルホスホ
リルアジド5.74g(20.9ミリモル)を加え、一
晩加熱還流した。反応液の溶媒を減圧留去し、得られた
粗生成物をシリカゲルカラムクロマトグラフィーにて精
製し(ヘキサン/酢酸エチル=3/1−1/1)、ジエ
チルエーテル−ヘキサンより結晶化して、目的物を得
た。白色結晶 収量5.985g 収率87% mp 127-128℃; 1H-NMR (CDCl3, 200MHz) δ 2.54-2.75
(2H, m), 4.25 (1H, ddd, 4.7 Hz, 8.0 Hz, 10.1 Hz),
5.10 (1H, br s), 5.72 (1H, d, J = 7.6 Hz), 6.89 (2
H, s), 7.22 (2H, d, J = 8.0 Hz), 7.58 (2H, d, J =
8.6 Hz); IR (KBr) 3248, 1736, 1327, 1159, 1127, 10
69 cm-1; Anal. Calcd for C15H11ClF3NO2S: C, 49.80;
H, 3.06; N, 3.87. Found: C, 49.77; H, 2.95; N, 3.
65. 6) (1RS,2RS)-2-アミノ-1-(5-クロロ-
2-チエニル)-3-[4-(トリフルオロメチル)フェニ
ル]プロパン-1-オール (4RS,5RS)-5-(5-クロロ-2-チエニル)-4
-[4-(トリフルオロメチル)ベンジル]-1,3-オキ
サゾリジン-2-オン2.951g(8.157ミリモ
ル)と水酸化ナトリウム1.31g(32.6ミリモ
ル)をエタノール30ml−水1.5ml中で、7時間
加熱還流した。反応液を食塩水で希釈し、酢酸エチルで
2回抽出した。集めた有機層を無水硫酸ナトリウムで乾
燥、溶媒を減圧留去した。残留物をシリカゲル(APS
タイプ)カラムクロマトグラフィーにて精製し(ヘキサ
ン/酢酸エチル=3/1−酢酸エチル)、酢酸エチル−
ヘキサンより結晶化して、目的物を得た。白色結晶 収
量1.318g 収率48% mp 86-87℃; 1H-NMR (CDCl3, 200MHz) δ 2.49 (1H, d
d, J = 9.7 Hz, 13.7 Hz), 2.92 (1H, dd, J = 3.9 Hz,
13.7 Hz), 3.28-3.38 (1H, m), 4.77 (1H, d, J= 4.8
Hz), 6.79 (1H, d, J = 3.8 Hz), 6.83 (1H, d, J = 3.
6 Hz), 7.30 (2H,d, J = 8.6 Hz), 7.57 (2H, d, J =
8.0 Hz); IR (KBr) 3100-2700, 1327, 1163, 1117, 106
9, 1038, 802 cm-1; Anal. Calcd for C14H13ClF3NOS:
C, 50.08;H, 3.90; N, 4.17. Found: C, 49.99; H, 3.9
2; N, 4.11. 7) N-[(1RS,2RS)-2-(5-クロロ-2-チ
エニル)-2-ヒドロキシ-1-[4-(トリフルオロメチ
ル)ベンジル]エチル]-4-フルオロナフタレン-1-カ
ルボキサミド (1RS,2RS)-2-アミノ-1-(5-クロロ-2-チ
エニル)-3-[4-(トリフルオロメチル)フェニル]
プロパン-1-オール0.168g(0.500ミリモ
ル)、4-フルオロ-1-ナフトエ酸0.10g(0.5
0ミリモル)、1-ヒドロキシベンゾトリアゾール水和
物77mg(0.50ミリモル)をアセトニトリル10
ml中で撹拌しながら1-エチル-3-(3-ジメチルアミ
ノプロピル)カルボジイミド・塩酸塩0.10g(0.
50ミリモル)を加え、室温で一晩撹拌した。反応液を
酢酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗
浄、無水硫酸マグネシウムで乾燥、シリカゲルを通した
後、溶媒を減圧留去した。得られた残留物を酢酸エチル
−ヘキサンより結晶化して、目的物を得た。白色結晶
収量0.186g 収率73% mp 201-203℃; 1H-NMR (CDCl3-DMSO-d6, 200MHz) δ 2.
95 (1H, dd, J = 10.6 Hz, 14.0 Hz), 3.21 (1H, dd, J
= 2.8 Hz, 14.6 Hz), 4.66-4.80 (1H, m), 5.10(1H,
t, J = 4.7 Hz), 5.86 (1H, d, J = 4.4 Hz), 6.85 (1
H, d, J = 3.6 Hz), 6.91 (1H, d, J = 4.0 Hz), 7.07
(1H, dd, J = 7.9 Hz, 10.1 Hz), 7.28 (1H, dd, J =
5.4 Hz, 8.0 Hz), 7.39-7.64 (7H, m), 7.79 (1H, d, J
= 9.6 Hz),8.06 (1H, d, J = 7.8 Hz); IR (KBr) 327
5, 1644, 1626, 1537, 1325, 1167, 1121, 1069, 760 c
m-1; Anal. Calcd for C25H18ClF4NO2S: C, 59.12; H,
3.57;N, 2.76. Found: C, 59.05; H, 3.47; N, 2.49.Example 197 N-[(1RS, 2RS) -2- (5-chloro-2-thienyl) -2-hydroxy-1- [4- (trifluoromethyl)
Benzyl] ethyl] -4-fluoronaphthalene-1-carboxamide 1) ethyl 3- (5-chloro-2-thienyl) -3-oxopropionate 10.12 g (6
To a solution of 2.24 mmol) in 80 ml of tetrahydrofuran was added 11.1 g (6,1'-carbonyldiimidazole).
(8.5 mmol) at room temperature and stirred for 6 hours. 9.81 g (34.2 mmol) of malonic acid monoethyl ester monomagnesium salt was added to this mixture at room temperature, and the mixture was stirred at 60 ° C. for 3 hours. After diluting the reaction solution with ethyl acetate and water and acidifying the reaction solution with concentrated hydrochloric acid, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure.
The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6/1) to obtain the desired product. Dark red liquid Yield 13.89 g Yield 96
% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.27 (3H, t, J = 7.2 H
z), 3.85 (2H, s), 4.21 (2H, q, J = 7.1 Hz), 6.99
(1H, d, J = 4.0 Hz), 7.53 (1H, d, J = 4.0 Hz); IR
(neat) 1738, 1667, 1418, 1329, 1215, 1017 cm -1 2) 3- (5-chloro-2-thienyl) -3-oxo-2-
Ethyl [4- (trifluoromethyl) benzyl] propionate 13.57 g (58.32 mmol) of ethyl 3- (5-chloro-2-thienyl) -3-oxopropionate in 1,2-
2.33 g of a liquid paraffin suspension of 60% sodium hydride in a 100 ml dimethoxyethane solution under ice-cooling (58.
3 mmol), and the mixture was stirred as it was for 0.5 hour. 4
13.9 g of-(trifluoromethyl) benzyl bromide
(58.3 mmol) of 1,2-dimethoxyethane 20
ml solution was added at room temperature and stirred at room temperature for 6 hours. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure.
The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-9 /
1) Crystallized from hexane to obtain the desired product. White crystals Yield 18.30 g Yield 80% mp 87-88 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.16 (3H, t,
J = 7.2 Hz), 3.36 (2H, d, J = 7.8 Hz), 4.14 (2H,
q, J = 7.2 Hz), 4.35 (1H, t, J = 7.5 Hz), 6.94 (1
H, d, J = 4.0 Hz), 7.33 (2H, d, J = 8.0 Hz), 7.53
(2H, d, J = 8.4 Hz), 7.55 (1H, d, J = 4.0 Hz); IR
(KBr) 1721, 1659, 1418, 1329, 1285, 1236, 1155, 11
. 19, 1071 cm -1; Anal Calcd for C 17 H 14 ClF 3 O 3 S: C, 5
2.25; H, 3.61. Found: C, 52.22; H, 3.42.3) (2RS, 3RS) -3- (5-Chloro-2-thienyl) -3-hydroxy-2- [4- (trifluoromethyl)
Ethyl benzyl] propionate While stirring 6.47 g (47.5 mmol) of zinc chloride in 100 ml of diethyl ether, 3.59 g (94.9 mmol) of sodium borohydride was added at room temperature, and the mixture was stirred for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. 9.272 g of ethyl 3- (5-chloro-2-thienyl) -3-oxo-2- [4- (trifluoromethyl) benzyl] propionate was added to the resulting solution.
(23.73 mmol) in 50 ml of diethyl ether was added at room temperature, and the mixture was stirred for 2 hours. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 9 / 1-3 / 1) to obtain the desired product. Colorless liquid Yield 9.093 g Yield 98% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.99 (3H, t, J = 7.1 H)
z), 2.96-3.16 (4H, m), 3.96 (2H, q, J = 7.1 Hz),
5.15 (1H, t, J = 4.2 Hz), 6.76 (1H, d, J = 3.8Hz),
6.79 (1H, d, J = 3.6 Hz), 7.26 (2H, d, J = 8.2 H
z), 7.52 (2H, d, J = 8.0 Hz); IR (neat) 3459, 1715,
1325, 1163, 1125, 1109, 1069, 1020 cm -1 4) (2RS, 3RS) -3- (5- chloro-2-thienyl) -3-hydroxy-2- [4- (trifluoromethyl)
Benzyl] propionic acid (2RS, 3RS) -3- (5-chloro-2-thienyl) -3
Ethyl -hydroxy-2- [4- (trifluoromethyl) benzyl] propionate 8.878 g (22.60 mmol) in methanol 30 ml-tetrahydrofuran 30
45.2 ml of 1N aqueous sodium hydroxide solution
(45.2 mmol) and stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from diethyl ether-hexane to obtain the desired product. White crystals Yield 7.092 g Yield 86% mp 150-151 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 3.06-3.15
(3H, m), 5.17 (1H, d, J = 4.8 Hz), 6.79 (2H, s), 7.
27 (2H, d, J = 8.0 Hz), 7.53 (2H, d, J = 8.4 Hz);
IR (KBr) 3382, 3050-2650, 1698, 1333, 1159, 1130,
1111, 1071, 802cm -1;. Anal Calcd for C 15 H 12 ClF 3 O
3 S:. C, 49.39; H, 3.32 Found:. C, 49.40; H, 3.29 5) (4RS, 5RS) -5- (5- chloro-2-thienyl) -4- [4- (trifluoromethyl ) Benzyl] -1,
3-oxazolidine-2-one (2RS, 3RS) -3- (5-chloro-2-thienyl) -3
6.918 g (18.97 mmol) of -hydroxy-2- [4- (trifluoromethyl) benzyl] propionic acid
3.97 ml (28.4 mmol) of triethylamine and 5.74 g (20.9 mmol) of diphenylphosphoryl azide were added to a solution of the above in 80 ml of tetrahydrofuran, and the mixture was refluxed overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from diethyl ether / hexane. I got something. White crystal Yield 5.985 g Yield 87% mp 127-128 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.54-2.75
(2H, m), 4.25 (1H, ddd, 4.7 Hz, 8.0 Hz, 10.1 Hz),
5.10 (1H, br s), 5.72 (1H, d, J = 7.6 Hz), 6.89 (2
H, s), 7.22 (2H, d, J = 8.0 Hz), 7.58 (2H, d, J =
8.6 Hz); IR (KBr) 3248, 1736, 1327, 1159, 1127, 10
. 69 cm -1; Anal Calcd for C 15 H 11 ClF 3 NO 2 S: C, 49.80;
H, 3.06; N, 3.87. Found: C, 49.77; H, 2.95; N, 3.
65.6) (1RS, 2RS) -2-amino-1- (5-chloro-
2-thienyl) -3- [4- (trifluoromethyl) phenyl] propan-1-ol (4RS, 5RS) -5- (5-chloro-2-thienyl) -4
2.951 g (8.157 mmol) of-[4- (trifluoromethyl) benzyl] -1,3-oxazolidin-2-one and 1.31 g (32.6 mmol) of sodium hydroxide in 30 ml of ethanol and 1. The mixture was heated under reflux in 5 ml for 7 hours. The reaction was diluted with brine and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified on silica gel (APS
Type) Purification by column chromatography (hexane / ethyl acetate = 3 / 1-ethyl acetate), and ethyl acetate-
Crystallization from hexane gave the desired product. White crystal Yield 1.318 g Yield 48% mp 86-87 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.49 (1H, d
d, J = 9.7 Hz, 13.7 Hz), 2.92 (1H, dd, J = 3.9 Hz,
13.7 Hz), 3.28-3.38 (1H, m), 4.77 (1H, d, J = 4.8
Hz), 6.79 (1H, d, J = 3.8 Hz), 6.83 (1H, d, J = 3.
6 Hz), 7.30 (2H, d, J = 8.6 Hz), 7.57 (2H, d, J =
8.0 Hz); IR (KBr) 3100-2700, 1327, 1163, 1117, 106
9, 1038, 802 cm -1 ; Anal.Calcd for C 14 H 13 ClF 3 NOS:
C, 50.08; H, 3.90; N, 4.17. Found: C, 49.99; H, 3.9
2; N, 4.11.7) N-[(1RS, 2RS) -2- (5-chloro-2-thienyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -4- Fluoronaphthalene-1-carboxamide (1RS, 2RS) -2-amino-1- (5-chloro-2-thienyl) -3- [4- (trifluoromethyl) phenyl]
0.168 g (0.500 mmol) of propan-1-ol 0.10 g (0.50 mmol) of 4-fluoro-1-naphthoic acid
0 mmol) 1-hydroxybenzotriazole hydrate 77 mg (0.50 mmol) in acetonitrile 10
While stirring in 0.1 ml, 0.10 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.
(50 mmol) and stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals
Yield 0.186 g Yield 73% mp 201-203 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ 2.
95 (1H, dd, J = 10.6 Hz, 14.0 Hz), 3.21 (1H, dd, J
= 2.8 Hz, 14.6 Hz), 4.66-4.80 (1H, m), 5.10 (1H,
t, J = 4.7 Hz), 5.86 (1H, d, J = 4.4 Hz), 6.85 (1
H, d, J = 3.6 Hz), 6.91 (1H, d, J = 4.0 Hz), 7.07
(1H, dd, J = 7.9 Hz, 10.1 Hz), 7.28 (1H, dd, J =
5.4 Hz, 8.0 Hz), 7.39-7.64 (7H, m), 7.79 (1H, d, J
= 9.6 Hz), 8.06 (1H, d, J = 7.8 Hz); IR (KBr) 327
5, 1644, 1626, 1537, 1325, 1167, 1121, 1069, 760 c
m -1 ; Anal.Calcd for C 25 H 18 ClF 4 NO 2 S: C, 59.12; H,
3.57; N, 2.76.Found: C, 59.05; H, 3.47; N, 2.49.
【0330】実施例198 N-[(1RS,2RS)-2-(5-クロロ-2-チエニ
ル)-2-ヒドロキシ-1-[4-(トリフルオロメチル)
ベンジル]エチル]-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド (1RS,2RS)-2-アミノ-1-(5-クロロ-2-チ
エニル)-3-[4-(トリフルオロメチル)フェニル]
プロパン-1-オール0.235g(0.700ミリモ
ル)、6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプ
テン-1-カルボン酸0.13g(0.70ミリモル)、
1-ヒドロキシベンゾトリアゾール水和物0.11g
(0.70ミリモル)をアセトニトリル10ml中で撹
拌しながら1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩0.13g(0.70ミリ
モル)を加え、室温で一晩撹拌した。反応液を酢酸エチ
ルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無水硫
酸マグネシウムで乾燥、シリカゲルを通した後、溶媒を
減圧留去した。得られた残留物をジイソプロピルエーテ
ル−ヘキサンより結晶化して、目的物を得た。白色結晶
収量0.298g 収率84% mp 184-185℃; 1H-NMR (CDCl3, 200MHz) δ 1.94-2.06
(2H, m), 2.15-2.24 (2H, m), 2.67 (2H, t, J = 5.8 H
z), 2.86 (1H, dd, J = 10.5 Hz, 14.5 Hz), 3.09 (1H,
dd, J = 4.5 Hz, 14.1 Hz), 4.25 (1H, d, J = 4.0 H
z), 4.63-4.76 (1H, m), .15 (1H, t, J = 3.8 Hz), 5.
83 (1H, d, J = 8.8 Hz), 5.91 (1H, td, J= 5.3 Hz, 1
1.8 Hz), 6.19 (1H, d, J = 11.8 Hz), 6.84 (2H, s),
7.00-7.21(3H, m), 7.33 (2H, d, J = 8.0 Hz), 7.57
(2H, d, J = 8.0 Hz); IR (KBr) 3283, 1638, 1526, 13
27, 1161, 1125, 1069 cm-1; Anal. Calcd for C26H23C
lF3NO2S: C, 61.72; H, 4.58; N, 2.77. Found: C, 61.
57; H, 4.35; N, 2.71.Example 198 N-[(1RS, 2RS) -2- (5-chloro-2-thienyl) -2-hydroxy-1- [4- (trifluoromethyl)
Benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2RS) -2-amino-1- (5-chloro-2-thienyl) -3- [4- ( Trifluoromethyl) phenyl]
0.235 g (0.700 mmol) of propan-1-ol, 0.13 g (0.70 mmol) of 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid,
0.11 g of 1-hydroxybenzotriazole hydrate
While stirring (0.70 mmol) in 10 ml of acetonitrile, 0.13 g (0.70 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystal Yield 0.298 g Yield 84% mp 184-185 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.94-2.06
(2H, m), 2.15-2.24 (2H, m), 2.67 (2H, t, J = 5.8 H
z), 2.86 (1H, dd, J = 10.5 Hz, 14.5 Hz), 3.09 (1H,
dd, J = 4.5 Hz, 14.1 Hz), 4.25 (1H, d, J = 4.0 H
z), 4.63-4.76 (1H, m), .15 (1H, t, J = 3.8 Hz), 5.
83 (1H, d, J = 8.8 Hz), 5.91 (1H, td, J = 5.3 Hz, 1
1.8 Hz), 6.19 (1H, d, J = 11.8 Hz), 6.84 (2H, s),
7.00-7.21 (3H, m), 7.33 (2H, d, J = 8.0 Hz), 7.57
(2H, d, J = 8.0 Hz); IR (KBr) 3283, 1638, 1526, 13
27, 1161, 1125, 1069 cm -1 ; Anal.Calcd for C 26 H 23 C
lF 3 NO 2 S: C, 61.72; H, 4.58; N, 2.77. Found: C, 61.
57; H, 4.35; N, 2.71.
【0331】実施例199 1,1-ジメチルエチル(1RS,2SR)-2-ヒドロ
キシ-2-(4-ピリジル)-1-((4-(トリフルオロメ
チル)フェニル)メチル)エチルカルバメート 1) 4-ピリジンカルボン酸(50.0g,406ミ
リモル)のテトラヒドロフラン(250ml)溶液に
1,1'-カルボニルビス-1H-イミダゾール(72.5
g,447ミリモル)を加え、室温で30分攪拌した。
反応液にマロン酸モノエチルマグネシウム塩(82.9
g,487ミリモル)を加え、30分加熱還流した。反
応液に酢酸エチル(200ml)および水(200m
l)を加え、更に水層のpHが7になるまでクエン酸を
加えた。反応液を酢酸エチル(400ml×2)で抽出
し、抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去した。残留物をジイソプロピルエー
テル−ヘキサンで洗浄後、ジイソプロピルエーテル−ヘ
キサンから再結晶させて、3-オキソ-3-(4-ピリジ
ル)プロピオン酸エチル(13.3g,17%)を得
た。 mp 60-61℃ IRνmaxKBrcm-1: 1744, 1699, 1651, 1634, 1595, 155
3. Anal. Calcd for C10H11NO3: C, 62.17; H, 5.74; N,
7.25 Found: C, 62.17; H, 5.86; N, 7.22.1 H-NMR (CDCl3)δ: 1.26 (3/7H, t, J = 7.2 Hz), 1.35
(18/7H, t, J = 7.2 Hz), 4.00 (2/7H, s), 4.18-4.40
(2H, m), 5.77 (6/7H, s), 7.61 (12/7H, d, J= 4.8 H
z), 7.74 (2/7H, d, J = 4.8 Hz), 8.71 (12/7H, d, J
= 4.8 Hz), 8.83(2/7H, d, J = 4.8 Hz), 12.44 (6/7H,
s). 2) 3-オキソ-3-(4-ピリジル)プロピオン酸エチ
ル(13.9g,72.0ミリモル)の1,2-ジメト
キシエタン(100ml)溶液に水素化ナトリウム(6
0%油性,2.88g,72.0ミリモル)を氷冷下加
え、室温で30分攪拌した。反応液の中に4-トリフル
オロメチルベンジルブロミド(17.2g,72.0ミ
リモル)の1,2-ジメトキシエタン(50ml)溶液
を滴下し、反応液を室温で4時間攪拌した。反応液を水
(300ml)の中に注ぎ、酢酸エチル(500ml×
2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=4:1)で精製し、酢酸エチル−ヘキサン
より再結晶させて、3-オキソ-3-(4-ピリジル)-2-
((4-(トリフルオロメチル)フェニル)メチル)プ
ロピオン酸エチル(10.9g,43%)を得た。 mp 64-65℃ IRνmaxKBrcm-1: 1738, 1699. Anal. Calcd for C18H16F3NO3: C, 61.54; H, 4.59; N,
3.99 Found: C, 61.61; H, 4.44; N, 3.93.1 H-NMR (CDCl3)δ: 1.11 (3H, t, J = 7.0 Hz), 3.39
(2H, d, J = 7.4 Hz), 4.11 (2H, q, J = 7.0 Hz), 4.5
6 (1H, t, J = 7.4 Hz), 7.35 (2H, d, J = 8.0 Hz),
7.54 (2H, d, J = 8.0 Hz), 7.66-7.78 (2H, m), 8.76-
8.88 (2H, m). 3) 塩化亜鉛(8.14g,59.8ミリモル)のジ
エチルエーテル(200ml)溶液に水素化ホウ素ナト
リウム(4.53g,120ミリモル)を加えて室温で
30分攪拌した。不溶物をろ去し、ろ液に3-オキソ-3
-(4-ピリジル)-2-((4-(トリフルオロメチル)
フェニル)メチル)プロピオン酸エチル(10.5g,
29.9ミリモル)のジエチルエーテル(50ml)溶
液を加えて室温で30分攪拌した。氷冷下、反応液に1
規定塩酸を加えてクエンチし、更に飽和重曹水をpHが
8になるまで加え、酢酸エチル(300ml×2)で抽
出した。抽出液を水および飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(酢酸エチル)で精製
し、ジイソプロピルエーテル−ヘキサンより再結晶させ
て、(2RS,3RS)-3-ヒドロキシ-3-(4-ピリ
ジル)-2-((4-(トリフルオロメチル)フェニル)
メチル)プロピオン酸エチル(9.52g,90%)を
得た。 mp 78-80℃ IRνmaxKBrcm-1: 1726, 1630, 1618.1 H-NMR (CDCl3)δ: 0.98 (3H, t, J = 7.4 Hz), 2.72-
2.82 (1H, m), 2.90-3.20(2H, m), 3.58 (1H, d, J =
2.6 Hz), 3.97 (2H, q, J = 7.4 Hz), 5.21 (1H,s), 7.
16 (2H, d, J = 8.0 Hz), 7.40-7.70 (4H, m), 8.59 (2
H, d, J = 6.2 Hz). 4) (2RS,3RS)-3-ヒドロキシ-3-(4-ピ
リジル)-2-((4-(トリフルオロメチル)フェニ
ル)メチル)プロピオン酸エチル(9.36g,26.
5ミリモル)のメタノール(40ml)溶液に、2規定
水酸化ナトリウム水溶液(26ml,52ミリモル)を
加えて室温で終夜攪拌した。反応液を1規定塩酸で酸性
とした後、飽和重曹水を加えpHを6に調整し、酢酸エ
チル(200ml×2)で抽出した。抽出液を水および
飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減
圧留去し(2RS,3RS)-3-ヒドロキシ-3-(4-
ピリジル)-2-((4-(トリフルオロメチル)フェニ
ル)メチル)プロピオン酸(7.8g,90%)を得
た。 IRνmaxKBrcm-1: 1725.1 H-NMR (CD3OD)δ: 3.10-3.24 (3H, m), 5.26 (1H, d,
J = 4.8 Hz), 7.34 (2H,d, J = 8.0 Hz), 7.49 (2H, d,
J = 8.0 Hz), 8.07 (2H, d, J = 6.6 Hz), 8.73 (2H,
d, J = 6.6 Hz). 5) (2RS,3RS)-3-ヒドロキシ-3-(4-ピ
リジル)-2-((4-(トリフルオロメチル)フェニ
ル)メチル)プロピオン酸(7.8g,24.0ミリモ
ル)のテトラヒドロフラン(100ml)溶液に、ジフ
ェニルホスホリルアジド(4.6ml,21.3ミリモ
ル)とトリエチルアミン(6.76ml,48.4ミリ
モル)を加え、終夜加熱還流した。反応液を放冷後、水
(200ml)を加えて酢酸エチル(200ml×2)
で抽出した。抽出液を飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(ヘキサン:酢酸エチル=
1:1)で精製しジイソプロピルエーテル−ヘキサンか
ら再結晶させて(4RS,5SR)-5-(4-ピリジ
ル)-4-((4-(トリフルオロメチル)フェニル)メ
チル)-1,3-オキサゾリジン-2-オン(2.50g,
58%)を得た。 mp 212-213℃ IRνmaxKBrcm-1: 1755, 1609. Anal. Calcd for C16H13F3N2O2: C, 59.63; H, 4.07;
N, 8.69 Found: C, 59.71; H, 3.99; N, 8.56.1 H-NMR (CDCl3)δ: 2.20-2.48 (2H, m), 4.26-4.38 (1
H, m), 5.33 (1H, brs),5.80 (1H, d, J = 8.2 Hz), 7.
16 (2H, d, J = 8.0 Hz), 7.33 (2H, d, J = 6.0Hz),
7.56 (2H, d, J = 8.0 Hz), 7.68 (2H, d, J = 6.0 H
z). 6) (4RS,5SR)-5-(4-ピリジル)-4-
((4-(トリフルオロメチル)フェニル)メチル)-
1,3-オキサゾリジン-2-オン(500mg,1.5
5ミリモル)のアセトニトリル(5ml)溶液に二炭酸
ジ-t-ブチル(406mg,1.86ミリモル)および
ジメチルアミノピリジン(19.6mg,0.16ミリ
モル)を加え、室温で1時間攪拌した。反応液に水(2
0ml)を加えて酢酸エチル(20ml×2)で抽出し
た。抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去した。残留物を酢酸エチル−ヘキサ
ンから再結晶させて(4RS,5SR)-2-オキソ-5-
(4-ピリジル)-4-((4-(トリフルオロメチル)フ
ェニル)メチル)-1,3-オキサゾリジン-3-カルボン
酸1,1-ジメチルエチル(571mg,87%)を得
た。 mp 166-168℃ IRνmaxKBrcm-1: 1821, 1726. Anal. Calcd for C21H21F3N2O4: C, 59.71; H, 5.01;
N, 6.63 Found: C, 59.65; H, 5.05; N, 6.34.1 H-NMR (CDCl3)δ: 1.48 (9H, s), 2.61 (1H, dd, J =
14.2, 8.0 Hz), 2.91 (1H, dd, J = 14.2, 5.4 Hz), 4.
80-4.98 (1H, m), 5.67 (1H, d, J = 7.0 Hz), 6.84 (2
H, d, J = 8.0 Hz), 7.13 (2H, d, J = 6.0 Hz), 7.37
(2H, d, J = 8.0Hz), 8.54 (2H, d, J = 6.0 Hz). 7) (4RS,5SR)-2-オキソ-5-(4-ピリジ
ル)-4-((4-(トリフルオロメチル)フェニル)メ
チル)-1,3-オキサゾリジン-3-カルボン酸1,1-
ジメチルエチル(500mg,1.18ミリモル)のメ
タノール(2.8ml)に0.5N水酸化ナトリウムの
メタノール溶液(2.8ml,1.40ミリモル)を加
え室温で1時間攪拌した。反応液に水(20ml)を加
えて酢酸エチル(20ml×2)で抽出した。抽出液を
飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減
圧留去した。残留物を酢酸エチル−ヘキサンから再結晶
させて表題化合物(391mg,83%)を得た。 mp 198-200℃ IRνmaxKBrcm-1: 1682, 1605, 1528.1 H-NMR (CDCl3)δ: 1.35 (9H, s), 2.72-2.82 (2H, m),
3.61 (1H, brs), 4.11(1H, brs), 4.65 (1H, d, J =
8.6 Hz), 4.99 (1H, s), 7.20 (2H, d, J = 8.0Hz), 7.
36 (2H, d, J = 6.0 Hz), 7.51 (2H, d, J = 8.0 Hz),
8.61 (2H, d, J= 6.0 Hz).Example 199 1,1-Dimethylethyl (1RS, 2SR) -2-hydroxy-2- (4-pyridyl) -1-((4- (trifluoromethyl) phenyl) methyl) ethyl carbamate 1) 4 To a solution of 1-pyridinecarboxylic acid (50.0 g, 406 mmol) in tetrahydrofuran (250 ml) was added 1,1′-carbonylbis-1H-imidazole (72.5 g).
g, 447 mmol) and stirred at room temperature for 30 minutes.
Monoethyl magnesium malonate (82.9) was added to the reaction mixture.
g, 487 mmol) and heated under reflux for 30 minutes. Ethyl acetate (200 ml) and water (200 m
l) was added, and citric acid was further added until the pH of the aqueous layer reached 7. The reaction solution was extracted with ethyl acetate (400 ml × 2), the extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was washed with diisopropyl ether-hexane and recrystallized from diisopropyl ether-hexane to obtain ethyl 3-oxo-3- (4-pyridyl) propionate (13.3 g, 17%). mp 60-61 ℃ IRνmax KBr cm -1 : 1744, 1699, 1651, 1634, 1595, 155
. 3. Anal Calcd for C 10 H 11 NO 3: C, 62.17; H, 5.74; N,
7.25 Found:. C, 62.17; H, 5.86; N, 7.22 1 H-NMR (CDCl 3) δ: 1.26 (3 / 7H, t, J = 7.2 Hz), 1.35
(18 / 7H, t, J = 7.2 Hz), 4.00 (2 / 7H, s), 4.18-4.40
(2H, m), 5.77 (6 / 7H, s), 7.61 (12 / 7H, d, J = 4.8 H
z), 7.74 (2 / 7H, d, J = 4.8 Hz), 8.71 (12 / 7H, d, J
= 4.8 Hz), 8.83 (2 / 7H, d, J = 4.8 Hz), 12.44 (6 / 7H,
s). 2) To a solution of ethyl 3-oxo-3- (4-pyridyl) propionate (13.9 g, 72.0 mmol) in 1,2-dimethoxyethane (100 ml) was added sodium hydride (6).
(0% oily, 2.88 g, 72.0 mmol) under ice-cooling and stirred at room temperature for 30 minutes. A solution of 4-trifluoromethylbenzyl bromide (17.2 g, 72.0 mmol) in 1,2-dimethoxyethane (50 ml) was added dropwise to the reaction solution, and the reaction solution was stirred at room temperature for 4 hours. The reaction solution was poured into water (300 ml), and ethyl acetate (500 ml ×
Extracted in 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Purified with ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give 3-oxo-3- (4-pyridyl) -2-.
Ethyl ((4- (trifluoromethyl) phenyl) methyl) propionate (10.9 g, 43%) was obtained. mp 64-65 ° C IRνmax KBr cm -1 : 1738, 1699. Anal.Calcd for C 18 H 16 F 3 NO 3 : C, 61.54; H, 4.59; N,
3.99 Found: C, 61.61; H, 4.44; N, 3.93. 1 H-NMR (CDCl 3 ) δ: 1.11 (3H, t, J = 7.0 Hz), 3.39
(2H, d, J = 7.4 Hz), 4.11 (2H, q, J = 7.0 Hz), 4.5
6 (1H, t, J = 7.4 Hz), 7.35 (2H, d, J = 8.0 Hz),
7.54 (2H, d, J = 8.0 Hz), 7.66-7.78 (2H, m), 8.76-
8.88 (2H, m). 3) Sodium borohydride (4.53 g, 120 mmol) was added to a solution of zinc chloride (8.14 g, 59.8 mmol) in diethyl ether (200 ml), and the mixture was stirred at room temperature for 30 minutes. . The insoluble material is removed by filtration, and the filtrate is treated with 3-oxo-3.
-(4-pyridyl) -2-((4- (trifluoromethyl)
Phenyl) methyl) ethyl propionate (10.5 g,
(29.9 mmol) in diethyl ether (50 ml) was added and stirred at room temperature for 30 minutes. Add 1 reaction solution under ice-cooling.
The mixture was quenched by addition of normal hydrochloric acid, and saturated aqueous sodium hydrogen carbonate was further added until the pH reached 8, followed by extraction with ethyl acetate (300 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from diisopropyl ether-hexane to give (2RS, 3RS) -3-hydroxy-3- (4-pyridyl) -2-((4- ( Trifluoromethyl) phenyl)
Ethyl (methyl) propionate (9.52 g, 90%) was obtained. mp 78-80 ℃ IRνmax KBr cm -1: 1726, 1630, 1618. 1 H-NMR (CDCl 3) δ: 0.98 (3H, t, J = 7.4 Hz), 2.72-
2.82 (1H, m), 2.90-3.20 (2H, m), 3.58 (1H, d, J =
2.6 Hz), 3.97 (2H, q, J = 7.4 Hz), 5.21 (1H, s), 7.
16 (2H, d, J = 8.0 Hz), 7.40-7.70 (4H, m), 8.59 (2
H, d, J = 6.2 Hz). 4) Ethyl (2RS, 3RS) -3-hydroxy-3- (4-pyridyl) -2-((4- (trifluoromethyl) phenyl) methyl) propionate (9 .36 g, 26.
To a solution of 5 mmol) in methanol (40 ml) was added a 2N aqueous sodium hydroxide solution (26 ml, 52 mmol), and the mixture was stirred at room temperature overnight. After the reaction solution was acidified with 1N hydrochloric acid, the pH was adjusted to 6 by adding saturated aqueous sodium hydrogen carbonate, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. (2RS, 3RS) -3-hydroxy-3- (4-
Pyridyl) -2-((4- (trifluoromethyl) phenyl) methyl) propionic acid (7.8 g, 90%) was obtained. IRνmax KBr cm -1: 1725. 1 H -NMR (CD 3 OD) δ: 3.10-3.24 (3H, m), 5.26 (1H, d,
J = 4.8 Hz), 7.34 (2H, d, J = 8.0 Hz), 7.49 (2H, d,
J = 8.0 Hz), 8.07 (2H, d, J = 6.6 Hz), 8.73 (2H,
d, J = 6.6 Hz). 5) (2RS, 3RS) -3-hydroxy-3- (4-pyridyl) -2-((4- (trifluoromethyl) phenyl) methyl) propionic acid (7.8 g, To a solution of 24.0 mmol) in tetrahydrofuran (100 ml) was added diphenylphosphoryl azide (4.6 ml, 21.3 mmol) and triethylamine (6.76 ml, 48.4 mmol), and the mixture was heated under reflux overnight. After allowing the reaction solution to cool, water (200 ml) was added, and ethyl acetate (200 ml × 2) was added.
Extracted. The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
1: 1) and recrystallized from diisopropyl ether-hexane to give (4RS, 5SR) -5- (4-pyridyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3- Oxazolidin-2-one (2.50 g,
58%). mp 212-213 ℃ IRνmax KBr cm -1 : 1755, 1609. Anal.Calcd for C 16 H 13 F 3 N 2 O 2 : C, 59.63; H, 4.07;
N, 8.69 Found:. C, 59.71; H, 3.99; N, 8.56 1 H-NMR (CDCl 3) δ: 2.20-2.48 (2H, m), 4.26-4.38 (1
H, m), 5.33 (1H, brs), 5.80 (1H, d, J = 8.2 Hz), 7.
16 (2H, d, J = 8.0 Hz), 7.33 (2H, d, J = 6.0 Hz),
7.56 (2H, d, J = 8.0 Hz), 7.68 (2H, d, J = 6.0 H
z). 6) (4RS, 5SR) -5- (4-pyridyl) -4-
((4- (trifluoromethyl) phenyl) methyl)-
1,3-oxazolidine-2-one (500 mg, 1.5
To a solution of 5 mmol) in acetonitrile (5 ml) were added di-t-butyl dicarbonate (406 mg, 1.86 mmol) and dimethylaminopyridine (19.6 mg, 0.16 mmol), and the mixture was stirred at room temperature for 1 hour. Water (2
0 ml) and extracted with ethyl acetate (20 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (4RS, 5SR) -2-oxo-5-.
There was obtained 1,1-dimethylethyl (571 mg, 87%) of (4-pyridyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-3-carboxylate. mp 166-168 ° C IRνmax KBr cm -1 : 1821, 1726. Anal.Calcd for C 21 H 21 F 3 N 2 O 4 : C, 59.71; H, 5.01;
N, 6.63 Found:. C, 59.65; H, 5.05; N, 6.34 1 H-NMR (CDCl 3) δ: 1.48 (9H, s), 2.61 (1H, dd, J =
14.2, 8.0 Hz), 2.91 (1H, dd, J = 14.2, 5.4 Hz), 4.
80-4.98 (1H, m), 5.67 (1H, d, J = 7.0 Hz), 6.84 (2
H, d, J = 8.0 Hz), 7.13 (2H, d, J = 6.0 Hz), 7.37
(2H, d, J = 8.0 Hz), 8.54 (2H, d, J = 6.0 Hz). 7) (4RS, 5SR) -2-oxo-5- (4-pyridyl) -4-((4- ( Trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-3-carboxylic acid 1,1-
A methanol solution (2.8 ml, 1.40 mmol) of 0.5N sodium hydroxide was added to methanol (2.8 ml) of dimethylethyl (500 mg, 1.18 mmol), and the mixture was stirred at room temperature for 1 hour. Water (20 ml) was added to the reaction solution, and extracted with ethyl acetate (20 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (391 mg, 83%). mp 198-200 ℃ IRνmax KBr cm -1: 1682, 1605, 1528. 1 H-NMR (CDCl 3) δ: 1.35 (9H, s), 2.72-2.82 (2H, m),
3.61 (1H, brs), 4.11 (1H, brs), 4.65 (1H, d, J =
8.6 Hz), 4.99 (1H, s), 7.20 (2H, d, J = 8.0Hz), 7.
36 (2H, d, J = 6.0 Hz), 7.51 (2H, d, J = 8.0 Hz),
8.61 (2H, d, J = 6.0 Hz).
【0332】実施例200 4-フルオロ-N-((1S,2R)-2-ヒドロキシ-2-
(4-ピリジル)-1-((4-(トリフルオロメチル)フ
ェニル)メチル)エチル)-1-ナフタレンカルボキサミ
ド 1) 1,1-ジメチルエチル(1RS,2SR)-2-
ヒドロキシ-2-(4-ピリジル)-1-((4-(トリフル
オロメチル)フェニル)メチル)エチルカルバメート
(300mg,0.76ミリモル)にトリフルオロ酢酸
(3ml)を加え、室温で10分攪拌した。反応液に1
N水酸化ナトリウム水溶液(10ml)を加え、酢酸エ
チル(20ml×2)で抽出した。抽出液を飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ジイソプロピルエーテルから
再結晶させて(1RS,2SR)-2-アミノ-1-(4-
ピリジル)-3-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(135mg,60%)を得た。 mp 97-98℃ IRνmaxKBrcm-1: 1603, 1418.1 H-NMR (CDCl3)δ: 2.43 (1H, dd, J = 13.6, 10.6 H
z), 2.71 (1H, dd, J = 13.6, 2.8 Hz), 3.30-3.42 (1
H, m), 4.74 (1H, d, J = 4.4 Hz), 7.23 (2H, d, J=
8.2 Hz), 7.35 (2H, d, J = 6.0 Hz), 7.55 (2H, d, J
= 8.2 Hz), 8.62 (2H, d, J = 6.0 Hz). 2) (1RS,2SR)-2-アミノ-1-(4-ピリジ
ル)-3-(4-(トリフルオロメチル)フェニル)-1-
プロパノール(70mg,0.24ミリモル)のアセト
ニトリル(5ml)溶液に4-フルオロナフタレンカル
ボン酸(45mg,0.24ミリモル)および1-エチ
ル-3-(3-ジメチルアミノプロピル)カルボジイミド
・塩酸塩(68mg,0.35ミリモル)および1-ヒ
ドロキシ-1H-ベンゾトリアゾール(36mg,0.2
4ミリモル)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を1規定塩酸、1規定水酸化ナ
トリウム水溶液、飽和食塩水で順次洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(酢酸エチル)で精製し、酢
酸エチル−ジイソプロピルエーテルから再結晶させて、
表題化合物(55mg,50%)を得た。 mp 239-243℃ IRνmaxKBrcm-1: 1638, 1620, 1603.1 H-NMR (CDCl3+CD3OD)δ: 2.80-3.00 (2H, m), 4.70-4.
92 (1H, m), 5.05 (1H,brs), 7.00-7.60 (13H, m), 8.0
7 (1H, d, J = 8.4 Hz), 8.50-8.62 (2H, m).Example 200 4-Fluoro-N-((1S, 2R) -2-hydroxy-2-
(4-pyridyl) -1-((4- (trifluoromethyl) phenyl
Enyl) methyl) ethyl) -1-naphthalenecarboxami
1) 1,1-dimethylethyl (1RS, 2SR) -2-
Hydroxy-2- (4-pyridyl) -1-((4- (trifur
Oromethyl) phenyl) methyl) ethyl carbamate
(300 mg, 0.76 mmol) in trifluoroacetic acid
(3 ml) was added and stirred at room temperature for 10 minutes. 1 in the reaction solution
N sodium hydroxide aqueous solution (10 ml) was added, and
Extracted with chill (20 ml × 2). Extracts were washed with saturated saline
, Dried over anhydrous magnesium sulfate and evaporated under reduced pressure.
Was. The residue was purified from ethyl acetate-diisopropyl ether.
After recrystallization, (1RS, 2SR) -2-amino-1- (4-
Pyridyl) -3- (4- (trifluoromethyl) phenyl
L) -1-Propanol (135 mg, 60%) was obtained. mp 97-98 ℃ IRνmax KBr cm -1 : 1603, 1418. 1 H-NMR (CDCl Three ) δ: 2.43 (1H, dd, J = 13.6, 10.6 H
z), 2.71 (1H, dd, J = 13.6, 2.8 Hz), 3.30-3.42 (1
H, m), 4.74 (1H, d, J = 4.4 Hz), 7.23 (2H, d, J =
8.2 Hz), 7.35 (2H, d, J = 6.0 Hz), 7.55 (2H, d, J
= 8.2 Hz), 8.62 (2H, d, J = 6.0 Hz). 2) (1RS, 2SR) -2-amino-1- (4-pyridyl)
) -3- (4- (trifluoromethyl) phenyl) -1-
Acetal of propanol (70 mg, 0.24 mmol)
4-Fluoronaphthalene carb in nitrile (5ml) solution
Boric acid (45 mg, 0.24 mmol) and 1-ethyl
3- (3-dimethylaminopropyl) carbodiimide
Hydrochloride (68 mg, 0.35 mmol) and 1-
Droxy-1H-benzotriazole (36 mg, 0.2
4 mmol) and stirred overnight at room temperature. Water
(100 ml) and diluted with ethyl acetate (100 ml ×
Extracted in 2). Extract solution is 1N hydrochloric acid, 1N hydroxide
Wash sequentially with aqueous thorium solution and saturated saline,
After drying with gnesium, it was distilled off under reduced pressure. Silica gel residue
Purified by column chromatography (ethyl acetate)
Recrystallized from ethyl acid-diisopropyl ether,
The title compound (55 mg, 50%) was obtained. mp 239-243 ℃ IRνmax KBr cm -1 : 1638, 1620, 1603. 1 H-NMR (CDCl Three + CD Three OD) δ: 2.80-3.00 (2H, m), 4.70-4.
92 (1H, m), 5.05 (1H, brs), 7.00-7.60 (13H, m), 8.0
7 (1H, d, J = 8.4 Hz), 8.50-8.62 (2H, m).
【0333】実施例201 1,1-ジメチルエチル(1RS,2SR)-2-(6-ク
ロロ-3-ピリジル)-2-ヒドロキシ-1-((4-(トリ
フルオロメチル)フェニル)メチル)エチルカルバメー
ト 1) 6-クロロ-3-ピリジンカルボン酸(10g,6
3.5ミリモル)のテトラヒドロフラン(150ml)
溶液に1,1'-カルボニルビス-1H-イミダゾール(1
1.3g,69.8ミリモル)を加え、30分加熱還流
した。反応液を冷却後、マロン酸モノエチルマグネシウ
ム塩(10g,34.9ミリモル)を加え、室温で30
分攪拌した。反応液に水(200ml)を加え、酢酸エ
チル(200ml×2)で抽出し、抽出液を飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=4:1)で精製し、3-(6-クロ
ロ-3-ピリジル)-3-オキソプロピオン酸エチル(9.
28g,64%)を褐色油状物として得た。 IRνmaxKBrcm-1: 1740, 1694, 1628, 1584.1 H-NMR (CDCl3)δ: 1.16 (3H×3/5, t, J = 7.4 Hz),
1.24 (3H×2/5, t, J = 7.0 Hz), 3.88 (2H×3/5, s),
4.04-4.24 (2H, m), 5.58 (1H×2/5, s), 7.29 (1H×2/
5, d, J = 8.0 Hz), 7.37 (1H×3/5, d, J = 8.0 Hz),
7.90 (1H×2/5, dd, J = 8.0, 2.6 Hz), 8.11 (1H×3/
5, dd, J = 8.0, 2.6 Hz), 8.66 (1H×2/5,d, J = 2.6
Hz), 8.81 (1H×3/5, d, J = 2.6 Hz). 2) 3-(6-クロロ-3-ピリジル)-3-オキソプロピ
オン酸エチル(9.0g,39.5ミリモル)の1,2
-ジメトキシエタン(50ml)溶液に水素化ナトリウ
ム(60%油性,1.58g,39.5ミリモル)を氷
冷下加え、室温で2時間攪拌した。反応液の中に4-ト
リフルオロメチルベンジルブロミド(9.45g,3
9.5ミリモル)の1,2-ジメトキシエタン(50m
l)溶液を滴下し、反応液を室温で終夜攪拌した。反応
液を水(200ml)の中に注ぎ、飽和重曹水を加え、
酢酸エチル(200ml×2)で抽出した。抽出液を水
および飽和食塩水で洗浄し、無水硫酸マグネシウムで乾
燥後減圧留去した。残留物をシリカゲルカラムクロマト
グラフィー(トルエン:酢酸エチル=1:1)で精製し
3-(6-クロロ-3-ピリジル)-3-オキソ-2-((4-
(トリフルオロメチル)フェニル)メチル)プロピオン
酸エチル(14.2g,93%)を無色油状物として得
た。 IRνmaxKBrcm-1: 1740, 1694, 1582.1 H-NMR (CDCl3)δ: 1.13 (3H, t, J = 7.0 Hz), 3.40
(2H, d, J = 7.4 Hz), 4.12 (2H, q, J = 7.0 Hz), 4.5
4 (1H, t, J = 7.4 Hz), 7.35 (2H, d, J = 8.4 Hz),
7.44 (1H, d, J = 7.0 Hz), 7.53 (2H, d, J = 8.4 H
z), 8.16-8.24 (1H, m), 8.95 (1H, d, J = 2.6 Hz). 3) 塩化亜鉛(9.89g,72.6ミリモル)のジ
エチルエーテル(150ml)溶液に水素化ホウ素ナト
リウム(5.49g,145ミリモル)を加えて室温で
30分攪拌した。不溶物をろ去し、ろ液に3-(6-クロ
ロ-3-ピリジル)-3-オキソ-2-((4-(トリフルオ
ロメチル)フェニル)メチル)プロピオン酸エチル(1
4g,36.3ミリモル)のジエチルエーテル(50m
l)溶液を加えて室温で30分攪拌した。氷冷下、反応
液に1規定塩酸を加えてクエンチし、更に水(200m
l)を加え、酢酸エチル(300ml×2)で抽出し
た。抽出液を水および飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物を中圧シリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=4:1)で精製し、(2RS,3RS)-3-(6-ク
ロロ-3-ピリジル)-3-ヒドロキシ-2-((4-(トリ
フルオロメチル)フェニル)メチル)プロピオン酸エチ
ル(9.32g,66%)を無色油状物として得た。 IRνmaxKBrcm-1: 1728, 1618, 1588, 1568.1 H-NMR (CDCl3)δ: 0.95 (3H, t, J = 7.0 Hz), 2.92-
3.18 (3H, m), 3.35 (1H,d, J = 2.4 Hz), 3.92 (2H,
q, J = 7.0 Hz), 5.04-5.12 (1H, m), 7.20 (2H,d, J =
8.2 Hz), 7.32 (1H, d, J = 8.4 Hz), 7.50 (2H, d, J
= 8.2 Hz), 7.73(1H, dd, J = 8.8, 2.8 Hz), 8.38 (1
H, d, J = 8.4 Hz). 4) (2RS,3RS)-3-(6-クロロ-3-ピリジ
ル)-3-ヒドロキシ-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸エチル(9.0
g,23.2ミリモル)のメタノール(23ml)溶液
に、2規定水酸化ナトリウム水溶液(23.2ml,4
6.4ミリモル)を加えて室温で終夜攪拌した。反応液
を1規定塩酸で酸性とした後、飽和重曹水を加えpHを
8に調整し、酢酸エチル(200ml×2)で抽出し
た。抽出液を水および飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をジイソプロ
ピルエーテル−ヘキサンから再結晶させて(2RS,3
RS)-3-(6-クロロ-3-ピリジル)-3-ヒドロキシ-
2-((4-(トリフルオロメチル)フェニル)メチル)
プロピオン酸(7.4g,89%)を得た。 mp 145-146℃ IRνmaxKBrcm-1: 1715, 1591, 1464. Anal. Calcd for C16H13NO3ClF3: C, 53.42; H, 3.64;
N, 3.89 Found: C, 53.48; H, 3.93; N, 3.66.1 H-NMR (CDCl3)δ: 2.90-3.20 (3H, m), 5.11 (1H, d,
J = 4.4 Hz), 7.24 (2H,d, J = 8.4 Hz), 7.33 (1H, d,
J = 8.2 Hz), 7.49 (2H, d, J = 8.4 Hz), 7.78 (1H,
dd, J = 8.2, 2.2 Hz), 8.35 (1H, d, J = 2.2 Hz). 5) (2RS,3RS)-3-(6-クロロ-3-ピリジ
ル)-3-ヒドロキシ-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸(5.0g,1
3.9ミリモル)のテトラヒドロフラン(150ml)
溶液に、ジフェニルホスホリルアジド(3.3ml,1
5.3ミリモル)とトリエチルアミン(2.9ml,2
0.9ミリモル)を加え、1時間加熱還流した。反応液
を放冷後、水(200ml)を加えて酢酸エチル(20
0ml×2)で抽出した。抽出液を1規定塩酸、飽和重
曹水、飽和食塩水で順次洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物をシリカゲルカラムクロ
マトグラフィー(酢酸エチル)で精製し、酢酸エチル−
ヘキサンから再結晶させて(4RS,5SR)-5-(6
-クロロ-3-ピリジル)-4-((4-(トリフルオロメチ
ル)フェニル)メチル)-1,3-オキサゾリジン-2-オ
ン(4.29g,87%)を得た。 mp 176-177℃ IRνmaxKBrcm-1: 1767, 1590, 1568. Anal. Calcd for C16H12N2O2ClF3: C, 53.87; H, 3.39;
N, 7.85 Found: C, 53.86; H, 3.57; N, 7.66.1 H-NMR (CDCl3)δ: 2.22-2.50 (2H, m), 4.26-4.40 (1
H, m), 5.16 (1H, brs),5.84 (1H, d, J = 8.0 Hz), 7.
16 (2H, d, J = 8.0 Hz), 7.43 (1H, d, J = 8.2Hz),
7.57 (2H, d, J = 8.0 Hz), 7.73 (1H, dd, J = 8.2,
2.6 Hz), 8.41 (1H, d, J = 2.6 Hz). 6) (4RS,5SR)-5-(6-クロロ-3-ピリジ
ル)-4-((4-(トリフルオロメチル)フェニル)メ
チル)-1,3-オキサゾリジン-2-オン(500mg,
1.40ミリモル)のアセトニトリル(5ml)溶液に
二炭酸ジ-t-ブチル(367mg,1.68ミリモル)
およびジメチルアミノピリジン(17mg,0.14ミ
リモル)を加え、室温で2時間攪拌した。反応液を濃縮
後、水(20ml)で希釈し、酢酸エチル(20ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて(4RS,5SR)-
5-(6-クロロ-3-ピリジル)-2-オキソ-4-((4-
(トリフルオロメチル)フェニル)メチル)-1,3-オ
キサゾリジン-3-カルボン酸1,1-ジメチルエチル
(1.19g,93%)を得た。 mp 170-174℃ IRνmaxKBrcm-1: 1821, 1723, 1464, 1362. Anal. Calcd for C21H20N2O4ClF3: C, 55.21; H, 4.41;
N, 6.13 Found: C, 55.44; H, 4.28; N, 6.22.1 H-NMR (CDCl3)δ: 1.49 (9H, s), 2.60 (1H, dd, J =
14.2, 8.8 Hz), 3.01 (1H, dd, J = 14.2, 5.2 Hz), 4.
82-4.96 (1H, m), 5.70 (1H, d, J = 7.0 Hz), 6.85 (2
H, d, J = 8.0 Hz), 7.18 (1H, d, J = 8.4 Hz), 7.36-
7.46 (3H, m), 8.27 (1H, d, J = 2.2 Hz). 7) (4RS,5SR)-5-(6-クロロ-3-ピリジ
ル)-2-オキソ-4-((4-(トリフルオロメチル)フ
ェニル)メチル)-1,3-オキサゾリジン-3-カルボン
酸1,1-ジメチルエチル(600mg,1.31ミリ
モル)のメタノール(3.1ml)に0.5Nの水酸化
ナトリウムメタノール溶液(3.1ml,1.55ミリ
モル)を氷冷下加え、室温で1時間攪拌した。反応液に
水(50ml)を加え、酢酸エチル(50ml×2)で
抽出した。抽出液を飽和食塩水で洗浄し、無水硫酸マグ
ネシウムで乾燥後減圧留去した。残留物を酢酸エチル−
ヘキサンから再結晶させて表題化合物(321mg,5
7%)を得た。 mp 157-158℃ IRνmaxKBrcm-1: 1682, 1618, 1588, 1522.1 H-NMR (CDCl3)δ: 1.34 (9H, s), 2.70-2.90 (2H, m),
3.85 (1H, brs), 4.09(1H, brs), 4.62 (1H, d, J =
8.8 Hz), 4.96 (1H, s), 7.24 (2H, d, J = 8.0Hz), 7.
35 (1H, d, J = 8.0 Hz), 7.53 (2H, d, J = 8.0 Hz),
7.73 (1H, dd, J= 8.0, 2.6 Hz), 8.4 (1H, d, J = 2.6
Hz).Example 201 1,1-Dimethylethyl (1RS, 2SR) -2- (6-chloro-3-pyridyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl Carbamate 1) 6-chloro-3-pyridinecarboxylic acid (10 g, 6
3.5 mmol) of tetrahydrofuran (150 ml)
Add 1,1'-carbonylbis-1H-imidazole (1
(1.3 g, 69.8 mmol) and heated under reflux for 30 minutes. After cooling the reaction solution, monoethyl magnesium malonate (10 g, 34.9 mmol) was added, and the mixture was added at room temperature for 30 minutes.
Minutes. Water (200 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed with brine, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1), and ethyl 3- (6-chloro-3-pyridyl) -3-oxopropionate (9.
(28 g, 64%) as a brown oil. IRνmax KBr cm -1: 1740, 1694 , 1628, 1584. 1 H-NMR (CDCl 3) δ: 1.16 (3H × 3/5, t, J = 7.4 Hz),
1.24 (3H × 2/5, t, J = 7.0 Hz), 3.88 (2H × 3/5, s),
4.04-4.24 (2H, m), 5.58 (1H × 2/5, s), 7.29 (1H × 2 /
5, d, J = 8.0 Hz), 7.37 (1H × 3/5, d, J = 8.0 Hz),
7.90 (1H × 2/5, dd, J = 8.0, 2.6 Hz), 8.11 (1H × 3 /
5, dd, J = 8.0, 2.6 Hz), 8.66 (1H × 2/5, d, J = 2.6
Hz), 8.81 (1H × 3/5, d, J = 2.6 Hz). 2) Ethyl 3- (6-chloro-3-pyridyl) -3-oxopropionate (9.0 g, 39.5 mmol) 1,2
Sodium hydride (60% oil, 1.58 g, 39.5 mmol) was added to a solution of -dimethoxyethane (50 ml) under ice cooling, and the mixture was stirred at room temperature for 2 hours. 4-trifluoromethylbenzyl bromide (9.45 g, 3
9.5 mmol) of 1,2-dimethoxyethane (50 m
l) The solution was added dropwise and the reaction was stirred at room temperature overnight. The reaction solution was poured into water (200 ml), and a saturated aqueous solution of sodium bicarbonate was added.
Extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene: ethyl acetate = 1: 1) to give 3- (6-chloro-3-pyridyl) -3-oxo-2-((4-
Ethyl (trifluoromethyl) phenyl) methyl) propionate (14.2 g, 93%) was obtained as a colorless oil. IRνmax KBr cm -1 : 1740, 1694, 1582. 1 H-NMR (CDCl 3 ) δ: 1.13 (3H, t, J = 7.0 Hz), 3.40
(2H, d, J = 7.4 Hz), 4.12 (2H, q, J = 7.0 Hz), 4.5
4 (1H, t, J = 7.4 Hz), 7.35 (2H, d, J = 8.4 Hz),
7.44 (1H, d, J = 7.0 Hz), 7.53 (2H, d, J = 8.4 H
z), 8.16-8.24 (1H, m), 8.95 (1H, d, J = 2.6 Hz). 3) Sodium borohydride was added to a solution of zinc chloride (9.89 g, 72.6 mmol) in diethyl ether (150 ml). (5.49 g, 145 mmol) and the mixture was stirred at room temperature for 30 minutes. The insoluble material was removed by filtration, and the filtrate was treated with ethyl 3- (6-chloro-3-pyridyl) -3-oxo-2-((4- (trifluoromethyl) phenyl) methyl) propionate (1).
4 g, 36.3 mmol) of diethyl ether (50 m
l) The solution was added and stirred at room temperature for 30 minutes. Under ice-cooling, the reaction solution was quenched by adding 1N hydrochloric acid, and further added with water (200 m 2).
1) and extracted with ethyl acetate (300 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by medium pressure silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give (2RS, 3RS) -3- (6-chloro-3-pyridyl) -3-hydroxy-2-((4 Ethyl-(trifluoromethyl) phenyl) methyl) propionate (9.32 g, 66%) was obtained as a colorless oil. IRνmax KBr cm -1: 1728, 1618 , 1588, 1568. 1 H-NMR (CDCl 3) δ: 0.95 (3H, t, J = 7.0 Hz), 2.92-
3.18 (3H, m), 3.35 (1H, d, J = 2.4 Hz), 3.92 (2H,
q, J = 7.0 Hz), 5.04-5.12 (1H, m), 7.20 (2H, d, J =
8.2 Hz), 7.32 (1H, d, J = 8.4 Hz), 7.50 (2H, d, J
= 8.2 Hz), 7.73 (1H, dd, J = 8.8, 2.8 Hz), 8.38 (1
H, d, J = 8.4 Hz). 4) (2RS, 3RS) -3- (6-chloro-3-pyridyl) -3-hydroxy-2-((4- (trifluoromethyl) phenyl) methyl) propion Ethyl acid (9.0
g, 23.2 mmol) in methanol (23 ml).
6.4 mmol) and stirred at room temperature overnight. After the reaction solution was acidified with 1N hydrochloric acid, the pH was adjusted to 8 by adding saturated aqueous sodium hydrogen carbonate, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane (2RS, 3
RS) -3- (6-Chloro-3-pyridyl) -3-hydroxy-
2-((4- (trifluoromethyl) phenyl) methyl)
Propionic acid (7.4 g, 89%) was obtained. mp 145-146 ° C IRνmax KBr cm -1 : 1715, 1591, 1464. Anal.Calcd for C 16 H 13 NO 3 ClF 3 : C, 53.42; H, 3.64;
N, 3.89 Found:. C, 53.48; H, 3.93; N, 3.66 1 H-NMR (CDCl 3) δ: 2.90-3.20 (3H, m), 5.11 (1H, d,
J = 4.4 Hz), 7.24 (2H, d, J = 8.4 Hz), 7.33 (1H, d,
J = 8.2 Hz), 7.49 (2H, d, J = 8.4 Hz), 7.78 (1H,
dd, J = 8.2, 2.2 Hz), 8.35 (1H, d, J = 2.2 Hz). 5) (2RS, 3RS) -3- (6-chloro-3-pyridyl) -3-hydroxy-2-(( 4- (trifluoromethyl) phenyl) methyl) propionic acid (5.0 g, 1
3.9 mmol) in tetrahydrofuran (150 ml)
To the solution was added diphenylphosphoryl azide (3.3 ml, 1
5.3 mmol) and triethylamine (2.9 ml, 2
(0.9 mmol) and heated to reflux for 1 hour. After allowing the reaction solution to cool, water (200 ml) was added, and ethyl acetate (20 ml) was added.
0 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate).
Recrystallized from hexane to give (4RS, 5SR) -5- (6
-Chloro-3-pyridyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2-one (4.29 g, 87%) was obtained. . mp 176-177 ℃ IRνmax KBr cm -1 : 1767, 1590, 1568. Anal Calcd for C 16 H 12 N 2 O 2 ClF 3: C, 53.87; H, 3.39;
N, 7.85 Found:. C, 53.86; H, 3.57; N, 7.66 1 H-NMR (CDCl 3) δ: 2.22-2.50 (2H, m), 4.26-4.40 (1
H, m), 5.16 (1H, brs), 5.84 (1H, d, J = 8.0 Hz), 7.
16 (2H, d, J = 8.0 Hz), 7.43 (1H, d, J = 8.2 Hz),
7.57 (2H, d, J = 8.0 Hz), 7.73 (1H, dd, J = 8.2,
2.6 Hz), 8.41 (1H, d, J = 2.6 Hz). 6) (4RS, 5SR) -5- (6-chloro-3-pyridyl) -4-((4- (trifluoromethyl) phenyl) methyl ) -1,3-Oxazolidin-2-one (500 mg,
To a solution of 1.40 mmol) in acetonitrile (5 ml) was added di-t-butyl dicarbonate (367 mg, 1.68 mmol).
And dimethylaminopyridine (17 mg, 0.14 mmol) were added, and the mixture was stirred at room temperature for 2 hours. After the reaction solution was concentrated, it was diluted with water (20 ml), and ethyl acetate (20 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane (4RS, 5SR)-
5- (6-chloro-3-pyridyl) -2-oxo-4-((4-
There was obtained 1,1-dimethylethyl (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-3-carboxylate (1.19 g, 93%). mp 170-174 ℃ IRνmax KBr cm -1 : 1821, 1723, 1464, 1362. Anal.Calcd for C 21 H 20 N 2 O 4 ClF 3 : C, 55.21; H, 4.41;
N, 6.13 Found:. C, 55.44; H, 4.28; N, 6.22 1 H-NMR (CDCl 3) δ: 1.49 (9H, s), 2.60 (1H, dd, J =
14.2, 8.8 Hz), 3.01 (1H, dd, J = 14.2, 5.2 Hz), 4.
82-4.96 (1H, m), 5.70 (1H, d, J = 7.0 Hz), 6.85 (2
H, d, J = 8.0 Hz), 7.18 (1H, d, J = 8.4 Hz), 7.36-
7.46 (3H, m), 8.27 (1H, d, J = 2.2 Hz). 7) (4RS, 5SR) -5- (6-chloro-3-pyridyl) -2-oxo-4-((4- ( 0.5N sodium hydroxide in methanol (3.1 ml) of 1,1-dimethylethyl (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-3-carboxylate (600 mg, 1.31 mmol) (3.1 ml, 1.55 mmol) was added under ice-cooling, and the mixture was stirred at room temperature for 1 hour. Water (50 ml) was added to the reaction solution, and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was ethyl acetate-
Recrystallization from hexane gave the title compound (321 mg, 5
7%). mp 157-158 ℃ IRνmax KBr cm -1: 1682, 1618, 1588, 1522. 1 H-NMR (CDCl 3) δ: 1.34 (9H, s), 2.70-2.90 (2H, m),
3.85 (1H, brs), 4.09 (1H, brs), 4.62 (1H, d, J =
8.8 Hz), 4.96 (1H, s), 7.24 (2H, d, J = 8.0Hz), 7.
35 (1H, d, J = 8.0 Hz), 7.53 (2H, d, J = 8.0 Hz),
7.73 (1H, dd, J = 8.0, 2.6 Hz), 8.4 (1H, d, J = 2.6
Hz).
【0334】実施例202 N-((1RS,2SR)-2-(6-クロロ-3-ピリジ
ル)-2-ヒドロキシ-1-((4-(トリフルオロメチ
ル)フェニル)メチル)エチル)-4-フルオロ-1-ナフ
タレンカルボキサミド 1) 1,1-ジメチルエチル(1RS,2SR)-2-
(6-クロロ-3-ピリジル)-2-ヒドロキシ-1-((4-
(トリフルオロメチル)フェニル)メチル)エチルカル
バメート(880mg,2.04ミリモル)にトリフル
オロ酢酸(8ml)を0℃で加え、10分攪拌した。反
応液を濃縮後、水(20ml)で希釈し、酢酸エチル
(20ml×2)で抽出した。抽出液を飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去した。残
留物を酢酸エチル−ジイソプロピルエーテルから再結晶
させて(1RS,2SR)-2-アミノ-1-(6-クロロ-
3-ピリジル)-3-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(602mg,89%)を得た。 mp 103-104℃ IRνmaxKBrcm-1: 1588, 1568, 1460. Anal. Calcd for C15H14N2OClF3: C, 54.47; H, 4.27;
N, 8.47 Found: C, 54.57; H, 4.19; N, 8.39.1 H-NMR (CDCl3)δ: 2.42 (1H, dd, J = 13.6, 10.4 H
z), 2.76 (1H, dd, J = 13.6, 3.0 Hz), 3.30-3.44 (1
H, m), 4.76 (1H, d, J = 4.4 Hz), 7.24 (2H, d, J=
8.4 Hz), 7.36 (1H, d, J = 8.4 Hz), 7.55 (2H, d, J
= 8.4 Hz), 7.75 (1H, dd, J = 8.4, 2.2 Hz). 2) (1RS,2SR)-2-アミノ-1-(6-クロロ-
3-ピリジル)-3-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(250mg,0.76ミリモ
ル)のアセトニトリル(15ml)溶液に4-フルオロ
ナフタレンカルボン酸(144mg,0.76ミリモ
ル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(218mg,1.14ミ
リモル)および1-ヒドロキシ-1H-ベンゾトリアゾー
ル(116mg,0.76ミリモル)を加えて室温で終
夜攪拌した。反応液を水(100ml)で希釈し、酢酸
エチル(100ml×2)で抽出した。抽出液を水、飽
和食塩水で順次洗浄し、無水硫酸マグネシウムで乾燥後
減圧留去した。残留物を酢酸エチル−ヘキサンから再結
晶させて、表題化合物(324mg,85%)を得た。 mp 188-189℃ IRνmaxKBrcm-1: 1642, 1626, 1601, 1534, 1462. Anal. Calcd for C26H19N2O2ClF4・0.2H2O: C, 61.66;
H, 3.86; N, 5.53 Found: C, 61.56; H, 3.91; N, 5.37.1 H-NMR (CDCl3)δ: 2.89 (1H, dd, J = 14.6, 11.0 H
z), 3.08 (1H, dd, J = 14.6, 4.4 Hz), 4.04 (1H, br
s), 4.68-4.84 (1H, m), 5.13 (1H, d, J = 3.6 Hz),
6.04 (1H, d, J = 8.4 Hz), 6.92-7.20 (2H, m), 7.22-
7.70 (8H, m), 7.82 (1H, dd, J = 8.0, 2.6 Hz), 8.09
(1H, d, J = 8.0 Hz), 8.44 (1H, d, J = 2.6Hz).Example 202 N-((1RS, 2SR) -2- (6-chloro-3-pyridyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4 -Fluoro-1-naphthalenecarboxamide 1) 1,1-dimethylethyl (1RS, 2SR) -2-
(6-chloro-3-pyridyl) -2-hydroxy-1-((4-
To (trifluoromethyl) phenyl) methyl) ethyl carbamate (880 mg, 2.04 mmol) was added trifluoroacetic acid (8 ml) at 0 ° C., and the mixture was stirred for 10 minutes. After concentration, the reaction solution was diluted with water (20 ml) and extracted with ethyl acetate (20 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-diisopropyl ether to give (1RS, 2SR) -2-amino-1- (6-chloro-
There was obtained 3-pyridyl) -3- (4- (trifluoromethyl) phenyl) -1-propanol (602 mg, 89%). mp 103-104 ° C IRνmax KBr cm -1 : 1588, 1568, 1460. Anal.Calcd for C 15 H 14 N 2 OClF 3 : C, 54.47; H, 4.27;
N, 8.47 Found:. C, 54.57; H, 4.19; N, 8.39 1 H-NMR (CDCl 3) δ: 2.42 (1H, dd, J = 13.6, 10.4 H
z), 2.76 (1H, dd, J = 13.6, 3.0 Hz), 3.30-3.44 (1
H, m), 4.76 (1H, d, J = 4.4 Hz), 7.24 (2H, d, J =
8.4 Hz), 7.36 (1H, d, J = 8.4 Hz), 7.55 (2H, d, J
= 8.4 Hz), 7.75 (1H, dd, J = 8.4, 2.2 Hz). 2) (1RS, 2SR) -2-amino-1- (6-chloro-
4-Fluoronaphthalenecarboxylic acid (144 mg, 0.76 mmol) in a solution of 3-pyridyl) -3- (4- (trifluoromethyl) phenyl) -1-propanol (250 mg, 0.76 mmol) in acetonitrile (15 ml) And 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (218 mg, 1.14 mmol) and 1-hydroxy-1H-benzotriazole (116 mg, 0.76 mmol) were added, and the mixture was stirred at room temperature overnight. did. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (324 mg, 85%). mp 188-189 ℃ IRνmax KBr cm -1 : 1642, 1626, 1601, 1534, 1462. Anal.Calcd for C 26 H 19 N 2 O 2 ClF 4・ 0.2H 2 O: C, 61.66;
H, 3.86; N, 5.53 Found :. C, 61.56; H, 3.91; N, 5.37 1 H-NMR (CDCl 3) δ: 2.89 (1H, dd, J = 14.6, 11.0 H
z), 3.08 (1H, dd, J = 14.6, 4.4 Hz), 4.04 (1H, br
s), 4.68-4.84 (1H, m), 5.13 (1H, d, J = 3.6 Hz),
6.04 (1H, d, J = 8.4 Hz), 6.92-7.20 (2H, m), 7.22-
7.70 (8H, m), 7.82 (1H, dd, J = 8.0, 2.6 Hz), 8.09
(1H, d, J = 8.0 Hz), 8.44 (1H, d, J = 2.6 Hz).
【0335】実施例203 N-((1RS,2SR)-2-(6-クロロ-3-ピリジ
ル)-2-ヒドロキシ-1-((4-(トリフルオロメチ
ル)フェニル)メチル)エチル)-3-フェニルプロパン
アミド (1RS,2SR)-2-アミノ-1-(6-クロロ-3-ピ
リジル)-3-(4-(トリフルオロメチル)フェニル)-
1-プロパノール(250mg,0.76ミリモル)の
酢酸エチル(10ml)溶液に3-フェニルプロピオニ
ルクロリド(168ml,1.13ミリモル)および飽
和重曹水(10ml)を加えて室温で終夜攪拌した。反
応液を水(100ml)で希釈し、酢酸エチル(100
ml×2)で抽出した。抽出液を飽和食塩水で洗浄し、
無水硫酸マグネシウムで乾燥後減圧留去した。残留物を
酢酸エチル−ヘキサンから再結晶させて表題化合物(3
02mg,86%)を得た。 mp 149-150℃ IRνmaxKBrcm-1: 1651, 1541, 1456. Anal. Calcd for C24H22N2O2ClF3: C, 62.27; H, 4.79;
N, 6.05 Found: C, 62.44; H, 4.96; N, 6.05.1 H-NMR (CDCl3)δ: 2.30-2.50 (2H, m), 2.60-2.92 (4
H, m), 3.90 (1H, s), 4.24-4.40 (1H, m), 4.80-4.90
(1H, m), 5.36 (1H, d, J = 8.2 Hz), 7.00-7.40(8H,
m), 7.48 (2H, d, J = 8.0 Hz), 7.56 (1H, dd, J = 8.
0, 2.6 Hz), 8.32(1H, d, J = 2.2 Hz).Example 203 N-((1RS, 2SR) -2- (6-chloro-3-pyridyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -3 -Phenylpropanamide (1RS, 2SR) -2-amino-1- (6-chloro-3-pyridyl) -3- (4- (trifluoromethyl) phenyl)-
To a solution of 1-propanol (250 mg, 0.76 mmol) in ethyl acetate (10 ml) was added 3-phenylpropionyl chloride (168 ml, 1.13 mmol) and saturated aqueous sodium hydrogen carbonate (10 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
ml × 2). Wash the extract with saturated saline,
After drying over anhydrous magnesium sulfate, the solution was distilled off under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (3
02 mg, 86%). mp 149-150 ° C IRνmax KBr cm -1 : 1651, 1541, 1456. Anal.Calcd for C 24 H 22 N 2 O 2 ClF 3 : C, 62.27; H, 4.79;
N, 6.05 Found:. C, 62.44; H, 4.96; N, 6.05 1 H-NMR (CDCl 3) δ: 2.30-2.50 (2H, m), 2.60-2.92 (4
H, m), 3.90 (1H, s), 4.24-4.40 (1H, m), 4.80-4.90
(1H, m), 5.36 (1H, d, J = 8.2 Hz), 7.00-7.40 (8H,
m), 7.48 (2H, d, J = 8.0 Hz), 7.56 (1H, dd, J = 8.
0, 2.6 Hz), 8.32 (1H, d, J = 2.2 Hz).
【0336】実施例204 1,1-ジメチルエチル(1RS,2RS)-2-(6-ク
ロロ-2-ピリジル)-2-ヒドロキシ-1-((4-(トリ
フルオロメチル)フェニル)メチル)エチルカルバメー
ト 1) 6-クロロ-2-ピリジンカルボン酸(10g,6
3.5ミリモル)のテトラヒドロフラン(150ml)
溶液に1,1'-カルボニルビス-1H-イミダゾール(1
1.3g,69.8ミリモル)を加え、30分加熱還流
した。反応液を冷却後、マロン酸モノエチルマグネシウ
ム塩(10g,34.9ミリモル)を加え、室温で30
分攪拌した。反応液に水(200ml)を加え、酢酸エ
チル(200ml×2)で抽出し、抽出液を飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=4:1)で精製し、3-(6-クロ
ロ-2-ピリジル)-3-オキソプロピオン酸エチル(7.
96g,55%)を褐色油状物として得た。 IRνmaxKBrcm-1: 1738, 1713, 1651, 1645. Anal. Calcd for C10H10NO3Cl: C, 52.76; H, 4.43; N,
6.15 Found: C, 52.63; H, 4.55; N, 6.02.1 H-NMR (CDCl3)δ: 1.20-1.40 (3H, m), 4.15 (2H×2/
3, s), 4.14-4.32 (2H, m), 6.35 (1H×1/3, s), 7.37
(1H×1/3, d, J = 6.6 Hz), 7.53 (1H×2/3, d, J= 7.0
Hz), 7.70-8.02 (2H, m), 12.31 (1H×1/3, s). 2) 3-(6-クロロ-2-ピリジル)-3-オキソプロピ
オン酸エチル(7.6g,33.4ミリモル)の1,2
-ジメトキシエタン(50ml)溶液に水素化ナトリウ
ム(60%油性,1.34g,33.4ミリモル)を氷
冷下加え、室温で2時間攪拌した。反応液の中に4-ト
リフルオロメチルベンジルブロミド(7.98g,3
3.4ミリモル)の1,2-ジメトキシエタン(50m
l)溶液を滴下し、反応液を室温で終夜攪拌した。反応
液を水(200ml)の中に注ぎ、飽和重曹水を加え、
酢酸エチル(200ml×2)で抽出した。抽出液を水
および飽和食塩水で洗浄し、無水硫酸マグネシウムで乾
燥後減圧留去した。残留物をシリカゲルカラムクロマト
グラフィー(トルエン)で精製し3-(6-クロロ-2-ピ
リジル)-3-オキソ-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸エチル(13.0
g,100%)を無色油状物として得た。 IRνmaxKBrcm-1: 1732, 1709, 1576, 1563.1 H-NMR (CDCl3)δ: 1.14 (3H, t, J = 7.0 Hz), 3.24-
3.50 (2H, m), 4.02-4.20(2H, m), 4.99 (1H, t, J =
7.2 Hz), 7.42 (2H, d, J = 8.0 Hz), 7.52 (2H,d, J =
8.0 Hz), 7.81 (1H, t, J = 8.0 Hz), 7.97 (1H, d, J
= 6.6 Hz). 3) 塩化亜鉛(9.0g,66.15ミリモル)のジ
エチルエーテル(200ml)溶液に水素化ホウ素ナト
リウム(5.0g,132ミリモル)を加えて室温で3
0分攪拌した。不溶物をろ去し、水素化ホウ素亜鉛のジ
エチルエーテル溶液を調製した。3-(6-クロロ-2-ピ
リジル)-3-オキソ-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸エチル(12.7
g,33.1ミリモル)のジエチルエーテル(100m
l)溶液に、−20℃にて先に調製した水素化ホウ素亜
鉛のジエチルエーテル溶液をゆっくり滴下した。反応液
を−20℃にて30分攪拌後、反応液に1規定塩酸を加
えてクエンチし、更に水(200ml)を加え、酢酸エ
チル(300ml×2)で抽出した。抽出液を水および
飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減
圧留去した。残留物をシリカゲルカラムクロマトグラフ
ィー(ヘキサン:酢酸エチル=4:1)で精製し、3-
(6-クロロ-2-ピリジル)-3-ヒドロキシ-2-((4-
(トリフルオロメチル)フェニル)メチル)プロピオン
酸エチル(4.1g,32%,(2RS,3RS)体:
(2RS,3SR)体=1:1,crude)を無色油
状物として得た。1 H-NMR (CDCl3)δ: 0.95-1.10 (3H, m), 2.80-3.40 (3
H, m), 3.82-4.08 (2H, m), 4.78 (1H×1/2, dd, J =
9.6, 4.4 Hz), 5.08 (1H×1/2, t, J = 5.0 Hz), 7.10-
7.70 (7H, m). 4) 3-(6-クロロ-2-ピリジル)-3-ヒドロキシ-
2-((4-(トリフルオロメチル)フェニル)メチル)
プロピオン酸エチル(4.1g,10.7ミリモル)の
メタノール(20ml)溶液に、2規定水酸化ナトリウ
ム水溶液(10.7ml,21.4ミリモル)を加えて
室温で終夜攪拌した。反応液を1規定塩酸で酸性とした
後、飽和重曹水を加えpHを8に調整し、酢酸エチル
(200ml×2)で抽出した。抽出液を水および飽和
食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留
去した。残留物をジイソプロピルエーテル−ヘキサンか
ら再結晶させて3-(6-クロロ-2-ピリジル)-3-ヒド
ロキシ-2-((4-(トリフルオロメチル)フェニル)
メチル)プロピオン酸(3.3g,86%,(2RS,
3RS)体:(2RS,3SR)体=1:1)を得た。1 H-NMR (CDCl3)δ: 2.20-2.60 (1H, m), 2.80-3.30 (2
H, m), 4.73 (1H×1/2, d, J = 7.4 Hz), 5.30 (1H×1/
2, s), 6.64-7.40 (7H, m). 5) 3-(6-クロロ-2-ピリジル)-3-ヒドロキシ-
2-((4-(トリフルオロメチル)フェニル)メチル)
プロピオン酸(3.1g,8.6ミリモル)のテトラヒ
ドロフラン(100ml)溶液に、ジフェニルホスホリ
ルアジド(2.0ml,9.5ミリモル)とトリエチル
アミン(1.8ml,12.9ミリモル)を加え、1時
間加熱還流した。反応液を放冷後、水(150ml)を
加えて酢酸エチル(150ml×2)で抽出した。抽出
液を飽和重曹水、飽和食塩水で順次洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をジイソプロ
ピルエーテル−ヘキサンから再結晶させて5-(6-クロ
ロ-2-ピリジル)-4-((4-(トリフルオロメチル)
フェニル)メチル)-1,3-オキサゾリジン-2-オン
(1.18g,38%,(4RS,5RS)体:(4R
S,5SR)体=3:2)を得た。1 H-NMR (CDCl3)δ: 2.18 (1H×3/5, dd, J = 13.4, 7.0
Hz), 2.62 (1H×3/5, dd, J = 13.4, 3.8 Hz), 3.05
(1H×2/5, dd, J = 13.4, 9.2 Hz), 3.36 (1H×2/5, d
d, J = 13.4, 4.4 Hz), 4.16-4.30 (1H×2/5, m), 4.40
-4.56 (1H×3/5, m), 5.19 (1H×3/5, s), 5.29 (1H×2
/5, d, J = 5.0 Hz), 5.37 (1H×2/5, s), 5.83 (1H×3
/5, d, J = 8.0 Hz), 7.10-7.82 (7H, m). 6) 5-(6-クロロ-2-ピリジル)-4-((4-(ト
リフルオロメチル)フェニル)メチル)-1,3-オキサ
ゾリジン-2-オン(1.08g,1.40ミリモル,
(4RS,5RS)体:(4RS,5SR)体=3:
2)のアセトニトリル(10ml)溶液に二炭酸ジ-t-
ブチル(793mg,3.63ミリモル)およびジメチ
ルアミノピリジン(37mg,0.30ミリモル)を加
え、室温で30分攪拌した。反応液を濃縮後、水(20
ml)で希釈し、酢酸エチル(20ml×2)で抽出し
た。抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去した。残留物をシリカゲルカラムク
ロマトグラフィーでヘキサン:酢酸エチル=4:1で溶
出し、ジイソプロピルエーテル−ヘキサンから再結晶さ
せて、(4RS,5SR)-5-(6-クロロ-2-ピリジ
ル)-2-オキソ-4-((4-(トリフルオロメチル)フ
ェニル)メチル)-1,3-オキサゾリジン-3-カルボン
酸1,1-ジメチルエチル(300mg,22%)を得
た。 IRνmaxKBrcm-1: 1817, 1726, 1566. mp 125-126℃1 H-NMR (CDCl3)δ: 1.55 (9H, s), 3.24 (1H, dd, J =
13.6, 8.0 Hz), 3.44 (1H, dd, J = 13.6, 4.4 Hz), 4.
76-4.86 (1H, m), 5.13 (1H, d, J = 2.6 Hz), 7.22-7.
32 (2H, m), 7.40 (2H, d, J = 8.0 Hz), 7.62 (2H, d,
J = 8.0 Hz), 7.66 (1H, t, J = 7.8 Hz). さらにヘキサン:酢酸エチル=1:1で溶出して、酢酸
エチル−ヘキサンから再結晶させて(4RS,5RS)
-5-(6-クロロ-2-ピリジル)-2-オキソ-4-((4-
(トリフルオロメチル)フェニル)メチル)-1,3-オ
キサゾリジン-3-カルボン酸1,1-ジメチルエチル
(735mg,53%)を得た。 IRνmaxKBrcm-1: 1823, 1726, 1566. mp 166-167℃1 H-NMR (CDCl3)δ: 1.44 (9H, s), 2.65 (1H, dd, J =
14.0, 8.0 Hz), 2.89 (1H, dd, J = 14.0, 5.4 Hz), 5.
02-5.16 (1H, m), 5.66 (1H, d, J = 6.6 Hz), 6.88 (2
H, d, J = 8.2 Hz), 7.26 (1H, d, J = 8.2 Hz), 7.40
(2H, d, J = 8.0Hz), 7.50 (1H, d, J = 7.6 Hz), 7.73
(1H, t, J = 7.8 Hz). 7) (4RS,5RS)-5-(6-クロロ-2-ピリジ
ル)-2-オキソ-4-((4-(トリフルオロメチル)フ
ェニル)メチル)-1,3-オキサゾリジン-3-カルボン
酸1,1-ジメチルエチル(677mg,1.46ミリ
モル)のメタノール(3.5ml)に0.5Nの水酸化
ナトリウムメタノール溶液(3.5ml,1.75ミリ
モル)を氷冷下加え、室温で1時間攪拌した。反応液に
水(50ml)を加え、酢酸エチル(50ml×2)で
抽出した。抽出液を飽和食塩水で洗浄し、無水硫酸マグ
ネシウムで乾燥後減圧留去した。残留物をシリカゲルカ
ラムクロマトグラフィー(酢酸エチル)で精製し、ジイ
ソプロピルエーテル−ヘキサンから再結晶させて表題化
合物(550mg,57%)を得た。 IRνmaxKBrcm-1: 1682, 1530. mp 159-160℃1 H-NMR (CDCl3)δ: 1.36 (9H, s), 2.67 (1H, dd, J =
15.0, 5.8 Hz), 2.87 (1H, dd, J = 15.0, 8.4 Hz), 4.
12-4.30 (1H, m), 4.60 (1H, d, J = 5.6 Hz), 4.90-5.
10 (2H, m), 7.19 (2H, d, J = 7.8 Hz), 7.20-7.32 (2
H, m), 7.45 (2H,d, J = 7.8 Hz), 7.61 (1H, t, J =
8.0 Hz).Example 204 1,1-Dimethylethyl (1RS, 2RS) -2- (6-chloro-2-pyridyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl Carbamate 1) 6-chloro-2-pyridinecarboxylic acid (10 g, 6
3.5 mmol) of tetrahydrofuran (150 ml)
Add 1,1'-carbonylbis-1H-imidazole (1
(1.3 g, 69.8 mmol) and heated under reflux for 30 minutes. After cooling the reaction solution, monoethyl magnesium malonate (10 g, 34.9 mmol) was added, and the mixture was added at room temperature for 30 minutes.
Minutes. Water (200 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed with brine, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1), and ethyl 3- (6-chloro-2-pyridyl) -3-oxopropionate (7.
96 g, 55%) as a brown oil. IRνmax KBr cm -1 : 1738, 1713, 1651, 1645. Anal.Calcd for C 10 H 10 NO 3 Cl: C, 52.76; H, 4.43; N,
6.15 Found:. C, 52.63; H, 4.55; N, 6.02 1 H-NMR (CDCl 3) δ: 1.20-1.40 (3H, m), 4.15 (2H × 2 /
3, s), 4.14-4.32 (2H, m), 6.35 (1H × 1/3, s), 7.37
(1H × 1/3, d, J = 6.6 Hz), 7.53 (1H × 2/3, d, J = 7.0
Hz), 7.70-8.02 (2H, m), 12.31 (1H × 1/3, s). 2) Ethyl 3- (6-chloro-2-pyridyl) -3-oxopropionate (7.6 g, 33.3 g). 4 mmol) 1,2
Sodium hydride (60% oily, 1.34 g, 33.4 mmol) was added to a solution of -dimethoxyethane (50 ml) under ice-cooling, and the mixture was stirred at room temperature for 2 hours. 4-trifluoromethylbenzyl bromide (7.98 g, 3
3.4 mmol) of 1,2-dimethoxyethane (50 m
l) The solution was added dropwise and the reaction was stirred at room temperature overnight. The reaction solution was poured into water (200 ml), and a saturated aqueous solution of sodium bicarbonate was added.
Extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene), and ethyl 3- (6-chloro-2-pyridyl) -3-oxo-2-((4- (trifluoromethyl) phenyl) methyl) propionate (13. 0
g, 100%) as a colorless oil. IRνmax KBr cm -1: 1732, 1709 , 1576, 1563. 1 H-NMR (CDCl 3) δ: 1.14 (3H, t, J = 7.0 Hz), 3.24-
3.50 (2H, m), 4.02-4.20 (2H, m), 4.99 (1H, t, J =
7.2 Hz), 7.42 (2H, d, J = 8.0 Hz), 7.52 (2H, d, J =
8.0 Hz), 7.81 (1H, t, J = 8.0 Hz), 7.97 (1H, d, J
= 6.6 Hz). 3) To a solution of zinc chloride (9.0 g, 66.15 mmol) in diethyl ether (200 ml) was added sodium borohydride (5.0 g, 132 mmol), and the solution was added at room temperature for 3 hours.
Stirred for 0 minutes. The insoluble material was removed by filtration to prepare a zinc borohydride solution in diethyl ether. Ethyl 3- (6-chloro-2-pyridyl) -3-oxo-2-((4- (trifluoromethyl) phenyl) methyl) propionate (12.7
g, 33.1 mmol) in diethyl ether (100 m
l) The solution of zinc borohydride in diethyl ether previously prepared was slowly added dropwise to the solution at -20 ° C. After stirring the reaction solution at −20 ° C. for 30 minutes, the reaction solution was quenched by adding 1N hydrochloric acid, further added with water (200 ml), and extracted with ethyl acetate (300 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give 3-
(6-chloro-2-pyridyl) -3-hydroxy-2-((4-
Ethyl (trifluoromethyl) phenyl) methyl) propionate (4.1 g, 32%, (2RS, 3RS) form:
(2RS, 3SR) form = 1: 1, crude) was obtained as a colorless oil. 1 H-NMR (CDCl 3 ) δ: 0.95-1.10 (3H, m), 2.80-3.40 (3
H, m), 3.82-4.08 (2H, m), 4.78 (1H × 1/2, dd, J =
9.6, 4.4 Hz), 5.08 (1H × 1/2, t, J = 5.0 Hz), 7.10-
7.70 (7H, m). 4) 3- (6-Chloro-2-pyridyl) -3-hydroxy-
2-((4- (trifluoromethyl) phenyl) methyl)
To a solution of ethyl propionate (4.1 g, 10.7 mmol) in methanol (20 ml) was added a 2N aqueous sodium hydroxide solution (10.7 ml, 21.4 mmol), and the mixture was stirred at room temperature overnight. After the reaction solution was acidified with 1N hydrochloric acid, the pH was adjusted to 8 by adding saturated aqueous sodium hydrogen carbonate, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to give 3- (6-chloro-2-pyridyl) -3-hydroxy-2-((4- (trifluoromethyl) phenyl)
Methyl) propionic acid (3.3 g, 86%, (2RS,
3RS) form: (2RS, 3SR) form = 1: 1) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.20-2.60 (1H, m), 2.80-3.30 (2
H, m), 4.73 (1H × 1/2, d, J = 7.4 Hz), 5.30 (1H × 1 /
2, s), 6.64-7.40 (7H, m). 5) 3- (6-Chloro-2-pyridyl) -3-hydroxy-
2-((4- (trifluoromethyl) phenyl) methyl)
To a solution of propionic acid (3.1 g, 8.6 mmol) in tetrahydrofuran (100 ml) were added diphenylphosphoryl azide (2.0 ml, 9.5 mmol) and triethylamine (1.8 ml, 12.9 mmol) for 1 hour. Heated to reflux. After allowing the reaction solution to cool, water (150 ml) was added, and the mixture was extracted with ethyl acetate (150 ml × 2). The extract was washed successively with saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to give 5- (6-chloro-2-pyridyl) -4-((4- (trifluoromethyl)
Phenyl) methyl) -1,3-oxazolidin-2-one (1.18 g, 38%, (4RS, 5RS) form: (4R
(S, 5SR) form = 3: 2) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.18 (1H × 3/5, dd, J = 13.4, 7.0
Hz), 2.62 (1H × 3/5, dd, J = 13.4, 3.8 Hz), 3.05
(1H × 2/5, dd, J = 13.4, 9.2 Hz), 3.36 (1H × 2/5, d
d, J = 13.4, 4.4 Hz), 4.16-4.30 (1H × 2/5, m), 4.40
-4.56 (1H × 3/5, m), 5.19 (1H × 3/5, s), 5.29 (1H × 2
/ 5, d, J = 5.0 Hz), 5.37 (1H × 2/5, s), 5.83 (1H × 3
/ 5, d, J = 8.0 Hz), 7.10-7.82 (7H, m). 6) 5- (6-Chloro-2-pyridyl) -4-((4- (trifluoromethyl) phenyl) methyl)- 1,3-oxazolidine-2-one (1.08 g, 1.40 mmol,
(4RS, 5RS) body: (4RS, 5SR) body = 3:
2) Di-t-dicarbonate was added to acetonitrile (10 ml) solution.
Butyl (793 mg, 3.63 mmol) and dimethylaminopyridine (37 mg, 0.30 mmol) were added, and the mixture was stirred at room temperature for 30 minutes. After concentrating the reaction solution, water (20
ml) and extracted with ethyl acetate (20 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography, eluting with hexane: ethyl acetate = 4: 1, and recrystallized from diisopropyl ether-hexane to give (4RS, 5SR) -5- (6-chloro-2-pyridyl) -2-. There was obtained 1,1-dimethylethyl oxo-4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-3-carboxylate (300 mg, 22%). IRνmax KBr cm -1 : 1817, 1726, 1566.mp 125-126 ° C 1 H-NMR (CDCl 3 ) δ: 1.55 (9H, s), 3.24 (1H, dd, J =
13.6, 8.0 Hz), 3.44 (1H, dd, J = 13.6, 4.4 Hz), 4.
76-4.86 (1H, m), 5.13 (1H, d, J = 2.6 Hz), 7.22-7.
32 (2H, m), 7.40 (2H, d, J = 8.0 Hz), 7.62 (2H, d,
J = 8.0 Hz), 7.66 (1H, t, J = 7.8 Hz). Further elute with hexane: ethyl acetate = 1: 1 and recrystallize from ethyl acetate-hexane (4RS, 5RS).
-5- (6-chloro-2-pyridyl) -2-oxo-4-((4-
There was obtained (1-dimethylethyl (trifluoromethyl) phenyl) methyl) -1,3-oxazolidine-3-carboxylate (735 mg, 53%). IRνmax KBr cm -1 : 1823, 1726, 1566.mp 166-167 ° C 1 H-NMR (CDCl 3 ) δ: 1.44 (9H, s), 2.65 (1H, dd, J =
14.0, 8.0 Hz), 2.89 (1H, dd, J = 14.0, 5.4 Hz), 5.
02-5.16 (1H, m), 5.66 (1H, d, J = 6.6 Hz), 6.88 (2
H, d, J = 8.2 Hz), 7.26 (1H, d, J = 8.2 Hz), 7.40
(2H, d, J = 8.0Hz), 7.50 (1H, d, J = 7.6Hz), 7.73
(1H, t, J = 7.8 Hz). 7) (4RS, 5RS) -5- (6-chloro-2-pyridyl) -2-oxo-4-((4- (trifluoromethyl) phenyl) methyl) 0.5N sodium hydroxide methanol solution (3.5 ml, 1.75) in methanol (3.5 ml) of 1,1-dimethylethyl-1,3-oxazolidine-3-carboxylate (677 mg, 1.46 mmol) (Mmol) was added under ice cooling, and the mixture was stirred at room temperature for 1 hour. Water (50 ml) was added to the reaction solution, and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from diisopropyl ether-hexane to give the title compound (550 mg, 57%). IRνmax KBr cm -1 : 1682, 1530.mp 159-160 ℃ 1 H-NMR (CDCl 3 ) δ: 1.36 (9H, s), 2.67 (1H, dd, J =
15.0, 5.8 Hz), 2.87 (1H, dd, J = 15.0, 8.4 Hz), 4.
12-4.30 (1H, m), 4.60 (1H, d, J = 5.6 Hz), 4.90-5.
10 (2H, m), 7.19 (2H, d, J = 7.8 Hz), 7.20-7.32 (2
H, m), 7.45 (2H, d, J = 7.8 Hz), 7.61 (1H, t, J =
8.0 Hz).
【0337】実施例205 N-((1RS,2RS)-2-(6-クロロ-2-ピリジ
ル)-2-ヒドロキシ-1-((4-(トリフルオロメチ
ル)フェニル)メチル)エチル)-4-フルオロ-1-ナフ
タレンカルボキサミド 1) 1,1-ジメチルエチル(1RS,2RS)-2-
(6-クロロ-2-ピリジル)-2-ヒドロキシ-1-((4-
(トリフルオロメチル)フェニル)メチル)エチルカル
バメート(500mg,1.16ミリモル)にトリフル
オロ酢酸(8ml)を0℃で加え、10分攪拌した。反
応液を濃縮後、水(20ml)で希釈し、酢酸エチル
(20ml×2)で抽出した。抽出液を飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去した。残
留物をジイソプロピルエーテル−ヘキサンから再結晶さ
せて(1RS,2RS)-2-アミノ-1-(6-クロロ-2
-ピリジル)-3-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(302mg,79%)を得た。 IRνmaxKBrcm-1: 1757, 1586, 1563. mp 89-90℃1 H-NMR (CDCl3)δ: 2.54 (1H, dd, J = 13.6, 9.8 Hz),
2.77 (1H, d, J = 13.0Hz), 3.44-3.58 (1H, m), 4.74
(1H, d, J = 4.4 Hz), 7.16-7.32 (3H, m), 7.57 (1H,
d, J = 7.4 Hz), 7.52 (2H, d, J = 7.4 Hz), 7.62-7.
74 (1H, m). 2) (1RS,2RS)-2-アミノ-1-(6-クロロ-
2-ピリジル)-3-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(250mg,0.76ミリモ
ル)のアセトニトリル(15ml)溶液に4-フルオロ
ナフタレンカルボン酸(144mg,0.76ミリモ
ル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(218mg,1.14ミ
リモル)および1-ヒドロキシ-1H-ベンゾトリアゾー
ル(116mg,0.76ミリモル)を加えて室温で終
夜攪拌した。反応液を水(100ml)で希釈し、酢酸
エチル(100ml×2)で抽出した。抽出液を水、飽
和食塩水で順次洗浄し、無水硫酸マグネシウムで乾燥後
減圧留去した。残留物をシリカゲルカラムクロマトグラ
フィー(ヘキサン:酢酸エチル=4:1)で精製し、酢
酸エチル−ヘキサンから再結晶させて、表題化合物(2
67mg,70%)を得た。 mp 225-226℃ IRνmaxKBrcm-1: 1639, 1624.1 H-NMR (CDCl3)δ: 2.83 (1H, dd, J = 14.0, 5.2 Hz),
3.02 (1H, dd, J = 14.0, 9.6 Hz), 4.74 (1H, d, J =
5.6 Hz), 4.80-5.00 (1H, m), 5.10-5.20 (1H,m), 6.4
6 (1H, d, J = 8.6 Hz), 7.00-7.12 (1H, m), 7.20-7.6
0 (9H, m), 7.64-7.76 (1H, m), 7.84 (1H, d, J = 7.6
Hz), 8.11 (1H, d, J = 8.0 Hz).Example 205 N-((1RS, 2RS) -2- (6-chloro-2-pyridyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -4 -Fluoro-1-naphthalenecarboxamide 1) 1,1-dimethylethyl (1RS, 2RS) -2-
(6-chloro-2-pyridyl) -2-hydroxy-1-((4-
To (trifluoromethyl) phenyl) methyl) ethyl carbamate (500 mg, 1.16 mmol) was added trifluoroacetic acid (8 ml) at 0 ° C., and the mixture was stirred for 10 minutes. After concentration, the reaction solution was diluted with water (20 ml) and extracted with ethyl acetate (20 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to give (1RS, 2RS) -2-amino-1- (6-chloro-2-
-Pyridyl) -3- (4- (trifluoromethyl) phenyl) -1-propanol (302 mg, 79%) was obtained. IRνmax KBr cm -1 : 1757, 1586, 1563.mp 89-90 ℃ 1 H-NMR (CDCl 3 ) δ: 2.54 (1H, dd, J = 13.6, 9.8 Hz),
2.77 (1H, d, J = 13.0Hz), 3.44-3.58 (1H, m), 4.74
(1H, d, J = 4.4 Hz), 7.16-7.32 (3H, m), 7.57 (1H,
d, J = 7.4 Hz), 7.52 (2H, d, J = 7.4 Hz), 7.62-7.
74 (1H, m). 2) (1RS, 2RS) -2-amino-1- (6-chloro-
4-Fluoronaphthalenecarboxylic acid (144 mg, 0.76 mmol) in a solution of 2-pyridyl) -3- (4- (trifluoromethyl) phenyl) -1-propanol (250 mg, 0.76 mmol) in acetonitrile (15 ml) And 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (218 mg, 1.14 mmol) and 1-hydroxy-1H-benzotriazole (116 mg, 0.76 mmol) were added, and the mixture was stirred at room temperature overnight. did. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the title compound (2
67 mg, 70%). mp 225-226 ℃ IRνmax KBr cm -1: 1639, 1624. 1 H-NMR (CDCl 3) δ: 2.83 (1H, dd, J = 14.0, 5.2 Hz),
3.02 (1H, dd, J = 14.0, 9.6 Hz), 4.74 (1H, d, J =
5.6 Hz), 4.80-5.00 (1H, m), 5.10-5.20 (1H, m), 6.4
6 (1H, d, J = 8.6 Hz), 7.00-7.12 (1H, m), 7.20-7.6
0 (9H, m), 7.64-7.76 (1H, m), 7.84 (1H, d, J = 7.6
Hz), 8.11 (1H, d, J = 8.0 Hz).
【0338】実施例206 1,1-ジメチルエチル(1RS,2SR)-2-(6-ク
ロロ-2-ピリジル)-2-ヒドロキシ-1-((4-(トリ
フルオロメチル)フェニル)メチル)エチルカルバメー
ト (4RS,5SR)-5-(6-クロロ-2-ピリジル)-2
-オキソ-4-((4-(トリフルオロメチル)フェニル)
メチル)-1,3-オキサゾリジン-3-カルボン酸1,1
-ジメチルエチル(237mg,0.52ミリモル)の
メタノール(1.25ml)溶液に0.5Nの水酸化ナ
トリウムメタノール溶液(1.25ml,0.62ミリ
モル)を氷冷下加え、室温で1時間攪拌した。反応液に
水(50ml)を加え、酢酸エチル(50ml×2)で
抽出した。抽出液を飽和食塩水で洗浄し、無水硫酸マグ
ネシウムで乾燥後減圧留去した。残留物を酢酸エチル−
ヘキサンから再結晶させて表題化合物(150mg,6
7%)を得た。 IRνmaxKBrcm-1: 1694, 1505. mp 134-135℃1 H-NMR (CDCl3)δ: 1.24 (9H, s), 3.13 (2H, d, J =
7.8 Hz), 4.10-4.30 (1H,m), 4.62-4.90 (2H, m), 7.20
-7.30 (2H, m), 7.30-7.52 (2H, m), 7.56-7.72(3H,
m).Example 206 1,1-Dimethylethyl (1RS, 2SR) -2- (6-chloro-2-pyridyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl Carbamate (4RS, 5SR) -5- (6-chloro-2-pyridyl) -2
-Oxo-4-((4- (trifluoromethyl) phenyl)
Methyl) -1,3-oxazolidine-3-carboxylic acid 1,1
To a solution of -dimethylethyl (237 mg, 0.52 mmol) in methanol (1.25 ml) was added a 0.5 N solution of sodium hydroxide in methanol (1.25 ml, 0.62 mmol) under ice-cooling, and the mixture was stirred at room temperature for 1 hour. did. Water (50 ml) was added to the reaction solution, and extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was ethyl acetate-
Recrystallized from hexane to give the title compound (150 mg, 6
7%). IRνmax KBr cm -1 : 1694, 1505.mp 134-135 ℃ 1 H-NMR (CDCl 3 ) δ: 1.24 (9H, s), 3.13 (2H, d, J =
(7.8 Hz), 4.10-4.30 (1H, m), 4.62-4.90 (2H, m), 7.20
-7.30 (2H, m), 7.30-7.52 (2H, m), 7.56-7.72 (3H,
m).
【0339】実施例207 N-((1RS,2SR)-2-ヒドロキシ-2-(4-フェ
ノキシフェニル)-1-((4-(トリフルオロメチル)
フェニル)メチル)エチル)-4-フルオロ-1-ナフタレ
ンカルボキサミド 1) 3-フェノキシ安息香酸(13.5g,63.0
ミリモル)のテトラヒドロフラン(150ml)溶液に
1,1'-カルボニルビス-1H-イミダゾール(11.2
g,69.3ミリモル)を加え、室温で30分攪拌し
た。反応液にマロン酸モノエチルマグネシウム塩(10
g,34.8ミリモル)を加え、室温で2時間攪拌し
た。反応液に酢酸エチル(50ml)および水(50m
l)を加え、更に水層のpHが酸性になるまで濃塩酸を
加えた。反応液を酢酸エチル(200ml×2)で抽出
し、抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去した。残留物をシリカゲルカラムク
ロマトグラフィー(ヘキサン:酢酸エチル=4:1)で
精製し、3-オキソ-3-(4-フェノキシフェニル)プロ
ピオン酸エチル(17.9g,100%)を褐色油状物
として得た。 IRνmaxKBrcm-1: 1744, 1694, 1582, 1489, 1439. Anal. Calcd for C17H16O4・0.1H2O: C, 71.37; H, 5.7
0 Found: C, 71.11; H, 5.89.1 H-NMR (CDCl3)δ: 1.20-1.40 (3H, m), 3.95 (2H×4/
5, s), 4.12-4.30 (2H, m), 5.62 (1H×1/5, s), 7.02
(2H, d, J = 7.4 Hz), 7.04-7.30 (2H, m), 7.30-7.60
(4H, m), 7.66 (1H, d, J = 7.6 Hz). 2) 3-オキソ-3-(4-フェノキシフェニル)プロピ
オン酸エチル(15g,52.8ミリモル)の1,2-
ジメトキシエタン(100ml)溶液に水素化ナトリウ
ム(60%油性,2.11g,52.8ミリモル)を氷
冷下加え、室温で30分攪拌した。反応液の中に4-ト
リフルオロメチルベンジルブロミド(12.6g,5
2.8ミリモル)の1,2-ジメトキシエタン(50m
l)溶液を滴下し、反応液を室温で4時間攪拌した。反
応液を水(200ml)の中に注ぎ、酢酸エチル(20
0ml×2)で抽出した。抽出液を水および飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて3
-オキソ-3-(4-フェノキシフェニル)-2-((4-
(トリフルオロメチル)フェニル)メチル)プロピオン
酸エチル(15.4g,66%)を得た。 mp 77-78℃ IRνmaxKBrcm-1: 1738, 1694, 1582, 1489, 1437. Anal. Calcd for C25H21F3O4: C, 67.87; H, 4.78 Found: C, 67.92; H, 4.89.1 H-NMR (CDCl3)δ: 1.10 (3H, t, J = 7.4 Hz), 3.35
(1H, d, J = 7.4 Hz), 4.09 (2H, q, J = 7.4 Hz), 4.5
3 (1H, t, J = 7.4 Hz), 6.94-7.04 (2H, m), 7.10-7.7
0 (11H, m). 3) 塩化亜鉛(7.39g,54.2ミリモル)のジ
エチルエーテル(150ml)溶液に水素化ホウ素ナト
リウム(4.11g,108.5ミリモル)を加えて室
温で30分攪拌した。不溶物をろ去し、ろ液に3-オキ
ソ-3-(4-フェノキシフェニル)-2-((4-(トリフ
ルオロメチル)フェニル)メチル)プロピオン酸エチル
(10g,25.9ミリモル)のジエチルエーテル(5
0ml)溶液を加えて室温で30分攪拌した。氷冷下、
反応液に1規定塩酸を加えてクエンチし、更に水(20
0ml)を加え、酢酸エチル(300ml×2)で抽出
した。抽出液を水および飽和食塩水で洗浄し、無水硫酸
マグネシウムで乾燥後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(酢酸エチル)で精製し、
(2RS,3RS)-3-ヒドロキシ-3-(4-フェノキ
シフェニル)-2-((4-(トリフルオロメチル)フェ
ニル)メチル)プロピオン酸エチル(12.0g,10
0%)を無色油状物として得た。 IRνmaxKBrcm-1: 1728, 1713, 1584, 1487, 1447. Anal. Calcd for C25H23F3O4: C, 67.56; H, 5.22 Found: C, 67.46; H, 5.201 H-NMR (CDCl3)δ: 0.94 (3H, t, J = 7.2 Hz), 2.90-
3.12 (4H, m), 3.90 (2H,q, J = 7.2 Hz), 4.98-5.08
(1H, m), 6.90-7.40 (11H, m), 7.48 (2H, d, J =8.0 H
z). 4) (2RS,3RS)-3-ヒドロキシ-3-(4-フ
ェノキシフェニル)-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸エチル(11.8
g,26.6ミリモル)のメタノール(40ml)溶液
に、2規定水酸化ナトリウム水溶液(26.6ml,5
3.2ミリモル)を加えて室温で4時間攪拌した。反応
液を1規定塩酸で酸性とした後、酢酸エチル(200m
l×2)で抽出した。抽出液を水および飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去した。残
留物を酢酸エチル−ヘキサンから再結晶させて(2R
S,3RS)-3-ヒドロキシ-3-(4-フェノキシフェ
ニル)-2-((4-(トリフルオロメチル)フェニル)
メチル)プロピオン酸(9.0g,81%)を得た。 mp 128-129℃ IRνmaxKBrcm-1: 1713, 1586, 1489, 1447. Anal. Calcd for C23H19F3O4: C, 66.34; H, 4.60 Found: C, 66.41; H, 4.58.1 H-NMR (CDCl3)δ: 2.86-3.14 (3H, m), 5.10 (1H, s),
6.90-7.02 (3H, m), 7.02-7.22 (5H, m), 7.22-7.40
(3H, m), 7.47 (2H, d, J = 8.0 Hz). 5) (2RS,3RS)-3-ヒドロキシ-3-(4-フ
ェノキシフェニル)-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸(7.0g,1
6.8ミリモル)のテトラヒドロフラン(180ml)
溶液に、ジフェニルホスホリルアジド(4.0ml,1
8.5ミリモル)とトリエチルアミン(3.5ml,2
5.2ミリモル)を加え、6時間加熱還流した。反応液
を放冷後、水(200ml)を加えて酢酸エチル(20
0ml×2)で抽出した。抽出液を1規定塩酸、飽和重
曹水、飽和食塩水で順次洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物をシリカゲルカラムクロ
マトグラフィー(酢酸エチル)で精製し、残留物を酢酸
エチル−ヘキサンから再結晶させて(4RS,5SR)
-5-(4-フェノキシフェニル)-4-((4-(トリフル
オロメチル)フェニル)メチル)-1,3-オキサゾリジ
ン-2-オン(6.40g,92%)を得た。 mp 110-111℃ IRνmaxKBrcm-1: 1759, 1617, 1586, 1489. Anal. Calcd for C23H18F3NO3: C, 66.82; H, 4.39; N,
3.39 Found: C, 66.78; H, 4.25; N, 3.14.1 H-NMR (CDCl3)δ: 2.30-2.50 (2H, m), 4.18-4.30 (1
H, m), 5.22 (1H, s), 5.77 (1H, d, J = 8.0 Hz), 6.9
6-7.04 (4H, m), 7.04-7.20 (4H, m), 7.30-7.44(3H,
m), 7.55 (2H, d, J = 8.0 Hz). 6) (4RS,5SR)-5-(4-フェノキシフェニ
ル)-4-((4-(トリフルオロメチル)フェニル)メ
チル)-1,3-オキサゾリジン-2-オン(6.0g,1
4.5ミリモル)のエタノール(100ml)溶液に8
規定水酸化ナトリウム水溶液(9.0ml,72ミリモ
ル)を加え、4時間加熱還流した。反応液を濃縮後、水
(300ml)で希釈し、酢酸エチル(300ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去し、(1RS,2S
R)-2-アミノ-1-(4-フェノキシフェニル)-3-
(4-(トリフルオロメチル)フェニル)-1-プロパノ
ール(4.21g,75%)を無色油状物として得た。
また一部を塩酸塩としてエタノール-エーテルから再結
晶し、元素分析値を測定した。 IRνmaxKBrcm-1: 1584, 1489, 1443, 1418. Anal. Calcd for C22H21ClF3NO2・0.2H2O: C, 61.82;
H, 5.04; N, 3.28 Found: C, 61.83; H, 5.26; N, 3.24.1 H-NMR (CDCl3)δ: 2.44 (1H, dd, J = 14.2, 10.2 H
z), 2.86 (1H, dd, J = 14.0, 2.8 Hz), 3.20-3.36 (1
H, m), 4.64 (1H, d, J = 4.8 Hz), 6.90-7.20 (6H,m),
7.20-7.42 (5H, m), 7.53 (2H, d, J = 8.0 Hz). 7) (1RS,2SR)-2-アミノ-1-(4-フェノ
キシフェニル)-3-(4-(トリフルオロメチル)フェ
ニル)-1-プロパノール(400mg,1.03ミリモ
ル)のアセトニトリル(30ml)溶液に4-フルオロ
ナフタレンカルボン酸(196mg,1.03ミリモ
ル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(247mg,1.55ミ
リモル)および1-ヒドロキシ-1H-ベンゾトリアゾー
ル(158mg,1.03ミリモル)を加えて室温で終
夜攪拌した。反応液を水(100ml)で希釈し、酢酸
エチル(100ml×2)で抽出した。抽出液を1規定
塩酸、1規定水酸化ナトリウム水溶液、飽和食塩水で順
次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて、
表題化合物(446mg,77%)を得た。 mp 184-185℃ IRνmaxKBrcm-1: 1642, 1537, 1489. Anal. Calcd for C33H25F4NO3: C, 70.83; H, 4.50; N,
2.50 Found: C, 70.65; H, 4.56; N, 2.44.1 H-NMR (CDCl3)δ: 2.88 (1H, dd, J = 14.4, 10.6 H
z), 3.08 (1H, dd, J = 14.4, 4.0 Hz), 4.76-4.94 (1
H, m), 5.09 (1H, s), 6.04 (1H, d, J = 8.8 Hz),6.95
-7.50 (14H, m), 7.50-7.60 (3H, m), 7.66 (1H, d, J
= 8.0 Hz), 8.10 (1H, d, J = 8.4 Hz).Example 207 N-((1RS, 2SR) -2-hydroxy-2- (4-phenoxyphenyl) -1-((4- (trifluoromethyl)
Phenyl) methyl) ethyl) -4-fluoro-1-naphthalenecarboxamide 1) 3-phenoxybenzoic acid (13.5 g, 63.0)
1,1′-carbonylbis-1H-imidazole (11.2 mmol) in a solution of tetrahydrofuran (150 ml).
g, 69.3 mmol) and stirred at room temperature for 30 minutes. The reaction solution was mixed with monoethyl magnesium malonate (10
g, 34.8 mmol) and stirred at room temperature for 2 hours. Ethyl acetate (50 ml) and water (50 m
l) was added, and concentrated hydrochloric acid was further added until the pH of the aqueous layer became acidic. The reaction solution was extracted with ethyl acetate (200 ml × 2), the extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give ethyl 3-oxo-3- (4-phenoxyphenyl) propionate (17.9 g, 100%) as a brown oil. Was. IRνmax KBr cm -1 : 1744, 1694, 1582, 1489, 1439.Anal.Calcd for C 17 H 16 O 4・ 0.1H 2 O: C, 71.37; H, 5.7
0 Found: C, 71.11; H, 5.89. 1 H-NMR (CDCl 3 ) δ: 1.20-1.40 (3H, m), 3.95 (2H × 4 /
5, s), 4.12-4.30 (2H, m), 5.62 (1H × 1/5, s), 7.02
(2H, d, J = 7.4 Hz), 7.04-7.30 (2H, m), 7.30-7.60
(4H, m), 7.66 (1H, d, J = 7.6 Hz). 2) 1,2-Ethyl 3-oxo-3- (4-phenoxyphenyl) propionate (15 g, 52.8 mmol)
Sodium hydride (60% oily, 2.11 g, 52.8 mmol) was added to a dimethoxyethane (100 ml) solution under ice-cooling, and the mixture was stirred at room temperature for 30 minutes. 4-trifluoromethylbenzyl bromide (12.6 g, 5
2.8 mmol) of 1,2-dimethoxyethane (50 m
l) The solution was added dropwise and the reaction was stirred at room temperature for 4 hours. The reaction solution was poured into water (200 ml), and ethyl acetate (20 ml) was added.
0 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give 3
-Oxo-3- (4-phenoxyphenyl) -2-((4-
Ethyl (trifluoromethyl) phenyl) methyl) propionate (15.4 g, 66%) was obtained. mp 77-78 ℃ IRνmax KBr cm -1 : 1738, 1694, 1582, 1489, 1437. Anal.Calcd for C 25 H 21 F 3 O 4 : C, 67.87; H, 4.78 Found: C, 67.92; H, 4.89 . 1 H-NMR (CDCl 3 ) δ: 1.10 (3H, t, J = 7.4 Hz), 3.35
(1H, d, J = 7.4 Hz), 4.09 (2H, q, J = 7.4 Hz), 4.5
3 (1H, t, J = 7.4 Hz), 6.94-7.04 (2H, m), 7.10-7.7
0 (11H, m). 3) To a solution of zinc chloride (7.39 g, 54.2 mmol) in diethyl ether (150 ml) was added sodium borohydride (4.11 g, 108.5 mmol) and the mixture was stirred at room temperature for 30 minutes. Stirred. The insolubles were removed by filtration, and the filtrate was treated with ethyl 3-oxo-3- (4-phenoxyphenyl) -2-((4- (trifluoromethyl) phenyl) methyl) propionate (10 g, 25.9 mmol). Diethyl ether (5
0 ml) solution and stirred at room temperature for 30 minutes. below freezing,
The reaction solution is quenched by adding 1N hydrochloric acid, and further added with water (20 mL).
0 ml) and extracted with ethyl acetate (300 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate),
Ethyl (2RS, 3RS) -3-hydroxy-3- (4-phenoxyphenyl) -2-((4- (trifluoromethyl) phenyl) methyl) propionate (12.0 g, 10
0%) as a colorless oil. IRνmax KBr cm -1 : 1728, 1713, 1584, 1487, 1447.Anal.Calcd for C 25 H 23 F 3 O 4 : C, 67.56; H, 5.22 Found: C, 67.46; H, 5.20 1 H-NMR ( CDCl 3 ) δ: 0.94 (3H, t, J = 7.2 Hz), 2.90-
3.12 (4H, m), 3.90 (2H, q, J = 7.2 Hz), 4.98-5.08
(1H, m), 6.90-7.40 (11H, m), 7.48 (2H, d, J = 8.0 H
z). 4) Ethyl (2RS, 3RS) -3-hydroxy-3- (4-phenoxyphenyl) -2-((4- (trifluoromethyl) phenyl) methyl) propionate (11.8
g, 26.6 mmol) in methanol (40 ml) was added to a 2N aqueous sodium hydroxide solution (26.6 ml, 5 ml).
3.2 mmol) and stirred at room temperature for 4 hours. After the reaction solution was acidified with 1N hydrochloric acid, ethyl acetate (200 m
1 × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane (2R
S, 3RS) -3-Hydroxy-3- (4-phenoxyphenyl) -2-((4- (trifluoromethyl) phenyl)
Methyl) propionic acid (9.0 g, 81%) was obtained. mp 128-129 ℃ IRνmax KBr cm -1 : 1713, 1586, 1489, 1447.Anal.Calcd for C 23 H 19 F 3 O 4 : C, 66.34; H, 4.60 Found: C, 66.41; H, 4.58. 1 H-NMR (CDCl 3 ) δ: 2.86-3.14 (3H, m), 5.10 (1H, s),
6.90-7.02 (3H, m), 7.02-7.22 (5H, m), 7.22-7.40
(3H, m), 7.47 (2H, d, J = 8.0 Hz). 5) (2RS, 3RS) -3-hydroxy-3- (4-phenoxyphenyl) -2-((4- (trifluoromethyl) Phenyl) methyl) propionic acid (7.0 g, 1
6.8 mmol) in tetrahydrofuran (180 ml)
To the solution was added diphenylphosphoryl azide (4.0 ml, 1 ml).
8.5 mmol) and triethylamine (3.5 ml, 2
(5.2 mmol) and heated to reflux for 6 hours. After allowing the reaction solution to cool, water (200 ml) was added, and ethyl acetate (20 ml) was added.
0 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate), and the residue was recrystallized from ethyl acetate-hexane (4RS, 5SR).
This gave -5- (4-phenoxyphenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2-one (6.40 g, 92%). mp 110-111 ° C IRνmax KBr cm -1 : 1759, 1617, 1586, 1489. Anal.Calcd for C 23 H 18 F 3 NO 3 : C, 66.82; H, 4.39; N,
3.39 Found:. C, 66.78; H, 4.25; N, 3.14 1 H-NMR (CDCl 3) δ: 2.30-2.50 (2H, m), 4.18-4.30 (1
H, m), 5.22 (1H, s), 5.77 (1H, d, J = 8.0 Hz), 6.9
6-7.04 (4H, m), 7.04-7.20 (4H, m), 7.30-7.44 (3H,
m), 7.55 (2H, d, J = 8.0 Hz). 6) (4RS, 5SR) -5- (4-phenoxyphenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1, 3-Oxazolidin-2-one (6.0 g, 1
4.5 mmol) in ethanol (100 ml).
A normal aqueous sodium hydroxide solution (9.0 ml, 72 mmol) was added, and the mixture was heated under reflux for 4 hours. After the reaction solution was concentrated, it was diluted with water (300 ml), and ethyl acetate (300 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure to give (1RS, 2S
R) -2-Amino-1- (4-phenoxyphenyl) -3-
(4- (Trifluoromethyl) phenyl) -1-propanol (4.21 g, 75%) was obtained as a colorless oil.
A part was converted into a hydrochloride and recrystallized from ethanol-ether, and the elemental analysis value was measured. IRνmax KBr cm -1 : 1584, 1489, 1443, 1418. Anal.Calcd for C 22 H 21 ClF 3 NO 2・ 0.2H 2 O: C, 61.82;
H, 5.04; N, 3.28 Found :. C, 61.83; H, 5.26; N, 3.24 1 H-NMR (CDCl 3) δ: 2.44 (1H, dd, J = 14.2, 10.2 H
z), 2.86 (1H, dd, J = 14.0, 2.8 Hz), 3.20-3.36 (1
H, m), 4.64 (1H, d, J = 4.8 Hz), 6.90-7.20 (6H, m),
7.20-7.42 (5H, m), 7.53 (2H, d, J = 8.0 Hz). 7) (1RS, 2SR) -2-amino-1- (4-phenoxyphenyl) -3- (4- (trifluoro Methyl) phenyl) -1-propanol (400 mg, 1.03 mmol) in acetonitrile (30 ml) solution of 4-fluoronaphthalenecarboxylic acid (196 mg, 1.03 mmol) and 1-ethyl-3- (3-dimethylaminopropyl ) Carbodiimide hydrochloride (247 mg, 1.55 mmol) and 1-hydroxy-1H-benzotriazole (158 mg, 1.03 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane,
The title compound (446 mg, 77%) was obtained. . mp 184-185 ℃ IRνmax KBr cm -1 : 1642, 1537, 1489. Anal Calcd for C 33 H 25 F 4 NO 3: C, 70.83; H, 4.50; N,
2.50 Found:. C, 70.65; H, 4.56; N, 2.44 1 H-NMR (CDCl 3) δ: 2.88 (1H, dd, J = 14.4, 10.6 H
z), 3.08 (1H, dd, J = 14.4, 4.0 Hz), 4.76-4.94 (1
H, m), 5.09 (1H, s), 6.04 (1H, d, J = 8.8 Hz), 6.95
-7.50 (14H, m), 7.50-7.60 (3H, m), 7.66 (1H, d, J
= 8.0 Hz), 8.10 (1H, d, J = 8.4 Hz).
【0340】実施例208 N-((1RS,2SR)-2-ヒドロキシ-2-(4-フェ
ノキシフェニル)-1-((4-(トリフルオロメチル)
フェニル)メチル)エチル)-3-フェニルプロパンアミ
ド (1RS,2SR)-2-アミノ-1-(4-フェノキシフ
ェニル)-3-(4-(トリフルオロメチル)フェニル)-
1-プロパノール(400mg,1.03ミリモル)の
酢酸エチル(20ml)溶液に3-フェニルプロピオニ
ルクロリド(230ml,1.55ミリモル)および飽
和重曹水(20ml)を加えて室温で終夜攪拌した。反
応液を水(100ml)で希釈し、酢酸エチル(100
ml×2)で抽出した。抽出液を飽和食塩水で洗浄し、
無水硫酸マグネシウムで乾燥後減圧留去した。残留物を
酢酸エチル−ヘキサンから再結晶させて表題化合物(4
72mg,88%)を得た。 mp 134-135℃ IRνmaxKBrcm-1: 1645, 1584, 1489, 1445. Anal. Calcd for C31H28F3NO3: C, 71.66; H, 5.43; N,
2.70 Found: C, 71.50; H, 5.47; N, 2.43.1 H-NMR (CDCl3)δ: 2.37 (2H, t, J = 7.6 Hz), 2.58-
2.78 (2H, m), 2.85 (2H,t, J = 7.6 Hz), 3.20 (1H,
d, J = 3.8 Hz), 4.30-4.48 (1H, m), 4.78-4.84(1H,
m), 5.37 (1H, d, J = 8.4 Hz), 6.90-7.20 (10H, m),
7.20-7.40 (6H, m), 7.45 (2H, d, J = 8.4 Hz).Example 208 N-((1RS, 2SR) -2-hydroxy-2- (4-phenoxyphenyl) -1-((4- (trifluoromethyl)
(Phenyl) methyl) ethyl) -3-phenylpropanamide (1RS, 2SR) -2-amino-1- (4-phenoxyphenyl) -3- (4- (trifluoromethyl) phenyl)-
To a solution of 1-propanol (400 mg, 1.03 mmol) in ethyl acetate (20 ml) were added 3-phenylpropionyl chloride (230 ml, 1.55 mmol) and saturated aqueous sodium hydrogen carbonate (20 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
ml × 2). Wash the extract with saturated saline,
After drying over anhydrous magnesium sulfate, the solution was distilled off under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (4
72 mg, 88%). mp 134-135 ℃ IRνmax KBr cm -1 : 1645, 1584, 1489, 1445. Anal.Calcd for C 31 H 28 F 3 NO 3 : C, 71.66; H, 5.43; N,
2.70 Found:. C, 71.50; H, 5.47; N, 2.43 1 H-NMR (CDCl 3) δ: 2.37 (2H, t, J = 7.6 Hz), 2.58-
2.78 (2H, m), 2.85 (2H, t, J = 7.6 Hz), 3.20 (1H,
d, J = 3.8 Hz), 4.30-4.48 (1H, m), 4.78-4.84 (1H,
m), 5.37 (1H, d, J = 8.4 Hz), 6.90-7.20 (10H, m),
7.20-7.40 (6H, m), 7.45 (2H, d, J = 8.4 Hz).
【0341】実施例209 N-((1RS,2SR)-2-ヒドロキシ-2-(4-フェ
ノキシフェニル)-1-((4-(トリフルオロメチル)
フェニル)メチル)エチル)-4-フルオロ-1-ナフタレ
ンカルボキサミド 1) 4-フェノキシ安息香酸(10.4g,48.7
ミリモル)のテトラヒドロフラン(150ml)溶液に
1,1'-カルボニルビス-1H-イミダゾール(8.68
g,53.6ミリモル)を加え、室温で30分攪拌し
た。反応液にマロン酸モノエチルマグネシウム塩(7.
67g,26.8ミリモル)を加え、室温で2時間攪拌
した。反応液に酢酸エチル(50ml)および水(50
ml)を加え、更に水層のpHが酸性になるまで濃塩酸
を加えた。反応液を酢酸エチル(200ml×2)で抽
出し、抽出液を飽和食塩水で洗浄し、無水硫酸マグネシ
ウムで乾燥後減圧留去した。残留物をシリカゲルカラム
クロマトグラフィー(ヘキサン:酢酸エチル=4:1)
で精製し、3-オキソ-3-(4-フェノキシフェニル)プ
ロピオン酸エチル(12.9g,93%)を褐色油状物
として得た。 IRνmaxKBrcm-1: 1738, 1682, 1586, 1505, 1489. Anal. Calcd for C17H16O4: C, 71.82; H, 5.67 Found: C, 71.63; H, 5.56.1 H-NMR (CDCl3)δ: 1.20-1.38 (3H, m), 3.95 (2H×5/
6, s), 4.16-4.32 (2H, m), 5.60 (1H×1/6, s), 6.94-
7.12 (4H, m), 7.12-7.28 (1H, m), 7.32-7.48 (2H,
m), 7.72-7.80 (2H×1/6, m), 7.88-8.00 (2H×5/6,
m). 2) 3-オキソ-3-(4-フェノキシフェニル)プロピ
オン酸エチル(12g,42.2ミリモル)の1,2-
ジメトキシエタン(80ml)溶液に水素化ナトリウム
(60%油性,1.69g,42.2ミリモル)を氷冷
下加え、室温で30分攪拌した。反応液の中に4-トリ
フルオロメチルベンジルブロミド(10.1g,42.
2ミリモル)の1,2-ジメトキシエタン(50ml)
溶液を滴下し、反応液を室温で4時間攪拌した。反応液
を水(200ml)の中に注ぎ、酢酸エチル(200m
l×2)で抽出した。抽出液を水および飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去した。残
留物を酢酸エチル−ヘキサンから再結晶させて3-オキ
ソ-3-(4-フェノキシフェニル)-2-((4-(トリフ
ルオロメチル)フェニル)メチル)プロピオン酸エチル
(14.0g,75%)を得た。 mp 67-68℃ IRνmaxKBrcm-1: 1738, 1682, 1586, 1505, 1489. Anal. Calcd for C25H21F3O4: C, 67.87; H, 4.78 Found: C, 67.88; H, 4.89.1 H-NMR (CDCl3)δ: 1.13 (3H, t, J = 7.2 Hz), 3.37
(2H, d, J = 7.2 Hz), 4.11 (2H, q, J = 7.2 Hz), 4.5
7 (1H, t, J = 7.2 Hz), 6.90-7.10 (4H, m), 7.12-7.2
6 (1H, m), 7.30-7.48 (4H, m), 7.51 (2H, d, J = 8.2
Hz), 7.90-8.00 (2H, m). 3) 塩化亜鉛(7.39g,54.2ミリモル)のジ
エチルエーテル(150ml)溶液に水素化ホウ素ナト
リウム(4.11g,108.5ミリモル)を加えて室
温で30分攪拌した。不溶物をろ去し、ろ液に3-オキ
ソ-3-(4-フェノキシフェニル)-2-((4-(トリフ
ルオロメチル)フェニル)メチル)プロピオン酸エチル
(12g,27.1ミリモル)のジエチルエーテル(5
0ml)溶液を加えて室温で30分攪拌した。氷冷下、
反応液に1規定塩酸を加えてクエンチし、更に水(20
0ml)を加え、酢酸エチル(300ml×2)で抽出
した。抽出液を水および飽和食塩水で洗浄し、無水硫酸
マグネシウムで乾燥後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(酢酸エチル)で精製し、
(2RS,3RS)-3-ヒドロキシ-3-(4-フェノキ
シフェニル)-2-((4-(トリフルオロメチル)フェ
ニル)メチル)プロピオン酸エチル(11.9g,99
%)を無色油状物として得た。 IRνmaxKBrcm-1: 1728, 1618, 1590, 1507, 1489. Anal. Calcd for C25H23F3O4: C, 67.56; H, 5.22 Found: C, 67.40; H, 5.04.1 H-NMR (CDCl3)δ: 0.94 (3H, t, J = 7.2 Hz), 2.85
(1H, d, J = 2.6 Hz), 2.90-3.12 (3H, m), 3.89 (2H,
q, J = 7.2 Hz), 4.98-5.06 (1H, m), 6.94-7.04(4H,
m), 7.04-7.18 (1H, m), 7.22 (2H, d, J = 8.0 Hz),
7.30-7.42 (4H, m),7.49 (2H, d, J = 8.0 Hz). 4) (2RS,3RS)-3-ヒドロキシ-3-(4-フ
ェノキシフェニル)-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸エチル(11.5
g,25.9ミリモル)のメタノール(40ml)溶液
に、2規定水酸化ナトリウム水溶液(25.9ml,5
1.8ミリモル)を加えて室温で終夜攪拌した。反応液
を1規定塩酸で酸性とした後、酢酸エチル(200ml
×2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物を酢酸エチル−ヘキサンから再結晶させて(2RS,
3RS)-3-ヒドロキシ-3-(4-フェノキシフェニ
ル)-2-((4-(トリフルオロメチル)フェニル)メ
チル)プロピオン酸(9.65g,90%)を得た。 mp 140-141℃ IRνmaxKBrcm-1: 1715, 1590, 1489. Anal. Calcd for C23H19F3O4: C, 66.34; H, 4.60 Found: C, 66.36; H, 4.49.1 H-NMR (CDCl3)δ: 2.98-3.10 (3H, m), 5.08 (1H, s),
6.92-7.04 (4H, m), 7.04-7.30 (3H, m), 7.30-7.40
(4H, m), 7.48 (2H, d, J = 8.2 Hz). 5) (2RS,3RS)-3-ヒドロキシ-3-(4-フ
ェノキシフェニル)-2-((4-(トリフルオロメチ
ル)フェニル)メチル)プロピオン酸(7.0g,1
6.8ミリモル)のテトラヒドロフラン(180ml)
溶液に、ジフェニルホスホリルアジド(4.0ml,1
8.5ミリモル)とトリエチルアミン(3.5ml,2
5.2ミリモル)を加え、6時間加熱還流した。反応液
を放冷後、水(200ml)を加えて酢酸エチル(20
0ml×2)で抽出した。抽出液を1規定塩酸、飽和重
曹水、飽和食塩水で順次洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物をシリカゲルカラムクロ
マトグラフィー(酢酸エチル)で精製し、酢酸エチル−
ヘキサンから再結晶させて(4RS,5SR)-5-(4
-フェノキシフェニル)-4-((4-(トリフルオロメチ
ル)フェニル)メチル)-1,3-オキサゾリジン-2-オ
ン(6.40g,92%)を得た。 mp 162-163℃ IRνmaxKBrcm-1: 1759, 1617, 1591, 1508, 1489. Anal. Calcd for C23H18F3NO3: C, 66.82; H, 4.39; N,
3.39 Found: C, 66.94; H, 4.17; N, 3.39.1 H-NMR (CDCl3)δ: 2.30-2.50 (2H, m), 4.20-4.32 (1
H, m), 5.11 (1H, brs),5.80 (1H, d, J = 7.8 Hz), 6.
90-7.10 (4H, m), 7.10-7.22 (3H, m), 7.22-7.50 (4H,
m), 7.56 (2H, d, J = 8.0 Hz). 6) (4RS,5SR)-5-(4-フェノキシフェニ
ル)-4-((4-(トリフルオロメチル)フェニル)メ
チル)-1,3-オキサゾリジン-2-オン(6.0g,1
4.5ミリモル)のエタノール(100ml)溶液に8
規定水酸化ナトリウム水溶液(9.0ml,72ミリモ
ル)を加え、4時間加熱還流した。反応液を濃縮後、水
(300ml)で希釈し、酢酸エチル(300ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去し、残留物を酢酸エチ
ル−ヘキサンから再結晶させて(1RS,2SR)-2-
アミノ-1-(4-フェノキシフェニル)-3-(4-(トリ
フルオロメチル)フェニル)-1-プロパノール(5.0
3g,90%)を得た。 mp 114-115℃ IRνmaxKBrcm-1: 1590, 1507, 1489. Anal. Calcd for C22H20F3NO2: C, 68.21; H, 5.20; N,
3.62 Found: C, 68.12; H, 5.27; N, 3.58.1 H-NMR (CDCl3)δ: 2.46 (1H, dd, J = 13.6, 10.2 H
z), 2.94 (1H, dd, J = 13.6, 2.8 Hz), 3.24-3.38 (1
H, m), 4.65 (1H, d, J = 5.0 Hz), 6.98-7.18 (5H,m),
7.22-7.42 (6H, m), 7.55 (2H, d, J = 8.0 Hz). 7) (1RS,2SR)-2-アミノ-1-(4-フェノ
キシフェニル)-3-(4-(トリフルオロメチル)フェ
ニル)-1-プロパノール(400mg,1.03ミリモ
ル)のアセトニトリル(30ml)溶液に4-フルオロ
ナフタレンカルボン酸(196mg,1.03ミリモ
ル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(297mg,1.55ミ
リモル)および1-ヒドロキシ-1H-ベンゾトリアゾー
ル(158mg,1.03ミリモル)を加えて室温で終
夜攪拌した。反応液を水(100ml)で希釈し、酢酸
エチル(100ml×2)で抽出した。抽出液を1規定
塩酸、1規定水酸化ナトリウム水溶液、飽和食塩水で順
次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて、
表題化合物(520mg,90%)を得た。 mp 205-210℃ IRνmaxKBrcm-1: 1644, 1626, 1599, 1510. Anal. Calcd for C33H25F4NO3: C, 70.83; H, 4.50; N,
2.50 Found: C, 70.59; H, 4.50; N, 2.57.1 H-NMR (CDCl3)δ: 2.89 (1H, dd, J = 14.2, 11.0 H
z), 3.06-3.24 (2H, m), 4.78-4.90 (1H, m), 5.09 (1
H, d, J = 4.0 Hz), 5.97 (1H, d, J = 9.0 Hz), 6.96-
7.20 (7H, m), 7.30-7.68 (11H, m), 8.08 (1H, d, J =
8.0 Hz).Example 209 N-((1RS, 2SR) -2-hydroxy-2- (4-phenoxyphenyl) -1-((4- (trifluoromethyl)
Phenyl) methyl) ethyl) -4-fluoro-1-naphthalenecarboxamide 1) 4-phenoxybenzoic acid (10.4 g, 48.7)
1,1′-carbonylbis-1H-imidazole (8.68 mmol) in a solution of (1 mmol).
g, 53.6 mmol) and stirred at room temperature for 30 minutes. Monoethyl malonate magnesium salt (7.
67 g, 26.8 mmol) and stirred at room temperature for 2 hours. Ethyl acetate (50 ml) and water (50
ml), and concentrated hydrochloric acid was further added until the pH of the aqueous layer became acidic. The reaction solution was extracted with ethyl acetate (200 ml × 2), the extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. Silica gel column chromatography of the residue (hexane: ethyl acetate = 4: 1)
To give ethyl 3-oxo-3- (4-phenoxyphenyl) propionate (12.9 g, 93%) as a brown oil. . IRνmax KBr cm -1: 1738, 1682, 1586, 1505, 1489. Anal Calcd for C 17 H 16 O 4: C, 71.82; H, 5.67 Found:. C, 71.63; H, 5.56 1 H-NMR (CDCl 3 ) δ: 1.20-1.38 (3H, m), 3.95 (2H × 5 /
6, s), 4.16-4.32 (2H, m), 5.60 (1H × 1/6, s), 6.94-
7.12 (4H, m), 7.12-7.28 (1H, m), 7.32-7.48 (2H,
m), 7.72-7.80 (2H × 1/6, m), 7.88-8.00 (2H × 5/6,
m). 2) 1,2-Ethyl 3-oxo-3- (4-phenoxyphenyl) propionate (12 g, 42.2 mmol)
Sodium hydride (60% oily, 1.69 g, 42.2 mmol) was added to a dimethoxyethane (80 ml) solution under ice-cooling, and the mixture was stirred at room temperature for 30 minutes. 4-trifluoromethylbenzyl bromide (10.1 g, 42.
2 mmol) of 1,2-dimethoxyethane (50 ml)
The solution was added dropwise and the reaction was stirred at room temperature for 4 hours. The reaction solution was poured into water (200 ml), and ethyl acetate (200 ml) was added.
1 × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give ethyl 3-oxo-3- (4-phenoxyphenyl) -2-((4- (trifluoromethyl) phenyl) methyl) propionate (14.0 g, 75% ) Got. mp 67-68 ℃ IRνmax KBr cm -1 : 1738, 1682, 1586, 1505, 1489.Anal.Calcd for C 25 H 21 F 3 O 4 : C, 67.87; H, 4.78 Found: C, 67.88; H, 4.89 . 1 H-NMR (CDCl 3 ) δ: 1.13 (3H, t, J = 7.2 Hz), 3.37
(2H, d, J = 7.2 Hz), 4.11 (2H, q, J = 7.2 Hz), 4.5
7 (1H, t, J = 7.2 Hz), 6.90-7.10 (4H, m), 7.12-7.2
6 (1H, m), 7.30-7.48 (4H, m), 7.51 (2H, d, J = 8.2
Hz), 7.90-8.00 (2H, m). 3) To a solution of zinc chloride (7.39 g, 54.2 mmol) in diethyl ether (150 ml) was added sodium borohydride (4.11 g, 108.5 mmol). And stirred at room temperature for 30 minutes. The insolubles were removed by filtration, and the filtrate was treated with ethyl 3-oxo-3- (4-phenoxyphenyl) -2-((4- (trifluoromethyl) phenyl) methyl) propionate (12 g, 27.1 mmol). Diethyl ether (5
0 ml) solution and stirred at room temperature for 30 minutes. below freezing,
The reaction solution is quenched by adding 1N hydrochloric acid, and further added with water (20 mL).
0 ml) and extracted with ethyl acetate (300 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate),
Ethyl (2RS, 3RS) -3-hydroxy-3- (4-phenoxyphenyl) -2-((4- (trifluoromethyl) phenyl) methyl) propionate (11.9 g, 99
%) As a colorless oil. . IRνmax KBr cm -1: 1728, 1618, 1590, 1507, 1489. Anal Calcd for C 25 H 23 F 3 O 4: C, 67.56; H, 5.22 Found:. C, 67.40; H, 5.04 1 H-NMR (CDCl 3 ) δ: 0.94 (3H, t, J = 7.2 Hz), 2.85
(1H, d, J = 2.6 Hz), 2.90-3.12 (3H, m), 3.89 (2H,
q, J = 7.2 Hz), 4.98-5.06 (1H, m), 6.94-7.04 (4H,
m), 7.04-7.18 (1H, m), 7.22 (2H, d, J = 8.0 Hz),
7.30-7.42 (4H, m), 7.49 (2H, d, J = 8.0 Hz). 4) (2RS, 3RS) -3-hydroxy-3- (4-phenoxyphenyl) -2-((4- (tri Fluoromethyl) phenyl) methyl) ethyl propionate (11.5
g, 25.9 mmol) in methanol (40 ml) was added to a 2N aqueous sodium hydroxide solution (25.9 ml, 55.9 ml).
(1.8 mmol) and stirred at room temperature overnight. After the reaction solution was acidified with 1N hydrochloric acid, ethyl acetate (200 ml) was added.
× 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane (2RS,
3RS) -3-Hydroxy-3- (4-phenoxyphenyl) -2-((4- (trifluoromethyl) phenyl) methyl) propionic acid (9.65 g, 90%) was obtained. mp 140-141 ℃ IRνmax KBr cm -1 : 1715, 1590, 1489.Anal.Calcd for C 23 H 19 F 3 O 4 : C, 66.34; H, 4.60 Found: C, 66.36; H, 4.49. 1 H- NMR (CDCl 3 ) δ: 2.98-3.10 (3H, m), 5.08 (1H, s),
6.92-7.04 (4H, m), 7.04-7.30 (3H, m), 7.30-7.40
(4H, m), 7.48 (2H, d, J = 8.2 Hz). 5) (2RS, 3RS) -3-hydroxy-3- (4-phenoxyphenyl) -2-((4- (trifluoromethyl) Phenyl) methyl) propionic acid (7.0 g, 1
6.8 mmol) in tetrahydrofuran (180 ml)
To the solution was added diphenylphosphoryl azide (4.0 ml, 1 ml).
8.5 mmol) and triethylamine (3.5 ml, 2
(5.2 mmol) and heated to reflux for 6 hours. After allowing the reaction solution to cool, water (200 ml) was added, and ethyl acetate (20 ml) was added.
0 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate).
Recrystallized from hexane to give (4RS, 5SR) -5- (4
-Phenoxyphenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1,3-oxazolidin-2-one (6.40 g, 92%) was obtained. mp 162-163 ° C IRνmax KBr cm -1 : 1759, 1617, 1591, 1508, 1489. Anal.Calcd for C 23 H 18 F 3 NO 3 : C, 66.82; H, 4.39; N,
3.39 Found:. C, 66.94; H, 4.17; N, 3.39 1 H-NMR (CDCl 3) δ: 2.30-2.50 (2H, m), 4.20-4.32 (1
H, m), 5.11 (1H, brs), 5.80 (1H, d, J = 7.8 Hz), 6.
90-7.10 (4H, m), 7.10-7.22 (3H, m), 7.22-7.50 (4H, m
m), 7.56 (2H, d, J = 8.0 Hz). 6) (4RS, 5SR) -5- (4-phenoxyphenyl) -4-((4- (trifluoromethyl) phenyl) methyl) -1, 3-Oxazolidin-2-one (6.0 g, 1
4.5 mmol) in ethanol (100 ml).
A normal aqueous sodium hydroxide solution (9.0 ml, 72 mmol) was added, and the mixture was heated under reflux for 4 hours. After the reaction solution was concentrated, it was diluted with water (300 ml), and ethyl acetate (300 ml ×
Extracted in 2). The extract was washed with brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR) -2-.
Amino-1- (4-phenoxyphenyl) -3- (4- (trifluoromethyl) phenyl) -1-propanol (5.0
3g, 90%). mp 114-115 ° C IRνmax KBr cm -1 : 1590, 1507, 1489. Anal.Calcd for C 22 H 20 F 3 NO 2 : C, 68.21; H, 5.20; N,
3.62 Found:. C, 68.12; H, 5.27; N, 3.58 1 H-NMR (CDCl 3) δ: 2.46 (1H, dd, J = 13.6, 10.2 H
z), 2.94 (1H, dd, J = 13.6, 2.8 Hz), 3.24-3.38 (1
H, m), 4.65 (1H, d, J = 5.0 Hz), 6.98-7.18 (5H, m),
7.22-7.42 (6H, m), 7.55 (2H, d, J = 8.0 Hz). 7) (1RS, 2SR) -2-amino-1- (4-phenoxyphenyl) -3- (4- (trifluoro Methyl) phenyl) -1-propanol (400 mg, 1.03 mmol) in acetonitrile (30 ml) solution of 4-fluoronaphthalenecarboxylic acid (196 mg, 1.03 mmol) and 1-ethyl-3- (3-dimethylaminopropyl ) Carbodiimide hydrochloride (297 mg, 1.55 mmol) and 1-hydroxy-1H-benzotriazole (158 mg, 1.03 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane,
The title compound (520 mg, 90%) was obtained. mp 205-210 ° C IRνmax KBr cm -1 : 1644, 1626, 1599, 1510. Anal.Calcd for C 33 H 25 F 4 NO 3 : C, 70.83; H, 4.50; N,
2.50 Found:. C, 70.59; H, 4.50; N, 2.57 1 H-NMR (CDCl 3) δ: 2.89 (1H, dd, J = 14.2, 11.0 H
z), 3.06-3.24 (2H, m), 4.78-4.90 (1H, m), 5.09 (1
H, d, J = 4.0 Hz), 5.97 (1H, d, J = 9.0 Hz), 6.96-
7.20 (7H, m), 7.30-7.68 (11H, m), 8.08 (1H, d, J =
8.0 Hz).
【0342】実施例210 N-((1RS,2SR)-2-ヒドロキシ-2-(4-フェ
ノキシフェニル)-1-((4-(トリフルオロメチル)
フェニル)メチル)エチル)-6,7-ジヒドロ-5H-ベ
ンゾ[a]シクロヘプテン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フェノキシフ
ェニル)-3-(4-(トリフルオロメチル)フェニル)-
1-プロパノール(206mg,0.53ミリモル)の
アセトニトリル(20ml)溶液に6,7-ジヒドロ-5
H-ベンゾ[a]シクロヘプテン-1-カルボン酸(10
0mg,0.53ミリモル)および1-エチル-3-(3-
ジメチルアミノプロピル)カルボジイミド・塩酸塩(1
53mg,0.80ミリモル)および1-ヒドロキシ-1
H-ベンゾトリアゾール(81mg,0.53ミリモ
ル)を加えて室温で終夜攪拌した。反応液を水(100
ml)で希釈し、酢酸エチル(100ml×2)で抽出
した。抽出液を1規定塩酸、1規定水酸化ナトリウム水
溶液、飽和食塩水で順次洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物を酢酸エチル−ヘキサン
から再結晶させて、表題化合物(268mg,90%)
を得た。 mp 191-192℃ IRνmaxKBrcm-1: 1642, 1590, 1507, 1489, 1327.1 H-NMR (CDCl3)δ: 1.90-2.06 (2H, m), 2.10-2.26 (2
H, m), 2.60-2.70 (2H, m), 2.85 (1H, dd, J = 14.4,
11.0 Hz), 3.07 (1H, dd, J = 14.4, 3.4 Hz), 3.42 (1
H, brs), 4.64-4.84 (1H, m), 5.03 (1H, d, J = 4.0 H
z), 5.80 (1H, d,J = 9.6 Hz), 5.80-5.96 (1H, m), 6.
13 (1H, d, J = 11.8 Hz), 6.90-7.20 (8H, m), 7.20-
7.50 (6H, m), 7.54 (2H, d, J = 8.2 Hz).Example 210 N-((1RS, 2SR) -2-hydroxy-2- (4-phenoxyphenyl) -1-((4- (trifluoromethyl)
(Phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-phenoxyphenyl) -3- (4- (tri Fluoromethyl) phenyl)-
6,7-dihydro-5 was added to a solution of 1-propanol (206 mg, 0.53 mmol) in acetonitrile (20 ml).
H-benzo [a] cycloheptene-1-carboxylic acid (10
0 mg, 0.53 mmol) and 1-ethyl-3- (3-
Dimethylaminopropyl) carbodiimide hydrochloride (1
53 mg, 0.80 mmol) and 1-hydroxy-1
H-benzotriazole (81 mg, 0.53 mmol) was added and the mixture was stirred at room temperature overnight. The reaction solution was washed with water (100
ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (268 mg, 90%).
I got mp 191-192 ℃ IRνmax KBr cm -1: 1642, 1590, 1507, 1489, 1327. 1 H-NMR (CDCl 3) δ: 1.90-2.06 (2H, m), 2.10-2.26 (2
H, m), 2.60-2.70 (2H, m), 2.85 (1H, dd, J = 14.4,
11.0 Hz), 3.07 (1H, dd, J = 14.4, 3.4 Hz), 3.42 (1
H, brs), 4.64-4.84 (1H, m), 5.03 (1H, d, J = 4.0 H
z), 5.80 (1H, d, J = 9.6 Hz), 5.80-5.96 (1H, m), 6.
13 (1H, d, J = 11.8 Hz), 6.90-7.20 (8H, m), 7.20-
7.50 (6H, m), 7.54 (2H, d, J = 8.2 Hz).
【0343】実施例211 N-((1RS,2SR)-2-ヒドロキシ-2-(4-フェ
ノキシフェニル)-1-((4-(トリフルオロメチル)
フェニル)メチル)エチル)-3-フェニルプロパンアミ
ド (1RS,2SR)-2-アミノ-1-(4-フェノキシフ
ェニル)-3-(4-(トリフルオロメチル)フェニル)-
1-プロパノール(400mg,1.03ミリモル)の
酢酸エチル(20ml)溶液に3-フェニルプロピオニ
ルクロリド(230ml,1.55ミリモル)および飽
和重曹水(20ml)を加えて室温で終夜攪拌した。反
応液を水(100ml)で希釈し、酢酸エチル(100
ml×2)で抽出した。抽出液を飽和食塩水で洗浄し、
無水硫酸マグネシウムで乾燥後減圧留去した。残留物を
酢酸エチル−ヘキサンから再結晶させて表題化合物(4
16mg,78%)を得た。 mp 133-134℃ IRνmaxKBrcm-1: 1645, 1590, 1507, 1489. Anal. Calcd for C31H28F3NO3: C, 71.66; H, 5.43; N,
2.70 Found: C, 71.84; H, 5.26; N, 2.69.1 H-NMR (CDCl3)δ: 2.32-2.42 (2H, m), 2.60-2.90 (4
H, m), 3.14-3.22 (1H, m), 4.32-4.50 (1H, m), 4.78-
4.86 (1H, m), 5.36 (1H, d, J = 8.4 Hz), 6.92-7.04
(4H, m), 7.06-7.40 (7H, m), 7.47 (2H, d, J = 8.0 H
z).Example 211 N-((1RS, 2SR) -2-hydroxy-2- (4-phenoxyphenyl) -1-((4- (trifluoromethyl)
(Phenyl) methyl) ethyl) -3-phenylpropanamide (1RS, 2SR) -2-amino-1- (4-phenoxyphenyl) -3- (4- (trifluoromethyl) phenyl)-
To a solution of 1-propanol (400 mg, 1.03 mmol) in ethyl acetate (20 ml) were added 3-phenylpropionyl chloride (230 ml, 1.55 mmol) and saturated aqueous sodium hydrogen carbonate (20 ml), and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
ml × 2). Wash the extract with saturated saline,
After drying over anhydrous magnesium sulfate, the solution was distilled off under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (4
(16 mg, 78%). mp 133-134 ℃ IRνmax KBr cm -1 : 1645, 1590, 1507, 1489. Anal.Calcd for C 31 H 28 F 3 NO 3 : C, 71.66; H, 5.43; N
2.70 Found:. C, 71.84; H, 5.26; N, 2.69 1 H-NMR (CDCl 3) δ: 2.32-2.42 (2H, m), 2.60-2.90 (4
H, m), 3.14-3.22 (1H, m), 4.32-4.50 (1H, m), 4.78-
4.86 (1H, m), 5.36 (1H, d, J = 8.4 Hz), 6.92-7.04
(4H, m), 7.06-7.40 (7H, m), 7.47 (2H, d, J = 8.0 H
z).
【0344】実施例212 N-((1RS,2SR)-1-((4-フルオロフェニ
ル)メチル)-2-ヒドロキシ-2-(4-(トリフルオロ
メチル)フェニル)エチル)-1-ナフタレンカルボキサ
ミド 1) 4-トリフルオロメチルアセトフェノン(57.
8g,0.307モル)とエタノール(1ml)の炭酸
ジエチル(300ml)溶液に水素化ナトリウム(2
4.5g,60%油性,0.63モル)を少量ずつ加え
た。徐々に発熱するので、氷冷し、その後室温で2時間
撹拌した。反応液に6規定塩酸を加えて反応を停止し、
水(300ml)で希釈した後、酢酸エチル(200m
l×2)で抽出した。抽出液を水洗後、無水硫酸マグネ
シウムで乾燥し、減圧留去した。残留物をシリカゲルカ
ラムクロマトグラフィー(ヘキサン:酢酸エチル=5
0:1−5:1)で精製して、3-オキソ-3-(4-トリ
フルオロメチルフェニル)プロピオン酸エチル(71.
2g,89%)を得た。 IRνmaxNeatcm-1: 1744, 1696, 1431, 1325, 1202, 113
2, 1069, 1017, 853.1 H-NMR (CDCl3)δ: 1.28 (3H×0.62, t, J = 7.8 Hz, k
eto), 1.37 (3H×0.38,t, J = 7.8 Hz, enol), 4.04 (2
H×0.62, s, keto), 4.25 (2H, ×0.62, q, J =7.8 Hz,
keto), 4.31 (2H, ×0.38, q, J = 7.8 Hz, enol), 5.
75 (1H×0.38,s, enol), 7.28 (1H×0.62, s, keto),
7.70 (2H×0.38, d, J = 8.0 Hz, enol), 7.78 (2H×0.
62, d, J = 8.0 Hz, keto), 7.90 (2H×0.38, d, J =
8.0 Hz),8.08 (2H×0.62, d, J = 8.0 Hz). 2) 3-オキソ-3-(4-トリフルオロメチルフェニ
ル)プロピオン酸エチル(38.2g,0.147モ
ル)と4-フルオロベンジルブロミド(25g,0.1
3モル)、炭酸カリウム(36.6g,0.26モ
ル)、アセトニトリル(500ml)の混合液を60℃
で3時間撹拌した。反応液を減圧濃縮し、水(500m
l)を加えて酢酸エチル(500,200ml)で抽出
した。抽出液を水洗後、無水硫酸マグネシウムで乾燥
し、減圧留去した。残留物をシリカゲルカラムクロマト
グラフィー(ヘキサン:酢酸エチル=50:1−10:
1,ヘキサン:トルエン=1:1)で精製し、冷ヘキサ
ンから結晶化させて、2-((4-フルオロフェニル)メ
チル)-3-オキソ-3-(4-(トリフルオロメチル)フ
ェニル)プロピオン酸エチル(29.5g,55%)を
得た。 mp 52-53℃ IRνmaxKBrcm-1: 1723, 1692, 1514, 1323, 1231, 113
0, 1067, 853, 824. 元素分析値C19H16F4O3として、 計算値: C, 61.96; H, 4.38 実測値: C, 61.97; H, 4.14.1 H-NMR (CDCl3)δ: 1.12 (3H, t, J = 7.1 Hz), 3.31
(2H, d, J = 7.6 Hz), 4.10 (2H, q, J = 7.1 Hz), 4.5
6 (1H, t, J = 7.3 Hz), 6.88-8.03 (2H, m), 7.12-7.3
2 (2H, m), 7.71 (2H, t, J = 8.0 Hz), 8.04 (2H, d,
J = 8.0 Hz). 3) 塩化亜鉛(21.54g,158ミリモル)のエ
ーテル(500ml)溶液に、水素化ホウ素ナトリウム
(11.96g,316ミリモル)を加え、室温で30
分攪拌し、析出した食塩をろ過した。ろ液の中に2-
((4-フルオロフェニル)メチル)-3-オキソ-3-
(4-(トリフルオロメチル)フェニル)プロピオン酸
エチル(28g,79ミリモル)のエーテル(200m
l)溶液を氷冷下、徐々に加え、室温で30分攪拌し
た。反応液を1規定塩酸水溶液(500ml)に注ぎ、
酢酸エチル(500ml×2)で抽出した。抽出液を飽
和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減圧
留去した。残留物をシリカゲルカラムクロマトグラフィ
ー(ヘキサン:酢酸エチル=4:1)で精製し、(2R
S,3RS)-2-((4-フルオロフェニル)メチル)-
3-ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)プロピオン酸エチル(28g,100%)を無色油
状物として得た。 IRνmaxKBrcm-1: 1713, 1510. Anal. Calcd for C19H18F4O3: C, 61.62; H, 4.90 Found: C, 61.51; H, 4.87.1 H-NMR (CDCl3)δ: 0.95 (3H, t, J = 7.4 Hz), 2.80-
3.06 (3H, m), 3.15 (1H,d, J = 2.6 Hz), 3.91 (2H,
q, J = 7.4 Hz), 5.11 (1H, brs), 6.84-7.06 (4H, m),
7.52 (2H, d, J = 8.4 Hz), 7.63 (2H, d, J = 8.4 H
z). 4) (2RS,3RS)-2-((4-フルオロフェニ
ル)メチル)-3-ヒドロキシ-3-(4-(トリフルオロ
メチル)フェニル)プロピオン酸エチル(27.5g,
74.3ミリモル)のメタノール(300ml)溶液
に、1規定水酸化ナトリウム水溶液(150ml,15
0ミリモル)を加え、室温で終夜攪拌した。反応液を1
規定塩酸水溶液(180ml)に注ぎ、酢酸エチル(3
00ml×2)で抽出した。抽出液を飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物を酢酸エチル−ヘキサンから再結晶させて、(2R
S,3RS)-2-((4-フルオロフェニル)メチル)-
3-ヒドロキシ-3-(4-(トリフルオロメチル)フェニ
ル)プロピオン酸(22.45g,88%)を得た。 mp 120-121℃ IRνmaxKBrcm-1: 1713. Anal. Calcd for C17H14F4O3: C, 59.65; H, 4.12 Found: C, 59.56; H, 4.03.1 H-NMR (CDCl3)δ: 2.90-3.10 (3H, m), 5.16 (1H, d,
J = 3.6 Hz), 6.82-7.12(4H, m), 7.52 (2H, d, J = 8.
0 Hz), 7.63 (2H, d, J = 8.0 Hz). 5) (2RS,3RS)-2-((4-フルオロフェニ
ル)メチル)-3-ヒドロキシ-3-(4-(トリフルオロ
メチル)フェニル)プロピオン酸(21.0g,61.
35ミリモル)のテトラヒドロフラン(500ml)溶
液にジフェニルホスホリルアジド(14.5ml,6
7.5ミリモル)およびトリエチルアミン(12.9m
l,92ミリモル)を加えて3時間加熱還流した。反応
液を水(500ml)で希釈し、酢酸エチル(500m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(酢酸エチル)で精
製し、酢酸エチル−ヘキサンから再結晶させて、(4R
S,5SR)-4-((4-フルオロフェニル)メチル)-
5-(4-(トリフルオロメチル)フェニル)-1,3-オ
キサゾリジン-2-オン(19.24g,92%)を得
た。 mp 160-161℃ IRνmaxKBrcm-1: 1738, 1508. Anal. Calcd for C17H13F4NO2: C, 60.18; H, 3.86; N,
4.13 Found: C, 60.01; H, 3.99; N, 4.06.1 H-NMR (CDCl3)δ: 2.10-2.34 (2H, m), 4.20-4.34 (1
H, m), 5.11 (1H, s), 5.86 (1H, d, J = 7.8 Hz), 6.9
7 (4H, d, J = 9.0 Hz), 7.51 (2H, d, J = 8.2 Hz),
7.70 (2H, d, J = 8.2 Hz). 6) (4RS,5SR)-4-((4-フルオロフェニ
ル)メチル)-5-(4-(トリフルオロメチル)フェニ
ル)-1,3-オキサゾリジン-2-オン(18g,53.
1ミリモル)のエタノール(300ml)溶液に8規定
水酸化ナトリウム水溶液(19.9ml,159ミリモ
ル)を加え、4時間加熱還流した。反応液を濃縮後、水
(300ml)で希釈し、酢酸エチル(300ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて、(1RS,2SR)
-2-アミノ-3-(4-フルオロフェニル)-1-(4-(ト
リフルオロメチル)フェニル)-1-プロパノール(1
4.1g,85%)を得た。 mp 130-131℃ IRνmaxKBrcm-1: 1618, 1601, 1588. Anal. Calcd for C16H15F4NO: C, 61.34; H, 4.83; N,
4.47 Found: C, 61.23; H, 4.72; N, 4.41.1 H-NMR (CDCl3)δ: 2.32 (1H, dd, J = 14.0, 10.6 H
z), 2.68 (1H, dd, J = 14.0, 3.4 Hz), 3.20-3.36 (1
H, m), 4.76 (1H, d, J = 4.4 Hz), 6.90-7.16 (4H,m),
7.52 (2H, d, J = 8.2 Hz), 7.65 (2H, d, J = 8.2 H
z). 7) (1RS,2SR)-2-アミノ-3-(4-フルオ
ロフェニル)-1-(4-(トリフルオロメチル)フェニ
ル)-1-プロパノール(450mg,1.44ミリモ
ル)の酢酸エチル(15ml)溶液に1-ナフトイルク
ロリド(282ml,1.87ミリモル)および飽和重
曹水(15ml)を加えて室温で2時間攪拌した。反応
液を水(100ml)で希釈し、酢酸エチル(100m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後減圧留去した。残留物を酢
酸エチル−ヘキサンから再結晶させて、表題化合物(6
14mg,91%)を得た。 mp 207-208℃ IRνmaxKBrcm-1: 1640. Anal. Calcd for C27H21F4NO2: C, 69.37; H, 4.53; N,
3.00 Found: C, 69.21; H, 4.46; N, 2.87.1 H-NMR (CDCl3)δ: 2.92 (1H, dd, J = 14.2, 10.4 H
z), 3.13 (1H, dd, J = 14.2, 4.0 Hz), 3.39 (1H, s),
4.72-4.90 (1H, m), 5.13 (1H, s), 5.98 (1H, d,J =
8.4 Hz), 7.04-7.60 (12H, m), 7.70-7.92 (3H, m).Example 212 N-((1RS, 2SR) -1-((4-fluorophenyl) methyl) -2-hydroxy-2- (4- (trifluoromethyl) phenyl) ethyl) -1-naphthalenecarboxamide 1) 4-trifluoromethylacetophenone (57.
8 g, 0.307 mol) and ethanol (1 ml) in diethyl carbonate (300 ml).
(4.5 g, 60% oily, 0.63 mol) was added in small portions. Since the mixture gradually generated heat, the mixture was cooled on ice and then stirred at room temperature for 2 hours. The reaction was stopped by adding 6N hydrochloric acid to the reaction solution,
After dilution with water (300 ml), ethyl acetate (200 m
1 × 2). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 5).
0: 1-5: 1) and ethyl 3-oxo-3- (4-trifluoromethylphenyl) propionate (71.
2 g, 89%). IRνmax Neat cm -1 : 1744, 1696, 1431, 1325, 1202, 113
2, 1069, 1017, 853. 1 H-NMR (CDCl 3) δ: 1.28 (3H × 0.62, t, J = 7.8 Hz, k
eto), 1.37 (3H × 0.38, t, J = 7.8 Hz, enol), 4.04 (2
H × 0.62, s, keto), 4.25 (2H, × 0.62, q, J = 7.8 Hz,
keto), 4.31 (2H, × 0.38, q, J = 7.8 Hz, enol), 5.
75 (1H × 0.38, s, enol), 7.28 (1H × 0.62, s, keto),
7.70 (2H × 0.38, d, J = 8.0 Hz, enol), 7.78 (2H × 0.
62, d, J = 8.0 Hz, keto), 7.90 (2H × 0.38, d, J =
8.0 Hz), 8.08 (2H x 0.62, d, J = 8.0 Hz). 2) Ethyl 3-oxo-3- (4-trifluoromethylphenyl) propionate (38.2 g, 0.147 mol) and 4- Fluorobenzyl bromide (25 g, 0.1
3 mol), potassium carbonate (36.6 g, 0.26 mol), and acetonitrile (500 ml) at 60 ° C.
For 3 hours. The reaction solution was concentrated under reduced pressure, and water (500 m
l) was added and extracted with ethyl acetate (500, 200 ml). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 50: 1-10:
Purified with 1, hexane: toluene = 1: 1) and crystallized from cold hexane to give 2-((4-fluorophenyl) methyl) -3-oxo-3- (4- (trifluoromethyl) phenyl) Ethyl propionate (29.5 g, 55%) was obtained. mp 52-53 ° C IRνmax KBr cm -1 : 1723, 1692, 1514, 1323, 1231, 113
0, 1067, 853, as 824. Elemental analysis C 19 H 16 F 4 O 3 , Calcd: C, 61.96; H, 4.38 Found:. C, 61.97; H, 4.14 1 H-NMR (CDCl 3) δ: 1.12 (3H, t, J = 7.1 Hz), 3.31
(2H, d, J = 7.6 Hz), 4.10 (2H, q, J = 7.1 Hz), 4.5
6 (1H, t, J = 7.3 Hz), 6.88-8.03 (2H, m), 7.12-7.3
2 (2H, m), 7.71 (2H, t, J = 8.0 Hz), 8.04 (2H, d,
J = 8.0 Hz). 3) To a solution of zinc chloride (21.54 g, 158 mmol) in ether (500 ml) was added sodium borohydride (11.96 g, 316 mmol), and the mixture was added at room temperature for 30 minutes.
After stirring for minutes, the precipitated salt was filtered. 2- in the filtrate
((4-fluorophenyl) methyl) -3-oxo-3-
Ether of ethyl (4- (trifluoromethyl) phenyl) propionate (28 g, 79 mmol) (200 m
l) The solution was gradually added under ice-cooling, followed by stirring at room temperature for 30 minutes. The reaction solution was poured into a 1N aqueous hydrochloric acid solution (500 ml),
Extracted with ethyl acetate (500 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give (2R
S, 3RS) -2-((4-Fluorophenyl) methyl)-
Ethyl 3-hydroxy-3- (4- (trifluoromethyl) phenyl) propionate (28 g, 100%) was obtained as a colorless oil. IRνmax KBr cm -1 : 1713, 1510.Anal.Calcd for C 19 H 18 F 4 O 3 : C, 61.62; H, 4.90 Found: C, 61.51; H, 4.87. 1 H-NMR (CDCl 3 ) δ: 0.95 (3H, t, J = 7.4 Hz), 2.80-
3.06 (3H, m), 3.15 (1H, d, J = 2.6 Hz), 3.91 (2H,
q, J = 7.4 Hz), 5.11 (1H, brs), 6.84-7.06 (4H, m),
7.52 (2H, d, J = 8.4 Hz), 7.63 (2H, d, J = 8.4 H
z). 4) Ethyl (2RS, 3RS) -2-((4-fluorophenyl) methyl) -3-hydroxy-3- (4- (trifluoromethyl) phenyl) propionate (27.5 g,
74.3 mmol) in methanol (300 ml) was added to a 1 N aqueous sodium hydroxide solution (150 ml, 15 ml).
0 mmol) and stirred at room temperature overnight. Reaction solution 1
Pour into a normal aqueous hydrochloric acid solution (180 ml) and add ethyl acetate (3
00 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (2R
S, 3RS) -2-((4-Fluorophenyl) methyl)-
3-Hydroxy-3- (4- (trifluoromethyl) phenyl) propionic acid (22.45 g, 88%) was obtained. . mp 120-121 ℃ IRνmax KBr cm -1 : 1713. Anal Calcd for C 17 H 14 F 4 O 3: C, 59.65; H, 4.12 Found:. C, 59.56; H, 4.03 1 H-NMR (CDCl 3 ) δ: 2.90-3.10 (3H, m), 5.16 (1H, d,
J = 3.6 Hz), 6.82-7.12 (4H, m), 7.52 (2H, d, J = 8.
0 Hz), 7.63 (2H, d, J = 8.0 Hz). 5) (2RS, 3RS) -2-((4-fluorophenyl) methyl) -3-hydroxy-3- (4- (trifluoromethyl) Phenyl) propionic acid (21.0 g, 61.
35 mmol) in tetrahydrofuran (500 ml) was added to diphenylphosphoryl azide (14.5 ml, 6 ml).
7.5 mmol) and triethylamine (12.9 m
(1, 92 mmol) and heated to reflux for 3 hours. The reaction solution was diluted with water (500 ml), and ethyl acetate (500 m
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to give (4R
S, 5SR) -4-((4-Fluorophenyl) methyl)-
5- (4- (Trifluoromethyl) phenyl) -1,3-oxazolidin-2-one (19.24 g, 92%) was obtained. mp 160-161 ℃ IRνmax KBr cm -1 : 1738, 1508. Anal.Calcd for C 17 H 13 F 4 NO 2 : C, 60.18; H, 3.86; N,
4.13 Found:. C, 60.01; H, 3.99; N, 4.06 1 H-NMR (CDCl 3) δ: 2.10-2.34 (2H, m), 4.20-4.34 (1
H, m), 5.11 (1H, s), 5.86 (1H, d, J = 7.8 Hz), 6.9
7 (4H, d, J = 9.0 Hz), 7.51 (2H, d, J = 8.2 Hz),
7.70 (2H, d, J = 8.2 Hz). 6) (4RS, 5SR) -4-((4-fluorophenyl) methyl) -5- (4- (trifluoromethyl) phenyl) -1,3-oxazolidine -2-one (18 g, 53.
To a solution of 1 mmol) in ethanol (300 ml) was added an 8 N aqueous sodium hydroxide solution (19.9 ml, 159 mmol), and the mixture was refluxed for 4 hours. After the reaction solution was concentrated, it was diluted with water (300 ml), and ethyl acetate (300 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR)
2-amino-3- (4-fluorophenyl) -1- (4- (trifluoromethyl) phenyl) -1-propanol (1
4.1 g, 85%). mp 130-131 ° C IRνmax KBr cm -1 : 1618, 1601, 1588. Anal.Calcd for C 16 H 15 F 4 NO: C, 61.34; H, 4.83; N,
4.47 Found:. C, 61.23; H, 4.72; N, 4.41 1 H-NMR (CDCl 3) δ: 2.32 (1H, dd, J = 14.0, 10.6 H
z), 2.68 (1H, dd, J = 14.0, 3.4 Hz), 3.20-3.36 (1
H, m), 4.76 (1H, d, J = 4.4 Hz), 6.90-7.16 (4H, m),
7.52 (2H, d, J = 8.2 Hz), 7.65 (2H, d, J = 8.2 H
z). 7) Acetic acid of (1RS, 2SR) -2-amino-3- (4-fluorophenyl) -1- (4- (trifluoromethyl) phenyl) -1-propanol (450 mg, 1.44 mmol) 1-Naphthoyl chloride (282 ml, 1.87 mmol) and saturated aqueous sodium hydrogen carbonate (15 ml) were added to the ethyl (15 ml) solution, and the mixture was stirred at room temperature for 2 hours. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
1 × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (6
14 mg, 91%). mp 207-208 ℃ IRνmax KBr cm -1 : 1640. Anal.Calcd for C 27 H 21 F 4 NO 2 : C, 69.37; H, 4.53; N,
3.00 Found:. C, 69.21; H, 4.46; N, 2.87 1 H-NMR (CDCl 3) δ: 2.92 (1H, dd, J = 14.2, 10.4 H
z), 3.13 (1H, dd, J = 14.2, 4.0 Hz), 3.39 (1H, s),
4.72-4.90 (1H, m), 5.13 (1H, s), 5.98 (1H, d, J =
8.4 Hz), 7.04-7.60 (12H, m), 7.70-7.92 (3H, m).
【0345】実施例213 4-フルオロ-N-((1RS,2SR)-1-((4-フル
オロフェニル)メチル)-2-ヒドロキシ-2-(4-(ト
リフルオロメチル)フェニル)エチル)-1-ナフタレン
カルボキサミド (1RS,2SR)-2-アミノ-3-(4-フルオロフェ
ニル)-1-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)のア
セトニトリル(30ml)溶液に4-フルオロナフタレ
ンカルボン酸(274mg,1.44ミリモル)および
1-エチル-3-(3-ジメチルアミノプロピル)カルボジ
イミド・塩酸塩(358mg,1.87ミリモル)およ
び1-ヒドロキシ-1H-ベンゾトリアゾール(220m
g,1.44ミリモル)を加えて室温で終夜攪拌した。
反応液を水(100ml)で希釈し、酢酸エチル(10
0ml×2)で抽出した。抽出液を飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(酢酸エチ
ル)で精製し、酢酸エチル−ヘキサンから再結晶させ
て、表題化合物(430mg,62%)を得た。 mp 235-236℃ IRνmaxKBrcm-1: 1651, 1605, 1510. Anal. Calcd for C27H20F5NO2: C, 66.80; H, 4.15; N,
2.89 Found: C, 66.59; H, 4.25; N, 2.90.1 H-NMR (CDCl3)δ: 2.79 (1H, dd, J = 14.2, 11.0 H
z), 2.98 (1H, dd, J = 14.2, 4.4 Hz), 3.75 (1H, s),
4.70-4.88 (1H, m), 5.18-5.22 (1H, m), 5.91 (1H,
d, J = 8.4 Hz), 6.92-7.10 (3H, m), 7.12-7.22 (3H,
m), 7.40-7.80 (7H,m), 8.10 (1H, d, J = 8.4 Hz).Example 213 4-Fluoro-N-((1RS, 2SR) -1-((4-fluorophenyl) methyl) -2-hydroxy-2- (4- (trifluoromethyl) phenyl) ethyl)- 1-naphthalenecarboxamide (1RS, 2SR) -2-amino-3- (4-fluorophenyl) -1- (4- (trifluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.44 mmol) in acetonitrile (30 ml) was added 4-fluoronaphthalenecarboxylic acid (274 mg, 1.44 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride ( 358 mg, 1.87 mmol) and 1-hydroxy-1H-benzotriazole (220 m
g, 1.44 mmol) and stirred at room temperature overnight.
The reaction solution was diluted with water (100 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to give the title compound (430 mg, 62%). mp 235-236 ° C IRνmax KBr cm -1 : 1651, 1605, 1510. Anal.Calcd for C 27 H 20 F 5 NO 2 : C, 66.80; H, 4.15; N,
2.89 Found:. C, 66.59; H, 4.25; N, 2.90 1 H-NMR (CDCl 3) δ: 2.79 (1H, dd, J = 14.2, 11.0 H
z), 2.98 (1H, dd, J = 14.2, 4.4 Hz), 3.75 (1H, s),
4.70-4.88 (1H, m), 5.18-5.22 (1H, m), 5.91 (1H, m
d, J = 8.4 Hz), 6.92-7.10 (3H, m), 7.12-7.22 (3H,
m), 7.40-7.80 (7H, m), 8.10 (1H, d, J = 8.4 Hz).
【0346】実施例214 N-((1RS,2SR)-1-((4-フルオロフェニ
ル)メチル)-2-ヒドロキシ-2-(4-(トリフルオロ
メチル)フェニル)エチル)シクロヘキサンカルボキサ
ミド (1RS,2SR)-2-アミノ-3-(4-フルオロフェ
ニル)-1-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)の酢
酸エチル(15ml)溶液にシクロヘキサンカルボニル
クロリド(288ml,2.15ミリモル)および飽和
重曹水(15ml)を加えて室温で3時間攪拌した。反
応液を水(100ml)で希釈し、酢酸エチル(100
ml×2)で抽出した。抽出液を飽和食塩水で洗浄し、
無水硫酸マグネシウムで乾燥後減圧留去した。残留物を
酢酸エチル−ヘキサンから再結晶させて、表題化合物
(550mg,90%)を得た。 mp 220-221℃ IRνmaxKBrcm-1: 1645, 1510, 1329. Anal. Calcd for C23H25F4NO2: C, 65.24; H, 5.95; N,
3.31 Found: C, 65.07; H, 5.85; N, 3.22.1 H-NMR (CDCl3)δ: 1.04-1.40 (5H, m), 1.50-1.80 (5
H, m), 1.82-2.10 (1H, m), 2.66 (1H, dd, J = 14.4,
10.8 Hz), 2.83 (1H, dd, J = 14.4, 4.6 Hz), 4.34-4.
50 (2H, m), 5.04 (1H, brs), 5.36 (1H, d, J = 7.4 H
z), 6.90-7.12 (4H, m), 7.52 (2H, d, J = 8.0 Hz),
7.66 (2H, d, J = 8.0 Hz).Example 214 N-((1RS, 2SR) -1-((4-fluorophenyl) methyl) -2-hydroxy-2- (4- (trifluoromethyl) phenyl) ethyl) cyclohexanecarboxamide (1RS, 2SR) -2-Amino-3- (4-fluorophenyl) -1- (4- (trifluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.44 mmol) in ethyl acetate (15 ml) were added cyclohexanecarbonyl chloride (288 ml, 2.15 mmol) and saturated aqueous sodium hydrogen carbonate (15 ml), and the mixture was stirred at room temperature for 3 hours. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
ml × 2). Wash the extract with saturated saline,
After drying over anhydrous magnesium sulfate, the solution was distilled off under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (550 mg, 90%). mp 220-221 ℃ IRνmax KBr cm -1 : 1645, 1510, 1329. Anal.Calcd for C 23 H 25 F 4 NO 2 : C, 65.24; H, 5.95; N,
3.31 Found:. C, 65.07; H, 5.85; N, 3.22 1 H-NMR (CDCl 3) δ: 1.04-1.40 (5H, m), 1.50-1.80 (5
H, m), 1.82-2.10 (1H, m), 2.66 (1H, dd, J = 14.4,
10.8 Hz), 2.83 (1H, dd, J = 14.4, 4.6 Hz), 4.34-4.
50 (2H, m), 5.04 (1H, brs), 5.36 (1H, d, J = 7.4 H
z), 6.90-7.12 (4H, m), 7.52 (2H, d, J = 8.0 Hz),
7.66 (2H, d, J = 8.0 Hz).
【0347】実施例215 N-((1RS,2SR)-1-((4-フルオロフェニ
ル)メチル)-2-ヒドロキシ-2-(4-(トリフルオロ
メチル)フェニル)エチル)-4-フェニル酪酸アミド (1RS,2SR)-2-アミノ-3-(4-フルオロフェ
ニル)-1-(4-(トリフルオロメチル)フェニル)-1
-プロパノール(450mg,1.44ミリモル)のア
セトニトリル(30ml)溶液に4-フェニル-n-酪酸
(236mg,1.44ミリモル)および1-エチル-3
-(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩(358mg,1.87ミリモル)および1-ヒドロ
キシ-1H-ベンゾトリアゾール(220mg,1.44
ミリモル)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(酢酸エチル)で精製
し、酢酸エチル−ヘキサンから再結晶させて、表題化合
物(450mg,68%)を得た。 mp 155-156℃ IRνmaxKBrcm-1: 1645, 1537, 1510. Anal. Calcd for C26H25F4NO2: C, 67.96; H, 5.48; N,
3.05 Found: C, 67.98; H, 5.68; N, 3.06.1 H-NMR (CDCl3)δ: 1.70-1.90 (2H, m), 2.00-2.20 (2
H, m), 2.44-2.60 (2H, m), 2.62-2.84 (2H, m), 4.10
(1H, d, J = 4.0 Hz), 4.32-4.48 (1H, m), 4.98-5.06
(1H, m), 5.40 (1H, d, J = 7.6 Hz), 6.86-7.14 (6H,
m), 7.16-7.34 (3H, m), 7.51 (2H, d, J = 8.0 Hz),
7.63 (2H, d, J = 8.0 Hz).Example 215 N-((1RS, 2SR) -1-((4-fluorophenyl) methyl) -2-hydroxy-2- (4- (trifluoromethyl) phenyl) ethyl) -4-phenylbutyric acid Amido (1RS, 2SR) -2-amino-3- (4-fluorophenyl) -1- (4- (trifluoromethyl) phenyl) -1
To a solution of -propanol (450 mg, 1.44 mmol) in acetonitrile (30 ml) was added 4-phenyl-n-butyric acid (236 mg, 1.44 mmol) and 1-ethyl-3.
-(3-Dimethylaminopropyl) carbodiimide hydrochloride (358 mg, 1.87 mmol) and 1-hydroxy-1H-benzotriazole (220 mg, 1.44)
Mmol) and stirred overnight at room temperature. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to give the title compound (450 mg, 68%). mp 155-156 ° C IRνmax KBr cm -1 : 1645, 1537, 1510. Anal.Calcd for C 26 H 25 F 4 NO 2 : C, 67.96; H, 5.48; N,
3.05 Found:. C, 67.98; H, 5.68; N, 3.06 1 H-NMR (CDCl 3) δ: 1.70-1.90 (2H, m), 2.00-2.20 (2
H, m), 2.44-2.60 (2H, m), 2.62-2.84 (2H, m), 4.10
(1H, d, J = 4.0 Hz), 4.32-4.48 (1H, m), 4.98-5.06
(1H, m), 5.40 (1H, d, J = 7.6 Hz), 6.86-7.14 (6H,
m), 7.16-7.34 (3H, m), 7.51 (2H, d, J = 8.0 Hz),
7.63 (2H, d, J = 8.0 Hz).
【0348】実施例216 N-[(1RS,2SR)-2-(4-クロロフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド 1) 3-(4-クロロフェニル)-3-オキソ-2-[3-
(1,1,2,2-テトラヒドロエトキシ)ベンジル]
プロピオン酸エチル 3-(1,1,2,2-テトラヒドロエトキシ)トルエン
(7.43ml,44ミリモル)の四塩化炭素(30m
l)溶液に、N-ブロモスクシンイミド(7.83g,
44ミリモル)と2,2'-アゾビスイソブチロニトリル
(0.2g)を加えて30分間加熱還流した。反応液を
冷却した後、不溶物を除去し、ジエチルエーテルで洗浄
した。濾液を減圧留去して、3-(1,1,2,2-テト
ラヒドロエトキシ)-1-ブロモメチルベンゼンを得た。
3-(4-クロロフェニル)-3-オキソプロピオン酸エチ
ル(9.07g,40ミリモル)をジメトキシエタン
(100ml)に溶解し、氷冷下水素化ナトリウム
(1.6g,60%油性,40ミリモル)を加えて1時
間撹拌した。これに上で得た3-(1,1,2,2-テト
ラヒドロエトキシ)-1-ブロモメチルベンゼンのジメト
キシエタン(20ml)溶液を滴下し、室温で15時間
撹拌した。反応液に水(100ml)を加えて酢酸エチ
ル(100ml×2)で抽出した。抽出液を水洗し、無
水硫酸マグネシウムで乾燥後、減圧留去した。残留物を
シリカゲルクロマトグラフィー(ヘキサン:酢酸エチル
=20:1−4:1)で精製し、ヘキサンから結晶化さ
せて、3-(4-クロロフェニル)-3-オキソ-2-[3-
(1,1,2,2-テトラヒドロエトキシ)ベンジル]
プロピオン酸エチル(7.85g,45%)を得た。 mp 60-61℃ IRνmaxKBrcm-1:1723, 1684, 1590, 1325, 1275, 1231,
1200, 1134, 1096. 元素分析値C20H17ClF4O4として、計算値:C,55.50;H,3.9
6、実測値:C,55.55;H,3.831 H-NMR(CDCl3)δ:1.12 (3H, t, J = 7.2 Hz), 3.33 (2
H, d, J = 8.0 Hz), 4.10(2H, q, J = 7.2 Hz), 4.55
(1H, t, J = 7.0 Hz), 5.89 (1H, tt, J = 53.1 Hz, 2.
2 Hz), 7.00-7.20 (3H, m), 7.20-7.35 (1H, m), 7.42
(2H, d, J = 8.0 Hz), 7.89 (2H, d, J = 8.0 Hz). 2) (2RS,3RS)-3-(4-クロロフェニル)-
3-ヒドロキシ-2-[3-(1,1,2,2-テトラヒド
ロエトキシ)ベンジル]プロピオン酸エチル 無水塩化亜鉛(4.09g,30ミリモル)のジエチル
エーテル(100ml)懸濁液に、水素化ほう素ナトリ
ウム(2.53g,60ミリモル)を少量ずつ加えて、
2時間撹拌した。不溶物を濾去し、ジエチルエーテルで
洗浄した。濾液を氷冷し、これに3-(4-クロロフェニ
ル)-3-オキソ-2-[3-(1,1,2,2-テトラヒド
ロエトキシ)ベンジル]プロピオン酸エチル(6.5
g,15ミリモル)のジエチルエーテル(20ml)溶
液を加えた。室温で1時間撹拌した後、再び氷冷し、1
規定塩酸で反応を停止した。得られた混合物を酢酸エチ
ル(100ml×2)で抽出し、水洗後、無水硫酸マグ
ネシウムで乾燥し、減圧留去した。残留物をシリカゲル
クロマトグラフィー(ヘキサン:酢酸エチル=10:1
−3:1)で精製して、(2RS,3RS)-3-(4-
クロロフェニル)-3-ヒドロキシ-2-[3-(1,1,
2,2-テトラヒドロエトキシ)ベンジル]プロピオン
酸エチル(6.5g,99%)を無色油状物として得
た。 IRνmaxNeatcm-1:1723, 1489, 1302, 1277, 1198, 112
3, 1094.1 H-NMR(CDCl3)δ:0.94 (3H, t, J = 7.2 Hz), 2.90-3.1
0 (3H, m), 3.90 (2H, d, J = 7.2 Hz), 5.02 (1H, b
r), 5.88 (1H, tt, J = 53.1 Hz, 2.3 Hz), 6.90-7.10
(3H, m), 7.22 (1H, d, J = 7.6 Hz), 7.27 (1H, d, J
= 3.4 Hz). 3) (2RS,3RS)-3-(4-クロロフェニル)-
3-ヒドロキシ-2-[3-(1,1,2,2-テトラヒド
ロエトキシ)ベンジル]プロピオン酸 (2RS,3RS)-3-(4-クロロフェニル)-3-ヒ
ドロキシ-2-[3-(1,1,2,2-テトラヒドロエト
キシ)ベンジル]プロピオン酸エチル(6.45g,1
4.8ミリモル)のメタノール(30ml)溶液に2規
定水酸化ナトリウム水溶液(14.8ml,29.6ミ
リモル)を加えて室温で4時間撹拌した。反応液に1規
定塩酸(100ml)を加えて酸性とした後、酢酸エチ
ル(100ml×2)で抽出した。抽出液を水洗し、無
水硫酸マグネシウムで乾燥した後、減圧留去した。残留
物をヘキサンから結晶化させて、(2RS,3RS)-
3-(4-クロロフェニル)-3-ヒドロキシ-2-[3-
(1,1,2,2-テトラヒドロエトキシ)ベンジル]
プロピオン酸(5.39g,89%)を得た。 mp 88-90℃ IRνmaxKBrcm-1:1694, 1489, 1277, 1206, 1127. 元素分析値C18H15ClF4O4として、計算値:C,53.15;H,3.7
2、実測値:C,53.26;H,3.871 H-NMR(CDCl3)δ:2.80-3.10 (3H, m), 5.07 (1H, d, J
= 3.6 Hz), 5.88 (1H, tt, J = 53.1 Hz, 2.6 Hz), 6.9
0-7.15 (4H, m), 7.20-7.35 (4H, m). 4) (4RS,5SR)-5-(4-クロロフェニル)-
4-[3-(1,1,2,2-テトラヒドロエトキシ)ベ
ンジル]-1,3-オキサゾリジン-2-オン (2RS,3RS)-3-(4-クロロフェニル)-3-ヒ
ドロキシ-2-[3-(1,1,2,2-テトラヒドロエト
キシ)ベンジル]プロピオン酸(5.39g,13.3
ミリモル)のテトラヒドロフラン(100ml)溶液に
ジフェニルホスホリルアジド(3.70ml,17.2
ミリモル)とトリエチルアミン(2.59ml,18.
6ミリモル)を加えて室温で1時間撹拌した。その後、
3時間加熱還流した後、反応液を減圧濃縮し、水(10
0ml)を加えて酢酸エチル(100ml×2)で抽出
した。抽出液を水洗し、無水硫酸マグネシウムで乾燥
後、減圧留去した。残留物をシリカゲルクロマトグラフ
ィー(ヘキサン:酢酸エチル=2:1−1:1)で精製
し、析出した結晶をヘキサンを加えて濾取して、(4R
S,5SR)-5-(4-クロロフェニル)-4-[3-
(1,1,2,2-テトラヒドロエトキシ)ベンジル]-
1,3-オキサゾリジン-2-オン(4.65g,87
%)を得た。 mp 134-135℃ IRνmaxKBrcm-1:3243, 1740, 1489, 1447, 1343, 1273,
1238, 1198, 1125, 1088. 元素分析値C18H14ClF4NO3として、計算値:C,53.55;H,3.
49;N,3.47、実測値:C,53.56;H,3.28;N,3.48.1 H-NMR(CDCl3)δ:2.18-2.40 (2H, m), 4.20-4.35 (1H,
m), 5.05 (1H, br s), 5.79 (1H, d, J = 8.0 Hz), 5.9
0 (1H, tt, J = 54.8 Hz, 2.6 Hz), 6.85-7.00 (2H,
m), 7.05-7.20 (1H, m), 7.20-7.50 (5H, m). 5) (1RS,2SR)-2-アミノ-1-(4-クロロ
フェニル)-3-[3-(1,1,2,2-テトラヒドロエ
トキシ)フェニル]-1-プロパノール (4RS,5SR)-5-(4-クロロフェニル)-4-
[3-(1,1,2,2-テトラヒドロエトキシ)ベンジ
ル]-1,3-オキサゾリジン-2-オン(4.35g,1
0.8ミリモル)のエタノール(20ml)溶液に、8
規定水酸化ナトリウム水溶液(5.39ml,43.1
ミリモル)を加えて6時間加熱還流した。反応液を減圧
濃縮し、水(100ml)を加えて酢酸エチル(100
ml×2)で抽出した。抽出液を水洗し、無水硫酸マグ
ネシウムで乾燥後、減圧留去した。残留物をヘキサンと
ジエチルエーテルの混合液から結晶化させて、(1R
S,2SR)-2-アミノ-1-(4-クロロフェニル)-3
-[3-(1,1,2,2-テトラヒドロエトキシ)フェ
ニル]-1-プロパノール(3.61g,89%)を得
た。 mp 96-97℃ IRνmaxKBrcm-1:1611, 1588, 1489, 1308, 1196, 1119. 元素分析値C17H16ClF4NO2として、計算値:C,54.05;H,4.
27;N,3.71、実測値:C,54.08;H,4.34;N,3.75.1 H-NMR(CDCl3)δ:2.36 (1H, dd, J = 13.6 Hz , 10.2 H
z), 2.77 (1H, dd, J =13.6 Hz, 3.2 Hz), 3.20-3.40
(1H, m), 4.66 (1H, d, J = 4.6 Hz), 5.89 (1H,tt, J
= 53.0 Hz, 2.5 Hz), 6.99 (1H, s), 7.00-7.15 (2H,
m), 7.20-7.40 (5H, m). 6) N-[(1RS,2SR)-2-(4-クロロフェニ
ル)-2-ヒドロキシ-1-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]エチル]-6,7-ジヒド
ロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミ
ド (1RS,2SR)-2-アミノ-1-(4-クロロフェニ
ル)-3-[3-(1,1,2,2-テトラフルオロエトキ
シ)フェニル]プロパン-1-オール0.280g(0.
741ミリモル)、6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボン酸0.14g(0.
74ミリモル)、1-ヒドロキシベンゾトリアゾール水
和物0.11g(0.74ミリモル)をアセトニトリル
10ml中で撹拌しながら1-エチル-3-(3-ジメチル
アミノプロピル)カルボジイミド・塩酸塩0.14g
(0.74ミリモル)を加え、室温で一晩撹拌した。反
応液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶液
で洗浄、無水硫酸マグネシウムで乾燥、シリカゲルを通
した後、溶媒を減圧留去した。得られた残留物をジイソ
プロピルエーテル−ヘキサンより結晶化して、目的物を
得た。白色粉末 収量0.373g 収率92% mp 182-183℃; 1H-NMR (CDCl3, 200MHz) δ 1.93-2.06
(2H, m), 2.15-2.24 (2H, m), 2.67 (2H, t, J = 6.1 H
z), 2.78 (1H, dd, J = 10.9 Hz, 14.9 Hz), 2.98 (1H,
dd, J = 4.2 Hz, 14.6 Hz), 3.71 (1H, d, J = 3.6 H
z), 4.60-4.73 (1H, m), 5.04 (1H, t, J = 3.7 Hz),
5.74 (1H, d, J = 8.4 Hz), 5.89 (1H, tt,J = 2.7 Hz,
53.0 Hz), 5.93 (1H, td, J = 5.6 Hz, 11.0 Hz), 6.2
1 (1H, d, J= 11.6 Hz), 6.95-7.18 (6H, m), 7.31-7.4
3 (5H, m); IR (KBr) 3270, 2940,1640, 1537, 1198, 1
125 cm-1; Anal. Calcd for C29H26ClF4NO3: C, 63.56;
H,4.78; N, 2.56. Found: C, 63.51; H, 4.69; N, 2.5
2.Example 216 N-[(1RS, 2SR) -2- (4-chlorophenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
5H-benzo [a] cycloheptene-1-carboxamide 1) 3- (4-chlorophenyl) -3-oxo-2- [3-
(1,1,2,2-tetrahydroethoxy) benzyl]
Ethyl propionate 3- (1,1,2,2-tetrahydroethoxy) toluene (7.43 ml, 44 mmol) in carbon tetrachloride (30 m
1) Add N-bromosuccinimide (7.83 g,
44 mmol) and 2,2'-azobisisobutyronitrile (0.2 g) were added, and the mixture was heated under reflux for 30 minutes. After the reaction solution was cooled, insolubles were removed and washed with diethyl ether. The filtrate was distilled off under reduced pressure to obtain 3- (1,1,2,2-tetrahydroethoxy) -1-bromomethylbenzene.
Ethyl 3- (4-chlorophenyl) -3-oxopropionate (9.07 g, 40 mmol) was dissolved in dimethoxyethane (100 ml), and sodium hydride (1.6 g, 60% oily, 40 mmol) was added under ice cooling. Was added and stirred for 1 hour. The solution of 3- (1,1,2,2-tetrahydroethoxy) -1-bromomethylbenzene obtained above in dimethoxyethane (20 ml) was added dropwise thereto, and the mixture was stirred at room temperature for 15 hours. Water (100 ml) was added to the reaction solution, and extracted with ethyl acetate (100 ml × 2). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 20: 1-4: 1), crystallized from hexane to give 3- (4-chlorophenyl) -3-oxo-2- [3-
(1,1,2,2-tetrahydroethoxy) benzyl]
Ethyl propionate (7.85 g, 45%) was obtained. mp 60-61 ° C IRνmax KBr cm -1 : 1723, 1684, 1590, 1325, 1275, 1231,
1200, 1134, 1096. Calculated as elemental analysis C 20 H 17 ClF 4 O 4 : C, 55.50; H, 3.9
6, actual value: C, 55.55; H, 3.83 1 H-NMR (CDCl 3 ) δ: 1.12 (3H, t, J = 7.2 Hz), 3.33 (2
H, d, J = 8.0 Hz), 4.10 (2H, q, J = 7.2 Hz), 4.55
(1H, t, J = 7.0 Hz), 5.89 (1H, tt, J = 53.1 Hz, 2.
2 Hz), 7.00-7.20 (3H, m), 7.20-7.35 (1H, m), 7.42
(2H, d, J = 8.0 Hz), 7.89 (2H, d, J = 8.0 Hz). 2) (2RS, 3RS) -3- (4-chlorophenyl)-
Ethyl 3-hydroxy-2- [3- (1,1,2,2-tetrahydroethoxy) benzyl] propionate Hydrogenation to a suspension of anhydrous zinc chloride (4.09 g, 30 mmol) in diethyl ether (100 ml). Sodium boron (2.53 g, 60 mmol) was added in small portions,
Stir for 2 hours. The insolubles were removed by filtration and washed with diethyl ether. The filtrate was cooled with ice, and ethyl 3- (4-chlorophenyl) -3-oxo-2- [3- (1,1,2,2-tetrahydroethoxy) benzyl] propionate (6.5) was added thereto.
g, 15 mmol) in diethyl ether (20 ml). After stirring at room temperature for 1 hour, the mixture was cooled again on ice and
The reaction was stopped with normal hydrochloric acid. The obtained mixture was extracted with ethyl acetate (100 ml × 2), washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. Silica gel chromatography of the residue (hexane: ethyl acetate = 10: 1)
-3: 1) and purified by (2RS, 3RS) -3- (4-
Chlorophenyl) -3-hydroxy-2- [3- (1,1,
Ethyl 2,2-tetrahydroethoxy) benzyl] propionate (6.5 g, 99%) was obtained as a colorless oil. IRνmax Neat cm -1 : 1723, 1489, 1302, 1277, 1198, 112
3, 1094. 1 H-NMR ( CDCl 3) δ: 0.94 (3H, t, J = 7.2 Hz), 2.90-3.1
0 (3H, m), 3.90 (2H, d, J = 7.2 Hz), 5.02 (1H, b
r), 5.88 (1H, tt, J = 53.1 Hz, 2.3 Hz), 6.90-7.10
(3H, m), 7.22 (1H, d, J = 7.6 Hz), 7.27 (1H, d, J
= 3.4 Hz). 3) (2RS, 3RS) -3- (4-chlorophenyl)-
3-hydroxy-2- [3- (1,1,2,2-tetrahydroethoxy) benzyl] propionic acid (2RS, 3RS) -3- (4-chlorophenyl) -3-hydroxy-2- [3- (1 , 1,2,2-Tetrahydroethoxy) benzyl] ethyl propionate (6.45 g, 1
To a solution of 4.8 mmol) in methanol (30 ml) was added a 2N aqueous sodium hydroxide solution (14.8 ml, 29.6 mmol) and the mixture was stirred at room temperature for 4 hours. The reaction solution was acidified by adding 1N hydrochloric acid (100 ml), and extracted with ethyl acetate (100 ml × 2). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was crystallized from hexane to give (2RS, 3RS)-
3- (4-chlorophenyl) -3-hydroxy-2- [3-
(1,1,2,2-tetrahydroethoxy) benzyl]
Propionic acid (5.39 g, 89%) was obtained. mp 88-90 ° C IRνmax KBr cm -1 : 1694, 1489, 1277, 1206, 1127. Calculated as C 18 H 15 ClF 4 O 4 : C, 53.15; H, 3.7
2, found: C, 53.26; H, 3.87 1 H-NMR (CDCl 3 ) δ: 2.80-3.10 (3H, m), 5.07 (1H, d, J
= 3.6 Hz), 5.88 (1H, tt, J = 53.1 Hz, 2.6 Hz), 6.9
0-7.15 (4H, m), 7.20-7.35 (4H, m). 4) (4RS, 5SR) -5- (4-chlorophenyl)-
4- [3- (1,1,2,2-tetrahydroethoxy) benzyl] -1,3-oxazolidin-2-one (2RS, 3RS) -3- (4-chlorophenyl) -3-hydroxy-2- [ 3- (1,1,2,2-tetrahydroethoxy) benzyl] propionic acid (5.39 g, 13.3
Mmol) in a solution of diphenylphosphoryl azide (3.70 ml, 17.2).
Mmol) and triethylamine (2.59 ml, 18.
6 mmol) and stirred at room temperature for 1 hour. afterwards,
After heating under reflux for 3 hours, the reaction solution was concentrated under reduced pressure and water (10
0 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 2: 1-1: 1), and the precipitated crystals were collected by filtration by adding hexane.
S, 5SR) -5- (4-Chlorophenyl) -4- [3-
(1,1,2,2-tetrahydroethoxy) benzyl]-
1,3-Oxazolidin-2-one (4.65 g, 87
%). mp 134-135 ℃ IRνmax KBr cm -1 : 3243, 1740, 1489, 1447, 1343, 1273,
1238, 1198, 1125, as 1088. Elemental analysis C 18 H 14 ClF 4 NO 3 , Calcd: C, 53.55; H, 3 .
49; N, 3.47, Found:. C, 53.56; H, 3.28; N, 3.48 1 H-NMR (CDCl 3) δ: 2.18-2.40 (2H, m), 4.20-4.35 (1H,
m), 5.05 (1H, br s), 5.79 (1H, d, J = 8.0 Hz), 5.9
0 (1H, tt, J = 54.8 Hz, 2.6 Hz), 6.85-7.00 (2H,
m), 7.05-7.20 (1H, m), 7.20-7.50 (5H, m). 5) (1RS, 2SR) -2-amino-1- (4-chlorophenyl) -3- [3- (1,1 , 2,2-Tetrahydroethoxy) phenyl] -1-propanol (4RS, 5SR) -5- (4-chlorophenyl) -4-
[3- (1,1,2,2-tetrahydroethoxy) benzyl] -1,3-oxazolidin-2-one (4.35 g, 1
0.8 mmol) in ethanol (20 ml)
Normal sodium hydroxide aqueous solution (5.39 ml, 43.1
(Mmol) and heated to reflux for 6 hours. The reaction solution was concentrated under reduced pressure, water (100 ml) was added, and ethyl acetate (100
ml × 2). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was crystallized from a mixture of hexane and diethyl ether to give (1R
S, 2SR) -2-Amino-1- (4-chlorophenyl) -3
There was obtained-[3- (1,1,2,2-tetrahydroethoxy) phenyl] -1-propanol (3.61 g, 89%). mp 96-97 ℃ IRνmax KBr cm -1: 1611, 1588, 1489, 1308, 1196, as 1119. Elemental analysis C 17 H 16 ClF 4 NO 2 , calc: C, 54.05; H, 4 .
27; N, 3.71, Found:. C, 54.08; H, 4.34; N, 3.75 1 H-NMR (CDCl 3) δ: 2.36 (1H, dd, J = 13.6 Hz, 10.2 H
z), 2.77 (1H, dd, J = 13.6 Hz, 3.2 Hz), 3.20-3.40
(1H, m), 4.66 (1H, d, J = 4.6 Hz), 5.89 (1H, tt, J
= 53.0 Hz, 2.5 Hz), 6.99 (1H, s), 7.00-7.15 (2H,
m), 7.20-7.40 (5H, m). 6) N-[(1RS, 2SR) -2- (4-chlorophenyl) -2-hydroxy-1- [3- (1,1,2,2-tetra Fluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-chlorophenyl) -3- [3- (1 , 1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol 0.280 g (0.
741 mmol), 0.14 g of 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (0.14 g).
0.11 g (0.74 mmol) of 1-hydroxybenzotriazole hydrate 0.14 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride while stirring in 10 ml of acetonitrile.
(0.74 mmol) and stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White powder Yield 0.373 g Yield 92% mp 182-183 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.93-2.06
(2H, m), 2.15-2.24 (2H, m), 2.67 (2H, t, J = 6.1 H
z), 2.78 (1H, dd, J = 10.9 Hz, 14.9 Hz), 2.98 (1H,
dd, J = 4.2 Hz, 14.6 Hz), 3.71 (1H, d, J = 3.6 H
z), 4.60-4.73 (1H, m), 5.04 (1H, t, J = 3.7 Hz),
5.74 (1H, d, J = 8.4 Hz), 5.89 (1H, tt, J = 2.7 Hz,
53.0 Hz), 5.93 (1H, td, J = 5.6 Hz, 11.0 Hz), 6.2
1 (1H, d, J = 11.6 Hz), 6.95-7.18 (6H, m), 7.31-7.4
3 (5H, m); IR (KBr) 3270, 2940,1640, 1537, 1198, 1
125 cm -1 ; Anal.Calcd for C 29 H 26 ClF 4 NO 3 : C, 63.56;
H, 4.78; N, 2.56.Found: C, 63.51; H, 4.69; N, 2.5
2.
【0349】実施例217 N-((1RS,2SR)-2-ヒドロキシ-2-(4-(フ
ェニルオキシ)フェニル)-1-((3-((1,1,
2,2-テトラフルオロエチル)オキシ)フェニル)メ
チル)エチル)-6,7-ジヒドロ-5H-ベンゾ[a]シ
クロヘプテン-1-カルボキサミド 1) 3-(1,1,2,2-テトラフルオロエトキシ)
トルエン(7.8g,37.5ミリモル)の四塩化炭素
(80ml)溶液にN-ブロモスクシンイミド(7.3
3g,41.2ミリモル)および2,2'-アゾビス(イ
ソブチロニトリル)(300mg,1.87ミリモル)
を加え、6時間加熱還流した。冷却後、反応液をろ過
し、ろ液を濃縮して3-(1,1,2,2-テトラフルオ
ロエトキシ)-α-ブロモトルエンを調製した。3-(4-
フェノキシフェニル)-3-オキソプロピオン酸エチル
(10.7g,37.5ミリモル)の1,2-ジメトキ
シエタン(120ml)溶液に水素化ナトリウム(60
%油性,1.50g,37.5ミリモル)を氷冷下加
え、室温で30分攪拌した。反応液の中に先に調製した
3-(1,1,2,2-テトラフルオロエトキシ)-α-ブ
ロモトルエンの1,2-ジメトキシエタン(10ml)
溶液を滴下し、反応液を室温で1時間攪拌した。反応液
を水(100ml)の中に注ぎ、酢酸エチル(100m
l×2)で抽出した。抽出液を水および飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(トルエ
ン)で精製し、3-オキソ-3-(4-フェニルオキシフェ
ニル)-2-((3-((1,1,2,2-テトラフルオロ
エチル)オキシ)フェニル)メチル)プロピオン酸エチ
ル(9.92g,54%)を無色油状物として得た。1 H-NMR (CDCl3)δ: 1.13 (3H, t, J = 7.0 Hz), 3.33
(2H, d, J = 6.8 Hz), 4.11 (2H, q, J = 7.0 Hz), 4.5
6 (1H, t, J = 7.6 Hz), 5.88 (1H, tt, J = 53.0, 2.8
Hz), 6.90-7.48 (11H, m), 7.90-8.02 (2H, m). IRνmaxKBrcm-1: 1738, 1682, 1605, 1586, 1505, 148
9, 1449, 1420. Anal. Calcd for C26H22F4O5・0.3H2O: C, 62.98; H,
4.59 Found: C, 62.84; H, 4.46. 2) 塩化亜鉛(5.34g,39.2ミリモル)のジ
エチルエーテル(120ml)溶液に水素化ホウ素ナト
リウム(2.97g,78.4ミリモル)を加えて室温
で30分攪拌した。不溶物をろ去し、ろ液に3-オキソ-
3-(4-フェニルオキシフェニル)-2-((3-
((1,1,2,2-テトラフルオロエチル)オキシ)
フェニル)メチル)プロピオン酸エチル(9.61g,
19.6ミリモル)のジエチルエーテル(60ml)溶
液を加えて室温で30分攪拌した。氷冷下、反応液に1
規定塩酸を加えてクエンチし、更に水(150ml)を
加え、酢酸エチル(200ml×2)で抽出した。抽出
液を水および飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去した。残留物をシリカゲルカラムク
ロマトグラフィー(ヘキサン:酢酸エチル=4:1)で
精製し、(2RS,3RS)-3-ヒドロキシ-3-(4-
(フェニルオキシ)フェニル)-2-((3-((1,
1,2,2-テトラフルオロエチル)オキシ)フェニ
ル)メチル)プロピオン酸エチル(6.50g,67
%)を無色油状物として得た。1 H-NMR (CDCl3)δ: 0.94 (3H, t, J = 7.0 Hz), 2.90-
3.10 (4H, m), 3.89 (2H,q, J = 7.0 Hz), 4.98-5.06
(1H, m), 5.89 (1H, tt, J = 53.0, 2.8 Hz), 6.92-7.4
2 (13H, m). IRνmaxKBrcm-1: 1725, 1611, 1590, 1507, 1489, 144
9. Anal. Calcd for C26H24F4O5: C, 63.41; H, 4.91 Found: C, 63.32; H, 4.97. 3) (2RS,3RS)-3-ヒドロキシ-3-(4-
(フェニルオキシ)フェニル)-2-((3-((1,
1,2,2-テトラフルオロエチル)オキシ)フェニ
ル)メチル)プロピオン酸エチル(6.14g,12.
5ミリモル)のメタノール(30ml)溶液に、2規定
水酸化ナトリウム水溶液(12.5ml,25.0ミリ
モル)を加えて室温で終夜攪拌した。反応液を1規定塩
酸で酸性とした後、酢酸エチル(200ml×2)で抽
出した。抽出液を水および飽和食塩水で洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて、(2RS,3RS)
-3-ヒドロキシ-3-(4-(フェニルオキシ)フェニ
ル)-2-((3-((1,1,2,2-テトラフルオロエ
チル)オキシ)フェニル)メチル)プロピオン酸(4.
51g,89%)を得た。1 H-NMR (CDCl3)δ: 2.94-3.10 (3H, m), 5.07 (1H, d,
J = 4.2 Hz), 5.87 (1H,t, J = 53.0, 3.0 Hz), 6.92-
7.40 (13H, m). IRνmaxKBrcm-1: 1711, 1613, 1590, 1508, 1489. mp 109-110℃ Anal. Calcd for C24H20F4O5: C, 62.07; H, 4.34 Found: C, 62.09; H, 4.42. 4) (2RS,3RS)-3-ヒドロキシ-3-(4-
(フェニルオキシ)フェニル)-2-((3-((1,
1,2,2-テトラフルオロエチル)オキシ)フェニ
ル)メチル)プロピオン酸(4.3g,10.6ミリモ
ル)のテトラヒドロフラン(80ml)溶液に、ジフェ
ニルホスホリルアジド(2.52ml,11.7ミリモ
ル)とトリエチルアミン(2.23ml,16.0ミリ
モル)を加え、2時間加熱還流した。反応液を放冷後、
水(200ml)を加えて酢酸エチル(100ml×
2)で抽出した。抽出液を1規定塩酸、飽和重曹水、飽
和食塩水で順次洗浄し、無水硫酸マグネシウムで乾燥後
減圧留去した。残留物をシリカゲルカラムクロマトグラ
フィー(ヘキサン:酢酸エチル=10:1−1:1)で
精製し、酢酸エチル−ヘキサンから再結晶させて、(4
RS,5SR)-5-(4-(フェニルオキシ)フェニ
ル)-4-((3-((1,1,2,2-テトラフルオロエ
チル)オキシ)フェニル)メチル)-1,3-オキサゾリ
ジン-2-オン(3.92g,80%)を得た。1 H-NMR (CDCl3)δ: 2.24-2.44 (2H, m), 4.18-4.32 (1
H, m), 5.08 (1H, brs),5.79 (1H, d, J = 8.0 Hz), 5.
90 (1H, tt, J = 53.0, 3.0 Hz), 6.86-7.20 (8H, m),
7.22-7.42 (5H, m). IRνmaxKBrcm-1: 1759, 1612, 1590, 1508, 1489. mp 90-91℃ Anal. Calcd for C24H19F4NO4: C, 62.47; H, 4.15; N,
3.04 Found: C, 62.54; H, 4.05; N, 3.04. 5) (4RS,5SR)-5-(4-(フェニルオキ
シ)フェニル)-4-((3-((1,1,2,2-テトラ
フルオロエチル)オキシ)フェニル)メチル)-1,3-
オキサゾリジン-2-オン(3.7g,8.02ミリモ
ル)のエタノール(10ml)溶液に8規定水酸化ナト
リウム水溶液(5.0ml,40ミリモル)を加え、4
時間加熱還流した。反応液を濃縮後、水(100ml)
で希釈し、酢酸エチル(100ml×2)で抽出した。
抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウムで
乾燥後減圧留去し、残留物を酢酸エチル−ヘキサンから
再結晶させて、(1RS,2SR)-2-アミノ-1-(4
-(フェニルオキシ)フェニル)-3-(3-((1,1,
2,2-テトラフルオロエチル)オキシ)フェニル)-1
-プロパノール(3.05g,87%)を得た。1 H-NMR (CDCl3)δ: 1.20-2.00 (2H, br), 2.41 (1H, d
d, J = 13.8, 10.2 Hz),2.88 (1H, dd, J = 13.8, 3.2
Hz), 3.22-3.38 (1H, m), 4.65 (1H, d, J = 5.2Hz),
5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.98-7.18 (8H,
m), 7.28-7.42 (5H,m). IRνmaxKBrcm-1: 1611, 1590, 1507, 1489, 1449. mp 85-86℃ Anal. Calcd for C23H21F4NO3: C, 63.44; H, 4.86; N,
3.22 Found: C, 63.44; H, 4.76; N, 3.22. 6) (1RS,2SR)-2-アミノ-1-(4-(フェ
ニルオキシ)フェニル)-3-(3-((1,1,2,2-
テトラフルオロエチル)オキシ)フェニル)-1-プロパ
ノール(300mg,0.69ミリモル)のアセトニト
リル(16ml)溶液に6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボン酸(130mg,
0.69ミリモル)および1-エチル-3-(3-ジメチル
アミノプロピル)カルボジイミド・塩酸塩(198m
g,1.03ミリモル)および1-ヒドロキシ-1H-ベ
ンゾトリアゾール(106mg,0.69ミリモル)を
加えて室温で終夜攪拌した。反応液を水(100ml)
で希釈し、酢酸エチル(100ml×2)で抽出した。
抽出液を1規定塩酸、1規定水酸化ナトリウム水溶液、
飽和食塩水で順次洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物を酢酸エチル−ヘキサンから再
結晶させて、表題化合物(285mg,68%)を得
た。1 H-NMR (CDCl3)δ: 1.90-2.10 (2H, m), 2.12-2.28 (2
H, m), 2.60-2.72 (2H, m), 2.8 (1H, dd, J = 14.8, 1
0.4 Hz), 3.04 (1H, dd, J = 14.8, 4.0 Hz), 3.53 (1
H, s), 4.60-4.80 (1H, m), 5.02 (1H, s), 5.75 (1H,
d, J = 8.4 Hz), 5.89 (1H, tt, J = 53.0, 2.8 Hz),
5.90-6.00 (1H, m), 6.23 (1H, d, J = 11.8Hz), 6.90-
7.20 (12H, m), 7.22-7.48 (4H, m). IRνmaxKBrcm-1: 1640, 1590, 1507, 1489, 1449. mp 95-96℃Example 217 N-((1RS, 2SR) -2-hydroxy-2- (4- (phenyloxy) phenyl) -1-((3-((1,1,1
2,2-tetrafluoroethyl) oxy) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1) 3- (1,1,2,2-tetrafluoroethoxy) )
N-bromosuccinimide (7.3 g) was added to a solution of toluene (7.8 g, 37.5 mmol) in carbon tetrachloride (80 ml).
3g, 41.2 mmol) and 2,2'-azobis (isobutyronitrile) (300 mg, 1.87 mmol)
Was added and heated under reflux for 6 hours. After cooling, the reaction solution was filtered, and the filtrate was concentrated to prepare 3- (1,1,2,2-tetrafluoroethoxy) -α-bromotoluene. 3- (4-
A solution of ethyl phenoxyphenyl) -3-oxopropionate (10.7 g, 37.5 mmol) in 1,2-dimethoxyethane (120 ml) was treated with sodium hydride (60 ml).
% Oily, 1.50 g, 37.5 mmol) under ice-cooling and stirred at room temperature for 30 minutes. 1,2-Dimethoxyethane of 3- (1,1,2,2-tetrafluoroethoxy) -α-bromotoluene previously prepared in the reaction solution (10 ml)
The solution was added dropwise and the reaction was stirred at room temperature for 1 hour. The reaction solution was poured into water (100 ml), and ethyl acetate (100 m
1 × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene) to give 3-oxo-3- (4-phenyloxyphenyl) -2-((3-((1,1,2,2-tetrafluoroethyl) oxy) Ethyl phenyl) methyl) propionate (9.92 g, 54%) was obtained as a colorless oil. 1 H-NMR (CDCl 3 ) δ: 1.13 (3H, t, J = 7.0 Hz), 3.33
(2H, d, J = 6.8 Hz), 4.11 (2H, q, J = 7.0 Hz), 4.5
6 (1H, t, J = 7.6 Hz), 5.88 (1H, tt, J = 53.0, 2.8
Hz), 6.90-7.48 (11H, m), 7.90-8.02 (2H, m) .IRνmax KBr cm -1 : 1738, 1682, 1605, 1586, 1505, 148
9, 1449, 1420. Anal.Calcd for C 26 H 22 F 4 O 5・ 0.3H 2 O: C, 62.98; H,
4.59 Found: C, 62.84; H, 4.46.2) To a solution of zinc chloride (5.34 g, 39.2 mmol) in diethyl ether (120 ml) was added sodium borohydride (2.97 g, 78.4 mmol). Stirred at room temperature for 30 minutes. Remove the insoluble material by filtration and add 3-oxo- to the filtrate.
3- (4-phenyloxyphenyl) -2-((3-
((1,1,2,2-tetrafluoroethyl) oxy)
Phenyl) methyl) ethyl propionate (9.61 g,
(19.6 mmol) in diethyl ether (60 ml) was added and stirred at room temperature for 30 minutes. Add 1 reaction solution under ice-cooling.
The mixture was quenched by the addition of normal hydrochloric acid, water (150 ml) was added, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give (2RS, 3RS) -3-hydroxy-3- (4-
(Phenyloxy) phenyl) -2-((3-((1,
Ethyl 1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) propionate (6.50 g, 67
%) As a colorless oil. 1 H-NMR (CDCl 3 ) δ: 0.94 (3H, t, J = 7.0 Hz), 2.90-
3.10 (4H, m), 3.89 (2H, q, J = 7.0 Hz), 4.98-5.06
(1H, m), 5.89 (1H, tt, J = 53.0, 2.8 Hz), 6.92-7.4
2 (13H, m) .IRνmax KBr cm -1 : 1725, 1611, 1590, 1507, 1489, 144
9. Anal. Calcd for C 26 H 24 F 4 O 5 : C, 63.41; H, 4.91 Found: C, 63.32; H, 4.97. 3) (2RS, 3RS) -3-hydroxy-3- (4-
(Phenyloxy) phenyl) -2-((3-((1,
Ethyl 1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) propionate (6.14 g, 12.
To a solution of 5 mmol) in methanol (30 ml) was added a 2N aqueous sodium hydroxide solution (12.5 ml, 25.0 mmol) and the mixture was stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (2RS, 3RS)
3-Hydroxy-3- (4- (phenyloxy) phenyl) -2-((3-((1,1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) propionic acid (4.
51 g, 89%). 1 H-NMR (CDCl 3 ) δ: 2.94-3.10 (3H, m), 5.07 (1H, d,
J = 4.2 Hz), 5.87 (1H, t, J = 53.0, 3.0 Hz), 6.92-
7.40 (13H, m) IRνmax KBr cm -1: 1711, 1613, 1590, 1508, 1489. mp 109-110 ℃ Anal Calcd for C 24 H 20 F 4 O 5:.. C, 62.07; H, 4.34 Found: C, 62.09; H, 4.42.4) (2RS, 3RS) -3-hydroxy-3- (4-
(Phenyloxy) phenyl) -2-((3-((1,
To a solution of 1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) propionic acid (4.3 g, 10.6 mmol) in tetrahydrofuran (80 ml) was added diphenylphosphoryl azide (2.52 ml, 11.7 mmol). Triethylamine (2.23 ml, 16.0 mmol) was added, and the mixture was heated under reflux for 2 hours. After allowing the reaction solution to cool,
Water (200 ml) was added and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1-1: 1) and recrystallized from ethyl acetate-hexane to give (4.
RS, 5SR) -5- (4- (phenyloxy) phenyl) -4-((3-((1,1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) -1,3-oxazolidine- 2-One (3.92 g, 80%) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.24-2.44 (2H, m), 4.18-4.32 (1
H, m), 5.08 (1H, brs), 5.79 (1H, d, J = 8.0 Hz), 5.
90 (1H, tt, J = 53.0, 3.0 Hz), 6.86-7.20 (8H, m),
7.22-7.42 (5H, m) .IRνmax KBr cm -1 : 1759, 1612, 1590, 1508, 1489.mp 90-91 ° C Anal.Calcd for C 24 H 19 F 4 NO 4 : C, 62.47; H, 4.15 ; N,
3.04 Found: C, 62.54; H, 4.05; N, 3.04.5) (4RS, 5SR) -5- (4- (phenyloxy) phenyl) -4-((3-((1,1,2,2 -Tetrafluoroethyl) oxy) phenyl) methyl) -1,3-
To a solution of oxazolidine-2-one (3.7 g, 8.02 mmol) in ethanol (10 ml) was added an 8 N aqueous sodium hydroxide solution (5.0 ml, 40 mmol), and the solution was added.
Heated to reflux for an hour. After concentrating the reaction solution, water (100 ml)
And extracted with ethyl acetate (100 ml × 2).
The extract was washed with brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR) -2-amino-1- (4
-(Phenyloxy) phenyl) -3- (3-((1,1,
2,2-tetrafluoroethyl) oxy) phenyl) -1
-Propanol (3.05 g, 87%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.20-2.00 (2H, br), 2.41 (1H, d
d, J = 13.8, 10.2 Hz), 2.88 (1H, dd, J = 13.8, 3.2
Hz), 3.22-3.38 (1H, m), 4.65 (1H, d, J = 5.2Hz),
5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.98-7.18 (8H,
m), 7.28-7.42 (5H, m) .IRνmax KBr cm -1 : 1611, 1590, 1507, 1489, 1449.mp 85-86 ° C Anal.Calcd for C 23 H 21 F 4 NO 3 : C, 63.44; H, 4.86; N,
3.22 Found: C, 63.44; H, 4.76; N, 3.22.6) (1RS, 2SR) -2-amino-1- (4- (phenyloxy) phenyl) -3- (3-((1,1, 2,2-
A solution of 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (130 mg,
0.69 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (198 m
g, 1.03 mmol) and 1-hydroxy-1H-benzotriazole (106 mg, 0.69 mmol) were added and stirred at room temperature overnight. The reaction solution was water (100 ml)
And extracted with ethyl acetate (100 ml × 2).
1N hydrochloric acid, 1N aqueous sodium hydroxide solution,
The extract was washed successively with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (285 mg, 68%). 1 H-NMR (CDCl 3 ) δ: 1.90-2.10 (2H, m), 2.12-2.28 (2
H, m), 2.60-2.72 (2H, m), 2.8 (1H, dd, J = 14.8, 1
0.4 Hz), 3.04 (1H, dd, J = 14.8, 4.0 Hz), 3.53 (1
H, s), 4.60-4.80 (1H, m), 5.02 (1H, s), 5.75 (1H,
d, J = 8.4 Hz), 5.89 (1H, tt, J = 53.0, 2.8 Hz),
5.90-6.00 (1H, m), 6.23 (1H, d, J = 11.8Hz), 6.90-
7.20 (12H, m), 7.22-7.48 (4H, m) .IRνmax KBr cm -1 : 1640, 1590, 1507, 1489, 1449.mp 95-96 ℃
【0350】実施例218 N-((1RS,2SR)-2-(4-((4-クロロ-3-
エチルフェニル)オキシ)フェニル)-2-ヒドロキシ-
1-((3-((1,1,2,2-テトラフルオロエチ
ル)オキシ)フェニル)メチル)エチル)-6,7-ジヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサ
ミド 1) 4-フルオロアセトフェノン(13.8g,10
0ミリモル)のN,N-ジメチルアセトアミド(100
ml)溶液に4-クロロ-3-エチルフェノール(15.
6g,100ミリモル)および炭酸カリウム(16.6
g,120ミリモル)を加え、10時間加熱還流した。
反応液を濃縮後、水(300ml)で希釈し、酢酸エチ
ル(300ml×2)で抽出した。抽出液を水、飽和食
塩水で順次洗浄し、無水硫酸マグネシウムで乾燥後減圧
留去した。残留物をシリカゲルカラムクロマトグラフィ
ー(ヘキサン:酢酸エチル=10:1)で精製し4-
((4-クロロ-3-エチルフェニル)オキシ)アセトフ
ェノン(24.2g,88%)を無色油状物として得
た。1 H-NMR (CDCl3)δ: 1.22 (3H, t, J = 7.4 Hz), 2.58
(3H, s), 2.74 (2H, q, J= 7.4 Hz), 6.84 (1H, dd, J
= 8.8, 3.0 Hz), 6.94-7.04 (3H, m), 7.34 (1H,d, J =
8.8 Hz), 7.90-8.00 (2H, m). IRνmaxKBrcm-1: 1682, 1595, 1574, 1503, 1472. Anal. Calcd for C16H15ClO2: C, 69.95; H, 5.50 Found: C, 69.93; H, 5.65 2) 4-((4-クロロ-3-エチルフェニル)オキシ)
アセトフェノン(24.2g,88.2ミリモル)の炭
酸ジエチル(100ml)溶液にエタノール(0.3m
l)を加え、氷冷下水素化ナトリウム(60%油性,
7.06g,176ミリモル)を加え、室温で2時間攪
拌した。反応液に6規定塩酸を加えクエンチし、水(3
00ml)を加え酢酸エチル(300ml×2)で抽出
した。抽出液を水、飽和食塩水で順次洗浄し、無水硫酸
マグネシウムで乾燥後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
50:1−5:1)で精製し3-(4-((4-クロロ-3
-エチルフェニル)オキシ)フェニル)-3-オキソプロ
ピオン酸エチル(29.3g,96%)を褐色油状物と
して得た。1 H-NMR (CDCl3)δ: 1.08-1.20 (6H, m), 2.68-2.82 (2
H, m), 3.95 (2H×7/8, s), 4.14-4.30 (2H, m), 5.60
(1H×1/8, s), 6.80-6.90 (1H, m), 6.92-7.04 (3H,
m), 7.32 (1H×1/8, d, J = 8.4 Hz), 7.35 (1H×7/8,
d, J = 8.4 Hz), 7.75 (2H×1/8, d, J = 9.2 Hz), 7.9
3 (2H×7/8, d, J = 9.2 Hz). IRνmaxKBrcm-1: 1744, 1682, 1595, 1576, 1505, 147
2, 1410. Anal. Calcd for C19H19F5ClO4: C, 65.80; H, 5.52 Found: C, 65.98; H, 5.53. 3) 3-(1,1,2,2-テトラフルオロエトキシ)
トルエン(6.0g,28.8ミリモル)の四塩化炭素
(60ml)溶液にN-ブロモスクシンイミド(5.6
5g,31.7ミリモル)および2,2'-アゾビス(イ
ソブチロニトリル)(237mg,1.44ミリモル)
を加え、6時間加熱還流した。冷却後、反応液をろ過
し、ろ液を濃縮して3-(1,1,2,2-テトラフルオ
ロエトキシ)-α-ブロモトルエンを調製した。3-(4-
((4-クロロ-3-エチルフェニル)オキシ)フェニ
ル)-3-オキソプロピオン酸エチル(10g,28.8
ミリモル)の1,2-ジメトキシエタン(100ml)
溶液に水素化ナトリウム(60%油性,1.15g,2
8.8ミリモル)を氷冷下加え、室温で30分攪拌し
た。反応液の中に先に調製した3-(1,1,2,2-テ
トラフルオロエトキシ)-α-ブロモトルエンの1,2-
ジメトキシエタン(10ml)溶液を滴下し、反応液を
室温で1時間攪拌した。反応液を水(100ml)の中
に注ぎ、酢酸エチル(100ml×2)で抽出した。抽
出液を水および飽和食塩水で洗浄し、無水硫酸マグネシ
ウムで乾燥後減圧留去した。残留物をシリカゲルカラム
クロマトグラフィー(トルエン)で精製し、3-(4-
((4-クロロ-3-エチルフェニル)オキシ)フェニ
ル)-3-オキソ-2-((3-((1,1,2,2-テトラ
フルオロエチル)オキシ)フェニル)メチル)プロピオ
ン酸エチル(9.26g,58%)を無色油状物として
得た。1 H-NMR (CDCl3)δ: 1.13 (3H, t, J = 7.0 Hz), 1.22
(3H, t, J = 7.6 Hz), 2.74 (2H, q, J = 7.6 Hz), 3.3
3 (2H, d, J = 7.2 Hz), 4.11 (2H, q, J = 7.0 Hz),
4.56 (1H, t, J = 7.2 Hz), 5.88 (1H, tt, J = 53.2,
2.8 Hz), 6.83 (1H,dd, J = 8.6, 3.0 Hz), 6.90-7.38
(8H, m), 7.90-8.00 (2H, m). IRνmaxKBrcm-1: 1738, 1682, 1595, 1576, 1505, 147
2. Anal. Calcd for C28H25ClF4O5: C, 60.82; H, 4.56 Found: C, 60.79; H, 4.38. 4) 塩化亜鉛(4.44g,32.6ミリモル)のジ
エチルエーテル(100ml)溶液に水素化ホウ素ナト
リウム(2.46g,65.1ミリモル)を加えて室温
で30分攪拌した。不溶物をろ去し、ろ液に3-(4-
((4-クロロ-3-エチルフェニル)オキシ)フェニ
ル)-3-オキソ-2-((3-((1,1,2,2-テトラ
フルオロエチル)オキシ)フェニル)メチル)プロピオ
ン酸エチル(9.0g,16.3ミリモル)のジエチル
エーテル(50ml)溶液を加えて室温で30分攪拌し
た。氷冷下、反応液に1規定塩酸を加えてクエンチし、
更に水(150ml)を加え、酢酸エチル(200ml
×2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=4:1)で精製し、(2RS,3RS)-
3-(4-((4-クロロ-3-エチルフェニル)オキシ)
フェニル)-3-ヒドロキシ-2-((3-((1,1,
2,2-テトラフルオロエチル)オキシ)フェニル)メ
チル)プロピオン酸エチル(6.79g,75%)を無
色油状物として得た。1 H-NMR (CDCl3)δ: 0.95 (3H, t, J = 7.0 Hz), 1.21
(3H, t, J = 7.6 Hz), 2.72 (2H, q, J = 7.6 Hz), 2.9
0-3.10 (4H, m), 3.90 (2H, q, J = 7.0 Hz), 4.93 (1
H, brs), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.76 (1
H, dd, J = 8.8, 3.0Hz), 6.82-7.10 (6H, m), 7.20-7.
42 (4H, m). IRνmaxKBrcm-1: 1726, 1611, 1588, 1507, 1474. Anal. Calcd for C28H27ClF4O5: C, 60.60; H, 4.90 Found: C, 60.53; H, 4.90. 5) (2RS,3RS)-3-(4-((4-クロロ-3-
エチルフェニル)オキシ)フェニル)-3-ヒドロキシ-
2-((3-((1,1,2,2-テトラフルオロエチ
ル)オキシ)フェニル)メチル)プロピオン酸エチル
(6.6g,11.9ミリモル)のメタノール(30m
l)溶液に、2規定水酸化ナトリウム水溶液(11.9
ml,23.8ミリモル)を加えて室温で終夜攪拌し
た。反応液を1規定塩酸で酸性とした後、酢酸エチル
(200ml×2)で抽出した。抽出液を水および飽和
食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留
去した。残留物をヘキサンから再結晶させて、(2R
S,3RS)-3-(4-((4-クロロ-3-エチルフェニ
ル)オキシ)フェニル)-3-ヒドロキシ-2-((3-
((1,1,2,2-テトラフルオロエチル)オキシ)
フェニル)メチル)プロピオン酸(5.28g,84
%)を得た。1 H-NMR (CDCl3)δ: 1.21 (3H, t, J = 7.6 Hz), 2.71
(2H, q, J = 7.6 Hz), 2.92-3.10 (3H, m), 5.07 (1H,
d, J = 4.0 Hz), 5.87 (1H, tt, J = 53.0, 3.0 Hz),
6.75 (1H, dd, J = 8.4, 3.0 Hz), 6.88-7.10 (6H, m),
7.20-7.40 (4H, m). IRνmaxKBrcm-1: 1713, 1611, 1599, 1507, 1472. mp 75-76℃ Anal. Calcd for C26H23ClF4O5: C, 59.27; H, 4.40 Found: C, 59.22; H, 4.43. 6) (2RS,3RS)-3-(4-((4-クロロ-3-
エチルフェニル)オキシ)フェニル)-3-ヒドロキシ-
2-((3-((1,1,2,2-テトラフルオロエチ
ル)オキシ)フェニル)メチル)プロピオン酸(5.1
8g,9.83ミリモル)のテトラヒドロフラン(75
ml)溶液に、ジフェニルホスホリルアジド(2.33
ml,10.8ミリモル)とトリエチルアミン(2.0
6ml,14.8ミリモル)を加え、2時間加熱還流し
た。反応液を放冷後、水(200ml)を加えて酢酸エ
チル(100ml×2)で抽出した。抽出液を1規定塩
酸、飽和重曹水、飽和食塩水で順次洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(酢酸エチル)で精製し、酢
酸エチル−ヘキサンから再結晶させて、(4RS,5S
R)-5-(4-((4-クロロ-3-エチルフェニル)オキ
シ)フェニル)-4-((3-((1,1,2,2-テトラ
フルオロエチル)オキシ)フェニル)メチル)-1,3-
オキサゾリジン-2-オン(4.56g,89%)を得
た。1 H-NMR (CDCl3)δ: 1.22 (3H, t, J = 7.6 Hz), 2.20-
2.44 (2H, m), 2.73 (2H,q, J = 7.6 Hz), 4.18-4.32
(1H, m), 4.98 (1H, s), 5.80 (1H, d, J = 7.8 Hz),
5.90 (1H, tt, J = 53.0, 3.0 Hz), 6.80 (1H, dd, J =
8.4, 3.0 Hz), 6.88-7.20 (5H, m), 7.22-7.44 (5H,
m). IRνmaxKBrcm-1: 1759, 1612, 1588, 1508, 1472. mp 100-101℃ Anal. Calcd for C26H22ClF4NO4: C, 59.61; H, 4.23;
N, 2.67 Found: C, 59.67; H, 4.27; N, 2.76. 7) (4RS,5SR)-5-(4-((4-クロロ-3-
エチルフェニル)オキシ)フェニル)-4-((3-
((1,1,2,2-テトラフルオロエチル)オキシ)
フェニル)メチル)-1,3-オキサゾリジン-2-オン
(4.3g,8.21ミリモル)のエタノール(20m
l)溶液に8規定水酸化ナトリウム水溶液(5.13m
l,41.1ミリモル)を加え、4時間加熱還流した。
反応液を濃縮後、水(100ml)で希釈し、酢酸エチ
ル(100ml×2)で抽出した。抽出液を飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し、
(1RS,2SR)-2-アミノ-1-(4-((4-クロロ
-3-エチルフェニル)オキシ)フェニル)-3-(3-
((1,1,2,2-テトラフルオロエチル)オキシ)
フェニル)-1-プロパノール(3.64g,89%)を
無色油状物として得た。1 H-NMR (CDCl3)δ: 1.21 (3H, t, J = 7.6 Hz), 2.41
(1H, dd, J = 13.6, 10.2Hz), 2.72 (2H, q, J = 7.6 H
z), 2.87 (1H, dd, J = 13.6, 3.2 Hz), 4.65 (1H, d,
J = 5.2 Hz), 5.90 (1H, tt, J = 53.0, 3.0 Hz), 6.78
(1H, dd, J = 8.4, 3.0 Hz), 6.88-7.18 (6H, m), 7.2
8-7.40 (4H, m). IRνmaxKBrcm-1: 1611, 1586, 1505, 1472, 1412. Anal. Calcd for C25H24ClF4NO3: C, 60.31; H, 4.86;
N, 32.81 Found: C, 60.31; H, 5.18; N, 2.85. 8) (1RS,2SR)-2-アミノ-1-(4-((4-
クロロ-3-エチルフェニル)オキシ)フェニル)-3-
(3-((1,1,2,2-テトラフルオロエチル)オキ
シ)フェニル)-1-プロパノール(300mg,0.6
0ミリモル)のアセトニトリル(16ml)溶液に6,
7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カ
ルボン酸(114mg,0.60ミリモル)および1-
エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩(174mg,0.91ミリモル)および
1-ヒドロキシ-1H-ベンゾトリアゾール(92mg,
0.60ミリモル)を加えて室温で終夜攪拌した。反応
液を水(100ml)で希釈し、酢酸エチル(100m
l×2)で抽出した。抽出液を1規定塩酸、1規定水酸
化ナトリウム水溶液、飽和食塩水で順次洗浄し、無水硫
酸マグネシウムで乾燥後減圧留去した。残留物を酢酸エ
チル−ヘキサンから再結晶させて、表題化合物(318
mg,79%)を得た。1 H-NMR (CDCl3)δ: 1.20 (3H, t, J = 7.2 Hz), 1.90-
2.08 (2H, m), 2.10-2.26(2H, m), 2.60-2.84 (5H, m),
3.02 (1H, dd, J = 14.6, 4.0 Hz), 3.50-3.90(1H, b
r), 4.60-4.78 (1H, m), 5.01 (1H, d, J = 3.6 Hz),
5.60-6.22 (4H, m), 6.77 (1H, dd, J = 8.8, 3.0 Hz),
6.84-7.20 (9H, m), 7.28 (2H, d, J = 7.8 Hz), 7.41
(2H, d, J = 8.8 Hz). IRνmaxKBrcm-1: 1613, 1588, 1505, 1472, 1453. mp 116-117℃ Anal. Calcd for C37H34ClF4NO4: C, 66.51; H, 5.13;
N, 2.10 Found: C, 66.22; H, 5.24; N, 2.25.Example 218 N-((1RS, 2SR) -2- (4-((4-chloro-3-
Ethylphenyl) oxy) phenyl) -2-hydroxy-
1-((3-((1,1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1) 4- Fluoroacetophenone (13.8 g, 10
0 mmol) of N, N-dimethylacetamide (100
ml) solution in 4-chloro-3-ethylphenol (15.
6 g, 100 mmol) and potassium carbonate (16.6).
g, 120 mmol) and heated under reflux for 10 hours.
After concentration, the reaction solution was diluted with water (300 ml) and extracted with ethyl acetate (300 ml × 2). The extract was washed successively with water and saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1) to give 4-
((4-Chloro-3-ethylphenyl) oxy) acetophenone (24.2 g, 88%) was obtained as a colorless oil. 1 H-NMR (CDCl 3 ) δ: 1.22 (3H, t, J = 7.4 Hz), 2.58
(3H, s), 2.74 (2H, q, J = 7.4 Hz), 6.84 (1H, dd, J
= 8.8, 3.0 Hz), 6.94-7.04 (3H, m), 7.34 (1H, d, J =
.. 8.8 Hz), 7.90-8.00 ( 2H, m) IRνmax KBr cm -1: 1682, 1595, 1574, 1503, 1472. Anal Calcd for C 16 H 15 ClO 2: C, 69.95; H, 5.50 Found: C H, 5.65 2) 4-((4-chloro-3-ethylphenyl) oxy)
To a solution of acetophenone (24.2 g, 88.2 mmol) in diethyl carbonate (100 ml) was added ethanol (0.3 mM).
l) and sodium hydride (60% oily,
(7.06 g, 176 mmol) and stirred at room temperature for 2 hours. The reaction solution is quenched by adding 6N hydrochloric acid, and the solution
00 ml) and extracted with ethyl acetate (300 ml × 2). The extract was washed successively with water and saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
50: 1-5: 1) to give 3- (4-((4-chloro-3
Ethyl -ethylphenyl) oxy) phenyl) -3-oxopropionate (29.3 g, 96%) was obtained as a brown oil. 1 H-NMR (CDCl 3 ) δ: 1.08-1.20 (6H, m), 2.68-2.82 (2
H, m), 3.95 (2H × 7/8, s), 4.14-4.30 (2H, m), 5.60
(1H × 1/8, s), 6.80-6.90 (1H, m), 6.92-7.04 (3H,
m), 7.32 (1H × 1/8, d, J = 8.4 Hz), 7.35 (1H × 7/8,
d, J = 8.4 Hz), 7.75 (2H × 1/8, d, J = 9.2 Hz), 7.9
3 (2H × 7/8, d, J = 9.2 Hz) .IRνmax KBr cm -1 : 1744, 1682, 1595, 1576, 1505, 147
2, 1410. Anal. Calcd for C 19 H 19 F 5 ClO 4 : C, 65.80; H, 5.52 Found: C, 65.98; H, 5.53.3. 3) 3- (1,1,2,2-tetrafluoroethoxy) )
To a solution of toluene (6.0 g, 28.8 mmol) in carbon tetrachloride (60 ml) was added N-bromosuccinimide (5.6).
5g, 31.7 mmol) and 2,2'-azobis (isobutyronitrile) (237 mg, 1.44 mmol)
Was added and heated under reflux for 6 hours. After cooling, the reaction solution was filtered, and the filtrate was concentrated to prepare 3- (1,1,2,2-tetrafluoroethoxy) -α-bromotoluene. 3- (4-
Ethyl ((4-chloro-3-ethylphenyl) oxy) phenyl) -3-oxopropionate (10 g, 28.8)
Mmol) 1,2-dimethoxyethane (100 ml)
Add sodium hydride (60% oily, 1.15 g, 2
(8.8 mmol) under ice-cooling, and the mixture was stirred at room temperature for 30 minutes. 1,2- (1,1,2,2-tetrafluoroethoxy) -α-bromotoluene prepared in advance in the reaction solution
A solution of dimethoxyethane (10 ml) was added dropwise, and the reaction solution was stirred at room temperature for 1 hour. The reaction solution was poured into water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene) to give 3- (4-
Ethyl ((4-chloro-3-ethylphenyl) oxy) phenyl) -3-oxo-2-((3-((1,1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) propionate ( 9.26 g, 58%) as a colorless oil. 1 H-NMR (CDCl 3 ) δ: 1.13 (3H, t, J = 7.0 Hz), 1.22
(3H, t, J = 7.6 Hz), 2.74 (2H, q, J = 7.6 Hz), 3.3
3 (2H, d, J = 7.2 Hz), 4.11 (2H, q, J = 7.0 Hz),
4.56 (1H, t, J = 7.2 Hz), 5.88 (1H, tt, J = 53.2,
2.8 Hz), 6.83 (1H, dd, J = 8.6, 3.0 Hz), 6.90-7.38
(8H, m), 7.90-8.00 (2H, m) .IRνmax KBr cm -1 : 1738, 1682, 1595, 1576, 1505, 147
. 2. Anal Calcd for C 28 H 25 ClF 4 O 5: C, 60.82; H, 4.56 Found:. C, 60.79; H, 4.38 4) in diethyl ether of zinc chloride (4.44 g, 32.6 mmol) ( Sodium borohydride (2.46 g, 65.1 mmol) was added to the solution (100 ml) and the mixture was stirred at room temperature for 30 minutes. The insoluble material was removed by filtration, and the filtrate was added with 3- (4-
Ethyl ((4-chloro-3-ethylphenyl) oxy) phenyl) -3-oxo-2-((3-((1,1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) propionate ( (9.0 g, 16.3 mmol) in diethyl ether (50 ml) was added, and the mixture was stirred at room temperature for 30 minutes. Under ice cooling, the reaction solution is quenched by adding 1N hydrochloric acid,
Further, water (150 ml) was added, and ethyl acetate (200 ml) was added.
× 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Purified with ethyl acetate = 4: 1) to give (2RS, 3RS)-
3- (4-((4-chloro-3-ethylphenyl) oxy)
Phenyl) -3-hydroxy-2-((3-((1,1,
Ethyl 2,2-tetrafluoroethyl) oxy) phenyl) methyl) propionate (6.79 g, 75%) was obtained as a colorless oil. 1 H-NMR (CDCl 3 ) δ: 0.95 (3H, t, J = 7.0 Hz), 1.21
(3H, t, J = 7.6 Hz), 2.72 (2H, q, J = 7.6 Hz), 2.9
0-3.10 (4H, m), 3.90 (2H, q, J = 7.0 Hz), 4.93 (1
H, brs), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.76 (1
H, dd, J = 8.8, 3.0Hz), 6.82-7.10 (6H, m), 7.20-7.
42 (4H, m) IRνmax KBr cm -1: 1726, 1611, 1588, 1507, 1474. Anal Calcd for C 28 H 27 ClF 4 O 5:.. C, 60.60; H, 4.90 Found: C, 60.53; H , 4.90.5) (2RS, 3RS) -3- (4-((4-chloro-3-
Ethylphenyl) oxy) phenyl) -3-hydroxy-
Ethyl 2-((3-((1,1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) propionate (6.6 g, 11.9 mmol) in methanol (30 m
1) Add 2N aqueous sodium hydroxide solution (11.9) to the solution.
ml, 23.8 mmol) and stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from hexane to give (2R
S, 3RS) -3- (4-((4-Chloro-3-ethylphenyl) oxy) phenyl) -3-hydroxy-2-((3-
((1,1,2,2-tetrafluoroethyl) oxy)
Phenyl) methyl) propionic acid (5.28 g, 84
%). 1 H-NMR (CDCl 3 ) δ: 1.21 (3H, t, J = 7.6 Hz), 2.71
(2H, q, J = 7.6 Hz), 2.92-3.10 (3H, m), 5.07 (1H,
d, J = 4.0 Hz), 5.87 (1H, tt, J = 53.0, 3.0 Hz),
6.75 (1H, dd, J = 8.4, 3.0 Hz), 6.88-7.10 (6H, m),
7.20-7.40 (4H, m) .IRνmax KBr cm -1 : 1713, 1611, 1599, 1507, 1472.mp 75-76 ° C Anal.Calcd for C 26 H 23 ClF 4 O 5 : C, 59.27; H, 4.40 Found: C, 59.22; H, 4.43.6) (2RS, 3RS) -3- (4-((4-chloro-3-
Ethylphenyl) oxy) phenyl) -3-hydroxy-
2-((3-((1,1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) propionic acid (5.1
8 g, 9.83 mmol) of tetrahydrofuran (75
ml) solution in diphenylphosphoryl azide (2.33).
ml, 10.8 mmol) and triethylamine (2.0
(6 ml, 14.8 mmol) was added and the mixture was refluxed for 2 hours. After allowing the reaction mixture to cool, water (200 ml) was added, and the mixture was extracted with ethyl acetate (100 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to give (4RS, 5S
R) -5- (4-((4-Chloro-3-ethylphenyl) oxy) phenyl) -4-((3-((1,1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) -1,3-
Oxazolidin-2-one (4.56 g, 89%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.22 (3H, t, J = 7.6 Hz), 2.20-
2.44 (2H, m), 2.73 (2H, q, J = 7.6 Hz), 4.18-4.32
(1H, m), 4.98 (1H, s), 5.80 (1H, d, J = 7.8 Hz),
5.90 (1H, tt, J = 53.0, 3.0 Hz), 6.80 (1H, dd, J =
8.4, 3.0 Hz), 6.88-7.20 (5H, m), 7.22-7.44 (5H,
.. m) IRνmax KBr cm -1 : 1759, 1612, 1588, 1508, 1472. mp 100-101 ℃ Anal Calcd for C 26 H 22 ClF 4 NO 4: C, 59.61; H, 4.23;
N, 2.67 Found: C, 59.67; H, 4.27; N, 2.76.7) (4RS, 5SR) -5- (4-((4-chloro-3-
Ethylphenyl) oxy) phenyl) -4-((3-
((1,1,2,2-tetrafluoroethyl) oxy)
Phenyl) methyl) -1,3-oxazolidin-2-one (4.3 g, 8.21 mmol) in ethanol (20 m
l) 8N aqueous sodium hydroxide solution (5.13 m
(4,11.1 mmol) and heated to reflux for 4 hours.
After concentration, the reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and then distilled off under reduced pressure.
(1RS, 2SR) -2-amino-1- (4-((4-chloro
-3-Ethylphenyl) oxy) phenyl) -3- (3-
((1,1,2,2-tetrafluoroethyl) oxy)
Phenyl) -1-propanol (3.64 g, 89%) was obtained as a colorless oil. 1 H-NMR (CDCl 3 ) δ: 1.21 (3H, t, J = 7.6 Hz), 2.41
(1H, dd, J = 13.6, 10.2Hz), 2.72 (2H, q, J = 7.6H
z), 2.87 (1H, dd, J = 13.6, 3.2 Hz), 4.65 (1H, d,
J = 5.2 Hz), 5.90 (1H, tt, J = 53.0, 3.0 Hz), 6.78
(1H, dd, J = 8.4, 3.0 Hz), 6.88-7.18 (6H, m), 7.2
8-7.40 (4H, m) .IRνmax KBr cm -1 : 1611, 1586, 1505, 1472, 1412. Anal.Calcd for C 25 H 24 ClF 4 NO 3 : C, 60.31; H, 4.86;
N, 32.81 Found: C, 60.31; H, 5.18; N, 2.85.8) (1RS, 2SR) -2-amino-1- (4-((4-
Chloro-3-ethylphenyl) oxy) phenyl) -3-
(3-((1,1,2,2-tetrafluoroethyl) oxy) phenyl) -1-propanol (300 mg, 0.6
0 mmol) in acetonitrile (16 ml) solution.
7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (114 mg, 0.60 mmol) and 1-
Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (174 mg, 0.91 mmol) and 1-hydroxy-1H-benzotriazole (92 mg,
(0.60 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
1 × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (318
mg, 79%). 1 H-NMR (CDCl 3 ) δ: 1.20 (3H, t, J = 7.2 Hz), 1.90-
2.08 (2H, m), 2.10-2.26 (2H, m), 2.60-2.84 (5H, m),
3.02 (1H, dd, J = 14.6, 4.0 Hz), 3.50-3.90 (1H, b
r), 4.60-4.78 (1H, m), 5.01 (1H, d, J = 3.6 Hz),
5.60-6.22 (4H, m), 6.77 (1H, dd, J = 8.8, 3.0 Hz),
6.84-7.20 (9H, m), 7.28 (2H, d, J = 7.8 Hz), 7.41
.. (2H, d, J = 8.8 Hz) IRνmax KBr cm -1: 1613, 1588, 1505, 1472, 1453. mp 116-117 ℃ Anal Calcd for C 37 H 34 ClF 4 NO 4: C, 66.51; H , 5.13;
N, 2.10 Found: C, 66.22; H, 5.24; N, 2.25.
【0351】実施例219 1,1-ジメチルエチル(1RS,2SR)-2-(2-フ
ルオロピリジン-4-イル)-2-ヒドロキシ-1-((3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)エチルカルバメート 1) 2-アミノ-4-メチルピリジン(100g,92
5ミリモル)の42%テトラフルオロほう酸(400m
l)溶液に亜硝酸ナトリウム(64g,927ミリモ
ル)の水(100ml)溶液を内温が10℃を超えない
ようにドライアイス-アセトンで冷却しながら徐々に加
えた。反応液を45℃で30分攪拌後、8規定水酸化ナ
トリウム水溶液(100ml)を徐々に加え、ジエチル
エーテル(300ml×2)で抽出した。抽出液を減圧
下濃縮後、残留物を蒸留して、2-フルオロ-4-メチル
ピリジン(48g)を得た。過マンガン酸カリウム(1
00g,632ミリモル)の水(1.2L)溶液を80
℃まで加熱し、2-フルオロ-4-メチルピリジン(48
g)を加え、1時間加熱還流した。反応液から不溶物を
セライトでろ過し、ろ液を200mlになるまで濃縮
し、6規定塩酸をpHが約3になるまで加えた。析出し
た結晶をろ取し、2-フルオロ-4-ピリジンカルボン酸
(19.8g,32%)を得た。1 H-NMR (CDCl3)δ: 7.50 (1H, s), 7.75 (1H, d, J =
5.0 Hz), 8.40 (1H, d, J= 5.0 Hz). IRνmaxKBrcm-1: 3100, 1730, 1620. mp 258-260℃ Anal. Calcd for C6H4FNO2: C, 51.07; H, 2.86; N, 9.
93 Found: C, 50.77; H, 2.80; N, 10.04. 2) 2-フルオロ-4-ピリジンカルボン酸(10g,
70.9ミリモル)のテトラヒドロフラン(150m
l)溶液に1,1'-カルボニルビス-1H-イミダゾール
(12.7g,78.0ミリモル)を加え、30分加熱
還流した。反応液を冷却後、マロン酸モノエチルマグネ
シウム塩(11.2g,39.0ミリモル)を加え、室
温で30分攪拌した。反応液に1規定塩酸(200m
l)を加え、酢酸エチル(200ml×2)で抽出し、
抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウムで
乾燥後減圧留去した。残留物をシリカゲルカラムクロマ
トグラフィー(ヘキサン:酢酸エチル=4:1)で精製
し、ヘキサンから再結晶させて3-(2-フルオロ-4-ピ
リジル)-3-オキソプロピオン酸エチル(7.32g,
49%)を得た。1 H-NMR (CDCl3)δ: 1.20-1.40 (3H, m), 3.98 (2H×1/
5, s), 4.18-4.40 (2H, m), 5.76 (1H×4/5, s), 7.26
(1H×4/5, s), 7.40 (1H×1/5, s), 7.50 (1H×4/5, d,
J = 7.4 Hz), 7.63 (1H×1/5, d, J = 7.4 Hz), 8.32
(1H×4/5, d, J =7.0 Hz), 8.43 (1H×1/5, d, J = 7.0
Hz), 12.44 (1H×4/5, s). IRνmaxKBrcm-1: 1744, 1705, 1651, 1607, 1563. mp 66-67℃ Anal. Calcd for C10H10FNO3: C, 56.87; H, 4.77; N,
6.63 Found: C, 56.92; H, 4.69; N, 6.82. 3) 3-(1,1,2,2-テトラフルオロエトキシ)
トルエン(3.80g,18.2ミリモル)の四塩化炭
素(50ml)溶液にN-ブロモスクシンイミド(3.
54g,19.9ミリモル)および2,2'-アゾビス
(イソブチロニトリル)(136mg,0.83ミリモ
ル)を加え、4時間加熱還流した。冷却後、反応液をろ
過し、ろ液を濃縮して3-(1,1,2,2-テトラフル
オロエトキシ)-α-ブロモトルエンを調製した。3-
(2-フルオロピリジン-4-イル)-3-オキソプロピオ
ン酸エチル(3.5g,16.6ミリモル)の1,2-
ジメトキシエタン(35ml)溶液に水素化ナトリウム
(60%油性,0.66g,16.6ミリモル)を氷冷
下加え、室温で30分攪拌した。反応液の中に先に調製
した3-(1,1,2,2-テトラフルオロエトキシ)-
α-ブロモトルエンの1,2-ジメトキシエタン(5m
l)溶液を滴下し、反応液を室温で1時間攪拌した。反
応液を水(100ml)の中に注ぎ、酢酸エチル(10
0ml×2)で抽出した。抽出液を水および飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ト
ルエン:ヘキサン=1:1)で精製し、3-(2-フルオ
ロピリジン-4-イル)-3-オキソ-2-((3-(1,
1,2,2-テトラフルオロエトキシ)フェニル)メチ
ル)プロピオン酸エチル(4.78g,69%)を無色
油状物として得た。1 H-NMR (CDCl3)δ: 1.14 (3H, t, J = 7.0 Hz), 3.35
(2H, d, J = 7.4 Hz), 4.13 (2H, q, J = 7.0 Hz), 4.4
4-4.56 (1H, m), 5.90 (1H, tt, J = 53.0, 3.0 Hz),
7.00-7.38 (5H, m). IRνmaxKBrcm-1: 1740, 1703, 1607, 1588, 1566. Anal. Calcd for C19H16F5NO4: C, 54.68; H, 3.86; N,
3.36 Found: C, 54.44; H, 3.76; N, 3.55. 4) 塩化亜鉛(3.12g,22.9ミリモル)のジ
エチルエーテル(100ml)溶液に水素化ホウ素ナト
リウム(1.74g,45.8ミリモル)を加えて室温
で30分攪拌した。不溶物をろ去し、ろ液に3-(2-フ
ルオロピリジン-4-イル)-3-オキソ-2-((3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)プロピオン酸エチル(4.78g,11.
5ミリモル)のジエチルエーテル(30ml)溶液を加
えて室温で30分攪拌した。氷冷下、反応液に1規定塩
酸を加えてクエンチし、更に水(100ml)を加え、
酢酸エチル(200ml×2)で抽出した。抽出液を水
および飽和食塩水で洗浄し、無水硫酸マグネシウムで乾
燥後減圧留去した。残留物をシリカゲルカラムクロマト
グラフィー(ヘキサン:酢酸エチル=4:1)で精製
し、3-(2-フルオロピリジン-4-イル)-3-ヒドロキ
シ-2-((3-(1,1,2,2-テトラフルオロエトキ
シ)フェニル)メチル)プロピオン酸エチル((2R
S,3RS)体:(2RS,3SR)体=9:1,4.
05g,84%)を無色油状物として得た。1 H-NMR (CDCl3)δ: 0.92-1.06 (3H, m), 2.70-3.10 (3
H, m), 3.54 (1H, dd, J= 2.6 Hz), 3.90-4.04 (2H,
m), 4.77 (1H×1/10, dd, J = 8.8, 3.4 Hz), 5.13(1H
×9/10, s), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.90-
7.30 (7H, m), 8.16-8.24 (1H, m). IRνmaxKBrcm-1: 1728, 1615, 1588, 1572, 1487. Anal. Calcd for C19H18F5NO4: C, 54.42; H, 4.33; N,
3.34 Found: C, 54.37; H, 4.39; N, 3.35. 5) (2RS,3RS)-3-(2-フルオロピリジン-
4-イル)-3-ヒドロキシ-2-((3-(1,1,2,2
-テトラフルオロエトキシ)フェニル)メチル)プロピ
オン酸エチル(3.8g,9.06ミリモル,(2R
S,3RS)体:(2RS,3SR)体=9:1)のメ
タノール(20ml)溶液に、2規定水酸化ナトリウム
水溶液(9.1ml,18.2ミリモル)を加えて室温
で2時間攪拌した。反応液を1規定塩酸で酸性とした
後、酢酸エチル(200ml×2)で抽出した。抽出液
を水および飽和食塩水で洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物を酢酸エチル−ヘキサン
から再結晶させて、(2RS,3RS)-3-(2-フル
オロピリジン-4-イル)-3-ヒドロキシ-2-((3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)プロピオン酸(2.14g,60%)を得
た。1 H-NMR (CDCl3)δ: 2.74-2.92 (1H, m), 2.98-3.16 (2
H, m), 5.18 (1H, d, J =3.2 Hz), 5.88 (1H, tt, J =
53.0, 3.0 Hz), 6.90-7.10 (4H, m), 7.16-7.30(2H,
m), 8.17 (1H, d, J = 5.2 Hz). IRνmaxKBrcm-1: 1717, 1615, 1588, 1570. mp 134-135℃ Anal. Calcd for C17H14F5NO4: C, 52.18; H, 3.61; N,
3.58 Found: C, 52.20; H, 3.51; N, 3.58. 6) (2RS,3RS)-3-(2-フルオロピリジン-
4-イル)-3-ヒドロキシ-2-((3-(1,1,2,2
-テトラフルオロエトキシ)フェニル)メチル)プロピ
オン酸(2.0g,5.11ミリモル)のテトラヒドロ
フラン(50ml)溶液に、ジフェニルホスホリルアジ
ド(1.21ml,5.62ミリモル)とトリエチルア
ミン(1.07ml,7.67ミリモル)を加え、2時
間加熱還流した。反応液を放冷後、水(200ml)を
加えて酢酸エチル(100ml×2)で抽出した。抽出
液を1規定塩酸、飽和重曹水、飽和食塩水で順次洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=1:1)で精製し、酢酸エチル−ヘキサン
から再結晶させて、(4RS,5SR)-5-(2-フル
オロピリジン-4-イル)-4-((3-(1,1,2,2-
テトラフルオロエトキシ)フェニル)メチル)-1,3-
オキサゾリジン-2-オン(1.36g,69%)を得
た。1 H-NMR (CDCl3)δ: 2.27 (1H, dd, J = 14.0, 10.2 H
z), 2.41 (1H, dd, J = 14.0, 4.4 Hz), 4.28-4.42 (1
H, m), 5.49 (1H, s), 5.81 (1H, d, J = 8.0 Hz),5.91
(1H, tt, J = 53.0, 2.6 Hz), 6.90-7.40 (6H, m), 8.
30 (1H, d, J = 5.2Hz). IRνmaxKBrcm-1: 1771, 1615, 1588, 1574, 1489. mp 118-119℃ Anal. Calcd for C17H13F5N2O3: C, 52.59; H, 3.37;
N, 7.21 Found: C, 52.70; H, 3.20; N, 7.20. 7) (4RS,5SR)-5-(2-フルオロピリジン-
4-イル)-4-((3-(1,1,2,2-テトラフルオ
ロエトキシ)フェニル)メチル)-1,3-オキサゾリジ
ン-2-オン(1.25g,3.22ミリモル)のアセト
ニトリル(20ml)溶液に二炭酸ジ-t-ブチル(0.
84g,3.86ミリモル)およびジメチルアミノピリ
ジン(39mg,0.32ミリモル)を加え、室温で2
時間攪拌した。反応液に水(50ml)を加えて酢酸エ
チル(50ml×2)で抽出した。抽出液を飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=4:1)で精製し、酢酸エチル−
ヘキサンから再結晶させて(4RS,5SR)-5-(2
-フルオロピリジン-4-イル)-2-オキソ-4-((3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)-1,3-オキサゾリジン-3-カルボン酸
1,1-ジメチルエチル(1.41g,89%)を得
た。1 H-NMR (CDCl3)δ: 1.51 (9H, s), 2.60 (1H, dd, J =
14.2, 8.8 Hz), 2.95 (1H, dd, J = 14.2, 4.6 Hz), 4.
82-4.98 (1H, m), 5.67 (1H, d, J = 7.0 Hz), 5.90 (1
H, tt, J = 53.0, 3.0 Hz), 6.54 (1H, d, J = 7.4 H
z), 6.73 (1H, s),6.82 (1H, s), 6.94 (1H, d, J = 5.
0 Hz), 6.98-7.20 (2H, m), 8.09 (1H, d,J = 5.2 Hz). IRνmaxKBrcm-1: 1821, 1726, 1615, 1588, 1574, 148
9, 1416. mp 113-114℃ Anal. Calcd for C22H21F5N2O5: C, 54.10; H, 4.33;
N, 5.74 Found: C, 54.10; H, 4.21; N, 5.72. 8) (4RS,5SR)-5-(2-フルオロピリジン-
4-イル)-2-オキソ-4-((3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル)メチル)-1,3-オ
キサゾリジン-3-カルボン酸1,1-ジメチルエチル
(1.30g,2.66ミリモル)のメタノール(7m
l)溶液に0.5規定水酸化ナトリウムのメタノール溶
液(6.39ml,3.19ミリモル)を加え室温で1
0分攪拌した。反応液に水(50ml)を加えて酢酸エ
チル(50ml×2)で抽出した。抽出液を飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて表
題化合物(1.08g,88%)を得た。1 H-NMR (CDCl3)δ: 1.37 (9H, s), 2.60-2.80 (2H, m),
3.82-4.10 (2H, m), 4.68 (1H, d, J = 8.0 Hz), 5.01
(1H, s), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.92-7.
12 (4H, m), 7.18-7.32 (2H, m), 8.20 (1H, d, J = 5.
0 Hz). IRνmaxKBrcm-1: 1752, 1694, 1615, 1570, 1512, 148
9, 1449, 1412. mp 143-144℃ Anal. Calcd for C21H23F5N2O4: C, 54.55; H, 5.01;
N, 6.06 Found: C, 54.32; H, 4.86; N, 6.07.Example 219 1,1-Dimethylethyl (1RS, 2SR) -2- (2-fluoropyridin-4-yl) -2-hydroxy-1-((3-
(1,1,2,2-tetrafluoroethoxy) phenyl) methyl) ethyl carbamate 1) 2-amino-4-methylpyridine (100 g, 92
5 mmol) of 42% tetrafluoroboric acid (400 m
l) A solution of sodium nitrite (64 g, 927 mmol) in water (100 ml) was gradually added to the solution while cooling with dry ice-acetone so that the internal temperature did not exceed 10 ° C. After stirring the reaction solution at 45 ° C. for 30 minutes, an 8 N aqueous sodium hydroxide solution (100 ml) was gradually added thereto, and the mixture was extracted with diethyl ether (300 ml × 2). After the extract was concentrated under reduced pressure, the residue was distilled to obtain 2-fluoro-4-methylpyridine (48 g). Potassium permanganate (1
00g, 632 mmol) in water (1.2 L)
And heated to 2-fluoro-4-methylpyridine (48
g) was added and the mixture was heated under reflux for 1 hour. Insolubles were filtered from the reaction solution through celite, the filtrate was concentrated to 200 ml, and 6N hydrochloric acid was added until the pH was about 3. The precipitated crystals were collected by filtration to obtain 2-fluoro-4-pyridinecarboxylic acid (19.8 g, 32%). 1 H-NMR (CDCl 3 ) δ: 7.50 (1H, s), 7.75 (1H, d, J =
5.0 Hz), 8.40 (1H, d, J = 5.0 Hz) .IRνmax KBr cm -1 : 3100, 1730, 1620.mp 258-260 ℃ Anal.Calcd for C 6 H 4 FNO 2 : C, 51.07; H, 2.86; N, 9.
93 Found: C, 50.77; H, 2.80; N, 10.04.2) 2-Fluoro-4-pyridinecarboxylic acid (10 g,
70.9 mmol) of tetrahydrofuran (150 m
l) 1,1′-Carbonylbis-1H-imidazole (12.7 g, 78.0 mmol) was added to the solution, and the mixture was heated under reflux for 30 minutes. After cooling the reaction solution, monoethyl magnesium malonate (11.2 g, 39.0 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. 1N hydrochloric acid (200m
l), and extracted with ethyl acetate (200 ml × 2).
The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from hexane to give ethyl 3- (2-fluoro-4-pyridyl) -3-oxopropionate (7.32 g,
49%). 1 H-NMR (CDCl 3 ) δ: 1.20-1.40 (3H, m), 3.98 (2H × 1 /
5, s), 4.18-4.40 (2H, m), 5.76 (1H × 4/5, s), 7.26
(1H × 4/5, s), 7.40 (1H × 1/5, s), 7.50 (1H × 4/5, d,
J = 7.4 Hz), 7.63 (1H × 1/5, d, J = 7.4 Hz), 8.32
(1H × 4/5, d, J = 7.0 Hz), 8.43 (1H × 1/5, d, J = 7.0
.. Hz), 12.44 (1H × 4/5, s) IRνmax KBr cm -1: 1744, 1705, 1651, 1607, 1563. mp 66-67 ℃ Anal Calcd for C 10 H 10 FNO 3: C, 56.87; H, 4.77; N,
6.63 Found: C, 56.92; H, 4.69; N, 6.82. 3) 3- (1,1,2,2-tetrafluoroethoxy)
To a solution of toluene (3.80 g, 18.2 mmol) in carbon tetrachloride (50 ml) was added N-bromosuccinimide (3.
54 g, 19.9 mmol) and 2,2′-azobis (isobutyronitrile) (136 mg, 0.83 mmol) were added, and the mixture was heated under reflux for 4 hours. After cooling, the reaction solution was filtered, and the filtrate was concentrated to prepare 3- (1,1,2,2-tetrafluoroethoxy) -α-bromotoluene. 3-
Ethyl (2-fluoropyridin-4-yl) -3-oxopropionate (3.5 g, 16.6 mmol) in 1,2-
Sodium hydride (60% oily, 0.66 g, 16.6 mmol) was added to a dimethoxyethane (35 ml) solution under ice-cooling, and the mixture was stirred at room temperature for 30 minutes. 3- (1,1,2,2-tetrafluoroethoxy)-previously prepared in the reaction solution
1,2-dimethoxyethane of α-bromotoluene (5 m
l) The solution was added dropwise and the reaction was stirred at room temperature for 1 hour. The reaction solution was poured into water (100 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene: hexane = 1: 1) to give 3- (2-fluoropyridin-4-yl) -3-oxo-2-((3- (1,
Ethyl 1,2,2-tetrafluoroethoxy) phenyl) methyl) propionate (4.78 g, 69%) was obtained as a colorless oil. 1 H-NMR (CDCl 3 ) δ: 1.14 (3H, t, J = 7.0 Hz), 3.35
(2H, d, J = 7.4 Hz), 4.13 (2H, q, J = 7.0 Hz), 4.4
4-4.56 (1H, m), 5.90 (1H, tt, J = 53.0, 3.0 Hz),
7.00-7.38 (5H, m) .IRνmax KBr cm -1 : 1740, 1703, 1607, 1588, 1566.Anal.Calcd for C 19 H 16 F 5 NO 4 : C, 54.68; H, 3.86; N,
3.36 Found: C, 54.44; H, 3.76; N, 3.55.4) In a solution of zinc chloride (3.12 g, 22.9 mmol) in diethyl ether (100 ml), sodium borohydride (1.74 g, 45.8 mmol) was added. ) And stirred at room temperature for 30 minutes. The insolubles were removed by filtration, and the filtrate was treated with 3- (2-fluoropyridin-4-yl) -3-oxo-2-((3-
Ethyl (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) propionate (4.78 g, 11.
(5 mmol) in diethyl ether (30 ml) and stirred at room temperature for 30 minutes. Under ice cooling, the reaction solution was quenched by adding 1N hydrochloric acid, and water (100 ml) was further added.
Extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give 3- (2-fluoropyridin-4-yl) -3-hydroxy-2-((3- (1,1,1,2 Ethyl 2,2-tetrafluoroethoxy) phenyl) methyl) propionate ((2R
(S, 3RS) body: (2RS, 3SR) body = 9: 1,4.
(05 g, 84%) as a colorless oil. 1 H-NMR (CDCl 3 ) δ: 0.92-1.06 (3H, m), 2.70-3.10 (3
H, m), 3.54 (1H, dd, J = 2.6 Hz), 3.90-4.04 (2H,
m), 4.77 (1H × 1/10, dd, J = 8.8, 3.4 Hz), 5.13 (1H
× 9/10, s), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.90-
7.30 (7H, m), 8.16-8.24 (1H, m) IRνmax KBr cm -1: 1728, 1615, 1588, 1572, 1487. Anal Calcd for C 19 H 18 F 5 NO 4:.. C, 54.42; H , 4.33; N,
3.34 Found: C, 54.37; H, 4.39; N, 3.35.5) (2RS, 3RS) -3- (2-fluoropyridine-
4-yl) -3-hydroxy-2-((3- (1,1,2,2
Ethyl-tetrafluoroethoxy) phenyl) methyl) propionate (3.8 g, 9.06 mmol, (2R
To a solution of (S, 3RS) form: (2RS, 3SR) form = 9: 1) in methanol (20 ml), 2N aqueous sodium hydroxide solution (9.1 ml, 18.2 mmol) was added and stirred at room temperature for 2 hours. . The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (2RS, 3RS) -3- (2-fluoropyridin-4-yl) -3-hydroxy-2-((3-
(1,1,2,2-tetrafluoroethoxy) phenyl) methyl) propionic acid (2.14 g, 60%) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.74-2.92 (1H, m), 2.98-3.16 (2
H, m), 5.18 (1H, d, J = 3.2 Hz), 5.88 (1H, tt, J =
53.0, 3.0 Hz), 6.90-7.10 (4H, m), 7.16-7.30 (2H,
m), 8.17 (1H, d, J = 5.2 Hz) .IRνmax KBr cm -1 : 1717, 1615, 1588, 1570.mp 134-135 ℃ Anal. Calcd for C 17 H 14 F 5 NO 4 : C, 52.18 ; H, 3.61; N,
3.58 Found: C, 52.20; H, 3.51; N, 3.58. 6) (2RS, 3RS) -3- (2-fluoropyridine-
4-yl) -3-hydroxy-2-((3- (1,1,2,2
To a solution of -tetrafluoroethoxy) phenyl) methyl) propionic acid (2.0 g, 5.11 mmol) in tetrahydrofuran (50 ml) was added diphenylphosphoryl azide (1.21 ml, 5.62 mmol) and triethylamine (1.07 ml, 7 .67 mmol) and heated to reflux for 2 hours. After allowing the reaction mixture to cool, water (200 ml) was added, and the mixture was extracted with ethyl acetate (100 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Purification with ethyl acetate = 1: 1) and recrystallization from ethyl acetate-hexane gave (4RS, 5SR) -5- (2-fluoropyridin-4-yl) -4-((3- (1,1 , 2,2-
Tetrafluoroethoxy) phenyl) methyl) -1,3-
Oxazolidin-2-one (1.36 g, 69%) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.27 (1H, dd, J = 14.0, 10.2 H
z), 2.41 (1H, dd, J = 14.0, 4.4 Hz), 4.28-4.42 (1
H, m), 5.49 (1H, s), 5.81 (1H, d, J = 8.0 Hz), 5.91
(1H, tt, J = 53.0, 2.6 Hz), 6.90-7.40 (6H, m), 8.
30 (1H, d, J = 5.2Hz) IRνmax KBr cm -1:. 1771, 1615, 1588, 1574, 1489. mp 118-119 ℃ Anal Calcd for C 17 H 13 F 5 N 2 O 3:. C, 52.59; H, 3.37;
N, 7.21 Found: C, 52.70; H, 3.20; N, 7.20.7) (4RS, 5SR) -5- (2-fluoropyridine-
Acetonitrile of 4-yl) -4-((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) -1,3-oxazolidin-2-one (1.25 g, 3.22 mmol) (20 ml) solution in di-t-butyl dicarbonate (0.
84 g, 3.86 mmol) and dimethylaminopyridine (39 mg, 0.32 mmol).
Stirred for hours. Water (50 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give ethyl acetate-
Recrystallized from hexane, (4RS, 5SR) -5- (2
-Fluoropyridin-4-yl) -2-oxo-4-((3-
1,1-Dimethylethyl (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) -1,3-oxazolidine-3-carboxylate (1.41 g, 89%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.51 (9H, s), 2.60 (1H, dd, J =
14.2, 8.8 Hz), 2.95 (1H, dd, J = 14.2, 4.6 Hz), 4.
82-4.98 (1H, m), 5.67 (1H, d, J = 7.0 Hz), 5.90 (1
H, tt, J = 53.0, 3.0 Hz), 6.54 (1H, d, J = 7.4 H
z), 6.73 (1H, s), 6.82 (1H, s), 6.94 (1H, d, J = 5.
0 Hz), 6.98-7.20 (2H, m), 8.09 (1H, d, J = 5.2 Hz) .IRνmax KBr cm -1 : 1821, 1726, 1615, 1588, 1574, 148
9, 1416.mp 113-114 ℃ Anal.Calcd for C 22 H 21 F 5 N 2 O 5 : C, 54.10; H, 4.33;
N, 5.74 Found: C, 54.10; H, 4.21; N, 5.72.8) (4RS, 5SR) -5- (2-fluoropyridine-
1,1-dimethylethyl 4-yl) -2-oxo-4-((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) -1,3-oxazolidine-3-carboxylate ( 1.30 g, 2.66 mmol) of methanol (7 m
l) To the solution was added 0.5N sodium hydroxide in methanol (6.39 ml, 3.19 mmol), and the mixture was added at room temperature for 1 hour.
Stirred for 0 minutes. Water (50 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (1.08 g, 88%). 1 H-NMR (CDCl 3 ) δ: 1.37 (9H, s), 2.60-2.80 (2H, m),
3.82-4.10 (2H, m), 4.68 (1H, d, J = 8.0 Hz), 5.01
(1H, s), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.92-7.
12 (4H, m), 7.18-7.32 (2H, m), 8.20 (1H, d, J = 5.
0 Hz) .IRνmax KBr cm -1 : 1752, 1694, 1615, 1570, 1512, 148
9, 1449, 1412.mp 143-144 ℃ Anal.Calcd for C 21 H 23 F 5 N 2 O 4 : C, 54.55; H, 5.01;
N, 6.06 Found: C, 54.32; H, 4.86; N, 6.07.
【0352】実施例220 N-((1RS,2SR)-2-(2-フルオロピリジン-
4-イル)-2-ヒドロキシ-1-((3-(1,1,2,2
-テトラフルオロエトキシ)フェニル)メチル)エチ
ル)-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテ
ン-1-カルボキサミド1) 1,1-ジメチルエチル
(1RS,2SR)-2-(2-フルオロピリジン-4-イ
ル)-2-ヒドロキシ-1-((3-(1,1,2,2-テト
ラフルオロエトキシ)フェニル)メチル)エチルカルバ
メート(0.8g,1.73ミリモル)にトリフルオロ
酢酸(10ml)を加え、室温で10分攪拌した。反応
液を減圧下濃縮後、1N水酸化ナトリウム水溶液(10
ml)を加え、酢酸エチル(20ml×2)で抽出し
た。抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去し、残留物を酢酸エチル−ヘキサン
から再結晶させて、(1RS,2SR)-2-アミノ-1-
(2-フルオロピリジン-4-イル)-3-(3-(1,1,
2,2-テトラフルオロエトキシ)フェニル)-1-プロ
パノール(0.59g,93%)を得た。1 H-NMR (CDCl3)δ: 2.40 (1H, dd, J = 13.6, 10.6 H
z), 2.63 (1H, dd, J = 13.6, 3.2 Hz), 3.32-3.48 (1
H, m), 4.79 (1H, d, J = 4.0 Hz), 5.92 (1H, tt,J =
53.0, 3.0 Hz), 6.92-7.40 (6H, m), 8.24 (1H, d, J =
5.2 Hz). IRνmaxKBrcm-1: 1613, 1588, 1568, 1487, 1449, 141
0. mp 119-120℃ Anal. Calcd for C16H15F5N2O2: C, 53.04; H, 4.17;
N, 7.73 Found: C, 52.91; H, 4.08; N, 7.60. 2) (1RS,2SR)-2-アミノ-1-(2-フルオ
ロピリジン-4-イル)-3-(3-(1,1,2,2-テト
ラフルオロエトキシ)フェニル)-1-プロパノール(3
00mg,0.83ミリモル)のアセトニトリル(20
ml)溶液に6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボン酸(156mg,0.83ミリ
モル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(238mg,1.24ミ
リモル)および1-ヒドロキシ-1H-ベンゾトリアゾー
ル(127mg,0.83ミリモル)を加えて室温で終
夜攪拌した。反応液を水(100ml)で希釈し、酢酸
エチル(100ml×2)で抽出した。抽出液を1規定
塩酸、1規定水酸化ナトリウム水溶液、飽和食塩水で順
次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて、
表題化合物(347mg,79%)を得た。1 H-NMR (CDCl3)δ: 1.90-2.08 (2H, m), 2.10-2.26 (2
H, m), 2.60-2.72 (2H, m), 2.80-2.92 (2H, m), 4.40-
4.70 (2H, m), 5.11 (1H, d, J = 2.6 Hz), 5.89(1H, t
t, J = 53.0, 3.0 Hz), 5.90-6.10 (2H, m), 6.24 (1H,
d, J = 11.6 Hz), 6.92-7.38 (9H, m), 8.08 (1H, d,
J = 5.2 Hz). IRνmaxKBrcm-1: 1636, 1615, 1588, 1570, 1516, 144
9, 1412. mp 159-160℃ Anal. Calcd for C28H25F5N2O3・0.2H2O: C, 62.73; H,
4.78; N, 5.23 Found: C, 62.64; H, 4.80; N, 5.37.Example 220 N-((1RS, 2SR) -2- (2-fluoropyridine-
4-yl) -2-hydroxy-1-((3- (1,1,2,2
-Tetrafluoroethoxy) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1) 1,1-dimethylethyl (1RS, 2SR) -2- (2-fluoropyridine -4-yl) -2-hydroxy-1-((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) ethylcarbamate (0.8 g, 1.73 mmol) was added to trifluoroacetic acid ( 10 ml) and stirred at room temperature for 10 minutes. After concentrating the reaction solution under reduced pressure, a 1N aqueous sodium hydroxide solution (10
ml) and extracted with ethyl acetate (20 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR) -2-amino-1-amino.
(2-Fluoropyridin-4-yl) -3- (3- (1,1,
2,2-Tetrafluoroethoxy) phenyl) -1-propanol (0.59 g, 93%) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.40 (1H, dd, J = 13.6, 10.6 H
z), 2.63 (1H, dd, J = 13.6, 3.2 Hz), 3.32-3.48 (1
H, m), 4.79 (1H, d, J = 4.0 Hz), 5.92 (1H, tt, J =
53.0, 3.0 Hz), 6.92-7.40 (6H, m), 8.24 (1H, d, J =
5.2 Hz) .IRνmax KBr cm -1 : 1613, 1588, 1568, 1487, 1449, 141
0.mp 119-120 ℃ Anal. Calcd for C 16 H 15 F 5 N 2 O 2 : C, 53.04; H, 4.17;
N, 7.73 Found: C, 52.91; H, 4.08; N, 7.60.2) (1RS, 2SR) -2-amino-1- (2-fluoropyridin-4-yl) -3- (3- (1, 1,2,2-tetrafluoroethoxy) phenyl) -1-propanol (3
00 mg, 0.83 mmol) of acetonitrile (20
ml) solution, 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (156 mg, 0.83 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (238 mg) , 1.24 mmol) and 1-hydroxy-1H-benzotriazole (127 mg, 0.83 mmol) were added and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane,
The title compound (347 mg, 79%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.90-2.08 (2H, m), 2.10-2.26 (2
H, m), 2.60-2.72 (2H, m), 2.80-2.92 (2H, m), 4.40-
4.70 (2H, m), 5.11 (1H, d, J = 2.6 Hz), 5.89 (1H, t
t, J = 53.0, 3.0 Hz), 5.90-6.10 (2H, m), 6.24 (1H,
d, J = 11.6 Hz), 6.92-7.38 (9H, m), 8.08 (1H, d,
J = 5.2 Hz) .IRνmax KBr cm -1 : 1636, 1615, 1588, 1570, 1516, 144
9, 1412.mp 159-160 ℃ Anal. Calcd for C 28 H 25 F 5 N 2 O 3・ 0.2H 2 O: C, 62.73; H,
4.78; N, 5.23 Found: C, 62.64; H, 4.80; N, 5.37.
【0353】実施例221 1,1-ジメチルエチル(1RS,2RS)-2-(6-フ
ルオロピリジン-2-イル)-2-ヒドロキシ-1-((3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)エチルカルバメート 1) 2-アミノ-6-メチルピリジン(75g,693
ミリモル)の42%テトラフルオロほう酸(291m
l)溶液に亜硝酸ナトリウム(47.8g,693ミリ
モル)の水(100ml)溶液を内温が10℃を超えな
いようにドライアイス-アセトンで冷却しながら徐々に
加えた。反応液を45℃で30分攪拌後、8規定水酸化
ナトリウム水溶液(100ml)を徐々に加え、ジエチ
ルエーテル(300ml×2)で抽出した。抽出液を減
圧下濃縮後、残留物を蒸留して、2-フルオロ-6-メチ
ルピリジン(27.9g)を得た。過マンガン酸カリウ
ム(100g,632ミリモル)の水(1.2L)溶液
を80℃まで加熱し、2-フルオロ-6-メチルピリジン
(27.9g)を加え、4時間加熱還流した。反応液か
ら不溶物をセライトでろ過し、ろ液を200mlになる
まで濃縮し、6規定塩酸をpHが約3になるまで加え
た。析出した結晶をろ取し、6-フルオロ-2-ピリジン
カルボン酸(5.84g,14%)を得た。1 H-NMR (CDCl3)δ: 7.26 (1H, d, J = 7.2 Hz), 7.36
(1H, s), 8.00-8.30 (1H,m). IRνmaxKBrcm-1: 3100, 1730, 1620. mp 248-250℃ Anal. Calcd for C6H4FNO2: C, 51.07; H, 2.86; N, 9.
93 Found: C, 51.10; H, 2.81; N, 9.87. 2) 6-フルオロ-2-ピリジンカルボン酸(15.0
g,106.3ミリモル)のテトラヒドロフラン(20
0ml)溶液に1,1'-カルボニルビス-1H-イミダゾ
ール(19.0g,116.9ミリモル)を加え、30
分加熱還流した。反応液を冷却後、マロン酸モノエチル
マグネシウム塩(16.8g,58.5ミリモル)を加
え、室温で30分攪拌した。反応液に1規定塩酸(20
0ml)を加え、酢酸エチル(200ml×2)で抽出
し、抽出液を飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後減圧留去した。残留物をシリカゲルカラムク
ロマトグラフィー(ヘキサン:酢酸エチル=4:1)で
精製し、3-(6-フルオロ-2-ピリジル)-3-オキソプ
ロピオン酸エチル(20.16g,90%)を褐色油状
物として得た。1 H-NMR (CDCl3)δ: 1.20-1.40 (3H, m), 4.13 (2H×2/
3, s), 4.14-4.34 (2H, m), 6.30 (1H×1/3, s), 6.96-
7.04 (1H×1/3, m), 7.12-7.24 (1H×2/3, m), 7.78-8.
04 (2H, m), 12.32 (1H×1/3, s). IRνmaxKBrcm-1: 1744, 1709, 1651, 1593, 1578, 145
3. Anal. Calcd for C10H10FNO3: C, 56.87; H, 4.77 Found: C, 56.74; H, 4.73 3) 3-(1,1,2,2-テトラフルオロエトキシ)
トルエン(7.51g,35.6ミリモル)の四塩化炭
素(100ml)溶液にN-ブロモスクシンイミド
(7.60g,42.7ミリモル)および2,2'-アゾ
ビス(イソブチロニトリル)(290mg,1.78ミ
リモル)を加え、4時間加熱還流した。冷却後、反応液
をろ過し、ろ液を濃縮して3-(1,1,2,2-テトラ
フルオロエトキシ)-α-ブロモトルエンを調製した。3
-(6-フルオロピリジン-2-イル)-3-オキソプロピオ
ン酸エチル(7.51g,35.6ミリモル)の1,2
-ジメトキシエタン(70ml)溶液に水素化ナトリウ
ム(60%油性,1.42g,35.6ミリモル)を氷
冷下加え、室温で30分攪拌した。反応液の中に先に調
製した3-(1,1,2,2-テトラフルオロエトキシ)
-α-ブロモトルエンの1,2-ジメトキシエタン(10
ml)溶液を滴下し、反応液を室温で1時間攪拌した。
反応液を水(100ml)の中に注ぎ、酢酸エチル(1
00ml×2)で抽出した。抽出液を水および飽和食塩
水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ト
ルエン:ヘキサン=1:1)で精製し、3-(6-フルオ
ロピリジン-2-イル)-3-オキソ-2-((3-(1,
1,2,2-テトラフルオロエトキシ)フェニル)メチ
ル)プロピオン酸エチル(7.74g,52%)を無色
油状物として得た。1 H-NMR (CDCl3)δ: 1.13 (3H, t, J = 9.0 Hz), 3.20-
3.44 (2H, m), 4.11 (2H,q, J = 9.0 Hz), 4.98 (1H,
t, J = 7.4 Hz), 5.89 (1H, tt, J = 53.0, 3.0 Hz),
7.00-7.32 (5H, m), 7.90-8.04 (2H, m). IRνmaxKBrcm-1: 1732, 1705, 1593, 1453. Anal. Calcd for C19H16F5NO4: C, 54.68; H, 3.86; N,
3.36 Found: C, 54.55; H, 3.92; N, 3.51. 4) 塩化亜鉛(4.19g,30.7ミリモル)のジ
エチルエーテル(100ml)溶液に水素化ホウ素ナト
リウム(2.33g,61.4ミリモル)を加えて室温
で30分攪拌した。不溶物をろ去し、ろ液に3-(6-フ
ルオロピリジン-2-イル)-3-オキソ-2-((3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)プロピオン酸エチル(6.41g,15.
4ミリモル)のジエチルエーテル(50ml)溶液を−
78℃にて加えて30分攪拌した。反応液に1規定塩酸
を加えてクエンチし、更に水(100ml)を加え、酢
酸エチル(200ml×2)で抽出した。抽出液を水お
よび飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=4:1)で精製し、
3-(6-フルオロピリジン-2-イル)-3-ヒドロキシ-
2-((3-(1,1,2,2-テトラフルオロエトキ
シ)フェニル)メチル)プロピオン酸エチル((2R
S,3RS)体:(2RS,3SR)体=6:1,5.
70g,88%)を無色油状物として得た。1 H-NMR (CDCl3)δ: 0.96-1.00 (3H, m), 2.87 (1H, dd,
J = 5.0 Hz), 2.96-3.14 (1H, m), 3.20-3.40 (1H,
m), 3.76 (1H, d, J = 5.6 Hz), 3.90-4.04 (2H, m),
4.76 (1H×1/7, dd, J = 9.6, 4.4 Hz), 5.00-5.08 (1H
×6/7, m), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.83
(1H, dd, J = 8.0, 2.6 Hz), 6.90-7.36 (5H,m), 7.70-
7.86 (1H, m). IRνmaxKBrcm-1: 1728, 1607, 1578, 1454. Anal. Calcd for C19H18F5NO4: C, 54.42; H, 4.33; N,
3.34 Found: C, 54.34; H, 4.37; N, 3.29. 5) (2RS,3RS)-3-(6-フルオロピリジン-
2-イル)-3-ヒドロキシ-2-((3-(1,1,2,2
-テトラフルオロエトキシ)フェニル)メチル)プロピ
オン酸エチル(5.5g,13.1ミリモル,(2R
S,3RS)体:(2RS,3SR)体=6:1)のメ
タノール(25ml)溶液に、2規定水酸化ナトリウム
水溶液(13.1ml,26.2ミリモル)を加えて室
温で2時間攪拌した。反応液を1規定塩酸で酸性とした
後、酢酸エチル(200ml×2)で抽出した。抽出液
を水および飽和食塩水で洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物を酢酸エチル−ヘキサン
から再結晶させて、(2RS,3RS)-3-(6-フル
オロピリジン-2-イル)-3-ヒドロキシ-2-((3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)プロピオン酸(3.82g,74%)を得
た。1 H-NMR (CDCl3)δ: 2.85 (1H, dd, J = 14.0, 5.2 Hz),
3.08 (1H, dd, J = 14.0, 9.0 Hz), 3.26-3.38 (1H,
m), 5.12 (1H, d, J = 4.4 Hz), 5.88 (1H, tt, J= 53.
0, 3.0 Hz), 6.81 (1H, dd, J = 8.2, 2.6 Hz), 6.90-
7.04 (3H, m), 7.18 (1H, d, J = 7.6 Hz), 7.27 (1H,
dd, J = 7.2, 2.2 Hz), 7.70-7.82 (1H, m). IRνmaxKBrcm-1: 1713, 1609, 1580, 1489, 1456. mp 103-104℃ Anal. Calcd for C17H14F5NO4: C, 52.18; H, 3.61; N,
3.58 Found: C, 52.16; H, 3.57; N, 3.57. 6) (2RS,3RS)-3-(6-フルオロピリジン-
2-イル)-3-ヒドロキシ-2-((3-(1,1,2,2
-テトラフルオロエトキシ)フェニル)メチル)プロピ
オン酸(3.6g,9.20ミリモル)のテトラヒドロ
フラン(90ml)溶液に、ジフェニルホスホリルアジ
ド(2.18ml,10.1ミリモル)とトリエチルア
ミン(1.93ml,13.8ミリモル)を加え、2時
間加熱還流した。反応液を放冷後、水(200ml)を
加えて酢酸エチル(100ml×2)で抽出した。抽出
液を1規定塩酸、飽和重曹水、飽和食塩水で順次洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=1:1)で精製し、酢酸エチル−ヘキサン
から再結晶させて、(4RS,5RS)-5-(6-フル
オロピリジン-2-イル)-4-((3-(1,1,2,2-
テトラフルオロエトキシ)フェニル)メチル)-1,3-
オキサゾリジン-2-オン(2.34g,65%)を得
た。1 H-NMR (CDCl3)δ: 2.14 (1H, dd, J = 13.6, 9.0 Hz),
2.58 (1H, dd, J = 13.6, 3.2 Hz), 4.36-4.50 (1H,
m), 5.13 (1H, s), 5.78 (1H, d, J = 8.0 Hz), 5.91
(1H, tt, J = 53.0, 3.0 Hz), 6.90-7.20 (4H, m), 7.2
6-7.42 (1H, m), 7.52 (1H, d, J = 5.2 Hz), 7.86-8.0
0 (1H, m). IRνmaxKBrcm-1: 1767, 1607, 1584, 1489, 1458, 144
7. mp 118-119℃ Anal. Calcd for C17H13F5N2O3: C, 52.59; H, 3.37;
N, 7.21 Found: C, 52.60; H, 3.31; N, 7.35. 7) (4RS,5RS)-5-(6-フルオロピリジン-
2-イル)-4-((3-(1,1,2,2-テトラフルオ
ロエトキシ)フェニル)メチル)-1,3-オキサゾリジ
ン-2-オン(2.2g,5.67ミリモル)のアセトニ
トリル(20ml)溶液に二炭酸ジ-t-ブチル(1.4
8g,6.80ミリモル)およびジメチルアミノピリジ
ン(70mg,0.57ミリモル)を加え、室温で2時
間攪拌した。反応液に水(50ml)を加えて酢酸エチ
ル(50ml×2)で抽出した。抽出液を飽和食塩水で
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去した。
残留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=4:1)で精製し、酢酸エチル−ヘキ
サンから再結晶させて(4RS,5RS)-5-(6-フ
ルオロピリジン-2-イル)-2-オキソ-4-((3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)-1,3-オキサゾリジン-3-カルボン酸
1,1-ジメチルエチル(2.59g,94%)を得
た。1 H-NMR (CDCl3)δ: 1.45 (9H, s), 2.65 (1H, dd, J =
14.2, 7.4 Hz), 2.84 (1H, dd, J = 14.2, 5.8 Hz), 4.
97-5.08 (1H, m), 5.61 (1H, d, J = 6.4 Hz), 5.88 (1
H, tt, J = 53.0, 3.0 Hz), 6.53 (1H, s), 6.75 (1H,
d, J = 7.6 Hz),6.88 (1H, dd, J = 8.0, 2.6 Hz), 7.0
2 (1H, d, J = 9.6 Hz), 7.10-7.22 (1H,m), 7.43 (1H,
dd, J = 7.4, 2.6 Hz), 7.80-7.94 (1H, m).IRνmax
KBrcm-1: 1823, 1728, 1607, 1584, 1460, 1447. mp 96-97℃ Anal. Calcd for C22H21F5N2O5: C, 54.10; H, 4.33;
N, 5.74 Found: C, 54.14; H, 4.25; N, 5.78. 8) (4RS,5RS)-5-(6-フルオロピリジン-
2-イル)-2-オキソ-4-((3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル)メチル)-1,3-オ
キサゾリジン-3-カルボン酸1,1-ジメチルエチル
(2.40g,4.91ミリモル)のメタノール(12
ml)に0.5N水酸化ナトリウムのメタノール溶液
(11.8ml,5.90ミリモル)を加え室温で10
分攪拌した。反応液に水(50ml)を加えて酢酸エチ
ル(50ml×2)で抽出した。抽出液を飽和食塩水で
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去した。
残留物を酢酸エチル−ヘキサンから再結晶させて表題化
合物(1.92g,84%)を得た。1 H-NMR (CDCl3)δ: 1.37 (9H, s), 2.65 (1H, dd, J =
13.6, 5.0 Hz), 2.85 (1H, dd, J = 13.6, 9.0 Hz), 4.
08-4.30 (1H, m), 4.45 (1H, d, J = 6.0 Hz), 4.88-5.
02 (2H, m), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.85
(1H, dd, J = 8.0, 2.2 Hz), 6.90-7.10 (3H, m), 7.10
-7.32 (2H, m), 7.70-7.86 (1H, m). IRνmaxKBrcm-1: 1682, 1607, 1576, 1532, 1487, 145
4. mp 140-141℃ Anal. Calcd for C21H23F5N2O4: C, 54.55; H, 5.01;
N, 6.06 Found: C, 54.27; H, 4.71; N, 6.12.Example 221 1,1-Dimethylethyl (1RS, 2RS) -2- (6-fluoropyridin-2-yl) -2-hydroxy-1-((3-
(1,1,2,2-tetrafluoroethoxy) phenyl) methyl) ethyl carbamate 1) 2-amino-6-methylpyridine (75 g, 693)
Mmol) of 42% tetrafluoroboric acid (291 m
l) A solution of sodium nitrite (47.8 g, 693 mmol) in water (100 ml) was gradually added to the solution while cooling with dry ice-acetone so that the internal temperature did not exceed 10 ° C. After stirring the reaction solution at 45 ° C. for 30 minutes, an 8 N aqueous sodium hydroxide solution (100 ml) was gradually added thereto, and the mixture was extracted with diethyl ether (300 ml × 2). After the extract was concentrated under reduced pressure, the residue was distilled to obtain 2-fluoro-6-methylpyridine (27.9 g). A solution of potassium permanganate (100 g, 632 mmol) in water (1.2 L) was heated to 80 ° C., 2-fluoro-6-methylpyridine (27.9 g) was added, and the mixture was heated under reflux for 4 hours. Insolubles were filtered from the reaction solution through celite, the filtrate was concentrated to 200 ml, and 6N hydrochloric acid was added until the pH was about 3. The precipitated crystals were collected by filtration to obtain 6-fluoro-2-pyridinecarboxylic acid (5.84 g, 14%). 1 H-NMR (CDCl 3 ) δ: 7.26 (1H, d, J = 7.2 Hz), 7.36
.. (1H, s), 8.00-8.30 (1H, m) IRνmax KBr cm -1: 3100, 1730, 1620. mp 248-250 ℃ Anal Calcd for C 6 H 4 FNO 2: C, 51.07; H, 2.86 ; N, 9.
93 Found: C, 51.10; H, 2.81; N, 9.87. 2) 6-Fluoro-2-pyridinecarboxylic acid (15.0
g, 106.3 mmol) of tetrahydrofuran (20
0 ml) to the solution, 1,1'-carbonylbis-1H-imidazole (19.0 g, 116.9 mmol) was added.
Heated to reflux for a minute. After cooling the reaction solution, monoethyl magnesium malonate (16.8 g, 58.5 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. 1N hydrochloric acid (20
0 ml), and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed with brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1), and ethyl 3- (6-fluoro-2-pyridyl) -3-oxopropionate (20.16 g, 90%) was obtained as a brown oil. Obtained as a product. 1 H-NMR (CDCl 3 ) δ: 1.20-1.40 (3H, m), 4.13 (2H × 2 /
3, s), 4.14-4.34 (2H, m), 6.30 (1H × 1/3, s), 6.96-
7.04 (1H × 1/3, m), 7.12-7.24 (1H × 2/3, m), 7.78-8.
04 (2H, m), 12.32 (1H × 1/3, s) .IRνmax KBr cm -1 : 1744, 1709, 1651, 1593, 1578, 145
. 3. Anal Calcd for C 10 H 10 FNO 3: C, 56.87; H, 4.77 Found: C, 56.74; H, 4.73 3) 3- (1,1,2,2- tetrafluoroethoxy)
To a solution of toluene (7.51 g, 35.6 mmol) in carbon tetrachloride (100 ml) was added N-bromosuccinimide (7.60 g, 42.7 mmol) and 2,2′-azobis (isobutyronitrile) (290 mg, (1.78 mmol) and heated to reflux for 4 hours. After cooling, the reaction solution was filtered, and the filtrate was concentrated to prepare 3- (1,1,2,2-tetrafluoroethoxy) -α-bromotoluene. 3
1,2- (6-fluoropyridin-2-yl) -3-oxopropionate ethyl (7.51 g, 35.6 mmol)
Sodium hydride (60% oily, 1.42 g, 35.6 mmol) was added to a solution of -dimethoxyethane (70 ml) under ice cooling, and the mixture was stirred at room temperature for 30 minutes. 3- (1,1,2,2-tetrafluoroethoxy) previously prepared in the reaction solution
1,2-dimethoxyethane of -α-bromotoluene (10
ml) solution was added dropwise and the reaction was stirred at room temperature for 1 hour.
The reaction solution was poured into water (100 ml), and ethyl acetate (1
00 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene: hexane = 1: 1) to give 3- (6-fluoropyridin-2-yl) -3-oxo-2-((3- (1,
Ethyl 1,2,2-tetrafluoroethoxy) phenyl) methyl) propionate (7.74 g, 52%) was obtained as a colorless oil. 1 H-NMR (CDCl 3 ) δ: 1.13 (3H, t, J = 9.0 Hz), 3.20-
3.44 (2H, m), 4.11 (2H, q, J = 9.0 Hz), 4.98 (1H,
t, J = 7.4 Hz), 5.89 (1H, tt, J = 53.0, 3.0 Hz),
7.00-7.32 (5H, m), 7.90-8.04 (2H, m) .IRνmax KBr cm -1 : 1732, 1705, 1593, 1453.Anal.Calcd for C 19 H 16 F 5 NO 4 : C, 54.68; H , 3.86; N,
3.36 Found: C, 54.55; H, 3.92; N, 3.51.4) In a solution of zinc chloride (4.19 g, 30.7 mmol) in diethyl ether (100 ml), sodium borohydride (2.33 g, 61.4 mmol) was added. ) And stirred at room temperature for 30 minutes. The insoluble material was removed by filtration, and the filtrate was treated with 3- (6-fluoropyridin-2-yl) -3-oxo-2-((3-
Ethyl (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) propionate (6.41 g, 15.
4 mmol) in diethyl ether (50 ml).
The mixture was added at 78 ° C and stirred for 30 minutes. The reaction solution was quenched by the addition of 1N hydrochloric acid, water (100 ml) was added, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1),
3- (6-fluoropyridin-2-yl) -3-hydroxy-
Ethyl 2-((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) propionate ((2R
(S, 3RS) body: (2RS, 3SR) body = 6: 1,5.
(70 g, 88%) as a colorless oil. 1 H-NMR (CDCl 3 ) δ: 0.96-1.00 (3H, m), 2.87 (1H, dd,
J = 5.0 Hz), 2.96-3.14 (1H, m), 3.20-3.40 (1H,
m), 3.76 (1H, d, J = 5.6 Hz), 3.90-4.04 (2H, m),
4.76 (1H × 1/7, dd, J = 9.6, 4.4 Hz), 5.00-5.08 (1H
× 6/7, m), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.83
(1H, dd, J = 8.0, 2.6 Hz), 6.90-7.36 (5H, m), 7.70-
7.86 (1H, m) .IRνmax KBr cm -1 : 1728, 1607, 1578, 1454.Anal.Calcd for C 19 H 18 F 5 NO 4 : C, 54.42; H, 4.33; N,
3.34 Found: C, 54.34; H, 4.37; N, 3.29.5) (2RS, 3RS) -3- (6-fluoropyridine-
2-yl) -3-hydroxy-2-((3- (1,1,2,2
-Tetrafluoroethoxy) phenyl) methyl) ethyl propionate (5.5 g, 13.1 mmol, (2R
To a solution of (S, 3RS) form: (2RS, 3SR) form = 6: 1) in methanol (25 ml), 2N aqueous sodium hydroxide solution (13.1 ml, 26.2 mmol) was added and stirred at room temperature for 2 hours. . The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (2RS, 3RS) -3- (6-fluoropyridin-2-yl) -3-hydroxy-2-((3-
(1,1,2,2-tetrafluoroethoxy) phenyl) methyl) propionic acid (3.82 g, 74%) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.85 (1H, dd, J = 14.0, 5.2 Hz),
3.08 (1H, dd, J = 14.0, 9.0 Hz), 3.26-3.38 (1H,
m), 5.12 (1H, d, J = 4.4 Hz), 5.88 (1H, tt, J = 53.
0, 3.0 Hz), 6.81 (1H, dd, J = 8.2, 2.6 Hz), 6.90-
7.04 (3H, m), 7.18 (1H, d, J = 7.6 Hz), 7.27 (1H,
. dd, J = 7.2, 2.2 Hz), 7.70-7.82 (1H, m) IRνmax KBr cm -1:. 1713, 1609, 1580, 1489, 1456. mp 103-104 ℃ Anal Calcd for C 17 H 14 F 5 NO 4 : C, 52.18; H, 3.61; N,
3.58 Found: C, 52.16; H, 3.57; N, 3.57.6.) (2RS, 3RS) -3- (6-fluoropyridine-)
2-yl) -3-hydroxy-2-((3- (1,1,2,2
To a solution of -tetrafluoroethoxy) phenyl) methyl) propionic acid (3.6 g, 9.20 mmol) in tetrahydrofuran (90 ml), diphenylphosphoryl azide (2.18 ml, 10.1 mmol) and triethylamine (1.93 ml, 13 (0.8 mmol) and heated under reflux for 2 hours. After allowing the reaction mixture to cool, water (200 ml) was added, and the mixture was extracted with ethyl acetate (100 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Purification with ethyl acetate = 1: 1) and recrystallization from ethyl acetate-hexane gave (4RS, 5RS) -5- (6-fluoropyridin-2-yl) -4-((3- (1,1 , 2,2-
Tetrafluoroethoxy) phenyl) methyl) -1,3-
Oxazolidin-2-one (2.34 g, 65%) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.14 (1H, dd, J = 13.6, 9.0 Hz),
2.58 (1H, dd, J = 13.6, 3.2 Hz), 4.36-4.50 (1H,
m), 5.13 (1H, s), 5.78 (1H, d, J = 8.0 Hz), 5.91
(1H, tt, J = 53.0, 3.0 Hz), 6.90-7.20 (4H, m), 7.2
6-7.42 (1H, m), 7.52 (1H, d, J = 5.2 Hz), 7.86-8.0
0 (1H, m) .IRνmax KBr cm -1 : 1767, 1607, 1584, 1489, 1458, 144
7.mp 118-119 ℃ Anal.Calcd for C 17 H 13 F 5 N 2 O 3 : C, 52.59; H, 3.37;
N, 7.21 Found: C, 52.60; H, 3.31; N, 7.35.7) (4RS, 5RS) -5- (6-fluoropyridine-
Acetonitrile of 2-yl) -4-((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) -1,3-oxazolidin-2-one (2.2 g, 5.67 mmol) (20 ml) solution in di-t-butyl dicarbonate (1.4).
8 g, 6.80 mmol) and dimethylaminopyridine (70 mg, 0.57 mmol) were added, and the mixture was stirred at room temperature for 2 hours. Water (50 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give (4RS, 5RS) -5- (6-fluoropyridin-2-yl) -2. -Oxo-4-((3-
1,1-Dimethylethyl (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) -1,3-oxazolidine-3-carboxylate (2.59 g, 94%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.45 (9H, s), 2.65 (1H, dd, J =
14.2, 7.4 Hz), 2.84 (1H, dd, J = 14.2, 5.8 Hz), 4.
97-5.08 (1H, m), 5.61 (1H, d, J = 6.4 Hz), 5.88 (1
H, tt, J = 53.0, 3.0 Hz), 6.53 (1H, s), 6.75 (1H,
d, J = 7.6 Hz), 6.88 (1H, dd, J = 8.0, 2.6 Hz), 7.0
2 (1H, d, J = 9.6 Hz), 7.10-7.22 (1H, m), 7.43 (1H,
dd, J = 7.4, 2.6 Hz), 7.80-7.94 (1H, m).
KBr cm -1 : 1823, 1728, 1607, 1584, 1460, 1447.mp 96-97 ° C Anal.Calcd for C 22 H 21 F 5 N 2 O 5 : C, 54.10; H, 4.33;
N, 5.74 Found: C, 54.14; H, 4.25; N, 5.78.8) (4RS, 5RS) -5- (6-fluoropyridine-
1,1-dimethylethyl 2-yl) -2-oxo-4-((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) -1,3-oxazolidine-3-carboxylate ( 2.40 g (4.91 mmol) of methanol (12
0.5N sodium hydroxide in methanol (11.8 ml, 5.90 mmol) was added to the mixture at room temperature.
Minutes. Water (50 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was recrystallized from ethyl acetate-hexane to give the title compound (1.92 g, 84%). 1 H-NMR (CDCl 3 ) δ: 1.37 (9H, s), 2.65 (1H, dd, J =
13.6, 5.0 Hz), 2.85 (1H, dd, J = 13.6, 9.0 Hz), 4.
08-4.30 (1H, m), 4.45 (1H, d, J = 6.0 Hz), 4.88-5.
02 (2H, m), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.85
(1H, dd, J = 8.0, 2.2 Hz), 6.90-7.10 (3H, m), 7.10
-7.32 (2H, m), 7.70-7.86 (1H, m) .IRνmax KBr cm -1 : 1682, 1607, 1576, 1532, 1487, 145
4.mp 140-141 ℃ Anal. Calcd for C 21 H 23 F 5 N 2 O 4 : C, 54.55; H, 5.01;
N, 6.06 Found: C, 54.27; H, 4.71; N, 6.12.
【0354】実施例222 N-((1RS,2RS)-2-(6-フルオロピリジン-
2-イル)-2-ヒドロキシ-1-((3-(1,1,2,2
-テトラフルオロエトキシ)フェニル)メチル)エチ
ル)-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテ
ン-1-カルボキサミド 1) 1,1-ジメチルエチル(1RS,2RS)-2-
(6-フルオロピリジン-2-イル)-2-ヒドロキシ-1-
((3-(1,1,2,2-テトラフルオロエトキシ)フ
ェニル)メチル)エチルカルバメート(1.6g,3.
46ミリモル)にトリフルオロ酢酸(20ml)を加
え、室温で10分攪拌した。反応液を減圧下濃縮後、1
N水酸化ナトリウム水溶液(10ml)を加え、酢酸エ
チル(20ml×2)で抽出した。抽出液を飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し、
(1RS,2RS)-2-アミノ-1-(6-フルオロピリ
ジン-2-イル)-3-(3-(1,1,2,2-テトラフル
オロエトキシ)フェニル)-1-プロパノール(1.3
g,100%)を得た。1 H-NMR (CDCl3)δ: 2.47 (1H, dd, J = 13.8, 10.0 H
z), 2.73 (1H, dd, J = 13.8, 3.4 Hz), 3.40-3.54 (1
H, m), 4.70 (1H, d, J = 4.4 Hz), 5.90 (1H, tt,J =
53.0, 3.0 Hz), 6.86 (1H, dd, J = 8.0, 2.6 Hz), 6.9
6-7.18 (3H, m), 7.20-7.40 (2H, m), 7.78-7.92 (1H,
m). IRνmaxKBrcm-1: 1755, 1607, 1578, 1489, 1454. Anal. Calcd for C16H15F5N2O2: C, 53.04; H, 4.17;
N, 7.73 Found: C, 53.19; H, 4.40; N, 7.51. 2) (1RS,2RS)-2-アミノ-1-(6-フルオ
ロピリジン-2-イル)-3-(3-(1,1,2,2-テト
ラフルオロエトキシ)フェニル)-1-プロパノール(3
00mg,0.83ミリモル)のアセトニトリル(20
ml)溶液に6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボン酸(156mg,0.83ミリ
モル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(238mg,1.24ミ
リモル)および1-ヒドロキシ-1H-ベンゾトリアゾー
ル(127mg,0.83ミリモル)を加えて室温で終
夜攪拌した。反応液を水(100ml)で希釈し、酢酸
エチル(100ml×2)で抽出した。抽出液を1規定
塩酸、1規定水酸化ナトリウム水溶液、飽和食塩水で順
次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて、
表題化合物(293mg,66%)を得た。1 H-NMR (CDCl3)δ: 1.92-2.10 (2H, m), 2.12-2.26 (2
H, m), 2.60-2.70 (2H, m), 2.81 (1H, dd, J = 14.6,
5.2 Hz), 3.03 (1H, dd, J = 14.6, 9.8 Hz), 4.66-4.8
2 (1H, m), 4.84 (1H, d, J = 5.8 Hz), 5.02-5.10 (1
H, m), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 5.90-6.02
(1H, m), 6.18-6.32 (2H, m), 6.86 (1H, dd, J = 8.0,
2.6 Hz), 7.00-7.30 (7H, m), 7.42 (1H, dd, J = 7.
4, 2.2 Hz), 7.76−7.90 (1H, m). IRνmaxKBrcm-1: 1642, 1607, 1578, 1516, 1454. mp 151-152℃ Anal. Calcd for C28H25F5N2O3・0.2H2O: C, 62.73; H,
4.78; N, 5.23 Found: C, 62.75; H, 4.75; N, 5.31.Example 222 N-((1RS, 2RS) -2- (6-fluoropyridine-
2-yl) -2-hydroxy-1-((3- (1,1,2,2
-Tetrafluoroethoxy) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1) 1,1-dimethylethyl (1RS, 2RS) -2-
(6-fluoropyridin-2-yl) -2-hydroxy-1-
((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) ethyl carbamate (1.6 g, 3.
Trifluoroacetic acid (20 ml) was added to the mixture, and the mixture was stirred at room temperature for 10 minutes. After concentrating the reaction solution under reduced pressure, 1
An aqueous solution of N sodium hydroxide (10 ml) was added, and the mixture was extracted with ethyl acetate (20 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and then distilled off under reduced pressure.
(1RS, 2RS) -2-amino-1- (6-fluoropyridin-2-yl) -3- (3- (1,1,2,2-tetrafluoroethoxy) phenyl) -1-propanol (1. 3
g, 100%). 1 H-NMR (CDCl 3 ) δ: 2.47 (1H, dd, J = 13.8, 10.0 H
z), 2.73 (1H, dd, J = 13.8, 3.4 Hz), 3.40-3.54 (1
H, m), 4.70 (1H, d, J = 4.4 Hz), 5.90 (1H, tt, J =
53.0, 3.0 Hz), 6.86 (1H, dd, J = 8.0, 2.6 Hz), 6.9
6-7.18 (3H, m), 7.20-7.40 (2H, m), 7.78-7.92 (1H,
m) .IRνmax KBr cm -1 : 1755, 1607, 1578, 1489, 1454. Anal.Calcd for C 16 H 15 F 5 N 2 O 2 : C, 53.04; H, 4.17;
N, 7.73 Found: C, 53.19; H, 4.40; N, 7.51.2) (1RS, 2RS) -2-amino-1- (6-fluoropyridin-2-yl) -3- (3- (1,1 1,2,2-tetrafluoroethoxy) phenyl) -1-propanol (3
00 mg, 0.83 mmol) of acetonitrile (20
ml) solution, 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (156 mg, 0.83 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (238 mg) , 1.24 mmol) and 1-hydroxy-1H-benzotriazole (127 mg, 0.83 mmol) were added and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane,
The title compound (293 mg, 66%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.92-2.10 (2H, m), 2.12-2.26 (2
H, m), 2.60-2.70 (2H, m), 2.81 (1H, dd, J = 14.6,
5.2 Hz), 3.03 (1H, dd, J = 14.6, 9.8 Hz), 4.66-4.8
2 (1H, m), 4.84 (1H, d, J = 5.8 Hz), 5.02-5.10 (1
H, m), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 5.90-6.02
(1H, m), 6.18-6.32 (2H, m), 6.86 (1H, dd, J = 8.0,
2.6 Hz), 7.00-7.30 (7H, m), 7.42 (1H, dd, J = 7.
4, 2.2 Hz), 7.76-7.90 (1H, m). IRνmax KBr cm -1 : 1642, 1607, 1578, 1516, 1454.mp 151-152 ° C Anal.Calcd for C 28 H 25 F 5 N 2 O 3・ 0.2H 2 O: C, 62.73; H,
4.78; N, 5.23 Found: C, 62.75; H, 4.75; N, 5.31.
【0355】実施例223 1,1-ジメチルエチル(1RS,2SR)-2-(6-フ
ルオロピリジン-3-イル)-2-ヒドロキシ-1-((3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)エチルカルバメート 1) 2-アミノ-5-メチルピリジン(75g,693
ミリモル)の42%テトラフルオロほう酸(291m
l)溶液に亜硝酸ナトリウム(47.8g,693ミリ
モル)の水(100ml)溶液を内温が10℃を超えな
いようにドライアイス-アセトンで冷却しながら徐々に
加えた。反応液を45℃で30分攪拌後、8規定水酸化
ナトリウム水溶液(100ml)を徐々に加え、ジエチ
ルエーテル(300ml×2)で抽出した。抽出液を減
圧下濃縮後、残留物を蒸留して、2-フルオロ-5-メチ
ルピリジン(30.4g)を得た。過マンガン酸カリウ
ム(100g,632ミリモル)の水(1.2L)溶液
を80℃まで加熱し、2-フルオロ-5-メチルピリジン
(30.4g,274ミリモル)を加え、4.5時間加
熱還流した。反応液から不溶物をセライトでろ過し、ろ
液を200mlになるまで濃縮し、6規定塩酸をpHが
約3になるまで加えた。析出した結晶をろ取し、6-フ
ルオロ-3-ピリジンカルボン酸(10.58g,11
%)を得た。 mp 151-152℃ IRνmaxKBrcm-1: 3100, 1730, 1620. Anal. Calcd for C6H4FNO2: C, 51.07; H, 2.86; N, 9.
93 Found: C, 50.78; H, 2.72; N, 9.87.1 H-NMR (CDCl3)δ: 7.07 (1H, dd, J = 8.8, 2.8 Hz),
8.40-8.52 (1H, m), 8.90-9.04 (1H, m). 2) 6-フルオロ-3-ピリジンカルボン酸(9.5
g,67.3ミリモル)のテトラヒドロフラン(150
ml)溶液に1,1'-カルボニルビス-1H-イミダゾー
ル(12.0g,74.1ミリモル)を加え、80℃で
10分攪拌した。反応液を室温まで冷却後マロン酸モノ
エチルマグネシウム塩(10.6g,37.0ミリモ
ル)を加え、室温で2時間攪拌した。反応液に酢酸エチ
ル(100ml)および水(100ml)を加え、更に
水層のpHが酸性になるまで濃塩酸を加えた。反応液を
酢酸エチル(200ml×2)で抽出し、抽出液を飽和
食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減圧留
去した。残留物をシリカゲルカラムクロマトグラフィー
(ヘキサン:酢酸エチル=4:1)で精製し、3-(6-
フルオロピリジン-3-イル)-3-オキソプロピオン酸エ
チル(9.74g,68%)を褐色油状物として得た。 IRνmaxKBrcm-1: 1738, 1694, 1634, 1593, 1485. Anal. Calcd for C10H10NO3F: C, 56.87; H, 4.77; N,
6.63 Found: C, 56.79; H, 4.78; N, 6.84.1 H-NMR (CDCl3)δ: 1.27 (3H×5/7, t, J = 7.0 Hz),
1.35 (3H×2/7, t, J = 7.4 Hz), 3.99 (2H×5/7, s),
4.16-4.36 (2H, m), 5.65 (1H×2/7, s), 6.96-7.10 (1
H, m), 8.16 (1H×2/7, td, J = 9.0, 3.8 Hz), 8.39
(1H×5/7, td, J =9.0, 3.8 Hz), 8.64 (1H×2/7, d, J
= 3.8 Hz), 8.81 (1H×5/7, d, J = 3.8 Hz). 3) 3-(1,1,2,2-テトラフルオロエトキシ)
トルエン(15g,72.1ミリモル)のクロロホルム
(200ml)溶液にN-ブロモスクシンイミド(1
4.11g,79.3ミリモル)および2,2'-アゾビ
ス(イソブチロニトリル)(590mg,3.60ミリ
モル)を加え、30分加熱還流した。反応液を冷却後、
水(100ml)を加え、クロロホルムで抽出した。抽
出液を水(100ml)、飽和食塩水(100ml)で
順次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=10:1)で精製し、3-(1,
1,2,2-テトラフルオロエトキシ)-α-ブロモトル
エン(19.4g,純度56%,53%)を得た。本化
合物は更に精製することなく次の反応に用いた。 4) 3-(6-フルオロピリジン-3-イル)-3-オキソ
プロピオン酸エチル(3.83g,18.1ミリモル)
の1,2-ジメトキシエタン(30ml)溶液に水素化
ナトリウム(60%油性,725mg,18.1ミリモ
ル)を氷冷下加え、室温で30分攪拌した。反応液の中
に3-(1,1,2,2-テトラフルオロエトキシ)-α-
ブロモトルエン(9.30g,純度56%,18.1ミ
リモル)の1,2-ジメトキシエタン(10ml)溶液
を滴下し、反応液を室温で2時間攪拌した。反応液を水
(100ml)の中に注ぎ、酢酸エチル(100ml×
2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後減圧留去した。残留
物をシリカゲルカラムクロマトグラフィー(トルエン-
トルエン:酢酸エチル=5:1)で精製し、3-(6-フ
ルオロピリジン-3-イル)-3-オキソ-2-((3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)プロピオン酸エチル(6.67g,88
%)を無色油状物として得た。 IRνmaxKBrcm-1: 1738, 1694, 1590, 1487. Anal. Calcd for C19H16F5NO4: C, 54.68; H, 3.86; N,
3.36 Found: C, 54.56; H, 4.13; N, 3.51.1 H-NMR (CDCl3)δ: 1.14 (3H, t, J = 7.0 Hz), 3.36
(2H, d, J = 7.4 Hz), 4.13 (2H, q, J = 7.0 Hz), 4.5
4 (1H, d, J = 7.4 Hz), 5.89 (1H, tt, J = 53.0, 2.8
Hz), 6.98-7.20 (4H, m), 7.20-7.36 (1H, m), 8.35
(1H, td, J = 8.4,2.4 Hz), 8.82 (1H, d, J = 2.4 H
z). 5) 塩化亜鉛(4.25g,31.2ミリモル)のジ
エチルエーテル(100ml)溶液に水素化ホウ素ナト
リウム(2.36g,62.3ミリモル)を加えて室温
で30分攪拌した。不溶物をろ去し、ろ液に3-(6-フ
ルオロピリジン-3-イル)-3-オキソ-2-((3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)プロピオン酸エチル(6.50g,15.
6ミリモル)のジエチルエーテル(50ml)溶液を加
えて室温で30分攪拌した。氷冷下、反応液に1規定塩
酸を加えてクエンチし、更に水(100ml)を加え、
酢酸エチル(200ml×2)で抽出した。抽出液を水
および飽和食塩水で洗浄し、無水硫酸マグネシウムで乾
燥後減圧留去した。残留物をシリカゲルカラムクロマト
グラフィー(ヘキサン:酢酸エチル=4:1−1:1)
で精製し、(2RS,3RS)-3-(6-フルオロピリ
ジン-3-イル)-3-ヒドロキシ-2-((3-(1,1,
2,2-テトラフルオロエトキシ)フェニル)メチル)
プロピオン酸エチル((1RS,2SR)体:(1R
S,2RS)体=10:1,5.15g,79%)を無
色油状物として得た。 IRνmaxKBrcm-1: 1728, 1601, 1487. Anal. Calcd for C19H18F5NO4・0.1H2O: C, 54.19; H,
4.35; N, 3.33 Found: C, 54.10; H, 4.20; N, 3.39.1 H-NMR (CDCl3)δ: 0.95 (3H×10/11, t, J = 7.0 Hz),
1.02 (3H×1/11, t, J= 7.4 Hz), 2.80-3.16 (3H, m),
3.23 (1H, d, J = 3.0 Hz), 3.84-4.00 (2H, m), 4.80
-4.90 (1H×1/11, m), 5.09 (1H×10/11, s), 5.89 (1
H, tt, J = 53.0,3.0 Hz), 6.90-7.12 (4H, m), 7.20-
7.30 (1H, m), 7.86 (1H, td, J = 8.2, 2.6 Hz), 8.16
-8.24 (1H, m). 6) (2RS,3RS)-3-(6-フルオロピリジン-
3-イル)-3-ヒドロキシ-2-((3-(1,1,2,2
-テトラフルオロエトキシ)フェニル)メチル)プロピ
オン酸エチル(5.0g,11.9ミリモル,(2R
S,3SR)体:(2RS,3RS)体=10:1)の
メタノール(20ml)溶液に、2規定水酸化ナトリウ
ム水溶液(11.9ml,23.8ミリモル)を加えて
室温で終夜攪拌した。反応液を1規定塩酸で酸性とした
後、酢酸エチル(200ml×2)で抽出した。抽出液
を水および飽和食塩水で洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物をシリカゲルカラムクロ
マトグラフィー(酢酸エチル)で精製し、(2RS,3
RS)-3-(6-フルオロピリジン-3-イル)-3-ヒド
ロキシ-2-((3-(1,1,2,2-テトラフルオロエ
トキシ)フェニル)メチル)プロピオン酸(3.75
g,(2RS,3SR)体:(2RS,3RS)体=1
0:1,80%)をアモルファスとして得た。 IRνmaxKBrcm-1: 1715, 1607, 1593, 1487. Anal. Calcd for C17H14F5NO4: C, 52.18; H, 3.61; N,
3.58 Found: C, 52.13; H, 3.43; N, 3.57.1 H-NMR (CDCl3)δ: 2.80-3.12 (3H, m), 4.85 (1H×1/1
1, d, J = 5.2 Hz), 5.10 (1H×10/11, s), 6.88-7.12
(4H, m), 7.22 (1H, t, J = 7.6 Hz), 7.87 (1H,td, J
= 7.6, 2.2 Hz), 8.14 (1H, s). 7) (2RS,3RS)-3-(6-フルオロピリジン-
3-イル)-3-ヒドロキシ-2-((3-(1,1,2,2
-テトラフルオロエトキシ)フェニル)メチル)プロピ
オン酸(3.6g,9.20ミリモル,(2RS,3S
R)体:(2RS,3RS)体=10:1)のテトラヒ
ドロフラン(90ml)溶液に、ジフェニルホスホリル
アジド(2.18ml,10.1ミリモル)とトリエチ
ルアミン(1.93ml,13.8ミリモル)を加え、
30分加熱還流した。反応液を放冷後、水(200m
l)を加えて酢酸エチル(100ml×2)で抽出し
た。抽出液を1規定塩酸、飽和重曹水、飽和食塩水で順
次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=1:1)で精製し、(4RS,5
SR)-5-(6-フルオロピリジン-3-イル)-4-
((3-(1,1,2,2-テトラフルオロエトキシ)フ
ェニル)メチル)-1,3-オキサゾリジン-2-オン
(3.31g,(4RS,5SR)体:(4RS,5R
S)体=10:1,93%)をアモルファスとして得
た。 IRνmaxKBrcm-1: 1767, 1603, 1489. Anal. Calcd for C17H13F5N2O3: C, 52.59; H, 3.37;
N, 7.21 Found: C, 52.46; H, 3.55; N, 7.03.1 H-NMR (CDCl3)δ: 2.34 (1H, d, J = 4.0 Hz), 2.38
(1H, s), 4.04-4.20 (1H×1/11, m), 4.28-4.42 (1H×1
0/11, m), 5.25 (1H×1/11, s), 5.29 (1H×10/11, s),
5.84 (1H, d, J = 8.0 Hz), 5.91 (1H, tt, J = 53.0,
3.0 Hz), 6.86-7.18 (4H, m), 7.22-7.40 (1H, m), 7.
60-7.78 (1H×1/11, m), 7.85 (1H×10/11, td, J = 8.
2, 2.6 Hz), 8.02 (1H×1/11, s), 8.22 (1H×10/11,
s). 8) (4RS,5SR)-5-(6-フルオロピリジン-
3-イル)-4-((3-(1,1,2,2-テトラフルオ
ロエトキシ)フェニル)メチル)-1,3-オキサゾリジ
ン-2-オン(3.10g,7.98ミリモル)のアセト
ニトリル(30ml)溶液に二炭酸ジ-t-ブチル(2.
09g,9.58ミリモル)およびジメチルアミノピリ
ジン(97mg,0.80ミリモル)を加え、室温で2
時間攪拌した。反応液に水(50ml)を加えて酢酸エ
チル(50ml×2)で抽出した。抽出液を飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=4:1)で精製し、酢酸エチル−
ヘキサンから再結晶させて(4RS,5SR)-5-(6
-フルオロピリジン-3-イル)-2-オキソ-4-((3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)-1,3-オキサゾリジン-3-カルボン酸
1,1-ジメチルエチル(2.55g,65%)を得
た。 mp 138-139℃ IRνmaxKBrcm-1: 1821, 1725, 1603. Anal. Calcd for C22H21F5N2O5: C, 54.10; H, 4.33;
N, 5.74 Found: C, 54.14; H, 4.41; N, 5.77.1 H-NMR (CDCl3)δ: 1.54 (9H, s), 2.06 (1H, dd, J =
14.2, 9.6 Hz), 3.04 (1H, dd, J = 14.2, 4.0 Hz), 4.
82-4.96 (1H, m), 5.72 (1H, d, J = 6.8 Hz), 5.89 (1
H, tt, J = 53.0, 3.0 Hz), 6.52-6.62 (2H, m), 6.81
(1H, dd, J = 8.4, 2.8 Hz), 6.94-7.04 (1H, m), 7.04
-7.20 (1H, m), 7.53 (1H, td, J = 8.0,2.6 Hz), 8.05
(1H, d, J = 2.0 Hz). 9) (4RS,5SR)-5-(6-フルオロピリジン-
3-イル)-2-オキソ-4-((3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル)メチル)-1,3-オ
キサゾリジン-3-カルボン酸1,1-ジメチルエチル
(2.40g,4.91ミリモル)のメタノール(12
ml)に0.5N水酸化ナトリウムのメタノール溶液
(11.8ml,5.90ミリモル)を加え室温で10
分攪拌した。反応液に水(50ml)を加えて酢酸エチ
ル(50ml×2)で抽出した。抽出液を飽和食塩水で
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去した。
残留物を酢酸エチル−ヘキサンから再結晶させて表題化
合物(1.98g,87%)を得た。 mp 128-129℃ IRνmaxKBrcm-1: 1694, 1601, 1487. Anal. Calcd for C21H23F5N2O4: C, 54.55; H, 5.01;
N, 6.06 Found: C, 54.49; H, 5.01; N, 6.23.1 H-NMR (CDCl3)δ: 1.34 (9H, s), 2.62-2.90 (2H, m),
3.92 (1H, brs), 3.98-4.16 (1H, m), 4.62 (1H, d, J
= 7.4 Hz), 4.94 (1H, s), 5.90 (1H, tt, J =53.0,
3.0 Hz), 6.90-7.12 (4H, m), 7.22-7.32 (1H, m), 7.8
0-7.92 (1H, m),8.21 (1H, s).Example 223 1,1-Dimethylethyl (1RS, 2SR) -2- (6-fluoropyridin-3-yl) -2-hydroxy-1-((3-
(1,1,2,2-tetrafluoroethoxy) phenyl) methyl) ethyl carbamate 1) 2-amino-5-methylpyridine (75 g, 693)
Mmol) of 42% tetrafluoroboric acid (291 m
l) A solution of sodium nitrite (47.8 g, 693 mmol) in water (100 ml) was gradually added to the solution while cooling with dry ice-acetone so that the internal temperature did not exceed 10 ° C. After stirring the reaction solution at 45 ° C. for 30 minutes, an 8 N aqueous sodium hydroxide solution (100 ml) was gradually added thereto, and the mixture was extracted with diethyl ether (300 ml × 2). After the extract was concentrated under reduced pressure, the residue was distilled to obtain 2-fluoro-5-methylpyridine (30.4 g). A solution of potassium permanganate (100 g, 632 mmol) in water (1.2 L) was heated to 80 ° C., 2-fluoro-5-methylpyridine (30.4 g, 274 mmol) was added, and the mixture was heated under reflux for 4.5 hours. did. Insolubles were filtered from the reaction solution through celite, the filtrate was concentrated to 200 ml, and 6N hydrochloric acid was added until the pH was about 3. The precipitated crystals were collected by filtration, and 6-fluoro-3-pyridinecarboxylic acid (10.58 g, 11
%). mp 151-152 ° C IRνmax KBr cm -1 : 3100, 1730, 1620. Anal.Calcd for C 6 H 4 FNO 2 : C, 51.07; H, 2.86; N, 9.
93 Found:. C, 50.78; H, 2.72; N, 9.87 1 H-NMR (CDCl 3) δ: 7.07 (1H, dd, J = 8.8, 2.8 Hz),
8.40-8.52 (1H, m), 8.90-9.04 (1H, m). 2) 6-Fluoro-3-pyridinecarboxylic acid (9.5
g, 67.3 mmol) of tetrahydrofuran (150
ml) solution, 1,1′-carbonylbis-1H-imidazole (12.0 g, 74.1 mmol) was added, and the mixture was stirred at 80 ° C. for 10 minutes. After cooling the reaction solution to room temperature, monoethyl magnesium malonate (10.6 g, 37.0 mmol) was added, and the mixture was stirred at room temperature for 2 hours. Ethyl acetate (100 ml) and water (100 ml) were added to the reaction solution, and concentrated hydrochloric acid was further added until the pH of the aqueous layer became acidic. The reaction solution was extracted with ethyl acetate (200 ml × 2), the extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give 3- (6-
Ethyl fluoropyridin-3-yl) -3-oxopropionate (9.74 g, 68%) was obtained as a brown oil. IRνmax KBr cm -1 : 1738, 1694, 1634, 1593, 1485.Anal.Calcd for C 10 H 10 NO 3 F: C, 56.87; H, 4.77; N,
6.63 Found:. C, 56.79; H, 4.78; N, 6.84 1 H-NMR (CDCl 3) δ: 1.27 (3H × 5/7, t, J = 7.0 Hz),
1.35 (3H × 2/7, t, J = 7.4 Hz), 3.99 (2H × 5/7, s),
4.16-4.36 (2H, m), 5.65 (1H × 2/7, s), 6.96-7.10 (1
H, m), 8.16 (1H × 2/7, td, J = 9.0, 3.8 Hz), 8.39
(1H × 5/7, td, J = 9.0, 3.8 Hz), 8.64 (1H × 2/7, d, J
= 3.8 Hz), 8.81 (1H × 5/7, d, J = 3.8 Hz). 3) 3- (1,1,2,2-tetrafluoroethoxy)
To a solution of toluene (15 g, 72.1 mmol) in chloroform (200 ml) was added N-bromosuccinimide (1
4.11 g (79.3 mmol) and 2,2′-azobis (isobutyronitrile) (590 mg, 3.60 mmol) were added and heated under reflux for 30 minutes. After cooling the reaction solution,
Water (100 ml) was added, and the mixture was extracted with chloroform. The extract was washed successively with water (100 ml) and saturated saline (100 ml), dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1) to give 3- (1,1).
(1,2,2-tetrafluoroethoxy) -α-bromotoluene (19.4 g, purity 56%, 53%) was obtained. This compound was used for the next reaction without further purification. 4) Ethyl 3- (6-fluoropyridin-3-yl) -3-oxopropionate (3.83 g, 18.1 mmol)
To a solution of the above in 1,2-dimethoxyethane (30 ml) was added sodium hydride (60% oil, 725 mg, 18.1 mmol) under ice-cooling, and the mixture was stirred at room temperature for 30 minutes. 3- (1,1,2,2-tetrafluoroethoxy) -α-
A solution of bromotoluene (9.30 g, purity 56%, 18.1 mmol) in 1,2-dimethoxyethane (10 ml) was added dropwise, and the reaction solution was stirred at room temperature for 2 hours. The reaction solution was poured into water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (toluene-
Purification with toluene: ethyl acetate = 5: 1) and purification of 3- (6-fluoropyridin-3-yl) -3-oxo-2-((3-
Ethyl (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) propionate (6.67 g, 88
%) As a colorless oil. IRνmax KBr cm -1 : 1738, 1694, 1590, 1487.Anal.Calcd for C 19 H 16 F 5 NO 4 : C, 54.68; H, 3.86; N,
3.36 Found: C, 54.56; H, 4.13; N, 3.51. 1 H-NMR (CDCl 3 ) δ: 1.14 (3H, t, J = 7.0 Hz), 3.36
(2H, d, J = 7.4 Hz), 4.13 (2H, q, J = 7.0 Hz), 4.5
4 (1H, d, J = 7.4 Hz), 5.89 (1H, tt, J = 53.0, 2.8
Hz), 6.98-7.20 (4H, m), 7.20-7.36 (1H, m), 8.35
(1H, td, J = 8.4,2.4 Hz), 8.82 (1H, d, J = 2.4 H
z). 5) To a solution of zinc chloride (4.25 g, 31.2 mmol) in diethyl ether (100 ml) was added sodium borohydride (2.36 g, 62.3 mmol), and the mixture was stirred at room temperature for 30 minutes. The insolubles were removed by filtration, and the filtrate was treated with 3- (6-fluoropyridin-3-yl) -3-oxo-2-((3-
Ethyl (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) propionate (6.50 g, 15.
(6 mmol) in diethyl ether (50 ml) and stirred at room temperature for 30 minutes. Under ice cooling, the reaction solution was quenched by adding 1N hydrochloric acid, and water (100 ml) was further added.
Extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue is subjected to silica gel column chromatography (hexane: ethyl acetate = 4: 1-1: 1)
And purified with (2RS, 3RS) -3- (6-fluoropyridin-3-yl) -3-hydroxy-2-((3- (1,1,
2,2-tetrafluoroethoxy) phenyl) methyl)
Ethyl propionate ((1RS, 2SR) form: (1R
(S, 2RS) form = 10: 1, 5.15 g, 79%) as a colorless oil. IRνmax KBr cm -1 : 1728, 1601, 1487. Anal.Calcd for C 19 H 18 F 5 NO 4・ 0.1H 2 O: C, 54.19; H,
4.35; N, 3.33 Found:. C, 54.10; H, 4.20; N, 3.39 1 H-NMR (CDCl 3) δ: 0.95 (3H × 10/11, t, J = 7.0 Hz),
1.02 (3H × 1/11, t, J = 7.4 Hz), 2.80-3.16 (3H, m),
3.23 (1H, d, J = 3.0 Hz), 3.84-4.00 (2H, m), 4.80
-4.90 (1H × 1/11, m), 5.09 (1H × 10/11, s), 5.89 (1
H, tt, J = 53.0,3.0 Hz), 6.90-7.12 (4H, m), 7.20-
7.30 (1H, m), 7.86 (1H, td, J = 8.2, 2.6 Hz), 8.16
-8.24 (1H, m). 6) (2RS, 3RS) -3- (6-fluoropyridine-
3-yl) -3-hydroxy-2-((3- (1,1,2,2
Ethyl-tetrafluoroethoxy) phenyl) methyl) propionate (5.0 g, 11.9 mmol, (2R
To a solution of (S, 3SR) form: (2RS, 3RS) form = 10: 1) in methanol (20 ml), 2N aqueous sodium hydroxide solution (11.9 ml, 23.8 mmol) was added and stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) to give (2RS, 3
RS) -3- (6-Fluoropyridin-3-yl) -3-hydroxy-2-((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) propionic acid (3.75)
g, (2RS, 3SR) body: (2RS, 3RS) body = 1
(0: 1, 80%) as amorphous. IRνmax KBr cm -1 : 1715, 1607, 1593, 1487.Anal.Calcd for C 17 H 14 F 5 NO 4 : C, 52.18; H, 3.61; N,
3.58 Found:. C, 52.13; H, 3.43; N, 3.57 1 H-NMR (CDCl 3) δ: 2.80-3.12 (3H, m), 4.85 (1H × 1/1
1, d, J = 5.2 Hz), 5.10 (1H × 10/11, s), 6.88-7.12
(4H, m), 7.22 (1H, t, J = 7.6 Hz), 7.87 (1H, td, J
= 7.6, 2.2 Hz), 8.14 (1H, s). 7) (2RS, 3RS) -3- (6-fluoropyridine-
3-yl) -3-hydroxy-2-((3- (1,1,2,2
-Tetrafluoroethoxy) phenyl) methyl) propionic acid (3.6 g, 9.20 mmol, (2RS, 3S
R) form: (2RS, 3RS) form = 10: 1) to a tetrahydrofuran (90 ml) solution was added diphenylphosphoryl azide (2.18 ml, 10.1 mmol) and triethylamine (1.93 ml, 13.8 mmol). ,
The mixture was refluxed for 30 minutes. After allowing the reaction solution to cool, water (200 m
1) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1) to give (4RS, 5
SR) -5- (6-Fluoropyridin-3-yl) -4-
((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) -1,3-oxazolidin-2-one (3.31 g, (4RS, 5SR) form: (4RS, 5R)
S) form = 10: 1, 93%) was obtained as amorphous. IRνmax KBr cm -1 : 1767, 1603, 1489. Anal.Calcd for C 17 H 13 F 5 N 2 O 3 : C, 52.59; H, 3.37;
N, 7.21 Found:. C, 52.46; H, 3.55; N, 7.03 1 H-NMR (CDCl 3) δ: 2.34 (1H, d, J = 4.0 Hz), 2.38
(1H, s), 4.04-4.20 (1H × 1/11, m), 4.28-4.42 (1H × 1
0/11, m), 5.25 (1H × 1/11, s), 5.29 (1H × 10/11, s),
5.84 (1H, d, J = 8.0 Hz), 5.91 (1H, tt, J = 53.0,
3.0 Hz), 6.86-7.18 (4H, m), 7.22-7.40 (1H, m), 7.
60-7.78 (1H × 1/11, m), 7.85 (1H × 10/11, td, J = 8.
2, 2.6 Hz), 8.02 (1H × 1/11, s), 8.22 (1H × 10/11,
s). 8) (4RS, 5SR) -5- (6-fluoropyridine-
Acetonitrile of 3-yl) -4-((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) -1,3-oxazolidin-2-one (3.10 g, 7.98 mmol) (30 ml) solution in di-t-butyl dicarbonate (2.
09 g, 9.58 mmol) and dimethylaminopyridine (97 mg, 0.80 mmol) were added at room temperature.
Stirred for hours. Water (50 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give ethyl acetate-
Recrystallized from hexane to give (4RS, 5SR) -5- (6
-Fluoropyridin-3-yl) -2-oxo-4-((3-
There was obtained 1,1-dimethylethyl (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) -1,3-oxazolidine-3-carboxylate (2.55 g, 65%). mp 138-139 ° C IRνmax KBr cm -1 : 1821, 1725, 1603. Anal.Calcd for C 22 H 21 F 5 N 2 O 5 : C, 54.10; H, 4.33;
N, 5.74 Found:. C, 54.14; H, 4.41; N, 5.77 1 H-NMR (CDCl 3) δ: 1.54 (9H, s), 2.06 (1H, dd, J =
14.2, 9.6 Hz), 3.04 (1H, dd, J = 14.2, 4.0 Hz), 4.
82-4.96 (1H, m), 5.72 (1H, d, J = 6.8 Hz), 5.89 (1
H, tt, J = 53.0, 3.0 Hz), 6.52-6.62 (2H, m), 6.81
(1H, dd, J = 8.4, 2.8 Hz), 6.94-7.04 (1H, m), 7.04
-7.20 (1H, m), 7.53 (1H, td, J = 8.0,2.6 Hz), 8.05
(1H, d, J = 2.0 Hz). 9) (4RS, 5SR) -5- (6-fluoropyridine-
1,1-dimethylethyl 3-yl) -2-oxo-4-((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) -1,3-oxazolidine-3-carboxylate 2.40 g (4.91 mmol) of methanol (12
0.5N sodium hydroxide in methanol (11.8 ml, 5.90 mmol) was added to the mixture at room temperature.
Minutes. Water (50 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was recrystallized from ethyl acetate-hexane to give the title compound (1.98 g, 87%). mp 128-129 ° C IRνmax KBr cm -1 : 1694, 1601, 1487. Anal.Calcd for C 21 H 23 F 5 N 2 O 4 : C, 54.55; H, 5.01;
N, 6.06 Found:. C, 54.49; H, 5.01; N, 6.23 1 H-NMR (CDCl 3) δ: 1.34 (9H, s), 2.62-2.90 (2H, m),
3.92 (1H, brs), 3.98-4.16 (1H, m), 4.62 (1H, d, J
= 7.4 Hz), 4.94 (1H, s), 5.90 (1H, tt, J = 53.0,
3.0 Hz), 6.90-7.12 (4H, m), 7.22-7.32 (1H, m), 7.8
0-7.92 (1H, m), 8.21 (1H, s).
【0356】実施例224 N-((1RS,2SR)-2-(6-フルオロピリジン-
3-イル)-2-ヒドロキシ-1-((3-(1,1,2,2
-テトラフルオロエトキシ)フェニル)メチル)エチ
ル)-4-フルオロ-1-ナフタレンカルボキサミド 1) 1,1-ジメチルエチル(1RS,2SR)-2-
(6-フルオロピリジン-3-イル)-2-ヒドロキシ-1-
((3-(1,1,2,2-テトラフルオロエトキシ)フ
ェニル)メチル)エチルカルバメート(1.0g,2.
16ミリモル)にトリフルオロ酢酸(10ml)を加
え、室温で10分攪拌した。反応液を減圧下濃縮後、1
N水酸化ナトリウム水溶液(10ml)を加え、酢酸エ
チル(20ml×2)で抽出した。抽出液を飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物を酢酸エチル−ヘキサンから再結晶させて
(1RS,2SR)-2-アミノ-1-(6-フルオロピリ
ジン-3-イル)-3-(3-(1,1,2,2-テトラフル
オロエトキシ)フェニル)-1-プロパノール(750m
g,96%)を得た。 mp 103-104℃ IRνmaxKBrcm-1: 1597, 1485, 1449, 1399. Anal. Calcd for C16H15F5N2O2: C, 53.04; H, 4.17;
N, 7.73 Found: C, 52.97; H, 4.17; N, 7.84.1 H-NMR (CDCl3)δ: 2.38 (1H, dd, J = 13.4, 10.4 H
z), 2.74 (1H, dd, J = 13.4, 3.0 Hz), 3.28-3.40 (1
H, m), 4.76 (1H, d, J = 4.4 Hz), 5.90 (1H, tt,J =
53.0, 3.0 Hz), 6.90-7.12 (4H, m), 7.22-7.40 (1H,
m), 7.88 (1H, td, J= 8.2, 2.6 Hz), 8.23 (1H, s). 2) (1RS,2SR)-2-アミノ-1-(6-フルオ
ロピリジン-3-イル)-3-(3-(1,1,2,2-テト
ラフルオロエトキシ)フェニル)-1-プロパノール(1
91mg,0.53ミリモル)のアセトニトリル(20
ml)溶液に4-フルオロナフタレンカルボン酸(10
0mg,0.53ミリモル)および1-エチル-3-(3-
ジメチルアミノプロピル)カルボジイミド・塩酸塩(1
51mg,0.79ミリモル)および1-ヒドロキシ-1
H-ベンゾトリアゾール(81mg,0.53ミリモ
ル)を加えて室温で終夜攪拌した。反応液を水(100
ml)で希釈し、酢酸エチル(100ml×2)で抽出
した。抽出液を1規定塩酸、1規定水酸化ナトリウム水
溶液、飽和食塩水で順次洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物を酢酸エチル−ヘキサン
から再結晶させて、表題化合物(130mg,48%)
を得た。 mp 148-149℃ IRνmaxKBrcm-1: 1640, 1626, 1601, 1514, 1485. Anal. Calcd for C27H20F6N2O3: C, 60.68; H, 3.77;
N, 5.24 Found: C, 60.87; H, 3.87; N, 5.11.1 H-NMR (CDCl3)δ: 2.84 (1H, dd, J = 14.2, 10.6 H
z), 3.09 (1H, dd, J = 14.2, 4.0 Hz), 4.02 (1H, br
s), 4.64-4.82 (1H, m), 5.15 (1H, d, J = 4.0 Hz),
5.89 (1H, tt, J = 53.0, 3.0 Hz), 5.97 (1H, d, J =
8.4 Hz), 6.90-7.70 (9H, m), 7.78-7.90 (1H, m), 7.9
7 (1H, td, J = 8.0, 2.2 Hz), 8.09 (1H, d,J = 7.2 H
z), 8.26 (1H, s).Example 224 N-((1RS, 2SR) -2- (6-fluoropyridine-
3-yl) -2-hydroxy-1-((3- (1,1,2,2
-Tetrafluoroethoxy) phenyl) methyl) ethyl) -4-fluoro-1-naphthalenecarboxamide 1) 1,1-dimethylethyl (1RS, 2SR) -2-
(6-fluoropyridin-3-yl) -2-hydroxy-1-
((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) ethyl carbamate (1.0 g, 2.
(16 mmol) was added with trifluoroacetic acid (10 ml), and the mixture was stirred at room temperature for 10 minutes. After concentrating the reaction solution under reduced pressure, 1
An aqueous solution of N sodium hydroxide (10 ml) was added, and the mixture was extracted with ethyl acetate (20 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR) -2-amino-1- (6-fluoropyridin-3-yl) -3- (3- (1,1,2,2-tetra (Fluoroethoxy) phenyl) -1-propanol (750m
g, 96%). mp 103-104 ° C IRνmax KBr cm -1 : 1597, 1485, 1449, 1399. Anal.Calcd for C 16 H 15 F 5 N 2 O 2 : C, 53.04; H, 4.17;
N, 7.73 Found:. C, 52.97; H, 4.17; N, 7.84 1 H-NMR (CDCl 3) δ: 2.38 (1H, dd, J = 13.4, 10.4 H
z), 2.74 (1H, dd, J = 13.4, 3.0 Hz), 3.28-3.40 (1
H, m), 4.76 (1H, d, J = 4.4 Hz), 5.90 (1H, tt, J =
53.0, 3.0 Hz), 6.90-7.12 (4H, m), 7.22-7.40 (1H,
m), 7.88 (1H, td, J = 8.2, 2.6 Hz), 8.23 (1H, s). 2) (1RS, 2SR) -2-amino-1- (6-fluoropyridin-3-yl) -3 -(3- (1,1,2,2-tetrafluoroethoxy) phenyl) -1-propanol (1
91 mg, 0.53 mmol) of acetonitrile (20
ml) solution with 4-fluoronaphthalenecarboxylic acid (10
0 mg, 0.53 mmol) and 1-ethyl-3- (3-
Dimethylaminopropyl) carbodiimide hydrochloride (1
51 mg, 0.79 mmol) and 1-hydroxy-1
H-benzotriazole (81 mg, 0.53 mmol) was added and the mixture was stirred at room temperature overnight. The reaction solution was washed with water (100
ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (130 mg, 48%).
I got mp 148-149 ° C IRνmax KBr cm -1 : 1640, 1626, 1601, 1514, 1485. Anal.Calcd for C 27 H 20 F 6 N 2 O 3 : C, 60.68; H, 3.77;
N, 5.24 Found:. C, 60.87; H, 3.87; N, 5.11 1 H-NMR (CDCl 3) δ: 2.84 (1H, dd, J = 14.2, 10.6 H
z), 3.09 (1H, dd, J = 14.2, 4.0 Hz), 4.02 (1H, br
s), 4.64-4.82 (1H, m), 5.15 (1H, d, J = 4.0 Hz),
5.89 (1H, tt, J = 53.0, 3.0 Hz), 5.97 (1H, d, J =
8.4 Hz), 6.90-7.70 (9H, m), 7.78-7.90 (1H, m), 7.9
7 (1H, td, J = 8.0, 2.2 Hz), 8.09 (1H, d, J = 7.2 H
z), 8.26 (1H, s).
【0357】実施例225 N-((1RS,2SR)-2-(6-フルオロピリジン-
3-イル)-2-ヒドロキシ-1-((3-(1,1,2,2
-テトラフルオロエトキシ)フェニル)メチル)エチ
ル)-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテ
ン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(6-フルオロピリ
ジン-3-イル)-3-(3-(1,1,2,2-テトラフル
オロエトキシ)フェニル)-1-プロパノール(193m
g,0.53ミリモル)のアセトニトリル(20ml)
溶液に6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプ
テン-1-カルボン酸(100mg,0.53ミリモル)
および1-エチル-3-(3-ジメチルアミノプロピル)カ
ルボジイミド・塩酸塩(153mg,0.80ミリモ
ル)および1-ヒドロキシ-1H-ベンゾトリアゾール
(81mg,0.53ミリモル)を加えて室温で終夜攪
拌した。反応液を水(100ml)で希釈し、酢酸エチ
ル(100ml×2)で抽出した。抽出液を1規定塩
酸、1規定水酸化ナトリウム水溶液、飽和食塩水で順次
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去した。
残留物を酢酸エチル−ヘキサンから再結晶させて、表題
化合物(232mg,82%)を得た。 mp 140-142℃ IRνmaxKBrcm-1: 1636, 1597, 1487.1 H-NMR (CDCl3)δ: 1.90-2.10 (2H, m), 2.10-2.28 (2
H, m), 2.58-2.72 (2H, m), 2.79 (1H, dd, J = 14.4,
10.8 Hz), 3.03 (1H, dd, J = 14.4, 4.0 Hz), 4.26 (1
H, brs), 4.58-4.74 (1H, m), 5.07 (1H, d, J = 3.6 H
z), 5.80 (1H, d,J = 7.6 Hz), 5.89 (1H, tt, J = 53.
0, 3.0 Hz), 5.90-6.00 (1H, m), 6.10-6.24 (1H, m),
6.90-7.22 (7H, m), 7.22-7.40 (1H, m), 7.94 (1H, t
d, J = 8.0,2.2 Hz), 8.23 (1H, s).Example 225 N-((1RS, 2SR) -2- (6-fluoropyridine-
3-yl) -2-hydroxy-1-((3- (1,1,2,2
-Tetrafluoroethoxy) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (6-fluoropyridin-3-yl ) -3- (3- (1,1,2,2-tetrafluoroethoxy) phenyl) -1-propanol (193 m
g, 0.53 mmol) of acetonitrile (20 ml)
6,7-Dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (100 mg, 0.53 mmol) was added to the solution.
And 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (153 mg, 0.80 mmol) and 1-hydroxy-1H-benzotriazole (81 mg, 0.53 mmol) were added, and the mixture was stirred at room temperature overnight. did. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was recrystallized from ethyl acetate-hexane to give the title compound (232 mg, 82%). mp 140-142 ° C IRνmax KBr cm -1 : 1636, 1597, 1487. 1 H-NMR (CDCl 3 ) δ: 1.90-2.10 (2H, m), 2.10-2.28 (2
H, m), 2.58-2.72 (2H, m), 2.79 (1H, dd, J = 14.4,
10.8 Hz), 3.03 (1H, dd, J = 14.4, 4.0 Hz), 4.26 (1
H, brs), 4.58-4.74 (1H, m), 5.07 (1H, d, J = 3.6 H
z), 5.80 (1H, d, J = 7.6 Hz), 5.89 (1H, tt, J = 53.
0, 3.0 Hz), 5.90-6.00 (1H, m), 6.10-6.24 (1H, m),
6.90-7.22 (7H, m), 7.22-7.40 (1H, m), 7.94 (1H, t
d, J = 8.0, 2.2 Hz), 8.23 (1H, s).
【0358】実施例226 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[4-(トリフルオロメチル)ベン
ジル]エチル]ナフタレン-1-カルボキサミドの光学分
割 ラセミ体を光学活性カラム(キラルセルOD、50mmID
×500mmL)を用いた高速液体クロマトグラフィーに
より光学分割(移動層:ヘキサン/エタノール=9/
1)した後、エタノールより再結晶して、各光学異性体
を得た。 (1R,2S)体 mp 239-240℃; [α]D 20 +37.3°(c = 0.507, MeOH); 1H
-NMR (CDCl3-CD3OD, 200MHz) δ 2.85 (1H, dd, J = 1
0.8 Hz, 14.0 Hz), 3.08 (1H, dd, J = 3.6 Hz, 13.8 H
z), 4.72-4.87 (1H, m), 5.02 (1H, d, J = 4.6 Hz),
6.79 (1H, br d, J= 8.8 Hz), 7.10 (2H, t, J = 8.6 H
z), 7.21 (1H, d, J = 7.0 Hz), 7.30-7.57(10H, m),
7.77-7.88 (2H, m); IR (KBr) 3268, 1638, 1534, 151
4, 1325, 1229, 1163, 1123, 1069, 831 cm-1; Anal. C
alcd for C27H21F4NO2: C, 69.37; H,4.53; N, 3.00. F
ound: C, 69.30; H, 4.27; N, 2.76. (1S,2R)体 mp 238-239℃; [α] D 20 -37.9°(c = 0.508, MeOH); 1
H-NMR (CDCl3-CD3OD, 200MHz) δ 2.85 (1H, dd, J = 1
1.4 Hz, 14.2 Hz), 3.09 (1H, dd, J = 3.9 Hz,13.7 H
z), 4.72-4.86 (1H, m), 5.01 (1H, d, J = 4.8 Hz),
6.90 (1H, br d, J= 9.6 Hz), 7.11 (2H, t, J = 8.8 H
z), 7.20 (1H, dd, J = 1.2 Hz, 7.0 Hz),7.29-7.57 (1
0H, m), 7.79-7.88 (2H, m); IR (KBr) 3279, 1638, 15
34, 1514,1325, 1229, 1163, 1123, 1069, 833 cm-1; A
nal. Calcd for C27H21F4NO2: C,69.37; H, 4.53; N,
3.00. Found: C, 69.28; H, 4.50; N, 2.98.Example 226 N-[(1RS, 2SR) -2- (4-fluorophenyl)
Optical Resolution of 2--2-Hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] naphthalene-1-carboxamide The racemate was converted to an optically active column (Chiralcel OD, 50 mm ID).
× 500 mmL) by high-performance liquid chromatography (mobile phase: hexane / ethanol = 9 /
After 1), recrystallization from ethanol yielded each optical isomer. (1R, 2S) form mp 239-240 ° C .; [α] D 20 + 37.3 ° (c = 0.507, MeOH); 1 H
-NMR (CDCl 3 -CD 3 OD, 200MHz) δ 2.85 (1H, dd, J = 1
0.8 Hz, 14.0 Hz), 3.08 (1H, dd, J = 3.6 Hz, 13.8 H
z), 4.72-4.87 (1H, m), 5.02 (1H, d, J = 4.6 Hz),
6.79 (1H, br d, J = 8.8 Hz), 7.10 (2H, t, J = 8.6 H
z), 7.21 (1H, d, J = 7.0 Hz), 7.30-7.57 (10H, m),
7.77-7.88 (2H, m); IR (KBr) 3268, 1638, 1534, 151
4, 1325, 1229, 1163, 1123, 1069, 831 cm -1 ; Anal. C
alcd for C 27 H 21 F 4 NO 2 : C, 69.37; H, 4.53; N, 3.00. F
ound: C, 69.30; H, 4.27; N, 2.76. (1S, 2R) form mp 238-239 ° C; [α] D 20 -37.9 ° (c = 0.508, MeOH); 1
H-NMR (CDCl 3 -CD 3 OD, 200MHz) δ 2.85 (1H, dd, J = 1
1.4 Hz, 14.2 Hz), 3.09 (1H, dd, J = 3.9 Hz, 13.7 H
z), 4.72-4.86 (1H, m), 5.01 (1H, d, J = 4.8 Hz),
6.90 (1H, br d, J = 9.6 Hz), 7.11 (2H, t, J = 8.8 H
z), 7.20 (1H, dd, J = 1.2 Hz, 7.0 Hz), 7.29-7.57 (1
0H, m), 7.79-7.88 (2H, m); IR (KBr) 3279, 1638, 15
34, 1514, 1325, 1229, 1163, 1123, 1069, 833 cm -1 ; A
nal.Calcd for C 27 H 21 F 4 NO 2 : C, 69.37; H, 4.53; N,
3.00. Found: C, 69.28; H, 4.50; N, 2.98.
【0359】実施例227 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[4-(トリフルオロ
メチル)ベンジル]エチル]ナフタレン-1-カルボキサ
ミドの光学分割 ラセミ体を光学活性カラム(キラルセルOD、50mmID
×500mmL)を用いた高速液体クロマトグラフィーに
より光学分割(移動層:ヘキサン/エタノール=95/
5)した後、エタノール-ジイソプロピルエーテルより
再結晶して、各光学異性体を得た。 (1R,2S)体 mp 251-252℃; [α] D 20 +33.4°(c = 0.499, MeOH); 1
H-NMR (CDCl3-DMSO-d6,200MHz) δ 2.92 (1H, dd, J =
11.0 Hz, 13.8 Hz), 3.19 (1H, dd, J = 3.3 Hz, 14.3
Hz), 4.62-4.76 (1H, m), 4.89 (1H, t, J = 5.2 Hz),
5.49 (1H, d, J= 4.4 Hz), 7.01-7.18 (4H, m), 7.32-
7.42 (4H, m), 7.48-7.60 (5H, m), 7.91(1H, d, J =
9.6 Hz), 8.03 (1H, d, J = 8.6 Hz); IR (KBr) 3275,
1642, 1626, 1539, 1514, 1327, 1229, 1167, 1125, 10
69, 835 cm-1; Anal. Calcd for C 27H20F5NO2: C, 66.8
0; H, 4.15; N, 2.89. Found: C, 66.55; H, 4.16; N,
2.76. (1S,2R)体 mp 252-253℃; [α] D 20 -33.9°(c = 0.504, MeOH); 1
H-NMR (CDCl3-DMSO-d6,200MHz) δ 2.93 (1H, dd, J =
11.0 Hz, 14.0 Hz), 3.15 (1H, dd, J = 3.2 Hz, 14.0
Hz), 4.66-4.79 (1H, m), 4.93 (1H, t, J = 4.8 Hz),
5.42 (1H, d, J= 3.6 Hz), 7.01-7.21 (4H, m), 7.34-
7.60 (9H, m), 7.78 (1H, d, J = 9.6 Hz), 8.04 (1H,
d, J = 8.2 Hz); IR (KBr) 3275, 1642, 1626, 1539, 1
514, 1327, 1227, 1167, 1125, 1069, 835 cm-1; Anal.
Calcd for C27H20F5NO2: C, 66.80; H, 4.15; N, 2.8
9. Found: C, 66.69; H, 4.09; N, 2.82.Example 227 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluoro
Rophenyl) -2-hydroxy-1- [4- (trifluoro
Methyl) benzyl] ethyl] naphthalene-1-carbox
Optical Resolution of Mid Racemate is converted to an optically active column (Chiral Cell OD, 50mmID
× 500mmL) for high performance liquid chromatography
More optical resolution (mobile layer: hexane / ethanol = 95 /
5) After ethanol-diisopropyl ether
Recrystallization afforded each optical isomer. (1R, 2S) form mp 251-252 ° C; [α]D 20 + 33.4 ° (c = 0.499, MeOH);1
H-NMR (CDClThree-DMSO-d6, 200MHz) δ 2.92 (1H, dd, J =
11.0 Hz, 13.8 Hz), 3.19 (1H, dd, J = 3.3 Hz, 14.3
Hz), 4.62-4.76 (1H, m), 4.89 (1H, t, J = 5.2 Hz),
5.49 (1H, d, J = 4.4 Hz), 7.01-7.18 (4H, m), 7.32-
7.42 (4H, m), 7.48-7.60 (5H, m), 7.91 (1H, d, J =
9.6 Hz), 8.03 (1H, d, J = 8.6 Hz); IR (KBr) 3275,
1642, 1626, 1539, 1514, 1327, 1229, 1167, 1125, 10
69, 835 cm-1; Anal. Calcd for C 27H20FFiveNOTwo: C, 66.8
0; H, 4.15; N, 2.89. Found: C, 66.55; H, 4.16; N,
2.76. (1S, 2R) form mp 252-253 ° C; [α]D 20 -33.9 ° (c = 0.504, MeOH);1
H-NMR (CDClThree-DMSO-d6, 200MHz) δ 2.93 (1H, dd, J =
11.0 Hz, 14.0 Hz), 3.15 (1H, dd, J = 3.2 Hz, 14.0
Hz), 4.66-4.79 (1H, m), 4.93 (1H, t, J = 4.8 Hz),
5.42 (1H, d, J = 3.6 Hz), 7.01-7.21 (4H, m), 7.34-
7.60 (9H, m), 7.78 (1H, d, J = 9.6 Hz), 8.04 (1H,
d, J = 8.2 Hz); IR (KBr) 3275, 1642, 1626, 1539, 1
514, 1327, 1227, 1167, 1125, 1069, 835 cm-1; Anal.
Calcd for C27H20FFiveNOTwo: C, 66.80; H, 4.15; N, 2.8
9. Found: C, 66.69; H, 4.09; N, 2.82.
【0360】実施例228 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]エチル]ナフ
タレン-1-カルボキサミドの光学分割 ラセミ体を光学活性カラム(キラルセルOD、50mmID
×500mmL)を用いた高速液体クロマトグラフィーに
より光学分割(移動層:ヘキサン/エタノール=95/
5)した後、酢酸エチル−ジイソプロピルエーテル−ヘ
キサンより再結晶して、各光学異性体を得た。 (1R,2S)体 mp 213-214℃; [α] D 20 +20.6°(c = 0.506, MeOH); 1
H-NMR (CDCl3-DMSO-d6,200MHz) δ 2.82-3.03 (2H, m),
4.70-4.84 (2H, m), 5.07 (1H, t, J = 3.3 Hz), 5.90
(1H, tt, J = 2.8 Hz, 53.0 Hz), 6.92 (1H, d, J =
9.4 Hz), 6.98-7.33 (8H, m), 7.42-7.57 (4H, m), 7.7
9 (1H, d, J = 8.4 Hz), 8.07 (1H, d, J= 7.4 Hz); IR
(KBr) 3270, 1642, 1624, 1601, 1537, 1512, 1235, 1
198, 1127, 835, 760 cm-1; Anal. Calcd for C28H21F6
NO3: C, 63.04; H, 3.97; N, 2.63. Found: C, 62.87;
H, 3.84; N, 2.64. (1S,2R)体 mp 213-214℃; [α] D 20 -20.6°(c = 0.520, MeOH); 1
H-NMR (CDCl3-DMSO-d6,200MHz) δ 2.82-3.03 (2H, m),
4.70-4.85 (2H, m), 5.07 (1H, t, J = 3.7 Hz), 5.90
(1H, tt, J = 2.9 Hz, 53.0 Hz), 6.92 (1H, d, J =
8.8 Hz), 6.98-7.33 (8H, m), 7.40-7.58 (4H, m), 7.8
0 (1H, d, J = 8.0 Hz), 8.07 (1H, d, J= 7.8 Hz); IR
(KBr) 3272, 1642, 1624, 1601, 1537, 1512, 1235, 1
198, 1127, 835, 760 cm-1; Anal. Calcd for C28H21F6
NO3: C, 63.04; H, 3.97; N, 2.63. Found: C, 62.97;
H, 3.87; N, 2.57.Example 228 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2,2
Optical Resolution of 2-Tetrafluoroethoxy) benzyl] ethyl] naphthalene-1-carboxamide The racemate was converted to an optically active column (Chiralcel OD, 50 mm ID).
× 500 mmL) by high-performance liquid chromatography (mobile layer: hexane / ethanol = 95 /
After 5), recrystallization from ethyl acetate-diisopropyl ether-hexane gave each optical isomer. (1R, 2S) form mp 213-214 ° C .; [α] D 20 + 20.6 ° (c = 0.506, MeOH); 1
H-NMR (CDCl 3 -DMSO-d 6 , 200MHz) δ 2.82-3.03 (2H, m),
4.70-4.84 (2H, m), 5.07 (1H, t, J = 3.3 Hz), 5.90
(1H, tt, J = 2.8 Hz, 53.0 Hz), 6.92 (1H, d, J =
9.4 Hz), 6.98-7.33 (8H, m), 7.42-7.57 (4H, m), 7.7
9 (1H, d, J = 8.4 Hz), 8.07 (1H, d, J = 7.4 Hz); IR
(KBr) 3270, 1642, 1624, 1601, 1537, 1512, 1235, 1
198, 1127, 835, 760 cm -1 ; Anal.Calcd for C 28 H 21 F 6
NO 3 : C, 63.04; H, 3.97; N, 2.63. Found: C, 62.87;
H, 3.84; N, 2.64. (1S, 2R) form mp 213-214 ° C; [α] D 20 -20.6 ° (c = 0.520, MeOH); 1
H-NMR (CDCl 3 -DMSO-d 6 , 200MHz) δ 2.82-3.03 (2H, m),
4.70-4.85 (2H, m), 5.07 (1H, t, J = 3.7 Hz), 5.90
(1H, tt, J = 2.9 Hz, 53.0 Hz), 6.92 (1H, d, J =
8.8 Hz), 6.98-7.33 (8H, m), 7.40-7.58 (4H, m), 7.8
0 (1H, d, J = 8.0 Hz), 8.07 (1H, d, J = 7.8 Hz); IR
(KBr) 3272, 1642, 1624, 1601, 1537, 1512, 1235, 1
198, 1127, 835, 760 cm -1 ; Anal.Calcd for C 28 H 21 F 6
NO 3 : C, 63.04; H, 3.97; N, 2.63. Found: C, 62.97;
H, 3.87; N, 2.57.
【0361】実施例229 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
の光学分割 ラセミ体を光学活性カラム(キラルセルOD、50mmID
×500mmL)を用いた高速液体クロマトグラフィーに
より光学分割(移動層:ヘキサン/エタノール=95/
5)した後、酢酸エチル−ジイソプロピルエーテル−ヘ
キサンより再結晶して、各光学異性体を得た。 (1R,2S)体 mp 199-200℃; [α] D 20 +20.3°(c = 0.536, MeOH); 1
H-NMR (CDCl3, 200MHz)δ 1.93-2.06 (2H, m), 2.15-2.
24 (2H, m), 2.67 (2H, t, J = 5.7 Hz), 2.79(1H, dd,
J = 10.8 Hz, 14.4 Hz), 3.00 (1H, dd, J = 3.7 Hz,
14.5 Hz), 3.59(1H, d, J = 3.6 Hz), 4.60-4.74 (1H,
m), 5.04 (1H, t, J = 3.7 Hz), 5.72(1H, d, J = 8.8
Hz), 5.89 (1H, tt, J = 2.8 Hz, 53.0 Hz), 5.91 (1H,
td, J= 5.3 Hz, 11.6 Hz), 6.21 (1H, d, J = 11.6 H
z), 6.95-7.17 (8H, m), 7.31(1H, t, J = 8.0 Hz), 7.
44 (2H, dd, J = 5.3 Hz, 8.7 Hz); IR (KBr) 3264, 16
40, 1512, 1227, 1198, 1128 cm-1; Anal. Calcd for C
29H26F5NO3: C, 65.53;H, 4.93; N, 2.64. Found: C, 6
5.52; H, 4.85; N, 2.63. (1S,2R)体 mp 200-201℃; [α] D 20 -20.8°(c = 0.544, MeOH); 1
H-NMR (CDCl3, 200MHz)δ 1.93-2.06 (2H, m), 2.15-2.
24 (2H, m), 2.67 (2H, t, J = 5.8 Hz), 2.79(1H, dd,
J = 10.6 Hz, 14.6 Hz), 3.00 (1H, dd, J = 4.3 Hz,
14.7 Hz), 3.59(1H, d, J = 3.8 Hz), 4.60-4.74 (1H,
m), 5.04 (1H, t, J = 3.7 Hz), 5.72(1H, d, J = 8.8
Hz), 5.89 (1H, tt, J = 3.0 Hz, 53.1 Hz), 5.91 (1H,
td, J= 5.3 Hz, 12.0 Hz), 6.21 (1H, d, J = 12.0 H
z), 6.95-7.17 (8H, m), 7.31(1H, t, J = 7.6 Hz), 7.
44 (2H, dd, J = 5.4 Hz, 8.6 Hz); IR (KBr) 3264, 16
37, 1512, 1227, 1198, 1130 cm-1; Anal. Calcd for C
29H26F5NO3: C, 65.53;H, 4.93; N, 2.64. Found: C, 6
5.56; H, 4.87; N, 2.64.Example 229 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
Optical Resolution of 5H-Benzo [a] cycloheptene-1-carboxamide The racemate was converted to an optically active column (Chiral Cell OD, 50 mm ID).
× 500 mmL) by high-performance liquid chromatography (mobile layer: hexane / ethanol = 95 /
After 5), recrystallization from ethyl acetate-diisopropyl ether-hexane gave each optical isomer. (1R, 2S) form mp 199-200 ° C .; [α] D 20 + 20.3 ° (c = 0.536, MeOH); 1
H-NMR (CDCl 3 , 200MHz) δ 1.93-2.06 (2H, m), 2.15-2.
24 (2H, m), 2.67 (2H, t, J = 5.7 Hz), 2.79 (1H, dd,
J = 10.8 Hz, 14.4 Hz), 3.00 (1H, dd, J = 3.7 Hz,
14.5 Hz), 3.59 (1H, d, J = 3.6 Hz), 4.60-4.74 (1H,
m), 5.04 (1H, t, J = 3.7 Hz), 5.72 (1H, d, J = 8.8
Hz), 5.89 (1H, tt, J = 2.8 Hz, 53.0 Hz), 5.91 (1H,
td, J = 5.3 Hz, 11.6 Hz), 6.21 (1H, d, J = 11.6 H
z), 6.95-7.17 (8H, m), 7.31 (1H, t, J = 8.0 Hz), 7.
44 (2H, dd, J = 5.3 Hz, 8.7 Hz); IR (KBr) 3264, 16
40, 1512, 1227, 1198, 1128 cm -1 ; Anal.Calcd for C
29 H 26 F 5 NO 3 : C, 65.53; H, 4.93; N, 2.64. Found: C, 6
5.52; H, 4.85; N, 2.63. (1S, 2R) form mp 200-201 ° C .; [α] D 20 -20.8 ° (c = 0.544, MeOH); 1
H-NMR (CDCl 3 , 200MHz) δ 1.93-2.06 (2H, m), 2.15-2.
24 (2H, m), 2.67 (2H, t, J = 5.8 Hz), 2.79 (1H, dd,
J = 10.6 Hz, 14.6 Hz), 3.00 (1H, dd, J = 4.3 Hz,
14.7 Hz), 3.59 (1H, d, J = 3.8 Hz), 4.60-4.74 (1H,
m), 5.04 (1H, t, J = 3.7 Hz), 5.72 (1H, d, J = 8.8
Hz), 5.89 (1H, tt, J = 3.0 Hz, 53.1 Hz), 5.91 (1H,
td, J = 5.3 Hz, 12.0 Hz), 6.21 (1H, d, J = 12.0 H
z), 6.95-7.17 (8H, m), 7.31 (1H, t, J = 7.6 Hz), 7.
44 (2H, dd, J = 5.4 Hz, 8.6 Hz); IR (KBr) 3264, 16
37, 1512, 1227, 1198, 1130 cm -1 ; Anal.Calcd for C
29 H 26 F 5 NO 3 : C, 65.53; H, 4.93; N, 2.64. Found: C, 6
5.56; H, 4.87; N, 2.64.
【0362】実施例230 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((5-メチル-3-(1,1,2,
2-テトラフルオロエトキシ)フェニル)メチル)エチ
ル)-4-フルオロ-1-ナフタレンカルボキサミド 1) 3,5-ジメチル1-(1,1,2,2-テトラフ
ルオロプロピルオキシ)ベンゼン(8.22g,32.
8ミリモル)の四塩化炭素(100ml)溶液にN-ブ
ロモスクシンイミド(6.42g,36.1ミリモル)
および2,2’-アゾビス(イソブチロニトリル)(2
70mg,1.64ミリモル)を加え、終夜加熱還流し
た。不溶物をセライトを用いてろ過し、ろ液を濃縮し、
ブロモ体を調製した。3-(4-フルオロフェニル)-3-
オキソプロピオン酸エチル(6.20g,29.5ミリ
モル)の1,2-ジメトキシエタン(60ml)溶液に
水素化ナトリウム(60%油性,1.18g,29.5
ミリモル)を氷冷下加え、室温で30分攪拌した。反応
液の中に先に合成したブロモ体の1,2-ジメトキシエ
タン(20ml)溶液を滴下し、反応液を室温で1時間
攪拌した。反応液を水(200ml)の中に注ぎ、酢酸
エチル(200ml×2)で抽出した。抽出液を水およ
び飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後
減圧留去した。残留物をシリカゲルカラムクロマトグラ
フィー(トルエン:ヘキサン=1:1-酢酸エチル)で
精製し、酢酸エチル-ヘキサンから再結晶させて、3-
(4-フルオロフェニル)-2-((3-メチル-5-(1,
1,2,2-テトラフルオロエトキシ)フェニル)メチ
ル)-3-オキソプロピオン酸エチル(6.68g,53
%)を得た。 mp 56-57℃ IRνmaxKBrcm-1: 1738, 1688, 1599, 1508. Anal. Calcd for C21H19F5O4: C, 58.12; H, 4.50 Found: C, 57.94; H, 4.27.1 H-NMR (CDCl3)δ: 1.13 (3H, t, J = 7.0 Hz), 2.30
(3H, s), 3.28 (2H, d, J= 7.4 Hz), 4.12 (2H, q, J =
7.0 Hz), 4.54 (1H, t, J = 7.4 Hz), 5.87 (1H, tt,
J = 53.0, 3.0 Hz), 6.87 (2H, s), 6.94 (1H, s), 7.1
2 (2H, t, J = 8.4 Hz), 7.92-8.06 (2H, m). 2) 塩化亜鉛(4.12g,30.2ミリモル)のジ
エチルエーテル(100ml)溶液に水素化ホウ素ナト
リウム(2.29g,60.4ミリモル)を加えて室温
で30分攪拌した。不溶物をろ去し、ろ液に3-(4-フ
ルオロフェニル)-2-((5-メチル-3-(1,1,
2,2-テトラフルオロエトキシ)フェニル)メチル)-
3-オキソプロピオン酸エチル(6.50g,15.1
ミリモル)のジエチルエーテル(50ml)溶液を加え
て室温で30分攪拌した。氷冷下、反応液に1規定塩酸
を加えてクエンチし、更に水(200ml)を加え、酢
酸エチル(300ml×2)で抽出した。抽出液を水お
よび飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=4:1)で精製し、
(2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-((5-メチル-3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル)メチル)プロピオン
酸エチル(6.56g,100%)を無色油状物として
得た。 IRνmaxKBrcm-1: 1715, 1605, 1512. Anal. Calcd for C21H21F5O4・0.3H2O: C, 57.62; H,
4.97 Found: C, 57.54; H, 4.85.1 H-NMR (CDCl3)δ: 0.94 (3H, t, J = 7.0 Hz), 2.29
(3H, s), 2.92-3.02 (4H,m), 3.89 (2H, q, J = 7.0 H
z), 5.00 (1H, s), 5.86 (1H, tt, J = 53.0, 3.0Hz),
6.72-6.86 (3H, m), 7.00-7.10 (2H, m), 7.30-7.42 (2
H, m). 3) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((5-メチル-3-(1,1,
2,2-トリフルオロエトキシ)フェニル)メチル)プ
ロピオン酸エチル(6.30g,14.6ミリモル)の
メタノール(50ml)溶液に、2規定水酸化ナトリウ
ム水溶液(14.6ml,29.2ミリモル)を加えて
室温で終夜攪拌した。反応液を1規定塩酸で酸性とした
後、酢酸エチル(100ml×2)で抽出した。抽出液
を水および飽和食塩水で洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物をジエチルエーテル−ヘ
キサンより再結晶させて、(2RS,3RS)-3-(4
-フルオロフェニル)-3-ヒドロキシ-2-((5-メチル
-3-(1,1,2,2-トリフルオロエトキシ)フェニ
ル)メチル)プロピオン酸(6.0g,100%)を得
た。 mp 82-83℃ IRνmaxKBrcm-1: 1713, 1607, 1512. Anal. Calcd for C19H17F5O4: C, 56.19; H, 4.26 Found: C, 56.05; H, 4.13.1 H-NMR (CDCl3)δ: 2.27 (3H, s), 2.80-3.08 (3H, m),
5.06 (1H, d, J = 4.0Hz), 5.86 (1H, tt, J = 53.0,
2.8 Hz), 6.76 (2H, d, J = 6.6 Hz), 6.84 (1H, s),
6.98-7.12 (2H, m), 7.30-7.42 (2H, m). 4) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((5-メチル-3-(1,1,
2,2-テトラフルオロエトキシ)フェニル)メチル)
プロピオン酸(5.8g,14.3ミリモル)のテトラ
ヒドロフラン(100ml)溶液に、ジフェニルホスホ
リルアジド(3.4ml,15.8ミリモル)とトリエ
チルアミン(3.0ml,21.5ミリモル)を加え、
30分加熱還流した。反応液を放冷後、水(200m
l)を加えて酢酸エチル(200ml×2)で抽出し
た。抽出液を1規定塩酸、飽和重曹水、飽和食塩水で順
次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=1:1)で精製し、酢酸エチル-
ヘキサンより再結晶させて、(4RS,5SR)-5-
(4-フルオロフェニル)-4-((5-メチル-3-(1,
1,2,2-テトラフルオロエトキシ)フェニル)メチ
ル)-1,3-オキサゾリジン-2-オン(4.1g,71
%)を得た。 mp 107-108℃ IRνmaxKBrcm-1: 1761, 1611, 1597, 1514. Anal. Calcd for C19H16F5NO3: C, 56.86; H, 4.02; N,
3.49 Found: C, 56.64; H, 4.01; N, 3.58.1 H-NMR (CDCl3)δ: 1.16-2.40 (2H, m), 2.32 (3H, s),
4.18-4.32 (1H, m), 5.12 (1H, brs), 5.79 (1H, d, J
= 7.8 Hz), 5.89 (1H, tt, J = 53.0, 3.0 Hz),6.70
(2H, d, J = 8.0 Hz), 6.91 (1H, s), 7.04-7.20 (2H,
m), 7.30-7.42 (2H, m). 5) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((5-メチル-3-(1,1,2,2-テトラフ
ルオロエトキシ)フェニル)メチル)-1,3-オキサゾ
リジン-2-オン(3.0g,7.48ミリモル)のエタ
ノール(30ml)溶液に8規定水酸化ナトリウム水溶
液(4.7ml,37.4ミリモル)を加え、3時間加
熱還流した。反応液を濃縮後、水(100ml)で希釈
し、酢酸エチル(100ml×2)で抽出した。抽出液
を飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後
減圧留去し、残留物を酢酸エチル-ヘキサンから再結晶
させて(1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(5-メチル-3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル)-1-プロパノール
(2.34g,83%)を得た。 mp 96-98℃ IRνmaxKBrcm-1: 1617, 1595, 1508, 1458. Anal. Calcd for C18H18F5NO2: C, 57.60; H, 4.83; N,
3.73 Found: C, 57.59; H, 4.79; N, 3.73.1 H-NMR (CDCl3)δ: 2.20-2.50 (1H, m), 2.32 (3H, s),
2.76 (1H, dd, J = 13.4, 3.2 Hz), 3.20-3.32 (1H,
m), 4.65 (1H, d, J = 4.8 Hz), 5.88 (1H, tt, J= 53.
0, 3.0 Hz), 6.80 (1H, s), 6.82-6.90 (2H, m), 7.00-
7.12 (2H, m), 7.30-7.42 (2H, m). 6) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(5-メチル-3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル)-1-プロパノール
(197mg,0.53ミリモル)のアセトニトリル
(20ml)溶液に4-フルオロナフタレンカルボン酸
(100mg,0.53ミリモル)および1-エチル-3
-(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩(151mg,0.79ミリモル)および1-ヒドロ
キシ-1H-ベンゾトリアゾール(81mg,0.53ミ
リモル)を加えて室温で終夜攪拌した。反応液を水(1
00ml)で希釈し、酢酸エチル(100ml×2)で
抽出した。抽出液を1規定塩酸、1規定水酸化ナトリウ
ム水溶液、飽和食塩水で順次洗浄し、無水硫酸マグネシ
ウムで乾燥後減圧留去した。残留物を酢酸エチル-ヘキ
サンから再結晶させて、表題化合物(234mg,81
%)を得た。 mp 189-190℃ IRνmaxKBrcm-1: 1642, 1626, 1601, 1512. Anal. Calcd for C29H23F6NO3・0.1H2O: C, 63.41; H,
4.25; N, 2.55 Found: C, 63.22; H, 4.24; N, 2.77.1 H-NMR (CDCl3)δ: 2.29 (3H, s), 2.77 (1H, dd, J =
14.0, 11.0 Hz), 3.00 (1H, dd, J = 14.0, 4.0 Hz),
4.62-4.82 (1H, m), 5.07 (1H, d, J = 3.6 Hz),5.87
(1H, tt, J = 53.0, 3.0 Hz), 5.95 (1H, d, J = 8.8 H
z), 6.80-7.20 (7H, m), 7.38-7.60 (4H, m), 7.80 (1
H, d, J = 8.0 Hz), 8.08 (1H, d, J = 7.6Hz).Example 230 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((5-methyl-3- (1,1,2,2
2-tetrafluoroethoxy) phenyl) methyl) ethyl) -4-fluoro-1-naphthalenecarboxamide 1) 3,5-dimethyl-1- (1,1,2,2-tetrafluoropropyloxy) benzene (8.22 g, 32.
N-bromosuccinimide (6.42 g, 36.1 mmol) in a solution of 8 mmol) in carbon tetrachloride (100 ml).
And 2,2′-azobis (isobutyronitrile) (2
(70 mg, 1.64 mmol) and heated to reflux overnight. The insolubles were filtered using Celite, the filtrate was concentrated,
The bromo form was prepared. 3- (4-fluorophenyl) -3-
Sodium hydride (60% oily, 1.18 g, 29.5) was added to a solution of ethyl oxopropionate (6.20 g, 29.5 mmol) in 1,2-dimethoxyethane (60 ml).
(Mmol) was added under ice-cooling, and the mixture was stirred at room temperature for 30 minutes. A solution of the previously synthesized bromo compound in 1,2-dimethoxyethane (20 ml) was dropped into the reaction solution, and the reaction solution was stirred at room temperature for 1 hour. The reaction solution was poured into water (200 ml) and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene: hexane = 1: 1-ethyl acetate), recrystallized from ethyl acetate-hexane, and
(4-fluorophenyl) -2-((3-methyl-5- (1,
Ethyl 1,2,2-tetrafluoroethoxy) phenyl) methyl) -3-oxopropionate (6.68 g, 53
%). . mp 56-57 ℃ IRνmax KBr cm -1 : 1738, 1688, 1599, 1508. Anal Calcd for C 21 H 19 F 5 O 4: C, 58.12; H, 4.50 Found:. C, 57.94; H, 4.27 1 H-NMR (CDCl 3 ) δ: 1.13 (3H, t, J = 7.0 Hz), 2.30
(3H, s), 3.28 (2H, d, J = 7.4 Hz), 4.12 (2H, q, J =
7.0 Hz), 4.54 (1H, t, J = 7.4 Hz), 5.87 (1H, tt,
J = 53.0, 3.0 Hz), 6.87 (2H, s), 6.94 (1H, s), 7.1
2 (2H, t, J = 8.4 Hz), 7.92-8.06 (2H, m). 2) To a solution of zinc chloride (4.12 g, 30.2 mmol) in diethyl ether (100 ml) was added sodium borohydride (2. (29 g, 60.4 mmol) and stirred at room temperature for 30 minutes. The insoluble material was removed by filtration, and the filtrate was added with 3- (4-fluorophenyl) -2-((5-methyl-3- (1,1,1).
2,2-tetrafluoroethoxy) phenyl) methyl)-
Ethyl 3-oxopropionate (6.50 g, 15.1)
Mmol) in diethyl ether (50 ml) and stirred at room temperature for 30 minutes. Under ice-cooling, the reaction solution was quenched by adding 1N hydrochloric acid, further added with water (200 ml), and extracted with ethyl acetate (300 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1),
(2RS, 3RS) -3- (4-fluorophenyl) -3-
Ethyl hydroxy-2-((5-methyl-3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) propionate (6.56 g, 100%) was obtained as a colorless oil. IRνmax KBr cm -1 : 1715, 1605, 1512. Anal.Calcd for C 21 H 21 F 5 O 4・ 0.3H 2 O: C, 57.62; H,
4.97 Found: C, 57.54; H, 4.85. 1 H-NMR (CDCl 3 ) δ: 0.94 (3H, t, J = 7.0 Hz), 2.29
(3H, s), 2.92-3.02 (4H, m), 3.89 (2H, q, J = 7.0 H
z), 5.00 (1H, s), 5.86 (1H, tt, J = 53.0, 3.0Hz),
6.72-6.86 (3H, m), 7.00-7.10 (2H, m), 7.30-7.42 (2
H, m). 3) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((5-methyl-3- (1,1,
To a methanol (50 ml) solution of ethyl 2,2-trifluoroethoxy) phenyl) methyl) propionate (6.30 g, 14.6 mmol) was added a 2N aqueous sodium hydroxide solution (14.6 ml, 29.2 mmol). In addition, the mixture was stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (100 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diethyl ether-hexane to give (2RS, 3RS) -3- (4
-Fluorophenyl) -3-hydroxy-2-((5-methyl
-3- (1,1,2,2-Trifluoroethoxy) phenyl) methyl) propionic acid (6.0 g, 100%) was obtained. . mp 82-83 ℃ IRνmax KBr cm -1 : 1713, 1607, 1512. Anal Calcd for C 19 H 17 F 5 O 4: C, 56.19; H, 4.26 Found:. C, 56.05; H, 4.13 1 H- NMR (CDCl 3 ) δ: 2.27 (3H, s), 2.80-3.08 (3H, m),
5.06 (1H, d, J = 4.0Hz), 5.86 (1H, tt, J = 53.0,
2.8 Hz), 6.76 (2H, d, J = 6.6 Hz), 6.84 (1H, s),
6.98-7.12 (2H, m), 7.30-7.42 (2H, m). 4) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((5-methyl-3- ( 1,1,
2,2-tetrafluoroethoxy) phenyl) methyl)
To a solution of propionic acid (5.8 g, 14.3 mmol) in tetrahydrofuran (100 ml), diphenylphosphoryl azide (3.4 ml, 15.8 mmol) and triethylamine (3.0 ml, 21.5 mmol) were added.
The mixture was refluxed for 30 minutes. After allowing the reaction solution to cool, water (200 m
1) and extracted with ethyl acetate (200 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1).
Recrystallized from hexane, (4RS, 5SR) -5-
(4-fluorophenyl) -4-((5-methyl-3- (1,
1,2,2-tetrafluoroethoxy) phenyl) methyl) -1,3-oxazolidin-2-one (4.1 g, 71
%). mp 107-108 ° C IRνmax KBr cm -1 : 1761, 1611, 1597, 1514. Anal.Calcd for C 19 H 16 F 5 NO 3 : C, 56.86; H, 4.02; N,
3.49 Found:. C, 56.64; H, 4.01; N, 3.58 1 H-NMR (CDCl 3) δ: 1.16-2.40 (2H, m), 2.32 (3H, s),
4.18-4.32 (1H, m), 5.12 (1H, brs), 5.79 (1H, d, J
= 7.8 Hz), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.70
(2H, d, J = 8.0 Hz), 6.91 (1H, s), 7.04-7.20 (2H,
m), 7.30-7.42 (2H, m). 5) (4RS, 5SR) -5- (4-fluorophenyl) -4-((5-methyl-3- (1,1,2,2-tetrafluoro To a solution of (ethoxy) phenyl) methyl) -1,3-oxazolidin-2-one (3.0 g, 7.48 mmol) in ethanol (30 ml) was added an 8 N aqueous sodium hydroxide solution (4.7 ml, 37.4 mmol). The mixture was heated under reflux for 3 hours. After concentration, the reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR) -2-amino-1- (4-fluorophenyl). ) -3- (5-Methyl-3- (1,1,2,2-tetrafluoroethoxy) phenyl) -1-propanol (2.34 g, 83%) was obtained. mp 96-98 ° C IRνmax KBr cm -1 : 1617, 1595, 1508, 1458. Anal.Calcd for C 18 H 18 F 5 NO 2 : C, 57.60; H, 4.83; N,
3.73 Found:. C, 57.59; H, 4.79; N, 3.73 1 H-NMR (CDCl 3) δ: 2.20-2.50 (1H, m), 2.32 (3H, s),
2.76 (1H, dd, J = 13.4, 3.2 Hz), 3.20-3.32 (1H,
m), 4.65 (1H, d, J = 4.8 Hz), 5.88 (1H, tt, J = 53.
0, 3.0 Hz), 6.80 (1H, s), 6.82-6.90 (2H, m), 7.00-
7.12 (2H, m), 7.30-7.42 (2H, m). 6) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (5-methyl-3- (1,1 In a solution of (2,2,2-tetrafluoroethoxy) phenyl) -1-propanol (197 mg, 0.53 mmol) in acetonitrile (20 ml), 4-fluoronaphthalenecarboxylic acid (100 mg, 0.53 mmol) and 1-ethyl-3
-(3-Dimethylaminopropyl) carbodiimide hydrochloride (151 mg, 0.79 mmol) and 1-hydroxy-1H-benzotriazole (81 mg, 0.53 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was washed with water (1
00 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (234 mg, 81
%). mp 189-190 ℃ IRνmax KBr cm -1 : 1642, 1626, 1601, 1512. Anal.Calcd for C 29 H 23 F 6 NO 3・ 0.1H 2 O: C, 63.41; H,
4.25; N, 2.55 Found:. C, 63.22; H, 4.24; N, 2.77 1 H-NMR (CDCl 3) δ: 2.29 (3H, s), 2.77 (1H, dd, J =
14.0, 11.0 Hz), 3.00 (1H, dd, J = 14.0, 4.0 Hz),
4.62-4.82 (1H, m), 5.07 (1H, d, J = 3.6 Hz), 5.87
(1H, tt, J = 53.0, 3.0 Hz), 5.95 (1H, d, J = 8.8 H
z), 6.80-7.20 (7H, m), 7.38-7.60 (4H, m), 7.80 (1
H, d, J = 8.0 Hz), 8.08 (1H, d, J = 7.6Hz).
【0363】実施例231 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((5-メチル-3-(1,1,2,
2-テトラフルオロエトキシ)フェニル)メチル)エチ
ル)-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテ
ン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(2-フルオロフェ
ニル)-3-(5-メチル-3-(1,1,2,2-テトラフ
ルオロエトキシ)フェニル)-1-プロパノール(200
mg,0.53ミリモル)のアセトニトリル(20m
l)溶液に6,7-ジヒドロ-5H-ベンゾ[a]シクロ
ヘプテン-1-カルボン酸(100mg,0.53ミリモ
ル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(153mg,0.80ミ
リモル)および1-ヒドロキシ-1H-ベンゾトリアゾー
ル(81mg,0.53ミリモル)を加えて室温で終夜
攪拌した。反応液を水(100ml)で希釈し、酢酸エ
チル(100ml×2)で抽出した。抽出液を1規定塩
酸、1規定水酸化ナトリウム水溶液、飽和食塩水で順次
洗浄し、無水硫酸マグネシウムで乾燥後減圧留去した。
残留物を酢酸エチル-ヘキサンから再結晶させて、表題
化合物(228mg,78%)を得た。 mp 175-176℃ IRνmaxKBrcm-1: 1636, 1510, 1449.1 H-NMR (CDCl3)δ: 1.90-2.10 (2H, m), 2.10-2.28 (2
H, m), 2.31 (3H, s), 2.60-2.82 (3H, m), 3.87 (1H,
brs), 4.56-4.72 (1H, m), 5.01 (1H, d, J = 3.8Hz),
5.76 (1H, d, J = 8.4 Hz), 5.87 (1H, tt, J = 53.0,
3.0 Hz), 5.90-6.00 (1H, m), 6.22 (1H, d, J = 11.6
Hz), 6.82 (1H, s), 6.84-7.20 (7H, m),7.36-7.50 (2
H, m).Example 231 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((5-methyl-3- (1,1,2,2
2-tetrafluoroethoxy) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (2-fluorophenyl) -3 -(5-Methyl-3- (1,1,2,2-tetrafluoroethoxy) phenyl) -1-propanol (200
mg, 0.53 mmol) of acetonitrile (20 m
l) To a solution, 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (100 mg, 0.53 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (153 mg) , 0.80 mmol) and 1-hydroxy-1H-benzotriazole (81 mg, 0.53 mmol) were added and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was recrystallized from ethyl acetate-hexane to give the title compound (228 mg, 78%). mp 175-176 ℃ IRνmax KBr cm -1: 1636, 1510, 1449. 1 H-NMR (CDCl 3) δ: 1.90-2.10 (2H, m), 2.10-2.28 (2
H, m), 2.31 (3H, s), 2.60-2.82 (3H, m), 3.87 (1H,
brs), 4.56-4.72 (1H, m), 5.01 (1H, d, J = 3.8Hz),
5.76 (1H, d, J = 8.4 Hz), 5.87 (1H, tt, J = 53.0,
3.0 Hz), 5.90-6.00 (1H, m), 6.22 (1H, d, J = 11.6
Hz), 6.82 (1H, s), 6.84-7.20 (7H, m), 7.36-7.50 (2
H, m).
【0364】実施例232 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-クロロ-3-(1,1,2,
2-テトラフルオロエトキシ)フェニル)メチル)エチ
ル)-4-フルオロ-1-ナフタレンカルボキサミド 1) 4-クロロ-3-(1,1,2,2-テトラフルオロ
プロピルオキシ)トルエン(7.63g,28.3ミリ
モル,90%純度)の四塩化炭素(100ml)溶液に
N-ブロモスクシンイミド(5.54g,31.1ミリ
モル)および2,2’-アゾビス(イソブチロニトリ
ル)(255mg,1.56ミリモル)を加え、終夜加
熱還流した。不溶物をセライトを用いてろ過し、ろ液を
濃縮し、ブロモ体を調製した。3-(4-フルオロフェニ
ル)-3-オキソプロピオン酸エチル(5.35g,2
5.5ミリモル)の1,2-ジメトキシエタン(50m
l)溶液に水素化ナトリウム(60%油性,1.02
g,25.5ミリモル)を氷冷下加え、室温で30分攪
拌した。反応液の中に先に合成したブロモ体の1,2-
ジメトキシエタン(20ml)溶液を滴下し、反応液を
室温で1時間攪拌した。反応液を水(200ml)の中
に注ぎ、酢酸エチル(200ml×2)で抽出した。抽
出液を水および飽和食塩水で洗浄し、無水硫酸マグネシ
ウムで乾燥後減圧留去した。残留物をシリカゲルカラム
クロマトグラフィー(トルエン:ヘキサン=1:1-酢
酸エチル)で精製し、酢酸エチル-ヘキサンから再結晶
させて、2-((4-クロロ-3-(1,1,2,2-テト
ラフルオロエトキシ)フェニル)メチル)-3-(4-フ
ルオロフェニル)-3-オキソプロピオン酸エチル(6.
71g,56%)を得た。 mp 73-74℃ IRνmaxKBrcm-1: 1738, 1688, 1599. Anal. Calcd for C20H16ClF5O4: C, 53.29; H, 3.58 Found: C, 53.38; H, 3.35.1 H-NMR (CDCl3)δ: 1.13 (3H, t, J = 7.0 Hz), 3.32
(2H, d, J = 7.2 Hz), 4.11 (2H, q, J = 7.0 Hz), 4.5
4 (1H, t, J = 7.2 Hz), 5.97 (1H, tt, J = 53.2, 3.0
Hz), 7.06-7.40 (5H, m), 7.92-8.08 (2H, m). 2) 塩化亜鉛(4.0g,29.3ミリモル)のジエ
チルエーテル(100ml)溶液に水素化ホウ素ナトリ
ウム(2.22g,58.6ミリモル)を加えて室温で
30分攪拌した。不溶物をろ去し、ろ液に2-((4-ク
ロロ-3-(1,1,2,2-テトラフルオロエトキシ)
フェニル)メチル)-3-(4-フルオロフェニル)-3-
オキソプロピオン酸エチル(6.60g,14.6ミリ
モル)のジエチルエーテル(50ml)溶液を加えて室
温で30分攪拌した。氷冷下、反応液に1規定塩酸を加
えてクエンチし、更に水(200ml)を加え、酢酸エ
チル(300ml×2)で抽出した。抽出液を水および
飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後減
圧留去した。残留物をシリカゲルカラムクロマトグラフ
ィー(ヘキサン:酢酸エチル=4:1)で精製し、(2
RS,3RS)-2-((4-クロロ-3-(1,1,2,
2-テトラフルオロエトキシ)フェニル)メチル)-3-
(4-フルオロフェニル)-3-ヒドロキシプロピオン酸
エチル(5.85g,88%)を無色油状物として得
た。 IRνmaxKBrcm-1: 1717, 1605, 1510, 1487. Anal. Calcd for C20H18ClF5O4: C, 53.05; H, 4.01 Found: C, 53.17; H, 4.13.1 H-NMR (CDCl3)δ: 0.95 (3H, t, J = 7.0 Hz), 2.84-
3.04 (4H, m), 3.89 (2H,q, J = 7.0 Hz), 4.98-5.06
(1H, m), 5.96 (1H, tt, J = 53.0, 3.4 Hz), 6.92-7.1
0 (4H, m), 7.30-7.44 (3H, m). 3) (2RS,3RS)-2-((4-クロロ-3-
(1,1,2,2-トリフルオロエトキシ)フェニル)
メチル)-3-(4-フルオロフェニル)-3-ヒドロキシ
プロピオン酸エチル(5.60g,12.37ミリモ
ル)のメタノール(50ml)溶液に、2規定水酸化ナ
トリウム水溶液(12.3ml,24.6ミリモル)を
加えて室温で終夜攪拌した。反応液を1規定塩酸で酸性
とした後、酢酸エチル(100ml×2)で抽出した。
抽出液を水および飽和食塩水で洗浄し、無水硫酸マグネ
シウムで乾燥後減圧留去した。残留物をジエチルエーテ
ル−ヘキサンより再結晶させて、(2RS,3RS)-
2-((4-クロロ-3-(1,1,2,2-トリフルオロ
エトキシ)フェニル)メチル)-3-(4-フルオロフェ
ニル)-3-ヒドロキシプロピオン酸(4.12g,78
%)を得た。 mp 121-122℃ IRνmaxKBrcm-1: 1713, 1607, 1512, 1489. Anal. Calcd for C18H14ClF5O4: C, 50.90; H, 3.32 Found: C, 50.92; H, 3.07.1 H-NMR (CDCl3)δ: 2.90-3.06 (3H, m), 5.07 (1H, s),
5.96 (1H, tt, J = 53.0, 3.2 Hz), 6.94 (1H, dd, J
= 8.2, 2.0 Hz), 7.00-7.12 (3H, m), 7.24-7.40(3H,
m). 4) (2RS,3RS)-2-((4-クロロ-3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)-3-(4-フルオロフェニル)-3-ヒドロ
キシプロピオン酸(2.0g,4.71ミリモル)のテ
トラヒドロフラン(40ml)溶液に、ジフェニルホス
ホリルアジド(1.12ml,5.18ミリモル)とト
リエチルアミン(0.99ml,7.07ミリモル)を
加え、3時間加熱還流した。反応液を放冷後、水(20
0ml)を加えて酢酸エチル(200ml×2)で抽出
した。抽出液を1規定塩酸、飽和重曹水、飽和食塩水で
順次洗浄し、無水硫酸マグネシウムで乾燥後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=1:1)で精製し、(4RS,5
SR)-4-((4-クロロ-3-(1,1,2,2-テトラ
フルオロエトキシ)フェニル)メチル)-5-(4-フル
オロフェニル)-1,3-オキサゾリジン-2-オン(1.
72g,87%)を無色油状物として得た。 IRνmaxKBrcm-1: 1759, 1514, 1489. Anal. Calcd for C18H13ClF5NO3: C, 51.26; H, 3.11;
N, 3.32 Found: C, 51.16; H, 3.13; N, 3.24.1 H-NMR (CDCl3)δ: 2.30 (2H, d, J = 6.8 Hz), 4.25
(1H, q, J = 6.8 Hz), 5.30 (1H, brs), 5.80 (1H, d,
J = 8.0 Hz), 5.98 (1H, tt, J = 53.0, 3.0 Hz),6.89
(1H, dd, J = 8.0, 2.0 Hz), 6.99 (1H, s), 7.06-7.20
(2H, m), 7.30-7.42 (3H, m). 5) (4RS,5SR)-4-((4-クロロ-3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)-5-(4-フルオロフェニル)-1,3-オ
キサゾリジン-2-オン(1.42g,3.37ミリモ
ル)のエタノール(20ml)溶液に8規定水酸化ナト
リウム水溶液(2.1ml,16.9ミリモル)を加
え、3時間加熱還流した。反応液を濃縮後、水(100
ml)で希釈し、酢酸エチル(100ml×2)で抽出
した。抽出液を飽和食塩水で洗浄し、無水硫酸マグネシ
ウムで乾燥後減圧留去し、残留物を酢酸エチル-ヘキサ
ンから再結晶させて(1RS,2SR)-2-アミノ-3-
(4-クロロ-3-(1,1,2,2-テトラフルオロエト
キシ)フェニル)-1-(4-フルオロフェニル)-1-プ
ロパノール(1.17g,88%)を得た。 mp 109-110℃ IRνmaxKBrcm-1: 1605, 1508, 1489. Anal. Calcd for C17H15ClF5NO2: C, 51.59; H, 3.82;
N, 3.54 Found: C, 51.62; H, 3.78; N, 3.55.1 H-NMR (CDCl3)δ: 2.39 (1H, dd, J = 14.0, 10.0 H
z), 2.81 (1H, dd, J = 14.0, 3.4 Hz), 3.18-3.32 (1
H, m), 4.63 (1H, d, J = 5.2 Hz), 5.98 (1H, tt,J =
53.0, 3.0 Hz), 7.00-7.20 (4H, m), 7.30-7.44 (3H,
m). 6) (1RS,2SR)-2-アミノ-3-(4-クロロ-
3-(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)-1-(4-フルオロフェニル)-1-プロパノール
(208mg,0.53ミリモル)のアセトニトリル
(20ml)溶液に4-フルオロナフタレンカルボン酸
(100mg,0.53ミリモル)および1-エチル-3
-(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩(151mg,0.79ミリモル)および1-ヒドロ
キシ-1H-ベンゾトリアゾール(81mg,0.53ミ
リモル)を加えて室温で終夜攪拌した。反応液を水(1
00ml)で希釈し、酢酸エチル(100ml×2)で
抽出した。抽出液を1規定塩酸、1規定水酸化ナトリウ
ム水溶液、飽和食塩水で順次洗浄し、無水硫酸マグネシ
ウムで乾燥後減圧留去した。残留物を酢酸エチル-ヘキ
サンから再結晶させて、表題化合物(273mg,91
%)を得た。 mp 206-207℃ IRνmaxKBrcm-1: 1642, 1626, 1601, 1512.1 H-NMR (CDCl3)δ: 2.84 (1H, dd, J = 14.2, 10.6 H
z), 3.02 (1H, dd, J = 14.2, 4.2 Hz), 4.68-4.84 (1
H, m), 5.07 (1H, d, J = 4.0 Hz), 5.95 (1H, tt,J =
53.0, 3.0 Hz), 5.99 (1H, d, J = 9.0 Hz), 6.92-7.30
(6H, m), 7.30-7.60 (5H, m), 7.73 (1H, d, J = 8.2
Hz), 8.08 (1H, d, J = 8.2 Hz).Example 232 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4-chloro-3- (1,1,2,2
2-tetrafluoroethoxy) phenyl) methyl) ethyl) -4-fluoro-1-naphthalenecarboxamide 1) 4-chloro-3- (1,1,2,2-tetrafluoropropyloxy) toluene (7.63 g, 28 N-bromosuccinimide (5.54 g, 31.1 mmol) and 2,2′-azobis (isobutyronitrile) (255 mg, 1.56 g) in a solution of 0.3 mmol, 90% purity) in carbon tetrachloride (100 ml). Mmol) and heated to reflux overnight. The insolubles were filtered using celite, and the filtrate was concentrated to prepare a bromo compound. Ethyl 3- (4-fluorophenyl) -3-oxopropionate (5.35 g, 2
5.5 mmol) of 1,2-dimethoxyethane (50 m
l) Add sodium hydride (60% oil, 1.02
g, 25.5 mmol) under ice-cooling and stirred at room temperature for 30 minutes. In the reaction solution, the 1,2-
A solution of dimethoxyethane (20 ml) was added dropwise and the reaction was stirred at room temperature for 1 hour. The reaction solution was poured into water (200 ml) and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene: hexane = 1: 1-ethyl acetate) and recrystallized from ethyl acetate-hexane to give 2-((4-chloro-3- (1,1,2,2, Ethyl 2-tetrafluoroethoxy) phenyl) methyl) -3- (4-fluorophenyl) -3-oxopropionate (6.
71 g, 56%). . mp 73-74 ℃ IRνmax KBr cm -1 : 1738, 1688, 1599. Anal Calcd for C 20 H 16 ClF 5 O 4: C, 53.29; H, 3.58 Found:. C, 53.38; H, 3.35 1 H- NMR (CDCl 3 ) δ: 1.13 (3H, t, J = 7.0 Hz), 3.32
(2H, d, J = 7.2 Hz), 4.11 (2H, q, J = 7.0 Hz), 4.5
4 (1H, t, J = 7.2 Hz), 5.97 (1H, tt, J = 53.2, 3.0
Hz), 7.06-7.40 (5H, m), 7.92-8.08 (2H, m). 2) To a solution of zinc chloride (4.0 g, 29.3 mmol) in diethyl ether (100 ml) was added sodium borohydride (2. (22 g, 58.6 mmol) and stirred at room temperature for 30 minutes. The insolubles were removed by filtration, and the filtrate was treated with 2-((4-chloro-3- (1,1,2,2-tetrafluoroethoxy).
Phenyl) methyl) -3- (4-fluorophenyl) -3-
A solution of ethyl oxopropionate (6.60 g, 14.6 mmol) in diethyl ether (50 ml) was added, and the mixture was stirred at room temperature for 30 minutes. Under ice-cooling, the reaction solution was quenched by adding 1N hydrochloric acid, further added with water (200 ml), and extracted with ethyl acetate (300 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give (2
RS, 3RS) -2-((4-chloro-3- (1,1,2,
2-tetrafluoroethoxy) phenyl) methyl) -3-
Ethyl (4-fluorophenyl) -3-hydroxypropionate (5.85 g, 88%) was obtained as a colorless oil. . IRνmax KBr cm -1: 1717, 1605, 1510, 1487. Anal Calcd for C 20 H 18 ClF 5 O 4: C, 53.05; H, 4.01 Found:. C, 53.17; H, 4.13 1 H-NMR (CDCl 3 ) δ: 0.95 (3H, t, J = 7.0 Hz), 2.84-
3.04 (4H, m), 3.89 (2H, q, J = 7.0 Hz), 4.98-5.06
(1H, m), 5.96 (1H, tt, J = 53.0, 3.4 Hz), 6.92-7.1
0 (4H, m), 7.30-7.44 (3H, m). 3) (2RS, 3RS) -2-((4-chloro-3-
(1,1,2,2-trifluoroethoxy) phenyl)
To a solution of ethyl (methyl) -3- (4-fluorophenyl) -3-hydroxypropionate (5.60 g, 12.37 mmol) in methanol (50 ml) was added 2N aqueous sodium hydroxide solution (12.3 ml, 24.6). Mmol) and stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (100 ml × 2).
The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diethyl ether-hexane to give (2RS, 3RS)-
2-((4-chloro-3- (1,1,2,2-trifluoroethoxy) phenyl) methyl) -3- (4-fluorophenyl) -3-hydroxypropionic acid (4.12 g, 78
%). . mp 121-122 ℃ IRνmax KBr cm -1 : 1713, 1607, 1512, 1489. Anal Calcd for C 18 H 14 ClF 5 O 4: C, 50.90; H, 3.32 Found:. C, 50.92; H, 3.07 1 H-NMR (CDCl 3 ) δ: 2.90-3.06 (3H, m), 5.07 (1H, s),
5.96 (1H, tt, J = 53.0, 3.2 Hz), 6.94 (1H, dd, J
= 8.2, 2.0 Hz), 7.00-7.12 (3H, m), 7.24-7.40 (3H,
m). 4) (2RS, 3RS) -2-((4-chloro-3-
(1,1,2,2-tetrafluoroethoxy) phenyl) methyl) -3- (4-fluorophenyl) -3-hydroxypropionic acid (2.0 g, 4.71 mmol) in tetrahydrofuran (40 ml) solution Diphenylphosphoryl azide (1.12 ml, 5.18 mmol) and triethylamine (0.99 ml, 7.07 mmol) were added, and the mixture was heated under reflux for 3 hours. After allowing the reaction solution to cool, water (20
0 ml) and extracted with ethyl acetate (200 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1) to give (4RS, 5
SR) -4-((4-Chloro-3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) -5- (4-fluorophenyl) -1,3-oxazolidin-2-one ( 1.
72 g, 87%) as a colorless oil. . IRνmax KBr cm -1: 1759, 1514, 1489. Anal Calcd for C 18 H 13 ClF 5 NO 3: C, 51.26; H, 3.11;
N, 3.32 Found:. C, 51.16; H, 3.13; N, 3.24 1 H-NMR (CDCl 3) δ: 2.30 (2H, d, J = 6.8 Hz), 4.25
(1H, q, J = 6.8 Hz), 5.30 (1H, brs), 5.80 (1H, d,
J = 8.0 Hz), 5.98 (1H, tt, J = 53.0, 3.0 Hz), 6.89
(1H, dd, J = 8.0, 2.0 Hz), 6.99 (1H, s), 7.06-7.20
(2H, m), 7.30-7.42 (3H, m). 5) (4RS, 5SR) -4-((4-chloro-3-
(1,1,2,2-tetrafluoroethoxy) phenyl) methyl) -5- (4-fluorophenyl) -1,3-oxazolidin-2-one (1.42 g, 3.37 mmol) in ethanol (20 ml) )) An 8 N aqueous sodium hydroxide solution (2.1 ml, 16.9 mmol) was added to the solution, and the mixture was heated under reflux for 3 hours. After concentrating the reaction solution, water (100
ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated brine, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR) -2-amino-3-amino-3-hexane.
(4-Chloro-3- (1,1,2,2-tetrafluoroethoxy) phenyl) -1- (4-fluorophenyl) -1-propanol (1.17 g, 88%) was obtained. . mp 109-110 ℃ IRνmax KBr cm -1 : 1605, 1508, 1489. Anal Calcd for C 17 H 15 ClF 5 NO 2: C, 51.59; H, 3.82;
N, 3.54 Found:. C, 51.62; H, 3.78; N, 3.55 1 H-NMR (CDCl 3) δ: 2.39 (1H, dd, J = 14.0, 10.0 H
z), 2.81 (1H, dd, J = 14.0, 3.4 Hz), 3.18-3.32 (1
H, m), 4.63 (1H, d, J = 5.2 Hz), 5.98 (1H, tt, J =
53.0, 3.0 Hz), 7.00-7.20 (4H, m), 7.30-7.44 (3H,
m). 6) (1RS, 2SR) -2-amino-3- (4-chloro-
To a solution of 3- (1,1,2,2-tetrafluoroethoxy) phenyl) -1- (4-fluorophenyl) -1-propanol (208 mg, 0.53 mmol) in acetonitrile (20 ml) was added 4-fluoronaphthalenecarboxylic acid. Acid (100 mg, 0.53 mmol) and 1-ethyl-3
-(3-Dimethylaminopropyl) carbodiimide hydrochloride (151 mg, 0.79 mmol) and 1-hydroxy-1H-benzotriazole (81 mg, 0.53 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was washed with water (1
00 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (273 mg, 91
%). mp 206-207 ℃ IRνmax KBr cm -1: 1642, 1626, 1601, 1512. 1 H-NMR (CDCl 3) δ: 2.84 (1H, dd, J = 14.2, 10.6 H
z), 3.02 (1H, dd, J = 14.2, 4.2 Hz), 4.68-4.84 (1
H, m), 5.07 (1H, d, J = 4.0 Hz), 5.95 (1H, tt, J =
53.0, 3.0 Hz), 5.99 (1H, d, J = 9.0 Hz), 6.92-7.30
(6H, m), 7.30-7.60 (5H, m), 7.73 (1H, d, J = 8.2
Hz), 8.08 (1H, d, J = 8.2 Hz).
【0365】実施例233 N-((1RS,2SR)-1-((4-クロロ-3-(1,
1,2,2-テトラフルオロエトキシ)フェニル)メチ
ル)エチル)-2-(4-フルオロフェニル)-2-ヒドロ
キシ-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテ
ン-1-カルボキサミド (1RS,2SR)-2-アミノ-3-(4-クロロ-3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)-1-(2-フルオロフェニル)-1-プロパノール
(210mg,0.53ミリモル)のアセトニトリル
(20ml)溶液に6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボン酸(100mg,
0.53ミリモル)および1-エチル-3-(3-ジメチル
アミノプロピル)カルボジイミド・塩酸塩(153m
g,0.80ミリモル)および1-ヒドロキシ-1H-ベ
ンゾトリアゾール(81mg,0.53ミリモル)を加
えて室温で終夜攪拌した。反応液を水(100ml)で
希釈し、酢酸エチル(100ml×2)で抽出した。抽
出液を1規定塩酸、1規定水酸化ナトリウム水溶液、飽
和食塩水で順次洗浄し、無水硫酸マグネシウムで乾燥後
減圧留去した。残留物を酢酸エチル-ヘキサンから再結
晶させて、表題化合物(213mg,71%)を得た。 mp 174-175℃ IRνmaxKBrcm-1: 1640, 1508, 1489.1 H-NMR (CDCl3)δ: 1.90-2.10 (2H, m), 2.12-2.26 (2
H, m), 2.60-2.72 (2H, m), 2.78 (1H, dd, J = 14.6,
10.4 Hz), 2.96 (1H, dd, J = 14.6, 4.4 Hz), 3.40 (1
H, brs), 4.58-4.72 (1H, m), 5.01 (1H, d, J = 4.0 H
z), 5.80 (1H, d,J = 8.8 Hz), 5.82-5.98 (1H, m), 5.
95 (1H, tt, J = 53.0, 3.0 Hz), 6.16 (1H, d, J = 1
1.6 Hz), 6.92-7.20 (7H, m), 7.32-7.50 (3H, m).Example 233 N-((1RS, 2SR) -1-((4-chloro-3- (1,1
1,2,2-tetrafluoroethoxy) phenyl) methyl) ethyl) -2- (4-fluorophenyl) -2-hydroxy-6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-3- (4-chloro-3-
6,7-Dihydro-5H was added to a solution of (1,1,2,2-tetrafluoroethoxy) phenyl) -1- (2-fluorophenyl) -1-propanol (210 mg, 0.53 mmol) in acetonitrile (20 ml). -Benzo [a] cycloheptene-1-carboxylic acid (100 mg,
0.53 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (153 m
g, 0.80 mmol) and 1-hydroxy-1H-benzotriazole (81 mg, 0.53 mmol) were added and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed sequentially with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (213 mg, 71%). mp 174-175 ° C IRνmax KBr cm -1 : 1640, 1508, 1489. 1 H-NMR (CDCl 3 ) δ: 1.90-2.10 (2H, m), 2.12-2.26 (2
H, m), 2.60-2.72 (2H, m), 2.78 (1H, dd, J = 14.6,
10.4 Hz), 2.96 (1H, dd, J = 14.6, 4.4 Hz), 3.40 (1
H, brs), 4.58-4.72 (1H, m), 5.01 (1H, d, J = 4.0 H
z), 5.80 (1H, d, J = 8.8 Hz), 5.82-5.98 (1H, m), 5.
95 (1H, tt, J = 53.0, 3.0 Hz), 6.16 (1H, d, J = 1
1.6 Hz), 6.92-7.20 (7H, m), 7.32-7.50 (3H, m).
【0366】実施例234 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-((4-メチル-3-((1,1,
2,2-テトラフルオロエチル)オキシ)フェニル)メ
チル)エチル)-6,7-ジヒドロ-5H-ベンゾ[a]シ
クロヘプテン-1-カルボキサミド 1) 水素化リチウムアルミニウム(1.02g,2
6.8ミリモル)のテトラヒドロフラン(100ml)
溶液に4-メチル-3-((1,1,2,2-テトラフルオ
ロエチル)オキシ)安息香酸エチル(5.0g,17.
8ミリモル)のテトラヒドロフラン(20ml)溶液を
氷冷下加えた。反応液を室温で30分攪拌後、1規定水
酸化ナトリウム水溶液(20ml)を加え、セライトを
用いてろ過した。ろ液を濃縮後、水を加え酢酸エチル
(50ml×2)で抽出した。抽出液を飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後減圧留去し、(4
-メチル-3-((1,1,2,2-テトラフルオロエチ
ル)オキシ)フェニル)メタノール(4.45g,10
0%)を無色油状物として得た。1 H-NMR (CDCl3)δ: 2.27 (3H, s), 4.67 (2H, s), 5.94
(1H, tt, J = 53.0, 2.6 Hz), 7.14-7.28 (3H, m). IRνmaxKBrcm-1: 1584, 1508, 1456, 1418. Anal. Calcd for C10H10F4O2: C, 50.43; H, 4.23 Found: C, 50.44; H, 4.18. 2) (4-メチル-3-((1,1,2,2-テトラフル
オロエチル)オキシ)フェニル)メタノール(4.26
g,17.9ミリモル)の酢酸エチル(60ml)溶液
にメタンスルホニルクロリド(2.25g,19.7ミ
リモル)およびトリエチルアミン(3.0ml,21.
5ミリモル)を0℃で加え、30分攪拌した。不溶物を
ろ過し、ろ液を濃縮し、メシル体を調製した。3-(4-
フルオロフェニル)-3-オキソプロピオン酸エチル
(3.76g,17.9ミリモル)の1,2-ジメトキ
シエタン(40ml)溶液に水素化ナトリウム(60%
油性,0.72g,17.9ミリモル)を氷冷下加え、
室温で30分攪拌した。反応液の中に先に合成したメシ
ル体の1,2-ジメトキシエタン(20ml)溶液を滴
下し、室温で終夜攪拌した。反応液を水(200ml)
の中に注ぎ、酢酸エチル(200ml×2)で抽出し
た。抽出液を水および飽和食塩水で洗浄し、無水硫酸マ
グネシウムで乾燥後減圧留去した。残留物をシリカゲル
カラムクロマトグラフィー(トルエン)で精製し、ヘキ
サンから再結晶させて、3-(4-フルオロフェニル)-
2-((4-メチル-3-((1,1,2,2-テトラフル
オロエチル)オキシ)フェニル)メチル)-3-オキソプ
ロピオン酸エチル(4.91g,64%)を得た。1 H-NMR (CDCl3)δ: 1.13 (3H, t, J = 7.0 Hz), 2.21
(3H, s), 3.30 (2H, d, J= 7.4 Hz), 4.10 (2H, q, J =
7.0 Hz), 4.54 (1H, t, J = 7.4 Hz), 5.92 (1H, tt,
J = 53.0, 2.8 Hz), 7.00-7.20 (5H, m), 7.94-8.04 (2
H, m). IRνmaxKBrcm-1: 1736, 1688, 1599, 1508, 1447, 141
2. mp 52-53℃ Anal. Calcd for C21H19F5O4: C, 58.61; H, 4.45 Found: C, 58.61; H, 4.55. 3) 塩化亜鉛(3.04g,22.3ミリモル)のジ
エチルエーテル(70ml)溶液に水素化ホウ素ナトリ
ウム(1.69g,44.6ミリモル)を加えて室温で
30分攪拌した。不溶物をろ去し、ろ液に3-(4-フル
オロフェニル)-2-((4-メチル-3-((1,1,
2,2-テトラフルオロエチル)オキシ)フェニル)メ
チル)-3-オキソプロピオン酸エチル(4.8g,1
1.2ミリモル)のジエチルエーテル(50ml)溶液
を加えて室温で30分攪拌した。氷冷下、反応液に1規
定塩酸を加えてクエンチし、更に水(100ml)を加
え、酢酸エチル(200ml×2)で抽出した。抽出液
を水および飽和食塩水で洗浄し、無水硫酸マグネシウム
で乾燥後減圧留去した。残留物をシリカゲルカラムクロ
マトグラフィー(ヘキサン:酢酸エチル=4:1)で精
製し、(2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((4-メチル-3-((1,
1,2,2-テトラフルオロエチル)オキシ)フェニ
ル)メチル)プロピオン酸エチル(4.69g,97
%)を無色油状物として得た。1 H-NMR (CDCl3)δ: 0.94 (3H, t, J = 7.4 Hz), 2.21
(3H, s), 2.80-3.10 (3H,m), 3.89 (2H, q, J = 7.4 H
z), 4.96-5.02 (1H, m), 5.92 (1H, tt, J = 52.2, 2.6
Hz), 6.86-7.12 (5H, m), 7.30-7.42 (2H, m). IRνmaxKBrcm-1: 1717, 1605, 1580, 1510, 1447. Anal. Calcd for C21H21F5O4: C, 58.33; H, 4.90 Found: C, 58.29; H, 4.88. 4) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((4-メチル-3-((1,
1,2,2-テトラフルオロエチル)オキシ)フェニ
ル)メチル)プロピオン酸エチル(4.5g,10.4
ミリモル)のメタノール(20ml)溶液に、2規定水
酸化ナトリウム水溶液(10.4ml,20.8ミリモ
ル)を加えて室温で終夜攪拌した。反応液を1規定塩酸
で酸性とした後、酢酸エチル(200ml×2)で抽出
した。抽出液を水および飽和食塩水で洗浄し、無水硫酸
マグネシウムで乾燥後減圧留去した。残留物をジイソプ
ロピルエーテル−ヘキサンから再結晶させて、(2R
S,3RS)-3-(4-フルオロフェニル)-3-ヒドロ
キシ-2-((4-メチル-3-((1,1,2,2-テトラ
フルオロエチル)オキシ)フェニル)メチル)プロピオ
ン酸(3.56g,85%)を得た。1 H-NMR (CDCl3)δ: 2.21 (3H, s), 2.80-3.02 (3H, m),
5.04 (1H, d, J = 3.8Hz), 5.90 (1H, tt, J = 53.0,
2.6 Hz), 6.84-7.12 (5H, m), 7.30-7.40 (2H,m). IRνmaxKBrcm-1: 1713, 1607, 1510, 1449, 1422. mp 102-103℃ Anal. Calcd for C19H17F5O4: C, 56.44; H, 4.24 Found: C, 56.56; H, 4.20. 5) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-((4-メチル-3-((1,
1,2,2-テトラフルオロエチル)オキシ)フェニ
ル)メチル)プロピオン酸(3.3g,8.16ミリモ
ル)のテトラヒドロフラン(60ml)溶液に、ジフェ
ニルホスホリルアジド(1.93ml,8.98ミリモ
ル)とトリエチルアミン(1.71ml,12.2ミリ
モル)を加え、2時間加熱還流した。反応液を放冷後、
水(200ml)を加えて酢酸エチル(100ml×
2)で抽出した。抽出液を1規定塩酸、飽和重曹水、飽
和食塩水で順次洗浄し、無水硫酸マグネシウムで乾燥後
減圧留去した。残留物をシリカゲルカラムクロマトグラ
フィー(酢酸エチル)で精製し、酢酸エチル-ヘキサン
から再結晶させて、(4RS,5SR)-5-(4-フル
オロフェニル)-4-((4-メチル-3-((1,1,
2,2-テトラフルオロエチル)オキシ)フェニル)メ
チル)-1,3-オキサゾリジン-2-オン(2.97g,
91%)を得た。1 H-NMR (CDCl3)δ: 2.23 (3H, s), 2.12-2.30 (2H, m),
4.18-4.30 (1H, m), 5.21 (1H, s), 5.78 (1H, d, J =
8.0 Hz), 5.93 (1H, tt, J = 53.0, 2.6 Hz), 6.80-6.
90 (2H, m), 7.04-7.20 (3H, m), 7.30-7.42 (2H, m). IRνmaxKBrcm-1: 1759, 1609, 1580, 1514, 1422. mp 112-113℃ Anal. Calcd for C19H16F5NO3: C, 56.86; H, 4.02; N,
3.49 Found: C, 56.87; H, 3.91; N, 3.59. 6) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-((4-メチル-3-((1,1,2,2-テトラ
フルオロエチル)オキシ)フェニル)メチル)-1,3-
オキサゾリジン-2-オン(2.7g,6.73ミリモ
ル)のエタノール(10ml)溶液に8規定水酸化ナト
リウム水溶液(4.2ml,33.6ミリモル)を加
え、4時間加熱還流した。反応液を濃縮後、水(100
ml)で希釈し、酢酸エチル(100ml×2)で抽出
した。抽出液を飽和食塩水で洗浄し、無水硫酸マグネシ
ウムで乾燥後減圧留去し、残留物を酢酸エチル-ヘキサ
ンから再結晶させて(1RS,2SR)-2-アミノ-1-
(4-フルオロフェニル)-3-(4-メチル-3-((1,
1,2,2-テトラフルオロエチル)オキシ)フェニ
ル)-1-プロパノール(2.25g,89%)を得た。1 H-NMR (CDCl3)δ: 2.24 (3H, s), 2.33 (1H, dd, J =
14.0, 10.6 Hz), 2.77 (1H, dd, J = 14.0, 3.2 Hz),
3.20-3.32 (1H, m), 4.65 (1H, d, J = 4.8 Hz),5.93
(1H, tt, J = 53.0, 3.0 Hz), 6.92-7.18 (5H, m), 7.3
0-7.42 (2H, m). IRνmaxKBrcm-1: 1605, 1582, 1508. mp 112-113℃ Anal. Calcd for C18H18F5NO2: C, 57.60; H, 4.83; N,
3.73 Found: C, 57.59; H, 4.75; N, 3.73. 7) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(4-メチル-3-((1,1,2,2-
テトラフルオロエチル)オキシ)フェニル)-1-プロパ
ノール(300mg,0.80ミリモル)のアセトニト
リル(20ml)溶液に6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボン酸(150mg,
0.80ミリモル)および1-エチル-3-(3-ジメチル
アミノプロピル)カルボジイミド・塩酸塩(230m
g,1.20ミリモル)および1-ヒドロキシ-1H-ベ
ンゾトリアゾール(123mg,0.80ミリモル)を
加えて室温で終夜攪拌した。反応液を水(100ml)
で希釈し、酢酸エチル(100ml×2)で抽出した。
抽出液を1規定塩酸、1規定水酸化ナトリウム水溶液、
飽和食塩水で順次洗浄し、無水硫酸マグネシウムで乾燥
後減圧留去した。残留物を酢酸エチル-ヘキサンから再
結晶させて、表題化合物(363mg,83%)を得
た。1 H-NMR (CDCl3)δ: 1.90-2.08 (2H, m), 2.12-2.30 (2
H, m), 2.24 (3H, s), 2.60-2.80 (3H, m), 2.95 (1H,
dd, J = 15.0, 4.0 Hz), 4.60-4.76 (1H, m), 5.00 (1
H, d, J = 3.6 Hz), 5.60-6.24 (4H, m), 6.94-7.20 (8
H, m), 7.38-7.48 (2H, m). IRνmaxKBrcm-1: 1640, 1607, 1508, 1447, 1424. mp 168-169℃ Anal. Calcd for C30H28F5NO3・0.1H2O: C, 65.83; H,
5.19; N, 2.56 Found: C, 65.60; H, 4.89; N, 2.82.Example 234 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-((4-methyl-3-((1,1,
2,2-tetrafluoroethyl) oxy) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1) Lithium aluminum hydride (1.02 g, 2
6.8 mmol) in tetrahydrofuran (100 ml)
Ethyl 4-methyl-3-((1,1,2,2-tetrafluoroethyl) oxy) benzoate (5.0 g, 17.
(8 mmol) in tetrahydrofuran (20 ml) was added under ice cooling. After stirring the reaction solution at room temperature for 30 minutes, a 1 N aqueous sodium hydroxide solution (20 ml) was added, and the mixture was filtered using celite. After the filtrate was concentrated, water was added, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
-Methyl-3-((1,1,2,2-tetrafluoroethyl) oxy) phenyl) methanol (4.45 g, 10
0%) as a colorless oil. 1 H-NMR (CDCl 3 ) δ: 2.27 (3H, s), 4.67 (2H, s), 5.94
(1H, tt, J = 53.0, 2.6 Hz), 7.14-7.28 (3H, m) .IRνmax KBr cm -1 : 1584, 1508, 1456, 1418.Anal.Calcd for C 10 H 10 F 4 O 2 : C H, 4.23 Found: C, 50.44; H, 4.18.2) (4-Methyl-3-((1,1,2,2-tetrafluoroethyl) oxy) phenyl) methanol (4.26)
methanesulfonyl chloride (2.25 g, 19.7 mmol) and triethylamine (3.0 ml, 21.g, 17.9 mmol) in ethyl acetate (60 ml).
(5 mmol) at 0 ° C. and stirred for 30 minutes. The insoluble material was filtered, and the filtrate was concentrated to prepare a mesyl compound. 3- (4-
Sodium hydride (60%) was added to a solution of ethyl (fluorophenyl) -3-oxopropionate (3.76 g, 17.9 mmol) in 1,2-dimethoxyethane (40 ml).
Oily, 0.72 g, 17.9 mmol) under ice cooling.
Stirred at room temperature for 30 minutes. A solution of the previously synthesized mesyl compound in 1,2-dimethoxyethane (20 ml) was added dropwise to the reaction solution, and the mixture was stirred at room temperature overnight. The reaction solution was water (200 ml)
And extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (toluene) and recrystallized from hexane to give 3- (4-fluorophenyl)-
Ethyl 2-((4-methyl-3-((1,1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) -3-oxopropionate (4.91 g, 64%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.13 (3H, t, J = 7.0 Hz), 2.21
(3H, s), 3.30 (2H, d, J = 7.4 Hz), 4.10 (2H, q, J =
7.0 Hz), 4.54 (1H, t, J = 7.4 Hz), 5.92 (1H, tt,
J = 53.0, 2.8 Hz), 7.00-7.20 (5H, m), 7.94-8.04 (2
H, m) .IRνmax KBr cm -1 : 1736, 1688, 1599, 1508, 1447, 141
2. mp 52-53 ° C Anal. Calcd for C 21 H 19 F 5 O 4 : C, 58.61; H, 4.45 Found: C, 58.61; H, 4.55.3.) Zinc chloride (3.04 g, 22.3 mmol) ) In diethyl ether (70 ml) was added with sodium borohydride (1.69 g, 44.6 mmol), and the mixture was stirred at room temperature for 30 minutes. The insoluble material was removed by filtration, and the filtrate was treated with 3- (4-fluorophenyl) -2-((4-methyl-3-((1,1,1
Ethyl 2,2-tetrafluoroethyl) oxy) phenyl) methyl) -3-oxopropionate (4.8 g, 1
(1.2 mmol) in diethyl ether (50 ml) and stirred at room temperature for 30 minutes. Under ice-cooling, the reaction solution was quenched by adding 1N hydrochloric acid, further added with water (100 ml), and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((4-methyl-3- ((1,
Ethyl 1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) propionate (4.69 g, 97
%) As a colorless oil. 1 H-NMR (CDCl 3 ) δ: 0.94 (3H, t, J = 7.4 Hz), 2.21
(3H, s), 2.80-3.10 (3H, m), 3.89 (2H, q, J = 7.4 H
z), 4.96-5.02 (1H, m), 5.92 (1H, tt, J = 52.2, 2.6
Hz), 6.86-7.12 (5H, m), 7.30-7.42 (2H, m) .IRνmax KBr cm -1 : 1717, 1605, 1580, 1510, 1447.Anal.Calcd for C 21 H 21 F 5 O 4 : C, 58.33; H, 4.90 Found: C, 58.29; H, 4.88. 4) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((4-methyl-3-(( 1,
Ethyl 1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) propionate (4.5 g, 10.4)
2 mmol sodium hydroxide aqueous solution (10.4 ml, 20.8 mmol) was added to a methanol (20 ml) solution and stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to give (2R
S, 3RS) -3- (4-Fluorophenyl) -3-hydroxy-2-((4-methyl-3-((1,1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) propionic acid (3.56 g, 85%). 1 H-NMR (CDCl 3 ) δ: 2.21 (3H, s), 2.80-3.02 (3H, m),
5.04 (1H, d, J = 3.8Hz), 5.90 (1H, tt, J = 53.0,
2.6 Hz), 6.84-7.12 (5H, m), 7.30-7.40 (2H, m) .IRνmax KBr cm -1 : 1713, 1607, 1510, 1449, 1422.mp 102-103 ℃ Anal.Calcd for C 19 H 17 F 5 O 4 : C, 56.44; H, 4.24 Found: C, 56.56; H, 4.20.5) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-((4- Methyl-3-((1,
To a solution of 1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) propionic acid (3.3 g, 8.16 mmol) in tetrahydrofuran (60 ml) was added diphenylphosphoryl azide (1.93 ml, 8.98 mmol). Triethylamine (1.71 ml, 12.2 mmol) was added, and the mixture was heated under reflux for 2 hours. After allowing the reaction solution to cool,
Water (200 ml) was added and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to give (4RS, 5SR) -5- (4-fluorophenyl) -4-((4-methyl-3- ((1,1,
2,2-tetrafluoroethyl) oxy) phenyl) methyl) -1,3-oxazolidin-2-one (2.97 g,
91%). 1 H-NMR (CDCl 3 ) δ: 2.23 (3H, s), 2.12-2.30 (2H, m),
4.18-4.30 (1H, m), 5.21 (1H, s), 5.78 (1H, d, J =
8.0 Hz), 5.93 (1H, tt, J = 53.0, 2.6 Hz), 6.80-6.
90 (2H, m), 7.04-7.20 (3H, m), 7.30-7.42 (2H, m) .IRνmax KBr cm -1 : 1759, 1609, 1580, 1514, 1422.mp 112-113 ℃ Anal.Calcd for C 19 H 16 F 5 NO 3 : C, 56.86; H, 4.02; N,
3.49 Found: C, 56.87; H, 3.91; N, 3.59.6) (4RS, 5SR) -5- (4-fluorophenyl) -4-((4-methyl-3-((1,1,2, 2-tetrafluoroethyl) oxy) phenyl) methyl) -1,3-
To a solution of oxazolidine-2-one (2.7 g, 6.73 mmol) in ethanol (10 ml) was added an 8 N aqueous sodium hydroxide solution (4.2 ml, 33.6 mmol), and the mixture was heated under reflux for 4 hours. After concentrating the reaction solution, water (100
ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with brine, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give (1RS, 2SR) -2-amino-1-amino.
(4-fluorophenyl) -3- (4-methyl-3-((1,
There was obtained 1,2,2-tetrafluoroethyl) oxy) phenyl) -1-propanol (2.25 g, 89%). 1 H-NMR (CDCl 3 ) δ: 2.24 (3H, s), 2.33 (1H, dd, J =
14.0, 10.6 Hz), 2.77 (1H, dd, J = 14.0, 3.2 Hz),
3.20-3.32 (1H, m), 4.65 (1H, d, J = 4.8 Hz), 5.93
(1H, tt, J = 53.0, 3.0 Hz), 6.92-7.18 (5H, m), 7.3
0-7.42 (2H, m) .IRνmax KBr cm -1 : 1605, 1582, 1508.mp 112-113 ℃ Anal. Calcd for C 18 H 18 F 5 NO 2 : C, 57.60; H, 4.83; N,
3.73 Found: C, 57.59; H, 4.75; N, 3.73.7) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (4-methyl-3-((1,1 , 2,2-
A solution of tetrafluoroethyl) oxy) phenyl) -1-propanol (300 mg, 0.80 mmol) in acetonitrile (20 ml) was prepared by adding 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (150 mg,
0.80 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (230 m
g, 1.20 mmol) and 1-hydroxy-1H-benzotriazole (123 mg, 0.80 mmol) were added and stirred at room temperature overnight. The reaction solution was water (100 ml)
And extracted with ethyl acetate (100 ml × 2).
1N hydrochloric acid, 1N aqueous sodium hydroxide solution,
The extract was washed successively with saturated saline, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the title compound (363 mg, 83%). 1 H-NMR (CDCl 3 ) δ: 1.90-2.08 (2H, m), 2.12-2.30 (2
H, m), 2.24 (3H, s), 2.60-2.80 (3H, m), 2.95 (1H,
dd, J = 15.0, 4.0 Hz), 4.60-4.76 (1H, m), 5.00 (1
H, d, J = 3.6 Hz), 5.60-6.24 (4H, m), 6.94-7.20 (8
. H, m), 7.38-7.48 ( 2H, m) IRνmax KBr cm -1:. 1640, 1607, 1508, 1447, 1424. mp 168-169 ℃ Anal Calcd for C 30 H 28 F 5 NO 3 · 0.1H 2 O: C, 65.83; H,
5.19; N, 2.56 Found: C, 65.60; H, 4.89; N, 2.82.
【0367】実施例235 N-{(1RS,2SR)-2-(3-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル}-6,7-ジヒドロ-
5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド 1) 3-(3-フルオロフェニル)-3-オキソ-2-[3
-(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]プロパン酸エチル 3-(1,1,2,2-テトラフルオロエトキシ)トルエ
ン(8.91g,42.8ミリモル)の酢酸エチル(1
00ml)溶液にN-ブロモスクシンイミド(8.35
g,46.9ミリモル)および2,2’-アゾビス(イ
ソブチロニトリル)(335mg,2.04ミリモル)
を加え、5時間加熱還流した。反応液を濃縮後、ヘキサ
ンで結晶をろ過し、ろ液を濃縮して3-(1,1,2,
2-テトラフルオロエトキシ)-α-ブロモトルエンを調
製した。3-(3-フルオロフェニル)-3-オキソプロパ
ン酸エチル(8.57g,40.8ミリモル)の1,2
-ジメトキシエタン(80ml)溶液に水素化ナトリウ
ム(60%油性,1.63g,40.8ミリモル)を氷
冷下加え、室温で30分攪拌した。反応液の中に先に調
製した3-(1,1,2,2-テトラフルオロエトキシ)
-α-ブロモトルエンの1,2-ジメトキシエタン(10
ml)溶液を滴下し、反応液を室温で終夜攪拌した。反
応液を水(100ml)の中に注ぎ、酢酸エチル(10
0ml×2)で抽出した。抽出液を水および飽和食塩水
で洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=10:1-6:1)で精製し、酢
酸エチル-ヘキサンから再結晶させて目的物(8.86
g,52%)を得た。1 H-NMR(CDCl3)δ:1.12 (3H, t, J = 7.2 Hz), 3.33 (2
H, d, J = 7.5 Hz), 4.02-4.18 (2H, m), 4.54 (1H, t,
J = 7.2 Hz), 5.89 (1H, tt, J = 53.1, 2.7 Hz), 7.0
2-7.10 (2H, m), 7.14 (1H, d, J = 7.8 Hz), 7.26-7.3
2 (2H, m), 7.38-7.48 (1H, m), 7.60-7.68 (1H, m),
7.72 (1H, d, J = 7.8 Hz). IRν maxKBrcm-1:1738, 1694, 1613, 1590, 1487, 144
5. mp 52-53℃ Anal. Calcd for C20H17O4F5: C, 57.70; H, 4.12 Found : C, 57.72; H, 4.13. 2) (2RS,3RS)-3-(3-フルオロフェニ
ル)-3-ヒドロキシ-2-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]プロパン酸エチル 塩化亜鉛(5.60g,41.1ミリモル)のジエチル
エーテル(140ml)溶液に水素化ホウ素ナトリウム
(3.11g,82.2ミリモル)を加えて室温で30
分攪拌した。不溶物をろ去し、ろ液に3-(3-フルオロ
フェニル)-3-オキソ-2-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]プロパン酸エチル
(8.56g,20.6ミリモル)のジエチルエーテル
(50ml)溶液を0℃にて加えて30分攪拌した。反
応液に1規定塩酸を加えて反応を止め、更に水(100
ml)を加え、酢酸エチル(200ml×2)で抽出し
た。抽出液を水および飽和食塩水で洗浄し、乾燥(無水
硫酸マグネシウム)後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
4:1)で精製し、目的物(7.04g,82%)を無
色油状物として得た。1 H-NMR(CDCl3)δ:0.95 (3H, t, J = 7.0 Hz), 2.86-3.0
6 (3H, m), 3.10 (1H, d, J = 3.0 Hz), 3.92 (2H, q,
J = 7.0 Hz), 5.06 (1H, s), 5.88 (1H, tt, J =53.0,
3.0 Hz), 6.90-7.08 (4H, m), 7.10-7.40 (4H, m). IRν maxKBrcm-1:1724, 1715, 1614, 1591, 1489, 145
1. Anal. Calcd for C20H19O4F5: C, 57.42; H, 4.58 Found : C, 57.36; H, 4.55. 3) (2RS,3RS)-3-(3-フルオロフェニ
ル)-3-ヒドロキシ-2-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]プロパン酸 (2RS,3RS)-3-(3-フルオロフェニル)-3-
ヒドロキシ-2-[3-(1,1,2,2-テトラフルオロ
エトキシ)ベンジル]プロパン酸エチル(6.92g,
16.5ミリモル)のメタノール(50ml)溶液に、
2規定水酸化ナトリウム水溶液(16.5ml,33.
0ミリモル)を加えて室温で2時間攪拌した。反応液を
1規定塩酸で酸性とした後、酢酸エチル(200ml×
2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物を酢酸エチル-ヘキサンから再結晶させて、目的物
(4.28g,66%)を得た。1 H-NMR(CDCl3)δ:2.80-3.16 (3H, m), 5.14 (1H, d, J
= 3.6 Hz), 5.90 (1H, tt, J = 53.0, 3.0 Hz), 6.90-
7.40 (8H, m). IRν maxKBrcm-1:1713, 1615, 1591, 1489, 1451. mp 116-117℃ Anal. Calcd for C18H15O4F5: C, 55.39; H, 3.87 Found : C, 55.42; H, 3.86. 4) (4RS,5SR)-5-(3-フルオロフェニ
ル)-4-[3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]-1,3-オキサゾリジン-2-オン (2RS,3RS)-3-(3-フルオロフェニル)-3-
ヒドロキシ-2-[3-(1,1,2,2-テトラフルオロ
エトキシ)ベンジル]プロパン酸(4.15g,10.
6ミリモル)のテトラヒドロフラン(80ml)溶液
に、ジフェニルホスホリルアジド(2.52ml,1
1.7ミリモル)とトリエチルアミン(2.23ml,
16.0ミリモル)を加え、3時間加熱還流した。反応
液を放冷後、水(200ml)を加えて酢酸エチル(1
00ml×2)で抽出した。抽出液を1規定塩酸、炭酸
水素ナトリウム水溶液、飽和食塩水で順次洗浄し、乾燥
(無水硫酸マグネシウム)後減圧留去した。残留物を酢
酸エチル-ヘキサンから再結晶させて、目的物(3.4
6g,84%)を得た。1 H-NMR(CDCl3)δ:2.20-2.40 (2H, m), 4.20-4.30 (1H,
m), 5.17 (1H, s), 5.80(1H, d, J = 7.8 Hz), 5.90 (1
H, tt, J = 53.1, 2.7 Hz), 6.89 (1H, s), 6.96 (1H,
d, J = 8.1 Hz), 7.04-7.20 (4H, m), 7.24-7.36 (1H,
m), 7.36-7.46 (1H, m). IRν maxKBrcm-1:1767, 1615, 1593, 1489, 1453. mp 110-111℃ Anal. Calcd for C18H14NO3F5: C, 55.82; H, 3.64; N,
3.62 Found : C, 55.81; H, 3.62; N, 3.58. 5) (1RS,2SR)-2-アミノ-1-(3-フルオ
ロフェニル)-3-[3-(1,1,2,2-テトラフルオ
ロエトキシ)フェニル]プロパン-1-オール (4RS,5SR)-5-(3-フルオロフェニル)-4-
[3-(1,1,2,2-テトラフルオロエトキシ)ベン
ジル]-1,3-オキサゾリジン-2-オン(3.30g,
8.52ミリモル)のエタノール(12ml)溶液に8
規定水酸化ナトリウム水溶液(5.3ml,42ミリモ
ル)を加え、5時間加熱還流した。反応液を濃縮後、水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、乾燥
(無水硫酸マグネシウム)後減圧留去し、残留物をジイ
ソプロピルエーテル-ヘキサンから再結晶させて目的物
(2.60g,84%)を得た。1 H-NMR(CDCl3)δ:1.85 (2H, brs), 2.38 (1H, dd, J =
13.8, 10.6 Hz), 2.77 (1H, dd, J = 13.8, 3.4 Hz),
3.24-3.36 (1H, m), 4.69 (1H, d, J = 4.8 Hz),5.89
(1H, tt, J = 53.0, 3.0 Hz), 6.94-7.22 (5H, m), 7.2
2-7.40 (3H, m). IRν maxKBrcm-1:1613, 1590, 1487, 1449, 1304, 127
9. mp 51-52℃ Anal. Calcd for C17H16NO2F5: C, 56.51; H, 4.46; N,
3.88 Found : C, 56.42; H, 4.39; N, 3.72. 6) N-{(1RS,2SR)-2-(3-フルオロフェ
ニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル}-6,7-ジヒ
ドロ-5H-ベンゾ[a][7]アンヌレン-1-カルボキ
サミド (1RS,2SR)-2-アミノ-1-(3-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール(448mg,
1.24ミリモル)のアセトニトリル(20ml)溶液
に6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-
1-カルボン酸(234mg,1.24ミリモル)およ
び1-エチル-3-(3-ジメチルアミノプロピル)カルボ
ジイミド・塩酸塩(357mg,1.86ミリモル)お
よび1-ヒドロキシベンゾトリアゾール水和物(190
mg,1.24ミリモル)を加えて室温で終夜攪拌し
た。反応液を水(100ml)で希釈し、酢酸エチル
(100ml×2)で抽出した。抽出液を1規定塩酸、
1規定水酸化ナトリウム水溶液、飽和食塩水で順次洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物を酢酸エチル-ヘキサンから再結晶させて、目的物
(444mg,67%)を得た。1 H-NMR(CDCl3)δ:1.94-2.06 (2H, m), 2.16-2.24 (2H,
m), 2.62-2.68 (2H, m),2.79 (1H, dd, J = 14.7, 10.8
Hz), 2.96 (1H, dd, J = 14.7, 4.2 Hz), 4.60-4.74
(1H, m), 5.07 (1H, d, J = 3.3 Hz), 5.81 (1H, d, J
= 8.1 Hz), 5.88(1H, tt, J = 53.1, 3.0 Hz), 5.90-6.
00 (1H, m), 6.23 (1H, d, J = 11.7 Hz), 6.94-7.40
(11H, m). IRν maxKBrcm-1:1634, 1615, 1590, 1514, 1489, 145
1. mp 150-155℃ Anal. Calcd for C29H26NO3F5: C, 65.53; H, 4.93; N,
2.64 Found : C, 65.25; H, 4.95; N, 2.66.Example 235 N-{(1RS, 2SR) -2- (3-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro-
5H-benzo [a] [7] annulene-1-carboxamide 1) 3- (3-fluorophenyl) -3-oxo-2- [3
Ethyl-(1,1,2,2-tetrafluoroethoxy) benzyl] propanoate Ethyl acetate of 3- (1,1,2,2-tetrafluoroethoxy) toluene (8.91 g, 42.8 mmol)
00 ml) solution with N-bromosuccinimide (8.35).
g, 46.9 mmol) and 2,2'-azobis (isobutyronitrile) (335 mg, 2.04 mmol)
Was added and heated under reflux for 5 hours. After concentrating the reaction solution, the crystals were filtered with hexane, and the filtrate was concentrated to give 3- (1,1,2,2,3).
2-Tetrafluoroethoxy) -α-bromotoluene was prepared. Ethyl 3- (3-fluorophenyl) -3-oxopropanoate (8.57 g, 40.8 mmol) in 1,2
Sodium hydride (60% oily, 1.63 g, 40.8 mmol) was added to a solution of -dimethoxyethane (80 ml) under ice-cooling, and the mixture was stirred at room temperature for 30 minutes. 3- (1,1,2,2-tetrafluoroethoxy) previously prepared in the reaction solution
1,2-dimethoxyethane of -α-bromotoluene (10
ml) solution was added dropwise and the reaction was stirred at room temperature overnight. The reaction solution was poured into water (100 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1-6: 1) and recrystallized from ethyl acetate-hexane to give the desired product (8.86).
g, 52%). 1 H-NMR (CDCl 3 ) δ: 1.12 (3H, t, J = 7.2 Hz), 3.33 (2
H, d, J = 7.5 Hz), 4.02-4.18 (2H, m), 4.54 (1H, t,
J = 7.2 Hz), 5.89 (1H, tt, J = 53.1, 2.7 Hz), 7.0
2-7.10 (2H, m), 7.14 (1H, d, J = 7.8 Hz), 7.26-7.3
2 (2H, m), 7.38-7.48 (1H, m), 7.60-7.68 (1H, m),
7.72 (1H, d, J = 7.8 Hz) .IRν max KBr cm -1 : 1738, 1694, 1613, 1590, 1487, 144
. 5. mp 52-53 ℃ Anal Calcd for C 20 H 17 O 4 F 5: C, 57.70; H, 4.12 Found:. C, 57.72; H, 4.13 2) (2RS, 3RS) -3- (3- Ethyl fluorophenyl) -3-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate A solution of zinc chloride (5.60 g, 41.1 mmol) in diethyl ether (140 ml) Sodium borohydride (3.11 g, 82.2 mmol) was added to the mixture at room temperature.
Minutes. The insoluble material was removed by filtration, and the filtrate was mixed with ethyl 3- (3-fluorophenyl) -3-oxo-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate (8.56 g). , 20.6 mmol) in diethyl ether (50 ml) was added at 0 ° C. and stirred for 30 minutes. The reaction was quenched by adding 1N hydrochloric acid to the reaction solution, and further added with water (100
ml) and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
4: 1) to give the desired product (7.04 g, 82%) as a colorless oil. 1 H-NMR (CDCl 3 ) δ: 0.95 (3H, t, J = 7.0 Hz), 2.86-3.0
6 (3H, m), 3.10 (1H, d, J = 3.0 Hz), 3.92 (2H, q,
J = 7.0 Hz), 5.06 (1H, s), 5.88 (1H, tt, J = 53.0,
3.0Hz), 6.90-7.08 (4H, m), 7.10-7.40 (4H, m) .IRν max KBr cm -1 : 1724, 1715, 1614, 1591, 1489, 145
. 1. Anal Calcd for C 20 H 19 O 4 F 5: C, 57.42; H, 4.58 Found:. C, 57.36; H, 4.55 3) (2RS, 3RS) -3- (3- fluorophenyl) -3 -Hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoic acid (2RS, 3RS) -3- (3-fluorophenyl) -3-
Ethyl hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate (6.92 g,
16.5 mmol) in methanol (50 ml)
2N aqueous sodium hydroxide solution (16.5 ml, 33.
0 mmol) and stirred at room temperature for 2 hours. After the reaction solution was acidified with 1N hydrochloric acid, ethyl acetate (200 ml ×
Extracted in 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to obtain the desired product (4.28 g, 66%). 1 H-NMR (CDCl 3 ) δ: 2.80-3.16 (3H, m), 5.14 (1H, d, J
= 3.6 Hz), 5.90 (1H, tt, J = 53.0, 3.0 Hz), 6.90-
7.40 (8H, m) .IRν max KBr cm -1 : 1713, 1615, 1591, 1489, 1451.mp 116-117 ℃ Anal.Calcd for C 18 H 15 O 4 F 5 : C, 55.39; H, 3.87 Found : C, 55.42; H, 3.86. 4) (4RS, 5SR) -5- (3-fluorophenyl) -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3 -Oxazolidin-2-one (2RS, 3RS) -3- (3-fluorophenyl) -3-
Hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoic acid (4.15 g, 10.
6 mmol) in tetrahydrofuran (80 ml) was added to diphenylphosphoryl azide (2.52 ml, 1).
1.7 mmol) and triethylamine (2.23 ml,
16.0 mmol) and heated to reflux for 3 hours. After allowing the reaction solution to cool, water (200 ml) was added, and ethyl acetate (1 mL) was added.
00 ml × 2). The extract was washed successively with 1N hydrochloric acid, an aqueous solution of sodium hydrogen carbonate and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the desired product (3.4).
(6 g, 84%). 1 H-NMR (CDCl 3 ) δ: 2.20-2.40 (2H, m), 4.20-4.30 (1H,
m), 5.17 (1H, s), 5.80 (1H, d, J = 7.8 Hz), 5.90 (1
H, tt, J = 53.1, 2.7 Hz), 6.89 (1H, s), 6.96 (1H,
d, J = 8.1 Hz), 7.04-7.20 (4H, m), 7.24-7.36 (1H,
m), 7.36-7.46 (1H, m) .IRν max KBr cm -1 : 1767, 1615, 1593, 1489, 1453.mp 110-111 ℃ Anal.Calcd for C 18 H 14 NO 3 F 5 : C, 55.82 ; H, 3.64; N,
3.62 Found: C, 55.81; H, 3.62; N, 3.58.5) (1RS, 2SR) -2-amino-1- (3-fluorophenyl) -3- [3- (1,1,2,2- Tetrafluoroethoxy) phenyl] propan-1-ol (4RS, 5SR) -5- (3-fluorophenyl) -4-
[3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidin-2-one (3.30 g,
8.52 mmol) in ethanol (12 ml).
A normal aqueous sodium hydroxide solution (5.3 ml, 42 mmol) was added, and the mixture was refluxed for 5 hours. After concentrating the reaction solution, the reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from diisopropyl ether-hexane to obtain the desired product (2.60 g, 84%). 1 H-NMR (CDCl 3 ) δ: 1.85 (2H, brs), 2.38 (1H, dd, J =
13.8, 10.6 Hz), 2.77 (1H, dd, J = 13.8, 3.4 Hz),
3.24-3.36 (1H, m), 4.69 (1H, d, J = 4.8 Hz), 5.89
(1H, tt, J = 53.0, 3.0 Hz), 6.94-7.22 (5H, m), 7.2
2-7.40 (3H, m) .IRν max KBr cm -1 : 1613, 1590, 1487, 1449, 1304, 127
9.mp 51-52 ℃ Anal. Calcd for C 17 H 16 NO 2 F 5 : C, 56.51; H, 4.46; N,
3.88 Found: C, 56.42; H, 4.39; N, 3.72.6) N-{(1RS, 2SR) -2- (3-fluorophenyl) -2-hydroxy-1- [3- (1,1,2 , 2-Tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro-5H-benzo [a] [7] annulene-1-carboxamide (1RS, 2SR) -2-amino-1- (3-fluorophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol (448 mg,
1.24 mmol) in acetonitrile (20 ml) was added to 6,7-dihydro-5H-benzo [a] cycloheptene-
1-carboxylic acid (234 mg, 1.24 mmol), 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (357 mg, 1.86 mmol) and 1-hydroxybenzotriazole hydrate (190
mg, 1.24 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). Extract solution is 1N hydrochloric acid,
The extract was washed sequentially with a 1N aqueous sodium hydroxide solution and a saturated saline solution, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to obtain the desired product (444 mg, 67%). 1 H-NMR (CDCl 3 ) δ: 1.94-2.06 (2H, m), 2.16-2.24 (2H,
m), 2.62-2.68 (2H, m), 2.79 (1H, dd, J = 14.7, 10.8
Hz), 2.96 (1H, dd, J = 14.7, 4.2 Hz), 4.60-4.74
(1H, m), 5.07 (1H, d, J = 3.3 Hz), 5.81 (1H, d, J
= 8.1 Hz), 5.88 (1H, tt, J = 53.1, 3.0 Hz), 5.90-6.
00 (1H, m), 6.23 (1H, d, J = 11.7 Hz), 6.94-7.40
(11H, m) .IRν max KBr cm -1 : 1634, 1615, 1590, 1514, 1489, 145
1.mp 150-155 ℃ Anal. Calcd for C 29 H 26 NO 3 F 5 : C, 65.53; H, 4.93; N,
2.64 Found: C, 65.25; H, 4.95; N, 2.66.
【0368】実施例236 N-{(1RS,2SR)-2-[4-(ベンジルオキシ)
フェニル]-2-ヒドロキシ-1-[3-(1,1,2,2-
テトラフルオロエトキシ)ベンジル]エチル}-6,7-
ジヒドロ-5H-ベンゾ[a][7]アンヌレン-1-カル
ボキサミド 1) 4-ベンジルオキシアセトフェノン 4-ヒドロキシアセトフェノン(25g,184ミリモ
ル)のアセトン(500ml)溶液に炭酸カリウム(5
0.7g,367ミリモル)およびベンジルブロミド
(32g,187ミリモル)を加えて室温で終夜攪拌し
た。反応液を濃縮後、水(500ml)で希釈し、酢酸
エチル(500ml×2)で抽出した。抽出液を水、飽
和食塩水で順次洗浄し、乾燥(無水硫酸マグネシウム)
後減圧留去した。残留物を酢酸エチル-ヘキサンから再
結晶させて、目的物(36.8g,89%)を得た。1 H-NMR(CDCl3)δ:2.56 (3H, s), 5.13 (2H, s), 7.01
(2H, d, J = 9.0 Hz), 7.30-7.44 (5H, m), 7.94 (2H,
d, J = 9.0 Hz). IRν maxKBrcm-1:1674, 1601, 1576, 1508, 1454, 142
0. mp 87-88℃ Anal. Calcd for C15H14O2 C, 79.62; H, 6.24 Found : C, 79.68; H, 6.23. 2) 3-[4-(ベンジルオキシ)フェニル]-3-オキ
ソプロパン酸エチル 4-ベンジルオキシアセトフェノン(36g,159ミ
リモル)の炭酸ジエチル(200ml)溶液にエタノー
ル(0.6ml)を加え、氷冷下水素化ナトリウム(6
0%油性,12.7g,318ミリモル)を加え、室温
で2時間攪拌した。反応液に6規定塩酸を加え反応を止
め、水(500ml)を加え酢酸エチル(500ml×
2)で抽出した。抽出液を水、飽和食塩水で順次洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(酢酸エチ
ル)で精製し、酢酸エチル-ヘキサンから再結晶させて
目的物(49.3g,100%)を得た。1 H-NMR(CDCl3)δ:1.26 (3H, t, J = 7.2 Hz), 3.94 (2
H, s), 4.21 (2H, q, J =7.2 Hz), 5.14 (2H, s), 6.98
-7.06 (2H, m), 7.30-7.48 (5H, m), 7.88-7.96(2
H, m). IRν maxKBrcm-1:1740, 1678, 1601, 1576, 1510. mp 53-54℃ Anal. Calcd for C18H18O4 C, 72.47; H, 6.08 Found : C, 72.56; H, 6.10. 3) 3-[4-(ベンジルオキシ)フェニル]-3-オキ
ソ-2-[3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]プロパン酸エチル 3-(1,1,2,2-テトラフルオロエトキシ)トルエ
ン(27.8g,133ミリモル)の酢酸エチル(25
0ml)溶液にN-ブロモスクシンイミド(26.1
g,147ミリモル)および2,2’-アゾビス(イソ
ブチロニトリル)(440mg,2.67ミリモル)を
加え、5時間加熱還流した。反応液を濃縮後、ヘキサン
で結晶をろ過し、ろ液を濃縮して3-(1,1,2,2-
テトラフルオロエトキシ)-α-ブロモトルエンを調製し
た。3-[4-(ベンジルオキシ)フェニル]-3-オキソ
プロパン酸エチル(37.8g,127ミリモル)の
1,2-ジメトキシエタン(250ml)溶液に水素化
ナトリウム(60%油性,5.07g,127ミリモ
ル)を氷冷下加え、室温で30分攪拌した。反応液の中
に先に調製した3-(1,1,2,2-テトラフルオロエ
トキシ)-α-ブロモトルエンの1,2-ジメトキシエタ
ン(50ml)溶液を滴下し、反応液を室温で終夜攪拌
した。反応液を水(500ml)の中に注ぎ、酢酸エチ
ル(500ml×2)で抽出した。抽出液を水および飽
和食塩水で洗浄し、乾燥(無水硫酸マグネシウム)後減
圧留去した。残留物をシリカゲルカラムクロマトグラフ
ィー(ヘキサン:酢酸エチル=4:1-1:1)で精製
し、酢酸エチル-ヘキサンから再結晶させて目的物(4
3.4g,68%)を得た。1 H-NMR(CDCl3)δ:1.12 (3H, t, J = 7.0 Hz), 3.20-3.4
2 (2H, m), 4.09 (2H, q, J = 7.0 Hz), 4.56 (1H, t,
J = 7.4 Hz), 5.12 (2H, s), 5.88 (1H, tt, J =53.0,
3.0 Hz), 6.92-7.50 (11H, m), 7.88-8.00 (2H, m). IRν maxKBrcm-1:1732, 1680, 1601, 1576, 1510, 145
4, 1422. mp 71-72℃ Anal. Calcd for C27H24O5F4 C, 64.28; H, 4.80 Found : C, 64.47; H, 4.78. 4) (2RS,3RS)-3-[4-(ベンジルオキ
シ)フェニル]-3-ヒドロキシ-2-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]プロパン
酸エチル 塩化亜鉛(18.9g,139ミリモル)のジエチルエ
ーテル(500ml)溶液に水素化ホウ素ナトリウム
(10.5g,278ミリモル)を加えて室温で30分
攪拌した。不溶物をろ去し、ろ液に3-[4-(ベンジル
オキシ)フェニル]-3-オキソ-2-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]プロパン
酸エチル(35.0g,69.4ミリモル)のジエチル
エーテル(200ml)溶液を0℃にて加えて30分攪
拌した。反応液に1規定塩酸を加えて反応を止め、更に
水(500ml)を加え、酢酸エチル(500ml×
2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=4:1)で精製し、酢酸エチル-ヘキ
サンから再結晶させて目的物(30.3g,86%)を
得た。1 H-NMR(CDCl3)δ:0.91 (3H, t, J = 7.0 Hz), 2.77 (1
H, d, J = 2.8 Hz), 2.90-3.08 (3H, m), 3.87 (2H, q,
J = 7.0 Hz), 4.92-5.00 (1H, m), 5.06 (2H, s), 5.8
8 (1H, tt, J = 53.0, 3.0 Hz), 6.92-7.08 (5H, m),
7.20-7.50 (8H, m). IRν maxKBrcm-1:1725, 1611, 1586, 1512, 1487, 145
4. mp 67-68℃ Anal. Calcd for C27H26O5F4 C, 64.03; H, 5.17 Found : C, 64.02; H, 5.15. 5) (2RS,3RS)-3-[4-(ベンジルオキ
シ)フェニル]-3-ヒドロキシ-2-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]プロパン
酸 (2RS,3RS)-3-[4-(ベンジルオキシ)フェ
ニル]-3-ヒドロキシ-2-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]プロパン酸エチル(2
5.0g,49.4ミリモル)のメタノール(200m
l)溶液に、2規定水酸化ナトリウム水溶液(49.0
ml,98.0ミリモル)を加えて室温で終夜攪拌し
た。反応液を1規定塩酸で酸性とした後、酢酸エチル
(500ml×2)で抽出した。抽出液を水および飽和
食塩水で洗浄し、乾燥(無水硫酸マグネシウム)後減圧
留去した。残留物をシリカゲルカラムクロマトグラフィ
ー(酢酸エチル)で精製し、酢酸エチル-ヘキサンから
再結晶させて、目的物(21g,89%)を得た。1 H-NMR(CDCl3)δ:2.90-3.08 (3H, m), 5.02 (1H, d, J
= 3.9 Hz), 5.05 (2H, s), 5.86 (1H, tt, J = 53.1,
3.0 Hz), 6.90-7.48 (13H, m). IRν maxKBrcm-1:1709, 1611, 1586, 1512, 1489, 145
4. mp 76-77℃ Anal. Calcd for C25H22O5F4 C, 62.76; H, 4.63 Found : C, 62.98; H, 4.57. 6) (4RS,5SR)-5-[4-(ベンジルオキ
シ)フェニル]-4-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]-1,3-オキサゾリジン-2-
オン (2RS,3RS)-3-[4-(ベンジルオキシ)フェ
ニル]-3-ヒドロキシ-2-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]プロパン酸(21.0
g,43.9ミリモル)のテトラヒドロフラン(300
ml)溶液に、ジフェニルホスホリルアジド(10.4
ml,48.3ミリモル)とトリエチルアミン(9.2
ml,65.9ミリモル)を加え、2時間加熱還流し
た。反応液を放冷後、水(400ml)を加えて酢酸エ
チル(200ml×2)で抽出した。抽出液を1規定塩
酸、炭酸水素ナトリウム水溶液、飽和食塩水で順次洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=1:1)で精製し酢酸エチル-ヘキサ
ンから再結晶させて、目的物(16.4g,79%)を
得た。1 H-NMR(CDCl3)δ:2.22-2.40 (2H, m), 4.16-4.30 (1H,
m), 5.08 (2H, s), 5.25(1H, s), 5.75 (1H, d, J = 8.
0 Hz), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.80-7.50
(13H, m). IRν maxKBrcm-1:1759, 1613, 1588, 1514, 1489, 145
4. mp 115-116℃ Anal. Calcd for C25H21NO4F4: C, 63.16; H, 4.45; N,
2.95 Found : C, 62.89; H, 4.48; N, 2.75. 7) (1RS,2SR)-2-アミノ-1-[4-(ベン
ジルオキシ)フェニル]-3-[3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル]プロパン-1-オール (4RS,5SR)-5-[4-(ベンジルオキシ)フェ
ニル]-4-[3-(1,1,2,2-テトラフルオロエト
キシ)ベンジル]-1,3-オキサゾリジン-2-オン
(2.50g,5.26ミリモル)のエタノール(30
ml)溶液に8規定水酸化ナトリウム水溶液(2ml,
16ミリモル)を加え、5時間加熱還流した。反応液を
濃縮後、水(100ml)で希釈し、酢酸エチル(10
0ml×2)で抽出した。抽出液を飽和食塩水で洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去して目的
物(2.4g,100%)を得た。1 H-NMR(CDCl3)δ:1.69 (2H, brs), 2.40 (1H, dd, J =
13.8, 10.2 Hz), 2.90 (1H, dd, J = 13.8, 3.0 Hz),
3.22-3.30 (1H, m), 4.59 (1H, d, J = 5.4 Hz),5.08
(2H, s), 5.89 (1H, tt, J = 53.1, 3.0 Hz), 6.96-7.1
0 (5H, m), 7.26-7.50 (8H, m). IRν maxKBrcm-1:1611, 1586, 1510, 1487, 1454. Anal. Calcd for C24H23NO3F4: C, 64.14; H, 5.16; N,
3.12 Found : C, 63.87; H, 5.20; N, 2.96. 8) N-{(1RS,2SR)-2-[4-(ベンジルオ
キシ)フェニル]-2-ヒドロキシ-1-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]エチル}-
6,7-ジヒドロ-5H-ベンゾ[a][7]アンヌレン-
1-カルボキサミド(1RS,2SR)-2-アミノ-1-
[4-(ベンジルオキシ)フェニル]-3-[3-(1,
1,2,2-テトラフルオロエトキシ)フェニル]プロ
パン-1-オール(617mg,1.37ミリモル)のア
セトニトリル(20ml)溶液に6,7-ジヒドロ-5H
-ベンゾ[a]シクロヘプテン-1-カルボン酸(258
mg,1.37ミリモル)および1-エチル-3-(3-ジ
メチルアミノプロピル)カルボジイミド・塩酸塩(39
4mg,2.06ミリモル)および1-ヒドロキシベン
ゾトリアゾール水和物(210mg,1.37ミリモ
ル)を加えて室温で終夜攪拌した。反応液を水(100
ml)で希釈し、酢酸エチル(100ml×2)で抽出
した。抽出液を1規定塩酸、1規定水酸化ナトリウム水
溶液、飽和食塩水で順次洗浄し、乾燥(無水硫酸マグネ
シウム)後減圧留去した。残留物を酢酸エチル-ヘキサ
ンから再結晶させて、目的物(474mg,56%)を
得た。1 H-NMR(CDCl3)δ:1.94-2.04 (2H, m), 2.12-2.24 (2H,
m), 2.62-2.70 (2H, m),2.78 (1H, dd, J = 14.7, 10.5
Hz), 3.02 (1H, dd, J = 14.7, 4.2 Hz), 3.40(1H, br
s), 4.64-4.76 (1H, m), 4.97 (1H, d, J = 3.9 Hz),
5.07 (2H, s), 5.72 (1H, d, J = 9.9 Hz), 5.70-6.08
(2H, m), 6.19 (1H, d, J = 11.7 Hz), 6.92-7.18 (8H,
m), 7.26-7.48 (8H, m). IRν maxKBrcm-1:1644, 1613, 1586, 1510, 1454. mp 115-116℃ Anal. Calcd for C36H33NO4F4・0.1H2O: C, 69.58; H,
5.38; N, 2.25 Found : C, 69.45; H, 5.40; N, 2.27.Example 236 N-{(1RS, 2SR) -2- [4- (benzyloxy)
Phenyl] -2-hydroxy-1- [3- (1,1,2,2-
Tetrafluoroethoxy) benzyl] ethyl} -6,7-
Dihydro-5H-benzo [a] [7] annulene-1-carboxamide 1) 4-benzyloxyacetophenone Potassium carbonate (5 ml) was added to a solution of 4-hydroxyacetophenone (25 g, 184 mmol) in acetone (500 ml).
0.7 g, 367 mmol) and benzyl bromide (32 g, 187 mmol) were added, and the mixture was stirred at room temperature overnight. After concentration, the reaction solution was diluted with water (500 ml) and extracted with ethyl acetate (500 ml × 2). The extract is washed sequentially with water and saturated saline, and dried (anhydrous magnesium sulfate)
After that, it was distilled off under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to obtain the desired product (36.8 g, 89%). 1 H-NMR (CDCl 3 ) δ: 2.56 (3H, s), 5.13 (2H, s), 7.01
(2H, d, J = 9.0 Hz), 7.30-7.44 (5H, m), 7.94 (2H,
d, J = 9.0 Hz) .IRν max KBr cm -1 : 1674, 1601, 1576, 1508, 1454, 142
. 0. mp 87-88 ℃ Anal Calcd for C 15 H 14 O 2 C, 79.62; H, 6.24 Found:. C, 79.68; H, 6.23 2) 3- [4- ( benzyloxy) phenyl] -3- Ethyl oxopropanoate Ethanol (0.6 ml) was added to a solution of 4-benzyloxyacetophenone (36 g, 159 mmol) in diethyl carbonate (200 ml), and sodium hydride (6 ml) was added under ice cooling.
(0% oily, 12.7 g, 318 mmol) and stirred at room temperature for 2 hours. 6N hydrochloric acid was added to the reaction solution to stop the reaction, water (500 ml) was added, and ethyl acetate (500 ml ×
Extracted in 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to obtain the desired product (49.3 g, 100%). 1 H-NMR (CDCl 3 ) δ: 1.26 (3H, t, J = 7.2 Hz), 3.94 (2
H, s), 4.21 (2H, q, J = 7.2 Hz), 5.14 (2H, s), 6.98
-7.06 (2H, m), 7.30-7.48 (5H, m), 7.88-7.96 (2
H, m). IRν max KBr cm -1 : 1740, 1678, 1601, 1576, 1510.mp 53-54 ° C Anal.Calcd for C 18 H 18 O 4 C, 72.47; H, 6.08 Found: C, 72.56; H, 6.10.3 ) Ethyl 3- [4- (benzyloxy) phenyl] -3-oxo-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate -Tetrafluoroethoxy) toluene (27.8 g, 133 mmol) in ethyl acetate (25
0 ml) solution with N-bromosuccinimide (26.1).
g, 147 mmol) and 2,2′-azobis (isobutyronitrile) (440 mg, 2.67 mmol) were added, and the mixture was refluxed for 5 hours. After concentrating the reaction solution, the crystals were filtered with hexane, and the filtrate was concentrated to give 3- (1,1,2,2-
Tetrafluoroethoxy) -α-bromotoluene was prepared. To a solution of ethyl 3- [4- (benzyloxy) phenyl] -3-oxopropanoate (37.8 g, 127 mmol) in 1,2-dimethoxyethane (250 ml) was added sodium hydride (60% oil, 5.07 g, (127 mmol) under ice-cooling and stirred at room temperature for 30 minutes. The previously prepared solution of 3- (1,1,2,2-tetrafluoroethoxy) -α-bromotoluene in 1,2-dimethoxyethane (50 ml) was added dropwise to the reaction solution, and the reaction solution was allowed to stand at room temperature overnight. Stirred. The reaction solution was poured into water (500 ml) and extracted with ethyl acetate (500 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-1: 1) and recrystallized from ethyl acetate-hexane to give the desired product (4.
(3.4 g, 68%). 1 H-NMR (CDCl 3 ) δ: 1.12 (3H, t, J = 7.0 Hz), 3.20-3.4
2 (2H, m), 4.09 (2H, q, J = 7.0 Hz), 4.56 (1H, t,
J = 7.4 Hz), 5.12 (2H, s), 5.88 (1H, tt, J = 53.0,
3.0Hz), 6.92-7.50 (11H, m), 7.88-8.00 (2H, m) .IRν max KBr cm -1 : 1732, 1680, 1601, 1576, 1510, 145
4, 1422. mp 71-72 ° C Anal. Calcd for C 27 H 24 O 5 F 4 C, 64.28; H, 4.80 Found: C, 64.47; H, 4.78. 4) (2RS, 3RS) -3- [4 -(Benzyloxy) phenyl] -3-hydroxy-2- [3- (1,1,
Ethyl 2,2-tetrafluoroethoxy) benzyl] propanoate To a solution of zinc chloride (18.9 g, 139 mmol) in diethyl ether (500 ml) was added sodium borohydride (10.5 g, 278 mmol) for 30 minutes at room temperature. Stirred. The insoluble material was removed by filtration, and the filtrate was subjected to 3- [4- (benzyloxy) phenyl] -3-oxo-2- [3- (1,1,1).
A solution of ethyl 2,2-tetrafluoroethoxy) benzyl] propanoate (35.0 g, 69.4 mmol) in diethyl ether (200 ml) was added at 0 ° C., and the mixture was stirred for 30 minutes. 1N hydrochloric acid was added to the reaction solution to stop the reaction, water (500 ml) was further added, and ethyl acetate (500 ml ×
Extracted in 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to obtain the desired product (30.3 g, 86%). 1 H-NMR (CDCl 3 ) δ: 0.91 (3H, t, J = 7.0 Hz), 2.77 (1
H, d, J = 2.8 Hz), 2.90-3.08 (3H, m), 3.87 (2H, q,
J = 7.0 Hz), 4.92-5.00 (1H, m), 5.06 (2H, s), 5.8
8 (1H, tt, J = 53.0, 3.0 Hz), 6.92-7.08 (5H, m),
7.20-7.50 (8H, m) .IRν max KBr cm -1 : 1725, 1611, 1586, 1512, 1487, 145
. 4. mp 67-68 ℃ Anal Calcd for C 27 H 26 O 5 F 4 C, 64.03; H, 5.17 Found:. C, 64.02; H, 5.15 5) (2RS, 3RS) -3- [4- ( Benzyloxy) phenyl] -3-hydroxy-2- [3- (1,1,
2,2-Tetrafluoroethoxy) benzyl] propanoic acid (2RS, 3RS) -3- [4- (benzyloxy) phenyl] -3-hydroxy-2- [3- (1,1,2,2-tetrafluoro) Ethoxy) benzyl] ethyl propanoate (2
5.0 g, 49.4 mmol) of methanol (200 m
l) A 2N aqueous sodium hydroxide solution (49.0) was added to the solution.
ml, 98.0 mmol) and stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid, and then extracted with ethyl acetate (500 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to obtain the desired product (21 g, 89%). 1 H-NMR (CDCl 3 ) δ: 2.90-3.08 (3H, m), 5.02 (1H, d, J
= 3.9 Hz), 5.05 (2H, s), 5.86 (1H, tt, J = 53.1,
3.0Hz), 6.90-7.48 (13H, m) .IRν max KBr cm -1 : 1709, 1611, 1586, 1512, 1489, 145
4. mp 76-77 ° C Anal. Calcd for C 25 H 22 O 5 F 4 C, 62.76; H, 4.63 Found: C, 62.98; H, 4.57.6) (4RS, 5SR) -5- [4- ( Benzyloxy) phenyl] -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine-2-
On (2RS, 3RS) -3- [4- (benzyloxy) phenyl] -3-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoic acid (21.0
g, 43.9 mmol) of tetrahydrofuran (300
ml) solution in diphenylphosphoryl azide (10.4
ml, 48.3 mmol) and triethylamine (9.2).
ml, 65.9 mmol) and heated to reflux for 2 hours. After allowing the reaction solution to cool, water (400 ml) was added, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed successively with 1N hydrochloric acid, an aqueous solution of sodium hydrogen carbonate and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1) and recrystallized from ethyl acetate-hexane to obtain the desired product (16.4 g, 79%). 1 H-NMR (CDCl 3 ) δ: 2.22-2.40 (2H, m), 4.16-4.30 (1H,
m), 5.08 (2H, s), 5.25 (1H, s), 5.75 (1H, d, J = 8.
0 Hz), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 6.80-7.50
(13H, m) .IRν max KBr cm -1 : 1759, 1613, 1588, 1514, 1489, 145
4.mp 115-116 ℃ Anal. Calcd for C 25 H 21 NO 4 F 4 : C, 63.16; H, 4.45; N,
2.95 Found: C, 62.89; H, 4.48; N, 2.5.7. 7) (1RS, 2SR) -2-amino-1- [4- (benzyloxy) phenyl] -3- [3- (1,1,2 , 2-Tetrafluoroethoxy) phenyl] propan-1-ol (4RS, 5SR) -5- [4- (benzyloxy) phenyl] -4- [3- (1,1,2,2-tetrafluoroethoxy) Benzyl] -1,3-oxazolidin-2-one (2.50 g, 5.26 mmol) in ethanol (30
8N aqueous sodium hydroxide solution (2 ml,
(16 mmol) and heated under reflux for 5 hours. After the reaction solution was concentrated, it was diluted with water (100 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure to give the desired product (2.4 g, 100%). 1 H-NMR (CDCl 3 ) δ: 1.69 (2H, brs), 2.40 (1H, dd, J =
13.8, 10.2 Hz), 2.90 (1H, dd, J = 13.8, 3.0 Hz),
3.22-3.30 (1H, m), 4.59 (1H, d, J = 5.4 Hz), 5.08
(2H, s), 5.89 (1H, tt, J = 53.1, 3.0 Hz), 6.96-7.1
.. 0 (5H, m) , 7.26-7.50 (8H, m) IRν max KBr cm -1: 1611, 1586, 1510, 1487, 1454. Anal Calcd for C 24 H 23 NO 3 F 4: C, 64.14; H, 5.16; N,
3.12 Found: C, 63.87; H, 5.20; N, 2.96.8) N-{(1RS, 2SR) -2- [4- (benzyloxy) phenyl] -2-hydroxy-1- [3- (1, 1,
2,2-tetrafluoroethoxy) benzyl] ethyl}-
6,7-dihydro-5H-benzo [a] [7] annulene-
1-carboxamide (1RS, 2SR) -2-amino-1-
[4- (benzyloxy) phenyl] -3- [3- (1,
6,7-Dihydro-5H was added to a solution of 1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol (617 mg, 1.37 mmol) in acetonitrile (20 ml).
-Benzo [a] cycloheptene-1-carboxylic acid (258
mg, 1.37 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (39
4 mg, 2.06 mmol) and 1-hydroxybenzotriazole hydrate (210 mg, 1.37 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was washed with water (100
ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the desired product (474 mg, 56%). 1 H-NMR (CDCl 3 ) δ: 1.94-2.04 (2H, m), 2.12-2.24 (2H,
m), 2.62-2.70 (2H, m), 2.78 (1H, dd, J = 14.7, 10.5
Hz), 3.02 (1H, dd, J = 14.7, 4.2 Hz), 3.40 (1H, br
s), 4.64-4.76 (1H, m), 4.97 (1H, d, J = 3.9 Hz),
5.07 (2H, s), 5.72 (1H, d, J = 9.9 Hz), 5.70-6.08
(2H, m), 6.19 (1H, d, J = 11.7 Hz), 6.92-7.18 (8H,
. m), 7.26-7.48 (8H, m) IRν max KBr cm -1:. 1644, 1613, 1586, 1510, 1454. mp 115-116 ℃ Anal Calcd for C 36 H 33 NO 4 F 4 · 0.1H 2 O: C, 69.58; H,
5.38; N, 2.25 Found: C, 69.45; H, 5.40; N, 2.27.
【0369】実施例237 N-{(1RS,2SR)-2-(3-クロロフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル}-6,7-ジヒドロ-
5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド 1) 3-(3-クロロフェニル)-3-オキソプロパン酸
エチル 3-クロロアセトフェノン(23.9g,154ミリモ
ル)の炭酸ジエチル(150ml)溶液にエタノール
(0.3ml)を加え、氷冷下水素化ナトリウム(60
%油性,12.4g,309ミリモル)を加え、室温で
2時間攪拌した。反応液に6規定塩酸を加え反応を止
め、水(500ml)を加え酢酸エチル(500ml×
2)で抽出した。抽出液を水、飽和食塩水で順次洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=50:1-5:1)で精製し、目的物
(24.8g,71%)を得た。1 H-NMR(CDCl3)δ:1.20-1.40 (3H, m), 3.97 (2H×3/4,
s), 4.16-4.32 (2H, m),5.65 (1H×1/4, s), 7.30-7.50
(1H, m), 7.54-7.68 (1H, m), 7.76-7.84 (1H,m), 7.9
0-7.96 (1H, m). IRν maxKBrcm-1:1740, 1694, 1651, 1628, 1568, 147
4. Anal. Calcd for C11H11O3Cl: C, 58.29; H, 4.89 Found : C, 58.54; H, 4.84. 2) 3-(3-クロロフェニル)-3-オキソ-2-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]プロパン酸エチル 3-(1,1,2,2-テトラフルオロエトキシ)トルエ
ン(10.2g,49.0ミリモル)の酢酸エチル(8
0ml)溶液にN-ブロモスクシンイミド(9.6g,
53.9ミリモル)および2,2’-アゾビス(イソブ
チロニトリル)(161mg,0.98ミリモル)を加
え、5時間加熱還流した。反応液を濃縮後、ヘキサンで
結晶をろ過し、ろ液を濃縮して3-(1,1,2,2-テ
トラフルオロエトキシ)-α-ブロモトルエンを調製し
た。3-(3-クロロフェニル)-3-オキソプロパン酸エ
チル(10.0g,44.1ミリモル)の1,2-ジメ
トキシエタン(100ml)溶液に水素化ナトリウム
(60%油性,1.76g,44.1ミリモル)を氷冷
下加え、室温で30分攪拌した。反応液の中に先に調製
した3-(1,1,2,2-テトラフルオロエトキシ)-
α-ブロモトルエンの1,2-ジメトキシエタン(50m
l)溶液を滴下し、反応液を室温で終夜攪拌した。反応
液を水(300ml)の中に注ぎ、酢酸エチル(300
ml×2)で抽出した。抽出液を水および飽和食塩水で
洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=4:1-1:1)で精製し、目的
物(7.5g,39%)を得た。1 H-NMR(CDCl3)δ:1.13 (3H, t, J = 7.2 Hz), 3.33 (2
H, d, J = 7.4 Hz), 4.02-4.20 (2H, m), 4.54 (1H, t,
J = 7.2 Hz), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 7.0
0-7.20 (2H, m), 7.20-7.46 (2H, m), 7.50-7.60 (1H,
m), 7.78-7.84 (1H, m), 7.90-7.98 (1H, m). IRν maxKBrcm-1:1738, 1694, 1613, 1588, 1572. 3) (2RS,3RS)-3-(3-クロロフェニル)-
3-ヒドロキシ-2-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]プロパン酸エチル 塩化亜鉛(4.66g,34.2ミリモル)のジエチル
エーテル(100ml)溶液に水素化ホウ素ナトリウム
(2.59g,68.4ミリモル)を加えて室温で30
分攪拌した。不溶物をろ去し、ろ液に3-(3-クロロフ
ェニル)-3-オキソ-2-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]プロパン酸エチル(7.
40g,17.1ミリモル)のジエチルエーテル(30
ml)溶液を0℃にて加えて30分攪拌した。反応液に
1規定塩酸を加えて反応を止め、更に水(100ml)
を加え、酢酸エチル(100ml×2)で抽出した。抽
出液を水および飽和食塩水で洗浄し、乾燥(無水硫酸マ
グネシウム)後減圧留去した。残留物をシリカゲルカラ
ムクロマトグラフィー(ヘキサン:酢酸エチル=4:
1)で精製し、目的物(6.6g,89%)を得た。1 H-NMR(CDCl3)δ:0.95 (3H, t, J = 7.2 Hz), 2.90-3.0
8 (3H, m), 3.10-3.16 (1H, m), 3.91 (2H, q, J = 7.2
Hz), 5.02 (1H, s), 5.88 (1H, tt, J = 53.1,3.0 H
z), 6.92-7.08 (3H, m), 7.20-7.32 (4H, m), 7.42 (1
H, s). IRν maxKBrcm-1:1725, 1613, 1588, 1487, 1449. Anal. Calcd for C20H19O4ClF4: C, 55.25; H, 4.40 Found : C, 58.33; H, 4.43. 4) (2RS,3RS)-3-(3-クロロフェニル)-
3-ヒドロキシ-2-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]プロパン酸 (2RS,3RS)-3-(3-クロロフェニル)-3-ヒ
ドロキシ-2-[3-(1,1,2,2-テトラフルオロエ
トキシ)ベンジル]プロパン酸エチル(6.08g,1
4.0ミリモル)のメタノール(30ml)溶液に、2
規定水酸化ナトリウム水溶液(14ml,28ミリモ
ル)を加えて室温で2時間攪拌した。反応液を1規定塩
酸で酸性とした後、酢酸エチル(200ml×2)で抽
出した。抽出液を水および飽和食塩水で洗浄し、乾燥
(無水硫酸マグネシウム)後減圧留去した。残留物を酢
酸エチル-ヘキサンから再結晶させて、目的物(4.6
g,81%)を得た。1 H-NMR(CDCl3)δ:2.80-3.12 (3H, m), 5.11 (1H, d, J
= 3.6 Hz), 5.88 (1H, tt, J = 53.2, 3.0 Hz), 6.90-
7.10 (3H, m), 7.18-7.32 (4H, m), 7.42 (1H, s). IRν maxKBrcm-1:1713, 1613, 1588, 1489, 1451.mp
94−95℃ Anal. Calcd for C18H15O4F4: C, 53.15; H, 3.72 Found : C, 53.03; H, 3.69. 5) (4RS,5SR)-5-(3-クロロフェニル)-
4-[3-(1,1,2,2-テトラフルオロエトキシ)
ベンジル]-1,3-オキサゾリジン-2-オン (2RS,3RS)-3-(3-クロロフェニル)-3-ヒ
ドロキシ-2-[3-(1,1,2,2-テトラフルオロエ
トキシ)ベンジル]プロパン酸(4.50g,11.1
ミリモル)のテトラヒドロフラン(90ml)溶液に、
ジフェニルホスホリルアジド(2.62ml,12.2
ミリモル)とトリエチルアミン(2.32ml,16.
6ミリモル)を加え、4時間加熱還流した。反応液を放
冷後、水(200ml)を加えて酢酸エチル(100m
l×2)で抽出した。抽出液を1規定塩酸、炭酸水素ナ
トリウム水溶液、飽和食塩水で順次洗浄し、乾燥(無水
硫酸マグネシウム)後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(酢酸エチル)および中性
アルミナカラムクロマトグラフィー(酢酸エチル)で精
製し、酢酸エチル-ヘキサンから再結晶させて、目的物
(4.70g,100%)を得た。1 H-NMR(CDCl3)δ:2.20-2.42 (2H, m), 4.20-4.34 (1H,
m), 5.06 (1H, s), 5.78(1H, d, J = 8.0 Hz), 5.90 (1
H, tt, J = 53.0, 2.6 Hz), 6.89 (1H, s), 6.96 (1H,
d, J = 7.6 Hz), 7.06-7.18 (1H, m), 7.20-7.44 (5H,
m). IRν maxKBrcm-1:1767, 1613, 1588, 1489, 1435. mp 102-103℃ Anal. Calcd for C18H14NO3ClF4: C, 53.55; H, 3.49;
N, 3.47 Found : C, 53.57; H, 3.55; N, 3.38. 6) (1RS,2SR)-2-アミノ-1-(3-クロロ
フェニル)-3-[3-(1,1,2,2-テトラフルオロ
エトキシ)フェニル]プロパン-1-オール (4RS,5SR)-5-(3-クロロフェニル)-4-
[3-(1,1,2,2-テトラフルオロエトキシ)ベン
ジル]-1,3-オキサゾリジン-2-オン(3.70g,
9.16ミリモル)のエタノール(30ml)溶液に8
規定水酸化ナトリウム水溶液(5.7ml,46ミリモ
ル)を加え、3時間加熱還流した。反応液を濃縮後、水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、乾燥
(無水硫酸マグネシウム)後減圧留去し、目的物(3.
0g,87%)を得た。1 H-NMR(CDCl3)δ:2.38 (1H, dd, J = 14.0, 10.2 Hz),
2.77 (1H, dd, J = 14.0, 3.0 Hz), 3.24-3.36 (1H,
m), 4.67 (1H, d, J = 4.8 Hz), 5.90 (1H, tt, J= 53.
0, 3.0 Hz), 6.94-7.18 (3H, m), 7.22-7.43 (5H, m). IRν maxKBrcm-1:1613, 1586, 1487, 1449, 1431. 7) N-{(1RS,2SR)-2-(3-クロロフェニ
ル)-2-ヒドロキシ-1-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]エチル}-6,7-ジヒド
ロ-5H-ベンゾ[a][7]アンヌレン-1-カルボキサ
ミド (1RS,2SR)-2-アミノ-1-(3-クロロフェニ
ル)-3-[3-(1,1,2,2-テトラフルオロエトキ
シ)フェニル]プロパン-1-オール(448mg,1.
24ミリモル)のアセトニトリル(20ml)溶液に
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボン酸(234mg,1.24ミリモル)および
1-エチル-3-(3-ジメチルアミノプロピル)カルボジ
イミド・塩酸塩(357mg,1.86ミリモル)およ
び1-ヒドロキシベンゾトリアゾール水和物(190m
g,1.24ミリモル)を加えて室温で終夜攪拌した。
反応液を水(100ml)で希釈し、酢酸エチル(10
0ml×2)で抽出した。抽出液を1規定塩酸、1規定
水酸化ナトリウム水溶液、飽和食塩水で順次洗浄し、乾
燥(無水硫酸マグネシウム)後減圧留去した。残留物を
酢酸エチル-ヘキサンから再結晶させて、目的物(44
4mg,67%)を得た。1 H-NMR(CDCl3)δ:1.92-2.04 (2H, m), 2.10-2.24 (2H,
m), 2.60-2.70 (2H, m),2.73-2.82 (1H, m), 2.90-3.00
(1H, m), 3.87 (1H, d, J = 3.6 Hz), 4.60-4.70 (1H,
m), 5.00-5.06 (1H, m), 5.70-6.08 (2H, m), 5.80 (1
H, d, J = 8.4 Hz), 6.22 (1H, d, J = 11.7 Hz), 6.92
-7.18 (6H, m), 7.22-7.36 (4H, m), 7.47 (1H, s). IRν maxKBrcm-1:1634, 1588, 1514, 1451, 1302. mp 160-161℃ Anal. Calcd for C29H26NO3ClF4: C, 63.56; H, 4.78;
N2.56 Found : C, 63.40; H, 4.65; N, 2.42.Example 237 N-{(1RS, 2SR) -2- (3-chlorophenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro-
5H-benzo [a] [7] annulene-1-carboxamide 1) Ethyl 3- (3-chlorophenyl) -3-oxopropanoate A solution of 3-chloroacetophenone (23.9 g, 154 mmol) in diethyl carbonate (150 ml). Ethanol (0.3 ml) was added, and sodium hydride (60
% Oily, 12.4 g, 309 mmol) and stirred at room temperature for 2 hours. 6N hydrochloric acid was added to the reaction solution to stop the reaction, water (500 ml) was added, and ethyl acetate (500 ml ×
Extracted in 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 50: 1-5: 1) to obtain the desired product (24.8 g, 71%). 1 H-NMR (CDCl 3 ) δ: 1.20-1.40 (3H, m), 3.97 (2H × 3/4,
s), 4.16-4.32 (2H, m), 5.65 (1H × 1/4, s), 7.30-7.50
(1H, m), 7.54-7.68 (1H, m), 7.76-7.84 (1H, m), 7.9
0-7.96 (1H, m) .IRν max KBr cm -1 : 1740, 1694, 1651, 1628, 1568, 147
. 4. Anal Calcd for C 11 H 11 O 3 Cl: C, 58.29; H, 4.89 Found:. C, 58.54; H, 4.84 2) 3- (3- chlorophenyl) -3-oxo-2- [3-
Ethyl (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate ethyl 3- (1,1,2,2-tetrafluoroethoxy) toluene (10.2 g, 49.0 mmol) in ethyl acetate (8
0 ml) to a solution of N-bromosuccinimide (9.6 g,
53.9 mmol) and 2,2′-azobis (isobutyronitrile) (161 mg, 0.98 mmol) were added, and the mixture was heated under reflux for 5 hours. After concentrating the reaction solution, the crystals were filtered with hexane, and the filtrate was concentrated to prepare 3- (1,1,2,2-tetrafluoroethoxy) -α-bromotoluene. To a solution of ethyl 3- (3-chlorophenyl) -3-oxopropanoate (10.0 g, 44.1 mmol) in 1,2-dimethoxyethane (100 ml) was added sodium hydride (60% oily, 1.76 g, 44.50 g). (1 mmol) under ice-cooling and stirred at room temperature for 30 minutes. 3- (1,1,2,2-tetrafluoroethoxy)-previously prepared in the reaction solution
1,2-dimethoxyethane of α-bromotoluene (50 m
l) The solution was added dropwise and the reaction was stirred at room temperature overnight. The reaction solution was poured into water (300 ml), and ethyl acetate (300 ml) was added.
ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-1: 1) to obtain the desired product (7.5 g, 39%). 1 H-NMR (CDCl 3 ) δ: 1.13 (3H, t, J = 7.2 Hz), 3.33 (2
H, d, J = 7.4 Hz), 4.02-4.20 (2H, m), 4.54 (1H, t,
J = 7.2 Hz), 5.89 (1H, tt, J = 53.0, 3.0 Hz), 7.0
0-7.20 (2H, m), 7.20-7.46 (2H, m), 7.50-7.60 (1H,
m), 7.78-7.84 (1H, m), 7.90-7.98 (1H, m). IRν max KBr cm -1 : 1738, 1694, 1613, 1588, 1572. -Chlorophenyl)-
Ethyl 3-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate Boron hydride in a solution of zinc chloride (4.66 g, 34.2 mmol) in diethyl ether (100 ml) Add sodium (2.59 g, 68.4 mmol) and add 30
Minutes. The insolubles were removed by filtration, and the filtrate was treated with ethyl 3- (3-chlorophenyl) -3-oxo-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate (7.
40 g, 17.1 mmol) of diethyl ether (30
ml) solution was added at 0 ° C. and stirred for 30 minutes. 1N hydrochloric acid was added to the reaction solution to stop the reaction, and water (100 ml) was further added.
And extracted with ethyl acetate (100 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 4:
Purification in 1) gave the desired product (6.6 g, 89%). 1 H-NMR (CDCl 3 ) δ: 0.95 (3H, t, J = 7.2 Hz), 2.90-3.0
8 (3H, m), 3.10-3.16 (1H, m), 3.91 (2H, q, J = 7.2
Hz), 5.02 (1H, s), 5.88 (1H, tt, J = 53.1,3.0 H
z), 6.92-7.08 (3H, m), 7.20-7.32 (4H, m), 7.42 (1
H, s) .IRν max KBr cm -1 : 1725, 1613, 1588, 1487, 1449.Anal.Calcd for C 20 H 19 O 4 ClF 4 : C, 55.25; H, 4.40 Found: C, 58.33; H, 4.43. 4) (2RS, 3RS) -3- (3-chlorophenyl)-
3-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoic acid (2RS, 3RS) -3- (3-chlorophenyl) -3-hydroxy-2- [3- ( Ethyl 1,1,2,2-tetrafluoroethoxy) benzyl] propanoate (6.08 g, 1
4.0 mmol) in methanol (30 ml).
A normal aqueous sodium hydroxide solution (14 ml, 28 mmol) was added, and the mixture was stirred at room temperature for 2 hours. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the desired product (4.6).
g, 81%). 1 H-NMR (CDCl 3 ) δ: 2.80-3.12 (3H, m), 5.11 (1H, d, J
= 3.6 Hz), 5.88 (1H, tt, J = 53.2, 3.0 Hz), 6.90-
7.10 (3H, m), 7.18-7.32 (4H, m), 7.42 (1H, s) .IRν max KBr cm -1 : 1713, 1613, 1588, 1489, 1451.mp
.. 94-95 ℃ Anal Calcd for C 18 H 15 O 4 F 4: C, 53.15; H, 3.72 Found: C, 53.03; H, 3.69 5) (4RS, 5SR) -5- (3- chlorophenyl) -
4- [3- (1,1,2,2-tetrafluoroethoxy)
Benzyl] -1,3-oxazolidin-2-one (2RS, 3RS) -3- (3-chlorophenyl) -3-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] Propanoic acid (4.50 g, 11.1)
Mmol) in tetrahydrofuran (90 ml).
Diphenyl phosphoryl azide (2.62 ml, 12.2
Mmol) and triethylamine (2.32 ml, 16.
6 mmol) and heated under reflux for 4 hours. After allowing the reaction mixture to cool, water (200 ml) was added thereto, and ethyl acetate (100 ml) was added.
1 × 2). The extract was washed successively with 1N hydrochloric acid, an aqueous solution of sodium hydrogen carbonate and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and neutral alumina column chromatography (ethyl acetate), and recrystallized from ethyl acetate-hexane to obtain the desired product (4.70 g, 100%). 1 H-NMR (CDCl 3 ) δ: 2.20-2.42 (2H, m), 4.20-4.34 (1H,
m), 5.06 (1H, s), 5.78 (1H, d, J = 8.0 Hz), 5.90 (1
H, tt, J = 53.0, 2.6 Hz), 6.89 (1H, s), 6.96 (1H,
d, J = 7.6 Hz), 7.06-7.18 (1H, m), 7.20-7.44 (5H,
.. m) IRν max KBr cm -1: 1767, 1613, 1588, 1489, 1435. mp 102-103 ℃ Anal Calcd for C 18 H 14 NO 3 ClF 4: C, 53.55; H, 3.49;
N, 3.47 Found: C, 53.57; H, 3.55; N, 3.38.6) (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [3- (1,1,2,2 -Tetrafluoroethoxy) phenyl] propan-1-ol (4RS, 5SR) -5- (3-chlorophenyl) -4-
[3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidin-2-one (3.70 g,
8.16 mmol) in ethanol (30 ml)
A normal aqueous sodium hydroxide solution (5.7 ml, 46 mmol) was added, and the mixture was heated under reflux for 3 hours. After concentrating the reaction solution, the reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure to give the desired product (3.
0 g, 87%). 1 H-NMR (CDCl 3 ) δ: 2.38 (1H, dd, J = 14.0, 10.2 Hz),
2.77 (1H, dd, J = 14.0, 3.0 Hz), 3.24-3.36 (1H,
m), 4.67 (1H, d, J = 4.8 Hz), 5.90 (1H, tt, J = 53.
0, 3.0 Hz), 6.94-7.18 (3H, m), 7.22-7.43 (5H, m). IRν max KBr cm -1 : 1613, 1586, 1487, 1449, 1431. 7) N- {(1RS, 2SR) ) -2- (3-Chlorophenyl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro-5H-benzo [a] [ 7] annulene-1-carboxamide (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol (448 mg, 1.
6,7-dihydro-5H-benzo [a] cycloheptene-1 in a solution of 24 mmol) in acetonitrile (20 ml).
-Carboxylic acid (234 mg, 1.24 mmol), 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (357 mg, 1.86 mmol) and 1-hydroxybenzotriazole hydrate (190 m
g, 1.24 mmol) and stirred at room temperature overnight.
The reaction solution was diluted with water (100 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed successively with 1N hydrochloric acid, 1N aqueous sodium hydroxide solution and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the desired product (44).
4 mg, 67%). 1 H-NMR (CDCl 3 ) δ: 1.92-2.04 (2H, m), 2.10-2.24 (2H,
m), 2.60-2.70 (2H, m), 2.73-2.82 (1H, m), 2.90-3.00
(1H, m), 3.87 (1H, d, J = 3.6 Hz), 4.60-4.70 (1H,
m), 5.00-5.06 (1H, m), 5.70-6.08 (2H, m), 5.80 (1
H, d, J = 8.4 Hz), 6.22 (1H, d, J = 11.7 Hz), 6.92
-7.18 (6H, m), 7.22-7.36 (4H, m), 7.47 (1H, s) .IRν max KBr cm -1 : 1634, 1588, 1514, 1451, 1302.mp 160-161 ℃ Anal. C 29 H 26 NO 3 ClF 4 : C, 63.56; H, 4.78;
N2.56 Found: C, 63.40; H, 4.65; N, 2.42.
【0370】実施例238 (1RS,2SR)-2-(4-フルオロフェニル)-2-
ヒドロキシ-1-{[6-(1,1,2,2-テトラフルオ
ロエトキシ)ピリジン-2-イル]メチル}エチルカルバ
ミン酸tert-ブチル 1) [6-(1,1,2,2-テトラフルオロエトキ
シ)ピリジン-2-イル]メタノール 6-(1,1,2,2-テトラフルオロエトキシ)ピリジ
ン-2-カルボン酸エチル(5.65g,21.2ミリモ
ル)のテトラヒドロフラン(60ml)溶液にRed-
Al(登録商標)(6.11g,21.2ミリモル)を
加えた。反応液を室温で30分攪拌後、アセトン(2m
l)を加えた。反応液に水(100ml)を加え、酢酸
エチル(100ml×2)で抽出した。抽出液を水、飽
和食塩水で順次洗浄し、乾燥(無水硫酸マグネシウム)
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=4:1)で精製し目
的物(4.2g,88%)を得た。1 H-NMR(CDCl3)δ:3.02 (1H, brs), 4.74 (2H, s), 6.17
(1H, tt, J = 53.0, 3.8 Hz), 6.96 (1H, d, J = 8.2
Hz), 7.23 (1H, d, J = 8.2 Hz), 7.79 (1H, t,J = 7.8
Hz). IRν maxKBrcm-1:1607, 1580, 1443, 1352. 2) 3-(4-フルオロフェニル)-3-オキソ-2-
{[6-(1,1,2,2-テトラフルオロエトキシ)ピ
リジン-2-イル]メチル}プロパン酸エチル [6-(1,1,2,2-テトラフルオロエトキシ)ピリ
ジン-2-イル]メタノール(4.14g,18.39ミ
リモル)の酢酸エチル(50ml)溶液に塩化メタンス
ルホニル(2.32g,20.23ミリモル)およびト
リエチルアミン(3.08ml,22.07ミリモル)
を加え、室温で2時間攪拌した。不溶物をろ過し、ろ液
を減圧留去しメシル体を調製した。3-(4-フルオロフ
ェニル)-3-オキソプロパン酸エチル(3.87g,1
8.4ミリモル)の1,2-ジメトキシエタン(40m
l)溶液に水素化ナトリウム(740mg,60%油
性,18.4ミリモル)を加え、室温で2時間攪拌し
た。反応液に先に調製したメシル体の1,2-ジメトキ
シエタン(10ml)溶液を滴下し、反応液を室温にて
終夜攪拌した。反応液を1規定塩酸で酸性とした後、酢
酸エチル(100ml×2)で抽出した。抽出液を水、
飽和食塩水で順次洗浄し、乾燥(無水硫酸マグネシウ
ム)後減圧留去した。残留物をシリカゲルカラムクロマ
トグラフィー(ヘキサン:酢酸エチル=4:1-2:
1)で精製し目的物(1.46g,19%)を得た。1 H-NMR(CDCl3)δ:1.15 (3H, t, J = 7.0 Hz), 3.47 (2
H, d, J = 7.4 Hz), 4.13(2H, q, J = 7.0 Hz), 5.08
(1H, t, J = 7.2 Hz), 6.12 (1H, tt, J = 53.0,3.6 H
z), 6.83 (1H, d, J = 8.0 Hz), 7.06-7.22 (3H, m),
7.60-7.72 (1H, m),8.02-8.18 (2H, m). IRν maxKBrcm-1:1738, 1688, 1601, 1578, 1508, 145
6, 1441. 3) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-{[6-(1,1,2,2-テト
ラフルオロエトキシ)ピリジン-2-イル]メチル}プロ
パン酸エチル 塩化亜鉛(915mg,6.71ミリモル)のジエチル
エーテル(20ml)溶液に水素化ホウ素ナトリウム
(508mg,13.4ミリモル)を加えて室温で30
分攪拌した。不溶物をろ去し、ろ液に3-(4-フルオロ
フェニル)-3-オキソ-2-{[6-(1,1,2,2-テ
トラフルオロエトキシ)ピリジン-2-イル]メチル}プ
ロパン酸エチル(1.40g,3.35ミリモル)のジ
エチルエーテル(10ml)溶液を0℃にて加えて30
分攪拌した。反応液に1規定塩酸を加えて反応を止め、
更に水(50ml)を加え、酢酸エチル(50ml×
2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=4:1-1:1)で精製し、目的物
(1.28g,91%)を得た。1 H-NMR(CDCl3)δ:1.03 (3H, t, J = 7.2 Hz), 2.92-3.1
0 (1H, m), 3.18-3.30 (2H, m), 3.43 (1H, d, J = 3.3
Hz), 3.92-4.06 (2H, m), 5.04-5.10 (1H, m),6.26 (1
H, tt, J = 53.1, 3.9 Hz), 6.84 (1H, d, J = 8.4 H
z), 6.96-7.06 (3H, m), 7.32-7.40 (2H, m), 7.64 (1
H, t, J = 8.1 Hz). IRν maxKBrcm-1:1728, 1605, 1576, 1512, 1456, 144
3. Anal. Calcd for C19H18NO4F5: C, 54.42; H, 4.33; N,
3.34 Found : C, 54.55; H, 4.16; N, 3.22. 4) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-{[6-(1,1,2,2-テト
ラフルオロエトキシ)ピリジン-2-イル]メチル}プロ
パン酸 (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-{[6-(1,1,2,2-テトラフルオ
ロエトキシ)ピリジン-2-イル]メチル}プロパン酸エ
チル(1.28g,3.05ミリモル)のメタノール
(6ml)溶液に、2規定水酸化ナトリウム水溶液
(3.05ml,6.1ミリモル)を加えて室温で終夜
攪拌した。反応液を1規定塩酸で酸性とした後、飽和重
曹水を加え、酢酸エチル(50ml×2)で抽出した。
抽出液を水および飽和食塩水で洗浄し、乾燥(無水硫酸
マグネシウム)後減圧留去し目的物(1.20g,10
0%)を得た。1 H-NMR(CDCl3)δ:2.82-3.10 (1H, m), 3.18-3.32 (2H,
m), 5.24 (1H, d, J = 3.9 Hz), 6.14 (1H, tt, J = 5
3.4, 3.6 Hz), 6.84-7.08 (4H, m), 7.28-7.40 (2H,
m), 7.62-7.70 (1H, m). IRν maxKBrcm-1:1713, 1605, 1578, 1512, 1456, 144
3. 5) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-{[6-(1,1,2,2-テトラフルオロエト
キシ)ピリジン-2-イル]メチル}-1,3-オキサゾリ
ジン-2-オン (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-{[6-(1,1,2,2-テトラフルオ
ロエトキシ)ピリジン-2-イル]メチル}プロパン酸
(1.20g,3.07ミリモル)のテトラヒドロフラ
ン(20ml)溶液に、ジフェニルホスホリルアジド
(730μl,3.37ミリモル)とトリエチルアミン
(706μl,5.06ミリモル)を加え、4時間加熱
還流した。反応液を放冷後、水(100ml)を加えて
酢酸エチル(50ml×2)で抽出した。抽出液を飽和
重曹水、水、飽和食塩水で順次洗浄し、乾燥(無水硫酸
マグネシウム)後減圧留去した。残留物をシリカゲルカ
ラムクロマトグラフィー(ヘキサン:酢酸エチル=3:
1-1:1)で精製し、目的物(808mg,68%)
を得た。1 H-NMR(CDCl3)δ:2.39 (1H, dd, J = 15.8, 4.0 Hz),
2.58 (1H, dd, J = 15.8,10.2 Hz), 4.52-4.66 (1H,
m), 5.81 (1H, d, J = 8.0 Hz), 6.03 (1H, tt, J= 53.
2, 3.0 Hz), 6.80 (1H, d, J = 7.2 Hz), 6.88 (1H, d,
J = 8.2 Hz), 7.00-7.16 (2H, m), 7.24-7.40 (2H,
m), 7.63 (1H, t, J = 8.0 Hz). IRν maxKBrcm-1:1761, 1607, 1576, 1514, 1456, 144
1. 6) (4RS,5SR)-5-(4-フルオロフェニ
ル)-2-オキソ-4-{[6-(1,1,2,2-テトラフ
ルオロエトキシ)ピリジン-2-イル]メチル}-1,3-
オキサゾリジン-3-カルボン酸tert-ブチル (4RS,5SR)-5-(4-フルオロフェニル)-4-
{[6-(1,1,2,2-テトラフルオロエトキシ)ピ
リジン-2-イル]メチル}-1,3-オキサゾリジン-2-
オン(808mg,2.08ミリモル)のアセトニトリ
ル(20ml)溶液に二炭酸ジ-tert-ブチル(54
5mg,2.50ミリモル)および4-N,N-ジメチル
アミノピリジン(25.6mg,0.21ミリモル)を
加え、室温で6時間攪拌した。反応液に水(50ml)
を加えて酢酸エチル(50ml×2)で抽出した。抽出
液を飽和食塩水で洗浄し、乾燥(無水硫酸マグネシウ
ム)後減圧留去した。残留物をシリカゲルカラムクロマ
トグラフィー(ヘキサン:酢酸エチル=10:1)で精
製し、目的物(850g,84%)を得た。1 H-NMR(CDCl3)δ:1.53 (9H, s), 2.70 (1H, dd, J = 1
4.8, 10.0 Hz), 3.12 (1H, dd, J = 14.8, 3.4 Hz), 5.
30-5.42 (1H, m), 5.70 (1H, d, J = 7.4 Hz), 6.20 (1
H, d, J = 7.2 Hz), 6.22 (1H, tdd, J = 53.4, 4.4,
3.0 Hz), 6.68-6.88(3H, m), 6.98-7.10 (2H, m), 7.30
-7.40 (1H, m). IRν maxKBrcm-1:1821, 1725, 1607, 1578, 1514, 145
6, 1443, 1370. Anal. Calcd for C22H21F5N2O5: C, 54.10; H, 4.33;
N, 5.74 Found : C, 54.06; H, 4.23; N, 5.52. 7) (1RS,2SR)-2-(4-フルオロフェニ
ル)-2-ヒドロキシ-1-{[6-(1,1,2,2-テト
ラフルオロエトキシ)ピリジン-2-イル]メチル}エチ
ルカルバミン酸tert-ブチル (4RS,5SR)-5-(4-フルオロフェニル)-2-
オキソ-4-{[6-(1,1,2,2-テトラフルオロエ
トキシ)ピリジン-2-イル]メチル}-1,3-オキサゾ
リジン-3-カルボン酸tert-ブチル(840mg,
1.72ミリモル)のメタノール(4ml)に0.5規
定水酸化ナトリウムのメタノール溶液(4.12ml,
2.06ミリモル)を加え室温で15分攪拌した。反応
液に水(50ml)を加えて酢酸エチル(50ml×
2)で抽出した。抽出液を飽和食塩水で洗浄し、乾燥
(無水硫酸マグネシウム)後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=1:1)で精製し、酢酸エチル-ヘキサンから再
結晶させて目的物(390mg,49%)を得た。1 H-NMR(CDCl3)δ:1.37 (9H, s), 2.90-3.02 (2H, m),
3.85 (1H, brs), 4.16-4.30 (1H, m), 4.89 (1H, brs),
5.26 (1H, d, J = 7.2 Hz), 6.19 (1H, tt, J =53.0,
3.6 Hz), 6.91 (1H, d, J = 8.0 Hz), 7.00-7.14 (3H,
m), 7.34-7.44 (2H, m), 7.71 (1H, t, J = 8.0 Hz). IRν maxKBrcm-1:1694, 1605, 1578, 1510, 1456, 144
1. mp 109-110℃ Anal. Calcd for C21H23F5N2O4・0.1H2O: C, 54.34; H,
5.03; N, 6.03 Found : C, 54.12; H, 4.93; N, 5.87.Example 238 (1RS, 2SR) -2- (4-fluorophenyl) -2-
Tert-butyl hydroxy-1-{[6- (1,1,2,2-tetrafluoroethoxy) pyridin-2-yl] methyl} ethylcarbamate 1) [6- (1,1,2,2-tetra Fluoroethoxy) pyridin-2-yl] methanol Red was added to a solution of ethyl 6- (1,1,2,2-tetrafluoroethoxy) pyridine-2-carboxylate (5.65 g, 21.2 mmol) in tetrahydrofuran (60 ml). -
Al® (6.11 g, 21.2 mmol) was added. After stirring the reaction solution at room temperature for 30 minutes, acetone (2 m
l) was added. Water (100 ml) was added to the reaction solution, and extracted with ethyl acetate (100 ml × 2). The extract is washed sequentially with water and saturated saline, and dried (anhydrous magnesium sulfate)
After that, it was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to obtain the desired product (4.2 g, 88%). 1 H-NMR (CDCl 3 ) δ: 3.02 (1H, brs), 4.74 (2H, s), 6.17
(1H, tt, J = 53.0, 3.8 Hz), 6.96 (1H, d, J = 8.2
Hz), 7.23 (1H, d, J = 8.2 Hz), 7.79 (1H, t, J = 7.8
Hz). IRν max KBr cm -1 : 1607, 1580, 1443, 135.2 2) 3- (4-Fluorophenyl) -3-oxo-2-
{[6- (1,1,2,2-tetrafluoroethoxy) pyridin-2-yl] methyl} ethyl propanoate [6- (1,1,2,2-tetrafluoroethoxy) pyridin-2-yl] To a solution of methanol (4.14 g, 18.39 mmol) in ethyl acetate (50 ml) was added methanesulfonyl chloride (2.32 g, 20.23 mmol) and triethylamine (3.08 ml, 22.07 mmol).
Was added and stirred at room temperature for 2 hours. The insolubles were filtered, and the filtrate was distilled off under reduced pressure to prepare a mesyl compound. Ethyl 3- (4-fluorophenyl) -3-oxopropanoate (3.87 g, 1
8.4 mmol) of 1,2-dimethoxyethane (40 m
l) Sodium hydride (740 mg, 60% oily, 18.4 mmol) was added to the solution, and the mixture was stirred at room temperature for 2 hours. The 1,2-dimethoxyethane (10 ml) solution of the mesyl compound previously prepared was added dropwise to the reaction solution, and the reaction solution was stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (100 ml × 2). Extract water with water,
The extract was washed successively with a saturated saline solution, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 4: 1-2:
Purification in 1) gave the desired product (1.46 g, 19%). 1 H-NMR (CDCl 3 ) δ: 1.15 (3H, t, J = 7.0 Hz), 3.47 (2
H, d, J = 7.4 Hz), 4.13 (2H, q, J = 7.0 Hz), 5.08
(1H, t, J = 7.2 Hz), 6.12 (1H, tt, J = 53.0,3.6 H
z), 6.83 (1H, d, J = 8.0 Hz), 7.06-7.22 (3H, m),
7.60-7.72 (1H, m), 8.02-8.18 (2H, m) .IRν max KBr cm -1 : 1738, 1688, 1601, 1578, 1508, 145
6, 1441.3) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-{[6- (1,1,2,2-tetrafluoroethoxy) pyridin-2-yl] Methyl ethyl propanoate To a solution of zinc chloride (915 mg, 6.71 mmol) in diethyl ether (20 ml) was added sodium borohydride (508 mg, 13.4 mmol), and the mixture was added at room temperature for 30 minutes.
Minutes. The insoluble material is removed by filtration, and the filtrate is treated with 3- (4-fluorophenyl) -3-oxo-2-{[6- (1,1,2,2-tetrafluoroethoxy) pyridin-2-yl] methyl}. A solution of ethyl propanoate (1.40 g, 3.35 mmol) in diethyl ether (10 ml) was added at 0 ° C.
Minutes. The reaction was stopped by adding 1N hydrochloric acid to the reaction solution.
Further, water (50 ml) was added, and ethyl acetate (50 ml ×
Extracted in 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-1: 1) to obtain the desired product (1.28 g, 91%). 1 H-NMR (CDCl 3 ) δ: 1.03 (3H, t, J = 7.2 Hz), 2.92-3.1
0 (1H, m), 3.18-3.30 (2H, m), 3.43 (1H, d, J = 3.3
Hz), 3.92-4.06 (2H, m), 5.04-5.10 (1H, m), 6.26 (1
H, tt, J = 53.1, 3.9 Hz), 6.84 (1H, d, J = 8.4 H
z), 6.96-7.06 (3H, m), 7.32-7.40 (2H, m), 7.64 (1
H, t, J = 8.1 Hz) .IRν max KBr cm -1 : 1728, 1605, 1576, 1512, 1456, 144
3. Anal.Calcd for C 19 H 18 NO 4 F 5 : C, 54.42; H, 4.33; N,
3.34 Found: C, 54.55; H, 4.16; N, 3.22.4) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-{[6- (1,1,2,2 -Tetrafluoroethoxy) pyridin-2-yl] methyl} propanoic acid (2RS, 3RS) -3- (4-fluorophenyl) -3-
To a solution of ethyl hydroxy-2-{[6- (1,1,2,2-tetrafluoroethoxy) pyridin-2-yl] methyl} propanoate (1.28 g, 3.05 mmol) in methanol (6 ml), A 2N aqueous sodium hydroxide solution (3.05 ml, 6.1 mmol) was added, and the mixture was stirred at room temperature overnight. After the reaction solution was acidified with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate was added, and the mixture was extracted with ethyl acetate (50 ml × 2).
The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate), and then distilled off under reduced pressure to obtain the desired product (1.20 g, 10
0%). 1 H-NMR (CDCl 3 ) δ: 2.82-3.10 (1H, m), 3.18-3.32 (2H,
m), 5.24 (1H, d, J = 3.9 Hz), 6.14 (1H, tt, J = 5
3.4, 3.6 Hz), 6.84-7.08 (4H, m), 7.28-7.40 (2H,
m), 7.62-7.70 (1H, m) .IRν max KBr cm -1 : 1713, 1605, 1578, 1512, 1456, 144
3.5) (4RS, 5SR) -5- (4-fluorophenyl) -4-{[6- (1,1,2,2-tetrafluoroethoxy) pyridin-2-yl] methyl} -1,3 -Oxazolidin-2-one (2RS, 3RS) -3- (4-fluorophenyl) -3-
To a solution of hydroxy-2-{[6- (1,1,2,2-tetrafluoroethoxy) pyridin-2-yl] methyl} propanoic acid (1.20 g, 3.07 mmol) in tetrahydrofuran (20 ml) was added diphenyl. Phosphoryl azide (730 μl, 3.37 mmol) and triethylamine (706 μl, 5.06 mmol) were added, and the mixture was heated under reflux for 4 hours. After allowing the reaction mixture to cool, water (100 ml) was added, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed successively with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 3:
1-1: 1) to give the desired product (808 mg, 68%)
I got 1 H-NMR (CDCl 3 ) δ: 2.39 (1H, dd, J = 15.8, 4.0 Hz),
2.58 (1H, dd, J = 15.8,10.2 Hz), 4.52-4.66 (1H,
m), 5.81 (1H, d, J = 8.0 Hz), 6.03 (1H, tt, J = 53.
2, 3.0 Hz), 6.80 (1H, d, J = 7.2 Hz), 6.88 (1H, d,
J = 8.2 Hz), 7.00-7.16 (2H, m), 7.24-7.40 (2H,
m), 7.63 (1H, t, J = 8.0 Hz) .IRν max KBr cm -1 : 1761, 1607, 1576, 1514, 1456, 144
1.6) (4RS, 5SR) -5- (4-fluorophenyl) -2-oxo-4-{[6- (1,1,2,2-tetrafluoroethoxy) pyridin-2-yl] methyl} -1,3-
Tert-Butyl oxazolidine-3-carboxylate (4RS, 5SR) -5- (4-fluorophenyl) -4-
{[6- (1,1,2,2-tetrafluoroethoxy) pyridin-2-yl] methyl} -1,3-oxazolidine-2-
(808 mg, 2.08 mmol) in acetonitrile (20 ml) was added to di-tert-butyl dicarbonate (54 ml).
5 mg, 2.50 mmol) and 4-N, N-dimethylaminopyridine (25.6 mg, 0.21 mmol) were added, and the mixture was stirred at room temperature for 6 hours. Water (50 ml) in the reaction solution
And extracted with ethyl acetate (50 ml × 2). The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1) to obtain the desired product (850 g, 84%). 1 H-NMR (CDCl 3 ) δ: 1.53 (9H, s), 2.70 (1H, dd, J = 1
4.8, 10.0 Hz), 3.12 (1H, dd, J = 14.8, 3.4 Hz), 5.
30-5.42 (1H, m), 5.70 (1H, d, J = 7.4 Hz), 6.20 (1
H, d, J = 7.2 Hz), 6.22 (1H, tdd, J = 53.4, 4.4,
3.0 Hz), 6.68-6.88 (3H, m), 6.98-7.10 (2H, m), 7.30
-7.40 (1H, m) .IRν max KBr cm -1 : 1821, 1725, 1607, 1578, 1514, 145
6, 1443, 1370. Anal.Calcd for C 22 H 21 F 5 N 2 O 5 : C, 54.10; H, 4.33;
N, 5.74 Found: C, 54.06; H, 4.23; N, 5.52.7) (1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-{[6- (1,1,2 Tert-butyl (2,2-tetrafluoroethoxy) pyridin-2-yl] methyldiethylcarbamate (4RS, 5SR) -5- (4-fluorophenyl) -2-
Tert-Butyl oxo-4-{[6- (1,1,2,2-tetrafluoroethoxy) pyridin-2-yl] methyl} -1,3-oxazolidine-3-carboxylate (840 mg,
1.72 mmol) in methanol (4 ml) in 0.5N sodium hydroxide in methanol (4.12 ml,
2.06 mmol) and stirred at room temperature for 15 minutes. Water (50 ml) was added to the reaction solution, and ethyl acetate (50 ml ×
Extracted in 2). The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1), and recrystallized from ethyl acetate-hexane to obtain the desired product (390 mg, 49%). 1 H-NMR (CDCl 3 ) δ: 1.37 (9H, s), 2.90-3.02 (2H, m),
3.85 (1H, brs), 4.16-4.30 (1H, m), 4.89 (1H, brs),
5.26 (1H, d, J = 7.2 Hz), 6.19 (1H, tt, J = 53.0,
3.6 Hz), 6.91 (1H, d, J = 8.0 Hz), 7.00-7.14 (3H,
m), 7.34-7.44 (2H, m), 7.71 (1H, t, J = 8.0 Hz) .IRν max KBr cm -1 : 1694, 1605, 1578, 1510, 1456, 144
1.mp 109-110 ℃ Anal. Calcd for C 21 H 23 F 5 N 2 O 4・ 0.1H 2 O: C, 54.34; H,
5.03; N, 6.03 Found: C, 54.12; H, 4.93; N, 5.87.
【0371】実施例239 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-{[6-(1,1,2,2-テトラフ
ルオロエトキシ)ピリジン-2-イル]メチル}エチル)
-6,7-ジヒドロ-5H-ベンゾ[a][7]アンヌレン
-1-カルボキサミド (1RS,2SR)-2-(4-フルオロフェニル)-2-
ヒドロキシ-1-{[6-(1,1,2,2-テトラフルオ
ロエトキシ)ピリジン-2-イル]メチル}エチルカルバ
ミン酸tert-ブチル(300mg,0.65ミリモ
ル)にトリフルオロ酢酸(3ml)を0℃にて加え、0
℃で10分攪拌した。反応液に飽和重曹水を加え、酢酸
エチル(20ml×2)で抽出した。抽出液を飽和食塩
水で洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去
した。残留物のアセトニトリル(25ml)溶液に6,
7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カ
ルボン酸(122mg,0.65ミリモル)および1-
エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩(187mg,0.97ミリモル)および
1-ヒドロキシベンゾトリアゾール水和物(99mg,
0.65ミリモル)を加えて室温で終夜攪拌した。反応
液を水(100ml)で希釈し、酢酸エチル(100m
l×2)で抽出した。抽出液を飽和重曹水、飽和食塩水
で順次洗浄し、乾燥(無水硫酸マグネシウム)後減圧留
去した。残留物をシリカゲルカラムクロマトグラフィー
(ヘキサン:酢酸エチル=2:1-1:1)で精製し酢
酸エチル-ヘキサンから再結晶させて、目的物(196
mg,57%)を得た。1 H-NMR(CDCl3)δ:1.92-2.06 (2H, m), 2.14-2.24 (2H,
m), 2.62-2.70 (2H, m),3.06 (1H, dd, J = 15.0, 6.9
Hz), 3.16 (1H, dd, J = 15.0, 5.1 Hz), 4.34(1H, d,
J = 5.1 Hz), 4.70-4.82 (1H, m), 5.00 (1H, t, J =
4.8 Hz), 5.88-6.26 (3H, m), 6.44 (1H, d, J = 7.8 H
z), 6.93 (1H, d, J = 7.8 Hz), 7.00-7.12 (4H, m),
7.12-7.20 (2H, m), 7.40-7.50 (2H, m), 7.72 (1H, t,
J = 7.5 Hz). IRν maxKBrcm-1:1645, 1605, 1576, 1508, 1456, 144
1. mp 134-135℃ Anal. Calcd for C28H25N2O3F5・0.1H2O: C, 62.94; H,
4.75; N, 5.24 Found : C, 62.84; H, 4.77; N, 5.16.Example 239 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-{[6- (1,1,2,2-tetrafluoroethoxy) pyridin-2-yl] methyl} ethyl)
-6,7-Dihydro-5H-benzo [a] [7] annulene
-1-Carboxamide (1RS, 2SR) -2- (4-fluorophenyl) -2-
Tert-butyl hydroxy-1-{[6- (1,1,2,2-tetrafluoroethoxy) pyridin-2-yl] methyl} ethylcarbamate (300 mg, 0.65 mmol) in trifluoroacetic acid (3 ml) At 0 ° C.
Stirred at C for 10 minutes. A saturated aqueous sodium hydrogen carbonate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate (20 ml × 2). The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The solution of the residue in acetonitrile (25 ml)
7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (122 mg, 0.65 mmol) and 1-
Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (187 mg, 0.97 mmol) and 1-hydroxybenzotriazole hydrate (99 mg,
(0.65 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
1 × 2). The extract was washed successively with saturated aqueous sodium hydrogen carbonate and saturated brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1-1: 1) and recrystallized from ethyl acetate-hexane to give the desired product (196).
mg, 57%). 1 H-NMR (CDCl 3 ) δ: 1.92-2.06 (2H, m), 2.14-2.24 (2H,
m), 2.62-2.70 (2H, m), 3.06 (1H, dd, J = 15.0, 6.9
Hz), 3.16 (1H, dd, J = 15.0, 5.1 Hz), 4.34 (1H, d,
J = 5.1 Hz), 4.70-4.82 (1H, m), 5.00 (1H, t, J =
4.8 Hz), 5.88-6.26 (3H, m), 6.44 (1H, d, J = 7.8 H
z), 6.93 (1H, d, J = 7.8 Hz), 7.00-7.12 (4H, m),
7.12-7.20 (2H, m), 7.40-7.50 (2H, m), 7.72 (1H, t,
J = 7.5 Hz) .IRν max KBr cm -1 : 1645, 1605, 1576, 1508, 1456, 144
1.mp 134-135 ℃ Anal.Calcd for C 28 H 25 N 2 O 3 F 5・ 0.1H 2 O: C, 62.94; H,
4.75; N, 5.24 Found: C, 62.84; H, 4.77; N, 5.16.
【0372】実施例240 N-{(1RS,2SR)-2-[3-(ベンジルオキシ)
フェニル]-2-ヒドロキシ-1-[3-(1,1,2,2-
テトラフルオロエトキシ)ベンジル]エチル}-6,7-
ジヒドロ-5H-ベンゾ[a][7]アンヌレン-1-カル
ボキサミド 1) 3-ベンジルオキシアセトフェノン 3-ヒドロキシアセトフェノン(101g,744ミリ
モル)のアセトン(1L)溶液に炭酸カリウム(154
g,1.12モル)およびベンジルブロミド(130
g,759ミリモル)を加えて室温で終夜攪拌した。反
応液を濃縮後、水(500ml)で希釈し、酢酸エチル
(500ml×2)で抽出した。抽出液を水、飽和食塩
水で順次洗浄し、乾燥(無水硫酸マグネシウム)後減圧
留去した。残留物をシリカゲルカラムクロマトグラフィ
ー(ヘキサン:酢酸エチル=10:1-4:1)で精製
し、目的物(128g,76%)を得た。1 H-NMR(CDCl3)δ:2.58 (3H, s), 5.11 (2H, s), 7.14-
7.20 (1H, m), 7.30-7.48(6H, m), 7.54-7.60 (2H, m). IRν maxKBrcm-1:1684, 1593, 1582, 1497, 1483, 143
9. Anal. Calcd for C15H14O2: C, 79.62; H, 6.24 Found : C, 79.44; H, 6.22. 2) 3-[3-(ベンジルオキシ)フェニル]-3-オキ
ソプロパン酸エチル 3-ベンジルオキシアセトフェノン(90g,400ミ
リモル)の炭酸ジエチル(500ml)溶液にエタノー
ル(1.5ml)を加え、氷冷下水素化ナトリウム(6
0%油性,31.8g,800ミリモル)を加え、室温
で4時間攪拌した。反応液に6規定塩酸を加え反応を止
め、水(500ml)を加え酢酸エチル(500ml×
2)で抽出した。抽出液を水、飽和食塩水で順次洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=50:1-10:1)で精製し、目的
物(107g,90%)を得た。1 H-NMR(CDCl3)δ:1.20-1.38 (3H, m), 3.96 (2H×6/7,
s), 4.18-4.32 (2H, m),5.09 (2H×1/7, s), 5.11 (2H
×6/7, s), 5.65 (1H×1/7, s), 7.02-7.60 (9H,m). IRν maxKBrcm-1:1740, 1688, 1582, 1485, 1441. Anal. Calcd for C15H14O2: C, 72.47; H, 6.08 Found : C, 72.77; H, 6.01. 3) 3-[3-(ベンジルオキシ)フェニル]-3-オキ
ソ-2-[3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]プロパン酸エチル [3-(1,1,2,2-テトラフルオロエトキシ)フェ
ニル]メタノール(7.91g,35.3ミリモル)の
酢酸エチル(100ml)溶液に塩化メタンスルホニル
(3.00ml,38.8ミリモル)およびトリエチル
アミン(5.91ml,42.4ミリモル)を加え、室
温で2時間攪拌した。不溶物をろ過し、ろ液を減圧留去
しメシル体を調製した。3-[3-(ベンジルオキシ)フ
ェニル]-3-オキソプロパン酸エチル(10g,33.
5ミリモル)の1,2-ジメトキシエタン(80ml)
溶液に水素化ナトリウム(1.34g,60%油性,3
3.5ミリモル)を加え、室温で3時間攪拌した。反応
液に先に調製したメシル体の1,2-ジメトキシエタン
(10ml)溶液を滴下し、反応液を室温にて終夜攪拌
した。反応液を1規定塩酸で酸性とした後、酢酸エチル
(300ml×2)で抽出した。抽出液を水、飽和食塩
水で順次洗浄し、乾燥(無水硫酸マグネシウム)後減圧
留去した。残留物をシリカゲルカラムクロマトグラフィ
ー(ヘキサン:酢酸エチル=4:1-1:1)で精製し
目的物(19.0g)を得た。1 H-NMR(CDCl3)δ:1.12 (3H, t, J = 7.0 Hz), 3.32 (2
H, d, J = 7.4 Hz), 4.09(2H, q, J = 7.0 Hz), 4.56
(1H, t, J = 7.4 Hz), 5.09 (2H, s), 5.88 (1H,tt, J
= 53.2, 3.0 Hz), 7.00-7.60 (13H, m). 4) (2RS,3RS)-3-[3-(ベンジルオキ
シ)フェニル]-3-ヒドロキシ-2-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]プロパン
酸エチル 塩化亜鉛(9.14g,67.0ミリモル)のジエチル
エーテル(100ml)溶液に水素化ホウ素ナトリウム
(5.07g,134ミリモル)を加えて室温で30分
攪拌した。不溶物をろ去し、ろ液に3-[3-(ベンジル
オキシ)フェニル]-3-オキソ-2-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]プロパン
酸エチル(19.0g,33.5ミリモル)のジエチル
エーテル(200ml)溶液を0℃にて加えて30分攪
拌した。反応液に1規定塩酸を加えて反応を止め、更に
水(500ml)を加え、酢酸エチル(500ml×
2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=1:1-酢酸エチル)で精製し、目的
物(10.7g,粗製)を得た。 5) (2RS,3RS)-3-[3-(ベンジルオキ
シ)フェニル]-3-ヒドロキシ-2-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]プロパン
酸 (2RS,3RS)-3-[3-(ベンジルオキシ)フェ
ニル]-3-ヒドロキシ-2-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]プロパン酸エチル(1
0.7g,21.2ミリモル,粗製)のメタノール(5
0ml)溶液に、2規定水酸化ナトリウム水溶液(21
ml,42ミリモル)を加えて室温で終夜攪拌した。反
応液を1規定塩酸で酸性とした後、酢酸エチル(50m
l×2)で抽出した。抽出液を水および飽和食塩水で洗
浄し、乾燥(無水硫酸マグネシウム)後減圧留去した。
得られた租結晶をヘキサンで洗浄し、目的物(7.90
g,3工程にて49%)を得た。1 H-NMR(CDCl3)δ:2.80-3.08 (3H, m), 5.06 (2H, s),
5.00-5.10 (1H, m), 5.86(1H, tt, J = 53.2, 2.8 Hz),
6.86-7.10 (6H, m), 7.10-7.50 (7H, m). IRν maxKBrcm-1:1713, 1588, 1489, 1451. mp 103-104℃ Anal. Calcd for C25H22O5F4: C, 62.76; H, 4.63 Found : C, 63.01; H, 4.58. 6) (4RS,5SR)-5-[3-(ベンジルオキ
シ)フェニル]-4-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]-1,3-オキサゾリジン-2-
オン (2RS,3RS)-3-[3-(ベンジルオキシ)フェ
ニル]-3-ヒドロキシ-2-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]プロパン酸(7.8
g,16.3ミリモル)のテトラヒドロフラン(100
ml)溶液に、ジフェニルホスホリルアジド(3.86
ml,17.9ミリモル)とトリエチルアミン(3.4
2ml,24.5ミリモル)を加え、4時間加熱還流し
た。反応液を放冷後、水(100ml)を加えて酢酸エ
チル(100ml×2)で抽出した。抽出液を1規定塩
酸、炭酸水素ナトリウム水溶液、飽和食塩水で順次洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物を酢酸エチル-ヘキサンから再結晶させて、目的物
(6.72g,87%)を得た。1 H-NMR(CDCl3)δ:2.10-2.38 (2H, m), 4.10-4.28 (1H,
m), 5.05 (1H, brs), 5.10 (2H, s), 5.77 (1H, d, J =
7.6 Hz), 5.90 (1H, tt, J = 53.2, 2.8 Hz), 6.80-7.
38 (6H, m), 7.20-7.50 (7H, m). IRν maxKBrcm-1:1759, 1613, 1588, 1489, 1451. mp 97-99℃ Anal. Calcd for C25H21 NO4F4: C, 63.16; H, 4.45;
N, 2.95 Found : C, 62.91; H, 4.30; N, 2.85. 7) (1RS,2SR)-2-アミノ-1-(3-(ベン
ジルオキシ)フェニル)-3-(3-((1,1,2,2-
テトラフルオロエチル)オキシ)フェニル)-1-プロパ
ノール (4RS,5SR)-5-[3-(ベンジルオキシ)フェ
ニル]-4-[3-(1,1,2,2-テトラフルオロエト
キシ)ベンジル]-1,3-オキサゾリジン-2-オン
(6.5g,13.7ミリモル)のエタノール(70m
l)溶液に8規定水酸化ナトリウム水溶液(5.13m
l,41ミリモル)を加え、4時間加熱還流した。反応
液を濃縮後、水(100ml)で希釈し、酢酸エチル
(100ml×2)で抽出した。抽出液を飽和食塩水で
洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去し、
目的物(6.26g,100%)を得た。1 H-NMR(CDCl3)δ:2.36 (1H, dd, J = 14.0, 10.4 Hz),
2.82 (1H, dd, J = 14.0, 3.0 Hz), 3.20-3.32 (1H,
m), 4.63 (1H, d, J = 4.8 Hz), 5.10 (2H, s), 5.89
(1H, tt, J = 53.0, 3.0 Hz), 6.90-7.12 (6H, m), 7.2
4-7.48 (7H, m). IRν maxKBrcm-1:1740, 1609, 1586, 1487, 1449. Anal. Calcd for C24H23 NO3F4: C, 64.14; H, 5.16;
N, 3.12 Found : C, 63.87; H, 5.26; N, 2.93. 8) N-{(1RS,2SR)-2-[3-(ベンジルオ
キシ)フェニル]-2-ヒドロキシ-1-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]エチル}-
6,7-ジヒドロ-5H-ベンゾ[a][7]アンヌレン-
1-カルボキサミド (1RS,2SR)-2-アミノ-1-(3-(ベンジルオ
キシ)フェニル)-3-(3-((1,1,2,2-テトラ
フルオロエチル)オキシ)フェニル)-1-プロパノール
(405mg,0.90ミリモル)のアセトニトリル
(30ml)溶液に6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボン酸(170mg,
0.90ミリモル)および1-エチル-3-(3-ジメチル
アミノプロピル)カルボジイミド・塩酸塩(259m
g,1.35ミリモル)および1-ヒドロキシベンゾト
リアゾール水和物(138mg,0.90ミリモル)を
加えて室温で終夜攪拌した。反応液を水(100ml)
で希釈し、酢酸エチル(100ml×2)で抽出した。
抽出液を1規定塩酸、1規定水酸化ナトリウム水溶液、
飽和食塩水で順次洗浄し、乾燥(無水硫酸マグネシウ
ム)後減圧留去した。残留物をシリカゲルカラムクロマ
トグラフィー(ヘキサン:酢酸エチル=2:1-1:
1)で精製し、酢酸エチル-ヘキサンから再結晶させ
て、目的物(407mg,73%)を得た。1 H-NMR(CDCl3)δ:1.92-2.02 (2H, m), 2.12-2.20 (2H,
m), 2.60-2.70 (2H, m),2.74 (1H, dd, J = 14.4, 10.5
Hz), 2.96 (1H, dd, J = 14.4, 3.9 Hz), 3.49(1H, d,
J = 3.6 Hz), 4.64-4.76 (1H, m), 5.00-5.10 (3H,
m), 5.76 (1H, d,J = 8.7 Hz), 5.68-6.08 (2H, m), 6.
23 (1H, d, J = 11.7 Hz), 6.90-7.18 (9H, m), 7.24-
7.44 (7H, m). IRν maxKBrcm-1:1640, 1611, 1588, 1510, 1489, 144
9. mp 128-129℃ Anal. Calcd for C36H33 NO4F4: C, 69.78; H, 5.37;
N, 2.26 Found : C, 69.62; H, 5.34; N, 2.03.Example 240 N-{(1RS, 2SR) -2- [3- (benzyloxy)
Phenyl] -2-hydroxy-1- [3- (1,1,2,2-
Tetrafluoroethoxy) benzyl] ethyl} -6,7-
Dihydro-5H-benzo [a] [7] annulene-1-carboxamide 1) 3-Benzyloxyacetophenone Potassium carbonate (154) was added to a solution of 3-hydroxyacetophenone (101 g, 744 mmol) in acetone (1 L).
g, 1.12 mol) and benzyl bromide (130
g, 759 mmol) and stirred at room temperature overnight. After concentration, the reaction solution was diluted with water (500 ml) and extracted with ethyl acetate (500 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1-4: 1) to obtain the desired product (128 g, 76%). 1 H-NMR (CDCl 3 ) δ: 2.58 (3H, s), 5.11 (2H, s), 7.14-
7.20 (1H, m), 7.30-7.48 (6H, m), 7.54-7.60 (2H, m) .IRν max KBr cm -1 : 1684, 1593, 1582, 1497, 1483, 143
9. Anal. Calcd for C 15 H 14 O 2 : C, 79.62; H, 6.24 Found: C, 79.44; H, 6.22.2. 2) Ethyl 3- [3- (benzyloxy) phenyl] -3-oxopropanoate Ethanol (1.5 ml) was added to a solution of 3-benzyloxyacetophenone (90 g, 400 mmol) in diethyl carbonate (500 ml), and sodium hydride (6 ml) was added under ice-cooling.
(0% oily, 31.8 g, 800 mmol) and stirred at room temperature for 4 hours. 6N hydrochloric acid was added to the reaction solution to stop the reaction, water (500 ml) was added, and ethyl acetate (500 ml ×
Extracted in 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 50: 1-10: 1) to obtain the desired product (107 g, 90%). 1 H-NMR (CDCl 3 ) δ: 1.20-1.38 (3H, m), 3.96 (2H × 6/7,
s), 4.18-4.32 (2H, m), 5.09 (2H × 1/7, s), 5.11 (2H
× 6/7, s), 5.65 (1H × 1/7, s), 7.02-7.60 (9H, m) .IRν max KBr cm -1 : 1740, 1688, 1582, 1485, 1441. Anal.Calcd for C 15 H 14 O 2 : C, 72.47; H, 6.08 Found: C, 72.77; H, 6.01.3) 3- [3- (benzyloxy) phenyl] -3-oxo-2- [3- (1,1 Ethyl [2,2,2-tetrafluoroethoxy) benzyl] propanoate [3- (1,1,2,2-tetrafluoroethoxy) phenyl] methanol (7.91 g, 35.3 mmol) in ethyl acetate (100 ml) To the mixture was added methanesulfonyl chloride (3.00 ml, 38.8 mmol) and triethylamine (5.91 ml, 42.4 mmol), and the mixture was stirred at room temperature for 2 hours. The insolubles were filtered, and the filtrate was distilled off under reduced pressure to prepare a mesyl compound. Ethyl 3- [3- (benzyloxy) phenyl] -3-oxopropanoate (10 g, 33.
5 mmol) of 1,2-dimethoxyethane (80 ml)
Add sodium hydride (1.34 g, 60% oily, 3
(3.5 mmol) and stirred at room temperature for 3 hours. The 1,2-dimethoxyethane (10 ml) solution of the mesyl compound previously prepared was added dropwise to the reaction solution, and the reaction solution was stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (300 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-1: 1) to obtain the desired product (19.0 g). 1 H-NMR (CDCl 3 ) δ: 1.12 (3H, t, J = 7.0 Hz), 3.32 (2
H, d, J = 7.4 Hz), 4.09 (2H, q, J = 7.0 Hz), 4.56
(1H, t, J = 7.4 Hz), 5.09 (2H, s), 5.88 (1H, tt, J
= 53.2, 3.0 Hz), 7.00-7.60 (13H, m). 4) (2RS, 3RS) -3- [3- (benzyloxy) phenyl] -3-hydroxy-2- [3- (1,1,
Ethyl 2,2-tetrafluoroethoxy) benzyl] propanoate To a solution of zinc chloride (9.14 g, 67.0 mmol) in diethyl ether (100 ml) was added sodium borohydride (5.07 g, 134 mmol) at room temperature. Stir for 30 minutes. The insoluble material was removed by filtration, and the filtrate was subjected to 3- [3- (benzyloxy) phenyl] -3-oxo-2- [3- (1,1,1).
A solution of ethyl 2,2-tetrafluoroethoxy) benzyl] propanoate (19.0 g, 33.5 mmol) in diethyl ether (200 ml) was added at 0 ° C., and the mixture was stirred for 30 minutes. 1N hydrochloric acid was added to the reaction solution to stop the reaction, water (500 ml) was further added, and ethyl acetate (500 ml ×
Extracted in 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1-ethyl acetate) to obtain the desired product (10.7 g, crude). 5) (2RS, 3RS) -3- [3- (benzyloxy) phenyl] -3-hydroxy-2- [3- (1,1,
2,2-Tetrafluoroethoxy) benzyl] propanoic acid (2RS, 3RS) -3- [3- (benzyloxy) phenyl] -3-hydroxy-2- [3- (1,1,2,2-tetrafluoro Ethoxy) benzyl] ethyl propanoate (1
0.7 g, 21.2 mmol, crude) of methanol (5
0 ml) solution and 2N aqueous sodium hydroxide solution (21 ml).
ml, 42 mmol) and stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid, and then ethyl acetate (50 m
1 × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure.
The obtained crystals were washed with hexane to give the desired product (7.90).
g, 3 steps, 49%). 1 H-NMR (CDCl 3 ) δ: 2.80-3.08 (3H, m), 5.06 (2H, s),
5.00-5.10 (1H, m), 5.86 (1H, tt, J = 53.2, 2.8 Hz),
6.86-7.10 (6H, m), 7.10-7.50 (7H, m) IRν max KBr cm -1:.. 1713, 1588, 1489, 1451. mp 103-104 ℃ Anal Calcd for C 25 H 22 O 5 F 4 : C, 62.76; H, 4.63 Found: C, 63.01; H, 4.58.6) (4RS, 5SR) -5- [3- (benzyloxy) phenyl] -4- [3- (1,1,2, 2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine-2-
ON (2RS, 3RS) -3- [3- (benzyloxy) phenyl] -3-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoic acid (7.8
g, 16.3 mmol) of tetrahydrofuran (100
ml) solution in diphenylphosphoryl azide (3.86).
ml, 17.9 mmol) and triethylamine (3.4
(2 ml, 24.5 mmol), and the mixture was heated under reflux for 4 hours. After allowing the reaction mixture to cool, water (100 ml) was added, and the mixture was extracted with ethyl acetate (100 ml × 2). The extract was washed successively with 1N hydrochloric acid, an aqueous solution of sodium hydrogen carbonate and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to obtain the desired product (6.72 g, 87%). 1 H-NMR (CDCl 3 ) δ: 2.10-2.38 (2H, m), 4.10-4.28 (1H,
m), 5.05 (1H, brs), 5.10 (2H, s), 5.77 (1H, d, J =
7.6 Hz), 5.90 (1H, tt, J = 53.2, 2.8 Hz), 6.80-7.
38 (6H, m), 7.20-7.50 (7H, m) .IRν max KBr cm -1 : 1759, 1613, 1588, 1489, 1451.mp 97-99 ° C Anal.Calcd for C 25 H 21 NO 4 F 4 : C, 63.16; H, 4.45;
N, 2.95 Found: C, 62.91; H, 4.30; N, 2.85.7) (1RS, 2SR) -2-amino-1- (3- (benzyloxy) phenyl) -3- (3-((1, 1,2,2-
(Tetrafluoroethyl) oxy) phenyl) -1-propanol (4RS, 5SR) -5- [3- (benzyloxy) phenyl] -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-Oxazolidin-2-one (6.5 g, 13.7 mmol) in ethanol (70 m
l) 8N aqueous sodium hydroxide solution (5.13 m
(1, 41 mmol) and heated to reflux for 4 hours. After concentration, the reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated saline, dried (anhydrous magnesium sulfate), and evaporated under reduced pressure.
The desired product (6.26 g, 100%) was obtained. 1 H-NMR (CDCl 3 ) δ: 2.36 (1H, dd, J = 14.0, 10.4 Hz),
2.82 (1H, dd, J = 14.0, 3.0 Hz), 3.20-3.32 (1H,
m), 4.63 (1H, d, J = 4.8 Hz), 5.10 (2H, s), 5.89
(1H, tt, J = 53.0, 3.0 Hz), 6.90-7.12 (6H, m), 7.2
4-7.48 (7H, m) IRν max KBr cm -1: 1740, 1609, 1586, 1487, 1449. Anal Calcd for C 24 H 23 NO 3 F 4:.. C, 64.14; H, 5.16;
N, 3.12 Found: C, 63.87; H, 5.26; N, 2.93.8) N-{(1RS, 2SR) -2- [3- (benzyloxy) phenyl] -2-hydroxy-1- [3- ( 1,1,
2,2-tetrafluoroethoxy) benzyl] ethyl}-
6,7-dihydro-5H-benzo [a] [7] annulene-
1-carboxamide (1RS, 2SR) -2-amino-1- (3- (benzyloxy) phenyl) -3- (3-((1,1,2,2-tetrafluoroethyl) oxy) phenyl) -1 To a solution of -propanol (405 mg, 0.90 mmol) in acetonitrile (30 ml) was added 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (170 mg,
0.90 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (259 m
g, 1.35 mmol) and 1-hydroxybenzotriazole hydrate (138 mg, 0.90 mmol) were added and stirred at room temperature overnight. The reaction solution was water (100 ml)
And extracted with ethyl acetate (100 ml × 2).
1N hydrochloric acid, 1N aqueous sodium hydroxide solution,
The extract was washed successively with a saturated saline solution, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 2: 1-1:
Purification in 1) and recrystallization from ethyl acetate-hexane gave the desired product (407 mg, 73%). 1 H-NMR (CDCl 3 ) δ: 1.92-2.02 (2H, m), 2.12-2.20 (2H,
m), 2.60-2.70 (2H, m), 2.74 (1H, dd, J = 14.4, 10.5
Hz), 2.96 (1H, dd, J = 14.4, 3.9 Hz), 3.49 (1H, d,
J = 3.6 Hz), 4.64-4.76 (1H, m), 5.00-5.10 (3H,
m), 5.76 (1H, d, J = 8.7 Hz), 5.68-6.08 (2H, m), 6.
23 (1H, d, J = 11.7 Hz), 6.90-7.18 (9H, m), 7.24-
7.44 (7H, m) .IRν max KBr cm -1 : 1640, 1611, 1588, 1510, 1489, 144
9. mp 128-129 ℃ Anal. Calcd for C 36 H 33 NO 4 F 4 : C, 69.78; H, 5.37;
N, 2.26 Found: C, 69.62; H, 5.34; N, 2.03.
【0373】実施例241 N-{(1RS,2SR)-2-ヒドロキシ-2-(4-ヒド
ロキシフェニル)-1-[3-(1,1,2,2-テトラフ
ルオロエトキシ)ベンジル]エチル}-6,7-ジヒドロ
-5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド 1) 4-{(1RS,2SR)-2-アミノ-1-ヒドロ
キシ-3-[3-(1,1,2,2-テトラフルオロエトキ
シ)フェニル]プロピル}フェノール (1RS,2SR)-2-アミノ-1-[4-(ベンジルオ
キシ)フェニル]-3-[3-(1,1,2,2-テトラフ
ルオロエトキシ)フェニル]プロパン-1-オール(2.
60g,5.79ミリモル)のエタノール(20ml)
溶液に10%パラジウム/炭素(50%含水,260m
g)を加え、水素気流下、終夜攪拌した。反応液からセ
ライトを用いて触媒を除き、ろ液を濃縮した。残留物を
中性アルミナカラムクロマトグラフィー(エタノール)
で精製し、目的物(0.80g,39%)をアモルファ
スとして得た。1 H-NMR(CDCl3)δ:2.45 (1H, dd, J = 13.6, 10.0 Hz),
2.97 (1H, dd, J = 13.6, 2.6 Hz), 3.16-3.28 (1H,
m), 4.55 (1H, d, J = 5.4 Hz), 5.89 (1H, tt, J= 53.
2, 3.0 Hz), 6.75 (2H, d, J = 8.0 Hz), 7.00-7.34 (6
H, m). IRν maxKBrcm-1:1613, 1588, 1514, 1489, 1449. Anal. Calcd for C17H17NO3F4・0.5H2O: C, 55.44; H,
4.92; N, 3.80 Found : C, 55.41; H, 4.83; N, 3.61. 2) N-{(1RS,2SR)-2-ヒドロキシ-2-
(4-ヒドロキシフェニル)-1-[3-(1,1,2,2
-テトラフルオロエトキシ)ベンジル]エチル}-6,7
-ジヒドロ-5H-ベンゾ[a][7]アンヌレン-1-カ
ルボキサミド 4-{(1RS,2SR)-2-アミノ-1-ヒドロキシ-3
-[3-(1,1,2,2-テトラフルオロエトキシ)フ
ェニル]プロピル}フェノール(125mg,0.35
ミリモル)のアセトニトリル(30ml)溶液に6,7
-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カル
ボン酸(66mg,0.35ミリモル)および1-エチ
ル-3-(3-ジメチルアミノプロピル)カルボジイミド
・塩酸塩(100mg,0.52ミリモル)および1-
ヒドロキシベンゾトリアゾール水和物(53mg,0.
35ミリモル)を加えて室温で終夜攪拌した。反応液を
水(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を1規定塩酸、飽和重曹水、飽
和食塩水で順次洗浄し、乾燥(無水硫酸マグネシウム)
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=1:1)で精製し、
クロロホルム-ヘキサンから再結晶させて、目的物(1
62mg,88%)を得た。1 H-NMR(CDCl3)δ:1.90-2.08 (2H, m), 2.10-2.22 (2H,
m), 2.58-2.70 (2H, m),2.80 (1H, dd, J = 14.4, 10.0
Hz), 3.06 (1H, dd, J = 14.4, 4.0 Hz), 3.24(1H, br
s), 4.64-4.82 (1H, m), 4.88 (1H, brs), 5.73 (1H,
d, J = 8.8 Hz),5.60-6.20 (3H, m), 6.82 (2H, d, J =
8.4 Hz), 6.86-7.18 (5H, m), 7.22-7.40 (3H, m). IRν maxKBrcm-1:1732, 1615, 1588, 1516, 1451. mp 167-168℃ Anal. Calcd for C29H17NO4F4・0.2H2O: C, 65.34; H,
5.18; N, 2.63 Found : C, 65.11; H, 4.99; N, 2.42.Example 241 N-{(1RS, 2SR) -2-hydroxy-2- (4-hydroxyphenyl) -1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro
-5H-benzo [a] [7] annulene-1-carboxamide 1) 4-{(1RS, 2SR) -2-amino-1-hydroxy-3- [3- (1,1,2,2-tetrafluoro Ethoxy) phenyl] propyl} phenol (1RS, 2SR) -2-amino-1- [4- (benzyloxy) phenyl] -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propane -1-all (2.
60 g, 5.79 mmol) of ethanol (20 ml)
Add 10% palladium / carbon (50% water content, 260m
g) was added, and the mixture was stirred overnight under a hydrogen stream. The catalyst was removed from the reaction solution using celite, and the filtrate was concentrated. The residue is neutral alumina column chromatography (ethanol)
Then, the target product (0.80 g, 39%) was obtained as an amorphous substance. 1 H-NMR (CDCl 3 ) δ: 2.45 (1H, dd, J = 13.6, 10.0 Hz),
2.97 (1H, dd, J = 13.6, 2.6 Hz), 3.16-3.28 (1H,
m), 4.55 (1H, d, J = 5.4 Hz), 5.89 (1H, tt, J = 53.
2, 3.0 Hz), 6.75 (2H, d, J = 8.0 Hz), 7.00-7.34 (6
H, m) .IRν max KBr cm -1 : 1613, 1588, 1514, 1489, 1449.Anal.Calcd for C 17 H 17 NO 3 F 4・ 0.5H 2 O: C, 55.44; H,
4.92; N, 3.80 Found: C, 55.41; H, 4.83; N, 3.61.2) N-{(1RS, 2SR) -2-hydroxy-2-
(4-hydroxyphenyl) -1- [3- (1,1,2,2
-Tetrafluoroethoxy) benzyl] ethyl} -6,7
-Dihydro-5H-benzo [a] [7] annulene-1-carboxamide 4-{(1RS, 2SR) -2-amino-1-hydroxy-3
-[3- (1,1,2,2-tetrafluoroethoxy) phenyl] propyl} phenol (125 mg, 0.35
Mmol) in acetonitrile (30 ml) solution.
-Dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (66 mg, 0.35 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (100 mg, 0.52 mmol) and 1-
Hydroxybenzotriazole hydrate (53 mg, 0.
(35 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium bicarbonate, and saturated saline, and dried (anhydrous magnesium sulfate).
After that, it was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1),
Recrystallize from chloroform-hexane to obtain the desired product (1
(62 mg, 88%). 1 H-NMR (CDCl 3 ) δ: 1.90-2.08 (2H, m), 2.10-2.22 (2H,
m), 2.58-2.70 (2H, m), 2.80 (1H, dd, J = 14.4, 10.0
Hz), 3.06 (1H, dd, J = 14.4, 4.0 Hz), 3.24 (1H, br
s), 4.64-4.82 (1H, m), 4.88 (1H, brs), 5.73 (1H,
d, J = 8.8 Hz), 5.60-6.20 (3H, m), 6.82 (2H, d, J =
. 8.4 Hz), 6.86-7.18 (5H , m), 7.22-7.40 (3H, m) IRν max KBr cm -1:. 1732, 1615, 1588, 1516, 1451. mp 167-168 ℃ Anal Calcd for C 29 H 17 NO 4 F 4・ 0.2H 2 O: C, 65.34; H,
5.18; N, 2.63 Found: C, 65.11; H, 4.99; N, 2.42.
【0374】実施例242 N-{(1RS,2SR)-2-ヒドロキシ-2-(4-メト
キシフェニル)-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル}-6,7-ジヒドロ-
5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド N-{(1RS,2SR)-2-ヒドロキシ-2-(4-ヒド
ロキシフェニル)-1-[3-(1,1,2,2-テトラフ
ルオロエトキシ)ベンジル]エチル}-6,7-ジヒドロ
-5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド(400mg,0.755ミリモル)のN,N-ジメ
チルホルムアミド(15ml)溶液に炭酸カリウム(3
13mg,2.27ミリモル)およびヨウ化メチル(2
ml)を加え、室温で終夜攪拌した。反応液を水(10
0ml)で希釈し、酢酸エチル(100ml×2)で抽
出した。抽出液を水、飽和食塩水で順次洗浄し、乾燥
(無水硫酸マグネシウム)後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=2:1)で精製し、酢酸エチル-ヘキサンから再
結晶させて、目的物(80mg,19%)を得た。1 H-NMR(CDCl3)δ:1.90-2.06 (2H, m), 2.08-2.24 (2H,
m), 2.58-2.72 (2H, m),2.78 (1H, dd, J = 14.2, 10.2
Hz), 3.02 (1H, dd, J = 14.2, 4.0 Hz), 3.38(1H, br
s), 3.82 (3H, s), 4.60-4.78 (1H, m), 4.94-5.00 (1
H, m), 5.73 (1H, d, J = 8.4 Hz), 5.60-6.24 (3H,
m), 6.84-7.20 (8H, m), 7.20-7.46 (3H, m). IRν maxKBrcm-1:1645, 1613, 1512, 1449. mp 151-152℃ Anal. Calcd for C30H29NO4F4・0.1H2O: C, 66.07; H,
5.39; N, 2.57 Found : C, 65.92; H, 5.23; N, 2.51.Example 242 N-{(1RS, 2SR) -2-hydroxy-2- (4-methoxyphenyl) -1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro-
5H-benzo [a] [7] annulene-1-carboxamide N-{(1RS, 2SR) -2-hydroxy-2- (4-hydroxyphenyl) -1- [3- (1,1,2,2- Tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro
-5H-benzo [a] [7] annulene-1-carboxamide (400 mg, 0.755 mmol) in N, N-dimethylformamide (15 ml) was dissolved in potassium carbonate (3 ml).
13 mg, 2.27 mmol) and methyl iodide (2
ml) and stirred at room temperature overnight. The reaction solution was diluted with water (10
0 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1), and recrystallized from ethyl acetate-hexane to obtain the desired product (80 mg, 19%). 1 H-NMR (CDCl 3 ) δ: 1.90-2.06 (2H, m), 2.08-2.24 (2H,
m), 2.58-2.72 (2H, m), 2.78 (1H, dd, J = 14.2, 10.2
Hz), 3.02 (1H, dd, J = 14.2, 4.0 Hz), 3.38 (1H, br
s), 3.82 (3H, s), 4.60-4.78 (1H, m), 4.94-5.00 (1
H, m), 5.73 (1H, d, J = 8.4 Hz), 5.60-6.24 (3H,
. m), 6.84-7.20 (8H, m), 7.20-7.46 (3H, m) IRν max KBr cm -1:. 1645, 1613, 1512, 1449. mp 151-152 ℃ Anal Calcd for C 30 H 29 NO 4 F 4・ 0.1H 2 O: C, 66.07; H,
5.39; N, 2.57 Found: C, 65.92; H, 5.23; N, 2.51.
【0375】実施例243 N-{(1RS,2SR)-2-ヒドロキシ-2-(4-イソ
プロポキシフェニル)-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル}-6,7-ジヒ
ドロ-5H-ベンゾ[a][7]アンヌレン-1-カルボキ
サミド N-{(1RS,2SR)-2-ヒドロキシ-2-(4-ヒド
ロキシフェニル)-1-[3-(1,1,2,2-テトラフ
ルオロエトキシ)ベンジル]エチル}-6,7-ジヒドロ
-5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド(400mg,0.755ミリモル)のN,N-ジメ
チルホルムアミド(15ml)溶液に炭酸カリウム(3
13mg,2.27ミリモル)および2-ヨードプロパ
ン(226μl,2.27ミリモル)を加え、室温で終
夜攪拌した。反応液を水(100ml)で希釈し、酢酸
エチル(100ml×2)で抽出した。抽出液を水、飽
和食塩水で順次洗浄し、乾燥(無水硫酸マグネシウム)
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=2:1)で精製し、
酢酸エチル-ヘキサンから再結晶させて、目的物(28
7mg,66%)を得た。1 H-NMR(CDCl3)δ:1.33 (3H, s), 1.36 (3H, s), 1.90-
2.08 (2H, m), 2.10-2.26(2H, m), 2.78 (1H, dd, J =
14.6, 10.2 Hz), 3.03 (1H, dd, J = 14.2, 4.0Hz), 3.
33 (1H, d, J = 3.4 Hz), 4.48-4.62 (1H, m), 4.62-4.
80 (1H, m), 4.92-5.00 (1H, m), 5.72 (1H, d, J = 8.
4 Hz), 5.60-6.24 (3H, m), 6.84-7.20 (8H, m), 7.20-
7.40 (3H, m). IRν maxKBrcm-1:1641, 1613, 1588, 1508, 1451. mp 134-135℃ Anal. Calcd for C32H33NO4F4・0.2H2O: C, 66.82; H,
5.85; N, 2.44 Found : C, 66.72; H, 5.85; N, 2.52.Example 243 N-{(1RS, 2SR) -2-hydroxy-2- (4-isopropoxyphenyl) -1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl {-6,7-dihydro-5H-benzo [a] [7] annulene-1-carboxamide N-{(1RS, 2SR) -2-hydroxy-2- (4-hydroxyphenyl) -1- [3- ( 1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro
-5H-benzo [a] [7] annulene-1-carboxamide (400 mg, 0.755 mmol) in N, N-dimethylformamide (15 ml) was dissolved in potassium carbonate (3 ml).
13 mg, 2.27 mmol) and 2-iodopropane (226 μl, 2.27 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract is washed sequentially with water and saturated saline, and dried (anhydrous magnesium sulfate)
After that, it was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1),
Recrystallization from ethyl acetate-hexane gave the desired product (28
7 mg, 66%). 1 H-NMR (CDCl 3 ) δ: 1.33 (3H, s), 1.36 (3H, s), 1.90-
2.08 (2H, m), 2.10-2.26 (2H, m), 2.78 (1H, dd, J =
14.6, 10.2 Hz), 3.03 (1H, dd, J = 14.2, 4.0Hz), 3.
33 (1H, d, J = 3.4 Hz), 4.48-4.62 (1H, m), 4.62-4.
80 (1H, m), 4.92-5.00 (1H, m), 5.72 (1H, d, J = 8.
4 Hz), 5.60-6.24 (3H, m), 6.84-7.20 (8H, m), 7.20-
7.40 (3H, m) IRν max KBr cm -1:. 1641, 1613, 1588, 1508, 1451. mp 134-135 ℃ Anal Calcd for C 32 H 33 NO 4 F 4 · 0.2H 2 O:. C, 66.82 ; H,
5.85; N, 2.44 Found: C, 66.72; H, 5.85; N, 2.52.
【0376】実施例244 N-{(1RS,2SR)-2-(4-ブトキシフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル}-6,7-ジヒドロ-
5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド N-{(1RS,2SR)-2-ヒドロキシ-2-(4-ヒド
ロキシフェニル)-1-[3-(1,1,2,2-テトラフ
ルオロエトキシ)ベンジル]エチル}-6,7-ジヒドロ
-5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド(400mg,0.755ミリモル)のN,N-ジメ
チルホルムアミド(15ml)溶液に炭酸カリウム(3
13mg,2.27ミリモル)および1-ヨードブタン
(417mg,2.27ミリモル)を加え、室温で終夜
攪拌した。反応液を水(100ml)で希釈し、酢酸エ
チル(100ml×2)で抽出した。抽出液を水、飽和
食塩水で順次洗浄し、乾燥(無水硫酸マグネシウム)後
減圧留去した。残留物を酢酸エチル-ヘキサンから再結
晶させて、目的物(298mg,67%)を得た。1 H-NMR(CDCl3)δ:0.98 (3H, t, J = 7.4 Hz), 1.40-1.6
0 (2H, m), 1.68-1.88 (2H, m), 1.90-2.10 (2H, m),
2.12-2.28 (2H, m), 2.60-2.72 (2H, m), 2.77 (1H, d
d, J = 14.6, 10.6 Hz), 3.02 (1H, dd, J = 14.6, 4.0
Hz), 3.36 (1H, d,J = 3.6 Hz), 3.96 (2H, t, J = 6.
4 Hz), 4.62-4.78 (1H, m), 4.96 (1H, t,J = 4.0 Hz),
5.72 (1H, d, J = 8.6 Hz), 5.60-6.22 (3H, m), 6.86
-7.20 (7H,m), 7.22-7.40 (4H, m). IRν maxKBrcm-1:1644, 1613, 1586, 1512, 1449. mp 126-127℃ Anal. Calcd for C33H35NO4F4: C, 67.68; H, 6.02; N,
2.39 Found : C, 67.64; H, 6.04; N, 2.23.Example 244 N-{(1RS, 2SR) -2- (4-butoxyphenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro-
5H-benzo [a] [7] annulene-1-carboxamide N-{(1RS, 2SR) -2-hydroxy-2- (4-hydroxyphenyl) -1- [3- (1,1,2,2- Tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro
-5H-benzo [a] [7] annulene-1-carboxamide (400 mg, 0.755 mmol) in N, N-dimethylformamide (15 ml) was dissolved in potassium carbonate (3 ml).
13 mg, 2.27 mmol) and 1-iodobutane (417 mg, 2.27 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to obtain the desired product (298 mg, 67%). 1 H-NMR (CDCl 3 ) δ: 0.98 (3H, t, J = 7.4 Hz), 1.40-1.6
0 (2H, m), 1.68-1.88 (2H, m), 1.90-2.10 (2H, m),
2.12-2.28 (2H, m), 2.60-2.72 (2H, m), 2.77 (1H, d
d, J = 14.6, 10.6 Hz), 3.02 (1H, dd, J = 14.6, 4.0
Hz), 3.36 (1H, d, J = 3.6 Hz), 3.96 (2H, t, J = 6.
4 Hz), 4.62-4.78 (1H, m), 4.96 (1H, t, J = 4.0 Hz),
5.72 (1H, d, J = 8.6 Hz), 5.60-6.22 (3H, m), 6.86
-7.20 (7H, m), 7.22-7.40 (4H, m) IRν max KBr cm -1:.. 1644, 1613, 1586, 1512, 1449. mp 126-127 ℃ Anal Calcd for C 33 H 35 NO 4 F 4 : C, 67.68; H, 6.02; N,
2.39 Found: C, 67.64; H, 6.04; N, 2.23.
【0377】実施例245 N-{(1RS,2SR)-2-{4-[(4-フルオロベ
ンジル)オキシ]フェニル}-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル}-6,7-ジヒドロ-5H-ベンゾ[a]
[7]アンヌレン-1-カルボキサミド N-{(1RS,2SR)-2-ヒドロキシ-2-(4-ヒド
ロキシフェニル)-1-[3-(1,1,2,2-テトラフ
ルオロエトキシ)ベンジル]エチル}-6,7-ジヒドロ
-5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド(400mg,0.755ミリモル)のN,N-ジメ
チルホルムアミド(15ml)溶液に炭酸カリウム(3
13mg,2.27ミリモル)および臭化4-フルオロ
ベンジル(428mg,2.27ミリモル)を加え、室
温で終夜攪拌した。反応液を水(100ml)で希釈
し、酢酸エチル(100ml×2)で抽出した。抽出液
を水、飽和食塩水で順次洗浄し、乾燥(無水硫酸マグネ
シウム)後減圧留去した。残留物を酢酸エチル-ヘキサ
ンから再結晶させて、目的物(381mg,79%)を
得た。1 H-NMR(CDCl3)δ:1.90-2.08 (2H, m), 2.10-2.26 (2H,
m), 2.60-2.76 (2H, m),2.77 (1H, dd, J = 14.6, 10.2
Hz), 3.02 (1H, dd, J = 14.6, 4.0 Hz), 3.43(1H, d,
J = 3.4 Hz), 4.80-4.98 (1H, m), 4.97 (1H, t, J =
4.0 Hz), 5.02(2H, s), 5.74 (1H, d, J = 8.4 Hz), 5.
60-6.24 (3H, m), 6.90-7.20 (10H, m), 7.24-7.48 (8
H, m). IRν maxKBrcm-1:1644, 1611, 1586, 1512, 1449. mp 144-145℃ Anal. Calcd for C36H32NO4F5: C, 67.81; H, 5.06; N,
2.20 Found : C, 67.69; H, 4.95; N, 1.98.Example 245 N-{(1RS, 2SR) -2- {4-[(4-fluorobenzyl) oxy] phenyl} -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro-5H-benzo [a]
[7] Annulene-1-carboxamide N-{(1RS, 2SR) -2-hydroxy-2- (4-hydroxyphenyl) -1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] Ethyl} -6,7-dihydro
-5H-benzo [a] [7] annulene-1-carboxamide (400 mg, 0.755 mmol) in N, N-dimethylformamide (15 ml) was dissolved in potassium carbonate (3 ml).
13 mg, 2.27 mmol) and 4-fluorobenzyl bromide (428 mg, 2.27 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to obtain the desired product (381 mg, 79%). 1 H-NMR (CDCl 3 ) δ: 1.90-2.08 (2H, m), 2.10-2.26 (2H,
m), 2.60-2.76 (2H, m), 2.77 (1H, dd, J = 14.6, 10.2
Hz), 3.02 (1H, dd, J = 14.6, 4.0 Hz), 3.43 (1H, d,
J = 3.4 Hz), 4.80-4.98 (1H, m), 4.97 (1H, t, J =
4.0 Hz), 5.02 (2H, s), 5.74 (1H, d, J = 8.4 Hz), 5.
60-6.24 (3H, m), 6.90-7.20 (10H, m), 7.24-7.48 (8
.. H, m) IRν max KBr cm -1: 1644, 1611, 1586, 1512, 1449. mp 144-145 ℃ Anal Calcd for C 36 H 32 NO 4 F 5: C, 67.81; H, 5.06; N,
2.20 Found: C, 67.69; H, 4.95; N, 1.98.
【0378】実施例246 N-{(1RS,2SR)-2-[4-(シクロヘキシルメ
トキシ)フェニル]-2-ヒドロキシ-1-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]エチ
ル}-6,7-ジヒドロ-5H-ベンゾ[a][7]アンヌ
レン-1-カルボキサミド N-{(1RS,2SR)-2-ヒドロキシ-2-(4-ヒド
ロキシフェニル)-1-[3-(1,1,2,2-テトラフ
ルオロエトキシ)ベンジル]エチル}-6,7-ジヒドロ
-5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド(400mg,0.755ミリモル)のN,N-ジメ
チルホルムアミド(15ml)溶液に炭酸カリウム(3
13mg,2.27ミリモル)および(ブロモメチル)
シクロヘキサン(401mg,2.27ミリモル)を加
え、室温で終夜攪拌した。反応液を水(100ml)で
希釈し、酢酸エチル(100ml×2)で抽出した。抽
出液を水、飽和食塩水で順次洗浄し、乾燥(無水硫酸マ
グネシウム)後減圧留去した。残留物をシリカゲルカラ
ムクロマトグラフィー(ヘキサン:酢酸エチル=1:
1)で精製し、酢酸エチル-ヘキサンから再結晶させ
て、目的物(129mg,27%)を得た。1 H-NMR(CDCl3)δ:0.90-1.45 (6H, m), 1.66-2.10 (7H,
m), 2.12-2.28 (2H, m),2.60-2.72 (2H, m), 2.79 (1H,
dd, J = 14.8, 10.6 Hz), 3.03 (1H, dd, J =14.8, 4.
0 Hz), 3.38 (1H, d, J = 3.4 Hz), 3.77 (2H, d, J =
5.8 Hz), 4.64-4.80 (1H, m), 4.90-5.02 (1H, m), 5.7
4 (1H, d, J = 8.8 Hz), 5.62-6.24 (3H, m), 6.88-7.2
0 (7H, m), 7.20-7.42 (4H, m). IRν maxKBrcm-1:1644, 1613, 1586, 1512, 1451. mp 141-142℃ Anal. Calcd for C36H39NO4F4: C, 69.11; H, 6.28; N,
2.24 Found : C, 69.05; H, 6.47; N, 2.14.Example 246 N-{(1RS, 2SR) -2- [4- (cyclohexylmethoxy) phenyl] -2-hydroxy-1- [3- (1,
1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro-5H-benzo [a] [7] annulene-1-carboxamide N-{(1RS, 2SR) -2-hydroxy-2- (4-Hydroxyphenyl) -1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro
-5H-benzo [a] [7] annulene-1-carboxamide (400 mg, 0.755 mmol) in N, N-dimethylformamide (15 ml) was dissolved in potassium carbonate (3 ml).
13 mg, 2.27 mmol) and (bromomethyl)
Cyclohexane (401 mg, 2.27 mmol) was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 1: 1).
Purification in 1) and recrystallization from ethyl acetate-hexane gave the desired product (129 mg, 27%). 1 H-NMR (CDCl 3 ) δ: 0.90-1.45 (6H, m), 1.66-2.10 (7H,
m), 2.12-2.28 (2H, m), 2.60-2.72 (2H, m), 2.79 (1H,
dd, J = 14.8, 10.6 Hz), 3.03 (1H, dd, J = 14.8, 4.
0 Hz), 3.38 (1H, d, J = 3.4 Hz), 3.77 (2H, d, J =
5.8 Hz), 4.64-4.80 (1H, m), 4.90-5.02 (1H, m), 5.7
4 (1H, d, J = 8.8 Hz), 5.62-6.24 (3H, m), 6.88-7.2
0 (7H, m), 7.20-7.42 (4H, m) IRν max KBr cm -1:.. 1644, 1613, 1586, 1512, 1451. mp 141-142 ℃ Anal Calcd for C 36 H 39 NO 4 F 4 : C, 69.11; H, 6.28; N,
2.24 Found: C, 69.05; H, 6.47; N, 2.14.
【0379】実施例247 N-{(1RS,2SR)-2-ヒドロキシ-2-[4-(3
-フェノキシプロポキシ)フェニル]-1-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]エチ
ル}-6,7-ジヒドロ-5H-ベンゾ[a][7]アンヌ
レン-1-カルボキサミド N-{(1RS,2SR)-2-ヒドロキシ-2-(4-ヒド
ロキシフェニル)-1-[3-(1,1,2,2-テトラフ
ルオロエトキシ)ベンジル]エチル}-6,7-ジヒドロ
-5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド(400mg,0.755ミリモル)のN,N-ジメ
チルホルムアミド(15ml)溶液に炭酸カリウム(3
13mg,2.27ミリモル)および3-フェノキシ-1
-ブロモプロパン(487mg,2.27ミリモル)を
加え、室温で終夜攪拌した。反応液を水(100ml)
で希釈し、酢酸エチル(100ml×2)で抽出した。
抽出液を水、飽和食塩水で順次洗浄し、乾燥(無水硫酸
マグネシウム)後減圧留去した。残留物をシリカゲルカ
ラムクロマトグラフィー(ヘキサン:酢酸エチル=2:
1)で精製し、酢酸エチル-ヘキサンから再結晶させ
て、目的物(245mg,50%)を得た。1 H-NMR(CDCl3)δ:1.92-2.02 (2H, m), 2.12-2.22 (2H,
m), 2.22-2.32 (2H, m),2.62-2.70 (2H, m), 2.76 (1H,
dd, J = 14.4, 10.2 Hz), 3.00 (1H, dd, J =14.4, 3.
9 Hz), 3.39 (1H, d, J = 3.6 Hz), 4.14-4.22 (4H,
m), 4.64-4.76 (1H, m), 4.96-5.00 (1H, m), 5.68-6.1
0 (3H, m), 6.19 (1H, d, J = 11.7 Hz),6.88-7.00 (6
H, m), 7.00-7.16 (5H, m), 7.24-7.40 (5H, m). IRν maxKBrcm-1:1644, 1613, 1601, 1588, 1512, 149
9. mp 142-143℃ Anal. Calcd for C38H37NO5F4: C, 68.77; H, 5.62; N,
2.11 Found : C, 68.67; H, 5.38; N, 1.92.Example 247 N-{(1RS, 2SR) -2-hydroxy-2- [4- (3
-Phenoxypropoxy) phenyl] -1- [3- (1,
1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro-5H-benzo [a] [7] annulene-1-carboxamide N-{(1RS, 2SR) -2-hydroxy-2- (4-Hydroxyphenyl) -1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro
-5H-benzo [a] [7] annulene-1-carboxamide (400 mg, 0.755 mmol) in N, N-dimethylformamide (15 ml) was dissolved in potassium carbonate (3 ml).
13 mg, 2.27 mmol) and 3-phenoxy-1
-Bromopropane (487 mg, 2.27 mmol) was added, and the mixture was stirred at room temperature overnight. The reaction solution was water (100 ml)
And extracted with ethyl acetate (100 ml × 2).
The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 2:
Purification in 1) and recrystallization from ethyl acetate-hexane gave the desired product (245 mg, 50%). 1 H-NMR (CDCl 3 ) δ: 1.92-2.02 (2H, m), 2.12-2.22 (2H,
m), 2.22-2.32 (2H, m), 2.62-2.70 (2H, m), 2.76 (1H,
dd, J = 14.4, 10.2 Hz), 3.00 (1H, dd, J = 14.4, 3.
9 Hz), 3.39 (1H, d, J = 3.6 Hz), 4.14-4.22 (4H,
m), 4.64-4.76 (1H, m), 4.96-5.00 (1H, m), 5.68-6.1
0 (3H, m), 6.19 (1H, d, J = 11.7 Hz), 6.88-7.00 (6
H, m), 7.00-7.16 (5H, m), 7.24-7.40 (5H, m) .IRν max KBr cm -1 : 1644, 1613, 1601, 1588, 1512, 149
. 9. mp 142-143 ℃ Anal Calcd for C 38 H 37 NO 5 F 4: C, 68.77; H, 5.62; N,
2.11 Found: C, 68.67; H, 5.38; N, 1.92.
【0380】実施例248 4-[(4-{(1RS,2SR)-2-[(6,7-ジヒ
ドロ-5H-ベンゾ[a][7]アンヌレン-1-イルカル
ボニル)アミノ]-1-ヒドロキシ-3-[3-(1,1,
2,2-テトラフルオロエトキシ)フェニル]プロピ
ル}フェノキシ)メチル]安息香酸メチル N-{(1RS,2SR)-2-ヒドロキシ-2-(4-ヒド
ロキシフェニル)-1-[3-(1,1,2,2-テトラフ
ルオロエトキシ)ベンジル]エチル}-6,7-ジヒドロ
-5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド(600mg,1.13ミリモル)のN,N-ジメチ
ルホルムアミド(20ml)溶液に炭酸カリウム(47
0mg,3.40ミリモル)および4-(ブロモメチ
ル)安息香酸メチル(780mg,3.40ミリモル)
を加え、室温で終夜攪拌した。反応液を水(100m
l)で希釈し、酢酸エチル(100ml×2)で抽出し
た。抽出液を水、飽和食塩水で順次洗浄し、乾燥(無水
硫酸マグネシウム)後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
4:1-2:1)で精製し、酢酸エチル-ヘキサンから再
結晶させて、目的物(361mg,47%)を得た。1 H-NMR(CDCl3)δ:1.90-2.08 (2H, m), 2.10-2.24 (2H,
m), 2.60-2.70 (2H, m),2.78 (1H, dd, J = 14.2, 10.4
Hz), 3.02 (1H, dd, J = 14.2, 4.0 Hz), 3.39(1H,
s), 3.92 (3H, s), 4.60-4.80 (1H, m), 4.98 (1H, s),
5.13 (2H, s), 5.72 (1H, d, J = 8.8 Hz), 5.60-6.24
(3H, m), 6.90-7.18 (8H, m), 7.20-7.36(1H, m), 7.3
8 (2H, d, J = 8.4 Hz), 7.51 (2H, d, J = 8.0 Hz),
8.06 (2H,d, J = 8.0 Hz). IRν maxKBrcm-1:1719, 1640, 1613, 1586, 1510, 143
7. mp 169-170℃ Anal. Calcd for C38H35F4NO6: C, 67.35; H, 5.21; N,
2.07 Found : C, 67.19; H, 4.94; N, 1.83.Example 248 4-[(4-{(1RS, 2SR) -2-[(6,7-dihydro-5H-benzo [a] [7] annulen-1-ylcarbonyl) amino] -1-] Hydroxy-3- [3- (1,1,
2,2-Tetrafluoroethoxy) phenyl] propyl {phenoxy) methyl] methyl benzoate N-{(1RS, 2SR) -2-hydroxy-2- (4-hydroxyphenyl) -1- [3- (1,1 , 2,2-Tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro
To a solution of -5H-benzo [a] [7] annulene-1-carboxamide (600 mg, 1.13 mmol) in N, N-dimethylformamide (20 ml) was added potassium carbonate (47 ml).
0 mg, 3.40 mmol) and methyl 4- (bromomethyl) benzoate (780 mg, 3.40 mmol)
Was added and stirred at room temperature overnight. The reaction solution was washed with water (100 m
1) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
4: 1-2: 1) and recrystallized from ethyl acetate-hexane to give the desired product (361 mg, 47%). 1 H-NMR (CDCl 3 ) δ: 1.90-2.08 (2H, m), 2.10-2.24 (2H,
m), 2.60-2.70 (2H, m), 2.78 (1H, dd, J = 14.2, 10.4
Hz), 3.02 (1H, dd, J = 14.2, 4.0 Hz), 3.39 (1H,
s), 3.92 (3H, s), 4.60-4.80 (1H, m), 4.98 (1H, s),
5.13 (2H, s), 5.72 (1H, d, J = 8.8 Hz), 5.60-6.24
(3H, m), 6.90-7.18 (8H, m), 7.20-7.36 (1H, m), 7.3
8 (2H, d, J = 8.4 Hz), 7.51 (2H, d, J = 8.0 Hz),
8.06 (2H, d, J = 8.0 Hz) .IRν max KBr cm -1 : 1719, 1640, 1613, 1586, 1510, 143
7.mp 169-170 ℃ Anal. Calcd for C 38 H 35 F 4 NO 6 : C, 67.35; H, 5.21; N,
2.07 Found: C, 67.19; H, 4.94; N, 1.83.
【0381】実施例249 (4-{(1RS,2SR)-2-[(6,7-ジヒドロ-
5H-ベンゾ[a][7]アンヌレン-1-イルカルボニ
ル)アミノ]-1-ヒドロキシ-3-[3-(1,1,2,
2-テトラフルオロエトキシ)フェニル]プロピル}フ
ェノキシ)酢酸エチル N-{(1RS,2SR)-2-ヒドロキシ-2-(4-ヒド
ロキシフェニル)-1-[3-(1,1,2,2-テトラフ
ルオロエトキシ)ベンジル]エチル}-6,7-ジヒドロ
-5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド(600mg,1.13ミリモル)のN,N-ジメチ
ルホルムアミド(20ml)溶液に炭酸カリウム(47
0mg,3.40ミリモル)およびブロモ酢酸エチル
(570mg,3.40ミリモル)を加え、室温で終夜
攪拌した。反応液を水(100ml)で希釈し、酢酸エ
チル(100ml×2)で抽出した。抽出液を水、飽和
食塩水で順次洗浄し、乾燥(無水硫酸マグネシウム)後
減圧留去した。残留物をシリカゲルカラムクロマトグラ
フィー(ヘキサン:酢酸エチル=4:1)で精製し、酢
酸エチル-ヘキサンから再結晶させて、目的物(167
mg,24%)を得た。1 H-NMR(CDCl3)δ:1.30 (3H, t, J = 7.2 Hz), 1.90-2.0
8 (2H, m), 2.12-2.24 (2H, m), 2.58-2.70 (2H, m),
2.77 (1H, dd, J = 14.1, 10.8 Hz), 3.00 (1H, dd, J
= 14.1, 3.9 Hz), 3.48 (1H, d, J = 3.6 Hz), 4.28 (2
H, q, J = 7.2 Hz), 4.63 (2H, s), 4.60-4.76 (1H,
m), 4.96-5.06 (1H, m), 5.70-6.10 (3H, m),6.21 (1H,
d, J = 11.7 Hz), 6.88-7.20 (8H, m), 7.26-7.38 (1
H, m), 7.38 (2H, d, J = 8.7 Hz). IRν maxKBrcm-1:1755, 1645, 1613, 1588, 1512, 144
9. mp 125-126℃ Anal. Calcd for C33H33F4NO6: C, 64.38; H, 5.40; N,
2.28 Found : C, 64.15; H, 5.36; N, 2.02.Example 249 (4-{(1RS, 2SR) -2-[(6,7-dihydro-
5H-benzo [a] [7] annulen-1-ylcarbonyl) amino] -1-hydroxy-3- [3- (1,1,2,2
2-Tetrafluoroethoxy) phenyl] propyl {phenoxy) ethyl acetate N-{(1RS, 2SR) -2-hydroxy-2- (4-hydroxyphenyl) -1- [3- (1,1,2,2- Tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro
To a solution of -5H-benzo [a] [7] annulene-1-carboxamide (600 mg, 1.13 mmol) in N, N-dimethylformamide (20 ml) was added potassium carbonate (47 ml).
0 mg, 3.40 mmol) and ethyl bromoacetate (570 mg, 3.40 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the desired product (167).
mg, 24%). 1 H-NMR (CDCl 3 ) δ: 1.30 (3H, t, J = 7.2 Hz), 1.90-2.0
8 (2H, m), 2.12-2.24 (2H, m), 2.58-2.70 (2H, m),
2.77 (1H, dd, J = 14.1, 10.8 Hz), 3.00 (1H, dd, J
= 14.1, 3.9 Hz), 3.48 (1H, d, J = 3.6 Hz), 4.28 (2
H, q, J = 7.2 Hz), 4.63 (2H, s), 4.60-4.76 (1H,
m), 4.96-5.06 (1H, m), 5.70-6.10 (3H, m), 6.21 (1H,
d, J = 11.7 Hz), 6.88-7.20 (8H, m), 7.26-7.38 (1
H, m), 7.38 (2H, d, J = 8.7 Hz) .IRν max KBr cm -1 : 1755, 1645, 1613, 1588, 1512, 144
9.mp 125-126 ℃ Anal.Calcd for C 33 H 33 F 4 NO 6 : C, 64.38; H, 5.40; N,
2.28 Found: C, 64.15; H, 5.36; N, 2.02.
【0382】実施例250 4-[(4-{(1RS,2SR)-2-[(6,7-ジヒ
ドロ-5H-ベンゾ[a][7]アンヌレン-1-イルカル
ボニル)アミノ]-1-ヒドロキシ-3-[3-(1,1,
2,2-テトラフルオロエトキシ)フェニル]プロピ
ル}フェノキシ)メチル]安息香酸 4-[(4-{(1RS,2SR)-2-[(6,7-ジヒ
ドロ-5H-ベンゾ[a][7]アンヌレン-1-イルカル
ボニル)アミノ]-1-ヒドロキシ-3-[3-(1,1,
2,2-テトラフルオロエトキシ)フェニル]プロピ
ル}フェノキシ)メチル]安息香酸メチル(260m
g,0.384ミリモル)のメタノール(10ml)溶
液に2規定水酸化ナトリウム水溶液(0.38ml,
0.76ミリモル)を加え、60℃で終夜攪拌した。反
応液を1規定塩酸で酸性とした後、酢酸エチル(100
ml×2)で抽出した。抽出液を水および飽和食塩水で
洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去し
た。残留物を酢酸エチル-ヘキサンから再結晶させて、
目的物(209mg,82%)を得た。1 H-NMR(CDCl3)δ:1.90-2.06 (2H, m), 2.10-2.26 (2H,
m), 2.60-2.80 (2H, m),2.77 (1H, dd, J = 14.6, 10.6
Hz), 3.03 (1H, dd, J = 14.6, 4.4 Hz), 4.62-4.80
(1H, m), 4.99 (1H, d, J = 3.6 Hz), 5.15 (2H, s),
5.75 (1H, d, J =8.8 Hz), 5.58-6.24 (3H, m), 6.90-
7.20 (8H, m), 7.20-7.40 (1H, m), 7.39 (2H, d, J =
8.4 Hz), 7.54 (2H, d, J = 8.4 Hz), 8.12 (2H, d, J
= 8.2 Hz). IRν maxKBrcm-1:1696, 1640, 1613, 1586, 1510, 148
9, 1449. mp 190-191℃ Anal. Calcd for C37H33F4NO6: C, 66.96; H, 5.01; N,
2.11 Found : C, 66.86; H, 4.88; N, 2.01.Example 250 4-[(4-{(1RS, 2SR) -2-[(6,7-diethyl
Dro-5H-benzo [a] [7] annulen-1-ylcar
Bonyl) amino] -1-hydroxy-3- [3- (1,1,
2,2-tetrafluoroethoxy) phenyl] propi
[Ruphenoxy) methyl] benzoic acid 4-[(4-{(1RS, 2SR) -2-[(6,7-dihi)
Dro-5H-benzo [a] [7] annulen-1-ylcar
Bonyl) amino] -1-hydroxy-3- [3- (1,1,
2,2-tetrafluoroethoxy) phenyl] propi
Ruphenoxy) methyl] methyl benzoate (260m
g, 0.384 mmol) in methanol (10 ml)
A 2N aqueous sodium hydroxide solution (0.38 ml,
(0.76 mmol) and stirred at 60 ° C. overnight. Anti
The reaction solution was acidified with 1N hydrochloric acid, and then ethyl acetate (100
ml × 2). Extract with water and saturated saline
Wash, dry (anhydrous magnesium sulfate) and evaporate under reduced pressure
Was. The residue was recrystallized from ethyl acetate-hexane,
The desired product (209 mg, 82%) was obtained. 1 H-NMR (CDCl Three ) δ: 1.90-2.06 (2H, m), 2.10-2.26 (2H,
m), 2.60-2.80 (2H, m), 2.77 (1H, dd, J = 14.6, 10.6
Hz), 3.03 (1H, dd, J = 14.6, 4.4 Hz), 4.62-4.80
(1H, m), 4.99 (1H, d, J = 3.6 Hz), 5.15 (2H, s),
5.75 (1H, d, J = 8.8 Hz), 5.58-6.24 (3H, m), 6.90-
7.20 (8H, m), 7.20-7.40 (1H, m), 7.39 (2H, d, J =
8.4 Hz), 7.54 (2H, d, J = 8.4 Hz), 8.12 (2H, d, J
= 8.2 Hz) .IRν max KBr cm -1 : 1696, 1640, 1613, 1586, 1510, 148
9, 1449.mp 190-191 ℃ Anal.Calcd for C 37 H 33 F Four NO 6 : C, 66.96; H, 5.01; N,
2.11 Found: C, 66.86; H, 4.88; N, 2.01.
【0383】実施例251 (4-{(1RS,2SR)-2-[(6,7-ジヒドロ-
5H-ベンゾ[a][7]アンヌレン-1-イルカルボニ
ル)アミノ]-1-ヒドロキシ-3-[3-(1,1,2,
2-テトラフルオロエトキシ)フェニル]プロピル}フ
ェノキシ)酢酸 (4-{(1RS,2SR)-2-[(6,7-ジヒドロ-
5H-ベンゾ[a][7]アンヌレン-1-イルカルボニ
ル)アミノ]-1-ヒドロキシ-3-[3-(1,1,2,
2-テトラフルオロエトキシ)フェニル]プロピル}フ
ェノキシ)酢酸エチル(100mg,0.163ミリモ
ル)のメタノール(20ml)溶液に2規定水酸化ナト
リウム水溶液(0.16ml,0.32ミリモル)を加
え、室温で終夜攪拌した。反応液を1規定塩酸で酸性と
した後、酢酸エチル(100ml×2)で抽出した。抽
出液を水および飽和食塩水で洗浄し、乾燥(無水硫酸マ
グネシウム)後減圧留去した。残留物をシリカゲルカラ
ムクロマトグラフィー(ヘキサン:酢酸エチル=4:1
-酢酸エチル-メタノール=10:1)で精製し、酢酸エ
チル-ヘキサンから再結晶させて、目的物(87mg,
91%)を得た。1 H-NMR(CDCl3)δ:1.86-2.04 (2H, m), 2.10-2.24 (2H,
m), 2.58-2.70 (2H, m),2.75 (1H, dd, J = 14.6, 10.6
Hz), 2.98 (1H, dd, J = 14.6, 3.6 Hz), 4.50-4.96
(5H, m), 4.96 (1H, d, J = 3.8 Hz), 5.58-6.20 (4H,
m), 6.82-7.20 (8H, m), 7.20-7.40 (3H, m). IRν maxKBrcm-1:1744, 1640, 1613, 1588, 1512. mp 119-120℃ Anal. Calcd for C31H29NO6F4・0.2H2O: C, 62.99; H,
5.01; N, 2.37 Found : C, 62.82; H, 5.13; N, 2.32.Example 251 (4-{(1RS, 2SR) -2-[(6,7-dihydro-
5H-benzo [a] [7] annulen-1-ylcarbonyl) amino] -1-hydroxy-3- [3- (1,1,2,2
2-tetrafluoroethoxy) phenyl] propyl {phenoxy) acetic acid (4-{(1RS, 2SR) -2-[(6,7-dihydro-
5H-benzo [a] [7] annulen-1-ylcarbonyl) amino] -1-hydroxy-3- [3- (1,1,2,2
To a solution of ethyl 2-tetrafluoroethoxy) phenyl] propyl @ phenoxy) acetate (100 mg, 0.163 mmol) in methanol (20 ml) was added a 2N aqueous sodium hydroxide solution (0.16 ml, 0.32 mmol), and the mixture was stirred at room temperature. Stirred overnight. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (100 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 4: 1).
-Ethyl acetate-methanol = 10: 1) and recrystallized from ethyl acetate-hexane to give the desired product (87 mg,
91%). 1 H-NMR (CDCl 3 ) δ: 1.86-2.04 (2H, m), 2.10-2.24 (2H,
m), 2.58-2.70 (2H, m), 2.75 (1H, dd, J = 14.6, 10.6
Hz), 2.98 (1H, dd, J = 14.6, 3.6 Hz), 4.50-4.96
(5H, m), 4.96 (1H, d, J = 3.8 Hz), 5.58-6.20 (4H,
. m), 6.82-7.20 (8H, m), 7.20-7.40 (3H, m) IRν max KBr cm -1:. 1744, 1640, 1613, 1588, 1512. mp 119-120 ℃ Anal Calcd for C 31 H 29 NO 6 F 4・ 0.2H 2 O: C, 62.99; H,
5.01; N, 2.37 Found: C, 62.82; H, 5.13; N, 2.32.
【0384】実施例252 N-{(1RS,2SR)-2-ヒドロキシ-2-(3-ヒド
ロキシフェニル)-1-[3-(1,1,2,2-テトラフ
ルオロエトキシ)ベンジル]エチル}-6,7-ジヒドロ
-5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド 1) 3-{(1RS,2SR)-2-アミノ-1-ヒドロ
キシ-3-[3-(1,1,2,2-テトラフルオロエトキ
シ)フェニル]プロピル}フェノール (1RS,2SR)-2-アミノ-1-[3-(ベンジルオ
キシ)フェニル]-3-[3-(1,1,2,2-テトラフ
ルオロエトキシ)フェニル]プロパン-1-オール(5.
50g,12.23ミリモル)のエタノール(100m
l)溶液に10%パラジウム/炭素(50%含水,50
0mg)を加え、水素気流下、終夜攪拌した。反応液か
らセライトを用いて触媒を除き、ろ液を濃縮し、目的物
(4.04g,92%,粗製)を得た。データ取得のた
め、一部をアルミナカラムクロマトグラフィー(エタノ
ール)で精製し、ジイソプロピルエーテル-ヘキサンか
ら再結晶した。1 H-NMR(CDCl3)δ:2.47 (1H, t, J = 12.6 Hz), 2.99 (1
H, d, J = 13.5 Hz), 3.22 (2H, s), 3.33 (2H, brs),
4.56 (1H, d, J = 3.4 Hz), 5.88 (1H, t, J = 53.1 H
z), 6.70-7.40 (8H, m). IRν maxKBrcm-1:1586, 1487, 1456. mp 130-131℃ Anal. Calcd for C17H17F4NO3: C, 56.83; H, 4.77; N,
3.90 Found : C, 56.73; H, 4.59; N, 3.79. 2) N-{(1RS,2SR)-2-ヒドロキシ-2-
(3-ヒドロキシフェニル)-1-[3-(1,1,2,2
-テトラフルオロエトキシ)ベンジル]エチル}-6,7
-ジヒドロ-5H-ベンゾ[a][7]アンヌレン-1-カ
ルボキサミド 3-{(1RS,2SR)-2-アミノ-1-ヒドロキシ-3
-[3-(1,1,2,2-テトラフルオロエトキシ)フ
ェニル]プロピル}フェノール(2.89g,8.04
ミリモル)のアセトニトリル(50ml)溶液に6,7
-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カル
ボン酸(1.51g,8.04ミリモル)および1-エ
チル-3-(3-ジメチルアミノプロピル)カルボジイミ
ド・塩酸塩(2.31g,12.06ミリモル)および
1-ヒドロキシベンゾトリアゾール水和物(1.23
g,8.04ミリモル)を加えて室温で終夜攪拌した。
反応液を水(200ml)で希釈し、酢酸エチル(20
0ml×2)で抽出した。抽出液を1規定塩酸、飽和重
曹水、飽和食塩水で順次洗浄し、乾燥(無水硫酸マグネ
シウム)後減圧留去した。残留物をシリカゲルカラムク
ロマトグラフィー(ヘキサン:酢酸エチル=2:1-
1:1)で精製し、目的物(2.75g,65%)をア
モルファスとして得た。1 H-NMR(CDCl3)δ:1.88-2.00 (2H, m), 2.08-2.18 (2H,
m), 2.54-2.64 (2H, m),2.74 (1H, dd, J = 14.4, 10.5
Hz), 2.98 (1H, dd, J = 14.4, 7.5 Hz), 4.07(1H, br
s), 4.64-4.78 (1H, m), 4.86-4.92 (1H, m), 5.66-6.0
4 (4H, m), 6.72-6.80 (1H, m), 6.84-7.28 (9H, m),
7.58 (1H, brs). IRν maxKBrcm-1:1636, 1588, 1520, 1489, 1453. Anal. Calcd for C29H27NO4F4・0.2H2O: C, 65.34; H,
5.18; N, 2.63 Found : C, 65.27; H, 5.34; N, 2.45.Example 252 N-{(1RS, 2SR) -2-hydroxy-2- (3-hydroxyphenyl) -1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro
-5H-benzo [a] [7] annulene-1-carboxamide 1) 3-{(1RS, 2SR) -2-amino-1-hydroxy-3- [3- (1,1,2,2-tetrafluoro) Ethoxy) phenyl] propyl} phenol (1RS, 2SR) -2-amino-1- [3- (benzyloxy) phenyl] -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propane -1-all (5.
50 g, 12.23 mmol) of ethanol (100 m
l) Add 10% palladium / carbon (50% water, 50%
0 mg) and stirred overnight under a stream of hydrogen. The catalyst was removed from the reaction solution using celite, and the filtrate was concentrated to give the desired product (4.04 g, 92%, crude). For data acquisition, a portion was purified by alumina column chromatography (ethanol) and recrystallized from diisopropyl ether-hexane. 1 H-NMR (CDCl 3 ) δ: 2.47 (1H, t, J = 12.6 Hz), 2.99 (1
H, d, J = 13.5 Hz), 3.22 (2H, s), 3.33 (2H, brs),
4.56 (1H, d, J = 3.4 Hz), 5.88 (1H, t, J = 53.1 H
.. z), 6.70-7.40 (8H , m) IRν max KBr cm -1: 1586, 1487, 1456. mp 130-131 ℃ Anal Calcd for C 17 H 17 F 4 NO 3: C, 56.83; H, 4.77 ; N,
3.90 Found: C, 56.73; H, 4.59; N, 3.79. 2) N-{(1RS, 2SR) -2-hydroxy-2-
(3-hydroxyphenyl) -1- [3- (1,1,2,2
-Tetrafluoroethoxy) benzyl] ethyl} -6,7
-Dihydro-5H-benzo [a] [7] annulene-1-carboxamide 3-{(1RS, 2SR) -2-amino-1-hydroxy-3
-[3- (1,1,2,2-tetrafluoroethoxy) phenyl] propyl} phenol (2.89 g, 8.04
Mmol) in acetonitrile (50 ml) solution.
-Dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (1.51 g, 8.04 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (2.31 g, 12.1 g). 06 mmol) and 1-hydroxybenzotriazole hydrate (1.23
g, 8.04 mmol) and stirred at room temperature overnight.
The reaction solution was diluted with water (200 ml), and ethyl acetate (20 ml) was added.
0 ml × 2). The extract was washed successively with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and saturated brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 2: 1-
1: 1) to give the desired product (2.75 g, 65%) as an amorphous product. 1 H-NMR (CDCl 3 ) δ: 1.88-2.00 (2H, m), 2.08-2.18 (2H,
m), 2.54-2.64 (2H, m), 2.74 (1H, dd, J = 14.4, 10.5
Hz), 2.98 (1H, dd, J = 14.4, 7.5 Hz), 4.07 (1H, br
s), 4.64-4.78 (1H, m), 4.86-4.92 (1H, m), 5.66-6.0
4 (4H, m), 6.72-6.80 (1H, m), 6.84-7.28 (9H, m),
7.58 (1H, brs) IRν max KBr cm -1: 1636, 1588, 1520, 1489, 1453. Anal Calcd for C 29 H 27 NO 4 F 4 · 0.2H 2 O:.. C, 65.34; H,
5.18; N, 2.63 Found: C, 65.27; H, 5.34; N, 2.45.
【0385】実施例253 N-{(1RS,2SR)-2-ヒドロキシ-2-(3-メト
キシフェニル)-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル}-6,7-ジヒドロ-
5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド N-{(1RS,2SR)-2-ヒドロキシ-2-(3-ヒド
ロキシフェニル)-1-[3-(1,1,2,2-テトラフ
ルオロエトキシ)ベンジル]エチル}-6,7-ジヒドロ
-5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド(400mg,0.755ミリモル)のN,N-ジメ
チルホルムアミド(15ml)溶液に炭酸カリウム(3
13mg,2.27ミリモル)およびヨウ化メチル(2
ml)を加え、室温で終夜攪拌した。反応液を水(10
0ml)で希釈し、酢酸エチル(100ml×2)で抽
出した。抽出液を水、飽和食塩水で順次洗浄し、乾燥
(無水硫酸マグネシウム)後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=2:1)で精製し、酢酸エチル-ヘキサンから再
結晶させて、目的物(115mg,28%)を得た。1 H-NMR(CDCl3)δ:1.90-2.06 (2H, m), 2.12-2.26 (2H,
m), 2.60-2.70 (2H, m),2.79 (1H, dd, J = 14.2, 10.6
Hz), 3.00 (1H, dd, J = 14.2, 4.0 Hz), 3.47(1H, d,
J = 3.6 Hz), 3.81 (3H, s), 4.64-4.80 (1H, m), 5.0
0-5.06 (1H, m), 5.79 (1H, d, J = 8.4 Hz), 5.60-6.2
6 (3H, m), 6.80-6.90 (1H, m), 6.90-7.20 (7H, m),
7.20-7.38 (3H, m). IRν maxKBrcm-1:1640, 1611, 1588, 1514, 1489, 145
3, 1439. mp 155-156℃ Anal. Calcd for C30H29F4NO4: C, 66.29; H, 5.38; N,
2.58 Found : C, 66.06; H, 5.08; N, 2.36.Example 253 N-{(1RS, 2SR) -2-hydroxy-2- (3-methoxyphenyl) -1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro-
5H-benzo [a] [7] annulene-1-carboxamide N-{(1RS, 2SR) -2-hydroxy-2- (3-hydroxyphenyl) -1- [3- (1,1,2,2- Tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro
-5H-benzo [a] [7] annulene-1-carboxamide (400 mg, 0.755 mmol) in N, N-dimethylformamide (15 ml) was dissolved in potassium carbonate (3 ml).
13 mg, 2.27 mmol) and methyl iodide (2
ml) and stirred at room temperature overnight. The reaction solution was diluted with water (10
0 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1) and recrystallized from ethyl acetate-hexane to obtain the desired product (115 mg, 28%). 1 H-NMR (CDCl 3 ) δ: 1.90-2.06 (2H, m), 2.12-2.26 (2H,
m), 2.60-2.70 (2H, m), 2.79 (1H, dd, J = 14.2, 10.6
Hz), 3.00 (1H, dd, J = 14.2, 4.0 Hz), 3.47 (1H, d,
J = 3.6 Hz), 3.81 (3H, s), 4.64-4.80 (1H, m), 5.0
0-5.06 (1H, m), 5.79 (1H, d, J = 8.4 Hz), 5.60-6.2
6 (3H, m), 6.80-6.90 (1H, m), 6.90-7.20 (7H, m),
7.20-7.38 (3H, m) .IRν max KBr cm -1 : 1640, 1611, 1588, 1514, 1489, 145
3, 1439.mp 155-156 ℃ Anal.Calcd for C 30 H 29 F 4 NO 4 : C, 66.29; H, 5.38; N,
2.58 Found: C, 66.06; H, 5.08; N, 2.36.
【0386】実施例254 (1RS,2RS)-2-ヒドロキシ-2-(5-フェノキ
シピリジン-2-イル)-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチルカルバミン酸t
ert-ブチル 1) 2-メチル-5-フェノキシピリジン 6-メチルピリジン-3-オール(25.2g,231ミ
リモル)のN,N-ジメチルホルムアミド(100m
l)溶液にtert-ブトキシカリウム(25.9g,
231ミリモル)を加え、室温で1時間攪拌した。反応
液を減圧留去後、N,N-ジメチルホルムアミド(10
0ml)で希釈し、銅粉末(3.7g,58ミリモル)
およびブロモベンゼン(36.3g,231ミリモル)
を加え、120℃で終夜攪拌した。反応液にメタノール
を加え、不溶物をセライトろ過し、ろ液を水(500m
l)で希釈し、酢酸エチル(500ml×2)で抽出し
た。抽出液を水、飽和食塩水で順次洗浄し、乾燥(無水
硫酸マグネシウム)後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
4:1)で精製し、目的物(31g,72%)を得た。1 H-NMR(CDCl3)δ:2.55 (3H, s), 6.94-7.04 (2H, m),
7.06-7.40 (5H, m), 8.30(1H, d, J = 2.4 Hz). IRν maxKBrcm-1:1603, 1590, 1574, 1483, 1385. Anal. Calcd for C12H11NO: C, 77.81; H, 5.99; N, 7.
56 Found : C, 77.51; H, 5.99; N, 7.41. 2) 5-フェノキシピリジン-2-カルボン酸 2-メチル-5-フェノキシピリジン(30g,162ミ
リモル)のピリジン(90ml)溶液に、二酸化セレン
(18.0g,162ミリモル)を加え、110℃で終
夜攪拌した。反応液をセライトろ過し、ろ液を濃縮し
た。残留物をクロロホルム(300ml)で希釈し、
0.2規定塩酸水溶液、水、飽和食塩水で順次洗浄し、
乾燥(無水硫酸マグネシウム)後減圧留去した。残留物
をエタノールから再結晶し、目的物(10.1g,29
%)を得た。1 H-NMR(CDCl3)δ:7.04-7.18 (2H, m), 7.20-7.54 (4H,
m), 8.18 (1H, d, J = 8.4 Hz), 8.43 (1H, d, J = 2.6
Hz), 9.59 (1H, brs). IRν maxKBrcm-1:1705, 1574, 1489. mp 149-150℃ Anal. Calcd for C12H9NO3: C, 66.97; H, 4.22; N, 6.
51 Found : C, 66.99; H, 4.04; N, 6.42. 3) 3-オキソ-3-(5-フェノキシピリジン-2-イ
ル)プロパン酸ベンジル 5-フェノキシピリジン-2-カルボン酸(10g,4
6.5ミリモル)のテトラヒドロフラン(150ml)
にN,N’-カルボニルジイミダゾール(8.29g,
51.1ミリモル)を加え、1時間加熱還流した。反応
液を室温まで冷却後、マロン酸モノベンジルマグネシウ
ム塩(10.5g,25.6ミリモル)を加え、2時間
加熱還流した。反応液を濃縮後、残留物をシリカゲルカ
ラムクロマトグラフィー(ヘキサン:酢酸エチル=2:
1)で精製し、目的物(11.2g,76%)を得た。1 H-NMR(CDCl3)δ:4.19 (2H, s), 5.18 (2H, s), 7.00-
7.50 (11H, m), 8.04 (1H, d, J = 8.8 Hz), 8.28 (1H,
d, J = 3.0 Hz). IRν maxKBrcm-1:1740, 1699, 1640, 1570, 1489, 147
2. 4) 3-オキソ-3-(5-フェノキシピリジン-2-イ
ル)-2-[3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]プロパン酸ベンジル [3-(1,1,2,2-テトラフルオロエトキシ)フェ
ニル]メタノール(8.29g,37.0ミリモル)の
酢酸エチル(100ml)溶液に塩化メタンスルホニル
(3.15ml,40.68ミリモル)およびトリエチ
ルアミン(6.19ml,44.4ミリモル)を加え、
室温で2時間攪拌した。不溶物をろ過し、ろ液を減圧留
去しメシル体を調製した。3-オキソ-3-(5-フェノキ
シピリジン-2-イル)プロパン酸ベンジル(11.2
g,35.1ミリモル)の1,2-ジメトキシエタン
(80ml)溶液に水素化ナトリウム(1.41g,6
0%油性,35.1ミリモル)を加え、室温で1時間攪
拌した。反応液に先に調製したメシル体の1,2-ジメ
トキシエタン(10ml)溶液を滴下し、反応液を70
℃にて終夜攪拌した。反応液を1規定塩酸で酸性とした
後、飽和重曹水で中和し、酢酸エチル(300ml×
2)で抽出した。抽出液を水、飽和食塩水で順次洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=4:1)で精製し目的物(9.32
g,48%,粗製)を得た。本化合物は粗製のまま次の
反応に用いた。 5) 3-ヒドロキシ-3-(5-フェノキシピリジン-2-
イル)-2-[3-(1,1,2,2-テトラフルオロエト
キシ)ベンジル]プロパン酸ベンジル 塩化亜鉛(4.57g,33.6ミリモル)のジエチル
エーテル(100ml)溶液に水素化ホウ素ナトリウム
(2.54g,67.1ミリモル)を加えて室温で30
分攪拌した。不溶物をろ去し、ろ液に3-オキソ-3-
(5-フェノキシピリジン-2-イル)-2-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]プロ
パン酸ベンジル(9.32g,16.8ミリモル,粗
製)のジエチルエーテル(100ml)溶液を0℃にて
加えて30分攪拌した。反応液に1規定塩酸を加えて反
応を止め、飽和重曹水で中和後、更に水(200ml)
を加え、酢酸エチル(500ml×2)で抽出した。抽
出液を水および飽和食塩水で洗浄し、乾燥(無水硫酸マ
グネシウム)後減圧留去した。残留物をシリカゲルカラ
ムクロマトグラフィー(ヘキサン:酢酸エチル=2:1
-1:1)で精製し、目的物(5.07g,54%,粗
製)を得た。本化合物は粗製のまま次の反応に用いた。 6) 3-ヒドロキシ-3-(5-フェノキシピリジン-2-
イル)-2-[3-(1,1,2,2-テトラフルオロエト
キシ)ベンジル]プロパン酸 3-ヒドロキシ-3-(5-フェノキシピリジン-2-イル)
-2-[3-(1,1,2,2-テトラフルオロエトキシ)
ベンジル]プロパン酸ベンジル(5.07g,9.09
ミリモル,粗製)のエタノール(500ml)溶液に、
10%パラジウム/炭素(50%含水)(500mg)
を加え、1気圧水素気流下で終夜攪拌した。反応液をセ
ライトでろ過し、ろ液を濃縮して目的物(4.22g,
100%,粗製)を得た。本化合物は粗製のまま次の反
応に用いた。 7) 5-(5-フェノキシピリジン-2-イル)-4-[3
-(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]-1,3-オキサゾリジン-2-オン 3-ヒドロキシ-3-(5-フェノキシピリジン-2-イル)
-2-[3-(1,1,2,2-テトラフルオロエトキシ)
ベンジル]プロパン酸(4.22g,9.07ミリモ
ル,粗製)のテトラヒドロフラン(200ml)溶液
に、ジフェニルホスホリルアジド(2.15ml,9.
97ミリモル)とトリエチルアミン(1.90ミリモ
ル,13.6ミリモル)を加え、3時間加熱還流した。
反応液を放冷後、水(100ml)を加えて酢酸エチル
(100ml×2)で抽出した。抽出液を1規定塩酸、
炭酸水素ナトリウム水溶液、飽和食塩水で順次洗浄し、
乾燥(無水硫酸マグネシウム)後減圧留去した。残留物
をシリカゲルカラムクロマトグラフィー(ヘキサン:酢
酸エチル=2:1-1:1)で精製し、目的物の(4R
S,5RS)体(1.06g,高極性成分,25%)お
よび(4RS,5SR)体(1.94g,低極性成分,
46%、ヘキサン-酢酸エチルより再結晶)を得た。 (4RS,5RS)体:1H-NMR(CDCl3)δ:2.04-2.22 (1
H, m), 2.53 (1H, dd, J= 14.0, 3.4 Hz), 4.38-4.50
(1H, m), 5.12 (1H, s), 5.87 (1H, d, J = 8.4Hz), 5.
90 (1H, tt, J = 53.2, 3.0 Hz), 6.90-7.48 (10H, m),
7.54 (1H, d, J= 8.4 Hz), 8.39 (1H, d, J = 2.6 H
z). IRν maxKBrcm-1:1761, 1588, 1574, 1487. (4RS,5SR)体:1H-NMR(CDCl3)δ:2.98 (1H, d
d, J = 13.6, 9.2 Hz), 3.28 (1H, dd, J = 13.6, 4.4
Hz), 4.20-4.34 (1H, m), 5.12 (1H, brs), 5.32(1H,
d, J = 5.4 Hz), 5.91 (1H, tt, J = 53.2, 3.0 Hz),
7.00-7.48 (11H, m), 8.38 (1H, d, J = 2.4 Hz). IRν maxKBrcm-11761, 1588, 1576, 1489. mp 87-88℃ Anal. Calcd for C23H18F4N2O4: C, 59.74; H, 3.92;
N, 6.06 Found : C, 59.70; H, 3.81; N, 6.03. 8) (4RS,5RS)-2-オキソ-5-(5-フェノ
キシピリジン-2-イル)-4-[3-(1,1,2,2-テ
トラフルオロエトキシ)ベンジル]-1,3-オキサゾリ
ジン-3-カルボン酸tert-ブチル (4RS,5RS)-5-(5-フェノキシピリジン-2-
イル)-4-[3-(1,1,2,2-テトラフルオロエト
キシ)ベンジル]-1,3-オキサゾリジン-2-オン
(1.01g,2.18ミリモル)のアセトニトリル
(15ml)溶液に二炭酸ジ-tert-ブチル(571
mg,2.62ミリモル)および4-N,N-ジメチルピ
リジン(26.9mg,0.22ミリモル)を加え、室
温で1時間攪拌した。反応液に水(50ml)を加え、
酢酸エチル(50ml×2)で抽出した。抽出液を水、
飽和食塩水で順次洗浄し、乾燥(無水硫酸マグネシウ
ム)後減圧留去した。残留物をシリカゲルカラムクロマ
トグラフィー(ヘキサン:酢酸エチル=10:1-1:
1)で精製し酢酸エチル-ヘキサンから再結晶させて、
目的物(1.07g,87%)を得た。1 H-NMR(CDCl3)δ:1.44 (9H, s), 2.66 (1H, dd, J = 1
4.2, 7.4 Hz), 2.83 (1H,dd, J = 14.2, 5.8 Hz), 5.02
(1H, q, J = 7.0 Hz), 5.70 (1H, d, J = 7.0 Hz), 5.
88 (1H, tt, J = 53.0, 3.0 Hz), 6.60 (1H, s), 6.76
(1H, d, J = 7.6Hz), 6.98-7.10 (3H, m), 7.10-7.32
(3H, m), 7.34-7.50 (3H, m), 8.18 (1H,d, J = 3.0 H
z). IRν maxKBrcm-1:1825, 1725, 1588, 1574, 1489. mp 113-114℃ Anal. Calcd for C28H26N2O6F4: C, 59.79; H, 4.66;
N, 4.98 Found : C, 59.75; H, 4.58; N, 4.90. 9) (1RS,2RS)-2-ヒドロキシ-2-(5-フ
ェノキシピリジン-2-イル)-1-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]エチルカルバ
ミン酸tert-ブチル (4RS,5RS)-2-オキソ-5-(5-フェノキシピ
リジン-2-イル)-4-[3-(1,1,2,2-テトラフ
ルオロエトキシ)ベンジル]-1,3-オキサゾリジン-
3-カルボン酸tert-ブチル(1.00g,1.78
ミリモル)のメタノール(12ml)に0.5規定水酸
化ナトリウムのメタノール溶液(4.3ml,2.13
ミリモル)を加え室温で1時間攪拌した。反応液に水
(50ml)を加えて酢酸エチル(50ml×2)で抽
出した。抽出液を飽和食塩水で洗浄し、乾燥(無水硫酸
マグネシウム)後減圧留去した。残留物を酢酸エチル-
ヘキサンから再結晶させて目的物(0.81g,85
%)を得た。1 H-NMR(CDCl3)δ:1.37 (9H, s), 2.58 (1H, dd, J = 1
4.6, 5.4 Hz), 2.78 (1H,dd, J = 14.6, 8.8 Hz), 4.10
-4.30 (1H, m), 4.76 (1H, d, J = 5.6 Hz), 4.84-4.96
(1H, m), 5.13 (1H, d, J = 9.0 Hz), 5.89 (1H, tt,
J = 53.0, 3.0 Hz), 6.90-7.10 (5H, m), 7.12-7.30 (4
H, m), 7.30-7.48 (2H, m), 8.32 (1H, s). IRν maxKBrcm-1:1694, 1588, 1483. mp 129-130℃ Anal. Calcd for C27H28F4N2O5: C, 60.44; H, 5.26;
N, 5.22 Found : C, 60.21; H, 5.23; N, 5.22.Example 254 (1RS, 2RS) -2-hydroxy-2- (5-phenoxypyridin-2-yl) -1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl Carbamic acid t
tert-butyl 1) 2-Methyl-5-phenoxypyridine 6-methylpyridin-3-ol (25.2 g, 231 mmol) in N, N-dimethylformamide (100 m
l) Add tert-butoxy potassium (25.9 g,
231 mmol) and stirred at room temperature for 1 hour. After the reaction solution was distilled off under reduced pressure, N, N-dimethylformamide (10
0 ml) and copper powder (3.7 g, 58 mmol)
And bromobenzene (36.3 g, 231 mmol)
And stirred at 120 ° C. overnight. Methanol was added to the reaction solution, the insolubles were filtered through celite, and the filtrate was washed with water (500 m
1) and extracted with ethyl acetate (500 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
4: 1) to give the desired product (31 g, 72%). 1 H-NMR (CDCl 3 ) δ: 2.55 (3H, s), 6.94-7.04 (2H, m),
7.06-7.40 (5H, m), 8.30 (1H, d, J = 2.4 Hz) .IRν max KBr cm -1 : 1603, 1590, 1574, 1483, 1385.Analytical calculation for C 12 H 11 NO: C, 77.81; H, 5.99; N, 7.
56 Found: C, 77.51; H, 5.99; N, 7.4.1.2. 5-Phenoxypyridine-2-carboxylic acid Selenium dioxide was added to a solution of 2-methyl-5-phenoxypyridine (30 g, 162 mmol) in pyridine (90 ml). (18.0 g, 162 mmol) was added and the mixture was stirred at 110 ° C. overnight. The reaction solution was filtered through celite, and the filtrate was concentrated. The residue was diluted with chloroform (300 ml),
Wash sequentially with 0.2N aqueous hydrochloric acid, water and saturated saline,
After drying (anhydrous magnesium sulfate), the solvent was distilled off under reduced pressure. The residue was recrystallized from ethanol to give the desired product (10.1 g, 29
%). 1 H-NMR (CDCl 3 ) δ: 7.04-7.18 (2H, m), 7.20-7.54 (4H,
m), 8.18 (1H, d, J = 8.4 Hz), 8.43 (1H, d, J = 2.6
.. Hz), 9.59 (1H , brs) IRν max KBr cm -1: 1705, 1574, 1489. mp 149-150 ℃ Anal Calcd for C 12 H 9 NO 3: C, 66.97; H, 4.22; N, 6 .
51, Found: C, 66.99; H, 4.04; N, 6.42. 3) Benzyl 3-oxo-3- (5-phenoxypyridin-2-yl) propanoate 5-phenoxypyridine-2-carboxylic acid (10 g, 4
6.5 mmol) of tetrahydrofuran (150 ml)
N, N'-carbonyldiimidazole (8.29 g,
51.1 mmol) and heated under reflux for 1 hour. After the reaction solution was cooled to room temperature, malonic acid monobenzylmagnesium salt (10.5 g, 25.6 mmol) was added, and the mixture was refluxed for 2 hours. After concentrating the reaction solution, the residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 2:
Purification in 1) gave the desired product (11.2 g, 76%). 1 H-NMR (CDCl 3 ) δ: 4.19 (2H, s), 5.18 (2H, s), 7.00-
7.50 (11H, m), 8.04 (1H, d, J = 8.8 Hz), 8.28 (1H,
d, J = 3.0 Hz) .IRν max KBr cm -1 : 1740, 1699, 1640, 1570, 1489, 147
2.4) Benzyl 3-oxo-3- (5-phenoxypyridin-2-yl) -2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate [3- (1, 1,2,2-Tetrafluoroethoxy) phenyl] methanol (8.29 g, 37.0 mmol) in ethyl acetate (100 ml) was treated with methanesulfonyl chloride (3.15 ml, 40.68 mmol) and triethylamine (6.19 ml). , 44.4 mmol).
Stirred at room temperature for 2 hours. The insolubles were filtered, and the filtrate was distilled off under reduced pressure to prepare a mesyl compound. Benzyl 3-oxo-3- (5-phenoxypyridin-2-yl) propanoate (11.2
g, 35.1 mmol) in 1,2-dimethoxyethane (80 ml) was added to sodium hydride (1.41 g, 6 ml).
(0% oily, 35.1 mmol) and stirred at room temperature for 1 hour. A solution of the previously prepared mesyl compound in 1,2-dimethoxyethane (10 ml) was added dropwise to the reaction solution.
Stirred at 0 ° C. overnight. The reaction solution was acidified with 1N hydrochloric acid, neutralized with a saturated aqueous sodium hydrogen carbonate solution, and ethyl acetate (300 ml ×
Extracted in 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give the desired product (9.32).
g, 48%, crude). This compound was used crude in the next reaction. 5) 3-Hydroxy-3- (5-phenoxypyridine-2-
Yl) -2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] benzyl benzylpropanoate Sodium borohydride in a solution of zinc chloride (4.57 g, 33.6 mmol) in diethyl ether (100 ml) (2.54 g, 67.1 mmol) at room temperature.
Minutes. The insolubles are removed by filtration and the filtrate is treated with 3-oxo-3-.
(5-phenoxypyridin-2-yl) -2- [3- (1,
A solution of benzyl 1,2,2-tetrafluoroethoxy) benzyl] propanoate (9.32 g, 16.8 mmol, crude) in diethyl ether (100 ml) was added at 0 ° C., and the mixture was stirred for 30 minutes. The reaction solution was quenched with 1N hydrochloric acid, neutralized with saturated aqueous sodium hydrogen carbonate, and further added with water (200 ml).
And extracted with ethyl acetate (500 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 2: 1).
-1: 1) to give the desired product (5.07 g, 54%, crude). This compound was used crude in the next reaction. 6) 3-Hydroxy-3- (5-phenoxypyridine-2-
Yl) -2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoic acid 3-hydroxy-3- (5-phenoxypyridin-2-yl)
-2- [3- (1,1,2,2-tetrafluoroethoxy)
Benzyl] benzyl propanoate (5.07 g, 9.09
Mmol, crude) in ethanol (500 ml)
10% palladium / carbon (50% water content) (500mg)
Was added, and the mixture was stirred overnight under a 1 atm hydrogen stream. The reaction solution was filtered through celite, and the filtrate was concentrated to give the desired product (4.22 g,
100%, crude). This compound was used crude in the next reaction. 7) 5- (5-phenoxypyridin-2-yl) -4- [3
-(1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine-2-one 3-hydroxy-3- (5-phenoxypyridin-2-yl)
-2- [3- (1,1,2,2-tetrafluoroethoxy)
To a solution of [benzyl] propanoic acid (4.22 g, 9.07 mmol, crude) in tetrahydrofuran (200 ml) was added diphenylphosphoryl azide (2.15 ml, 9.9 ml).
97 mmol) and triethylamine (1.90 mmol, 13.6 mmol) were added, and the mixture was heated under reflux for 3 hours.
After allowing the reaction mixture to cool, water (100 ml) was added, and the mixture was extracted with ethyl acetate (100 ml × 2). Extract solution is 1N hydrochloric acid,
Wash sequentially with aqueous sodium hydrogen carbonate solution and saturated saline,
After drying (anhydrous magnesium sulfate), the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1-1: 1) to give the desired product (4R
S, 5RS) form (1.06 g, high polarity component, 25%) and (4RS, 5SR) form (1.94 g, low polarity component,
46%, recrystallized from hexane-ethyl acetate). (4RS, 5RS) form: 1 H-NMR (CDCl 3 ) δ: 2.04-2.22 (1
H, m), 2.53 (1H, dd, J = 14.0, 3.4 Hz), 4.38-4.50
(1H, m), 5.12 (1H, s), 5.87 (1H, d, J = 8.4Hz), 5.
90 (1H, tt, J = 53.2, 3.0 Hz), 6.90-7.48 (10H, m),
7.54 (1H, d, J = 8.4 Hz), 8.39 (1H, d, J = 2.6 H
z). IRν max KBr cm -1 : 1761, 1588, 1574, 1487. (4RS, 5SR) form: 1 H-NMR (CDCl 3 ) δ: 2.98 (1H, d
d, J = 13.6, 9.2 Hz), 3.28 (1H, dd, J = 13.6, 4.4
Hz), 4.20-4.34 (1H, m), 5.12 (1H, brs), 5.32 (1H,
d, J = 5.4 Hz), 5.91 (1H, tt, J = 53.2, 3.0 Hz),
7.00-7.48 (11H, m), 8.38 (1H, d, J = 2.4 Hz) .IRν max KBr cm -1 1761, 1588, 1576, 1489.mp 87-88 ℃ Anal. Calcd for C 23 H 18 F 4 N 2 O 4 : C, 59.74; H, 3.92;
N, 6.06 Found: C, 59.70; H, 3.81; N, 6.03.8) (4RS, 5RS) -2-oxo-5- (5-phenoxypyridin-2-yl) -4- [3- (1, Tert-Butyl (1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine-3-carboxylate (4RS, 5RS) -5- (5-phenoxypyridine-2-
Yl) -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidin-2-one (1.01 g, 2.18 mmol) in acetonitrile (15 ml). Di-tert-butyl dicarbonate (571
mg, 2.62 mmol) and 4-N, N-dimethylpyridine (26.9 mg, 0.22 mmol), and the mixture was stirred at room temperature for 1 hour. Water (50 ml) was added to the reaction solution,
Extracted with ethyl acetate (50 ml × 2). Extract water with water,
The extract was washed successively with a saturated saline solution, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 10: 1-1:
Purified in 1) and recrystallized from ethyl acetate-hexane,
The desired product (1.07 g, 87%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.44 (9H, s), 2.66 (1H, dd, J = 1
4.2, 7.4 Hz), 2.83 (1H, dd, J = 14.2, 5.8 Hz), 5.02
(1H, q, J = 7.0 Hz), 5.70 (1H, d, J = 7.0 Hz), 5.
88 (1H, tt, J = 53.0, 3.0 Hz), 6.60 (1H, s), 6.76
(1H, d, J = 7.6Hz), 6.98-7.10 (3H, m), 7.10-7.32
(3H, m), 7.34-7.50 (3H, m), 8.18 (1H, d, J = 3.0 H
z) .IRν max KBr cm -1 : 1825, 1725, 1588, 1574, 1489.mp 113-114 ℃ Anal. Calcd for C 28 H 26 N 2 O 6 F 4 : C, 59.79; H, 4.66;
N, 4.98 Found: C, 59.75; H, 4.58; N, 4.0.9. 9) (1RS, 2RS) -2-hydroxy-2- (5-phenoxypyridin-2-yl) -1- [3- (1, 1,2,
Tert-Butyl 2-tetrafluoroethoxy) benzyl] ethylcarbamate (4RS, 5RS) -2-oxo-5- (5-phenoxypyridin-2-yl) -4- [3- (1,1,2,2 -Tetrafluoroethoxy) benzyl] -1,3-oxazolidine-
Tert-Butyl 3-carboxylate (1.00 g, 1.78)
0.5N sodium hydroxide in methanol (12 ml) (4.3 ml, 2.13).
(Mmol) was added and stirred at room temperature for 1 hour. Water (50 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (50 ml × 2). The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. Ethyl acetate-residue
Recrystallization from hexane gave the desired product (0.81 g, 85
%). 1 H-NMR (CDCl 3 ) δ: 1.37 (9H, s), 2.58 (1H, dd, J = 1
4.6, 5.4 Hz), 2.78 (1H, dd, J = 14.6, 8.8 Hz), 4.10
-4.30 (1H, m), 4.76 (1H, d, J = 5.6 Hz), 4.84-4.96
(1H, m), 5.13 (1H, d, J = 9.0 Hz), 5.89 (1H, tt,
J = 53.0, 3.0 Hz), 6.90-7.10 (5H, m), 7.12-7.30 (4
. H, m), 7.30-7.48 ( 2H, m), 8.32 (1H, s) IRν max KBr cm -1:. 1694, 1588, 1483. mp 129-130 ℃ Anal Calcd for C 27 H 28 F 4 N 2 O 5 : C, 60.44; H, 5.26;
N, 5.22 Found: C, 60.21; H, 5.23; N, 5.22.
【0387】実施例255 N-{(1RS,2RS)-2-ヒドロキシ-2-(5-フェ
ノキシピリジン-2-イル)-1-[3-(1,1,2,2-
テトラフルオロエトキシ)ベンジル]エチル}-6,7-
ジヒドロ-5H-ベンゾ[a][7]アンヌレン-1-カル
ボキサミド (1RS,2RS)-2-ヒドロキシ-2-(5-フェノキ
シピリジン-2-イル)-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチルカルバミン酸t
ert-ブチル(300mg,0.56ミリモル)にト
リフルオロ酢酸(5ml)を加え、0℃で10分攪拌し
た。反応液を飽和重曹水で中和し、酢酸エチル(20m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、乾
燥(無水硫酸マグネシウム)後減圧留去した。残留物の
アセトニトリル(20ml)溶液に6,7-ジヒドロ-5
H-ベンゾ[a]シクロヘプテン-1-カルボン酸(10
5mg,0.56ミリモル)および1-エチル-3-(3-
ジメチルアミノプロピル)カルボジイミド・塩酸塩(1
61mg,0.84ミリモル)および1-ヒドロキシベ
ンゾトリアゾール水和物(86mg,0.56ミリモ
ル)を加えて室温で終夜攪拌した。反応液を水(100
ml)で希釈し、酢酸エチル(100ml×2)で抽出
した。抽出液を水、飽和食塩水で順次洗浄し、乾燥(無
水硫酸マグネシウム)後減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=2:1)で精製し、酢酸エチル-ヘキサンから再結晶
させて、目的物(140mg,41%)を得た。1 H-NMR(CDCl3)δ:1.92-2.12 (2H, m), 2.18-2.30 (2H,
m), 2.64-2.80 (3H, m),2.94 (1H, dd, J = 14.8, 9.6
Hz), 4.78-4.92 (1H, m), 4.96 (1H, d, J = 5.4 Hz),
5.02-5.10 (1H, m), 5.91 (1H, tt, J = 53.0, 3.0 H
z), 5.94-6.04 (1H, m), 6.30-6.44 (2H, m), 7.00-7.5
0 (14H, m), 8.34 (1H, d, J = 2.6 Hz). IRν maxKBrcm-1:1638, 1588, 1572, 1483. mp 147-148℃ Anal. Calcd for C34H30F4N2O4: C, 67.32; H, 4.98;
N, 4.62 Found : C, 67.16; H, 4.79; N, 4.52.Example 255 N-{(1RS, 2RS) -2-hydroxy-2- (5-phenoxypyridin-2-yl) -1- [3- (1,1,2,2-
Tetrafluoroethoxy) benzyl] ethyl} -6,7-
Dihydro-5H-benzo [a] [7] annulene-1-carboxamide (1RS, 2RS) -2-hydroxy-2- (5-phenoxypyridin-2-yl) -1- [3- (1,1,1,2 , 2-Tetrafluoroethoxy) benzyl] ethylcarbamic acid t
Trifluoroacetic acid (5 ml) was added to tert-butyl (300 mg, 0.56 mmol), and the mixture was stirred at 0 ° C. for 10 minutes. The reaction solution was neutralized with a saturated aqueous sodium hydrogen carbonate solution, and ethyl acetate (20 m
1 × 2). The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. To a solution of the residue in acetonitrile (20 ml) was added 6,7-dihydro-5.
H-benzo [a] cycloheptene-1-carboxylic acid (10
5 mg, 0.56 mmol) and 1-ethyl-3- (3-
Dimethylaminopropyl) carbodiimide hydrochloride (1
61 mg, 0.84 mmol) and 1-hydroxybenzotriazole hydrate (86 mg, 0.56 mmol) were added, and the mixture was stirred at room temperature overnight. The reaction solution was washed with water (100
ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1), and recrystallized from ethyl acetate-hexane to obtain the desired product (140 mg, 41%). 1 H-NMR (CDCl 3 ) δ: 1.92-2.12 (2H, m), 2.18-2.30 (2H,
m), 2.64-2.80 (3H, m), 2.94 (1H, dd, J = 14.8, 9.6
Hz), 4.78-4.92 (1H, m), 4.96 (1H, d, J = 5.4 Hz),
5.02-5.10 (1H, m), 5.91 (1H, tt, J = 53.0, 3.0 H
z), 5.94-6.04 (1H, m), 6.30-6.44 (2H, m), 7.00-7.5
0 (14H, m), 8.34 (1H, d, J = 2.6 Hz) IRν max KBr cm -1:.. 1638, 1588, 1572, 1483. mp 147-148 ℃ Anal Calcd for C 34 H 30 F 4 N 2 O 4 : C, 67.32; H, 4.98;
N, 4.62 Found: C, 67.16; H, 4.79; N, 4.52.
【0388】実施例256 4-フルオロ-N-{(1RS,2RS)-2-ヒドロキシ-
2-(5-フェノキシピリジン-2-イル)-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル}-1-ナフトアミド (1RS,2RS)-2-ヒドロキシ-2-(5-フェノキ
シピリジン-2-イル)-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチルカルバミン酸t
ert-ブチル(300mg,0.56ミリモル)にト
リフルオロ酢酸(5ml)を加え、0℃で10分攪拌し
た。反応液を飽和重曹水で中和し、酢酸エチル(20m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、乾
燥(無水硫酸マグネシウム)後減圧留去した。残留物の
アセトニトリル(20ml)溶液に4-フルオロナフタ
レンカルボン酸(106mg,0.56ミリモル)およ
び1-エチル-3-(3-ジメチルアミノプロピル)カルボ
ジイミド・塩酸塩(161mg,0.84ミリモル)お
よび1-ヒドロキシベンゾトリアゾール水和物(86m
g,0.56ミリモル)を加えて室温で終夜攪拌した。
反応液を水(100ml)で希釈し、酢酸エチル(10
0ml×2)で抽出した。抽出液を水、飽和食塩水で順
次洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=2:1)で精製し、酢酸エチル-
ヘキサンから再結晶させて、目的物(133mg,39
%)を得た。1 H-NMR(CDCl3)δ:2.72 (1H, dd, J = 14.4, 4.5 Hz),
2.92 (1H, dd, J = 14.7,9.6 Hz), 4.88-5.00 (2H, m),
5.10-5.16 (1H, m), 5.88 (1H, tt, J = 53.1,3.0 H
z), 6.55 (1H, d, J = 9.0 Hz), 7.00-7.60 (15H, m),
7.98 (1H, d, J =8.1 Hz), 8.10 (1H, d, J = 8.1 Hz),
8.34 (1H, d, J = 2.7 Hz). IRν maxKBrcm-1:1642, 1626, 1601, 1586, 1535, 148
5. mp 146-147℃ Anal. Calcd for C33H25F5N2O4: C, 65.13; H, 4.14;
N, 4.60 Found : C, 64.99; H, 4.11; N, 4.53.Example 256 4-Fluoro-N-{(1RS, 2RS) -2-hydroxy-
2- (5-phenoxypyridin-2-yl) -1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -1-naphthamide (1RS, 2RS) -2-hydroxy-2- (5-phenoxypyridin-2-yl) -1- [3- ( 1,1,2,2-tetrafluoroethoxy) benzyl] ethylcarbamic acid t
Trifluoroacetic acid (5 ml) was added to tert-butyl (300 mg, 0.56 mmol), and the mixture was stirred at 0 ° C. for 10 minutes. The reaction solution was neutralized with a saturated aqueous sodium hydrogen carbonate solution, and ethyl acetate (20 m
1 × 2). The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. To a solution of the residue in acetonitrile (20 ml) was added 4-fluoronaphthalenecarboxylic acid (106 mg, 0.56 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (161 mg, 0.84 mmol) and 1-hydroxybenzotriazole hydrate (86m
g, 0.56 mmol) and stirred at room temperature overnight.
The reaction solution was diluted with water (100 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1),
Recrystallization from hexane gave the desired product (133 mg, 39 mg).
%). 1 H-NMR (CDCl 3 ) δ: 2.72 (1H, dd, J = 14.4, 4.5 Hz),
2.92 (1H, dd, J = 14.7,9.6 Hz), 4.88-5.00 (2H, m),
5.10-5.16 (1H, m), 5.88 (1H, tt, J = 53.1,3.0 H
z), 6.55 (1H, d, J = 9.0 Hz), 7.00-7.60 (15H, m),
7.98 (1H, d, J = 8.1 Hz), 8.10 (1H, d, J = 8.1 Hz),
8.34 (1H, d, J = 2.7 Hz) .IRν max KBr cm -1 : 1642, 1626, 1601, 1586, 1535, 148
5.mp 146-147 ℃ Anal. Calcd for C 33 H 25 F 5 N 2 O 4 : C, 65.13; H, 4.14;
N, 4.60 Found: C, 64.99; H, 4.11; N, 4.53.
【0389】実施例257 (1RS,2SR)-2-ヒドロキシ-2-[4-(ピリジ
ン-2-イルオキシ)フェニル]-1-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]エチルカ
ルバミン酸tert-ブチル 1) 4-(ピリジン-2-イルオキシ)安息香酸ベンジ
ル 4-ヒドロキシ安息香酸ベンジル(25.3g,111
ミリモル)のN,N-ジメチルホルムアミド(60m
l)溶液にtert-ブトキシカリウム(12.4g,
111ミリモル)を加え、室温で1時間攪拌した。反応
液を減圧留去後、2-ブロモピリジン(24.5g,1
55ミリモル)および銅粉末(1.76g,27.7ミ
リモル)およびN,N-ジメチルホルムアミド(80m
l)を加え、120℃で8時間攪拌した。反応液をセラ
イト用いてろ過後、ろ液を減圧留去した。残留物に水
(500ml)を加え酢酸エチル(500ml)で抽出
した。抽出液を水、飽和食塩水で順次洗浄し、乾燥(無
水硫酸マグネシウム)後減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=10:1)で精製し、酢酸エチル-ヘキサンから再結
晶させて、目的物(25.5g,73%)を得た。1 H-NMR(CDCl3)δ:5.36 (2H, s), 6.97 (1H, d, J = 8.4
Hz), 7.00-7.10 (1H, m), 7.16-7.22 (2H, m), 7.30-
7.48 (5H, m), 7.68-7.78 (1H, m), 8.08-8.16 (2H,
m), 8.18-8.24 (1H, m). IRν maxKBrcm-1:1717, 1589, 1574, 1505, 1466, 142
9. mp 68-69℃ Anal. Calcd for C19H15NO3: C, 74.74; H, 4.95; N,
4.59 Found : C, 74.90; H, 5.14; N, 4.67. 2) 4-(ピリジン-2-イルオキシ)安息香酸 4-(ピリジン-2-イルオキシ)安息香酸ベンジル(2
4.8g,81.5ミリモル)のエタノール(300m
l)溶液に10%パラジウム/炭素(50%含水)
(2.0g)を加え、水素気流下、80℃で終夜攪拌し
た。反応液をセライトを用いてろ過し、ろ液を濃縮し
た。残留物をエタノールから再結晶させて、目的物(1
4.1g,80%)を得た。1 H-NMR(CDCl3)δ:7.04-7.20 (2H, m), 7.20-7.52 (4H,
m), 8.18 (1H, d, J = 8.4 Hz), 8.43 (1H, d, J = 2.6
Hz), 9.59 (1H, brs). IRν maxKBrcm-1:1682, 1599, 1588, 1570, 1508. mp 175-176℃ Anal. Calcd for C12H9NO3: C, 66.97; H, 4.22; N, 6.
51 Found : C, 66.78; H, 3.94; N, 6.37. 3) 3-オキソ-3-[4-(ピリジン-2-イルオキシ)
フェニル]プロパン酸ベンジル 4-(ピリジン-2-イルオキシ)安息香酸(20g,9
2.9ミリモル)のテトラヒドロフラン(300ml)
にN,N’-カルボニルジイミダゾール(16.6g,
102ミリモル)を加え、1時間加熱還流した。反応液
を室温まで冷却後、マロン酸モノベンジルマグネシウム
塩(21g,51.2ミリモル)を加え、2時間加熱還
流した。反応液を濃縮後、残留物をシリカゲルカラムク
ロマトグラフィー(ヘキサン:酢酸エチル=2:1)で
精製し、目的物(20.6g,64%)を得た。1 H-NMR(CDCl3)δ:4.03 (2H, s), 5.17 (2H, s), 6.90-
7.50 (7H, m), 7.70-7.88(2H, m), 7.90-8.02 (2H, m),
8.10-8.24 (2H, m). IRν maxKBrcm-1:1740, 1684, 1590, 1572, 1505, 146
6, 1429. Anal. Calcd for C21H17NO4: C, 72.61; H, 4.93; N,
4.03 Found : C, 72.48; H, 4.88; N, 4.06. 4) 3-オキソ-3-[4-(ピリジン-2-イルオキシ)
フェニル]-2-[3-(1,1,2,2-テトラフルオロ
エトキシ)ベンジル]プロパン酸ベンジル [3-(1,1,2,2-テトラフルオロエトキシ)フェ
ニル]メタノール(6.79g,30.3ミリモル)の
酢酸エチル(100ml)溶液に塩化メタンスルホニル
(2.58ml,33.3ミリモル)およびトリエチル
アミン(5.07ml,36.4ミリモル)を加え、室
温で2時間攪拌した。不溶物をろ過し、ろ液を減圧留去
しメシル体を調製した。3-オキソ-3-[4-(ピリジン
-2-イルオキシ)フェニル]プロパン酸ベンジル(10
g,28.8ミリモル)の1,2-ジメトキシエタン
(80ml)溶液に水素化ナトリウム(1.15g,6
0%油性,28.8ミリモル)を加え、室温で1時間攪
拌した。反応液に先に調製したメシル体の1,2-ジメ
トキシエタン(10ml)溶液を滴下し、反応液を60
℃にて終夜攪拌した。反応液を1規定塩酸で酸性とした
後、飽和重曹水で中和し、酢酸エチル(300ml×
2)で抽出した。抽出液を水、飽和食塩水で順次洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=4:1)で精製し目的物(13.0
g,74%)を得た。1 H-NMR(CDCl3)δ:3.35 (2H, d, J = 7.5 Hz), 4.63 (1
H, t, J = 7.5 Hz), 5.08(2H, s), 5.88 (1H, tt, J =
53.1, 3.0 Hz), 6.98-7.20 (13H, m), 7.72-7.80(1H,
m), 7.96-8.02 (2H, m), 8.20-8.26 (1H, m). IRν maxKBrcm-1:1738, 1684, 1590, 1580. 5) (2RS,3RS)-3-ヒドロキシ-3-[4-
(ピリジン-2-イルオキシ)フェニル]-2-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]プロパン酸ベンジル 塩化亜鉛(3.19g,23.4ミリモル)のジエチル
エーテル(100ml)溶液に水素化ホウ素ナトリウム
(1.77g,67.1ミリモル)を加えて室温で30
分攪拌した。不溶物をろ去し、ろ液に3-オキソ-3-
[4-(ピリジン-2-イルオキシ)フェニル]-2-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]プロパン酸ベンジル(6.5g,11.7ミリモ
ル)のジエチルエーテル(50ml)溶液を0℃にて加
えて30分攪拌した。反応液に1規定塩酸を加えて反応
を止め、飽和重曹水で中和後、更に水(200ml)を
加え、酢酸エチル(200ml×2)で抽出した。抽出
液を水および飽和食塩水で洗浄し、乾燥(無水硫酸マグ
ネシウム)後減圧留去した。残留物をシリカゲルカラム
クロマトグラフィー(ヘキサン:酢酸エチル=2:1-
1:1)で精製し、目的物(4.78g,73%)を得
た。1 H-NMR(CDCl3)δ:2.83 (1H, d, J = 3.0 Hz), 2.96-3.2
0 (3H, m), 4.84 (2H, s), 4.98-5.04 (1H, m), 5.88
(1H, tt, J = 53.2, 3.0 Hz), 6.88-7.30 (13H, m), 7.
30-7.44 (2H, m), 7.62-7.76 (1H, m), 8.16-8.22 (1H,
m). IRν maxKBrcm-1:1728, 1593, 1507, 1468, 1429. 6) (2RS,3RS)-3-ヒドロキシ-3-[4-
(ピリジン-2-イルオキシ)フェニル]-2-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]プロパン酸 (2RS,3RS)-3-ヒドロキシ-3-[4-(ピリジ
ン-2-イルオキシ)フェニル]-2-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]プロパン
酸ベンジル(4.99g,8.95ミリモル)のエタノ
ール(500ml)溶液に、10%パラジウム/炭素
(50%含水,500mg)を加え、1気圧水素気流下
で2時間攪拌した。反応液をセライトでろ過し、ろ液を
濃縮して目的物(4.50g,100%,粗製)を得
た。本化合物は粗製のまま次の反応に用いた。1 H-NMR(CDCl3)δ:2.90-3.10 (3H, m), 3.83 (1H, brs),
5.01 (1H, d, J = 3.0Hz), 5.87 (1H, tt, J = 53.0,
3.0 Hz), 6.86-7.16 (7H, m), 7.18-7.30 (1H,m), 7.40
(2H, d, J = 8.4 Hz), 7.64-7.76 (1H, m), 8.14 (1H,
d, J = 3.8 Hz). IRν maxKBrcm-1:1717, 1597, 1508, 1470, 1431. 7) (4RS,5SR)-5-[4-(ピリジン-2-イ
ルオキシ)フェニル]-4-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]-1,3-オキサゾリジ
ン-2-オン (2RS,3RS)-3-ヒドロキシ-3-[4-(ピリジ
ン-2-イルオキシ)フェニル]-2-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]プロパン
酸(4.49g,9.65ミリモル,粗製)のテトラヒ
ドロフラン(60ml)溶液に、ジフェニルホスホリル
アジド(2.29ml,10.6ミリモル)とトリエチ
ルアミン(2.02ミリモル,14.5ミリモル)を加
え、2時間加熱還流した。反応液を放冷後、水(100
ml)を加えて酢酸エチル(100ml×2)で抽出し
た。抽出液を炭酸水素ナトリウム水溶液、飽和食塩水で
順次洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去
した。残留物をシリカゲルカラムクロマトグラフィー
(ヘキサン:酢酸エチル=2:1-1:1)で精製し、
酢酸エチル-ヘキサンから再結晶させて、目的物(3.
56g,80%)を得た。1 H-NMR(CDCl3)δ:2.28-2.44 (2H, m), 4.20-4.30 (1H,
m), 5.20-5.30 (1H, m),5.81 (1H, d, J = 7.5 Hz), 5.
90 (1H, tt, J = 53.1, 2.7 Hz), 6.84-7.00 (3H, m),
7.00-7.38 (5H, m), 7.39 (2H, d, J = 8.4 Hz), 7.68-
7.78 (1H, m), 8.16-8.24 (1H, m). IRν maxKBrcm-1:1753, 1589, 1508, 1489, 1468, 143
1. mp 99-100℃ Anal. Calcd for C23H18N2O4F4: C, 59.74; H, 3.92;
N, 6.06 Found : C, 59.60; H, 3.85; N, 6.11. 8) (4RS,5SR)-2-オキソ-5-[4-(ピリ
ジン-2-イルオキシ)フェニル]-4-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]-1,3-
オキサゾリジン-3-カルボン酸tert-ブチル (4RS,5SR)-5-[4-(ピリジン-2-イルオキ
シ)フェニル]-4-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]-1,3-オキサゾリジン-2-
オン(3.3g,7.14ミリモル)のアセトニトリル
(50ml)溶液に二炭酸ジ-tert-ブチル(1.8
7g,8.56ミリモル)および4-N,N-ジメチルピ
リジン(87mg,0.71ミリモル)を加え、室温で
15分攪拌した。反応液に水(100ml)を加え、酢
酸エチル(100ml×2)で抽出した。抽出液を水、
飽和食塩水で順次洗浄し、乾燥(無水硫酸マグネシウ
ム)後減圧留去した。残留物をシリカゲルカラムクロマ
トグラフィー(ヘキサン:酢酸エチル=4:1-1:
1)で精製し酢酸エチル-ヘキサンから再結晶させて、
目的物(3.46g,86%)を得た。1 H-NMR(CDCl3)δ:1.50 (9H, s), 2.67 (1H, dd, J = 1
4.2, 8.4 Hz), 2.89 (1H,dd, J = 14.2, 4.8 Hz), 4.72
-4.84 (1H, m), 5.71 (1H, d, J = 7.0 Hz), 5.89 (1H,
tt, J = 53.1, 3.0 Hz), 6.59 (1H, d, J = 7.6 Hz),
6.66 (1H, s), 6.88-7.28 (8H, m), 7.64-7.78 (1H,
m), 8.16-8.22 (1H, m). IRν maxKBrcm-1:1817, 1719, 1595, 1510, 1468. mp 123-124℃ Anal. Calcd for C28H26N2O6F4: C, 59.79; H, 4.66;
N, 4.98 Found : C, 59.83; H, 4.68; N, 4.96. 9) (1RS,2SR)-2-ヒドロキシ-2-[4-
(ピリジン-2-イルオキシ)フェニル]-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチルカルバミン酸tert-ブチル (4RS,5SR)-2-オキソ-5-[4-(ピリジン-2
-イルオキシ)フェニル]-4-[3-(1,1,2,2-
テトラフルオロエトキシ)ベンジル]-1,3-オキサゾ
リジン-3-カルボン酸tert-ブチル(3.00g,
5.33ミリモル)のメタノール(20ml)に0.5
規定水酸化ナトリウムのメタノール溶液(12.8m
l,6.4ミリモル)を加え室温で1時間攪拌した。反
応液に水(100ml)を加えて酢酸エチル(100m
l×2)で抽出した。抽出液を飽和食塩水で洗浄し、乾
燥(無水硫酸マグネシウム)後減圧留去した。残留物を
酢酸エチル-ヘキサンから再結晶させて目的物(2.6
7g,93%)を得た。1 H-NMR(CDCl3)δ:1.35 (9H, m), 2.64-2.80 (1H, m),
2.85 (1H, dd, J = 15.0,4.2 Hz), 3.23 (1H, s), 4.12
(1H, s), 4.64 (1H, d, J = 8.4 Hz), 4.93 (1H, s),
5.89 (1H, tt, J = 53.1, 3.0 Hz), 6.92 (1H, d, J =
8.4 Hz), 6.96-7.10 (4H, m), 7.10-7.20 (2H, m), 7.2
0-7.36 (1H, m), 7.38-7.46 (2H, m), 7.66-7.72 (1H,
m), 8.18-8.24 (1H, m). IRν maxKBrcm-1:1696, 1590, 1574, 1507, 1468, 143
1. mp 130-131℃ Anal. Calcd for C27H28F4N2O5: C, 60.44; H, 5.26;
N, 5.22 Found : C, 60.36; H, 5.06; N, 5.23.Example 257 (1RS, 2SR) -2-hydroxy-2- [4- (pyridin-2-yloxy) phenyl] -1- [3- (1,1,1
Tert-Butyl 2,2-tetrafluoroethoxy) benzyl] ethylcarbamate 1) Benzyl 4- (pyridin-2-yloxy) benzoate Benzyl 4-hydroxybenzoate (25.3 g, 111
Mmol) of N, N-dimethylformamide (60 m
l) Add tert-butoxy potassium (12.4 g,
111 mmol) and stirred at room temperature for 1 hour. After evaporating the reaction solution under reduced pressure, 2-bromopyridine (24.5 g, 1
55 mmol) and copper powder (1.76 g, 27.7 mmol) and N, N-dimethylformamide (80 m
l) was added and the mixture was stirred at 120 ° C for 8 hours. After the reaction solution was filtered using Celite, the filtrate was distilled off under reduced pressure. Water (500 ml) was added to the residue, and the mixture was extracted with ethyl acetate (500 ml). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1), and recrystallized from ethyl acetate-hexane to obtain the desired product (25.5 g, 73%). 1 H-NMR (CDCl 3 ) δ: 5.36 (2H, s), 6.97 (1H, d, J = 8.4
Hz), 7.00-7.10 (1H, m), 7.16-7.22 (2H, m), 7.30-
7.48 (5H, m), 7.68-7.78 (1H, m), 8.08-8.16 (2H,
m), 8.18-8.24 (1H, m) .IRν max KBr cm -1 : 1717, 1589, 1574, 1505, 1466, 142
. 9. mp 68-69 ℃ Anal Calcd for C 19 H 15 NO 3: C, 74.74; H, 4.95; N,
4.59 Found: C, 74.90; H, 5.14; N, 4.67. 2) 4- (Pyridin-2-yloxy) benzoic acid 4- (Pyridin-2-yloxy) benzyl benzoate (2
4.8 g, 81.5 mmol) of ethanol (300 m
l) 10% palladium / carbon (50% water-containing) in solution
(2.0 g), and the mixture was stirred at 80 ° C. overnight under a hydrogen stream. The reaction solution was filtered using celite, and the filtrate was concentrated. The residue was recrystallized from ethanol to give the desired product (1
4.1 g, 80%). 1 H-NMR (CDCl 3 ) δ: 7.04-7.20 (2H, m), 7.20-7.52 (4H,
m), 8.18 (1H, d, J = 8.4 Hz), 8.43 (1H, d, J = 2.6
Hz), 9.59 (1H, brs) .IRν max KBr cm -1 : 1682, 1599, 1588, 1570, 1508.mp 175-176 ° C Anal.Calcd for C 12 H 9 NO 3 : C, 66.97; H, 4.22 ; N, 6.
51 Found: C, 66.78; H, 3.94; N, 6.37. 3) 3-oxo-3- [4- (pyridin-2-yloxy)
Benzyl phenyl] propanoate 4- (pyridin-2-yloxy) benzoic acid (20 g, 9
2.9 mmol) in tetrahydrofuran (300 ml)
N, N'-carbonyldiimidazole (16.6 g,
(102 mmol) and heated under reflux for 1 hour. After the reaction solution was cooled to room temperature, malonic acid monobenzylmagnesium salt (21 g, 51.2 mmol) was added, and the mixture was heated under reflux for 2 hours. After concentrating the reaction solution, the residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1) to obtain the desired product (20.6 g, 64%). 1 H-NMR (CDCl 3 ) δ: 4.03 (2H, s), 5.17 (2H, s), 6.90-
7.50 (7H, m), 7.70-7.88 (2H, m), 7.90-8.02 (2H, m),
8.10-8.24 (2H, m) .IRν max KBr cm -1 : 1740, 1684, 1590, 1572, 1505, 146
6, 1429. Anal.Calcd for C 21 H 17 NO 4 : C, 72.61; H, 4.93; N,
4.03 Found: C, 72.48; H, 4.88; N, 4.06.4. 4) 3-oxo-3- [4- (pyridin-2-yloxy)
Phenyl] -2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] benzyl propanoate [3- (1,1,2,2-tetrafluoroethoxy) phenyl] methanol (6.79 g, Methanesulfonyl chloride (2.58 ml, 33.3 mmol) and triethylamine (5.07 ml, 36.4 mmol) were added to a solution of 30.3 mmol) in ethyl acetate (100 ml), and the mixture was stirred at room temperature for 2 hours. The insolubles were filtered, and the filtrate was distilled off under reduced pressure to prepare a mesyl compound. 3-oxo-3- [4- (pyridine
-2-yloxy) phenyl] benzyl propanoate (10
g, 28.8 mmol) in 1,2-dimethoxyethane (80 ml) was added to sodium hydride (1.15 g, 6
0% oily, 28.8 mmol) and stirred at room temperature for 1 hour. The 1,2-dimethoxyethane (10 ml) solution of the previously prepared mesyl compound was added dropwise to the reaction solution, and the reaction solution was
Stirred at 0 ° C. overnight. The reaction solution was acidified with 1N hydrochloric acid, neutralized with a saturated aqueous sodium hydrogen carbonate solution, and ethyl acetate (300 ml ×
Extracted in 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give the desired product (13.0).
g, 74%). 1 H-NMR (CDCl 3 ) δ: 3.35 (2H, d, J = 7.5 Hz), 4.63 (1
H, t, J = 7.5 Hz), 5.08 (2H, s), 5.88 (1H, tt, J =
53.1, 3.0 Hz), 6.98-7.20 (13H, m), 7.72-7.80 (1H,
m), 7.96-8.02 (2H, m), 8.20-8.26 (1H, m). IRν max KBr cm -1 : 1738, 1684, 1590, 15580. 5) (2RS, 3RS) -3-hydroxy-3- [4-
(Pyridin-2-yloxy) phenyl] -2- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] benzyl benzyl propanate Sodium borohydride (1.77 g, 67.1) was added to a solution of zinc chloride (3.19 g, 23.4 mmol) in diethyl ether (100 ml). Mmol) at room temperature for 30 minutes.
Minutes. The insolubles are removed by filtration and the filtrate is treated with 3-oxo-3-.
[4- (Pyridin-2-yloxy) phenyl] -2- [3-
A solution of benzyl (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate (6.5 g, 11.7 mmol) in diethyl ether (50 ml) was added at 0 ° C., and the mixture was stirred for 30 minutes. The reaction solution was quenched with 1N hydrochloric acid, neutralized with saturated aqueous sodium hydrogen carbonate, further added with water (200 ml), and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 2: 1-
1: 1) to give the desired product (4.78 g, 73%). 1 H-NMR (CDCl 3 ) δ: 2.83 (1 H, d, J = 3.0 Hz), 2.96-3.2
0 (3H, m), 4.84 (2H, s), 4.98-5.04 (1H, m), 5.88
(1H, tt, J = 53.2, 3.0 Hz), 6.88-7.30 (13H, m), 7.
30-7.44 (2H, m), 7.62-7.76 (1H, m), 8.16-8.22 (1H,
m). IRν max KBr cm -1 : 1728, 1593, 1507, 1468, 142.9 6) (2RS, 3RS) -3-hydroxy-3- [4-
(Pyridin-2-yloxy) phenyl] -2- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] propanoic acid (2RS, 3RS) -3-hydroxy-3- [4- (pyridin-2-yloxy) phenyl] -2- [3- (1, 1,
To a solution of benzyl 2,2-tetrafluoroethoxy) benzyl] propanoate (4.99 g, 8.95 mmol) in ethanol (500 ml) was added 10% palladium / carbon (50% water content, 500 mg), and a 1 atm hydrogen stream was added. Stirred under for 2 hours. The reaction solution was filtered through celite, and the filtrate was concentrated to obtain the desired product (4.50 g, 100%, crude). This compound was used crude in the next reaction. 1 H-NMR (CDCl 3 ) δ: 2.90-3.10 (3H, m), 3.83 (1H, brs),
5.01 (1H, d, J = 3.0Hz), 5.87 (1H, tt, J = 53.0,
3.0 Hz), 6.86-7.16 (7H, m), 7.18-7.30 (1H, m), 7.40
(2H, d, J = 8.4 Hz), 7.64-7.76 (1H, m), 8.14 (1H,
d, J = 3.8 Hz). IRν max KBr cm -1 : 1717, 1597, 1508, 1470, 141.7. (4) (4RS, 5SR) -5- [4- (pyridin-2-yloxy) phenyl] -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidin-2-one (2RS, 3RS) -3-hydroxy-3- [4- (pyridin-2-yloxy) Phenyl] -2- [3- (1,1,
In a solution of 2,2-tetrafluoroethoxy) benzyl] propanoic acid (4.49 g, 9.65 mmol, crude) in tetrahydrofuran (60 ml), diphenylphosphoryl azide (2.29 ml, 10.6 mmol) and triethylamine (2. 02 mmol, 14.5 mmol) and heated under reflux for 2 hours. After allowing the reaction solution to cool, water (100
ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with an aqueous solution of sodium hydrogen carbonate and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1-1: 1),
Recrystallization from ethyl acetate-hexane gave the desired product (3.
56 g, 80%). 1 H-NMR (CDCl 3 ) δ: 2.28-2.44 (2H, m), 4.20-4.30 (1H,
m), 5.20-5.30 (1H, m), 5.81 (1H, d, J = 7.5 Hz), 5.
90 (1H, tt, J = 53.1, 2.7 Hz), 6.84-7.00 (3H, m),
7.00-7.38 (5H, m), 7.39 (2H, d, J = 8.4 Hz), 7.68-
7.78 (1H, m), 8.16-8.24 (1H, m) .IRν max KBr cm -1 : 1753, 1589, 1508, 1489, 1468, 143
1.mp 99-100 ℃ Anal.Calcd for C 23 H 18 N 2 O 4 F 4 : C, 59.74; H, 3.92;
N, 6.06 Found: C, 59.60; H, 3.85; N, 6.11.8) (4RS, 5SR) -2-oxo-5- [4- (pyridin-2-yloxy) phenyl] -4- [3- ( 1,1,
2,2-tetrafluoroethoxy) benzyl] -1,3-
Tert-Butyl oxazolidine-3-carboxylate (4RS, 5SR) -5- [4- (pyridin-2-yloxy) phenyl] -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine-2-
To a solution of ON (3.3 g, 7.14 mmol) in acetonitrile (50 ml) was added di-tert-butyl dicarbonate (1.8).
7 g, 8.56 mmol) and 4-N, N-dimethylpyridine (87 mg, 0.71 mmol) were added, and the mixture was stirred at room temperature for 15 minutes. Water (100 ml) was added to the reaction solution, and extracted with ethyl acetate (100 ml × 2). Extract water with water,
The extract was washed successively with a saturated saline solution, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 4: 1-1:
Purified in 1) and recrystallized from ethyl acetate-hexane,
The desired product (3.46 g, 86%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.50 (9H, s), 2.67 (1H, dd, J = 1
4.2, 8.4 Hz), 2.89 (1H, dd, J = 14.2, 4.8 Hz), 4.72
-4.84 (1H, m), 5.71 (1H, d, J = 7.0 Hz), 5.89 (1H,
tt, J = 53.1, 3.0 Hz), 6.59 (1H, d, J = 7.6 Hz),
6.66 (1H, s), 6.88-7.28 (8H, m), 7.64-7.78 (1H,
. m), 8.16-8.22 (1H, m) IRν max KBr cm -1: 1817, 1719, 1595, 1510, 1468. mp 123-124 ℃ Anal Calcd for C 28 H 26 N 2 O 6 F 4:. C , 59.79; H, 4.66;
N, 4.98 Found: C, 59.83; H, 4.68; N, 4.99.9) (1RS, 2SR) -2-hydroxy-2- [4-
(Pyridin-2-yloxy) phenyl] -1- [3-
Tert-Butyl (1,1,2,2-tetrafluoroethoxy) benzyl] ethylcarbamate (4RS, 5SR) -2-oxo-5- [4- (pyridine-2
-Yloxy) phenyl] -4- [3- (1,1,2,2-
Tert-butyl tetrafluoroethoxy) benzyl] -1,3-oxazolidine-3-carboxylate (3.00 g,
5.33 mmol) in methanol (20 ml).
Normal methanol solution of sodium hydroxide (12.8m
1,6.4 mmol) and stirred at room temperature for 1 hour. Water (100 ml) was added to the reaction solution, and ethyl acetate (100 m
1 × 2). The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the desired product (2.6).
7g, 93%). 1 H-NMR (CDCl 3 ) δ: 1.35 (9H, m), 2.64-2.80 (1H, m),
2.85 (1H, dd, J = 15.0,4.2 Hz), 3.23 (1H, s), 4.12
(1H, s), 4.64 (1H, d, J = 8.4 Hz), 4.93 (1H, s),
5.89 (1H, tt, J = 53.1, 3.0 Hz), 6.92 (1H, d, J =
8.4 Hz), 6.96-7.10 (4H, m), 7.10-7.20 (2H, m), 7.2
0-7.36 (1H, m), 7.38-7.46 (2H, m), 7.66-7.72 (1H,
m), 8.18-8.24 (1H, m) .IRν max KBr cm -1 : 1696, 1590, 1574, 1507, 1468, 143
1.mp 130-131 ℃ Anal. Calcd for C 27 H 28 F 4 N 2 O 5 : C, 60.44; H, 5.26;
N, 5.22 Found: C, 60.36; H, 5.06; N, 5.23.
【0390】実施例258 N-{(1RS,2SR)-2-ヒドロキシ-2-[4-(ピ
リジン-2-イルオキシ)フェニル]-1-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]エチ
ル}-6,7-ジヒドロ-5H-ベンゾ[a][7]アンヌ
レン-1-カルボキサミド (1RS,2SR)-2-ヒドロキシ-2-[4-(ピリジ
ン-2-イルオキシ)フェニル]-1-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]エチルカ
ルバミン酸tert-ブチル(500mg,0.93ミ
リモル)にトリフルオロ酢酸(10ml)を加え、0℃
で10分攪拌した。反応液を飽和重曹水で中和し、酢酸
エチル(30ml×2)で抽出した。抽出液を飽和食塩
水で洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去
した。残留物のアセトニトリル(20ml)溶液に6,
7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カ
ルボン酸(175mg,0.93ミリモル)および1-
エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩(268mg,1.40ミリモル)および
1-ヒドロキシベンゾトリアゾール水和物(143m
g,0.93ミリモル)を加えて室温で終夜攪拌した。
反応液を水(150ml)で希釈し、酢酸エチル(10
0ml×2)で抽出した。抽出液を水、飽和食塩水で順
次洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=4:1-1:1)で精製し、酢酸
エチル-ヘキサンから再結晶させて、目的物(181m
g,32%)を得た。1 H-NMR(CDCl3)δ:1.90-2.08 (2H, m), 2.10-2.24 (2H,
m), 2.60-2.70 (2H, m),2.82 (1H, dd, J = 14.6, 10.6
Hz), 3.04 (1H, dd, J = 14.6, 4.0 Hz), 3.71(1H, d,
J = 3.4 Hz), 4.62-4.80 (1H, m), 5.00-5.08 (1H,
m), 5.60-6.20 (2H, m), 6.23 (1H, d, J = 11.6 Hz),
6.84-7.20 (10H, m), 7.20-7.38 (1H, m),7.48 (2H, d,
J = 8.4 Hz), 7.64-7.76 (1H, m), 8.16-8.24 (1H,
m). IRν maxKBrcm-1:1644, 1590, 1507, 1468, 1429. mp 160-161℃ Anal. Calcd for C34H30F4N2O4: C, 67.32; H, 4.98;
N, 4.62 Found : C, 67.09; H, 4.96; N, 4.56.Example 258 N-{(1RS, 2SR) -2-hydroxy-2- [4- (pyridin-2-yloxy) phenyl] -1- [3- (1,
1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro-5H-benzo [a] [7] annulene-1-carboxamide (1RS, 2SR) -2-hydroxy-2- [4- (Pyridin-2-yloxy) phenyl] -1- [3- (1,1,
Trifluoroacetic acid (10 ml) was added to tert-butyl 2,2-tetrafluoroethoxy) benzyl] ethylcarbamate (500 mg, 0.93 mmol), and the mixture was added at 0 ° C.
For 10 minutes. The reaction solution was neutralized with saturated aqueous sodium hydrogen carbonate and extracted with ethyl acetate (30 ml × 2). The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The solution of the residue in acetonitrile (20 ml)
7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (175 mg, 0.93 mmol) and 1-
Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (268 mg, 1.40 mmol) and 1-hydroxybenzotriazole hydrate (143 m
g, 0.93 mmol) and stirred at room temperature overnight.
The reaction solution was diluted with water (150 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-1: 1) and recrystallized from ethyl acetate-hexane to give the desired product (181 m
g, 32%). 1 H-NMR (CDCl 3 ) δ: 1.90-2.08 (2H, m), 2.10-2.24 (2H,
m), 2.60-2.70 (2H, m), 2.82 (1H, dd, J = 14.6, 10.6
Hz), 3.04 (1H, dd, J = 14.6, 4.0 Hz), 3.71 (1H, d,
J = 3.4 Hz), 4.62-4.80 (1H, m), 5.00-5.08 (1H,
m), 5.60-6.20 (2H, m), 6.23 (1H, d, J = 11.6 Hz),
6.84-7.20 (10H, m), 7.20-7.38 (1H, m), 7.48 (2H, d,
J = 8.4 Hz), 7.64-7.76 (1H, m), 8.16-8.24 (1H,
.. m) IRν max KBr cm -1: 1644, 1590, 1507, 1468, 1429. mp 160-161 ℃ Anal Calcd for C 34 H 30 F 4 N 2 O 4: C, 67.32; H, 4.98;
N, 4.62 Found: C, 67.09; H, 4.96; N, 4.56.
【0391】実施例259 4-フルオロ-N-{(1RS,2SR)-2-ヒドロキシ-
2-[4-(ピリジン-2-イルオキシ)フェニル]-1-
[3-(1,1,2,2-テトラフルオロエトキシ)ベン
ジル]エチル}-1-ナフトアミド (1RS,2SR)-2-ヒドロキシ-2-[4-(ピリジ
ン-2-イルオキシ)フェニル]-1-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]エチルカ
ルバミン酸tert-ブチル(500mg,0.93ミ
リモル)にトリフルオロ酢酸(10ml)を加え、0℃
で10分攪拌した。反応液を飽和重曹水で中和し、酢酸
エチル(30ml×2)で抽出した。抽出液を飽和食塩
水で洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去
した。残留物のアセトニトリル(20ml)溶液に4-
フルオロナフタレンカルボン酸(177mg,0.93
ミリモル)および1-エチル-3-(3-ジメチルアミノプ
ロピル)カルボジイミド・塩酸塩(268mg,1.4
0ミリモル)および1-ヒドロキシベンゾトリアゾール
水和物(143mg,0.93ミリモル)を加えて室温
で終夜攪拌した。反応液を水(150ml)で希釈し、
酢酸エチル(100ml×2)で抽出した。抽出液を
水、飽和食塩水で順次洗浄し、乾燥(無水硫酸マグネシ
ウム)後減圧留去した。残留物をシリカゲルカラムクロ
マトグラフィー(ヘキサン:酢酸エチル=4:1-1:
1)で精製し、酢酸エチル-ヘキサンから再結晶させ
て、目的物(312mg,55%)を得た。1 H-NMR(CDCl3)δ:2.88 (1H, dd, J = 14.4, 10.8 Hz),
3.11 (1H, dd, J = 14.4, 4.2 Hz), 3.59 (1H, s), 4.7
6-4.90 (1H, m), 5.08 (1H, s), 5.88 (1H, tt,J = 53.
1, 2.7 Hz), 6.05 (1H, d, J = 7.8 Hz), 6.90-7.10 (3
H, m), 7.10-7.22 (6H, m), 7.22-7.38 (1H, m), 7.40-
7.60 (4H, m), 7.64-7.74 (1H, m), 7.84(1H, d, J =
8.4 Hz), 8.07 (1H, d, J = 8.1 Hz), 8.14-8.20 (1H,
m). IRν maxKBrcm-1:1715, 1644, 1597, 1508, 1468, 143
1. mp 176-177℃ Anal. Calcd for C33H25N2O4F5・1.0H2O: C, 63.26; H,
4.34; N, 4.47 Found : C, 63.41; H, 4.07; N, 4.57.Example 259 4-Fluoro-N-{(1RS, 2SR) -2-hydroxy-
2- [4- (pyridin-2-yloxy) phenyl] -1-
[3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -1-naphthamide (1RS, 2SR) -2-hydroxy-2- [4- (pyridin-2-yloxy) phenyl] -1 -[3- (1,1,
Trifluoroacetic acid (10 ml) was added to tert-butyl 2,2-tetrafluoroethoxy) benzyl] ethylcarbamate (500 mg, 0.93 mmol), and the mixture was added at 0 ° C.
For 10 minutes. The reaction solution was neutralized with saturated aqueous sodium hydrogen carbonate and extracted with ethyl acetate (30 ml × 2). The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. 4-to the solution of the residue in acetonitrile (20 ml)
Fluoronaphthalenecarboxylic acid (177 mg, 0.93
Mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (268 mg, 1.4).
0 mmol) and 1-hydroxybenzotriazole hydrate (143 mg, 0.93 mmol) were added, and the mixture was stirred at room temperature overnight. Dilute the reaction with water (150 ml)
Extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 4: 1-1:
Purification in 1) and recrystallization from ethyl acetate-hexane gave the desired product (312 mg, 55%). 1 H-NMR (CDCl 3 ) δ: 2.88 (1H, dd, J = 14.4, 10.8 Hz),
3.11 (1H, dd, J = 14.4, 4.2 Hz), 3.59 (1H, s), 4.7
6-4.90 (1H, m), 5.08 (1H, s), 5.88 (1H, tt, J = 53.
1, 2.7 Hz), 6.05 (1H, d, J = 7.8 Hz), 6.90-7.10 (3
H, m), 7.10-7.22 (6H, m), 7.22-7.38 (1H, m), 7.40-
7.60 (4H, m), 7.64-7.74 (1H, m), 7.84 (1H, d, J =
8.4 Hz), 8.07 (1H, d, J = 8.1 Hz), 8.14-8.20 (1H,
m) .IRν max KBr cm -1 : 1715, 1644, 1597, 1508, 1468, 143
1.mp 176-177 ℃ Anal. Calcd for C 33 H 25 N 2 O 4 F 5・ 1.0H 2 O: C, 63.26; H,
4.34; N, 4.47 Found: C, 63.41; H, 4.07; N, 4.57.
【0392】実施例260 (1RS,2SR)-2-ヒドロキシ-2-[4-(ピリジ
ン-3-イルオキシ)フェニル]-1-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]エチルカ
ルバミン酸tert-ブチル 1) 4-(ピリジン-3-イルオキシ)安息香酸ベンジ
ル 4-ヒドロキシ安息香酸ベンジル(25.0g,110
ミリモル)のN,N-ジメチルホルムアミド(60m
l)溶液にtert-ブトキシカリウム(12.3g,
110ミリモル)を加え、室温で1時間攪拌した。反応
液を減圧留去後、3-ブロモピリジン(25.0g,1
10ミリモル)および銅粉末(1.76g,27.2ミ
リモル)およびN,N-ジメチルホルムアミド(80m
l)を加え、120℃で8時間攪拌した。反応液をセラ
イト用いてろ過後、ろ液を減圧留去した。残留物に水
(500ml)を加え酢酸エチル(500ml)で抽出
した。抽出液を水、飽和食塩水で順次洗浄し、乾燥(無
水硫酸マグネシウム)後減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=10:1-2:1)で精製し、目的物(18.0g,
54%,粗製)を得た。1 H-NMR(CDCl3)δ:5.36 (2H, s), 6.96-7.06 (2H, m),
7.26-7.50 (7H, m), 8.04-8.12 (2H, m), 8.46 (2H, br
s). IRν maxKBrcm-1:1717, 1605, 1574, 1505, 1474, 142
4. 2) 4-(ピリジン-3-イルオキシ)安息香酸 4-(ピリジン-3-イルオキシ)安息香酸ベンジル(1
8.0g,5.90ミリモル)のエタノール(300m
l)溶液に10%パラジウム/炭素(50%含水,2.
0g)を加え、水素気流下、80℃で終夜攪拌した。反
応液をセライトを用いてろ過し、ろ液を濃縮した。残留
物をエタノール-ヘキサンから再結晶させて、目的物
(11.2g,88%)を得た。1 H-NMR(DMSO-d6)δ:7.10 (2H, d, J = 8.8 Hz), 7.42-
7.66 (2H, m), 7.98 (2H,d, J = 8.8 Hz), 8.47 (2H,
s). IRν maxKBrcm-1:1690, 1597, 1574. mp 204-205℃ Anal. Calcd for C12H9NO3: C, 66.97; H, 4.22; N, 6.
51 Found : C, 66.88; H, 4.15; N, 6.42. 3) 3-オキソ-3-[4-(ピリジン-3-イルオキシ)
フェニル]プロパン酸ベンジル 4-(ピリジン-3-イルオキシ)安息香酸(11.2
g,52.0ミリモル)のテトラヒドロフラン(160
ml)にN,N’-カルボニルジイミダゾール(9.2
8g,57.3ミリモル)を加え、3時間加熱還流し
た。反応液を室温まで冷却後、マロン酸モノベンジルマ
グネシウム塩(11.7g,28.6ミリモル)を加
え、2時間加熱還流した。反応液を濃縮後、残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=1:1)で精製し、目的物(14.1g,78
%)を得た。1 H-NMR(CDCl3)δ:4.02 (2H, s), 5.20 (2H, s), 6.94-
7.08 (2H, m), 7.30-7.48(6H, m), 7.90-7.96 (2H, m),
8.40-8.52 (3H, m). IRν maxKBrcm-1:1740, 1682, 1601, 1574, 1505, 147
3, 1424. 4) 3-オキソ-3-[4-(ピリジン-3-イルオキシ)
フェニル]-2-[3-(1,1,2,2-テトラフルオロ
エトキシ)ベンジル]プロパン酸ベンジル [3-(1,1,2,2-テトラフルオロエトキシ)フェ
ニル]メタノール(4.97g,22.2ミリモル)の
酢酸エチル(100ml)溶液に塩化メタンスルホニル
(1.87ml,24.2ミリモル)およびトリエチル
アミン(3.65ml,26.2ミリモル)を加え、室
温で2時間攪拌した。不溶物をろ過し、ろ液を減圧留去
しメシル体を調製した。3-オキソ-3-[4-(ピリジン
-3-イルオキシ)フェニル]プロパン酸ベンジル(7
g,20.2ミリモル)の1,2-ジメトキシエタン
(80ml)溶液に水素化ナトリウム(806mg,6
0%油性,20.2ミリモル)を加え、室温で1時間攪
拌した。反応液に先に調製したメシル体の1,2-ジメ
トキシエタン(10ml)溶液を滴下し、反応液を60
℃にて終夜攪拌した。反応液を1規定塩酸で酸性とした
後、飽和重曹水で中和し、酢酸エチル(300ml×
2)で抽出した。抽出液を水、飽和食塩水で順次洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=2:1)で精製し目的物(6.0g,
54%,粗製)を得た。1 H-NMR(CDCl3)δ:3.35 (2H, d, J = 7.6 Hz), 4.60 (1
H, t, J = 7.6 Hz), 5.08(2H, s), 5.88 (1H, tt, J =
53.0, 3.0 Hz), 6.90-7.40 (13H, m), 7.86-7.98(2H,
m), 8.40-8.52 (2H, m). IRν maxKBrcm-1:1740, 1684, 1601, 1574, 1505, 147
3, 1424. 5) (2RS,3RS)-3-ヒドロキシ-3-[4-
(ピリジン-3-イルオキシ)フェニル]-2-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]プロパン酸ベンジル 塩化亜鉛(2.95g,21.6ミリモル)のジエチル
エーテル(100ml)溶液に水素化ホウ素ナトリウム
(1.64g,43.3ミリモル)を加えて室温で30
分攪拌した。不溶物をろ去し、ろ液に3-オキソ-3-
[4-(ピリジン-3-イルオキシ)フェニル]-2-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]プロパン酸ベンジル(6.0g,10.8ミリモ
ル,粗製)のジエチルエーテル(50ml)溶液を0℃
にて加えて30分攪拌した。反応液に1規定塩酸を加え
て反応を止め、飽和重曹水で中和後、更に水(200m
l)を加え、酢酸エチル(200ml×2)で抽出し
た。抽出液を水および飽和食塩水で洗浄し、乾燥(無水
硫酸マグネシウム)後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
2:1)で精製し、酢酸エチル-ヘキサンから再結晶さ
せて目的物(3.13g,73%)を得た。1 H-NMR(CDCl3)δ:2.92-3.14 (4H, m), 4.86 (2H, d, J
= 3.3 Hz), 5.03 (1H, s), 5.88 (1H, tt, J = 53.1,
3.0 Hz), 6.90-7.08 (7H, m), 7.18-7.32 (6H, m), 7.3
6 (2H, d, J = 8.4 Hz), 8.34-8.40 (2H, m). IRν maxKBrcm-1:1730, 1611, 1576, 1507, 1478, 145
1, 1426. mp 120-122℃ Anal. Calcd for C30H25NO5F4: C, 64.86; H, 4.54; N,
2.52 Found : C, 64.91; H, 4.75; N, 2.56. 6) (2RS,3RS)-3-ヒドロキシ-3-[4-
(ピリジン-3-イルオキシ)フェニル]-2-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]プロパン酸 (2RS,3RS)-3-ヒドロキシ-3-[4-(ピリジ
ン-3-イルオキシ)フェニル]-2-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]プロパン
酸ベンジル(3.00g,5.38ミリモル)のエタノ
ール(200ml)溶液に、10%パラジウム/炭素
(50%含水,300mg)を加え、1気圧水素気流下
で1時間攪拌した。反応液をセライトでろ過し、ろ液を
濃縮して目的物(2.8g,100%,粗製)を得た。
本化合物は粗製のまま次の反応に用いた。1 H-NMR(CDCl3)δ:2.92-3.10 (3H, m), 5.05 (1H, m),
5.88 (1H, tt, J = 53.0,3.0 Hz), 6.96-7.16 (5H, m),
7.20-7.48 (5H, m), 8.20-8.32 (2H, m). IRν maxKBrcm-1:1711, 1611, 1578, 1507, 1480, 142
7. 7) (4RS,5SR)-5-[4-(ピリジン-3-イ
ルオキシ)フェニル]-4-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]-1,3-オキサゾリジ
ン-2-オン (2RS,3RS)-3-ヒドロキシ-3-[4-(ピリジ
ン-3-イルオキシ)フェニル]-2-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]プロパン
酸(2.83g,6.08ミリモル,粗製)のテトラヒ
ドロフラン(100ml)溶液に、ジフェニルホスホリ
ルアジド(1.44ml,6.69ミリモル)とトリエ
チルアミン(1.27ミリモル,9.12ミリモル)を
加え、1時間加熱還流した。反応液を放冷後、水(10
0ml)を加えて酢酸エチル(100ml×2)で抽出
した。抽出液を炭酸水素ナトリウム水溶液、飽和食塩水
で順次洗浄し、乾燥(無水硫酸マグネシウム)後減圧留
去した。残留物をシリカゲルカラムクロマトグラフィー
(ヘキサン:酢酸エチル=4:1-1:1)で精製し、
酢酸エチル-ヘキサンから再結晶させて、目的物(3.
56g,73%)を得た。1 H-NMR(CDCl3)δ:2.24-2.42 (2H, m), 4.22-4.32 (1H,
m), 5.12-5.22 (1H, m),5.80 (1H, d, J = 7.8 Hz), 5.
90 (1H, tt, J = 53.1, 2.7 Hz), 6.89 (1H, s), 6.96
(1H, d, J = 7.8 Hz), 7.00-7.18 (3H, m), 7.26-7.40
(5H, m), 8.18-8.24 (2H, m). IRν maxKBrcm-1:1759, 1613, 1576, 1508, 1478, 142
4. mp 123-124℃ Anal. Calcd for C23H18N2O4F4: C, 59.74; H, 3.92;
N, 6.06 Found : C, 59.60; H, 3.85; N, 6.11. 8) (4RS,5SR)-2-オキソ-5-[4-(ピリ
ジン-3-イルオキシ)フェニル]-4-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]-1,3-
オキサゾリジン-3-カルボン酸tert-ブチル (4RS,5SR)-5-[4-(ピリジン-3-イルオキ
シ)フェニル]-4-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]-1,3-オキサゾリジン-2-
オン(1.80g,3.89ミリモル)のアセトニトリ
ル(40ml)溶液に二炭酸ジ-tert-ブチル(1.
02g,4.67ミリモル)および4-N,N-ジメチル
ピリジン(47mg,0.39ミリモル)を加え、室温
で1時間攪拌した。反応液に水(100ml)を加え、
酢酸エチル(100ml×2)で抽出した。抽出液を
水、飽和食塩水で順次洗浄し、乾燥(無水硫酸マグネシ
ウム)後減圧留去した。残留物をシリカゲルカラムクロ
マトグラフィー(ヘキサン:酢酸エチル=4:1-1:
1)で精製し酢酸エチル-ヘキサンから再結晶させて、
目的物(1.87g,85%)を得た。1 H-NMR(CDCl3)δ:1.51 (9H, s), 2.65 (1H, dd, J = 1
4.2, 8.8 Hz), 2.93 (1H,dd, J = 14.2, 4.4 Hz), 4.76
-4.88 (1H, m), 5.69 (1H, d, J = 7.0 Hz), 5.91 (1H,
tt, J = 53.0, 3.0 Hz), 6.58 (1H, s), 6.66 (1H, d,
J = 7.6 Hz), 6.84-7.04 (3H, m), 7.08-7.20 (3H,
m), 7.26-7.36 (2H, m), 8.36-8.44 (2H, m). IRν maxKBrcm-1:1819, 1721, 1613, 1578, 1508, 147
6, 1424. mp 146-147℃ Anal. Calcd for C28H26N2O6F4: C, 59.79; H, 4.66;
N, 4.98 Found : C, 59.83; H, 4.65; N, 4.84. 9) (1RS,2SR)-2-ヒドロキシ-2-[4-
(ピリジン-3-イルオキシ)フェニル]-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチルカルバミン酸tert-ブチル (4RS,5SR)-2-オキソ-5-[4-(ピリジン-3
-イルオキシ)フェニル]-4-[3-(1,1,2,2-
テトラフルオロエトキシ)ベンジル]-1,3-オキサゾ
リジン-3-カルボン酸tert-ブチル(1.70g,
3.02ミリモル)のメタノール(10ml)に0.5
規定水酸化ナトリウムのメタノール溶液(7.26m
l,3.63ミリモル)を加え室温で1時間攪拌した。
反応液に水(100ml)を加えて酢酸エチル(100
ml×2)で抽出した。抽出液を飽和食塩水で洗浄し、
乾燥(無水硫酸マグネシウム)後減圧留去した。残留物
を酢酸エチル-ヘキサンから再結晶させて目的物(1.
39g,86%)を得た。1 H-NMR(CDCl3)δ:1.35 (9H, s), 2.60-2.84 (2H, m),
3.45 (1H, s), 4.02-4.16(1H, m), 4.63 (1H, d, J =
8.4 Hz), 4.93 (1H, s), 5.90 (1H, tt, J = 52.8, 3.0
Hz), 6.96-7.10 (5H, m), 7.24-7.34 (3H, m), 7.41
(2H, d, J = 8.4 Hz), 8.34-8.44 (2H, m). IRν maxKBrcm-1:1698, 1576, 1505, 1478. mp 123-124℃ Anal. Calcd for C27H28F4N2O5: C, 60.44; H, 5.26;
N, 5.22 Found : C, 60.24; H, 5.45; N, 5.15.Example 260 (1RS, 2SR) -2-hydroxy-2- [4- (pyridin-3-yloxy) phenyl] -1- [3- (1,1,
Tert-Butyl 2,2-tetrafluoroethoxy) benzyl] ethylcarbamate 1) Benzyl 4- (pyridin-3-yloxy) benzoate Benzyl 4-hydroxybenzoate (25.0 g, 110
Mmol) of N, N-dimethylformamide (60 m
l) Potassium tert-butoxide (12.3 g,
(110 mmol) and stirred at room temperature for 1 hour. After evaporating the reaction solution under reduced pressure, 3-bromopyridine (25.0 g, 1
10 mmol) and copper powder (1.76 g, 27.2 mmol) and N, N-dimethylformamide (80 m
l) was added and the mixture was stirred at 120 ° C for 8 hours. After the reaction solution was filtered using Celite, the filtrate was distilled off under reduced pressure. Water (500 ml) was added to the residue, and the mixture was extracted with ethyl acetate (500 ml). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1-2: 1) to give the desired product (18.0 g,
54%, crude). 1 H-NMR (CDCl 3 ) δ: 5.36 (2H, s), 6.96-7.06 (2H, m),
7.26-7.50 (7H, m), 8.04-8.12 (2H, m), 8.46 (2H, br
s) .IRν max KBr cm -1 : 1717, 1605, 1574, 1505, 1474, 142
4.2) 4- (Pyridin-3-yloxy) benzoic acid Benzyl 4- (pyridin-3-yloxy) benzoate (1
8.0 g, 5.90 mmol) of ethanol (300 m
l) 10% palladium on carbon (50% water, 2.
0 g), and the mixture was stirred at 80 ° C. overnight under a hydrogen stream. The reaction solution was filtered using celite, and the filtrate was concentrated. The residue was recrystallized from ethanol-hexane to obtain the desired product (11.2 g, 88%). 1 H-NMR (DMSO-d 6 ) δ: 7.10 (2H, d, J = 8.8 Hz), 7.42-
7.66 (2H, m), 7.98 (2H, d, J = 8.8 Hz), 8.47 (2H,
s) .IRν max KBr cm -1 : 1690, 1597, 1574.mp 204-205 ° C Anal.Calcd for C 12 H 9 NO 3 : C, 66.97; H, 4.22; N, 6.
51 Found: C, 66.88; H, 4.15; N, 6.42. 3) 3-oxo-3- [4- (pyridin-3-yloxy)
Benzyl phenyl] propanoate 4- (pyridin-3-yloxy) benzoic acid (11.2
g, 52.0 mmol) of tetrahydrofuran (160
ml) with N, N'-carbonyldiimidazole (9.2
(8 g, 57.3 mmol) and heated under reflux for 3 hours. After the reaction solution was cooled to room temperature, malonic acid monobenzylmagnesium salt (11.7 g, 28.6 mmol) was added, and the mixture was heated under reflux for 2 hours. After concentrating the reaction solution, the residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1) to obtain the desired product (14.1 g, 78).
%). 1 H-NMR (CDCl 3 ) δ: 4.02 (2H, s), 5.20 (2H, s), 6.94-
7.08 (2H, m), 7.30-7.48 (6H, m), 7.90-7.96 (2H, m),
8.40-8.52 (3H, m) .IRν max KBr cm -1 : 1740, 1682, 1601, 1574, 1505, 147
3, 1424. 4) 3-Oxo-3- [4- (pyridin-3-yloxy)
Phenyl] -2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] benzyl propanoate [3- (1,1,2,2-tetrafluoroethoxy) phenyl] methanol (4.97 g, To a solution of 22.2 mmol) in ethyl acetate (100 ml) were added methanesulfonyl chloride (1.87 ml, 24.2 mmol) and triethylamine (3.65 ml, 26.2 mmol), and the mixture was stirred at room temperature for 2 hours. The insolubles were filtered, and the filtrate was distilled off under reduced pressure to prepare a mesyl compound. 3-oxo-3- [4- (pyridine
Benzyl-3-yloxy) phenyl] propanoate (7
g, 20.2 mmol) in 1,2-dimethoxyethane (80 ml).
(0% oily, 20.2 mmol) and stirred at room temperature for 1 hour. The 1,2-dimethoxyethane (10 ml) solution of the previously prepared mesyl compound was added dropwise to the reaction solution, and the reaction solution was
Stirred at 0 ° C. overnight. The reaction solution was acidified with 1N hydrochloric acid, neutralized with a saturated aqueous sodium hydrogen carbonate solution, and ethyl acetate (300 ml ×
Extracted in 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1) to give the desired product (6.0 g,
54%, crude). 1 H-NMR (CDCl 3 ) δ: 3.35 (2H, d, J = 7.6 Hz), 4.60 (1
H, t, J = 7.6 Hz), 5.08 (2H, s), 5.88 (1H, tt, J =
53.0, 3.0 Hz), 6.90-7.40 (13H, m), 7.86-7.98 (2H,
m), 8.40-8.52 (2H, m) .IRν max KBr cm -1 : 1740, 1684, 1601, 1574, 1505, 147
3, 1424.5) (2RS, 3RS) -3-hydroxy-3- [4-
(Pyridin-3-yloxy) phenyl] -2- [3-
Benzyl (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate Sodium borohydride (1.64 g, 43.3) was added to a solution of zinc chloride (2.95 g, 21.6 mmol) in diethyl ether (100 ml). Mmol) at room temperature for 30 minutes.
Minutes. The insolubles are removed by filtration and the filtrate is treated with 3-oxo-3-.
[4- (Pyridin-3-yloxy) phenyl] -2- [3-
A solution of benzyl (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate (6.0 g, 10.8 mmol, crude) in diethyl ether (50 ml) was added at 0 ° C.
And stirred for 30 minutes. The reaction solution was quenched with 1N hydrochloric acid, neutralized with saturated aqueous sodium hydrogen carbonate, and further added with water (200 ml).
l) was added, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
2: 1) and recrystallized from ethyl acetate-hexane to give the desired product (3.13 g, 73%). 1 H-NMR (CDCl 3 ) δ: 2.92-3.14 (4H, m), 4.86 (2H, d, J
= 3.3 Hz), 5.03 (1H, s), 5.88 (1H, tt, J = 53.1,
3.0 Hz), 6.90-7.08 (7H, m), 7.18-7.32 (6H, m), 7.3
6 (2H, d, J = 8.4 Hz), 8.34-8.40 (2H, m) .IRν max KBr cm -1 : 1730, 1611, 1576, 1507, 1478, 145
1, 1426.mp 120-122 ℃ Anal.Calcd for C 30 H 25 NO 5 F 4 : C, 64.86; H, 4.54; N,
2.52 Found: C, 64.91; H, 4.75; N, 2.56.6) (2RS, 3RS) -3-hydroxy-3- [4-
(Pyridin-3-yloxy) phenyl] -2- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] propanoic acid (2RS, 3RS) -3-hydroxy-3- [4- (pyridin-3-yloxy) phenyl] -2- [3- (1, 1,
To a solution of benzyl 2,2-tetrafluoroethoxy) benzyl] propanoate (3.00 g, 5.38 mmol) in ethanol (200 ml) was added 10% palladium / carbon (50% water content, 300 mg), and a 1 atm hydrogen stream was added. Stirred under for 1 hour. The reaction solution was filtered through celite, and the filtrate was concentrated to obtain the desired product (2.8 g, 100%, crude).
This compound was used crude in the next reaction. 1 H-NMR (CDCl 3 ) δ: 2.92-3.10 (3H, m), 5.05 (1H, m),
5.88 (1H, tt, J = 53.0,3.0 Hz), 6.96-7.16 (5H, m),
7.20-7.48 (5H, m), 8.20-8.32 (2H, m) .IRν max KBr cm -1 : 1711, 1611, 1578, 1507, 1480, 142
7.7) (4RS, 5SR) -5- [4- (pyridin-3-yloxy) phenyl] -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3- Oxazolidin-2-one (2RS, 3RS) -3-hydroxy-3- [4- (pyridin-3-yloxy) phenyl] -2- [3- (1,1,
In a solution of (2,2-tetrafluoroethoxy) benzyl] propanoic acid (2.83 g, 6.08 mmol, crude) in tetrahydrofuran (100 ml), diphenylphosphoryl azide (1.44 ml, 6.69 mmol) and triethylamine (1. (27 mmol, 9.12 mmol), and the mixture was heated under reflux for 1 hour. After allowing the reaction solution to cool, water (10
0 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with an aqueous solution of sodium hydrogen carbonate and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-1: 1),
Recrystallization from ethyl acetate-hexane gave the desired product (3.
56 g, 73%). 1 H-NMR (CDCl 3 ) δ: 2.24-2.42 (2H, m), 4.22-4.32 (1H,
m), 5.12-5.22 (1H, m), 5.80 (1H, d, J = 7.8 Hz), 5.
90 (1H, tt, J = 53.1, 2.7 Hz), 6.89 (1H, s), 6.96
(1H, d, J = 7.8 Hz), 7.00-7.18 (3H, m), 7.26-7.40
(5H, m), 8.18-8.24 (2H, m) .IRν max KBr cm -1 : 1759, 1613, 1576, 1508, 1478, 142
4.mp 123-124 ℃ Anal. Calcd for C 23 H 18 N 2 O 4 F 4 : C, 59.74; H, 3.92;
N, 6.06 Found: C, 59.60; H, 3.85; N, 6.11.8) (4RS, 5SR) -2-oxo-5- [4- (pyridin-3-yloxy) phenyl] -4- [3- ( 1,1,
2,2-tetrafluoroethoxy) benzyl] -1,3-
Tert-Butyl oxazolidine-3-carboxylate (4RS, 5SR) -5- [4- (pyridin-3-yloxy) phenyl] -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine-2-
To a solution of ON (1.80 g, 3.89 mmol) in acetonitrile (40 ml) was added di-tert-butyl dicarbonate (1.
02 g, 4.67 mmol) and 4-N, N-dimethylpyridine (47 mg, 0.39 mmol) were added, and the mixture was stirred at room temperature for 1 hour. Water (100 ml) was added to the reaction solution,
Extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 4: 1-1:
Purified in 1) and recrystallized from ethyl acetate-hexane,
The desired product (1.87 g, 85%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.51 (9H, s), 2.65 (1H, dd, J = 1
4.2, 8.8 Hz), 2.93 (1H, dd, J = 14.2, 4.4 Hz), 4.76
-4.88 (1H, m), 5.69 (1H, d, J = 7.0 Hz), 5.91 (1H,
tt, J = 53.0, 3.0 Hz), 6.58 (1H, s), 6.66 (1H, d,
J = 7.6 Hz), 6.84-7.04 (3H, m), 7.08-7.20 (3H,
m), 7.26-7.36 (2H, m), 8.36-8.44 (2H, m) .IRν max KBr cm -1 : 1819, 1721, 1613, 1578, 1508, 147
6, 1424.mp 146-147 ° C Anal.Calcd for C 28 H 26 N 2 O 6 F 4 : C, 59.79; H, 4.66;
N, 4.98 Found: C, 59.83; H, 4.65; N, 4.84. 9) (1RS, 2SR) -2-hydroxy-2- [4-
(Pyridin-3-yloxy) phenyl] -1- [3-
Tert-Butyl (1,1,2,2-tetrafluoroethoxy) benzyl] ethylcarbamate (4RS, 5SR) -2-oxo-5- [4- (pyridine-3
-Yloxy) phenyl] -4- [3- (1,1,2,2-
Tert-butyl tetrafluoroethoxy) benzyl] -1,3-oxazolidine-3-carboxylate (1.70 g,
3.02 mmol) in methanol (10 ml).
Normal methanol solution of sodium hydroxide (7.26 m
1, 3.63 mmol) and stirred at room temperature for 1 hour.
Water (100 ml) was added to the reaction solution, and ethyl acetate (100 ml) was added.
ml × 2). Wash the extract with saturated saline,
After drying (anhydrous magnesium sulfate), the solvent was distilled off under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the desired product (1.
39 g, 86%). 1 H-NMR (CDCl 3 ) δ: 1.35 (9H, s), 2.60-2.84 (2H, m),
3.45 (1H, s), 4.02-4.16 (1H, m), 4.63 (1H, d, J =
8.4 Hz), 4.93 (1H, s), 5.90 (1H, tt, J = 52.8, 3.0
Hz), 6.96-7.10 (5H, m), 7.24-7.34 (3H, m), 7.41
(2H, d, J = 8.4 Hz), 8.34-8.44 (2H, m) .IRν max KBr cm -1 : 1698, 1576, 1505, 1478.mp 123-124 ℃ Anal. Calcd for C 27 H 28 F 4 N 2 O 5 : C, 60.44; H, 5.26;
N, 5.22 Found: C, 60.24; H, 5.45; N, 5.15.
【0393】実施例261 N-{(1RS,2SR)-2-ヒドロキシ-2-[4-(ピ
リジン-3-イルオキシ)フェニル]-1-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]エチ
ル}-6,7-ジヒドロ-5H-ベンゾ[a][7]アンヌ
レン-1-カルボキサミド (1RS,2SR)-2-ヒドロキシ-2-[4-(ピリジ
ン-3-イルオキシ)フェニル]-1-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]エチルカ
ルバミン酸tert-ブチル(500mg,0.93ミ
リモル)にトリフルオロ酢酸(10ml)を加え、0℃
で10分攪拌した。反応液を飽和重曹水で中和し、酢酸
エチル(30ml×2)で抽出した。抽出液を飽和食塩
水で洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去
した。残留物のアセトニトリル(20ml)溶液に6,
7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カ
ルボン酸(175mg,0.93ミリモル)および1-
エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩(268mg,1.40ミリモル)および
1-ヒドロキシベンゾトリアゾール水和物(143m
g,0.93ミリモル)を加えて室温で終夜攪拌した。
反応液を水(150ml)で希釈し、酢酸エチル(10
0ml×2)で抽出した。抽出液を水、飽和食塩水で順
次洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=1:1-酢酸エチル)で精製し、
酢酸エチル-ヘキサンから再結晶させて、目的物(31
7mg,56%)を得た。1 H-NMR(CDCl3)δ:1.90-2.08 (2H, m), 2.10-2.28 (2H,
m), 2.60-2.70 (2H, m),2.81 (1H, dd, J = 14.8, 10.2
Hz), 3.02 (1H, dd, J = 14.8, 4.0 Hz), 3.97(1H,
s), 4.60-4.80 (1H, m), 5.00-5.08 (1H, m), 5.60-6.1
8 (2H, m), 6.21(1H, d, J = 11.8 Hz), 6.90-7.20 (8
H, m), 7.20-7.40 (3H, m), 7.40-7.52 (2H, m), 8.35
(2H, s). IRν maxKBrcm-1:1642, 1613, 1576, 1505, 1478, 142
6. mp 133-134℃ Anal. Calcd for C34H30F4N2O4: C, 67.12; H, 5.00;
N, 4.60 Found : C, 66.98; H, 4.85; N, 4.61.Example 261 N-{(1RS, 2SR) -2-hydroxy-2- [4- (pyridin-3-yloxy) phenyl] -1- [3- (1,
1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro-5H-benzo [a] [7] annulene-1-carboxamide (1RS, 2SR) -2-hydroxy-2- [4- (Pyridin-3-yloxy) phenyl] -1- [3- (1,1,
Trifluoroacetic acid (10 ml) was added to tert-butyl 2,2-tetrafluoroethoxy) benzyl] ethylcarbamate (500 mg, 0.93 mmol), and the mixture was added at 0 ° C.
For 10 minutes. The reaction solution was neutralized with saturated aqueous sodium hydrogen carbonate and extracted with ethyl acetate (30 ml × 2). The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The solution of the residue in acetonitrile (20 ml)
7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (175 mg, 0.93 mmol) and 1-
Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (268 mg, 1.40 mmol) and 1-hydroxybenzotriazole hydrate (143 m
g, 0.93 mmol) and stirred at room temperature overnight.
The reaction solution was diluted with water (150 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1-ethyl acetate),
Recrystallization from ethyl acetate-hexane gave the desired product (31
7 mg, 56%). 1 H-NMR (CDCl 3 ) δ: 1.90-2.08 (2H, m), 2.10-2.28 (2H,
m), 2.60-2.70 (2H, m), 2.81 (1H, dd, J = 14.8, 10.2
Hz), 3.02 (1H, dd, J = 14.8, 4.0 Hz), 3.97 (1H,
s), 4.60-4.80 (1H, m), 5.00-5.08 (1H, m), 5.60-6.1
8 (2H, m), 6.21 (1H, d, J = 11.8 Hz), 6.90-7.20 (8
H, m), 7.20-7.40 (3H, m), 7.40-7.52 (2H, m), 8.35
. (2H, s) IRν max KBr cm -1: 1642, 1613, 1576, 1505, 1478, 142
. 6. mp 133-134 ℃ Anal Calcd for C 34 H 30 F 4 N 2 O 4: C, 67.12; H, 5.00;
N, 4.60 Found: C, 66.98; H, 4.85; N, 4.61.
【0394】実施例262 4-フルオロ-N-{(1RS,2SR)-2-ヒドロキシ-
2-[4-(ピリジン-3-イルオキシ)フェニル]-1-
[3-(1,1,2,2-テトラフルオロエトキシ)ベン
ジル]エチル}-1-ナフトアミド (1RS,2SR)-2-ヒドロキシ-2-[4-(ピリジ
ン-3-イルオキシ)フェニル]-1-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]エチルカ
ルバミン酸tert-ブチル(500mg,0.93ミ
リモル)にトリフルオロ酢酸(10ml)を加え、0℃
で10分攪拌した。反応液を飽和重曹水で中和し、酢酸
エチル(30ml×2)で抽出した。抽出液を飽和食塩
水で洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去
した。残留物のアセトニトリル(20ml)溶液に4-
フルオロナフタレンカルボン酸(177mg,0.93
ミリモル)および1-エチル-3-(3-ジメチルアミノプ
ロピル)カルボジイミド・塩酸塩(268mg,1.4
0ミリモル)および1-ヒドロキシベンゾトリアゾール
水和物(143mg,0.93ミリモル)を加えて室温
で終夜攪拌した。反応液を水(150ml)で希釈し、
酢酸エチル(100ml×2)で抽出した。抽出液を
水、飽和食塩水で順次洗浄し、乾燥(無水硫酸マグネシ
ウム)後減圧留去した。残留物をシリカゲルカラムクロ
マトグラフィー(ヘキサン:酢酸エチル=4:1-1:
1)で精製し、酢酸エチル-ヘキサンから再結晶させ
て、目的物(347mg,61%)を得た。1 H-NMR(CDCl3)δ:2.89 (1H, dd, J = 14.6, 10.6 Hz),
3.12 (1H, dd, J = 14.6, 4.0 Hz), 3.59 (1H, s), 4.7
0-4.90 (1H, m), 5.14 (1H, s), 5.91 (1H, tt,J = 53.
0, 3.0 Hz), 6.00 (1H, d, J = 8.4 Hz), 6.90-7.65 (1
4H, m), 7.88 (1H, d, J = 8.0 Hz), 8.11 (1H, d, J =
8.0 Hz), 8.41 (2H, brs). IRν maxKBrcm-1:1642, 1626, 1582, 1505, 1480, 142
6. mp 183-184℃ Anal. Calcd for C33H25F5N2O4: C, 65.13; H, 4.14;
N, 4.60 Found : C, 65.03; H, 4.01; N, 4.35.Example 262 4-Fluoro-N-{(1RS, 2SR) -2-hydroxy-
2- [4- (pyridin-3-yloxy) phenyl] -1-
[3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -1-naphthamide (1RS, 2SR) -2-hydroxy-2- [4- (pyridin-3-yloxy) phenyl] -1 -[3- (1,1,
Trifluoroacetic acid (10 ml) was added to tert-butyl 2,2-tetrafluoroethoxy) benzyl] ethylcarbamate (500 mg, 0.93 mmol), and the mixture was added at 0 ° C.
For 10 minutes. The reaction solution was neutralized with saturated aqueous sodium hydrogen carbonate and extracted with ethyl acetate (30 ml × 2). The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. 4-to the solution of the residue in acetonitrile (20 ml)
Fluoronaphthalenecarboxylic acid (177 mg, 0.93
Mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (268 mg, 1.4).
0 mmol) and 1-hydroxybenzotriazole hydrate (143 mg, 0.93 mmol) were added, and the mixture was stirred at room temperature overnight. Dilute the reaction with water (150 ml)
Extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 4: 1-1:
Purification in 1) and recrystallization from ethyl acetate-hexane gave the desired product (347 mg, 61%). 1 H-NMR (CDCl 3 ) δ: 2.89 (1H, dd, J = 14.6, 10.6 Hz),
3.12 (1H, dd, J = 14.6, 4.0 Hz), 3.59 (1H, s), 4.7
0-4.90 (1H, m), 5.14 (1H, s), 5.91 (1H, tt, J = 53.
0, 3.0 Hz), 6.00 (1H, d, J = 8.4 Hz), 6.90-7.65 (1
4H, m), 7.88 (1H, d, J = 8.0 Hz), 8.11 (1H, d, J =
8.0Hz), 8.41 (2H, brs) .IRν max KBr cm -1 : 1642, 1626, 1582, 1505, 1480, 142
6. mp 183-184 ℃ Anal. Calcd for C 33 H 25 F 5 N 2 O 4 : C, 65.13; H, 4.14;
N, 4.60 Found: C, 65.03; H, 4.01; N, 4.35.
【0395】実施例263 4-フルオロ-N-{(1RS,2SR)-2-(3-フルオ
ロフェニル)-2-ヒドロキシ-1-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]エチル}-1-
ナフトアミド (1RS,2SR)-2-アミノ-1-(3-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール(300mg,
0.83ミリモル)のアセトニトリル(20ml)溶液
に4-フルオロナフタレンカルボン酸(156mg,
0.83ミリモル)および1-エチル-3-(3-ジメチル
アミノプロピル)カルボジイミド・塩酸塩(239m
g,1.25ミリモル)および1-ヒドロキシベンゾト
リアゾール水和物(127mg,0.83ミリモル)を
加えて室温で終夜攪拌した。反応液を水(100ml)
で希釈し、酢酸エチル(100ml×2)で抽出した。
抽出液を水、飽和食塩水で順次洗浄し、乾燥(無水硫酸
マグネシウム)後減圧留去した。残留物をシリカゲルカ
ラムクロマトグラフィー(ヘキサン:酢酸エチル=4:
1-2:1)で精製し、酢酸エチル-ヘキサンから再結晶
させて、目的物(283mg,64%)を得た。1 H-NMR(CDCl3)δ:2.85 (1H, dd, J = 14.6, 10.6 Hz),
3.03 (1H, dd, J = 14.6, 4.4 Hz), 3.60 (1H, d, J =
3.8 Hz), 4.68-4.86 (1H, m), 5.10-5.20 (1H, m), 5.8
8 (1H, tt, J = 53.0, 3.0 Hz), 5.99 (1H, d, J = 8.4
Hz), 6.92-7.60(12H, m), 7.84 (1H, d, J = 8.0 Hz),
8.08 (1H, d, J = 7.8 Hz). IRν maxKBrcm-1:1642, 1626, 1601, 1590, 1539. mp 175-176℃ Anal. Calcd for C28H21F6NO3・0.1H2O: C, 62.83; H,
3.99; N, 2.62 Found : C, 62.62; H, 3.79; N, 2.52.Example 263 4-Fluoro-N-{(1RS, 2SR) -2- (3-fluorophenyl) -2-hydroxy-1- [3- (1,1,2,2
2-tetrafluoroethoxy) benzyl] ethyl} -1-
Naphthamide (1RS, 2SR) -2-amino-1- (3-fluorophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol (300 mg,
0.83 mmol) in acetonitrile (20 ml) was added to 4-fluoronaphthalenecarboxylic acid (156 mg,
0.83 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (239 m
g, 1.25 mmol) and 1-hydroxybenzotriazole hydrate (127 mg, 0.83 mmol) were added and stirred at room temperature overnight. The reaction solution was water (100 ml)
And extracted with ethyl acetate (100 ml × 2).
The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 4:
1-2: 1) and recrystallized from ethyl acetate-hexane to give the desired product (283 mg, 64%). 1 H-NMR (CDCl 3 ) δ: 2.85 (1H, dd, J = 14.6, 10.6 Hz),
3.03 (1H, dd, J = 14.6, 4.4 Hz), 3.60 (1H, d, J =
3.8 Hz), 4.68-4.86 (1H, m), 5.10-5.20 (1H, m), 5.8
8 (1H, tt, J = 53.0, 3.0 Hz), 5.99 (1H, d, J = 8.4
Hz), 6.92-7.60 (12H, m), 7.84 (1H, d, J = 8.0 Hz),
8.08 (1H, d, J = 7.8 Hz) IRν max KBr cm -1:.. 1642, 1626, 1601, 1590, 1539. mp 175-176 ℃ Anal Calcd for C 28 H 21 F 6 NO 3 · 0.1H 2 O: C, 62.83; H,
3.99; N, 2.62 Found: C, 62.62; H, 3.79; N, 2.52.
【0396】実施例264 4-フルオロ-N-{(1RS,2SR)-2-(3-クロロ
フェニル)-2-ヒドロキシ-1-[3-(1,1,2,2-
テトラフルオロエトキシ)ベンジル]エチル}-1-ナフ
トアミド (1RS,2SR)-2-アミノ-1-(3-クロロフェニ
ル)-3-[3-(1,1,2,2-テトラフルオロエトキ
シ)フェニル]プロパン-1-オール(300mg,0.
79ミリモル)のアセトニトリル(20ml)溶液に4
-フルオロナフタレンカルボン酸(151mg,0.7
9ミリモル)および1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド・塩酸塩(228mg,1.
19ミリモル)および1-ヒドロキシベンゾトリアゾー
ル水和物(122mg,0.79ミリモル)を加えて室
温で終夜攪拌した。反応液を水(100ml)で希釈
し、酢酸エチル(100ml×2)で抽出した。抽出液
を水、飽和食塩水で順次洗浄し、乾燥(無水硫酸マグネ
シウム)後減圧留去した。残留物をシリカゲルカラムク
ロマトグラフィー(ヘキサン:酢酸エチル=4:1-酢
酸エチル)で精製し、酢酸エチル-ヘキサンから再結晶
させて、目的物(163mg,37%)を得た。1 H-NMR(CDCl3)δ:2.84 (1H, dd, J = 14.4, 10.8 Hz),
3.01 (1H, dd, J = 14.4, 4.2 Hz), 3.73 (1H, d, J =
3.9 Hz), 4.68-4.80 (1H, m), 5.06-5.12 (1H, m), 5.8
8 (1H, tt, J = 52.8, 3.0 Hz), 6.02 (1H, d, J = 8.7
Hz), 6.92-7.00(1H, m), 7.06 (1H, s), 7.08-7.18 (3
H, m), 7.24-7.40 (4H, m), 7.40-7.58 (3H, m), 7.80
(1H, d, J = 8.4 Hz), 8.07 (1H, d, J = 8.1 Hz). IRν maxKBrcm-1:1642, 1626, 1601, 1537. mp 177-178℃ Anal. Calcd for C28H21ClF5NO3: C, 61.15; H, 3.85;
N, 2.55 Found : C, 61.09; H, 3.70; N, 2.49.Example 264 4-Fluoro-N-{(1RS, 2SR) -2- (3-chlorophenyl) -2-hydroxy-1- [3- (1,1,2,2-
Tetrafluoroethoxy) benzyl] ethyl} -1-naphthamide (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] Propan-1-ol (300 mg, 0.1 mg).
79 mmol) in acetonitrile (20 ml) solution.
-Fluoronaphthalenecarboxylic acid (151 mg, 0.7
9 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (228 mg, 1.
19 mmol) and 1-hydroxybenzotriazole hydrate (122 mg, 0.79 mmol) were added and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-ethyl acetate) and recrystallized from ethyl acetate-hexane to obtain the desired product (163 mg, 37%). 1 H-NMR (CDCl 3 ) δ: 2.84 (1H, dd, J = 14.4, 10.8 Hz),
3.01 (1H, dd, J = 14.4, 4.2 Hz), 3.73 (1H, d, J =
(3.9 Hz), 4.68-4.80 (1H, m), 5.06-5.12 (1H, m), 5.8
8 (1H, tt, J = 52.8, 3.0 Hz), 6.02 (1H, d, J = 8.7
Hz), 6.92-7.00 (1H, m), 7.06 (1H, s), 7.08-7.18 (3
H, m), 7.24-7.40 (4H, m), 7.40-7.58 (3H, m), 7.80
. (1H, d, J = 8.4 Hz), 8.07 (1H, d, J = 8.1 Hz) IRν max KBr cm -1:. 1642, 1626, 1601, 1537. mp 177-178 ℃ Anal Calcd for C 28 H 21 ClF 5 NO 3 : C, 61.15; H, 3.85;
N, 2.55 Found: C, 61.09; H, 3.70; N, 2.49.
【0397】実施例265 4-フルオロ-N-{(1RS,2SR)-2-(2-フルオ
ロピリジン-4-イル)-2-ヒドロキシ-1-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]エチ
ル}-1-ナフトアミド (1RS,2SR)-2-アミノ-1-(2-フルオロピリ
ジン-4-イル)-3-[3-(1,1,2,2-テトラフル
オロエトキシ)フェニル]プロパン-1-オール(194
mg,0.54ミリモル)のアセトニトリル(20m
l)溶液に4-フルオロナフタレンカルボン酸(101
mg,0.54ミリモル)および1-エチル-3-(3-ジ
メチルアミノプロピル)カルボジイミド・塩酸塩(15
4mg,0.80ミリモル)および1-ヒドロキシベン
ゾトリアゾール水和物(82mg,0.54ミリモル)
を加えて室温で終夜攪拌した。反応液を水(100m
l)で希釈し、酢酸エチル(100ml×2)で抽出し
た。抽出液を水、飽和食塩水で順次洗浄し、乾燥(無水
硫酸マグネシウム)後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
2:1-酢酸エチル)で精製し、酢酸エチル-ヘキサンか
ら再結晶させて、目的物(189mg,66%)を得
た。1 H-NMR(CDCl3)δ:2.80-3.02 (2H, m), 4.39 (1H, s),
4.62-4.80 (1H, m), 5.18(1H, s), 5.60-6.20 (1H, m),
6.27 (1H, d, J = 7.4 Hz), 6.90-7.20 (6H, m), 7.20
-7.40 (2H, m), 7.42-7.62 (2H, m), 7.88 (1H, d, J =
8.0 Hz), 8.02-8.20 (2H, d, J = 6.2 Hz). IRν maxKBrcm-1:1642, 1615, 1601, 1585. mp 170-171℃ Anal. Calcd for C27H20F6N2O3・0.2H2O: C, 60.27; H,
3.82; N, 5.21 Found : C, 60.04; H, 3.63; N, 5.20.Example 265 4-Fluoro-N-{(1RS, 2SR) -2- (2-fluoropyridin-4-yl) -2-hydroxy-1- [3- (1,
1,2,2-tetrafluoroethoxy) benzyl] ethyl} -1-naphthamide (1RS, 2SR) -2-amino-1- (2-fluoropyridin-4-yl) -3- [3- (1,1 , 2,2-Tetrafluoroethoxy) phenyl] propan-1-ol (194
mg, 0.54 mmol) of acetonitrile (20 m
l) Add 4-fluoronaphthalenecarboxylic acid (101
mg, 0.54 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (15 mg).
4 mg, 0.80 mmol) and 1-hydroxybenzotriazole hydrate (82 mg, 0.54 mmol)
Was added and stirred at room temperature overnight. The reaction solution was washed with water (100 m
1) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
2: 1-ethyl acetate) and recrystallized from ethyl acetate-hexane to give the desired product (189 mg, 66%). 1 H-NMR (CDCl 3 ) δ: 2.80-3.02 (2H, m), 4.39 (1H, s),
4.62-4.80 (1H, m), 5.18 (1H, s), 5.60-6.20 (1H, m),
6.27 (1H, d, J = 7.4 Hz), 6.90-7.20 (6H, m), 7.20
-7.40 (2H, m), 7.42-7.62 (2H, m), 7.88 (1H, d, J =
. 8.0 Hz), 8.02-8.20 (2H , d, J = 6.2 Hz) IRν max KBr cm -1:. 1642, 1615, 1601, 1585. mp 170-171 ℃ Anal Calcd for C 27 H 20 F 6 N 2 O 3・ 0.2H 2 O: C, 60.27; H,
3.82; N, 5.21 Found: C, 60.04; H, 3.63; N, 5.20.
【0398】実施例266 4-フルオロ-N-{(1RS,2RS)-2-(6-フルオ
ロピリジン-2-イル)-2-ヒドロキシ-1-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]エチ
ル}-1-ナフトアミド (1RS,2RS)-2-アミノ-1-(6-フルオロピリ
ジン-2-イル)-3-[3-(1,1,2,2-テトラフル
オロエトキシ)フェニル]プロパン-1-オール塩酸塩
(300mg,0.75ミリモル)のアセトニトリル
(20ml)溶液に4-フルオロナフタレンカルボン酸
(141mg,0.75ミリモル)、1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩(216mg,1.13ミリモル)、1-ヒドロキシ
ベンゾトリアゾール水和物(115mg,0.75ミリ
モル)およびトリエチルアミン(1.03ml,0.7
5ミリモル)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を水、飽和食塩水で順次洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=2:1-酢酸エチル)で精製し、酢酸
エチル-ヘキサンから再結晶させて、目的物(306m
g,76%)を得た。1 H-NMR(CDCl3)δ:2.82 (1H, dd, J = 14.4, 5.0 Hz),
3.02 (1H, dd, J = 14.4,9.8 Hz), 4.67 (1H, d, J =
5.4 Hz), 4.80-4.96 (1H, m), 5.10-5.20 (1H, m), 5.8
8 (1H, tt, J = 53.0, 3.0 Hz), 6.42 (1H, d, J = 8.8
Hz), 6.89 (1H, dd, J = 8.2, 2.6 Hz), 7.00-7.20 (4
H, m), 7.20-7.40 (2H, m), 7.40-7.62 (3H, m), 7.78-
7.94 (1H, m), 7.97 (1H, d, J = 8.4 Hz), 8.10 (1H,
d, J = 7.2Hz). IRν maxKBrcm-1:1642, 1626, 1603, 1578, 1535, 145
4. mp 185-186℃ Anal. Calcd for C27H20F6N2O3: C, 60.68; H, 3.77;
N, 5.24 Found : C, 60.40; H, 3.61; N, 5.14.Example 266 4-Fluoro-N-{(1RS, 2RS) -2- (6-fluoropyridin-2-yl) -2-hydroxy-1- [3- (1,1
1,2,2-tetrafluoroethoxy) benzyl] ethyl} -1-naphthamide (1RS, 2RS) -2-amino-1- (6-fluoropyridin-2-yl) -3- [3- (1,1 , 2,2-Tetrafluoroethoxy) phenyl] propan-1-ol hydrochloride (300 mg, 0.75 mmol) in acetonitrile (20 ml) solution was treated with 4-fluoronaphthalenecarboxylic acid (141 mg, 0.75 mmol), 1- Ethyl-3-
(3-Dimethylaminopropyl) carbodiimide hydrochloride (216 mg, 1.13 mmol), 1-hydroxybenzotriazole hydrate (115 mg, 0.75 mmol) and triethylamine (1.03 ml, 0.7
(5 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1-ethyl acetate) and recrystallized from ethyl acetate-hexane to give the desired product (306 m
g, 76%). 1 H-NMR (CDCl 3 ) δ: 2.82 (1H, dd, J = 14.4, 5.0 Hz),
3.02 (1H, dd, J = 14.4,9.8 Hz), 4.67 (1H, d, J =
5.4 Hz), 4.80-4.96 (1H, m), 5.10-5.20 (1H, m), 5.8
8 (1H, tt, J = 53.0, 3.0 Hz), 6.42 (1H, d, J = 8.8
Hz), 6.89 (1H, dd, J = 8.2, 2.6 Hz), 7.00-7.20 (4
H, m), 7.20-7.40 (2H, m), 7.40-7.62 (3H, m), 7.78-
7.94 (1H, m), 7.97 (1H, d, J = 8.4 Hz), 8.10 (1H,
d, J = 7.2Hz) .IRν max KBr cm -1 : 1642, 1626, 1603, 1578, 1535, 145
. 4. mp 185-186 ℃ Anal Calcd for C 27 H 20 F 6 N 2 O 3: C, 60.68; H, 3.77;
N, 5.24 Found: C, 60.40; H, 3.61; N, 5.14.
【0399】実施例267 4-フルオロ-N-{(1RS,2SR)-2-ヒドロキシ-
2-(4-フェノキシフェニル)-1-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]エチル}-
1-ナフトアミド (1RS,2SR)-2-アミノ-1-(4-フェノキシフ
ェニル)-3-[3-(1,1,2,2-テトラフルオロエ
トキシ)フェニル]プロパン-1-オール(300mg,
0.69ミリモル)のアセトニトリル(20ml)溶液
に4-フルオロナフタレンカルボン酸(131mg,
0.69ミリモル)および1-エチル-3-(3-ジメチル
アミノプロピル)カルボジイミド・塩酸塩(198m
g,1.03ミリモル)および1-ヒドロキシベンゾト
リアゾール水和物(105mg,0.69ミリモル)を
加えて室温で終夜攪拌した。反応液を水(100ml)
で希釈し、酢酸エチル(100ml×2)で抽出した。
抽出液を水、飽和食塩水で順次洗浄し、乾燥(無水硫酸
マグネシウム)後減圧留去した。残留物をシリカゲルカ
ラムクロマトグラフィー(ヘキサン:酢酸エチル=2:
1-酢酸エチル)で精製し、酢酸エチル-ヘキサンから再
結晶させて、目的物(286mg,68%)を得た。1 H-NMR(CDCl3)δ:2.85 (1H, dd, J = 14.4, 10.8 Hz),
3.10 (1H, dd, J = 14.4, 4.2 Hz), 3.41 (1H, d, J =
3.0 Hz), 4.72-4.86 (1H, m), 5.04-5.10 (1H, m), 5.8
8 (1H, tt, J = 52.8, 3.0 Hz), 5.95 (1H, d, J = 8.7
Hz), 6.94-7.04(5H, m), 7.06-7.20 (5H, m), 7.28-7.
40 (3H, m), 7.40-7.60 (4H, m), 7.81 (1H, d, J = 8.
4 Hz), 8.08 (1H, d, J = 8.1 Hz). IRν maxKBrcm-1:1644, 1626, 1599, 1590, 1537, 150
8, 1489. mp 155-156℃ Anal. Calcd for C34H26F5NO4: C, 67.21; H, 4.31; N,
2.31 Found : C, 67.02; H, 4.27; N, 2.21.Example 267 4-Fluoro-N-{(1RS, 2SR) -2-hydroxy-
2- (4-phenoxyphenyl) -1- [3- (1,1,
2,2-tetrafluoroethoxy) benzyl] ethyl}-
1-Naphthamide (1RS, 2SR) -2-amino-1- (4-phenoxyphenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol (300 mg,
0.69 mmol) in acetonitrile (20 ml) was added to 4-fluoronaphthalenecarboxylic acid (131 mg,
0.69 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (198 m
g, 1.03 mmol) and 1-hydroxybenzotriazole hydrate (105 mg, 0.69 mmol) were added and stirred at room temperature overnight. The reaction solution was water (100 ml)
And extracted with ethyl acetate (100 ml × 2).
The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 2:
The residue was purified with 1-ethyl acetate) and recrystallized from ethyl acetate-hexane to give the desired product (286 mg, 68%). 1 H-NMR (CDCl 3 ) δ: 2.85 (1H, dd, J = 14.4, 10.8 Hz),
3.10 (1H, dd, J = 14.4, 4.2 Hz), 3.41 (1H, d, J =
3.0 Hz), 4.72-4.86 (1H, m), 5.04-5.10 (1H, m), 5.8
8 (1H, tt, J = 52.8, 3.0 Hz), 5.95 (1H, d, J = 8.7
Hz), 6.94-7.04 (5H, m), 7.06-7.20 (5H, m), 7.28-7.
40 (3H, m), 7.40-7.60 (4H, m), 7.81 (1H, d, J = 8.
4 Hz), 8.08 (1H, d, J = 8.1 Hz) .IRν max KBr cm -1 : 1644, 1626, 1599, 1590, 1537, 150
8, 1489.mp 155-156 ℃ Anal.Calcd for C 34 H 26 F 5 NO 4 : C, 67.21; H, 4.31; N,
2.31 Found: C, 67.02; H, 4.27; N, 2.21.
【0400】実施例268 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-{3-[(トリフルオロメチル)チ
オ]ベンジル}エチル)-6,7-ジヒドロ-5H-ベンゾ
[a][7]アンヌレン-1-カルボキサミド 1) 3-(4-フルオロフェニル)-3-オキソ-2-{3
-[(トリフルオロメチル)チオ]ベンジル}プロパン
酸エチル 3-[(トリフルオロメチル)チオ]ベンジルアルコー
ル(4.82g,23.1ミリモル)の酢酸エチル(6
0ml)溶液に塩化メタンスルホニル(2.92g,2
5.5ミリモル)およびトリエチルアミン(3.87m
l,27.8ミリモル)を加え、室温で2時間攪拌し
た。不溶物をろ過し、ろ液を減圧留去しメシル体を調製
した。3-(4-フルオロフェニル)-3-オキソプロパン
酸エチル(4.87g,23.2ミリモル)の1,2-
ジメトキシエタン(50ml)溶液に水素化ナトリウム
(0.93g,60%油性,23.2ミリモル)を加
え、室温で1時間攪拌した。反応液に先に調製したメシ
ル体の1,2-ジメトキシエタン(10ml)溶液を滴
下し、反応液を室温にて終夜攪拌した。反応液を1規定
塩酸で酸性とした後、飽和重曹水で中和し、酢酸エチル
(300ml×2)で抽出した。抽出液を水、飽和食塩
水で順次洗浄し、乾燥(無水硫酸マグネシウム)後減圧
留去した。残留物をシリカゲルカラムクロマトグラフィ
ー(ヘキサン:酢酸エチル=4:1)で精製し酢酸エチ
ル-ヘキサンから再結晶させて目的物(5.67g,6
1%)を得た。1 H-NMR(CDCl3)δ:1.12 (3H, t, J = 7.2 Hz), 3.26-7.4
2 (2H, m), 4.11 (2H, q, J = 7.2 Hz), 4.56 (1H, t,
J = 7.5 Hz), 7.06-7.16 (2H, m), 7.26-7.38 (2H, m),
7.44-7.54 (2H, m), 7.94-8.02 (2H, m). IRν maxKBrcm-1:1738, 1688, 1599, 1508. mp 72-73℃ Anal. Calcd for C19H16F3O3 S: C, 57.00; H, 4.03 Found : C, 56.99; H, 4.06. 2) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-{3-[(トリフルオロメチ
ル)チオ]ベンジル}プロパン酸エチル 塩化亜鉛(3.74g,27.4ミリモル)のジエチル
エーテル(100ml)溶液に水素化ホウ素ナトリウム
(2.08g,54.8ミリモル)を加えて室温で30
分攪拌した。不溶物をろ去し、ろ液に3-(4-フルオロ
フェニル)-3-オキソ-2-{3-[(トリフルオロメチ
ル)チオ]ベンジル}プロパン酸エチル(5.5g,1
3.7ミリモル)のジエチルエーテル(50ml)溶液
を0℃にて加えて30分攪拌した。反応液に1規定塩酸
を加えて反応を止め、飽和重曹水で中和後、更に水(2
00ml)を加え、酢酸エチル(200ml×2)で抽
出した。抽出液を水および飽和食塩水で洗浄し、乾燥
(無水硫酸マグネシウム)後減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=4:1)で精製し、目的物(5.40g,98
%)を得た。1 H-NMR(CDCl3)δ:0.91 (3H, t, J = 7.2 Hz), 2.88-3.1
0 (4H, m), 3.87 (2H, q, J = 7.2 Hz), 5.02 (1H, d,
J = 4.8 Hz), 6.98-7.12 (2H, m), 7.18-7.52 (6H, m). IRν maxKBrcm-1:1725, 1605, 1510. 3) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-{3-[(トリフルオロメチ
ル)チオ]ベンジル}プロパン酸 (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-{3-[(トリフルオロメチル)チオ]
ベンジル}プロパン酸エチル(5.30g,13.17
ミリモル)のメタノール(150ml)溶液に2規定水
酸化ナトリウム水溶液(13.2ml,26.4ミリモ
ル)を加え、室温で終夜攪拌した。反応液を濃縮後、1
規定塩酸を加え酸性とした後、酢酸エチル(200ml
×2)で抽出した。抽出液を水および飽和食塩水で洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物を酢酸エチル-ヘキサンから再結晶させて目的物
(3.98g,81%)を得た。1 H-NMR(CDCl3)δ:2.90-3.10 (3H, m), 5.07 (1H, s),
6.98-7.10 (2H, m), 7.12-7.42 (5H, m), 7.47 (1H, d,
J = 7.4 Hz). IRν maxKBrcm-1:1712, 1607. mp 121-122℃ Anal. Calcd for C17H14O3SF4: C, 54.54; H, 3.77 Found : C, 54.58; H, 3.80. 5) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-{3-[(トリフルオロメチル)チオ]ベンジ
ル}-1,3-オキサゾリジン-2-オン (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-{3-[(トリフルオロメチル)チオ]
ベンジル}プロパン酸(3.9g,10.42ミリモ
ル)のテトラヒドロフラン(150ml)溶液に、ジフ
ェニルホスホリルアジド(2.47ml,11.5ミリ
モル)とトリエチルアミン(2.18ml,15.6ミ
リモル)を加え、1時間加熱還流した。反応液を放冷
後、減圧留去した。残留物をシリカゲルカラムクロマト
グラフィー(ヘキサン:酢酸エチル=2:1-酢酸エチ
ル)で精製し、酢酸エチル-ヘキサンから再結晶させ
て、目的物(3.45g,89%)を得た。1 H-NMR(CDCl3)δ:2.31 (1H, d, J = 3.0 Hz), 2.35 (1
H, s), 4.20-4.34 (1H, m), 5.13 (1H, brs), 5.79 (1
H, d, J = 7.8 Hz), 7.04-7.20 (3H, m), 7.20-7.44 (4
H, m), 7.54 (1H, d, J = 7.6 Hz). IRν maxKBrcm-1:1755, 1609, 1595, 1514. mp 132-133℃ Anal. Calcd for C17H13NO2SF4: C, 54.98; H, 3.53;
N, 3.77 Found : C, 55.28; H, 3.47; N, 3.98. 6) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-{3-[(トリフルオロメチル)チ
オ]フェニル}プロパン-1-オール (4RS,5SR)-5-(4-フルオロフェニル)-4-
{3-[(トリフルオロメチル)チオ]ベンジル}-1,
3-オキサゾリジン-2-オン(1.30g,3.50ミ
リモル)のエタノール(3ml)溶液に8規定水酸化ナ
トリウム水溶液(1.31ml,10.5ミリモル)を
加え、80℃にて4時間攪拌した。反応液に水(20m
l)を加え、酢酸エチル(50ml×2)で抽出した。
抽出液を水および飽和食塩水で洗浄し、乾燥(無水硫酸
マグネシウム)後減圧留去して目的物(0.8g,77
%)を得た。1 H-NMR(CDCl3)δ:1.80-2.30 (2H, m), 2.42 (1H, dd, J
= 13.6, 10.2 Hz), 2.83 (1H, dd, J = 14.0, 2.6 H
z), 3.20-3.40 (1H, m), 4.69 (1H, d, J = 4.8 Hz),
7.00-7.20 (2H, m), 7.20-7.56 (6H, m). IRν maxKBrcm-1:1752, 1605, 1508, 1476. 7) N-((1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-{3-[(トリフルオロメチ
ル)チオ]ベンジル}エチル)-6,7-ジヒドロ-5H-
ベンゾ[a][7]アンヌレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-{3-[(トリフルオロメチル)チオ]フェ
ニル}プロパン-1-オール(450mg,1.51ミリ
モル)のアセトニトリル(20ml)溶液に6,7-ジ
ヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボン
酸(284mg,1.51ミリモル)および1-エチル-
3-(3-ジメチルアミノプロピル)カルボジイミド・塩
酸塩(435mg,2.27ミリモル)および1-ヒド
ロキシベンゾトリアゾール水和物(231mg,1.5
1ミリモル)を加えて室温で終夜攪拌した。反応液を水
(100ml)で希釈し、酢酸エチル(100ml×
2)で抽出した。抽出液を水、飽和食塩水で順次洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=2:1-酢酸エチル)で精製し、酢酸
エチル-ヘキサンから再結晶させて、目的物(396m
g,51%)を得た。1 H-NMR(CDCl3)δ:1.90-2.08 (2H, m), 2.12-2.24 (2H,
m), 2.60-2.72 (2H, m),2.81 (1H, dd, J = 14.7, 10.5
Hz), 3.00 (1H, dd, J = 14.7, 4.2 Hz), 3.52(1H, d,
J = 3.6 Hz), 4.62-4.74 (1H, m), 5.00-5.08 (1H,
m), 5.77 (1H, d,J = 8.7 Hz), 5.88-5.96 (1H, m), 6.
19 (1H, d, J = 12.0 Hz), 6.90-7.00 (1H, m), 7.00-
7.20 (4H, m), 7.30-7.60 (6H, m). IRν maxKBrcm-1:1638, 1512. mp 163-164℃ Anal. Calcd for C28H25F4NO2 S: C, 65.23; H, 4.89;
N, 2.72; S, 6.22 Found : C, 65.02; H, 5.02; N, 2.79; S, 6.22.Example 268 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- {3-[(trifluoromethyl) thio] benzyl} ethyl) -6,7-dihydro-5H-benzo [a] [7] annulene-1-carboxamide 1) 3- (4-) Fluorophenyl) -3-oxo-2- {3
-[(Trifluoromethyl) thio] benzyl} propanoate ethyl 3-[(trifluoromethyl) thio] benzyl alcohol (4.82 g, 23.1 mmol) in ethyl acetate (6
Methanesulfonyl chloride (2.92 g, 2 ml).
5.5 mmol) and triethylamine (3.87 m
1,27.8 mmol) and stirred at room temperature for 2 hours. The insolubles were filtered, and the filtrate was distilled off under reduced pressure to prepare a mesyl compound. Ethyl 3- (4-fluorophenyl) -3-oxopropanoate (4.87 g, 23.2 mmol) in 1,2-
Sodium hydride (0.93 g, 60% oily, 23.2 mmol) was added to a dimethoxyethane (50 ml) solution, and the mixture was stirred at room temperature for 1 hour. The 1,2-dimethoxyethane (10 ml) solution of the mesyl compound previously prepared was added dropwise to the reaction solution, and the reaction solution was stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid, neutralized with saturated aqueous sodium hydrogen carbonate, and extracted with ethyl acetate (300 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the desired product (5.67 g, 6
1%). 1 H-NMR (CDCl 3 ) δ: 1.12 (3H, t, J = 7.2 Hz), 3.26-7.4
2 (2H, m), 4.11 (2H, q, J = 7.2 Hz), 4.56 (1H, t,
J = 7.5 Hz), 7.06-7.16 (2H, m), 7.26-7.38 (2H, m),
7.44-7.54 (2H, m), 7.94-8.02 (2H, m) IRν max KBr cm -1:.. 1738, 1688, 1599, 1508. mp 72-73 ℃ Anal Calcd for C 19 H 16 F 3 O 3 S, C, 57.00; H, 4.03 Found: C, 56.99; H, 4.06.2) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- {3-[(trifluoromethyl ) Thio] benzyl @ ethyl propanoate To a solution of zinc chloride (3.74 g, 27.4 mmol) in diethyl ether (100 ml) was added sodium borohydride (2.08 g, 54.8 mmol), and the mixture was added at room temperature for 30 minutes.
Minutes. The insoluble material was removed by filtration, and the filtrate was subjected to ethyl 3- (4-fluorophenyl) -3-oxo-2- {3-[(trifluoromethyl) thio] benzyl} propanoate (5.5 g, 1
(3.7 mmol) in diethyl ether (50 ml) was added at 0 ° C., and the mixture was stirred for 30 minutes. The reaction solution was quenched with 1N hydrochloric acid, neutralized with saturated aqueous sodium hydrogen carbonate, and further added with water (2%).
00 ml) and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give the desired product (5.40 g, 98%).
%). 1 H-NMR (CDCl 3 ) δ: 0.91 (3H, t, J = 7.2 Hz), 2.88-3.1
0 (4H, m), 3.87 (2H, q, J = 7.2 Hz), 5.02 (1H, d,
J = 4.8 Hz), 6.98-7.12 (2H, m), 7.18-7.52 (6H, m). IRν max KBr cm -1 : 1725, 1605, 1510.3) (2RS, 3RS) -3- (4- (Fluorophenyl) -3-hydroxy-2- {3-[(trifluoromethyl) thio] benzyl} propanoic acid (2RS, 3RS) -3- (4-fluorophenyl) -3-
Hydroxy-2- {3-[(trifluoromethyl) thio]
Benzyl ethyl propanoate (5.30 g, 13.17)
A 2N aqueous solution of sodium hydroxide (13.2 ml, 26.4 mmol) was added to a methanol (150 ml) solution of the above (mole), and the mixture was stirred at room temperature overnight. After concentrating the reaction solution,
After adding normal hydrochloric acid to make it acidic, ethyl acetate (200 ml)
× 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to obtain the desired product (3.98 g, 81%). 1 H-NMR (CDCl 3 ) δ: 2.90-3.10 (3H, m), 5.07 (1H, s),
6.98-7.10 (2H, m), 7.12-7.42 (5H, m), 7.47 (1H, d,
.. J = 7.4 Hz) IRν max KBr cm -1: 1712, 1607. mp 121-122 ℃ Anal Calcd for C 17 H 14 O 3 SF 4: C, 54.54; H, 3.77 Found: C, 54.58; H, 3.80.5) (4RS, 5SR) -5- (4-Fluorophenyl) -4- {3-[(trifluoromethyl) thio] benzyl} -1,3-oxazolidin-2-one (2RS, 3RS)- 3- (4-fluorophenyl) -3-
Hydroxy-2- {3-[(trifluoromethyl) thio]
To a solution of benzyl dipropanoic acid (3.9 g, 10.42 mmol) in tetrahydrofuran (150 ml), diphenylphosphoryl azide (2.47 ml, 11.5 mmol) and triethylamine (2.18 ml, 15.6 mmol) were added. The mixture was refluxed for 1 hour. After allowing the reaction solution to cool, it was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1-ethyl acetate) and recrystallized from ethyl acetate-hexane to obtain the desired product (3.45 g, 89%). 1 H-NMR (CDCl 3 ) δ: 2.31 (1H, d, J = 3.0 Hz), 2.35 (1
H, s), 4.20-4.34 (1H, m), 5.13 (1H, brs), 5.79 (1
H, d, J = 7.8 Hz), 7.04-7.20 (3H, m), 7.20-7.44 (4
. H, m), 7.54 ( 1H, d, J = 7.6 Hz) IRν max KBr cm -1:. 1755, 1609, 1595, 1514. mp 132-133 ℃ Anal Calcd for C 17 H 13 NO 2 SF 4: C, 54.98; H, 3.53;
N, 3.77 Found: C, 55.28; H, 3.47; N, 3.98.6) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- {3-[(trifluoromethyl) thio ] Phenyl} propan-1-ol (4RS, 5SR) -5- (4-fluorophenyl) -4-
{3-[(trifluoromethyl) thio] benzyl} -1,
To a solution of 3-oxazolidin-2-one (1.30 g, 3.50 mmol) in ethanol (3 ml) was added an 8 N aqueous sodium hydroxide solution (1.31 ml, 10.5 mmol) and the mixture was stirred at 80 ° C. for 4 hours. did. Water (20m
l) was added, and the mixture was extracted with ethyl acetate (50 ml × 2).
The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and then distilled off under reduced pressure to obtain the desired product (0.8 g, 77 g).
%). 1 H-NMR (CDCl 3 ) δ: 1.80-2.30 (2H, m), 2.42 (1H, dd, J
= 13.6, 10.2 Hz), 2.83 (1H, dd, J = 14.0, 2.6 H
z), 3.20-3.40 (1H, m), 4.69 (1H, d, J = 4.8 Hz),
7.00-7.20 (2H, m), 7.20-7.56 (6H, m). IRν max KBr cm -1 : 1752, 1605, 1508, 1476. 7) N-((1RS, 2SR) -2- (4-fluoro Phenyl) -2-hydroxy-1- {3-[(trifluoromethyl) thio] benzyl} ethyl) -6,7-dihydro-5H-
Benzo [a] [7] annulene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- {3-[(trifluoromethyl) thio] phenyl} propane-1- To a solution of all (450 mg, 1.51 mmol) in acetonitrile (20 ml) was added 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (284 mg, 1.51 mmol) and 1-ethyl-
3- (3-dimethylaminopropyl) carbodiimide hydrochloride (435 mg, 2.27 mmol) and 1-hydroxybenzotriazole hydrate (231 mg, 1.5
(1 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1-ethyl acetate) and recrystallized from ethyl acetate-hexane to give the desired product (396 m
g, 51%). 1 H-NMR (CDCl 3 ) δ: 1.90-2.08 (2H, m), 2.12-2.24 (2H,
m), 2.60-2.72 (2H, m), 2.81 (1H, dd, J = 14.7, 10.5
Hz), 3.00 (1H, dd, J = 14.7, 4.2 Hz), 3.52 (1H, d,
J = 3.6 Hz), 4.62-4.74 (1H, m), 5.00-5.08 (1H,
m), 5.77 (1H, d, J = 8.7 Hz), 5.88-5.96 (1H, m), 6.
19 (1H, d, J = 12.0 Hz), 6.90-7.00 (1H, m), 7.00-
7.20 (4H, m), 7.30-7.60 (6H, m) .IRν max KBr cm -1 : 1638, 1512.mp 163-164 ℃ Anal. Calcd for C 28 H 25 F 4 NO 2 S: C, 65.23; H, 4.89;
N, 2.72; S, 6.22 Found: C, 65.02; H, 5.02; N, 2.79; S, 6.22.
【0401】実施例269 4-フルオロ-N-((1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-{3-[(トリフルオ
ロメチル)チオ]ベンジル}エチル)-1-ナフトアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-{3-[(トリフルオロメチル)チオ]フェ
ニル}プロパン-1-オール(450mg,1.51ミリ
モル)のアセトニトリル(20ml)溶液に4-フルオ
ロナフタレンカルボン酸(287mg,1.51ミリモ
ル)および1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド・塩酸塩(435mg,2.27ミ
リモル)および1-ヒドロキシベンゾトリアゾール水和
物(231mg,1.51ミリモル)を加えて室温で終
夜攪拌した。反応液を水(100ml)で希釈し、酢酸
エチル(100ml×2)で抽出した。抽出液を水、飽
和食塩水で順次洗浄し、乾燥(無水硫酸マグネシウム)
後減圧留去した。残留物をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=2:1-酢酸エチ
ル)で精製し、酢酸エチル-ヘキサンから再結晶させ
て、目的物(447mg,57%)を得た。1 H-NMR(CDCl3)δ:2.85 (1H, dd, J = 15.2, 10.8 Hz),
3.04 (1H, dd, J = 15.0, 3.9 Hz), 3.43 (1H, d, J =
3.6 Hz), 4.70-4.82 (1H, m), 5.04-5.10 (1H, m), 5.9
8 (1H, d, J = 9.3 Hz), 6.92-7.02 (1H, m), 7.02-7.1
2 (3H, m), 7.30-7.58 (8H, m), 7.77 (1H, d, J = 8.7
Hz), 8.08 (1H, d, J = 8.4 Hz). IRν maxKBrcm-1:1642, 1626, 1601, 1537, 1512. mp 192-193℃ Anal. Calcd for C27H20F5NO2 S: C, 62.66; H, 3.90;
N, 2.71; S, 6.20 Found : C, 62.56; H, 3.86; N, 2.66; S, 6.34.Example 269 4-Fluoro-N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- {3-[(trifluoromethyl) thio] benzyl} ethyl)- 1-Naphthamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- {3-[(trifluoromethyl) thio] phenyl} propan-1-ol (450 mg, 1.51 mmol) To acetonitrile (20 ml) solution of 4-fluoronaphthalenecarboxylic acid (287 mg, 1.51 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (435 mg, 2.27 mmol) and 1- Hydroxybenzotriazole hydrate (231 mg, 1.51 mmol) was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract is washed sequentially with water and saturated saline, and dried (anhydrous magnesium sulfate)
After that, it was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2: 1-ethyl acetate) and recrystallized from ethyl acetate-hexane to obtain the desired product (447 mg, 57%). 1 H-NMR (CDCl 3 ) δ: 2.85 (1H, dd, J = 15.2, 10.8 Hz),
3.04 (1H, dd, J = 15.0, 3.9 Hz), 3.43 (1H, d, J =
3.6 Hz), 4.70-4.82 (1H, m), 5.04-5.10 (1H, m), 5.9
8 (1H, d, J = 9.3 Hz), 6.92-7.02 (1H, m), 7.02-7.1
2 (3H, m), 7.30-7.58 (8H, m), 7.77 (1H, d, J = 8.7
. Hz), 8.08 (1H, d, J = 8.4 Hz) IRν max KBr cm -1:. 1642, 1626, 1601, 1537, 1512. mp 192-193 ℃ Anal Calcd for C 27 H 20 F 5 NO 2 S : C, 62.66; H, 3.90;
N, 2.71; S, 6.20 Found: C, 62.56; H, 3.86; N, 2.66; S, 6.34.
【0402】実施例270 N-{(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[(2,2,3,3-テトラフルオ
ロ-2,3-ジヒドロ-1,4-ベンゾジオキシン-6-イ
ル)メチル]エチル}-6,7-ジヒドロ-5H-ベンゾ
[a][7]アンヌレン-1-カルボキサミド 1) 2,2,3,3-テトラフルオロ-2,3-ジヒド
ロ-1,4-ベンゾジオキシン-6-カルボン酸 2,2,3,3-テトラフルオロ-2,3-ジヒドロ-1,
4-ベンゾジオキシン-6-カルボニトリル(5.0g,
21.44ミリモル)の酢酸(20ml)溶液に濃塩酸
(20ml)を加え、終夜加熱還流した。反応液を濃縮
後、析出した結晶をろ取し、水で洗浄し、目的物(4.
76g,88%)を得た。1 H-NMR(CDCl3)δ:7.26 (1H, d, J = 8.7 Hz), 7.90-8.0
0 (2H, m), 11.00-11.80(1H, br). IRν maxKBrcm-1:1726, 1701, 1624, 1597, 1508. mp 103-104℃ Anal. Calcd for C9H4O4F4: C, 42.88; H, 1.60 Found : C, 43.13; H, 1.60. 2) (2,2,3,3-テトラフルオロ-2,3-ジヒ
ドロ-1,4-ベンゾジオキシン-6-イル)メタノール 水素化リチウムアルミニウム(1.40g,36.89
ミリモル)のテトラヒドロフラン(30ml)溶液に
2,2,3,3-テトラフルオロ-2,3-ジヒドロ-1,
4-ベンゾジオキシン-6-カルボン酸(4.65g,1
8.44ミリモル)を0℃にて徐々に加えた。反応液を
0℃にて10分攪拌後、1規定水酸化ナトリウム水溶液
を加えた。不溶物をセライトでろ過後、ろ液を濃縮し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=4:1)で精製し、目的物(3.
54g,81%)を得た。1 H-NMR(CDCl3)δ:1.87 (1H, t, J = 6.0 Hz), 4.69 (2
H, d, J = 6.0 Hz), 7.08-7.20 (3H, m). IRν maxKBrcm-1:1611, 1510, 1441. 3) 3-(4-フルオロフェニル)-3-オキソ-2-
[(2,2,3,3-テトラフルオロ-2,3-ジヒドロ-
1,4-ベンゾジオキシン-6-イル)メチル]プロパン
酸エチル (2,2,3,3-テトラフルオロ-2,3-ジヒドロ-
1,4-ベンゾジオキシン-6-イル)メタノール(3.
48g,14.6ミリモル)の酢酸エチル(100m
l)溶液に塩化メタンスルホニル(1.25ml,1
6.1ミリモル)およびトリエチルアミン(3.05m
l,21.9ミリモル)を加え、室温で2時間攪拌し
た。不溶物をろ過し、ろ液を減圧留去しメシル体を調製
した。3-(4-フルオロフェニル)-3-オキソプロパン
酸エチル(3.07g,14.6ミリモル)の1,2-
ジメトキシエタン(20ml)溶液に水素化ナトリウム
(0.58g,60%油性,14.6ミリモル)を加
え、室温で1時間攪拌した。反応液に先に調製したメシ
ル体の1,2-ジメトキシエタン(10ml)溶液を滴
下し、反応液を室温にて終夜攪拌した。反応液を1規定
塩酸で酸性とした後、飽和重曹水で中和し、酢酸エチル
(300ml×2)で抽出した。抽出液を水、飽和食塩
水で順次洗浄し、乾燥(無水硫酸マグネシウム)後減圧
留去した。残留物をシリカゲルカラムクロマトグラフィ
ー(ヘキサン:酢酸エチル=4:1)で精製し酢酸エチ
ル-ヘキサンから再結晶させて目的物(4.49g,7
1%)を得た。1 H-NMR(CDCl3)δ:1.12 (3H, t, J = 7.2 Hz), 3.30 (2
H, d, J = 7.5 Hz), 4.11(2H, q, J = 7.2 Hz), 4.51
(1H, t, J = 7.5 Hz), 7.03 (3H, s), 7.08-7.20(2H,
m), 7.96-8.04 (2H, m). IRν maxKBrcm-1:1736, 1688, 1599, 1508. mp 83-84℃ Anal. Calcd for C20H15O5F5: C, 55.82; H, 3.51 Found : C, 55.87; H, 3.42. 4) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[(2,2,3,3-テトラフ
ルオロ-2,3-ジヒドロ-1,4-ベンゾジオキシン-6-
イル)メチル]プロパン酸エチル 塩化亜鉛(2.79g,20.5ミリモル)のジエチル
エーテル(100ml)溶液に水素化ホウ素ナトリウム
(1.55g,40.9ミリモル)を加えて室温で30
分攪拌した。不溶物をろ去し、ろ液に3-(4-フルオロ
フェニル)-3-オキソ-2-[(2,2,3,3-テトラ
フルオロ-2,3-ジヒドロ-1,4-ベンゾジオキシン-
6-イル)メチル]プロパン酸エチル(4.4g,1
0.2ミリモル)のジエチルエーテル(50ml)溶液
を0℃にて加えて30分攪拌した。反応液に1規定塩酸
を加えて反応を止め、飽和重曹水で中和後、更に水(2
00ml)を加え、酢酸エチル(200ml×2)で抽
出した。抽出液を水および飽和食塩水で洗浄し、乾燥
(無水硫酸マグネシウム)後減圧留去し目的物(4.4
0g,100%)を得た。1 H-NMR(CDCl3)δ:0.95 (3H, t, J = 7.2 Hz), 2.84-3.0
2 (4H, m), 3.80-4.00 (2H, m), 4.96-5.04 (1H, m),
6.84-6.90 (2H, m), 6.96-7.10 (3H, m), 7.30-7.40 (2
H, m). IRν maxKBrcm-1:1725, 1607, 1510. Anal. Calcd for C20H17O5F5: C, 55.56; H, 3.96 Found : C, 55.33; H, 3.97. 5) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[(2,2,3,3-テトラフ
ルオロ-2,3-ジヒドロ-1,4-ベンゾジオキシン-6-
イル)メチル]プロパン酸 (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[(2,2,3,3-テトラフルオロ-
2,3-ジヒドロ-1,4-ベンゾジオキシン-6-イル)
メチル]プロパン酸エチル(4.20g,9.71ミリ
モル)のメタノール(20ml)溶液に2規定水酸化ナ
トリウム水溶液(9.7ml,19.4ミリモル)を加
え、室温で終夜攪拌した。反応液を濃縮後、1規定塩酸
を加え酸性とした後、酢酸エチル(200ml×2)で
抽出した。抽出液を水および飽和食塩水で洗浄し、乾燥
(無水硫酸マグネシウム)後減圧留去した。残留物を酢
酸エチル-ヘキサンから再結晶させて目的物(3.50
g,89%)を得た。1 H-NMR(CDCl3)δ:2.84-3.10 (3H, m), 5.08 (1H, s),
6.80-6.92 (2H, m), 6.92-7.12 (3H, m), 7.26-7.42 (2
H, m). IRν maxKBrcm-1:1752, 1676. mp 90-91℃ Anal. Calcd for C18H13O5F5: C, 53.48; H, 3.24 Found : C, 53.48; H, 3.18. 6) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-[(2,2,3,3-テトラフルオロ-2,3-
ジヒドロ-1,4-ベンゾジオキシン-6-イル)メチル]
-1,3-オキサゾリジン-2-オン (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[(2,2,3,3-テトラフルオロ-
2,3-ジヒドロ-1,4-ベンゾジオキシン-6-イル)
メチル]プロパン酸(3.3g,8.16ミリモル)の
テトラヒドロフラン(120ml)溶液に、ジフェニル
ホスホリルアジド(1.94ml,8.98ミリモル)
とトリエチルアミン(1.71ml,12.2ミリモ
ル)を加え、1時間加熱還流した。反応液を放冷後、減
圧留去した。残留物をシリカゲルカラムクロマトグラフ
ィー(酢酸エチル)で精製し、酢酸エチル-ヘキサンか
ら再結晶させて、目的物(2.74g,84%)を得
た。1 H-NMR(CDCl3)δ:2.20-2.40 (2H, m), 4.18-4.30 (1H,
m), 5.28 (1H, brs), 5.79 (1H, d, J = 8.2 Hz), 6.77
(1H, s), 6.81 (1H, d, J = 8.8 Hz), 7.00-7.20 (3H,
m), 7.20-7.40 (2H, m). IRν maxKBrcm-1:1751, 1736, 1611, 1513. mp 191-192℃ Anal. Calcd for C18H12F5NO4: C, 53.88; H, 3.01; N,
3.49 Found : C, 54.06; H, 3.22; N, 3.60. 7) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(2,2,3,3-テトラフルオロ-
2,3-ジヒドロ-1,4-ベンゾジオキシン-6-イル)
プロパン-1-オール (4RS,5SR)-5-(4-フルオロフェニル)-4-
[(2,2,3,3-テトラフルオロ-2,3-ジヒドロ-
1,4-ベンゾジオキシン-6-イル)メチル]-1,3-
オキサゾリジン-2-オン(1.50g,3.74ミリモ
ル)のエタノール(10ml)溶液に8規定水酸化ナト
リウム水溶液(1.40ml,11.2ミリモル)を加
え、80℃にて終夜攪拌した。反応液に水(20ml)
を加え、酢酸エチル(50ml×2)で抽出した。抽出
液を水および飽和食塩水で洗浄し、乾燥(無水硫酸マグ
ネシウム)後減圧留去した。残留物を酢酸エチル-ヘキ
サンから再結晶させて目的物(0.81g,58%)を
得た。1 H-NMR(CDCl3)δ:1.00-1.60 (2H, br), 2.36 (1H, dd,
J = 14.0, 10.2 Hz), 2.80 (1H, dd, J = 14.0, 2.8 H
z), 3.18-3.30 (1H, m), 4.62 (1H, d, J = 5.2 Hz),
6.90-7.00 (2H, m), 7.00-7.14 (3H, m), 7.30-7.42 (2
H, m). IRν maxKBrcm-1:1605, 1508, 1279, 1219. mp 87-88℃ Anal. Calcd for C17H14F5NO3: C, 54.41; H, 3.76; N,
3.73 Found : C, 54.40; H, 3.66; N, 3.66. 8) N-{(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[(2,2,3,3-テトラ
フルオロ-2,3-ジヒドロ-1,4-ベンゾジオキシン-
6-イル)メチル]エチル}-6,7-ジヒドロ-5H-ベ
ンゾ[a][7]アンヌレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(2,2,3,3-テトラフルオロ-2,3-
ジヒドロ-1,4-ベンゾジオキシン-6-イル)プロパン
-1-オール(250mg,0.67ミリモル)のアセト
ニトリル(20ml)溶液に6,7-ジヒドロ-5H-ベ
ンゾ[a]シクロヘプテン-1-カルボン酸(125m
g,0.67ミリモル)および1-エチル-3-(3-ジメ
チルアミノプロピル)カルボジイミド・塩酸塩(191
mg,1.00ミリモル)および1-ヒドロキシベンゾ
トリアゾール水和物(102mg,0.67ミリモル)
を加えて室温で終夜攪拌した。反応液を水(100m
l)で希釈し、酢酸エチル(100ml×2)で抽出し
た。抽出液を水、飽和食塩水で順次洗浄し、乾燥(無水
硫酸マグネシウム)後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(酢酸エチル)で精製し、
酢酸エチル-ヘキサンから再結晶させて、目的物(25
7mg,69%)を得た。1 H-NMR(CDCl3)δ:1.90-2.10 (2H, m), 2.12-2.26 (2H,
m), 2.60-2.74 (2H, m),2.79 (1H, dd, J = 14.6, 10.2
Hz), 2.95 (1H, dd, J = 14.6, 4.4 Hz), 3.35(1H, d,
J = 3.8 Hz), 4.50-4.70 (1H, m), 4.98-5.08 (1H,
m), 5.78 (1H, d,J = 8.8 Hz), 5.84-6.00 (1H, m), 6.
19 (1H, d, J = 11.6 Hz), 6.90-7.20 (8H, m), 7.38-
7.50 (2H, m). IRν maxKBrcm-1:1636, 1607, 1510. mp 184-185℃ Anal. Calcd for C29H24NO4F5: C, 63.85; H, 4.43; N,
2.57 Found : C, 63.79; H, 4.70; N, 2.64.Example 270 N-{(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-[(2,2,3,3-tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-yl) methyl] ethyl} -6,7-dihydro-5H- Benzo [a] [7] annulene-1-carboxamide 1) 2,2,3,3-tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-carboxylic acid 2,2,3,3-carboxylic acid Tetrafluoro-2,3-dihydro-1,
4-benzodioxin-6-carbonitrile (5.0 g,
Concentrated hydrochloric acid (20 ml) was added to a solution of acetic acid (21.44 mmol) in acetic acid (20 ml), and the mixture was refluxed overnight. After concentrating the reaction solution, the precipitated crystals were collected by filtration and washed with water to obtain the desired product (4.
76 g, 88%). 1 H-NMR (CDCl 3) δ: 7.26 (1H, d, J = 8.7 Hz), 7.90-8.0
0 (2H, m), 11.00-11.80 (1H, br) .IRν max KBr cm -1 : 1726, 1701, 1624, 1597, 1508.mp 103-104 ° C Anal.Calcd for C 9 H 4 O 4 F 4 : C, 42.88; H, 1.60 Found: C, 43.13; H, 1.60. 2) (2,2,3,3-tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-yl) methanol Lithium aluminum hydride (1.40 g, 36.89)
Mmol) in 2,2,3,3-tetrafluoro-2,3-dihydro-1,2.
4-benzodioxin-6-carboxylic acid (4.65 g, 1
(8.44 mmol) at 0 ° C. After stirring the reaction solution at 0 ° C. for 10 minutes, a 1 N aqueous solution of sodium hydroxide was added. The filtrate was concentrated after filtering an insoluble matter through celite. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to give the desired product (3.
54 g, 81%). 1 H-NMR (CDCl 3 ) δ: 1.87 (1H, t, J = 6.0 Hz), 4.69 (2
H, d, J = 6.0 Hz), 7.08-7.20 (3H, m). IRν max KBr cm -1 : 1611, 1510, 1441. 3) 3- (4-Fluorophenyl) -3-oxo-2-
[(2,2,3,3-tetrafluoro-2,3-dihydro-
1,4-benzodioxin-6-yl) methyl] ethyl propanoate (2,2,3,3-tetrafluoro-2,3-dihydro-
1,4-benzodioxin-6-yl) methanol (3.
48 g, 14.6 mmol) of ethyl acetate (100 m
l) Add methanesulfonyl chloride (1.25 ml, 1
6.1 mmol) and triethylamine (3.05 m
1,21.9 mmol) and stirred at room temperature for 2 hours. The insolubles were filtered, and the filtrate was distilled off under reduced pressure to prepare a mesyl compound. 1,3-Ethyl 3- (4-fluorophenyl) -3-oxopropanoate (3.07 g, 14.6 mmol)
Sodium hydride (0.58 g, 60% oily, 14.6 mmol) was added to a dimethoxyethane (20 ml) solution, and the mixture was stirred at room temperature for 1 hour. The 1,2-dimethoxyethane (10 ml) solution of the mesyl compound previously prepared was added dropwise to the reaction solution, and the reaction solution was stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid, neutralized with saturated aqueous sodium hydrogen carbonate, and extracted with ethyl acetate (300 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the desired product (4.49 g, 7
1%). 1 H-NMR (CDCl 3 ) δ: 1.12 (3H, t, J = 7.2 Hz), 3.30 (2
H, d, J = 7.5 Hz), 4.11 (2H, q, J = 7.2 Hz), 4.51
(1H, t, J = 7.5 Hz), 7.03 (3H, s), 7.08-7.20 (2H,
m), 7.96-8.04 (2H, m) .IRν max KBr cm -1 : 1736, 1688, 1599, 1508.mp 83-84 ℃ Anal. Calcd for C 20 H 15 O 5 F 5 : C, 55.82; H , 3.51 Found: C, 55.87; H, 3.42.4.4) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-[(2,2,3,3-tetrafluoro-2, 3-dihydro-1,4-benzodioxin-6-
Yl) methyl] ethyl propanoate To a solution of zinc chloride (2.79 g, 20.5 mmol) in diethyl ether (100 ml) was added sodium borohydride (1.55 g, 40.9 mmol), and the mixture was added at room temperature for 30 minutes.
Minutes. The insoluble material was removed by filtration, and the filtrate was treated with 3- (4-fluorophenyl) -3-oxo-2-[(2,2,3,3-tetrafluoro-2,3-dihydro-1,4-benzodioxin. -
6-yl) methyl] ethyl propanoate (4.4 g, 1
(0.2 mmol) in diethyl ether (50 ml) was added at 0 ° C. and stirred for 30 minutes. The reaction solution was quenched with 1N hydrochloric acid, neutralized with saturated aqueous sodium hydrogen carbonate, and further added with water (2%).
00 ml) and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate), and then distilled off under reduced pressure to obtain the desired product (4.4).
0 g, 100%). 1 H-NMR (CDCl 3 ) δ: 0.95 (3H, t, J = 7.2 Hz), 2.84-3.0
2 (4H, m), 3.80-4.00 (2H, m), 4.96-5.04 (1H, m),
6.84-6.90 (2H, m), 6.96-7.10 (3H, m), 7.30-7.40 (2
H, m). IRν max KBr cm -1 : 1725, 1607, 1510. Anal. Calcd for C 20 H 17 O 5 F 5 : C, 55.56; H, 3.96 Found: C, 55.33; H, 3.97.5) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2-[(2,2,3,3-tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-
Yl) methyl] propanoic acid (2RS, 3RS) -3- (4-fluorophenyl) -3-
Hydroxy-2-[(2,2,3,3-tetrafluoro-
2,3-dihydro-1,4-benzodioxin-6-yl)
To a solution of ethyl [methyl] propanoate (4.20 g, 9.71 mmol) in methanol (20 ml) was added a 2N aqueous sodium hydroxide solution (9.7 ml, 19.4 mmol), and the mixture was stirred at room temperature overnight. The reaction mixture was concentrated, acidified with 1N hydrochloric acid, and extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to give the desired product (3.50).
g, 89%). 1 H-NMR (CDCl 3 ) δ: 2.84-3.10 (3H, m), 5.08 (1H, s),
6.80-6.92 (2H, m), 6.92-7.12 (3H, m), 7.26-7.42 (2
.. H, m) IRν max KBr cm -1: 1752, 1676. mp 90-91 ℃ Anal Calcd for C 18 H 13 O 5 F 5: C, 53.48; H, 3.24 Found: C, 53.48; H, 3.18 .6) (4RS, 5SR) -5- (4-fluorophenyl) -4-[(2,2,3,3-tetrafluoro-2,3-
Dihydro-1,4-benzodioxin-6-yl) methyl]
-1,3-oxazolidine-2-one (2RS, 3RS) -3- (4-fluorophenyl) -3-
Hydroxy-2-[(2,2,3,3-tetrafluoro-
2,3-dihydro-1,4-benzodioxin-6-yl)
To a solution of [methyl] propanoic acid (3.3 g, 8.16 mmol) in tetrahydrofuran (120 ml) was added diphenylphosphoryl azide (1.94 ml, 8.98 mmol).
And triethylamine (1.71 ml, 12.2 mmol) were added, and the mixture was heated under reflux for 1 hour. After allowing the reaction solution to cool, it was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to obtain the desired product (2.74 g, 84%). 1 H-NMR (CDCl 3 ) δ: 2.20-2.40 (2H, m), 4.18-4.30 (1H,
m), 5.28 (1H, brs), 5.79 (1H, d, J = 8.2 Hz), 6.77
(1H, s), 6.81 (1H, d, J = 8.8 Hz), 7.00-7.20 (3H,
m), 7.20-7.40 (2H, m) .IRν max KBr cm -1 : 1751, 1736, 1611, 1513.mp 191-192 ° C Anal.Calcd for C 18 H 12 F 5 NO 4 : C, 53.88; H , 3.01; N,
3.49 Found: C, 54.06; H, 3.22; N, 3.60.7) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (2,2,3,3-tetrafluoro-
2,3-dihydro-1,4-benzodioxin-6-yl)
Propan-1-ol (4RS, 5SR) -5- (4-fluorophenyl) -4-
[(2,2,3,3-tetrafluoro-2,3-dihydro-
1,4-benzodioxin-6-yl) methyl] -1,3-
To a solution of oxazolidin-2-one (1.50 g, 3.74 mmol) in ethanol (10 ml) was added an 8 N aqueous sodium hydroxide solution (1.40 ml, 11.2 mmol), and the mixture was stirred at 80 ° C. overnight. Water (20 ml) in the reaction solution
And extracted with ethyl acetate (50 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to obtain the desired product (0.81 g, 58%). 1 H-NMR (CDCl 3 ) δ: 1.00-1.60 (2H, br), 2.36 (1H, dd,
J = 14.0, 10.2 Hz), 2.80 (1H, dd, J = 14.0, 2.8 H
z), 3.18-3.30 (1H, m), 4.62 (1H, d, J = 5.2 Hz),
6.90-7.00 (2H, m), 7.00-7.14 (3H, m), 7.30-7.42 (2
H, m) .IRν max KBr cm -1 : 1605, 1508, 1279, 1219.mp 87-88 ℃ Anal. Calcd for C 17 H 14 F 5 NO 3 : C, 54.41; H, 3.76; N,
3.73 Found: C, 54.40; H, 3.66; N, 3.66.8) N-{(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-[(2,2,3,3 -Tetrafluoro-2,3-dihydro-1,4-benzodioxin-
6-yl) methyl] ethyl} -6,7-dihydro-5H-benzo [a] [7] annulene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (2,2,3,3-tetrafluoro-2,3-
Dihydro-1,4-benzodioxin-6-yl) propane
To a solution of -1-ol (250 mg, 0.67 mmol) in acetonitrile (20 ml) was added 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (125 ml).
g, 0.67 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (191)
mg, 1.00 mmol) and 1-hydroxybenzotriazole hydrate (102 mg, 0.67 mmol)
Was added and stirred at room temperature overnight. The reaction solution was washed with water (100 m
1) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate),
Recrystallization from ethyl acetate-hexane gave the desired product (25
7 mg, 69%). 1 H-NMR (CDCl 3 ) δ: 1.90-2.10 (2H, m), 2.12-2.26 (2H,
m), 2.60-2.74 (2H, m), 2.79 (1H, dd, J = 14.6, 10.2
Hz), 2.95 (1H, dd, J = 14.6, 4.4 Hz), 3.35 (1H, d,
J = 3.8 Hz), 4.50-4.70 (1H, m), 4.98-5.08 (1H,
m), 5.78 (1H, d, J = 8.8 Hz), 5.84-6.00 (1H, m), 6.
19 (1H, d, J = 11.6 Hz), 6.90-7.20 (8H, m), 7.38-
7.50 (2H, m) .IRν max KBr cm -1 : 1636, 1607, 1510.mp 184-185 ° C Anal.Calcd for C 29 H 24 NO 4 F 5 : C, 63.85; H, 4.43; N,
2.57 Found: C, 63.79; H, 4.70; N, 2.64.
【0403】実施例271 4-フルオロ-N-{(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[(2,2,3,3-
テトラフルオロ-2,3-ジヒドロ-1,4-ベンゾジオキ
シン-6-イル)メチル]エチル}-1-ナフトアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(2,2,3,3-テトラフルオロ-2,3-
ジヒドロ-1,4-ベンゾジオキシン-6-イル)プロパン
-1-オール(250mg,0.67ミリモル)のアセト
ニトリル(20ml)溶液に4-フルオロナフタレンカ
ルボン酸(127mg,0.67ミリモル)および1-
エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩(191mg,1.00ミリモル)および
1-ヒドロキシベンゾトリアゾール水和物(102m
g,0.67ミリモル)を加えて室温で終夜攪拌した。
反応液を水(100ml)で希釈し、酢酸エチル(10
0ml×2)で抽出した。抽出液を水、飽和食塩水で順
次洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(酢
酸エチル)で精製し、酢酸エチル-ヘキサンから再結晶
させて、目的物(290mg,80%)を得た。1 H-NMR(CDCl3)δ:2.84 (1H, dd, J = 14.6, 10.6 Hz),
3.02 (1H, dd, J = 14.6, 4.0 Hz), 3.27 (1H, s), 4.6
4-4.82 (1H, m), 5.09 (1H, s), 6.04 (1H, d, J= 9.0
Hz), 6.90-7.22 (7H, m), 7.36-7.66 (4H, m), 7.77 (1
H, d, J = 8.0 Hz), 8.01 (1H, d, J = 8.2 Hz). IRν maxKBrcm-1:1642, 1626, 1603, 1534, 1512. mp 193-194℃ Anal. Calcd for C28H19NO4F6: C, 61.43; H, 3.50; N,
2.56 Found : C, 61.32; H, 3.57; N, 2.58.Example 271 4-Fluoro-N-{(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-[(2,2,3,3-
Tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-yl) methyl] ethyl} -1-naphthamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- ( 2,2,3,3-tetrafluoro-2,3-
Dihydro-1,4-benzodioxin-6-yl) propane
To a solution of -1-ol (250 mg, 0.67 mmol) in acetonitrile (20 ml) was added 4-fluoronaphthalenecarboxylic acid (127 mg, 0.67 mmol) and 1-ol.
Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (191 mg, 1.00 mmol) and 1-hydroxybenzotriazole hydrate (102 m
g, 0.67 mmol) and stirred at room temperature overnight.
The reaction solution was diluted with water (100 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate) and recrystallized from ethyl acetate-hexane to obtain the desired product (290 mg, 80%). 1 H-NMR (CDCl 3 ) δ: 2.84 (1H, dd, J = 14.6, 10.6 Hz),
3.02 (1H, dd, J = 14.6, 4.0 Hz), 3.27 (1H, s), 4.6
4-4.82 (1H, m), 5.09 (1H, s), 6.04 (1H, d, J = 9.0
Hz), 6.90-7.22 (7H, m), 7.36-7.66 (4H, m), 7.77 (1
H, d, J = 8.0 Hz), 8.01 (1H, d, J = 8.2 Hz) .IRν max KBr cm -1 : 1642, 1626, 1603, 1534, 1512.mp 193-194 ℃ Anal. Calcd for C 28 H 19 NO 4 F 6 : C, 61.43; H, 3.50; N,
2.56 Found: C, 61.32; H, 3.57; N, 2.58.
【0404】実施例272 N-[(1RS,2SR)-1-(4-tert-ブチルベ
ンジル)-2-(3-クロロフェニル)-2-ヒドロキシエ
チル]-6,7-ジヒドロ-5H-ベンゾ[a][7]アン
ヌレン-1-カルボキサミド 1) 2-(4-tert-ブチルベンジル)-3-(3-ク
ロロフェニル)-3-オキソプロパン酸エチル (4-tert-ブチルフェニル)メタノール(14.1
g,86.0ミリモル)の酢酸エチル(200ml)溶
液に塩化メタンスルホニル(7.47ml,94.6ミ
リモル)およびトリエチルアミン(18.0ml,12
9ミリモル)を加え、室温で2時間攪拌した。不溶物を
ろ過し、ろ液を減圧留去しメシル体を調製した。3-
(3-クロロフェニル)-3-オキソプロパン酸エチル
(19.5g,86.0ミリモル)の1,2-ジメトキ
シエタン(100ml)溶液に水素化ナトリウム(3.
44g,60%油性,86.0ミリモル)を加え、室温
で1時間攪拌した。反応液に先に調製したメシル体の
1,2-ジメトキシエタン(10ml)溶液を滴下し、
反応液を室温にて終夜攪拌した。反応液を1規定塩酸で
酸性とした後、酢酸エチル(300ml×2)で抽出し
た。抽出液を水、飽和食塩水で順次洗浄し、乾燥(無水
硫酸マグネシウム)後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
4:1)で精製し目的物(31.1g,97%)を得
た。1 H-NMR(CDCl3)δ:1.13 (3H, t, J = 7.0 Hz), 1.28 (9
H, s), 3.29 (2H, d, J =7.4 Hz), 4.11 (2H, q, J =
7.0 Hz), 4.54 (1H, t, J = 7.4 Hz), 7.08-7.18(2H,
m), 7.22-7.44 (3H, m), 7.48-7.56 (1H, m), 7.81 (1
H, dt, J = 7.6, 1.6 Hz), 7.89 (1H, t, J = 1.8 Hz). IRν maxKBrcm-1:1738, 1694, 1570. Anal. Calcd for C22H25ClO3 0.1H2O: C, 70.53; H, 6.
77 Found : C, 70.38; H, 7.02. 2) (2RS,3RS)-2-(4-tert-ブチルベ
ンジル)-3-(3-クロロフェニル)-3-ヒドロキシプ
ロパン酸エチル 塩化亜鉛(22.3g,163.6ミリモル)のジエチ
ルエーテル(500ml)溶液に水素化ホウ素ナトリウ
ム(12.4g,327.2ミリモル)を加えて室温で
30分攪拌した。不溶物をろ去し、ろ液に2-(4-te
rt-ブチルベンジル)-3-(3-クロロフェニル)-3-
オキソプロパン酸エチル(30.5g,81.8ミリモ
ル)のジエチルエーテル(200ml)溶液を0℃にて
加えて30分攪拌した。反応液に1規定塩酸を加えて反
応を止め、更に水(200ml)を加え、酢酸エチル
(200ml×2)で抽出した。抽出液を水および飽和
食塩水で洗浄し、乾燥(無水硫酸マグネシウム)後減圧
留去し目的物(26.8g,87%)を得た。1 H-NMR(CDCl3)δ:0.92 (3H, t, J = 7.0 Hz), 1.27 (9
H, s), 2.80-3.00 (3H, m), 3.14 (1H, d, J = 3.0 H
z), 3.80-4.00 (2H, m), 4.96-5.04 (1H, m), 7.01(2H,
d, J = 8.4 Hz), 7.18-7.30 (5H, m), 7.41 (1H, s). IRν maxKBrcm-1:1728, 1713, 1597, 1574. Anal. Calcd for C22H27ClO3 0.5H2O: C, 68.83; H, 7.
34 Found : C, 68.71; H, 7.32. 3) (2RS,3RS)-2-(4-tert-ブチルベ
ンジル)-3-(3-クロロフェニル)-3-ヒドロキシプ
ロパン酸 (2RS,3RS)-2-(4-tert-ブチルベンジ
ル)-3-(3-クロロフェニル)-3-ヒドロキシプロパ
ン酸エチル(26.5g,70.7ミリモル)のメタノ
ール(200ml)溶液に2規定水酸化ナトリウム水溶
液(70ml,140ミリモル)を加え、室温で終夜攪
拌した。反応液を濃縮後、1規定塩酸を加え酸性とした
後、酢酸エチル(500ml×2)で抽出した。抽出液
を水および飽和食塩水で洗浄し、乾燥(無水硫酸マグネ
シウム)後減圧留去した。残留物を酢酸エチル-ヘキサ
ンから再結晶させて目的物(15.0g,59%)を得
た。1 H-NMR(CDCl3)δ:1.28 (9H, s), 2.80-3.10 (3H, m),
5.08 (1H, d, J = 4.0 Hz), 7.00 (2H, d, J = 8.4 H
z), 7.20-7.30 (5H, m), 7.41 (1H, s). IRν maxKBrcm-1:1713, 1599, 1576. mp 117-118℃ Anal. Calcd for C20H23ClO3: C, 69.26; H, 6.68 Found : C, 69.18; H, 6.68. 4) (4RS,5SR)-4-(4-tert-ブチルベ
ンジル)-5-(3-クロロフェニル)-1,3-オキサゾ
リジン-2-オン (2RS,3RS)-2-(4-tert-ブチルベンジ
ル)-3-(3-クロロフェニル)-3-ヒドロキシプロパ
ン酸(14.5g,40.6ミリモル)のテトラヒドロ
フラン(400ml)溶液に、ジフェニルホスホリルア
ジド(9.63ml,44.7ミリモル)とトリエチル
アミン(8.50ml,60.9ミリモル)を加え、1
時間加熱還流した。反応液を放冷後、減圧留去した。残
留物に水(500ml)を加え、酢酸エチル-テトラヒ
ドロフランで抽出した。抽出液を水および飽和食塩水で
洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去し
た。残留物を酢酸エチルで洗浄し、目的物(9.6g,
69%)を得た。1 H-NMR(CDCl3)δ:1.29 (9H, s), 2.04-2.36 (2H, m),
4.16-4.30 (1H, m), 5.03(1H, brs), 5.76 (1H, d, J =
7.6 Hz), 6.96 (2H, d, J = 8.4 Hz), 7.24-7.40 (6H,
m). IRν maxKBrcm-1:1734. mp 215-216℃ Anal. Calcd for C20H22Cl NO2: C, 69.86; H, 6.45;
N, 4.07 Found : C, 69.65; H, 6.46; N, 4.10. 5) (1RS,2SR)-2-アミノ-3-(4-ter
t-ブチルフェニル)-1-(3-クロロフェニル)プロパ
ン-1-オール (4RS,5SR)-4-(4-tert-ブチルベンジ
ル)-5-(3-クロロフェニル)-1,3-オキサゾリジ
ン-2-オン(9.50g,27.6ミリモル)のエタノ
ール(70ml)溶液に8規定水酸化ナトリウム水溶液
(17.3ml,138ミリモル)を加え、80℃にて
終夜攪拌した。反応液に水(20ml)を加え、酢酸エ
チル(50ml×2)で抽出した。抽出液を水および飽
和食塩水で洗浄し、乾燥(無水硫酸マグネシウム)後減
圧留去し、目的物(8.82g,100%)を得た。1 H-NMR(CDCl3)δ:1.30 (9H, s), 2.31 (1H, dd, J = 1
4.0, 10.6 Hz), 2.73 (1H, dd, J = 14.0, 3.4 Hz), 3.
22-3.34 (1H, m), 4.67 (1H, d, J = 4.8 Hz), 7.05 (2
H, d, J = 8.0 Hz), 7.24-7.36 (5H, m), 7.42 (1H,
s). IRν maxKBrcm-1:1597, 1574, 1512, 1474. 6) N-[(1RS,2SR)-1-(4-tert-ブ
チルベンジル)-2-(3-クロロフェニル)-2-ヒドロ
キシエチル]-6,7-ジヒドロ-5H-ベンゾ[a]
[7]アンヌレン-1-カルボキサミド (1RS,2SR)-2-アミノ-3-(4-tert-ブチ
ルフェニル)-1-(3-クロロフェニル)プロパン-1-
オール(355mg,1.17ミリモル)のアセトニト
リル(20ml)溶液に6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボン酸(220mg,
1.17ミリモル)および1-エチル-3-(3-ジメチル
アミノプロピル)カルボジイミド・塩酸塩(336m
g,1.76ミリモル)および1-ヒドロキシベンゾト
リアゾール水和物(179mg,1.17ミリモル)を
加えて室温で終夜攪拌した。反応液を水(100ml)
で希釈し、酢酸エチル(100ml×2)で抽出した。
抽出液を水、飽和食塩水で順次洗浄し、乾燥(無水硫酸
マグネシウム)後減圧留去した。残留物をシリカゲルカ
ラムクロマトグラフィー(ヘキサン:酢酸エチル=4:
1-2:1)で精製し、酢酸エチル-ヘキサンから再結晶
させて、目的物(348mg,64%)を得た。1 H-NMR(CDCl3)δ:1.30 (9H, s), 1.90-2.08 (2H, m),
2.10-2.24 (2H, m), 2.60-2.78 (3H, m), 2.96 (1H, d
d, J = 14.4, 4.8 Hz), 4.35 (1H, d, J = 4.4 Hz), 4.
60-4.76 (1H, m), 4.98-5.06 (1H, m), 5.67 (1H, d, J
= 7.8 Hz), 5.88-6.02 (1H, m), 6.28 (1H, d, J = 1
1.8 Hz), 6.88 (1H, dd, J = 7.4, 1.4 Hz),6.98-7.18
(4H, m), 7.20-7.38 (8H, m), 7.47 (1H, s). IRν maxKBrcm-1:1633, 1514. mp 142-143℃ Anal. Calcd for C31H34Cl NO2: C, 76.29; H, 7.02;
N, 2.87 Found : C, 76.19; H, 7.15; N, 2.83.Example 272 N-[(1RS, 2SR) -1- (4-tert-butylbenzyl) -2- (3-chlorophenyl) -2-hydroxyethyl] -6,7-dihydro-5H-benzo [ a] [7] Annulene-1-carboxamide 1) Ethyl 2- (4-tert-butylbenzyl) -3- (3-chlorophenyl) -3-oxopropanoate (4-tert-butylphenyl) methanol (14.1)
g, 86.0 mmol) in acetic acid (200 ml) in methanesulfonyl chloride (7.47 ml, 94.6 mmol) and triethylamine (18.0 ml, 128.0 mmol).
9 mmol) and stirred at room temperature for 2 hours. The insolubles were filtered, and the filtrate was distilled off under reduced pressure to prepare a mesyl compound. 3-
To a solution of ethyl (3-chlorophenyl) -3-oxopropanoate (19.5 g, 86.0 mmol) in 1,2-dimethoxyethane (100 ml) was added sodium hydride (3.
44 g, 60% oily, 86.0 mmol) and stirred at room temperature for 1 hour. The 1,2-dimethoxyethane (10 ml) solution of the previously prepared mesyl compound was added dropwise to the reaction solution,
The reaction was stirred overnight at room temperature. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (300 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
4: 1) to give the desired product (31.1 g, 97%). 1 H-NMR (CDCl 3 ) δ: 1.13 (3H, t, J = 7.0 Hz), 1.28 (9
H, s), 3.29 (2H, d, J = 7.4 Hz), 4.11 (2H, q, J =
7.0 Hz), 4.54 (1H, t, J = 7.4 Hz), 7.08-7.18 (2H,
m), 7.22-7.44 (3H, m), 7.48-7.56 (1H, m), 7.81 (1
H, dt, J = 7.6, 1.6 Hz), 7.89 (1H, t, J = 1.8 Hz) .IRν max KBr cm -1 : 1738, 1694, 1570. Anal.Calcd for C 22 H 25 ClO 3 0.1H 2 O: C, 70.53; H, 6.
77 Found: C, 70.38; H, 7.02.2) Ethyl (2RS, 3RS) -2- (4-tert-butylbenzyl) -3- (3-chlorophenyl) -3-hydroxypropanoate Zinc chloride (22.3 g) , 163.6 mmol) in diethyl ether (500 ml) was added with sodium borohydride (12.4 g, 327.2 mmol) and stirred at room temperature for 30 minutes. The insoluble material was removed by filtration, and the filtrate was 2- (4-te)
rt-butylbenzyl) -3- (3-chlorophenyl) -3-
A solution of ethyl oxopropanoate (30.5 g, 81.8 mmol) in diethyl ether (200 ml) was added at 0 ° C., and the mixture was stirred for 30 minutes. 1N hydrochloric acid was added to the reaction solution to stop the reaction, water (200 ml) was further added, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure to obtain the desired product (26.8 g, 87%). 1 H-NMR (CDCl 3 ) δ: 0.92 (3H, t, J = 7.0 Hz), 1.27 (9
H, s), 2.80-3.00 (3H, m), 3.14 (1H, d, J = 3.0 H
z), 3.80-4.00 (2H, m), 4.96-5.04 (1H, m), 7.01 (2H,
. d, J = 8.4 Hz) , 7.18-7.30 (5H, m), 7.41 (1H, s) IRν max KBr cm -1:. 1728, 1713, 1597, 1574. Anal Calcd for C 22 H 27 ClO 3 0.5 H 2 O: C, 68.83; H, 7.
34 Found: C, 68.71; H, 7.32. 3) (2RS, 3RS) -2- (4-tert-butylbenzyl) -3- (3-chlorophenyl) -3-hydroxypropanoic acid (2RS, 3RS) -2 To a solution of ethyl 2- (4-tert-butylbenzyl) -3- (3-chlorophenyl) -3-hydroxypropanoate (26.5 g, 70.7 mmol) in methanol (200 ml) was added a 2N aqueous sodium hydroxide solution (70 ml, 140 mmol) and stirred overnight at room temperature. The reaction solution was concentrated, acidified with 1N hydrochloric acid, and extracted with ethyl acetate (500 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to obtain the desired product (15.0 g, 59%). 1 H-NMR (CDCl 3 ) δ: 1.28 (9H, s), 2.80-3.10 (3H, m),
5.08 (1H, d, J = 4.0 Hz), 7.00 (2H, d, J = 8.4 H
. z), 7.20-7.30 (5H, m), 7.41 (1H, s) IRν max KBr cm -1: 1713, 1599, 1576. mp 117-118 ℃ Anal Calcd for C 20 H 23 ClO 3:. C, 69.26; H, 6.68 Found: C, 69.18; H, 6.68. 4) (4RS, 5SR) -4- (4-tert-butylbenzyl) -5- (3-chlorophenyl) -1,3-oxazolidine-2- Diphenyl was added to a solution of (2RS, 3RS) -2- (4-tert-butylbenzyl) -3- (3-chlorophenyl) -3-hydroxypropanoic acid (14.5 g, 40.6 mmol) in tetrahydrofuran (400 ml). Phosphoryl azide (9.63 ml, 44.7 mmol) and triethylamine (8.50 ml, 60.9 mmol) were added and 1
Heated to reflux for an hour. After allowing the reaction solution to cool, it was evaporated under reduced pressure. Water (500 ml) was added to the residue, and the mixture was extracted with ethyl acetate-tetrahydrofuran. The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was washed with ethyl acetate, and the desired product (9.6 g,
69%). 1 H-NMR (CDCl 3 ) δ: 1.29 (9H, s), 2.04-2.36 (2H, m),
4.16-4.30 (1H, m), 5.03 (1H, brs), 5.76 (1H, d, J =
7.6 Hz), 6.96 (2H, d, J = 8.4 Hz), 7.24-7.40 (6H,
m) .IRν max KBr cm -1 : 1734.mp 215-216 ° C Anal.Calcd for C 20 H 22 Cl NO 2 : C, 69.86; H, 6.45;
N, 4.07 Found: C, 69.65; H, 6.46; N, 4.10. 5) (1RS, 2SR) -2-amino-3- (4-ter
t-butylphenyl) -1- (3-chlorophenyl) propan-1-ol (4RS, 5SR) -4- (4-tert-butylbenzyl) -5- (3-chlorophenyl) -1,3-oxazolidine-2 To a solution of -one (9.50 g, 27.6 mmol) in ethanol (70 ml) was added an 8N aqueous sodium hydroxide solution (17.3 ml, 138 mmol), and the mixture was stirred at 80 ° C overnight. Water (20 ml) was added to the reaction solution, and extracted with ethyl acetate (50 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure to obtain the desired product (8.82 g, 100%). 1 H-NMR (CDCl 3 ) δ: 1.30 (9H, s), 2.31 (1H, dd, J = 1
4.0, 10.6 Hz), 2.73 (1H, dd, J = 14.0, 3.4 Hz), 3.
22-3.34 (1H, m), 4.67 (1H, d, J = 4.8 Hz), 7.05 (2
H, d, J = 8.0 Hz), 7.24-7.36 (5H, m), 7.42 (1H,
s). IRν max KBr cm -1 : 1597, 1574, 1512, 1474. 6) N-[(1RS, 2SR) -1- (4-tert-butylbenzyl) -2- (3-chlorophenyl) -2- Hydroxyethyl] -6,7-dihydro-5H-benzo [a]
[7] Annulene-1-carboxamide (1RS, 2SR) -2-amino-3- (4-tert-butylphenyl) -1- (3-chlorophenyl) propane-1-
To a solution of all (355 mg, 1.17 mmol) in acetonitrile (20 ml) was added 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (220 mg,
1.17 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (336 m
g, 1.76 mmol) and 1-hydroxybenzotriazole hydrate (179 mg, 1.17 mmol) were added and stirred at room temperature overnight. The reaction solution was water (100 ml)
And extracted with ethyl acetate (100 ml × 2).
The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 4:
1-2: 1) and recrystallized from ethyl acetate-hexane to give the desired product (348 mg, 64%). 1 H-NMR (CDCl 3 ) δ: 1.30 (9H, s), 1.90-2.08 (2H, m),
2.10-2.24 (2H, m), 2.60-2.78 (3H, m), 2.96 (1H, d
d, J = 14.4, 4.8 Hz), 4.35 (1H, d, J = 4.4 Hz), 4.
60-4.76 (1H, m), 4.98-5.06 (1H, m), 5.67 (1H, d, J
= 7.8 Hz), 5.88-6.02 (1H, m), 6.28 (1H, d, J = 1
1.8 Hz), 6.88 (1H, dd, J = 7.4, 1.4 Hz), 6.98-7.18
(4H, m), 7.20-7.38 (8H, m), 7.47 (1H, s) .IRν max KBr cm -1 : 1633, 1514.mp 142-143 ° C Anal.Calcd for C 31 H 34 Cl NO 2 : C, 76.29; H, 7.02;
N, 2.87 Found: C, 76.19; H, 7.15; N, 2.83.
【0405】実施例273 N-[(1RS,2SR)-1-(4-tert-ブチルベ
ンジル)-2-(3-クロロフェニル)-2-ヒドロキシエ
チル]-4-フルオロ-1-ナフトアミド (1RS,2SR)-2-アミノ-3-(4-tert-ブチ
ルフェニル)-1-(3-クロロフェニル)プロパン-1-
オール(355mg,1.17ミリモル)のアセトニト
リル(20ml)溶液に4-フルオロナフタレンカルボ
ン酸(223mg,1.17ミリモル)および1-エチ
ル-3-(3-ジメチルアミノプロピル)カルボジイミド
・塩酸塩(336mg,1.76ミリモル)および1-
ヒドロキシベンゾトリアゾール水和物(179mg,
1.17ミリモル)を加えて室温で終夜攪拌した。反応
液を水(100ml)で希釈し、酢酸エチル(100m
l×2)で抽出した。抽出液を水、飽和食塩水で順次洗
浄し、乾燥(無水硫酸マグネシウム)後減圧留去した。
残留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=4:1-2:1)で精製し、酢酸エチ
ル-ヘキサンから再結晶させて、目的物(333mg,
61%)を得た。1 H-NMR(CDCl3)δ:2.74 (1H, dd, J = 14.4, 11.0 Hz),
3.02 (1H, dd, J = 14.4, 4.4 Hz), 4.15 (1H, d, J =
4.4 Hz), 4.70-4.86 (1H, m), 5.04-5.12 (1H, m), 5.8
5 (1H, d, J = 8.0 Hz), 6.90-7.20 (4H, m), 7.24-7.6
0 (8H, m), 7.89(1H, d, J = 7.6 Hz), 8.07 (1H, d, J
= 8.0 Hz) IRν maxKBrcm-1:1640, 1624, 1599, 1580, 1514. mp 144-145℃ Anal. Calcd for C30H29Cl FNO2・0.1H2O: C, 73.27; H,
5.98; N, 2.85 Found : C, 73.05; H, 5.74; N, 3.09.Example 273 N-[(1RS, 2SR) -1- (4-tert-butylbenzyl) -2- (3-chlorophenyl) -2-hydroxyethyl] -4-fluoro-1-naphthamide (1RS, 2SR) -2-Amino-3- (4-tert-butylphenyl) -1- (3-chlorophenyl) propane-1-
In a solution of all (355 mg, 1.17 mmol) in acetonitrile (20 ml), 4-fluoronaphthalenecarboxylic acid (223 mg, 1.17 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (336 mg) , 1.76 mmol) and 1-
Hydroxybenzotriazole hydrate (179 mg,
1.17 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
1 × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure.
The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-2: 1) and recrystallized from ethyl acetate-hexane to give the desired product (333 mg,
61%). 1 H-NMR (CDCl 3 ) δ: 2.74 (1H, dd, J = 14.4, 11.0 Hz),
3.02 (1H, dd, J = 14.4, 4.4 Hz), 4.15 (1H, d, J =
4.4 Hz), 4.70-4.86 (1H, m), 5.04-5.12 (1H, m), 5.8
5 (1H, d, J = 8.0 Hz), 6.90-7.20 (4H, m), 7.24-7.6
0 (8H, m), 7.89 (1H, d, J = 7.6 Hz), 8.07 (1H, d, J
= 8.0 Hz) IRν max KBr cm -1 : 1640, 1624, 1599, 1580, 1514.mp 144-145 ° C Anal.Calcd for C 30 H 29 Cl FNO 2・ 0.1H 2 O: C, 73.27; H,
5.98; N, 2.85 Found: C, 73.05; H, 5.74; N, 3.09.
【0406】実施例274 N-[(1RS,2SR)-1-(4-tert-ブチルベ
ンジル)-2-(3-クロロフェニル)-2-ヒドロキシエ
チル]-5-クロロ-1-ナフトアミド (1RS,2SR)-2-アミノ-3-(4-tert-ブチ
ルフェニル)-1-(3-クロロフェニル)プロパン-1-
オール(1.0g,3.15ミリモル)のアセトニトリ
ル(40ml)溶液に5-クロロナフタレンカルボン酸
(651mg,3.15ミリモル)および1-エチル-3
-(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩(725mg,3.78ミリモル)および1-ヒドロ
キシベンゾトリアゾール水和物(482mg,3.15
ミリモル)を加えて室温で終夜攪拌した。反応液を水
(200ml)で希釈し、酢酸エチル(200ml×
2)で抽出した。抽出液を水、飽和食塩水で順次洗浄
し、乾燥(無水硫酸マグネシウム)後減圧留去した。残
留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=4:1-1:1)で精製し、酢酸エチ
ル-ヘキサンから再結晶させて、目的物(1.04g,
66%)を得た。1 H-NMR(CDCl3)δ:1.31 (9H, s), 2.74 (1H, dd, J = 1
4.2, 11.0 Hz), 3.01 (1H, dd, J = 14.2, 4.4 Hz), 3.
98 (1H, d, J = 4.4 Hz), 4.70-4.88 (1H, m), 5.02-5.
10 (1H, m), 5.90 (1H, d, J = 8.0 Hz), 7.13 (2H, d,
J = 8.4 Hz), 7.22-7.60 (10H, m), 7.73 (1H, d, J =
8.8 Hz), 8.31 (1H, d, J = 8.4 Hz). IRν maxKBrcm-1:1636, 1572, 1518. mp 112-113℃ Anal. Calcd for C30H29Cl2NO2 : C, 71.15; H, 5.77;
N, 2.77 Found : C, 71.10; H, 5.83; N, 2.56.Example 274 N-[(1RS, 2SR) -1- (4-tert-butylbenzyl) -2- (3-chlorophenyl) -2-hydroxyethyl] -5-chloro-1-naphthamide (1RS, 2SR) -2-Amino-3- (4-tert-butylphenyl) -1- (3-chlorophenyl) propane-1-
To a solution of all (1.0 g, 3.15 mmol) in acetonitrile (40 ml) was added 5-chloronaphthalenecarboxylic acid (651 mg, 3.15 mmol) and 1-ethyl-3.
-(3-Dimethylaminopropyl) carbodiimide hydrochloride (725 mg, 3.78 mmol) and 1-hydroxybenzotriazole hydrate (482 mg, 3.15)
Mmol) and stirred overnight at room temperature. The reaction solution was diluted with water (200 ml), and ethyl acetate (200 ml ×
Extracted in 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-1: 1) and recrystallized from ethyl acetate-hexane to give the desired product (1.04 g,
66%). 1 H-NMR (CDCl 3 ) δ: 1.31 (9H, s), 2.74 (1H, dd, J = 1
4.2, 11.0 Hz), 3.01 (1H, dd, J = 14.2, 4.4 Hz), 3.
98 (1H, d, J = 4.4 Hz), 4.70-4.88 (1H, m), 5.02-5.
10 (1H, m), 5.90 (1H, d, J = 8.0 Hz), 7.13 (2H, d,
J = 8.4 Hz), 7.22-7.60 (10H, m), 7.73 (1H, d, J =
. 8.8 Hz), 8.31 (1H , d, J = 8.4 Hz) IRν max KBr cm -1: 1636, 1572, 1518. mp 112-113 ℃ Anal Calcd for C 30 H 29 Cl 2 NO 2:. C, 71.15 ; H, 5.77;
N, 2.77 Found: C, 71.10; H, 5.83; N, 2.56.
【0407】実施例275 N-[(1RS,2SR)-1-(4-tert-ブチルベ
ンジル)-2-(3-クロロフェニル)-2-ヒドロキシエ
チル]-5-フルオロ-1-ナフトアミド (1RS,2SR)-2-アミノ-3-(4-tert-ブチ
ルフェニル)-1-(3-クロロフェニル)プロパン-1-
オール(300mg,0.94ミリモル)のアセトニト
リル(20ml)溶液に5-フルオロナフタレンカルボ
ン酸(180mg,0.94ミリモル)および1-エチ
ル-3-(3-ジメチルアミノプロピル)カルボジイミド
・塩酸塩(217mg,1.13ミリモル)および1-
ヒドロキシベンゾトリアゾール水和物(145mg,
0.94ミリモル)を加えて室温で終夜攪拌した。反応
液を水(100ml)で希釈し、酢酸エチル(100m
l×2)で抽出した。抽出液を水、飽和食塩水で順次洗
浄し、乾燥(無水硫酸マグネシウム)後減圧留去した。
残留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=4:1)で精製し、酢酸エチル-ヘキ
サンから再結晶させて、目的物(0.24g,53%)
を得た。1 H-NMR(CDCl3)δ:1.31 (9H, s), 2.74 (1H, dd, J = 1
4.2, 10.6 Hz), 3.01 (1H, dd, J = 14.2, 4.4 Hz), 4.
02 (1H, s), 4.70-4.88 (1H, m), 5.07 (1H, t, J= 4.0
Hz), 5.89 (1H, d, J = 7.0 Hz), 7.04-7.20 (4H, m),
7.22-7.44 (7H,m), 7.50 (1H, s), 7.60 (1H, d, J =
8.4 Hz), 8.12 (1H, d, J = 8.4 Hz). IRν maxKBrcm-1:1636, 1595, 1584, 1520, 1507. mp 102-103℃ Anal. Calcd for C30H29ClFNO2 : C, 72.47; H, 6.04;
N, 2.82 Found : C, 72.47; H, 6.23; N, 2.60.Example 275 N-[(1RS, 2SR) -1- (4-tert-butylbenzyl) -2- (3-chlorophenyl) -2-hydroxyethyl] -5-fluoro-1-naphthamide (1RS, 2SR) -2-Amino-3- (4-tert-butylphenyl) -1- (3-chlorophenyl) propane-1-
In a solution of all (300 mg, 0.94 mmol) in acetonitrile (20 ml), 5-fluoronaphthalenecarboxylic acid (180 mg, 0.94 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (217 mg) , 1.13 mmol) and 1-
Hydroxybenzotriazole hydrate (145 mg,
0.94 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
1 × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure.
The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) and recrystallized from ethyl acetate-hexane to give the desired product (0.24 g, 53%).
I got 1 H-NMR (CDCl 3 ) δ: 1.31 (9H, s), 2.74 (1H, dd, J = 1
4.2, 10.6 Hz), 3.01 (1H, dd, J = 14.2, 4.4 Hz), 4.
02 (1H, s), 4.70-4.88 (1H, m), 5.07 (1H, t, J = 4.0
Hz), 5.89 (1H, d, J = 7.0 Hz), 7.04-7.20 (4H, m),
7.22-7.44 (7H, m), 7.50 (1H, s), 7.60 (1H, d, J =
. 8.4 Hz), 8.12 (1H , d, J = 8.4 Hz) IRν max KBr cm -1: 1636, 1595, 1584, 1520, 1507. mp 102-103 ℃ Anal Calcd for C 30 H 29 ClFNO 2:. C , 72.47; H, 6.04;
N, 2.82 Found: C, 72.47; H, 6.23; N, 2.60.
【0408】実施例276 1) 2-(4-tert-ブトキシルベンジル)-3-
(3-クロロフェニル)-3-オキソプロパン酸エチル (4-tert-ブトキシフェニル)メタノール(5.0
g,27.7ミリモル)の酢酸エチル(70ml)溶液
に塩化メタンスルホニル(2.36ml,30.5ミリ
モル)およびトリエチルアミン(5.8ml,41.6
ミリモル)を加え、室温で2時間攪拌した。不溶物をろ
過し、ろ液を減圧留去しメシル体を調製した。3-(3-
クロロフェニル)-3-オキソプロパン酸エチル(6.2
9g,27.7ミリモル)の1,2-ジメトキシエタン
(50ml)溶液に水素化ナトリウム(1.11g,6
0%油性,27.7ミリモル)を加え、室温で1時間攪
拌した。反応液に先に調製したメシル体の1,2-ジメ
トキシエタン(10ml)溶液を滴下し、反応液を室温
にて終夜攪拌した。反応液を1規定塩酸で酸性とした
後、酢酸エチル(300ml×2)で抽出した。抽出液
を水、飽和食塩水で順次洗浄し、乾燥(無水硫酸マグネ
シウム)後減圧留去した。残留物をシリカゲルカラムク
ロマトグラフィー(ヘキサン:酢酸エチル=4:1)で
精製し目的物(8.26g,77%,粗製)を得た。 2) (2RS,3RS)-2-(4-tert-ブトキシ
ルベンジル)-3-(3-クロロフェニル)-3-ヒドロキ
シプロパン酸エチル 塩化亜鉛(5.79g,42.5ミリモル)のジエチル
エーテル(150ml)溶液に水素化ホウ素ナトリウム
(3.22g,85.0ミリモル)を加えて室温で30
分攪拌した。不溶物をろ去し、ろ液に2-(4-tert
-ブトキシルベンジル)-3-(3-クロロフェニル)-3-
オキソプロパン酸エチル(8.26g,21.2ミリモ
ル)のジエチルエーテル(100ml)溶液を0℃にて
加えて30分攪拌した。反応液に1規定塩酸を加えて反
応を止め、更に水(200ml)を加え、酢酸エチル
(200ml×2)で抽出した。抽出液を水および飽和
食塩水で洗浄し、乾燥(無水硫酸マグネシウム)後減圧
留去し、残留物をシリカゲルカラムクロマトグラフィー
(ヘキサン:酢酸エチル=10:1-2:1)で精製し
目的物(7.12g,86%)を得た。1 H-NMR(CDCl3)δ:0.94 (3H, t, J = 7.0 Hz), 1.30 (9
H, s), 2.80-3.00 (3H, m), 3.12-3.22 (1H, m), 3.89
(2H, q, J = 7.0 Hz), 5.01 (1H, s), 6.80-6.88(2H,
m), 6.92-7.00 (2H, m), 7.20-7.30 (3H, m), 7.42 (1
H, s). IRν maxKBrcm-1:1726, 1609, 1597, 1574, 1507. 3) (2RS,3RS)-2-(4-tert-ブトキシ
ルベンジル)-3-(3-クロロフェニル)-3-ヒドロキ
シプロパン酸 (2RS,3RS)-2-(4-tert-ブトキシルベン
ジル)-3-(3-クロロフェニル)-3-ヒドロキシプロ
パン酸エチル(7.12g,18.2ミリモル)のメタ
ノール(60ml)溶液に2規定水酸化ナトリウム水溶
液(18.2ml,36.4ミリモル)を加え、室温で
終夜攪拌した。反応液を濃縮後、1規定塩酸を加え酸性
とした後、酢酸エチル(200ml×2)で抽出した。
抽出液を水および飽和食塩水で洗浄し、乾燥(無水硫酸
マグネシウム)後減圧留去した。残留物を酢酸エチル-
ヘキサンから再結晶させて目的物(4.70g,82
%)を得た。1 H-NMR(CDCl3)δ:1.29 (9H, s), 2.80-3.02 (3H, m),
5.06 (1H, d, J = 4.4 Hz), 6.80-6.90 (2H, m), 6.90-
7.02 (2H, m), 7.20-7.30 (3H, m), 7.42 (1H, s). IRν maxKBrcm-1:1713, 1705. mp 81-82℃ 4) (4RS,5SR)-4-(4-tert-ブトキシ
ルベンジル)-5-(3-クロロフェニル)-1,3-オキ
サゾリジン-2-オン (2RS,3RS)-2-(4-tert-ブトキシルベン
ジル)-3-(3-クロロフェニル)-3-ヒドロキシプロ
パン酸(4.50g,14.3ミリモル)のテトラヒド
ロフラン(150ml)溶液に、ジフェニルホスホリル
アジド(3.39ml,15.7ミリモル)とトリエチ
ルアミン(3.00ml,21.4ミリモル)を加え、
1時間加熱還流した。反応液を放冷後、減圧留去した。
残留物に水(200ml)を加え、酢酸エチルで抽出し
た。抽出液を水および飽和食塩水で洗浄し、乾燥(無水
硫酸マグネシウム)後減圧留去した。残留物をヘキサン
-酢酸エチルで再結晶し目的物(4.01g,80%)
を得た。1 H-NMR(CDCl3)δ:1.32 (9H, s), 2.18 (1H, dd, J = 1
3.8, 11.1 Hz), 2.28 (1H, dd, J = 13.8, 3.9 Hz), 4.
18-4.28 (1H, m), 4.95 (1H, s), 5.76 (1H, d, J= 7.8
Hz), 6.90-6.98 (2H, m), 7.24-7.30 (2H, m), 7.30-
7.40 (4H, m). IRν maxKBrcm-1:1734, 1507, 1476, 1435, 1391, 136
4. mp 165-166℃ Anal. Calcd for C20H22NO3Cl: C, 66.75; H, 6.16; N,
3.89 Found : C, 66.65; H, 6.26; N, 3.69. 5) (1RS,2SR)-2-アミノ-3-(4-ter
t-ブトキシルフェニル)-1-(3-クロロフェニル)プ
ロパン-1-オール (4RS,5SR)-4-(4-tert-ブトキシルベン
ジル)-5-(3-クロロフェニル)-1,3-オキサゾリ
ジン-2-オン(3.80g,10.6ミリモル)のエタ
ノール(20ml)溶液に8規定水酸化ナトリウム水溶
液(3.96ml,31.7ミリモル)を加え、80℃
にて6時間攪拌した。反応液に水(20ml)を加え、
酢酸エチル(50ml×2)で抽出した。抽出液を水お
よび飽和食塩水で洗浄し、乾燥(無水硫酸マグネシウ
ム)後減圧留去し、残留物をヘキサン-酢酸エチルで再
結晶し目的物(2.67g,76%)を得た。1 H-NMR(CDCl3)δ:1.32 (9H, s), 2.30 (1H, dd, J = 1
3.8, 10.4 Hz), 2.70 (1H, dd, J = 13.8, 3.4 Hz), 3.
22-3.34 (1H, m), 4.67 (1H, d, J = 4.8 Hz), 6.86-6.
96 (2H, m), 6.96-7.06 (2H, m), 7.20-7.34 (3H, m),
7.42 (1H, s). IRν maxKBrcm-1:1574,1507,1476,1366. mp 93-94℃ Anal. Calcd for C19H24NO2Cl: C, 68.35; H, 7.25; N,
4.20 Found : C, 68.21; H, 7.28; N, 4.18. 6) N-[(1RS,2SR)-1-(4-tert-ブ
トキシルベンジル)-2-(3-クロロフェニル)-2-ヒ
ドロキシエチル]-6,7-ジヒドロ-5H-ベンゾ[a]
[7]アンヌレン-1-カルボキサミド (1RS,2SR)-2-アミノ-3-(4-tert-ブト
キシルフェニル)-1-(3-クロロフェニル)プロパン-
1-オール(300mg,0.90ミリモル)のアセト
ニトリル(20ml)溶液に6,7-ジヒドロ-5H-ベ
ンゾ[a]シクロヘプテン-1-カルボン酸(169m
g,0.90ミリモル)および1-エチル-3-(3-ジメ
チルアミノプロピル)カルボジイミド・塩酸塩(258
mg,1.35ミリモル)および1-ヒドロキシベンゾ
トリアゾール水和物(138mg,0.90ミリモル)
を加えて室温で終夜攪拌した。反応液を水(100m
l)で希釈し、酢酸エチル(100ml×2)で抽出し
た。抽出液を水、飽和食塩水で順次洗浄し、乾燥(無水
硫酸マグネシウム)後減圧留去した。残留物をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
4:1-2:1)で精製し、酢酸エチル-ヘキサンから再
結晶させて、目的物(351mg,77%)を得た。1 H-NMR(CDCl3)δ:1.32 (9H, s), 1.90-2.08 (2H, m),
2.12-2.24 (2H, m), 2.60-2.76 (3H, m), 2.94 (1H, d
d, J = 14.6, 4.4 Hz), 4.32 (1H, d, J = 4.0 Hz), 4.
58-4.72 (1H, m), 5.00-5.08 (1H, m), 5.73 (1H, d, J
= 7.6 Hz), 5.92-6.08 (1H, m), 6.33 (1H, d, J = 1
2.0 Hz), 6.88-7.20 (7H, m), 7.24-7.36 (3H, m), 7.4
7 (1H, s). IRν maxKBrcm-1:1640, 1507. mp 180-181℃ Anal. Calcd for C31H34NO3Cl: C, 73.87; H, 6.80; N,
2.78 Found : C, 73.62; H, 6.81; N, 2.85.Example 276 1) 2- (4-tert-butoxylbenzyl) -3-
Ethyl (3-chlorophenyl) -3-oxopropanoate (4-tert-butoxyphenyl) methanol (5.0
g, 27.7 mmol) in acetic acid (70 ml) in methanesulfonyl chloride (2.36 ml, 30.5 mmol) and triethylamine (5.8 ml, 41.6).
Mmol) and stirred at room temperature for 2 hours. The insolubles were filtered, and the filtrate was distilled off under reduced pressure to prepare a mesyl compound. 3- (3-
Ethyl chlorophenyl) -3-oxopropanoate (6.2
9g, 27.7 mmol) in 1,2-dimethoxyethane (50 ml).
(0% oily, 27.7 mmol) and stirred at room temperature for 1 hour. The 1,2-dimethoxyethane (10 ml) solution of the mesyl compound previously prepared was added dropwise to the reaction solution, and the reaction solution was stirred at room temperature overnight. The reaction solution was acidified with 1N hydrochloric acid and extracted with ethyl acetate (300 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1) to obtain the desired product (8.26 g, 77%, crude). 2) Ethyl (2RS, 3RS) -2- (4-tert-butoxylbenzyl) -3- (3-chlorophenyl) -3-hydroxypropanoate Diethyl ether of zinc chloride (5.79 g, 42.5 mmol) Sodium borohydride (3.22 g, 85.0 mmol) was added to the solution at room temperature for 30 minutes.
Minutes. The insolubles were removed by filtration, and the filtrate was treated with 2- (4-tert-
-Butoxylbenzyl) -3- (3-chlorophenyl) -3-
A solution of ethyl oxopropanoate (8.26 g, 21.2 mmol) in diethyl ether (100 ml) was added at 0 ° C., and the mixture was stirred for 30 minutes. 1N hydrochloric acid was added to the reaction solution to stop the reaction, water (200 ml) was further added, and the mixture was extracted with ethyl acetate (200 ml × 2). The extract was washed with water and brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1-2: 1) to give the desired product (7.12 g, 86%). 1 H-NMR (CDCl 3 ) δ: 0.94 (3H, t, J = 7.0 Hz), 1.30 (9
H, s), 2.80-3.00 (3H, m), 3.12-3.22 (1H, m), 3.89
(2H, q, J = 7.0 Hz), 5.01 (1H, s), 6.80-6.88 (2H,
m), 6.92-7.00 (2H, m), 7.20-7.30 (3H, m), 7.42 (1
H, s). IRν max KBr cm -1 : 1726, 1609, 1597, 1574, 1507.3. (3) (2RS, 3RS) -2- (4-tert-butoxylbenzyl) -3- (3-chlorophenyl)- Ethyl 3-hydroxypropanoate (2RS, 3RS) -2- (4-tert-butoxylbenzyl) -3- (3-chlorophenyl) -3-hydroxypropanoate (7.12 g, 18.2 mmol) in methanol ( 2N aqueous sodium hydroxide solution (18.2 ml, 36.4 mmol) was added to the solution, and the mixture was stirred at room temperature overnight. The reaction mixture was concentrated, acidified with 1N hydrochloric acid, and extracted with ethyl acetate (200 ml × 2).
The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. Ethyl acetate-residue
Recrystallization from hexane gave the desired product (4.70 g, 82
%). 1 H-NMR (CDCl 3 ) δ: 1.29 (9H, s), 2.80-3.02 (3H, m),
5.06 (1H, d, J = 4.4 Hz), 6.80-6.90 (2H, m), 6.90-
7.02 (2H, m), 7.20-7.30 (3H, m), 7.42 (1H, s). IRν max KBr cm -1 : 1713, 1705. mp 81-82 ° C 4) (4RS, 5SR) -4- 4-tert-butoxylbenzyl) -5- (3-chlorophenyl) -1,3-oxazolidin-2-one (2RS, 3RS) -2- (4-tert-butoxylbenzyl) -3- (3-chlorophenyl In a solution of) -3-hydroxypropanoic acid (4.50 g, 14.3 mmol) in tetrahydrofuran (150 ml), diphenylphosphoryl azide (3.39 ml, 15.7 mmol) and triethylamine (3.00 ml, 21.4 mmol). And add
The mixture was refluxed for 1 hour. After allowing the reaction solution to cool, it was evaporated under reduced pressure.
Water (200 ml) was added to the residue, and the mixture was extracted with ethyl acetate. The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. Hexane residue
-Recrystallized from ethyl acetate to give the desired product (4.01 g, 80%)
I got 1 H-NMR (CDCl 3 ) δ: 1.32 (9H, s), 2.18 (1H, dd, J = 1
3.8, 11.1 Hz), 2.28 (1H, dd, J = 13.8, 3.9 Hz), 4.
18-4.28 (1H, m), 4.95 (1H, s), 5.76 (1H, d, J = 7.8
Hz), 6.90-6.98 (2H, m), 7.24-7.30 (2H, m), 7.30-
7.40 (4H, m) .IRν max KBr cm -1 : 1734, 1507, 1476, 1435, 1391, 136
4.mp 165-166 ℃ Anal. Calcd for C 20 H 22 NO 3 Cl: C, 66.75; H, 6.16; N,
3.89 Found: C, 66.65; H, 6.26; N, 3.69.5) (1RS, 2SR) -2-amino-3- (4-ter
t-butoxylphenyl) -1- (3-chlorophenyl) propan-1-ol (4RS, 5SR) -4- (4-tert-butoxylbenzyl) -5- (3-chlorophenyl) -1,3-oxazolidine To a solution of -2-one (3.80 g, 10.6 mmol) in ethanol (20 ml) was added an 8 N aqueous sodium hydroxide solution (3.96 ml, 31.7 mmol), and the mixture was heated at 80 ° C.
For 6 hours. Water (20 ml) was added to the reaction solution,
Extracted with ethyl acetate (50 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from hexane-ethyl acetate to obtain the desired product (2.67 g, 76%). 1 H-NMR (CDCl 3 ) δ: 1.32 (9H, s), 2.30 (1H, dd, J = 1
3.8, 10.4 Hz), 2.70 (1H, dd, J = 13.8, 3.4 Hz), 3.
22-3.34 (1H, m), 4.67 (1H, d, J = 4.8 Hz), 6.86-6.
96 (2H, m), 6.96-7.06 (2H, m), 7.20-7.34 (3H, m),
7.42 (1H, s) .IRν max KBr cm -1 : 1574,1507,1476,1366.mp 93-94 ° C Anal.Calcd for C 19 H 24 NO 2 Cl: C, 68.35; H, 7.25; N,
4.20 Found: C, 68.21; H, 7.28; N, 4.18.6) N-[(1RS, 2SR) -1- (4-tert-butoxylbenzyl) -2- (3-chlorophenyl) -2-hydroxyethyl ] -6,7-Dihydro-5H-benzo [a]
[7] Annulene-1-carboxamide (1RS, 2SR) -2-amino-3- (4-tert-butoxylphenyl) -1- (3-chlorophenyl) propane-
To a solution of 1-ol (300 mg, 0.90 mmol) in acetonitrile (20 ml) was added 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (169 m
g, 0.90 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (258
mg, 1.35 mmol) and 1-hydroxybenzotriazole hydrate (138 mg, 0.90 mmol)
Was added and stirred at room temperature overnight. The reaction solution was washed with water (100 m
1) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
4: 1-2: 1) and recrystallized from ethyl acetate-hexane to give the desired product (351 mg, 77%). 1 H-NMR (CDCl 3 ) δ: 1.32 (9H, s), 1.90-2.08 (2H, m),
2.12-2.24 (2H, m), 2.60-2.76 (3H, m), 2.94 (1H, d
d, J = 14.6, 4.4 Hz), 4.32 (1H, d, J = 4.0 Hz), 4.
58-4.72 (1H, m), 5.00-5.08 (1H, m), 5.73 (1H, d, J
= 7.6 Hz), 5.92-6.08 (1H, m), 6.33 (1H, d, J = 1
2.0 Hz), 6.88-7.20 (7H, m), 7.24-7.36 (3H, m), 7.4
7 (1H, s) .IRν max KBr cm -1 : 1640, 1507.mp 180-181 ° C Anal.Calcd for C 31 H 34 NO 3 Cl: C, 73.87; H, 6.80; N,
2.78 Found: C, 73.62; H, 6.81; N, 2.85.
【0409】実施例277 N-[(1RS,2SR)-1-(4-tert-ブトキシ
ルベンジル)-2-(3-クロロフェニル)-2-ヒドロキ
シエチル]-4-フルオロ-1-ナフトアミド (1RS,2SR)-2-アミノ-3-(4-tert-ブト
キシルフェニル)-1-(3-クロロフェニル)プロパン-
1-オール(300mg,0.90ミリモル)のアセト
ニトリル(20ml)溶液に4-フルオロナフタレンカ
ルボン酸(171mg,0.90ミリモル)および1-
エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩(258mg,1.35ミリモル)および
1-ヒドロキシベンゾトリアゾール水和物(138m
g,0.90ミリモル)を加えて室温で終夜攪拌した。
反応液を水(100ml)で希釈し、酢酸エチル(10
0ml×2)で抽出した。抽出液を水、飽和食塩水で順
次洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=4:1-2:1)で精製し、酢酸
エチル-ヘキサンから再結晶させて、目的物(278m
g,61%)を得た。1 H-NMR(CDCl3)δ:1.32 (9H, s), 2.73 (1H, dd, J = 1
4.6, 11.0 Hz), 3.01 (1H, dd, J = 14.6, 4.4 Hz), 4.
13 (1H, d, J = 4.0 Hz), 4.66-4.82 (1H, m), 5.10 (1
H, s), 5.87 (1H, d, J = 8.6 Hz), 6.90-7.02 (3H,
m), 7.04-7.16 (3H,m), 7.26-7.38 (3H, m), 7.44-7.60
(3H, m), 7.95 (1H, d, J = 7.6 Hz), 8.02-8.10 (1H,
m). IRν maxKBrcm-1:1640, 1626, 1599, 1582, 1507. mp 161-162℃ Anal. Calcd for C30H29NO3ClF: C, 71.21; H, 5.78;
N, 2.77 Found : C 71.10; H, 5.94; N, 2.53.Example 277 N-[(1RS, 2SR) -1- (4-tert-butoxylbenzyl) -2- (3-chlorophenyl) -2-hydroxyethyl] -4-fluoro-1-naphthamide (1RS , 2SR) -2-Amino-3- (4-tert-butoxylphenyl) -1- (3-chlorophenyl) propane-
To a solution of 1-ol (300 mg, 0.90 mmol) in acetonitrile (20 ml) was added 4-fluoronaphthalenecarboxylic acid (171 mg, 0.90 mmol) and 1-ol.
Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (258 mg, 1.35 mmol) and 1-hydroxybenzotriazole hydrate (138 m
g, 0.90 mmol) and stirred at room temperature overnight.
The reaction solution was diluted with water (100 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-2: 1) and recrystallized from ethyl acetate-hexane to give the desired product (278 m
g, 61%). 1 H-NMR (CDCl 3 ) δ: 1.32 (9H, s), 2.73 (1H, dd, J = 1
4.6, 11.0 Hz), 3.01 (1H, dd, J = 14.6, 4.4 Hz), 4.
13 (1H, d, J = 4.0 Hz), 4.66-4.82 (1H, m), 5.10 (1
H, s), 5.87 (1H, d, J = 8.6 Hz), 6.90-7.02 (3H,
m), 7.04-7.16 (3H, m), 7.26-7.38 (3H, m), 7.44-7.60
(3H, m), 7.95 (1H, d, J = 7.6 Hz), 8.02-8.10 (1H,
.. m) IRν max KBr cm -1: 1640, 1626, 1599, 1582, 1507. mp 161-162 ℃ Anal Calcd for C 30 H 29 NO 3 ClF: C, 71.21; H, 5.78;
N, 2.77 Found: C 71.10; H, 5.94; N, 2.53.
【0410】実施例278 N-[(1RS,2SR)-1-(4-tert-ブトキシ
ルベンジル)-2-(3-クロロフェニル)-2-ヒドロキ
シエチル]-5-クロロ-1-ナフトアミド (1RS,2SR)-2-アミノ-3-(4-tert-ブト
キシルフェニル)-1-(3-クロロフェニル)プロパン-
1-オール(300mg,0.90ミリモル)のアセト
ニトリル(20ml)溶液に5-クロロナフタレンカル
ボン酸(186mg,0.90ミリモル)および1-エ
チル-3-(3-ジメチルアミノプロピル)カルボジイミ
ド・塩酸塩(258mg,1.35ミリモル)および1
-ヒドロキシベンゾトリアゾール水和物(138mg,
0.90ミリモル)を加えて室温で終夜攪拌した。反応
液を水(100ml)で希釈し、酢酸エチル(100m
l×2)で抽出した。抽出液を水、飽和食塩水で順次洗
浄し、乾燥(無水硫酸マグネシウム)後減圧留去した。
残留物をシリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=4:1-2:1)で精製し、酢酸エチ
ル-ヘキサンから再結晶させて、目的物(136mg,
29%)を得た。1 H-NMR(CDCl3)δ:1.32 (9H, s), 2.72 (1H, dd, J = 1
4.4, 11.0 Hz), 3.00 (1H, dd, J = 14.4, 4.0 Hz), 3.
96 (1H, d, J = 3.6 Hz), 4.70-4.84 (1H, m), 5.09 (1
H, s), 5.90 (1H, d, J = 8.2 Hz), 6.93 (2H, d, J =
8.4 Hz), 7.10 (2H, d, J = 8.4 Hz), 7.14-7.62 (8H,
m), 7.78 (1H, d, J = 8.4 Hz), 8.32 (1H,d, J = 8.4
Hz). IRν maxKBrcm-1:1638, 1572, 1507. mp 132-133℃ Anal. Calcd for C30H29NO3Cl2: C, 68.97; H, 5.59;
N, 2.68 Found : C, 68.68; H, 5.69; N, 2.53.Example 278 N-[(1RS, 2SR) -1- (4-tert-butoxylbenzyl) -2- (3-chlorophenyl) -2-hydroxyethyl] -5-chloro-1-naphthamide (1RS , 2SR) -2-Amino-3- (4-tert-butoxylphenyl) -1- (3-chlorophenyl) propane-
In a solution of 1-ol (300 mg, 0.90 mmol) in acetonitrile (20 ml), 5-chloronaphthalenecarboxylic acid (186 mg, 0.90 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (258 mg, 1.35 mmol) and 1
-Hydroxybenzotriazole hydrate (138 mg,
(0.90 mmol) and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml), and ethyl acetate (100 ml) was added.
1 × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure.
The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-2: 1) and recrystallized from ethyl acetate-hexane to give the desired product (136 mg,
29%). 1 H-NMR (CDCl 3 ) δ: 1.32 (9H, s), 2.72 (1H, dd, J = 1
4.4, 11.0 Hz), 3.00 (1H, dd, J = 14.4, 4.0 Hz), 3.
96 (1H, d, J = 3.6 Hz), 4.70-4.84 (1H, m), 5.09 (1
H, s), 5.90 (1H, d, J = 8.2 Hz), 6.93 (2H, d, J =
8.4 Hz), 7.10 (2H, d, J = 8.4 Hz), 7.14-7.62 (8H,
m), 7.78 (1H, d, J = 8.4 Hz), 8.32 (1H, d, J = 8.4
Hz) .IRν max KBr cm -1 : 1638, 1572, 1507.mp 132-133 ℃ Anal. Calcd for C 30 H 29 NO 3 Cl 2 : C, 68.97; H, 5.59;
N, 2.68 Found: C, 68.68; H, 5.69; N, 2.53.
【0411】実施例279 (1RS,2SR)-2-(4-フルオロフェニル)-2-
ヒドロキシ-1-{3-[(トリフルオロメチル)スルホ
ニル]ベンジル}エチルカルバミン酸tert-ブチル 1) (4RS,5SR)-5-(4-フルオロフェニ
ル)-2-オキソ-4-{3-[(トリフルオロメチル)チ
オ]ベンジル}-1,3-オキサゾリジン-3-カルボン酸
tert-ブチル (4RS,5RS)-5-(4-フルオロフェニル)-4-
{3-[(トリフルオロメチル)チオ]ベンジル}-1,
3-オキサゾリジン-2-オン(2.06g,5.55ミ
リモル)のアセトニトリル(20ml)溶液に二炭酸ジ
-tert-ブチル(1.45g,6.66ミリモル)お
よび4-N,N-ジメチルピリジン(68mg,0.56
ミリモル)を加え、室温で1時間攪拌した。反応液に水
(100ml)を加え、酢酸エチル(100ml×2)
で抽出した。抽出液を水、飽和食塩水で順次洗浄し、乾
燥(無水硫酸マグネシウム)後減圧留去した。残留物を
シリカゲルカラムクロマトグラフィー(ヘキサン:酢酸
エチル=10:1-1:1)で精製し酢酸エチル-ヘキサ
ンから再結晶させて、目的物(2.17g,83%)を
得た。1 H-NMR(CDCl3)δ:1.54 (9H, s), 2.62 (1H, dd, J = 1
4.4, 9.0 Hz), 2.96 (1H,dd, J = 14.4, 4.0 Hz), 4.76
-4.88 (1H, m), 5.67 (1H, d, J = 6.8 Hz), 6.73 (1H,
d, J = 7.8 Hz), 6.82-7.00 (3H, m), 7.04-7.20 (3H,
m), 7.39 (1H, d, J = 7.8 Hz). IRν maxKBrcm-1:1823, 1725, 1611, 1597, 1514. mp 112-113℃ Anal. Calcd for C22H21NO4SF4: C, 56.05; H, 4.49;
N, 2.97 Found : C, 56.08; H, 4.56; N, 2.98. 2) (4RS,5SR)-5-(4-フルオロフェニ
ル)-2-オキソ-4-{3-[(トリフルオロメチル)ス
ルホニル]ベンジル}-1,3-オキサゾリジン-3-カル
ボン酸tert-ブチル (4RS,5SR)-5-(4-フルオロフェニル)-2-
オキソ-4-{3-[(トリフルオロメチル)チオ]ベン
ジル}-1,3-オキサゾリジン-3-カルボン酸tert
-ブチル(1.0g,2.12ミリモル)のアセトニト
リル(100ml)溶液に過よう素酸ナトリウム(1.
36g,6.36ミリモル)の水溶液(50ml)を加
えた。反応液を10分攪拌後、塩化ルテニウム(41m
g,0.21ミリモル)を加え、終夜攪拌した。反応液
を濃縮後、水(100ml)を加え、酢酸エチル(20
0ml×2)で抽出した。抽出液を水および飽和食塩水
で洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去し
た。残留物を酢酸エチル-ヘキサンから再結晶させて、
目的物(0.93g,87%)を得た。1 H-NMR(CDCl3)δ:1.54 (9H, s), 2.76 (1H, dd, J = 1
4.6, 9.2 Hz), 3.03 (1H,dd, J = 14.6, 4.0 Hz), 4.78
-4.92 (1H, m), 5.70 (1H, d, J = 6.8 Hz), 6.90-7.20
(5H, m), 7.30-7.44 (2H, m), 7.79 (1H, d, J = 8.2
Hz). IRν maxKBrcm-1:1817, 1725, 1611, 1514. mp 158-159℃ Anal. Calcd for C22H21NO6SF4: C, 52.48; H, 4.20;
N, 2.78; F, 15.09; S, 6.37 Found : C, 52.51; H, 4.00; N, 2.55; F, 15.06; S,
6.40. 3) (1RS,2SR)-2-(4-フルオロフェニ
ル)-2-ヒドロキシ-1-{3-[(トリフルオロメチ
ル)スルホニル]ベンジル}エチルカルバミン酸ter
t-ブチル (4RS,5SR)-5-(4-フルオロフェニル)-2-
オキソ-4-{3-[(トリフルオロメチル)スルホニ
ル]ベンジル}-1,3-オキサゾリジン-3-カルボン酸
tert-ブチル(0.90g,1.79ミリモル)の
メタノール(10ml)溶液に0.5規定水酸化ナトリ
ウムのメタノール溶液(10.8ml,5.40ミリモ
ル)を加え室温で30分攪拌した。反応液に水(50m
l)を加えて酢酸エチル(100ml×2)で抽出し
た。抽出液を飽和食塩水で洗浄し、乾燥(無水硫酸マグ
ネシウム)後減圧留去した。残留物を酢酸エチル-ヘキ
サンから再結晶させて目的物(0.72g,84%)を
得た。1 H-NMR(CDCl3)δ:1.31 (9H, s), 2.74-3.00 (3H, m),
3.96-4.16 (1H, m), 4.69(1H, d, J = 8.4 Hz), 4.95
(1H, s), 7.02-7.14 (2H, m), 7.32-7.44 (2H, m), 7.5
0-7.64 (2H, m), 7.77 (1H, s), 7.87 (1H, d, J = 6.6
Hz). IRν maxKBrcm-1:1694, 1510, 1368. mp 152-153℃ Anal. Calcd for C21H23NO5SF4: C, 52.83; H, 4.86;
N, 2.93 Found : C, 52.67; H, 4.74; N, 2.97.Example 279 (1RS, 2SR) -2- (4-fluorophenyl) -2-
Tert-butyl hydroxy-1- {3-[(trifluoromethyl) sulfonyl] benzyl} ethylcarbamate 1) (4RS, 5SR) -5- (4-fluorophenyl) -2-oxo-4- {3- [ Tert-Butyl (trifluoromethyl) thio] benzyl} -1,3-oxazolidine-3-carboxylate (4RS, 5RS) -5- (4-fluorophenyl) -4-
{3-[(trifluoromethyl) thio] benzyl} -1,
To a solution of 3-oxazolidine-2-one (2.06 g, 5.55 mmol) in acetonitrile (20 ml) was added dicarbonate.
-tert-butyl (1.45 g, 6.66 mmol) and 4-N, N-dimethylpyridine (68 mg, 0.56
Mmol) and stirred at room temperature for 1 hour. Water (100 ml) was added to the reaction solution, and ethyl acetate (100 ml × 2) was added.
Extracted. The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1-1: 1) and recrystallized from ethyl acetate-hexane to obtain the desired product (2.17 g, 83%). 1 H-NMR (CDCl 3 ) δ: 1.54 (9H, s), 2.62 (1H, dd, J = 1
4.4, 9.0 Hz), 2.96 (1H, dd, J = 14.4, 4.0 Hz), 4.76
-4.88 (1H, m), 5.67 (1H, d, J = 6.8 Hz), 6.73 (1H,
d, J = 7.8 Hz), 6.82-7.00 (3H, m), 7.04-7.20 (3H,
m), 7.39 (1H, d, J = 7.8 Hz) .IRν max KBr cm -1 : 1823, 1725, 1611, 1597, 1514.mp 112-113 ℃ Anal.Calcd for C 22 H 21 NO 4 SF 4 : C, 56.05; H, 4.49;
N, 2.97 Found: C, 56.08; H, 4.56; N, 2.98.2) (4RS, 5SR) -5- (4-fluorophenyl) -2-oxo-4- {3-[(trifluoromethyl) sulfonyl Tert-Butyl benzyl} -1,3-oxazolidine-3-carboxylate (4RS, 5SR) -5- (4-fluorophenyl) -2-
Oxo-4- {3-[(trifluoromethyl) thio] benzyl} -1,3-oxazolidine-3-carboxylic acid tert
To a solution of -butyl (1.0 g, 2.12 mmol) in acetonitrile (100 ml) was added sodium periodate (1.
36 g, 6.36 mmol) of an aqueous solution (50 ml) was added. After stirring the reaction solution for 10 minutes, ruthenium chloride (41 m
g, 0.21 mmol) and stirred overnight. After concentrating the reaction solution, water (100 ml) was added and ethyl acetate (20 ml) was added.
0 ml × 2). The extract was washed with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane,
The desired product (0.93 g, 87%) was obtained. 1 H-NMR (CDCl 3 ) δ: 1.54 (9H, s), 2.76 (1H, dd, J = 1
4.6, 9.2 Hz), 3.03 (1H, dd, J = 14.6, 4.0 Hz), 4.78
-4.92 (1H, m), 5.70 (1H, d, J = 6.8 Hz), 6.90-7.20
(5H, m), 7.30-7.44 (2H, m), 7.79 (1H, d, J = 8.2
Hz) .IRν max KBr cm -1 : 1817, 1725, 1611, 1514.mp 158-159 ℃ Anal. Calcd for C 22 H 21 NO 6 SF 4 : C, 52.48; H, 4.20;
N, 2.78; F, 15.09; S, 6.37 Found: C, 52.51; H, 4.00; N, 2.55; F, 15.06; S,
6.40. 3) (1RS, 2SR) -2- (4-Fluorophenyl) -2-hydroxy-1- {3-[(trifluoromethyl) sulfonyl] benzyl} ethylcarbamic acid ter
t-butyl (4RS, 5SR) -5- (4-fluorophenyl) -2-
To a solution of tert-butyl oxo-4- {3-[(trifluoromethyl) sulfonyl] benzyl} -1,3-oxazolidine-3-carboxylate (0.90 g, 1.79 mmol) in methanol (10 ml) was added a solution of 0.1 g in methanol (10 ml). A methanol solution of 5N sodium hydroxide (10.8 ml, 5.40 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. Water (50m
1) and extracted with ethyl acetate (100 ml × 2). The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to obtain the desired product (0.72 g, 84%). 1 H-NMR (CDCl 3 ) δ: 1.31 (9H, s), 2.74-3.00 (3H, m),
3.96-4.16 (1H, m), 4.69 (1H, d, J = 8.4 Hz), 4.95
(1H, s), 7.02-7.14 (2H, m), 7.32-7.44 (2H, m), 7.5
0-7.64 (2H, m), 7.77 (1H, s), 7.87 (1H, d, J = 6.6
Hz) .IRν max KBr cm -1 : 1694, 1510, 1368.mp 152-153 ℃ Anal. Calcd for C 21 H 23 NO 5 SF 4 : C, 52.83; H, 4.86;
N, 2.93 Found: C, 52.67; H, 4.74; N, 2.97.
【0412】実施例280 N-((1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-{3-[(トリフルオロメチル)ス
ルホニル]ベンジル}エチル)-6,7-ジヒドロ-5H-
ベンゾ[a][7]アンヌレン-1-カルボキサミド 1) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-{3-[(トリフルオロメチル)スル
ホニル]フェニル}プロパン-1-オール (1RS,2SR)-2-(4-フルオロフェニル)-2-
ヒドロキシ-1-{3-[(トリフルオロメチル)スルホ
ニル]ベンジル}エチルカルバミン酸tert-ブチル
(620mg,1.30ミリモル)にトリフルオロ酢酸
(5ml)を加え、0℃で10分攪拌した。反応液を濃
縮後、飽和重曹水を加え、酢酸エチル(30ml×2)
で抽出した。抽出液を飽和食塩水で洗浄し、乾燥(無水
硫酸マグネシウム)後減圧留去し目的物(0.52g,
100%)を得た。1 H-NMR(CDCl3)δ:2.55 (1H, dd, J = 13.8, 9.9 Hz),
2.98 (1H, dd, J = 13.8,3.0 Hz), 3.22-3.36 (1H, m),
4.63 (1H, d, J = 5.1 Hz), 7.02-7.12 (2H, m), 7.30
-7.42 (2H, m), 7.52-7.70 (2H, m), 7.85 (1H, s), 7.
90 (1H, d, J = 8.4 Hz). IRν maxKBrcm-1:1603, 1508, 1431, 1366. 2) N-((1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-{3-[(トリフルオロメチ
ル)スルホニル]ベンジル}エチル)-6,7-ジヒドロ
-5H-ベンゾ[a][7]アンヌレン-1-カルボキサミ
ド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-{3-[(トリフルオロメチル)スルホニ
ル]フェニル}プロパン-1-オール(260mg,0.
69ミリモル)のアセトニトリル(20ml)溶液に
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボン酸(130mg,0.69ミリモル)および
1-エチル-3-(3-ジメチルアミノプロピル)カルボジ
イミド・塩酸塩(198mg,1.03ミリモル)およ
び1-ヒドロキシベンゾトリアゾール水和物(105m
g,0.69ミリモル)を加えて室温で終夜攪拌した。
反応液を水(100ml)で希釈し、酢酸エチル(10
0ml×2)で抽出した。抽出液を水、飽和食塩水で順
次洗浄し、乾燥(無水硫酸マグネシウム)後減圧留去し
た。残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=4:1-2:1)で精製し、酢酸
エチル-ヘキサンから再結晶させて、目的物(252m
g,67%)を得た。1 H-NMR(CDCl3)δ:1.90-2.06 (2H, m), 2.12-2.26 (2H,
m), 2.60-2.70 (2H, m),2.90-3.20 (3H, m), 4.60-4.80
(1H, m), 5.04 (1H, s), 5.82-5.98 (2H, m),6.13 (1
H, d, J = 11.8 Hz), 6.95 (1H, dd, J = 7.4, 1.8 H
z), 7.00-7.20 (4H, m), 7.40-7.50 (2H, m), 7.52-7.6
4 (1H, m), 7.70 (1H, d, J = 7.6 Hz), 7.81 (1H, s),
7.89 (1H, d, J = 7.8 Hz). IRν maxKBrcm-1:1638, 1508, 1449, 1366. mp 156-157℃ Anal. Calcd for C28H25NO4SF4: C, 61.42; H, 4.60;
N, 2.56 Found : C, 61.25; H, 4.57; N, 2.57.Example 280 N-((1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- {3-[(trifluoromethyl) sulfonyl] benzyl} ethyl) -6,7-dihydro-5H-
Benzo [a] [7] annulene-1-carboxamide 1) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- {3-[(trifluoromethyl) sulfonyl] phenyl} propane- 1-ol (1RS, 2SR) -2- (4-fluorophenyl) -2-
Trifluoroacetic acid (5 ml) was added to tert-butyl hydroxy-1- {3-[(trifluoromethyl) sulfonyl] benzyl} ethylcarbamate (620 mg, 1.30 mmol), and the mixture was stirred at 0 ° C. for 10 minutes. After concentrating the reaction solution, saturated aqueous sodium hydrogen carbonate was added, and ethyl acetate (30 ml × 2) was added.
Extracted. The extract was washed with brine, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure to give the desired product (0.52 g,
100%). 1 H-NMR (CDCl 3 ) δ: 2.55 (1H, dd, J = 13.8, 9.9 Hz),
2.98 (1H, dd, J = 13.8,3.0 Hz), 3.22-3.36 (1H, m),
4.63 (1H, d, J = 5.1 Hz), 7.02-7.12 (2H, m), 7.30
-7.42 (2H, m), 7.52-7.70 (2H, m), 7.85 (1H, s), 7.
90 (1H, d, J = 8.4 Hz). IRν max KBr cm -1 : 1603, 1508, 1431, 1366. 2) N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy -1- {3-[(Trifluoromethyl) sulfonyl] benzyl} ethyl) -6,7-dihydro
-5H-benzo [a] [7] annulene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- {3-[(trifluoromethyl) sulfonyl] phenyl} propane -1-ol (260 mg, 0.
6,7-dihydro-5H-benzo [a] cycloheptene-1 in a solution of 69 mmol) in acetonitrile (20 ml).
-Carboxylic acid (130 mg, 0.69 mmol), 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (198 mg, 1.03 mmol) and 1-hydroxybenzotriazole hydrate (105 m
g, 0.69 mmol) and stirred at room temperature overnight.
The reaction solution was diluted with water (100 ml), and ethyl acetate (10 ml) was added.
0 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 4: 1-2: 1) and recrystallized from ethyl acetate-hexane to give the desired product (252 m 2).
g, 67%). 1 H-NMR (CDCl 3 ) δ: 1.90-2.06 (2H, m), 2.12-2.26 (2H,
m), 2.60-2.70 (2H, m), 2.90-3.20 (3H, m), 4.60-4.80
(1H, m), 5.04 (1H, s), 5.82-5.98 (2H, m), 6.13 (1
H, d, J = 11.8 Hz), 6.95 (1H, dd, J = 7.4, 1.8 H
z), 7.00-7.20 (4H, m), 7.40-7.50 (2H, m), 7.52-7.6
4 (1H, m), 7.70 (1H, d, J = 7.6 Hz), 7.81 (1H, s),
7.89 (1H, d, J = 7.8 Hz) IRν max KBr cm -1: 1638, 1508, 1449, 1366. mp 156-157 ℃ Anal Calcd for C 28 H 25 NO 4 SF 4:.. C, 61.42; H , 4.60;
N, 2.56 Found: C, 61.25; H, 4.57; N, 2.57.
【0413】実施例281 4-フルオロ-N-((1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-{3-[(トリフルオ
ロメチル)スルホニル]ベンジル}エチル)-1-ナフト
アミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-{3-[(トリフルオロメチル)スルホニ
ル]フェニル}プロパン-1-オール(260mg,0.
69ミリモル)のアセトニトリル(20ml)溶液に4
-フルオロナフタレンカルボン酸(131mg,0.6
9ミリモル)および1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド・塩酸塩(198mg,1.
03ミリモル)および1-ヒドロキシベンゾトリアゾー
ル水和物(105mg,0.69ミリモル)を加えて室
温で終夜攪拌した。反応液を水(100ml)で希釈
し、酢酸エチル(100ml×2)で抽出した。抽出液
を水、飽和食塩水で順次洗浄し、乾燥(無水硫酸マグネ
シウム)後減圧留去した。残留物をシリカゲルカラムク
ロマトグラフィー(ヘキサン:酢酸エチル=4:1-
2:1)で精製し、酢酸エチル-ヘキサンから再結晶さ
せて、目的物(218mg,58%)を得た。1 H-NMR(CDCl3)δ:2.84-3.20 (3H, m), 4.70-4.86 (1H,
m), 5.09 (1H, s), 6.10(1H, d, J = 9.0 Hz), 6.96-7.
24 (4H, m), 7.40-7.62 (5H, m), 7.64-7.80 (2H, m),
7.84-7.94 (2H, m), 8.08 (1H, d, J = 7.6 Hz). IRν maxKBrcm-1:1642, 1626, 1601, 1514, 1369. mp 157-158℃ Anal. Calcd for C27H20NO4SF5: C, 59.01; H, 3.67;
N, 2.55 Found : C, 58.88; H, 3.64; N, 2.53.Example 281 4-Fluoro-N-((1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- {3-[(trifluoromethyl) sulfonyl] benzyl} ethyl)- 1-Naphthamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- {3-[(trifluoromethyl) sulfonyl] phenyl} propan-1-ol (260 mg, 0.
69 mmol) in acetonitrile (20 ml) solution.
-Fluoronaphthalenecarboxylic acid (131 mg, 0.6
9 mmol) and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (198 mg, 1.
03 mmol) and 1-hydroxybenzotriazole hydrate (105 mg, 0.69 mmol) were added and stirred at room temperature overnight. The reaction solution was diluted with water (100 ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed successively with water and saturated saline, dried (anhydrous magnesium sulfate) and evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 4: 1-
2: 1) and recrystallized from ethyl acetate-hexane to give the desired product (218 mg, 58%). 1 H-NMR (CDCl 3 ) δ: 2.84-3.20 (3H, m), 4.70-4.86 (1H,
m), 5.09 (1H, s), 6.10 (1H, d, J = 9.0 Hz), 6.96-7.
24 (4H, m), 7.40-7.62 (5H, m), 7.64-7.80 (2H, m),
7.84-7.94 (2H, m), 8.08 (1H, d, J = 7.6 Hz) IRν max KBr cm -1:.. 1642, 1626, 1601, 1514, 1369. mp 157-158 ℃ Anal Calcd for C 27 H 20 NO 4 SF 5 : C, 59.01; H, 3.67;
N, 2.55 Found: C, 58.88; H, 3.64; N, 2.53.
【0414】実施例282 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-(3-イソプロポキシベンジル)エ
チル]-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプ
テン-1-カルボキサミド 1) 3-イソプロピルオキシ安息香酸エチル 3-ヒドロキシ安息香酸エチル(15.2g,0.10
モル)のN,N-ジメチルホルムアミド(100ml)
溶液に、臭化イソプロピル(12.1ml,0.13モ
ル)とヨウ化ナトリウム(19.5g,0.13モル)
を加えて70℃で15時間攪拌した。反応液に水(50
0ml)を加えて酢酸エチル(500,200ml)で
抽出した。抽出液を水洗し、無水硫酸マグネシウムで乾
燥後、減圧留去した。残留物をシリカゲルクロマトグラ
フィー(ヘキサン:酢酸エチル=10:1)で精製し
て、目的物(12.4g,64%)を油状物として得
た。1 H-NMR(CDCl3)δ: 1.35(6H, d, J = 6.2 Hz), 3.90(3H,
s), 4.55-4.65(1H, m),7.07(1H, dd, J = 8.2, 1.8 H
z), 7.33(1H, t, J = 8.2 Hz), 7.50-7.70(2H, m). 2) 3-イソプロピルオキシベンジルアルコール 3-イソプロピルオキシ安息香酸エチル(12.0g,
61.8ミリモル)のテトラヒドロフラン(100m
l)溶液に、氷冷下水素化リチウムアルミニウム(3.
52g,92.7ミリモル)を少量ずつ加えた。室温で
1時間攪拌した後、氷冷下で水(10ml)を加えて分
解した。不溶物を濾去した後、溶媒を減圧留去した。残
留物をシリカゲルクロマトグラフィー(ヘキサン:酢酸
エチル=3:1)で精製して、目的物(10.0g,9
7%)を油状物として得た。1 H-NMR(CDCl3) δ: 1.34(6H, d, J = 6.4 Hz), 4.50-
4.65(1H, m), 4.66(1H, d, J = 6.2 Hz), 6.78-6.90(1
H, m), 6.90-7.00(2H, m), 7.26(1H, t, J = 8.2 Hz). 3) 3-(4-フルオロフェニル)-3-オキソ-2-[3
-(イソプロピルオキシ)ベンジル]プロパン酸エチル 3-イソプロピルオキシベンジルアルコール(7.31
g,44ミリモル)の酢酸エチル(50ml)溶液に、
氷冷下塩化メタンスルホニル(3.56ml,46ミリ
モル)とトリエチルアミン(6.69ml,48ミリモ
ル)を加えて室温で2.5時間攪拌した。不溶物を濾去
し、溶媒を減圧留去し、メシレートを得た。3-(4-フ
ルオロフェニル)-3-オキソプロパン酸エチル(8.4
1g,40ミリモル)のジメトキシエタン(50ml)
溶液に、氷冷下水素化ナトリウム(1.60g,60%
油性,40ミリモル)を加えて1時間撹拌した。これに
上で得たメシレートのジメトキシエタン(20ml)溶
液を滴下し、室温で10時間撹拌した。反応液に水(2
00ml)を加えて酢酸エチル(200ml)で抽出し
た。抽出液を水洗し、無水硫酸マグネシウムで乾燥後、
減圧留去した。残留物をシリカゲルクロマトグラフィー
(ヘキサン:酢酸エチル=10:1-5:1)で精製し
て、目的物(12.5g,87%)を得た。 IRνmaxNeatcm-1:1736, 1688, 1599, 1508, 1258, 123
3, 1157.1 H-NMR(CDCl3) δ: 1.13(3H, t, J = 7.2 Hz), 1.30(6
H, d, J = 6.2 Hz), 3.28(2H, d, J = 7.4 Hz), 4.15(2
H, q, J = 7.2 Hz), 4.57(1H, d, J = 7.8 Hz), 4.40-
4.60(1H, m), 6.60-6.80(3H, m), 7.00-7.25(3H, m),
7.90-8.10(2H, m). 4) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[3-(イソプロピルオキシ)
ベンジル]プロパン酸エチル 無水塩化亜鉛(9.12g,67.0ミリモル)のジエ
チルエーテル(100ml)懸濁液に、水素化ホウ素ナ
トリウム(5.07g,134ミリモル)を少量ずつ加
えて、2時間撹拌した。不溶物を濾去し、ジエチルエー
テルで洗浄した。濾液を氷冷し、これに3-(4-フルオ
ロフェニル)-3-オキソ-2-[3-(イソプロピルオキ
シ)ベンジル]プロパン酸エチル(12.0g,33.
5ミリモル)のジエチルエーテル(20ml)溶液を加
えた。室温で2時間撹拌した後、再び氷冷し、1規定塩
酸で反応を止めた。混合物を水洗後、無水硫酸マグネシ
ウムで乾燥し、減圧留去した。残留物をシリカゲルクロ
マトグラフィー(ヘキサン:酢酸エチル=10:1)で
精製して、目的物(10g,83%)を無色油状物とし
て得た。 IRνmaxNeatcm-1:1728, 1603, 1510, 1260, 1157.1 H-NMR(CDCl3) δ: 0.94(3H, t, J = 7.2 Hz), 1.30(6
H, d, J = 6.2 Hz), 2.80-3.00(4H, m), 3.89(2H, d, J
= 7.2 Hz), 4.40-4.60(1H, m), 5.01(1H, s), 6.58-6.
75(3H, m), 6.98-7.20(3H, m), 7.30-7.45(2H, m). 5) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[3-(イソプロピルオキシ)
ベンジル]プロパン酸 (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[3-(イソプロピルオキシ)ベンジ
ル]プロパン酸エチル(9.8g,27.2ミリモル)
のメタノール(50ml)溶液に2規定水酸化ナトリウ
ム水溶液(27.2ml,54.4ミリモル)を加えて
室温で3時間撹拌した。反応液に6規定塩酸(100m
l)を加えて酸性とした後、酢酸エチル(200,10
0ml)で抽出した。抽出液を水洗し、無水硫酸マグネ
シウムで乾燥後、減圧留去した。残留物をヘキサンから
結晶化させて、目的物(7.44g,82%)を得た。 mp 101-102℃ IRνmaxKBrcm-1:1694, 1514, 1451, 1292, 1260, 1229,
1152, 1119. Anal. Calcd for C19H21FO4 (MW332.37) Calcd: C, 68.66; H, 6.37 Found: C, 68.52; H, 6.371 H-NMR(CDCl3) δ: 1.29(6H, d, J = 6.2 Hz), 2.80-3.
15(3H, m), 4.40-4.60(1H, m), 5.00-5.10(1H, m), 6.5
5-6.80(3H, m), 6.95-7.20(3H, m), 7.30-7.45(2H, m). 6) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-[3-(イソプロピルオキシ)ベンジル]-1,
3-オキサゾリジン-2-オン (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[3-(イソプロピルオキシ)ベンジ
ル]プロパン酸(7.14g,21.5ミリモル)のテ
トラヒドロフラン(100ml)溶液にアジ化ジフェニ
ルホスホリル(6.0ml,27.9ミリモル)とトリ
エチルアミン(4.19ml,30.1ミリモル)を加
えて室温で1時間撹拌した。その後、5時間加熱還流し
た後、反応液を減圧濃縮し、飽和重曹水(100ml)
を加えて酢酸エチル(200ml)で抽出した。抽出液
を水で洗浄し、無水硫酸マグネシウムで乾燥後、減圧留
去した。残留物をシリカゲルクロマトグラフィー(ヘキ
サン:酢酸エチル=4:1-2:1)で精製して、目的
物(14.7g,91%)を得た。 mp 114-115℃ IRνmaxKBrcm-1:1738, 1582, 1514, 1385, 1248, 1227,
1157. Anal. Calcd for C19H20FNO3 (MW329.36) Calcd: C, 69.29; H, 6.12; N, 4.25 Found: C, 69.27; H, 6.16; N, 4.26.1 H-NMR(CDCl3) δ: 1.32(6H, d, J = 6.0 Hz), 2.05-2.
35(2H, m), 4.15-4.60(1H, m), 4.96(1H, brs), 5.78(1
H, d, J = 7.6 Hz), 6.50-6.65(2H, m), 6.70-6.80(1H,
m), 7.00-7.25(3H, m), 7.30-7.45(2H, m). 7) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-[3-(イソプロピルオキシ)フェニ
ル]-1-プロパノール (4RS,5SR)-5-(4-フルオロフェニル)-4-
[3-(イソプロピルオキシ)ベンジル]-1,3-オキ
サゾリジン-2-オン(5.85g,17.8ミリモル)
のエタノール(30ml)溶液に、8規定水酸化ナトリ
ウム水溶液(8.9ml,71.0ミリモル)を加えて
5時間加熱還流した。反応液を減圧濃縮し、水(100
ml)を加えて酢酸エチル(100ml×2)で抽出し
た。抽出液を水洗し、無水硫酸マグネシウムで乾燥後、
減圧留去した。残留物をヘキサン-ジエチルエーテルか
ら結晶化させて、目的物(5.0g,93%)を得た。 mp 98-99℃ IRνmaxKBrcm-1:3364, 1605, 1582, 1508, 1252, 1211,
1154, 1044. Anal. Calcd for C18H22FNO2 (MW303.37) Calcd: C, 71.26; H, 7.31; N, 4.62 Found: C, 71.30; H, 7.46; N, 4.55.1 H-NMR(CDCl3) δ: 1.32(6H, d, J = 6.0 Hz), 2.28(1
H, dd, J = 13.6, 10.2 Hz), 2.73(1H, dd, J = 13.6,
3.0 Hz), 3.20-3.40(1H, m), 4.45-4.60(1H, m),4.67(1
H, d, J = 4.8 Hz), 6.60-6.80(3H, m), 7.00-7.45(5H,
m). 8) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-(3-イソプロポキシベンジ
ル)エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(イソプロピルオキシ)フェニル]-1
-プロパノール(0.46g,1.5ミリモル)と6,
7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カ
ルボン酸(0.34g,1.8ミリモル)のアセトニト
リル(20ml)溶液に、1-エチル-3-(3-ジメチル
アミノプロピル)カルボジイミド・塩酸塩(0.36
g,2.1ミリモル)と1-ヒドロキシベンゾトリアゾ
ール水和物(0.32g,2.1ミリモル)を加えて室
温で5時間攪拌した。反応液に水(100ml)を加え
て酢酸エチル(100ml×2)で抽出した。抽出液を
水で洗浄し、無水硫酸マグネシウムで乾燥後、減圧留去
した。残留物をシリカゲルクロマトグラフィー(ヘキサ
ン:酢酸エチル=4:1)で精製して、目的物(0.5
5g,77%)を結晶として得た。 mp 161-162℃ IRνmaxKBrcm-1:3274, 1638, 1510, 1258, 1225, 833. Anal. Calcd for C30H32FNO3 (MW473.58) Calcd: C, 76.08; H, 6.81; N, 2.96 Found: C, 76.10; H, 6.73; N, 2.89.1 H-NMR(CDCl3) δ: 1.30(6H, d, J = 6.0 Hz), 1.90-2.
10(2H, m), 2.10-2.30(2H, m), 2.60-2.80(2H, m), 2.9
6(1H, dd, J = 14.0, 4.4 Hz), 4.10(1H, d, J =4.4 H
z), 4.40-4.60(1H, m), 4.60-4.80(1H, m), 5.00-5.10
(1H, m), 5.66(1H,d, J = 7.8 Hz), 5.90-6.00(1H, m),
6.40(1H, d, J = 11.8 Hz), 6.65-6.85(3H, m), 6.95-
7.25(7H, m), 7.35-7.50(2H, m).Example 282 N-[(1RS, 2SR) -2- (4-fluorophenyl)
2-Hydroxy-1- (3-isopropoxybenzyl) ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1) Ethyl 3-isopropyloxybenzoate Ethyl 3-hydroxybenzoate ( 15.2 g, 0.10
Mol) N, N-dimethylformamide (100 ml)
Add isopropyl bromide (12.1 ml, 0.13 mol) and sodium iodide (19.5 g, 0.13 mol) to the solution.
Was added and stirred at 70 ° C. for 15 hours. Add water (50
0 ml) and extracted with ethyl acetate (500, 200 ml). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 10: 1) to give the desired product (12.4 g, 64%) as an oil. 1 H-NMR (CDCl 3 ) δ: 1.35 (6H, d, J = 6.2 Hz), 3.90 (3H,
s), 4.55-4.65 (1H, m), 7.07 (1H, dd, J = 8.2, 1.8 H
z), 7.33 (1H, t, J = 8.2 Hz), 7.50-7.70 (2H, m). 2) 3-isopropyloxybenzyl alcohol ethyl 3-isopropyloxybenzoate (12.0 g,
61.8 mmol) of tetrahydrofuran (100 m
1) Lithium aluminum hydride (3.
52 g, 92.7 mmol) were added in small portions. After stirring at room temperature for 1 hour, water (10 ml) was added under ice cooling to decompose. After filtering off the insoluble matter, the solvent was distilled off under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 3: 1) to give the desired product (10.0 g, 9 g).
7%) as an oil. 1 H-NMR (CDCl 3 ) δ: 1.34 (6H, d, J = 6.4 Hz), 4.50-
4.65 (1H, m), 4.66 (1H, d, J = 6.2 Hz), 6.78-6.90 (1
H, m), 6.90-7.00 (2H, m), 7.26 (1H, t, J = 8.2 Hz). 3) 3- (4-Fluorophenyl) -3-oxo-2- [3
-(Isopropyloxy) benzyl] ethyl propanoate 3-isopropyloxybenzyl alcohol (7.31
g, 44 mmol) in ethyl acetate (50 ml).
Under ice cooling, methanesulfonyl chloride (3.56 ml, 46 mmol) and triethylamine (6.69 ml, 48 mmol) were added, and the mixture was stirred at room temperature for 2.5 hours. The insoluble material was removed by filtration, and the solvent was distilled off under reduced pressure to obtain mesylate. Ethyl 3- (4-fluorophenyl) -3-oxopropanoate (8.4
1 g, 40 mmol) of dimethoxyethane (50 ml)
To the solution was added sodium hydride (1.60 g, 60%
(Oily, 40 mmol) and stirred for 1 hour. A solution of the mesylate obtained above in dimethoxyethane (20 ml) was added dropwise thereto, and the mixture was stirred at room temperature for 10 hours. Water (2
00 ml) and extracted with ethyl acetate (200 ml). After washing the extract with water and drying over anhydrous magnesium sulfate,
The solvent was distilled off under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 10: 1-5: 1) to obtain the desired product (12.5 g, 87%). IRνmax Neat cm -1 : 1736, 1688, 1599, 1508, 1258, 123
3, 1157. 1 H-NMR ( CDCl 3) δ: 1.13 (3H, t, J = 7.2 Hz), 1.30 (6
H, d, J = 6.2 Hz), 3.28 (2H, d, J = 7.4 Hz), 4.15 (2
H, q, J = 7.2 Hz), 4.57 (1H, d, J = 7.8 Hz), 4.40-
4.60 (1H, m), 6.60-6.80 (3H, m), 7.00-7.25 (3H, m),
7.90-8.10 (2H, m). 4) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- [3- (isopropyloxy)
Ethyl benzyl] propanoate To a suspension of anhydrous zinc chloride (9.12 g, 67.0 mmol) in diethyl ether (100 ml) was added sodium borohydride (5.07 g, 134 mmol) little by little and stirred for 2 hours. did. The insolubles were removed by filtration and washed with diethyl ether. The filtrate was ice-cooled, and ethyl 3- (4-fluorophenyl) -3-oxo-2- [3- (isopropyloxy) benzyl] propanoate (12.0 g, 33.0 g) was added.
(5 mmol) in diethyl ether (20 ml) was added. After stirring at room temperature for 2 hours, the mixture was ice-cooled again and the reaction was stopped with 1N hydrochloric acid. The mixture was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 10: 1) to give the desired product (10 g, 83%) as a colorless oil. IRνmax Neat cm -1: 1728, 1603 , 1510, 1260, 1157. 1 H-NMR (CDCl 3) δ: 0.94 (3H, t, J = 7.2 Hz), 1.30 (6
H, d, J = 6.2 Hz), 2.80-3.00 (4H, m), 3.89 (2H, d, J
= 7.2 Hz), 4.40-4.60 (1H, m), 5.01 (1H, s), 6.58-6.
75 (3H, m), 6.98-7.20 (3H, m), 7.30-7.45 (2H, m). 5) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- [3 -(Isopropyloxy)
Benzyl] propanoic acid (2RS, 3RS) -3- (4-fluorophenyl) -3-
Ethyl hydroxy-2- [3- (isopropyloxy) benzyl] propanoate (9.8 g, 27.2 mmol)
2N aqueous sodium hydroxide solution (27.2 ml, 54.4 mmol) was added to a methanol (50 ml) solution and the mixture was stirred at room temperature for 3 hours. 6N hydrochloric acid (100m
l) to make it acidic, and then ethyl acetate (200, 10
0 ml). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was crystallized from hexane to give the desired product (7.44 g, 82%). mp 101-102 ℃ IRνmax KBr cm -1 : 1694, 1514, 1451, 1292, 1260, 1229,
. 1152, 1119. Anal Calcd for C 19 H 21 FO 4 (MW332.37) Calcd: C, 68.66; H, 6.37 Found: C, 68.52; H, 6.37 1 H-NMR (CDCl 3) δ: 1.29 (6H , d, J = 6.2 Hz), 2.80-3.
15 (3H, m), 4.40-4.60 (1H, m), 5.00-5.10 (1H, m), 6.5
5-6.80 (3H, m), 6.95-7.20 (3H, m), 7.30-7.45 (2H, m). 6) (4RS, 5SR) -5- (4-fluorophenyl) -4- [3- ( Isopropyloxy) benzyl] -1,
3-oxazolidine-2-one (2RS, 3RS) -3- (4-fluorophenyl) -3-
In a solution of hydroxy-2- [3- (isopropyloxy) benzyl] propanoic acid (7.14 g, 21.5 mmol) in tetrahydrofuran (100 ml), diphenylphosphoryl azide (6.0 ml, 27.9 mmol) and triethylamine (4 .19 ml, 30.1 mmol) and stirred at room temperature for 1 hour. After heating under reflux for 5 hours, the reaction solution was concentrated under reduced pressure, and saturated aqueous sodium hydrogen carbonate (100 ml).
And extracted with ethyl acetate (200 ml). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 4: 1-2: 1) to obtain the desired product (14.7 g, 91%). mp 114-115 ° C IRνmax KBr cm -1 : 1738, 1582, 1514, 1385, 1248, 1227,
. 1157. Anal Calcd for C 19 H 20 FNO 3 (MW329.36) Calcd: C, 69.29; H, 6.12; N, 4.25 Found:. C, 69.27; H, 6.16; N, 4.26 1 H-NMR (CDCl 3 ) δ: 1.32 (6H, d, J = 6.0 Hz), 2.05-2.
35 (2H, m), 4.15-4.60 (1H, m), 4.96 (1H, brs), 5.78 (1
H, d, J = 7.6 Hz), 6.50-6.65 (2H, m), 6.70-6.80 (1H,
m), 7.00-7.25 (3H, m), 7.30-7.45 (2H, m). 7) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (isopropyloxy ) Phenyl] -1-propanol (4RS, 5SR) -5- (4-fluorophenyl) -4-
[3- (isopropyloxy) benzyl] -1,3-oxazolidine-2-one (5.85 g, 17.8 mmol)
To a solution of the above in ethanol (30 ml) was added an 8 N aqueous sodium hydroxide solution (8.9 ml, 71.0 mmol), and the mixture was refluxed for 5 hours. The reaction solution was concentrated under reduced pressure, and water (100
ml) and extracted with ethyl acetate (100 ml × 2). After washing the extract with water and drying over anhydrous magnesium sulfate,
The solvent was distilled off under reduced pressure. The residue was crystallized from hexane-diethyl ether to obtain the desired product (5.0 g, 93%). mp 98-99 ℃ IRνmax KBr cm -1 : 3364, 1605, 1582, 1508, 1252, 1211,
. 1154, 1044. Anal Calcd for C 18 H 22 FNO 2 (MW303.37) Calcd: C, 71.26; H, 7.31; N, 4.62 Found:. C, 71.30; H, 7.46; N, 4.55 1 H-NMR (CDCl 3 ) δ: 1.32 (6H, d, J = 6.0 Hz), 2.28 (1
H, dd, J = 13.6, 10.2 Hz), 2.73 (1H, dd, J = 13.6,
3.0 Hz), 3.20-3.40 (1H, m), 4.45-4.60 (1H, m), 4.67 (1
H, d, J = 4.8 Hz), 6.60-6.80 (3H, m), 7.00-7.45 (5H,
m). 8) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- (3-isopropoxybenzyl) ethyl] -6,7-dihydro-5H-benzo [a Cyclohepten-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (isopropyloxy) phenyl] -1
-Propanol (0.46 g, 1.5 mmol) and 6,
To a solution of 7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (0.34 g, 1.8 mmol) in acetonitrile (20 ml), 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide.hydrochloride Salt (0.36
g, 2.1 mmol) and 1-hydroxybenzotriazole hydrate (0.32 g, 2.1 mmol) were added and stirred at room temperature for 5 hours. Water (100 ml) was added to the reaction solution, and extracted with ethyl acetate (100 ml × 2). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 4: 1) to give the desired product (0.5%).
(5 g, 77%) as crystals. . mp 161-162 ℃ IRνmax KBr cm -1 : 3274, 1638, 1510, 1258, 1225, 833. Anal Calcd for C 30 H 32 FNO 3 (MW473.58) Calcd: C, 76.08; H, 6.81; N, 2.96 Found:. C, 76.10; H, 6.73; N, 2.89 1 H-NMR (CDCl 3) δ: 1.30 (6H, d, J = 6.0 Hz), 1.90-2.
10 (2H, m), 2.10-2.30 (2H, m), 2.60-2.80 (2H, m), 2.9
6 (1H, dd, J = 14.0, 4.4 Hz), 4.10 (1H, d, J = 4.4 H
z), 4.40-4.60 (1H, m), 4.60-4.80 (1H, m), 5.00-5.10
(1H, m), 5.66 (1H, d, J = 7.8 Hz), 5.90-6.00 (1H, m),
6.40 (1H, d, J = 11.8 Hz), 6.65-6.85 (3H, m), 6.95-
7.25 (7H, m), 7.35-7.50 (2H, m).
【0415】実施例283 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-(3-イソプロポキシ
ベンジル)エチル]-1-ナフトアミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(イソプロピルオキシ)フェニル]-1
-プロパノール(0.46g,1.5ミリモル)と4-フ
ルオロナフタレン-1-カルボン酸(0.34g,1.8
ミリモル)のアセトニトリル(20ml)溶液に、1-
エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩(0.36g,2.1ミリモル)と1-ヒ
ドロキシベンゾトリアゾール水和物(0.32g,2.
1ミリモル)を加えて室温で5時間攪拌した。反応液に
水(100ml)を加えて酢酸エチル(100ml×
2)で抽出した。抽出液を水で洗浄し、無水硫酸マグネ
シウムで乾燥後、減圧留去した。残留物をシリカゲルク
ロマトグラフィー(クロロホルム:酢酸エチル=10:
1)で精製して、目的物(0.65g,91%)を結晶
として得た。 mp 190-191℃ IRνmaxKBrcm-1:3281, 1640, 1624, 1539, 1514, 1256,
1229. Anal. Calcd for C29H27F2NO3 (MW475.53) Calcd: C, 73.25; H, 5.72; N, 2.95 Found: C, 72.87; H, 5.57; N, 2.84.1 H-NMR(CDCl3-DMSO-d6 (1drop)) δ: 1.26(6H, d, J =
6.0 Hz), 2.70-3.00(2H,m), 4.40- 4.60(1H, m), 4.65-
4.85(1H, m), 4.95-5.10(2H, m), 6.70-6.85(3H, m),
6.85-7.60(10H, m), 7.74(1H, d, J = 6.8 Hz), 8.06(1
H, d, J = 7.6 Hz).Example 283 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- (3-isopropoxybenzyl) ethyl] -1-naphthamide (1RS, 2SR) -2-Amino-1- (4-fluorophenyl) -3- [3- (isopropyloxy) phenyl] -1
-Propanol (0.46 g, 1.5 mmol) and 4-fluoronaphthalene-1-carboxylic acid (0.34 g, 1.8
Mmol) in acetonitrile (20 ml).
Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.36 g, 2.1 mmol) and 1-hydroxybenzotriazole hydrate (0.32 g, 2.
(1 mmol) and stirred at room temperature for 5 hours. Water (100 ml) was added to the reaction solution, and ethyl acetate (100 ml ×
Extracted in 2). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel chromatography (chloroform: ethyl acetate = 10:
Purification in 1) gave the desired product (0.65 g, 91%) as crystals. mp 190-191 ° C IRνmax KBr cm -1 : 3281, 1640, 1624, 1539, 1514, 1256,
1229. Anal.Calcd for C 29 H 27 F 2 NO 3 (MW475.53) Calcd: C, 73.25; H, 5.72; N, 2.95 Found: C, 72.87; H, 5.57; N, 2.84. 1 H-NMR (CDCl 3 -DMSO-d 6 (1drop)) δ: 1.26 (6H, d, J =
6.0 Hz), 2.70-3.00 (2H, m), 4.40- 4.60 (1H, m), 4.65-
4.85 (1H, m), 4.95-5.10 (2H, m), 6.70-6.85 (3H, m),
6.85-7.60 (10H, m), 7.74 (1H, d, J = 6.8 Hz), 8.06 (1
(H, d, J = 7.6 Hz).
【0416】実施例284 4-フルオロ-N-[(1RS,2SR)-1-(3-ter
t-ブチルオキシベンジル)エチル]-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-ナフトアミド 1) 3-tert-ブチルオキシ安息香酸エチル 3-ヒドロキシ安息香酸エチル(20g,0.13モ
ル)のジクロロメタン(200ml)溶液に、イソブテ
ン(約30g)と濃硫酸(0.5ml)を加えて2日間
放置した。反応液を飽和重曹水で洗浄し、無水硫酸マグ
ネシウムで乾燥後、減圧留去した。残留物をシリカゲル
クロマトグラフィー(ヘキサン:酢酸エチル=10:
1)で精製して、目的物(17.3g,63%)を油状
物として得た。1 H-NMR(CDCl3) δ: 1.37(9H, s, But), 3.91(3H, s),
7.15-7.25(1H, m), 7.33(1H, t, J = 7.9 Hz), 7.65-7.
70(1H, m), 7.76(1H, d, J = 7.9 Hz). 2) 3-tert-ブチルオキシベンジルアルコール 3-tert-ブチルオキシ安息香酸エチル(16.7
g,80ミリモル)のテトラヒドロフラン(100m
l)溶液に、氷冷下水素化リチウムアルミニウム(4.
55g,120ミリモル)を少量ずつ加えた。室温で1
時間攪拌した後、氷冷下で水(10ml)を加えて分解
した。不溶物を濾去した後、溶媒を減圧留去した。残留
物をシリカゲルクロマトグラフィー(ヘキサン:酢酸エ
チル=3:1-2:1)で精製して、目的物(12.8
g,88%)を油状物として得た。1 H-NMR(CDCl3) δ: 1.35(9H, s, But), 4.66(2H, d, H=
6.0 Hz), 6.93(1H, m),7.00(1H, brs), 7.07(1H, d, J
= 7.4 Hz), 7.25(1H, t, J = 7.4 Hz). 3) 3-(4-フルオロフェニル)-2-[3-(ter
t-ブチルオキシ)ベンジル]-3-オキソプロパン酸エ
チル 3-tert-ブチルオキシベンジルアルコール(10.
8g,60ミリモル)の酢酸エチル(100ml)溶液
に、氷冷下塩化メタンスルホニル(4.88ml,63
ミリモル)とトリエチルアミン(9.2ml,66ミリ
モル)を加えて室温で1時間攪拌した。不溶物を濾去
し、溶媒を減圧留去し、メシレートを得た。3-(4-フ
ルオロフェニル)-3-オキソプロパン酸エチル(12.
6g,60ミリモル)のジメトキシエタン(100m
l)溶液に、氷冷下水素化ナトリウム(2.4g,60
%油性,60ミリモル)を加えて10分間撹拌した。こ
れに上で得たメシレートのジメトキシエタン(20m
l)溶液を滴下し、室温で4時間撹拌した。反応液に水
(200ml)を加えて酢酸エチル(200ml×2)
で抽出した。抽出液を水洗し、無水硫酸マグネシウムで
乾燥後、減圧留去した。残留物をシリカゲルクロマトグ
ラフィー(ヘキサン:酢酸エチル=10:1)で精製し
て、目的物(20.1g,90%)を得た。 IRνmaxNeatcm-1:1740, 1686, 1599, 1508, 1485, 136
6, 1233, 1152.1 H-NMR(CDCl3) δ: 1.13(3H, t, J = 7.0 Hz), 1.28(9
H, s, But), 3.29(2H, d,J = 7.4 Hz), 4.10 (2H, q,
J = 7.0 Hz), 4.56(1H, t, J = 7.4 Hz), 6.67-6.90(2
H, m), 6.95(1H, d, J = 7.6 Hz), 7.05-7.20(3H, m),
7.90-8.05(2H, m). 4) (2RS,3RS)-2-[3-(tert-ブチル
オキシ)ベンジル]-3-(4-フルオロフェニル)-3-
ヒドロキシプロパン酸エチル 無水塩化亜鉛(8.17g,60ミリモル)のジエチル
エーテル(100ml)懸濁液に、水素化ホウ素ナトリ
ウム(4.54g,120ミリモル)を少量ずつ加え
て、2時間撹拌した。不溶物を濾去し、ジエチルエーテ
ルで洗浄した。濾液を氷冷し、これに3-(4-フルオロ
フェニル)-2-[3-(tert-ブチルオキシ)ベンジ
ル]-3-オキソプロパン酸エチル(10.8g,30ミ
リモル)のジエチルエーテル(20ml)溶液を加え
た。室温で1時間撹拌した後、再び氷冷し、水で反応を
止めた。混合物を5%硫酸水素カリウム水溶液と水で洗
浄後、無水硫酸マグネシウムで乾燥し、減圧留去した。
残留物をシリカゲルクロマトグラフィー(ヘキサン:酢
酸エチル=10:1)で精製して、目的物(8.9g,
79%)を無色油状物として得た。 IRνmaxNeatcm-1:1728, 1605, 1510, 1260, 1225, 117
9, 1154.1 H-NMR(CDCl3) δ: 0.93(3H, t, J = 7.2 Hz), 1.31(9
H, s, But), 2.90-3.05(3H, m), 3.87(2H, d, J = 7.2
Hz), 4.95-5.10(1H, m), 6.70-6.80(1H, m), 6.80(1H,
d, J = 7.8 Hz), 7.00-7.20(3H, m), 7.30-7.45(2H,
m). 5) (4RS,5SR)-4-[3-(tert-ブチル
オキシ)ベンジル]-5-(4-フルオロフェニル)-1,
3-オキサゾリジン-2-オン (2RS,3RS)-2-[3-(tert-ブチルオキ
シ)ベンジル]-3-(4-フルオロフェニル)-3-ヒド
ロキシプロパン酸エチル(8.8g,23.5ミリモ
ル)のメタノール(100ml)溶液に2規定水酸化ナ
トリウム水溶液(23.5ml,47ミリモル)を加え
て室温で3時間撹拌した。反応液に5%硫酸水素カリウ
ム水溶液(100ml)を加えて酸性とした後、酢酸エ
チル(200ml)で抽出した。抽出液を水洗し、無水
硫酸マグネシウムで乾燥後、減圧留去した。残留物をヘ
キサンから結晶化させて、(2RS,3RS)-2-[3
-(tert-ブチルオキシ)ベンジル]-3-(4-フル
オロフェニル)-3-ヒドロキシプロパン酸を得た。上で
得た化合物のテトラヒドロフラン(150ml)溶液に
アジ化ジフェニルホスホリル(6.57ml,30.6
ミリモル)とトリエチルアミン(4.59ml,32.
9ミリモル)を加えて室温で1時間撹拌した。その後、
2時間加熱還流した後、反応液を減圧濃縮し、水(20
0ml)を加えて酢酸エチル(200ml)で抽出し
た。抽出液を水で洗浄し、無水硫酸マグネシウムで乾燥
後、減圧留去した。残留物をシリカゲルクロマトグラフ
ィー(ヘキサン:酢酸エチル=3:1-2:1)で精製
して、目的物(6.92g,86%)を得た。 mp 131-132℃ IRνmaxKBrcm-1:1742, 1603, 1514, 1364, 1240, 1223,
1148. Anal. Calcd for C20H22FNO3 (MW343.40) Calcd: C, 69.95; H, 6.46; N, 4.08 Found: C, 69.96; H, 6.38; N, 4.11.1 H-NMR(CDCl3) δ: 1.33(9H, s, But), 2.10-2.40(2H,
m), 4.15-4.30(1H, m),4.91(1H, brs), 5.79(1H, d, J
= 7.8 Hz), 6.60-6.80(2H, m), 6.80-6.95(1H,m), 7.05
-7.25(3H, m), 7.30-7.50 (2H, m). 6) (1RS,2SR)-2-アミノ-3-[3-(te
rt-ブチルオキシ)フェニル]-1-(4-フルオロフェ
ニル)-1-プロパノール (4RS,5SR)-4-[3-(tert-ブチルオキ
シ)ベンジル]-5-(4-フルオロフェニル)-1,3-
オキサゾリジン-2-オン(6.6g,19.2ミリモ
ル)のエタノール(30ml)溶液に、8規定水酸化ナ
トリウム水溶液(9.6ml,76.9ミリモル)を加
えて4時間加熱還流した。反応液を減圧濃縮し、水(1
50ml)を加えて酢酸エチル(200ml)で抽出し
た。抽出液を水洗し、無水硫酸マグネシウムで乾燥後、
減圧留去した。残留物をヘキサン-ジエチルエーテルか
ら結晶化させて、目的物(5.86g,96%)を得
た。 mp 132-133℃ IRνmaxKBrcm-1:3362, 3295, 1601, 1582, 1507, 1485,
1363, 1208, 1152, 1036. Anal. Calcd for C19H24FNO2 (MW317.40) Calcd: C, 71.90; H, 7.62; N, 4.41 Found: C, 71.69; H, 7.65; N, 4.35.1 H-NMR(CDCl3) δ: 1.33(9H, s, But), 2.29(1H, dd, J
= 14.0, 10.2 Hz), 2.74(1H, dd, J = 14.0, 3.0 Hz),
3.20-3.35(1H, m), 4.66(1H, d, J = 5.2 Hz),6.75-6.
90(3H, m), 7.70-7.25 (3H, m), 7.30-7.45(2H, m). 7) 4-フルオロ-N-[(1RS,2SR)-1-(3-
tert-ブチルオキシベンジル)エチル]-2-(4-フ
ルオロフェニル)-2-ヒドロキシ-1-ナフトアミド (1RS,2SR)-2-アミノ-3-[3-(tert-ブ
チルオキシ)フェニル]-1-(4-フルオロフェニル)-
1-プロパノール(1.59g,5.0ミリモル)と4-
フルオロナフタレン-1-カルボン酸(1.14g,6.
0ミリモル)のアセトニトリル(30ml)溶液に、1
-エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩(1.20g,7.0ミリモル)と1-ヒ
ドロキシベンゾトリアゾール水和物(1.07g,7.
0ミリモル)を加えて室温で5時間攪拌した。反応液に
水(100ml)を加えて酢酸エチル(150ml)で
抽出した。抽出液を水で洗浄し、無水硫酸マグネシウム
で乾燥後、減圧留去した。残留物をシリカゲルクロマト
グラフィー(クロロホルム:酢酸エチル=10:1)で
精製して、目的物(2.27g,93%)を結晶として
得た。 mp 180-181℃ IRνmaxKBrcm-1:3420, 3312, 1644, 1539, 1508, 1223,
1150. Anal. Calcd for C30H29F2NO3 (MW489.55) Calcd: C, 73.60; H, 5.97; N, 2.86 Found: C, 73.61; H, 6.00; N, 2.76.1 H-NMR(CDCl3) δ: 1.28(9H, s, But), 2.73(1H, dd, J
= 14.1, 10.6 Hz), 3.03(1H, dd, J = 14.4, 4.4 Hz),
3.90(1H, d, J = 3.6 Hz), 4.70-4.90(1H, m),5.00-5.
15(1H, m), 5.85(1H, brd, J = 4.4 Hz), 6.80-7.30(8
H, m), 7.4-7.60(4H, m), 7.83(1H, d, J = 8.0 Hz),
8.08(1H, d, J = 7.2 Hz).Example 284 4-Fluoro-N-[(1RS, 2SR) -1- (3-ter
t-Butyloxybenzyl) ethyl] -2- (4-fluorophenyl) -2-hydroxy-1-naphthamide 1) Ethyl 3-tert-butyloxybenzoate Ethyl 3-hydroxybenzoate (20 g, 0.13 mol) Isobutene (about 30 g) and concentrated sulfuric acid (0.5 ml) were added to a dichloromethane (200 ml) solution and left for 2 days. The reaction solution was washed with saturated aqueous sodium hydrogen carbonate, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel chromatography (hexane: ethyl acetate = 10:
Purification in 1) gave the desired product (17.3 g, 63%) as an oil. 1 H-NMR (CDCl 3) δ: 1.37 (9H, s, Bu t), 3.91 (3H, s),
7.15-7.25 (1H, m), 7.33 (1H, t, J = 7.9 Hz), 7.65-7.
70 (1H, m), 7.76 (1H, d, J = 7.9 Hz). 2) 3-tert-butyloxybenzyl alcohol ethyl 3-tert-butyloxybenzoate (16.7)
g, 80 mmol) of tetrahydrofuran (100 m
1) Lithium aluminum hydride (4.
55 g, 120 mmol) were added in small portions. 1 at room temperature
After stirring for an hour, water (10 ml) was added under ice cooling to decompose. After filtering off the insoluble matter, the solvent was distilled off under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 3: 1-2: 1) to give the desired product (12.8).
g, 88%) as an oil. 1 H-NMR (CDCl 3) δ: 1.35 (9H, s, Bu t), 4.66 (2H, d, H =
6.0 Hz), 6.93 (1H, m), 7.00 (1H, brs), 7.07 (1H, d, J
= 7.4 Hz), 7.25 (1H, t, J = 7.4 Hz). 3) 3- (4-Fluorophenyl) -2- [3- (ter
[tert-butyloxy) benzyl] ethyl 3-oxopropanoate 3-tert-butyloxybenzyl alcohol (10.
Methanesulfonyl chloride (4.88 ml, 63 mmol) in a solution of 8 g (60 mmol) in ethyl acetate (100 ml) under ice cooling.
Mmol) and triethylamine (9.2 ml, 66 mmol) were added and stirred at room temperature for 1 hour. The insoluble material was removed by filtration, and the solvent was distilled off under reduced pressure to obtain mesylate. Ethyl 3- (4-fluorophenyl) -3-oxopropanoate (12.
6 g, 60 mmol) of dimethoxyethane (100 m
1) Add sodium hydride (2.4 g, 60
% Oily, 60 mmol) and stirred for 10 minutes. The dimethoxyethane of the mesylate obtained above (20 m
l) The solution was added dropwise and stirred at room temperature for 4 hours. Water (200 ml) was added to the reaction solution, and ethyl acetate (200 ml × 2) was added.
Extracted. The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 10: 1) to obtain the desired product (20.1 g, 90%). IRνmax Neat cm -1 : 1740, 1686, 1599, 1508, 1485, 136
6, 1233, 1152. 1 H- NMR (CDCl 3) δ: 1.13 (3H, t, J = 7.0 Hz), 1.28 (9
H, s, Bu t), 3.29 (2H, d, J = 7.4 Hz), 4.10 (2H, q,
J = 7.0 Hz), 4.56 (1H, t, J = 7.4 Hz), 6.67-6.90 (2
H, m), 6.95 (1H, d, J = 7.6 Hz), 7.05-7.20 (3H, m),
7.90-8.05 (2H, m). 4) (2RS, 3RS) -2- [3- (tert-butyloxy) benzyl] -3- (4-fluorophenyl) -3-
Ethyl hydroxypropanoate To a suspension of anhydrous zinc chloride (8.17 g, 60 mmol) in diethyl ether (100 ml) was added sodium borohydride (4.54 g, 120 mmol) little by little, and the mixture was stirred for 2 hours. The insolubles were removed by filtration and washed with diethyl ether. The filtrate was cooled on ice, and ethyl 3- (4-fluorophenyl) -2- [3- (tert-butyloxy) benzyl] -3-oxopropanoate (10.8 g, 30 mmol) in diethyl ether (20 ml) was added. The solution was added. After stirring at room temperature for 1 hour, the mixture was ice-cooled again and the reaction was stopped with water. The mixture was washed with a 5% aqueous solution of potassium hydrogen sulfate and water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was purified by silica gel chromatography (hexane: ethyl acetate = 10: 1) to give the desired product (8.9 g,
79%) as a colorless oil. IRνmax Neat cm -1 : 1728, 1605, 1510, 1260, 1225, 117
9, 1154. 1 H-NMR ( CDCl 3) δ: 0.93 (3H, t, J = 7.2 Hz), 1.31 (9
H, s, Bu t), 2.90-3.05 (3H, m), 3.87 (2H, d, J = 7.2
Hz), 4.95-5.10 (1H, m), 6.70-6.80 (1H, m), 6.80 (1H, m
d, J = 7.8 Hz), 7.00-7.20 (3H, m), 7.30-7.45 (2H,
m). 5) (4RS, 5SR) -4- [3- (tert-butyloxy) benzyl] -5- (4-fluorophenyl) -1,
Ethyl 3-oxazolidin-2-one (2RS, 3RS) -2- [3- (tert-butyloxy) benzyl] -3- (4-fluorophenyl) -3-hydroxypropanoate (8.8 g, 23.5 mmol) ) Was added to a methanol (100 ml) solution, and a 2N aqueous sodium hydroxide solution (23.5 ml, 47 mmol) was added thereto, followed by stirring at room temperature for 3 hours. The reaction solution was acidified by adding a 5% aqueous solution of potassium hydrogen sulfate (100 ml), and extracted with ethyl acetate (200 ml). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was crystallized from hexane to give (2RS, 3RS) -2- [3
-(Tert-Butyloxy) benzyl] -3- (4-fluorophenyl) -3-hydroxypropanoic acid was obtained. To a solution of the compound obtained above in tetrahydrofuran (150 ml) was added diphenylphosphoryl azide (6.57 ml, 30.6 ml).
Mmol) and triethylamine (4.59 ml, 32.
9 mmol) and stirred at room temperature for 1 hour. afterwards,
After heating under reflux for 2 hours, the reaction solution was concentrated under reduced pressure and water (20
0 ml) and extracted with ethyl acetate (200 ml). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 3: 1-2: 1) to obtain the desired product (6.92 g, 86%). mp 131-132 ℃ IRνmax KBr cm -1 : 1742, 1603, 1514, 1364, 1240, 1223,
. 1148. Anal Calcd for C 20 H 22 FNO 3 (MW343.40) Calcd: C, 69.95; H, 6.46; N, 4.08 Found:. C, 69.96; H, 6.38; N, 4.11 1 H-NMR (CDCl 3) δ: 1.33 (9H, s, Bu t), 2.10-2.40 (2H,
m), 4.15-4.30 (1H, m), 4.91 (1H, brs), 5.79 (1H, d, J
= 7.8 Hz), 6.60-6.80 (2H, m), 6.80-6.95 (1H, m), 7.05
-7.25 (3H, m), 7.30-7.50 (2H, m). 6) (1RS, 2SR) -2-amino-3- [3- (te
rt-butyloxy) phenyl] -1- (4-fluorophenyl) -1-propanol (4RS, 5SR) -4- [3- (tert-butyloxy) benzyl] -5- (4-fluorophenyl) -1,3 -
To a solution of oxazolidin-2-one (6.6 g, 19.2 mmol) in ethanol (30 ml) was added an 8 N aqueous sodium hydroxide solution (9.6 ml, 76.9 mmol), and the mixture was heated under reflux for 4 hours. The reaction solution was concentrated under reduced pressure, and water (1
50 ml) and extracted with ethyl acetate (200 ml). After washing the extract with water and drying over anhydrous magnesium sulfate,
The solvent was distilled off under reduced pressure. The residue was crystallized from hexane-diethyl ether to obtain the desired product (5.86 g, 96%). mp 132-133 ℃ IRνmax KBr cm -1 : 3362, 3295, 1601, 1582, 1507, 1485,
. 1363, 1208, 1152, 1036. Anal Calcd for C 19 H 24 FNO 2 (MW317.40) Calcd: C, 71.90; H, 7.62; N, 4.41 Found: C, 71.69; H, 7.65; N, 4.35. 1 H-NMR (CDCl 3) δ: 1.33 (9H, s, Bu t), 2.29 (1H, dd, J
= 14.0, 10.2 Hz), 2.74 (1H, dd, J = 14.0, 3.0 Hz),
3.20-3.35 (1H, m), 4.66 (1H, d, J = 5.2 Hz), 6.75-6.
90 (3H, m), 7.70-7.25 (3H, m), 7.30-7.45 (2H, m). 7) 4-Fluoro-N-[(1RS, 2SR) -1- (3-
tert-butyloxybenzyl) ethyl] -2- (4-fluorophenyl) -2-hydroxy-1-naphthamide (1RS, 2SR) -2-amino-3- [3- (tert-butyloxy) phenyl] -1- (4-fluorophenyl)-
1-propanol (1.59 g, 5.0 mmol) and 4-
Fluoronaphthalene-1-carboxylic acid (1.14 g, 6.
0 mmol) in acetonitrile (30 ml) solution.
-Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (1.20 g, 7.0 mmol) and 1-hydroxybenzotriazole hydrate (1.07 g, 7.
0 mmol) and stirred at room temperature for 5 hours. Water (100 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (150 ml). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel chromatography (chloroform: ethyl acetate = 10: 1) to obtain the desired product (2.27 g, 93%) as crystals. mp 180-181 ° C IRνmax KBr cm -1 : 3420, 3312, 1644, 1539, 1508, 1223,
1150.Anal.Calcd for C 30 H 29 F 2 NO 3 (MW489.55) Calcd: C, 73.60; H, 5.97; N, 2.86 Found: C, 73.61; H, 6.00; N, 2.76. 1 H-NMR (CDCl 3) δ: 1.28 ( 9H, s, Bu t), 2.73 (1H, dd, J
= 14.1, 10.6 Hz), 3.03 (1H, dd, J = 14.4, 4.4 Hz),
3.90 (1H, d, J = 3.6 Hz), 4.70-4.90 (1H, m), 5.00-5.
15 (1H, m), 5.85 (1H, brd, J = 4.4 Hz), 6.80-7.30 (8
H, m), 7.4-7.60 (4H, m), 7.83 (1H, d, J = 8.0 Hz),
8.08 (1H, d, J = 7.2 Hz).
【0417】実施例285 N-[(1RS,2SR)-1-(3-tert-ブチルオ
キシベンジル)エチル]-2-(4-フルオロフェニル)-
2-ヒドロキシ-6,7-ジヒドロ-5H-ベンゾ[a]シ
クロヘプテン-1-カルボキサミド (1RS,2SR)-2-アミノ-3-[3-(tert-ブ
チルオキシ)フェニル]-1-(4-フルオロフェニル)-
1-プロパノール(0.48g,1.5ミリモル)と
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボン酸(0.34g,1.8ミリモル)のアセト
ニトリル(20ml)溶液に、1-エチル-3-(3-ジメ
チルアミノプロピル)カルボジイミド・塩酸塩(0.3
6g,2.1ミリモル)と1-ヒドロキシベンゾトリア
ゾール水和物(0.32g,2.1ミリモル)を加えて
室温で5時間攪拌した。反応液に水(100ml)を加
えて酢酸エチル(150m)で抽出した。抽出液を水で
洗浄し、無水硫酸マグネシウムで乾燥後、減圧留去し
た。残留物をシリカゲルクロマトグラフィー(ヘキサ
ン:酢酸エチル=4:1-3:1)で精製して、目的物
(0.63g,86%)を結晶として得た。 mp 149-150℃ IRνmaxKBrcm-1:3303, 1638, 1537, 1512, 1443, 1256,
1225, 1150, 1032. Anal. Calcd for C31H34FNO3 (MW487.61) Calcd: C, 76.36; H, 7.03; N, 2.87 Found: C, 76.29; H, 7.20; N, 2.80.1 H-NMR(CDCl3) δ: 1.30(9H, s, But), 1.90-2.10(2H,
m), 2.10-2.30(2H, m),2.60-2.80 (2H, m), 2.96(1H, d
d, J = 7.3, 4.4 Hz), 4.06(1H, d, J = 4.0 Hz), 4.60
-4.80(1H, m), 5.01(1H, t, J = 3.7 Hz), 5.65(1H, br
d, J = 8.0 Hz),5.90-6.05(1H, m), 6.25(1H, d, J = 1
1.4 Hz), 6.78-7.30 (9H, m), 7.30-7.50(2H, m).Example 285 N-[(1RS, 2SR) -1- (3-tert-butyloxybenzyl) ethyl] -2- (4-fluorophenyl)-
2-hydroxy-6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-3- [3- (tert-butyloxy) phenyl] -1- (4-fluoro Phenyl)-
1-propanol (0.48 g, 1.5 mmol) and 6,7-dihydro-5H-benzo [a] cycloheptene-1
To a solution of -carboxylic acid (0.34 g, 1.8 mmol) in acetonitrile (20 ml) was added 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.3
6 g, 2.1 mmol) and 1-hydroxybenzotriazole hydrate (0.32 g, 2.1 mmol) were added, and the mixture was stirred at room temperature for 5 hours. Water (100 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (150 m). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 4: 1-3: 1) to give the desired product (0.63 g, 86%) as crystals. mp 149-150 ℃ IRνmax KBr cm -1 : 3303, 1638, 1537, 1512, 1443, 1256,
. 1225, 1150, 1032. Anal Calcd for C 31 H 34 FNO 3 (MW487.61) Calcd: C, 76.36; H, 7.03; N, 2.87 Found:. C, 76.29; H, 7.20; N, 2.80 1 H -NMR (CDCl 3) δ: 1.30 (9H, s, Bu t), 1.90-2.10 (2H,
m), 2.10-2.30 (2H, m), 2.60-2.80 (2H, m), 2.96 (1H, d
d, J = 7.3, 4.4 Hz), 4.06 (1H, d, J = 4.0 Hz), 4.60
-4.80 (1H, m), 5.01 (1H, t, J = 3.7 Hz), 5.65 (1H, br
d, J = 8.0 Hz), 5.90-6.05 (1H, m), 6.25 (1H, d, J = 1
1.4 Hz), 6.78-7.30 (9H, m), 7.30-7.50 (2H, m).
【0418】実施例286 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-(3-ヒドロキシベン
ジル)エチル]-1-ナフトアミド 4-フルオロ-N-[(1RS,2SR)-1-(3-ter
t-ブチルオキシベンジル)エチル]-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-ナフトアミド(0.30
g,0.61ミリモル)のテトラヒドロフラン(10m
l)溶液にトリフルオロ酢酸(5ml)を加えて、50
℃で2時間撹拌した。溶媒を減圧留去し、残留物をシリ
カゲルクロマトグラフィー(クロロホルム:酢酸エチル
=5:1)で精製して、目的物(0.18g,68%)
を結晶として得た。 mp 179-180℃ IRνmaxKBrcm-1:1644, 1601, 1537, 1512, 1262, 1231,
1157, 1053. Anal. Calcd for C26H21F2NO3 (MW433.45) Calcd: C, 72.05; H, 4.88; N, 3.23 Found: C, 71.61; H, 5.14; N, 3.07.1 H-NMR(CDCl3) δ: 2.50-2.75(2H, m), 3.10-3.30(1H,
m), 4.30-4.55(1H, m),4.55-4.65 (1H, m), 5.73(1H,
d, J = 4.4 Hz), 6.60-6.75(3H, m), 7.00-7.70(9H,
m), 7.99(1H, d, J = 7.6 Hz), 8.25-8.40(1H, m), 9.2
1(1H, s).Example 286 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- (3-hydroxybenzyl) ethyl] -1-naphthamide 4-fluoro- N-[(1RS, 2SR) -1- (3-ter
t-butyloxybenzyl) ethyl] -2- (4-fluorophenyl) -2-hydroxy-1-naphthamide (0.30
g, 0.61 mmol) of tetrahydrofuran (10 m
l) Add trifluoroacetic acid (5 ml) to the solution and add 50 ml
Stirred at C for 2 hours. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel chromatography (chloroform: ethyl acetate = 5: 1) to obtain the desired product (0.18 g, 68%).
Was obtained as crystals. mp 179-180 ℃ IRνmax KBr cm -1 : 1644, 1601, 1537, 1512, 1262, 1231,
. 1157, 1053. Anal Calcd for C 26 H 21 F 2 NO 3 (MW433.45) Calcd: C, 72.05; H, 4.88; N, 3.23 Found:. C, 71.61; H, 5.14; N, 3.07 1 H -NMR (CDCl 3 ) δ: 2.50-2.75 (2H, m), 3.10-3.30 (1H,
m), 4.30-4.55 (1H, m), 4.55-4.65 (1H, m), 5.73 (1H,
d, J = 4.4 Hz), 6.60-6.75 (3H, m), 7.00-7.70 (9H,
m), 7.99 (1H, d, J = 7.6 Hz), 8.25-8.40 (1H, m), 9.2
1 (1H, s).
【0419】実施例287 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]カルバミン酸ベンジ
ル (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.278g
(0.769ミリモル)と炭酸水素ナトリウム0.13
g(1.54ミリモル)をテトラヒドロフラン10ml
中で撹拌しながら室温でクロロ炭酸ベンジル0.12m
l(0.85ミリモル)を、そのまま3時間撹拌した。
反応液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶
液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲルを
通した後、溶媒を減圧留去した。得られた残留物をジイ
ソプロピルエーテル-ヘキサンより結晶化して、目的物
を得た。白色結晶 収量0.344g 収率90% mp 136-137℃; 1H-NMR (CDCl3, 200 MHz) δ 2.64-2.91
(3H, m), 4.09-4.20 (1H, m), 4.82 (1H, br d, J =
9.2 Hz), 4.85-5.04 (3H, m), 5.88 (1H, tt, J =2.9 H
z, 53.1 Hz), 6.96-7.09 (5H, m), 7.21-7.39 (8H, m);
IR (KBr) 3326,1692, 1545, 1198, 1115 cm-1; Anal.
Calcd for C25H22F5NO4: C, 60.61; H, 4.48; N, 2.83.
Found: C, 60.81; H, 4.53; N, 2.99.Example 287 N-[(1RS, 2SR) -2- (4-fluorophenyl)
Benzyl-2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] carbamate (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3 -0.278 g of-[3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol
(0.769 mmol) and sodium hydrogen carbonate 0.13
g (1.54 mmol) in 10 ml of tetrahydrofuran
0.12m at room temperature with stirring in the benzyl carbonate
(0.85 mmol) was allowed to stir for 3 hours.
The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.344 g Yield 90% mp 136-137 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.64-2.91
(3H, m), 4.09-4.20 (1H, m), 4.82 (1H, br d, J =
9.2 Hz), 4.85-5.04 (3H, m), 5.88 (1H, tt, J = 2.9 H
z, 53.1 Hz), 6.96-7.09 (5H, m), 7.21-7.39 (8H, m);
IR (KBr) 3326,1692, 1545, 1198, 1115 cm -1 ; Anal.
Calcd for C 25 H 22 F 5 NO 4 : C, 60.61; H, 4.48; N, 2.83.
Found: C, 60.81; H, 4.53; N, 2.99.
【0420】実施例288 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,6-ジメチル-
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボキサミド 1) (E)-4,4-ジメチル-5-フェニル-2-ペンテ
ン酸エチル 60%水素化ナトリウムの流動パラフィン懸濁物17.
8g(445ミリモル)をトルエン300ml中に懸濁
し、ジエチルホスホノ酢酸エチル99.8g(445ミ
リモル)のトルエン50ml溶液を室温で加え、30分
間撹拌した。これに2,2-ジメチル-3-フェニルプロ
パナール(Tetrahedron Lett.,12
73-1275(1973)参照)60.16g(37
0.8ミリモル)のトルエン50ml溶液を滴下し、室
温で2時間撹拌した。反応液を水に注ぎ、ジエチルエー
テルで2回抽出した。集めた有機層を無水硫酸マグネシ
ウムで乾燥、溶媒を減圧留去した。得られた粗生成物を
シリカゲルカラムクロマトグラフィーにて精製し(ヘキ
サン/酢酸エチル=20/1-9/1)、目的物を得
た。無色液体 収量55.97g 収率65%1 H-NMR (CDCl3, 200 MHz) δ 1.06 (6H, s), 1.29 (3H,
t, J = 7.2 Hz), 2.66(2H, s), 4.19 (2H, q, J = 7.1
Hz), 5.63 (1H, d, J = 16.2 Hz), 7.03 (1H,d, J = 1
6.2 Hz), 7.06-7.10 (2H, m), 7.20-7.38 (3H, m); IR
(neat) 2963, 1717, 1310, 1167, 1038, 702 cm-1 2) 4,4-ジメチル-5-フェニルペンタン酸エチル (E)-4,4-ジメチル-5-フェニル-2-ペンテン酸エ
チル55.97g(240.9ミリモル)のエタノール
150ml溶液を10%パラジウム/炭素(50%含
水)5gを触媒として、室温常圧で一晩水素添加した。
反応液の触媒をろ別し、触媒はエタノールで洗浄した。
集めたろ液の溶媒を減圧留去した。得られた粗生成物を
シリカゲルカラムクロマトグラフィーにて精製し(ヘキ
サン/酢酸エチル=15/1-9/1)、目的物を得
た。無色液体 収量45.47g 収率81%1 H-NMR (CDCl3, 200 MHz) δ 0.86 (6H, s), 1.26 (3H,
t, J = 7.2 Hz), 1.56-1.64 (2H, m), 2.30-2.38 (2H,
m), 2.51 (2H, s), 4.13 (2H, q, J = 7.1 Hz),7.10-
7.15 (2H, m), 7.20-7.32 (3H, m); IR (neat) 2961, 1
736, 1171, 704 cm-1 3) 4,4-ジメチル-5-フェニルペンタン酸 4,4-ジメチル-5-フェニルペンタン酸エチル45.
47g(194.0ミリモル)、水酸化ナトリウム1
5.5g(388ミリモル)、水200ml、メタノー
ル200ml、テトラヒドロフラン100mlの混合物
を室温で一晩撹拌した。反応液を減圧濃縮後、水で希釈
した。これをジエチルエーテルで洗浄した後、濃塩酸で
酸性にし、酢酸エチルで2回抽出した。集めた有機層を
無水硫酸ナトリウムで乾燥、溶媒を減圧留去した。得ら
れた粗生成物をシリカゲルカラムクロマトグラフィーに
て精製し(酢酸エチル)、目的物を得た。無色液体 収
量38.35g 収率96%1 H-NMR (CDCl3, 200 MHz) δ 0.88 (6H, s), 1.57-1.65
(2H, m), 2.35-2.43 (2H, m), 2.52 (2H, s), 7.10-7.
15 (2H, m), 7.21-7.32 (3H, m); IR (neat) 3100-285
0, 1715, 1452, 1416, 1302, 702 cm-1 4) 8,8-ジメチル-6,7,8,9-テトラヒドロ-
5H-ベンゾ[a]シクロヘプテン-5-オン 4,4-ジメチル-5-フェニルペンタン酸38.30g
(185.7ミリモル)、N,N-ジメチルホルムアミ
ド0.1mlのテトラヒドロフラン150ml溶液に室
温で塩化オキザリル24.3ml(279ミリモル)を
滴下した後、そのまま0.5時間撹拌した。反応混合物
の溶媒を減圧留去し、酸塩化物を黄色液体として得た。
塩化アルミニウム49.5g(371ミリモル)の塩化
メチレン250ml懸濁液を撹拌しながら、これに上で
得た酸塩化物の塩化メチレン800ml溶液を2日間か
けて滴下した。反応液を氷冷しながら、水を加えて反応
を止めた。混合物の塩化メチレン層を分離し、水層をジ
エチルエーテルで抽出した。集めた有機層を無水硫酸マ
グネシウムで乾燥、溶媒を減圧留去した。得られた残留
物をシリカゲルカラムクロマトグラフィーにて精製して
(ヘキサン/酢酸エチル=15/1-6/1)、目的物
を得た。黄色液体 収量29.55g 収率85%1 H-NMR (CDCl3, 200 MHz) δ 1.02 (6H, s), 1.45-1.51
(2H, m), 2.62 (2H, s), 2.63-2.69 (2H, m), 7.12 (1
H, dd, J = 1.0 Hz, 7.2 Hz), 7.31 (1H, dt, J= 1.5 H
z, 7.5 Hz), 7.43 (1H, dt, J = 1.6 Hz, 7.5 Hz), 7.7
2 (1H, dd, J =1.4 Hz, 7.4 Hz); IR (neat) 2953, 292
8, 1682, 1601, 1468, 1289, 770 cm-1 5) 8,8-ジメチル-6,7,8,9-テトラヒドロ-
5H-ベンゾ[a]シクロヘプテン-5-オール 8,8-ジメチル-6,7,8,9-テトラヒドロ-5H-
ベンゾ[a]シクロヘプテン-5-オン29.20g(1
55.1ミリモル)のメタノール150ml溶液に、氷
冷下、水素化ほう素ナトリウム5.87g(155ミリ
モル)を少しずつ加えた後、室温で1時間撹拌した。反
応液を水で希釈し、酢酸エチルで2回抽出した。集めた
有機層を無水硫酸ナトリウムで乾燥、溶媒を減圧留去し
た。得られた残留物をシリカゲルカラムクロマトグラフ
ィーにて精製して(ヘキサン/酢酸エチル=9/1-6
/1)、目的物を得た。黄色液体 収量28.96g
収率98%1 H-NMR (CDCl3, 200 MHz) δ 0.72 (3H, s), 0.94 (3H,
s), 1.54-1.97 (4H, m), 1.78 (1H, d, J = 4.0 Hz),
2.67 (2H, br s), 4.85-4.93 (1H, m), 7.02 (1H, dd,
J = 1.6 Hz, 7.2 Hz), 7.11-7.23 (2H, m), 7.42 (1H,
d, J = 7.0 Hz);IR (neat) 3353, 2951, 2928, 1456, 1
044, 756 cm-1 6) 4-(ヒドロキシメチル)-8,8-ジメチル-6,
7,8,9-テトラヒドロ-5H-ベンゾ[a]シクロヘ
プテン-5-オール 8,8-ジメチル-6,7,8,9-テトラヒドロ-5H-
ベンゾ[a]シクロヘプテン-5-オール28.72g
(150.9ミリモル)とN,N,N’,N’-テトラ
メチルエチレンジアミン50.1ml(332ミリモ
ル)のヘキサン200ml溶液に、氷冷下で1.6Mn
-ブチルリチウムのヘキサン溶液208ml(332ミ
リモル)を滴下した後、35℃で一晩撹拌した。反応混
合物を−78℃に冷却した後、砕いたドライアイス50
gを加え、撹拌しながら室温まで昇温した。反応液を水
で希釈した後、濃塩酸で酸性にし、酢酸エチルで3回抽
出した。集めた有機層を無水硫酸マグネシウムで乾燥、
溶媒を減圧留去した。得られた粗生成物をシリカゲルカ
ラムクロマトグラフィー(ヘキサン/酢酸エチル=6/
1)に通し、7,7-ジメチル-7,8,9,9a-テト
ラヒドロシクロヘプタ[cd][2]ベンゾフラン-2
(6H)-オンの粗生成物(31.00g)を黄色の湿
った固体として得た。水素化リチウムアルミニウム5.
73g(151ミリモル)のテトラヒドロフラン200
ml懸濁液に、氷冷下、上で得た固体のテトラヒドロフ
ラン100ml溶液を滴下し、室温で1時間撹拌した。
反応液を氷冷した後、水6ml、15%水酸化ナトリウ
ム水溶液6ml、水15mlを順次滴下して、過剰の水
素化リチウムアルミニウムを分解し、そのまま室温で2
時間撹拌した。生じた沈殿をろ過して除き、沈殿を酢酸
エチルで洗浄した。集めた濾液の溶媒を減圧留去した。
得られた粗生成物をシリカゲルカラムクロマトグラフィ
ーにて精製し(ヘキサン/酢酸エチル=6/1-1/
2)、ヘキサンより結晶化して目的物を得た。白色結晶
収量19.15g 収率58% mp 107-108℃; 1H-NMR (CDCl3, 200 MHz) δ 0.76 (3H,
s), 0.99 (3H, s), 1.16-1.28 (1H, m), 1.68-1.82 (1
H, m), 1.91-2.03 (2H, m), 2.30 (1H, d, J = 13.6 H
z), 2.63 (1H, br t, J = 5.3 Hz), 2.93 (1H, br s),
3.22 (1H, d, J =13.8 Hz), 4.58 (1H, dd, J = 5.3 H
z, 11.9 Hz), 4.85 (1H, dd, J = 5.7 Hz,11.9 Hz), 5.
24-5.32 (1H, m), 7.00-7.06 (1H, m), 7.08-7.17 (2H,
m); IR (KBr) 3312, 2951, 1402, 1016, 997, 762 cm
-1; Anal. Calcd for C14H20O2: C,76.33; H, 9.15. Fo
und: C, 76.37; H, 9.28. 7) 4-[[[tert-ブチル(ジメチル)シリル]
オキシ]メチル]-8,8-ジメチル-6,7,8,9-テ
トラヒドロ-5H-ベンゾ[a]シクロヘプテン-5-オー
ル 4-(ヒドロキシメチル)-8,8-ジメチル-6,7,
8,9-テトラヒドロ-5H-ベンゾ[a]シクロヘプテ
ン-5-オール18.87g(85.65ミリモル)、4
-N,N-ジメチルアミノピリジン0.5g、トリエチル
アミン14.3ml(103ミリモル)のテトラヒドロ
フラン100ml溶液に、室温でtert-ブチルジメ
チルクロロシラン14.2g(94.2ミリモル)を加
え、そのまま一晩撹拌した。反応液を水に注ぎ、酢酸エ
チルで2回抽出した。集めた有機層を無水硫酸マグネシ
ウムで乾燥、溶媒を減圧留去した。得られた粗生成物を
シリカゲルカラムクロマトグラフィーにて精製し(ヘキ
サン/酢酸エチル=15/1-9/1)、目的物を得
た。無色液体 収量28.90g 収率100%1 H-NMR (CDCl3, 200 MHz) δ 0.08 (3H, s), 0.11 (3H,
s), 0.76 (3H, s), 0.90 (9H, s), 0.99 (3H, s), 1.1
6-1.30 (1H, m), 1.67-1.80 (1H, m), 1.88-2.05(2H,
m), 2.30 (1H, d, J = 13.6 Hz), 3.02 (1H, br s), 3.
23 (1H, d, J = 14.0 Hz), 4.64 (1H, d, J = 11.8 H
z), 4.94 (1H, d, J = 12.0 Hz), 5.23-5.31(1H, m),
6.98-7.04 (1H, m), 7.06-7.15 (2H, m); IR (neat) 33
91, 2951, 2928, 2857, 1470, 1254, 1076, 837, 775 c
m-1 8) tert-ブチル(6,6-ジメチル-6,7-ジヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-1-イルメトキ
シ)ジメチルシラン 4-[[[tert-ブチル(ジメチル)シリル]オキ
シ]メチル]-8,8-ジメチル-6,7,8,9-テトラ
ヒドロ-5H-ベンゾ[a]シクロヘプテン-5-オール2
8.90g(86.38ミリモル)、トリエチルアミン
24.1ml(173ミリモル)、4-N,N-ジメチル
アミノピリジン1.06g(8.64ミリモル)のアセ
トニトリル100ml溶液に氷冷下、メタンスルホニル
クロリド14.8g(130ミリモル)のアセトニトリ
ル10ml溶液を氷冷下滴下した。これに塩化リチウム
5.49g(130ミリモル)を加え、室温で6時間撹
拌した。反応液を水に注ぎ、酢酸エチルで2回抽出し
た。集めた有機層を無水硫酸マグネシウムで乾燥、溶媒
を減圧留去した。得られた残留物をN,N-ジメチルホ
ルムアミド100mlにとかし1,8-ジアザビシクロ
[5.4.0]-7-ウンデセン25.8ml(173ミ
リモル)を加え、80℃で一晩撹拌した。反応液を水に
注ぎ、酢酸エチルで2回抽出した。集めた有機層を無水
硫酸マグネシウムで乾燥、溶媒を減圧留去した。得られ
た粗生成物をシリカゲルカラムクロマトグラフィーにて
精製し(ヘキサン/酢酸エチル=15/1)、目的物を
得た。淡黄色液体 収量10.25g 収率38%1 H-NMR (CDCl3, 200 MHz) δ 0.09 (6H, s), 0.94 (9H,
s), 1.01 (6H, s), 1.65 (2H, d, J = 7.0 Hz), 2.32
(2H, s), 4.71 (2H, s), 6.25 (1H, td, J = 7.0Hz, 1
0.7 Hz), 6.64 (1H, d, J = 10.8 Hz), 7.07 (1H, d, J
= 8.8 Hz), 7.17(1H, t, J = 7.5 Hz), 7.37 (1H, d,
J = 8.0 Hz); IR (neat) 2953, 2928, 1464, 1256, 111
1, 1074, 837, 775 cm-1 9) 6,6-ジメチル-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-イルメタノール tert-ブチル(6,6-ジメチル-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-イルメトキシ)
ジメチルシラン7.306g(23.08ミリモル)の
テトラヒドロフラン30ml溶液に室温で1.0Mテト
ラブチルアンモニウムフルオリドのテトラヒドロフラン
溶液27.7ml(27.7ミリモル)を加え、室温で
15分間撹拌した。反応液を水に注ぎ、酢酸エチルで2
回抽出した。集めた有機層を無水硫酸マグネシウムで乾
燥、溶媒を減圧留去した。得られた粗生成物をシリカゲ
ルカラムクロマトグラフィーにて精製し(ヘキサン/酢
酸エチル=6/1-3/1)、目的物を得た。無色液体
収量4.484g 収率96%1 H-NMR (CDCl3, 200 MHz) δ 1.02 (6H, s), 1.59 (1H,
t, J = 5.9 Hz), 1.67(2H, d, J = 7.4 Hz), 2.35 (2
H, s), 4.70 (2H, d, J = 6.2 Hz), 6.32 (1H, td, J =
7.0 Hz, 10.6 Hz), 6.79 (1H, d, J = 10.6 Hz), 7.11
-7.31 (3H, m); IR (neat) 3318, 2951, 1454, 774 cm
-1 10) 6,6-ジメチル-6,7-ジヒドロ-5H-ベン
ゾ[a]シクロヘプテン-1-カルボン酸 6,6-ジメチル-6,7-ジヒドロ-5H-ベンゾ[a]
シクロヘプテン-1-イルメタノール4.429g(2
1.90ミリモル)のアセトン100ml溶液に、氷冷
下、無水クロム酸5.47g(53.7ミリモル)と濃
硫酸4mlを水15mlに溶解した溶液をゆっくりと滴
下し、滴下終了後、室温で1.5時間撹拌した。反応液
を再び氷冷した後、イソプロパノール20mlを加え、
そのまま0.5時間撹拌した。反応液のアセトンを減圧
下留去した後、酢酸エチルに希釈し、水で3回洗浄、無
水硫酸マグネシウムで乾燥、溶媒を減圧留去した。得ら
れた残留物を酢酸エチル-ヘキサンより結晶化して、目
的物を得た。黄色結晶 収量3.087g 収率65% mp 132-134℃; 1H-NMR (CDCl3, 200 MHz) δ 1.03 (6H,
s), 1.66 (2H, d, J =7.4 Hz), 2.37 (2H, s), 6.33
(1H, td, J = 7.3 Hz, 10.6 Hz), 7.23 (1H, d,J = 10.
6 Hz), 7.26 (1H, t, J = 7.5 Hz), 7.39 (1H, dd, J =
1.3 Hz, 7.5 Hz), 8.00 (1H, dd, J = 1.5 Hz, 7.6 H
z); IR (KBr) 3050-2550, 1682, 1464, 1451, 1308, 12
79, 775 cm-1; Anal. Calcd for C14H16O2: C, 77.75;
H, 7.46. Found: C, 77.97; H, 7.57. 11) N-[(1RS,2SR)-2-(4-フルオロフ
ェニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テ
トラフルオロエトキシ)ベンジル]エチル]-6,6-ジ
メチル-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプ
テン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.367g
(1.016ミリモル)、6,6-ジメチル-6,7-ジ
ヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボン
酸0.22g(1.02ミリモル)、1-ヒドロキシベ
ンゾトリアゾール水和物0.16g(1.02ミリモ
ル)をアセトニトリル10ml中で撹拌しながら1-エ
チル-3-(3-ジメチルアミノプロピル)カルボジイミ
ド・塩酸塩0.19g(1.02ミリモル)を加え、室
温で一晩撹拌した。反応液を酢酸エチルに希釈し、炭酸
水素ナトリウム水溶液で洗浄、無水硫酸マグネシウムで
乾燥、シリカゲルを通した後、溶媒を減圧留去した。得
られた残留物をジイソプロピルエーテル-ヘキサンより
結晶化して、目的物を得た。白色粉末 収量0.443
g 収率78% mp 115-116℃; 1H-NMR (CDCl3, 300 MHz) δ 0.99 (6H,
s), 1.64 (2H, d, J =7.2 Hz), 2.29 (2H, s), 2.79
(1H, dd, J = 10.4 Hz, 14.6 Hz), 2.98 (1H, dd, J =
4.1 Hz, 14.6 Hz), 3.78 (1H, d, J = 4.2 Hz), 4.59-
4.68 (1H, m), 5.04 (1H, t, J = 3.8 Hz), 5.76 (1H,
d, J = 8.4 Hz), 5.89 (1H, tt, J = 2.8 Hz, 53.0 H
z), 6.13 (1H, td, J = 7.1 Hz, 10.6 Hz), 6.34 (1H,
d, J = 10.5 Hz), 7.01-7.14 (7H, m), 7.17-7.22 (1H,
m), 7.30 (1H, t, J = 7.8 Hz), 7.42(2H, dd, J = 5.
3 Hz, 8.6 Hz); IR (KBr) 3287, 1638, 1512, 1227, 12
00, 1125 cm-1; Anal. Calcd for C31H30F5NO3: C, 66.
54; H, 5.40; N, 2.50. Found:C, 66.47; H, 5.46; N,
2.49.Example 288 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,6-dimethyl-
6,7-dihydro-5H-benzo [a] cycloheptene-1
-Carboxamide 1) Ethyl (E) -4,4-dimethyl-5-phenyl-2-pentenoate Liquid paraffin suspension of 60% sodium hydride 17.
8 g (445 mmol) was suspended in 300 ml of toluene, a solution of 99.8 g (445 mmol) of ethyl diethylphosphonoacetate in 50 ml of toluene was added at room temperature, and the mixture was stirred for 30 minutes. To this, 2,2-dimethyl-3-phenylpropanal (Tetrahedron Lett., 12
73-1275 (1973)) 60.16 g (37
(0.8 mmol) in 50 ml of toluene was added dropwise and stirred at room temperature for 2 hours. The reaction solution was poured into water and extracted twice with diethyl ether. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 20 / 1-9 / 1) to obtain the desired product. Colorless liquid Yield 55.97 g Yield 65% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.06 (6H, s), 1.29 (3H,
t, J = 7.2 Hz), 2.66 (2H, s), 4.19 (2H, q, J = 7.1
Hz), 5.63 (1H, d, J = 16.2 Hz), 7.03 (1H, d, J = 1
6.2 Hz), 7.06-7.10 (2H, m), 7.20-7.38 (3H, m); IR
(neat) 2963, 1717, 1310, 1167, 1038, 702 cm -1 2) Ethyl 4,4-dimethyl-5-phenylpentanoate Ethyl (E) -4,4-dimethyl-5-phenyl-2-pentenoate A solution of 55.97 g (240.9 mmol) in 150 ml of ethanol was hydrogenated overnight at room temperature and normal pressure using 5 g of 10% palladium / carbon (containing 50% water) as a catalyst.
The catalyst in the reaction solution was filtered off, and the catalyst was washed with ethanol.
The solvent of the collected filtrate was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-9 / 1) to obtain the desired product. Colorless liquid Yield 45.47 g Yield 81% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.86 (6H, s), 1.26 (3H,
t, J = 7.2 Hz), 1.56-1.64 (2H, m), 2.30-2.38 (2H,
m), 2.51 (2H, s), 4.13 (2H, q, J = 7.1 Hz), 7.10-
7.15 (2H, m), 7.20-7.32 (3H, m); IR (neat) 2961, 1
736, 1171, 704 cm -1 3) Ethyl 4,4-dimethyl-5-phenylpentanoate Ethyl 4,4-dimethyl-5-phenylpentanoate 45.
47 g (194.0 mmol), sodium hydroxide 1
A mixture of 5.5 g (388 mmol), 200 ml of water, 200 ml of methanol and 100 ml of tetrahydrofuran was stirred at room temperature overnight. After the reaction solution was concentrated under reduced pressure, it was diluted with water. This was washed with diethyl ether, acidified with concentrated hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (ethyl acetate) to obtain the desired product. Colorless liquid Yield 38.35 g 96% yield 1 H-NMR (CDCl 3 , 200 MHz) δ 0.88 (6H, s), 1.57-1.65
(2H, m), 2.35-2.43 (2H, m), 2.52 (2H, s), 7.10-7.
15 (2H, m), 7.21-7.32 (3H, m); IR (neat) 3100-285
0, 1715, 1452, 1416, 1302, 702 cm -1 4) 8,8-dimethyl-6,7,8,9-tetrahydro-
38.30 g of 5H-benzo [a] cyclohepten-5-one 4,4-dimethyl-5-phenylpentanoic acid
(185.7 mmol) and 24.3 ml (279 mmol) of oxalyl chloride were added dropwise to a solution of 0.1 ml of N, N-dimethylformamide in 150 ml of tetrahydrofuran at room temperature, followed by stirring for 0.5 hour. The solvent of the reaction mixture was distilled off under reduced pressure to obtain an acid chloride as a yellow liquid.
While stirring a suspension of 49.5 g (371 mmol) of aluminum chloride in 250 ml of methylene chloride, a solution of the acid chloride obtained above in 800 ml of methylene chloride was added dropwise thereto over 2 days. While cooling the reaction solution with ice, water was added to stop the reaction. The methylene chloride layer of the mixture was separated, and the aqueous layer was extracted with diethyl ether. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-6 / 1) to obtain the desired product. Yellow liquid Yield 29.55 g Yield 85% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.02 (6H, s), 1.45-1.51
(2H, m), 2.62 (2H, s), 2.63-2.69 (2H, m), 7.12 (1
H, dd, J = 1.0 Hz, 7.2 Hz), 7.31 (1H, dt, J = 1.5 H
z, 7.5 Hz), 7.43 (1H, dt, J = 1.6 Hz, 7.5 Hz), 7.7
2 (1H, dd, J = 1.4 Hz, 7.4 Hz); IR (neat) 2953, 292
8, 1682, 1601, 1468, 1289, 770 cm -1 5) 8,8-dimethyl-6,7,8,9-tetrahydro-
5H-benzo [a] cyclohepten-5-ol 8,8-dimethyl-6,7,8,9-tetrahydro-5H-
Benzo [a] cyclohepten-5-one 29.20 g (1
To a solution of 55.1 mmol) in 150 ml of methanol was added little by little 5.87 g (155 mmol) of sodium borohydride under ice-cooling, followed by stirring at room temperature for 1 hour. The reaction was diluted with water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 9 / 1-6).
/ 1) to obtain the desired product. 28.96 g of yellow liquid
Yield 98% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.72 (3H, s), 0.94 (3H,
s), 1.54-1.97 (4H, m), 1.78 (1H, d, J = 4.0 Hz),
2.67 (2H, br s), 4.85-4.93 (1H, m), 7.02 (1H, dd,
J = 1.6 Hz, 7.2 Hz), 7.11-7.23 (2H, m), 7.42 (1H,
d, J = 7.0 Hz); IR (neat) 3353, 2951, 2928, 1456, 1
044, 756 cm -1 6) 4- ( hydroxymethyl) -8,8-dimethyl-6,
7,8,9-tetrahydro-5H-benzo [a] cyclohepten-5-ol 8,8-dimethyl-6,7,8,9-tetrahydro-5H-
Benzo [a] cyclohepten-5-ol 28.72 g
(150.9 mmol) and 50.1 ml (332 mmol) of N, N, N ', N'-tetramethylethylenediamine in 200 ml of hexane under ice-cooling to 1.6 Mn.
After dropping 208 ml (332 mmol) of a hexane solution of -butyllithium, the mixture was stirred at 35 ° C overnight. After cooling the reaction mixture to −78 ° C.,
g was added and the temperature was raised to room temperature with stirring. The reaction mixture was diluted with water, acidified with concentrated hydrochloric acid, and extracted three times with ethyl acetate. The collected organic layer is dried over anhydrous magnesium sulfate,
The solvent was distilled off under reduced pressure. The obtained crude product is subjected to silica gel column chromatography (hexane / ethyl acetate = 6 /
7,7-dimethyl-7,8,9,9a-tetrahydrocyclohepta [cd] [2] benzofuran-2
The crude product of (6H) -one (31.00 g) was obtained as a yellow wet solid. Lithium aluminum hydride5.
73 g (151 mmol) of tetrahydrofuran 200
A 100 ml solution of the solid obtained above in tetrahydrofuran was added dropwise to the ml suspension under ice cooling, and the mixture was stirred at room temperature for 1 hour.
After cooling the reaction solution with ice, 6 ml of water, 6 ml of a 15% aqueous sodium hydroxide solution and 15 ml of water are sequentially added dropwise to decompose excess lithium aluminum hydride and leave it at room temperature for 2 hours.
Stirred for hours. The resulting precipitate was removed by filtration, and the precipitate was washed with ethyl acetate. The solvent of the collected filtrate was distilled off under reduced pressure.
The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-1 /
2) Crystallized from hexane to obtain the desired product. White crystals Yield 19.15 g Yield 58% mp 107-108 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 0.76 (3H,
s), 0.99 (3H, s), 1.16-1.28 (1H, m), 1.68-1.82 (1
H, m), 1.91-2.03 (2H, m), 2.30 (1H, d, J = 13.6 H
z), 2.63 (1H, br t, J = 5.3 Hz), 2.93 (1H, br s),
3.22 (1H, d, J = 13.8 Hz), 4.58 (1H, dd, J = 5.3 H
z, 11.9 Hz), 4.85 (1H, dd, J = 5.7 Hz, 11.9 Hz), 5.
24-5.32 (1H, m), 7.00-7.06 (1H, m), 7.08-7.17 (2H, m
m); IR (KBr) 3312, 2951, 1402, 1016, 997, 762 cm
-1 ; Anal.Calcd for C 14 H 20 O 2 : C, 76.33; H, 9.15. Fo
und: C, 76.37; H, 9.28.7) 4-[[[tert-butyl (dimethyl) silyl]
[Oxy] methyl] -8,8-dimethyl-6,7,8,9-tetrahydro-5H-benzo [a] cyclohepten-5-ol 4- (hydroxymethyl) -8,8-dimethyl-6,7,
18.87 g (85.65 mmol) of 8,9-tetrahydro-5H-benzo [a] cyclohepten-5-ol, 4
To a solution of 0.5 g of -N, N-dimethylaminopyridine and 14.3 ml (103 mmol) of triethylamine in 100 ml of tetrahydrofuran was added 14.2 g (94.2 mmol) of tert-butyldimethylchlorosilane at room temperature, and the mixture was stirred overnight. . The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-9 / 1) to obtain the desired product. Colorless liquid Yield 28.90 g Yield 100% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.08 (3H, s), 0.11 (3H,
s), 0.76 (3H, s), 0.90 (9H, s), 0.99 (3H, s), 1.1
6-1.30 (1H, m), 1.67-1.80 (1H, m), 1.88-2.05 (2H,
m), 2.30 (1H, d, J = 13.6 Hz), 3.02 (1H, br s), 3.
23 (1H, d, J = 14.0 Hz), 4.64 (1H, d, J = 11.8 H
z), 4.94 (1H, d, J = 12.0 Hz), 5.23-5.31 (1H, m),
6.98-7.04 (1H, m), 7.06-7.15 (2H, m); IR (neat) 33
91, 2951, 2928, 2857, 1470, 1254, 1076, 837, 775 c
m - 18) tert-butyl (6,6-dimethyl-6,7-dihydro-5H-benzo [a] cyclohepten-1-ylmethoxy) dimethylsilane 4-[[[tert-butyl (dimethyl) silyl] oxy] Methyl] -8,8-dimethyl-6,7,8,9-tetrahydro-5H-benzo [a] cyclohepten-5-ol 2
Methanesulfonyl chloride 14 was added to a solution of 8.90 g (86.38 mmol), 24.1 ml (173 mmol) of triethylamine and 1.06 g (8.64 mmol) of 4-N, N-dimethylaminopyridine in 100 ml of acetonitrile under ice-cooling. A solution of 2.8 g (130 mmol) in 10 ml of acetonitrile was added dropwise under ice cooling. To this, 5.49 g (130 mmol) of lithium chloride was added, and the mixture was stirred at room temperature for 6 hours. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was dissolved in 100 ml of N, N-dimethylformamide, 25.8 ml (173 mmol) of 1,8-diazabicyclo [5.4.0] -7-undecene was added, and the mixture was stirred at 80 ° C. overnight. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15/1) to obtain the desired product. Light yellow liquid Yield 10.25 g Yield 38% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.09 (6H, s), 0.94 (9H,
s), 1.01 (6H, s), 1.65 (2H, d, J = 7.0 Hz), 2.32
(2H, s), 4.71 (2H, s), 6.25 (1H, td, J = 7.0Hz, 1
0.7 Hz), 6.64 (1H, d, J = 10.8 Hz), 7.07 (1H, d, J
= 8.8 Hz), 7.17 (1H, t, J = 7.5 Hz), 7.37 (1H, d,
J = 8.0 Hz); IR (neat) 2953, 2928, 1464, 1256, 111
1, 1074, 837, 775 cm- 1 9) 6,6-dimethyl-6,7-dihydro-5H-benzo [a] cyclohepten-1-ylmethanol tert-butyl (6,6-dimethyl-6,7- Dihydro-
5H-benzo [a] cyclohepten-1-ylmethoxy)
To a solution of 7.306 g (23.08 mmol) of dimethylsilane in 30 ml of tetrahydrofuran was added 27.7 ml (27.7 mmol) of a 1.0 M solution of tetrabutylammonium fluoride in tetrahydrofuran at room temperature, followed by stirring at room temperature for 15 minutes. The reaction solution was poured into water, and extracted with ethyl acetate.
Extracted times. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-3 / 1) to obtain the desired product. Colorless liquid Yield 4.484 g Yield 96% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.02 (6H, s), 1.59 (1H,
t, J = 5.9 Hz), 1.67 (2H, d, J = 7.4 Hz), 2.35 (2
H, s), 4.70 (2H, d, J = 6.2 Hz), 6.32 (1H, td, J =
7.0 Hz, 10.6 Hz), 6.79 (1H, d, J = 10.6 Hz), 7.11
-7.31 (3H, m); IR (neat) 3318, 2951, 1454, 774 cm
-1 10) 6,6-Dimethyl-6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid 6,6-dimethyl-6,7-dihydro-5H-benzo [a]
4.429 g of cyclohepten-1-ylmethanol (2
A solution of 5.47 g (53.7 mmol) of chromic anhydride and 4 ml of concentrated sulfuric acid in 15 ml of water was slowly added dropwise to a solution of 1.90 mmol) in acetone under ice-cooling. Stir for 1.5 hours. After ice-cooling the reaction solution again, 20 ml of isopropanol was added,
The mixture was stirred for 0.5 hours as it was. The acetone in the reaction solution was distilled off under reduced pressure, diluted with ethyl acetate, washed three times with water, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. Yellow crystals Yield 3.087 g Yield 65% mp 132-134 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.03 (6H,
s), 1.66 (2H, d, J = 7.4 Hz), 2.37 (2H, s), 6.33
(1H, td, J = 7.3 Hz, 10.6 Hz), 7.23 (1H, d, J = 10.
6 Hz), 7.26 (1H, t, J = 7.5 Hz), 7.39 (1H, dd, J =
1.3 Hz, 7.5 Hz), 8.00 (1H, dd, J = 1.5 Hz, 7.6 H
z); IR (KBr) 3050-2550, 1682, 1464, 1451, 1308, 12
79, 775 cm -1 ; Anal.Calcd for C 14 H 16 O 2 : C, 77.75;
H, 7.46. Found: C, 77.97; H, 7.57.11) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2, 2-tetrafluoroethoxy) benzyl] ethyl] -6,6-dimethyl-6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluoro Phenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol 0.367 g
(1.016 mmol), 0.22 g (1.02 mmol) of 6,6-dimethyl-6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid, 1-hydroxybenzotriazole hydrate 0 0.16 g (1.02 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added while stirring 0.16 g (1.02 mmol) of 0.16 g (1.02 mmol) in 10 ml of acetonitrile, and the mixture was stirred at room temperature overnight. did. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. 0.443 white powder yield
g Yield 78% mp 115-116 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 0.99 (6H,
s), 1.64 (2H, d, J = 7.2 Hz), 2.29 (2H, s), 2.79
(1H, dd, J = 10.4 Hz, 14.6 Hz), 2.98 (1H, dd, J =
4.1 Hz, 14.6 Hz), 3.78 (1H, d, J = 4.2 Hz), 4.59-
4.68 (1H, m), 5.04 (1H, t, J = 3.8 Hz), 5.76 (1H,
d, J = 8.4 Hz), 5.89 (1H, tt, J = 2.8 Hz, 53.0 H
z), 6.13 (1H, td, J = 7.1 Hz, 10.6 Hz), 6.34 (1H,
d, J = 10.5 Hz), 7.01-7.14 (7H, m), 7.17-7.22 (1H,
m), 7.30 (1H, t, J = 7.8 Hz), 7.42 (2H, dd, J = 5.
3 Hz, 8.6 Hz); IR (KBr) 3287, 1638, 1512, 1227, 12
. 00, 1125 cm -1; Anal Calcd for C 31 H 30 F 5 NO 3: C, 66.
54; H, 5.40; N, 2.50. Found: C, 66.47; H, 5.46; N,
2.49.
【0421】実施例289 N-[(1RS,2RS)-2-(5-クロロ-2-チエニ
ル)-2-ヒドロキシ-1-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]エチル]-6,7-ジヒド
ロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミ
ド 1) 3-(5-クロロ-2-チエニル)-3-オキソ-2-
[3-(1,1,2,2-テトラフルオロエトキシ)ベン
ジル]プロピオン酸エチル 3-(1,1,2,2-テトラフルオロエトキシ)トルエ
ン12.5g(60.0ミリモル)、N-ブロモスクシ
ンイミド10.7g(60.0ミリモル)、2,2’-
アゾビス(イソブチロニトリル)30mgの四塩化炭素
30ml溶液を0.5時間加熱還流した。反応液を室温
に冷却した後、白色沈殿を濾過して除き、沈殿をジエチ
ルエーテルで洗浄した。集めた濾液の溶媒を減圧留去し
て、3-(1,1,2,2-テトラフルオロエトキシ)ベ
ンジルブロミドの粗生成物を淡黄色液体として得た。3
-(5-クロロ-2-チエニル)-3-オキソプロピオン酸エ
チル11.63g(49.98ミリモル)の1,2-ジ
メトキシエタン50ml溶液に氷冷下60%水素化ナト
リウムの流動パラフィン懸濁物2.00g(50.0ミ
リモル)を加え、そのまま0.5時間撹拌した。これに
上で得た3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジルブロミドの1,2-ジメトキシエタン10
ml溶液を室温で加え、室温で8時間撹拌した。反応液
を水に注ぎ、酢酸エチルで2回抽出した。集めた有機層
を無水硫酸マグネシウムで乾燥、溶媒を減圧留去した。
得られた残留物をシリカゲルカラムクロマトグラフィー
にて精製し(ヘキサン/酢酸エチル=15/1-9/
1)、ヘキサンより結晶化して、目的物を得た。白色結
晶 収量12.58g 収率57% mp 49-51℃; 1H-NMR (CDCl3, 200 MHz) δ 1.16 (3H,
t, J = 7.2 Hz), 3.27 (1H, dd, J = 7.5 Hz, 14.1 H
z), 3.36 (1H, dd, J = 7.5 Hz, 14.1 Hz), 4.13 (2H,
q, J = 7.1 Hz), 4.34 (1H, t, J = 7.5 Hz), 5.89 (1
H, tt, J = 2.9 Hz, 53.1 Hz), 6.93 (1H, d, J = 4.2
Hz), 7.04-7.14 (3H, m), 7.23-7.32 (1H, m),7.53 (1
H, d, J = 4.0 Hz); IR (KBr) 1725, 1661, 1434, 121
5, 1148, 1132 cm-1; Anal. Calcd for C18H15ClF4O4S:
C, 49.27; H, 3.45. Found: C, 49.24;H, 3.20. 2) (2RS,3RS)-3-(5-クロロ-2-チエニ
ル)-3-ヒドロキシ-2-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]プロピオン酸エチル 塩化亜鉛7.76g(57.0ミリモル)をジエチルエ
ーテル150ml中で撹拌しながら水素化ホウ素ナトリ
ウム4.31g(114ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、3-(5-クロロ
-2-チエニル)-3-オキソ-2-[3-(1,1,2,2-
テトラフルオロエトキシ)ベンジル]プロピオン酸エチ
ル12.50g(28.48ミリモル)を氷冷下で加
え、室温にて2時間撹拌した。反応液に希塩酸を少しず
つ加えて過剰の水素化ホウ素亜鉛を分解した後、酢酸エ
チルで2回抽出した。集めた有機層を無水硫酸マグネシ
ウムで乾燥、溶媒を減圧留去した。得られた粗生成物を
シリカゲルカラムクロマトグラフィーにて精製し(ヘキ
サン/酢酸エチル=6/1-1/1)、目的物を得た。
無色液体 収量12.70g 収率100%1 H-NMR (CDCl3, 200 MHz) δ 1.00 (3H, t, J = 7.2 H
z), 2.95-3.09 (3H, m),3.14 (1H, d, J = 3.6 Hz), 3.
96 (2H, q, J = 7.2 Hz), 5.14 (1H, t, J = 3.9Hz),
5.90 (1H, tt, J = 2.9 Hz, 53.1 Hz), 6.75 (1H, d, J
= 4.0 Hz), 6.79(1H, d, J = 4.0 Hz), 7.00 (1H, s),
7.06 (2H, d, J = 7.8 Hz), 7.28 (1H,t, J = 7.9 H
z); IR (neat) 3463, 1725, 1451, 1302, 1277, 1198,
1125, 801cm-1 3) (2RS,3RS)-3-(5-クロロ-2-チエニ
ル)-3-ヒドロキシ-2-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]プロピオン酸 (2RS,3RS)-3-(5-クロロ-2-チエニル)-3
-ヒドロキシ-2-[3-(1,1,2,2-テトラフルオ
ロエトキシ)ベンジル]プロピオン酸エチル14.27
g(32.37ミリモル)、水酸化ナトリウム2.39
g(64.7ミリモル)、メタノール50ml、テトラ
ヒドロフラン50mlの混合物を室温で6時間撹拌し
た。反応液を濃縮、水で希釈し、希塩酸で反応液を酸性
にした後、酢酸エチルで2回抽出した。集めた有機層を
無水硫酸ナトリウムで乾燥、溶媒を減圧留去した。残留
物をジエチルエーテル-ヘキサンより結晶化して、目的
物を得た。白色結晶 収量9.181g 収率69% mp 105-106℃; 1H-NMR (CDCl3, 300 MHz) δ 3.03-3.11
(3H, m), 5.15-5.17 (1H, m), 5.89 (1H, tt, J = 2.9
Hz, 53.1 Hz), 6.76 (1H, d, J = 3.9 Hz), 6.79 (1H,
d, J = 3.6 Hz), 7.01 (1H, s), 7.06 (2H, d, J = 8.
7 Hz), 7.27 (1H,t, J = 7.8 Hz); IR (KBr) 3358, 310
0-2550, 1692, 1453, 1287, 1204, 1117,801 cm-1; Ana
l. Calcd for C16H13ClF4O4S: C, 46.56; H, 3.17. Fou
nd: C, 46.59; H, 3.20. 4) (4RS,5RS)-5-(5-クロロ-2-チエニ
ル)-4-[3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]-1,3-オキサゾリジン-2-オン(2R
S,3RS)-3-(5-クロロ-2-チエニル)-3-ヒド
ロキシ-2-[3-(1,1,2,2-テトラフルオロエト
キシ)ベンジル]プロピオン酸8.996g(21.7
9ミリモル)のテトラヒドロフラン80ml溶液にトリ
エチルアミン3.65ml(26.2ミリモル)、ジフ
ェニルホスホリルアジド6.60g(24.0ミリモ
ル)を加え、一晩加熱還流した。反応液の溶媒を減圧留
去し、得られた粗生成物をシリカゲルカラムクロマトグ
ラフィーにて精製し(ヘキサン/酢酸エチル=3/1-
1/1)、目的物を得た。褐色液体 収量8.480g
収率95%1 H-NMR (CDCl3, 200 MHz) δ 2.55 (1H, dd, J = 9.8 H
z, 14.0 Hz), 2.66 (1H,dd, J = 4.6 Hz, 13.4 Hz), 4.
20-4.31 (1H, m), 5.19 (1H, br s), 5.86 (1H,d, J =
7.6 Hz), 5.91 (1H, tt, J = 2.8 Hz, 53.0 Hz), 6.87
(2H, s), 6.94(1H, s), 7.01 (1H, d, J = 7.6 Hz), 7.
13 (1H, dd, J = 1.2 Hz, 8.2 Hz), 7.34 (1H, t, J =
7.9 Hz); IR (neat) 3274, 1761, 1451, 1196, 1119, 1
001 cm- 1 5) (1RS,2RS)-2-アミノ-1-(5-クロロ-
2-チエニル)-3-[3-(1,1,2,2-テトラフル
オロエトキシ)フェニル]プロパン-1-オール (4RS,5RS)-5-(5-クロロ-2-チエニル)-4
-[3-(1,1,2,2-テトラフルオロエトキシ)ベ
ンジル]-1,3-オキサゾリジン-2-オン8.480g
(20.69ミリモル)と水酸化ナトリウム3.31g
(82.8ミリモル)をエタノール40ml-水3ml
中で、4時間加熱還流した。反応液を食塩水で希釈し、
酢酸エチルで2回抽出した。集めた有機層を無水硫酸ナ
トリウムで乾燥、溶媒を減圧留去した。残留物をシリカ
ゲル(APSタイプ)カラムクロマトグラフィーにて精
製し(ヘキサン/酢酸エチル=3/1-酢酸エチル)、
目的物を得た。黄色液体 収量7.648g 収率96
%1 H-NMR (CDCl3, 200 MHz) δ 2.45 (1H, dd, J = 9.8 H
z, 13.8 Hz), 2.86 (1H,dd, J = 4.1 Hz, 13.5 Hz), 3.
27-3.36 (1H, m), 4.76 (1H, d, J = 4.8 Hz),5.91 (1
H, tt, J = 2.7 Hz, 53.1 Hz), 6.78 (1H, d, J = 3.6
Hz), 6.83 (1H,d, J = 3.6 Hz), 7.06 (2H, d, J = 7.4
Hz), 7.12 (1H, d, J = 1.6 Hz), 7.32(1H, t, J = 7.
8 Hz); IR (neat) 3360-2860, 1586, 1487, 1451, 130
2, 1279,1196, 1121, 801 cm-1 6) N-[(1RS,2RS)-2-(5-クロロ-2-チ
エニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テ
トラフルオロエトキシ)ベンジル]エチル]-6,7-ジ
ヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキ
サミド (1RS,2RS)-2-アミノ-1-(5-クロロ-2-チ
エニル)-3-[3-(1,1,2,2-テトラフルオロエ
トキシ)フェニル]プロパン-1-オール0.582g
(1.516ミリモル)、6,7-ジヒドロ-5H-ベン
ゾ[a]シクロヘプテン-1-カルボン酸0.29g
(1.52ミリモル)、1-ヒドロキシベンゾトリアゾ
ール水和物0.23g(1.52ミリモル)をアセトニ
トリル10ml中で撹拌しながら1-エチル-3-(3-ジ
メチルアミノプロピル)カルボジイミド・塩酸塩0.2
9g(1.52ミリモル)を加え、室温で一晩撹拌し
た。反応液を酢酸エチルに希釈し、炭酸水素ナトリウム
水溶液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲ
ルを通した後、溶媒を減圧留去した。得られた残留物を
ジイソプロピルエーテル-ヘキサンより結晶化して、目
的物を得た。白色粉末 収量0.623g 収率74% mp 177-178℃; 1H-NMR (CDCl3, 200 MHz) δ 1.95-2.07
(2H, m), 2.16-2.25 (2H, m), 2.68 (2H, t, J = 5.9
Hz), 2.80 (1H, dd, J = 10.4 Hz, 14.6 Hz), 3.06 (1
H, dd, J = 4.8 Hz, 14.2 Hz), 4.40 (1H, d, J = 4.2
Hz), 4.62-4.76 (1H, m), 5.15 (1H, t, J = 3.6 Hz),
5.81 (1H, d, J = 7.6 Hz), 5.90 (1H, tt,J = 2.9 Hz,
53.1 Hz), 5.96 (1H, td, J = 5.3 Hz, 11.6 Hz), 6.2
7 (1H, d,J = 11.8 Hz), 6.83 (2H, s), 7.02-7.21 (6
H, m), 7.35 (1H, t, J = 7.7 Hz);IR (KBr) 3264, 164
0, 1537, 1451, 1202, 1117 cm-1; Anal. Calcd for C
27H2 4ClF4NO3S: C, 58.54; H, 4.37; N, 2.53. Found:
C, 58.29; H, 4.36; N, 2.47.Example 289 N-[(1RS, 2RS) -2- (5-chloro-2-thienyl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl ] Ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1) 3- (5-chloro-2-thienyl) -3-oxo-2-
Ethyl [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionate 12.5 g (60.0 mmol) of 3- (1,1,2,2-tetrafluoroethoxy) toluene, N-bromo 10.7 g (60.0 mmol) of succinimide, 2,2'-
A solution of 30 mg of azobis (isobutyronitrile) in 30 ml of carbon tetrachloride was heated under reflux for 0.5 hour. After cooling the reaction solution to room temperature, a white precipitate was removed by filtration, and the precipitate was washed with diethyl ether. The solvent of the collected filtrate was distilled off under reduced pressure to obtain a crude product of 3- (1,1,2,2-tetrafluoroethoxy) benzyl bromide as a pale yellow liquid. 3
Liquid paraffin suspension of 60% sodium hydride in a solution of 11.63 g (49.98 mmol) of ethyl-(5-chloro-2-thienyl) -3-oxopropionate in 50 ml of 1,2-dimethoxyethane under ice-cooling 2.00 g (50.0 mmol) was added, and the mixture was stirred as it was for 0.5 hour. The 3- (1,1,2,2-tetrafluoroethoxy) benzyl bromide obtained above was treated with 1,2-dimethoxyethane 10
ml solution was added at room temperature and stirred at room temperature for 8 hours. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure.
The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-9 /
1) Crystallized from hexane to obtain the desired product. White crystals Yield 12.58 g Yield 57% mp 49-51 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.16 (3H,
t, J = 7.2 Hz), 3.27 (1H, dd, J = 7.5 Hz, 14.1 H
z), 3.36 (1H, dd, J = 7.5 Hz, 14.1 Hz), 4.13 (2H,
q, J = 7.1 Hz), 4.34 (1H, t, J = 7.5 Hz), 5.89 (1
H, tt, J = 2.9 Hz, 53.1 Hz), 6.93 (1H, d, J = 4.2
Hz), 7.04-7.14 (3H, m), 7.23-7.32 (1H, m), 7.53 (1
H, d, J = 4.0 Hz); IR (KBr) 1725, 1661, 1434, 121
. 5, 1148, 1132 cm -1 ; Anal Calcd for C 18 H 15 ClF 4 O 4 S:
H, 3.45. Found: C, 49.24; H, 3.20.2) (2RS, 3RS) -3- (5-chloro-2-thienyl) -3-hydroxy-2- [3- (1, Ethyl 1,2,2-tetrafluoroethoxy) benzyl] propionate While stirring 7.76 g (57.0 mmol) of zinc chloride in 150 ml of diethyl ether, 4.31 g (114 mmol) of sodium borohydride was added at room temperature. The mixture was stirred for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. To the resulting solution, add 3- (5-chloro
-2-thienyl) -3-oxo-2- [3- (1,1,2,2-
12.50 g (28.48 mmol) of ethyl tetrafluoroethoxy) benzyl] propionate was added under ice-cooling, and the mixture was stirred at room temperature for 2 hours. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-1 / 1) to obtain the desired product.
Colorless liquid Yield 12.70 g Yield 100% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.00 (3H, t, J = 7.2 H)
z), 2.95-3.09 (3H, m), 3.14 (1H, d, J = 3.6 Hz), 3.
96 (2H, q, J = 7.2 Hz), 5.14 (1H, t, J = 3.9Hz),
5.90 (1H, tt, J = 2.9 Hz, 53.1 Hz), 6.75 (1H, d, J
= 4.0 Hz), 6.79 (1H, d, J = 4.0 Hz), 7.00 (1H, s),
7.06 (2H, d, J = 7.8 Hz), 7.28 (1H, t, J = 7.9 H
z); IR (neat) 3463, 1725, 1451, 1302, 1277, 1198,
1125, 801cm -1 3) (2RS , 3RS) -3- (5- chloro-2-thienyl) -3-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionic Acid (2RS, 3RS) -3- (5-chloro-2-thienyl) -3
Ethyl ethyl-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionate 14.27
g (32.37 mmol), sodium hydroxide 2.39
g (64.7 mmol), a mixture of 50 ml of methanol and 50 ml of tetrahydrofuran were stirred at room temperature for 6 hours. The reaction solution was concentrated, diluted with water, acidified with dilute hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from diethyl ether-hexane to obtain the desired product. White crystals Yield 9.181 g Yield 69% mp 105-106 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 3.03-3.11
(3H, m), 5.15-5.17 (1H, m), 5.89 (1H, tt, J = 2.9
Hz, 53.1 Hz), 6.76 (1H, d, J = 3.9 Hz), 6.79 (1H,
d, J = 3.6 Hz), 7.01 (1H, s), 7.06 (2H, d, J = 8.
7 Hz), 7.27 (1H, t, J = 7.8 Hz); IR (KBr) 3358, 310
0-2550, 1692, 1453, 1287, 1204, 1117,801 cm -1 ; Ana
l. Calcd for C 16 H 13 ClF 4 O 4 S: C, 46.56; H, 3.17. Fou
nd: C, 46.59; H, 3.20.4) (4RS, 5RS) -5- (5-chloro-2-thienyl) -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine-2-one (2R
8.996 g (21.7) of S, 3RS) -3- (5-chloro-2-thienyl) -3-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionic acid
To a solution of 9 mmol) in 80 ml of tetrahydrofuran were added 3.65 ml (26.2 mmol) of triethylamine and 6.60 g (24.0 mmol) of diphenylphosphoryl azide, and the mixture was heated under reflux overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-
1/1) to obtain the desired product. Brown liquid yield 8.480g
Yield 95% 1 H-NMR (CDCl 3 , 200 MHz) δ 2.55 (1H, dd, J = 9.8 H
z, 14.0 Hz), 2.66 (1H, dd, J = 4.6 Hz, 13.4 Hz), 4.
20-4.31 (1H, m), 5.19 (1H, br s), 5.86 (1H, d, J =
7.6 Hz), 5.91 (1H, tt, J = 2.8 Hz, 53.0 Hz), 6.87
(2H, s), 6.94 (1H, s), 7.01 (1H, d, J = 7.6 Hz), 7.
13 (1H, dd, J = 1.2 Hz, 8.2 Hz), 7.34 (1H, t, J =
7.9 Hz); IR (neat) 3274, 1761, 1451, 1196, 1119, 1
001 cm - 1 5) (1RS , 2RS) -2- amino-1- (5-chloro -
2-thienyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol (4RS, 5RS) -5- (5-chloro-2-thienyl) -4
-[3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidin-2-one 8.480 g
(20.69 mmol) and 3.31 g of sodium hydroxide
(82.8 mmol) in 40 ml of ethanol-3 ml of water
And heated under reflux for 4 hours. Dilute the reaction with saline,
Extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel (APS type) column chromatography (hexane / ethyl acetate = 3 / 1-ethyl acetate),
The desired product was obtained. Yellow liquid Yield 7.648 g Yield 96
% 1 H-NMR (CDCl 3 , 200 MHz) δ 2.45 (1H, dd, J = 9.8 H
z, 13.8 Hz), 2.86 (1H, dd, J = 4.1 Hz, 13.5 Hz), 3.
27-3.36 (1H, m), 4.76 (1H, d, J = 4.8 Hz), 5.91 (1
H, tt, J = 2.7 Hz, 53.1 Hz), 6.78 (1H, d, J = 3.6
Hz), 6.83 (1H, d, J = 3.6 Hz), 7.06 (2H, d, J = 7.4
Hz), 7.12 (1H, d, J = 1.6 Hz), 7.32 (1H, t, J = 7.
8 Hz); IR (neat) 3360-2860, 1586, 1487, 1451, 130
2, 1279,1196, 1121, 801 cm -1 6) N - [(1RS, 2RS) -2- (5- chloro-2-thienyl) -2-hydroxy-1- [3- (1,1,2 , 2-Tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2RS) -2-amino-1- (5-chloro-2-thienyl) 0.582 g of -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol
(1.516 mmol), 0.29 g of 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid
(1.52 mmol) 1-Hydroxybenzotriazole hydrate 0.23 g (1.52 mmol) in 10 ml of acetonitrile while stirring 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 0 .2
9 g (1.52 mmol) was added and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White powder Yield 0.623 g Yield 74% mp 177-178 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.95-2.07
(2H, m), 2.16-2.25 (2H, m), 2.68 (2H, t, J = 5.9
Hz), 2.80 (1H, dd, J = 10.4 Hz, 14.6 Hz), 3.06 (1
H, dd, J = 4.8 Hz, 14.2 Hz), 4.40 (1H, d, J = 4.2
Hz), 4.62-4.76 (1H, m), 5.15 (1H, t, J = 3.6 Hz),
5.81 (1H, d, J = 7.6 Hz), 5.90 (1H, tt, J = 2.9 Hz,
53.1 Hz), 5.96 (1H, td, J = 5.3 Hz, 11.6 Hz), 6.2
7 (1H, d, J = 11.8 Hz), 6.83 (2H, s), 7.02-7.21 (6
H, m), 7.35 (1H, t, J = 7.7 Hz); IR (KBr) 3264, 164
0, 1537, 1451, 1202, 1117 cm -1 ; Anal.Calcd for C
27 H 2 4 ClF 4 NO 3 S: C, 58.54; H, 4.37; N, 2.53. Found:
C, 58.29; H, 4.36; N, 2.47.
【0422】実施例290 N-[(1RS,2SR)-2-(4-ブロモフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド 1) 3-(4-ブロモフェニル)-3-オキソプロパン酸
エチル 4-ブロモアセトフェノン(80g,0.40モル)と
エタノール(1ml)、炭酸ジエチル(350ml)の
混合液に水素化ナトリウム(32g,60%油性)を氷
冷下に少量ずつ加えて室温で4時間撹拌した。反応液を
0℃に冷却し、6規定塩酸(200ml)を加えて、酢
酸エチル(200,100ml)で抽出した。抽出液を
水洗し、無水硫酸マグネシウムで乾燥後、減圧留去し
た。残留物をシリカゲルクロマトグラフィー(ヘキサ
ン:酢酸エチル=10:1-5:1)で精製して、目的
物(108.9g,定量的)を油状物として得た。 IRνmaxNeatcm-1:1742, 1688, 1586, 1424, 1323, 126
4, 1200, 1073, 1009.1 H-NMR(CDCl3) δ : 1.26(3H×3/4, t, J = 7.2 Hz),
1.31(3H×1/4, t, J = 7.2 Hz), 3.96(2H×3/4, s), 4.
21(2H×3/4, q, J = 7.2 Hz), 4.27(2H×1/4, q,J = 7.
2 Hz), 5.65(1H×1/4, s), 7.50-7.70(2H×5/4, m), 7.
75-7.90(2H×3/4,m). 2) 3-(4-ブロモフェニル)-3-オキソ-2-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]プロパン酸エチル 3-(1,1,2,2-テトラフルオロエトキシ)トルエ
ン(25g,0.12モル)の酢酸エチル(400m
l)溶液に、N-ブロモスクシンイミド(21.4,
0.12モル)と2,2'-アゾビスイソブチロニトリル
(0.2g)を加えて2.5時間加熱還流した。反応液
を減圧濃縮した後、ジエチルエーテルとヘキサンを加え
て不溶物を除去し、ジエチルエーテルで洗浄した。濾液
を減圧留去して、3-(1,1,2,2-テトラフルオロ
エトキシ)-1-ブロモメチルベンゼンを得た。3-(4-
ブロモフェニル)-3-オキソプロパン酸エチル(27.
1g,100ミリモル)のジメトキシエタン(150m
l)溶液に、氷冷下水素化ナトリウム(4.0g,60
%油性,0.1モル)を加えて1時間撹拌した。これに
上で得た3-(1,1,2,2-テトラフルオロエトキ
シ)-1-ブロモメチルベンゼンのジメトキシエタン(2
0ml)溶液を滴下し、室温で15時間撹拌した。反応
液に水(300ml)を加えて酢酸エチル(200ml
×2)で抽出した。抽出液を水洗し、無水硫酸マグネシ
ウムで乾燥後、減圧留去した。残留物をシリカゲルクロ
マトグラフィー(ヘキサン:トルエン=1:2-1:
5)で精製し、ヘキサンから結晶化させて、目的物(2
1.1g,44%)を得た。 mp 48-49℃ IRνmaxKBrcm-1:1721, 1684, 1588, 1277, 1198, 1134,
845. Anal. Calcd for C20H17BrF4O4 (MW477.24) Calcd: C,50.33; H,3.96 Found: C,55.55; H,3.831 H-NMR(CDCl3) δ :1.12(3H, t, J = 7.2 Hz), 3.33(2
H, d, J = 8.0 Hz), 4.10(2H, q, J = 7.2 Hz), 4.55(1
H, t, J = 7.0 Hz), 5.89(1H, tt, J = 53.1, 2.2Hz),
7.00-7.20(3H, m), 7.20-7.35(1H, m), 7.42(2H, d, J
= 8.0 Hz), 7.89(2H,d,J = 8.0 Hz). 3) (2RS,3RS)-3-(4-ブロモフェニル)-
3-ヒドロキシ-2-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]プロパン酸エチル 無水塩化亜鉛(11.4g,83.8ミリモル)のジエ
チルエーテル(200ml)懸濁液に、水素化ホウ素ナ
トリウム(6.34g,168ミリモル)を少量ずつ加
えて、2時間撹拌した。不溶物を濾去し、ジエチルエー
テルで洗浄した。濾液を氷冷し、これに3-(4-ブロモ
フェニル)-3-オキソ-2-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]プロパン酸エチル(2
0g,41.9ミリモル)のジエチルエーテル(50m
l)溶液を加えた。室温で2時間撹拌した後、再び氷冷
し、2規定塩酸で反応を止めた。得られた混合物を酢酸
エチル(200,100ml)で抽出し、水洗後、無水
硫酸マグネシウムで乾燥し、減圧留去した。残留物をシ
リカゲルクロマトグラフィー(ヘキサン:酢酸エチル=
5:1-2:1)で精製して、目的物(20g,定量
的)を無色油状物として得た。 IRνmaxNeatcm-1:1715, 1590, 1487, 1302, 1279, 119
8, 1123, 1011.1 H-NMR(CDCl3) δ : 0.95(3H, t, J = 7.2 Hz), 2.90-
3.15(4H, m), 3.90(2H, d, J = 7.2 Hz), 5.02(1H, b
r), 5.89(1H, tt, J = 53.1, 2.8 Hz), 6.90-7.15(3H,
m), 7.20-7.40(3H, m), 7.40-7.60(2H, m). 4) (2RS,3RS)-3-(4-ブロモフェニル)-
3-ヒドロキシ-2-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]プロパン酸 (2RS,3RS)-3-(4-ブロモフェニル)-3-ヒ
ドロキシ-2-[3-(1,1,2,2-テトラフルオロエ
トキシ)ベンジル]プロパン酸エチル(19.5g,4
0.7ミリモル)のメタノール(100ml)溶液に2
規定水酸化ナトリウム水溶液(40.7ml,81.4
ミリモル)を加えて室温で2.5時間撹拌した。反応液
に6規定塩酸(50ml)を加えて酸性とした後、酢酸
エチル(100ml×2)で抽出した。抽出液を水洗
し、無水硫酸マグネシウムで乾燥後、減圧留去した。残
留物をヘキサンから結晶化させて、目的物(16.7
g,91%)を得た。 mp 85-86℃ IRνmaxKBrcm-1:1696, 1487, 1279, 1206, 1127. Anal. Calcd for C18H15BrF4O4 (MW451.21) Calcd: C,47.91; H,3.35 Found: C,47.97; H,3.331 H-NMR(CDCl3) δ : 2.85-3.15(3H, m), 5.06(1H, d, J
= 3.8 Hz), 5.88(1H, tt, J = 53.1, 2.8 Hz), 6.90-
7.15(3H, m), 7.20-7.40 (2H, m), 7.49(2H, d, J= 8.4
Hz). 5) (4RS,5SR)-5-(4-ブロモフェニル)-
4-[3-(1,1,2,2-テトラフルオロエトキシ)
ベンジル]-1,3-オキサゾリジン-2-オン (2RS,3RS)-3-(4-ブロモフェニル)-3-ヒ
ドロキシ-2-[3-(1,1,2,2-テトラフルオロエ
トキシ)ベンジル]プロパン酸(16.2g,35.9
ミリモル)のテトラヒドロフラン(150ml)溶液に
アジ化ジフェニルホスホリル(10.0ml,46.7
ミリモル)とトリエチルアミン(7.0ml,50.3
ミリモル)を加えて室温で1時間撹拌した。その後、2
時間加熱還流した後、反応液を減圧濃縮し、水(100
ml)を加えて酢酸エチル(100ml×2)で抽出し
た。抽出液を1規定塩酸と飽和重曹水で洗浄し、無水硫
酸マグネシウムで乾燥後、減圧留去した。残留物をシリ
カゲルクロマトグラフィー(ヘキサン:酢酸エチル=
3:1-1:1)で精製し、析出した結晶をヘキサンを
加えて濾取して、目的物(14.7g,91%)を得
た。 mp 136-137℃ IRνmaxKBrcm-1:1738, 1489, 1200, 1125, 848. Anal. Calcd for C18H14BrF4NO3 (MW448.21) Calcd: C,48.24; H,3.15; N, 3.13 Found: C,48.30; H,2.87; N, 3.14.1 H-NMR(CDCl3) δ : 2.15-2.40(2H, m), 4.20-4.35(1H,
m), 5.03(1H, brs), 5.77(1H, d, J = 8.0 Hz), 5.90
(1H, tt, J = 53.2, 2.7 Hz), 6.87(1H, s), 6.94(1H,
d, J = 7.6 Hz), 7.05-7.15 (1H, m), 7.20-7.40(3H,
m), 7.55-7.65(2H,m). 6) (1RS,2SR)-2-アミノ-1-(4-ブロモ
フェニル)-3-[3-(1,1,2,2-テトラフルオロ
エトキシ)フェニル]-1-プロパノール (4RS,5SR)-5-(4-ブロモフェニル)-4-
[3-(1,1,2,2-テトラフルオロエトキシ)ベン
ジル]-1,3-オキサゾリジン-2-オン(14.0g,
31.2ミリモル)のエタノール(50ml)溶液に、
8規定水酸化ナトリウム水溶液(15.6ml,125
ミリモル)を加えて2時間加熱還流した。反応液を減圧
濃縮し、水(200ml)を加えて酢酸エチル(200
ml×2)で抽出した。抽出液を水洗し、無水硫酸マグ
ネシウムで乾燥後、減圧留去した。残留物をヘキサン-
ジエチルエーテルから結晶化させて、目的物(12.8
g,97%)を得た。 mp 84-86℃ IRνmaxKBrcm-1:3362, 1611, 1588, 1485, 1308, 1196,
1119, 1034, 1007. Anal. Calcd for C17H16BrF4NO2 (MW422.21) Calcd: C,48.36; H,3.82; N, 3.32 Found: C,48.59; H,3.57; N, 3.37.1 H-NMR(CDCl3) δ: 2.36(1H, dd, J = 13.4, 10.6 Hz),
2.76(1H, dd, J = 13.4, 3.4 Hz), 3.20-3.40(1H, m),
4.65(1H, d, J = 4.8 Hz), 5.91(1H, tt, J = 53.1,
2.8 Hz), 6.99(1H, s), 7.06(2H, t, J = 6.6 Hz), 7.2
0-7.40(3H, m), 7.51(2H, d, J = 8.6 Hz). 7) N-[(1RS,2SR)-2-(4-ブロモフェニ
ル)-2-ヒドロキシ-1-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]エチル]-6,7-ジヒド
ロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミ
ド (1RS,2SR)-2-アミノ-1-(4-ブロモフェニ
ル)-3-[3-(1,1,2,2-テトラフルオロエトキ
シ)フェニル]-1-プロパノール5.647g(13.
37ミリモル)、6,7-ジヒドロ-5H-ベンゾ[a]
シクロヘプテン-1-カルボン酸2.52g(13.4ミ
リモル)、1-ヒドロキシベンゾトリアゾール水和物
2.05g(13.4ミリモル)をアセトニトリル40
ml中で撹拌しながら1-エチル-3-(3-ジメチルアミ
ノプロピル)カルボジイミド・塩酸塩2.56g(1
3.4ミリモル)を加え、室温で一晩撹拌した。反応液
を酢酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗
浄、無水硫酸マグネシウムで乾燥、シリカゲルを通した
後、溶媒を減圧留去した。得られた残留物を酢酸エチル
-ジイソプロピルエーテル-ヘキサンより結晶化して、目
的物を得た。白色粉末 収量7.306g 収率92% mp 184-185℃; 1H-NMR (CDCl3, 300 MHz) δ 1.95-2.04
(2H, m), 2.16-2.23 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.77 (1H, dd, J = 10.7 Hz, 14.6 Hz), 2.97 (1
H, dd, J = 4.1 Hz, 14.6 Hz), 3.76 (1H, d, J = 3.9
Hz), 4.61-4.70 (1H, m), 5.02 (1H, t, J = 3.9 Hz),
5.75 (1H, d, J = 8.4 Hz), 5.89 (1H, tt,J = 2.8 Hz,
53.1 Hz), 5.92 (1H, td, J = 5.9 Hz, 11.4 Hz), 6.2
0 (1H, d,J = 11.7 Hz), 6.96 (1H, dd, J = 1.5 Hz,
7.8 Hz), 7.01 (1H, s), 7.03-7.17(4H, m), 7.30 (1H,
t, J = 7.8 Hz), 7.34 (2H, d, J = 8.1 Hz), 7.51 (2
H,d, J = 8.4 Hz); IR (KBr) 3260, 1640, 1532, 1487,
1198, 1125 cm-1; Anal.Calcd for C29H26BrF4NO3: C,
58.80; H, 4.42; N, 2.36. Found: C, 58.75; H,4.43;
N, 2.35.Example 290 N-[(1RS, 2SR) -2- (4-bromophenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
5H-benzo [a] cycloheptene-1-carboxamide 1) Ethyl 3- (4-bromophenyl) -3-oxopropanoate 4-bromoacetophenone (80 g, 0.40 mol), ethanol (1 ml), diethyl carbonate (350 ml) Sodium hydride (32 g, 60% oil) was added little by little to the mixture under ice cooling, and the mixture was stirred at room temperature for 4 hours. The reaction solution was cooled to 0 ° C., 6N hydrochloric acid (200 ml) was added, and the mixture was extracted with ethyl acetate (200, 100 ml). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 10: 1-5: 1) to give the desired product (108.9 g, quantitative) as an oil. IRνmax Neat cm -1 : 1742, 1688, 1586, 1424, 1323, 126
4, 1200, 1073, 1009. 1 H-NMR (CDCl 3) δ: 1.26 (3H × 3/4, t, J = 7.2 Hz),
1.31 (3H × 1/4, t, J = 7.2 Hz), 3.96 (2H × 3/4, s), 4.
21 (2H x 3/4, q, J = 7.2 Hz), 4.27 (2H x 1/4, q, J = 7.
2 Hz), 5.65 (1H x 1/4, s), 7.50-7.70 (2H x 5/4, m), 7.
75-7.90 (2H × 3/4, m). 2) 3- (4-bromophenyl) -3-oxo-2- [3-
Ethyl (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate Ethyl acetate of 3- (1,1,2,2-tetrafluoroethoxy) toluene (25 g, 0.12 mol) (400 m
1) Add N-bromosuccinimide (21.4,
0.12 mol) and 2,2'-azobisisobutyronitrile (0.2 g) were added, and the mixture was heated under reflux for 2.5 hours. After the reaction solution was concentrated under reduced pressure, diethyl ether and hexane were added to remove insolubles, and washed with diethyl ether. The filtrate was distilled off under reduced pressure to obtain 3- (1,1,2,2-tetrafluoroethoxy) -1-bromomethylbenzene. 3- (4-
Ethyl bromophenyl) -3-oxopropanoate (27.
1 g, 100 mmol) of dimethoxyethane (150 m
l) Add sodium hydride (4.0 g, 60
% Oily, 0.1 mol) and stirred for 1 hour. The dimethoxyethane (2) of 3- (1,1,2,2-tetrafluoroethoxy) -1-bromomethylbenzene obtained above was added thereto.
0 ml) solution was added dropwise and stirred at room temperature for 15 hours. Water (300 ml) was added to the reaction solution, and ethyl acetate (200 ml) was added.
× 2). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel chromatography (hexane: toluene = 1: 2-1: 1).
Purified in 5) and crystallized from hexane to give the desired product (2
1.1 g, 44%). mp 48-49 ° C IRνmax KBr cm -1 : 1721, 1684, 1588, 1277, 1198, 1134,
845.Analyzed Calcd for C 20 H 17 BrF 4 O 4 (MW477.24) Calcd: C, 50.33; H, 3.96 Found: C, 55.55; H, 3.83 1 H-NMR (CDCl 3 ) δ: 1.12 (3H , t, J = 7.2 Hz), 3.33 (2
H, d, J = 8.0 Hz), 4.10 (2H, q, J = 7.2 Hz), 4.55 (1
H, t, J = 7.0 Hz), 5.89 (1H, tt, J = 53.1, 2.2Hz),
7.00-7.20 (3H, m), 7.20-7.35 (1H, m), 7.42 (2H, d, J
= 8.0 Hz), 7.89 (2H, d, J = 8.0 Hz). 3) (2RS, 3RS) -3- (4-bromophenyl)-
Ethyl 3-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate To a suspension of anhydrous zinc chloride (11.4 g, 83.8 mmol) in diethyl ether (200 ml). Then, sodium borohydride (6.34 g, 168 mmol) was added little by little, and the mixture was stirred for 2 hours. The insolubles were removed by filtration and washed with diethyl ether. The filtrate was ice-cooled, and ethyl 3- (4-bromophenyl) -3-oxo-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate (2
0 g, 41.9 mmol) of diethyl ether (50 m
l) The solution was added. After stirring at room temperature for 2 hours, the mixture was ice-cooled again and the reaction was stopped with 2N hydrochloric acid. The obtained mixture was extracted with ethyl acetate (200, 100 ml), washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was chromatographed on silica gel (hexane: ethyl acetate =
5: 1-2: 1) to give the desired product (20 g, quantitative) as a colorless oil. IRνmax Neat cm -1 : 1715, 1590, 1487, 1302, 1279, 119
8, 1123, 1011. 1 H- NMR (CDCl 3) δ: 0.95 (3H, t, J = 7.2 Hz), 2.90-
3.15 (4H, m), 3.90 (2H, d, J = 7.2 Hz), 5.02 (1H, b
r), 5.89 (1H, tt, J = 53.1, 2.8 Hz), 6.90-7.15 (3H,
m), 7.20-7.40 (3H, m), 7.40-7.60 (2H, m). 4) (2RS, 3RS) -3- (4-bromophenyl)-
3-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoic acid (2RS, 3RS) -3- (4-bromophenyl) -3-hydroxy-2- [3- Ethyl (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate (19.5 g, 4
0.7 mmol) in methanol (100 ml).
Normal sodium hydroxide aqueous solution (40.7 ml, 81.4
Mmol) and stirred at room temperature for 2.5 hours. The reaction solution was acidified by adding 6N hydrochloric acid (50 ml), and then extracted with ethyl acetate (100 ml × 2). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was crystallized from hexane to give the desired product (16.7).
g, 91%). . mp 85-86 ℃ IRνmax KBr cm -1 : 1696, 1487, 1279, 1206, 1127. Anal Calcd for C 18 H 15 BrF 4 O 4 (MW451.21) Calcd: C, 47.91; H, 3.35 Found: C , 47.97; H, 3.33 1 H-NMR (CDCl 3 ) δ: 2.85-3.15 (3H, m), 5.06 (1H, d, J
= 3.8 Hz), 5.88 (1H, tt, J = 53.1, 2.8 Hz), 6.90-
7.15 (3H, m), 7.20-7.40 (2H, m), 7.49 (2H, d, J = 8.4
Hz). 5) (4RS, 5SR) -5- (4-bromophenyl)-
4- [3- (1,1,2,2-tetrafluoroethoxy)
Benzyl] -1,3-oxazolidin-2-one (2RS, 3RS) -3- (4-bromophenyl) -3-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl ] Propanoic acid (16.2 g, 35.9)
Mmol) in a solution of diphenylphosphoryl azide (10.0 ml, 46.7).
Mmol) and triethylamine (7.0 ml, 50.3)
Mmol) and stirred at room temperature for 1 hour. Then 2
After heating under reflux for a period of time, the reaction solution was concentrated under reduced pressure and water (100
ml) and extracted with ethyl acetate (100 ml × 2). The extract was washed with 1N hydrochloric acid and saturated aqueous sodium hydrogen carbonate, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was chromatographed on silica gel (hexane: ethyl acetate =
3: 1-1: 1), and the precipitated crystals were added with hexane and collected by filtration to obtain the desired product (14.7 g, 91%). . mp 136-137 ℃ IRνmax KBr cm -1 : 1738, 1489, 1200, 1125, 848. Anal Calcd for C 18 H 14 BrF 4 NO 3 (MW448.21) Calcd: C, 48.24; H, 3.15; N, 3.13 Found:. C, 48.30; H, 2.87; N, 3.14 1 H-NMR (CDCl 3) δ: 2.15-2.40 (2H, m), 4.20-4.35 (1H,
m), 5.03 (1H, brs), 5.77 (1H, d, J = 8.0 Hz), 5.90
(1H, tt, J = 53.2, 2.7 Hz), 6.87 (1H, s), 6.94 (1H,
d, J = 7.6 Hz), 7.05-7.15 (1H, m), 7.20-7.40 (3H,
m), 7.55-7.65 (2H, m). 6) (1RS, 2SR) -2-amino-1- (4-bromophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) ) Phenyl] -1-propanol (4RS, 5SR) -5- (4-bromophenyl) -4-
[3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidin-2-one (14.0 g,
31.2 mmol) in ethanol (50 ml)
8N aqueous sodium hydroxide solution (15.6 ml, 125
(Mmol) was added and heated under reflux for 2 hours. The reaction solution was concentrated under reduced pressure, water (200 ml) was added, and ethyl acetate (200 ml) was added.
ml × 2). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. Hexane residue
Crystallization from diethyl ether gave the desired product (12.8).
g, 97%). mp 84-86 ℃ IRνmax KBr cm -1 : 3362, 1611, 1588, 1485, 1308, 1196,
. 1119, 1034, 1007. Anal Calcd for C 17 H 16 BrF 4 NO 2 (MW422.21) Calcd: C, 48.36; H, 3.82; N, 3.32 Found: C, 48.59; H, 3.57; N, 3.37. 1 H-NMR (CDCl 3 ) δ: 2.36 (1H, dd, J = 13.4, 10.6 Hz),
2.76 (1H, dd, J = 13.4, 3.4 Hz), 3.20-3.40 (1H, m),
4.65 (1H, d, J = 4.8 Hz), 5.91 (1H, tt, J = 53.1,
2.8 Hz), 6.99 (1H, s), 7.06 (2H, t, J = 6.6 Hz), 7.2
0-7.40 (3H, m), 7.51 (2H, d, J = 8.6 Hz). 7) N-[(1RS, 2SR) -2- (4-bromophenyl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (4- 5.647 g of bromophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] -1-propanol (13.
37 mmol), 6,7-dihydro-5H-benzo [a]
2.52 g (13.4 mmol) of cycloheptene-1-carboxylic acid and 2.05 g (13.4 mmol) of 1-hydroxybenzotriazole hydrate were added to acetonitrile 40
2.56 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (1 ml)
3.4 mmol) and stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The residue obtained is ethyl acetate
Crystallization from -diisopropyl ether-hexane gave the desired product. White powder Yield 7.306 g Yield 92% mp 184-185 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.95-2.04
(2H, m), 2.16-2.23 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.77 (1H, dd, J = 10.7 Hz, 14.6 Hz), 2.97 (1
H, dd, J = 4.1 Hz, 14.6 Hz), 3.76 (1H, d, J = 3.9
Hz), 4.61-4.70 (1H, m), 5.02 (1H, t, J = 3.9 Hz),
5.75 (1H, d, J = 8.4 Hz), 5.89 (1H, tt, J = 2.8 Hz,
53.1 Hz), 5.92 (1H, td, J = 5.9 Hz, 11.4 Hz), 6.2
0 (1H, d, J = 11.7 Hz), 6.96 (1H, dd, J = 1.5 Hz,
7.8 Hz), 7.01 (1H, s), 7.03-7.17 (4H, m), 7.30 (1H,
t, J = 7.8 Hz), 7.34 (2H, d, J = 8.1 Hz), 7.51 (2
H, d, J = 8.4 Hz); IR (KBr) 3260, 1640, 1532, 1487,
1198, 1125 cm -1 ; Anal.Calcd for C 29 H 26 BrF 4 NO 3 : C,
58.80; H, 4.42; N, 2.36. Found: C, 58.75; H, 4.43;
N, 2.35.
【0423】実施例291 N-[(1RS,2SR)-2-(1,1’-ビフェニル-
4-イル)-2-ヒドロキシ-1-[3-(1,1,2,2-
テトラフルオロエトキシ)ベンジル]エチル]-6,7-
ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボ
キサミド N-[(1RS,2SR)-2-(4-ブロモフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.511g(0.863ミリモル)、フェニルボロン
酸0.16g(1.29ミリモル)、テトラキス(トリ
フェニルホスフィン)パラジウム(0)0.10g
(0.086ミリモル)と炭酸ナトリウム0.18g
(1.73ミリモル)をトルエン8ml-水8ml中
で、90℃で1日間撹拌した。反応液を水に注ぎ、酢酸
エチルで2回抽出した。集めた有機層を無水硫酸ナトリ
ウムで乾燥、溶媒を減圧留去した。残留物をシリカゲル
カラムクロマトグラフィーにて精製し(ヘキサン/酢酸
エチル=3/1-1/1)、ジイソプロピルエーテルよ
り結晶化して、目的物を得た。白色粉末 収量0.26
9g 収率53% mp 122-123℃; 1H-NMR (CDCl3, 200 MHz) δ 1.96-2.05
(2H, m), 2.14-2.24 (2H, m), 2.66 (2H, t, J = 5.8
Hz), 2.83 (1H, dd, J = 10.8 Hz, 14.6 Hz), 3.06 (1
H, dd, J = 4.5 Hz, 14.7 Hz), 3.60 (1H, d, J = 3.6
Hz), 4.72-4.82 (1H, m), 5.11 (1H, t, J = 3.7 Hz),
5.80 (1H, d, J = 8.0 Hz), 5.88 (1H, tt,J = 3.0 Hz,
53.1 Hz), 5.91 (1H, td, J = 5.4 Hz, 11.6 Hz), 6.2
3 (1H, d,J = 11.6 Hz), 6.97-7.17 (6H, m), 7.31-7.6
4 (10H, m); IR (KBr) 3250, 1634, 1530, 1487, 1285,
1194, 1115, 770, 700 cm-1; Anal. Calcd for C35H31
F4NO3・0.1H2O・0.5i-Pr2O: C, 71.04; H, 5.99; N, 2.1
8. Found: C, 70.75; H, 5.99; N, 2.23.Example 291 N-[(1RS, 2SR) -2- (1,1′-biphenyl-
4-yl) -2-hydroxy-1- [3- (1,1,2,2-
Tetrafluoroethoxy) benzyl] ethyl] -6,7-
Dihydro-5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- (4-bromophenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
0.511 g (0.863 mmol) of 5H-benzo [a] cycloheptene-1-carboxamide, 0.16 g (1.29 mmol) of phenylboronic acid, 0.10 g of tetrakis (triphenylphosphine) palladium (0)
(0.086 mmol) and 0.18 g of sodium carbonate
(1.73 mmol) was stirred in 8 ml of toluene-8 ml of water at 90 ° C. for 1 day. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from diisopropyl ether to obtain the desired product. White powder Yield 0.26
9g Yield 53% mp 122-123 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.96-2.05
(2H, m), 2.14-2.24 (2H, m), 2.66 (2H, t, J = 5.8
Hz), 2.83 (1H, dd, J = 10.8 Hz, 14.6 Hz), 3.06 (1
H, dd, J = 4.5 Hz, 14.7 Hz), 3.60 (1H, d, J = 3.6
Hz), 4.72-4.82 (1H, m), 5.11 (1H, t, J = 3.7 Hz),
5.80 (1H, d, J = 8.0 Hz), 5.88 (1H, tt, J = 3.0 Hz,
53.1 Hz), 5.91 (1H, td, J = 5.4 Hz, 11.6 Hz), 6.2
3 (1H, d, J = 11.6 Hz), 6.97-7.17 (6H, m), 7.31-7.6
4 (10H, m); IR (KBr) 3250, 1634, 1530, 1487, 1285,
1194, 1115, 770, 700 cm -1 ; Anal.Calcd for C 35 H 31
F 4 NO 3・ 0.1H 2 O ・ 0.5i-Pr 2 O: C, 71.04; H, 5.99; N, 2.1
8. Found: C, 70.75; H, 5.99; N, 2.23.
【0424】実施例292 N-[(1RS,2SR)-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]-2-[4-(3-チエニル)フェニル]エチル]-
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボキサミド N-[(1RS,2SR)-2-(4-ブロモフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.519g(0.876ミリモル)、チオフェン-3-
ボロン酸0.17g(1.31ミリモル)、テトラキス
(トリフェニルホスフィン)パラジウム(0)0.10
g(0.088ミリモル)と炭酸ナトリウム0.19g
(1.75ミリモル)をトルエン8ml-水8ml中
で、90℃で1日間撹拌した。反応液を水に注ぎ、酢酸
エチルで2回抽出した。集めた有機層を無水硫酸ナトリ
ウムで乾燥、溶媒を減圧留去した。残留物をシリカゲル
カラムクロマトグラフィーにて精製し(ヘキサン/酢酸
エチル=3/1-1/1)、酢酸エチル-ジイソプロピル
エーテル-ヘキサンより結晶化して、目的物を得た。淡
褐色粉末 収量0.334g 収率64% mp 178-179℃; 1H-NMR (CDCl3, 200 MHz) δ 1.92-2.04
(2H, m), 2.14-2.23 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.81 (1H, dd, J = 10.5 Hz, 14.7 Hz), 3.03 (1
H, dd, J = 4.6 Hz, 14.4 Hz), 3.63 (1H, d, J = 3.6
Hz), 4.67-4.81 (1H, m), 5.07 (1H, t, J = 3.7 Hz),
5.80 (1H, d, J = 8.4 Hz), 5.88 (1H, tt,J = 2.9 Hz,
53.1 Hz), 5.90 (1H, td, J = 5.0 Hz, 12.2 Hz), 6.2
2 (1H, d,J = 11.8 Hz), 6.95-7.17 (6H, m), 7.26-7.5
0 (6H, m), 7.62 (2H, d, J = 8.2Hz); IR (KBr) 3283,
2936, 1640, 1532, 1200, 1123, 783 cm-1; Anal. Cal
cdfor C33H29F4NO3S: C, 66.54; H, 4.91; N, 2.35. Fo
und: C, 66.37; H, 4.86;N, 2.28.Example 292 N-[(1RS, 2SR) -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] -2- [4- (3-thienyl) phenyl] ethyl]-
6,7-dihydro-5H-benzo [a] cycloheptene-1
-Carboxamide N-[(1RS, 2SR) -2- (4-bromophenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
0.519 g (0.876 mmol) of 5H-benzo [a] cycloheptene-1-carboxamide, thiophen-3-
0.17 g (1.31 mmol) of boronic acid, tetrakis (triphenylphosphine) palladium (0) 0.10
g (0.088 mmol) and 0.19 g of sodium carbonate
(1.75 mmol) was stirred at 90 ° C. for 1 day in 8 ml of toluene and 8 ml of water. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from ethyl acetate / diisopropyl ether / hexane to obtain the desired product. Light brown powder Yield 0.334 g Yield 64% mp 178-179 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.92-2.04
(2H, m), 2.14-2.23 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.81 (1H, dd, J = 10.5 Hz, 14.7 Hz), 3.03 (1
H, dd, J = 4.6 Hz, 14.4 Hz), 3.63 (1H, d, J = 3.6
Hz), 4.67-4.81 (1H, m), 5.07 (1H, t, J = 3.7 Hz),
5.80 (1H, d, J = 8.4 Hz), 5.88 (1H, tt, J = 2.9 Hz,
53.1 Hz), 5.90 (1H, td, J = 5.0 Hz, 12.2 Hz), 6.2
2 (1H, d, J = 11.8 Hz), 6.95-7.17 (6H, m), 7.26-7.5
0 (6H, m), 7.62 (2H, d, J = 8.2Hz); IR (KBr) 3283,
2936, 1640, 1532, 1200, 1123, 783 cm -1 ; Anal. Cal
cdfor C 33 H 29 F 4 NO 3 S:. C, 66.54; H, 4.91; N, 2.35 Fo
und: C, 66.37; H, 4.86; N, 2.28.
【0425】実施例293 N-[(1RS,2SR)-2-(2’-クロロ[1,1’
-ビフェニル]-4-イル)-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド N-[(1RS,2SR)-2-(4-ブロモフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.529g(0.893ミリモル)、2-クロロフェ
ニルボロン酸0.42g(2.68ミリモル)、テトラ
キス(トリフェニルホスフィン)パラジウム(0)0.
20g(0.18ミリモル)と炭酸ナトリウム0.38
g(3.58ミリモル)をトルエン8ml-水8ml中
で、90℃で2日間撹拌した。反応液を水に注ぎ、酢酸
エチルで2回抽出した。集めた有機層を無水硫酸ナトリ
ウムで乾燥、溶媒を減圧留去した。残留物をシリカゲル
カラムクロマトグラフィーにて精製し(ヘキサン/酢酸
エチル=3/1-1/1)、ジイソプロピルエーテル-ヘ
キサンより結晶化して、目的物を得た。白色粉末 収量
0.203g 収率36% mp 172-173℃; 1H-NMR (CDCl3, 300 MHz) δ 1.95-2.04
(2H, m), 2.16-2.22 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.86 (1H, dd, J = 10.8 Hz, 14.4 Hz), 3.07 (1
H, dd, J = 4.5 Hz, 14.7 Hz), 3.62 (1H, d, J = 3.9
Hz), 4.72-4.81 (1H, m), 5.11 (1H, t, J = 3.9 Hz),
5.83 (1H, d, J = 8.4 Hz), 5.89 (1H, tt,J = 2.9 Hz,
53.0 Hz), 5.93 (1H, td, J = 5.7 Hz, 11.6 Hz), 6.2
5 (1H, d,J = 11.7 Hz), 6.96-7.16 (6H, m), 7.26-7.3
6 (4H, m), 7.46-7.54 (5H, m); IR (KBr) 3753, 3233,
3061, 1640, 1306, 1198, 1123, 1030, 762 cm-1; Ana
l.Calcd for C35H30ClF4NO3: C, 67.36; H, 4.85; N,
2.24. Found: C, 66.99; H,5.05; N, 2.08.Example 293 N-[(1RS, 2SR) -2- (2′-chloro [1,1 ′]
-Biphenyl] -4-yl) -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- (4-bromo Phenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
0.529 g (0.893 mmol) of 5H-benzo [a] cycloheptene-1-carboxamide, 0.42 g (2.68 mmol) of 2-chlorophenylboronic acid, tetrakis (triphenylphosphine) palladium (0).
20 g (0.18 mmol) and 0.38 sodium carbonate
g (3.58 mmol) was stirred in 8 ml of toluene-8 ml of water at 90 ° C. for 2 days. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from diisopropyl ether / hexane to obtain the desired product. White powder Yield 0.203 g Yield 36% mp 172-173 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.95-2.04
(2H, m), 2.16-2.22 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.86 (1H, dd, J = 10.8 Hz, 14.4 Hz), 3.07 (1
H, dd, J = 4.5 Hz, 14.7 Hz), 3.62 (1H, d, J = 3.9
Hz), 4.72-4.81 (1H, m), 5.11 (1H, t, J = 3.9 Hz),
5.83 (1H, d, J = 8.4 Hz), 5.89 (1H, tt, J = 2.9 Hz,
53.0 Hz), 5.93 (1H, td, J = 5.7 Hz, 11.6 Hz), 6.2
5 (1H, d, J = 11.7 Hz), 6.96-7.16 (6H, m), 7.26-7.3
6 (4H, m), 7.46-7.54 (5H, m); IR (KBr) 3753, 3233,
3061, 1640, 1306, 1198, 1123, 1030, 762 cm -1 ; Ana
l.Calcd for C 35 H 30 ClF 4 NO 3: C, 67.36; H, 4.85; N,
2.24. Found: C, 66.99; H, 5.05; N, 2.08.
【0426】実施例294 N-[(1RS,2SR)-2-(4’-クロロ[1,1’
-ビフェニル]-4-イル)-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド N-[(1RS,2SR)-2-(4-ブロモフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.500g(0.844ミリモル)、4-クロロフェ
ニルボロン酸0.26g(1.69ミリモル)、テトラ
キス(トリフェニルホスフィン)パラジウム(0)0.
20g(0.17ミリモル)と炭酸ナトリウム0.27
g(2.53ミリモル)をトルエン10ml-水10m
l中で、90℃で2日間撹拌した。反応液を水に注ぎ、
酢酸エチルで2回抽出した。集めた有機層を無水硫酸ナ
トリウムで乾燥、溶媒を減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィーにて精製し(ヘキサン/
酢酸エチル=3/1-1/1)、ジイソプロピルエーテ
ル-ヘキサンより結晶化して、目的物を得た。淡褐色結
晶 収量0.136g 収率26% mp 167-168℃; 1H-NMR (CDCl3, 300 MHz) δ 1.95-2.03
(2H, m), 2.15-2.22 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.83 (1H, dd, J = 10.7 Hz, 14.6 Hz), 3.04 (1
H, dd, J = 4.1 Hz, 14.9 Hz), 3.63 (1H, d, J = 3.6
Hz), 4.71-4.79 (1H, m), 5.11 (1H, t, J = 3.8 Hz),
5.80 (1H, d, J = 8.4 Hz), 5.88 (1H, tt,J = 2.9 Hz,
53.1 Hz), 5.90 (1H, td, J = 5.7 Hz, 11.4 Hz), 6.2
3 (1H, d,J = 12.0 Hz), 6.96-7.16 (6H, m), 7.30 (1
H, t, J = 8.0 Hz), 7.41 (2H, d,J = 8.7 Hz), 7.50-
7.59 (6H, m); IR (KBr) 3289, 2932, 1638, 1530, 148
7, 1204, 1123, 1096, 818 cm-1; Anal. Calcd for C35
H30ClF4NO3: C, 67.36; H, 4.85; N, 2.24. Found: C,
67.37; H, 4.87; N, 2.15.Example 294 N-[(1RS, 2SR) -2- (4'-chloro [1,1 '
-Biphenyl] -4-yl) -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- (4-bromo Phenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
0.500 g (0.844 mmol) of 5H-benzo [a] cycloheptene-1-carboxamide, 0.26 g (1.69 mmol) of 4-chlorophenylboronic acid, tetrakis (triphenylphosphine) palladium (0).
20 g (0.17 mmol) and sodium carbonate 0.27
g (2.53 mmol) in 10 ml of toluene and 10 m of water
and stirred at 90 ° C. for 2 days. Pour the reaction into water,
Extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane /
Crystallization from ethyl acetate = 3 / 1-1 / 1) and diisopropyl ether / hexane gave the desired product. Light brown crystal Yield 0.136 g Yield 26% mp 167-168 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.95-2.03
(2H, m), 2.15-2.22 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.83 (1H, dd, J = 10.7 Hz, 14.6 Hz), 3.04 (1
H, dd, J = 4.1 Hz, 14.9 Hz), 3.63 (1H, d, J = 3.6
Hz), 4.71-4.79 (1H, m), 5.11 (1H, t, J = 3.8 Hz),
5.80 (1H, d, J = 8.4 Hz), 5.88 (1H, tt, J = 2.9 Hz,
53.1 Hz), 5.90 (1H, td, J = 5.7 Hz, 11.4 Hz), 6.2
3 (1H, d, J = 12.0 Hz), 6.96-7.16 (6H, m), 7.30 (1
H, t, J = 8.0 Hz), 7.41 (2H, d, J = 8.7 Hz), 7.50-
7.59 (6H, m); IR (KBr) 3289, 2932, 1638, 1530, 148
7, 1204, 1123, 1096, 818 cm -1 ; Anal.Calcd for C 35
H 30 ClF 4 NO 3 : C, 67.36; H, 4.85; N, 2.24. Found: C,
67.37; H, 4.87; N, 2.15.
【0427】実施例295 N-[(1RS,2SR)-2-(3’-クロロ[1,1’
-ビフェニル]-4-イル)-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド N-[(1RS,2SR)-2-(4-ブロモフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.500g(0.844ミリモル)、3-クロロフェ
ニルボロン酸0.26g(1.69ミリモル)、テトラ
キス(トリフェニルホスフィン)パラジウム(0)0.
20g(0.17ミリモル)と炭酸ナトリウム0.27
g(2.53ミリモル)をトルエン10ml-水10m
l中で、90℃で2日間撹拌した。反応液を水に注ぎ、
酢酸エチルで2回抽出した。集めた有機層を無水硫酸ナ
トリウムで乾燥、溶媒を減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィーにて精製し(ヘキサン/
酢酸エチル=3/1-1/1)、ジイソプロピルエーテ
ル-ヘキサンより結晶化して、目的物を得た。淡褐色結
晶 収量0.165g 収率31% mp 131-132℃; 1H-NMR (CDCl3, 300 MHz) δ 1.95-2.03
(2H, m), 2.16-2.22 (2H, m), 2.67 (2H, t, J = 5.9
Hz), 2.83 (1H, dd, J = 10.5 Hz, 14.4 Hz), 3.03 (1
H, dd, J = 4.2 Hz, 14.7 Hz), 3.66 (1H, d, J = 3.9
Hz), 4.70-4.79 (1H, m), 5.11 (1H, t, J = 3.8 Hz),
5.80 (1H, d, J = 8.1 Hz), 5.88 (1H, tt,J = 2.9 Hz,
53.0 Hz), 5.91 (1H, td, J = 5.7 Hz, 11.4 Hz), 6.2
3 (1H, d,J = 11.7 Hz), 6.98-7.17 (6H, m), 7.28-7.4
3 (3H, m), 7.46-7.60 (6H, m); IR (KBr) 3270, 2938,
1640, 1514, 1200, 1125, 783 cm-1; Anal. Calcd for
C3 5H30ClF4NO3: C, 67.36; H, 4.85; N, 2.24. Found:
C, 67.42; H, 4.80; N, 2.10.Example 295 N-[(1RS, 2SR) -2- (3′-chloro [1,1 ′]
-Biphenyl] -4-yl) -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- (4-bromo Phenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
0.500 g (0.844 mmol) of 5H-benzo [a] cycloheptene-1-carboxamide, 0.26 g (1.69 mmol) of 3-chlorophenylboronic acid, tetrakis (triphenylphosphine) palladium (0).
20 g (0.17 mmol) and sodium carbonate 0.27
g (2.53 mmol) in 10 ml of toluene and 10 m of water
and stirred at 90 ° C. for 2 days. Pour the reaction into water,
Extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane /
Crystallization from ethyl acetate = 3 / 1-1 / 1) and diisopropyl ether / hexane gave the desired product. Light brown crystal Yield 0.165 g Yield 31% mp 131-132 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.95-2.03
(2H, m), 2.16-2.22 (2H, m), 2.67 (2H, t, J = 5.9
Hz), 2.83 (1H, dd, J = 10.5 Hz, 14.4 Hz), 3.03 (1
H, dd, J = 4.2 Hz, 14.7 Hz), 3.66 (1H, d, J = 3.9
Hz), 4.70-4.79 (1H, m), 5.11 (1H, t, J = 3.8 Hz),
5.80 (1H, d, J = 8.1 Hz), 5.88 (1H, tt, J = 2.9 Hz,
53.0 Hz), 5.91 (1H, td, J = 5.7 Hz, 11.4 Hz), 6.2
3 (1H, d, J = 11.7 Hz), 6.98-7.17 (6H, m), 7.28-7.4
3 (3H, m), 7.46-7.60 (6H, m); IR (KBr) 3270, 2938,
1640, 1514, 1200, 1125, 783 cm -1 ; Anal.Calcd for
C 3 5 H 30 ClF 4 NO 3 : C, 67.36; H, 4.85; N, 2.24. Found:
C, 67.42; H, 4.80; N, 2.10.
【0428】実施例296 N-[(1RS,2SR)-2-ヒドロキシ-2-(2’-メ
トキシ[1,1’-ビフェニル]-4-イル)-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド N-[(1RS,2SR)-2-(4-ブロモフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.530g(0.895ミリモル)、2-メトキシフ
ェニルボロン酸0.20g(1.34ミリモル)、テト
ラキス(トリフェニルホスフィン)パラジウム(0)
0.10g(0.089ミリモル)と炭酸ナトリウム
0.19g(1.79ミリモル)をトルエン8ml-水
8ml中で、90℃で1日間撹拌した。反応液を水に注
ぎ、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸ナトリウムで乾燥、溶媒を減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィーにて精製し(ヘキサ
ン/酢酸エチル=3/1-1/1)、酢酸エチル-ジイソ
プロピルエーテル-ヘキサンより結晶化して、目的物を
得た。白色粉末 収量0.307g 収率55% mp 148-150℃; 1H-NMR (CDCl3, 300 MHz) δ 1.95-2.05
(2H, m), 2.16-2.22 (2H, m), 2.66 (2H, t, J = 5.7
Hz), 2.85 (1H, dd, J = 10.7 Hz, 14.9 Hz), 3.08 (1
H, dd, J = 4.2 Hz, 14.7 Hz), 3.48 (1H, d, J = 3.9
Hz), 3.82 (3H, s), 4.74-4.82 (1H, m), 5.09 (1H, t,
J = 3.6 Hz), 5.79 (1H, d, J = 8.7 Hz),5.89 (1H, t
t, J = 2.9 Hz, 53.1 Hz), 5.91 (1H, td, J = 5.5 Hz,
11.2 Hz),6.24 (1H, d, J = 11.7 Hz), 6.97-7.18 (8
H, m), 7.28-7.36 (3H, m), 7.49 (2H, d, J = 8.1 H
z), 7.57 (2H, d, J = 8.1 Hz); IR (KBr) 3264, 2938,
1638,1528, 1487, 1275, 1190, 1117, 762 cm-1; Ana
l. Calcd for C36H33F4NO4・0.2H2O: C, 69.38; H, 5.4
0; N, 2.25. Found: C, 69.11; H, 5.33; N, 2.05.Example 296 N-[(1RS, 2SR) -2-hydroxy-2- (2'-methoxy [1,1'-biphenyl] -4-yl) -1- [3-]
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- (4-bromo Phenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
0.530 g (0.895 mmol) of 5H-benzo [a] cycloheptene-1-carboxamide, 0.20 g (1.34 mmol) of 2-methoxyphenylboronic acid, tetrakis (triphenylphosphine) palladium (0)
0.10 g (0.089 mmol) and 0.19 g (1.79 mmol) of sodium carbonate were stirred at 90 ° C. for 1 day in 8 ml of toluene and 8 ml of water. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from ethyl acetate / diisopropyl ether / hexane to obtain the desired product. White powder Yield 0.307 g Yield 55% mp 148-150 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.95-2.05
(2H, m), 2.16-2.22 (2H, m), 2.66 (2H, t, J = 5.7
Hz), 2.85 (1H, dd, J = 10.7 Hz, 14.9 Hz), 3.08 (1
H, dd, J = 4.2 Hz, 14.7 Hz), 3.48 (1H, d, J = 3.9
Hz), 3.82 (3H, s), 4.74-4.82 (1H, m), 5.09 (1H, t,
J = 3.6 Hz), 5.79 (1H, d, J = 8.7 Hz), 5.89 (1H, t
t, J = 2.9 Hz, 53.1 Hz), 5.91 (1H, td, J = 5.5 Hz,
11.2 Hz), 6.24 (1H, d, J = 11.7 Hz), 6.97-7.18 (8
H, m), 7.28-7.36 (3H, m), 7.49 (2H, d, J = 8.1 H
z), 7.57 (2H, d, J = 8.1 Hz); IR (KBr) 3264, 2938,
1638,1528, 1487, 1275, 1190, 1117, 762 cm -1 ; Ana
l. Calcd for C 36 H 33 F 4 NO 4・ 0.2H 2 O: C, 69.38; H, 5.4
0; N, 2.25. Found: C, 69.11; H, 5.33; N, 2.05.
【0429】実施例297 N-[(1RS,2SR)-2-ヒドロキシ-2-(4’-メ
トキシ[1,1’-ビフェニル]-4-イル)-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド N-[(1RS,2SR)-2-(4-ブロモフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.500g(0.844ミリモル)、4-メトキシフ
ェニルボロン酸0.26g(1.69ミリモル)、テト
ラキス(トリフェニルホスフィン)パラジウム(0)
0.20g(0.17ミリモル)と炭酸ナトリウム0.
27g(2.53ミリモル)をトルエン10ml-水1
0ml中で、90℃で1日間撹拌した。反応液を水に注
ぎ、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸ナトリウムで乾燥、溶媒を減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィーにて精製し(ヘキサ
ン/酢酸エチル=3/1-1/1)、ジイソプロピルエ
ーテル-ヘキサンより結晶化して、目的物を得た。白色
結晶 収量0.310g 収率59% mp 162-163℃; 1H-NMR (CDCl3, 300 MHz) δ 1.94-2.03
(2H, m), 2.15-2.22 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.83 (1H, dd, J = 10.7 Hz, 14.6 Hz), 3.05 (1
H, dd, J = 4.2 Hz, 14.7 Hz), 3.54 (1H, d, J = 3.6
Hz), 3.86 (3H, s), 4.73-4.81 (1H, m), 5.09 (1H, t,
J = 3.9 Hz), 5.78 (1H, d, J = 8.7 Hz),5.88 (1H, t
t, J = 2.9 Hz, 53.1 Hz), 5.90 (1H, td, J = 5.7 Hz,
11.4 Hz),6.23 (1H, d, J = 11.7 Hz), 6.96-7.16 (8
H, m), 7.30 (1H, t, J = 8.0 Hz),7.49-7.59 (6H, m);
IR (KBr) 3299, 2930, 1638, 1530, 1503, 1277, 122
9, 1198, 1125, 820 cm-1; Anal. Calcd for C36H33F4N
O4: C, 69.78; H, 5.37; N,2.26. Found: C, 69.69; H,
5.17; N, 2.10.Example 297 N-[(1RS, 2SR) -2-hydroxy-2- (4′-methoxy [1,1′-biphenyl] -4-yl) -1- [3-]
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- (4-bromo Phenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
0.5H g (0.844 mmol) of 5H-benzo [a] cycloheptene-1-carboxamide, 0.26 g (1.69 mmol) of 4-methoxyphenylboronic acid, tetrakis (triphenylphosphine) palladium (0)
0.20 g (0.17 mmol) and sodium carbonate 0.1.
27 g (2.53 mmol) of toluene 10 ml-water 1
Stir in 0 ml at 90 ° C. for 1 day. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from diisopropyl ether / hexane to obtain the desired product. White crystal Yield 0.310 g Yield 59% mp 162-163 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.94-2.03
(2H, m), 2.15-2.22 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.83 (1H, dd, J = 10.7 Hz, 14.6 Hz), 3.05 (1
H, dd, J = 4.2 Hz, 14.7 Hz), 3.54 (1H, d, J = 3.6
Hz), 3.86 (3H, s), 4.73-4.81 (1H, m), 5.09 (1H, t,
J = 3.9 Hz), 5.78 (1H, d, J = 8.7 Hz), 5.88 (1H, t
t, J = 2.9 Hz, 53.1 Hz), 5.90 (1H, td, J = 5.7 Hz,
11.4 Hz), 6.23 (1H, d, J = 11.7 Hz), 6.96-7.16 (8
H, m), 7.30 (1H, t, J = 8.0 Hz), 7.49-7.59 (6H, m);
IR (KBr) 3299, 2930, 1638, 1530, 1503, 1277, 122
9, 1198, 1125, 820 cm -1 ; Anal.Calcd for C 36 H 33 F 4 N
O 4 : C, 69.78; H, 5.37; N, 2.26. Found: C, 69.69; H,
5.17; N, 2.10.
【0430】実施例298 N-[(1RS,2SR)-2-ヒドロキシ-2-(3’-メ
トキシ[1,1’-ビフェニル]-4-イル)-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド N-[(1RS,2SR)-2-(4-ブロモフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.500g(0.844ミリモル)、3-メトキシフ
ェニルボロン酸0.26g(1.69ミリモル)、テト
ラキス(トリフェニルホスフィン)パラジウム(0)
0.20g(0.17ミリモル)と炭酸ナトリウム0.
27g(2.53ミリモル)をトルエン10ml-水1
0ml中で、90℃で1日間撹拌した。反応液を水に注
ぎ、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸ナトリウムで乾燥、溶媒を減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィーにて精製し(ヘキサ
ン/酢酸エチル=3/1-1/1)、ジイソプロピルエ
ーテル-ヘキサンより結晶化して、目的物を得た。白色
結晶 収量0.241g 収率46% mp 79-81℃; 1H-NMR (CDCl3, 300 MHz) δ 1.95-2.03
(2H, m), 2.16-2.22 (2H,m), 2.66 (2H, t, J = 5.7 H
z), 2.83 (1H, dd, J = 10.5 Hz, 14.7 Hz), 3.05(1H,
dd, J = 4.1 Hz, 14.6 Hz), 3.60 (1H, d, J = 3.9 H
z), 3.87 (3H, s),4.73-4.80 (1H, m), 5.10 (1H, t, J
= 3.8 Hz), 5.79 (1H, d, J = 8.4 Hz), 5.88 (1H, t
t, J = 2.9 Hz, 53.0 Hz), 5.91 (1H, td, J = 5.7 Hz,
11.4 Hz), 6.23 (1H, d, J = 11.7 Hz), 6.91 (1H, d
d, J = 2.1 Hz, 7.8 Hz), 6.99 (1H, dd, J = 1.5 Hz,
7.5 Hz), 7.03-7.20 (7H, m), 7.30 (1H, t, J = 7.8 H
z), 7.37 (1H, t, J = 8.0 Hz), 7.52 (2H, d, J = 8.1
Hz), 7.61 (2H, d, J = 8.1 Hz); IR (KBr) 3268, 293
2, 1638, 1518, 1483, 1298, 1277, 1194, 1121, 779 c
m -1; Anal. Calcd for C36H33F4NO4: C, 69.78; H, 5.3
7; N, 2.26. Found: C, 69.76; H, 5.70; N, 2.07.Example 298 N-[(1RS, 2SR) -2-hydroxy-2- (3′-me
Toxi [1,1'-biphenyl] -4-yl) -1- [3-
(1,1,2,2-tetrafluoroethoxy) benzene
[Ethyl] -6,7-dihydro-5H-benzo [a] cycl
Roheptene-1-carboxamide N-[(1RS, 2SR) -2- (4-bromophenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafur
Oroethoxy) benzyl] ethyl] -6,7-dihydro-
5H-benzo [a] cycloheptene-1-carboxamide
0.500 g (0.844 mmol), 3-methoxyph
0.26 g (1.69 mmol) of phenylboronic acid, tet
Lakis (triphenylphosphine) palladium (0)
0.20 g (0.17 mmol) and sodium carbonate 0.1.
27 g (2.53 mmol) of toluene 10 ml-water 1
Stir in 0 ml at 90 ° C. for 1 day. Pour the reaction solution into water
And extracted twice with ethyl acetate. The collected organic layer is anhydrous sulfur
The extract was dried over sodium acid and the solvent was distilled off under reduced pressure. Remove the residue
Purified by Ricagel column chromatography (hexa
/ Ethyl acetate = 3 / 1-1 / 1), diisopropyl
Crystallization from ether-hexane gave the desired product. White
Crystal yield 0.241 g yield 46% mp 79-81 ° C;1H-NMR (CDClThree, 300 MHz) δ 1.95-2.03
(2H, m), 2.16-2.22 (2H, m), 2.66 (2H, t, J = 5.7 H
z), 2.83 (1H, dd, J = 10.5 Hz, 14.7 Hz), 3.05 (1H,
dd, J = 4.1 Hz, 14.6 Hz), 3.60 (1H, d, J = 3.9 H
z), 3.87 (3H, s), 4.73-4.80 (1H, m), 5.10 (1H, t, J
= 3.8 Hz), 5.79 (1H, d, J = 8.4 Hz), 5.88 (1H, t
t, J = 2.9 Hz, 53.0 Hz), 5.91 (1H, td, J = 5.7 Hz,
11.4 Hz), 6.23 (1H, d, J = 11.7 Hz), 6.91 (1H, d
d, J = 2.1 Hz, 7.8 Hz), 6.99 (1H, dd, J = 1.5 Hz,
7.5 Hz), 7.03-7.20 (7H, m), 7.30 (1H, t, J = 7.8 H
z), 7.37 (1H, t, J = 8.0 Hz), 7.52 (2H, d, J = 8.1
Hz), 7.61 (2H, d, J = 8.1 Hz); IR (KBr) 3268, 293
2, 1638, 1518, 1483, 1298, 1277, 1194, 1121, 779 c
m -1; Anal. Calcd for C36H33FFourNOFour: C, 69.78; H, 5.3
7; N, 2.26. Found: C, 69.76; H, 5.70; N, 2.07.
【0431】実施例299 N-[(1RS,2SR)-2-(4’-ホルミル[1,
1’-ビフェニル]-4-イル)-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド N-[(1RS,2SR)-2-(4-ブロモフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.822g(1.388ミリモル)、4-ホルミルフ
ェニルボロン酸0.31g(2.08ミリモル)、テト
ラキス(トリフェニルホスフィン)パラジウム(0)
0.16g(0.14ミリモル)と炭酸ナトリウム0.
29g(2.78ミリモル)をトルエン10ml-水1
0ml中で、90℃で1日間撹拌した。反応液を水に注
ぎ、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸ナトリウムで乾燥、溶媒を減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィーにて精製し(ヘキサ
ン/酢酸エチル=3/1-1/1)、ジイソプロピルエ
ーテル-ヘキサンより結晶化して、目的物を得た。白色
粉末 収量0.214g 収率25% mp 174-176℃; 1H-NMR (CDCl3, 300 MHz) δ 1.97-2.04
(2H, m), 2.16-2.22 (2H, m), 2.67 (2H, t, J = 5.9
Hz), 2.85 (1H, dd, J = 10.5 Hz, 14.7 Hz), 3.04 (1
H, dd, J = 3.8 Hz, 14.3 Hz), 3.69 (1H, d, J = 3.9
Hz), 4.72-4.80 (1H, m), 5.14 (1H, t, J = 3.5 Hz),
5.81 (1H, d, J = 8.4 Hz), 5.88 (1H, tt,J = 2.6 Hz,
53.0 Hz), 5.91 (1H, td, J = 5.6 Hz, 11.4 Hz), 6.2
4 (1H, d,J = 11.7 Hz), 6.98-7.17 (6H, m), 7.31 (1
H, t, J = 7.8 Hz), 7.58 (2H, d,J = 8.1 Hz), 7.67
(2H, d, J = 8.4 Hz), 7.77 (2H, d, J = 8.1 Hz), 7.9
7 (2H, d, J = 8.1 Hz), 10.06 (1H, s); IR (KBr) 332
4, 2940, 1701, 1626, 1605,1532, 1308, 1275, 1200,
1119, 806, 774 cm-1; Anal. Calcd for C36H31F4NO 4:
C, 70.01; H, 5.06; N, 2.27. Found: C, 69.89; H, 5.
19; N, 2.01.Example 299 N-[(1RS, 2SR) -2- (4'-formyl [1,
1'-biphenyl] -4-yl) -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzene
[Ethyl] -6,7-dihydro-5H-benzo [a] cycl
Roheptene-1-carboxamide N-[(1RS, 2SR) -2- (4-bromophenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafur
Oroethoxy) benzyl] ethyl] -6,7-dihydro-
5H-benzo [a] cycloheptene-1-carboxamide
0.822 g (1.388 mmol), 4-formylph
0.31 g (2.08 mmol) of phenylboronic acid, tet
Lakis (triphenylphosphine) palladium (0)
0.16 g (0.14 mmol) and sodium carbonate 0.1.
29 g (2.78 mmol) of toluene 10 ml-water 1
Stir in 0 ml at 90 ° C. for 1 day. Pour the reaction solution into water
And extracted twice with ethyl acetate. The collected organic layer is anhydrous sulfur
The extract was dried over sodium acid and the solvent was distilled off under reduced pressure. Remove the residue
Purified by Ricagel column chromatography (hexa
/ Ethyl acetate = 3 / 1-1 / 1), diisopropyl
Crystallization from ether-hexane gave the desired product. White
Powder Yield 0.214 g Yield 25% mp 174-176 ° C;1H-NMR (CDClThree, 300 MHz) δ 1.97-2.04
(2H, m), 2.16-2.22 (2H, m), 2.67 (2H, t, J = 5.9
Hz), 2.85 (1H, dd, J = 10.5 Hz, 14.7 Hz), 3.04 (1
H, dd, J = 3.8 Hz, 14.3 Hz), 3.69 (1H, d, J = 3.9
Hz), 4.72-4.80 (1H, m), 5.14 (1H, t, J = 3.5 Hz),
5.81 (1H, d, J = 8.4 Hz), 5.88 (1H, tt, J = 2.6 Hz,
53.0 Hz), 5.91 (1H, td, J = 5.6 Hz, 11.4 Hz), 6.2
4 (1H, d, J = 11.7 Hz), 6.98-7.17 (6H, m), 7.31 (1
H, t, J = 7.8 Hz), 7.58 (2H, d, J = 8.1 Hz), 7.67
(2H, d, J = 8.4 Hz), 7.77 (2H, d, J = 8.1 Hz), 7.9
7 (2H, d, J = 8.1 Hz), 10.06 (1H, s); IR (KBr) 332
4, 2940, 1701, 1626, 1605,1532, 1308, 1275, 1200,
1119, 806, 774 cm-1; Anal. Calcd for C36H31FFourNO Four:
C, 70.01; H, 5.06; N, 2.27. Found: C, 69.89; H, 5.
19; N, 2.01.
【0432】実施例300 N-[(1RS,2SR)-2-(3’-ホルミル[1,
1’-ビフェニル]-4-イル)-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド N-[(1RS,2SR)-2-(4-ブロモフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.812g(1.371ミリモル)、3-ホルミルフ
ェニルボロン酸0.41g(2.74ミリモル)、テト
ラキス(トリフェニルホスフィン)パラジウム(0)
0.32g(0.27ミリモル)と炭酸ナトリウム0.
44g(4.11ミリモル)をトルエン10ml-水1
0ml中で、90℃で1日間撹拌した。反応液を水に注
ぎ、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸ナトリウムで乾燥、溶媒を減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィーにて精製し(ヘキサ
ン/酢酸エチル=3/1-1/1)、ジイソプロピルエ
ーテル-ヘキサンより結晶化して、目的物を得た。淡褐
色粉末 収量0.285g 収率34% mp 103-105℃; 1H-NMR (CDCl3, 300 MHz) δ 1.95-2.04
(2H, m), 2.16-2.22 (2H, m), 2.67 (2H, t, J = 5.9
Hz), 2.84 (1H, dd, J = 10.8 Hz, 14.7 Hz), 3.05 (1
H, dd, J = 4.2 Hz, 14.4 Hz), 3.67 (1H, d, J = 3.9
Hz), 4.71-4.80 (1H, m), 5.14 (1H, t, J = 3.9 Hz),
5.81 (1H, d, J = 8.4 Hz), 5.89 (1H, tt,J = 2.8 Hz,
53.0 Hz), 5.91 (1H, td, J = 5.4 Hz, 12.9 Hz), 6.2
5 (1H, d,J = 12.0 Hz), 6.98-7.17 (6H, m), 7.31 (1
H, t, J = 8.0 Hz), 7.57-7.67 (5H, m), 7.88 (2H, d
d, J = 2.1 Hz, 7.2 Hz), 8.12 (1H, s), 10.10 (1H,
s); IR(KBr) 3264, 2938, 1701, 1640, 1518, 1449, 13
04, 1279, 1198, 1123, 793 cm-1; Anal. Calcd for C
36H31F4NO4: C, 70.01; H, 5.06; N, 2.27. Found: C,7
0.08; H, 5.19; N, 2.16.Example 300 N-[(1RS, 2SR) -2- (3′-formyl [1,
1'-biphenyl] -4-yl) -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- (4-bromo Phenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
0.812 g (1.371 mmol) of 5H-benzo [a] cycloheptene-1-carboxamide, 0.41 g (2.74 mmol) of 3-formylphenylboronic acid, tetrakis (triphenylphosphine) palladium (0)
0.32 g (0.27 mmol) and sodium carbonate 0.1.
44 g (4.11 mmol) of toluene 10 ml-water 1
Stir in 0 ml at 90 ° C. for 1 day. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from diisopropyl ether / hexane to obtain the desired product. Light brown powder Yield 0.285 g Yield 34% mp 103-105 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.95-2.04
(2H, m), 2.16-2.22 (2H, m), 2.67 (2H, t, J = 5.9
Hz), 2.84 (1H, dd, J = 10.8 Hz, 14.7 Hz), 3.05 (1
H, dd, J = 4.2 Hz, 14.4 Hz), 3.67 (1H, d, J = 3.9
Hz), 4.71-4.80 (1H, m), 5.14 (1H, t, J = 3.9 Hz),
5.81 (1H, d, J = 8.4 Hz), 5.89 (1H, tt, J = 2.8 Hz,
53.0 Hz), 5.91 (1H, td, J = 5.4 Hz, 12.9 Hz), 6.2
5 (1H, d, J = 12.0 Hz), 6.98-7.17 (6H, m), 7.31 (1
H, t, J = 8.0 Hz), 7.57-7.67 (5H, m), 7.88 (2H, d
d, J = 2.1 Hz, 7.2 Hz), 8.12 (1H, s), 10.10 (1H,
s); IR (KBr) 3264, 2938, 1701, 1640, 1518, 1449, 13
04, 1279, 1198, 1123, 793 cm -1 ; Anal.Calcd for C
36 H 31 F 4 NO 4 : C, 70.01; H, 5.06; N, 2.27. Found: C, 7
0.08; H, 5.19; N, 2.16.
【0433】実施例301 N-[(1RS,2SR)-2-(2’-ホルミル[1,
1’-ビフェニル]-4-イル)-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド N-[(1RS,2SR)-2-(4-ブロモフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.812g(1.371ミリモル)、2-ホルミルフ
ェニルボロン酸0.41g(2.74ミリモル)、テト
ラキス(トリフェニルホスフィン)パラジウム(0)
0.32g(0.27ミリモル)と炭酸ナトリウム0.
44g(4.11ミリモル)をトルエン10ml-水1
0ml中で、90℃で1日間撹拌した。反応液を水に注
ぎ、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸ナトリウムで乾燥、溶媒を減圧留去した。残留物をシ
リカゲルカラムクロマトグラフィーにて精製し(ヘキサ
ン/酢酸エチル=3/1-1/1)、ジイソプロピルエ
ーテル-ヘキサンより結晶化して、目的物を得た。淡褐
色結晶 収量0.423g 収率50% mp 195-196℃; 1H-NMR (CDCl3, 300 MHz) δ 1.96-2.04
(2H, m), 2.16-2.22 (2H, m), 2.67 (2H, t, J = 5.9
Hz), 2.86 (1H, dd, J = 10.5 Hz, 14.7 Hz), 3.06 (1
H, dd, J = 4.4 Hz, 14.6 Hz), 3.77 (1H, d, J = 3.9
Hz), 4.72-4.81 (1H, m), 5.16 (1H, t, J = 3.6 Hz),
5.85 (1H, d, J = 8.4 Hz), 5.90 (1H, tt,J = 2.7 Hz,
53.0 Hz), 5.93 (1H, td, J = 5.7 Hz, 11.4 Hz), 6.2
6 (1H, d,J = 11.7 Hz), 6.98-7.18 (6H, m), 7.32 (1
H, t, J = 7.8 Hz), 7.40-7.68 (7H, m), 8.04 (1H, d,
J = 8.1 Hz), 9.99 (1H, s); IR (KBr) 3227, 2930, 1
688,1636, 1304, 1198, 1123, 770 cm-1; Anal. Calcd
for C36H31F4NO4: C, 70.01; H, 5.06; N, 2.27. Foun
d: C, 70.00; H, 5.13; N, 2.20.Example 301 N-[(1RS, 2SR) -2- (2′-formyl [1,
1'-biphenyl] -4-yl) -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- (4-bromo Phenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
0.812 g (1.371 mmol) of 5H-benzo [a] cycloheptene-1-carboxamide, 0.41 g (2.74 mmol) of 2-formylphenylboronic acid, tetrakis (triphenylphosphine) palladium (0)
0.32 g (0.27 mmol) and sodium carbonate 0.1.
44 g (4.11 mmol) of toluene 10 ml-water 1
Stir in 0 ml at 90 ° C. for 1 day. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from diisopropyl ether / hexane to obtain the desired product. Light brown crystal Yield 0.423 g Yield 50% mp 195-196 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.96-2.04
(2H, m), 2.16-2.22 (2H, m), 2.67 (2H, t, J = 5.9
Hz), 2.86 (1H, dd, J = 10.5 Hz, 14.7 Hz), 3.06 (1
H, dd, J = 4.4 Hz, 14.6 Hz), 3.77 (1H, d, J = 3.9
Hz), 4.72-4.81 (1H, m), 5.16 (1H, t, J = 3.6 Hz),
5.85 (1H, d, J = 8.4 Hz), 5.90 (1H, tt, J = 2.7 Hz,
53.0 Hz), 5.93 (1H, td, J = 5.7 Hz, 11.4 Hz), 6.2
6 (1H, d, J = 11.7 Hz), 6.98-7.18 (6H, m), 7.32 (1
H, t, J = 7.8 Hz), 7.40-7.68 (7H, m), 8.04 (1H, d,
J = 8.1 Hz), 9.99 (1H, s); IR (KBr) 3227, 2930, 1
688,1636, 1304, 1198, 1123, 770 cm -1 ; Anal.Calcd
for C 36 H 31 F 4 NO 4 : C, 70.01; H, 5.06; N, 2.27. Foun
d: C, 70.00; H, 5.13; N, 2.20.
【0434】実施例302 N-[(1RS,2SR)-2-[2’-(ヒドロキシメチ
ル)[1,1’-ビフェニル]-4-イル]-2-ヒドロキ
シ-1-[3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]エチル]-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド N-[(1RS,2SR)-2-(2’-ホルミル[1,
1’-ビフェニル]-4-イル)-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド168mg(0.272
ミリモル)のメタノール3ml溶液に室温で、水素化ホ
ウ素ナトリウム10mg(0.27ミリモル)を加え、
そのまま0.5時間撹拌した。反応液に塩化アンモニウ
ム水溶液を加え、そのまま1時間撹拌した。生じた沈殿
を集め、水およびジイソプロピルエーテル-ヘキサンで
洗浄して、目的物を得た。白色粉末 収量137mg
収率81% mp 152-154℃; 1H-NMR (CDCl3, 300 MHz) δ 1.60 (1H,
t, J = 5.7 Hz), 1.95-2.04 (2H, m), 2.16-2.22 (2H,
m), 2.64-2.69 (2H, m), 2.86 (1H, dd, J = 10.7 Hz,
14.9 Hz), 3.08 (1H, dd, J = 4.1 Hz, 14.6 Hz), 3.6
2 (1H, d, J = 3.0 Hz), 4.62 (2H, d, J = 5.4 Hz),
4.72-4.80 (1H, m), 5.11 (1H, t, J = 3.8Hz), 5.82
(1H, d, J = 8.7 Hz), 5.90 (1H, tt, J = 2.7 Hz, 53.
0 Hz), 5.93(1H, td, J = 5.8 Hz, 11.6 Hz), 6.25 (1
H, d, J = 11.7 Hz), 6.98 (1H, dd,J = 1.5 Hz, 7.5 H
z), 7.04-7.17 (5H, m), 7.27-7.43 (6H, m), 7.51-7.5
8 (3H, m); IR (KBr) 3289, 1638, 1526, 1200, 1125,
1036, 762 cm-1; Anal. Calcd for C36H33F4NO4: C, 6
9.78; H, 5.37; N, 2.26. Found: C, 69.47; H, 5.39;
N, 2.16.Example 302 N-[(1RS, 2SR) -2- [2 ′-(hydroxymethyl) [1,1′-biphenyl] -4-yl] -2-hydroxy-1- [3- (1 , 1,2,2-Tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- (2'-formyl [ 1,
1'-biphenyl] -4-yl) -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 168 mg (0.272
Sodium borohydride (10 mg, 0.27 mmol) was added to a 3 ml solution of
The mixture was stirred for 0.5 hours as it was. An aqueous ammonium chloride solution was added to the reaction solution, and the mixture was stirred for 1 hour. The resulting precipitate was collected and washed with water and diisopropyl ether-hexane to obtain the desired product. White powder yield 137mg
Yield 81% mp 152-154 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.60 (1H,
t, J = 5.7 Hz), 1.95-2.04 (2H, m), 2.16-2.22 (2H,
m), 2.64-2.69 (2H, m), 2.86 (1H, dd, J = 10.7 Hz,
14.9 Hz), 3.08 (1H, dd, J = 4.1 Hz, 14.6 Hz), 3.6
2 (1H, d, J = 3.0 Hz), 4.62 (2H, d, J = 5.4 Hz),
4.72-4.80 (1H, m), 5.11 (1H, t, J = 3.8Hz), 5.82
(1H, d, J = 8.7 Hz), 5.90 (1H, tt, J = 2.7 Hz, 53.
0 Hz), 5.93 (1H, td, J = 5.8 Hz, 11.6 Hz), 6.25 (1
H, d, J = 11.7 Hz), 6.98 (1H, dd, J = 1.5 Hz, 7.5 H
z), 7.04-7.17 (5H, m), 7.27-7.43 (6H, m), 7.51-7.5
8 (3H, m); IR (KBr) 3289, 1638, 1526, 1200, 1125,
1036, 762 cm -1 ; Anal.Calcd for C 36 H 33 F 4 NO 4 : C, 6
9.78; H, 5.37; N, 2.26. Found: C, 69.47; H, 5.39;
N, 2.16.
【0435】実施例303 N-[(1RS,2SR)-2-[3’-(ヒドロキシメチ
ル)[1,1’-ビフェニル]-4-イル]-2-ヒドロキ
シ-1-[3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]エチル]-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド N-[(1RS,2SR)-2-(3’-ホルミル[1,
1’-ビフェニル]-4-イル)-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド123mg(0.199
ミリモル)のメタノール3ml溶液に室温で、水素化ホ
ウ素ナトリウム8mg(0.20ミリモル)を加え、そ
のまま0.5時間撹拌した。反応液に塩化アンモニウム
水溶液を加え、そのまま1時間撹拌した。生じた沈殿を
集め、水およびジイソプロピルエーテル-ヘキサンで洗
浄して、目的物を得た。白色粉末 収量101mg 収
率82% mp 178-179℃; 1H-NMR (CDCl3, 300 MHz) δ 1.74 (1H,
t, J = 5.3 Hz), 1.95-2.03 (2H, m), 2.16-2.22 (2H,
m), 2.66 (2H, t, J = 5.9 Hz), 2.83 (1H, dd,J = 1
0.4 Hz, 14.6 Hz), 3.05 (1H, dd, J = 4.2 Hz, 14.4 H
z), 3.60 (1H, d,J = 3.9 Hz), 4.72-4.80 (1H, m), 4.
78 (2H, d, J = 4.2 Hz), 5.11 (1H, t,J = 3.6 Hz),
5.79 (1H, d, J = 8.4 Hz), 5.88 (1H, tt, J = 3.2 H
z, 53.0 Hz), 5.91 (1H, td, J = 5.9 Hz, 11.7 Hz),
6.24 (1H, d, J = 12.0 Hz), 6.98-7.16 (6H, m), 7.26
-7.64 (9H, m); IR (KBr) 3268, 1638, 1532, 1198, 11
27, 787 cm-1; Anal. Calcd for C36H33F4NO4: C, 69.7
8; H, 5.37; N, 2.26. Found:C, 69.47; H, 5.22; N,
2.15.Example 303 N-[(1RS, 2SR) -2- [3 ′-(hydroxymethyl) [1,1′-biphenyl] -4-yl] -2-hydroxy-1- [3- (1 , 1,2,2-Tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- (3′-formyl [ 1,
1'-biphenyl] -4-yl) -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 123 mg (0.199
(Mmol) in a solution of methanol (3 ml) at room temperature, and 8 mg (0.20 mmol) of sodium borohydride was added thereto, followed by stirring for 0.5 hour. An aqueous ammonium chloride solution was added to the reaction solution, and the mixture was stirred for 1 hour. The resulting precipitate was collected and washed with water and diisopropyl ether-hexane to obtain the desired product. White powder Yield 101 mg Yield 82% mp 178-179 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.74 (1H,
t, J = 5.3 Hz), 1.95-2.03 (2H, m), 2.16-2.22 (2H,
m), 2.66 (2H, t, J = 5.9 Hz), 2.83 (1H, dd, J = 1
0.4 Hz, 14.6 Hz), 3.05 (1H, dd, J = 4.2 Hz, 14.4 H
z), 3.60 (1H, d, J = 3.9 Hz), 4.72-4.80 (1H, m), 4.
78 (2H, d, J = 4.2 Hz), 5.11 (1H, t, J = 3.6 Hz),
5.79 (1H, d, J = 8.4 Hz), 5.88 (1H, tt, J = 3.2 H
z, 53.0 Hz), 5.91 (1H, td, J = 5.9 Hz, 11.7 Hz),
6.24 (1H, d, J = 12.0 Hz), 6.98-7.16 (6H, m), 7.26
-7.64 (9H, m); IR (KBr) 3268, 1638, 1532, 1198, 11
27, 787 cm -1 ; Anal.Calcd for C 36 H 33 F 4 NO 4 : C, 69.7
8; H, 5.37; N, 2.26. Found: C, 69.47; H, 5.22; N,
2.15.
【0436】実施例304 N-[(1RS,2SR)-2-[4’-(ヒドロキシメチ
ル)[1,1’-ビフェニル]-4-イル]-2-ヒドロキ
シ-1-[3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]エチル]-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド N-[(1RS,2SR)-2-(4’-ホルミル[1,
1’-ビフェニル]-4-イル)-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド107mg(0.173
ミリモル)のメタノール3ml溶液に室温で、水素化ホ
ウ素ナトリウム7mg(0.17ミリモル)を加え、そ
のまま0.5時間撹拌した。反応液に塩化アンモニウム
水溶液を加え、そのまま1時間撹拌した。生じた沈殿を
集め、水およびジイソプロピルエーテル-ヘキサンで洗
浄して、目的物を得た。白色粉末 収量85mg 収率
80% mp 189-191℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
1.95-2.01 (2H, m), 2.14-2.24 (2H, m), 2.67 (2H, t,
J = 5.6 Hz), 2.89 (1H, dd, J = 11.0 Hz, 14.3Hz),
2.98 (1H, dd, J = 4.1 Hz, 14.6 Hz), 3.69 (1H, br
s), 4.72 (2H, d,J = 5.1 Hz), 4.72-4.81 (1H, m), 4.
87 (1H, d, J = 2.7 Hz), 5.06 (1H, t, J= 3.5 Hz),
5.87 (1H, td, J = 5.7 Hz, 11.6 Hz), 5.92 (1H, tt,
J = 2.9 Hz, 53.1 Hz), 6.20 (1H, d, J = 12.3 Hz),
6.69 (1H, d, J = 8.7 Hz), 6.96 (1H, d, J = 7.5 H
z), 7.02-7.16 (5H, m), 7.27 (1H, t, J = 7.8 Hz),
7.46 (2H, d, J = 7.8 Hz), 7.56-7.63 (6H, m); IR (K
Br) 3268, 1636, 1520, 1206, 1119 cm-1; Anal. Calcd
for C36H33F4NO4: C, 69.78; H, 5.37; N, 2.26. Foun
d:C, 69.53; H, 5.24; N, 2.14.Example 304 N-[(1RS, 2SR) -2- [4 ′-(hydroxymethyl) [1,1′-biphenyl] -4-yl] -2-hydroxy-1- [3- (1 , 1,2,2-Tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- (4'-formyl [ 1,
1'-biphenyl] -4-yl) -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 107 mg (0.173
7 mmol (0.17 mmol) of sodium borohydride was added to a 3 ml solution of methanol (3 mmol) in methanol at room temperature, and the mixture was stirred as it was for 0.5 hour. An aqueous ammonium chloride solution was added to the reaction solution, and the mixture was stirred for 1 hour. The resulting precipitate was collected and washed with water and diisopropyl ether-hexane to obtain the desired product. White powder Yield 85 mg Yield 80% mp 189-191 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
1.95-2.01 (2H, m), 2.14-2.24 (2H, m), 2.67 (2H, t,
J = 5.6 Hz), 2.89 (1H, dd, J = 11.0 Hz, 14.3Hz),
2.98 (1H, dd, J = 4.1 Hz, 14.6 Hz), 3.69 (1H, br
s), 4.72 (2H, d, J = 5.1 Hz), 4.72-4.81 (1H, m), 4.
87 (1H, d, J = 2.7 Hz), 5.06 (1H, t, J = 3.5 Hz),
5.87 (1H, td, J = 5.7 Hz, 11.6 Hz), 5.92 (1H, tt,
J = 2.9 Hz, 53.1 Hz), 6.20 (1H, d, J = 12.3 Hz),
6.69 (1H, d, J = 8.7 Hz), 6.96 (1H, d, J = 7.5 H
z), 7.02-7.16 (5H, m), 7.27 (1H, t, J = 7.8 Hz),
7.46 (2H, d, J = 7.8 Hz), 7.56-7.63 (6H, m); IR (K
Br) 3268, 1636, 1520, 1206, 1119 cm -1 ; Anal.Calcd
for C 36 H 33 F 4 NO 4 : C, 69.78; H, 5.37; N, 2.26. Foun
d: C, 69.53; H, 5.24; N, 2.14.
【0437】実施例305 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-5,5-ジメチル-
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボキサミド 1) 3-メチル-3-フェニルブタン酸 粉末状マグネシウム9.56g(393ミリモル)、ヨ
ウ素1かけらをテトラヒドロフラン10ml中で撹拌し
ながら、1-クロロ-2-メチル-2-フェニルプロパン2
6.53g(157.3ミリモル)、1,2-ジブロモ
エタン29.6g(157ミリモル)のテトラヒドロフ
ラン100ml溶液を反応液がゆるやかに還流する速度
で滴下した。滴下終了後、60℃で4時間撹拌した。こ
の反応液を−78℃に冷却し、砕いたドライアイス50
gを注意して加え、反応液を撹拌しながら徐々に室温ま
で昇温した。反応液を水で希釈し、濃塩酸で酸性とした
後、酢酸エチルで2回抽出した。集めた有機層の溶媒を
減圧留去した。得られた残留物を水酸化ナトリウム6g
と水200mlと混合した。得られた水溶液をジエチル
エーテル-ヘキサンで洗浄し、濃塩酸で酸性とした後、
酢酸エチルで2回抽出した。集めた有機層を無水硫酸マ
グネシウムで乾燥、溶媒を減圧留去して、目的物を得
た。黄色液体 収量20.83g 収率74%1 H-NMR (CDCl3, 200 MHz) δ 1.47 (6H, s), 2.65 (2H,
s), 7.17-7.40 (5H, m), 10.48 (1H, br s); IR (nea
t) 2967, 1699, 1634, 1260, 1167, 772, 700 cm- 1 2) 3-メチル-3-フェニル-1-ブタノール 水素化リチウムアルミニウム8.62g(228ミリモ
ル)のテトラヒドロフラン200ml懸濁液に、氷冷
下、3-メチル-3-フェニルブタン酸20.26g(1
13.7ミリモル)のテトラヒドロフラン100ml溶
液を滴下し、室温で一晩撹拌した。反応液を氷冷した
後、水8ml、15%水酸化ナトリウム水溶液8ml、
水20mlを順次滴下して、過剰の水素化リチウムアル
ミニウムを分解し、そのまま室温で2時間撹拌した。生
じた沈殿をろ過して除き、沈殿を酢酸エチルで洗浄し
た。集めた濾液の溶媒を減圧留去した。得られた残留物
をシリカゲルカラムクロマトグラフィーにて精製し(ヘ
キサン/酢酸エチル=1/1)、目的物を得た。無色液
体 収量18.09g 収率97%1 H-NMR (CDCl3, 200 MHz) δ 1.00 (1H, t, J = 5.3 H
z), 1.35 (6H, s), 1.95(2H, t, J = 7.4 Hz), 3.44-3.
54 (2H, m), 7.14-7.40 (5H, m); IR (neat) 3333, 296
5, 1497, 1445, 1057, 1022, 764, 700 cm-1 3) 5,5-ジメチル-5-フェニル-2-ペンタン酸 3-メチル-3-フェニル-1-ブタノール18.09g
(110.1ミリモル)、トリエチルアミン23.0m
l(165ミリモル)の酢酸エチル150ml溶液に氷
冷下、塩化メタンスルホニル15.1g(132ミリモ
ル)の酢酸エチル30ml溶液を滴下し、そのまま15
分間撹拌した。生じた沈殿(トリエチルアミン塩酸塩)
を濾過して除き、沈殿を酢酸エチルで洗浄した。集めた
酢酸エチル溶液を、減圧下濃縮し、メシレートの粗生成
物を黄色液体として得た。マロン酸ジエチル22.8g
(132ミリモル)のテトラヒドロフラン100ml溶
液に氷冷下で60%水素化ナトリウムのパラフィン懸濁
物5.29g(132ミリモル)を徐々に加え、そのま
ま0.5時間撹拌した。これに、上で得た液体のテトラ
ヒドロフラン50ml溶液を室温で滴下し、60℃で一
晩撹拌した。反応液に水を加えて撹拌した後、酢酸エチ
ルで2回抽出した。集めた有機層を無水硫酸マグネシウ
ムで乾燥、溶媒を減圧留去した。得られた残留物をシリ
カゲルカラムクロマトグラフィーにて精製し(ヘキサン
/酢酸エチル=15/1-6/1)、(3-メチル-3-フ
ェニルブチル)マロン酸ジエチル(31.8g)を無色
液体として得た。上で得た液体と濃塩酸50mlを酢酸
100ml中で100℃にて一晩撹拌した。反応液を減
圧留去した後、得られた残留物を175℃で4時間撹拌
し、目的物を得た。黄色液体 収量18.86g 収率
83%1 H-NMR (CDCl3, 200 MHz) δ 1.21-1.47 (2H, m), 1.31
(6H, s), 1.63-1.69 (2H, m), 2.25 (2H, t, J = 7.3
Hz), 7.14-7.23 (1H, m), 7.29-7.35 (4H, m); IR (nea
t) 2963, 1709, 1279, 766, 700 cm-1 4) 9,9-ジメチル-6,7,8,9-テトラヒドロ-
5H-ベンゾ[a]シクロヘプテン-5-オン 5,5-ジメチル-5-フェニル-2-ペンタン酸18.8
6g(91.43ミリモル)、N,N-ジメチルホルム
アミド2滴のテトラヒドロフラン100ml溶液に室温
で塩化オキザリル12.0ml(137ミリモル)を滴
下した後、そのまま0.5時間撹拌した。反応混合物の
溶媒を減圧留去し、酸塩化物を黄色液体として得た。塩
化アルミニウム24.4g(183ミリモル)の塩化メ
チレン100ml懸濁液を撹拌しながら、これに上で得
た酸塩化物の塩化メチレン400ml溶液を2日間かけ
て滴下した。反応液を氷冷しながら、水を加えて反応を
止めた。混合物の塩化メチレン層を分離し、水層をジエ
チルエーテルで抽出した。集めた有機層を無水硫酸マグ
ネシウムで乾燥、溶媒を減圧留去した。得られた残留物
をシリカゲルカラムクロマトグラフィーにて精製して
(ヘキサン/酢酸エチル=15/1-6/1)、目的物
を得た。黄色液体 収量5.780g 収率34%1 H-NMR (CDCl3, 200 MHz) δ 1.36 (6H, s), 1.83-2.02
(4H, m), 2.75 (2H, t,J = 6.8 Hz), 7.21-7.29 (1H,
m), 7.36-7.43 (3H, m); IR (neat) 2965, 1684, 1597,
1456, 1250, 764 cm-1 5) 9,9-ジメチル-6,7,8,9-テトラヒドロ-
5H-ベンゾ[a]シクロヘプテン-5-オール 9,9-ジメチル-6,7,8,9-テトラヒドロ-5H-
ベンゾ[a]シクロヘプテン-5-オン5.780g(3
0.70ミリモル)のメタノール40ml溶液に、氷冷
下、水素化ほう素ナトリウム1.16g(30.7ミリ
モル)を少しずつ加えた後、室温で一晩撹拌した。反応
液を減圧濃縮した後、水で希釈し、酢酸エチルで2回抽
出した。集めた有機層を無水硫酸マグネシウムで乾燥、
溶媒を減圧留去した。得られた残留物をシリカゲルカラ
ムクロマトグラフィーにて精製し(ヘキサン/酢酸エチ
ル=9/1-6/1)、目的物を得た。黄色液体 収量
5.245g 収率90%1 H-NMR (CDCl3, 300 MHz) δ 1.33 (3H, s), 1.45 (3H,
s), 1.61-1.94 (5H, m), 1.76 (1H, d, J = 4.5 Hz),
2.01-2.10 (1H, m), 5.15-5.20 (1H, m), 7.19-7.25 (2
H, m), 7.39-7.44 (1H, m), 7.58-7.62 (1H, m); IR (n
eat) 3335, 2926,1476, 1443, 1362, 1030, 760 cm-1 6) 4-ブロモ-9,9-ジメチル-6,7,8,9-テ
トラヒドロ-5H-ベンゾ[a]シクロヘプテン-5-オー
ル 9,9-ジメチル-6,7,8,9-テトラヒドロ-5H-
ベンゾ[a]シクロヘプテン-5-オール5.128g
(26.95ミリモル)とN,N,N’,N’-テトラ
メチルエチレンジアミン6.89g(59.3ミリモ
ル)のヘキサン100ml溶液に、氷冷下で1.6Mn
-ブチルリチウムのヘキサン溶液37.1ml(59.
3ミリモル)を滴下した後、35℃で一晩撹拌した。反
応混合物を−78℃に冷却した後、1,2-ジブロモテ
トラフルオロエタン14.0g(53.9ミリモル)を
加え、撹拌しながら室温まで昇温し、室温で2時間撹拌
した。反応液を水に注ぎ、酢酸エチルで2回抽出した。
集めた有機層を無水硫酸マグネシウムで乾燥、溶媒を減
圧留去した。得られた粗生成物をシリカゲルカラムクロ
マトグラフィーにて精製し(ヘキサン/酢酸エチル=1
5/1)、目的物を得た。黄色固体 収量4.614g
収率64% ヘキサンより再結晶して、白色結晶を得た。 mp 91-92℃; 1H-NMR (CDCl3, 300 MHz) δ 1.38 (3H,
s), 1.40 (3H, s), 1.54-1.62 (1H, m), 1.71-1.88 (2
H, m), 2.05-2.36 (3H, m), 2.22 (1H, d, J = 4.8Hz),
5.56-5.59 (1H, m), 7.05 (1H, t, J = 8.0 Hz), 7.42
-7.45 (2H, m); IR(KBr) 3354, 2955, 1447, 945, 918,
775, 747 cm-1; Anal. Calcd for C13H17BrO: C, 58.0
1; H, 6.37. Found: C, 58.34; H, 6.51. 7) 1-ブロモ-5,5-ジメチル-6,7-ジヒドロ-5
H-ベンゾ[a]シクロヘプテン 4-ブロモ-9,9-ジメチル-6,7,8,9-テトラヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-5-オール4.
402g(16.35ミリモル)とp-トルエンスルホ
ン酸一水和物0.31g(1.64ミリモル)のトルエ
ン80ml溶液をディーン-スタークトラップを取り付
けた反応容器中で脱水条件下0.5時間加熱還流した。
反応液を室温まで冷却した後、溶媒を減圧留去した。得
られた粗生成物をシリカゲルカラムクロマトグラフィー
にて精製し(ヘキサン)、目的物を得た。無色液体 収
量3.887g 収率95%1 H-NMR (CDCl3, 200 MHz) δ 1.34 (6H, s), 1.83 (2H,
t, J = 6.8 Hz), 2.42-2.52 (2H, m), 6.05 (1H, td,
J = 4.4 Hz, 12.5 Hz), 6.91 (1H, td, J = 1.9Hz), 6.
98 (1H, t, J = 8.0 Hz), 7.33 (1H, d, J = 7.8 Hz),
7.49 (1H, dd, J= 1.3 Hz, 7.9 Hz); IR (neat) 2965,
2919, 1454, 1420, 1404, 885, 766 cm- 1 8) 5,5-ジメチル-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボン酸 1-ブロモ-5,5-ジメチル-6,7-ジヒドロ-5H-ベ
ンゾ[a]シクロヘプテン3.879g(15.44ミ
リモル)のジエチルエーテル30ml溶液に、−78℃
で1.6Mn-ブチルリチウムのヘキサン溶液11.6
ml(18.5ミリモル)を滴下した後、室温で4時間
撹拌した。反応混合物を−78℃に冷却した後、砕いた
ドライアイス5gを加え、撹拌しながら室温まで昇温し
た。反応液を水で希釈した後、ジエチルエーテルで洗浄
し、1規定塩酸で酸性にした後、酢酸エチルで2回抽出
した。集めた有機層を無水硫酸マグネシウムで乾燥、溶
媒を減圧留去した。得られた粗結晶をヘキサンで洗浄し
て目的物を得た。白色結晶 収量1.540g 収率4
6% mp 165-166℃; 1H-NMR (CDCl3, 200 MHz) δ 1.37 (6H,
s), 1.89 (2H, t, J =6.6 Hz), 2.44-2.54 (2H, m),
6.08 (1H, td, J = 4.4 Hz, 12.4 Hz), 6.92 (1H, td,
J = 2.0 Hz, 12.3 Hz), 7.22 (1H, t, J = 7.9 Hz), 7.
57 (1H, dd, J =1.2 Hz, 8.0 Hz), 7.66 (1H, dd, J =
1.4 Hz, 7.6 Hz); IR (KBr) 3050-2650,1688, 1426, 13
06, 1279, 775, 764 cm-1; Anal. Calcd for C14H16O2:
C, 77.75; H, 7.46. Found: C, 77.99; H, 7.34. 9) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]-5,5-ジメ
チル-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテ
ン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.379g
(1.049ミリモル)、5,5-ジメチル-6,7-ジ
ヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボン
酸0.23g(1.05ミリモル)、1-ヒドロキシベ
ンゾトリアゾール水和物0.16g(1.05ミリモ
ル)をアセトニトリル10ml中で撹拌しながら1-エ
チル-3-(3-ジメチルアミノプロピル)カルボジイミ
ド・塩酸塩0.20g(1.05ミリモル)を加え、室
温で一晩撹拌した。反応液を酢酸エチルに希釈し、炭酸
水素ナトリウム水溶液で洗浄、無水硫酸マグネシウムで
乾燥、シリカゲルを通した後、溶媒を減圧留去した。得
られた残留物を酢酸エチル-ジイソプロピルエーテル-ヘ
キサンより結晶化して、目的物を得た。白色粉末 収量
0.545g 収率93% mp 101-104℃; 1H-NMR (CDCl3, 200 MHz) δ 1.28 (6H,
s), 1.76 (2H, t, J =6.6 Hz), 2.36-2.45 (2H, m),
2.74 (1H, dd, J = 10.6 Hz, 14.2 Hz), 3.00 (1H, dd,
J = 3.8 Hz, 14.4 Hz), 3.45 (1H, br s), 4.65-4.79
(1H, m), 5.01 (1H, d, J = 3.6 Hz), 5.69 (1H, d, J
= 9.4 Hz), 5.74 (1H, td, J = 4.2 Hz, 12.3 Hz), 5.8
9 (1H, tt, J = 2.9 Hz, 53.3 Hz), 6.12 (1H, d, J =
13.2 Hz),6.77 (1H, d, J = 6.6 Hz), 7.02-7.15 (6H,
m), 7.26-7.40 (2H, m), 7.45 (2H, dd, J = 5.3 Hz,
8.7 Hz); IR (KBr) 3357, 2965, 1638, 1505, 1227, 11
98,1130 cm-1; Anal. Calcd for C31H30F5NO3: C, 66.5
4; H, 5.40; N, 2.50. Found: C, 66.30; H, 5.50; N,
2.60.Example 305 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -5,5-dimethyl-
6,7-dihydro-5H-benzo [a] cycloheptene-1
-Carboxamide 1) 3-Methyl-3-phenylbutanoic acid 9.56 g (393 mmol) of powdered magnesium and 1 fragment of iodine were stirred in 10 ml of tetrahydrofuran while stirring 1-chloro-2-methyl-2-phenylpropane 2
A solution of 6.53 g (157.3 mmol) and 29.6 g (157 mmol) of 1,2-dibromoethane in 100 ml of tetrahydrofuran was added dropwise at a rate at which the reaction solution was slowly refluxed. After completion of the dropwise addition, the mixture was stirred at 60 ° C. for 4 hours. The reaction was cooled to -78 ° C and crushed dry ice 50
g was carefully added, and the temperature of the reaction solution was gradually raised to room temperature while stirring. The reaction solution was diluted with water, acidified with concentrated hydrochloric acid, and extracted twice with ethyl acetate. The solvent of the collected organic layer was distilled off under reduced pressure. The obtained residue was treated with sodium hydroxide (6 g).
And 200 ml of water. The resulting aqueous solution was washed with diethyl ether-hexane, acidified with concentrated hydrochloric acid,
Extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain the desired product. Yellow liquid Yield 20.83 g Yield 74% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.47 (6H, s), 2.65 (2H,
s), 7.17-7.40 (5H, m), 10.48 (1H, br s); IR (nea
t) 2967, 1699, 1634, 1260, 1167, 772, 700 cm - 1 2) 3-Methyl-3-phenyl-1-butanol A suspension of 8.62 g (228 mmol) of lithium aluminum hydride in 200 ml of tetrahydrofuran was Under ice-cooling, 20.26 g of 3-methyl-3-phenylbutanoic acid (1
(13.7 mmol) in 100 ml of tetrahydrofuran was added dropwise and stirred overnight at room temperature. After cooling the reaction solution with ice, 8 ml of water, 8 ml of 15% aqueous sodium hydroxide solution,
Excess lithium aluminum hydride was decomposed by sequentially adding 20 ml of water dropwise, and the mixture was stirred at room temperature for 2 hours. The resulting precipitate was removed by filtration, and the precipitate was washed with ethyl acetate. The solvent of the collected filtrate was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 1/1) to obtain the desired product. Colorless liquid Yield 18.09 g Yield 97% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.00 (1 H, t, J = 5.3 H)
z), 1.35 (6H, s), 1.95 (2H, t, J = 7.4 Hz), 3.44-3.
54 (2H, m), 7.14-7.40 (5H, m); IR (neat) 3333, 296
5, 1497, 1445, 1057, 1022, 764, 700 cm -1 3) 18.09 g of 3,5-dimethyl-5-phenyl-2-pentanoic acid 3-methyl-3-phenyl-1-butanol
(110.1 mmol), triethylamine 23.0 m
1 (165 mmol) in 150 ml of ethyl acetate was added dropwise with a solution of 15.1 g (132 mmol) of methanesulfonyl chloride in 30 ml of ethyl acetate under ice-cooling.
Stirred for minutes. The resulting precipitate (triethylamine hydrochloride)
Was filtered off and the precipitate was washed with ethyl acetate. The collected ethyl acetate solution was concentrated under reduced pressure to obtain a crude product of mesylate as a yellow liquid. 22.8 g of diethyl malonate
To a solution of (132 mmol) in 100 ml of tetrahydrofuran was slowly added 5.29 g (132 mmol) of a 60% sodium hydride paraffin suspension under ice-cooling, followed by stirring for 0.5 hour. To this, a solution of the liquid obtained above in 50 ml of tetrahydrofuran was added dropwise at room temperature, and the mixture was stirred at 60 ° C. overnight. After adding water to the reaction solution and stirring, the mixture was extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-6 / 1), and diethyl (3-methyl-3-phenylbutyl) malonate (31.8 g) was added as a colorless liquid. As obtained. The liquid obtained above and 50 ml of concentrated hydrochloric acid were stirred in 100 ml of acetic acid at 100 ° C. overnight. After evaporating the reaction solution under reduced pressure, the obtained residue was stirred at 175 ° C for 4 hours to obtain the desired product. Yellow liquid Yield 18.86 g Yield 83% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.21-1.47 (2H, m), 1.31
(6H, s), 1.63-1.69 (2H, m), 2.25 (2H, t, J = 7.3
Hz), 7.14-7.23 (1H, m), 7.29-7.35 (4H, m); IR (nea
t) 2963, 1709, 1279, 766, 700 cm -1 4) 9,9-dimethyl-6,7,8,9-tetrahydro-
5H-benzo [a] cyclohepten-5-one 5,5-dimethyl-5-phenyl-2-pentanoic acid 18.8
To a solution of 6 g (91.43 mmol) and 2 drops of N, N-dimethylformamide in 100 ml of tetrahydrofuran was added dropwise 12.0 ml (137 mmol) of oxalyl chloride at room temperature, followed by stirring for 0.5 hour. The solvent of the reaction mixture was distilled off under reduced pressure to obtain an acid chloride as a yellow liquid. While stirring a suspension of 24.4 g (183 mmol) of aluminum chloride in 100 ml of methylene chloride, a solution of the acid chloride obtained above in 400 ml of methylene chloride was added dropwise thereto over 2 days. While cooling the reaction solution with ice, water was added to stop the reaction. The methylene chloride layer of the mixture was separated, and the aqueous layer was extracted with diethyl ether. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-6 / 1) to obtain the desired product. Yellow liquid Yield 5.780 g Yield 34% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.36 (6H, s), 1.83-2.02
(4H, m), 2.75 (2H, t, J = 6.8 Hz), 7.21-7.29 (1H,
m), 7.36-7.43 (3H, m); IR (neat) 2965, 1684, 1597,
1456, 1250, 764 cm -1 5) 9,9-dimethyl-6,7,8,9-tetrahydro-
5H-benzo [a] cyclohepten-5-ol 9,9-dimethyl-6,7,8,9-tetrahydro-5H-
5.780 g of benzo [a] cyclohepten-5-one (3
To a solution of 0.70 mmol) in 40 ml of methanol was added little by little 1.16 g (30.7 mmol) of sodium borohydride under ice-cooling, followed by stirring at room temperature overnight. The reaction solution was concentrated under reduced pressure, diluted with water, and extracted twice with ethyl acetate. The collected organic layer is dried over anhydrous magnesium sulfate,
The solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 9 / 1-6 / 1) to obtain the desired product. Yellow liquid Yield 5.245 g Yield 90% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.33 (3H, s), 1.45 (3H,
s), 1.61-1.94 (5H, m), 1.76 (1H, d, J = 4.5 Hz),
2.01-2.10 (1H, m), 5.15-5.20 (1H, m), 7.19-7.25 (2
H, m), 7.39-7.44 (1H, m), 7.58-7.62 (1H, m); IR (n
eat) 3335, 2926,1476, 1443, 1362, 1030, 760 cm -1 6) 4- bromo-9,9-dimethyl-6,7,8,9-tetrahydro -5H- benzo [a] cycloheptene-5- All 9,9-dimethyl-6,7,8,9-tetrahydro-5H-
Benzo [a] cyclohepten-5-ol 5.128 g
(26.95 mmol) and 6.89 g (59.3 mmol) of N, N, N ', N'-tetramethylethylenediamine in 100 ml of hexane under ice-cooling, 1.6 Mn.
37.1 ml of a hexane solution of -butyllithium (59.
(3 mmol) was added dropwise, followed by stirring at 35 ° C. overnight. After cooling the reaction mixture to −78 ° C., 14.0 g (53.9 mmol) of 1,2-dibromotetrafluoroethane was added, the temperature was raised to room temperature with stirring, and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into water and extracted twice with ethyl acetate.
The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product is purified by silica gel column chromatography (hexane / ethyl acetate = 1).
5/1), the desired product was obtained. 4.614 g of a yellow solid
The crystals were recrystallized from hexane to give white crystals. mp 91-92 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.38 (3H,
s), 1.40 (3H, s), 1.54-1.62 (1H, m), 1.71-1.88 (2
H, m), 2.05-2.36 (3H, m), 2.22 (1H, d, J = 4.8Hz),
5.56-5.59 (1H, m), 7.05 (1H, t, J = 8.0 Hz), 7.42
-7.45 (2H, m); IR (KBr) 3354, 2955, 1447, 945, 918,
775, 747 cm -1 ; Anal.Calcd for C 13 H 17 BrO: C, 58.0
1; H, 6.37. Found: C, 58.34; H, 6.51.7. 1) 1-Bromo-5,5-dimethyl-6,7-dihydro-5
3. H-benzo [a] cycloheptene 4-bromo-9,9-dimethyl-6,7,8,9-tetrahydro-5H-benzo [a] cyclohepten-5-ol
A solution of 402 g (16.35 mmol) and 0.31 g (1.64 mmol) of p-toluenesulfonic acid monohydrate in 80 ml of toluene was heated in a reaction vessel equipped with a Dean-Stark trap for 0.5 hour under dehydrating conditions. Refluxed.
After cooling the reaction solution to room temperature, the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane) to obtain the desired product. Colorless liquid Yield 3.887 g Yield 95% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.34 (6H, s), 1.83 (2H,
t, J = 6.8 Hz), 2.42-2.52 (2H, m), 6.05 (1H, td,
J = 4.4 Hz, 12.5 Hz), 6.91 (1H, td, J = 1.9Hz), 6.
98 (1H, t, J = 8.0 Hz), 7.33 (1H, d, J = 7.8 Hz),
7.49 (1H, dd, J = 1.3 Hz, 7.9 Hz); IR (neat) 2965,
2919, 1454, 1420, 1404, 885, 766 cm - 1 8) 5,5- dimethyl-6,7-dihydro -5H- benzo [a] cycloheptene-1-carboxylic acid 1-bromo-5,5-dimethyl - To a solution of 3.879 g (15.44 mmol) of 6,7-dihydro-5H-benzo [a] cycloheptene in 30 ml of diethyl ether was added -78 ° C.
1.6 Mn-butyllithium hexane solution 11.6
After dropwise addition of 1 ml (18.5 mmol), the mixture was stirred at room temperature for 4 hours. After cooling the reaction mixture to −78 ° C., 5 g of crushed dry ice was added, and the temperature was raised to room temperature with stirring. The reaction mixture was diluted with water, washed with diethyl ether, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude crystals were washed with hexane to obtain the desired product. White crystals Yield 1.540 g Yield 4
6% mp 165-166 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.37 (6H,
s), 1.89 (2H, t, J = 6.6 Hz), 2.44-2.54 (2H, m),
6.08 (1H, td, J = 4.4 Hz, 12.4 Hz), 6.92 (1H, td,
J = 2.0 Hz, 12.3 Hz), 7.22 (1H, t, J = 7.9 Hz), 7.
57 (1H, dd, J = 1.2 Hz, 8.0 Hz), 7.66 (1H, dd, J =
1.4 Hz, 7.6 Hz); IR (KBr) 3050-2650,1688, 1426, 13
06, 1279, 775, 764 cm -1 ; Anal.Calcd for C 14 H 16 O 2 :
C, 77.75; H, 7.46. Found: C, 77.99; H, 7.34.9) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1, 1,2,2-tetrafluoroethoxy) benzyl] ethyl] -5,5-dimethyl-6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- 0.379 g of (4-fluorophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol
(1.049 mmol), 0.23 g (1.05 mmol) of 5,5-dimethyl-6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid, 1-hydroxybenzotriazole hydrate 0 While stirring 0.16 g (1.05 mmol) in 10 ml of acetonitrile, 0.20 g (1.05 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. did. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White powder Yield 0.545 g Yield 93% mp 101-104 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.28 (6H,
s), 1.76 (2H, t, J = 6.6 Hz), 2.36-2.45 (2H, m),
2.74 (1H, dd, J = 10.6 Hz, 14.2 Hz), 3.00 (1H, dd,
J = 3.8 Hz, 14.4 Hz), 3.45 (1H, br s), 4.65-4.79
(1H, m), 5.01 (1H, d, J = 3.6 Hz), 5.69 (1H, d, J
= 9.4 Hz), 5.74 (1H, td, J = 4.2 Hz, 12.3 Hz), 5.8
9 (1H, tt, J = 2.9 Hz, 53.3 Hz), 6.12 (1H, d, J =
13.2 Hz), 6.77 (1H, d, J = 6.6 Hz), 7.02-7.15 (6H,
m), 7.26-7.40 (2H, m), 7.45 (2H, dd, J = 5.3 Hz,
8.7 Hz); IR (KBr) 3357, 2965, 1638, 1505, 1227, 11
. 98,1130 cm -1; Anal Calcd for C 31 H 30 F 5 NO 3: C, 66.5
4; H, 5.40; N, 2.50. Found: C, 66.30; H, 5.50; N,
2.60.
【0438】実施例306 N-[(1RS,2SR)-2-ヒドロキシ-2-[4-(メ
チルスルホニル)フェニル]-1-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]エチル]-6,
7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カ
ルボキサミド 1) 3-[4-(メチルスルホニル)フェニル]-3-オ
キソプロパン酸エチル 4-(メチルスルホニル)アセトフェノン(10g,4
2.2ミリモル)とエタノール(0.2ml)、炭酸ジ
エチル(50ml)の混合液に水素化ナトリウム(3.
37g,60%油性,84.4ミリモル)を少量ずつ加
えて室温で2時間、60℃で1時間撹拌した。反応液を
冷却し、1規定塩酸(30ml)を加えて、酢酸エチル
(100ml)で抽出した。抽出液を水洗し、無水硫酸
マグネシウムで乾燥後、減圧留去した。残留物をシリカ
ゲルクロマトグラフィー(ヘキサン:酢酸エチル=3:
1)で精製して、目的物(3.76g,33%)を結晶
として得た。 mp 50-52℃ IRνmaxKBrcm-1:1738, 1622, 1427, 1304, 1250, 1198,
1148, 1090. Anal. Calcd for C12H14O5S (MW270.30) Calcd: C,53.32; H,5.22 Found: C,53.46; H,5.25.1 H-NMR(CDCl3) δ: 1.27(3H×1/2, t, J = 7.1 Hz), 1.
36(3H×1/2, t, J = 7.1Hz), 3.08(3H×1/2, s), 3.10
(3H×1/2, s), 4.04(2H×1/2, q, J = 7.1 Hz),4.23(2H
×1/2, q, J = 7.1 Hz), 5.76(1H×1/2, s), 7.95-8.20
(4H, m). 2) 3-[4-(メチルスルホニル)フェニル]-3-オ
キソ-2-[3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]プロパン酸エチル 3-(1,1,2,2-テトラフルオロエトキシ)トルエ
ン(2.84ml,16.8ミリモル)の酢酸エチル
(30ml)溶液に、N-ブロモスクシンイミド(3.
0g,16.8ミリモル)と2,2'-アゾビスイソブチ
ロニトリル(0.1g)を加えて2時間加熱還流した。
反応液を減圧濃縮した後、ジエチルエーテルとヘキサン
を加えて不溶物を除去し、ジエチルエーテルで洗浄し
た。濾液を減圧留去して、3-(1,1,2,2-テトラ
フルオロエトキシ)-1-ブロモメチルベンゼンを得た。
3-[4-(メチルスルホニル)フェニル]-3-オキソプ
ロパン酸エチル(3.5g,13.0ミリモル)の1,
2-ジメトキシエタン(30ml)溶液に、氷冷下水素
化ナトリウム(0.52g,60%油性,13.0ミリ
モル)を加えて10分間撹拌した。これに上で得た3-
(1,1,2,2-テトラフルオロエトキシ)-1-ブロ
モメチルベンゼンの1,2-ジメトキシエタン(5m
l)溶液を滴下し、室温で4時間撹拌した。反応液に水
(100ml)を加えて酢酸エチル(100ml)で抽
出した。抽出液を水洗し、無水硫酸マグネシウムで乾燥
後、減圧留去した。残留物をシリカゲルクロマトグラフ
ィー(ヘキサン:酢酸エチル=3:1-2:1)で精製
し、目的物(3.03g,49%)を油状物として得
た。 IRνmaxNeatcm-1:1738, 1694, 1319, 1302, 1196, 115
4, 1121.1 H-NMR(CDCl3) δ: 1.13(3H, t, J = 7.1 Hz), 3.07(3
H, s), 3.37(2H, d, J =7.6 Hz), 4.11(2H, q, J = 7.1
Hz), 4.60(1H, t, J = 7.6 Hz), 5.89(1H, tt,J = 53.
2, 3.0 Hz), 7.00-7.35 (4H, m), 7.95-8.20(4H, m). 3) (2RS,3RS)-3-[4-(メチルスルホニ
ル)フェニル]-3-ヒドロキシ-2-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]プロパン
酸エチル 無水塩化亜鉛(1.72g,12.6ミリモル)のジエ
チルエーテル(20ml)懸濁液に、水素化ホウ素ナト
リウム(0.95g,25.2ミリモル)を少量ずつ加
えて、1時間撹拌した。不溶物を濾去し、ジエチルエー
テルで洗浄した。濾液を氷冷し、これに3-[4-(メチ
ルスルホニル)フェニル]-3-オキソ-2-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]プロ
パン酸エチル(3.0g,6.30ミリモル)のジエチ
ルエーテル(10ml)溶液を加えた。室温で1時間撹
拌した後、再び氷冷し、1規定塩酸で反応を止めた。得
られた混合物を酢酸エチル(100ml)で抽出し、水
洗後、無水硫酸マグネシウムで乾燥し、減圧留去した。
残留物をシリカゲルクロマトグラフィー(ヘキサン:酢
酸エチル=2:1-1:1)で精製して、目的物(2.
60g,86%)を無色油状物として得た。 IRνmaxNeatcm-1:1726, 1306, 1198, 1152, 1090, 774.1 H-NMR(CDCl3) δ: 0.97(3H, t, J = 7.1 Hz), 2.80-3.
10(3H, m), 3.06(3H, s), 3.35 (1H, d, J = 2.6 Hz),
3.95(2H, d, J = 7.1 Hz), 5.15-5.25(1H, m), 5.89(1
H, tt, J = 53.1, 3.0 Hz), 6.85-7.10(3H, m), 7.21(1
H, d, J = 7.6 Hz), 7.61(2H, d, J = 8.6 Hz), 7.94(2
H, d, J = 8.6 Hz). 4) (2RS,3RS)-3-[4-(メチルスルホニ
ル)フェニル]-3-ヒドロキシ-2-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]プロパン
酸 (2RS,3RS)-3-[4-(メチルスルホニル)フ
ェニル]-3-ヒドロキシ-2-[3-(1,1,2,2-テ
トラフルオロエトキシ)ベンジル]プロパン酸エチル
(2.55g,5.33ミリモル)のエタノール(20
ml)溶液に1規定水酸化ナトリウム水溶液(10.7
ml,10.7ミリモル)を加えて室温で1時間撹拌し
た。反応液に1規定塩酸(30ml)を加えて酸性とし
た後、酢酸エチル(100ml)で抽出した。抽出液を
水洗し、無水硫酸マグネシウムで乾燥後、減圧留去し
て、目的物(2.30g,96%)を油状物として得
た。 IRνmaxNeatcm-1:1715, 1302, 1198, 1148, 1121, 109
0, 961.1 H-NMR(CDCl3) δ: 2.80-3.05(2H, m), 3.05(3H, s),
3.08(1H, d, J = 4.0 Hz), 5.22 (1H, d, J = 4.0 H
z), 5.89(1H, tt, J = 53.0, 2.8 Hz), 6.90-7.10(3H,
m), 7.22(1H, d, J = 8.0 Hz), 7.60(2H, d, J = 8.2 H
z), 7.90(2H, d, J =8.2 Hz). 5) (4RS,5SR)-5-[4-(メチルスルホニ
ル)フェニル]-4-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]-1,3-オキサゾリジン-2-
オン (2RS,3RS)-3-[4-(メチルスルホニル)フ
ェニル]-3-ヒドロキシ-2-[3-(1,1,2,2-テ
トラフルオロエトキシ)ベンジル]プロパン酸(2.2
0g,4.88ミリモル)のテトラヒドロフラン(20
ml)溶液にアジ化ジフェニルホスホリル(1.37m
l,6.35ミリモル)とトリエチルアミン(0.95
ml,6.84ミリモル)を加えて室温で1時間撹拌し
た。その後、1時間加熱還流した後、水(100ml)
を加えて酢酸エチル(100ml×2)で抽出した。抽
出液を飽和重曹水で洗浄し、無水硫酸マグネシウムで乾
燥後、減圧留去した。残留物をシリカゲルクロマトグラ
フィー(ヘキサン:酢酸エチル=1:1-1:3)で精
製し、析出した結晶をヘキサンを加えて濾取して、目的
物(2.07g,95%)を得た。 mp 123-125℃ IRνmaxKBrcm-1:1740, 1588, 1314, 1152, 1115, 959. Anal. Calcd for C19H17F4NO5S (MW447.40) Calcd: C,51.01; H,3.83; N, 3.13 Found: C,50.87; H,3.68; N, 2.98.1 H-NMR(CDCl3) δ: 2.20-2.40(2H, m), 3.10(3H, s),
4.25-4.45(1H, m), 5.10(1H, s), 5.89(1H, d, J = 7.8
Hz), 5.90(1H, tt, J = 53.2, 3.0 Hz), 6.80-7.00(2
H, m), 7.10-7.20(1H, m), 7.34(1H, d, J = 8.0 Hz),
7.60(2H, d, J = 8.0 Hz). 6) (1RS,2SR)-2-アミノ-1-[4-(メチ
ルスルホニル)フェニル]-3-[3-(1,1,2,2-
テトラフルオロエトキシ)フェニル]-1-プロパノール (4RS,5SR)-5-[4-(メチルスルホニル)フ
ェニル]-4-[3-(1,1,2,2-テトラフルオロエ
トキシ)ベンジル]-1,3-オキサゾリジン-2-オン
(1.80g,4.02ミリモル)のエタノール(20
ml)溶液に、8規定水酸化ナトリウム水溶液(1.5
1ml,12.07ミリモル)を加えて3時間加熱還流
した。反応液に水(100ml)を加えて酢酸エチル
(200ml×2)で抽出した。抽出液を水洗し、無水
硫酸マグネシウムで乾燥後、減圧留去した。残留物をヘ
キサン-ジエチルエーテルから結晶化させて、目的物
(1.49g,86%)を得た。 mp 93-95℃ IRνmaxKBrcm-1:1586, 1298, 1200, 1148, 1117, 766. Anal. Calcd for C18H19F4NO4S・1/2H2O(MW430.42) Calcd: C,50.22; H,4.68; N, 3.25 Found: C,50.11; H,4.43; N, 3.10.1 H-NMR(CDCl3) δ: 2.37(1H, dd, J = 13.6, 10.2 Hz),
2.66(1H, dd, J = 13.6, 2.8 Hz), 3.08(3H, s), 3.30
-3.50(1H, m), 4.81(1H, d, J = 4.4 Hz), 5.90(1H, t
t, J = 53.1, 2.5 Hz), 6.9-7.20(3H, m), 7.30-7.40(1
H, m), 7.62(2H, d, J = 8.2 Hz), 7.96(2H, d, J = 8.
2 Hz). 7) N-[(1RS,2SR)-2-ヒドロキシ-2-
[4-(メチルスルホニル)フェニル]-1-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]エチ
ル]-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテ
ン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-[4-(メチルスル
ホニル)フェニル]-3-[3-(1,1,2,2-テトラ
フルオロエトキシ)フェニル]-1-プロパノール0.3
01g(0.714ミリモル)、6,7-ジヒドロ-5H
-ベンゾ[a]シクロヘプテン-1-カルボン酸0.13
g(0.71ミリモル)、1-ヒドロキシベンゾトリア
ゾール水和物0.11g(0.71ミリモル)をアセト
ニトリル10ml中で撹拌しながら1-エチル-3-(3-
ジメチルアミノプロピル)カルボジイミド・塩酸塩0.
14g(0.71ミリモル)を加え、室温で一晩撹拌し
た。反応液を酢酸エチルに希釈し、炭酸水素ナトリウム
水溶液で洗浄、無水硫酸マグネシウムで乾燥、溶媒を減
圧留去した。残留物をシリカゲルカラムクロマトグラフ
ィーにて精製し(ヘキサン/酢酸エチル=3/1-酢酸
エチル)、酢酸エチル-ジイソプロピルエーテル-ヘキサ
ンより結晶化して、目的物を得た。白色粉末収量0.2
93g収率69% mp 154-157℃; 1H-NMR (CDCl3, 200 MHz) δ 1.93-2.06
(2H, m), 2.15-2.24 (2H, m), 2.67 (2H, t, J = 5.6
Hz), 2.80 (1H, dd, J = 11.8 Hz, 14.6 Hz), 2.95 (1
H, dd, J = 4.6 Hz, 14.4 Hz), 3.06 (3H, s), 4.22 (1
H, d, J = 4.2 Hz), 4.62-4.75 (1H, m), 5.19 (1H, t,
J = 3.5 Hz), 5.86 (1H, d, J = 8.2 Hz),5.89 (1H, t
t, J = 3.0 Hz, 53.1 Hz), 5.95 (1H, td, J = 5.5 Hz,
11.8 Hz),6.25 (1H, d, J = 12.0 Hz), 6.97-7.35 (7
H, m), 7.67 (2H, d, J = 8.4 Hz),7.93 (2H, d, J =
8.0 Hz); IR (KBr) 3486, 3330, 2932, 1645, 1532, 13
02,1271, 1200, 1146, 1123, 768 cm-1; Anal. Calcd f
or CHFNOS・0.5H2O: C, 59.99; H, 5.03; N, 2.33. Foun
d: C, 60.02; H, 4.88; N, 2.48.Example 306 N-[(1RS, 2SR) -2-hydroxy-2- [4- (methylsulfonyl) phenyl] -1- [3- (1,1,2,2
2-tetrafluoroethoxy) benzyl] ethyl] -6
7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1) Ethyl 3- [4- (methylsulfonyl) phenyl] -3-oxopropanoate 4- (methylsulfonyl) acetophenone (10 g, 4
2.2 mmol), a mixture of ethanol (0.2 ml) and diethyl carbonate (50 ml) was mixed with sodium hydride (3.
(37 g, 60% oily, 84.4 mmol) was added little by little, and the mixture was stirred at room temperature for 2 hours and at 60 ° C for 1 hour. The reaction solution was cooled, 1N hydrochloric acid (30 ml) was added, and the mixture was extracted with ethyl acetate (100 ml). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was subjected to silica gel chromatography (hexane: ethyl acetate = 3:
Purification in 1) gave the desired product (3.76 g, 33%) as crystals. mp 50-52 ° C IRνmax KBr cm -1 : 1738, 1622, 1427, 1304, 1250, 1198,
1148, 1090. Anal Calcd for C 12 H 14 O 5 S (MW270.30) Calcd:. C, 53.32; H, 5.22 Found:. C, 53.46; H, 5.25 1 H-NMR (CDCl 3) δ: 1.27 (3H × 1/2, t, J = 7.1 Hz), 1.
36 (3H × 1/2, t, J = 7.1Hz), 3.08 (3H × 1/2, s), 3.10
(3H × 1/2, s), 4.04 (2H × 1/2, q, J = 7.1 Hz), 4.23 (2H
× 1/2, q, J = 7.1 Hz), 5.76 (1H × 1/2, s), 7.95-8.20
(4H, m). 2) Ethyl 3- [4- (methylsulfonyl) phenyl] -3-oxo-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoate 3- ( To a solution of 1,1,2,2-tetrafluoroethoxy) toluene (2.84 ml, 16.8 mmol) in ethyl acetate (30 ml) was added N-bromosuccinimide (3.
(0 g, 16.8 mmol) and 2,2'-azobisisobutyronitrile (0.1 g) were added and the mixture was refluxed for 2 hours.
After the reaction solution was concentrated under reduced pressure, diethyl ether and hexane were added to remove insolubles, and washed with diethyl ether. The filtrate was distilled off under reduced pressure to obtain 3- (1,1,2,2-tetrafluoroethoxy) -1-bromomethylbenzene.
Ethyl 3- [4- (methylsulfonyl) phenyl] -3-oxopropanoate (3.5 g, 13.0 mmol) in 1,
Sodium hydride (0.52 g, 60% oily, 13.0 mmol) was added to a solution of 2-dimethoxyethane (30 ml) under ice cooling, and the mixture was stirred for 10 minutes. This was obtained above 3-
1,2-dimethoxyethane of (1,1,2,2-tetrafluoroethoxy) -1-bromomethylbenzene (5 m
l) The solution was added dropwise and stirred at room temperature for 4 hours. Water (100 ml) was added to the reaction solution, and the mixture was extracted with ethyl acetate (100 ml). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 3: 1-2: 1) to give the desired product (3.03 g, 49%) as an oil. IRνmax Neat cm -1 : 1738, 1694, 1319, 1302, 1196, 115
4, 1121. 1 H-NMR ( CDCl 3) δ: 1.13 (3H, t, J = 7.1 Hz), 3.07 (3
H, s), 3.37 (2H, d, J = 7.6 Hz), 4.11 (2H, q, J = 7.1
Hz), 4.60 (1H, t, J = 7.6 Hz), 5.89 (1H, tt, J = 53.
2, 3.0 Hz), 7.00-7.35 (4H, m), 7.95-8.20 (4H, m). 3) (2RS, 3RS) -3- [4- (methylsulfonyl) phenyl] -3-hydroxy-2- [3- (1,1,
Ethyl 2,2-tetrafluoroethoxy) benzyl] propanoate To a suspension of anhydrous zinc chloride (1.72 g, 12.6 mmol) in diethyl ether (20 ml) was added sodium borohydride (0.95 g, 25.2 mmol). ) Was added in small portions and stirred for 1 hour. The insolubles were removed by filtration and washed with diethyl ether. The filtrate was cooled on ice, and 3- [4- (methylsulfonyl) phenyl] -3-oxo-2- [3- (1,
A solution of ethyl 1,2,2-tetrafluoroethoxy) benzyl] propanoate (3.0 g, 6.30 mmol) in diethyl ether (10 ml) was added. After stirring at room temperature for 1 hour, the mixture was ice-cooled again and the reaction was stopped with 1N hydrochloric acid. The obtained mixture was extracted with ethyl acetate (100 ml), washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure.
The residue was purified by silica gel chromatography (hexane: ethyl acetate = 2: 1-1: 1) to give the desired product (2.
(60 g, 86%) as a colorless oil. IRνmax Neat cm -1: 1726, 1306 , 1198, 1152, 1090, 774. 1 H-NMR (CDCl 3) δ: 0.97 (3H, t, J = 7.1 Hz), 2.80-3.
10 (3H, m), 3.06 (3H, s), 3.35 (1H, d, J = 2.6 Hz),
3.95 (2H, d, J = 7.1 Hz), 5.15-5.25 (1H, m), 5.89 (1
H, tt, J = 53.1, 3.0 Hz), 6.85-7.10 (3H, m), 7.21 (1
H, d, J = 7.6 Hz), 7.61 (2H, d, J = 8.6 Hz), 7.94 (2
H, d, J = 8.6 Hz). 4) (2RS, 3RS) -3- [4- (methylsulfonyl) phenyl] -3-hydroxy-2- [3- (1,1,
2,2-Tetrafluoroethoxy) benzyl] propanoic acid (2RS, 3RS) -3- [4- (methylsulfonyl) phenyl] -3-hydroxy-2- [3- (1,1,2,2-tetrafluoro Ethoxy) benzyl] ethyl propanoate (2.55 g, 5.33 mmol) in ethanol (20
1N sodium hydroxide aqueous solution (10.7 ml)
ml, 10.7 mmol) and stirred at room temperature for 1 hour. The reaction mixture was acidified with 1N hydrochloric acid (30 ml), and extracted with ethyl acetate (100 ml). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure to give the desired product (2.30 g, 96%) as an oil. IRνmax Neat cm -1 : 1715, 1302, 1198, 1148, 1121, 109
0, 961. 1 H-NMR ( CDCl 3) δ: 2.80-3.05 (2H, m), 3.05 (3H, s),
3.08 (1H, d, J = 4.0 Hz), 5.22 (1H, d, J = 4.0 H
z), 5.89 (1H, tt, J = 53.0, 2.8 Hz), 6.90-7.10 (3H,
m), 7.22 (1H, d, J = 8.0 Hz), 7.60 (2H, d, J = 8.2 H
z), 7.90 (2H, d, J = 8.2 Hz). 5) (4RS, 5SR) -5- [4- (methylsulfonyl) phenyl] -4- [3- (1,1,2,2-tetra Fluoroethoxy) benzyl] -1,3-oxazolidine-2-
On (2RS, 3RS) -3- [4- (methylsulfonyl) phenyl] -3-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propanoic acid (2.2
0 g, 4.88 mmol) of tetrahydrofuran (20
ml) solution into diphenylphosphoryl azide (1.37 m
1, 6.35 mmol) and triethylamine (0.95
ml, 6.84 mmol) and stirred at room temperature for 1 hour. Then, after heating and refluxing for 1 hour, water (100 ml)
And extracted with ethyl acetate (100 ml × 2). The extract was washed with saturated aqueous sodium hydrogen carbonate, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 1: 1-1: 3), and the precipitated crystals were added to hexane and collected by filtration to obtain the desired product (2.07 g, 95%). . . mp 123-125 ℃ IRνmax KBr cm -1 : 1740, 1588, 1314, 1152, 1115, 959. Anal Calcd for C 19 H 17 F 4 NO 5 S (MW447.40) Calcd: C, 51.01; H, 3.83 ; N, 3.13 Found:. C , 50.87; H, 3.68; N, 2.98 1 H-NMR (CDCl 3) δ: 2.20-2.40 (2H, m), 3.10 (3H, s),
4.25-4.45 (1H, m), 5.10 (1H, s), 5.89 (1H, d, J = 7.8
Hz), 5.90 (1H, tt, J = 53.2, 3.0 Hz), 6.80-7.00 (2
H, m), 7.10-7.20 (1H, m), 7.34 (1H, d, J = 8.0 Hz),
7.60 (2H, d, J = 8.0 Hz). 6) (1RS, 2SR) -2-amino-1- [4- (methylsulfonyl) phenyl] -3- [3- (1,1,2,2-
Tetrafluoroethoxy) phenyl] -1-propanol (4RS, 5SR) -5- [4- (methylsulfonyl) phenyl] -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1 , 3-Oxazolidin-2-one (1.80 g, 4.02 mmol) in ethanol (20
ml) solution, 8N aqueous sodium hydroxide solution (1.5
(1 ml, 12.07 mmol) and the mixture was heated under reflux for 3 hours. Water (100 ml) was added to the reaction solution, and extracted with ethyl acetate (200 ml × 2). The extract was washed with water, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue was crystallized from hexane-diethyl ether to obtain the desired product (1.49 g, 86%). mp 93-95 ° C IRνmax KBr cm -1 : 1586, 1298, 1200, 1148, 1117, 766. Anal.Calcd for C 18 H 19 F 4 NO 4 S ・ 1 / 2H 2 O (MW430.42) Calcd: C , 50.22; H, 4.68; N , 3.25 Found:. C, 50.11; H, 4.43; N, 3.10 1 H-NMR (CDCl 3) δ: 2.37 (1H, dd, J = 13.6, 10.2 Hz),
2.66 (1H, dd, J = 13.6, 2.8 Hz), 3.08 (3H, s), 3.30
-3.50 (1H, m), 4.81 (1H, d, J = 4.4 Hz), 5.90 (1H, t
t, J = 53.1, 2.5 Hz), 6.9-7.20 (3H, m), 7.30-7.40 (1
H, m), 7.62 (2H, d, J = 8.2 Hz), 7.96 (2H, d, J = 8.
2 Hz). 7) N-[(1RS, 2SR) -2-hydroxy-2-
[4- (methylsulfonyl) phenyl] -1- [3- (1,
1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- [4- (methylsulfonyl) ) Phenyl] -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] -1-propanol 0.3
01g (0.714 mmol), 6,7-dihydro-5H
-Benzo [a] cycloheptene-1-carboxylic acid 0.13
g (0.71 mmol) and 0.11 g (0.71 mmol) of 1-hydroxybenzotriazole hydrate in 10 ml of acetonitrile while stirring with 1-ethyl-3- (3- (3-ethyl-3-benzotriazole).
Dimethylaminopropyl) carbodiimide hydrochloride
14 g (0.71 mmol) was added and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-ethyl acetate), and crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White powder yield 0.2
93g yield 69% mp 154-157 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.93-2.06
(2H, m), 2.15-2.24 (2H, m), 2.67 (2H, t, J = 5.6
Hz), 2.80 (1H, dd, J = 11.8 Hz, 14.6 Hz), 2.95 (1
H, dd, J = 4.6 Hz, 14.4 Hz), 3.06 (3H, s), 4.22 (1
H, d, J = 4.2 Hz), 4.62-4.75 (1H, m), 5.19 (1H, t,
J = 3.5 Hz), 5.86 (1H, d, J = 8.2 Hz), 5.89 (1H, t
t, J = 3.0 Hz, 53.1 Hz), 5.95 (1H, td, J = 5.5 Hz,
11.8 Hz), 6.25 (1H, d, J = 12.0 Hz), 6.97-7.35 (7
H, m), 7.67 (2H, d, J = 8.4 Hz), 7.93 (2H, d, J =
8.0 Hz); IR (KBr) 3486, 3330, 2932, 1645, 1532, 13
02,1271, 1200, 1146, 1123, 768 cm -1 ; Anal.Calcd f
or CHFNOS ・ 0.5H 2 O: C, 59.99; H, 5.03; N, 2.33. Foun
d: C, 60.02; H, 4.88; N, 2.48.
【0439】実施例307 1-(2-エチルブチル)-N-[(1RS,2SR)-2-
(4-フルオロフェニル)-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]シクロヘキサンカルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.335g
(0.927ミリモル)、1-(2-エチルブチル)シク
ロヘキサンカルボン酸0.22g(1.02ミリモ
ル)、4-N,N-ジメチルアミノピリジン0.11g
(0.93ミリモル)1-ヒドロキシベンゾトリアゾー
ル水和物0.14g(0.93ミリモル)をアセトニト
リル10ml中で撹拌しながら1-エチル-3-(3-ジメ
チルアミノプロピル)カルボジイミド・塩酸塩0.18
g(0.93ミリモル)を加え、80℃で1日間撹拌し
た。反応液を酢酸エチルに希釈し、炭酸水素ナトリウム
水溶液で洗浄、無水硫酸マグネシウムで乾燥、溶媒を減
圧留去した。残留物をシリカゲルカラムクロマトグラフ
ィーにて精製し(ヘキサン/酢酸エチル=3/1-2/
1)、目的物を得た。無色液体 収量0.416g 収
率81%1 H-NMR (CDCl3, 300 MHz) δ 0.69-0.75 (6H, m), 0.96
-1.47 (15H, m), 1.64-1.76 (2H, m), 2.67 (1H, dd, J
= 11.0 Hz, 14.6 Hz), 4.1 Hz, 14.6 Hz), 4.03(1H,
d, J = 4.2 Hz), 4.42-4.50 (1H, m), 4.98 (1H, t, J
= 3.0 Hz), 5.60(1H, d, J = 7.2 Hz), 5.88 (1H, tt,
J = 2.9 Hz, 53.1 Hz), 6.97 (1H, s), 7.04-7.11 (4H,
m), 7.28 (1H, t, J = 8.0 Hz), 7.40 (2H, dd, J =
5.3 Hz, 8.6 Hz); IR (neat) 3378, 2932, 2861, 1636,
1609, 1508, 1449, 1304, 1279, 1223, 1196, 1123 cm
-1 Example 307 1- (2-Ethylbutyl) -N-[(1RS, 2SR) -2-
(4-Fluorophenyl) -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] cyclohexanecarboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (1,1,2,2 0.335 g of 2-tetrafluoroethoxy) phenyl] propan-1-ol
(0.927 mmol), 0.22 g (1.02 mmol) of 1- (2-ethylbutyl) cyclohexanecarboxylic acid, 0.11 g of 4-N, N-dimethylaminopyridine
0.14 g (0.93 mmol) of 1-hydroxybenzotriazole hydrate (0.93 mmol) in 10 ml of acetonitrile while stirring 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide. 18
g (0.93 mmol) was added and the mixture was stirred at 80 ° C. for 1 day. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-2 /
1) The desired product was obtained. Colorless liquid Yield 0.416 g Yield 81% 1 H-NMR (CDCl 3 , 300 MHz) δ 0.69-0.75 (6H, m), 0.96
-1.47 (15H, m), 1.64-1.76 (2H, m), 2.67 (1H, dd, J
= 11.0 Hz, 14.6 Hz), 4.1 Hz, 14.6 Hz), 4.03 (1H,
d, J = 4.2 Hz), 4.42-4.50 (1H, m), 4.98 (1H, t, J
= 3.0 Hz), 5.60 (1H, d, J = 7.2 Hz), 5.88 (1H, tt,
J = 2.9 Hz, 53.1 Hz), 6.97 (1H, s), 7.04-7.11 (4H,
m), 7.28 (1H, t, J = 8.0 Hz), 7.40 (2H, dd, J =
5.3 Hz, 8.6 Hz); IR (neat) 3378, 2932, 2861, 1636,
1609, 1508, 1449, 1304, 1279, 1223, 1196, 1123 cm
-1
【0440】実施例308 4-[(1RS,2SR)-2-[(tert-ブトキシカ
ルボニル)アミノ]-1-ヒドロキシ-3-[3-(1,
1,2,2-テトラフルオロエトキシ)フェニル]プロ
ピル]安息香酸メチル 1) 3-[4-(メトキシカルボニル)フェニル]-3-
オキソプロピオン酸ベンジル 4-(メトキシカルボニル)安息香酸50.95g(2
82.8ミリモル)のテトラヒドロフラン400ml溶
液に1,1’-カルボニルジイミダゾール50.4g
(311ミリモル)を室温で加え、そのまま2時間撹拌
した。この混合物にジメチルスルホキシド200ml、
マロン酸モノベンジルエステルモノカリウム塩78.8
g(339ミリモル)、塩化マグネシウム16.2g
(170ミリモル)を室温で加え、室温で一晩撹拌し
た。反応液を酢酸エチルと水で希釈し、濃塩酸で反応液
を酸性にした後、酢酸エチル層を分離し、水層を酢酸エ
チルで抽出した。集めた有機層を無水硫酸ナトリウムで
乾燥、溶媒を減圧留去した。得られた粗生成物をシリカ
ゲルカラムクロマトグラフィーにて精製して(ヘキサン
/酢酸エチル=3/1-2/1)、目的物を得た。淡黄
色固体 収量31.19g 収率35% 酢酸エチル-ジエチルエーテル-ヘキサンより再結晶し
て、淡黄色結晶を得た。mp 74-75℃; 1H-NMR (CDCl3, 2
00 MHz) δ 3.94 (1.2H, s), 3.96 (1.8H, s), 4.07
(1.2 Hz, s), 5.20 (1.2H,s), 5.27 (0.8H, s), 5.80
(0.4H,s), 7.22-7.43(5H, m), 7.84 (0.8H, d, J = 8.8
Hz), 7.97 (1.2H, d, J = 8.4 Hz), 8.08 (0.8H, d, J
= 8.0 Hz), 8.12 (1.2H, d, J = 8.8 Hz); IR (KBr) 1
721, 1281, 1211, 1204, 1109, 818, 731 cm-1; Anal.
Calcd for C18H16O5: C, 69.22; H, 5.16. Found: C, 6
9.40; H, 5.24. 2) 3-[4-(メトキシカルボニル)フェニル]-3-
オキソ-2-[3-(1,1,2,2-テトラフルオロエト
キシ)ベンジル]プロピオン酸ベンジル 3-(1,1,2,2-テトラフルオロエトキシ)トルエ
ン48.4g(233ミリモル)、N-ブロモスクシン
イミド41.4g(233ミリモル)、2,2’-アゾ
ビス(イソブチロニトリル)0.1gを四塩化炭素10
0ml中で0.5時間加熱還流した。反応液を室温に冷
却した後、白色沈殿を濾過して除き、沈殿をジエチルエ
ーテルで洗浄した。集めた濾液の溶媒を減圧留去して、
3-(1,1,2,2-テトラフルオロエトキシ)ベンジ
ルブロミドの粗生成物を淡黄色液体として得た。3-
[4-(メトキシカルボニル)フェニル]-3-オキソプ
ロピオン酸ベンジル66.08g(211.6ミリモ
ル)の1,2-ジメトキシエタン200ml溶液に氷冷
下60%水素化ナトリウムの流動パラフィン懸濁物8.
89g(222ミリモル)を加え、そのまま0.5時間
撹拌した。これに上で得た3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジルブロミドの1,2-ジメト
キシエタン50ml溶液を室温で加え、室温で一晩撹拌
した。反応液を水に注ぎ、酢酸エチルで2回抽出した。
集めた有機層を無水硫酸マグネシウムで乾燥、溶媒を減
圧留去した。得られた残留物をシリカゲルカラムクロマ
トグラフィーにて精製し(ヘキサン/酢酸エチル=3/
1-2/1)、目的物を得た。淡黄色液体 収量98.
99g 収率90%1 H-NMR (CDCl3, 300 MHz) δ 3.36 (2H, d, J = 7.2 H
z), 3.95 (3H, s), 4.63(1H, t, J = 7.4 Hz), 5.03 (1
H, d, J = 16.8 Hz), 5.08 (1H, d, J = 15.9 Hz), 5.8
8 (1H, tt, J = 2.7 Hz, 53.1 Hz), 7.01-7.49 (9H,
m), 7.93 (2H, d, J= 8.4 Hz), 8.05 (2H, d, J = 8.1
Hz); IR (neat) 1728, 1694, 1281, 1196,1119 cm-1 3) (2RS,3RS)-3-ヒドロキシ-3-[4-
(メトキシカルボニル)フェニル]-2-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]プロ
ピオン酸ベンジル 塩化亜鉛52.0g(382ミリモル)をジエチルエー
テル250ml中で撹拌しながら水素化ホウ素ナトリウ
ム28.9g(764ミリモル)を室温で加え、そのま
ま2時間撹拌した。混合物の不溶物をろ過で除き(ジエ
チルエーテルで洗浄)、水素化ホウ素亜鉛のジエチルエ
ーテル溶液を得た。得られた溶液に、3-[4-(メトキ
シカルボニル)フェニル]-3-オキソ-2-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]プロ
ピオン酸ベンジル98.98g(190.9ミリモル)
のジエチルエーテル100ml溶液を氷冷下で滴下し、
そのまま1時間撹拌した。反応液に希塩酸を少しずつ加
えて過剰の水素化ホウ素亜鉛を分解した後、酢酸エチル
で2回抽出した。集めた有機層を無水硫酸マグネシウム
で乾燥、溶媒を減圧留去した。得られた粗生成物をシリ
カゲルカラムクロマトグラフィーにて精製し(ヘキサン
/酢酸エチル=6/1-2/1)、目的物を得た。無色
液体 収量69.90g 収率70%1 H-NMR (CDCl3, 300 MHz) δ 2.93-3.10 (4H, m), 3.92
(3H, s), 4.83 (1H, d,J = 12.3 Hz), 4.89 (1H, d, J
= 12.3 Hz), 5.11 (1H, t, J = 3.6 Hz), 5.87(1H, t
t, J = 2.9 Hz, 53.2 Hz), 6.91-7.03 (5H, m), 7.16-
7.38 (4H, m), 7.44 (2H, d, J = 8.4 Hz), 7.99 (2H,
d, J = 8.4 Hz); IR (neat) 3480, 1723,1281, 1196, 1
119 cm-1 4) (4RS,5SR)-5-[4-(メトキシカルボ
ニル)フェニル]-4-[3-(1,1,2,2-テトラフ
ルオロエトキシ)ベンジル]-1,3-オキサゾリジン-
2-オン (2RS,3RS)-3-ヒドロキシ-3-[4-(メトキ
シカルボニル)フェニル]-2-[3-(1,1,2,2-
テトラフルオロエトキシ)ベンジル]プロピオン酸ベン
ジル69.90g(134.3ミリモル)のエタノール
200ml溶液を10%パラジウム/炭素(50%含
水)5gを触媒として、一晩常温常圧下で水素添加し
た。触媒をろ過して除いた後、エタノールで洗浄し、集
めたろ液の溶媒を減圧留去して、粗(2RS,3RS)
-3-ヒドロキシ-3-[4-(メトキシカルボニル)フェ
ニル]-2-[3-(1,1,2,2-テトラフルオロエト
キシ)ベンジル]プロピオン酸を無色泡状物として得
た。上で得た泡状物をテトラヒドロフラン150mlに
溶かし、トリエチルアミン22.5ml(161ミリモ
ル)、ジフェニルホスホリルアジド40.7g(148
ミリモル)を加え、70℃で一晩撹拌した。反応液の溶
媒を減圧留去し、得られた残留物をシリカゲルカラムク
ロマトグラフィーにて精製し(ヘキサン/酢酸エチル=
3/1-酢酸エチル)、N,N-ジメチルホルムアミド-
ジイソプロピルエーテルより結晶化して、目的物を得
た。白色粉末 収量40.33g 収率70% mp 155-158℃; 1H-NMR (CDCl3, 200 MHz) δ 2.17-2.34
(2H, m), 3.95 (3H, s), 4.25-4.36 (1H, m), 5.07 (1
H, br s), 5.87 (1H, d, J = 7.8 Hz), 5.89 (1H, tt,
J = 2.8 Hz, 53.0 Hz), 6.85 (1H, s), 6.94 (1H, d, J
= 7.8 Hz), 7.10(1H, d, J = 8.4 Hz), 7.30 (1H, t,
J = 8.0 Hz), 7.46 (2H, d, J = 8.0 Hz), 8.11 (2H,
d, J = 8.4 Hz); IR (KBr) 3250, 1736, 1279, 1206, 1
113 cm-1;Anal. Calcd for C20H17F4NO5・0.5DMF:C,55.6
7;H,4.45;N, 4.53. Found: C, 55.60; H, 4.18; N, 4.8
3. 5) (4RS,5SR)-5-[4-(メトキシカルボ
ニル)フェニル]-2-オキソ-4-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]-1,3-オキ
サゾリジン-3-カルボン酸tert-ブチル (4RS,5SR)-5-[4-(メトキシカルボニル)
フェニル]-4-[3-(1,1,2,2-テトラフルオロ
エトキシ)ベンジル]-1,3-オキサゾリジン-2-オン
20.04g(46.89ミリモル)、二炭酸ジ-te
rt-ブチル12.3g(56.3ミリモル)、4-N,
N-ジメチルアミノピリジン0.57g(4.69ミリ
モル)のアセトニトリル150ml溶液を室温で一晩撹
拌した。反応液の溶媒を減圧留去し、得られた残留物を
シリカゲルカラムクロマトグラフィーにて精製し(ヘキ
サン/酢酸エチル=3/1-2/1)、酢酸エチル-ジイ
ソプロピルエーテル-ヘキサンより結晶化して、目的物
を得た。白色結晶 収量21.14g 収率86% mp 140-141℃; 1H-NMR (CDCl3, 300 MHz) δ 1.52 (9H,
s), 2.59 (1H, dd, J =8.9 Hz, 14.3 Hz), 2.91 (1H,
dd, J = 4.2 Hz, 14.1 Hz), 3.93 (3H, s), 4.81-4.88
(1H, m), 5.73 (1H, d, J = 6.9 Hz), 5.85 (1H, tt, J
= 2.9 Hz, 53.1Hz), 6.35 (1H, s), 6.62 (1H, d, J =
7.5 Hz), 6.95 (1H, d, J = 8.7 Hz),7.06 (1H, t, J
= 8.0 Hz), 7.24 (2H, d, J = 8.1 Hz), 7.93 (2H, d,
J = 8.7Hz); IR (KBr) 1786, 1717, 1360, 1331, 1281,
1200, 1113, 1071 cm-1; Anal. Calcd for C25H25F4NO
7: C, 56.93; H, 4.78; N, 2.66. Found: C, 57.05; H,
4.76; N, 2.71. 6) 4-[(1RS,2SR)-2-[(tert-ブト
キシカルボニル)アミノ]-1-ヒドロキシ-3-[3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル]プロピル]安息香酸メチル (4RS,5SR)-5-[4-(メトキシカルボニル)
フェニル]-2-オキソ-4-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]-1,3-オキサゾリジ
ン-3-カルボン酸tert-ブチル20.82g(3
9.47ミリモル)のメタノール50ml-テトラヒド
ロフラン100ml溶液に水酸化ナトリウム1.66g
(41.4ミリモル)のメタノール20ml溶液を氷冷
下加え、室温で10分間撹拌した。反応液を酢酸エチル
に希釈し、水で洗浄、無水硫酸マグネシウムで乾燥、シ
リカゲルを通した後、溶媒を減圧留去した。得られた残
留物を酢酸エチル-ヘキサンより結晶化して、目的物を
得た。白色結晶 収量16.05g 収率81% mp 148-150℃; 1H-NMR (CDCl3, 300 MHz) δ 1.36 (9H,
s), 2.73 (2H, d, J =6.0 Hz), 3.45 (1H, br s), 3.9
3 (3H, s), 4.05-4.11 (1H, m), 4.61 (1H, brd, J =
8.4 Hz), 5.03 (1H, br s), 5.89 (1H, tt, J = 2.9 H
z, 53.1 Hz), 6.94 (1H, s), 7.00 (1H, d, J = 7.5 H
z), 7.05 (1H, dd, J = 1.4 Hz, 8.3 Hz),7.26 (1H, t,
J = 8.0 Hz), 7.49 (2H, d, J = 8.1 Hz), 8.05 (2H,
d, J = 8.4Hz); IR (KBr) 3330, 3206, 1721, 1678, 15
51, 1300, 1283, 1202, 1175, 1113, 1098 cm-1; Anal.
Calcd for C24H27F4NO6: C, 57.48; H, 5.43; N, 2.7
9. Found: C, 57.43; H, 5.71; N, 2.62.Example 308 4-[(1RS, 2SR) -2-[(tert-butoxycarbonyl) amino] -1-hydroxy-3- [3- (1,
Methyl 1,2,2-tetrafluoroethoxy) phenyl] propyl] benzoate 1) 3- [4- (methoxycarbonyl) phenyl] -3-
Benzyl oxopropionate 50.95 g of 4- (methoxycarbonyl) benzoic acid (2
52.8 g of 1,1'-carbonyldiimidazole was added to a solution of 82.8 mmol) in 400 ml of tetrahydrofuran.
(311 mmol) was added at room temperature, and the mixture was stirred as it was for 2 hours. 200 ml of dimethyl sulfoxide was added to this mixture,
Malonic acid monobenzyl ester monopotassium salt 78.8
g (339 mmol), magnesium chloride 16.2 g
(170 mmol) at room temperature and stirred at room temperature overnight. After diluting the reaction solution with ethyl acetate and water and acidifying the reaction solution with concentrated hydrochloric acid, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-2 / 1) to obtain the desired product. Light yellow solid Yield: 31.19 g Yield: 35% Recrystallization from ethyl acetate-diethyl ether-hexane gave pale yellow crystals. mp 74-75 ° C; 1 H-NMR (CDCl 3 , 2
00 MHz) δ 3.94 (1.2H, s), 3.96 (1.8H, s), 4.07
(1.2 Hz, s), 5.20 (1.2H, s), 5.27 (0.8H, s), 5.80
(0.4H, s), 7.22-7.43 (5H, m), 7.84 (0.8H, d, J = 8.8
Hz), 7.97 (1.2H, d, J = 8.4 Hz), 8.08 (0.8H, d, J
= 8.0 Hz), 8.12 (1.2H, d, J = 8.8 Hz); IR (KBr) 1
721, 1281, 1211, 1204, 1109, 818, 731 cm -1 ; Anal.
Calcd for C 18 H 16 O 5 : C, 69.22; H, 5.16. Found: C, 6
9.40; H, 5.24.2) 3- [4- (methoxycarbonyl) phenyl] -3-
Benzo oxo-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionate 48.4 g (233 mmol) of 3- (1,1,2,2-tetrafluoroethoxy) toluene, N -Bromosuccinimide (41.4 g, 233 mmol) and 2,2'-azobis (isobutyronitrile) 0.1 g
The mixture was heated under reflux in 0 ml for 0.5 hours. After cooling the reaction solution to room temperature, a white precipitate was removed by filtration, and the precipitate was washed with diethyl ether. The solvent of the collected filtrate was distilled off under reduced pressure,
A crude product of 3- (1,1,2,2-tetrafluoroethoxy) benzyl bromide was obtained as a pale yellow liquid. 3-
Liquid paraffin suspension 8 of 60% sodium hydride in a solution of 66.08 g (211.6 mmol) of benzyl [4- (methoxycarbonyl) phenyl] -3-oxopropionate in 200 ml of 1,2-dimethoxyethane 8 under ice-cooling .
89 g (222 mmol) was added, and the mixture was stirred as it was for 0.5 hour. To this was added a solution of 3- (1,1,2,2-tetrafluoroethoxy) benzyl bromide obtained above in 50 ml of 1,2-dimethoxyethane at room temperature, and the mixture was stirred at room temperature overnight. The reaction solution was poured into water and extracted twice with ethyl acetate.
The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 /
1-2 / 1) to obtain the desired product. Pale yellow liquid yield 98.
99 g Yield 90% 1 H-NMR (CDCl 3 , 300 MHz) δ 3.36 (2H, d, J = 7.2 H
z), 3.95 (3H, s), 4.63 (1H, t, J = 7.4 Hz), 5.03 (1
H, d, J = 16.8 Hz), 5.08 (1H, d, J = 15.9 Hz), 5.8
8 (1H, tt, J = 2.7 Hz, 53.1 Hz), 7.01-7.49 (9H,
m), 7.93 (2H, d, J = 8.4 Hz), 8.05 (2H, d, J = 8.1
Hz); IR (neat) 1728 , 1694, 1281, 1196,1119 cm -1 3) (2RS, 3RS) -3- hydroxy-3- [4-
(Methoxycarbonyl) phenyl] -2- [3- (1,
1,2,2-Tetrafluoroethoxy) benzyl] benzyl benzyl propionate While stirring 25.0 g (382 mmol) of zinc chloride in 250 ml of diethyl ether, 28.9 g (764 mmol) of sodium borohydride was added at room temperature, and the mixture was allowed to stand. Stir for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. The resulting solution was added to 3- [4- (methoxycarbonyl) phenyl] -3-oxo-2- [3- (1,
98.98 g (190.9 mmol) of benzyl 1,2,2-tetrafluoroethoxy) benzyl] propionate
Is added dropwise under ice-cooling to a 100 ml solution of diethyl ether.
The mixture was stirred for 1 hour. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-2 / 1) to obtain the desired product. Colorless liquid Yield 69.90 g Yield 70% 1 H-NMR (CDCl 3 , 300 MHz) δ 2.93-3.10 (4H, m), 3.92
(3H, s), 4.83 (1H, d, J = 12.3 Hz), 4.89 (1H, d, J
= 12.3 Hz), 5.11 (1H, t, J = 3.6 Hz), 5.87 (1H, t
t, J = 2.9 Hz, 53.2 Hz), 6.91-7.03 (5H, m), 7.16-
7.38 (4H, m), 7.44 (2H, d, J = 8.4 Hz), 7.99 (2H,
d, J = 8.4 Hz); IR (neat) 3480, 1723,1281, 1196, 1
119 cm -1 4) (4RS, 5SR) -5- [4- ( methoxycarbonyl) phenyl] -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine -
2-one (2RS, 3RS) -3-hydroxy-3- [4- (methoxycarbonyl) phenyl] -2- [3- (1,1,2,2-
A solution of 69.90 g (134.3 mmol) of benzyl tetrafluoroethoxy) benzyl] propionate in 200 ml of ethanol was hydrogenated overnight at room temperature and normal pressure using 5 g of 10% palladium / carbon (containing 50% water) as a catalyst. After removing the catalyst by filtration, washing with ethanol, the solvent of the collected filtrate was distilled off under reduced pressure to obtain crude (2RS, 3RS)
3-Hydroxy-3- [4- (methoxycarbonyl) phenyl] -2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionic acid was obtained as a colorless foam. The foam obtained above was dissolved in 150 ml of tetrahydrofuran, 22.5 ml (161 mmol) of triethylamine and 40.7 g of diphenylphosphoryl azide (148)
Mmol) and stirred at 70 ° C. overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate =
3 / 1-ethyl acetate), N, N-dimethylformamide-
Crystallization from diisopropyl ether gave the desired product. White powder Yield 40.33 g Yield 70% mp 155-158 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 2.17-2.34
(2H, m), 3.95 (3H, s), 4.25-4.36 (1H, m), 5.07 (1
H, br s), 5.87 (1H, d, J = 7.8 Hz), 5.89 (1H, tt,
J = 2.8 Hz, 53.0 Hz), 6.85 (1H, s), 6.94 (1H, d, J
= 7.8 Hz), 7.10 (1H, d, J = 8.4 Hz), 7.30 (1H, t,
J = 8.0 Hz), 7.46 (2H, d, J = 8.0 Hz), 8.11 (2H,
d, J = 8.4 Hz); IR (KBr) 3250, 1736, 1279, 1206, 1
113 cm -1 ; Anal.Calcd for C 20 H 17 F 4 NO 5・ 0.5DMF: C, 55.6
7; H, 4.45; N, 4.53.Found: C, 55.60; H, 4.18; N, 4.8
3.5) (4RS, 5SR) -5- [4- (methoxycarbonyl) phenyl] -2-oxo-4- [3- (1,1,2,2
Tert-Butyl 2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine-3-carboxylate (4RS, 5SR) -5- [4- (methoxycarbonyl)
20.04 g (46.89 mmol) of phenyl] -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidin-2-one, di-te dicarbonate
tert-butyl 12.3 g (56.3 mmol), 4-N,
A solution of 0.57 g (4.69 mmol) of N-dimethylaminopyridine in 150 ml of acetonitrile was stirred at room temperature overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-2 / 1), and crystallized from ethyl acetate-diisopropyl ether-hexane. The desired product was obtained. White crystals Yield 21.14 g Yield 86% mp 140-141 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.52 (9H,
s), 2.59 (1H, dd, J = 8.9 Hz, 14.3 Hz), 2.91 (1H,
dd, J = 4.2 Hz, 14.1 Hz), 3.93 (3H, s), 4.81-4.88
(1H, m), 5.73 (1H, d, J = 6.9 Hz), 5.85 (1H, tt, J
= 2.9 Hz, 53.1 Hz), 6.35 (1H, s), 6.62 (1H, d, J =
7.5 Hz), 6.95 (1H, d, J = 8.7 Hz), 7.06 (1H, t, J
= 8.0 Hz), 7.24 (2H, d, J = 8.1 Hz), 7.93 (2H, d,
J = 8.7Hz); IR (KBr) 1786, 1717, 1360, 1331, 1281,
1200, 1113, 1071 cm -1 ; Anal.Calcd for C 25 H 25 F 4 NO
7 : C, 56.93; H, 4.78; N, 2.66. Found: C, 57.05; H,
4.76; N, 2.71.6) 4-[(1RS, 2SR) -2-[(tert-butoxycarbonyl) amino] -1-hydroxy-3- [3-
Methyl (1,1,2,2-tetrafluoroethoxy) phenyl] propyl] benzoate (4RS, 5SR) -5- [4- (methoxycarbonyl)
Tert-butyl phenyl] -2-oxo-4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine-3-carboxylate 20.82 g (3
1.66 g of sodium hydroxide was added to a solution of 9.47 mmol) in 50 ml of methanol and 100 ml of tetrahydrofuran.
A solution of (41.4 mmol) in methanol (20 ml) was added under ice-cooling, and the mixture was stirred at room temperature for 10 minutes. The reaction solution was diluted with ethyl acetate, washed with water, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 16.05 g Yield 81% mp 148-150 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.36 (9H,
s), 2.73 (2H, d, J = 6.0 Hz), 3.45 (1H, br s), 3.9
3 (3H, s), 4.05-4.11 (1H, m), 4.61 (1H, brd, J =
8.4 Hz), 5.03 (1H, br s), 5.89 (1H, tt, J = 2.9 H
z, 53.1 Hz), 6.94 (1H, s), 7.00 (1H, d, J = 7.5 H
z), 7.05 (1H, dd, J = 1.4 Hz, 8.3 Hz), 7.26 (1H, t,
J = 8.0 Hz), 7.49 (2H, d, J = 8.1 Hz), 8.05 (2H,
d, J = 8.4Hz); IR (KBr) 3330, 3206, 1721, 1678, 15
51, 1300, 1283, 1202, 1175, 1113, 1098 cm -1 ; Anal.
Calcd for C 24 H 27 F 4 NO 6: C, 57.48; H, 5.43; N, 2.7
9.Found: C, 57.43; H, 5.71; N, 2.62.
【0441】実施例309 4-[(1RS,2SR)-2-[(6,7-ジヒドロ-5
H-ベンゾ[a]シクロヘプテン-1-イルカルボニル)
アミノ]-1-ヒドロキシ-3-[3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル]プロピル]安息香酸
メチル 1) 4-[(1RS,2SR)-2-アミノ-1-ヒドロ
キシ-3-[3-(1,1,2,2-テトラフルオロエトキ
シ)フェニル]プロピル]安息香酸メチル 4-[(1RS,2SR)-2-[(tert-ブトキシカ
ルボニル)アミノ]-1-ヒドロキシ-3-[3-(1,
1,2,2-テトラフルオロエトキシ)フェニル]プロ
ピル]安息香酸メチル15.72g(31.35ミリモ
ル)、濃塩酸10mlのメタノール150ml溶液を6
0℃で1時間撹拌した。反応液を減圧濃縮した後、水で
希釈し、炭酸カリウムでアルカリ性とし、酢酸エチルで
2回抽出した。集めた有機層を無水硫酸ナトリウムで乾
燥、溶媒を減圧留去した。残留物をジイソプロピルエー
テル-ヘキサンより結晶化して、目的物を得た。白色結
晶 収量12.27g 収率98% mp 100-101℃; 1H-NMR (CDCl3, 300 MHz) δ 2.37 (1H,
dd, J = 10.5 Hz, 13.8Hz), 2.72 (1H, dd, J = 3.2 H
z, 13.7 Hz), 3.34 (1H, ddd, J = 3.4 Hz, 4.3Hz, 10.
4 Hz), 3.93 (3H, s), 4.77 (1H, d, J = 4.5 Hz), 5.8
9 (1H, tt, J =2.8 Hz, 53.3 Hz), 6.97 (1H, s), 7.02
-7.09 (2H, m), 7.29 (1H, t, J = 7.8Hz), 7.48 (2H,
d, J = 8.1 Hz), 8.06 (2H, d, J = 8.4 Hz); IR (KBr)
3150-2850, 1725, 1281, 1198, 1111 cm-1; Anal. Cal
cd for C19H19F4NO4: C, 56.86; H, 4.77; N, 3.49. Fo
und: C, 56.68; H, 4.92; N, 3.26. 2) 4-[(1RS,2SR)-2-[(6,7-ジヒド
ロ-5H-ベンゾ[a]シクロヘプテン-1-イルカルボニ
ル)アミノ]-1-ヒドロキシ-3-[3-(1,1,2,
2-テトラフルオロエトキシ)フェニル]プロピル]安
息香酸メチル 4-[(1RS,2SR)-2-アミノ-1-ヒドロキシ-3
-[3-(1,1,2,2-テトラフルオロエトキシ)フ
ェニル]プロピル]安息香酸メチル10.80g(2
6.91ミリモル)、6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボン酸5.06g(2
6.9ミリモル)、1-ヒドロキシベンゾトリアゾール
水和物4.12g(26.9ミリモル)をアセトニトリ
ル10ml中で撹拌しながら1-エチル-3-(3-ジメチ
ルアミノプロピル)カルボジイミド・塩酸塩5.16g
(26.9ミリモル)を加え、室温で一晩撹拌した。反
応液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶液
で洗浄、無水硫酸マグネシウムで乾燥、シリカゲルを通
した後、溶媒を減圧留去した。得られた残留物をジイソ
プロピルエーテルより結晶化して、目的物を得た。白色
結晶 収量13.24g 収率86% mp 137-138℃; 1H-NMR (CDCl3, 300 MHz) δ 1.98-2.04
(2H, m), 2.16-2.22 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.80 (1H, dd, J = 10.8 Hz, 14.4 Hz), 2.95 (1
H, dd, J = 4.4 Hz, 14.6 Hz), 3.86 (1H, d, J = 4.2
Hz), 3.93 (3H, s), 4.66-4.72 (1H, m), 5.15 (1H, t,
J = 3.8 Hz), 5.79 (1H, d, J = 8.4 Hz),5.88 (1H, t
t, J = 2.9 Hz, 53.1 Hz), 5.92 (1H, td, J = 5.7 Hz,
11.4 Hz),6.23 (1H, d, J = 11.4 Hz), 6.97-7.11 (5
H, m), 7.16 (1H, dd, J = 1.1 Hz,7.4 Hz), 7.29 (1H,
t, J = 8.0 Hz), 7.55 (2H, d, J = 8.4 Hz), 8.06 (2
H,d, J = 8.1 Hz); IR (KBr) 3256, 2934, 1719, 1636,
1528, 1439, 1285, 1194,1115, 775 cm-1; Anal. Calc
d for C31H29F4NO5: C, 65.14; H, 5.11; N, 2.45. Fou
nd: C, 64.98; H, 5.39; N, 2.35.Example 309 4-[(1RS, 2SR) -2-[(6,7-dihydro-5
H-benzo [a] cyclohepten-1-ylcarbonyl)
Amino] -1-hydroxy-3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propyl] methyl benzoate 1) 4-[(1RS, 2SR) -2-amino-1-hydroxy Methyl-3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propyl] benzoate 4-[(1RS, 2SR) -2-[(tert-butoxycarbonyl) amino] -1-hydroxy -3- [3- (1,
A solution of 15.72 g (31.35 mmol) of methyl 1,2,2-tetrafluoroethoxy) phenyl] propyl] benzoate and 10 ml of concentrated hydrochloric acid in 150 ml of methanol was prepared.
Stirred at 0 ° C. for 1 hour. The reaction solution was concentrated under reduced pressure, diluted with water, made alkaline with potassium carbonate, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 12.27 g Yield 98% mp 100-101 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 2.37 (1H,
dd, J = 10.5 Hz, 13.8Hz), 2.72 (1H, dd, J = 3.2 H
z, 13.7 Hz), 3.34 (1H, ddd, J = 3.4 Hz, 4.3Hz, 10.
4 Hz), 3.93 (3H, s), 4.77 (1H, d, J = 4.5 Hz), 5.8
9 (1H, tt, J = 2.8 Hz, 53.3 Hz), 6.97 (1H, s), 7.02
-7.09 (2H, m), 7.29 (1H, t, J = 7.8Hz), 7.48 (2H,
d, J = 8.1 Hz), 8.06 (2H, d, J = 8.4 Hz); IR (KBr)
3150-2850, 1725, 1281, 1198, 1111 cm -1 ; Anal.
cd for C 19 H 19 F 4 NO 4 : C, 56.86; H, 4.77; N, 3.49. Fo
und: C, 56.68; H, 4.92; N, 3.26.2) 4-[(1RS, 2SR) -2-[(6,7-dihydro-5H-benzo [a] cyclohepten-1-ylcarbonyl) amino] -1-Hydroxy-3- [3- (1,1,2,2
Methyl 2-tetrafluoroethoxy) phenyl] propyl] benzoate 4-[(1RS, 2SR) -2-amino-1-hydroxy-3
Methyl-[3- (1,1,2,2-tetrafluoroethoxy) phenyl] propyl] benzoate (10.80 g (2
6.91 mmol), 5.06 g of 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (2
4.12 g (26.9 mmol) of 1-hydroxybenzotriazole hydrate in 10 ml of acetonitrile while stirring 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride. 16g
(26.9 mmol) was added and stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether to obtain the desired product. White crystals Yield 13.24 g Yield 86% mp 137-138 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.98-2.04
(2H, m), 2.16-2.22 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.80 (1H, dd, J = 10.8 Hz, 14.4 Hz), 2.95 (1
H, dd, J = 4.4 Hz, 14.6 Hz), 3.86 (1H, d, J = 4.2
Hz), 3.93 (3H, s), 4.66-4.72 (1H, m), 5.15 (1H, t,
J = 3.8 Hz), 5.79 (1H, d, J = 8.4 Hz), 5.88 (1H, t
t, J = 2.9 Hz, 53.1 Hz), 5.92 (1H, td, J = 5.7 Hz,
11.4 Hz), 6.23 (1H, d, J = 11.4 Hz), 6.97-7.11 (5
H, m), 7.16 (1H, dd, J = 1.1 Hz, 7.4 Hz), 7.29 (1H,
t, J = 8.0 Hz), 7.55 (2H, d, J = 8.4 Hz), 8.06 (2
H, d, J = 8.1 Hz); IR (KBr) 3256, 2934, 1719, 1636,
1528, 1439, 1285, 1194,1115, 775 cm -1 ; Anal.Calc
d for C 31 H 29 F 4 NO 5 : C, 65.14; H, 5.11; N, 2.45. Fou
nd: C, 64.98; H, 5.39; N, 2.35.
【0442】実施例310 4-[(1RS,2SR)-2-[(6,7-ジヒドロ-5
H-ベンゾ[a]シクロヘプテン-1-イルカルボニル)
アミノ]-1-ヒドロキシ-3-[3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル]プロピル]安息香酸 4-[(1RS,2SR)-2-[(6,7-ジヒドロ-5
H-ベンゾ[a]シクロヘプテン-1-イルカルボニル)
アミノ]-1-ヒドロキシ-3-[3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル]プロピル]安息香酸
メチル12.93g(22.62ミリモル)のメタノー
ル40ml-テトラヒドロフラン50ml溶液に1規定
水酸化ナトリウム水溶液67.9ml(67.9ミリモ
ル)を加え、室温で一晩撹拌した。反応液を濃縮、水で
希釈し、希塩酸で反応液を酸性にした後、酢酸エチルで
2回抽出した。集めた有機層を無水硫酸ナトリウムで乾
燥、溶媒を減圧留去した。得られた固体を酢酸エチル-
ジイソプロピルエーテルで洗浄して、目的物を得た。白
色粉末 収量10.52g 収率83% mp 210-211℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
1.92-2.00 (2H, m), 2.18-2.26 (2H, m), 2.65-2.69 (2
H, m), 2.82-2.93 (2H, m), 4.64-4.74 (1H, m),5.03
(1H, d, J = 3.6 Hz), 5.31 (1H, br s), 5.85 (1H, t
d, J = 5.3 Hz, 11.8 Hz), 5.98 (1H, tt, J = 3.0 Hz,
53.1 Hz), 6.14 (1H, d, J = 11.7 Hz), 6.89 (1H, d
d, J = 1.5 Hz, 7.8 Hz), 7.01-7.13 (5H, m), 7.26 (1
H, t, J = 8.1Hz), 7.61 (2H, d, J = 8.4 Hz), 8.05
(2H, d, J = 8.1 Hz); IR (KBr) 3268,3020-2860, 168
6, 1640, 1279, 1202, 1123 cm-1; Anal. Calcd for C
30H27F4NO5: C, 64.63; H, 4.88; N, 2.51. Found: C,
64.50; H, 4.80; N, 2.39.Example 310 4-[(1RS, 2SR) -2-[(6,7-dihydro-5
H-benzo [a] cyclohepten-1-ylcarbonyl)
Amino] -1-hydroxy-3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propyl] benzoic acid 4-[(1RS, 2SR) -2-[(6,7-dihydro- 5
H-benzo [a] cyclohepten-1-ylcarbonyl)
A solution of 12.93 g (22.62 mmol) of methyl [amino] -1-hydroxy-3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propyl] benzoate in a solution of 40 ml of methanol and 50 ml of tetrahydrofuran was added. 67.9 ml (67.9 mmol) of a normal aqueous sodium hydroxide solution was added, and the mixture was stirred overnight at room temperature. The reaction solution was concentrated, diluted with water, acidified with dilute hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained solid is ethyl acetate-
The desired product was obtained by washing with diisopropyl ether. White powder Yield 10.52 g Yield 83% mp 210-211 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
1.92-2.00 (2H, m), 2.18-2.26 (2H, m), 2.65-2.69 (2
H, m), 2.82-2.93 (2H, m), 4.64-4.74 (1H, m), 5.03
(1H, d, J = 3.6 Hz), 5.31 (1H, br s), 5.85 (1H, t
d, J = 5.3 Hz, 11.8 Hz), 5.98 (1H, tt, J = 3.0 Hz,
53.1 Hz), 6.14 (1H, d, J = 11.7 Hz), 6.89 (1H, d
d, J = 1.5 Hz, 7.8 Hz), 7.01-7.13 (5H, m), 7.26 (1
H, t, J = 8.1Hz), 7.61 (2H, d, J = 8.4 Hz), 8.05
(2H, d, J = 8.1 Hz); IR (KBr) 3268,3020-2860, 168
6, 1640, 1279, 1202, 1123 cm -1 ; Anal.Calcd for C
30 H 27 F 4 NO 5 : C, 64.63; H, 4.88; N, 2.51. Found: C,
64.50; H, 4.80; N, 2.39.
【0443】実施例311 N-[(1RS,2SR)-2-[4-(アミノカルボニ
ル)フェニル]-2-ヒドロキシ-1-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]エチル]-
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボキサミド 4-[(1RS,2SR)-2-[(6,7-ジヒドロ-5
H-ベンゾ[a]シクロヘプテン-1-イルカルボニル)
アミノ]-1-ヒドロキシ-3-[3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル]プロピル]安息香酸
0.284g(0.509ミリモル)、1-ヒドロキシ
ベンゾトリアゾール水和物86mg(0.56ミリモ
ル)をアセトニトリル10ml-N,N-ジメチルホルム
アミド2ml中で撹拌しながら1-エチル-3-(3-ジメ
チルアミノプロピル)カルボジイミド・塩酸塩0.11
g(0.56ミリモル)を加え、室温で0.5時間撹拌
した。これに塩化アンモニウム54mg(1.02ミリ
モル)、トリエチルアミン0.21ml(1.53ミリ
モル)を加え、室温で1時間撹拌した。反応液に炭酸水
素ナトリウム水溶液を加え、室温で0.5時間撹拌し
た。生じた沈殿を集め、水およびジイソプロピルエーテ
ル-ヘキサンで洗浄して、目的物を得た。白色粉末 収
量0.227g 収率80% mp 197-199℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
1.91-1.99 (2H, m), 2.20-2.25 (2H, m), 2.67 (2H, t,
J = 5.6 Hz), 2.81-2.95 (2H, m), 4.64-4.73 (1H,
m), 5.01 (1H, d, J = 4.2 Hz), 5.35 (1H, br s), 5.8
4 (1H, td, J = 5.1Hz, 11.7 Hz), 6.00 (1H, tt, J =
2.9 Hz, 53.0 Hz), 6.11 (1H, d, J = 12.0Hz), 6.29
(1H, br s), 6.87 (1H, dd, J = 1.5 Hz, 7.5 Hz), 7.0
0-7.14 (5H,m), 7.22-7.29 (2H, m), 7.61 (2H, d, J =
8.1 Hz), 7.91 (2H, d, J = 8.4 Hz); IR (KBr) 3310,
1636, 1615, 1524, 1206, 1121, 777 cm-1; Anal. Cal
cd for C30H28F4N2O4・0.5H2O: C, 63.71; H, 5.17; N,
4.95. Found: C, 63.68; H, 5.30; N, 4.88.Example 311 N-[(1RS, 2SR) -2- [4- (aminocarbonyl) phenyl] -2-hydroxy-1- [3- (1,1,
2,2-tetrafluoroethoxy) benzyl] ethyl]-
6,7-dihydro-5H-benzo [a] cycloheptene-1
-Carboxamide 4-[(1RS, 2SR) -2-[(6,7-dihydro-5
H-benzo [a] cyclohepten-1-ylcarbonyl)
Amino] -1-hydroxy-3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propyl] benzoic acid 0.284 g (0.509 mmol), 1-hydroxybenzotriazole hydrate 86 mg (0.56 mmol) was stirred in 10 ml of acetonitrile-2 ml of N, N-dimethylformamide while stirring 0.11 of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride.
g (0.56 mmol) was added and the mixture was stirred at room temperature for 0.5 hour. 54 mg (1.02 mmol) of ammonium chloride and 0.21 ml (1.53 mmol) of triethylamine were added thereto, and the mixture was stirred at room temperature for 1 hour. An aqueous solution of sodium hydrogen carbonate was added to the reaction solution, and the mixture was stirred at room temperature for 0.5 hour. The resulting precipitate was collected and washed with water and diisopropyl ether-hexane to obtain the desired product. White powder Yield 0.227 g Yield 80% mp 197-199 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
1.91-1.99 (2H, m), 2.20-2.25 (2H, m), 2.67 (2H, t,
J = 5.6 Hz), 2.81-2.95 (2H, m), 4.64-4.73 (1H,
m), 5.01 (1H, d, J = 4.2 Hz), 5.35 (1H, br s), 5.8
4 (1H, td, J = 5.1Hz, 11.7 Hz), 6.00 (1H, tt, J =
2.9 Hz, 53.0 Hz), 6.11 (1H, d, J = 12.0Hz), 6.29
(1H, br s), 6.87 (1H, dd, J = 1.5 Hz, 7.5 Hz), 7.0
0-7.14 (5H, m), 7.22-7.29 (2H, m), 7.61 (2H, d, J =
8.1 Hz), 7.91 (2H, d, J = 8.4 Hz); IR (KBr) 3310,
1636, 1615, 1524, 1206, 1121, 777 cm -1 ; Anal.
cd for C 30 H 28 F 4 N 2 O 4・ 0.5H 2 O: C, 63.71; H, 5.17; N,
4.95. Found: C, 63.68; H, 5.30; N, 4.88.
【0444】実施例312 N-[(1RS,2SR)-2-[4-[(ジメチルアミ
ノ)カルボニル]フェニル]-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド アミンとしてジメチルアミン・塩酸塩を用い、実施例3
11と同様にして、目的物0.244g(82%)を白
色粉末として得た。 mp 165-166℃; 1H-NMR (CDCl3, 300 MHz) δ 1.96-2.05
(2H, m), 2.16-2.22 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.75 (1H, dd, J = 10.8 Hz, 14.7 Hz), 2.93 (1
H, dd, J = 3.9 Hz, 15.6 Hz), 2.97 (3H, s), 3.11 (3
H, s), 4.41 (1H,d, J = 4.2 Hz), 4.67-4.74 (1H, m),
5.03 (1H, t, J = 3.8 Hz), 5.86 (1H, d, J = 8.4 H
z), 5.89 (1H, tt, J = 2.7 Hz, 53.1 Hz), 5.94 (1H,
td, J = 5.6Hz, 11.3 Hz), 6.26 (1H, d, J = 12.0 H
z), 6.99-7.17 (6H, m), 7.29 (1H, t, J = 8.1 Hz),
7.38 (2H, d, J = 8.1 Hz), 7.45 (2H, d, J = 8.1 H
z); IR (KBr) 3326, 2942, 1638, 1620, 1518, 1194, 1
115 cm-1; Anal. Calcd for C32H3 2F4N2O4: C, 65.74;
H, 5.52; N, 4.79. Found: C, 65.58; H, 5.63; N, 4.8
1.Example 312 N-[(1RS, 2SR) -2- [4-[(dimethylamino) carbonyl] phenyl] -2-hydroxy-1- [3-
Example 3 using dimethylamine hydrochloride as (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide amine
In the same manner as in Example 11, 0.244 g (82%) of the target product was obtained as a white powder. mp 165-166 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.96-2.05
(2H, m), 2.16-2.22 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.75 (1H, dd, J = 10.8 Hz, 14.7 Hz), 2.93 (1
H, dd, J = 3.9 Hz, 15.6 Hz), 2.97 (3H, s), 3.11 (3
H, s), 4.41 (1H, d, J = 4.2 Hz), 4.67-4.74 (1H, m),
5.03 (1H, t, J = 3.8 Hz), 5.86 (1H, d, J = 8.4 H
z), 5.89 (1H, tt, J = 2.7 Hz, 53.1 Hz), 5.94 (1H,
td, J = 5.6Hz, 11.3 Hz), 6.26 (1H, d, J = 12.0 H
z), 6.99-7.17 (6H, m), 7.29 (1H, t, J = 8.1 Hz),
7.38 (2H, d, J = 8.1 Hz), 7.45 (2H, d, J = 8.1 H)
z); IR (KBr) 3326, 2942, 1638, 1620, 1518, 1194, 1
115 cm -1 ; Anal.Calcd for C 32 H 3 2 F 4 N 2 O 4 : C, 65.74;
H, 5.52; N, 4.79.Found: C, 65.58; H, 5.63; N, 4.8
1.
【0445】実施例313 N-[(1RS,2SR)-2-ヒドロキシ-2-[4-(ピ
ペリジノカルボニル)フェニル]-1-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]エチル]-
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボキサミドアミンとしてピペリジンを用い、実施
例311と同様にして、目的物0.275g(86%)
を白色結晶として得た。 mp 176-177℃; 1H-NMR (CDCl3, 300 MHz) δ 1.51 (2H,
br s), 1.68 (4H, br s), 1.96-2.04 (2H, m), 2.16-
2.22 (2H, m), 2.66 (2H, t, J = 5.9 Hz), 2.75(1H, d
d, J = 10.7 Hz, 14.6 Hz), 2.95 (1H, dd, J = 3.9 H
z, 14.7 Hz), 3.32(2H, br s), 3.70 (2H, br s), 4.36
(1H, d, J = 3.6 Hz), 4.67-4.75 (1H, m), 5.03 (1H,
t, J = 3.8 Hz), 5.82 (1H, d, J = 8.1 Hz), 5.89 (1
H, tt, J =2.9 Hz, 53.2 Hz), 5.94 (1H, td, J = 5.7
Hz, 11.3 Hz), 6.25 (1H, d, J =11.7 Hz), 6.99-7.17
(6H, m), 7.29 (1H, t, J = 7.8 Hz), 7.36 (2H, d, J
=8.1 Hz), 7.45 (2H, d, J = 8.1 Hz); IR (KBr) 3430,
3328, 2940, 2863, 1640, 1516, 1437, 1277, 1209, 1
123, 768 cm-1; Anal. Calcd for C35H36F4N2O4:C, 67.
30; H, 5.81; N, 4.48. Found: C, 67.20; H, 5.78; N,
4.47.Example 313 N-[(1RS, 2SR) -2-hydroxy-2- [4- (piperidinocarbonyl) phenyl] -1- [3- (1,1,
2,2-tetrafluoroethoxy) benzyl] ethyl]-
6,7-dihydro-5H-benzo [a] cycloheptene-1
-In the same manner as in Example 311, using piperidine as the carboxamidoamine, 0.275 g (86%) of the desired product
Was obtained as white crystals. mp 176-177 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.51 (2H,
br s), 1.68 (4H, br s), 1.96-2.04 (2H, m), 2.16-
2.22 (2H, m), 2.66 (2H, t, J = 5.9 Hz), 2.75 (1H, d
d, J = 10.7 Hz, 14.6 Hz), 2.95 (1H, dd, J = 3.9 H
z, 14.7 Hz), 3.32 (2H, br s), 3.70 (2H, br s), 4.36
(1H, d, J = 3.6 Hz), 4.67-4.75 (1H, m), 5.03 (1H,
t, J = 3.8 Hz), 5.82 (1H, d, J = 8.1 Hz), 5.89 (1
H, tt, J = 2.9 Hz, 53.2 Hz), 5.94 (1H, td, J = 5.7
Hz, 11.3 Hz), 6.25 (1H, d, J = 11.7 Hz), 6.99-7.17
(6H, m), 7.29 (1H, t, J = 7.8 Hz), 7.36 (2H, d, J
= 8.1 Hz), 7.45 (2H, d, J = 8.1 Hz); IR (KBr) 3430,
3328, 2940, 2863, 1640, 1516, 1437, 1277, 1209, 1
123, 768 cm -1 ; Anal.Calcd for C 35 H 36 F 4 N 2 O 4 : C, 67.
30; H, 5.81; N, 4.48. Found: C, 67.20; H, 5.78; N,
4.47.
【0446】実施例314 N-[(1RS,2SR)-2-[4-(アニリノカルボニ
ル)フェニル]-2-ヒドロキシ-1-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]エチル]-
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボキサミド アミンとしてアニリンを用い、実施例311と同様にし
て、目的物0.275g(85%)を白色粉末として得
た。 mp 205-206℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
1.94-2.00 (2H, m), 2.19-2.25 (2H, m), 2.67 (2H, t,
J = 5.4 Hz), 2.88 (2H, d, J = 7.5 Hz), 4.68-4.76
(1H, m), 5.06 (1H, t, J = 3.5 Hz), 5.25 (1H, d, J
= 3.6 Hz), 5.88 (1H, td, J = 5.6 Hz, 11.4 Hz), 5.9
5 (1H, tt, J = 2.9 Hz, 53.0 Hz), 6.17 (1H, d, J =
11.4 Hz), 6.92 (1H, dd, J = 1.1 Hz, 7.4 Hz), 7.01-
7.13 (7H, m), 7.27 (1H, t, J = 8.3 Hz), 7.35 (2H,
t, J = 7.8 Hz), 7.64 (2H, d, J =8.4 Hz), 7.76 (2H,
d, J = 7.8 Hz), 7.99 (2H, d, J = 8.4 Hz), 9.31 (1
H, s); IR (KBr) 3297, 2938, 1647, 1532, 1507, 144
3, 1323, 1200, 1121, 752, 694 cm-1; Anal. Calcd fo
r C36H32F4N2O4: C, 68.35; H, 5.10; N, 4.43. Found:
C, 68.10; H, 5.07; N, 4.42.Example 314 N-[(1RS, 2SR) -2- [4- (anilinocarbonyl) phenyl] -2-hydroxy-1- [3- (1,1,1
2,2-tetrafluoroethoxy) benzyl] ethyl]-
6,7-dihydro-5H-benzo [a] cycloheptene-1
-Carboxamide Using aniline as the amine, 0.275 g (85%) of the desired product was obtained as a white powder in the same manner as in Example 311. mp 205-206 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
1.94-2.00 (2H, m), 2.19-2.25 (2H, m), 2.67 (2H, t,
J = 5.4 Hz), 2.88 (2H, d, J = 7.5 Hz), 4.68-4.76
(1H, m), 5.06 (1H, t, J = 3.5 Hz), 5.25 (1H, d, J
= 3.6 Hz), 5.88 (1H, td, J = 5.6 Hz, 11.4 Hz), 5.9
5 (1H, tt, J = 2.9 Hz, 53.0 Hz), 6.17 (1H, d, J =
11.4 Hz), 6.92 (1H, dd, J = 1.1 Hz, 7.4 Hz), 7.01-
7.13 (7H, m), 7.27 (1H, t, J = 8.3 Hz), 7.35 (2H,
t, J = 7.8 Hz), 7.64 (2H, d, J = 8.4 Hz), 7.76 (2H,
d, J = 7.8 Hz), 7.99 (2H, d, J = 8.4 Hz), 9.31 (1
H, s); IR (KBr) 3297, 2938, 1647, 1532, 1507, 144
3, 1323, 1200, 1121, 752, 694 cm -1 ; Anal.Calcd fo
r C 36 H 32 F 4 N 2 O 4 : C, 68.35; H, 5.10; N, 4.43. Found:
C, 68.10; H, 5.07; N, 4.42.
【0447】実施例315 N-[(1RS,2SR)-2-ヒドロキシ-2-[4-
[(イソプロピルアミノ)カルボニル]フェニル]-1-
[3-(1,1,2,2-テトラフルオロエトキシ)ベン
ジル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シ
クロヘプテン-1-カルボキサミド アミンとしてイソプロピルアミンを用い、実施例311
と同様にして、目的物0.258g(84%)を白色粉
末として得た。 mp 215-217℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
1.27 (6H, d, J = 6.6 Hz), 1.93-2.02 (2H, m), 2.19-
2.25 (2H, m), 2.67 (2H, t, J = 5.1 Hz), 2.85(2H,
d, J = 7.5 Hz), 4.25-4.32 (1H, m), 4.67-4.75 (1H,
m), 5.06 (2H, s),5.88 (1H, td, J = 5.7 Hz, 11.4 H
z), 5.92 (1H, tt, J = 3.0 Hz, 53.0 Hz),6.18 (1H,
d, J = 12.0 Hz), 6.46 (1H, d, J = 7.8 Hz), 6.80 (1
H, d, J = 9.0 Hz), 6.94 (1H, dd, J = 1.2 Hz, 7.5 H
z), 7.01-7.14 (5H, m), 7.26 (1H,t, J = 7.8 Hz), 7.
58 (2H, d, J = 8.4 Hz), 7.80 (2H, d, J = 8.4 Hz);
IR (KBr) 3295, 2971, 2930, 1638, 1537, 1213, 1123
cm-1; Anal. Calcd for C33H 34F4N2O4: C, 66.21; H,
5.72; N, 4.68. Found: C, 66.00; H, 5.50; N, 4.65.Example 315 N-[(1RS, 2SR) -2-hydroxy-2- [4-
[(Isopropylamino) carbonyl] phenyl] -1-
[3- (1,1,2,2-tetrafluoroethoxy) benne
[Zyl] ethyl] -6,7-dihydro-5H-benzo [a] si
Example 311 Using isopropylamine as cloheptene-1-carboxamide amine
0.258 g (84%) of the target product was obtained as white powder
I got it at the end. mp 215-217 ° C;1H-NMR (CDClThree-DMSO-d6, 300 MHz) δ
1.27 (6H, d, J = 6.6 Hz), 1.93-2.02 (2H, m), 2.19-
2.25 (2H, m), 2.67 (2H, t, J = 5.1 Hz), 2.85 (2H, m
d, J = 7.5 Hz), 4.25-4.32 (1H, m), 4.67-4.75 (1H,
m), 5.06 (2H, s), 5.88 (1H, td, J = 5.7 Hz, 11.4 H
z), 5.92 (1H, tt, J = 3.0 Hz, 53.0 Hz), 6.18 (1H,
d, J = 12.0 Hz), 6.46 (1H, d, J = 7.8 Hz), 6.80 (1
H, d, J = 9.0 Hz), 6.94 (1H, dd, J = 1.2 Hz, 7.5 H
z), 7.01-7.14 (5H, m), 7.26 (1H, t, J = 7.8 Hz), 7.
58 (2H, d, J = 8.4 Hz), 7.80 (2H, d, J = 8.4 Hz);
IR (KBr) 3295, 2971, 2930, 1638, 1537, 1213, 1123
cm-1; Anal. Calcd for C33H 34FFourNTwoOFour: C, 66.21; H,
5.72; N, 4.68. Found: C, 66.00; H, 5.50; N, 4.65.
【0448】実施例316 N-[(1RS,2SR)-2-[4-[(ベンジルアミ
ノ)カルボニル]フェニル]-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド アミンとしてベンジルアミンを用い、実施例311と同
様にして、目的物0.297g(90%)を白色粉末と
して得た。 mp 216-217℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
1.91-1.99 (2H, m), 2.19-2.24 (2H, m), 2.67 (2H, t,
J = 5.9 Hz), 2.86-2.89 (2H, m), 4.62 (2H, d,J =
6.0 Hz), 4.65-4.71 (1H, m), 5.01 (1H, t, J = 3.8 H
z), 5.30 (1H, d,J = 3.3 Hz), 5.84 (1H, td, J = 5.5
Hz, 11.3 Hz), 5.99 (1H, tt, J = 2.8 Hz, 52.9 Hz),
6.11 (1H, d, J = 12.0 Hz), 6.88 (1H, dd, J = 1.2
Hz, 7.5 Hz), 7.00-7.05 (3H, m), 7.11 (2H, d, J =
9.9 Hz), 7.17-7.39 (7H, m), 7.60(2H, d, J = 8.1 H
z), 7.93 (2H, d, J = 8.1 Hz), 8.05 (1H, t, J = 5.6
Hz);IR (KBr) 3297, 2932, 1638, 1615, 1537, 1200,
1130, 698 cm-1; Anal. Calcd for C37H34F4N2O4: C, 6
8.72; H, 5.30; N, 4.33. Found: C, 68.59; H, 5.06;
N, 4.22.Example 316 N-[(1RS, 2SR) -2- [4-[(benzylamino) carbonyl] phenyl] -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide Using benzylamine as the amine, in the same manner as in Example 311, 0.297 g (90%) of the desired product was obtained as a white powder. mp 216-217 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
1.91-1.99 (2H, m), 2.19-2.24 (2H, m), 2.67 (2H, t,
J = 5.9 Hz), 2.86-2.89 (2H, m), 4.62 (2H, d, J =
6.0 Hz), 4.65-4.71 (1H, m), 5.01 (1H, t, J = 3.8 H
z), 5.30 (1H, d, J = 3.3 Hz), 5.84 (1H, td, J = 5.5
Hz, 11.3 Hz), 5.99 (1H, tt, J = 2.8 Hz, 52.9 Hz),
6.11 (1H, d, J = 12.0 Hz), 6.88 (1H, dd, J = 1.2
Hz, 7.5 Hz), 7.00-7.05 (3H, m), 7.11 (2H, d, J =
9.9 Hz), 7.17-7.39 (7H, m), 7.60 (2H, d, J = 8.1 H
z), 7.93 (2H, d, J = 8.1 Hz), 8.05 (1H, t, J = 5.6
Hz); IR (KBr) 3297, 2932, 1638, 1615, 1537, 1200,
1130, 698 cm -1 ; Anal.Calcd for C 37 H 34 F 4 N 2 O 4 : C, 6
8.72; H, 5.30; N, 4.33. Found: C, 68.59; H, 5.06;
N, 4.22.
【0449】実施例317 N-[(1RS,2SR)-2-[4-[(ブチルアミノ)
カルボニル]フェニル]-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド アミンとしてブチルアミンを用い、実施例311と同様
にして、目的物0.284g(91%)を白色粉末とし
て得た。 mp 207-208℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
0.96 (3H, t, J = 7.4 Hz), 1.35-1.48 (2H, m), 1.56-
1.66 (2H, m), 1.94-2.01 (2H, m), 2.20-2.26 (2H,
m), 2.68 (2H, t, J = 6.0 Hz), 2.87 (2H, d, J = 8.4
Hz), 3.42 (2H, q,J = 6.7 Hz), 4.64-4.72 (1H, m),
5.03 (1H, t, J = 3.8 Hz), 5.23 (1H, d, J= 3.6 Hz),
5.86 (1H, td, J = 5.2 Hz, 12.1 Hz), 5.97 (1H, tt,
J = 2.9 Hz, 53.0 Hz), 6.14 (1H, d, J = 11.7 Hz),
6.90 (1H, dd, J = 1.2 Hz, 7.5 Hz), 7.01-7.17 (7H,
m), 7.26 (1H, t, J = 8.3 Hz), 7.59 (2H, d, J = 7.8
Hz),7.84 (2H, d, J = 8.4 Hz); IR (KBr) 3308, 293
4, 1640, 1612, 1537, 1201,1128, 696 cm-1; Anal. Ca
lcd for C34H36F4N2O4: C, 66.66; H, 5.92; N, 4.57.
Found: C, 66.44; H, 5.88; N, 4.40.Example 317 N-[(1RS, 2SR) -2- [4-[(butylamino)
Carbonyl] phenyl] -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide Using butylamine as the amine, the same procedure as in Example 311 was carried out. 0.284 g (91%) of the product as a white powder. mp 207-208 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
0.96 (3H, t, J = 7.4 Hz), 1.35-1.48 (2H, m), 1.56-
1.66 (2H, m), 1.94-2.01 (2H, m), 2.20-2.26 (2H, m
m), 2.68 (2H, t, J = 6.0 Hz), 2.87 (2H, d, J = 8.4
Hz), 3.42 (2H, q, J = 6.7 Hz), 4.64-4.72 (1H, m),
5.03 (1H, t, J = 3.8 Hz), 5.23 (1H, d, J = 3.6 Hz),
5.86 (1H, td, J = 5.2 Hz, 12.1 Hz), 5.97 (1H, tt,
J = 2.9 Hz, 53.0 Hz), 6.14 (1H, d, J = 11.7 Hz),
6.90 (1H, dd, J = 1.2 Hz, 7.5 Hz), 7.01-7.17 (7H,
m), 7.26 (1H, t, J = 8.3 Hz), 7.59 (2H, d, J = 7.8
Hz), 7.84 (2H, d, J = 8.4 Hz); IR (KBr) 3308, 293
4, 1640, 1612, 1537, 1201,1128, 696 cm -1 ; Anal.Ca
lcd for C 34 H 36 F 4 N 2 O 4 : C, 66.66; H, 5.92; N, 4.57.
Found: C, 66.44; H, 5.88; N, 4.40.
【0450】実施例318 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-4-メチル-6,7-
ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボ
キサミド 1) (E)-5-(2-メチルフェニル)-3-オキソ-4
-ペンテン酸エチル 2-メチル桂皮酸50.71g(312.7ミリモル)
のテトラヒドロフラン500ml溶液に1,1’-カル
ボニルジイミダゾール55.8g(344ミリモル)を
室温で加え、そのまま1時間撹拌した。この混合物にマ
ロン酸モノエチルエステルモノカリウム塩58.5g
(344ミリモル)および塩化マグネシウム16.4g
(172ミリモル)を室温で加え、60℃で一晩撹拌し
た。反応液を酢酸エチルと水で希釈し、濃塩酸で反応液
を酸性にした後、酢酸エチル層を分離し、水層を酢酸エ
チルで抽出した。集めた有機層を無水硫酸ナトリウムで
乾燥、溶媒を減圧留去した。得られた粗生成物をシリカ
ゲルカラムクロマトグラフィーにて精製して(ヘキサン
/酢酸エチル=9/1-6/1)、目的物を得た。黄色
液体 収量37.24g 収率51%1 H-NMR (CDCl3, 200 MHz) δ 1.29 (1.2H, t, J = 7.1
Hz), 1.32 (1.8H, t, J= 7.1 Hz), 2.43 (1.8H, s), 2.
45 (1.2H, s), 3.70 (0.8H, s), 4.23 (0.8H, q, J =
7.2 Hz), 4.24 (1.2H, q, J = 7.1 Hz), 5.17 (0.6H,
s), 6.36 (0.6H, dd, J = 1.4 Hz, 15.8 Hz), 6.74 (0.
4H, d, J = 15.8 Hz), 7.15-7.35 (3H, m),7.52-7.61
(1H, m), 7.70 (0.6H, d, J = 15.8 Hz), 7.93 (0.4H,
d, J = 16.2Hz); IR (neat) 2980, 1740, 1636, 1595,
1420, 1236, 1148, 1038, 754 cm-1 2) 5-(2-メチルフェニル)ペンタン酸エチル (E)-5-(2-メチルフェニル)-3-オキソ-4-ペン
テン酸エチル37.24g(160.3ミリモル)のエ
タノール100ml溶液に、氷冷下、水素化ほう素ナト
リウム3.03g(80.2ミリモル)を少しずつ加え
た後、そのまま10分間撹拌した。反応液を水で希釈
し、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸ナトリウムで乾燥、溶媒を減圧留去して、(E)-3-
ヒドロキシ-5-(2-メチルフェニル)ペンタ-4-エン
酸エチルの粗生成物を黄色液体として得た。上で得た液
体とトリエチルアミン33.5ml(240ミリモル)
の酢酸エチル180ml溶液に氷冷下、メタンスルホニ
ルクロリド22.0g(192ミリモル)を氷冷下滴下
し、そのまま15分間撹拌した。生じた沈殿(トリエチ
ルアミン塩酸塩)を濾過して除き、沈殿を酢酸エチルで
洗浄した。集めた酢酸エチル溶液を、減圧下濃縮した。
得られた残渣をテトラヒドロフラン200mlに溶か
し、1,8-ジアザビシクロ[5.4.0]-7-ウンデ
セン28.8ml(192ミリモル)を加え、室温で
0.5時間撹拌した。反応液を水に注ぎ、酢酸エチルで
2回抽出した。集めた有機層を無水硫酸マグネシウムで
乾燥、溶媒を減圧留去した。得られた粗生成物をシリカ
ゲルカラムクロマトグラフィーにて精製し(ヘキサン/
酢酸エチル=15/1-9/1)、5-(2-メチルフェ
ニル)ペンタ-2,4-ジエン酸エチル((2E,4E)
体と(2Z,4E)体の混合物)を黄色液体として得
た。上で得た液体のエタノール40ml溶液を10%パ
ラジウム/炭素(50%含水)1.5gを触媒として、
原料が消失するまで常温常圧下で水素添加した。触媒を
濾過して除いた後、溶媒を減圧留去した。得られた粗生
成物をシリカゲルカラムクロマトグラフィーにて精製し
(ヘキサン/酢酸エチル=15/1-6/1)、目的物
を得た。無色液体 収量13.92g 収率39%1 H-NMR (CDCl3, 200 MHz) δ 1.25 (3H, t, J = 7.2 H
z), 1.52-1.80 (4H, m),2.30 (3H, s), 2.34 (2H, t, J
= 7.0 Hz), 2.61 (2H, t, J = 7.6 Hz), 4.12 (2H, q,
J = 7.2 Hz), 7.12 (4H, s); IR (neat) 2938, 1736,
1181, 745 cm-1 3) 5-(2-メチルフェニル)ペンタン酸 5-(2-メチルフェニル)ペンタン酸エチル13.92
g(63.18ミリモル)、水酸化ナトリウム5.05
g(126ミリモル)、水30ml、メタノール50m
l、テトラヒドロフラン50mlの混合物を室温で一晩
撹拌した。反応液を濃縮、水で希釈し、ジエチルエーテ
ルにて洗浄後、得られた水溶液を濃塩酸で酸性にした
後、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸ナトリウムで乾燥、溶媒を減圧留去して、目的物を得
た。白色結晶 収量12.04g 収率99% mp 57-58℃; 1H-NMR (CDCl3, 200 MHz) δ 1.54-1.82
(4H, m), 2.30 (3H, s),2.40 (2H, t, J = 7.1 Hz), 2.
62 (2H, t, J = 7.6 Hz), 7.12 (4H, s); IR (KBr) 307
0-2520, 1698, 1462, 1437, 1406, 1329, 1289, 1260,
1208, 941, 739 cm-1 4) 1-メチル-6,7,8,9-テトラヒドロ-5H-
ベンゾ[a]シクロヘプテン-5-オン 5-(2-メチルフェニル)ペンタン酸11.92g(6
2.00ミリモル)、N,N-ジメチルホルムアミド2
滴のテトラヒドロフラン50ml溶液に室温で塩化オキ
ザリル8.11ml(93.0ミリモル)を滴下した
後、そのまま0.5時間撹拌した。反応混合物の溶媒を
減圧留去し、酸塩化物を黄色液体として得た。塩化アル
ミニウム16.5g(124ミリモル)の塩化メチレン
100ml懸濁液に撹拌しながら、これに上で得た酸塩
化物の塩化メチレン250ml溶液を1日間かけて滴下
した。反応液を氷冷しながら、水を加えて反応を止め
た。混合物の塩化メチレン層を分離し、水層をジエチル
エーテルで抽出した。集めた有機層を無水硫酸マグネシ
ウムで乾燥、溶媒を減圧留去した。得られた残留物をシ
リカゲルカラムクロマトグラフィーにて精製して(ヘキ
サン/酢酸エチル=9/1)、目的物を得た。淡黄色固
体 収量10.14g 収率94% ヘキサンより再結晶して白色結晶を得た。 mp 65-66℃; 1H-NMR (CDCl3, 200 MHz) δ 1.69-1.91
(4H, m), 2.37 (3H, s),2.67 (2H, t, J = 5.9 Hz), 2.
88 (2H, t, J = 6.2 Hz), 7.17 (1H, t, J = 7.5Hz),
7.30 (1H, d, J = 6.6 Hz), 7.44 (1H, d, J = 7.4 H
z); IR (KBr) 2940,1671, 1586, 1460, 1271, 793 c
m-1; Anal. Calcd for C12H14O: C, 82.72; H,8.10. Fo
und: C, 82.68; H, 8.15. 5) 1-メチル-6,7,8,9-テトラヒドロ-5H-
ベンゾ[a]シクロヘプテン-5-オール 1-メチル-6,7,8,9-テトラヒドロ-5H-ベンゾ
[a]シクロヘプテン-5-オン9.797g(56.2
3ミリモル)のメタノール40ml溶液に、氷冷下、水
素化ほう素ナトリウム2.13g(56.2ミリモル)
を少しずつ加えた後、室温で1時間撹拌した。反応液を
水で希釈し、酢酸エチルで2回抽出した。集めた有機層
を無水硫酸マグネシウムで乾燥、溶媒を減圧留去した。
得られた残留物をシリカゲルカラムクロマトグラフィー
にて精製し(ヘキサン/酢酸エチル=6/1)、酢酸エ
チル-ヘキサンより結晶化して、目的物を得た。白色結
晶 収量8.345g 収率84% mp 109-110℃; 1H-NMR (CDCl3, 300 MHz) δ 1.30-1.42
(1H, m), 1.66-1.86 (4H, m), 1.91-2.05 (2H, m), 2.
32 (3H, s), 2.57 (1H, dd, J = 11.1 Hz, 12.9Hz), 3.
08 (1H, ddd, J = 1.6 Hz, 7.9 Hz, 14.5 Hz), 5.01 (1
H, dd, J = 3.6Hz, 9.0 Hz), 7.06 (1H, dd, J = 1.7 H
z, 7.7 Hz), 7.11 (1H, t, J = 7.4 Hz), 7.32 (1H, d,
J = 6.9 Hz); IR (KBr) 3293, 3189, 2928, 1466, 143
9, 1096,1049, 781, 747 cm-1; Anal. Calcd for C12H
16O: C, 81.77; H, 9.15. Found:C, 81.73; H, 8.93. 6) 4-ブロモ-1-メチル-6,7,8,9-テトラヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-5-オール 1-メチル-6,7,8,9-テトラヒドロ-5H-ベンゾ
[a]シクロヘプテン-5-オール8.193g(46.
48ミリモル)とN,N,N’,N’-テトラメチルエ
チレンジアミン11.9g(102ミリモル)のヘキサ
ン100ml溶液に、氷冷下で1.6Mn-ブチルリチ
ウムのヘキサン溶液63.9ml(102ミリモル)を
滴下した後、35℃で一晩撹拌した。反応混合物を−7
8℃に冷却した後、1,2-ジブロモテトラフルオロエ
タン24.2g(93.0ミリモル)を加え、撹拌しな
がら室温まで昇温し、室温で2時間撹拌した。反応液を
水に注ぎ、酢酸エチルで2回抽出した。集めた有機層を
無水硫酸マグネシウムで乾燥、溶媒を減圧留去した。得
られた粗生成物をシリカゲルカラムクロマトグラフィー
にて精製し(ヘキサン/酢酸エチル=15/1)、目的
物を得た。黄色固体 収量6.439g 収率54% ヘキサンより再結晶して、白色結晶を得た。 mp 74-75℃; 1H-NMR (CDCl3, 200 MHz) δ 1.25-1.44
(1H, m), 1.57-2.23 (6H,m), 2.26 (3H, s), 2.88 (1H,
ddd, J = 1.7 Hz, 6.8 Hz, 14.3 Hz), 3.26 (1H, dt,
J = 1.8 Hz, 13.0 Hz), 5.65-5.71 (1H, m), 6.90 (1H,
d, J = 8.2 Hz),7.26 (1H, d, J = 8.0 Hz); IR (KBr)
3326, 2930, 1456, 1090, 1049, 995, 930, 856, 806
cm-1; Anal. Calcd for C12H15BrO: C, 56.49; H, 5.9
3. Found:C, 56.48; H, 5.83. 7) 1-ブロモ-4-メチル-6,7-ジヒドロ-5H-ベ
ンゾ[a]シクロヘプテン 4-ブロモ-1-メチル-6,7,8,9-テトラヒドロ-5
H-ベンゾ[a]シクロヘプテン-5-オール6.213
g(24.35ミリモル)、p-トルエンスルホン酸一
水和物0.46g(2.44ミリモル)のトルエン10
0ml溶液をディーン-スタークトラップを取り付けた
反応容器中で0.5時間加熱還流した。反応液を室温ま
で冷却し、溶媒を減圧留去した。得られた粗生成物をシ
リカゲルカラムクロマトグラフィーにて精製し(ヘキサ
ン)、目的物を得た。無色液体 収量2.485g 収
率43%1 H-NMR (CDCl3, 300 MHz) δ 1.99-2.13 (4H, m), 2.31
(3H, s), 2.64 (2H, t,J = 6.3 Hz), 6.22 (1H, td, J
= 6.2 Hz, 11.2 Hz), 6.71 (1H, d, J = 11.1Hz), 6.9
0 (1H, d, J = 8.1 Hz), 7.31 (1H, d, J = 8.1 Hz); I
R (neat) 2930,1451, 1127, 802, 779 cm-1 8) 4-メチル-6,7-ジヒドロ-5H-ベンゾ[a]
シクロヘプテン-1-カルボン酸 1-ブロモ-4-メチル-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン2.485g(10.48ミリモ
ル)のジエチルエーテル30ml溶液に、−78℃で
1.6Mn-ブチルリチウムのヘキサン溶液9.82m
l(15.7ミリモル)を滴下した後、室温で4時間撹
拌した。反応混合物を−78℃に冷却した後、砕いたド
ライアイス5gを加え、撹拌しながら室温まで昇温し
た。反応液を水で希釈した後、ジエチルエーテルにて洗
浄し、得られた水溶液を1規定塩酸で酸性にした後、酢
酸エチルで2回抽出した。集めた有機層を無水硫酸マグ
ネシウムで乾燥、溶媒を減圧留去した。得られた粗結晶
をヘキサンで洗浄して、目的物を得た。白色結晶 収量
1.080g 収率51% mp 152-153℃; 1H-NMR (CDCl3, 200 MHz) δ 1.91-2.18
(4H, m), 2.43 (3H, s), 2.66 (2H, t, J = 6.6 Hz),
6.26 (1H, td, J = 6.6 Hz, 11.0 Hz), 7.13 (1H, d, J
= 7.8 Hz), 7.21 (1H, d, J = 11.0 Hz), 7.85 (1H,
d, J = 8.2 Hz); IR (KBr) 3044-2510, 1686, 1300, 12
71, 1258 cm-1; Anal. Calcd for C13H14O2: C, 77.20;
H, 6.98. Found: C, 76.98; H, 7.03. 9) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]-4-メチル-
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.366g
(1.013ミリモル)、4-メチル-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボン酸0.
20g(1.01ミリモル)、1-ヒドロキシベンゾト
リアゾール水和物0.16g(1.01ミリモル)をア
セトニトリル10ml中で撹拌しながら1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩0.19g(1.01ミリモル)を加え、室温で一晩
撹拌した。反応液を酢酸エチルに希釈し、炭酸水素ナト
リウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、シ
リカゲルを通した後、溶媒を減圧留去した。得られた残
留物を酢酸エチル-ジイソプロピルエーテル-ヘキサンよ
り結晶化して、目的物を得た。白色結晶 収量0.46
1g 収率83% mp 177-178℃; 1H-NMR (CDCl3, 300 MHz) δ 1.95-2.07
(4H, m), 2.33 (3H, s), 2.59 (2H, t, J = 5.7 Hz),
2.78 (1H, dd, J = 10.7 Hz, 14.6 Hz), 2.98 (1H, dd,
J = 4.2 Hz, 14.4 Hz), 3.90 (1H, d, J = 3.9 Hz),
4.58-4.67 (1H, m), 5.03 (1H, t, J = 3.6 Hz), 5.74
(1H, d, J = 7.5 Hz), 5.89 (1H, tt, J =2.8 Hz, 53.0
Hz), 6.02 (1H, td, J = 6.2 Hz, 11.3 Hz), 6.29 (1
H, d, J = 11.1 Hz), 6.96-7.11 (7H, m), 7.29 (1H,
t, J = 7.8 Hz), 7.42 (2H, dd, J =5.4 Hz, 8.7 Hz);
IR (KBr) 3279, 1638, 1512, 1200, 1127 cm-1; Anal.
Calcdfor C30H28F5NO3: C, 66.05; H, 5.17; N, 2.57.
Found: C, 66.03; H, 5.21;N, 2.52.Example 318 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -4-methyl-6,7-
Dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1) (E) -5- (2-methylphenyl) -3-oxo-4
50.71 g (312.7 mmol) of ethyl 2-pentenoate 2-methylcinnamic acid
Was added to a solution of 500 ml of tetrahydrofuran at room temperature, and the mixture was stirred as it was for 1 hour. 58.5 g of monoethyl malonate monopotassium salt was added to this mixture.
(344 mmol) and 16.4 g of magnesium chloride
(172 mmol) at room temperature and stirred at 60 ° C. overnight. After diluting the reaction solution with ethyl acetate and water and acidifying the reaction solution with concentrated hydrochloric acid, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 9 / 1-6 / 1) to obtain the desired product. Yellow liquid Yield 37.24 g Yield 51% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.29 (1.2 H, t, J = 7.1)
Hz), 1.32 (1.8H, t, J = 7.1 Hz), 2.43 (1.8H, s), 2.
45 (1.2H, s), 3.70 (0.8H, s), 4.23 (0.8H, q, J =
7.2 Hz), 4.24 (1.2H, q, J = 7.1 Hz), 5.17 (0.6H,
s), 6.36 (0.6H, dd, J = 1.4 Hz, 15.8 Hz), 6.74 (0.
4H, d, J = 15.8 Hz), 7.15-7.35 (3H, m), 7.52-7.61
(1H, m), 7.70 (0.6H, d, J = 15.8 Hz), 7.93 (0.4H,
d, J = 16.2Hz); IR (neat) 2980, 1740, 1636, 1595,
1420, 1236, 1148, 1038, 754 cm -1 2) Ethyl 5- (2-methylphenyl) pentanoate 37.24 g of ethyl (E) -5- (2-methylphenyl) -3-oxo-4-pentenoate To a solution of (160.3 mmol) in 100 ml of ethanol, 3.03 g (80.2 mmol) of sodium borohydride was added little by little under ice-cooling, followed by stirring for 10 minutes. The reaction was diluted with water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain (E) -3-
A crude product of ethyl hydroxy-5- (2-methylphenyl) penta-4-enoate was obtained as a yellow liquid. The liquid obtained above and 33.5 ml (240 mmol) of triethylamine
Was added dropwise to a solution of the above in 180 ml of ethyl acetate under ice-cooling, and methanesulfonyl chloride (22.0 g, 192 mmol) was added dropwise under ice-cooling, followed by stirring for 15 minutes. The resulting precipitate (triethylamine hydrochloride) was removed by filtration, and the precipitate was washed with ethyl acetate. The collected ethyl acetate solution was concentrated under reduced pressure.
The obtained residue was dissolved in 200 ml of tetrahydrofuran, 28.8 ml (192 mmol) of 1,8-diazabicyclo [5.4.0] -7-undecene was added, and the mixture was stirred at room temperature for 0.5 hour. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / hexane).
Ethyl acetate = 15 / 1-9 / 1) 5- (2-methylphenyl) penta-2,4-dienoate ((2E, 4E)
And a mixture of the (2Z, 4E) form) as a yellow liquid. Using a solution of the liquid obtained above in 40 ml of ethanol with 1.5 g of 10% palladium / carbon (containing 50% water) as a catalyst,
Hydrogenation was performed under normal temperature and normal pressure until the raw materials disappeared. After removing the catalyst by filtration, the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-6 / 1) to obtain the desired product. Colorless liquid Yield 13.92 g Yield 39% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.25 (3H, t, J = 7.2 H)
z), 1.52-1.80 (4H, m), 2.30 (3H, s), 2.34 (2H, t, J
= 7.0 Hz), 2.61 (2H, t, J = 7.6 Hz), 4.12 (2H, q,
J = 7.2 Hz), 7.12 (4H, s); IR (neat) 2938, 1736,
1181, 745 cm -1 3) Ethyl 5- (2-methylphenyl) pentanoate 13.92 Ethyl 5- (2-methylphenyl) pentanoate
g (63.18 mmol), sodium hydroxide 5.05
g (126 mmol), water 30 ml, methanol 50 m
1 and a mixture of 50 ml of tetrahydrofuran were stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, washed with diethyl ether, and the obtained aqueous solution was acidified with concentrated hydrochloric acid, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain the desired product. White crystals Yield 12.04 g Yield 99% mp 57-58 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.54-1.82
(4H, m), 2.30 (3H, s), 2.40 (2H, t, J = 7.1 Hz), 2.
62 (2H, t, J = 7.6 Hz), 7.12 (4H, s); IR (KBr) 307
0-2520, 1698, 1462, 1437, 1406, 1329, 1289, 1260,
1208, 941, 739 cm -1 4) 1-methyl-6,7,8,9-tetrahydro-5H-
Benzo [a] cyclohepten-5-one 11.92 g of 5- (2-methylphenyl) pentanoic acid (6.
2.00 mmol), N, N-dimethylformamide 2
8.11 ml (93.0 mmol) of oxalyl chloride was added dropwise to a solution of the drops in 50 ml of tetrahydrofuran at room temperature, followed by stirring for 0.5 hour. The solvent of the reaction mixture was distilled off under reduced pressure to obtain an acid chloride as a yellow liquid. While stirring a suspension of 16.5 g (124 mmol) of aluminum chloride in 100 ml of methylene chloride, a solution of the acid chloride obtained above in 250 ml of methylene chloride was added dropwise over 1 day. While cooling the reaction solution with ice, water was added to stop the reaction. The methylene chloride layer of the mixture was separated, and the aqueous layer was extracted with diethyl ether. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 9/1) to obtain the desired product. Light yellow solid Yield 10.14 g Yield 94% Recrystallization from hexane gave white crystals. mp 65-66 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.69-1.91
(4H, m), 2.37 (3H, s), 2.67 (2H, t, J = 5.9 Hz), 2.
88 (2H, t, J = 6.2 Hz), 7.17 (1H, t, J = 7.5Hz),
7.30 (1H, d, J = 6.6 Hz), 7.44 (1H, d, J = 7.4 H
z); IR (KBr) 2940,1671, 1586, 1460, 1271, 793 c
m -1 ; Anal.Calcd for C 12 H 14 O: C, 82.72; H, 8.10. Fo
und: C, 82.68; H, 8.15.5) 1-methyl-6,7,8,9-tetrahydro-5H-
Benzo [a] cyclohepten-5-ol 9.797 g (56.2) of 1-methyl-6,7,8,9-tetrahydro-5H-benzo [a] cyclohepten-5-one
2.13 g (56.2 mmol) of sodium borohydride in a solution of methanol (3 mmol) in 40 ml of methanol under ice-cooling.
Was added little by little, and the mixture was stirred at room temperature for 1 hour. The reaction was diluted with water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure.
The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 6/1), and crystallized from ethyl acetate-hexane to obtain the desired product. White crystals Yield 8.345 g Yield 84% mp 109-110 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.30-1.42
(1H, m), 1.66-1.86 (4H, m), 1.91-2.05 (2H, m), 2.
32 (3H, s), 2.57 (1H, dd, J = 11.1 Hz, 12.9Hz), 3.
08 (1H, ddd, J = 1.6 Hz, 7.9 Hz, 14.5 Hz), 5.01 (1
H, dd, J = 3.6Hz, 9.0 Hz), 7.06 (1H, dd, J = 1.7 H
z, 7.7 Hz), 7.11 (1H, t, J = 7.4 Hz), 7.32 (1H, d,
J = 6.9 Hz); IR (KBr) 3293, 3189, 2928, 1466, 143
9, 1096,1049, 781, 747 cm -1 ; Anal.Calcd for C 12 H
16 O: C, 81.77; H, 9.15. Found: C, 81.73; H, 8.93. 6) 4-Bromo-1-methyl-6,7,8,9-tetrahydro-5H-benzo [a] cycloheptene-5 -All 1-methyl-6,7,8,9-tetrahydro-5H-benzo [a] cyclohepten-5-ol 8.193 g (46.
To a solution of 48 mmol) and 11.9 g (102 mmol) of N, N, N ', N'-tetramethylethylenediamine in 100 ml of hexane, 63.9 ml (102 mmol) of a 1.6 Mn-butyllithium hexane solution under ice-cooling. After dropwise addition, the mixture was stirred at 35 ° C. overnight. The reaction mixture was
After cooling to 8 ° C., 24.2 g (93.0 mmol) of 1,2-dibromotetrafluoroethane was added, the temperature was raised to room temperature with stirring, and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15/1) to obtain the desired product. Yellow solid Yield 6.439 g Yield 54% Recrystallization from hexane gave white crystals. mp 74-75 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.25-1.44
(1H, m), 1.57-2.23 (6H, m), 2.26 (3H, s), 2.88 (1H,
ddd, J = 1.7 Hz, 6.8 Hz, 14.3 Hz), 3.26 (1H, dt,
J = 1.8 Hz, 13.0 Hz), 5.65-5.71 (1H, m), 6.90 (1H,
d, J = 8.2 Hz), 7.26 (1H, d, J = 8.0 Hz); IR (KBr)
3326, 2930, 1456, 1090, 1049, 995, 930, 856, 806
cm -1 ; Anal.Calcd for C 12 H 15 BrO: C, 56.49; H, 5.9
3. Found: C, 56.48; H, 5.83.7) 1-bromo-4-methyl-6,7-dihydro-5H-benzo [a] cycloheptene 4-bromo-1-methyl-6,7,8,9 -Tetrahydro-5
H-benzo [a] cyclohepten-5-ol 6.213
g (24.35 mmol), 0.46 g (2.44 mmol) of p-toluenesulfonic acid monohydrate in toluene 10
The 0 ml solution was heated to reflux for 0.5 hours in a reaction vessel fitted with a Dean-Stark trap. The reaction solution was cooled to room temperature, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane) to obtain the desired product. Colorless liquid Yield 2.485 g Yield 43% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.99-2.13 (4H, m), 2.31
(3H, s), 2.64 (2H, t, J = 6.3 Hz), 6.22 (1H, td, J
= 6.2 Hz, 11.2 Hz), 6.71 (1H, d, J = 11.1Hz), 6.9
0 (1H, d, J = 8.1 Hz), 7.31 (1H, d, J = 8.1 Hz); I
R (neat) 2930,1451, 1127, 802, 779 cm -1 8) 4- methyl-6,7-dihydro -5H- benzo [a]
Cycloheptene-1-carboxylic acid 1-bromo-4-methyl-6,7-dihydro-5H-benzo [a] cycloheptene 2.485 g (10.48 mmol) of diethyl ether in 30 ml of 1.6 M at −78 ° C. 9.82m of hexane solution of -butyllithium
After the dropwise addition of 1 (15.7 mmol), the mixture was stirred at room temperature for 4 hours. After cooling the reaction mixture to −78 ° C., 5 g of crushed dry ice was added, and the temperature was raised to room temperature with stirring. The reaction solution was diluted with water, washed with diethyl ether, and the obtained aqueous solution was acidified with 1N hydrochloric acid, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude crystals were washed with hexane to obtain the desired product. White crystals Yield 1.080 g Yield 51% mp 152-153 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.91-2.18
(4H, m), 2.43 (3H, s), 2.66 (2H, t, J = 6.6 Hz),
6.26 (1H, td, J = 6.6 Hz, 11.0 Hz), 7.13 (1H, d, J
= 7.8 Hz), 7.21 (1H, d, J = 11.0 Hz), 7.85 (1H,
d, J = 8.2 Hz); IR (KBr) 3044-2510, 1686, 1300, 12
71, 1258 cm -1 ; Anal.Calcd for C 13 H 14 O 2 : C, 77.20;
H, 6.98. Found: C, 76.98; H, 7.03.9) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2, 2-tetrafluoroethoxy) benzyl] ethyl] -4-methyl-
6,7-dihydro-5H-benzo [a] cycloheptene-1
-Carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol 0.366 g
(1.013 mmol), 4-methyl-6,7-dihydro-
5H-benzo [a] cycloheptene-1-carboxylic acid
20 g (1.01 mmol) and 0.16 g (1.01 mmol) of 1-hydroxybenzotriazole hydrate are stirred in 10 ml of acetonitrile with 1-ethyl-3-ethyl.
0.19 g (1.01 mmol) of (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.46
1g Yield 83% mp 177-178 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.95-2.07
(4H, m), 2.33 (3H, s), 2.59 (2H, t, J = 5.7 Hz),
2.78 (1H, dd, J = 10.7 Hz, 14.6 Hz), 2.98 (1H, dd,
J = 4.2 Hz, 14.4 Hz), 3.90 (1H, d, J = 3.9 Hz),
4.58-4.67 (1H, m), 5.03 (1H, t, J = 3.6 Hz), 5.74
(1H, d, J = 7.5 Hz), 5.89 (1H, tt, J = 2.8 Hz, 53.0
Hz), 6.02 (1H, td, J = 6.2 Hz, 11.3 Hz), 6.29 (1
H, d, J = 11.1 Hz), 6.96-7.11 (7H, m), 7.29 (1H,
t, J = 7.8 Hz), 7.42 (2H, dd, J = 5.4 Hz, 8.7 Hz);
IR (KBr) 3279, 1638, 1512, 1200, 1127 cm -1 ; Anal.
Calcdfor C 30 H 28 F 5 NO 3 : C, 66.05; H, 5.17; N, 2.57.
Found: C, 66.03; H, 5.21; N, 2.52.
【0451】実施例319 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[[3-(1,1,2,2-テトラフ
ルオロエトキシ)イソオキサゾール-5-イル]メチル]
エチル]カルバミン酸tert-ブチル 1) 3-(4-フルオロフェニル)-3-オキソ-2-
[[3-(1,1,2,2-テトラフルオロエトキシ)イ
ソオキサゾール-5-イル]メチル]プロピオン酸エチル 3-(1,1,2,2-テトラフルオロエトキシ)-5-イ
ソオキサゾールカルボン酸メチル1.975g(8.1
24ミリモル)のメタノール30ml溶液に、氷冷下、
水素化ほう素ナトリウム0.40g(10.6ミリモ
ル)を少しずつ加えた後、室温で一晩撹拌した。反応液
に希塩酸を加え、室温で1時間撹拌した後、酢酸エチル
で3回抽出した。集めた有機層を無水硫酸マグネシウム
で乾燥、シリカゲルを通した後、溶媒を減圧留去して、
[3-(1,1,2,2-テトラフルオロエトキシ)イソ
オキサゾール-5-イル]メタノールの粗生成物を黄色液
体(1.72g)として得た。上で得た液体、トリエチ
ルアミン1.70ml(12.2ミリモル)の酢酸エチ
ル40ml溶液に氷冷下塩化メタンスルホニル0.75
ml(9.75ミリモル)を滴下し、そのまま10分間
撹拌した。生じた沈殿を濾過して除き、沈殿を酢酸エチ
ルで洗浄した。集めた濾液の溶媒を減圧留去して、メタ
ンスルホン酸エステルの粗生成物を黄色液体として得
た。(4-フルオロベンゾイル)酢酸エチル1.88g
(8.94ミリモル)の1,2-ジメトキシエタン30
ml溶液に氷冷下60%水素化ナトリウムの流動パラフ
ィン懸濁物0.36g(8.94ミリモル)を加え、そ
のまま0.5時間撹拌した。これに上で得たメタンスル
ホン酸エステルの1,2-ジメトキシエタン10ml溶
液を室温で加え、70℃で4時間撹拌した。反応液を水
に注ぎ、酢酸エチルで2回抽出した。集めた有機層を無
水硫酸マグネシウムで乾燥、溶媒を減圧留去した。得ら
れた残留物をシリカゲルカラムクロマトグラフィーにて
精製し(ヘキサン/酢酸エチル=9/1-6/1)、目
的物を得た。淡黄色液体 収量2.418g 収率73
%1 H-NMR (CDCl3, 200 MHz) δ 1.16 (3H, t, J = 7.2 H
z), 3.46 (2H, d, J = 7.4 Hz), 4.16 (2H, q, J = 7.1
Hz), 4.77 (1H, t, J = 7.4 Hz), 6.00 (1H, tt,J =
3.3 Hz, 52.7 Hz), 6.07 (1H, s), 7.18 (2H, t, J =
8.7 Hz), 8.06 (2H,dd, J = 5.3 Hz, 8.9 Hz); IR (nea
t) 1738, 1690, 1601, 1447, 1283, 1233,1182, 1159 c
m-1 2) (2RS,3SR)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[[3-(1,1,2,2-テト
ラフルオロエトキシ)イソオキサゾール-5-イル]メチ
ル]プロピオン酸エチル 塩化亜鉛6.35g(46.6ミリモル)をジエチルエ
ーテル100ml中で撹拌しながら水素化ホウ素ナトリ
ウム3.53g(93.2ミリモル)を室温で加え、そ
のまま2時間撹拌した。混合物の不溶物をろ過で除き
(ジエチルエーテルで洗浄)、水素化ホウ素亜鉛のジエ
チルエーテル溶液を得た。得られた溶液に、3-(4-フ
ルオロフェニル)-3-オキソ-2-[[3-(1,1,
2,2-テトラフルオロエトキシ)イソオキサゾール-5
-イル]メチル]プロピオン酸エチル2.372g
(5.824ミリモル)のジエチルエーテル30ml溶
液を氷冷下加え、4時間加熱還流した。反応液に希塩酸
を少しずつ加えて過剰の水素化ホウ素亜鉛を分解した
後、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸マグネシウムで乾燥、溶媒を減圧留去した。得られた
粗生成物をシリカゲルカラムクロマトグラフィーにて精
製し(ヘキサン/酢酸エチル=6/1-3/1)、目的
物を得た。無色液体 収量1.402g 収率59%1 H-NMR (CDCl3, 300 MHz) δ 1.11 (3H, t, J = 7.1 H
z), 2.72 (1H, d, J = 3.0 Hz), 2.98-3.26 (3H, m),
4.02-4.11 (2H, m), 5.11 (1H, dd, J = 3.3 Hz, 5.1 H
z), 5.93 (1H, s), 6.00 (1H, tt, J = 3.3 Hz, 52.7 H
z), 7.06 (2H, t, J= 8.7 Hz), 7.36 (2H, dd, J = 5.3
Hz, 8.6 Hz); IR (neat) 3465, 1728, 1609, 1512, 14
49, 1225, 1184, 1146 cm-1 3) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-[[3-(1,1,2,2-テトラフルオロエト
キシ)イソオキサゾール-5-イル]メチル]-1,3-オ
キサゾリジン-2-オン (2RS,3SR)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[[3-(1,1,2,2-テトラフルオ
ロエトキシ)イソオキサゾール-5-イル]メチル]プロ
ピオン酸エチル1.402g(3.425ミリモル)の
メタノール30ml溶液に1規定水酸化ナトリウム水溶
液6.85ml(6.85ミリモル)を加え、室温で2
時間撹拌した。反応液を濃縮、水で希釈し、1規定塩酸
で反応液を酸性にした後、酢酸エチルで2回抽出した。
集めた有機層を無水硫酸ナトリウムで乾燥、溶媒を減圧
留去して、(2RS,3SR)-3-(4-フルオロフェ
ニル)-3-ヒドロキシ-2-[[3-(1,1,2,2-テ
トラフルオロエトキシ)イソオキサゾール-5-イル]メ
チル]プロピオン酸の粗生成物を、無色液体として得
た。上で得た液体のテトラヒドロフラン30ml溶液に
トリエチルアミン0.57ml(4.11ミリモル)、
ジフェニルホスホリルアジド1.04g(3.77ミリ
モル)を加え、一晩70℃で撹拌した。反応液の溶媒を
減圧留去し、得られた粗生成物をシリカゲルカラムクロ
マトグラフィーにて精製し(ヘキサン/酢酸エチル=3
/1-1/1)、ジエチルエーテル-ヘキサンより結晶化
して、目的物を得た。白色結晶 収量0.921g 収
率71% mp 124-125℃; 1H-NMR (CDCl3, 300 MHz) δ 2.48 (1H,
dd, J = 5.3 Hz, 15.5Hz), 2.59 (1H, dd, J = 8.4 H
z, 15.6 Hz), 4.45-4.53 (1H, m), 5.52 (1H, brs), 5.
83 (1H, s), 6.00 (1H, tt, J = 3.2 Hz, 52.7 Hz), 7.
12 (2H, t, J =8.6 Hz), 7.32 (2H, dd, J = 5.3 Hz,
8.3 Hz); IR (KBr) 3156, 1755, 1447, 1235, 1209, 11
50,1119 cm-1; Anal. Calcd for C15H11F5N2O4: C, 47.
63; H, 2.93; N, 7.41. Found: C, 47.60; H, 2.98; N,
7.21. 4) (4RS,5SR)-5-(4-フルオロフェニ
ル)-2-オキソ-4-[[3-(1,1,2,2-テトラフ
ルオロエトキシ)イソオキサゾール-5-イル]メチル]
-1,3-オキサゾリジン-3-カルボン酸tert-ブチ
ル (4RS,5SR)-5-(4-フルオロフェニル)-4-
[[3-(1,1,2,2-テトラフルオロエトキシ)イ
ソオキサゾール-5-イル]メチル]-1,3-オキサゾリ
ジン-2-オン0.866g(2.289ミリモル)、二
炭酸ジ-tert-ブチル0.60g(2.75ミリモ
ル)、4-N,N-ジメチルアミノピリジン28mg
(0.23ミリモル)のアセトニトリル10ml溶液を
室温で一晩撹拌した。反応液の溶媒を減圧留去し、得ら
れた粗生成物をシリカゲルカラムクロマトグラフィーに
て精製し(酢酸エチル)、酢酸エチル-ジイソプロピル
エーテル-ヘキサンより結晶化して、目的物を得た。白
色結晶 収量0.785g 収率72% mp 177-178℃; 1H-NMR (CDCl3, 300 MHz) δ 1.55 (9H,
s), 2.81 (1H, dd, J =9.3 Hz, 15.6 Hz), 3.01 (1H,
ddd, J = 1.0 Hz, 4.6 Hz, 15.4 Hz), 4.96-5.03 (1H,
m), 5.36 (1H, s), 5.72 (1H, d, J = 7.2 Hz), 5.97
(1H, tt, J = 3.3Hz, 52.8 Hz), 7.04 (2H, t, J = 8.6
Hz), 7.23 (2H, dd, J = 5.3 Hz, 8.6 Hz); IR (KBr)
1802, 1372, 1298, 1163 cm-1; Anal. Calcd for C20H
19F5N2O6:C, 50.22; H, 4.00; N, 5.86. Found: C, 50.
16; H, 3.79; N, 5.88. 5) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[[3-(1,1,2,2-テ
トラフルオロエトキシ)イソオキサゾール-5-イル]メ
チル]エチル]カルバミン酸tert-ブチル (4RS,5SR)-5-(4-フルオロフェニル)-2-
オキソ-4-[[3-(1,1,2,2-テトラフルオロエ
トキシ)イソオキサゾール-5-イル]メチル]-1,3-
オキサゾリジン-3-カルボン酸tert-ブチル0.7
35g(1.536ミリモル)のテトラヒドロフラン1
0ml溶液に水酸化ナトリウム61mg(1.54ミリ
モル)のメタノール2ml溶液を氷冷下加え、室温で1
0分間撹拌した。反応液を酢酸エチルに希釈し、水で洗
浄、無水硫酸マグネシウムで乾燥、シリカゲルを通した
後、溶媒を減圧留去した。得られた残留物をジイソプロ
ピルエーテル-ヘキサンより結晶化して、目的物を得
た。白色結晶 収量0.626g 収率90% mp 114-115℃; 1H-NMR (CDCl3, 300 MHz) δ 1.39 (9H,
s), 2.69 (1H, br d, J= 2.7 Hz), 2.86 (1H, dd, J =
4.2 Hz, 15.3 Hz), 3.01 (1H, dd, J = 10.7 Hz, 15.5
Hz), 4.09-4.18 (1H, m), 4.89 (1H, br d, J = 7.5 H
z), 4.94 (1H, br s), 6.00 (1H, tt, J = 3.4 Hz, 52.
7 Hz), 6.03 (1H, s), 7.08 (2H, t, J =8.7 Hz), 7.38
(2H, dd, J = 5.1 Hz, 8.4 Hz); IR (KBr) 3360, 168
0, 1530,1449, 1190, 1125 cm-1; Anal. Calcd for C19
H21F5N2O5: C, 50.45; H, 4.68;N, 6.19. Found: C, 5
0.32; H, 4.58; N, 6.25.Example 319 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-[[3- (1,1,2,2-tetrafluoroethoxy) isoxazol-5-yl] methyl]
Tert-Butyl ethyl] carbamate 1) 3- (4-fluorophenyl) -3-oxo-2-
Ethyl [[3- (1,1,2,2-tetrafluoroethoxy) isoxazol-5-yl] methyl] propionate 3- (1,1,2,2-tetrafluoroethoxy) -5-isoxazolecarboxylic acid 1.975 g of methyl acid salt (8.1
24 mmol) in 30 ml of methanol under ice-cooling.
After adding 0.40 g (10.6 mmol) of sodium borohydride little by little, the mixture was stirred at room temperature overnight. Dilute hydrochloric acid was added to the reaction solution, and the mixture was stirred at room temperature for 1 hour, and then extracted three times with ethyl acetate. After drying the collected organic layer over anhydrous magnesium sulfate and passing through silica gel, the solvent was distilled off under reduced pressure.
A crude product of [3- (1,1,2,2-tetrafluoroethoxy) isoxazol-5-yl] methanol was obtained as a yellow liquid (1.72 g). To a solution of 1.70 ml (12.2 mmol) of the above-obtained liquid, triethylamine, in 40 ml of ethyl acetate, was added 0.75 methanesulfonyl chloride under ice cooling.
ml (9.75 mmol) was added dropwise and stirred for 10 minutes. The resulting precipitate was removed by filtration, and the precipitate was washed with ethyl acetate. The solvent of the collected filtrate was distilled off under reduced pressure to obtain a crude product of methanesulfonic acid ester as a yellow liquid. 1.88 g of ethyl (4-fluorobenzoyl) acetate
(8.94 mmol) of 1,2-dimethoxyethane 30
0.36 g (8.94 mmol) of a 60% sodium hydride liquid paraffin suspension was added to the ml solution under ice-cooling, and the mixture was stirred for 0.5 hour as it was. To this was added a solution of methanesulfonic acid ester obtained above in 1,2-dimethoxyethane (10 ml) at room temperature, and the mixture was stirred at 70 ° C. for 4 hours. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 9 / 1-6 / 1) to obtain the desired product. Pale yellow liquid yield 2.418 g yield 73
% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.16 (3H, t, J = 7.2 H
z), 3.46 (2H, d, J = 7.4 Hz), 4.16 (2H, q, J = 7.1
Hz), 4.77 (1H, t, J = 7.4 Hz), 6.00 (1H, tt, J =
3.3 Hz, 52.7 Hz), 6.07 (1H, s), 7.18 (2H, t, J =
8.7 Hz), 8.06 (2H, dd, J = 5.3 Hz, 8.9 Hz); IR (nea
t) 1738, 1690, 1601, 1447, 1283, 1233,1182, 1159 c
m- 1 2) (2RS, 3SR) -3- (4-fluorophenyl) -3-hydroxy-2-[[3- (1,1,2,2-tetrafluoroethoxy) isoxazol-5-yl] Ethyl methyl] propionate While stirring 6.35 g (46.6 mmol) of zinc chloride in 100 ml of diethyl ether, 3.53 g (93.2 mmol) of sodium borohydride was added at room temperature, and the mixture was stirred for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. The resulting solution was added to 3- (4-fluorophenyl) -3-oxo-2-[[3- (1,1,
2,2-tetrafluoroethoxy) isoxazole-5
2.372 g of ethyl -yl] methyl] propionate
A solution of (5.824 mmol) in 30 ml of diethyl ether was added under ice-cooling, and the mixture was refluxed for 4 hours. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-3 / 1) to obtain the desired product. Colorless liquid Yield 1.402 g Yield 59% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.11 (3H, t, J = 7.1 H)
z), 2.72 (1H, d, J = 3.0 Hz), 2.98-3.26 (3H, m),
4.02-4.11 (2H, m), 5.11 (1H, dd, J = 3.3 Hz, 5.1 H
z), 5.93 (1H, s), 6.00 (1H, tt, J = 3.3 Hz, 52.7 H
z), 7.06 (2H, t, J = 8.7 Hz), 7.36 (2H, dd, J = 5.3
Hz, 8.6 Hz); IR (neat) 3465, 1728, 1609, 1512, 14
49, 1225, 1184, 1146 cm -1 3) (4RS, 5SR) -5- (4- fluorophenyl) -4 - [[3- (1,1,2,2-tetrafluoroethoxy) isoxazole -5 -Yl] methyl] -1,3-oxazolidin-2-one (2RS, 3SR) -3- (4-fluorophenyl) -3-
1N water was added to a solution of 1.402 g (3.425 mmol) of ethyl hydroxy-2-[[3- (1,1,2,2-tetrafluoroethoxy) isoxazol-5-yl] methyl] propionate in 30 ml of methanol. 6.85 ml (6.85 mmol) of an aqueous sodium oxide solution was added, and the mixture was added at room temperature for 2 hours.
Stirred for hours. The reaction solution was concentrated, diluted with water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate.
The collected organic layer was dried over anhydrous sodium sulfate and the solvent was distilled off under reduced pressure to give (2RS, 3SR) -3- (4-fluorophenyl) -3-hydroxy-2-[[3- (1,1,2 A crude product of 2,2-tetrafluoroethoxy) isoxazol-5-yl] methyl] propionic acid was obtained as a colorless liquid. 0.57 ml (4.11 mmol) of triethylamine was added to a solution of the liquid obtained above in 30 ml of tetrahydrofuran,
1.04 g (3.77 mmol) of diphenylphosphoryl azide was added, and the mixture was stirred at 70 ° C. overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3).
/ 1-1 / 1) and crystallized from diethyl ether-hexane to obtain the desired product. White crystals Yield 0.921 g Yield 71% mp 124-125 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 2.48 (1H,
dd, J = 5.3 Hz, 15.5Hz), 2.59 (1H, dd, J = 8.4 H
z, 15.6 Hz), 4.45-4.53 (1H, m), 5.52 (1H, brs), 5.
83 (1H, s), 6.00 (1H, tt, J = 3.2 Hz, 52.7 Hz), 7.
12 (2H, t, J = 8.6 Hz), 7.32 (2H, dd, J = 5.3 Hz,
8.3 Hz); IR (KBr) 3156, 1755, 1447, 1235, 1209, 11
50,1119 cm -1 ; Anal.Calcd for C 15 H 11 F 5 N 2 O 4 : C, 47.
63; H, 2.93; N, 7.41. Found: C, 47.60; H, 2.98; N,
7.21.4) (4RS, 5SR) -5- (4-fluorophenyl) -2-oxo-4-[[3- (1,1,2,2-tetrafluoroethoxy) isoxazol-5-yl] methyl ]
Tert-Butyl-1,3-oxazolidine-3-carboxylate (4RS, 5SR) -5- (4-fluorophenyl) -4-
0.866 g (2.289 mmol) of [[3- (1,1,2,2-tetrafluoroethoxy) isoxazol-5-yl] methyl] -1,3-oxazolidin-2-one, di-dicarbonate tert-butyl 0.60 g (2.75 mmol), 4-N, N-dimethylaminopyridine 28 mg
(0.23 mmol) in 10 ml of acetonitrile was stirred at room temperature overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (ethyl acetate) and crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.785 g Yield 72% mp 177-178 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.55 (9H,
s), 2.81 (1H, dd, J = 9.3 Hz, 15.6 Hz), 3.01 (1H,
ddd, J = 1.0 Hz, 4.6 Hz, 15.4 Hz), 4.96-5.03 (1H,
m), 5.36 (1H, s), 5.72 (1H, d, J = 7.2 Hz), 5.97
(1H, tt, J = 3.3Hz, 52.8 Hz), 7.04 (2H, t, J = 8.6
Hz), 7.23 (2H, dd, J = 5.3 Hz, 8.6 Hz); IR (KBr)
1802, 1372, 1298, 1163 cm -1 ; Anal.Calcd for C 20 H
19 F 5 N 2 O 6 : C, 50.22; H, 4.00; N, 5.86. Found: C, 50.
16; H, 3.79; N, 5.88. 5) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-[[3- (1,1,2,2-tetra Tert-Butyl fluoroethoxy) isoxazol-5-yl] methyl] ethyl] carbamate (4RS, 5SR) -5- (4-fluorophenyl) -2-
Oxo-4-[[3- (1,1,2,2-tetrafluoroethoxy) isoxazol-5-yl] methyl] -1,3-
Tert-butyl oxazolidine-3-carboxylate 0.7
35 g (1.536 mmol) of tetrahydrofuran 1
To a 0 ml solution was added a solution of 61 mg (1.54 mmol) of sodium hydroxide in 2 ml of methanol under ice-cooling.
Stirred for 0 minutes. The reaction solution was diluted with ethyl acetate, washed with water, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystal Yield 0.626 g Yield 90% mp 114-115 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.39 (9H,
s), 2.69 (1H, br d, J = 2.7 Hz), 2.86 (1H, dd, J =
4.2 Hz, 15.3 Hz), 3.01 (1H, dd, J = 10.7 Hz, 15.5
Hz), 4.09-4.18 (1H, m), 4.89 (1H, br d, J = 7.5 H
z), 4.94 (1H, br s), 6.00 (1H, tt, J = 3.4 Hz, 52.
7 Hz), 6.03 (1H, s), 7.08 (2H, t, J = 8.7 Hz), 7.38
(2H, dd, J = 5.1 Hz, 8.4 Hz); IR (KBr) 3360, 168
0, 1530,1449, 1190, 1125 cm -1 ; Anal.Calcd for C 19
H 21 F 5 N 2 O 5 : C, 50.45; H, 4.68; N, 6.19. Found: C, 5
0.32; H, 4.58; N, 6.25.
【0452】実施例320 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[[3-(1,1,2,2-テトラフ
ルオロエトキシ)イソオキサゾール-5-イル]メチル]
エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘ
プテン-1-カルボキサミド N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[[3-(1,1,2,2-テトラフ
ルオロエトキシ)イソオキサゾール-5-イル]メチル]
エチル]カルバミン酸tert-ブチル0.291g
(0.643ミリモル)、濃塩酸0.2mlのメタノー
ル5ml溶液を0.5時間60℃で撹拌した。反応液を
水で希釈し、炭酸カリウムでアルカリ性とし、酢酸エチ
ルで2回抽出した。集めた有機層を無水硫酸ナトリウム
で乾燥、溶媒を減圧留去して、(1RS,2SR)-2-
アミノ-1-(4-フルオロフェニル)-3-[3-(1,
1,2,2-テトラフルオロエトキシ)イソオキサゾー
ル-5-イル]プロパン-1-オールの粗生成物を、白色固
体(0.227g)として得た。上で得た固体、6,7
-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カル
ボン酸0.13g(0.71ミリモル)、1-ヒドロキ
シベンゾトリアゾール水和物0.10g(0.71ミリ
モル)をアセトニトリル10ml中で撹拌しながら1-
エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩0.14g(0.71ミリモル)を加え、
室温で一晩撹拌した。反応液を酢酸エチルに希釈し、炭
酸水素ナトリウム水溶液で洗浄、無水硫酸マグネシウム
で乾燥、溶媒を減圧留去した。得られた残留物をシリカ
ゲルカラムクロマトグラフィーにて精製し(ヘキサン/
酢酸エチル=3/1-1/1)、ジイソプロピルエーテ
ル-ヘキサンより結晶化して、目的物を得た。白色粉末
収量0.251g 収率75% mp 127-128℃; 1H-NMR (CDCl3, 300 MHz) δ 1.98-2.06
(2H, m), 2.20-2.26 (2H, m), 2.67-2.71 (2H, m), 3.
01 (1H, dd, J = 4.2 Hz, 15.9 Hz), 3.12 (1H,d, J =
3.9 Hz), 3.16 (1H, dd, J = 10.2 Hz, 16.2 Hz), 4.61
-4.70 (1H, m),5.02 (1H, t, J = 3.9 Hz), 6.00 (1H,
tt, J = 3.3 Hz, 52.5 Hz), 6.03 (1H,td, J = 5.6 Hz,
11.7 Hz), 6.11 (1H, s), 6.15 (1H, d, J = 8.7 Hz),
6.33 (1H, d, J = 11.7 Hz), 7.05-7.14 (4H, m), 7.1
6-7.22 (1H, m), 7.42 (2H, dd,J = 5.3 Hz, 8.9 Hz);
IR (KBr) 3289, 1640, 1514, 1449, 1188, 1146 cm-1;A
nal. Calcd for C26H23F5N2O4: C, 59.77; H, 4.44; N,
5.36. Found: C, 59.82; H, 4.48; N, 5.34.Example 320 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-[[3- (1,1,2,2-tetrafluoroethoxy) isoxazol-5-yl] methyl]
Ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1-[[3- (1,1,2,2-tetrafluoroethoxy) isoxazol-5-yl] methyl]
0.291 g of tert-butyl ethyl] carbamate
(0.643 mmol), a solution of 0.2 ml of concentrated hydrochloric acid in 5 ml of methanol was stirred for 0.5 hour at 60 ° C. The reaction was diluted with water, made alkaline with potassium carbonate and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and (1RS, 2SR) -2-
Amino-1- (4-fluorophenyl) -3- [3- (1,
The crude product of 1,2,2-tetrafluoroethoxy) isoxazol-5-yl] propan-1-ol was obtained as a white solid (0.227 g). The solid obtained above, 6,7
0.13 g (0.71 mmol) of 1-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid, 0.10 g (0.71 mmol) of 1-hydroxybenzotriazole hydrate were stirred in 10 ml of acetonitrile. 1-
0.14 g (0.71 mmol) of ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added,
Stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The resulting residue was purified by silica gel column chromatography (hexane / hexane).
Crystallization from ethyl acetate = 3 / 1-1 / 1) and diisopropyl ether / hexane gave the desired product. White powder Yield 0.251 g Yield 75% mp 127-128 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.98-2.06
(2H, m), 2.20-2.26 (2H, m), 2.67-2.71 (2H, m), 3.
01 (1H, dd, J = 4.2 Hz, 15.9 Hz), 3.12 (1H, d, J =
3.9 Hz), 3.16 (1H, dd, J = 10.2 Hz, 16.2 Hz), 4.61
-4.70 (1H, m), 5.02 (1H, t, J = 3.9 Hz), 6.00 (1H,
tt, J = 3.3 Hz, 52.5 Hz), 6.03 (1H, td, J = 5.6 Hz,
11.7 Hz), 6.11 (1H, s), 6.15 (1H, d, J = 8.7 Hz),
6.33 (1H, d, J = 11.7 Hz), 7.05-7.14 (4H, m), 7.1
6-7.22 (1H, m), 7.42 (2H, dd, J = 5.3 Hz, 8.9 Hz);
IR (KBr) 3289, 1640, 1514, 1449, 1188, 1146 cm -1 ; A
nal.Calcd for C 26 H 23 F 5 N 2 O 4 : C, 59.77; H, 4.44; N,
5.36. Found: C, 59.82; H, 4.48; N, 5.34.
【0453】実施例321 N-[(1RS,2SR)-2-[4-[(tert-ブト
キシカルボニル)アミノ]フェニル]-2-ヒドロキシ-
1-[3-(1,1,2,2-テトラフルオロエトキシ)
ベンジル]エチル]-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド 4-[(1RS,2SR)-2-[(6,7-ジヒドロ-5
H-ベンゾ[a]シクロヘプテン-1-イルカルボニル)
アミノ]-1-ヒドロキシ-3-[3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル]プロピル]安息香酸
3.283g(5.888ミリモル)のtert-ブチ
ルアルコール60ml溶液にトリエチルアミン1.23
ml(8.83ミリモル)、ジフェニルホスホリルアジ
ド1.78g(6.48ミリモル)を加え、80℃で2
日間撹拌した。溶媒を減圧留去し、得られた粗生成物を
シリカゲルカラムクロマトグラフィーにて精製し(ヘキ
サン−ヘキサン/酢酸エチル=1/1)、ジイソプロピ
ルエーテル-ヘキサンより結晶化して、目的物を得た。
白色粉末 収量2.714g 収率73% mp 153-156℃; 1H-NMR (CDCl3, 300 MHz) δ 1.52 (9H,
s), 1.95-2.03 (2H, m), 2.16-2.23 (2H, m), 2.66 (2
H, t, J = 5.7 Hz), 2.75 (1H, dd, J = 10.5 Hz, 14.4
Hz), 2.99 (1H, dd, J = 3.6 Hz, 14.4 Hz), 3.57 (1
H, d, J = 3.6 Hz), 4.65-4.75 (1H, m), 5.00 (1H, t,
J = 3.6 Hz), 5.74 (1H, d, J = 8.4 Hz),5.89 (1H, t
t, J = 2.9 Hz, 53.0 Hz), 5.91 (1H, td, J = 5.6 Hz,
11.4 Hz),6.22 (1H, d, J = 12.0 Hz), 6.52 (1H, s),
6.95-7.16 (6H, m), 7.30 (1H, t, J = 7.8 Hz), 7.38
(4H, s); IR (KBr) 3314, 1694, 1676, 1636, 1532, 1
314, 1211, 1161, 1115 cm-1; Anal. Calcd for C34H36
F4N2O5・DMF:C,63.33;H,6.18;N, 5.99. Found: C, 63.3
0; H, 6.07; N, 5.84.Example 321 N-[(1RS, 2SR) -2- [4-[(tert-butoxycarbonyl) amino] phenyl] -2-hydroxy-
1- [3- (1,1,2,2-tetrafluoroethoxy)
Benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 4-[(1RS, 2SR) -2-[(6,7-dihydro-5
H-benzo [a] cyclohepten-1-ylcarbonyl)
Triethylamine 1 was added to a solution of 3.283 g (5.888 mmol) of amino] -1-hydroxy-3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propyl] benzoic acid in 60 ml of tert-butyl alcohol. .23
ml (8.83 mmol) and 1.78 g (6.48 mmol) of diphenylphosphoryl azide.
Stirred for days. The solvent was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane-hexane / ethyl acetate = 1/1) and crystallized from diisopropyl ether-hexane to obtain the desired product.
White powder Yield 2.714g yield 73% mp 153-156 ℃; 1 H -NMR (CDCl 3, 300 MHz) δ 1.52 (9H,
s), 1.95-2.03 (2H, m), 2.16-2.23 (2H, m), 2.66 (2
H, t, J = 5.7 Hz), 2.75 (1H, dd, J = 10.5 Hz, 14.4
Hz), 2.99 (1H, dd, J = 3.6 Hz, 14.4 Hz), 3.57 (1
H, d, J = 3.6 Hz), 4.65-4.75 (1H, m), 5.00 (1H, t,
J = 3.6 Hz), 5.74 (1H, d, J = 8.4 Hz), 5.89 (1H, t
t, J = 2.9 Hz, 53.0 Hz), 5.91 (1H, td, J = 5.6 Hz,
11.4 Hz), 6.22 (1H, d, J = 12.0 Hz), 6.52 (1H, s),
6.95-7.16 (6H, m), 7.30 (1H, t, J = 7.8 Hz), 7.38
(4H, s); IR (KBr) 3314, 1694, 1676, 1636, 1532, 1
314, 1211, 1161, 1115 cm -1 ; Anal.Calcd for C 34 H 36
F 4 N 2 O 5・ DMF: C, 63.33; H, 6.18; N, 5.99. Found: C, 63.3
0; H, 6.07; N, 5.84.
【0454】実施例322 N-[(1RS,2SR)-2-(4-アミノフェニル)-
2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド N-[(1RS,2SR)-2-[4-[(tert-ブト
キシカルボニル)アミノ]フェニル]-2-ヒドロキシ-
1-[3-(1,1,2,2-テトラフルオロエトキシ)
ベンジル]エチル]-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド1.547g
(2.461ミリモル)、濃塩酸0.5mlのメタノー
ル10ml溶液を60℃で2時間撹拌した。反応液を水
で希釈し、炭酸カリウムでアルカリ性とし、酢酸エチル
で2回抽出した。集めた有機層を無水硫酸ナトリウムで
乾燥、溶媒を減圧留去した。得られた残留物をシリカゲ
ルカラムクロマトグラフィーにて精製し(ヘキサン/酢
酸エチル=1/1-1/3)、ジイソプロピルエーテル-
ヘキサンより結晶化して、目的物を得た。淡褐色粉末
収量0.150g 収率12% mp 153-155℃; 1H-NMR (CDCl3, 300 MHz) δ 1.94-2.03
(2H, m), 2.15-2.23 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.77 (1H, dd, J = 10.2 Hz, 14.7 Hz), 3.03 (1
H, dd, J = 4.2 Hz, 14.4 Hz), 3.19 (1H, d, J = 3.9
Hz), 3.70 (2H, brs), 4.65-4.74 (1H, m), 4.90 (1H,
t, J = 3.8 Hz), 5.71 (1H, d, J = 8.4 Hz), 5.89 (1
H, tt, J = 2.9 Hz, 53.1 Hz), 5.91 (1H, td, J = 5.3
Hz, 11.7 Hz), 6.20 (1H, d, J = 11.7 Hz), 6.69 (2
H, d, J = 8.1 Hz), 6.97 (1H, dd, J= 1.4 Hz, 7.7 H
z), 7.03-7.15 (5H, m), 7.21-7.32 (3H, m); IR (KBr)
3270,1642, 1518, 1275, 1198, 1125 cm-1; Anal. Cal
cd for C29H28F4N2O3: C, 65.90; H, 5.34; N, 5.30. F
ound: C, 65.68; H, 5.15; N, 5.02.Example 322 N-[(1RS, 2SR) -2- (4-aminophenyl)-
2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- [4-[(tert-butoxycarbonyl) amino] phenyl] -2-hydroxy-
1- [3- (1,1,2,2-tetrafluoroethoxy)
[Benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1.547 g
(2.461 mmol), a solution of 0.5 ml of concentrated hydrochloric acid in 10 ml of methanol was stirred at 60 ° C. for 2 hours. The reaction was diluted with water, made alkaline with potassium carbonate and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 1-1-1 / 3), and diisopropyl ether-
Crystallization from hexane gave the desired product. Light brown powder
Yield 0.150 g Yield 12% mp 153-155 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.94-2.03
(2H, m), 2.15-2.23 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.77 (1H, dd, J = 10.2 Hz, 14.7 Hz), 3.03 (1
H, dd, J = 4.2 Hz, 14.4 Hz), 3.19 (1H, d, J = 3.9
Hz), 3.70 (2H, brs), 4.65-4.74 (1H, m), 4.90 (1H,
t, J = 3.8 Hz), 5.71 (1H, d, J = 8.4 Hz), 5.89 (1
H, tt, J = 2.9 Hz, 53.1 Hz), 5.91 (1H, td, J = 5.3
Hz, 11.7 Hz), 6.20 (1H, d, J = 11.7 Hz), 6.69 (2
H, d, J = 8.1 Hz), 6.97 (1H, dd, J = 1.4 Hz, 7.7 H
z), 7.03-7.15 (5H, m), 7.21-7.32 (3H, m); IR (KBr)
3270,1642, 1518, 1275, 1198, 1125 cm -1 ; Anal.
cd for C 29 H 28 F 4 N 2 O 3 : C, 65.90; H, 5.34; N, 5.30. F
ound: C, 65.68; H, 5.15; N, 5.02.
【0455】実施例323 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-(3-イソプロピルベンジル)エチ
ル]-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテ
ン-1-カルボキサミド 1) 3-イソプロピルベンジルアルコール 粉末状マグネシウム3.33g(137ミリモル)、ヨ
ウ素1かけらをテトラヒドロフラン10ml中で撹拌し
ながら、3-イソプロピルブロモベンゼン10.91g
(54.80ミリモル)、1,2-ジブロモエタン1
0.3g(54.8ミリモル)のテトラヒドロフラン1
00ml溶液をゆっくりと滴下した。滴下終了後、70
℃で1時間撹拌した。この反応液を−78℃に冷却し、
砕いたドライアイス10gを注意して加え、反応液を撹
拌しながら徐々に室温まで昇温した。反応液を水で希釈
し、濃塩酸で酸性とした後、酢酸エチルで2回抽出し
た。集めた有機層の溶媒を減圧留去し、3-イソプロピ
ル安息香酸の粗生成物を黄色液体として得た。水素化リ
チウムアルミニウム3.12g(82.2ミリモル)の
テトラヒドロフラン100ml懸濁液に、氷冷下、上で
得た液体のテトラヒドロフラン50ml溶液を滴下し、
室温で1時間撹拌した。反応液を氷冷して、水3ml、
15%水酸化ナトリウム水溶液3ml、水7.5mlを
順次滴下して、過剰の水素化リチウムアルミニウムを分
解し、そのまま室温で1時間撹拌した。生じた沈殿をろ
過して除き、沈殿を酢酸エチルで洗浄した。集めた濾液
の溶媒を減圧留去した。得られた残留物をシリカゲルカ
ラムクロマトグラフィーにて精製して(ヘキサン/酢酸
エチル=6/1-3/1)、目的物を得た。黄色液体
収量5.610g 収率68%1 H-NMR (CDCl3, 200 MHz) δ 1.26 (6H, d, J = 7.0 H
z), 1.64 (1H, t, J = 5.9 Hz), 2.85-2.99 (1H, m),
4.68 (2H, d, J = 5.6 Hz), 7.15-7.34 (4H, m); IR (n
eat) 3320, 2961, 1464, 1017, 791, 704 cm-1 2) 3-(4-フルオロフェニル)-2-(3-イソプロ
ピルベンジル)-3-オキソプロピオン酸エチル 3-イソプロピルベンジルアルコール2.595g(1
7.27ミリモル)、トリエチルアミン3.61ml
(25.9ミリモル)の酢酸エチル30ml溶液に氷冷
下塩化メタンスルホニル2.37g(20.7ミリモ
ル)の酢酸エチル10ml溶液を滴下し、そのまま10
分間撹拌した。生じた沈殿を濾過して除き、沈殿を酢酸
エチルで洗浄した。集めた濾液の溶媒を減圧留去して、
メタンスルホン酸エステルの粗生成物を黄色液体として
得た。(4-フルオロベンゾイル)酢酸エチル3.63
g(17.3ミリモル)の1,2-ジメトキシエタン3
0ml溶液に氷冷下60%水素化ナトリウムの流動パラ
フィン懸濁物0.69g(17.3ミリモル)を加え、
そのまま0.5時間撹拌した。これに上で得たメタンス
ルホン酸エステルの1,2-ジメトキシエタン10ml
溶液を室温で加え、60℃で一晩撹拌した。反応液を水
に注ぎ、酢酸エチルで2回抽出した。集めた有機層を無
水硫酸マグネシウムで乾燥、溶媒を減圧留去した。得ら
れた残留物をシリカゲルカラムクロマトグラフィーにて
精製し(ヘキサン/酢酸エチル=9/1-6/1)、目
的物を得た。淡黄色液体 収量5.108g 収率86
%1 H-NMR (CDCl3, 200 MHz) δ 1.13 (3H, t, J = 7.2 H
z), 1.18 (6H, d, J = 7.0 Hz), 2.76-2.90 (1H, m),
3.30 (1H, d, J = 7.4 Hz), 3.31 (1H, d, J = 7.4Hz),
4.11 (2H, q, J = 7.1 Hz), 4.57 (1H, t, J = 7.3 H
z), 7.00-7.22 (6H,m), 7.96 (2H, dd, J = 5.4 Hz, 9.
0 Hz); IR (neat) 2961, 1738, 1688, 1599, 1507, 127
1, 1233, 1159 cm-1 3) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-(3-イソプロピルベンジル)
プロピオン酸エチル 塩化亜鉛3.99g(29.3ミリモル)をジエチルエ
ーテル30ml中で撹拌しながら水素化ホウ素ナトリウ
ム2.22g(58.6ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、3-(4-フルオ
ロフェニル)-2-(3-イソプロピルベンジル)-3-オ
キソプロピオン酸エチル5.016g(14.65ミリ
モル)のジエチルエーテル30ml溶液を氷冷下加え、
0℃で20分間撹拌した。反応液に希塩酸を少しずつ加
えて過剰の水素化ホウ素亜鉛を分解した後、酢酸エチル
で2回抽出した。集めた有機層を無水硫酸マグネシウム
で乾燥、溶媒を減圧留去した。得られた粗生成物をシリ
カゲルカラムクロマトグラフィーにて精製し(ヘキサン
/酢酸エチル=6/1-3/1)、目的物を得た。無色
液体 収量4.166g 収率83%1 H-NMR (CDCl3, 300 MHz) δ 0.91 (3H, t, J = 7.2 H
z), 1.20 (6H, d, J = 7.2 Hz), 2.78-2.87 (1H, m),
2.91-3.00 (4H, m), 3.87 (2H, q, J = 7.2 Hz), 5.01
(1H, t, J = 3.3 Hz), 6.89-6.93 (2H, m), 7.02-7.08
(3H, m), 7.16 (1H,t, J = 7.5 Hz), 7.38 (2H, dd, J
= 5.7 Hz, 8.7 Hz); IR (neat) 3466, 2961, 1726, 171
3, 1605, 1510, 1375, 1225, 1179, 1157, 1032, 837 c
m-1 4) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-(3-イソプロピルベンジル)
プロピオン酸 (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-(3-イソプロピルベンジル)プロピオ
ン酸エチル4.166g(12.10ミリモル)、水酸
化ナトリウム0.97g(24.2ミリモル)、メタノ
ール30ml、水30ml、テトラヒドロフラン30m
lの混合物を、60℃で6時間撹拌した。反応液を濃
縮、水で希釈し、1規定塩酸で反応液を酸性にした後、
酢酸エチルで2回抽出した。集めた有機層を無水硫酸ナ
トリウムで乾燥、溶媒を減圧留去した。残留物をジイソ
プロピルエーテル-ヘキサンより結晶化して、目的物を
得た。白色結晶 収量3.208g 収率84% mp 102-104℃; 1H-NMR (CDCl3, 300 MHz) δ 1.19 (6H,
d, J = 6.9 Hz), 2.77-2.86 (1H, m), 2.89-3.07 (3H,
m), 5.04 (1H, d, J = 4.8 Hz), 6.88-6.91 (2H, m),
7.01-7.07 (3H, m), 7.15 (1H, t, J = 7.5 Hz), 7.36
(2H, dd, J = 5.6Hz, 8.6 Hz); IR (KBr) 3341, 3100-2
550, 1694, 1514, 1229, 1020, 837, 785, 702 cm-1; A
nal. Calcd for C19H21FO3: C, 72.13; H, 6.69. Foun
d: C, 72.02; H, 6.64. 5) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-(3-イソプロピルベンジル)-1,3-オキサ
ゾリジン-2-オン (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-(3-イソプロピルベンジル)プロピオ
ン酸2.982g(9.426ミリモル)のテトラヒド
ロフラン50ml溶液にトリエチルアミン1.58ml
(11.3ミリモル)、ジフェニルホスホリルアジド
2.85g(10.4ミリモル)を加え、65℃で一晩
撹拌した。反応液の溶媒を減圧留去し、得られた粗生成
物をシリカゲルカラムクロマトグラフィーにて精製し
(ヘキサン/酢酸エチル=3/1-1/1)、ジイソプ
ロピルエーテル-ヘキサンより結晶化して、目的物を得
た。白色結晶 収量2.680g 収率91% mp 153-154℃; 1H-NMR (CDCl3, 300 MHz) δ 1.21 (6H,
d, J = 6.9 Hz), 2.19(1H, dd, J = 10.8 Hz, 13.8 H
z), 2.28 (1H, dd, J = 4.1 Hz, 13.7 Hz), 2.77-2.91
(1H, m), 4.24 (1H, ddd, J = 3.7 Hz, 8.2 Hz, 11.2 H
z), 4.94 (1H, brs), 5.79 (1H, d, J = 8.1 Hz), 6.84
-6.87 (2H, m), 7.09-7.24 (4H, m), 7.38 (2H, dd, J
= 5.3 Hz, 8.6 Hz); IR (KBr) 3306, 2969, 1759, 172
3, 1701, 1510, 1424, 1225, 1078, 1007 cm-1; Anal.
Calcd for C19H20FNO2: C, 72.82;H, 6.43; N, 4.47. F
ound: C, 72.81; H, 6.60; N, 4.41. 6) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-(3-イソプロピルフェニル)プロパ
ン-1-オール (4RS,5SR)-5-(4-フルオロフェニル)-4-
(3-イソプロピルベンジル)-1,3-オキサゾリジン-
2-オン2.453g(7.828ミリモル)と水酸化
ナトリウム1.25g(31.3ミリモル)をエタノー
ル25ml-水1.5ml中で、3時間加熱還流した。
反応液を水で希釈し、酢酸エチルで2回抽出した。集め
た有機層を無水硫酸ナトリウムで乾燥、APS-シリカ
ゲルを通した後、溶媒を減圧留去した。残留物をジイソ
プロピルエーテル-ヘキサンより結晶化して、目的物を
得た。白色結晶 収量1.999g 収率89% mp 88-90℃; 1H-NMR (CDCl3, 300 MHz) δ 1.23 (6H,
d, J = 6.6 Hz), 2.30 (1H, dd, J = 10.4 Hz, 13.4 H
z), 2.77 (1H, dd, J = 3.3 Hz, 13.5 Hz), 2.82-2.91
(1H, m), 3.29 (1H, ddd, J = 3.3 Hz, 5.0 Hz, 10.4 H
z), 4.67 (1H, d, J= 5.1 Hz), 6.94-6.98 (2H, m), 7.
05-7.11 (3H, m), 7.22 (1H, t, J = 7.4 Hz), 7.38 (2
H, dd, J = 5.6 Hz, 8.6 Hz); IR (KBr) 3150-2780, 15
08, 1215, 1046, 980, 818, 710 cm-1; Anal. Calcd fo
r C18H22FNO: C, 75.23; H, 7.72; N, 4.87. Found: C,
75.33; H, 7.82; N, 4.78. 7) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-(3-イソプロピルベンジ
ル)エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-(3-イソプロピルフェニル)プロパン-1-
オール0.250g(0.870ミリモル)、6,7-
ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボ
ン酸0.16g(0.87ミリモル)、1-ヒドロキシ
ベンゾトリアゾール水和物0.13g(0.87ミリモ
ル)をアセトニトリル10ml中で撹拌しながら1-エ
チル-3-(3-ジメチルアミノプロピル)カルボジイミ
ド・塩酸塩0.17g(0.87ミリモル)を加え、室
温で一晩撹拌した。反応液を酢酸エチルに希釈し、炭酸
水素ナトリウム水溶液で洗浄、無水硫酸マグネシウムで
乾燥、シリカゲルを通した後、溶媒を減圧留去した。得
られた残留物をジイソプロピルエーテル-ヘキサンより
結晶化して、目的物を得た。白色結晶 収量0.330
g 収率83% mp 165-167℃; 1H-NMR (CDCl3, 300 MHz) δ 1.20 (6H,
d, J = 6.9 Hz), 1.94-2.03 (2H, m), 2.14-2.22 (2H,
m), 2.66 (2H, t, J = 5.9 Hz), 2.68 (1H, dd,J = 1
1.1 Hz, 14.1 Hz), 2.80-2.89 (1H, m), 2.99 (1H, dd,
J = 4.5 Hz, 14.1 Hz), 4.18 (1H, d, J = 3.9 Hz),
4.64-4.73 (1H, m), 5.02 (1H, t, J = 3.6Hz), 5.65
(1H, d, J = 7.5 Hz), 5.91 (1H, td, J = 5.6 Hz, 11.
2 Hz), 6.24(1H, d, J = 11.7 Hz), 6.89 (1H, dd, J =
0.9 Hz, 7.2 Hz), 6.98-7.15 (7H,m), 7.22 (1H, t, J
= 8.0 Hz), 7.43 (2H, dd, J = 5.4 Hz, 8.7 Hz); IR
(KBr) 3281, 2961, 2942, 1640, 1510, 1225, 833, 704
cm-1; Anal. Calcd for C3 0H32FNO2: C, 78.75; H, 7.
05; N, 3.06. Found: C, 78.66; H, 7.15; N, 2.98.Example 323 N-[(1RS, 2SR) -2- (4-fluorophenyl)
2-Hydroxy-1- (3-isopropylbenzyl) ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1) 3-isopropylbenzyl alcohol 3.33 g (137 mmol) of powdered magnesium While stirring 1 piece of iodine in 10 ml of tetrahydrofuran, 10.91 g of 3-isopropylbromobenzene
(54.80 mmol), 1,2-dibromoethane 1
0.3 g (54.8 mmol) of tetrahydrofuran 1
The 00 ml solution was slowly added dropwise. After dropping, 70
Stirred at C for 1 hour. The reaction was cooled to -78 ° C,
10 g of crushed dry ice was carefully added, and the reaction solution was gradually heated to room temperature while stirring. The reaction solution was diluted with water, acidified with concentrated hydrochloric acid, and extracted twice with ethyl acetate. The solvent of the collected organic layer was distilled off under reduced pressure to obtain a crude product of 3-isopropylbenzoic acid as a yellow liquid. To a suspension of 3.12 g (82.2 mmol) of lithium aluminum hydride in 100 ml of tetrahydrofuran was added dropwise a solution of the liquid obtained above in 50 ml of tetrahydrofuran under ice-cooling.
Stirred at room temperature for 1 hour. The reaction solution was cooled on ice and 3 ml of water was added.
Excess lithium aluminum hydride was decomposed by sequentially adding 3 ml of a 15% aqueous sodium hydroxide solution and 7.5 ml of water dropwise, and the mixture was stirred at room temperature for 1 hour. The resulting precipitate was removed by filtration, and the precipitate was washed with ethyl acetate. The solvent of the collected filtrate was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-3 / 1) to obtain the desired product. Yellow liquid
Yield 5.610 g Yield 68% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.26 (6H, d, J = 7.0 H)
z), 1.64 (1H, t, J = 5.9 Hz), 2.85-2.99 (1H, m),
4.68 (2H, d, J = 5.6 Hz), 7.15-7.34 (4H, m); IR (n
eat) 3320, 2961, 1464, 1017, 791, 704 cm -1 2) Ethyl 3- (4-fluorophenyl) -2- (3-isopropylbenzyl) -3-oxopropionate 2.595 g of 3-isopropylbenzyl alcohol (1
7.27 mmol), 3.61 ml of triethylamine
(25.9 mmol) of 30 ml of ethyl acetate was added dropwise with a solution of 2.37 g (20.7 mmol) of methanesulfonyl chloride in 10 ml of ethyl acetate under ice-cooling.
Stirred for minutes. The resulting precipitate was removed by filtration, and the precipitate was washed with ethyl acetate. The solvent of the collected filtrate was distilled off under reduced pressure,
The crude product of methanesulfonic acid ester was obtained as a yellow liquid. Ethyl (4-fluorobenzoyl) acetate 3.63
g (17.3 mmol) of 1,2-dimethoxyethane 3
0.69 g (17.3 mmol) of a liquid paraffin suspension of 60% sodium hydride was added to the 0 ml solution under ice cooling,
The mixture was stirred for 0.5 hours as it was. 10 ml of 1,2-dimethoxyethane of the methanesulfonate obtained above
The solution was added at room temperature and stirred at 60 ° C. overnight. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 9 / 1-6 / 1) to obtain the desired product. Light yellow liquid Yield 5.108 g Yield 86
% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.13 (3H, t, J = 7.2 H
z), 1.18 (6H, d, J = 7.0 Hz), 2.76-2.90 (1H, m),
3.30 (1H, d, J = 7.4 Hz), 3.31 (1H, d, J = 7.4 Hz),
4.11 (2H, q, J = 7.1 Hz), 4.57 (1H, t, J = 7.3 H
z), 7.00-7.22 (6H, m), 7.96 (2H, dd, J = 5.4 Hz, 9.
0 Hz); IR (neat) 2961, 1738, 1688, 1599, 1507, 127
1, 1233, 1159 cm -1 3 ) (2RS, 3RS) -3- (4- fluorophenyl) -3-hydroxy-2- (3-isopropyl-benzyl)
Ethyl propionate While stirring 3.99 g (29.3 mmol) of zinc chloride in 30 ml of diethyl ether, 2.22 g (58.6 mmol) of sodium borohydride was added at room temperature, and the mixture was stirred as it was for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. To the resulting solution, a solution of 5.016 g (14.65 mmol) of ethyl 3- (4-fluorophenyl) -2- (3-isopropylbenzyl) -3-oxopropionate in 30 ml of diethyl ether was added under ice-cooling.
Stirred at 0 ° C. for 20 minutes. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 6 / 1-3 / 1) to obtain the desired product. Colorless liquid Yield 4.166 g Yield 83% 1 H-NMR (CDCl 3 , 300 MHz) δ 0.91 (3H, t, J = 7.2 H)
z), 1.20 (6H, d, J = 7.2 Hz), 2.78-2.87 (1H, m),
2.91-3.00 (4H, m), 3.87 (2H, q, J = 7.2 Hz), 5.01
(1H, t, J = 3.3 Hz), 6.89-6.93 (2H, m), 7.02-7.08
(3H, m), 7.16 (1H, t, J = 7.5 Hz), 7.38 (2H, dd, J
= 5.7 Hz, 8.7 Hz); IR (neat) 3466, 2961, 1726, 171
3, 1605, 1510, 1375, 1225, 1179, 1157, 1032, 837 c
m - 14) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- (3-isopropylbenzyl)
Propionic acid (2RS, 3RS) -3- (4-fluorophenyl) -3-
Ethyl hydroxy-2- (3-isopropylbenzyl) propionate 4.166 g (12.10 mmol), sodium hydroxide 0.97 g (24.2 mmol), methanol 30 ml, water 30 ml, tetrahydrofuran 30 m
The mixture was stirred at 60 ° C. for 6 hours. The reaction mixture was concentrated, diluted with water, and acidified with 1N hydrochloric acid.
Extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 3.208 g Yield 84% mp 102-104 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.19 (6H,
d, J = 6.9 Hz), 2.77-2.86 (1H, m), 2.89-3.07 (3H,
m), 5.04 (1H, d, J = 4.8 Hz), 6.88-6.91 (2H, m),
7.01-7.07 (3H, m), 7.15 (1H, t, J = 7.5 Hz), 7.36
(2H, dd, J = 5.6Hz, 8.6 Hz); IR (KBr) 3341, 3100-2
550, 1694, 1514, 1229, 1020, 837, 785, 702 cm -1 ; A
nal.Calcd for C 19 H 21 FO 3 : C, 72.13; H, 6.69. Foun
d: C, 72.02; H, 6.64.5) (4RS, 5SR) -5- (4-fluorophenyl) -4- (3-isopropylbenzyl) -1,3-oxazolidin-2-one (2RS, 3RS) -3- (4-Fluorophenyl) -3-
1.58 ml of triethylamine was added to a solution of 2.982 g (9.426 mmol) of hydroxy-2- (3-isopropylbenzyl) propionic acid in 50 ml of tetrahydrofuran.
(11.3 mmol) and 2.85 g (10.4 mmol) of diphenylphosphoryl azide, and the mixture was stirred at 65 ° C. overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from diisopropyl ether / hexane. I got something. White crystal Yield 2.680 g Yield 91% mp 153-154 ° C .; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.21 (6H,
d, J = 6.9 Hz), 2.19 (1H, dd, J = 10.8 Hz, 13.8 H
z), 2.28 (1H, dd, J = 4.1 Hz, 13.7 Hz), 2.77-2.91
(1H, m), 4.24 (1H, ddd, J = 3.7 Hz, 8.2 Hz, 11.2 H
z), 4.94 (1H, brs), 5.79 (1H, d, J = 8.1 Hz), 6.84
-6.87 (2H, m), 7.09-7.24 (4H, m), 7.38 (2H, dd, J
= 5.3 Hz, 8.6 Hz); IR (KBr) 3306, 2969, 1759, 172
3, 1701, 1510, 1424, 1225, 1078, 1007 cm -1 ; Anal.
Calcd for C 19 H 20 FNO 2 :. C, 72.82; H, 6.43; N, 4.47 F
ound: C, 72.81; H, 6.60; N, 4.41.6) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (3-isopropylphenyl) propan-1-ol (4RS , 5SR) -5- (4-Fluorophenyl) -4-
(3-isopropylbenzyl) -1,3-oxazolidine-
2.453 g (7.828 mmol) of 2-one and 1.25 g (31.3 mmol) of sodium hydroxide were heated to reflux in 25 ml of ethanol-1.5 ml of water for 3 hours.
The reaction was diluted with water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, passed through APS-silica gel, and the solvent was distilled off under reduced pressure. The residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystal Yield 1.999 g Yield 89% mp 88-90 ° C .; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.23 (6H,
d, J = 6.6 Hz), 2.30 (1H, dd, J = 10.4 Hz, 13.4 H
z), 2.77 (1H, dd, J = 3.3 Hz, 13.5 Hz), 2.82-2.91
(1H, m), 3.29 (1H, ddd, J = 3.3 Hz, 5.0 Hz, 10.4 H
z), 4.67 (1H, d, J = 5.1 Hz), 6.94-6.98 (2H, m), 7.
05-7.11 (3H, m), 7.22 (1H, t, J = 7.4 Hz), 7.38 (2
H, dd, J = 5.6 Hz, 8.6 Hz); IR (KBr) 3150-2780, 15
08, 1215, 1046, 980, 818, 710 cm -1 ; Anal.Calcd fo
r C 18 H 22 FNO: C, 75.23; H, 7.72; N, 4.87. Found: C,
75.33; H, 7.82; N, 4.78.7) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- (3-isopropylbenzyl) ethyl] -6,7-dihydro -5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- (3-isopropylphenyl) propane-1-
All 0.250 g (0.870 mmol), 6,7-
0.16 g (0.87 mmol) of dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid and 0.13 g (0.87 mmol) of 1-hydroxybenzotriazole hydrate were added to 10 ml of acetonitrile while stirring. 0.17 g (0.87 mmol) of -ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.330
g Yield 83% mp 165-167 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.20 (6H,
d, J = 6.9 Hz), 1.94-2.03 (2H, m), 2.14-2.22 (2H,
m), 2.66 (2H, t, J = 5.9 Hz), 2.68 (1H, dd, J = 1
1.1 Hz, 14.1 Hz), 2.80-2.89 (1H, m), 2.99 (1H, dd,
J = 4.5 Hz, 14.1 Hz), 4.18 (1H, d, J = 3.9 Hz),
4.64-4.73 (1H, m), 5.02 (1H, t, J = 3.6Hz), 5.65
(1H, d, J = 7.5 Hz), 5.91 (1H, td, J = 5.6 Hz, 11.
2 Hz), 6.24 (1H, d, J = 11.7 Hz), 6.89 (1H, dd, J =
0.9 Hz, 7.2 Hz), 6.98-7.15 (7H, m), 7.22 (1H, t, J
= 8.0 Hz), 7.43 (2H, dd, J = 5.4 Hz, 8.7 Hz); IR
(KBr) 3281, 2961, 2942, 1640, 1510, 1225, 833, 704
cm -1 ; Anal.Calcd for C 3 0 H 32 FNO 2 : C, 78.75; H, 7.
05; N, 3.06. Found: C, 78.66; H, 7.15; N, 2.98.
【0456】実施例324 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-(3-イソプロピルベ
ンジル)エチル]ナフタレン-1-カルボキサミド(1R
S,2SR)-2-アミノ-1-(4-フルオロフェニル)-
3-(3-イソプロピルフェニル)プロパン-1-オール
0.250g(0.870ミリモル)、4-フルオロ-1
-ナフトエ酸0.17g(0.87ミリモル)、1-ヒド
ロキシベンゾトリアゾール水和物0.13g(0.87
ミリモル)をアセトニトリル10ml中で撹拌しながら
1-エチル-3-(3-ジメチルアミノプロピル)カルボジ
イミド・塩酸塩0.17g(0.87ミリモル)を加
え、室温で一晩撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物をジイソプロピルエーテル-ヘキ
サンより結晶化して、目的物を得た。白色結晶 収量
0.355g 収率89% mp 159-160℃; 1H-NMR (CDCl3, 300 MHz) δ 1.18 (3H,
d, J = 7.2 Hz), 1.19(3H, d, J = 7.2 Hz), 2.73 (1
H, dd, J = 11.1 Hz, 14.4 Hz), 2.80-2.89 (1H,m), 3.
06 (1H, dd, J = 4.2 Hz, 14.4 Hz), 4.02 (1H, d, J =
4.2 Hz), 4.74-4.83 (1H, m), 5.08 (1H, t, J = 3.9
Hz), 5.81 (1H, d, J = 7.8 Hz), 6.96 (1H, dd, J =
8.1 Hz, 9.9 Hz), 7.01-7.15 (6H, m), 7.25 (1H, t, J
= 7.5 Hz), 7.42-7.47 (3H, m), 7.54 (1H, t, J = 8.
1 Hz), 7.80 (1H, d, J = 8.4 Hz),8.07 (1H, d, J =
8.4 Hz); IR (KBr) 3272, 2965, 1640, 1626, 1601, 15
39,1512, 1329, 1264, 1229, 1051, 833, 760 cm-1; An
al. Calcd for C29H27F2NO2・0.1H2O: C, 75.50; H, 5.9
4; N, 3.04. Found: C, 75.24; H, 5.94; N, 3.44.Example 324 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- (3-isopropylbenzyl) ethyl] naphthalene-1-carboxamide (1R
S, 2SR) -2-Amino-1- (4-fluorophenyl)-
0.250 g (0.870 mmol) of 3- (3-isopropylphenyl) propan-1-ol, 4-fluoro-1
-Naphthoic acid 0.17 g (0.87 mmol), 1-hydroxybenzotriazole hydrate 0.13 g (0.87 g)
(Mmol) was added to 10 ml of acetonitrile while 0.17 g (0.87 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added thereto, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.355 g Yield 89% mp 159-160 ° C .; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.18 (3H,
d, J = 7.2 Hz), 1.19 (3H, d, J = 7.2 Hz), 2.73 (1
H, dd, J = 11.1 Hz, 14.4 Hz), 2.80-2.89 (1H, m), 3.
06 (1H, dd, J = 4.2 Hz, 14.4 Hz), 4.02 (1H, d, J =
4.2 Hz), 4.74-4.83 (1H, m), 5.08 (1H, t, J = 3.9
Hz), 5.81 (1H, d, J = 7.8 Hz), 6.96 (1H, dd, J =
8.1 Hz, 9.9 Hz), 7.01-7.15 (6H, m), 7.25 (1H, t, J
= 7.5 Hz), 7.42-7.47 (3H, m), 7.54 (1H, t, J = 8.
1 Hz), 7.80 (1H, d, J = 8.4 Hz), 8.07 (1H, d, J =
8.4 Hz); IR (KBr) 3272, 2965, 1640, 1626, 1601, 15
39,1512, 1329, 1264, 1229, 1051, 833, 760 cm -1 ; An
al. Calcd for C 29 H 27 F 2 NO 2・ 0.1H 2 O: C, 75.50; H, 5.9
4; N, 3.04. Found: C, 75.24; H, 5.94; N, 3.44.
【0457】実施例325 N-[(1RS,2SR)-2-(4-ホルミルフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]カルバミン酸ter
t-ブチル 1) (4RS,5SR)-5-[4-(ヒドロキシメチ
ル)フェニル]-4-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]-1,3-オキサゾリジン-2-
オン (4RS,5SR)-5-[4-(メトキシカルボニル)
フェニル]-4-[3-(1,1,2,2-テトラフルオロ
エトキシ)ベンジル]-1,3-オキサゾリジン-2-オン
1.518g(3.552ミリモル)と水素化ホウ素ナ
トリウム1.34g(35.5ミリモル)のメタノール
3ml-テトラヒドロフラン50ml溶液を6時間加熱
還流した。反応液を室温に冷却した後、希塩酸を少しず
つ加えて室温で0.5時間撹拌した後、酢酸エチルで2
回抽出した。集めた有機層を無水硫酸マグネシウムで乾
燥、溶媒を減圧留去した。得られた粗生成物をシリカゲ
ルカラムクロマトグラフィーにて精製し(ヘキサン/酢
酸エチル=1/1-1/2)、ジイソプロピルエーテル-
ヘキサンより結晶化して目的物を得た。白色結晶 収量
0.899g 収率63% mp 124-125℃; 1H-NMR (CDCl3, 300 MHz) δ 1.75 (1H,
t, J = 5.9 Hz), 2.26(1H, dd, J = 10.2 Hz, 13.8 H
z), 2.33 (1H, dd, J = 4.5 Hz, 13.8 Hz), 4.22-4.29
(1H, m), 4.75 (2H, d, J = 6.0 Hz), 4.94 (1H, br
s), 5.83 (1H, d, J= 8.1 Hz), 5.90 (1H, tt, J = 2.8
Hz, 53.0 Hz), 6.85 (1H, s), 6.96 (1H,d, J = 7.8 H
z), 7.10 (1H, dd, J = 1.1 Hz, 8.3 Hz), 7.31 (1H,
t, J = 8.0Hz), 7.37 (2H, d, J = 8.1 Hz), 7.45 (2H,
d, J = 8.4 Hz); IR (KBr) 3243,1746, 1208, 1123 cm
-1; Anal. Calcd for C19H17F4NO4: C, 57.15; H, 4.2
9; N, 3.51. Found: C, 56.95; H, 4.05; N, 3.40. 2) 4-[(4RS,5SR)-2-オキソ-4-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]-1,3-オキサゾリジン-5-イル]ベンズアルデヒ
ド 塩化オキザリル5.58g(44.0ミリモル)のテト
ラヒドロフラン100ml溶液に−78℃でジメチルス
ルホキシド6.24ml(88.0ミリモル)のテトラ
ヒドロフラン30ml溶液を滴下した。5分間撹拌した
後、(4RS,5SR)-5-[4-(ヒドロキシメチ
ル)フェニル]-4-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]-1,3-オキサゾリジン-2-
オン11.71g(29.32ミリモル)のテトラヒド
ロフラン50ml-ジクロロメタン70ml-ジメチルス
ルホキシド30ml溶液を−78℃で加え、15分間撹
拌した。これにトリエチルアミン24.5ml(176
ミリモル)を加え、室温まで昇温した。反応混合物を水
に注ぎ、酢酸エチルで2回抽出した。集めた有機層を無
水硫酸マグネシウムで乾燥、シリカゲルを通した後、溶
媒を減圧留去した。得られた粗生成物をジイソプロピル
エーテル-ヘキサンより結晶化して、目的物を得た。淡
黄色結晶 収量11.39g 収率98% mp 132-133℃; 1H-NMR (CDCl3, 300 MHz) δ 2.26 (1H,
dd, J = 9.9 Hz, 13.5Hz), 2.33 (1H, dd, J = 4.8 H
z, 13.8 Hz), 4.30-4.37 (1H, m), 5.10 (1H, brs), 5.
89 (1H, d, J = 8.1 Hz), 5.89 (1H, tt, J = 2.8 Hz,
53.1 Hz), 6.85(1H, s), 6.94 (1H, d, J = 7.8 Hz),
7.11 (1H, dd, J = 1.2 Hz, 8.1 Hz), 7.30 (1H, t, J
= 8.0 Hz), 7.57 (2H, d, J = 7.8 Hz), 7.96 (2H, d,
J = 8.4 Hz), 10.06 (1H, s); IR (KBr) 3243, 3144, 1
742, 1703, 1238, 1198, 1144, 1121, 1090 cm-1; Ana
l. Calcd for C19H15F4NO4: C, 57.44; H, 3.81; N, 3.
53.Found: C, 57.28; H, 3.87; N, 3.39. 3) (4RS,5SR)-5-(4-ホルミルフェニ
ル)-2-オキソ-4-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]-1,3-オキサゾリジン-3-
カルボン酸tert-ブチル 4-[(4RS,5SR)-2-オキソ-4-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]-1,
3-オキサゾリジン-5-イル]ベンズアルデヒド11.
29g(28.41ミリモル)、二炭酸ジ-tert-ブ
チル7.44g(34.1ミリモル)、4-N,N-ジメ
チルアミノピリジン0.35g(2.84ミリモル)の
アセトニトリル50ml溶液を室温で一晩撹拌した。反
応液の溶媒を減圧留去し、得られた残留物をシリカゲル
カラムクロマトグラフィーにて精製し(ヘキサン/酢酸
エチル=3/1-2/1)、酢酸エチル-ジイソプロピル
エーテル-ヘキサンより結晶化して、目的物を得た。白
色結晶 収量12.38g 収率88% mp 143-144℃; 1H-NMR (CDCl3, 300 MHz) δ 1.53 (9H,
s), 2.59 (1H, dd, J =8.9 Hz, 14.6 Hz), 2.94 (1H,
dd, J = 4.4 Hz, 14.3 Hz), 4.85-4.91 (1H, m), 5.75
(1H, d, J = 6.9 Hz), 5.84 (1H, tt, J = 2.9 Hz, 53.
1 Hz), 6.37 (1H, s), 6.60 (1H, d, J = 7.8 Hz), 6.9
4 (1H, dd, J = 1.4 Hz, 8.0 Hz), 7.05(1H, t, J = 8.
0 Hz), 7.34 (2H, d, J = 8.1 Hz), 7.77 (2H, d, J =
8.7 Hz),9.99 (1H, s); IR (KBr) 1804, 1690, 1364, 1
348, 1304, 1196, 1155, 1121,1092, 1061 cm-1; Anal.
Calcd for C24H23F4NO6: C, 57.95; H, 4.66; N, 2.8
2. Found: C, 57.88; H, 4.49; N, 2.71. 4) N-[(1RS,2SR)-2-(4-ホルミルフェ
ニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]カルバミン酸
tert-ブチル (4RS,5SR)-5-(4-ホルミルフェニル)-2-
オキソ-4-[3-(1,1,2,2-テトラフルオロエト
キシ)ベンジル]-1,3-オキサゾリジン-3-カルボン
酸tert-ブチル12.20g(24.53ミリモ
ル)のメタノール20ml-テトラヒドロフラン50m
l溶液に水酸化ナトリウム1.03g(25.8ミリモ
ル)のメタノール15ml溶液を氷冷下加え、室温で1
時間撹拌した。反応液を酢酸エチルに希釈し、水で洗
浄、無水硫酸マグネシウムで乾燥、シリカゲルを通した
後、溶媒を減圧留去した。得られた残留物を酢酸エチル
-ジイソプロピルエーテル-ヘキサンより結晶化して、目
的物を得た。白色結晶 収量8.681g 収率75% mp 140-142℃; 1H-NMR (CDCl3, 300 MHz) δ 1.36 (9H,
s), 2.75 (2H, d, J =7.5 Hz), 3.54 (1H, br s), 4.0
4-4.13 (1H, m), 4.63 (1H, br d, J = 8.1 Hz), 5.06
(1H, br s), 5.89 (1H, tt, J = 2.9 Hz, 53.0 Hz), 6.
94 (1H, s), 7.00 (1H, d, J = 7.8 Hz), 7.06 (1H, d
d, J = 1.4 Hz, 8.3 Hz), 7.26 (1H, t, J= 8.0 Hz),
7.59 (2H, d, J = 8.4 Hz), 7.90 (2H, d, J = 8.1 H
z), 10.03 (1H, s); IR (KBr) 3358, 1684, 1530, 127
7, 1211, 1169, 1125 cm-1; Anal. Calcd for C23H25F4
NO5・0.5H2O: C, 57.50; H, 5.45; N, 2.92. Found: C,
57.33;H, 5.27; N, 2.89.Example 325 N-[(1RS, 2SR) -2- (4-formylphenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] carbamic acid ter
t-butyl 1) (4RS, 5SR) -5- [4- (hydroxymethyl) phenyl] -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine- 2-
ON (4RS, 5SR) -5- [4- (methoxycarbonyl)
Phenyl] -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidin-2-one 1.518 g (3.552 mmol) and 1.34 g of sodium borohydride A solution of (35.5 mmol) in 3 ml of methanol-50 ml of tetrahydrofuran was heated to reflux for 6 hours. After the reaction solution was cooled to room temperature, dilute hydrochloric acid was added little by little, and the mixture was stirred at room temperature for 0.5 hour.
Extracted times. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 1 / 1-1 / 2), and diisopropyl ether-
Crystallization from hexane gave the desired product. White crystals Yield 0.899 g Yield 63% mp 124-125 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.75 (1H,
t, J = 5.9 Hz), 2.26 (1H, dd, J = 10.2 Hz, 13.8 H
z), 2.33 (1H, dd, J = 4.5 Hz, 13.8 Hz), 4.22-4.29
(1H, m), 4.75 (2H, d, J = 6.0 Hz), 4.94 (1H, br
s), 5.83 (1H, d, J = 8.1 Hz), 5.90 (1H, tt, J = 2.8
Hz, 53.0 Hz), 6.85 (1H, s), 6.96 (1H, d, J = 7.8 H
z), 7.10 (1H, dd, J = 1.1 Hz, 8.3 Hz), 7.31 (1H,
t, J = 8.0Hz), 7.37 (2H, d, J = 8.1 Hz), 7.45 (2H,
d, J = 8.4 Hz); IR (KBr) 3243,1746, 1208, 1123 cm
-1 ; Anal.Calcd for C 19 H 17 F 4 NO 4 : C, 57.15; H, 4.2
9; N, 3.51. Found: C, 56.95; H, 4.05; N, 3.40. 2) 4-[(4RS, 5SR) -2-oxo-4- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidin-5-yl] benzaldehyde To a solution of 5.58 g (44.0 mmol) of oxalyl chloride in 100 ml of tetrahydrofuran was added dimethylsulfoxide 6 at -78 ° C. A solution of .24 ml (88.0 mmol) in 30 ml of tetrahydrofuran was added dropwise. After stirring for 5 minutes, (4RS, 5SR) -5- [4- (hydroxymethyl) phenyl] -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine -2-
A solution of 11.71 g (29.32 mmol) of ON in 50 ml of tetrahydrofuran-70 ml of dichloromethane-30 ml of dimethylsulfoxide was added at -78 ° C, and the mixture was stirred for 15 minutes. 24.5 ml of triethylamine (176
Mmol) and the temperature was raised to room temperature. The reaction mixture was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained crude product was crystallized from diisopropyl ether-hexane to obtain the desired product. Pale yellow crystal yield 11.39 g yield 98% mp 132-133 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 2.26 (1H,
dd, J = 9.9 Hz, 13.5Hz), 2.33 (1H, dd, J = 4.8 H
z, 13.8 Hz), 4.30-4.37 (1H, m), 5.10 (1H, brs), 5.
89 (1H, d, J = 8.1 Hz), 5.89 (1H, tt, J = 2.8 Hz,
53.1 Hz), 6.85 (1H, s), 6.94 (1H, d, J = 7.8 Hz),
7.11 (1H, dd, J = 1.2 Hz, 8.1 Hz), 7.30 (1H, t, J
= 8.0 Hz), 7.57 (2H, d, J = 7.8 Hz), 7.96 (2H, d,
J = 8.4 Hz), 10.06 (1H, s); IR (KBr) 3243, 3144, 1
742, 1703, 1238, 1198, 1144, 1121, 1090 cm -1 ; Ana
. l Calcd for C 19 H 15 F 4 NO 4: C, 57.44; H, 3.81; N, 3.
53.Found: C, 57.28; H, 3.87; N, 3.39. 3) (4RS, 5SR) -5- (4-formylphenyl) -2-oxo-4- [3- (1,1,2,2 -Tetrafluoroethoxy) benzyl] -1,3-oxazolidine-3-
Tert-Butyl carboxylate 4-[(4RS, 5SR) -2-oxo-4- [3- (1,
1,2,2-tetrafluoroethoxy) benzyl] -1,
3-Oxazolidin-5-yl] benzaldehyde
A solution of 29 g (28.41 mmol), 7.44 g (34.1 mmol) of di-tert-butyl dicarbonate, 0.35 g (2.84 mmol) of 4-N, N-dimethylaminopyridine in 50 ml of acetonitrile at room temperature. Stirred overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-2 / 1), and crystallized from ethyl acetate-diisopropyl ether-hexane. The desired product was obtained. White crystal Yield 12.38 g Yield 88% mp 143-144 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.53 (9H,
s), 2.59 (1H, dd, J = 8.9 Hz, 14.6 Hz), 2.94 (1H,
dd, J = 4.4 Hz, 14.3 Hz), 4.85-4.91 (1H, m), 5.75
(1H, d, J = 6.9 Hz), 5.84 (1H, tt, J = 2.9 Hz, 53.
1 Hz), 6.37 (1H, s), 6.60 (1H, d, J = 7.8 Hz), 6.9
4 (1H, dd, J = 1.4 Hz, 8.0 Hz), 7.05 (1H, t, J = 8.
0 Hz), 7.34 (2H, d, J = 8.1 Hz), 7.77 (2H, d, J =
8.7 Hz), 9.99 (1H, s); IR (KBr) 1804, 1690, 1364, 1
348, 1304, 1196, 1155, 1121,1092, 1061 cm -1 ; Anal.
Calcd for C 24 H 23 F 4 NO 6 : C, 57.95; H, 4.66; N, 2.8
2. Found: C, 57.88; H, 4.49; N, 2.71.4) N-[(1RS, 2SR) -2- (4-formylphenyl) -2-hydroxy-1- [3- (1,1, Tert-Butyl 2,2-tetrafluoroethoxy) benzyl] ethyl] carbamate (4RS, 5SR) -5- (4-formylphenyl) -2-
Tert-Butyl oxo-4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine-3-carboxylate 12.20 g (24.53 mmol) of methanol 20 ml-tetrahydrofuran 50m
To this solution, a solution of 1.03 g (25.8 mmol) of sodium hydroxide in 15 ml of methanol was added under ice-cooling.
Stirred for hours. The reaction solution was diluted with ethyl acetate, washed with water, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The residue obtained is ethyl acetate
Crystallization from -diisopropyl ether-hexane gave the desired product. White crystals Yield 8.681 g Yield 75% mp 140-142 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.36 (9H,
s), 2.75 (2H, d, J = 7.5 Hz), 3.54 (1H, br s), 4.0
4-4.13 (1H, m), 4.63 (1H, br d, J = 8.1 Hz), 5.06
(1H, br s), 5.89 (1H, tt, J = 2.9 Hz, 53.0 Hz), 6.
94 (1H, s), 7.00 (1H, d, J = 7.8 Hz), 7.06 (1H, d
d, J = 1.4 Hz, 8.3 Hz), 7.26 (1H, t, J = 8.0 Hz),
7.59 (2H, d, J = 8.4 Hz), 7.90 (2H, d, J = 8.1 H
z), 10.03 (1H, s); IR (KBr) 3358, 1684, 1530, 127
7, 1211, 1169, 1125 cm -1 ; Anal.Calcd for C 23 H 25 F 4
NO 5・ 0.5H 2 O: C, 57.50; H, 5.45; N, 2.92. Found: C,
57.33; H, 5.27; N, 2.89.
【0458】実施例326 N-[(1RS,2SR)-2-(4-ホルミルフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド N-[(1RS,2SR)-2-(4-ホルミルフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]カルバミン酸ter
t-ブチル8.465g(17.96ミリモル)、トリ
フルオロ酢酸20mlのテトラヒドロフラン20ml溶
液を0.5時間50℃で撹拌した。反応液を減圧留去し
た後、水で希釈し、炭酸カリウムでアルカリ性とし、酢
酸エチルで2回抽出した。集めた有機層を無水硫酸ナト
リウムで乾燥、溶媒を減圧留去して褐色液体を得た。上
で得た液体、6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボン酸3.38g(18.0ミリモ
ル)、1-ヒドロキシベンゾトリアゾール水和物2.7
5g(18.0ミリモル)をアセトニトリル60ml中
で撹拌しながら1-エチル-3-(3-ジメチルアミノプロ
ピル)カルボジイミド・塩酸塩3.44g(18.0ミ
リモル)を加え、室温で3日間撹拌した。反応液を酢酸
エチルに希釈し、炭酸水素ナトリウム水溶液で洗浄、無
水硫酸マグネシウムで乾燥、溶媒を減圧留去した。得ら
れた残留物をシリカゲルカラムクロマトグラフィーにて
精製し(ヘキサン/酢酸エチル=2/1-3/2)、酢
酸エチル-ジイソプロピルエーテル-ヘキサンより結晶化
して、目的物を得た。白色結晶 収量4.388g 収
率45% mp 164-166℃; 1H-NMR (CDCl3, 300 MHz) δ 1.96-2.04
(2H, m), 2.15-2.22 (2H, m), 2.66 (2H, t, J = 6.0
Hz), 2.82 (1H, dd, J = 10.8 Hz, 14.4 Hz), 2.96 (1
H, dd, J = 4.4 Hz, 14.6 Hz), 3.96 (1H, d, J = 3.9
Hz), 4.65-4.74 (1H, m), 5.18 (1H, t, J = 3.8 Hz),
5.82 (1H, d, J = 7.8 Hz), 5.88 (1H, tt,J = 2.7 Hz,
53.0 Hz), 5.93 (1H, td, J = 5.7 Hz, 11.4 Hz), 6.2
3 (1H, d,J = 11.7 Hz), 6.97-7.11 (5H, m), 7.17 (1
H, d, J = 7.2 Hz), 7.30 (1H, t,J = 8.1 Hz), 7.66
(2H, d, J = 8.4 Hz), 7.91 (2H, d, J = 8.1 Hz), 10.
03 (1H, s); IR (KBr) 3503, 3252, 1694, 1636, 1537,
1285, 1190, 1107, 775 cm- 1; Anal. Calcd for C30H
27F4NO4: C, 66.54; H, 5.03; N, 2.59. Found: C, 66.
20; H, 5.00; N, 2.32.Example 326 N-[(1RS, 2SR) -2- (4-formylphenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- (4-formylphenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] carbamic acid ter
A solution of 8.465 g (17.96 mmol) of t-butyl and 20 ml of trifluoroacetic acid in 20 ml of tetrahydrofuran was stirred at 50 ° C. for 0.5 hour. After evaporating the reaction solution under reduced pressure, the solution was diluted with water, made alkaline with potassium carbonate, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain a brown liquid. 3.38 g (18.0 mmol) of the liquid obtained above, 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid, 1-hydroxybenzotriazole hydrate 2.7
While stirring 5 g (18.0 mmol) in 60 ml of acetonitrile, 3.44 g (18.0 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature for 3 days. . The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 2 / 1-3 / 2), and crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White crystals Yield 4.388 g Yield 45% mp 164-166 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.96-2.04
(2H, m), 2.15-2.22 (2H, m), 2.66 (2H, t, J = 6.0
Hz), 2.82 (1H, dd, J = 10.8 Hz, 14.4 Hz), 2.96 (1
H, dd, J = 4.4 Hz, 14.6 Hz), 3.96 (1H, d, J = 3.9
Hz), 4.65-4.74 (1H, m), 5.18 (1H, t, J = 3.8 Hz),
5.82 (1H, d, J = 7.8 Hz), 5.88 (1H, tt, J = 2.7 Hz,
53.0 Hz), 5.93 (1H, td, J = 5.7 Hz, 11.4 Hz), 6.2
3 (1H, d, J = 11.7 Hz), 6.97-7.11 (5H, m), 7.17 (1
H, d, J = 7.2 Hz), 7.30 (1H, t, J = 8.1 Hz), 7.66
(2H, d, J = 8.4 Hz), 7.91 (2H, d, J = 8.1 Hz), 10.
03 (1H, s); IR (KBr) 3503, 3252, 1694, 1636, 1537,
1285, 1190, 1107, 775 cm - 1 ; Anal.Calcd for C 30 H
27 F 4 NO 4 : C, 66.54; H, 5.03; N, 2.59. Found: C, 66.
20; H, 5.00; N, 2.32.
【0459】実施例327 N-[(1RS,2SR)-2-(4-ホルミルフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.300g(0.554ミリモル)、ピペリジン0.
11ml(1.1ミリモル)、酢酸0.06ml(1.
1ミリモル)のメタノール10ml溶液を室温で1時間
撹拌した後、シアノ水素化ほう素ナトリウム70mg
(1.1ミリモル)を室温で加え、室温で一晩撹拌し
た。反応混合物を炭酸水素ナトリウム水溶液に注ぎ、酢
酸エチルで2回抽出した。集めた有機層を無水硫酸マグ
ネシウムで乾燥、溶媒を減圧留去した。得られた残留物
をシリカゲルカラムクロマトグラフィーにて精製し(ヘ
キサン/酢酸エチル=3:2-クロロホルム/メタノー
ル=20/1)、ヘキサンより沈殿化して、3種の生成
物を得た。N-[(1RS,2SR)-2-ヒドロキシ-2
-[4-(ピペリジノメチル)フェニル]-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド 白色粉末 収量0.127g 収率38% mp 104-106℃; 1H-NMR (CDCl3, 300 MHz) δ 1.40-1.46
(2H, m), 1.53-1.60 (4H, m), 1.94-2.02 (2H, m), 2.
15-2.22 (2H, m), 2.37 (4H, br s), 2.65 (2H,t, J =
5.6 Hz), 2.79 (1H, dd, J = 10.7 Hz, 14.9 Hz), 3.00
(1H, dd, J = 4.5 Hz, 14.7 Hz), 3.46 (2H, s), 3.67
(1H, br s), 4.68-4.75 (1H, m), 5.01(1H, d, J = 3.
6 Hz), 5.81 (1H, d, J = 8.4 Hz), 5.88 (1H, tt, J =
2.7 Hz,53.1 Hz), 5.90 (1H, td, J = 5.1 Hz, 12.3 H
z), 6.19 (1H, d, J = 12.0 Hz), 6.95 (1H, dd, J =
1.2 Hz, 7.8 Hz), 7.01-7.15 (5H, m), 7.26-7.33 (3H,
m), 7.39 (2H, d, J = 8.1 Hz); IR (KBr) 3258, 293
2, 1632, 1535, 1285, 1198, 1113 cm-1; Anal. Calcd
for C35H38F4N2O3・1.0H2O: C, 66.86; H, 6.41; N,4.4
6. Found: C, 66.55; H, 6.35; N, 4.54. N-[(1RS,2SR)-2-[4-[シアノ(ピペリジ
ノ)メチル]フェニル]-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド 白色粉末 収量35mg mp 152-154℃; 1H-NMR (CDCl3, 300 MHz) δ 1.43-1.67
(6H, m), 1.96-2.04 (2H, m), 2.16-2.22 (2H, m), 2.
51 (4H, br s), 2.66 (2H, t, J = 5.9 Hz), 2.74-2.84
(1H, m), 2.94-3.02 (1H, m), 3.78 (0.5H, d, J = 3.
9 Hz), 3.81 (0.5H, d, J = 4.2 Hz), 4.67-4.74 (1H,
m), 4.81 (1H, s), 5.06-5.93 (1H, m), 5.79-5.84 (1
H, m), 5.88-5.96 (1H, m), 5.89 (1H, tt, J = 2.9 H
z, 53.0 Hz),6.17-6.24 (1H, m), 6.94-7.17 (6H, m),
7.29 (1H, t, J = 7.8 Hz), 7.48 (2H, d, J = 8.7 H
z), 7.55 (2H, d, J = 8.4 Hz); IR (KBr) 3353, 2940,
1638,1522, 1202, 1121 cm-1; Anal. Calcd for C36H
37F4N3O3: C, 68.02; H, 5.87;N, 6.61. Found: C, 67.
81; H, 6.02; N, 6.54. N-[(1RS,2SR)-2-ヒドロキシ-2-[4-(ヒ
ドロキシメチル)フェニル]-1-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]エチル]-6,
7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カ
ルボキサミド 白色粉末 収量41g mp 151-152℃; 1H-NMR (CDCl3, 300 MHz) δ 1.75 (1H,
t, J = 5.7 Hz), 1.96-2.04 (2H, m), 2.16-2.22 (2H,
m), 2.66 (2H, t, J = 5.9 Hz), 2.78 (1H, dd,J = 1
0.8 Hz, 14.7 Hz), 2.99 (1H, dd, J = 4.1 Hz, 14.6 H
z), 3.61 (1H, d,J = 4.2 Hz), 4.68-4.75 (1H, m), 4.
71 (2H, d, J = 6.0 Hz), 5.06 (1H, t,J = 3.6 Hz),
5.77 (1H, d, J = 8.1 Hz), 5.89 (1H, tt, J = 2.9 H
z, 53.0 Hz), 5.91 (1H, td, J = 5.4 Hz, 11.7 Hz),
6.22 (1H, d, J = 11.4 Hz), 6.96-7.16 (6H, m), 7.29
(1H, t, J = 8.0 Hz), 7.38 (2H, d, J = 8.1 Hz), 7.
46 (2H, d, J = 7.8 Hz); IR (KBr) 3270, 2932, 1638,
1522, 1202, 1123 cm-1; Anal. Calcd for C30H29F4NO
4・0.1H2O: C, 66.07; H, 5.40; N, 2.57. Found: C, 6
5.88; H, 5.29; N, 2.47.Example 327 N-[(1RS, 2SR) -2- (4-formylphenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
0.300 g (0.554 mmol) of 5H-benzo [a] cycloheptene-1-carboxamide, piperidine 0.1.
11 ml (1.1 mmol), acetic acid 0.06 ml (1.
(1 mmol) in 10 ml of methanol was stirred at room temperature for 1 hour, and then 70 mg of sodium cyanoborohydride
(1.1 mmol) was added at room temperature and stirred at room temperature overnight. The reaction mixture was poured into aqueous sodium hydrogen carbonate solution and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3: 2-chloroform / methanol = 20/1), and precipitated from hexane to obtain three kinds of products. N-[(1RS, 2SR) -2-hydroxy-2
-[4- (Piperidinomethyl) phenyl] -1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide White powder Yield 0.127 g Yield 38% mp 104-106 ° C ; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.40-1.46
(2H, m), 1.53-1.60 (4H, m), 1.94-2.02 (2H, m), 2.
15-2.22 (2H, m), 2.37 (4H, br s), 2.65 (2H, t, J =
5.6 Hz), 2.79 (1H, dd, J = 10.7 Hz, 14.9 Hz), 3.00
(1H, dd, J = 4.5 Hz, 14.7 Hz), 3.46 (2H, s), 3.67
(1H, br s), 4.68-4.75 (1H, m), 5.01 (1H, d, J = 3.
6 Hz), 5.81 (1H, d, J = 8.4 Hz), 5.88 (1H, tt, J =
2.7 Hz, 53.1 Hz), 5.90 (1H, td, J = 5.1 Hz, 12.3 H
z), 6.19 (1H, d, J = 12.0 Hz), 6.95 (1H, dd, J =
1.2 Hz, 7.8 Hz), 7.01-7.15 (5H, m), 7.26-7.33 (3H,
m), 7.39 (2H, d, J = 8.1 Hz); IR (KBr) 3258, 293
2, 1632, 1535, 1285, 1198, 1113 cm -1 ; Anal.Calcd
for C 35 H 38 F 4 N 2 O 3・ 1.0H 2 O: C, 66.86; H, 6.41; N, 4.4
6. Found: C, 66.55; H, 6.35; N, 4.54. N-[(1RS, 2SR) -2- [4- [cyano (piperidino) methyl] phenyl] -2-hydroxy-1- [3-.
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide White powder Yield 35 mg mp 152-154 ° C .; 1 H-NMR ( (CDCl 3 , 300 MHz) δ 1.43-1.67
(6H, m), 1.96-2.04 (2H, m), 2.16-2.22 (2H, m), 2.
51 (4H, br s), 2.66 (2H, t, J = 5.9 Hz), 2.74-2.84
(1H, m), 2.94-3.02 (1H, m), 3.78 (0.5H, d, J = 3.
9 Hz), 3.81 (0.5H, d, J = 4.2 Hz), 4.67-4.74 (1H,
m), 4.81 (1H, s), 5.06-5.93 (1H, m), 5.79-5.84 (1
H, m), 5.88-5.96 (1H, m), 5.89 (1H, tt, J = 2.9 H
z, 53.0 Hz), 6.17-6.24 (1H, m), 6.94-7.17 (6H, m),
7.29 (1H, t, J = 7.8 Hz), 7.48 (2H, d, J = 8.7 H
z), 7.55 (2H, d, J = 8.4 Hz); IR (KBr) 3353, 2940,
1638,1522, 1202, 1121 cm -1 ; Anal.Calcd for C 36 H
37 F 4 N 3 O 3 : C, 68.02; H, 5.87; N, 6.61. Found: C, 67.
81; H, 6.02; N, 6.54. N-[(1RS, 2SR) -2-hydroxy-2- [4- (hydroxymethyl) phenyl] -1- [3- (1,1,2,
2-tetrafluoroethoxy) benzyl] ethyl] -6
7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide White powder Yield 41 g mp 151-152 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.75 (1H,
t, J = 5.7 Hz), 1.96-2.04 (2H, m), 2.16-2.22 (2H,
m), 2.66 (2H, t, J = 5.9 Hz), 2.78 (1H, dd, J = 1
0.8 Hz, 14.7 Hz), 2.99 (1H, dd, J = 4.1 Hz, 14.6 H
z), 3.61 (1H, d, J = 4.2 Hz), 4.68-4.75 (1H, m), 4.
71 (2H, d, J = 6.0 Hz), 5.06 (1H, t, J = 3.6 Hz),
5.77 (1H, d, J = 8.1 Hz), 5.89 (1H, tt, J = 2.9 H
z, 53.0 Hz), 5.91 (1H, td, J = 5.4 Hz, 11.7 Hz),
6.22 (1H, d, J = 11.4 Hz), 6.96-7.16 (6H, m), 7.29
(1H, t, J = 8.0 Hz), 7.38 (2H, d, J = 8.1 Hz), 7.
46 (2H, d, J = 7.8 Hz); IR (KBr) 3270, 2932, 1638,
1522, 1202, 1123 cm -1 ; Anal.Calcd for C 30 H 29 F 4 NO
4・ 0.1H 2 O: C, 66.07; H, 5.40; N, 2.57. Found: C, 6
5.88; H, 5.29; N, 2.47.
【0460】実施例328 N-[(1RS,2SR)-2-(6-クロロピリジン-3-
イル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]カルバミン酸
tert-ブチル 1) 3-(6-クロロピリジン-3-イル)-3-オキソ-
2-[3-(1,1,2,2-テトラフルオロエトキシ)
ベンジル]プロピオン酸エチル 3-(1,1,2,2-テトラフルオロエトキシ)ベンジ
ルアルコール10.5g(46.8ミリモル)、トリエ
チルアミン7.83ml(56.2ミリモル)の酢酸エ
チル80ml溶液に氷冷下塩化メタンスルホニル5.9
0g(51.5ミリモル)の酢酸エチル20ml溶液を
滴下し、そのまま10分間撹拌した。生じた沈殿を濾過
して除き、沈殿をジエチルエーテルで洗浄した。集めた
濾液の溶媒を減圧留去して、メタンスルホン酸エステル
の粗生成物を黄色液体として得た。3-(6-クロロピリ
ジン-3-イル)-3-オキソプロピオン酸エチル10.6
6g(46.83ミリモル)の1,2-ジメトキシエタ
ン100ml溶液に氷冷下60%水素化ナトリウムの流
動パラフィン懸濁物1.87g(46.8ミリモル)を
加え、そのまま0.5時間撹拌した。これに上で得たメ
タンスルホン酸エステルの1,2-ジメトキシエタン1
0ml溶液を室温で加え、60℃で一晩撹拌した。反応
液を水に注ぎ、酢酸エチルで2回抽出した。集めた有機
層を無水硫酸マグネシウムで乾燥、溶媒を減圧留去し
た。得られた残留物をシリカゲルカラムクロマトグラフ
ィーにて精製し(ヘキサン/酢酸エチル=9/1-6/
1)、目的物を得た。淡黄色液体 収量17.22g
収率85%1 H-NMR (CDCl3, 300 MHz) δ 1.14 (3H, t, J = 7.2 H
z), 3.36 (2H, d, J = 7.2 Hz), 4.12 (2H, q, J = 7.1
Hz), 4.52 (1H, t, J = 7.4 Hz), 5.89 (1H, t,J = 2.
8 Hz, 53.2 Hz), 7.05-7.07 (2H, m), 7.13 (1H, d, J
= 7.8 Hz), 7.29(1H, t, J = 8.3 Hz), 7.42 (1H, dd,
J = 0.8 Hz, 8.3 Hz), 8.16 (1H, dd, J= 2.6 Hz, 8.3
Hz), 8.92 (1H, dd, J = 0.8 Hz, 2.7 Hz); IR (neat)
1738, 1694, 1582, 1364, 1302, 1277, 1196, 1113 cm
-1 2) (2RS,3RS)-3-(6-クロロピリジン-3
-イル)-3-ヒドロキシ-2-[3-(1,1,2,2-テ
トラフルオロエトキシ)ベンジル]プロピオン酸エチル 塩化亜鉛10.8g(79.0ミリモル)をジエチルエ
ーテル50ml中で撹拌しながら水素化ホウ素ナトリウ
ム5.98g(158ミリモル)を室温で加え、そのま
ま2時間撹拌した。混合物の不溶物をろ過で除き(ジエ
チルエーテルで洗浄)、水素化ホウ素亜鉛のジエチルエ
ーテル溶液を得た。得られた溶液に、3-(6-クロロピ
リジン-3-イル)-3-オキソ-2-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]プロピオン酸
エチル17.14g(39.51ミリモル)のジエチル
エーテル50ml溶液を氷冷下で加え、そのまま20分
間撹拌した。反応液に希塩酸を少しずつ加えて過剰の水
素化ホウ素亜鉛を分解した後、酢酸エチルで2回抽出し
た。集めた有機層を無水硫酸マグネシウムで乾燥、溶媒
を減圧留去した。得られた粗生成物をシリカゲルカラム
クロマトグラフィーにて精製し(ヘキサン/酢酸エチル
=3/1-2/1)、目的物を得た。淡黄色液体 収量
13.52g 収率79%1 H-NMR (CDCl3, 300 MHz) δ 0.97 (3H, t, J = 7.1 H
z), 2.90-3.07 (3H, m),3.28 (1H, d, J = 3.0 Hz), 3.
93 (2H, q, J = 7.2 Hz), 5.10 (1H, t, J = 3.3Hz),
5.89 (1H, tt, J = 2.8 Hz, 53.2 Hz), 6.95 (1H, s),
6.98-7.07 (2H, m), 7.27 (1H, t, J = 7.8 Hz), 7.33
(1H, d, J = 8.4 Hz), 7.73 (1H, ddd, J= 0.5 Hz, 2.5
Hz, 8.3 Hz), 8.39 (1H, dd, J = 0.9 Hz, 2.1 Hz); I
R (neat)3353, 1728, 1588, 1460, 1375, 1302, 1279,
1198, 1119, 1026 cm-1 3) (2RS,3RS)-3-(6-クロロピリジン-3
-イル)-3-ヒドロキシ-2-[3-(1,1,2,2-テ
トラフルオロエトキシ)ベンジル]プロピオン酸 (2RS,3RS)-3-(6-クロロピリジン-3-イ
ル)-3-ヒドロキシ-2-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]プロピオン酸エチル1
3.52g(31.02ミリモル)、水酸化ナトリウム
2.48g(62.0ミリモル)、メタノール50m
l、テトラヒドロフラン20ml、水50mlの混合物
を室温で2時間撹拌した。反応液を濃縮、水で希釈し、
塩酸で反応液を酸性にした後、酢酸エチルで2回抽出し
た。集めた有機層を無水硫酸ナトリウムで乾燥、溶媒を
減圧留去した。残留物をジイソプロピルエーテル-ヘキ
サンより結晶化して、目的物を得た。淡黄色結晶 収量
11.32g 収率90% mp 88-91℃; 1H-NMR (CDCl3, 300 MHz) δ 2.92-3.11
(3H, m), 5.10 (1H, d, J= 4.5 Hz), 5.88 (1H, tt, J
= 2.9 Hz, 53.1 Hz), 6.99-7.10 (3H, m), 7.23(1H, t,
J = 7.8 Hz), 7.31 (1H, d, J = 8.1 Hz), 7.77 (1H,
dd, J = 2.4 Hz,8.4 Hz), 8.34 (1H, d, J = 2.4 Hz);
IR (KBr) 3364, 2900-2400, 1686, 1590, 1462, 1316,
1279, 1227, 1202, 1113, 1082 cm-1; Anal. Calcd for
C17H14ClF4NO4: C, 50.08; H, 3.46; N, 3.44. Found:
C, 50.01; H, 3.53; N, 3.42.4) (4RS,5S
R)-5-(6-クロロピリジン-3-イル)-4-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]-1,3-オキサゾリジン-2-オン (2RS,3RS)-3-(6-クロロピリジン-3-イ
ル)-3-ヒドロキシ-2-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]プロピオン酸10.94
g(26.83ミリモル)のテトラヒドロフラン80m
l溶液にトリエチルアミン4.49ml(32.2ミリ
モル)、ジフェニルホスホリルアジド8.12g(2
9.5ミリモル)を加え、65℃で一晩撹拌した。反応
液の溶媒を減圧留去し、得られた粗生成物をシリカゲル
カラムクロマトグラフィーにて精製し(ヘキサン/酢酸
エチル=3/1-1/1)、ジイソプロピルエーテル-ヘ
キサンより結晶化して、目的物を得た。白色結晶 収量
8.107g 収率75% mp 131-132℃; 1H-NMR (CDCl3, 300 MHz) δ 2.31 (1H,
dd, J = 10.5 Hz, 13.8Hz), 2.38 (1H, dd, J = 5.1 H
z, 13.8 Hz), 4.30-4.38 (1H, m), 5.23 (1H, s), 5.83
(1H, d, J = 7.8 Hz), 5.91 (1H, tt, J = 2.9 Hz, 5
3.0 Hz), 6.89 (1H, s), 6.93 (1H, d, J = 7.8 Hz),
7.13 (1H, d, J = 8.1 Hz), 7.32 (1H, t,J = 7.8 Hz),
7.42 (1H, d, J = 8.4 Hz), 7.71 (1H, dd, J = 2.4 H
z, 8.4 Hz), 8.39 (1H, d, J = 2.4 Hz); IR (KBr) 325
2, 1740, 1208, 1134, 1105, 758 cm-1; Anal. Calcd f
or C17H13ClF4N2O3: C, 50.45; H, 3.24; N, 6.92. Fou
nd:C, 50.41; H, 3.04; N, 6.95. 5) (4RS,5SR)-5-(6-クロロピリジン-3
-イル)-2-オキソ-4-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]-1,3-オキサゾリジン
-3-カルボン酸tert-ブチル (4RS,5SR)-5-(6-クロロピリジン-3-イ
ル)-4-[3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]-1,3-オキサゾリジン-2-オン7.8
89g(19.49ミリモル)、二炭酸ジ-tert-ブ
チル5.10g(23.4ミリモル)、4-N,N-ジメ
チルアミノピリジン0.24g(1.95ミリモル)の
アセトニトリル80ml溶液を室温で一晩撹拌した。反
応液の溶媒を減圧留去し、得られた残留物をシリカゲル
カラムクロマトグラフィーにて精製し(ヘキサン/酢酸
エチル=3/1-1/1)、ジイソプロピルエーテル-ヘ
キサンより結晶化して、目的物を得た。白色結晶 収量
9.444g 収率96% mp 130-131℃; 1H-NMR (CDCl3, 200 MHz) δ 1.54 (9H,
s), 2.58 (1H, dd, J =9.7 Hz, 14.5 Hz), 3.03 (1H,
dd, J = 4.2 Hz, 14.2 Hz), 4.83-4.93 (1H, m), 5.70
(1H, d, J = 7.0 Hz), 5.90 (1H, tt, J = 2.6 Hz, 53.
0 Hz), 6.52-6.57 (2H, m), 7.01 (1H, br d, J = 8.2
Hz), 7.11 (1H, d, J = 7.2 Hz), 7.19 (1H, d, J = 8.
4 Hz), 7.39 (1H, dd, J = 2.6 Hz, 8.4 Hz), 8.19 (1
H, d, J =1.8 Hz); IR (KBr) 2988, 1796, 1730, 1366,
1343, 1319, 1204, 1154, 1115,1074, 1024, 845, 760
cm-1; Anal. Calcd for C22H21ClF4N2O5: C, 52.34;
H,4.19; N, 5.55. Found: C, 52.27; H, 4.03; N, 5.3
5. 6) N-[(1RS,2SR)-2-(6-クロロピリジ
ン-3-イル)-2-ヒドロキシ-1-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]エチル]カル
バミン酸tert-ブチル (4RS,5SR)-5-(6-クロロピリジン-3-イ
ル)-2-オキソ-4-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]-1,3-オキサゾリジン-3-
カルボン酸tert-ブチル9.144g(18.11
ミリモル)のメタノール10ml-テトラヒドロフラン
50ml溶液に水酸化ナトリウム0.76g(19.0
ミリモル)のメタノール10ml溶液を氷冷下加え、室
温で10分間撹拌した。反応液を酢酸エチルに希釈し、
水で洗浄、無水硫酸マグネシウムで乾燥、シリカゲルを
通した後、溶媒を減圧留去した。得られた残留物を酢酸
エチル-ジイソプロピルエーテル-ヘキサンより結晶化し
て、目的物を得た。白色結晶 収量8.441g 収率
97% mp 119-121℃; 1H-NMR (CDCl3, 300 MHz) δ 1.36 (9H,
s), 2.70-2.85 (2H, m), 3.86 (1H, br s), 4.00-4.09
(1H, m), 4.55 (1H, d, J = 8.1 Hz), 4.95 (1H, s),
5.90 (1H, tt, J = 2.8 Hz, 53.1 Hz), 6.98 (1H, s),
7.03 (1H, d, J =7.8 Hz), 7.08 (1H, d, J = 7.8 Hz),
7.26-7.36 (2H, m), 7.73 (1H, dd, J =2.3 Hz, 8.0 H
z), 8.39 (1H, d, J = 1.8 Hz); IR (KBr) 3378, 3175,
2982, 1682, 1524, 1460, 1196, 1125, 1105 cm-1; An
al. Calcd for C21H23ClF4N2O4:C, 52.67; H, 4.84; N,
5.85. Found: C, 52.95; H, 4.88; N, 5.83.Example 328 N-[(1RS, 2SR) -2- (6-chloropyridine-3-
Tert-Butyl yl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] carbamate 1) 3- (6-chloropyridin-3-yl) -3 -Oxo-
2- [3- (1,1,2,2-tetrafluoroethoxy)
Benzyl] ethyl propionate 3- (1,1,2,2-tetrafluoroethoxy) benzyl alcohol 10.5 g (46.8 mmol) and triethylamine 7.83 ml (56.2 mmol) in 80 ml of ethyl acetate are ice-cooled. Methanesulfonyl chloride 5.9
A solution of 0 g (51.5 mmol) in 20 ml of ethyl acetate was added dropwise, and the mixture was stirred for 10 minutes. The resulting precipitate was removed by filtration, and the precipitate was washed with diethyl ether. The solvent of the collected filtrate was distilled off under reduced pressure to obtain a crude product of methanesulfonic acid ester as a yellow liquid. Ethyl 3- (6-chloropyridin-3-yl) -3-oxopropionate 10.6
To a solution of 6 g (46.83 mmol) in 1,2-dimethoxyethane (100 ml) was added 1.87 g (46.8 mmol) of a 60% sodium hydride liquid paraffin suspension under ice cooling, and the mixture was stirred for 0.5 hour. . The methanesulfonic acid ester of 1,2-dimethoxyethane 1 obtained above was added thereto.
0 ml solution was added at room temperature and stirred at 60 ° C. overnight. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 9 / 1-6 /
1) The desired product was obtained. 17.22g pale yellow liquid yield
Yield 85% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.14 (3H, t, J = 7.2 H
z), 3.36 (2H, d, J = 7.2 Hz), 4.12 (2H, q, J = 7.1
Hz), 4.52 (1H, t, J = 7.4 Hz), 5.89 (1H, t, J = 2.
8 Hz, 53.2 Hz), 7.05-7.07 (2H, m), 7.13 (1H, d, J
= 7.8 Hz), 7.29 (1H, t, J = 8.3 Hz), 7.42 (1H, dd,
J = 0.8 Hz, 8.3 Hz), 8.16 (1H, dd, J = 2.6 Hz, 8.3
Hz), 8.92 (1H, dd, J = 0.8 Hz, 2.7 Hz); IR (neat)
1738, 1694, 1582, 1364, 1302, 1277, 1196, 1113 cm
-1 2) (2RS, 3RS) -3- (6-chloropyridine-3)
Ethyl -yl) -3-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionate 10.8 g (79.0 mmol) of zinc chloride were stirred in 50 ml of diethyl ether. While stirring, 5.98 g (158 mmol) of sodium borohydride was added at room temperature, and the mixture was stirred for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. To the resulting solution was added 3- (6-chloropyridin-3-yl) -3-oxo-2- [3- (1,1,2,2
A solution of 17.14 g (39.51 mmol) of ethyl 2-tetrafluoroethoxy) benzyl] propionate in 50 ml of diethyl ether was added under ice-cooling, and the mixture was stirred for 20 minutes. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-2 / 1) to obtain the desired product. Light yellow liquid Yield 13.52 g Yield 79% 1 H-NMR (CDCl 3 , 300 MHz) δ 0.97 (3H, t, J = 7.1 H)
z), 2.90-3.07 (3H, m), 3.28 (1H, d, J = 3.0 Hz), 3.
93 (2H, q, J = 7.2 Hz), 5.10 (1H, t, J = 3.3Hz),
5.89 (1H, tt, J = 2.8 Hz, 53.2 Hz), 6.95 (1H, s),
6.98-7.07 (2H, m), 7.27 (1H, t, J = 7.8 Hz), 7.33
(1H, d, J = 8.4 Hz), 7.73 (1H, ddd, J = 0.5 Hz, 2.5
Hz, 8.3 Hz), 8.39 (1H, dd, J = 0.9 Hz, 2.1 Hz); I
R (neat) 3353, 1728, 1588, 1460, 1375, 1302, 1279,
1198, 1119, 1026 cm -1 3) (2RS, 3RS) -3- (6-chloropyridine-3)
-Yl) -3-Hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionic acid (2RS, 3RS) -3- (6-chloropyridin-3-yl) -3 Ethyl 2-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionate 1
3.52 g (31.02 mmol), sodium hydroxide 2.48 g (62.0 mmol), methanol 50 m
l, a mixture of 20 ml of tetrahydrofuran and 50 ml of water were stirred at room temperature for 2 hours. Concentrate the reaction, dilute with water,
After acidifying the reaction solution with hydrochloric acid, it was extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was crystallized from diisopropyl ether-hexane to obtain the desired product. Pale yellow crystal yield 11.32 g yield 90% mp 88-91 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 2.92-3.11
(3H, m), 5.10 (1H, d, J = 4.5 Hz), 5.88 (1H, tt, J
= 2.9 Hz, 53.1 Hz), 6.99-7.10 (3H, m), 7.23 (1H, t,
J = 7.8 Hz), 7.31 (1H, d, J = 8.1 Hz), 7.77 (1H,
dd, J = 2.4 Hz, 8.4 Hz), 8.34 (1H, d, J = 2.4 Hz);
IR (KBr) 3364, 2900-2400, 1686, 1590, 1462, 1316,
1279, 1227, 1202, 1113, 1082 cm -1 ; Anal.Calcd for
C 17 H 14 ClF 4 NO 4 : C, 50.08; H, 3.46; N, 3.44. Found:
C, 50.01; H, 3.53; N, 3.42.4) (4RS, 5S
R) -5- (6-Chloropyridin-3-yl) -4- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine-2-one (2RS, 3RS) -3- (6-chloropyridin-3-yl) -3-hydroxy-2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionic acid 10.94
g (26.83 mmol) of tetrahydrofuran 80m
4.49 ml (32.2 mmol) of triethylamine and 8.12 g of diphenylphosphoryl azide (2
9.5 mmol) and stirred at 65 ° C. overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from diisopropyl ether / hexane. I got something. White crystals Yield 8.107 g Yield 75% mp 131-132 ° C .; 1 H-NMR (CDCl 3 , 300 MHz) δ 2.31 (1H,
dd, J = 10.5 Hz, 13.8Hz), 2.38 (1H, dd, J = 5.1 H
z, 13.8 Hz), 4.30-4.38 (1H, m), 5.23 (1H, s), 5.83
(1H, d, J = 7.8 Hz), 5.91 (1H, tt, J = 2.9 Hz, 5
3.0 Hz), 6.89 (1H, s), 6.93 (1H, d, J = 7.8 Hz),
7.13 (1H, d, J = 8.1 Hz), 7.32 (1H, t, J = 7.8 Hz),
7.42 (1H, d, J = 8.4 Hz), 7.71 (1H, dd, J = 2.4 H
z, 8.4 Hz), 8.39 (1H, d, J = 2.4 Hz); IR (KBr) 325
2, 1740, 1208, 1134, 1105, 758 cm -1 ; Anal.Calcd f
or C 17 H 13 ClF 4 N 2 O 3 : C, 50.45; H, 3.24; N, 6.92. Fou
nd: C, 50.41; H, 3.04; N, 6.955.5) (4RS, 5SR) -5- (6-chloropyridine-3)
-Yl) -2-oxo-4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine
Tert-Butyl-3-carboxylate (4RS, 5SR) -5- (6-chloropyridin-3-yl) -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1, 3-Oxazolidin-2-one 7.8
A solution of 89 g (19.49 mmol), 5.10 g (23.4 mmol) of di-tert-butyl dicarbonate and 0.24 g (1.95 mmol) of 4-N, N-dimethylaminopyridine in 80 ml of acetonitrile at room temperature. Stirred overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from diisopropyl ether-hexane to give the desired product. I got White crystals Yield 9.444 g Yield 96% mp 130-131 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.54 (9H,
s), 2.58 (1H, dd, J = 9.7 Hz, 14.5 Hz), 3.03 (1H,
dd, J = 4.2 Hz, 14.2 Hz), 4.83-4.93 (1H, m), 5.70
(1H, d, J = 7.0 Hz), 5.90 (1H, tt, J = 2.6 Hz, 53.
0 Hz), 6.52-6.57 (2H, m), 7.01 (1H, br d, J = 8.2
Hz), 7.11 (1H, d, J = 7.2 Hz), 7.19 (1H, d, J = 8.
4 Hz), 7.39 (1H, dd, J = 2.6 Hz, 8.4 Hz), 8.19 (1
H, d, J = 1.8 Hz); IR (KBr) 2988, 1796, 1730, 1366,
1343, 1319, 1204, 1154, 1115,1074, 1024, 845, 760
cm -1 ; Anal.Calcd for C 22 H 21 ClF 4 N 2 O 5 : C, 52.34;
H, 4.19; N, 5.55.Found: C, 52.27; H, 4.03; N, 5.3
5.6) N-[(1RS, 2SR) -2- (6-chloropyridin-3-yl) -2-hydroxy-1- [3- (1,1,2,2
Tert-Butyl 2-tetrafluoroethoxy) benzyl] ethyl] carbamate (4RS, 5SR) -5- (6-chloropyridin-3-yl) -2-oxo-4- [3- (1,1,2,2 2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine-3-
9.144 g of tert-butyl carboxylate (18.11
0.76 g of sodium hydroxide (19.0 mmol) in a solution of 10 ml of methanol in 50 ml of tetrahydrofuran.
(Mmol) was added under ice-cooling, and the mixture was stirred at room temperature for 10 minutes. Dilute the reaction in ethyl acetate,
After washing with water, drying over anhydrous magnesium sulfate and passing through silica gel, the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White crystals Yield 8.441 g Yield 97% mp 119-121 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.36 (9H,
s), 2.70-2.85 (2H, m), 3.86 (1H, br s), 4.00-4.09
(1H, m), 4.55 (1H, d, J = 8.1 Hz), 4.95 (1H, s),
5.90 (1H, tt, J = 2.8 Hz, 53.1 Hz), 6.98 (1H, s),
7.03 (1H, d, J = 7.8 Hz), 7.08 (1H, d, J = 7.8 Hz),
7.26-7.36 (2H, m), 7.73 (1H, dd, J = 2.3 Hz, 8.0 H
z), 8.39 (1H, d, J = 1.8 Hz); IR (KBr) 3378, 3175,
2982, 1682, 1524, 1460, 1196, 1125, 1105 cm -1 ; An
al. Calcd for C 21 H 23 ClF 4 N 2 O 4 : C, 52.67; H, 4.84; N,
5.85. Found: C, 52.95; H, 4.88; N, 5.83.
【0461】実施例329 N-[(1RS,2SR)-2-(6-クロロピリジン-3-
イル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]-6,7-ジヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサ
ミド 1) (1RS,2SR)-2-アミノ-1-(6-クロロ
ピリジン-3-イル)-3-[3-(1,1,2,2-テトラ
フルオロエトキシ)フェニル]プロパン-1-オール N-[(1RS,2SR)-2-(6-クロロピリジン-3-
イル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]カルバミン酸
tert-ブチル8.196g(17.12ミリモル)
とトリフルオロ酢酸20mlの混合物を1時間室温で撹
拌した。反応液を減圧留去した後、水で希釈し、炭酸カ
リウムでアルカリ性とし、酢酸エチルで2回抽出した。
集めた有機層を無水硫酸ナトリウムで乾燥、APS-シ
リカゲルを通した後、溶媒を減圧留去した。得られた残
留物をジイソプロピルエーテル-ヘキサンより結晶化し
て、目的物を得た。白色結晶 収量6.118g 収率
94% mp 97-98℃; 1H-NMR (CDCl3, 300 MHz) δ 2.37 (1H, d
d, J = 10.4 Hz, 13.7 Hz), 2.70 (1H, dd, J = 3.2 H
z, 14.0 Hz), 3.34 (1H, ddd, J = 3.5 Hz, 4.2 Hz, 1
0.1 Hz), 3.58 (1H, br s), 4.75 (1H, d, J = 4.2 H
z), 5.90 (1H, tt, J= 2.9 Hz, 53.1 Hz), 6.98 (1H,
s), 7.04 (1H, d, J = 7.5 Hz), 7.09 (1H, d,J = 8.1
Hz), 7.31 (1H, t, J = 7.8 Hz), 7.36 (1H, d, J = 8.
1 Hz), 7.75 (1H, dd, J = 2.6 Hz, 8.3 Hz), 8.40 (1
H, d, J = 2.4 Hz); IR (KBr) 3358, 3065-2755, 1588,
1568, 1454, 1279, 1202, 1119, 1100, 1047 cm-1; An
al. Calcd for C16H15ClF4N2O2: C, 50.74; H, 3.99;
N, 7.40. Found: C, 50.60; H, 3.72; N, 7.13. 2) N-[(1RS,2SR)-2-(6-クロロピリジ
ン-3-イル)-2-ヒドロキシ-1-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]エチル]-6,
7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カ
ルボキサミド (1RS,2SR)-2-アミノ-1-(6-クロロピリジ
ン-3-イル)-3-[3-(1,1,2,2-テトラフルオ
ロエトキシ)フェニル]プロパン-1-オール1.000
g(2.640ミリモル)、6,7-ジヒドロ-5H-ベ
ンゾ[a]シクロヘプテン-1-カルボン酸0.50g
(2.64ミリモル)、1-ヒドロキシベンゾトリアゾ
ール水和物0.40g(2.64ミリモル)をアセトニ
トリル20ml中で撹拌しながら1-エチル-3-(3-ジ
メチルアミノプロピル)カルボジイミド・塩酸塩0.5
1g(2.64ミリモル)を加え、室温で一晩撹拌し
た。反応液を酢酸エチルに希釈し、炭酸水素ナトリウム
水溶液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲ
ルを通した後、溶媒を減圧留去した。得られた残留物を
ジイソプロピルエーテル-ヘキサンより結晶化して、目
的物を得た。白色結晶 収量1.311g 収率91% mp 170-172℃; 1H-NMR (CDCl3, 300 MHz) δ 1.96-2.05
(2H, m), 2.14-2.22 (2H, m), 2.66 (2H, t, J = 6.0
Hz), 2.79 (1H, dd, J = 11.0 Hz, 14.3 Hz), 3.01 (1
H, dd, J = 4.2 Hz, 14.4 Hz), 4.29 (1H, d, J = 3.9
Hz), 4.61-4.69 (1H, m), 5.08 (1H, t, J = 3.9 Hz),
5.76 (1H, d, J = 7.8 Hz), 5.90 (1H, tt,J = 2.8 Hz,
53.0 Hz), 5.94 (1H, td, J = 5.8 Hz, 11.7 Hz), 6.1
9 (1H, d,J = 11.4 Hz), 6.96 (1H, dd, J = 1.5 Hz,
7.8 Hz), 7.03-7.18 (5H, m), 7.33(1H, t, J = 8.0 H
z), 7.35 (1H, d, J = 8.1 Hz), 7.81 (1H, dd, J = 2.
4 Hz, 8.4 Hz), 8.42 (1H, d, J = 2.7 Hz); IR (KBr)
3247, 1634, 1530, 1462, 1277, 1198, 1121 cm-1; Ana
l. Calcd for C28H25ClF4N2O3: C, 61.26; H, 4.59;N,
5.10. Found: C, 61.32; H, 4.75; N, 5.07.Example 329 N-[(1RS, 2SR) -2- (6-chloropyridine-3-
Yl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1) ( 1RS, 2SR) -2-amino-1- (6-chloropyridin-3-yl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol N- [ (1RS, 2SR) -2- (6-chloropyridine-3-
8.196 g (17.12 mmol) of tert-butyl yl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] carbamate
And 20 ml of trifluoroacetic acid were stirred at room temperature for 1 hour. After evaporating the reaction solution under reduced pressure, the solution was diluted with water, made alkaline with potassium carbonate, and extracted twice with ethyl acetate.
The collected organic layer was dried over anhydrous sodium sulfate, passed through APS-silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystal Yield 6.118 g Yield 94% mp 97-98 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 2.37 (1H, d
d, J = 10.4 Hz, 13.7 Hz), 2.70 (1H, dd, J = 3.2 H
z, 14.0 Hz), 3.34 (1H, ddd, J = 3.5 Hz, 4.2 Hz, 1
0.1 Hz), 3.58 (1H, br s), 4.75 (1H, d, J = 4.2 H
z), 5.90 (1H, tt, J = 2.9 Hz, 53.1 Hz), 6.98 (1H,
s), 7.04 (1H, d, J = 7.5 Hz), 7.09 (1H, d, J = 8.1
Hz), 7.31 (1H, t, J = 7.8 Hz), 7.36 (1H, d, J = 8.
1 Hz), 7.75 (1H, dd, J = 2.6 Hz, 8.3 Hz), 8.40 (1
H, d, J = 2.4 Hz); IR (KBr) 3358, 3065-2755, 1588,
1568, 1454, 1279, 1202, 1119, 1100, 1047 cm -1 ; An
al. Calcd for C 16 H 15 ClF 4 N 2 O 2 : C, 50.74; H, 3.99;
N, 7.40. Found: C, 50.60; H, 3.72; N, 7.13.2) N-[(1RS, 2SR) -2- (6-chloropyridin-3-yl) -2-hydroxy-1- [3 -(1,1,2,
2-tetrafluoroethoxy) benzyl] ethyl] -6
7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (6-chloropyridin-3-yl) -3- [3- (1,1,2,2 2-tetrafluoroethoxy) phenyl] propan-1-ol 1.000
g (2.640 mmol), 0.50 g of 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid
(2.64 mmol) 1-Hydroxybenzotriazole hydrate 0.40 g (2.64 mmol) in 20 ml of acetonitrile while stirring 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 0 .5
1 g (2.64 mmol) was added and stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystal Yield 1.311 g Yield 91% mp 170-172 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.96-2.05
(2H, m), 2.14-2.22 (2H, m), 2.66 (2H, t, J = 6.0
Hz), 2.79 (1H, dd, J = 11.0 Hz, 14.3 Hz), 3.01 (1
H, dd, J = 4.2 Hz, 14.4 Hz), 4.29 (1H, d, J = 3.9
Hz), 4.61-4.69 (1H, m), 5.08 (1H, t, J = 3.9 Hz),
5.76 (1H, d, J = 7.8 Hz), 5.90 (1H, tt, J = 2.8 Hz,
53.0 Hz), 5.94 (1H, td, J = 5.8 Hz, 11.7 Hz), 6.1
9 (1H, d, J = 11.4 Hz), 6.96 (1H, dd, J = 1.5 Hz,
7.8 Hz), 7.03-7.18 (5H, m), 7.33 (1H, t, J = 8.0 H
z), 7.35 (1H, d, J = 8.1 Hz), 7.81 (1H, dd, J = 2.
4 Hz, 8.4 Hz), 8.42 (1H, d, J = 2.7 Hz); IR (KBr)
3247, 1634, 1530, 1462, 1277, 1198, 1121 cm -1 ; Ana
l. Calcd for C 28 H 25 ClF 4 N 2 O 3 : C, 61.26; H, 4.59; N,
5.10. Found: C, 61.32; H, 4.75; N, 5.07.
【0462】実施例330 N-[(1RS,2SR)-2-ヒドロキシ-2-(6-フェ
ニルピリジン-3-イル)-1-[3-(1,1,2,2-テ
トラフルオロエトキシ)ベンジル]エチル]-6,7-ジ
ヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキ
サミド N-[(1RS,2SR)-2-(6-クロロピリジン-3-
イル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]-6,7-ジヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサ
ミド0.523g(0.953ミリモル)、フェニルボ
ロン酸0.35g(2.86ミリモル)、テトラキス
(トリフェニルホスフィン)パラジウム(0)0.22
g(0.19ミリモル)と炭酸ナトリウム0.40g
(3.81ミリモル)をトルエン10ml-水10ml
中で、110℃で3日間撹拌した。反応液を水に注ぎ、
酢酸エチルで2回抽出した。集めた有機層を無水硫酸ナ
トリウムで乾燥、溶媒を減圧留去した。残留物をシリカ
ゲルカラムクロマトグラフィーにて精製し(ヘキサン/
酢酸エチル=3/1-1/1)、ジイソプロピルエーテ
ル-ヘキサンより結晶化して、目的物を得た。淡褐色粉
末 収量0.344g 収率61% mp 174-175℃; 1H-NMR (CDCl3, 300 MHz) δ 1.95-2.03
(2H, m), 2.14-2.20 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.82 (1H, dd, J = 10.7 Hz, 14.0 Hz), 3.07 (1
H, dd, J = 4.1 Hz, 14.9 Hz), 4.25 (1H, d, J = 3.9
Hz), 4.70-4.79 (1H, m), 5.12 (1H, t, J = 3.3 Hz),
5.79 (1H, d, J = 8.4 Hz), 5.89 (1H, tt,J = 2.7 Hz,
53.0 Hz), 5.91 (1H, td, J = 5.5 Hz, 11.4 Hz), 6.2
1 (1H, d,J = 11.7 Hz), 6.98 (1H, dd, J = 1.0 Hz,
7.5 Hz), 7.03-7.17 (5H, m), 7.32(1H, t, J = 8.0 H
z), 7.40-7.52 (3H, m), 7.75 (1H, d, J = 8.1 Hz),
7.90(1H, dd, J = 2.3 Hz, 8.3 Hz), 7.99 (2H, dd, J
= 2.1 Hz, 8.7 Hz), 8.70 (1H, d, J = 2.1 Hz); IR (K
Br) 3270, 2932, 1640, 1518, 1478, 1277, 1200, 112
3, 743, 694 cm-1; Anal. Calcd for C34H30F4N2O3: C,
69.14; H, 5.12; N, 4.74. Found: C, 69.04; H, 5.0
4; N, 4.71.Example 330 N-[(1RS, 2SR) -2-hydroxy-2- (6-phenylpyridin-3-yl) -1- [3- (1,1,2,2-tetrafluoroethoxy) Benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide N-[(1RS, 2SR) -2- (6-chloropyridine-3-
Il) -2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 0.523 g (0.953 mmol), phenylboronic acid 0.35 g (2.86 mmol), tetrakis (triphenylphosphine) palladium (0) 0.22
g (0.19 mmol) and 0.40 g of sodium carbonate
(3.81 mmol) in 10 ml of toluene and 10 ml of water
And stirred at 110 ° C. for 3 days. Pour the reaction into water,
Extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane /
Crystallization from ethyl acetate = 3 / 1-1 / 1) and diisopropyl ether / hexane gave the desired product. Light brown powder Yield 0.344 g Yield 61% mp 174-175 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.95-2.03
(2H, m), 2.14-2.20 (2H, m), 2.66 (2H, t, J = 5.9
Hz), 2.82 (1H, dd, J = 10.7 Hz, 14.0 Hz), 3.07 (1
H, dd, J = 4.1 Hz, 14.9 Hz), 4.25 (1H, d, J = 3.9
Hz), 4.70-4.79 (1H, m), 5.12 (1H, t, J = 3.3 Hz),
5.79 (1H, d, J = 8.4 Hz), 5.89 (1H, tt, J = 2.7 Hz,
53.0 Hz), 5.91 (1H, td, J = 5.5 Hz, 11.4 Hz), 6.2
1 (1H, d, J = 11.7 Hz), 6.98 (1H, dd, J = 1.0 Hz,
7.5 Hz), 7.03-7.17 (5H, m), 7.32 (1H, t, J = 8.0 H
z), 7.40-7.52 (3H, m), 7.75 (1H, d, J = 8.1 Hz),
7.90 (1H, dd, J = 2.3 Hz, 8.3 Hz), 7.99 (2H, dd, J
= 2.1 Hz, 8.7 Hz), 8.70 (1H, d, J = 2.1 Hz); IR (K
Br) 3270, 2932, 1640, 1518, 1478, 1277, 1200, 112
3, 743, 694 cm -1 ; Anal.Calcd for C 34 H 30 F 4 N 2 O 3 : C,
69.14; H, 5.12; N, 4.74. Found: C, 69.04; H, 5.0
4; N, 4.71.
【0463】実施例331 N-[(1RS,2SR)-2-(6-クロロピリジン-3-
イル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]-4-フルオロ
ナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(6-クロロピリジ
ン-3-イル)-3-[3-(1,1,2,2-テトラフルオ
ロエトキシ)フェニル]プロパン-1-オール1.000
g(2.640ミリモル)、4-フルオロ-1-ナフトエ
酸0.50g(2.64ミリモル)、1-ヒドロキシベ
ンゾトリアゾール水和物0.40g(2.64ミリモ
ル)をアセトニトリル20ml中で撹拌しながら1-エ
チル-3-(3-ジメチルアミノプロピル)カルボジイミ
ド・塩酸塩0.51g(2.64ミリモル)を加え、室
温で一晩撹拌した。反応液を酢酸エチルに希釈し、炭酸
水素ナトリウム水溶液で洗浄、無水硫酸マグネシウムで
乾燥、シリカゲルを通した後、溶媒を減圧留去した。得
られた残留物をジイソプロピルエーテル-ヘキサンより
結晶化して、目的物を得た。白色結晶 収量1.338
g 収率92% mp 185-187℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
2.91 (1H, dd, J = 10.8Hz, 14.1 Hz), 3.17 (1H, dd,
J = 3.8 Hz, 14.0 Hz), 4.68-4.78 (1H, m), 4.95 (1H,
t, J = 5.0 Hz), 5.61 (1H, d, J = 4.2 Hz), 6.00 (1
H, tt, J = 2.9 Hz, 53.0 Hz), 7.03 (1H, dd, J = 7.7
Hz, 10.1 Hz), 7.08-7.23 (4H, m), 7.29-7.38 (2H,
m), 7.42-7.56 (3H, m), 7.85 (1H, d, J = 9.3 Hz, 7.
93 (1H, dd,J = 2.4 Hz, 8.1 Hz), 8.05 (1H, d, J =
8.1 Hz), 8.49 (1H, d, J = 2.1 Hz); IR (KBr) 3291,
1638, 1624, 1539, 1456, 1196, 1125, 837, 766 cm-1;
Anal. Calcd for C27H20ClF5N2O3: C, 58.87; H, 3.6
6; N, 5.08. Found: C, 58.84;H, 3.59; N, 5.13.Example 331 N-[(1RS, 2SR) -2- (6-chloropyridine-3-
Yl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -4-fluoronaphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (6-chloropyridin-3-yl) -3- [3- (1,1,2,2-tetrafluoroethoxy) phenyl] propan-1-ol 1.000
g (2.640 mmol), 0.50 g (2.64 mmol) of 4-fluoro-1-naphthoic acid and 0.40 g (2.64 mmol) of 1-hydroxybenzotriazole hydrate were stirred in 20 ml of acetonitrile. While adding 0.51 g (2.64 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride, the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 1.338
g Yield 92% mp 185-187 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
2.91 (1H, dd, J = 10.8Hz, 14.1 Hz), 3.17 (1H, dd,
J = 3.8 Hz, 14.0 Hz), 4.68-4.78 (1H, m), 4.95 (1H,
t, J = 5.0 Hz), 5.61 (1H, d, J = 4.2 Hz), 6.00 (1
H, tt, J = 2.9 Hz, 53.0 Hz), 7.03 (1H, dd, J = 7.7
Hz, 10.1 Hz), 7.08-7.23 (4H, m), 7.29-7.38 (2H,
m), 7.42-7.56 (3H, m), 7.85 (1H, d, J = 9.3 Hz, 7.
93 (1H, dd, J = 2.4 Hz, 8.1 Hz), 8.05 (1H, d, J =
8.1 Hz), 8.49 (1H, d, J = 2.1 Hz); IR (KBr) 3291,
1638, 1624, 1539, 1456, 1196, 1125, 837, 766 cm -1 ;
. Anal Calcd for C 27 H 20 ClF 5 N 2 O 3: C, 58.87; H, 3.6
6; N, 5.08. Found: C, 58.84; H, 3.59; N, 5.13.
【0464】実施例332 4-フルオロ-N-[(1RS,2SR)-2-ヒドロキシ-
2-(6-フェニルピリジン-3-イル)-1-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]エチ
ル]ナフタレン-1-カルボキサミド N-[(1RS,2SR)-2-(6-クロロピリジン-3-
イル)-2-ヒドロキシ-1-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]エチル]-4-フルオロ
ナフタレン-1-カルボキサミド0.516g(0.93
7ミリモル)、フェニルボロン酸0.34g(2.81
ミリモル)、テトラキス(トリフェニルホスフィン)パ
ラジウム(0)0.22g(0.19ミリモル)と炭酸
ナトリウム0.40g(3.74ミリモル)をトルエン
10ml-水10ml中で、110℃で3日間撹拌し
た。反応液を水に注ぎ、酢酸エチルで2回抽出した。集
めた有機層を無水硫酸ナトリウムで乾燥、溶媒を減圧留
去した。残留物をシリカゲルカラムクロマトグラフィー
にて精製し(ヘキサン/酢酸エチル=3/1-酢酸エチ
ル)、ジイソプロピルエーテル-ヘキサンより結晶化し
て、目的物を得た。褐色非晶粉末 収量0.154g
収率28%1 H-NMR (CDCl3-DMSO-d6, 300 MHz) δ 2.95 (1H, dd, J
= 10.8 Hz, 14.4 Hz),3.10 (1H, dd, J = 3.6 Hz, 14.
1 Hz), 4.82-4.90 (1H, m), 5.12 (1H, t, J =3.9 Hz),
5.32 (1H, d, J = 3.9 Hz), 5.92 (1H, tt, J = 2.8 H
z, 53.1 Hz), 7.02 (1H, dd, J = 7.8 Hz, 10.2 Hz),
7.09 (1H, d, J = 7.8 Hz), 7.15 (1H, s), 7.19-7.53
(9H, m), 7.73 (1H, d, J = 9.0 Hz), 7.78 (1H, d, J
= 8.4 Hz), 7.97-8.07 (4H, m), 8.82 (1H, d, J = 2.4
Hz); IR (KBr) 3289, 1644, 1601, 1532, 1476, 1264,
1236, 1202, 1123, 758 cm-1; Anal. Calcd for C33H
25F5N2O3: C, 66.89; H, 4.25; N, 4.73. Found: C, 6
6.57; H, 4.13; N, 4.82.Example 332 4-Fluoro-N-[(1RS, 2SR) -2-hydroxy-
2- (6-phenylpyridin-3-yl) -1- [3- (1,
1,2,2-tetrafluoroethoxy) benzyl] ethyl] naphthalene-1-carboxamide N-[(1RS, 2SR) -2- (6-chloropyridine-3-
Yl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -4-fluoronaphthalene-1-carboxamide 0.516 g (0.93 g)
7 mmol), 0.34 g (2.81) of phenylboronic acid
Mmol), 0.22 g (0.19 mmol) of tetrakis (triphenylphosphine) palladium (0) and 0.40 g (3.74 mmol) of sodium carbonate were stirred at 110 ° C. for 3 days in 10 ml of toluene and 10 ml of water. . The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-ethyl acetate), and crystallized from diisopropyl ether-hexane to obtain the desired product. Brown amorphous powder Yield 0.154g
Yield 28% 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ 2.95 (1H, dd, J
= 10.8 Hz, 14.4 Hz), 3.10 (1H, dd, J = 3.6 Hz, 14.
1 Hz), 4.82-4.90 (1H, m), 5.12 (1H, t, J = 3.9 Hz),
5.32 (1H, d, J = 3.9 Hz), 5.92 (1H, tt, J = 2.8 H
z, 53.1 Hz), 7.02 (1H, dd, J = 7.8 Hz, 10.2 Hz),
7.09 (1H, d, J = 7.8 Hz), 7.15 (1H, s), 7.19-7.53
(9H, m), 7.73 (1H, d, J = 9.0 Hz), 7.78 (1H, d, J
= 8.4 Hz), 7.97-8.07 (4H, m), 8.82 (1H, d, J = 2.4
Hz); IR (KBr) 3289, 1644, 1601, 1532, 1476, 1264,
1236, 1202, 1123, 758 cm -1 ; Anal.Calcd for C 33 H
25 F 5 N 2 O 3 : C, 66.89; H, 4.25; N, 4.73. Found: C, 6
6.57; H, 4.13; N, 4.82.
【0465】実施例333 5-クロロ-N-[(1RS,2SR)-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-[3-(1,1,2,2-
テトラフルオロエトキシ)ベンジル]エチル]ナフタレ
ン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.200g
(0.554ミリモル)、5-クロロ-1-ナフトエ酸
0.11g(0.55ミリモル)、1-ヒドロキシベン
ゾトリアゾール水和物85mg(0.55ミリモル)を
アセトニトリル10ml中で撹拌しながら1-エチル-3
-(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩0.11g(0.55ミリモル)を加え、室温で一晩
撹拌した。反応液を酢酸エチルに希釈し、炭酸水素ナト
リウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、シ
リカゲルを通した後、溶媒を減圧留去した。得られた残
留物を酢酸エチル-ジイソプロピルエーテル-ヘキサンよ
り結晶化して、目的物を得た。白色粉末 収量0.25
8g 収率85% mp 174-175℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
2.87 (1H, dd, J = 10.7Hz, 14.9 Hz), 2.98 (1H, dd,
J = 4.7 Hz, 14.0 Hz), 4.64 (1H, d, J = 3.3 Hz), 4.
75-4.84 (1H, m), 5.06 (1H, t, J = 4.1 Hz), 5.90 (1
H, tt, J = 2.9 Hz, 53.3 Hz), 6.93 (1H, d, J = 9.3
Hz), 7.04-7.16 (5H, m), 7.26-7.32 (3H,m), 7.45-7.6
2 (5H, m), 8.31 (1H, d, J = 8.4 Hz); IR (KBr) 327
0, 1634, 1537, 1512, 1227, 1192, 1119, 785 cm-1; A
nal. Calcd for C28H21ClF5NO3: C,61.16; H, 3.85; N,
2.55. Found: C, 61.23; H, 3.86; N, 2.39.Example 333 5-Chloro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2,2-
Tetrafluoroethoxy) benzyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (1,1,2,2-tetrafluoroethoxy) Phenyl] propan-1-ol 0.200 g
(0.554 mmol) 5-chloro-1-naphthoic acid 0.11 g (0.55 mmol) 1-hydroxybenzotriazole hydrate 85 mg (0.55 mmol) in 10 ml of acetonitrile with stirring 1-. Ethyl-3
0.11 g (0.55 mmol) of-(3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White powder Yield 0.25
8g Yield 85% mp 174-175 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
2.87 (1H, dd, J = 10.7Hz, 14.9 Hz), 2.98 (1H, dd,
J = 4.7 Hz, 14.0 Hz), 4.64 (1H, d, J = 3.3 Hz), 4.
75-4.84 (1H, m), 5.06 (1H, t, J = 4.1 Hz), 5.90 (1
H, tt, J = 2.9 Hz, 53.3 Hz), 6.93 (1H, d, J = 9.3
Hz), 7.04-7.16 (5H, m), 7.26-7.32 (3H, m), 7.45-7.6
2 (5H, m), 8.31 (1H, d, J = 8.4 Hz); IR (KBr) 327
0, 1634, 1537, 1512, 1227, 1192, 1119, 785 cm -1 ; A
nal.Calcd for C 28 H 21 ClF 5 NO 3 : C, 61.16; H, 3.85; N,
2.55. Found: C, 61.23; H, 3.86; N, 2.39.
【0466】実施例334 5-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]エチル]ナフ
タレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(1,1,2,2-テトラフルオロエト
キシ)フェニル]プロパン-1-オール0.200g
(0.554ミリモル)、5-フルオロ-1-ナフトエ酸
0.11g(0.55ミリモル)、1-ヒドロキシベン
ゾトリアゾール水和物85mg(0.55ミリモル)を
アセトニトリル10ml中で撹拌しながら1-エチル-3
-(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩0.11g(0.55ミリモル)を加え、室温で一晩
撹拌した。反応液を酢酸エチルに希釈し、炭酸水素ナト
リウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、シ
リカゲルを通した後、溶媒を減圧留去した。得られた残
留物を酢酸エチル-ジイソプロピルエーテル-ヘキサンよ
り結晶化して、目的物を得た。白色粉末 収量0.24
0g 収率81% mp 178-180℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
2.89 (1H, dd, J = 10.7Hz, 14.6 Hz), 2.98 (1H, dd,
J = 4.5 Hz, 14.7 Hz), 4.73 (1H, d, J = 3.6 Hz), 4.
75-4.84 (1H, m), 5.07 (1H, t, J = 3.8 Hz), 5.90 (1
H, tt, J = 2.9 Hz, 53.1 Hz), 6.98 (1H, d, J = 9.0
Hz), 7.05-7.17 (6H, m), 7.26-7.35 (3H,m), 7.41-7.5
5 (4H, m), 8.12 (1H, d, J = 8.4 Hz); IR (KBr) 327
5, 1640, 1541, 1512, 1250, 1229, 1198, 1128, 785 c
m-1; Anal. Calcd for C28H21F6NO3: C, 63.04; H, 3.9
7; N, 2.63. Found: C, 63.09; H, 4.24; N, 2.56.Example 334 5-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2,2
2-tetrafluoroethoxy) benzyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (1,1,2,2-tetrafluoro Ethoxy) phenyl] propan-1-ol 0.200 g
(0.554 mmol) 5-fluoro-1-naphthoic acid 0.11 g (0.55 mmol), 1-hydroxybenzotriazole hydrate 85 mg (0.55 mmol) in 10 ml of acetonitrile with stirring. Ethyl-3
0.11 g (0.55 mmol) of-(3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White powder Yield 0.24
0 g Yield 81% mp 178-180 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
2.89 (1H, dd, J = 10.7Hz, 14.6 Hz), 2.98 (1H, dd,
J = 4.5 Hz, 14.7 Hz), 4.73 (1H, d, J = 3.6 Hz), 4.
75-4.84 (1H, m), 5.07 (1H, t, J = 3.8 Hz), 5.90 (1
H, tt, J = 2.9 Hz, 53.1 Hz), 6.98 (1H, d, J = 9.0
Hz), 7.05-7.17 (6H, m), 7.26-7.35 (3H, m), 7.41-7.5
5 (4H, m), 8.12 (1H, d, J = 8.4 Hz); IR (KBr) 327
5, 1640, 1541, 1512, 1250, 1229, 1198, 1128, 785 c
m -1 ; Anal.Calcd for C 28 H 21 F 6 NO 3 : C, 63.04; H, 3.9
7; N, 2.63. Found: C, 63.09; H, 4.24; N, 2.56.
【0467】実施例335 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(2,3,3-トリフルオロ-
1-プロペニル)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド 1) 2,2,3,3-テトラフルオロ-1-(3-メチル
フェニル)プロパン-1-オン マグネシウム14.1g(579ミリモル)、ヨウ素1
かけらをジエチルエーテル100ml中で撹拌しなが
ら、3-メチルブロモベンゼン90.0g(526ミリ
モル)のジエチルエーテル200ml溶液を室温でゆっ
くりと滴下し、滴下終了後、室温で一晩撹拌した。この
反応液を−78℃に冷却して2,2,3,3-テトラフ
ルオロプロピオン酸25.61g(175.4ミリモ
ル)のジエチルエーテル100ml溶液を滴下し、4時
間加熱還流した。反応液に氷冷下1規定塩酸を滴下し
た。ジエチルエーテル層を分離し、水層をジエチルエー
テルで抽出した。集めたジエチルエーテル溶液を無水硫
酸マグネシウムで乾燥、溶媒を減圧留去した。得られた
残留物をシリカゲルカラムクロマトグラフィーにて精製
して(ヘキサン-ヘキサン/酢酸エチル=15/1)、
目的物を得た。淡黄色液体 収量27.97g 収率7
2%1 H-NMR (CDCl3, 300 MHz) δ 2.45 (3H, s), 6.29 (1H,
tt, J = 5.5 Hz, 53.6Hz), 7.42 (1H, dt, J = 1.2 H
z, 7.4 Hz), 7.51 (1H, dd, J = 0.6 Hz, 7.8 Hz), 7.8
9-7.92 (2H, m); IR (neat) 1698, 1240, 1142, 1115,
1092, 789, 770,743 cm-1 2) 2,2,3,3-テトラフルオロ-1-(3-メチル
フェニル)プロパン-1-オール 2,2,3,3-テトラフルオロ-1-(3-メチルフェニ
ル)プロパン-1-オン9.11g(41.4ミリモル)
のメタノール50ml溶液に、氷冷下、水素化ほう素ナ
トリウム0.76g(20ミリモル)を少しずつ加えた
後、室温で1時間撹拌した。反応液を水で希釈し、酢酸
エチルで2回抽出した。集めた有機層を無水硫酸ナトリ
ウムで乾燥、溶媒を減圧留去した。残留物をシリカゲル
カラムクロマトグラフィーにて精製し(ヘキサン/酢酸
エチル=9/1-3/1)、目的物を得た。無色液体
収量6.131g 収率67%1 H-NMR (CDCl3, 200 MHz) δ 2.35 (1H, d, J = 4.8 H
z), 2.39 (3H, s), 4.95-5.10 (1H, m), 5.97 (1H, dd
t, J = 3.3 Hz, 8.1 Hz, 53.2 Hz), 7.21-7.36 (4H,
m); IR (neat) 3426, 1240, 1161, 1107, 1059, 762, 7
43 cm-1 3) チオ酢酸O-フェニルO-[2,2,3,3-テト
ラフルオロ-1-(3-メチルフェニル)プロピル] 2,2,3,3-テトラフルオロ-1-(3-メチルフェニ
ル)プロパン-1-オール3.814g(17.17ミリ
モル)とフェニルクロロチオノホルメート3.26g
(18.9ミリモル)のアセトニトリル40ml溶液に
4-N,N-ジメチルアミノピリジン4.62g(37.
8ミリモル)を氷冷下加え、室温で一晩撹拌した。生じ
た沈殿をろ過して除き、アセトニトリルで洗浄した。集
めたろ液の溶媒を減圧留去し、得られた粗生成物をシリ
カゲルカラムクロマトグラフィーにて精製し(ヘキサン
/酢酸エチル=9/1-6/1)、目的物を得た。無色
液体 収量6.189g 収率100%1 H-NMR (CDCl3, 300 MHz) δ 2.41 (3H, s), 5.89 (1H,
tt, J = 5.0 Hz, 53.0Hz), 6.56 (1H, dd, J = 10.7 H
z, 14.0 Hz), 7.08 (2H, d, J = 7.5 Hz), 7.21-7.49
(7H, m); IR (neat) 1591, 1489, 1279, 1211, 1127, 1
107, 1065, 774,689 cm-1 4) 1-メチル-3-(2,2,3,3-テトラフルオロ
プロピル)ベンゼン チオ酢酸O-フェニルO-[2,2,3,3-テトラフル
オロ-1-(3-メチルフェニル)プロピル]6.189
g(17.27ミリモル)、水素化トリブチルスズ7.
49g(25.7ミリモル)、2,2’-アゾビス(イ
ソブチロニトリル)0.56g(3.43ミリモル)の
ベンゼン50ml溶液を80℃で6時間撹拌した。反応
液を室温に冷却した後、溶媒を減圧留去した。得られた
残留物をシリカゲルカラムクロマトグラフィーにて精製
し(ヘキサン)、目的物を得た。無色液体 収量1.4
12g 収率40%1 H-NMR (CDCl3, 300 MHz) δ 2.36 (3H, s), 3.24 (2H,
t, J = 17.7 Hz), 5.69(1H, tt, J = 3.5 Hz, 53.7 H
z), 7.08-7.15 (3H, m), 7.23 (1H, d, J = 7.8Hz); IR
(neat) 1165, 1101, 1057 cm-1 5) 3-(4-フルオロフェニル)-2-[3-(2,
2,3,3-テトラフルオロプロピル)ベンジル]-3-
オキソプロピオン酸エチル 1-メチル-3-(2,2,3,3-テトラフルオロプロピ
ル)ベンゼン1.363g(6.611ミリモル)、N
-ブロモスクシンイミド1.18g(6.61ミリモ
ル)、2,2’-アゾビス(イソブチロニトリル)30
mgの四塩化炭素20ml溶液を1.5時間加熱還流し
た。反応液を室温に冷却した後、白色沈殿を濾過して除
き、沈殿をヘキサンで洗浄した。集めた濾液の溶媒を減
圧留去して、3-(2,2,3,3-テトラフルオロプロ
ピル)ベンジルブロミドの粗生成物を無色液体として得
た。(4-フルオロベンゾイル)酢酸エチル1.39g
(6.61ミリモル)の1,2-ジメトキシエタン30
ml溶液に氷冷下60%水素化ナトリウムの流動パラフ
ィン懸濁物0.26g(6.61ミリモル)を加え、そ
のまま0.5時間撹拌した。これに上で得た3-(2,
2,3,3-テトラフルオロプロピル)ベンジルブロミ
ドの1,2-ジメトキシエタン10ml溶液を室温で加
え、室温で一晩撹拌した。反応液を水に注ぎ、酢酸エチ
ルで2回抽出した。集めた有機層を無水硫酸マグネシウ
ムで乾燥、溶媒を減圧留去した。得られた残留物をシリ
カゲルカラムクロマトグラフィーにて精製し(ヘキサン
/酢酸エチル=15/1-9/1)、目的物を得た。黄
色液体 収量1.849g 収率68%1 H-NMR (CDCl3, 300 MHz) δ 1.12 (3H, t, J = 7.1 H
z), 3.22 (2H, t, J = 18.0 Hz), 3.32 (1H, d, J = 7.
5 Hz), 3.33 (1H, d, J = 7.2 Hz), 4.10 (2H, dq, J =
1.7 Hz, 7.2 Hz), 4.56 (1H, t, J = 7.7 Hz), 5.63
(1H, tt, J = 3.3 Hz, 53.6 Hz), 7.08-7.24 (6H, m),
7.97 (2H, dd, 5.6 Hz, 8.9 Hz); IR (neat)1738, 168
8, 1599, 1508, 1233, 1159, 1101, 849 cm-1 6) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[3-(2,2,3,3-テトラ
フルオロプロピル)ベンジル]プロピオン酸エチル塩化
亜鉛1.22g(8.92ミリモル)をジエチルエーテ
ル30ml中で撹拌しながら水素化ホウ素ナトリウム
0.68g(17.8ミリモル)を室温で加え、そのま
ま2時間撹拌した。混合物の不溶物をろ過で除き(ジエ
チルエーテルで洗浄)、水素化ホウ素亜鉛のジエチルエ
ーテル溶液を得た。得られた溶液に、3-(4-フルオロ
フェニル)-2-[3-(2,2,3,3-テトラフルオロ
プロピル)ベンジル]-3-オキソプロピオン酸エチル
1.849g(4.462ミリモル)のジエチルエーテ
ル20ml溶液を氷冷下で加え、そのまま20分間撹拌
した。反応液に希塩酸を少しずつ加えて過剰の水素化ホ
ウ素亜鉛を分解した後、酢酸エチルで2回抽出した。集
めた有機層を無水硫酸マグネシウムで乾燥、溶媒を減圧
留去した。得られた粗生成物をシリカゲルカラムクロマ
トグラフィーにて精製し(ヘキサン/酢酸エチル=3/
1)、目的物を得た。無色液体 収量1.378g 収
率74%1 H-NMR (CDCl3, 300 MHz) δ 0.91 (3H, t, J = 7.1 H
z), 2.92 (1H, d, J = 2.7 Hz), 2.98 (2H, s), 3.20
(2H, t, J = 17.9 Hz), 3.87 (2H, dq, J = 2.0 Hz, 7.
2 Hz), 5.01 (1H, t, J = 3.6 Hz), 5.66 (1H, tt, J =
3.3 Hz, 53.7 Hz),7.01-7.11 (5H, m), 7.22 (1H, t,
J = 7.5 Hz), 7.37 (2H, dd, J = 5.3 Hz,8.6 Hz); IR
(neat) 3445, 1715, 1607, 1512, 1375, 1346, 1223, 1
159, 1100,1057, 839 cm-1 7) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-[3-(2,2,3,3-テトラフルオロプロピ
ル)ベンジル]-1,3-オキサゾリジン-2-オン (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[3-(2,2,3,3-テトラフルオロ
プロピル)ベンジル]プロピオン酸エチル1.378g
(3.309ミリモル)、水酸化ナトリウム0.26g
(6.62ミリモル)、メタノール10ml、水5m
l、テトラヒドロフラン10mlの混合物を室温で一晩
撹拌した。反応液を濃縮、水で希釈し、1規定塩酸で反
応液を酸性にした後、酢酸エチルで2回抽出した。集め
た有機層を無水硫酸ナトリウムで乾燥、溶媒を減圧留去
して、(2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[3-(2,2,3,3-テトラ
フルオロプロピル)ベンジル]プロピオン酸の粗生成物
を液体として得た。上で得た液体のテトラヒドロフラン
30ml溶液にトリエチルアミン0.55ml(3.9
7ミリモル)、ジフェニルホスホリルアジド1.00g
(3.64ミリモル)を加え、65℃で一晩撹拌した。
反応液の溶媒を減圧留去し、得られた粗生成物をシリカ
ゲルカラムクロマトグラフィーにて精製し(ヘキサン/
酢酸エチル=3/1-1/1)、ジイソプロピルエーテ
ル-ヘキサンより結晶化して、目的物を得た。白色結晶
収量1.022g 収率80% mp 91-93℃; 1H-NMR (CDCl3, 300 MHz) δ 2.24 (1H, d
d, J = 10.1 Hz, 14.0 Hz), 2.31 (1H, dd, J = 4.8 H
z, 13.5 Hz), 3.22 (2H, t, J = 17.9 Hz), 4.21-4.28
(1H, m), 5.15 (1H, s), 5.72 (1H, tt, J = 3.0 Hz, 5
3.9 Hz), 5.79 (1H, d, J = 7.8 Hz), 6.95 (1H, s),
6.99 (1H, d, J = 7.8 Hz), 7.10-7.18 (3H,m), 7.28
(1H, t, J = 7.7 Hz), 7.36 (2H, dd, J = 5.1 Hz, 8.4
Hz); IR (KBr) 3241, 1757, 1740, 1512, 1343, 1223,
1167, 1094, 1051, 835, 712 cm-1;Anal. Calcd for C
19H16F5NO2: C, 59.22; H, 4.19; N, 3.63. Found: C,
59.20; H, 4.22; N, 3.66. 8) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-[3-(2,3,3-トリフルオロ-1-
プロペニル)フェニル]プロパン-1-オール (4RS,5SR)-5-(4-フルオロフェニル)-4-
[3-(2,2,3,3-テトラフルオロプロピル)ベン
ジル]-1,3-オキサゾリジン-2-オン0.880g
(2.284ミリモル)と水酸化ナトリウム0.37g
(9.14ミリモル)をエタノール10ml-水0.5
ml中で、3時間加熱還流した。反応液を水で希釈し、
酢酸エチルで2回抽出した。集めた有機層を無水硫酸ナ
トリウムで乾燥、APS-シリカゲルを通した後、溶媒
を減圧留去した。残留物を酢酸エチル-ジエチルエーテ
ル-ヘキサンより結晶化して、目的物を得た。白色結晶
収量0.462g 収率60% mp 98-99℃; 1H-NMR (CDCl3, 300 MHz) δ 2.36 (1H, d
d, J = 10.2 Hz, 13.5 Hz), 2.81 (1H, dd, J = 3.3 H
z, 13.8 Hz), 3.26-3.32 (1H, m), 4.67 (1H, d,J = 4.
8 Hz), 6.07 (1H, d, J = 37.2 Hz), 6.15 (1H, dt, J
= 7.2 Hz, 53.8 Hz), 7.05-7.14 (3H, m), 7.28-7.43
(5H, m); IR (KBr) 3100-2750, 1508, 1406, 1362, 122
3, 1103, 1042 cm-1; Anal. Calcd for C18H17F4NO: C,
63.71; H,5.05; N, 4.13. Found: C, 63.49; H, 5.07;
N, 4.12. 9) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[3-(2,3,3-トリフル
オロ-1-プロペニル)ベンジル]エチル]-6,7-ジヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサ
ミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(2,3,3-トリフルオロ-1-プロペ
ニル)フェニル]プロパン-1-オール0.100g
(0.295ミリモル)、6,7-ジヒドロ-5H-ベン
ゾ[a]シクロヘプテン-1-カルボン酸55mg(0.
29ミリモル)、1-ヒドロキシベンゾトリアゾール水
和物45mg(0.29ミリモル)をアセトニトリル1
0ml中で撹拌しながら1-エチル-3-(3-ジメチルア
ミノプロピル)カルボジイミド・塩酸塩56mg(0.
29ミリモル)を加え、室温で一晩撹拌した。反応液を
酢酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗
浄、無水硫酸マグネシウムで乾燥、シリカゲルを通した
後、溶媒を減圧留去した。得られた残留物をジイソプロ
ピルエーテル-ヘキサンより結晶化して、目的物を得
た。白色粉末 収量0.122g 収率81% mp 165-167℃; 1H-NMR (CDCl3, 300 MHz) δ 1.95-2.03
(2H, m), 2.16-2.22 (2H, m), 2.66 (2H, t, J = 6.2
Hz), 2.76 (1H, dd, J = 10.8 Hz, 14.7 Hz), 3.00 (1
H, dd, J = 4.4 Hz, 14.6 Hz), 3.69 (1H, d, J = 4.2
Hz), 4.64-4.73 (1H, m), 5.04 (1H, t, J = 3.9 Hz),
5.72 (1H, d, J = 8.1 Hz), 5.89 (1H, td,J = 5.6 Hz,
11.3 Hz), 6.06 (1H, d, J = 37.2 Hz), 6.14 (1H, d
t, J = 7.2Hz, 53.7 Hz), 6.17 (1H, d, J = 11.7 Hz),
6.97 (1H, dd, J = 1.5 Hz, 7.8 Hz), 7.03-7.19 (5H,
m), 7.29-7.34 (2H, m), 7.41-7.48 (3H, m); IR (KB
r) 3272, 2938, 1638, 1512, 1345, 1227, 1182, 1101,
1038, 772 cm-1; Anal. Calcd for C30H27F4NO2: C, 7
0.72; H, 5.34; N, 2.75. Found: C, 70.43; H, 5.26;
N, 2.71.Example 335 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (2,3,3-trifluoro-
1-propenyl) benzyl] ethyl] -6,7-dihydro-
5H-benzo [a] cyclohepten-1-carboxamide 1) 2,2,3,3-tetrafluoro-1- (3-methylphenyl) propan-1-one magnesium 14.1 g (579 mmol), iodine 1
While stirring the fragments in 100 ml of diethyl ether, a solution of 90.0 g (526 mmol) of 3-methylbromobenzene in 200 ml of diethyl ether was slowly added dropwise at room temperature. After completion of the addition, the mixture was stirred at room temperature overnight. The reaction solution was cooled to -78 ° C, a solution of 25.61 g (175.4 mmol) of 2,2,3,3-tetrafluoropropionic acid in 100 ml of diethyl ether was added dropwise, and the mixture was refluxed for 4 hours. 1N hydrochloric acid was added dropwise to the reaction solution under ice cooling. The diethyl ether layer was separated, and the aqueous layer was extracted with diethyl ether. The collected diethyl ether solution was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane-hexane / ethyl acetate = 15/1),
The desired product was obtained. Light yellow liquid Yield 27.97 g Yield 7
2% 1 H-NMR (CDCl 3 , 300 MHz) δ 2.45 (3H, s), 6.29 (1H,
tt, J = 5.5 Hz, 53.6Hz), 7.42 (1H, dt, J = 1.2 H
z, 7.4 Hz), 7.51 (1H, dd, J = 0.6 Hz, 7.8 Hz), 7.8
9-7.92 (2H, m); IR (neat) 1698, 1240, 1142, 1115,
1092, 789, 770,743 cm -1 2) 2,2,3,3-tetrafluoro-1- (3-methylphenyl) propan-1-ol 2,2,3,3-tetrafluoro-1- (3- 9.11 g (41.4 mmol) of methylphenyl) propan-1-one
Then, 0.76 g (20 mmol) of sodium borohydride was added little by little to a 50 ml solution of methanol under ice-cooling, followed by stirring at room temperature for 1 hour. The reaction was diluted with water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 9 / 1-3 / 1) to obtain the desired product. Colorless liquid
Yield 6.131 g Yield 67% 1 H-NMR (CDCl 3 , 200 MHz) δ 2.35 (1H, d, J = 4.8 H)
z), 2.39 (3H, s), 4.95-5.10 (1H, m), 5.97 (1H, dd
t, J = 3.3 Hz, 8.1 Hz, 53.2 Hz), 7.21-7.36 (4H,
m); IR (neat) 3426, 1240, 1161, 1107, 1059, 762, 7
43 cm -1 3) O-phenyl O- [2,2,3,3-tetrafluoro-1- (3-methylphenyl) propyl] thioacetate 2,2,3,3-tetrafluoro-1- (3 3.814 g (17.17 mmol) of -methylphenyl) propan-1-ol and 3.26 g of phenylchlorothionoformate
(18.9 mmol) in a solution of acetonitrile in 40 ml of 4.62 g of 4-N, N-dimethylaminopyridine (37.
(8 mmol) under ice-cooling and stirred at room temperature overnight. The resulting precipitate was removed by filtration and washed with acetonitrile. The solvent of the collected filtrate was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 9 / 1-6 / 1) to obtain the desired product. Colorless liquid Yield 6.189 g Yield 100% 1 H-NMR (CDCl 3 , 300 MHz) δ 2.41 (3H, s), 5.89 (1H,
tt, J = 5.0 Hz, 53.0Hz), 6.56 (1H, dd, J = 10.7 H
z, 14.0 Hz), 7.08 (2H, d, J = 7.5 Hz), 7.21-7.49
(7H, m); IR (neat) 1591, 1489, 1279, 1211, 1127, 1
107, 1065, 774,689 cm -1 4) 1-methyl-3- (2,2,3,3-tetrafluoropropyl) benzene O-phenyl O- [2,2,3,3-tetrafluoro-1 thioacetate -(3-Methylphenyl) propyl] 6.189
g (17.27 mmol), tributyltin hydride 7.
A solution of 49 g (25.7 mmol) and 0.56 g (3.43 mmol) of 2,2′-azobis (isobutyronitrile) in 50 ml of benzene was stirred at 80 ° C. for 6 hours. After cooling the reaction solution to room temperature, the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane) to obtain the desired product. Colorless liquid, yield 1.4
12 g Yield 40% 1 H-NMR (CDCl 3 , 300 MHz) δ 2.36 (3H, s), 3.24 (2H,
t, J = 17.7 Hz), 5.69 (1H, tt, J = 3.5 Hz, 53.7 H
z), 7.08-7.15 (3H, m), 7.23 (1H, d, J = 7.8Hz); IR
(neat) 1165, 1101, 1057 cm -15 ) 3- (4-fluorophenyl) -2- [3- (2,
2,3,3-tetrafluoropropyl) benzyl] -3-
Ethyl oxopropionate 1.363 g (6.611 mmol) of 1-methyl-3- (2,2,3,3-tetrafluoropropyl) benzene, N
-Bromosuccinimide 1.18 g (6.61 mmol), 2,2'-azobis (isobutyronitrile) 30
A solution of mg of carbon tetrachloride in 20 ml was heated to reflux for 1.5 hours. After cooling the reaction solution to room temperature, a white precipitate was removed by filtration, and the precipitate was washed with hexane. The solvent of the collected filtrate was distilled off under reduced pressure to obtain a crude product of 3- (2,2,3,3-tetrafluoropropyl) benzyl bromide as a colorless liquid. 1.39 g of ethyl (4-fluorobenzoyl) acetate
(6.61 mmol) of 1,2-dimethoxyethane 30
To the ml solution was added 0.26 g (6.61 mmol) of a 60% sodium hydride liquid paraffin suspension under ice cooling, and the mixture was stirred for 0.5 hour as it was. The 3- (2,
A solution of 2,3,3-tetrafluoropropyl) benzyl bromide in 10 ml of 1,2-dimethoxyethane was added at room temperature, and the mixture was stirred at room temperature overnight. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-9 / 1) to obtain the desired product. Yellow liquid Yield 1.849 g Yield 68% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.12 (3H, t, J = 7.1 H)
z), 3.22 (2H, t, J = 18.0 Hz), 3.32 (1H, d, J = 7.
5 Hz), 3.33 (1H, d, J = 7.2 Hz), 4.10 (2H, dq, J =
1.7 Hz, 7.2 Hz), 4.56 (1H, t, J = 7.7 Hz), 5.63
(1H, tt, J = 3.3 Hz, 53.6 Hz), 7.08-7.24 (6H, m),
7.97 (2H, dd, 5.6 Hz, 8.9 Hz); IR (neat) 1738, 168
8, 1599, 1508, 1233, 1159, 1101, 849 cm -1 6) (2RS, 3RS) -3- (4- fluorophenyl) -3-hydroxy-2- [3- (2,2,3,3 -Tetrafluoropropyl) benzyl] ethyl propionate Zinc chloride (1.22 g, 8.92 mmol) was stirred in diethyl ether (30 ml) while sodium borohydride (0.68 g, 17.8 mmol) was added at room temperature. Stirred for hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. 1.849 g (4.462 mmol) of ethyl 3- (4-fluorophenyl) -2- [3- (2,2,3,3-tetrafluoropropyl) benzyl] -3-oxopropionate was added to the resulting solution. ) In 20 ml of diethyl ether was added under ice-cooling, and the mixture was stirred for 20 minutes. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 /
1) The desired product was obtained. Colorless liquid Yield 1.378 g Yield 74% 1 H-NMR (CDCl 3 , 300 MHz) δ 0.91 (3H, t, J = 7.1 H)
z), 2.92 (1H, d, J = 2.7 Hz), 2.98 (2H, s), 3.20
(2H, t, J = 17.9 Hz), 3.87 (2H, dq, J = 2.0 Hz, 7.
2 Hz), 5.01 (1H, t, J = 3.6 Hz), 5.66 (1H, tt, J =
3.3 Hz, 53.7 Hz), 7.01-7.11 (5H, m), 7.22 (1H, t,
J = 7.5 Hz), 7.37 (2H, dd, J = 5.3 Hz, 8.6 Hz); IR
(neat) 3445, 1715, 1607, 1512, 1375, 1346, 1223, 1
159, 1100, 1057, 839 cm - 17 17) (4RS, 5SR) -5- (4-fluorophenyl) -4- [3- (2,2,3,3-tetrafluoropropyl) benzyl] -1, 3-oxazolidine-2-one (2RS, 3RS) -3- (4-fluorophenyl) -3-
1.378 g of ethyl hydroxy-2- [3- (2,2,3,3-tetrafluoropropyl) benzyl] propionate
(3.309 mmol), 0.26 g of sodium hydroxide
(6.62 mmol), 10 ml of methanol, 5 m of water
1 and a mixture of 10 ml of tetrahydrofuran were stirred at room temperature overnight. The reaction solution was concentrated, diluted with water, acidified with 1N hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- [3- (2,2,3, A crude product of [3-tetrafluoropropyl) benzyl] propionic acid was obtained as a liquid. To a solution of the liquid obtained above in 30 ml of tetrahydrofuran, 0.55 ml of triethylamine (3.9
7 mmol), 1.00 g of diphenylphosphoryl azide
(3.64 mmol) and stirred at 65 ° C. overnight.
The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / hexane).
Crystallization from ethyl acetate = 3 / 1-1 / 1) and diisopropyl ether / hexane gave the desired product. White crystals Yield 1.022 g Yield 80% mp 91-93 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 2.24 (1H, d
d, J = 10.1 Hz, 14.0 Hz), 2.31 (1H, dd, J = 4.8 H
z, 13.5 Hz), 3.22 (2H, t, J = 17.9 Hz), 4.21-4.28
(1H, m), 5.15 (1H, s), 5.72 (1H, tt, J = 3.0 Hz, 5
3.9 Hz), 5.79 (1H, d, J = 7.8 Hz), 6.95 (1H, s),
6.99 (1H, d, J = 7.8 Hz), 7.10-7.18 (3H, m), 7.28
(1H, t, J = 7.7 Hz), 7.36 (2H, dd, J = 5.1 Hz, 8.4
Hz); IR (KBr) 3241, 1757, 1740, 1512, 1343, 1223,
1167, 1094, 1051, 835, 712 cm -1 ; Anal.Calcd for C
19 H 16 F 5 NO 2 : C, 59.22; H, 4.19; N, 3.63. Found: C,
59.20; H, 4.22; N, 3.66.8) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (2,3,3-trifluoro-1-)
Propenyl) phenyl] propan-1-ol (4RS, 5SR) -5- (4-fluorophenyl) -4-
0.880 g of [3- (2,2,3,3-tetrafluoropropyl) benzyl] -1,3-oxazolidin-2-one
(2.284 mmol) and 0.37 g of sodium hydroxide
(9.14 mmol) in 10 ml ethanol-0.5 water
The mixture was heated under reflux for 3 hours. Dilute the reaction with water,
Extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, passed through APS-silica gel, and the solvent was distilled off under reduced pressure. The residue was crystallized from ethyl acetate-diethyl ether-hexane to obtain the desired product. White crystals Yield 0.462 g Yield 60% mp 98-99 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 2.36 (1H, d
d, J = 10.2 Hz, 13.5 Hz), 2.81 (1H, dd, J = 3.3 H
z, 13.8 Hz), 3.26-3.32 (1H, m), 4.67 (1H, d, J = 4.
8 Hz), 6.07 (1H, d, J = 37.2 Hz), 6.15 (1H, dt, J
= 7.2 Hz, 53.8 Hz), 7.05-7.14 (3H, m), 7.28-7.43
(5H, m); IR (KBr) 3100-2750, 1508, 1406, 1362, 122
3, 1103, 1042 cm -1 ; Anal.Calcd for C 18 H 17 F 4 NO: C,
63.71; H, 5.05; N, 4.13. Found: C, 63.49; H, 5.07;
N, 4.12.9) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (2,3,3-trifluoro-1-propenyl) benzyl] ethyl ] -6,7-Dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (2,3,3- 0.100 g of trifluoro-1-propenyl) phenyl] propan-1-ol
(0.295 mmol), 55 mg of 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (0.
29 mmol) 1-hydroxybenzotriazole hydrate (45 mg, 0.29 mmol) in acetonitrile 1
While stirring in 0 ml, 56 mg of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.
29 mmol) and stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White powder Yield 0.122 g Yield 81% mp 165-167 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.95-2.03
(2H, m), 2.16-2.22 (2H, m), 2.66 (2H, t, J = 6.2
Hz), 2.76 (1H, dd, J = 10.8 Hz, 14.7 Hz), 3.00 (1
H, dd, J = 4.4 Hz, 14.6 Hz), 3.69 (1H, d, J = 4.2
Hz), 4.64-4.73 (1H, m), 5.04 (1H, t, J = 3.9 Hz),
5.72 (1H, d, J = 8.1 Hz), 5.89 (1H, td, J = 5.6 Hz,
11.3 Hz), 6.06 (1H, d, J = 37.2 Hz), 6.14 (1H, d
t, J = 7.2Hz, 53.7 Hz), 6.17 (1H, d, J = 11.7 Hz),
6.97 (1H, dd, J = 1.5 Hz, 7.8 Hz), 7.03-7.19 (5H,
m), 7.29-7.34 (2H, m), 7.41-7.48 (3H, m); IR (KB
r) 3272, 2938, 1638, 1512, 1345, 1227, 1182, 1101,
. 1038, 772 cm -1; Anal Calcd for C 30 H 27 F 4 NO 2: C, 7
0.72; H, 5.34; N, 2.75. Found: C, 70.43; H, 5.26;
N, 2.71.
【0468】実施例336 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[3-(2,3,3-ト
リフルオロ-1-プロペニル)ベンジル]エチル]ナフタ
レン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(2,3,3-トリフルオロ-1-プロペ
ニル)フェニル]プロパン-1-オール0.100g
(0.295ミリモル)、4-フルオロ-1-ナフトエ酸
56mg(0.29ミリモル)、1-ヒドロキシベンゾ
トリアゾール水和物45mg(0.29ミリモル)をア
セトニトリル10ml中で撹拌しながら1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩56mg(0.29ミリモル)を加え、室温で一晩撹
拌した。反応液を酢酸エチルに希釈し、炭酸水素ナトリ
ウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、シリ
カゲルを通した後、溶媒を減圧留去した。得られた残留
物をジイソプロピルエーテル-ヘキサンより結晶化し
て、目的物を得た。白色粉末 収量0.122g 収率
81% mp 184-185℃; 1H-NMR (CDCl3, 300 MHz) δ 2.81 (1H,
dd, J = 10.7 Hz, 14.3Hz), 3.06 (1H, dd, J = 4.1 H
z, 14.6 Hz), 3.49 (1H, d, J = 3.3 Hz), 4.73-4.82
(1H, m), 5.10 (1H, t, J = 3.8 Hz), 5.89 (1H, d, J
= 8.1 Hz), 6.05(1H, d, J = 37.2 Hz), 6.12 (1H, dt,
J = 7.2 Hz, 53.7 Hz), 7.01 (1H, dd,J = 7.7 Hz, 1
0.1 Hz), 7.09 (2H, t, J = 8.6 Hz), 7.16-7.57 (9H,
m), 7.75(1H, d, J = 8.7 Hz), 8.08 (1H, d, J = 8.4
Hz); IR (KBr) 3275, 1642, 1512, 1229, 1051, 837, 7
60 cm-1; Anal. Calcd for C29H22F5NO2: C, 68.10; H,
4.34; N, 2.74. Found: C, 67.77; H, 4.19; N, 2.74.Example 336 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (2,3,3-trifluoro-1-propenyl) ) Benzyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (2,3,3-trifluoro-1-propenyl) phenyl] 0.100 g of propan-1-ol
(0.295 mmol) 56 mg (0.29 mmol) of 4-fluoro-1-naphthoic acid, 45 mg (0.29 mmol) of 1-hydroxybenzotriazole hydrate in 10 ml of acetonitrile with stirring in 1-ethyl- 3-
56 mg (0.29 mmol) of (3-dimethylaminopropyl) carbodiimide hydrochloride was added and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White powder Yield 0.122 g Yield 81% mp 184-185 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 2.81 (1H,
dd, J = 10.7 Hz, 14.3Hz), 3.06 (1H, dd, J = 4.1 H
z, 14.6 Hz), 3.49 (1H, d, J = 3.3 Hz), 4.73-4.82
(1H, m), 5.10 (1H, t, J = 3.8 Hz), 5.89 (1H, d, J
= 8.1 Hz), 6.05 (1H, d, J = 37.2 Hz), 6.12 (1H, dt,
J = 7.2 Hz, 53.7 Hz), 7.01 (1H, dd, J = 7.7 Hz, 1
0.1 Hz), 7.09 (2H, t, J = 8.6 Hz), 7.16-7.57 (9H,
m), 7.75 (1H, d, J = 8.7 Hz), 8.08 (1H, d, J = 8.4
Hz); IR (KBr) 3275, 1642, 1512, 1229, 1051, 837, 7
60 cm -1 ; Anal.Calcd for C 29 H 22 F 5 NO 2 : C, 68.10; H,
4.34; N, 2.74. Found: C, 67.77; H, 4.19; N, 2.74.
【0469】実施例337 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(2,2,3,3-テトラフル
オロプロピル)ベンジル]エチル]カルバミン酸ter
t-ブチル 1) (4RS,5SR)-5-(4-フルオロフェニ
ル)-2-オキソ-4-[3-(2,2,3,3-テトラフル
オロプロピル)ベンジル]-1,3-オキサゾリジン-3-
カルボン酸tert-ブチル (4RS,5SR)-5-(4-フルオロフェニル)-4-
[3-(2,2,3,3-テトラフルオロプロピル)ベン
ジル]-1,3-オキサゾリジン-2-オン2.368g
(6.145ミリモル)、二炭酸ジ-tert-ブチル
1.61g(7.37ミリモル)、4-N,N-ジメチル
アミノピリジン75mg(0.61ミリモル)のアセト
ニトリル30ml溶液を室温で一晩撹拌した。反応液の
溶媒を減圧留去し、得られた残留物をシリカゲルカラム
クロマトグラフィーにて精製し(ヘキサン/酢酸エチル
=3/1-1/1)、目的物を得た。淡黄色液体 収量
3.014g 収率100%1 H-NMR (CDCl3, 200 MHz) δ 1.51 (9H, s), 2.57 (1H,
dd, J = 9.0 Hz, 14.0Hz), 2.90 (1H, dd, J = 4.4 H
z, 14.4 Hz), 3.11 (2H, br t, J = 18.3 Hz), 4.77-4.
87 (1H, m), 5.67 (1H, d, J = 8.0 Hz), 5.69 (1H, t
t, J = 3.2 Hz, 53.8 Hz), 6.60-6.64 (2H, m), 6.93
(2H, t, J = 8.6 Hz), 7.03-7.16 (4H, m);IR (neat) 2
982, 1817, 1723, 1514, 1360, 1302, 1227, 1155, 110
1, 1067 cm- 1 2) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[3-(2,2,3,3-テト
ラフルオロプロピル)ベンジル]エチル]カルバミン酸
tert-ブチル (4RS,5SR)-5-(4-フルオロフェニル)-2-
オキソ-4-[3-(2,2,3,3-テトラフルオロプロ
ピル)ベンジル]-1,3-オキサゾリジン-3-カルボン
酸tert-ブチル3.014g(6.209ミリモ
ル)のテトラヒドロフラン30ml溶液に水酸化ナトリ
ウム0.26g(6.52ミリモル)のメタノール10
ml溶液を氷冷下加え、0℃で0.5時間撹拌した。反
応液を酢酸エチルに希釈し、水で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物を酢酸エチル-ジイソプロピルエ
ーテル-ヘキサンより結晶化して、目的物を得た。白色
結晶 収量2.367g 収率83% mp 168-169℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
1.30 (9H, s), 2.64-2.78(2H, m), 3.21 (2H, t, J = 1
7.7 Hz), 4.05 (1H, br s), 4.54 (1H, s), 4.87(1H, b
r s), 5.08 (1H, br d, J = 8.4 Hz), 5.70 (1H, tt, J
= 3.9 Hz, 53.4Hz), 7.01-7.10 (5H, m), 7.21 (1H,
t, J = 7.7 Hz), 7.41 (2H, dd, J = 5.6Hz, 8.6 Hz);
IR (KBr) 3349, 1680, 1535, 1227, 1173, 1113, 1007,
837 cm- 1; Anal. Calcd for C23H26F5NO3: C, 60.13;
H, 5.70; N, 3.05. Found: C, 60.04; H, 5.73; N, 2.9
1.Example 337 N-[(1RS, 2SR) -2- (4-fluorophenyl)
Tert--2-Hydroxy-1- [3- (2,2,3,3-tetrafluoropropyl) benzyl] ethyl] carbamic acid
t-butyl 1) (4RS, 5SR) -5- (4-fluorophenyl) -2-oxo-4- [3- (2,2,3,3-tetrafluoropropyl) benzyl] -1,3-oxazolidine -3-
Tert-Butyl carboxylate (4RS, 5SR) -5- (4-fluorophenyl) -4-
[3- (2,2,3,3-tetrafluoropropyl) benzyl] -1,368-oxazolidine-2-one 2.368 g
(6.145 mmol), 1.61 g (7.37 mmol) of di-tert-butyl dicarbonate, 75 mg (0.61 mmol) of 4-N, N-dimethylaminopyridine in 30 ml of acetonitrile were stirred at room temperature overnight. did. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1) to obtain the desired product. Light yellow liquid Yield 3.014 g Yield 100% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.51 (9H, s), 2.57 (1H,
dd, J = 9.0 Hz, 14.0Hz), 2.90 (1H, dd, J = 4.4 H
z, 14.4 Hz), 3.11 (2H, br t, J = 18.3 Hz), 4.77-4.
87 (1H, m), 5.67 (1H, d, J = 8.0 Hz), 5.69 (1H, t
t, J = 3.2 Hz, 53.8 Hz), 6.60-6.64 (2H, m), 6.93
(2H, t, J = 8.6 Hz), 7.03-7.16 (4H, m); IR (neat) 2
982, 1817, 1723, 1514, 1360, 1302, 1227, 1155, 110
1, 1067 cm - 1 2) N - [(1RS, 2SR) -2- (4- fluorophenyl) -2-hydroxy-1- [3- (2,2,3,3-tetrafluoro propyl) benzyl] Ethyl tert-butyl carbamate (4RS, 5SR) -5- (4-fluorophenyl) -2-
To a solution of 3.014 g (6.209 mmol) of tert-butyl oxo-4- [3- (2,2,3,3-tetrafluoropropyl) benzyl] -1,3-oxazolidine-3-carboxylate in 30 ml of tetrahydrofuran was added. 0.26 g (6.52 mmol) of sodium hydroxide in methanol 10
The solution was added under ice-cooling and stirred at 0 ° C. for 0.5 hour. The reaction solution was diluted with ethyl acetate, washed with water, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White crystal Yield 2.367 g Yield 83% mp 168-169 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
1.30 (9H, s), 2.64-2.78 (2H, m), 3.21 (2H, t, J = 1
7.7 Hz), 4.05 (1H, br s), 4.54 (1H, s), 4.87 (1H, b
rs), 5.08 (1H, br d, J = 8.4 Hz), 5.70 (1H, tt, J
= 3.9 Hz, 53.4Hz), 7.01-7.10 (5H, m), 7.21 (1H,
t, J = 7.7 Hz), 7.41 (2H, dd, J = 5.6Hz, 8.6 Hz);
IR (KBr) 3349, 1680, 1535, 1227, 1173, 1113, 1007,
837 cm - 1 ; Anal.Calcd for C 23 H 26 F 5 NO 3 : C, 60.13;
H, 5.70; N, 3.05. Found: C, 60.04; H, 5.73; N, 2.9
1.
【0470】実施例338 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(2,2,3,3-テトラフル
オロプロピル)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド 1) (1RS,2SR)-2-アミノ-1-(4-フルオ
ロフェニル)-3-[3-(2,2,3,3-テトラフルオ
ロプロピル)フェニル]プロパン-1-オール N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(2,2,3,3-テトラフル
オロプロピル)ベンジル]エチル]カルバミン酸ter
t-ブチル2.188g(4.762ミリモル)とトリ
フルオロ酢酸10mlの混合物を1時間室温で撹拌し
た。反応液を減圧留去した後、水で希釈し、炭酸カリウ
ムでアルカリ性とし、酢酸エチルで2回抽出した。集め
た有機層を無水硫酸ナトリウムで乾燥、APS-シリカ
ゲルを通した後、溶媒を減圧留去して、目的物を得た。
黄色液体 収量1.720g 収率100%1 H-NMR (CDCl3, 300 MHz) δ 2.35 (1H, dd, J = 10.4
Hz, 13.7 Hz), 2.80 (1H, dd, J = 3.3 Hz, 13.5 Hz),
3.24 (2H, t, J = 18.6 Hz), 3.25-3.29 (1H, m), 4.66
(1H, d, J = 4.8 Hz), 5.70 (1H, tt, J = 3.2 Hz, 5
3.8 Hz), 7.04-7.16 (5H, m), 7.28 (1H, t, J = 7.7 H
z), 7.37 (2H, dd, J = 5.4 Hz, 8.7 Hz);IR (neat) 33
65-2860, 1605, 1508, 1223, 1157, 1101, 1057, 837 c
m-1 2) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシ-1-[3-(2,2,3,3-テト
ラフルオロプロピル)ベンジル]エチル]-6,7-ジヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサ
ミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(2,2,3,3-テトラフルオロプロ
ピル)フェニル]プロパン-1-オール0.300g
(0.835ミリモル)、6,7-ジヒドロ-5H-ベン
ゾ[a]シクロヘプテン-1-カルボン酸0.16g
(0.83ミリモル)、1-ヒドロキシベンゾトリアゾ
ール水和物0.13g(0.83ミリモル)をアセトニ
トリル10ml中で撹拌しながら1-エチル-3-(3-ジ
メチルアミノプロピル)カルボジイミド・塩酸塩0.1
6g(0.83ミリモル)を加え、室温で一晩撹拌し
た。反応液を酢酸エチルに希釈し、炭酸水素ナトリウム
水溶液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲ
ルを通した後、溶媒を減圧留去した。得られた残留物を
酢酸エチル-ジイソプロピルエーテル-ヘキサンより結晶
化して、目的物を得た。白色粉末 収量0.325g
収率74% mp 165-166℃; 1H-NMR (CDCl3, 300 MHz) δ 1.95-2.04
(2H, m), 2.16-2.22 (2H, m), 2.64-2.68 (2H, m), 2.
74 (1H, dd, J = 10.5 Hz, 14.4 Hz), 2.99 (1H,dd, J
= 4.1 Hz, 14.6 Hz), 3.22 (2H, t, J = 18.0 Hz), 3.7
5 (1H, d, J = 3.9 Hz), 4.65-4.74 (1H, m), 5.02 (1
H, t, J = 3.9 Hz), 5.68 (1H, tt, J = 3.4 Hz, 53.7
Hz), 5.70 (1H, d, J = 9.0 Hz), 5.91 (1H, td, J =
5.5 Hz, 11.7 Hz), 6.21 (1H, d, J = 11.7 Hz), 6.91
(1H, d, J = 7.8 Hz), 7.02-7.10 (4H, m), 7.14-7.17
(3H, m), 7.7.28 (1H, t, J = 7.2 Hz), 7.43 (2H, dd,
J =5.3 Hz, 8.6 Hz); IR (KBr) 3281, 1638, 1514, 12
29, 1105, 835 cm-1; Anal.Calcd for C30H28F5NO2: C,
68.04; H, 5.33; N, 2.65. Found: C, 67.89; H, 5.3
4; N, 2.47.Example 338 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (2,2,3,3-tetrafluoropropyl) benzyl] ethyl] -6,7-dihydro-
5H-benzo [a] cycloheptene-1-carboxamide 1) (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (2,2,3,3-tetrafluoropropyl) Phenyl] propan-1-ol N-[(1RS, 2SR) -2- (4-fluorophenyl)
Tert--2-Hydroxy-1- [3- (2,2,3,3-tetrafluoropropyl) benzyl] ethyl] carbamic acid
A mixture of 2.188 g (4.762 mmol) of t-butyl and 10 ml of trifluoroacetic acid was stirred at room temperature for 1 hour. After evaporating the reaction solution under reduced pressure, the solution was diluted with water, made alkaline with potassium carbonate, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate and passed through APS-silica gel, and then the solvent was distilled off under reduced pressure to obtain the desired product.
Yellow liquid Yield 1.720 g Yield 100% 1 H-NMR (CDCl 3 , 300 MHz) δ 2.35 (1H, dd, J = 10.4)
Hz, 13.7 Hz), 2.80 (1H, dd, J = 3.3 Hz, 13.5 Hz),
3.24 (2H, t, J = 18.6 Hz), 3.25-3.29 (1H, m), 4.66
(1H, d, J = 4.8 Hz), 5.70 (1H, tt, J = 3.2 Hz, 5
3.8 Hz), 7.04-7.16 (5H, m), 7.28 (1H, t, J = 7.7 H
z), 7.37 (2H, dd, J = 5.4 Hz, 8.7 Hz); IR (neat) 33
65-2860, 1605, 1508, 1223, 1157, 1101, 1057, 837 c
m - 12) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (2,2,3,3-tetrafluoropropyl) benzyl] ethyl]- 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (2,2,3,3- Tetrafluoropropyl) phenyl] propan-1-ol 0.300 g
(0.835 mmol), 0.16 g of 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid
0.18 g (0.83 mmol) of 1-hydroxybenzotriazole hydrate in 10 ml of acetonitrile was stirred with 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 0 (0.83 mmol). .1
6 g (0.83 mmol) was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. 0.325 g of white powder
Yield 74% mp 165-166 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.95-2.04
(2H, m), 2.16-2.22 (2H, m), 2.64-2.68 (2H, m), 2.
74 (1H, dd, J = 10.5 Hz, 14.4 Hz), 2.99 (1H, dd, J
= 4.1 Hz, 14.6 Hz), 3.22 (2H, t, J = 18.0 Hz), 3.7
5 (1H, d, J = 3.9 Hz), 4.65-4.74 (1H, m), 5.02 (1
H, t, J = 3.9 Hz), 5.68 (1H, tt, J = 3.4 Hz, 53.7
Hz), 5.70 (1H, d, J = 9.0 Hz), 5.91 (1H, td, J =
5.5 Hz, 11.7 Hz), 6.21 (1H, d, J = 11.7 Hz), 6.91
(1H, d, J = 7.8 Hz), 7.02-7.10 (4H, m), 7.14-7.17
(3H, m), 7.7.28 (1H, t, J = 7.2 Hz), 7.43 (2H, dd,
J = 5.3 Hz, 8.6 Hz); IR (KBr) 3281, 1638, 1514, 12
29, 1105, 835 cm -1 ; Anal.Calcd for C 30 H 28 F 5 NO 2 : C,
68.04; H, 5.33; N, 2.65. Found: C, 67.89; H, 5.3
4; N, 2.47.
【0471】実施例339 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[3-(2,2,3,
3-テトラフルオロプロピル)ベンジル]エチル]ナフ
タレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(2,2,3,3-テトラフルオロプロ
ピル)フェニル]プロパン-1-オール0.300g
(0.835ミリモル)、4-フルオロ-1-ナフトエ酸
0.16g(0.83ミリモル)、1-ヒドロキシベン
ゾトリアゾール水和物0.13g(0.83ミリモル)
をアセトニトリル10ml中で撹拌しながら1-エチル-
3-(3-ジメチルアミノプロピル)カルボジイミド・塩
酸塩0.16g(0.83ミリモル)を加え、室温で一
晩撹拌した。反応液を酢酸エチルに希釈し、炭酸水素ナ
トリウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、
シリカゲルを通した後、溶媒を減圧留去した。得られた
残留物を酢酸エチル-ジイソプロピルエーテル-ヘキサン
より結晶化して、目的物を得た。白色粉末 収量0.3
49g 収率79% mp 172-173℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
2.86 (1H, dd, J = 10.7Hz, 14.3 Hz), 2.97 (1H, dd,
J = 4.2 Hz, 14.1 Hz), 3.20 (2H, t, J = 17.9Hz), 4.
73-4.82 (1H, m), 4.92 (1H, d, J = 3.6 Hz), 5.06 (1
H, t, J = 3.5 Hz), 5.69 (1H, tt, J = 3.5 Hz, 53.5
Hz), 6.90 (1H, d, J = 9.0 Hz), 7.01 (1H, dd, J =
7.7 Hz, 10.1 Hz), 7.08 (2H, t, J = 8.4 Hz), 7.14-
7.29 (5H, m), 7.43 (1H, t, J = 7.5 Hz), 7.50-7.55
(3H, m), 7.73 (1H, d, J = 8.4 Hz), 8.06 (1H, d, J
= 8.1 Hz); IR (KBr) 3274, 1644, 1539, 1514, 1236,
1103,1055, 837, 760 cm-1; Anal. Calcd for C29H23F6
NO2: C, 65.54; H, 4.36; N,2.64. Found: C, 65.53;
H, 4.39; N, 2.34.Example 339 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (2,2,3,
3-tetrafluoropropyl) benzyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (2,2,3,3-tetrafluoro Propyl) phenyl] propan-1-ol 0.300 g
(0.835 mmol) 4-fluoro-1-naphthoic acid 0.16 g (0.83 mmol) 1-hydroxybenzotriazole hydrate 0.13 g (0.83 mmol)
Was stirred in 10 ml of acetonitrile while stirring in 1-ethyl-
0.16 g (0.83 mmol) of 3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous solution of sodium hydrogen carbonate, and dried over anhydrous magnesium sulfate.
After passing through silica gel, the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White powder Yield 0.3
49g Yield 79% mp 172-173 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
2.86 (1H, dd, J = 10.7Hz, 14.3 Hz), 2.97 (1H, dd,
J = 4.2 Hz, 14.1 Hz), 3.20 (2H, t, J = 17.9Hz), 4.
73-4.82 (1H, m), 4.92 (1H, d, J = 3.6 Hz), 5.06 (1
H, t, J = 3.5 Hz), 5.69 (1H, tt, J = 3.5 Hz, 53.5
Hz), 6.90 (1H, d, J = 9.0 Hz), 7.01 (1H, dd, J =
7.7 Hz, 10.1 Hz), 7.08 (2H, t, J = 8.4 Hz), 7.14-
7.29 (5H, m), 7.43 (1H, t, J = 7.5 Hz), 7.50-7.55
(3H, m), 7.73 (1H, d, J = 8.4 Hz), 8.06 (1H, d, J
= 8.1 Hz); IR (KBr) 3274, 1644, 1539, 1514, 1236,
1103,1055, 837, 760 cm -1 ; Anal.Calcd for C 29 H 23 F 6
NO 2 : C, 65.54; H, 4.36; N, 2.64. Found: C, 65.53;
H, 4.39; N, 2.34.
【0472】実施例340 5-クロロ-N-[(1RS,2SR)-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-[3-(2,2,3,3-
テトラフルオロプロピル)ベンジル]エチル]ナフタレ
ン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(4-フルオロフェ
ニル)-3-[3-(2,2,3,3-テトラフルオロプロ
ピル)フェニル]プロパン-1-オール0.300g
(0.835ミリモル)、5-クロロ-1-ナフトエ酸
0.16g(0.83ミリモル)、1-ヒドロキシベン
ゾトリアゾール水和物0.13g(0.83ミリモル)
をアセトニトリル10ml中で撹拌しながら1-エチル-
3-(3-ジメチルアミノプロピル)カルボジイミド・塩
酸塩0.16g(0.83ミリモル)を加え、室温で一
晩撹拌した。反応液を酢酸エチルに希釈し、炭酸水素ナ
トリウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、
溶媒を減圧留去した。得られた残留物をシリカゲルカラ
ムクロマトグラフィーにて精製し(ヘキサン/酢酸エチ
ル=3/1-1/1)、酢酸エチル-ジイソプロピルエー
テル-ヘキサンより結晶化して、目的物を得た。白色結
晶 収量0.285g 収率62% mp 174-175℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
2.85 (1H, dd, J = 11.0Hz, 14.3 Hz), 2.98 (1H, dd,
J = 3.6 Hz, 14.7 Hz), 3.21 (2H, t, J = 18.0Hz), 4.
75-4.85 (1H, m), 4.90 (1H, d, J = 3.6 Hz), 5.05 (1
H, t, J = 3.5 Hz), 5.69 (1H, tt, J = 3.6 Hz, 53.7
Hz), 7.00 (1H, d, J = 9.0 Hz), 7.05-7.29 (8H, m),
7.45-7.56 (5H, m), 8.30 (1H, d, J = 8.4 Hz); IR (K
Br) 3275,1638, 1539, 1514, 1233, 1100, 837, 785, 7
08 cm-1; Anal. Calcd for C29H2 3ClF5NO2: C, 63.57;
H, 4.23; N, 2.56. Found: C, 63.59; H, 4.14; N, 2.6
8.Example 340 5-Chloro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (2,2,3,3-
Tetrafluoropropyl) benzyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (4-fluorophenyl) -3- [3- (2,2,3,3-tetrafluoropropyl) Phenyl] propan-1-ol 0.300 g
(0.835 mmol) 0.16 g (0.83 mmol) of 5-chloro-1-naphthoic acid 0.13 g (0.83 mmol) of 1-hydroxybenzotriazole hydrate
Was stirred in 10 ml of acetonitrile while stirring in 1-ethyl-
0.16 g (0.83 mmol) of 3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous solution of sodium hydrogen carbonate, and dried over anhydrous magnesium sulfate.
The solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1), and crystallized from ethyl acetate / diisopropyl ether / hexane to obtain the desired product. White crystals Yield 0.285 g Yield 62% mp 174-175 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
2.85 (1H, dd, J = 11.0Hz, 14.3 Hz), 2.98 (1H, dd,
J = 3.6 Hz, 14.7 Hz), 3.21 (2H, t, J = 18.0Hz), 4.
75-4.85 (1H, m), 4.90 (1H, d, J = 3.6 Hz), 5.05 (1
H, t, J = 3.5 Hz), 5.69 (1H, tt, J = 3.6 Hz, 53.7
Hz), 7.00 (1H, d, J = 9.0 Hz), 7.05-7.29 (8H, m),
7.45-7.56 (5H, m), 8.30 (1H, d, J = 8.4 Hz); IR (K
Br) 3275,1638, 1539, 1514, 1233, 1100, 837, 785, 7
08 cm -1 ; Anal.Calcd for C 29 H 2 3 ClF 5 NO 2 : C, 63.57;
H, 4.23; N, 2.56. Found: C, 63.59; H, 4.14; N, 2.6
8.
【0473】実施例341 N-[(1RS,2SR)-1-[3-(1,2-ジフルオ
ロ-2-メチルプロピル)ベンジル]-2-(4-フルオロ
フェニル)-2-ヒドロキシエチル]カルバミン酸ter
t-ブチル 1) 2-メチル-2-(3-メチルフェニル)プロピオン
酸エチル 3-トリル酢酸エチル30.92g(173.5ミリモ
ル)のN,N-ジメチルホルムアミド150ml溶液に
氷冷下60%水素化ナトリウムの流動パラフィン懸濁物
15.3g(382ミリモル)を加え、室温で0.5時
間撹拌した。これにヨウ化メチル32.2ml(520
ミリモル)を0℃で加え、室温で一晩撹拌した。反応液
を水に注ぎ、酢酸エチルで2回抽出した。集めた有機層
を無水硫酸マグネシウムで乾燥、溶媒を減圧留去した。
得られた残留物をシリカゲルカラムクロマトグラフィー
にて精製し(ヘキサン/酢酸エチル=50/1-15/
1)、目的物を得た。無色液体 収量30.22g 収
率84%1 H-NMR (CDCl3, 200 MHz) δ 1.19 (3H, t, J = 7.1 H
z), 1.56 (6H, s), 2.35(3H, s), 4.12 (2H, q, J = 7.
2 Hz), 7.03-7.22 (4H, m); IR (neat) 2976, 1730, 12
52, 1146, 702 cm-1 2) 2-メチル-2-(3-メチルフェニル)プロパン-
1-オール 水素化リチウムアルミニウム3.52g(92.9ミリ
モル)のテトラヒドロフラン150ml懸濁液に、氷冷
下、2-メチル-2-(3-メチルフェニル)プロピオン酸
エチル19.16g(92.88ミリモル)のテトラヒ
ドロフラン100ml溶液を滴下し、室温で1時間撹拌
した。反応液を氷冷した後、水3.5ml、15%水酸
化ナトリウム水溶液3.5ml、水9mlを順次滴下し
て、過剰の水素化リチウムアルミニウムを分解し、その
まま室温で2時間撹拌した。生じた沈殿をろ過して除
き、沈殿を酢酸エチルで洗浄した。集めた濾液の溶媒を
減圧留去した。得られた残留物をシリカゲルカラムクロ
マトグラフィーにて精製して(ヘキサン/酢酸エチル=
6/1)、目的物を得た。無色液体 収量12.99g
収率85%1 H-NMR (CDCl3, 300 MHz) δ 1.22 (1H, t, J = 6.6 H
z), 1.33 (6H, s), 2.36(3H, s), 3.61 (2H, d, J = 6.
9 Hz), 7.04 (1H, d, J = 7.2 Hz), 7.17-7.27 (3H,
m); IR (neat) 3370, 2963, 1042, 783, 704 cm-1 3) 2-メチル-2-(3-メチルフェニル)プロパナー
ル 塩化オキザリル15.1g(119ミリモル)のテトラ
ヒドロフラン150ml溶液に−78℃でジメチルスル
ホキシド16.8ml(237ミリモル)のテトラヒド
ロフラン50ml溶液を滴下した。5分間撹拌した後、
2-メチル-2-(3-メチルフェニル)プロパン-1-オー
ル12.99g(79.09ミリモル)のテトラヒドロ
フラン80ml溶液を−78℃で加え、15分間撹拌し
た。これにトリエチルアミン66.1ml(475ミリ
モル)を加え、室温まで昇温した。反応混合物を水に注
ぎ、酢酸エチルで2回抽出した。集めた有機層を無水硫
酸マグネシウムで乾燥、溶媒を減圧留去した。得られた
粗生成物をシリカゲルカラムクロマトグラフィーにて精
製して(ヘキサン/酢酸エチル=15/1)、目的物を
得た。淡黄色液体 収量11.72g 収率91%1 H-NMR (CDCl3, 300 MHz) δ 1.45 (6H, s), 2.36 (3H,
s), 7.07-7.7.12 (3H,m), 7.27 (1H, t, J = 8.0 Hz),
9.49 (1H, s); IR (neat) 2975, 1728, 785, 704 cm-1 4) 1-(1,2-ジフルオロ-2-メチルプロピル)-
3-メチルベンゼン (ジエチルアミノ)サルファートリフルオリド7.31
g(45.4ミリモル)の塩化メチレン20ml溶液に
−78℃で2-メチル-2-(3-メチルフェニル)プロパ
ナール7.360g(45.37ミリモル)の塩化メチ
レン10ml溶液を室温で加え、室温で0.5時間撹拌
した。反応液に水を加え、撹拌した後、塩化メチレン層
を分離した。水層はジエチルエーテルで抽出し、集めた
有機層を無水硫酸マグネシウムで乾燥、溶媒を減圧留去
した。得られた残留物をシリカゲルカラムクロマトグラ
フィーにて精製して(ヘキサン-ヘキサン/酢酸エチル
=30/1)、目的物を得た。無色液体 収量2.74
7g 収率33%1 H-NMR (CDCl3, 300 MHz) δ 1.33 (3H, dd, J = 1.5 H
z, 16.2 Hz), 1.40 (3H,dd, J = 2.0 Hz, 16.4 Hz), 2.
37 (3H, s), 5.29 (1H, dd, J = 13.8 Hz, 45.3Hz), 7.
14-7.18 (3H, m), 7.27 (1H, t, J = 7.8 Hz); IR (nea
t) 2988, 1387,1157, 1036, 775, 702 cm-1 5) 2-[3-(1,2-ジフルオロ-2-メチルプロピ
ル)ベンジル]-3-(4-フルオロフェニル)-3-オキ
ソプロピオン酸エチル 1-(1,2-ジフルオロ-2-メチルプロピル)-3-メチ
ルベンゼン2.747g(14.91ミリモル)、N-
ブロモスクシンイミド2.65g(14.9ミリモ
ル)、2,2’-アゾビス(イソブチロニトリル)0.
1gの四塩化炭素30ml溶液を1.5時間加熱還流し
た。反応液を室温に冷却した後、白色沈殿を濾過して除
き、沈殿をヘキサンで洗浄した。集めた濾液の溶媒を減
圧留去して、3-(1,2-ジフルオロ-2-メチルプロピ
ル)ベンジルブロミドの粗生成物を黄色液体として得
た。(4-フルオロベンゾイル)酢酸エチル3.13g
(14.9ミリモル)の1,2-ジメトキシエタン40
ml溶液に氷冷下60%水素化ナトリウムの流動パラフ
ィン懸濁物0.60g(14.9ミリモル)を加え、そ
のまま0.5時間撹拌した。これに上で得た液体の1,
2-ジメトキシエタン10ml溶液を室温で加え、室温
で一晩撹拌した。反応液を水に注ぎ、酢酸エチルで2回
抽出した。集めた有機層を無水硫酸マグネシウムで乾
燥、溶媒を減圧留去した。得られた残留物をシリカゲル
カラムクロマトグラフィーにて精製し(ヘキサン/酢酸
エチル=15/1-9/1)、目的物を得た。黄色液体
収量3.484g 収率60%1 H-NMR (CDCl3, 300 MHz) δ 1.12 (3H, t, J = 7.1 H
z), 1.23-1.39 (6H, m),3.34 (1H, d, J = 7.5 Hz), 3.
35 (1H, d, J = 7.2 Hz), 4.10 (2H, q, J = 7.1Hz),
4.55 (0.5H, t, J = 7.7 Hz), 4.58 (0.5H, t, J = 7.5
Hz), 5.25 (0.5H, dd, J = 14.1 Hz, 45.0 Hz), 5.26
(0.5H, dd, J = 13.4 Hz, 45.2 Hz), 7.10(2H, t, J =
8.4 Hz), 7.16-7.24 (4H, m), 7.97 (2H, dd, J = 5.4
Hz, 9.0 Hz); IR (neat) 2986, 1736, 1686, 1599, 150
8, 1269, 1236, 1159, 1032, 849cm-1 6) (2RS,3RS)-2-[3-(1,2-ジフルオ
ロ-2-メチルプロピル)ベンジル]-3-(4-フルオロ
フェニル)-3-ヒドロキシプロピオン酸エチル 塩化亜鉛2.37g(17.4ミリモル)をジエチルエ
ーテル50ml中で撹拌しながら水素化ホウ素ナトリウ
ム1.32g(34.8ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、2-[3-(1,
2-ジフルオロ-2-メチルプロピル)ベンジル]-3-
(4-フルオロフェニル)-3-オキソプロピオン酸エチ
ル3.412g(8.695ミリモル)のジエチルエー
テル20ml溶液を氷冷下で加え、そのまま20分間撹
拌した。反応液に希塩酸を少しずつ加えて過剰の水素化
ホウ素亜鉛を分解した後、酢酸エチルで2回抽出した。
集めた有機層を無水硫酸マグネシウムで乾燥、溶媒を減
圧留去した。得られた粗生成物をシリカゲルカラムクロ
マトグラフィーにて精製し(ヘキサン/酢酸エチル=3
/1)、目的物を得た。無色液体 収量2.919g
収率85%1 H-NMR (CDCl3, 200 MHz) δ 0.92 (3H, t, J = 7.1 H
z), 1.25-1.42 (6H, m),2.89-2.93 (1H, m), 2.96-3.05
(3H, m), 3.86 (2H, q, J = 7.1 Hz), 5.00 (1H, t, J
= 3.7 Hz), 5.24 (1H, dd, J = 14.2 Hz, 45.2 Hz),
7.00-7.29 (6H, m), 7.37 (2H, dd, J = 5.2 Hz, 8.8 H
z); IR (neat) 3445, 2986, 1728, 1605, 1510, 1375,
1225, 1159, 1032, 839 cm-1 7) (4RS,5SR)-4-[3-(1,2-ジフルオ
ロ-2-メチルプロピル)ベンジル]-5-(4-フルオロ
フェニル)-1,3-オキサゾリジン-2-オン (2RS,3RS)-2-[3-(1,2-ジフルオロ-2-
メチルプロピル)ベンジル]-3-(4-フルオロフェニ
ル)-3-ヒドロキシプロピオン酸エチル2.849g
(7.223ミリモル)、水酸化ナトリウム0.58g
(14.4ミリモル)、メタノール10ml、水10m
l、テトラヒドロフラン10mlの混合物を室温で一晩
撹拌した。反応液を濃縮、水で希釈し、塩酸で反応液を
酸性にした後、酢酸エチルで2回抽出した。集めた有機
層を無水硫酸ナトリウムで乾燥、溶媒を減圧留去して、
(2RS,3RS)-2-[3-(1,2-ジフルオロ-2-
メチルプロピル)ベンジル]-3-(4-フルオロフェニ
ル)-3-ヒドロキシプロピオン酸の粗生成物を液体とし
て得た。上で得た液体のテトラヒドロフラン40ml溶
液にトリエチルアミン1.21ml(8.67ミリモ
ル)、ジフェニルホスホリルアジド2.19g(7.9
5ミリモル)を加え、65℃で一晩撹拌した。反応液の
溶媒を減圧留去し、得られた粗生成物をシリカゲルカラ
ムクロマトグラフィーにて精製し(ヘキサン/酢酸エチ
ル=3/1-1/1)、目的物を得た。白色固体 収量
2.245g 収率86% mp 130-131℃; 1H-NMR (CDCl3, 300 MHz) δ 1.28-1.41
(6H, m), 2.20-2.36 (2H, m), 4.21-4.30 (1H, m), 4.
97 (1H, s), 5.24 (0.5H, dd, J = 13.7 Hz, 44.9 Hz),
5.25 (0.5H, dd, J = 14.0 Hz, 45.2 Hz), 5.80 (1H,
d, J = 8.1 Hz),7.01-7.39 (8H, m); IR (KBr) 3250, 1
742, 1514, 1236, 1223, 1022, 849 cm-1; Anal. Calcd
for C20H20F3NO2・0.1H2O: C, 65.78; H, 5.58; N, 3.8
4. Found:C, 65.64; H, 5.50; N, 3.96. 8) (4RS,5SR)-4-[3-(1,2-ジフルオ
ロ-2-メチルプロピル)ベンジル]-5-(4-フルオロ
フェニル)-2-オキソ-1,3-オキサゾリジン-3-カル
ボン酸tert-ブチル (4RS,5SR)-4-[3-(1,2-ジフルオロ-2-
メチルプロピル)ベンジル]-5-(4-フルオロフェニ
ル)-1,3-オキサゾリジン-2-オン2.124g
(5.845ミリモル)、二炭酸ジ-tert-ブチル
1.53g(7.01ミリモル)、4-N,N-ジメチル
アミノピリジン71mg(0.58ミリモル)のアセト
ニトリル40ml溶液を室温で一晩撹拌した。反応液の
溶媒を減圧留去し、得られた残留物をシリカゲルカラム
クロマトグラフィーにて精製し(ヘキサン/酢酸エチル
=3/1-2/1)、目的物を得た。淡黄色液体 収量
2.633g 収率97%1 H-NMR (CDCl3, 300 MHz) δ 1.24-1.38 (6H, m), 1.49
(4.5H, s), 1.53 (4.5H, s), 2.55-2.64 (1H, m), 2.8
5-2.96 (1H, m), 4.79-4.86 (1H, m), 5.10 (0.5H, dd,
J = 13.2 Hz, 45.0 Hz), 5.17 (0.5H, dd, J = 14.6 H
z, 45.2 Hz), 5.66 (0.5H, d, J = 7.2 Hz), 5.67 (0.5
H, d, J = 6.6 Hz), 6.59-6.65 (1H, m),6.67 (0.5H,
s), 6.82 (0.5H, s), 6.91-6.98 (2H, m), 7.04-7.17
(4H, m); IR(neat) 2984, 1817, 1723, 1514, 1358, 13
08, 1229, 1155, 1069 cm-1 9) N-[(1RS,2SR)-1-[3-(1,2-ジ
フルオロ-2-メチルプロピル)ベンジル]-2-(4-フ
ルオロフェニル)-2-ヒドロキシエチル]カルバミン酸
tert-ブチル (4RS,5SR)-4-[3-(1,2-ジフルオロ-2-
メチルプロピル)ベンジル]-5-(4-フルオロフェニ
ル)-2-オキソ-1,3-オキサゾリジン-3-カルボン酸
tert-ブチル2.584g(5.575ミリモル)
のテトラヒドロフラン20ml溶液に水酸化ナトリウム
0.22g(5.57ミリモル)のメタノール5ml溶
液を氷冷下加え、室温で1時間撹拌した。反応液を酢酸
エチルに希釈し、水で洗浄、無水硫酸マグネシウムで乾
燥、シリカゲルを通した後、溶媒を減圧留去して、目的
物を得た。白色固体 収量2.300g 収率94% mp 148-149℃; 1H-NMR (CDCl3, 300 MHz) δ 1.28-1.41
(6H, m), 1.34 (9H, s), 2.65 (1H, dd, J = 10.1 Hz,
14.3 Hz), 2.80 (1H, dd, J = 4.7 Hz, 14.3 Hz), 3.3
8 (1H, br s), 4.09 (1H, br s), 4.50 (1H, br d, J =
6.9 Hz), 4.90 (1H, br s), 5.27 (1H, dd, J = 13.7
Hz, 45.2 Hz), 7.07 (2H, t, J = 8.7 Hz), 7.11-7.13
(2H, m), 7.18-7.31 (2H, m), 7.37 (2H, dd, J = 5.6
Hz, 8.6 Hz); IR (KBr) 3366, 2988, 1682, 1532, 151
4, 1225, 1171, 1007 cm-1; Anal. Calcd for C24H30F3
NO3: C, 65.89; H, 6.91; N, 3.20. Found: C, 65.62;
H, 6.88; N, 3.22.Example 341 N-[(1RS, 2SR) -1- [3- (1,2-difluoro-2-methylpropyl) benzyl] -2- (4-fluorophenyl) -2-hydroxyethyl] carbamine Acid ter
t-Butyl 1) Ethyl 2-methyl-2- (3-methylphenyl) propionate A solution of 30.92 g (173.5 mmol) of ethyl 3-tolylacetate in 150 ml of N, N-dimethylformamide under ice cooling with 60% hydrogen 15.3 g (382 mmol) of a liquid paraffin suspension of sodium chloride was added, and the mixture was stirred at room temperature for 0.5 hour. 32.2 ml of methyl iodide (520
(Mmol) at 0 ° C and stirred overnight at room temperature. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure.
The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 50 / 1-15 /
1) The desired product was obtained. Colorless liquid Yield 30.22 g Yield 84% 1 H-NMR (CDCl 3 , 200 MHz) δ 1.19 (3H, t, J = 7.1 H)
z), 1.56 (6H, s), 2.35 (3H, s), 4.12 (2H, q, J = 7.
2 Hz), 7.03-7.22 (4H, m); IR (neat) 2976, 1730, 12
52, 1146, 702 cm -1 2) 2-Methyl-2- (3-methylphenyl) propane-
1-ol To a suspension of 3.52 g (92.9 mmol) of lithium aluminum hydride in 150 ml of tetrahydrofuran was added 19.16 g (92.88 g) of ethyl 2-methyl-2- (3-methylphenyl) propionate under ice-cooling. (Mmol) was added dropwise and stirred at room temperature for 1 hour. After the reaction solution was cooled with ice, 3.5 ml of water, 3.5 ml of a 15% aqueous sodium hydroxide solution and 9 ml of water were sequentially added dropwise to decompose excess lithium aluminum hydride and stirred at room temperature for 2 hours. The resulting precipitate was removed by filtration, and the precipitate was washed with ethyl acetate. The solvent of the collected filtrate was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate =
6/1) to obtain the desired product. Colorless liquid Yield 12.99g
Yield 85% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.22 (1H, t, J = 6.6 H
z), 1.33 (6H, s), 2.36 (3H, s), 3.61 (2H, d, J = 6.
9 Hz), 7.04 (1H, d, J = 7.2 Hz), 7.17-7.27 (3H,
m); tetrahydrofuran 150ml solution of IR (neat) 3370, 2963, 1042, 783, 704 cm -1 3) 2- methyl-2- (3-methylphenyl) propanal oxalyl chloride 15.1 g (119 mmol) - At 78 ° C., a solution of 16.8 ml (237 mmol) of dimethyl sulfoxide in 50 ml of tetrahydrofuran was added dropwise. After stirring for 5 minutes,
A solution of 12.99 g (79.09 mmol) of 2-methyl-2- (3-methylphenyl) propan-1-ol in 80 ml of tetrahydrofuran was added at -78 ° C, and the mixture was stirred for 15 minutes. To this, 66.1 ml (475 mmol) of triethylamine was added, and the temperature was raised to room temperature. The reaction mixture was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15/1) to obtain the desired product. Light yellow liquid Yield 11.72 g Yield 91% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.45 (6H, s), 2.36 (3H,
s), 7.07-7.7.12 (3H, m), 7.27 (1H, t, J = 8.0 Hz),
9.49 (1H, s); IR (neat) 2975, 1728, 785, 704 cm -14 ) 1- (1,2-difluoro-2-methylpropyl)-
3-methylbenzene (diethylamino) sulfur trifluoride 7.31
g (45.4 mmol) in 20 ml of methylene chloride at -78 ° C. was added with a solution of 7.360 g (45.37 mmol) of 2-methyl-2- (3-methylphenyl) propanal in 10 ml of methylene chloride at room temperature. Stirred at room temperature for 0.5 hour. Water was added to the reaction solution, and after stirring, the methylene chloride layer was separated. The aqueous layer was extracted with diethyl ether, the collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane-hexane / ethyl acetate = 30/1) to obtain the desired product. Colorless liquid, yield 2.74
7 g Yield 33% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.33 (3H, dd, J = 1.5 H
z, 16.2 Hz), 1.40 (3H, dd, J = 2.0 Hz, 16.4 Hz), 2.
37 (3H, s), 5.29 (1H, dd, J = 13.8 Hz, 45.3Hz), 7.
14-7.18 (3H, m), 7.27 (1H, t, J = 7.8 Hz); IR (nea
t) 2988, 1387,1157, 1036, 775, 702 cm -1 5) 2- [3- (1,2- difluoro-2-methylpropyl) benzyl] -3- (4-fluorophenyl) -3-oxo Ethyl propionate 2.747 g (14.91 mmol) of 1- (1,2-difluoro-2-methylpropyl) -3-methylbenzene, N-
2.65 g (14.9 mmol) of bromosuccinimide, 0.2% of 2,2'-azobis (isobutyronitrile).
A solution of 1 g of carbon tetrachloride in 30 ml was refluxed under heating for 1.5 hours. After cooling the reaction solution to room temperature, a white precipitate was removed by filtration, and the precipitate was washed with hexane. The solvent of the collected filtrate was distilled off under reduced pressure to obtain a crude product of 3- (1,2-difluoro-2-methylpropyl) benzyl bromide as a yellow liquid. 3.13 g of ethyl (4-fluorobenzoyl) acetate
(14.9 mmol) of 1,2-dimethoxyethane 40
0.60 g (14.9 mmol) of a 60% sodium hydride liquid paraffin suspension was added to the ml solution under ice cooling, and the mixture was stirred for 0.5 hour as it was. To this, the liquid 1 obtained above
A solution of 10 ml of 2-dimethoxyethane was added at room temperature, and the mixture was stirred at room temperature overnight. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-9 / 1) to obtain the desired product. Yellow liquid Yield 3.484 g Yield 60% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.12 (3H, t, J = 7.1 H)
z), 1.23-1.39 (6H, m), 3.34 (1H, d, J = 7.5 Hz), 3.
35 (1H, d, J = 7.2 Hz), 4.10 (2H, q, J = 7.1Hz),
4.55 (0.5H, t, J = 7.7 Hz), 4.58 (0.5H, t, J = 7.5
Hz), 5.25 (0.5H, dd, J = 14.1 Hz, 45.0 Hz), 5.26
(0.5H, dd, J = 13.4 Hz, 45.2 Hz), 7.10 (2H, t, J =
8.4 Hz), 7.16-7.24 (4H, m), 7.97 (2H, dd, J = 5.4
Hz, 9.0 Hz); IR (neat) 2986, 1736, 1686, 1599, 150
8, 1269, 1236, 1159, 1032, 849cm -1 6) (2RS, 3RS) -2- [3- (1,2- difluoro-2-methylpropyl) benzyl] -3- (4-fluorophenyl) - Ethyl 3-hydroxypropionate While stirring 2.37 g (17.4 mmol) of zinc chloride in 50 ml of diethyl ether, 1.32 g (34.8 mmol) of sodium borohydride was added at room temperature, and the mixture was stirred for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. In the obtained solution, 2- [3- (1,
2-difluoro-2-methylpropyl) benzyl] -3-
A solution of 3.412 g (8.695 mmol) of ethyl (4-fluorophenyl) -3-oxopropionate in 20 ml of diethyl ether was added under ice-cooling, and the mixture was stirred for 20 minutes. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate.
The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3).
/ 1) to obtain the desired product. Colorless liquid, yield 2.919 g
Yield 85% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.92 (3H, t, J = 7.1 H
z), 1.25-1.42 (6H, m), 2.89-2.93 (1H, m), 2.96-3.05
(3H, m), 3.86 (2H, q, J = 7.1 Hz), 5.00 (1H, t, J
= 3.7 Hz), 5.24 (1H, dd, J = 14.2 Hz, 45.2 Hz),
7.00-7.29 (6H, m), 7.37 (2H, dd, J = 5.2 Hz, 8.8 H
z); IR (neat) 3445, 2986, 1728, 1605, 1510, 1375,
1225, 1159, 1032, 839 cm - 17 17) (4RS, 5SR) -4- [3- (1,2-difluoro-2-methylpropyl) benzyl] -5- (4-fluorophenyl) -1,3 -Oxazolidin-2-one (2RS, 3RS) -2- [3- (1,2-difluoro-2-
Methylpropyl) benzyl] 2.849 g of ethyl 3- (4-fluorophenyl) -3-hydroxypropionate
(7.223 mmol), 0.58 g of sodium hydroxide
(14.4 mmol), methanol 10 ml, water 10 m
1 and a mixture of 10 ml of tetrahydrofuran were stirred at room temperature overnight. The reaction mixture was concentrated, diluted with water, acidified with hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure.
(2RS, 3RS) -2- [3- (1,2-difluoro-2-
A crude product of [methylpropyl) benzyl] -3- (4-fluorophenyl) -3-hydroxypropionic acid was obtained as a liquid. To a solution of the liquid obtained above in 40 ml of tetrahydrofuran, 1.21 ml (8.67 mmol) of triethylamine and 2.19 g of diphenylphosphoryl azide (7.9 g)
5 mmol) and stirred at 65 ° C. overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1) to obtain the desired product. White solid Yield 2.245 g Yield 86% mp 130-131 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.28-1.41
(6H, m), 2.20-2.36 (2H, m), 4.21-4.30 (1H, m), 4.
97 (1H, s), 5.24 (0.5H, dd, J = 13.7 Hz, 44.9 Hz),
5.25 (0.5H, dd, J = 14.0 Hz, 45.2 Hz), 5.80 (1H,
d, J = 8.1 Hz), 7.01-7.39 (8H, m); IR (KBr) 3250, 1
742, 1514, 1236, 1223, 1022, 849 cm -1 ; Anal.Calcd
for C 20 H 20 F 3 NO 2・ 0.1H 2 O: C, 65.78; H, 5.58; N, 3.8
4. Found: C, 65.64; H, 5.50; N, 3.96.8) (4RS, 5SR) -4- [3- (1,2-difluoro-2-methylpropyl) benzyl] -5- (4-fluoro Tert-Butyl (phenyl) -2-oxo-1,3-oxazolidine-3-carboxylate (4RS, 5SR) -4- [3- (1,2-difluoro-2-
Methylpropyl) benzyl] -5- (4-fluorophenyl) -1,3-oxazolidine-2-one 2.124 g
(5.845 mmol), 1.53 g (7.01 mmol) of di-tert-butyl dicarbonate and a solution of 71 mg (0.58 mmol) of 4-N, N-dimethylaminopyridine in 40 ml of acetonitrile were stirred at room temperature overnight. did. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-2 / 1) to obtain the desired product. Light yellow liquid Yield 2.633 g Yield 97% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.24-1.38 (6H, m), 1.49
(4.5H, s), 1.53 (4.5H, s), 2.55-2.64 (1H, m), 2.8
5-2.96 (1H, m), 4.79-4.86 (1H, m), 5.10 (0.5H, dd,
J = 13.2 Hz, 45.0 Hz), 5.17 (0.5H, dd, J = 14.6 H
z, 45.2 Hz), 5.66 (0.5H, d, J = 7.2 Hz), 5.67 (0.5
H, d, J = 6.6 Hz), 6.59-6.65 (1H, m), 6.67 (0.5H,
s), 6.82 (0.5H, s), 6.91-6.98 (2H, m), 7.04-7.17
(4H, m); IR (neat) 2984, 1817, 1723, 1514, 1358, 13
08, 1229, 1155, 1069 cm -1 9) N - [(1RS, 2SR) -1- [3- (1,2- difluoro-2-methylpropyl) benzyl] -2- (4-fluorophenyl) - Tert-Butyl 2-hydroxyethyl] carbamate (4RS, 5SR) -4- [3- (1,2-difluoro-2-
Methylpropyl) benzyl] 2.584 g (5.575 mmol) of tert-butyl-5- (4-fluorophenyl) -2-oxo-1,3-oxazolidine-3-carboxylate
To a solution of the above in 20 ml of tetrahydrofuran was added a solution of 0.22 g (5.57 mmol) of sodium hydroxide in 5 ml of methanol under ice-cooling, followed by stirring at room temperature for 1 hour. The reaction solution was diluted with ethyl acetate, washed with water, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure to obtain the desired product. White solid Yield 2.300 g Yield 94% mp 148-149 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.28-1.41
(6H, m), 1.34 (9H, s), 2.65 (1H, dd, J = 10.1 Hz,
14.3 Hz), 2.80 (1H, dd, J = 4.7 Hz, 14.3 Hz), 3.3
8 (1H, br s), 4.09 (1H, br s), 4.50 (1H, br d, J =
6.9 Hz), 4.90 (1H, br s), 5.27 (1H, dd, J = 13.7
Hz, 45.2 Hz), 7.07 (2H, t, J = 8.7 Hz), 7.11-7.13
(2H, m), 7.18-7.31 (2H, m), 7.37 (2H, dd, J = 5.6
Hz, 8.6 Hz); IR (KBr) 3366, 2988, 1682, 1532, 151
4, 1225, 1171, 1007 cm -1 ; Anal.Calcd for C 24 H 30 F 3
NO 3 : C, 65.89; H, 6.91; N, 3.20. Found: C, 65.62;
H, 6.88; N, 3.22.
【0474】実施例342 N-[(1RS,2SR)-1-[3-(1,2-ジフルオ
ロ-2-メチルプロピル)ベンジル]-2-(4-フルオロ
フェニル)-2-ヒドロキシエチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド 1) (1RS,2SR)-2-アミノ-3-[3-(1,
2-ジフルオロ-2-メチルプロピル)フェニル]-1-
(4-フルオロフェニル)プロパン-1-オール N-[(1RS,2SR)-1-[3-(1,2-ジフルオ
ロ-2-メチルプロピル)ベンジル]-2-(4-フルオロ
フェニル)-2-ヒドロキシエチル]カルバミン酸ter
t-ブチル2.139g(4.889ミリモル)とトリ
フルオロ酢酸10mlの混合物を1時間室温で撹拌し
た。反応液を減圧留去した後、水で希釈し、炭酸カリウ
ムでアルカリ性とし、酢酸エチルで2回抽出した。集め
た有機層を無水硫酸ナトリウムで乾燥、APS-シリカ
ゲルを通した後、溶媒を減圧留去して、目的物を得た。
淡黄色液体 収量1.650g 収率100%1 H-NMR (CDCl3, 300 MHz) δ 1.31 (3H, d, J = 15.3 H
z), 1.38 (3H, d, J = 14.7 Hz), 2.36 (1H, dd, J = 1
0.2 Hz, 13.5 Hz), 2.81 (1H, dd, J = 3.2 Hz,13.4 H
z), 3.25-3.32 (1H, m), 4.66 (1H, d, J = 4.8 Hz),
5.28 (1H, dd, J =13.8 Hz, 45.3 Hz), 7.08 (2H, t, J
= 8.7 Hz), 7.11-7.33 (4H, m), 7.37 (2H, dd, J =
5.6 Hz, 8.6 Hz); IR (neat) 3360-2860, 1605, 1508,
1387, 1373,1223, 1157, 1034, 839 cm-1 2) N-[(1RS,2SR)-1-[3-(1,2-ジ
フルオロ-2-メチルプロピル)ベンジル]-2-(4-フ
ルオロフェニル)-2-ヒドロキシエチル]-6,7-ジヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサ
ミド (1RS,2SR)-2-アミノ-3-[3-(1,2-ジフ
ルオロ-2-メチルプロピル)フェニル]-1-(4-フル
オロフェニル)プロパン-1-オール0.200g(0.
593ミリモル)、6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボン酸0.11g(0.
59ミリモル)、1-ヒドロキシベンゾトリアゾール水
和物91mg(0.59ミリモル)をアセトニトリル1
0ml中で撹拌しながら1-エチル-3-(3-ジメチルア
ミノプロピル)カルボジイミド・塩酸塩0.11g
(0.59ミリモル)を加え、室温で一晩撹拌した。反
応液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶液
で洗浄、無水硫酸マグネシウムで乾燥、溶媒を減圧留去
した。得られた残留物をシリカゲルカラムクロマトグラ
フィーにて精製し(ヘキサン/酢酸エチル=3/1-1
/1)、ジイソプロピルエーテル-ヘキサンより結晶化
して、目的物を得た。白色粉末 収量0.184g 収
率61% mp 102-104℃; 1H-NMR (CDCl3, 300 MHz) δ 1.25-1.39
(6H, m), 1.95-2.03 (2H, m), 2.16-2.22 (2H, m), 2.
66 (2H, t, J = 5.7 Hz), 2.69-2.82 (1H, m), 2.98-3.
03 (1H, m), 3.79 (0.5H, d, J = 3.9 Hz), 3.82 (0.5
H, d, J = 3.9 Hz), 4.65-4.74 (1H, m), 5.02 (1H, t,
J = 3.6 Hz), 5.24 (0.5H, dd, J = 14.0Hz, 45.2 H
z), 5.27 (0.5H, dd, J = 13.5 Hz, 45.0 Hz), 5.70 (1
H, d, J = 8.7 Hz), 5.88-5.96 (1H, m), 6.20 (1H, d,
J = 12.3 Hz), 6.91-6.95 (1H, m),7.02-7.34 (8H,
m), 7.43 (2H, dd, J = 5.3 Hz, 8.6 Hz); IR (KBr) 32
95, 2938, 1638, 1510, 1225, 1034, 772 cm-1; Anal.
Calcd for C31H32F3NO2・0.1H2O:C, 73.09; H, 6.37; N,
2.75. Found: C, 72.87; H, 6.31; N, 2.62.Example 342 N-[(1RS, 2SR) -1- [3- (1,2-difluoro-2-methylpropyl) benzyl] -2- (4-fluorophenyl) -2-hydroxyethyl]- 6,7-dihydro-
5H-benzo [a] cycloheptene-1-carboxamide 1) (1RS, 2SR) -2-amino-3- [3- (1,
2-difluoro-2-methylpropyl) phenyl] -1-
(4-Fluorophenyl) propan-1-ol N-[(1RS, 2SR) -1- [3- (1,2-difluoro-2-methylpropyl) benzyl] -2- (4-fluorophenyl) -2 -Hydroxyethyl] carbamic acid ter
A mixture of 2.139 g (4.889 mmol) of t-butyl and 10 ml of trifluoroacetic acid was stirred at room temperature for 1 hour. After evaporating the reaction solution under reduced pressure, the solution was diluted with water, made alkaline with potassium carbonate, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate and passed through APS-silica gel, and then the solvent was distilled off under reduced pressure to obtain the desired product.
Light yellow liquid Yield 1.650 g Yield 100% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.31 (3H, d, J = 15.3 H)
z), 1.38 (3H, d, J = 14.7 Hz), 2.36 (1H, dd, J = 1
0.2 Hz, 13.5 Hz), 2.81 (1H, dd, J = 3.2 Hz, 13.4 H
z), 3.25-3.32 (1H, m), 4.66 (1H, d, J = 4.8 Hz),
5.28 (1H, dd, J = 13.8 Hz, 45.3 Hz), 7.08 (2H, t, J
= 8.7 Hz), 7.11-7.33 (4H, m), 7.37 (2H, dd, J =
5.6 Hz, 8.6 Hz); IR (neat) 3360-2860, 1605, 1508,
1387, 1373,1223, 1157, 1034, 839 cm- 1 2) N-[(1RS, 2SR) -1- [3- (1,2-difluoro-2-methylpropyl) benzyl] -2- (4- Fluorophenyl) -2-hydroxyethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-3- [3- (1,2-difluoro-2 -Methylpropyl) phenyl] -1- (4-fluorophenyl) propan-1-ol 0.200 g (0.
593 mmol), 0.11 g of 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (0.15 g).
59 mg) of 1-hydroxybenzotriazole hydrate (91 mg, 0.59 mmol) was added to acetonitrile 1
0.11 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride while stirring in 0 ml
(0.59 mmol) and stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1).
/ 1) and crystallized from diisopropyl ether-hexane to obtain the desired product. White powder Yield 0.184 g Yield 61% mp 102-104 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.25-1.39
(6H, m), 1.95-2.03 (2H, m), 2.16-2.22 (2H, m), 2.
66 (2H, t, J = 5.7 Hz), 2.69-2.82 (1H, m), 2.98-3.
03 (1H, m), 3.79 (0.5H, d, J = 3.9 Hz), 3.82 (0.5
H, d, J = 3.9 Hz), 4.65-4.74 (1H, m), 5.02 (1H, t,
J = 3.6 Hz), 5.24 (0.5H, dd, J = 14.0Hz, 45.2 H
z), 5.27 (0.5H, dd, J = 13.5 Hz, 45.0 Hz), 5.70 (1
H, d, J = 8.7 Hz), 5.88-5.96 (1H, m), 6.20 (1H, d,
J = 12.3 Hz), 6.91-6.95 (1H, m), 7.02-7.34 (8H,
m), 7.43 (2H, dd, J = 5.3 Hz, 8.6 Hz); IR (KBr) 32
95, 2938, 1638, 1510, 1225, 1034, 772 cm -1 ; Anal.
Calcd for C 31 H 32 F 3 NO 2・ 0.1H 2 O: C, 73.09; H, 6.37; N,
2.75. Found: C, 72.87; H, 6.31; N, 2.62.
【0475】実施例343 4-フルオロ-N-[(1RS,2SR)-1-[3-(1,
2-ジフルオロ-2-メチルプロピル)ベンジル]-2-
(4-フルオロフェニル)-2-ヒドロキシエチル]ナフ
タレン-1-カルボキサミド (1RS,2SR)-2-アミノ-3-[3-(1,2-ジフ
ルオロ-2-メチルプロピル)フェニル]-1-(4-フル
オロフェニル)プロパン-1-オール0.200g(0.
593ミリモル)、4-フルオロ-1-ナフトエ酸0.1
1g(0.59ミリモル)、1-ヒドロキシベンゾトリ
アゾール水和物91mg(0.59ミリモル)をアセト
ニトリル10ml中で撹拌しながら1-エチル-3-(3-
ジメチルアミノプロピル)カルボジイミド・塩酸塩0.
11g(0.59ミリモル)を加え、室温で一晩撹拌し
た。反応液を酢酸エチルに希釈し、炭酸水素ナトリウム
水溶液で洗浄、無水硫酸マグネシウムで乾燥、溶媒を減
圧留去した。得られた残留物をシリカゲルカラムクロマ
トグラフィーにて精製し(ヘキサン/酢酸エチル=3/
1-1/1)、ジイソプロピルエーテル-ヘキサンより結
晶化して、目的物を得た。白色粉末 収量0.218g
収率72% mp 163-165℃; 1H-NMR (CDCl3, 300 MHz) δ 1.24-1.38
(6H, m), 2.74-2.87 (1H, m), 3.07 (1H, dd, J = 4.1
Hz, 14.3 Hz), 3.62-3.64 (1H, m), 4.74-4.83(1H,
m), 5.07 (0.5H, t, J = 4.1 Hz), 5.08 (0.5H, t, J =
3.9 Hz), 5.22 (0.5H, dd, J = 14.9 Hz, 45.2 Hz),
5.27 (0.5H, dd, J = 13.4 Hz, 44.9 Hz), 5.86 (0.5H,
d, J = 8.1 Hz), 5.88 (0.5H, d, J = 8.1 Hz), 6.96-
7.37 (8H, m), 7.43-7.57 (4H, m), 7.77-7.84 (1H,
m), 8.08 (1H, d, J = 8.1 Hz); IR (KBr) 3291, 1642,
1626, 1512, 1231, 837, 768 cm-1; Anal. Calcd for
C30H27F4NO2・0.2H2O: C, 70.22; H, 5.38; N, 2.73. Fo
und: C, 69.96; H, 5.24; N, 2.70.Example 343 4-Fluoro-N-[(1RS, 2SR) -1- [3- (1,
2-difluoro-2-methylpropyl) benzyl] -2-
(4-Fluorophenyl) -2-hydroxyethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-3- [3- (1,2-difluoro-2-methylpropyl) phenyl] -1- ( 0.200 g of 4-fluorophenyl) propan-1-ol (0.
593 mmol) 4-fluoro-1-naphthoic acid 0.1
1 g (0.59 mmol), 91 mg (0.59 mmol) of 1-hydroxybenzotriazole hydrate were stirred in 10 ml of acetonitrile while stirring 1-ethyl-3- (3- (3-methyl-3-hydroxybenzotriazole).
Dimethylaminopropyl) carbodiimide hydrochloride
11 g (0.59 mmol) was added and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 /
1-1-1) and crystallization from diisopropyl ether-hexane to obtain the desired product. 0.218 g of white powder
Yield 72% mp 163-165 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.24-1.38
(6H, m), 2.74-2.87 (1H, m), 3.07 (1H, dd, J = 4.1
Hz, 14.3 Hz), 3.62-3.64 (1H, m), 4.74-4.83 (1H,
m), 5.07 (0.5H, t, J = 4.1 Hz), 5.08 (0.5H, t, J =
3.9 Hz), 5.22 (0.5H, dd, J = 14.9 Hz, 45.2 Hz),
5.27 (0.5H, dd, J = 13.4 Hz, 44.9 Hz), 5.86 (0.5H,
d, J = 8.1 Hz), 5.88 (0.5H, d, J = 8.1 Hz), 6.96-
7.37 (8H, m), 7.43-7.57 (4H, m), 7.77-7.84 (1H,
m), 8.08 (1H, d, J = 8.1 Hz); IR (KBr) 3291, 1642,
1626, 1512, 1231, 837, 768 cm -1 ; Anal.Calcd for
C 30 H 27 F 4 NO 2・ 0.2H 2 O: C, 70.22; H, 5.38; N, 2.73. Fo
und: C, 69.96; H, 5.24; N, 2.70.
【0476】実施例344 N-[(1RS,2SR)-2-(3-クロロフェニル)-
2-ヒドロキシ-1-(4-ネオペンチルベンジル)エチ
ル]-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテ
ン-1-カルボキサミド 1) 4-ネオペンチル安息香酸 塩化アルミニウム4.43g(33.2ミリモル)の塩
化メチレン20ml懸濁液に撹拌しながら、塩化トリク
ロロアセチル6.04g(33.2ミリモル)の塩化メ
チレン10ml溶液を−78℃で滴下した。反応液を1
5分撹拌した後、−50℃に昇温し、ネオペンチルベン
ゼン4.922g(33.20ミリモル)の塩化メチレ
ン10ml溶液を加え、室温で一晩撹拌した。反応液を
氷水に注ぎ、混合物の塩化メチレン層を分離し、水層を
ジエチルエーテルで抽出した。集めた有機層を無水硫酸
マグネシウムで乾燥、溶媒を減圧留去した。得られた残
留物をテトラヒドロフラン30mlに溶かし、水酸化カ
リウム3.73g(66.4ミリモル)を水40mlに
溶かした溶液を加え、室温で10分撹拌した。反応液を
ジエチルエーテルと水で希釈し、水層を分離した。得ら
れた水溶液を濃塩酸で酸性とし、酢酸エチルで2回抽出
した。集めた有機層を無水硫酸マグネシウムで乾燥、溶
媒を減圧留去、目的物を得た。褐色結晶 収量5.34
3g 収率84% ジイソプロピルエーテル-ヘキサンより再結晶して、白
色結晶を得た。 mp 193-194℃; 1H-NMR (CDCl3, 300 MHz) δ 0.92 (9H,
s), 2.58 (2H, s), 2.24 (2H, d, J = 8.1 Hz), 8.02
(2H, d, J = 8.4 Hz), 8.02 (1H, br s); IR (KBr) 310
0-2550, 1682, 1426, 1319, 1296, 951, 731 cm-1; Ana
l. Calcd for C12H16O2: C, 74.97; H, 8.39. Found:
C, 74.85; H, 8.47. 2) 4-ネオペンチルベンジルアルコール 水素化リチウムアルミニウム1.13g(29.9ミリ
モル)のテトラヒドロフラン50ml懸濁液に、氷冷
下、4-ネオペンチル安息香酸3.830g(19.9
2ミリモル)のテトラヒドロフラン30ml溶液を滴下
し、室温で一晩撹拌した。反応液を氷冷した後、水1m
l、15%水酸化ナトリウム水溶液1ml、水2.5m
lを順次滴下して、過剰の水素化リチウムアルミニウム
を分解し、そのまま室温で2時間撹拌した。生じた沈殿
をろ過して除き、沈殿を酢酸エチルで洗浄した。集めた
濾液の溶媒を減圧留去した。得られた残留物をシリカゲ
ルカラムクロマトグラフィーにて精製して(ヘキサン/
酢酸エチル=6/1-3/1)、目的物を得た。黄色液
体 収量2.446g 収率69%1 H-NMR (CDCl3, 300 MHz) δ 0.90 (9H, s), 1.62 (1H,
t, J = 5.9 Hz), 2.49(2H, s), 4.67 (2H, d, J = 5.7
Hz), 7.12 (2H, d, J = 8.1 Hz), 7.27 (2H, d, J =
7.8 Hz); IR (neat) 3330, 2951, 1364, 1017 cm-1 3) 3-(3-クロロフェニル)-2-(4-ネオペンチ
ルベンジル)-3-オキソプロピオン酸エチル 4-ネオペンチルベンジルアルコール2.446g(1
3.72ミリモル)、トリエチルアミン2.87ml
(20.6ミリモル)の酢酸エチル50ml溶液に氷冷
下塩化メタンスルホニル1.89g(16.5ミリモ
ル)の酢酸エチル10ml溶液を滴下し、そのまま10
分間撹拌した。生じた沈殿を濾過して除き、沈殿をジエ
チルエーテルで洗浄した。集めた濾液の溶媒を減圧留去
して、メタンスルホン酸エステルの粗生成物を黄色液体
として得た。(3-クロロベンゾイル)酢酸エチル3.
11g(13.7ミリモル)の1,2-ジメトキシエタ
ン20ml溶液に氷冷下60%水素化ナトリウムの流動
パラフィン懸濁物0.55g(13.7ミリモル)を加
え、そのまま0.5時間撹拌した。これに上で得たメタ
ンスルホン酸エステルの1,2-ジメトキシエタン20
ml溶液を室温で加え、室温で3日間撹拌した。反応液
を水に注ぎ、酢酸エチルで2回抽出した。集めた有機層
を無水硫酸マグネシウムで乾燥、溶媒を減圧留去した。
得られた残留物をシリカゲルカラムクロマトグラフィー
にて精製し(ヘキサン/酢酸エチル=15/1)、目的
物を得た。淡黄色液体 収量4.648g 収率88%1 H-NMR (CDCl3, 300 MHz) δ 0.85 (9H, s), 1.13 (3H,
t, J = 7.1 Hz), 2.42(2H, s), 3.28-3.31 (2H, m),
4.07-4.15 (2H, m), 4.55 (1H, t, J = 7.4 Hz),7.00
(2H, d, J = 7.8 Hz), 7.09 (2H, d, J = 8.1 Hz), 7.3
6 (1H, t, J = 7.7 Hz), 7.51 (1H, ddd, J = 1.1 Hz,
1.9 Hz, 8.0 Hz), 7.78 (1H, ddd, J = 1.1 Hz, 1.7 H
z, 7.7 Hz), 7.89 (1H, t, J = 1.8 Hz); IR (neat) 29
53, 1738, 1694, 1229 cm-1 4) (2RS,3RS)-3-(3-クロロフェニル)-
3-ヒドロキシ-2-(4-ネオペンチルベンジル)プロピ
オン酸エチル 塩化亜鉛3.22g(23.6ミリモル)をジエチルエ
ーテル30ml中で撹拌しながら水素化ホウ素ナトリウ
ム1.78g(47.2ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、3-(3-クロロ
フェニル)-2-(4-ネオペンチルベンジル)-3-オキ
ソプロピオン酸エチル4.564g(11.80ミリモ
ル)のジエチルエーテル30ml溶液を氷冷下で加え、
そのまま20分間撹拌した。反応液に希塩酸を少しずつ
加えて過剰の水素化ホウ素亜鉛を分解した後、酢酸エチ
ルで2回抽出した。集めた有機層を無水硫酸マグネシウ
ムで乾燥、溶媒を減圧留去した。得られた粗生成物をシ
リカゲルカラムクロマトグラフィーにて精製し(ヘキサ
ン/酢酸エチル=15/1-6/1)、目的物を得た。
無色液体 収量3.828g 収率83%1 H-NMR (CDCl3, 200 MHz) δ 0.86 (9H, s), 0.95 (3H,
t, J = 7.2 Hz), 2.42(2H, s), 2.84-3.00 (3H, m),
3.13 (1H, d, J = 2.6 Hz), 3.91 (2H, q, J = 7.1 H
z), 5.03 (1H, t, J = 3.1 Hz), 6.98 (4H, s), 7.26
(3H, s), 7.42 (1H,s); IR (neat) 3468, 2951, 1726,
1709, 1476, 1375, 1364, 1236, 1184, 1032cm-1 5) (4RS,5SR)-5-(3-クロロフェニル)-
4-(4-ネオペンチルベンジル)-1,3-オキサゾリジ
ン-2-オン (2RS,3RS)-3-(3-クロロフェニル)-3-ヒ
ドロキシ-2-(4-ネオペンチルベンジル)プロピオン
酸エチル3.756g(9.657ミリモル)、水酸化
ナトリウム0.77g(19.3ミリモル)、メタノー
ル20ml、水10ml、テトラヒドロフラン20ml
の混合物を室温で一晩撹拌した。反応液を濃縮、水で希
釈し、塩酸で反応液を酸性にした後、酢酸エチルで2回
抽出した。集めた有機層を無水硫酸ナトリウムで乾燥、
溶媒を減圧留去して、(2RS,3RS)-3-(3-ク
ロロフェニル)-3-ヒドロキシ-2-(4-ネオペンチル
ベンジル)プロピオン酸の粗生成物を白色固体として得
た。上で得た固体のテトラヒドロフラン30ml溶液に
トリエチルアミン1.62ml(11.6ミリモル)、
ジフェニルホスホリルアジド2.92g(10.6ミリ
モル)を加え、65℃で一晩撹拌した。反応液の溶媒を
減圧留去し、得られた粗生成物をシリカゲルカラムクロ
マトグラフィーにて精製し(ヘキサン/酢酸エチル=3
/1-1/1)、酢酸エチル-ジイソプロピルエーテル-
ヘキサンより結晶化して、目的物を得た。白色結晶 収
量2.517g 収率73% mp 197-198℃; 1H-NMR (CDCl3, 200 MHz) δ 0.87 (9H,
s), 2.18 (1H, dd, J =11.0 Hz, 13.6 Hz), 2.30 (1H,
dd, J = 4.0 Hz, 13.8 Hz), 2.44 (2H, s), 4.18-4.30
(1H, m), 4.99 (1H, br s), 5.76 (1H, d, J = 8.2 H
z), 6.92 (2H, d,J = 8.0 Hz), 7.04 (2H, d, J = 8.0
Hz), 7.24-7.38 (4H, m); IR (KBr) 3268, 2959, 1740,
1240, 1017, 791 cm-1; Anal. Calcd for C21H24ClN
O2: C, 70.48; H, 6.76; N, 3.91. Found: C, 70.56;
H, 7.00; N, 3.62. 6) (1RS,2SR)-2-アミノ-1-(3-クロロ
フェニル)-3-(4-ネオペンチルフェニル)プロパン-
1-オール (4RS,5SR)-5-(3-クロロフェニル)-4-
(4-ネオペンチルベンジル)-1,3-オキサゾリジン-
2-オン2.335g(6.525ミリモル)と水酸化
ナトリウム1.04g(26.1ミリモル)をエタノー
ル30ml-水1ml中で、5時間加熱還流した。反応
液を水で希釈し、そのまま0.5時間撹拌した。生じた
沈殿を集め、水とジイソプロピルエーテル-ヘキサンで
洗浄して、目的物を得た。白色粉末 収量1.814g
収率84% mp 118-120℃; 1H-NMR (CDCl3, 300 MHz) δ 0.88 (9H,
s), 2.31 (1H, dd, J =10.5 Hz, 13.8 Hz), 2.45 (2H,
s), 2.72 (1H, dd, J = 3.3 Hz, 13.8 Hz), 3.29 (1H,
ddd, J = 3.3 Hz, 4.8 Hz, 10.5 Hz), 4.67 (1H, d, J
= 4.5 Hz), 7.00-7.06 (5H, m), 7.24-7.32 (2H, m),
7.42 (1H, s); IR (KBr) 3130-2770, 2953, 1576, 147
6, 1420, 1364, 1192, 1040, 949, 855, 779, 729 c
m-1; Anal. Calcd for C20H26ClNO: C, 72.38; H, 7.9
0; N, 4.22. Found: C, 72.24; H, 7.97; N, 4.02. 7) N-[(1RS,2SR)-2-(3-クロロフェニ
ル)-2-ヒドロキシ-1-(4-ネオペンチルベンジル)
エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘ
プテン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(3-クロロフェニ
ル)-3-(4-ネオペンチルフェニル)プロパン-1-オ
ール0.300g(0.904ミリモル)、6,7-ジ
ヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボン
酸0.17g(0.90ミリモル)、1-ヒドロキシベ
ンゾトリアゾール水和物0.14g(0.90ミリモ
ル)をアセトニトリル10ml-N,N-ジメチルホルム
アミド2ml中で撹拌しながら1-エチル-3-(3-ジメ
チルアミノプロピル)カルボジイミド・塩酸塩0.17
g(0.90ミリモル)を加え、室温で一晩撹拌した。
反応液を酢酸エチルに希釈し、炭酸水素ナトリウム水溶
液で洗浄、無水硫酸マグネシウムで乾燥、シリカゲルを
通した後、溶媒を減圧留去した。得られた残留物を、酢
酸エチル-ジイソプロピルエーテル-ヘキサンより結晶化
して、目的物を得た。白色粉末 収量0.377g 収
率83% mp 147-149℃; 1H-NMR (CDCl3, 300 MHz) δ 0.88 (9H,
s), 1.95-2.04 (2H, m), 2.17-2.23 (2H, m), 2.46 (2
H, s), 2.62-2.71 (3H, m), 2.97 (1H, dd, J =4.2 Hz,
14.4 Hz), 4.38 (1H, d, J = 4.2 Hz), 4.63-4.72 (1
H, m), 5.04 (1H,t, J = 3.8 Hz), 5.69 (1H, d, J =
7.5 Hz), 5.99 (1H, td, J = 5.4 Hz, 12.0 Hz), 6.33
(1H, d, J = 11.7 Hz), 6.88 (1H, dd, J = 1.2 Hz, 7.
5 Hz), 7.01 (1H, t, J = 7.5 Hz), 7.05 (4H, s), 7.1
4 (1H, d, J = 6.3 Hz), 7.27-7.35(3H, m), 7.48 (1H,
s); IR (KBr) 3376, 3331, 2959, 1626, 1528, 779, 7
66cm-1; Anal. Calcd for C32H36ClNO2: C, 76.55; H,
7.23; N, 2.79. Found: C,76.38; H, 7.19; N, 2.52.Example 344 N-[(1RS, 2SR) -2- (3-chlorophenyl)-
2-hydroxy-1- (4-neopentylbenzyl) ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 1) 4-neopentylbenzoic acid 4.43 g (33.2 mmol) of aluminum chloride )), A solution of 6.04 g (33.2 mmol) of trichloroacetyl chloride in 10 ml of methylene chloride was added dropwise at -78 ° C while stirring. Reaction solution 1
After stirring for 5 minutes, the temperature was raised to −50 ° C., a solution of 4.922 g (33.20 mmol) of neopentylbenzene in 10 ml of methylene chloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was poured into ice water, the methylene chloride layer of the mixture was separated, and the aqueous layer was extracted with diethyl ether. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was dissolved in 30 ml of tetrahydrofuran, a solution of 3.73 g (66.4 mmol) of potassium hydroxide in 40 ml of water was added, and the mixture was stirred at room temperature for 10 minutes. The reaction solution was diluted with diethyl ether and water, and the aqueous layer was separated. The resulting aqueous solution was acidified with concentrated hydrochloric acid and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain the desired product. Brown crystals Yield 5.34
Recrystallization from 3 g of 84% diisopropyl ether-hexane gave 3 g of white crystals. mp 193-194 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 0.92 (9H,
s), 2.58 (2H, s), 2.24 (2H, d, J = 8.1 Hz), 8.02
(2H, d, J = 8.4 Hz), 8.02 (1H, br s); IR (KBr) 310
0-2550, 1682, 1426, 1319, 1296, 951, 731 cm -1 ; Ana
l. Calcd for C 12 H 16 O 2 : C, 74.97; H, 8.39. Found:
H, 8.47.2) 4-Neopentylbenzyl alcohol To a suspension of 1.13 g (29.9 mmol) of lithium aluminum hydride in 50 ml of tetrahydrofuran was added 3.830 g of 4-neopentylbenzoic acid under ice-cooling. 19.9
(2 mmol) in 30 ml of tetrahydrofuran was added dropwise and stirred at room temperature overnight. After cooling the reaction mixture with ice, 1 m of water
1, 15% aqueous sodium hydroxide solution 1 ml, water 2.5 m
1 was sequentially added dropwise to decompose excess lithium aluminum hydride and stirred at room temperature for 2 hours. The resulting precipitate was removed by filtration, and the precipitate was washed with ethyl acetate. The solvent of the collected filtrate was distilled off under reduced pressure. The resulting residue was purified by silica gel column chromatography (hexane / hexane).
Ethyl acetate = 6 / 1-3 / 1) to obtain the desired product. Yellow liquid Yield 2.446 g Yield 69% 1 H-NMR (CDCl 3 , 300 MHz) δ 0.90 (9H, s), 1.62 (1H,
t, J = 5.9 Hz), 2.49 (2H, s), 4.67 (2H, d, J = 5.7
Hz), 7.12 (2H, d, J = 8.1 Hz), 7.27 (2H, d, J =
7.8 Hz); IR (neat) 3330, 2951, 1364, 1017 cm -1 3) ethyl 3- (3-chlorophenyl) -2- (4-neopentylbenzyl) -3-oxopropionate 4-neopentylbenzyl alcohol 2.446 g (1
3.72 mmol), 2.87 ml of triethylamine
(20.6 mmol) in 50 ml of ethyl acetate was added dropwise with a solution of 1.89 g (16.5 mmol) of methanesulfonyl chloride in 10 ml of ethyl acetate under ice-cooling.
Stirred for minutes. The resulting precipitate was removed by filtration, and the precipitate was washed with diethyl ether. The solvent of the collected filtrate was distilled off under reduced pressure to obtain a crude product of methanesulfonic acid ester as a yellow liquid. 2. ethyl (3-chlorobenzoyl) acetate
To a solution of 11 g (13.7 mmol) in 1,2-dimethoxyethane (20 ml) was added 0.55 g (13.7 mmol) of a 60% sodium hydride liquid paraffin suspension under ice cooling, and the mixture was stirred for 0.5 hour. . The methanesulfonic acid ester of 1,2-dimethoxyethane 20 obtained above was added to this.
ml solution was added at room temperature and stirred at room temperature for 3 days. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure.
The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15/1) to obtain the desired product. Light yellow liquid Yield 4.648 g Yield 88% 1 H-NMR (CDCl 3 , 300 MHz) δ 0.85 (9H, s), 1.13 (3H,
t, J = 7.1 Hz), 2.42 (2H, s), 3.28-3.31 (2H, m),
4.07-4.15 (2H, m), 4.55 (1H, t, J = 7.4 Hz), 7.00
(2H, d, J = 7.8 Hz), 7.09 (2H, d, J = 8.1 Hz), 7.3
6 (1H, t, J = 7.7 Hz), 7.51 (1H, ddd, J = 1.1 Hz,
1.9 Hz, 8.0 Hz), 7.78 (1H, ddd, J = 1.1 Hz, 1.7 H
z, 7.7 Hz), 7.89 (1H, t, J = 1.8 Hz); IR (neat) 29
53, 1738, 1694, 1229 cm -1 4) (2RS, 3RS) -3- (3- chlorophenyl) -
Ethyl 3-hydroxy-2- (4-neopentylbenzyl) propionate While stirring 3.22 g (23.6 mmol) of zinc chloride in 30 ml of diethyl ether, 1.78 g (47.2 mmol) of sodium borohydride was added. The mixture was added at room temperature and stirred for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. To the obtained solution, a solution of 4.564 g (11.80 mmol) of ethyl 3- (3-chlorophenyl) -2- (4-neopentylbenzyl) -3-oxopropionate in 30 ml of diethyl ether was added under ice-cooling. ,
The mixture was stirred for 20 minutes as it was. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-6 / 1) to obtain the desired product.
Colorless liquid Yield 3.828 g Yield 83% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.86 (9H, s), 0.95 (3H,
t, J = 7.2 Hz), 2.42 (2H, s), 2.84-3.00 (3H, m),
3.13 (1H, d, J = 2.6 Hz), 3.91 (2H, q, J = 7.1 H
z), 5.03 (1H, t, J = 3.1 Hz), 6.98 (4H, s), 7.26
(3H, s), 7.42 (1H, s); IR (neat) 3468, 2951, 1726,
1709, 1476, 1375, 1364, 1236, 1184, 1032cm -1 5) (4RS, 5SR) -5- (3- chlorophenyl) -
Ethyl 4- (4-neopentylbenzyl) -1,3-oxazolidin-2-one (2RS, 3RS) -3- (3-chlorophenyl) -3-hydroxy-2- (4-neopentylbenzyl) propionate 3 0.756 g (9.657 mmol), sodium hydroxide 0.77 g (19.3 mmol), methanol 20 ml, water 10 ml, tetrahydrofuran 20 ml
Was stirred overnight at room temperature. The reaction mixture was concentrated, diluted with water, acidified with hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer is dried over anhydrous sodium sulfate,
The solvent was distilled off under reduced pressure to obtain a crude product of (2RS, 3RS) -3- (3-chlorophenyl) -3-hydroxy-2- (4-neopentylbenzyl) propionic acid as a white solid. 1.62 ml (11.6 mmol) of triethylamine was added to a solution of the solid obtained above in 30 ml of tetrahydrofuran,
2.92 g (10.6 mmol) of diphenylphosphoryl azide was added and stirred at 65 ° C. overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3).
/ 1-1-1), ethyl acetate-diisopropyl ether-
Crystallization from hexane gave the desired product. White crystals Yield 2.517 g Yield 73% mp 197-198 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 0.87 (9H,
s), 2.18 (1H, dd, J = 11.0 Hz, 13.6 Hz), 2.30 (1H,
dd, J = 4.0 Hz, 13.8 Hz), 2.44 (2H, s), 4.18-4.30
(1H, m), 4.99 (1H, br s), 5.76 (1H, d, J = 8.2 H
z), 6.92 (2H, d, J = 8.0 Hz), 7.04 (2H, d, J = 8.0
Hz), 7.24-7.38 (4H, m); IR (KBr) 3268, 2959, 1740,
1240, 1017, 791 cm -1 ; Anal.Calcd for C 21 H 24 ClN
O 2 : C, 70.48; H, 6.76; N, 3.91. Found: C, 70.56;
H, 7.00; N, 3.62.6) (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- (4-neopentylphenyl) propane-
1-ol (4RS, 5SR) -5- (3-chlorophenyl) -4-
(4-neopentylbenzyl) -1,3-oxazolidine-
2.335 g (6.525 mmol) of 2-one and 1.04 g (26.1 mmol) of sodium hydroxide were heated to reflux in 30 ml of ethanol-1 ml of water for 5 hours. The reaction solution was diluted with water and stirred as it was for 0.5 hour. The resulting precipitate was collected and washed with water and diisopropyl ether-hexane to obtain the desired product. White powder Yield 1.814 g
Yield 84% mp 118-120 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 0.88 (9H,
s), 2.31 (1H, dd, J = 10.5 Hz, 13.8 Hz), 2.45 (2H,
s), 2.72 (1H, dd, J = 3.3 Hz, 13.8 Hz), 3.29 (1H,
ddd, J = 3.3 Hz, 4.8 Hz, 10.5 Hz), 4.67 (1H, d, J
= 4.5 Hz), 7.00-7.06 (5H, m), 7.24-7.32 (2H, m),
7.42 (1H, s); IR (KBr) 3130-2770, 2953, 1576, 147
6, 1420, 1364, 1192, 1040, 949, 855, 779, 729 c
m -1 ; Anal.Calcd for C 20 H 26 ClNO: C, 72.38; H, 7.9
0, N, 4.22. Found: C, 72.24; H, 7.97; N, 4.02.7) N-[(1RS, 2SR) -2- (3-chlorophenyl) -2-hydroxy-1- (4-neopentyl) Benzyl)
Ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- (4-neopentylphenyl) propane-1 0.300 g (0.904 mmol), 0.17 g (0.90 mmol) of 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid, 1-hydroxybenzotriazole hydrate. 14 g (0.90 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride 0.17 was stirred in 10 ml of acetonitrile-2 ml of N, N-dimethylformamide while stirring.
g (0.90 mmol) was added and stirred at room temperature overnight.
The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White powder Yield 0.377 g Yield 83% mp 147-149 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 0.88 (9H,
s), 1.95-2.04 (2H, m), 2.17-2.23 (2H, m), 2.46 (2
H, s), 2.62-2.71 (3H, m), 2.97 (1H, dd, J = 4.2 Hz,
14.4 Hz), 4.38 (1H, d, J = 4.2 Hz), 4.63-4.72 (1
H, m), 5.04 (1H, t, J = 3.8 Hz), 5.69 (1H, d, J =
7.5 Hz), 5.99 (1H, td, J = 5.4 Hz, 12.0 Hz), 6.33
(1H, d, J = 11.7 Hz), 6.88 (1H, dd, J = 1.2 Hz, 7.
5 Hz), 7.01 (1H, t, J = 7.5 Hz), 7.05 (4H, s), 7.1
4 (1H, d, J = 6.3 Hz), 7.27-7.35 (3H, m), 7.48 (1H,
s); IR (KBr) 3376, 3331, 2959, 1626, 1528, 779, 7
66cm -1 ; Anal.Calcd for C 32 H 36 ClNO 2 : C, 76.55; H,
7.23; N, 2.79. Found: C, 76.38; H, 7.19; N, 2.52.
【0477】実施例345 4-フルオロ-N-[(1RS,2SR)-2-(3-クロロ
フェニル)-2-ヒドロキシ-1-(4-ネオペンチルベン
ジル)エチル]ナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(3-クロロフェニ
ル)-3-(4-ネオペンチルフェニル)プロパン-1-オ
ール0.300g(0.904ミリモル)、4-フルオ
ロ-1-ナフトエ酸0.17g(0.90ミリモル)、1
-ヒドロキシベンゾトリアゾール水和物0.14g
(0.90ミリモル)をアセトニトリル10ml-N,
N-ジメチルホルムアミド2ml中で撹拌しながら1-エ
チル-3-(3-ジメチルアミノプロピル)カルボジイミ
ド・塩酸塩0.17g(0.90ミリモル)を加え、室
温で一晩撹拌した。反応液を酢酸エチルに希釈し、炭酸
水素ナトリウム水溶液で洗浄、無水硫酸マグネシウムで
乾燥、シリカゲルを通した後、溶媒を減圧留去した。得
られた残留物を、酢酸エチル-ジイソプロピルエーテル-
ヘキサンより結晶化して、目的物を得た。白色粉末 収
量0.300g 収率66% mp 150-151℃; 1H-NMR (CDCl3, 300 MHz) δ 0.89 (9H,
s), 2.48 (2H, s), 2.73 (1H, dd, J = 11.3 Hz, 14.6
Hz), 3.04 (1H, dd, J = 4.2 Hz, 14.4 Hz), 4.19 (1
H, d, J = 4.5 Hz), 4.72-4.81 (1H, m), 5.11 (1H, t,
J = 3.9 Hz), 5.86 (1H, d, J = 8.1 Hz), 6.94 (1H,
dd, J = 8.1 Hz, 9.9 Hz), 7.04-7.12 (5H,m), 7.27-7.
40 (3H, m), 7.46-7.58 (3H, m), 7.94 (1H, d, J = 8.
1 Hz), 8.08 (1H, d, J = 7.5 Hz); IR (KBr) 3275, 29
55, 1642, 1626, 1541, 1426, 1264, 1236, 1051, 760
cm-1; Anal. Calcd for C31H31ClFNO2: C, 73.87; H,
6.20;N, 2.78. Found: C, 73.69; H, 6.02; N, 2.59.Example 345 4-Fluoro-N-[(1RS, 2SR) -2- (3-chlorophenyl) -2-hydroxy-1- (4-neopentylbenzyl) ethyl] naphthalene-1-carboxamide (1RS, 0.300 g (0.904 mmol) of 2SR) -2-amino-1- (3-chlorophenyl) -3- (4-neopentylphenyl) propan-1-ol 0.17 g of 4-fluoro-1-naphthoic acid (0.90 mmol), 1
-Hydroxybenzotriazole hydrate 0.14g
(0.90 mmol) in acetonitrile 10 ml-N,
While stirring in 2 ml of N-dimethylformamide, 0.17 g (0.90 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was purified with ethyl acetate-diisopropyl ether-
Crystallization from hexane gave the desired product. White powder Yield 0.300 g Yield 66% mp 150-151 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 0.89 (9H,
s), 2.48 (2H, s), 2.73 (1H, dd, J = 11.3 Hz, 14.6
Hz), 3.04 (1H, dd, J = 4.2 Hz, 14.4 Hz), 4.19 (1
H, d, J = 4.5 Hz), 4.72-4.81 (1H, m), 5.11 (1H, t,
J = 3.9 Hz), 5.86 (1H, d, J = 8.1 Hz), 6.94 (1H,
dd, J = 8.1 Hz, 9.9 Hz), 7.04-7.12 (5H, m), 7.27-7.
40 (3H, m), 7.46-7.58 (3H, m), 7.94 (1H, d, J = 8.
1 Hz), 8.08 (1H, d, J = 7.5 Hz); IR (KBr) 3275, 29
55, 1642, 1626, 1541, 1426, 1264, 1236, 1051, 760
cm -1 ; Anal.Calcd for C 31 H 31 ClFNO 2 : C, 73.87; H,
6.20; N, 2.78.Found: C, 73.69; H, 6.02; N, 2.59.
【0478】実施例346 5-クロロ-N-[(1RS,2SR)-2-(3-クロロフ
ェニル)-2-ヒドロキシ-1-(4-ネオペンチルベンジ
ル)エチル]ナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(3-クロロフェニ
ル)-3-(4-ネオペンチルフェニル)プロパン-1-オ
ール0.300g(0.904ミリモル)、5-クロロ-
1-ナフトエ酸0.19g(0.90ミリモル)、1-ヒ
ドロキシベンゾトリアゾール水和物0.14g(0.9
0ミリモル)をアセトニトリル10ml-N,N-ジメチ
ルホルムアミド2ml中で撹拌しながら1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩0.17g(0.90ミリモル)を加え、室温で一晩
撹拌した。反応液を酢酸エチルに希釈し、炭酸水素ナト
リウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、シ
リカゲルを通した後、溶媒を減圧留去した。得られた残
留物を、酢酸エチル-ジイソプロピルエーテル-ヘキサン
より結晶化して、目的物を得た。白色結晶 収量0.3
67g 収率78% mp 168-169℃; 1H-NMR (CDCl3-DMSO-d6, 200 MHz) δ
0.88 (9H, s), 2.46 (2H,s), 2.81 (1H, dd, J = 10.6
Hz, 14.6 Hz), 2.94 (1H, dd, J = 4.6 Hz, 14.4Hz),
4.72-4.86 (1H, m), 5.04-5.11 (2H, m), 6.97-7.14 (5
H, m), 7.23-7.37(4H, m), 7.42-7.58 (4H, m), 7.67
(1H, d, J = 8.4 Hz), 8.29 (1H, d, J =8.6 Hz); IR
(KBr) 3272, 2957, 1636, 1537, 785 cm-1; Anal. Calc
d for C31H 31Cl2NO2: C, 71.54; H, 6.00; N, 2.69. Fo
und: C, 71.63; H, 6.09; N, 2.58.Example 346 5-Chloro-N-[(1RS, 2SR) -2- (3-chlorofurf
Enyl) -2-hydroxy-1- (4-neopentylbenzy
Ru) ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (3-chlorophenyl)
) -3- (4-neopentylphenyl) propane-1-o
0.300 g (0.904 mmol), 5-chloro-
0.19 g (0.90 mmol) of 1-naphthoic acid
0.14 g of droxybenzotriazole hydrate (0.9
0 mmol) in 10 ml of acetonitrile-N, N-dimethyl
1-ethyl-3- while stirring in 2 ml of formamide
(3-dimethylaminopropyl) carbodiimide / hydrochloric acid
Add 0.17 g (0.90 mmol) of salt and allow to stand at room temperature overnight
Stirred. Dilute the reaction mixture with ethyl acetate and add sodium hydrogen carbonate
Wash with aqueous solution of lithium, dry over anhydrous magnesium sulfate,
After passing through Licagel, the solvent was distilled off under reduced pressure. Obtained residue
The distillate was extracted with ethyl acetate-diisopropyl ether-hexane
Further crystallization gave the desired product. White crystals Yield 0.3
67g yield 78% mp 168-169 ° C;1H-NMR (CDClThree-DMSO-d6, 200 MHz) δ
0.88 (9H, s), 2.46 (2H, s), 2.81 (1H, dd, J = 10.6
Hz, 14.6 Hz), 2.94 (1H, dd, J = 4.6 Hz, 14.4Hz),
4.72-4.86 (1H, m), 5.04-5.11 (2H, m), 6.97-7.14 (5
H, m), 7.23-7.37 (4H, m), 7.42-7.58 (4H, m), 7.67
(1H, d, J = 8.4 Hz), 8.29 (1H, d, J = 8.6 Hz); IR
(KBr) 3272, 2957, 1636, 1537, 785 cm-1; Anal. Calc
d for C31H 31ClTwoNOTwo: C, 71.54; H, 6.00; N, 2.69. Fo
und: C, 71.63; H, 6.09; N, 2.58.
【0479】実施例347 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシエチル-1-[3-(2,2,3,3-テト
ラフルオロプロピオニル)ベンジル]]カルバミン酸t
ert-ブチル 1) 3-(4-フルオロフェニル)-2-[3-(2,
2,3,3-テトラフルオロプロピオニル)ベンジル]-
3-オキソプロピオン酸エチル 2,2,3,3-テトラフルオロ-1-(3-メチルフェニ
ル)プロパン-1-オン7.484g(33.99ミリモ
ル)、N-ブロモスクシンイミド6.05g(34.0
ミリモル)、2,2’-アゾビス(イソブチロニトリ
ル)0.2gの四塩化炭素40ml溶液を1.5時間加
熱還流した。反応液を室温に冷却した後、白色沈殿を濾
過して除き、沈殿をヘキサンで洗浄した。集めた濾液の
溶媒を減圧留去して、淡黄色液体を得た。(4-フルオ
ロベンゾイル)酢酸エチル7.15g(34.0ミリモ
ル)の1,2-ジメトキシエタン50ml溶液に氷冷下
60%水素化ナトリウムの流動パラフィン懸濁物1.3
6g(34.0ミリモル)を加え、そのまま0.5時間
撹拌した。これに上で得た液体の1,2-ジメトキシエ
タン30ml溶液を室温で加え、室温で一晩撹拌した。
反応液を水に注ぎ、酢酸エチルで2回抽出した。集めた
有機層を無水硫酸マグネシウムで乾燥、溶媒を減圧留去
した。得られた残留物をシリカゲルカラムクロマトグラ
フィーにて精製し(ヘキサン/酢酸エチル=15/1-
9/1)、目的物を得た。黄色液体 収量6.608g
収率45%1 H-NMR (CDCl3, 300 MHz) δ 1.12 (3H, t, J = 7.2 H
z), 3.41 (2H, d, J = 7.5 Hz), 3.40-4.15 (2H, m),
4.59 (1H, t, J = 7.4 Hz), 6.28 (1H, tt, J = 5.6 H
z, 52.5 Hz), 7.13 (2H, t, J = 8.7 Hz), 7.44 (1H,
t, J = 8.0 Hz), 7.59(1H, d, J = 7.5 Hz), 7.93-7.96
(2H, m), 8.01 (2H, dd, J = 5.6 Hz, 8.9 Hz); IR (n
eat) 1736, 1686, 1599, 1508, 1302, 1273, 1238, 115
9, 1115, 849cm-1 2) (2RS,3RS)-3-(4-フルオロフェニ
ル)-3-ヒドロキシ-2-[3-(2,2,3,3-テトラ
フルオロ-1-ヒドロキシプロピル)ベンジル]プロピオ
ン酸エチル 塩化亜鉛4.16g(30.5ミリモル)をジエチルエ
ーテル50ml中で撹拌しながら水素化ホウ素ナトリウ
ム2.31g(61.1ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、3-(4-フルオ
ロフェニル)-2-[3-(2,2,3,3-テトラフルオ
ロプロピオニル)ベンジル]-3-オキソプロピオン酸エ
チル6.540g(15.27ミリモル)のジエチルエ
ーテル30ml溶液を氷冷下で加え、そのまま20分間
撹拌した。反応液に希塩酸を少しずつ加えて過剰の水素
化ホウ素亜鉛を分解した後、酢酸エチルで2回抽出し
た。集めた有機層を無水硫酸マグネシウムで乾燥、溶媒
を減圧留去した。得られた粗生成物をシリカゲルカラム
クロマトグラフィーにて精製し(ヘキサン/酢酸エチル
=3/1-1/1)、目的物を得た。淡黄色液体 収量
5.958g 収率90%1 H-NMR (CDCl3, 300 MHz) δ 0.90 (3H, t, J = 7.1 H
z), 2.78 (1H, s), 2.93-3.03 (4H, m), 3.78-3.89 (2
H, m), 4.93-5.03 (2H, m), 5.96 (1H, ddt, J = 2.4 H
z, 8.5 Hz, 53.2 Hz), 7.03 (2H, t, J = 8.7 Hz), 7.1
1-7.15 (1H, m), 7.19 (1H, d, J = 7.2 Hz), 7.24-7.2
8 (2H, m), 7.34 (2H, dd, J = 5.4 Hz, 9.0Hz); IR (n
eat) 3418, 1715, 1607, 1512, 1377, 1229, 1186, 115
9, 1100, 1057, 839 cm-1 3) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-[3-(2,2,3,3-テトラフルオロ-1-ヒ
ドロキシプロピル)ベンジル]-1,3-オキサゾリジン
-2-オン (2RS,3RS)-3-(4-フルオロフェニル)-3-
ヒドロキシ-2-[3-(2,2,3,3-テトラフルオロ
-1-ヒドロキシプロピル)ベンジル]プロピオン酸エチ
ル5.878g(13.59ミリモル)、水酸化ナトリ
ウム1.09g(27.2ミリモル)、メタノール20
ml、水30ml、テトラヒドロフラン20mlの混合
物を室温で一晩撹拌した。反応液を濃縮、水で希釈し、
塩酸で反応液を酸性にした後、酢酸エチルで2回抽出し
た。集めた有機層を無水硫酸ナトリウムで乾燥、溶媒を
減圧留去して、(2RS,3RS)-3-(4-フルオロ
フェニル)-3-ヒドロキシ-2-[3-(2,2,3,3-
テトラフルオロ-1-ヒドロキシプロピル)ベンジル]プ
ロピオン酸の粗生成物を液体として得た。上で得た液体
のテトラヒドロフラン50ml溶液にトリエチルアミン
2.27ml(16.3ミリモル)、ジフェニルホスホ
リルアジド4.12g(15.0ミリモル)を加え、6
5℃で一晩撹拌した。反応液の溶媒を減圧留去し、得ら
れた粗生成物をシリカゲルカラムクロマトグラフィーに
て精製し(ヘキサン/酢酸エチル=3/1-1/2)、
目的物を得た。淡黄色液体 収量5.001g 収率9
2%1 H-NMR (CDCl3, 300 MHz) δ 2.14-2.38 (2H, m), 4.17
-4.25 (1H, m), 4.34-4.42 (0.5H, m), 4.87-4.89 (0.5
H, m), 4.96 (0.5H, br s), 5.02 (0.5H, br s),5.73
(0.5H, d, J = 8.7 Hz), 5.78 (0.5H, d, J = 8.7 Hz),
6.08 (1H, dt, J= 9.7 Hz, 53.4 Hz), 6.85 (0.5H,
s), 6.99-7.36 (7.5H, m); IR (neat) 3304, 1744, 151
4, 1236, 1101, 1067, 735 cm-1 4) (4RS,5SR)-5-(4-フルオロフェニ
ル)-4-[3-(2,2,3,3-テトラフルオロプロピ
オニル)ベンジル]-1,3-オキサゾリジン-2-オン (4RS,5SR)-5-(4-フルオロフェニル)-4-
[3-(2,2,3,3-テトラフルオロ-1-ヒドロキシ
プロピル)ベンジル]-1,3-オキサゾリジン-2-オン
5.779g(14.40ミリモル)とトリエチルアミ
ン16.1ml(115ミリモル)をジメチルスルホキ
シド20ml中で撹拌し、これに室温で三酸化硫黄ピリ
ジン錯体9.17g(57.6ミリモル)のジメチルス
ルホキシド30ml溶液を加え、そのまま一晩撹拌し
た。反応混合物を水に注ぎ、濃塩酸で酸性とした後、酢
酸エチルで2回抽出した。集めた有機層を無水硫酸マグ
ネシウムで乾燥、溶媒を減圧留去した。得られた粗生成
物をシリカゲルカラムクロマトグラフィーにて精製して
(ヘキサン/酢酸エチル=2/1-1/1)、目的物を
得た。黄色固体 収量3.772g 収率66% ジイソプロピルエーテルより再結晶して、白色粉末を得
た。 mp 149-150℃; 1H-NMR (CDCl3, 300 MHz) δ 2.41 (2H,
d, J = 7.5 Hz), 4.31(1H, q, J = 7.4 Hz), 5.69 (1
H, s), 5.79 (1H, d, J = 8.1 Hz), 6.27 (1H, tt,
J = 5.4 Hz, 52.6 Hz), 7.1
1 (2H, t, J = 8.6 Hz), 7.
31−7.36 (3H, m), 7.46 (1
H, t, J = 7.7 Hz), 7.68
(1H, s), 7.96 (1H, d, J =
8.1 Hz); IR (KBr)3250, 1
740, 1690, 1516, 1240, 11
15, 1096 cm−1; Anal. Calc
d for C19H14F5NO3: C, 57.
15; H, 3.53; N, 3.51. Fou
nd: C, 57.12; H, 3.57; N,
3.41. 5) (4RS,5SR)-5-(4-フルオロフェニ
ル)-2-オキソ-4-[3-(2,2,3,3-テトラフル
オロプロピオニル)ベンジル]-1,3-オキサゾリジン
-3-カルボン酸tert-ブチル (4RS,5SR)-5-(4-フルオロフェニル)-4-
[3-(2,2,3,3-テトラフルオロプロピオニル)
ベンジル]-1,3-オキサゾリジン-2-オン2.199
g(5.507ミリモル)、二炭酸ジ-tert-ブチル
1.44g(6.61ミリモル)、4-N,N-ジメチル
アミノピリジン67mg(0.55ミリモル)のアセト
ニトリル30ml溶液を室温で一晩撹拌した。反応液の
溶媒を減圧留去し、得られた残留物をシリカゲルカラム
クロマトグラフィーにて精製し(ヘキサン/酢酸エチル
=3/1)、ジイソプロピルエーテル-ヘキサンより結
晶化して、目的物を得た。白色結晶 収量2.178g
収率79% mp 116-118℃; 1H-NMR (CDCl3, 300 MHz) δ 1.52 (9H,
s), 2.69 (1H, dd, J =9.0 Hz, 14.4 Hz), 2.99 (1H,
dd, J = 4.1 Hz, 14.3 Hz), 4.83 (1H, ddd, J= 4.4 H
z, 7.1 Hz, 9.2 Hz), 5.68 (1H, d, J = 7.2 Hz), 6.27
(1H, tt, J = 5.6 Hz, 52.5 Hz), 6.94 (2H, t, J =
8.7 Hz), 7.04 (1H, d, J = 7.8 Hz), 7.13 (2H, dd, J
= 5.1 Hz, 8.4 Hz), 7.28 (1H, t, J = 8.0 Hz), 7.33
(1H, s),7.84 (1H, d, J = 8.1 Hz); IR (KBr) 1806,
1701, 1516, 1372, 1159, 1113, 1076 cm-1; Anal. Cal
cd for C24H22F5NO5: C, 57.72; H, 4.44; N, 2.80. Fo
und: C, 57.66; H, 4.41; N, 2.66. 6) N-[(1RS,2SR)-2-(4-フルオロフェ
ニル)-2-ヒドロキシエチル-1-[3-(2,2,3,
3-テトラフルオロプロピオニル)ベンジル]]カルバ
ミン酸tert-ブチル (4RS,5SR)-5-(4-フルオロフェニル)-2-
オキソ-4-[3-(2,2,3,3-テトラフルオロプロ
ピオニル)ベンジル]-1,3-オキサゾリジン-3-カル
ボン酸tert-ブチル2.030g(4.065ミリ
モル)のテトラヒドロフラン20ml溶液に水酸化ナト
リウム0.16g(4.06ミリモル)のメタノール1
0ml溶液を氷冷下加え、室温で1時間撹拌した。反応
液を酢酸エチルに希釈し、水で洗浄、無水硫酸マグネシ
ウムで乾燥、シリカゲルを通した後、溶媒を減圧留去し
た。得られた残留物を酢酸エチル-ジイソプロピルエー
テル-ヘキサンより結晶化して、目的物を得た。白色粉
末 収量1.692g 収率88% mp 157-158℃; 1H-NMR (CDCl3, 300 MHz) δ 1.31 (9H,
s), 2.76 (1H, dd, J =9.9 Hz, 14.4 Hz), 2.86 (1H,
dd, J = 4.2 Hz, 14.1 Hz), 3.07 (1H, s), 4.04-4.13
(1H, m), 4.65 (1H, br d, J = 9.3 Hz), 4.94 (1H,
s), 6.29 (1H,, tt, J = 5.6 Hz, 52.5 Hz), 7.08 (2H,
t, J = 8.7 Hz), 7.34-7.48 (4H, m), 7.81 (1H, s),
7.93 (1H, d, J = 6.9 Hz); IR (KBr) 3353, 1682, 153
4, 1514, 1242, 1225, 1171, 1113, 1005 cm-1; Anal.
Calcd for C23H24F5NO4: C, 58.35;H, 5.11; N, 2.96.
Found: C, 58.12; H, 4.94; N, 2.79.Example 347 N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxyethyl-1- [3- (2,2,3,3-tetrafluoropropionyl) benzyl]] carbamic acid
ert-butyl 1) 3- (4-fluorophenyl) -2- [3- (2,
2,3,3-tetrafluoropropionyl) benzyl]-
Ethyl 3-oxopropionate 7.484 g (33.99 mmol) of 2,2,3,3-tetrafluoro-1- (3-methylphenyl) propan-1-one, 6.05 g of N-bromosuccinimide (34. 0
Mmol) and 0.2 g of 2,2'-azobis (isobutyronitrile) in 40 ml of carbon tetrachloride were heated under reflux for 1.5 hours. After cooling the reaction solution to room temperature, a white precipitate was removed by filtration, and the precipitate was washed with hexane. The solvent of the collected filtrate was distilled off under reduced pressure to obtain a pale yellow liquid. 1.34 g (34.0 mmol) of ethyl (4-fluorobenzoyl) acetate in 50 ml of 1,2-dimethoxyethane in a liquid paraffin suspension of 60% sodium hydride under ice-cooling 1.3
6 g (34.0 mmol) was added, and the mixture was stirred for 0.5 hour. A solution of the liquid obtained above in 30 ml of 1,2-dimethoxyethane was added thereto at room temperature, and the mixture was stirred at room temperature overnight.
The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-
9/1), the desired product was obtained. 6.608 g of yellow liquid
Yield 45% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.12 (3H, t, J = 7.2 H
z), 3.41 (2H, d, J = 7.5 Hz), 3.40-4.15 (2H, m),
4.59 (1H, t, J = 7.4 Hz), 6.28 (1H, tt, J = 5.6 H
z, 52.5 Hz), 7.13 (2H, t, J = 8.7 Hz), 7.44 (1H,
t, J = 8.0 Hz), 7.59 (1H, d, J = 7.5 Hz), 7.93-7.96
(2H, m), 8.01 (2H, dd, J = 5.6 Hz, 8.9 Hz); IR (n
eat) 1736, 1686, 1599, 1508, 1302, 1273, 1238, 115
9, 1115, 849 cm -1 2) (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- [3- (2,2,3,3-tetrafluoro-1-hydroxypropyl) Ethyl benzyl] propionate While stirring 4.16 g (30.5 mmol) of zinc chloride in 50 ml of diethyl ether, 2.31 g (61.1 mmol) of sodium borohydride was added at room temperature, and the mixture was stirred as it was for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. To the resulting solution, 6.540 g (15.27 mmol) of ethyl 3- (4-fluorophenyl) -2- [3- (2,2,3,3-tetrafluoropropionyl) benzyl] -3-oxopropionate ) Was added under ice-cooling, and the mixture was stirred for 20 minutes. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1) to obtain the desired product. Light yellow liquid Yield 5.958 g Yield 90% 1 H-NMR (CDCl 3 , 300 MHz) δ 0.90 (3H, t, J = 7.1 H)
z), 2.78 (1H, s), 2.93-3.03 (4H, m), 3.78-3.89 (2
H, m), 4.93-5.03 (2H, m), 5.96 (1H, ddt, J = 2.4 H
z, 8.5 Hz, 53.2 Hz), 7.03 (2H, t, J = 8.7 Hz), 7.1
1-7.15 (1H, m), 7.19 (1H, d, J = 7.2 Hz), 7.24-7.2
8 (2H, m), 7.34 (2H, dd, J = 5.4 Hz, 9.0Hz); IR (n
eat) 3418, 1715, 1607, 1512, 1377, 1229, 1186, 115
9, 1100, 1057, 839 cm -1 3) (4RS, 5SR) -5- (4-fluorophenyl) -4- [3- (2,2,3,3-tetrafluoro-1-hydroxypropyl) benzyl ] -1,3-oxazolidine
-2-one (2RS, 3RS) -3- (4-fluorophenyl) -3-
Hydroxy-2- [3- (2,2,3,3-tetrafluoro
5.878 g (13.59 mmol) of ethyl 1-hydroxypropyl) benzyl] propionate, 1.09 g (27.2 mmol) of sodium hydroxide, methanol 20
A mixture of 30 ml of water, 30 ml of water and 20 ml of tetrahydrofuran was stirred at room temperature overnight. Concentrate the reaction, dilute with water,
After acidifying the reaction solution with hydrochloric acid, it was extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and (2RS, 3RS) -3- (4-fluorophenyl) -3-hydroxy-2- [3- (2,2,3, 3-
A crude product of tetrafluoro-1-hydroxypropyl) benzyl] propionic acid was obtained as a liquid. To a solution of the liquid obtained above in 50 ml of tetrahydrofuran, 2.27 ml (16.3 mmol) of triethylamine and 4.12 g (15.0 mmol) of diphenylphosphoryl azide were added.
Stirred at 5 ° C. overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 2).
The desired product was obtained. Light yellow liquid Yield 5.001 g Yield 9
2% 1 H-NMR (CDCl 3 , 300 MHz) δ 2.14-2.38 (2H, m), 4.17
-4.25 (1H, m), 4.34-4.42 (0.5H, m), 4.87-4.89 (0.5
H, m), 4.96 (0.5H, br s), 5.02 (0.5H, br s), 5.73
(0.5H, d, J = 8.7 Hz), 5.78 (0.5H, d, J = 8.7 Hz),
6.08 (1H, dt, J = 9.7 Hz, 53.4 Hz), 6.85 (0.5H,
s), 6.99-7.36 (7.5H, m); IR (neat) 3304, 1744, 151
4, 1236, 1101, 1067, 735 cm -1 4) (4RS, 5SR) -5- (4- fluorophenyl) -4- [3- (2,2,3,3-tetrafluoro-propionyl) benzyl] - 1,3-oxazolidine-2-one (4RS, 5SR) -5- (4-fluorophenyl) -4-
5.779 g (14.40 mmol) of [3- (2,2,3,3-tetrafluoro-1-hydroxypropyl) benzyl] -1,3-oxazolidin-2-one and 16.1 ml (115 mmol) of triethylamine Was stirred in 20 ml of dimethyl sulfoxide, a solution of 9.17 g (57.6 mmol) of sulfur trioxide pyridine complex in 30 ml of dimethyl sulfoxide was added at room temperature, and the mixture was stirred overnight as it was. The reaction mixture was poured into water, acidified with concentrated hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 2 / 1-1 / 1) to obtain the desired product. Yellow solid Yield 3.772 g Yield 66% Recrystallization from diisopropyl ether gave a white powder. mp 149-150 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 2.41 (2H,
d, J = 7.5 Hz), 4.31 (1H, q, J = 7.4 Hz), 5.69 (1
H, s), 5.79 (1H, d, J = 8.1 Hz), 6.27 (1H, tt,
J = 5.4 Hz, 52.6 Hz), 7.1
6. 1 (2H, t, J = 8.6 Hz);
31-7.36 (3H, m), 7.46 (1
H, t, J = 7.7 Hz), 7.68
(1H, s), 7.96 (1H, d, J =
8.1 Hz); IR (KBr) 3250, 1
740, 1690, 1516, 1240, 11
15, 1096 cm -1 ; Anal. Calc
d for C 19 H 14 F 5 NO 3: C, 57.
15; H, 3.53; N, 3.51. Fou
nd: C, 57.12; H, 3.57; N,
3.41. 5) (4RS, 5SR) -5- (4-fluorophenyl) -2-oxo-4- [3- (2,2,3,3-tetrafluoropropionyl) benzyl] -1,3-oxazolidine
Tert-Butyl-3-carboxylate (4RS, 5SR) -5- (4-fluorophenyl) -4-
[3- (2,2,3,3-tetrafluoropropionyl)
Benzyl] -1,3-oxazolidin-2-one 2.199
g (5.507 mmol), 1.44 g (6.61 mmol) of di-tert-butyl dicarbonate, a solution of 67 mg (0.55 mmol) of 4-N, N-dimethylaminopyridine in 30 ml of acetonitrile at room temperature overnight. Stirred. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3/1) and crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 2.178 g
Yield 79% mp 116-118 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.52 (9H,
s), 2.69 (1H, dd, J = 9.0 Hz, 14.4 Hz), 2.99 (1H,
dd, J = 4.1 Hz, 14.3 Hz), 4.83 (1H, ddd, J = 4.4 H
z, 7.1 Hz, 9.2 Hz), 5.68 (1H, d, J = 7.2 Hz), 6.27
(1H, tt, J = 5.6 Hz, 52.5 Hz), 6.94 (2H, t, J =
8.7 Hz), 7.04 (1H, d, J = 7.8 Hz), 7.13 (2H, dd, J
= 5.1 Hz, 8.4 Hz), 7.28 (1H, t, J = 8.0 Hz), 7.33
(1H, s), 7.84 (1H, d, J = 8.1 Hz); IR (KBr) 1806,
1701, 1516, 1372, 1159, 1113, 1076 cm -1 ; Anal. Cal
cd for C 24 H 22 F 5 NO 5 : C, 57.72; H, 4.44; N, 2.80. Fo
und: C, 57.66; H, 4.41; N, 2.6.6. 6) N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxyethyl-1- [3- (2,2,3 ,
3-tetrafluoropropionyl) benzyl]] tert-butyl carbamate (4RS, 5SR) -5- (4-fluorophenyl) -2-
To a solution of 2.030 g (4.065 mmol) of tert-butyl oxo-4- [3- (2,2,3,3-tetrafluoropropionyl) benzyl] -1,3-oxazolidine-3-carboxylate in 20 ml of tetrahydrofuran 0.16 g (4.06 mmol) of sodium hydroxide in methanol 1
A 0 ml solution was added under ice cooling, and the mixture was stirred at room temperature for 1 hour. The reaction solution was diluted with ethyl acetate, washed with water, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White powder Yield 1.692 g 88% mp 157-158 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.31 (9H,
s), 2.76 (1H, dd, J = 9.9 Hz, 14.4 Hz), 2.86 (1H,
dd, J = 4.2 Hz, 14.1 Hz), 3.07 (1H, s), 4.04-4.13
(1H, m), 4.65 (1H, br d, J = 9.3 Hz), 4.94 (1H,
s), 6.29 (1H ,, tt, J = 5.6 Hz, 52.5 Hz), 7.08 (2H,
t, J = 8.7 Hz), 7.34-7.48 (4H, m), 7.81 (1H, s),
7.93 (1H, d, J = 6.9 Hz); IR (KBr) 3353, 1682, 153
4, 1514, 1242, 1225, 1171, 1113, 1005 cm -1 ; Anal.
Calcd for C 23 H 24 F 5 NO 4 : C, 58.35; H, 5.11; N, 2.96.
Found: C, 58.12; H, 4.94; N, 2.79.
【0480】実施例348 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[3-(2,2,3,
3-テトラフルオロプロピオニル)ベンジル]エチル]
ナフタレン-1-カルボキサミド N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシエチル-1-[3-(2,2,3,3-テト
ラフルオロプロピオニル)ベンジル]]カルバミン酸t
ert-ブチル0.423g(0.893ミリモル)の
トリフルオロ酢酸5ml溶液を室温で15分間撹拌し
た。反応液を減圧留去した後、水で希釈し、炭酸カリウ
ムでアルカリ性とし、酢酸エチルで2回抽出した。集め
た有機層を無水硫酸ナトリウムで乾燥、溶媒を減圧留去
して淡黄色液体を得た。上で得た液体、4-フルオロ-1
-ナフトエ酸0.17g(0.89ミリモル)、1-ヒド
ロキシベンゾトリアゾール水和物0.14g(0.89
ミリモル)をアセトニトリル15ml中で撹拌しながら
1-エチル-3-(3-ジメチルアミノプロピル)カルボジ
イミド・塩酸塩0.17g(0.89ミリモル)を加
え、室温で一晩撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、溶媒を減圧留去した。得られた残留物を
シリカゲルカラムクロマトグラフィーにて精製し(ヘキ
サン/酢酸エチル=2/1-1/1)、ジイソプロピル
エーテル-ヘキサンより結晶化して、目的物を得た。白
色結晶 収量0.364g 収率75% mp 160-162℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
2.94 (1H, dd, J = 10.5Hz, 14.4 Hz), 3.01 (1H, dd,
J = 5.1 Hz, 14.1 Hz), 4.66 (1H, d, J = 3.6 Hz), 4.
74-4.83 (1H, m), 5.07 (1H, t, J = 3.6 Hz), 6.26 (1
H, tt, J = 5.6 Hz, 52.5 Hz), 6.97-7.11 (4H, m), 7.
24 (1H, dd, J = 5.3 Hz, 8.0 Hz), 7.38-7.61 (6H,
m), 7.68 (1H, d, J = 8.7 Hz), 7.90 (1H, s), 7.96
(1H, d, J = 8.1 Hz), 8.06 (1H, d, J = 8.1 Hz); IR
(KBr) 3277, 1703, 1644, 1626, 1601,1512, 1231, 111
3, 835, 762 cm-1; Anal. Calcd for C29H21F6NO3: C,
63.86;H, 3.88; N, 2.57. Found: C, 63.49; H, 3.49;
N, 2.45.Example 348 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (2,2,3,
3-tetrafluoropropionyl) benzyl] ethyl]
Naphthalene-1-carboxamide N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxyethyl-1- [3- (2,2,3,3-tetrafluoropropionyl) benzyl]] carbamic acid
A solution of 0.423 g (0.893 mmol) of tert-butyl in 5 ml of trifluoroacetic acid was stirred at room temperature for 15 minutes. After evaporating the reaction solution under reduced pressure, the solution was diluted with water, made alkaline with potassium carbonate, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain a pale yellow liquid. The liquid obtained above, 4-fluoro-1
-Naphthoic acid 0.17 g (0.89 mmol), 1-hydroxybenzotriazole hydrate 0.14 g (0.89
(Mmol) was added to 15 ml of acetonitrile, and 0.17 g (0.89 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added thereto, followed by stirring at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 2 / 1-1 / 1), and crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.364 g Yield 75% mp 160-162 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
2.94 (1H, dd, J = 10.5Hz, 14.4 Hz), 3.01 (1H, dd,
J = 5.1 Hz, 14.1 Hz), 4.66 (1H, d, J = 3.6 Hz), 4.
74-4.83 (1H, m), 5.07 (1H, t, J = 3.6 Hz), 6.26 (1
H, tt, J = 5.6 Hz, 52.5 Hz), 6.97-7.11 (4H, m), 7.
24 (1H, dd, J = 5.3 Hz, 8.0 Hz), 7.38-7.61 (6H,
m), 7.68 (1H, d, J = 8.7 Hz), 7.90 (1H, s), 7.96
(1H, d, J = 8.1 Hz), 8.06 (1H, d, J = 8.1 Hz); IR
(KBr) 3277, 1703, 1644, 1626, 1601,1512, 1231, 111
3, 835, 762 cm -1 ; Anal.Calcd for C 29 H 21 F 6 NO 3 : C,
63.86; H, 3.88; N, 2.57. Found: C, 63.49; H, 3.49;
N, 2.45.
【0481】実施例349 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[3-[1-(1,1,
2,2-テトラフルオロエチル)ビニル]ベンジル]エ
チル]ナフタレン-1-カルボキサミド 臭化メチルトリフェニルホスホニウム0.36g(1.
00ミリモル)のテトラヒドロフラン15ml溶液に室
温でtert-ブトキシカリウム0.11g(1.00
ミリモル)を加え、0.5時間撹拌した。これに、4-
フルオロ-N-[(1RS,2SR)-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-[3-(2,2,3,3-
テトラフルオロプロピオニル)ベンジル]エチル]ナフ
タレン-1-カルボキサミド0.181g(0.332ミ
リモル)のテトラヒドロフラン10ml溶液を加え、室
温で3日間撹拌した。反応液を水に注ぎ、酢酸エチルで
2回抽出した。集めた有機層を無水硫酸マグネシウムで
乾燥、溶媒を減圧留去した。得られた粗生成物をシリカ
ゲルカラムクロマトグラフィーにて精製し(ヘキサン/
酢酸エチル=2/1-1/1)、ジイソプロピルエーテ
ル-ヘキサンより結晶化して、目的物を得た。白色固体
収量0.146g 収率81% mp 162-163℃; 1H-NMR (CDCl3-DMSO-d6, 200 MHz) δ
2.86 (1H, dd, J = 10.6Hz, 14.2 Hz), 2.99 (1H, dd,
J = 6.6 Hz, 14.2 Hz), 4.73-4.86 (1H, m), 5.01-5.06
(2H, m), 5.63 (1H, s), 5.75 (1H, tt, J = 4.6 Hz,
53.2 Hz), 5.87 (1H, t, J = 1.7 Hz), 6.96-7.27 (9H,
m), 7.37-7.57 (4H, m), 7.67 (1H, d, J= 8.6 Hz),
8.06 (1H, d, J = 8.4 Hz); IR (KBr) 3262, 1642, 162
6, 1601, 1537, 1510, 1264, 1229, 1111, 1053, 833,
758 cm-1; Anal. Calcd for C30H23F6NO2・0.3H2O: C, 6
5.64; H, 4.33; N, 2.55. Found: C, 65.53; H, 4.04;
N, 2.37.Example 349 4-Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- [1- (1,1,1
2,2-tetrafluoroethyl) vinyl] benzyl] ethyl] naphthalene-1-carboxamide 0.36 g of methyltriphenylphosphonium bromide (1.
(0.1 mmol) of potassium tert-butoxide (1.00 mmol) in a solution of
Mmol) and stirred for 0.5 h. In addition, 4-
Fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (2,2,3,3-
A solution of 0.181 g (0.332 mmol) of tetrafluoropropionyl) benzyl] ethyl] naphthalene-1-carboxamide in 10 ml of tetrahydrofuran was added, and the mixture was stirred at room temperature for 3 days. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / hexane).
Ethyl acetate = 2 / 1-1 / 1) and crystallization from diisopropyl ether-hexane gave the desired product. White solid Yield 0.146 g Yield 81% mp 162-163 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ
2.86 (1H, dd, J = 10.6Hz, 14.2 Hz), 2.99 (1H, dd,
J = 6.6 Hz, 14.2 Hz), 4.73-4.86 (1H, m), 5.01-5.06
(2H, m), 5.63 (1H, s), 5.75 (1H, tt, J = 4.6 Hz,
53.2 Hz), 5.87 (1H, t, J = 1.7 Hz), 6.96-7.27 (9H,
m), 7.37-7.57 (4H, m), 7.67 (1H, d, J = 8.6 Hz),
8.06 (1H, d, J = 8.4 Hz); IR (KBr) 3262, 1642, 162
6, 1601, 1537, 1510, 1264, 1229, 1111, 1053, 833,
758 cm -1 ; Anal.Calcd for C 30 H 23 F 6 NO 2・ 0.3H 2 O: C, 6
5.64; H, 4.33; N, 2.55. Found: C, 65.53; H, 4.04;
N, 2.37.
【0482】実施例350 5-クロロ-N-[(1RS,2SR)-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-[3-(2,2,3,3-
テトラフルオロプロピオニル)ベンジル]エチル]ナフ
タレン-1-カルボキサミド N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシエチル-1-[3-(2,2,3,3-テト
ラフルオロプロピオニル)ベンジル]]カルバミン酸t
ert-ブチル0.462g(0.976ミリモル)の
トリフルオロ酢酸5ml溶液を室温で15分間撹拌し
た。反応液を減圧留去した後、水で希釈し、炭酸カリウ
ムでアルカリ性とし、酢酸エチルで2回抽出した。集め
た有機層を無水硫酸ナトリウムで乾燥、溶媒を減圧留去
して淡黄色液体を得た。上で得た液体、5-クロロ-1-
ナフトエ酸0.20g(0.98ミリモル)、1-ヒド
ロキシベンゾトリアゾール水和物0.15g(0.98
ミリモル)をアセトニトリル15ml中で撹拌しながら
1-エチル-3-(3-ジメチルアミノプロピル)カルボジ
イミド・塩酸塩0.19g(0.98ミリモル)を加
え、室温で一晩撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、溶媒を減圧留去した。得られた残留物を
シリカゲルカラムクロマトグラフィーにて精製し(ヘキ
サン/酢酸エチル=2/1-1/1)、ジイソプロピル
エーテル-ヘキサンより結晶化して、目的物を得た。白
色結晶 収量0.429g 収率78% mp 154-155℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
2.94 (1H, dd, J = 10.7Hz, 14.0 Hz), 3.04 (1H, dd,
J = 4.1 Hz, 14.0 Hz), 4.75-4.85 (1H, m), 4.87 (1H,
d, J = 3.6 Hz), 5.05 (1H, t, J = 3.9 Hz), 6.28 (1
H, tt, J = 5.5 Hz, 52.4 Hz), 7.09 (2H, t, J = 8.6
Hz), 7.23 (1H, t, J = 8.0 Hz), 7.33 (1H, t, J = 9.
0 Hz), 7.44-7.56 (6H, m), 7.61 (1H, d, J = 7.5 H
z), 7.91 (1H, s), 7.98 (1H, t, J = 8.4 Hz), 8.30
(1H, d, J = 8.1 Hz); IR (KBr) 3279,1703, 1640, 153
7, 1512, 1231, 1113, 787 cm-1; Anal. Calcd for C29
H21ClF 5NO3・0.5H2O: C, 61.01; H, 3.88; N, 2.45. Fou
nd: C, 61.21; H, 3.96; N, 2.82.Example 350 5-Chloro-N-[(1RS, 2SR) -2- (4-fluoro
Phenyl) -2-hydroxy-1- [3- (2,2,3,3-
Tetrafluoropropionyl) benzyl] ethyl] naph
Taren-1-carboxamide N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxyethyl-1- [3- (2,2,3,3-tet
Lafluoropropionyl) benzyl]] carbamic acid t
0.462 g (0.976 mmol) of tert-butyl
A solution of 5 ml of trifluoroacetic acid was stirred at room temperature for 15 minutes.
Was. After distilling off the reaction solution under reduced pressure, it was diluted with water, and potassium carbonate was added.
The mixture was made alkaline with a solvent and extracted twice with ethyl acetate. gather
The dried organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure.
This gave a pale yellow liquid. The liquid obtained above, 5-chloro-1-
0.20 g (0.98 mmol) of naphthoic acid, 1-hydr
Roxybenzotriazole hydrate 0.15 g (0.98
Mmol) in 15 ml of acetonitrile with stirring
1-ethyl-3- (3-dimethylaminopropyl) carbodi
0.19 g (0.98 mmol) of imide / hydrochloride was added.
And stirred overnight at room temperature. Dilute the reaction solution in ethyl acetate
And washed with aqueous sodium bicarbonate solution, anhydrous magnesium sulfate
After drying with sodium, the solvent was distilled off under reduced pressure. The resulting residue
Purify by silica gel column chromatography.
Sun / ethyl acetate = 2 / 1-1 / 1), diisopropyl
Crystallization from ether-hexane gave the desired product. White
Color crystal yield 0.429 g yield 78% mp 154-155 ° C;1H-NMR (CDClThree-DMSO-d6, 300 MHz) δ
2.94 (1H, dd, J = 10.7Hz, 14.0 Hz), 3.04 (1H, dd,
J = 4.1 Hz, 14.0 Hz), 4.75-4.85 (1H, m), 4.87 (1H,
d, J = 3.6 Hz), 5.05 (1H, t, J = 3.9 Hz), 6.28 (1
H, tt, J = 5.5 Hz, 52.4 Hz), 7.09 (2H, t, J = 8.6
Hz), 7.23 (1H, t, J = 8.0 Hz), 7.33 (1H, t, J = 9.
0 Hz), 7.44-7.56 (6H, m), 7.61 (1H, d, J = 7.5 H
z), 7.91 (1H, s), 7.98 (1H, t, J = 8.4 Hz), 8.30
(1H, d, J = 8.1 Hz); IR (KBr) 3279,1703, 1640, 153
7, 1512, 1231, 1113, 787 cm-1; Anal. Calcd for C29
Htwenty oneClF FiveNOThree・ 0.5HTwoO: C, 61.01; H, 3.88; N, 2.45. Fou
nd: C, 61.21; H, 3.96; N, 2.82.
【0483】実施例351 5-クロロ-N-[(1RS,2SR)-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-[3-[1-(1,1,
2,2-テトラフルオロエチル)ビニル]ベンジル]エ
チル]ナフタレン-1-カルボキサミド 臭化メチルトリフェニルホスホニウム0.39g(1.
10ミリモル)のテトラヒドロフラン15ml溶液に室
温でtert-ブトキシカリウム0.12g(1.10
ミリモル)を加え、0.5時間撹拌した。これに、5-
クロロ-N-[(1RS,2SR)-2-(4-フルオロフ
ェニル)-2-ヒドロキシ-1-[3-(2,2,3,3-テ
トラフルオロプロピオニル)ベンジル]エチル]ナフタ
レン-1-カルボキサミド0.206g(0.367ミリ
モル)のテトラヒドロフラン10ml溶液を加え、室温
で3日間撹拌した。反応液を水に注ぎ、酢酸エチルで2
回抽出した。集めた有機層を無水硫酸マグネシウムで乾
燥、溶媒を減圧留去した。得られた粗生成物をシリカゲ
ルカラムクロマトグラフィーにて精製し(ヘキサン/酢
酸エチル=2/1-1/1)、ジイソプロピルエーテル-
ヘキサンより結晶化して、目的物を得た。白色粉末 収
量0.100g 収率49% mp 162-163℃; 1H-NMR (CDCl3, 300 MHz) δ 2.81 (1H,
dd, J = 10.7 Hz, 14.3Hz), 3.08 (1H, dd, J = 4.2 H
z, 14.1 Hz), 3.28 (1H, d, J = 3.6 Hz), 4.79-4.89
(1H, m), 5.08 (1H, t, J = 3.8 Hz), 5.63 (1H, s),
5.72 (1H, tt, J =4.0 Hz, 53.4 Hz), 5.89 (1H, s),
7.10 (2H, t, J = 8.7 Hz), 7.18-7.32 (7H, m), 7.43-
7.50 (3H, m), 7.57 (1H, d, J = 8.4 Hz), 7.59 (1H,
d, J = 8.4Hz), 8.33 (1H, d, J = 8.4 Hz); IR (KBr)
3621, 3248, 1638, 1541, 1508, 1223, 1101, 789 cm-1 Example 351 5-Chloro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- [1- (1,1,1
2,2-tetrafluoroethyl) vinyl] benzyl] ethyl] naphthalene-1-carboxamide 0.39 g of methyltriphenylphosphonium bromide (1.
0.12 g (1.10 mmol) of potassium tert-butoxide in a solution of 10 mmol) in 15 ml of tetrahydrofuran at room temperature.
Mmol) and stirred for 0.5 h. In addition, 5-
Chloro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (2,2,3,3-tetrafluoropropionyl) benzyl] ethyl] naphthalene-1- A solution of 0.206 g (0.367 mmol) of carboxamide in 10 ml of tetrahydrofuran was added, and the mixture was stirred at room temperature for 3 days. The reaction solution was poured into water, and extracted with ethyl acetate.
Extracted times. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 2 / 1-1 / 1), and diisopropyl ether-
Crystallization from hexane gave the desired product. White powder Yield 0.100 g Yield 49% mp 162-163 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 2.81 (1H,
dd, J = 10.7 Hz, 14.3Hz), 3.08 (1H, dd, J = 4.2 H
z, 14.1 Hz), 3.28 (1H, d, J = 3.6 Hz), 4.79-4.89
(1H, m), 5.08 (1H, t, J = 3.8 Hz), 5.63 (1H, s),
5.72 (1H, tt, J = 4.0 Hz, 53.4 Hz), 5.89 (1H, s),
7.10 (2H, t, J = 8.7 Hz), 7.18-7.32 (7H, m), 7.43-
7.50 (3H, m), 7.57 (1H, d, J = 8.4 Hz), 7.59 (1H,
d, J = 8.4 Hz), 8.33 (1H, d, J = 8.4 Hz); IR (KBr)
3621, 3248, 1638, 1541, 1508, 1223, 1101, 789 cm -1
【0484】実施例352 N-[(1RS,2SR)-2-(3-クロロフェニル)-
1-[4-(2,2-ジフルオロ-3-メチルブチル)ベン
ジル]-2-ヒドロキシエチル]カルバミン酸tert-
ブチル 1) 3-メチル-1-(4-メチルフェニル)ブタン-2-
オン マグネシウム22.5g(925ミリモル)、ヨウ素1
かけらをジエチルエーテル400ml中で撹拌しなが
ら、4-メチルベンジルクロリド65.0g(463ミ
リモル)のジエチルエーテル500ml溶液を室温でゆ
っくりと滴下し、滴下終了後、室温で0.5時間撹拌し
た。この反応液にイソブチロニトリル21.31g(3
08.3ミリモル)のジエチルエーテル100ml溶液
を氷冷下で滴下し、室温で一晩撹拌した。反応液に1規
定塩酸を氷冷下滴下し、室温で1時間撹拌した。混合物
のジエチルエーテル層を分離し、水層をジエチルエーテ
ルで抽出した。集めた有機層を無水硫酸マグネシウムで
乾燥後、溶媒を減圧留去した。得られた残留物をシリカ
ゲルカラムクロマトグラフィーにて精製して(ヘキサン
/酢酸エチル=15/1-9/1)、目的物を得た。淡
黄色液体 収量52.64g 収率97%1 H-NMR (CDCl3, 300 MHz) δ 1.09 (6H, d, J = 6.9 H
z), 2.33 (3H, s), 2.67-2.77 (1H, m), 3.70 (2H, s),
7.08 (2H, d, J = 8.1 Hz), 7.13 (2H, d, J = 7.8 H
z); IR (neat) 2971, 1713, 1514, 1464, 1042, 781 cm
-1 2) 4-(2,2-ジフルオロ-3-メチルブチル)トル
エン 3-メチル-1-(4-メチルフェニル)ブタン-2-オン2
5.00g(141.8ミリモル)と(ジエチルアミ
ノ)サルファートリフルオリド25.1g(156ミリ
モル)の混合物を室温で一晩撹拌した。反応液を氷水に
注ぎ、撹拌した後、ジエチルエーテルで2回抽出した。
集めた有機層を無水硫酸マグネシウムで乾燥、溶媒を減
圧留去した。得られた残留物をシリカゲルカラムクロマ
トグラフィーにて精製して(ヘキサン-ヘキサン/酢酸
エチル=20/1)、目的物を得た。無色液体 収量
8.562g 収率31%1 H-NMR (CDCl3, 300 MHz) δ 1.04 (6H, d, J = 6.9 H
z), 1.91-2.05 (1H, m),2.33 (3H, s), 3.09 (2H, t, J
= 17.0 Hz), 7.12 (2H, d, J = 8.1 Hz), 7.17(2H, d,
J = 8.4 Hz); IR (neat) 2975, 1514, 999 cm-1 3) (4RS,5SR)-5-(3-クロロフェニル)-
4-[4-(2,2-ジフルオロ-3-メチルブチル)ベン
ジル]-2-オキソ-1,3-オキサゾリジン-3-カルボン
酸tert-ブチル 4-(2,2-ジフルオロ-3-メチルブチル)トルエン
4.06g、N-ブロモスクシンイミド3.64g(2
0.5ミリモル)、2,2’-アゾビス(イソブチロニ
トリル)30mgの四塩化炭素30ml溶液を1.5時
間加熱還流した。反応液を室温に冷却した後、白色沈殿
を濾過して除き、沈殿をヘキサンで洗浄した。集めた濾
液の溶媒を減圧留去して、黄色液体を得た。(3-クロ
ロベンゾイル)酢酸エチル4.64g(20.5ミリモ
ル)の1,2-ジメトキシエタン40ml溶液に氷冷下
60%水素化ナトリウムの流動パラフィン懸濁物0.8
2g(20.5ミリモル)を加え、そのまま0.5時間
撹拌した。これに上で得た液体の1,2-ジメトキシエ
タン20ml溶液を室温で加え、室温で一晩撹拌した。
反応液を水に注ぎ、酢酸エチルで2回抽出した。集めた
有機層を無水硫酸マグネシウムで乾燥、溶媒を減圧留去
した。得られた残留物をシリカゲルカラムクロマトグラ
フィー(ヘキサン/酢酸エチル=15/1-9/1)に
通し、3-(3-クロロフェニル)-2-[4-(2,2-ジ
フルオロ-3-メチルブチル)ベンジル]-3-オキソプロ
ピオン酸エチルの粗生成物を黄色液体として得た。塩化
亜鉛2.49g(18.3ミリモル)をジエチルエーテ
ル30ml中で撹拌しながら水素化ホウ素ナトリウム
1.38g(36.6ミリモル)を室温で加え、そのま
ま2時間撹拌した。混合物の不溶物をろ過で除き(ジエ
チルエーテルで洗浄)、水素化ホウ素亜鉛のジエチルエ
ーテル溶液を得た。得られた溶液に、上で得た液体のジ
エチルエーテル20ml溶液を氷冷下で加え、そのまま
20分間撹拌した。反応液に希塩酸を少しずつ加えて過
剰の水素化ホウ素亜鉛を分解した後、酢酸エチルで2回
抽出した。集めた有機層を無水硫酸マグネシウムで乾
燥、溶媒を減圧留去した。得られた残留物をシリカゲル
カラムクロマトグラフィー(ヘキサン/酢酸エチル=9
/1-6/1)に通し、(2RS,3RS)-3-(3-ク
ロロフェニル)-2-[4-(2,2-ジフルオロ-3-メチ
ルブチル)ベンジル]-3-ヒドロキシプロピオン酸エチ
ルの粗生成物を黄色液体として得た。上で得た液体、1
規定水酸化ナトリウム水溶液9.26ml(9.26ミ
リモル)、メタノール20ml、テトラヒドロフラン2
0mlの混合物を室温で一晩撹拌した。反応液を濃縮、
水で希釈し、塩酸で反応液を酸性にした後、酢酸エチル
で2回抽出した。集めた有機層を無水硫酸ナトリウムで
乾燥、溶媒を減圧留去して、(2RS,3RS)-3-
(3-クロロフェニル)-2-[4-(2,2-ジフルオロ-
3-メチルブチル)ベンジル]-3-ヒドロキシプロピオ
ン酸の粗生成物を黄色固体として得た。上で得た固体の
テトラヒドロフラン40ml溶液にトリエチルアミン
0.77ml(5.56ミリモル)、ジフェニルホスホ
リルアジド1.40g(5.09ミリモル)を加え、6
5℃で一晩撹拌した。反応液の溶媒を減圧留去し、得ら
れた残留物をシリカゲルカラムクロマトグラフィー(ヘ
キサン/酢酸エチル=3/1-1/1)に通し、(4R
S,5SR)-5-(3-クロロフェニル)-4-[4-
(2,2-ジフルオロ-3-メチルブチル)ベンジル]-
1,3-オキサゾリジン-2-オンの粗生成物を白色固体
として得た。上で得た固体、二炭酸ジ-tert-ブチル
0.69g(3.18ミリモル)、4-N,N-ジメチル
アミノピリジン32mg(0.27ミリモル)のアセト
ニトリル30ml溶液を室温で一晩撹拌した。反応液の
溶媒を減圧留去し、得られた残留物をシリカゲルカラム
クロマトグラフィーにて精製し(ヘキサン/酢酸エチル
=9/1-6/1)、目的物を得た。淡黄色液体 収量
0.684g 収率7%1 H-NMR (CDCl3, 300 MHz) δ 1.03 (6H, d, J = 6.9 H
z), 1.49 (9H, s), 1.88-2.02 (1H, m), 2.57 (1H, dd,
J = 8.7 Hz, 14.1 Hz), 2.86 (1H, dd, J = 4.7Hz, 1
4.3 Hz), 3.02 (2H, t, J = 17.3 Hz), 4.82 (1H, ddd,
J = 4.9 Hz, 7.1Hz, 8.5 Hz), 5.64 (1H, d, J = 7.2
Hz), 6.63 (2H, d, J = 7.8 Hz), 6.99-7.05 (3H, m),
7.15-7.20 (2H, m), 7.27 (1H, d, J = 8.1 Hz); IR (n
eat) 2980,1809, 1728, 1360, 1312, 1155, 1071, 733
cm-1 4) N-[(1RS,2SR)-2-(3-クロロフェニ
ル)-1-[4-(2,2-ジフルオロ-3-メチルブチル)
ベンジル]-2-ヒドロキシエチル]カルバミン酸ter
t-ブチル (4RS,5SR)-5-(3-クロロフェニル)-4-
[4-(2,2-ジフルオロ-3-メチルブチル)ベンジ
ル]-2-オキソ-1,3-オキサゾリジン-3-カルボン酸
tert-ブチル0.684g(1.385ミリモル)
のテトラヒドロフラン20ml溶液に水酸化ナトリウム
58mg(1.45ミリモル)のメタノール2ml溶液
を氷冷下加え、そのまま0.5時間撹拌した。反応液を
酢酸エチルに希釈し、水で洗浄、無水硫酸マグネシウム
で乾燥、シリカゲルを通した後、溶媒を減圧留去した。
得られた残留物を酢酸エチル-ジイソプロピルエーテル-
ヘキサンより結晶化して、目的物を得た。白色粉末 収
量0.524g 収率81% mp 139-141℃; 1H-NMR (CDCl3, 200 MHz) δ 1.03 (6H,
d, J = 6.8 Hz), 1.37(9H, s), 1.85-2.06 (1H, m),
2.64 (1H, dd, J = 10.2 Hz, 14.6 Hz), 2.75 (1H, dd,
J = 5.4 Hz, 14.6 Hz), 3.09 (2H, t, J = 17.0 Hz),
3.63 (1H, br s),4.12 (1H, br s), 4.53 (1H, br d, J
= 6.2 Hz), 4.91 (1H, br s), 7.07 (2H, d, J = 8.0
Hz), 7.19 (2H, d, J = 8.0 Hz), 7.28 (3H, s), 7.41
(1H, s);IR (KBr) 3358, 2984, 1682, 1530, 1167, 100
9 cm-1; Anal. Calcd for C25H32ClF2NO3: C, 64.16;
H, 6.89; N, 2.99. Found: C, 64.21; H, 6.90; N, 3.0
1.Example 352 N-[(1RS, 2SR) -2- (3-chlorophenyl)-
Tert- 1- [4- (2,2-Difluoro-3-methylbutyl) benzyl] -2-hydroxyethyl] carbamic acid
Butyl 1) 3-Methyl-1- (4-methylphenyl) butane-2-
On magnesium 22.5 g (925 mmol), iodine 1
While stirring the fragments in 400 ml of diethyl ether, a solution of 65.0 g (463 mmol) of 4-methylbenzyl chloride in 500 ml of diethyl ether was slowly added dropwise at room temperature. After the addition was completed, the mixture was stirred at room temperature for 0.5 hour. 21.31 g of isobutyronitrile (3.
(08.3 mmol) in 100 ml of diethyl ether was added dropwise under ice-cooling, and the mixture was stirred at room temperature overnight. 1N hydrochloric acid was added dropwise to the reaction solution under ice cooling, and the mixture was stirred at room temperature for 1 hour. The diethyl ether layer of the mixture was separated, and the aqueous layer was extracted with diethyl ether. After drying the collected organic layer over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-9 / 1) to obtain the desired product. Light yellow liquid Yield 52.64 g Yield 97% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.09 (6H, d, J = 6.9 H)
z), 2.33 (3H, s), 2.67-2.77 (1H, m), 3.70 (2H, s),
7.08 (2H, d, J = 8.1 Hz), 7.13 (2H, d, J = 7.8 H
z); IR (neat) 2971, 1713, 1514, 1464, 1042, 781 cm
-12 ) 4- (2,2-difluoro-3-methylbutyl) toluene 3-methyl-1- (4-methylphenyl) butan-2-one 2
A mixture of 5.00 g (141.8 mmol) and 25.1 g (156 mmol) of (diethylamino) sulfur trifluoride was stirred at room temperature overnight. The reaction solution was poured into ice water, stirred, and extracted twice with diethyl ether.
The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane-hexane / ethyl acetate = 20/1) to obtain the desired product. Colorless liquid Yield 8.562 g Yield 31% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.04 (6H, d, J = 6.9 H)
z), 1.91-2.05 (1H, m), 2.33 (3H, s), 3.09 (2H, t, J
= 17.0 Hz), 7.12 (2H, d, J = 8.1 Hz), 7.17 (2H, d,
J = 8.4 Hz); IR (neat) 2975, 1514, 999 cm -1 3) (4RS, 5SR) -5- (3-chlorophenyl)-
Tert-Butyl 4- [4- (2,2-difluoro-3-methylbutyl) benzyl] -2-oxo-1,3-oxazolidine-3-carboxylate 4- (2,2-difluoro-3-methylbutyl) toluene 4.06 g, N-bromosuccinimide 3.64 g (2
0.5 mmol) and a solution of 30 mg of 2,2′-azobis (isobutyronitrile) in 30 ml of carbon tetrachloride were heated under reflux for 1.5 hours. After cooling the reaction solution to room temperature, a white precipitate was removed by filtration, and the precipitate was washed with hexane. The solvent of the collected filtrate was distilled off under reduced pressure to obtain a yellow liquid. Liquid paraffin suspension of 60% sodium hydride in a solution of 4.64 g (20.5 mmol) of ethyl (3-chlorobenzoyl) acetate in 40 ml of 1,2-dimethoxyethane under ice-cooling 0.8
2 g (20.5 mmol) was added, and the mixture was stirred as it was for 0.5 hour. A solution of the liquid obtained above in 1,2-dimethoxyethane (20 ml) was added thereto at room temperature, and the mixture was stirred at room temperature overnight.
The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was passed through silica gel column chromatography (hexane / ethyl acetate = 15 / 1-9 / 1) to give 3- (3-chlorophenyl) -2- [4- (2,2-difluoro-3-methylbutyl). ) Benzyl] -3-oxopropionate as a yellow liquid. While stirring 2.49 g (18.3 mmol) of zinc chloride in 30 ml of diethyl ether, 1.38 g (36.6 mmol) of sodium borohydride was added at room temperature, and the mixture was stirred for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. To the obtained solution, a solution of the above obtained liquid in 20 ml of diethyl ether was added under ice-cooling, and the mixture was stirred for 20 minutes. Dilute hydrochloric acid was added little by little to the reaction solution to decompose excess zinc borohydride, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue is subjected to silica gel column chromatography (hexane / ethyl acetate = 9).
/ 1-6 / 1) to give ethyl (2RS, 3RS) -3- (3-chlorophenyl) -2- [4- (2,2-difluoro-3-methylbutyl) benzyl] -3-hydroxypropionate. The crude product was obtained as a yellow liquid. The liquid obtained above, 1
9.26 ml (9.26 mmol) of a normal aqueous sodium hydroxide solution, 20 ml of methanol, and tetrahydrofuran 2
0 ml of the mixture was stirred at room temperature overnight. Concentrate the reaction solution,
The mixture was diluted with water, acidified with hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to give (2RS, 3RS) -3-.
(3-chlorophenyl) -2- [4- (2,2-difluoro-
The crude product of 3-methylbutyl) benzyl] -3-hydroxypropionic acid was obtained as a yellow solid. 0.77 ml (5.56 mmol) of triethylamine and 1.40 g (5.09 mmol) of diphenylphosphoryl azide were added to a solution of the solid obtained above in 40 ml of tetrahydrofuran.
Stirred at 5 ° C. overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was passed through silica gel column chromatography (hexane / ethyl acetate = 3 / 1-1 / 1) to give (4R
S, 5SR) -5- (3-Chlorophenyl) -4- [4-
(2,2-difluoro-3-methylbutyl) benzyl]-
The crude product of 1,3-oxazolidin-2-one was obtained as a white solid. A solution of the solid obtained above, 0.69 g (3.18 mmol) of di-tert-butyl dicarbonate, 32 mg (0.27 mmol) of 4-N, N-dimethylaminopyridine in 30 ml of acetonitrile was stirred at room temperature overnight. . The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 9 / 1-6 / 1) to obtain the desired product. Light yellow liquid Yield 0.684 g Yield 7% 1 H-NMR (CDCl 3 , 300 MHz) δ 1.03 (6H, d, J = 6.9 H)
z), 1.49 (9H, s), 1.88-2.02 (1H, m), 2.57 (1H, dd,
J = 8.7 Hz, 14.1 Hz), 2.86 (1H, dd, J = 4.7Hz, 1
4.3 Hz), 3.02 (2H, t, J = 17.3 Hz), 4.82 (1H, ddd,
J = 4.9 Hz, 7.1Hz, 8.5 Hz), 5.64 (1H, d, J = 7.2
Hz), 6.63 (2H, d, J = 7.8 Hz), 6.99-7.05 (3H, m),
7.15-7.20 (2H, m), 7.27 (1H, d, J = 8.1 Hz); IR (n
eat) 2980,1809, 1728, 1360, 1312, 1155, 1071, 733
cm - 14) N-[(1RS, 2SR) -2- (3-chlorophenyl) -1- [4- (2,2-difluoro-3-methylbutyl)
[Benzyl] -2-hydroxyethyl] carbamic acid ter
t-butyl (4RS, 5SR) -5- (3-chlorophenyl) -4-
0.684 g (1.385 mmol) of tert-butyl [4- (2,2-difluoro-3-methylbutyl) benzyl] -2-oxo-1,3-oxazolidine-3-carboxylate
Was added to a solution of sodium hydroxide in 20 ml of tetrahydrofuran, and a solution of 58 mg (1.45 mmol) of sodium hydroxide in 2 ml of methanol was added under ice-cooling, followed by stirring for 0.5 hour. The reaction solution was diluted with ethyl acetate, washed with water, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure.
The obtained residue is ethyl acetate-diisopropyl ether-
Crystallization from hexane gave the desired product. White powder Yield 0.524 g Yield 81% mp 139-141 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.03 (6H,
d, J = 6.8 Hz), 1.37 (9H, s), 1.85-2.06 (1H, m),
2.64 (1H, dd, J = 10.2 Hz, 14.6 Hz), 2.75 (1H, dd,
J = 5.4 Hz, 14.6 Hz), 3.09 (2H, t, J = 17.0 Hz),
3.63 (1H, br s), 4.12 (1H, br s), 4.53 (1H, br d, J
= 6.2 Hz), 4.91 (1H, br s), 7.07 (2H, d, J = 8.0
Hz), 7.19 (2H, d, J = 8.0 Hz), 7.28 (3H, s), 7.41
(1H, s); IR (KBr) 3358, 2984, 1682, 1530, 1167, 100
. 9 cm -1; Anal Calcd for C 25 H 32 ClF 2 NO 3: C, 64.16;
H, 6.89; N, 2.99. Found: C, 64.21; H, 6.90; N, 3.0
1.
【0485】実施例353 N-[(1RS,2SR)-2-(3-クロロフェニル)-
1-[4-(2,2-ジフルオロ-3-メチルブチル)ベン
ジル]-2-ヒドロキシエチル]-4-フルオロナフタレン
-1-カルボキサミド N-[(1RS,2SR)-2-(3-クロロフェニル)-
1-[4-(2,2-ジフルオロ-3-メチルブチル)ベン
ジル]-2-ヒドロキシエチル]カルバミン酸tert-
ブチル0.200g(0.427ミリモル)のトリフル
オロ酢酸2ml溶液を室温で15分間撹拌した。反応液
を減圧留去した後、水で希釈し、炭酸カリウムでアルカ
リ性とし、酢酸エチルで2回抽出した。集めた有機層を
無水硫酸ナトリウムで乾燥、溶媒を減圧留去して白色固
体を得た。上で得た固体、4-フルオロ-1-ナフトエ酸
81mg(0.43ミリモル)、1-ヒドロキシベンゾ
トリアゾール水和物65mg(0.43ミリモル)をア
セトニトリル10ml中で撹拌しながら1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩82mg(0.43ミリモル)を加え、室温で一晩撹
拌した。反応液を酢酸エチルに希釈し、炭酸水素ナトリ
ウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、溶媒
を減圧留去した。得られた残留物をシリカゲルカラムク
ロマトグラフィーにて精製し(ヘキサン/酢酸エチル=
2/1-1/1)、ジイソプロピルエーテル-ヘキサンよ
り結晶化して、目的物を得た。白色結晶 収量0.15
3g 収率66% mp 181-182℃; 1H-NMR (CDCl3-DMSO-d6, 200 MHz) δ
1.02 (3H, d, J = 7.0 Hz), 1.02 (3H, d, J = 6.8 H
z), 1.86-2.06 (1H, m), 2.80-2.97 (2H, m), 3.09(2H,
t, J = 17.2 Hz), 4.68-4.82 (1H, m), 5.07 (1H, t,
J = 4.0 Hz), 5.19(1H, d, J = 3.6 Hz), 6.98-7.37 (9
H, m), 7.40-7.58 (4H, m), 7.82 (1H, d,J = 8.2 Hz),
8.06 (1H, d, J = 8.4 Hz); IR (KBr) 3297, 1640, 15
34, 1264,1057, 774, 760 cm-1; Anal. Calcd for C31H
29ClF3NO2: C, 68.95; H, 5.41; N, 2.59. Found: C, 6
8.88; H, 5.33; N, 2.55.Example 353 N-[(1RS, 2SR) -2- (3-chlorophenyl)-
1- [4- (2,2-difluoro-3-methylbutyl) benzyl] -2-hydroxyethyl] -4-fluoronaphthalene
-1-Carboxamide N-[(1RS, 2SR) -2- (3-chlorophenyl)-
Tert- 1- [4- (2,2-Difluoro-3-methylbutyl) benzyl] -2-hydroxyethyl] carbamic acid
A solution of 0.200 g (0.427 mmol) of butyl in 2 ml of trifluoroacetic acid was stirred at room temperature for 15 minutes. After evaporating the reaction solution under reduced pressure, the solution was diluted with water, made alkaline with potassium carbonate, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain a white solid. 81 mg (0.43 mmol) of the solid obtained above, 4-fluoro-1-naphthoic acid, 65 mg (0.43 mmol) of 1-hydroxybenzotriazole hydrate were stirred in 10 ml of acetonitrile with 1-ethyl-3. -
82 mg (0.43 mmol) of (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue is purified by silica gel column chromatography (hexane / ethyl acetate =
2 / 1-1-1) and crystallized from diisopropyl ether-hexane to give the desired product. White crystals Yield 0.15
3g Yield 66% mp 181-182 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 200 MHz) δ
1.02 (3H, d, J = 7.0 Hz), 1.02 (3H, d, J = 6.8 H
z), 1.86-2.06 (1H, m), 2.80-2.97 (2H, m), 3.09 (2H,
t, J = 17.2 Hz), 4.68-4.82 (1H, m), 5.07 (1H, t,
J = 4.0 Hz), 5.19 (1H, d, J = 3.6 Hz), 6.98-7.37 (9
H, m), 7.40-7.58 (4H, m), 7.82 (1H, d, J = 8.2 Hz),
8.06 (1H, d, J = 8.4 Hz); IR (KBr) 3297, 1640, 15
34, 1264,1057, 774, 760 cm -1 ; Anal.Calcd for C 31 H
29 ClF 3 NO 2 : C, 68.95; H, 5.41; N, 2.59. Found: C, 6
8.88; H, 5.33; N, 2.55.
【0486】実施例354 5-クロロ-N-[(1RS,2SR)-2-(3-クロロフ
ェニル)-1-[4-(2,2-ジフルオロ-3-メチルブチ
ル)ベンジル]-2-ヒドロキシエチル]ナフタレン-1-
カルボキサミド N-[(1RS,2SR)-2-(3-クロロフェニル)-
1-[4-(2,2-ジフルオロ-3-メチルブチル)ベン
ジル]-2-ヒドロキシエチル]カルバミン酸tert-
ブチル0.200g(0.427ミリモル)のトリフル
オロ酢酸2ml溶液を室温で15分間撹拌した。反応液
を減圧留去した後、水で希釈し、炭酸カリウムでアルカ
リ性とし、酢酸エチルで2回抽出した。集めた有機層を
無水硫酸ナトリウムで乾燥、溶媒を減圧留去して白色固
体を得た。上で得た固体、5-クロロ-1-ナフトエ酸8
8mg(0.43ミリモル)、1-ヒドロキシベンゾト
リアゾール水和物65mg(0.43ミリモル)をアセ
トニトリル10ml中で撹拌しながら1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド・塩酸
塩82mg(0.43ミリモル)を加え、室温で一晩撹
拌した。反応液を酢酸エチルに希釈し、炭酸水素ナトリ
ウム水溶液で洗浄、無水硫酸マグネシウムで乾燥、溶媒
を減圧留去した。得られた残留物をシリカゲルカラムク
ロマトグラフィーにて精製し(ヘキサン/酢酸エチル=
2/1-1/1)、ジイソプロピルエーテル-ヘキサンよ
り結晶化して、目的物を得た。白色結晶 収量0.17
8g 収率75% mp 170-171℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
1.02 (3H, d, J = 6.9 Hz), 1.03 (3H, d, J = 6.9 H
z), 1.89-2.03 (1H, m), 2.86 (1H, dd, J = 10.8 Hz,
14.1 Hz), 2.95 (1H, dd, J = 4.5 Hz, 14.4 Hz), 3.10
(2H, t, J = 17.4 Hz), 4.73-4.82 (1H, m), 5.05 (1
H, t, J = 3.8 Hz), 5.19 (1H, d, J = 3.9 Hz), 7.16-
7.38 (8H, m), 7.44-7.58 (5H, m), 7.64 (1H, d, J =
8.7 Hz), 8.29(1H, d, J = 8.7 Hz); IR (KBr) 3272, 1
638, 1535, 1202, 785 cm-1; Anal. Calcd for C31H29C
l2F2NO2: C, 66.91; H, 5.25; N, 2.52. Found: C, 67.
01; H,5.27; N, 2.41.Example 354 5-Chloro-N-[(1RS, 2SR) -2- (3-chlorophenyl) -1- [4- (2,2-difluoro-3-methylbutyl) benzyl] -2-hydroxyethyl ] Naphthalene-1-
Carboxamide N-[(1RS, 2SR) -2- (3-chlorophenyl)-
Tert- 1- [4- (2,2-Difluoro-3-methylbutyl) benzyl] -2-hydroxyethyl] carbamic acid
A solution of 0.200 g (0.427 mmol) of butyl in 2 ml of trifluoroacetic acid was stirred at room temperature for 15 minutes. After evaporating the reaction solution under reduced pressure, the solution was diluted with water, made alkaline with potassium carbonate, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain a white solid. The solid obtained above, 5-chloro-1-naphthoic acid 8
8 mg (0.43 mmol) of 1-hydroxybenzotriazole hydrate 65 mg (0.43 mmol) are stirred in 10 ml of acetonitrile with 1-ethyl-3-ethyl.
82 mg (0.43 mmol) of (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue is purified by silica gel column chromatography (hexane / ethyl acetate =
2 / 1-1-1) and crystallized from diisopropyl ether-hexane to give the desired product. White crystals Yield 0.17
8g Yield 75% mp 170-171 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
1.02 (3H, d, J = 6.9 Hz), 1.03 (3H, d, J = 6.9 H
z), 1.89-2.03 (1H, m), 2.86 (1H, dd, J = 10.8 Hz,
14.1 Hz), 2.95 (1H, dd, J = 4.5 Hz, 14.4 Hz), 3.10
(2H, t, J = 17.4 Hz), 4.73-4.82 (1H, m), 5.05 (1
H, t, J = 3.8 Hz), 5.19 (1H, d, J = 3.9 Hz), 7.16-
7.38 (8H, m), 7.44-7.58 (5H, m), 7.64 (1H, d, J =
8.7 Hz), 8.29 (1H, d, J = 8.7 Hz); IR (KBr) 3272, 1
638, 1535, 1202, 785 cm -1 ; Anal.Calcd for C 31 H 29 C
l 2 F 2 NO 2 : C, 66.91; H, 5.25; N, 2.52. Found: C, 67.
01; H, 5.27; N, 2.41.
【0487】実施例355 4-フルオロ-N-[(1RS,2SR)-2-(3-クロロ
フェニル)-2-ヒドロキシ-1-[4-(tert-ペンチ
ル)ベンジル]エチル]ナフタレン-1-カルボキサミド 1) 4-(tert-ペンチル)ベンジルアルコール tert-ペンチルベンゼン10.04g(67.72
ミリモル)とヘキサメチレンテトラミン9.49g(6
7.7ミリモル)のトリフルオロ酢酸100ml溶液を
90℃で一晩撹拌した。反応液を減圧留去した後、水で
希釈し、炭酸カリウムでアルカリ性とし、酢酸エチルで
2回抽出した。集めた有機層を無水硫酸ナトリウムで乾
燥、溶媒を減圧留去して4-(tert-ペンチル)ベン
ズアルデヒドの粗生成物を暗褐色液体として得た。上で
得た液体のメタノール100ml溶液に、氷冷下、水素
化ほう素ナトリウム1.28g(33.9ミリモル)を
少しずつ加えた後、室温で一晩撹拌した。反応液を濃縮
した後、水で希釈し、ジエチルエーテルで2回抽出し
た。集めた有機層を無水硫酸ナトリウムで乾燥、溶媒を
減圧留去した。残留物をシリカゲルカラムクロマトグラ
フィーにて精製し(ヘキサン/酢酸エチル=9/1-6
/1)、目的物を得た。黄色液体 収量10.83g
収率74%1 H-NMR (CDCl3, 300 MHz) δ 0.68 (3H, t, J = 7.4 H
z), 1.28 (6H, s), 1.65(2H, q, J = 7.4 Hz), 4.66 (2
H, d, J = 5.7 Hz), 7.30 (2H, d, J = 8.4 Hz),7.33
(2H, d, J = 8.7 Hz); IR (neat) 3281, 2965, 1462, 1
015 cm-1 2) 3-(3-クロロフェニル)-3-オキソ-2-[4-
(tert-ペンチル)ベンジル]プロピオン酸エチル 4-(tert-ペンチル)ベンジルアルコール4.07
5g(22.86ミリモル)、トリエチルアミン4.7
8ml(34.3ミリモル)の酢酸エチル50ml溶液
に氷冷下塩化メタンスルホニル3.14g(27.4ミ
リモル)の酢酸エチル10ml溶液を滴下し、そのまま
10分間撹拌した。生じた沈殿を濾過して除き、沈殿を
ジエチルエーテルで洗浄した。集めた濾液の溶媒を減圧
留去して、メタンスルホン酸エステルの粗生成物を黄色
液体として得た。(3-クロロベンゾイル)酢酸エチル
5.18g(22.9ミリモル)の1,2-ジメトキシ
エタン40ml溶液に氷冷下60%水素化ナトリウムの
流動パラフィン懸濁物0.91g(22.9ミリモル)
を加え、そのまま0.5時間撹拌した。これに上で得た
メタンスルホン酸エステルの1,2-ジメトキシエタン
20ml溶液を室温で加え、50℃で一晩撹拌した。反
応液を水に注ぎ、酢酸エチルで2回抽出した。集めた有
機層を無水硫酸マグネシウムで乾燥、溶媒を減圧留去し
た。得られた残留物をシリカゲルカラムクロマトグラフ
ィーにて精製し(ヘキサン/酢酸エチル=15/1)、
目的物を得た。黄色液体 収量6.969g 収率79
%1 H-NMR (CDCl3, 300 MHz) δ 0.62 (3H, t, J = 7.4 H
z), 1.12 (3H, t, J = 7.2 Hz), 1.23 (6H, s), 1.59
(2H, q, J = 7.4 Hz), 3.26 (1H, dd, J = 7.5 Hz,14.1
Hz), 3.32 (1H, dd, J = 7.2 Hz, 14.4 Hz), 4.10 (1
H, q, J = 7.0 Hz),4.11 (1H, q, J = 7.2 Hz), 4.54
(1H, t, J = 7.4 Hz), 7.13 (2H, d, J = 8.4 Hz), 7.2
1 (2H, d, J = 8.4 Hz), 7.36 (1H, t, J = 8.0 Hz),
7.51 (1H, dd,J = 1.2 Hz, 7.8 Hz), 7.78 (1H, dd, J
= 1.5 Hz, 7.8 Hz), 7.89 (1H, t, J= 1.8 Hz); IR (ne
at) 2965, 1736, 1692, 1229 cm-1 3) (2RS,3RS)-3-(3-クロロフェニル)-
3-ヒドロキシ-2-[4-(tert-ペンチル)ベンジ
ル]プロピオン酸エチル 塩化亜鉛4.91g(36.0ミリモル)をジエチルエ
ーテル50ml中で撹拌しながら水素化ホウ素ナトリウ
ム2.73g(72.0ミリモル)を室温で加え、その
まま2時間撹拌した。混合物の不溶物をろ過で除き(ジ
エチルエーテルで洗浄)、水素化ホウ素亜鉛のジエチル
エーテル溶液を得た。得られた溶液に、3-(3-クロロ
フェニル)-3-オキソ-2-[4-(tert-ペンチル)
ベンジル]プロピオン酸エチル6.969g(18.0
1ミリモル)のジエチルエーテル30ml溶液を氷冷下
で加え、そのまま20分間撹拌した。反応液に希塩酸を
少しずつ加えて過剰の水素化ホウ素亜鉛を分解した後、
酢酸エチルで2回抽出した。集めた有機層を無水硫酸マ
グネシウムで乾燥、溶媒を減圧留去した。得られた粗生
成物をシリカゲルカラムクロマトグラフィーにて精製し
(ヘキサン/酢酸エチル=15/1-6/1)、目的物
を得た。黄色液体 収量6.751g 収率96%1 H-NMR (CDCl3, 200 MHz) δ 0.63 (3H, t, J = 7.4 H
z), 0.923 (3H, t, J = 7.1 Hz), 1.23 (6H, s), 1.59
(2H, q, J = 7.4 Hz), 2.84-2.99 (3H, m), 3.13(1H,
d, J = 3.0 Hz), 3.90 (1H, q, J = 7.2 Hz), 3.91 (1
H, q, J = 7.4 Hz),5.02 (1H, t, J = 3.1 Hz), 7.00
(2H, d, J = 8.0 Hz), 7.18 (2H, d, J = 8.0 Hz), 7.2
6 (3H, s), 7.42 (1H, s); IR (neat) 3480, 2965, 172
8, 1715, 1375, 1192, 1159, 1032, 789 cm-1 4) (4RS,5SR)-5-(3-クロロフェニル)-
4-[4-(tert-ペンチル)ベンジル]-1,3-オ
キサゾリジン-2-オン (2RS,3RS)-3-(3-クロロフェニル)-3-ヒ
ドロキシ-2-[4-(tert-ペンチル)ベンジル]プ
ロピオン酸エチル6.650g(17.10ミリモ
ル)、水酸化ナトリウム1.37g(34.2ミリモ
ル)、メタノール20ml、水20ml、テトラヒドロ
フラン20mlの混合物を室温で一晩撹拌した。反応液
を濃縮、水で希釈し、塩酸で反応液を酸性にした後、酢
酸エチルで2回抽出した。集めた有機層を無水硫酸ナト
リウムで乾燥、溶媒を減圧留去して、(2RS,3R
S)-3-(3-クロロフェニル)-3-ヒドロキシ-2-
[4-(tert-ペンチル)ベンジル]プロピオン酸の
粗生成物を白色固体として得た。上で得た固体のテトラ
ヒドロフラン70ml溶液にトリエチルアミン2.86
ml(20.5ミリモル)、ジフェニルホスホリルアジ
ド5.18g(18.8ミリモル)を加え、65℃で一
晩撹拌した。反応液の溶媒を減圧留去し、 酢酸エチル
で希釈した。得られた酢酸エチル溶液を水で洗浄後、シ
リカゲルを通し、溶媒を減圧留去した。得られた結晶を
ジイソプロピルエーテルで洗浄して、目的物を得た。白
色結晶 収量4.312g 収率71% mp 223-224℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
0.65 (3H, t, J = 7.4 Hz), 1.24 (6H, s), 1.60 (2H,
q, J = 7.4 Hz), 2.30 (1H, dd, J = 6.3 Hz, 14.1 H
z), 2.37 (1H, dd, J = 9.0 Hz, 14.4 Hz), 4.33-4.41
(1H, m), 5.70 (1H,d, J = 7.8 Hz), 6.84-6.87 (3H,
m), 7.15-7.23 (3H, m), 7.27-7.33 (3H, m);IR (KBr)
3247, 2965, 1738, 1240, 1019 cm-1; Anal. Calcd for
C21H24ClNO2: C, 70.48; H, 6.76; N, 3.91. Found:
C, 70.35; H, 6.59; N, 3.77. 5) (1RS,2SR)-2-アミノ-1-(3-クロロ
フェニル)-3-[4-(tert-ペンチル)フェニル]
プロパン-1-オール (4RS,5SR)-5-(3-クロロフェニル)-4-
[4-(tert-ペンチル)ベンジル]-1,3-オキサ
ゾリジン-2-オン4.046g(11.31ミリモル)
と水酸化ナトリウム1.81g(45.2ミリモル)を
エタノール40ml-水2ml中で、5時間加熱還流し
た。反応液を水で希釈し、そのまま0.5時間撹拌し
た。生じた沈殿を集め、水とジイソプロピルエーテル-
ヘキサンで洗浄して、目的物を得た。白色結晶 収量
2.833g 収率76% mp 86-87℃; 1H-NMR (CDCl3, 200 MHz) δ 0.66 (3H,
t, J = 7.3 Hz), 1.26 (6H, s), 1.61 (2H, q, J = 7.4
Hz), 2.30 (1H, dd, J = 10.2 Hz, 14.0 Hz), 2.72 (1
H, dd, J = 3.2 Hz, 13.6 Hz), 3.30 (1H, ddd, J = 3.
5 Hz, 4.7 Hz, 10.4 Hz), 4.67 (1H, d, J = 4.8 Hz),
7.05 (2H, d, J = 8.4 Hz), 7.22-7.30 (5H, m), 7.42
(1H, s); IR (KBr) 3400-2700, 1576, 1474, 1460, 142
0, 1044, 781 cm-1; Anal. Calcd for C20H26ClNO・0.1H
2O: C, 71.99; H, 7.91; N, 4.20. Found: C, 71.96;
H, 7.85; N, 4.14. 6) 4-フルオロ-N-[(1RS,2SR)-2-(3-
クロロフェニル)-2-ヒドロキシ-1-[4-(tert-
ペンチル)ベンジル]エチル]ナフタレン-1-カルボキ
サミド (1RS,2SR)-2-アミノ-1-(3-クロロフェニ
ル)-3-[4-(tert-ペンチル)フェニル]プロパ
ン-1-オール0.300g(0.904ミリモル)、4
-フルオロ-1-ナフトエ酸0.17g(0.90ミリモ
ル)、1-ヒドロキシベンゾトリアゾール水和物0.1
4g(0.90ミリモル)をアセトニトリル10ml-
N,N-ジメチルホルムアミド2ml中で撹拌しながら
1-エチル-3-(3-ジメチルアミノプロピル)カルボジ
イミド・塩酸塩0.17g(0.90ミリモル)を加
え、室温で一晩撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物を酢酸エチル-ジイソプロピルエ
ーテル-ヘキサンより結晶化して、目的物を得た。白色
非晶粉末 収量0.381g 収率84%1 H-NMR (CDCl3-DMSO-d6, 300 MHz) δ 0.64 (3H, t, J
= 7.5 Hz), 1.25 (6H, s), 1.61 (2H, q, J = 7.5 Hz),
2.84 (1H, dd, J = 10.5 Hz, 14.4 Hz), 2.93 (1H, d
d, J = 4.2 Hz, 14.4 Hz), 4.72-4.81 (1H, m), 5.05
(1H, t, J = 3.6 Hz), 5.28 (1H, d, J = 3.6 Hz), 7.0
0 (1H, dd, J = 8.1 Hz, 10.2 Hz), 7.12-7.35 (8H,
m), 7.41-7.58 (4H, m), 7.82 (1H, d, J = 8.1 Hz),
8.05 (1H, d, J= 8.1 Hz); IR (KBr) 3414, 3250, 296
5, 1638, 1628, 1599, 1514, 1262, 1233, 766 cm-1; A
nal. Calcd for C31H31ClFNO2: C, 73.87; H, 6.20; N,
2.78. Found: C, 73.53; H, 6.13; N, 2.84.Example 355 4-Fluoro-N-[(1RS, 2SR) -2- (3-chlorophenyl) -2-hydroxy-1- [4- (tert-pentyl) benzyl] ethyl] naphthalene-1-carboxamide 1) 4- (tert-pentyl) benzyl alcohol 10.04 g of tert-pentylbenzene (67.72)
Mmol) and 9.49 g of hexamethylenetetramine (6
(7.7 mmol) in 100 ml of trifluoroacetic acid was stirred at 90 ° C. overnight. After evaporating the reaction solution under reduced pressure, the solution was diluted with water, made alkaline with potassium carbonate, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain a crude product of 4- (tert-pentyl) benzaldehyde as a dark brown liquid. To a solution of the liquid obtained above in 100 ml of methanol, 1.28 g (33.9 mmol) of sodium borohydride was added little by little under ice-cooling, followed by stirring at room temperature overnight. After concentrating the reaction solution, it was diluted with water and extracted twice with diethyl ether. The collected organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (hexane / ethyl acetate = 9 / 1-6).
/ 1) to obtain the desired product. Yellow liquid yield 10.83g
Yield 74% 1 H-NMR (CDCl 3 , 300 MHz) δ 0.68 (3H, t, J = 7.4 H
z), 1.28 (6H, s), 1.65 (2H, q, J = 7.4 Hz), 4.66 (2
H, d, J = 5.7 Hz), 7.30 (2H, d, J = 8.4 Hz), 7.33
(2H, d, J = 8.7 Hz); IR (neat) 3281, 2965, 1462, 1
015 cm -1 2) 3- (3-chlorophenyl) -3-oxo-2- [4-
(Tert-Pentyl) benzyl] ethyl propionate 4- (tert-pentyl) benzyl alcohol 4.07
5 g (22.86 mmol), triethylamine 4.7
A solution of 3.14 g (27.4 mmol) of methanesulfonyl chloride in 10 ml of ethyl acetate was added dropwise to a solution of 8 ml (34.3 mmol) of ethyl acetate in 50 ml under ice-cooling, and the mixture was stirred for 10 minutes. The resulting precipitate was removed by filtration, and the precipitate was washed with diethyl ether. The solvent of the collected filtrate was distilled off under reduced pressure to obtain a crude product of methanesulfonic acid ester as a yellow liquid. 0.91 g (22.9 mmol) of a 60% sodium hydride liquid paraffin suspension in a solution of 5.18 g (22.9 mmol) of ethyl (3-chlorobenzoyl) acetate in 40 ml of 1,2-dimethoxyethane under ice-cooling
Was added and the mixture was stirred as it was for 0.5 hour. A solution of the methanesulfonic acid ester obtained above in 1,2-dimethoxyethane (20 ml) was added thereto at room temperature, and the mixture was stirred at 50 ° C. overnight. The reaction solution was poured into water and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 15/1),
The desired product was obtained. Yellow liquid Yield 6.969 g Yield 79
% 1 H-NMR (CDCl 3 , 300 MHz) δ 0.62 (3H, t, J = 7.4 H
z), 1.12 (3H, t, J = 7.2 Hz), 1.23 (6H, s), 1.59
(2H, q, J = 7.4 Hz), 3.26 (1H, dd, J = 7.5 Hz, 14.1
Hz), 3.32 (1H, dd, J = 7.2 Hz, 14.4 Hz), 4.10 (1
H, q, J = 7.0 Hz), 4.11 (1H, q, J = 7.2 Hz), 4.54
(1H, t, J = 7.4 Hz), 7.13 (2H, d, J = 8.4 Hz), 7.2
1 (2H, d, J = 8.4 Hz), 7.36 (1H, t, J = 8.0 Hz),
7.51 (1H, dd, J = 1.2 Hz, 7.8 Hz), 7.78 (1H, dd, J
= 1.5 Hz, 7.8 Hz), 7.89 (1H, t, J = 1.8 Hz); IR (ne
at) 2965, 1736, 1692, 1229 cm -1 3) (2RS, 3RS) -3- (3- chlorophenyl) -
Ethyl 3-hydroxy-2- [4- (tert-pentyl) benzyl] propionate While stirring 4.91 g (36.0 mmol) of zinc chloride in 50 ml of diethyl ether, 2.73 g (72.0 g) of sodium borohydride was stirred. (Mmol) at room temperature and stirred for 2 hours. The insoluble matter of the mixture was removed by filtration (washed with diethyl ether) to obtain a diethyl ether solution of zinc borohydride. The resulting solution was added to 3- (3-chlorophenyl) -3-oxo-2- [4- (tert-pentyl)
6.969 g of ethyl benzyl] propionate (18.0
(1 mmol) in 30 ml of diethyl ether was added under ice-cooling, and the mixture was stirred as it was for 20 minutes. After decomposing excess zinc borohydride by adding dilute hydrochloric acid little by little to the reaction solution,
Extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 15 / 1-6 / 1) to obtain the desired product. Yellow liquid Yield 6.751 g Yield 96% 1 H-NMR (CDCl 3 , 200 MHz) δ 0.63 (3H, t, J = 7.4 H)
z), 0.923 (3H, t, J = 7.1 Hz), 1.23 (6H, s), 1.59
(2H, q, J = 7.4 Hz), 2.84-2.99 (3H, m), 3.13 (1H,
d, J = 3.0 Hz), 3.90 (1H, q, J = 7.2 Hz), 3.91 (1
H, q, J = 7.4 Hz), 5.02 (1H, t, J = 3.1 Hz), 7.00
(2H, d, J = 8.0 Hz), 7.18 (2H, d, J = 8.0 Hz), 7.2
6 (3H, s), 7.42 (1H, s); IR (neat) 3480, 2965, 172
8, 1715, 1375, 1192, 1159, 1032, 789 cm -1 4) (4RS, 5SR) -5- (3- chlorophenyl) -
4- [4- (tert-pentyl) benzyl] -1,3-oxazolidin-2-one (2RS, 3RS) -3- (3-chlorophenyl) -3-hydroxy-2- [4- (tert-pentyl) A mixture of 6.650 g (17.10 mmol) of ethyl benzyl] propionate, 1.37 g (34.2 mmol) of sodium hydroxide, 20 ml of methanol, 20 ml of water and 20 ml of tetrahydrofuran was stirred at room temperature overnight. The reaction mixture was concentrated, diluted with water, acidified with hydrochloric acid, and extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and (2RS, 3R
S) -3- (3-Chlorophenyl) -3-hydroxy-2-
A crude product of [4- (tert-pentyl) benzyl] propionic acid was obtained as a white solid. To a solution of the solid obtained above in 70 ml of tetrahydrofuran was added 2.86 of triethylamine.
ml (20.5 mmol) and 5.18 g (18.8 mmol) of diphenylphosphoryl azide were added, and the mixture was stirred at 65 ° C overnight. The solvent of the reaction solution was distilled off under reduced pressure, and diluted with ethyl acetate. The obtained ethyl acetate solution was washed with water, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained crystals were washed with diisopropyl ether to obtain the desired product. White crystals Yield 4.312 g Yield 71% mp 223-224 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
0.65 (3H, t, J = 7.4 Hz), 1.24 (6H, s), 1.60 (2H,
q, J = 7.4 Hz), 2.30 (1H, dd, J = 6.3 Hz, 14.1 H
z), 2.37 (1H, dd, J = 9.0 Hz, 14.4 Hz), 4.33-4.41
(1H, m), 5.70 (1H, d, J = 7.8 Hz), 6.84-6.87 (3H,
m), 7.15-7.23 (3H, m), 7.27-7.33 (3H, m); IR (KBr)
3247, 2965, 1738, 1240, 1019 cm -1 ; Anal.Calcd for
C 21 H 24 ClNO 2 : C, 70.48; H, 6.76; N, 3.91. Found:
C, 70.35; H, 6.59; N, 3.77.5) (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [4- (tert-pentyl) phenyl]
Propan-1-ol (4RS, 5SR) -5- (3-chlorophenyl) -4-
[4- (tert-pentyl) benzyl] -1,4-oxazolidin-2-one 4.046 g (11.31 mmol)
And 1.81 g (45.2 mmol) of sodium hydroxide were heated under reflux for 5 hours in 40 ml of ethanol and 2 ml of water. The reaction solution was diluted with water and stirred as it was for 0.5 hour. Collect the resulting precipitate, add water and diisopropyl ether
Washing with hexane gave the desired product. White crystal yield 2.833 g yield 76% mp 86-87 ° C .; 1 H-NMR (CDCl 3 , 200 MHz) δ 0.66 (3H,
t, J = 7.3 Hz), 1.26 (6H, s), 1.61 (2H, q, J = 7.4
Hz), 2.30 (1H, dd, J = 10.2 Hz, 14.0 Hz), 2.72 (1
H, dd, J = 3.2 Hz, 13.6 Hz), 3.30 (1H, ddd, J = 3.
5 Hz, 4.7 Hz, 10.4 Hz), 4.67 (1H, d, J = 4.8 Hz),
7.05 (2H, d, J = 8.4 Hz), 7.22-7.30 (5H, m), 7.42
(1H, s); IR (KBr) 3400-2700, 1576, 1474, 1460, 142
0, 1044, 781 cm -1 ; Anal.Calcd for C 20 H 26 ClNO ・ 0.1H
2 O: C, 71.99; H, 7.91; N, 4.20. Found: C, 71.96;
H, 7.85; N, 4.14.6) 4-Fluoro-N-[(1RS, 2SR) -2- (3-
Chlorophenyl) -2-hydroxy-1- [4- (tert-
Pentyl) benzyl] ethyl] naphthalene-1-carboxamide (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [4- (tert-pentyl) phenyl] propan-1-ol 0.300 g ( 0.904 mmol), 4
-Fluoro-1-naphthoic acid 0.17 g (0.90 mmol), 1-hydroxybenzotriazole hydrate 0.1
4 g (0.90 mmol) of acetonitrile 10 ml
While stirring in 2 ml of N, N-dimethylformamide, 0.17 g (0.90 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White amorphous powder Yield 0.381 g Yield 84% 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ 0.64 (3H, t, J
= 7.5 Hz), 1.25 (6H, s), 1.61 (2H, q, J = 7.5 Hz),
2.84 (1H, dd, J = 10.5 Hz, 14.4 Hz), 2.93 (1H, d
d, J = 4.2 Hz, 14.4 Hz), 4.72-4.81 (1H, m), 5.05
(1H, t, J = 3.6 Hz), 5.28 (1H, d, J = 3.6 Hz), 7.0
0 (1H, dd, J = 8.1 Hz, 10.2 Hz), 7.12-7.35 (8H,
m), 7.41-7.58 (4H, m), 7.82 (1H, d, J = 8.1 Hz),
8.05 (1H, d, J = 8.1 Hz); IR (KBr) 3414, 3250, 296
5, 1638, 1628, 1599, 1514, 1262, 1233, 766 cm -1 ; A
nal.Calcd for C 31 H 31 ClFNO 2 : C, 73.87; H, 6.20; N,
2.78. Found: C, 73.53; H, 6.13; N, 2.84.
【0488】実施例356 5-クロロ-N-[(1RS,2SR)-2-(3-クロロフ
ェニル)-2-ヒドロキシ-1-[4-(tert-ペンチ
ル)ベンジル]エチル]ナフタレン-1-カルボキサミド (1RS,2SR)-2-アミノ-1-(3-クロロフェニ
ル)-3-[4-(tert-ペンチル)フェニル]プロパ
ン-1-オール0.300g(0.904ミリモル)、5
-クロロ-1-ナフトエ酸0.19g(0.90ミリモ
ル)、1-ヒドロキシベンゾトリアゾール水和物0.1
4g(0.90ミリモル)をアセトニトリル10ml-
N,N-ジメチルホルムアミド2ml中で撹拌しながら
1-エチル-3-(3-ジメチルアミノプロピル)カルボジ
イミド・塩酸塩0.17g(0.90ミリモル)を加
え、室温で一晩撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物を酢酸エチル-ジイソプロピルエ
ーテル-ヘキサンより結晶化して、目的物を得た。白色
非晶粉末 収量0.363g 収率77%1 H-NMR (CDCl3-DMSO-d6, 300 MHz) δ 0.64 (3H, t, J
= 7.4 Hz), 1.26 (6H, s), 1.62 (2H, q, J = 7.4 Hz),
2.83 (1H, dd, J = 11.0 Hz, 14.6 Hz), 2.95 (1H, d
d, J = 4.2 Hz, 14.7 Hz), 4.73-4.82 (1H, m), 5.03
(1H, t, J = 3.9 Hz), 5.26 (1H, d, J = 3.9 Hz), 7.1
6 (2H, d, J = 8.4 Hz), 7.22-7.36 (7H, m), 7.42-7.4
9 (2H, m), 7.55 (1H, d, J = 7.5 Hz), 7.58 (1H, s),
7.65 (1H, d, J = 8.4 Hz), 8.28 (1H, d, J = 8.7 H
z); IR (KBr) 3262, 2963, 1636, 1516, 785 cm-1; Ana
l. Calcd for C31H31Cl2NO2: C, 71.54; H, 6.00; N,
2.69. Found: C, 71.24; H, 6.11; N, 2.42.Example 356 5-Chloro-N-[(1RS, 2SR) -2- (3-chlorophenyl) -2-hydroxy-1- [4- (tert-pentyl) benzyl] ethyl] naphthalene-1-carboxamide 0.300 g (0.904 mmol) of (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [4- (tert-pentyl) phenyl] propan-1-ol, 5
-Chloro-1-naphthoic acid 0.19 g (0.90 mmol), 1-hydroxybenzotriazole hydrate 0.1
4 g (0.90 mmol) of acetonitrile 10 ml
While stirring in 2 ml of N, N-dimethylformamide, 0.17 g (0.90 mmol) of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride was added, and the mixture was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from ethyl acetate-diisopropyl ether-hexane to obtain the desired product. White amorphous powder Yield 0.363 g Yield 77% 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ 0.64 (3H, t, J
= 7.4 Hz), 1.26 (6H, s), 1.62 (2H, q, J = 7.4 Hz),
2.83 (1H, dd, J = 11.0 Hz, 14.6 Hz), 2.95 (1H, d
d, J = 4.2 Hz, 14.7 Hz), 4.73-4.82 (1H, m), 5.03
(1H, t, J = 3.9 Hz), 5.26 (1H, d, J = 3.9 Hz), 7.1
6 (2H, d, J = 8.4 Hz), 7.22-7.36 (7H, m), 7.42-7.4
9 (2H, m), 7.55 (1H, d, J = 7.5 Hz), 7.58 (1H, s),
7.65 (1H, d, J = 8.4 Hz), 8.28 (1H, d, J = 8.7 H
z); IR (KBr) 3262, 2963, 1636, 1516, 785 cm -1 ; Ana
l. Calcd for C 31 H 31 Cl 2 NO 2 : C, 71.54; H, 6.00; N,
2.69. Found: C, 71.24; H, 6.11; N, 2.42.
【0489】実施例357 N-[(1RS,2SR)-1-(4-tert-ブチルベ
ンジル)-2-(4-フルオロフェニル)-2-ヒドロキシ
エチル]-4-フルオロ-1-ナフトアミド 1) エチル2-[4-(tert-ブチル)ベンジル]-
3-(4-フルオロフェニル)-3-オキソプロピオネート p-tert-ブチルベンジルアルコール(5ml,2
8.2ミリモル)の酢酸エチル(60ml)溶液にトリ
エチルアミン(5.9ml,42.3ミリモル)を加え
氷冷下でメタンスルホニルクロライド(2.4ml,3
1.0ミリモル)を滴下し、そのまま1時間撹拌した。
析出した結晶をろ過し、ろ液を濃縮してメシラートを得
た。これはこのまま次の反応に用いた。エチル3-(4-
フルオロフェニル)-3-オキソプロピオネート(5.6
8g,27ミリモル)のジメトキシエタン(50ml)
溶液を氷冷し、水素化ナトリウム(60%,1.13
g,28ミリモル)を加え、氷冷下で30分撹拌した
後、メシラートのジメトキシエタン(30ml)溶液を
加え、室温で1時間撹拌した。反応終了後、1規定の塩
酸でクエンチし、酢酸エチルで抽出した。無水硫酸マグ
ネシウムで乾燥後、ろ過、減圧濃縮した。残渣をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=10:1、8:1)で精製し、エチル2-[4-(te
rt-ブチル)ベンジル]-3-(4-フルオロフェニル)
-3-オキソプロピオネート(8.97g,93%)を無
色透明オイルとして得た。 IRνmaxKBr(cm-1) : 1736, 1685, 1599, 1508, 1267, 1
234, 11591 H-NMR(CDCl3)δ (ppm) 1.11 (3H, t, J = 4.8 Hz) 1.2
7 (9H, s) 3.28 (1H, dd, J = 2.0, 4.8 Hz) 4.10 (2H,
q, J = 4.8 Hz) 4.56 (1H, t, J = 4.8 Hz) 7.07-7.15
(4H, m) 7.27 (2H, d, J = 5.4 Hz) 7.95-8.00 (2H,
m). 2) エチル(2RS,3RS)-2-[4-(tert-
ブチル)ベンジル]-3-(4-フルオロフェニル)-3-
ヒドロキシプロピオネート 塩化亜鉛(6.59g,48.3ミリモル)のエーテル
懸濁液(80ml)に水素化ホウ素ナトリウム(3.6
6g,96.6ミリモル)を室温で加えそのまま2時間
撹拌した。その後、エチル2-[4-(tert-ブチ
ル)ベンジル]-3-(4-フルオロフェニル)-3-オキ
ソプロピオネート(8.61g,24.15ミリモル)
のエーテル(40ml)溶液を加え、室温で15分間撹
拌した。1規定塩酸で反応を終了させ、酢酸エチルで希
釈し、水で洗浄した。無水硫酸マグネシウムで乾燥後、
ろ過、減圧濃縮した。残渣をシリカゲルカラムクロマト
グラフィー(ヘキサン:酢酸エチル=8:1、5:1)
で精製し、エチル(2RS,3RS)-2-[4-(te
rt-ブチル)ベンジル]-3-(4-フルオロフェニル)
-3-ヒドロキシプロピオネート(8.00g,92%)
を無色透明オイルとして得た。 IRνmaxKBr(cm-1): 3452, 1726, 1604, 1510, 1464, 13
94, 1373, 1224, 1157,10301 H-NMR(CDCl3) δ (ppm) 0.89 (3H, t, J = 7.4 Hz) 1.
27 (9H, s) 2.95 (2H, s) 3.04 (1H, d, J = 3.0 Hz)
3.87-3.95 (2H, m) 4.99 (1H, s) 6.97-7.07 (4H,m) 7.
21-7.28 (2H, m) 7.32-7.39 (2H, m). 3) (2RS,3RS)-2-[4-(tert-ブチ
ル)ベンジル]-3-(4-フルオロフェニル)-3-ヒド
ロキシプロピオン酸 エチル2-[4-(tert-ブチル)ベンジル]-3-
(4-フルオロフェニル)-3-オキソプロピオネート
(7.43g,20.7ミリモル)のテトラヒドロフラ
ン-メタノール(20ml-20ml)溶液に室温で2規
定の水酸化ナトリウムを加え、室温で終夜撹拌した。反
応終了後、有機溶媒を減圧留去し、水層を1規定塩酸で
酸性とし、酢酸エチルで抽出した。有機層を無水硫酸マ
グネシウムで乾燥後、ろ過、減圧濃縮した。ヘキサン-
酢酸エチルで再結晶を行い、(2RS,3RS)-2-
[4-(tert-ブチル)ベンジル]-3-(4-フルオ
ロフェニル)-3-ヒドロキシプロピオン酸(5.51
g,81%)を無色結晶として得た。 mp 102-104℃ IRνmaxKBr(cm-1): 2500-3300, 1709, 1606, 1510, 122
6, 1159, 8391 H-NMR(CDCl3) δ (ppm) 1.27 (9H, s) 2.85-3.02 (3H,
m) 5.04 (1H, d, J = 4.4 Hz) 6.98-7.06 (4H, m) 7.2
2-7.27 (2H, m) 7.31-7.38 (2H, m). 4) (4RS,5SR)-4-[4-(tert-ブチ
ル)ベンジル]-5-(4-フルオロフェニル)-1,3-
オキサゾリジン-2-オン (2RS,3RS)-2-[4-(tert-ブチル)ベン
ジル]-3-(4-フルオロフェニル)-3-ヒドロキシプ
ロピオン酸(5.07g,15.3ミリモル)のテトラ
ヒドロフラン(150ml)溶液にトリエチルアミン
(3.2ml,22.95ミリモル)、ジフェニルリン
酸アジド(3.63ml,16.8ミリモル)を加え、
5時間加熱還流した。溶媒を留去し、シリカゲルカラム
に通した後、再結晶(ヘキサン-酢酸エチル)で精製
し、(4RS,5SR)-4-[4-(tert-ブチル)
ベンジル]-5-(4-フルオロフェニル)-1,3-オキ
サゾリジン-2-オン(3.98g,79%)を無色結晶
として得た。 mp 218-219℃ IRνmaxKBr(cm-1) : 3284, 1736, 1610, 1514, 1363, 1
2301 H-NMR(CDCl3) δ (ppm) 1.28 (9H, s) 2.10-2.86 (2H,
m) 4.15-4.26 (1H, m)4.95 (1H, s) 5.78 (1H, d, J =
7.6 Hz) 6.95 (2H, d, J = 8.4 Hz) 7.08-7.18(2H, m)
7.26-7.40 (4H, m). 5) (1RS,2RS)-2-アミノ-3-[4-(te
rt-ブチル)ベンジル]-1-(4-フルオロフェニル)
プロパン-1-オール (4RS,5SR)-4-[4-(tert-ブチル)ベン
ジル]-5-(4-フルオロフェニル)-1,3-オキサゾ
リジン-2-オン(3.80g,11.6ミリモル)のエ
タノール溶液に8規定水酸化ナトリウム水溶液(7.3
ml,58.4ミリモル)を加え、5時間加熱還流し
た。反応終了後、水で希釈し、酢酸エチルで抽出した。
有機層を合わせ、飽和食塩水で洗浄し、無水硫酸マグネ
シウムで乾燥後、ろ過、減圧濃縮した。残渣を再結晶
(ヘキサン-酢酸エチル)で精製し、(1RS,2R
S)-2-アミノ-3-[4-(tert-ブチル)ベンジ
ル]-1-(4-フルオロフェニル)プロパン-1-オール
(2.57g,74%)を無色結晶として得た。 mp 139-140℃ IRνmaxKBr(cm-1): 2500-3300, 1603, 1508, 1363, 122
4, 1155, 10431 H-NMR(CDCl3) δ (ppm) 1.29 (9H, s) 2.06 (2H, br)
2.30 (1H, dd, J = 10.4, 13.6 Hz) 2.72 (1H, dd, J =
3.4, 14.0 Hz) 3.26 (1H, ddd, J = 3.8, 4.8,10.6 H
z) 4.69 (1H, d, J = 4.8 Hz) 7.01-7.10 (4H, m) 7.25
-7.40 (4H, m). 6) N-[(1RS,2SR)-1-(4-tert-ブ
チルベンジル)-2-(4-フルオロフェニル)-2-ヒド
ロキシエチル]-4-フルオロ-1-ナフトアミド (1RS,2RS)-2-アミノ-3-[4-(tert-ブ
チル)ベンジル]-1-(4-フルオロフェニル)プロパ
ン-1-オール(0.30g,0.998ミリモル)のア
セトニトリル(10ml)溶液に4-フルオロナフタレ
ン-1-カルボン酸(0.20g,1.05ミリモル)、
1-ヒドロキシベンゾトリアゾール1水和物(0.16
g,1.05ミリモル)を加え、最後に1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド塩酸塩
(0.20g,1.05ミリモル)を加え、室温で12
時間撹拌した。酢酸エチルで希釈し、飽和重曹水、水、
飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後、
ろ過、減圧濃縮した。残渣をシリカゲルカラムクロマト
グラフィー(ヘキサン:酢酸エチル=5:1、3:
1)、その後、再結晶(ヘキサン-酢酸エチル)で精製
し、N-[(1RS,2SR)-1-(4-tert-ブチ
ルベンジル)-2-(4-フルオロフェニル)-2-ヒドロ
キシエチル]-4-フルオロ-1-ナフトアミド(0.30
g,64%)を無色結晶として得た。 mp 149-150℃ 元素分析値C30H29NO2F2 として 計算値: C, 76.09; H, 6.17; N, 2.96 実測値: C, 76.07; H, 6.09; N, 2.92 IRνmaxKBr(cm-1) : 3263, 1639, 1601, 1510, 1263, 1
226, 1051, 8351 H-NMR(CDCl3) δ (ppm) 1.31 (9H, s) 2.72 (1H, dd,
J = 10.6, 14.4 Hz) 3.03 (1H, dd, J = 4.4, 14.2 Hz)
4.70-4.84 (1H,m) 5.04-5.08 (1H, m) 5.83 (1H, d,
J = 8.0 Hz) 6.90-7.15 (6H, m) 7.31-7.57 (6H, m) 7.
85 (1H, d, J = 8.0 Hz) 8.97 (1H, d, J = 7.6 Hz).Example 357 N-[(1RS, 2SR) -1- (4-tert-butylbenzyl) -2- (4-fluorophenyl) -2-hydroxyethyl] -4-fluoro-1-naphthamide 1) Ethyl 2- [4- (tert-butyl) benzyl]-
3- (4-fluorophenyl) -3-oxopropionate p-tert-butylbenzyl alcohol (5 ml, 2
To a solution of 8.2 mmol) in ethyl acetate (60 ml) was added triethylamine (5.9 ml, 42.3 mmol), and methanesulfonyl chloride (2.4 ml, 3 ml) was added under ice-cooling.
1.0 mmol) was added dropwise, and the mixture was stirred for 1 hour.
The precipitated crystals were filtered, and the filtrate was concentrated to obtain a mesylate. This was used for the next reaction as it was. Ethyl 3- (4-
Fluorophenyl) -3-oxopropionate (5.6
8 g, 27 mmol) of dimethoxyethane (50 ml)
The solution was cooled on ice and sodium hydride (60%, 1.13
g, 28 mmol), and the mixture was stirred under ice-cooling for 30 minutes. Then, a solution of mesylate in dimethoxyethane (30 ml) was added, and the mixture was stirred at room temperature for 1 hour. After completion of the reaction, the reaction was quenched with 1N hydrochloric acid and extracted with ethyl acetate. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1, 8: 1) to give ethyl 2- [4- (te
rt-butyl) benzyl] -3- (4-fluorophenyl)
-3-Oxopropionate (8.97 g, 93%) was obtained as a colorless transparent oil. IRνmax KBr (cm -1 ): 1736, 1685, 1599, 1508, 1267, 1
234, 1159 1 H-NMR (CDCl 3 ) δ (ppm) 1.11 (3H, t, J = 4.8 Hz) 1.2
7 (9H, s) 3.28 (1H, dd, J = 2.0, 4.8 Hz) 4.10 (2H,
q, J = 4.8 Hz) 4.56 (1H, t, J = 4.8 Hz) 7.07-7.15
(4H, m) 7.27 (2H, d, J = 5.4 Hz) 7.95-8.00 (2H,
m). 2) Ethyl (2RS, 3RS) -2- [4- (tert-
Butyl) benzyl] -3- (4-fluorophenyl) -3-
Hydroxypropionate Sodium borohydride (3.6) was added to an ether suspension (80 ml) of zinc chloride (6.59 g, 48.3 mmol).
(6 g, 96.6 mmol) at room temperature and stirred for 2 hours. Then, ethyl 2- [4- (tert-butyl) benzyl] -3- (4-fluorophenyl) -3-oxopropionate (8.61 g, 24.15 mmol)
Was added and stirred at room temperature for 15 minutes. The reaction was terminated with 1N hydrochloric acid, diluted with ethyl acetate, and washed with water. After drying over anhydrous magnesium sulfate,
Filtration and concentration under reduced pressure. The residue is subjected to silica gel column chromatography (hexane: ethyl acetate = 8: 1, 5: 1).
And purified with ethyl (2RS, 3RS) -2- [4- (te
rt-butyl) benzyl] -3- (4-fluorophenyl)
-3-Hydroxypropionate (8.00 g, 92%)
Was obtained as a colorless transparent oil. IRνmax KBr (cm -1 ): 3452, 1726, 1604, 1510, 1464, 13
94, 1373, 1224, 1157,1030 1 H-NMR (CDCl 3 ) δ (ppm) 0.89 (3H, t, J = 7.4 Hz) 1.
27 (9H, s) 2.95 (2H, s) 3.04 (1H, d, J = 3.0 Hz)
3.87-3.95 (2H, m) 4.99 (1H, s) 6.97-7.07 (4H, m) 7.
21-7.28 (2H, m) 7.32-7.39 (2H, m). 3) (2RS, 3RS) -2- [4- (tert-butyl) benzyl] -3- (4-fluorophenyl) -3-hydroxy Ethyl propionate 2- [4- (tert-butyl) benzyl] -3-
To a solution of (4-fluorophenyl) -3-oxopropionate (7.43 g, 20.7 mmol) in tetrahydrofuran-methanol (20 ml to 20 ml) was added 2N sodium hydroxide at room temperature, and the mixture was stirred at room temperature overnight. . After completion of the reaction, the organic solvent was distilled off under reduced pressure, the aqueous layer was acidified with 1N hydrochloric acid, and extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. Hexane-
Recrystallization from ethyl acetate gave (2RS, 3RS) -2-
[4- (tert-butyl) benzyl] -3- (4-fluorophenyl) -3-hydroxypropionic acid (5.51
g, 81%) as colorless crystals. mp 102-104 ℃ IRνmax KBr (cm -1 ): 2500-3300, 1709, 1606, 1510, 122
6, 1159, 839 1 H-NMR (CDCl 3 ) δ (ppm) 1.27 (9H, s) 2.85-3.02 (3H,
m) 5.04 (1H, d, J = 4.4 Hz) 6.98-7.06 (4H, m) 7.2
2-7.27 (2H, m) 7.31-7.38 (2H, m). 4) (4RS, 5SR) -4- [4- (tert-butyl) benzyl] -5- (4-fluorophenyl) -1,3 -
Oxazolidine-2-one (2RS, 3RS) -2- [4- (tert-butyl) benzyl] -3- (4-fluorophenyl) -3-hydroxypropionic acid (5.07 g, 15.3 mmol) in tetrahydrofuran (150 ml) solution, triethylamine (3.2 ml, 22.95 mmol) and diphenylphosphoric azide (3.63 ml, 16.8 mmol) were added,
The mixture was refluxed for 5 hours. After the solvent was distilled off, the residue was passed through a silica gel column and purified by recrystallization (hexane-ethyl acetate) to give (4RS, 5SR) -4- [4- (tert-butyl).
Benzyl] -5- (4-fluorophenyl) -1,3-oxazolidin-2-one (3.98 g, 79%) was obtained as colorless crystals. mp 218-219 ℃ IRνmax KBr (cm -1 ): 3284, 1736, 1610, 1514, 1363, 1
230 1 H-NMR (CDCl 3 ) δ (ppm) 1.28 (9H, s) 2.10-2.86 (2H,
m) 4.15-4.26 (1H, m) 4.95 (1H, s) 5.78 (1H, d, J =
(7.6 Hz) 6.95 (2H, d, J = 8.4 Hz) 7.08-7.18 (2H, m)
7.26-7.40 (4H, m). 5) (1RS, 2RS) -2-amino-3- [4- (te
rt-butyl) benzyl] -1- (4-fluorophenyl)
Propan-1-ol (4RS, 5SR) -4- [4- (tert-butyl) benzyl] -5- (4-fluorophenyl) -1,3-oxazolidin-2-one (3.80 g, 11.6 Mmol) in an ethanol solution of 8N sodium hydroxide solution (7.3).
ml, 58.4 mmol) and heated under reflux for 5 hours. After completion of the reaction, the reaction mixture was diluted with water and extracted with ethyl acetate.
The organic layers were combined, washed with saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate) and (1RS, 2R
S) -2-Amino-3- [4- (tert-butyl) benzyl] -1- (4-fluorophenyl) propan-1-ol (2.57 g, 74%) was obtained as colorless crystals. mp 139-140 ℃ IRνmax KBr (cm -1 ): 2500-3300, 1603, 1508, 1363, 122
4, 1155, 1043 1 H-NMR (CDCl 3 ) δ (ppm) 1.29 (9H, s) 2.06 (2H, br)
2.30 (1H, dd, J = 10.4, 13.6 Hz) 2.72 (1H, dd, J =
3.4, 14.0 Hz) 3.26 (1H, ddd, J = 3.8, 4.8,10.6 H
z) 4.69 (1H, d, J = 4.8 Hz) 7.01-7.10 (4H, m) 7.25
-7.40 (4H, m). 6) N-[(1RS, 2SR) -1- (4-tert-butylbenzyl) -2- (4-fluorophenyl) -2-hydroxyethyl] -4-fluoro-1 -Naphthamide acetonitrile of (1RS, 2RS) -2-amino-3- [4- (tert-butyl) benzyl] -1- (4-fluorophenyl) propan-1-ol (0.30 g, 0.998 mmol) (10 ml) solution was added 4-fluoronaphthalene-1-carboxylic acid (0.20 g, 1.05 mmol),
1-hydroxybenzotriazole monohydrate (0.16
g, 1.05 mmol) and finally 1-ethyl-3-
(3-Dimethylaminopropyl) carbodiimide hydrochloride (0.20 g, 1.05 mmol) was added, and
Stirred for hours. Dilute with ethyl acetate, add saturated aqueous sodium bicarbonate, water,
After washing with saturated saline and drying over anhydrous magnesium sulfate,
Filtration and concentration under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 5: 1, 3: 2).
1) Then, the product was purified by recrystallization (hexane-ethyl acetate) to give N-[(1RS, 2SR) -1- (4-tert-butylbenzyl) -2- (4-fluorophenyl) -2-hydroxyethyl. ] -4-Fluoro-1-naphthamide (0.30
g, 64%) as colorless crystals. mp 149-150 ° C. Elemental analysis C 30 H 29 NO 2 F 2 Calculated: C, 76.09; H, 6.17 ; N, 2.96 Found: C, 76.07; H, 6.09 ; N, 2.92 IRνmax KBr (cm - 1 ): 3263, 1639, 1601, 1510, 1263, 1
226, 1051, 835 1 H-NMR (CDCl 3 ) δ (ppm) 1.31 (9H, s) 2.72 (1H, dd,
J = 10.6, 14.4 Hz) 3.03 (1H, dd, J = 4.4, 14.2 Hz)
4.70-4.84 (1H, m) 5.04-5.08 (1H, m) 5.83 (1H, d,
J = 8.0 Hz) 6.90-7.15 (6H, m) 7.31-7.57 (6H, m) 7.
85 (1H, d, J = 8.0 Hz) 8.97 (1H, d, J = 7.6 Hz).
【0490】実施例358 N-[(1RS,2SR)-1-(4-tert-ブチルベ
ンジル)-2-(4-フルオロフェニル)-2-ヒドロキシ
エチル]-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘ
プテン-1-カルボキサミド (1RS,2RS)-2-アミノ-3-[4-(tert-ブ
チル)ベンジル]-1-(4-フルオロフェニル)プロパ
ン-1-オール(0.41g,1.36ミリモル)のアセ
トニトリル(10ml)溶液に6,7-ジヒドロ-5H-
ベンゾ[a]シクロヘプテン-1-カルボン酸(0.20
g,1.05ミリモル)、1-ヒドロキシベンゾトリア
ゾール1水和物(0.16g,1.05ミリモル)を加
え、最後に1-エチル-3-(3-ジメチルアミノプロピ
ル)カルボジイミド塩酸塩(0.20g,1.05ミリ
モル)を加え、室温で3日間撹拌した。酢酸エチルで希
釈し、飽和重曹水、水、飽和食塩水で洗浄し、無水硫酸
マグネシウムで乾燥後、ろ過、減圧濃縮した。残渣をシ
リカゲルカラムクロマトグラフィー(ヘキサン:酢酸エ
チル=5:1、2:1)、その後、再結晶(ヘキサン-
酢酸エチル)で精製し、N-[(1RS,2SR)-1-
(4-tert-ブチルベンジル)-2-(4-フルオロフ
ェニル)-2-ヒドロキシエチル]-6,7-ジヒドロ-5
H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
(0.43g,67%)を無色結晶として得た。 mp 140-142℃ 元素分析値C31H34NO2・0.25H2O として 計算値: C, 78.20; H, 7.30; N, 2.94 実測値: C, 78.16; H, 7.20; N, 2.86 IRνmaxKBr(cm-1) : 1637, 1508, 1363, 1222, 11551 H-NMR(CDCl3)δ (ppm) 1.29 (9H, s) 1.96-2.04 (2H,
m) 2.13-2.23 (2H, m) 2.62-2.73 (3H, m) 2.96 (1H, d
d, J = 4.4, 14.6 Hz) 4.17 (1H, d, J = 3.2 Hz) 4.99
-5.01 (1H, m) 5.63 (1H, d, J = 7.6 Hz) 5.90 (1H, d
t, J = 5.6, 11.4Hz) 6.24 (1H, d, J = 11.8 Hz) 6.87
(1H, d, J = 1.0 Hz) 7.01-7.16 (5H, m) 7.25-7.33
(3H, m) 7.38-7.45 (2H, m).Example 358 N-[(1RS, 2SR) -1- (4-tert-butylbenzyl) -2- (4-fluorophenyl) -2-hydroxyethyl] -6,7-dihydro-5H-benzo [A] Cycloheptene-1-carboxamide (1RS, 2RS) -2-amino-3- [4- (tert-butyl) benzyl] -1- (4-fluorophenyl) propan-1-ol (0.41 g, 1 .36 mmol) in acetonitrile (10 ml) was added to 6,7-dihydro-5H-
Benzo [a] cycloheptene-1-carboxylic acid (0.20
g, 1.05 mmol) and 1-hydroxybenzotriazole monohydrate (0.16 g, 1.05 mmol), and finally 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0%). .20 g, 1.05 mmol) and stirred at room temperature for 3 days. The mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 5: 1, 2: 1), and then recrystallized (hexane-ethyl acetate).
Ethyl acetate) and purified by N-[(1RS, 2SR) -1-
(4-tert-butylbenzyl) -2- (4-fluorophenyl) -2-hydroxyethyl] -6,7-dihydro-5
H-benzo [a] cycloheptene-1-carboxamide (0.43 g, 67%) was obtained as colorless crystals. mp 140-142 ° C Elemental analysis: C 31 H 34 NO 2・ 0.25H 2 O Calculated: C, 78.20; H, 7.30; N, 2.94 Found: C, 78.16; H, 7.20; N, 2.86 IRνmax KBr (cm -1 ): 1637, 1508, 1363, 1222, 1155 1 H-NMR (CDCl 3 ) δ (ppm) 1.29 (9H, s) 1.96-2.04 (2H,
m) 2.13-2.23 (2H, m) 2.62-2.73 (3H, m) 2.96 (1H, d
d, J = 4.4, 14.6 Hz) 4.17 (1H, d, J = 3.2 Hz) 4.99
-5.01 (1H, m) 5.63 (1H, d, J = 7.6 Hz) 5.90 (1H, d
t, J = 5.6, 11.4Hz) 6.24 (1H, d, J = 11.8 Hz) 6.87
(1H, d, J = 1.0 Hz) 7.01-7.16 (5H, m) 7.25-7.33
(3H, m) 7.38-7.45 (2H, m).
【0491】実施例359 N-[(1RS,2SR)-1-[3-(1,1-ジフルオ
ロエチル)ベンジル]-2-(4-フルオロフェニル)-2
-ヒドロキシエチル]-4-フルオロ-1-ナフトアミド 1) 3-(1,1-ジフルオロエチル)ベンゾニトリル 3-アセチルベンゾフェノン(5.81g,40.0ミ
リモル)の入ったナスコルに、ビス(2-メトキシエチ
ル)アミノサルファートリフルオライド(12.5m
l,67.8ミリモル)を滴下し、エタノール(0.4
6ml,8.14ミリモル)をゆっくり滴下し、80-
85℃で終夜撹拌した。反応混合物を飽和重曹水に流し
込み,エーテルで抽出した。無水硫酸マグネシウムで乾
燥後、ろ過、減圧濃縮した。残渣をシリカゲルカラムク
ロマトグラフィー(ヘキサン:エーテル=10:1、
8:1、5:1)で精製し、3-(1,1-ジフルオロエ
チル)ベンゾニトリル(5.16g,77%)を無色透
明オイルとして得た。 IRνmaxKBr(cm-1) : 2223, 1485, 1429, 1386, 1304, 1
1861 H-NMR(CDCl3) δ(ppm) 1.93 (3H, t, J = 18.3 Hz) 7.
55-7.60 (1H, m) 7.72-7.80 (3H, m). 2) 3-(1,1-ジフルオロエチル)安息香酸 3-(1,1-ジフルオロエチル)ベンゾニトリル(5.
10g,30.5ミリモル)の水懸濁液(100ml)
に水酸化ナトリウム(3.05g,76.25ミリモ
ル)を加えて、100℃で5時間撹拌した。反応終了
後、6規定の塩酸で酸性とし、酢酸エチルで抽出した。
あわせた有機層を飽和食塩水で洗浄し、無水硫酸マグネ
シウムで乾燥後、ろ過、減圧濃縮し、3-(1,1-ジフ
ルオロエチル)安息香酸(5.10g,90%)を無色
結晶として得た。 mp 96-97℃ IRνmaxKBr(cm-1) : 2500-3300, 1689, 1616, 1423, 13
85, 1323, 1278, 1263,11761 H-NMR(CDCl3)δ (ppm) : 1.97 (3H, t, J = 18.4 Hz)
7.52-7.65 (1H, m) 7.76-7.79 (1H, m) 8.17-8.34 (2H,
m). 3) 3-(1,1-ジフルオロエチル)ベンジルアルコ
ール 水素化リチウムアルミニウム(2.24g,54.4ミ
リモル)のエーテル懸濁液(100ml)に3-(1,
1-ジフルオロエチル)ベンゾニトリル(5.48g,
29.4ミリモル)のエーテル(50m)溶液を氷冷下
で滴下し、室温で4時間撹拌した。反応終了後、水
(2.24ml)、15%水酸化ナトリウム水溶液
(2.24ml)、水(6.72ml)を順にゆっくり
と氷冷下で滴下した。生じた固体をセライトでろ過し、
酢酸エチルで洗浄した。ろ液を濃縮し、残渣をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
3:1、1:1)で精製し、3-(1,1-ジフルオロエ
チル)ベンジルアルコール(3.82g,75%)を無
色透明オイルとして得た。 IRνmaxKBr(cm-1): 3292, 1439, 1389, 1305, 1180, 11
431 H-NMR(CDCl3) δ (ppm) 1.91 (3H, t, J = 17.8 Hz)
2.08 (1H, s) 4.71 (2H,s) 7.41-7.44 (3H, m) 7.50 (1
H, s). 4) エチル2-[3-(1,1-ジフルオロエチル)ベ
ンジル]-3-(4-フルオロフェニル)-3-オキソプロ
ピオネート 3-(1,1-ジフルオロエチル)ベンジルアルコール
(3.71ml,21.5ミリモル)の酢酸エチル(5
0ml)溶液にトリエチルアミン(4.5ml,32.
25ミリモル)を加え氷冷下でメタンスルホニルクロラ
イド(1.83ml,23.6ミリモル)を滴下し、そ
のまま45分間撹拌した。析出した結晶をろ過し、ろ液
を濃縮してメシレートを得た。これはこのまま次の反応
に用いた。エチル3-(4-フルオロフェニル)-3-オキ
ソプロピオネート(4.52g,21.5ミリモル)の
ジメトキシエタン(50ml)溶液を氷冷し、水素化ナ
トリウム(60%,0.86g,21.5ミリモル)を
加え、氷冷下で30分撹拌した後、メシレートのジメト
キシエタン(50ml)溶液を加え、室温で終夜撹拌し
た。反応終了後、1規定の塩酸でクエンチし、酢酸エチ
ルで希釈し、水、飽和食塩水で洗浄した。無水硫酸マグ
ネシウムで乾燥後、ろ過、減圧濃縮した。残渣をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=8:1、5:1)で精製し、エチル2-[3-(1,1
-ジフルオロエチル)ベンジル]-3-(4-フルオロフェ
ニル)-3-オキソプロピオネート(7.31g,93
%)を無色透明オイルとして得た。 IRνmaxKBr(cm-1) : 1736, 1685, 1508, 1446, 1385, 1
304, 1234, 11591 H-NMR(CDCl3)δ (ppm) 1.12 (3H, t, J = 7.2 Hz) 1.8
6 (3H, t, J = 18.3 Hz)3.35 (2H, dd, J = 2.7, 7.2 H
z) 4.10 (2H, q, J = 7.2 Hz) 4.57 (1H, t, J= 7.5 H
z) 7.08-7.15 (2H, m) 7.26-7.35 (4H, m) 7.96-8.01
(2H, m). 5) エチル(2RS,3RS)-2-[3-(1,1-ジ
フルオロエチル)ベンジル]-3-(4-フルオロフェニ
ル)-3-ヒドロキシプロピオネート 塩化亜鉛(5.35g,39.2ミリモル)のエーテル
懸濁液(40ml)に水素化ホウ素ナトリウム(2.9
7g,78.4ミリモル)を室温で加えそのまま2時間
撹拌した。不溶物をろ過し、そのろ液にエチル2-[3-
(1,1-ジフルオロエチル)ベンジル]-3-(4-フル
オロフェニル)-3-オキソプロピオネート(7.16
g,19.6ミリモル)のエーテル(40ml)溶液を
加え、室温で1.5時間撹拌した。1規定塩酸で反応を
終了させ、酢酸エチルで希釈し、水、飽和食塩水で洗浄
した。無水硫酸マグネシウムで乾燥後、ろ過、減圧濃縮
した。残渣をシリカゲルカラムクロマトグラフィー(ヘ
キサン:酢酸エチル=8:1、4:1)で精製し、エチ
ル(2RS,3RS)-2-[3-(1,1-ジフルオロエ
チル)ベンジル]-3-(4-フルオロフェニル)-3-ヒ
ドロキシプロピオネート(6.24g,87%)を無色
透明オイルとして得た。 IRνmaxKBr(cm-1): 1728, 1604, 1510, 1446, 1385, 13
041 H-NMR(CDCl3) δ(ppm) 0.91 (3H, t, J = 7.4 Hz) 1.8
7 (3H, t, J = 17.6 Hz)2.90-3.05 (4H, m) 3.87 (1H,
q, J = 7.8 Hz) 4.99-5.02 (1H, m) 6.98-7.40(8H, m). 6) (2RS,3RS)-2-[3-(1,1-ジフルオ
ロエチル)ベンジル]-3-(4-フルオロフェニル)-3
-ヒドロキシプロピオン酸 エチル(2RS,3RS)-2-[3-(1,1-ジフルオ
ロエチル)ベンジル]-3-(4-フルオロフェニル)-3
-ヒドロキシプロピオネート(5.97g,17.6ミ
リモル)のテトラヒドロフラン-エタノール(30ml-
20ml)溶液に室温で2規定の水酸化ナトリウム(1
8ml,36ミリモル)を加え、室温で終夜撹拌した。
反応終了後、有機溶媒を減圧留去し、水層を1規定塩酸
で酸性とし、酢酸エチルで抽出した。有機層を無水硫酸
マグネシウムで乾燥後、ろ過、減圧濃縮した。ヘキサン
-酢酸エチルで再結晶を行い、(2RS,3RS)-2-
[3-(1,1-ジフルオロエチル)ベンジル]-3-(4
-フルオロフェニル)-3-ヒドロキシプロピオン酸
(4.48g,82%)を無色結晶として得た。 mp 132-133℃ IRνmaxKBr(cm-1): 2800-3300, 1709, 1606, 1512, 138
5, 1304, 1226, 11781 H-NMR(CDCl3)δ (ppm) 1.85 (3H, t, J = 18.2 Hz) 3.
01 (3H, m) 5.06 (1H, s) 6.99-7.39 (8H, m). 7) (4RS,5SR)-4-[3-(1,1-ジフルオ
ロエチル)ベンジル]-5-(4-フルオロフェニル)-
1,3-オキサゾリジン-2-オン (2RS,3RS)-2-[3-(1,1-ジフルオロエチ
ル)ベンジル]-3-(4-フルオロフェニル)-3-ヒド
ロキシプロピオン酸(4.22g,13.6ミリモル)
のテトラヒドロフラン(130ml)溶液にトリエチル
アミン(2.85ml,20.4ミリモル)、ジフェニ
ルリン酸アジド(3.23ml,14.96ミリモル)
を加え、5時間加熱還流した。溶媒を留去し、酢酸エチ
ルで希釈し、水,飽和重曹水、飽和食塩水で洗浄した。
有機層を無水硫酸マグネシウムで乾燥後、ろ過、減圧濃
縮した。ヘキサン-酢酸エチルで再結晶を行い、(4R
S,5SR)-4-[3-(1,1-ジフルオロエチル)ベ
ンジル]-5-(4-フルオロフェニル)-1,3-オキサ
ゾリジン-2-オン(3.99g,95%)を無色結晶と
して得た。 mp 143-144℃ IRνmaxKBr(cm-1): 3231, 1763, 1608, 1512, 1386, 13
00, 12301 H-NMR(CDCl3) δ (ppm) 1.88 (3H, t, J = 18.4 Hz)
2.29-2.38 (2H, m) 4.22-4.33 (1H, m) 5.17 (1H, s)
5.79 (1H, d, J = 8.0 Hz) 7.06-7.18 (4H, m) 7.29-7.
39 (4H, m). 8) (1RS,2SR)-2-アミノ-3-[3-(1,
1-ジフルオロエチル)フェニル]-1-(4-フルオロフ
ェニル)-1-プロパノール (4RS,5SR)-4-[3-(1,1-ジフルオロエチ
ル)ベンジル]-5-(4-フルオロフェニル)-1,3-
オキサゾリジン-2-オン(3.83g,12.5ミリモ
ル)のエタノール(100ml)溶液に8規定水酸化ナ
トリウム水溶液(7.8ml,39.0ミリモル)を加
え、5時間加熱還流した。反応終了後、水で希釈し、酢
酸エチルで抽出した。有機層を合わせ、飽和食塩水で洗
浄し、無水硫酸マグネシウムで乾燥後、ろ過、減圧濃縮
した。残渣を再結晶(ヘキサン-酢酸エチル)で精製
し、(1RS,2SR)-2-アミノ-3-[3-(1,1-
ジフルオロエチル)フェニル]-1-(4-フルオロフェ
ニル)-1-プロパノール(3.08g,88%)を無色
結晶として得た。 mp 101-102℃ IRνmaxKBr(cm-1): 3363, 1604, 1508, 1448, 1385, 13
02, 1224, 11761 H-NMR(CDCl3) δ (ppm) 1.89 (3H, t, J = 18.4 Hz)
2.39 (1H, dd, J = 10.4,13.6 Hz) 2.82 (1H, dd, J =
3.0, 13.6 Hz) 3.25-3.34 (1H, m) 4.69 (1H, d,J = 5.
0 Hz) 7.03-7.11 (2H, m) 7.11-7.21 (1H, m) 7.26-7.4
1 (5H, m). 9) N-[(1RS,2SR)-1-[3-(1,1-ジ
フルオロエチル)ベンジル]-2-(4-フルオロフェニ
ル)-2-ヒドロキシエチル]-4-フルオロ-1-ナフトア
ミド (1RS,2SR)-2-アミノ-3-[3-(1,1-ジフ
ルオロエチル)フェニル]-1-(4-フルオロフェニ
ル)-1-プロパノール(0.40g,1.42ミリモ
ル)のアセトニトリル(10ml)溶液に4-フルオロ
ナフタレン-1-カルボン酸(0.283g,1.49ミ
リモル)、1-ヒドロキシベンゾトリアゾール1水和物
(0.22g,1.49ミリモル)を加え、最後に1-
エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド塩酸塩(0.27g,1.49ミリモル)を加え、
室温で終夜撹拌した。酢酸エチルで希釈し、飽和重曹
水、水、飽和食塩水で洗浄し、無水硫酸マグネシウムで
乾燥後、ろ過、減圧濃縮した。残渣をシリカゲルカラム
クロマトグラフィー(ヘキサン:酢酸エチル=5:1、
2:1)、その後、再結晶(ヘキサン-酢酸エチル)で
精製し、N-[(1RS,2SR)-1-[3-(1,1-
ジフルオロエチル)ベンジル]-2-(4-フルオロフェ
ニル)-2-ヒドロキシエチル]-4-フルオロ-1-ナフト
アミド(0.52g,81%)を無色結晶として得た。 mp 182-183℃ 元素分析値C28H23NO2F4 として 計算値: C, 69.85; H, 4.81; N, 2.91 実測値: C, 69.86; H, 4.75; N, 2.74 IRνmaxKBr(cm-1): 3277, 1641, 1626, 1601, 1512, 14
25, 1307, 12301 H-NMR(CDCl3)δ (ppm) 1.84 (3H, t, J = 18.0 Hz) 2.
84 (1H, dd, J = 10.2,14.1 Hz) 3.07 (1H, dd, J = 4.
2, 14.7 Hz) 3.55 (1H, s) 4.72-4.81 (1H, m)5.08 (1
H, s) 5.92 (1H, d, J = 8.7 Hz) 6.98 (1H, dd, J =
8.1, 9.9 Hz) 7.05-7.15 (3H, m) 7.27-7.48 (7H, m)
7.50-7.55 (1H, m) 7.75 (1H, d, J = 8.7Hz) 8.07 (1
H, d, J = 8.7 Hz).Example 359 N-[(1RS, 2SR) -1- [3- (1,1-difluoroethyl) benzyl] -2- (4-fluorophenyl) -2
-Hydroxyethyl] -4-fluoro-1-naphthamide 1) 3- (1,1-difluoroethyl) benzonitrile Nascol containing 3-acetylbenzophenone (5.81 g, 40.0 mmol) was added with bis (2- Methoxyethyl) aminosulfur trifluoride (12.5m
1,67.8 mmol) was added dropwise and ethanol (0.4%) was added.
6 ml, 8.14 mmol) was slowly added dropwise.
Stirred at 85 ° C. overnight. The reaction mixture was poured into saturated aqueous sodium hydrogen carbonate and extracted with ether. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ether = 10: 1,
8: 1, 5: 1) to give 3- (1,1-difluoroethyl) benzonitrile (5.16 g, 77%) as a clear, colorless oil. IRνmax KBr (cm -1 ): 2223, 1485, 1429, 1386, 1304, 1
186 1 H-NMR (CDCl 3 ) δ (ppm) 1.93 (3H, t, J = 18.3 Hz) 7.
55-7.60 (1H, m) 7.72-7.80 (3H, m). 2) 3- (1,1-difluoroethyl) benzoic acid 3- (1,1-difluoroethyl) benzonitrile (5.
10 g, 30.5 mmol) in water (100 ml)
To the mixture was added sodium hydroxide (3.05 g, 76.25 mmol), and the mixture was stirred at 100 ° C for 5 hours. After completion of the reaction, the mixture was acidified with 6N hydrochloric acid and extracted with ethyl acetate.
The combined organic layers were washed with brine, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to give 3- (1,1-difluoroethyl) benzoic acid (5.10 g, 90%) as colorless crystals. Was. mp 96-97 ℃ IRνmax KBr (cm -1 ): 2500-3300, 1689, 1616, 1423, 13
85, 1323, 1278, 1263,1176 1 H-NMR (CDCl 3 ) δ (ppm): 1.97 (3H, t, J = 18.4 Hz)
7.52-7.65 (1H, m) 7.76-7.79 (1H, m) 8.17-8.34 (2H,
m). 3) 3- (1,1-Difluoroethyl) benzyl alcohol 3- (1,1-Difluoroethyl) benzyl alcohol was added to an ether suspension (100 ml) of lithium aluminum hydride (2.24 g, 54.4 mmol).
1-difluoroethyl) benzonitrile (5.48 g,
(29.4 mmol) in ether (50 m) was added dropwise under ice cooling, and the mixture was stirred at room temperature for 4 hours. After the completion of the reaction, water (2.24 ml), a 15% aqueous sodium hydroxide solution (2.24 ml) and water (6.72 ml) were slowly added dropwise in succession under ice cooling. The resulting solid is filtered through Celite,
Washed with ethyl acetate. The filtrate is concentrated, and the residue is subjected to silica gel column chromatography (hexane: ethyl acetate =
Purification by 3: 1, 1: 1) afforded 3- (1,1-difluoroethyl) benzyl alcohol (3.82 g, 75%) as a clear, colorless oil. IRνmax KBr (cm -1 ): 3292, 1439, 1389, 1305, 1180, 11
43 1 H-NMR (CDCl 3 ) δ (ppm) 1.91 (3H, t, J = 17.8 Hz)
2.08 (1H, s) 4.71 (2H, s) 7.41-7.44 (3H, m) 7.50 (1
H, s). 4) Ethyl 2- [3- (1,1-difluoroethyl) benzyl] -3- (4-fluorophenyl) -3-oxopropionate 3- (1,1-difluoroethyl) benzyl The alcohol (3.71 ml, 21.5 mmol) in ethyl acetate (5
0ml) solution in triethylamine (4.5ml, 32.
Methanesulfonyl chloride (1.83 ml, 23.6 mmol) was added dropwise under ice-cooling, and the mixture was stirred for 45 minutes. The precipitated crystals were filtered, and the filtrate was concentrated to obtain mesylate. This was used for the next reaction as it was. A solution of ethyl 3- (4-fluorophenyl) -3-oxopropionate (4.52 g, 21.5 mmol) in dimethoxyethane (50 ml) was cooled with ice, and sodium hydride (60%, 0.86 g, 21%) was added. After stirring for 30 minutes under ice-cooling, a solution of mesylate in dimethoxyethane (50 ml) was added, and the mixture was stirred at room temperature overnight. After completion of the reaction, the reaction was quenched with 1N hydrochloric acid, diluted with ethyl acetate, and washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 8: 1, 5: 1) to give ethyl 2- [3- (1,1).
-Difluoroethyl) benzyl] -3- (4-fluorophenyl) -3-oxopropionate (7.31 g, 93
%) As a clear, colorless oil. IRνmax KBr (cm -1 ): 1736, 1685, 1508, 1446, 1385, 1
304, 1234, 1159 1 H-NMR (CDCl 3 ) δ (ppm) 1.12 (3H, t, J = 7.2 Hz) 1.8
6 (3H, t, J = 18.3 Hz) 3.35 (2H, dd, J = 2.7, 7.2 H
z) 4.10 (2H, q, J = 7.2 Hz) 4.57 (1H, t, J = 7.5 H
z) 7.08-7.15 (2H, m) 7.26-7.35 (4H, m) 7.96-8.01
(2H, m). 5) Ethyl (2RS, 3RS) -2- [3- (1,1-difluoroethyl) benzyl] -3- (4-fluorophenyl) -3-hydroxypropionate Zinc chloride (5 Sodium borohydride (2.9 ml) in an ether suspension (40 ml) of 0.35 g (39.2 mmol).
(7 g, 78.4 mmol) at room temperature and stirred for 2 hours. The insolubles were filtered off and the filtrate was added with ethyl 2- [3-
(1,1-difluoroethyl) benzyl] -3- (4-fluorophenyl) -3-oxopropionate (7.16
g, 19.6 mmol) in ether (40 ml) was added and stirred at room temperature for 1.5 hours. The reaction was terminated with 1N hydrochloric acid, diluted with ethyl acetate, and washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 8: 1, 4: 1), and ethyl (2RS, 3RS) -2- [3- (1,1-difluoroethyl) benzyl] -3- ( 4-Fluorophenyl) -3-hydroxypropionate (6.24 g, 87%) was obtained as a clear, colorless oil. IRνmax KBr (cm -1 ): 1728, 1604, 1510, 1446, 1385, 13
04 1 H-NMR (CDCl 3 ) δ (ppm) 0.91 (3H, t, J = 7.4 Hz) 1.8
7 (3H, t, J = 17.6 Hz) 2.90-3.05 (4H, m) 3.87 (1H,
q, J = 7.8 Hz) 4.99-5.02 (1H, m) 6.98-7.40 (8H, m). 6) (2RS, 3RS) -2- [3- (1,1-difluoroethyl) benzyl] -3- (4-fluorophenyl) -3
Ethyl 2-hydroxypropionate (2RS, 3RS) -2- [3- (1,1-difluoroethyl) benzyl] -3- (4-fluorophenyl) -3
-Hydroxypropionate (5.97 g, 17.6 mmol) in tetrahydrofuran-ethanol (30 ml-
20 ml) solution at room temperature with 2N sodium hydroxide (1
(8 ml, 36 mmol) and stirred at room temperature overnight.
After completion of the reaction, the organic solvent was distilled off under reduced pressure, the aqueous layer was acidified with 1N hydrochloric acid, and extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. Hexane
-Recrystallize with ethyl acetate to give (2RS, 3RS) -2-
[3- (1,1-difluoroethyl) benzyl] -3- (4
-Fluorophenyl) -3-hydroxypropionic acid (4.48 g, 82%) was obtained as colorless crystals. mp 132-133 ℃ IRνmax KBr (cm -1 ): 2800-3300, 1709, 1606, 1512, 138
5, 1304, 1226, 1178 1 H-NMR (CDCl 3 ) δ (ppm) 1.85 (3H, t, J = 18.2 Hz) 3.
01 (3H, m) 5.06 (1H, s) 6.99-7.39 (8H, m). 7) (4RS, 5SR) -4- [3- (1,1-difluoroethyl) benzyl] -5- (4- Fluorophenyl)-
1,3-Oxazolidin-2-one (2RS, 3RS) -2- [3- (1,1-difluoroethyl) benzyl] -3- (4-fluorophenyl) -3-hydroxypropionic acid (4.22 g, 13.6 mmol)
Of triethylamine (2.85 ml, 20.4 mmol) and azide diphenylphosphoric acid (3.23 ml, 14.96 mmol) in a tetrahydrofuran (130 ml) solution of
Was added and heated under reflux for 5 hours. The solvent was distilled off, diluted with ethyl acetate, and washed with water, saturated aqueous sodium hydrogen carbonate and saturated saline.
The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. Recrystallized with hexane-ethyl acetate, (4R
S, 5SR) -4- [3- (1,1-difluoroethyl) benzyl] -5- (4-fluorophenyl) -1,3-oxazolidin-2-one (3.99 g, 95%) as colorless crystals. As obtained. mp 143-144 ℃ IRνmax KBr (cm -1 ): 3231, 1763, 1608, 1512, 1386, 13
00, 1230 1 H-NMR (CDCl 3 ) δ (ppm) 1.88 (3H, t, J = 18.4 Hz)
2.29-2.38 (2H, m) 4.22-4.33 (1H, m) 5.17 (1H, s)
5.79 (1H, d, J = 8.0 Hz) 7.06-7.18 (4H, m) 7.29-7.
39 (4H, m). 8) (1RS, 2SR) -2-amino-3- [3- (1,
1-difluoroethyl) phenyl] -1- (4-fluorophenyl) -1-propanol (4RS, 5SR) -4- [3- (1,1-difluoroethyl) benzyl] -5- (4-fluorophenyl) -1,3-
To a solution of oxazolidin-2-one (3.83 g, 12.5 mmol) in ethanol (100 ml) was added an 8 N aqueous sodium hydroxide solution (7.8 ml, 39.0 mmol), and the mixture was heated under reflux for 5 hours. After completion of the reaction, the reaction mixture was diluted with water and extracted with ethyl acetate. The organic layers were combined, washed with saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate) to give (1RS, 2SR) -2-amino-3- [3- (1,1-
[Difluoroethyl) phenyl] -1- (4-fluorophenyl) -1-propanol (3.08 g, 88%) was obtained as colorless crystals. mp 101-102 ° C IRνmax KBr (cm -1 ): 3363, 1604, 1508, 1448, 1385, 13
02, 1224, 1176 1 H-NMR (CDCl 3 ) δ (ppm) 1.89 (3H, t, J = 18.4 Hz)
2.39 (1H, dd, J = 10.4,13.6 Hz) 2.82 (1H, dd, J =
3.0, 13.6 Hz) 3.25-3.34 (1H, m) 4.69 (1H, d, J = 5.
0 Hz) 7.03-7.11 (2H, m) 7.11-7.21 (1H, m) 7.26-7.4
1 (5H, m). 9) N-[(1RS, 2SR) -1- [3- (1,1-difluoroethyl) benzyl] -2- (4-fluorophenyl) -2-hydroxyethyl] -4 -Fluoro-1-naphthamide (1RS, 2SR) -2-amino-3- [3- (1,1-difluoroethyl) phenyl] -1- (4-fluorophenyl) -1-propanol (0.40 g, 1 .42 mmol) in acetonitrile (10 ml) solution in 4-fluoronaphthalene-1-carboxylic acid (0.283 g, 1.49 mmol), 1-hydroxybenzotriazole monohydrate (0.22 g, 1.49 mmol) And finally 1-
Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.27 g, 1.49 mmol) was added,
Stirred at room temperature overnight. The mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 5: 1,
2: 1) and then purified by recrystallization (hexane-ethyl acetate) to give N-[(1RS, 2SR) -1- [3- (1,1-
Difluoroethyl) benzyl] -2- (4-fluorophenyl) -2-hydroxyethyl] -4-fluoro-1-naphthamide (0.52 g, 81%) was obtained as colorless crystals. mp 182-183 ° C. Elemental analysis C 28 H 23 NO 2 F 4 Calculated: C, 69.85; H, 4.81 ; N, 2.91 Found: C, 69.86; H, 4.75 ; N, 2.74 IRνmax KBr (cm - 1 ): 3277, 1641, 1626, 1601, 1512, 14
25, 1307, 1230 1 H-NMR (CDCl 3 ) δ (ppm) 1.84 (3H, t, J = 18.0 Hz) 2.
84 (1H, dd, J = 10.2, 14.1 Hz) 3.07 (1H, dd, J = 4.
2, 14.7 Hz) 3.55 (1H, s) 4.72-4.81 (1H, m) 5.08 (1
H, s) 5.92 (1H, d, J = 8.7 Hz) 6.98 (1H, dd, J =
8.1, 9.9 Hz) 7.05-7.15 (3H, m) 7.27-7.48 (7H, m)
7.50-7.55 (1H, m) 7.75 (1H, d, J = 8.7Hz) 8.07 (1
(H, d, J = 8.7 Hz).
【0492】実施例360 N-[(1RS,2SR)-1-[3-(1,1-ジフルオ
ロエチル)ベンジル]-2-(4-フルオロフェニル)-2
-ヒドロキシエチル]-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド (1RS,2SR)-2-アミノ-3-[3-(1,1-ジフ
ルオロエチル)フェニル]-1-(4-フルオロフェニ
ル)-1-プロパノール(0.40g,1.42ミリモ
ル)のアセトニトリル(10ml)溶液に6,7-ジヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボン酸
(0.28g,1.49ミリモル)、1-ヒドロキシベ
ンゾトリアゾール1水和物(0.22g,1.49ミリ
モル)を加え、最後に1-エチル-3-(3-ジメチルアミ
ノプロピル)カルボジイミド塩酸塩(0.27g,1.
49ミリモル)を加え、室温で終夜撹拌した。酢酸エチ
ルで希釈し、飽和重曹水、水、飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥後、ろ過、減圧濃縮した。残
渣をシリカゲルカラムクロマトグラフィー(ヘキサン:
酢酸エチル=5:1、2:1)、その後、再結晶(ヘキ
サン-酢酸エチル)で精製し、N-[(1RS,2SR)
-1-[3-(1,1-ジフルオロエチル)ベンジル]-2-
(4-フルオロフェニル)-2-ヒドロキシエチル]-6,
7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カ
ルボキサミド(0.50g,78%)を無色結晶として
得た。 mp 170-171℃ IRνmaxKBr(cm-1): 1639, 1510, 1448, 1385, 1305, 12
22, 1174, 1086 元素分析値C29H28NO2F3 として 計算値: C, 72.64; H, 5.89; N, 2.92 実測値: C, 72.61; H, 5.91; N, 2.651 H-NMR(CDCl3) δ (ppm) 1.87 (3H, t, J = 18.3 Hz)
1.96-2.04 (2H, m) 2.15-2.21 (2H, m) 2.63-2.67 (2H,
m) 2.78 (1H, dd, J = 10.8, 14.4 Hz) 3.01 (1H, dd,
J = 4.5, 14.7 Hz) 3.70 (1H, d, J = 3.3 Hz) 4.65-
4.72 (1H, m) 5.03(1H, t, J = 3.9 Hz) 5.72 (1H, d,
J = 7.8 Hz) 5.90 (1H, dt, J = 5.1, 12.0Hz) 6.16 (1
H, d, J = 11.7 Hz) 6.93 (1H, dd, J = 1.2, 7.5 Hz)
7.04-7.15(4H, m) 7.25-7.31 (2H, m) 7.34-7.38 (2H,
m) 7.41-7.46 (2H, m).Example 360 N-[(1RS, 2SR) -1- [3- (1,1-difluoroethyl) benzyl] -2- (4-fluorophenyl) -2
-Hydroxyethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-3- [3- (1,1-difluoroethyl) phenyl] -1- To a solution of (4-fluorophenyl) -1-propanol (0.40 g, 1.42 mmol) in acetonitrile (10 ml) was added 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (0.28 g, 1.49 mmol), 1-hydroxybenzotriazole monohydrate (0.22 g, 1.49 mmol) and finally 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.27 g) , 1.
49 mmol) and stirred at room temperature overnight. The mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane:
Ethyl acetate = 5: 1, 2: 1), then purified by recrystallization (hexane-ethyl acetate) to give N-[(1RS, 2SR)
-1- [3- (1,1-difluoroethyl) benzyl] -2-
(4-Fluorophenyl) -2-hydroxyethyl] -6
7-Dihydro-5H-benzo [a] cycloheptene-1-carboxamide (0.50 g, 78%) was obtained as colorless crystals. mp 170-171 ° C IRνmax KBr (cm -1 ): 1639, 1510, 1448, 1385, 1305, 12
22, 1174, 1086 Elemental analysis: C 29 H 28 NO 2 F 3 Calculated: C, 72.64; H, 5.89; N, 2.92 Found: C, 72.61; H, 5.91; N, 2.65 1 H-NMR ( CDCl 3 ) δ (ppm) 1.87 (3H, t, J = 18.3 Hz)
1.96-2.04 (2H, m) 2.15-2.21 (2H, m) 2.63-2.67 (2H, m
m) 2.78 (1H, dd, J = 10.8, 14.4 Hz) 3.01 (1H, dd,
J = 4.5, 14.7 Hz) 3.70 (1H, d, J = 3.3 Hz) 4.65-
4.72 (1H, m) 5.03 (1H, t, J = 3.9 Hz) 5.72 (1H, d,
J = 7.8 Hz) 5.90 (1H, dt, J = 5.1, 12.0Hz) 6.16 (1
H, d, J = 11.7 Hz) 6.93 (1H, dd, J = 1.2, 7.5 Hz)
7.04-7.15 (4H, m) 7.25-7.31 (2H, m) 7.34-7.38 (2H, m
m) 7.41-7.46 (2H, m).
【0493】実施例361 tert-ブチル(1RS,2RS)-2-ヒドロキシ-2
-(2-フェニル-1,3-チアゾール-4-イル)-1-[3
-(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチルカーバメート 1) エチル3-オキソ-3-(2-フェニル-1,3-チア
ゾール-4-イル)プロピオネート 2-フェニル-1,3-チアゾール-4-カルボン酸(1
g,4.87ミリモル)のテトラヒドロフラン(10m
l)溶液にN,N'-カルボニルジイミダゾール(0.8
7g,5.37ミリモル)を加え、室温で3時間撹拌
し、イミダゾライド溶液を調整した。別に用意したナス
コルにエチルハイドロゲンマロネート(0.78g,
5.84ミリモル)のテトラヒドロフラン(10ml)
溶液にマグネシウムエトキシド(0.34g,2.92
ミリモル)を加え、室温で一時間撹拌した後、溶媒を減
圧濃縮して、淡黄色の非結晶性粉末を得た。ここに、先
に調整したイミダゾライド溶液を滴下し、室温で終夜撹
拌した。酢酸エチルで希釈し、1M硫酸水素カリウム、
飽和重曹水、水、飽和食塩水で洗浄し、無水硫酸マグネ
シウムで乾燥後、ろ過、減圧濃縮した。残渣をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
4:1)で精製し、エチル3-オキソ-3-(2-フェニル
-1,3-チアゾール-4-イル)プロピオネート(1.2
9g,96%)を無色結晶として得た。 mp 66-68℃ IRνmaxKBr(cm-1) : 3117, 1739, 1693, 1628, 1483, 1
304, 1219, 1153, 10281 H-NMR(CDCl3) δ (ppm) 1.24, 1.34 (3H, each t, J =
7.0, 7.2 Hz respectively) 4.15 (1.2H, s) 4.21, 4.
28 (2H, each q, J = 6.8, 7.2 Hz respectively) 6.21
(0.4H, s) 7.41-7.49 (3H, m) 7.83 (0.4H, s) 7.93-
7.99 (2H, m) 8.19(0.6H, s) 12.16 (0.4H, s) 2) エチル3-オキソ-3-(2-フェニル-1,3-チア
ゾール-4-イル)-2-[3-(1,1,2,2-テトラフ
ルオロエトキシ)ベンジル]プロピオネート 3-(1,1,2,2-テトラフルオロエトキシ)ベンジ
ルアルコール(5.53ml,24.7ミリモル)の酢
酸エチル(50ml)溶液にトリエチルアミン(5.2
ml,37.05ミリモル)を加え氷冷下でメタンスル
ホニルクロライド(2.1ml,27.17ミリモル)
を滴下し、そのまま30分間撹拌した。析出した結晶を
ろ過し、ろ液を濃縮してメシレートを得た。これはこの
まま次の反応に用いた。エチル3-オキソ-3-(2-フェ
ニル-1,3-チアゾール-4-イル)プロピオネート
(6.80g,24.7ミリモル)のジメトキシエタン
(50ml)溶液を氷冷し、水素化ナトリウム(60
%,0.99g,24.7ミリモル)を加え、氷冷下で
30分撹拌した後、メシレートのジメトキシエタン(5
0ml)溶液を加え、室温で終夜撹拌した。反応終了
後、1規定の塩酸でクエンチし、酢酸エチルで希釈し、
水、飽和食塩水で洗浄した。無水硫酸マグネシウムで乾
燥後、ろ過、減圧濃縮した。残渣をシリカゲルカラムク
ロマトグラフィー(ヘキサン:酢酸エチル=10:1、
5:1)で精製し、エチル3-オキソ-3-(2-フェニル
-1,3-チアゾール-4-イル)-2-[3-(1,1,
2,2-テトラフルオロエトキシ)ベンジル]プロピオ
ネート(8.65g,73%)を淡黄色オイルとして得
た。 IRνmaxKBr(cm-1): 1736, 1691, 1612, 1587, 1487, 14
67, 1444, 1197, 11221 H-NMR(CDCl3) δ (ppm) 1.12 (3H, t, J = 7.2 Hz) 3.
37 (2H, m) 4.12 (2H, q, J = 7.0 Hz) 4.84 (1H, dd,
J = 7.0, 7.8 Hz) 5.87 (1H, dt, J = 2.8, 53.0Hz) 7.
02-7.06 (1H, m) 7.18-7.32 (3H, m) 7.44-7.51 (3H,
m) 7.94-7.98 (2H, m) 8.19 (1H, s). 3) エチル3-ヒドロキシ-3-(2-フェニル-1,3-
チアゾール-4-イル)-2-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]プロピオネート 塩化亜鉛(3.41g,25ミリモル)のエーテル懸濁
液(50ml)に水素化ホウ素ナトリウム(1.89
g,50ミリモル)を室温で加えそのまま2時間撹拌し
た。不溶物をろ過し、そのろ液にエチル3-オキソ-3-
(2-フェニル-1,3-チアゾール-4-イル)-2-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]プロピオネート(6.01g,12.5ミリモル)
のエーテル(40ml)溶液を氷冷下加え、そのまま1
時間撹拌した。1規定塩酸で反応を終了させ、酢酸エチ
ルで希釈し、水、飽和食塩水で洗浄した。無水硫酸マグ
ネシウムで乾燥後、ろ過、減圧濃縮した。残渣をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=6:1、4:1)で精製し、エチル3-ヒドロキシ-3
-(2-フェニル-1,3-チアゾール-4-イル)-2-[3
-(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]プロピオネート(4.61g,76%)を無色透明
オイルとして得た。 IRνmaxKBr(cm-1) : 1726, 1612, 1587, 1460, 1302, 1
277, 1197, 11201 H-NMR(CDCl3)δ (ppm) 0.96-107 (3H, m) 2.93-3.15
(2H, m) 3.36-3.49 (1H,m) 3.54 (0.74H, d, J = 5.2 H
z) 3.69 (0.26H, d, J = 9.4 Hz) 3.99, 4.01 (2H, eac
h q, J = 6.8, 7.0 Hz) 4.94 (0.26H, dd, J = 5.6, 9.
6 Hz) 5.18-5.23(0.74H, m) 5.85, 5.89 (1H, each dt,
J = 3.0, 53.0 Hz) 6.99-7.32 (5H, m)7.39-7.47 (3H,
m) 7.89-7.95 (2H, m). (シンとアンチの比は 4.94ppmと 5.18-5.23ppm のピー
クの積分比より 2.8:1と決定した。) 4) 3-ヒドロキシ-3-(2-フェニル-1,3-チアゾ
ール-4-イル)-2-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]プロピオン酸 エチル3-ヒドロキシ-3-(2-フェニル-1,3-チアゾ
ール-4-イル)-2-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]プロピオネート(6.28
g,13.0ミリモル)のテトラヒドロフラン-エタノ
ール(20ml-20ml)溶液に室温で2規定の水酸
化ナトリウム(17ml,34ミリモル)を加え、室温
で終夜撹拌した。反応終了後、有機溶媒を減圧留去し、
水で希釈した。水層をエーテルで洗浄した後、1規定塩
酸で酸性とし、酢酸エチルで抽出した。有機層を無水硫
酸マグネシウムで乾燥後、ろ過、減圧濃縮し、3-ヒド
ロキシ-3-(2-フェニル-1,3-チアゾール-4-イ
ル)-2-[3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]プロピオン酸(5.51g,93%)を
淡黄色オイルとして得た。 IRνmaxKBr(cm-1): 250-3300, 1707, 1612, 1587, 145
8, 1278, 1197, 11201 H-NMR(CDCl3)δ (ppm) 2.85-3.14 (2H, m) 3.39-3.52
(1H, m) 4.93 (0.33H, d, J = 5.8 Hz) 5.24 (0.66H,
d, J = 4.4 Hz) 5.81, 5.85 (1H, dt, J = 3.0, 53.0 H
z, J = 3.0, 56.0 Hz respectively) 6.98-7.31 (5H,
m) 7.39-7.45 (3H,m) 7.82-7.89 (2H, m). (シンとアンチの比は 4.93ppmと 5.24ppm のピークの
積分比より 2:1 と決定した。) 5) 5-(2-フェニル-1,3-チアゾール-4-イル)
-4-[3-(1,1,2,2-テトラフルオロエトキシ)
ベンジル]-1,3-オキサゾリジン-2-オン 3-ヒドロキシ-3-(2-フェニル-1,3-チアゾール-
4-イル)-2-[3-(1,1,2,2-テトラフルオロ
エトキシ)ベンジル]プロピオン酸(5.23g,1
1.48ミリモル)のテトラヒドロフラン(120m
l)溶液にトリエチルアミン(2.40ml,17.2
2ミリモル)、ジフェニルリン酸アジド(2.73m
l,12.63ミリモル)を加え、5時間加熱還流し
た。溶媒を留去し、酢酸エチルで希釈した。水,飽和重
曹水、飽和食塩水で洗浄した。有機層を無水硫酸マグネ
シウムで乾燥後、ろ過、減圧濃縮した。残渣をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
3:1、1:1)で精製し、5-(2-フェニル-1,3-
チアゾール-4-イル)-4-[3-(1,1,2,2-テト
ラフルオロエトキシ)ベンジル]-1,3-オキサゾリジ
ン-2-オン(4.57g,88%)を淡黄色オイルとし
て得た。 IRνmaxKBr(cm-1) : 3260, 1761, 1612, 1587, 1462, 1
302, 1277, 1197, 11201 H-NMR(CDCl3) δ (ppm) 2.33 (0.66H, dd, J = 11.0,
13.8 Hz) 2.71 (0.66H,dd, J = 4.0, 14.0 Hz) 3.01
(0.33H, dd, J = 8.8, 13.8 Hz) 3.26 (0.33H, dd, J =
5.0, 13.4 Hz) 4.27-4.51 (1H, m) 5.20 (0.66H, m)
5.42 (0.33H, d, J= 5.5 Hz) 5.30-5.50 (0.33H, br)
5.61-5.65 (0.25H, m) 5.87-5.91 (0.5H, m)6.00 (0.66
H, d, J = 8.2 Hz) 6.13-6.16 (0.25H, m) 6.95-7.19
(3H, m) 7.19-7.47 (5H, m) 7.90-7.95 (2H, m). 6) tert-ブチル(4RS,5RS)-2-オキソ-
5-(2-フェニル-1,3-チアゾール-4-イル)-4-
[3-(1,1,2,2-テトラフルオロエトキシ)ベン
ジル]-1,3-オキサゾリジン-3-カルボキシレート 5-(2-フェニル-1,3-チアゾール-4-イル)-4-
[3-(1,1,2,2-テトラフルオロエトキシ)ベン
ジル]-1,3-オキサゾリジン-2-オン(4.43g,
9.79ミリモル)のアセトニトリル(50ml)溶液
にジ-tert-ブチル-ジカーボネート(2.58g,
11.8ミリモル)と4-(ジメチルアミノ)ピリジン
(0.12g,0.98ミリモル)を順に加え、室温で
終夜撹拌した。溶媒を減圧留去し、残渣をフラッシュカ
ラムクロマトグラフィー(ヘキサン:酢酸エチル:トル
エン=4:1:1)で精製し、tert-ブチル(4R
S,5RS)-2-オキソ-5-(2-フェニル-1,3-チ
アゾール-4-イル)-4-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]-1,3-オキサゾリジン
-3-カルボキシレート(3.40g,63%)を淡黄色
オイルとして得た。 シン(4RS,5RS)体 (more polar) IRνmaxKBr(cm-1) : 1824, 1724, 1612, 1587, 1489, 1
464, 1356, 11161 H-NMR(CDCl3)δ (ppm): 1.49 (9H, s) 2.78 (1H, dd,
J = 8.2, 14.0 Hz) 2.94(1H, dd, J = 4.6, 13.8 Hz)
4.98-5.08 (1H, m) 5.79-5.83 (1H, m) 5.82 (1H, dt,
J = 3.0, 53.0 Hz) 6.69 (2H, d, J = 7.4 Hz) 6.81 (1
H, d, J = 8.0 Hz) 6.99-7.07 (1H, m) 7.15-7.29 (1H,
m) 7.34-7.43 (3H, m) 7.68-7.73 (2H, m). アンチ(4RS,5SR)体(less polar) IRνmaxKBr(cm-1) : 1871, 1724, 1612, 1587, 1489, 1
464, 1356, 11161 H-NMR(CDCl3) δ (ppm): 1.59 (9H, s) 3.06 (1H, dd,
J = 8.8, 13.6 Hz) 3.44 (1H, dd, J = 4.2, 14.0 Hz)
4.73-4.81 (1H, m) 5.28 (1H, dd, J = 1.2, 3.0 Hz)
5.90 (1H, dt, J = 2.8, 53.0 Hz) 7.18-7.25 (4H, m)
7.34-7.45 (4H, m) 7.82-7.87 (2H, m). 7) tert-ブチル(1RS,2RS)-2-ヒドロ
キシ-2-(2-フェニル-1,3-チアゾール-4-イル)-
1-[3-(1,1,2,2-テトラフルオロエトキシ)
ベンジル]エチルカーバメート tert-ブチル(4RS,5RS)-2-オキソ-5-
(2-フェニル-1,3-チアゾール-4-イル)-4-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]-1,3-オキサゾリジン-3-カルボキシレート
(3.17g,5.74ミリモル)のメタノール(60
ml)溶液に1規定水酸化ナトリウム(6.9ml,
6.9ミリモル)を加え、室温で終夜撹拌した。水で希
釈した後、酢酸エチルで抽出した。有機層を飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後、ろ過、減圧
濃縮した。残渣を再結晶(ヘキサン-酢酸エチル)で精
製し、tert-ブチル(1RS,2RS)-2-ヒドロ
キシ-2-(2-フェニル-1,3-チアゾール-4-イル)-
1-[3-(1,1,2,2-テトラフルオロエトキシ)
ベンジル]エチルカーバメート(1.72g,57%)
を無色結晶として得た。 mp 127-128℃ IRνmaxKBr(cm-1) : 3341, 1691, 1612, 1587, 1508, 1
558, 1367, 1278, 1195,1167, 11221 H-NMR(CD3OD) δ (ppm) : 1.39 (9H, s) 2.80 (1H, d
d, J = 6.0, 14.1 Hz) 2.92 (1H, dd, J = 8.7, 14.1 H
z) 3.96 (1H, d, J = 6.0 Hz) 4.29-4.34 (1H, m)4.97
(1H, s) 5.22 (1H, d, J = 5.8 Hz) 5.88 (1H, dt, J =
2.7, 53.7 Hz) 7.07 (2H, s) 7.12 (1H, d, J = 7.2 H
z) 7.24-7.30 (2H, m) 7.44-7.46 (3H, m)7.95-7.98 (2
H, m).Example 361 Tert-butyl (1RS, 2RS) -2-hydroxy-2
-(2-Phenyl-1,3-thiazol-4-yl) -1- [3
-(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl carbamate 1) ethyl 3-oxo-3- (2-phenyl-1,3-thiazol-4-yl) propionate 2-phenyl-1,3 -Thiazole-4-carboxylic acid (1
g, 4.87 mmol) in tetrahydrofuran (10 m
l) N, N'-carbonyldiimidazole (0.8
7g, 5.37 mmol) and stirred at room temperature for 3 hours to prepare an imidazolide solution. Ethyl hydrogen malonate (0.78 g,
5.84 mmol) in tetrahydrofuran (10 ml)
Add magnesium ethoxide (0.34 g, 2.92) to the solution.
Mmol), and the mixture was stirred at room temperature for 1 hour, and then the solvent was concentrated under reduced pressure to obtain a pale yellow amorphous powder. The previously prepared imidazolide solution was added dropwise thereto, and the mixture was stirred at room temperature overnight. Diluted with ethyl acetate, 1M potassium bisulfate,
The extract was washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
4: 1) to give ethyl 3-oxo-3- (2-phenyl)
-1,3-thiazol-4-yl) propionate (1.2
9g, 96%) as colorless crystals. mp 66-68 ℃ IRνmax KBr (cm -1 ): 3117, 1739, 1693, 1628, 1483, 1
304, 1219, 1153, 1028 1 H-NMR (CDCl 3 ) δ (ppm) 1.24, 1.34 (3H, each t, J =
7.0, 7.2 Hz respectively) 4.15 (1.2H, s) 4.21, 4.
28 (2H, each q, J = 6.8, 7.2 Hz respectively) 6.21
(0.4H, s) 7.41-7.49 (3H, m) 7.83 (0.4H, s) 7.93-
7.99 (2H, m) 8.19 (0.6H, s) 12.16 (0.4H, s) 2) Ethyl 3-oxo-3- (2-phenyl-1,3-thiazol-4-yl) -2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionate 3- (1,1,2,2-tetrafluoroethoxy) benzyl alcohol (5.53 ml, 24.7 mmol) solution in ethyl acetate (50 ml) To triethylamine (5.2
methanesulfonyl chloride (2.1 ml, 27.17 mmol) under ice cooling.
Was added dropwise, and the mixture was stirred as it was for 30 minutes. The precipitated crystals were filtered, and the filtrate was concentrated to obtain mesylate. This was used for the next reaction as it was. A solution of ethyl 3-oxo-3- (2-phenyl-1,3-thiazol-4-yl) propionate (6.80 g, 24.7 mmol) in dimethoxyethane (50 ml) was cooled on ice, and sodium hydride (60%) was added.
%, 0.99 g, 24.7 mmol), and the mixture was stirred under ice-cooling for 30 minutes, and then dimethoxyethane of mesylate (5%) was added.
0 ml) solution and stirred at room temperature overnight. After completion of the reaction, the reaction is quenched with 1N hydrochloric acid, diluted with ethyl acetate,
Washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 10: 1,
5: 1) to give ethyl 3-oxo-3- (2-phenyl)
-1,3-thiazol-4-yl) -2- [3- (1,1,
2,2-Tetrafluoroethoxy) benzyl] propionate (8.65 g, 73%) was obtained as a pale yellow oil. IRνmax KBr (cm -1 ): 1736, 1691, 1612, 1587, 1487, 14
67, 1444, 1197, 1122 1 H-NMR (CDCl 3 ) δ (ppm) 1.12 (3H, t, J = 7.2 Hz) 3.
37 (2H, m) 4.12 (2H, q, J = 7.0 Hz) 4.84 (1H, dd,
J = 7.0, 7.8 Hz) 5.87 (1H, dt, J = 2.8, 53.0Hz) 7.
02-7.06 (1H, m) 7.18-7.32 (3H, m) 7.44-7.51 (3H,
m) 7.94-7.98 (2H, m) 8.19 (1H, s). 3) Ethyl 3-hydroxy-3- (2-phenyl-1,3-
Thiazol-4-yl) -2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionate Boron hydride was added to an ether suspension (50 ml) of zinc chloride (3.41 g, 25 mmol). Sodium (1.89
g, 50 mmol) at room temperature and stirred for 2 hours. The insolubles were filtered off and the filtrate was added to ethyl 3-oxo-3-
(2-phenyl-1,3-thiazol-4-yl) -2- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] propionate (6.01 g, 12.5 mmol)
Of ether (40 ml) was added under ice-cooling.
Stirred for hours. The reaction was terminated with 1N hydrochloric acid, diluted with ethyl acetate, and washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 6: 1, 4: 1) to give ethyl 3-hydroxy-3.
-(2-phenyl-1,3-thiazol-4-yl) -2- [3
-(1,1,2,2-Tetrafluoroethoxy) benzyl] propionate (4.61 g, 76%) was obtained as a colorless transparent oil. IRνmax KBr (cm -1 ): 1726, 1612, 1587, 1460, 1302, 1
277, 1197, 1120 1 H-NMR (CDCl 3 ) δ (ppm) 0.96-107 (3H, m) 2.93-3.15
(2H, m) 3.36-3.49 (1H, m) 3.54 (0.74H, d, J = 5.2 H
z) 3.69 (0.26H, d, J = 9.4 Hz) 3.99, 4.01 (2H, eac
hq, J = 6.8, 7.0 Hz) 4.94 (0.26H, dd, J = 5.6, 9.
6 Hz) 5.18-5.23 (0.74H, m) 5.85, 5.89 (1H, each dt,
J = 3.0, 53.0 Hz) 6.99-7.32 (5H, m) 7.39-7.47 (3H,
m) 7.89-7.95 (2H, m). (The ratio of syn to anti was determined to be 2.8: 1 based on the integration ratio of the peaks at 4.94 ppm and 5.18-5.23 ppm.) 4) 3-Hydroxy-3- (2- Ethyl phenyl-1,3-thiazol-4-yl) -2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionate 3-hydroxy-3- (2-phenyl-1,3 -Thiazol-4-yl) -2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionate (6.28
g, 13.0 mmol) in tetrahydrofuran-ethanol (20 ml-20 ml) was added 2N sodium hydroxide (17 ml, 34 mmol) at room temperature and stirred at room temperature overnight. After completion of the reaction, the organic solvent was distilled off under reduced pressure.
Diluted with water. The aqueous layer was washed with ether, acidified with 1N hydrochloric acid, and extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure, and then 3-hydroxy-3- (2-phenyl-1,3-thiazol-4-yl) -2- [3- (1,1,2, 2-Tetrafluoroethoxy) benzyl] propionic acid (5.51 g, 93%) was obtained as a pale yellow oil. IRνmax KBr (cm -1 ): 250-3300, 1707, 1612, 1587, 145
8, 1278, 1197, 1120 1 H-NMR (CDCl 3 ) δ (ppm) 2.85-3.14 (2H, m) 3.39-3.52
(1H, m) 4.93 (0.33H, d, J = 5.8 Hz) 5.24 (0.66H,
d, J = 4.4 Hz) 5.81, 5.85 (1H, dt, J = 3.0, 53.0 H
z, J = 3.0, 56.0 Hz respectively) 6.98-7.31 (5H,
m) 7.39-7.45 (3H, m) 7.82-7.89 (2H, m). (The ratio of syn to anti was determined to be 2: 1 from the integration ratio of the peaks at 4.93 ppm and 5.24 ppm.) 5) 5- ( 2-phenyl-1,3-thiazol-4-yl)
-4- [3- (1,1,2,2-tetrafluoroethoxy)
Benzyl] -1,3-oxazolidin-2-one 3-hydroxy-3- (2-phenyl-1,3-thiazole-
4-yl) -2- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] propionic acid (5.23 g, 1
1.48 mmol) of tetrahydrofuran (120 m
l) Add triethylamine (2.40 ml, 17.2) to the solution.
2 mmol), diphenylphosphate azide (2.73 m
1, 12.63 mmol) and heated under reflux for 5 hours. The solvent was distilled off and diluted with ethyl acetate. Washed with water, saturated aqueous sodium bicarbonate, and saturated saline. The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
3: 1, 1: 1) and purified by 5- (2-phenyl-1,3-
Thiazol-4-yl) -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidin-2-one (4.57 g, 88%) as a pale yellow oil Obtained. IRνmax KBr (cm -1 ): 3260, 1761, 1612, 1587, 1462, 1
302, 1277, 1197, 1120 1 H-NMR (CDCl 3 ) δ (ppm) 2.33 (0.66H, dd, J = 11.0,
13.8 Hz) 2.71 (0.66H, dd, J = 4.0, 14.0 Hz) 3.01
(0.33H, dd, J = 8.8, 13.8 Hz) 3.26 (0.33H, dd, J =
5.0, 13.4 Hz) 4.27-4.51 (1H, m) 5.20 (0.66H, m)
5.42 (0.33H, d, J = 5.5 Hz) 5.30-5.50 (0.33H, br)
5.61-5.65 (0.25H, m) 5.87-5.91 (0.5H, m) 6.00 (0.66
(H, d, J = 8.2 Hz) 6.13-6.16 (0.25H, m) 6.95-7.19
(3H, m) 7.19-7.47 (5H, m) 7.90-7.95 (2H, m). 6) tert-butyl (4RS, 5RS) -2-oxo-
5- (2-phenyl-1,3-thiazol-4-yl) -4-
[3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine-3-carboxylate 5- (2-phenyl-1,3-thiazol-4-yl) -4-
[3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidin-2-one (4.43 g,
9.79 mmol) in acetonitrile (50 ml) was added to a solution of di-tert-butyl-dicarbonate (2.58 g,
11.8 mmol) and 4- (dimethylamino) pyridine (0.12 g, 0.98 mmol) were added in that order, and the mixture was stirred at room temperature overnight. The solvent was distilled off under reduced pressure, the residue was purified by flash column chromatography (hexane: ethyl acetate: toluene = 4: 1: 1), and tert-butyl (4R
S, 5RS) -2-Oxo-5- (2-phenyl-1,3-thiazol-4-yl) -4- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] -1, 3-oxazolidine
-3-Carboxylate (3.40 g, 63%) was obtained as a pale yellow oil. Thin (4RS, 5RS) body (more polar) IRνmax KBr (cm -1 ): 1824, 1724, 1612, 1587, 1489, 1
464, 1356, 1116 1 H-NMR (CDCl 3 ) δ (ppm): 1.49 (9H, s) 2.78 (1H, dd,
J = 8.2, 14.0 Hz) 2.94 (1H, dd, J = 4.6, 13.8 Hz)
4.98-5.08 (1H, m) 5.79-5.83 (1H, m) 5.82 (1H, dt,
J = 3.0, 53.0 Hz) 6.69 (2H, d, J = 7.4 Hz) 6.81 (1
H, d, J = 8.0 Hz) 6.99-7.07 (1H, m) 7.15-7.29 (1H,
m) 7.34-7.43 (3H, m) 7.68-7.73 (2H, m). Anti (4RS, 5SR) form (less polar) IRνmax KBr (cm -1 ): 1871, 1724, 1612, 1587, 1489, 1
464, 1356, 1116 1 H-NMR (CDCl 3 ) δ (ppm): 1.59 (9H, s) 3.06 (1H, dd,
J = 8.8, 13.6 Hz) 3.44 (1H, dd, J = 4.2, 14.0 Hz)
4.73-4.81 (1H, m) 5.28 (1H, dd, J = 1.2, 3.0 Hz)
5.90 (1H, dt, J = 2.8, 53.0 Hz) 7.18-7.25 (4H, m)
7.34-7.45 (4H, m) 7.82-7.87 (2H, m). 7) tert-butyl (1RS, 2RS) -2-hydroxy-2- (2-phenyl-1,3-thiazol-4-yl)-
1- [3- (1,1,2,2-tetrafluoroethoxy)
[Benzyl] ethylcarbamate tert-butyl (4RS, 5RS) -2-oxo-5-
(2-phenyl-1,3-thiazol-4-yl) -4- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] -1,3-oxazolidine-3-carboxylate (3.17 g, 5.74 mmol) in methanol (60
1N sodium hydroxide (6.9 ml,
6.9 mmol) and stirred at room temperature overnight. After dilution with water, the mixture was extracted with ethyl acetate. The organic layer was washed with brine, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue is purified by recrystallization (hexane-ethyl acetate) and tert-butyl (1RS, 2RS) -2-hydroxy-2- (2-phenyl-1,3-thiazol-4-yl)-.
1- [3- (1,1,2,2-tetrafluoroethoxy)
[Benzyl] ethyl carbamate (1.72 g, 57%)
Was obtained as colorless crystals. mp 127-128 ℃ IRνmax KBr (cm -1 ): 3341, 1691, 1612, 1587, 1508, 1
558, 1367, 1278, 1195,1167, 1122 1 H-NMR (CD 3 OD) δ (ppm): 1.39 (9H, s) 2.80 (1H, d
d, J = 6.0, 14.1 Hz) 2.92 (1H, dd, J = 8.7, 14.1 H
z) 3.96 (1H, d, J = 6.0 Hz) 4.29-4.34 (1H, m) 4.97
(1H, s) 5.22 (1H, d, J = 5.8 Hz) 5.88 (1H, dt, J =
2.7, 53.7 Hz) 7.07 (2H, s) 7.12 (1H, d, J = 7.2 H
z) 7.24-7.30 (2H, m) 7.44-7.46 (3H, m) 7.95-7.98 (2
H, m).
【0494】実施例362 4-フルオロ-N-{(1RS,2RS)-2-ヒドロキシ-
2-(2-フェニル-1,3-チアゾール-4-イル)-1-
[3-(1,1,2,2-テトラフルオロエトキシ)ベン
ジル]エチル}-1-ナフトアミド 1) (1RS,2RS)-2-アミノ-1-(2-フェニ
ル-1,3-チアゾール-4-イル)-3-[3-(1,1,
2,2-テトラフルオロエトキシ)フェニル]-1-プロ
パノール tert-ブチル(1RS,2RS)-2-ヒドロキシ-2
-(2-フェニル-1,3-チアゾール-4-イル)-1-[3
-(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチルカーバメート(1.67g,3.17ミリモ
ル)のクロロホルム(20ml)溶液にトリフルオロ酢
酸(20ml)を加え、室温で一時間撹拌した。減圧濃
縮した後、残渣に水を加え、飽和重曹水で塩基性とし
た。水層を酢酸エチルで抽出し、無水硫酸マグネシウム
で乾燥後、ろ過、減圧濃縮した。残渣を再結晶(ヘキサ
ン-酢酸エチル)で精製し、(1RS,2RS)-2-ア
ミノ-1-(2-フェニル-1,3-チアゾール-4-イル)-
3-[3-(1,1,2,2-テトラフルオロエトキシ)
フェニル]-1-プロパノール(1.17g,87%)を
無色結晶として得た。 mp 128-130℃ IRνmaxKBr(cm-1): 3300, 1676, 1462, 1199, 11261 H-NMR(CDCl3) δ (ppm) : 2.76 (1H, dd, J = 7.8, 1
4.1 Hz) 3.00 (1H, dd, J= 6.3, 14.1 Hz) 3.77-3.83
(1H, m) 4.93 (1H, dd, J = 0.9, 4.2 Hz) 6.27 (1H, d
t, J = 3.0, 52.5 Hz) 7.07 (1H, d, J = 8.1 Hz) 7.16
-7.20 (2H, m) 7.33 (1H, t, J = 7.8 Hz) 7.46-7.49
(4H, m) 7.93-7.97 (2H, m). 2) 4-フルオロ-N-{(1RS,2RS)-2-ヒド
ロキシ-2-(2-フェニル-1,3-チアゾール-4-イ
ル)-1-[3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]エチル}-1-ナフトアミド (1RS,2RS)-2-アミノ-1-(2-フェニル-1,
3-チアゾール-4-イル)-3-[3-(1,1,2,2-
テトラフルオロエトキシ)フェニル]-1-プロパノール
(311mg,0.73ミリモル)のN,N-ジメチル
ホルムアミド(10ml)溶液に4-フルオロナフタレ
ン-1-カルボン酸(133mg,0.70ミリモル)、
1-ヒドロキシベンゾトリアゾール1水和物(112m
g,0.73ミリモル)を加え、最後に1-エチル-3-
(3-ジメチルアミノプロピル)カルボジイミド塩酸塩
(140mg,0.73ミリモル)を加え、室温で3日
間撹拌した。酢酸エチルで希釈し、飽和重曹水、水、飽
和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後、ろ
過、減圧濃縮した。残渣をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=5:1、1:2)、
その後、再結晶(ヘキサン-酢酸エチル)で精製し、4-
フルオロ-N-{(1RS,2RS)-2-ヒドロキシ-2-
(2-フェニル-1,3-チアゾール-4-イル)-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル}-1-ナフトアミド(217mg,52%)
を無色結晶として得た。 mp 148-150℃ IRνmaxKBr(cm-1) : 3258, 1641, 1514, 1462, 1197, 1
124 元素分析値C31H23N2O3SF5 として 計算値: C, 62.20; H, 3.87; N, 4.68 実測値: C, 62.06; H, 3.78; N, 4.631 H-NMR(CDCl3) δ (ppm) 2.95 (1H, dd, J = 6.0, 13.6
Hz) 3.13 (1H, dd, J =5.6, 14.0 Hz) 3.95 (1H, d, J
= 6.0 Hz) 4.89-5.02 (1H, m) 5.08-512 (1H,m) 5.87
(1H, dt, J = 2.8, 53.0 Hz) 6.99-7.08 (4H, m) 7.21-
7.59 (8H, m) 7.81-7.86 (2H, m) 8.09-8.15 (2H, m).Example 362 4-Fluoro-N-{(1RS, 2RS) -2-hydroxy-
2- (2-phenyl-1,3-thiazol-4-yl) -1-
[3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -1-naphthamide 1) (1RS, 2RS) -2-amino-1- (2-phenyl-1,3-thiazole-4) -Il) -3- [3- (1,1,
2,2-tetrafluoroethoxy) phenyl] -1-propanol tert-butyl (1RS, 2RS) -2-hydroxy-2
-(2-Phenyl-1,3-thiazol-4-yl) -1- [3
To a solution of-(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl carbamate (1.67 g, 3.17 mmol) in chloroform (20 ml) was added trifluoroacetic acid (20 ml), and the mixture was stirred at room temperature for 1 hour. . After concentration under reduced pressure, water was added to the residue, and the mixture was basified with saturated aqueous sodium hydrogen carbonate. The aqueous layer was extracted with ethyl acetate, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate) to give (1RS, 2RS) -2-amino-1- (2-phenyl-1,3-thiazol-4-yl)-.
3- [3- (1,1,2,2-tetrafluoroethoxy)
[Phenyl] -1-propanol (1.17 g, 87%) was obtained as colorless crystals. mp 128-130 ° C IRνmax KBr (cm -1 ): 3300, 1676, 1462, 1199, 1126 1 H-NMR (CDCl 3 ) δ (ppm): 2.76 (1H, dd, J = 7.8, 1
4.1 Hz) 3.00 (1H, dd, J = 6.3, 14.1 Hz) 3.77-3.83
(1H, m) 4.93 (1H, dd, J = 0.9, 4.2 Hz) 6.27 (1H, d
t, J = 3.0, 52.5 Hz) 7.07 (1H, d, J = 8.1 Hz) 7.16
-7.20 (2H, m) 7.33 (1H, t, J = 7.8 Hz) 7.46-7.49
(4H, m) 7.93-7.97 (2H, m). 2) 4-Fluoro-N-{(1RS, 2RS) -2-hydroxy-2- (2-phenyl-1,3-thiazol-4-yl) -1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -1-naphthamide (1RS, 2RS) -2-amino-1- (2-phenyl-1,1
3-thiazol-4-yl) -3- [3- (1,1,2,2-
4-Fluoronaphthalene-1-carboxylic acid (133 mg, 0.70 mmol) in a solution of tetrafluoroethoxy) phenyl] -1-propanol (311 mg, 0.73 mmol) in N, N-dimethylformamide (10 ml),
1-hydroxybenzotriazole monohydrate (112m
g, 0.73 mmol) and finally 1-ethyl-3-
(3-Dimethylaminopropyl) carbodiimide hydrochloride (140 mg, 0.73 mmol) was added, and the mixture was stirred at room temperature for 3 days. The mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 5: 1, 1: 2),
Then, it is purified by recrystallization (hexane-ethyl acetate) and
Fluoro-N-{(1RS, 2RS) -2-hydroxy-2-
(2-phenyl-1,3-thiazol-4-yl) -1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl} -1-naphthamide (217 mg, 52%)
Was obtained as colorless crystals. mp 148-150 ° C IRνmax KBr (cm -1 ): 3258, 1641, 1514, 1462, 1197, 1
124 Elemental analysis: C 31 H 23 N 2 O 3 SF 5 Calculated: C, 62.20; H, 3.87; N, 4.68 Found: C, 62.06; H, 3.78; N, 4.63 1 H-NMR (CDCl 3 ) δ (ppm) 2.95 (1H, dd, J = 6.0, 13.6
Hz) 3.13 (1H, dd, J = 5.6, 14.0 Hz) 3.95 (1H, d, J
= 6.0 Hz) 4.89-5.02 (1H, m) 5.08-512 (1H, m) 5.87
(1H, dt, J = 2.8, 53.0 Hz) 6.99-7.08 (4H, m) 7.21-
7.59 (8H, m) 7.81-7.86 (2H, m) 8.09-8.15 (2H, m).
【0495】実施例363 N-{(1RS,2RS)-2-ヒドロキシ-2-(2-フェ
ニル-1,3-チアゾール-4-イル)-1-[3-(1,
1,2,2-テトラフルオロエトキシ)ベンジル]エチ
ル}-6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテ
ン-1-カルボキサミド (1RS,2RS)-2-アミノ-1-(2-フェニル-1,
3-チアゾール-4-イル)-3-[3-(1,1,2,2-
テトラフルオロエトキシ)フェニル]-1-プロパノール
(310mg,0.73ミリモル)のアセトニトリル
(10ml)溶液に6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボン酸(132mg,
0.70ミリモル)、1-ヒドロキシベンゾトリアゾー
ル1水和物(112mg,0.73ミリモル)を加え、
最後に1-エチル-3-(3-ジメチルアミノプロピル)カ
ルボジイミド塩酸塩(140mg,0.73ミリモル)
を加え、室温で3日間撹拌した。酢酸エチルで希釈し、
飽和重曹水、水、飽和食塩水で洗浄し、無水硫酸マグネ
シウムで乾燥後、ろ過、減圧濃縮した。残渣をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
5:1、2:1)、その後、再結晶(ヘキサン-酢酸エ
チル)で精製し、N-{(1RS,2RS)-2-ヒドロ
キシ-2-(2-フェニル-1,3-チアゾール-4-イル)-
1-[3-(1,1,2,2-テトラフルオロエトキシ)
ベンジル]エチル}-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド(247m
g,59%)を無色結晶として得た。 mp 137-138℃ 元素分析値C32H28N2O3SF5 として 計算値: C, 64.42; H, 4.73; N, 4.70 実測値: C, 64.34; H, 4.64; N, 4.55 IRνmaxKBr(cm-1): 3265, 1641, 1512, 1304, 1195, 11
221 H-NMR(CDCl3) δ (ppm) 1.96-2.05 (2H, m) 2.12-2.22
(2H, m) 2.64-2.70 (2H, m) 3.00 (1H, dd, J = 6.2,
14.2 Hz) 3.14 (1H, dd, J = 8.6, 13.8 Hz) 4.34 (1H,
d, J = 5.8 Hz) 4.75-4.89 (1H, m) 5.08 (1H, dd, J
= 2.6, 5.4 Hz) 5.88 (1H, dt, J = 3.0, 53.0 Hz) 5.9
4 (1H, dt, J = 5.6, 11.6 Hz) 6.36 (1H,d, J = 11.8
Hz) 6.50 (1H, d, J = 8.0 Hz) 7.04-7.34 (8H, m) 7.4
2-7.47 (3H, m) 7.89-7.93 (2H, m).Example 363 N-{(1RS, 2RS) -2-hydroxy-2- (2-phenyl-1,3-thiazol-4-yl) -1- [3- (1,
1,2,2-tetrafluoroethoxy) benzyl] ethyl} -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (1RS, 2RS) -2-amino-1- (2-phenyl-1 ,
3-thiazol-4-yl) -3- [3- (1,1,2,2-
Tetrafluoroethoxy) phenyl] -1-propanol (310 mg, 0.73 mmol) in acetonitrile (10 ml) was treated with 6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (132 mg,
0.70 mmol), 1-hydroxybenzotriazole monohydrate (112 mg, 0.73 mmol) was added,
Finally, 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (140 mg, 0.73 mmol)
Was added and stirred at room temperature for 3 days. Diluted with ethyl acetate,
The extract was washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
5: 1, 2: 1) and then purified by recrystallization (hexane-ethyl acetate) to give N-{(1RS, 2RS) -2-hydroxy-2- (2-phenyl-1,3-thiazole-4). -Il)-
1- [3- (1,1,2,2-tetrafluoroethoxy)
Benzyl] ethyl} -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (247 m
g, 59%) as colorless crystals. mp 137-138 ° C Elemental analysis: C 32 H 28 N 2 O 3 SF 5 Calculated: C, 64.42; H, 4.73; N, 4.70 Found: C, 64.34; H, 4.64; N, 4.55 IRνmax KBr ( cm -1 ): 3265, 1641, 1512, 1304, 1195, 11
22 1 H-NMR (CDCl 3 ) δ (ppm) 1.96-2.05 (2H, m) 2.12-2.22
(2H, m) 2.64-2.70 (2H, m) 3.00 (1H, dd, J = 6.2,
14.2 Hz) 3.14 (1H, dd, J = 8.6, 13.8 Hz) 4.34 (1H,
d, J = 5.8 Hz) 4.75-4.89 (1H, m) 5.08 (1H, dd, J
= 2.6, 5.4 Hz) 5.88 (1H, dt, J = 3.0, 53.0 Hz) 5.9
4 (1H, dt, J = 5.6, 11.6 Hz) 6.36 (1H, d, J = 11.8
Hz) 6.50 (1H, d, J = 8.0 Hz) 7.04-7.34 (8H, m) 7.4
2-7.47 (3H, m) 7.89-7.93 (2H, m).
【0496】実施例364 N-[(1RS,2SR)-1-(4-tert-ブチルベ
ンジル)-2-(4-フルオロフェニル)-2-ヒドロキシ
エチル]-5-フルオロ-1-ナフトアミド (1RS,2RS)-2-アミノ-3-[4-(tert-ブ
チル)ベンジル]-1-(4-フルオロフェニル)プロパ
ン-1-オール(0.22g,0.70ミリモル)のN,
N-ジメチルホルムアミド(10ml)溶液に5-フルオ
ロナフタレン-1-カルボン酸(122mg,0.64ミ
リモル)、1-ヒドロキシベンゾトリアゾール1水和物
(108mg,0.70ミリモル)を加え、最後に1-
エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド塩酸塩(134mg,0.70ミリモル)を加え、
室温で終夜撹拌した。酢酸エチルで希釈し、飽和重曹
水、水、飽和食塩水で洗浄し、無水硫酸マグネシウムで
乾燥後、ろ過、減圧濃縮した。残渣をシリカゲルカラム
クロマトグラフィー(ヘキサン:酢酸エチル=2:
1)、その後、再結晶(ヘキサン-酢酸エチル)で精製
し、N-[(1RS,2SR)-1-(4-tert-ブチ
ルベンジル)-2-(4-フルオロフェニル)-2-ヒドロ
キシエチル]-5-フルオロ-1-ナフトアミド(153m
g,50%)を無色結晶として得た。 mp 148-149℃ 元素分析値C30H29NO2F2 として 計算値: C, 76.09; H, 6.17; N, 2.96 実測値: C, 76.02; H, 6.16; N, 2.78 IRνmaxKBr(cm-1) : 3267, 1637, 1508, 1412, 1244, 1
2241 H-NMR(CDCl3) δ (ppm) 1.31 (9H, s) 2.73 (1H, dd,
J = 10.8, 14.4 Hz) 3.03 (1H, dd, J = 4.5, 14.4 Hz)
3.82 (1H,d, J = 2.6 Hz) 4.77-4.84 (1H, m) 5.06-5.
08 (1H, m) 5.84 (1H, d, J = 5.6 Hz) 7.04-7.17 (6H,
m) 7.26-7.57 (6H, m) 7.59 (1H, d, J = 5.6 Hz) 8.1
4 (1H, d, J = 5.4 Hz).Example 364 N-[(1RS, 2SR) -1- (4-tert-butylbenzyl) -2- (4-fluorophenyl) -2-hydroxyethyl] -5-fluoro-1-naphthamide (1RS , 2RS) -2-Amino-3- [4- (tert-butyl) benzyl] -1- (4-fluorophenyl) propan-1-ol (0.22 g, 0.70 mmol) N,
To a solution of N-dimethylformamide (10 ml) was added 5-fluoronaphthalene-1-carboxylic acid (122 mg, 0.64 mmol) and 1-hydroxybenzotriazole monohydrate (108 mg, 0.70 mmol). -
Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (134 mg, 0.70 mmol) was added,
Stirred at room temperature overnight. The mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 2:
1) Then, the product was purified by recrystallization (hexane-ethyl acetate) to give N-[(1RS, 2SR) -1- (4-tert-butylbenzyl) -2- (4-fluorophenyl) -2-hydroxyethyl. ] -5-Fluoro-1-naphthamide (153m
g, 50%) as colorless crystals. mp 148-149 ° C. Elemental analysis C 30 H 29 NO 2 F 2 Calculated: C, 76.09; H, 6.17 ; N, 2.96 Found: C, 76.02; H, 6.16 ; N, 2.78 IRνmax KBr (cm - 1 ): 3267, 1637, 1508, 1412, 1244, 1
224 1 H-NMR (CDCl 3 ) δ (ppm) 1.31 (9H, s) 2.73 (1H, dd,
J = 10.8, 14.4 Hz) 3.03 (1H, dd, J = 4.5, 14.4 Hz)
3.82 (1H, d, J = 2.6 Hz) 4.77-4.84 (1H, m) 5.06-5.
08 (1H, m) 5.84 (1H, d, J = 5.6 Hz) 7.04-7.17 (6H,
m) 7.26-7.57 (6H, m) 7.59 (1H, d, J = 5.6 Hz) 8.1
4 (1H, d, J = 5.4 Hz).
【0497】実施例365 N-[(1RS,2SR)-1-(4-tert-ブチルベ
ンジル)-2-(4-フルオロフェニル)-2-ヒドロキシ
エチル]-5-クロロ-1-ナフトアミド (1RS,2RS)-2-アミノ-3-[4-(tert-ブ
チル)ベンジル]-1-(4-フルオロフェニル)プロパ
ン-1-オール(0.34g,1.1ミリモル)のN,N
-ジメチルホルムアミド(10ml)溶液に5-クロロナ
フタレン-1-カルボン酸(208mg,1.0ミリモ
ル)、1-ヒドロキシベンゾトリアゾール1水和物(1
70mg,1.1ミリモル)を加え、最後に1-エチル-
3-(3-ジメチルアミノプロピル)カルボジイミド塩酸
塩(210mg,1.1ミリモル)を加え、室温で終夜
撹拌した。酢酸エチルで希釈し、飽和重曹水、水、飽和
食塩水で洗浄し、無水硫酸マグネシウムで乾燥後、ろ
過、減圧濃縮した。残渣をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=2:1)、その後、
再結晶(ヘキサン-酢酸エチル)で精製し、N-[(1R
S,2SR)-1-(4-tert-ブチルベンジル)-2-
(4-フルオロフェニル)-2-ヒドロキシエチル]-5-
クロロ-1-ナフトアミド(265mg,57%)を無色
結晶として得た。元素分析値C30H29NO2ClF2 として 計算値: C, 73.53; H, 5.97; N, 2.86 実測値: C, 73.68; H, 5.93; N, 2.75 IRνmaxKBr(cm-1) : 3261, 1637, 1508, 1222, 11571 H-NMR(CDCl3) δ (ppm) 1.31 (9H, s) 2.72 (1H, dd,
J = 10.6, 14.2 Hz) 3.03 (1H, dd, J = 4.4, 14.4 Hz)
3.73 (1H, d, J = 3.6 Hz) 4.72-4.86 (1H, m)5.03-5.
07 (1H, m) 5.83 (1H, d, J = 8.4 Hz) 7.01-7.13 (5H,
m) 7.15-7.47 (6H, m) 7.56 (1H, dd, J = 1.0, 7.6 H
z) 7.70 (1H, d, J = 8.8 Hz) 8.31 (1H,d, J = 8.4 H
z).Example 365 N-[(1RS, 2SR) -1- (4-tert-butylbenzyl) -2- (4-fluorophenyl) -2-hydroxyethyl] -5-chloro-1-naphthamide (1RS , 2RS) -2-Amino-3- [4- (tert-butyl) benzyl] -1- (4-fluorophenyl) propan-1-ol (0.34 g, 1.1 mmol) N, N
5-Chloronaphthalene-1-carboxylic acid (208 mg, 1.0 mmol) and 1-hydroxybenzotriazole monohydrate (1
70 mg, 1.1 mmol) and finally 1-ethyl-
3- (3-Dimethylaminopropyl) carbodiimide hydrochloride (210 mg, 1.1 mmol) was added, and the mixture was stirred at room temperature overnight. The mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 2: 1), and then
The product was purified by recrystallization (hexane-ethyl acetate) and N-[(1R
S, 2SR) -1- (4-tert-butylbenzyl) -2-
(4-Fluorophenyl) -2-hydroxyethyl] -5-
Chloro-1-naphthamide (265 mg, 57%) was obtained as colorless crystals. Elemental analysis: C 30 H 29 NO 2 ClF 2 Calculated: C, 73.53; H, 5.97; N, 2.86 Found: C, 73.68; H, 5.93; N, 2.75 IRνmax KBr (cm -1 ): 3261, 1637, 1508, 1222, 1157 1 H-NMR (CDCl 3 ) δ (ppm) 1.31 (9H, s) 2.72 (1H, dd,
J = 10.6, 14.2 Hz) 3.03 (1H, dd, J = 4.4, 14.4 Hz)
3.73 (1H, d, J = 3.6 Hz) 4.72-4.86 (1H, m) 5.03-5.
07 (1H, m) 5.83 (1H, d, J = 8.4 Hz) 7.01-7.13 (5H,
m) 7.15-7.47 (6H, m) 7.56 (1H, dd, J = 1.0, 7.6 H
z) 7.70 (1H, d, J = 8.8 Hz) 8.31 (1H, d, J = 8.4 H
z).
【0498】実施例366 N-[(1RS,2SR)-1-[3-(ネオペンチルオキ
シ)ベンジル]-2-(3-クロロフェニル)-2-ヒドロ
キシエチル]-4-フルオロ-1-ナフトアミド 1) メチル3-(ネオペンチルオキシ)ベンゾエート メチル3-ヒドロキシベンゾエート(7.68g,5
0.5ミリモル)のN,N-ジメチルホルムアミド(1
00ml)溶液に炭酸カリウム(13.96g,101
ミリモル)、ヨウ化ネオペンチル(10g,50.5ミ
リモル)を加え、100℃で終夜撹拌した。酢酸エチル
で希釈し、水、飽和食塩水で洗浄した。無水硫酸マグネ
シウムで乾燥後、ろ過、減圧濃縮した。残渣をシリカゲ
ルカラムクロマトグラフィー(ヘキサン:酢酸エチル=
20:1、10:1)で精製し、メチル3-(ネオペン
チルオキシ)ベンゾエート(4.69g,42%)を無
色透明オイルとして得た。 IRνmaxKBr(cm-1) : 1724, 1601, 1587, 1489, 1477, 1
444, 1400, 1365, 1292,1278, 12241 H-NMR(CDCl3)δ (ppm) 1.04 (9H, s) 3.63 (2H, s) 3.
91 (3H, s) 7.10 (1H, ddd, J = 0.8, 2.6, 8.2 Hz) 7.
32 (1H, t, J = 7.8 Hz) 7.54-7.56 (1H, m) 7.60 (1H,
dt, J = 1.4, 7.8 Hz). 2) 3-(ネオペンチルオキシ)ベンジルアルコール メチル3-(ネオペンチルオキシ)ベンゾエート(4.
51g,20.3ミリモル)のテトラヒドロフラン(1
00ml)溶液に氷冷下で水素化リチウムアルミニウム
(1.93g,50.75ミリモル)を少量ずつ加えて
室温で2時間撹拌した。水(2ml)、15%水酸化ナ
トリウム水溶液(2ml)、水(6ml)を順に氷冷下
でゆっくりと加え、生じた固体をセライトでろ過した。
酢酸エチルでよく洗浄し、ろ液を減圧濃縮した。残渣を
シリカゲルカラムクロマトグラフィー(ヘキサン:酢酸
エチル=5:1)で精製し、3-(ネオペンチルオキ
シ)ベンジルアルコール(3.81g,97%)を無色
透明オイルとして得た。 IRνmaxKBr(cm-1): 3231, 1601, 1585, 1489, 1477, 14
48, 1400, 1363, 1259,11551 H-NMR(CDCl3) δ (ppm) 1.03 (9H, s) 1.81 (1H, br)
3.59 (2H, s) 4.65 (2H,s) 6.80-6.93 (3H, m) 7.25 (1
H, t, J = 7.6 Hz). 3) 6-エチル2-[3-(ネオペンチルオキシ)ベン
ジル]-3-(3-クロロフェニル)-3-オキソプロピオ
ネート 3-(ネオペンチルオキシ)ベンジルアルコール(3.
76g,19.4ミリモル)の酢酸エチル(40ml)
溶液にトリエチルアミン(4.06ml,29.1ミリ
モル)を加え氷冷下でメタンスルホニルクロライド
(1.65ml,21.34ミリモル)を滴下し、その
まま45分間撹拌した。析出した結晶をろ過し、ろ液を
濃縮してメシレートを得た。これはこのまま次の反応に
用いた。エチル3-(3-クロロフェニル)-3-オキソプ
ロピオネート(4.40g,19.4ミリモル)のジメ
トキシエタン(40ml)溶液を氷冷し、水素化ナトリ
ウム(60%,0.78g,19.4ミリモル)を加
え、氷冷下で30分撹拌した後、メシレートのジメトキ
シエタン(30ml)溶液を加え、室温で終夜撹拌し
た。反応終了後、1規定の塩酸でクエンチし、酢酸エチ
ルで希釈し、水、飽和食塩水で洗浄した。無水硫酸マグ
ネシウムで乾燥後、ろ過、減圧濃縮した。残渣をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=15:1、7:1)で精製し、エチル2-[3-(ネオ
ペンチルオキシ)ベンジル]-3-(3-クロロフェニ
ル)-3-オキソプロピオネート(7.11g,91%)
を淡黄色オイルとして得た。 IRνmaxKBr(cm-1) : 1736, 1691, 1585, 1475, 1448, 1
365, 1255, 1226, 11591 H-NMR(CDCl3) δ (ppm) 1.01 (9H, s) 1.14 (3H, t, J
= 7.2 Hz) 3.28 (2H, d, J = 7.4 Hz) 3.52 (2H, s)
4.12 (2H, q, J = 6.8 Hz) 4.55 (1H, t, J = 7.4Hz)
6.69-6.78 (3H, m) 7.11-7.18 (1H, m) 7.33-7.41 (1H,
m) 7.49-7.55 (1H, m) 7.82 (1H, dt, J = 1.0, 7.6 H
z) 7.90-7.92 (1H, m). 4) エチル(2RS,3RS)-2-[3-(ネオペン
チルオキシ)ベンジル]-3-(3-クロロフェニル)-3
-ヒドロキシプロピオネート 塩化亜鉛(4.75g,34.8ミリモル)のエーテル
懸濁液(60ml)に水素化ホウ素ナトリウム(2.6
4g,69.6ミリモル)を室温で加えそのまま2時間
撹拌した。不溶物をろ過し、そのろ液にエチル2-[3-
(ネオペンチルオキシ)ベンジル]-3-(3-クロロフ
ェニル)-3-オキソプロピオネート(2.64g,6
9.6ミリモル)のエーテル(40ml)溶液を加え、
室温で1時間撹拌した。1規定塩酸で反応を終了させ、
酢酸エチルで希釈し、水、飽和食塩水で洗浄した。無水
硫酸マグネシウムで乾燥後、ろ過、減圧濃縮した。残渣
をシリカゲルカラムクロマトグラフィー(ヘキサン:酢
酸エチル=8:1、3:1)で精製し、エチル(2R
S,3RS)-2-[3-(ネオペンチルオキシ)ベンジ
ル]-3-(3-クロロフェニル)-3-ヒドロキシプロピ
オネート(5.82g,81%)を無色透明オイルとし
て得た。 IRνmaxKBr(cm-1) : 3472, 1726, 1599, 1583, 1477, 1
448, 1400, 1257, 11591 H-NMR(CDCl3) δ (ppm) 0.98 (3H, t, J = 7.4 Hz) 1.
01 (9H, s) 2.84-2.99 (3H, m) 3.10 (1H, d, J = 2.4
Hz) 3.93 (2H, q, J = 7.4 Hz) 5.01 (1H, t, J= 3.0 H
z) 6.61-6.72 (3H, m) 7.08-7.15 (1H, m) 7.25-7.28
(3H, m) 7.41 (1H, s). 5) (4RS,5SR)-4-[3-(ネオペンチルオ
キシ)ベンジル]-5-(3-クロロフェニル)-1,3-
オキサゾリジン-2-オン エチル(2RS,3RS)-2-[3-(ネオペンチルオ
キシ)ベンジル]-3-(3-クロロフェニル)-3-ヒド
ロキシプロピオネート(5.71g,14.1ミリモ
ル)のテトラヒドロフラン-エタノール(15ml-15
ml)溶液に室温で2規定の水酸化ナトリウム(15m
l,30ミリモル)を加え、室温で終夜撹拌した。反応
終了後、有機溶媒を減圧留去し、水層を1規定塩酸で酸
性とし、酢酸エチルで抽出した。有機層を無水硫酸マグ
ネシウムで乾燥後、ろ過、減圧濃縮し、無色透明オイル
を得た。上で得たオイルのテトラヒドロフラン(150
ml)溶液にトリエチルアミン(2.95ml,21.
15ミリモル)、ジフェニルリン酸アジド(3.35m
l,15.51ミリモル)を加え、4時間加熱還流し
た。溶媒を留去し、酢酸エチルで希釈し、水,飽和重曹
水、飽和食塩水で洗浄した。有機層を無水硫酸マグネシ
ウムで乾燥後、ろ過、減圧濃縮した。ヘキサン-酢酸エ
チルで再結晶を行い、(4RS,5SR)-4-[3-
(ネオペンチルオキシ)ベンジル]-5-(3-クロロフ
ェニル)-1,3-オキサゾリジン-2-オン(4.15
g,79%)を無色結晶として得た。 mp 141-142℃ IRνmaxKBr(cm-1): 3248, 1763, 1601, 1583, 1477, 14
00, 13631 H-NMR(CDCl3) δ (ppm) 1.02 (9H, s) 2.15 (1H, dd,
J = 10.8, 13.2 Hz) 2.29 (1H, dd, J = 4.2, 14.1 Hz)
3.54 (2H, s) 4.21-4.28 (1H, m) 4.99 (1H, s)5.76
(1H, d, J = 7.8 Hz) 6.57-6.62 (2H, m) 6.76 (1H, d
d, J = 2.1, 7.8 Hz) 7.16-7.21 (1H, m) 7.26-7.28 (1
H, m) 7.34-7.39 (3H, m). 6) (1RS,2SR)-2-アミノ-3-[3-(ネオ
ペンチルオキシ)フェニル]-1-(3-クロロフェニ
ル)-1-プロパノール (4RS,5SR)-4-[3-(ネオペンチルオキシ)
ベンジル]-5-(3-クロロフェニル)-1,3-オキサ
ゾリジン-2-オン(4.0g,10.7ミリモル)のエ
タノール(80ml)溶液に8規定水酸化ナトリウム水
溶液(6.7ml,53.5ミリモル)を加え、5時間
加熱還流した。反応終了後、水で希釈し、酢酸エチルで
抽出した。有機層を合わせ、飽和食塩水で洗浄し、無水
硫酸マグネシウムで乾燥後、ろ過、減圧濃縮した。残渣
を再結晶(ヘキサン-酢酸エチル)で精製し、(1R
S,2SR)-2-アミノ-3-[3-(ネオペンチルオキ
シ)フェニル]-1-(3-クロロフェニル)-1-プロパ
ノール(2.95g,79%)を無色結晶として得た。 mp 115-116℃ IRνmaxKBr(cm-1) : 3300, 1599, 1583, 1477, 1448, 1
400, 1363, 1255, 1159,10531 H-NMR(CDCl3) δ (ppm) 1.02 (9H, s) 2.29 (1H, dd,
J = 10.4, 13.6 Hz) 2.72 (1H, dd, J = 3.0, 13.6 Hz)
3.30 (1H, dt, J = 3.8, 14.4 Hz) 3.55 (2H, s) 4.66
(1H, d, J = 4.8 Hz) 6.67-6.77 (3H, m) 7.14-7.30
(4H, m) 7.41 (1H,s). 7) N-[(1RS,2SR)-1-[3-(ネオペンチ
ルオキシ)ベンジル]-2-(3-クロロフェニル)-2-
ヒドロキシエチル]-4-フルオロ-1-ナフトアミド (1RS,2SR)-2-アミノ-3-[3-(ネオペンチ
ルオキシ)フェニル]-1-(3-クロロフェニル)-1-
プロパノール(0.30g,0.86ミリモル)のN,
N-ジメチルホルムアミド(5ml)溶液に4-フルオロ
ナフタレン-1-カルボン酸(0.17g,0.90ミリ
モル)、1-ヒドロキシベンゾトリアゾール1水和物
(0.138g,0.90ミリモル)を加え、最後に1
-エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド塩酸塩(0.173g,0.90ミリモル)を加
え、室温で終夜撹拌した。酢酸エチルで希釈し、飽和重
曹水、水、飽和食塩水で洗浄し、無水硫酸マグネシウム
で乾燥後、ろ過、減圧濃縮した。残渣を再結晶(ヘキサ
ン-酢酸エチル)で精製し、N-[(1RS,2SR)-
1-[3-(ネオペンチルオキシ)ベンジル]-2-(3-
クロロフェニル)-2-ヒドロキシエチル]-4-フルオロ
-1-ナフトアミド(0.354g,79%)を無色結晶
として得た。 mp 165-166℃ IRνmaxKBr(cm-1): 3263, 1639, 1599, 1583, 1518, 14
77, 1448, 1400, 12591 H-NMR(CDCl3) δ (ppm) 0.99 (9H, s) 2.73 (1H, dd,
J = 11.0, 14.4 Hz) 3.01 (1H, dd, J = 4.0, 14.4 Hz)
3.52 (2H, dd, J = 8.6, 11.4 Hz) 4.17 (1H, br) 4.7
0-4.81 (1H, m) 5.09 (1H, s) 5.87 (1H, d, J = 7.2 H
z) 6.74-6.83 (3H, m) 7.00 (1H, dd, J = 7.6, 9.8 H
z) 7.18-7.36 (5H, m) 7.41-7.57 (3H, m)7.80 (1H, d,
J = 7.6 Hz) 8.07 (1H, d, J = 7.6 Hz).Example 366 N-[(1RS, 2SR) -1- [3- (neopentyloxy) benzyl] -2- (3-chlorophenyl) -2-hydroxyethyl] -4-fluoro-1-naphthamide 1 ) Methyl 3- (neopentyloxy) benzoate Methyl 3-hydroxybenzoate (7.68 g, 5
0.5 mmol) of N, N-dimethylformamide (1
00 ml) solution and potassium carbonate (13.96 g, 101
Mmol) and neopentyl iodide (10 g, 50.5 mmol) were added and stirred at 100 ° C. overnight. The mixture was diluted with ethyl acetate and washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate =
20: 1 and 10: 1) to give methyl 3- (neopentyloxy) benzoate (4.69 g, 42%) as a clear, colorless oil. IRνmax KBr (cm -1 ): 1724, 1601, 1587, 1489, 1477, 1
444, 1400, 1365, 1292,1278, 1224 1 H-NMR (CDCl 3 ) δ (ppm) 1.04 (9H, s) 3.63 (2H, s) 3.
91 (3H, s) 7.10 (1H, ddd, J = 0.8, 2.6, 8.2 Hz) 7.
32 (1H, t, J = 7.8 Hz) 7.54-7.56 (1H, m) 7.60 (1H,
dt, J = 1.4, 7.8 Hz). 2) 3- (neopentyloxy) benzyl alcohol methyl 3- (neopentyloxy) benzoate (4.
51 g, 20.3 mmol) of tetrahydrofuran (1
Lithium aluminum hydride (1.93 g, 50.75 mmol) was added little by little to the solution under ice-cooling, and the mixture was stirred at room temperature for 2 hours. Water (2 ml), a 15% aqueous sodium hydroxide solution (2 ml) and water (6 ml) were slowly added in that order under ice cooling, and the resulting solid was filtered through celite.
After washing well with ethyl acetate, the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 5: 1) to obtain 3- (neopentyloxy) benzyl alcohol (3.81 g, 97%) as a colorless transparent oil. IRνmax KBr (cm -1 ): 3231, 1601, 1585, 1489, 1477, 14
48, 1400, 1363, 1259,1155 1 H-NMR (CDCl 3 ) δ (ppm) 1.03 (9H, s) 1.81 (1H, br)
3.59 (2H, s) 4.65 (2H, s) 6.80-6.93 (3H, m) 7.25 (1
H, t, J = 7.6 Hz). 3) 6-ethyl 2- [3- (neopentyloxy) benzyl] -3- (3-chlorophenyl) -3-oxopropionate 3- (neopentyloxy) benzyl Alcohol (3.
76 g, 19.4 mmol) of ethyl acetate (40 ml)
Triethylamine (4.06 ml, 29.1 mmol) was added to the solution, and methanesulfonyl chloride (1.65 ml, 21.34 mmol) was added dropwise under ice-cooling, followed by stirring for 45 minutes. The precipitated crystals were filtered, and the filtrate was concentrated to obtain mesylate. This was used for the next reaction as it was. A solution of ethyl 3- (3-chlorophenyl) -3-oxopropionate (4.40 g, 19.4 mmol) in dimethoxyethane (40 ml) was ice-cooled and sodium hydride (60%, 0.78 g, 19.30 g). 4 mmol), and the mixture was stirred under ice-cooling for 30 minutes, and then a solution of mesylate in dimethoxyethane (30 ml) was added, followed by stirring at room temperature overnight. After completion of the reaction, the reaction was quenched with 1N hydrochloric acid, diluted with ethyl acetate, and washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 15: 1, 7: 1), and ethyl 2- [3- (neopentyloxy) benzyl] -3- (3-chlorophenyl) -3-oxopro. Pionate (7.11 g, 91%)
Was obtained as a pale yellow oil. IRνmax KBr (cm -1 ): 1736, 1691, 1585, 1475, 1448, 1
365, 1255, 1226, 1159 1 H-NMR (CDCl 3 ) δ (ppm) 1.01 (9H, s) 1.14 (3H, t, J
= 7.2 Hz) 3.28 (2H, d, J = 7.4 Hz) 3.52 (2H, s)
4.12 (2H, q, J = 6.8 Hz) 4.55 (1H, t, J = 7.4Hz)
6.69-6.78 (3H, m) 7.11-7.18 (1H, m) 7.33-7.41 (1H, m
m) 7.49-7.55 (1H, m) 7.82 (1H, dt, J = 1.0, 7.6 H
z) 7.90-7.92 (1H, m). 4) Ethyl (2RS, 3RS) -2- [3- (neopentyloxy) benzyl] -3- (3-chlorophenyl) -3
-Hydroxypropionate Sodium borohydride (2.6) was added to an ether suspension (60 ml) of zinc chloride (4.75 g, 34.8 mmol).
(4 g, 69.6 mmol) at room temperature and stirred for 2 hours. The insolubles were filtered off and the filtrate was added with ethyl 2- [3-
(Neopentyloxy) benzyl] -3- (3-chlorophenyl) -3-oxopropionate (2.64 g, 6
9.6 mmol) in ether (40 ml)
Stirred at room temperature for 1 hour. Terminate the reaction with 1N hydrochloric acid,
The mixture was diluted with ethyl acetate and washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 8: 1, 3: 1) to give ethyl (2R
S, 3RS) -2- [3- (Neopentyloxy) benzyl] -3- (3-chlorophenyl) -3-hydroxypropionate (5.82 g, 81%) was obtained as a colorless transparent oil. IRνmax KBr (cm -1 ): 3472, 1726, 1599, 1583, 1477, 1
448, 1400, 1257, 1159 1 H-NMR (CDCl 3 ) δ (ppm) 0.98 (3H, t, J = 7.4 Hz) 1.
01 (9H, s) 2.84-2.99 (3H, m) 3.10 (1H, d, J = 2.4
Hz) 3.93 (2H, q, J = 7.4 Hz) 5.01 (1H, t, J = 3.0 H
z) 6.61-6.72 (3H, m) 7.08-7.15 (1H, m) 7.25-7.28
(3H, m) 7.41 (1H, s). 5) (4RS, 5SR) -4- [3- (neopentyloxy) benzyl] -5- (3-chlorophenyl) -1,3-
Oxazolidin-2-one Ethyl (2RS, 3RS) -2- [3- (neopentyloxy) benzyl] -3- (3-chlorophenyl) -3-hydroxypropionate (5.71 g, 14.1 mmol) Tetrahydrofuran-ethanol (15ml-15
2N sodium hydroxide (15 m
1, 30 mmol) and stirred at room temperature overnight. After completion of the reaction, the organic solvent was distilled off under reduced pressure, the aqueous layer was acidified with 1N hydrochloric acid, and extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain a colorless transparent oil. The oil obtained above in tetrahydrofuran (150
ml) solution in triethylamine (2.95 ml, 21.
15 mmol), azide diphenylphosphate (3.35 m
1, 15.51 mmol) and heated to reflux for 4 hours. The solvent was distilled off, diluted with ethyl acetate, and washed with water, saturated aqueous sodium hydrogen carbonate and saturated saline. The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. Recrystallization from hexane-ethyl acetate gave (4RS, 5SR) -4- [3-
(Neopentyloxy) benzyl] -5- (3-chlorophenyl) -1,3-oxazolidin-2-one (4.15
g, 79%) as colorless crystals. mp 141-142 ℃ IRνmax KBr (cm -1 ): 3248, 1763, 1601, 1583, 1477, 14
00, 1363 1 H-NMR (CDCl 3 ) δ (ppm) 1.02 (9H, s) 2.15 (1H, dd,
J = 10.8, 13.2 Hz) 2.29 (1H, dd, J = 4.2, 14.1 Hz)
3.54 (2H, s) 4.21-4.28 (1H, m) 4.99 (1H, s) 5.76
(1H, d, J = 7.8 Hz) 6.57-6.62 (2H, m) 6.76 (1H, d
d, J = 2.1, 7.8 Hz) 7.16-7.21 (1H, m) 7.26-7.28 (1
H, m) 7.34-7.39 (3H, m). 6) (1RS, 2SR) -2-amino-3- [3- (neopentyloxy) phenyl] -1- (3-chlorophenyl) -1-propanol ( 4RS, 5SR) -4- [3- (neopentyloxy)
Benzyl] -5- (3-chlorophenyl) -1,3-oxazolidin-2-one (4.0 g, 10.7 mmol) in ethanol (80 ml) was treated with an 8N aqueous sodium hydroxide solution (6.7 ml, 53.50 ml). (5 mmol) and heated under reflux for 5 hours. After completion of the reaction, the reaction mixture was diluted with water and extracted with ethyl acetate. The organic layers were combined, washed with saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate), and (1R
(S, 2SR) -2-Amino-3- [3- (neopentyloxy) phenyl] -1- (3-chlorophenyl) -1-propanol (2.95 g, 79%) was obtained as colorless crystals. mp 115-116 ℃ IRνmax KBr (cm -1 ): 3300, 1599, 1583, 1477, 1448, 1
400, 1363, 1255, 1159,1053 1 H-NMR (CDCl 3 ) δ (ppm) 1.02 (9H, s) 2.29 (1H, dd,
J = 10.4, 13.6 Hz) 2.72 (1H, dd, J = 3.0, 13.6 Hz)
3.30 (1H, dt, J = 3.8, 14.4 Hz) 3.55 (2H, s) 4.66
(1H, d, J = 4.8 Hz) 6.67-6.77 (3H, m) 7.14-7.30
(4H, m) 7.41 (1H, s). 7) N-[(1RS, 2SR) -1- [3- (neopentyloxy) benzyl] -2- (3-chlorophenyl) -2-
Hydroxyethyl] -4-fluoro-1-naphthamide (1RS, 2SR) -2-amino-3- [3- (neopentyloxy) phenyl] -1- (3-chlorophenyl) -1-
N in propanol (0.30 g, 0.86 mmol)
To a solution of N-dimethylformamide (5 ml) was added 4-fluoronaphthalene-1-carboxylic acid (0.17 g, 0.90 mmol) and 1-hydroxybenzotriazole monohydrate (0.138 g, 0.90 mmol). And finally one
-Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.173 g, 0.90 mmol) was added, and the mixture was stirred at room temperature overnight. The mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate), and N-[(1RS, 2SR)-
1- [3- (neopentyloxy) benzyl] -2- (3-
Chlorophenyl) -2-hydroxyethyl] -4-fluoro
-1-Naphthamide (0.354 g, 79%) was obtained as colorless crystals. mp 165-166 ° C IRνmax KBr (cm -1 ): 3263, 1639, 1599, 1583, 1518, 14
77, 1448, 1400, 1259 1 H-NMR (CDCl 3 ) δ (ppm) 0.99 (9H, s) 2.73 (1H, dd,
J = 11.0, 14.4 Hz) 3.01 (1H, dd, J = 4.0, 14.4 Hz)
3.52 (2H, dd, J = 8.6, 11.4 Hz) 4.17 (1H, br) 4.7
0-4.81 (1H, m) 5.09 (1H, s) 5.87 (1H, d, J = 7.2 H
z) 6.74-6.83 (3H, m) 7.00 (1H, dd, J = 7.6, 9.8 H
z) 7.18-7.36 (5H, m) 7.41-7.57 (3H, m) 7.80 (1H, d,
J = 7.6 Hz) 8.07 (1H, d, J = 7.6 Hz).
【0499】実施例367 N-[(1RS,2SR)-1-[3-(ネオペンチルオキ
シ)ベンジル]-2-(3-クロロフェニル)-2-ヒドロ
キシエチル]-5-クロロ-1-ナフトアミド (1RS,2SR)-2-アミノ-3-[3-(ネオペンチ
ルオキシ)フェニル]-1-(3-クロロフェニル)-1-
プロパノール(0.30g,0.86ミリモル)のN,
N-ジメチルホルムアミド(5ml)溶液に5-クロロナ
フタレン-1-カルボン酸(0.186g,0.90ミリ
モル)、1-ヒドロキシベンゾトリアゾール1水和物
(0.138g,0.90ミリモル)を加え、最後に1
-エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド塩酸塩(0.173g,0.90ミリモル)を加
え、室温で終夜撹拌した。酢酸エチルで希釈し、飽和重
曹水、水、飽和食塩水で洗浄し、無水硫酸マグネシウム
で乾燥後、ろ過、減圧濃縮した。残渣を再結晶(ヘキサ
ン-酢酸エチル)で精製し、N-[(1RS,2SR)-
1-[3-(ネオペンチルオキシ)ベンジル]-2-(3-
クロロフェニル)-2-ヒドロキシエチル]-5-クロロ-
1-ナフトアミド(0.350g,76%)を無色結晶
として得た。 mp 142-143℃ IRνmaxKBr(cm-1) : 3252, 1637, 1518, 1477, 1448, 1
398, 1363, 1255, 1159,1059, 10221 H-NMR(CDCl3) δ (ppm) 0.99 (9H, s) 2.71 (1H, dd,
J = 11.0, 14.4 Hz) 2.98 (1H, dd, J = 4.2, 14.4 Hz)
3.51 (2H, dd, J = 8.8, 11.6 Hz) 4.05 (1H, br) 4.7
0-4.79 (1H, m) 5.04 (1H, d, J = 3.4 Hz) 5.97 (1H,
d, J = 7.6 Hz) 6.72-6.81 (3H, m) 7.16-7.62 (10H,
m) 8.28 (1H, d, J = 8.4 Hz).Example 367 N-[(1RS, 2SR) -1- [3- (neopentyloxy) benzyl] -2- (3-chlorophenyl) -2-hydroxyethyl] -5-chloro-1-naphthamide ( 1RS, 2SR) -2-amino-3- [3- (neopentyloxy) phenyl] -1- (3-chlorophenyl) -1-
N in propanol (0.30 g, 0.86 mmol)
To a solution of N-dimethylformamide (5 ml) was added 5-chloronaphthalene-1-carboxylic acid (0.186 g, 0.90 mmol) and 1-hydroxybenzotriazole monohydrate (0.138 g, 0.90 mmol). And finally one
-Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.173 g, 0.90 mmol) was added, and the mixture was stirred at room temperature overnight. The mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate), and N-[(1RS, 2SR)-
1- [3- (neopentyloxy) benzyl] -2- (3-
Chlorophenyl) -2-hydroxyethyl] -5-chloro-
1-Naphthamide (0.350 g, 76%) was obtained as colorless crystals. mp 142-143 ℃ IRνmax KBr (cm -1 ): 3252, 1637, 1518, 1477, 1448, 1
398, 1363, 1255, 1159,1059, 1022 1 H-NMR (CDCl 3 ) δ (ppm) 0.99 (9H, s) 2.71 (1H, dd,
J = 11.0, 14.4 Hz) 2.98 (1H, dd, J = 4.2, 14.4 Hz)
3.51 (2H, dd, J = 8.8, 11.6 Hz) 4.05 (1H, br) 4.7
0-4.79 (1H, m) 5.04 (1H, d, J = 3.4 Hz) 5.97 (1H, m
d, J = 7.6 Hz) 6.72-6.81 (3H, m) 7.16-7.62 (10H,
m) 8.28 (1H, d, J = 8.4 Hz).
【0500】実施例368 N-[(1RS,2SR)-1-[3-(ネオペンチルオキ
シ)ベンジル]-2-(3-クロロフェニル)-2-ヒドロ
キシエチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド (1RS,2SR)-2-アミノ-3-[3-(ネオペンチ
ルオキシ)フェニル]-1-(3-クロロフェニル)-1-
プロパノール(0.40g,0.86ミリモル)のN,
N-ジメチルホルムアミド(5ml)溶液に6,7-ジヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボン酸
(0.17g,0.90ミリモル)、1-ヒドロキシベ
ンゾトリアゾール1水和物(0.138g,0.90ミ
リモル)を加え、最後に1-エチル-3-(3-ジメチルア
ミノプロピル)カルボジイミド塩酸塩(0.173g,
0.90ミリモル)を加え、室温で終夜撹拌した。酢酸
エチルで希釈し、飽和重曹水、水、飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後、ろ過、減圧濃縮し
た。残渣をシリカゲルカラムクロマトグラフィー(ヘキ
サン:酢酸エチル=1:1、0:1)、その後、再結晶
(ヘキサン-酢酸エチル)で精製し、N-[(1RS,2
SR)-1-[3-(ネオペンチルオキシ)ベンジル]-2
-(3-クロロフェニル)-2-ヒドロキシエチル]-6,
7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カ
ルボキサミド(0.174g,39%)を無色結晶とし
て得た。 mp 128-129℃ IRνmaxKBr(cm-1): 3265, 1633, 1599, 1585, 1514, 14
77, 1450, 1363, 1255,11591 H-NMR(CDCl3)δ (ppm) 1.01 (9H, s) 1.99-2.01 (1H,
m) 2.14-2.20 (1H, m) 2.63-2.73 (3H, m) 2.94 (1H, d
d, J = 3.8, 13.6 Hz) 3.54 (2H, s) 4.33 (1H,d, J =
4.4 Hz) 4.65 (1H, m) 5.03 (1H, br) 5.71 (1H, d, J
= 6.6 Hz) 5.90-6.01 (1H, m) 6.26 (1H, d, J = 11.6
Hz) 6.71-6.78 (3H, m) 7.02-7.30 (7H,m).Example 368 N-[(1RS, 2SR) -1- [3- (neopentyloxy) benzyl] -2- (3-chlorophenyl) -2-hydroxyethyl] -6,7-dihydro-5H- Benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-3- [3- (neopentyloxy) phenyl] -1- (3-chlorophenyl) -1-
N in propanol (0.40 g, 0.86 mmol)
6,7-Dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (0.17 g, 0.90 mmol) and 1-hydroxybenzotriazole monohydrate (0.1 ml) in N-dimethylformamide (5 ml) solution. 138 g, 0.90 mmol) and finally 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.173 g,
0.90 mmol) and stirred at room temperature overnight. The mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1, 0: 1) and then recrystallized (hexane-ethyl acetate) to give N-[(1RS, 2
SR) -1- [3- (Neopentyloxy) benzyl] -2
-(3-chlorophenyl) -2-hydroxyethyl] -6
7-Dihydro-5H-benzo [a] cycloheptene-1-carboxamide (0.174 g, 39%) was obtained as colorless crystals. mp 128-129 ° C IRνmax KBr (cm -1 ): 3265, 1633, 1599, 1585, 1514, 14
77, 1450, 1363, 1255,1159 1 H-NMR (CDCl 3 ) δ (ppm) 1.01 (9H, s) 1.99-2.01 (1H,
m) 2.14-2.20 (1H, m) 2.63-2.73 (3H, m) 2.94 (1H, d
d, J = 3.8, 13.6 Hz) 3.54 (2H, s) 4.33 (1H, d, J =
4.4 Hz) 4.65 (1H, m) 5.03 (1H, br) 5.71 (1H, d, J
= 6.6 Hz) 5.90-6.01 (1H, m) 6.26 (1H, d, J = 11.6
(Hz) 6.71-6.78 (3H, m) 7.02-7.30 (7H, m).
【0501】実施例369 N-[(1RS,2SR)-1-[3-(tert-ブチ
ル)ベンジル]-2-(3-クロロフェニル)-2-ヒドロ
キシエチル]-4-フルオロ-1-ナフトアミド 1) 3-tert-ブチルフェニルトリフルオロメタン
スルホネート 3-tert-ブチルフェノールl(15g,100ミリ
モル)のジクロロメタン(300ml)溶液にN-エチ
ルジイソプロピルアミン(17.5ml,100ミリモ
ル)、N-フェニルトリフルオロメタンスルホンイミド
(44.7g,125ミリモル)を加え、室温で終夜撹
拌した。ジクロロメタンを減圧留去し、酢酸エチルで希
釈し、水、飽和食塩水で洗浄した。無水硫酸マグネシウ
ムで乾燥後、ろ過、減圧濃縮した。残渣をシリカゲルカ
ラムクロマトグラフィー(ヘキサン:酢酸エチル=3
0:1)で精製し、3-tert-ブチルフェニルトリフ
ルオロメタンスルホネート(7.17g,25%)を無
色透明オイルとして得た。 IRνmaxKBr(cm-1): 1612, 1577, 1489, 1423, 1246, 12
15, 1145, 9251 H-NMR(CDCl3) δ (ppm) 1.33 (9H, s) 7.06-7.10 (1H,
m) 7.24-7.25 (1H, m)7.33-7.42 (2H, m). 2) 3-tert-ブチルベンジルベンゾニトリル 3-tert-ブチルフェニルトリフルオロメタンスルホ
ネート(6.17g,21.9ミリモル)のアセトニト
リル(80ml)溶液にシアン化ナトリウム(2.15
g,43.8ミリモル)、ヨウ化銅(0.42g,2.
19ミリモル)を加え、窒素気流下でテトラキス(トリ
フェニルホスフィン)パラジウム(1.27g,1.1
0ミリモル)を加え、5時間加熱還流した。酢酸エチル
で希釈後、不溶物をセライトでろ過し、ろ液を水、飽和
食塩水で洗浄した。無水硫酸マグネシウムで乾燥後、ろ
過、減圧濃縮した。残渣をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:エーテル=1:0、20:1)、
で精製し、3-tert-ブチルベンジルベンゾニトリル
(4.13g)を無色透明オイルとして得た。このもの
は不純物を含んでいるが、そのまま次の反応に用いた。 IRνmaxKBr(cm-1) : 2229, 1599, 1579, 1485, 1417, 1
365, 1273, 11131 H-NMR(CDCl3) δ(ppm) 1.32 (9H, s) 7.33-7.35 (2H,
m) 7.39-7.50 (1H, m) 7.60-7.66 (1H, m). 3) 3-tert-ブチル安息香酸 3-tert-ブチルベンジルベンゾニトリル(4.13
g,21.9ミリモル)の水(80ml)懸濁液に水酸
化ナトリウム(2.19g,54.8ミリモル)を加え
て終夜加熱還流した。反応終了後、水で希釈し、エーテ
ルで水層を洗浄した。次いで、この水層を6規定の塩酸
で酸性とし、酢酸エチルで抽出した。あわせた有機層を
飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥後、
ろ過、減圧濃縮し、3-tert-ブチル安息香酸(3.
23g,83%in2steps)を無色結晶として得
た。 mp 96-97℃ IRνmaxKBr(cm-1): 2500-3300, 1693, 1604, 1585, 144
0, 1412, 1286, 12591 H-NMR(CDCl3) δ (ppm) : 1.36 (9H, s) 7.41 (1H, t,
J = 7.5 Hz) 7.65 (1H,ddd, J = 1.5, 2.1, 7.8 Hz)
7.94 (1H, dt, J = 1.5, 7.8 Hz) 8.16 (1H, t,J = 1.8
Hz). 4) 3-tert-ブチルベンジルアルコール 水素化リチウムアルミニウム(1.38g,36.2ミ
リモル)のエーテル懸濁液(40ml)に3-tert-
ブチル安息香酸(3.13g,17.6ミリモル)のエ
ーテル(40m)溶液を氷冷下で滴下し、室温で2時間
撹拌した。反応終了後、水(1.38ml)、15%水
酸化ナトリウム水溶液(1.38ml)、水(4.2m
l)を順にゆっくりと氷冷下で滴下した。生じた固体を
セライトでろ過し、酢酸エチルで洗浄した。ろ液を濃縮
し、残渣をシリカゲルカラムクロマトグラフィー(ヘキ
サン:酢酸エチル=8:1、4:1)で精製し、3-t
ert-ブチルベンジルアルコール(2.59g,90
%)を無色透明オイルとして得た。 IRνmaxKBr(cm-1): 3277, 1606, 1489, 1363, 1275, 12
03, 10161 H-NMR(CDCl3) δ(ppm) 1.32 (9H, s) 1.85 (1H, s) 4.
66 (2H, s) 7.14-7.19 (1H, m) 7.29-7.38 (3H, m). 5) エチル2-[3-(tert-ブチル)ベンジル]-
3-(3-クロロフェニル)-3-オキソプロピオネート 3-tert-ブチルベンジルアルコール(2.50g,
15.2ミリモル)の酢酸エチル(30ml)溶液にト
リエチルアミン(3.18ml,22.8ミリモル)を
加え氷冷下でメタンスルホニルクロライド(1.29m
l,16.72ミリモル)を滴下し、そのまま1時間撹
拌した。析出した結晶をろ過し、ろ液を濃縮してメシレ
ートを得た。これはこのまま次の反応に用いた。エチル
3-(3-クロロフェニル)-3-オキソプロピオネート
(3.45g,15.2ミリモル)のジメトキシエタン
(30ml)溶液を氷冷し、水素化ナトリウム(60
%,0.61g,15.2ミリモル)を加え、氷冷下で
30分撹拌した後、メシレートのジメトキシエタン(2
5ml)溶液を加え、室温で終夜撹拌した。反応終了
後、1規定の塩酸でクエンチし、酢酸エチルで希釈し、
水、飽和食塩水で洗浄した。無水硫酸マグネシウムで乾
燥後、ろ過、減圧濃縮した。残渣をシリカゲルカラムク
ロマトグラフィー(ヘキサン:酢酸エチル=10:1、
8:1)で精製し、エチル2-[3-(tert-ブチ
ル)ベンジル]-3-(3-クロロフェニル)-3-オキソ
プロピオネート(5.01g,88%)を淡黄色オイル
として得た。 IRνmaxKBr(cm-1) : 1739, 1691, 1572, 1475, 1423, 1
365, 12281 H-NMR(CDCl3) δ (ppm) 1.13 (3H, t, J = 7.0 Hz) 1.
25 (9H, s) 3.32 (2H, dd, J = 2.2, 7.8 Hz) 4.12 (2
H, dq, J = 1.8, 7.4 Hz) 4.55 (1H, t, J = 7.4Hz) 6.
98-7.03 (1H, m) 7.18-7.21 (3H, m) 7.29-7.39 (1H,
m) 7.48-7.53 (1H,m) 7.77 (1H, dt, J = 1.6, 7.8 Hz)
7.85-7.87 (1H, m). 6) エチル(2RS,3RS)-2-[3-(tert-
ブチル)ベンジル]-3-(3-クロロフェニル)-3-ヒ
ドロキシプロピオネート 塩化亜鉛(3.60g,26.4ミリモル)のエーテル
懸濁液(50ml)に水素化ホウ素ナトリウム(2.0
g,52.8ミリモル)を室温で加えそのまま2時間撹
拌した。不溶物をろ過し、そのろ液にエチル2-[3-
(tert-ブチル)ベンジル]-3-(3-クロロフェニ
ル)-3-オキソプロピオネート(4.91g,13.2
ミリモル)のエーテル(40ml)溶液を加え、室温で
1時間撹拌した。1規定塩酸で反応を終了させ、酢酸エ
チルで希釈し、水、飽和食塩水で洗浄した。無水硫酸マ
グネシウムで乾燥後、ろ過、減圧濃縮した。残渣をシリ
カゲルカラムクロマトグラフィー(ヘキサン:酢酸エチ
ル=10:1、3:1)で精製し、エチル(2RS,3
RS)-2-[3-(tert-ブチル)ベンジル]-3-
(3-クロロフェニル)-3-ヒドロキシプロピオネート
(4.16g,82%)を無色透明オイルとして得た。 IRνmaxKBr(cm-1): 3456, 1728, 1599, 1477, 1373, 13
46, 1180, 10321 H-NMR(CDCl3) δ (ppm) 0.92 (3H, t, J = 7.0 Hz) 1.
27 (9H, s) 2.88-3.02 (3H, m) 3.14 (1H, d, J = 3.0
Hz) 3.88 (2H, q, J = 7.4 Hz) 4.99-5.01 (1H,m) 6.86
-6.91 (1H, m) 7.07 (1H, s) 7.15-7.18 (2H, m) 7.25-
7.27 (3H, m) 7.41 (1H, s). 7) (4RS,5SR)-4-[3-(tert-ブチ
ル)ベンジル]-5-(3-クロロフェニル)-1,3-オ
キサゾリジン-2-オン エチル(2RS,3RS)-2-[3-(tert-ブチ
ル)ベンジル]-3-(3-クロロフェニル)-3-ヒドロ
キシプロピオネート(4.05g,10.8ミリモル)
のテトラヒドロフラン-エタノール(10ml-10m
l)溶液に室温で2規定の水酸化ナトリウム(11m
l,22ミリモル)を加え、室温で終夜撹拌した。反応
終了後、有機溶媒を減圧留去し、水層を1規定塩酸で酸
性とし、酢酸エチルで抽出した。有機層を無水硫酸マグ
ネシウムで乾燥後、ろ過、減圧濃縮し、無色透明オイル
を得た。上で得たオイルのテトラヒドロフラン(100
ml)溶液にトリエチルアミン(2.26ml,16.
2ミリモル)、ジフェニルリン酸アジド(2.56m
l,11.88ミリモル)を加え、4時間加熱還流し
た。溶媒を留去し、酢酸エチルで希釈し、水,飽和重曹
水、飽和食塩水で洗浄した。有機層を無水硫酸マグネシ
ウムで乾燥後、ろ過、減圧濃縮した。ヘキサン-酢酸エ
チルで再結晶を行い、(4RS,5SR)-4-[3-
(tert-ブチル)ベンジル]-5-(3-クロロフェニ
ル)-1,3-オキサゾリジン-2-オン(2.47g,6
0%)を無色結晶として得た。 mp 136-137℃ IRνmaxKBr(cm-1): 3263, 1763, 1601, 1477, 1433, 13
63, 12341 H-NMR(CDCl3) δ (ppm) 1.28 (9H, s) 2.20 (1H, dd,
J = 11.1, 13.8 Hz) 2.32 (1H, dd, J = 3.9, 13.8 Hz)
4.23-4.30 (1H, m) 4.99 (1H, s) 5.77 (1H, d,J = 8.
1 Hz) 6.85 (1H, d, J = 7.2 Hz) 7.01 (1H, s) 7.19-
7.31 (3H, m) 7.34-7.40 (3H, m). 8) (1RS,2SR)-2-アミノ-3-[3-(te
rt-ブチル)フェニル]-1-(3-クロロフェニル)-
1-プロパノール (4RS,5SR)-4-[3-(tert-ブチル)ベン
ジル]-5-(3-クロロフェニル)-1,3-オキサゾリ
ジン-2-オン(2.36g,6.86ミリモル)のエタ
ノール(60ml)溶液に8規定水酸化ナトリウム水溶
液(4.3ml,34.3ミリモル)を加え、5時間加
熱還流した。反応終了後、エタノールを減圧留去した
後、水で希釈し、酢酸エチルで抽出した。有機層を合わ
せ、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後、ろ過、減圧濃縮した。残渣を再結晶(ヘキサン-酢
酸エチル)で精製し、(1RS,2SR)-2-アミノ-
3-[3-(tert-ブチル)フェニル]-1-(3-クロ
ロフェニル)-1-プロパノール(1.21g,55%)
を無色結晶として得た。 mp 102-103℃ IRνmaxKBr(cm-1) : 3063, 1597, 1576, 1476, 1429, 1
363, 11991H-NMR(CDCl3) δ (ppm) 1.30 (9H, s) 2.32
(1H, dd, J = 10.4, 13.6 Hz) 2.75 (1H, dd, J = 3.2,
13.8 Hz) 3.31 (1H, dt, J = 4.0, 9.6 Hz) 4.68 (1H,
d,J = 4.8 Hz) 6.94-6.96 (1H, m) 7.13 (1H, s) 7.21
-7.31 (5H, m) 7.42 (1H,s) 9) N-[(1RS,2SR)-1-[3-(tert-
ブチル)ベンジル]-2-(3-クロロフェニル)-2-ヒ
ドロキシエチル]-4-フルオロ-1-ナフトアミド (1RS,2SR)-2-アミノ-3-[3-(tert-ブ
チル)フェニル]-1-(3-クロロフェニル)-1-プロ
パノール(0.30g,0.944ミリモル)のN,N
-ジメチルホルムアミド(5ml)溶液に4-フルオロナ
フタレン-1-カルボン酸(0.189g,0.99ミリ
モル)、1-ヒドロキシベンゾトリアゾール1水和物
(0.152g,0.99ミリモル)を加え、最後に1
-エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド塩酸塩(0.190g,0.99ミリモル)を加
え、室温で終夜撹拌した。酢酸エチルで希釈し、飽和重
曹水、水、飽和食塩水で洗浄し、無水硫酸マグネシウム
で乾燥後、ろ過、減圧濃縮した。残渣をシリカゲルカラ
ムクロマトグラフィー(ヘキサン:酢酸エチル=1:
1、0:1)、その後、再結晶(ヘキサン-酢酸エチ
ル)で精製し、N-[(1RS,2SR)-1-[3-(t
ert-ブチル)ベンジル]-2-(3-クロロフェニル)
-2-ヒドロキシエチル]-4-フルオロ-1-ナフトアミド
(0.245g,53%)を無色結晶として得た。 mp 76-78℃ IRνmaxKBr(cm-1) : 3312, 1639, 1599, 1516, 1425, 1
261, 1236, 1201, 10511 H-NMR(CDCl3) δ (ppm) 0.99 (9H, s) 2.73 (1H, dd,
J = 11.0, 14.4 Hz) 3.01 (1H, dd, J = 4.0, 14.4 Hz)
3.52 (2H, dd, J = 8.6, 11.4 Hz) 4.17 (1H, br) 4.7
0-4.81 (1H, m) 5.09 (1H, s) 5.87 (1H, d, J = 7.2 H
z) 6.74-6.83 (3H, m) 7.00 (1H, dd, J = 7.6, 9.8 H
z) 7.18-7.36 (5H, m) 7.41-7.57 (3H, m)7.80 (1H, d,
J = 7.6 Hz) 8.07 (1H, d, J = 7.6 Hz).Example 369 N-[(1RS, 2SR) -1- [3- (tert-butyl) benzyl] -2- (3-chlorophenyl) -2-hydroxyethyl] -4-fluoro-1-naphthamide 1 3-tert-butylphenyltrifluoromethanesulfonate N-ethyldiisopropylamine (17.5 ml, 100 mmol) in a solution of 3-tert-butylphenol 1 (15 g, 100 mmol) in dichloromethane (300 ml), N-phenyltrifluoromethanesulfonimide (44.7 g, 125 mmol) and stirred at room temperature overnight. The dichloromethane was distilled off under reduced pressure, diluted with ethyl acetate, and washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 3
0: 1) to give 3-tert-butylphenyltrifluoromethanesulfonate (7.17 g, 25%) as a clear, colorless oil. IRνmax KBr (cm -1 ): 1612, 1577, 1489, 1423, 1246, 12
15, 1145, 925 1 H-NMR (CDCl 3 ) δ (ppm) 1.33 (9H, s) 7.06-7.10 (1H,
m) 7.24-7.25 (1H, m) 7.33-7.42 (2H, m). 2) 3-tert-butylbenzylbenzonitrile acetonitrile of 3-tert-butylphenyltrifluoromethanesulfonate (6.17 g, 21.9 mmol) (80 ml) solution in sodium cyanide (2.15
g, 43.8 mmol), copper iodide (0.42 g, 2.
19 mmol) and tetrakis (triphenylphosphine) palladium (1.27 g, 1.1) under a nitrogen stream.
(0 mmol) and heated to reflux for 5 hours. After dilution with ethyl acetate, insolubles were filtered through celite, and the filtrate was washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ether = 1: 0, 20: 1),
To give 3-tert-butylbenzylbenzonitrile (4.13 g) as a colorless transparent oil. Although this substance contained impurities, it was used for the next reaction as it was. IRνmax KBr (cm -1 ): 2229, 1599, 1579, 1485, 1417, 1
365, 1273, 1113 1 H-NMR (CDCl 3 ) δ (ppm) 1.32 (9H, s) 7.33-7.35 (2H,
m) 7.39-7.50 (1H, m) 7.60-7.66 (1H, m). 3) 3-tert-butylbenzoic acid 3-tert-butylbenzylbenzonitrile (4.13
g, 21.9 mmol) in water (80 ml) was added with sodium hydroxide (2.19 g, 54.8 mmol) and heated under reflux overnight. After completion of the reaction, the reaction mixture was diluted with water, and the aqueous layer was washed with ether. Then, the aqueous layer was acidified with 6N hydrochloric acid and extracted with ethyl acetate. The combined organic layer was washed with saturated saline, dried over anhydrous magnesium sulfate,
After filtration and concentration under reduced pressure, 3-tert-butylbenzoic acid (3.
23 g, 83% in 2 steps) were obtained as colorless crystals. mp 96-97 ℃ IRνmax KBr (cm -1 ): 2500-3300, 1693, 1604, 1585, 144
0, 1412, 1286, 1259 1 H-NMR (CDCl 3 ) δ (ppm): 1.36 (9H, s) 7.41 (1H, t,
J = 7.5 Hz) 7.65 (1H, ddd, J = 1.5, 2.1, 7.8 Hz)
7.94 (1H, dt, J = 1.5, 7.8 Hz) 8.16 (1H, t, J = 1.8
4) 3-tert-butylbenzyl alcohol A solution of lithium aluminum hydride (1.38 g, 36.2 mmol) in ether suspension (40 ml) was 3-tert-butylbenzyl alcohol.
A solution of butylbenzoic acid (3.13 g, 17.6 mmol) in ether (40 m) was added dropwise under ice-cooling, and the mixture was stirred at room temperature for 2 hours. After completion of the reaction, water (1.38 ml), 15% aqueous sodium hydroxide solution (1.38 ml), water (4.2 m)
1) was slowly added dropwise under ice-cooling. The resulting solid was filtered through celite and washed with ethyl acetate. The filtrate was concentrated, and the residue was purified by silica gel column chromatography (hexane: ethyl acetate = 8: 1, 4: 1) to give 3-t
tert-butylbenzyl alcohol (2.59 g, 90
%) As a clear, colorless oil. IRνmax KBr (cm -1 ): 3277, 1606, 1489, 1363, 1275, 12
03, 1016 1 H-NMR (CDCl 3 ) δ (ppm) 1.32 (9H, s) 1.85 (1H, s) 4.
66 (2H, s) 7.14-7.19 (1H, m) 7.29-7.38 (3H, m). 5) Ethyl 2- [3- (tert-butyl) benzyl]-
3- (3-chlorophenyl) -3-oxopropionate 3-tert-butylbenzyl alcohol (2.50 g,
Triethylamine (3.18 ml, 22.8 mmol) was added to a solution of 15.2 mmol) in ethyl acetate (30 ml), and methanesulfonyl chloride (1.29 mmol) was added under ice-cooling.
1, 16.72 mmol) was added dropwise, followed by stirring for 1 hour. The precipitated crystals were filtered, and the filtrate was concentrated to obtain mesylate. This was used for the next reaction as it was. A solution of ethyl 3- (3-chlorophenyl) -3-oxopropionate (3.45 g, 15.2 mmol) in dimethoxyethane (30 ml) was cooled on ice, and sodium hydride (60 ml) was added.
%, 0.61 g, 15.2 mmol), and the mixture was stirred under ice-cooling for 30 minutes, and then dimethoxyethane of mesylate (2
5 ml) solution and stirred at room temperature overnight. After completion of the reaction, the reaction is quenched with 1N hydrochloric acid, diluted with ethyl acetate,
Washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 10: 1,
8: 1) to give ethyl 2- [3- (tert-butyl) benzyl] -3- (3-chlorophenyl) -3-oxopropionate (5.01 g, 88%) as a pale yellow oil. Was. IRνmax KBr (cm -1 ): 1739, 1691, 1572, 1475, 1423, 1
365, 1228 1 H-NMR (CDCl 3 ) δ (ppm) 1.13 (3H, t, J = 7.0 Hz) 1.
25 (9H, s) 3.32 (2H, dd, J = 2.2, 7.8 Hz) 4.12 (2
H, dq, J = 1.8, 7.4 Hz) 4.55 (1H, t, J = 7.4Hz) 6.
98-7.03 (1H, m) 7.18-7.21 (3H, m) 7.29-7.39 (1H, m
m) 7.48-7.53 (1H, m) 7.77 (1H, dt, J = 1.6, 7.8 Hz)
7.85-7.87 (1H, m). 6) Ethyl (2RS, 3RS) -2- [3- (tert-
Butyl) benzyl] -3- (3-chlorophenyl) -3-hydroxypropionate Sodium borohydride (2.0 ml) was added to an ether suspension (50 ml) of zinc chloride (3.60 g, 26.4 mmol).
g, 52.8 mmol) at room temperature and stirred for 2 hours. The insolubles were filtered off and the filtrate was added with ethyl 2- [3-
(Tert-butyl) benzyl] -3- (3-chlorophenyl) -3-oxopropionate (4.91 g, 13.2)
(Mmol) was added and the mixture was stirred at room temperature for 1 hour. The reaction was terminated with 1N hydrochloric acid, diluted with ethyl acetate, and washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1, 3: 1) to give ethyl (2RS, 3
RS) -2- [3- (tert-butyl) benzyl] -3-
(3-Chlorophenyl) -3-hydroxypropionate (4.16 g, 82%) was obtained as a clear, colorless oil. IRνmax KBr (cm -1 ): 3456, 1728, 1599, 1477, 1373, 13
46, 1180, 1032 1 H-NMR (CDCl 3 ) δ (ppm) 0.92 (3H, t, J = 7.0 Hz) 1.
27 (9H, s) 2.88-3.02 (3H, m) 3.14 (1H, d, J = 3.0
Hz) 3.88 (2H, q, J = 7.4 Hz) 4.99-5.01 (1H, m) 6.86
-6.91 (1H, m) 7.07 (1H, s) 7.15-7.18 (2H, m) 7.25-
7.27 (3H, m) 7.41 (1H, s). 7) (4RS, 5SR) -4- [3- (tert-butyl) benzyl] -5- (3-chlorophenyl) -1,3-oxazolidine-2- On ethyl (2RS, 3RS) -2- [3- (tert-butyl) benzyl] -3- (3-chlorophenyl) -3-hydroxypropionate (4.05 g, 10.8 mmol)
Of tetrahydrofuran-ethanol (10ml-10m
l) Add 2N sodium hydroxide (11m
1,22 mmol) and stirred at room temperature overnight. After completion of the reaction, the organic solvent was distilled off under reduced pressure, the aqueous layer was acidified with 1N hydrochloric acid, and extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain a colorless transparent oil. The oil obtained above in tetrahydrofuran (100
ml) solution in triethylamine (2.26 ml, 16.
2 mmol), azide diphenylphosphate (2.56 m
1, 11.88 mmol) and heated to reflux for 4 hours. The solvent was distilled off, diluted with ethyl acetate, and washed with water, saturated aqueous sodium hydrogen carbonate and saturated saline. The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. Recrystallization from hexane-ethyl acetate gave (4RS, 5SR) -4- [3-
(Tert-butyl) benzyl] -5- (3-chlorophenyl) -1,3-oxazolidin-2-one (2.47 g, 6
0%) as colorless crystals. mp 136-137 ℃ IRνmax KBr (cm -1 ): 3263, 1763, 1601, 1477, 1433, 13
63, 1234 1 H-NMR (CDCl 3 ) δ (ppm) 1.28 (9H, s) 2.20 (1H, dd,
J = 11.1, 13.8 Hz) 2.32 (1H, dd, J = 3.9, 13.8 Hz)
4.23-4.30 (1H, m) 4.99 (1H, s) 5.77 (1H, d, J = 8.
1 Hz) 6.85 (1H, d, J = 7.2 Hz) 7.01 (1H, s) 7.19-
7.31 (3H, m) 7.34-7.40 (3H, m). 8) (1RS, 2SR) -2-amino-3- [3- (te
rt-butyl) phenyl] -1- (3-chlorophenyl)-
1-propanol (4RS, 5SR) -4- [3- (tert-butyl) benzyl] -5- (3-chlorophenyl) -1,3-oxazolidin-2-one (2.36 g, 6.86 mmol) An 8 N aqueous sodium hydroxide solution (4.3 ml, 34.3 mmol) was added to an ethanol (60 ml) solution, and the mixture was heated under reflux for 5 hours. After completion of the reaction, ethanol was distilled off under reduced pressure, diluted with water, and extracted with ethyl acetate. The organic layers were combined, washed with saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate) to give (1RS, 2SR) -2-amino-
3- [3- (tert-butyl) phenyl] -1- (3-chlorophenyl) -1-propanol (1.21 g, 55%)
Was obtained as colorless crystals. mp 102-103 ℃ IRνmax KBr (cm -1 ): 3063, 1597, 1576, 1476, 1429, 1
363, 1199 1 H-NMR (CDCl 3 ) δ (ppm) 1.30 (9H, s) 2.32
(1H, dd, J = 10.4, 13.6 Hz) 2.75 (1H, dd, J = 3.2,
13.8 Hz) 3.31 (1H, dt, J = 4.0, 9.6 Hz) 4.68 (1H,
d, J = 4.8 Hz) 6.94-6.96 (1H, m) 7.13 (1H, s) 7.21
-7.31 (5H, m) 7.42 (1H, s) 9) N-[(1RS, 2SR) -1- [3- (tert-
Butyl) benzyl] -2- (3-chlorophenyl) -2-hydroxyethyl] -4-fluoro-1-naphthamide (1RS, 2SR) -2-amino-3- [3- (tert-butyl) phenyl] -1 N, N of-(3-chlorophenyl) -1-propanol (0.30 g, 0.944 mmol)
To a solution of -dimethylformamide (5 ml) was added 4-fluoronaphthalene-1-carboxylic acid (0.189 g, 0.99 mmol) and 1-hydroxybenzotriazole monohydrate (0.152 g, 0.99 mmol), Finally one
-Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.190 g, 0.99 mmol) was added, and the mixture was stirred at room temperature overnight. The mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 1: 1).
1,0: 1) and then purified by recrystallization (hexane-ethyl acetate) to give N-[(1RS, 2SR) -1- [3- (t
tert-butyl) benzyl] -2- (3-chlorophenyl)
[-2-Hydroxyethyl] -4-fluoro-1-naphthamide (0.245 g, 53%) was obtained as colorless crystals. mp 76-78 ℃ IRνmax KBr (cm -1 ): 3312, 1639, 1599, 1516, 1425, 1
261, 1236, 1201, 1051 1 H-NMR (CDCl 3 ) δ (ppm) 0.99 (9H, s) 2.73 (1H, dd,
J = 11.0, 14.4 Hz) 3.01 (1H, dd, J = 4.0, 14.4 Hz)
3.52 (2H, dd, J = 8.6, 11.4 Hz) 4.17 (1H, br) 4.7
0-4.81 (1H, m) 5.09 (1H, s) 5.87 (1H, d, J = 7.2 H
z) 6.74-6.83 (3H, m) 7.00 (1H, dd, J = 7.6, 9.8 H
z) 7.18-7.36 (5H, m) 7.41-7.57 (3H, m) 7.80 (1H, d,
J = 7.6 Hz) 8.07 (1H, d, J = 7.6 Hz).
【0502】実施例370 N-[(1RS,2SR)-1-[3-(tert-ブチ
ル)ベンジル]-2-(3-クロロフェニル)-2-ヒドロ
キシエチル]-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド (1RS,2SR)-2-アミノ-3-[3-(tert-ブ
チル)フェニル]-1-(3-クロロフェニル)-1-プロ
パノール(0.30g,0.944ミリモル)のN,N
-ジメチルホルムアミド(5ml)溶液に6,7-ジヒド
ロ-5H-ベンゾ[a]シクロヘプテン-1-カルボン酸
(0.187g,0.99ミリモル)、1-ヒドロキシ
ベンゾトリアゾール1水和物(.152g,0.99ミ
リモル)を加え、最後に1-エチル-3-(3-ジメチルア
ミノプロピル)カルボジイミド塩酸塩(0.190g,
0.99ミリモル)を加え、室温で終夜撹拌した。酢酸
エチルで希釈し、飽和重曹水、水、飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後、ろ過、減圧濃縮し
た。残渣をシリカゲルカラムクロマトグラフィー(ヘキ
サン:酢酸エチル=1:1、0:1)、その後、再結晶
(ヘキサン-酢酸エチル)で精製し、N-[(1RS,2
SR)-1-[3-(tert-ブチル)ベンジル]-2-
(3-クロロフェニル)-2-ヒドロキシエチル]-6,7
-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カル
ボキサミド(0.230g,50%)を無色結晶として
得た。 mp 104-105℃ IRνmaxKBr(cm-1) : 3300, 1635, 1514, 1425, 1363, 1
298, 1273, 1197, 1103,10761 H-NMR(CDCl3)δ (ppm) 1.27 (9H, s) 1.95-2.01 (2H,
m) 2.14-2.20 (2H, m) 2.63-2.75 (3H, m) 297 (1H, d
d, J = 4.0, 14.2 Hz) 4.36 (1H, s) 4.67-4.69 (1H,
m) 5.02 (1H, s) 5.69 (1H, d, J = 7.4 Hz) 5.87-5.98
(1H, m) 6.26 (1H,d, J = 12.0 Hz) 6.86-7.30 (10H,
m) 7.47 (1H, s).Example 370 N-[(1RS, 2SR) -1- [3- (tert-butyl) benzyl] -2- (3-chlorophenyl) -2-hydroxyethyl] -6,7-dihydro-5H- Benzo [a] cycloheptene-1-carboxamide (1RS, 2SR) -2-amino-3- [3- (tert-butyl) phenyl] -1- (3-chlorophenyl) -1-propanol (0.30 g, 0. 944 mmol) N, N
6,7-Dihydro-5H-benzo [a] cycloheptene-1-carboxylic acid (0.187 g, 0.99 mmol), 1-hydroxybenzotriazole monohydrate (.152 g, 0.99 mmol) and finally 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.190 g,
0.99 mmol) and stirred at room temperature overnight. The mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 1, 0: 1) and then recrystallized (hexane-ethyl acetate) to give N-[(1RS, 2
SR) -1- [3- (tert-butyl) benzyl] -2-
(3-Chlorophenyl) -2-hydroxyethyl] -6,7
-Dihydro-5H-benzo [a] cycloheptene-1-carboxamide (0.230 g, 50%) was obtained as colorless crystals. mp 104-105 ℃ IRνmax KBr (cm -1 ): 3300, 1635, 1514, 1425, 1363, 1
298, 1273, 1197, 1103, 1076 1 H-NMR (CDCl 3 ) δ (ppm) 1.27 (9H, s) 1.95-2.01 (2H,
m) 2.14-2.20 (2H, m) 2.63-2.75 (3H, m) 297 (1H, d
d, J = 4.0, 14.2 Hz) 4.36 (1H, s) 4.67-4.69 (1H,
m) 5.02 (1H, s) 5.69 (1H, d, J = 7.4 Hz) 5.87-5.98
(1H, m) 6.26 (1H, d, J = 12.0 Hz) 6.86-7.30 (10H,
m) 7.47 (1H, s).
【0503】実施例371 N-[(1RS,2SR)-1-[3-(tert-ブチ
ル)ベンジル]-2-(3-クロロフェニル)-2-ヒドロ
キシエチル]-5-クロロ-1-ナフトアミド (1RS,2SR)-2-アミノ-3-[3-(tert-ブ
チル)フェニル]-1-(3-クロロフェニル)-1-プロ
パノール(0.313g,0.985ミリモル)のN,
N-ジメチルホルムアミド(5ml)溶液に5-クロロナ
フタレン-1-カルボン酸(0.214g,1.04ミリ
モル)、1-ヒドロキシベンゾトリアゾール1水和物
(0.160g,1.04ミリモル)を加え、最後に1
-エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド塩酸塩(0.20g,1.04ミリモル)を加え、
室温で終夜撹拌した。酢酸エチルで希釈し、飽和重曹
水、水、飽和食塩水で洗浄し、無水硫酸マグネシウムで
乾燥後、ろ過、減圧濃縮した。残渣を再結晶(ヘキサン
-酢酸エチル)で精製し、N-[(1RS,2SR)-1-
[3-(tert-ブチル)ベンジル]-2-(3-クロロ
フェニル)-2-ヒドロキシエチル]-5-クロロ-1-ナフ
トアミド(0.307g,62%)を無色結晶として得
た。 mp 91-93℃ IRνmaxKBr(cm-1) : 3267, 1631, 1572, 1518, 1203, 1
0371 H-NMR(CDCl3)δ (ppm) 1.25 (9H, s) 2.74 (1H, dd, J
= 11.0, 14.4 Hz) 3.05(1H, dd, J = 4.0, 14.2 Hz)
4.02 (1H, d, J = 4.4 Hz) 4.77-4.86 (1H, m) 5.05-5.
09 (1H, m) 5.87 (1H, d, J = 7.8 Hz) 7.01 (1H, d, J
= 7.4 Hz) 7.12-7.66 (12H, m) 8.29 (1H, d, J = 8.8
Hz).Example 371 N-[(1RS, 2SR) -1- [3- (tert-butyl) benzyl] -2- (3-chlorophenyl) -2-hydroxyethyl] -5-chloro-1-naphthamide ( 1RS, 2SR) -2-Amino-3- [3- (tert-butyl) phenyl] -1- (3-chlorophenyl) -1-propanol (0.313 g, 0.985 mmol) N,
To a solution of N-dimethylformamide (5 ml) was added 5-chloronaphthalene-1-carboxylic acid (0.214 g, 1.04 mmol) and 1-hydroxybenzotriazole monohydrate (0.160 g, 1.04 mmol). And finally one
-Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (0.20 g, 1.04 mmol) was added,
Stirred at room temperature overnight. The mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. Recrystallize the residue (hexane
-Ethyl acetate) to give N-[(1RS, 2SR) -1-]
[3- (tert-Butyl) benzyl] -2- (3-chlorophenyl) -2-hydroxyethyl] -5-chloro-1-naphthamide (0.307 g, 62%) was obtained as colorless crystals. mp 91-93 ° C IRνmax KBr (cm -1 ): 3267, 1631, 1572, 1518, 1203, 1
037 1 H-NMR (CDCl 3 ) δ (ppm) 1.25 (9H, s) 2.74 (1H, dd, J
= 11.0, 14.4 Hz) 3.05 (1H, dd, J = 4.0, 14.2 Hz)
4.02 (1H, d, J = 4.4 Hz) 4.77-4.86 (1H, m) 5.05-5.
09 (1H, m) 5.87 (1H, d, J = 7.8 Hz) 7.01 (1H, d, J
= 7.4 Hz) 7.12-7.66 (12H, m) 8.29 (1H, d, J = 8.8
Hz).
【0504】実施例372 tert-ブチル(1RS,2SR)-2-(3-クロロフ
ェニル)-2-ヒドロキシ-1-[4-(2,2,3,3,
3-ペンタフルオロプロピル)ベンジル]エチルカーバ
メート 1) 2,2,3,3,3-ペンタフルオロ-1-(4-メ
チルフェニル)プロパン-1-オール 窒素置換した3径フラスコにマグネシウム(12.2
g,502ミリモル)、エーテル(100ml)を加
え,4-ブロモトルエン(56.1ml,456ミリモ
ル)のエーテル(200ml)溶液を滴下し、1.5時
間加熱還流した。反応容器をドライアイスーアセトン浴
で冷却し、ペンタフルオロプロピオン酸(25g,15
2ミリモル)のエーテル(100ml)溶液を滴下し、
ゆっくりと室温に戻したのち、3時間加熱還流し、終
夜、室温で撹拌した。反応混合物を氷冷し、3規定塩酸
でクエンチした。酢酸エチルで希釈し、有機層を分離、
飽和重曹水、飽和食塩水で洗浄し、無水硫酸マグネシウ
ムで乾燥後、ろ過、減圧濃縮した。残渣をシリカゲルカ
ラムクロマトグラフィー(ヘキサン:酢酸エチル=1:
0、30:1)を行い、無色透明オイルを得た。これを
メタノールに溶解させ、氷冷下で水素化ホウ素ナトリウ
ムを加えた。室温に戻し,1時間撹拌した。反応終了
後、6規定塩酸でクエンチし、酢酸エチルで抽出した。
有機層を飽和食塩水で洗浄し、無水硫酸マグネシウムで
乾燥後、ろ過、減圧濃縮した。残渣をシリカゲルカラム
クロマトグラフィー(ヘキサン:酢酸エチル=10:
1、5:1)で精製し、2,2,3,3,3-ペンタフ
ルオロ-1-(4-メチルフェニル)プロパン-1-オール
(20.28g,56%)を無色透明オイルとして得
た。 IRνmaxKBr(cm-1) : 3400, 1616, 1518, 1363, 1331, 1
213, 1184, 11321 H-NMR(CDCl3) δ (ppm) 2.37 (3H, s) 2.50 (1H, d, J
= 4.8 Hz) 4.98-5.13 (1H, m) 7.21 (2H, d, J = 8.4
Hz) 7.33 (2H, d, J = 8.0 Hz). 2) O-フェニルO-[2,2,3,3,3-ペンタフ
ルオロ-1-(4-メチルフェニル)プロピル]カルボノ
チオネート 2,2,3,3,3-ペンタフルオロ-1-(4-メチルフ
ェニル)プロパン-1-オール(15.93g,66.3
ミリモル)の酢酸エチル(200ml)溶液にトリエチ
ルアミン(13.9ml,99.45ミリモル)を加
え、氷冷下でクロロフェニルチオノホルメート(10.
1ml,72.8ミリモル)を加え、氷冷下で2時間撹
拌した。析出した固体をろ過して除去し、酢酸エチルで
洗浄した。ろ液を減圧濃縮し、残渣をシリカゲルカラム
クロマトグラフィー(ヘキサン:酢酸エチル=30:
1)で精製し、O-フェニルO-[2,2,3,3,3-
ペンタフルオロ-1-(4-メチルフェニル)プロピル]
カルボノチオネート(22.82g,91%)を無色透
明オイルとして得た。 IRνmaxKBr(cm-1): 1616, 1591, 1518, 1491, 1290, 11
92, 11431 H-NMR(CDCl3) δ (ppm) 2.39 (3H, s) 6.67 (1H, dd,
J = 7.5, 16.5 Hz) 7.05(2H, d, J = 8.1 Hz) 7.24-7.3
1 (3H, m) 7.37-7.42 (4H, m). 3) 4-(2,2,3,3,3-ペンタフルオロプロピ
ル)トルエン O-フェニルO-[2,2,3,3,3-ペンタフルオロ-
1-(4-メチルフェニル)プロピル]カルボノチオネー
ト(16.55g,44.0ミリモル)のベンゼン(1
00ml)溶液に2,2'-アゾビスイソブチロニトリル
(1.45g,8.8ミリモル)、水素化トリ-n-ブチ
ルスズ(17.8ml,66.0ミリモル)を加え、8
0℃で5時間撹拌した。反応終了後、ベンゼンを減圧留
去し、シリカゲルカラムクロマトグラフィー(ヘキサ
ン)で精製し、4-(2,2,3,3,3-ペンタフルオ
ロプロピル)トルエン(11.13g,)を無色透明オ
イルとして得た。これは若干のスズ化合物と思われる不
純物が含まれるが、このまま次の反応に用いた。 IRνmaxKBr(cm-1): 1518, 1464, 1377, 1315, 1203, 11
18, 1080, 10301 H-NMR(CDCl3) δ (ppm) 2.34 (3H, s) 3.26 (2H, t, J
= 18.8 Hz) 7.16 (4H,s). 4) 1-(ブロモメチル)-4-(2,2,3,3,3-
ペンタフルオロプロピル)ベンゼン 4-(2,2,3,3,3-ペンタフルオロプロピル)ト
ルエン(9.97g,39.4ミリモル)の四塩化炭素
(300ml)溶液に2,2'-アゾビスイソブチロニト
リル(0.33g,197ミリモル)、N-ブロモスク
シンイミド(8.50g,47.3ミリモル)を加え、
終夜、加熱還流した。室温に冷却後、不溶物をろ過、減
圧濃縮した。残渣をシリカゲルカラムクロマトグラフィ
ー(ヘキサン:酢酸エチル=1:0、50:1、20:
1)で精製し、1-(ブロモメチル)-4-(2,2,
3,3,3-ペンタフルオロプロピル)ベンゼン(3.
66g,31%(2工程の収率))を無色結晶として得
た。 mp 62-63℃ IRνmaxKBr(cm-1): 1518, 1437, 1323, 1190, 1101, 10
70, 10451 H-NMR(CDCl3) δ (ppm) 3.31 (2H, t, J = 17.8 Hz)
7.27 (2H, d, J = 8.0 Hz) 7.40 (2H, d, J = 8.4 Hz). 5) エチル3-(3-クロロフェニル)-3-オキソ-2-
[4-(2,2,3,3,3-ペンタフルオロプロピル)
ベンジル]プロピオネート エチル3-(3-クロロフェニル)-3-オキソプロピオネ
ート(2.74g,12.08ミリモル)のジメトキシ
エタン(30ml)溶液を氷冷し、水素化ナトリウム
(60%,0.49g,12.08ミリモル)を加え、
氷冷下で30分撹拌した後、1-(ブロモメチル)-4-
(2,2,3,3,3-ペンタフルオロプロピル)ベン
ゼン(3.66g,12.08ミリモル)のジメトキシ
エタン(15ml)溶液を加え、室温で終夜撹拌した。
反応終了後、0.5規定の塩酸でクエンチし、酢酸エチ
ルで希釈し、水、飽和食塩水で洗浄した。無水硫酸マグ
ネシウムで乾燥後、ろ過、減圧濃縮した。残渣をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=15:1、10:1)で精製し、エチル3-(3-クロ
ロフェニル)-3-オキソ-2-[4-(2,2,3,3,
3-ペンタフルオロプロピル)ベンジル]プロピオネー
ト(4.64g,86%)を無色結晶として得た。 mp 81-82℃ IRνmaxKBr(cm-1): 1738, 1693, 1572, 1425, 1317, 11
95, 10281 H-NMR(CDCl3) δ (ppm) 1.11 (3H, t, J = 7.2 Hz) 3.
25 (2H, t, J = 18.3 Hz) 3.32 (2H, d, J = 7.2 Hz)
4.05-4.14 (2H, m) 4.54 (1H, t, J = 7.5 Hz) 7.16-7.
23 (4H, m) 7.37 (1H, t, J = 8.1 Hz) 7.51-7.54 (1H,
m) 7.77-7.81 (1H,m) 7.90-7.92 (1H, m). 6) エチル(2RS,3RS)-3-(3-クロロフェ
ニル)-3-ヒドロキシ-2-[4-(2,2,3,3,3-
ペンタフルオロプロピル)ベンジル]プロピオネート 塩化亜鉛(2.70g,19.84ミリモル)のエーテ
ル懸濁液(30ml)に水素化ホウ素ナトリウム(1.
50g,39.68ミリモル)を室温で加えそのまま2
時間撹拌した。不溶物をろ過し、そのろ液にエチル3-
(3-クロロフェニル)-3-オキソ-2-[4-(2,2,
3,3,3-ペンタフルオロプロピル)ベンジル]プロ
ピオネート(4.45g,9.92ミリモル)のエーテ
ル(20ml)溶液を加え、室温で1時間撹拌した。1
規定塩酸で反応を終了させ、酢酸エチルで希釈し、水、
飽和食塩水で洗浄した。無水硫酸マグネシウムで乾燥
後、ろ過、減圧濃縮した。残渣をシリカゲルカラムクロ
マトグラフィー(ヘキサン:酢酸エチル=10:1、
5:1)で精製し、エチル(2RS,3RS)-3-(3
-クロロフェニル)-3-ヒドロキシ-2-[4-(2,2,
3,3,3-ペンタフルオロプロピル)ベンジル]プロ
ピオネート(3.95g,89%)を無色透明オイルと
して得た。 IRνmaxKBr(cm-1): 3450, 1709, 1576, 1518, 1435, 13
15, 1195, 1113, 10301 H-NMR(CDCl3) δ (ppm) 0.91 (3H, t, J = 7.0 Hz) 2.
87-3.02 (3H, m) 3.18 (1H, d, J = 2.6 Hz) 3.25 (2H,
t, J = 18.2 Hz) 3.88 (2H, q, J = 6.8 Hz) 5.02 (1
H, d, J = 1.8 Hz) 7.04-7.17 (4H, m) 7.26-7.28 (3H,
m) 7.41-7.42 (1H, m). 7) (2RS,3RS)-3-(3-クロロフェニル)-
3-ヒドロキシ-2-[4-(2,2,3,3,3-ペンタ
フルオロプロピル)ベンジル]プロピオン酸 エチル(2RS,3RS)-3-(3-クロロフェニル)-
3-ヒドロキシ-2-[4-(2,2,3,3,3-ペンタ
フルオロプロピル)ベンジル]プロピオネート(3.8
4g,8.52ミリモル)のテトラヒドロフラン-エタ
ノール(20ml-20ml)溶液に室温で1規定の水
酸化ナトリウム(17ml,17ミリモル)を加え、室
温で終夜撹拌した。反応終了後、有機溶媒を減圧留去
し、水層を1規定塩酸で酸性とし、酢酸エチルで抽出し
た。有機層を無水硫酸マグネシウムで乾燥後、ろ過、減
圧濃縮した。ヘキサン-酢酸エチルで再結晶を行い、
(2RS,3RS)-3-(3-クロロフェニル)-3-ヒ
ドロキシ-2-[4-(2,2,3,3,3-ペンタフルオ
ロプロピル)ベンジル]プロピオン酸(2.85g,7
9%)を無色結晶として得た。 mp 150-151℃ IRνmaxKBr(cm-1) : 2500-3300, 1693, 1433, 1315, 12
38, 1194, 1103, 1078,10301 H-NMR(CDCl3) δ (ppm) 2.87-3.05 (3H, m) 3.24 (2H,
t, J = 18.4 Hz) 5.09(1H, d, J = 4.0 Hz) 7.05 (2H,
d, J = 8.0 Hz) 7.14 (2H, d, J = 8.4 Hz) 7.24-7.29
(3H, m) 7.41 (1H, s). 8) (4RS,5SR)-5-(3-クロロフェニル)-
4-[4-(2,2,3,3,3-ペンタフルオロプロピ
ル)ベンジル]-1,3-オキサゾリジン-2-オン (2RS,3RS)-3-(3-クロロフェニル)-3-ヒ
ドロキシ-2-[4-(2,2,3,3,3-ペンタフルオ
ロプロピル)ベンジル]プロピオン酸(2.75g,
6.50ミリモル)のテトラヒドロフラン(70ml)
溶液にトリエチルアミン(1.36ml,9.75ミリ
モル)、ジフェニルリン酸アジド(1.54ml,7.
15ミリモル)を加え、4時間加熱還流した。溶媒を留
去し、酢酸エチルで希釈し、水,飽和重曹水、飽和食塩
水で洗浄した。有機層を無水硫酸マグネシウムで乾燥
後、ろ過、減圧濃縮した。ヘキサン-酢酸エチルで再結
晶を行い、(4RS,5SR)-5-(3-クロロフェニ
ル)-4-[4-(2,2,3,3,3-ペンタフルオロプ
ロピル)ベンジル]-1,3-オキサゾリジン-2-オン
(2.54g,93%)を無色結晶として得た。 mp 137-138℃ IRνmaxKBr(cm-1): 3234, 1761, 1435, 1317, 1194, 10
30, 9121 H-NMR(CDCl3) δ (ppm) 2.17-2.36 (2H, m) 3.28 (2H,
t, J = 18.6 Hz) 4.19-4.30 (1H, m) 4.95 (1H, s) 5.
77 (1H, d, J = 8.2 Hz) 7.03 (2H, d, J = 7.6Hz) 7.2
7-7.38 (3H, m). 9) tert-ブチル(4RS,5SR)-5-(3-ク
ロロフェニル)-2-オキソ-4-[4-(2,2,3,
3,3-ペンタフルオロプロピル)ベンジル]-1,3-
オキサゾリジン-3-カルボキシレート (4RS,5SR)-5-(3-クロロフェニル)-4-
[4-(2,2,3,3,3-ペンタフルオロプロピル)
ベンジル]-1,3-オキサゾリジン-2-オン(2.43
g,5.79ミリモル)のアセトニトリル(40ml)
溶液にジ-tert-ブチルジカーボネート(1.52
g,6.95ミリモル)と4-(ジメチルアミノ)ピリ
ジン(71mg,0.579ミリモル)を順に加え、室
温で終夜撹拌した。溶媒を減圧留去し、ヘキサン-酢酸
エチルで再結晶を行い、tert-ブチル(4RS,5
SR)-5-(3-クロロフェニル)-2-オキソ-4-[4-
(2,2,3,3,3-ペンタフルオロプロピル)ベン
ジル]-1,3-オキサゾリジン-3-カルボキシレート
(2.77g,92%)を無色結晶として得た。 mp 136-138℃ IRνmaxKBr(cm-1): 1813, 1724, 1358, 1315, 1251, 11
95, 157, 1076, 10281 H-NMR(CDCl3) δ(ppm): 1.49 (9H, s) 2.58 (1H, dd,
J = 8.8, 14.4 Hz) 2.88(1H, dd, J = 4.6, 14.4 Hz)
3.21 (2H, t, J = 18.4H) 4.77-4.87 (1H, m) 5.64 (1
H, d, J = 7.0 Hz) 6.67 (2H, d, J = 8.0 Hz) 6.99-7.
03 (3H, m) 7.12-7.19 (2H, m) 7.24-7.30 (1H, m). 10) tert-ブチル(1RS,2SR)-2-(3-
クロロフェニル)-2-ヒドロキシ-1-[4-(2,2,
3,3,3-ペンタフルオロプロピル)ベンジル]エチ
ルカーバメート tert-ブチル(4RS,5SR)-5-(3-クロロフ
ェニル)-2-オキソ-4-[4-(2,2,3,3,3-ペ
ンタフルオロプロピル)ベンジル]-1,3-オキサゾリ
ジン-3-カルボキシレート(2.66g,5.12ミリ
モル)のメタノール-テトラヒドロフラン(20ml-2
0ml)溶液に1規定水酸化ナトリウム(6.2ml,
6.2ミリモル)を加え、室温で終夜撹拌した。水で希
釈した後、酢酸エチルで抽出した。有機層を飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後、ろ過、減圧
濃縮した。残渣を再結晶(ヘキサン-酢酸エチル)で精
製し、tert-ブチル(1RS,2SR)-2-(3-ク
ロロフェニル)-2-ヒドロキシ-1-[4-(2,2,
3,3,3-ペンタフルオロプロピル)ベンジル]エチ
ルカーバメート(2.11g,83%)を無色結晶とし
て得た。 mp 156-157℃ IRνmaxKBr(cm-1): 3348, 1682, 1531, 1444, 1311, 12
44, 1178, 10321 H-NMR(CDCl3) δ(ppm) : 1.34 (9H, s) 2.59-2.79 (2
H, m) 3.26 (2H, t, J =18.4 Hz) 3.49 (1H, br) 4.09
(1H, br) 4.55 (1H, d, J = 7.6 Hz) 4.91 (1H,br) 7.0
8-7.20 (4H, m) 7.26-7.29 (3H, m) 7.1 (1H, s).Example 372 tert-Butyl (1RS, 2SR) -2- (3-chlorophenyl) -2-hydroxy-1- [4- (2,2,3,3,3
3-Pentafluoropropyl) benzyl] ethyl carbamate 1) 2,2,3,3,3-Pentafluoro-1- (4-methylphenyl) propan-1-ol Magnesium (12.2.
g, 502 mmol) and ether (100 ml), a solution of 4-bromotoluene (56.1 ml, 456 mmol) in ether (200 ml) was added dropwise, and the mixture was heated under reflux for 1.5 hours. The reaction vessel was cooled in a dry ice-acetone bath, and pentafluoropropionic acid (25 g, 15
2 mmol) in ether (100 ml) was added dropwise,
After slowly returning to room temperature, the mixture was heated under reflux for 3 hours and stirred at room temperature overnight. The reaction mixture was ice-cooled and quenched with 3N hydrochloric acid. Dilute with ethyl acetate and separate the organic layer,
The extract was washed with saturated aqueous sodium hydrogen carbonate and saturated brine, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 1: 1).
0, 30: 1) to obtain a colorless transparent oil. This was dissolved in methanol, and sodium borohydride was added under ice cooling. It returned to room temperature and stirred for 1 hour. After completion of the reaction, the reaction was quenched with 6N hydrochloric acid and extracted with ethyl acetate.
The organic layer was washed with brine, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 10:
1,5: 1) to give 2,2,3,3,3-pentafluoro-1- (4-methylphenyl) propan-1-ol (20.28 g, 56%) as a colorless transparent oil. Was. IRνmax KBr (cm -1 ): 3400, 1616, 1518, 1363, 1331, 1
213, 1184, 1132 1 H-NMR (CDCl 3 ) δ (ppm) 2.37 (3H, s) 2.50 (1H, d, J
= 4.8 Hz) 4.98-5.13 (1H, m) 7.21 (2H, d, J = 8.4
Hz) 7.33 (2H, d, J = 8.0 Hz). 2) O-phenyl O- [2,2,3,3,3-pentafluoro-1- (4-methylphenyl) propyl] carbonothionate 2, 2,3,3,3-pentafluoro-1- (4-methylphenyl) propan-1-ol (15.93 g, 66.3)
Triethylamine (13.9 ml, 99.45 mmol) was added to a solution of ethyl chlorophenylthionoformate (10. mmol) in ethyl acetate (200 ml).
1 ml, 72.8 mmol) and stirred for 2 hours under ice cooling. The precipitated solid was removed by filtration and washed with ethyl acetate. The filtrate was concentrated under reduced pressure, and the residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 30:
Purified in 1), O-phenyl O- [2,2,3,3,3-
Pentafluoro-1- (4-methylphenyl) propyl]
Carbonothionate (22.82 g, 91%) was obtained as a clear, colorless oil. IRνmax KBr (cm -1 ): 1616, 1591, 1518, 1491, 1290, 11
92, 1143 1 H-NMR (CDCl 3 ) δ (ppm) 2.39 (3H, s) 6.67 (1H, dd,
J = 7.5, 16.5 Hz) 7.05 (2H, d, J = 8.1 Hz) 7.24-7.3
1 (3H, m) 7.37-7.42 (4H, m). 3) 4- (2,2,3,3,3-pentafluoropropyl) toluene O-phenyl O- [2,2,3,3,3 -Pentafluoro-
1- (4-Methylphenyl) propyl] carbonothionate (16.55 g, 44.0 mmol) in benzene (1
To the solution, 2,2′-azobisisobutyronitrile (1.45 g, 8.8 mmol) and tri-n-butyltin hydride (17.8 ml, 66.0 mmol) were added.
Stirred at 0 ° C. for 5 hours. After completion of the reaction, benzene was distilled off under reduced pressure and purified by silica gel column chromatography (hexane), and 4- (2,2,3,3,3-pentafluoropropyl) toluene (11.13 g,) was added to a colorless transparent oil. As obtained. Although this contains some impurities considered to be tin compounds, it was used for the next reaction as it was. IRνmax KBr (cm -1 ): 1518, 1464, 1377, 1315, 1203, 11
18, 1080, 1030 1 H-NMR (CDCl 3 ) δ (ppm) 2.34 (3H, s) 3.26 (2H, t, J
= 18.8 Hz) 7.16 (4H, s). 4) 1- (Bromomethyl) -4- (2,2,3,3,3-
Pentafluoropropyl) benzene To a solution of 4- (2,2,3,3,3-pentafluoropropyl) toluene (9.97 g, 39.4 mmol) in carbon tetrachloride (300 ml), 2,2′-azobisisopropane Butyronitrile (0.33 g, 197 mmol) and N-bromosuccinimide (8.50 g, 47.3 mmol) were added,
Heated to reflux overnight. After cooling to room temperature, insolubles were filtered and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 1: 0, 50: 1, 20:
Purified in 1), 1- (bromomethyl) -4- (2,2,
3,3,3-pentafluoropropyl) benzene (3.
66 g, 31% (yield in two steps) were obtained as colorless crystals. mp 62-63 ℃ IRνmax KBr (cm -1 ): 1518, 1437, 1323, 1190, 1101, 10
70, 1045 1 H-NMR (CDCl 3 ) δ (ppm) 3.31 (2H, t, J = 17.8 Hz)
7.27 (2H, d, J = 8.0 Hz) 7.40 (2H, d, J = 8.4 Hz). 5) Ethyl 3- (3-chlorophenyl) -3-oxo-2-
[4- (2,2,3,3,3-pentafluoropropyl)
Benzyl] propionate Ethyl 3- (3-chlorophenyl) -3-oxopropionate (2.74 g, 12.08 mmol) in dimethoxyethane (30 ml) was ice-cooled and sodium hydride (60%, 0.49 g) , 12.08 mmol)
After stirring for 30 minutes under ice cooling, 1- (bromomethyl) -4-
A solution of (2,2,3,3,3-pentafluoropropyl) benzene (3.66 g, 12.08 mmol) in dimethoxyethane (15 ml) was added, and the mixture was stirred at room temperature overnight.
After completion of the reaction, the reaction was quenched with 0.5N hydrochloric acid, diluted with ethyl acetate, and washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 15: 1, 10: 1), and ethyl 3- (3-chlorophenyl) -3-oxo-2- [4- (2,2,3,3) was used. ,
[3-Pentafluoropropyl) benzyl] propionate (4.64 g, 86%) was obtained as colorless crystals. mp 81-82 ℃ IRνmax KBr (cm -1 ): 1738, 1693, 1572, 1425, 1317, 11
95, 1028 1 H-NMR (CDCl 3 ) δ (ppm) 1.11 (3H, t, J = 7.2 Hz) 3.
25 (2H, t, J = 18.3 Hz) 3.32 (2H, d, J = 7.2 Hz)
4.05-4.14 (2H, m) 4.54 (1H, t, J = 7.5 Hz) 7.16-7.
23 (4H, m) 7.37 (1H, t, J = 8.1 Hz) 7.51-7.54 (1H,
m) 7.77-7.81 (1H, m) 7.90-7.92 (1H, m). 6) Ethyl (2RS, 3RS) -3- (3-chlorophenyl) -3-hydroxy-2- [4- (2,2, 3,3,3-
[Pentafluoropropyl) benzyl] propionate An ether suspension (30 ml) of zinc chloride (2.70 g, 19.84 mmol) was added to sodium borohydride (1.
50 g, 39.68 mmol) at room temperature.
Stirred for hours. The insoluble material is filtered, and the filtrate is ethyl 3-
(3-chlorophenyl) -3-oxo-2- [4- (2,2,
A solution of (3,3,3-pentafluoropropyl) benzyl] propionate (4.45 g, 9.92 mmol) in ether (20 ml) was added, and the mixture was stirred at room temperature for 1 hour. 1
Terminate the reaction with normal hydrochloric acid, dilute with ethyl acetate, add water,
Washed with saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 10: 1,
5: 1) to give ethyl (2RS, 3RS) -3- (3
-Chlorophenyl) -3-hydroxy-2- [4- (2,2,
[3,3,3-pentafluoropropyl) benzyl] propionate (3.95 g, 89%) was obtained as a colorless transparent oil. IRνmax KBr (cm -1 ): 3450, 1709, 1576, 1518, 1435, 13
15, 1195, 1113, 1030 1 H-NMR (CDCl 3 ) δ (ppm) 0.91 (3H, t, J = 7.0 Hz) 2.
87-3.02 (3H, m) 3.18 (1H, d, J = 2.6 Hz) 3.25 (2H, m
t, J = 18.2 Hz) 3.88 (2H, q, J = 6.8 Hz) 5.02 (1
H, d, J = 1.8 Hz) 7.04-7.17 (4H, m) 7.26-7.28 (3H,
m) 7.41-7.42 (1H, m). 7) (2RS, 3RS) -3- (3-chlorophenyl)-
Ethyl 3-hydroxy-2- [4- (2,2,3,3,3-pentafluoropropyl) benzyl] propionate (2RS, 3RS) -3- (3-chlorophenyl)-
3-hydroxy-2- [4- (2,2,3,3,3-pentafluoropropyl) benzyl] propionate (3.8
To a solution of 4 g (8.52 mmol) in tetrahydrofuran-ethanol (20 ml-20 ml) was added 1N sodium hydroxide (17 ml, 17 mmol) at room temperature, and the mixture was stirred at room temperature overnight. After completion of the reaction, the organic solvent was distilled off under reduced pressure, the aqueous layer was acidified with 1N hydrochloric acid, and extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. Recrystallize with hexane-ethyl acetate,
(2RS, 3RS) -3- (3-chlorophenyl) -3-hydroxy-2- [4- (2,2,3,3,3-pentafluoropropyl) benzyl] propionic acid (2.85 g, 7
9%) as colorless crystals. mp 150-151 ℃ IRνmax KBr (cm -1 ): 2500-3300, 1693, 1433, 1315, 12
38, 1194, 1103, 1078,1030 1 H-NMR (CDCl 3 ) δ (ppm) 2.87-3.05 (3H, m) 3.24 (2H,
t, J = 18.4 Hz) 5.09 (1H, d, J = 4.0 Hz) 7.05 (2H,
d, J = 8.0 Hz) 7.14 (2H, d, J = 8.4 Hz) 7.24-7.29
(3H, m) 7.41 (1H, s). 8) (4RS, 5SR) -5- (3-chlorophenyl)-
4- [4- (2,2,3,3,3-pentafluoropropyl) benzyl] -1,3-oxazolidin-2-one (2RS, 3RS) -3- (3-chlorophenyl) -3-hydroxy- 2- [4- (2,2,3,3,3-pentafluoropropyl) benzyl] propionic acid (2.75 g,
6.50 mmol) in tetrahydrofuran (70 ml)
Triethylamine (1.36 ml, 9.75 mmol), diphenylphosphoric azide (1.54 ml, 7.7 ml) were added to the solution.
(15 mmol) and heated under reflux for 4 hours. The solvent was distilled off, diluted with ethyl acetate, and washed with water, saturated aqueous sodium hydrogen carbonate and saturated saline. The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. Recrystallization from hexane-ethyl acetate gave (4RS, 5SR) -5- (3-chlorophenyl) -4- [4- (2,2,3,3,3-pentafluoropropyl) benzyl] -1,3. -Oxazolidin-2-one (2.54 g, 93%) was obtained as colorless crystals. mp 137-138 ℃ IRνmax KBr (cm -1 ): 3234, 1761, 1435, 1317, 1194, 10
30, 912 1 H-NMR (CDCl 3 ) δ (ppm) 2.17-2.36 (2H, m) 3.28 (2H,
(t, J = 18.6 Hz) 4.19-4.30 (1H, m) 4.95 (1H, s) 5.
77 (1H, d, J = 8.2 Hz) 7.03 (2H, d, J = 7.6Hz) 7.2
9-7.38 (3H, m). 9) tert-Butyl (4RS, 5SR) -5- (3-chlorophenyl) -2-oxo-4- [4- (2,2,3,
3,3-pentafluoropropyl) benzyl] -1,3-
Oxazolidine-3-carboxylate (4RS, 5SR) -5- (3-chlorophenyl) -4-
[4- (2,2,3,3,3-pentafluoropropyl)
Benzyl] -1,3-oxazolidin-2-one (2.43
g, 5.79 mmol) of acetonitrile (40 ml)
Di-tert-butyl dicarbonate (1.52
g, 6.95 mmol) and 4- (dimethylamino) pyridine (71 mg, 0.579 mmol) were added in this order, and the mixture was stirred at room temperature overnight. The solvent was distilled off under reduced pressure, recrystallized from hexane-ethyl acetate, and tert-butyl (4RS, 5
SR) -5- (3-Chlorophenyl) -2-oxo-4- [4-
(2,2,3,3,3-pentafluoropropyl) benzyl] -1,3-oxazolidine-3-carboxylate (2.77 g, 92%) was obtained as colorless crystals. mp 136-138 ℃ IRνmax KBr (cm -1 ): 1813, 1724, 1358, 1315, 1251, 11
95, 157, 1076, 1028 1 H-NMR (CDCl 3 ) δ (ppm): 1.49 (9H, s) 2.58 (1H, dd,
J = 8.8, 14.4 Hz) 2.88 (1H, dd, J = 4.6, 14.4 Hz)
3.21 (2H, t, J = 18.4H) 4.77-4.87 (1H, m) 5.64 (1
(H, d, J = 7.0 Hz) 6.67 (2H, d, J = 8.0 Hz) 6.99-7.
03 (3H, m) 7.12-7.19 (2H, m) 7.24-7.30 (1H, m). 10) tert-Butyl (1RS, 2SR) -2- (3-
Chlorophenyl) -2-hydroxy-1- [4- (2,2,
3,3,3-pentafluoropropyl) benzyl] ethylcarbamate tert-butyl (4RS, 5SR) -5- (3-chlorophenyl) -2-oxo-4- [4- (2,2,3,3,3 -Pentafluoropropyl) benzyl] -1,3-oxazolidine-3-carboxylate (2.66 g, 5.12 mmol) in methanol-tetrahydrofuran (20 ml-2)
0 ml) solution in 1N sodium hydroxide (6.2 ml,
6.2 mmol) and stirred at room temperature overnight. After dilution with water, the mixture was extracted with ethyl acetate. The organic layer was washed with brine, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate), and tert-butyl (1RS, 2SR) -2- (3-chlorophenyl) -2-hydroxy-1- [4- (2,2,2
[3,3,3-pentafluoropropyl) benzyl] ethyl carbamate (2.11 g, 83%) was obtained as colorless crystals. mp 156-157 ℃ IRνmax KBr (cm -1 ): 3348, 1682, 1531, 1444, 1311, 12
44, 1178, 1032 1 H-NMR (CDCl 3 ) δ (ppm): 1.34 (9H, s) 2.59-2.79 (2
(H, m) 3.26 (2H, t, J = 18.4 Hz) 3.49 (1H, br) 4.09
(1H, br) 4.55 (1H, d, J = 7.6 Hz) 4.91 (1H, br) 7.0
8-7.20 (4H, m) 7.26-7.29 (3H, m) 7.1 (1H, s).
【0505】実施例373 N-[(1RS,2SR)-1-[4-(2,2,3,3,
3-ペンタフルオロプロピル)ベンジル]-2-(3-クロ
ロフェニル)-2-ヒドロキシエチル]-4-フルオロ-1-
ナフトアミド 1) (1RS,2SR)-2-アミノ-1-(3-クロロ
フェニル)-3-[4-(2,2,3,3,3-ペンタフル
オロプロピル)フェニル]-1-プロパノール tert-ブチル(1RS,2SR)-2-(3-クロロフ
ェニル)-2-ヒドロキシ-1-[4-(2,2,3,3,
3-ペンタフルオロプロピル)ベンジル]エチルカーバ
メート(2.00g,4.05ミリモル)のクロロホル
ム(20ml)溶液にトリフルオロ酢酸(20ml)を
加え、室温で一時間撹拌した。減圧濃縮した後、残渣に
水を加え、飽和重曹水で塩基性とした。水層を酢酸エチ
ルで抽出し、無水硫酸マグネシウムで乾燥後、ろ過、減
圧濃縮した。残渣を再結晶(ヘキサン-酢酸エチル)で
精製し、(1RS,2SR)-2-アミノ-1-(3-クロ
ロフェニル)-3-[4-(2,2,3,3,3-ペンタフ
ルオロプロピル)フェニル]-1-プロパノール(1.0
8g,68%)を無色結晶として得た。 mp 109-110℃ IRνmaxKBr(cm-1) : 3000-3300, 1576, 1518, 1433, 13
17, 1078, 10281 H-NMR(CDCl3) δ (ppm) : 1.60 (2H, br) 2.35 (1H, d
d, J = 10.2, 13.4 Hz)2.75 (1H, dd, J = 3.0, 13.6 H
z) 3.18-3.36 (3H, m) 4.66 (1H, d, J = 4.8 Hz) 7.10
-7.35 (7H, m) 7.41 (1H, s). 2) N-[(1RS,2SR)-1-[4-(2,2,
3,3,3-ペンタフルオロプロピル)ベンジル]-2-
(3-クロロフェニル)-2-ヒドロキシエチル]-4-フ
ルオロ-1-ナフトアミド 4-フルオロナフタレン-1-カルボン酸(153mg,
0.801ミリモル)のN,N-ジメチルホルムアミド
(5ml)溶液に、1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド塩酸塩(154g,0.80
1ミリモル)、1-ヒドロキシベンゾトリアゾール1水
和物(123mg,0.801ミリモル)を加え、最後
に(1RS,2SR)-2-アミノ-1-(3-クロロフェ
ニル)-3-[4-(2,2,3,3,3-ペンタフルオロ
プロピル)フェニル]-1-プロパノール(0.30g,
0.763ミリモル)を加え、室温で終夜撹拌した。酢
酸エチルで希釈し、飽和重曹水、水、飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後、シリカゲルをつめ
たグラスフィルターでろ過し、酢酸エチルで洗浄し、減
圧濃縮した。残渣を再結晶(ヘキサン-酢酸エチル)で
精製し、N-[(1RS,2SR)-1-[4-(2,2,
3,3,3-ペンタフルオロプロピル)ベンジル]-2-
(3-クロロフェニル)-2-ヒドロキシエチル]-4-フ
ルオロ-1-ナフトアミド(0.284g,66%)を無
色結晶として得た。 mp 191-192℃ 元素分析値C29H22NO2ClF6 として 計算値: C, 61.55; H, 3.92; N, 2.47 実測値: C, 61.27; H, 3.75; N, 2.45 IRνmaxKBr(cm-1) : 3265, 1641, 1626, 1516, 1425, 1
236, 1178, 10321 H-NMR(CDCl3) δ (ppm) 2.80 (1H, dd, J = 10.8, 14.
1 Hz) 3.02 (1H, dd, J= 4.2, 14.4 Hz) 3.29 (2H, t,
J = 18.0 Hz) 3.91 (1H, s) 4.70-4.77 (1H, m)5.10 (1
H, d, J = 2.2 Hz) 5.95 (1H, d, J = 8.1 Hz) 6.90-6.
96 (1H, m) 7.03 (1H, dd, J = 5.4, 7.8 Hz) 7.17-7.3
6 (7H, m) 7.43-7.56 (3H, m) 7.88 (1H, d, J = 8.4 H
z) 8.07 (1H, d, J = 8.4 Hz).Example 373 N-[(1RS, 2SR) -1- [4- (2,2,3,3,3)
3-Pentafluoropropyl) benzyl] -2- (3-chlorophenyl) -2-hydroxyethyl] -4-fluoro-1-
Naphthamide 1) (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [4- (2,2,3,3,3-pentafluoropropyl) phenyl] -1-propanol tert-butyl (1RS, 2SR) -2- (3-chlorophenyl) -2-hydroxy-1- [4- (2,2,3,3
To a solution of [3-pentafluoropropyl) benzyl] ethyl carbamate (2.00 g, 4.05 mmol) in chloroform (20 ml) was added trifluoroacetic acid (20 ml), and the mixture was stirred at room temperature for 1 hour. After concentration under reduced pressure, water was added to the residue, and the mixture was basified with saturated aqueous sodium hydrogen carbonate. The aqueous layer was extracted with ethyl acetate, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate) to give (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [4- (2,2,3,3,3-pentafluoro). Propyl) phenyl] -1-propanol (1.0
8g, 68%) as colorless crystals. mp 109-110 ℃ IRνmax KBr (cm -1 ): 3000-3300, 1576, 1518, 1433, 13
17, 1078, 1028 1 H-NMR (CDCl 3 ) δ (ppm): 1.60 (2H, br) 2.35 (1H, d
d, J = 10.2, 13.4 Hz) 2.75 (1H, dd, J = 3.0, 13.6 H
z) 3.18-3.36 (3H, m) 4.66 (1H, d, J = 4.8 Hz) 7.10
-7.35 (7H, m) 7.41 (1H, s). 2) N-[(1RS, 2SR) -1- [4- (2,2,
3,3,3-pentafluoropropyl) benzyl] -2-
(3-Chlorophenyl) -2-hydroxyethyl] -4-fluoro-1-naphthamide 4-fluoronaphthalene-1-carboxylic acid (153 mg,
0.801 mmol) in N, N-dimethylformamide (5 ml) was added to a solution of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (154 g, 0.80 mmol).
1 mmol), 1-hydroxybenzotriazole monohydrate (123 mg, 0.801 mmol), and finally (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [4- ( 2,2,3,3,3-pentafluoropropyl) phenyl] -1-propanol (0.30 g,
(0.763 mmol) and stirred at room temperature overnight. It was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water, and saturated saline, dried over anhydrous magnesium sulfate, filtered through a glass filter filled with silica gel, washed with ethyl acetate, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate) to give N-[(1RS, 2SR) -1- [4- (2,2,2).
3,3,3-pentafluoropropyl) benzyl] -2-
(3-Chlorophenyl) -2-hydroxyethyl] -4-fluoro-1-naphthamide (0.284 g, 66%) was obtained as colorless crystals. mp 191-192 ° C. Elemental analysis C 29 H 22 NO 2 ClF 6 Calculated: C, 61.55; H, 3.92 ; N, 2.47 Found: C, 61.27; H, 3.75 ; N, 2.45 IRνmax KBr (cm - 1 ): 3265, 1641, 1626, 1516, 1425, 1
236, 1178, 1032 1 H-NMR (CDCl 3 ) δ (ppm) 2.80 (1H, dd, J = 10.8, 14.
1 Hz) 3.02 (1H, dd, J = 4.2, 14.4 Hz) 3.29 (2H, t,
J = 18.0 Hz) 3.91 (1H, s) 4.70-4.77 (1H, m) 5.10 (1
(H, d, J = 2.2 Hz) 5.95 (1H, d, J = 8.1 Hz) 6.90-6.
96 (1H, m) 7.03 (1H, dd, J = 5.4, 7.8 Hz) 7.17-7.3
6 (7H, m) 7.43-7.56 (3H, m) 7.88 (1H, d, J = 8.4 H
z) 8.07 (1H, d, J = 8.4 Hz).
【0506】実施例374 N-[(1RS,2SR)-1-[4-(2,2,3,3,
3-ペンタフルオロプロピル)ベンジル]-2-(3-クロ
ロフェニル)-2-ヒドロキシエチル]-6,7-ジヒドロ
-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド 6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボン酸(151mg,0.801ミリモル)の
N,N-ジメチルホルムアミド(5ml)溶液に、1-エ
チル-3-(3-ジメチルアミノプロピル)カルボジイミ
ド塩酸塩(154g,0.801ミリモル)、1-ヒド
ロキシベンゾトリアゾール1水和物(123mg,0.
801ミリモル)を加え、最後に(1RS,2SR)-
2-アミノ-1-(3-クロロフェニル)-3-[4-(2,
2,3,3,3-ペンタフルオロプロピル)フェニル]-
1-プロパノール(0.30g,0.763ミリモル)
を加え、室温で終夜撹拌した。酢酸エチルで希釈し、飽
和重曹水、水、飽和食塩水で洗浄し、無水硫酸マグネシ
ウムで乾燥後、シリカゲルをつめたグラスフィルターで
ろ過し、酢酸エチルで洗浄し、減圧濃縮した。残渣を再
結晶(ヘキサン-酢酸エチル)で精製し、N-[(1R
S,2SR)-1-[4-(2,2,3,3,3-ペンタフ
ルオロプロピル)ベンジル]-2-(3-クロロフェニ
ル)-2-ヒドロキシエチル]-6,7-ジヒドロ-5H-ベ
ンゾ[a]シクロヘプテン-1-カルボキサミド(0.2
84g,66%)を無色結晶として得た。 mp 176-177℃ 元素分析値C30H27NO2ClF5 として 計算値: C, 63.89; H, 4.83; N, 2.48 実測値: C, 63.70; H, 4.85; N, 2.22 IRνmaxKBr(cm-1): 3281, 1635, 1518, 1433, 1315, 11
97, 10301 H-NMR(CDCl3) δ (ppm) 1.95-2.04 (2H, m )2.16-2.28
(2H, m) 2.64-2.68 (2H, m) 2.75 (1H, dd, J = 11.1,
14.7 Hz) 2.97 (1H, dd, J = 4.5, 14.7 Hz) 3.28 (2
H, t, J = 18.3 Hz) 4.01 (1H, br) 4.62-4.71 (1H, m)
5.05 (1H, d, J =2.7 Hz) 5.74 (1H, d, J = 7.8 Hz)
5.95 (1H, dt, J = 5.7, 11.4 Hz) 6.29 (1H, d, J = 1
1.7 Hz) 6.88 (1H, dd, J = 1.2, 7.2 Hz) 7.03 (1H,
t, J = 7.8Hz) 7.0-7.36 (8H, m) 7.48 (1H, s).Example 374 N-[(1RS, 2SR) -1- [4- (2,2,3,3,3)
3-Pentafluoropropyl) benzyl] -2- (3-chlorophenyl) -2-hydroxyethyl] -6,7-dihydro
-5H-benzo [a] cycloheptene-1-carboxamide 6,7-dihydro-5H-benzo [a] cycloheptene-1
To a solution of -carboxylic acid (151 mg, 0.801 mmol) in N, N-dimethylformamide (5 ml), 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (154 g, 0.801 mmol), 1 -Hydroxybenzotriazole monohydrate (123 mg, 0.
801 mmol), and (1RS, 2SR)-
2-amino-1- (3-chlorophenyl) -3- [4- (2,
2,3,3,3-pentafluoropropyl) phenyl]-
1-propanol (0.30 g, 0.763 mmol)
Was added and stirred at room temperature overnight. It was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water, and saturated saline, dried over anhydrous magnesium sulfate, filtered through a glass filter filled with silica gel, washed with ethyl acetate, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate) and N-[(1R
(S, 2SR) -1- [4- (2,2,3,3,3-pentafluoropropyl) benzyl] -2- (3-chlorophenyl) -2-hydroxyethyl] -6,7-dihydro-5H- Benzo [a] cycloheptene-1-carboxamide (0.2
(84 g, 66%) as colorless crystals. mp 176-177 ° C. Elemental analysis C 30 H 27 NO 2 ClF 5 Calculated: C, 63.89; H, 4.83 ; N, 2.48 Found: C, 63.70; H, 4.85 ; N, 2.22 IRνmax KBr (cm - 1 ): 3281, 1635, 1518, 1433, 1315, 11
97, 1030 1 H-NMR (CDCl 3 ) δ (ppm) 1.95-2.04 (2H, m) 2.16-2.28
(2H, m) 2.64-2.68 (2H, m) 2.75 (1H, dd, J = 11.1,
14.7 Hz) 2.97 (1H, dd, J = 4.5, 14.7 Hz) 3.28 (2
(H, t, J = 18.3 Hz) 4.01 (1H, br) 4.62-4.71 (1H, m)
5.05 (1H, d, J = 2.7 Hz) 5.74 (1H, d, J = 7.8 Hz)
5.95 (1H, dt, J = 5.7, 11.4 Hz) 6.29 (1H, d, J = 1
1.7 Hz) 6.88 (1H, dd, J = 1.2, 7.2 Hz) 7.03 (1H,
t, J = 7.8Hz) 7.0-7.36 (8H, m) 7.48 (1H, s).
【0507】実施例375 N-[(1RS,2SR)-1-[4-(2,2,3,3,
3-ペンタフルオロフェニル)ベンジル]-2-(3-クロ
ロフェニル)-2-ヒドロキシエチル]-5-クロロ-1-ナ
フトアミド 5-クロロナフタレン-1-カルボン酸(176mg,
0.849ミリモル)のN,N-ジメチルホルムアミド
(5ml)溶液に、1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド塩酸塩(163mg,0.8
49ミリモル)、1-ヒドロキシベンゾトリアゾール1
水和物(130mg,0.849ミリモル)を加え、最
後に(1RS,2SR)-2-アミノ-1-(3-クロロフ
ェニル)-3-[4-(2,2,3,3,3-ペンタフルオ
ロプロピル)フェニル]-1-プロパノール(318m
g,0.809ミリモル)を加え、室温で終夜撹拌し
た。酢酸エチルで希釈し、飽和重曹水、水、飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後、シリガゲル
をつめたグラスフィルターでろ過し、酢酸エチルで洗浄
し、減圧濃縮した。残渣を再結晶(ヘキサン-酢酸エチ
ル)で精製し、N-[(1RS,2SR)-1-[4-
(2,2,3,3,3-ペンタフルオロフェニル)ベン
ジル]-2-(3-クロロフェニル)-2-ヒドロキシエチ
ル]-5-クロロ-1-ナフトアミド(330mg,70
%)を無色結晶として得た。 mp 216-217℃ 元素分析値C29H22NO2Cl2F5 として 計算値: C, 59.81; H, 3.81; N, 2.41 実測値: C, 59.75; H, 3.81; N, 2.41 IRνmaxKBr(cm-1): 3260, 1637, 1539, 1319, 1180, 11
18, 10301 H-NMR(CDCl3) δ (ppm) 2.80 (1H, dd, J = 11.0, 14.
4 Hz) 3.02 (1H, dd, J= 4.0, 14.6 Hz) 3.30 (2H, t,
J = 18.2 Hz) 3.74 (1H, br) 4.72-4.84 (1H, m) 5.09
(1H, s) 5.96 (1H, d, J = 8.6 Hz) 7.11-7.58 (12H,
m) 7.74 (1H, d,J = 8.8 Hz) 8.31 (1H, d, J = 8.4 H
z).Example 375 N-[(1RS, 2SR) -1- [4- (2,2,3,3,3)
[3-pentafluorophenyl) benzyl] -2- (3-chlorophenyl) -2-hydroxyethyl] -5-chloro-1-naphthamide 5-chloronaphthalene-1-carboxylic acid (176 mg,
0.849 mmol) in N, N-dimethylformamide (5 ml) was added to 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (163 mg, 0.8 ml).
49 mmol) 1-hydroxybenzotriazole 1
Hydrate (130 mg, 0.849 mmol) was added, and finally (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [4- (2,2,3,3-3- Pentafluoropropyl) phenyl] -1-propanol (318m
g, 0.809 mmol) and stirred at room temperature overnight. The mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water and saturated saline, dried over anhydrous magnesium sulfate, filtered through a glass filter filled with silica gel, washed with ethyl acetate, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate) to give N-[(1RS, 2SR) -1- [4-
(2,2,3,3,3-pentafluorophenyl) benzyl] -2- (3-chlorophenyl) -2-hydroxyethyl] -5-chloro-1-naphthamide (330 mg, 70
%) As colorless crystals. mp 216-217 ° C Elemental analysis: C 29 H 22 NO 2 Cl 2 F 5 Calculated: C, 59.81; H, 3.81; N, 2.41 Found: C, 59.75; H, 3.81; N, 2.41 IRνmax KBr ( cm -1 ): 3260, 1637, 1539, 1319, 1180, 11
18, 1030 1 H-NMR (CDCl 3 ) δ (ppm) 2.80 (1H, dd, J = 11.0, 14.
4 Hz) 3.02 (1H, dd, J = 4.0, 14.6 Hz) 3.30 (2H, t,
J = 18.2 Hz) 3.74 (1H, br) 4.72-4.84 (1H, m) 5.09
(1H, s) 5.96 (1H, d, J = 8.6 Hz) 7.11-7.58 (12H,
m) 7.74 (1H, d, J = 8.8 Hz) 8.31 (1H, d, J = 8.4 H
z).
【0508】実施例376 N-{(1RS,2SR)-2-(3-クロロフェニル)-
1-[(3,3-ジメチル-2,3-ジヒドロ-1-ベンゾフ
ラン-5-イル)メチル]-2-ヒドロキシエチル}-4-フ
ルオロ-1-ナフトアミド 1) 2-ブロモ-4-メチル-1-[(2-メチル-2-プロ
ペニル)オキシ]ベンゼン 2-ブロモ-p-クレゾール(10ml,82.7ミリモ
ル)のN,N-ジメチルホルムアミド(200ml)溶
液に炭酸カリウム(17.2g,124ミリモル)、塩
化メタリル(9.8ml,99.2ミリモル)を加え、
100℃で終夜撹拌した。酢酸エチルで希釈し、水、飽
和食塩水で洗浄した。無水硫酸マグネシウムで乾燥後、
ろ過、減圧濃縮した。残渣をシリカゲルカラムクロマト
グラフィー(ヘキサン:酢酸エチル=5:1)で精製
し、2-ブロモ-4-メチル-1-[(2-メチル-2-プロペ
ニル)オキシ]ベンゼン(19.67g,99%)を無
色透明オイルとして得た。 IRνmaxKBr(cm-1) : 1658, 1604, 1494, 1452, 1377, 1
286, 1251, 1230, 1207,11531 H-NMR(CDCl3) δ (ppm) 1.84 (3H, s) 2.25 (3H, s)
4.45 (2H, s) 4.98-5.00(1H, m) 5.13-5.14 (1H, m) 6.
56 (1H, d, J = 8.4 Hz) 6.99-7.03 (1H, m) 7.35-7.36
(1H, m). 2) 3,3,5-トリメチル-2,3-ジヒドロ-1-ベ
ンゾフラン 2-ブロモ-4-メチル-1-[(2-メチル-2-プロペニ
ル)オキシ]ベンゼン(5.0g,20.7ミリモル)
のトルエン(100ml)溶液に2,2'-アゾビスイソ
ブチロニトリル(1.45g,8.8ミリモル)、水素
化トリ-n-ブチルスズ(8.34ml,31ミリモル)
を加え、終夜加熱還流した。反応終了後、溶媒を減圧留
去し、シリカゲルカラムクロマトグラフィー(ヘキサ
ン:酢酸エチル=1:0、50:1)で精製し、3,
3,5-トリメチル-2,3-ジヒドロ-1-ベンゾフラン
(3.70g,100%)を無色透明オイルとして得
た。 IRνmaxKBr(cm-1): 1612, 1489, 1464, 1192, 9911 H-NMR(CDCl3) δ (ppm) 1.32 (6H, s) 2.29 (3H, s)
4.20 (2H, s) 6.67 (1H,d, J = 8.4 Hz) 6.90-6.92 (2
H, m). 3) エチル3-(3-クロロフェニル)-2-[(3,3
-ジメチル-2,3-ジヒドロ-1-ベンゾフラン-5-イ
ル)メチル]-3-オキソプロピオネート 3,3,5-トリメチル-2,3-ジヒドロ-1-ベンゾフ
ラン(9.42g,58ミリモル)の四塩化炭素(30
0ml)溶液に2,2'-アゾビスイソブチロニトリル
(0.48g,2.9ミリモル)、N-ブロモスクシン
イミド(10.84g,60.9ミリモル)を加え、終
夜、加熱還流した。室温に冷却後、不溶物をろ過、減圧
濃縮し、臭素体を得た。エチル3-(3-クロロフェニ
ル)-3-オキソプロピオネート(13.15g,58ミ
リモル)のジメトキシエタン(100ml)溶液を氷冷
し、水素化ナトリウム(60%,2.32g,58ミリ
モル)を加え、氷冷下で30分撹拌した後、臭素体(5
8ミリモル)のジメトキシエタン(150ml)溶液を
加え、室温で終夜撹拌した。反応終了後、0.5規定の
塩酸でクエンチし、酢酸エチルで希釈し、水、飽和食塩
水で洗浄した。無水硫酸マグネシウムで乾燥後、ろ過、
減圧濃縮した。残渣をシリカゲルカラムクロマトグラフ
ィー(ヘキサン:酢酸エチル=20:1、15:1)で
精製し、エチル3-(3-クロロフェニル)-2-[(3,
3-ジメチル-2,3-ジヒドロ-1-ベンゾフラン-5-イ
ル)メチル]-3-オキソプロピオネート(14.04
g,63%)を淡黄色オイルとして得た。 IRνmaxKBr(cm-1) : 1738, 1693, 1612, 1572, 1487, 1
469, 1423, 1365, 1228,11921 H-NMR(CDCl3)δ (ppm) 1.14 (3H, t, J = 7.0 Hz) 1.2
4 (3H, s) 1.28 (3H, s)3.27 (2H, dd, J = 1.8, 7.6 H
z) 4.06-4.17 (4H, q, J = 7.2 Hz) 6.65 (1H,d, J =
8.0 Hz) 6.89-6.90 (1H, m) 6.95 (1H, dd, J = 1.8,
8.0 Hz) 7.36 (1H, t, J = 8.0 Hz) 7.51 (1H, ddd, J
= 1.2, 2.2, 8.0 Hz) 7.77 (1H, dt, J =1.0, 7.6 Hz)
7.85-7.86 (1H, m). 4) エチル(2RS,3RS)-3-(3-クロロフェ
ニル)-2-[(3,3-ジメチル-2,3-ジヒドロ-1-
ベンゾフラン-5-イル)メチル]-3-ヒドロキシプロピ
オネート 塩化亜鉛(9.90g,72.6ミリモル)のエーテル
懸濁液(140ml)に水素化ホウ素ナトリウム(5.
50g,145.2ミリモル)を室温で加えそのまま2
時間撹拌した。不溶物をろ過し、そのろ液にエチル3-
(3-クロロフェニル)-2-[(3,3-ジメチル-2,
3-ジヒドロ-1-ベンゾフラン-5-イル)メチル]-3-
オキソプロピオネート(14.04g,36.3ミリモ
ル)のエーテル(50ml)溶液を加え、室温で1.5
時間撹拌した。3規定塩酸で反応を終了させ、酢酸エチ
ルで希釈し、水、飽和食塩水で洗浄した。無水硫酸マグ
ネシウムで乾燥後、ろ過、減圧濃縮した。残渣をシリカ
ゲルカラムクロマトグラフィー(ヘキサン:酢酸エチル
=10:1、5:1)で精製し、エチル(2RS,3R
S)-3-(3-クロロフェニル)-2-[(3,3-ジメチ
ル-2,3-ジヒドロ-1-ベンゾフラン-5-イル)メチ
ル]-3-ヒドロキシプロピオネート(12.07g,8
6%)を淡黄色オイルとして得た。 IRνmaxKBr(cm-1) : 3460, 1726, 1487, 1467, 1373, 1
190, 1032, 9871 H-NMR(CDCl3) δ (ppm) 0.95 (3H, t, J = 7.0 Hz) 1.
27 (3H, s) 1.29 (3H, s) 2.89-2.97 (3H, m) 3.18 (1
H, d, J = 2.4 Hz) 3.90 (2H, q, J = 7.0 Hz) 4.18 (2
H, s) 4.98-4.99 (1H, m) 6.03 (1H, d, J = 8.2 Hz)
6.78-6.84 (2H, m)7.24-7.28 (3H, m) 7.40-7.42 (1H,
m). 5) (4RS,5SR)-5-(3-クロロフェニル)-
4-[(3,3-ジメチル-2,3-ジヒドロ-1-ベンゾフ
ラン-5-イル)メチル]-1,3-オキサゾリジン-2-オ
ン エチル(2RS,3RS)-3-(3-クロロフェニル)-
2-[(3,3-ジメチル-2,3-ジヒドロ-1-ベンゾフ
ラン-5-イル)メチル]-3-ヒドロキシプロピオネート
(11.44g,29.4ミリモル)のテトラヒドロフ
ラン-エタノール(60ml-60ml)溶液に室温で1
規定の水酸化ナトリウム(60ml,60ミリモル)を
加え、室温で終夜撹拌した。反応終了後、有機溶媒を減
圧留去し、水層を1規定塩酸で酸性とし、酢酸エチルで
抽出した。有機層を無水硫酸マグネシウムで乾燥後、ろ
過、減圧濃縮し、無色透明オイルを得た。このテトラヒ
ドロフラン(300ml)溶液にトリエチルアミン
(6.2ml,44.1ミリモル)、ジフェニルリン酸
アジド(7.6ml,35.3ミリモル)を加え、4時
間加熱還流した。溶媒を留去し、酢酸エチルで希釈し、
水、飽和重曹水、飽和食塩水で洗浄した。有機層を無水
硫酸マグネシウムで乾燥後、ろ過、減圧濃縮した。ヘキ
サン-酢酸エチルで再結晶を行い、(4RS,5SR)-
5-(3-クロロフェニル)-4-[(3,3-ジメチル-
2,3-ジヒドロ-1-ベンゾフラン-5-イル)メチル]-
1,3-オキサゾリジン-2-オン(8.11g,77
%)を無色結晶として得た。 mp 183-184℃ IRνmaxKBr(cm-1): 3271, 1759, 1489, 1236, 11941 H-NMR(CDCl3) δ (ppm) 1.29, 1.30 (each s, 6H) 2.1
5 (1H, dd, J = 11.4, 13.8 Hz) 2.27 (1H, dd, J = 3.
9, 13.8 Hz) 4.18-4.25 (3H, m) 4.98 (1H, s) 5.75 (1
H, d, J = 7.8 Hz) 6.68 (1H, d, J = 8.1 Hz) 6.74-6.
79 (2H, m) 7.25-7.28 (1H, m) 7.34-7.39 (3H, m). 6) (1RS,2SR)-2-アミノ-1-(3-クロロ
フェニル)-3-(3,3-ジメチル-2,3-ジヒドロ-1
-ベンゾフラン-5-イル)-1-プロパノール (4RS,5SR)-5-(3-クロロフェニル)-4-
[(3,3-ジメチル-2,3-ジヒドロ-1-ベンゾフラ
ン-5-イル)メチル]-1,3-オキサゾリジン-2-オン
(5.33g,14.9ミリモル)のエタノール(10
0ml)溶液に8規定水酸化ナトリウム水溶液(9.3
ml,74.5ミリモル)を加え、5時間加熱還流し
た。反応終了後、エタノールを減圧留去した後、水で希
釈し、酢酸エチルで抽出した。有機層を合わせ、飽和食
塩水で洗浄し、無水硫酸マグネシウムで乾燥後、ろ過、
減圧濃縮した。残渣を再結晶(ヘキサン-酢酸エチル)
で精製し、(1RS,2SR)-2-アミノ-1-(3-ク
ロロフェニル)-3-(3,3-ジメチル-2,3-ジヒド
ロ-1-ベンゾフラン-5-イル)-1-プロパノール(3.
68g,74%)を無色結晶として得た。 mp 83-86℃ IRνmaxKBr(cm-1) : 3000-3300, 1597, 1574, 1487, 14
69, 1192, 1076, 9871 H-NMR(CDCl3) δ (ppm) 1.30 (3H, s) 1.31 (3H, s)
2.28 (1H, dd, J = 7.5,13.8 Hz) 2.70 (1H, dd, J =
3.3, 13.8 Hz) 3.21-3.27 (1H, m) 4.20 (2H, s)4.66
(1H, d, J = 5.1 Hz) 6.69 (1H, d, J = 7.8 Hz) 6.84-
6.88 (2H, m) 7.24-7.33 (3H, m) 7.41 (1H, s). 7) N-{(1RS,2SR)-2-(3-クロロフェニ
ル)-1-[(3,3-ジメチル-2,3-ジヒドロ-1-ベ
ンゾフラン-5-イル)メチル]-2-ヒドロキシエチル}
-4-フルオロ-1-ナフトアミド 4-フルオロナフタレン-1-カルボン酸(242mg,
1.27ミリモル)のN,N-ジメチルホルムアミド
(10ml)溶液に、1-エチル-3-(3-ジメチルアミ
ノプロピル)カルボジイミド塩酸塩(243mg,1.
27ミリモル)、1-ヒドロキシベンゾトリアゾール1
水和物(195mg,1.27ミリモル)を加え、最後
に(1RS,2SR)-2-アミノ-1-(3-クロロフェ
ニル)-3-(3,3-ジメチル-2,3-ジヒドロ-1-ベ
ンゾフラン-5-イル)-1-プロパノール(0.40g,
1.21ミリモル)を加え、室温で終夜撹拌した。酢酸
エチルで希釈し、飽和重曹水、水、飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後、シリカゲルをつめ
たグラスフィルターでろ過し、酢酸エチルで洗浄し、減
圧濃縮した。残渣を再結晶(ヘキサン-酢酸エチル)で
精製し、N-{(1RS,2SR)-2-(3-クロロフェ
ニル)-1-[(3,3-ジメチル-2,3-ジヒドロ-1-
ベンゾフラン-5-イル)メチル]-2-ヒドロキシエチ
ル}-4-フルオロ-1-ナフトアミド(383mg,68
%)を無色結晶として得た。 mp 131-133℃ 元素分析値C30H27NO3Cl・H2O として 計算値: C, 71.63; H, 5.81; N, 2.78 実測値: C, 71.28; H, 5.54; N, 2.79 IRνmaxKBr(cm-1): 3281, 1641, 1626, 1518, 1487, 14
64, 1425, 1261, 1236,11941 H-NMR(CDCl3) δ (ppm) 1.22 (3H, s) 1.27 (3H, s)
2.71 (1H, dd, J = 11.1,14.7 Hz) 3.00 (1H, dd, J =
4.2, 14.4 Hz) 4.12 (1H, d, J = 4.2 Hz) 4.21(2H, d,
J = 0.9 Hz) 4.69-4.78 (1H, m) 5.08-5.10 (1H, m)
5.83 (1H, d, J =7.5 Hz) 6.72 (1H, d, J = 8.4 Hz)
6.91-7.02 (3H, m) 7.16 (1H, dd, J = 5.4, 7.8 Hz)
7.27-7.38 (3H, m) 7.45-7.57 (3H, m) 7.80 (1H, d, J
= 8.1 Hz)8.07 (1H, d, J = 7.8 Hz).Example 376 N-{(1RS, 2SR) -2- (3-chlorophenyl)-
1-[(3,3-Dimethyl-2,3-dihydro-1-benzofuran-5-yl) methyl] -2-hydroxyethyl} -4-fluoro-1-naphthamide 1) 2-bromo-4-methyl- 1-[(2-Methyl-2-propenyl) oxy] benzene Potassium carbonate (17.2 g, 124 ml) was added to a solution of 2-bromo-p-cresol (10 ml, 82.7 mmol) in N, N-dimethylformamide (200 ml). Mmol), methallyl chloride (9.8 ml, 99.2 mmol),
Stirred at 100 ° C. overnight. The mixture was diluted with ethyl acetate and washed with water and saturated saline. After drying over anhydrous magnesium sulfate,
Filtration and concentration under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 5: 1), and 2-bromo-4-methyl-1-[(2-methyl-2-propenyl) oxy] benzene (19.67 g, 99%) ) Was obtained as a clear, colorless oil. IRνmax KBr (cm -1 ): 1658, 1604, 1494, 1452, 1377, 1
286, 1251, 1230, 1207,1153 1 H-NMR (CDCl 3 ) δ (ppm) 1.84 (3H, s) 2.25 (3H, s)
4.45 (2H, s) 4.98-5.00 (1H, m) 5.13-5.14 (1H, m) 6.
56 (1H, d, J = 8.4 Hz) 6.99-7.03 (1H, m) 7.35-7.36
(1H, m). 2) 3,3,5-trimethyl-2,3-dihydro-1-benzofuran 2-bromo-4-methyl-1-[(2-methyl-2-propenyl) oxy] benzene (5 0.0 g, 20.7 mmol)
2,2'-azobisisobutyronitrile (1.45 g, 8.8 mmol) and tri-n-butyltin hydride (8.34 ml, 31 mmol) in a toluene (100 ml) solution of
Was added and heated to reflux overnight. After completion of the reaction, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (hexane: ethyl acetate = 1: 0, 50: 1).
3,5-Trimethyl-2,3-dihydro-1-benzofuran (3.70 g, 100%) was obtained as a clear, colorless oil. IRνmax KBr (cm -1 ): 1612, 1489, 1464, 1192, 991 1 H-NMR (CDCl 3 ) δ (ppm) 1.32 (6H, s) 2.29 (3H, s)
4.20 (2H, s) 6.67 (1H, d, J = 8.4 Hz) 6.90-6.92 (2
H, m). 3) Ethyl 3- (3-chlorophenyl) -2-[(3,3
-Dimethyl-2,3-dihydro-1-benzofuran-5-yl) methyl] -3-oxopropionate 3,3,5-trimethyl-2,3-dihydro-1-benzofuran (9.42 g, 58 mmol) ) Carbon tetrachloride (30
0 ml) solution, 2,2'-azobisisobutyronitrile (0.48 g, 2.9 mmol) and N-bromosuccinimide (10.84 g, 60.9 mmol) were added, and the mixture was heated under reflux overnight. After cooling to room temperature, insolubles were filtered and concentrated under reduced pressure to obtain a bromine. A solution of ethyl 3- (3-chlorophenyl) -3-oxopropionate (13.15 g, 58 mmol) in dimethoxyethane (100 ml) was ice-cooled, and sodium hydride (60%, 2.32 g, 58 mmol) was added. After stirring for 30 minutes under ice-cooling, bromine (5
(8 mmol) in dimethoxyethane (150 ml) and stirred overnight at room temperature. After completion of the reaction, the reaction was quenched with 0.5N hydrochloric acid, diluted with ethyl acetate, and washed with water and saturated saline. After drying over anhydrous magnesium sulfate, filtration,
It was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 20: 1, 15: 1), and ethyl 3- (3-chlorophenyl) -2-[(3,
3-dimethyl-2,3-dihydro-1-benzofuran-5-yl) methyl] -3-oxopropionate (14.04
g, 63%) as a pale yellow oil. IRνmax KBr (cm -1 ): 1738, 1693, 1612, 1572, 1487, 1
469, 1423, 1365, 1228,1192 1 H-NMR (CDCl 3 ) δ (ppm) 1.14 (3H, t, J = 7.0 Hz) 1.2
4 (3H, s) 1.28 (3H, s) 3.27 (2H, dd, J = 1.8, 7.6 H
z) 4.06-4.17 (4H, q, J = 7.2 Hz) 6.65 (1H, d, J =
8.0 Hz) 6.89-6.90 (1H, m) 6.95 (1H, dd, J = 1.8,
8.0 Hz) 7.36 (1H, t, J = 8.0 Hz) 7.51 (1H, ddd, J
= 1.2, 2.2, 8.0 Hz) 7.77 (1H, dt, J = 1.0, 7.6 Hz)
7.85-7.86 (1H, m). 4) Ethyl (2RS, 3RS) -3- (3-chlorophenyl) -2-[(3,3-dimethyl-2,3-dihydro-1-)
Benzofuran-5-yl) methyl] -3-hydroxypropionate Sodium borohydride (5.10 g) was added to an ether suspension (140 ml) of zinc chloride (9.90 g, 72.6 mmol).
50 g, 145.2 mmol) at room temperature.
Stirred for hours. The insoluble material is filtered, and the filtrate is ethyl 3-
(3-chlorophenyl) -2-[(3,3-dimethyl-2,2
3-dihydro-1-benzofuran-5-yl) methyl] -3-
A solution of oxopropionate (14.04 g, 36.3 mmol) in ether (50 ml) was added, and the mixture was added at room temperature for 1.5 hours.
Stirred for hours. The reaction was terminated with 3N hydrochloric acid, diluted with ethyl acetate, and washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 10: 1, 5: 1) to give ethyl (2RS, 3R).
S) -3- (3-Chlorophenyl) -2-[(3,3-dimethyl-2,3-dihydro-1-benzofuran-5-yl) methyl] -3-hydroxypropionate (12.07 g, 8
6%) as a pale yellow oil. IRνmax KBr (cm -1 ): 3460, 1726, 1487, 1467, 1373, 1
190, 1032, 987 1 H-NMR (CDCl 3 ) δ (ppm) 0.95 (3H, t, J = 7.0 Hz) 1.
27 (3H, s) 1.29 (3H, s) 2.89-2.97 (3H, m) 3.18 (1
H, d, J = 2.4 Hz) 3.90 (2H, q, J = 7.0 Hz) 4.18 (2
(H, s) 4.98-4.99 (1H, m) 6.03 (1H, d, J = 8.2 Hz)
6.78-6.84 (2H, m) 7.24-7.28 (3H, m) 7.40-7.42 (1H,
m). 5) (4RS, 5SR) -5- (3-chlorophenyl)-
4-[(3,3-dimethyl-2,3-dihydro-1-benzofuran-5-yl) methyl] -1,3-oxazolidin-2-one ethyl (2RS, 3RS) -3- (3-chlorophenyl) -
2-[(3,3-dimethyl-2,3-dihydro-1-benzofuran-5-yl) methyl] -3-hydroxypropionate (11.44 g, 29.4 mmol) in tetrahydrofuran-ethanol (60 ml- 60 ml) solution at room temperature
Normal sodium hydroxide (60 ml, 60 mmol) was added, and the mixture was stirred at room temperature overnight. After completion of the reaction, the organic solvent was distilled off under reduced pressure, the aqueous layer was acidified with 1N hydrochloric acid, and extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain a colorless transparent oil. To this tetrahydrofuran (300 ml) solution were added triethylamine (6.2 ml, 44.1 mmol) and diphenylphosphoric azide (7.6 ml, 35.3 mmol), and the mixture was heated under reflux for 4 hours. Evaporate the solvent, dilute with ethyl acetate,
Washed with water, saturated aqueous sodium bicarbonate, and saturated saline. The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. Recrystallization with hexane-ethyl acetate gave (4RS, 5SR)-
5- (3-chlorophenyl) -4-[(3,3-dimethyl-
2,3-dihydro-1-benzofuran-5-yl) methyl]-
1,3-oxazolidine-2-one (8.11 g, 77
%) As colorless crystals. mp 183-184 ° C IRνmax KBr (cm -1 ): 3271, 1759, 1489, 1236, 1194 1 H-NMR (CDCl 3 ) δ (ppm) 1.29, 1.30 (each s, 6H) 2.1
5 (1H, dd, J = 11.4, 13.8 Hz) 2.27 (1H, dd, J = 3.
9, 13.8 Hz) 4.18-4.25 (3H, m) 4.98 (1H, s) 5.75 (1
(H, d, J = 7.8 Hz) 6.68 (1H, d, J = 8.1 Hz) 6.74-6.
79 (2H, m) 7.25-7.28 (1H, m) 7.34-7.39 (3H, m). 6) (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- (3,3- Dimethyl-2,3-dihydro-1
-Benzofuran-5-yl) -1-propanol (4RS, 5SR) -5- (3-chlorophenyl) -4-
[(3,3-Dimethyl-2,3-dihydro-1-benzofuran-5-yl) methyl] -1,3-oxazolidin-2-one (5.33 g, 14.9 mmol) in ethanol (10
0 ml) solution to an 8N aqueous sodium hydroxide solution (9.3 ml).
ml, 74.5 mmol) and heated under reflux for 5 hours. After completion of the reaction, ethanol was distilled off under reduced pressure, diluted with water, and extracted with ethyl acetate. The organic layers were combined, washed with saturated saline, dried over anhydrous magnesium sulfate, filtered,
It was concentrated under reduced pressure. Recrystallize the residue (hexane-ethyl acetate)
And purified by (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- (3,3-dimethyl-2,3-dihydro-1-benzofuran-5-yl) -1-propanol ( 3.
(68 g, 74%) as colorless crystals. mp 83-86 ℃ IRνmax KBr (cm -1 ): 3000-3300, 1597, 1574, 1487, 14
69, 1192, 1076, 987 1 H-NMR (CDCl 3 ) δ (ppm) 1.30 (3H, s) 1.31 (3H, s)
2.28 (1H, dd, J = 7.5,13.8 Hz) 2.70 (1H, dd, J =
(3.3, 13.8 Hz) 3.21-3.27 (1H, m) 4.20 (2H, s) 4.66
(1H, d, J = 5.1 Hz) 6.69 (1H, d, J = 7.8 Hz) 6.84-
6.88 (2H, m) 7.24-7.33 (3H, m) 7.41 (1H, s). 7) N-{(1RS, 2SR) -2- (3-chlorophenyl) -1-[(3,3-dimethyl- 2,3-dihydro-1-benzofuran-5-yl) methyl] -2-hydroxyethyl
4-Fluoro-1-naphthamide 4-fluoronaphthalene-1-carboxylic acid (242 mg,
To a solution of 1.27 mmol) in N, N-dimethylformamide (10 ml) was added 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (243 mg, 1.
27 mmol) 1-hydroxybenzotriazole 1
Hydrate (195 mg, 1.27 mmol) was added, and finally (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- (3,3-dimethyl-2,3-dihydro-1). -Benzofuran-5-yl) -1-propanol (0.40 g,
1.21 mmol) and stirred at room temperature overnight. It was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water, and saturated saline, dried over anhydrous magnesium sulfate, filtered through a glass filter filled with silica gel, washed with ethyl acetate, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate) to give N-{(1RS, 2SR) -2- (3-chlorophenyl) -1-[(3,3-dimethyl-2,3-dihydro-1-).
Benzofuran-5-yl) methyl] -2-hydroxyethyl} -4-fluoro-1-naphthamide (383 mg, 68
%) As colorless crystals. mp 131-133 ° C Elemental analysis: C 30 H 27 NO 3 Cl ・ H 2 O Calculated: C, 71.63; H, 5.81; N, 2.78 Found: C, 71.28; H, 5.54; N, 2.79 IRνmax KBr (cm -1 ): 3281, 1641, 1626, 1518, 1487, 14
64, 1425, 1261, 1236,1194 1 H-NMR (CDCl 3 ) δ (ppm) 1.22 (3H, s) 1.27 (3H, s)
2.71 (1H, dd, J = 11.1,14.7 Hz) 3.00 (1H, dd, J =
4.2, 14.4 Hz) 4.12 (1H, d, J = 4.2 Hz) 4.21 (2H, d,
J = 0.9 Hz) 4.69-4.78 (1H, m) 5.08-5.10 (1H, m)
5.83 (1H, d, J = 7.5 Hz) 6.72 (1H, d, J = 8.4 Hz)
6.91-7.02 (3H, m) 7.16 (1H, dd, J = 5.4, 7.8 Hz)
7.27-7.38 (3H, m) 7.45-7.57 (3H, m) 7.80 (1H, d, J
= 8.1 Hz) 8.07 (1H, d, J = 7.8 Hz).
【0509】実施例377 N-{(1RS,2SR)-2-(3-クロロフェニル)-
1-[(3,3-ジメチル-2,3-ジヒドロ-1-ベンゾフ
ラン-5-イル)メチル]-2-ヒドロキシエチル}-6,
7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カ
ルボキサミド 6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボン酸(239mg,1.27ミリモル)のN,
N-ジメチルホルムアミド(5ml)溶液に、1-エチル
-3-(3-ジメチルアミノプロピル)カルボジイミド塩
酸塩(243mg,1.27ミリモル)、1-ヒドロキ
シベンゾトリアゾール1水和物(195mg,1.27
ミリモル)を加え、最後に(1RS,2SR)-2-アミ
ノ-1-(3-クロロフェニル)-3-(3,3-ジメチル-
2,3-ジヒドロ-1-ベンゾフラン-5-イル)-1-プロ
パノール(0.40g,1.21ミリモル)を加え、室
温で終夜撹拌した。酢酸エチルで希釈し、飽和重曹水、
水、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後、シリカゲルをつめたグラスフィルターでろ過し、酢
酸エチルで洗浄し、減圧濃縮した。残渣を再結晶(ヘキ
サン-酢酸エチル)で精製し、N-{(1RS,2SR)
-2-(3-クロロフェニル)-1-[(3,3-ジメチル-
2,3-ジヒドロ-1-ベンゾフラン-5-イル)メチル]-
2-ヒドロキシエチル}-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド(326m
g,54%)を無色結晶として得た。 mp 149-150℃ 元素分析値C31H32NO3Cl・0.5H2O として 計算値: C, 72.86; H, 6.51; N, 2.74 実測値: C, 73.04; H, 6.26; N, 3.04 IRνmaxKBr(cm-1) : 3304, 1635, 1514, 1487, 1192, 1
076, 987, 9101 H-NMR(CDCl3) δ (ppm) 1.28 (6H, s) 1.98-2.01 (2H,
m) 2.16-2.21 (2H, m)2.58-2.69 (3H, m) 2.87-2.95
(1H, m) 4.20 (2H, s) 4.62 (1H, br) 5.00 (1H,s) 5.7
1 (1H, d, J = 7.4 Hz) 5.89-6.00 (1H,, m) 6.26 (1H,
d, J = 11.8 Hz) 6.68 (1H, d, J = 8.8 Hz) 6.88-7.1
6 (5H, m) 7.26-7.30 (3H, m) 7.46 (1H,s)Example 377 N-{(1RS, 2SR) -2- (3-chlorophenyl)-
1-[(3,3-dimethyl-2,3-dihydro-1-benzofuran-5-yl) methyl] -2-hydroxyethyl} -6
7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 6,7-dihydro-5H-benzo [a] cycloheptene-1
-Carboxylic acid (239 mg, 1.27 mmol) N,
N-dimethylformamide (5 ml) solution in 1-ethyl
-3- (3-Dimethylaminopropyl) carbodiimide hydrochloride (243 mg, 1.27 mmol), 1-hydroxybenzotriazole monohydrate (195 mg, 1.27
Mmol) and finally (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- (3,3-dimethyl-
2,3-Dihydro-1-benzofuran-5-yl) -1-propanol (0.40 g, 1.21 mmol) was added, and the mixture was stirred at room temperature overnight. Dilute with ethyl acetate, add saturated aqueous sodium bicarbonate,
After washing with water and saturated saline and drying over anhydrous magnesium sulfate, the mixture was filtered through a glass filter filled with silica gel, washed with ethyl acetate, and concentrated under reduced pressure. The residue is purified by recrystallization (hexane-ethyl acetate) and N-{(1RS, 2SR)
-2- (3-chlorophenyl) -1-[(3,3-dimethyl-
2,3-dihydro-1-benzofuran-5-yl) methyl]-
2-hydroxyethyl} -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide (326 m
g, 54%) as colorless crystals. mp 149-150 ° C Elemental analysis: C 31 H 32 NO 3 Cl ・ 0.5H 2 O Calculated: C, 72.86; H, 6.51; N, 2.74 Found: C, 73.04; H, 6.26; N, 3.04 IRνmax KBr (cm -1 ): 3304, 1635, 1514, 1487, 1192, 1
076, 987, 910 1 H-NMR (CDCl 3 ) δ (ppm) 1.28 (6H, s) 1.98-2.01 (2H,
m) 2.16-2.21 (2H, m) 2.58-2.69 (3H, m) 2.87-2.95
(1H, m) 4.20 (2H, s) 4.62 (1H, br) 5.00 (1H, s) 5.7
1 (1H, d, J = 7.4 Hz) 5.89-6.00 (1H ,, m) 6.26 (1H,
d, J = 11.8 Hz) 6.68 (1H, d, J = 8.8 Hz) 6.88-7.1
6 (5H, m) 7.26-7.30 (3H, m) 7.46 (1H, s)
【0510】実施例378 5-クロロ-N-{(1RS,2SR)-2-(3-クロロフ
ェニル)-1-[(3,3-ジメチル-2,3-ジヒドロ-1
-ベンゾフラン-5-イル)メチル]-2-ヒドロキシエチ
ル}-1-ナフトアミド 5-クロロナフタレン-1-カルボン酸(260mg,
1.26ミリモル)のN,N-ジメチルホルムアミド
(5ml)溶液に、1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド塩酸塩(242mg,1.2
6ミリモル)、1-ヒドロキシベンゾトリアゾール1水
和物(193mg,1.26ミリモル)を加え、最後に
(1RS,2SR)-2-アミノ-1-(3-クロロフェニ
ル)-3-(3,3-ジメチル-2,3-ジヒドロ-1-ベン
ゾフラン-5-イル)-1-プロパノール(0.40g,
1.20ミリモル)を加え、室温で終夜撹拌した。酢酸
エチルで希釈し、飽和重曹水、水、飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後、シリカゲルをつめ
たグラスフィルターでろ過し、酢酸エチルで洗浄し、減
圧濃縮した。残渣を再結晶(ヘキサン-酢酸エチル)で
精製し、5-クロロ-N-{(1RS,2SR)-2-(3-
クロロフェニル)-1-[(3,3-ジメチル-2,3-ジ
ヒドロ-1-ベンゾフラン-5-イル)メチル]-2-ヒドロ
キシエチル}-1-ナフトアミド(473mg,76%)
を無色結晶として得た。 mp 191-192℃ 元素分析値C30H27NO3Cl2 として 計算値: C, 69.23; H, 5.23; N, 2.69 実測値: C, 69.02; H, 5.04; N, 2.71 IRνmaxKBr(cm-1): 3271, 1639, 1572, 1520, 1487, 11
94, 9081 H-NMR(CDCl3)δ (ppm) 1.23 (3H, s) 1.26 (3H, s) 2.
70 (1H, dd, J = 11.0,14.6 Hz) 2.99 (1H, dd, J = 4.
4, 14.8 Hz) 4.21 (2H, s) 4.71-4.78 (1H, m)5.07 (1
H, d, J = 3.2 Hz) 5.86 (1H, d, J = 8.2 Hz) 6.71 (1
H, d, J = 8.8 Hz) 6.90-6.93 (2H, m) 7.22-7.64 (9H,
m) 8.31 (1H, d, J = 8.4 Hz).Example 378 5-Chloro-N-{(1RS, 2SR) -2- (3-chlorophenyl) -1-[(3,3-dimethyl-2,3-dihydro-1
-Benzofuran-5-yl) methyl] -2-hydroxyethyl} -1-naphthamide 5-chloronaphthalene-1-carboxylic acid (260 mg,
1.26 mmol) in N, N-dimethylformamide (5 ml) was added to 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (242 mg, 1.2 mg).
6 mmol), 1-hydroxybenzotriazole monohydrate (193 mg, 1.26 mmol) and finally (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- (3,3 -Dimethyl-2,3-dihydro-1-benzofuran-5-yl) -1-propanol (0.40 g,
1.20 mmol) and stirred overnight at room temperature. It was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water, and saturated saline, dried over anhydrous magnesium sulfate, filtered through a glass filter filled with silica gel, washed with ethyl acetate, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate) to give 5-chloro-N-{(1RS, 2SR) -2- (3-
Chlorophenyl) -1-[(3,3-dimethyl-2,3-dihydro-1-benzofuran-5-yl) methyl] -2-hydroxyethyl} -1-naphthamide (473 mg, 76%)
Was obtained as colorless crystals. mp 191-192 ° C. Elemental analysis C 30 H 27 NO 3 Cl 2 Calculated: C, 69.23; H, 5.23 ; N, 2.69 Found: C, 69.02; H, 5.04 ; N, 2.71 IRνmax KBr (cm - 1 ): 3271, 1639, 1572, 1520, 1487, 11
94, 908 1 H-NMR (CDCl 3 ) δ (ppm) 1.23 (3H, s) 1.26 (3H, s) 2.
70 (1H, dd, J = 11.0,14.6 Hz) 2.99 (1H, dd, J = 4.
4, 14.8 Hz) 4.21 (2H, s) 4.71-4.78 (1H, m) 5.07 (1
H, d, J = 3.2 Hz) 5.86 (1H, d, J = 8.2 Hz) 6.71 (1
H, d, J = 8.8 Hz) 6.90-6.93 (2H, m) 7.22-7.64 (9H,
m) 8.31 (1H, d, J = 8.4 Hz).
【0511】実施例379 N-{(1RS,2SR)-2-(3-クロロフェニル)-
1-[4-(1,1-ジフルオロ-2,2-ジメチルプロピ
ル)ベンジル]-2-ヒドロキシエチル}-4-フルオロ-
1-ナフトアミド 1) 2,2-ジメチル-1-(4-メチルフェニル)-1-
プロパノン 三径フラスコにマグネシウム(7.14g,294ミリ
モル)のエーテル懸濁液(200ml)にp-ブロモト
ルエン(34ml,276ミリモル)のエーテル(10
0ml)溶液を滴下し、1.5時間加熱還流した。その
後、室温で、トリメチルアセトニトリル(25ml,2
26ミリモル)のエーテル(100ml)溶液を加え、
二時間撹拌した。ついで、氷冷し、6規定塩酸を滴下
し、30分、室温で撹拌した。エーテルで希釈し、水、
飽和食塩水で洗浄した。無水硫酸マグネシウムで乾燥
後、ろ過、減圧濃縮した。残渣をシリカゲルカラムクロ
マトグラフィー(ヘキサン:酢酸エチル=1:0、1
0:1)で精製し、2,2-ジメチル-1-(4-メチルフ
ェニル)-1-プロパノン(10.94g,27%)を無
色透明オイルとして得た。 IRνmaxKBr(cm-1) : 1672, 1608, 1477, 1396, 1365, 1
278, 9601 H-NMR(CDCl3) δ(ppm)1.35 (9H, s) 2.38 (3H, s) 7.2
0 (2H, d, J = 8.1 Hz)7.66 (2H, d, J = 8.4 Hz). 2) 1-(1,1-ジフルオロ-2,2-ジメチルプロピ
ル)-4-メチルベンゼン 2,2-ジメチル-1-(4-メチルフェニル)-1-プロパ
ノン(4.69g,26.6ミリモル)の入ったナスコ
ルに、ビス(2-メトキシエチル)アミノサルファート
リフルオライド(10g,45.2ミリモル)を滴下
し、80-85℃で終夜撹拌した。反応混合物を飽和重
曹水に流し込み,酢酸エチルで抽出した。無水硫酸マグ
ネシウムで乾燥後、ろ過、減圧濃縮した。残渣をシリカ
ゲルカラムクロマトグラフィー(ヘキサン)で精製し、
1-(1,1-ジフルオロ-2,2-ジメチルプロピル)-
4-メチルベンゼン(5.16g,77%)を無色透明
オイルとして得た。 IRνmaxKBr(cm-1):1618, 1518, 1485, 1464, 1308, 128
6, 1259, 1209, 1093, 1072, 9761 H-NMR(CDCl3) δ (ppm) 1.02 (9H, s) 2.37 (3H, s)
7.15-7.19 (2H, m) 7.31(2H, d, J = 8.4 Hz). 3) エチル3-(3-クロロフェニル)-2-[4-
(1,1-ジフルオロ-2,2-ジメチルプロピル)ベン
ジル]-3-オキソプロピオネート 1-(1,1-ジフルオロ-2,2-ジメチルプロピル)-
4-メチルベンゼン(4.52g,22.8ミリモル)
の四塩化炭素(150ml)溶液に2,2'-アゾビスイ
ソブチロニトリル(188mg,1.14ミリモル)、
N-ブロモスクシンイミド(4.06g,22.8ミリ
モル)を加え、終夜、加熱還流した。室温に冷却後、不
溶物をろ過、減圧濃縮した。臭素体を得た。これはこの
まま次の反応に用いた。エチル3-(3-クロロフェニ
ル)-3-オキソプロピオネート(5.17g,22.8
ミリモル)のジメトキシエタン(60ml)溶液を氷冷
し、水素化ナトリウム(60%,0.92g,22.8
ミリモル)を加え、氷冷下で15分撹拌した後、臭素体
(22.8ミリモル)のジメトキシエタン(40ml)
溶液を加え、室温で終夜撹拌した。反応終了後、1規定
の塩酸でクエンチし、酢酸エチルで希釈し、水、飽和食
塩水で洗浄した。無水硫酸マグネシウムで乾燥後、ろ
過、減圧濃縮した。残渣をシリカゲルカラムクロマトグ
ラフィー(ヘキサン:酢酸エチル=20:1、15:
1)で精製し、エチル3-(3-クロロフェニル)-2-
[4-(1,1-ジフルオロ-2,2-ジメチルプロピル)
ベンジル]-3-オキソプロピオネート(7.44g,7
7%)を淡黄色オイルとして得た。 IRνmaxKBr(cm-1) : 1736, 1691, 1570, 1483, 1425, 1
367, 1259, 1093, 10721 H-NMR(CDCl3)δ (ppm) 0.99 (9H, s) 1.12 (3H, t, J
= 6.9 Hz) 3.34 (2H, d,J = 7.5 Hz) 3.96-4.15 (2H,
m) 4.56 (1H, t, J = 7.2 Hz) 7.21-7.45 (5H, m) 7.50
-7.55 (1H, m) 7.78-7.90 (1H, m) 7.90-7.92 (1H, m). 4) エチル(2RS,3RS)-3-(3-クロロフェ
ニル)-3-ヒドロキシ-2-[4-(1,1-ジフルオロ-
2,2-ジメチルプロピル)ベンジル]プロピオネート 塩化亜鉛(4.94g,36.2ミリモル)のエーテル
懸濁液(70ml)に水素化ホウ素ナトリウム(2.7
4g,72.4ミリモル)を室温で加えそのまま2時間
撹拌した。不溶物をろ過し、そのろ液にエチル3-(3-
クロロフェニル)-2-[4-(1,1-ジフルオロ-2,
2-ジメチルプロピル)ベンジル]-3-オキソプロピオ
ネート(7.59g,18.1ミリモル)のエーテル
(50ml)溶液を加え、室温で1時間撹拌した。1規
定塩酸で反応を終了させ、酢酸エチルで希釈し、水、飽
和食塩水で洗浄した。無水硫酸マグネシウムで乾燥後、
ろ過、減圧濃縮した。残渣をシリカゲルカラムクロマト
グラフィー(ヘキサン:酢酸エチル=15:1、10:
1、5:1)で精製し、エチル(2RS,3RS)-3-
(3-クロロフェニル)-3-ヒドロキシ-2-[4-(1,
1-ジフルオロ-2,2-ジメチルプロピル)ベンジル]
プロピオネート(6.12g,80%)を淡黄色オイル
として得た。 IRνmaxKBr(cm-1) : 3454, 1712, 1616, 1597, 1576, 1
483, 1398, 1371, 1398,1286, 1259, 11901 H-NMR(CDCl3) δ (ppm) 0.94 (3H, t, J = 7.2 Hz) 1.
00 (9H, s) 2.90-3.04 (2H, m) 3.11 (1H, d, J = 1.8
Hz) 3.90 (2H, q, J = 7.0 Hz) 5.03 (1H, d, J= 2.2 H
z) 7.09 (2H, d, J = 8.0 Hz) 7.25-7.29 (5H, m) 7.42
(1H, s). 5) (2RS,3RS)-3-(3-クロロフェニル)-
3-ヒドロキシ-2-[4-(1,1-ジフルオロ-2,2-
ジメチルプロピル)ベンジル]プロピオン酸 エチル(2RS,3RS)-3-(3-クロロフェニル)-
3-ヒドロキシ-2-[4-(1,1-ジフルオロ-2,2-
ジメチルプロピル)ベンジル]プロピオネート(5.8
8g,13.8ミリモル)のテトラヒドロフラン-エタ
ノール(30ml-30ml)溶液に室温で1規定の水
酸化ナトリウム(28ml,28ミリモル)を加え、室
温で終夜撹拌した。反応終了後、有機溶媒を減圧留去
し、水層を1規定塩酸で酸性とし、酢酸エチルで抽出し
た。有機層を無水硫酸マグネシウムで乾燥後、ろ過、減
圧濃縮した。ヘキサン-酢酸エチルで再結晶を行い、
(2RS,3RS)-3-(3-クロロフェニル)-3-ヒ
ドロキシ-2-[4-(1,1-ジフルオロ-2,2-ジメチ
ルプロピル)ベンジル]プロピオン酸(4.24g,7
7%)を無色結晶として得た。 mp 141-142℃ IRνmaxKBr(cm-1) : 2500-3300, 1709, 1599, 1574, 14
83, 1413, 1398, 1369,1286, 12591 H-NMR(CDCl3) δ (ppm) 0.99 (9H, s) 2.90-3.05 (3H,
m) 5.10 (1H, d, J = 3.6 Hz) 7.07 (2H, d, J = 8.1
Hz) 7.25-7.28 (5H, m) 7.42 (1H, s). 6) (4RS,5SR)-5-(3-クロロフェニル)-
4-[4-(1,1-ジフルオロ-2,2-ジメチルプロピ
ル)ベンジル]-1,3-オキサゾリジン-2-オン (2RS,3RS)-3-(3-クロロフェニル)-3-ヒ
ドロキシ-2-[4-(1,1-ジフルオロ-2,2-ジメチ
ルプロピル)ベンジル]プロピオン酸(4.09g,1
0.3ミリモル)のテトラヒドロフラン(100ml)
溶液にトリエチルアミン(2.16ml,15.45ミ
リモル)、ジフェニルリン酸アジド(2.67ml,1
2.36ミリモル)を加え、4時間加熱還流した。溶媒
を留去し、酢酸エチルで希釈し、1規定塩酸、飽和重曹
水、飽和食塩水で洗浄した。有機層を無水硫酸マグネシ
ウムで乾燥後、ろ過、減圧濃縮した。ヘキサン-酢酸エ
チルで再結晶を行い、(4RS,5SR)-5-(3-ク
ロロフェニル)-4-[4-(1,1-ジフルオロ-2,2-
ジメチルプロピル)ベンジル]-1,3-オキサゾリジン
-2-オン(3.97g,98%)を無色結晶として得
た。 mp 188-190℃ IRνmaxKBr(cm-1): 3246, 1739, 1437, 1369, 1286, 12
38, 10781 H-NMR(CDCl3) δ (ppm) 1.01 (9H, s) 2.27 (1H, dd,
J = 10.8, 13.1 Hz) 2.36 (1H, dd, J = 4.2, 12.8 Hz)
4.23-4.31 (1H, m) 5.09 (1H, s) 5.77 (1H, d,J = 8.
1 Hz) 7.05 (2H, d, J = 8.1 Hz) 7.24-7.29 (1H, m)
7.32-7.38 (5H, m). 7) (1RS,2SR)-2-アミノ-1-(3-クロロ
フェニル)-3-[4-(1,1-ジフルオロ-2,2-ジメ
チルプロピル)フェニル]-1-プロパノール (4RS,5SR)-5-(3-クロロフェニル)-4-
[4-(1,1-ジフルオロ-2,2-ジメチルプロピル)
ベンジル]-1,3-オキサゾリジン-2-オン(3.82
g,9.70ミリモル)のエタノール(100ml)溶
液に8規定水酸化ナトリウム水溶液(6.1ml,4
8.5ミリモル)を加え、4時間加熱還流した。反応終
了後、エタノールを減圧留去した後、水で希釈し、酢酸
エチルで抽出した。有機層を合わせ、飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後、ろ過、減圧濃縮し
た。残渣を再結晶(ヘキサン-酢酸エチル)で精製し、
(1RS,2SR)-2-アミノ-1-(3-クロロフェニ
ル)-3-[4-(1,1-ジフルオロ-2,2-ジメチルプ
ロピル)フェニル]-1-プロパノール(2.56g,7
2%)を無色結晶として得た。 mp 105-107℃ IRνmaxKBr(cm-1) : 3352, 1597, 1483, 1286, 1259, 1
093, 1068, 1037, 1008,9781 H-NMR(CDCl3) δ (ppm) 1.02 (9H, s) 2.38 (1H, dd,
J = 10.6, 13.6 Hz) 2.80 (1H, dd, J = 2.8, 13.2 Hz)
3.27-3.36 (1H, m) 4.68 (1H, d, J = 4.8 Hz)7.15 (2
H, d, J = 8.2 Hz) 7.26-7.35 (5H, m) 7.42 (1H, s). 8) N-{(1RS,2SR)-2-(3-クロロフェニ
ル)-1-[4-(1,1-ジフルオロ-2,2-ジメチルプ
ロピル)ベンジル]-2-ヒドロキシエチル}-4-フルオ
ロ-1-ナフトアミド 4-フルオロナフタレン-1-カルボン酸(216mg,
1.15ミリモル)のN,N-ジメチルホルムアミド
(5ml)溶液に、1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド塩酸塩(220mg,1.1
5ミリモル)、1-ヒドロキシベンゾトリアゾール1水
和物(176mg,1.15ミリモル)を加え、最後に
(1RS,2SR)-2-アミノ-1-(3-クロロフェニ
ル)-3-[4-(1,1-ジフルオロ-2,2-ジメチルプ
ロピル)フェニル]-1-プロパノール(0.40g,
1.09ミリモル)を加え、室温で終夜撹拌した。酢酸
エチルで希釈し、飽和重曹水、水、飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後、シリカゲルをつめ
たグラスフィルターでろ過し、酢酸エチルで洗浄し、減
圧濃縮した。残渣を再結晶(ヘキサン-酢酸エチル)で
精製し、N-{(1RS,2SR)-2-(3-クロロフェ
ニル)-1-[4-(1,1-ジフルオロ-2,2-ジメチル
プロピル)ベンジル]-2-ヒドロキシエチル}-4-フル
オロ-1-ナフトアミド(289mg,49%)を無色結
晶として得た。 mp 104-106℃ IRνmaxKBr(cm-1) : 3244, 1639, 1626, 1599, 1516, 1
425, 1286, 1261, 1091,1072, 1008, 9781 H-NMR(CDCl3) δ (ppm) 1.01 (9H, s) 2.82 (1H, dd,
J = 11.0, 14.4 Hz) 3.03 (1H, dd, 4.4, 14.4 Hz) 3.8
5 (1H, s) 4.72-4.81 (1H, m) 5.10 (1H, d, J =3.4 H
z) 5.98 (1H, d, J = 8.4 Hz) 6.93 (1H, dd, J = 7.6,
9.8 Hz) 7.10 (1H, dd, J = 5.0, 7.6 Hz) 7.19-7.56
(10H, m) 7.75 (1H, d, J = 7.6 Hz) 8.06(1H, d, J =
8.0 Hz).Example 379 N-{(1RS, 2SR) -2- (3-chlorophenyl)-
1- [4- (1,1-difluoro-2,2-dimethylpropyl) benzyl] -2-hydroxyethyl {-4-fluoro-
1-Naphthamide 1) 2,2-dimethyl-1- (4-methylphenyl) -1-
Propanone In a three-necked flask, a suspension of ether (200 ml) of magnesium (7.14 g, 294 mmol) was added to ether (10 ml) of p-bromotoluene (34 ml, 276 mmol).
0 ml) solution was added dropwise and heated under reflux for 1.5 hours. Then, at room temperature, trimethylacetonitrile (25 ml, 2
26 mmol) in ether (100 ml)
Stir for 2 hours. Then, the mixture was ice-cooled, 6N hydrochloric acid was added dropwise, and the mixture was stirred for 30 minutes at room temperature. Diluted with ether, water,
Washed with saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 1: 0, 1
0: 1) to give 2,2-dimethyl-1- (4-methylphenyl) -1-propanone (10.94 g, 27%) as a colorless transparent oil. IRνmax KBr (cm -1 ): 1672, 1608, 1477, 1396, 1365, 1
278, 960 1 H-NMR (CDCl 3 ) δ (ppm) 1.35 (9H, s) 2.38 (3H, s) 7.2
0 (2H, d, J = 8.1 Hz) 7.66 (2H, d, J = 8.4 Hz). 2) 1- (1,1-Difluoro-2,2-dimethylpropyl) -4-methylbenzene 2,2- Bis (2-methoxyethyl) aminosulfur trifluoride (10 g, 45.2 mmol) was added to nascol containing dimethyl-1- (4-methylphenyl) -1-propanone (4.69 g, 26.6 mmol). The mixture was added dropwise and stirred at 80-85 ° C overnight. The reaction mixture was poured into saturated aqueous sodium hydrogen carbonate and extracted with ethyl acetate. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane),
1- (1,1-difluoro-2,2-dimethylpropyl)-
4-Methylbenzene (5.16 g, 77%) was obtained as a clear, colorless oil. IRνmax KBr (cm -1 ): 1618, 1518, 1485, 1464, 1308, 128
6, 1259, 1209, 1093, 1072, 976 1 H-NMR (CDCl 3 ) δ (ppm) 1.02 (9H, s) 2.37 (3H, s)
7.15-7.19 (2H, m) 7.31 (2H, d, J = 8.4 Hz). 3) Ethyl 3- (3-chlorophenyl) -2- [4-
(1,1-Difluoro-2,2-dimethylpropyl) benzyl] -3-oxopropionate 1- (1,1-difluoro-2,2-dimethylpropyl)-
4-methylbenzene (4.52 g, 22.8 mmol)
2,2′-azobisisobutyronitrile (188 mg, 1.14 mmol) in a solution of
N-Bromosuccinimide (4.06 g, 22.8 mmol) was added, and the mixture was heated under reflux overnight. After cooling to room temperature, insolubles were filtered and concentrated under reduced pressure. Bromine was obtained. This was used for the next reaction as it was. Ethyl 3- (3-chlorophenyl) -3-oxopropionate (5.17 g, 22.8)
(Mmol) of dimethoxyethane (60 ml) was cooled on ice, and sodium hydride (60%, 0.92 g, 22.8) was added.
Mmol), and the mixture was stirred under ice-cooling for 15 minutes, and then brominated (22.8 mmol) in dimethoxyethane (40 ml).
The solution was added and stirred at room temperature overnight. After completion of the reaction, the reaction was quenched with 1N hydrochloric acid, diluted with ethyl acetate, and washed with water and saturated saline. After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 20: 1, 15:15).
Purified in 1), and ethyl 3- (3-chlorophenyl) -2-
[4- (1,1-difluoro-2,2-dimethylpropyl)
Benzyl] -3-oxopropionate (7.44 g, 7
7%) as a pale yellow oil. IRνmax KBr (cm -1 ): 1736, 1691, 1570, 1483, 1425, 1
367, 1259, 1093, 1072 1 H-NMR (CDCl 3 ) δ (ppm) 0.99 (9H, s) 1.12 (3H, t, J
= 6.9 Hz) 3.34 (2H, d, J = 7.5 Hz) 3.96-4.15 (2H,
m) 4.56 (1H, t, J = 7.2 Hz) 7.21-7.45 (5H, m) 7.50
-7.55 (1H, m) 7.78-7.90 (1H, m) 7.90-7.92 (1H, m). 4) Ethyl (2RS, 3RS) -3- (3-chlorophenyl) -3-hydroxy-2- [4- (1,1-difluoro-
2,2-Dimethylpropyl) benzyl] propionate Sodium borohydride (2.7) was added to an ether suspension (70 ml) of zinc chloride (4.94 g, 36.2 mmol).
(4 g, 72.4 mmol) at room temperature and stirred for 2 hours. The insolubles were filtered, and the filtrate was treated with ethyl 3- (3-
Chlorophenyl) -2- [4- (1,1-difluoro-2,
A solution of 2-dimethylpropyl) benzyl] -3-oxopropionate (7.59 g, 18.1 mmol) in ether (50 ml) was added, and the mixture was stirred at room temperature for 1 hour. The reaction was terminated with 1N hydrochloric acid, diluted with ethyl acetate, and washed with water and saturated saline. After drying over anhydrous magnesium sulfate,
Filtration and concentration under reduced pressure. The residue was subjected to silica gel column chromatography (hexane: ethyl acetate = 15: 1, 10:
1,5: 1) and purified by ethyl (2RS, 3RS) -3-
(3-chlorophenyl) -3-hydroxy-2- [4- (1,
1-difluoro-2,2-dimethylpropyl) benzyl]
Propionate (6.12 g, 80%) was obtained as a pale yellow oil. IRνmax KBr (cm -1 ): 3454, 1712, 1616, 1597, 1576, 1
483, 1398, 1371, 1398, 1286, 1259, 1190 1 H-NMR (CDCl 3 ) δ (ppm) 0.94 (3H, t, J = 7.2 Hz) 1.
00 (9H, s) 2.90-3.04 (2H, m) 3.11 (1H, d, J = 1.8
Hz) 3.90 (2H, q, J = 7.0 Hz) 5.03 (1H, d, J = 2.2 H
z) 7.09 (2H, d, J = 8.0 Hz) 7.25-7.29 (5H, m) 7.42
(1H, s). 5) (2RS, 3RS) -3- (3-chlorophenyl)-
3-hydroxy-2- [4- (1,1-difluoro-2,2-
Dimethylpropyl) benzyl] ethyl propionate (2RS, 3RS) -3- (3-chlorophenyl)-
3-hydroxy-2- [4- (1,1-difluoro-2,2-
Dimethylpropyl) benzyl] propionate (5.8
To a solution of 8 g (13.8 mmol) in tetrahydrofuran-ethanol (30 ml-30 ml) was added 1N sodium hydroxide (28 ml, 28 mmol) at room temperature, and the mixture was stirred at room temperature overnight. After completion of the reaction, the organic solvent was distilled off under reduced pressure, the aqueous layer was acidified with 1N hydrochloric acid, and extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. Recrystallize with hexane-ethyl acetate,
(2RS, 3RS) -3- (3-chlorophenyl) -3-hydroxy-2- [4- (1,1-difluoro-2,2-dimethylpropyl) benzyl] propionic acid (4.24 g, 7
7%) as colorless crystals. mp 141-142 ℃ IRνmax KBr (cm -1 ): 2500-3300, 1709, 1599, 1574, 14
83, 1413, 1398, 1369, 1286, 1259 1 H-NMR (CDCl 3 ) δ (ppm) 0.99 (9H, s) 2.90-3.05 (3H,
m) 5.10 (1H, d, J = 3.6 Hz) 7.07 (2H, d, J = 8.1
Hz) 7.25-7.28 (5H, m) 7.42 (1H, s). 6) (4RS, 5SR) -5- (3-chlorophenyl)-
4- [4- (1,1-difluoro-2,2-dimethylpropyl) benzyl] -1,3-oxazolidin-2-one (2RS, 3RS) -3- (3-chlorophenyl) -3-hydroxy-2 -[4- (1,1-difluoro-2,2-dimethylpropyl) benzyl] propionic acid (4.09 g, 1
0.3 mmol) of tetrahydrofuran (100 ml)
Triethylamine (2.16 ml, 15.45 mmol), diphenylphosphoric azide (2.67 ml, 1
(2.36 mmol) and heated to reflux for 4 hours. The solvent was distilled off, diluted with ethyl acetate, and washed with 1 N hydrochloric acid, saturated aqueous sodium bicarbonate, and saturated saline. The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. Recrystallization from hexane-ethyl acetate gave (4RS, 5SR) -5- (3-chlorophenyl) -4- [4- (1,1-difluoro-2,2-
Dimethylpropyl) benzyl] -1,3-oxazolidine
-2-One (3.97 g, 98%) was obtained as colorless crystals. mp 188-190 ℃ IRνmax KBr (cm -1 ): 3246, 1739, 1437, 1369, 1286, 12
38, 1078 1 H-NMR (CDCl 3 ) δ (ppm) 1.01 (9H, s) 2.27 (1H, dd,
J = 10.8, 13.1 Hz) 2.36 (1H, dd, J = 4.2, 12.8 Hz)
4.23-4.31 (1H, m) 5.09 (1H, s) 5.77 (1H, d, J = 8.
1 Hz) 7.05 (2H, d, J = 8.1 Hz) 7.24-7.29 (1H, m)
7.32-7.38 (5H, m). 7) (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [4- (1,1-difluoro-2,2-dimethylpropyl) phenyl] -1-propanol (4RS, 5SR) -5- (3-chlorophenyl) -4-
[4- (1,1-difluoro-2,2-dimethylpropyl)
Benzyl] -1,3-oxazolidin-2-one (3.82
g, 9.70 mmol) in an ethanol (100 ml) solution and an 8 N aqueous sodium hydroxide solution (6.1 ml, 4 ml).
(8.5 mmol) and heated to reflux for 4 hours. After completion of the reaction, ethanol was distilled off under reduced pressure, diluted with water, and extracted with ethyl acetate. The organic layers were combined, washed with saturated saline, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate),
(1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [4- (1,1-difluoro-2,2-dimethylpropyl) phenyl] -1-propanol (2.56 g, 7
2%) as colorless crystals. mp 105-107 ℃ IRνmax KBr (cm -1 ): 3352, 1597, 1483, 1286, 1259, 1
093, 1068, 1037, 1008,978 1 H-NMR (CDCl 3 ) δ (ppm) 1.02 (9H, s) 2.38 (1H, dd,
J = 10.6, 13.6 Hz) 2.80 (1H, dd, J = 2.8, 13.2 Hz)
3.27-3.36 (1H, m) 4.68 (1H, d, J = 4.8 Hz) 7.15 (2
H, d, J = 8.2 Hz) 7.26-7.35 (5H, m) 7.42 (1H, s). 8) N-{(1RS, 2SR) -2- (3-chlorophenyl) -1- [4- (1 , 1-Difluoro-2,2-dimethylpropyl) benzyl] -2-hydroxyethyl} -4-fluoro-1-naphthamide 4-fluoronaphthalene-1-carboxylic acid (216 mg,
1.15 mmol) in N, N-dimethylformamide (5 ml) solution, 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (220 mg, 1.1
5 mmol), 1-hydroxybenzotriazole monohydrate (176 mg, 1.15 mmol) and finally (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [4- ( 1,1-difluoro-2,2-dimethylpropyl) phenyl] -1-propanol (0.40 g,
(1.09 mmol) and stirred at room temperature overnight. It was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water, and saturated saline, dried over anhydrous magnesium sulfate, filtered through a glass filter filled with silica gel, washed with ethyl acetate, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate) to give N-{(1RS, 2SR) -2- (3-chlorophenyl) -1- [4- (1,1-difluoro-2,2-dimethylpropyl). [Benzyl] -2-hydroxyethyl} -4-fluoro-1-naphthamide (289 mg, 49%) was obtained as colorless crystals. mp 104-106 ℃ IRνmax KBr (cm -1 ): 3244, 1639, 1626, 1599, 1516, 1
425, 1286, 1261, 1091,1072, 1008, 978 1 H-NMR (CDCl 3 ) δ (ppm) 1.01 (9H, s) 2.82 (1H, dd,
J = 11.0, 14.4 Hz) 3.03 (1H, dd, 4.4, 14.4 Hz) 3.8
5 (1H, s) 4.72-4.81 (1H, m) 5.10 (1H, d, J = 3.4 H
z) 5.98 (1H, d, J = 8.4 Hz) 6.93 (1H, dd, J = 7.6,
9.8 Hz) 7.10 (1H, dd, J = 5.0, 7.6 Hz) 7.19-7.56
(10H, m) 7.75 (1H, d, J = 7.6 Hz) 8.06 (1H, d, J =
8.0 Hz).
【0512】実施例380 N-{(1RS,2SR)-2-(3-クロロフェニル)-
1-[4-(1,1-ジフルオロ-2,2-ジメチルプロピ
ル)ベンジル]-2-ヒドロキシエチル}-6,7-ジヒド
ロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミ
ド 6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボン酸(216mg,1.15ミリモル)のN,
N-ジメチルホルムアミド(5ml)溶液に、1-エチル
-3-(3-ジメチルアミノプロピル)カルボジイミド塩
酸塩(220mg,1.15ミリモル)、1-ヒドロキ
シベンゾトリアゾール1水和物(176mg,1.15
ミリモル)を加え、最後に(1RS,2SR)-2-アミ
ノ-1-(3-クロロフェニル)-3-[4-(1,1-ジフ
ルオロ-2,2-ジメチルプロピル)フェニル]-1-プロ
パノール(0.40g,1.09ミリモル)を加え、室
温で終夜撹拌した。酢酸エチルで希釈し、飽和重曹水、
水、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
後、シリカゲルをつめたグラスフィルターでろ過し、酢
酸エチルで洗浄し、減圧濃縮した。残渣を再結晶(ヘキ
サン-酢酸エチル)で精製し、N-{(1RS,2SR)
-2-(3-クロロフェニル)-1-[4-(1,1-ジフル
オロ-2,2-ジメチルプロピル)ベンジル]-2-ヒドロ
キシエチル}-6,7-ジヒドロ-5H-ベンゾ[a]シク
ロヘプテン-1-カルボキサミド(316mg,54%)
を無色結晶として得た。 mp 119-120℃ IRνmaxKBr(cm-1): 3265, 1635, 1516, 1485, 1286, 12
591 H-NMR(CDCl3) δ (ppm) 1.28 (6H, s) 1.98-2.01 (2H,
m) 2.16-2.21 (2H, m)2.58-2.69 (3H, m) 2.87-2.95
(1H, m) 4.20 (2H, s) 4.62 (1H, br) 5.00 (1H,s) 5.7
1 (1H, d, J = 7.4 Hz) 5.89-6.00 (1H,, m) 6.26 (1H,
d, J = 11.8 Hz) 6.68 (1H, d, J = 8.8 Hz) 6.88-7.1
6 (5H, m) 7.26-7.30 (3H, m) 7.46 (1H,s)Example 380 N-{(1RS, 2SR) -2- (3-chlorophenyl)-
1- [4- (1,1-difluoro-2,2-dimethylpropyl) benzyl] -2-hydroxyethyl} -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide 6,7-dihydro -5H-benzo [a] cycloheptene-1
-Carboxylic acid (216 mg, 1.15 mmol) N,
N-dimethylformamide (5 ml) solution in 1-ethyl
-3- (3-Dimethylaminopropyl) carbodiimide hydrochloride (220 mg, 1.15 mmol), 1-hydroxybenzotriazole monohydrate (176 mg, 1.15)
Mmol) and finally (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [4- (1,1-difluoro-2,2-dimethylpropyl) phenyl] -1-propanol (0.40 g, 1.09 mmol) and the mixture was stirred at room temperature overnight. Dilute with ethyl acetate, add saturated aqueous sodium bicarbonate,
After washing with water and saturated saline and drying over anhydrous magnesium sulfate, the mixture was filtered through a glass filter filled with silica gel, washed with ethyl acetate, and concentrated under reduced pressure. The residue is purified by recrystallization (hexane-ethyl acetate) and N-{(1RS, 2SR)
-2- (3-chlorophenyl) -1- [4- (1,1-difluoro-2,2-dimethylpropyl) benzyl] -2-hydroxyethyl} -6,7-dihydro-5H-benzo [a] cycloheptene -1-carboxamide (316 mg, 54%)
Was obtained as colorless crystals. mp 119-120 ℃ IRνmax KBr (cm -1 ): 3265, 1635, 1516, 1485, 1286, 12
59 1 H-NMR (CDCl 3 ) δ (ppm) 1.28 (6H, s) 1.98-2.01 (2H,
m) 2.16-2.21 (2H, m) 2.58-2.69 (3H, m) 2.87-2.95
(1H, m) 4.20 (2H, s) 4.62 (1H, br) 5.00 (1H, s) 5.7
1 (1H, d, J = 7.4 Hz) 5.89-6.00 (1H ,, m) 6.26 (1H,
d, J = 11.8 Hz) 6.68 (1H, d, J = 8.8 Hz) 6.88-7.1
6 (5H, m) 7.26-7.30 (3H, m) 7.46 (1H, s)
【0513】実施例381 5-クロロ-N-{(1RS,2SR)-2-(3-クロロフ
ェニル)-1-[4-(1,1-ジフルオロ-2,2-ジメチ
ルプロピル)ベンジル]-2-ヒドロキシエチル}-1-ナ
フトアミド 5-クロロナフタレン-1-カルボン酸(238mg,
1.15ミリモル)のN,N-ジメチルホルムアミド
(5ml)溶液に、1-エチル-3-(3-ジメチルアミノ
プロピル)カルボジイミド塩酸塩(220mg,1.1
5ミリモル)、1-ヒドロキシベンゾトリアゾール1水
和物(176mg,1.15ミリモル)を加え、最後に
(1RS,2SR)-2-アミノ-1-(3-クロロフェニ
ル)-3-[4-(1,1-ジフルオロ-2,2-ジメチルプ
ロピル)フェニル]-1-プロパノール(0.40g,
1.09ミリモル)を加え、室温で終夜撹拌した。酢酸
エチルで希釈し、飽和重曹水、水、飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後、シリカゲルをつめ
たグラスフィルターでろ過し、酢酸エチルで洗浄し、減
圧濃縮した。残渣を再結晶(ヘキサン-酢酸エチル)で
精製し、5-クロロ-N-{(1RS,2SR)-2-(3-
クロロフェニル)-1-[4-(1,1-ジフルオロ-2,
2-ジメチルプロピル)ベンジル]-2-ヒドロキシエチ
ル}-1-ナフトアミド(252mg,42%)を無色結
晶として得た。 mp 99-101℃ IRνmaxKBr(cm-1) : 3260, 1635, 1521, 1286, 1093, 1
072, 1037, 1008, 978,9081 H-NMR(CDCl3) δ (ppm) 1.01 (9H, s) 2.79 (1H, dd,
J = 11.1, 14.4 Hz) 3.02 (1H, dd, J = 3.6, 14.1 Hz)
4.74-4.82 (1H, m) 5.07 (1H, d, J = 3.6 Hz)6.02 (1
H, d, J = 8.7 Hz) 7.15-7.41 (10H, m) 7.53-7.57 (3
H, m) 8.28 (1H,d, J = 8.7 Hz).Example 381 5-Chloro-N-{(1RS, 2SR) -2- (3-chlorophenyl) -1- [4- (1,1-difluoro-2,2-dimethylpropyl) benzyl] -2 -Hydroxyethyl} -1-naphthamide 5-chloronaphthalene-1-carboxylic acid (238 mg,
1.15 mmol) in N, N-dimethylformamide (5 ml) solution, 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (220 mg, 1.1
5 mmol), 1-hydroxybenzotriazole monohydrate (176 mg, 1.15 mmol) and finally (1RS, 2SR) -2-amino-1- (3-chlorophenyl) -3- [4- ( 1,1-difluoro-2,2-dimethylpropyl) phenyl] -1-propanol (0.40 g,
(1.09 mmol) and stirred at room temperature overnight. It was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate, water, and saturated saline, dried over anhydrous magnesium sulfate, filtered through a glass filter filled with silica gel, washed with ethyl acetate, and concentrated under reduced pressure. The residue was purified by recrystallization (hexane-ethyl acetate) to give 5-chloro-N-{(1RS, 2SR) -2- (3-
Chlorophenyl) -1- [4- (1,1-difluoro-2,
2-Dimethylpropyl) benzyl] -2-hydroxyethyl} -1-naphthamide (252 mg, 42%) was obtained as colorless crystals. mp 99-101 ℃ IRνmax KBr (cm -1 ): 3260, 1635, 1521, 1286, 1093, 1
072, 1037, 1008, 978,908 1 H-NMR (CDCl 3 ) δ (ppm) 1.01 (9H, s) 2.79 (1H, dd,
J = 11.1, 14.4 Hz) 3.02 (1H, dd, J = 3.6, 14.1 Hz)
4.74-4.82 (1H, m) 5.07 (1H, d, J = 3.6 Hz) 6.02 (1
H, d, J = 8.7 Hz) 7.15-7.41 (10H, m) 7.53-7.57 (3
H, m) 8.28 (1H, d, J = 8.7 Hz).
【0514】実施例382 酢酸(1RS,2SR)-2-[(6,7-ジヒドロ-5H
-ベンゾ[a]シクロヘプテン-1-イルカルボニル)ア
ミノ]-1-(4-フルオロフェニル)-3-[3-(1,
1,2,2-テトラフルオロエトキシ)フェニル]プロ
ピル N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.359g(0.675ミリモル)、無水酢酸2m
l、ピリジン5mlの混合物を100℃で一晩撹拌し
た。反応液の溶媒を減圧留去し、得られた残留物をシリ
カゲルカラムクロマトグラフィーにて精製し(酢酸エチ
ル)、ジイソプロピルエーテル-ヘキサンより結晶化し
て、目的物を得た。白色結晶 収量0.347g 収率
90% mp 176-177℃; 1H-NMR (CDCl3, 200 MHz) δ 1.91-2.05
(2H, m), 2.15 (3H, s), 2.13-2.32 (2H, m), 2.63-2.
66 (2H, m), 2.71 (1H, dd, J = 10.2 Hz, 15.2Hz), 3.
07 (1H, dd, J = 4.3 Hz, 14.7 Hz), 4.89-5.03 (1H,
m), 5.51 (1H, d,J = 9.6 Hz), 5.89 (1H, tt, J = 2.9
Hz, 53.0 Hz), 5.81-6.06 (3H, m), 6.82 (1H, dd, J
= 2.0 Hz, 7.2 Hz), 6.97-7.15 (7H, m), 7.32 (1H, t,
J = 7.9Hz), 7.41 (2H, dd, J = 5.4 Hz, 8.6 Hz); IR
(KBr) 3241, 1746, 1642, 1512,1275, 1236, 1113, 77
2 cm-1; Anal. Calcd for C31H28F5NO4: C, 64.92; H,
4.92; N, 2.44. Found: C, 64.87; H, 4.84; N, 2.30.Example 382 Acetic acid (1RS, 2SR) -2-[(6,7-dihydro-5H
-Benzo [a] cyclohepten-1-ylcarbonyl) amino] -1- (4-fluorophenyl) -3- [3- (1,
1,2,2-tetrafluoroethoxy) phenyl] propyl N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
0.359 g (0.675 mmol) of 5H-benzo [a] cycloheptene-1-carboxamide, 2 m of acetic anhydride
l, 5 ml of pyridine was stirred at 100 ° C. overnight. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (ethyl acetate) and crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.347 g Yield 90% mp 176-177 ° C; 1 H-NMR (CDCl 3 , 200 MHz) δ 1.91-2.05
(2H, m), 2.15 (3H, s), 2.13-2.32 (2H, m), 2.63-2.
66 (2H, m), 2.71 (1H, dd, J = 10.2 Hz, 15.2Hz), 3.
07 (1H, dd, J = 4.3 Hz, 14.7 Hz), 4.89-5.03 (1H,
m), 5.51 (1H, d, J = 9.6 Hz), 5.89 (1H, tt, J = 2.9
Hz, 53.0 Hz), 5.81-6.06 (3H, m), 6.82 (1H, dd, J
= 2.0 Hz, 7.2 Hz), 6.97-7.15 (7H, m), 7.32 (1H, t,
J = 7.9Hz), 7.41 (2H, dd, J = 5.4Hz, 8.6Hz); IR
(KBr) 3241, 1746, 1642, 1512,1275, 1236, 1113, 77
2 cm -1 ; Anal.Calcd for C 31 H 28 F 5 NO 4 : C, 64.92; H,
4.92; N, 2.44. Found: C, 64.87; H, 4.84; N, 2.30.
【0515】実施例383 コハク酸(1RS,2SR)-2-[(6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-イルカルボニ
ル)アミノ]-1-(4-フルオロフェニル)-3-[3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル]プロピル メチル N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.301g(0.566ミリモル)、コハク酸モノメ
チルモノクロリド0.10ml(0.85ミリモル)、
4-N,N-ジメチルアミノピリジン0.14g(1.1
3ミリモル)のアセトニトリル15ml溶液を80℃で
2時間撹拌した。反応液の溶媒を減圧留去し、得られた
残留物をシリカゲルカラムクロマトグラフィーにて精製
し(ヘキサン/酢酸エチル=3/1-2/1)、目的物
を得た。白色固体 収量0.365g 収率100% 酢酸エチル-ヘキサンより再結晶して、白色結晶を得
た。 mp 170-171℃; 1H-NMR (CDCl3, 300 MHz) δ 1.92-2.00
(2H, m), 2.18-2.24 (2H, m), 2.61-2.81 (7H, m), 3.
02 (1H, dd, J = 4.2 Hz, 14.4 Hz), 3.50 (3H,s), 4.8
7-4.97 (1H, m), 5.85 (1H, td, J = 5.2 Hz, 11.9 H
z), 5.89 (1H, tt,J = 2.8 Hz, 53.0 Hz), 5.90 (1H,
d, J = 9.9 Hz), 6.03 (1H, d, J = 12.0 Hz), 6.16 (1
H, d, J = 4.8 Hz), 6.86 (1H, dd, J = 1.5 Hz, 7.5 H
z), 6.99-7.13 (7H, m), 7.30 (1H, t, J = 8.0 Hz),
7.43 (2H, dd, J = 5.3 Hz, 8.6 Hz);IR (KBr) 3239, 1
742, 1640, 1512, 1223, 1165, 1128 cm-1; Anal. Calc
d forC34H32F5NO6: C, 63.25; H, 5.00; N, 2.17. Foun
d: C, 63.21; H, 5.03; N, 2.13.Example 383 Succinic acid (1RS, 2SR) -2-[(6,7-dihydro-
5H-benzo [a] cyclohepten-1-ylcarbonyl) amino] -1- (4-fluorophenyl) -3- [3-
(1,1,2,2-tetrafluoroethoxy) phenyl] propyl methyl N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
0.31 g (0.566 mmol) of 5H-benzo [a] cycloheptene-1-carboxamide, 0.10 ml (0.85 mmol) of monomethyl succinate monochloride,
0.14 g of 4-N, N-dimethylaminopyridine (1.1
(3 mmol) in 15 ml of acetonitrile was stirred at 80 ° C. for 2 hours. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (hexane / ethyl acetate = 3 / 1-2 / 1) to obtain the desired product. White solid Yield 0.365 g Yield 100% Recrystallization from ethyl acetate-hexane gave white crystals. mp 170-171 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.92-2.00
(2H, m), 2.18-2.24 (2H, m), 2.61-2.81 (7H, m), 3.
02 (1H, dd, J = 4.2 Hz, 14.4 Hz), 3.50 (3H, s), 4.8
7-4.97 (1H, m), 5.85 (1H, td, J = 5.2 Hz, 11.9 H
z), 5.89 (1H, tt, J = 2.8 Hz, 53.0 Hz), 5.90 (1H,
d, J = 9.9 Hz), 6.03 (1H, d, J = 12.0 Hz), 6.16 (1
H, d, J = 4.8 Hz), 6.86 (1H, dd, J = 1.5 Hz, 7.5 H
z), 6.99-7.13 (7H, m), 7.30 (1H, t, J = 8.0 Hz),
7.43 (2H, dd, J = 5.3 Hz, 8.6 Hz); IR (KBr) 3239, 1
742, 1640, 1512, 1223, 1165, 1128 cm -1 ; Anal.Calc
d forC 34 H 32 F 5 NO 6 : C, 63.25; H, 5.00; N, 2.17. Foun
d: C, 63.21; H, 5.03; N, 2.13.
【0516】実施例384 コハク酸(1RS,2SR)-2-[(6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-イルカルボニ
ル)アミノ]-1-(4-フルオロフェニル)-3-[3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル]プロピル水素 N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.566g(1.065ミリモル)とコハク酸クロリ
ド0.41g(2.66ミリモル)のアセトニトリル3
0ml溶液に、4-N,N-ジメチルアミノピリジン0.
26g(2.13ミリモル)を加え、70℃で3時間撹
拌した。反応液を室温に冷却した後、水30mlを加
え、そのまま0.5時間撹拌した。これを希塩酸で酸性
とした後、酢酸エチルで2回抽出した。集めた有機層を
無水硫酸マグネシウムで乾燥、溶媒を減圧留去した。得
られた粗生成物をシリカゲルカラムクロマトグラフィー
にて精製し(ヘキサン/酢酸エチル=1/1-酢酸エチ
ル)、ジイソプロピルエーテル-ヘキサンより結晶化し
て、目的物を得た。淡褐色粉末 収量0.466g 収
率69% mp 154-155℃; 1H-NMR (CDCl3, 300 MHz) δ 1.92-2.01
(2H, m), 2.17-2.23 (2H, m), 2.58-2.77 (7H, m), 3.
04 (1H, dd, J = 3.8 Hz, 14.3 Hz), 4.89-4.99(1H,
m), 5.71 (1H, d, J = 9.3 Hz), 5.85 (1H, td, J = 5.
1 Hz, 11.7 Hz), 5.89 (1H, tt, J = 2.9 Hz, 53.1 H
z), 6.00 (1H, d, J = 11.7 Hz), 6.06 (1H,d, J = 5.4
Hz), 6.84 (1H, dd, J = 1.4 Hz, 7.7 Hz), 6.98-7.13
(7H, m), 7.30 (1H, t, J = 7.8 Hz), 7.41 (2H, dd,
J = 5.3 Hz, 8.6 Hz); IR (KBr) 3243, 3067, 2940, 17
34, 1640, 1512, 1211, 1155, 1123 cm-1; Anal. Calcd
for C 33H30F5NO6・0.5H2O: C, 61.87; H, 4.88; N, 2.1
9. Found: C, 61.78; H, 4.77;N, 2.15.Example 384 Succinic acid (1RS, 2SR) -2-[(6,7-dihydro-
5H-benzo [a] cyclohepten-1-ylcarboni
Ru) amino] -1- (4-fluorophenyl) -3- [3-
(1,1,2,2-tetrafluoroethoxy) phenyl
] Propyl hydrogen N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafur
Oroethoxy) benzyl] ethyl] -6,7-dihydro-
5H-benzo [a] cycloheptene-1-carboxamide
0.566 g (1.065 mmol) and chlorinated succinate
0.41 g (2.66 mmol) of acetonitrile 3
To a 0 ml solution was added 4-N, N-dimethylaminopyridine.
26 g (2.13 mmol) were added and stirred at 70 ° C. for 3 hours.
Stirred. After cooling the reaction solution to room temperature, 30 ml of water was added.
Then, the mixture was stirred for 0.5 hour. Acidify with dilute hydrochloric acid
And extracted twice with ethyl acetate. The collected organic layer
After drying over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure. Profit
The crude product was purified by silica gel column chromatography.
(Hexane / ethyl acetate = 1 / 1-ethyl acetate)
), Crystallized from diisopropyl ether-hexane
Then, the desired product was obtained. Light brown powder Yield 0.466 g
Rate 69% mp 154-155 ° C;1H-NMR (CDClThree, 300 MHz) δ 1.92-2.01
(2H, m), 2.17-2.23 (2H, m), 2.58-2.77 (7H, m), 3.
04 (1H, dd, J = 3.8 Hz, 14.3 Hz), 4.89-4.99 (1H,
m), 5.71 (1H, d, J = 9.3 Hz), 5.85 (1H, td, J = 5.
1 Hz, 11.7 Hz), 5.89 (1H, tt, J = 2.9 Hz, 53.1 H
z), 6.00 (1H, d, J = 11.7 Hz), 6.06 (1H, d, J = 5.4
Hz), 6.84 (1H, dd, J = 1.4 Hz, 7.7 Hz), 6.98-7.13
(7H, m), 7.30 (1H, t, J = 7.8 Hz), 7.41 (2H, dd,
J = 5.3 Hz, 8.6 Hz); IR (KBr) 3243, 3067, 2940, 17
34, 1640, 1512, 1211, 1155, 1123 cm-1; Anal. Calcd
for C 33H30FFiveNO6・ 0.5HTwoO: C, 61.87; H, 4.88; N, 2.1
9. Found: C, 61.78; H, 4.77; N, 2.15.
【0517】実施例385 コハク酸ナトリウム(1RS,2SR)-2-[(6,7
-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-イル
カルボニル)アミノ]-1-(4-フルオロフェニル)-3
-[3-(1,1,2,2-テトラフルオロエトキシ)フ
ェニル]プロピル コハク酸(1RS,2SR)-2-[(6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-イルカルボニ
ル)アミノ]-1-(4-フルオロフェニル)-3-[3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル]プロピル水素165mg(0.261ミリモル)の
テトラヒドロフラン2ml溶液に、1規定水酸化ナトリ
ウム水溶液0.26ml(0.26ミリモル)を加え、
室温で5分撹拌した。反応液の溶媒を減圧留去し、得ら
れた残留物をエタノール-ヘキサンより結晶化して、目
的物を得た。淡褐色粉末 収量130mg 収率76% mp 165-170℃; 1H-NMR (CDCl3, 300 MHz) δ 1.92-2.00
(2H, m), 2.17-2.23 (2H, m), 2.60-2.75 (7H, m), 3.
03 (1H, dd, J = 3.9 Hz, 14.1 Hz), 4.90-5.00(1H,
m), 5.66 (1H, d, J = 9.6 Hz), 5.85 (1H, td, J = 5.
3 Hz, 10.5 Hz), 5.89 (1H, tt, J = 2.9 Hz, 53.0 H
z), 6.01 (1H, d, J = 12.0 Hz), 6.04 (1H,d, J = 5.1
Hz), 6.83 (1H, dd, J = 1.5 Hz, 7.5 Hz), 6.99-7.13
(7H, m), 7.29 (1H, t, J = 7.8 Hz), 7.40 (2H, dd,
J = 5.3 Hz, 8.9 Hz); IR (KBr) 3400-2900, 1730, 164
0, 1534, 1514, 1200, 1159, 1128 cm-1; Anal. Calcd
for C3 3H29F5NO6Na・2.0H2O: C, 57.48; H, 4.82; N, 2.
03. Found: C, 57.49; H, 4.46; N, 1.88.Example 385 Sodium succinate (1RS, 2SR) -2-[(6,7
-Dihydro-5H-benzo [a] cyclohepten-1-ylcarbonyl) amino] -1- (4-fluorophenyl) -3
-[3- (1,1,2,2-tetrafluoroethoxy) phenyl] propyl succinic acid (1RS, 2SR) -2-[(6,7-dihydro-
5H-benzo [a] cyclohepten-1-ylcarbonyl) amino] -1- (4-fluorophenyl) -3- [3-
To a solution of 165 mg (0.261 mmol) of (1,1,2,2-tetrafluoroethoxy) phenyl] propyl hydrogen in 2 ml of tetrahydrofuran was added 0.26 ml (0.26 mmol) of a 1 N aqueous sodium hydroxide solution,
Stir at room temperature for 5 minutes. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was crystallized from ethanol-hexane to obtain the desired product. Light brown powder Yield 130 mg Yield 76% mp 165-170 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.92-2.00
(2H, m), 2.17-2.23 (2H, m), 2.60-2.75 (7H, m), 3.
03 (1H, dd, J = 3.9 Hz, 14.1 Hz), 4.90-5.00 (1H,
m), 5.66 (1H, d, J = 9.6 Hz), 5.85 (1H, td, J = 5.
3 Hz, 10.5 Hz), 5.89 (1H, tt, J = 2.9 Hz, 53.0 H
z), 6.01 (1H, d, J = 12.0 Hz), 6.04 (1H, d, J = 5.1
Hz), 6.83 (1H, dd, J = 1.5 Hz, 7.5 Hz), 6.99-7.13
(7H, m), 7.29 (1H, t, J = 7.8 Hz), 7.40 (2H, dd,
J = 5.3 Hz, 8.9 Hz); IR (KBr) 3400-2900, 1730, 164
0, 1534, 1514, 1200, 1159, 1128 cm -1 ; Anal.Calcd
for C 3 3 H 29 F 5 NO 6 Na ・ 2.0H 2 O: C, 57.48; H, 4.82; N, 2.
03. Found: C, 57.49; H, 4.46; N, 1.88.
【0518】実施例386 N-(tert-ブトキシカルボニル)グリシン(1R
S,2SR)-2-[(6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-イルカルボニル)アミノ]-
1-(4-フルオロフェニル)-3-[3-(1,1,2,
2-テトラフルオロエトキシ)フェニル]プロピルエス
テル N-[(1RS,2SR)-2-(4-フルオロフェニル)
-2-ヒドロキシ-1-[3-(1,1,2,2-テトラフル
オロエトキシ)ベンジル]エチル]-6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-カルボキサミド
0.304g(0.572ミリモル)、BOC-グリシ
ン0.12g(0.69ミリモル)、4-N,N-ジメチ
ルアミノピリジン0.14g(1.14ミリモル)、1
-エチル-3-(3-ジメチルアミノプロピル)カルボジイ
ミド・塩酸塩0.16g(0.86ミリモル)のアセト
ニトリル10ml溶液を、室温で一晩撹拌した。反応液
を酢酸エチルに希釈し、炭酸水素ナトリウム水溶液で洗
浄、無水硫酸マグネシウムで乾燥、シリカゲルを通した
後、溶媒を減圧留去して、目的物を得た。白色固体 収
量0.411g 収率100% ジイソプロピルエーテル-ヘキサンより結晶化して、白
色粉末を得た。 mp 151-152℃; 1H-NMR (CDCl3, 300 MHz) δ 1.41 (9H,
s), 1.93-2.01 (2H, m), 2.18-2.24 (2H, m), 2.66 (2
H, t, J = 5.9 Hz), 2.70 (1H, dd, J = 10.5 Hz, 14.4
Hz), 3.04 (1H, dd, J = 4.1 Hz, 14.3 Hz), 3.91-4.0
6 (2H, m), 4.91-5.00 (1H, m), 5.07 (1H, br t, J =
4.5 Hz), 5.68 (1H, d, J = 9.9 Hz), 5.86 (1H, td, J
= 5.4 Hz, 12.0 Hz), 5.89 (1H, tt, J = 2.9 Hz, 53.
1 Hz), 6.02 (1H, d, J = 11.7 Hz), 6.11 (1H, d, J =
5.4 Hz), 6.87 (1H, d, J = 7.2 Hz), 7.01-7.13 (7H,
m), 7.31 (1H, t, J = 8.0 Hz), 7.41 (2H, dd, J =
5.4 Hz, 8.7 Hz); IR (KBr) 3370, 3310, 2936, 1750,
1684, 1638, 1512, 1225, 1196, 1157, 1125 cm-1; Ana
l. Calcd for C36H37F5N2O6: C, 62.79; H, 5.42; N,4.
07. Found: C, 62.60; H, 5.49; N, 4.00.Example 386 N- (tert-butoxycarbonyl) glycine (1R
S, 2SR) -2-[(6,7-dihydro-5H-benzo [a] cyclohepten-1-ylcarbonyl) amino]-
1- (4-fluorophenyl) -3- [3- (1,1,2,2
2-tetrafluoroethoxy) phenyl] propyl ester N-[(1RS, 2SR) -2- (4-fluorophenyl)
-2-Hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro-
0.34 g (0.572 mmol) of 5H-benzo [a] cycloheptene-1-carboxamide, 0.12 g (0.69 mmol) of BOC-glycine 0.14 g (1.14 g) of 4-N, N-dimethylaminopyridine Mmol), 1
A solution of 0.16 g (0.86 mmol) of -ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride in 10 ml of acetonitrile was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure to obtain the desired product. White solid Yield: 0.411 g Yield: 100% Crystallization from diisopropyl ether-hexane gave a white powder. mp 151-152 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.41 (9H,
s), 1.93-2.01 (2H, m), 2.18-2.24 (2H, m), 2.66 (2
H, t, J = 5.9 Hz), 2.70 (1H, dd, J = 10.5 Hz, 14.4
Hz), 3.04 (1H, dd, J = 4.1 Hz, 14.3 Hz), 3.91-4.0
6 (2H, m), 4.91-5.00 (1H, m), 5.07 (1H, br t, J =
4.5 Hz), 5.68 (1H, d, J = 9.9 Hz), 5.86 (1H, td, J
= 5.4 Hz, 12.0 Hz), 5.89 (1H, tt, J = 2.9 Hz, 53.
1 Hz), 6.02 (1H, d, J = 11.7 Hz), 6.11 (1H, d, J =
5.4 Hz), 6.87 (1H, d, J = 7.2 Hz), 7.01-7.13 (7H,
m), 7.31 (1H, t, J = 8.0 Hz), 7.41 (2H, dd, J =
5.4 Hz, 8.7 Hz); IR (KBr) 3370, 3310, 2936, 1750,
1684, 1638, 1512, 1225, 1196, 1157, 1125 cm -1 ; Ana
l. Calcd for C 36 H 37 F 5 N 2 O 6 : C, 62.79; H, 5.42; N, 4.
07. Found: C, 62.60; H, 5.49; N, 4.00.
【0519】実施例387 グリシン(1RS,2SR)-2-[(6,7-ジヒドロ-
5H-ベンゾ[a]シクロヘプテン-1-イルカルボニ
ル)アミノ]-1-(4-フルオロフェニル)-3-[3-
(1,1,2,2-テトラフルオロエトキシ)フェニ
ル]プロピルエステル塩酸塩 N-(tert-ブトキシカルボニル)グリシン(1R
S,2SR)-2-[(6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-イルカルボニル)アミノ]-
1-(4-フルオロフェニル)-3-[3-(1,1,2,
2-テトラフルオロエトキシ)フェニル]プロピルエス
テル0.351g(0.510ミリモル)、濃塩酸0.
3ml、メタノール8mlの混合物を50℃で1時間撹
拌した。反応液の溶媒を減圧留去し、得られた残留物を
ジエチルエーテルより結晶化して、目的物を得た。白色
粉末 収量0.270g 収率85% mp 174-177℃(dec.); 1H-NMR (CD3OD, 300 MHz) δ 1.8
8-1.96 (2H, m), 2.19-2.24 (2H, m), 2.63-2.72 (3H,
m), 3.24 (1H, dd, J = 3.3 Hz, 14.1 Hz), 3.90(1H,
d, J = 17.1 Hz), 3.99 (1H, d, J = 17.1 Hz), 4.86-
4.98 (1H, m), 5.69-5.79 (2H, m), 6.04 (1H, d, J =
6.9 Hz), 6.24 (1H, tt, J = 2.9 Hz, 52.6Hz), 6.59
(1H, dd, J = 1.2 Hz, 7.5 Hz), 7.00 (1H, t, J = 7.4
Hz), 7.10-7.17 (5H, m), 7.23 (1H, d, J = 7.8 Hz),
7.38 (1H, t, J = 7.8 Hz), 7.55 (2H, dd, J = 5.3 H
z, 8.9 Hz); IR (KBr) 3283, 3100-2800, 1744, 1640,
1514,1271, 1233, 1200, 1125 cm-1; Anal. Calcd for
C31H30ClF5N2O4・0.5H2O: C,58.72; H, 4.93; N, 4.42.
Found: C, 58.46; H, 4.84; N, 4.51.Example 387 Glycine (1RS, 2SR) -2-[(6,7-dihydro-
5H-benzo [a] cyclohepten-1-ylcarbonyl) amino] -1- (4-fluorophenyl) -3- [3-
(1,1,2,2-tetrafluoroethoxy) phenyl] propyl ester hydrochloride N- (tert-butoxycarbonyl) glycine (1R
S, 2SR) -2-[(6,7-dihydro-5H-benzo [a] cyclohepten-1-ylcarbonyl) amino]-
1- (4-fluorophenyl) -3- [3- (1,1,2,2
0.351 g (0.510 mmol) of 2-tetrafluoroethoxy) phenyl] propyl ester, concentrated hydrochloric acid 0.1%.
A mixture of 3 ml and 8 ml of methanol was stirred at 50 ° C. for 1 hour. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was crystallized from diethyl ether to obtain the desired product. White powder Yield 0.270 g Yield 85% mp 174-177 ° C. (dec.); 1 H-NMR (CD 3 OD, 300 MHz) δ 1.8
8-1.96 (2H, m), 2.19-2.24 (2H, m), 2.63-2.72 (3H,
m), 3.24 (1H, dd, J = 3.3 Hz, 14.1 Hz), 3.90 (1H,
d, J = 17.1 Hz), 3.99 (1H, d, J = 17.1 Hz), 4.86-
4.98 (1H, m), 5.69-5.79 (2H, m), 6.04 (1H, d, J =
6.9 Hz), 6.24 (1H, tt, J = 2.9 Hz, 52.6Hz), 6.59
(1H, dd, J = 1.2 Hz, 7.5 Hz), 7.00 (1H, t, J = 7.4
Hz), 7.10-7.17 (5H, m), 7.23 (1H, d, J = 7.8 Hz),
7.38 (1H, t, J = 7.8 Hz), 7.55 (2H, dd, J = 5.3 H
z, 8.9 Hz); IR (KBr) 3283, 3100-2800, 1744, 1640,
1514,1271, 1233, 1200, 1125 cm -1 ; Anal.Calcd for
C 31 H 30 ClF 5 N 2 O 4・ 0.5H 2 O: C, 58.72; H, 4.93; N, 4.42.
Found: C, 58.46; H, 4.84; N, 4.51.
【0520】実施例388 コハク酸(1RS,2SR)-2-[(4-フルオロ-1-
ナフトイル)アミノ]-1-(4-フルオロフェニル)-3
-[3-(1,1,2,2-テトラフルオロエトキシ)フ
ェニル]プロピル水素 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]エチル]ナフ
タレン-1-カルボキサミド0.664g(1.245ミ
リモル)とコハク酸クロリド0.48g(3.11ミリ
モル)のアセトニトリル30ml溶液に、4-N,N-ジ
メチルアミノピリジン0.30g(2.49ミリモル)
を加え、70℃で3時間撹拌した。反応液を室温に冷却
した後、水30mlを加え、そのまま0.5時間撹拌し
た。これを希塩酸で酸性とした後、酢酸エチルで2回抽
出した。集めた有機層を無水硫酸マグネシウムで乾燥、
溶媒を減圧留去した。得られた粗生成物をシリカゲルカ
ラムクロマトグラフィーにて精製し(ヘキサン/酢酸エ
チル=1/1-酢酸エチル)、ジイソプロピルエーテル-
ヘキサンより結晶化して、目的物を得た。淡褐色粉末
収量0.438g 収率56% mp 181-182℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
2.70-2.76 (4H, m), 2.84(1H, dd, J = 11.7 Hz, 14.4
Hz), 3.07 (1H, dd, J = 3.9 Hz, 14.4 Hz), 4.93-5.02
(1H, m), 5.94 (1H, tt, J = 2.9 Hz, 53.0 Hz), 6.27
(1H, d, J = 5.4Hz), 7.01-7.32 (8H, m), 7.40-7.53
(5H, m), 8.03 (1H, d, J = 9.0 Hz); IR(KBr) 3308, 3
100-2800, 1740, 1723, 1640, 1624, 1530, 1516, 123
5, 1179,1119 cm-1; Anal. Calcd for C32H25F6NO6: C,
60.67; H, 3.98; N, 2.21. Found: C, 60.37; H, 3.7
6; N, 2.05.Example 388 Succinic acid (1RS, 2SR) -2-[(4-fluoro-1-
Naphthoyl) amino] -1- (4-fluorophenyl) -3
-[3- (1,1,2,2-tetrafluoroethoxy) phenyl] propyl hydrogen 4-fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [ 3- (1,1,2,2
4-N, N-dimethyl was added to a solution of 0.664 g (1.245 mmol) of 2-tetrafluoroethoxy) benzyl] ethyl] naphthalene-1-carboxamide and 0.48 g (3.11 mmol) of succinic chloride in 30 ml of acetonitrile. Aminopyridine 0.30 g (2.49 mmol)
Was added and stirred at 70 ° C. for 3 hours. After the reaction solution was cooled to room temperature, 30 ml of water was added and the mixture was stirred for 0.5 hour. This was acidified with diluted hydrochloric acid, and then extracted twice with ethyl acetate. The collected organic layer is dried over anhydrous magnesium sulfate,
The solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 1 / 1-ethyl acetate), and diisopropyl ether-
Crystallization from hexane gave the desired product. Light brown powder
Yield 0.438 g Yield 56% mp 181-182 ° C .; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
2.70-2.76 (4H, m), 2.84 (1H, dd, J = 11.7 Hz, 14.4
Hz), 3.07 (1H, dd, J = 3.9 Hz, 14.4 Hz), 4.93-5.02
(1H, m), 5.94 (1H, tt, J = 2.9 Hz, 53.0 Hz), 6.27
(1H, d, J = 5.4Hz), 7.01-7.32 (8H, m), 7.40-7.53
(5H, m), 8.03 (1H, d, J = 9.0 Hz); IR (KBr) 3308, 3
100-2800, 1740, 1723, 1640, 1624, 1530, 1516, 123
5, 1179,1119 cm -1 ; Anal.Calcd for C 32 H 25 F 6 NO 6 : C,
60.67; H, 3.98; N, 2.21. Found: C, 60.37; H, 3.7
6; N, 2.05.
【0521】実施例389 コハク酸ナトリウム(1RS,2SR)-2-[(4-フ
ルオロ-1-ナフトイル)アミノ]-1-(4-フルオロフ
ェニル)-3-[3-(1,1,2,2-テトラフルオロエ
トキシ)フェニル]プロピル コハク酸(1RS,2SR)-2-[(4-フルオロ-1-
ナフトイル)アミノ]-1-(4-フルオロフェニル)-3
-[3-(1,1,2,2-テトラフルオロエトキシ)フ
ェニル]プロピル水素242mg(0.382ミリモ
ル)のテトラヒドロフラン2ml溶液に、1規定水酸化
ナトリウム水溶液0.38ml(0.38ミリモル)を
加え、室温で5分撹拌した。反応液の溶媒を減圧留去
し、得られた残留物をエタノール-ヘキサンより結晶化
して、目的物を得た。淡褐色粉末 収量165mg 収
率66% mp 192-198℃; 1H-NMR (DMSO-d6, 300 MHz) δ 2.42-2.
64 (4H, m), 2.81 (1H,dd, J = 11.7 Hz, 13.2 Hz), 3.
08 (1H, dd, J = 2.1 Hz, 13.5 Hz), 4.68-4.79(1H,
m), 5.93 (1H, d, J = 6.9 Hz), 6.73 (1H, tt, J = 2.
9 Hz, 51.8 Hz),7.08-7.42 (10H, m), 7.50 (2H, dd, J
= 5.7 Hz, 8.4 Hz), 7.58 (1H, t, J =7.4 Hz), 8.01
(1H, d, J = 8.7 Hz), 8.73 (1H, d, J = 9.3 Hz); IR
(KBr) 3304, 1738, 1842, 1574, 1530, 1514, 1119 cm
-1; Anal. Calcd for C32H24F6NO6Na・1.0H2O: C, 57.0
6; H, 3.89; N, 2.08. Found: C, 56.79; H, 3.86; N,
1.90.Example 389 Sodium succinate (1RS, 2SR) -2-[(4-fluoro-1-naphthoyl) amino] -1- (4-fluorophenyl) -3- [3- (1,1,2 , 2-Tetrafluoroethoxy) phenyl] propyl succinic acid (1RS, 2SR) -2-[(4-fluoro-1-
Naphthoyl) amino] -1- (4-fluorophenyl) -3
To a solution of 242 mg (0.382 mmol) of-[3- (1,1,2,2-tetrafluoroethoxy) phenyl] propyl hydrogen in 2 ml of tetrahydrofuran was added 0.38 ml (0.38 mmol) of a 1 N aqueous sodium hydroxide solution. The mixture was stirred at room temperature for 5 minutes. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was crystallized from ethanol-hexane to obtain the desired product. Light brown powder Yield 165 mg Yield 66% mp 192-198 ° C .; 1 H-NMR (DMSO-d 6 , 300 MHz) δ 2.42-2.
64 (4H, m), 2.81 (1H, dd, J = 11.7 Hz, 13.2 Hz), 3.
08 (1H, dd, J = 2.1 Hz, 13.5 Hz), 4.68-4.79 (1H,
m), 5.93 (1H, d, J = 6.9 Hz), 6.73 (1H, tt, J = 2.
9 Hz, 51.8 Hz), 7.08-7.42 (10H, m), 7.50 (2H, dd, J
= 5.7 Hz, 8.4 Hz), 7.58 (1H, t, J = 7.4 Hz), 8.01
(1H, d, J = 8.7 Hz), 8.73 (1H, d, J = 9.3 Hz); IR
(KBr) 3304, 1738, 1842, 1574, 1530, 1514, 1119 cm
-1 ; Anal.Calcd for C 32 H 24 F 6 NO 6 Na ・ 1.0H 2 O: C, 57.0
6; H, 3.89; N, 2.08. Found: C, 56.79; H, 3.86; N,
1.90.
【0522】実施例390 N-(tert-ブトキシカルボニル)グリシン(1R
S,2SR)-2-[(4-フルオロ-1-ナフトイル)ア
ミノ]-1-(4-フルオロフェニル)-3-[3-(1,
1,2,2-テトラフルオロエトキシ)フェニル]プロ
ピルエステル 4-フルオロ-N-[(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]エチル]ナフ
タレン-1-カルボキサミド0.486g(0.911ミ
リモル)、BOC-グリシン0.19g(1.09ミリ
モル)、4-N,N-ジメチルアミノピリジン0.22g
(1.82ミリモル)、1-エチル-3-(3-ジメチルア
ミノプロピル)カルボジイミド・塩酸塩0.26g
(1.37ミリモル)のアセトニトリル20ml溶液
を、室温で一晩撹拌した。反応液を酢酸エチルに希釈
し、炭酸水素ナトリウム水溶液で洗浄、無水硫酸マグネ
シウムで乾燥、シリカゲルを通した後、溶媒を減圧留去
した。得られた残留物をジイソプロピルエーテル-ヘキ
サンより結晶化して、目的物を得た。白色粉末 収量
0.582g 収率93% mp 126-127℃; 1H-NMR (CDCl3, 300 MHz) δ 1.33 (9H,
s), 2.81 (1H, dd, J =11.0 Hz, 14.6 Hz), 3.10 (1H,
dd, J = 3.9 Hz, 14.4 Hz), 3.93 (1H, dd, J= 6.0 H
z, 17.4 Hz), 4.04 (1H, dd, J = 5.9 Hz, 1.9 Hz), 4.
98-5.09 (2H, m), 5.88 (1H, tt, J = 2.8 Hz, 53.2 H
z), 6.08 (1H, d, J = 9.9 Hz), 6.26 (1H, d, J = 3.9
Hz), 7.00 (1H, dd, J = 7.8 Hz, 9.9 Hz), 7.08-7.19
(6H, m),7.32 (1H, t, J = 8.0 Hz), 7.40-7.54 (4H,
m), 7.62 (1H, d, J = 7.8 Hz), 8.06 (1H, d, J = 7.8
Hz); IR (KBr) 3360, 3297, 2982, 1746, 1682, 1642,
1530, 1514, 1227, 2300, 1161, 1125 cm-1; Anal. Ca
lcd for C35H32F6N2O6: C,60.87; H, 4.67; N, 4.06. F
ound: C, 60.73; H, 4.65; N, 4.05.Example 390 N- (tert-butoxycarbonyl) glycine (1R
S, 2SR) -2-[(4-Fluoro-1-naphthoyl) amino] -1- (4-fluorophenyl) -3- [3- (1,
1,2,2-tetrafluoroethoxy) phenyl] propyl ester 4-fluoro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1, 2,
0.486 g (0.911 mmol) of 2-tetrafluoroethoxy) benzyl] ethyl] naphthalene-1-carboxamide, 0.19 g (1.09 mmol) of BOC-glycine, 0.22 g of 4-N, N-dimethylaminopyridine
(1.82 mmol) 0.26 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride
A solution of (1.37 mmol) in 20 ml of acetonitrile was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate, washed with an aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, passed through silica gel, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized from diisopropyl ether-hexane to obtain the desired product. White powder Yield 0.582 g Yield 93% mp 126-127 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.33 (9H,
s), 2.81 (1H, dd, J = 11.0 Hz, 14.6 Hz), 3.10 (1H,
dd, J = 3.9 Hz, 14.4 Hz), 3.93 (1H, dd, J = 6.0 H
z, 17.4 Hz), 4.04 (1H, dd, J = 5.9 Hz, 1.9 Hz), 4.
98-5.09 (2H, m), 5.88 (1H, tt, J = 2.8 Hz, 53.2 H
z), 6.08 (1H, d, J = 9.9 Hz), 6.26 (1H, d, J = 3.9
Hz), 7.00 (1H, dd, J = 7.8 Hz, 9.9 Hz), 7.08-7.19
(6H, m), 7.32 (1H, t, J = 8.0 Hz), 7.40-7.54 (4H,
m), 7.62 (1H, d, J = 7.8 Hz), 8.06 (1H, d, J = 7.8
Hz); IR (KBr) 3360, 3297, 2982, 1746, 1682, 1642,
1530, 1514, 1227, 2300, 1161, 1125 cm -1 ; Anal.Ca
lcd for C 35 H 32 F 6 N 2 O 6 : C, 60.87; H, 4.67; N, 4.06. F
ound: C, 60.73; H, 4.65; N, 4.05.
【0523】実施例391 グリシン(1RS,2SR)-2-[(4-フルオロ-1-
ナフトイル)アミノ]-1-(4-フルオロフェニル)-3
-[3-(1,1,2,2-テトラフルオロエトキシ)フ
ェニル]プロピルエステル塩酸塩 N-(tert-ブトキシカルボニル)グリシン(1R
S,2SR)-2-[(4-フルオロ-1-ナフトイル)ア
ミノ]-1-(4-フルオロフェニル)-3-[3-(1,
1,2,2-テトラフルオロエトキシ)フェニル]プロ
ピルエステル0.404g(0.585ミリモル)、濃
塩酸0.4ml、メタノール6mlの混合物を50℃で
1時間撹拌した。反応液の溶媒を減圧留去し、得られた
残留物をジエチルエーテルより結晶化して、目的物を得
た。白色粉末 収量0.331g 収率90% mp 209-212℃(dec.); 1H-NMR (CD3OD, 300 MHz) δ 2.7
8 (1H, dd, J = 11.9 Hz, 14.3 Hz), 3.33 (1H, dd, J
= 3.9 Hz, 14.3 Hz), 3.95 (1H, d, J = 17.4 Hz), 4.0
4 (1H, d, J = 17.4 Hz), 4.98-5.06 (1H, m), 6.08 (1
H, d, J = 7.5 Hz), 6.249 (1H, tt, J = 2.9 Hz, 52.7
Hz), 7.00 (1H, dd, J = 5.4 Hz, 8.1 Hz), 7.07 (1H,
dd, J = 7.7 Hz, 10.1 Hz), 7.14-7.28 (6H, m), 7.36
-7.41 (2H,m), 7.51-7.61 (3H, m), 8.03 (1H, d, J =
8.4 Hz); IR (KBr) 3301, 3100-2800, 1740, 1644, 151
4, 1275, 1235, 1206, 1121 cm-1; Anal. Calcd for C
30H2 5ClF6N2O4・0.5H2O: C, 56.66; H, 4.12; N, 4.40.
Found: C, 56.81; H, 4.35;N, 4.62.Example 391 Glycine (1RS, 2SR) -2-[(4-fluoro-1-
Naphthoyl) amino] -1- (4-fluorophenyl) -3
-[3- (1,1,2,2-tetrafluoroethoxy) phenyl] propyl ester hydrochloride N- (tert-butoxycarbonyl) glycine (1R
S, 2SR) -2-[(4-Fluoro-1-naphthoyl) amino] -1- (4-fluorophenyl) -3- [3- (1,
A mixture of 0.404 g (0.585 mmol) of 1,2,2-tetrafluoroethoxy) phenyl] propyl ester, 0.4 ml of concentrated hydrochloric acid and 6 ml of methanol was stirred at 50 ° C. for 1 hour. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was crystallized from diethyl ether to obtain the desired product. White powder Yield 0.331 g Yield 90% mp 209-212 ° C (dec.); 1 H-NMR (CD 3 OD, 300 MHz) δ 2.7
8 (1H, dd, J = 11.9 Hz, 14.3 Hz), 3.33 (1H, dd, J
= 3.9 Hz, 14.3 Hz), 3.95 (1H, d, J = 17.4 Hz), 4.0
4 (1H, d, J = 17.4 Hz), 4.98-5.06 (1H, m), 6.08 (1
H, d, J = 7.5 Hz), 6.249 (1H, tt, J = 2.9 Hz, 52.7
Hz), 7.00 (1H, dd, J = 5.4 Hz, 8.1 Hz), 7.07 (1H,
dd, J = 7.7 Hz, 10.1 Hz), 7.14-7.28 (6H, m), 7.36
-7.41 (2H, m), 7.51-7.61 (3H, m), 8.03 (1H, d, J =
8.4 Hz); IR (KBr) 3301, 3100-2800, 1740, 1644, 151
4, 1275, 1235, 1206, 1121 cm -1 ; Anal.Calcd for C
30 H 2 5 ClF 6 N 2 O 4 · 0.5H 2 O: C, 56.66; H, 4.12; N, 4.40.
Found: C, 56.81; H, 4.35; N, 4.62.
【0524】実施例392 コハク酸(1RS,2SR)-3-(4-tert-ブチル
フェニル)-2-[(5-クロロ-1-ナフトイル)アミ
ノ]-1-(4-フルオロフェニル)プロピル水素 N-[(1RS,2SR)-1-(4-tert-ブチルベ
ンジル)-2-(3-クロロフェニル)-2-ヒドロキシエ
チル]-5-クロロ-1-ナフトアミド0.499g(0.
985ミリモル)とコハク酸クロリド0.38g(2.
46ミリモル)のアセトニトリル30ml溶液に、4-
N,N-ジメチルアミノピリジン0.24g(1.97
ミリモル)を加え、70℃で3時間撹拌した。反応液を
室温に冷却した後、水30mlを加え、そのまま0.5
時間撹拌した。これを希塩酸で酸性とした後、酢酸エチ
ルで2回抽出した。集めた有機層を無水硫酸マグネシウ
ムで乾燥、溶媒を減圧留去した。得られた粗生成物をシ
リカゲルカラムクロマトグラフィーにて精製し(ヘキサ
ン/酢酸エチル=2/1-1/1)、ジイソプロピルエ
ーテル-ヘキサンより結晶化して、目的物を得た。白色
結晶 収量0.325g 収率54% mp 161-162℃; 1H-NMR (CDCl3, 300 MHz) δ 1.31 (9H,
s), 2.63-2.84 (5H, m), 3.02 (1H, dd, J = 4.1 Hz,
14.0 Hz), 4.98-5.06 (1H, m), 5.97 (1H, d, J= 9.3 H
z), 6.21 (1H, d, J = 4.8 Hz), 7.11 (2H, d, J = 8.4
Hz), 7.18-7.54(11H, m), 8.28 (1H, d, J = 8.7 Hz);
IR (KBr) 3300-3020, 2961, 1734, 1644, 1532, 1213,
1165, 783 cm-1; Anal. Calcd for C34H33Cl2NO5・0.5H
2O: C, 66.34; H, 5.57; N, 2.28. Found: C, 66.28;
H, 5.34; N, 2.28.Example 392 (1RS, 2SR) -3- (4-tert-butylphenyl) -2-[(5-chloro-1-naphthoyl) amino] -1- (4-fluorophenyl) propyl hydrogen succinate 0.499 g of N-[(1RS, 2SR) -1- (4-tert-butylbenzyl) -2- (3-chlorophenyl) -2-hydroxyethyl] -5-chloro-1-naphthamide (0.
985 mmol) and 0.38 g of succinic chloride (2.
46 mmol) in 30 ml of acetonitrile
0.24 g of N, N-dimethylaminopyridine (1.97
Mmol) and stirred at 70 ° C. for 3 hours. After cooling the reaction solution to room temperature, 30 ml of water was added, and
Stirred for hours. This was acidified with diluted hydrochloric acid, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 2 / 1-1 / 1), and crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.325 g Yield 54% mp 161-162 ° C; 1 H-NMR (CDCl 3 , 300 MHz) δ 1.31 (9H,
s), 2.63-2.84 (5H, m), 3.02 (1H, dd, J = 4.1 Hz,
14.0 Hz), 4.98-5.06 (1H, m), 5.97 (1H, d, J = 9.3 H
z), 6.21 (1H, d, J = 4.8 Hz), 7.11 (2H, d, J = 8.4
Hz), 7.18-7.54 (11H, m), 8.28 (1H, d, J = 8.7 Hz);
IR (KBr) 3300-3020, 2961, 1734, 1644, 1532, 1213,
1165, 783 cm -1 ; Anal.Calcd for C 34 H 33 Cl 2 NO 5・ 0.5H
2 O: C, 66.34; H, 5.57; N, 2.28. Found: C, 66.28;
H, 5.34; N, 2.28.
【0525】実施例393 コハク酸ナトリウム(1RS,2SR)-3-(4-te
rt-ブチルフェニル)-2-[(5-クロロ-1-ナフトイ
ル)アミノ]-1-(4-フルオロフェニル)プロピル コハク酸(1RS,2SR)-3-(4-tert-ブチル
フェニル)-2-[(5-クロロ-1-ナフトイル)アミ
ノ]-1-(4-フルオロフェニル)プロピル水素217
mg(0.358ミリモル)のテトラヒドロフラン3m
l溶液に、1規定水酸化ナトリウム水溶液0.36ml
(0.36ミリモル)を加え、室温で5分撹拌した。反
応液の溶媒を減圧留去し、得られた残留物をメタノール
-ジエチルエーテル-ヘキサンより結晶化して、目的物を
得た。白色粉末 収量200mg 収率89% mp 174-178℃; 1H-NMR (CDCl3-CD3OD, 300 MHz) δ 1.3
0 (9H, s), 2.53-2.58 (2H, m), 2.65-2.83 (3H, m),
3.00 (1H, dd, J = 2.7 Hz, 14.4 Hz), 4.89-4.98(1H,
m), 6.17 (1H, d, J = 4.8 Hz), 7.12 (2H, d, J = 8.4
Hz), 7.20-7.54(11H, m), 8.28 (1H, d, J = 8.4 Hz);
IR (KBr) 3245, 2965, 1730, 1640, 1574, 1418, 115
7, 785 cm-1; Anal. Calcd for C34H32Cl2NO5Na・1.0H
2O: C, 63.16; H, 5.30; N, 2.17. Found: C, 62.93;
H, 5.57; N, 2.04.Example 393 Sodium succinate (1RS, 2SR) -3- (4-te)
rt-butylphenyl) -2-[(5-chloro-1-naphthoyl) amino] -1- (4-fluorophenyl) propyl (1RS, 2SR) -3- (4-tert-butylphenyl) -2 succinate -[(5-Chloro-1-naphthoyl) amino] -1- (4-fluorophenyl) propyl hydrogen 217
mg (0.358 mmol) of tetrahydrofuran 3m
0.36 ml of 1N aqueous sodium hydroxide solution
(0.36 mmol) and stirred at room temperature for 5 minutes. The solvent of the reaction solution was distilled off under reduced pressure.
Crystallization from -diethyl ether-hexane gave the desired product. White powder Yield 200 mg Yield 89% mp 174-178 ° C .; 1 H-NMR (CDCl 3 -CD 3 OD, 300 MHz) δ 1.3
0 (9H, s), 2.53-2.58 (2H, m), 2.65-2.83 (3H, m),
3.00 (1H, dd, J = 2.7 Hz, 14.4 Hz), 4.89-4.98 (1H,
m), 6.17 (1H, d, J = 4.8 Hz), 7.12 (2H, d, J = 8.4
Hz), 7.20-7.54 (11H, m), 8.28 (1H, d, J = 8.4 Hz);
IR (KBr) 3245, 2965, 1730, 1640, 1574, 1418, 115
7, 785 cm -1 ; Anal.Calcd for C 34 H 32 Cl 2 NO 5 Na ・ 1.0H
2 O: C, 63.16; H, 5.30; N, 2.17. Found: C, 62.93;
H, 5.57; N, 2.04.
【0526】実施例394 コハク酸(1RS,2SR)-2-[(5-クロロ-1-ナ
フトイル)アミノ]-1-(4-フルオロフェニル)-3-
[4-(トリフルオロメチル)フェニル]プロピル水素 5-クロロ-N-[(1RS,2SR)-2-(4-フルオロ
フェニル)-2-ヒドロキシ-1-[4-(トリフルオロメ
チル)ベンジル]エチル]ナフタレン-1-カルボキサミ
ド0.549g(1.094ミリモル)とコハク酸クロ
リド0.42g(2.73ミリモル)のアセトニトリル
30ml溶液に、4-N,N-ジメチルアミノピリジン
0.27g(2.19ミリモル)を加え、70℃で3時
間撹拌した。反応液を室温に冷却した後、水30mlを
加え、そのまま0.5時間撹拌した。これを希塩酸で酸
性とした後、酢酸エチルで2回抽出した。集めた有機層
を無水硫酸マグネシウムで乾燥、溶媒を減圧留去した。
得られた粗生成物をシリカゲルカラムクロマトグラフィ
ーにて精製し(ヘキサン/酢酸エチル=2/1-1/
1)、ジイソプロピルエーテル-ヘキサンより結晶化し
て、目的物を得た。白色結晶 収量0.408g 収率
62% mp 228-229℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
2.65-2.79 (4H, m), 2.87(1H, dd, J = 11.7 Hz, 13.5
Hz), 3.13 (1H, dd, J = 3.3 Hz, 14.1 Hz), 4.94-5.04
(1H, m), 6.21 (1H, d, J = 6.0 Hz), 7.08-7.23 (5H,
m), 7.38 (2H, d, J = 7.8 Hz), 7.47-7.54 (6H, m),
7.75 (1H, d, J = 9.6 Hz), 8.25 (1H, d,J = 8.4 Hz);
IR (KBr) 3300-2640, 1730, 1636, 1528, 1510, 1323,
1221, 1177, 1155, 1109 cm-1; Anal. Calcd for C31H
24ClF4NO5・0.3H2O: C, 61.30; H,4.08; N, 2.31. Foun
d: C, 61.21; H, 3.72; N, 2.36.Example 394 (1RS, 2SR) -2-succinic acid-2-[(5-chloro-1-naphthoyl) amino] -1- (4-fluorophenyl) -3-
[4- (trifluoromethyl) phenyl] propyl hydrogen 5-chloro-N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] To a solution of 0.549 g (1.094 mmol) of ethyl] naphthalene-1-carboxamide and 0.42 g (2.73 mmol) of succinic chloride in 30 ml of acetonitrile, 0.27 g of 4-N, N-dimethylaminopyridine (2. 19 mmol) and stirred at 70 ° C. for 3 hours. After the reaction solution was cooled to room temperature, 30 ml of water was added and the mixture was stirred for 0.5 hour. This was acidified with diluted hydrochloric acid, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure.
The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 2 / 1-1 / 1).
1) Crystallized from diisopropyl ether-hexane to obtain the desired product. White crystals Yield 0.408 g Yield 62% mp 228-229 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
2.65-2.79 (4H, m), 2.87 (1H, dd, J = 11.7 Hz, 13.5
Hz), 3.13 (1H, dd, J = 3.3 Hz, 14.1 Hz), 4.94-5.04
(1H, m), 6.21 (1H, d, J = 6.0 Hz), 7.08-7.23 (5H,
m), 7.38 (2H, d, J = 7.8 Hz), 7.47-7.54 (6H, m),
7.75 (1H, d, J = 9.6 Hz), 8.25 (1H, d, J = 8.4 Hz);
IR (KBr) 3300-2640, 1730, 1636, 1528, 1510, 1323,
1221, 1177, 1155, 1109 cm -1 ; Anal.Calcd for C 31 H
24 ClF 4 NO 5・ 0.3H 2 O: C, 61.30; H, 4.08; N, 2.31. Foun
d: C, 61.21; H, 3.72; N, 2.36.
【0527】実施例395 コハク酸ナトリウム(1RS,2SR)-2-[(5-ク
ロロ-1-ナフトイル)アミノ]-1-(4-フルオロフェ
ニル)-3-[4-(トリフルオロメチル)フェニル]プ
ロピル コハク酸(1RS,2SR)-2-[(5-クロロ-1-ナ
フトイル)アミノ]-1-(4-フルオロフェニル)-3-
[4-(トリフルオロメチル)フェニル]プロピル水素
214mgのテトラヒドロフラン3ml溶液に、1規定
水酸化ナトリウム水溶液0.36ml(0.36ミリモ
ル)を加え、室温で5分撹拌した。反応液の溶媒を減圧
留去し、得られた残留物をメタノール-ジエチルエーテ
ル-ヘキサンより結晶化して、目的物を得た。淡黄色非
晶粉末 収量132mg1 H-NMR (CDCl3-DMSO-d6-CD3OD, 300 MHz) δ 2.54-2.79
(4H, m), 2.91 (1H, dd, J = 11.7 Hz, 14.1 Hz), 3.0
8 (1H, dd, J = 2.6 Hz, 14.0 Hz), 4.86-4.93 (1H,
m), 6.18 (1H, d, J = 5.7 Hz), 7.04-7.22 (4H, m),
7.26 (1H, d, J = 6.6 Hz), 7.39 (2H, d, J = 8.4 H
z), 7.47-7.55 (6H, m), 8.26 (1H, d, J = 8.1Hz); IR
(KBr) 3650-2940, 1730, 1640, 1574, 1539, 1512, 13
27, 1159, 1123cm-1; Anal. Calcd for C31H23ClF4NO5N
a・1.1H2O: C, 57.84; H, 3.95; N, 2.18. Found: C, 5
7.68; H, 3.97; N, 2.13.Example 395 Sodium succinate (1RS, 2SR) -2-[(5-chloro-1-naphthoyl) amino] -1- (4-fluorophenyl) -3- [4- (trifluoromethyl) phenyl ] Propyl (1RS, 2SR) -2-[(5-chloro-1-naphthoyl) amino] -1- (4-fluorophenyl) -3-succinate
To a solution of 214 mg of [4- (trifluoromethyl) phenyl] propyl hydrogen in 3 ml of tetrahydrofuran was added 0.36 ml (0.36 mmol) of a 1N aqueous sodium hydroxide solution, and the mixture was stirred at room temperature for 5 minutes. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was crystallized from methanol-diethyl ether-hexane to obtain the desired product. Light yellow amorphous powder Yield 132 mg 1 H-NMR (CDCl 3 -DMSO-d 6 -CD 3 OD, 300 MHz) δ 2.54-2.79
(4H, m), 2.91 (1H, dd, J = 11.7 Hz, 14.1 Hz), 3.0
8 (1H, dd, J = 2.6 Hz, 14.0 Hz), 4.86-4.93 (1H,
m), 6.18 (1H, d, J = 5.7 Hz), 7.04-7.22 (4H, m),
7.26 (1H, d, J = 6.6 Hz), 7.39 (2H, d, J = 8.4 H
z), 7.47-7.55 (6H, m), 8.26 (1H, d, J = 8.1Hz); IR
(KBr) 3650-2940, 1730, 1640, 1574, 1539, 1512, 13
27, 1159, 1123cm -1;. Anal Calcd for C 31 H 23 ClF 4 NO 5 N
a ・ 1.1H 2 O: C, 57.84; H, 3.95; N, 2.18. Found: C, 5
7.68; H, 3.97; N, 2.13.
【0528】実施例396 コハク酸(1RS,2SR)-1-(4-フルオロフェニ
ル)-2-[(4-フルオロ-1-ナフトイル)アミノ]-3
-(2,2,3,3-テトラフルオロ-2,3-ジヒドロ-
1,4-ベンゾジオキシン-6-イル)プロピル水素 4-フルオロ-N-{(1RS,2SR)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[(2,2,3,3-
テトラフルオロ-2,3-ジヒドロ-1,4-ベンゾジオキ
シン-6-イル)メチル]エチル}-1-ナフトアミド0.
278g(0.508ミリモル)とコハク酸クロリド
0.20g(1.27ミリモル)のアセトニトリル30
ml溶液に、4-N,N-ジメチルアミノピリジン0.1
2g(1.02ミリモル)を加え、70℃で3時間撹拌
した。反応液を室温に冷却した後、水30mlを加え、
そのまま0.5時間撹拌した。これを希塩酸で酸性とし
た後、酢酸エチルで2回抽出した。集めた有機層を無水
硫酸マグネシウムで乾燥、溶媒を減圧留去した。得られ
た粗生成物をシリカゲルカラムクロマトグラフィーにて
精製し(ヘキサン/酢酸エチル=2/1-1/1)、ジ
イソプロピルエーテル-ヘキサンより結晶化して、目的
物を得た。白色結晶 収量0.184g 収率56% mp 196-197℃; 1H-NMR (CDCl3-DMSO-d6, 300 MHz) δ
2.71-2.75 (4H, m), 2.78(1H, dd, J = 11.4 Hz, 14.4
Hz), 2.98 (1H, dd, J = 3.6 Hz, 14.7 Hz), 4.89-4.98
(1H, m), 6.33 (1H, d, J = 4.5 Hz), 7.01-7.16 (6H,
m), 7.27 (1H, dd, J = 5.4 Hz, 8.1 Hz), 7.38-7.54
(6H, m), 8.05 (1H, d, J = 7.8 Hz); IR(KBr) 3285-26
20, 1728, 1512, 1279, 1223, 1159, 1084 cm-1; Anal.
Calcd for C32H23F6NO7・0.5H2O: C, 58.54; H, 3.68;
N, 2.13. Found: C, 58.76; H, 3.85; N, 2.31.Example 396 (1RS, 2SR) -1- (4-Fluorophenyl) -2-[(4-fluoro-1-naphthoyl) amino] -3 succinate
-(2,2,3,3-tetrafluoro-2,3-dihydro-
1,4-benzodioxin-6-yl) propyl hydrogen 4-fluoro-N-{(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1-[(2,2,3,3 -
Tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-yl) methyl] ethyl} -1-naphthamide
278 g (0.508 mmol) and 0.20 g (1.27 mmol) of succinic chloride in acetonitrile 30
0.1 ml of 4-N, N-dimethylaminopyridine
2 g (1.02 mmol) was added, and the mixture was stirred at 70 ° C. for 3 hours. After cooling the reaction solution to room temperature, 30 ml of water was added,
The mixture was stirred for 0.5 hours as it was. This was acidified with diluted hydrochloric acid, and then extracted twice with ethyl acetate. The collected organic layer was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography (hexane / ethyl acetate = 2 / 1-1 / 1), and crystallized from diisopropyl ether-hexane to obtain the desired product. White crystal Yield 0.184 g Yield 56% mp 196-197 ° C; 1 H-NMR (CDCl 3 -DMSO-d 6 , 300 MHz) δ
2.71-2.75 (4H, m), 2.78 (1H, dd, J = 11.4 Hz, 14.4
Hz), 2.98 (1H, dd, J = 3.6 Hz, 14.7 Hz), 4.89-4.98
(1H, m), 6.33 (1H, d, J = 4.5 Hz), 7.01-7.16 (6H,
m), 7.27 (1H, dd, J = 5.4 Hz, 8.1 Hz), 7.38-7.54
(6H, m), 8.05 (1H, d, J = 7.8 Hz); IR (KBr) 3285-26
20, 1728, 1512, 1279, 1223, 1159, 1084 cm -1 ; Anal.
Calcd for C 32 H 23 F 6 NO 7・ 0.5H 2 O: C, 58.54; H, 3.68;
N, 2.13. Found: C, 58.76; H, 3.85; N, 2.31.
【0529】実施例397 コハク酸ナトリウム(1RS,2SR)-1-(4-フル
オロフェニル)-2-[(5-フルオロ-1-ナフトイル)
アミノ]-3-(2,2,3,3-テトラフルオロ-2,3
-ジヒドロ-1,4-ベンゾジオキシン-6-イル)プロピ
ル コハク酸(1RS,2SR)-1-(4-フルオロフェニ
ル)-2-[(4-フルオロ-1-ナフトイル)アミノ]-3
-(2,2,3,3-テトラフルオロ-2,3-ジヒドロ-
1,4-ベンゾジオキシン-6-イル)プロピル水素14
5mgのテトラヒドロフラン3ml溶液に、1規定水酸
化ナトリウム水溶液0.22ml(0.22ミリモル)
を加え、室温で5分撹拌した。反応液の溶媒を減圧留去
し、得られた残留物をメタノール-ジエチルエーテル-ヘ
キサンより結晶化して、目的物を得た。白色粉末 収量
79mg1 H-NMR (CDCl3-DMSO-d6-CD3OD, 300 MHz) δ 2.54-2.76
(4H, m), 2.85 (1H, dd, J = 11.6 Hz, 14.3 Hz), 2.9
8 (1H, dd, J = 3.5 Hz, 14.3 Hz), 4.80-4.86 (1H,
m), 6.21 (1H, d, J = 4.8 Hz), 7.03-7.14 (6H, m),
7.25 (1H, dd, J = 5.4 Hz, 7.8 Hz), 7.40 (1H, dd, J
= 6.5 Hz, 8.6 Hz), 7.50-7.53 (4H, m), 8.04 (1H,
d, J = 8.7 Hz); IR (KBr) 3630-2930, 1728, 1642, 16
01, 1574, 1512, 1279, 1227, 1157, 1084 cm-1; Anal.
Calcd for C32H22F6NO7Na・1.5H2O: C,55.18; H, 3.62;
N, 2.01. Found: C, 55.41; H, 3.67; N, 2.00.Example 397 Sodium succinate (1RS, 2SR) -1- (4-fluorophenyl) -2-[(5-fluoro-1-naphthoyl)
Amino] -3- (2,2,3,3-tetrafluoro-2,3
-Dihydro-1,4-benzodioxin-6-yl) propyl succinic acid (1RS, 2SR) -1- (4-fluorophenyl) -2-[(4-fluoro-1-naphthoyl) amino] -3
-(2,2,3,3-tetrafluoro-2,3-dihydro-
1,4-benzodioxin-6-yl) propyl hydrogen 14
0.25 ml (0.22 mmol) of 1N aqueous sodium hydroxide solution in 5 ml of a solution of 5 mg of tetrahydrofuran
Was added and stirred at room temperature for 5 minutes. The solvent of the reaction solution was distilled off under reduced pressure, and the obtained residue was crystallized from methanol-diethyl ether-hexane to obtain the desired product. White powder Yield 79 mg 1 H-NMR (CDCl 3 -DMSO-d 6 -CD 3 OD, 300 MHz) δ 2.54-2.76
(4H, m), 2.85 (1H, dd, J = 11.6 Hz, 14.3 Hz), 2.9
8 (1H, dd, J = 3.5 Hz, 14.3 Hz), 4.80-4.86 (1H,
m), 6.21 (1H, d, J = 4.8 Hz), 7.03-7.14 (6H, m),
7.25 (1H, dd, J = 5.4 Hz, 7.8 Hz), 7.40 (1H, dd, J
= 6.5 Hz, 8.6 Hz), 7.50-7.53 (4H, m), 8.04 (1H,
d, J = 8.7 Hz); IR (KBr) 3630-2930, 1728, 1642, 16
01, 1574, 1512, 1279, 1227, 1157, 1084 cm -1 ; Anal.
Calcd for C 32 H 22 F 6 NO 7 Na ・ 1.5H 2 O: C, 55.18; H, 3.62;
N, 2.01. Found: C, 55.41; H, 3.67; N, 2.00.
【0530】[0530]
【発明の効果】本発明の化合物(I)および化合物
(I’)は、優れたコレステリルエステル転送蛋白阻害
作用等を有するので、これらの化合物を含有する医薬製
剤は、例えば、脂質低下剤等として安全かつ有利に用い
ることができる。The compounds (I) and (I ') of the present invention have excellent cholesteryl ester transfer protein inhibitory activity and the like, and pharmaceutical preparations containing these compounds can be used, for example, as lipid-lowering agents and the like. It can be used safely and advantageously.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 31/275 A61K 31/275 4C056 31/341 31/341 4C062 31/343 31/343 4C086 31/351 31/351 4C206 31/357 31/357 4H006 31/36 31/36 31/381 31/381 31/42 31/42 31/426 31/426 31/44 31/44 31/4409 31/4409 31/47 31/47 A61P 3/06 A61P 3/06 9/04 9/04 9/10 9/10 43/00 111 43/00 111 123 123 C07C 233/19 C07C 233/19 233/21 233/21 233/22 233/22 233/60 233/60 233/63 233/63 233/73 233/73 235/48 235/48 235/66 235/66 235/82 235/82 235/84 235/84 237/48 237/48 255/57 255/57 255/60 255/60 271/16 271/16 271/22 271/22 275/28 275/28 311/17 311/17 323/40 323/40 323/60 323/60 C07D 213/40 C07D 213/40 213/61 213/61 213/64 213/64 213/65 213/65 215/50 215/50 261/12 261/12 277/28 277/28 307/52 307/52 307/54 307/54 307/79 307/79 309/38 309/38 317/46 317/46 317/68 317/68 319/20 319/20 321/10 321/10 333/24 333/24 333/54 333/54 333/68 333/68 // C07M 7:00 C07M 7:00 9:00 9:00 (72)発明者 山本 敏弘 大阪府吹田市山田西1丁目7番C−1206号 Fターム(参考) 4C022 AA05 4C023 EA11 4C033 AD10 4C037 AA01 HA30 PA01 4C055 AA01 BA01 BA02 BA03 BA13 BA28 BA42 BB04 BB07 CA01 CA02 CA42 CB04 DA01 DA08 DA28 FA03 4C056 AA01 AB01 AC01 AD01 AE03 AF05 4C062 CC41 4C086 AA01 AA02 AA03 BA02 BA03 BA06 BA07 BA08 BA13 BA15 BA16 BA17 BC29 BC67 BC82 MA01 MA04 NA14 NA15 ZA36 ZC31 ZC33 4C206 AA01 AA02 AA03 BA07 GA26 HA14 MA01 MA04 NA14 ZA36 ZC33 ZC41 4H006 AA01 AA03 AB20 AB23 BJ20 BJ30 BJ50 BM10 BM30 BM71 BM72 BM73 BN10 BP30 BP60 BR60 BR70 BT12 BV22 BV42 BV53 BV62 BV72 RA10 RA12 TA04 TB40 TB52 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) / 351 4C206 31/357 31/357 4H006 31/36 31/36 31/381 31/381 31/42 31/42 31/426 31/426 31/44 31/44 31/4409 31/4409 31/47 31 / 47 A61P 3/06 A61P 3/06 9/04 9/04 9/10 9/10 43/00 111 43/00 111 123 123 123 C07C 233/19 C07C 233/19 233/21 233/21 233/22 233 / 22 233/60 233/60 233/63 233/63 233/73 233/73 235/48 235/48 235/66 235/66 235/82 235/82 235/84 235/84 237/48 237/48 255/57 255/57 255/60 255/60 271/16 271/16 271/22 271/22 275/28 275/28 311/17 311/17 323/40 323/40 323/60 323/60 C07D 213 / 40 C07D 213/40 213/61 213/61 213/64 213/64 213/65 2 13/65 215/50 215/50 261/12 261/12 277/28 277/28 307/52 307/52 307/54 307/54 307/79 307/79 309/38 309/38 317/46 317 / 46 317/68 317/68 319/20 319/20 321/10 321/10 333/24 333/24 333/54 333/54 333/68 333/68 // C07M 7:00 C07M 7:00 9:00 9:00 (72) Inventor Toshihiro Yamamoto 1-7-7-1 Yamada Nishi, Suita-shi, Osaka F-term (reference) 4C022 AA05 4C023 EA11 4C033 AD10 4C037 AA01 HA30 PA01 4C055 AA01 BA01 BA02 BA03 BA13 BA28 BA42 BB04 BB07 CA01 CA02 CA42 CB04 DA01 DA08 DA28 FA03 4C056 AA01 AB01 AC01 AD01 AE03 AF05 4C062 CC41 4C086 AA01 AA02 AA03 BA02 BA03 BA06 BA07 BA08 BA13 BA15 BA16 BA17 BC29 BC67 BC82 MA01 MA04 NA14 NA15 ZA36 ZC31 ZA33 A03A03 A02A03 ZC33 ZC41 4H006 AA01 AA03 AB20 AB23 BJ20 BJ30 BJ50 BM10 BM30 BM71 BM72 BM73 BN10 BP30 BP60 BR60 BR70 BT12 BV22 BV42 BV53 BV62 BV72 RA10 RA12 TA04 TB40 TB52
Claims (58)
を、Ar2は置換基を有する芳香環基を、OR’’は保
護されていてもよい水酸基を、Rはアシル基を、R’は
水素原子または置換基を有していてもよい炭化水素基を
示す。〕で表される化合物またはその塩(ただし、ベン
ジル-[2(S)-ヒドロキシ-2-チアゾール-2-イル-
1(S)-(4-トリフルオロメチル-ベンジル)-エチ
ル]-カルバミン酸 tert-ブチルエステルは除
く)。(1) Formula (1) [Wherein, Ar 1 represents an aromatic ring group which may have a substituent, Ar 2 represents an aromatic ring group having a substituent, OR ″ represents a hydroxyl group which may be protected, and R represents an acyl group. And R ′ represents a hydrogen atom or a hydrocarbon group which may have a substituent. Or a salt thereof (provided that benzyl- [2 (S) -hydroxy-2-thiazol-2-yl-
1 (S)-(4-trifluoromethyl-benzyl) -ethyl] -carbamic acid tert-butyl ester).
たは6員の芳香環基である請求項1記載の化合物。2. The compound according to claim 1, wherein Ar 1 is an optionally substituted 5- or 6-membered aromatic ring group.
ニル基である請求項1記載の化合物。3. The compound according to claim 1, wherein Ar 1 is a phenyl group which may have a substituent.
芳香環基である請求項1記載の化合物。4. The compound according to claim 1, wherein Ar 2 is a 5- or 6-membered aromatic ring group having a substituent.
る請求項1記載の化合物。5. The compound according to claim 1, wherein Ar 2 is a phenyl group having a substituent.
していてもよい炭化水素基または置換基を有していても
よい複素環基を示す)で表される基である請求項1記載
の化合物。6. R is a group represented by the formula R 1N CO— (R 1N represents a hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent). A compound according to claim 1.
化水素基または置換基を有していてもよい複素環基であ
る請求項6記載の化合物。7. The compound according to claim 6, wherein R 1N is a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent.
請求項1記載の化合物。8. The compound according to claim 1, wherein R ″ is a hydrogen atom or an acyl group.
を有していてもよい炭化水素基または置換基を有してい
てもよい複素環基を示す)で表される基である請求項1
記載の化合物。9. R ″ is represented by the formula R 1O CO—, wherein R 1O represents a hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent. Claim 1 which is a group
A compound as described.
キル基である請求項8記載の化合物。10. The compound according to claim 8, wherein R 1O is an alkyl group which may have a substituent.
の化合物。11. The compound according to claim 1, wherein R ″ is a hydrogen atom.
化合物。12. The compound according to claim 1, wherein R ′ is a hydrogen atom.
有していてもよい環状炭化水素基または置換基を有して
いてもよい複素環基を示す)で表される基であり、
R’’が水素原子であり、R’が水素原子である請求項
1記載の化合物。13. A group in which R is represented by the formula R 1N CO— (R 1N represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent). And
The compound according to claim 1, wherein R ″ is a hydrogen atom and R ′ is a hydrogen atom.
れていてもよい低級アルキル基、ハロゲン化されていて
もよい低級アルコキシ基および置換基を有してもよいア
リールオキシ基から選ばれる置換基を有していてもよい
5または6員の芳香環基であり、Ar2がハロゲン原
子、ハロゲン化されていてもよい低級アルキル基および
ハロゲン化されていてもよい低級アルコキシ基から選ば
れる置換基を有する5または6員の芳香環基であり、R
がハロゲン原子、ハロゲン化されていてもよいC1-6ア
ルコキシおよびハロゲン化されていてもよいC1-6アル
キルから選ばれた置換基をそれぞれ有していてもよいC
1-6アルコキシ−カルボニル、C1-6アルキル−カルボニ
ル、C6-10アリール−カルボニル、ジヒドロナフタレン
カルボニル、テトラヒドロナフタレンカルボニル、ベン
ゾシクロヘプテンカルボニルまたはベンゾシクロオクテ
ンカルボニルであり、R’’が水素原子であり、R’が
水素原子である請求項1記載の化合物。14. Ar 1 is a substituent selected from a halogen atom, a lower alkyl group which may be halogenated, a lower alkoxy group which may be halogenated, and an aryloxy group which may have a substituent. A 5- or 6-membered aromatic ring group which may have a substituent, wherein Ar 2 is a substituent selected from a halogen atom, a lower alkyl group which may be halogenated, and a lower alkoxy group which may be halogenated. A 5- or 6-membered aromatic ring group having
May have a substituent selected from a halogen atom, an optionally halogenated C 1-6 alkoxy and an optionally halogenated C 1-6 alkyl.
1-6 alkoxy-carbonyl, C 1-6 alkyl-carbonyl, C 6-10 aryl-carbonyl, dihydronaphthalenecarbonyl, tetrahydronaphthalenecarbonyl, benzocycloheptenecarbonyl or benzocyclooctenecarbonyl, wherein R '' is a hydrogen atom The compound according to claim 1, wherein R 'is a hydrogen atom.
基、ピリジル基、チエニル基、フリル基またはチアゾリ
ル基である請求項14記載の化合物。15. The compound according to claim 14, wherein the 5- or 6-membered aromatic ring group is a phenyl group, a pyridyl group, a thienyl group, a furyl group or a thiazolyl group.
基、ピリジル基またはチエニル基であり、Rがハロゲン
原子、ハロゲン化されていてもよいC1-6アルコキシお
よびハロゲン化されていてもよいC1-6アルキルから選
ばれた置換基をそれぞれ有していてもよいナフタレンカ
ルボニル、ジヒドロナフタレンカルボニル、テトラヒド
ロナフタレンカルボニル、ベンゾシクロヘプテンカルボ
ニルまたはベンゾシクロオクテンカルボニルである請求
項14記載の化合物。16. The 5- or 6-membered aromatic ring group is a phenyl group, a pyridyl group or a thienyl group, and R is a halogen atom, an optionally halogenated C 1-6 alkoxy and an optionally halogenated group. C 1-6 good naphthalene carbonyl optionally having respective selected substituents from alkyl, dihydronaphthalene carbonyl, tetrahydronaphthalene carbonyl, benzocycloheptene carbonyl or compound of claim 14 wherein the benzocyclooctene carbonyl.
ルオロフェニル)-2-ヒドロキシ-1-[4-(トリフル
オロメチル)ベンジル]エチル]-6,7-ジヒドロ-5
H-ベンゾ[a]シクロヘプテン-1-カルボキサミド、
4-フルオロ-N-((1R,2S)-2-(4-フルオロフ
ェニル)-2-ヒドロキシ-1-((4-(トリフルオロメ
チル)フェニル)メチル)エチル)-1-ナフタレンカル
ボキサミド、N-[(1R,2S)-2-(4-フルオロフ
ェニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テ
トラフルオロエトキシ)ベンジル]エチル]-6,7-ジ
ヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキ
サミド、N-[(1RS,2SR)-2-(4-フルオロフ
ェニル)-2-ヒドロキシ-1-[3-(1,1,2,2-テ
トラフルオロエトキシ)ベンジル]エチル]-5,6-ジ
ヒドロナフタレン-1-カルボキサミド、N-[(1R
S,2SR)-2-(4-フルオロフェニル)-2-ヒドロ
キシ-1-[3-(1,1,2,2-テトラフルオロエトキ
シ)ベンジル]エチル]-6,7,8,9-テトラヒドロ
-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミ
ド、4-フルオロ-N-[(1R,2S)-2-(4-フルオ
ロフェニル)-2-ヒドロキシ-1-[3-(1,1,2,
2-テトラフルオロエトキシ)ベンジル]エチル]ナフ
タレン-1-カルボキサミド、N-[(1RS,2SR)-
2-(4-フルオロフェニル)-2-ヒドロキシ-1-[3-
(1,1,2,2-テトラフルオロエトキシ)ベンジ
ル]エチル]-5,6,7,8-テトラヒドロベンゾ
[a]シクロオクテン-1-カルボキサミド、N-[(1
RS,2SR)-2-(4-フルオロフェニル)-2-ヒド
ロキシ-1-(4-イソプロピルベンジル)エチル]-6,
7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1-カ
ルボキサミド、N-((1RS,2SR)-2-(3-フル
オロフェニル)-2-ヒドロキシ-1-((4-(トリフル
オロメチル)フェニル)メチル)エチル)-6,7-ジヒ
ドロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサ
ミド、N-((1RS,2SR)-2-ヒドロキシ-2-
(4-フェノキシフェニル)-1-((4-(トリフルオロ
メチル)フェニル)メチル)エチル)-6,7-ジヒドロ
-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミ
ド、N-[(1RS,2SR)-2-(4-クロロフェニ
ル)-2-ヒドロキシ-1-[3-(1,1,2,2-テトラ
フルオロエトキシ)ベンジル]エチル]-6,7-ジヒド
ロ-5H-ベンゾ[a]シクロヘプテン-1-カルボキサミ
ド、N-((1RS,2SR)-2-ヒドロキシ-2-(4-
(フェニルオキシ)フェニル)-1-((3-((1,
1,2,2-テトラフルオロエチル)オキシ)フェニ
ル)メチル)エチル)-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド、N-((1
RS,2SR)-2-(4-((4-クロロ-3-エチルフェ
ニル)オキシ)フェニル)-2-ヒドロキシ-1-((3-
((1,1,2,2-テトラフルオロエチル)オキシ)
フェニル)メチル)エチル)-6,7-ジヒドロ-5H-ベ
ンゾ[a]シクロヘプテン-1-カルボキサミド、N-
((1RS,2SR)-2-(2-フルオロピリジン-4-
イル)-2-ヒドロキシ-1-((3-(1,1,2,2-テ
トラフルオロエトキシ)フェニル)メチル)エチル)-
6,7-ジヒドロ-5H-ベンゾ[a]シクロヘプテン-1
-カルボキサミド、N-((1RS,2RS)-2-(6-
フルオロピリジン-2-イル)-2-ヒドロキシ-1-((3
-(1,1,2,2-テトラフルオロエトキシ)フェニ
ル)メチル)エチル)-6,7-ジヒドロ-5H-ベンゾ
[a]シクロヘプテン-1-カルボキサミド、N−[(1
RS,2SR)−1−(4−tert−ブチルベンジ
ル)−2−(3−クロロフェニル)−2−ヒドロキシエ
チル]−5−クロロ−1−ナフトアミド、4−フルオロ
−N−{(1RS,2SR)−2−(4−フルオロフェ
ニル)−2−ヒドロキシ−1−[(2,2,3,3−テ
トラフルオロ−2,3−ジヒドロ−1,4−ベンゾジオ
キシン−6−イル)メチル]エチル}−1−ナフトアミ
ドまたはその塩である請求項1記載の化合物。17. N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [4- (trifluoromethyl) benzyl] ethyl] -6,7-dihydro-5
H-benzo [a] cycloheptene-1-carboxamide,
4-fluoro-N-((1R, 2S) -2- (4-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -1-naphthalenecarboxamide, N -[(1R, 2S) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7-dihydro- 5H-benzo [a] cycloheptene-1-carboxamide, N-[(1RS, 2SR) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoro Ethoxy) benzyl] ethyl] -5,6-dihydronaphthalene-1-carboxamide, N-[(1R
S, 2SR) -2- (4-Fluorophenyl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -6,7,8,9-tetrahydro
-5H-benzo [a] cycloheptene-1-carboxamide, 4-fluoro-N-[(1R, 2S) -2- (4-fluorophenyl) -2-hydroxy-1- [3- (1,1,2 ,
2-tetrafluoroethoxy) benzyl] ethyl] naphthalene-1-carboxamide, N-[(1RS, 2SR)-
2- (4-fluorophenyl) -2-hydroxy-1- [3-
(1,1,2,2-tetrafluoroethoxy) benzyl] ethyl] -5,6,7,8-tetrahydrobenzo [a] cyclooctene-1-carboxamide, N-[(1
RS, 2SR) -2- (4-Fluorophenyl) -2-hydroxy-1- (4-isopropylbenzyl) ethyl] -6
7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-((1RS, 2SR) -2- (3-fluorophenyl) -2-hydroxy-1-((4- (trifluoromethyl) phenyl ) Methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-((1RS, 2SR) -2-hydroxy-2-
(4-phenoxyphenyl) -1-((4- (trifluoromethyl) phenyl) methyl) ethyl) -6,7-dihydro
-5H-benzo [a] cycloheptene-1-carboxamide, N-[(1RS, 2SR) -2- (4-chlorophenyl) -2-hydroxy-1- [3- (1,1,2,2-tetrafluoro) Ethoxy) benzyl] ethyl] -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-((1RS, 2SR) -2-hydroxy-2- (4-
(Phenyloxy) phenyl) -1-((3-((1,
1,2,2-tetrafluoroethyl) oxy) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-((1
RS, 2SR) -2- (4-((4-chloro-3-ethylphenyl) oxy) phenyl) -2-hydroxy-1-((3-
((1,1,2,2-tetrafluoroethyl) oxy)
Phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-
((1RS, 2SR) -2- (2-fluoropyridine-4-
Yl) -2-hydroxy-1-((3- (1,1,2,2-tetrafluoroethoxy) phenyl) methyl) ethyl)-
6,7-dihydro-5H-benzo [a] cycloheptene-1
-Carboxamide, N-((1RS, 2RS) -2- (6-
Fluoropyridin-2-yl) -2-hydroxy-1-((3
-(1,1,2,2-tetrafluoroethoxy) phenyl) methyl) ethyl) -6,7-dihydro-5H-benzo [a] cycloheptene-1-carboxamide, N-[(1
RS, 2SR) -1- (4-tert-butylbenzyl) -2- (3-chlorophenyl) -2-hydroxyethyl] -5-chloro-1-naphthamide, 4-fluoro-N-{(1RS, 2SR) -2- (4-Fluorophenyl) -2-hydroxy-1-[(2,2,3,3-tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-yl) methyl] ethyl} The compound according to claim 1, which is -1-naphthamide or a salt thereof.
を、Ar2は置換基を有する芳香環基を、OR’’は保
護されていてもよい水酸基を、Rはアシル基を、R’は
水素原子または置換基を有していてもよい炭化水素基を
示す。〕で表される化合物またはその塩のプロドラッグ
(ただし、ベンジル-[2(S)-ヒドロキシ-2-チアゾ
ール-2-イル-1(S)-(4-トリフルオロメチル-ベン
ジル)-エチル]-カルバミン酸 tert-ブチルエス
テルは除く)。18. The formula: [Wherein, Ar 1 represents an aromatic ring group which may have a substituent, Ar 2 represents an aromatic ring group having a substituent, OR ″ represents a hydroxyl group which may be protected, and R represents an acyl group. And R ′ represents a hydrogen atom or a hydrocarbon group which may have a substituent. (Provided that benzyl- [2 (S) -hydroxy-2-thiazol-2-yl-1 (S)-(4-trifluoromethyl-benzyl) -ethyl] is used). -Excluding carbamic acid tert-butyl ester).
を、Ar2は置換基を有する芳香環基を、OR’’は保
護されていてもよい水酸基を、Rはアシル基を、R’は
水素原子または置換基を有していてもよい炭化水素基を
示す。〕で表される化合物またはその塩、またはそのプ
ロドラッグを含有してなる医薬組成物。19. A compound of the formula [Wherein, Ar 1 represents an aromatic ring group which may have a substituent, Ar 2 represents an aromatic ring group having a substituent, OR ″ represents a hydroxyl group which may be protected, and R represents an acyl group. And R ′ represents a hydrogen atom or a hydrocarbon group which may have a substituent. Or a salt thereof, or a prodrug thereof.
である請求項19記載の組成物。20. The composition according to claim 19, which is a cholesteryl ester transfer protein inhibitor.
剤である請求項19記載の組成物。21. The composition according to claim 19, which is a high-density lipoprotein-cholesterol increasing agent.
剤である請求項19記載の組成物。22. The composition according to claim 19, which is a low-density lipoprotein-cholesterol lowering agent.
下剤である請求項19記載の組成物。23. The composition according to claim 19, which is an extremely low density lipoprotein-cholesterol lowering agent.
9記載の組成物。24. The method according to claim 1, which is a triglyceride lowering agent.
9. The composition according to 9.
請求項19記載の組成物。(25) The composition according to the above (19), which is an agent for preventing or treating acute coronary syndrome.
項19記載の組成物。26. The composition according to claim 19, which is an agent for preventing or treating acute myocardial infarction.
項19記載の組成物。27. The composition according to claim 19, which is a preventive or therapeutic agent for unstable angina.
窄の予防治療剤である請求項19記載の組成物。28. The composition according to claim 19, which is an agent for preventing or treating arterial restenosis after PTCA or stent implantation.
求項19記載の組成物。(29) The composition according to the above (19), which is an agent for preventing or treating peripheral arterial occlusion.
9記載の組成物。30. The method according to claim 1, which is a preventive or therapeutic agent for hyperlipidemia.
9. The composition according to 9.
記載の組成物。(31) the agent for preventing or treating cerebral infarction;
A composition as described.
記載の組成物。32. The method according to claim 19, which is an agent for preventing or treating stroke.
A composition as described.
19記載の組成物。33. The composition according to claim 19, which is an agent for inhibiting the progression of atherosclerotic lesions.
を、Ar2'は置換基を有していてもよい芳香環基を、O
R’’は保護されていてもよい水酸基を、Rはアシル基
を、R’は水素原子または置換基を有していてもよい炭
化水素基を示す。〕で表される化合物またはその塩、ま
たはそのプロドラッグを含有してなるコレステリルエス
テル転送蛋白阻害剤。34. The formula [Wherein, Ar 1 represents an aromatic ring group which may have a substituent, Ar 2 ′ represents an aromatic ring group which may have a substituent;
R ″ represents a hydroxyl group which may be protected, R represents an acyl group, and R ′ represents a hydrogen atom or a hydrocarbon group which may have a substituent. A cholesteryl ester transfer protein inhibitor comprising the compound represented by the formula: or a salt thereof, or a prodrug thereof.
4記載の剤。35. The method according to claim 3, which is an agent for preventing or treating hyperlipidemia.
4. The agent according to 4.
請求項34記載の剤。36. The agent according to claim 34, which is a preventive or therapeutic agent for acute coronary syndrome.
項34記載の剤。37. The agent according to claim 34, which is a preventive or therapeutic agent for acute myocardial infarction.
項34記載の剤。38. The agent according to claim 34, which is a preventive or therapeutic agent for unstable angina.
狭窄の予防治療剤である請求項34記載の剤。39. The agent according to claim 34, which is a preventive or therapeutic agent for arterial restenosis after PTCA or stent implantation.
求項34記載の剤。(40) the agent of the above (34), which is a prophylactic or therapeutic agent for peripheral arterial occlusion;
記載の剤。41. The agent according to claim 34, which is a prophylactic or therapeutic agent for cerebral infarction.
Agents as described.
記載の剤。42. The preventive and therapeutic agent for stroke.
Agents as described.
34記載の剤。43. The agent according to claim 34, which is an agent for inhibiting the progression of atherosclerotic lesions.
有効量を哺乳動物に投与することを特徴とする哺乳動物
におけるコレステリルエステル転送蛋白の阻害方法。44. A method for inhibiting cholesteryl ester transfer protein in a mammal, which comprises administering an effective amount of the compound according to claim 1 or a salt thereof to the mammal.
有効量を哺乳動物に投与することを特徴とする哺乳動物
における高脂血症の予防または治療方法。45. A method for preventing or treating hyperlipidemia in a mammal, which comprises administering an effective amount of the compound according to claim 1 or a salt thereof to the mammal.
ための医薬の製造のための請求項1記載の化合物または
その塩の使用。46. Use of the compound according to claim 1 or a salt thereof for the manufacture of a medicament for inhibiting cholesteryl ester transfer protein.
製造のための請求項1記載の化合物またはその塩の使
用。47. Use of the compound according to claim 1 or a salt thereof for the manufacture of a medicament for preventing or treating hyperlipidemia.
有効量を哺乳動物に投与することを特徴とする哺乳動物
における急性冠動脈症候群の予防または治療方法。48. A method for preventing or treating acute coronary syndrome in a mammal, which comprises administering an effective amount of the compound according to claim 1 or a salt thereof to the mammal.
有効量を哺乳動物に投与することを特徴とする哺乳動物
における急性心筋梗塞の予防または治療方法。49. A method for preventing or treating acute myocardial infarction in a mammal, which comprises administering an effective amount of the compound of claim 1 or a salt thereof to the mammal.
有効量を哺乳動物に投与することを特徴とする哺乳動物
における不安定狭心症の予防または治療方法。50. A method for preventing or treating unstable angina in a mammal, which comprises administering an effective amount of the compound according to claim 1 or a salt thereof to the mammal.
有効量を哺乳動物に投与することを特徴とする哺乳動物
におけるPTCAあるいはステント留置後の冠動脈再狭窄の
予防または治療方法。51. A method for preventing or treating coronary restenosis after PTCA or stent implantation in a mammal, which comprises administering an effective amount of the compound according to claim 1 or a salt thereof to the mammal.
有効量を哺乳動物に投与することを特徴とする哺乳動物
における末梢動脈閉塞症の予防または治療方法。52. A method for preventing or treating peripheral arterial occlusion in a mammal, which comprises administering an effective amount of the compound according to claim 1 or a salt thereof to the mammal.
有効量を哺乳動物に投与することを特徴とする哺乳動物
における脳梗塞の予防または治療方法。53. A method for preventing or treating cerebral infarction in a mammal, which comprises administering an effective amount of the compound according to claim 1 or a salt thereof to the mammal.
有効量を哺乳動物に投与することを特徴とする哺乳動物
における脳卒中の予防または治療方法。54. A method for preventing or treating stroke in a mammal, which comprises administering an effective amount of the compound according to claim 1 or a salt thereof to the mammal.
有効量を哺乳動物に投与することを特徴とする哺乳動物
における動脈硬化巣の進展抑制方法。55. A method for inhibiting the progression of atherosclerotic lesions in a mammal, which comprises administering an effective amount of the compound according to claim 1 or a salt thereof to the mammal.
る化合物またはその塩、またはそのプロドラッグの有効
量を哺乳動物に投与することを特徴とする哺乳動物にお
けるコレステリルエステル転送蛋白の阻害方法。56. A cholesteryl ester transfer protein in a mammal, which comprises administering an effective amount of the compound represented by the formula (I ′) according to claim 34, a salt thereof, or a prodrug thereof to the mammal. Inhibition method.
ための医薬の製造のため請求項34記載の式(I’)で
表される化合物またはその塩、またはそのプロドラッグ
の使用。57. Use of the compound represented by the formula (I ') according to claim 34, a salt thereof, or a prodrug thereof for the manufacture of a medicament for inhibiting cholesteryl ester transfer protein.
合物またはその塩をアシル化反応に付し、式 【化6】 [式中の記号は、請求項1記載と同意義]で表される化
合物またはその塩を得、所望により、水酸基の保護反応
に付すことを特徴とする請求項1記載またはその塩の製
造法。58. The formula A compound represented by the formula [wherein the symbols are as defined in claim 1] or a salt thereof is subjected to an acylation reaction to obtain a compound represented by the formula: The method for producing a compound according to claim 1 or a salt thereof, wherein a compound represented by the formula [Symbols are as defined in claim 1] or a salt thereof is obtained, and if necessary, the compound is subjected to a hydroxyl group protection reaction. .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002017487A JP2002293764A (en) | 2001-01-26 | 2002-01-25 | Aminoethanol derivative |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001019280 | 2001-01-26 | ||
| JP2001-19280 | 2001-01-26 | ||
| JP2002017487A JP2002293764A (en) | 2001-01-26 | 2002-01-25 | Aminoethanol derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2002293764A true JP2002293764A (en) | 2002-10-09 |
Family
ID=26608390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002017487A Pending JP2002293764A (en) | 2001-01-26 | 2002-01-25 | Aminoethanol derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2002293764A (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005005648A1 (en) * | 2003-07-11 | 2005-01-20 | Mitsubishi Pharma Corporation | Novel process for producing optically active carboxylic acid |
| WO2005058790A1 (en) * | 2003-12-19 | 2005-06-30 | Ono Pharmaceutical Co., Ltd. | Compounds having lysophosphatidic acid receptor antagonism and uses thereof |
| WO2006098394A1 (en) * | 2005-03-14 | 2006-09-21 | Japan Tobacco Inc. | Method for inhibiting lipid absorption and lipid absorption inhibitor |
| JP2009522291A (en) * | 2005-12-30 | 2009-06-11 | メルク エンド カムパニー インコーポレーテッド | CETP inhibitor |
| US7820682B2 (en) | 2002-10-03 | 2010-10-26 | Ono Pharmaceutical Co., Ltd. | LPA receptor antagonist |
| EP2316447A1 (en) | 2003-09-26 | 2011-05-04 | Japan Tobacco, Inc. | Method of inhibiting remnant lipoprotein production |
| JP2011207871A (en) * | 2010-03-11 | 2011-10-20 | Agc Seimi Chemical Co Ltd | Liquid crystal compound, method for producing the same, liquid crystal composition and liquid crystal electrooptical element |
| JP2016538316A (en) * | 2013-08-21 | 2016-12-08 | アリオス バイオファーマ インク. | Antiviral compounds |
| JP2018507887A (en) * | 2015-03-11 | 2018-03-22 | ビオマリン プハルマセウトイカル インコーポレイテッド | Glucosylceramide synthase inhibitors for the treatment of disease |
| JP2018115169A (en) * | 2007-02-09 | 2018-07-26 | リガンド・ファーマシューティカルズ・インコーポレイテッド | Novel antagonist of glucagon receptor |
| US11014935B2 (en) | 2012-08-23 | 2021-05-25 | Janssen Biopharma, Inc. | Compounds for the treatment of paramyxovirus viral infections |
| JP2023539113A (en) * | 2020-08-18 | 2023-09-13 | サイビン アイアールエル リミテッド | Phenethylamine derivatives, compositions and methods of use thereof |
-
2002
- 2002-01-25 JP JP2002017487A patent/JP2002293764A/en active Pending
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7820682B2 (en) | 2002-10-03 | 2010-10-26 | Ono Pharmaceutical Co., Ltd. | LPA receptor antagonist |
| US8124645B2 (en) | 2002-10-03 | 2012-02-28 | Ono Pharmaceutical Co., Ltd. | LPA receptor antagonist |
| JPWO2005005648A1 (en) * | 2003-07-11 | 2007-09-20 | 三菱ウェルファーマ株式会社 | Process for producing novel optically active carboxylic acids |
| WO2005005648A1 (en) * | 2003-07-11 | 2005-01-20 | Mitsubishi Pharma Corporation | Novel process for producing optically active carboxylic acid |
| EP2316447A1 (en) | 2003-09-26 | 2011-05-04 | Japan Tobacco, Inc. | Method of inhibiting remnant lipoprotein production |
| EP2319509A1 (en) | 2003-09-26 | 2011-05-11 | Japan Tobacco, Inc. | Method of Inhibiting remnant lipoprotein production |
| WO2005058790A1 (en) * | 2003-12-19 | 2005-06-30 | Ono Pharmaceutical Co., Ltd. | Compounds having lysophosphatidic acid receptor antagonism and uses thereof |
| US7875745B2 (en) | 2003-12-19 | 2011-01-25 | Ono Pharmaceutical Co., Ltd. | Compounds having lysophosphatidic acid receptor antagonism and uses thereof |
| JP4766384B2 (en) * | 2003-12-19 | 2011-09-07 | 小野薬品工業株式会社 | Compound having lysophosphatidic acid receptor antagonistic activity and use thereof |
| JPWO2005058790A1 (en) * | 2003-12-19 | 2007-07-12 | 小野薬品工業株式会社 | Compound having lysophosphatidic acid receptor antagonistic activity and use thereof |
| WO2006098394A1 (en) * | 2005-03-14 | 2006-09-21 | Japan Tobacco Inc. | Method for inhibiting lipid absorption and lipid absorption inhibitor |
| JP2009522291A (en) * | 2005-12-30 | 2009-06-11 | メルク エンド カムパニー インコーポレーテッド | CETP inhibitor |
| JP2018115169A (en) * | 2007-02-09 | 2018-07-26 | リガンド・ファーマシューティカルズ・インコーポレイテッド | Novel antagonist of glucagon receptor |
| JP2011207871A (en) * | 2010-03-11 | 2011-10-20 | Agc Seimi Chemical Co Ltd | Liquid crystal compound, method for producing the same, liquid crystal composition and liquid crystal electrooptical element |
| US11014935B2 (en) | 2012-08-23 | 2021-05-25 | Janssen Biopharma, Inc. | Compounds for the treatment of paramyxovirus viral infections |
| JP2016538316A (en) * | 2013-08-21 | 2016-12-08 | アリオス バイオファーマ インク. | Antiviral compounds |
| US11021444B2 (en) | 2013-08-21 | 2021-06-01 | Janssen Biopharma, Inc. | Antiviral compounds |
| JP2018507887A (en) * | 2015-03-11 | 2018-03-22 | ビオマリン プハルマセウトイカル インコーポレイテッド | Glucosylceramide synthase inhibitors for the treatment of disease |
| JP2023539113A (en) * | 2020-08-18 | 2023-09-13 | サイビン アイアールエル リミテッド | Phenethylamine derivatives, compositions and methods of use thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6982348B2 (en) | Aminoethanol derivatives | |
| US7553867B2 (en) | Furan or thiophene derivative and medicinal use thereof | |
| CN1048015C (en) | Bicyclic Tetrahydropyrazolopyridines | |
| AU781141B2 (en) | Novel use of phenylheteroalkylamine derivatives | |
| CN114945566A (en) | Substituted tetrahydrofurans as sodium channel modulators | |
| AU633767B2 (en) | Thiophene carboxylic acid intermediates | |
| JP6251259B2 (en) | Novel 5-aminotetrahydroquinoline-2-carboxylic acid and use thereof | |
| KR102430906B1 (en) | PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| OA12444A (en) | Acylated indanylamines and their use as pharmaceuticals | |
| WO2007106469A2 (en) | Bicyclic carboxylic acid derivatives useful for treating metabolic disorders | |
| TW202012408A (en) | Substituted dihydropyrazolo pyrazine carboxamide derivatives | |
| JP2002293764A (en) | Aminoethanol derivative | |
| SK2242004A3 (en) | Quinoline compound | |
| CA2549385A1 (en) | Triazole, oxadiazole and thiadiazole derivative as ppar modulators for the treatment of diabetes | |
| JPWO2008007780A1 (en) | Pentadienamide derivatives | |
| EA012704B1 (en) | Novel pharmaceutical compounds | |
| IL259199A (en) | Ion channel inhibitory compounds, pharmaceutical formulations and uses | |
| JPWO2005063222A1 (en) | Hsp90 family protein inhibitors | |
| EP3204361A1 (en) | Substituted benzothiophenyl derivatives as gpr40 agonists for the treatment of type ii diabetes | |
| JP2005511516A (en) | Selective RXR ligand | |
| WO2017180457A1 (en) | Gpr40 agonists in anti-diabetic drug combinations | |
| JP2005514455A (en) | Aromatic thioether liver X receptor modulator | |
| JPH0819069B2 (en) | Acetylene derivative having lipoxygenase inhibitory activity | |
| JP2976003B2 (en) | 4-position substituted isoquinolone derivative | |
| KR20050106421A (en) | Carboxylic acid compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041215 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071113 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080115 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080226 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080722 |